PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Wang, H; Semenova, S; Kuusela, S; Panula, P; Lehtonen, S				Wang, Hong; Semenova, Svetlana; Kuusela, Sara; Panula, Pertti; Lehtonen, Sanna			Tankyrases regulate glucoregulatory mechanisms and somatic growth via the central melanocortin system in zebrafish larvae	FASEB JOURNAL			English	Article						pro-opiomelanocortin; melanocortin receptor; morpholino antisense oligonucleotides; XAV939; PARylation	TELOMERE LENGTH; FOOD-INTAKE; OBESITY; RECEPTOR; ENERGY; MICE; PROOPIOMELANOCORTIN; EXPRESSION; NEURONS; INSULIN	The central melanocortin system is a key regulator of energy homeostasis. Recent studies indicate that tankyrases (TNKSs), which poly(ADP-ribosyl) ate target proteins and direct them toward proteasomal degradation, affect overall metabolism, but the exact molecular mechanisms remain unclear. We used zebrafish larvae as a model to study the mechanisms by which TNKS1b, the zebrafish ortholog of mammalian TNKS1, regulates glucose homeostasis and somatic growth. In situ hybridization revealed that TNKS1b mRNA is prominently expressed in the hypothalamus and pituitary of the embryonic and larval brain. In the pituitary, TNKS1b is coexpressed with proopiomelanocortin a (pomca) gene in corticotropes and melanotropes. Knockdown of TNKS1b reduced the linear growth of the larvae, stimulated insulin gene and glucose transporter 4 protein, and suppressed gluconeogenic phosphoenolpyruvate carboxykinase 1 gene. This result indicates rapid glucose utilization and reduction of gluconeogenesis in TNKS1b-deficient larvae. Knockdown of TNKS1b down-regulated pomca expression and diminished alpha-melanocyte-stimulating hormone in the pars intermedia. Furthermore, down-regulation of TNKS1b suppressed the expression of melanocortin receptor 3 and increased the expression of melanocortin receptor 4. The collective data suggest that TNKS1b modulates glucoregulatorymechanisms and the somatic growth of zebrafish larvae via the central melanocortin system.	[Wang, Hong; Kuusela, Sara; Lehtonen, Sanna] Univ Helsinki, Dept Pathol, FIN-00290 Helsinki, Finland; [Semenova, Svetlana; Panula, Pertti] Univ Helsinki, Inst Biomed, Anat & Neurosci Ctr, FIN-00290 Helsinki, Finland	University of Helsinki; University of Helsinki	Lehtonen, S (corresponding author), Univ Helsinki, Dept Pathol, Haartmaninkatu 3,B241, FIN-00290 Helsinki, Finland.	sanna.h.lehtonen@helsinki.fi	Wang, Hong/AAW-6913-2020; Lehtonen, Sanna/AAE-4545-2020; Lehtonen, Sanna/GRJ-3642-2022	Wang, Hong/0000-0001-5700-6786; Lehtonen, Sanna/0000-0003-4189-2415; Panula, Pertti/0000-0002-1189-5132; Kuusela, Sara/0000-0002-2790-5841	European Research Council [242820]; Academy of Finland [131255, 218021, 277485]; Sigrid Juselius Foundation; Paivikki and Sakari Sohlberg Foundation	European Research Council(European Research Council (ERC)European Commission); Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Paivikki and Sakari Sohlberg Foundation	The authors thank N. Ruoho, A. Wilenius (both from the Department of Pathology, University of Helsinki, Helsinki, Finland), and H. Koivula (Institute of Biomedicine/Anatomy and Neuroscience Center, University of Helsinki) for expert technical assistance; Y. Chen for kindly providing dissected brains and M. Sundvik for assistance with the locomotion assays (both from Institute of Biomedicine/Anatomy and Neuroscience Centre, University of Helsinki); and Dr. R. Cone (Vanderbilt University School of Medicine, Nashville, TN, USA) for kindly providing the pomca construct. This work was supported by the European Research Council (Grant 242820); the Academy of Finland (Grants 131255, 218021, and 277485); the Sigrid Juselius Foundation; and the Paivikki and Sakari Sohlberg Foundation (all to S.L.). H.W designed the experiments. H.W., S.S., and S.K. performed the experiments and analyzed the data. H.W. wrote the manuscript. H.W., S.S., P.P., and S.L. edited the manuscript. The authors declare no conflicts of interest.	Angotzi AR, 2011, GEN COMP ENDOCR, V171, P332, DOI 10.1016/j.ygcen.2011.02.026; Brend Tim, 2009, J Vis Exp, DOI 10.3791/1229; Butler AA, 2000, ENDOCRINOLOGY, V141, P3518, DOI 10.1210/en.141.9.3518; Cai F, 2007, J ENDOCRINOL, V192, P605, DOI 10.1677/JOE-06-0080; Castro MG, 1997, CRIT REV NEUROBIOL, V11, P35; Chiang YJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002639; Chiang YJ, 2006, MOL CELL BIOL, V26, P2037, DOI 10.1128/MCB.26.6.2037-2043.2006; Cho-Park PF, 2013, CELL, V153, P614, DOI 10.1016/j.cell.2013.03.040; Cone RD, 2005, NAT NEUROSCI, V8, P571, DOI 10.1038/nn1455; Cone RD, 2006, ENDOCR REV, V27, P736, DOI 10.1210/er.2006-0034; Dickmeis T, 2007, PLOS BIOL, V5, P854, DOI 10.1371/journal.pbio.0050078; Dunn JS, 2006, ANN HUM GENET, V70, P587, DOI 10.1111/j.1469-1809.2005.00248.x; Elo B, 2007, J MOL ENDOCRINOL, V38, P433, DOI 10.1677/JME-06-0037; Farooqi IS, 2003, NEW ENGL J MED, V348, P1085, DOI 10.1056/NEJMoa022050; Forlano PM, 2007, J COMP NEUROL, V505, P235, DOI 10.1002/cne.21447; Graham M, 1997, NAT GENET, V17, P273, DOI 10.1038/ng1197-273; Guo HL, 2012, CELL RES, V22, P1246, DOI 10.1038/cr.2012.52; Gut P, 2013, NAT CHEM BIOL, V9, P97, DOI [10.1038/NCHEMBIO.1136, 10.1038/nchembio.1136]; Herzog W, 2003, DEV BIOL, V254, P36, DOI 10.1016/S0012-1606(02)00124-0; Hsiao SJ, 2006, MOL CELL BIOL, V26, P2044, DOI 10.1128/MCB.26.6.2044-2054.2006; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; Jurczyk A, 2011, GEN COMP ENDOCR, V170, P334, DOI 10.1016/j.ygcen.2010.10.010; Krude H, 1998, NAT GENET, V19, P155, DOI 10.1038/509; Lee M, 2008, PEPTIDES, V29, P440, DOI 10.1016/j.peptides.2007.11.005; Liu NA, 2008, DEV BIOL, V319, P192, DOI 10.1016/j.ydbio.2008.03.039; Lohr H, 2011, ANNU REV PHYSIOL, V73, P183, DOI 10.1146/annurev-physiol-012110-142320; Marks DL, 2006, PEPTIDES, V27, P259, DOI 10.1016/j.peptides.2005.01.025; Marks DL, 2003, ENDOCRINOLOGY, V144, P1513, DOI 10.1210/en.2002-221099; Martinelli CE, 2011, J CLIN ENDOCR METAB, V96, pE181, DOI 10.1210/jc.2010-1369; Peitsaro N, 2007, BIOCHEM PHARMACOL, V73, P1205, DOI 10.1016/j.bcp.2007.01.014; Pezzolesi MG, 2004, DIABETES, V53, P486, DOI 10.2337/diabetes.53.2.486; Renquist BJ, 2013, ZEBRAFISH, V10, P343, DOI 10.1089/zeb.2012.0841; Rossi J, 2011, CELL METAB, V13, P195, DOI 10.1016/j.cmet.2011.01.010; Scherag A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000916; Sebag JA, 2013, SCIENCE, V341, P278, DOI 10.1126/science.1232995; Seth A, 2013, DIS MODEL MECH, V6, P1080, DOI 10.1242/dmm.011346; Sohn JW, 2012, MOL NEUROBIOL, V45, P225, DOI 10.1007/s12035-012-8240-6; Song Y, 2003, ENDOCRINE, V22, P257, DOI 10.1385/ENDO:22:3:257; Song Y, 2007, FASEB J, V21, P2042, DOI 10.1096/fj.06-7503com; Tao YX, 2010, METHOD ENZYMOL, V484, P267, DOI [10.1016/S0076-6879(10)84014-5, 10.1016/B978-0-12-381298-8.00014-9]; Vaisse C, 1998, NAT GENET, V20, P113, DOI 10.1038/2407; Wang H, 2012, DIFFERENTIATION, V83, P38, DOI 10.1016/j.diff.2011.08.007; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Williams KW, 2011, EUR J PHARMACOL, V660, P2, DOI 10.1016/j.ejphar.2010.11.042; Xu Y, 2011, ANN NY ACAD SCI, V1243, P1, DOI 10.1111/j.1749-6632.2011.06248.x; Yeh TYJ, 2007, BIOCHEM J, V402, P279, DOI 10.1042/BJ20060793; Yeh TYJ, 2009, DIABETES, V58, P2476, DOI 10.2337/db08-1781; Zhang C, 2012, CELL METAB, V15, P256, DOI 10.1016/j.cmet.2011.12.014	49	3	4	2	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2015	29	11					4435	4448		10.1096/fj.15-271817	http://dx.doi.org/10.1096/fj.15-271817			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CV8EZ	26169937				2022-12-26	WOS:000364514700005
J	Meyer, NH; Mayerhofer, H; Tripsianes, K; Blindow, S; Barths, D; Mewes, A; Weimar, T; Kohli, T; Bade, S; Madl, T; Frey, A; Haas, H; Mueller-Dieckmann, J; Sattler, M; Schramm, G				Meyer, N. Helge; Mayerhofer, Hubert; Tripsianes, Konstantinos; Blindow, Silke; Barths, Daniela; Mewes, Astrid; Weimar, Thomas; Koehli, Thies; Bade, Steffen; Madl, Tobias; Frey, Andreas; Haas, Helmut; Mueller-Dieckmann, Jochen; Sattler, Michael; Schramm, Gabriele			A Crystallin Fold in the Interleukin-4-inducing Principle of Schistosoma mansoni Eggs (IPSE/alpha-1) Mediates IgE Binding for Antigen-independent Basophil Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN STRUCTURES; IL-4 PRODUCTION; CUTTING EDGE; IN-VIVO; RECEPTOR; NMR; CELLS; PURIFICATION; GLYCOPROTEIN; AGGREGATION	The IL-4-inducing principle from Schistosoma mansoni eggs (IPSE/alpha-1), the major secretory product of eggs from the parasitic worm S. mansoni, efficiently triggers basophils to release the immunomodulatory key cytokine interleukin-4. Activation by IPSE/alpha-1 requires the presence of IgE on the basophils, but the detailed molecular mechanism underlying activation is unknown. NMR and crystallographic analysis of IPSE Delta NLS, a monomeric IPSE/alpha-1 mutant, revealed that IPSE/alpha-1 is a new member of the beta gamma-crystallin superfamily. We demonstrate that this molecule is a general immunoglobulin-binding factor with highest affinity for IgE. NMR binding studies of IPSE Delta NLS with the 180-kDa molecule IgE identified a large positively charged binding surface that includes a flexible loop, which is unique to the IPSE/alpha-1 crystallin fold. Mutational analysis of amino acids in the binding interface showed that residues contributing to IgE binding are important for IgE-dependent activation of basophils. As IPSE/alpha-1 is unable to cross-link IgE, we propose that this molecule, by taking advantage of its unique IgE-binding crystallin fold, activates basophils by a novel, cross-linking-independent mechanism.	[Meyer, N. Helge; Tripsianes, Konstantinos; Madl, Tobias; Sattler, Michael] Helmholtz Zentrum Munchen, Inst Biol Struct, D-85764 Neuherberg, Germany; [Meyer, N. Helge; Tripsianes, Konstantinos; Madl, Tobias; Sattler, Michael] Tech Univ Munich, Dept Chem, Munich Ctr Integrated Prot Sci & Biomol NMR, D-85747 Garching, Germany; [Mayerhofer, Hubert; Mueller-Dieckmann, Jochen] DESY, EMBL Hamburg Outstn, D-22603 Hamburg, Germany; [Blindow, Silke; Barths, Daniela; Mewes, Astrid; Haas, Helmut; Schramm, Gabriele] Res Ctr Borstel, Cellular Allergol, D-23845 Borstel, Germany; [Bade, Steffen; Frey, Andreas] Res Ctr Borstel, Mucosal Immunol & Diagnost Sect, D-23845 Borstel, Germany; [Weimar, Thomas; Koehli, Thies] Univ Lubeck, Inst Chem, D-23562 Lubeck, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; European Molecular Biology Laboratory (EMBL); Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); Forschungszentrum Borstel; Forschungszentrum Borstel; University of Lubeck	Mueller-Dieckmann, J (corresponding author), DESY, EMBL Hamburg Outstn, D-22603 Hamburg, Germany.	jochen.mueller-dieckmann@uni-hamburg.de; Sattler@helmholtz-muenchen.de; gschramm@fz-borstel.de	Madl, Tobias/B-1682-2012; Sattler, Michael/A-2407-2012; Tripsianes, Konstantinos/I-8382-2014	Madl, Tobias/0000-0002-9725-5231; Sattler, Michael/0000-0002-1594-0527; Tripsianes, Konstantinos/0000-0003-0948-813X; Meyer, Niels Helge/0000-0003-1018-4942; Mayerhofer, Hubert/0000-0002-3291-2376	Deutsche Forschungsgemeinschaft [EXC114, SFB 594]; Bavarian Ministry of Sciences, Research, and the Arts in the framework of the Bavarian Molecular Biosystems Research Network; Alexander von Humboldt Foundation; EMBO Long Term Fellowship; Schrodinger Fellowship by the Austrian Science Fund; APART Fellowship from the Austrian Academy of Sciences	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bavarian Ministry of Sciences, Research, and the Arts in the framework of the Bavarian Molecular Biosystems Research Network; Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); EMBO Long Term Fellowship(European Molecular Biology Organization (EMBO)); Schrodinger Fellowship by the Austrian Science Fund(Austrian Science Fund (FWF)); APART Fellowship from the Austrian Academy of Sciences	This work was supported in part by Deutsche Forschungsgemeinschaft Grants EXC114 and SFB 594 (to M. S) and the Bavarian Ministry of Sciences, Research, and the Arts in the framework of the Bavarian Molecular Biosystems Research Network (to T. M.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by the Alexander von Humboldt Foundation. Present address: Central European Institute of Technology, Masaryk University, 601 77Brno, Czech Republic.; Supported by an EMBO Long Term Fellowship, a Schrodinger Fellowship by the Austrian Science Fund, and an APART Fellowship from the Austrian Academy of Sciences. Present address: Institute of Molecular Biology and Biochemistry, Center of Molecular Medicine, Medical University of Graz, 8010 Graz, Austria.	Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Brunet LR, 1997, J IMMUNOL, V159, P777; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Comeau SR, 2004, NUCLEIC ACIDS RES, V32, pW96, DOI 10.1093/nar/gkh354; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DUNNE DW, 1991, PARASITOLOGY, V103, P225, DOI 10.1017/S0031182000059503; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Falcone FH, 1996, EUR J IMMUNOL, V26, P1147, DOI 10.1002/eji.1830260528; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Guntert P, 2009, EUR BIOPHYS J BIOPHY, V38, P129, DOI 10.1007/s00249-008-0367-z; Haisch K, 1999, J IMMUNOL METHODS, V226, P129, DOI 10.1016/S0022-1759(99)00059-9; HEMMINGSEN JM, 1994, PROTEIN SCI, V3, P1927, DOI 10.1002/pro.5560031104; Herbert DR, 2008, J IMMUNOL, V180, P4948, DOI 10.4049/jimmunol.180.7.4948; Holowka D, 2007, IMMUNOL REV, V217, P269, DOI 10.1111/j.1600-065X.2007.00517.x; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Jaenicke R, 2001, CRIT REV BIOCHEM MOL, V36, P435, DOI 10.1080/20014091074237; Kaur I, 2011, INFECT IMMUN, V79, P1779, DOI 10.1128/IAI.01048-10; Kitaura J, 2004, J IMMUNOL, V173, P4317, DOI 10.4049/jimmunol.173.7.4317; Kitaura J, 2003, P NATL ACAD SCI USA, V100, P12911, DOI 10.1073/pnas.1735525100; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lillemeier BF, 2010, NAT IMMUNOL, V11, P90, DOI 10.1038/ni.1832; Linge JP, 2003, PROTEINS, V50, P496, DOI 10.1002/prot.10299; Mathieson W, 2010, INT J PARASITOL, V40, P617, DOI 10.1016/j.ijpara.2009.10.014; Mayerhofer H, 2009, ACTA CRYSTALLOGR F, V65, P594, DOI 10.1107/S1744309109015899; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meyer NH, 2011, BIOMOL NMR ASSIGN, V5, P225, DOI 10.1007/s12104-011-9305-6; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nederveen AJ, 2005, PROTEINS, V59, P662, DOI 10.1002/prot.20408; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Patella V, 2000, J IMMUNOL, V164, P589, DOI 10.4049/jimmunol.164.2.589; Riek R, 1999, P NATL ACAD SCI USA, V96, P4918, DOI 10.1073/pnas.96.9.4918; Rockendorf N, 2007, BIOCONJUGATE CHEM, V18, P573, DOI 10.1021/bc0602376; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Schramm G, 2006, MOL BIOCHEM PARASIT, V147, P9, DOI 10.1016/j.molbiopara.2006.01.003; Schramm G, 2003, J BIOL CHEM, V278, P18384, DOI 10.1074/jbc.M300497200; Schramm G, 2010, MICROBES INFECT, V12, P881, DOI 10.1016/j.micinf.2010.06.001; Schramm G, 2007, J IMMUNOL, V178, P6023, DOI 10.4049/jimmunol.178.10.6023; Schweitzer-Stenner R, 2005, J IMMUNOL, V174, P4461, DOI 10.4049/jimmunol.174.8.4461; SEDER RA, 1992, J EXP MED, V176, P1091, DOI 10.1084/jem.176.4.1091; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Smith P, 2005, J EXP MED, V202, P1319, DOI 10.1084/jem.20050955; Sullivan BM, 2011, NAT IMMUNOL, V12, P527, DOI 10.1038/ni.2036; van Panhuys N, 2011, J IMMUNOL, V186, P2719, DOI 10.4049/jimmunol.1000940; Watanabe T, 1999, EUR J IMMUNOL, V29, P413, DOI 10.1002/(SICI)1521-4141(199902)29:02<413::AID-IMMU413>3.3.CO;2-P; Wuhrer M, 2006, FEBS J, V273, P2276, DOI 10.1111/j.1742-4658.2006.05242.x; Yang JY, 2010, FEBS LETT, V584, P4872, DOI 10.1016/j.febslet.2010.09.045; Yang JY, 2010, NATURE, V467, P465, DOI 10.1038/nature09357; Young ND, 2012, NAT GENET, V44, P221, DOI 10.1038/ng.1065	48	23	25	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2015	290	36					22111	22126		10.1074/jbc.M115.675066	http://dx.doi.org/10.1074/jbc.M115.675066			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ9XI	26163514	Green Published, hybrid			2022-12-26	WOS:000360968500029
J	Panneton, V; Nath, A; Sader, F; Delaunay, N; Pelletier, A; Maier, D; Oh, K; Hipfner, DR				Panneton, Vincent; Nath, Apurba; Sader, Fadi; Delaunay, Nathalie; Pelletier, Ariane; Maier, Dominic; Oh, Karen; Hipfner, David R.			Regulation of Catalytic and Non-catalytic Functions of the Drosophila Ste20 Kinase Slik by Activation Segment Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROMOTES CELLULAR GROWTH; PROTEIN-KINASES; STE20-RELATED KINASE; EPITHELIAL-CELLS; HIPPO PATHWAY; SLK; APOPTOSIS; PROLIFERATION; MOESIN; MERLIN	Protein kinases carry out important functions in cells both by phosphorylating substrates and by means of regulated non-catalytic activities. Such non-catalytic functions have been ascribed to many kinases, including some members of the Ste20 family. The Drosophila Ste20 kinase Slik phosphorylates and activates Moesin in developing epithelial tissues to promote epithelial tissue integrity. It also functions non-catalytically to promote epithelial cell proliferation and tissue growth. We carried out a structure-function analysis to determine how these two distinct activities of Slik are controlled. We find that the conserved C-terminal coiled-coil domain of Slik, which is necessary and sufficient for apical localization of the kinase in epithelial cells, is not required for Moesin phosphorylation but is critical for the growth-promoting function of Slik. Slik is auto-and trans-phosphorylated in vivo. Phosphorylation of at least two of three conserved sites in the activation segment is required for both efficient catalytic activity and non-catalytic signaling. Slik function is thus dependent upon proper localization of the kinase via the C-terminal coiled-coil domain and activation via activation segment phosphorylation, which enhances both phosphorylation of substrates like Moesin and engagement of effectors of its non-catalytic growth-promoting activity.	[Panneton, Vincent; Nath, Apurba; Sader, Fadi; Delaunay, Nathalie; Pelletier, Ariane; Maier, Dominic; Oh, Karen; Hipfner, David R.] Inst Rech Clin Montreal, Montreal, PQ H2W 1R7, Canada; [Panneton, Vincent; Nath, Apurba; Hipfner, David R.] Univ Montreal, Program Mol Biol, Montreal, PQ H3T 3J7, Canada; [Maier, Dominic; Hipfner, David R.] McGill Univ, Dept Anat & Cell Biol, Montreal, PQ H3A 2B2, Canada; [Hipfner, David R.] Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada	Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Universite de Montreal; McGill University; Universite de Montreal	Hipfner, DR (corresponding author), Inst Rech Clin Montreal, 110 Ave Pins Ouest, Montreal, PQ H2W 1R7, Canada.	david.hipfner@ircm.qc.ca			Natural Sciences and Engineering Research Council of Canada (NSERC)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by a Natural Sciences and Engineering Research Council of Canada (NSERC) grant (to D. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Avruch J, 2012, SEMIN CELL DEV BIOL, V23, P770, DOI 10.1016/j.semcdb.2012.07.002; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Boggiano JC, 2011, DEV CELL, V21, P888, DOI 10.1016/j.devcel.2011.08.028; Burakov AV, 2008, MOL BIOL CELL, V19, P1952, DOI 10.1091/mbc.E06-12-1156; Carreno S, 2008, J CELL BIOL, V180, P739, DOI 10.1083/jcb.200709161; Chaar Z, 2006, J BIOL CHEM, V281, P28193, DOI 10.1074/jbc.M605665200; Cohen-Armon M, 2007, MOL CELL, V25, P297, DOI 10.1016/j.molcel.2006.12.012; Datar SA, 2000, EMBO J, V19, P4543, DOI 10.1093/emboj/19.17.4543; Delpire E, 2009, PFLUG ARCH EUR J PHY, V458, P953, DOI 10.1007/s00424-009-0674-y; Du W, 1996, EMBO J, V15, P3684, DOI 10.1002/j.1460-2075.1996.tb00738.x; Fehon RG, 2010, NAT REV MOL CELL BIO, V11, P276, DOI 10.1038/nrm2866; Fievet BT, 2004, J CELL BIOL, V164, P653, DOI 10.1083/jcb.200307032; Gagnon KBE, 2006, MOL CELL BIOL, V26, P689, DOI 10.1128/MCB.26.2.689-698.2006; Gagnon KB, 2012, PHYSIOL REV, V92, P1577, DOI 10.1152/physrev.00009.2012; GRETHER ME, 1995, GENE DEV, V9, P1694, DOI 10.1101/gad.9.14.1694; Hamaratoglu F, 2006, NAT CELL BIOL, V8, P27, DOI 10.1038/ncb1339; Hao W, 2006, J BIOL CHEM, V281, P3075, DOI 10.1074/jbc.M511744200; Harvey KF, 2003, CELL, V114, P457, DOI 10.1016/S0092-8674(03)00557-9; Hipfner DR, 2003, PLOS BIOL, V1, P244, DOI 10.1371/journal.pbio.0000035; Hipfner DR, 2002, GENETICS, V161, P1527; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Hughes SC, 2006, J CELL BIOL, V175, P305, DOI 10.1083/jcb.200608009; Igaki T, 2002, EMBO J, V21, P3009, DOI 10.1093/emboj/cdf306; Johnston LA, 1999, CELL, V98, P779, DOI 10.1016/S0092-8674(00)81512-3; Johnston LA, 2009, SCIENCE, V324, P1679, DOI 10.1126/science.1163862; Karagiosis SA, 2004, DEVELOPMENT, V131, P725, DOI 10.1242/dev.00976; King CC, 2000, J BIOL CHEM, V275, P41201, DOI 10.1074/jbc.M006553200; Kumar R, 2006, NAT REV CANCER, V6, P459, DOI 10.1038/nrc1892; Kunda P, 2008, CURR BIOL, V18, P91, DOI 10.1016/j.cub.2007.12.051; LaJeunesse DR, 1998, J CELL BIOL, V141, P1589, DOI 10.1083/jcb.141.7.1589; Leevers SJ, 1996, EMBO J, V15, P6584, DOI 10.1002/j.1460-2075.1996.tb01049.x; Lim J, 2003, BIOCHEM BIOPH RES CO, V300, P694, DOI 10.1016/S0006-291X(02)02909-1; Luhovy AY, 2012, J BIOL CHEM, V287, P5446, DOI 10.1074/jbc.M111.302018; Machicoane M, 2014, J CELL BIOL, V205, P791, DOI 10.1083/jcb.201401049; Madhani HD, 1997, CELL, V91, P673, DOI 10.1016/S0092-8674(00)80454-7; Matakatsu H, 2006, DEVELOPMENT, V133, P2315, DOI 10.1242/dev.02401; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; O'Neill E, 2004, SCIENCE, V306, P2267, DOI 10.1126/science.1103233; O'Reilly PG, 2005, J BIOL CHEM, V280, P42383, DOI 10.1074/jbc.M510763200; Pantalacci S, 2003, NAT CELL BIOL, V5, P921, DOI 10.1038/ncb1051; Pike ACW, 2008, EMBO J, V27, P704, DOI 10.1038/emboj.2008.8; Poon CLC, 2011, DEV CELL, V21, P896, DOI 10.1016/j.devcel.2011.09.012; Praskova M, 2004, BIOCHEM J, V381, P453, DOI 10.1042/BJ20040025; Prober DA, 2000, CELL, V100, P435, DOI 10.1016/S0092-8674(00)80679-0; Quizi JL, 2013, ONCOGENE, V32, P4656, DOI 10.1038/onc.2012.488; Rauch J, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-23; Rong R, 2004, ONCOGENE, V23, P8447, DOI 10.1038/sj.onc.1207794; Ryoo HD, 2004, DEV CELL, V7, P491, DOI 10.1016/j.devcel.2004.08.019; Sabourin LA, 1999, ONCOGENE, V18, P7566, DOI 10.1038/sj.onc.1203119; Shapiro PS, 1999, MOL CELL BIOL, V19, P3551; Shaw AS, 2014, MOL CELL BIOL, V34, P1538, DOI 10.1128/MCB.00057-14; Speck O, 2003, NATURE, V421, P83, DOI 10.1038/nature01295; Storbeck CJ, 2009, MOL BIOL CELL, V20, P4174, DOI 10.1091/mbc.E08-07-0707; Surace EI, 2004, ONCOGENE, V23, P580, DOI 10.1038/sj.onc.1207142; Taylor SS, 2012, PHILOS T R SOC B, V367, P2517, DOI 10.1098/rstb.2012.0054; Tepass U, 2012, ANNU REV CELL DEV BI, V28, P655, DOI 10.1146/annurev-cellbio-092910-154033; Udan RS, 2003, NAT CELL BIOL, V5, P914, DOI 10.1038/ncb1050; Viswanatha R, 2012, J CELL BIOL, V199, P969, DOI 10.1083/jcb.201207047; Vitari AC, 2005, BIOCHEM J, V391, P17, DOI 10.1042/BJ20051180; Wagner S, 2002, J BIOL CHEM, V277, P37685, DOI 10.1074/jbc.M205899200; Wu S, 2003, CELL, V114, P445, DOI 10.1016/S0092-8674(03)00549-X; Yin F, 2013, CELL, V154, P1342, DOI 10.1016/j.cell.2013.08.025; Yu JZ, 2010, DEV CELL, V18, P288, DOI 10.1016/j.devcel.2009.12.012; Zhang NL, 2010, DEV CELL, V19, P27, DOI 10.1016/j.devcel.2010.06.015	64	7	7	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2015	290	34					20960	20971		10.1074/jbc.M115.645952	http://dx.doi.org/10.1074/jbc.M115.645952			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP6QC	26170449	Green Published, hybrid			2022-12-26	WOS:000360011800030
J	Hammes, HP; Welp, R; Kempe, HP; Wagner, C; Siegel, E; Holl, RW				Hammes, Hans-Peter; Welp, Reinhard; Kempe, Hans-Peter; Wagner, Christian; Siegel, Erhard; Holl, Reinhard W.		DPV Initiative-German BMBF Compete	Risk Factors for Retinopathy and DME in Type 2 Diabetes-Results from the German/Austrian DPV Database	PLOS ONE			English	Article							MACULAR EDEMA; PREVALENCE; OBESITY; COMPLICATIONS; NEPHROPATHY; MECHANISMS	To assess the prevalence and risk factors for early and severe diabetic retinopathy and macular edema in a large cohort of patients with type 2 diabetes Retinopathy grading (any retinopathy, severe retinopathy, diabetic macular edema) and risk factors of 64784 were prospectively recorded between January 2000 and March 2013 and analyzed by Kaplan-Meier analysis and logistic regression. Retinopathy was present in 20.12% of subjects, maculopathy was found in 0.77%. HbA1c > 8%, microalbuminuria, hypertension, BMI > 35 kg/m(2) and male sex were significantly associated with any retinopathy, while HbA1c and micro-and macroalbuminuria were the strongest risk predictors for severe retinopathy. Presence of macroalbuminuria increased the risk for DME by 177%. Retinopathy remains a significant clinical problem in patients with type 2 diabetes. Metabolic control and blood pressure are relevant factors amenable to treatment. Concomitant kidney disease identifies high risk patients and should be emphasized in interdisciplinary communication.	[Hammes, Hans-Peter] Heidelberg Univ, Univ Med Ctr, Dept Med 5, Mannheim, Germany; [Welp, Reinhard] Knappschafts Krankenhaus, Dept Internal Med, Bottrop, Germany; [Kempe, Hans-Peter] Ctr Diabet & Nutr Ludwigshafen, Ludwigshafen, Germany; [Wagner, Christian] Specialized Diabet Practice, Saaldorf, Germany; [Siegel, Erhard] St Josefs Hosp, Dept Internal Med, Heidelberg, Germany; [Holl, Reinhard W.] Univ Med Ctr, Inst Epidemiol & Med Biometry, Ulm, Germany	Ruprecht Karls University Heidelberg; Ulm University	Hammes, HP (corresponding author), Heidelberg Univ, Univ Med Ctr, Dept Med 5, Mannheim, Germany.	hp.hammes@umm.de	Hammes, Hans-Peter/S-3719-2019	Holl, Reinhard/0000-0003-1395-4842	Kompetenznetz Diabetes mellitus (Competence Network for Diabetes mellitus) - Federal Ministry of Education and Research [FKZ 01GI1106]; European Foundation for the Study of Diabetes (EFSD); European Foundation for the Study of Diabetes [AZ Macrov 2014_2] Funding Source: researchfish	Kompetenznetz Diabetes mellitus (Competence Network for Diabetes mellitus) - Federal Ministry of Education and Research; European Foundation for the Study of Diabetes (EFSD); European Foundation for the Study of Diabetes	This work was supported by the Kompetenznetz Diabetes mellitus (Competence Network for Diabetes mellitus) funded by the Federal Ministry of Education and Research (FKZ 01GI1106). Additional funds were provided by the European Foundation for the Study of Diabetes (EFSD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonetti DA, 2012, NEW ENGL J MED, V366, P1227, DOI 10.1056/NEJMra1005073; Awa WL, 2013, PEDIATR DIABETES, V14, P562, DOI 10.1111/pedi.12043; Bottazzo GF, 2005, DIABETOLOGIA, V48, P703, DOI 10.1007/s00125-005-1691-9; Chang SA, 2012, DIABETES METAB J, V36, P399, DOI 10.4093/dmj.2012.36.6.399; Cheung N, 2010, LANCET, V376, P124, DOI 10.1016/S0140-6736(09)62124-3; Dirani M, 2011, INVEST OPHTH VIS SCI, V52, P4416, DOI 10.1167/iovs.11-7208; Forbes JM, 2013, PHYSIOL REV, V93, P137, DOI 10.1152/physrev.00045.2011; Gaede P, 2008, NEW ENGL J MED, V358, P580, DOI 10.1056/NEJMoa0706245; Gangaputra S, 2013, RETINA-J RET VIT DIS, V33, P1393, DOI 10.1097/IAE.0b013e318286c952; Hammes HP, 2011, DIABETOLOGIA, V54, P1977, DOI 10.1007/s00125-011-2198-1; Hammes HP, 2004, DIAGNOSTIK THERAPIE; Hermann Julia M, 2014, PLoS One, V9, pe91137, DOI 10.1371/journal.pone.0091137; Hesse L, 2001, OPHTHALMOLOGE, V98, P1065, DOI 10.1007/s003470170026; Klein R, 1997, ARCH INTERN MED, V157, P650, DOI 10.1001/archinte.157.6.650; Klein R, 2010, DIABETES, V59, P1853, DOI 10.2337/db09-1904; Klein R, 2006, CONTEMP DIAB, P473; Knudsen LL, 2007, BRIT J OPHTHALMOL, V91, P1593, DOI 10.1136/bjo.2006.111872; Knudsen ST, 2002, DIABETES CARE, V25, P2328, DOI 10.2337/diacare.25.12.2328; Lammert A, 2012, OBESITY, V20, P2262, DOI 10.1038/oby.2012.122; Levitsky LL, 2013, DIABETES CARE, V36, P1772, DOI 10.2337/dc12-2387; de Faria JBL, 2011, HYPERTENS RES, V34, P413, DOI 10.1038/hr.2010.263; Martin-Merino E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100283; Mendel TA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065691; Pfister F, 2013, PFLUG ARCH EUR J PHY, V465, P789, DOI 10.1007/s00424-013-1272-6; Schwab KO, 2006, DIABETES CARE, V29, P218, DOI 10.2337/diacare.29.02.06.dc05-0724; Silva PS, 2012, TELEMED E-HEALTH, V18, P492, DOI 10.1089/tmj.2011.0232; Stratton IM, 2001, DIABETOLOGIA, V44, P156, DOI 10.1007/s001250051594; van Leiden HA, 2002, DIABETES CARE, V25, P1320, DOI 10.2337/diacare.25.8.1320; Yau JWY, 2012, DIABETES CARE, V35, P556, DOI 10.2337/dc11-1909	29	69	69	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132492	10.1371/journal.pone.0132492	http://dx.doi.org/10.1371/journal.pone.0132492			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177037	Green Published, gold, Green Submitted			2022-12-26	WOS:000358197600117
J	Sieni, E; Barba, C; Mortilla, M; Savelli, S; Grisotto, L; Di Giacomo, G; Romano, K; Fonda, C; Biggeri, A; Guerrini, R; Arico, M				Sieni, Elena; Barba, Carmen; Mortilla, Marzia; Savelli, Sara; Grisotto, Laura; Di Giacomo, Gianpiero; Romano, Katiuscia; Fonda, Claudio; Biggeri, Annibale; Guerrini, Renzo; Arico, Maurizio			Early Diagnosis and Monitoring of Neurodegenerative Langerhans Cell Histiocytosis	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; PERMANENT CONSEQUENCES; DISEASE; CHILDREN; EXPERIENCE; CHILDHOOD; SEQUELAE; SOCIETY; PATTERN; BLOOD	Background Neurodegenerative Langerhans Cell Histiocytosis (ND-LCH) is a rare, unpredictable consequence that may devastate the quality of life of patients cured from LCH. We prospectively applied a multidisciplinary diagnostic work-up to early identify and follow-up patients with ND-LCH, with the ultimate goal of better determining the appropriate time for starting therapy. Methods We studied 27 children and young adults with either ND-LCH verified by structural magnetic resonance imaging (MRI) (group 1) or specific risk factors for (diabetes insipidus, craniofacial bone lesions), but no evidence of, neurodegenerative MRI changes (group 2). All patients underwent clinical, neurophysiological and MRI studies. Results Seventeen patients had MRI alterations typical for ND-LCH. Nine showed neurological impairment but only three were symptomatic; 11 had abnormal somatosensory evoked potentials (SEPs), and five had abnormal brainstem auditory evoked potentials (BAEPs). MR spectroscopy (MRS) showed reduced cerebellar NAA/Cr ratio in nine patients. SEPs showed sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) for predicting ND-LCH of 70.6% (95% CI, 44.0%-89.7%), 100% (69.2%-100%), 100% (73.5%-100%), and 66.7%(38.4%-88.2%), respectively. Repeated investigations in group 1 revealed increasingly abnormal EP parameters, or neurological examination, or both, in nine of fifteen patients while MRI remained unchanged in all but one patient. Conclusion A targeted MRI study should be performed in all patients with risk factors for ND-LCH for early identification of demyelination. The combined use of SEPs and careful neurological evaluation may represent a valuable, low-cost, well-tolerated and easily available methodology to monitor patients from pre-symptomatic to symptomatic stages. We suggest a multidisciplinary protocol including clinical, MRS, and neurophysiological investigations to identify a population target for future therapeutic trials.	[Sieni, Elena; Arico, Maurizio] Meyer Childrens Univ Hosp, Pediat Hematol Oncol, Florence, Italy; [Barba, Carmen; Di Giacomo, Gianpiero; Romano, Katiuscia; Guerrini, Renzo] Meyer Childrens Univ Hosp, Pediat Neurol, Florence, Italy; [Mortilla, Marzia; Savelli, Sara; Fonda, Claudio] Meyer Childrens Univ Hosp, Pediat Radiol, Florence, Italy; [Savelli, Sara] Bambino Gesu Pediat Hosp, IRCCS, Dept Diagnost Imaging, Rome, Italy; [Grisotto, Laura; Biggeri, Annibale] Univ Florence, Dept Stat Informat & Applicat G Parenti, Florence, Italy; [Biggeri, Annibale] ISPO Canc Prevent & Res Inst, Biostat Unit, Florence, Italy; [Arico, Maurizio] Azienda Sanit Prov 7, Direz Gen, Ragusa, Italy	University of Florence; Azienda Ospedaliera Universitaria (AOU) MEYER; University of Florence; Azienda Ospedaliera Universitaria (AOU) MEYER; University of Florence; Azienda Ospedaliera Universitaria (AOU) MEYER; IRCCS Bambino Gesu; University of Florence; ISPRO Istituto per lo studio, la prevenzione e la rete oncologica	Sieni, E (corresponding author), Meyer Childrens Univ Hosp, Pediat Hematol Oncol, Florence, Italy.	e.sieni@meyer.it	Savelli, Sara/AAA-6103-2020; Sieni, Elena/J-8729-2018; Barba, Carmen/AAB-7162-2022; barba, carmen/K-4942-2016; Arico, Maurizio/S-3039-2019; Mortilla, Marzia/AAV-5525-2020	Sieni, Elena/0000-0002-6192-9812; barba, carmen/0000-0001-5445-5842; Arico, Maurizio/0000-0002-1908-6671; Guerrini, Renzo/0000-0002-7272-7079	Ministero della Salute [RF-TOS-2008-1219488]; Associazione Italiana Ricerca Istiocitosi (AIRI); Associazione Ciemmeesse-Girotondo per il Meyer O.N.L.U.S	Ministero della Salute(Ministry of Health, Italy); Associazione Italiana Ricerca Istiocitosi (AIRI); Associazione Ciemmeesse-Girotondo per il Meyer O.N.L.U.S	This work was supported by the Ministero della Salute (RF-TOS-2008-1219488), Associazione Italiana Ricerca Istiocitosi (AIRI), and Associazione Ciemmeesse-Girotondo per il Meyer O.N.L.U.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arico M, 1998, HEMATOL ONCOL CLIN N, V12, P247, DOI 10.1016/S0889-8588(05)70508-6; Arico M, 1999, BRIT J HAEMATOL, V107, P883, DOI 10.1046/j.1365-2141.1999.01777.x; Badalian-Very G, 2013, ANNU REV PATHOL-MECH, V8, P1, DOI 10.1146/annurev-pathol-020712-163959; Barthez MA, 2000, J CHILD NEUROL, V15, P150, DOI 10.1177/088307380001500302; Bernstrand C, 2005, ACTA PAEDIATR, V94, P1073, DOI 10.1080/08035250510028263; Chaudhary V, 2013, JPN J RADIOL, V31, P786, DOI 10.1007/s11604-013-0254-0; Delprat C, 2014, BLOOD, V124, P867, DOI 10.1182/blood-2014-02-556407; Euskirchen P, 2015, NEUROL-NEUROIMMUNOL, V2, DOI 10.1212/NXI.0000000000000078; Gadner H, 2001, J PEDIATR-US, V138, P728, DOI 10.1067/mpd.2001.111331; Gadner H, 2008, BLOOD, V111, P2556, DOI 10.1182/blood-2007-08-106211; Gadner H, 2013, BLOOD, V121, P5006, DOI 10.1182/blood-2012-09-455774; Grois N, 2006, PEDIATR BLOOD CANCER, V46, P228, DOI 10.1002/pbc.20425; Grois N, 2005, BRAIN, V128, P829, DOI 10.1093/brain/awh403; Grois NG, 1998, HEMATOL ONCOL CLIN N, V12, P287, DOI 10.1016/S0889-8588(05)70511-6; Guyot-Goubin A, 2008, PEDIATR BLOOD CANCER, V51, P71, DOI 10.1002/pbc.21498; HARRELL FE, 1982, JAMA-J AM MED ASSOC, V247, P2543, DOI 10.1001/jama.247.18.2543; Haupt R, 2004, PEDIATR BLOOD CANCER, V42, P438, DOI 10.1002/pbc.20021; Horibe K, 2013, INT J HEMATOL, V98, P74, DOI 10.1007/s12185-013-1364-2; Kolodziejak A, 2000, J PHYSIOL PHARMACOL, V51, P41; Laurencikas E, 2011, PEDIATR BLOOD CANCER, V56, P250, DOI 10.1002/pbc.22791; Le Guennec L, 2014, J NEUROL, V261, P1537, DOI 10.1007/s00415-014-7375-y; Lee EK, 1998, J CLIN NEUROPHYSIOL, V15, P227, DOI 10.1097/00004691-199805000-00006; Mittheisz E, 2007, PEDIATR BLOOD CANCER, V48, P50, DOI 10.1002/pbc.20760; Munoz A, 2008, AJNR Am J Neuroradiol, V29, pe15, DOI 10.3174/ajnr.A0911; Murakami I, 2014, HUM PATHOL, V45, P119, DOI 10.1016/j.humpath.2013.05.028; Nanduri VR, 2003, J CLIN ONCOL, V21, P2961, DOI 10.1200/JCO.2003.05.048; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Prayer D, 2004, AM J NEURORADIOL, V25, P880; Prosch H, 2007, AM J NEURORADIOL, V28, P1022, DOI 10.3174/ajnr.A0509; Schmitz-Hubsch T, 2006, NEUROLOGY, V66, P1717, DOI 10.1212/01.wnl.0000219042.60538.92; Steiner M, 2005, J CHILD NEUROL, V20, P253, DOI 10.1177/08830738050200031501; van't Hooft I, 2008, PEDIATR BLOOD CANCER, V51, P669, DOI 10.1002/pbc.21656; Whitsett SF, 1999, MED PEDIATR ONCOL, V33, P486, DOI 10.1002/(SICI)1096-911X(199911)33:5<486::AID-MPO9>3.3.CO;2-A; Willis B, 1996, J CLIN ONCOL, V14, P2073, DOI 10.1200/JCO.1996.14.7.2073; Wnorowski M, 2008, J PEDIATR-US, V153, P127, DOI 10.1016/j.jpeds.2007.12.042	35	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0131635	10.1371/journal.pone.0131635	http://dx.doi.org/10.1371/journal.pone.0131635			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176859	Green Published, Green Submitted, gold			2022-12-26	WOS:000358197600055
J	Zhang, HJ; Jiang, XJ; Lu, LP; Xiao, WF				Zhang, Hangjun; Jiang, Xiaojun; Lu, Liping; Xiao, Wenfeng			Biodegradation of polychlorinated biphenyls (PCBs) by the novel identified cyanobacterium Anabaena PD-1	PLOS ONE			English	Article							CONTAMINATED SOIL; RISK-ASSESSMENT; CHLOROPHYLL-A; DEGRADATION; PHYTOPLANKTON; AROCLOR-1242; RESPONSES; MICROORGANISMS; METABOLISM; SEDIMENTS	Polychlorinated biphenyls (PCBs), a class of hazardous pollutants, are difficult to dissipate in the natural environment. In this study, a cyanobacterial strain Anabaena PD-1 showed good resistance against PCB congeners. Compared to a control group, chlorophyll a content decreased 3.7% and 11.7% when Anabaena PD-1 was exposed to 2 and 5 mg/L PCBs for 7 d. This cyanobacterial strain was capable of decomposing PCB congeners which was conclusively proved by determination of chloride ion concentrations in chlorine-free medium. After 7 d, the chloride ion concentrations in PCB-treated groups (1, 2, 5 mg/L) were 3.55, 3.05, and 2.25 mg/L, respectively. The genetic information of strain PD-1 was obtained through 16S rRNA sequencing analysis. The GenBank accession number of 16S rRNA of Anabaena PD-1 was KF201693.1. Phylogenetic tree analysis clearly indicated that Anabaena PD-1 belonged to the genus Anabaena. The degradation half-life of Aroclor 1254 by Anabaena PD-1 was 11.36 d; the total degradation rate for Aroclor 1254 was 84.4% after 25 d. Less chlorinated PCB congeners were more likely to be degraded by Anabaena PD-1 in comparison with highly chlorinated congeners. Meta- and para-chlorines in trichlorodiphenyls and tetrachlorobiphenyls were more susceptible to dechlorination than ortho-chlorines during the PCB-degradation process by Anabaena PD-1. Furthermore, Anabaena PD-1 can decompose dioxin-like PCBs. The percent biodegradation of 12 dioxin-like PCBs by strain PD-1 ranged from 37.4% to 68.4% after 25 days. Results above demonstrate that Anabaena PD-1 is a PCB-degrader with great potential for the in situ bioremediation of PCB-contaminated paddy soils.	[Zhang, Hangjun; Jiang, Xiaojun; Lu, Liping; Xiao, Wenfeng] Hangzhou Normal Univ, Coll Life & Environm Sci, Hangzhou 310036, Zhejiang, Peoples R China; [Zhang, Hangjun] Hangzhou Normal Univ, Key Lab Hangzhou City Ecosyst Protect & Restorat, Hangzhou 310036, Zhejiang, Peoples R China	Hangzhou Normal University; Hangzhou Normal University	Zhang, HJ (corresponding author), Hangzhou Normal Univ, Coll Life & Environm Sci, Xuelin Rd 16, Hangzhou 310036, Zhejiang, Peoples R China.	zhanghangjun@gmail.com		zhang, hangjun/0000-0002-3281-6093	Natural Science Foundation of China [21077030]; Program for Excellent Young Teachers in Hangzhou Normal University [JTAS 2011-01-012]; Program for '131' talents in Hangzhou City; Undergraduates innovation ability promotion project in Hangzhou Normal University [CX2013078]; Chinese Scholarship Council [201208330300]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Excellent Young Teachers in Hangzhou Normal University; Program for '131' talents in Hangzhou City; Undergraduates innovation ability promotion project in Hangzhou Normal University; Chinese Scholarship Council(China Scholarship Council)	This work was financially supported by the Natural Science Foundation of China (21077030), the Program for Excellent Young Teachers in Hangzhou Normal University (JTAS 2011-01-012), the Program for '131' talents in Hangzhou City, the Undergraduates innovation ability promotion project in Hangzhou Normal University (CX2013078) and the Grant of Chinese Scholarship Council (No: 201208330300). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adebusoye SA, 2008, CHEMOSPHERE, V73, P126, DOI 10.1016/j.chemosphere.2008.04.055; An Qiong, 2006, Huanjing Kexue, V27, P528; Baek SY, 2008, ENVIRON SCI TECHNOL, V42, P7336, DOI 10.1021/es801019k; BEDARD DL, 1987, APPL ENVIRON MICROB, V53, P1094, DOI 10.1128/AEM.53.5.1094-1102.1987; BEDARD DL, 1986, APPL ENVIRON MICROB, V51, P761, DOI 10.1128/AEM.51.4.761-768.1986; Borja J, 2005, PROCESS BIOCHEM, V40, P1999, DOI 10.1016/j.procbio.2004.08.006; Boyle Alfred W., 1992, Biodegradation, V3, P285, DOI 10.1007/BF00129089; Camara B, 2004, ENVIRON MICROBIOL, V6, P842, DOI 10.1111/j.1462-2920.2004.00630.x; Chavez FP, 2006, BIOTECHNOL ADV, V24, P309, DOI 10.1016/j.biotechadv.2005.11.007; Chen Yuwei, 2006, Hupo Kexue, V18, P550; Cogliano VJ, 1998, ENVIRON HEALTH PERSP, V106, P317, DOI 10.2307/3434037; Cvancarova M, 2012, CHEMOSPHERE, V88, P1317, DOI 10.1016/j.chemosphere.2012.03.107; Dalla Valle M, 2005, ENVIRON POLLUT, V134, P153, DOI 10.1016/j.envpol.2004.07.011; Dobbins DC, 1995, BIODEGRADATION POLLU, P1; Fischer LJ, 1998, TOXICOL SCI, V41, P49; Furukawa K, 2008, J BIOSCI BIOENG, V105, P433, DOI 10.1263/jbb.105.433; Furukawa Kensuke, 1994, P33; Galban-Malagon CJ, 2013, ENVIRON SCI TECHNOL, V47, P5578, DOI 10.1021/es400030q; Ge J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071521; Giesy JP, 1998, CRIT REV TOXICOL, V28, P511, DOI 10.1080/10408449891344263; Gilbert ES, 1997, APPL ENVIRON MICROB, V63, P1933, DOI 10.1128/AEM.63.5.1933-1938.1997; HARKNESS MR, 1993, SCIENCE, V259, P503, DOI 10.1126/science.8424172; Hatamian-Zarmi A, 2009, INT BIODETER BIODEGR, V63, P788, DOI 10.1016/j.ibiod.2009.06.009; Hong CY, 2013, J ENVIRON SCI HEAL A, V48, P1280, DOI 10.1080/10934529.2013.777242; IWASAKI I, 1952, B CHEM SOC JPN, V25, P226, DOI 10.1246/bcsj.25.226; Iwasaki T, 2007, BIOSCI BIOTECH BIOCH, V71, P993, DOI 10.1271/bbb.60663; JESPERSEN AM, 1987, ARCH HYDROBIOL, V109, P445; Kim IS, 2001, FEMS MICROBIOL LETT, V200, P17, DOI 10.1016/S0378-1097(01)00195-1; KOHLER HPE, 1988, APPL ENVIRON MICROB, V54, P1940, DOI 10.1128/AEM.54.8.1940-1945.1988; Lee SE, 2003, J AGR FOOD CHEM, V51, P1336, DOI 10.1021/jf0257289; Meijer SN, 2003, ENVIRON SCI TECHNOL, V37, P667, DOI 10.1021/es025809l; Mezzetta S, 2011, CHEMOSPHERE, V82, P1293, DOI 10.1016/j.chemosphere.2010.12.028; Moeckel C, 2008, ENVIRON SCI TECHNOL, V42, P8374, DOI 10.1021/es801703k; Narasimhan K, 2003, PLANT PHYSIOL, V132, P146, DOI 10.1104/pp.102.016295; Nie Xiang-ping, 2002, Acta Scientiarum Naturalium Universitatis Sunyatseni, V41, P68; Nollet H, 2003, CHEMOSPHERE, V53, P655, DOI 10.1016/S0045-6535(03)00517-4; Papazi A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061682; Papazi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049037; Parnell JJ, 2006, APPL ENVIRON MICROB, V72, P6607, DOI 10.1128/AEM.01129-06; Pieper DH, 2008, J MOL MICROB BIOTECH, V15, P121, DOI 10.1159/000121325; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; RISEBROUGH RW, 1968, NATURE, V220, P1098, DOI 10.1038/2201098a0; Rodrigues JLM, 2006, APPL ENVIRON MICROB, V72, P2476, DOI 10.1128/AEM.72.4.2476-2482.2006; SAFE S, 1993, ENVIRON HEALTH PERSP, V100, P259, DOI 10.2307/3431532; SAFE SH, 1994, CRIT REV TOXICOL, V24, P87, DOI 10.3109/10408449409049308; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Shen CF, 2008, ENVIRON SCI TECHNOL, V42, P49, DOI 10.1021/es071162z; Simon T, 2007, REGUL TOXICOL PHARM, V48, P148, DOI 10.1016/j.yrtph.2007.03.005; Singer AC, 2000, APPL MICROBIOL BIOT, V54, P838, DOI 10.1007/s002530000472; Singh DP, 2011, ENVIRON SCI POLLUT R, V18, P1351, DOI 10.1007/s11356-011-0472-x; Tigini V, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-5; Tsuji N, 2003, BIOTECHNOL LETT, V25, P241, DOI 10.1023/A:1022333406348; Villacieros M, 2005, APPL ENVIRON MICROB, V71, P2687, DOI 10.1128/AEM.71.5.2687-2694.2005; Wang S, 2014, CHEMOSPHERE, V95, P200, DOI 10.1016/j.chemosphere.2013.08.066; Wiegel J, 2000, FEMS MICROBIOL ECOL, V32, P1, DOI 10.1111/j.1574-6941.2000.tb00693.x; YADAV JS, 1995, APPL ENVIRON MICROB, V61, P2560, DOI 10.1128/AEM.61.7.2560-2565.1995; Zabelina ON, 2010, J ANAL CHEM+, V65, P1098, DOI 10.1134/S106193481011002X; Zhang HJ, 2012, J APPL PHYCOL, V24, P221, DOI 10.1007/s10811-011-9670-7; Zhao GF, 2009, SCI TOTAL ENVIRON, V407, P2565, DOI 10.1016/j.scitotenv.2008.11.062	59	15	18	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0131450	10.1371/journal.pone.0131450	http://dx.doi.org/10.1371/journal.pone.0131450			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177203	Green Published, gold, Green Submitted			2022-12-26	WOS:000358197600044
J	Bertrand, S; Joo, R; Fablet, R				Bertrand, Sophie; Joo, Rocio; Fablet, Ronan			Generalized Pareto for Pattern-Oriented Random Walk Modelling of Organisms' Movements	PLOS ONE			English	Article							FLIGHT SEARCH PATTERNS; STATISTICAL-INFERENCE; SPATIAL-DISTRIBUTION; ANIMAL MOVEMENT; SCALING LAWS; LEVY FLIGHTS; LIKELIHOOD; DISTRIBUTIONS; ECOLOGY	How organisms move and disperse is crucial to understand how population dynamics relates to the spatial heterogeneity of the environment. Random walk (RW) models are typical tools to describe movement patterns. Whether Levy or alternative RW better describes forager movements is keenly debated. We get around this issue using the Generalized Pareto Distribution (GPD). GPD includes as specific cases Normal, exponential and power law distributions, which underlie Brownian, Poisson-like and Levy walks respectively. Whereas previous studies typically confronted a limited set of candidate models, GPD lets the most likely RW model emerge from the data. We illustrate the wide applicability of the method using GPS-tracked seabird foraging movements and fishing vessel movements tracked by Vessel Monitoring System (VMS), both collected in the Peruvian pelagic ecosystem. The two parameters from the fitted GPD, a scale and a shape parameter, provide a synoptic characterization of the observed movement in terms of characteristic scale and diffusive property. They reveal and quantify the variability, among species and individuals, of the spatial strategies selected by predators foraging on a common prey field. The GPD parameters constitute relevant metrics for (1) providing a synthetic and pattern-oriented description of movement, (2) using top predators as ecosystem indicators and (3) studying the variability of spatial behaviour among species or among individuals with different personalities.	[Bertrand, Sophie; Joo, Rocio] Ctr Rech Halieut Mediterraneenne & Trop, IRD, EME UMR212, F-34203 Sete, France; [Joo, Rocio] IMARPE, Lima, Peru; [Fablet, Ronan] Inst TELECOM, F-29238 Brest, France; [Fablet, Ronan] TELECOM Bretagne, F-29238 Brest, France; [Fablet, Ronan] CNRS, UMR Lab STICC 3192, F-29238 Brest, France	Ifremer; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Instituto del Mar del Peru; IMT - Institut Mines-Telecom; IMT Atlantique; IMT - Institut Mines-Telecom; IMT Atlantique; Centre National de la Recherche Scientifique (CNRS); Universite de Bretagne Occidentale	Bertrand, S (corresponding author), Ctr Rech Halieut Mediterraneenne & Trop, IRD, EME UMR212, Ave Jean Monnet,BP 171, F-34203 Sete, France.	Sophie.Bertrand@ird.fr	fablet, ronan/L-5574-2019; Joo, Rocio/H-8238-2019; bertrand, sophie/F-4161-2012	fablet, ronan/0000-0002-6462-423X; bertrand, sophie/0000-0003-1976-3799				AKAIKE H, 1981, J ECONOMETRICS, V16, P3, DOI 10.1016/0304-4076(81)90071-3; ALLEN PM, 1986, CAN J FISH AQUAT SCI, V43, P1187, DOI 10.1139/f86-148; Bartumeus F, 2003, P NATL ACAD SCI USA, V100, P12771, DOI 10.1073/pnas.2137243100; Benhamou S, 2007, ECOLOGY, V88, P1962, DOI 10.1890/06-1769.1; Benoit-Bird KJ, 2013, MAR ECOL PROG SER, V479, P283, DOI 10.3354/meps10209; Berkolaiko G, 1996, PHYS REV E, V53, P5774, DOI 10.1103/PhysRevE.53.5774; Bertrand S, 2005, ICES J MAR SCI, V62, P477, DOI 10.1016/j.icesjms.2004.12.002; Bertrand S, 2007, ECOL APPL, V17, P331, DOI 10.1890/06-0303; Bertrand S, 2012, J APPL ECOL, V49, P1168, DOI 10.1111/j.1365-2664.2012.02190.x; Bertrand S, 2008, PROG OCEANOGR, V79, P379, DOI 10.1016/j.pocean.2008.10.009; Boyd C, 2014, ECOL MODEL, V286, P13, DOI 10.1016/j.ecolmodel.2014.03.015; Boyd IL, 2006, CONSERV BIOL SER, P1, DOI 10.2277/ 052161256X; Boyer D, 2006, P ROY SOC B-BIOL SCI, V273, P1743, DOI 10.1098/rspb.2005.3462; Bradshaw CJA, 2007, ECOL APPL, V17, P628, DOI 10.1890/06-0964; Brockmann D, 2006, NATURE, V439, P462, DOI 10.1038/nature04292; Brown CT, 2007, HUM ECOL, V35, P129, DOI 10.1007/s10745-006-9083-4; BUSH JG, 1983, COMMUN STAT-THEOR M, V12, P2465, DOI 10.1080/03610928308828613; Chaouche A, 2006, COMMUN STAT-THEOR M, V35, P785, DOI 10.1080/03610920500501429; Chavez FP, 2008, PROG OCEANOGR, V79, P95, DOI 10.1016/j.pocean.2008.10.012; Codling EA, 2010, THEORETICAL ECOLOGY, V4, P397; Cote J, 2010, PHILOS T R SOC B, V365, P4065, DOI 10.1098/rstb.2010.0176; DAVISON AC, 1990, J ROY STAT SOC B MET, V52, P393; Edwards AM, 2008, J ANIM ECOL, V77, P1212, DOI 10.1111/j.1365-2656.2008.01428.x; Edwards AM, 2007, NATURE, V449, P1044, DOI 10.1038/nature06199; Edwards AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045174; Edwards AM, 2011, ECOLOGY, V92, P1247, DOI 10.1890/10-1182.1; Fraser DF, 2001, AM NAT, V158, P124, DOI 10.1086/321307; FreuEn P., 1999, DYNAMICS PELAGIC FIS; Gautestad AO, 2013, OIKOS, V122, P612, DOI 10.1111/j.1600-0706.2012.19998.x; Giuggioli L, 2010, J ANIM ECOL, V79, P906, DOI 10.1111/j.1365-2656.2010.01682.x; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; GRIMSHAW SD, 1993, TECHNOMETRICS, V35, P185, DOI 10.2307/1269663; Humphries NE, 2010, NATURE, V465, P1066, DOI 10.1038/nature09116; Joo R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071246; MURPHY R.C., 1936, OCEANIC BIRDS S AM, V2; Nathan R, 2008, P NATL ACAD SCI USA, V105, P19052, DOI 10.1073/pnas.0800375105; Nelson JB, 2005, PELICANS CORMORANTS; Peraltilla S, 2014, FISH RES, V149, P92, DOI 10.1016/j.fishres.2013.09.002; PICKANDS J, 1975, ANN STAT, V3, P119; Plank MJ, 2009, ECOLOGY, V90, P3546, DOI 10.1890/09-0079.1; Reynolds A, 2008, ECOLOGY, V89, P2347, DOI 10.1890/07-1688.1; Scherrer B., 2007, BIOSTATISTIQUE; Schick RS, 2008, ECOL LETT, V11, P1338, DOI 10.1111/j.1461-0248.2008.01249.x; SHLESINGER MF, 1993, NATURE, V363, P31, DOI 10.1038/363031a0; Sims DW, 2008, NATURE, V451, P1098, DOI 10.1038/nature06518; Sokal R. R., 2001, BIOMETRY PRINCIPLES; Turchin Peter, 1998; van Overveld T, 2010, BIOL LETTERS, V6, P187, DOI 10.1098/rsbl.2009.0764; Viswanathan GM, 1996, NATURE, V381, P413, DOI 10.1038/381413a0; Weimerskirch H, 2012, MAR ECOL PROG SER, V458, P231, DOI 10.3354/meps09752; White EP, 2008, ECOLOGY, V89, P905, DOI 10.1890/07-1288.1	51	3	3	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132231	10.1371/journal.pone.0132231	http://dx.doi.org/10.1371/journal.pone.0132231			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26172045	Green Published, gold			2022-12-26	WOS:000358194900037
J	Bustnes, JO; Bourgeon, S; Leat, EHK; Magnusdottir, E; Strom, H; Hanssen, SA; Petersen, A; Olafsdottir, K; Borga, K; Gabrielsen, GW; Furness, RW				Bustnes, Jan O.; Bourgeon, Sophie; Leat, Eliza H. K.; Magnusdottir, Ellen; Strom, Hallvard; Hanssen, Sveinn A.; Petersen, Aevar; Olafsdottir, Kristin; Borga, Katrine; Gabrielsen, Geir W.; Furness, Robert W.			Multiple Stressors in a Top Predator Seabird: Potential Ecological Consequences of Environmental Contaminants, Population Health and Breeding Conditions	PLOS ONE			English	Article							PERSISTENT ORGANIC POLLUTANTS; SKUAS STERCORARIUS-SKUA; EGG-SIZE; ORGANOCHLORINE POLLUTANTS; REPRODUCTIVE-PERFORMANCE; FLAME-RETARDANT; GLAUCOUS GULL; BIRDS; MORTALITY; IMPACTS	Environmental contaminants may have impacts on reproduction and survival in wildlife populations suffering from multiple stressors. This study examined whether adverse effects of persistent organic pollutants (POPs) increased with poor population health and breeding conditions in three colonies (60-74 degrees N) of great skua (Stercorarius skua) in the north-eastern Atlantic (Shetland, Iceland and Bjornoya [Bear Island]). POPs (organochlorines [OCs] and polybrominated diphenyl ethers [BDEs]) were measured in plasma of incubating birds (n = 222), concentrations differing nearly tenfold among colonies: Bjornoya (2009) > Bjornoya (2010) > Iceland (2009) > Shetland (2009). Reproductive success (hatching success and chick survival) showed that breeding conditions were favourable in Shetland and at Bjornoya (2010), but were very poor in Iceland and at Bjornoya (2009). Biomarkers indicated that health was poor in the Shetland population compared to the other populations. Females whose chicks hatched late had high POP concentrations in all colonies except at Bjornoya (2010), and females losing their eggs at Bjornoya (2009) tended to have higher concentrations than those hatching. Moreover, there was a negative relationship between female POP concentrations and chick body condition at hatching in Iceland and at Bjornoya (2010). Supplementary feeding experiments were conducted, and in Iceland where feeding conditions were poor, significant negative relationships were found between female POP concentrations and daily growth-rate in first-hatched chicks of control nests, but not in food supplemented nests. This suggests that negative impacts of POPs were mitigated by improved feeding conditions. For second-chicks, there was a strong negative relationship between the female POP concentrations and growth-rate, but no effects of supplementary feeding. Lowered adult return-rate between breeding seasons with increasing POP loads were found both at Bjornoya (2009) and in Shetland, especially related to BDEs. This indicates stronger fitness consequences of POPs following seasons with very poor breeding conditions and/or high reproductive effort. This study suggests that the impacts of POPs may differ depending on population health and breeding conditions, and that even low concentrations of POPs could have ecological consequences during adverse circumstances. This is important with regard to risk assessment of biomagnifying contaminants in marine ecosystems.	[Bustnes, Jan O.; Bourgeon, Sophie; Hanssen, Sveinn A.] Norwegian Inst Nat Res NINA, Fram Ctr, N-9296 Tromso, Norway; [Bourgeon, Sophie; Strom, Hallvard; Gabrielsen, Geir W.] Norwegian Polar Res Inst, Fram Ctr, N-9296 Tromso, Norway; [Leat, Eliza H. K.; Furness, Robert W.] Univ Glasgow, Coll Med Vet & Life Sci, Glasgow G12 8QQ, Lanark, Scotland; [Magnusdottir, Ellen; Olafsdottir, Kristin] Univ Iceland, Dept Pharmacol & Toxicol, IS-107 Reykjavik, Iceland; [Borga, Katrine] Univ Oslo, Dept Biosci, N-0316 Oslo, Norway	Norwegian Institute Nature Research; Norwegian Polar Institute; University of Glasgow; University of Iceland; University of Oslo	Bustnes, JO (corresponding author), Norwegian Inst Nat Res NINA, Fram Ctr, N-9296 Tromso, Norway.	Jan.O.Bustnes@nina.no	Hanssen, Sveinn Are/C-9989-2009; Olafsdottir, Kristin/L-9430-2015	Hanssen, Sveinn Are/0000-0003-1792-435X; Olafsdottir, Kristin/0000-0002-3241-836X	Norwegian Research Council [184830]	Norwegian Research Council(Research Council of NorwayEuropean Commission)	The project was fully funded by the Norwegian Research Council (Grant Number: 184830).	AMAP Assessment, 2002, PERS ORG POLL ARCT; Arnold JM, 2004, J AVIAN BIOL, V35, P33, DOI 10.1111/j.0908-8857.2004.03059.x; Bourgeon S, 2013, ENVIRON SCI TECHNOL, V47, P5963, DOI 10.1021/es400442q; Bourgeon S, 2012, ENVIRON RES, V118, P31, DOI 10.1016/j.envres.2012.08.004; Bustnes JO, 2008, ENVIRON INT, V34, P193, DOI 10.1016/j.envint.2007.07.016; Bustnes JO, 2007, ENVIRON INT, V33, P911, DOI 10.1016/j.envint.2007.04.010; Bustnes JO, 2006, P ROY SOC B-BIOL SCI, V273, P3117, DOI 10.1098/rspb.2006.3687; Bustnes JO, 2008, ENVIRON POLLUT, V156, P417, DOI 10.1016/j.envpol.2008.01.028; Bustnes JO, 2000, ECOTOXICOLOGY, V9, P179, DOI 10.1023/A:1008938603257; Bustnes JO, 2005, ENVIRON POLLUT, V136, P175, DOI 10.1016/j.envpol.2004.09.026; Bustnes JO, 2006, J TOXICOL ENV HEAL A, V68, P1; Carere C, 2010, ANN I SUPER SANITA, V46, P81, DOI 10.4415/ANN_10_01_10; Chen D, 2010, ENVIRON INT, V36, P800, DOI 10.1016/j.envint.2010.05.013; Cury PM, 2011, SCIENCE, V334, P1703, DOI 10.1126/science.1212928; Danhardt A, 2011, ECOSYSTEMS, V14, P791, DOI 10.1007/s10021-011-9445-7; Eng ML, 2013, ENVIRON POLLUT, V178, P343, DOI 10.1016/j.envpol.2013.03.037; Erikstad KE, 1998, ECOLOGY, V79, P1781; Erikstad KE, 1998, J AVIAN BIOL, V29, P3, DOI 10.2307/3677334; Erikstad KE, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1483; Evenset A, 2005, ENVIRON POLLUT, V136, P419, DOI 10.1016/j.envpol.2005.01.018; Fischer BB, 2013, SCI TOTAL ENVIRON, V449, P253, DOI 10.1016/j.scitotenv.2013.01.066; Forbes VE, 2010, ECOL APPL, V20, P1449, DOI 10.1890/09-1063.1; Fridolfsson AK, 1999, J AVIAN BIOL, V30, P116, DOI 10.2307/3677252; Furness R. W., 1987, SKUAS; GILBERTSON M, 1991, J TOXICOL ENV HEALTH, V33, P455, DOI 10.1080/15287399109531538; Goldberg M, 2011, ENVIRON RES, V111, P1007, DOI 10.1016/j.envres.2011.08.010; Hamlin HJ, 2010, SYST BIOL REPROD MED, V56, P113, DOI 10.3109/19396360903244598; Henriksen EO, 1998, CHEMOSPHERE, V37, P2627, DOI 10.1016/S0045-6535(98)00162-3; Hipfner JM, 2001, CONDOR, V103, P240, DOI 10.1650/0010-5422(2001)103[0240:FSATCO]2.0.CO;2; Institute SAS, 2011, SAS 9 3 FDN MICR WIN; Kalmbach E, 2004, J AVIAN BIOL, V35, P501, DOI 10.1111/j.0908-8857.2004.03271.x; Kozak K, 2013, TRAC-TREND ANAL CHEM, V50, P107, DOI 10.1016/j.trac.2013.04.016; Leat EHK, 2013, MAR ECOL PROG SER, V491, P277, DOI 10.3354/meps10455; Leat EHK, 2011, ENVIRON POLLUT, V159, P1222, DOI 10.1016/j.envpol.2011.01.036; Letcher RJ, 2010, SCI TOTAL ENVIRON, V408, P2995, DOI 10.1016/j.scitotenv.2009.10.038; Lund-Hansen L.C., 1991, Acta Naturalia Islandica, V34, P1; Mitchell PI, 2004, SEABIRD POPULATIONS; Nakagawa S, 2004, BEHAV ECOL, V15, P1044, DOI 10.1093/beheco/arh107; Ottinger MA, 2011, J TOXICOL ENV HEAL B, V14, P413, DOI 10.1080/10937404.2011.578560; Perrins CM, 1996, IBIS, V138, P2, DOI 10.1111/j.1474-919X.1996.tb04308.x; Ratcliffe N, 1998, J ANIM ECOL, V67, P853, DOI 10.1046/j.1365-2656.1998.6760853.x; Ratcliffe N, 2002, IBIS, V144, P384, DOI 10.1046/j.1474-919X.2002.00066.x; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Sih A, 2004, TRENDS ECOL EVOL, V19, P274, DOI 10.1016/j.tree.2004.02.010; Slagsvold T, 2007, ANIM BEHAV, V73, P691, DOI 10.1016/j.anbehav.2006.05.021; Strom H., 2007, SEAPOP STUDIES LOFOT, V249, P50; Van Straalen NM, 2003, ENV SCI TECHNOL A, V325A; Venables WN., 2002, MODERN APPL STAT S 4; Verreault J, 2010, REV ENVIRON CONTAM T, V205, P77, DOI 10.1007/978-1-4419-5623-1_2; Votier SC, 2007, J AVIAN BIOL, V38, P234, DOI 10.1111/j.0908-8857.2007.03893.x; WILLIAMS TD, 1994, BIOL REV, V69, P35, DOI 10.1111/j.1469-185X.1994.tb01485.x; Wingfield JC, 2008, GEN COMP ENDOCR, V157, P207, DOI 10.1016/j.ygcen.2008.04.017; Wingfield JC, 2013, FUNCT ECOL, V27, P37, DOI 10.1111/1365-2435.12039	53	21	21	1	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0131769	10.1371/journal.pone.0131769	http://dx.doi.org/10.1371/journal.pone.0131769			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26172383	Green Published, gold, Green Accepted			2022-12-26	WOS:000358194900024
J	Hou, LY; Li, YZ; Song, HC; Zhang, ZH; Sun, YP; Zhang, XG; Wu, K				Hou, Liying; Li, Yuze; Song, Huacui; Zhang, Zhihong; Sun, Yanpei; Zhang, Xuguang; Wu, Kun			Protective Macroautophagy Is Involved in Vitamin E Succinate Effects on Human Gastric Carcinoma Cell Line SGC-7901 by Inhibiting mTOR Axis Phosphorylation	PLOS ONE			English	Article							ALPHA-TOCOPHERYL SUCCINATE; BREAST-CANCER CELLS; INDUCED APOPTOSIS; ANTICANCER AGENTS; MAMMALIAN TARGET; E ANALOGS; AUTOPHAGY; KINASE; PROTEIN; DEATH	Vitamin E succinate (VES), a potential cancer therapeutic agent, potently induces apoptosis and inhibits the growth of various cancer cells. Autophagy has been supposed to promote cancer cell survival or trigger cell death, depending on particular cancer types and tumor microenvironments. The role of autophagy in the growth suppressive effect of VES on gastric cancer cell is basically unknown. We aimed to determine whether and how autophagy affected the VES-induced inhibition of SGC-7901 human gastric carcinoma cell growth. SGC-7901 cells were treated with VES or pre-treated with autophagy inhibitor, chloroquine (CQ) and 3-methyladenine (3-MA). Electron microscopy, fluorescence microscopy and Western blot were used to study whether VES induced autophagy reaction in SGC-7901 cells. Western blot evaluated the activities of the mammalian target of rapamycin (mTOR) axis. Then we used 3-(4,5dimethylthiazol- 2-yl)-2,5-diphenyltetrazolium bromide (MTT) and flow cytometry to detect the level of cell viability and apoptosis. Collectively, our data indeed strongly support our hypothesis that VES treatment produced cytological variations that depict autophagy, increased the amount of intracellular green fluorescent protein-microtubule associated protein 1 light chain 3 (GFP-LC3) punctate fluorescence and the number of autophagic vacuoles. It altered the expression of endogenous autophagy marker LC3. VES activated the suppression of mTOR through inhibiting upstream regulators p38 MAPK and Akt. mTOR suppression consequently inhibited the activation of mTOR downstream targets p70S6K and 4E-BP-1. The activation of the upstream mTOR inhibitor AMPK had been up-regulated by VES. The results showed that pre-treatment SGC-7901 with autophagy inhibitors before VES treatment could increase the capacity of VES to reduce cell viability and to provoke apoptosis. In conclusion, VES-induced autophagy participates in SGC-7901 cell protection by inhibitingmTOR axis phosphorylation. Our findings not only strengthen our understanding of the roles of autophagy in cancer biology, but may also be useful for developing new treatments for gastric cancer patients.	[Hou, Liying; Li, Yuze; Song, Huacui; Zhang, Zhihong; Sun, Yanpei; Zhang, Xuguang; Wu, Kun] Harbin Med Univ, Sch Publ Hlth, Dept Nutr & Food Hyg, Harbin, Peoples R China; [Li, Yuze] Fourth Hosp Heilongjiang Prov, Dept Internal Med 4, Harbin, Peoples R China; [Zhang, Zhihong] Heilongjiang Acad Agr Sci, Food Proc Inst, Harbin, Peoples R China; [Zhang, Xuguang] Harbin Childrens Hosp, Dept Internal Med Hematol & Oncol, Harbin, Peoples R China	Harbin Medical University; Heilongjiang Academy of Agricultural Sciences	Wu, K (corresponding author), Harbin Med Univ, Sch Publ Hlth, Dept Nutr & Food Hyg, Harbin, Peoples R China.	wukun_15000@126.com	zhang, zh/GWV-4677-2022		National Natural Science Foundation of China [81172651]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (no. 81172651) to KW.	Abedin MJ, 2007, CELL DEATH DIFFER, V14, P500, DOI 10.1038/sj.cdd.4402039; Ahn CH, 2007, APMIS, V115, P1344, DOI 10.1111/j.1600-0463.2007.00858.x; Asnaghi L, 2004, PHARMACOL RES, V50, P545, DOI 10.1016/j.phrs.2004.03.007; Baehrecke EH, 2005, NAT REV MOL CELL BIO, V6, P505, DOI 10.1038/nrm1666; Bang OS, 2001, BIOCHEM BIOPH RES CO, V288, P789, DOI 10.1006/bbrc.2001.5839; Beljanski V, 2010, J PHARMACOL EXP THER, V333, P454, DOI 10.1124/jpet.109.163337; Bonapace L, 2010, J CLIN INVEST, V120, P1310, DOI 10.1172/JCI39987; Brech A, 2009, MOL ONCOL, V3, P366, DOI 10.1016/j.molonc.2009.05.007; Bursch W, 2000, ANN NY ACAD SCI, V926, P1, DOI 10.1111/j.1749-6632.2000.tb05594.x; Carracedo A, 2008, J CLIN INVEST, V118, P3065, DOI [10.1172/jCI34739, 10.1172/JCI34739]; Degtyarev M, 2008, J CELL BIOL, V183, P101, DOI 10.1083/jcb.200801099; Feng ZH, 2005, P NATL ACAD SCI USA, V102, P8204, DOI 10.1073/pnas.0502857102; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hu C, 2012, TOXICOL LETT, V210, P78, DOI 10.1016/j.toxlet.2012.01.019; Huang XL, 2010, CANCER LETT, V296, P123, DOI 10.1016/j.canlet.2010.04.002; Israel K, 2000, NUTR CANCER, V36, P90, DOI 10.1207/S15327914NC3601_13; Iwamaru A, 2007, ONCOGENE, V26, P1840, DOI 10.1038/sj.onc.1209992; Jung CH, 2010, FEBS LETT, V584, P1287, DOI 10.1016/j.febslet.2010.01.017; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Karim MR, 2010, BIOCHEM BIOPH RES CO, V394, P981, DOI 10.1016/j.bbrc.2010.03.103; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kimura N, 2003, GENES CELLS, V8, P65, DOI 10.1046/j.1365-2443.2003.00615.x; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Kondo Y, 2005, NAT REV CANCER, V5, P726, DOI 10.1038/nrc1692; Liang CY, 2010, CURR OPIN CELL BIOL, V22, P226, DOI 10.1016/j.ceb.2009.11.003; Liang CY, 2012, ONCOL REP, V27, P1079, DOI 10.3892/or.2011.1593; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Lockshin RA, 2004, INT J BIOCHEM CELL B, V36, P2405, DOI 10.1016/j.biocel.2004.04.011; Mahoney E, 2013, AUTOPHAGY, V9, P434, DOI 10.4161/auto.23027; Mann SS, 1996, J NEUROSCI RES, V43, P535, DOI 10.1002/(SICI)1097-4547(19960301)43:5<535::AID-JNR3>3.0.CO;2-J; Moreau K, 2010, CURR OPIN CELL BIOL, V22, P206, DOI 10.1016/j.ceb.2009.12.002; Morselli E, 2009, BBA-MOL CELL RES, V1793, P1524, DOI 10.1016/j.bbamcr.2009.01.006; Neuzil J, 2001, FASEB J, V15, P403, DOI 10.1096/fj.00-0251com; Neuzil J, 2001, BRIT J CANCER, V84, P87, DOI 10.1054/bjoc.2000.1559; Neuzil J, 2007, MOL PHARMACOL, V71, P1185, DOI 10.1124/mol.106.030122; Parkin DM, 2005, CA CANC J CLIN, V55, P74; Prasad KN, 2003, J AM COLL NUTR, V22, P108, DOI 10.1080/07315724.2003.10719283; PRASAD RN, 1987, IMMUNOL CELL BIOL, V65, P211, DOI 10.1038/icb.1987.23; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Ren JH, 2010, CANCER BIOTHER RADIO, V25, P75, DOI 10.1089/cbr.2009.0701; SAHU SN, 1988, J AM COLL NUTR, V7, P285, DOI 10.1080/07315724.1988.10720245; Shi Z, 2013, CANCER LETT, V337, P149, DOI 10.1016/j.canlet.2013.06.004; Tang GM, 2008, HUM MOL GENET, V17, P1540, DOI 10.1093/hmg/ddn042; Turcotte S, 2008, CANCER CELL, V14, P90, DOI 10.1016/j.ccr.2008.06.004; Wang XF, 2006, MOL NUTR FOOD RES, V50, P675, DOI 10.1002/mnfr.200500267; Wu K, 2002, WORLD J GASTROENTERO, V8, P982, DOI 10.3748/wjg.v8.i6.982; Wu K, 2002, WORLD J GASTROENTERO, V8, P26, DOI 10.3748/wjg.v8.i1.26; Wu K, 2004, WORLD J GASTROENTERO, V10, P1110; Wu WKK, 2010, AUTOPHAGY, V6, P228, DOI 10.4161/auto.6.2.11042; Yang L, 2005, CANCER EPIDEM BIOMAR, V14, P243; Yang ZF, 2010, CURR OPIN CELL BIOL, V22, P124, DOI 10.1016/j.ceb.2009.11.014; Yin F, 2003, BIOSENS BIOELECTRON, V19, P297, DOI 10.1016/S0956-5663(03)00197-0; Yoshioka A, 2008, INT J ONCOL, V33, P461, DOI 10.3892/ijo_00000028; Yu WP, 1999, CANCER RES, V59, P953; Zhang XN, 2013, TOXICOL APPL PHARM, V270, P122, DOI 10.1016/j.taap.2013.04.011; Zhang XG, 2011, CANCER LETT, V307, P174, DOI 10.1016/j.canlet.2011.04.001; Zhang Y, 2002, P NATL ACAD SCI USA, V99, P7408, DOI 10.1073/pnas.102014399	58	12	14	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0132829	10.1371/journal.pone.0132829	http://dx.doi.org/10.1371/journal.pone.0132829			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26168048	Green Published, gold, Green Submitted			2022-12-26	WOS:000358193100086
J	Fernandez, V; Buffetaut, E; Suteethorn, V; Rage, JC; Tafforeau, P; Kundrat, M				Fernandez, Vincent; Buffetaut, Eric; Suteethorn, Varavudh; Rage, Jean-Claude; Tafforeau, Paul; Kundrat, Martin			Evidence of Egg Diversity in Squamate Evolution from Cretaceous Anguimorph Embryos	PLOS ONE			English	Article							RED-BED SEQUENCES; SPHENODON-PUNCTATUS; REPTILIA SQUAMATA; FOSSIL RECORD; DINOSAUR EGGS; KHORAT GROUP; SE ASIA; SHELLS; THAILAND; LIZARDS	Lizards are remarkable amongst amniotes, for they display a unique mosaic of reproduction modes ranging from egg-laying to live-bearing. Within this patchwork, geckoes are believed to represent the only group to ever have produced fully calcified rigid-shelled eggs, contrasting with the ubiquitous parchment shelled-eggs observed in other lineages. However, this hypothesis relies only on observations of modern taxa and fossilised gecko-like eggshells which have never been found in association with any embryonic or parental remains. We report here the first attested fossil eggs of lizards from the Early Cretaceous of Thailand, combining hard eggshells with exquisitely preserved embryos of anguimoph (e.g. Komodo dragons, mosasaurs). These fossils shed light on an apparently rare reproduction strategy of squamates, demonstrate that the evolution of rigid-shelled eggs are not an exclusive specialization of geckoes, and suggest a high plasticity in the reproductive organs mineralizing eggshells.	[Fernandez, Vincent; Tafforeau, Paul] European Synchrotron Radiat Facil, F-38043 Grenoble, France; [Fernandez, Vincent] Univ Witwatersrand, Evolutionary Studies Inst, ZA-2050 Johannesburg, South Africa; [Buffetaut, Eric] Ecole Normale Super, Geol Lab, CNRS, UMR Unite Mixte Rech 8538, F-75231 Paris, France; [Suteethorn, Varavudh] Mahasarakham Univ, Palaeontol Res & Educ Ctr, Kantharawichai Dist 44150, Maha Sarakham P, Thailand; [Rage, Jean-Claude] UPMC Paris6, CNRS, Univ Paris 04, Museum Natl Hist Nat,MNHN CR2P, F-75005 Paris, France; [Kundrat, Martin] Uppsala Univ, Dept Organismal Biol, Evolutionary Biol Ctr, Subdept Dev & Evolut, S-75236 Uppsala, Sweden; [Kundrat, Martin] Acad Sci Czech Republ, Inst Physiol, Dept Biomath, CR-14220 Prague, Czech Republic	European Synchrotron Radiation Facility (ESRF); University of Witwatersrand; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Mahasarakham University; Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Uppsala University; Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences	Fernandez, V (corresponding author), European Synchrotron Radiat Facil, 71 Rue Martyrs, F-38043 Grenoble, France.	vinfernand@gmail.com; martin.kundrat@ebc.uu.se	Kundrát, Martin/F-4959-2017	Kundrát, Martin/0000-0001-9361-2273; Fernandez, Vincent/0000-0002-8315-1458; Tafforeau, Paul/0000-0002-5962-1683	European Synchrotron Radiation Facility (ESRF, France); ECLIPSE 2 programme of the Centre National de la Recherche Scientifique (CNRS, France); CNRS-Thailand Research Fund joint project; Biodiversity Research and Training Program (BRT, Thailand); Department of Mineral Resources (Bangkok, Thailand); Linnaeus Framework Grant "The Genomics of Phenotypic Diversity in Natural Populations" (the Swedish Research Council); Czech Science Foundation [P302/12/1207]	European Synchrotron Radiation Facility (ESRF, France); ECLIPSE 2 programme of the Centre National de la Recherche Scientifique (CNRS, France); CNRS-Thailand Research Fund joint project; Biodiversity Research and Training Program (BRT, Thailand); Department of Mineral Resources (Bangkok, Thailand); Linnaeus Framework Grant "The Genomics of Phenotypic Diversity in Natural Populations" (the Swedish Research Council); Czech Science Foundation(Grant Agency of the Czech Republic)	This project was funded by the European Synchrotron Radiation Facility (ESRF, France), the ECLIPSE 2 programme of the Centre National de la Recherche Scientifique (CNRS, France), the CNRS-Thailand Research Fund joint project, the Biodiversity Research and Training Program (BRT, Thailand), the Department of Mineral Resources (Bangkok, Thailand), the Linnaeus Framework Grant "The Genomics of Phenotypic Diversity in Natural Populations" (the Swedish Research Council), and the Czech Science Foundation (P302/12/1207).	[Anonymous], 1984, PALAEONTOL POLONICA; Bhullar BAS, 2012, J EXP ZOOL PART B, V318B, P521, DOI 10.1002/jez.b.22456; Blackburn DG, 1998, J EXP ZOOL, V282, P560; Buffetaut E, 2005, NATURWISSENSCHAFTEN, V92, P477, DOI 10.1007/s00114-005-0022-9; Carlson KJ, 2011, SCIENCE, V333, P1402, DOI 10.1126/science.1203922; Carpenter K., 1999, EGGS NESTS BABY DINO; Conrad JL, 2008, B AM MUS NAT HIST, P1, DOI 10.1206/310.1; Conrad JL, 2011, CLADISTICS, V27, P230, DOI 10.1111/j.1096-0031.2010.00330.x; Deeming DC, 2014, ROY SOC OPEN SCI, V1, DOI 10.1098/rsos.140311; DEEMING DC, 1988, HERPETOL J, V1, P230; Estes R., 1988, P119; Evans SE, 2003, BIOL REV, V78, P513, DOI 10.1017/S1464793103006134; Evans SE, 2006, CRETACEOUS RES, V27, P673, DOI 10.1016/j.cretres.2006.03.004; Fernandez V, 2012, MICROSC MICROANAL, V18, P179, DOI 10.1017/S1431927611012426; Fernandez V, 2009, GEOL SOC SPEC PUBL, V315, P285, DOI 10.1144/SP315.20; Gauthier JA, 2012, B PEABODY MUS NAT HI, V53, P3, DOI 10.3374/014.053.0101; Grellet-Tinner G, 2006, PALAEOGEOGR PALAEOCL, V232, P294, DOI 10.1016/j.palaeo.2005.10.029; Grigorescu D, 1994, DINOSAUR EGGS BABIES, P85; Grigorescu D, 2010, PALAEOGEOGR PALAEOCL, V293, P360, DOI 10.1016/j.palaeo.2010.03.031; Hirsch K., 1989, Historical Biology, V3, P61; HIRSCH K F, 1987, Annals of Carnegie Museum, V56, P223; Hirsch KF, 1996, J VERTEBR PALEONTOL, V16, P752, DOI 10.1080/02724634.1996.10011363; HORNER JR, 1988, NATURE, V332, P256, DOI 10.1038/332256a0; Horner JR, 1996, NATURE, V383, P103, DOI 10.1038/383103b0; Horner JR, 1997, J VERTEBR PALEONTOL, V17, P431, DOI 10.1080/02724634.1997.10010987; KOHRING R, 1991, PALAEONTOLOGY, V34, P237; MACHATSCHKI F, 1936, FORTSCHRITTE MINERAL, V0020; McDOWELL SAMUEL BOOKER, 1954, BULL AMER MUS NAT HIST, V105, P1; NORELL MA, 1994, SCIENCE, V266, P779, DOI 10.1126/science.266.5186.779; PACKARD GC, 1977, BIOL REV, V52, P71, DOI 10.1111/j.1469-185X.1977.tb01346.x; PACKARD MJ, 1991, CAN J ZOOL, V69, P303, DOI 10.1139/z91-049; PACKARD MJ, 1982, J MORPHOL, V174, P197, DOI 10.1002/jmor.1051740208; PACKARD MJ, 1988, J MORPHOL, V197, P147, DOI 10.1002/jmor.1051970203; PACKARD MJ, 1982, ZOOL J LINN SOC-LOND, V75, P297, DOI 10.1111/j.1096-3642.1982.tb01950.x; PACKARD MJ, 1982, HERPETOLOGICA, V38, P136; PACKARD MJ, 1989, CAN J ZOOL, V67, P746, DOI 10.1139/z89-106; Pilati T, 1998, ACTA CRYSTALLOGR B, V54, P515, DOI 10.1107/S0108768197018181; PREGILL G K, 1986, Transactions of the San Diego Society of Natural History, V21, P167; Preibisch S, 2009, BIOINFORMATICS, V25, P1463, DOI 10.1093/bioinformatics/btp184; Racey A, 2009, GEOL SOC SPEC PUBL, V315, P41, DOI 10.1144/SP315.5; Racey A, 2009, GEOL SOC SPEC PUBL, V315, P69, DOI 10.1144/SP315.6; Rage JC, 2010, GEOBIOS-LYON, V43, P253, DOI 10.1016/j.geobios.2009.08.002; Rieppel O., 1992, FIELDIANA, V68, P1; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Shukla UK, 2008, CRETACEOUS RES, V29, P674, DOI 10.1016/j.cretres.2008.02.003; Tumpeesuwan Sakboworn, 2010, Tropical Natural History, V10, P93; Varricchio DJ, 2011, HIST BIOL, V23, P91, DOI 10.1080/08912963.2010.500379; Weitkamp T, 2011, J SYNCHROTRON RADIAT, V18, P617, DOI 10.1107/S0909049511002895	48	21	23	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0128610	10.1371/journal.pone.0128610	http://dx.doi.org/10.1371/journal.pone.0128610			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176757	Green Published, gold, Green Submitted			2022-12-26	WOS:000358197600009
J	Gaetano, LC; Abdala, F				Gaetano, Leandro C.; Abdala, Fernando			The Stapes of Gomphodont Cynodonts: Insights into the Middle Ear Structure of Non-Mammaliaform Cynodonts	PLOS ONE			English	Article							SOUTH-AFRICA; EVOLUTION; ORIGIN; PHYLOGENY; SKULL	The stapes is known in several non-mammaliaform cynodonts, although it has only been cursorily studied. Here we thoroughly analyze the stapedial anatomy of several basal cynodonts in a phylogenetic framework. Our study shows that the stapedial anatomy is more variable than previously thought. The morphological variation of the stapes led to the recognition of 11 phylogenetic characters that were included in a total evidence data matrix centered in the analysis of gomphodont cynodonts. Stapes morphology does not provide evidence to suggest a direct connection between the stapes and a postquadrate tympanic membrane (if present) and the hypothesis of a dorsal process as the site of attachment of a small ligament or the stapedial muscle is supported. The re-evaluation of the theories concerning the position of the tympanic membrane in non-mammaliaform cynodonts allowed us to conclude that the hypothetical postquadrate tympanic membrane associated with the squamosal sulcus is at best relictual and most likely non-functional (not connected with the stapes). The sound waves were most likely transmitted to the stapes from a postdentary tympanic membrane through the quadrate. Our analysis results in a better understanding of the auditory system in basal cynodonts and its evolution, highlighting the variability of the stapedial anatomy.	[Gaetano, Leandro C.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Ciencias Geol, Inst Estudios Andinos Don Pablo Groeber, Buenos Aires, DF, Argentina; [Gaetano, Leandro C.; Abdala, Fernando] Univ Witwatersrand, Evolutionary Studies Inst, Johannesburg, South Africa; [Abdala, Fernando] NRF DST Ctr Excellence Palaeosci, Johannesburg, South Africa	University of Buenos Aires; University of Witwatersrand	Gaetano, LC (corresponding author), Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Ciencias Geol, Inst Estudios Andinos Don Pablo Groeber, Buenos Aires, DF, Argentina.	lcgaetano@gl.fcen.uba.ar	Abdala, Fernando/I-8054-2019		Agencia Nacional de Promocion Cientifica y Tecnologica (Proyecto de Investigacion Cientifica y Tecnologica) [2013-2701]; National Research Foundation of South Africa; South Africa (Department of Science and Technology); National Research Foundation Research Incentive; Universidad de Buenos Aires Ciencia y Tecnica [X 133, 00728 2011-2014]; Proyecto de Investigacion Cientifica y Tecnologica [07-373]; Proyecto de Investigacion Plurianual Consejo Nacional de Investigaciones Cientificas y Tecnicas [0209/10]	Agencia Nacional de Promocion Cientifica y Tecnologica (Proyecto de Investigacion Cientifica y Tecnologica); National Research Foundation of South Africa(National Research Foundation - South Africa); South Africa (Department of Science and Technology); National Research Foundation Research Incentive; Universidad de Buenos Aires Ciencia y Tecnica; Proyecto de Investigacion Cientifica y Tecnologica; Proyecto de Investigacion Plurianual Consejo Nacional de Investigaciones Cientificas y Tecnicas	This research was supported by grants from the Agencia Nacional de Promocion Cientifica y Tecnologica (Proyecto de Investigacion Cientifica y Tecnologica-2013-2701 to LCG) and the National Research Foundation of South Africa (to FA). Travel funds were provided by the Bi-National Cooperation Project between South Africa (Department of Science and Technology to B. Rubidge) and Argentina (Ministerio de Ciencia, Tecnica e Innovacion Productiva to C. Marsicano) and by the National Research Foundation Research Incentive to FA. Field exploration was supported by Universidad de Buenos Aires Ciencia y Tecnica X 133, Universidad de Buenos Aires Ciencia y Tecnica 00728 2011-2014, Proyecto de Investigacion Cientifica y Tecnologica 07-373, and Proyecto de Investigacion Plurianual Consejo Nacional de Investigaciones Cientificas y Tecnicas 0209/10. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdala F, 2006, ZOOL J LINN SOC-LOND, V147, P383, DOI 10.1111/j.1096-3642.2006.00224.x; Abdala F, 2002, J VERTEBR PALEONTOL, V22, P313, DOI 10.1671/0272-4634(2002)022[0313:ANSOTT]2.0.CO;2; Abdala F, 2000, J VERTEBR PALEONTOL, V20, P501, DOI 10.1671/0272-4634(2000)020[0501:GCOTCA]2.0.CO;2; Abdala F, 2010, PALAEOGEOGR PALAEOCL, V286, P202, DOI 10.1016/j.palaeo.2010.01.011; Abdala F, 2009, J VERTEBR PALEONTOL, V29, P837, DOI 10.1671/039.029.0303; Allin E.F., 1986, P283; ALLIN EF, 1992, EVOLUTIONARY BIOLOGY OF HEARING, P587; ALLIN EF, 1975, J MORPHOL, V147, P403, DOI 10.1002/jmor.1051470404; Anthwal N, 2013, J ANAT, V222, P147, DOI 10.1111/j.1469-7580.2012.01526.x; BARGHUSEN HERBERT R., 1968, POSTILLA [YALE PEABODY MUS], V116, P1; BARGHUSEN HR, 1970, SCIENCE, V168, P573, DOI 10.1126/science.168.3931.573; BONAPARTE JF, 1966, ACTA GEOLOGICA LILLO, V8, P5; Broom R, 1912, P ZOOL SOC LOND, V1912, P419; Clack JA, 2004, SPR HDB AUD, V22, P128; Crompton A.W., 1972, P231; CROMPTON A. W., 1963, PROC ZOOL SOC LONDON, V140, P697; Estes R., 1961, Bulletin of the Museum of Comparative Zoology, V125, P165; Faurie S., 1974, Annals S Afr Mus, V65, P337; Flynn JJ, 2000, J VERTEBR PALEONTOL, V20, P422, DOI 10.1671/0272-4634(2000)020[0422:NTSEFT]2.0.CO;2; FOURIE S, 1968, South African Journal of Science, V64, P255; Gaetano LC, 2014, 4 INT PAL C, P526; Gao KQ, 2010, AM MUS NOVIT, P1, DOI 10.1206/649.1; Gaupp E., 1913, ARCH ANATOMIE ENTWIC, P1; Goloboff P.A., 2003, TREE ANAL USING NEW; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Goodrich ES., 1930, STUDIES STRUCTURE DE, DOI [DOI 10.5962/BHL.TITLE.82144, 10.5962/bhl.title.82144]; HOPSON JA, 1966, AM ZOOL, V6, P437; Hopson James A., 2005, Palaeontologia Africana, V41, P53; HOTTON N, 1959, EVOLUTION, V13, P99; Jenkins F. A. Jr., 1970, Breviora, V352, P1; Kammerer CF, 2008, J VERTEBR PALEONTOL, V28, P445, DOI 10.1671/0272-4634(2008)28[445:NMOMBC]2.0.CO;2; Kemp TS, 2007, J VERTEBR PALEONTOL, V27, P431, DOI 10.1671/0272-4634(2007)27[431:ATFOTP]2.0.CO;2; KEMP TS, 1979, PHILOS T ROY SOC B, V285, P73, DOI 10.1098/rstb.1979.0001; KEMP TS, 2005, ORIGIN EVOLUTION MAM; KERMACK K A, 1983, Acta Palaeontologica Polonica, V28, P147; Kermack K.A., 1982, Geobios Memoire Special (Lyon), P151; KERMACK KA, 1981, ZOOL J LINN SOC-LOND, V71, P1, DOI 10.1111/j.1096-3642.1981.tb01127.x; Kielan-Jaworowska Z., 2005, MAMMALS AGE DINOSAUR; KlaauW C.J., 1923, Z ANATOMIE ENTWICKLU, V69, P32; Lillegraven J.A., 1991, Contributions to Geology University of Wyoming, V28, P39; Liu J, 2014, VERTEBR PALEOBIOL PA, P255, DOI 10.1007/978-94-007-6841-3_15; Liu J, 2010, J MAMM EVOL, V17, P151, DOI 10.1007/s10914-010-9136-8; Luo ZX, 2007, NATURE, V450, P1011, DOI 10.1038/nature06277; MAIER W, 1990, NETH J ZOOL, V40, P55, DOI 10.1163/156854289X00183; Melo T, J VERT PALE IN PRESS; Meng J, 2011, NATURE, V472, P181, DOI 10.1038/nature09921; Novacek M.J., 1986, Contributions to Geology Special Paper, P35; PARRINGTON F. R., 1955, PROC ZOOL SOC LONDON, V125, P1; PARRINGTON FR, 1979, BIOL REV, V54, P369, DOI 10.1111/j.1469-185X.1979.tb00842.x; PARRINGTON FR, 1974, J NAT HIST, V8, P421, DOI 10.1080/00222937400770351; PARRINGTON FR, 1946, P ZOOL SOC LOND, V116, P181; Presley R., 1984, S ZOOL SOC LOND, V52, P127; Reichert C., 1837, ARCH ANATOMIE PHYSL, V1837, P120; Romer A, 1956, OSTEOLOGY REPTILES; Romer A. S., 1970, Breviora, VNo. 344, P1; Romer A.S., 1972, Breviora, VNo. 396, P1; ROMER ALFRED SHERWOOD, 1967, BREV MUS COMP ZOOL [HARVARD], V264, P1; Rowe T., 1988, Journal of Vertebrate Paleontology, V8, P241; Schumacher, 1972, MORPHOLOGY MAXILLOMA, P26; SHUTE CCD, 1956, J ANAT, V90, P261; Takechi M, 2010, J EXP ZOOL PART B, V314B, P417, DOI 10.1002/jez.b.21347; TUMARKIN A, 1948, J Laryngol Otol, V62, P687, DOI 10.1017/S002221510000952X; WATSON DMS, 1953, EVOLUTION, V7, P159, DOI 10.1111/j.1558-5646.1953.tb00074.x; Westoll TS, 1943, PROC R SOC SER B-BIO, V131, P393, DOI 10.1098/rspb.1943.0014; WESTOLL TS, 1945, NATURE, V155, P114, DOI 10.1038/155114a0; Westoll TS, 1944, NATURE, V154, P770, DOI 10.1038/154770b0; WIBLE JR, 1993, MAMMAL PHYLOGENY, P45; Williams PL, 1989, GRAYS ANATOMY; YOUNG CC, 1947, P ZOOL SOC LOND, V117, P537	69	17	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0131174	10.1371/journal.pone.0131174	http://dx.doi.org/10.1371/journal.pone.0131174			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176619	Green Published, gold, Green Submitted			2022-12-26	WOS:000358197600037
J	Altamiranda, EG; Manrique, JM; Perez, SE; Rios, GL; Odeon, AC; Leunda, MR; Jones, LR; Verna, A				Gonzalez Altamiranda, Erika; Manrique, Julieta M.; Perez, Sandra E.; Rios, Glenda L.; Odeon, Anselmo C.; Leunda, Maria R.; Jones, Leandro R.; Verna, Andrea			Molecular Characterization of the First Bovine Herpesvirus 4 (BoHV-4) Strains Isolated from In Vitro Bovine Embryos production in Argentina	PLOS ONE			English	Article							POSTPARTUM METRITIS; TYPE-4; INFECTION; VIRUS; BOVINE-HERPESVIRUS-4; ENDOMETRITIS; DISEASE; CATTLE; HERD	Bovine herpesvirus 4 (BoHV-4) is increasingly considered as responsible for various problems of the reproductive tract. The virus infects mainly blood mononuclear cells and displays specific tropism for vascular endothelia, reproductive and fetal tissues. Epidemiological studies suggest its impact on reproductive performance, and its presence in various sites in the reproductive tract highlights its potential transmission in transfer-stage embryos. This work describes the biological and genetic characterization of BoHV-4 strains isolated from an in vitro bovine embryo production system. BoHV-4 strains were isolated in 2011 and 2013 from granulosa cells and bovine oocytes from ovary batches collected at a local abattoir, used as "starting material" for in vitro production of bovine embryos. Compatible BoHV-4-CPE was observed in the co-culture of granulosa cells and oocytes with MDBK cells. The identity of the isolates was confirmed by PCR assays targeting three ORFs of the viral genome. The phylogenetic analyses of the strains suggest that they were evolutionary unlinked. Therefore it is possible that BoHV-4 ovary infections occurred regularly along the evolution of the virus, at least in Argentina, which can have implications in the systems of in vitro embryo production. Thus, although BoHV-4 does not appear to be a frequent risk factor for in vitro embryo production, data are still limited. This study reveals the potential of BoHV-4 transmission via embryo transfer. Moreover, the high variability among the BoHV-4 strains isolated from aborted cows in Argentina highlights the importance of further research on the role of this virus as an agent with the potential to cause reproductive disease in cattle. The genetic characterization of the isolated strains provides data to better understand the pathogenesis of BoHV-4 infections. Furthermore, it will lead to fundamental insights into the molecular aspects of the virus and the means by which these strains circulate in the herds.	[Gonzalez Altamiranda, Erika; Odeon, Anselmo C.; Leunda, Maria R.; Verna, Andrea] Inst Nacl Tecnol Agr, Virol Lab, Dept Anim Prod, Buenos Aires, DF, Argentina; [Manrique, Julieta M.; Jones, Leandro R.] Univ Nacl Patagonia San Juan Bosco, Lab Virol & Genet Mol, Fac Ciencias Nat Sede Trelew, Comodoro Rivadavia, Chubut, Argentina; [Perez, Sandra E.] Univ Nacl Ctr Prov Buenos Aires, Fac Ciencias Vet, Buenos Aires, DF, Argentina; [Rios, Glenda L.] Inst Nacl Tecnol Agr, Lab Prod Embriones, Dept Anim Prod, Buenos Aires, DF, Argentina; [Gonzalez Altamiranda, Erika; Manrique, Julieta M.; Perez, Sandra E.; Jones, Leandro R.; Verna, Andrea] Consejo Nacl Invest Cient & Tecn, Buenos Aires, DF, Argentina	Instituto Nacional de Tecnologia Agropecuaria (INTA); Universidad Nacional de la Patagonia San Juan Bosco; Comision Nacional de Energia Atomica (CNEA); Instituto Nacional de Tecnologia Agropecuaria (INTA); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Verna, A (corresponding author), Inst Nacl Tecnol Agr, Virol Lab, Dept Anim Prod, Buenos Aires, DF, Argentina.	verna.andrea@inta.gob.ar	perez, sandra elizabeth/S-9336-2019	Jones, Leandro/0000-0002-5877-4194	Instituto Nacional de Tecnologia Agropecuaria [PNSA1115053, PNSA1115052]; Agencia Nacional de Promocion Cientifica y Tecnologica [PICT 2011-0312]	Instituto Nacional de Tecnologia Agropecuaria; Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT)	Support was provided by Instituto Nacional de Tecnologia Agropecuaria: Project PNSA1115053 and PNSA1115052; Agencia Nacional de Promocion Cientifica y Tecnologica: Project PICT 2011-0312. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARTHA A, 1966, ACTA VET ACAD SCI H, V16, P357; BIELANSKI A, 1993, THERIOGENOLOGY, V40, P531, DOI 10.1016/0093-691X(93)90406-U; Bilge Dagalp S, 2007, REV MED VET-TOULOUSE, V158, P201; Brenner MPC, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-53; BUBLOT M, 1992, VIROLOGY, V190, P654, DOI 10.1016/0042-6822(92)90903-3; Chastant-Maillard S, 2013, TRANSBOUNDARY EMRGIN, P1; Czaplicki G, 1998, PREV VET MED, V33, P235, DOI 10.1016/S0167-5877(97)00036-6; Deim Z, 2007, CAN J VET RES, V71, P226; Deim Z, 2006, MICROB PATHOGENESIS, V41, P144, DOI 10.1016/j.micpath.2006.03.006; Donofrio G, 2003, VET RES COMMUN, V27, P415, DOI 10.1023/A:1024889606158; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Duffy S, 2008, NAT REV GENET, V9, P267, DOI 10.1038/nrg2323; Egyed L, 1996, J CLIN MICROBIOL, V34, P1091, DOI 10.1128/JCM.34.5.1091-1095.1996; Egyed L, 2011, MICROB PATHOGENESIS, V50, P322, DOI 10.1016/j.micpath.2010.10.006; FABIAN K, 2008, VET J, V177, P289, DOI DOI 10.1016/j.tvjl.2007.04.010; Felsenstein J., 2004, INFERRING PHYLOGENIE; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Frazier K, 2001, J VET DIAGN INVEST, V13, P502, DOI 10.1177/104063870101300608; Gillet L, 2004, J VIROL, V78, P2336, DOI 10.1128/JVI.78.5.2336-2347.2004; Gur S, 2010, ANIM SCI J, V81, P304, DOI 10.1111/j.1740-0929.2010.00743.x; HENRY BE, 1986, AM J VET RES, V47, P2242; Kalman D, 2004, MICROB PATHOGENESIS, V37, P125, DOI 10.1016/j.micpath.2004.06.011; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Lete C, 2012, J VIROL, V86, P11567, DOI 10.1128/JVI.00456-12; McGeoch DJ, 2006, VIRUS RES, V117, P90, DOI 10.1016/j.virusres.2006.01.002; Monge A, 2006, RES VET SCI, V80, P120, DOI 10.1016/j.rvsc.2005.04.001; Moran P E, 2013, Open Vet J, V3, P126; NAEEM K, 1989, AM J VET RES, V50, P1931; Nikolin VM, 2007, NEW MICROBIOL, V30, P53; Nylander JAA, 2004, PROGRAM DISTRIBUTED; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Shin YC, 2010, VIROLOGY, V400, P175, DOI 10.1016/j.virol.2010.01.030; Silva-Frade C, 2010, THERIOGENOLOGY, V74, P1296, DOI 10.1016/j.theriogenology.2010.06.001; STRINGFELLOW DA, 1990, THERIOGENOLOGY, V34, P427, DOI 10.1016/0093-691X(90)90755-I; THIRY E, 1992, VET MICROBIOL, V33, P79, DOI 10.1016/0378-1135(92)90037-T; Verna A., 2008, REV ARGENT MICROBIOL, V40, P130; Verna AE, 2012, VET MICROBIOL, V160, P1, DOI 10.1016/j.vetmic.2012.04.039; WELLEMANS G, 1986, ANN RECH VET, V17, P89; Wellenberg GJ, 2001, J VIROL METHODS, V97, P101, DOI 10.1016/S0166-0934(01)00341-X	40	11	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132212	10.1371/journal.pone.0132212	http://dx.doi.org/10.1371/journal.pone.0132212			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177382	Green Published, Green Submitted, gold			2022-12-26	WOS:000358197600091
J	Gordon, SP; Tseng, E; Salamov, A; Zhang, JW; Meng, XD; Zhao, ZY; Kang, DW; Underwood, J; Grigoriev, IV; Figueroa, M; Schilling, JS; Chen, F; Wang, Z				Gordon, Sean P.; Tseng, Elizabeth; Salamov, Asaf; Zhang, Jiwei; Meng, Xiandong; Zhao, Zhiying; Kang, Dongwan; Underwood, Jason; Grigoriev, Igor V.; Figueroa, Melania; Schilling, Jonathan S.; Chen, Feng; Wang, Zhong			Widespread Polycistronic Transcripts in Fungi Revealed by Single-Molecule mRNA Sequencing	PLOS ONE			English	Article							POLY(A) SIGNALS; HUMAN GENOME; SEQ; EXPRESSION; GENES; INTERFERENCE; MECHANISMS; COMPLEXITY; GENERATION; PLATFORM	Genes in prokaryotic genomes are often arranged into clusters and co-transcribed into polycistronic RNAs. Isolated examples of polycistronic RNAs were also reported in some higher eukaryotes but their presence was generally considered rare. Here we developed a long-read sequencing strategy to identify polycistronic transcripts in several mushroom forming fungal species including Plicaturopsis crispa, Phanerochaete chrysosporium, Trametes versicolor, and Gloeophyllum trabeum. We found genome-wide prevalence of polycistronic transcription in these Agaricomycetes, involving up to 8% of the transcribed genes. Unlike polycistronic mRNAs in prokaryotes, these co-transcribed genes are also independently transcribed. We show that polycistronic transcription may interfere with expression of the downstream tandem gene. Further comparative genomic analysis indicates that polycistronic transcription is conserved among a wide range of mushroom forming fungi. In summary, our study revealed, for the first time, the genome prevalence of polycistronic transcription in a phylogenetic range of higher fungi. Furthermore, we systematically show that our long-read sequencing approach and combined bioinformatics pipeline is a generic powerful tool for precise characterization of complex transcriptomes that enables identification of mRNA isoforms not recovered via short-read assembly.	[Gordon, Sean P.; Salamov, Asaf; Meng, Xiandong; Zhao, Zhiying; Kang, Dongwan; Grigoriev, Igor V.; Chen, Feng; Wang, Zhong] Joint Genome Inst, Dept Energy, Walnut Creek, CA 94598 USA; [Tseng, Elizabeth; Underwood, Jason] Pacific Biosci, Menlo Pk, CA USA; [Zhang, Jiwei; Schilling, Jonathan S.] Univ Minnesota, Dept Bioprod & Biosyst Engn, St Paul, MN 55108 USA; [Figueroa, Melania] Univ Minnesota, Dept Plant Pathol, St Paul, MN USA; [Wang, Zhong] Univ Calif, Sch Nat Sci, Merced, CA USA	United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of California System; University of California Merced	Wang, Z (corresponding author), Joint Genome Inst, Dept Energy, Walnut Creek, CA 94598 USA.	zhongwang@lbl.gov	Figueroa, Melania/R-7696-2017; Figueroa, Melania/AAI-8692-2021	Figueroa, Melania/0000-0003-2636-661X; Figueroa, Melania/0000-0003-2636-661X; Grigoriev, Igor/0000-0002-3136-8903; Zhao, zhiying/0000-0001-7524-397X	Office of Science of the U.S. Department of Energy [DE-AC02-05CH11231]; Pacific Biosciences	Office of Science of the U.S. Department of Energy(United States Department of Energy (DOE)); Pacific Biosciences	The work was conducted by the U.S. Department of Energy Joint Genome Institute and supported by the Office of Science of the U.S. Department of Energy under Contract No. DE-AC02-05CH11231. Pacific Biosciences provided support in the form of salaries for authors ET and JU, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Akiva P, 2006, GENOME RES, V16, P30, DOI 10.1101/gr.4137606; Au KF, 2013, P NATL ACAD SCI USA, V110, pE4821, DOI 10.1073/pnas.1320101110; Blin K, 2013, NUCLEIC ACIDS RES, V41, pW204, DOI 10.1093/nar/gkt449; Blumenthal Thomas, 2004, Briefings in Functional Genomics & Proteomics, V3, P199, DOI 10.1093/bfgp/3.3.199; Calvo SE, 2009, P NATL ACAD SCI USA, V106, P7507, DOI 10.1073/pnas.0810916106; Di Giammartino DC, 2011, MOL CELL, V43, P853, DOI 10.1016/j.molcel.2011.08.017; Filichkin SA, 2010, GENOME RES, V20, P45, DOI 10.1101/gr.093302.109; Floudas D, 2012, SCIENCE, V336, P1715, DOI 10.1126/science.1221748; Galagan JE, 2004, TRENDS GENET, V20, P417, DOI 10.1016/j.tig.2004.07.007; Grigoriev IV, 2014, NUCLEIC ACIDS RES, V42, pD699, DOI 10.1093/nar/gkt1183; Grutzmann K, 2014, DNA RES, V21, P27, DOI 10.1093/dnares/dst038; Gullerova M, 2008, CELL, V132, P983, DOI 10.1016/j.cell.2008.02.040; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Hainer SJ, 2011, GENE DEV, V25, P29, DOI 10.1101/gad.1975011; Horns F, 2012, GENOME BIOL EVOL, V4, P240, DOI 10.1093/gbe/evs005; Kim KE, 2014, SCI DATA, V1, DOI 10.1038/sdata.2014.45; Koren S, 2012, NAT BIOTECHNOL, V30, P692, DOI 10.1038/nbt.2280; Kung JTY, 2013, GENETICS, V193, P651, DOI 10.1534/genetics.112.146704; Lee HC, 2010, MOL CELL, V38, P803, DOI 10.1016/j.molcel.2010.04.005; Loftus BJ, 2005, SCIENCE, V307, P1321, DOI 10.1126/science.1103773; Martin J, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-663; Martin JA, 2011, NAT REV GENET, V12, P671, DOI 10.1038/nrg3068; Matlin AJ, 2005, NAT REV MOL CELL BIO, V6, P386, DOI 10.1038/nrm1645; McGary KL, 2013, P NATL ACAD SCI USA, V110, P11481, DOI 10.1073/pnas.1304461110; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Munk C, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-3-r48; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Palmer AC, 2009, MOL CELL, V34, P545, DOI 10.1016/j.molcel.2009.04.018; Parra G, 2006, GENOME RES, V16, P37, DOI 10.1101/gr.4145906; Pelechano V, 2013, NATURE, V497, P127, DOI 10.1038/nature12121; Prasanth KV, 2005, CELL, V123, P249, DOI 10.1016/j.cell.2005.08.033; Proudfoot NJ, 2011, GENE DEV, V25, P1770, DOI 10.1101/gad.17268411; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Sharon D, 2013, NAT BIOTECHNOL, V31, P1009, DOI 10.1038/nbt.2705; Shearwin KE, 2005, TRENDS GENET, V21, P339, DOI 10.1016/j.tig.2005.04.009; Shen YJ, 2008, GENETICS, V179, P167, DOI 10.1534/genetics.108.088971; Tanaka M, 2011, DNA RES, V18, P189, DOI 10.1093/dnares/dsr011; Thomas S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094650; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Treutlein B, 2014, P NATL ACAD SCI USA, V111, pE1291, DOI 10.1073/pnas.1403244111; Ulitsky I, 2013, CELL, V154, P26, DOI 10.1016/j.cell.2013.06.020; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wu TD, 2005, BIOINFORMATICS, V21, P1859, DOI 10.1093/bioinformatics/bti310	43	195	203	4	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132628	10.1371/journal.pone.0132628	http://dx.doi.org/10.1371/journal.pone.0132628			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177194	gold, Green Submitted, Green Published			2022-12-26	WOS:000358197600134
J	Lammert, AC; Narayanan, SS				Lammert, Adam C.; Narayanan, Shrikanth S.			On Short-Time Estimation of Vocal Tract Length from Formant Frequencies	PLOS ONE			English	Article							SPEAKER NORMALIZATION; BODY-SIZE; SPEECH; ACOUSTICS; VOWELS; ROARS	Vocal tract length is highly variable across speakers and determines many aspects of the acoustic speech signal, making it an essential parameter to consider for explaining behavioral variability. A method for accurate estimation of vocal tract length from formant frequencies would afford normalization of interspeaker variability and facilitate acoustic comparisons across speakers. A framework for considering estimation methods is developed from the basic principles of vocal tract acoustics, and an estimation method is proposed that follows naturally from this framework. The proposed method is evaluated using acoustic characteristics of simulated vocal tracts ranging from 14 to 19 cm in length, as well as real-time magnetic resonance imaging data with synchronous audio from five speakers whose vocal tracts range from 14.5 to 18.0 cm in length. Evaluations show improvements in accuracy over previously proposed methods, with 0.631 and 1.277 cm root mean square error on simulated and human speech data, respectively. Empirical results show that the effectiveness of the proposed method is based on emphasizing higher formant frequencies, which seem less affected by speech articulation. Theoretical predictions of formant sensitivity reinforce this empirical finding. Moreover, theoretical insights are explained regarding the reason for differences in formant sensitivity.	[Lammert, Adam C.] Swarthmore Coll, Dept Comp Sci, Swarthmore, PA 19081 USA; [Narayanan, Shrikanth S.] Univ So Calif, Signal Anal & Interpretat Lab, Los Angeles, CA USA	Swarthmore College; University of Southern California	Lammert, AC (corresponding author), Swarthmore Coll, Dept Comp Sci, Swarthmore, PA 19081 USA.	alammer1@swarthmore.edu	Narayanan, Shrikanth S/D-5676-2012		National Institutes of Health [DC007124]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [T32DC009975, R01DC007124] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by National Institutes of Health, grant DC007124 (SSN received funding). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boersma Paul, 2002, GLOT INT, V5, P341; Bresch E, 2008, IEEE SIGNAL PROC MAG, V25, P123, DOI 10.1109/MSP.2008.918034; Bresch E, 2006, J ACOUST SOC AM, V120, P1791, DOI 10.1121/1.2335423; CANNY J, 1986, IEEE T PATTERN ANAL, V8, P679, DOI 10.1109/TPAMI.1986.4767851; Chiba T, 1941, VOWEL ITS NATURE STR; Claes T, 1998, IEEE T SPEECH AUDI P, V6, P549, DOI 10.1109/89.725321; de Boer B., 2007, ACLC WORKING PAPERS, V2, P61; Echternach M, 2011, J VOICE, V25, P670, DOI 10.1016/j.jvoice.2010.09.008; Eide E, 1996, INT CONF ACOUST SPEE, P346, DOI 10.1109/ICASSP.1996.541103; Fant G., 1960, ACOUSTIC THEORY SPEE; Fitch WT, 1999, J ACOUST SOC AM, V106, P1511, DOI 10.1121/1.427148; Fitch WT, 1997, J ACOUST SOC AM, V102, P1213, DOI 10.1121/1.421048; Gouvea E. B., 1997, 5 EUR C SPEECH COMM, P1139; Harris TR, 2006, ETHOLOGY, V112, P911, DOI 10.1111/j.1439-0310.2006.01247.x; Iskarous K, 2010, J PHONETICS, V38, P375, DOI 10.1016/j.wocn.2010.03.002; Kay S, 1988, MODERN SPECTRAL ESTI; Kelly J., 1962, P 4 INT C AC, P1; Kim YC, 2011, MAGN RESON MED, V65, P1365, DOI 10.1002/mrm.22714; KIRLIN RL, 1978, IEEE T ACOUST SPEECH, V26, P571, DOI 10.1109/TASSP.1978.1163151; Lee L, 1998, IEEE T SPEECH AUDI P, V6, P49, DOI 10.1109/89.650310; Lee L, 1996, INT CONF ACOUST SPEE, P353, DOI 10.1109/ICASSP.1996.541105; Lee S, 1999, J ACOUST SOC AM, V105, P1455, DOI 10.1121/1.426686; MERMELSTEIN P, 1967, J ACOUST SOC AM, V41, P1283, DOI 10.1121/1.1910470; MRAYATI M, 1988, SPEECH COMMUN, V7, P257, DOI 10.1016/0167-6393(88)90073-8; Narayanan S, 2004, J ACOUST SOC AM, V115, P1771, DOI 10.1121/1.1652588; Necioglu BF, 2000, INT CONF ACOUST SPEE, P1319, DOI 10.1109/ICASSP.2000.861821; Paige A, 1970, IEEE T AUDIO ELECTRO, P18; PETERSON GE, 1952, J ACOUST SOC AM, V24, P175, DOI 10.1121/1.1906875; Pitz M., 2001, EUROSPEECH, P721; Preparata F, 1990, COMPUTATIONAL GEOMET, P185; Rabiner L, 1978, DIGITAL PROCESSING S; Reby D, 2003, ANIM BEHAV, V65, P519, DOI 10.1006/anbe.2003.2078; Rendall D, 2005, J ACOUST SOC AM, V117, P944, DOI 10.1121/1.1848011; Riede T, 1999, J EXP BIOL, V202, P2859; Santos GM, 2004, P ANN INT IEEE EMBS, V26, P1048; SCHROEDER MR, 1967, J ACOUST SOC AM, V41, P1002, DOI 10.1121/1.1910429; Stevens K, 1998, ACOUSTIC PHONETICS; STEVENS KN, 1989, J PHONETICS, V17, P3, DOI 10.1016/S0095-4470(19)31520-7; Story BH, 2006, J ACOUST SOC AM, V119, P715, DOI 10.1121/1.2151802; Story BH, 1996, J ACOUST SOC AM, V100, P537, DOI 10.1121/1.415960; Takemoto H, 2006, J ACOUST SOC AM, V119, P1037, DOI 10.1121/1.2151823; Turner RE, 2009, J ACOUST SOC AM, V125, P2374, DOI 10.1121/1.3079772; Vorperian HK, 2005, J ACOUST SOC AM, V117, P338, DOI 10.1121/1.1835958; Vorperian HK, 2009, J ACOUST SOC AM, V125, P1666, DOI 10.1121/1.3075589; WAKITA H, 1977, IEEE T ACOUST SPEECH, V25, P183, DOI 10.1109/TASSP.1977.1162929; Wegmann S, 1996, INT CONF ACOUST SPEE, P339, DOI 10.1109/ICASSP.1996.541101; WOOD S, 1979, J PHONETICS, V7, P25, DOI 10.1016/S0095-4470(19)31031-9	47	21	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132193	10.1371/journal.pone.0132193	http://dx.doi.org/10.1371/journal.pone.0132193			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177102	Green Published, Green Submitted, gold			2022-12-26	WOS:000358197600088
J	Lu, Y; Wang, AH; Shi, P; Zhang, H; Li, ZS				Lu, Yang; Wang, AiHua; Shi, Peng; Zhang, Hui; Li, ZeSheng			Quantum Chemical Study on the Antioxidation Mechanism of Piceatannol and Isorhapontigenin toward Hydroxyl and Hydroperoxyl Radicals	PLOS ONE			English	Article							INDUCED PEROXIDATION; OXIDATIVE STRESS; RESVERATROL; ANALOGS; STILBENE; APOPTOSIS; ENERGIES; DESIGN; WINE; ROS	A systematic study of the antioxidation mechanisms behind hydroxyl (center dot OH) and hydroperoxyl (center dot OOH) radical scavenging activity of piceatannol (PIC) and isorhapontigenin (ISO) was carried out using density functional theory (DFT) method. Two reaction mechanisms, abstraction (ABS) and radical adduct formation (RAF), were discussed. A total of 24 reaction pathways of scavenging center dot OH and center dot OOH with PIC and ISO were investigated in the gas phase and solution. The thermodynamic and kinetic properties of all pathways were calculated. Based on these results, we evaluated the antioxidant activity of every active site of PIC and ISO and compared the abilities of PIC and ISO to scavenge radicals. According to our results, PIC and ISO may act as effective center dot OH and center dot OOH scavengers in organism. A4-hydroxyl group is a very important active site for PIC and ISO to scavenge radicals. The introducing of -OH or -OCH3 group to the ortho-position of A4-hydroxyl group would increase its antioxidant activity. Meanwhile, the conformational effect was researched, the results suggest that the presence and pattern of intramolecular hydrogen bond (IHB) are considerable in determining the antioxidant activity of PIC and ISO.	[Lu, Yang; Wang, AiHua; Shi, Peng] Harbin Univ Sci & Technol, Coll Mat Sci & Engn, Harbin 150080, Peoples R China; [Zhang, Hui] Harbin Univ Sci & Technol, Coll Chem & Environm Engn, Harbin 150080, Peoples R China; [Li, ZeSheng] Beijing Inst Technol, Minist Educ, Key Lab Cluster Sci, Beijing 100081, Peoples R China; [Li, ZeSheng] Beijing Inst Technol, Sch Chem, Beijing 100081, Peoples R China	Harbin University of Science & Technology; Harbin University of Science & Technology; Beijing Institute of Technology; Beijing Institute of Technology	Zhang, H (corresponding author), Harbin Univ Sci & Technol, Coll Chem & Environm Engn, Harbin 150080, Peoples R China.	hust_zhanghui11@hotmail.com			National Basic Research Program of China [2012CB723308]; National Natural Science Foundation of China [51337002, 50977019]; Doctoral Foundation by the Ministry of Education of China [20112303110005]; Science Foundation for Distinguished Young Scholar of Heilongjiang Province [JC201206]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Doctoral Foundation by the Ministry of Education of China; Science Foundation for Distinguished Young Scholar of Heilongjiang Province(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars)	This work is supported by the National Basic Research Program of China (2012CB723308), the National Natural Science Foundation of China (51337002 and 50977019), the Doctoral Foundation by the Ministry of Education of China (20112303110005), and the Science Foundation for Distinguished Young Scholar of Heilongjiang Province (JC201206). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardura D, 2005, J PHYS CHEM B, V109, P23618, DOI 10.1021/jp0540499; Bastianetto S, 2009, CNS NEUROSCI THER, V15, P76, DOI 10.1111/j.1755-5949.2008.00074.x; Bavaresco L, 2002, VITIS, V41, P133; Cai YJ, 2003, BBA-MOL BASIS DIS, V1637, P31, DOI 10.1016/S0925-4439(02)00174-6; Cordova-Gomez M, 2013, RSC ADV, V3, P20209, DOI 10.1039/c3ra42923g; Djoko B, 2007, J AGR FOOD CHEM, V55, P2376, DOI 10.1021/jf062741a; Docherty JJ, 1999, ANTIVIR RES, V43, P145, DOI 10.1016/S0166-3542(99)00042-X; ESTERBAUER H, 1990, MUTAT RES, V238, P223, DOI 10.1016/0165-1110(90)90014-3; Fang JG, 2002, CHEM-EUR J, V8, P4191, DOI 10.1002/1521-3765(20020916)8:18<4191::AID-CHEM4191>3.0.CO;2-S; Fang YN, 2002, PHYTOMEDICINE, V9, P734, DOI 10.1078/094471102321621359; FERRIGNI NR, 1984, J NAT PROD, V47, P347, DOI 10.1021/np50032a019; Frisch G. W., 2013, GAUSSIAN 09; Galano A, 2010, J PHYS CHEM B, V114, P6625, DOI 10.1021/jp912001c; Hagen TM, 2003, ANTIOXID REDOX SIGN, V5, P503, DOI 10.1089/152308603770310149; HAMMOND GS, 1955, J AM CHEM SOC, V77, P334, DOI 10.1021/ja01607a027; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Fernandez-Marin MI, 2012, FOOD CHEM, V135, P1353, DOI 10.1016/j.foodchem.2012.05.086; Iuga C, 2011, J PHYS CHEM B, V115, P12234, DOI 10.1021/jp206347u; Jancinvoa V, 2013, OXIDATIVE MED CELLUL, P1; Jang MS, 1997, SCIENCE, V275, P218, DOI 10.1126/science.275.5297.218; KIMURA Y, 1985, BIOCHIM BIOPHYS ACTA, V834, P275; King RE, 2006, COMPR REV FOOD SCI F, V5, P65, DOI 10.1111/j.1541-4337.2006.00001.x; Ku KL, 2005, J AGR FOOD CHEM, V53, P3877, DOI 10.1021/jf050242o; Lee SK, 1998, COMB CHEM HIGH T SCR, V1, P35; Leopoldini M, 2011, FOOD CHEM, V125, P288, DOI 10.1016/j.foodchem.2010.08.012; Liu YL, 2004, BIOCHEM PHARMACOL, V67, P777, DOI 10.1016/j.bcp.2003.09.025; Marenich AV, 2009, J PHYS CHEM B, V113, P6378, DOI 10.1021/jp810292n; MARNETT LJ, 1987, CARCINOGENESIS, V8, P1365, DOI 10.1093/carcin/8.10.1365; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; Mikulski D, 2012, J MOL MODEL, V18, P3255, DOI 10.1007/s00894-011-1342-7; Okuno Y, 1997, CHEM-EUR J, V3, P212, DOI 10.1002/chem.19970030208; Pastor N, 2000, J MOL BIOL, V304, P55, DOI 10.1006/jmbi.2000.4173; Perez-Gonzalez A, 2012, J MEX CHEM SOC, V56, P241; Potter GA, 2002, BRIT J CANCER, V86, P774, DOI 10.1038/sj.bjc.6600197; PRYOR WA, 1986, ANNU REV PHYSIOL, V48, P657, DOI 10.1146/annurev.ph.48.030186.003301; Ricks AB, 2010, J AM CHEM SOC, V132, P15427, DOI 10.1021/ja107420a; Rimando AM, 2004, J AGR FOOD CHEM, V52, P4713, DOI 10.1021/jf040095e; Rossi M, 2008, J AGR FOOD CHEM, V56, P10557, DOI 10.1021/jf801923j; Shang YJ, 2010, FOOD CHEM, V119, P1435, DOI 10.1016/j.foodchem.2009.09.024; Simon HU, 2000, APOPTOSIS, V5, P415, DOI 10.1023/A:1009616228304; Stivala LA, 2001, J BIOL CHEM, V276, P22586, DOI 10.1074/jbc.M101846200; Stojanovic S, 2001, ARCH BIOCHEM BIOPHYS, V391, P79, DOI 10.1006/abbi.2001.2388; Surh YJ, 1999, CANCER LETT, V140, P1, DOI 10.1016/S0304-3835(99)00039-7; Wang MF, 1998, J AGR FOOD CHEM, V46, P4869, DOI 10.1021/jf980614b; Wang QL, 2001, JPN J PHARMACOL, V87, P61, DOI 10.1254/jjp.87.61; Zavala-Oseguera C, 2009, J PHYS CHEM A, V113, P13913, DOI 10.1021/jp906144d; Zhang HY, 2003, CHEM-EUR J, V9, P502, DOI 10.1002/chem.200390052; Zhao Y, 2006, J CHEM THEORY COMPUT, V2, P364, DOI 10.1021/ct0502763	49	19	19	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0133259	10.1371/journal.pone.0133259	http://dx.doi.org/10.1371/journal.pone.0133259			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176778	Green Published, Green Submitted, gold			2022-12-26	WOS:000358197600234
J	McGill, LA; Scott, AD; Ferreira, PF; Nielles-Vallespin, S; Ismail, T; Kilner, PJ; Gatehouse, PD; de Silva, R; Prasad, SK; Giannakidis, A; Firmin, DN; Pennell, DJ				McGill, Laura-Ann; Scott, Andrew D.; Ferreira, Pedro F.; Nielles-Vallespin, Sonia; Ismail, Tevfik; Kilner, Philip J.; Gatehouse, Peter D.; de Silva, Ranil; Prasad, Sanjay K.; Giannakidis, Archontis; Firmin, David N.; Pennell, Dudley J.			Heterogeneity of Fractional Anisotropy and Mean Diffusivity Measurements by In Vivo Diffusion Tensor Imaging in Normal Human Hearts	PLOS ONE			English	Article							CARDIOVASCULAR MAGNETIC-RESONANCE; MUSCLE CELL DISORGANIZATION; CARDIAC FIBER ARCHITECTURE; CANINE LEFT-VENTRICLE; HYPERTROPHIC CARDIOMYOPATHY; LAMINAR STRUCTURE; MYOCARDIAL MICROSTRUCTURE; HISTOLOGICAL VALIDATION; QUANTITATIVE-ANALYSIS; WATER DIFFUSION	Background Cardiac diffusion tensor imaging (cDTI) by cardiovascular magnetic resonance has the potential to assess microstructural changes through measures of fractional anisotropy (FA) and mean diffusivity (MD). However, normal variation in regional and transmural FA and MD is not well described. Methods Twenty normal subjects were scanned using an optimised cDTI sequence at 3T in systole. FA and MD were quantified in 3 transmural layers and 4 regional myocardial walls. Results FA was higher in the mesocardium (0.46 +/- 0.04) than the endocardium (0.40 +/- 0.04, p <= 0.001) and epicardium (0.39 +/- 0.04, p <= 0.001). On regional analysis, the FA in the septum was greater than the lateral wall (0.44 +/- 0.03 vs 0.40 +/- 0.05 p = 0.04). There was a transmural gradient in MD increasing towards the endocardium (epicardium 0.87 +/- 0.07 vs endocardium 0.91 +/- 0.08x10(-3) mm(2)/s, p = 0.04). With the lateral wall (0.87 +/- 0.08x10(-3) mm(2)/s) as the reference, the MD was higher in the anterior wall (0.92 +/- 0.08x10(-3) mm(2)/s, p = 0.016) and septum (0.92 +/- 0.07x10(-3) mm(2)/s, p = 0.028). Transmurally the signal to noise ratio (SNR) was greatest in the mesocardium (14.5 +/- 2.5 vs endocardium 13.1 +/- 2.2, p<0.001; vs epicardium 12.0 +/- 2.4, p<0.001) and regionally in the septum (16.0 +/- 3.4 vs lateral wall 11.5 +/- 1.5, p<0.001). Transmural analysis suggested a relative reduction in the rate of change in helical angle (HA) within the mesocardium. Conclusions In vivo FA and MD measurements in normal human heart are heterogeneous, varying significantly transmurally and regionally. Contributors to this heterogeneity are many, complex and interactive, but include SNR, variations in cardiac microstructure, partial volume effects and strain. These data indicate that the potential clinical use of FA and MD would require measurement standardisation by myocardial region and layer, unless pathological changes substantially exceed the normal variation identified.	[McGill, Laura-Ann; Scott, Andrew D.; Ferreira, Pedro F.; Nielles-Vallespin, Sonia; Ismail, Tevfik; Kilner, Philip J.; Gatehouse, Peter D.; de Silva, Ranil; Prasad, Sanjay K.; Giannakidis, Archontis; Firmin, David N.; Pennell, Dudley J.] Royal Brompton Hosp, NIHR Cardiovasc Biomed Res Unit, London SW3 6NP, England; [McGill, Laura-Ann; Scott, Andrew D.; Ferreira, Pedro F.; Ismail, Tevfik; Kilner, Philip J.; Gatehouse, Peter D.; de Silva, Ranil; Prasad, Sanjay K.; Giannakidis, Archontis; Firmin, David N.; Pennell, Dudley J.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England	Royal Brompton Hospital; Imperial College London	Firmin, DN (corresponding author), Royal Brompton Hosp, NIHR Cardiovasc Biomed Res Unit, Sydney St, London SW3 6NP, England.	d.firmin@imperial.ac.uk	Ismail, Tevfik F/AAG-3303-2020	Ismail, Tevfik F/0000-0002-1691-7599; Gatehouse, Peter/0000-0002-0260-4719; Scott, Andrew/0000-0001-7656-3123; Giannakidis, Archontis/0000-0001-7403-923X; Pennell, Dudley/0000-0001-5523-1314; Ferreira, Pedro/0000-0002-0436-3496	National Institute for Health Research (NIHR) Cardiovascular Biomedical Research Unit based at Royal Brompton & Harefield Trust, Imperial College London; National Institute for Health Research [NF-SI-0508-10081] Funding Source: researchfish	National Institute for Health Research (NIHR) Cardiovascular Biomedical Research Unit based at Royal Brompton & Harefield Trust, Imperial College London; National Institute for Health Research(National Institute for Health Research (NIHR))	The research was funded by the National Institute for Health Research (NIHR) Cardiovascular Biomedical Research Unit based at Royal Brompton & Harefield Trust, Imperial College London. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angeli S, 2014, J CARDIOVASC MAGN R, V16, DOI 10.1186/s12968-014-0077-x; [Anonymous], DIFFUSION WEIGHTED M; Arts T, 2001, AM J PHYSIOL-HEART C, V280, pH2222, DOI 10.1152/ajpheart.2001.280.5.H2222; Axel L, 2014, J CARDIOVASC MAGN R, V16, DOI 10.1186/s12968-014-0089-6; Bammer R, 2009, MAGN RESON IMAGING C, V17, P175, DOI 10.1016/j.mric.2009.01.011; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Basser PJ, 1995, NMR BIOMED, V8, P333, DOI 10.1002/nbm.1940080707; Benson AP, 2011, INTERFACE FOCUS, V1, P101, DOI 10.1098/rsfs.2010.0005; BULKLEY BH, 1977, CIRCULATION, V56, P292, DOI 10.1161/01.CIR.56.2.292; Callot V, 2003, MAGN RESON MED, V50, P531, DOI 10.1002/mrm.10568; Delattre BMA, 2012, INVEST RADIOL, V47, P662, DOI 10.1097/RLI.0b013e31826ef901; Dou JG, 2003, MAGNET RESON MED, V50, P107, DOI 10.1002/mrm.10482; Dou JG, 2002, MAGNET RESON MED, V48, P105, DOI 10.1002/mrm.10188; EDELMAN RR, 1994, MAGNET RESON MED, V32, P423, DOI 10.1002/mrm.1910320320; Ferreira PF, 2014, J CARDIOVASC MAGN R, V16, DOI 10.1186/s12968-014-0087-8; Gilbert SH, 2012, AM J PHYSIOL-HEART C, V302, pH287, DOI 10.1152/ajpheart.00824.2011; GREENBAUM RA, 1981, BRIT HEART J, V45, P248; Griswold MA, 2002, MAGN RESON MED, V47, P1202, DOI 10.1002/mrm.10171; Guizar-Sicairos M, 2008, OPT LETT, V33, P156, DOI 10.1364/OL.33.000156; Healy LJ, 2011, J CARDIOVASC MAGN R, V13, DOI 10.1186/1532-429X-13-74; Helm PA, 2005, MAGN RESON MED, V54, P850, DOI 10.1002/mrm.20622; Holmes AA, 2000, MAGNET RESON MED, V44, P157, DOI 10.1002/1522-2594(200007)44:1<157::AID-MRM22>3.0.CO;2-F; Hooks DA, 2007, CIRC RES, V101, pE103, DOI 10.1161/CIRCRESAHA.107.161075; Hsu EW, 1998, AM J PHYSIOL-HEART C, V274, pH1627, DOI 10.1152/ajpheart.1998.274.5.H1627; Jiang Y, 2007, AM J PHYSIOL-HEART C, V293, pH2377, DOI 10.1152/ajpheart.00337.2007; Jones DK, 2004, MAGN RESON MED, V52, P979, DOI 10.1002/mrm.20283; Kingsley PB, 2006, CONCEPT MAGN RESON A, V28A, P155, DOI 10.1002/cmr.a.20050; LEBIHAN D, 1988, RADIOLOGY, V168, P497, DOI 10.1148/radiology.168.2.3393671; LEGRICE IJ, 1995, AM J PHYSIOL-HEART C, V269, pH571, DOI 10.1152/ajpheart.1995.269.2.H571; LEGRICE IJ, 1995, CIRC RES, V77, P182, DOI 10.1161/01.RES.77.1.182; Lombaert H, 2012, IEEE T MED IMAGING, V31, P1436, DOI 10.1109/TMI.2012.2192743; MARON BJ, 1979, CIRCULATION, V59, P689, DOI 10.1161/01.CIR.59.4.689; MARON BJ, 1981, CIRCULATION, V63, P882, DOI 10.1161/01.CIR.63.4.882; McGill LA, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-86; MOSELEY ME, 1990, RADIOLOGY, V176, P439, DOI 10.1148/radiology.176.2.2367658; Nguyen C, 2014, MAGN RESON MED, V72, P1257, DOI 10.1002/mrm.25038; Nielles-Vallespin S, 2013, MAGN RESON MED, V70, P454, DOI 10.1002/mrm.24488; Pierpaoli C, 1996, MAGNET RESON MED, V36, P893, DOI 10.1002/mrm.1910360612; RADEMAKERS FE, 1994, CIRCULATION, V89, P1174, DOI 10.1161/01.CIR.89.3.1174; Reeder SB, 2005, MAGNET RESON MED, V54, P748, DOI 10.1002/mrm.20636; REESE TG, 1995, MAGNET RESON MED, V34, P786, DOI 10.1002/mrm.1910340603; Reese TG, 1996, J MAGN RESON SER B, V112, P253, DOI 10.1006/jmrb.1996.0139; Scollan DF, 1998, AM J PHYSIOL-HEART C, V275, pH2308, DOI 10.1152/ajpheart.1998.275.6.H2308; Scott AD, 2015, MAGN RESON MED, V74, P420, DOI 10.1002/mrm.25418; Stoeck CT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107159; STREETER DD, 1969, CIRC RES, V24, P339, DOI 10.1161/01.RES.24.3.339; Toussaint N, 2013, MED IMAGE ANAL, V17, P1243, DOI 10.1016/j.media.2013.02.008; Tseng WI, 1999, MAGNET RESON MED, V42, P393, DOI 10.1002/(SICI)1522-2594(199908)42:2<393::AID-MRM22>3.0.CO;2-F; Tseng WYI, 2006, J MAGN RESON IMAGING, V23, P1, DOI 10.1002/jmri.20473; Tseng WYI, 2003, J MAGN RESON IMAGING, V17, P31, DOI 10.1002/jmri.10223; Tunnicliffe EM, 2014, J CARDIOVASC MAGN R, V16, DOI 10.1186/1532-429X-16-31; WALDMAN LK, 1988, CIRC RES, V63, P550, DOI 10.1161/01.RES.63.3.550; Wu EX, 2007, MAGN RESON MED, V58, P687, DOI 10.1002/mrm.21350; Wu MT, 2006, CIRCULATION, V114, P1036, DOI 10.1161/CIRCULATIONAHA.105.545863	54	21	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132360	10.1371/journal.pone.0132360	http://dx.doi.org/10.1371/journal.pone.0132360			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177211	Green Submitted, gold, Green Published, Green Accepted			2022-12-26	WOS:000358197600104
J	Wang, H; Ji, FX; Liang, HB; Gu, HL; Ning, ZY; Liu, RC; Zhang, GH				Wang, Heng; Ji, Fangxiao; Liang, Huanbin; Gu, Honglang; Ning, Zhangyong; Liu, Rongchang; Zhang, Guihong			A Proline-Rich Domain in the Genotype 4 Hepatitis E Virus ORF3 C-Terminus Is Crucial for Downstream (VDLP108)-D-105 Immunoactivity	PLOS ONE			English	Article							PHYLOGENETIC ANALYSIS; PROTECTIVE EFFICACY; PROTEIN; INFECTION; SWINE; CHINA; IMMUNOGENICITY; ANTIBODIES; RELEASE; HUMANS	The hepatitis E virus (HEV) is responsible for serious viral hepatitis worldwide. Animals are considered a reservoir of HEV, particularly pigs. While HEV infection in pigs and dogs is always asymptomatic, the virus causes high death rates in patients with pre-existing chronic liver disease and pregnant women in developing countries. HEV open reading frame 2 (ORF2) has been used as a diagnostic target to detect specific antibodies against HEV in serum samples. Recent research has additionally supported the potential utility of the ORF3 protein as a target in serum anti-HEV detection. However, the epitope distribution of ORF3 protein remains ambiguous. In the current study, we showed that continuous amino acid motif, VDLP, at the C-terminus of genotype 4 HEV ORF3 is a core sequence of the ORF3 protein epitope. Moreover, cooperative interaction with upstream elements is essential for its immunoactivity. Three proline residues (P99, P102 and P103) in the upstream proline-rich domain exerted significant effects on the immunocompetence of VDLP. ELISA results revealed that SAPPLPPVVDLP and SAPPLPPVVDLPQLGL peptides containing the identified VDLP epitope display weaker reactions with anti-HEV serum than the commercial ELISA kit. Our collective findings provide valuable information on the epitope distribution characteristics of HEV ORF3 and improve our understanding of the influence of the proline-rich domain on the immunoactivity of downstream amino acids in the C-terminal region.	[Wang, Heng; Ji, Fangxiao; Ning, Zhangyong; Zhang, Guihong] South China Agr Univ, Coll Vet Med, Guangzhou 510642, Guangdong, Peoples R China; [Wang, Heng; Ning, Zhangyong; Liu, Rongchang] Key Lab Comprehens Prevent & Control Severe Clin, Guangzhou 510642, Guangdong, Peoples R China; [Ji, Fangxiao; Liang, Huanbin; Gu, Honglang; Zhang, Guihong] MOA Key Lab Anim Vaccine Dev, Guangzhou 510642, Guangdong, Peoples R China	South China Agricultural University	Zhang, GH (corresponding author), South China Agr Univ, Coll Vet Med, Guangzhou 510642, Guangdong, Peoples R China.	guihongzh@scau.edu.cn			Ph.D. Programs Foundation of Ministry of Education of China [20104404110009, 20114404120010]; Department of Education of Guangdong province [2012LYM 0031]; Industry technology system of modern agriculture construction fund [CARS-36]	Ph.D. Programs Foundation of Ministry of Education of China(Ministry of Education, China); Department of Education of Guangdong province(National Natural Science Foundation of Guangdong Province); Industry technology system of modern agriculture construction fund	This work was supported by the Ph.D. Programs Foundation of Ministry of Education of China (No. 20104404110009 and No. 20114404120010), the Grant from the Department of Education of Guangdong province (No. 2012LYM 0031), and the Industry technology system of modern agriculture construction fund (No. CARS-36). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya SK, 2011, J HEPATOL, V54, P9, DOI 10.1016/j.jhep.2010.08.008; Chandra V, 2008, J BIOSCIENCES, V33, P451, DOI 10.1007/s12038-008-0064-1; Colson P, 2010, J INFECT DIS, V202, P825, DOI 10.1086/655898; Deshmukh TM, 2007, VACCINE, V25, P4350, DOI 10.1016/j.vaccine.2007.03.040; Guu TSY, 2009, P NATL ACAD SCI USA, V106, P12992, DOI 10.1073/pnas.0904848106; Izopet J, 2012, EMERG INFECT DIS, V18, P1274, DOI 10.3201/eid1808.120057; Kamili S, 2004, J INFECT DIS, V189, P258, DOI 10.1086/380801; Kenney SP, 2012, J VIROL, V86, P5637, DOI 10.1128/JVI.06711-11; KOONIN EV, 1992, P NATL ACAD SCI USA, V89, P8259, DOI 10.1073/pnas.89.17.8259; Korkaya H, 2001, J BIOL CHEM, V276, P42389, DOI 10.1074/jbc.M101546200; Lack JB, 2012, EMERG INFECT DIS, V18, P1268, DOI 10.3201/eid1808.120070; Lesinski GB, 2001, J MICROBIOL METH, V47, P135, DOI 10.1016/S0167-7012(01)00290-1; Li G, 2010, LETT APPL MICROBIOL, V51, P499, DOI 10.1111/j.1472-765X.2010.02919.x; Li WG, 2009, VET MICROBIOL, V133, P75, DOI 10.1016/j.vetmic.2008.06.026; Li XJ, 2008, J MED VIROL, V80, P1391, DOI 10.1002/jmv.21246; Liang HB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088106; Lu L, 2006, REV MED VIROL, V16, P5, DOI 10.1002/rmv.482; Matsuda H, 2003, J INFECT DIS, V188, P944, DOI 10.1086/378074; Meng XJ, 1997, P NATL ACAD SCI USA, V94, P9860, DOI 10.1073/pnas.94.18.9860; Moin SM, 2009, CELL MICROBIOL, V11, P1409, DOI 10.1111/j.1462-5822.2009.01340.x; Nagashima S, 2011, J GEN VIROL, V92, P269, DOI 10.1099/vir.0.025791-0; Nan YC, 2014, J VIROL, V88, P11924, DOI 10.1128/JVI.01935-14; Ratra R, 2008, BIOCHEMISTRY-US, V47, P1957, DOI 10.1021/bi7016552; Ren XF, 2010, J CLIN MICROBIOL, V48, P1875, DOI 10.1128/JCM.01707-09; Sarangi AN, 2011, INDIAN J MED RES, V133, P548; Takahashi H, 2012, ARCH VIROL, V157, P235, DOI 10.1007/s00705-011-1153-2; Turner J, 2010, J MED VIROL, V82, P1899, DOI 10.1002/jmv.21905; Xing L, 2011, J VIROL, V85, P1117, DOI 10.1128/JVI.00657-10; Yamada K, 2009, J GEN VIROL, V90, P1880, DOI 10.1099/vir.0.010561-0; Yamashita T, 2009, P NATL ACAD SCI USA, V106, P12986, DOI 10.1073/pnas.0903699106; Zhang MD, 2001, VACCINE, V20, P853, DOI 10.1016/S0264-410X(01)00399-1; Zhang W, 2008, ZOONOSES PUBLIC HLTH, V55, P291, DOI 10.1111/j.1863-2378.2008.01136.x; Zhao K, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-186; Zhou YH, 2004, VACCINE, V22, P2578, DOI 10.1016/j.vaccine.2003.12.017; Zhu YM, 2011, J CLIN VIROL, V52, P155, DOI 10.1016/j.jcv.2011.06.023	35	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0133282	10.1371/journal.pone.0133282	http://dx.doi.org/10.1371/journal.pone.0133282			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177202	Green Published, Green Submitted, gold			2022-12-26	WOS:000358197600239
J	Wu, Y; Chen, P; Jing, YY; Wang, C; Men, YL; Zhan, W; Wang, Q; Gan, ZX; Huang, J; Xie, K; Mi, JS; Yu, CH; Yu, XQ; Chen, PC; Chang, JF; Cai, FF; Chen, S				Wu, You; Chen, Ping; Jing, Yuanya; Wang, Chen; Men, Yu-Long; Zhan, Wang; Wang, Qiang; Gan, Zhixue; Huang, Jin; Xie, Kun; Mi, Jiangsheng; Yu, Chenghua; Yu, Xiuqing; Chen, Pei-Chao; Chang, Jian-Feng; Cai, Fengfeng; Chen, Su			Microarray Analysis Reveals Potential Biological Functions of Histone H2B Monoubiquitination	PLOS ONE			English	Article							STEM-CELL DIFFERENTIATION; HOMOLOGOUS RECOMBINATION; H3K4 METHYLATION; CHROMATIN; UBIQUITINATION; YEAST; BRE1; DNA; MONOUBIQUITYLATION; TRIMETHYLATION	Histone H2B monoubiquitination is a key histone modification that has significant effects on chromatin higher-order structure and gene transcription. Multiple biological processes have been suggested to be tightly related to the dynamics of H2B monoubiquitination. However, a comprehensive understanding of biological roles of H2B monoubiquitination is still poorly understood. In the present study, we developed an efficient tool to disrupt endogenous H2B monoubiquitination levels by using an H2BK120R mutant construct expressed in human cells. Genome-wide microarray analysis of these cells revealed a potential global view of biological functions of H2B monoubiquitination. Bioinformatics analysis of our data demonstrated that while H2B monoubiquitination expectedly affected a number of previously reported biological pathways, we also uncovered the influence of this histone modification on many novel biological processes. Therefore, our work provided valuable information for understanding the role of H2B monoubiquitination and indicated potential directions for its further studies.	[Wu, You; Chen, Ping; Jing, Yuanya; Wang, Chen; Men, Yu-Long; Zhan, Wang; Gan, Zhixue; Huang, Jin; Xie, Kun; Chang, Jian-Feng; Cai, Fengfeng; Chen, Su] Tongji Univ, Yangpu Hosp, Dept Breast Surg, Res Ctr Translat Med,East Hosp,Sch Life Sci & Tec, Shanghai 200092, Peoples R China; [Mi, Jiangsheng; Yu, Chenghua; Yu, Xiuqing; Chen, Su] Peoples Hosp Zunhua, Dept Sci & Educ, Tangshan 064200, Hebei, Peoples R China; [Wang, Qiang] Tongji Univ, Sch Med, Shanghai Peoples Hosp 10, Dept Nephrol & Rheumatol, Shanghai 200092, Peoples R China; [Chen, Pei-Chao] Wenzhou Univ, Coll Life & Environm Sci, Wenzhou 325035, Zhejiang, Peoples R China	Tongji University; Tongji University; Wenzhou University	Cai, FF (corresponding author), Tongji Univ, Yangpu Hosp, Dept Breast Surg, Res Ctr Translat Med,East Hosp,Sch Life Sci & Tec, Shanghai 200092, Peoples R China.	fengfengcai@gmail.com; chensu@tongji.edu.cn	Men, Yulong/AFP-4952-2022	Men, Yulong/0000-0002-3954-7922; Chen, Peichao/0000-0001-9587-7080	National Basic Research Program of China (973 Program) [2015CB964800]; National Natural Science Foundation of China [31201051]; Shanghai Municipal Natural Science Foundation [12ZR1433100, 12ZR1433000]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Natural Science Foundation	This work was supported by the National Basic Research Program of China (973 Program, Grant No. 2015CB964800), the National Natural Science Foundation of China (Grant No. 31201051), and the Shanghai Municipal Natural Science Foundation (Grant No. 12ZR1433100, 12ZR1433000). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson R, 2009, GENOME RES, V19, P1732, DOI 10.1101/gr.092353.109; Nguyen AT, 2011, GENE DEV, V25, P1345, DOI 10.1101/gad.2057811; ARENTS G, 1993, P NATL ACAD SCI USA, V90, P10489, DOI 10.1073/pnas.90.22.10489; ARENTS G, 1991, P NATL ACAD SCI USA, V88, P10148, DOI 10.1073/pnas.88.22.10148; Chen P, 2010, PROTEIN CELL, V1, P967, DOI 10.1007/s13238-010-0130-y; Chen S, 2015, MOL CELL BIOL, V35, P406, DOI 10.1128/MCB.01044-14; Chen S, 2012, CELL RES, V22, P1402, DOI 10.1038/cr.2012.114; Chernikova SB, 2012, CANCER RES, V72, P2111, DOI 10.1158/0008-5472.CAN-11-2209; Daniel JA, 2005, CELL CYCLE, V4, P919, DOI 10.4161/cc.4.7.1824; Fonseca GJ, 2012, CELL HOST MICROBE, V11, P597, DOI 10.1016/j.chom.2012.05.005; Fonseca GJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003411; Fuchs G, 2012, MOL CELL, V46, P662, DOI 10.1016/j.molcel.2012.05.023; Herz HM, 2014, SCIENCE, V345, P1065, DOI 10.1126/science.1255104; Karpiuk O, 2012, MOL CELL, V46, P705, DOI 10.1016/j.molcel.2012.05.022; Kim J, 2005, MOL CELL, V20, P759, DOI 10.1016/j.molcel.2005.11.012; Kim J, 2009, CELL, V137, P459, DOI 10.1016/j.cell.2009.02.027; Kleefstra T, 2012, AM J HUM GENET, V91, P73, DOI 10.1016/j.ajhg.2012.05.003; KORNBERG RD, 1974, SCIENCE, V184, P868, DOI 10.1126/science.184.4139.868; Lee JS, 2007, CELL, V131, P1084, DOI 10.1016/j.cell.2007.09.046; Li E, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a019133; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Minsky N, 2008, NAT CELL BIOL, V10, P483, DOI 10.1038/ncb1712; Moyal L, 2011, MOL CELL, V41, P529, DOI 10.1016/j.molcel.2011.02.015; Nakamura K, 2011, MOL CELL, V41, P515, DOI 10.1016/j.molcel.2011.02.002; Nakanishi S, 2009, J CELL BIOL, V186, P371, DOI 10.1083/jcb.200906005; Pal S, 2007, J CELL PHYSIOL, V213, P306, DOI 10.1002/jcp.21180; Prenzel T, 2011, CANCER RES, V71, P5739, DOI 10.1158/0008-5472.CAN-11-1896; Robzyk K, 2000, SCIENCE, V287, P501, DOI 10.1126/science.287.5452.501; Shilatifard A, 2008, CURR OPIN CELL BIOL, V20, P341, DOI 10.1016/j.ceb.2008.03.019; Sun ZW, 2002, NATURE, V418, P104, DOI 10.1038/nature00883; Vethantham V, 2012, MOL CELL BIOL, V32, P1044, DOI 10.1128/MCB.06026-11; Wagner EJ, 2012, NAT REV MOL CELL BIO, V13, P115, DOI 10.1038/nrm3274; Weake VM, 2008, MOL CELL, V29, P653, DOI 10.1016/j.molcel.2008.02.014; Wood A, 2003, MOL CELL, V11, P267, DOI 10.1016/S1097-2765(02)00802-X	34	6	6	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0133444	10.1371/journal.pone.0133444	http://dx.doi.org/10.1371/journal.pone.0133444			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177367	Green Published, gold, Green Submitted			2022-12-26	WOS:000358197600256
J	Xu, XL; Zheng, WH; Zhu, SM; Zhao, A; Mao, WM				Xu, Xiao-Ling; Zheng, Wei-Hui; Zhu, Shuang-Mei; Zhao, An; Mao, Wei-Min			The Prognostic Impact of Lymph Node Involvement in Large Scale Operable Node-Positive Esophageal Squamous Cell Carcinoma Patients: A 10-Year Experience	PLOS ONE			English	Article							AMERICAN JOINT COMMITTEE; 7TH EDITION; INTERNATIONAL UNION; TNM CLASSIFICATION; CANCER; SURVIVAL; METASTASES; NUMBER	Background Lymph node (LN)-related factors including the number of LN regions involved, the LN ratio (LNR), and the number of metastatic LNs are strong prognostic indicators for esophageal squamous cell carcinoma (ESCC) patients. Accurately staging LN involvement may improve the stratification of patients and guide the management of patients. Methods A total of 688 potentially resectable patients who had regional LN metastases were enrolled in this retrospective study. Results ESCC involving a single region was associated with better outcomes than that involving multiple regions (P < 0.001 for both PFS and OS). An increased number of metastatic LNs was significantly associated with reduced PFS and OS based on univariate analysis (P < 0.001). PFS and OS were significantly higher in patients with a lower cancer-involved LNR, with 5year OS rates of 9.7% and 31.4% for patients with a lower and higher cancer-involved LNR, respectively. Based on multivariate analysis, patients with N1 LN involvement experienced longer survival than patients with N2 LN involvement (HR: 1.37; 95% CI: 1.12-1.68) or N3 LN involvement (HR: 1.96; 95% CI: 1.52-2.53). Higher LNR resulted in longer OS than lower LNR based on multivariate analysis (HR: 1.45; 95% CI: 1.15-1.84; P = 0.002). Conclusions Our study has shown that not only the number of metastatic LNs but also the number of involved LN regions predicts outcomes after definitive surgery among Chinese patients with N-positive ESCC. LNR might serve as a powerful indicator that should be included in TNM staging for EC patients.	[Xu, Xiao-Ling] Zhejiang Canc Hosp, Dept Med Oncol, Hangzhou, Zhejiang, Peoples R China; [Xu, Xiao-Ling; Zheng, Wei-Hui; Zhao, An; Mao, Wei-Min] Zhejiang Canc Hosp, Zhejiang Canc Res Inst, Key Lab Diag & Treatment Technol Thorac Canc, Hangzhou, Zhejiang, Peoples R China; [Zhu, Shuang-Mei] Wenzhou Med Univ, Affiliated Hosp 6, Lishui Peoples Hosp, Dept Radio Chemotherapy Oncol, Wenzhou, Zhejiang, Peoples R China; [Mao, Wei-Min] Zhejiang Canc Hosp, Dept Thorac Surg, Hangzhou, Zhejiang, Peoples R China	Zhejiang Cancer Hospital; Zhejiang Cancer Hospital; Wenzhou Medical University; Zhejiang Cancer Hospital	Mao, WM (corresponding author), Zhejiang Canc Hosp, Zhejiang Canc Res Inst, Key Lab Diag & Treatment Technol Thorac Canc, Hangzhou, Zhejiang, Peoples R China.	maowm1418@163.com	ZHAO, AN/O-1547-2014	ZHAO, An/0000-0002-2716-9733	Province Important Technology and Science Program (Special Feature of Major Province Scientific and Technological Program [2011C13039-1]	Province Important Technology and Science Program (Special Feature of Major Province Scientific and Technological Program	This work was supported by the Province Important Technology and Science Program (Special Feature of Major Province Scientific and Technological Program 2011), No. 2011C13039-1.	Ajani JA, 2015, J NATL COMPR CANC NE, V13, P194, DOI 10.6004/jnccn.2015.0028; Chen JQ, 2012, INT J RADIAT ONCOL, V82, P475, DOI 10.1016/j.ijrobp.2010.08.037; Chen XL, 2014, J KOREAN MED SCI, V29, P217, DOI 10.3346/jkms.2014.29.2.217; He ZY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073446; Hofstetter W, 2007, ANN THORAC SURG, V84, P365, DOI 10.1016/j.athoracsur.2007.01.067; Hsu PK, 2010, ANN THORAC SURG, V89, P1024, DOI 10.1016/j.athoracsur.2010.01.017; Hsu WH, 2009, J GASTROINTEST SURG, V13, P1913, DOI 10.1007/s11605-009-0982-8; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kelty CJ, 2010, J THORAC ONCOL, V5, P1467, DOI 10.1097/JTO.0b013e3181e8f6b1; LERUT TE, 1994, WORLD J SURG, V18, P379, DOI 10.1007/BF00316818; Li H, 2011, DIS ESOPHAGUS, V24, P108, DOI 10.1111/j.1442-2050.2010.01108.x; Liu YP, 2010, EJSO-EUR J SURG ONC, V36, P155, DOI 10.1016/j.ejso.2009.09.005; Reeh M, 2012, ANN THORAC SURG, V93, P890, DOI 10.1016/j.athoracsur.2011.11.035; Rice TW, 2009, DIS ESOPHAGUS, V22, P1, DOI 10.1111/j.1442-2050.2008.00901.x; Rice TW, 2010, CANCER-AM CANCER SOC, V116, P3763, DOI 10.1002/cncr.25146; Siewert JR, 2001, ANN SURG, V234, P360, DOI 10.1097/00000658-200109000-00010; Sobin LHGM., 2010, INT UNION CANC TNM C; Takeno S, 2012, EXP THER MED, V4, P1087, DOI 10.3892/etm.2012.705; Talsma K, 2012, ANN SURG ONCOL, V19, P2142, DOI 10.1245/s10434-012-2218-5; Wang J, 2014, WORLD J GASTROENTERO, V20, P18397, DOI 10.3748/wjg.v20.i48.18397; Wang NN, 2015, TUMOR BIOL, V36, P2335, DOI 10.1007/s13277-014-2840-x; Waterman TA, 2004, ANN THORAC SURG, V78, P1161, DOI 10.1016/j.athoracsur.2004.04.045; Xu QR, 2011, WORLD J SURG, V35, P1303, DOI 10.1007/s00268-011-1015-9; Yamasaki M, 2014, ANN SURG ONCOL, V21, P2850, DOI 10.1245/s10434-014-3696-4	24	10	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0133076	10.1371/journal.pone.0133076	http://dx.doi.org/10.1371/journal.pone.0133076			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177369	gold, Green Published, Green Submitted			2022-12-26	WOS:000358197600211
J	Schofield, PW; Malacova, E; Preen, DB; D'Este, C; Tate, R; Reekie, J; Wand, H; Butler, T				Schofield, Peter W.; Malacova, Eva; Preen, David B.; D'Este, Catherine; Tate, Robyn; Reekie, Joanne; Wand, Handan; Butler, Tony			Does Traumatic Brain Injury Lead to Criminality? A Whole-Population Retrospective Cohort Study Using Linked Data	PLOS ONE			English	Article							HEAD-INJURY; PSYCHIATRIC-ILLNESS; AFGHANISTAN; DISORDERS; PRISONERS; IRAQ; TBI	Background Traumatic brain injury (TBI) may be a risk factor for criminal behaviour however multiple factors potentially confound the association. Methods Record linkage and Cox proportional hazards regression analyses were used to examine the association between hospital-recorded TBI (n = 7,694) and subsequent first criminal conviction in a retrospective cohort matched 1: 3 with 22,905 unaffected community controls and full-sibling controls (n = 2,397). Aboriginality, substance abuse, social disadvantage, and mental illness were included in analyses as potential confounders Results In multivariable models, relative to general population controls, TBI was associated with any conviction (males: Hazard Ratio (HR) = 1.58 (95% CI 1.46 to 1.72); females: HR = 1.52 (95% CI 1.28 to 1.81)); and similar Hazard Ratios were obtained for the sibling analyses in males (HR = 1.68 (95% CI 1.31-2.18)) and females (HR 1.27 (95% CI 0.71-2.29)). TBI was also associated with violent convictions relative to the general population, (males: HR = 1.65 (95% CI 1.42 to 1.92); females HR = 1.73 (95% CI 1.21 to 2.47)), and in analyses with sibling controls in men (HR = 1.89 (95% CI 1.20-3.00)), but not in women (HR 0.73, 95% CI 0.29-1.81)). Conclusion The results support a modest causal link between TBI and criminality after comprehensive adjustment for confounding. Reducing the rate of TBI, a major public health imperative, might have benefits in terms of crime reduction.	[Schofield, Peter W.] Hunter New England Local Hlth Dist, Neuropsychiat Serv, Newcastle, NSW, Australia; [Schofield, Peter W.] Univ Newcastle, Ctr Translat Neurosci & Mental Hlth, Newcastle, NSW 2300, Australia; [Malacova, Eva; Preen, David B.] Univ Western Australia, Sch Populat Hlth, Ctr Hlth Serv Res, Perth, WA 6009, Australia; [D'Este, Catherine] Australian Natl Univ, Natl Ctr Epidemiol & Publ Hlth, Canberra, ACT, Australia; [Tate, Robyn] Univ Sydney, Rehabil Studies Unit, Sydney, NSW 2006, Australia; [Reekie, Joanne; Wand, Handan; Butler, Tony] UNSW Australia, Kirby Inst, Sydney, NSW, Australia	University of Newcastle; University of Western Australia; Australian National University; University of Sydney; University of New South Wales Sydney; Kirby Institute	Schofield, PW (corresponding author), Hunter New England Local Hlth Dist, Neuropsychiat Serv, Newcastle, NSW, Australia.	peter.schofield@hnehealth.nsw.gov.au	; Preen, David/H-5663-2014	Butler, Tony/0000-0002-2679-2769; Schofield, Peter/0000-0001-8298-8590; Preen, David/0000-0002-2982-2169	National Health and Medical Research Council [533504]; MRC [MR/K006525/1] Funding Source: UKRI; Medical Research Council [MR/K006525/1] Funding Source: researchfish	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Funding was supplied by the National Health and Medical Research Council (grant # 533504) to TB, PWS, RT, DBP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1996, AUSTR VERS INT CLASS, V1; [Anonymous], 2010, INT STAT CLASS DIS R; Australian Bureau of Statistics, 2006, SOC IND AR SEIFA TEC; BIJUR PE, 1990, PEDIATRICS, V86, P337; Briffa TG, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-111; Caspi A, 1996, ARCH GEN PSYCHIAT, V53, P1033; Cobb BK, 1995, J ADOLESCENT HEALTH, V17, P381, DOI 10.1016/1054-139X(95)00059-2; Dams-O'Connor K, 2014, J HEAD TRAUMA REHAB, V29, P479, DOI 10.1097/HTR.0000000000000099; Elbogen EB, 2012, J CONSULT CLIN PSYCH, V80, P1097, DOI 10.1037/a0029967; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; Fann JR, 2002, J NEUROL NEUROSUR PS, V72, P615, DOI 10.1136/jnnp.72.5.615; Fazel S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001150; Frisell T, 2012, EPIDEMIOLOGY, V23, P713, DOI 10.1097/EDE.0b013e31825fa230; Frisell T, 2012, BEHAV GENET, V42, P3, DOI 10.1007/s10519-011-9483-0; Hodgins S, 1996, ARCH GEN PSYCHIAT, V53, P489, DOI 10.1001/archpsyc.1996.01830060031004; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Hosmer D. W., 1999, APPL SURVIVAL ANAL; Institute for Digital Research and Education, INTR TO SAS; Jamieson LM, 2008, MED J AUSTRALIA, V188, P576, DOI 10.5694/j.1326-5377.2008.tb01793.x; Kelman CW, 2002, AUST NZ J PUBL HEAL, V26, P251, DOI 10.1111/j.1467-842X.2002.tb00682.x; Lahey BB, 2010, CURR DIR PSYCHOL SCI, V19, P319, DOI 10.1177/0963721410383977; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Mayhew P, 2003, TRENDS ISS CRIME CRI, V247, P1; McKinlay A, 2014, J HEAD TRAUMA REHAB, V29, P498, DOI 10.1097/HTR.0000000000000001; Mulder E, 2011, INT J OFFENDER THER, V55, P118, DOI 10.1177/0306624X09356683; Preen D, 2003, AUST EPIDEMIOL, V10, P24; Rowe DC, 1997, CRIMINOLOGY, V35, P177, DOI 10.1111/j.1745-9125.1997.tb00874.x; Sarapatta M, 1998, BRAIN INJURY, V12, P821, DOI 10.1080/026990598122061; Schofield P, 2011, BRAIN INJURY, V25, P74, DOI 10.3109/02699052.2010.531690; Schofield PW, 2006, BRAIN INJURY, V20, P1409, DOI 10.1080/02699050601130443; Schofield PW, 2006, BRAIN INJURY, V20, P499, DOI 10.1080/02699050600664749; Shiroma Eric J, 2010, J Correct Health Care, V16, P147, DOI 10.1177/1078345809356538; Sourander A, 2011, SOC PSYCH PSYCH EPID, V46, P1211, DOI 10.1007/s00127-010-0292-1; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; Timonen M, 2002, PSYCHIAT RES, V113, P217, DOI 10.1016/S0165-1781(02)00269-X; Turkstra L, 2003, BRAIN INJURY, V17, P39, DOI 10.1080/0269905021000010122; Walker R, 2003, J PSYCHOACTIVE DRUGS, V35, P343, DOI 10.1080/02791072.2003.10400017	37	38	38	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132558	10.1371/journal.pone.0132558	http://dx.doi.org/10.1371/journal.pone.0132558			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1QN	26172545	Green Published, gold			2022-12-26	WOS:000358194900058
J	Sigdel, S; Singh, R; Kim, TS; Li, J; Kim, SY; Kim, IW; Jung, WS; Pan, CH; Kang, YC; Lee, JK				Sigdel, Sujan; Singh, Ranjitha; Kim, Tae-Su; Li, Jinglin; Kim, Sang-Yong; Kim, In-Won; Jung, Woo-Suk; Pan, Cheol-Ho; Kang, Yun Chan; Lee, Jung-Kul			Characterization of a Mannose-6-Phosphate Isomerase from Bacillus amyloliquefaciens and Its Application in Fructose-6-Phosphate Production	PLOS ONE			English	Article							D-FRUCTOSE 6-PHOSPHATE; L-ARABINOSE ISOMERASE; PHOSPHOMANNOSE ISOMERASE; CLONING; SUBSTRATE; BINDING; BIOSYNTHESIS; SEQUENCE; ENZYMES; LACCASE	The BaM6PI gene encoding a mannose-6-phosphate isomerase (M6PI, EC 5.3.1.8) was cloned from Bacillus amyloliquefaciens DSM7 and overexpressed in Escherichia coli. The enzyme activity of BaM6PI was optimal at pH and temperature of 7.5 and 70 degrees C, respectively, with a k(cat)/K-m of 13,900 s(-1) mM(-1) for mannose-6-phosphate (M6P). The purified BaM6PI demonstrated the highest catalytic efficiency of all characterized M6PIs. Although M6PIs have been characterized from several other sources, BaM6PI is distinguished from other M6PIs by its wide pH range and high catalytic efficiency for M6P. The binding orientation of the substrate M6P in the active site of BaM6PI shed light on the molecular basis of its unusually high activity. BaM6PI showed 97% substrate conversion from M6P to fructose-6-phosphate demonstrating the potential for using BaM6PI in industrial applications.	[Sigdel, Sujan; Singh, Ranjitha; Kim, Tae-Su; Li, Jinglin; Kim, In-Won; Lee, Jung-Kul] Konkuk Univ, Dept Chem Engn, Seoul 143701, South Korea; [Kim, Sang-Yong] BioNgene Co Ltd, Seoul 110521, South Korea; [Jung, Woo-Suk; Pan, Cheol-Ho] Korea Inst Sci & Technol, Gangneung Inst, Funct Food Ctr, Kangnung 210340, South Korea; [Kang, Yun Chan] Korea Univ, Dept Mat Sci & Engn, Seoul 136713, South Korea	Konkuk University; Korea Institute of Science & Technology (KIST); Korea University	Kang, YC (corresponding author), Korea Univ, Dept Mat Sci & Engn, Seoul 136713, South Korea.	yckang@korea.ac.kr; jkrhee@konkuk.ac.kr	Lee, Jungkukl/D-9104-2011; Ramakrishnan, Ranjitha/K-7554-2019; Ramakrishnan, Ranjitha/D-9087-2011; Kang, Yun Chan/H-2457-2015	Ramakrishnan, Ranjitha/0000-0001-9697-9070; Ramakrishnan, Ranjitha/0000-0001-9697-9070; Kang, Yun Chan/0000-0001-5769-5761	Energy Efficiency & Resources Core Technology Program of the Korea Institute of Energy Technology Evaluation and Planning (KETEP), from the Ministry of Trade, Industry & Energy, Republic of Korea [201320200000420]; Intelligent Synthetic Biology Center of Global Frontier Project - Ministry of Science, ICT and Future Planning, Republic of Korea [2011-0031955]	Energy Efficiency & Resources Core Technology Program of the Korea Institute of Energy Technology Evaluation and Planning (KETEP), from the Ministry of Trade, Industry & Energy, Republic of Korea; Intelligent Synthetic Biology Center of Global Frontier Project - Ministry of Science, ICT and Future Planning, Republic of Korea	This work was supported by the Energy Efficiency & Resources Core Technology Program of the Korea Institute of Energy Technology Evaluation and Planning (KETEP), granted financial resources from the Ministry of Trade, Industry & Energy, Republic of Korea (201320200000420). This research was also supported by a grant from the Intelligent Synthetic Biology Center of Global Frontier Project (2011-0031955) funded by the Ministry of Science, ICT and Future Planning, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beerens K, 2012, J IND MICROBIOL BIOT, V39, P823, DOI 10.1007/s10295-012-1089-x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Cleasby A, 1996, NAT STRUCT BIOL, V3, P470, DOI 10.1038/nsb0596-470; COLLINS LV, 1991, GENE, V103, P135, DOI 10.1016/0378-1119(91)90406-2; DISCHE Z, 1951, J BIOL CHEM, V192, P583; Fessner WD, 2012, CATAL SCI TECHNOL, V2, P1596, DOI 10.1039/c2cy20092a; Helanto M, 2007, APPL ENVIRON MICROB, V73, P7083, DOI 10.1128/AEM.01180-07; HICKS KB, 1980, CARBOHYD RES, V82, P393, DOI 10.1016/S0008-6215(00)85716-X; Izumori K, 2002, NATURWISSENSCHAFTEN, V89, P120, DOI 10.1007/s00114-002-0297-z; Jensen SO, 1998, BBA-PROTEIN STRUCT M, V1382, P5, DOI 10.1016/S0167-4838(97)00122-2; Kalam Y, 2012, CLIN TOXICOL, V50, P546, DOI 10.3109/15563650.2012.705847; Kim JH, 2010, APPL MICROBIOL BIOT, V85, P1839, DOI 10.1007/s00253-009-2210-6; Kim NH, 2008, APPL ENVIRON MICROB, V74, P3008, DOI 10.1128/AEM.00249-08; Kim TS, 2015, J MICROBIOL BIOTECHN, V25, P1093, DOI 10.4014/jmb.1503.03023; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee KM, 2012, BIORESOURCE TECHNOL, V123, P636, DOI 10.1016/j.biortech.2012.07.066; Lee SY, 2012, J MICROBIOL BIOTECHN, V22, P571, DOI 10.4014/jmb.1110.10010; Li YJ, 2011, EXTREMOPHILES, V15, P441, DOI 10.1007/s00792-011-0375-2; Marangos P J, 1998, Expert Opin Investig Drugs, V7, P615, DOI 10.1517/13543784.7.4.615; MELDAL M, 1992, CARBOHYD RES, V235, P115, DOI 10.1016/0008-6215(92)80082-C; MILES JS, 1984, NUCLEIC ACIDS RES, V12, P3631, DOI 10.1093/nar/12.8.3631; Narasaki CT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025514; Pascual C, 1981, FOLIA MICROBIOL PRAH, V26, P103; Patel SKS, 2014, J MICROBIOL BIOTECHN, V24, P639, DOI 10.4014/jmb.1401.01025; PAYTON MA, 1991, J BACTERIOL, V173, P2006, DOI 10.1128/jb.173.6.2006-2010.1991; Prabhu P, 2008, APPL MICROBIOL BIOT, V81, P283, DOI 10.1007/s00253-008-1652-6; Prabhu P, 2014, FEBS J, V281, P3446, DOI 10.1111/febs.12872; Prabhu P, 2011, APPL MICROBIOL BIOT, V89, P635, DOI 10.1007/s00253-010-2844-4; PROUDFOOT AEI, 1994, EUR J BIOCHEM, V219, P415, DOI 10.1111/j.1432-1033.1994.tb19954.x; Ramachandran P, 2012, PROCESS BIOCHEM, V47, P99, DOI 10.1016/j.procbio.2011.10.015; Roux C, 2011, PROTEINS, V79, P203, DOI 10.1002/prot.22873; Sagurthi SR, 2009, ACTA CRYSTALLOGR D, V65, P724, DOI 10.1107/S0907444909013328; Salonen N, 2013, BIOPROC BIOSYST ENG, V36, P489, DOI 10.1007/s00449-012-0805-2; Sanchez-Moreno I, 2012, ADV SYNTH CATAL, V354, P1725, DOI 10.1002/adsc.201200150; Singh RK, 2013, APPL MICROBIOL BIOT, V97, P7205, DOI 10.1007/s00253-012-4577-z; Thibodeaux CJ, 2008, ANGEW CHEM INT EDIT, V47, P9814, DOI 10.1002/anie.200801204; Tiwari M, 2010, J MOL GRAPH MODEL, V28, P707, DOI 10.1016/j.jmgm.2010.01.004; Tiwari MK, 2012, J BIOL CHEM, V287, P19429, DOI 10.1074/jbc.M111.335752; VALLEE BL, 1984, ADV ENZYMOL RAMB, V56, P283; WELLS TNC, 1993, BIOCHEMISTRY-US, V32, P1294, DOI 10.1021/bi00056a014; Widjaja A, 1999, J BIOSCI BIOENG, V87, P611, DOI 10.1016/S1389-1723(99)80123-6; Wu BY, 2002, FEBS LETT, V519, P87, DOI 10.1016/S0014-5793(02)02717-5; Wu GS, 2003, J COMPUT CHEM, V24, P1549, DOI 10.1002/jcc.10306; Yeom SJ, 2011, BIOCHIMIE, V93, P1659, DOI 10.1016/j.biochi.2011.05.040; Yeom SJ, 2009, APPL ENVIRON MICROB, V75, P4705, DOI 10.1128/AEM.00310-09; Zhang YW, 2012, ENZYME MICROB TECH, V50, P255, DOI 10.1016/j.enzmictec.2012.01.009; Zhang YW, 2010, APPL MICROBIOL BIOT, V87, P1993, DOI 10.1007/s00253-010-2600-9	48	12	12	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0131585	10.1371/journal.pone.0131585	http://dx.doi.org/10.1371/journal.pone.0131585			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26171785	gold, Green Published, Green Submitted			2022-12-26	WOS:000358194900018
J	Wiedmann, RT; Nonneman, DJ; Rohrer, GA				Wiedmann, Ralph T.; Nonneman, Dan J.; Rohrer, Gary A.			Genome-Wide Copy Number Variations Using SNP Genotyping in a Mixed Breed Swine Population	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; DOMESTIC PIG; VARIANTS; IDENTIFICATION; EXPRESSION; DISEASE	Copy number variations (CNVs) are increasingly understood to affect phenotypic variation. This study uses SNP genotyping of trios of mixed breed swine to add to the catalog of known genotypic variation in an important agricultural animal. PorcineSNP60 BeadChip genotypes were collected from 1802 pigs that combined to form 1621 trios. These trios were from the crosses of 50 boars with 525 sows producing 1621 piglets. The pigs were part of a population that was a mix of 1/4 Duroc, 1/2 Landrace and 1/4 Yorkshire breeds. Merging the overlapping CNVs that were observed in two or more individuals to form CNV regions (CNVRs) yielded 502 CNVRs across the autosomes. The CNVRs intersected genes, as defined by RefSeq, 84% of the time - 420 out of 502. The results of this study are compared and contrasted to other swine studies using similar and different methods of detecting CNVR. While progress is being made in this field, more work needs to be done to improve consistency and confidence in CNVR results.	[Wiedmann, Ralph T.; Nonneman, Dan J.; Rohrer, Gary A.] ARS, USDA, US Meat Anim Res Ctr, Clay Ctr, NE 68933 USA	United States Department of Agriculture (USDA)	Rohrer, GA (corresponding author), ARS, USDA, US Meat Anim Res Ctr, Clay Ctr, NE 68933 USA.	gary.rohrer@ars.usda.gov	Wiedmann, Ralph T/F-6530-2016	Rohrer, Gary/0000-0002-8252-9308	Agricultural Research Service, a division of the US Department of Agriculture [5438-31000-083-00D]; ARS [ARS-0426415] Funding Source: Federal RePORTER	Agricultural Research Service, a division of the US Department of Agriculture; ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This work was funded by Current Research Information System #5438-31000-083-00D of the Agricultural Research Service, a division of the US Department of Agriculture. The funder did not contribute to the study design, data collation and analysis, decision to publish, or preparation of the manuscript.	Alkan C, 2011, NAT REV GENET, V12, P363, DOI 10.1038/nrg2958; Chen CY, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-733; Clop A, 2012, ANIM GENET, V43, P503, DOI 10.1111/j.1365-2052.2012.02317.x; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Fadista J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003916; Fernandez AI, 2014, ANIM GENET, V45, P357, DOI 10.1111/age.12137; Fowler KE, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-784; Giuffra E, 2002, MAMM GENOME, V13, P569, DOI 10.1007/s00335-002-2184-5; Graubert TA, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030003; Henrichsen CN, 2009, HUM MOL GENET, V18, pR1, DOI 10.1093/hmg/ddp011; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Jiang JC, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-593; Li Y, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-725; Lindholm-Perry AK, 2009, ANIM GENET, V40, P713, DOI 10.1111/j.1365-2052.2009.01903.x; Liu GE, 2010, GENOME RES, V20, P693, DOI 10.1101/gr.105403.110; Marklund S, 1998, GENOME RES, V8, P826, DOI 10.1101/gr.8.8.826; Paudel Y, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-449; Pruitt KD, 2014, NUCLEIC ACIDS RES, V42, pD756, DOI 10.1093/nar/gkt1114; Ramayo-Caldas Y, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-593; Ramos AM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006524; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Revay T, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1473-9; Rubin CJ, 2012, P NATL ACAD SCI USA, V109, P19529, DOI 10.1073/pnas.1217149109; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Stankiewicz P, 2010, ANNU REV MED, V61, P437, DOI 10.1146/annurev-med-100708-204735; Wang JY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087571; Wang Jiying, 2013, PLoS One, V8, pe68683, DOI 10.1371/journal.pone.0068683; Wang JY, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-273; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Wang LG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074879; Wang YN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106780; Winchester Laura, 2009, Briefings in Functional Genomics & Proteomics, V8, P353, DOI 10.1093/bfgp/elp017; Zhang F, 2009, ANNU REV GENOM HUM G, V10, P451, DOI 10.1146/annurev.genom.9.081307.164217	33	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0133529	10.1371/journal.pone.0133529	http://dx.doi.org/10.1371/journal.pone.0133529			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26172260	gold, Green Published, Green Submitted			2022-12-26	WOS:000358194900151
J	Capellini, I; Nunn, CL; Barton, RA				Capellini, Isabella; Nunn, Charles L.; Barton, Robert A.			Microparasites and Placental Invasiveness in Eutherian Mammals	PLOS ONE			English	Article							VERTICAL TRANSMISSION; PHYLOGENETIC ANALYSIS; HUMAN-PREGNANCY; IMMUNE-SYSTEM; EVOLUTION; INTERFACE; ADAPTATION; ALLOMETRY; INFECTION; PRIMATES	Placental invasiveness-the number of maternal tissue layers separating fetal tissues from maternal blood-is variable across mammalian species. Although this diversity is likely to be functionally important, variation in placental invasiveness remains unexplained. Here we test the hypothesis that increased risk of transplacental transmission of pathogens from the mother to the fetus promotes the evolution of non-invasive placentation, the most likely derived condition in eutherian mammals. Specifically, we predict that non-invasive placentation is associated with increased microparasite species richness relative to more invasive placental types, based on the assumption that higher numbers of microparasites in a population reflects greater risk of transplacental transmission to fetuses. As predicted, higher bacteria species richness is associated with non-invasive placentation. Protozoa species richness, however, shows the opposite pattern. Because invasive placentae facilitate the transfer of maternal antibodies to the fetus, we propose that the ancestral condition of invasive placentation is retained under selection for protection of newborns from higher risk of postnatal protozoan infection. Hence, our findings suggest that a tradeoff exists between protection against bacterial infection prenatally and protozoan infection postnatally. Future studies are needed to investigate how maternal prevalence of infection and the relative preversus postnatal risk of fetal infection by different microparasite groups vary among mammalian hosts in relation to placental invasiveness.	[Capellini, Isabella] Univ Hull, Sch Biol Biomed & Environm Sci, Kingston Upon Hull HU6 7RX, N Humberside, England; [Nunn, Charles L.] Duke Univ, Dept Evolutionary Anthropol, Durham, NC USA; [Nunn, Charles L.] Duke Univ, Duke Global Hlth Inst Biol Sci, Durham, NC USA; [Barton, Robert A.] Univ Durham, Dept Anthropol, Durham, England	University of Hull; Duke University; Duke University; Durham University	Capellini, I (corresponding author), Univ Hull, Sch Biol Biomed & Environm Sci, Kingston Upon Hull HU6 7RX, N Humberside, England.	I.Capellini@hull.ac.uk	Capellini, Isabella/H-4813-2013	Capellini, Isabella/0000-0001-8065-2436	Biotechnology and Biological Sciences Research Council (UK); Natural Environment Research Council (UK) [BB/E014593/1]; BBSRC [BB/E014593/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E014593/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (UK)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council (UK)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study was joint grant funded by Biotechnology and Biological Sciences Research Council (UK) and Natural Environment Research Council (UK), Grant N: BB/E014593/1, PI: RAB, Co-I: IC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard K, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008599; [Anonymous], 2014, ADV BIOL; Baintner K, 2007, VET IMMUNOL IMMUNOP, V117, P153, DOI 10.1016/j.vetimm.2007.03.001; Bakardjiev AI, 2004, INFECT IMMUN, V72, P489, DOI 10.1128/IAI.72.1.489-497.2004; Benirschke K, 2012, PATHOLOGY HUMAN PLAC; Bininda-Emonds ORP, 2008, NATURE, V456, P274, DOI 10.1038/nature07347; Blomberg SP, 2002, J EVOLUTION BIOL, V15, P899, DOI 10.1046/j.1420-9101.2002.00472.x; Bordes F, 2009, OIKOS, V118, P801, DOI 10.1111/j.1600-0706.2008.17169.x; Capellini I, 2012, PLACENTA, V33, P763, DOI 10.1016/j.placenta.2012.07.004; Capellini I, 2011, AM NAT, V177, P86, DOI 10.1086/657435; Chucri TM, 2010, J REPROD IMMUNOL, V87, P14, DOI 10.1016/j.jri.2010.08.062; Crespi B, 2004, AM NAT, V163, P635, DOI 10.1086/382734; Duaso J, 2010, PLACENTA, V31, P705, DOI 10.1016/j.placenta.2010.05.007; Dubey JP, 2014, VET PARASITOL, V202, P270, DOI 10.1016/j.vetpar.2014.01.006; Elliot MG, 2008, J EVOLUTION BIOL, V21, P1763, DOI 10.1111/j.1420-9101.2008.01590.x; Elliot MG, 2009, PLACENTA, V30, P949, DOI 10.1016/j.placenta.2009.08.004; Erlebacher A, 2010, TRENDS ENDOCRIN MET, V21, P428, DOI 10.1016/j.tem.2010.02.003; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Freckleton RP, 2002, AM NAT, V160, P712, DOI 10.1086/343873; Freyer C, 2009, J EXP ZOOL PART B, V312B, P545, DOI 10.1002/jez.b.21239; Garamszegi LZ, 2011, J EVOLUTION BIOL, V24, P184, DOI 10.1111/j.1420-9101.2010.02156.x; Garland T, 2005, J EXP BIOL, V208, P3015, DOI 10.1242/jeb.01745; Goldenberg RL, 2000, NEW ENGL J MED, V342, P1500, DOI 10.1056/NEJM200005183422007; Grindstaff JL, 2003, P ROY SOC B-BIOL SCI, V270, P2309, DOI 10.1098/rspb.2003.2485; HAIG D, 1993, Q REV BIOL, V68, P495, DOI 10.1086/418300; HANSEN PJ, 1995, J REPROD FERTIL, P69; Harvey PH, 1998, COMP METHOD EVOLUTIO; Hemberger M, 2013, J REPROD IMMUNOL, V97, P36, DOI 10.1016/j.jri.2012.10.006; KIRKBRIDE CA, 1993, J VET DIAGN INVEST, V5, P64, DOI 10.1177/104063879300500114; Langer P, 2009, J MAMMAL, V90, P332, DOI 10.1644/08-MAMM-A-071.1; Lecuit M, 2004, P NATL ACAD SCI USA, V101, P6152, DOI 10.1073/pnas.0401434101; LEISER R, 1994, EXP CLIN ENDOCRINOL, V102, P122, DOI 10.1055/s-0029-1211275; Lindenfors P, 2007, GLOBAL ECOL BIOGEOGR, V16, P496, DOI 10.1111/j.1466-8238.2006.00301.x; LOKE YW, 1982, ADV PARASIT, V21, P155, DOI 10.1016/S0065-308X(08)60276-6; Meeusen ENT, 2001, AM J REPROD IMMUNOL, V46, P169, DOI 10.1111/j.8755-8920.2001.460208.x; Moffett A, 2015, PHILOS T R SOC B, V370, DOI [10.1093/ije/dyg238, DOI 10.1093/IJE/DYG238]; Moffett A, 2006, NAT REV IMMUNOL, V6, P584, DOI 10.1038/nri1897; Mossman HW, 1987, VERTEBRATE FETAL MEM; Nunn CL, 2005, EVOL ANTHROPOL, V14, P1, DOI 10.1002/evan.20041; Nunn CL, 2001, EVOL ANTHROPOL, V10, P81, DOI 10.1002/evan.1019; Nunn CL, 2006, INFECT DIS PRIMATES; Nunn CL, 2011, COMP APPROACHES EVOL; Oliveira LJ, 2012, REPROD DOMEST ANIM, V47, P384, DOI 10.1111/j.1439-0531.2012.02102.x; Orme C. D. L., 2014, CAPER COMP ANAL PHYL; Pagel M, 1997, ZOOL SCR, V26, P331, DOI 10.1111/j.1463-6409.1997.tb00423.x; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Petroff MG, 2005, J REPROD IMMUNOL, V68, P1, DOI 10.1016/j.jri.2005.08.003; Quinn GP, 2003, EXPT DESIGN DATA ANA; Revell LJ, 2010, METHODS ECOL EVOL, V1, P319, DOI 10.1111/j.2041-210X.2010.00044.x; Robbins JR, 2012, CURR OPIN MICROBIOL, V15, P36, DOI 10.1016/j.mib.2011.11.006; Robbins JR, 2012, INFECT IMMUN, V80, P418, DOI 10.1128/IAI.05899-11; Robbins JR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000732; Thellin O, 2003, TOXICOLOGY, V185, P179, DOI 10.1016/S0300-483X(02)00607-8; Vacca P, 2013, J REPROD IMMUNOL, V97, P14, DOI 10.1016/j.jri.2012.10.008; Vogel P, 2005, PLACENTA, V26, P591, DOI 10.1016/j.placenta.2004.11.005; Webster P, 2005, VET PARASITOL, V130, P255, DOI 10.1016/j.vetpar.2005.03.031; Wildman DE, 2006, P NATL ACAD SCI USA, V103, P3203, DOI 10.1073/pnas.0511344103; Wilson D. E., 2005, MAMMAL SPECIES WORLD; Wooding P., 2008, COMP PLACENTATION ST; Zeldovich VB, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002005	60	10	10	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0132563	10.1371/journal.pone.0132563	http://dx.doi.org/10.1371/journal.pone.0132563			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26168031	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000358193100055
J	Reinprecht, Y; Arif, M; Simon, LC; Pauls, KP				Reinprecht, Yarmilla; Arif, Muhammad; Simon, Leonardo C.; Pauls, K. Peter			Genome Regions Associated with Functional Performance of Soybean Stem Fibers in Polypropylene Thermoplastic Composites	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; CINNAMYL-ALCOHOL-DEHYDROGENASE; RECOMBINANT INBRED LINES; GLYCINE-RICH PROTEINS; CELL-WALLS; MECHANICAL-PROPERTIES; CHEMICAL-COMPOSITION; PHYSICAL-PROPERTIES; AGRONOMIC TRAITS; GENETIC-ANALYSIS	Plant fibers can be used to produce composite materials for automobile parts, thus reducing plastic used in their manufacture, overall vehicle weight and fuel consumption when they replace mineral fillers and glass fibers. Soybean stem residues are, potentially, significant sources of inexpensive, renewable and biodegradable natural fibers, but are not curretly used for biocomposite production due to the functional properties of their fibers in composites being unknown. The current study was initiated to investigate the effects of plant genotype on the performance characteristics of soybean stem fibers when incorporated into a polypropylene (PP) matrix using a selective phenotyping approach. Fibers from 50 lines of a recombinant inbred line population (169 RILs) grown in different environments were incorporated into PP at 20% (wt/wt) by extrusion. Test samples were injection molded and characterized for their mechanical properties. The performance of stem fibers in the composites was significantly affected by genotype and environment. Fibers from different genotypes had significantly different chemical compositions, thus composites prepared with these fibers displayed different physical properties. This study demonstrates that thermoplastic composites with soybean stem-derived fibers have mechanical properties that are equivalent or better than wheat straw fiber composites currently being used for manufacturing interior automotive parts. The addition of soybean stem residues improved flexural, tensile and impact properties of the composites. Furthermore, by linkage and in silico mapping we identified genomic regions to which quantitative trait loci (QTL) for compositional and functional properties of soybean stem fibers in thermoplastic composites, as well as genes for cell wall synthesis, were co-localized. These results may lead to the development of high value uses for soybean stem residue.	[Reinprecht, Yarmilla; Arif, Muhammad; Pauls, K. Peter] Univ Guelph, Dept Plant Agr, Guelph, ON N1G 2W1, Canada; [Arif, Muhammad; Simon, Leonardo C.] Univ Waterloo, Dept Chem Engn, Waterloo, ON N2L 3G1, Canada	University of Guelph; University of Waterloo	Reinprecht, Y (corresponding author), Univ Guelph, Dept Plant Agr, Guelph, ON N1G 2W1, Canada.	yreinpre@uoguelph.ca			Ontario Ministry of Agriculture, Food and Rural Affairs, KPP Ontario Ministry of Research and Innovation, KPP	Ontario Ministry of Agriculture, Food and Rural Affairs, KPP Ontario Ministry of Research and Innovation, KPP	Ontario Ministry of Agriculture, Food and Rural Affairs, KPP Ontario Ministry of Research and Innovation, KPP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson M, 2010, PLANT SCI, V178, P61, DOI 10.1016/j.plantsci.2009.11.003; [Anonymous], 2010, D170810 ASTM, DOI [10.1520/D1708-10, DOI 10.1520/D1708-10]; Appenzeller L, 2004, CELLULOSE, V11, P287, DOI 10.1023/B:CELL.0000046417.84715.27; Ashori A, 2009, J APPL POLYM SCI, V111, P1684, DOI 10.1002/app.29189; ASTM INTERNATIONAL, 2010, ANN BOOK ASTM STAND, P1, DOI DOI 10.1520/C0109; Banniza S, 2005, CAN J BOT, V83, P954, DOI [10.1139/B05-044, 10.1139/b05-044]; Barchi L, 2009, THEOR APPL GENET, V118, P1157, DOI 10.1007/s00122-009-0970-0; Barriere Y., 2007, GENES GENOMES GENOMI, V1, P133; Bengtsson M, 2007, COMPOS PART A-APPL S, V38, P1922, DOI 10.1016/j.compositesa.2007.03.004; Boerjan W, 2003, ANNU REV PLANT BIOL, V54, P519, DOI 10.1146/annurev.arplant.54.031902.134938; Brown RM, 2004, J POLYM SCI POL CHEM, V42, P487, DOI 10.1002/pola.10877; Capron A, 2013, J EXP BOT, V64, P185, DOI 10.1093/jxb/ers319; Cardinal AJ, 2003, THEOR APPL GENET, V106, P866, DOI 10.1007/s00122-002-1136-5; CARPITA NC, 1993, PLANT J, V3, P1, DOI 10.1111/j.1365-313X.1993.tb00007.x; Chen AP, 2007, J PLANT RES, V120, P337, DOI 10.1007/s10265-006-0058-8; DELMER DP, 1995, PLANT CELL, V7, P987, DOI 10.1105/tpc.7.7.987; Falconer D. S., 1996, INTRO QUANTITATIVE G; Fang DD, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-397; Fletcher RS, 2005, J SCI FOOD AGR, V85, P2429, DOI 10.1002/jsfa.2270; Fowler PA, 2006, J SCI FOOD AGR, V86, P1781, DOI 10.1002/jsfa.2558; FREY K. J., 1957, AGRON JOUR, V49, P59; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Grant D, 2010, NUCLEIC ACIDS RES, V38, pD843, DOI 10.1093/nar/gkp798; Gu Y, 2010, P NATL ACAD SCI USA, V107, P12866, DOI 10.1073/pnas.1007092107; Hallac BB, 2011, BIOFUEL BIOPROD BIOR, V5, P215, DOI 10.1002/bbb.269; Harholt J, 2010, PLANT PHYSIOL, V153, P384, DOI 10.1104/pp.110.156588; Jannink JL, 2005, CROP SCI, V45, P901, DOI 10.2135/cropsci2004.0278; Jestin C, 2012, OPEN J GENET CYTOL, V2, P190, DOI DOI 10.4236/0JGEN.2012.24025; Jin CF, 2004, GENETICS, V168, P2285, DOI 10.1534/genetics.104.027524; Johnson JMF, 2007, SOIL SCI SOC AM J, V71, P155, DOI 10.2136/sssaj2005.0419; Julson JL, 2004, J APPL POLYM SCI, V93, P2484, DOI 10.1002/app.20823; Kong EY, 2013, CROP J, V1, P43, DOI 10.1016/j.cj.2013.07.012; Kosambi D. D., 1944, ANN EUGENICS, V12, P172; Krakowsky MD, 2005, THEOR APPL GENET, V111, P337, DOI 10.1007/s00122-005-2026-4; Krakowsky MD, 2003, MAYDICA, V48, P283; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; Lee S, 2006, HOLZ ROH WERKST, V64, P74, DOI 10.1007/s00107-005-0062-z; Lin S, 1997, MOL BREEDING, V3, P219, DOI 10.1023/A:1009637320805; Lorenz AJ, 2010, CROP SCI, V50, P842, DOI 10.2135/cropsci2009.04.0168; Luiz H.C., 2000, NATURAL POLYM AGROFI, P115; Mangeon A, 2010, PLANT SIGNAL BEHAV, V5, P99, DOI 10.4161/psb.5.2.10336; MANSUR LM, 1993, THEOR APPL GENET, V86, P907, DOI 10.1007/BF00211040; Mansur LM, 1996, CROP SCI, V36, P1327, DOI 10.2135/cropsci1996.0011183X003600050042x; Mehdinia M., 2013, World Journal of Agricultural Sciences, V9, P238; Minic Z, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-6; Mittal A, 2011, BIOTECHNOL BIOFUELS, V4, DOI 10.1186/1754-6834-4-41; Mohanty AK, 2002, J POLYM ENVIRON, V10, P19, DOI 10.1023/A:1021013921916; Novaes E, 2009, NEW PHYTOL, V182, P878, DOI 10.1111/j.1469-8137.2009.02785.x; Nutzmann HW, 2014, CURR OPIN BIOTECH, V26, P91, DOI 10.1016/j.copbio.2013.10.009; Orf JH, 1999, CROP SCI, V39, P1642, DOI 10.2135/cropsci1999.3961642x; Peng DL, 2014, FIELD CROP RES, V157, P1, DOI 10.1016/j.fcr.2013.11.015; Penning BW, 2009, PLANT PHYSIOL, V151, P1703, DOI 10.1104/pp.109.136804; Perrin RM, 2001, CURR BIOL, V11, pR213, DOI 10.1016/S0960-9822(01)00108-7; Reddy N, 2005, TRENDS BIOTECHNOL, V23, P22, DOI 10.1016/j.tibtech.2004.11.002; Reddy N, 2009, BIORESOURCE TECHNOL, V100, P3593, DOI 10.1016/j.biortech.2008.09.063; Reinprecht Y, 2006, GENOME, V49, P1510, DOI 10.1139/G06-112; Reinprecht Y, 2011, SOYBEAN - MOLECULAR ASPECTS OF BREEDING, P119; Richmond TA, 2000, PLANT PHYSIOL, V124, P495, DOI 10.1104/pp.124.2.495; Rong J, 2007, GENETICS, V176, P2577, DOI 10.1534/genetics.107.074518; Rowell R.M., 1997, LIGNOCELLUL COMPOS, V13, P23; Rowell RM, 1997, J COMPOS, V18, P23; Sachetto-Martins G, 2000, BBA-GENE STRUCT EXPR, V1492, P1, DOI 10.1016/S0167-4781(00)00064-6; Said JI, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-776; Sanadi A.R., 1997, PAPER COMPOSITES AGR, P377; Sarkar P, 2009, J EXP BOT, V60, P3615, DOI 10.1093/jxb/erp245; SAS S., 2009, STAT US GUID VERS 9; Schlueter JA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-330; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Schuetz M, 2014, PLANT PHYSIOL, V166, P798, DOI 10.1104/pp.114.245597; Shen H, 2009, BIOENERG RES, V2, P217, DOI 10.1007/s12155-009-9047-9; Sibout R, 2005, PLANT CELL, V17, P2059, DOI 10.1105/tpc.105.030767; Sindhu A, 2007, PLANT PHYSIOL, V145, P1444, DOI 10.1104/pp.107.102582; StatSoft Inc, 2009, STAT VERS 9; Stombaugh SK, 2004, CROP SCI, V44, P2101, DOI 10.2135/cropsci2004.2101; Sukumaran K., 1997, MET MATER PROCESS, V13, P121; Sykes R, 2008, WOOD SCI TECHNOL, V42, P649, DOI 10.1007/s00226-008-0199-0; Taylor-Teeples M, 2015, NATURE, V517, P571, DOI 10.1038/nature14099; Thomas S, 2011, CELLULOSE FIBERS: BIO- AND NANO-POLYMER COMPOSITES, P3, DOI 10.1007/978-3-642-17370-7_1; Toriz G, 2002, POLYM COMPOSITE, V23, P806, DOI 10.1002/pc.10478; VANSOEST PJ, 1991, J DAIRY SCI, V74, P3583, DOI 10.3168/jds.S0022-0302(91)78551-2; Vassilev SV, 2010, FUEL, V89, P913, DOI 10.1016/j.fuel.2009.10.022; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wang S, 2012, WINDOWS QTL CARTOGRA; WHETTEN R, 1995, PLANT CELL, V7, P1001, DOI 10.2307/3870053; Xu W, 1996, PLANT J, V9, P879, DOI 10.1046/j.1365-313X.1996.9060879.x; Yokoyama R, 2004, PLANT CELL PHYSIOL, V45, P1111, DOI 10.1093/pcp/pch151; Zhang, 2007, CROP MANAGE, V6, DOI [10.1094/cm-2007-0927-01-rs, DOI 10.1094/CM-2007-0927-01-RS, 10.1094/CM-2007-0927-01-RS]; Zhong RQ, 2007, CURR OPIN PLANT BIOL, V10, P564, DOI 10.1016/j.pbi.2007.09.001; Zhong RQ, 2015, PLANT CELL PHYSIOL, V56, P195, DOI 10.1093/pcp/pcu140	89	3	3	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0130371	10.1371/journal.pone.0130371	http://dx.doi.org/10.1371/journal.pone.0130371			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26167917	Green Submitted, Green Published, gold			2022-12-26	WOS:000358193100004
J	Pan, B; Chen, JZ; Lian, JM; Huang, XF; Deng, C				Pan, Bo; Chen, Jiezhong; Lian, Jiamei; Huang, Xu-Feng; Deng, Chao			Unique Effects of Acute Aripiprazole Treatment on the Dopamine D2 Receptor Downstream cAMP-PKA and Akt-GSK3 beta Signalling Pathways in Rats	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; OLANZAPINE-INDUCED HYPERPHAGIA; GLYCOGEN-SYNTHASE KINASE-3; TYROSINE-HYDROXYLASE; ANTIPSYCHOTIC-DRUGS; CYCLIC-AMP; FUNCTIONAL SELECTIVITY; PARTIAL AGONIST; BETA-CATENIN; MOUSE-BRAIN	Aripiprazole is a wide-used antipsychotic drug with therapeutic effects on both positive and negative symptoms of schizophrenia, and reduced side-effects. Although aripiprazole was developed as a dopamine D-2 receptor (D2R) partial agonist, all other D2R partial agonists that aimed to mimic aripiprazole failed to exert therapeutic effects in clinic. The present in vivo study aimed to investigate the effects of aripiprazole on the D2R downstream cAMP-PKA and Akt-GSK3 beta signalling pathways in comparison with a D2R antagonist - haloperidol and a D2R partial agonist - bifeprunox. Rats were injected once with aripiprazole (0.75mg/kg, i.p.), bifeprunox (0.8mg/kg, i.p.), haloperidol (0.1mg/kg, i.p.) or vehicle. Five brain regions - the prefrontal cortex (PFC), nucleus accumbens (NAc), caudate putamen (CPu), ventral tegmental area (VTA) and substantia nigra (SN) were collected. The protein levels of PKA, Akt and GSK3 beta were measured by Western Blotting; the cAMP levels were examined by ELISA tests. The results showed that aripiprazole presented similar acute effects on PKA expression to haloperidol, but not bifeprunox, in the CPU and VTA. Additionally, aripiprazole was able to increase the phosphorylation of GSK3 beta in the PFC, NAc, CPu and SN, respectively, which cannot be achieved by bifeprunox and haloperidol. These results suggested that acute treatment of aripiprazole had differential effects on the cAMP-PKA and Akt-GSK3 beta signalling pathways from haloperidol and bifeprunox in these brain areas. This study further indicated that, by comparison with bifeprunox, the unique pharmacological profile of aripiprazole may be attributed to the relatively lower intrinsic activity at D2R.	[Pan, Bo; Chen, Jiezhong; Lian, Jiamei; Deng, Chao] Illawarra Hlth & Med Res Inst, Antipsychot Res Lab, Wollongong, NSW, Australia; [Pan, Bo; Lian, Jiamei; Huang, Xu-Feng; Deng, Chao] Univ Wollongong, Sch Med, Ctr Translat Neurosci, Wollongong, NSW, Australia	University of Wollongong; University of Wollongong	Deng, C (corresponding author), Illawarra Hlth & Med Res Inst, Antipsychot Res Lab, Wollongong, NSW, Australia.	chao@uow.edu.au	Huang, Xu-Feng/H-7408-2015; Deng, Chao/F-4417-2016; Pan, Bo/L-9742-2015; Pan, Bo/HHD-1463-2022; Huang, Xu-Feng/D-6053-2013	Huang, Xu-Feng/0000-0002-5895-2253; Deng, Chao/0000-0003-1147-5741; Pan, Bo/0000-0001-8478-5252; Pan, Bo/0000-0001-8478-5252; Huang, Xu-Feng/0000-0002-5895-2253; Lian, Jiamei/0000-0002-8850-2536; Chen, Jiezhong/0000-0003-1977-6143	Australian National Health; Medical Research Council project [APP108473]	Australian National Health(National Health and Medical Research Council (NHMRC) of Australia); Medical Research Council project(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by the Australian National Health and Medical Research Council project grant (APP108473) to Chao Deng. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adell A, 2004, NEUROSCI BIOBEHAV R, V28, P415, DOI 10.1016/j.neubiorev.2004.05.001; Alimohamad H, 2005, J NEUROCHEM, V95, P513, DOI 10.1111/j.1471-4159.2005.03388.x; Alimohamad H, 2005, BIOL PSYCHIAT, V57, P533, DOI 10.1016/j.biopsych.2004.11.036; Allen JA, 2011, P NATL ACAD SCI USA, V108, P18488, DOI 10.1073/pnas.1104807108; Batchelor M, 1998, J NEUROSCI, V18, P10304; Bateup HS, 2008, NAT NEUROSCI, V11, P932, DOI 10.1038/nn.2153; Beasley C, 2001, NEUROSCI LETT, V302, P117, DOI 10.1016/S0304-3940(01)01688-3; Beaulieu JM, 2007, TRENDS PHARMACOL SCI, V28, P166, DOI 10.1016/j.tips.2007.02.006; Beaulieu JM, 2007, J NEUROSCI, V27, P881, DOI 10.1523/JNEUROSCI.5074-06.2007; Beaulieu JM, 2009, ANNU REV PHARMACOL, V49, P327, DOI 10.1146/annurev.pharmtox.011008.145634; Beaulieu JM, 2004, P NATL ACAD SCI USA, V101, P5099, DOI 10.1073/pnas.0307921101; Beaulieu JM, 2005, CELL, V122, P261, DOI 10.1016/j.cell.2005.05.012; Boyd KN, 2012, HANDB EXP PHARMACOL, V212, P53, DOI 10.1007/978-3-642-25761-2_3; Burris KD, 2002, J PHARMACOL EXP THER, V302, P381, DOI 10.1124/jpet.102.033175; CADD G, 1989, NEURON, V3, P71, DOI 10.1016/0896-6273(89)90116-5; CARLSSON A, 1963, ACTA PHARMACOL TOX, V20, P140; Clegg CH, 1996, J BIOL CHEM, V271, P1638, DOI 10.1074/jbc.271.3.1638; CLEGG CH, 1987, J BIOL CHEM, V262, P13111; DeLeon A, 2004, CLIN THER, V26, P649, DOI 10.1016/S0149-2918(04)90066-5; Der-Ghazarian T, 2010, J NEURAL TRANSM, V117, P573, DOI 10.1007/s00702-010-0396-5; Dwivedi Y, 2002, J PHARMACOL EXP THER, V301, P197, DOI 10.1124/jpet.301.1.197; ELMESTIKAWY S, 1986, J NEUROCHEM, V47, P1425; Emamian ES, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00033; Emamian ES, 2004, NAT GENET, V36, P131, DOI 10.1038/ng1296; Greengard P, 2001, SCIENCE, V294, P1024, DOI 10.1126/science.294.5544.1024; Gurevich EV, 2002, NEUROSCIENCE, V109, P421, DOI 10.1016/S0306-4522(01)00511-5; Han M, 2009, NEUROSCIENCE, V164, P1754, DOI 10.1016/j.neuroscience.2009.09.041; Han M, 2009, INT J NEUROPSYCHOPH, V12, P941, DOI 10.1017/S1461145709009948; Harada K, 1996, J NEUROCHEM, V67, P629; He M, 2014, PSYCHONEUROENDOCRINO, V42, P153, DOI 10.1016/j.psyneuen.2014.01.018; Hirose Tsuyoshi, 2005, J Med Invest, V52 Suppl, P284, DOI 10.2152/jmi.52.284; Jope RS, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00016; KANEKO M, 1992, PROSTAG LEUKOTR ESS, V46, P53, DOI 10.1016/0952-3278(92)90059-R; Kang UG, 2004, FEBS LETT, V560, P115, DOI 10.1016/S0014-5793(04)00082-1; Khanna P, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006569.pub4; KIKUCHI T, 1995, J PHARMACOL EXP THER, V274, P329; Koros E, 2007, DRUG NEWS PERSPECT, V20, P437, DOI 10.1358/dnp.2007.20.7.1149632; Kozlovsky N, 2001, SCHIZOPHR RES, V52, P101, DOI 10.1016/S0920-9964(00)00174-2; Lawler CP, 1999, NEUROPSYCHOPHARMACOL, V20, P612, DOI 10.1016/S0893-133X(98)00099-2; Li XH, 2007, INT J NEUROPSYCHOPH, V10, P7, DOI 10.1017/S1461145706006547; Lieberman JA, 2004, CNS DRUGS, V18, P251, DOI 10.2165/00023210-200418040-00005; Lovestone S, 2007, TRENDS NEUROSCI, V30, P142, DOI 10.1016/j.tins.2007.02.002; Mailman RB, 2007, TRENDS PHARMACOL SCI, V28, P390, DOI 10.1016/j.tips.2007.06.002; Mailman RB, 2010, CURR PHARM DESIGN, V16, P488, DOI 10.2174/138161210790361461; Malling D, 2007, SCHIZOPHR B; Masri B, 2008, P NATL ACAD SCI USA, V105, P13656, DOI 10.1073/pnas.0803522105; MIYAZAKI H, 1986, ARZNEIMITTEL-FORSCH, V36-1, P443; Mizrahi R, 2009, INT J NEUROPSYCHOPH, V12, P715, DOI 10.1017/S1461145709000327; NISSBRANDT H, 1985, J PHARM PHARMACOL, V37, P884, DOI 10.1111/j.2042-7158.1985.tb04994.x; ONALI P, 1992, NEUROCHEM INT, V20, pS89; Page G, 2004, NEUROCHEM INT, V45, P627, DOI 10.1016/j.neuint.2004.04.002; Park SW, 2011, NEUROSCI RES, V71, P335, DOI 10.1016/j.neures.2011.08.010; Paxinos G, 2005, THE RAT BRAIN IN STE; Polter AM, 2012, CELL SIGNAL, V24, P265, DOI 10.1016/j.cellsig.2011.09.009; ROSKOSKI R, 1987, J NEUROCHEM, V48, P236, DOI 10.1111/j.1471-4159.1987.tb13153.x; Seeman Philip, 2010, Clin Schizophr Relat Psychoses, V4, P56, DOI 10.3371/CSRP.4.1.5; Shapiro DA, 2003, NEUROPSYCHOPHARMACOL, V28, P1400, DOI 10.1038/sj.npp.1300203; Shimokawa Y, 2005, J CHROMATOGR B, V821, P8, DOI 10.1016/j.jchromb.2005.03.024; Sibley DR, 1999, ANNU REV PHARMACOL, V39, P313, DOI 10.1146/annurev.pharmtox.39.1.313; Smith GC, 2014, PSYCHOPHARMACOLOGY, V231, P4553, DOI 10.1007/s00213-014-3608-0; Soberg K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060935; STRAIT KA, 1986, MOL PHARMACOL, V29, P561; Sutton LP, 2007, J NEUROCHEM, V102, P153, DOI 10.1111/j.1471-4159.2007.04527.x; Svenningsson P, 1998, NEUROSCIENCE, V84, P223, DOI 10.1016/S0306-4522(97)00510-1; SVENSSON K, 1991, N-S ARCH PHARMACOL, V344, P263; Tadori Y, 2008, EUR J PHARMACOL, V597, P27, DOI 10.1016/j.ejphar.2008.09.008; Tadori Y, 2007, EUR J PHARMACOL, V574, P103, DOI 10.1016/j.ejphar.2007.07.031; Tamminga CA, 2002, CNS NEUROL DISORD-DR, V1, P141, DOI 10.2174/1568007024606195; TAYLOR SS, 1990, ANNU REV BIOCHEM, V59, P971, DOI 10.1146/annurev.bi.59.070190.004543; Thiselton DL, 2008, BIOL PSYCHIAT, V63, P449, DOI 10.1016/j.biopsych.2007.06.005; Turalba AV, 2004, NEUROSCI LETT, V357, P53, DOI 10.1016/j.neulet.2003.11.059; UHLER MD, 1986, J BIOL CHEM, V261, P5360; Urban JD, 2007, J PHARMACOL EXP THER, V320, P1, DOI 10.1124/jpet.106.104463; Urban JD, 2007, NEUROPSYCHOPHARMACOL, V32, P67, DOI 10.1038/sj.npp.1301071; Urs NM, 2012, P NATL ACAD SCI USA, V109, P20732, DOI 10.1073/pnas.1215489109; Usiello A, 2000, NATURE, V408, P199, DOI 10.1038/35041572; Vernaleken I, 2006, NEUROIMAGE, V30, P1332, DOI 10.1016/j.neuroimage.2005.11.014; WEINER DM, 1991, P NATL ACAD SCI USA, V88, P1859, DOI 10.1073/pnas.88.5.1859; WOLF ME, 1990, ANN NY ACAD SCI, V604, P323, DOI 10.1111/j.1749-6632.1990.tb32003.x; Zhang QS, 2014, INT J NEUROPSYCHOPH, V17, P807, DOI 10.1017/S1461145713001697; Zhang QS, 2014, PROG NEURO-PSYCHOPH, V51, P172, DOI 10.1016/j.pnpbp.2014.02.003	81	19	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132722	10.1371/journal.pone.0132722	http://dx.doi.org/10.1371/journal.pone.0132722			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26162083	Green Submitted, gold, Green Published			2022-12-26	WOS:000358162300171
J	Salfati, E; Morrison, AC; Boerwinkle, E; Chakravarti, A				Salfati, Elias; Morrison, Alanna C.; Boerwinkle, Eric; Chakravarti, Aravinda			Direct Estimates of the Genomic Contributions to Blood Pressure Heritability within a Population-Based Cohort (ARIC)	PLOS ONE			English	Article							COMMON SNPS EXPLAIN; WIDE ASSOCIATION; GENETIC-VARIATION; DISEASE; SUSCEPTIBILITY; HYPERTENSION; TRAITS; LOCI; IDENTIFICATION; ANNOTATION	Blood pressure (BP) is a heritable trait with multiple environmental and genetic contributions, with current heritability estimates from twin and family studies being similar to 40%. Here, we use genome-wide polymorphism data from the Atherosclerosis Risk in Communities (ARIC) study to estimate BP heritability from genomic relatedness among cohort members. We utilized data on 6,365,596 and 9,578,528 genotyped and imputed common single nucleotide polymorphisms (SNPs), in 8,901 European ancestry (EA) and 2,860 African Ancestry (AA) ARIC participants, respectively, and a mixed linear model for analyses, to make four observations. First, for BP measurements, the heritability is similar to 20%/similar to 50% and similar to 27%/similar to 39% for systolic (SBP)/diastolic (DBP) blood pressure in European and African ancestry individuals, respectively, consistent with prior studies. Second, common variants with allele frequency >10% recapitulate most of the BP heritability in these data. Third, the vast majority of BP heritability varies by chromosome, depending on its length, and is largely concentrated in noncoding genomic regions annotated as DNaseI hypersensitive sites (DHSs). Fourth, the majority of this heritability arises from loci not harboring currently known cardiovascular and renal genes. Recent meta-analyses of large-scale genome-wide association studies (GWASs) and admixture mapping have identified similar to 50 loci associated with BP and hypertension (HTN), and yet they account for only a small fraction (similar to 2%) of the heritability.	[Salfati, Elias; Chakravarti, Aravinda] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Ctr Complex Dis Genom, Baltimore, MD 21205 USA; [Salfati, Elias] Univ Paris 05, Sorbonne Paris Cite, F-75005 Paris, France; [Morrison, Alanna C.; Boerwinkle, Eric] Univ Texas Hlth Sci Ctr Houston, Ctr Human Genet, Houston, TX 77030 USA	Johns Hopkins University; UDICE-French Research Universities; Universite Paris Cite; University of Texas System; University of Texas Health Science Center Houston	Chakravarti, A (corresponding author), Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Ctr Complex Dis Genom, Baltimore, MD 21205 USA.	aravinda@jhmi.edu		Morrison, Alanna/0000-0001-6381-4296	National Heart, Lung, and Blood Institute (NHLBI) [HL086694]; NHLBI [HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, HHSN268201100012C, R01HL087641, R01HL59367, R01HL086694]; National Human Genome Research Institute [U01HG004402]; National Institutes of Health, a component of the National Institutes of Health [HHSN268200625226C, UL1RR025005]; NIH Roadmap for Medical Research; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025005] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087641, R01HL086694, R01HL059367] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004402] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institutes of Health, a component of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by grant HL086694 from the National Heart, Lung, and Blood Institute (NHLBI) to A.C. The Atherosclerosis Risk in Communities Study was carried out as a collaborative study supported by NHLBI contracts (HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, and HHSN268201100012C), R01HL087641, R01HL59367 and R01HL086694; National Human Genome Research Institute contract U01HG004402; and National Institutes of Health contract HHSN268200625226C. Infrastructure was partly supported by Grant Number UL1RR025005, a component of the National Institutes of Health and NIH Roadmap for Medical Research.	ARIC Investigators, 1988, SITT BLOOD PRESS POS; Barkley RA, 2004, HYPERTENSION, V43, P477, DOI 10.1161/01.HYP.0000111585.76299.f7; Cook NR, 2000, STAT MED, V19, P2625, DOI 10.1002/1097-0258(20001015)19:19<2625::AID-SIM536>3.0.CO;2-H; Dimmer EC, 2012, NUCLEIC ACIDS RES, V40, pD565, DOI 10.1093/nar/gkr1048; Ehret GB, 2013, EUR HEART J, V34, P951, DOI 10.1093/eurheartj/ehs455; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; Fox ER, 2011, HUM MOL GENET, V20, P2273, DOI 10.1093/hmg/ddr092; Ganesh SK, 2014, AM J HUM GENET, V95, P49, DOI 10.1016/j.ajhg.2014.06.002; Gusev A, 2014, AM J HUM GENET, V95, P535, DOI 10.1016/j.ajhg.2014.10.004; Harvey PR, 2013, J NEPHROL, V26, P94, DOI 10.5301/jn.5000119; Ho JE, 2011, J HYPERTENS, V29, P62, DOI 10.1097/HJH.0b013e3283406927; Ji WZ, 2008, NAT GENET, V40, P592, DOI 10.1038/ng.118; Johnson AD, 2011, HYPERTENSION, V57, P903, DOI 10.1161/HYPERTENSIONAHA.110.158667; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Lee SH, 2013, HUM MOL GENET, V22, P832, DOI 10.1093/hmg/dds491; Lee SH, 2012, NAT GENET, V44, P247, DOI 10.1038/ng.1108; Levy D, 2000, HYPERTENSION, V36, P477, DOI 10.1161/01.HYP.36.4.477; Levy D, 2009, NAT GENET, V41, P677, DOI 10.1038/ng.384; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; LIFTON RP, 1993, J HYPERTENS, V11, P231, DOI 10.1097/00004872-199303000-00002; Maher B, 2008, NATURE, V456, P18, DOI 10.1038/456018a; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Newton-Cheh C, 2009, NAT GENET, V41, P666, DOI 10.1038/ng.361; Olden M, 2013, AM J KIDNEY DIS, V61, P889, DOI 10.1053/j.ajkd.2012.12.024; Padmanabhan S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001177; Salvi E, 2012, HYPERTENSION, V59, P248, DOI 10.1161/HYPERTENSIONAHA.111.181990; Schaub MA, 2012, GENOME RES, V22, P1748, DOI 10.1101/gr.136127.111; Vattikuti S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002637; Vinkhuyzen AAE, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.27; Voight BF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002793; Wain LV, 2011, NAT GENET, V43, P1005, DOI 10.1038/ng.922; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; Westra HJ, 2014, BBA-MOL BASIS DIS, V1842, P1896, DOI 10.1016/j.bbadis.2014.04.024; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184; World Health Organization, 2012, WORLD HLTH STAT, V2012, P35; Yang J, 2011, NAT GENET, V43, P519, DOI 10.1038/ng.823; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Zhang SC, 2009, OBESITY, V17, P1581, DOI 10.1038/oby.2009.125; Zhu XF, 2011, HUM MOL GENET, V20, P2285, DOI 10.1093/hmg/ddr113	40	29	30	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0133031	10.1371/journal.pone.0133031	http://dx.doi.org/10.1371/journal.pone.0133031			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26162070	Green Published, gold, Green Submitted			2022-12-26	WOS:000358162300183
J	Fernandes, JDS; Martho, K; Tofik, V; Vallim, MA; Pascon, RC				Santos Fernandes, Joao Daniel; Martho, Kevin; Tofik, Veridiana; Vallim, Marcelo A.; Pascon, Renata C.			The Role of Amino Acid Permeases and Tryptophan Biosynthesis in Cryptococcus neoformans Survival	PLOS ONE			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; MYCOBACTERIUM-TUBERCULOSIS; GENE-EXPRESSION; COMPLETE GENOME; VIRULENCE; SYNTHASE; MUTANTS; PATHWAY; METABOLISM; INFECTION	Metabolic diversity is an important factor during microbial adaptation to different environments. Among metabolic processes, amino acid biosynthesis has been demonstrated to be relevant for survival for many microbial pathogens, whereas the association between pathogenesis and amino acid uptake and recycling are less well-established. Cryptococcus neoformans is an opportunistic fungal pathogen with many habitats. As a result, it faces frequent metabolic shifts and challenges during its life cycle. Here we studied the C. neoformans tryptophan biosynthetic pathway and found that the pathway is essential. RNAi indicated that interruptions in the biosynthetic pathway render strains inviable. However, auxotroph complementation can be partially achieved by tryptophan uptake when a non preferred nitrogen source and lower growth temperature are applied, suggesting that amino acid permeases may be the target of nitrogen catabolism repression (NCR). We used bioin-formatics to search for amino acid permeases in the C. neoformans and found eight potential global permeases (AAP1 to AAP8). The transcriptional profile of them revealed that they are subjected to regulatory mechanisms which are known to respond to nutritional status in other fungi, such as (i) quality of nitrogen (Nitrogen Catabolism Repression, NCR) and carbon sources (Carbon Catabolism Repression, CCR), (ii) amino acid availability in the extracellular environment (SPS-sensing) and (iii) nutritional deprivation (Global Amino Acid Control, GAAC). This study shows that C. neoformans has fewer amino acid permeases than other model yeasts, and that these proteins may be subjected to complex regulatory mechanisms. Our data suggest that the C. neoformans tryptophan biosynthetic pathway is an excellent pharmacological target. Furthermore, inhibitors of this pathway cause Cryptococcus growth arrest in vitro.	[Santos Fernandes, Joao Daniel; Martho, Kevin; Tofik, Veridiana; Vallim, Marcelo A.; Pascon, Renata C.] Univ Fed Sao Paulo, Dept Ciencias Biol, Inst Ciencias Ambientais Quim & Farmaceut, Lab Interacoes Microbianas,Lab 29, BR-09972270 Diadema, SP, Brazil; [Santos Fernandes, Joao Daniel] Univ Sao Paulo, BR-05508900 Sao Paulo, SP, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo	Pascon, RC (corresponding author), Univ Fed Sao Paulo, Dept Ciencias Biol, Inst Ciencias Ambientais Quim & Farmaceut, Lab Interacoes Microbianas,Lab 29, Campus Diadema,Rua Arthur Ridel 275, BR-09972270 Diadema, SP, Brazil.	renata.pascon@gmail.com	Pascon, Renata/E-1494-2012; Vallim, Marcelo/J-2624-2013	Pascon, Renata/0000-0001-9902-9396; Vallim, Marcelo/0000-0002-6929-0566	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2011/51298-4, 2007/50536-3]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo 2011/51298-4 (RCP) and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo 2007/50536-3 (MAV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alspaugh JA, 2015, FUNGAL GENET BIOL, V78, P55, DOI 10.1016/j.fgb.2014.09.004; Antinori Spinello, 2013, ISRN AIDS, V2013, P471363, DOI 10.1155/2013/471363; BRAUS GH, 1991, MICROBIOL REV, V55, P349, DOI 10.1128/MMBR.55.3.349-370.1991; Brown GD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004404; Brown SM, 2007, CURR OPIN MICROBIOL, V10, P320, DOI 10.1016/j.mib.2007.05.014; Chittur SV, 2001, BIOCHEMISTRY-US, V40, P876, DOI 10.1021/bi0014047; Cox GM, 2003, INFECT IMMUN, V71, P173, DOI 10.1128/IAI.71.1.173-180.2003; Datta K, 2009, EMERG INFECT DIS, V15, P1185, DOI 10.3201/eid1508.081384; Davidson RC, 2002, MICROBIOL-SGM, V148, P2607, DOI 10.1099/00221287-148-8-2607; de Gontijo FA, 2014, FUNGAL GENET BIOL, V70, P12, DOI 10.1016/j.fgb.2014.06.003; Fan WH, 2005, EUKARYOT CELL, V4, P1420, DOI 10.1128/EC.4.8.1420-1433.2005; Fernandez J, 2014, ANNU REV PHYTOPATHOL, V52, P155, DOI 10.1146/annurev-phyto-102313-050135; Fraser JA, 2005, NATURE, V437, P1360, DOI 10.1038/nature04220; Gahan CGM, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00009; Godard P, 2007, MOL CELL BIOL, V27, P3065, DOI 10.1128/MCB.01084-06; Hinnebusch AG, 2005, ANNU REV MICROBIOL, V59, P407, DOI 10.1146/annurev.micro.59.031805.133833; Hu GG, 2008, MOL MICROBIOL, V69, P1456, DOI 10.1111/j.1365-2958.2008.06374.x; Jones EW, 2008, YEAST, V25, P41, DOI 10.1002/yea.1552; Jung WH, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040045; Jung WH, 2008, CELL MICROBIOL, V10, P277, DOI 10.1111/j.1462-5822.2007.01077.x; Jung WH, 2011, MOL CELLS, V31, P73, DOI 10.1007/s10059-011-0011-0; Jung WH, 2009, EUKARYOT CELL, V8, P1511, DOI 10.1128/EC.00166-09; Kim MS, 2009, BIOCHEM BIOPH RES CO, V390, P983, DOI 10.1016/j.bbrc.2009.10.089; Kingsbury JM, 2004, MICROBIOL-SGM, V150, P1547, DOI 10.1099/mic.0.26928-0; Kingsbury JM, 2004, EUKARYOT CELL, V3, P752, DOI 10.1128/EC.3.3.752-763.2004; Kingsbury JM, 2008, MICROBIOL-SGM, V154, P2767, DOI 10.1099/mic.0.2008/019729-0; Kingsbury JM, 2010, EUKARYOT CELL, V9, P729, DOI 10.1128/EC.00045-10; Kingsbury JM, 2010, MICROBIOL-SGM, V156, P929, DOI 10.1099/mic.0.034348-0; Kmetzsch L, 2011, FUNGAL GENET BIOL, V48, P192, DOI 10.1016/j.fgb.2010.07.011; Kretschmer M, 2014, INFECT IMMUN, V82, P2697, DOI 10.1128/IAI.01607-14; Kronstad J, 2012, EUKARYOT CELL, V11, P109, DOI 10.1128/EC.05273-11; Lee IR, 2013, FEMS MICROBIOL LETT, V345, P77, DOI 10.1111/1574-6968.12181; Lee IR, 2011, GENETICS, V188, P309, DOI 10.1534/genetics.111.128538; Lee IS, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/872142; Li Shu Shun, 2010, Proc Am Thorac Soc, V7, P186, DOI 10.1513/pats.200907-063AL; Lin XR, 2006, ANNU REV MICROBIOL, V60, P69, DOI 10.1146/annurev.micro.60.080805.142102; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ljungdahl PO, 2012, GENETICS, V190, P885, DOI 10.1534/genetics.111.133306; Ljungdahl PO, 2009, BIOCHEM SOC T, V37, P242, DOI 10.1042/BST0370242; MAURER R, 1971, J BACTERIOL, V106, P331, DOI 10.1128/JB.106.2.331-338.1971; MIOZZARI G, 1977, ARCH MICROBIOL, V115, P307, DOI 10.1007/BF00446457; Moran GP, 2011, EUKARYOT CELL, V10, P34, DOI 10.1128/EC.00242-10; Morya VK, 2011, INT J LATEST TRENDS, V2, P178; Nazi I, 2007, ANTIMICROB AGENTS CH, V51, P1731, DOI 10.1128/AAC.01400-06; Nelissen B, 1995, FEBS LETT, V377, P232, DOI 10.1016/0014-5793(95)01380-6; Nelissen B, 1997, FEMS MICROBIOL REV, V21, P113, DOI 10.1111/j.1574-6976.1997.tb00347.x; Nosanchuk JD, 2001, J INFECT DIS, V183, P1093, DOI 10.1086/319272; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; Pascon RC, 2004, MICROBIOL-SGM, V150, P3013, DOI 10.1099/mic.0.27235-0; Paulsen IT, 1998, FEBS LETT, V430, P116, DOI 10.1016/S0014-5793(98)00629-2; Payne RJ, 2010, ORG BIOMOL CHEM, V8, P3534, DOI 10.1039/c004062b; Payne RJ, 2009, ORG BIOMOL CHEM, V7, P2421, DOI 10.1039/b901694e; Payne RJ, 2005, ORG BIOMOL CHEM, V3, P3629, DOI 10.1039/b510633h; PERFECT JR, 1992, GENE, V122, P213, DOI 10.1016/0378-1119(92)90053-R; Peter GJ, 2006, J BIOL CHEM, V281, P5546, DOI 10.1074/jbc.M513842200; Raboni S, 2009, CELL MOL LIFE SCI, V66, P2391, DOI 10.1007/s00018-009-0028-0; Regenberg B, 1999, CURR GENET, V36, P317, DOI 10.1007/s002940050506; Reilly MC, 2009, J BIOL CHEM, V284, P36118, DOI 10.1074/jbc.M109.056226; Sasaki T, 2012, J BIOSCI BIOENG, V113, P726, DOI 10.1016/j.jbiosc.2012.01.012; Sassetti CM, 2003, P NATL ACAD SCI USA, V100, P12989, DOI 10.1073/pnas.2134250100; Shen HB, 2010, J MICROBIOL, V48, P337, DOI 10.1007/s12275-010-9315-6; Shen HB, 2009, FEBS J, V276, P144, DOI 10.1111/j.1742-4658.2008.06763.x; Skowyra Michael L, 2012, Methods Mol Biol, V845, P165, DOI 10.1007/978-1-61779-539-8_11; Smith DA, 2001, INFECT IMMUN, V69, P1142, DOI 10.1128/IAI.69.2.1442-1150.2001; TILBY MJ, 1976, J GEN MICROBIOL, V93, P126, DOI 10.1099/00221287-93-1-126; TOFFALETTI DL, 1993, J BACTERIOL, V175, P1405, DOI 10.1128/JB.175.5.1405-1411.1993; Toyn JH, 2000, YEAST, V16, P553, DOI 10.1002/(SICI)1097-0061(200004)16:6<553::AID-YEA554>3.0.CO;2-7; Webby CJ, 2010, J BIOL CHEM, V285, P30567, DOI 10.1074/jbc.M110.111856; Yang ZH, 2002, MICROBIOL-SGM, V148, P2617, DOI 10.1099/00221287-148-8-2617; Ziebart KT, 2010, J MED CHEM, V53, P3718, DOI 10.1021/jm100158v	70	29	28	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132369	10.1371/journal.pone.0132369	http://dx.doi.org/10.1371/journal.pone.0132369			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26162077	gold, Green Submitted, Green Published			2022-12-26	WOS:000358162300123
J	Drever, MC; Gyug, LW; Nielsen, J; Stuart-Smith, AK; Ohanjanian, IP; Martin, K				Drever, Mark C.; Gyug, Les W.; Nielsen, Jennifer; Stuart-Smith, A. Kari; Ohanjanian, I. Penny; Martin, Kathy			Using Field Data and GIS-Derived Variables to Model Occurrence of Williamson's Sapsucker Nesting Habitat at Multiple Spatial Scales	PLOS ONE			English	Article							BRITISH-COLUMBIA; INTERIOR; FORESTS; TREES	Williamson's sapsucker (Sphyrapicus thyroideus) is a migratory woodpecker that breeds in mixed coniferous forests in western North America. In Canada, the range of this woodpecker is restricted to three small populations in southern British Columbia, precipitating a national listing as 'Endangered' in 2005, and the need to characterize critical habitat for its survival and recovery. We compared habitat attributes between Williamson's sapsucker nest territories and random points without nests or detections of this sapsucker as part of a resource selection analysis to identify the habitat features that best explain the probability of nest occurrence in two separate geographic regions in British Columbia. We compared the relative explanatory power of generalized linear models based on field-derived and Geographic Information System (GIS) data within both a 225 m and 800 m radius of a nest or random point. The model based on field-derived variables explained the most variation in nest occurrence in the Okanagan-East Kootenay Region, whereas nest occurrence was best explained by GIS information at the 800 m scale in the Western Region. Probability of nest occurrence was strongly tied to densities of potential nest trees, which included open forests with very large (diameter at breast height, DBH, >= 57.5 cm) western larch (Larix occidentalis) trees in the Okanagan-East Kootenay Region, and very large ponderosa pine (Pinus ponderosa) and large (DBH 17.5-57.5 cm) trembling aspen (Populus tremuloides) trees in the Western Region. Our results have the potential to guide identification and protection of critical habitat as required by the Species at Risk Act in Canada, and to better manage Williamson's sapsucker habitat overall in North America. In particular, management should focus on the maintenance and recruitment of very large western larch and ponderosa pine trees.	[Drever, Mark C.; Martin, Kathy] Environm Canada, Canadian Wildlife Serv, Delta, BC, Canada; [Drever, Mark C.; Nielsen, Jennifer; Martin, Kathy] Univ British Columbia, Dept Forest & Conservat Sci, Ctr Appl Conservat Res, Vancouver, BC V5Z 1M9, Canada; [Gyug, Les W.] Okanagan Wildlife Consulting, West Kelowna, BC, Canada; [Stuart-Smith, A. Kari] Canadian Forest Prod Ltd, Cranbrook, BC, Canada	Environment & Climate Change Canada; Canadian Wildlife Service; University of British Columbia	Drever, MC (corresponding author), Environm Canada, Canadian Wildlife Serv, Delta, BC, Canada.	mark.drever@ec.gc.ca; j.nielsen@alumni.ubc.ca		Drever, Mark/0000-0001-5303-9230	Environment Canada; Natural Sciences and Engineering Research Council of Canada; Canadian Wildlife Service; B.C. Ministry of Environment; Forest Investment Account (B.C. Ministry of Forests); B.C. Timber Sales; Weyerhaeuser Ltd.; Interfor; Canadian Forest Products Ltd.; Tolko Industries Ltd	Environment Canada(CGIAR); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Wildlife Service; B.C. Ministry of Environment; Forest Investment Account (B.C. Ministry of Forests); B.C. Timber Sales; Weyerhaeuser Ltd.; Interfor; Canadian Forest Products Ltd.(Natural Resources CanadaCanadian Forest Service); Tolko Industries Ltd	This research was funded by Environment Canada (support to MCD) and The Natural Sciences and Engineering Research Council of Canada (to JN). Funding was provided for various phases of the field project to LWG by Canadian Wildlife Service, B.C. Ministry of Environment, Forest Investment Account (B.C. Ministry of Forests), B.C. Timber Sales, Weyerhaeuser Ltd., Pope and Talbot Ltd. (now Interfor), Tembec Industries Ltd. (now Canadian Forest Products Ltd.), and Tolko Industries Ltd. The funders had a limited role in discussions of study design, and data collection, but no role in the analysis, decision to publish, or preparation of the manuscript, and does not alter our adherence to PLOS ONE policies on sharing data and materials.	ARNO SF, 1997, INTRP495 USDA FOR SE; Birds and Burns Network, 2005, INSTR VEG MEAS NESTS; British Columbia. Ministry of Forests, 2003, SILV SYST HDB BRIT C; British Columbia Ministry of Forests and Range, 2009, VEG RES INV; BULL EL, 1986, PNWRN444 USDA FOR SE; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Committee on the Status of Endangered Wildlife in Canada, 2005, SPHYR THYR, p[vii, 45]; CONWAY CJ, 1993, J WILDLIFE MANAGE, V57, P322, DOI 10.2307/3809429; CROCKETT AB, 1975, CONDOR, V77, P365, DOI 10.2307/1366254; Crockett AB., 1975, THESIS U COLORADO; Drever MC, 2008, BIOL CONSERV, V141, P624, DOI 10.1016/j.biocon.2007.12.004; Environment Canada, 2014, SPEC RISK ACT REC ST; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Fiedler C.E., 2004, ECOL RESTOR, V22, P133; Gyug LW, 2009, CAN J FOREST RES, V39, P2319, DOI 10.1139/X09-138; Gyug Les W., 2014, British Columbia Birds, V24, P9; Gyug LW, 2014, CAN J FOREST RES, V44, P628, DOI 10.1139/cjfr-2013-0380; Gyug Les W., 2009, British Columbia Birds, V19, P6; Gyug LW, 2012, BIRDS N AM ONLINE, P285; Gyug LW, 2007, BRIT COLUMBIA BIRDS, V16, P15; Hall FC, 1976, P 15 ANN TALL TIMB F, P155; Husch B., 1972, FOREST MENSURATION; Klenner W, 2008, FOREST ECOL MANAG, V256, P1711, DOI 10.1016/j.foreco.2008.02.047; Manly B.F.J., 2002, RESOURCE SELECTION A; MARSHALL PL, 2000, TR003 BRIT COL FOR S; Martin K, 2004, CONDOR, V106, P5, DOI 10.1650/7482; McClelland B. R., 1977, THESIS U MONTANA; McClelland BR, 1999, WILDLIFE SOC B, V27, P846; MCCLELLAND BR, 1979, J FOREST, V77, P480; Nielsen-Pincus Nicole, 2007, Northwestern Naturalist, V88, P135, DOI 10.1898/1051-1733(2007)88[135:ROCBTC]2.0.CO;2; Seidel KW, 1986, PNWRN455 USDA FOR SE; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Sousa PJ, 1983, FWSOBS821047 US DEP; Thomas J.W., 1979, U S Department of Agriculture Agriculture Handbook, P60; Venables WN., 2002, MODERN APPL STAT S 4	35	3	3	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0130849	10.1371/journal.pone.0130849	http://dx.doi.org/10.1371/journal.pone.0130849			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177286	Green Published, gold, Green Submitted			2022-12-26	WOS:000358197600030
J	Fogolari, F; Corazza, A; Fortuna, S; Soler, MA; VanSchouwen, B; Brancolini, G; Corni, S; Melacini, G; Esposito, G				Fogolari, Federico; Corazza, Alessandra; Fortuna, Sara; Soler, Miguel Angel; VanSchouwen, Bryan; Brancolini, Giorgia; Corni, Stefano; Melacini, Giuseppe; Esposito, Gennaro			Distance-Based Configurational Entropy of Proteins from Molecular Dynamics Simulations	PLOS ONE			English	Article							CONFORMATIONAL ENTROPY; FORCE-FIELD; THERMODYNAMIC PROPERTIES; STATISTICAL-MECHANICS; BINDING AFFINITIES; CHAIN CONFORMATION; INTERNAL-ROTATION; LIQUID WATER; CYCLIC-AMP; RECOGNITION	Estimation of configurational entropy from molecular dynamics trajectories is a difficult task which is often performed using quasi-harmonic or histogram analysis. An entirely different approach, proposed recently, estimates local density distribution around each conformational sample by measuring the distance from its nearest neighbors. In this work we show this theoretically well grounded the method can be easily applied to estimate the entropy from conformational sampling. We consider a set of systems that are representative of important biomolecular processes. In particular: i. reference entropies for amino acids in unfolded proteins are obtained from a database of residues not participating in secondary structure elements; ii. the conformational entropy of folding of beta 2-microglobulin is computed from molecular dynamics simulations using reference entropies for the unfolded state; iii. backbone conformational entropy is computed from molecular dynamics simulations of four different states of the EPAC protein and compared with order parameters (often used as a measure of entropy); iv. the conformational and rototranslational entropy of binding is computed from simulations of 20 tripeptides bound to the peptide binding protein OppA and of beta 2-microglobulin bound to a citrate coated gold surface. This work shows the potential of the method in the most representative biological processes involving proteins, and provides a valuable alternative, principally in the shown cases, where other approaches are problematic.	[Fogolari, Federico; Corazza, Alessandra; Fortuna, Sara; Soler, Miguel Angel; Esposito, Gennaro] Univ Udine, Dipartimento Sci Med & Biol, I-33100 Udine, Italy; [Fogolari, Federico; Corazza, Alessandra; Esposito, Gennaro] Ist Nazl Biostrutture & Biosistemi, I-00136 Rome, Italy; [VanSchouwen, Bryan; Melacini, Giuseppe] McMaster Univ, Dept Chem & Chem Biol, Hamilton, ON L8S 4M1, Canada; [Brancolini, Giorgia; Corni, Stefano] CNR, Ctr S3, Inst Nanosci, I-41125 Modena, Italy	University of Udine; McMaster University; Consiglio Nazionale delle Ricerche (CNR); Istituto Nanoscienze (NANO-CNR)	Fogolari, F (corresponding author), Univ Udine, Dipartimento Sci Med & Biol, Piazzale Kolbe 4, I-33100 Udine, Italy.	federico.fogolari@uniud.it	Corazza, Alessandra/AGB-1457-2022; SOLER, MIGUEL/J-2389-2013; Brancolini, Giorgia/AAY-3318-2020; Fortuna, Sara/G-2356-2014	Corazza, Alessandra/0000-0003-2272-1928; SOLER, MIGUEL/0000-0002-5780-9949; Brancolini, Giorgia/0000-0002-1083-9198; Fortuna, Sara/0000-0002-8059-6064; Fogolari, Federico/0000-0001-9862-250X; Corni, Stefano/0000-0001-6707-108X	Oak Ridge National Laboratory by the Scientific User Facilities Division, Office of Basic Energy Sciences, U.S. Department of Energy [CNMS2013-064]; Office of Science of the U.S. Department of Energy [DE-AC02-05CH11231]; Ministero dell'Istruzione, dell'Universita' e della Ricerca [PRIN 2012A7LMS3 001]	Oak Ridge National Laboratory by the Scientific User Facilities Division, Office of Basic Energy Sciences, U.S. Department of Energy(United States Department of Energy (DOE)); Office of Science of the U.S. Department of Energy(United States Department of Energy (DOE)); Ministero dell'Istruzione, dell'Universita' e della Ricerca(Ministry of Education, Universities and Research (MIUR))	This work was partly supported by Ministero dell'Istruzione, dell'Universita' e della Ricerca (PRIN 2012A7LMS3 001). Oak Ridge National Laboratory by the Scientific User Facilities Division, Office of Basic Energy Sciences, U.S. Department of Energy is acknowledged for the supercomputing project CNMS2013-064. Facilities of the National Energy Research Scientific Computing Center (NERSC), which is supported by the Office of Science of the U.S. Department of Energy under Contract No. DE-AC02-05CH11231, are also acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adcock SA, 2006, CHEM REV, V106, P1589, DOI 10.1021/cr040426m; Anandakrishnan R, 2012, NUCLEIC ACIDS RES, V40, pW537, DOI 10.1093/nar/gks375; Andricioaei I, 2001, J CHEM PHYS, V115, P6289, DOI 10.1063/1.1401821; Berrera M, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-8; Brancolini G, 2015, ACS NANO, V9, P2600, DOI 10.1021/nn506161j; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; Darian E, 2005, J COMPUT CHEM, V26, P651, DOI 10.1002/jcc.20198; Das R, 2008, J BIOL CHEM, V283, P19691, DOI 10.1074/jbc.M802164200; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; DOIG AJ, 1995, PROTEIN SCI, V4, P2247, DOI 10.1002/pro.5560041101; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Fenley AT, 2014, J PHYS CHEM B, V118, P6447, DOI 10.1021/jp411588b; FINKELSTEIN AV, 1989, PROTEIN ENG, V3, P1, DOI 10.1093/protein/3.1.1; Fogolari F, 2011, PROTEINS, V79, P986, DOI 10.1002/prot.22940; Frederick KK, 2007, NATURE, V448, P325, DOI 10.1038/nature05959; Gilson MK, 2007, ANNU REV BIOPH BIOM, V36, P21, DOI 10.1146/annurev.biophys.36.040306.132550; Gilson MK, 1997, BIOPHYS J, V72, P1047, DOI 10.1016/S0006-3495(97)78756-3; Glykos NM, 2006, J COMPUT CHEM, V27, P1765, DOI 10.1002/jcc.20482; GO N, 1976, MACROMOLECULES, V9, P535, DOI 10.1021/ma60052a001; GUYER CA, 1986, J BACTERIOL, V168, P775, DOI 10.1128/jb.168.2.775-779.1986; HARPAZ Y, 1994, STRUCTURE, V2, P641, DOI 10.1016/S0969-2126(00)00065-4; Hnizdo V, 2003, J COMPUT CHEM, V24, P1172, DOI 10.1002/jcc.10289; Hnizdo V, 2008, J COMPUT CHEM, V29, P1605, DOI 10.1002/jcc.20919; Hnizdo V, 2007, J COMPUT CHEM, V28, P655, DOI 10.1002/jcc.20589; Hnizdo V, 2010, ENTROPY-SWITZ, V12, P578, DOI 10.3390/e12030578; Huggins DJ, 2014, J COMPUT CHEM, V35, P377, DOI 10.1002/jcc.23504; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Huynh DQ, 2009, J MATH IMAGING VIS, V35, P155, DOI 10.1007/s10851-009-0161-2; Iori F, 2009, J COMPUT CHEM, V30, P1465, DOI 10.1002/jcc.21165; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kale L, 1999, J COMPUT PHYS, V151, P283, DOI 10.1006/jcph.1999.6201; KARPLUS M, 1987, BIOPHYS J, V52, P1083, DOI 10.1016/S0006-3495(87)83303-9; KARPLUS M, 1981, MACROMOLECULES, V14, P325, DOI 10.1021/ma50003a019; Killian BJ, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2746329; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; KOEHL P, 1994, J MOL BIOL, V239, P249, DOI 10.1006/jmbi.1994.1366; Kokh DB, 2010, J CHEM THEORY COMPUT, V6, P1753, DOI 10.1021/ct100086j; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; LEVITT M, 1976, J MOL BIOL, V104, P59, DOI 10.1016/0022-2836(76)90004-8; LEVY RM, 1984, MACROMOLECULES, V17, P1370, DOI 10.1021/ma00137a013; Li ZG, 1996, PROTEIN SCI, V5, P2647, DOI 10.1002/pro.5560051228; Lindorff-Larsen K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032131; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; MARTYNA GJ, 1994, J CHEM PHYS, V101, P4177, DOI 10.1063/1.467468; MCCAMMON JA, 1977, NATURE, V267, P585, DOI 10.1038/267585a0; MCGREGOR MJ, 1987, J MOL BIOL, V198, P295, DOI 10.1016/0022-2836(87)90314-7; McQuarrie D.A., 2000, STATISTICAL MECHANIC; MILES RE, 1965, BIOMETRIKA, V52, P636, DOI 10.2307/2333716; Minh DDL, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2794754; Minh DDL, 2005, BIOPHYS J, V89, pL25, DOI 10.1529/biophysj.105.069336; Misra N, 2010, ENTROPY-SWITZ, V12, P1125, DOI 10.3390/e12051125; Mukherjee A, 2011, J PHYS CHEM LETT, V2, P3021, DOI 10.1021/jz2013566; Nguyen CN, 2014, J CHEM THEORY COMPUT, V10, P2769, DOI 10.1021/ct401110x; Nguyen CN, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4733951; Numata J, 2007, GENOME INFORM SER, V18, P192; Onufriev A, 2004, PROTEINS, V55, P383, DOI 10.1002/prot.20033; Piana S, 2011, BIOPHYS J, V100, pL47, DOI 10.1016/j.bpj.2011.03.051; Polyansky AA, 2012, METHODS MOL BIOL, V819, P327, DOI 10.1007/978-1-61779-465-0_21; Porcelli SA, 1999, ANNU REV IMMUNOL, V17, P297, DOI 10.1146/annurev.immunol.17.1.297; R Core Team, 2018, R LANG ENV STAT COMP; Rennella E, 2012, BBA-PROTEINS PROTEOM, V1824, P842, DOI 10.1016/j.bbapap.2012.04.002; Rennella E, 2012, J AM CHEM SOC, V134, P4457, DOI 10.1021/ja209004q; Roux B, 1999, BIOPHYS CHEM, V78, P1, DOI 10.1016/S0301-4622(98)00226-9; SAPER MA, 1991, J MOL BIOL, V219, P277, DOI 10.1016/0022-2836(91)90567-P; SCHLITTER J, 1993, CHEM PHYS LETT, V215, P617, DOI 10.1016/0009-2614(93)89366-P; Singh H., 2003, American Journal of Mathematical and Management Sciences, V23, P301; Sugita Y, 1999, CHEM PHYS LETT, V314, P141, DOI 10.1016/S0009-2614(99)01123-9; TIDOR B, 1993, PROTEINS, V15, P71, DOI 10.1002/prot.340150109; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; van der Spoel D., 2010, GROMACS USER MANUAL; VanSchouwen B, 2011, J BIOL CHEM, V286, P42655, DOI 10.1074/jbc.M111.277723; Verdone G, 2002, PROTEIN SCI, V11, P487, DOI 10.1110/ps.29002; Wang GL, 2003, BIOINFORMATICS, V19, P1589, DOI 10.1093/bioinformatics/btg224; Wang L, 2009, J CHEM THEORY COMPUT, V5, P1462, DOI 10.1021/ct900078k; Wang T, 2002, J MED CHEM, V45, P4828, DOI 10.1021/jm020900l; Wereszczynski J, 2012, Q REV BIOPHYS, V45, P1, DOI 10.1017/S0033583511000096; Word JM, 1999, J MOL BIOL, V285, P1735, DOI 10.1006/jmbi.1998.2401; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Zhou HX, 2009, CHEM REV, V109, P4092, DOI 10.1021/cr800551w	81	25	25	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132356	10.1371/journal.pone.0132356	http://dx.doi.org/10.1371/journal.pone.0132356			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177039	Green Published, Green Submitted, gold			2022-12-26	WOS:000358197600102
J	Hamasaki, H; Kawashima, Y; Tamada, Y; Furuta, M; Katsuyama, H; Sako, A; Yanai, H				Hamasaki, Hidetaka; Kawashima, Yu; Tamada, Yoshiki; Furuta, Masashi; Katsuyama, Hisayuki; Sako, Akahito; Yanai, Hidekatsu			Associations of Low-Intensity Resistance Training with Body Composition and Lipid Profile in Obese Patients with Type 2 Diabetes	PLOS ONE			English	Article							LIPOPROTEIN(A) LEVELS; SARCOPENIC OBESITY; INSULIN-RESISTANCE; PHYSICAL-EXERCISE; OLDER-ADULTS; MUSCLE; METABOLISM; STRENGTH; MEN	Resistance training to increase muscle mass and functional capacity is an integral part of diet and exercise programs for the management of obesity and type 2 diabetes. Low-intensity resistance training with slow movement and tonic force generation (LST) may be a practical and safe regimen for elderly obese individuals but the health benefits are uncertain. This study investigated the effects of LST on body composition and metabolic parameters in obese patients with type 2 diabetes. Twenty-six obese patients with type 2 diabetes engaged in LST training during hospitalization and were advised to maintain this regimen for 12 weeks after discharge. We compared lipid profile, arterial stiffness, and body composition before and after LST training. After 12 weeks of LST training, the ratio of lower extremity muscle mass to body weight increased significantly (0.176 +/- 0.028 to 0.184 +/- 0.023, mean +/- SD), while body fat mass and body fat percentage decreased significantly (36.2 +/- 10.9 kg to 34.3 +/- 9.4 kg and 41.2 +/- 8.6% to 40.1 +/- 7.7%, respectively). Moreover, high-density lipoprotein cholesterol was significantly increased (42.2 +/- 14 mg/dl to 46.3 +/- 12.4 mg/dl) and both free fatty acids and lipoprotein(a) were decreased (665.2 +/- 212.1 mu Eq/l to 525.4 +/- 231.3 mu Eq/l and 15.4 +/- 18 mg/dl to 13.8 +/- 18 mg/dl, respectively). No significant change was observed in arterial stiffness. Although this study was a non-controlled investigation and some confounding factors including dietary intake, medication and compliance with training might affect the study result, a brief (12-week) LST training program may be a safe and effective strategy for the management of obesity and type 2 diabetes.	[Hamasaki, Hidetaka; Kawashima, Yu; Katsuyama, Hisayuki; Sako, Akahito; Yanai, Hidekatsu] Kohnodai Hosp, Natl Ctr Global Hlth & Med, Dept Internal Med, Chiba, Japan; [Hamasaki, Hidetaka] Jichi Med Univ, Grad Sch, Community Healthcare Studies, Gen Internal Med, Shimotsuke, Tochigi, Japan; [Tamada, Yoshiki] Kohnodai Hosp, Natl Ctr Global Hlth & Med, Dept Rehabil, Chiba, Japan; [Furuta, Masashi] Kohnodai Hosp, Natl Ctr Global Hlth & Med, Dept Nutr, Chiba, Japan	National Center for Global Health & Medicine - Japan; Jichi Medical University; National Center for Global Health & Medicine - Japan; National Center for Global Health & Medicine - Japan	Hamasaki, H (corresponding author), Kohnodai Hosp, Natl Ctr Global Hlth & Med, Dept Internal Med, Chiba, Japan.	hhamasaki78@gmail.com	Hamasaki, Hidetaka/H-2928-2016; Yanai, Hidekatsu/AFN-9517-2022	Hamasaki, Hidetaka/0000-0002-0124-597X; Sako, Akahito/0000-0002-2555-1293	National Center for Global Health and Medicine [26A-201]	National Center for Global Health and Medicine(National Center for Global Health & Medicine - Japan)	This study was supported in part by a Grant-in-Aid for Research from the National Center for Global Health and Medicine (26A-201). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alley DE, 2007, JAMA-J AM MED ASSOC, V298, P2020, DOI 10.1001/jama.298.17.2020; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS11, DOI 10.2337/dc13-S011; Anderson LJ, 2012, NUTR RES, V32, P479, DOI 10.1016/j.nutres.2012.05.009; AUSTIN A, 1993, DIABETES CARE, V16, P421, DOI 10.2337/diacare.16.2.421; Braith RW, 2006, CIRCULATION, V113, P2642, DOI 10.1161/CIRCULATIONAHA.105.584060; Castaneda C, 2002, DIABETES CARE, V25, P2335, DOI 10.2337/diacare.25.12.2335; Coyle D, 2012, INT J TECHNOL ASSESS, V28, P228, DOI 10.1017/S0266462312000256; Durstine JL, 1996, MED SCI SPORT EXER, V28, P1277, DOI 10.1097/00005768-199610000-00011; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Goodpaster BH, 2000, METABOLISM, V49, P467, DOI 10.1016/S0026-0495(00)80010-4; HELLSTEN G, 1989, ATHEROSCLEROSIS, V75, P93, DOI 10.1016/0021-9150(89)90211-6; Hills AP, 2010, OBES REV, V11, P740, DOI 10.1111/j.1467-789X.2009.00692.x; Hubinger L, 1997, MED SCI SPORT EXER, V29, P436, DOI 10.1097/00005768-199704000-00003; Hubinger L, 1996, MED SCI SPORT EXER, V28, P757, DOI 10.1097/00005768-199606000-00015; Hulver MW, 2003, AM J PHYSIOL-ENDOC M, V284, pE741, DOI 10.1152/ajpendo.00514.2002; Hurley BF, 2011, SPORTS MED, V41, P289, DOI 10.2165/11585920-000000000-00000; Jensen MD, 2003, ACTA PHYSIOL SCAND, V178, P385, DOI 10.1046/j.1365-201X.2003.01167.x; Karelis AD, 2004, J CLIN ENDOCR METAB, V89, P2569, DOI 10.1210/jc.2004-0165; KARVONEN MJ, 1957, ANN MED EXP BIOL FEN, V35, P307; Kelley DE, 1999, AM J PHYSIOL-ENDOC M, V277, pE1130; Kuh D, 2005, J GERONTOL A-BIOL, V60, P224, DOI 10.1093/gerona/60.2.224; Matsuzawa Y, 2002, CIRC J, V66, P987, DOI 10.1253/circj.66.987; Mavros Y, 2013, DIABETES CARE, V36, P2372, DOI 10.2337/dc12-2196; Misra A, 2008, DIABETES CARE, V31, P1282, DOI 10.2337/dc07-2316; Miyachi M, 2013, BRIT J SPORT MED, V47, P393, DOI 10.1136/bjsports-2012-090488; MULS E, 1993, INT J OBESITY, V17, P711; Phillips SM, 1996, J APPL PHYSIOL, V81, P2182, DOI 10.1152/jappl.1996.81.5.2182; PONJEE GAE, 1995, ANN CLIN BIOCHEM, V32, P181, DOI 10.1177/000456329503200208; Prado CMM, 2012, CLIN NUTR, V31, P583, DOI 10.1016/j.clnu.2012.06.010; Rigla M, 2000, METABOLISM, V49, P640, DOI 10.1016/S0026-0495(00)80041-4; Romero-Corral A, 2010, EUR HEART J, V31, P737, DOI 10.1093/eurheartj/ehp487; Strasser B, 2010, SPORTS MED, V40, P397, DOI 10.2165/11531380-000000000-00000; Subramanian S, 2012, BBA-MOL CELL BIOL L, V1821, P819, DOI 10.1016/j.bbalip.2011.10.003; Tanimoto M, 2006, J APPL PHYSIOL, V100, P1150, DOI 10.1152/japplphysiol.00741.2005; Tarnopolsky MA, 2007, AM J PHYSIOL-REG I, V292, pR1271, DOI 10.1152/ajpregu.00472.2006; Tuttle Lori J, 2012, J Aging Res, V2012, P172957, DOI 10.1155/2012/172957; Yagi S, 2014, DIABETOL METAB SYNDR, V6, DOI 10.1186/1758-5996-6-27; Zamboni M, 2008, NUTR METAB CARDIOVAS, V18, P388, DOI 10.1016/j.numecd.2007.10.002	38	13	13	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132959	10.1371/journal.pone.0132959	http://dx.doi.org/10.1371/journal.pone.0132959			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176700	gold, Green Published, Green Submitted			2022-12-26	WOS:000358197600188
J	Han, SY; You, BH; Kim, YC; Chin, YW; Choi, YH				Han, Seung Yon; You, Byoung Hoon; Kim, Yu Chul; Chin, Young-Won; Choi, Young Hee			Dose-Independent ADME Properties and Tentative Identification of Metabolites of alpha-Mangostin from Garcinia mangostana in Mice by Automated Microsampling and UPLC-MS/MS Methods	PLOS ONE			English	Article							TISSUE DISTRIBUTION; KAEMPFERIA-PARVIFLORA; GAMMA-MANGOSTINS; FRUIT EXTRACT; XANTHONES; PHARMACOKINETICS; BIOTRANSFORMATION; ISOLIQUIRITIGENIN; CONSTITUENTS; ABSORPTION	The information about a marker compound's pharmacokinetics in herbal products including the characteristics of absorption, distribution, metabolism, excretion (ADME) is closely related to the efficacy/toxicity. Also dose range and administration route are critical factors to determine the ADME profiles. Since the supply of a sufficient amount of a marker compound in in vivo study is still difficult, pharmacokinetic investigations which overcome the limit of blood collection in mice are desirable. Thus, we have attempted to investigate concurrently the ADME and proposed metabolite identification of alpha-mangostin, a major constituent of mangosteen, Garcinia mangostana L, in mice with a wide dose range using an in vitro as well as in vivo automated micro-sampling system together. alpha-mangostin showed dose-proportional pharmacokinetics at intravenous doses of 5-20 mg/kg and oral doses of 10-100 mg/kg. The gastrointestinal absorption of a-mangostin was poor and the distribution of alpha-mangostin was relatively high in the liver, intestine, kidney, fat, and lung. alpha-mangostin was extensively metabolized in the liver and intestine. With regards to the formation of metabolites, the glucuronidated, bis-glucuronidated, dehydrogenated, hydrogenated, oxidized, and methylated alpha-mangostins were tentatively identified. We suggest that these dose-independent pharmacokinetic characteristics of alpha-mangostin in mice provide an important basis for preclinical applications of alpha-mangostin as well as mangosteen. In addition, these experimental methods can be applied to evaluate the pharmacokinetics of natural products in mice.	[Han, Seung Yon; You, Byoung Hoon; Chin, Young-Won; Choi, Young Hee] Dongguk Univ Seoul, Coll Pharm, Goyang 410820, Gyeonggi Do, South Korea; [Han, Seung Yon; You, Byoung Hoon; Chin, Young-Won; Choi, Young Hee] Dongguk Univ Seoul, PLUS R FIND Team BK21, Goyang 410820, Gyeonggi Do, South Korea; [Kim, Yu Chul] C&C Res Labs, Discovery Res Ctr, Suwon 440746, Gyeonggi Do, South Korea	Dongguk University; Dongguk University	Choi, YH (corresponding author), Dongguk Univ Seoul, Coll Pharm, 32 Dongguk Lo, Goyang 410820, Gyeonggi Do, South Korea.	choiyh@dongguk.edu		Choi, Young Hee/0000-0002-9360-6436; Leggas, Markos/0000-0003-4314-4533; Chin, Young-Won/0000-0001-6964-1779	National Research Foundation of Korea (NRF) - government of Korea [S-2014-004424]; GRRC program of Gyeonggi province [GRRC-DONGGUK2015-B01, GRRC-DONGGUK2015-B03]	National Research Foundation of Korea (NRF) - government of Korea; GRRC program of Gyeonggi province	This work was supported by the National Research Foundation of Korea (NRF) funded by the government of Korea (S-2014-004424, Y. H. Choi) and GRRC program of Gyeonggi province [Development of new health supplements/therapeutics for neurodegenerative diseases (GRRC-DONGGUK2015-B01) and Development of functional food to alleviating metabolic syndromes and circulatory disorders (GRRC-DONGGUK2015-B03)]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An GH, 2012, AAPS J, V14, P352, DOI 10.1208/s12248-012-9344-7; Arunrattiyakorn P, 2014, J MOL CATAL B-ENZYM, V102, P174, DOI 10.1016/j.molcatb.2014.02.010; Bumrungpert A, 2009, MOL NUTR FOOD RES, V53, pS54, DOI 10.1002/mnfr.200800260; Chae HS, 2012, FOOD CHEM, V134, P397, DOI 10.1016/j.foodchem.2012.02.075; Chin YW, 2008, MINI-REV ORG CHEM, V5, P355, DOI 10.2174/157019308786242223; Chiou WL, 1998, PHARMACEUT RES, V15, P1792, DOI 10.1023/A:1011981317451; Chitchumroonchokchai C, 2013, MOL NUTR FOOD RES, V57, P203, DOI 10.1002/mnfr.201200539; Chitchumroonchokchai C, 2012, J NUTR, V142, P675, DOI 10.3945/jn.111.156992; Choi YH, 2015, PLANTA MED IN PRESS; Choi YH, 2014, FOOD CHEM TOXICOL, V66, P140, DOI 10.1016/j.fct.2014.01.028; Cui JH, 2010, PHARMACOL BIOCHEM BE, V95, P166, DOI 10.1016/j.pbb.2009.12.021; DAVIES B, 1993, PHARMACEUT RES, V10, P1093, DOI 10.1023/A:1018943613122; DeSmet PAGM, 1997, CLIN PHARMACOKINET, V32, P427, DOI 10.2165/00003088-199732060-00001; Fang HY, 2012, FOOD CHEM TOXICOL, V50, P4042, DOI 10.1016/j.fct.2012.08.037; Foti RS, 2009, DRUG METAB DISPOS, V37, P1848, DOI 10.1124/dmd.109.028043; Gibaldi M., 1982, PHARMACOKINEICS; Guo J, 2008, DRUG METAB DISPOS, V36, P2104, DOI 10.1124/dmd.108.021857; Han SY, 2013, CHROMATOGRAPHIA, V76, P643, DOI 10.1007/s10337-013-2437-3; Han SY, 2013, BIOMED CHROMATOGR, V27, P741, DOI 10.1002/bmc.2854; Holcapek M, 2008, ANAL BIOANAL CHEM, V391, P59, DOI 10.1007/s00216-008-1962-7; Jamali F, 1999, BRIT J CLIN PHARMACO, V47, P391, DOI 10.1046/j.1365-2125.1999.00902.x; Jia W, 2015, DRUG METAB DISPOS; Lee YB, 2010, J FOOD SCI, V75, pH13, DOI 10.1111/j.1750-3841.2009.01407.x; Li L, 2013, PLANTA MED, V79, P646, DOI 10.1055/s-0032-1328543; Li L, 2011, MOL NUTR FOOD RES, V55, pS67, DOI 10.1002/mnfr.201000511; Li LH, 2013, EUR J CANCER, V49, P1752, DOI 10.1016/j.ejca.2012.12.013; Malaney P, 2014, CANCER LETT, V344, P1, DOI 10.1016/j.canlet.2013.10.010; Medhi B, 2009, PHARMACOLOGY, V84, P323, DOI 10.1159/000252658; Mekjaruskul C, 2012, DRUG METAB DISPOS, V40, P2342, DOI 10.1124/dmd.112.047142; Mitruka B M, 1987, CLIN BIOCH HEMATOLOG; Moridani MY, 2002, TOXICOL LETT, V133, P141, DOI 10.1016/S0378-4274(02)00105-4; Peerapattana J, 2013, J NAT MED-TOKYO, V67, P452, DOI 10.1007/s11418-012-0698-z; Peternel L, 2010, J PHARMACOL TOX MET, V61, P20, DOI 10.1016/j.vascn.2009.07.004; Petiwala SM, 2014, NUTR RES, V34, P336, DOI 10.1016/j.nutres.2014.03.002; Quan GH, 2010, PHYTOTHER RES, V24, P1575, DOI 10.1002/ptr.3177; Ramaiya A, 2012, CURR DRUG TARGETS, V13, P1698, DOI 10.2174/138945012804545524; Ritchie MR, 2007, P NUTR SOC, V66, P479, DOI 10.1017/S0029665107005794; Sanchez-Perez Y, 2010, CHEM-BIOL INTERACT, V188, P144, DOI 10.1016/j.cbi.2010.06.014; Shargel L., 2005, APPL BIOPHARMACEUTIC; Singh SS, 2006, CURR DRUG METAB, V7, P165, DOI 10.2174/138920006775541552; Skalli S, 2007, THER DRUG MONIT, V29, P679, DOI 10.1097/FTD.0b013e31815c17f6; Sutthanut K, 2007, J CHROMATOGR A, V1143, P227, DOI 10.1016/j.chroma.2007.01.033; Tanaka C, 2000, DRUG METAB DISPOS, V28, P582; Viana AFSC, 2013, J ETHNOPHARMACOL, V150, P316, DOI 10.1016/j.jep.2013.08.047; Yodhnu S, 2009, J CHROMATOGR SCI, V47, P185, DOI 10.1093/chromsci/47.3.185; Yokozawa T, 2000, RENAL FAILURE, V22, P115, DOI 10.1081/JDI-100100858	46	16	18	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0131587	10.1371/journal.pone.0131587	http://dx.doi.org/10.1371/journal.pone.0131587			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176540	Green Published, Green Submitted, gold			2022-12-26	WOS:000358197600051
J	Hoots, BE; Finlayson, TJ; Wejnert, C; Paz-Bailey, G				Hoots, Brooke E.; Finlayson, Teresa J.; Wejnert, Cyprian; Paz-Bailey, Gabriela		NHBS Study Grp	Early Linkage to HIV Care and Antiretroviral Treatment among Men Who Have Sex with Men-20 Cities, United States, 2008 and 2011	PLOS ONE			English	Article							WHITE MEN; DISPARITIES; RISK; PREVENTION; INFECTION; THERAPY; SURVEILLANCE; TRANSMISSION; ADHERENCE; BEHAVIORS	Early linkage to care and antiretroviral (ARV) treatment are associated with reduced HIV transmission. Male-to-male sexual contact represents the largest HIV transmission category in the United States; men who have sex with men (MSM) are an important focus of care and treatment efforts. With the release of the National HIV/AIDS Strategy and expanded HIV treatment guidelines, increases in early linkage to care and ARV treatment are expected. We examined differences in prevalence of early linkage to care and ARV treatment among HIV-positive MSM between 2008 and 2011. Data are from the National HIV Behavioral Surveillance System, which monitors behaviors among populations at high risk of HIV infection in 20 U.S. cities with high AIDS burden. MSM were recruited through venue-based, time-space sampling. Prevalence ratios comparing 2011 to 2008 were estimated using linear mixed models. Early linkage was defined as an HIV clinic visit within 3 months of diagnosis. ARV treatment was defined as use at interview. Prevalence of early linkage to care was 79% (187/236) in 2008 and 83% (241/291) in 2011. In multivariable analysis, prevalence of early linkage did not differ significantly between years overall (P = 0.44). Prevalence of ARV treatment was 69% (790/1,142) in 2008 and 79% (1,049/1,336) in 2001. In multivariable analysis, ARV treatment increased overall (P = 0.0003) and among most sub-groups. Black MSM were less likely than white MSM to report ARV treatment (P = 0.01). While early linkage to care did not increase significantly between 2008 and 2011, ARV treatment increased among most sub-groups. Progress is being made in getting MSM on HIV treatment, but more efforts are needed to decrease disparities in ARV coverage.	[Hoots, Brooke E.; Finlayson, Teresa J.; Wejnert, Cyprian; Paz-Bailey, Gabriela] Ctr Dis Control & Prevent, Natl Ctr HIV Viral Hepatitis STD & TB Prevent, Div HIV AIDS Prevent, Atlanta, GA 30329 USA	Centers for Disease Control & Prevention - USA	Hoots, BE (corresponding author), Ctr Dis Control & Prevent, Natl Ctr HIV Viral Hepatitis STD & TB Prevent, Div HIV AIDS Prevent, Atlanta, GA 30329 USA.	vie2@cdc.gov		Al-Tayyib, Alia/0000-0002-5909-6719; Raymond, Henry/0000-0001-8621-2749				[Anonymous], 2010, NAT HIV AIDS STRAT U; [Anonymous], C RETR OPP INF MAR 3; [Anonymous], ASSESSING IMPACT AFF; [Anonymous], GUID US ANT AG HIV 1; [Anonymous], DIAGN HIV INF US DEP; Beer L, 2014, AIDS, V28, P105, DOI 10.1097/QAD.0000000000000021; Centers for Disease Control and Prevention, 2012, EST HIV INC US 2007; Centers for Disease Control and Prevention (CDC), 2006, MMWR Morb Mortal Wkly Rep, V55, P121; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Cohen Stacy M., 2011, Morbidity and Mortality Weekly Report, V60, P1618; Donnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2; Finlayson Teresa J., 2011, Morbidity and Mortality Weekly Report, V60, P1; Gebo KA, 2005, JAIDS-J ACQ IMM DEF, V38, P96, DOI 10.1097/00126334-200501010-00017; Golin CE, 2002, J GEN INTERN MED, V17, P756, DOI 10.1046/j.1525-1497.2002.11214.x; Halkitis P, 2008, AIDS PATIENT CARE ST, V22, P323, DOI 10.1089/apc.2007.0122; Hall HI, 2013, JAMA INTERN MED, V173, P1337, DOI 10.1001/jamainternmed.2013.6841; Karon JM, 2012, J URBAN HEALTH, V89, P565, DOI 10.1007/s11524-012-9676-8; King WD, 2008, J EPIDEMIOL COMMUN H, V62, P798, DOI 10.1136/jech.2005.045567; MacKellar DA, 2007, PUBLIC HEALTH REP, V122, P39, DOI 10.1177/00333549071220S107; Millett GA, 2007, AIDS, V21, P2083, DOI 10.1097/QAD.0b013e3282e9a64b; MOORE RD, 1994, NEW ENGL J MED, V330, P763, DOI 10.1056/NEJM199403173301107; Oster AM, 2011, AIDS, V25, P1103, DOI 10.1097/QAD.0b013e3283471efa; Snider JT, 2014, HEALTH AFFAIR, V33, P386, DOI 10.1377/hlthaff.2013.1453; Wejnert C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076878	24	20	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132962	10.1371/journal.pone.0132962	http://dx.doi.org/10.1371/journal.pone.0132962			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176856	gold, Green Submitted, Green Published			2022-12-26	WOS:000358197600190
J	Mezyk-Kopec, R; Wyroba, B; Stalinska, K; Prochnicki, T; Wiatrowska, K; Kilarski, WW; Swartz, MA; Bereta, J				Mezyk-Kopec, Renata; Wyroba, Barbara; Stalinska, Krystyna; Prochnicki, Tomasz; Wiatrowska, Karolina; Kilarski, Witold W.; Swartz, Melody A.; Bereta, Joanna			ADAM17 Promotes Motility, Invasion, and Sprouting of Lymphatic Endothelial Cells	PLOS ONE			English	Article							EGFR TRANSACTIVATION; THERAPEUTIC TARGET; TNF-ALPHA; IN-VITRO; MIGRATION; EXPRESSION; INTEGRIN; ADAM-17; PROLIFERATION; REGENERATION	Tumor-associated lymphatic vessels actively participate in tumor progression and dissemination. ADAM17, a sheddase for numerous growth factors, cytokines, receptors, and cell adhesion molecules, is believed to promote tumor development, facilitating both tumor cell proliferation and migration, as well as tumor angiogenesis. In this work we addressed the issue of whether ADAM17 may also promote tumor lymphangiogenesis. First, we found that ADAM17 is important for the migratory potential of immortalized human dermal lymphatic endothelial cells (LEC). When ADAM17 was stably silenced in LEC, their proliferation was not affected, but: (i) single-cell motility, (ii) cell migration through a 3D Matrigel/collagen type I matrix, and (iii) their ability to form sprouts in a 3D matrix were significantly diminished. The differences in the cell motility between ADAM17-proficient and ADAM17-silenced cells were eliminated by inhibitors of EGFR and HER2, indicating that ADAM17-mediated shedding of growth factors accounts for LEC migratory potential. Interestingly, ADAM17 depletion affected the integrin surface expression/functionality in LEC. ADAM17-silenced cells adhered to plastic, type I collagen, and fibronectin faster than their ADAM17-proficient counterparts. The difference in adhesion to fibronectin was abolished by a cyclic RGD peptide, emphasizing the involvement of integrins in the process. Using a soluble receptor array, we identified BIG-H3 among several candidate proteins involved in the phenotypic and behavioral changes of LEC upon ADAM17 silencing. In additional assays, we confirmed the increased expression of BIG-H3, as well as TGF beta 2 in ADAM17-silenced LEC. The antilym-phangiogenic effects of ADAM17 silencing in lymphatic endothelial cells suggest further relevance of ADAM17 as a potential target in cancer therapy.	[Mezyk-Kopec, Renata; Wyroba, Barbara; Stalinska, Krystyna; Prochnicki, Tomasz; Wiatrowska, Karolina; Bereta, Joanna] Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Dept Cell Biochem, Krakow, Poland; [Mezyk-Kopec, Renata; Kilarski, Witold W.; Swartz, Melody A.] Ecole Polytech Fed Lausanne, Sch Life Sci, Inst Bioengn, Lausanne, Switzerland; [Mezyk-Kopec, Renata; Kilarski, Witold W.; Swartz, Melody A.] Ecole Polytech Fed Lausanne, Sch Life Sci, Swiss Inst Canc Res ISREC, Lausanne, Switzerland; [Mezyk-Kopec, Renata; Kilarski, Witold W.; Swartz, Melody A.] Univ Chicago, Inst Mol Engn, Chicago, IL 60637 USA	Jagiellonian University; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research; University of Chicago	Bereta, J (corresponding author), Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Dept Cell Biochem, Krakow, Poland.	joanna.bereta@uj.edu.pl	Kilarski, Witold/AAA-1843-2019; Kilarski, Witold W./G-8673-2012; Swartz, Melody A./F-9563-2011	Kilarski, Witold W./0000-0003-0734-4749; Bereta, Joanna/0000-0001-7930-2770	Polish-Swiss Research Programme [PSPB 057/2010]	Polish-Swiss Research Programme	Funding provided by Polish-Swiss Research Programme, http://www.swiss.opi.org.pl/, grant no. PSPB 057/2010 to MAS and JB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arribas J, 2009, CURR PHARM DESIGN, V15, P2319, DOI 10.2174/138161209788682398; Avraham T, 2010, AM J PATHOL, V177, P3202, DOI 10.2353/ajpath.2010.100594; Avraham T, 2009, PLAST RECONSTR SURG, V124, P438, DOI 10.1097/PRS.0b013e3181adcf4b; Bax DV, 2004, J BIOL CHEM, V279, P22377, DOI 10.1074/jbc.M400180200; Bell JH, 2007, J LEUKOCYTE BIOL, V82, P173, DOI 10.1189/jlb.0307193; Blacher S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097019; Blobel CP, 2005, NAT REV MOL CELL BIO, V6, P32, DOI 10.1038/nrm1548; Cells J., 1998, CELL BIOL LAB HDB; Chalaris A, 2010, J EXP MED, V207, P1617, DOI 10.1084/jem.20092366; Chen Jie, 2012, Int J Cell Biol, V2012, P853703, DOI 10.1155/2012/853703; Christiansen Ailsa, 2011, Genes Cancer, V2, P1146, DOI 10.1177/1947601911423028; Clavin NW, 2008, AM J PHYSIOL-HEART C, V295, pH2113, DOI 10.1152/ajpheart.00879.2008; Coligan J, 1997, CURRENT PROTOCOLS IN; Das S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050791; Dreymueller D, 2012, EMBO MOL MED, V4, P412, DOI 10.1002/emmm.201200217; Duffy Michael J, 2011, Clin Proteomics, V8, P9, DOI 10.1186/1559-0275-8-9; Ebi M, 2010, BIOCHEM BIOPH RES CO, V402, P449, DOI 10.1016/j.bbrc.2010.09.130; Edwards DR, 2008, MOL ASPECTS MED, V29, P258, DOI 10.1016/j.mam.2008.08.001; Eliceiri BP, 2001, CIRC RES, V89, P1104, DOI 10.1161/hh2401.101084; Fedak PWM, 2006, CIRCULATION, V113, P238, DOI 10.1161/CIRCULATIONAHA.105.571414; Franovic A, 2006, CANCER RES, V66, P8083, DOI 10.1158/0008-5472.CAN-06-1595; Fukaya S, 2013, LAB INVEST, V93, P72, DOI 10.1038/labinvest.2012.153; Gooz P, 2009, BIOCHEM BIOPH RES CO, V380, P33, DOI 10.1016/j.bbrc.2009.01.013; Goitre L, 2012, J SIGNAL TRANSDUCT, V2012, DOI DOI 10.1155/2012/807682; Goldman J, 2007, FASEB J, V21, P1003, DOI 10.1096/fj.06-6656com; Gschwind A, 2003, EMBO J, V22, P2411, DOI 10.1093/emboj/cdg231; Hirosue S, 2014, J IMMUNOL, V192, P5002, DOI 10.4049/jimmunol.1302492; Huttenlocher A, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005074; James JM, 2013, DEVELOPMENT, V140, P3903, DOI 10.1242/dev.095026; Karaman S, 2014, J CLIN INVEST, V124, P922, DOI 10.1172/JCI71606; Kenny PA, 2007, J CLIN INVEST, V117, P337, DOI 10.1172/JCI29518; Klamer SE, 2013, CELL ADHES MIGR, V7, P434, DOI 10.4161/cam.26596; Korff T, 1998, J CELL BIOL, V143, P1341, DOI 10.1083/jcb.143.5.1341; Lee NY, 2008, J BIOL CHEM, V283, P32527, DOI 10.1074/jbc.M803059200; Liu C, 2009, MOL CELL, V35, P26, DOI 10.1016/j.molcel.2009.06.018; Malapeira J, 2011, ONCOGENE, V30, P1912, DOI 10.1038/onc.2010.565; Maretzky T, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1232; McGowan PM, 2013, ANN ONCOL, V24, P362, DOI 10.1093/annonc/mds279; McGowan PM, 2007, CLIN CANCER RES, V13, P2335, DOI 10.1158/1078-0432.CCR-06-2092; Miteva DO, 2010, CIRC RES, V106, P920, DOI 10.1161/CIRCRESAHA.109.207274; Mochizuki S, 2007, CANCER SCI, V98, P621, DOI 10.1111/j.1349-7006.2007.00434.x; Moreno-Caceres J, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.294; Morgan MR, 2013, DEV CELL, V24, P472, DOI 10.1016/j.devcel.2013.01.027; Murphy G, 2008, NAT REV CANCER, V8, P929, DOI 10.1038/nrc2459; Nam EJ, 2006, ARTHRITIS RHEUM-US, V54, P2734, DOI 10.1002/art.22076; Nees M, 2000, CANCER RES, V60, P4289; Oka M, 2008, BLOOD, V111, P4571, DOI 10.1182/blood-2007-10-120337; Scheller J, 2011, TRENDS IMMUNOL, V32, P380, DOI 10.1016/j.it.2011.05.005; Schoppmann SF, 2004, MICROCIRCULATION, V11, P261, DOI 10.1080/10739680490425967; Sroka J, 2007, BIOL CELL, V99, P677, DOI 10.1042/BC20070024; Tape CJ, 2011, P NATL ACAD SCI USA, V108, P5578, DOI 10.1073/pnas.1017067108; Tewalt EF, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00305; Tsubota Y, 2013, J IMMUNOL, V190, P4236, DOI 10.4049/jimmunol.1300046; Tumbarello DA, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-36; Uchiyama-Tanaka Y, 2002, KIDNEY INT, V62, P799, DOI 10.1046/j.1523-1755.2002.00537.x; Wang YD, 2010, GENE DEV, V24, P2115, DOI 10.1101/gad.1955910; Weskamp G, 2010, CIRC RES, V106, P932, DOI 10.1161/CIRCRESAHA.109.207415; Wick N, 2008, AM J PATHOL, V173, P1202, DOI 10.2353/ajpath.2008.080101; Yan A, 2011, FUTURE ONCOL, V7, P1457, DOI [10.2217/fon.11.121, 10.2217/FON.11.121]; Yang JW, 1999, J BIOL CHEM, V274, P26141, DOI 10.1074/jbc.274.37.26141; Yang JW, 2001, NAT BIOTECHNOL, V19, P219, DOI 10.1038/85655; Yoda M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054412; Zhang Y, 2009, CANCER RES, V69, P37, DOI 10.1158/0008-5472.CAN-08-1648; Zheng XG, 2012, MOL CARCINOGEN, V51, P150, DOI 10.1002/mc.20772	65	15	15	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132661	10.1371/journal.pone.0132661	http://dx.doi.org/10.1371/journal.pone.0132661			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176220	Green Published, gold, Green Submitted			2022-12-26	WOS:000358197600140
J	Navarro, F; Lieberman, J				Navarro, Francisco; Lieberman, Judy			miR-34 and p53: New Insights into a Complex Functional Relationship	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; TUMOR-SUPPRESSOR NETWORK; LARGE GENE LISTS; DOWN-REGULATION; NEGATIVE REGULATOR; POSITIVE FEEDBACK; IN-VIVO; MICRORNAS; APOPTOSIS; ACTIVATION	miR-34, a tumor suppressor miRNA family transcriptionally activated by p53, is considered a critical mediator of p53 function. However, knockout of the mouse miR-34 family has little or no effect on the p53 response. The relative contribution of different miR-34 family members to p53 function or how much p53 relies on miR-34 in human cells is unclear. Here we show that miR-34a has a complex effect on the p53 response in human cells. In HCT116 cells miR-34a overexpression enhances p53 transcriptional activity, but the closely related family members, miR-34b and miR-34c, even when over-expressed, have little effect. Both TP53 itself and MDM4, a strong p53 transactivation inhibitor, are direct targets of miR-34a. The genes regulated by miR-34a also include four other post-translational inhibitors of p53. miR-34a overexpression leads to variable effects on p53 levels in p53-sufficient human cancer cell lines. In HCT116, miR-34a overexpression increases p53 protein levels and stability. About a quarter of all mRNAs that participate in the human p53 network bind to biotinylated miR-34a, suggesting that many are direct miR-34a targets. However, only about a fifth of the mRNAs that bind to miR-34a also bind to miR-34b or miR-34c. Two human cell lines knocked out for miR-34a have unimpaired p53-mediated responses to genotoxic stress, like mouse cells. The complex positive and negative effects of miR-34 on the p53 network suggest that rather than simply promoting the p53 response, miR-34a might act at a systems level to stabilize the robustness of the p53 response to genotoxic stress.	[Navarro, Francisco; Lieberman, Judy] Boston Childrens Hosp, Cellular & Mol Med Program, Boston, MA 02115 USA; [Lieberman, Judy] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Navarro, F (corresponding author), Boston Childrens Hosp, Cellular & Mol Med Program, Boston, MA 02115 USA.	francisco.navarro.lop@gmail.com; judy.lieberman@childrens.harvard.edu	Lieberman, Judy/A-2717-2015		NIH [NIH-P50-NS40828, NIH-P30-HD18655]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS040828] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Microarray experiments were supported by NIH grants NIH-P50-NS40828 and NIH-P30-HD18655. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebi S, 1996, CANCER RES, V56, P3087; Bader Andreas G., 2012, Frontiers in Genetics, V3, P120, DOI 10.3389/fgene.2012.00120; Bommer GT, 2007, CURR BIOL, V17, P1298, DOI 10.1016/j.cub.2007.06.068; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Chen QR, 2011, J PROTEOME RES, V10, P479, DOI 10.1021/pr1006697; Choi YJ, 2011, NAT CELL BIOL, V13, P1353, DOI 10.1038/ncb2366; Christoffersen NR, 2010, CELL DEATH DIFFER, V17, P236, DOI 10.1038/cdd.2009.109; Cole KA, 2008, MOL CANCER RES, V6, P735, DOI 10.1158/1541-7786.MCR-07-2102; Comazzetto S, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004597; Concepcion CP, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002797; Ebner OA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092166; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Finch RA, 2002, CANCER RES, V62, P3221; Freeman JA, 2013, BRIEF FUNCT GENOMICS, V12, P46, DOI 10.1093/bfgp/els058; Gronroos E, 2004, P NATL ACAD SCI USA, V101, P12165, DOI 10.1073/pnas.0402283101; Hahn S, 2013, EMBO J; He L, 2007, NAT REV CANCER, V7, P819, DOI 10.1038/nrc2232; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; He XY, 2007, CANCER RES, V67, P11099, DOI 10.1158/0008-5472.CAN-07-2672; Hermeking H, 2010, CELL DEATH DIFFER, V17, P193, DOI 10.1038/cdd.2009.56; Hermeking H, 2012, NAT REV CANCER, V12, P613, DOI 10.1038/nrc3318; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Javeri A, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0413-7; Juan LJ, 2000, J BIOL CHEM, V275, P20436, DOI 10.1074/jbc.M000202200; Kaller M, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.010462; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Kim NH, 2013, CELL CYCLE, V12, P1578, DOI 10.4161/cc.24739; Kim NH, 2011, J CELL BIOL, V195, P417, DOI 10.1083/jcb.201103097; Kim T, 2011, J EXP MED, V208, P875, DOI 10.1084/jem.20110235; Krzeszinski JY, 2014, NATURE, V512, P431, DOI 10.1038/nature13375; Lal A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002363; Liu C, 2011, NAT MED, V17, P211, DOI 10.1038/nm.2284; Lize M, 2011, CELL CYCLE, V10, P2874, DOI 10.4161/cc.10.17.17181; Luo JY, 2000, NATURE, V408, P377, DOI 10.1038/35042612; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Mandke P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042034; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; MIYASHITA T, 1995, CELL, V80, P293; Navarro F, 2009, BLOOD, V114, P2181, DOI 10.1182/blood-2009-02-205062; Okada N, 2014, GENE DEV, V28, P438, DOI 10.1101/gad.233585.113; Parant J, 2001, NAT GENET, V29, P92, DOI 10.1038/ng714; Pichiorri F, 2010, CANCER CELL, V18, P367, DOI 10.1016/j.ccr.2010.09.005; Piovan C, 2012, MOL ONCOL, V6, P458, DOI 10.1016/j.molonc.2012.03.003; Raver-Shapira N, 2007, MOL CELL, V26, P731, DOI 10.1016/j.molcel.2007.05.017; Sanjana NE, 2012, NAT PROTOC, V7, P171, DOI 10.1038/nprot.2011.431; Shvarts A, 1996, EMBO J, V15, P5349, DOI 10.1002/j.1460-2075.1996.tb00919.x; Siemens H, 2011, CELL CYCLE, V10, P4256, DOI 10.4161/cc.10.24.18552; Song R, 2014, NATURE, V510, P115, DOI 10.1038/nature13413; Sui GC, 2004, CELL, V117, P859, DOI 10.1016/j.cell.2004.06.004; Sullivan KD, 2012, BBA-REV CANCER, V1825, P229, DOI 10.1016/j.bbcan.2012.01.004; Sun F, 2008, FEBS LETT, V582, P1564, DOI 10.1016/j.febslet.2008.03.057; Tang Y, 2008, CELL, V133, P612, DOI 10.1016/j.cell.2008.03.025; Tarasov V, 2007, CELL CYCLE, V6, P1586, DOI 10.4161/cc.6.13.4436; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wang P, 2007, P NATL ACAD SCI USA, V104, P4054, DOI 10.1073/pnas.0700020104; Wang XW, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng154; Xiao JN, 2011, EMBO J, V30, P5021, DOI 10.1038/emboj.2011.463; Yamakuchi M, 2008, P NATL ACAD SCI USA, V105, P13421, DOI 10.1073/pnas.0801613105; Zhang F, 2011, NAT BIOTECHNOL, V29, P149, DOI 10.1038/nbt.1775; Zhang J, 2013, ONCOGENE, V32, P61, DOI 10.1038/onc.2012.28; Zilfou JT, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001883	65	114	118	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132767	10.1371/journal.pone.0132767	http://dx.doi.org/10.1371/journal.pone.0132767			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177460	gold, Green Published			2022-12-26	WOS:000358197600152
J	Akiyama, H; Uchino, K; Hasegawa, Y				Akiyama, Hisanao; Uchino, Kenji; Hasegawa, Yasuhiro			Characteristics of Symptomatic Intracranial Hemorrhage in Patients Receiving Non-Vitamin K Antagonist Oral Anticoagulant Therapy	PLOS ONE			English	Article							ATRIAL-FIBRILLATION; INTRACEREBRAL HEMORRHAGE; DABIGATRAN; WARFARIN; RIVAROXABAN; RISK; PREVENTION; APIXABAN; STROKE; COHORT	Objectives The first non-vitamin K antagonist oral anticoagulant (NOAC) introduced to the market in Japan was dabigatran in March 2011, and three more NOACs, rivaroxaban, apixaban, and edoxaban, have since become available. Randomized controlled trials of NOACs have revealed that intracranial hemorrhage (ICH) occurs less frequently with NOACs compared with warfarin. However, the absolute incidence of ICH associated with NOACs has increased with greater use of these anticoagulants, and we wanted to explore the incidence, clinical characteristics, and treatment course of patients with NOACs-associated ICH. Methods We retrospectively analyzed the characteristics of symptomatic ICH patients receiving NOACs between March 2011 and September 2014. Results ICH occurred in 6 patients (5 men, 1 woman; mean +/- SD age, 72.8 +/- 3.2 years). Mean time to onset was 146.2 +/- 111.5 days after starting NOACs. Five patients received rivaroxaban and 1 patient received apixaban. None received dabigatran or edoxaban. Notably, no hematoma expansion was observed within 24 h of onset in the absence of infusion of fresh frozen plasma, activated prothrombin complex concentrate, recombinant activated factor VIIa or hemodialysis. When NOAC therapy was initiated, mean HAS-BLED and PANWARDS scores were 1.5 +/- 0.5 and 39.5 +/- 7.7, respectively. Mean systolic blood pressure was 137.8 +/- 15.9 mmHg within 1 month before spontaneous ICH onset. Conclusion Six symptomatic ICHs occurred early in NOAC therapy but hematoma volume was small and did not expand in the absence of infusion of reversal agents or hemodialysis. The occurrence of ICH during NOAC therapy is possible even when there is acceptable mean systolic blood pressure control (137.8 +/- 15.9 mmHg) and HAS-BLED score <= 2. Even stricter blood pressure lowering and control within the acceptable range may be advisable to prevent ICH during NOAC therapy.	[Akiyama, Hisanao; Uchino, Kenji; Hasegawa, Yasuhiro] St Marianna Univ, Sch Med, Dept Neurol, Kawasaki, Kanagawa, Japan	Saint Marianna University	Akiyama, H (corresponding author), St Marianna Univ, Sch Med, Dept Neurol, Kawasaki, Kanagawa, Japan.	h2akiyama@marianna-u.ac.jp		Akiyama, Hisanao/0000-0003-4491-6064				Arima H, 2012, STROKE, V43, P1675, DOI 10.1161/STROKEAHA.112.651448; Awad AJ, 2013, NEUROSURG FOCUS, V34, DOI 10.3171/2013.2.FOCUS1323; Benavente OR, 2013, LANCET, V382, P507, DOI 10.1016/S0140-6736(13)60852-1; Chang DN, 2013, AM J KIDNEY DIS, V61, P487, DOI 10.1053/j.ajkd.2012.08.047; Chatterjee S, 2013, JAMA NEUROL, V70, P1486, DOI 10.1001/jamaneurol.2013.4021; Chen BC, 2012, CLIN TOXICOL, V50, P854, DOI 10.3109/15563650.2012.721888; Ciura VA, 2014, STROKE, V45, P3293, DOI 10.1161/STROKEAHA.114.005570; Connolly SJ, 2011, NEW ENGL J MED, V364, P806, DOI 10.1056/NEJMoa1007432; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; DEBATA A, 2015, JPN J STROKE, V37, P41; Demchuk AM, 2012, LANCET NEUROL, V11, P307, DOI 10.1016/S1474-4422(12)70038-8; Ezekowitz MD, 2007, AM J CARDIOL, V100, P1419, DOI 10.1016/j.amjcard.2007.06.034; Faust AC, 2014, J EMERG MED, V46, P525, DOI 10.1016/j.jemermed.2013.11.097; Garber ST, 2012, J NEUROSURG, V116, P1093, DOI 10.3171/2012.2.JNS112132; Giugliano RP, 2013, NEW ENGL J MED, V369, P2093, DOI 10.1056/NEJMoa1310907; Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039; Hagii J, 2014, STROKE, V45, P2805, DOI 10.1161/STROKEAHA.114.006661; HANA A, 2014, B SOC SCI MED GRAND, V1, P57; Hankey GJ, 2014, STROKE, V45, P1304, DOI 10.1161/STROKEAHA.113.004506; Hippisley-Cox J, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4606; Hori M, 2012, CIRC J, V76, P2104, DOI 10.1253/circj.CJ-12-0454; Kaneko M, 2013, DRUG METAB PHARMACOK, V28, P321, DOI 10.2133/dmpk.DMPK-12-RG-109; Kasliwal MK, 2015, J CLIN NEUROSCI, V22, P212, DOI 10.1016/j.jocn.2014.04.025; Komori M, 2014, CIRC J, V78, P1335, DOI 10.1253/circj.CJ-13-1534; Kono S, 2014, STROKE, V45, P2404, DOI 10.1161/STROKEAHA.114.005316; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; Pisters R, 2010, CHEST, V138, P1093, DOI 10.1378/chest.10-0134; Ross B, 2014, J MED TOXICOL, V10, P223, DOI 10.1007/s13181-013-0364-1; Saji N, 2015, CIRC J, V79, P1018, DOI 10.1253/circj.CJ-14-1209; SHOJI A, 2014, JPN J STROKE, V36, P186; Simonsen CZ, 2014, J STROKE CEREBROVASC, V23, pE133, DOI 10.1016/j.jstrokecerebrovasdis.2013.08.011; Toyoda K, 2010, STROKE, V41, P1440, DOI 10.1161/STROKEAHA.110.580506; Uchiyama S, 2014, CEREBROVASC DIS, V37, P296, DOI 10.1159/000360811; Wassef SN, 2013, NEUROSURGERY, V73, pE368, DOI 10.1227/01.neu.0000430763.95349.5f	34	22	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132900	10.1371/journal.pone.0132900	http://dx.doi.org/10.1371/journal.pone.0132900			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26171862	gold, Green Submitted, Green Published			2022-12-26	WOS:000358194900099
J	Cheng, XE; Wang, SH; Qian, ZM; Chen, YQ				Cheng, Xi En; Wang, Shuo Hong; Qian, Zhi-Ming; Chen, Yan Qiu			Estimating Orientation of Flying Fruit Flies	PLOS ONE			English	Article							FLIGHT INITIATION; TRACKING; MANEUVERS; MOTION; BEHAVIOR; TARGETS; SYSTEM	The recently growing interest in studying flight behaviours of fruit flies, Drosophila melanogaster, has highlighted the need for developing tools that acquire quantitative motion data. Despite recent advance of video tracking systems, acquiring a flying fly's orientation remains a challenge for these tools. In this paper, we present a novel method for estimating individual flying fly's orientation using image cues. Thanks to the line reconstruction algorithm in computer vision field, this work can thereby focus on the practical detail of implementation and evaluation of the orientation estimation algorithm. The orientation estimation algorithm can be incorporated into tracking algorithms. We rigorously evaluated the effectiveness and accuracy of the proposed algorithm by running experiments both on simulation data and on real-world data. This work complements methods for studying the fruit fly's flight behaviours in a three-dimensional environment.	[Cheng, Xi En; Wang, Shuo Hong; Qian, Zhi-Ming; Chen, Yan Qiu] Fudan Univ, Sch Comp Sci, Shanghai Key Lab Intelligent Informat Proc, Shanghai 200433, Peoples R China; [Cheng, Xi En] Jingdezhen Ceram Inst, Jingdezhen, Peoples R China	Fudan University; Jingdezhen Ceramic Institute	Chen, YQ (corresponding author), Fudan Univ, Sch Comp Sci, Shanghai Key Lab Intelligent Informat Proc, Shanghai 200433, Peoples R China.	chenyq@fudan.edu.cn			National Natural Science Foundation of China [61175036, 60875024]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The research work presented in this paper is supported by National Natural Science Foundation of China, grant nos. 61175036 and 60875024 awarded to YQC.	Ardekani R, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0547; Arulampalam MS, 2002, IEEE T SIGNAL PROCES, V50, P174, DOI 10.1109/78.978374; Attanasi A, 2014, ARXIV13075631; Bergou AJ, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.148101; Card G, 2008, J EXP BIOL, V211, P341, DOI 10.1242/jeb.012682; Censi A, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002891; Cheng B, 2011, J EXP BIOL, V214, P4092, DOI 10.1242/jeb.062760; Corke P, 2011, ROBOTICS VISION CONT, VSecond, P219; Dankert H, 2009, NAT METHODS, V6, P297, DOI [10.1038/NMETH.1310, 10.1038/nmeth.1310]; Dell AI, 2014, TRENDS ECOL EVOL, V29, P417, DOI 10.1016/j.tree.2014.05.004; Fontaine EI, 2009, J EXP BIOL, V212, P1307, DOI 10.1242/jeb.025379; Fry SN, 2003, SCIENCE, V300, P495, DOI 10.1126/science.1081944; Grover D, 2008, J R SOC INTERFACE, V5, P1181, DOI 10.1098/rsif.2007.1333; Hartley R., 2004, ROBOTICA; Inan OT, 2011, J NEUROSCI METH, V202, P45, DOI 10.1016/j.jneumeth.2011.08.039; Kelley DH, 2013, SCI REP-UK, V3, DOI 10.1038/srep01073; Kohlhoff KJ, 2011, INTEGR BIOL-UK, V3, P755, DOI 10.1039/c0ib00149j; Liu Y, 2012, LECT NOTES COMPUT SC, V7575, P730, DOI 10.1007/978-3-642-33765-9_52; Maimon G, 2008, CURR BIOL, V18, P464, DOI 10.1016/j.cub.2008.02.054; Muijres FT, 2014, SCIENCE, V344, P172, DOI 10.1126/science.1248955; Perez-Escudero A, 2014, NAT METHODS, V11, P743, DOI [10.1038/NMETH.2994, 10.1038/nmeth.2994]; Reiser MB, 2013, J EXP BIOL, V216, P719, DOI 10.1242/jeb.074732; Reynolds C.W., 1987, P 14 ANN C COMPUTER, V21, P25, DOI DOI 10.1145/37402.37406; Ristroph L, 2009, J EXP BIOL, V212, P1324, DOI 10.1242/jeb.025502; Schilstra C, 1999, J EXP BIOL, V202, P1481; Straw AD, 2011, J R SOC INTERFACE, V8, P395, DOI 10.1098/rsif.2010.0230; Tammero LF, 2002, J EXP BIOL, V205, P327; van Breugel F, 2012, J EXP BIOL, V215, P1783, DOI 10.1242/jeb.066498; Weir PT, 2012, CURR BIOL, V22, P21, DOI 10.1016/j.cub.2011.11.026	29	1	1	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132101	10.1371/journal.pone.0132101	http://dx.doi.org/10.1371/journal.pone.0132101			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26173128	Green Submitted, gold, Green Published			2022-12-26	WOS:000358194900032
J	Drgonova, J; Walther, D; Singhal, S; Johnson, K; Kessler, B; Troncoso, J; Uhl, GR				Drgonova, Jana; Walther, Donna; Singhal, Sulabh; Johnson, Kennedy; Kessler, Brice; Troncoso, Juan; Uhl, George R.			Altered CSMD1 Expression Alters Cocaine-Conditioned Place Preference: Mutual Support for a Complex Locus from Human and Mouse Models	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SMOKING-CESSATION SUCCESS; RISK VARIANT RS10503253; MOLECULAR-GENETICS; NICOTINE REPLACEMENT; SCHIZOPHRENIA; ADDICTION; MICE; DEPENDENCE; TRIAL	The CUB and sushi multiple domains 1 (CSMD1) gene harbors signals provided by clusters of nearby SNPs with 10(-2) > p > 10(-8) associations in genome wide association (GWAS) studies of addiction-related phenotypes. A CSMD1 intron 3 SNP displays p < 10(-8) association with schizophrenia and more modest associations with individual differences in performance on tests of cognitive abilities. CSDM1 encodes a cell adhesion molecule likely to influence development, connections and plasticity of brain circuits in which it is expressed. We tested association between CSMD1 genotypes and expression of its mRNA in postmortem human brains (n = 181). Expression of CSMD1 mRNA in human postmortem cerebral cortical samples differs 15-25%, in individuals with different alleles of simple sequence length and SNP polymorphisms located in the gene's third/ fifth introns, providing nominal though not Bonferroni-corrected significance. These data support mice with altered CSMD1 expression as models for common human CSMD1 allelic variation. We tested baseline and/ or cocaine-evoked addiction, emotion, motor and memory-related behaviors in +/- and -/-csmd1 knockout mice on mixed and on C57-backcrossed genetic backgrounds. Initial csmd1 knockout mice on mixed genetic backgrounds displayed a variety of coat colors and sizable individual differences in responses during behavioral testing. Backcrossed mice displayed uniform black coat colors. Cocaine conditioned place preference testing revealed significant influences of genotype (p = 0.02). Homozygote knockouts displayed poorer performance on aspects of the Morris water maze task. They displayed increased locomotion in some, though not all, environments. The combined data thus support roles for common level-of-expression CSMD1 variation in a drug reward phenotype relevant to addiction and in cognitive differences that might be relevant to schizophrenia. Mouse model results can complement data from human association findings of modest magnitude that identify likely polygenic influences.	[Drgonova, Jana; Walther, Donna; Singhal, Sulabh; Johnson, Kennedy; Kessler, Brice] NIDA, Mol Nuropsychiatry Res Branch, NIH IRP, Baltimore, MD 21224 USA; [Troncoso, Juan] Johns Hopkins Sch Med, Div Neuropathol, Baltimore, MD USA; [Uhl, George R.] New Mexico VA Healthcare Syst, Off Res Dev, Albuquerque, NM 87108 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); Johns Hopkins University; Johns Hopkins Medicine	Uhl, GR (corresponding author), New Mexico VA Healthcare Syst, Off Res Dev, Albuquerque, NM 87108 USA.	george.uhl@va.gov		Kessler, Brice/0000-0002-2006-5026	National Institutes on Drug Abuse Intramural Research Program; NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000165] Funding Source: NIH RePORTER	National Institutes on Drug Abuse Intramural Research Program; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Funding was provided by National Institutes on Drug Abuse Intramural Research Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnedo J, 2015, AM J PSYCHIAT, V172, P139, DOI 10.1176/appi.ajp.2014.14040435; Bergen SE, 2012, MOL PSYCHIATR, V17, P880, DOI 10.1038/mp.2012.73; Bhatia S, 2014, HUM GENET, V133, P815, DOI 10.1007/s00439-014-1424-6; Distler MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051235; Donohoe G, 2013, GENES BRAIN BEHAV, V12, P203, DOI 10.1111/gbb.12016; Drgon T, 2011, AM J MED GENET B, V156B, P125, DOI 10.1002/ajmg.b.31143; Drgon T, 2009, MOL MED, V15, P268, DOI 10.2119/molmed.2009.00040; Drgon T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008832; Drgon T, 2009, MOL MED, V15, P21, DOI 10.2119/molmed.2008.00096; Drgonova J, 2010, NEUROSCIENCE, V165, P882, DOI 10.1016/j.neuroscience.2009.10.007; Hall FS, 2012, PSYCHOPHARMACOLOGY, V219, P35, DOI 10.1007/s00213-011-2370-9; Havik B, 2011, BIOL PSYCHIAT, V70, P35, DOI 10.1016/j.biopsych.2011.01.030; Hishimoto A, 2007, HUM MOL GENET, V16, P2880, DOI 10.1093/hmg/ddm247; Ishiguro H, 2006, NEUROPSYCHOPHARMACOL, V31, P572, DOI 10.1038/sj.npp.1300855; Jackson KJ, 2010, J PHARMACOL EXP THER, V334, P137, DOI 10.1124/jpet.110.165738; Johnson C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019210; Johnson C, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-113; Koiliari E, 2014, SCHIZOPHR RES, V154, P42, DOI 10.1016/j.schres.2014.02.017; Kraus DM, 2006, J IMMUNOL, V176, P4419, DOI 10.4049/jimmunol.176.7.4419; Li M, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-79; McCleery A, 2014, SCHIZOPHR RES, V157, P33, DOI 10.1016/j.schres.2014.04.039; McGue M, 2013, BEHAV GENET, V43, P363, DOI 10.1007/s10519-013-9606-x; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Ripke S, 2013, NAT GENET, V45, P1150, DOI 10.1038/ng.2742; Ripke S, 2011, NAT GENET, V43, P969, DOI 10.1038/ng.940; Rose EJ, 2013, AM J MED GENET B, V162, P530, DOI 10.1002/ajmg.b.32182; Sleiman P, 2013, SCI REP-UK, V3, DOI 10.1038/srep03075; Sora I, 2010, ANN NY ACAD SCI, V1187, P218, DOI 10.1111/j.1749-6632.2009.05276.x; Steen VM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079501; Swaminathan S., 2011, INT J ALZHEIMERS DIS, V2011, DOI DOI 10.4061/2011/729478; Tzschentke TM, 1998, PROG NEUROBIOL, V56, P613, DOI 10.1016/S0301-0082(98)00060-4; Uhl GR, 2014, MOL PSYCHIATR, V19, P50, DOI 10.1038/mp.2012.155; Uhl GR, 2008, ARCH GEN PSYCHIAT, V65, P683, DOI 10.1001/archpsyc.65.6.683; Uhl GR, 2008, BIOCHEM PHARMACOL, V75, P98, DOI 10.1016/j.bcp.2007.06.042; Uhl GR, 2010, MOL MED, V16, P513, DOI 10.2119/molmed.2010.00052; Uhl GR, 2010, PHARMACOGENOMICS, V11, P357, DOI [10.2217/pgs.09.156, 10.2217/PGS.09.156]; Uhl GR, 2008, ANN NY ACAD SCI, V1141, P318, DOI 10.1196/annals.1441.018; Xiang Bo, 2012, Zhonghua Yixue Yichuanxue Zazhi, V29, P255, DOI 10.3760/cma.j.issn.1003-9406.2012.03.002	38	4	4	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0120908	10.1371/journal.pone.0120908	http://dx.doi.org/10.1371/journal.pone.0120908			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26171607	Green Published, Green Submitted, gold			2022-12-26	WOS:000358194900001
J	Narayanan, S; Dubarry, M; Lawless, C; Banks, AP; Wilkinson, DJ; Whitehall, SK; Lydall, D				Narayanan, Siddharth; Dubarry, Marion; Lawless, Conor; Banks, A. Peter; Wilkinson, Darren J.; Whitehall, Simon K.; Lydall, David			Quantitative Fitness Analysis Identifies exo1 Delta and Other Suppressors or Enhancers of Telomere Defects in Schizosaccharomyces pombe	PLOS ONE			English	Article							TERT PROMOTER MUTATIONS; GENETIC INTERACTIONS; RIBOSOMAL-PROTEIN; HIGH-THROUGHPUT; DNA-DAMAGE; YEAST; CONSERVATION; ORGANIZATION; SUMOYLATION; MARKER	Synthetic genetic array (SGA) has been successfully used to identify genetic interactions in S. cerevisiae and S. pombe. In S. pombe, SGA methods use either cycloheximide (C) or heat shock (HS) to select double mutants before measuring colony size as a surrogate for fitness. Quantitative Fitness Analysis (QFA) is a different method for determining fitness of microbial strains. In QFA, liquid cultures are spotted onto solid agar and growth curves determined for each spot by photography and model fitting. Here, we compared the two S. pombe SGA methods and found that the HS method was more reproducible for us. We also developed a QFA procedure for S. pombe. We used QFA to identify genetic interactions affecting two temperature sensitive, telomere associated query mutations (taz1 Delta and pot11). We identify exo1 Delta and other gene deletions as suppressors or enhancers of S. pombe telomere defects. Our study identifies known and novel gene deletions affecting the fitness of strains with telomere defects. The interactions we identify may be relevant in human cells.	[Narayanan, Siddharth; Dubarry, Marion; Lawless, Conor; Whitehall, Simon K.; Lydall, David] Newcastle Univ, Sch Med, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Banks, A. Peter] Newcastle Univ, Newcastle Biomed, High Throughput Screening Facil, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Wilkinson, Darren J.] Newcastle Univ, Sch Math & Stat, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK; Newcastle University - UK	Lydall, D (corresponding author), Newcastle Univ, Sch Med, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	david.lydall@newcastle.ac.uk	Narayanan, Siddharth/AAZ-2384-2021	Dubarry, Marion/0000-0001-5648-5770; Lydall, David/0000-0003-2478-085X; Narayanan, Siddharth/0000-0002-5553-3221; Wilkinson, Darren James/0000-0003-0736-802X	 [C23629/A13314]; BBSRC [BB/M002314/1, BB/F023545/1] Funding Source: UKRI; MRC [MR/L001284/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [1093879, 1368997, BB/M002314/1, BB/F023545/1] Funding Source: researchfish; Cancer Research UK [13314] Funding Source: researchfish; Medical Research Council [MR/L001284/1, 1094244] Funding Source: researchfish	; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Funding provided by C23629/A13314 (http://www.cancerresearchuk.org/).	Addinall SG, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001362; Artandi SE, 2010, CARCINOGENESIS, V31, P9, DOI 10.1093/carcin/bgp268; Aubert G, 2008, PHYSIOL REV, V88, P557, DOI 10.1152/physrev.00026.2007; Babu M, 2011, METHODS MOL BIOL, V765, P125, DOI 10.1007/978-1-61779-197-0_9; Banks AP, 2012, JOVE-J VIS EXP, DOI 10.3791/4018; Baryshnikova A, 2010, NAT METHODS, V7, P1017, DOI 10.1038/NMETH.1534; Beltrao P, 2010, CELL, V141, P739, DOI 10.1016/j.cell.2010.05.019; Boone C, 2014, GENETICS, V198, P435, DOI 10.1534/genetics.114.169128; Boucher Benjamin, 2013, Frontiers in Genetics, V4, P290, DOI 10.3389/fgene.2013.00290; Breslow DK, 2008, NAT METHODS, V5, P711, DOI 10.1038/nmeth.1234; Butland G, 2008, NAT METHODS, V5, P789, DOI 10.1038/NMETH.1239; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Cremona CA, 2012, BIOMOLECULES, V2, P376, DOI 10.3390/biom2030376; Dixon SJ, 2008, P NATL ACAD SCI USA, V105, P16653, DOI 10.1073/pnas.0806261105; Dixon SJ, 2009, ANNU REV GENET, V43, P601, DOI 10.1146/annurev.genet.39.073003.114751; Fiedler D, 2009, CELL, V136, P952, DOI 10.1016/j.cell.2008.12.039; Forsburg SL, 2003, CURR PROTOC MOL BIOL, V13; Galanty Y, 2012, GENE DEV, V26, P1179, DOI 10.1101/gad.188284.112; Garg M, 2014, EMBO REP, V15, P871, DOI 10.15252/embr.201438919; Gibbs-Seymour I, 2014, MOL CELL; Gibson TJ, 2009, TRENDS BIOCHEM SCI, V34, P471, DOI 10.1016/j.tibs.2009.06.007; Gunes C, 2013, CELL, V152, P390, DOI 10.1016/j.cell.2013.01.010; Hentges P, 2005, YEAST, V22, P1013, DOI 10.1002/yea.1291; Hoppins S, 2011, J CELL BIOL, V195, P323, DOI 10.1083/jcb.201107053; Horn S, 2013, SCIENCE, V339, P959, DOI 10.1126/science.1230062; Huang FW, 2013, SCIENCE, V339, P957, DOI 10.1126/science.1229259; Jain D, 2010, ANNU REV GENET, V44, P243, DOI 10.1146/annurev-genet-102108-134841; Jonikas MC, 2009, SCIENCE, V323, P1693, DOI 10.1126/science.1167983; KAWAI S, 1992, J BACTERIOL, V174, P254, DOI 10.1128/jb.174.1.254-262.1992; Kim DU, 2010, NAT BIOTECHNOL, V28, P617, DOI 10.1038/nbt.1628; KONDO K, 1995, J BACTERIOL, V177, P7171, DOI 10.1128/jb.177.24.7171-7177.1995; Lawless C, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-287; Lehner B, 2007, J EXP BIOL, V210, P1559, DOI 10.1242/jeb.002311; Lewis KA, 2012, STRUCTURE, V20, P28, DOI 10.1016/j.str.2011.10.017; Linger BR, 2009, CRIT REV BIOCHEM MOL, V44, P434, DOI 10.3109/10409230903307329; Mani R, 2008, P NATL ACAD SCI USA, V105, P3461, DOI 10.1073/pnas.0712255105; Maringele L, 2002, GENE DEV, V16, P1919, DOI 10.1101/gad.225102; Miller KM, 2006, NATURE, V440, P824, DOI 10.1038/nature04638; Miller KM, 2005, EMBO J, V24, P3128, DOI 10.1038/sj.emboj.7600779; Miller KM, 2003, MOL CELL, V11, P303, DOI 10.1016/S1097-2765(03)00041-8; Miyagawa K, 2014, P NATL ACAD SCI USA, V111, P5950, DOI 10.1073/pnas.1401359111; Nagai S, 2011, CELL RES, V21, P474, DOI 10.1038/cr.2011.31; Nakamura TM, 2002, GENETICS, V161, P1437; Nandakumar J, 2013, NAT REV MOL CELL BIO, V14, P71, DOI 10.1038/nrm3505; Nault JC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3218; Ngo GHP, 2014, NUCLEIC ACIDS RES; Park S, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.2; Pitt CW, 2010, NUCLEIC ACIDS RES, V38, P6968, DOI 10.1093/nar/gkq580; Ramsay AJ, 2013, NAT GENET, V45, P526, DOI 10.1038/ng.2584; Robles-Espinoza CD, 2014, NAT GENET, V46, P478, DOI 10.1038/ng.2947; Roguev A, 2008, SCIENCE, V322, P405, DOI 10.1126/science.1162609; Roguev A, 2007, NAT METHODS, V4, P861, DOI 10.1038/NMETH1098; Roguev A, 2013, NAT METHODS, V10, P432, DOI [10.1038/nmeth.2398, 10.1038/NMETH.2398]; Ryan CJ, 2012, MOL CELL, V46, P691, DOI 10.1016/j.molcel.2012.05.028; Sabatinos SA, 2010, METHOD ENZYMOL, V470, P759, DOI 10.1016/S0076-6879(10)70032-X; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Shi J, 2014, NAT GENET; Sipiczki M, 2000, GENOME BIOL, V1, DOI [10.1186/gb-2000-1-2-reviews1011, DOI 10.1186/GB-2000-1-2-REVIEWS1011]; St Onge RP, 2007, NAT GENET, V39, P199, DOI 10.1038/ng1948; Stevens DR, 2001, MOL GEN GENET, V264, P790, DOI 10.1007/s004380000368; Sugioka-Sugiyama R, 2011, BIOCHEM BIOPH RES CO, V406, P444, DOI 10.1016/j.bbrc.2011.02.068; SUNNERHAGEN P, 1993, BIOTECHNIQUES, V14, P18; Tomita K, 2004, MOL CELL BIOL, V24, P9557, DOI 10.1128/MCB.24.21.9557-9567.2004; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Tong Amy Hin Yan, 2006, Methods Mol Biol, V313, P171; Tosti E, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0068-4; Typas A, 2008, NAT METHODS, V5, P781, DOI 10.1038/NMETH.1240; Varma A, 2000, YEAST, V16, P1397, DOI 10.1002/1097-0061(200011)16:15&lt;1397::AID-YEA636&gt;3.0.CO;2-1	71	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0132240	10.1371/journal.pone.0132240	http://dx.doi.org/10.1371/journal.pone.0132240			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26168240	Green Published, Green Submitted, gold			2022-12-26	WOS:000358193100032
J	Wang, ZJ; de la Fuente-Nunez, C; Shen, Y; Haapasalo, M; Hancock, REW				Wang, Zhejun; de la Fuente-Nunez, Cesar; Shen, Ya; Haapasalo, Markus; Hancock, Robert E. W.			Treatment of Oral Multispecies Biofilms by an Anti-Biofilm Peptide	PLOS ONE			English	Article							2 CHLORHEXIDINE PREPARATIONS; ENTEROCOCCUS-FAECALIS; PSEUDOMONAS-AERUGINOSA; CATIONIC PEPTIDES; IN-VITRO; BACTERIA; AGENTS	Human oral biofilms are multispecies microbial communities that exhibit high resistance to antimicrobial agents. Dental plaque gives rise to highly prevalent and costly biofilm-related oral infections, which lead to caries or other types of oral infections. We investigated the ability of the recently identified anti-biofilm peptide 1018 to induce killing of bacterial cells present within oral multispecies biofilms. At 10 mu g/ml (6.5 mu M), peptide 1018 was able to significantly (p<0.05) prevent biofilm formation over 3 days. The activity of the peptide on preformed biofilms was found to be concentration-dependent since more than 60% of the total plaque biofilm cell population was killed by 10 mu g/ml of peptide 1018 in 3 days, while at 5 mu g/ml 50% of cells were dead and at 1 mu g/ml the peptide triggered cell death in around 30% of the total bacterial population, as revealed by confocal microscopy. The presence of saliva did not affect peptide activity, since no statistically significant difference was found in the ability of peptide 1018 to kill oral biofilms using either saliva coated and non-saliva coated hydroxyapatite surfaces. Scanning electron microscopy experiments indicated that peptide 1018 induced cell lysis in plaque biofilms. Furthermore, combined treatment using peptide 1018 and chlorhexidine (CHX) increased the anti-biofilm activity of each compound compared to when these were used alone, resulting in >50% of the biofilm being killed and >35% being dispersed in only 3 minutes. Peptide 1018 may potentially be used by itself or in combination with CHX as a non-toxic and effective anti-biofilm agent for plaque disinfection in clinical dentistry.	[Wang, Zhejun; Shen, Ya; Haapasalo, Markus] Univ British Columbia, Fac Dent, Dept Oral Biol & Med Sci, Div Endodont, Vancouver, BC V5Z 1M9, Canada; [de la Fuente-Nunez, Cesar; Hancock, Robert E. W.] Univ British Columbia, Dept Microbiol & Immunol, Ctr Microbial Dis & Immun Res, Vancouver, BC V5Z 1M9, Canada; [Wang, Zhejun] Wuhan Univ, Sch & Hosp Stomatol, State Key Lab Breeding Base Basic Sci Stomatol Hu, Wuhan 430072, Peoples R China; [Wang, Zhejun] Wuhan Univ, Sch & Hosp Stomatol, Minist Educ, Key Lab Oral Biomed, Wuhan 430072, Peoples R China	University of British Columbia; University of British Columbia; Wuhan University; Wuhan University	Haapasalo, M (corresponding author), Univ British Columbia, Fac Dent, Dept Oral Biol & Med Sci, Div Endodont, Vancouver, BC V5Z 1M9, Canada.	markush@dentistry.ubc.ca; bob@hancocklab.com	Hancock, Robert E. W./E-1145-2013; de la Fuente, Cesar/ABE-2369-2021; Shen, Ya/X-5855-2019	Hancock, Robert E. W./0000-0001-5989-8503; de la Fuente, Cesar/0000-0002-2005-5629; , Ya/0000-0002-0792-4279	Faculty of Dentistry, University of British Columbia, Canada; Canada Foundation for Innovation (CFI fund) [32623]; National Natural Science Foundation of China (NSFC) [81300904]; Canadian Institutes for Health Research (CIHR); National Institute of Allergy and Infectious Diseases of the National Institutes of Health [R21AI098701]; Fundacion "la Caixa"; Fundacion Canada (Spain); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI098701, R33AI098701] Funding Source: NIH RePORTER	Faculty of Dentistry, University of British Columbia, Canada; Canada Foundation for Innovation (CFI fund); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); National Institute of Allergy and Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Fundacion "la Caixa"(La Caixa Foundation); Fundacion Canada (Spain); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by start-up funds from the Faculty of Dentistry, University of British Columbia, Canada, Canada Foundation for Innovation (CFI fund; Project No. 32623), National Natural Science Foundation of China (NSFC; Grant No. 81300904), and by grants from the Canadian Institutes for Health Research (CIHR). Research reported in this publication was supported by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under Award Number R21AI098701. R.E.W.H. holds a Canada Research Chair in Health and Genomics. C.D.L.F.-N. received a scholarship from the Fundacion "la Caixa" and Fundacion Canada (Spain).	Athanassiadis B, 2007, AUST DENT J, V52, pS64, DOI 10.1111/j.1834-7819.2007.tb00527.x; Baehni PC, 2003, ORAL DIS, V9, P23, DOI 10.1034/j.1601-0825.9.s1.5.x; Basrani Bettina, 2005, Aust Endod J, V31, P48; Brown A T, 1986, Compendium, V7, P719; Bucki R, 2008, J ANTIMICROB CHEMOTH, V62, P329, DOI 10.1093/jac/dkn176; de la Fuente-Nunez C, 2015, CHEM BIOL, V22, P196, DOI 10.1016/j.chembiol.2015.01.002; de la Fuente-Nunez C, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004152; de la Fuente-Nunez C, 2013, CURR OPIN MICROBIOL, V16, P580, DOI 10.1016/j.mib.2013.06.013; de la Fuente-Nunez C, 2012, ANTIMICROB AGENTS CH, V56, P2696, DOI 10.1128/AAC.00064-12; Falconer SB, 2011, NAT CHEM BIOL, V7, P416, DOI [10.1038/nchembio.590, 10.1038/NCHEMBIO.590]; Fjell CD, 2012, NAT REV DRUG DISCOV, V11, P37, DOI 10.1038/nrd3591; Friedrich CL, 2000, ANTIMICROB AGENTS CH, V44, P2086, DOI 10.1128/AAC.44.8.2086-2092.2000; Happasalo M., 2005, ENDODONTIC TOPICS, V10, P77; Hirt H, 2013, ANTIMICROB AGENTS CH, V57, P4903, DOI 10.1128/AAC.00311-13; Hojo K, 2009, J DENT RES, V88, P982, DOI 10.1177/0022034509346811; Hosoya Y, 2010, J DENT, V38, P423, DOI 10.1016/j.jdent.2010.02.001; Kim SS, 2003, CARIES RES, V37, P425, DOI 10.1159/000073394; Kim YS, 2014, J DENT, V42, P691, DOI 10.1016/j.jdent.2014.03.006; Leung KP, 2005, J DENT RES, V84, P1172, DOI 10.1177/154405910508401215; Love RM, 2001, INT ENDOD J, V34, P399, DOI 10.1046/j.1365-2591.2001.00437.x; Chau NPT, 2014, J DENT, V42, P726, DOI 10.1016/j.jdent.2014.03.009; Scott MG, 2007, NAT BIOTECHNOL, V25, P465, DOI 10.1038/nbt1288; Shen Y, 2011, J ENDODONT, V37, P657, DOI 10.1016/j.joen.2011.02.007; Shen Y, 2010, J ENDODONT, V36, P100, DOI 10.1016/j.joen.2009.09.018; Shen Y, 2009, J ENDODONT, V35, P981, DOI 10.1016/j.joen.2009.04.030; Steinstraesser L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039373; Tao R, 2011, PEPTIDES, V32, P1748, DOI 10.1016/j.peptides.2011.06.008; Tong ZX, 2013, J ENDODONT, V39, P674, DOI 10.1016/j.joen.2012.12.010; Wang ZJ, 2012, J ENDODONT, V38, P1376, DOI 10.1016/j.joen.2012.06.035; Wieczorek M, 2010, CHEM BIOL, V17, P970, DOI 10.1016/j.chembiol.2010.07.007; Wiegand I, 2008, NAT PROTOC, V3, P163, DOI 10.1038/nprot.2007.521; Wiradharma N, 2011, BIOMATERIALS, V32, P2204, DOI 10.1016/j.biomaterials.2010.11.054; Xiao J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002623; Zhang W, 2014, J DENT, V42, P1078, DOI 10.1016/j.jdent.2014.06.001	34	57	57	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0132512	10.1371/journal.pone.0132512	http://dx.doi.org/10.1371/journal.pone.0132512			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26168273	gold, Green Submitted, Green Published			2022-12-26	WOS:000358193100048
J	El Hadri, K; Denoyelle, C; Ravaux, L; Viollet, B; Foretz, M; Friguet, B; Rouis, M; Raymondjean, M				El Hadri, Khadija; Denoyelle, Chantal; Ravaux, Lucas; Viollet, Benoit; Foretz, Marc; Friguet, Bertrand; Rouis, Mustapha; Raymondjean, Michel			AMPK Signaling Involvement for the Repression of the IL-1 beta-Induced Group IIA Secretory Phospholipase A2 Expression in VSMCs	PLOS ONE			English	Article							ACTIVATED-PROTEIN-KINASE; SMOOTH-MUSCLE-CELLS; NF-KAPPA-B; A(2) GENE; TRANSCRIPTIONAL REGULATION; ENDOTHELIAL-CELLS; METFORMIN; ATHEROSCLEROSIS; INFLAMMATION; BCL6	Secretory Phospholipase A2 of type IIA (sPLA2 IIA) plays a crucial role in the production of lipid mediators by amplifying the neointimal inflammatory context of the vascular smooth muscle cells (VSMCs), especially during atherogenesis. Phenformin, a biguanide family member, by its anti-inflammatory properties presents potential for promoting beneficial effects upon vascular cells, however its impact upon the IL-1 beta-induced sPLA2 gene expression has not been deeply investigated so far. The present study was designed to determine the relationship between phenformin coupling AMP-activated protein kinase (AMPK) function and the molecular mechanism by which the sPLA2 IIA expression was modulated in VSMCs. Here we find that 5-aminoimidazole-4-carboxamide-1-beta-D-ribonucleotide (AICAR) treatment strongly repressed IL-1 beta-induced sPLA2 expression at least at the transcriptional level. Our study reveals that phenformin elicited a dose-dependent inhibition of the sPLA2 IIA expression and transient overexpression experiments of constitutively active AMPK demonstrate clearly that AMPK signaling is involved in the transcriptional inhibition of sPLA2-IIA gene expression. Furthermore, although the expression of the transcriptional repressor B-cell lymphoma-6 protein (BCL-6) was markedly enhanced by phenformin and AICAR, the repression of sPLA2 gene occurs through a mechanism independent of BCL-6 DNA binding site. In addition we show that activation of AMPK limits IL-1 beta-induced NF-kappa B pathway activation. Our results indicate that BCL-6, once activated by AMPK, functions as a competitor of the IL-1 beta induced NF-kappa B transcription complex. Our findings provide insights on a new anti-inflammatory pathway linking phenformin, AMPK and molecular control of sPLA2 IIA gene expression in VSMCs.	[El Hadri, Khadija; Ravaux, Lucas; Friguet, Bertrand; Rouis, Mustapha; Raymondjean, Michel] Univ Paris 06, Sorbonne Univ, Biol Adaptat & Ageing CNRS UMR8256 B2A, INSERM ERL U1064, F-75005 Paris, France; [Denoyelle, Chantal] Univ Paris Diderot, Sorbonne Paris Cite, BFA CNRS UMR8251, F-75013 Paris, France; [Viollet, Benoit; Foretz, Marc] Inst Cochin, Inserm U1016, Paris, France; [Viollet, Benoit; Foretz, Marc] CNRS, UMR 8104, Paris, France; [Viollet, Benoit; Foretz, Marc] Univ Paris 05, Sorbonne Paris Cite, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	El Hadri, K (corresponding author), Univ Paris 06, Sorbonne Univ, Biol Adaptat & Ageing CNRS UMR8256 B2A, INSERM ERL U1064, F-75005 Paris, France.	khadija.zegouagh@upmc.fr	Viollet, Benoit/N-2397-2019; FORETZ, Marc/O-7334-2017; Rouis, Mustapha/E-4993-2016; Viollet, Benoit/O-6927-2017	Viollet, Benoit/0000-0002-0121-0224; FORETZ, Marc/0000-0001-7017-9032; Viollet, Benoit/0000-0002-0121-0224; EL HADRI, KHADIJA/0000-0002-1275-9861; Rouis, Mustapha/0000-0003-4197-6555	Universite Pierre et Marie Curie (University Paris 6); Chancellerie des Universites de Paris; Ministere de l'Education Nationale de la Recherche et de la Technologie	Universite Pierre et Marie Curie (University Paris 6); Chancellerie des Universites de Paris; Ministere de l'Education Nationale de la Recherche et de la Technologie	This work was supported by the Universite Pierre et Marie Curie (University Paris 6) and by grants from the "Leg Poix-2007" and "Leg Poix-2009" of the Chancellerie des Universites de Paris. Dr. Lucas Ravaux was supported by doctoral fellowships from the Ministere de l'Education Nationale de la Recherche et de la Technologie.	Andreani M, 2000, BBA-MOL CELL BIOL L, V1488, P149, DOI 10.1016/S1388-1981(00)00117-7; Antonio V, 2003, BIOCHEM J, V376, P351, DOI 10.1042/BJ20030098; Antonio V, 2002, BIOCHEM J, V368, P415, DOI 10.1042/BJ20020658; Barish GD, 2012, CELL METAB, V15, P554, DOI 10.1016/j.cmet.2012.02.012; Barish GD, 2010, GENE DEV, V24, P2760, DOI 10.1101/gad.1998010; Barroso E, 2011, BIOCHEM PHARMACOL, V81, P534, DOI 10.1016/j.bcp.2010.12.004; Basso K, 2010, ADV IMMUNOL, V105, P193, DOI 10.1016/S0065-2776(10)05007-8; Bereshchenko OR, 2002, NAT GENET, V32, P606, DOI 10.1038/ng1018; Boudeau J, 2004, J CELL SCI, V117, P6365, DOI 10.1242/jcs.01571; Bousserouel S, 2004, EUR J BIOCHEM, V271, P4462, DOI 10.1111/j.1432-1033.2004.04385.x; Bousserouel S, 2003, J LIPID RES, V44, P601, DOI 10.1194/jlr.M200092-JLR200; Cacicedo JM, 2004, BIOCHEM BIOPH RES CO, V324, P1204, DOI 10.1016/j.bbrc.2004.09.177; Cai XJ, 2010, MOL ENDOCRINOL, V24, P218, DOI 10.1210/me.2009-0128; Chang CC, 1996, P NATL ACAD SCI USA, V93, P6947, DOI 10.1073/pnas.93.14.6947; Clement N, 2006, J CELL PHYSIOL, V208, P495, DOI 10.1002/jcp.20673; Couturier C, 1999, J BIOL CHEM, V274, P23085, DOI 10.1074/jbc.274.33.23085; Csiszar A, 2011, ANN NY ACAD SCI, V1215, P117, DOI 10.1111/j.1749-6632.2010.05848.x; Devaraj S, 2008, ARTERIOSCL THROM VAS, V28, P1368, DOI 10.1161/ATVBAHA.108.163303; Dhordain P, 1997, P NATL ACAD SCI USA, V94, P10762, DOI 10.1073/pnas.94.20.10762; Doran AC, 2008, ARTERIOSCL THROM VAS, V28, P812, DOI 10.1161/ATVBAHA.107.159327; Ewart MA, 2008, ARTERIOSCL THROM VAS, V28, P2255, DOI 10.1161/ATVBAHA.108.175919; Foretz M, 2014, CELL METAB, V20, P953, DOI 10.1016/j.cmet.2014.09.018; Fryer LGD, 2002, J BIOL CHEM, V277, P25226, DOI 10.1074/jbc.M202489200; Glass CK, 2001, CELL, V104, P503, DOI 10.1016/S0092-8674(01)00238-0; Gongol B, 2013, P NATL ACAD SCI USA, V110, P3161, DOI 10.1073/pnas.1222051110; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hamaguchi K, 2003, BBA-MOL CELL BIOL L, V1635, P37, DOI 10.1016/j.bbalip.2003.10.004; Hansson GK, 2001, ARTERIOSCL THROM VAS, V21, P1876, DOI 10.1161/hq1201.100220; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hardie DG, 2011, GENE DEV, V25, P1895, DOI 10.1101/gad.17420111; Hattori Y, 2006, HYPERTENSION, V47, P265, DOI 10.1161/01.HYP.0000198425.21604.aa; Hattori Y, 2006, HYPERTENSION, V47, P1183, DOI 10.1161/01.HYP.0000221429.94591.72; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Heishi M, 2008, J TOXICOL SCI, V33, P339, DOI 10.2131/jts.33.339; Hurt-Camejo E, 2013, ARTERIOSCL THROM VAS, V33, P2707, DOI 10.1161/ATVBAHA.113.301410; HurtCamejo E, 1997, ATHEROSCLEROSIS, V132, P1, DOI 10.1016/S0021-9150(97)00085-3; Igata M, 2005, CIRC RES, V97, P837, DOI 10.1161/01.RES.0000185823.73556.06; Isoda K, 2006, ARTERIOSCL THROM VAS, V26, P611, DOI 10.1161/01.ATV.0000201938.78044.75; Jaulmes A, 2005, ARTERIOSCL THROM VAS, V25, P1161, DOI 10.1161/01.ATV.0000164310.67356.a9; Jaulmes A, 2006, FASEB J, V20, P1727, DOI 10.1096/fj.05-5514fje; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kundu JK, 2006, CARCINOGENESIS, V27, P1465, DOI 10.1093/carcin/bgi349; LEBAIL O, 1993, EMBO J, V12, P5043, DOI 10.1002/j.1460-2075.1993.tb06197.x; Lee CH, 2003, SCIENCE, V302, P453, DOI 10.1126/science.1087344; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Moore KJ, 2011, CELL, V145, P341, DOI 10.1016/j.cell.2011.04.005; Motoshima H, 2004, BIOCHEM BIOPH RES CO, V315, P264, DOI 10.1016/j.bbrc.2004.01.049; Murakami M, 2010, BIOCHIMIE, V92, P561, DOI 10.1016/j.biochi.2010.03.015; Musi N, 2002, DIABETES, V51, P2074, DOI 10.2337/diabetes.51.7.2074; Nazari-Jahantigh M, 2012, J CLIN INVEST, V122, P4190, DOI 10.1172/JCI61716; Neumann D, 2007, MOL BIOTECHNOL, V36, P220, DOI 10.1007/s12033-007-0029-x; O'Neill LAJ, 2013, NATURE, V493, P346, DOI 10.1038/nature11862; Orr AW, 2010, J VASC RES, V47, P168, DOI 10.1159/000250095; Ouchi N, 2008, ARTERIOSCL THROM VAS, V28, P1219, DOI 10.1161/ATVBAHA.108.165068; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Parekh S, 2007, BLOOD, V110, P2067, DOI 10.1182/blood-2007-01-069575; Perez-Rosado A, 2008, J PATHOL, V214, P498, DOI 10.1002/path.2279; Ravaux L, 2007, MOL CELL BIOL, V27, P8374, DOI 10.1128/MCB.00623-07; Rosengren B, 2006, BBA-MOL CELL BIOL L, V1761, P1301, DOI 10.1016/j.bbalip.2006.06.008; Ross R, 1999, AM HEART J, V138, pS419, DOI 10.1016/S0002-8703(99)70266-8; Schuhmacher S, 2011, ARTERIOSCL THROM VAS, V31, P560, DOI 10.1161/ATVBAHA.110.219543; Sharma P, 2013, J BIOL CHEM, V288, P16321, DOI 10.1074/jbc.M112.445569; Song P, 2011, CIRC RES, V109, P1230, DOI 10.1161/CIRCRESAHA.111.250423; Sullivan CP, 2010, J BIOL CHEM, V285, P565, DOI 10.1074/jbc.M109.070565; Thompson AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085495; Tili E, 2011, J NUCLEIC ACIDS, V2011, DOI 10.4061/2011/102431; Tili E, 2010, CARCINOGENESIS, V31, P1561, DOI 10.1093/carcin/bgq143; Tischfield JA, 1997, J BIOL CHEM, V272, P17247, DOI 10.1074/jbc.272.28.17247; Um JH, 2010, DIABETES, V59, P554, DOI 10.2337/db09-0482; Woods A, 2005, CELL METAB, V2, P21, DOI 10.1016/j.cmet.2005.06.005; Wu YZ, 2010, BIOCHIMIE, V92, P583, DOI 10.1016/j.biochi.2010.01.024; Xie Z, 2008, CIRCULATION, V117, P952, DOI 10.1161/CIRCULATIONAHA.107.744490; Zang MW, 2006, DIABETES, V55, P2180, DOI 10.2337/db05-1188; Zhang Y, 2011, ARTERIOSCL THROM VAS, V31, P2897, DOI 10.1161/ATVBAHA.111.237453; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505; Zou MH, 2004, J BIOL CHEM, V279, P43940, DOI 10.1074/jbc.M404421200	78	5	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132498	10.1371/journal.pone.0132498	http://dx.doi.org/10.1371/journal.pone.0132498			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26162096	Green Published, gold, Green Submitted			2022-12-26	WOS:000358162300141
J	Techasintana, P; Davis, JW; Gubin, MM; Magee, JD; Atasoy, U				Techasintana, Patsharaporn; Davis, J. Wade; Gubin, Matthew M.; Magee, Joseph D.; Atasoy, Ulus			Transcriptomic-Wide Discovery of Direct and Indirect HuR RNA Targets in Activated CD4(+) T Cells	PLOS ONE			English	Article							BINDING PROTEIN HUR; DIFFERENTIAL EXPRESSION ANALYSIS; MESSENGER-RNA; GENE-EXPRESSION; NUCLEAR; ICOS; IDENTIFICATION; COSTIMULATION; TRANSLATION; COMPLEXES	Due to poor correlation between steady state mRNA levels and protein product, purely transcriptomic profiling methods may miss genes posttranscriptionally regulated by RNA binding proteins (RBPs) and microRNAs (miRNAs). RNA immunoprecipitation (RIP) methods developed to identify in vivo targets of RBPs have greatly elucidated those mRNAs which may be regulated via transcript stability and translation. The RBP HuR (ELAVL1) and family members are major stabilizers of mRNA. Many labs have identified HuR mRNA targets; however, many of these analyses have been performed in cell lines and oftentimes are not independent biological replicates. Little is known about how HuR target mRNAs behave in conditional knock-out models. In the present work, we performed HuR RIP-Seq and RNASeq to investigate HuR direct and indirect targets using a novel conditional knock-out model of HuR genetic ablation during CD4+ T activation and Th2 differentiation. Using independent biological replicates, we generated a high coverage RIP-Seq data set (>160 million reads) that was analyzed using bioinformatics methods specifically designed to find direct mRNA targets in RIP-Seq data. Simultaneously, another set of independent biological replicates were sequenced by RNA-Seq (>425 million reads) to identify indirect HuR targets. These direct and indirect targets were combined to determine canonical pathways in CD4+ T cell activation and differentiation for which HuR plays an important role. We show that HuR may regulate genes in multiple canonical pathways involved in T cell activation especially the CD28 family signaling pathway. These data provide insights into potential HuRregulated genes during T cell activation and immune mechanisms.	[Techasintana, Patsharaporn; Atasoy, Ulus] Univ Missouri, Dept Surg, Columbia, MO 65201 USA; [Techasintana, Patsharaporn; Atasoy, Ulus] Univ Missouri, Dept Mol Microbiol & Immunol, Columbia, MO USA; [Davis, J. Wade] Univ Missouri, Dept Biostat, Columbia, MO USA; [Gubin, Matthew M.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA; [Magee, Joseph D.] Univ Missouri, Dalton Cardiovasc Res Ctr, Columbia, MO USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; Washington University (WUSTL); University of Missouri System; University of Missouri Columbia	Atasoy, U (corresponding author), Univ Missouri, Dept Surg, Columbia, MO 65201 USA.	atasoyu@health.missouri.edu		Gubin, Matthew/0000-0001-7443-2752	National Institutes of Health [R21AI079341, R01AI080870]; NIH [2R01AI080870-05A1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080870, R21AI079341] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work is funded by grant R21AI079341 National Institutes of Health (www.nih.gov) to UA; R01AI080870 National Institutes of Health (www.nih.gov) to UA; NIH grant 2R01AI080870-05A1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atasoy U, 1998, J CELL SCI, V111, P3145; Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031; Bourgon R, 2010, P NATL ACAD SCI USA, V107, P9546, DOI 10.1073/pnas.0914005107; Calaluce R, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-126; Calvano SE, 2005, NATURE, V437, P1032, DOI 10.1038/nature03985; Chatr-aryamontri A, 2013, NUCLEIC ACIDS RES, V41, pD816, DOI 10.1093/nar/gks1158; Chen J, 2013, J IMMUNOL, V191, P5441, DOI 10.4049/jimmunol.1301188; Choi YS, 2011, IMMUNITY, V34, P932, DOI 10.1016/j.immuni.2011.03.023; Dahm GM, 2012, JOVE-J VIS EXP, DOI 10.3791/3851; de Silanes IL, 2004, P NATL ACAD SCI USA, V101, P2987, DOI 10.1073/pnas.0306453101; Gubin MM, 2014, MOL MED, V20, P93, DOI 10.2119/molmed.2013.00127; Gubin MM, 2010, CELL CYCLE, V9, P3337, DOI 10.4161/cc.9.16.12711; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Hafner Markus, 2010, J Vis Exp, DOI 10.3791/2034; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Hieronymus H, 2004, GENE DEV, V18, P2652, DOI 10.1101/gad.1241204; Hieronymus H, 2003, NAT GENET, V33, P155, DOI 10.1038/ng1080; Hutloff A, 1999, NATURE, V397, P263, DOI 10.1038/16717; Ideker T, 2001, SCIENCE, V292, P929, DOI 10.1126/science.292.5518.929; Keene JD, 2003, MOL CELL, V12, P1347, DOI 10.1016/S1097-2765(03)00496-9; Kim HH, 2009, GENE DEV, V23, P1743, DOI 10.1101/gad.1812509; Kraushar ML, 2014, P NATL ACAD SCI USA, V111, pE3815, DOI 10.1073/pnas.1408305111; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Lebedeva S, 2011, MOL CELL, V43, P340, DOI 10.1016/j.molcel.2011.06.008; Leung AKL, 2010, MOL CELL, V40, P205, DOI 10.1016/j.molcel.2010.09.027; Li Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt142; Lin MY, 2005, J IMMUNOL, V174, P5583, DOI 10.4049/jimmunol.174.9.5583; Mazan-Mamczarz K, 2003, P NATL ACAD SCI USA, V100, P8354, DOI 10.1073/pnas.1432104100; Mukherjee N, 2011, MOL CELL, V43, P327, DOI 10.1016/j.molcel.2011.06.007; Padilla J, 2011, AM J PHYSIOL-HEART C, V301, pH555, DOI 10.1152/ajpheart.00065.2011; Raghavan A, 2001, J BIOL CHEM, V276, P47958, DOI 10.1074/jbc.M109511200; Rapaport F, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-9-r95; Rattenbacher B, 2010, MOL CELL BIOL, V30, P3970, DOI 10.1128/MCB.00624-10; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Shapiro VS, 1997, MOL CELL BIOL, V17, P4051, DOI 10.1128/MCB.17.7.4051; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Stark C, 2011, NUCLEIC ACIDS RES, V39, pD698, DOI 10.1093/nar/gkq1116; Stellato C, 2011, J IMMUNOL, V187, P441, DOI 10.4049/jimmunol.1001881; Stoecklin G, 2008, J BIOL CHEM, V283, P11689, DOI 10.1074/jbc.M709657200; Tenenbaum SA, 2002, METHODS, V26, P191, DOI 10.1016/S1046-2023(02)00022-1; Tenenbaum SA, 2003, GENE, V317, P79, DOI 10.1016/S0378-1119(03)00661-9; Tenenbaum SA, 2000, P NATL ACAD SCI USA, V97, P14085, DOI 10.1073/pnas.97.26.14085; UMLAUF SW, 1995, MOL CELL BIOL, V15, P3197; Uren PJ, 2011, J BIOL CHEM, V286, P37063, DOI 10.1074/jbc.C111.266882; Wang JG, 2006, J IMMUNOL, V176, P2105, DOI 10.4049/jimmunol.176.4.2105; Watanabe M, 2005, J IMMUNOL, V174, P1989, DOI 10.4049/jimmunol.174.4.1989	48	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0129321	10.1371/journal.pone.0129321	http://dx.doi.org/10.1371/journal.pone.0129321			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26162078	Green Published, gold, Green Submitted			2022-12-26	WOS:000358162300009
J	Alloy, AP; Kayode, O; Wang, RY; Hockla, A; Soares, AS; Radisky, ES				Alloy, Alexandre P.; Kayode, Olumide; Wang, Ruiying; Hockla, Alexandra; Soares, Alexei S.; Radisky, Evette S.			Mesotrypsin Has Evolved Four Unique Residues to Cleave Trypsin Inhibitors as Substrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						crystal structure; enzyme catalysis; protease inhibitor; protein evolution; protein structure; proteolysis; serine protease; site-directed mutagenesis; substrate specificity; trypsin	HEPATOCYTE GROWTH-FACTOR; PROTEIN INHIBITORS; SERINE PROTEASES; TUMOR-GROWTH; ACTIVE-SITE; KUNITZ; METASTASIS; EXPRESSION; MECHANISM; AFFINITY	Background: Canonical serine protease inhibitors normally behave as uncleavable substrates; mesotrypsin targets these inhibitors as substrates. Results: Four spatially separated amino acid residues cooperate to facilitate inhibitor cleavage by mesotrypsin. Conclusion: Inhibitor cleavage is a complex evolutionary adaptation. Significance: Mesotrypsin may regulate a network of serine proteases through its ability to cleave and inactivate multiple protease inhibitors. Human mesotrypsin is highly homologous to other mammalian trypsins, and yet it is functionally unique in possessing resistance to inhibition by canonical serine protease inhibitors and in cleaving these inhibitors as preferred substrates. Arg-193 and Ser-39 have been identified as contributors to the inhibitor resistance and cleavage capability of mesotrypsin, but it is not known whether these residues fully account for the unusual properties of mesotrypsin. Here, we use human cationic trypsin as a template for engineering a gain of catalytic function, assessing mutants containing mesotrypsin-like mutations for resistance to inhibition by bovine pancreatic trypsin inhibitor (BPTI) and amyloid precursor protein Kunitz protease inhibitor (APPI), and for the ability to hydrolyze these inhibitors as substrates. We find that Arg-193 and Ser-39 are sufficient to confer mesotrypsin-like resistance to inhibition; however, compared with mesotrypsin, the trypsin-Y39S/G193R double mutant remains 10-fold slower at hydrolyzing BPTI and 2.5-fold slower at hydrolyzing APPI. We identify two additional residues in mesotrypsin, Lys-74 and Asp-97, which in concert with Arg-193 and Ser-39 confer the full catalytic capability of mesotrypsin for proteolysis of BPTI and APPI. Novel crystal structures of trypsin mutants in complex with BPTI suggest that these four residues function cooperatively to favor conformational dynamics that assist in dissociation of cleaved inhibitors. Our results reveal that efficient inhibitor cleavage is a complex capability to which at least four spatially separated residues of mesotrypsin contribute. These findings suggest that inhibitor cleavage represents a functional adaptation of mesotrypsin that may have evolved in response to positive selection pressure.	[Alloy, Alexandre P.; Kayode, Olumide; Wang, Ruiying; Hockla, Alexandra; Radisky, Evette S.] Mayo Clin, Dept Canc Biol, Ctr Comprehens Canc, Jacksonville, FL 32224 USA; [Soares, Alexei S.] Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA	Mayo Clinic; United States Department of Energy (DOE); Brookhaven National Laboratory	Radisky, ES (corresponding author), Mayo Clin, Dept Canc Biol, 310 Griffin Bldg,4500 San Pablo Rd, Jacksonville, FL 32224 USA.	radisky.evette@mayo.edu	Regan, Clinton/E-6250-2012; Radisky, Evette S/C-8526-2012	Radisky, Evette S/0000-0003-3121-109X	National Institutes of Health [R01CA154387]; NATIONAL CANCER INSTITUTE [R01CA154387] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01CA154387 (to E. S. R.). The authors declare that they have no conflicts of interest with the contents of this article.	Arolas JL, 2011, ANGEW CHEM INT EDIT, V50, P10357, DOI 10.1002/anie.201103262; Carroll MJ, 2012, NAT CHEM BIOL, V8, P246, DOI [10.1038/NCHEMBIO.769, 10.1038/nchembio.769]; Cattaruzza F, 2014, BRIT J PHARMACOL, V171, P3814, DOI 10.1111/bph.12738; Ceppa EP, 2011, AM J PHYSIOL-GASTR L, V300, pG1033, DOI 10.1152/ajpgi.00305.2010; CHASE T, 1967, BIOCHEM BIOPH RES CO, V29, P508, DOI 10.1016/0006-291X(67)90513-X; DELMAR EG, 1979, ANAL BIOCHEM, V99, P316, DOI 10.1016/S0003-2697(79)80013-5; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ESTELL DA, 1980, BIOCHEMISTRY-US, V19, P124, DOI 10.1021/bi00542a019; ESTELL DA, 1980, BIOCHEMISTRY-US, V19, P131, DOI 10.1021/bi00542a020; Fortelny N, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001869; Fukuoka S, 2002, BBA-MOL BASIS DIS, V1588, P106, DOI 10.1016/S0925-4439(02)00153-9; Gherardi E, 2012, NAT REV CANCER, V12, P89, DOI 10.1038/nrc3205; Gil-Bernabe AM, 2013, BRIT J HAEMATOL, V162, P433, DOI 10.1111/bjh.12381; Halabi N, 2009, CELL, V138, P774, DOI 10.1016/j.cell.2009.07.038; Han S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076667; Hayashi H, 2011, P NATL ACAD SCI USA, V108, P18766, DOI 10.1073/pnas.1116273108; Hockla A, 2012, MOL CANCER RES, V10, P1555, DOI 10.1158/1541-7786.MCR-12-0314; Hockla A, 2010, BREAST CANCER RES TR, V124, P27, DOI 10.1007/s10549-009-0699-0; Huntington JA, 2011, J THROMB HAEMOST, V9, P26, DOI 10.1111/j.1538-7836.2011.04360.x; Jiang GZ, 2010, GUT, V59, P1535, DOI 10.1136/gut.2009.200105; Katona G, 2002, J MOL BIOL, V315, P1209, DOI 10.1006/jmbi.2001.5305; Kirchhofer D, 2005, FEBS LETT, V579, P1945, DOI 10.1016/j.febslet.2005.01.085; Knecht W, 2007, J BIOL CHEM, V282, P26089, DOI 10.1074/jbc.M703840200; KOBAYASHI H, 1994, CANCER RES, V54, P844; Krowarsch D, 2003, CELL MOL LIFE SCI, V60, P2427, DOI 10.1007/s00018-003-3120-x; Laskowski Jr M., 1974, PROTEINASE INHIBITOR, P597; LASKOWSKI M, 1980, ANNU REV BIOCHEM, V49, P593, DOI 10.1146/annurev.bi.49.070180.003113; Lengyel Z, 1998, PROTEIN EXPRES PURIF, V12, P291, DOI 10.1006/prep.1997.0837; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nierodzik ML, 2006, CANCER CELL, V10, P355, DOI 10.1016/j.ccr.2006.10.002; Nyaruhucha CNM, 1997, J BIOL CHEM, V272, P10573; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pendlebury D, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.609560; Qin L, 1998, FEBS LETT, V436, P111, DOI 10.1016/S0014-5793(98)01105-3; Radisky ES, 2006, P NATL ACAD SCI USA, V103, P6835, DOI 10.1073/pnas.0601910103; Radisky ES, 2002, P NATL ACAD SCI USA, V99, P10316, DOI 10.1073/pnas.112332899; Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI [10.1093/nar/gkr987, 10.1093/nar/gkt953]; Read RJ, 2011, STRUCTURE, V19, P1395, DOI 10.1016/j.str.2011.08.006; RINDERKNECHT H, 1984, GASTROENTEROLOGY, V86, P681; Rowen L, 2005, MOL BIOL EVOL, V22, P1712, DOI 10.1093/molbev/msi166; Ruf W, 2006, SEMIN THROMB HEMOST, V32, P61, DOI 10.1055/s-2006-939555; Sahin-Toth M, 2000, J BIOL CHEM, V275, P22750, DOI 10.1074/jbc.M002943200; Salameh MA, 2008, J BIOL CHEM, V283, P4115, DOI 10.1074/jbc.M708268200; Salameh Moh'd A, 2013, Int J Biochem Mol Biol, V4, P129; Salameh MA, 2012, PROTEIN SCI, V21, P1103, DOI 10.1002/pro.2097; Salameh MA, 2011, BIOCHEM J, V440, P95, DOI 10.1042/BJ20110788; Salameh MA, 2010, J BIOL CHEM, V285, P36884, DOI 10.1074/jbc.M110.171348; Salameh MA, 2010, J BIOL CHEM, V285, P1939, DOI 10.1074/jbc.M109.057216; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Seo MH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4724; Szabo R, 2008, J BIOL CHEM, V283, P29495, DOI 10.1074/jbc.M801970200; Szabo R, 2009, DEVELOPMENT, V136, P2653, DOI 10.1242/dev.038430; Szmola R, 2003, J BIOL CHEM, V278, P48580, DOI 10.1074/jbc.M310301200; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; VANNOSTRAND WE, 1994, BBA-PROTEIN STRUCT M, V1209, P165, DOI 10.1016/0167-4838(94)90180-5; VANNOSTRAND WE, 1990, J BIOL CHEM, V265, P9591; WAGNER SL, 1992, BIOCHEM BIOPH RES CO, V186, P1138, DOI 10.1016/0006-291X(92)90865-I; Yagyu T, 2006, INT J CANCER, V118, P2322, DOI 10.1002/ijc.21293; Zakharova E, 2008, J MOL BIOL, V382, P998, DOI 10.1016/j.jmb.2008.07.063; Zakharova E, 2009, P NATL ACAD SCI USA, V106, P11034, DOI 10.1073/pnas.0902463106	60	20	21	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2015	290	35					21523	21535		10.1074/jbc.M115.662429	http://dx.doi.org/10.1074/jbc.M115.662429			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ5IS	26175157	hybrid, Green Published, Green Submitted			2022-12-26	WOS:000360637600027
J	Vogan, JM; Collins, K				Vogan, Jacob M.; Collins, Kathleen			Dynamics of Human Telomerase Holoenzyme Assembly and Subunit Exchange across the Cell Cycle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell cycle; mitosis; telomerase; telomerase reverse transcriptase (TERT); telomere; Cajal bodies; RNP assembly; RNP trafficking	CAJAL BODY LOCALIZATION; HUMAN CANCER-CELLS; DYSKERATOSIS-CONGENITA; REVERSE-TRANSCRIPTASE; CHROMOSOME ENDS; PCR DATA; RNA; RECRUITMENT; BODIES; TRAFFICKING	Background: Telomerase elongation of chromosome ends is restricted within the cell cycle. Results: A human telomerase holoenzyme subunit mediating Cajal body and telomere localization disassembles reversibly from the RNP catalytic core in each cell cycle. Conclusion: Telomerase holoenzyme assembly and disassembly are favored at distinct stages of the cell cycle. Significance: Human telomerase is relicensed for telomere synthesis in G(1). Human telomerase acts on telomeres during the genome synthesis phase of the cell cycle, accompanied by its concentration in Cajal bodies and transient colocalization with telomeres. Whether the regulation of human telomerase holoenzyme assembly contributes to the cell cycle restriction of telomerase function is unknown. We investigated the steady-state levels, assembly, and exchange dynamics of human telomerase subunits with quantitative in vivo cross-linking and other methods. We determined the physical association of telomerase subunits in cells blocked or progressing through the cell cycle as synchronized by multiple protocols. The total level of human telomerase RNA (hTR) was invariant across the cell cycle. In vivo snapshots of telomerase holoenzyme composition established that hTR remains bound to human telomerase reverse transcriptase (hTERT) throughout all phases of the cell cycle, and subunit competition assays suggested that hTERT-hTR interaction is not readily exchangeable. In contrast, the telomerase holoenzyme Cajal body-associated protein, TCAB1, was released from hTR in mitotic cells coincident with TCAB1 delocalization from Cajal bodies. This telomerase holoenzyme disassembly was reversible with cell cycle progression without any change in total TCAB1 protein level. Consistent with differential cell cycle regulation of hTERT-hTR and TCAB1-hTR protein-RNA interactions, overexpression of hTERT or TCAB1 had limited if any influence on hTR assembly of the other subunit. Overall, these findings revealed a cell cycle regulation that disables human telomerase association with telomeres while preserving the co-folded hTERT-hTR ribonucleoprotein catalytic core. Studies here, integrated with previous work, led to a unifying model for telomerase subunit assembly and trafficking in human cells.	[Vogan, Jacob M.; Collins, Kathleen] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Collins, K (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	kcollins@berkeley.edu	Regan, Clinton/E-6250-2012		National Institutes of Health [RO1 HL079585, T32 GM007232]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079585] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007232] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 HL079585 (to K.C.) and T32 GM007232 (to J.M.V.). The authors declare that they have no conflicts of interest with the contents of this article.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Armanios M, 2012, NAT REV GENET, V13, P693, DOI 10.1038/nrg3246; Aubert G, 2014, PROG MOL BIOL TRANSL, V125, P89, DOI 10.1016/B978-0-12-397898-1.00004-9; Batista LFZ, 2011, NATURE, V474, P399, DOI 10.1038/nature10084; Blackburn EH, 2006, NAT MED, V12, P1133, DOI 10.1038/nm1006-1133; Blackburn Elizabeth H, 2011, Cold Spring Harb Perspect Biol, V3, DOI 10.1101/cshperspect.a003558; Cesare AJ, 2012, CURR OPIN CELL BIOL, V24, P731, DOI 10.1016/j.ceb.2012.08.007; Chen YL, 2015, NUCLEIC ACIDS RES, V43, P385, DOI 10.1093/nar/gku1277; Chow TT, 2012, GENE DEV, V26, P1167, DOI 10.1101/gad.187211.112; Collins K, 2008, MECH AGEING DEV, V129, P91, DOI 10.1016/j.mad.2007.10.008; Cristofari G, 2007, MOL CELL, V27, P882, DOI 10.1016/j.molcel.2007.07.020; de Lange T, 2010, COLD SH Q B, V75, P167, DOI 10.1101/sqb.2010.75.017; Dionne I, 2013, RNA, V19, P992, DOI 10.1261/rna.037663.112; Dubravka D, 2000, CELL RES, V10, P1, DOI 10.1038/sj.cr.7290031; Egan ED, 2012, RNA, V18, P1747, DOI 10.1261/rna.034629.112; Egan ED, 2012, MOL CELL BIOL, V32, P2428, DOI 10.1128/MCB.00286-12; Etheridge KT, 2002, J BIOL CHEM, V277, P24764, DOI 10.1074/jbc.M201227200; Forsyth NR, 2002, DIFFERENTIATION, V69, P188, DOI 10.1046/j.1432-0436.2002.690412.x; Fu D, 2006, GENE DEV, V20, P531, DOI 10.1101/gad.1390306; Fu D, 2003, MOL CELL, V11, P1361, DOI 10.1016/S1097-2765(03)00196-5; Fu D, 2007, MOL CELL, V28, P773, DOI 10.1016/j.molcel.2007.09.023; Gallardo F, 2012, RNA BIOL, V9, P1139, DOI 10.4161/rna.21498; Holt SE, 1997, P NATL ACAD SCI USA, V94, P10687, DOI 10.1073/pnas.94.20.10687; Huang J, 2014, NAT STRUCT MOL BIOL, V21, P507, DOI 10.1038/nsmb.2819; Jady BE, 2006, MOL BIOL CELL, V17, P944, DOI 10.1091/mbc.E05-09-0904; Jady BE, 2004, J CELL BIOL, V164, P647, DOI 10.1083/jcb.200310138; Lee JH, 2014, HISTOCHEM CELL BIOL, V141, P137, DOI 10.1007/s00418-013-1166-x; Li S, 2009, CELL, V136, P50, DOI 10.1016/j.cell.2008.11.027; Mitchell JR, 2000, MOL CELL, V6, P361, DOI 10.1016/S1097-2765(00)00036-8; Mitchell JR, 1999, MOL CELL BIOL, V19, P567; Mitchell JR, 1999, NATURE, V402, P551, DOI 10.1038/990141; Moser BA, 2009, BIOCHEM CELL BIOL, V87, P747, DOI 10.1139/O09-037; Nandakumar J, 2013, NAT REV MOL CELL BIO, V14, P71, DOI 10.1038/nrm3505; Podlevsky JD, 2012, MUTAT RES-FUND MOL M, V730, P3, DOI 10.1016/j.mrfmmm.2011.11.002; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Ribeyre C, 2013, CHROMOSOMA, V122, P159, DOI 10.1007/s00412-013-0404-2; Richard P, 2006, MOL CELL BIOL, V26, P2540, DOI 10.1128/MCB.26.7.2540-2549.2006; Seto AG, 1999, NATURE, V401, P177, DOI 10.1038/43694; Shay JW, 2011, SEMIN CANCER BIOL, V21, P349, DOI 10.1016/j.semcancer.2011.10.001; Stern JL, 2012, MOL CELL BIOL, V32, P2384, DOI 10.1128/MCB.00379-12; Teixeira MT, 2004, CELL, V117, P323, DOI 10.1016/S0092-8674(04)00334-4; Theimer CA, 2007, MOL CELL, V27, P869, DOI 10.1016/j.molcel.2007.07.017; Tomlinson RL, 2008, MOL BIOL CELL, V19, P3793, DOI 10.1091/mbc.E08-02-0184; Tomlinson RL, 2010, EXP CELL RES, V316, P2797, DOI 10.1016/j.yexcr.2010.07.001; Tomlinson RL, 2006, MOL BIOL CELL, V17, P955, DOI 10.1091/mbc.E05-09-0903; Tucey TM, 2014, GENE DEV, V28, P2077, DOI 10.1101/gad.246256.114; Tycowski KT, 2009, MOL CELL, V34, P47, DOI 10.1016/j.molcel.2009.02.020; Upton HE, 2014, MOL CELL BIOL, V34, P4200, DOI 10.1128/MCB.01030-14; Venteicher AS, 2009, SCIENCE, V323, P644, DOI 10.1126/science.1165357; Wege H, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng003; Weinrich SL, 1997, NAT GENET, V17, P498, DOI 10.1038/ng1297-498; Wellinger RJ, 2012, GENETICS, V191, P1073, DOI 10.1534/genetics.111.137851; Wenz C, 2001, EMBO J, V20, P3526, DOI 10.1093/emboj/20.13.3526; Wong JMY, 2002, NAT CELL BIOL, V4, P731, DOI 10.1038/ncb846; Wu RA, 2014, EMBO J, V33, P921, DOI 10.1002/embj.201387205; Xi LH, 2014, NUCLEIC ACIDS RES, V42, P8565, DOI 10.1093/nar/gku560; Yi XM, 1999, MOL CELL BIOL, V19, P3989; Zhao Y, 2011, MOL CELL, V42, P297, DOI 10.1016/j.molcel.2011.03.020; Zhao Y, 2009, CELL, V138, P463, DOI 10.1016/j.cell.2009.05.026; Zhong F, 2011, GENE DEV, V25, P11, DOI 10.1101/gad.2006411; Zhong FL, 2012, CELL, V150, P481, DOI 10.1016/j.cell.2012.07.012; Zhu X, 1996, P NATL ACAD SCI USA, V93, P5091	62	14	14	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2015	290	35					21320	21335		10.1074/jbc.M115.659359	http://dx.doi.org/10.1074/jbc.M115.659359			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ5IS	26170453	Green Published, hybrid			2022-12-26	WOS:000360637600011
J	Badawi, D; Saleh, S; Natafgi, N; Mourad, Y; Behbehani, K				Badawi, Dalia; Saleh, Shadi; Natafgi, Nabil; Mourad, Yara; Behbehani, Kazem			Quality of Type II Diabetes Care in Primary Health Care Centers in Kuwait: Employment of a Diabetes Quality Indicator Set (DQIS)	PLOS ONE			English	Article							GLYCEMIC CONTROL; OF-CARE; MANAGEMENT; IMPLEMENTATION; DECLARATION; IMPROVEMENT; COUNTRIES	Diabetes Mellitus is one of the major public health challenges, affecting more than 347 million adults worldwide. The impact of diabetes necessitates assessing the quality of care received by people with diabetes, especially in countries with a significant diabetes burden such as Kuwait. This paper aimed at piloting an approach for measuring Type II diabetes care performance through the use of a diabetes quality indicator set (DQIS) in primary health care. The DQIS for Kuwait was adapted from that developed by the National Diabetes Quality Improvement Alliance and the International Diabetes Federation. Five key care domains/measures were employed: (1) Blood glucose level measurement, (2) Cholesterol level measurement, (3) Blood pressure measurement, (4) Kidney function testing and (5) Smoking status check. The sample included the four major primary health care centers with the highest case load in Kuwait City, 4,241 patients in 2012 and 3,211 in 2010. Findings revealed the applicability and utility of employing performance indicators for diabetes care in Kuwait. Furthermore, findings revealed that many of the primary health care centers have achieved noteworthy improvement in diabetes care between 2010 and 2012, with the exception of smoking status check. The DQIS can help policymakers identify performance gaps and investigate key system roadblocks related to diabetes care in Kuwait.	[Badawi, Dalia; Behbehani, Kazem] Dasman Diabet Inst, Kuwait, Kuwait; [Saleh, Shadi; Mourad, Yara] Amer Univ Beirut, Dept Hlth Management & Policy, Fac Hlth Sci, Beirut, Lebanon; [Natafgi, Nabil] Univ Iowa, Coll Publ Hlth, Dept Hlth Management & Policy, Iowa City, IA USA	American University of Beirut; University of Iowa	Saleh, S (corresponding author), Amer Univ Beirut, Dept Hlth Management & Policy, Fac Hlth Sci, Beirut, Lebanon.	ss117@aub.edu.lb		Natafgi, Nabil/0000-0003-4979-0317				Agency for Healthcare Research and Quality (AHRQ), 2008, APP G IND DIAB QUAL; Akbar D H, 2001, East Mediterr Health J, V7, P671; Al-Adsani A, 2008, MED PRIN PRACT, V17, P14, DOI 10.1159/000109584; Al-Baho A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043895; Al-Sultan F., 2005, KUWAIT MED J, V37, P98; Alhyas L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022186; [Anonymous], 2015, DIAB FACT SHEET; Beaton SJ, 2004, DIABETES CARE, V27, P694, DOI 10.2337/diacare.27.3.694; Cagliero E, 1999, DIABETES CARE, V22, P1785, DOI 10.2337/diacare.22.11.1785; Campbell SM, 2003, BRIT MED J, V326, P816, DOI 10.1136/bmj.326.7393.816; Diabetes UK, 2012, STAT NAT 2012 ENGL; Eledrisi M, 2007, DIABETES RES CLIN PR, V78, P145, DOI 10.1016/j.diabres.2007.02.017; Ezenwaka CE, 2001, CLIN EXP MED, V1, P91, DOI 10.1007/s10238-001-8018-z; Fleming BB, 2001, DIABETES CARE, V24, P1815, DOI 10.2337/diacare.24.10.1815; Giuffrida A, 1999, BRIT MED J, V319, P94, DOI 10.1136/bmj.319.7202.94; Gudbjornsdottir S, 2003, DIABETES CARE, V26, P1270, DOI 10.2337/diacare.26.4.1270; International Diabetes Federation, 2013, IDF DIAB ATL; International Diabetes Federation (IDF), 2012, GLOB GUID TYP 2 DIAB; IOM, 2000, ERR IS HUMAN BUILDIN; Khattab M, 2010, J DIABETES COMPLICAT, V24, P84, DOI 10.1016/j.jdiacomp.2008.12.008; Mainz J, 2003, INT J QUAL HEALTH C, V15, pI5, DOI 10.1093/intqhc/mzg084; National Committee for Quality Assurance, 2010, STAT HLTH CAR QUAL; National Institutes of Health (NIH) National Heart Lung and Blood Institute (NHLBI), 2011, COR HEART DIS RISK F; O'Connor PJ, 2011, DIABETES CARE, V34, P1651, DOI 10.2337/dc11-0735; PIWERNETZ K, 1993, DIABETIC MED, V10, P371, DOI 10.1111/j.1464-5491.1993.tb00083.x; Saaddine JB, 2006, ANN INTERN MED, V144, P465, DOI 10.7326/0003-4819-144-7-200604040-00005; Saydah SH, 2004, JAMA-J AM MED ASSOC, V291, P335, DOI 10.1001/jama.291.3.335; Schoen C, 2009, HEALTH AFFAIR, V28, pW1171, DOI 10.1377/hlthaff.28.6.w1171; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Si DM, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-169; Toh MPHS, 2007, ANN ACAD MED SINGAP, V36, P980; World Heart Federation, 2013, DIABETES	32	9	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132883	10.1371/journal.pone.0132883	http://dx.doi.org/10.1371/journal.pone.0132883			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176691	Green Published, gold, Green Submitted			2022-12-26	WOS:000358197600173
J	Czarniecka, A; Kowal, M; Rusinek, D; Krajewska, J; Jarzab, M; Stobiecka, E; Chmielik, E; Zembala-Nozynska, E; Poltorak, S; Sacher, A; Maciejewski, A; Zebracka-Gala, J; Lange, D; Oczko-Wojciechowska, M; Handkiewicz-Junak, D; Jarzab, B				Czarniecka, Agnieszka; Kowal, Monika; Rusinek, Dagmara; Krajewska, Jolanta; Jarzab, Michal; Stobiecka, Ewa; Chmielik, Ewa; Zembala-Nozynska, Ewa; Poltorak, Stanislaw; Sacher, Aleksander; Maciejewski, Adam; Zebracka-Gala, Jadwiga; Lange, Dariusz; Oczko-Wojciechowska, Malgorzata; Handkiewicz-Junak, Daria; Jarzab, Barbara			The Risk of Relapse in Papillary Thyroid Cancer (PTC) in the Context of BRAF(V600E) Mutation Status and Other Prognostic Factors	PLOS ONE			English	Article							BRAF V600E MUTATION; NEEDLE-ASPIRATION BIOPSY; TERT PROMOTER MUTATIONS; LYMPH-NODE METASTASIS; CLINICOPATHOLOGICAL FEATURES; PREOPERATIVE RISK; CLINICAL-PRACTICE; KOREAN PATIENTS; FOLLOW-UP; CARCINOMA	Introduction The risk of over-treatment in low-advanced PTC stages has prompted clinicians to search for new reliable prognostic factors. The presence of BRAF mutation, the most frequent molecular event in PTC, seems to be a good candidate. However, there is still lack of randomised trials and its significance has been proved by retrospective analyses, involving a large group of patients. The question arises whether this factor is useful in smaller populations, characterised for specialised centres. Thus, the aim of the study was to evaluate the use of BRAF mutation as a potential predictive marker in PTC patients. Material 233 PTC subjects treated between 2004-2006, were retrospectively analysed. Stage pT1 was diagnosed in 64.8% patients and lymph node metastases in 30.9%. Median follow-up was 7.5 years. BRAF(V600E) mutation was assessed postoperatively in all cases. Results BRAF(V600E) mutation was found in 54.5%. It was more frequent in patients > 45 years (p=0.0001), and associated with larger tumour size (p=0.004). Patients with tumours <= 10 mm were over-represented among BRAF negative population (p=0.03). No association between BRAF mutation and other clinicopathological factors was observed. BRAF status was associated neither with relapse nor with disease-free survival (DFS) (p=0.76). Nodal status, extrathyroidal invasion and tumour size significantly influenced DFS. Conclusion The risk of PTC recurrence is mainly related to the presence of lymph node metastases and extrathyroidal invasion, whereas no impact of BRAF(V600E) mutation has been demonstrated.	[Czarniecka, Agnieszka; Poltorak, Stanislaw; Sacher, Aleksander; Maciejewski, Adam] Maria Sklodowska Curie Mem Canc Ctr & Inst Oncol, Oncol & Reconstruct Surg Clin, Gliwice Branch, Gliwice, Poland; [Kowal, Monika; Rusinek, Dagmara; Krajewska, Jolanta; Zebracka-Gala, Jadwiga; Oczko-Wojciechowska, Malgorzata; Handkiewicz-Junak, Daria; Jarzab, Barbara] Maria Sklodowska Curie Mem Canc Ctr & Inst Oncol, Gliwice Branch, Dept Nucl Med & Endocrine Oncol, Gliwice, Poland; [Jarzab, Michal] Maria Sklodowska Curie Mem Canc Ctr & Inst Oncol, Gliwice Branch, Dept Radiotherapy & Chemotherapy 3, Gliwice, Poland; [Stobiecka, Ewa; Chmielik, Ewa; Zembala-Nozynska, Ewa; Lange, Dariusz] Maria Sklodowska Curie Mem Canc Ctr & Inst Oncol, Gliwice Branch, Dept Tumor Pathol, Gliwice, Poland	Maria Sklodowska-Curie National Research Institute of Oncology; Maria Sklodowska-Curie National Research Institute of Oncology; Maria Sklodowska-Curie National Research Institute of Oncology; Maria Sklodowska-Curie National Research Institute of Oncology	Czarniecka, A (corresponding author), Maria Sklodowska Curie Mem Canc Ctr & Inst Oncol, Oncol & Reconstruct Surg Clin, Gliwice Branch, Gliwice, Poland.	Agnieszka.Czarniecka@io.gliwice.pl	Barbara, Jarzab/I-4654-2019; Maciejewski, Adam/GOH-0319-2022; Jarząb, Michał/G-4319-2012; Oczko-Wojciechowska, Malgorzata/P-2272-2018; Krajewska, Jolanta/AAW-9781-2020; Jarząb, Barbara/AAI-7942-2020; Czarniecka, Agnieszka/I-5137-2014	Maciejewski, Adam/0000-0002-4098-5233; Jarząb, Michał/0000-0002-2642-9724; Oczko-Wojciechowska, Malgorzata/0000-0002-8989-0075; Jarząb, Barbara/0000-0001-9811-9584; Rusinek, Dagmara/0000-0003-4115-3751; Handkiewicz-Junak, Daria/0000-0003-0802-2880; Czarniecka, Agnieszka/0000-0003-1249-7205; Krajewska, Jolanta/0000-0003-0479-4998; Chmielik, Ewa/0000-0001-8316-0541; Zembala-Nozynska, Ewa/0000-0002-6045-2995; Lange, Dariusz/0000-0001-7088-5439	Polish National Science Center [NN 403 194340]	Polish National Science Center	The study was partially funded by Polish National Science Center grant NN 403 194340 to A. C. The study was also conducted as an internal research project in MSC Memorial Cancer Center and Institute of Oncology, Gliwice Branch, Poland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn D, 2012, AURIS NASUS LARYNX, V39, P198, DOI 10.1016/j.anl.2011.07.011; Alzahrani AS, 2013, ENDOCR-RELAT CANCER, V20, P13, DOI 10.1530/ERC-12-0309; Aschebrook-Kilfoy B, 2013, CANCER EPIDEM BIOMAR, V22, P1252, DOI 10.1158/1055-9965.EPI-13-0242; Barbaro D, 2014, ENDOCRINE, V45, P462, DOI 10.1007/s12020-013-0029-5; Bernstein J, 2013, THYROID, V23, P1525, DOI 10.1089/thy.2013.0154; Carling T, 2012, THYROID, V22, P237, DOI 10.1089/thy.2011.0317; Chakraborty A, 2012, ENDOCR PATHOL, V23, P83, DOI 10.1007/s12022-011-9184-5; Cho BY, 2013, THYROID, V23, P797, DOI 10.1089/thy.2012.0329; Choi SY, 2013, WORLD J SURG ONCOL, V11, DOI 10.1186/1477-7819-11-291; Cooper DS, 2009, THYROID, V19, P1167, DOI 10.1089/thy.2009.0110; Czarniecka A, ENDOKRYNOL POL, V61, P462; Czarniecka A, 2014, EUR THYROID J, V3, P104; Danilovic DLS, 2014, EUR J ENDOCRINOL, V170, P619, DOI 10.1530/EJE-13-0944; Didkowska J, 2013, CANC POLAND 2011; Elisei R, 2008, J CLIN ENDOCR METAB, V93, P3943, DOI 10.1210/jc.2008-0607; Elisei R, 2012, J CLIN ENDOCR METAB, V97, P4390, DOI 10.1210/jc.2012-1775; Handkiewicz-Junak D, 2010, MOL CELL ENDOCRINOL, V322, P8, DOI 10.1016/j.mce.2010.01.007; Howell GM, 2013, ANN SURG ONCOL, V20, P47, DOI 10.1245/s10434-012-2611-0; Howell GM, 2011, ANN SURG ONCOL, V18, P3566, DOI 10.1245/s10434-011-1781-5; Huang YB, 2013, EUR J ENDOCRINOL, V168, P675, DOI 10.1530/EJE-12-1029; Ito Y, 2009, ENDOCR J, V56, P89, DOI 10.1507/endocrj.K08E-208; Jarzab B, 2010, ENDOKRYNOL POL, V61, P518; Joo JY, 2012, J CLIN ENDOCR METAB, V97, P3996, DOI 10.1210/jc.2012-2444; Kebebew E, 2007, ANN SURG, V246, P466, DOI 10.1097/SLA.0b013e318148563d; Kim J, 2006, ANN SURG, V244, P799, DOI 10.1097/01.sla.0000224751.80858.13; Kim SJ, 2012, WORLD J SURG, V36, P310, DOI 10.1007/s00268-011-1383-1; Kim TY, 2006, CLIN ENDOCRINOL, V65, P364, DOI 10.1111/j.1365-2265.2006.02605.x; KIM TH, 2012, CANCER-AM CANCER SOC, V118, P1764, DOI DOI 10.1002/cncr.26500; Kim TY, 2005, CLIN ENDOCRINOL, V63, P588, DOI 10.1111/j.1365-2265.2005.02389.x; Kurtulmus N, 2012, ENDOCRINE, V42, P404, DOI 10.1007/s12020-012-9651-x; Lee JH, 2007, CANCER-AM CANCER SOC, V110, P38, DOI 10.1002/cncr.22754; Li C, 2013, J CLIN ENDOCR METAB, V98, P3702, DOI 10.1210/jc.2013-1584; Li C, 2012, J CLIN ENDOCR METAB, V97, P4559, DOI 10.1210/jc.2012-2104; Liu XL, 2014, J CLIN ENDOCR METAB, V99, pE1130, DOI 10.1210/jc.2013-4048; Matosin N, 2014, DIS MODEL MECH, V7, P171, DOI 10.1242/dmm.015123; Mond M, 2014, INTERN MED J, V44, P727, DOI 10.1111/imj.12476; Nam JK, 2012, AM J SURG, V203, P436, DOI 10.1016/j.amjsurg.2011.02.013; Niederer-Wust SM, 2015, SURGERY, V157, P119, DOI 10.1016/j.surg.2014.07.015; Pacini F, 2012, ANN ONCOL, V23, P110, DOI 10.1093/annonc/mds230; Pelizzo MR, 2014, BIOMED PHARMACOTHER, V68, P413, DOI 10.1016/j.biopha.2014.03.008; Puxeddu E, 2014, ENDOCRINE, V45, P341, DOI 10.1007/s12020-013-0139-0; Randolph GW, 2012, THYROID, V22, P1144, DOI 10.1089/thy.2012.0043; Russo M, 2014, THYROID, V24, P1267, DOI 10.1089/thy.2013.0675; Song F, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14080; Sun Y, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/128735; Virk RK, 2013, MODERN PATHOL, V26, P62, DOI 10.1038/modpathol.2012.152; Walczyk A, 2014, CLIN ENDOCRINOL, V80, P899, DOI 10.1111/cen.12386; Watkinson JC, 2004, NUCL MED COMMUN, V25, P897, DOI 10.1097/00006231-200409000-00006; Xing M, 2014, CLIN ONCOL, DOI [10.1200/JCO.2014.55.5094, DOI 10.1200/JCO.2014.55.5094]; Xing MZ, 2015, J CLIN ONCOL, V33, P42, DOI 10.1200/JCO.2014.56.8253; Xing MZ, 2014, J CLIN ONCOL, V32, P2718, DOI 10.1200/JCO.2014.55.5094; Xing MZ, 2013, LANCET, V381, P1058, DOI 10.1016/S0140-6736(13)60109-9; Xing MZ, 2013, JAMA-J AM MED ASSOC, V309, P1493, DOI 10.1001/jama.2013.3190; Xing MZ, 2013, NAT REV CANCER, V13, P184, DOI 10.1038/nrc3431; Xing MZ, 2010, MOL CELL ENDOCRINOL, V321, P86, DOI 10.1016/j.mce.2009.10.012; Xing MZ, 2009, J CLIN ONCOL, V27, P2977, DOI 10.1200/JCO.2008.20.1426; Xing MZ, 2009, ANN SURG ONCOL, V16, P801, DOI 10.1245/s10434-008-0298-z; Xing MZ, 2005, J CLIN ENDOCR METAB, V90, P6373, DOI 10.1210/jc.2005-0987	58	30	34	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132821	10.1371/journal.pone.0132821	http://dx.doi.org/10.1371/journal.pone.0132821			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177218	Green Published, Green Submitted, gold			2022-12-26	WOS:000358197600164
J	Lu, N; Sun, HX; Yu, JJ; Wang, XJ; Liu, DM; Zhao, L; Sun, LH; Zhao, HY; Tao, B; Liu, JM				Lu, Nan; Sun, Hanxiao; Yu, JingJia; Wang, Xiaojing; Liu, Dongmei; Zhao, Lin; Sun, Lihao; Zhao, Hongyan; Tao, Bei; Liu, Jianmin			Glucagon-like peptide-1 receptor agonist Liraglutide has anabolic bone effects in ovariectomized rats without diabetes	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; GLP-1 RECEPTOR; IN-VITRO; OSTEOBLAST FORMATION; DIFFERENTIATION; MARROW; PROGENITORS; EXENDIN-4; MICE; RESORPTION	Recently, a number of studies have demonstrated the potential beneficial role for novel antidiabetic GLP-1 receptor agonists (GLP-1RAs) in the skeleton metabolism in diabetic rodents and patients. In this study, we evaluated the impacts of the synthetic GLP-1RA Liraglutide on bone mass and quality in osteoporotic rats induced by ovariectomy (OVX) but without diabetes, as well as its effect on the adipogenic and osteoblastogenic differentiation of bone marrow stromal cells (BMSCs). Three months after sham surgery or bilateral OVX, eighteen 5-month old female Wistar rats were randomly divided into three groups to receive the following treatments for 2 months: (1) Sham + normal saline; (2) OVX + normal saline; and (3) OVX + Liraglutide (0.6 mg/day). As revealed by micro-CT analysis, Liraglutide improved trabecular volume, thickness and number, increased BMD, and reduced trabecular spacing in the femurs in OVX rats; similar results were observed in the lumbar vertebrae of OVX rats treated with Liraglutide. Following in vitro treatment of rat and human BMSCs with 10 nM Liraglutide, there was a significant increase in the mRNA expression of osteoblast-specific transcriptional factor Runx2 and the osteoblast markers alkaline phosphatase (ALP) and collagen alpha 1 (Col-1), but a significant decrease in peroxisome proliferator-activated receptor gamma (PPAR gamma). In conclusion, our results indicate that the anti-diabetic drug Liraglutide can exert a bone protective effect even in non-diabetic osteoporotic OVX rats. This protective effect is likely attributable to the impact of Liraglutide on the lineage fate determination of BMSCs.	[Lu, Nan; Sun, Hanxiao; Yu, JingJia; Wang, Xiaojing; Liu, Dongmei; Zhao, Lin; Sun, Lihao; Zhao, Hongyan; Tao, Bei; Liu, Jianmin] Shanghai Jiao Tong Univ, Shanghai Clin Ctr Endocrine & Metab Dis, Shanghai Inst Endocrine & Metab Dis, Rui Jin Hosp,Sch Med,Dept Endocrine & Metab Dis, Shanghai 200025, Peoples R China	Shanghai Jiao Tong University	Tao, B (corresponding author), Shanghai Jiao Tong Univ, Shanghai Clin Ctr Endocrine & Metab Dis, Shanghai Inst Endocrine & Metab Dis, Rui Jin Hosp,Sch Med,Dept Endocrine & Metab Dis, Shanghai 200025, Peoples R China.	catherine-tao@163.com; liujianmin@medmail.com.cn			National Nature Science Foundation of China [81370977, 81370018, 81170804]; Shanghai Municipal Health Bureau Project [2012-235]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Health Bureau Project	This work was supported by: National Nature Science Foundation of China No. 81370977 (JML); National Nature Science Foundation of China No. 81370018 (BT); National Nature Science Foundation of China No. 81170804 (HYZ); Shanghai Municipal Health Bureau Project 2012-235 (JML). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah BM, 2012, BONE, V50, P540, DOI 10.1016/j.bone.2011.06.030; Akune T, 2004, J CLIN INVEST, V113, P846, DOI 10.1172/JCI200419900; Aoyama E, 2014, INT J MOL MED, V34, P475, DOI 10.3892/ijmm.2014.1787; Astrup A, 2009, LANCET, V374, P1606, DOI 10.1016/S0140-6736(09)61375-1; Bollag RJ, 2000, ENDOCRINOLOGY, V141, P1228, DOI 10.1210/en.141.3.1228; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Campbell JE, 2013, CELL METAB, V17, P819, DOI 10.1016/j.cmet.2013.04.008; Dicembrini I, 2012, EXP DIABETES RES, DOI 10.1155/2012/519784; Dienelt A, 2011, STEM CELLS DEV, V20, P465, DOI 10.1089/scd.2010.0205; Drucker DJ, 2006, CELL METAB, V3, P153, DOI 10.1016/j.cmet.2006.01.004; Ellenbroek JH, 2013, DIABETOLOGIA, V56, P1980, DOI 10.1007/s00125-013-2957-2; Garber AJ, 2012, EXPERT OPIN INV DRUG, V21, P45, DOI 10.1517/13543784.2012.638282; Giuliani N, 2005, BLOOD, V106, P2472, DOI 10.1182/blood-2004-12-4986; Holscher C, 2012, CNS DRUGS, V26, P871, DOI 10.2165/11635890-000000000-00000; Jaiswal N, 1997, J CELL BIOCHEM, V64, P295, DOI 10.1002/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.0.CO;2-I; Kazakos K, 2011, DIABETES RES CLIN PR, V93, pS32, DOI 10.1016/S0168-8227(11)70011-0; Knudsen LB, 2010, ENDOCRINOLOGY, V151, P1473, DOI 10.1210/en.2009-1272; Ko CH, 2011, J AGR FOOD CHEM, V59, P9870, DOI 10.1021/jf202015t; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Larsen PJ, 2001, DIABETES, V50, P2530, DOI 10.2337/diabetes.50.11.2530; Ma X, 2013, J BONE MINER RES, V28, P1641, DOI 10.1002/jbmr.1898; Mabilleau G, 2013, J ENDOCRINOL, V219, P59, DOI 10.1530/JOE-13-0146; Mieczkowska A, 2015, OSTEOPOROSIS INT, V26, P209, DOI 10.1007/s00198-014-2845-8; Nauck MA, 2011, AM J MED, V124, pS19, DOI 10.1016/j.amjmed.2010.11.002; Nomiyama T, 2014, DIABETES, V63, P3891, DOI 10.2337/db13-1169; Nuche-Berenguer B, 2011, J ENDOCRINOL, V209, P203, DOI 10.1530/JOE-11-0015; Nuche-Berenguer B, 2010, J CELL PHYSIOL, V225, P585, DOI 10.1002/jcp.22243; Nuche-Berenguer B, 2010, REGUL PEPTIDES, V159, P61, DOI 10.1016/j.regpep.2009.06.010; Nuche-Berenguer B, 2009, CALCIFIED TISSUE INT, V84, P453, DOI 10.1007/s00223-009-9220-3; Pacheco-Pantoja Elda L., 2011, BMC Physiology, V11, P12, DOI 10.1186/1472-6793-11-12; Panjwani N, 2013, ENDOCRINOLOGY, V154, P127, DOI 10.1210/en.2012-1937; Papazafiropoulou A, 2014, CURR DIABETES REV, V10, P43, DOI 10.2174/1573399810666140217114848; Sanz C, 2010, AM J PHYSIOL-ENDOC M, V298, pE634, DOI 10.1152/ajpendo.00460.2009; Schwartz AV, 2012, DIABETES CARE, V35, P1525, DOI 10.2337/dc11-2184; Molinuevo MS, 2010, J BONE MINER RES, V25, P211, DOI 10.1359/jbmr.090732; Su B, 2015, ENDOCRINE, V48, P107, DOI 10.1007/s12020-014-0361-4; Taipaleenmaki H, 2011, EXP CELL RES, V317, P745, DOI 10.1016/j.yexcr.2010.12.015; Tang Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066263; Ussher JR, 2012, ENDOCR REV, V33, P187, DOI 10.1210/er.2011-1052; Wittrant Y, 2008, BONE, V42, P1122, DOI 10.1016/j.bone.2008.02.006; Wu JY, 2011, J CLIN INVEST, V121, P3492, DOI 10.1172/JCI46406; Yamada C, 2008, ENDOCRINOLOGY, V149, P574, DOI 10.1210/en.2007-1292	42	56	70	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132744	10.1371/journal.pone.0132744	http://dx.doi.org/10.1371/journal.pone.0132744			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177280	Green Published, gold, Green Submitted			2022-12-26	WOS:000358197600150
J	Nowak, DM; Gajecka, M				Nowak, Dorota M.; Gajecka, Marzena			Nonrandom Distribution of miRNAs Genes and Single Nucleotide Variants in Keratoconus Loci	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; CORNEAL ALDEHYDE DEHYDROGENASE; AUTOSOMAL-DOMINANT KERATOCONUS; VSX1 GENE; OXIDATIVE STRESS; CANDIDATE GENE; SEQUENCE VARIANTS; GROWTH-FACTOR; MUTATION; PROMOTER	Despite numerous studies, the causes of both development and progression of keratoconus remain elusive. Previous studies of this disorder focused mainly on one or two genetic factors only. However, in the analysis of such complex diseases all potential factors should be taken into consideration. The purpose of this study was a comprehensive analysis of known keratoconus loci to uncover genetic factors involved in this disease causation in the general population, which could be omitted in the original studies. In this investigation genomic data available in various databases and experimental own data were assessed. The lists of single nucleotide variants and miRNA genes localized in reported keratoconus loci were obtained from Ensembl and miRBase, respectively. The potential impact of nonsynonymous amino acid substitutions on protein structure and function was assessed with PolyPhen-2 and SIFT. For selected protein genes the ranking was made to choose those most promising for keratoconus development. Ranking results were based on topological features in the protein-protein interaction network. High specificity for the populations in which the causative sequence variants have been identified was found. In addition, the possibility of links between previously analyzed keratoconus loci was confirmed including miRNA-gene interactions. Identified number of genes associated with oxidative stress and inflammatory agents corroborated the hypothesis of their effect on the disease etiology. Distribution of the numerous sequences variants within both exons and mature miRNA which forces you to search for a broader look at the determinants of keratoconus. Our findings highlight the complexity of the keratoconus genetics.	[Nowak, Dorota M.; Gajecka, Marzena] Poznan Univ Med Sci, Dept Genet & Pharmaceut Microbiol, Poznan, Poland; [Nowak, Dorota M.; Gajecka, Marzena] Polish Acad Sci, Inst Human Genet, PL-60479 Poznan, Poland	Poznan University of Medical Sciences; Polish Academy of Sciences; Institute of Human Genetics of the Polish Academy of Sciences	Gajecka, M (corresponding author), Poznan Univ Med Sci, Dept Genet & Pharmaceut Microbiol, Poznan, Poland.	gamar@man.poznan.pl	Gajecka, Marzena/V-9706-2019	Gajecka, Marzena/0000-0001-7468-2604; Nowak-Malczewska, Dorota/0000-0002-3836-979X	Polish Ministry of Science and Higher Education [N N402 097837, N N402 591740]; National Science Centre in Poland [2011/03/N/NZ5/01470, 2012/05/E/NZ5/02127]	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); National Science Centre in Poland(National Science Centre, Poland)	This work was supported by the Polish Ministry of Science and Higher Education, grants no. N N402 097837 (DMN) and N N402 591740 (MG DMN) and National Science Centre in Poland, grants no. 2011/03/N/NZ5/01470 (DMN) and 2012/05/E/NZ5/02127 (MG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABEDINIA M, 1990, EXP EYE RES, V51, P419, DOI 10.1016/0014-4835(90)90154-M; Abu-Amero KK, 2014, MOL VIS, V20, P1203; Agrawal Vinay B, 2011, J Ophthalmic Vis Res, V6, P87; Al-Muammar AM, 2015, OPHTHALMIC GENET, V36, P373, DOI 10.3109/13816810.2014.889173; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Arnal E, 2011, INVEST OPHTH VIS SCI, V52, P8592, DOI 10.1167/iovs.11-7732; Atilano SR, 2005, INVEST OPHTH VIS SCI, V46, P1256, DOI 10.1167/iovs.04-1395; Bisceglia L, 2005, INVEST OPHTH VIS SCI, V46, P39, DOI 10.1167/iovs.04-0533; Brancati F, 2004, J MED GENET, V41, P188, DOI 10.1136/jmg.2003.012872; Brown KA, 2008, J CELL BIOCHEM, V105, P596, DOI 10.1002/jcb.21860; Buddi R, 2002, J HISTOCHEM CYTOCHEM, V50, P341, DOI 10.1177/002215540205000306; Burdon KP, 2008, HUM GENET, V124, P379, DOI 10.1007/s00439-008-0555-z; Burdon KP, 2011, INVEST OPHTH VIS SCI, V52, P8514, DOI 10.1167/iovs.11-8261; Bykhovskaya Y, 2012, INVEST OPHTH VIS SCI, V53, P4152, DOI 10.1167/iovs.11-9268; Chen J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-73; Chwa M, 2008, INVEST OPHTH VIS SCI, V49, P4361, DOI 10.1167/iovs.08-1969; Chwa M, 2006, INVEST OPHTH VIS SCI, V47, P1902, DOI 10.1167/iovs.05-0828; Czugala M, 2012, EUR J HUM GENET, V20, P389, DOI 10.1038/ejhg.2011.203; Engler C, 2011, AM J OPHTHALMOL, V151, P752, DOI 10.1016/j.ajo.2010.11.008; Eran P, 2008, OPHTHALMIC GENET, V29, P53, DOI 10.1080/13816810802008242; Flicek P, 2014, NUCLEIC ACIDS RES, V42, pD749, DOI 10.1093/nar/gkt1196; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Funnell C, 2006, CORNEA, V25, P1224, DOI 10.1097/01.ico.0000240092.20849.e3; Gajecka M, 2009, INVEST OPHTH VIS SCI, V50, P1531, DOI 10.1167/iovs.08-2173; Gao XY, 2013, INVEST OPHTH VIS SCI, V54, P2435, DOI 10.1167/iovs.13-11692; GASSET AR, 1978, AM J OPHTHALMOL, V85, P339, DOI 10.1016/S0002-9394(14)77725-6; GONDHOWIARDJO TD, 1993, CORNEA, V12, P146, DOI 10.1097/00003226-199303000-00010; GONDHOWIARDJO TD, 1993, CORNEA, V12, P310, DOI 10.1097/00003226-199307000-00006; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Guan T, 2012, GENE, V503, P137, DOI 10.1016/j.gene.2012.04.061; HARRISON RJ, 1989, BRIT J OPHTHALMOL, V73, P816, DOI 10.1136/bjo.73.10.816; Heon E, 2002, HUM MOL GENET, V11, P1029, DOI 10.1093/hmg/11.9.1029; Hirota T, 2012, NAT GENET, V44, P1222, DOI 10.1038/ng.2438; HOPPENREIJS VPT, 1993, INVEST OPHTH VIS SCI, V34, P637; Hughes AE, 2011, AM J HUM GENET, V89, P628, DOI 10.1016/j.ajhg.2011.09.014; Jacq PL, 1997, J FR OPHTALMOL, V20, P97; Jung K, 2011, J ALLERGY CLIN IMMUN, V127, P420, DOI 10.1016/j.jaci.2010.10.043; Karamichos D, 2014, SCI REP-UK, V4, DOI 10.1038/srep04608; Karolak JA, 2011, MOL VIS, V17, P827; Kenney M. Cristina, 2000, CLAO Journal, V26, P10; Kim SH, 2008, MOL VIS, V14, P2109; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Lee S, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1015; Li X, 2013, INVEST OPHTH VIS SCI, V54, P2696, DOI 10.1167/iovs.13-11601; Li XH, 2012, HUM MOL GENET, V21, P421, DOI 10.1093/hmg/ddr460; Liskova P, 2007, MOL VIS, V13, P1887; Lu Y, 2013, NAT GENET, V45, P155, DOI 10.1038/ng.2506; Maltseva I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069642; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Mikami T, 2013, MOL VIS, V19, P845; Mok JW, 2008, J HUM GENET, V53, P842, DOI 10.1007/s10038-008-0319-6; Mukhopadhyay A, 2006, INVEST OPHTH VIS SCI, V47, P3565, DOI 10.1167/iovs.06-0141; Nowak DM, 2013, INVEST OPHTH VIS SCI, V54, P2207, DOI 10.1167/iovs.13-11592; Nowak DM, 2011, MIDDLE EAST AFR J OP, V18, P2, DOI 10.4103/0974-9233.75876; Paliwal P, 2011, MOL VIS, V17, P481; Rabinowitz YS, 1998, SURV OPHTHALMOL, V42, P297, DOI 10.1016/S0039-6257(97)00119-7; RAHI A, 1977, BRIT J OPHTHALMOL, V61, P761, DOI 10.1136/bjo.61.12.761; Roy S, 2007, P NATL ACAD SCI USA, V104, P14472, DOI 10.1073/pnas.0706793104; Ryan D, 2006, MOL VIS, V12, P1175; Sabarinathan R, 2013, HUM MUTAT, V34, P546, DOI 10.1002/humu.22273; Saee-Rad S, 2011, MOL VIS, V17, P3128; Sahebjada S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084067; Stabuc-Silih M, 2010, CORNEA, V29, P172, DOI 10.1097/ICO.0b013e3181aebf7a; Stark MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009685; Szczesniak MW, 2011, MOL BIOL EVOL, V28, P33, DOI 10.1093/molbev/msq260; Tang YMG, 2008, CORNEA, V27, P189, DOI 10.1097/ICO.0b013e31815a50e7; Tremblay F, 2009, J BIOL CHEM, V284, P8136, DOI 10.1074/jbc.M809535200; Udar N, 2006, INVEST OPHTH VIS SCI, V47, P3345, DOI 10.1167/iovs.05-1500; WACHTMEISTER L, 1982, ACTA OPHTHALMOL, V60, P113; Wang XW, 2008, RNA, V14, P1012, DOI 10.1261/rna.965408; Wight TN, 2002, CURR OPIN CELL BIOL, V14, P617, DOI 10.1016/S0955-0674(02)00375-7	71	5	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132143	10.1371/journal.pone.0132143	http://dx.doi.org/10.1371/journal.pone.0132143			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176855	Green Published, Green Submitted, gold			2022-12-26	WOS:000358197600085
J	Park, SH; Park, S; Kim, DY; Pyo, A; Kimura, RH; Sathirachinda, A; Choy, HE; Min, JJ; Gambhir, SS; Hong, Y				Park, Seung-Hwan; Park, Sukho; Kim, Dong-Yeon; Pyo, Ayoung; Kimura, Richard H.; Sathirachinda, Ataya; Choy, Hyon E.; Min, Jung-Joon; Gambhir, Sanjiv Sam; Hong, Yeongjin			Isolation and Characterization of a Monobody with a Fibronectin Domain III Scaffold That Specifically Binds EphA2	PLOS ONE			English	Article							YEAST SURFACE DISPLAY; CANCER-CELLS; HIGH-AFFINITY; IN-VIVO; TYROSINE KINASE; RECEPTOR; ANTIBODY; PEPTIDE; INVASION; DELIVERY	Monobodies are binding scaffold proteins originating from a human fibronectin domain III (Fn3) scaffold that can be easily engineered with specificity and affinity. Human EphA2 (hEphA2) is an early detection marker protein for various tumors including lung, breast, and colon cancer. In this study, we isolated two hEphA2-specific monobodies (E1 and E10) by screening a yeast surface display library. They showed the same amino acid sequence except in the DE loop and had high affinity (similar to 2 nM Kd) against hEphA2. E1 bound only hEphA2 and mEphA2, although it bound hEphA2 with an affinity 2-fold higher than that of mEphA2. However, E10 also bound the mEphA6 and mEphA8 homologs as well as hEphA2 and mEphA2. Thus, E1 but not E10 was highly specific for hEphA2. E1 specifically bound human cells and xenograft tumor tissues expressing hEphA on the cell surface. In vivo optical imaging showed strong targeting of Cy5.5-labeled E1 to mouse tumor tissue induced by PC3 cells, a human prostate cancer cell line that expresses a high level of hEphA2. In conclusion, the highly specific monobody E1 is useful as a hEphA2 probe candidate for in vivo diagnosis and therapy.	[Park, Seung-Hwan; Kim, Dong-Yeon; Pyo, Ayoung; Min, Jung-Joon] Chonnam Natl Univ, Sch Med, Dept Nucl Med, Gwangju, South Korea; [Park, Sukho; Choy, Hyon E.; Hong, Yeongjin] Chonnam Natl Univ, Sch Med, Dept Microbiol, Gwangju, South Korea; [Kimura, Richard H.; Sathirachinda, Ataya; Gambhir, Sanjiv Sam] Stanford Univ, Dept Radiol, Mol Imaging Program Stanford, BioX Program, Palo Alto, CA 94304 USA	Chonnam National University; Chonnam National University; Stanford University	Hong, Y (corresponding author), Chonnam Natl Univ, Sch Med, Dept Microbiol, 5,Hak 1 Dong, Gwangju, South Korea.	yjhong@chonnam.ac.kr		Park, Seung-Hwan/0000-0003-4613-4680	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2014R1A6A3A04057492]; Chonnam National University Hwasun Hospital Institute for Biomedical Science [HCRI14006-1]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education; Chonnam National University Hwasun Hospital Institute for Biomedical Science	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF-2014R1A6A3A04057492). Y. H was supported by a grant (HCRI14006-1) from Chonnam National University Hwasun Hospital Institute for Biomedical Science.	Blackburn WH, 2009, BIOCONJUGATE CHEM, V20, P960, DOI 10.1021/bc800547c; Bloom L, 2009, DRUG DISCOV TODAY, V14, P949, DOI 10.1016/j.drudis.2009.06.007; Bruckheimer EM, 2009, NEOPLASIA, V11, P509, DOI 10.1593/neo.81578; Cai WB, 2007, EUR J NUCL MED MOL I, V34, P2024, DOI 10.1007/s00259-007-0503-5; Chao G, 2006, NAT PROTOC, V1, P755, DOI 10.1038/nprot.2006.94; Cheng N, 2002, MOL CANCER RES, V1, P2; Coffman KT, 2003, CANCER RES, V63, P7907; Dickerson EB, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-10; DICKINSON CD, 1994, J MOL BIOL, V236, P1079, DOI 10.1016/0022-2836(94)90013-2; Faoro L, 2010, J BIOL CHEM, V285, P18575, DOI 10.1074/jbc.M109.075085; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Gebauer M, 2009, CURR OPIN CHEM BIOL, V13, P245, DOI 10.1016/j.cbpa.2009.04.627; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Gobin AM, 2008, INT J NANOMED, V3, P351; Hackel BJ, 2008, J MOL BIOL, V381, P1238, DOI 10.1016/j.jmb.2008.06.051; Hackel BJ, 2012, RADIOLOGY, V263, P179, DOI 10.1148/radiol.12111504; Hackel BJ, 2010, J MOL BIOL, V401, P84, DOI 10.1016/j.jmb.2010.06.004; Hackel BJ, 2010, PROTEIN ENG DES SEL, V23, P211, DOI 10.1093/protein/gzp083; Hafner C, 2004, CLIN CHEM, V50, P490, DOI 10.1373/clinchem.2003.026849; Hammond SA, 2007, CANCER RES, V67, P3927, DOI 10.1158/0008-5472.CAN-06-2760; Herath NI, 2010, INT J CANCER, V126, P2003, DOI 10.1002/ijc.25147; Jackson D, 2008, CANCER RES, V68, P9367, DOI 10.1158/0008-5472.CAN-08-1933; Jiang SN, 2013, MOL THER, V21, P1985, DOI 10.1038/mt.2013.183; Johansson Staffan, 1997, Frontiers in Bioscience (online), V2, pD126; Kinch MS, 2003, CLIN EXP METASTAS, V20, P59, DOI 10.1023/A:1022546620495; Koolpe M, 2002, J BIOL CHEM, V277, P46974, DOI 10.1074/jbc.M208495200; Landen CN, 2006, J NATL CANCER I, V98, P1558, DOI 10.1093/jnci/djj414; Lee JW, 2009, JNCI-J NATL CANCER I, V101, P1193, DOI 10.1093/jnci/djp231; Lipovsek D, 2011, PROTEIN ENG DES SEL, V24, P3, DOI 10.1093/protein/gzq097; Lipovsek D, 2007, J MOL BIOL, V368, P1024, DOI 10.1016/j.jmb.2007.02.029; Liu Y, 2014, NUCL MED BIOL, V41, P450, DOI 10.1016/j.nucmedbio.2014.03.020; MAIN AL, 1992, CELL, V71, P671, DOI 10.1016/0092-8674(92)90600-H; Mitra S, 2010, BIOCHEMISTRY-US, V49, P6687, DOI 10.1021/bi1006223; Mosch B, 2010, J ONCOL, V2010, DOI 10.1155/2010/135285; Noblitt LW, 2004, CANCER GENE THER, V11, P757, DOI 10.1038/sj.cgt.7700761; Ogawa K, 2000, ONCOGENE, V19, P6043, DOI 10.1038/sj.onc.1204004; Parri M, 2009, CANCER RES, V69, P2072, DOI 10.1158/0008-5472.CAN-08-1845; Pasquale EB, 2010, NAT REV CANCER, V10, P165, DOI 10.1038/nrc2806; Ponsel D, 2011, MOLECULES, V16, P3675, DOI 10.3390/molecules16053675; Scarberry KE, 2008, J AM CHEM SOC, V130, P10258, DOI 10.1021/ja801969b; Scarberry KE, 2010, NANOMED-NANOTECHNOL, V6, P399, DOI 10.1016/j.nano.2009.11.003; Taddei ML, 2009, AM J PATHOL, V174, P1492, DOI 10.2353/ajpath.2009.080473; Thomas SM, 2004, CANCER TREAT REV, V30, P255, DOI 10.1016/j.ctrv.2003.10.003; Wesa AK, 2008, J IMMUNOL, V181, P7721, DOI 10.4049/jimmunol.181.11.7721; Wykosky J, 2007, MOL CANCER THER, V6, P3208, DOI 10.1158/1535-7163.MCT-07-0200	45	20	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132976	10.1371/journal.pone.0132976	http://dx.doi.org/10.1371/journal.pone.0132976			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177208	Green Published, Green Submitted, gold			2022-12-26	WOS:000358197600194
J	Pham, CQ; Bremen, P; Shen, WD; Yang, SM; Middlebrooks, JC; Zeng, FG; Mc Laughlin, M				Pham, Carol Q.; Bremen, Peter; Shen, Weidong; Yang, Shi-Ming; Middlebrooks, John C.; Zeng, Fan-Gang; Mc Laughlin, Myles			Central Auditory Processing of Temporal and Spectral-Variance Cues in Cochlear Implant Listeners	PLOS ONE			English	Article							SPATIAL TUNING CURVES; INFORMATIONAL MASKING; MULTICOMPONENT MASKERS; FREQUENCY-SELECTIVITY; STREAM SEGREGATION; SPEECH RECOGNITION; USERS; NERVE; NOISE; RESOLUTION	Cochlear implant (CI) listeners have difficulty understanding speech in complex listening environments. This deficit is thought to be largely due to peripheral encoding problems arising from current spread, which results in wide peripheral filters. In normal hearing (NH) listeners, central processing contributes to segregation of speech from competing sounds. We tested the hypothesis that basic central processing abilities are retained in post-lingually deaf CI listeners, but processing is hampered by degraded input from the periphery. In eight CI listeners, we measured auditory nerve compound action potentials to characterize peripheral filters. Then, we measured psychophysical detection thresholds in the presence of multi-electrode maskers placed either inside (peripheral masking) or outside (central masking) the peripheral filter. This was intended to distinguish peripheral from central contributions to signal detection. Introduction of temporal asynchrony between the signal and masker improved signal detection in both peripheral and central masking conditions for all CI listeners. Randomly varying components of the masker created spectral-variance cues, which seemed to benefit only two out of eight CI listeners. Contrastingly, the spectral-variance cues improved signal detection in all five NH listeners who listened to our CI simulation. Together these results indicate that widened peripheral filters significantly hamper central processing of spectral-variance cues but not of temporal cues in post-lingually deaf CI listeners. As indicated by two CI listeners in our study, however, post-lingually deaf CI listeners may retain some central processing abilities similar to NH listeners.	[Pham, Carol Q.; Bremen, Peter; Middlebrooks, John C.; Zeng, Fan-Gang; Mc Laughlin, Myles] Univ Calif Irvine, Ctr Hearing Res, Irvine, CA 92697 USA; [Pham, Carol Q.; Zeng, Fan-Gang] Univ Calif Irvine, Dept Anat & Neurobiol, Irvine, CA 92717 USA; [Bremen, Peter; Middlebrooks, John C.; Zeng, Fan-Gang; Mc Laughlin, Myles] Univ Calif Irvine, Dept Otolaryngol Head & Neck Surg, Irvine, CA USA; [Shen, Weidong; Yang, Shi-Ming] Chinese PLA Genera Hosp, Inst Otolaryngol, Beijing, Peoples R China; [Middlebrooks, John C.] Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA USA; [Middlebrooks, John C.; Zeng, Fan-Gang] Univ Calif Irvine, Dept Biomed Engn, Irvine, CA USA; [Middlebrooks, John C.; Zeng, Fan-Gang] Univ Calif Irvine, Dept Cognit Sci, Irvine, CA 92717 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Pham, CQ (corresponding author), Univ Calif Irvine, Ctr Hearing Res, Irvine, CA 92697 USA.	carol.pham@uci.edu	Mc Laughlin, Myles/G-3497-2015	Mc Laughlin, Myles/0000-0001-8574-1841; Bremen, Peter/0000-0003-1709-6224; Pham, Carol/0000-0002-3968-0600	National Institutes of Health [RO1-DC000420, RO1-DC008858, P30-DC008369, T32-DC010775, UL1 TR000153]; European Union; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000153, TL1TR001415] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC000420, P30DC008369, T32DC010775, R01DC008858] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Union(European Commission); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	The authors express gratitude toward all of the listeners for their dedication to the study. The authors would also like to thank Dr. Thomas Lu for technical assistance and Dr. Ginger Stickney for facilitating subject recruitment. This work was supported by grants from the National Institutes of Health: RO1-DC000420, RO1-DC008858, P30-DC008369, T32-DC010775, UL1 TR000153, and by a European Union FP7 Marie Curie Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas PJ, 1999, EAR HEARING, V20, P45, DOI 10.1097/00003446-199902000-00005; Abbas PJ, 2004, COCHLEAR IMPLANTS AU, P187; Bernstein JGW, 2006, J ACOUST SOC AM, V120, P3929, DOI 10.1121/1.2372452; Bizley JK, 2013, NAT REV NEUROSCI, V14, P693, DOI 10.1038/nrn3565; Bregman A.S., 1990, AUDITORY SCENE ANAL; Bremen P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059815; BROWN CJ, 1990, J ACOUST SOC AM, V88, P1385, DOI 10.1121/1.399716; Chatterjee M, 2006, HEARING RES, V222, P100, DOI 10.1016/j.heares.2006.09.001; Choi I, 2014, HEARING RES, V314, P10, DOI 10.1016/j.heares.2014.04.008; Dorman MF, 1998, J ACOUST SOC AM, V104, P3583, DOI 10.1121/1.423940; Durlach NI, 2003, J ACOUST SOC AM, V113, P2984, DOI 10.1121/1.1570435; Evans AJ, 2009, J BIOMED MATER RES A, V91A, P241, DOI 10.1002/jbm.a.32228; Friesen LM, 2001, J ACOUST SOC AM, V110, P1150, DOI 10.1121/1.1381538; Fu QJ, 2005, JARO-J ASSOC RES OTO, V6, P19, DOI 10.1007/s10162-004-5024-3; HARTMANN R, 1984, HEARING RES, V13, P47, DOI 10.1016/0378-5955(84)90094-7; Hartmann R., 1990, COCHLEAR IMPLANTS MO, P135; Hong RS, 2009, J ACOUST SOC AM, V126, P291, DOI 10.1121/1.3140592; Javel E., 1990, COCHLEAR IMPLANTS MO, P247, DOI [10.1007/978-1-4612-3256-8_17, DOI 10.1007/978-1-4612-3256-8_17]; Joris PX, 2011, P NATL ACAD SCI USA, V108, P17516, DOI 10.1073/pnas.1105867108; KIDD G, 1995, J ACOUST SOC AM, V97, P3782, DOI 10.1121/1.413107; KIDD G, 1994, J ACOUST SOC AM, V95, P3475, DOI 10.1121/1.410023; Kidd Gerald Jr., 2008, V29, P143; Kral A, 1998, HEARING RES, V121, P11, DOI 10.1016/S0378-5955(98)00061-6; Kral A, 2012, TRENDS NEUROSCI, V35, P111, DOI 10.1016/j.tins.2011.09.004; Lai WK, 2000, AUDIOL NEURO-OTOL, V5, P333, DOI 10.1159/000013899; Leake PA, 2011, J COMP NEUROL, V519, P1526, DOI 10.1002/cne.22582; LEVITT H, 1971, J ACOUST SOC AM, V49, P467, DOI 10.1121/1.1912375; Loizou PC, 2000, EAR HEARING, V21, P25, DOI 10.1097/00003446-200002000-00006; Middlebrooks JC, 2007, JARO-J ASSOC RES OTO, V8, P258, DOI 10.1007/s10162-007-0070-2; MOORE B C J, 1985, British Journal of Audiology, V19, P189; NEFF DL, 1988, J ACOUST SOC AM, V83, P1833, DOI 10.1121/1.396518; NEFF DL, 1987, PERCEPT PSYCHOPHYS, V41, P409, DOI 10.3758/BF03203033; NEFF DL, 1993, J ACOUST SOC AM, V94, P3112, DOI 10.1121/1.407217; Nelson DA, 1996, J ACOUST SOC AM, V100, P2393, DOI 10.1121/1.417949; Nelson DA, 2008, J ACOUST SOC AM, V123, P1522, DOI 10.1121/1.2836786; Nelson DA, 2011, J ACOUST SOC AM, V129, P3916, DOI 10.1121/1.3583503; Nourski KV, 2013, JARO-J ASSOC RES OTO, V14, P435, DOI 10.1007/s10162-013-0382-3; Shera CA, 2002, P NATL ACAD SCI USA, V99, P3318, DOI 10.1073/pnas.032675099; Stickney GS, 2004, J ACOUST SOC AM, V116, P1081, DOI 10.1121/1.1772399; Stickney GS, 2004, INT CONGR SER, V1273, P23, DOI 10.1016/j.ics.2004.09.017; Unoki M, 2006, J ACOUST SOC AM, V120, P1474, DOI 10.1121/1.2228539; VANDENHONERT C, 1984, HEARING RES, V14, P225, DOI 10.1016/0378-5955(84)90052-2; VANDENHONERT C, 1987, HEARING RES, V29, P207, DOI 10.1016/0378-5955(87)90168-7; Won JH, 2007, JARO-J ASSOC RES OTO, V8, P384, DOI 10.1007/s10162-007-0085-8; WYGONSKI J, 2002, HEI NUCL RES INTERFA	45	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132423	10.1371/journal.pone.0132423	http://dx.doi.org/10.1371/journal.pone.0132423			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176553	Green Published, gold			2022-12-26	WOS:000358197600111
J	Riordan, DP; Varma, S; West, RB; Brown, PO				Riordan, Daniel P.; Varma, Sushama; West, Robert B.; Brown, Patrick O.			Automated Analysis and Classification of Histological Tissue Features by Multi-Dimensional Microscopic Molecular Profiling	PLOS ONE			English	Article							CELL; CYTOMETRY; PLATFORM; TOOL	Characterization of the molecular attributes and spatial arrangements of cells and features within complex human tissues provides a critical basis for understanding processes involved in development and disease. Moreover, the ability to automate steps in the analysis and interpretation of histological images that currently require manual inspection by pathologists could revolutionize medical diagnostics. Toward this end, we developed a new imaging approach called multidimensional microscopic molecular profiling (MMMP) that can measure several independent molecular properties in situ at subcellular resolution for the same tissue specimen. MMMP involves repeated cycles of antibody or histochemical staining, imaging, and signal removal, which ultimately can generate information analogous to a multidimensional flow cytometry analysis on intact tissue sections. We performed a MMMP analysis on a tissue microarray containing a diverse set of 102 human tissues using a panel of 15 informative antibody and 5 histochemical stains plus DAPI. Large-scale unsupervised analysis of MMMP data, and visualization of the resulting classifications, identified molecular profiles that were associated with functional tissue features. We then directly annotated H&E images from this MMMP series such that canonical histological features of interest (e.g. blood vessels, epithelium, red blood cells) were individually labeled. By integrating image annotation data, we identified molecular signatures that were associated with specific histological annotations and we developed statistical models for automatically classifying these features. The classification accuracy for automated histology labeling was objectively evaluated using a cross-validation strategy, and significant accuracy (with a median per-pixel rate of 77% per feature from 15 annotated samples) for de novo feature prediction was obtained. These results suggest that high-dimensional profiling may advance the development of computer-based systems for automatically parsing relevant histological and cellular features from molecular imaging data of arbitrary human tissue samples, and can provide a framework and resource to spur the optimization of these technologies.	[Riordan, Daniel P.; Brown, Patrick O.] Stanford Univ, Dept Biochem, Sch Med, Stanford, CA 94305 USA; [Riordan, Daniel P.; Brown, Patrick O.] Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA; [Varma, Sushama; West, Robert B.] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA	Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University	Riordan, DP (corresponding author), Stanford Univ, Dept Biochem, Sch Med, Stanford, CA 94305 USA.	driordan@stanford.edu		West, Robert/0000-0002-8330-8283	National Heart, Lung, and Blood Institute (NHLBI) Progenitor Cell Biology Consortium Grant [U01HL099995]; Howard Hughes Medical Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL099995] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute (NHLBI) Progenitor Cell Biology Consortium Grant; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Heart, Lung, and Blood Institute (NHLBI) U01HL099995 Progenitor Cell Biology Consortium Grant (POB, DPR, SV, RBW) and by the Howard Hughes Medical Institute (POB and DPR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Angelo M, 2014, NAT MED, V20, P436, DOI 10.1038/nm.3488; Arganda-Carreras I, 2006, LECT NOTES COMPUT SC, V4241, P85; Autissier P, 2010, CYTOM PART A, V77A, P410, DOI 10.1002/cyto.a.20859; Bendall SC, 2011, SCIENCE, V332, P687, DOI 10.1126/science.1198704; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Chung K, 2013, NATURE, V497, P332, DOI 10.1038/nature12107; Ferte C, 2010, NAT REV CLIN ONCOL, V7, P367, DOI 10.1038/nrclinonc.2010.84; Friedenberger M, 2007, NAT PROTOC, V2, P2285, DOI 10.1038/nprot.2007.320; Gerdes MJ, 2013, P NATL ACAD SCI USA, V110, P11982, DOI 10.1073/pnas.1300136110; Giesen C, 2014, NAT METHODS, V11, P417, DOI [10.1038/NMETH.2869, 10.1038/nmeth.2869]; Gurcan Metin N, 2009, IEEE Rev Biomed Eng, V2, P147, DOI 10.1109/RBME.2009.2034865; Kolling J, 2012, BIOINFORMATICS, V28, P1143, DOI 10.1093/bioinformatics/bts104; Kovacheva VN, 2014, BIOINFORMATICS, V30, P420, DOI 10.1093/bioinformatics/btt676; Lassmann S, 2012, HISTOL HISTOPATHOL, V27, P289, DOI 10.14670/HH-27.289; Marinelli RJ, 2008, NUCLEIC ACIDS RES, V36, pD871, DOI 10.1093/nar/gkm861; Micheva KD, 2007, NEURON, V55, P25, DOI 10.1016/j.neuron.2007.06.014; Preibisch S, 2009, BIOINFORMATICS, V25, P1463, DOI 10.1093/bioinformatics/btp184; Qiu P, 2011, NAT BIOTECHNOL, V29, P886, DOI 10.1038/nbt.1991; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schubert W, 2006, NAT BIOTECHNOL, V24, P1270, DOI 10.1038/nbt1250; Tsurui H, 2000, J HISTOCHEM CYTOCHEM, V48, P653, DOI 10.1177/002215540004800509; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; West RB, 2006, HISTOPATHOLOGY, V48, P22, DOI 10.1111/j.1365-2559.2005.02286.x; Zrazhevskiy P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2635	25	17	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0128975	10.1371/journal.pone.0128975	http://dx.doi.org/10.1371/journal.pone.0128975			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176839	Green Published, Green Submitted, gold			2022-12-26	WOS:000358197600010
J	Sehgal, D; Vikram, P; Sansaloni, CP; Ortiz, C; St Pierre, C; Payne, T; Ellis, M; Amri, A; Petroli, CD; Wenzl, P; Singh, S				Sehgal, Deepmala; Vikram, Prashant; Paola Sansaloni, Carolina; Ortiz, Cynthia; St Pierre, Carolina; Payne, Thomas; Ellis, Marc; Amri, Ahmed; Daniel Petroli, Cesar; Wenzl, Peter; Singh, Sukhwinder			Exploring and Mobilizing the Gene Bank Biodiversity for Wheat Improvement	PLOS ONE			English	Article							BREAD WHEAT; HEXAPLOID WHEAT; MOLECULAR DIVERSITY; TEMPORAL TRENDS; GERMPLASM; BARLEY; POLYMORPHISM; RESOURCES; LANDRACES; CULTIVARS	Identifying and mobilizing useful genetic variation from germplasm banks to breeding programs is an important strategy for sustaining crop genetic improvement. The molecular diversity of 1,423 spring bread wheat accessions representing major global production environments was investigated using high quality genotyping-by-sequencing (GBS) loci, and gene-based markers for various adaptive and quality traits. Mean diversity index (DI) estimates revealed synthetic hexaploids to be genetically more diverse (DI = 0.284) than elites (DI = 0.267) and landraces (DI = 0.245). GBS markers discovered thousands of new SNP variations in the landraces which were well known to be adapted to drought (1273 novel GBS SNPs) and heat (4473 novel GBS SNPs) stress environments. This may open new avenues for pre-breeding by enriching the elite germplasm with novel alleles for drought and heat tolerance. Furthermore, new allelic variation for vernalization and glutenin genes was also identified from 47 landraces originating from Iraq, Iran, India, Afghanistan, Pakistan, Uzbekistan and Turkmenistan. The information generated in the study has been utilized to select 200 diverse gene bank accessions to harness their potential in pre-breeding and for allele mining of candidate genes for drought and heat stress tolerance, thus channeling novel variation into breeding pipelines. This research is part of CIMMYT's ongoing 'Seeds of Discovery' project visioning towards the development of high yielding wheat varieties that address future challenges from climate change.	[Sehgal, Deepmala; Vikram, Prashant; Paola Sansaloni, Carolina; Ortiz, Cynthia; St Pierre, Carolina; Payne, Thomas; Ellis, Marc; Daniel Petroli, Cesar; Singh, Sukhwinder] Int Maize & Wheat Improvement Ctr CIMMYT, Texcoco 56130, Edo De Mexico, Mexico; [Amri, Ahmed] Int Ctr Agr Res Dry Areas, Beirut 11082010, Lebanon; [Wenzl, Peter] Global Crop Div Trust, DivSeek, D-53113 Bonn, Germany	CGIAR; International Maize & Wheat Improvement Center (CIMMYT); CGIAR; International Center for Agricultural Research in the Dry Areas (ICARDA)	Singh, S (corresponding author), Int Maize & Wheat Improvement Ctr CIMMYT, Km 45 Carretera Mexico Veracruz, Texcoco 56130, Edo De Mexico, Mexico.	suk.singh@cgiar.org		Vikram, Prashant/0000-0002-3740-6608; Saint Pierre, Carolina/0000-0003-1291-7468	SAGARPA (Mexican Government agency), CIMMYT project [R0153]	SAGARPA (Mexican Government agency), CIMMYT project	Seeds of Discovery was funded by SAGARPA (Mexican Government agency), http://www.sagarpa.gob.mx/Paginas/default.aspx, CIMMYT project # R0153.	[Anonymous], 2013, CROP BREEDING J; [Anonymous], 1997, MOL BIOL BIOTECHNOLO; [Anonymous], 2002, BREAD WHEAT IMPROVEM; Bass C, 2006, GENOME, V49, P1140, DOI 10.1139/G06-064; Brisson N, 2010, FIELD CROP RES, V119, P201, DOI 10.1016/j.fcr.2010.07.012; Cavanagh CR, 2013, P NATL ACAD SCI USA, V110, P8057, DOI 10.1073/pnas.1217133110; Chao SM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-727; Chao SM, 2009, MOL BREEDING, V23, P23, DOI 10.1007/s11032-008-9210-6; Chen F, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-199; Chen XJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044510; Christiansen MJ, 2002, MOL BREEDING, V9, P1, DOI 10.1023/A:1019234323372; Donini P, 2000, THEOR APPL GENET, V100, P912, DOI 10.1007/s001220051370; Dreisigacker S, 2008, AUST J AGR RES, V59, P413, DOI 10.1071/AR07225; Dreisigacker S, 2012, MOL BREEDING, V29, P529, DOI 10.1007/s11032-011-9569-7; El Bouhssini M, 2011, PLANT BREEDING, V130, P96, DOI 10.1111/j.1439-0523.2010.01814.x; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; FAO repository, 2009, GLOB AGR 2050 ROM FA; Fu DL, 2005, MOL GENET GENOMICS, V273, P54, DOI 10.1007/s00438-004-1095-4; Fu YB, 2011, PLANT GENOME-US, V4, P226, DOI 10.3835/plantgenome2011.08.0022; Graybosch RA, 2010, CROP SCI, V50, P1882, DOI 10.2135/cropsci2009.11.0685; Heslot N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074612; Hoisington D, 1999, P NATL ACAD SCI USA, V96, P5937, DOI 10.1073/pnas.96.11.5937; HOISINGTON D, 1994, LAB PROTOCOLS CIMMYT; Huang XQ, 2002, THEOR APPL GENET, V105, P699, DOI 10.1007/s00122-002-0959-4; Huang XH, 2009, GENOME RES, V19, P1068, DOI 10.1101/gr.089516.108; Ito M, 2011, BREEDING SCI, V61, P281, DOI 10.1270/jsbbs.61.281; Keilwagen J, 2014, SCI REP-UK, V4, DOI 10.1038/srep05231; Kihara H., 1983, P 6 INT WHEAT GEN S; Kilian B, 2012, BRIEF FUNCT GENOMICS, V11, P38, DOI 10.1093/bfgp/elr046; Koebner RMD, 2003, THEOR APPL GENET, V106, P550, DOI 10.1007/s00122-002-1065-3; Liu L, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-124; Lu H, 2001, THEOR APPL GENET, V103, P613, DOI 10.1007/PL00002917; Manickavelu A, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0320-5; Manifesto MM, 2001, CROP SCI, V41, P682, DOI 10.2135/cropsci2001.413682x; Martin JM, 2001, CROP SCI, V41, P228, DOI 10.2135/cropsci2001.411228x; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Nielsen NH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094000; Osborn TC, 2003, TRENDS GENET, V19, P141, DOI 10.1016/S0168-9525(03)00015-5; Perrier X., 2006, DARWIN SOFTWARE; Poland J, 2012, PLANT GENOME-US, V5, P103, DOI 10.3835/plantgenome2012.06.0006; Rajaram S., 2001, WORLD WHEAT BOOK HIS, P579; Ray DK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066428; Reif JC, 2005, THEOR APPL GENET, V110, P859, DOI 10.1007/s00122-004-1881-8; Roussel V, 2005, THEOR APPL GENET, V111, P162, DOI 10.1007/s00122-005-2014-8; Roussel V, 2004, THEOR APPL GENET, V108, P920, DOI 10.1007/s00122-003-1502-y; Russell JR, 2000, MOL BREEDING, V6, P553, DOI 10.1023/A:1011372312962; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Singh S, 2014, PLANT AN GEN C SAN D, P207; Smale M, 2002, CROP SCI, V42, P1766, DOI 10.2135/cropsci2002.1766; Solh M, 2014, WEATHER CLIM EXTREME, V3, P62, DOI 10.1016/j.wace.2014.03.003; Somers DJ, 2003, GENOME, V46, P431, DOI 10.1139/G03-027; Sultan B, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/1/014040; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Trethowan RM, 2008, CROP SCI, V48, P1255, DOI 10.2135/cropsci2007.08.0477; van Ginkel M, 2007, FIELD CROP RES, V104, P86, DOI 10.1016/j.fcr.2007.02.005; Wang SC, 2014, PLANT BIOTECHNOL J, V12, P787, DOI 10.1111/pbi.12183; Warburton ML, 2006, EUPHYTICA, V149, P289, DOI 10.1007/s10681-005-9077-0; Yan LL, 2004, SCIENCE, V303, P1640, DOI 10.1126/science.1094305; Zhang LY, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-42; Zhang PZ, 2005, MOL BREEDING, V15, P1, DOI 10.1007/s11032-004-1167-5	60	65	65	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132112	10.1371/journal.pone.0132112	http://dx.doi.org/10.1371/journal.pone.0132112			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176697	Green Submitted, Green Published, gold			2022-12-26	WOS:000358197600083
J	Silva, RC; Dautel, M; Di Genova, BM; Amberg, DC; Castilho, BA; Sattlegger, E				Silva, Richard C.; Dautel, Martina; Di Genova, Bruno M.; Amberg, David C.; Castilho, Beatriz A.; Sattlegger, Evelyn			The Gcn2 Regulator Yih1 Interacts with the Cyclin Dependent Kinase Cdc28 and Promotes Cell Cycle Progression through G2/M in Budding Yeast	PLOS ONE			English	Article							INITIATION-FACTOR 2-ALPHA; AMINO-ACID CONTROL; RIBOSOME ENTRY SITE; PROTEIN-KINASE; SACCHAROMYCES-CEREVISIAE; GLOBAL ANALYSIS; INCREASED PHOSPHORYLATION; TRANSLATIONAL REGULATION; INTRINSIC DISORDER; BINDING-PROTEIN	The Saccharomyces cerevisiae protein Yih1, when overexpressed, inhibits the eIF2 alpha kinase Gcn2 by competing for Gcn1 binding. However, deletion of YIH1 has no detectable effect on Gcn2 activity, suggesting that Yih1 is not a general inhibitor of Gcn2, and has no phenotypic defect identified so far. Thus, its physiological role is largely unknown. Here, we show that Yih1 is involved in the cell cycle. Yeast lacking Yih1 displays morphological patterns and DNA content indicative of a delay in the G2/M phases of the cell cycle, and this phenotype is independent of Gcn1 and Gcn2. Accordingly, the levels of phosphorylated eIF2a, which show a cell cycle-dependent fluctuation, are not altered in cells devoid of Yih1. We present several lines of evidence indicating that Yih1 is in a complex with Cdc28. Yih1 pulls down endogenous Cdc28 in vivo and this interaction is enhanced when Cdc28 is active, suggesting that Yih1 modulates the function of Cdc28 in specific stages of the cell cycle. We also demonstrate, by Bimolecular Fluorescence Complementation, that endogenous Yih1 and Cdc28 interact with each other, confirming Yih1 as a bona fide Cdc28 binding partner. Amino acid substitutions within helix H2 of the RWD domain of Yih1 enhance Yih1- Cdc28 association. Overexpression of this mutant, but not of wild type Yih1, leads to a phenotype similar to that of YIH1 deletion, supporting the view that Yih1 is involved through Cdc28 in the regulation of the cell cycle. We further show that IMPACT, the mammalian homologue of Yih1, interacts with CDK1, the mammalian counterpart of Cdc28, indicating that the involvement with the cell cycle is conserved. Together, these data provide insights into the cellular function of Yih1/IMPACT, and provide the basis for future studies on the role of this protein in the cell cycle.	[Silva, Richard C.; Di Genova, Bruno M.; Castilho, Beatriz A.] Univ Fed Sao Paulo, Dept Microbiol Immunol & Parasitol, Escola Paulista Med, Sao Paulo, Brazil; [Dautel, Martina; Sattlegger, Evelyn] Massey Univ, Inst Nat & Math Sci, Auckland, New Zealand; [Amberg, David C.] SUNY Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA	Universidade Federal de Sao Paulo (UNIFESP); Massey University; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Castilho, BA (corresponding author), Univ Fed Sao Paulo, Dept Microbiol Immunol & Parasitol, Escola Paulista Med, Sao Paulo, Brazil.	bacastilho@unifesp.br; e.sattlegger@massey.ac.nz	Castilho, Beatriz A/C-2503-2012	Castilho, Beatriz A/0000-0003-4509-5237; Silva, Richard/0000-0003-2767-2053	Fundacao da Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [09/52047-5]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [478903/2012-0, 309860/2011-3]; Health Research Council of New Zealand Emerging Researcher grant [06/410]; Auckland Medical Research Foundation; Maurice AMP; Phyllis Paykel Trust; National Institutes of Health [GM-56189]; CNPq [153660/2010-4]; CAPES-PSDE fellowship (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)) [1915-13-4]; Massey University; Institute of Natural and Mathematical Sciences; FAPESP; Massey University Research Fund	Fundacao da Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Health Research Council of New Zealand Emerging Researcher grant; Auckland Medical Research Foundation; Maurice AMP; Phyllis Paykel Trust; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES-PSDE fellowship (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Massey University; Institute of Natural and Mathematical Sciences; FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Massey University Research Fund	This work was supported by grants 09/52047-5 (Fundacao da Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), http://www.fapesp.br/), 478903/2012-0 and and 309860/2011-3 (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), http://www.cnpq.br/) to B.A.C., Health Research Council of New Zealand Emerging Researcher grant (06/410, http://www.hrc.govt.nz/), Auckland Medical Research Foundation (http://www.medicalresearch.org.nz/), Maurice & Phyllis Paykel Trust (http://www.paykeltrust.co.nz/), and Massey University Research Fund (http://www.massey.ac.nz) to E.S. and by grant GM-56189 (National Institutes of Health, http://www.nih.gov/) awarded to D.A.R.C.S. was a recipient of a CNPq doctoral fellowship (153660/2010-4) and a CAPES-PSDE fellowship (1915-13-4, Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), http://www.capes.gov.br/). M.D was supported in part by the Massey University doctoral scholarship and the Institute of Natural and Mathematical Sciences. B.M.D.G received a doctoral fellowship from FAPESP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberghina L, 2004, J CELL BIOL, V167, P433, DOI 10.1083/jcb.200405102; AMBERG DC, 1995, NAT STRUCT BIOL, V2, P28, DOI 10.1038/nsb0195-28; AMON A, 1994, CELL, V77, P1037, DOI 10.1016/0092-8674(94)90443-X; Bittencourt S, 2008, J COMP NEUROL, V507, P1811, DOI 10.1002/cne.21652; Bloom J, 2007, NAT REV MOL CELL BIO, V8, P149, DOI 10.1038/nrm2105; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cambiaghi TD, 2014, BIOCHEM BIOPH RES CO, V443, P592, DOI 10.1016/j.bbrc.2013.12.021; Castilho BA, 2014, BBA-MOL CELL RES, V1843, P1948, DOI 10.1016/j.bbamcr.2014.04.006; Chymkowitch P, 2012, P NATL ACAD SCI USA, V109, P10450, DOI 10.1073/pnas.1200067109; Costa-Mattioli M, 2005, NATURE, V436, P1166, DOI 10.1038/nature03897; Datta B, 1999, EXP CELL RES, V250, P223, DOI 10.1006/excr.1999.4508; DEBONDT HL, 1993, NATURE, V363, P595, DOI 10.1038/363595a0; Enserink JM, 2010, CELL DIV, V5, DOI 10.1186/1747-1028-5-11; Farrell A, 2000, MOL CELL BIOL, V20, P749, DOI 10.1128/MCB.20.3.749-754.2000; Gavet O, 2010, J CELL BIOL, V189, P247, DOI 10.1083/jcb.200909144; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Guldener U, 1996, NUCLEIC ACIDS RES, V24, P2519, DOI 10.1093/nar/24.13.2519; Hagiwara Y, 1997, P NATL ACAD SCI USA, V94, P9249, DOI 10.1073/pnas.94.17.9249; Hamanaka RB, 2005, MOL BIOL CELL, V16, P5493, DOI 10.1091/mbc.E05-03-0268; Hashimoto NN, 2002, BIOCHEM J, V367, P359, DOI 10.1042/BJ20020556; Hinnebusch AG, 2005, ANNU REV MICROBIOL, V59, P407, DOI 10.1146/annurev.micro.59.031805.133833; Holt LJ, 2009, SCIENCE, V325, P1682, DOI 10.1126/science.1172867; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Humphrey T, 2005, CELL CYCLE MOL MECH, P3; Jeoung DI, 1998, MOL CELL BIOL, V18, P433, DOI 10.1128/MCB.18.1.433; Kerppola TK, 2008, ANNU REV BIOPHYS, V37, P465, DOI 10.1146/annurev.biophys.37.032807.125842; KRANENBURG O, 1995, J CELL BIOL, V131, P227, DOI 10.1083/jcb.131.1.227; Kronja I, 2011, PHILOS T R SOC B, V366, P3638, DOI 10.1098/rstb.2011.0084; Kubota H, 2000, J BIOL CHEM, V275, P20243, DOI 10.1074/jbc.C000262200; LEW DJ, 1995, J CELL BIOL, V129, P739, DOI 10.1083/jcb.129.3.739; Lew DJ, 1997, MOL CELLULAR BIOL YE, P607; Li YC, 2010, ANTI-CANCER DRUG, V21, P389, DOI 10.1097/CAD.0b013e328336b383; Loog M, 2005, NATURE, V434, P104, DOI 10.1038/nature03329; Manderson EN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001500; Martin R, 2013, J CELL SCI, V126, P3010, DOI 10.1242/jcs.118067; Maurin AC, 2005, CELL METAB, V1, P273, DOI 10.1016/j.cmet.2005.03.004; Menacho-Marquez M, 2007, CELL CYCLE, V6, P2302, DOI 10.4161/cc.6.18.4668; MENDENHALL MD, 1987, CELL, V50, P927, DOI 10.1016/0092-8674(87)90519-8; Mendenhall MD, 1998, MICROBIOL MOL BIOL R, V62, P1191, DOI 10.1128/MMBR.62.4.1191-1243.1998; MEYERSON M, 1992, EMBO J, V11, P2909, DOI 10.1002/j.1460-2075.1992.tb05360.x; Miao YS, 2013, P NATL ACAD SCI USA, V110, pE4446, DOI 10.1073/pnas.1314000110; Myster DL, 2000, CURR BIOL, V10, pR302, DOI 10.1016/S0960-9822(00)00435-8; Pereira CM, 2005, J BIOL CHEM, V280, P28316, DOI 10.1074/jbc.M408571200; PETER M, 1994, SCIENCE, V265, P1228, DOI 10.1126/science.8066461; Pyronnet S, 2000, MOL CELL, V5, P607, DOI 10.1016/S1097-2765(00)80240-3; Pyronnet S, 2001, CURR OPIN GENET DEV, V11, P13, DOI 10.1016/S0959-437X(00)00150-7; Roffe M, 2013, J BIOL CHEM, V288, P10860, DOI 10.1074/jbc.M113.461970; Rojas M, 2014, P NATL ACAD SCI USA, V111, pE1344, DOI 10.1073/pnas.1400129111; Rudner AD, 2000, J CELL BIOL, V149, P1377, DOI 10.1083/jcb.149.7.1377; Sattlegger E, 2000, EMBO J, V19, P6622, DOI 10.1093/emboj/19.23.6622; Sattlegger E, 2004, J BIOL CHEM, V279, P29952, DOI 10.1074/jbc.M404009200; Sattlegger E., 2011, PROTOC EXCH, DOI [10.1038/protex.2011.212, DOI 10.1038/PROTEX.2011.212]; Sattlegger E, 2011, J BIOL CHEM, V286, P10341, DOI 10.1074/jbc.M110.171587; SCHWOB E, 1994, CELL, V79, P233, DOI 10.1016/0092-8674(94)90193-7; Sung MK, 2007, YEAST, V24, P767, DOI 10.1002/yea.1504; Tantos A, 2012, MOL CELL ENDOCRINOL, V348, P457, DOI 10.1016/j.mce.2011.07.015; Tinton SA, 2005, BIOCHEM J, V385, P155, DOI 10.1042/BJ20040963; Tvegard T, 2007, GENE DEV, V21, P649, DOI 10.1101/gad.421807; Ubersax JA, 2003, NATURE, V425, P859, DOI 10.1038/nature02062; Waller T, 2012, FEBS J, V279, P1761, DOI 10.1111/j.1742-4658.2012.08553.x; WEK RC, 1992, MOL CELL BIOL, V12, P5700, DOI 10.1128/MCB.12.12.5700; Wiedemann M, 2013, NATURE PROTOCOL EXCH, DOI [10.1038/protex.2013.095, DOI 10.1038/PROTEX.2013.095]; WITTENBERG C, 1989, MOL CELL BIOL, V9, P4064, DOI 10.1128/MCB.9.9.4064; Xie HB, 2007, J PROTEOME RES, V6, P1882, DOI 10.1021/pr060392u; Ye JB, 2010, EMBO J, V29, P2082, DOI 10.1038/emboj.2010.81	65	10	10	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0131070	10.1371/journal.pone.0131070	http://dx.doi.org/10.1371/journal.pone.0131070			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176233	Green Submitted, gold, Green Published			2022-12-26	WOS:000358197600035
J	Van Belle, V; Van Calster, B				Van Belle, Vanya; Van Calster, Ben			Visualizing Risk Prediction Models	PLOS ONE			English	Article							CLINICAL DECISION-SUPPORT; ODDS RATIO; LOGISTIC-REGRESSION; VALIDATION; SYSTEMS; SCORE	Objective Risk prediction models can assist clinicians in making decisions. To boost the uptake of these models in clinical practice, it is important that end-users understand how the model works and can efficiently communicate its results. We introduce novel methods for interpretable model visualization. Methods The proposed visualization techniques are applied to two prediction models from the Framingham Heart Study for the prediction of intermittent claudication and stroke after atrial fibrillation. We represent models using color bars, and visualize the risk estimation process for a specific patient using patient-specific contribution charts. Results The color-based model representations provide users with an attractive tool to instantly gauge the relative importance of the predictors. The patient-specific representations allow users to understand the relative contribution of each predictor to the patient's estimated risk, potentially providing insightful information on which to base further patient management. Extensions towards non-linear models and interactions are illustrated on an artificial dataset. Conclusion The proposed methods summarize risk prediction models and risk predictions for specific patients in an alternative way. These representations may facilitate communication between clinicians and patients.	[Van Belle, Vanya] Katholieke Univ Leuven, Dept Elect Engn ESAT, STADIUS Ctr Dynam Syst Signal Proc & Data Analyt, Leuven, Belgium; [Van Belle, Vanya] Katholieke Univ Leuven, iMinds Med IT, Leuven, Belgium; [Van Calster, Ben] Katholieke Univ Leuven, Dept Dev & Regenerat, Leuven, Belgium	KU Leuven; IMEC; KU Leuven; KU Leuven	Van Belle, V (corresponding author), Katholieke Univ Leuven, Dept Elect Engn ESAT, STADIUS Ctr Dynam Syst Signal Proc & Data Analyt, Leuven, Belgium.	vanya.vanbelle@esat.kuleuven.be	Van Calster, Ben/F-9150-2010	Van Calster, Ben/0000-0003-1613-7450	Research Council KUL (GOA MaNet) [PFV/10/002]; Flemish Government (Research Foundation Flanders (FWO)) [G049312N]; Flemish Government (Agency for Innovation by Science and Technology (IWT)) [IWT-TBM 070706-IOTA3]; Flemish Government (iMinds); Belgian Federal Science Policy Office IUAP P7 (DYSCO, Dynamical systems, control and optimization)	Research Council KUL (GOA MaNet); Flemish Government (Research Foundation Flanders (FWO)); Flemish Government (Agency for Innovation by Science and Technology (IWT))(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Flemish Government (iMinds); Belgian Federal Science Policy Office IUAP P7 (DYSCO, Dynamical systems, control and optimization)(Belgian Federal Science Policy Office)	Research supported by: Research Council KUL (GOA MaNet, PFV/10/002 (OPTEC)), Flemish Government (Research Foundation Flanders (FWO) project G049312N, Agency for Innovation by Science and Technology (IWT) project IWT-TBM 070706-IOTA3, and iMinds); Belgian Federal Science Policy Office IUAP P7 (DYSCO, Dynamical systems, control and optimization, 2012-2017). VVB is a postdoctoral fellow of the FWO.	Agrawal D, 2005, PEDIATRICS, V116, P1612, DOI 10.1542/peds.2005-2269; Altman DG, 1998, BRIT MED J, V317, P1318, DOI 10.1136/bmj.317.7168.1318; Barry MJ, 2012, NEW ENGL J MED, V366, P780, DOI 10.1056/NEJMp1109283; Bates DW, 2003, J AM MED INFORM ASSN, V10, P523, DOI 10.1197/jamia.M1370; Bjork J, 2012, J CLIN EPIDEMIOL, V65, P335, DOI 10.1016/j.jclinepi.2011.06.019; Borkin MA, 2011, IEEE T VIS COMPUT GR, V17, P2479, DOI 10.1109/TVCG.2011.192; Borland D, 2007, IEEE COMPUT GRAPH, V27, P14, DOI 10.1109/MCG.2007.323435; Brabanter J.D., 2002, LEAST SQUARES SUPPOR, DOI DOI 10.1142/9789812776655; Chalmers J, 2013, EUR J CARDIO-THORAC, V43, P688, DOI 10.1093/ejcts/ezs406; Collins GS, 2015, CIRCULATION, V131, P211, DOI [10.1016/j.jclinepi.2014.11.010, 10.1161/CIRCULATIONAHA.114.014508, 10.1002/bjs.9736, 10.7326/M14-0697, 10.1016/j.eururo.2014.11.025, 10.1186/s12916-014-0241-z, 10.1136/bmj.g7594, 10.1038/bjc.2014.639, 10.7326/M14-0698]; Cooney MT, 2010, CIRCULATION, V122, P300, DOI 10.1161/CIRCULATIONAHA.109.852756; Edwards A, 2002, BMJ-BRIT MED J, V324, P827, DOI 10.1136/bmj.324.7341.827; GALEA MH, 1992, BREAST CANCER RES TR, V22, P207, DOI 10.1007/BF01840834; Harrell FE, 2001, REGRESSION MODELING; Harrower M, 2003, CARTOGR J, V40, P27, DOI 10.1179/000870403235002042; Karakiewicz PI, 2005, J UROLOGY, V173, P1930, DOI 10.1097/01.ju.0000158039.94467.5d; Karvanen J, 2009, STAT MED, V28, P1957, DOI 10.1002/sim.3591; Kattan MW, 2010, SEMIN ONCOL, V37, P23, DOI 10.1053/j.seminoncol.2009.12.003; Kattan MW, 2005, NAT CLIN PRACT UROL, V2, P183, DOI 10.1038/ncpuro0144; Kawamoto K, 2005, BMJ-BRIT MED J, V330, P765, DOI 10.1136/bmj.38398.500764.8F; KNAUS WA, 1991, CHEST, V100, P1619, DOI 10.1378/chest.100.6.1619; Lamina C, 2012, J CLIN EPIDEMIOL, V65, P855, DOI 10.1016/j.jclinepi.2012.02.013; Lipkus I M, 1999, J Natl Cancer Inst Monogr, P149; Murabito JM, 1997, CIRCULATION, V96, P44; Musen MA, 2006, BIOMEDICAL INFORM CO, P698, DOI DOI 10.1007/0-387-36278-920; Nashef SAM, 1999, EUR J CARDIO-THORAC, V16, P9, DOI 10.1016/S1010-7940(99)00134-7; Newcombe RG, 2006, STAT MED, V25, P4235, DOI 10.1002/sim.2683; Pepe MS, 2004, AM J EPIDEMIOL, V159, P882, DOI 10.1093/aje/kwh101; Royston P., 2008, MULTIVARIABLE MODEL; Sackett DL, 1996, EVIDENCE BASED MED, V1, P164, DOI DOI 10.1136/EBM.1996.1.164; Steyerberg E., 2009, CLIN PREDICTION MODE; Stiggelbout AM, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e256; Strumbelj E, 2010, J MACH LEARN RES, V11, P1; Sullivan LM, 2004, STAT MED, V23, P1631, DOI 10.1002/sim.1742; Timmerman D, 2005, J CLIN ONCOL, V23, P8794, DOI 10.1200/JCO.2005.01.7632; Vapnik V., 1998, STAT LEARNING THEORY; Vickers AJ, 2011, CA-CANCER J CLIN, V61, P315, DOI 10.3322/caac.20118; Waldron CA, 2011, PATIENT EDUC COUNS, V82, P169, DOI 10.1016/j.pec.2010.04.014; Wang TJ, 2003, JAMA-J AM MED ASSOC, V290, P1049, DOI 10.1001/jama.290.8.1049; WYATT JC, 1995, BMJ-BRIT MED J, V311, P1539, DOI 10.1136/bmj.311.7019.1539	41	18	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132614	10.1371/journal.pone.0132614	http://dx.doi.org/10.1371/journal.pone.0132614			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176945	Green Published, gold, Green Submitted			2022-12-26	WOS:000358197600131
J	Wickens, S; Perry, C				Wickens, Steven; Perry, Conrad			What Do You Mean by That?! An Electrophysiological Study of Emotional and Attitudinal Prosody	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; TEMPORAL DYNAMICS; RIGHT-HEMISPHERE; SARCASTIC IRONY; PERCEPTION; SPEECH; IDENTIFICATION; VOCALIZATIONS; SEMANTICS; SENTENCE	The use of prosody during verbal communication is pervasive in everyday language and whilst there is a wealth of research examining the prosodic processing of emotional information, much less is known about the prosodic processing of attitudinal information. The current study investigated the online neural processes underlying the prosodic processing of non-verbal emotional and attitudinal components of speech via the analysis of event-related brain potentials related to the processing of anger and sarcasm. To examine these, sentences with prosodic expectancy violations created by cross-splicing a prosodically neutral head ('he has') and a prosodically neutral, angry, or sarcastic ending (e.g., 'a serious face') were used. Task demands were also manipulated, with participants in one experiment performing prosodic classification and participants in another performing probe-verification. Overall, whilst minor differences were found across the tasks, the results suggest that angry and sarcastic prosodic expectancy violations follow a similar processing time-course underpinned by similar neural resources.	[Wickens, Steven; Perry, Conrad] Swinburne Univ Technol, Hawthorn, Vic 3122, Australia	Swinburne University of Technology	Perry, C (corresponding author), Swinburne Univ Technol, Hawthorn, Vic 3122, Australia.	cperry@swin.edu.au		Perry, Conrad/0000-0002-3429-0240	Australian Research Council [DP120100883]	Australian Research Council(Australian Research Council)	Australian Research Council (DP120100883) grant awarded to CP.	Astesano C, 2004, COGNITIVE BRAIN RES, V18, P172, DOI 10.1016/j.cogbrainres.2003.10.002; Banse R, 1996, J PERS SOC PSYCHOL, V70, P614, DOI 10.1037/0022-3514.70.3.614; Bidelman GM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060676; Blanc JM, 2003, COGNITIVE BRAIN RES, V17, P693, DOI 10.1016/S0926-6410(03)00195-2; Boersma P., 2013, PRAAT DOING PHONETIC; Breitenstein C, 2001, COGNITION EMOTION, V15, P57, DOI 10.1080/0269993004200114; Bryant GA, 2005, LANG SPEECH, V48, P257, DOI 10.1177/00238309050480030101; Cheang HS, 2008, SPEECH COMMUN, V50, P366, DOI 10.1016/j.specom.2007.11.003; Chen XH, 2011, BIOL PSYCHOL, V86, P158, DOI 10.1016/j.biopsycho.2010.11.004; Culpeper J, 1996, J PRAGMATICS, V25, P349, DOI 10.1016/0378-2166(95)00014-3; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Eckstein K, 2005, COGNITIVE BRAIN RES, V25, P130, DOI 10.1016/j.cogbrainres.2005.05.003; Gandour J. T, 2006, ENCY LANGUAGE LINGUI, V12, P751, DOI DOI 10.1016/B0-08-044854-2/04796-9; Grichkovtsova I, 2012, SPEECH COMMUN, V54, P414, DOI 10.1016/j.specom.2011.10.005; HILLYARD SA, 1973, SCIENCE, V182, P177, DOI 10.1126/science.182.4108.177; Hirst D., 1998, INTONATION SYSTEMS A; Jorgensen J, 1996, J PRAGMATICS, V26, P613, DOI 10.1016/0378-2166(95)00067-4; Kochunov P, 2003, NEUROREPORT, V14, P961, DOI 10.1097/01.wnr.0000075417.59944.00; Kotz SA, 2003, BRAIN LANG, V86, P366, DOI 10.1016/S0093-934X(02)00532-1; Kotz SA, 2007, BRAIN RES, V1151, P107, DOI 10.1016/j.brainres.2007.03.015; Liu TS, 2012, NEUROREPORT, V23, P108, DOI 10.1097/WNR.0b013e32834ea757; Loevenbruck H, 2013, PROCEEDINGS OF INTER; Meyer M, 2004, BRAIN LANG, V89, P277, DOI 10.1016/S0093-934X(03)00350-X; Mitchell RLC, 2013, NEUROSCI BIOBEHAV R, V37, P471, DOI 10.1016/j.neubiorev.2013.01.027; Morlec Y, 2001, SPEECH COMMUN, V33, P357, DOI 10.1016/S0167-6393(00)00065-0; Mozziconacci SJ, 2011, USER MODELING AND US, V11, P297; Naatanen R, 1995, Int J Neurosci, V80, P317, DOI 10.3109/00207459508986107; Paulmann S, 2008, BRAIN LANG, V105, P59, DOI 10.1016/j.bandl.2007.11.005; Paulmann S, 2008, NEUROREPORT, V19, P209, DOI 10.1097/WNR.0b013e3282f454db; Paulmann S, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00345; Paulmann S, 2012, NEUROPSYCHOLOGIA, V50, P1609, DOI 10.1016/j.neuropsychologia.2012.03.014; Pell MD, 2006, PROG BRAIN RES, V156, P303, DOI 10.1016/S0079-6123(06)56017-0; Pell MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027256; Pell MD, 2009, J PHONETICS, V37, P417, DOI 10.1016/j.wocn.2009.07.005; Picton TW, 2000, PSYCHOPHYSIOLOGY, V37, P127, DOI 10.1111/1469-8986.3720127; Regel S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096840; Regel S, 2011, J COGNITIVE NEUROSCI, V23, P277, DOI 10.1162/jocn.2010.21411; Rigoulot S, 2014, BRAIN RES, V1565, P48, DOI 10.1016/j.brainres.2014.04.022; Rockwell P, 2000, J PSYCHOLINGUIST RES, V29, P483, DOI 10.1023/A:1005120109296; Sauter DA, 2010, J COGNITIVE NEUROSCI, V22, P474, DOI 10.1162/jocn.2009.21215; Scherer KR, 2003, SPEECH COMMUN, V40, P227, DOI 10.1016/S0167-6393(02)00084-5; Schirmer A, 2005, NEUROREPORT, V16, P635, DOI 10.1097/00001756-200504250-00024; Schirmer A, 2006, TRENDS COGN SCI, V10, P24, DOI 10.1016/j.tics.2005.11.009; Sidtis John J., 2003, Seminars in Speech and Language, V24, P93, DOI 10.1055/s-2003-38901; Sobin C, 1999, J PSYCHOLINGUIST RES, V28, P347, DOI 10.1023/A:1023237014909; Spachtholz P, 2014, J EXP PSYCHOL GEN, V143, P1450, DOI 10.1037/xge0000012; Thonnessen H, 2010, NEUROIMAGE, V50, P250, DOI 10.1016/j.neuroimage.2009.11.082; Toplak M, 2000, J PRAGMATICS, V32, P1467, DOI 10.1016/S0378-2166(99)00101-0; VANLANCKER D, 1992, J SPEECH HEAR RES, V35, P963, DOI 10.1044/jshr.3505.963; Warren P., 2005, LANG VAR CHANGE, V17, P209, DOI [10.1017/S095439450505009X, DOI 10.1017/S095439450505009X]; Wichmann Anne, 2000, P ISCA WORKSHOP SPEE, P143; Wildgruber D, 2004, CEREB CORTEX, V14, P1384, DOI 10.1093/cercor/bhh099; Witteman J, 2011, NEUROPSYCHOLOGIA, V49, P3722, DOI 10.1016/j.neuropsychologia.2011.09.028; Woodman GF, 2010, ATTEN PERCEPT PSYCHO, V72, P2031, DOI 10.3758/APP.72.8.2031; Yildirim S., 2004, 8 INT C SPOK LANG PR, P2193	55	12	12	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132947	10.1371/journal.pone.0132947	http://dx.doi.org/10.1371/journal.pone.0132947			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1RL	26176622	Green Published, Green Submitted, gold			2022-12-26	WOS:000358197600187
J	Zhang, L; Ma, RJ; Hu, J; Ding, XL; Xu, YX				Zhang, Liang; Ma, Rujun; Hu, Jin; Ding, Xiaolin; Xu, Yinxue			Sirtuin Inhibition Adversely Affects Porcine Oocyte Meiosis	PLOS ONE			English	Article							IN-VITRO; MOUSE OOCYTES; DEVELOPMENTAL COMPETENCE; HISTONE DEACETYLASE; ASYMMETRIC DIVISION; MEIOTIC MATURATION; ORGANIZATION; CYTOSKELETON; POLARITY; NUCLEAR	Sirtuins have been implicated in diverse biological processes, including oxidative stress, energy metabolism, cell migration, and aging. Here, we employed Sirtuin inhibitors, nicotinamide (NAM) and Sirtinol, to investigate their effects on porcine oocyte maturation respectively. The rate of polar body extrusion in porcine oocytes decreased after treatment with NAM and Sirtinol, accompanied with the failure of cumulus cell expansion. We further found that NAM and Sirtinol significantly disrupted oocyte polarity, and inhibited the formation of actin cap and cortical granule-free domain (CGFD). Moreover, the abnormal spindles and misaligned chromosomes were readily detected during porcine oocyte maturation after treatment with NAM and Sirtinol. Together, these results suggest that Sirtuins are involved in cortical polarity and spindle organization in porcine oocytes.	[Zhang, Liang; Hu, Jin; Ding, Xiaolin; Xu, Yinxue] Nanjing Agr Univ, Coll Anim Sci & Technol, Nanjing, Jiangsu, Peoples R China; [Ma, Rujun] Nanjing Agr Univ, Coll Vet Med, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University; Nanjing Agricultural University	Xu, YX (corresponding author), Nanjing Agr Univ, Coll Anim Sci & Technol, Nanjing, Jiangsu, Peoples R China.	xuyinxue@njau.edu.cn			Research Fund for the Doctoral Program of the Ministry of Education of China [20130097110020];  [CXLX12-0301]	Research Fund for the Doctoral Program of the Ministry of Education of China; 	This work was supported by Research Fund for the Doctoral Program of the Ministry of Education of China (20130097110020) and The Innovative Project for Postgraduates (CXLX12-0301).	Azoury J, 2009, BIOL CELL, V101, P69, DOI 10.1042/BC20080003; Brunet S, 2005, REPRODUCTION, V130, P801, DOI 10.1530/rep.1.00364; Brunet S, 2011, HUM REPROD UPDATE, V17, P68, DOI 10.1093/humupd/dmq044; Combelles CMH, 2003, HUM REPROD, V18, P2124, DOI 10.1093/humrep/deg419; Damiani P, 1996, MOL REPROD DEV, V45, P521, DOI 10.1002/(SICI)1098-2795(199612)45:4&lt;521::AID-MRD15&gt;3.0.CO;2-Z; Deng MQ, 2007, DEV CELL, V12, P301, DOI 10.1016/j.devcel.2006.11.008; Deng MQ, 2005, DEV BIOL, V278, P358, DOI 10.1016/j.ydbio.2004.11.013; Eppig JJ, 1996, REPROD FERT DEVELOP, V8, P485, DOI 10.1071/RD9960485; Houtkooper RH, 2012, NAT REV MOL CELL BIO, V13, P225, DOI 10.1038/nrm3293; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Kawamura Y, 2010, J CLIN INVEST, V120, P2817, DOI 10.1172/JCI42020; Kim NH, 1996, MOL REPROD DEV, V43, P513, DOI 10.1002/(SICI)1098-2795(199604)43:4&lt;513::AID-MRD14&gt;3.0.CO;2-#; Kim NH, 1998, HUM REPROD, V13, P2217, DOI 10.1093/humrep/13.8.2217; Kwak SS, 2012, THERIOGENOLOGY, V78, P1597, DOI 10.1016/j.theriogenology.2012.07.006; Lenart P, 2005, NATURE, V436, P812, DOI 10.1038/nature03810; Li GP, 2005, MOL REPROD DEV, V71, P220, DOI 10.1002/mrd.20255; Liu MY, 2013, HUM REPROD, V28, P707, DOI 10.1093/humrep/des437; Liu XY, 2005, HUM REPROD, V20, P3402, DOI 10.1093/humrep/dei265; Maddox AS, 2012, CYTOSKELETON, V69, P855, DOI 10.1002/cm.21064; Miao YL, 2007, THERIOGENOLOGY, V68, P640, DOI 10.1016/j.theriogenology.2007.04.061; Miyara F, 2003, HUM REPROD, V18, P1494, DOI 10.1093/humrep/deg272; Mukherjee A, 2014, J ASSIST REPROD GEN, V31, P229, DOI 10.1007/s10815-013-0116-9; Spricigo J., 2015, REPRODUCTION FERTILI, V27, P115, DOI [10.1071/RDV27N1AB45, DOI 10.1071/RDV27N1AB45]; Su YQ, 2002, ENDOCRINOLOGY, V143, P2221, DOI 10.1210/en.143.6.2221; Sun SC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018392; Takeo S, 2014, J REPROD DEVELOP, V60, P92, DOI 10.1262/jrd.2013-102; Tremoleda JL, 2001, MOL REPROD DEV, V60, P260, DOI 10.1002/mrd.1086; TSAI FCH, 1994, FERTIL STERIL, V61, P376; Vaquero A, 2007, NATURE, V450, P440, DOI 10.1038/nature06268; Vaquero A, 2006, GENE DEV, V20, P1256, DOI 10.1101/gad.1412706; Wang Q, 2007, REPROD FERT DEVELOP, V19, P1, DOI 10.1071/RD06103; Yi KX, 2012, CYTOSKELETON, V69, P727, DOI 10.1002/cm.21048; Zhang L, 2014, FASEB J, V28, P1435, DOI 10.1096/fj.13-244111; Zhang Y, 2014, THERIOGENOLOGY, V82, P49, DOI 10.1016/j.theriogenology.2014.02.020	34	18	20	4	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132941	10.1371/journal.pone.0132941	http://dx.doi.org/10.1371/journal.pone.0132941			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176547	gold, Green Published, Green Submitted			2022-12-26	WOS:000358197600186
J	Brooks, JD; Wei, W; Hawley, S; Auman, H; Newcomb, L; Boyer, H; Fazli, L; Simko, J; Hurtado-Coll, A; Troyer, DA; Carroll, PR; Gleave, M; Lance, R; Lin, DW; Nelson, PS; Thompson, IM; True, LD; Feng, ZD; McKenney, JK				Brooks, James D.; Wei, Wei; Hawley, Sarah; Auman, Heidi; Newcomb, Lisa; Boyer, Hilary; Fazli, Ladan; Simko, Jeff; Hurtado-Coll, Antonio; Troyer, Dean A.; Carroll, Peter R.; Gleave, Martin; Lance, Raymond; Lin, Daniel W.; Nelson, Peter S.; Thompson, Ian M.; True, Lawrence D.; Feng, Ziding; McKenney, Jesse K.			Evaluation of ERG and SPINK1 by Immunohistochemical Staining and Clinicopathological Outcomes in a Multi-Institutional Radical Prostatectomy Cohort of 1067 Patients	PLOS ONE			English	Article							ACTIVE SURVEILLANCE; PROTEIN EXPRESSION; PSA RECURRENCE; INCREASED RISK; CANCER; FUSION; TMPRSS2-ERG; PROGRESSION; PTEN; REARRANGEMENT	Distinguishing between patients with early stage, screen detected prostate cancer who must be treated from those that can be safely watched has become a major issue in prostate cancer care. Identification of molecular subtypes of prostate cancer has opened the opportunity for testing whether biomarkers that characterize these subtypes can be used as biomarkers of prognosis. Two established molecular subtypes are identified by high expression of the ERG oncoprotein, due to structural DNA alterations that encode for fusion transcripts in approximately 1/2 of prostate cancers, and over-expression of SPINK1, which is purportedly found only in ERG-negative tumors. We used a multi-institutional prostate cancer tissue microarray constructed from radical prostatectomy samples with associated detailed clinical data and with rigorous selection of recurrent and non-recurrent cases to test the prognostic value of immunohistochemistry staining results for the ERG and SPINK1 proteins. In univariate analysis, ERG positive cases (419/1067; 39%) were associated with lower patient age, pre-operative serum PSA levels, lower Gleason scores (<3+4=7) and improved recurrence free survival (RFS). On multivariate analysis, ERG status was not correlated with RFS, disease specific survival (DSS) or overall survival (OS). High-level SPINK1 protein expression (33/1067 cases; 3%) was associated with improved RFS on univariate and multivariate Cox regression analysis. Over-expression of either protein was not associated with clinical outcome. While expression of ERG and SPINK1 proteins was inversely correlated, it was not mutually exclusive since 3 (0.28%) cases showed high expression of both. While ERG and SPINK1 appear to identify discrete molecular subtypes of prostate cancer, only high expression of SPINK1 was associated with improved clinical outcome. However, by themselves, neither ERG nor SPINK1 appear to be useful biomarkers for prognostication of early stage prostate cancer.	[Brooks, James D.] Stanford Univ, Dept Urol, Stanford, CA 94305 USA; [Wei, Wei; Feng, Ziding] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA; [Hawley, Sarah; Auman, Heidi] Canary Ctr Stanford, Canary Fdn, Palo Alto, CA USA; [Newcomb, Lisa; Lin, Daniel W.] Univ Washington, Med Ctr, Dept Urol, Seattle, WA 98195 USA; [Boyer, Hilary; Fazli, Ladan; Gleave, Martin] Univ British Columbia, Vancouver Gen Hosp, Prostate Ctr, Vancouver, BC V5Z 1M9, Canada; [Simko, Jeff] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA; [Hurtado-Coll, Antonio; Troyer, Dean A.] Univ Texas Hlth Sci Ctr San Antonio, Dept Pathol, San Antonio, TX 78229 USA; [Troyer, Dean A.] Eastern Virginia Med Sch, Pathol Microbiol & Mol Biol, Norfolk, VA 23501 USA; [Carroll, Peter R.] Univ Calif San Francisco, Dept Urol, San Francisco, CA USA; [Lance, Raymond] Eastern Virginia Med Sch, Dept Urol, Norfolk, VA 23501 USA; [Nelson, Peter S.] Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98104 USA; [Thompson, Ian M.] Univ Texas Hlth Sci Ctr San Antonio, Dept Urol, San Antonio, TX 78229 USA; [True, Lawrence D.] Univ Washington, Med Ctr, Dept Pathol, Seattle, WA 98195 USA; [McKenney, Jesse K.] Cleveland Clin, Dept Pathol, Cleveland, OH 44106 USA	Stanford University; University of Texas System; UTMD Anderson Cancer Center; University of Washington; University of Washington Seattle; University of British Columbia; University of California System; University of California San Francisco; University of Texas System; University of Texas Health San Antonio; Eastern Virginia Medical School; University of California System; University of California San Francisco; Eastern Virginia Medical School; Fred Hutchinson Cancer Center; University of Texas System; University of Texas Health San Antonio; University of Washington; University of Washington Seattle; Cleveland Clinic Foundation	Brooks, JD (corresponding author), Stanford Univ, Dept Urol, Stanford, CA 94305 USA.	jdbrooks@stanford.edu		Gleave, Martin/0000-0003-4235-0167; Wei, Wei/0000-0002-0960-7269	Canary Foundation; Department of Defense [W81XWH-11-1-0380]; NCI Early Detection Research Network [CA152737-01, CA08636815]; NATIONAL CANCER INSTITUTE [U01CA152737, P30CA016672] Funding Source: NIH RePORTER	Canary Foundation; Department of Defense(United States Department of Defense); NCI Early Detection Research Network(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by the Canary Foundation, the Department of Defense (W81XWH-11-1-0380) and the NCI Early Detection Research Network (CA152737-01, JDB and CA08636815, ZF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Bashir S, 2014, J HEMATOL ONCOL, V7, DOI 10.1186/1756-8722-7-21; Andriole GL, 2009, NEW ENGL J MED, V360, P1310, DOI 10.1056/NEJMoa0810696; Ateeq B, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001498; Attard G, 2015, CLIN CANCER RES, V21, P1621, DOI 10.1158/1078-0432.CCR-14-1961; Baca SC, 2013, CELL, V153, P666, DOI 10.1016/j.cell.2013.03.021; Berg KD, 2014, EUR UROL, V66, P851, DOI 10.1016/j.eururo.2014.02.058; Bill-Axelson A, 2014, NEW ENGL J MED, V370, P932, DOI 10.1056/NEJMoa1311593; Brooks JD, 2013, CANCER-AM CANCER SOC, V119, P3906, DOI 10.1002/cncr.28301; Carver BS, 2009, NAT GENET, V41, P619, DOI 10.1038/ng.370; Chaux A, 2012, MODERN PATHOL, V25, P1543, DOI 10.1038/modpathol.2012.104; Chaux A, 2011, AM J SURG PATHOL, V35, P1014, DOI 10.1097/PAS.0b013e31821e8761; Demichelis F, 2007, ONCOGENE, V26, P4596, DOI 10.1038/sj.onc.1210237; Flavin R, 2014, CLIN CANCER RES, V20, P4904, DOI 10.1158/1078-0432.CCR-13-1341; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; Grupp K, 2013, PROSTATE, V73, P1690, DOI 10.1002/pros.22707; Guo CC, 2009, MODERN PATHOL, V22, P866, DOI 10.1038/modpathol.2009.57; Hawley S, 2013, ADV ANAT PATHOL, V20, P39, DOI 10.1097/PAP.0b013e31827b665b; Hermans KG, 2009, CLIN CANCER RES, V15, P6398, DOI 10.1158/1078-0432.CCR-09-1176; Jhavar S, 2009, BJU INT, V103, P1256, DOI 10.1111/j.1464-410X.2008.08200.x; Karnes RJ, 2010, CANCER RES, V70, P8994, DOI 10.1158/0008-5472.CAN-10-1358; King CR, 2009, UROL ONCOL-SEMIN ORI, V27, P592, DOI 10.1016/j.urolonc.2008.05.009; Klein EA, 2014, EUR UROL, V66, P550, DOI 10.1016/j.eururo.2014.05.004; Krohn A, 2012, AM J PATHOL, V181, P401, DOI 10.1016/j.ajpath.2012.04.026; Lee JJ, 2015, PROSTATE, V75, P183, DOI 10.1002/pros.22903; Leinonen KA, 2013, CANCER EPIDEM BIOMAR, V22, P2333, DOI 10.1158/1055-9965.EPI-13-0333-T; Leinonen KA, 2010, CLIN CANCER RES, V16, P2845, DOI 10.1158/1078-0432.CCR-09-2505; Lichtensztajn DY, 2014, J UROLOGY, V191, P952, DOI 10.1016/j.juro.2013.10.075; Lin DW, 2013, CLIN CANCER RES, V19, P2442, DOI 10.1158/1078-0432.CCR-12-3283; Lu B, 2009, UROLOGY, V74, P1156, DOI 10.1016/j.urology.2009.01.087; Magi-Galluzzi C, 2011, PROSTATE, V71, P489, DOI 10.1002/pros.21265; Minner S, 2011, CLIN CANCER RES, V17, P5878, DOI 10.1158/1078-0432.CCR-11-1251; Mosquera JM, 2009, CLIN CANCER RES, V15, P4706, DOI 10.1158/1078-0432.CCR-08-2927; Park K, 2010, NEOPLASIA, V12, P590, DOI 10.1593/neo.10726; Pettersson A, 2012, CANCER EPIDEM BIOMAR, V21, P1497, DOI 10.1158/1055-9965.EPI-12-0042; Reid AHM, 2010, BRIT J CANCER, V102, P678, DOI 10.1038/sj.bjc.6605554; Sabaliauskaite R, 2012, GENE CHROMOSOME CANC, V51, P781, DOI 10.1002/gcc.21963; SAKR WA, 1994, IN VIVO, V8, P439; Sanda MG, 2008, NEW ENGL J MED, V358, P1250, DOI 10.1056/NEJMoa074311; Schaefer G, 2013, PROSTATE CANCER P D, V16, P132, DOI 10.1038/pcan.2013.4; Schroder FH, 2012, NEW ENGL J MED, V366, P981, DOI 10.1056/NEJMoa1113135; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Sirma H, 2013, ONCOL LETT, V6, P1245, DOI 10.3892/ol.2013.1563; Terry S, 2015, CANCER-AM CANCER SOC, V121, P1422, DOI 10.1002/cncr.29233; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Tomlins SA, 2008, CANCER CELL, V13, P519, DOI 10.1016/j.ccr.2008.04.016; Tomlins SA, 2015, EUR UROL, V68, P555, DOI 10.1016/j.eururo.2015.04.033; Weinmann S, 2013, PROSTATE, V73, P1371, DOI 10.1002/pros.22684; Wilt TJ, 2012, NEW ENGL J MED, V367, P203, DOI 10.1056/NEJMoa1113162; Xu B, 2014, HUM PATHOL, V45, P488, DOI 10.1016/j.humpath.2013.10.012	49	24	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132343	10.1371/journal.pone.0132343	http://dx.doi.org/10.1371/journal.pone.0132343			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26172920	Green Submitted, Green Published, gold			2022-12-26	WOS:000358194900044
J	Shargorodsky, J; Garcia-Esquinas, E; Galan, I; Navas-Acien, A; Lin, SY				Shargorodsky, Josef; Garcia-Esquinas, Esther; Galan, Inaki; Navas-Acien, Ana; Lin, Sandra Y.			Allergic Sensitization, Rhinitis and Tobacco Smoke Exposure in US Adults	PLOS ONE			English	Article							RESPIRATORY SYMPTOMS; CIGARETTE-SMOKE; NASAL SYMPTOMS; RISK-FACTORS; PREVALENCE; ASTHMA; INFLAMMATION; ADOLESCENTS; CHILDREN; DISEASE	Introduction Tobacco exposure has been linked with sinonasal pathology and may be associated with allergic sensitization. This study evaluates the association between exposure to active smoking or secondhand smoke (SHS) and the prevalence of rhinitis and allergic sensitization in the US adult population. Methods Cross-sectional study in 4,339 adults aged 20-85 in the National Health and Nutrition Examination Survey, 2005-2006. Never smoking was defined as reported lifetime smoking less than 100 cigarettes and serum cotinine levels <10ng/ml, while active smoking was defined as self-reported smoking or serum cotinine concentrations > 10 ng/mL. Self-reported rhinitis was based on symptoms during the past 12 months, and allergen sensitization was defined as a positive response to any of the 19 specific IgE antigens tested. Results Almost half of the population (43%) had detectable levels of IgE specific to at least one inhaled allergen and 32% reported a history of rhinitis. After multivariate adjustment, there was a statistically significant association between the highest serum cotinine tertile and rhinitis in active smokers (OR 1.42; 95% CI 1.00-2.00). The association between active smoking and rhinitis was stronger in individuals without allergic sensitization (OR 2.47; 95% CI 1.44-4.23). There was a statistically significant association between increasing cotinine tertiles and decreased odds of inhaled allergen sensitization (p-trend <.01). Conclusion Tobacco smoke exposure was associated with increased prevalence of rhinitis symptoms, but not with allergic sensitization. The results indicate that the relationship between tobacco smoke exposure and sinonasal pathology in adults may be independent of allergic sensitization.	[Shargorodsky, Josef; Lin, Sandra Y.] Johns Hopkins Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21205 USA; [Shargorodsky, Josef] Coastal Ear Nose & Throat, Neptune, NJ USA; [Garcia-Esquinas, Esther; Galan, Inaki] Univ Autonoma Madrid, Sch Med, Dept Prevent Med & Publ Hlth, Madrid, Spain; [Galan, Inaki] Carlos III Hlth Inst, Natl Ctr Epidemiol, Madrid, Spain; [Garcia-Esquinas, Esther] Ciber Epidemiol & Publ Hlth CIBERESP, Madrid, Spain; [Garcia-Esquinas, Esther; Navas-Acien, Ana] Johns Hopkins Univ, Dept Environm Hlth Sci, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; [Navas-Acien, Ana] Johns Hopkins Med Inst, Welch Ctr Prevent Epidemiol & Clin Res, Baltimore, MD 21205 USA	Johns Hopkins University; Autonomous University of Madrid; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Medicine	Shargorodsky, J (corresponding author), Johns Hopkins Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21205 USA.	jshargo1@gmail.com	garcia, esther/AAR-8372-2021; Galán, Ignacio/P-6451-2015	Galán, Ignacio/0000-0003-0624-9993; garcia-esquinas, Esther/0000-0002-8688-5174	Flight Attendant Medical Research Institute	Flight Attendant Medical Research Institute	This work was supported in part by the Flight Attendant Medical Research Institute (ANA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benowitz NL, 1996, EPIDEMIOL REV, V18, P188, DOI 10.1093/oxfordjournals.epirev.a017925; Berania I, 2014, INT FORUM ALLERGY RH; Bottema RWB, 2008, EUR RESPIR J, V32, P593, DOI 10.1183/09031936.00162407; Centers for Disease Control and Prevention, NAT HLTH NUTR EX SUR; Chen H, 2007, J IMMUNOL, V179, P6097, DOI 10.4049/jimmunol.179.9.6097; Ciaccio CE, 2013, ANN ALLERG ASTHMA IM, V111, P387, DOI 10.1016/j.anai.2013.07.023; Eisner MD, 2005, THORAX, V60, P814, DOI 10.1136/thx.2004.037283; Eriksson J, 2011, INT ARCH ALLERGY IMM, V154, P155, DOI 10.1159/000320230; Garcia-Esquinas E, 2013, PEDIATRICS, V131, pE1415, DOI 10.1542/peds.2012-3201; GELBER LE, 1993, AM REV RESPIR DIS, V147, P573, DOI 10.1164/ajrccm/147.3.573; Gibson PG, 2001, CHEST, V119, P1329, DOI 10.1378/chest.119.5.1329; HALKEN S, 1995, ALLERGY, V50, P97; Hancox RJ, 2008, J ALLERGY CLIN IMMUN, V121, P38, DOI 10.1016/j.jaci.2007.09.052; Hogg JC, 2004, LANCET, V364, P709, DOI 10.1016/S0140-6736(04)16900-6; Hoppin JA, 2013, ENVIRON HEALTH PERSP, V121, P1129, DOI 10.1289/ehp.1206211; Kulig M, 1999, ALLERGY, V54, P220, DOI 10.1034/j.1398-9995.1999.00753.x; Kum-Nji P, 2006, PEDIATRICS, V117, P1745, DOI 10.1542/peds.2005-1886; Lin SY, 2011, AM J RHINOL ALLERGY, V25, pE66, DOI 10.2500/ajra.2011.25.3580; MEGGS WJ, 1993, ENVIRON HEALTH PERSP, V101, P234, DOI 10.2307/3431548; Meltzer EO, 2011, ANN ALLERG ASTHMA IM, V106, pS12, DOI 10.1016/j.anai.2010.10.014; Menzies D, 2006, JAMA-J AM MED ASSOC, V296, P1742, DOI 10.1001/jama.296.14.1742; Nathan RA, 2008, ALLERGY ASTHMA PROC, V29, P600, DOI 10.2500/aap.2008.29.3179; Ouyang Y, 2000, J ALLERGY CLIN IMMUN, V106, P280, DOI 10.1067/mai.2000.107751; Quinto Kenneth B, 2013, NCHS Data Brief, P1; Reh DD, 2012, INT FORUM ALLERGY RH, V2, P362, DOI 10.1002/alr.21054; Salo PM, 2011, J ALLERGY CLIN IMMUN, V127, P1226, DOI 10.1016/j.jaci.2010.12.1106; Saulyte J, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001611; Shargorodsky J, 2010, JAMA-J AM MED ASSOC, V304, P772, DOI 10.1001/jama.2010.1124; Singh Daljit, 2002, Indian Pediatr, V39, P23; Sopori M, 2002, NAT REV IMMUNOL, V2, P372, DOI 10.1038/nri803; Tsai CH, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-11; WHITE JR, 1980, NEW ENGL J MED, V302, P720, DOI 10.1056/NEJM198003273021304	32	27	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0131957	10.1371/journal.pone.0131957	http://dx.doi.org/10.1371/journal.pone.0131957			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26172447	Green Published, gold			2022-12-26	WOS:000358194900025
J	Walpita, P; Johns, LM; Tandon, R; Moore, ML				Walpita, Pramila; Johns, Lisa M.; Tandon, Ravi; Moore, Martin L.			Mammalian Cell-Derived Respiratory Syncytial Virus-Like Particles Protect the Lower as well as the Upper Respiratory Tract	PLOS ONE			English	Article							MONOPHOSPHORYL-LIPID-A; ENHANCED PULMONARY HISTOPATHOLOGY; INNATE IMMUNITY; FUSION PROTEIN; COTTON RATS; PROVIDES PROTECTION; BALB/C MICE; VACCINE; INFECTION; GLYCOPROTEIN	Globally, Respiratory Syncytial Virus (RSV) is a leading cause of bronchiolitis and pneumonia in children less than one year of age and in USA alone, between 85,000 and 144,000 infants are hospitalized every year. To date, there is no licensed vaccine. We have evaluated vaccine potential of mammalian cell-derived native RSV virus-like particles (RSV VLPs) composed of the two surface glycoproteins G and F, and the matrix protein M. Results of in vitro testing showed that the VLPs were functionally assembled and immunoreactive, and that the recombinantly expressed F protein was cleaved intracellularly similarly to the virus-synthesized F protein to produce the F1 and F2 subunits; the presence of the F1 fragment is critical for vaccine development since all the neutralizing epitopes present in the F protein are embedded in this fragment. Additional in vitro testing in human macrophage cell line THP-1 showed that both virus and the VLPs were sensed by TLR-4 and induced a Th1-biased cytokine response. Cotton rats vaccinated with RSV VLPs adjuvanted with alum and monophosphoryl lipid A induced potent neutralizing antibody response, and conferred protection in the lower as well as the upper respiratory tract based on substantial virus clearance from these sites. To the best of our knowledge, this is the first VLP/virosome vaccine study reporting protection of the lower as well as the upper respiratory tract: Prevention from replication in the nose is an important consideration if the target population is infants < 6 months of age. This is because continued virus replication in the nose results in nasal congestion and babies at this age are obligate nose breathers. In conclusion, these results taken together suggest that our VLPs show promise to be a safe and effective vaccine for RSV.	[Walpita, Pramila; Johns, Lisa M.; Tandon, Ravi] Univ Hawaii Manoa, Dept Trop Med Med Microbiol & Pharmacol, John A Burns Sch Med, Honolulu, HI 96822 USA; [Moore, Martin L.] Emory Univ, Dept Pediat, Atlanta, GA 30322 USA; [Moore, Martin L.] Childrens Healthcare Atlanta, Atlanta, GA USA	University of Hawaii System; University of Hawaii Manoa; Emory University; Children's Healthcare of Atlanta (CHOA)	Walpita, P (corresponding author), Univ Hawaii Manoa, Dept Trop Med Med Microbiol & Pharmacol, John A Burns Sch Med, Honolulu, HI 96822 USA.	walpitap@hawaii.edu			Department of Tropical Medicine, University of Hawaii; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI095464] Funding Source: NIH RePORTER	Department of Tropical Medicine, University of Hawaii; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was done with the help of Preclinical Services provided by NIAID. It was initiated at the University of Texas Medical Branch, Galveston TX, and is being continued at University of Hawaii School of Medicine, Honolulu, HI. A startup fund was provided to PW from the Department of Tropical Medicine, University of Hawaii.	Anderson R, 2010, FUTURE MICROBIOL, V5, P585, DOI 10.2217/FMB.10.22; Awate S, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00114; Blanco JCG, 2010, HUM VACCINES, V6, P482, DOI 10.4161/hv.6.6.11562; Borchers AT, 2013, CLIN REV ALLERGY IMM; Boukhvalova MS, 2006, VACCINE, V24, P5027, DOI 10.1016/j.vaccine.2006.03.064; Casella CR, 2008, CELL MOL LIFE SCI, V65, P3231, DOI 10.1007/s00018-008-8228-6; Chackerian B, 2007, EXPERT REV VACCINES, V6, P381, DOI 10.1586/14760584.6.3.381; Cheon IS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094269; Coffman RL, 2010, IMMUNITY, V33, P492, DOI 10.1016/j.immuni.2010.10.002; Collins P. L., 2007, FIELDS VIROLOGY; Collins PL, 1999, ADV VIRUS RES, V54, P423, DOI 10.1016/S0065-3527(08)60374-7; CONNORS M, 1992, VACCINE, V10, P475, DOI 10.1016/0264-410X(92)90397-3; CONNORS M, 1994, J VIROL, V68, P5321, DOI 10.1128/JVI.68.8.5321-5325.1994; Crameri G, 2002, J VIROL METHODS, V99, P41, DOI 10.1016/S0166-0934(01)00377-9; Didierlaurent AM, 2009, J IMMUNOL, V183, P6186, DOI 10.4049/jimmunol.0901474; Falsey AR, 2005, NEW ENGL J MED, V352, P1749, DOI 10.1056/NEJMoa043951; Falsey AR, 2000, CLIN MICROBIOL REV, V13, P371, DOI 10.1128/CMR.13.3.371-384.2000; Feldman SA, 1999, J VIROL, V73, P6610, DOI 10.1128/JVI.73.8.6610-6617.1999; Delgado MF, 2009, NAT MED, V15, P34, DOI 10.1038/nm.1894; Garcon N, 2011, BIODRUGS, V25, P217, DOI 10.2165/11591760-000000000-00000; Garcon N, 2011, EXPERT OPIN BIOL TH, V11, P667, DOI 10.1517/14712598.2011.573624; Graham BS, 2011, IMMUNOL REV, V239, P149, DOI 10.1111/j.1600-065X.2010.00972.x; GRAHAM BS, 1993, J IMMUNOL, V151, P2032; Hall CB, 2009, NEW ENGL J MED, V360, P588, DOI 10.1056/NEJMoa0804877; Haynes LM, 2001, J VIROL, V75, P10730, DOI 10.1128/JVI.75.22.10730-10737.2001; HENDRY RM, 1986, J INFECT DIS, V153, P291, DOI 10.1093/infdis/153.2.291; Heydenreich B, 2014, CLIN EXP IMMUNOL, V176, P310, DOI 10.1111/cei.12294; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Jensen S, 2012, J VIROL, V86, P2900, DOI 10.1128/JVI.05738-11; Johnson TR, 2014, MOL THER, V22, P196, DOI 10.1038/mt.2013.142; Jorquera PA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074905; Kamphuis T, 2013, INFLUENZA OTHER RESP, V7, P1227, DOI 10.1111/irv.12112; Kamphuis T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036812; KAPIKIAN AZ, 1969, AM J EPIDEMIOL, V89, P405, DOI 10.1093/oxfordjournals.aje.a120954; KIM HW, 1969, AM J EPIDEMIOL, V89, P422, DOI 10.1093/oxfordjournals.aje.a120955; Kurt-Jones EA, 2000, NAT IMMUNOL, V1, P398, DOI 10.1038/80833; Legg JP, 2003, AM J RESP CRIT CARE, V168, P633, DOI 10.1164/rccm.200210-1148OC; Liu FX, 2013, PROTEIN EXPRES PURIF, V90, P104, DOI 10.1016/j.pep.2013.05.009; Luchsinger V, 2012, CLIN INFECT DIS, V54, P905, DOI 10.1093/cid/cir955; McGinnes LW, 2011, J VIROL, V85, P366, DOI 10.1128/JVI.01861-10; Murawski MR, 2010, J VIROL, V84, P1110, DOI 10.1128/JVI.01709-09; Murawski MR, 2009, J VIROL, V83, P1492, DOI 10.1128/JVI.00671-08; MURPHY BR, 1986, J CLIN MICROBIOL, V24, P197, DOI 10.1128/JCM.24.2.197-202.1986; MURPHY BR, 1990, VACCINE, V8, P497, DOI 10.1016/0264-410X(90)90253-I; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Neuzil KM, 1996, AM J MED SCI, V311, P201, DOI 10.1097/00000441-199605000-00001; Nish S, 2011, IMMUNITY, V34, P629, DOI 10.1016/j.immuni.2011.05.009; Oshansky CM, 2009, FUTURE MICROBIOL, V4, P279, DOI 10.2217/FMB.09.1; Piedra PA, 2003, VACCINE, V21, P2448, DOI 10.1016/S0264-410X(03)00098-7; PIEDRA PA, 1993, VACCINE, V11, P1415, DOI 10.1016/0264-410X(93)90170-3; Plotkin SA, 2010, CLIN VACCINE IMMUNOL, V17, P1055, DOI 10.1128/CVI.00131-10; Prince GA, 2003, J VIROL, V77, P13156, DOI 10.1128/JVI.77.24.13156-13160.2003; Quan FS, 2011, J INFECT DIS, V204, P987, DOI 10.1093/infdis/jir474; Rixon HWM, 2002, J GEN VIROL, V83, P61, DOI 10.1099/0022-1317-83-1-61; Sandritter T, 1999, J Pediatr Health Care, V13, P191, DOI 10.1016/S0891-5245(99)90039-1; Sandritter T, 1999, J PEDIATR HEALTH CAR, V13, P196; Schmidt AC, 2011, SEMIN RESP CRIT CARE, V32, P527, DOI 10.1055/s-0031-1283289; Schmitt AP, 2002, J VIROL, V76, P3952, DOI 10.1128/JVI.76.8.3952-3964.2002; Shafique M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061287; Shafique M, 2012, VACCINE, V30, P597, DOI 10.1016/j.vaccine.2011.11.054; Singleton R, 2003, J VIROL, V77, P11303, DOI 10.1128/JVI.77.21.11303-11311.2003; Stokes KL, 2013, J VIROL, V87, P10070, DOI 10.1128/JVI.01347-13; Stone J, 2013, NANOTECHNOLOGY, V24, DOI 10.1088/0957-4484/24/29/295102; Tayyari F, 2011, NAT MED, V17, P1132, DOI 10.1038/nm.2444; Teng MN, 2000, J VIROL, V74, P9317, DOI 10.1128/JVI.74.19.9317-9321.2000; Walpita P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018437; Waris ME, 1996, J VIROL, V70, P2852, DOI 10.1128/JVI.70.5.2852-2860.1996; Wright PF, 2000, J INFECT DIS, V182, P1331, DOI 10.1086/315859	68	10	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0130755	10.1371/journal.pone.0130755	http://dx.doi.org/10.1371/journal.pone.0130755			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26172453	Green Submitted, Green Published, gold			2022-12-26	WOS:000358194900009
J	Braid, ACR; Nielsen, SE				Braid, Andrew C. R.; Nielsen, Scott E.			Prioritizing Sites for Protection and Restoration for Grizzly Bears (Ursus arctos) in Southwestern Alberta, Canada	PLOS ONE			English	Article							RESOURCE-EXTRACTION INDUSTRIES; MULTIPLE-USE LANDSCAPE; HABITAT MODELS; CONSERVATION; MORTALITY; ECOSYSTEM; ROADS; CONNECTIVITY; BIODIVERSITY; MOUNTAINS	As the influence of human activities on natural systems continues to expand, there is a growing need to prioritize not only pristine sites for protection, but also degraded sites for restoration. We present an approach for simultaneously prioritizing sites for protection and restoration that considers landscape patterns for a threatened population of grizzly bears (Ursus arctos) in southwestern Alberta, Canada. We considered tradeoffs between bottom-up (food resource supply) and top-down (mortality risk from roads) factors affecting seasonal habitat quality for bears. Simulated annealing was used to prioritize source-like sites (high habitat productivity, low mortality risk) for protection, as well as sink-like sites (high habitat productivity, high mortality risk) for restoration. Priority source-like habitats identified key conservation areas where future developments should be limited, whereas priority sink-like habitats identified key areas for mitigating road-related mortality risk with access management. Systematic conservation planning methods can be used to complement traditional habitat-based methods for individual focal species by identifying habitats where conservation actions (both protection and restoration) have the highest potential utility.	[Braid, Andrew C. R.; Nielsen, Scott E.] Univ Alberta, Dept Renewable Resources, Edmonton, AB, Canada	University of Alberta	Braid, ACR (corresponding author), Univ Alberta, Dept Renewable Resources, Edmonton, AB, Canada.	abraid@ualberta.ca	Nielsen, Scott/C-2842-2013; Nielsen, Scott/O-7482-2019	Nielsen, Scott/0000-0002-9754-0630; Nielsen, Scott/0000-0002-9754-0630	Natural Sciences and Engineering Research Council of Canada [445196]; Alberta Conservation Association	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Alberta Conservation Association	Funding for this project was provided by the Natural Sciences and Engineering Research Council of Canada (ACRB; Industrial Postgraduate Scholarship Program; Application ID 445196; http://www.nserc-crsng.gc.ca/index_eng.asp), as well as the Alberta Conservation Association (ACRB; http://www.ab-conservation.com/go/default/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akcakaya H. Resit, 2000, Ecological Bulletins, V48, P9; Aune K., 1989, FINAL REPORT E FRONT; Ball I., 2000, MARXAN V1 8 2 MARINE; Ball I. R., 2009, SPATIAL CONSERVATION, P185, DOI DOI 10.1111/EVA.12631; Benn B, 2002, URSUS, V13, P213; BOYCE M.S., 2001, INT ASS BEAR RES MAN, V4; Briers RA, 2002, BIOL CONSERV, V103, P77, DOI 10.1016/S0006-3207(01)00123-9; Brooks TM, 2006, SCIENCE, V313, P58, DOI 10.1126/science.1127609; Carroll C, 2001, ECOL APPL, V11, P961, DOI 10.1890/1051-0761(2001)011[0961:CAFSFC]2.0.CO;2; Carwardine J, 2007, BIODIVERS CONSERV, V16, P245, DOI 10.1007/s10531-006-9055-4; Carwardine J, 2009, CONSERV LETT, V2, P3, DOI 10.1111/j.1755-263X.2008.00042.x; Ceballos G, 2005, SCIENCE, V309, P603, DOI 10.1126/science.1114015; Elith J., 2009, SPATIAL CONSERVATION, P70; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Esri, 2013, ARCGIS DESKT 10 2; Fleishman Erica, 2000, Ecological Bulletins, V48, P85; Government of Alberta, 2010, C5 LANDSC ASS C5 FOR; Government of Alberta, 2010, C5 FOR MAN PLAN 2006; Government of Alberta, 2005, ALB VEG INV INT STAN; HAMER D, 1991, CAN FIELD NAT, V105, P325; Hamer D., 1987, INT C BEAR RES MANAG, V7, P179, DOI DOI 10.2307/3872624; Luan XF, 2011, J ENVIRON MANAGE, V92, P31, DOI 10.1016/j.jenvman.2010.08.001; Mace RD, 1996, J APPL ECOL, V33, P1395, DOI 10.2307/2404779; Margules CR, 2002, J BIOSCIENCES, V27, P309, DOI 10.1007/BF02704962; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; McCarthy M. A., 2009, SPATIAL CONSERVATION, P122; McLellan BN, 2011, CAN J ZOOL, V89, P546, DOI 10.1139/Z11-026; MCLELLAN BN, 1989, J APPL ECOL, V26, P371, DOI 10.2307/2404067; MCLELLAN BN, 1989, WILDLIFE SOC B, V17, P269; McLellan BN, 1999, J WILDLIFE MANAGE, V63, P911, DOI 10.2307/3802805; McLellan BN, 2001, J WILDLIFE MANAGE, V65, P92, DOI 10.2307/3803280; MCLELLAN BN, 1988, J APPL ECOL, V25, P451, DOI 10.2307/2403836; Merrill T, 1999, BIOL CONSERV, V87, P231, DOI 10.1016/S0006-3207(98)00057-3; Munro RHM, 2006, J MAMMAL, V87, P1112, DOI 10.1644/05-MAMM-A-410R3.1; Natural Regions Committee, 2006, NAT REG SUBR ALB; Naves J, 2003, CONSERV BIOL, V17, P1276, DOI 10.1046/j.1523-1739.2003.02144.x; Nielsen S.E., 2009, J CONSERVATION PLANN, V5, P38; Nielsen Scott, 2011, British Columbia Journal of Ecosystems and Management, V12, P136; Nielsen SE, 2010, BIOL CONSERV, V143, P1623, DOI 10.1016/j.biocon.2010.04.007; Nielsen SE, 2006, BIOL CONSERV, V130, P217, DOI 10.1016/j.biocon.2005.12.016; Nielsen SE, 2004, BIOL CONSERV, V120, P101, DOI 10.1016/j.biocon.2004.02.020; Nielsen SE, 2003, ECOSCIENCE, V10, P1; Northrup JM, 2012, J APPL ECOL, V49, P1159, DOI 10.1111/j.1365-2664.2012.02180.x; Noss R, 2009, SPATIAL CONSERVATION, P158; Pierce SM, 2005, BIOL CONSERV, V125, P441, DOI 10.1016/j.biocon.2005.04.019; Pressey RL, 2007, TRENDS ECOL EVOL, V22, P583, DOI 10.1016/j.tree.2007.10.001; Roberts DR, 2014, ECOL APPL, V24, P1144, DOI 10.1890/13-0829.1; Sala E, 2002, SCIENCE, V298, P1991, DOI 10.1126/science.1075284; SAUNDERS DA, 1991, CONSERV BIOL, V5, P18, DOI 10.1111/j.1523-1739.1991.tb00384.x; Schwartz CC, 2010, J WILDLIFE MANAGE, V74, P654, DOI 10.2193/2009-206; Smith RJ, 2006, ORYX, V40, P400, DOI 10.1017/S0030605306001232; TAYLOR PD, 1993, OIKOS, V68, P571, DOI 10.2307/3544927; Watson J.E.M., 2011, CONSERVATION BIOGEOG, P136, DOI [DOI 10.1002/9781444390001.CH6, 10.1002/9781444390001.ch6]; Watts ME, 2009, ENVIRON MODELL SOFTW, V24, P1513, DOI 10.1016/j.envsoft.2009.06.005; Wielgus RB, 2002, CAN J FOREST RES, V32, P1597, DOI 10.1139/X02-084	55	13	13	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0132501	10.1371/journal.pone.0132501	http://dx.doi.org/10.1371/journal.pone.0132501			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26168055	Green Published, gold, Green Submitted			2022-12-26	WOS:000358193100046
J	Fu, H; Zhong, JY; Yuan, GX; Guo, CJ; Lou, Q; Zhang, W; Xu, J; Ni, LY; Xie, P; Cao, T				Fu, Hui; Zhong, Jiayou; Yuan, Guixiang; Guo, Chunjing; Lou, Qian; Zhang, Wei; Xu, Jun; Ni, Leyi; Xie, Ping; Cao, Te			Predicting Changes in Macrophyte Community Structure from Functional Traits in a Freshwater Lake: A Test of Maximum Entropy Model	PLOS ONE			English	Article							AQUATIC MACROPHYTES; ECOSYSTEM PROCESSES; COASTAL CALIFORNIA; PLASTIC RESPONSES; DEPTH GRADIENT; PLANT TRAITS; DIVERSITY; ECOLOGY; NUTRIENTS; ZONATION	Trait-based approaches have been widely applied to investigate how community dynamics respond to environmental gradients. In this study, we applied a series of maximum entropy (maxent) models incorporating functional traits to unravel the processes governing macro-phyte community structure along water depth gradient in a freshwater lake. We sampled 42 plots and 1513 individual plants, and measured 16 functional traits and abundance of 17 macrophyte species. Study results showed that maxent model can be highly robust (99.8%) in predicting the species relative abundance of macrophytes with observed community-weighted mean (CWM) traits as the constraints, while relative low (about 30%) with CWM traits fitted from water depth gradient as the constraints. The measured traits showed notably distinct importance in predicting species abundances, with lowest for perennial growth form and highest for leaf dry mass content. For tuber and leaf nitrogen content, there were significant shifts in their effects on species relative abundance from positive in shallow water to negative in deep water. This result suggests that macrophyte species with tuber organ and greater leaf nitrogen content would become more abundant in shallow water, but would become less abundant in deep water. Our study highlights how functional traits distributed across gradients provide a robust path towards predictive community ecology.	[Fu, Hui; Zhong, Jiayou; Yuan, Guixiang; Guo, Chunjing; Lou, Qian; Zhang, Wei] Jiangxi Inst Water Sci, Jiangxi Prov Key Lab Water Resources & Environm P, Nanchang, Peoples R China; [Fu, Hui; Xu, Jun; Ni, Leyi; Xie, Ping; Cao, Te] Chinese Acad Sci, Inst Hydrobiol, State Key Lab Freshwater Ecol & Biotechnol, Donghu Expt Stn Lake Ecosyst, Wuhan, Peoples R China	Chinese Academy of Sciences; Institute of Hydrobiology, CAS	Zhong, JY (corresponding author), Jiangxi Inst Water Sci, Jiangxi Prov Key Lab Water Resources & Environm P, Nanchang, Peoples R China.	jiayou@jxsl.gov.cn; caote@ihb.ac.cn	Xie, Ping/AAL-7532-2020		National Science Foundation of China [31300398, 31400404]; Science and Technology Program of Jiangxi Provincial Department of Water Resources [KT201212]; Science program for postdoctoral of Jiangxi Province [2012RC20, 2013KY20]; National High Technology Research and Development Program of China [2012ZX07105-004]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Program of Jiangxi Provincial Department of Water Resources; Science program for postdoctoral of Jiangxi Province; National High Technology Research and Development Program of China(National High Technology Research and Development Program of China)	This study (the study design, data collection and analysis, decision to publish, or preparation of the manuscript) was supported by the National Science Foundation of China (Grant No. 31300398, 31400404), the Science and Technology Program of Jiangxi Provincial Department of Water Resources (Grant No. KT201212), the Science program for postdoctoral of Jiangxi Province (Grant No. 2012RC20, 2013KY20) and the National High Technology Research and Development Program of China (Grant No. 2012ZX07105-004).	Bornette G, 2011, AQUAT SCI, V73, P1, DOI 10.1007/s00027-010-0162-7; Butterfield BJ, 2013, J ECOL, V101, P9, DOI 10.1111/1365-2745.12013; Cardinale BJ, 2007, P NATL ACAD SCI USA, V104, P18123, DOI 10.1073/pnas.0709069104; CHAMBERS PA, 1987, J ECOL, V75, P611, DOI 10.2307/2260193; CHAMBERS PA, 1987, J ECOL, V75, P621, DOI 10.2307/2260194; Cornwell WK, 2010, J ECOL, V98, P814, DOI 10.1111/j.1365-2745.2010.01662.x; Cornwell WK, 2009, ECOL MONOGR, V79, P109, DOI 10.1890/07-1134.1; Diaz S, 2001, TRENDS ECOL EVOL, V16, P646, DOI 10.1016/S0169-5347(01)02283-2; Engelhardt KAM, 2006, ECOL APPL, V16, P1808, DOI 10.1890/1051-0761(2006)016[1808:REARTI]2.0.CO;2; Fu H, 2014, FRESHWATER BIOL, V59, P2462, DOI 10.1111/fwb.12443; Fu H, 2014, ECOL EVOL, V4, P1516, DOI 10.1002/ece3.1022; Fu H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062794; Fu H, 2012, ECOL RES, V27, P1087, DOI 10.1007/s11284-012-0991-z; Garnier E, 2004, ECOLOGY, V85, P2630, DOI 10.1890/03-0799; IdestamAlmquist J, 1995, AQUAT BOT, V52, P205, DOI 10.1016/0304-3770(95)00499-8; Laughlin D.C., 2013, TRENDS PLANT SCI; Laughlin DC, 2011, J ECOL, V99, P1489, DOI 10.1111/j.1365-2745.2011.01885.x; MABERLY SC, 1993, J AQUAT PLANT MANAGE, V31, P34; McGill BJ, 2006, TRENDS ECOL EVOL, V21, P178, DOI 10.1016/j.tree.2006.02.002; Messier J, 2010, ECOL LETT, V13, P838, DOI 10.1111/j.1461-0248.2010.01476.x; Mokany K, 2008, J ECOL, V96, P884, DOI 10.1111/j.1365-2745.2008.01395.x; Moreira B, 2012, OECOLOGIA, V168, P671, DOI 10.1007/s00442-011-2127-5; Roscher C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036760; Santamaria L, 2002, ACTA OECOL, V23, P137, DOI 10.1016/S1146-609X(02)01146-3; Shipley B, 2006, SCIENCE, V314, P812, DOI 10.1126/science.1131344; Shipley B, 2011, ECOLOGY, V92, P507, DOI 10.1890/10-0394.1; Shipley B, 2010, ECOLOGY, V91, P2794, DOI 10.1890/09-1255.1; SPENCE DHN, 1970, NEW PHYTOL, V69, P205, DOI 10.1111/j.1469-8137.1970.tb04064.x; SPENCE DHN, 1973, J ECOL, V61, P317, DOI 10.2307/2259028; Strand JA, 2001, J ECOL, V89, P166, DOI 10.1046/j.1365-2745.2001.00530.x; Suding KN, 2008, GLOBAL CHANGE BIOL, V14, P1125, DOI 10.1111/j.1365-2486.2008.01557.x; WEIHER E, 1995, OIKOS, V74, P159, DOI 10.2307/3545686; Westoby M, 2002, ANNU REV ECOL SYST, V33, P125, DOI 10.1146/annurev.ecolsys.33.010802.150452; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403; Yuan GX, 2013, FRESHWATER BIOL, V58, P2532, DOI 10.1111/fwb.12230	35	11	12	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0131630	10.1371/journal.pone.0131630	http://dx.doi.org/10.1371/journal.pone.0131630			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26167856	Green Published, gold			2022-12-26	WOS:000358193100011
J	Mahdipour, M; Leitoguinho, ARC; Silva, RAZ; van Tol, HTA; Stout, TAE; Rodrigues, G; Roelen, BAJ				Mahdipour, Mahdi; Canhoto Leitoguinho, Ana Rita; Zacarias Silva, Ricardo A.; van Tol, Helena T. A.; Stout, Tom A. E.; Rodrigues, Gabriela; Roelen, Bernard A. J.			TACC3 Is Important for Correct Progression of Meiosis in Bovine Oocytes	PLOS ONE			English	Article							SMALL-MOLECULE INHIBITOR; AURORA-A; SPINDLE FORMATION; MOUSE OOCYTES; EXPRESSION; MATURATION; PROTEIN; KINASE; CLATHRIN; MLN8054	Transforming acidic coiled-coil (TACC) proteins are key players during mitosis via stabilization of the spindle. The roles of TACCs during meiosis are however less clear. We used bovine oocytes to study the expression and function of TACC3 during meiosis. TACC3 mRNA was detected in bovine oocytes during meiosis using qRT-PCR, and while it was also expressed in cleavage stage embryos, its expression was down-regulated at the morula and blastocyst stages. Immunofluorescence was used to demonstrate that TACC3 co-localized with tubulin in the metaphase I and II spindles. However, TACC3 was not detected at anaphase or telophase of the first meiotic division. Aurora A, which is known to phosphorylate and activate TACC3 in mitotic cells, showed a similar pattern of gene expression to that of TACC3 in meiotic oocytes and preimplantation embryos. Aurora A protein was however only very transiently associated to the meiotic spindle. Pharmaceutical inhibition of Aurora A activity inhibited TACC3 phosphorylation but did not prevent TACC3 appearance in the spindle. Inhibiting Aurora A activity did however lead to abnormal meiotic spindle formation and impaired maturation of bovine oocytes. Similar results were obtained by knockdown of TACC3 expression using siRNA injection. These results suggest that TACC3 is important for stabilizing the meiotic spindle, but phosphorylation of TACC3 by Aurora A is not required for its recruitment to the meiotic spindle although phosphorylation of TACC3 by other kinases cannot be excluded.	[Mahdipour, Mahdi; Canhoto Leitoguinho, Ana Rita; Zacarias Silva, Ricardo A.; van Tol, Helena T. A.; Stout, Tom A. E.; Roelen, Bernard A. J.] Univ Utrecht, Fac Vet Med, Dept Farm Anim Hlth, NL-3584 CM Utrecht, Netherlands; [Canhoto Leitoguinho, Ana Rita; Zacarias Silva, Ricardo A.; Rodrigues, Gabriela] Univ Lisbon, Fac Ciencias, Ctr Biol Ambiental, P-1749016 Lisbon, Portugal; [Canhoto Leitoguinho, Ana Rita; Zacarias Silva, Ricardo A.; Rodrigues, Gabriela] Univ Lisbon, Fac Ciencias, Dept Biol Anim, P-1749016 Lisbon, Portugal; [Stout, Tom A. E.; Roelen, Bernard A. J.] Univ Utrecht, Fac Vet Med, Dept Equine Sci, NL-3584 CM Utrecht, Netherlands	Utrecht University; Universidade de Lisboa; Universidade de Lisboa; Utrecht University	Roelen, BAJ (corresponding author), Univ Utrecht, Fac Vet Med, Dept Farm Anim Hlth, Yalelaan 104, NL-3584 CM Utrecht, Netherlands.	b.a.j.roelen@uu.nl	Rodrigues, Gabriela/GQH-1711-2022; Rodrigues, Gabriela/A-1909-2013	Rodrigues, Gabriela/0000-0002-0598-4040; Mahdipour, Mahdi/0000-0002-2729-4593	Ministry of Science, Resreach and Technology (MSRT), Iran [42/5/33681]; EU Seventh Framework Programme (FP7) Anistem Industry-Academia Partnerships and Pathways (IAPP) [GA-2011-286264]; Epigenetics and periconception environment (EpiConcept) European Cooperation in Science and Technology (COST) Action [FA1201]; Erasmus programme EUC [29206-IC-2007-1-PT-ERASMUS-EUCX-1];  [GA-2013-317146]	Ministry of Science, Resreach and Technology (MSRT), Iran; EU Seventh Framework Programme (FP7) Anistem Industry-Academia Partnerships and Pathways (IAPP); Epigenetics and periconception environment (EpiConcept) European Cooperation in Science and Technology (COST) Action; Erasmus programme EUC; 	Ministry of Science, Resreach and Technology (MSRT), Iran 42/5/33681; EU Seventh Framework Programme (FP7) Anistem Industry-Academia Partnerships and Pathways (IAPP)-GA-2011-286264; EU Seventh Framework Programme (FP7) EpiHealthNet Initial Training Networks (ITN)-GA-2013-317146; Epigenetics and periconception environment (EpiConcept) European Cooperation in Science and Technology (COST) Action FA1201; and Erasmus programme EUC n. 29206-IC-2007-1-PT-ERASMUS-EUCX-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript The Anistem Industry-Academia Partnerships and Pathways is a European FP7 IAPP project (non-commercial); EpiHealthNet Initial Training Networks is a European FP7 ITN project (non-commercial). The funding does not alter the authors' adherence to PLOS ONE policies on sharing our data and materials. There are no restrictions on sharing the authors' data and/or materials.	Beaujean N, 2004, P NATL ACAD SCI USA, V101, P7636, DOI 10.1073/pnas.0400730101; Beker-van Woudenberg AR, 2004, BIOL REPROD, V70, P1465, DOI 10.1095/biolreprod.103.025684; Brunet S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003338; Fu WX, 2010, J CELL SCI, V123, P3645, DOI 10.1242/jcs.075911; Gergely F, 2000, P NATL ACAD SCI USA, V97, P14352, DOI 10.1073/pnas.97.26.14352; Gruss OJ, 2002, NAT CELL BIOL, V4, P871, DOI 10.1038/ncb870; Hoar K, 2007, MOL CELL BIOL, V27, P4513, DOI 10.1128/MCB.02364-06; Holzenspies JJ, 2010, REPRODUCTION, V140, P223, DOI 10.1530/REP-10-0045; Kimura M, 1997, J BIOL CHEM, V272, P13766, DOI 10.1074/jbc.272.21.13766; Kinoshita K, 2005, J CELL BIOL, V170, P1047, DOI 10.1083/jcb.200503023; LeRoy PJ, 2007, CANCER RES, V67, P5362, DOI 10.1158/0008-5472.CAN-07-0122; Li R, 2013, NAT REV MOL CELL BIO, V14, P141, DOI 10.1038/nrm3531; Luders J, 2007, NAT REV MOL CELL BIO, V8, P161, DOI 10.1038/nrm2100; Macarulla T, 2010, MOL CANCER THER, V9, P2844, DOI 10.1158/1535-7163.MCT-10-0299; Manfredi MG, 2007, P NATL ACAD SCI USA, V104, P4106, DOI 10.1073/pnas.0608798104; Memili E, 2000, ZYGOTE, V8, P87, DOI 10.1017/S0967199400000861; Morgan HD, 2005, HUM MOL GENET, V14, pR47, DOI 10.1093/hmg/ddi114; MUNNE S, 1995, FERTIL STERIL, V64, P382, DOI 10.1016/S0015-0282(16)57739-5; O'Connell CB, 2007, J CELL SCI, V120, P1717, DOI 10.1242/jcs.03442; Peset I, 2008, TRENDS CELL BIOL, V18, P379, DOI 10.1016/j.tcb.2008.06.005; Piekorz RP, 2002, EMBO J, V21, P653, DOI 10.1093/emboj/21.4.653; Raff JW, 2002, TRENDS CELL BIOL, V12, P222, DOI 10.1016/S0962-8924(02)02268-7; Royle SJ, 2012, J CELL SCI, V125, P19, DOI 10.1242/jcs.094607; Sadek CM, 2003, GENE EXPR PATTERNS, V3, P203, DOI 10.1016/S1567-133X(02)00066-2; Uzbekova S, 2008, BIOL REPROD, V78, P218, DOI 10.1095/biolreprod.107.061036; van Tol HTA, 2008, MOL REPROD DEV, V75, P578, DOI 10.1002/mrd.20801; Yao LJ, 2004, BIOL REPROD, V70, P1392, DOI 10.1095/biolreprod.103.025155	27	13	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0132591	10.1371/journal.pone.0132591	http://dx.doi.org/10.1371/journal.pone.0132591			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26168150	Green Published, Green Submitted, gold			2022-12-26	WOS:000358193100056
J	Oikawa, A; Otsuka, T; Nakabayashi, R; Jikumaru, Y; Isuzugawa, K; Murayama, H; Saito, K; Shiratake, K				Oikawa, Akira; Otsuka, Takao; Nakabayashi, Ryo; Jikumaru, Yusuke; Isuzugawa, Kanji; Murayama, Hideki; Saito, Kazuki; Shiratake, Katsuhiro			Metabolic Profiling of Developing Pear Fruits Reveals Dynamic Variation in Primary and Secondary Metabolites, Including Plant Hormones	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; MASS-SPECTROMETRY; GENETIC METABOLOMICS; SIGNAL-TRANSDUCTION; PATHWAY; ARABIDOPSIS; NETWORKS; TOMATO; GRAPES; ACID	Metabolites in the fruits of edible plants include sweet sugars, visually appealing pigments, various products with human nutritional value, and biologically active plant hormones. Although quantities of these metabolites vary during fruit development and ripening because of cell division and enlargement, there are few reports describing the actual dynamics of these changes. Therefore, we applied multiple metabolomic techniques to identify the changes in metabolite levels during the development and ripening of pear fruits (Pyrus communis L. 'La France'). We quantified and classified over 250 metabolites into six groups depending on their specific patterns of variation during development and ripening. Approximately half the total number of metabolites, including histidine and malate, accumulated transiently around the blooming period, during which cells are actively dividing, and then decreased either rapidly or slowly. Furthermore, the amounts of sulfur-containing amino acids also increased in pear fruits around 3-4 months after the blooming period, when fruit cells are enlarging, but virtually disappeared from ripened fruits. Some metabolites, including the plant hormone abscisic acid, accumulated particularly in the receptacle prior to blooming and/or fruit ripening. Our results show several patterns of variation in metabolite levels in developing and ripening pear fruits, and provide fundamental metabolomic data that is useful for understanding pear fruit physiology and enhancing the nutritional traits of new cultivars.	[Oikawa, Akira; Otsuka, Takao; Nakabayashi, Ryo; Jikumaru, Yusuke; Saito, Kazuki] RIKEN, Ctr Sustainable Resource Sci, Yokohama, Kanagawa 2300045, Japan; [Oikawa, Akira; Murayama, Hideki] Yamagata Univ, Fac Agr, Tsuruoka, Yamagata 9978555, Japan; [Isuzugawa, Kanji] Yamagata Integrated Agr Res Ctr, Sagae, Yamagata 9997601, Japan; [Saito, Kazuki] Chiba Univ, Grad Sch Pharmaceut Sci, Chiba 2608675, Japan; [Shiratake, Katsuhiro] Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan	RIKEN; Yamagata University; Chiba University; Nagoya University	Oikawa, A (corresponding author), RIKEN, Ctr Sustainable Resource Sci, Yokohama, Kanagawa 2300045, Japan.	oikawa@tds1.tr.yamagata-u.ac.jp	Nakabayashi, Ryo/C-9734-2017; 亮, 中林/GVU-2660-2022; Oikawa, Akira/D-2715-2017; Saito, Kazuki/D-2670-2009	Nakabayashi, Ryo/0000-0002-8674-0928; Saito, Kazuki/0000-0001-6310-5342	Promotion of Basic and Applied Research for Innovation in Bio-oriented Industry (BRAIN)	Promotion of Basic and Applied Research for Innovation in Bio-oriented Industry (BRAIN)	This work was funded by Promotion of Basic and Applied Research for Innovation in Bio-oriented Industry (BRAIN) (http://www.naro.affrc.go.jp/english/brain/index.html) to AO, KI, and K. Shiratake.	Albers E, 2009, IUBMB LIFE, V61, P1132, DOI 10.1002/iub.278; Ashikari M, 2006, TRENDS PLANT SCI, V11, P344, DOI 10.1016/j.tplants.2006.05.008; BARHAM D, 1972, ANALYST, V97, P142, DOI 10.1039/an9729700142; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Caraux G, 2005, BIOINFORMATICS, V21, P1280, DOI 10.1093/bioinformatics/bti141; Cruz-Hernandez A, 2012, CRIT REV FOOD SCI, V52, P272, DOI 10.1080/10408398.2010.499844; ECKER JR, 1995, SCIENCE, V268, P667, DOI 10.1126/science.7732375; Gambetta GA, 2010, PLANTA, V232, P219, DOI 10.1007/s00425-010-1165-2; Hoekstra FA, 2001, TRENDS PLANT SCI, V6, P431, DOI 10.1016/S1360-1385(01)02052-0; Jacob JK, 2012, ANNU REV FOOD SCI T, V3, P79, DOI 10.1146/annurev-food-022811-101127; Jia HF, 2011, PLANT PHYSIOL, V157, P188, DOI 10.1104/pp.111.177311; Klee HJ, 2010, NEW PHYTOL, V187, P44, DOI 10.1111/j.1469-8137.2010.03281.x; Koulman A, 2009, RAPID COMMUN MASS SP, V23, P2253, DOI 10.1002/rcm.4142; Lin LZ, 2008, J AGR FOOD CHEM, V56, P9094, DOI 10.1021/jf8013487; Lombardo VA, 2011, PLANT PHYSIOL, V157, P1696, DOI 10.1104/pp.111.186064; Matsuda F, 2012, PLANT J, V70, P624, DOI 10.1111/j.1365-313X.2012.04903.x; MAZZA G, 1995, CRIT REV FOOD SCI, V35, P341, DOI 10.1080/10408399509527704; McAtee P, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00079; McDougall G, 2008, J CHROMATOGR B, V871, P362, DOI 10.1016/j.jchromb.2008.06.032; Moco S, 2006, PLANT PHYSIOL, V141, P1205, DOI 10.1104/pp.106.078428; Morreel K, 2006, PLANT J, V47, P224, DOI 10.1111/j.1365-313X.2006.02786.x; Murayama H, 2002, POSTHARVEST BIOL TEC, V26, P15, DOI 10.1016/S0925-5214(01)00200-9; Ohkama-Ohtsu N, 2008, PLANT PHYSIOL, V148, P1603, DOI 10.1104/pp.108.125716; Oikawa A, 2006, PLANT PHYSIOL, V142, P398, DOI 10.1104/pp.106.080317; Oikawa A, 2011, J SEP SCI, V34, P3561, DOI 10.1002/jssc.201100466; Oikawa A, 2011, J SEP SCI, V34, P1063, DOI 10.1002/jssc.201000890; Osorio S, 2012, PLANT PHYSIOL, V159, P1713, DOI 10.1104/pp.112.199711; Ostergaard L, 2009, CURR OPIN PLANT BIOL, V12, P36, DOI 10.1016/j.pbi.2008.09.011; Rowe HC, 2008, PLANT CELL, V20, P1199, DOI 10.1105/tpc.108.058131; SCHRAM E, 1954, BIOCHEM J, V57, P33, DOI 10.1042/bj0570033; Son HS, 2009, J AGR FOOD CHEM, V57, P1481, DOI 10.1021/jf803388w; Symons GM, 2006, PLANT PHYSIOL, V140, P150, DOI 10.1104/pp.105.070706; Takahashi H, 2011, ANNU REV PLANT BIOL, V62, P157, DOI 10.1146/annurev-arplant-042110-103921; Toennies G, 1942, J AM CHEM SOC, V64, P3054, DOI 10.1021/ja01264a518; Tuteja N, 2007, METHOD ENZYMOL, V428, P419, DOI 10.1016/S0076-6879(07)28024-3; Vardhini BV, 2002, PHYTOCHEMISTRY, V61, P843, DOI 10.1016/S0031-9422(02)00223-6; Wu J, 2013, GENOME RES, V23, P396, DOI 10.1101/gr.144311.112; Yoshimoto K, 2009, PLANT CELL, V21, P2914, DOI 10.1105/tpc.109.068635; Zamboni A, 2010, PLANT PHYSIOL, V154, P1439, DOI 10.1104/pp.110.160275; Zhang JJ, 2011, J EXP BOT, V62, P1103, DOI 10.1093/jxb/erq343; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329	41	53	53	5	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0131408	10.1371/journal.pone.0131408	http://dx.doi.org/10.1371/journal.pone.0131408			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26168247	Green Published, Green Submitted, gold			2022-12-26	WOS:000358193100008
J	Ren, ZY; Machuca-Gayet, I; Domenget, C; Buchet, R; Wu, YQ; Jurdic, P; Mebarek, S				Ren, Zhong-Yuan; Machuca-Gayet, Irma; Domenget, Chantal; Buchet, Rene; Wu, Yuqing; Jurdic, Pierre; Mebarek, Saida			Azanitrile Cathepsin K Inhibitors: Effects on Cell Toxicity, Osteoblast-Induced Mineralization and Osteoclast-Mediated Bone Resorption	PLOS ONE			English	Article							AZADIPEPTIDE NITRILE INHIBITORS; OSTEOPOROSIS; ODANACATIB; DESIGN; DENSITY; LIGAND; POTENT; ASSAYS; ACID; MICE	Aim The cysteine protease cathepsin K (CatK), abundantly expressed in osteoclasts, is responsible for the degradation of bone matrix proteins, including collagen type 1. Thus, CatK is an attractive target for new anti-resorptive osteoporosis therapies, but the wider effects of CatK inhibitors on bone cells also need to be evaluated to assess their effects on bone. Therefore, we selected, among a series of synthetized isothiosemicarbazides, two molecules which are highly selective CatK inhibitors (CKIs) to test their effects on osteoblasts and osteoclasts. Research Design and Methods Cell viability upon treatment of CKIs were was assayed on human osteoblast-like Saos-2, mouse monocyte cell line RAW 264.7 and mature mouse osteoclasts differentiated from bone marrow. Osteoblast-induced mineralization in Saos-2 cells and in mouse primary osteoblasts from calvaria, with or without CKIs,; were was monitored by Alizarin Red staining and alkaline phosphatase activity, while osteoclast-induced bone resorption was performed on bovine slices. Results Treatments with two CKIs, CKI-8 and CKI-13 in human osteoblast-like Saos-2, murine RAW 264.7 macrophages stimulated with RANKL and mouse osteoclasts differentiated from bone marrow stimulated with RANKL and MCSF were found not to be toxic at doses of up to 100 nM. As probed by Alizarin Red staining, CKI-8 did not inhibit osteoblast-induced mineralization in mouse primary osteoblasts as well as in osteoblast-like Saos-2 cells. However, CKI-13 led to a reduction in mineralization of around 40% at 10-100 nM concentrations in osteoblast-like Saos-2 cells while it did not in primary cells. After a 48-hour incubation, both CKI-8 and CKI-13 decreased bone resorption on bovine bone slices. CKI-13 was more efficient than the commercial inhibitor E-64 in inhibiting bone resorption induced by osteoclasts on bovine bone slices. Both CKI-8 and CKI-13 created smaller bone resorption pits on bovine bone slices, suggesting that the mobility of osteoclasts was slowed down by the addition of CKI-8 and CKI-13. Conclusion CKI-8 and CKI-13 screened here show promise as antiresorptive osteoporosis therapeutics but some off target effects on osteoblasts were found with CKI-13.	[Ren, Zhong-Yuan; Wu, Yuqing] Jilin Univ, State Key Lab Supramol Struct & Mat, Changchun 130012, Peoples R China; [Ren, Zhong-Yuan; Machuca-Gayet, Irma; Domenget, Chantal; Buchet, Rene; Jurdic, Pierre; Mebarek, Saida] Univ Lyon, F-69622 Villeurbanne, France; [Ren, Zhong-Yuan; Machuca-Gayet, Irma; Domenget, Chantal; Buchet, Rene; Jurdic, Pierre; Mebarek, Saida] Univ Lyon 1, F-69622 Villeurbanne, France; [Ren, Zhong-Yuan; Buchet, Rene; Mebarek, Saida] CPE Lyon, F-69622 Villeurbanne, France; [Ren, Zhong-Yuan; Buchet, Rene; Mebarek, Saida] Inst Natl Sci Appl, F-69622 Villeurbanne, France; [Ren, Zhong-Yuan; Buchet, Rene; Mebarek, Saida] Inst Chim & Biochim Mol & Supramol, F-69622 Villeurbanne, France; [Ren, Zhong-Yuan; Buchet, Rene; Mebarek, Saida] CNRS UMR 5246, F-69622 Villeurbanne, France; [Machuca-Gayet, Irma; Domenget, Chantal; Jurdic, Pierre] Ecole Normale Super Lyon, F-69634 Lyon, France; [Machuca-Gayet, Irma; Domenget, Chantal; Jurdic, Pierre] Inst Genom Fonct Lyon, F-69634 Lyon, France; [Machuca-Gayet, Irma; Domenget, Chantal; Jurdic, Pierre] CNRS UMR3444, F-69634 Lyon, France	Jilin University; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National des Sciences Appliquees de Lyon - INSA Lyon; Institut National des Sciences Appliquees de Lyon - INSA Lyon; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Institut National des Sciences Appliquees de Lyon - INSA Lyon; Ecole Normale Superieure de Lyon (ENS de LYON); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON)	Mebarek, S (corresponding author), Univ Lyon, F-69622 Villeurbanne, France.	saida.youjil@univ-lyon1.fr	Rene, Buchet/I-9781-2019; Mebarek, Saida/AAI-8237-2020	Rene, Buchet/0000-0002-7966-3856; Machuca- Gayet, irma/0000-0002-3010-9774; Mebarek, Saida/0000-0001-8806-8904; Ren, Zhongyuan/0000-0002-0300-7801	National Natural Science Foundation of China [21373101]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by a grant from National Natural Science Foundation of China (No. 21373101) (YW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baron R, 2011, BONE, V48, P677, DOI 10.1016/j.bone.2010.11.020; Bone HG, 2015, OSTEOPOROSIS INT, V26, P699, DOI 10.1007/s00198-014-2944-6; Bone HG, 2010, J BONE MINER RES, V25, P937, DOI 10.1359/jbmr.091035; Boonen S, 2012, CURR OSTEOPOROS REP, V10, P73, DOI 10.1007/s11914-011-0085-9; Chambers TJ, 2013, J CLIN ENDOCR METAB, V98, P4329, DOI 10.1210/jc.2013-2630; Collin-Osdoby P, 2012, METHODS MOL BIOL, V816, P187, DOI 10.1007/978-1-61779-415-5_13; CYBORON GW, 1981, J BIOL CHEM, V256, P7262; Delbeck M, 2012, Patent Application, Patent No. [A1, WO2012156311, 2012156311]; Duong Le T, 2012, Bonekey Rep, V1, P67, DOI 10.1038/bonekey.2012.67; Frizler M, 2011, CHEM-EUR J, V17, P11419, DOI 10.1002/chem.201101350; Frizler M, 2011, J MED CHEM, V54, P396, DOI 10.1021/jm101272p; Fuller K, 2010, BONE, V46, P1400, DOI 10.1016/j.bone.2010.01.374; Georgess D, 2014, MOL BIOL CELL, V25, P380, DOI 10.1091/mbc.E13-07-0363; Gillette JM, 2004, J CELL SCI, V117, P441, DOI 10.1242/jcs.00909; Henriksen K, 2009, BONE, V44, P1026, DOI 10.1016/j.bone.2009.03.671; Hsu HL, 1999, P NATL ACAD SCI USA, V96, P3540, DOI 10.1073/pnas.96.7.3540; Kim MK, 2006, J PHARMACOL EXP THER, V318, P555, DOI 10.1124/jpet.106.102798; Kiviranta R, 2001, J BONE MINER RES, V16, P1444, DOI 10.1359/jbmr.2001.16.8.1444; Lems WF, 2014, CURR OPIN RHEUMATOL, V26, P245, DOI 10.1097/BOR.0000000000000057; Li WA, 2010, ANAL BIOCHEM, V401, P91, DOI 10.1016/j.ab.2010.02.035; Loser R, 2008, ANGEW CHEM INT EDIT, V47, P4331, DOI 10.1002/anie.200705858; Loh YH, 2010, CHEM COMMUN, V46, P8407, DOI 10.1039/c0cc03738a; Martin TJ, 2009, CRIT REV EUKAR GENE, V19, P73, DOI 10.1615/CritRevEukarGeneExpr.v19.i1.40; Martin TJ, 2005, TRENDS MOL MED, V11, P76, DOI 10.1016/j.molmed.2004.12.004; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nakamura T, 2014, OSTEOPOROSIS INT, V25, P367, DOI 10.1007/s00198-013-2398-2; Ng KW, 2012, CLIN INTERV AGING, V7, P235, DOI 10.2147/CIA.S26729; Novack DV, 2011, AGEING RES REV, V10, P54, DOI 10.1016/j.arr.2009.09.005; Pennypacker B, 2009, BONE, V44, P199, DOI 10.1016/j.bone.2008.08.130; Rachner TD, 2011, LANCET, V377, P1276, DOI 10.1016/S0140-6736(10)62349-5; Ren XF, 2013, ORG BIOMOL CHEM, V11, P1143, DOI 10.1039/c2ob26624e; Rousselle AV, 2002, BONE, V30, P533, DOI 10.1016/S8756-3282(02)00672-5; Schmitz J, 2014, ACS MED CHEM LETT, V5, P1076, DOI 10.1021/ml500238q; STANFORD CM, 1995, J BIOL CHEM, V270, P9420, DOI 10.1074/jbc.270.16.9420; Stoch SA, 2008, CLIN PHARMACOL THER, V83, P172, DOI 10.1038/sj.clpt.6100450; Stoch SA, 2013, BRIT J CLIN PHARMACO, V75, P1240, DOI 10.1111/j.1365-2125.2012.04471.x; Suda T, 1997, J BONE MINER RES, V12, P869, DOI 10.1359/jbmr.1997.12.6.869; Thouverey C, 2009, J CELL BIOCHEM, V106, P127, DOI 10.1002/jcb.21992; Vaingankar SM, 2004, AM J PHYSIOL-CELL PH, V286, pC1177, DOI 10.1152/ajpcell.00320.2003; Yamamoto A, 2002, J BONE MINER RES, V17, P612, DOI 10.1359/jbmr.2002.17.4.612; Yang PY, 2012, CHEM-EUR J, V18, P6528, DOI 10.1002/chem.201103322; Yuan XY, 2013, ORG BIOMOL CHEM, V11, P5847, DOI 10.1039/c3ob41165f	42	7	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0132513	10.1371/journal.pone.0132513	http://dx.doi.org/10.1371/journal.pone.0132513			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26168340	Green Submitted, Green Published, gold			2022-12-26	WOS:000358193100049
J	Shaw, AG; Sim, K; Randell, P; Cox, MJ; McClure, ZE; Li, MS; Donaldson, H; Langford, PR; Cookson, WOCM; Moffatt, MF; Kroll, JS				Shaw, Alexander G.; Sim, Kathleen; Randell, Paul; Cox, Michael J.; McClure, Zoe E.; Li, Ming-Shi; Donaldson, Hugo; Langford, Paul R.; Cookson, William O. C. M.; Moffatt, Miriam F.; Kroll, J. Simon			Late-Onset Bloodstream Infection and Perturbed Maturation of the Gastrointestinal Microbiota in Premature Infants	PLOS ONE			English	Article							BIRTH-WEIGHT INFANTS; SEPSIS; GUT; TRANSLOCATION; POPULATIONS; DIAGNOSIS	Background Late-onset bloodstream infection (LO-BSI) is a common complication of prematurity, and lack of timely diagnosis and treatment can have life-threatening consequences. We sought to identify clinical characteristics and microbial signatures in the gastrointestinal microbiota preceding diagnosis of LO-BSI in premature infants. Method Daily faecal samples and clinical data were collected over two years from 369 premature neonates (<32 weeks gestation). We analysed samples from 22 neonates who developed LO-BSI and 44 matched control infants. Next-generation sequencing of 16S rRNA gene regions amplified by PCR from total faecal DNA was used to characterise the microbiota of faecal samples preceding diagnosis from infants with LO-BSI and controls. Culture of selected samples was undertaken, and bacterial isolates identified using MALDI-TOF. Antibiograms from bloodstream and faecal isolates were compared to explore strain similarity. Results From the week prior to diagnosis, infants with LO-BSI had higher proportions of faecal aerobes/facultative anaerobes compared to controls. Risk factors for LO-BSI were identified by multivariate analysis. Enterobacteriaceal sepsis was associated with antecedent multiple lines, low birth weight and a faecal microbiota with prominent Enterobacteriaceae. Staphylococcal sepsis was associated with Staphylococcus OTU faecal over-abundance, and the number of days prior to diagnosis of mechanical ventilation and of the presence of centrally-placed lines. In 12 cases, the antibiogram of the bloodstream isolate matched that of a component of the faecal microbiota in the sample collected closest to diagnosis. Conclusions The gastrointestinal tract is an important reservoir for LO-BSI organisms, pathogens translocating across the epithelial barrier. LO-BSI is associated with an aberrant microbiota, with abundant staphylococci and Enterobacteriaceae and a failure to mature towards predominance of obligate anaerobes.	[Shaw, Alexander G.; Sim, Kathleen; Randell, Paul; McClure, Zoe E.; Li, Ming-Shi; Langford, Paul R.; Kroll, J. Simon] Univ London Imperial Coll Sci Technol & Med, Dept Med, Paediat Sect, London, England; [Cox, Michael J.; Cookson, William O. C. M.; Moffatt, Miriam F.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Dept Mol Genet & Genom, London, England; [Donaldson, Hugo] NHS Trust, Imperial Coll, Dept Microbiol, London, England	Imperial College London; Imperial College London; Imperial College London	Kroll, JS (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Med, Paediat Sect, London, England.	a.shaw@imperial.ac.uk	Shaw, Alex/GWC-7464-2022; Langford, Paul/AAU-4189-2020; Cookson, William/HHC-1790-2022	Langford, Paul/0000-0002-6368-4724; Cox, Michael/0000-0002-4002-1506; Shaw, Alex/0000-0002-3166-872X	Meningitis Now [WMNP_35505]; Winnicott Foundation [WMNP_26859]; Livanos Trust; Wellcome Trust; Asmarley Trust; National Institute for Health Research (NIHR) Biomedical Research Centre based at Imperial Healthcare NHS Trust and Imperial College London [WMNP_P35969]; NIHR Doctoral Research Fellowship [NIHR-DRF-2011-04-128]; Medical Research Council [G1000758] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10126, DRF-2011-04-128] Funding Source: researchfish; Wellcome Trust [096964/Z/11/Z] Funding Source: researchfish; Asthma UK [MRC-Asthma UK Centre, MRC-AsthmaUKCentre] Funding Source: researchfish	Meningitis Now; Winnicott Foundation; Livanos Trust; Wellcome Trust(Wellcome TrustEuropean Commission); Asmarley Trust; National Institute for Health Research (NIHR) Biomedical Research Centre based at Imperial Healthcare NHS Trust and Imperial College London(National Institute for Health Research (NIHR)); NIHR Doctoral Research Fellowship; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome TrustEuropean Commission); Asthma UK	This work was supported by funding from Meningitis Now, https://www.meningitisnow.org/ [WMNP_35505] (AGS); the Winnicott Foundation, http://www.winnicott.org.uk/ [WMNP_26859] (AGS, KS, PR, PRL, JSK); the Livanos Trust (MSL); the Wellcome Trust, http://www.wellcome.ac.uk/ (MFM, WOCMC); the Asmarley Trust (MJC); and the National Institute for Health Research (NIHR) Biomedical Research Centre based at Imperial Healthcare NHS Trust and Imperial College London, http://www.nihr.ac.uk/ [WMNP_P35969] (KS). KS is funded by an NIHR Doctoral Research Fellowship [NIHR-DRF-2011-04-128]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arboleya S, 2012, FEMS MICROBIOL ECOL, V79, P763, DOI 10.1111/j.1574-6941.2011.01261.x; Benitz WE, 1998, PEDIATRICS, V102, DOI 10.1542/peds.102.4.e41; Boghossian NS, 2013, J PEDIATR-US, V162, P1120, DOI 10.1016/j.jpeds.2012.11.089; British Society for Antimicrobial Chemotherapy, 2014, BSAC METH ANT SUSC T; Brooks B, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-1; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Carl MA, 2014, CLIN INFECT DIS, V58, P1211, DOI 10.1093/cid/ciu084; Cole JR, 2014, NUCLEIC ACIDS RES, V42, pD633, DOI 10.1093/nar/gkt1244; Costa SF, 2004, LANCET INFECT DIS, V4, P278, DOI 10.1016/S1473-3099(04)01003-5; Darmstadt GL, 2009, J INFECT DIS, V200, P906, DOI 10.1086/605473; Duffy LC, 2000, J NUTR, V130, p432S, DOI 10.1093/jn/130.2.432S; Eaves-Pyles T, 2001, SHOCK, V16, P148, DOI 10.1097/00024382-200116020-00011; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Eggesbo M, 2011, APMIS, V119, P17, DOI 10.1111/j.1600-0463.2010.02688.x; Ewaschuk JB, 2008, AM J PHYSIOL-GASTR L, V295, pG1025, DOI 10.1152/ajpgi.90227.2008; Fierer N, 2008, P NATL ACAD SCI USA, V105, P17994, DOI 10.1073/pnas.0807920105; Gosbell IB, 2005, INTERN MED J, V35, pS45, DOI 10.1111/j.1444-0903.2005.00979.x; Graham PL, 2006, PEDIATR INFECT DIS J, V25, P113, DOI 10.1097/01.inf.0000199310.52875.10; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Koser CU, 2012, NEW ENGL J MED, V366, P2267, DOI 10.1056/NEJMoa1109910; La Rosa PS, 2014, P NATL ACAD SCI USA, V111, P12522, DOI 10.1073/pnas.1409497111; LaTuga MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027858; Madan JC, 2012, ARCH DIS CHILD-FETAL, V97, pF456, DOI 10.1136/fetalneonatal-2011-301373; Mai V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052876; Manzoni P, 2009, JAMA-J AM MED ASSOC, V302, P1421, DOI 10.1001/jama.2009.1403; Marchant EA, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/586076; Moles L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066986; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Nair V, 2013, INT J PEDIAT, V2013, DOI 10.1155/2013/874726; Parm U, 2011, J HOSP INFECT, V78, P327, DOI 10.1016/j.jhin.2011.03.025; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Qin HL, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-63; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; Sannasiddappa TH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023227; Schlapbach LJ, 2011, PEDIATRICS, V128, pE348, DOI 10.1542/peds.2010-3338; Sim K, 2015, CLIN INFECT DIS, V60, P389, DOI 10.1093/cid/ciu822; Sim K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032543; Team RDC, 2019, R LANG ENV STAT COMP; van den Berg JP, 2011, EARLY HUM DEV, V87, P67, DOI 10.1016/j.earlhumdev.2010.11.003; Vergnano S, 2011, ARCH DIS CHILD-FETAL, V96, pF9, DOI 10.1136/adc.2009.178798; Vermont Oxford Network Database, MAN OP 2	41	57	60	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0132923	10.1371/journal.pone.0132923	http://dx.doi.org/10.1371/journal.pone.0132923			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26167683	Green Published, gold, Green Submitted			2022-12-26	WOS:000358193100098
J	Song, MA; Dasgupta, C; Zhang, LB				Song, Minwoo A.; Dasgupta, Chiranjib; Zhang, Lubo			Chronic Losartan Treatment Up-Regulates AT(1)R and Increases the Heart Vulnerability to Acute Onset of Ischemia and Reperfusion Injury in Male Rats	PLOS ONE			English	Article							II TYPE-2 RECEPTOR; KINASE-C-EPSILON; CIRCULATING MICRORNAS; MYOCARDIAL-INFARCTION; FUNCTIONAL RECOVERY; DELTA-PKC; ANGIOTENSIN; EXPRESSION; CARDIOPROTECTION; BLOCKADE	Inhibition of angiotensin II type 1 receptor (AT(1)R) is an important therapy in the management of hypertension, particularly in the immediate post-myocardial infarction period. Yet, the role of AT(1)R in the acute onset of myocardial ischemia and reperfusion injury still remains controversial. Thus, the present study determined the effects of chronic losartan treatment on heart ischemia and reperfusion injury in rats. Losartan (10 mg/kg/day) was administered to six-month-old male rats via an osmotic pump for 14 days and hearts were then isolated and were subjected to ischemia and reperfusion injury in a Langendorff preparation. Losartan significantly decreased mean arterial blood pressure. However, heart weight, left ventricle to body weight ratio and baseline cardiac function were not significantly altered by the losartan treatment. Of interest, chronic in vivo losartan treatment significantly increased ischemia-induced myocardial injury and decreased post-ischemic recovery of left ventricular function. This was associated with significant increases in AT(1)R and PKC delta expression in the left ventricle. In contrast, AT(2)R and PKCe were not altered. Furthermore, losartan treatment significantly increased microRNA (miR)-1, -15b, -92a, -133a, -133b, -210, and -499 expression but decreased miR-21 in the left ventricle. Of importance, addition of losartan to isolated heart preparations blocked the effect of increased ischemic-injury induced by in vivo chronic losartan treatment. The results demonstrate that chronic losartan treatment up-regulates AT(1)R/PKC delta and alters miR expression patterns in the heart, leading to increased cardiac vulnerability to ischemia and reperfusion injury.	[Song, Minwoo A.; Dasgupta, Chiranjib; Zhang, Lubo] Loma Linda Univ, Sch Med, Dept Basic Sci, Ctr Perinatal Biol,Div Pharmacol, Loma Linda, CA 92354 USA	Loma Linda University	Zhang, LB (corresponding author), Loma Linda Univ, Sch Med, Dept Basic Sci, Ctr Perinatal Biol,Div Pharmacol, Loma Linda, CA 92354 USA.	lzhang@llu.edu		Zhang, Lubo/0000-0002-9386-8938	NIH [HL118861]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL118861] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NIH HL118861.	AbdAlla S, 2001, J BIOL CHEM, V276, P39721, DOI 10.1074/jbc.M105253200; Abengozar MA, 2012, BLOOD, V119, P4565, DOI 10.1182/blood-2011-09-380006; Bae SC, 2005, J PHARMACOL EXP THER, V315, P1125, DOI 10.1124/jpet.105.090803; Baines CP, 2003, CIRC RES, V92, P873, DOI 10.1161/01.RES.0000069215.36389.8D; Bonauer A, 2009, SCIENCE, V324, P1710, DOI 10.1126/science.1174381; Bove CM, 2004, HYPERTENSION, V43, P680, DOI 10.1161/01.HYP.0000115924.94236.91; Care A, 2007, NAT MED, V13, P613, DOI 10.1038/nm1582; Cheng YH, 2009, J MOL CELL CARDIOL, V47, P5, DOI 10.1016/j.yjmcc.2009.01.008; D'Alessandra Y, 2010, EUR HEART J, V31, P2765, DOI 10.1093/eurheartj/ehq167; D'Ascenzo F, 2014, EUROINTERVENTION, V9, P1463, DOI 10.4244/EIJV9I12A244; Dasgupta C, 2011, DRUG DISCOV TODAY, V16, P22, DOI 10.1016/j.drudis.2010.11.016; Dong DL, 2010, HYPERTENSION, V55, P946, DOI 10.1161/HYPERTENSIONAHA.109.139519; Fasanaro P, 2008, J BIOL CHEM, V283, P15878, DOI 10.1074/jbc.M800731200; Fiedler J, 2011, CIRCULATION, V124, P720, DOI 10.1161/CIRCULATIONAHA.111.039008; Flynn JD, 2003, PHARMACOTHERAPY, V23, P1401, DOI 10.1592/phco.23.14.1401.31947; Ford WR, 1996, CIRCULATION, V94, P3087, DOI 10.1161/01.CIR.94.12.3087; Giricz Z, 2014, J MOL CELL CARDIOL, V68, P75, DOI 10.1016/j.yjmcc.2014.01.004; Hausenloy DJ, 2008, REMOTE ISCHEMIC PREC; Hinkel R, 2013, CIRCULATION, V128, P1066, DOI 10.1161/CIRCULATIONAHA.113.001904; Hosoda T, 2011, CIRCULATION, V123, P1287, DOI 10.1161/CIRCULATIONAHA.110.982918; Hullinger TG, 2012, CIRC RES, V110, P71, DOI 10.1161/CIRCRESAHA.111.244442; Jalowy A, 1998, J AM COLL CARDIOL, V32, P1787, DOI 10.1016/S0735-1097(98)00441-0; Karakikes I, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000078; Kukreja RC, 2011, MOL PHARMACOL, V80, P558, DOI 10.1124/mol.111.073528; Kumar D, 2004, MOL CELL BIOCHEM, V258, P211, DOI 10.1023/B:MCBI.0000012857.06723.81; Lange SA, 2007, J CARDIOVASC PHARM, V49, P46, DOI 10.1097/FJC.0b013e31802c2f77; Lv P, 2012, CIRC RES, V111, P697, DOI 10.1161/CIRCRESAHA.112.272013; Meder B, 2011, BASIC RES CARDIOL, V106, P13, DOI 10.1007/s00395-010-0123-2; Moudgil R, 2001, J Cardiovasc Pharmacol Ther, V6, P183, DOI 10.1177/107424840100600210; Murriel CL, 2003, ARCH BIOCHEM BIOPHYS, V420, P246, DOI 10.1016/j.abb.2003.08.038; Nabialek E, 2013, MINERVA CARDIOANGIOL, V61, P627; Olson ER, 2008, HYPERTENSION, V51, P704, DOI 10.1161/HYPERTENSIONAHA.107.098459; Osboume A, 2014, J MOL CELL CARDIOL, V74, P53, DOI 10.1016/j.yjmcc.2014.04.024; Ozer MK, 2002, PHARMACOL RES, V45, P257, DOI 10.1006/phrs.2002.0965; Pan ZW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050515; Parlakpinar H, 2011, CYTOKINE, V56, P688, DOI 10.1016/j.cyto.2011.09.002; Patterson AJ, 2010, CIRC RES, V107, P365, DOI 10.1161/CIRCRESAHA.110.221259; Paul M, 2006, PHYSIOL REV, V86, P747, DOI 10.1152/physrev.00036.2005; Raff U, 2014, J HYPERTENS, V32, P76; Raff U, 2014, J HYPERTENS, V32, P2267, DOI 10.1097/HJH.0000000000000313; Sato M, 2000, CIRCULATION, V102, P346; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Song MA, 2015, DRUG DISCOV TODAY, V20, P223, DOI 10.1016/j.drudis.2014.10.004; Tang YH, 2009, INT HEART J, V50, P377, DOI 10.1536/ihj.50.377; Urata H, 1996, AM J HYPERTENS, V9, P277, DOI 10.1016/0895-7061(95)00349-5; Wong SL, 2011, ARTERIOSCL THROM VAS, V31, P1169, DOI 10.1161/ATVBAHA.110.216044; Xu Y, 2000, HYPERTENSION, V36, P506, DOI 10.1161/01.HYP.36.4.506; Xu Y, 2002, AM J PHYSIOL-HEART C, V282, pH1206, DOI 10.1152/ajpheart.00839.2000; Xu Y, 2000, J Renin Angiotensin Aldosterone Syst, V1, P184, DOI 10.3317/jraas.2000.024; Xue Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106827; Xue Q, 2011, CARDIOVASC RES, V89, P300, DOI 10.1093/cvr/cvq303; Yan XH, 2003, AM J PHYSIOL-HEART C, V285, pH2179, DOI 10.1152/ajpheart.00361.2003; Yang BF, 2007, NAT MED, V13, P486, DOI 10.1038/nm1569; Yang BC, 1997, CIRCULATION, V96, P922; Yang ZQ, 2002, CIRCULATION, V106, P106, DOI 10.1161/01.CIR.0000020014.14176.6D; Yogalingam G, 2013, J BIOL CHEM, V288, P18947, DOI 10.1074/jbc.M113.466870	56	11	14	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0132712	10.1371/journal.pone.0132712	http://dx.doi.org/10.1371/journal.pone.0132712			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26168042	Green Published, gold, Green Submitted			2022-12-26	WOS:000358193100070
J	An, WW; Zhang, ZZ; Zeng, LY; Yang, Y; Zhu, XL; Wu, JR				An, Weiwei; Zhang, Zhuzhen; Zeng, Liyong; Yang, Ying; Zhu, Xueliang; Wu, Jiarui			Cyclin Y Is Involved in the Regulation of Adipogenesis and Lipid Production	PLOS ONE			English	Article							ADIPOCYTE DIFFERENTIATION; HEPATIC STEATOSIS; CONSERVED CYCLIN; CELL-CYCLE; TRANSCRIPTION; METABOLISM; EXPRESSION; GLUCOSE; OBESITY; LIVER	A new member of the cyclin family cyclin Y (CCNY) is involved in the regulation of various physiological processes. In this study, the role of CCNY in energy metabolism was characterized. We found that compared with wild-type (WT) mice, Ccny knockout (KO) mice had both lower body weight and lower fat content. The Ccny KO mice also had a higher metabolic rate, resisted the stress of a high-fat diet, and were sensitive to calorie restriction. The expression levels of UCP1 and PGC1 alpha were significantly higher in the brown adipose tissue (BAT) of the Ccny KO mice than that of the WT littermate controls, whereas there was no significant difference in BAT weight between the WT and the Ccny KO mice. In addition, the down-regulation of Ccny resulted in suppression of white adipocyte differentiation both in vivo and in vitro, while the expression of Ccny was up-regulated by C/EBP alpha. Furthermore, both hepatocytes and HepG2 cells that were depleted of Ccny were insensitive to insulin stimulation, consistent with the significant inhibition of insulin sensitivity in the liver of the Ccny KO mice, but no significant changes in WAT and muscle, indicating that CCNY is involved in regulating the hepatic insulin signaling pathway. The hepatic insulin resistance generated by Ccny depletion resulted in down-regulation of the sterol-regulatory element-binding protein (SREBP1) and fatty acid synthase (FASN). Together, these results provide a new link between CCNY and lipid metabolism in mice, and suggest that inhibition of CCNY may offer a therapeutic approach to obesity and diabetes.	[An, Weiwei; Zhang, Zhuzhen; Yang, Ying; Wu, Jiarui] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Key Lab Syst Biol, Shanghai 200031, Peoples R China; [Zeng, Liyong; Zhu, Xueliang] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Cell Biol, Shanghai 200031, Peoples R China; [Wu, Jiarui] Chinese Acad Sci, Shanghai Adv Res Inst, Shanghai 201210, Peoples R China; [Wu, Jiarui] ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai 201210, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Advanced Research Institute, CAS; ShanghaiTech University	Wu, JR (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Key Lab Syst Biol, Shanghai 200031, Peoples R China.	wujr@sibs.ac.cn		Zhang, Zhuzhen/0000-0001-6787-3920	National Natural Science Foundation of China [31130034, 31470808]; Science and Technology Commission of Shanghai Municipality [13DZ1940100]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This work was supported by grants to Wu JR from the National Natural Science Foundation of China (31130034 and 31470808) and from the Science and Technology Commission of Shanghai Municipality (13DZ1940100). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amemiya-Kudo M, 2002, J LIPID RES, V43, P1220, DOI 10.1194/jlr.M100417-JLR200; Bengoechea-Alonso MT, 2009, J BIOL CHEM, V284, P5885, DOI 10.1074/jbc.M807906200; Blessing W, 2012, PHYSIOL BEHAV, V105, P966, DOI 10.1016/j.physbeh.2011.11.009; Chao PT, 2011, CELL METAB, V13, P573, DOI 10.1016/j.cmet.2011.02.019; Davidson G, 2009, DEV CELL, V17, P788, DOI 10.1016/j.devcel.2009.11.006; Eberle D, 2004, BIOCHIMIE, V86, P839, DOI 10.1016/j.biochi.2004.09.018; Fu MF, 2005, J BIOL CHEM, V280, P16934, DOI 10.1074/jbc.M500403200; Gesta S, 2007, CELL, V131, P242, DOI 10.1016/j.cell.2007.10.004; GREEN H, 1974, CELL, V3, P127, DOI 10.1016/0092-8674(74)90116-0; Guzzardi Maria A, 2011, Rev Diabet Stud, V8, P403, DOI 10.1900/RDS.2011.8.403; Hermann GE, 2006, BRAIN RES, V1117, P118, DOI 10.1016/j.brainres.2006.08.018; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Jiang M, 2009, FEBS LETT, V583, P2171, DOI 10.1016/j.febslet.2009.06.010; Kennell JA, 2005, J BIOL CHEM, V280, P24004, DOI 10.1074/jbc.M501080200; Kim JB, 1996, GENE DEV, V10, P1096, DOI 10.1101/gad.10.9.1096; Kohn AD, 1996, J BIOL CHEM, V271, P31372, DOI 10.1074/jbc.271.49.31372; Li XY, 2009, MOL BIOL REP, V36, P97, DOI 10.1007/s11033-007-9156-5; Lin S, 2004, NEUROPEPTIDES, V38, P189, DOI 10.1016/j.npep.2004.05.005; Liu DM, 2010, FLY, V4, P278, DOI 10.4161/fly.4.4.12881; Liu DM, 2010, GENETICS, V184, P1025, DOI 10.1534/genetics.110.114017; Lu MJ, 2012, NAT MED, V18, P388, DOI 10.1038/nm.2686; Mikolcevic P, 2012, MOL CELL BIOL, V32, P868, DOI 10.1128/MCB.06261-11; Muoio DM, 2006, ANNU REV BIOCHEM, V75, P367, DOI 10.1146/annurev.biochem.75.103004.142512; Noble MEM, 1997, TRENDS BIOCHEM SCI, V22, P482, DOI 10.1016/S0968-0004(97)01144-4; Ootsuka Y, 2009, NEUROSCIENCE, V164, P849, DOI 10.1016/j.neuroscience.2009.08.013; Park M, 2011, NEURON, V70, P742, DOI 10.1016/j.neuron.2011.04.002; Pei H, 2011, CELL DEATH DIFFER, V18, P315, DOI 10.1038/cdd.2010.100; Petersen KF, 2002, J CLIN INVEST, V109, P1345, DOI [10.1172/JCI0215001, 10.1172/JCI200215001]; Porstmann T, 2005, ONCOGENE, V24, P6465, DOI 10.1038/sj.onc.1208802; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Shi YC, 2013, CELL METAB, V17, P236, DOI 10.1016/j.cmet.2013.01.006; Shimano H, 1999, J BIOL CHEM, V274, P35832, DOI 10.1074/jbc.274.50.35832; Shimomura L, 1999, P NATL ACAD SCI USA, V96, P13656, DOI 10.1073/pnas.96.24.13656; Speakman JR, 2007, J NUTR, V137, P1078, DOI 10.1093/jn/137.4.1078; Tang QQ, 2003, P NATL ACAD SCI USA, V100, P850, DOI 10.1073/pnas.0337434100; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Taniguchi CM, 2006, CELL METAB, V3, P343, DOI 10.1016/j.cmet.2006.04.005; van den Beukel JC, 2014, FRONT HORM RES, V42, P107, DOI 10.1159/000358320; Yang L, 2010, J HEPATOL, V53, P339, DOI 10.1016/j.jhep.2010.03.004	41	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132721	10.1371/journal.pone.0132721	http://dx.doi.org/10.1371/journal.pone.0132721			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161966	gold, Green Published, Green Submitted			2022-12-26	WOS:000358162300170
J	Baltazar, BM; Espinoza, LC; Banda, AE; Martinez, JMD; Tiznado, JAG; Garcia, JG; Gutierrez, MA; Rodriguez, JLG; Diaz, OH; Horak, MJ; Martinez, JIM; Schapaugh, AW; Stojsin, D; Montes, HRU; Garcia, FZ				Baltazar, Baltazar M.; Castro Espinoza, Luciano; Espinoza Banda, Armando; de la Fuente Martinez, Juan Manuel; Garzon Tiznado, Jose Antonio; Gonzalez Garcia, Juvencio; Antonio Gutierrez, Marco; Guzman Rodriguez, Jose Luis; Heredia Diaz, Oscar; Horak, Michael J.; Madueno Martinez, Jesus Ignacio; Schapaugh, Adam W.; Stojsin, Duska; Uribe Montes, Hugo Rau; Zavala Garcia, Francisco			Pollen-Mediated Gene Flow in Maize: Implications for Isolation Requirements and Coexistence in Mexico, the Center of Origin of Maize	PLOS ONE			English	Article							GRAIN PRODUCTION PRACTICES; GM; VARIABILITY; TIME; ZEA	Mexico, the center of origin of maize (Zea mays L.), has taken actions to preserve the identity and diversity of maize landraces and wild relatives. Historically, spatial isolation has been used in seed production to maintain seed purity. Spatial isolation can also be a key component for a strategy to minimize pollen-mediated gene flow in Mexico between transgenic maize and sexually compatible plants of maize conventional hybrids, landraces, and wild relatives. The objective of this research was to generate field maize-to-maize outcrossing data to help guide coexistence discussions in Mexico. In this study, outcrossing rates were determined and modeled from eight locations in six northern states, which represent the most economically important areas for the cultivation of hybrid maize in Mexico. At each site, pollen source plots were planted with a yellow-kernel maize hybrid and surrounded by plots with a white-kernel conventional maize hybrid (pollen recipient) of the same maturity. Outcrossing rates were then quantified by assessing the number of yellow kernels harvested from white-kernel hybrid plots. The highest outcrossing values were observed near the pollen source (12.9% at 1 m distance). The outcrossing levels declined sharply to 4.6, 2.7, 1.4, 1.0, 0.9, 0.5, and 0.5% as the distance from the pollen source increased to 2, 4, 8, 12, 16, 20, and 25 m, respectively. At distances beyond 20 m outcrossing values at all locations were below 1%. These trends are consistent with studies conducted in other world regions. The results suggest that coexistence measures that have been implemented in other geographies, such as spatial isolation, would be successful in Mexico to minimize transgenic maize pollen flow to conventional maize hybrids, landraces and wild relatives.	[Baltazar, Baltazar M.; Horak, Michael J.; Schapaugh, Adam W.; Stojsin, Duska] Monsanto Co, St Louis, MO 63167 USA; [Castro Espinoza, Luciano; Antonio Gutierrez, Marco] Inst Tecnol Sonora, Direcc Recursos Nat, Obregon 85000, Sonora, Mexico; [Espinoza Banda, Armando] Univ Autonoma Agr Antonio Narro, Unidad Laguna, Torreon 27059, Coahuila, Mexico; [de la Fuente Martinez, Juan Manuel; Heredia Diaz, Oscar] Monsanto Comercial, Mexico City 01210, DF, Mexico; [Garzon Tiznado, Jose Antonio; Madueno Martinez, Jesus Ignacio] Univ Autonoma Sinaloa, Fac Ciencias Quim Biol, Sinaloa 80000, Mexico; [Gonzalez Garcia, Juvencio; Uribe Montes, Hugo Rau] Univ Autonoma Chihuahua, Fac Ciencias Agr & Forestales, Chihuahua 33000, Mexico; [Guzman Rodriguez, Jose Luis; Zavala Garcia, Francisco] Univ Autonoma Nuevo Leon, Fac Agron, Escobedo 66050, Nuevo Leon, Mexico	Monsanto; Universidad Autonoma de Sinaloa; Universidad Autonoma de Nuevo Leon	Baltazar, BM (corresponding author), Monsanto Co, 800 N Lindbergh Blvd, St Louis, MO 63167 USA.	baltazar.baltazar@monsanto.com		/0000-0002-4384-1286; Schapaugh, Adam/0000-0001-8060-846X	Monsanto Company	Monsanto Company	Funding for these research studies was provided by Monsanto Company. Authors LCE, AEB, JAGT, FZG, JGG, MAG, JLGR, JIMM, and HRUM are full time researchers working for public Mexican research institutions and participated directly in study design, data collection, decision to publish and preparation of the manuscript.	[Anonymous], 2002, SAS SOFTWARE RELEASE; AOSCA, 1997, GENETIC CROP STANDAR; AOSCA, 2004, OPERATIONAL PROCEDUR; Baltazar BM, 2005, THEOR APPL GENET, V110, P519, DOI 10.1007/s00122-004-1859-6; Bannert M, 2007, EUR J AGRON, V27, P44, DOI 10.1016/j.eja.2007.01.002; BATEMAN AJ, 1947, HEREDITY, V1, P235, DOI 10.1038/hdy.1947.15; Bellon MR, 2006, AGR HUM VALUES, V23, P3, DOI 10.1007/s10460-004-5861-z; Bellon MR, 2004, PLANT PHYSIOL, V134, P883, DOI 10.1104/pp.103.038331; Bellon MR, 2001, WORLD DEV, V29, P799, DOI 10.1016/S0305-750X(01)00013-4; Brookes G., 2004, COEXISTENCE GM NONGM; Brookes G, 2003, COEXISTENCE GM NONGM; Burris JS, 2002, ADVENTITIOUS POLLEN; Cervantes MJE, 1998, THESIS COLEGIO POSTG; Diario Oficial de la Federacion, 2012, ACUERDO DETERMINATIO; Diario Oficial de la Federacion, 2008, REGLAMENTO LEY BIOSE; DIGIOVANNI F, 1995, GRANA, V34, P39, DOI 10.1080/00173139509429031; DIGIOVANNI F, 1991, CAN J FOREST RES, V21, P1155, DOI 10.1139/x91-163; Goggi AS, 2007, INT J BIOMETEOROL, V51, P493, DOI 10.1007/s00484-007-0088-5; Goggi AS, 2006, FIELD CROP RES, V99, P147, DOI 10.1016/j.fcr.2006.04.005; Gustafson DI, 2006, CROP SCI, V46, P2133, DOI 10.2135/cropsci2006.01.0060; Haegele JW, 2007, MAYDICA, V52, P117; Halsey ME, 2005, CROP SCI, V45, P2172, DOI 10.2135/cropsci2003.0664; ISAAA, CROP BIOTECH UPDATE; Jemison John M. Jr., 2001, AgBioForum, V4, P87; Jones JM, 1950, OKLAHOMA AGR EXP STA; JONES MD, 1948, J AM SOC AGRON, V40, P136; Kiesselbach TA, 1999, STRUCT REPRODUCTION; Kim S, 2012, R PACKAGE VERSION 10; LOUETTE D, 1996, 9603 NRG; Luna S, 2001, CROP SCI, V41, P1551, DOI 10.2135/cropsci2001.4151551x; Ma BL, 2004, CROP SCI, V44, P1273, DOI 10.2135/cropsci2004.1273; Marceau A, 2013, CROP SCI, V53, P1712, DOI 10.2135/cropsci2012.04.0224; Matsuoka Y, 2005, BREEDING SCI, V55, P383, DOI 10.1270/jsbbs.55.383; Mendoza RJL, 2003, FOLLETO TECNICO; Messeguer J, 2006, PLANT BIOTECHNOL J, V4, P633, DOI 10.1111/j.1467-7652.2006.00207.x; Nascimento VE, 2012, PESQUI AGROPECU BRAS, V47, P784, DOI 10.1590/S0100-204X2012000600008; OECD. (Organisation for Economic Co-operation and Development) Environment Health and Safety Publications, 2006, SERIES HARMONISATION, V23; OGDEN EC, 1969, AM J BOT, V56, P16, DOI 10.2307/2440389; Pla M, 2006, TRANSGENIC RES, V15, P219, DOI 10.1007/s11248-005-4945-x; R Core Team, 2021, R LANGUAGE ENV STAT; RAYNOR GS, 1972, AGRON J, V64, P420, DOI 10.2134/agronj1972.00021962006400040004x; Rodriguez JG, 2006, MAYDICA, V51, P383; Serratos JA, 1996, GENE FLOW MAIZE LAND, P1; Vargas-Parada L, 2014, NATURE, V511, P16, DOI 10.1038/511016a; Wang ChenYu, 2013, Crop, Environment & Bioinformatics, V10, P172; Weber WE, 2007, J AGRON CROP SCI, V193, P79, DOI 10.1111/j.1439-037X.2006.00245.x; WODEHOUSE RP, 1935, POLLEN GRAINS STRUCT	47	24	29	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0131549	10.1371/journal.pone.0131549	http://dx.doi.org/10.1371/journal.pone.0131549			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26162097	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000358162300045
J	Hofmann, T; Ahnis, A; Elbelt, U; Rose, M; Klapp, BF; Stengel, A				Hofmann, Tobias; Ahnis, Anne; Elbelt, Ulf; Rose, Matthias; Klapp, Burghard F.; Stengel, Andreas			NUCB2/nesfatin-1 Is Associated with Elevated Levels of Anxiety in Anorexia Nervosa	PLOS ONE			English	Article							AMPHETAMINE-REGULATED TRANSCRIPT; PERCEIVED STRESS QUESTIONNAIRE; EATING-DISORDER INVENTORY; PLASMA NESFATIN-1 LEVEL; BODY-MASS INDEX; FOOD-INTAKE; OBESE; IMMUNOREACTIVITY; VALIDATION; IDENTIFICATION	Objective NUCB2/nesfatin-1 is an anorexigenic hormone with elevated levels in obese and decreased levels in anorexia nervosa (AN) patients. Moreover, a role in the regulation of stress and emotions was suggested by several rodent and preliminary human studies. Since anxiety and depression are common comorbidities in AN, we investigated the association of NUCB2/nesfatin-1 with anxiety, depression and perceived stress in AN. Methods We analyzed circulating NUCB2/nesfatin-1 levels in 64 female inpatients diagnosed with anorexia nervosa (body mass index, BMI; mean +/- SD, 14.7 +/- 2.3 kg/m(2)). At the same time anxiety (GAD-7), depression (PHQ-9), stress (PSQ-20) and disordered eating (EDI-2) were measured psychometrically. Results No correlation was observed between NUCB2/nesfatin-1 and BMI (r = 0.06, p = 0.70). The study population was divided in patients with low anxiety (n = 32, GAD-7 scores, mean +/- SD, 7.5 +/- 3.3) and high anxiety (n = 32, 16.0 +/- 3.0, p<0.001). Patients with high anxiety scores displayed 65% higher NUCB2/nesfatin-1 levels (p = 0.04). This was reflected by a positive correlation of GAD-7 and NUCB2/nesfatin-1-levels (r = 0.32, p = 0.04). Scores of PSQ-20 (73.3 +/- 14.3 vs. 48.6 +/- 17.2) and PHQ-9 (18.8 +/- 5.0 vs. 10.3 +/- 5.1) were higher in the high anxiety group (p<0.001) but did not correlate with NUCB2/nesfatin-1 (p>0.05). EDI-2 total score was also higher in the high anxiety group (52.3 +/- 14.1 vs. 40.2 +/- 16.0, p = 0.02), while no correlations of EDI-2-scores with plasma NUCB2/nesfatin-1 were observed (p>0.05). Conclusions Circulating NUCB2/nesfatin-1 levels correlated positively with perceived anxiety, whereas no association with BMI or eating disorder symptoms was observed. NUCB2/nesfatin-1 might be primarily involved in the modulation of anxiety and subsequently in the regulation of eating habits and body weight in AN.	[Hofmann, Tobias; Ahnis, Anne; Elbelt, Ulf; Rose, Matthias; Klapp, Burghard F.; Stengel, Andreas] Charite, Charite Ctr Internal Med & Dermatol, Div Gen Internal & Psychosomat Med, D-13353 Berlin, Germany; [Elbelt, Ulf] Charite, Div Endocrinol Diabet & Nutr, Charite Ctr Internal Med Gastroenterol & Nephrol, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Hofmann, T (corresponding author), Charite, Charite Ctr Internal Med & Dermatol, Div Gen Internal & Psychosomat Med, D-13353 Berlin, Germany.	tobias.hofmann@charite.de	Elbelt, Ulf/AAJ-6469-2020	Stengel, Andreas/0000-0003-3294-4340; Elbelt, Ulf/0000-0002-7510-9284; Hofmann, Tobias/0000-0002-4002-3552	German Research Foundation [STE 1765/3-1]; Charite University [UFF 89-441-176]	German Research Foundation(German Research Foundation (DFG)); Charite University	German Research Foundation STE 1765/3-1 (http://www.dfg.de) and Charite University Funding UFF 89-441-176 (www.charite.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaci A, 2013, PEDIATR DIABETES, V14, P189, DOI 10.1111/pedi.12009; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; American Psychiatric Association, 2000, DIAGN STAT MAN MENT, V4th; Ari M, 2011, PROG NEURO-PSYCHOPH, V35, P497, DOI 10.1016/j.pnpbp.2010.12.004; Basar O, 2012, SCAND J CLIN LAB INV, V72, P479, DOI 10.3109/00365513.2012.699097; Bloem B, 2012, NEUROPHARMACOLOGY, V62, P297, DOI 10.1016/j.neuropharm.2011.07.023; Brailoiu GC, 2007, ENDOCRINOLOGY, V148, P5088, DOI 10.1210/en.2007-0701; Emmerzaal TL, 2013, CURR PHARM DESIGN, V19, P6941, DOI 10.2174/138161281939131127125042; Fliege H, 2005, PSYCHOSOM MED, V67, P78, DOI 10.1097/01.psy.0000151491.80178.78; Foo KS, 2008, NEUROSCIENCE, V156, P563, DOI 10.1016/j.neuroscience.2008.07.054; Foo KS, 2010, J ENDOCRINOL, V204, P255, DOI 10.1677/JOE-09-0254; GARNER DM, 1983, INT J EAT DISORDER, V2, P15, DOI 10.1002/1098-108X(198321)2:2<15::AID-EAT2260020203>3.0.CO;2-6; Garner DM, 1991, EATING DISORDER INVE; Gilbody S, 2007, J GEN INTERN MED, V22, P1596, DOI 10.1007/s11606-007-0333-y; Godart N, 2006, INT J EAT DISORDER, V39, P772, DOI 10.1002/eat.20274; Godart NT, 2000, EUR PSYCHIAT, V15, P38, DOI 10.1016/S0924-9338(00)00212-1; Goebel M, 2009, BRAIN RES, V1300, P114, DOI 10.1016/j.brainres.2009.08.082; Goebel M, 2009, NEUROSCI LETT, V452, P241, DOI 10.1016/j.neulet.2009.01.064; Gonzalez R, 2009, BIOCHEM BIOPH RES CO, V381, P643, DOI 10.1016/j.bbrc.2009.02.104; Gunay H, 2012, PSYCHONEUROENDOCRINO, V37, P1949, DOI 10.1016/j.psyneuen.2012.04.007; Guo YF, 2014, ACUPUNCT MED, V32, P313, DOI 10.1136/acupmed-2014-010530; Hofmann T, 2013, PSYCHONEUROENDOCRINO, V38, P2502, DOI 10.1016/j.psyneuen.2013.05.013; Kaye WH, 2004, AM J PSYCHIAT, V161, P2215, DOI 10.1176/appi.ajp.161.12.2215; Keel PK, 2005, INT J EAT DISORDER, V38, P99, DOI 10.1002/eat.20168; Kroenke K, 2010, GEN HOSP PSYCHIAT, V32, P345, DOI 10.1016/j.genhosppsych.2010.03.006; L/we B., 2002, GESUNDHEITSFRAGEBOGE; LEVENSTEIN S, 1993, J PSYCHOSOM RES, V37, P19, DOI 10.1016/0022-3999(93)90120-5; Lowe B, 2008, MED CARE, V46, P266, DOI 10.1097/MLR.0b013e318160d093; Merali Z, 2008, PSYCHOPHARMACOLOGY, V201, P115, DOI 10.1007/s00213-008-1252-2; Ogiso K, 2011, PEPTIDES, V32, P150, DOI 10.1016/j.peptides.2010.10.004; Oh-I S, 2006, NATURE, V443, P709, DOI 10.1038/nature05162; Okere B, 2010, BRAIN RES, V1317, P92, DOI 10.1016/j.brainres.2009.12.053; Ramanjaneya M, 2010, ENDOCRINOLOGY, V151, P3169, DOI 10.1210/en.2009-1358; Saldanha JF, 2012, REGUL PEPTIDES, V173, P82, DOI 10.1016/j.regpep.2011.09.010; Shimizu H, 2009, ENDOCRINOLOGY, V150, P662, DOI 10.1210/en.2008-0598; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Stengel A, 2013, HORM METAB RES, V45, P975, DOI 10.1055/s-0033-1351324; Stengel A, 2013, OBES REV, V14, P859, DOI 10.1111/obr.12063; Stengel A, 2009, ENDOCRINOLOGY, V150, P232, DOI 10.1210/en.2008-0747; Stengel A, 2013, HISTOCHEM CELL BIOL, V139, P909, DOI 10.1007/s00418-013-1087-8; Thiel A, 1997, PSYCHOTHER PSYCH MED, V47, P365; Tsuchiya T, 2010, CLIN ENDOCRINOL, V73, P484, DOI 10.1111/j.1365-2265.2010.03835.x; Wittkampf K, 2009, GEN HOSP PSYCHIAT, V31, P451, DOI 10.1016/j.genhosppsych.2009.06.001; WorldHealthOrganization, 2008, INT STAT CLASS DIS R; Yoshida N, 2010, AGING-US, V2, P775, DOI 10.18632/aging.100207	46	38	40	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132058	10.1371/journal.pone.0132058	http://dx.doi.org/10.1371/journal.pone.0132058			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1FD	26162003	Green Published, Green Submitted, gold			2022-12-26	WOS:000358162300086
J	Hong, DQ; Zhang, YA; Gao, BX; Wang, JW; Li, GS; Wang, L; Zhang, LX				Hong, Daqing; Zhang, Yuan; Gao, Bixia; Wang, Jinwei; Li, Guisen; Wang, Li; Zhang, Luxia		China Natl Survey CKD Working Grp	Metabolic Syndrome without Diabetes or Hypertension Still Necessitates Early Screening for Chronic Kidney Disease: Information from a Chinese National Cross-Sectional Study	PLOS ONE			English	Article							RISK; ASSOCIATION; PREVALENCE; ADULTS; CKD	Metabolic syndrome (MS) is prevalent, with an increasing contribution to the incidence of chronic kidney disease (CKD). The study of the relationship between them is important. The CKD survey, a national cross-sectional study, provided a large database to accomplish this study. The study population were 41 131 adults from this survey between 2008 and 2009. CKD was defined as estimate glomerular filtration rate (eGFR) less than 60 mL/min per 1.73 m(2) or the presence of albuminuria. MS was diagnosed by National Cholesterol Education Program-Adult Treatment Panel III (ATPIII), ATPIII-modified or International Diabetes Federation (IDF) criteria. Logistic regression model was applied to study the impact of MS or its components on CKD or its components. The age and sex standardized prevalence of MS by ATPIII, ATPIII-modified and IDF criteria was 11.77% (11.13%-12.40%), 21.51% (20.69%-22.34%) and 16.67% (15.92-17.42)% respectively. Multivariate logistic regression models showed that MS and its components were associated with higher CKD prevalence. The risk for CKD and its components increased with the number of MS components. After adjusting for hypertension and diabetes, the odds ratios of MS for CKD decreased, but remained significantly more than 1 between 1.16(95% CI 1.07-1.26) and 1.37 (95% CI 1.25-1.50) across the different models. Similar results were found with albuminuria, while for decreased eGFR, after adjusting for hypertension and diabetes, the odds ratios of MS and MS components (except elevated TG) became insignificant. In conclusion, MS is prevalent and associated with a higher prevalence of CKD. Different MS components are associated with different risks for CKD, even after adjusting for hypertension and diabetes, which may mainly be contributed more by the increased risk for albuminuria than that for decreased eGFR. More attention must be paid to the population with MS, including those with elevated blood pressure and serum glucose.	[Hong, Daqing; Zhang, Yuan; Li, Guisen; Wang, Li] Sichuan Acad Med Sci, Div Nephrol, Chengdu, Peoples R China; [Hong, Daqing; Zhang, Yuan; Li, Guisen; Wang, Li] Sichuan Prov Peoples Hosp, Chengdu, Peoples R China; [Gao, Bixia; Wang, Jinwei; Zhang, Luxia] Peking Univ, Hosp 1, Inst Nephrol, Div Nephrol, Beijing 100871, Peoples R China	Sichuan Provincial People's Hospital; Sichuan Provincial People's Hospital; Peking University	Wang, L (corresponding author), Sichuan Acad Med Sci, Div Nephrol, Chengdu, Peoples R China.	scwangli62@163.com; zhanglx@bjmu.edu.cn	Li, Guisen/AAS-9461-2021	Li, Guisen/0000-0003-1970-9979; Luxia, Zhang/0000-0003-2349-2936	National Key Technology R&D Program from the Ministry of Science and Technology (China) [2007BAI04B10]; Science and Technology Commission of Shanghai [08dz1900502, 07JC14037]; Natural Science Funds of Ning Xia [NZ08102]; Science and Technology Department; National Natural Science Funds [30660069]; National Natural Science Foundation of China; Department of Health, Jiangsu Province [H200936]; Key Scientific and Technology Project from the Sichuan Science and Technology Department [05SG1635]; Program for New Century Excellent Talents in University from the Ministry of Education (China) [BMU2009131]; International Society of Nephrology Research Committee; China Health and Medical Development Foundation	National Key Technology R&D Program from the Ministry of Science and Technology (China)(National Key Technology R&D Program); Science and Technology Commission of Shanghai(Science & Technology Commission of Shanghai Municipality (STCSM)); Natural Science Funds of Ning Xia; Science and Technology Department(Science and Technology Development Fund (STDF)United States Agency for International Development (USAID)US-Egypt Science and Technology Joint Fund); National Natural Science Funds(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Department of Health, Jiangsu Province; Key Scientific and Technology Project from the Sichuan Science and Technology Department; Program for New Century Excellent Talents in University from the Ministry of Education (China); International Society of Nephrology Research Committee; China Health and Medical Development Foundation	This study was supported by the National Key Technology R&D Program from the Ministry of Science and Technology (China; 2007BAI04B10); the Science and Technology Commission of Shanghai (08dz1900502 and 07JC14037); the Natural Science Funds of Ning Xia (NZ08102); the Science and Technology Department, the National Natural Science Funds (30660069); the National Natural Science Foundation of China; the Department of Health, Jiangsu Province (H200936); the Key Scientific and Technology Project from the Sichuan Science and Technology Department (05SG1635); the Program for New Century Excellent Talents in University from the Ministry of Education (China; BMU2009131); the International Society of Nephrology Research Committee; and the China Health and Medical Development Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Chang A, 2013, AM J KIDNEY DIS, V62, P900, DOI 10.1053/j.ajkd.2013.04.022; Chen BD, 2010, CLIN CHIM ACTA, V411, P705, DOI 10.1016/j.cca.2010.01.038; Chen SY, 2013, CLIN NEPHROL, V80, P361, DOI 10.5414/CN108002; Elsayed EF, 2008, AM J KIDNEY DIS, V52, P29, DOI 10.1053/j.ajkd.2008.02.363; Gatti A, 2008, OBESITY, V16, P899, DOI 10.1038/oby.2007.59; group C.D.S.M.S.R.C, 2004, CHIN J DIABETES, V12, P151, DOI [10.3321/j.issn:1006-6187.2004.03.002, DOI 10.3321/J.ISSN:1006-6187.2004.03.002]; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Gu DF, 2005, LANCET, V365, P1398, DOI 10.1016/S0140-6736(05)66375-1; Hradec J, 2013, CURR MED RES OPIN, V29, P589, DOI 10.1185/03007995.2013.783795; Jang CM, 2014, INSULIN RESISTANCE I; Kang YU, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093795; Kurella M, 2005, J AM SOC NEPHROL, V16, P2134, DOI 10.1681/ASN.2005010106; Lee IT, 2008, DIABETES RES CLIN PR, V81, P345, DOI 10.1016/j.diabres.2008.05.010; Li YQ, 2014, NEPHROLOGY, V19, P325, DOI 10.1111/nep.12219; Lucove J, 2008, AM J KIDNEY DIS, V51, P21, DOI 10.1053/j.ajkd.2007.09.014; Ma YC, 2006, J AM SOC NEPHROL, V17, P2937, DOI 10.1681/ASN.2006040368; Ming J, 2014, CLIN CHIM ACTA, V430, P115, DOI 10.1016/j.cca.2014.01.004; Palaniappan L, 2003, AM J HYPERTENS, V16, P952, DOI 10.1016/S0895-7061(03)01009-4; Palaniappan LP, 2011, INT J OBESITY, V35, P393, DOI 10.1038/ijo.2010.152; Pang C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097928; Rashidi A, 2007, CLIN J AM SOC NEPHRO, V2, P976, DOI 10.2215/CJN.01020207; Ryu S, 2009, AM J KIDNEY DIS, V53, P59, DOI 10.1053/j.ajkd.2008.07.027; Sun F, 2010, NEPHROLOGY, V15, P84, DOI 10.1111/j.1440-1797.2009.01150.x; Thomas G, 2011, CLIN J AM SOC NEPHRO, V6, P2364, DOI 10.2215/CJN.02180311; USRDS, 2013, ANN DAT REP; Wang HY, 2005, KIDNEY INT, V67, pS63, DOI 10.1111/j.1523-1755.2005.09416.x; Watanabe H, 2010, DIABETES-METAB RES, V26, P26, DOI 10.1002/dmrr.1058; Zhang LX, 2012, LANCET, V379, P815, DOI 10.1016/S0140-6736(12)60033-6; Zuo L, 2010, CLIN NEPHROL, V74, pS20	32	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132220	10.1371/journal.pone.0132220	http://dx.doi.org/10.1371/journal.pone.0132220			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161991	Green Published, gold, Green Submitted			2022-12-26	WOS:000358162300104
J	Shioda, N; Sawai, M; Ishizuka, Y; Shirao, T; Fukunaga, K				Shioda, Norifumi; Sawai, Masahiro; Ishizuka, Yuta; Shirao, Tomoaki; Fukunaga, Kohji			Nuclear Translocation of Calcium/Calmodulin-dependent Protein Kinase II delta 3 Promoted by Protein Phosphatase-1 Enhances Brain-derived Neurotrophic Factor Expression in Dopaminergic Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						BDNF; Ca2+; calmodulin-dependent protein kinase II (CaMKII); dopamine receptor; nuclear translocation; protein phosphatase 1 (PP1)	BINDING PROTEIN; CAM KINASE; LOCALIZATION SIGNAL; GENE-EXPRESSION; II ACTIVITY; ISOFORMS; ACTIVATION; PHOSPHORYLATION; RECEPTOR; RAT	Background: The physiological function of CaMKII3 phosphorylation at Ser(332) remains unclear. Results: CaMKII3 dephosphorylation at Ser(332) promotes its nuclear localization and stimulates BDNF expression. Conclusion: Dopamine D-2 receptor stimulation triggers CaMKII3 dephosphorylation at Ser(332) by PP1. Significance: CaMKII3 (Ser(332)) dephosphorylation is critical for neurite extension and survival of dopaminergic neurons. We have reported previously that dopamine D-2 receptor stimulation activates calcium/calmodulin-dependent protein kinase II (CaMKII) 3, a CaMKII nuclear isoform, increasing BDNF gene expression. However, the mechanisms underlying that activity remained unclear. Here we report that CaMKII3 is dephosphorylated at Ser(332) by protein phosphatase 1 (PP1), promoting CaMKII3 nuclear translocation. Neuro-2a cells transfected with CaMKII3 showed cytoplasmic and nuclear staining, but the staining was predominantly nuclear when CaMKII3 was coexpressed with PP1. Indeed, PP1 and CaMKII3 coexpression significantly increased nuclear CaMKII activity and enhanced BDNF expression. In support of this idea, chronic administration of the dopamine D-2 receptor partial agonist aripiprazole increased PP1 activity and promoted nuclear CaMKII3 translocation and BDNF expression in the rat brain substantia nigra. Moreover, aripiprazole treatment enhanced neurite extension and inhibited cell death in cultured dopaminergic neurons, effects blocked by PP1 knockdown. Taken together, nuclear translocation of CaMKII3 following dephosphorylation at Ser(332) by PP1 likely accounts for BDNF expression and subsequent neurite extension and survival of dopaminergic neurons.	[Shioda, Norifumi; Sawai, Masahiro; Fukunaga, Kohji] Tohoku Univ, Grad Sch Pharmaceut Sci, Dept Pharmacol, Sendai, Miyagi 9808578, Japan; [Ishizuka, Yuta; Shirao, Tomoaki] Gunma Univ, Dept Neurobiol & Behav, Grad Sch Med, Maebashi, Gunma 3718511, Japan	Tohoku University; Gunma University	Shioda, N (corresponding author), Tohoku Univ, Grad Sch Pharmaceut Sci, Dept Pharmacol, Aoba Ku, 6-3 Aramaki Aoba, Sendai, Miyagi 9808578, Japan.	shioda@m.tohoku.ac.jp; kfukunaga@m.tohoku.ac.jp	Ishizuka, Yuta/ACN-8245-2022; Ishizuka, Yuta/AAB-9170-2019; Fukunaga, Kohji/AAI-8811-2021; Shirao, Tomoaki/I-9257-2016	Ishizuka, Yuta/0000-0002-2036-902X; Shirao, Tomoaki/0000-0003-4323-028X; Fukunaga, Kohji/0000-0001-8526-2824	Ministry of Education, Culture, Sports, Science, and Technology, Japan [25110705, 25460090, 24102505, 25293124]	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grant-in-Aids 25110705 and 25460090 (to N. S.) and 24102505 and 25293124 (to K. F.) for Scientific Research in the Innovative Area "Foundation of Synapse and Neurocircuit Pathology" from the Ministry of Education, Culture, Sports, Science, and Technology, Japan. The authors declare that they have no conflicts of interest with the contents of this article.	An JJ, 2008, CELL, V134, P175, DOI 10.1016/j.cell.2008.05.045; BARKER HM, 1993, BIOCHIM BIOPHYS ACTA, V1178, P228, DOI 10.1016/0167-4889(93)90014-G; BARKER HM, 1994, BBA-MOL CELL RES, V1220, P212, DOI 10.1016/0167-4889(94)90138-4; BEULLENS M, 1992, J BIOL CHEM, V267, P16538; Bordelon JR, 2005, CEREB CORTEX, V15, P1928, DOI 10.1093/cercor/bhi070; BRAUN AP, 1995, ANNU REV PHYSIOL, V57, P417, DOI 10.1146/annurev.ph.57.030195.002221; Brocke L, 1999, J BIOL CHEM, V274, P22713, DOI 10.1074/jbc.274.32.22713; BROCKE L, 1995, J NEUROSCI, V15, P6797; COHEN PTW, 1988, FEBS LETT, V232, P17, DOI 10.1016/0014-5793(88)80378-8; Cohen PTW, 2002, J CELL SCI, V115, P241; Colbran R J, 1990, Curr Top Cell Regul, V31, P181; DOMBRADI V, 1990, EUR J BIOCHEM, V194, P739, DOI 10.1111/j.1432-1033.1990.tb19464.x; EDMAN CF, 1994, BBA-MOL CELL RES, V1221, P89, DOI 10.1016/0167-4889(94)90221-6; Fan W, 2007, INVEST OPHTH VIS SCI, V48, P3854, DOI 10.1167/iovs.06-1382; FUKUNAGA K, 1988, J NEUROCHEM, V51, P1070, DOI 10.1111/j.1471-4159.1988.tb03070.x; FUKUNAGA K, 1982, J NEUROCHEM, V39, P1607, DOI 10.1111/j.1471-4159.1982.tb07994.x; Fukunaga K, 2000, J NEUROCHEM, V74, P807, DOI 10.1046/j.1471-4159.2000.740807.x; FUKUNAGA K, 1989, J BIOL CHEM, V264, P21830; Fukunaga K, 2000, NEUROSCI RES, V38, P3, DOI 10.1016/S0168-0102(00)00139-5; Greengard P, 1999, NEURON, V23, P435, DOI 10.1016/S0896-6273(00)80798-9; HANSON PI, 1992, ANNU REV BIOCHEM, V61, P559, DOI 10.1146/annurev.bi.61.070192.003015; Heist EK, 1998, J BIOL CHEM, V273, P19763, DOI 10.1074/jbc.273.31.19763; HYMAN C, 1991, NATURE, V350, P230, DOI 10.1038/350230a0; Kamata A, 2006, J NEUROCHEM, V96, P195, DOI 10.1111/j.1471-4159.2005.03531.x; Kim SY, 2008, EXP NEUROL, V214, P69, DOI 10.1016/j.expneurol.2008.07.014; Lewin GR, 1996, ANNU REV NEUROSCI, V19, P289, DOI 10.1146/annurev.ne.19.030196.001445; LO DC, 1995, NEURON, V15, P979, DOI 10.1016/0896-6273(95)90085-3; Lu WY, 2001, NEURON, V29, P243, DOI 10.1016/S0896-6273(01)00194-5; Luoni A, 2014, PHARMACOL RES, V80, P1, DOI 10.1016/j.phrs.2013.11.008; Ma H, 2014, CELL, V159, P281, DOI 10.1016/j.cell.2014.09.019; MATTHEWS RP, 1994, MOL CELL BIOL, V14, P6107, DOI 10.1128/MCB.14.9.6107; MAYER P, 1993, FEBS LETT, V333, P315, DOI 10.1016/0014-5793(93)80678-N; Miglio G, 2004, EUR J PHARMACOL, V489, P157, DOI 10.1016/j.ejphar.2004.03.006; MISRA RP, 1994, J BIOL CHEM, V269, P25483; Mogi M, 1999, NEUROSCI LETT, V270, P45, DOI 10.1016/S0304-3940(99)00463-2; Mullasseril P, 2007, J NEUROCHEM, V103, P357, DOI 10.1111/j.1471-4159.2007.04744.x; Murer MG, 2001, PROG NEUROBIOL, V63, P71, DOI 10.1016/S0301-0082(00)00014-9; Parain K, 1999, NEUROREPORT, V10, P557, DOI 10.1097/00001756-199902250-00021; Przedborski S, 2004, J BIOENERG BIOMEMBR, V36, P375, DOI 10.1023/B:JOBB.0000041771.66775.d5; SASAKI K, 1990, JPN J CANCER RES, V81, P1272, DOI 10.1111/j.1349-7006.1990.tb02690.x; Sawada H, 1998, ANN NEUROL, V44, P110, DOI 10.1002/ana.410440117; SCHULMAN H, 1993, NEUROCHEM RES, V18, P65, DOI 10.1007/BF00966924; Shen K, 1998, NEURON, V21, P593, DOI 10.1016/S0896-6273(00)80569-3; Shimomura A, 1996, J BIOL CHEM, V271, P17957, DOI 10.1074/jbc.271.30.17957; Shioda N, 2006, J NEUROCHEM, V98, P310, DOI 10.1111/j.1471-4159.2006.03874.x; Shioda N, 2012, J BIOL CHEM, V287, P23318, DOI 10.1074/jbc.M112.349142; Shioda N, 2010, J NEUROSCI, V30, P3146, DOI 10.1523/JNEUROSCI.4140-09.2010; SNIDER WD, 1994, CELL, V77, P627, DOI 10.1016/0092-8674(94)90048-5; Soderling TR, 2001, J BIOL CHEM, V276, P3719, DOI 10.1074/jbc.R000013200; SRINIVASAN M, 1994, J CELL BIOL, V126, P839, DOI 10.1083/jcb.126.4.839; Strack S, 1997, J BIOL CHEM, V272, P13467, DOI 10.1074/jbc.272.21.13467; Strack Stefan, 2008, P459, DOI 10.1007/978-0-387-77232-5_16; SUN PQ, 1994, GENE DEV, V8, P2527, DOI 10.1101/gad.8.21.2527; Sun PQ, 1996, J BIOL CHEM, V271, P3066, DOI 10.1074/jbc.271.6.3066; Takahashi H, 2009, J CELL SCI, V122, P1211, DOI 10.1242/jcs.043729; Takao K, 2005, J NEUROSCI, V25, P3107, DOI 10.1523/JNEUROSCI.0085-05.2005; Takeuchi Y, 2002, J NEUROCHEM, V82, P316, DOI 10.1046/j.1471-4159.2002.00967.x; Takeuchi Y, 2000, J NEUROCHEM, V74, P2557, DOI 10.1046/j.1471-4159.2000.0742557.x; Terry-Lorenzo RT, 2002, J BIOL CHEM, V277, P27716, DOI 10.1074/jbc.M203365200; THOENEN H, 1995, SCIENCE, V270, P593, DOI 10.1126/science.270.5236.593; TOBIMATSU T, 1988, J BIOL CHEM, V263, P16082; WEGNER M, 1992, SCIENCE, V256, P370, DOI 10.1126/science.256.5055.370; WOODGETT JR, 1983, EUR J BIOCHEM, V136, P481, DOI 10.1111/j.1432-1033.1983.tb07766.x; Yano S, 1996, J BIOL CHEM, V271, P23520, DOI 10.1074/jbc.271.38.23520; Yoshimura R, 2012, HUM PSYCHOPHARM CLIN, V27, P33, DOI 10.1002/hup.1257; Yoshioka M, 2002, NEUROSCI RES, V43, P259, DOI 10.1016/S0168-0102(02)00040-8; Zhou ZL, 2006, NEURON, V52, P255, DOI 10.1016/j.neuron.2006.09.037	67	16	18	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2015	290	35					21663	21675		10.1074/jbc.M115.664920	http://dx.doi.org/10.1074/jbc.M115.664920			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ5IS	26163515	Green Published, hybrid			2022-12-26	WOS:000360637600038
J	Blanco, F; Barberia, I; Matute, H				Blanco, Fernando; Barberia, Itxaso; Matute, Helena			Individuals Who Believe in the Paranormal Expose Themselves to Biased Information and Develop More Causal Illusions than Nonbelievers in the Laboratory	PLOS ONE			English	Article							PROBABILITY MISJUDGMENT; PSYCHOLOGICAL-RESEARCH; CRITICAL THINKING; CONTINGENCY; JUDGMENTS; STRATEGY; STUDENTS; SAMPLE; LOCUS; CUE	In the reasoning literature, paranormal beliefs have been proposed to be linked to two related phenomena: a biased perception of causality and a biased information-sampling strategy (believers tend to test fewer hypotheses and prefer confirmatory information). In parallel, recent contingency learning studies showed that, when two unrelated events coincide frequently, individuals interpret this ambiguous pattern as evidence of a causal relationship. Moreover, the latter studies indicate that sampling more cause-present cases than cause-absent cases strengthens the illusion. If paranormal believers actually exhibit a biased exposure to the available information, they should also show this bias in the contingency learning task: they would in fact expose themselves to more cause-present cases than cause-absent trials. Thus, by combining the two traditions, we predicted that believers in the paranormal would be more vulnerable to developing causal illusions in the laboratory than nonbelievers because there is a bias in the information they experience. In this study, we found that paranormal beliefs (measured using a questionnaire) correlated with causal illusions (assessed by using contingency judgments). As expected, this correlation was mediated entirely by the believers' tendency to expose themselves to more cause-present cases. The association between paranormal beliefs, biased exposure to information, and causal illusions was only observed for ambiguous materials (i.e., the noncontingent condition). In contrast, the participants' ability to detect causal relationships which did exist (i.e., the contingent condition) was unaffected by their susceptibility to believe in paranormal phenomena.	[Blanco, Fernando; Matute, Helena] Univ Deusto, Labpsico, Dept Fundamentos & Metodos Psicol, Bilbao, Spain; [Barberia, Itxaso] Univ Barcelona, Fac Psicol, Event Lab, Barcelona, Spain; [Barberia, Itxaso] Univ Barcelona, Fac Psicol, Dept Psicol Basica, Barcelona, Spain	University of Deusto; University of Barcelona; University of Barcelona	Blanco, F (corresponding author), Univ Deusto, Labpsico, Dept Fundamentos & Metodos Psicol, Bilbao, Spain.	fernandoblanco@deusto.es	BARBERIA, ITXASO/L-8477-2014; Blanco, Fernando/E-8941-2010; Matute, Helena/A-8256-2011	BARBERIA, ITXASO/0000-0003-3045-2289; Blanco, Fernando/0000-0003-1283-8313; Matute, Helena/0000-0001-7221-1366	Direccion General de Investigacion (Spanish Government) [PSI2011-26965]; Departamento de Educacion, Universidades e Investigacion (Basque Government) [IT363-10]	Direccion General de Investigacion (Spanish Government); Departamento de Educacion, Universidades e Investigacion (Basque Government)	This research was supported by Direccion General de Investigacion (Spanish Government; Grant PSI2011-26965) and Departamento de Educacion, Universidades e Investigacion (Basque Government; Grant IT363-10).	ALLOY LB, 1979, J EXP PSYCHOL GEN, V108, P441, DOI 10.1037/0096-3445.108.4.441; BAKER AG, 1989, Q J EXP PSYCHOL-B, V41, P65; Barberia I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071303; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Beck J, 2007, HUM NATURE-INT BIOS, V18, P35, DOI 10.1007/BF02820845; BLACKMORE S, 1985, BRIT J PSYCHOL, V76, P459, DOI 10.1111/j.2044-8295.1985.tb01969.x; Blackmore SJ, 1997, BRIT J PSYCHOL, V88, P683, DOI 10.1111/j.2044-8295.1997.tb02665.x; Blanco F, 2013, LEARN BEHAV, V41, P333, DOI 10.3758/s13420-013-0108-8; Blanco F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046203; Blanco F, 2011, Q J EXP PSYCHOL, V64, P1290, DOI 10.1080/17470218.2011.552727; Blanco F, 2010, PSYCHON B REV, V17, P117, DOI 10.3758/PBR.17.1.117; Brugger P, 1997, Cogn Neuropsychiatry, V2, P251, DOI 10.1080/135468097396270; Burger J. M., 1979, MOTIV EMOTION, V3, P381, DOI DOI 10.1007/BF00994052; Dag I, 1999, PERS INDIV DIFFER, V26, P723, DOI 10.1016/S0191-8869(98)00184-6; De Miguel Calvo JM, 2013, SPAN J PSYCHOL, V15, P1432; Diaz-Vilela L, 2004, J PARAPSYCHOL, V68, P405; ECKBLAD M, 1983, J CONSULT CLIN PSYCH, V51, P215, DOI 10.1037/0022-006X.51.2.215; European Commission, 2010, SPEC EUR 340 SCI TEC; French C. C., 2007, TALL TALES MIND BRAI, P3, DOI DOI 10.1093/ACPROF:OSO/9780198568773.003.0002; Gianotti LRR, 2001, PSYCHIAT CLIN NEUROS, V55, P595, DOI 10.1046/j.1440-1819.2001.00911.x; Groth-Marnat G, 1998, SOC BEHAV PERSONAL, V26, P291, DOI 10.2224/sbp.1998.26.3.291; Hannah S, 2007, BEHAV PROCESS, V74, P265, DOI 10.1016/j.beproc.2006.09.007; IRWIN HJ, 1993, J AM SOC PSYCHICAL R, V87, P1; Ferrando PJ, 2011, PSICOTHEMA, V23, P282; Judd CM, 2001, PSYCHOL METHODS, V6, P115, DOI 10.1037/1082-989X.6.2.115; Katagiri M, 2007, BEHAV PROCESS, V74, P251, DOI 10.1016/j.beproc.2006.09.001; Keinan G, 2002, PERS SOC PSYCHOL B, V28, P102, DOI 10.1177/0146167202281009; KILLEN P, 1974, PSYCHOL REP, V34, P1158, DOI 10.2466/pr0.1974.34.3c.1158; KLAYMAN J, 1987, PSYCHOL REV, V94, P211, DOI 10.1037/0033-295X.94.2.211; Lilienfeld SO, 2009, PERSPECT PSYCHOL SCI, V4, P390, DOI 10.1111/j.1745-6924.2009.01144.x; Liljeholm M, 2009, J EXP PSYCHOL LEARN, V35, P157, DOI 10.1037/a0013972; Lindeman M, 2012, REV GEN PSYCHOL, V16, P241, DOI 10.1037/a0027158; Mandel DR, 2009, Q J EXP PSYCHOL, V62, P2388, DOI 10.1080/17470210902794148; Matute H, 1996, PSYCHOL SCI, V7, P289, DOI 10.1111/j.1467-9280.1996.tb00376.x; Matute H, 2012, ENCY SCI LEARNING, DOI [10.1007/SpringerReference_301904, DOI 10.1007/SPRINGERREFERENCE_301904]; Matute H, 2007, CYBERPSYCHOL BEHAV, V10, P176, DOI 10.1089/cpb.2006.9971; Matute H, 2011, BRIT J PSYCHOL, V102, P392, DOI 10.1348/000712610X532210; McKay RT, 2009, BEHAV BRAIN SCI, V32, P493, DOI 10.1017/S0140525X09990975; McKenzie CRM, 2007, COGNITIVE PSYCHOL, V54, P33, DOI 10.1016/j.cogpsych.2006.04.004; MILL D, 1994, CAN J BEHAV SCI, V26, P246, DOI 10.1037/0008-400X.26.2.246; Moore David W., 2005, 3 4 AM BELIEVE PARAN; Musch J, 2002, BRIT J PSYCHOL, V93, P169, DOI 10.1348/000712602162517; Perales JC, 2007, PSYCHON B REV, V14, P577, DOI 10.3758/BF03196807; Roe CA, 1999, BRIT J PSYCHOL, V90, P85, DOI 10.1348/000712699161288; ROTTER JB, 1966, PSYCHOL MONOGR, V80, P1, DOI 10.1037/h0092976; Royalty J, 1995, J GENET PSYCHOL, V156, P477, DOI 10.1080/00221325.1995.9914838; Schmaltz R, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00336; Schmied-Knittel I., 2005, EUROPEAN J PARAPSYCH, V20, P3; SHANKS DR, 1987, PSYCHOL LEARN MOTIV, V21, P229; Tobacyk Jerome., 2004, INT J TRANSPERSONAL, V23, P94, DOI [DOI 10.24972/IJTS.2004.23.1.94, DOI 10.1037/T14015-000]; Vadillo MA, 2005, LEARN BEHAV, V33, P172; van Elk M, 2013, CONSCIOUS COGN, V22, P1041, DOI 10.1016/j.concog.2013.07.004; Vazquez-Alonso A, 1997, ENSEN CIENC, V15, P199; WASSERMAN EA, 1990, J EXP PSYCHOL LEARN, V16, P509, DOI 10.1037/0278-7393.16.3.509; WASSERMAN EA, 1990, PSYCHOL LEARN MOTIV, V26, P27, DOI DOI 10.1016/S0079-7421(08)60051-1; Wiseman R, 2004, PERS INDIV DIFFER, V37, P1533, DOI 10.1016/j.paid.2004.02.009	56	29	29	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0131378	10.1371/journal.pone.0131378	http://dx.doi.org/10.1371/journal.pone.0131378			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1RL	26177025	Green Submitted, gold, Green Published			2022-12-26	WOS:000358197600042
J	Humphries, DJ; Finch, FM; Bell, MBV; Ridley, AR				Humphries, David J.; Finch, Fiona M.; Bell, Matthew B. V.; Ridley, Amanda R.			Calling Where It Counts: Subordinate Pied Babblers Target the Audience of Their Vocal Advertisements	PLOS ONE			English	Article							KIN RECOGNITION; INBREEDING DEPRESSION; DELAYED DISPERSAL; SPATIAL STRUCTURE; LIFE-HISTORY; FAIRY-WRENS; AVOIDANCE; EVOLUTION; COSTS; TERRITORIALITY	For territorial group-living species, opportunities to reproduce on the natal territory can be limited by a number of factors including the availability of resources within a territory, access to unrelated individuals, and monopolies on reproduction by dominant group members. Individuals looking to reproduce are therefore faced with the options of either waiting for a breeding opportunity to arise in the natal territory, or searching for reproductive opportunities in non-natal groups. In the cooperatively breeding Southern pied babbler, Turdoides bicolor, most individuals who achieve reproductive success do so through taking up dominant breeding positions within non-natal groups. For subordinate pied babblers therefore, searching for breeding opportunities in non-natal groups is of primary importance as this represents the major route to reproductive success. However, prospecting (where individuals leave the group to search for reproductive opportunities within other groups) is costly and individuals rapidly lose weight when not part of a group. Here we demonstrate that subordinate pied babblers adopt an alternative strategy for mate attraction by vocal advertisement from within their natal territories. We show that subordinates focus their calling efforts on the edges of their territory, and specifically near boundaries with neighbouring groups that have potential breeding partners (unrelated individuals of the opposite sex). In contrast to prospecting, calling individuals showed no body mass loss associated with this behaviour, suggesting that calling from within the group may provide a 'cheap' advertisement strategy. Additionally, we show that subordinates use information regarding the composition of neighbouring groups to target the greatest number of potential mating partners.	[Humphries, David J.; Ridley, Amanda R.] Macquarie Univ, Dept Biol Sci, Sydney, NSW 2109, Australia; [Bell, Matthew B. V.] Univ Edinburgh, Inst Evolutionary Biol, Sch Biol Sci, Edinburgh EH9 3JT, Midlothian, Scotland; [Ridley, Amanda R.] Univ Cape Town, Percy FitzPatrick Inst, DST NRF Ctr Excellence, ZA-7925 Cape Town, Western Cape, South Africa; [Humphries, David J.; Finch, Fiona M.; Bell, Matthew B. V.; Ridley, Amanda R.] Kuruman River Reserve, Pied Babbler Res Project, Van Zylsrus, South Africa; [Ridley, Amanda R.] Univ Western Australia, Sch Anim Biol, Ctr Evolutionary Biol, Perth, WA 6009, Australia	Macquarie University; University of Edinburgh; National Research Foundation - South Africa; University of Cape Town; University of Western Australia	Humphries, DJ (corresponding author), Macquarie Univ, Dept Biol Sci, Sydney, NSW 2109, Australia.	davidhumphries@outlook.com	Ridley, Amanda/D-2636-2011	Ridley, Amanda/0000-0001-5886-0992	iMQRES PhD Scholarship	iMQRES PhD Scholarship	This work was funded through an iMQRES PhD Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonadonna F, 2012, ANIM BEHAV, V84, P509, DOI 10.1016/j.anbehav.2012.06.014; Bonte D, 2012, BIOL REV, V87, P290, DOI 10.1111/j.1469-185X.2011.00201.x; Boulinier T, 1996, J AVIAN BIOL, V27, P252, DOI 10.2307/3677230; BROOKER M, 1995, J ANIM ECOL, V64, P614, DOI 10.2307/5804; BUCKLEY PA, 1970, AUK, V87, P1; Calenge C, 2007, J STAT SOFTWARE, V22; Cant MA, 2002, ETHOLOGY, V108, P541, DOI 10.1046/j.1439-0310.2002.00795.x; Charlesworth B, 1999, GENET RES, V74, P329, DOI 10.1017/S0016672399004152; CHARLESWORTH D, 1987, ANNU REV ECOL SYST, V18, P237, DOI 10.1146/annurev.es.18.110187.001321; Clutton-Brock TH, 1999, J ANIM ECOL, V68, P672, DOI 10.1046/j.1365-2656.1999.00317.x; Covas R, 2007, P ROY SOC B-BIOL SCI, V274, P1349, DOI 10.1098/rspb.2007.0117; Dale J, 2001, AM NAT, V158, P75, DOI 10.1086/320861; Doerr ED, 2005, OECOLOGIA, V142, P1, DOI 10.1007/s00442-004-1707-z; Doolan SP, 1996, J ZOOL, V240, P59, DOI 10.1111/j.1469-7998.1996.tb05486.x; du Plessis KL, 2012, GLOBAL CHANGE BIOL, V18, P3063, DOI 10.1111/j.1365-2486.2012.02778.x; Ekman J, 2001, J ANIM ECOL, V70, P317, DOI 10.1046/j.1365-2656.2001.00490.x; Getz WM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000207; Golabek KA, 2013, BEHAVIOUR, V150, P691, DOI 10.1163/1568539X-00003074; Golabek KA, 2012, ANIM BEHAV, V83, P613, DOI 10.1016/j.anbehav.2011.11.034; Griffiths R, 1998, MOL ECOL, V7, P1071, DOI 10.1046/j.1365-294x.1998.00389.x; Griffiths SW, 2002, J ANIM ECOL, V71, P480, DOI 10.1046/j.1365-2656.2002.00614.x; Hale AM, 2003, AUK, V120, P446, DOI 10.1642/0004-8038(2003)120[0446:TANAIB]2.0.CO;2; Hass CC, 2002, BEHAV ECOL SOCIOBIOL, V51, P570, DOI 10.1007/s00265-002-0463-5; Hatchwell BJ, 2001, J ANIM ECOL, V70, P820, DOI 10.1046/j.0021-8790.2001.00541.x; Hatchwell BJ, 2001, P ROY SOC B-BIOL SCI, V268, P885, DOI 10.1098/rspb.2001.1598; Hatchwell BJ, 2000, ANIM BEHAV, V59, P1079, DOI 10.1006/anbe.2000.1394; Henzi SP, 1998, ANIM BEHAV, V55, P1421, DOI 10.1006/anbe.1997.0716; Kahlenberg SM, 2008, ANIM BEHAV, V76, P1497, DOI 10.1016/j.anbehav.2008.05.029; KELLER L, 1994, TRENDS ECOL EVOL, V9, P98, DOI 10.1016/0169-5347(94)90204-6; Kitchen AM, 2005, J ANIM ECOL, V74, P1173, DOI 10.1111/j.1365-2656.2005.01017.x; Koenig WD, 1998, AM NAT, V151, P243, DOI 10.1086/286115; KOENIG WD, 1992, Q REV BIOL, V67, P111, DOI 10.1086/417552; Komdeur J, 2001, P ROY SOC B-BIOL SCI, V268, P2007, DOI 10.1098/rspb.2001.1742; Kraaijeveld K, 2001, ANIM BEHAV, V61, P109, DOI 10.1006/anbe.2000.1591; Krause ET, 2012, BIOL LETTERS, V8, P327, DOI 10.1098/rsbl.2011.1093; Legge S, 2000, BEHAV ECOL SOCIOBIOL, V47, P220, DOI 10.1007/s002650050659; Magrath Robert D., 2004, P157, DOI 10.1017/CBO9780511606816.011; Mares R, 2012, P ROYAL SOC B; Mares R, 2012, EXTRATERRITORIAL PRO; MCGREGOR PK, 1993, PHILOS T ROY SOC B, V340, P237, DOI 10.1098/rstb.1993.0063; MULDER RA, 1994, P ROY SOC B-BIOL SCI, V255, P223, DOI 10.1098/rspb.1994.0032; Nelson-Flower MJ, 2012, J ANIM ECOL, V81, P876, DOI 10.1111/j.1365-2656.2012.01983.x; Nelson-Flower MJ, 2011, BEHAV ECOL, V22, P559, DOI 10.1093/beheco/arr018; Nelson-Flower MJ, 2010, TURDIODES BICOLOR; Nielsen JF, 2012, MOL ECOL, V21, P2788, DOI 10.1111/j.1365-294X.2012.05565.x; Otter K, 1999, P ROY SOC B-BIOL SCI, V266, P1305, DOI 10.1098/rspb.1999.0779; PAYNE RB, 1988, ANIM BEHAV, V36, P1341, DOI 10.1016/S0003-3472(88)80203-3; Price JJ, 1999, ANIM BEHAV, V57, P483, DOI 10.1006/anbe.1998.1018; Radford AN, 2006, CURR BIOL, V16, P1700, DOI 10.1016/j.cub.2006.06.053; Raihani NJ, 2010, J AVIAN BIOL, V41, P681, DOI 10.1111/j.1600-048X.2010.05211.x; Reed J. Michael, 1999, Current Ornithology, V15, P189; Ridley AR, 2007, BEHAV ECOL, V18, P324, DOI 10.1093/beheco/arl092; Ridley AR, 2008, J AVIAN BIOL, V39, P389, DOI 10.1111/j.2008.0908-8857.04479.x; Schjorring S, 1999, ANIM BEHAV, V57, P647, DOI 10.1006/anbe.1998.0993; SERA WE, 1994, ECOLOGY, V75, P1560, DOI 10.2307/1939617; Sharp SP, 2005, NATURE, V434, P1127, DOI 10.1038/nature03522; Stacey P.B., 1990, COOPERATIVE BREEDING; STODDARD PK, 1983, AUK, V100, P795, DOI 10.1093/auk/100.4.795; Stoen OG, 2005, BEHAV ECOL SOCIOBIOL, V59, P191, DOI 10.1007/s00265-005-0024-9; Walker FM, 2008, MOL ECOL, V17, P1361, DOI 10.1111/j.1365-294X.2008.03670.x; Young AJ, 2005, ANIM BEHAV, V70, P829, DOI 10.1016/j.anbehav.2005.01.019; Young AJ, 2007, P ROY SOC B-BIOL SCI, V274, P1603, DOI 10.1098/rspb.2007.0316; Young AJ, 2009, BIOL LETTERS, V5, P439, DOI 10.1098/rsbl.2009.0032; ZACK S, 1990, ETHOLOGY, V86, P265	64	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0130795	10.1371/journal.pone.0130795	http://dx.doi.org/10.1371/journal.pone.0130795			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177094	gold, Green Submitted, Green Published			2022-12-26	WOS:000358197600028
J	Mukherjee, A; Syeb, K; Concannon, J; Callegari, K; Soto, C; Glicksman, MA				Mukherjee, Abhisek; Syeb, Kathleen; Concannon, John; Callegari, Keri; Soto, Claudio; Glicksman, Marcie A.			Development of a Fluorescent Quenching Based High Throughput Assay to Screen for Calcineurin Inhibitors	PLOS ONE			English	Article							PROTEIN PHOSPHATASE CALCINEURIN; CALMODULIN-BINDING PROTEIN; AMYLOID-BETA; NERVOUS-SYSTEM; CATALYTIC SUBUNIT; ESCHERICHIA-COLI; MEMORY; DISEASE; ACTIVATION; BRAIN	Currently there is no effective treatment available for major neurodegenerative disorders associated to protein misfolding, including Alzheimer's and Parkinson's disease. One of most promising therapeutic approaches under development focuses on inhibiting the misfolding and aggregation pathway. However, it is likely that by the time clinical symptoms appear, there is a large accumulation of misfolded aggregates and a very substantial damage to the brain. Thus, it seems that at the clinical stage of the disease it is necessary also to develop strategies aiming to prevent the neuronal damage produced by already formed misfolded aggregates. Chronic activation of calcineurin (CaN), a type IIB phosphatase, has been implicated as a pivotal molecule connecting synaptic loss and neuronal damage to protein misfolding. The fact that the crystal structure of CaN is also well established makes it an ideal target for drug discovery. CaN activity assays for High Throughput Screening (HTS) reported so far are based on absorbance. In this article we report the development of a fluorescent quenching based CaN activity assay suitable for robotic screening of large chemical libraries to find novel inhibitors. The assay yielded a Z score of 0.84 with coefficient of variance <= 15%. Our results also show that this assay can be used to identify CaN inhibitors with a wide range of potencies.	[Mukherjee, Abhisek; Callegari, Keri; Soto, Claudio] Univ Texas Hlth Sci Ctr Houston, Dept Neurol, Houston, TX 77030 USA; [Syeb, Kathleen; Concannon, John; Glicksman, Marcie A.] Brigham & Womens Hosp, Dept Neurol, Lab Drug Discovery Neurodegenerat, Cambridge, MA USA; [Syeb, Kathleen; Concannon, John; Glicksman, Marcie A.] Harvard Univ, Sch Med, Cambridge, MA 02138 USA	University of Texas System; University of Texas Health Science Center Houston; Harvard University; Brigham & Women's Hospital; Harvard University	Glicksman, MA (corresponding author), ORIG3N INC, Boston, MA 02210 USA.	Abhisek.Mukherjee@uth.tmc.edu; marcie@orig3n.com		Callegari, Keri/0000-0003-1433-6659	National Center for Drug Discovery in Neurodegeneration; NIH National Institute of Neurological Disorders and Stroke (NINDS) Cooperative Agreement Award [(U24) NS04933901]; Harvard NeuroDiscovery Center	National Center for Drug Discovery in Neurodegeneration; NIH National Institute of Neurological Disorders and Stroke (NINDS) Cooperative Agreement Award; Harvard NeuroDiscovery Center	This work was supported by National Center for Drug Discovery in Neurodegeneration, NIH National Institute of Neurological Disorders and Stroke (NINDS) Cooperative Agreement Award (U24) NS04933901 and the Harvard NeuroDiscovery Center.	Abdul HM, 2009, J NEUROSCI, V29, P12957, DOI 10.1523/JNEUROSCI.1064-09.2009; Agostinho P, 2008, NEUROCHEM INT, V52, P1226, DOI 10.1016/j.neuint.2008.01.005; AUSSEL C, 1995, J BIOL CHEM, V270, P8032, DOI 10.1074/jbc.270.14.8032; Carrell RW, 1997, LANCET, V350, P134, DOI 10.1016/S0140-6736(97)02073-4; Dineley KT, 2007, NEUROBIOL LEARN MEM, V88, P217, DOI 10.1016/j.nlm.2007.03.010; Dineley KT, 2010, J NEUROSCI RES, V88, P2923, DOI 10.1002/jnr.22445; ENZ A, 1994, ANAL BIOCHEM, V216, P147, DOI 10.1006/abio.1994.1018; GIRI PR, 1992, DNA CELL BIOL, V11, P415, DOI 10.1089/dna.1992.11.415; Jiang HS, 1997, MOL IMMUNOL, V34, P663, DOI 10.1016/S0161-5890(97)00054-0; Jin L, 2002, P NATL ACAD SCI USA, V99, P13522, DOI 10.1073/pnas.212504399; KAHAN BD, 1989, NEW ENGL J MED, V321, P1725; Kingsbury TJ, 2007, J NEUROCHEM, V103, P761, DOI 10.1111/j.1471-4159.2007.04801.x; KISSINGER CR, 1995, NATURE, V378, P641, DOI 10.1038/378641a0; KLEE CB, 1979, P NATL ACAD SCI USA, V76, P6270, DOI 10.1073/pnas.76.12.6270; Lehotsky J, 2003, PHYSIOL RES, V52, P269; LI HC, 1984, J BIOL CHEM, V259, P8801; Liu EH, 2007, NAT IMMUNOL, V8, P25, DOI 10.1038/ni1429; Liu F, 2005, J BIOL CHEM, V280, P37755, DOI 10.1074/jbc.M507475200; Mansuy IM, 2003, BIOCHEM BIOPH RES CO, V311, P1195, DOI 10.1016/j.bbrc.2003.10.046; Martin ZS, 2012, J NEUROCHEM, V120, P440, DOI 10.1111/j.1471-4159.2011.07576.x; Miyata Y, 2010, J BIOMOL SCREEN, V15, P1211, DOI 10.1177/1087057110380571; Mondragon A, 1997, BIOCHEMISTRY-US, V36, P4934, DOI 10.1021/bi9631935; Mukherjee A, 2011, CURR OPIN CELL BIOL, V23, P223, DOI 10.1016/j.ceb.2010.12.006; Mukherjee A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001138; Naesens M, 2009, CLIN J AM SOC NEPHRO, V4, P481, DOI 10.2215/CJN.04800908; Pardo R, 2006, J NEUROSCI, V26, P1635, DOI 10.1523/JNEUROSCI.3706-05.2006; Pineda JR, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-33; Pinton P, 2008, ONCOGENE, V27, P6407, DOI 10.1038/onc.2008.308; Reese LC, 2008, AGING CELL, V7, P824, DOI 10.1111/j.1474-9726.2008.00434.x; Rusnak F, 2000, PHYSIOL REV, V80, P1483, DOI 10.1152/physrev.2000.80.4.1483; Sellar KJ, 2006, ANAL BIOCHEM, V358, P104, DOI 10.1016/j.ab.2006.08.013; Sieber M, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-25; Soto C, 2003, NAT REV NEUROSCI, V4, P49, DOI 10.1038/nrn1007; Taglialatela G, 2009, BEHAV BRAIN RES, V200, P95, DOI 10.1016/j.bbr.2008.12.034; Tang XH, 2012, J BIOMOL SCREEN, V17, P314, DOI 10.1177/1087057111429595; Usuda N, 1996, J HISTOCHEM CYTOCHEM, V44, P13, DOI 10.1177/44.1.8543776; Wang HG, 1999, SCIENCE, V284, P339, DOI 10.1126/science.284.5412.339; WOOD JG, 1980, J CELL BIOL, V84, P66, DOI 10.1083/jcb.84.1.66; Wu HY, 2010, J NEUROSCI, V30, P2636, DOI 10.1523/JNEUROSCI.4456-09.2010; Yamamoto-Sasaki M, 1999, BRAIN RES, V824, P300, DOI 10.1016/S0006-8993(99)01220-2; Zuck P, 2005, ANAL BIOCHEM, V342, P254, DOI 10.1016/j.ab.2005.04.029	41	2	3	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0131297	10.1371/journal.pone.0131297	http://dx.doi.org/10.1371/journal.pone.0131297			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176772	Green Published, Green Submitted, gold			2022-12-26	WOS:000358197600039
J	Nodvig, CS; Nielsen, JB; Kogle, ME; Mortensen, UH				Nodvig, Christina S.; Nielsen, Jakob B.; Kogle, Martin E.; Mortensen, Uffe H.			A CRISPR-Cas9 System for Genetic Engineering of Filamentous Fungi	PLOS ONE			English	Article							ASPERGILLUS-NIDULANS; SACCHAROMYCES-CEREVISIAE; CAS SYSTEMS; GUIDE RNAS; SPECIFICITY; TRANSFORMATION; ENDONUCLEASE; CRISPR/CAS9; EXPRESSION; EFFECTORS	The number of fully sequenced fungal genomes is rapidly increasing. Since genetic tools are poorly developed for most filamentous fungi, it is currently difficult to employ genetic engineering for understanding the biology of these fungi and to fully exploit them industrially. For that reason there is a demand for developing versatile methods that can be used to genetically manipulate non-model filamentous fungi. To facilitate this, we have developed a CRISPR-Cas9 based system adapted for use in filamentous fungi. The system is simple and versatile, as RNA guided mutagenesis can be achieved by transforming a target fungus with a single plasmid. The system currently contains four CRISPR- Cas9 vectors, which are equipped with commonly used fungal markers allowing for selection in a broad range of fungi. Moreover, we have developed a script that allows identification of protospacers that target gene homologs in multiple species to facilitate introduction of common mutations in different filamentous fungi. With these tools we have performed RNA-guided mutagenesis in six species of which one has not previously been genetically engineered. Moreover, for a wild-type Aspergillus aculeatus strain, we have used our CRISPR Cas9 system to generate a strain that contains an AACU_pyrG marker and demonstrated that the resulting strain can be used for iterative gene targeting.	[Nodvig, Christina S.; Nielsen, Jakob B.; Kogle, Martin E.; Mortensen, Uffe H.] Tech Univ Denmark, Dept Syst Biol, Sect Eukaryot Biotechnol, Eukaryot Mol Cell Biol, DK-2800 Lyngby, Denmark	Technical University of Denmark	Mortensen, UH (corresponding author), Tech Univ Denmark, Dept Syst Biol, Sect Eukaryot Biotechnol, Eukaryot Mol Cell Biol, DK-2800 Lyngby, Denmark.	um@bio.dtu.dk	Mortensen, Uffe/AAQ-1150-2021; Hoof, Jakob Blæsbjerg/L-6019-2015	Hoof, Jakob Blæsbjerg/0000-0002-7650-9300	Danish Council for Strategic Research [11-116803]	Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF))	This work was supported by Grant 11-116803 from The Danish Council for Strategic Research.	Aleksenko A, 1997, FUNGAL GENET BIOL, V21, P373, DOI 10.1006/fgbi.1997.0980; Arnaud MB, 2012, NUCLEIC ACIDS RES, V40, pD653, DOI 10.1093/nar/gkr875; BALLANCE DJ, 1983, BIOCHEM BIOPH RES CO, V112, P284, DOI 10.1016/0006-291X(83)91828-4; Belhaj K, 2013, PLANT METHODS, V9, DOI 10.1186/1746-4811-9-39; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; BOEKE JD, 1984, MOL GEN GENET, V197, P345, DOI 10.1007/BF00330984; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; COVE DJ, 1966, BIOCHIM BIOPHYS ACTA, V113, P51, DOI 10.1016/S0926-6593(66)80120-0; Cradick TJ, 2013, NUCLEIC ACIDS RES, V41, P9584, DOI 10.1093/nar/gkt714; DiCarlo JE, 2013, NUCLEIC ACIDS RES, V41, P4336, DOI 10.1093/nar/gkt135; Fleissner A, 2010, APPL MICROBIOL BIOT, V87, P1255, DOI 10.1007/s00253-010-2672-6; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Gao YB, 2014, J INTEGR PLANT BIOL, V56, P343, DOI 10.1111/jipb.12152; GEMS D, 1991, GENE, V98, P61, DOI 10.1016/0378-1119(91)90104-J; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Hansen BG, 2011, APPL ENVIRON MICROB, V77, P3044, DOI 10.1128/AEM.01768-10; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Jacobs JZ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6344; Jakounas T, 2015, METAB ENG, V28, P213, DOI 10.1016/j.ymben.2015.01.008; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kaminskyj SGW., 2001, FUNGAL GENET REP, V48, P25, DOI [10.4148/1941-4765.1175, DOI 10.4148/1941-4765.1175]; Kim YG, 1996, P NATL ACAD SCI USA, V93, P1156, DOI 10.1073/pnas.93.3.1156; Kitamoto N, 1998, APPL MICROBIOL BIOT, V50, P85, DOI 10.1007/s002530051260; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; Li Mamie Z, 2012, Methods Mol Biol, V852, P51, DOI 10.1007/978-1-61779-564-0_5; Liu R, 2015, CELL DISCOV, V1, DOI 10.1038/celldisc.2015.7; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Moretti A, 2013, INT J FOOD MICROBIOL, V167, P57, DOI 10.1016/j.ijfoodmicro.2013.06.033; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Nielsen ML, 2006, FUNGAL GENET BIOL, V43, P54, DOI 10.1016/j.fgb.2005.09.005; Nissim L, 2014, MULTIPLEXED PROGRAMM; Norholm MHH, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-21; Nour-Eldin HH, 2010, METHODS MOL BIOL, V643, P185, DOI 10.1007/978-1-60761-723-5_13; OHARA EB, 1989, GENETICS, V121, P249; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Ruiz-Diez B, 2002, J APPL MICROBIOL, V92, P189, DOI 10.1046/j.1365-2672.2002.01516.x; Ryan OW, 2014, ELIFE, V3, DOI 10.7554/eLife.03703; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Tamano K, 2013, APPL MICROBIOL BIOT, V97, P269, DOI 10.1007/s00253-012-4193-y; Wu F, 2014, ANNU REV FOOD SCI T, V5, P351, DOI 10.1146/annurev-food-030713-092431; YUILL EDWARD, 1950, TRANS BRIT MYCOL SOC, V33, P324; Zhang YW, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1288	46	329	374	29	357	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0133085	10.1371/journal.pone.0133085	http://dx.doi.org/10.1371/journal.pone.0133085			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177455	gold, Green Submitted, Green Published			2022-12-26	WOS:000358197600212
J	Olsen, AB; Hjortaas, M; Tengs, T; Hellberg, H; Johansen, R				Olsen, Anne Berit; Hjortaas, Monika; Tengs, Torstein; Hellberg, Hege; Johansen, Renate			First Description of a New Disease in Rainbow Trout (Oncorhynchus mykiss (Walbaum)) Similar to Heart and Skeletal Muscle Inflammation (HSMI) and Detection of a Gene Sequence Related to Piscine Orthoreovirus (PRV)	PLOS ONE			English	Article							SALMON SALMO-SALAR; RT-PCR ASSAY; ATLANTIC SALMON; REOVIRUS PRV; ALPHAVIRUS SAV; VIRUS; NORWAY; VALIDATION; TAQMAN(R); INFECTION	In fall 2013, anorexia, lethargy and mortalities up to 10-12,000 dead fish per week were observed in rainbow trout Oncorhynchus mykiss in three fresh water hatcheries (salinity 0-1 %) on the west coast of Norway. The fish (25-100 g) showed signs of circulatory failure with haemorrhages, ascites and anaemia. The histopathological findings comprised inflammation of the heart and red muscle and liver necrosis. The affected fish had a common origin. Disease and mortalities were also observed up to four months after sea water transfer. Microbiological examination did not reveal presence of any known pathogens. Based on histopathological similarities to heart and skeletal inflammation (HSMI) in Atlantic salmon, associated with piscine orthoreovirus (PRV), extended investigations to detect a virus within the family Reoviridae were conducted. By the use of primer sets targeting the PRV genome, a sequence with 85% identity to a part of segment S1 of PRV was obtained. Further analysis showed that the virus sequence could only be aligned with PRV and no other reoviruses both on amino acid and nucleotide level. Two PCR assays were developed for specific detection of the virus. High amounts of the virus were detected in diseased fish at all affected farms and low amounts were detected in low prevalence at the broodfish farms. Further investigations are needed to determine if the virus is associated with the new disease in rainbow trout and to further characterize the virus with respect to classification, relationship with PRV, virulence, pathology and epidemiology.	[Olsen, Anne Berit; Hellberg, Hege] Norwegian Vet Inst, Bergen, Norway; [Hjortaas, Monika; Tengs, Torstein; Johansen, Renate] Norwegian Vet Inst, Oslo, Norway	Norwegian Veterinary Institute; Norwegian Veterinary Institute	Olsen, AB (corresponding author), Norwegian Vet Inst, Bergen, Norway.	anne-berit.olsen@vetinst.no			Norwegian Veterinary Institute	Norwegian Veterinary Institute	This work has been financed by internal funding at the Norwegian Veterinary Institute.	ANACKER RL, 1959, J BACTERIOL, V78, P33, DOI 10.1128/JB.78.1.33-40.1959; Blindheim S, 2015, ARCH VIROL, V160, P91, DOI 10.1007/s00705-014-2235-8; Evensen O, 1996, DIS AQUAT ORGAN, V25, P53, DOI 10.3354/dao025053; Finstad OW, 2014, VET RES, V45, DOI 10.1186/1297-9716-45-35; Finstad OW, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-27; Garseth AH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082202; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Hjeltnes B., 2014, FISH HLTH REPORT 201; Hodneland K, 2006, J VIROL METHODS, V131, P184, DOI 10.1016/j.jviromet.2005.08.012; Jansen MD, 2010, J FISH DIS, V33, P391, DOI 10.1111/j.1365-2761.2009.01131.x; Jansen MD, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-188; Jonstrup SP, 2013, J FISH DIS, V36, P9, DOI 10.1111/j.1365-2761.2012.01416.x; Kibenge MJT, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-230; Kongtorp RT, 2009, J FISH DIS, V32, P253, DOI 10.1111/j.1365-2761.2008.00983.x; Kongtorp RT, 2004, J FISH DIS, V27, P351, DOI 10.1111/j.1365-2761.2004.00549.x; Kongtorp RT., 2008, SERIES OF DISSERTATI, V47; Liu ZX, 2008, J VIROL METHODS, V149, P103, DOI 10.1016/j.jviromet.2007.12.017; Lovoll M, 2012, DIS AQUAT ORGAN, V99, P7, DOI 10.3354/dao02451; Lovoll M, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-309; Lupiani Blanca, 1995, Annual Review of Fish Diseases, V5, P175, DOI 10.1016/0959-8030(95)00006-2; MacWilliams C, 2007, DIS AQUAT ORGAN, V78, P1, DOI 10.3354/dao01866; Meyers TR, 2007, DIS AQUAT ORGAN, V76, P169, DOI 10.3354/dao076169; Nilsen H, 2011, J FISH DIS, V34, P403, DOI 10.1111/j.1365-2761.2011.01249.x; Orpetveit I, 2010, J VET DIAGN INVEST, V22, P886, DOI 10.1177/104063871002200606; Palacios G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011487; Rodger HD, 2007, J FISH DIS, V30, P411, DOI 10.1111/j.1365-2761.2007.00831.x; Seng EK, 2004, J VIROL METHODS, V118, P111, DOI 10.1016/j.jviromet.2004.01.023; Snow M, 2006, DEV BIOLOGICALS, V126, P133	28	57	59	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0131638	10.1371/journal.pone.0131638	http://dx.doi.org/10.1371/journal.pone.0131638			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176955	Green Published, gold			2022-12-26	WOS:000358197600056
J	Emerson, KJ; Conn, JE; Bergo, ES; Randel, MA; Sallum, MAM				Emerson, Kevin J.; Conn, Jan E.; Bergo, Eduardo S.; Randel, Melissa A.; Sallum, Maria Anice M.			Brazilian Anopheles darlingi Root (Diptera: Culicidae) Clusters by Major Biogeographical Region	PLOS ONE			English	Article							NEOTROPICAL MALARIA VECTOR; POPULATION-STRUCTURE; SOUTH-AMERICA; GENETIC-STRUCTURE; DNA-SEQUENCES; MARKERS; GAMBIAE; DIFFERENTIATION; PHYLOGEOGRAPHY; POLYMORPHISM	The major drivers of the extensive biodiversity of the Neotropics are proposed to be geological and tectonic events together with Pliocene and Pleistocene environmental and climatic change. Geographical barriers represented by the rivers Amazonas/Solimoes, the Andes and the coastal mountain ranges in eastern Brazil have been hypothesized to lead to diversification within the primary malaria vector, Anopheles(Nyssorhynchus) darlingi Root, which primarily inhabits rainforest. To test this biogeographical hypothesis, we analyzed 786 single nucleotide polymorphisms (SNPs) in 12 populations of An. darlingi from across the complex Brazilian landscape. Both model-based (STRUCTURE) and non-model-based (Principal Components and Discriminant Analysis) analysis of population structure detected three major genetic clusters that correspond with newly described Neotropical biogeographical regions: 1) Atlantic Forest province (= southeast population); 2) Parana Forest province (= West Atlantic forest population, with one Chacoan population -SP); and 3) Brazilian dominion population (= Amazonian population with one Chacoan population -TO). Significant levels of pairwise genetic divergences were found among the three clusters, allele sharing among clusters was negligible, and geographical distance did not contribute to differentiation. We infer that the Atlantic forest coastal mountain range limited dispersal between the Atlantic Forest province and the Parana Forest province populations, and that the large, diagonal open vegetation region of the Chacoan dominion dramatically reduced dispersal between the Parana and Brazilian dominion populations. We hypothesize that the three genetic clusters may represent three putative species.	[Emerson, Kevin J.] St Marys Coll Maryland, Dept Biol, St Marys City, MD 20686 USA; [Conn, Jan E.] New York State Dept Hlth, Wadsworth Ctr, Albany, NY USA; [Conn, Jan E.] SUNY Albany, Sch Publ Hlth, Dept Biomed Sci, Albany, NY USA; [Bergo, Eduardo S.] Secretaria Estado Saude Sao Paulo, Superintendencia Controle Endemias, Araraquara, SP, Brazil; [Randel, Melissa A.] Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA; [Sallum, Maria Anice M.] Univ Sao Paulo, Fac Saude Publ, Dept Epidemiol, BR-01255 Sao Paulo, Brazil	State University of New York (SUNY) System; Wadsworth Center; State University of New York (SUNY) System; State University of New York (SUNY) Albany; University of Oregon; Universidade de Sao Paulo	Emerson, KJ (corresponding author), St Marys Coll Maryland, Dept Biol, St Marys City, MD 20686 USA.	kjemerson@smcm.edu	Sallum, Maria Anice Mureb/B-8537-2012; Emerson, Kevin/AAC-8207-2020; Bergo, Eduardo/F-5374-2014	Sallum, Maria Anice Mureb/0000-0002-7051-2891; Emerson, Kevin/0000-0003-3283-0693; Bergo, Eduardo/0000-0003-4928-0368; Conn, Jan/0000-0002-5301-7020	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2011/20397-7]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [301666/2011-3]; St. Mary's College of Maryland; NIH [AI R0154139, AI R01110112]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054139, R01AI110112] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007759] Funding Source: NIH RePORTER	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); St. Mary's College of Maryland; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Financial support from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP Grant no. 2011/20397-7) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq Grant no. 301666/2011-3) was provided to MAMS and ESB; additionally, support was provided by St. Mary's College of Maryland to KJE and by NIH AI R0154139 and NIH AI R01110112 to JEC.	Alves LF, 2010, FOREST ECOL MANAG, V260, P679, DOI 10.1016/j.foreco.2010.05.023; Amorim DS, 1996, NEOTROPICAL BIOGEOGR, P183; Angella AF, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-203; Armstrong KE, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00362; Arnold B, 2013, MOL ECOL, V22, P3179, DOI 10.1111/mec.12276; Cassone BJ, 2014, MOL ECOL, V23, P2242, DOI 10.1111/mec.12733; Castro MC, 2011, ECOLOGIES POLITICS H, P296; CATAO E, 2014, INT J MICROBIOL, V2014, P12, DOI DOI 10.1155/2014/156341; Catchen J, 2013, MOL ECOL, V22, P3124, DOI 10.1111/mec.12354; Conn JE, 2006, AM J TROP MED HYG, V74, P798, DOI 10.4269/ajtmh.2006.74.798; Costa LP, 2003, J BIOGEOGR, V30, P71, DOI 10.1046/j.1365-2699.2003.00792.x; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Emerson KJ, 2010, P NATL ACAD SCI USA, V107, P16196, DOI 10.1073/pnas.1006538107; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fitzpatrick SW, 2009, MOL ECOL, V18, P2877, DOI 10.1111/j.1365-294X.2009.04245.x; Forattini O.P., 2002, CULICIDOLOGIA MED ID; FORATTINI OP, 1987, REV SAUDE PUBL, V21, P291, DOI 10.1590/S0034-89101987000400002; GALVAO A. A., 1937, Revista de Biologia e Hygiene, V8, P37; Gutierrez LA, 2010, AM J TROP MED HYG, V83, P38, DOI 10.4269/ajtmh.2010.09-0381; Hahn MB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085725; Hiwat H, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-177; Jombart T, 2010, BMC GENET, V11, DOI [DOI 10.1186/1471-2156-11-94, 10.1186/1471-2156-11-94]; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; KREUTZER RD, 1972, MOSQ NEWS, V32, P555; Lane J, 1939, CATALOGO MOSQUITOS N; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lounibos L. Philip, 2000, American Entomologist, V46, P238; Luca F, 2011, GENOME RES, V21, P1087, DOI 10.1101/gr.119792.110; Malafronte RS, 1999, J MED ENTOMOL, V36, P631, DOI 10.1093/jmedent/36.5.631; Manguin S, 1999, AM J TROP MED HYG, V60, P364, DOI 10.4269/ajtmh.1999.60.364; Marinotti O, 2013, NUCL ACIDS RES; Meirmans PG, 2012, MOL ECOL, V21, P2839, DOI 10.1111/j.1365-294X.2012.05578.x; Merz C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072262; Mirabello L, 2006, HEREDITY, V96, P311, DOI 10.1038/sj.hdy.6800805; Mirabello Lisa, 2008, BMC Ecology, V8, P3, DOI 10.1186/1472-6785-8-3; Morrone J. J., 1996, Zoologische Mededelingen (Leiden), V70, P1; Morrone JJ, 2014, ZOOTAXA, V 3782, P1, DOI 10.11646/zootaxa.3782.1.1; Morrone JJ, 2014, CLADISTICS, V30, P202, DOI 10.1111/cla.12039; Motoki MT, 2012, INFECT GENET EVOL, V12, P1246, DOI 10.1016/j.meegid.2012.04.002; Nihei SS, 2007, SYST ENTOMOL, V32, P477, DOI 10.1111/j.1365-3113.2006.00376.x; O'Loughlin SM, 2014, MOL BIOL EVOL, V31, P889, DOI 10.1093/molbev/msu040; Pedro PM, 2009, BIOL J LINN SOC, V97, P854, DOI 10.1111/j.1095-8312.2009.01226.x; Prado CPA, 2012, MOL ECOL, V21, P921, DOI 10.1111/j.1365-294X.2011.05409.x; Pritchard JK, 2000, GENETICS, V155, P945; Reidenbach KR, 2012, GENOME BIOL EVOL, V4, P1202, DOI 10.1093/gbe/evs095; Rona LDP, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-91; Rona LDP, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-33; Root FM, 1926, AM J HYG, V6, P684, DOI 10.1093/oxfordjournals.aje.a120038; ROSAFREITAS MG, 1992, J AM MOSQUITO CONTR, V8, P357; Scarpassa VM, 2007, MEM I OSWALDO CRUZ, V102, P319, DOI 10.1590/S0074-02762007005000045; Silva Daniel P., 2014, PLoS ONE, V9, pe113246, DOI 10.1371/journal.pone.0113246; Silva JMC, 2005, MATA ATLANTICA BIODI; Zheng XW, 2012, BIOINFORMATICS, V28, P3326, DOI 10.1093/bioinformatics/bts606	55	35	35	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0130773	10.1371/journal.pone.0130773	http://dx.doi.org/10.1371/journal.pone.0130773			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26172559	Green Submitted, Green Published, gold			2022-12-26	WOS:000358194900010
J	Konnikova, Y; Zaman, MM; Makda, M; D'Onofrio, D; Freedman, SD; Martin, CR				Konnikova, Yelizaveta; Zaman, Munir M.; Makda, Meher; D'Onofrio, Danila; Freedman, Steven D.; Martin, Camilia R.			Late Enteral Feedings Are Associated with Intestinal Inflammation and Adverse Neonatal Outcomes	PLOS ONE			English	Article							NECROTIZING ENTEROCOLITIS; INFANTS BORN; 28TH WEEK; COLONIZATION; RETINOPATHY; NUTRITION; GUT	Background Morbidities of impaired immunity and dysregulated inflammation are common in preterm infants. Postnatal Intestinal development plays a critical role in the maturation of the immune system and is, in part, driven by exposure to an enteral diet. Objective The aim of this study was to evaluate the influence of the timing of the first enteral feeding on intestinal inflammation and risk of disease. Methods 30 infants <33 weeks' gestation were studied. Maternal and infant data were abstracted from the medical record. Single and multiplex ELISA assays quantified cytokines from fecal and serum samples at two weeks postnatal age. Results A delay in enteral feedings after the third postnatal day is associated with a 4.5 (95% CI 1.8-11.5, p=0.002) fold increase in chronic lung disease, 2.9 (1.1-7.8, p=0.03) fold increase in retinopathy of prematurity, and 3.4 (1.2-9.8, p=0.02) fold increase in multiple comorbidities compared to infants fed on or before the third day. Additionally, a delay in the initiation of feedings is associated with increased fecal IL-8 levels and a decreased IL-10: IL-8 ratio. Conclusions A delay in enteral feeding is associated with intestinal inflammation and increased risks of morbidities. To improve neonatal outcomes, early nutritional practices need to be reevaluated.	[Konnikova, Yelizaveta] Boston Childrens Hosp, Dept Pediat, Div Newborn Med, Boston, MA USA; [Zaman, Munir M.; Makda, Meher; D'Onofrio, Danila; Freedman, Steven D.] Beth Israel Deaconess Med Ctr, Div Gastroenterol, Boston, MA 02215 USA; [Freedman, Steven D.; Martin, Camilia R.] Beth Israel Deaconess Med Ctr, Div Translat Res, Boston, MA 02215 USA; [Martin, Camilia R.] Beth Israel Deaconess Med Ctr, Dept Neonatol, Boston, MA 02215 USA	Harvard University; Boston Children's Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center	Martin, CR (corresponding author), Beth Israel Deaconess Med Ctr, Div Translat Res, Boston, MA 02215 USA.	cmartin1@bidmc.harvard.edu		Konnikova, Yelizaveta/0000-0003-4804-5497	Program for Faculty Development and Diversity of Harvard Catalyst, Harvard Clinical and Translational Science Center, National Center for Research Resources [UL1 RR 025758]; Program for Faculty Development and Diversity of Harvard Catalyst, Harvard Clinical and Translational Science Center, National Center for Research Resources (Harvard University and its affiliated academic health care centers) [1R01DK104346-01]; Charles H. Hood Foundation; Alden Trust; Gerber Foundation	Program for Faculty Development and Diversity of Harvard Catalyst, Harvard Clinical and Translational Science Center, National Center for Research Resources; Program for Faculty Development and Diversity of Harvard Catalyst, Harvard Clinical and Translational Science Center, National Center for Research Resources (Harvard University and its affiliated academic health care centers); Charles H. Hood Foundation; Alden Trust; Gerber Foundation	CRM was supported by the Program for Faculty Development and Diversity of Harvard Catalyst, Harvard Clinical and Translational Science Center, National Center for Research Resources (award UL1 RR 025758 and financial contributions from Harvard University and its affiliated academic health care centers), 1R01DK104346-01, the Charles H. Hood Foundation, the Alden Trust, the Gerber Foundation, and the generous philanthropic donors to the Infant Health Research Program at Beth Israel Deaconess Medical Center. The content is solely the responsibility of the authors and does not necessarily represent the official views of Harvard Catalyst, Harvard University and its affiliated academic health care centers, the National Center for Research Resources, or the National Institutes of Health. None of the funding bodies had any role in the study design or conduct; data collection, management, analysis or interpretation; or manuscript preparation, review, or approval.	Ambalavanan N, 2009, PEDIATRICS, V123, P1132, DOI 10.1542/peds.2008-0526; Arranz E, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/865638; Ballabh P, 2010, PEDIATR RES, V67, P1, DOI 10.1203/PDR.0b013e3181c1b176; Bhandari V, 2014, BIRTH DEFECTS RES A, V100, P189, DOI 10.1002/bdra.23220; Bose C, 2011, PEDIATR RES, V69, P347, DOI 10.1203/PDR.0b013e31820a58f3; Clark JA, 2007, SHOCK, V28, P384, DOI 10.1097/shk.0b013e31805569df; Deng WB, 2008, ARCH NEUROL-CHICAGO, V65, P1291, DOI 10.1001/archneur.65.10.1291; Good WV, 2005, PEDIATRICS, V116, P15, DOI 10.1542/peds.2004-1413; Hapfelmeier S, 2010, SCIENCE, V328, P1705, DOI 10.1126/science.1188454; Holman RC, 2006, PAEDIATR PERINAT EP, V20, P498, DOI 10.1111/j.1365-3016.2006.00756.x; Jantscher-Krenn E, 2012, GUT, V61, P1417, DOI 10.1136/gutjnl-2011-301404; Jung C, 2010, INT J INFLAMM, V2010, DOI 10.4061/2010/823710; Kalish BT, 2013, AM J PHYSIOL-GASTR L, V305, pG818, DOI 10.1152/ajpgi.00106.2013; Kudsk KA, 2002, AM J SURG, V183, P390, DOI 10.1016/S0002-9610(02)00821-8; Lee J, 2012, SEMIN FETAL NEONAT M, V17, P26, DOI 10.1016/j.siny.2011.08.007; Leviton A, 2011, CYTOKINE, V56, P392, DOI 10.1016/j.cyto.2011.07.014; Leviton A, 2011, J PEDIATR-US, V158, P897, DOI 10.1016/j.jpeds.2010.11.059; Leviton A, 2010, ACTA PAEDIATR, V99, P1795, DOI 10.1111/j.1651-2227.2010.01973.x; Martin CR, 2011, J PEDIATR-US, V159, P743, DOI 10.1016/j.jpeds.2011.04.039; Neu J, 2007, AM J CLIN NUTR, V85, p629S, DOI 10.1093/ajcn/85.2.629S; Niinikoski H, 2004, J NUTR, V134, P1467, DOI 10.1093/jn/134.6.1467; O'Shea TM, 2012, J PEDIATR-US, V160, P395, DOI 10.1016/j.jpeds.2011.08.069; Ostman S, 2006, EUR J IMMUNOL, V36, P2336, DOI 10.1002/eji.200535244; Payne NR, 2010, PEDIATRICS, V125, P437, DOI 10.1542/peds.2009-1272; Peterson DA, 2007, CELL HOST MICROBE, V2, P328, DOI 10.1016/j.chom.2007.09.013; Sangild PT, 2006, GASTROENTEROLOGY, V130, P1776, DOI 10.1053/j.gastro.2006.02.026; Silveira RC, 2011, INVEST OPHTH VIS SCI, V52, P1297, DOI 10.1167/iovs.10-6279; Stoll B, 2010, J NUTR, V140, P2193, DOI 10.3945/jn.110.125799; Taschuk Ryan, 2012, Animal Health Research Reviews, V13, P129, DOI 10.1017/S1466252312000096; Wang X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058838; Wereszczynska-Siemiatkowska U, 2013, PANCREAS, V42, P640, DOI 10.1097/MPA.0b013e318271bb61; Wildhaber BE, 2005, J SURG RES, V123, P8, DOI 10.1016/j.jss.2004.06.015	32	19	20	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132924	10.1371/journal.pone.0132924	http://dx.doi.org/10.1371/journal.pone.0132924			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26172126	Green Published, Green Submitted, gold			2022-12-26	WOS:000358194900102
J	Leghmar, K; Cenac, N; Rolland, M; Martin, H; Rauwel, B; Bertrand-Michel, J; Le Faouder, P; Benard, M; Casper, C; Davrinche, C; Fournier, T; Chavanas, S				Leghmar, Kaoutar; Cenac, Nicolas; Rolland, Maude; Martin, Helene; Rauwel, Benjamin; Bertrand-Michel, Justine; Le Faouder, Pauline; Benard, Melinda; Casper, Charlotte; Davrinche, Christian; Fournier, Thierry; Chavanas, Stephane			Cytomegalovirus Infection Triggers the Secretion of the PPAR gamma Agonists 15-Hydroxyeicosatetraenoic Acid (15-HETE) and 13-Hydroxyoctadecadienoic Acid (13-HODE) in Human Cytotrophoblasts and Placental Cultures	PLOS ONE			English	Article							ACTIVATED RECEPTOR-GAMMA; INTRAUTERINE GROWTH RESTRICTION; CELL INVASION; IN-VITRO; MECHANISMS; LIPIDS; PREECLAMPSIA; PREGNANCY; ATHEROSCLEROSIS; TRANSMISSION	Introduction Congenital infection by human cytomegalovirus (HCMV) is a leading cause of congenital abnormalities of the central nervous system. Placenta infection by HCMV allows for viral spread to fetus and may result in intrauterine growth restriction, preeclampsia-like symptoms, or miscarriages. We previously reported that HCMV activates peroxisome proliferator-activated receptor gamma (PPAR gamma) for its own replication in cytotrophoblasts. Here, we investigated the molecular bases of PPAR. activation in infected cytotrophoblasts. Results We show that onboarded cPLA(2) carried by HCMV particles is required for effective PPAR. activation in infected HIPEC cytotrophoblasts, and for the resulting inhibition of cell migration. Natural PPAR. agonists are generated by PLA(2) driven oxidization of linoleic and arachidonic acids. Therefore, using HPLC coupled with mass spectrometry, we disclosed that cellular and secreted levels of 13-hydroxyoctadecadienoic acid (13-HODE) and 15-hydroxyeicosatetraenoic acid (15-HETE) were significantly increased in and from HIPEC cytotrophoblasts at soon as 6 hours post infection. 13-HODE treatment of uninfected HIPEC recapitulated the effect of infection (PPAR gamma activation, migration impairment). We found that infection of histocultures of normal, first-term, human placental explants resulted in significantly increased levels of secreted 15-HETE and 13-HODE. Conclusion Our findings reveal that 15-HETE and 13-HODE could be new pathogenic effectors of HCMV congenital infection They provide a new insight about the pathogenesis of congenital infection by HCMV.	[Leghmar, Kaoutar; Cenac, Nicolas; Rolland, Maude; Martin, Helene; Rauwel, Benjamin; Benard, Melinda; Casper, Charlotte; Davrinche, Christian; Chavanas, Stephane] INSERM U1043, Ctr Physiopathol Toulouse Purpan, Toulouse, France; [Leghmar, Kaoutar; Cenac, Nicolas; Rolland, Maude; Martin, Helene; Rauwel, Benjamin; Benard, Melinda; Casper, Charlotte; Davrinche, Christian; Chavanas, Stephane] CNRS U5282, Toulouse, France; [Leghmar, Kaoutar; Cenac, Nicolas; Rolland, Maude; Martin, Helene; Rauwel, Benjamin; Benard, Melinda; Casper, Charlotte; Davrinche, Christian; Chavanas, Stephane] Univ Toulouse 3, F-31062 Toulouse, France; [Bertrand-Michel, Justine; Le Faouder, Pauline] MetaToul Lipid Facil, Toulouse, France; [Bertrand-Michel, Justine; Le Faouder, Pauline] I2MC INSERM U1048, Toulouse, France; [Benard, Melinda; Casper, Charlotte] Childrens Hosp, Neonatal Unit, Toulouse, France; [Fournier, Thierry] INSERM UMR S1139, Paris, France; [Fournier, Thierry] Univ Paris 05, Paris, France; [Fournier, Thierry] PremUP, Paris, France	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; CHU de Toulouse; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Chavanas, S (corresponding author), INSERM U1043, Ctr Physiopathol Toulouse Purpan, Toulouse, France.	stephane.chavanas@inserm.fr	Cenac, Nicolas/P-4557-2017; Rolland, Maude/AAA-1756-2022; Fournier, Thierry C/E-5836-2016	Cenac, Nicolas/0000-0002-1552-7812; Rolland, Maude/0000-0002-8858-8915; chavanas, stephane/0000-0003-4323-2656; Tscherning, Charlotte/0000-0001-7111-8979; Fournier, Thierry/0000-0002-7515-339X	Agence Nationale de la Recherche, HCMV-PPAR-PREG	Agence Nationale de la Recherche, HCMV-PPAR-PREG(French National Research Agency (ANR))	This work was supported by Agence Nationale de la Recherche, HCMV-PPAR-PREG, http://www.agence-nationale-recherche.fr/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allal C, 2004, J VIROL, V78, P7717, DOI 10.1128/JVI.78.14.7717-7726.2004; Alsalem M, 2013, BRIT J PHARMACOL, V168, P1961, DOI 10.1111/bph.12092; Boppana SB, 2013, CLIN INFECT DIS, V57, pS178, DOI 10.1093/cid/cit629; Cannon MJ, 2009, J CLIN VIROL, V46, pS6, DOI 10.1016/j.jcv.2009.09.002; Cheeran MCJ, 2009, CLIN MICROBIOL REV, V22, P99, DOI 10.1128/CMR.00023-08; Coutant F, 2004, J IMMUNOL, V172, P54, DOI 10.4049/jimmunol.172.1.54; Daynes RA, 2002, NAT REV IMMUNOL, V2, P748, DOI 10.1038/nri912; Fei J, 2012, ATHEROSCLEROSIS, V222, P395, DOI 10.1016/j.atherosclerosis.2012.02.040; Fisher S, 2000, J VIROL, V74, P6808, DOI 10.1128/JVI.74.15.6808-6820.2000; Fournier T, 2007, PLACENTA, V28, P65, DOI 10.1016/j.placenta.2006.04.009; Gunthorpe MJ, 2008, CURR PHARM DESIGN, V14, P32; Holdsworth-Carson SJ, 2010, PLACENTA, V31, P222, DOI 10.1016/j.placenta.2009.12.009; Huang JT, 1999, NATURE, V400, P378, DOI 10.1038/22572; Johnson RD, 1998, AM J OBSTET GYNECOL, V178, P54, DOI 10.1016/S0002-9378(98)70626-X; Le Faouder P, 2013, J CHROMATOGR B, V932, P123, DOI 10.1016/j.jchromb.2013.06.014; Leesnitzer LM, 2002, BIOCHEMISTRY-US, V41, P6640, DOI 10.1021/bi0159581; Lopez H, 2011, PLACENTA, V32, P522, DOI 10.1016/j.placenta.2011.04.016; Maidji E, 2010, AM J PATHOL, V177, P1298, DOI 10.2353/ajpath.2010.091210; Majed BH, 2012, PHARMACOL REV, V64, P540, DOI 10.1124/pr.111.004770; Nagy L, 1998, CELL, V93, P229, DOI 10.1016/S0092-8674(00)81574-3; Pavan L, 2004, ENDOCRINOLOGY, V145, P4583, DOI 10.1210/en.2003-1747; Pavan L, 2004, J CLIN ENDOCR METAB, V89, P1969, DOI 10.1210/jc.2003-032042; Pavan L, 2003, CARCINOGENESIS, V24, P1325, DOI 10.1093/carcin/bgg074; Pereira L, 2005, TRENDS MICROBIOL, V13, P164, DOI 10.1016/j.tim.2005.02.009; Pereira L, 2014, J INFECT DIS, V209, P1573, DOI 10.1093/infdis/jiu019; Pereira L, 2011, J INFECT DIS, V203, P1510, DOI 10.1093/infdis/jir126; Rak-Mardyla A, 2014, THERIOGENOLOGY, V82, P1, DOI 10.1016/j.theriogenology.2014.02.016; Rauwel B, 2010, J VIROL, V84, P2946, DOI 10.1128/JVI.01779-09; Schild RL, 2002, J CLIN ENDOCR METAB, V87, P1105, DOI 10.1210/jc.87.3.1105; Six DA, 2000, BBA-MOL CELL BIOL L, V1488, P1, DOI 10.1016/S1388-1981(00)00105-0; Staff AC, 2010, HYPERTENSION, V56, P1026, DOI 10.1161/HYPERTENSIONAHA.110.157743; Subbarayan V, 2006, ONCOGENE, V25, P6015, DOI 10.1038/sj.onc.1209617; Torry DS, 1999, AM J REPROD IMMUNOL, V41, P79; Toth A, 2005, MOL BRAIN RES, V135, P162, DOI 10.1016/j.molbrainres.2004.12.003; Wang Y, 2011, PROSTAGLANDINS LEUKO, V86, P79; Winkler K, 2000, J CLIN ENDOCR METAB, V85, P4543, DOI 10.1210/jc.85.12.4543; Wittwer J, 2007, PROSTAG LEUKOTR ESS, V77, P67, DOI 10.1016/j.plefa.2007.08.001; Wu MY, 2013, EUR J PHARMACOL, V714, P388, DOI 10.1016/j.ejphar.2013.07.010; Yuan DD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096510	39	12	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132627	10.1371/journal.pone.0132627	http://dx.doi.org/10.1371/journal.pone.0132627			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26171612	Green Published, Green Submitted, gold			2022-12-26	WOS:000358194900065
J	Schuback, N; Schallenberg, C; Duckham, C; Maldonado, MT; Tortell, PD				Schuback, Nina; Schallenberg, Christina; Duckham, Carolyn; Maldonado, Maria T.; Tortell, Philippe D.			Interacting Effects of Light and Iron Availability on the Coupling of Photosynthetic Electron Transport and CO2-Assimilation in Marine Phytoplankton	PLOS ONE			English	Article							REPETITION RATE FLUOROMETRY; DUNALIELLA-TERTIOLECTA CHLOROPHYCEAE; PRIMARY PRODUCTION-RATES; PHOTOSYSTEM-II; PRIMARY PRODUCTIVITY; CARBON-FIXATION; MICROALGAL PHOTOSYNTHESIS; QUENCHING MECHANISMS; CLIMATE-CHANGE; QUANTUM YIELD	Iron availability directly affects photosynthesis and limits phytoplankton growth over vast oceanic regions. For this reason, the availability of iron is a crucial variable to consider in the development of active chlorophyll a fluorescence based estimates of phytoplankton primary productivity. These bio-optical approaches require a conversion factor to derive ecologically-relevant rates of CO2-assimilation from estimates of electron transport in photosystem II. The required conversion factor varies significantly across phytoplankton taxa and environmental conditions, but little information is available on its response to iron limitation. In this study, we examine the role of iron limitation, and the interacting effects of iron and light availability, on the coupling of photosynthetic electron transport and CO2-assimilation in marine phytoplankton. Our results show that excess irradiance causes increased decoupling of carbon fixation and electron transport, particularly under iron limiting conditions. We observed that reaction center II specific rates of electron transport (ETRRCII, mol e- mol RCII-1 s(-1)) increased under iron limitation, and we propose a simple conceptual model for this observation. We also observed a strong correlation between the derived conversion factor and the expression of non-photochemical quenching. Utilizing a dataset from in situ phytoplankton assemblages across a coastal - oceanic transect in the Northeast subarctic Pacific, this relationship was used to predict ETRRCII: CO2-assimilation conversion factors and carbon-based primary productivity from FRRF data, without the need for any additional measurements.	[Schuback, Nina; Duckham, Carolyn; Maldonado, Maria T.; Tortell, Philippe D.] Univ British Columbia, Dept Earth Ocean & Atmospher Sci, Vancouver, BC V5Z 1M9, Canada; [Schallenberg, Christina] Univ Victoria, Sch Earth & Ocean Sci, Victoria, BC, Canada; [Tortell, Philippe D.] Univ British Columbia, Dept Bot, Vancouver, BC, Canada	University of British Columbia; University of Victoria; University of British Columbia	Schuback, N (corresponding author), Univ British Columbia, Dept Earth Ocean & Atmospher Sci, Vancouver, BC V5Z 1M9, Canada.	nschuback@eos.ubc.ca	Maldonado, Maria T/N-2877-2017; Schallenberg, Christina/N-4187-2017	Maldonado, Maria T/0000-0001-8134-9375; Schallenberg, Christina/0000-0002-3073-7500; Tortell, Philippe/0000-0003-0212-2151	National Sciences and Engineering Research Council of Canada; UBC Peter Wall Institute for Advanced Studies	National Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); UBC Peter Wall Institute for Advanced Studies	This research was funded by grants to PDT and MTM from the National Sciences and Engineering Research Council of Canada, and from support from the UBC Peter Wall Institute for Advanced Studies to PDT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen AE, 2008, P NATL ACAD SCI USA, V105, P10438, DOI 10.1073/pnas.0711370105; Arrigo KR, 2010, INTEGR COMP BIOL, V50, P950, DOI 10.1093/icb/icq021; Babin M, 1996, DEEP-SEA RES PT I, V43, P1241, DOI 10.1016/0967-0637(96)00058-1; Barranguet C, 2000, MAR ECOL PROG SER, V204, P39, DOI 10.3354/meps204039; Beardall J, 2004, PHYCOLOGIA, V43, P26, DOI 10.2216/i0031-8884-43-1-26.1; BEARDALL J, 1989, AQUAT BOT, V34, P105, DOI 10.1016/0304-3770(89)90052-1; Behrenfeld MJ, 2009, BIOGEOSCIENCES, V6, P779, DOI 10.5194/bg-6-779-2009; Behrenfeld MJ, 2008, PHILOS T R SOC B, V363, P2687, DOI 10.1098/rstb.2008.0019; Behrenfeld MJ, 2013, ANNU REV MAR SCI, V5, P217, DOI 10.1146/annurev-marine-121211-172356; Berges JA, 1996, PLANT PHYSIOL, V110, P689, DOI 10.1104/pp.110.2.689; BOOTH BC, 1988, MAR BIOL, V97, P275, DOI 10.1007/BF00391313; Boyd PW, 2007, SCIENCE, V315, P612, DOI 10.1126/science.1131669; Boyd PW, 2001, DEEP-SEA RES PT II, V48, P2529, DOI 10.1016/S0967-0645(01)00007-8; Boyd PW, 1997, OCEANOGR LIT REV, V44; BRAND L E, 1981, Journal of Plankton Research, V3, P193, DOI 10.1093/plankt/3.2.193; Briat JF, 2007, CURR OPIN PLANT BIOL, V10, P276, DOI 10.1016/j.pbi.2007.04.003; Cardol P, 2008, P NATL ACAD SCI USA, V105, P7881, DOI 10.1073/pnas.0802762105; Cardol P, 2011, BBA-BIOENERGETICS, V1807, P912, DOI 10.1016/j.bbabio.2010.12.004; Chappell PD, 2015, ISME J, V9, P592, DOI 10.1038/ismej.2014.171; Chavez FP, 2011, ANNU REV MAR SCI, V3, P227, DOI 10.1146/annurev.marine.010908.163917; Cheah W, 2011, DEEP-SEA RES PT II, V58, P2179, DOI 10.1016/j.dsr2.2011.05.023; Corno G, 2006, J PHYCOL, V42, P51, DOI 10.1111/j.1529-8817.2006.00163.x; Debes H, 2008, J MARINE SYST, V74, P686, DOI 10.1016/j.jmarsys.2008.07.004; DUBINSKY Z, 1986, PLANT CELL PHYSIOL, V27, P1335, DOI 10.1093/oxfordjournals.pcp.a077232; DUYSENS L. N. M., 1963, P353; Estevez-Blanco P, 2006, J PLANKTON RES, V28, P1153, DOI 10.1093/plankt/fbl046; Falkowski PG, 1998, SCIENCE, V281, P200, DOI 10.1126/science.281.5374.200; FALKOWSKI PG, 1981, PLANT PHYSIOL, V68, P969, DOI 10.1104/pp.68.4.969; FALKOWSKI PG, 1986, PLANT PHYSIOL, V81, P310, DOI 10.1104/pp.81.1.310; Feikema WO, 2006, BBA-BIOENERGETICS, V1757, P829, DOI 10.1016/j.bbabio.2006.06.003; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; Fraser JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059861; Fujiki T, 2007, J PLANKTON RES, V29, P199, DOI 10.1093/plankt/fbm007; Fujiki T, 2011, J OCEANOGR, V67, P295, DOI 10.1007/s10872-011-0028-1; GEIDER RJ, 1994, PHOTOSYNTH RES, V39, P275, DOI 10.1007/BF00014588; GENTY B, 1989, BIOCHIM BIOPHYS ACTA, V990, P87, DOI 10.1016/S0304-4165(89)80016-9; Gilbert M, 2000, PHOTOSYNTHETICA, V38, P111, DOI 10.1023/A:1026708327185; Goss R, 2015, J PLANT PHYSIOL, V172, P13, DOI 10.1016/j.jplph.2014.03.004; Goto N, 2008, FUND APPL LIMNOL, V172, P121, DOI 10.1127/1863-9135/2008/0172-0121; GREENE RM, 1994, LIMNOL OCEANOGR, V39, P1061, DOI 10.4319/lo.1994.39.5.1061; GREENE RM, 1992, PLANT PHYSIOL, V100, P565, DOI 10.1104/pp.100.2.565; GREENE RM, 1991, LIMNOL OCEANOGR, V36, P1772, DOI 10.4319/lo.1991.36.8.1772; Grossman AR, 2010, J PHYCOL, V46, P629, DOI 10.1111/j.1529-8817.2010.00852.x; Halsey KH, 2015, ANNU REV MAR SCI, V7, P265, DOI 10.1146/annurev-marine-010814-015813; Halsey KH, 2013, NEW PHYTOL, V198, P1030, DOI 10.1111/nph.12209; Halsey KH, 2011, J PHYCOL, V47, P66, DOI 10.1111/j.1529-8817.2010.00945.x; Halsey KH, 2010, PHOTOSYNTH RES, V103, P125, DOI 10.1007/s11120-009-9526-z; Hancke K, 2008, J PHYCOL, V44, P501, DOI 10.1111/j.1529-8817.2008.00487.x; Hays GC, 2005, TRENDS ECOL EVOL, V20, P337, DOI 10.1016/j.tree.2005.03.004; Hopkinson BM, 2007, LIMNOL OCEANOGR, V52, P2540, DOI 10.4319/lo.2007.52.6.2540; Horton P, 2012, PHILOS T R SOC B, V367, P3455, DOI 10.1098/rstb.2012.0069; Huot Y, 2010, DEVEL APPL PHYCOL, V4, P31, DOI 10.1007/978-90-481-9268-7_3; Imre V, 2011, PHYSIOL PLANTARUM, V142, P6, DOI 10.1111/j.1399-3054.2011.01454.x; Ivanov AG, 2008, PHOTOSYNTH RES, V98, P565, DOI 10.1007/s11120-008-9365-3; Johnson WK, 2005, DEEP-SEA RES PT II, V52, P933, DOI 10.1016/j.dsr2.2004.08.017; Kaiblinger C, 2006, PHOTOSYNTH RES, V88, P19, DOI 10.1007/s11120-005-9018-8; KITAJIMA M, 1975, BIOCHIM BIOPHYS ACTA, V376, P105, DOI 10.1016/0005-2728(75)90209-1; Knap A., 1996, 19 JGOFS UNESCO; KOLBER Z, 1993, LIMNOL OCEANOGR, V38, P1646, DOI 10.4319/lo.1993.38.8.1646; KOLBER ZS, 1994, NATURE, V371, P145, DOI 10.1038/371145a0; Kolber ZS, 1998, BBA-BIOENERGETICS, V1367, P88, DOI 10.1016/S0005-2728(98)00135-2; Krause GH, 2003, LIGHT HARVESTING ANT, P373; Kromkamp JC, 2008, EUR J PHYCOL, V43, P327, DOI 10.1080/09670260802080895; Kromkamp JC, 2011, EUROPEAN J PHYCOLOGY, P53; Laney SR, 2006, THESIS; Laureau C, 2013, PLANT CELL ENVIRON, V36, P1296, DOI 10.1111/pce.12059; Lawrenz E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058137; LAWS EA, 1991, DEEP-SEA RES, V38, P143, DOI 10.1016/0198-0149(91)90059-O; Lee Yong Woo, 2011, Sea (Seoul), V16, P117; LEWIS MR, 1983, MAR ECOL PROG SER, V13, P99, DOI 10.3354/meps013099; Macey AI, 2014, LIMNOL OCEANOGR, V59, P1853, DOI 10.4319/lo.2014.59.6.1853; Mackey KRM, 2008, LIMNOL OCEANOGR, V53, P900, DOI 10.4319/lo.2008.53.3.0900; Mackey KRM, 2010, RESPONSE MARINE PHYT; Maldonado MT, 2006, LIMNOL OCEANOGR, V51, P1729, DOI 10.4319/lo.2006.51.4.1729; Marchetti A, 2006, DEEP-SEA RES PT II, V53, P2131, DOI 10.1016/j.dsr2.2006.05.032; Marra J, 2009, AQUAT MICROB ECOL, V56, P123, DOI 10.3354/ame01306; MAUZERALL D, 1989, BIOCHIM BIOPHYS ACTA, V974, P119, DOI 10.1016/S0005-2728(89)80365-2; McDonald AE, 2011, BBA-BIOENERGETICS, V1807, P954, DOI 10.1016/j.bbabio.2010.10.024; McKew BA, 2013, NEW PHYTOL, V200, P74, DOI 10.1111/nph.12373; Melrose DC, 2006, MAR ECOL PROG SER, V311, P37, DOI 10.3354/meps311037; Mitchell B.G., 2002, OCEAN OPTICS PROTOCO, V3, P231; Miyake C, 2003, ADV PHOTO RESPIRAT, V14, P183; Moore CM, 2006, LIMNOL OCEANOGR, V51, P936, DOI 10.4319/lo.2006.51.2.0936; Moore CM, 2003, MAR ECOL PROG SER, V259, P29, DOI 10.3354/meps259029; Moore JK, 2001, DEEP-SEA RES PT II, V49, P463; Napoleon C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066423; Napoleon C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040284; Nawrocki WJ, 2015, ANNU REV PLANT BIOL, V66, P49, DOI 10.1146/annurev-arplant-043014-114744; NIELSEN ES, 1951, NATURE, V167, P684, DOI 10.1038/167684b0; Niyogi KK, 2000, CURR OPIN PLANT BIOL, V3, P455, DOI 10.1016/S1369-5266(00)00113-8; Niyogi KK, 2013, CURR OPIN PLANT BIOL, V16, P307, DOI 10.1016/j.pbi.2013.03.011; Ort DR, 2002, CURR OPIN PLANT BIOL, V5, P193, DOI 10.1016/S1369-5266(02)00259-5; Oxborough K, 1997, PHOTOSYNTH RES, V54, P135, DOI 10.1023/A:1005936823310; Oxborough K, 2012, LIMNOL OCEANOGR-METH, V10, P142, DOI 10.4319/lom.2012.10.142; Pei S, 2013, DEEP-SEA RES PT I, V82, P1, DOI 10.1016/j.dsr.2013.07.011; Peltier G, 2010, PHOTOSYNTH RES, V106, P19, DOI 10.1007/s11120-010-9575-3; Pemberton KL, 2006, MAR ECOL PROG SER, V322, P51, DOI 10.3354/meps322051; Petrou K, 2011, DEEP-SEA RES PT II, V58, P2200, DOI 10.1016/j.dsr2.2011.05.020; Prasil O, 1996, PHOTOSYNTH RES, V48, P395, DOI 10.1007/BF00029472; PRICE N M, 1988, Biological Oceanography, V6, P443; Prieto L, 2008, J PLANKTON RES, V30, P43, DOI 10.1093/plankt/fbm093; Raateoja M, 2004, MAR ECOL PROG SER, V267, P9, DOI 10.3354/meps267009; Raateoja MP, 2004, BOREAL ENVIRON RES, V9, P263; Raven JA, 1999, PHOTOSYNTH RES, V60, P111, DOI 10.1023/A:1006282714942; Robinson C, 2014, J MARINE SYST, V139, P299, DOI 10.1016/j.jmarsys.2014.07.016; Robinson C, 2009, AQUAT MICROB ECOL, V54, P13, DOI 10.3354/ame01250; Rochaix JD, 2011, BBA-BIOENERGETICS, V1807, P878, DOI 10.1016/j.bbabio.2011.05.009; Rohacek K, 2002, PHOTOSYNTHETICA, V40, P13, DOI 10.1023/A:1020125719386; Ruban AV, 2015, J EXP BOT, V66, P7, DOI 10.1093/jxb/eru400; Ruban AV, 2012, BBA-BIOENERGETICS, V1817, P977, DOI 10.1016/j.bbabio.2012.03.026; Ruban AV, 2012, BBA-BIOENERGETICS, V1817, P167, DOI 10.1016/j.bbabio.2011.04.007; Ryan-Keogh TJ, 2012, J PHYCOL; Scheibe R, 2004, PHYSIOL PLANTARUM, V120, P21, DOI 10.1111/j.0031-9317.2004.0222.x; Schrader PS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018753; Shinopoulos KE, 2012, BBA-BIOENERGETICS, V1817, P66, DOI 10.1016/j.bbabio.2011.08.002; Silsbe GM, 2015, LIMNOL OCEANOGR-METH, V13, P138, DOI 10.1002/lom3.10014; Smyth TJ, 2004, J PLANKTON RES, V26, P1337, DOI 10.1093/plankt/fbh124; Strzepek RF, 2004, NATURE, V431, P689, DOI 10.1038/nature02954; Suggett D, 2001, LIMNOL OCEANOGR, V46, P802, DOI 10.4319/lo.2001.46.4.0802; Suggett DJ, 2006, LIMNOL OCEANOGR, V51, P2064, DOI 10.4319/lo.2006.51.5.2064; Suggett DJ, 2010, DEVEL APPL PHYCOL, V4, P103, DOI 10.1007/978-90-481-9268-7_6; Suggett DJ, 2009, AQUAT MICROB ECOL, V56, P147, DOI 10.3354/ame01303; Suggett DJ, 2004, LIMNOL OCEANOGR-METH, V2, P316, DOI 10.4319/lom.2004.2.316; Taylor RL, 2013, J GEOPHYS RES-OCEANS, V118, P3260, DOI 10.1002/jgrc.20244; Thamatrakoln K, 2013, P NATL ACAD SCI USA, V110, P20123, DOI 10.1073/pnas.1304727110; Timmermans KR, 2001, MAR ECOL PROG SER, V217, P287, DOI 10.3354/meps217287; Tripathy SC, 2010, ESTUAR COAST SHELF S, V87, P163, DOI 10.1016/j.ecss.2010.01.006; Vass I, 2009, TRENDS PLANT SCI, V14, P200, DOI 10.1016/j.tplants.2009.01.009; VASSILIEV IR, 1995, PLANT PHYSIOL, V109, P963, DOI 10.1104/pp.109.3.963; WEBB WL, 1974, OECOLOGIA, V17, P281, DOI 10.1007/BF00345747; WELSCHMEYER NA, 1994, LIMNOL OCEANOGR, V39, P1985, DOI 10.4319/lo.1994.39.8.1985; Williams P J L B, 2008, PHYTOPLANKTON PRODUC; Yruela I, 2013, METALLOMICS, V5, P1090, DOI 10.1039/c3mt00086a; Zaks J, 2013, PHOTOSYNTH RES, V116, P389, DOI 10.1007/s11120-013-9857-7; Zehr JP, 2009, SCIENCE, V326, P945, DOI 10.1126/science.1181277	135	55	56	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0133235	10.1371/journal.pone.0133235	http://dx.doi.org/10.1371/journal.pone.0133235			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26171963	Green Published, gold, Green Submitted			2022-12-26	WOS:000358194900148
J	Bjorngaard, JH; Carslake, D; Nilsen, TIL; Linthorst, ACE; Smith, GD; Gunnell, D; Romundstad, PR				Bjorngaard, Johan Hakon; Carslake, David; Nilsen, Tom Ivar Lund; Linthorst, Astrid C. E.; Smith, George Davey; Gunnell, David; Romundstad, Pal Richard			Association of Body Mass Index with Depression, Anxiety and Suicide-An Instrumental Variable Analysis of the HUNT Study	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; MENTAL-ILLNESS; RISK-FACTORS; OBESITY; POPULATION; DISORDERS; TESTOSTERONE; OVERWEIGHT; ADIPOSITY; GENETICS	Objective While high body mass index is associated with an increased risk of depression and anxiety, cumulative evidence indicates that it is a protective factor for suicide. The associations from conventional observational studies of body mass index with mental health outcomes are likely to be influenced by reverse causality or confounding by ill-health. In the present study, we investigated the associations between offspring body mass index and parental anxiety, depression and suicide in order to avoid problems with reverse causality and confounding by ill-health. Methods We used data from 32,457 mother-offspring and 27,753 father-offspring pairs from the Norwegian HUNT-study. Anxiety and depression were assessed using the Hospital Anxiety and Depression Scale and suicide death from national registers. Associations between offspring and own body mass index and symptoms of anxiety and depression and suicide mortality were estimated using logistic and Cox regression. Causal effect estimates were estimated with a two sample instrument variable approach using offspring body mass index as an instrument for parental body mass index. Results Both own and offspring body mass index were positively associated with depression, while the results did not indicate any substantial association between body mass index and anxiety. Although precision was low, suicide mortality was inversely associated with own body mass index and the results from the analysis using offspring body mass index supported these results. Adjusted odds ratios per standard deviation body mass index from the instrumental variable analysis were 1.22 (95% CI: 1.05, 1.43) for depression, 1.10 (95% CI: 0.95, 1.27) for anxiety, and the instrumental variable estimated hazard ratios for suicide was 0.69 (95% CI: 0.30, 1.63). Conclusion The present study's results indicate that suicide mortality is inversely associated with body mass index. We also found support for a positive association between body mass index and depression, but not for anxiety.	[Bjorngaard, Johan Hakon; Romundstad, Pal Richard] Norwegian Univ Sci & Technol, Dept Publ Hlth, Fac Med, N-7491 Trondheim, Norway; [Bjorngaard, Johan Hakon] Broset St Olavs Univ Hosp, Forens Dept, Trondheim, Norway; [Bjorngaard, Johan Hakon] Broset St Olavs Univ Hosp, Res Ctr, Trondheim, Norway; [Carslake, David; Smith, George Davey; Gunnell, David] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Carslake, David; Smith, George Davey] Univ Bristol, MRC Integrat Epidemiol Unit, Bristol, Avon, England; [Nilsen, Tom Ivar Lund] Norwegian Univ Sci & Technol, Dept Human Movement Sci, N-7491 Trondheim, Norway; [Linthorst, Astrid C. E.] Univ Bristol, Sch Clin Sci, Neurobiol Stress & Behav Res Grp, Bristol, Avon, England	Norwegian University of Science & Technology (NTNU); University of Bristol; University of Bristol; Norwegian University of Science & Technology (NTNU); University of Bristol	Bjorngaard, JH (corresponding author), Norwegian Univ Sci & Technol, Dept Publ Hlth, Fac Med, N-7491 Trondheim, Norway.	johan.h.bjorngaard@ntnu.no	Davey Smith, George/A-7407-2013; Gunnell, David/ABE-6653-2020	Davey Smith, George/0000-0002-1407-8314; Gunnell, David/0000-0002-0829-6470; Romundstad, Pal Richard/0000-0003-2061-4336; Venkatasubramanian, Siddharth/0000-0002-5860-0768; s, hema/0000-0002-3440-9475; Carslake, David/0000-0003-2916-4546	UK Medical Research Council; University of Bristol; MRC [MR/K006525/1, MC_UU_12013/9, MC_UU_12013/1] Funding Source: UKRI; Medical Research Council [MR/K006525/1, MC_UU_12013/1, MC_UU_12013/9] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10068] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of Bristol; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	David Carslake works in a unit that receives funds from the UK Medical Research Council and the University of Bristol. David Gunnell is a National Institute for Health Research Senior Investigator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors state that there are no conflicts of interest.	ANGRIST JD, 1992, J AM STAT ASSOC, V87, P328; Batty GD, 2010, AM J EPIDEMIOL, V172, P890, DOI 10.1093/aje/kwq274; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Bjerkeset O, 2008, AM J EPIDEMIOL, V167, P193, DOI 10.1093/aje/kwm280; Cawley J, 2012, J HEALTH ECON, V31, P219, DOI 10.1016/j.jhealeco.2011.10.003; Chang SS, 2012, AM J EPIDEMIOL, V175, P804, DOI 10.1093/aje/kwr386; Costanza A, 2014, INT J LEGAL MED, V128, P73, DOI 10.1007/s00414-013-0835-6; Daumit GL, 2005, J NERV MENT DIS, V193, P641, DOI 10.1097/01.nmd.0000180737.85895.60; Dent R, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0036889, 10.1371/journal.pone.0037135]; Didelez V, 2010, STAT SCI, V25, P22, DOI 10.1214/09-STS316; Elovainio M, 2009, J AFFECT DISORDERS, V116, P218, DOI 10.1016/j.jad.2008.12.002; Erritzoe D, 2010, NEUROIMAGE, V52, P284, DOI 10.1016/j.neuroimage.2010.03.086; Gariepy G, 2010, INT J OBESITY, V34, P407, DOI 10.1038/ijo.2009.252; Greenland S, 2000, INT J EPIDEMIOL, V29, P722, DOI 10.1093/ije/29.4.722; Gunnell D, 2005, BRIT J PSYCHIAT, V187, P206, DOI 10.1192/bjp.187.3.206; Gunnell D, 2011, INT HDB SUICIDE PREV; Harrell FE, 2001, REGRESSION MODELING, Vxxii; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; Herpertz S, 2003, INT J OBESITY, V27, P1300, DOI 10.1038/sj.ijo.0802410; Hung CF, 2014, BRIT J PSYCHIAT, V205, P24, DOI 10.1192/bjp.bp.113.130419; Kendler KS, 2001, ARCH GEN PSYCHIAT, V58, P1005, DOI 10.1001/archpsyc.58.11.1005; Kivimaki M, 2011, AM J EPIDEMIOL, V173, P421, DOI 10.1093/aje/kwq444; Kivimaki M, 2009, BRIT J PSYCHIAT, V195, P149, DOI 10.1192/bjp.bp.108.057299; Klinitzke G, 2013, J AFFECT DISORDERS, V145, P277, DOI 10.1016/j.jad.2012.07.010; Laaksonen DE, 2004, DIABETES CARE, V27, P1036, DOI 10.2337/diacare.27.5.1036; Lam DD, 2010, PHARMACOL BIOCHEM BE, V97, P84, DOI 10.1016/j.pbb.2010.09.003; Lasser K, 2000, JAMA-J AM MED ASSOC, V284, P2606, DOI 10.1001/jama.284.20.2606; Lawlor DA, 2011, J INTERN MED, V269, P525, DOI 10.1111/j.1365-2796.2011.02343.x; Luppino FS, 2010, ARCH GEN PSYCHIAT, V67, P220, DOI 10.1001/archgenpsychiatry.2010.2; Moore ME, 1997, OBES RES, V5, P503, DOI 10.1002/j.1550-8528.1997.tb00678.x; Mukamal KJ, 2010, AM J EPIDEMIOL, V172, P900, DOI 10.1093/aje/kwq278; Mukamal KJ, 2010, EPIDEMIOLOGY, V21, P82, DOI 10.1097/EDE.0b013e3181c1fa2d; Mukamal KJ, 2009, OBESITY, V17, P532, DOI 10.1038/oby.2008.538; Mustelin L, 2009, INT J OBESITY, V33, P29, DOI 10.1038/ijo.2008.258; Nock MK, 2008, EPIDEMIOL REV, V30, P133, DOI 10.1093/epirev/mxn002; O'Rahilly S, 2006, PHILOS T R SOC B, V361, P1095, DOI 10.1098/rstb.2006.1850; Osborn DPJ, 2007, SOC PSYCH PSYCH EPID, V42, P787, DOI 10.1007/s00127-007-0247-3; Parikh NI, 2007, AM J MED, V120, P242, DOI 10.1016/j.amjmed.2006.06.004; Pelusi C, 2012, CURR OBES REP, V1, P181, DOI 10.1007/s13679-012-0029-4; Peterhansel C, 2013, OBES REV, V14, P369, DOI 10.1111/obr.12014; Pompili M, 2010, EUR ARCH PSY CLIN N, V260, P583, DOI 10.1007/s00406-010-0108-z; REGIER DA, 1990, JAMA-J AM MED ASSOC, V264, P2511; Ressler KJ, 2000, DEPRESS ANXIETY, V12, P2, DOI 10.1002/1520-6394(2000)12:1+<2::AID-DA2>3.3.CO;2-W; Samaan Z, 2012, MOL PSYCHIAT; Silventoinen K, 2009, OBESITY FACTS, V2, P196, DOI 10.1159/000219675; Simon GE, 2006, ARCH GEN PSYCHIAT, V63, P824, DOI 10.1001/archpsyc.63.7.824; Smith GD, 2004, INT J EPIDEMIOL, V33, P30, DOI 10.1093/ije/dyh132; Smith GD, 2007, PLOS MED, V4, P1985, DOI 10.1371/journal.pmed.0040352; Smith GD, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5043; Spencer SJ, 2011, STRESS, V14, P233, DOI 10.3109/10253890.2010.534831; Steckler T, 1999, BEST PRACT RES CL EN, V13, P597, DOI 10.1053/beem.1999.0046; STUNKARD AJ, 1986, NEW ENGL J MED, V314, P193, DOI 10.1056/NEJM198601233140401; Thomas DC, 2007, ANN EPIDEMIOL, V17, P511, DOI 10.1016/j.annepidem.2006.12.005; Tyrer P, 2008, BRIT J PSYCHIAT, V192, P242, DOI 10.1192/bjp.192.3.242; Yamada N, 2011, ENDOCRINOLOGY, V152, P2634, DOI 10.1210/en.2011-0004; Zhang J, 2013, J AFFECT DISORDERS, V148, P147, DOI 10.1016/j.jad.2012.05.048	56	31	32	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0131708	10.1371/journal.pone.0131708	http://dx.doi.org/10.1371/journal.pone.0131708			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26167892	Green Published, Green Submitted, gold			2022-12-26	WOS:000358193100012
J	Cornet, V; Henry, J; Goux, D; Duval, E; Bernay, B; Le Corguille, G; Corre, E; Zatylny-Gaudin, C				Cornet, Valerie; Henry, Joel; Goux, Didier; Duval, Emilie; Bernay, Benoit; Le Corguille, Gildas; Corre, Erwan; Zatylny-Gaudin, Celine			How Egg Case Proteins Can Protect Cuttlefish Offspring?	PLOS ONE			English	Article							CHICKEN EGGSHELL MATRIX; SEA-HARE; APLYSIANIN-E; SEPIA-OFFICINALIS; CHEMICAL DEFENSE; ANTIBACTERIAL; CAPSULES; PURIFICATION; COLLAGEN; PEPTIDE	Sepia officinalis egg protection is ensured by a complex capsule produced by the female accessory genital glands and the ink bag. Our study is focused on the proteins constituting the main egg case. De novo transcriptomes from female genital glands provided essential databases for protein identification. A proteomic approach in SDS-PAGE coupled with MS unveiled a new egg case protein family: SepECPs, for Sepia officinalis Egg Case Proteins. N-glycosylation was demonstrated by PAS staining SDS-PAGE gels. These glycoproteins are mainly produced in the main nidamental glands. SepECPs share high sequence homology, especially in the signal peptide and the three cysteine-rich domains. SepECPs have a high number of cysteines, with conserved motifs involved in 3D-structure. SDS-PAGE showed that SepECPs could form dimers; this result was confirmed by TEM observations, which also revealed a protein network. This network is similar to the capsule network, and it associates these structural proteins with polysaccharides, melanin and bacteria to form a tight mesh. Its hardness and elasticity provide physical protection to the embryo. In addition, SepECPs also have bacteriostatic antimicrobial activity on GRAM-bacteria. By observing the SepECP / Vibrio aestuarianus complex in SEM, we demonstrated the ability of these proteins to agglomerate bacteria and thus inhibit their growth. These original proteins identified from the outer egg case ensure the survival of the species by providing physical and chemical protection to the embryos released in the environment without any maternal protection.	[Cornet, Valerie; Henry, Joel; Goux, Didier; Duval, Emilie; Bernay, Benoit; Zatylny-Gaudin, Celine] Univ Caen Basse Normandie, F-14032 Caen, France; [Cornet, Valerie; Henry, Joel; Zatylny-Gaudin, Celine] BOREA CNRS INEE, UMR 7208, F-14032 Caen, France; [Henry, Joel; Bernay, Benoit] Plateforme Postgen PROTEOGEN, F-14032 Caen, France; [Goux, Didier] CMAbio, F-14032 Caen, France; [Le Corguille, Gildas; Corre, Erwan] UPMC CNRS, Stn Biol Roscoff, Plateforme ABiMS, F-29688 Roscoff, France	Universite de Caen Normandie; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite; Institut de Recherche pour le Developpement (IRD); Museum National d'Histoire Naturelle (MNHN); Universite de Caen Normandie; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite	Zatylny-Gaudin, C (corresponding author), Univ Caen Basse Normandie, F-14032 Caen, France.	celine.gaudin@unicaen.fr	corre, erwan/O-4669-2019	corre, erwan/0000-0001-6354-2278; Zatylny-Gaudin, Celine/0000-0001-9258-9876; Le Corguille, Gildas/0000-0003-1742-9711				Ahlborn GJ, 2006, PROTEIN J, V25, P71, DOI 10.1007/s10930-006-0010-8; ALOYZ RS, 1995, PEPTIDES, V16, P331, DOI 10.1016/0196-9781(94)00140-5; Arrieta MC, 2006, EXP APPL ACAROL, V39, P297, DOI 10.1007/s10493-006-9014-5; Benkendorff K, 2001, J INVERTEBR PATHOL, V78, P109, DOI 10.1006/jipa.2001.5047; BERTRAM BCR, 1981, IBIS, V123, P207, DOI 10.1111/j.1474-919X.1981.tb00927.x; BIGGS J, 1991, J EXP ZOOL, V259, P263, DOI 10.1002/jez.1402590217; BLOODGOOD RA, 1977, TISSUE CELL, V9, P197, DOI 10.1016/0040-8166(77)90016-7; BOLETZKY SV, 1973, HELGOLAND WISS MEER, V25, P135, DOI 10.1007/BF01609965; Boletzky SV, 2003, ADV MAR BIOL, V44, P143, DOI 10.1016/S0065-2881(03)44003-0; BOLETZKY SV, 1986, AM MALACOL BULL, V4, P217; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROWN CH, 1955, Q J MICROSC SCI, V96, P483; Bulet P, 1999, M S-MED SCI, V15, P23, DOI 10.4267/10608/1192; Calvery HO, 1933, J BIOL CHEM, V100, P183; Cordeiro CMM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084112; Cornet V, 2014, J PROTEOMICS, V108, P209, DOI 10.1016/j.jprot.2014.05.019; COULOMBE PA, 1990, J CELL BIOL, V111, P153, DOI 10.1083/jcb.111.1.153; Cummins SF, 2011, CURR BIOL, V21, P322, DOI 10.1016/j.cub.2011.01.038; Cummins SF, 2005, PEPTIDES, V26, P589, DOI 10.1016/j.peptides.2004.11.006; Cyran N, 2013, ZOOL ANZ, V253, P66, DOI 10.1016/j.jcz.2013.04.001; DASARO CN, 1988, NAUTILUS, V102, P134; Derby CD, 2013, BIOL BULL-US, V225, P152, DOI 10.1086/BBLv225n3p152; Duval E, 2009, PEPTIDES, V30, P1608, DOI 10.1016/j.peptides.2009.06.022; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Gabe M., 1968, TECHNIQUES HISTOLOGI; Gautron J, 2001, J BIOL CHEM, V276, P39243, DOI 10.1074/jbc.M104543200; Gautron J, 2007, J BIOL CHEM, V282, P5273, DOI 10.1074/jbc.M610294200; Gautron J, 2011, BIOCHEM SOC T, V39, P971, DOI 10.1042/BST0390971; GILTURNES MS, 1989, SCIENCE, V246, P116, DOI 10.1126/science.2781297; GOMI F, 1986, ZOOL SCI, V3, P641; GUILLETTE LJ, 1989, J MORPHOL, V201, P145, DOI 10.1002/jmor.1052010205; Herfurth AH., 1936, BEITRAGE KENNTNIS BA; HINCKE MT, 1995, CALCIFIED TISSUE INT, V56, P578, DOI 10.1007/BF00298593; Hu XY, 2005, J BIOL CHEM, V280, P21220, DOI 10.1074/jbc.M412316200; IIJIMA R, 1995, DEV COMP IMMUNOL, V19, P13, DOI 10.1016/0145-305X(94)00055-K; Jecklin L., 1934, Revue Suisse de Zoologie, V41, P593; Jonchere V, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-57; KAMIYA H, 1988, NIPPON SUISAN GAKK, V54, P773; Kamiya H, 1986, EXPERIENTIA, V42, P1984; Kaviarasan T., 2012, Asian Pacific Journal of Tropical Biomedicine, V2, P916, DOI 10.1016/S2221-1691(12)60253-6; KAWASAKI H, 1971, INSECT BIOCHEM, V1, P130, DOI 10.1016/0020-1790(71)90067-9; KELLETT E, 1994, J NEUROSCI, V14, P6564; KISUGI J, 1989, CHEM PHARM BULL, V37, P3050; KISUGI J, 1987, CANCER RES, V47, P5649; Klussmann-Kolb A, 1999, MAR BIOL, V133, P443, DOI 10.1007/s002270050483; Knupp C, 1998, J STRUCT BIOL, V122, P101, DOI 10.1006/jsbi.1998.3994; Kodali VK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018187; LORD A, 1986, AM MALACOL BULL, V4, P201; Luong TT, 1998, BIOCHEM BIOPH RES CO, V250, P657, DOI 10.1006/bbrc.1998.9282; Mann K, 2003, MATRIX BIOL, V22, P397, DOI 10.1016/S0945-053X(03)00072-6; Mann K, 2002, MATRIX BIOL, V21, P383, DOI 10.1016/S0945-053X(02)00031-8; Marie P, 2015, J PROTEOMICS, V113, P178, DOI 10.1016/j.jprot.2014.09.024; Milne I, 2013, BRIEF BIOINFORM, V14, P193, DOI 10.1093/bib/bbs012; Mine Y, 2003, J AGR FOOD CHEM, V51, P249, DOI 10.1021/jf020597x; Parry DAD, 1999, Q REV BIOPHYS, V32, P99, DOI 10.1017/S0033583500003516; Ramasamy MS, 2007, BIOFOULING, V23, P259, DOI 10.1080/08927010701278857; Rapoport HS, 2002, BIOMACROMOLECULES, V3, P42, DOI 10.1021/bm0155470; RAWLINGS TA, 1995, VELIGER, V38, P54; Rose-Martel M, 2013, EGGSHELL SOURCE NOVE, V3, P219; RUSAOUEN M, 1976, COMP BIOCHEM PHYS B, V53, P539, DOI 10.1016/0305-0491(76)90214-5; Sangster CR, 2003, BIOL BULL-US, V205, P233, DOI 10.2307/1543270; Thomason JC, 2009, J MAR BIOL ASSOC UK, V76, P777; von Boletzky S, 1998, OCEANOGR MAR BIOL<D>, V36, P341; Wang X, 2002, POULTRY SCI, V81, P805, DOI 10.1093/ps/81.6.805; WONG M, 1984, DEV BIOL, V104, P28, DOI 10.1016/0012-1606(84)90033-2; ZACHARIUS RM, 1969, ANAL BIOCHEM, V30, P148, DOI 10.1016/0003-2697(69)90383-2; Zatylny C, 2000, BIOCHEM BIOPH RES CO, V275, P217, DOI 10.1006/bbrc.2000.3286; Zatylny C, 2002, BIOCHEM BIOPH RES CO, V296, P1186, DOI 10.1016/S0006-291X(02)02036-3; Zhao AC, 2006, BIOCHEMISTRY-US, V45, P3348, DOI 10.1021/bi052414g	69	13	13	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0132836	10.1371/journal.pone.0132836	http://dx.doi.org/10.1371/journal.pone.0132836			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26168161	gold, Green Published, Green Submitted			2022-12-26	WOS:000358193100087
J	Zhao, MH; Liang, S; Kim, SH; Cui, XS; Kim, NH				Zhao, Ming-Hui; Liang, Shuang; Kim, Seon-Hyang; Cui, Xiang-Shun; Kim, Nam-Hyung			Fe(III) Is Essential for Porcine Embryonic Development via Mitochondrial Function Maintenance	PLOS ONE			English	Article							DIETARY IRON-DEFICIENCY; OOCYTE MATURATION; CYTOCHROME-C; FOLLICULAR-FLUID; ERYTHROID-CELLS; IN-VITRO; APOPTOSIS; BIOGENESIS; DEFEROXAMINE; METABOLISM	Iron is an important trace element involved in several biological processes. The role of iron in porcine early embryonic development remains unknown. In the present study, we depleted iron (III, Fe3+) with deferoxamine (DFM), a specific Fe3+ chelator, in cultured porcine parthenotes and monitored embryonic development, apoptosis, mitochondrial membrane potential, and ATP production. Results showed biphasic function of Fe3+ in porcine embryo development. 0.5 mu M DFM obviously increased blastocyst formation (57.49 +/- 2.18% vs. control, 43.99 +/- 1.72%, P < 0.05) via reduced (P < 0.05) production of reactive oxygen species (ROS), further increased mitochondrial membrane potential and ATP production in blastocysts (P < 0.05). 0.5 mu M DFM decreased mRNA expression of Caspase 3 (Casp3) and increased Bcl-xL. However, results showed a significant reduction in blastocyst formation in the presence of 5.0 mu M DFM compared with the control group (DFM, 21.62 +/- 3.92% vs. control, 43.99 +/- 1.73%, P < 0.05). Fe3+ depletion reduced the total (DFM, 21.10 +/- 8.78 vs. control, 44.09 +/- 13.65, P < 0.05) and increased apoptotic cell number (DFM, 11.10 +/- 5.24 vs. control, 2.64 +/- 1.43, P < 0.05) in the blastocyst. An obvious reduction in mitochondrial membrane potential and ATP level after 5.0 mu M DFM treatment was observed. Co-localization between mitochondria and cytochrome c was reduced after high concentration of DFM treatment. In conclusion, Fe3+ is essential for porcine embryonic development via mitochondrial function maintenance, but redundant Fe3+ impairs the function of mitochondria.	[Zhao, Ming-Hui; Liang, Shuang; Kim, Seon-Hyang; Cui, Xiang-Shun; Kim, Nam-Hyung] Chungbuk Natl Univ, Dept Anim Sci, Cheongju, Chungbuk, South Korea; [Zhao, Ming-Hui; Liang, Shuang; Kim, Seon-Hyang; Cui, Xiang-Shun; Kim, Nam-Hyung] Brain Korea 21 Ctr Bioresource Dev, Cheongju, Chungbuk, South Korea	Chungbuk National University	Cui, XS (corresponding author), Chungbuk Natl Univ, Dept Anim Sci, Cheongju, Chungbuk, South Korea.	xscui@chungbuk.ac.kr; nhkim@chungbuk.ac.kr			Next-Generation BioGreen 21 Program, Rural Development Administration, Republic of Korea [PJ011126]	Next-Generation BioGreen 21 Program, Rural Development Administration, Republic of Korea	This work was supported by grants from the Next-Generation BioGreen 21 Program (PJ011126), Rural Development Administration, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen HS, 2006, J NUTR, V136, P1171, DOI 10.1093/jn/136.5.1171; Balk J, 2005, TRENDS PLANT SCI, V10, P324, DOI 10.1016/j.tplants.2005.05.002; Baltz JM, 2010, HUM REPROD UPDATE, V16, P166, DOI 10.1093/humupd/dmp045; Barcroft LC, 2003, DEV BIOL, V256, P342, DOI 10.1016/S0012-1606(02)00127-6; BOSQUE MA, 1995, ARCH TOXICOL, V69, P467, DOI 10.1007/s002040050200; Cao ZB, 2012, ZYGOTE, V20, P229, DOI 10.1017/S0967199411000153; Cui XS, 2013, REPROD FERT DEVELOP, V25, P691, DOI 10.1071/RD12138; Desagher S, 2000, TRENDS CELL BIOL, V10, P369, DOI 10.1016/S0962-8924(00)01803-1; Dong F, 2005, CLIN SCI, V109, P277, DOI 10.1042/CS20040278; Duce JA, 2010, PROG NEUROBIOL, V92, P1, DOI 10.1016/j.pneurobio.2010.04.003; Dunn LL, 2007, TRENDS CELL BIOL, V17, P93, DOI 10.1016/j.tcb.2006.12.003; Ge HS, 2012, MOL REPROD DEV, V79, P392, DOI 10.1002/mrd.22042; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; HWANG YF, 1964, ARCH INTERN MED, V114, P741, DOI 10.1001/archinte.1964.03860120053003; Jeong YW, 2008, ANIM REPROD SCI, V106, P13, DOI 10.1016/j.anireprosci.2007.03.021; Jiang XJ, 2004, ANNU REV BIOCHEM, V73, P87, DOI 10.1146/annurev.biochem.73.011303.073706; Kim AM, 2010, NAT CHEM BIOL, V6, P674, DOI [10.1038/NCHEMBIO.419, 10.1038/nchembio.419]; Lee SK, 2015, THERIOGENOLOGY, V83, P121, DOI 10.1016/j.theriogenology.2014.08.019; Lee SK, 2014, J REPROD DEVELOP, V60, P128, DOI 10.1262/jrd.2013-098; Leist M, 1997, BIOCHEM BIOPH RES CO, V236, P1, DOI 10.1006/bbrc.1997.6890; Lill R, 2006, ANNU REV CELL DEV BI, V22, P457, DOI 10.1146/annurev.cellbio.22.010305.104538; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MARCIANI MG, 1991, HAEMATOLOGICA, V76, P131; Martindale W., 1993, MARTINDALE THE EXTRA; MASINI A, 1994, BBA-BIOENERGETICS, V1188, P46, DOI 10.1016/0005-2728(94)90020-5; NOMIZU T, 1993, MOL REPROD DEV, V36, P419, DOI 10.1002/mrd.1080360403; Ohgami RS, 2005, NAT GENET, V37, P1264, DOI 10.1038/ng1658; Okonko DO, 2004, J CARD FAIL, V10, pS5, DOI 10.1016/j.cardfail.2004.01.004; Perez GI, 2007, CELL DEATH DIFFER, V14, P524, DOI 10.1038/sj.cdd.4402050; Ponka P, 1997, BLOOD, V89, P1; Reubinoff BE, 1996, AM J OBSTET GYNECOL, V174, P914, DOI 10.1016/S0002-9378(96)70325-3; Rosell FI, 2002, BIOCHEMISTRY-US, V41, P7811, DOI 10.1021/bi016060e; Sendamarai AK, 2008, P NATL ACAD SCI USA, V105, P7410, DOI 10.1073/pnas.0801318105; Sluhots'ka I B, 2002, Lik Sprava, P141; Suzuki C, 2004, J REPROD DEVELOP, V50, P487, DOI 10.1262/jrd.50.487; Tong WH, 2007, BIOMETALS, V20, P549, DOI 10.1007/s10534-006-9047-6; Van Blerkom J, 2007, MOL HUM REPROD, V13, P759, DOI 10.1093/molehr/gam068; Van Thuan N, 2002, BIOL REPROD, V67, P1688, DOI DOI 10.1095/BIOLREPROD.102.004812; VAYSSIERE JL, 1994, P NATL ACAD SCI USA, V91, P11752, DOI 10.1073/pnas.91.24.11752; Walter PB, 2002, P NATL ACAD SCI USA, V99, P2264, DOI 10.1073/pnas.261708798; WATSON AJ, 1990, DEV GENET, V11, P41, DOI 10.1002/dvg.1020110106; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Winterbourn CC, 1995, TOXICOL LETT, V82-3, P969, DOI 10.1016/0378-4274(95)03532-X; Yang CR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014242; Zhao MH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102097	45	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0130791	10.1371/journal.pone.0130791	http://dx.doi.org/10.1371/journal.pone.0130791			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161974	Green Published, Green Submitted, gold			2022-12-26	WOS:000358162300020
J	Reilly, L; Howie, J; Wypijewski, K; Ashford, MLJ; Hilgemann, DW; Fuller, W				Reilly, Louise; Howie, Jacqueline; Wypijewski, Krzysztof; Ashford, Michael L. J.; Hilgemann, Donald W.; Fuller, William			Palmitoylation of the Na/Ca exchanger cytoplasmic loop controls its inactivation and internalization during stress signaling	FASEB JOURNAL			English	Article						acylation; patch clamp; resin-assisted capture; ion transport; heart	CARDIAC NA+/CA2+ EXCHANGER; SODIUM-CALCIUM EXCHANGE; NA+-CA2+ EXCHANGER; HEART-FAILURE; ISCHEMIA/REPERFUSION INJURY; DYNAMIC PROPERTIES; STEADY-STATE; XIP REGION; CA2+ ENTRY; PROTEIN	The electrogenic Na/Ca exchanger (NCX) mediates bidirectional Ca movements that are highly sensitive to changes of Na gradients in many cells. NCX1 is implicated in the pathogenesis of heart failure and a number of cardiac arrhythmias. We measured NCX1 palmitoylation using resin-assisted capture, the subcellular location of yellow fluorescent protein-NCX1 fusion proteins, and NCX1 currents using whole-cell voltage clamping. Rat NCX1 is substantially palmitoylated in all tissues examined. Cysteine 739 in the NCX1 large intracellular loop is necessary and sufficient for NCX1 palmitoylation. Palmitoylation of NCX1 occurs in the Golgi and anchors theNCX1 large regulatory intracellular loop to membranes. Surprisingly, palmitoylation does not influence trafficking or localization of NCX1 to surface membranes, nor does it strongly affect the normal forward or reverse transport modes of NCX1. However, exchangers that cannot be palmitoylated do not inactivate normally (leading to substantial activity in conditions when wild-type exchangers are inactive) and do not promote cargo-dependent endocytosis that internalizes 50% of the cell surface following strong G-protein activation or large Ca transients. The palmitoylated cysteine in NCX1 is found in all vertebrate and some invertebrate NCX homologs. Thus, NCX palmitoylation ubiquitously modulates Ca homeostasis and membrane domain function in cells that express NCX proteins.	[Reilly, Louise; Howie, Jacqueline; Wypijewski, Krzysztof; Ashford, Michael L. J.; Fuller, William] Univ Dundee, Div Cardiovasc & Diabet Med, Med Res Inst, Coll Med Dent & Nursing, Dundee, Scotland; [Hilgemann, Donald W.] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA	University of Dundee; University of Texas System; University of Texas Southwestern Medical Center Dallas	Fuller, W (corresponding author), Ninewells Hosp, Div Cardiovasc & Diabet Med, Mail Box 12 Level 5, Dundee DD1 9SY, Scotland.	donald.hilgemann@utsouthwestern.edu; w.fuller@dundee.ac.uk		Reilly, Louise/0000-0002-2224-1708; Ashford, Michael/0000-0002-0861-7676; Fuller, William/0000-0002-5883-4433	British Heart Foundation [PG/12/6/29366]; U.S. National Institutes of Health, National Heart, Lung, and Blood Institute [RO1HL119843-01A1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL119843] Funding Source: NIH RePORTER; British Heart Foundation [PG/10/93/28650] Funding Source: researchfish; Medical Research Council [1218481] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); U.S. National Institutes of Health, National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The authors thank Dr. Lindsay Davidson for providing induced pluripotent stem cell-derived cardiac myocytes, and Mei-Jung Lin for technical assistance (University of Dundee iPSC facility, Dundee, United Kingdom). This work was supported by grants from the British Heart Foundation (PG/12/6/29366 to W.F. and M.L.J.A.) and U.S. National Institutes of Health, National Heart, Lung, and Blood Institute (RO1HL119843-01A1; to D.W.H.).	Annunziato L., 2013, ADV EXPT MED BIOL, V961; Antoons G, 2012, PHARMACOL THERAPEUT, V134, P26, DOI 10.1016/j.pharmthera.2011.12.001; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Bers DM, 2000, CIRC RES, V87, P275, DOI 10.1161/01.RES.87.4.275; Bossuyt J, 2002, FEBS LETT, V511, P113, DOI 10.1016/S0014-5793(01)03323-3; Boyman L, 2011, J BIOL CHEM, V286, P28811, DOI 10.1074/jbc.M110.214106; Boyman L, 2009, J BIOL CHEM, V284, P6185, DOI 10.1074/jbc.M809012200; Burr AR, 2014, MOL CELL BIOL, V34, P1991, DOI 10.1128/MCB.00339-14; Cai XJ, 2004, MOL BIOL EVOL, V21, P1692, DOI 10.1093/molbev/msh177; Cavalli A, 2007, CELL CALCIUM, V42, P313, DOI 10.1016/j.ceca.2007.01.003; Chernysh O, 2008, AM J PHYSIOL-CELL PH, V295, pC872, DOI 10.1152/ajpcell.00221.2008; Cirri E, 2013, J MEMBRANE BIOL, V246, P967, DOI 10.1007/s00232-013-9600-5; Davda D, 2013, ACS CHEM BIOL, V8, P1912, DOI 10.1021/cb400380s; Drozdetskiy A, 2015, NUCLEIC ACIDS RES, V43, pW389, DOI 10.1093/nar/gkv332; Feng NC, 2006, J CARDIOVASC PHARM, V47, P263, DOI 10.1097/01.fjc.0000202561.69291.ac; Flesch M, 1996, CIRCULATION, V94, P992, DOI 10.1161/01.CIR.94.5.992; Giladi M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039985; He ZP, 2000, AM J PHYSIOL-CELL PH, V278, pC661, DOI 10.1152/ajpcell.2000.278.4.C661; He ZP, 1998, J GEN PHYSIOL, V111, P857, DOI 10.1085/jgp.111.6.857; Herchuelz A, 2007, ANN NY ACAD SCI, V1099, P456, DOI 10.1196/annals.1387.048; Hilge M, 2009, P NATL ACAD SCI USA, V106, P14333, DOI 10.1073/pnas.0902171106; Hilgemann D W, 2001, Sci STKE, V2001, pre19, DOI 10.1126/stke.2001.111.re19; Hilgemann Donald W, 2006, J Cardiovasc Electrophysiol, V17 Suppl 1, pS47, DOI 10.1111/j.1540-8167.2006.00383.x; Hilgemann DW, 2013, ELIFE, V2, DOI 10.7554/eLife.01293; Hilgemann DW, 1996, SCIENCE, V273, P956, DOI 10.1126/science.273.5277.956; HILGEMANN DW, 1992, J GEN PHYSIOL, V100, P905, DOI 10.1085/jgp.100.6.905; HILGEMANN DW, 1990, NATURE, V344, P242, DOI 10.1038/344242a0; HILGEMANN DW, 1992, J GEN PHYSIOL, V100, P933, DOI 10.1085/jgp.100.6.933; HILGEMANN DW, 1992, J PHYSIOL-LONDON, V454, P59, DOI 10.1113/jphysiol.1992.sp019254; Hobai IA, 2000, CIRC RES, V87, P690, DOI 10.1161/01.RES.87.8.690; Hobai IA, 2004, CIRC RES, V95, P292, DOI 10.1161/01.RES.0000136817.28691.2d; Howie J, 2014, P NATL ACAD SCI USA, V111, P17534, DOI 10.1073/pnas.1413627111; Imahashi K, 2005, CIRC RES, V97, P916, DOI 10.1161/01.RES.0000187456.06162.cb; Iwamoto T, 2004, NAT MED, V10, P1193, DOI 10.1038/nm1118; John SA, 2011, P NATL ACAD SCI USA, V108, P1699, DOI 10.1073/pnas.1016114108; Kang RJ, 2008, NATURE, V456, P904, DOI 10.1038/nature07605; KIMURA J, 1986, NATURE, V319, P596, DOI 10.1038/319596a0; Lariccia V, 2011, J GEN PHYSIOL, V137, P111, DOI 10.1085/jgp.201010468; Levental I, 2010, P NATL ACAD SCI USA, V107, P22050, DOI 10.1073/pnas.1016184107; Liao J, 2012, SCIENCE, V335, P686, DOI 10.1126/science.1215759; Lin MJ, 2013, ELIFE, V2, DOI 10.7554/eLife.01295; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; Lytton J, 2007, BIOCHEM J, V406, P365, DOI 10.1042/BJ20070619; Maack C, 2005, CIRC RES, V96, P91, DOI 10.1161/01.RES.0000151334.48676.68; Matsuoka S, 1997, J GEN PHYSIOL, V109, P273, DOI 10.1085/jgp.109.2.273; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; Ohtsuka M, 2004, BIOCHEM BIOPH RES CO, V314, P849, DOI 10.1016/j.bbrc.2003.12.165; Ottolia M, 2009, J BIOL CHEM, V284, P32735, DOI 10.1074/jbc.M109.055434; Philipson KD, 2000, ANNU REV PHYSIOL, V62, P111, DOI 10.1146/annurev.physiol.62.1.111; Pignataro G, 2013, STROKE, V44, pE237, DOI 10.1161/01.str.0000436975.51525.16; Pinton P, 1998, EMBO J, V17, P5298, DOI 10.1093/emboj/17.18.5298; Pogwizd SM, 1999, CIRC RES, V85, P1009; Ren XY, 2013, J MOL CELL CARDIOL, V57, P68, DOI 10.1016/j.yjmcc.2013.01.010; Ruknudin AM, 2007, ANN NY ACAD SCI, V1099, P103, DOI 10.1196/annals.1387.036; Schapiro FB, 2000, J BIOL CHEM, V275, P21025, DOI 10.1074/jbc.M002386200; Shipston MJ, 2011, J BIOL CHEM, V286, P8709, DOI 10.1074/jbc.R110.210005; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sipido KR, 2002, CARDIOVASC RES, V53, P782, DOI 10.1016/S0008-6363(01)00470-9; Tulloch LB, 2011, J BIOL CHEM, V286, P36020, DOI 10.1074/jbc.M111.282145; Venetucci LA, 2007, ANN NY ACAD SCI, V1099, P315, DOI 10.1196/annals.1387.033; Voigt N, 2012, CIRCULATION, V125, P2059, DOI 10.1161/CIRCULATIONAHA.111.067306; Wanichawan P, 2011, AM J PHYSIOL-CELL PH, V300, pC989, DOI 10.1152/ajpcell.00196.2010; Wypijewski KJ, 2013, J BIOL CHEM, V288, P13808, DOI 10.1074/jbc.M113.460956; Yamashita T, 2005, SCIENCE, V307, P124, DOI 10.1126/science.1103631; Yang ZR, 2005, BIOINFORMATICS, V21, P3369, DOI 10.1093/bioinformatics/bti534; Yaradanakul A, 2008, J GEN PHYSIOL, V132, P29, DOI 10.1085/jgp.200709865; Zhang YH, 2009, CELL CALCIUM, V45, P1, DOI 10.1016/j.ceca.2008.05.005	67	38	39	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2015	29	11					4532	4543		10.1096/fj.15-276493	http://dx.doi.org/10.1096/fj.15-276493			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CV8EZ	26174834	Green Published, Green Accepted, hybrid			2022-12-26	WOS:000364514700013
J	Dias, FC; Gomes-Pereira, J; Tojeira, I; Souto, M; Afonso, A; Calado, A; Madureira, P; Campos, A				Dias, Frederico Carvalho; Gomes-Pereira, Jose; Tojeira, Ines; Souto, Miguel; Afonso, Andreia; Calado, Antonio; Madureira, Pedro; Campos, Aldino			Area Estimation of Deep-Sea Surfaces from Oblique Still Images	PLOS ONE			English	Article							SOFTWARE	Estimating the area of seabed surfaces from pictures or videos is an important problem in seafloor surveys. This task is complex to achieve with moving platforms such as submersibles, towed or remotely operated vehicles (ROV), where the recording camera is typically not static and provides an oblique view of the seafloor. A new method for obtaining seabed surface area estimates is presented here, using the classical set up of two laser devices fixed to the ROV frame projecting two parallel lines over the seabed. By combining lengths measured directly from the image containing the laser lines, the area of seabed surfaces is estimated, as well as the camera's distance to the seabed, pan and tilt angles. The only parameters required are the distance between the parallel laser lines and the camera's horizontal and vertical angles of view. The method was validated with a controlled in situ experiment using a deep-sea ROV, yielding an area estimate error of 1.5%. Further applications and generalizations of the method are discussed, with emphasis on deep-sea applications.	[Dias, Frederico Carvalho; Gomes-Pereira, Jose; Tojeira, Ines; Souto, Miguel; Afonso, Andreia; Calado, Antonio; Madureira, Pedro; Campos, Aldino] Task Grp Extens Continental Shelf EMEPC, Paco De Arcos, Portugal; [Gomes-Pereira, Jose] Univ Acores, Ctr IMAR, Dept Oceanog & Pescas, MARE Marine & Environm Sci Ctr, Horta, Portugal	Universidade dos Acores	Dias, FC (corresponding author), Task Grp Extens Continental Shelf EMEPC, Paco De Arcos, Portugal.	frederico.dias@emepc.mam.gov.pt	Tojeira, Ines/GYU-7749-2022	Tojeira, Ines/0000-0001-5778-6196; Madureira, Pedro Miguel/0000-0003-4762-6273	Regional Directorate for Education, Science and Culture of the Regional Government of the Azores [M3.1.2/F/062/2011]	Regional Directorate for Education, Science and Culture of the Regional Government of the Azores	JG-P was supported by the doctoral grant from the Regional Directorate for Education, Science and Culture of the Regional Government of the Azores (M3.1.2/F/062/2011). URL: http://educacaocienciaculturaazoresgov.pai.pt/. The other authors received no specific funding for this work.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Argus [Internet], 2010, ARG HD SDI CAM 10 X; Barker BAJ, 1999, CONT SHELF RES, V19, P1161, DOI 10.1016/S0278-4343(99)00017-5; Coggan R., 2007, REV STANDARDS PROTOC, P152; International Seabed Authority, 2010, ISA TECHN STUD; JPI Oceans, EC ASP DEEP SEA MIN; Masson DG, 2011, DEEP-SEA RES PT II, V58, P2369, DOI 10.1016/j.dsr2.2011.04.003; Parry DM, 2003, J EXP MAR BIOL ECOL, V285, P497, DOI 10.1016/S0022-0981(02)00546-4; Pham CK, 2013, DEEP-SEA RES PT II, V98, P204, DOI 10.1016/j.dsr2.2013.01.011; Pham CK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095839; Pilgrim DA, 2000, UNDERWATER TECHNOL, V24, P93, DOI 10.3723/175605400783259684; Schoening T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038179; Service M, 2001, MARINE MONITORING HD, P331; Sharma R, 2011, MAR TECHNOL SOC J, V45, P28, DOI 10.4031/MTSJ.45.5.2; SMITH KL, 1994, LIMNOL OCEANOGR, V39, P1101, DOI 10.4319/lo.1994.39.5.1101; Stierhoff K., 2012, NAT MAR FISH SERV AU, P13; Taylor J.R., 1997, INTRO ERROR ANAL STU, P181; Teixido N, 2011, MAR ECOL PROG SER, V431, P45, DOI 10.3354/meps09127; Tong RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043534; Trygonis V, 2012, J EXP MAR BIOL ECOL, V424, P99, DOI 10.1016/j.jembe.2012.04.018; Tusting RF, 1993, DIVING SCI 1993, P157; Van Rooij D, 2010, DEEP-SEA RES PT I, V57, P1561, DOI 10.1016/j.dsr.2010.09.002; WAKEFIELD WW, 1987, DEEP-SEA RES, V34, P469, DOI 10.1016/0198-0149(87)90148-8; White J., 2007, SEAFLOOR VIDEO MAPPI; [No title captured]	25	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0133290	10.1371/journal.pone.0133290	http://dx.doi.org/10.1371/journal.pone.0133290			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177287	Green Published, Green Submitted, gold			2022-12-26	WOS:000358197600240
J	Imai, H; Nakao, H; Shinohara, H; Watarai, M; Matsumoto, N; Yamagishi, T; Saito, M; Kitamura, T				Imai, Hirohisa; Nakao, Hiroyuki; Shinohara, Hisae; Watarai, Mutsuko; Matsumoto, Noriko; Yamagishi, Takuya; Saito, Masuko; Kitamura, Tadaichi			Prevalence, Potential Predictors, and Genotype-Specific Prevalence of Human Papillomavirus Infection among Sexually Active Students in Japan	PLOS ONE			English	Article							RISK-FACTORS; HPV INFECTION; WOMEN	Background and Methods We conducted a community-based study to evaluate genotype-specific prevalence of high-risk HPV (HR-HPV) and potential predictors of its presence in young, asymptomatic, female college students. Self-administered surveys and vaginal swabs for self collection were distributed to students of participating schools. A sufficient cellular component in cervical samples was verified by examining for the presence of human beta-globin DNA by PCR. A total of 1,118 valid cervical samples were subjected to screening for HR-HPV infection with the Digene Hybrid Capture 2 assay, followed by identification of HPV genotypes with GENOSEARCH HPV31 kit. Logistic regression was used to adjust for confounding factors associated with HR-HPV positivity and the adjusted odds ratio (AOR) was calculated. Results The median age of recruited students was 20 years. Of the 1,118 women who provided valid cervical samples for testing, 770 had sexual intercourse in the past, of which 125 (16.2%) were positive for HR-HPV. Logistic regression analysis revealed that HR-HPV infection was associated with smoking history (AOR 2.13; 95% confidence interval [CI] 1.98 to 5.05; p < 0.01), total number of partners (AOR 4.72; 95% CI 1.97 to 11.32 if > 5 partners; p < 0.001), number of partners in the past 6 months (AOR 3.12; 95% CI 1.42 to 6.87; p < 0.01), improper use of condoms (AOR 2.21; 95% CI 1.25 to 3.90; p < 0.01), and chlamydia infection (AOR 2.61; 95% CI 1.28 to 5.34; p < 0.01). The most common HR-HPV genotype was type 52 (6.4%), followed by 16 (3.1%), 56 (3.0%), and 58 (2.6%). Conclusion Compared with previous reports in East Asian coutries, the prevalence of HR-HPV infection among young, asymptomatic, female students before the nationwide use of vaccination in Japan was in the intermediate range. The most common HR-HPV genotypes were HPV 52, 16, 56, and 58.	[Imai, Hirohisa] Natl Inst Publ Hlth, Dept Epidemiol & Hlth Policy, Wako, Saitama 3510197, Japan; [Nakao, Hiroyuki; Matsumoto, Noriko] Miyazaki Prefectural Nursing Univ, Dept Epidemiol, Miyazaki, Japan; [Shinohara, Hisae] Miyazaki Univ, Fac Educ & Culture, Miyazaki, Japan; [Watarai, Mutsuko] Tokyo Healthcare Univ, Fac Healthcare, Div Nursing, Shinagawa Ku, Tokyo, Japan; [Yamagishi, Takuya] Natl Inst Infect Dis, Infect Dis Surveillance Ctr, Shinjuku Ku, Tokyo 1628640, Japan; [Saito, Masuko] Teikyo Univ Sci, Dept Nursing, Adachi Ku, Tokyo, Japan; [Kitamura, Tadaichi] Asoka Hosp, Dept Urol, Koto Ku, Tokyo, Japan	National Institute of Public Health - Japan; University of Miyazaki; National Institute of Infectious Diseases (NIID)	Imai, H (corresponding author), Natl Inst Publ Hlth, Dept Epidemiol & Hlth Policy, Wako, Saitama 3510197, Japan.	imaihiro@niph.go.jp			Japanese Foundation for Sexual Health Medicine	Japanese Foundation for Sexual Health Medicine	This study was made possible by funding from the Japanese Foundation for Sexual Health Medicine, a public benefit corporation (http://www.jfshm.org/). HI received the funding. There is no grant number. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammatuna P, 2008, CANCER EPIDEM BIOMAR, V17, P2002, DOI 10.1158/1055-9965.EPI-08-0180; [Anonymous], 2006, FDA Consum, V40, P37; Castle PE, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2569; Cercato MC, 2010, J MED VIROL, V82, P1921, DOI 10.1002/jmv.21887; Dillner J, 2015, SEMIN ONCOL, V42, P272, DOI 10.1053/j.seminoncol.2014.12.028; Doorbar J, 2012, VACCINE, V30, pF55, DOI 10.1016/j.vaccine.2012.06.083; Dunne EF, 2007, JAMA-J AM MED ASSOC, V297, P813, DOI 10.1001/jama.297.8.813; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Gaydos CA, 1998, NEW ENGL J MED, V339, P739, DOI 10.1056/NEJM199809103391105; Iftner T, 2010, J MED VIROL, V82, P1928, DOI 10.1002/jmv.21910; Johnson AM, 2012, SEX TRANSM INFECT, V88, P212, DOI 10.1136/sextrans-2011-050306; Kim MA, 2010, OBSTET GYNECOL, V116, P932, DOI 10.1097/AOG.0b013e3181edbeba; Kim S, 2011, SEX TRANSM DIS, V38, P587, DOI 10.1097/OLQ.0b013e31820a9324; Kliucinskas M, 2006, GYNECOL OBSTET INVES, V62, P173, DOI 10.1159/000093572; Leigh BC, 2008, J STUD ALCOHOL DRUGS, V69, P773, DOI 10.15288/jsad.2008.69.773; Louvanto K, 2010, J CLIN MICROBIOL, V48, P2665, DOI 10.1128/JCM.00783-10; Oakeshott P, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e4168; Soboe T, 2012, WHITE PAPER CANC 201; Sun LL, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-153; Uuskula A, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-63; Verteramo R, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-16; Winer RL, 2006, NEW ENGL J MED, V354, P2645, DOI 10.1056/NEJMoa053284	22	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132462	10.1371/journal.pone.0132462	http://dx.doi.org/10.1371/journal.pone.0132462			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176861	Green Submitted, Green Published, gold			2022-12-26	WOS:000358197600115
J	Maia, S; Cardoso, M; Pinto, P; Pinheiro, M; Santos, C; Peixoto, A; Bento, MJ; Oliveira, J; Henrique, R; Jeronimo, C; Teixeira, MR				Maia, Sofia; Cardoso, Marta; Pinto, Pedro; Pinheiro, Manuela; Santos, Catarina; Peixoto, Ana; Bento, Maria Jose; Oliveira, Jorge; Henrique, Rui; Jeronimo, Carmen; Teixeira, Manuel R.			Identification of Two Novel HOXB13 Germline Mutations in Portuguese Prostate Cancer Patients	PLOS ONE			English	Article							G84E MUTATION; P.GLY84GLU MUTATION; INCREASED RISK; GENE; MEN; BREAST; BRCA2; ASSOCIATION; POPULATION; PREVALENCE	The HOXB13 germline variant G84E (rs138213197) was recently described in men of European descent, with the highest prevalence in Northern Europe. The G84E mutation has not been found in patients of African or Asian ancestry, which may carry other HOXB13 variants, indicating allelic heterogeneity depending on the population. In order to gain insight into the full scope of coding HOXB13 mutations in Portuguese prostate cancer patients, we decided to sequence the entire coding region of the HOXB13 gene in 462 early-onset or familial/hereditary cases. Additionally, we searched for somatic HOXB13 mutations in 178 prostate carcinomas to evaluate their prevalence in prostate carcinogenesis. Three different patients were found to carry in their germline DNA two novel missense variants, which were not identified in 132 control subjects. Both variants are predicted to be deleterious by different in silico tools. No somatic mutations were found. These findings further support the hypothesis that different rare HOXB13 mutations may be found in different ethnic groups. Detection of mutations predisposing to prostate cancer may require re-sequencing rather than genotyping, as appropriate to the population under investigation.	[Maia, Sofia; Cardoso, Marta; Pinto, Pedro; Pinheiro, Manuela; Santos, Catarina; Peixoto, Ana; Teixeira, Manuel R.] Portuguese Oncol Inst Porto, Dept Genet, Oporto, Portugal; [Maia, Sofia; Cardoso, Marta; Pinto, Pedro; Pinheiro, Manuela; Santos, Catarina; Peixoto, Ana; Teixeira, Manuel R.] Portuguese Oncol Inst Porto, Canc Genet Grp CI IPOP, Oporto, Portugal; [Bento, Maria Jose] Portuguese Oncol Inst Porto, Dept Epidemiol, Oporto, Portugal; [Bento, Maria Jose] Portuguese Oncol Inst Porto, North Reg Canc Registry, Oporto, Portugal; [Bento, Maria Jose; Henrique, Rui; Jeronimo, Carmen; Teixeira, Manuel R.] Univ Porto, Biomed Sci Inst ICBAS, P-4100 Oporto, Portugal; [Oliveira, Jorge] Portuguese Oncol Inst Porto, Dept Urol, Oporto, Portugal; [Henrique, Rui; Jeronimo, Carmen] Portuguese Oncol Inst Porto, Canc Biol & Epigenet Grp CI IPOP, Oporto, Portugal; [Henrique, Rui] Portuguese Oncol Inst Porto, Dept Pathol, Oporto, Portugal	Portuguese Institute of Oncology; Portuguese Institute of Oncology; Portuguese Institute of Oncology; Portuguese Institute of Oncology; Universidade do Porto; Portuguese Institute of Oncology; Portuguese Institute of Oncology; Portuguese Institute of Oncology	Teixeira, MR (corresponding author), Portuguese Oncol Inst Porto, Dept Genet, Oporto, Portugal.	manuel.teixeira@ipoporto.min-saude.pt	Teixeira, Manuel AC/AAZ-7251-2020; Henrique, Rui Manuel Ferreira/I-2757-2013; Pinheiro, Manuela/AAV-4114-2020; Jerónimo, Carmen/H-3284-2013; Pinheiro, Manuela/AAG-2543-2021; Teixeira, Manuel António Rodrigues/E-4885-2011	Teixeira, Manuel AC/0000-0002-1959-0624; Henrique, Rui Manuel Ferreira/0000-0003-3171-4666; Pinheiro, Manuela/0000-0001-8228-3435; Jerónimo, Carmen/0000-0003-4186-5345; Teixeira, Manuel António Rodrigues/0000-0002-4896-5982; Santos, Catarina/0000-0002-9102-757X; Pinto, Pedro/0000-0001-6289-5792; Cardoso, Marta/0000-0002-3633-1659; Peixoto, Ana/0000-0002-1404-5897	Portuguese Foundation for Science and Technology [SFRH/BD/71397/2010]; Portuguese Oncology Institute-Porto [CI-IPOP 16-2012]	Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); Portuguese Oncology Institute-Porto	SM was awarded a PhD grant (SFRH/BD/71397/2010) by the Portuguese Foundation for Science and Technology (http://www.fct.pt/index.phtml.en). MC and MP are research fellows of the Portuguese Cancer League (http://www.ligacontracancro.pt/). The project was funded by the Portuguese Oncology Institute-Porto (http://www.ipoporto.pt/en/; grant reference: CI-IPOP 16-2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Akbari MR, 2013, CANCER EPIDEMIOL, V37, P424, DOI 10.1016/j.canep.2013.03.003; Akbari MR, 2012, BREAST CANCER RES TR, V136, P907, DOI 10.1007/s10549-012-2295-y; Akbari MR, 2012, J NATL CANCER I, V104, P1260, DOI 10.1093/jnci/djs288; Alanee S, 2013, FAM CANCER, V12, P597, DOI 10.1007/s10689-013-9618-y; Alanee S, 2012, NEW ENGL J MED, V367, P480, DOI 10.1056/NEJMc1205138; Breyer JP, 2012, CANCER EPIDEM BIOMAR, V21, P1348, DOI 10.1158/1055-9965.EPI-12-0495; Bruner DW, 2003, INT J CANCER, V107, P797, DOI 10.1002/ijc.11466; Cartegni L, 2003, NUCLEIC ACIDS RES, V31, P3568, DOI 10.1093/nar/gkg616; CARTER BS, 1992, P NATL ACAD SCI USA, V89, P3367, DOI 10.1073/pnas.89.8.3367; CARTER BS, 1993, J UROLOGY, V150, P797, DOI 10.1016/S0022-5347(17)35617-3; Castro E, 2012, ASIAN J ANDROL, V14, P409, DOI 10.1038/aja.2011.150; Chen Z, 2013, CARCINOGENESIS, V34, P1260, DOI 10.1093/carcin/bgt055; Choi YH, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0039927, 10.1371/journal.pone.0046688]; Cooper GM, 2005, GENOME RES, V15, P901, DOI 10.1101/gr.3577405; Crawford ED, 2003, UROLOGY, V62, P3, DOI 10.1016/j.urology.2003.10.013; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; Edwards SM, 2003, AM J HUM GENET, V72, P1, DOI 10.1086/345310; Ewing CM, 2012, NEW ENGL J MED, V366, P141, DOI 10.1056/NEJMoa1110000; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; GRANTHAM R, 1974, SCIENCE, V185, P862, DOI 10.1126/science.185.4154.862; Hoffmann TJ, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004930; Jung CY, 2004, CANCER RES, V64, P3046, DOI 10.1158/0008-5472.CAN-03-2614; Karlsson R, 2014, EUR UROL, V65, P169, DOI 10.1016/j.eururo.2012.07.027; Kim SD, 2010, ANAT CELL BIOL, V43, P284, DOI 10.5115/acb.2010.43.4.284; Kim YR, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-124; Kluzniak W, 2013, PROSTATE, V73, P542, DOI 10.1002/pros.22594; Kote-Jarai Z, 2015, ANN ONCOL, V26, P756, DOI 10.1093/annonc/mdv004; Laitinen VH, 2013, CANCER EPIDEM BIOMAR, V22, P452, DOI 10.1158/1055-9965.EPI-12-1000-T; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li B, 2009, BIOINFORMATICS, V25, P2744, DOI 10.1093/bioinformatics/btp528; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Lin XL, 2013, PROSTATE, V73, P169, DOI 10.1002/pros.22552; Muthusamy V, 2006, CANCER RES, V66, P11187, DOI 10.1158/0008-5472.CAN-06-1274; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Okuda H, 2006, ONCOGENE, V25, P1733, DOI 10.1038/sj.onc.1209200; Paulo P, 2012, GENE CHROMOSOME CANC, V51, P240, DOI 10.1002/gcc.20948; Pertea M, 2001, NUCLEIC ACIDS RES, V29, P1185, DOI 10.1093/nar/29.5.1185; Reese MG, 1997, J COMPUT BIOL, V4, P311, DOI 10.1089/cmb.1997.4.311; Reva B, 2011, NUCLEIC ACIDS RES, V39, pE118, DOI 10.1093/nar/gkr407; Schwarz JM, 2014, NAT METHODS, V11, P361, DOI 10.1038/nmeth.2890; SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Simard J, 2002, ENDOCRINOLOGY, V143, P2029, DOI 10.1210/en.143.6.2029; Thompson D, 2001, AM J HUM GENET, V68, P410, DOI 10.1086/318181; Witte JS, 2013, CANCER EPIDEM BIOMAR, V22, P675, DOI 10.1158/1055-9965.EPI-12-1154; Xu JF, 2013, HUM GENET, V132, P5, DOI 10.1007/s00439-012-1229-4; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Yeo G, 2004, J COMPUT BIOL, V11, P377, DOI 10.1089/1066527041410418	49	29	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132728	10.1371/journal.pone.0132728	http://dx.doi.org/10.1371/journal.pone.0132728			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176944	Green Submitted, Green Published, gold			2022-12-26	WOS:000358197600146
J	Maurer, JM; Schellekens, RCA; van Rieke, HM; Wanke, C; Iordanov, V; Stellaard, F; Wutzke, KD; Dijkstra, G; van der Zee, M; Woerdenbag, HJ; Frijlink, HW; Kosterink, JGW				Maurer, Jacoba M.; Schellekens, Reinout C. A.; van Rieke, Helen M.; Wanke, Christoph; Iordanov, Ventzeslav; Stellaard, Frans; Wutzke, Klaus D.; Dijkstra, Gerard; van der Zee, Margot; Woerdenbag, Herman J.; Frijlink, Henderik W.; Kosterink, Jos G. W.			Gastrointestinal pH and Transit Time Profiling in Healthy Volunteers Using the IntelliCap System Confirms Ileo-Colonic Release of ColoPulse Tablets	PLOS ONE			English	Article							INTRALUMINAL PH; DOSAGE FORMS; LUMINAL PH; DELIVERY; BEHAVIOR	Introduction ColoPulse tablets are an innovative development in the field of oral dosage forms characterized by a distal ileum and colon-specific release. Previous studies in humans showed release in the ileo-colonic region, but the relationship between gastrointestinal pH and release was not experimentally proven in vivo. This information will complete the in vivo release-profile of ColoPulse tablets. Materials and Methods Release from ColoPulse tablets was studied in 16 healthy volunteers using the dual label isotope strategy. To determine gastrointestinal pH profiles and transit times the IntelliCap system was used. A ColoPulse tablet containing C-13-urea and an uncoated, immediate release tablet containing N-15(2)-urea were taken simultaneously followed by a standardized breakfast after three hours. Five minutes after intake of the tablets the IntelliCap capsule was swallowed and pH was measured until excretion in the feces. Breath and urine samples were collected for isotope analysis. Results Full analysis could be performed in 12 subjects. Median bioavailability of C-13-urea was 82% (95% CI 74-94%, range 61-114%). The median lag time (5% release of C-13) was 5: 42 h (95% CI 5: 18-6: 18 h, range 2: 36-6: 36 h,) There was no statistically significant difference between lag time based on isotope signal and colon arrival time (CAT) based on pH (median 5: 42 vs 5: 31 h p = 0.903). In all subjects an intestinal pH value of 7.0 was reached before release of C-13 from the ColoPulse tablet occurred. Discussion and Conclusions From the combined data from the IntelliCap system and the C-13-isotope signal it can be concluded that release from a ColoPulse tablet in vivo is not related to transit times but occurs in the ileo-colonic region after pH 7.0 is reached. This supports our earlier findings and confirms that the ColoPulse system is a promising delivery system for targeting the distal ileum and colon.	[Maurer, Jacoba M.; Schellekens, Reinout C. A.; van Rieke, Helen M.; Kosterink, Jos G. W.] Univ Groningen, Univ Med Ctr Groningen, Dept Clin Pharm & Pharmacol, Groningen, Netherlands; [Wanke, Christoph; Iordanov, Ventzeslav] Medimetr Personalized Drug Delivery BV, Eindhoven, Netherlands; [Stellaard, Frans] Univ Groningen, Univ Med Ctr Groningen, Dept Lab Med, Groningen, Netherlands; [Wutzke, Klaus D.] Univ Rostock, Childrens Hosp, Res Lab Gastroenterol & Nutr, D-18055 Rostock, Germany; [Dijkstra, Gerard] Univ Groningen, Univ Med Ctr Groningen, Dept Gastroenterol & Hepatol, Groningen, Netherlands; [van der Zee, Margot; Woerdenbag, Herman J.; Frijlink, Henderik W.] Univ Groningen, Dept Pharm, Sect Pharmaceut Technol & Biopharm, Groningen, Netherlands; [Kosterink, Jos G. W.] Univ Groningen, Sect Pharmacotherapy & Pharmaceut Care, Dept Pharm, Groningen, Netherlands	University of Groningen; University of Groningen; University of Rostock; University of Groningen; University of Groningen; University of Groningen	Maurer, JM (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Clin Pharm & Pharmacol, Groningen, Netherlands.	m.maurer@umcg.nl	Woerdenbag, Herman/HDM-2961-2022; Frijlink, Henderik Willem/AAD-7382-2020	Frijlink, Henderik Willem/0000-0001-7901-8198; Kosterink, Jos/0000-0001-8358-765X; Woerdenbag, Herman/0000-0002-9450-5880; /0000-0003-4563-7462	Medimetrics Personalized Drug Delivery, Eindhoven, The Netherlands; IntelliCap systems	Medimetrics Personalized Drug Delivery, Eindhoven, The Netherlands; IntelliCap systems	Medimetrics Personalized Drug Delivery, Eindhoven, The Netherlands, provided support in the form of salaries for authors CW and VI and IntelliCap systems, but did not have any role in study design and decision to publish. The specific roles of these authors are articulated in the author contributions section.	DAVIS SS, 1986, GUT, V27, P886, DOI 10.1136/gut.27.8.886; EVANS DF, 1988, GUT, V29, P1035, DOI 10.1136/gut.29.8.1035; Ewe K, 1999, DIGEST DIS SCI, V44, P1434, DOI 10.1023/A:1026664105112; FALLINGBORG J, 1993, DIGEST DIS SCI, V38, P1989, DOI 10.1007/BF01297074; Fallingborg J, 1998, DIGEST DIS SCI, V43, P702, DOI 10.1023/A:1018893409596; FALLINGBORG J, 1989, ALIMENT PHARM THERAP, V3, P605; Koziolek M, 2015, J PHARM SCI-US, V104, P2855, DOI 10.1002/jps.24274; Lalezari D, 2012, ANN GASTROENTEROL, V25, P333; Maqbool S, 2009, DIGEST DIS SCI, V54, P2167, DOI 10.1007/s10620-009-0899-9; Maurer JM, 2013, J CONTROL RELEASE, V172, P618, DOI 10.1016/j.jconrel.2013.09.021; Maurer MJM, 2013, ISOT ENVIRON HEALT S, V49, P473, DOI 10.1080/10256016.2013.803099; Maurer MJM, 2012, PHARM RES-DORDR, V29, P2070, DOI 10.1007/s11095-012-0735-3; McConnell EL, 2009, J DRUG TARGET, V17, P335, DOI 10.1080/10611860902839502; MELDRUM SJ, 1972, BRIT MED J, V2, P104; Nugent SG, 2001, GUT, V48, P571, DOI 10.1136/gut.48.4.571; Press AG, 1998, ALIMENT PHARM THER, V12, P673; RAIMUNDO A H, 1992, Gastroenterology, V102, pA681; Rubin DT, 2009, GASTROENTEROLOGY S1, V136, pM1097; Sasaki Y, 1997, AM J GASTROENTEROL, V92, P114; Schellekens RCA, 2007, EUR J PHARM SCI, V30, P15, DOI 10.1016/j.ejps.2006.09.004; Schellekens RCA, 2010, J CONTROL RELEASE, V146, P334, DOI 10.1016/j.jconrel.2010.05.028; Schellekens RCA, 2009, BRIT J PHARMACOL, V158, P532, DOI 10.1111/j.1476-5381.2009.00302.x; Schellekens RCA, 2012, PHARM DEV TECHNOL, V17, P40, DOI 10.3109/10837450.2010.513986; Schiller C, 2005, ALIMENT PHARM THER, V22, P971, DOI 10.1111/j.1365-2036.2005.02683.x; Singh Brahma N, 2007, Recent Pat Drug Deliv Formul, V1, P53, DOI 10.2174/187221107779814122; van der Schaar PJ, 2013, GASTROINTEST ENDOSC, V78, P520, DOI 10.1016/j.gie.2013.03.170	27	53	56	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0129076	10.1371/journal.pone.0129076	http://dx.doi.org/10.1371/journal.pone.0129076			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177019	Green Submitted, Green Published, gold			2022-12-26	WOS:000358197600012
J	Perelygina, L; Adebayo, A; Metcalfe, M; Icenogle, J				Perelygina, Ludmila; Adebayo, Adebola; Metcalfe, Maureen; Icenogle, Joseph			Differences in Establishment of Persistence of Vaccine and Wild Type Rubella Viruses in Fetal Endothelial Cells	PLOS ONE			English	Article							UNKNOWINGLY PREGNANT-WOMEN; DOUBLE-STRANDED-RNA; NEGATIVE-STRAND; FOLLOW-UP; REPLICATION; INTERFERON; ELIMINATION; ANTIBODIES; AMERICA; MEASLES	Both wild type (WT) and vaccine rubella virus (RV) can pass through the placenta to infect a human fetus, but only wtRV routinely causes pathology. To investigate possible reasons for this, we compared establishment of persistence of wtRV and RA27/3 vaccine strains in fetal endothelial cells. We showed that yields of RA27/3 and wtRV were similar after the first round of replication, but then only vaccine-infected cultures went through a crisis characterized by partial cell loss and gradual decline of virus titer followed by recovery and establishment of persistent cultures with low levels of RA27/3 secretion. We compared various steps of virus replication, but we were unable to identify changes, which might explain the 2-log difference in RA27/3 and wtRV yields in persistently infected cultures. Whole genome sequencing did not reveal selection of virus variants in either the wtRV or RA27/3 cultures. Quantitative single-cell analysis of RV replication by in situ hybridization detected, on average, 1-4 copies of negative-strand RNA and similar to 50 copies of positive-strand genomic RNA in cells infected with both vaccine and WT viruses. The distinct characteristics of RA27/3 replication were the presence of large amounts of negative-strand RV RNA and RV dsRNA at the beginning of the crisis and the accumulation of high amounts of genomic RNA in a sub-population of infected cells during crisis and persistence. These results suggest that RA27/3 can persist in fetal endothelial cells, but the characteristics of persistence and mechanisms for the establishment and maintenance of persistence are different from wtRV.	[Perelygina, Ludmila; Adebayo, Adebola; Metcalfe, Maureen; Icenogle, Joseph] Ctr Dis Control & Prevent, Atlanta, GA 30329 USA	Centers for Disease Control & Prevention - USA	Icenogle, J (corresponding author), Ctr Dis Control & Prevent, Atlanta, GA 30329 USA.	jci1@cdc.gov		Perelygina, Ludmila/0000-0003-0812-8124	Centers for Disease Control and Prevention	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This work was supported by core funding from the Centers for Disease Control and Prevention. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abernathy E, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-32; Abernathy E, 2009, J CLIN MICROBIOL, V47, P182, DOI 10.1128/JCM.01231-08; [Anonymous], 2011, Wkly Epidemiol Rec, V86, P301; BANATVALA JE, 1981, LANCET, V1, P392; BERNSTEIN DI, 1980, J PEDIATR-US, V97, P467, DOI 10.1016/S0022-3476(80)80208-3; BOWDEN DS, 1985, J GEN VIROL, V66, P201, DOI 10.1099/0022-1317-66-1-201; Castillo-Solorzano C, 2011, J INFECT DIS, V204, pS713, DOI 10.1093/infdis/jir489; Castillo-Solorzano C, 2011, J INFECT DIS, V204, pS571, DOI 10.1093/infdis/jir472; Chen MH, 2007, J VIROL METHODS, V146, P414, DOI 10.1016/j.jviromet.2007.08.021; Sa GRDE, 2011, J INFECT DIS, V204, pS722, DOI 10.1093/infdis/jir408; Davidkin I, 2008, J INFECT DIS, V197, P950, DOI 10.1086/528993; Feng X, 2003, J VIROL, V77, P13389, DOI 10.1128/JVI.77.24.13389-13395.2003; Ginart P, 2014, NAT BIOTECHNOL, V32, P543, DOI 10.1038/nbt.2921; Hobman T. C., 2013, FIELDS VIROLOGY, P687; Hofmann J, 2000, J MED VIROL, V61, P155, DOI 10.1002/(SICI)1096-9071(200005)61:1&lt;155::AID-JMV25&gt;3.0.CO;2-O; Itzkovitz S, 2011, NAT METHODS, V8, pS12, DOI [10.1038/NMETH.1573, 10.1038/nmeth.1573]; Jumat MR, 2015, ANTIVIR RES, V114, P11, DOI 10.1016/j.antiviral.2014.11.007; Kaiser WJ, 2004, J IMMUNOL, V172, P1699, DOI 10.4049/jimmunol.172.3.1699; LEE JY, 1994, VIROLOGY, V200, P307, DOI 10.1006/viro.1994.1192; LERMAN SJ, 1981, PEDIATRICS, V68, P18; Liang YY, 2001, VIROLOGY, V282, P307, DOI 10.1006/viro.2001.0862; Mai JB, 2009, J VIROL, V83, P8553, DOI 10.1128/JVI.00056-09; MIFUNE K, 1970, Infection and Immunity, V2, P132; MIKI NPH, 1992, CLIN EXP RHEUMATOL, V10, P3; Papania MJ, 2014, JAMA PEDIATR, V168, P148, DOI 10.1001/jamapediatrics.2013.4342; Perelygina L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073014; Plotkin S., 2011, INFECT DIS FETUS NEW, P861; Plotkin S A, 1976, Dev Biol Stand, V37, P291; PLOTKIN SA, 1973, JAMA-J AM MED ASSOC, V225, P585, DOI 10.1001/jama.225.6.585; Pugachev KV, 1997, ARCH VIROL, V142, P1165, DOI 10.1007/s007050050150; Rowe R D, 1973, Cardiovasc Clin, V5, P61; Sato HK, 2011, J INFECT DIS, V204, pS737, DOI 10.1093/infdis/jir419; Schneider WM, 2014, ANN REV IMMUNOL; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Soares RC, 2011, J INFECT DIS, V204, pS729, DOI 10.1093/infdis/jir429; STANWICK TL, 1974, INFECT IMMUN, V10, P810, DOI 10.1128/IAI.10.4.810-815.1974; STRAUSS JH, 1994, MICROBIOL REV, V58, P491, DOI 10.1128/MMBR.58.3.491-562.1994; Tillieux SL, 2009, VACCINE, V27, P2265, DOI 10.1016/j.vaccine.2009.01.112; VAHERI A, 1969, J GEN VIROL, V5, P39, DOI 10.1099/0022-1317-5-1-39; Verhelst J, 2012, J VIROL, V86, P13445, DOI 10.1128/JVI.01682-12; VETRO S W, 1989, Fetal Therapy, V4, P82; Weber F, 2006, J VIROL, V80, P5059, DOI 10.1128/JVI.80.10.5059-5064.2006; Woods MW, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-95	43	5	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0133267	10.1371/journal.pone.0133267	http://dx.doi.org/10.1371/journal.pone.0133267			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177032	Green Published, gold, Green Submitted			2022-12-26	WOS:000358197600237
J	Polgar, Z; Miklosi, A; Gacsi, M				Polgar, Zita; Miklosi, Adam; Gacsi, Marta			Strategies Used by Pet Dogs for Solving Olfaction-Based Problems at Various Distances	PLOS ONE			English	Article							ENVIRONMENTAL-FACTORS; CANIS-FAMILIARIS; SEARCH BEHAVIOR; SPATIAL MEMORY; EFFICACY; ODOR; CUES	The olfactory acuity of domestic dogs has been well established through numerous studies on trained canines, however whether untrained dogs spontaneously utilize this ability for problem solving is less clear. In the present paper we report two studies that examine what strategies family dogs use in two types of olfaction-based problems as well as their success at various distances. In Study 1, thirty dogs were tasked with distinguishing a target, either their covered owner (Exp 1) or baited food (Exp 2), from three visually identical choices at distances of 0m (touching distance), 1m, and 3m. There were nine consecutive trials for each target. We found that in Exp 1 the dogs successfully chose their owners over strangers at 0m and 1m, but not at 3m, where they used a win-stay strategy instead. In Exp 2 the dogs were only successful in choosing the baited pot at 0m. They used the win-stay strategy at 1m, but chose randomly at 3m. In Study 2, a different group of dogs was tested with their owners (Exp 1) and baited food (Exp 2) at just the 3m distance with two possible targets in 10-10 trials. In Exp 1 the dogs' overall performance was at chance level; however, when analyzed by trial, we noticed that despite tending to find their owners on the first trial, they generally switched to a win-stay strategy in subsequent trials, only to return to correctly choosing their owners based on olfaction in the later trials. In Exp 2, the dogs chose randomly throughout. We also found that dogs who relied on visual information in the warm-up trials were less successful in the olfaction-based test. Our results suggest that despite their ability to successfully collect information through olfaction, family dogs often prioritize other strategies to solve basic choice tasks.	[Polgar, Zita; Miklosi, Adam] Eotvos Lorand Univ, Dept Ethol, Budapest, Hungary; [Miklosi, Adam; Gacsi, Marta] MTA ELTE Comparat Ethol Res Grp, Budapest, Hungary	Eotvos Lorand University; MTA-ELTE Comparative Ethology Research Group	Polgar, Z (corresponding author), Eotvos Lorand Univ, Dept Ethol, Budapest, Hungary.	zita@polgarweb.com	Miklosi, Adam/N-5147-2017	Miklosi, Adam/0000-0003-4831-8985; Gacsi, Marta/0000-0003-3080-7545	Hungarian Academy of Sciences [MTA 01 031]; Hungarian Scientific Research Fund [OTKA K 100695/ K 84036]	Hungarian Academy of Sciences(Hungarian Academy of Sciences); Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	The research was supported by the Hungarian Academy of Sciences (MTA 01 031) (http://mta.hu/english/) and Hungarian Scientific Research Fund (OTKA K 100695/ K 84036) (http://www.otka.hu/en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashton R, 2009, J VET BEHAV, V4, P50; Bijland LR, 2013, NETH J MED, V71, P300; Brauer J, 2006, J COMP PSYCHOL, V120, P38, DOI 10.1037/0735-7036.120.1.38; Cablk ME, 2008, SENSORS-BASEL, V8, P2208, DOI 10.3390/s8042208; Dumas C, 1998, BEHAV PROCESS, V42, P101, DOI 10.1016/S0376-6357(97)00071-5; FENTON V, 1992, J WILDERNESS MED, V3, P292, DOI 10.1580/0953-9859-3.3.292; Furton KG, 2001, TALANTA, V54, P487, DOI 10.1016/S0039-9140(00)00546-4; Gacsi M, 2009, ANIM COGN, V12, P471, DOI 10.1007/s10071-008-0208-6; GAGNON S, 1992, J COMP PSYCHOL, V106, P58, DOI 10.1037/0735-7036.106.1.58; Gazit I, 2003, APPL ANIM BEHAV SCI, V82, P65, DOI 10.1016/S0168-1591(03)00051-0; Hare B, 1999, J COMP PSYCHOL, V113, P173, DOI 10.1037/0735-7036.113.2.173; Horowitz A, 2013, LEARN MOTIV, V44, P207, DOI 10.1016/j.lmot.2013.02.002; Jezierski T, 2014, FORENSIC SCI INT, V237, P112, DOI 10.1016/j.forsciint.2014.01.013; Kerepesi A, 2014, DOGS THEIR HUMAN COM; Lakatos G, 2012, ANIM COGN, V15, P201, DOI 10.1007/s10071-011-0446-x; Macpherson K, 2010, J COMP PSYCHOL, V124, P47, DOI 10.1037/a0018084; Miklosi A, 1998, Anim Cogn, V1, P113, DOI 10.1007/s100710050016; Miklosi A, 2006, ANIM COGN, V9, P81, DOI 10.1007/s10071-005-0008-1; Panzacchi M, 2009, J ANIM ECOL, V78, P1124, DOI 10.1111/j.1365-2656.2009.01584.x; Plourde V, 2013, LEARN MOTIV, V44, P282, DOI 10.1016/j.lmot.2013.03.004; Pongracz P, 2013, ANIM COGN, V16, P721, DOI 10.1007/s10071-013-0607-1; Reed SE, 2011, J WILDLIFE MANAGE, V75, P243, DOI 10.1002/jwmg.8; Rolland Rosalind M., 2006, Journal of Cetacean Research and Management, V8, P121; Salvin HE, 2011, J EXP ANAL BEHAV, V95, P109, DOI 10.1901/jeab.2011.95-109; Shivik JA, 2002, WILDLIFE SOC B, V30, P721; SONERUD GA, 1985, OIKOS, V44, P287, DOI 10.2307/3544702; Szetei V, 2003, APPL ANIM BEHAV SCI, V83, P141, DOI 10.1016/S0168-1591(03)00114-X; Udell MAR, 2008, ANIM BEHAV, V76, P1767, DOI 10.1016/j.anbehav.2008.07.028; Udell MAR, 2010, ANIM BEHAV, V79, pE9, DOI 10.1016/j.anbehav.2009.11.033; Wells DL, 2003, APPL ANIM BEHAV SCI, V84, P297, DOI 10.1016/j.applanim.2003.08.009	30	22	23	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0131610	10.1371/journal.pone.0131610	http://dx.doi.org/10.1371/journal.pone.0131610			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176609	Green Published, gold, Green Submitted			2022-12-26	WOS:000358197600052
J	Puxty, RJ; Perez-Sepulveda, B; Rihtman, B; Evans, DJ; Millard, AD; Scanlan, DJ				Puxty, Richard J.; Perez-Sepulveda, Blanca; Rihtman, Branko; Evans, David J.; Millard, Andrew D.; Scanlan, David J.			Spontaneous Deletion of an "ORFanage" Region Facilitates Host Adaptation in a "Photosynthetic" Cyanophage	PLOS ONE			English	Article							MARINE VIRUSES; ANTAGONISTIC COEVOLUTION; T4-LIKE MYOVIRUSES; SYNECHOCOCCUS; GENOME; GENES; BACTERIOPHAGE; EVOLUTION; CASSETTES; FITNESS	Viruses have been suggested to be the largest source of genetic diversity on Earth. Genome sequencing and metagenomic surveys reveal that novel genes with unknown functions are abundant in viral genomes. Yet few observations exist for the processes and frequency by which these genes are gained and lost. The surface waters of marine environments are dominated by marine picocyanobacteria and their co-existing viruses (cyanophages). Recent genome sequencing of cyanophages has revealed a vast array of genes that have been acquired from their cyanobacterial hosts. Here, we re-sequenced the cyanophage S-PM2 genome after 10 years of near continuous passage through its marine Synechococcus host. During this time a spontaneous mutant (S-PM2d) lacking 13% of the S-PM2 ORFs became dominant in the cyanophage population. These ORFs are found at one loci and are not homologous to any proteins in any other sequenced organism (ORFans). We demonstrate a fitness cost to S-PM2(WT) associated with possession of these ORFs under standard laboratory growth. Metagenomic surveys reveal these ORFs are present in various aquatic environments, are likely of cyanophage origin and appear to be enriched in environments from the extremes of salinity (freshwater and hypersaline). We posit that these ORFs contribute to the flexible gene content of cyanophages and offer a distinct fitness advantage in freshwater and hypersaline environments.	[Puxty, Richard J.; Perez-Sepulveda, Blanca; Rihtman, Branko; Evans, David J.; Scanlan, David J.] Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England; [Millard, Andrew D.] Univ Warwick, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England	University of Warwick; University of Warwick	Scanlan, DJ (corresponding author), Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England.	D.J.Scanlan@warwick.ac.uk	Evans, David/C-7553-2012; Scanlan, David J/G-4080-2016; Perez-Sepulveda, Blanca/R-9410-2017	Scanlan, David J/0000-0003-3093-4245; Perez-Sepulveda, Blanca/0000-0002-2891-4010; Rihtman, Branko/0000-0002-3226-5500; Evans, David J./0000-0002-1315-4258	National Environment Research Council Studentship; Warwick University Chancellors International Scholarship; Natural Environment Research Council [NE/J02273X/1, NBAF010002] Funding Source: researchfish; NERC [NE/J02273X/1, NBAF010002] Funding Source: UKRI	National Environment Research Council Studentship; Warwick University Chancellors International Scholarship; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Funding for this work was provided by National Environment Research Council Studentship (http://www.nerc.ac.uk/) to RJP, Warwick University Chancellors International Scholarship (http://www2.warwick.ac.uk/services/academicoffice/gsp/scholarship/typesoffunding/chancellorsinternational/) to BPS, and Warwick University Chancellors International Scholarship (http://www2.warwick.ac.uk/services/academicoffice/gsp/scholarship/typesoffunding/chancellorsinternational/) to BR.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Alam TI, 2008, MOL MICROBIOL, V69, P1180, DOI 10.1111/j.1365-2958.2008.06344.x; Arbiol C, 2010, GENOME BIOL EVOL, V2, P140, DOI 10.1093/gbe/evq006; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Barrick JE, 2009, NATURE, V461, P1243, DOI 10.1038/nature08480; Bragg JG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003550; Breitbart M, 2007, OCEANOGRAPHY, V20, P135, DOI 10.5670/oceanog.2007.58; Buckling A, 2002, P ROY SOC B-BIOL SCI, V269, P931, DOI 10.1098/rspb.2001.1945; Casjens Sherwood R., 2009, V502, P91, DOI 10.1007/978-1-60327-565-1_7; Clokie MRJ, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-291; Clokie Martha Rj, 2011, Bacteriophage, V1, P31, DOI 10.4161/bact.1.1.14942; Comeau AM, 2014, GENOME BIOL EVOL, V6, P1611, DOI 10.1093/gbe/evu129; Enav H, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-9; Flombaum P, 2013, P NATL ACAD SCI USA, V110, P9824, DOI 10.1073/pnas.1307701110; GROSSI GF, 1983, Z NATURFORSCH C, V38, P294; Hatfull GF, 2010, J MOL BIOL, V397, P119, DOI 10.1016/j.jmb.2010.01.011; Hellweger FL, 2009, ENVIRON MICROBIOL, V11, P1386, DOI 10.1111/j.1462-2920.2009.01866.x; Hyman Paul, 2009, V501, P175, DOI 10.1007/978-1-60327-164-6_18; Ignacio-Espinoza J Cesar, 2013, Curr Opin Virol, V3, P566, DOI 10.1016/j.coviro.2013.07.004; Ignacio-Espinoza JC, 2012, ENVIRON MICROBIOL, V14, P2113, DOI 10.1111/j.1462-2920.2012.02704.x; Joshi N. A., 2011, SICKLE SLIDING WINDO; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li SF, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0097189, 10.1371/journal.pone.0085806]; Lin HC, 1998, VIROLOGY, V242, P118, DOI 10.1006/viro.1997.9019; Mann NH, 2005, J BACTERIOL, V187, P3188, DOI 10.1128/JB.187.9.3188-3200.2005; Mann NH, 2003, NATURE, V424, P741, DOI 10.1038/424741a; Marston MF, 2012, P NATL ACAD SCI USA, V109, P4544, DOI 10.1073/pnas.1120310109; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Martiny JBH, 2014, ANNU REV MAR SCI, V6, P393, DOI 10.1146/annurev-marine-010213-135108; Millard AD, 2009, ENVIRON MICROBIOL, V11, P2370, DOI 10.1111/j.1462-2920.2009.01966.x; Miller ES, 2003, MICROBIOL MOL BIOL R, V67, P86, DOI 10.1128/MMBR.67.1.86-156.2003; Philosof A, 2011, ISME J, V5, P1568, DOI 10.1038/ismej.2011.43; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Sharon I, 2011, ISME J, V5, P1178, DOI 10.1038/ismej.2011.2; Sharon I, 2009, NATURE, V461, P258, DOI 10.1038/nature08284; Sullivan MB, 2010, ENVIRON MICROBIOL, V12, P3035, DOI 10.1111/j.1462-2920.2010.02280.x; Suttle CA, 2007, NAT REV MICROBIOL, V5, P801, DOI 10.1038/nrmicro1750; Thompson LR, 2011, P NATL ACAD SCI USA, V108, pE757, DOI 10.1073/pnas.1102164108; Wilhelm SW, 1999, BIOSCIENCE, V49, P781, DOI 10.2307/1313569; WYMAN M, 1985, SCIENCE, V230, P818, DOI 10.1126/science.230.4727.818; Zeng QL, 2012, CURR BIOL, V22, P124, DOI 10.1016/j.cub.2011.11.055	43	8	8	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132642	10.1371/journal.pone.0132642	http://dx.doi.org/10.1371/journal.pone.0132642			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177354	Green Published, Green Submitted, gold			2022-12-26	WOS:000358197600136
J	Sarachana, T; Dahiya, N; Simhadri, VL; Pandey, GS; Saini, S; Guelcher, C; Guerrera, MF; Kimchi-Sarfaty, C; Sauna, ZE; Atreya, CD				Sarachana, Tewarit; Dahiya, Neetu; Simhadri, Vijaya L.; Pandey, Gouri Shankar; Saini, Surbhi; Guelcher, Christine; Guerrera, Michael F.; Kimchi-Sarfaty, Chava; Sauna, Zuben E.; Atreya, Chintamani D.			Small ncRNA Expression-Profiling of Blood from Hemophilia A Patients Identifies miR-1246 as a Potential Regulator of Factor 8 Gene	PLOS ONE			English	Article							FACTOR-VIII; MUTATION; MICRORNAS; RNAS	Hemophilia A (HA) is a bleeding disorder caused by deficiency of functional plasma clotting factor VIII (FVIII). Genetic mutations in the gene encoding FVIII (F8) have been extensively studied. Over a thousand different mutations have been reported in the F8 gene. These span a diverse range of mutation types, namely, missense, splice-site, deletions of single and multiple exons, inversions, etc. There is nonetheless evidence that other molecular mechanisms, in addition to mutations in the gene encoding the FVIII protein, may be involved in the pathobiology of HA. In this study, global small ncRNA expression profiling analysis of whole blood from HA patients, and controls, was performed using high-throughput ncRNA microarrays. Patients were further sub-divided into those that developed neutralizing-anti-FVIII antibodies (inhibitors) and those that did not. Selected differentially expressed ncRNAs were validated by quantitative reverse transcription-polymerase chain reaction (qRT-PCR) analysis. We identified several ncRNAs, and among them hsa-miR-1246 was significantly up-regulated in HA patients. In addition, miR-1246 showed a six-fold higher expression in HA patients without inhibitors. We have identified an miR-1246 target site in the noncoding region of F8 mRNA and were able to confirm the suppressory role of hsa-miR-1246 on F8 expression in a stable lymphoblastoid cell line expressing FVIII. These findings suggest several testable hypotheses vis-a-vis the role of nc-RNAs in the regulation of F8 expression. These hypotheses have not been exhaustively tested in this study as they require carefully curated clinical samples.	[Sarachana, Tewarit; Dahiya, Neetu; Atreya, Chintamani D.] US FDA, Lab Cellular Hematol, Div Hematol Res & Review, Ctr Biol Evaluat & Res, Silver Spring, MD 20993 USA; [Sarachana, Tewarit] Chulalongkorn Univ, Fac Allied Hlth Sci, Dept Clin Chem, Bangkok 10330, Thailand; [Simhadri, Vijaya L.; Pandey, Gouri Shankar; Saini, Surbhi; Kimchi-Sarfaty, Chava; Sauna, Zuben E.] US FDA, Lab Hemostasis, Div Hematol Res & Review, Ctr Biol Evaluat & Res, Silver Spring, MD 20993 USA; [Saini, Surbhi; Guelcher, Christine; Guerrera, Michael F.] Childrens Natl Med Ctr, Ctr Canc & Blood Disorders, Washington, DC 20010 USA; [Guerrera, Michael F.] George Washington Univ, Sch Med & Hlth Sci, Washington, DC 20037 USA	US Food & Drug Administration (FDA); Chulalongkorn University; US Food & Drug Administration (FDA); Children's National Health System; George Washington University	Sauna, ZE (corresponding author), US FDA, Lab Hemostasis, Div Hematol Res & Review, Ctr Biol Evaluat & Res, Silver Spring, MD 20993 USA.	zuben.sauna@fda.hhs.gov; chintamani.atreya@fda.hhs.gov	Sauna, Zuben E./AAA-7149-2019; Saini, Surbhi/HCH-3424-2022	Guelcher, Christine/0000-0001-9226-2347; Kimchi-Sarfaty, Chava/0000-0002-9355-8585	Center for Cancer and Blood Disorders, Children's National Medical Center, Washington, D. C; CBER, FDA intramural funding	Center for Cancer and Blood Disorders, Children's National Medical Center, Washington, D. C; CBER, FDA intramural funding	Research conducted in the laboratories of CDA and ZES is funded by the CBER, FDA intramural funding. SS received a fellowship from the Center for Cancer and Blood Disorders, Children's National Medical Center, Washington, D. C.	Bachellerie JP, 2002, BIOCHIMIE, V84, P775, DOI 10.1016/S0300-9084(02)01402-5; Bloem E, 2012, J BIOL CHEM, V287, P5775, DOI 10.1074/jbc.M111.308627; Bolton-Maggs PHB, 2003, LANCET, V361, P1801, DOI 10.1016/S0140-6736(03)13405-8; Chang TR, 2014, CLIN APPL THROMB-HEM, V20, P124, DOI 10.1177/1076029613488936; Chen K, 2007, NAT REV GENET, V8, P93, DOI 10.1038/nrg1990; Chu TM, 2002, MATH BIOSCI, V176, P35, DOI 10.1016/S0025-5564(01)00107-9; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gouw SC, 2012, BLOOD, V119, P2922, DOI 10.1182/blood-2011-09-379453; Graw J, 2005, NAT REV GENET, V6, P488, DOI 10.1038/nrg1617; Hwang Sung Ho, 2011, Korean J Hematol, V46, P49, DOI 10.5045/kjh.2011.46.1.49; Kim J, 2007, SCIENCE, V317, P1220, DOI 10.1126/science.1140481; KOSTER T, 1995, LANCET, V345, P152, DOI 10.1016/S0140-6736(95)90166-3; Kraaijenhagen RA, 2000, THROMB HAEMOSTASIS, V83, P5; Lillicrap D, 2010, CURR OPIN HEMATOL, V17, P393, DOI 10.1097/MOH.0b013e32833c06c6; Matera AG, 2007, NAT REV MOL CELL BIO, V8, P209, DOI 10.1038/nrm2124; ODonnell J, 1997, THROMB HAEMOSTASIS, V77, P825; Pandey GS, 2013, NAT MED, V19, P1318, DOI 10.1038/nm.3270; Payne AB, 2013, HUM MUTAT, V34, pE2382, DOI 10.1002/humu.22247; Pezeshkpoor B, 2013, J THROMB HAEMOST, V11, P1679, DOI 10.1111/jth.12339; Quackenbush J, 2002, NAT GENET, V32, P496, DOI 10.1038/ng1032; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sethupathy P, 2008, TRENDS GENET, V24, P489, DOI 10.1016/j.tig.2008.07.004; Summers RJ, 2011, BLOOD, V117, P3190, DOI 10.1182/blood-2010-09-307074; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wight J, 2003, HAEMOPHILIA, V9, P418, DOI 10.1046/j.1365-2516.2003.00780.x	25	18	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132433	10.1371/journal.pone.0132433	http://dx.doi.org/10.1371/journal.pone.0132433			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176629	Green Published, gold, Green Submitted			2022-12-26	WOS:000358197600112
J	Subramanian, N; Kanwar, JR; Kanwar, RK; Sreemanthula, J; Biswas, J; Khetan, V; Krishnakumar, S				Subramanian, Nithya; Kanwar, Jagat R.; Kanwar, Rupinder K.; Sreemanthula, JagadeeshBabu; Biswas, Jyotirmay; Khetan, Vikas; Krishnakumar, Subramanian			EpCAM Aptamer-siRNA Chimera Targets and Regress Epithelial Cancer	PLOS ONE			English	Article							CELL ADHESION MOLECULE; DRUG-DELIVERY; BREAST-CANCER; RNA MOLECULES; STEM-CELLS; IN-VITRO; RETINOBLASTOMA; SELECTION; THERAPY; DNA	Epithelial cell adhesion molecule (EpCAM), a cancer stem cell (CSC) marker is over expressed in epithelial cancers and in retinoblastoma (RB). We fabricated an EpCAM targeting aptamer-siRNA chimera and investigated its anti-tumor property and EpCAM intracellular domain (EpICD) mediated signaling in epithelial cancer. The anti-tumor efficacy of EpCAM aptamer-siEpCAM chimera (EpApt-siEp) was evaluated by qPCR, northern and Western blotting in WERI-Rb1-RB cell line, primary RB tumor cells and in MCF7-breast cancer cell line. Anti-tumor activity of EpApt-siEp was studied in vivo using epithelial cancer (MCF7) mice xenograft model. The mechanism and pathways involved in the anti-tumor activity was further studied using protein arrays and qPCR. EpApt-siEp chimera was processed in vitro by dicer enzyme. Treatment of the WERI-Rb1 and MCF7 cells with EpApt-siEp revealed statistically significant down regulation of EpCAM expression (P<0.005) and concomitant reduction in cellular proliferation. In primary RB cells cultured from RB tumors, EpApt-siEp silenced EpCAM, significantly inhibited (P<0.01) cell proliferation and induced cytotoxicity. Knockdown of EpICD expressed in RB primary tumors led to repression of pluripotency markers, SOX2, OCT4, NANOG, and CD133. In vivo studies showed complete tumor growth regression without any toxicity in animals (P<0.001) and tumor tissues showed significant downregulation (P<0.05) of EpCAM, MRP1, ABCG2, stathmin, survivin and upregulation of ATM (P<0.05) leading to apoptosis by intrinsic pathway with minor alteration in cytokines. Our results revealed that EpApt-siEp potentially eradicated EpCAM positive cancer cells through CSC marker suppression and apoptosis, while sparing normal EpCAM negative adjacent cells.	[Subramanian, Nithya; Krishnakumar, Subramanian] Kamalnayan Bajaj Inst Res Vis & Ophthalmol, Vis Res Fdn, Dept Nanobiotechnol, Madras, Tamil Nadu, India; [Subramanian, Nithya; Kanwar, Jagat R.; Kanwar, Rupinder K.] Deakin Univ, Fac Hlth, Nanomed Lab Immunol & Mol Biomed Res, Ctr Mol & Med Res,Sch Med SoM, Geelong, Vic 3217, Australia; [Sreemanthula, JagadeeshBabu; Biswas, Jyotirmay; Krishnakumar, Subramanian] Vis Res Fdn, L&T Ocular Pathol Dept, Kamalnayan Bajaj Inst Res Vis & Ophthalmol, Chennai, Tamil Nadu, India; [Khetan, Vikas] Sankara Nethralaya, Med Res Fdn, Dept Ocular Oncol & Vitreoretina, Chennai, Tamil Nadu, India	Deakin University	Kanwar, JR (corresponding author), Deakin Univ, Fac Hlth, Nanomed Lab Immunol & Mol Biomed Res, Ctr Mol & Med Res,Sch Med SoM, Geelong, Vic 3217, Australia.	jagat.kanwar@deakin.edu.au; drkrishnakumar_2000@yahoo.com		Khetan, Vikas/0000-0003-4396-9877	Department of Biotechnology- Indo-Australian grant [BT/Indo-Aus/06/08/2011]; Department of Biotechnology- COE-Grant [BT/01/CE1B/11/V/16];  [BARC-2010/35/19/BRNS]	Department of Biotechnology- Indo-Australian grant; Department of Biotechnology- COE-Grant; 	This work was supported by BARC-2010/35/19/BRNS and in part from Department of Biotechnology- Indo-Australian grant- BT/Indo-Aus/06/08/2011 and COE-Grant BT/01/CE1B/11/ V/16-programme support on RB.	Angele S, 2000, CLIN CANCER RES, V6, P3536; Baeuerle PA, 2007, BRIT J CANCER, V96, P417, DOI 10.1038/sj.bjc.6603494; Bagalkot V, 2011, ACS NANO, V5, P8131, DOI 10.1021/nn202772p; Bellaousov S, 2013, NUCLEIC ACIDS RES, V41, pW471, DOI 10.1093/nar/gkt290; Bruno JG, 2013, PHARMACEUTICALS, V6, P340, DOI 10.3390/ph6030340; Dassie JP, 2009, NAT BIOTECHNOL, V27, P839, DOI 10.1038/nbt.1560; Davidson BL, 2006, NAT BIOTECHNOL, V24, P951, DOI 10.1038/nbt0806-951; Dranoff G, 2004, NAT REV CANCER, V4, P11, DOI 10.1038/nrc1252; Du WQ, 2009, J CANCER RES CLIN, V135, P1277, DOI 10.1007/s00432-009-0569-5; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Germer Katherine, 2013, Int J Biochem Mol Biol, V4, P27; Gires O, 2009, NAT REV CANCER, V9, P143, DOI 10.1038/nrc2499-c1; Gonzalez B, 2009, STEM CELLS, V27, P1782, DOI 10.1002/stem.97; Kandalam MM, 2012, MOL VIS, V18, P2279; Kanwar JR, 2014, DRUG DISCOV TODAY, V19, P1309, DOI 10.1016/j.drudis.2014.02.009; Kanwar JR, 2011, CRIT REV BIOCHEM MOL, V46, P459, DOI 10.3109/10409238.2011.614592; Krishnakumar S, 2004, INVEST OPHTH VIS SCI, V45, P4247, DOI 10.1167/iovs.04-0591; Kwiatt ME, 2012, J TRAUMA ACUTE CARE, V73, P625, DOI 10.1097/TA.0b013e318265cab9; Li LY, 2014, BIOMATERIALS, V35, P3840, DOI 10.1016/j.biomaterials.2014.01.019; Liu HY, 2013, SCI REP-UK, V3, DOI 10.1038/srep03129; Lu TY, 2010, J BIOL CHEM, V285, P8719, DOI 10.1074/jbc.M109.077081; Maetzel D, 2009, NAT CELL BIOL, V11, P162, DOI 10.1038/ncb1824; Marton S, 2010, MOLECULES, V15, P4610, DOI 10.3390/molecules15074610; Mitra M, 2012, MOL VIS, V18, P290; Mitra M, 2010, MOL VIS, V16, P828; Munz M, 2009, CANCER RES, V69, P5627, DOI 10.1158/0008-5472.CAN-09-0654; Ogura E, 1998, ANTICANCER RES, V18, P3669; Osta WA, 2004, CANCER RES, V64, P5818, DOI 10.1158/0008-5472.CAN-04-0754; Salomon J, 2014, HUM GENET, V133, P299, DOI 10.1007/s00439-013-1380-6; Schmidt M, 2010, ANN ONCOL, V21, P275, DOI 10.1093/annonc/mdp314; Schnell U, 2013, BIOSCIENCE REP, V33, P321, DOI 10.1042/BSR20120128; Semple JI, 2007, CELL DEATH DIFFER, V14, P1433, DOI 10.1038/sj.cdd.4402134; Shigdar S, 2013, CANCER LETT, V330, P84, DOI 10.1016/j.canlet.2012.11.032; Shigdar S, 2011, CANCER SCI, V102, P991, DOI 10.1111/j.1349-7006.2011.01897.x; Simon M, 2013, EXPERT OPIN DRUG DEL, V10, P451, DOI 10.1517/17425247.2013.759938; Singh S, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-73; Somasunderam A, 2010, BIOCHEMISTRY-US, V49, P9106, DOI 10.1021/bi1009503; Song KM, 2012, SENSORS-BASEL, V12, P612, DOI 10.3390/s120100612; Song LB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025454; Song YL, 2013, ANAL CHEM, V85, P4141, DOI 10.1021/ac400366b; Subramanian N, 2015, J BIOMED SCI, V22, DOI 10.1186/s12929-014-0108-9; Subramanian N, 2014, CHEM COMMUN, V50, P11810, DOI 10.1039/c4cc02996h; Subramanian N, 2012, MOL VIS, V18, P2783; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; van der Gun BTF, 2010, CARCINOGENESIS, V31, P1913, DOI 10.1093/carcin/bgq187; Vermeulen A, 2005, RNA, V11, P674, DOI 10.1261/rna.7272305; Wang CS, 2006, ANN CLIN LAB SCI, V36, P23; Wong RSY, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-87; Zhou Jiehua, 2010, Silence, V1, P4, DOI 10.1186/1758-907X-1-4; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	50	29	32	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132407	10.1371/journal.pone.0132407	http://dx.doi.org/10.1371/journal.pone.0132407			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176230	Green Published, gold			2022-12-26	WOS:000358197600110
J	Ashraf, MI; Meng, FR; Bourque, CPA; MacLean, DA				Ashraf, M. Irfan; Meng, Fan-Rui; Bourque, Charles P. -A.; MacLean, David A.			A Novel Modelling Approach for Predicting Forest Growth and Yield under Climate Change	PLOS ONE			English	Article							TRANSIENT-RESPONSE; POTENTIAL IMPACTS; NOVA-SCOTIA; ECOSYSTEM; MANAGEMENT	Global climate is changing due to increasing anthropogenic emissions of greenhouse gases. Forest managers need growth and yield models that can be used to predict future forest dynamics during the transition period of present-day forests under a changing climatic regime. In this study, we developed a forest growth and yield model that can be used to predict individual-tree growth under current and projected future climatic conditions. The model was constructed by integrating historical tree growth records with predictions from an ecological process-based model using neural networks. The new model predicts basal area (BA) and volume growth for individual trees in pure or mixed species forests. For model development, tree-growth data under current climatic conditions were obtained using over 3000 permanent sample plots from the Province of Nova Scotia, Canada. Data to reflect tree growth under a changing climatic regime were projected with JABOWA-3 (an ecological process-based model). Model validation with designated data produced model efficiencies of 0.82 and 0.89 in predicting individual-tree BA and volume growth. Model efficiency is a relative index of model performance, where 1 indicates an ideal fit, while values lower than zero means the predictions are no better than the average of the observations. Overall mean prediction error (BIAS) of basal area and volume growth predictions was nominal (i.e., for BA: -0.0177 cm(2) 5-year(-1) and volume: 0.0008 m(3) 5-year(-1)). Model variability described by root mean squared error (RMSE) in basal area prediction was 40.53 cm(2) 5-year(-1) and 0.0393 m(3) 5-year(-1) in volume prediction. The new modelling approach has potential to reduce uncertainties in growth and yield predictions under different climate change scenarios. This novel approach provides an avenue for forest managers to generate required information for the management of forests in transitional periods of climate change. Artificial intelligence technology has substantial potential in forest modelling.	[Ashraf, M. Irfan] Arid Agr Univ, Fac Forestry Range Management & Wildlife, Rawalpindi 46300, Pakistan; [Ashraf, M. Irfan; Meng, Fan-Rui; Bourque, Charles P. -A.; MacLean, David A.] Univ New Brunswick, Fac Forestry & Environm Management, Fredericton, NB E3B 5A3, Canada	University of New Brunswick	Ashraf, MI (corresponding author), Arid Agr Univ, Fac Forestry Range Management & Wildlife, Murree Rd, Rawalpindi 46300, Pakistan.	irfan.ashraf@unb.ca	Bond-Lamberty, Benjamin/C-6058-2008; MacLean, David A/G-6011-2011; Ashraf, Irfan M./AAW-6619-2020	Bond-Lamberty, Benjamin/0000-0001-9525-4633; MacLean, David A/0000-0002-0314-4435; Ashraf, Irfan M./0000-0003-4794-3754	Higher Education Commission of Pakistan; Natural Sciences and Engineering Research Council of Canada (NSERC)	Higher Education Commission of Pakistan(Higher Education Commission of Pakistan); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	The financial support to Dr. M. Irfan Ashraf for his doctoral studies at the University of New Brunswick (UNB), Canada was provided by Higher Education Commission of Pakistan. The partial funding for this study was provided by Natural Sciences and Engineering Research Council of Canada (NSERC) to Fan-Rui Meng and Charles P.-A. Bourque. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agriculture and Agri-Food Canada, 2013, PLANT HARD ZON CAN; Andreassen K, 2003, FOREST ECOL MANAG, V180, P11, DOI 10.1016/S0378-1127(02)00560-1; [Anonymous], 2000, SPECIAL REPORT EMISS; Ashraf MI, 2015, MITIG ADAPT STRAT GL, V20, P159, DOI 10.1007/s11027-013-9484-9; Ashraf MI, 2013, CAN J FOREST RES, V43, P1162, DOI 10.1139/cjfr-2013-0090; Ashraf MI, 2012, FOREST CHRON, V88, P708, DOI 10.5558/tfc2012-137; Beale M.H., 2010, THE MATHWORKS; Beale MH, 2012, NEURAL NETWORK TOOLB; Botkin D.B., 1993, FOREST DYNAMICS ECOL; Botkin DB, 2007, BIOSCIENCE, V57, P227, DOI 10.1641/B570306; Bourque C.P.A., 2010, MODELLED POTENTIAL S; Bourque CPA, 2000, CAN J FOREST RES, V30, P1179, DOI 10.1139/cjfr-30-8-1179; Bugmann H, 2001, CLIMATIC CHANGE, V51, P249, DOI 10.1023/A:1012512102489; Bugmann H, 2001, CLIMATIC CHANGE, V51, P259, DOI 10.1023/A:1012525626267; BURKHART HE, 1994, FOREST MEASUREMENTS; Crookston NL, 2010, FOREST ECOL MANAG, V260, P1198, DOI 10.1016/j.foreco.2010.07.013; DALE VH, 1989, CAN J FOREST RES, V19, P1581, DOI 10.1139/x89-240; Dessai S., 2007, NWSE2007198 UTR U CO; Ehman JL, 2002, FOREST ECOL MANAG, V155, P237, DOI 10.1016/S0378-1127(01)00561-8; Environment Canada, 2014, CAN CTR CLIM MOD AN; Froese RE, 2007, CAN J FOREST RES, V37, P1438, DOI 10.1139/X07-002; Garcia-Gonzalo J, 2007, FOREST ECOL MANAG, V241, P243, DOI 10.1016/j.foreco.2007.01.008; Hamann A, 2006, ECOLOGY, V87, P2773, DOI 10.1890/0012-9658(2006)87[2773:PEOCCO]2.0.CO;2; Harkonen S, 2010, FOREST ECOL MANAG, V259, P573, DOI 10.1016/j.foreco.2009.11.015; Higgins J, 2011, THESIS DALHOUSIE U H; Honer T.G, 1983, MX140 MAR FOR RES CT; IPCC, 2007, CLIM CHANG PHYS SCI; IPCC-TGICA, 2007, GEN GUID US SCEN DAT; Iyer MS, 1999, IEEE T NEURAL NETWOR, V10, P427, DOI 10.1109/72.750573; Johnsen K, 2001, FOREST SCI, V47, P2; Keller T, 1997, J BIOGEOGR, V24, P857, DOI 10.1046/j.1365-2699.1997.00140.x; Kimmins J.P., 2004, FOREST ECOLOGY FDN S, V3rd; KIMMINS JP, 1990, FOREST CHRON, V66, P271, DOI 10.5558/tfc66271-3; Korzukhin MD, 1996, CAN J FOREST RES, V26, P879, DOI 10.1139/x26-096; Lek S., 2008, ENCY ECOLOGY, P237, DOI [10.1016/B978-008045405-4.00173-7, DOI 10.1016/B978-008045405-4.00173-7]; Loehle C, 1996, ECOL MODEL, V90, P1, DOI 10.1016/0304-3800(96)83709-4; Mckenney DW, 2007, BIOSCIENCE, V57, P939, DOI 10.1641/B571106; Mckenney DW, 2007, BIOSCIENCE, V57, P929, DOI 10.1641/B571105; Medlyn BE, 2011, WIRES CLIM CHANGE, V2, P332, DOI 10.1002/wcc.108; Miehle P, 2009, ECOL MODEL, V220, P734, DOI 10.1016/j.ecolmodel.2008.12.010; MOHREN GMJ, 1994, FOREST ECOL MANAG, V69, P1, DOI 10.1016/0378-1127(94)90215-1; Monserud R.A., 2003, BIOMODELL INFO SCI, V1, P35; Morrison J. L., 2006, PLANT GROWTH CLIMATE; NS DNR, 2004, 20043 FOR NOV SCOT D; NS DNR, 2008, 20083 NS DNR FOR; Pachauri R. K., 2007, CLIMATE CHANGE SYNTH; Park YR, 1996, IEEE T NEURAL NETWOR, V7, P501, DOI 10.1109/72.485683; PASTOR J, 1988, NATURE, V334, P55, DOI 10.1038/334055a0; Peng CH, 2000, FOREST ECOL MANAG, V132, P259, DOI 10.1016/S0378-1127(99)00229-7; Porte A, 2002, ECOL MODEL, V150, P141, DOI 10.1016/S0304-3800(01)00476-8; Pretzsch H, 2009, FOREST DYNAMICS, GROWTH AND YIELD: FROM MEASUREMENT TO MODEL, P1, DOI 10.1007/978-3-540-88307-4_1; Rumelhart G.E., 1986, PARALLEL DISTRIBUTED, P318, DOI DOI 10.1016/B978-1-4832-1446-7.50035-2; Schwalm CR, 2002, US FOR SERV T R NC, V230, P130; Scrinzi G, 2007, ECOL MODEL, V206, P331, DOI 10.1016/j.ecolmodel.2007.04.001; SOLOMON AM, 1986, OECOLOGIA, V68, P567, DOI 10.1007/BF00378773; Solomon S., 2007, PHYS SCI BASIS WORKI; Sullivan M., 2007, STAT INFORM DECISION; Vanclay J. K., 1994, Modelling forest growth and yield: applications to mixed tropical forests.; VANCLAY JK, 1995, FOREST SCI, V41, P7, DOI 10.1093/forestscience/41.1.7; Vanclay JK, 1997, ECOL MODEL, V98, P1, DOI 10.1016/S0304-3800(96)01932-1; Vasseur L., 2008, IMPACTS ADAPTATION C, P119; Weiskittel AR, 2011, FOREST GROWTH AND YIELD MODELING, P1, DOI 10.1002/9781119998518; Williamson T.B., 2009, CLIMATE CHANGE CANAD; Winnett SM, 1998, CLIMATE RES, V11, P39, DOI 10.3354/cr011039; Woodbridge Associates, 2015, EC IMP AN TIMB MAN S	65	35	36	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132066	10.1371/journal.pone.0132066	http://dx.doi.org/10.1371/journal.pone.0132066			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26173081	Green Published, Green Submitted, gold			2022-12-26	WOS:000358194900030
J	Kasperkiewicz, P; Poreba, M; Snipas, SJ; Lin, SJ; Kirchhofer, D; Salvesen, GS; Drag, M				Kasperkiewicz, Paulina; Poreba, Marcin; Snipas, Scott J.; Lin, S. Jack; Kirchhofer, Daniel; Salvesen, Guy S.; Drag, Marcin			Design of a Selective Substrate and Activity Based Probe for Human Neutrophil Serine Protease 4	PLOS ONE			English	Article							UNNATURAL AMINO-ACIDS; CATHEPSIN-G; IRREVERSIBLE INHIBITION; SPECIFICITY; ELASTASE; LIBRARIES; NSP4; PROTEINASE-3; DERIVATIVES; CYSTEINE	Human neutrophil serine protease 4 (NSP4), also known as PRSS57, is a recently discovered fourth member of the neutrophil serine proteases family. Although its biological function is not precisely defined, it is suggested to regulate neutrophil response and innate immune reactions. To create optimal substrates and visualization probes for NSP4 that distinguish it from other NSPs we have employed a Hybrid Combinatorial Substrate Library approach that utilizes natural and unnatural amino acids to explore protease subsite preferences. Library results were validated by synthesizing individual substrates, leading to the identification of an optimal substrate peptide. This substrate was converted to a covalent diphenyl phosphonate probe with an embedded biotin tag. This probe demonstrated high inhibitory activity and stringent specificity and may be suitable for visualizing NSP4 in the background of other NSPs.	[Kasperkiewicz, Paulina; Poreba, Marcin; Drag, Marcin] Wroclaw Univ Technol, Div Bioorgan Chem, Fac Chem, PL-50370 Wroclaw, Poland; [Kasperkiewicz, Paulina; Snipas, Scott J.; Salvesen, Guy S.] Sanford Burnham Med Res Inst, Program Cell Death & Survival Networks, La Jolla, CA 92024 USA; [Lin, S. Jack; Kirchhofer, Daniel] Genentech Inc, Dept Early Discovery Biochem, San Francisco, CA 94080 USA	Wroclaw University of Science & Technology; Sanford Burnham Prebys Medical Discovery Institute; Roche Holding; Genentech	Salvesen, GS (corresponding author), Sanford Burnham Med Res Inst, Program Cell Death & Survival Networks, 10901 N Torrey Pines Rd, La Jolla, CA 92024 USA.	gsalvesen@sanfordburnham.org; marcin.drag@pwr.edu.pl			SKILLS project from European Union's funds under the European Social Fund; NIH grant [GM099040]; National Science Centre grant [2014/14/M/ST5/00619]; Polish Ministry of Science and Higher Education; Genentech Inc.; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099040] Funding Source: NIH RePORTER	SKILLS project from European Union's funds under the European Social Fund; NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Centre grant(National Science Centre, Poland); Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); Genentech Inc.(Roche HoldingGenentech); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	PK is funded by SKILLS project financed from the European Union's funds under the European Social Fund (the Human Capital Operational Programme, Priority IV, Higher Education and Science, Measure 4.2. Developing R&D staff qualifications and increasing awareness of importance of science to economic growth). GSS and SJS are supported by NIH grant GM099040. MD is supported by National Science Centre grant 2014/14/M/ST5/00619. The work was also supported by a statutory activity subsidy from the Polish Ministry of Science and Higher Education for the Faculty of Chemistry at Wroclaw University of Technology. The funder (Genentech Inc.) provided support in the form of salaries for authors SJL and DK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Backes BJ, 2000, NAT BIOTECHNOL, V18, P187, DOI 10.1038/72642; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; de Veer SJ, 2012, BIOL CHEM, V393, P331, DOI [10.1515/BC-2011-250, 10.1515/bc-2011-250]; Harris JL, 2000, P NATL ACAD SCI USA, V97, P7754, DOI 10.1073/pnas.140132697; Kasperkiewicz P, 2014, P NATL ACAD SCI USA, V111, P2518, DOI 10.1073/pnas.1318548111; Kato D, 2005, NAT CHEM BIOL, V1, P33, DOI 10.1038/nchembio707; Korkmaz B, 2008, BIOCHIMIE, V90, P227, DOI 10.1016/j.biochi.2007.10.009; Korkmaz B, 2010, PHARMACOL REV, V62, P726, DOI 10.1124/pr.110.002733; Lin SJ, 2014, STRUCTURE, V22, P1333, DOI 10.1016/j.str.2014.07.008; Liu YS, 1999, P NATL ACAD SCI USA, V96, P14694, DOI 10.1073/pnas.96.26.14694; Maly DJ, 2002, J ORG CHEM, V67, P910, DOI 10.1021/jo016140o; MATTHEWS DJ, 1993, SCIENCE, V260, P1113, DOI 10.1126/science.8493554; Ng NM, 2009, BIOL CHEM, V390, P401, DOI 10.1515/BC.2009.065; O'Donoghue AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075141; OLEKSYSZYN J, 1989, BIOCHEM BIOPH RES CO, V161, P143, DOI 10.1016/0006-291X(89)91572-6; Papayannopoulos V, 2010, J CELL BIOL, V191, P677, DOI 10.1083/jcb.201006052; Perera NC, 2013, J IMMUNOL, V191, P2700, DOI 10.4049/jimmunol.1301293; Perera NC, 2012, EXPERT REV CLIN IMMU, V8, P501, DOI 10.1586/ECI.12.39; Perera NC, 2012, P NATL ACAD SCI USA, V109, P6229, DOI 10.1073/pnas.1200470109; Pham CTN, 2006, NAT REV IMMUNOL, V6, P541, DOI 10.1038/nri1841; Polanowska J, 1998, BBA-PROTEIN STRUCT M, V1386, P189, DOI 10.1016/S0167-4838(98)00085-5; Poreba M, 2014, CELL DEATH DIFFER, V21, P1482, DOI 10.1038/cdd.2014.64; Powers JC, 2002, CHEM REV, V102, P4639, DOI 10.1021/cr010182v; Rut W, 2015, BIOL CHEM, V396, P329, DOI 10.1515/hsz-2014-0315; Salvesen GS, 2001, INHIBITION PROTEOLYT, P105; Schilling O, 2008, NAT BIOTECHNOL, V26, P685, DOI 10.1038/nbt1408; Sienczyk M, 2009, CURR MED CHEM, V16, P1673, DOI 10.2174/092986709788186246; Sivaraman KK, 2013, J MED CHEM, V56, P5213, DOI 10.1021/jm4005972; Urban CF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000639	29	43	44	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132818	10.1371/journal.pone.0132818	http://dx.doi.org/10.1371/journal.pone.0132818			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26172376	Green Published, Green Submitted, gold			2022-12-26	WOS:000358194900088
J	Obala, AA; Mangeni, JN; Platt, A; Aswa, D; Abel, L; Namae, J; O'Meara, WP				Obala, Andrew A.; Mangeni, Judith Nekesa; Platt, Alyssa; Aswa, Daniel; Abel, Lucy; Namae, Jane; O'Meara, Wendy Prudhomme			What Is Threatening the Effectiveness of Insecticide-Treated Bednets? A Case-Control Study of Environmental, Behavioral, and Physical Factors Associated with Prevention Failure	PLOS ONE			English	Article							VECTOR ANOPHELES-GAMBIAE; BED NET EFFECTIVENESS; MALARIA TRANSMISSION; RESISTANCE MECHANISMS; PYRETHROID RESISTANCE; DETOXIFICATION GENES; CHILD-MORTALITY; MOSQUITO LARVAE; AEDES-AEGYPTI; OWNERSHIP	Background Insecticide-treated nets are the cornerstone of global malaria control and have been shown to reduce malaria morbidity by 50-60%. However, some areas are experiencing a resurgence in malaria following successful control. We describe an efficacy decay framework to understand why high malaria burden persists even under high ITN coverage in a community in western Kenya. Methods We enrolled 442 children hospitalized with malaria and paired them with age, time, village and gender-matched controls. We completed comprehensive household and neighborhood assessments including entomological surveillance. The indicators are grouped into five domains in an efficacy decay framework: ITN ownership, compliance, physical integrity, vector susceptibility and facilitating factors. After variable selection, case-control data were analyzed using conditional logistic regression models and mosquito data were analyzed using negative binomial regression. Predictive margins were calculated from logistic regression models. Results Measures of ITN coverage and physical integrity were not correlated with hospitalized malaria in our study. However, consistent ITN use (Adjusted Odds Ratio (AOR) = 0.23, 95% CI: 0.12-0.43), presence of nearby larval sites (AOR = 1.137, 95% CI: 1.02-1.27), and specific types of crops (AOR (grains) = 0.446, 95% CI: 0.24-0.82) were significantly correlated with malaria amongst children who owned an ITN. The odds of hospitalization for febrile malaria nearly tripled when one other household member had symptomatic malaria infection (AOR-2.76, 95% CI: 1.83-4.18). Overall, perfect household adherence could reduce the probability of hospitalization for malaria to less than 30% ( 95% CI: 0.12-0.46) and adjusting environmental factors such as elimination of larval sites and growing grains nearby could reduce the probability of hospitalization for malaria to less than 20% ( 95% CI: 0.04-0.31). Conclusion Availability of ITNs is not the bottleneck for malaria prevention in this community. Behavior change interventions to improve compliance and environmental management of mosquito breeding habitats may greatly enhance ITN efficacy. A better understanding of the relationship between agriculture and mosquito survival and feeding success is needed.	[Obala, Andrew A.; Mangeni, Judith Nekesa; O'Meara, Wendy Prudhomme] Moi Univ, Coll Hlth Sci, Eldoret, Kenya; [Platt, Alyssa; O'Meara, Wendy Prudhomme] Duke Global Hlth Inst, Durham, NC USA; [Aswa, Daniel; Abel, Lucy] Acad Model Providing Access Healthcare, Eldoret, Kenya; [Namae, Jane] Moi Univ, Webuye Hlth & Demog Surveillance Syst, Eldoret, Kenya; [O'Meara, Wendy Prudhomme] Duke Univ, Dept Med, Durham, NC USA	Moi University; Duke University; Moi University; Duke University	O'Meara, WP (corresponding author), Moi Univ, Coll Hlth Sci, Eldoret, Kenya.	wpo@duke.edu		Platt, Alyssa/0000-0001-6396-0170	Malaria Eradication Scientific Alliance (MESA)	Malaria Eradication Scientific Alliance (MESA)	This work was supported by a grant from the Malaria Eradication Scientific Alliance (MESA). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of MESA.	ABBOTT WS, 1987, J AM MOSQUITO CONTR, V3, P302; Abuelmaali SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080549; Aderibigbe SA, 2014, PAN AFR MED J, V17, DOI 10.11604/pamj.2014.17.263.3927; Alaii JA, 2003, AM J TROP MED HYG, V68, P137, DOI 10.4269/ajtmh.2003.68.137; [Anonymous], 2004, COCHRANE DB SYST REV; [Anonymous], PLOS ONE; Asidi A, 2012, EMERG INFECT DIS, V18, P1101, DOI 10.3201/eid1807.120218; Atieli HE, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-113; Batisso E, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-183; Bayoh MN, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-62; Bennett A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037927; Biadgilign S, 2012, J TROP MED-US, V2012, DOI 10.1155/2012/235015; Castro MC, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-57; Central Bureau of Statistics-CBS/Kenya Ministry of Health-MOH/Kenya ORC Macro, 2004, KEN DEM HLTH SURV 20; Chouaibou M, 2008, TROP MED INT HEALTH, V13, P476, DOI 10.1111/j.1365-3156.2008.02025.x; Corbel V, 2007, ACTA TROP, V101, P207, DOI 10.1016/j.actatropica.2007.01.005; David JP, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-216; David JP, 2006, INSECT BIOCHEM MOLEC, V36, P410, DOI 10.1016/j.ibmb.2006.02.004; Deressa W, 2014, T ROY SOC TROP MED H, V108, P616, DOI 10.1093/trstmh/tru129; Diabate A, 2002, AM J TROP MED HYG, V67, P617, DOI 10.4269/ajtmh.2002.67.617; Division of Malaria Control [Ministry of Public Health and Sanitation], 2011, KEN NAT BUR STAT ICF; Furnival GM, 2000, TECHNOMETRICS, V42, P69, DOI 10.2307/1271435; Hamel MJ, 2011, AM J TROP MED HYG, V85, P597, DOI 10.4269/ajtmh.2011.10-0678; Hemingway J, 2000, ANNU REV ENTOMOL, V45, P371, DOI 10.1146/annurev.ento.45.1.371; Howard SC, 2000, T ROY SOC TROP MED H, V94, P357, DOI 10.1016/S0035-9203(00)90103-2; Jagannathan P, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-435; Kebede A, 2005, AM J TROP MED HYG, V73, P676, DOI 10.4269/ajtmh.2005.73.676; Keiser J, 2005, LANCET INFECT DIS, V5, P695, DOI 10.1016/S1473-3099(05)70268-1; Killeen GF, 2007, PLOS MED, V4, P1246, DOI 10.1371/journal.pmed.0040229; Koenker H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097496; Koudou BG, 2010, ANN TROP MED PARASIT, V104, P109, DOI 10.1179/136485910X12607012374154; Larsen DA, 2014, AM J TROP MED HYG, V91, P950, DOI 10.4269/ajtmh.14-0318; Lwetoijera DW, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-57; Nkya TE, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-28; Nkya TE, 2013, INSECT BIOCHEM MOLEC, V43, P407, DOI 10.1016/j.ibmb.2012.10.006; O'Meara WP, 2008, LANCET, V372, P1555, DOI 10.1016/S0140-6736(08)61655-4; O'Meara WP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025949; Ochomo E, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-310; Ochomo EO, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-368; Okiro Emelda A, 2009, BMC Med, V7, P75, DOI 10.1186/1741-7015-7-75; Ouedraogo LT, 2013, REV EPIDEMIOL SANTE, V61, P121, DOI 10.1016/j.respe.2012.09.004; Poupardin R, 2008, INSECT BIOCHEM MOLEC, V38, P540, DOI 10.1016/j.ibmb.2008.01.004; Riaz MA, 2009, AQUAT TOXICOL, V93, P61, DOI 10.1016/j.aquatox.2009.03.005; Rumisha SF, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-452; Sena LD, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-406; Shililu JI, 1998, TROP MED INT HEALTH, V3, P706; Smithuis FM, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-364; Sougoufara S, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-125; Stresman GH, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-265; Strode C, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001619; Sturrock HJW, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001467; Toe KH, 2014, EMERG INFECT DIS, V20, P1691, DOI 10.3201/eid2010.140619; Tokponnon FT, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-265; Trape JF, 2011, LANCET INFECT DIS, V11, P925, DOI 10.1016/S1473-3099(11)70194-3; Ursing J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101167; Wanzira H, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-185; WHO, 2013, WORLD MALARIA REPORT 2013, P1; Wielgosz B, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-251; World Health Organization, 2003, WHOCDSCPESMT200218RE; Wotodjo AN, 2015, AM J TROP MED HYG, V92, P565, DOI 10.4269/ajtmh.14-0485; Yadouleton A, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-60; Yadouleton AWM, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-103; Ye-Ebiyo Y, 2000, AM J TROP MED HYG, V63, P90, DOI 10.4269/ajtmh.2000.63.90	63	15	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132778	10.1371/journal.pone.0132778	http://dx.doi.org/10.1371/journal.pone.0132778			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26171962	Green Published, gold, Green Submitted			2022-12-26	WOS:000358194900084
J	Shen, CY; Tyan, YS; Kuo, LW; Wu, CW; Weng, JC				Shen, Chao-Yu; Tyan, Yeu-Sheng; Kuo, Li-Wei; Wu, Changwei W.; Weng, Jun-Cheng			Quantitative Evaluation of Rabbit Brain Injury after Cerebral Hemisphere Radiation Exposure Using Generalized q-Sampling Imaging	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; RAT-BRAIN; DIFFUSION; MECHANISMS; DAMAGE; DEMYELINATION; IRRADIATION; TOXICITY; TISSUE; MRI	Radiation therapy is widely used for the treatment of brain tumors and may result in cellular, vascular and axonal injury and further behavioral deficits. The non-invasive longitudinal imaging assessment of brain injury caused by radiation therapy is important for determining patient prognoses. Several rodent studies have been performed using magnetic resonance imaging (MRI), but further studies in rabbits and large mammals with advanced magnetic resonance (MR) techniques are needed. Previously, we used diffusion tensor imaging (DTI) to evaluate radiation-induced rabbit brain injury. However, DTI is unable to resolve the complicated neural structure changes that are frequently observed during brain injury after radiation exposure. Generalized q-sampling imaging (GQI) is a more accurate and sophisticated diffusion MR approach that can extract additional information about the altered diffusion environments. Therefore, herein, a longitudinal study was performed that used GQI indices, including generalized fractional anisotropy (GFA), quantitative anisotropy (QA), and the isotropic value (ISO) of the orientation distribution function and DTI indices, including fractional anisotropy (FA) and mean diffusivity (MD) over a period of approximately half a year to observe long-term, radiation-induced changes in the different brain compartments of a rabbit model after a hemi-brain single dose (30 Gy) radiation exposure. We revealed that in the external capsule, the GFA right to left (R/L) ratio showed similar trends as the FA R/L ratio, but no clear trends in the remaining three brain compartments. Both the QA and ISO R/L ratios showed similar trends in the all four different compartments during the acute to early delayed post-irradiation phase, which could be explained and reflected the histopathological changes of the complicated dynamic interactions among astrogliosis, demyelination and vasogenic edema. We suggest that GQI is a promising non-invasive technique and as compared with DTI, it has better potential ability in detecting and monitoring the pathophysiological cascades in acute to early delayed radiation-induced brain injury by using clinical MR scanners.	[Shen, Chao-Yu; Tyan, Yeu-Sheng; Weng, Jun-Cheng] Chung Shan Med Univ, Sch Med Imaging & Radiol Sci, Taichung, Taiwan; [Shen, Chao-Yu; Tyan, Yeu-Sheng; Weng, Jun-Cheng] Chung Shan Med Univ Hosp, Dept Med Imaging, Taichung, Taiwan; [Shen, Chao-Yu; Tyan, Yeu-Sheng] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Kuo, Li-Wei] Natl Hlth Res Inst, Div Med Engn Res, Zhunan Township, Miaoli County, Taiwan; [Wu, Changwei W.] Natl Cent Univ, Grad Inst Biomed Engn, Taoyuan, Taiwan	Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; National Health Research Institutes - Taiwan; National Central University	Weng, JC (corresponding author), Chung Shan Med Univ, Sch Med Imaging & Radiol Sci, Taichung, Taiwan.	jcweng@csmu.edu.tw	Kuo, Li-Wei/O-1312-2019	Kuo, Li-Wei/0000-0002-0306-7329; Wu, Changwei W./0000-0001-8968-9366	Ministry of Science and Technology, Taipei, Taiwan [NSC102-2320-B-040-002]; Chung Shan Medical University and Hospital, Taichung, Taiwan [CSMU-INT-103-08, CSH-2011-C-011]	Ministry of Science and Technology, Taipei, Taiwan; Chung Shan Medical University and Hospital, Taichung, Taiwan	This study was supported in part by the research program NSC102-2320-B-040-002 of the Ministry of Science and Technology, Taipei, Taiwan, and the intramural research programs CSMU-INT-103-08 and CSH-2011-C-011 of the Chung Shan Medical University and Hospital, Taichung, Taiwan.	Belka C, 2001, BRIT J CANCER, V85, P1233, DOI 10.1054/bjoc.2001.2100; Chan KC, 2009, J MAGN RESON IMAGING, V29, P1013, DOI 10.1002/jmri.21736; Greene-Schloesser D, 2012, FRONT ONCOL, V2, P1, DOI 10.3389/fonc.2012.00073; Haldar JP, 2013, MAGN RESON MED, V69, P277, DOI 10.1002/mrm.24229; Hopewell JW, 1999, FRONT RADIAT THER ON, V33, P265; Illa M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076453; Jensen JH, 2005, MAGNET RESON MED, V53, P1432, DOI 10.1002/mrm.20508; KENNEDY AS, 1995, INVEST RADIOL, V30, P214, DOI 10.1097/00004424-199504000-00003; Kim JH, 2008, J NEURO-ONCOL, V87, P279, DOI 10.1007/s11060-008-9520-x; Lim SY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119932; Liu Y, 2010, AM J NEURORADIOL, V31, P383, DOI 10.3174/ajnr.A1801; LO EH, 1991, INT J RADIAT ONCOL, V20, P689, DOI 10.1016/0360-3016(91)90010-2; Lyubimova N, 2004, BRIT J RADIOL, V77, P488, DOI 10.1259/bjr/15169876; MiotNoirault E, 1996, AM J NEURORADIOL, V17, P907; NORTON WT, 1984, ANN NY ACAD SCI, V436, P5, DOI 10.1111/j.1749-6632.1984.tb14772.x; Peiffer AM, 2010, BRAIN RES, V1351, P23, DOI 10.1016/j.brainres.2010.06.049; REINHOLD HS, 1990, INT J RADIAT ONCOL, V18, P37, DOI 10.1016/0360-3016(90)90264-K; SHELINE GE, 1980, INT J RADIAT ONCOL, V6, P1215, DOI 10.1016/0360-3016(80)90175-3; SHEN CY, 2013, J NEUROSCIENCE NEURO, V2, P355; Siu A, 2012, ACTA NEUROCHIR, V154, P191, DOI 10.1007/s00701-011-1228-6; Song SK, 2005, NEUROIMAGE, V26, P132, DOI 10.1016/j.neuroimage.2005.01.028; Stone HB, 2003, LANCET ONCOL, V4, P529, DOI 10.1016/S1470-2045(03)01191-4; Sykova E, 1996, NEUROSCIENCE, V70, P597, DOI 10.1016/0306-4522(95)00361-4; Tofilon PJ, 2000, RADIAT RES, V153, P357, DOI 10.1667/0033-7587(2000)153[0357:TROTCN]2.0.CO;2; Tsao MN, 2012, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD003869.PUB3; Tuch DS, 2004, MAGN RESON MED, V52, P1358, DOI 10.1002/mrm.20279; Wang SL, 2009, CANCER RES, V69, P1190, DOI 10.1158/0008-5472.CAN-08-2661; Wang XJ, 2014, NMR BIOMED, V27, P843, DOI 10.1002/nbm.3129; Wang Y, 2011, BRAIN, V134, P3587, DOI 10.1093/brain/awr307; Wedeen VJ, 2005, MAGN RESON MED, V54, P1377, DOI 10.1002/mrm.20642; Yeh FC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080713; Yeh FC, 2010, IEEE T MED IMAGING, V29, P1626, DOI 10.1109/TMI.2010.2045126; Zhang HL, 2013, NEUROSURGERY, V73, P1044, DOI 10.1227/NEU.0000000000000146; Zhang H, 2012, NEUROIMAGE, V61, P1000, DOI 10.1016/j.neuroimage.2012.03.072	34	14	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0133001	10.1371/journal.pone.0133001	http://dx.doi.org/10.1371/journal.pone.0133001			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26168047	gold, Green Submitted, Green Published			2022-12-26	WOS:000358193100102
J	Kim, BJ; Chang, SA; Yang, J; Oh, SH; Xu, L				Kim, Bong Jik; Chang, Son-A; Yang, Jing; Oh, Seung-Ha; Xu, Li			Relative Contributions of Spectral and Temporal Cues to Korean Phoneme Recognition	PLOS ONE			English	Article							SPEECH RECOGNITION; SIGNAL PROCESSORS; CHANNELS; NOISE; STIMULATION; PROSTHESES; FEATURES; NUMBER; STOPS	This study was aimed to evaluate the relative contributions of spectral and temporal information to Korean phoneme recognition and to compare them with those to English phoneme recognition. Eleven normal-hearing Korean-speaking listeners participated in the study. Korean phonemes, including 18 consonants in a /Ca/ format and 17 vowels in a /hVd/ format, were processed through a noise vocoder. The spectral information was controlled by varying the number of channels (1, 2, 3, 4, 6, 8, 12, and 16) whereas the temporal information was controlled by varying the lowpass cutoff frequency of the envelope extractor (1 to 512 Hz in octave steps). A total of 80 vocoder conditions (8 numbers of channels x 10 lowpass cutoff frequencies) were presented to listeners for phoneme recognition. While vowel recognition depended on the spectral cues predominantly, a tradeoff between the spectral and temporal information was evident for consonant recognition. The overall consonant recognition was dramatically lower than that of English consonant recognition under similar vocoder conditions. The complexity of the Korean consonant repertoire, the three-way distinction of stops in particular, hinders recognition of vocoder-processed phonemes.	[Kim, Bong Jik; Oh, Seung-Ha] Seoul Natl Univ, Coll Med, Dept Otorhinolaryngol, Seoul, South Korea; [Chang, Son-A] Woosong Univ, Sch Speech Language Therapy & Aural Rehabil, Taejon, South Korea; [Yang, Jing] Univ Cent Arkansas, Commun Sci & Disorders, Conway, AR 72035 USA; [Oh, Seung-Ha] Seoul Natl Univ, Med Res Ctr, Sensory Organ Res Inst, Seoul, South Korea; [Xu, Li] Ohio Univ, Commun Sci & Disorders, Athens, OH 45701 USA	Seoul National University (SNU); Woosong University; University of Central Arkansas; Seoul National University (SNU); University System of Ohio; Ohio University	Oh, SH (corresponding author), Seoul Natl Univ, Coll Med, Dept Otorhinolaryngol, Seoul, South Korea.	shaoh@snu.ac.kr; xul@ohio.edu	Xu, Li/C-5908-2008	Xu, Li/0000-0002-0988-7934; Kim, Bong Jik/0000-0002-6384-2171	National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [2014043923]	National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning	This research was supported by the Brain Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (No. 2014043923). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cho TH, 2002, J PHONETICS, V30, P193, DOI 10.1006/jpho.2001.0153; Dorman MF, 1998, J ACOUST SOC AM, V104, P3583, DOI 10.1121/1.423940; Dorman MF, 1997, J ACOUST SOC AM, V102, P2403, DOI 10.1121/1.419603; Dudley H., 1939, BELL LABS RECORD, V18, P122; GREENWOOD DD, 1990, J ACOUST SOC AM, V87, P2592, DOI 10.1121/1.399052; HAN MS, 1970, PHONETICA, V22, P112, DOI 10.1159/000259311; Kim MR, 2004, J EAST ASIAN LINGUIS, V13, P59, DOI 10.1023/B:JEAL.0000007344.43938.4e; Kong YY, 2006, J ACOUST SOC AM, V120, P2830, DOI 10.1121/1.2346009; Lee H. B, 1999, HDB INT PHONETIC ASS, P120; SHANNON RV, 1995, SCIENCE, V270, P303, DOI 10.1126/science.270.5234.303; Shannon RV, 2004, ACTA OTO-LARYNGOL, V124, P50, DOI 10.1080/03655230410017562; Svirsky MA, 2013, INT CONF ACOUST SPEE, P8629, DOI 10.1109/ICASSP.2013.6639350; Warton DI, 2011, ECOLOGY, V92, P3, DOI 10.1890/10-0340.1; Xu L, 2005, J ACOUST SOC AM, V117, P3255, DOI 10.1121/1.1886405; Xu L, 2002, J ACOUST SOC AM, V112, P247, DOI 10.1121/1.1487843; Xu L, 2008, HEARING RES, V242, P132, DOI 10.1016/j.heares.2007.12.010; Xu L, 2007, J ACOUST SOC AM, V122, P1758, DOI 10.1121/1.2767000; Yang HI, 2013, SCI REP-UK, V3, DOI 10.1038/srep01419	18	7	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0131807	10.1371/journal.pone.0131807	http://dx.doi.org/10.1371/journal.pone.0131807			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26162017	gold, Green Published, Green Submitted			2022-12-26	WOS:000358162300062
J	Salamone, M; Nicosia, A; Bennici, C; Quatrini, P; Catania, V; Mazzola, S; Ghersi, G; Cuttitta, A				Salamone, Monica; Nicosia, Aldo; Bennici, Carmelo; Quatrini, Paola; Catania, Valentina; Mazzola, Salvatore; Ghersi, Giulio; Cuttitta, Angela			Comprehensive Analysis of a Vibrio parahaemolyticus Strain Extracellular Serine Protease VpSP37	PLOS ONE			English	Article							STREPTOMYCES-GRISEUS TRYPSIN; HUMAN ISLET ISOLATION; CLASS-II; ENZYME BLENDS; SEQUENCE; PURIFICATION; COLLAGENASE; DISSOCIATION; EXPRESSION; MECHANISM	Proteases play an important role in the field of tissue dissociation combined with regenerative medicine. During the years new sources of proteolytic enzymes have been studied including proteases from different marine organisms both eukaryotic and prokaryotic. Herein we have purified a secreted component of an isolate of Vibrio parahaemolyticus, with electrophoretic mobilities corresponding to 36 kDa, belonging to the serine proteases family. Sequencing of the N-terminus enabled the in silico identification of the whole primary structure consisting of 345 amino acid residues with a calculated molecular mass of 37.4 KDa. The purified enzyme, named VpSP37, contains a Serine protease domain between residues 35 and 276 and a canonical Trypsin/Chimotrypsin 3D structure. Functional assays were performed to evaluate protease activity of purified enzyme. Additionally the performance of VpSP37 was evaluated in tissue dissociations experiments and the use of such enzyme as a component of enzyme blend for tissue dissociation procedures is strongly recommended.	[Salamone, Monica; Nicosia, Aldo; Bennici, Carmelo; Cuttitta, Angela] CNR, Inst Marine & Coastal Environm IAMC CNR, Lab Mol Ecol & Biotechnol, Detached Unit Capo Granitola, I-91021 Trapani, Sicily, Italy; [Quatrini, Paola; Catania, Valentina; Ghersi, Giulio; Cuttitta, Angela] Univ Palermo, Dipartimento Sci & Tecnol Biol Chim & Farmaceut S, Palermo, Sicily, Italy; [Mazzola, Salvatore; Ghersi, Giulio; Cuttitta, Angela] CNR, Inst Marine & Coastal Environm IAMC CNR, I-80133 Naples, Italy; [Ghersi, Giulio; Cuttitta, Angela] ABIEL Srl, I-91021 Trapani, Sicily, Italy	Consiglio Nazionale delle Ricerche (CNR); L'Istituto per l'Ambiente Marino Costiero (IAMC-CNR); University of Palermo; Consiglio Nazionale delle Ricerche (CNR); L'Istituto per l'Ambiente Marino Costiero (IAMC-CNR)	Cuttitta, A (corresponding author), CNR, Inst Marine & Coastal Environm IAMC CNR, Lab Mol Ecol & Biotechnol, Detached Unit Capo Granitola, I-91021 Trapani, Sicily, Italy.	angela.cuttitta@iamc.cnr.it	Nicosia, Aldo/R-4462-2017; Cuttitta, Angela/AAK-2097-2020; salamone, monica/P-7422-2018	Nicosia, Aldo/0000-0002-1013-2862; Cuttitta, Angela/0000-0002-4896-5114; Mazzola, Salvatore/0000-0002-4622-8129; Ghersi, Giulio/0000-0001-7250-9808; salamone, monica/0000-0002-2274-927X	PON MIUR Project "Technologies and processes for an improved shelf-life of products in the agro-food industry through the use of innovative edible pectin films"	PON MIUR Project "Technologies and processes for an improved shelf-life of products in the agro-food industry through the use of innovative edible pectin films"	Funds were provided by PON MIUR Project "Technologies and processes for an improved shelf-life of products in the agro-food industry through the use of innovative edible pectin films" by A. Cuttitta.	BENDER ML, 1962, J AM CHEM SOC, V84, P2582, DOI 10.1021/ja00872a024; Berg JM, 2002, BIOCHEMISTRY-US, V5th; Brandhorst H, 1999, TRANSPLANTATION, V68, P355, DOI 10.1097/00007890-199908150-00006; Brandhorst H, 2008, TRANSPLANTATION, V85, P456, DOI 10.1097/TP.0b013e31816050c8; Brandhorst H, 2009, TRANSPLANTATION, V87, P370, DOI 10.1097/TP.0b013e31819499f0; BUCK JD, 1984, J CLIN MICROBIOL, V20, P849, DOI 10.1128/JCM.20.5.849-851.1984; Cammarata M, 2014, DEV COMP IMMUNOL, V44, P332, DOI 10.1016/j.dci.2014.01.019; Castillo-Yanez FJ, 2005, COMP BIOCHEM PHYS B, V140, P91, DOI 10.1016/j.cbpc.2004.09.031; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; Dodson G, 1998, TRENDS BIOCHEM SCI, V23, P347, DOI 10.1016/S0968-0004(98)01254-7; ERICKSON T, 1992, ANN EMERG MED, V21, P212, DOI 10.1016/S0196-0644(05)80169-6; FEHLHAMMER H, 1977, J MOL BIOL, V111, P415, DOI 10.1016/S0022-2836(77)80062-4; Frank JA, 2008, APPL ENVIRON MICROB, V74, P2461, DOI 10.1128/AEM.02272-07; Gadwal S, 2014, J BIOL CHEM, V289, P8288, DOI 10.1074/jbc.M113.525261; Gerday C, 2000, TRENDS BIOTECHNOL, V18, P103, DOI 10.1016/S0167-7799(99)01413-4; Haddad Jr V., 2000, REV SOC BRASILEIRA M; Haddad Junior Vidal, 2004, An. Bras. Dermatol., V79, P157, DOI 10.1590/S0365-05962004000200004; Haddar A, 2009, BIORESOURCE TECHNOL, V100, P3366, DOI 10.1016/j.biortech.2009.01.061; HOGE CW, 1989, J INFECT DIS, V160, P985, DOI 10.1093/infdis/160.6.985; Ishihara M, 2002, MICROBIOL IMMUNOL, V46, P299, DOI 10.1111/j.1348-0421.2002.tb02699.x; Jonsdottir G, 2004, PROTEIN EXPRES PURIF, V33, P110, DOI 10.1016/j.pep.2003.09.012; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; KIM JC, 1991, BIOCHEM BIOPH RES CO, V181, P707, DOI 10.1016/0006-291X(91)91248-B; Kim SK, 2002, GENE, V283, P277, DOI 10.1016/S0378-1119(01)00882-4; Kin T, 2007, AM J TRANSPLANT, V7, P1233, DOI 10.1111/j.1600-6143.2007.01760.x; Kin T, 2008, TRANSPL INT, V21, P1059, DOI 10.1111/j.1432-2277.2008.00734.x; Klomklao S, 2006, COMP BIOCHEM PHYS B, V144, P47, DOI 10.1016/j.cbpb.2006.01.006; Kumar BK, 2014, GENOME ANNOUNC, V26, P2; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lawrence DA, 2011, J BIOL CHEM, V13, P286; Lee CY, 2002, FEMS MICROBIOL LETT, V209, P31, DOI 10.1111/j.1574-6968.2002.tb11105.x; Lin SJ, 2014, STRUCTURE, V22, P1333, DOI 10.1016/j.str.2014.07.008; Macouzet M, 2005, FEMS YEAST RES, V5, P851, DOI 10.1016/j.femsyr.2005.02.007; Makino K, 2003, LANCET, V361, P743, DOI 10.1016/S0140-6736(03)12659-1; MANDL I, 1961, ADV ENZYMOL REL S BI, V23, P163; Mineo D, 2009, DIABETES CARE, V32, P1563, DOI 10.2337/dc09-0490; Miyoshi S, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00339; MOORE S, 1948, J BIOL CHEM, V176, P367; Nagaraj SH, 2007, BRIEF BIOINFORM, V8, P6, DOI 10.1093/bib/bbl015; Nelson JS, 2006, FISHES WORLD, DOI DOI 10.1002/9781119174844; Nicosia A, 2013, MAR DRUGS, V11, P4213, DOI 10.3390/md11114213; OLAFSON RW, 1975, BIOCHEMISTRY-US, V14, P1168, DOI 10.1021/bi00677a011; PAVIA AT, 1989, ANN INTERN MED, V111, P85, DOI 10.7326/0003-4819-111-1-85; Perona JJ, 1997, J BIOL CHEM, V272, P29987, DOI 10.1074/jbc.272.48.29987; PIEN FD, 1983, DIAGN MICR INFEC DIS, V1, P229, DOI 10.1016/0732-8893(83)90022-6; Polgar L, 2005, CELL MOL LIFE SCI, V62, P2161, DOI 10.1007/s00018-005-5160-x; Riordan C, 2004, WILD ENVIRON MED, V15, P194, DOI 10.1580/1080-6032(2004)15[194:MEAITT]2.0.CO;2; Salamone M, 2010, TRANSPL P, V42, P2043, DOI 10.1016/j.transproceed.2010.05.107; Salamone M, 2014, CHEM ENGINEER TRANS, V38, P247, DOI 10.3303/CET1438042; Sawabe T, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00414; Selvarajan S, 2001, NAT CELL BIOL, V3, P267, DOI 10.1038/35060059; TRAVERSO LW, 1978, TRANSPLANTATION, V25, P226, DOI 10.1097/00007890-197804000-00015; Uesugi Y, 2008, BBA-PROTEINS PROTEOM, V1784, P716, DOI 10.1016/j.bbapap.2008.01.017; Urbarova I, 2012, MAR DRUGS, V10, P2265, DOI 10.3390/md10102265; VANWART HE, 1985, BIOCHEMISTRY-US, V24, P6520, DOI 10.1021/bi00344a032; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; WOLTERS GHJ, 1992, DIABETOLOGIA, V35, P735, DOI 10.1007/BF00429093; WOLTERS GHJ, 1995, DIABETES, V44, P227, DOI 10.2337/diabetes.44.2.227; Zhang C, 2010, MAR DRUGS, V8, P1920, DOI 10.3390/md8061920; Zmuda EJ, 2011, JOVE-J VIS EXP, DOI 10.3791/2096	60	15	16	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0126349	10.1371/journal.pone.0126349	http://dx.doi.org/10.1371/journal.pone.0126349			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26162075	Green Submitted, Green Published, gold			2022-12-26	WOS:000358162300003
J	Maltseva, EA; Rechkunova, NI; Sukhanova, MV; Lavrik, OI				Maltseva, Ekaterina A.; Rechkunova, Nadejda I.; Sukhanova, Maria V.; Lavrik, Olga I.			Poly(ADP-ribose) Polymerase 1 Modulates Interaction of the Nucleotide Excision Repair Factor XPC-RAD23B with DNA via Poly(ADP-ribosyl)ation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEOME-WIDE IDENTIFICATION; RIBOSE ACCEPTOR SITES; BINDING-PROTEINS; DAMAGE; BETA; MECHANISM; NUCLEASE; PARP1; MICE; CONFORMATION	Poly(ADP-ribosyl)ation is a reversible post-translational modification that plays an essential role in many cellular processes, including regulation of DNA repair. Cellular DNA damage response by the synthesis of poly(ADP-ribose) (PAR) is mediated mainly by poly(ADP-ribose) polymerase 1 (PARP1). The XPC-RAD23B complex is one of the key factors of nucleotide excision repair participating in the primary DNA damage recognition. By using several biochemical approaches, we have analyzed the influence of PARP1 and PAR synthesis on the interaction of XPC-RAD23B with damaged DNA. Free PAR binds to XPC-RAD23B with an affinity that depends on the length of the poly(ADP-ribose) strand and competes with DNA for protein binding. Using P-32-labeled NAD(+) and immuno-blotting, we also demonstrate that both subunits of the XPC-RAD23B are poly(ADP-ribosyl)ated by PARP1. The efficiency of XPC-RAD23B PARylation depends on DNA structure and increases after UV irradiation of DNA. Therefore, our study clearly shows that XPC-RAD23B is a target of poly(ADP-ribosyl)ation catalyzed by PARP1, which can be regarded as a universal regulator of DNA repair processes.	[Maltseva, Ekaterina A.; Rechkunova, Nadejda I.; Sukhanova, Maria V.; Lavrik, Olga I.] Inst Chem Biol & Fundamental Med, Novosibirsk 630090, Russia; [Rechkunova, Nadejda I.; Sukhanova, Maria V.; Lavrik, Olga I.] Novosibirsk State Univ, Dept Nat Sci, Novosibirsk 630090, Russia	Institute of Chemical Biology & Fundamental Medicine, Siberian Branch of the RAS; Novosibirsk State University	Lavrik, OI (corresponding author), Inst Chem Biol & Fundamental Med, 8 Lavrentiev Ave, Novosibirsk 630090, Russia.	lavrik@niboch.nsc.ru	Rechkunova, Nadezda I/G-5093-2013; Maltseva, Ekaterina/ABE-2612-2021; Lavrik, Olga I/G-4641-2013	Maltseva, Ekaterina/0000-0002-6800-5989; 	Russian Scientific Foundation [14-24-00038]; Russian Foundation for Basic Research [14-04-31363]	Russian Scientific Foundation(Russian Science Foundation (RSF)); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR))	This work was supported by Russian Scientific Foundation Project 14-24-00038 and Russian Foundation for Basic Research Project 14-04-31363. The authors declare that they have no conflicts of interest with the contents of this article.	Altmeyer M, 2009, NUCLEIC ACIDS RES, V37, P3723, DOI 10.1093/nar/gkp229; Caldecott KW, 1996, NUCLEIC ACIDS RES, V24, P4387, DOI 10.1093/nar/24.22.4387; CLEAVER JE, 1983, J BIOL CHEM, V258, P9059; D'Amours D, 1999, BIOCHEM J, V342, P249, DOI 10.1042/0264-6021:3420249; deMurcia JM, 1997, P NATL ACAD SCI USA, V94, P7303, DOI 10.1073/pnas.94.14.7303; Evdokimov AN, 2011, BIOCHEMISTRY-MOSCOW+, V76, P157, DOI 10.1134/S0006297911010159; Fahrer J, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm944; Fischer JMF, 2014, FEBS J, V281, P3625, DOI 10.1111/febs.12885; Gagne JP, 2008, NUCLEIC ACIDS RES, V36, P6959, DOI 10.1093/nar/gkn771; Gillet LCJ, 2006, CHEM REV, V106, P253, DOI 10.1021/cr040483f; Hassa PO, 2006, MICROBIOL MOL BIOL R, V70, P789, DOI 10.1128/MMBR.00040-05; Illuzzi G, 2014, NUCLEIC ACIDS RES, V42, P7776, DOI 10.1093/nar/gku505; Jungmichel S, 2013, MOL CELL, V52, P272, DOI 10.1016/j.molcel.2013.08.026; KANAI Y, 1978, IMMUNOLOGY, V34, P501; Khodyreva SN, 2010, P NATL ACAD SCI USA, V107, P22090, DOI 10.1073/pnas.1009182107; KIEHLBAUCH CC, 1993, ANAL BIOCHEM, V208, P26, DOI 10.1006/abio.1993.1004; King BS, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.393504; Luijsterburg MS, 2012, J CELL BIOL, V197, P267, DOI 10.1083/jcb.201106074; Masson M, 1998, MOL CELL BIOL, V18, P3563, DOI 10.1128/MCB.18.6.3563; MENDOZAALVAREZ H, 1993, J BIOL CHEM, V268, P22575; Min JH, 2007, NATURE, V449, P570, DOI 10.1038/nature06155; MINAGA T, 1983, J BIOL CHEM, V258, P725; MINAGA T, 1983, J BIOL CHEM, V258, P5726; Mu D, 1996, J BIOL CHEM, V271, P8285, DOI 10.1074/jbc.271.14.8285; MU D, 1995, J BIOL CHEM, V270, P2415, DOI 10.1074/jbc.270.6.2415; Nishi R, 2005, MOL CELL BIOL, V25, P5664, DOI 10.1128/MCB.25.13.5664-5674.2005; OGATA N, 1981, J BIOL CHEM, V256, P4135; Pines A, 2012, J CELL BIOL, V199, P235, DOI 10.1083/jcb.201112132; Robu M, 2013, P NATL ACAD SCI USA, V110, P1658, DOI 10.1073/pnas.1209507110; Rosenthal F, 2014, FRONT BIOSCI-LANDMRK, V19, P1041, DOI 10.2741/4266; Sambrook J., 1989, MOL CLONING LAB MANU; SIBLEY JT, 1988, J IMMUNOL, V140, P3502; SIBLEY JT, 1986, CLIN EXP IMMUNOL, V64, P563; Sukhanova M, 2010, MUTAT RES-FUND MOL M, V685, P80, DOI 10.1016/j.mrfmmm.2009.08.009; Sukhanova MV, 2005, NUCLEIC ACIDS RES, V33, P1222, DOI 10.1093/nar/gki266; Sukhanova MV, 2004, BIOCHEMISTRY-MOSCOW+, V69, P558, DOI 10.1023/B:BIRY.0000029855.68502.fa; Vodenicharov MD, 2005, J CELL SCI, V118, P589, DOI 10.1242/jcs.01636; Wakasugi M, 1998, P NATL ACAD SCI USA, V95, P6669, DOI 10.1073/pnas.95.12.6669; Woodhouse BC, 2008, DNA REPAIR, V7, P1077, DOI 10.1016/j.dnarep.2008.03.009; Zhang YJ, 2013, NAT METHODS, V10, P981, DOI 10.1038/nmeth.2603	40	25	26	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2015	290	36					21811	21820		10.1074/jbc.M115.646638	http://dx.doi.org/10.1074/jbc.M115.646638			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ9XI	26170451	hybrid, Green Published			2022-12-26	WOS:000360968500004
J	Reardon-Robinson, ME; Osipiuk, J; Chang, CY; Wu, CG; Jooya, N; Joachimiak, A; Das, A; Ton-That, H				Reardon-Robinson, Melissa E.; Osipiuk, Jerzy; Chang, Chungyu; Wu, Chenggang; Jooya, Neda; Joachimiak, Andrzej; Das, Asis; Ton-That, Hung			A Disulfide Bond-forming Machine Is Linked to the Sortase-mediated Pilus Assembly Pathway in the Gram-positive Bacterium Actinomyces oris	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						actinobacteria; crystal structure; crystallography; disulfide; secretion; Actinomyces; coaggregation; oxidative protein folding; pili; sortase	FORMATION IN-VIVO; ORAL BIOFILM DEVELOPMENT; CORYNEBACTERIUM-DIPHTHERIAE; MYCOBACTERIUM-TUBERCULOSIS; CRYSTAL-STRUCTURE; PROTEIN; DSBA; IDENTIFICATION; ENZYME; COAGGREGATION	Background: Gram-positive bacteria secrete pilins through the Sec translocon in unfolded states. Results: Disruption of pilus disulfide bonds or genetic disruption of oxidoreductase-encoding genes mdbA and vkor abrogates pilus assembly in Actinomyces oris. Conclusion: MdbA and VKOR constitute a disulfide bond-forming machine in A. oris. Significance: Oxidative protein folding may be common in Actinobacteria and an attractive target for antimicrobials. Export of cell surface pilins in Gram-positive bacteria likely occurs by the translocation of unfolded precursor polypeptides; however, how the unfolded pilins gain their native conformation is presently unknown. Here, we present physiological studies to demonstrate that the FimA pilin of Actinomyces oris contains two disulfide bonds. Alanine substitution of cysteine residues forming the C-terminal disulfide bridge abrogates pilus assembly, in turn eliminating biofilm formation and polymicrobial interaction. Transposon mutagenesis of A. oris yielded a mutant defective in adherence to Streptococcus oralis, and revealed the essential role of a vitamin K epoxide reductase (VKOR) gene in pilus assembly. Targeted deletion of vkor results in the same defects, which are rescued by ectopic expression of VKOR, but not a mutant containing an alanine substitution in its conserved CXXC motif. Depletion of mdbA, which encodes a membrane-bound thiol-disulfide oxidoreductase, abrogates pilus assembly and alters cell morphology. Remarkably, overexpression of MdbA or a counterpart from Corynebacterium diphtheriae, rescues the vkor mutant. By alkylation assays, we demonstrate that VKOR is required for MdbA reoxidation. Furthermore, crystallographic studies reveal that A. oris MdbA harbors a thioredoxin-like fold with the conserved CXXC active site. Consistently, each MdbA enzyme catalyzes proper disulfide bond formation within FimA in vitro that requires the catalytic CXXC motif. Because the majority of signal peptide-containing proteins encoded by A. oris possess multiple Cys residues, we propose that MdbA and VKOR constitute a major folding machine for the secretome of this organism. This oxidative protein folding pathway may be a common feature in Actinobacteria.	[Reardon-Robinson, Melissa E.; Chang, Chungyu; Wu, Chenggang; Jooya, Neda; Ton-That, Hung] Univ Texas Hlth Sci Ctr Houston, Dept Microbiol & Mol Genet, Houston, TX 77030 USA; [Osipiuk, Jerzy; Joachimiak, Andrzej] Argonne Natl Lab, Midwest Ctr Struct Genom, Dept Biosci, Argonne, IL 60439 USA; [Osipiuk, Jerzy; Joachimiak, Andrzej] Argonne Natl Lab, Struct Biol Ctr, Dept Biosci, Argonne, IL 60439 USA; [Das, Asis] Univ Connecticut, Ctr Hlth, Dept Mol Biol & Biophys, Farmington, CT 06030 USA	University of Texas System; University of Texas Health Science Center Houston; United States Department of Energy (DOE); Argonne National Laboratory; United States Department of Energy (DOE); Argonne National Laboratory; University of Connecticut	Ton-That, H (corresponding author), Univ Texas Hlth Sci Ctr Houston, 6431 Fannin St,R224 MSE, Houston, TX 77030 USA.	ton-that.hung@uth.tmc.edu	Ton-That, Hung/AAB-6155-2020	Wu, chenggang/0000-0002-5700-7188; Joachimiak, Andrzej/0000-0003-2535-6209; Ton-That, Hung/0000-0003-1611-0469	United States Department of Energy, Office of Biological and Environmental Research [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI055449] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE017382, R01DE025015, F31DE024004] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094585] Funding Source: NIH RePORTER	United States Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Structural Biology Center at Argonne National Laboratory for their help in conducting x-ray diffraction data collection and our lab members for critical review and discussion of the manuscript. Argonne is operated by the University of Chicago Argonne, LLC, for the United States Department of Energy, Office of Biological and Environmental Research under contract DE-AC02-06CH11357.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BARDWELL JCA, 1993, P NATL ACAD SCI USA, V90, P1038, DOI 10.1073/pnas.90.3.1038; BARDWELL JCA, 1991, CELL, V67, P581, DOI 10.1016/0092-8674(91)90532-4; Bayan N, 2003, J BIOTECHNOL, V104, P55, DOI 10.1016/S0168-1656(03)00163-9; Burkovski A, 2013, ISRN MICROBIOL, V2013, P935736, DOI 10.1155/2013/935736; Chang Chungyu, 2013, Methods Mol Biol, V966, P77, DOI 10.1007/978-1-62703-245-2_5; Chim N, 2013, BMC STRUCT BIOL, V13, DOI 10.1186/1472-6807-13-23; Crow A, 2009, J BIOL CHEM, V284, P23719, DOI 10.1074/jbc.M109.005785; Daniels R, 2010, J BIOL CHEM, V285, P3300, DOI 10.1074/jbc.M109.081398; Davis IW, 2004, NUCLEIC ACIDS RES, V32, pW615, DOI 10.1093/nar/gkh398; Dutton RJ, 2008, P NATL ACAD SCI USA, V105, P11933, DOI 10.1073/pnas.0804621105; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GIRARD AE, 1974, ARCH ORAL BIOL, V19, P71, DOI 10.1016/0003-9969(74)90228-3; GOLDBERGER RF, 1964, J BIOL CHEM, V239, P1406; GOLDBERGER RF, 1963, J BIOL CHEM, V238, P628; Gorrec F, 2011, ACTA CRYSTALLOGR D, V67, P463, DOI 10.1107/S0907444911008754; Guttilla IK, 2009, J BACTERIOL, V191, P5603, DOI 10.1128/JB.00627-09; Heras B, 2008, J BIOL CHEM, V283, P4261, DOI 10.1074/jbc.M707838200; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hung TT, 2011, ORAL MICROBIAL COMMUNITIES: GENOMIC INQUIRY AND INTERSPECIES COMMUNICATION, P63; Hung TT, 2004, MOL MICROBIOL, V53, P251, DOI 10.1111/j.1365-2958.2004.04117.x; Kadokura H, 2009, CELL, V138, P1164, DOI 10.1016/j.cell.2009.07.030; Kang HJ, 2009, P NATL ACAD SCI USA, V106, P16967, DOI 10.1073/pnas.0906826106; Kline KA, 2009, J BACTERIOL, V191, P3237, DOI 10.1128/JB.01837-08; Kobayashi T, 1999, EMBO J, V18, P1192, DOI 10.1093/emboj/18.5.1192; Kolenbrander PE, 2010, NAT REV MICROBIOL, V8, P471, DOI 10.1038/nrmicro2381; Kosuri P, 2012, CELL, V151, P794, DOI 10.1016/j.cell.2012.09.036; LIU YG, 1995, GENOMICS, V25, P674, DOI 10.1016/0888-7543(95)80010-J; Makmura L, 2001, ANTIOXID REDOX SIGN, V3, P1105, DOI 10.1089/152308601317203611; Mandlik A, 2008, TRENDS MICROBIOL, V16, P33, DOI 10.1016/j.tim.2007.10.010; Marraffini LA, 2006, MICROBIOL MOL BIOL R, V70, P192, DOI 10.1128/MMBR.70.1.192-221.2006; MARTIN JL, 1993, NATURE, V365, P464, DOI 10.1038/365464a0; McMahon RM, 2014, BBA-PROTEINS PROTEOM, V1844, P1391, DOI 10.1016/j.bbapap.2014.01.013; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Mishra A, 2011, MOL MICROBIOL, V81, P1205, DOI 10.1111/j.1365-2958.2011.07745.x; Mishra A, 2010, MOL MICROBIOL, V77, P841, DOI 10.1111/j.1365-2958.2010.07252.x; MISSIAKAS D, 1993, P NATL ACAD SCI USA, V90, P7084, DOI 10.1073/pnas.90.15.7084; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Pedone E, 2008, ANTIOXID REDOX SIGN, V10, P157, DOI 10.1089/ars.2007.1855; Persson K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048364; Premkumar L, 2013, ACTA CRYSTALLOGR D, V69, P1981, DOI 10.1107/S0907444913017800; Reardon-Robinson ME, 2014, P NATL ACAD SCI USA, V111, P3835, DOI 10.1073/pnas.1321417111; Ren G, 2014, MOL MICROBIOL, V94, P926, DOI 10.1111/mmi.12808; Ren GP, 2009, J BIOL CHEM, V284, P10150, DOI 10.1074/jbc.M809509200; Rosch JW, 2005, MOL MICROBIOL, V58, P959, DOI 10.1111/j.1365-2958.2005.04887.x; Rosenbaum G, 2006, J SYNCHROTRON RADIAT, V13, P30, DOI 10.1107/S0909049505036721; Sarvas M, 2004, BBA-MOL CELL RES, V1694, P311, DOI 10.1016/j.bbamcr.2004.04.009; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Shouldice SR, 2011, ANTIOXID REDOX SIGN, V14, P1729, DOI 10.1089/ars.2010.3344; Stols L, 2002, PROTEIN EXPRES PURIF, V25, P8, DOI 10.1006/prep.2001.1603; Swaminathan A, 2007, MOL MICROBIOL, V66, P961, DOI 10.1111/j.1365-2958.2007.05968.x; Terwilliger TC, 2003, METHOD ENZYMOL, V374, P22, DOI 10.1016/S0076-6879(03)74002-6; Ton-That H, 2003, MOL MICROBIOL, V50, P1429, DOI 10.1046/j.1365-2958.2003.03782.x; Walsh MA, 1999, ACTA CRYSTALLOGR D, V55, P1168, DOI 10.1107/S0907444999003698; Wang L, 2013, PROTEIN CELL, V4, P628, DOI 10.1007/s13238-013-3033-x; Wang XY, 2011, ANTIOXID REDOX SIGN, V14, P1413, DOI 10.1089/ars.2010.3558; Wu CG, 2014, MOL MICROBIOL, V94, P1227, DOI 10.1111/mmi.12780; Wu C, 2011, J BACTERIOL, V193, P3197, DOI 10.1128/JB.00173-11	59	24	24	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2015	290	35					21393	21405		10.1074/jbc.M115.672253	http://dx.doi.org/10.1074/jbc.M115.672253			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ5IS	26170452	Green Published, hybrid			2022-12-26	WOS:000360637600016
J	Chen, HJ; Chen, CL; Hsieh, HL				Chen, Huai-Ju; Chen, Cheng-Ling; Hsieh, Hsu-Liang			Far-Red Light-Mediated Seedling Development in Arabidopsis Involves FAR-RED INSENSITIVE 219/JASMONATE RESISTANT 1-Dependent and -Independent Pathways	PLOS ONE			English	Article							HELIX TRANSCRIPTION FACTOR; JASMONIC ACID; PLANT-GROWTH; LAND PLANTS; DEFENSE; GENES; MYC2; PHYTOCHROME; MECHANISM; RESPONSES	Plant growth and development is often regulated by the interaction of environmental factors such as light and various phytohormones. Arabidopsis FAR-RED INSENSITIVE 219 (FIN219)/JASMONATE RESISTANT 1 (JAR1) participates in phytochrome A-mediated far-red (FR) light signaling and interacts with different light signaling regulators. FIN219/JAR1 is a jasmonic acid (JA)-conjugating enzyme responsible for the formation of JA-isoleucine. However, how FIN219/JAR1 integrates FR light and JA signaling remains largely unknown. We used a microarray approach to dissect the effect of fin219 mutation on the interaction of FR light and JA signaling. The fin219-2 mutant was less sensitive than the wild type to various concentrations of methyl jasmonate (MeJA) under low and high FR light. High FR light reduced the sensitivity of Arabidopsis seedlings to MeJA likely through FIN219. Intriguingly, in response to MeJA, FIN219 levels showed a negative feedback regulation. Further microarray assay revealed that FR light could regulate gene expression by FIN219-dependent or-independent pathways. The expression profiles affected in fin219-2 indicated that FIN219/JAR1 plays a critical role in the integration of multiple hormone-related signaling. In particular, FIN219 regulates a number of transcription factors (TFs), including 94 basic helix-loophelix (bHLH) TFs, in response to FR light and MeJA. Loss-of-function mutants of some bHLH TFs affected by FIN219 showed altered responses to MeJA in the regulation of hypocotyl and root elongation. Thus, FIN219/JAR1 is tightly regulated in response to exogenous MeJA. It also interacts with multiple plant hormones to modulate hypocotyl and root elongation of Arabidopsis seedlings likely by regulating a group of TFs.	[Chen, Huai-Ju; Chen, Cheng-Ling; Hsieh, Hsu-Liang] Natl Taiwan Univ, Inst Plant Biol, Coll Life Sci, Taipei 106, Taiwan	National Taiwan University	Hsieh, HL (corresponding author), Natl Taiwan Univ, Inst Plant Biol, Coll Life Sci, Taipei 106, Taiwan.	hlhsieh@ntu.edu.tw		Hsieh, Hsu-Liang/0000-0003-3201-3677	National Science Council, Taiwan [NSC 100-2811-B-002-100, NSC 99-2311-B-002-001, NSC 101-2311-B-002-002-MY3]; Excellence Research Program of National Taiwan University [97R0061-03]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Excellence Research Program of National Taiwan University(National Taiwan University)	H.J.C. is a postdoc fellow supported by the National Science Council, Taiwan (NSC 100-2811-B-002-100). This work was supported by the National Science Council, Taiwan (NSC 99-2311-B-002-001 & NSC 101-2311-B-002-002-MY3) and Excellence Research Program of National Taiwan University (97R0061-03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2003, PLANT CELL, V15, P63, DOI 10.1105/tpc.006130; Alabadi D, 2009, PLANT MOL BIOL, V69, P409, DOI 10.1007/s11103-008-9400-y; BERGER S, 1995, PLANT MOL BIOL, V27, P933, DOI 10.1007/BF00037021; Boter M, 2004, GENE DEV, V18, P1577, DOI 10.1101/gad.297704; Bruex A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002446; Cerrudo I, 2012, PLANT PHYSIOL, V158, P2042, DOI 10.1104/pp.112.193359; Chen IC, 2007, PLANT PHYSIOL, V143, P1189, DOI 10.1104/pp.106.094185; Chini A, 2007, NATURE, V448, P666, DOI 10.1038/nature06006; Collados R, 2006, FEBS LETT, V580, P4934, DOI 10.1016/j.febslet.2006.07.087; De Geyter N, 2012, TRENDS PLANT SCI, V17, P349, DOI 10.1016/j.tplants.2012.03.001; Depuydt S, 2011, CURR BIOL, V21, pR365, DOI 10.1016/j.cub.2011.03.013; Dombrecht B, 2007, PLANT CELL, V19, P2225, DOI 10.1105/tpc.106.048017; Erb M, 2012, TRENDS PLANT SCI, V17, P250, DOI 10.1016/j.tplants.2012.01.003; Fernandez-Calvo P, 2011, PLANT CELL, V23, P701, DOI 10.1105/tpc.110.080788; Gremski K, 2007, DEVELOPMENT, V134, P3593, DOI 10.1242/dev.011510; Hong GJ, 2012, PLANT CELL, V24, P2635, DOI 10.1105/tpc.112.098749; Hou XL, 2010, DEV CELL, V19, P884, DOI 10.1016/j.devcel.2010.10.024; Jang G, 2011, DEVELOPMENT, V138, P2273, DOI 10.1242/dev.060582; Jin J, 2011, PLANT J, V65, P319, DOI 10.1111/j.1365-313X.2010.04424.x; Katsir L, 2008, CURR OPIN PLANT BIOL, V11, P428, DOI 10.1016/j.pbi.2008.05.004; Kazan K, 2011, J EXP BOT, V62, P4087, DOI 10.1093/jxb/err142; Lau OS, 2010, CURR OPIN PLANT BIOL, V13, P571, DOI 10.1016/j.pbi.2010.07.001; Laudert D, 1998, PLANT J, V15, P675, DOI 10.1046/j.1365-313x.1998.00245.x; Liu HT, 2008, SCIENCE, V322, P1535, DOI 10.1126/science.1163927; Lorenzo O, 2004, PLANT CELL, V16, P1938, DOI 10.1105/tpc.022319; McConn M, 1997, P NATL ACAD SCI USA, V94, P5473, DOI 10.1073/pnas.94.10.5473; Menand B, 2007, SCIENCE, V316, P1477, DOI 10.1126/science.1142618; Moreno JE, 2009, P NATL ACAD SCI USA, V106, P4935, DOI 10.1073/pnas.0900701106; Pauwels L, 2011, PLANT CELL, V23, P3089, DOI 10.1105/tpc.111.089300; Pauwels L, 2010, NATURE, V464, P788, DOI 10.1038/nature08854; Robert-Seilaniantz A, 2011, ANNU REV PHYTOPATHOL, V49, P317, DOI 10.1146/annurev-phyto-073009-114447; Robson F, 2010, PLANT CELL, V22, P1143, DOI 10.1105/tpc.109.067728; Routaboul JM, 2012, J EXP BOT, V63, P1435, DOI 10.1093/jxb/err381; Sambrook J, 2001, SDS POYLACRYLAMIDE G; Shan XY, 2012, CURR OPIN PLANT BIOL, V15, P84, DOI 10.1016/j.pbi.2011.09.006; Sheard LB, 2010, NATURE, V468, P400, DOI 10.1038/nature09430; Shin J, 2012, PLANT CELL, V24, P2470, DOI 10.1105/tpc.111.095430; Staswick PE, 2002, PLANT CELL, V14, P1405, DOI 10.1105/tpc.000885; Stelmach BA, 1999, PHYTOCHEMISTRY, V51, P187, DOI 10.1016/S0031-9422(99)00017-5; Stenzel I, 2003, PLANT J, V33, P577, DOI 10.1046/j.1365-313X.2003.01647.x; Stenzel I, 2012, J EXP BOT, V63, P6125, DOI 10.1093/jxb/ers261; Suzuki A, 2011, P NATL ACAD SCI USA, V108, P16837, DOI 10.1073/pnas.1105892108; Thines B, 2007, NATURE, V448, P661, DOI 10.1038/nature05960; Toledo-Ortiz G, 2003, PLANT CELL, V15, P1749, DOI 10.1105/tpc.013839; Vanstraelen M, 2012, ANNU REV CELL DEV BI, V28, P463, DOI 10.1146/annurev-cellbio-101011-155741; Wang JG, 2011, PLANT PHYSIOL, V156, P631, DOI 10.1104/pp.111.177667; Yadav V, 2005, PLANT CELL, V17, P1953, DOI 10.1105/tpc.105.032060; Yan JB, 2009, PLANT CELL, V21, P2220, DOI 10.1105/tpc.109.065730; Yang DL, 2012, P NATL ACAD SCI USA, V105, P7100; Zhai QZ, 2007, PLANT CELL PHYSIOL, V48, P1061, DOI 10.1093/pcp/pcm076; Zhu CH, 2006, J EXP BOT, V57, P1299, DOI 10.1093/jxb/erj103; Zhu ZQ, 2011, P NATL ACAD SCI USA, V108, P12539, DOI 10.1073/pnas.1103959108	52	1	1	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132723	10.1371/journal.pone.0132723	http://dx.doi.org/10.1371/journal.pone.0132723			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176841	Green Published, Green Submitted, gold			2022-12-26	WOS:000358197600145
J	Jiang, SH; Zou, ZZ; Nie, PP; Wen, RL; Xiao, YY; Tang, J				Jiang, Suhua; Zou, Zhengzhi; Nie, Peipei; Wen, Ruiling; Xiao, Yingying; Tang, Jun			Synergistic Effects between mTOR Complex 1/2 and Glycolysis Inhibitors in Non-Small-Cell Lung Carcinoma Cells	PLOS ONE			English	Article							TUMOR METABOLISM; MAMMALIAN TARGET; UP-REGULATION; CANCER; AUTOPHAGY; AKT; PHOSPHORYLATION; PATHWAY; KINASE; RICTOR	Cancer metabolism has greatly interested researchers. Mammalian target of rapamycin (mTOR) is dysregulated in a variety of cancers and considered to be an appealing therapeutic target. It has been proven that growth factor signal, mediated by mTOR complex 1 (mTORC1), drives cancer metabolism by regulating key enzymes in metabolic pathways. However, the role of mTORC2 in cancer metabolism has not been thoroughly investigated. In this study, by employing automated spectrophotometry, we found the level of glucose uptake was decreased in non-small-cell lung carcinoma (NSCLC) A549, PC-9 and SK-MES- 1 cells treated with rapamycin or siRNA against Raptor, indicating that the inhibition of mTORC1 attenuated glycolytic metabolism in NSCLC cells. Moreover, the inhibition of AKT reduced glucose uptake in the cells as well, suggesting the involvement of AKT pathway in mTORC1 mediated glycolytic metabolism. Furthermore, our results showed a significant decrease in glucose uptake in rictor down-regulated NSCLC cells, implying a critical role of mTORC2 in NSCLC cell glycolysis. In addition, the experiments for MTT, ATP, and clonogenic assays demonstrated a reduction in cell proliferation, cell viability, and colony forming ability in mTOR inhibiting NSCLC cells. Interestingly, the combined application of mTORC1/2 inhibitors and glycolysis inhibitor not only suppressed the cell proliferation and colony formation, but also induced cell apoptosis, and such an effect of the combined application was stronger than that caused by mTORC1/2 inhibitors alone. In conclusion, this study reports a novel effect of mTORC2 on NSCLC cell metabolism, and reveals the synergistic effects between mTOR complex 1/2 and glycolysis inhibitors, suggesting that the combined application of mTORC1/2 and glycolysis inhibitors may be a new promising approach to treat NSCLC.	[Jiang, Suhua] Guangzhou Med Univ, Affiliated Hosp 2, Dept Oncol, Guangzhou, Guangdong, Peoples R China; [Zou, Zhengzhi; Nie, Peipei; Wen, Ruiling; Xiao, Yingying; Tang, Jun] Guangzhou Med Univ, KingMed Diagnost, Guangzhou, Guangdong, Peoples R China; [Zou, Zhengzhi; Nie, Peipei; Wen, Ruiling; Xiao, Yingying; Tang, Jun] Guangzhou Med Univ, KingMed Sch Lab Med, Guangzhou, Guangdong, Peoples R China	Guangzhou Medical University; Guangzhou Medical University; Guangzhou Medical University	Tang, J (corresponding author), Guangzhou Med Univ, KingMed Diagnost, Guangzhou, Guangdong, Peoples R China.	jtanguc@gmail.com			Medical Science Research Grant of Guangdong Province [A2010248]; Science and Information Technology Bureau of Guangzhou [2011Y1-00022, [2012]224-8]; Science and Information Technology Bureau of Guangzhou Haizhu District grant [2012-ZD-02]	Medical Science Research Grant of Guangdong Province; Science and Information Technology Bureau of Guangzhou; Science and Information Technology Bureau of Guangzhou Haizhu District grant	This work was supported by the Medical Science Research Grant of Guangdong Province (A2010248, to S. Jiang), http://www.gdwst.gov.cn/; the Science and Information Technology Bureau of Guangzhou (2011Y1-00022 and [2012]224-8, to J. Tang), http://www.gzsi.gov.cn/; and the Science and Information Technology Bureau of Guangzhou Haizhu District grant (2012-ZD-02, to J. Tang), http:// www.hzkxj.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birsoy K, 2012, NAT MED, V18, P1022, DOI 10.1038/nm.2870; Blagosklonny MV, 2013, AUTOPHAGY, V9, P260, DOI 10.4161/auto.22783; Breuleux M, 2009, MOL CANCER THER, V8, P742, DOI 10.1158/1535-7163.MCT-08-0668; Buller CL, 2008, AM J PHYSIOL-CELL PH, V295, pC836, DOI 10.1152/ajpcell.00554.2007; Cheong H, 2012, NAT BIOTECHNOL, V30, P671, DOI 10.1038/nbt.2285; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Crazzolara R, 2009, AUTOPHAGY, V5, P727, DOI 10.4161/auto.5.5.8507; de Mattos SF, 2000, BIOCHEM J, V349, P59; Egan DF, 2011, AUTOPHAGY, V7, P645, DOI 10.4161/auto.7.6.15123; Esen E, 2013, CELL METAB, V17, P745, DOI 10.1016/j.cmet.2013.03.017; Faivre S, 2006, NAT REV DRUG DISCOV, V5, P671, DOI 10.1038/nrd2062; Frauwirth KA, 2002, IMMUNITY, V16, P769, DOI 10.1016/S1074-7613(02)00323-0; Frias MA, 2006, CURR BIOL, V16, P1865, DOI 10.1016/j.cub.2006.08.001; Gridelli C, 2008, ONCOLOGIST, V13, P139, DOI 10.1634/theoncologist.2007-0171; Guerra JLL, 2013, ANN ONCOL, V24, P67, DOI 10.1093/annonc/mds274; Hagiwara A, 2012, CELL METAB, V15, P725, DOI 10.1016/j.cmet.2012.03.015; Hay N, 2005, CANCER CELL, V8, P179, DOI 10.1016/j.ccr.2005.08.008; Heesom KJ, 1999, FEBS LETT, V457, P489, DOI 10.1016/S0014-5793(99)01094-7; Hsu PP, 2008, CANC CELL METABOLISM; Keith B, 2012, NAT REV CANCER, V12, P9, DOI 10.1038/nrc3183; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kumar A, 2008, MOL CELL BIOL, V28, P61, DOI 10.1128/MCB.01405-07; Le A, 2010, P NATL ACAD SCI USA, V107, P2037, DOI 10.1073/pnas.0914433107; Li W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064924; Liu LL, 2013, MOL CANCER RES, V11, P1326, DOI 10.1158/1541-7786.MCR-13-0172; Lou YF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097719; Lu CW, 2008, J BIOL CHEM, V283, P28106, DOI 10.1074/jbc.M803508200; Masui K, 2013, CELL METAB, V18, P726, DOI 10.1016/j.cmet.2013.09.013; Ramanathan A, 2009, P NATL ACAD SCI USA, V106, P22229, DOI 10.1073/pnas.0912074106; Risson V, 2009, J CELL BIOL, V187, P859, DOI 10.1083/jcb.200903131; Sabatini DM, 2006, NAT REV CANCER, V6, P729, DOI 10.1038/nrc1974; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Sattler UGA, 2010, CURR MED CHEM, V17, P96, DOI 10.2174/092986710790112657; Semenza GL, 2008, J CLIN INVEST, V118, P3835, DOI 10.1172/JCI37373; Shackelford DB, 2009, P NATL ACAD SCI USA, V106, P11137, DOI 10.1073/pnas.0900465106; Sini P, 2010, AUTOPHAGY, V6, P553, DOI 10.4161/auto.6.4.11671; Soliman GA, 2011, CELL CYCLE, V10, P861, DOI 10.4161/cc.10.6.14930; Sommermann TG, 2011, CANCER RES, V71, P7291, DOI 10.1158/0008-5472.CAN-11-1715; Sun QA, 2011, P NATL ACAD SCI USA, V108, P4129, DOI 10.1073/pnas.1014769108; Tang J, 2010, J BIOL CHEM, V285, P34072, DOI 10.1074/jbc.M110.137380; Teicher BA, 2012, CLIN CANCER RES, V18, P5537, DOI 10.1158/1078-0432.CCR-12-2587; Toschi A, 2010, CANCER LETT, V299, P72, DOI 10.1016/j.canlet.2010.08.006; Toschi A, 2009, MOL CELL BIOL, V29, P1411, DOI 10.1128/MCB.00782-08; Wang XR, 2008, CANCER RES, V68, P7409, DOI 10.1158/0008-5472.CAN-08-1522; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Yecies JL, 2011, J MOL MED, V89, P221, DOI 10.1007/s00109-011-0726-6; Zhao Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.60; Zou ZZ, 2012, AUTOPHAGY, V8, P1798, DOI 10.4161/auto.22110	48	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132880	10.1371/journal.pone.0132880	http://dx.doi.org/10.1371/journal.pone.0132880			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176608	Green Submitted, Green Published, gold			2022-12-26	WOS:000358197600172
J	Konno, M; Koseki, J; Kawamoto, K; Nishida, N; Matsui, H; Dewi, DL; Ozaki, M; Noguchi, Y; Mimori, K; Gotoh, N; Tanuma, N; Shima, H; Doki, Y; Mori, M; Ishii, H				Konno, Masamitsu; Koseki, Jun; Kawamoto, Koichi; Nishida, Naohiro; Matsui, Hidetoshi; Dewi, Dyah Laksmi; Ozaki, Miyuki; Noguchi, Yuko; Mimori, Koshi; Gotoh, Noriko; Tanuma, Nobuhiro; Shima, Hiroshi; Doki, Yuichiro; Mori, Masaki; Ishii, Hideshi			Embryonic MicroRNA-369 Controls Metabolic Splicing Factors and Urges Cellular Reprograming	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; UP-REGULATION; MOUSE; TRANSLATION; ACTIVATION; REPRESSION; CHROMATIN; PATHWAYS; CANCER; GENES	Noncoding microRNAs inhibit translation and lower the transcript stability of coding mRNA, however miR-369 s, in aberrant silencing genomic regions, stabilizes target proteins under cellular stress. We found that in vitro differentiation of embryonic stem cells led to chromatin methylation of histone H3K4 at the miR-369 region on chromosome 12qF in mice, which is expressed in embryonic cells and is critical for pluripotency. Proteomic analyses revealed that miR-369 stabilized translation of pyruvate kinase (Pkm2) splicing factors such as HNRNPA2B1. Overexpression of miR-369 stimulated Pkm2 splicing and enhanced induction of cellular reprogramming by induced pluripotent stem cell factors, whereas miR-369 knockdown resulted in suppression. Furthermore, immunoprecipitation analysis showed that the Argonaute complex contained the fragile X mental retardation-related protein 1 and HNRNPA2B1 in a miR-369-depedent manner. Our findings demonstrate a unique role of the embryonic miR-369-HNRNPA2B1 axis in controlling metabolic enzyme function, and suggest a novel pathway linking epigenetic, transcriptional, and metabolic control in cell reprogramming.	[Konno, Masamitsu; Kawamoto, Koichi; Nishida, Naohiro; Dewi, Dyah Laksmi; Ozaki, Miyuki; Noguchi, Yuko; Doki, Yuichiro; Mori, Masaki; Ishii, Hideshi] Osaka Univ, Dept Frontier Sci Canc & Chemotherapy, Grad Sch Med, Osaka 5650871, Japan; [Koseki, Jun; Doki, Yuichiro; Mori, Masaki; Ishii, Hideshi] Osaka Univ, Dept Canc Profiling Discovery, Grad Sch Med, Osaka 5650871, Japan; [Kawamoto, Koichi; Dewi, Dyah Laksmi; Doki, Yuichiro; Mori, Masaki] Osaka Univ, Dept Gastrointestinal Surg, Grad Sch Med, Osaka 5650871, Japan; [Matsui, Hidetoshi] Kyushu Univ, Fac Sci, Fukuoka 8190395, Japan; [Mimori, Koshi] Kyushu Univ, Dept Mol & Surg Oncol, Beppu, Oita 8740838, Japan; [Gotoh, Noriko] Kanazawa Univ, Div Canc Cell Biol, Canc Res Inst, Kanazawa, Ishikawa 9201192, Japan; [Tanuma, Nobuhiro; Shima, Hiroshi] Miyagi Canc Ctr Res Inst, Div Canc Chemotherapy, Natori, Miyagi 9811293, Japan	Osaka University; Osaka University; Osaka University; Kyushu University; Kyushu University; Kanazawa University; Miyagi Cancer Center	Mori, M (corresponding author), Osaka Univ, Dept Frontier Sci Canc & Chemotherapy, Grad Sch Med, Osaka 5650871, Japan.	mmori@gesurg.med.osaka-u.ac.jp; hishii@gesurg.med.osaka-u.ac.jp	Matsui, Hidetoshi/AAM-1339-2020; Koseki, Jun/ABH-7420-2020; GOTOH, Noriko/D-8430-2015; Dewi, Dyah Laksmi/GOP-2412-2022; Ishii, Hideshi/AAV-5317-2020	Matsui, Hidetoshi/0000-0002-6286-5072; Gotoh, Noriko/0000-0003-3733-260X; Dewi, Dyah Laksmi/0000-0001-7937-4221; Mimori, Koshi/0000-0003-3897-9974	Ministry of Education, Culture, Sports, Science, and Technology [23390199, 25112708, 25134711, 30253420, 26670604]; Ministry of Health, Labor and Welfare [H23-003]; National Institute of Biomedical Innovation [12-4]; Osaka University Drug Discovery Funds; Takeda Science and Medical Research Foundation; Princess Takamatsu Cancer Research Fund; Suzuken Memorial Foundation; Yasuda Medical Foundation; Pancreas Research Foundation; Nakatani Foundation; Nakatomi Foundation of Japan	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan); National Institute of Biomedical Innovation(National Institute of Biomedical Innovation); Osaka University Drug Discovery Funds; Takeda Science and Medical Research Foundation; Princess Takamatsu Cancer Research Fund; Suzuken Memorial Foundation; Yasuda Medical Foundation; Pancreas Research Foundation; Nakatani Foundation; Nakatomi Foundation of Japan	This work was supported in part by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology (http://www.mext.go.jp/english/; #23390199, #25112708, #25134711, #30253420, #26670604; M.M., K.M., H.I.); a Grant-in-Aid from the Ministry of Health, Labor and Welfare (http://www.mhlw.go.jp/english/; #H23-003; M.M., H.I.); a grant from the National Institute of Biomedical Innovation (http://www.nibio.go.jp/english/index.html; #12-4; M.M., H.I.); and a grant from the Osaka University Drug Discovery Funds (http://www.osaka-u.ac.jp/en/index.html; M.M., H.I.). Partial support was received from Takeda Science and Medical Research Foundation (http://www.takeda-sci.or.jp/index.html; M.M., H.I.), Princess Takamatsu Cancer Research Fund (http://www.ptcrf.or.jp/english; M.M., H.I.), Suzuken Memorial Foundation (http://www.suzukenzaidan.or.jp; M.K.), Yasuda Medical Foundation (http://www.yasuda-mf.or.jp; N.N.), Pancreas Research Foundation (http://www.jprf.or.jp/shoreisho.html; K.K.), Nakatani Foundation (http://www.nakatani-foundation.jp; H.I.), and Nakatomi Foundation of Japan (https://www.nakatomi.or.jp/en/index.html; M.K.). Institutional endowments were received partially from Taiho Pharmaceutical Co., Ltd. (http://www.taiho.co.jp/english/), Evidence Based Medical (EBM) Research Center (http://ebmrce.co.jp/index.html), Chugai Co., Ltd. (http://www.chugai-pharm.co.jp/english/index.html), Yakult Honsha Co., Ltd. (http://www.yakult.co.jp/english/index.html), and Merck Co., Ltd. (http://www.merck.co.jp/en/index.html); those funders had no role in main experimental equipments, supplies expenses, study design, data collection and analysis, decision to publish, or preparation of the manuscript, in this work.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Anokye-Danso F, 2011, CELL STEM CELL, V8, P376, DOI 10.1016/j.stem.2011.03.001; Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; Chen CZ, 2005, NEW ENGL J MED, V353, P1768, DOI 10.1056/NEJMp058190; Cummins JM, 2006, P NATL ACAD SCI USA, V103, P3687, DOI 10.1073/pnas.0511155103; David CJ, 2010, NATURE, V463, P364, DOI 10.1038/nature08697; Gangaraju VK, 2009, NAT REV MOL CELL BIO, V10, P116, DOI 10.1038/nrm2621; Gaspar-Maia A, 2011, NAT REV MOL CELL BIO, V12, P36, DOI 10.1038/nrm3036; Hu J, 2012, BIOCHEM J, V447, P407, DOI 10.1042/BJ20120256; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Konno M, 2015, REGENERATIV IN PRESS; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee Y, 2002, EMBO J, V21, P4663, DOI 10.1093/emboj/cdf476; Liao BJ, 2011, J BIOL CHEM, V286, P17359, DOI 10.1074/jbc.C111.235960; Lim LP, 2003, SCIENCE, V299, P1540, DOI 10.1126/science.1080372; Lin SL, 2008, RNA, V14, P2115, DOI 10.1261/rna.1162708; Lin SL, 2011, NUCLEIC ACIDS RES, V39, P1054, DOI 10.1093/nar/gkq850; Lin SL, 2010, CANCER RES, V70, P9473, DOI 10.1158/0008-5472.CAN-10-2746; Liu XH, 2012, MOL CELL, V46, P507, DOI 10.1016/j.molcel.2012.03.010; Ma J, 2010, CURR BIOL, V20, P265, DOI 10.1016/j.cub.2009.12.042; Miyoshi N, 2011, CELL STEM CELL, V8, P633, DOI 10.1016/j.stem.2011.05.001; Shyh-Chang N, 2013, SCIENCE, V339, P222, DOI 10.1126/science.1226603; Papp B, 2013, CELL, V152, P1324, DOI 10.1016/j.cell.2013.02.043; Prigione A, 2014, STEM CELLS, V32, P364, DOI 10.1002/stem.1552; Rana TM, 2007, NAT REV MOL CELL BIO, V8, P23, DOI 10.1038/nrm2085; Shyh-Chang N, 2013, DEVELOPMENT, V140, P2535, DOI 10.1242/dev.091777; Stadtfeld M, 2010, NATURE, V465, P175, DOI 10.1038/nature09017; Suh N, 2010, CURR BIOL, V20, P271, DOI 10.1016/j.cub.2009.12.044; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Vasudevan S, 2007, CELL, V128, P1105, DOI 10.1016/j.cell.2007.01.038; Wang J, 2009, SCIENCE, V325, P435, DOI 10.1126/science.1173288	36	11	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132789	10.1371/journal.pone.0132789	http://dx.doi.org/10.1371/journal.pone.0132789			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176628	gold, Green Published, Green Submitted			2022-12-26	WOS:000358197600157
J	Kortum, F; Harms, FL; Hennighausen, N; Rosenberger, G				Kortuem, Fanny; Harms, Frederike Leonie; Hennighausen, Natascha; Rosenberger, Georg			alpha PIX Is a Trafficking Regulator that Balances Recycling and Degradation of the Epidermal Growth Factor Receptor	PLOS ONE			English	Article							INTERACTING EXCHANGE FACTOR; GTPASE-ACTIVATING PROTEINS; KINASE-BINDING PROTEINS; RHO-GTPASES; EGF RECEPTOR; MEMBRANE-TRANSPORT; DOWN-REGULATION; C-CBL; P21-ACTIVATED KINASES; MENTAL-RETARDATION	Endosomal sorting is an essential control mechanism for signaling through the epidermal growth factor receptor (EGFR). We report here that the guanine nucleotide exchange factor alpha PIX, which modulates the activity of Rho-GTPases, is a potent bimodal regulator of EGFR trafficking. alpha PIX interacts with the E3 ubiquitin ligase c-Cbl, an enzyme that attaches ubiquitin to EGFR, thereby labelling this tyrosine kinase receptor for lysosomal degradation. We show that EGF stimulation induces alpha PIX::c-Cbl complex formation. Simultaneously, c-Cbl ubiquitin ligase activity. Through interaction alpha PIX sequesters c-Cbl from EGFR and this results in reduced EGFR ubiquitination and decreased EGFR degradation upon EGF treatment. However, quantitatively more decisive for cellular EGFR distribution than impaired EGFR degradation is a strong stimulating effect of alpha PIX on EGFR recycling to the cell surface. This function depends on the GIT binding domain of alpha PIX but not on interaction with c-Cbl or alpha PIX exchange activity. In summary, our data demonstrate a previously unappreciated function of alpha PIX as a strong promoter of EGFR recycling. We suggest that the novel recycling regulator alpha PIX and the degradation factor c-Cbl closely cooperate in the regulation of EGFR trafficking: uncomplexed alpha PIX and c-Cbl mediate a positive and a negative feedback on EGFR signaling, respectively; alpha PIX::c-Cbl complex formation, however, results in mutual inhibition, which may reflect a stable condition in the homeostasis of EGF-induced signal flow.	[Kortuem, Fanny; Harms, Frederike Leonie; Hennighausen, Natascha; Rosenberger, Georg] Univ Med Ctr Hamburg Eppendorf, Inst Human Genet, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf	Rosenberger, G (corresponding author), Univ Med Ctr Hamburg Eppendorf, Inst Human Genet, Hamburg, Germany.	rosenberger@uke.de		Harms, Frederike Leonie/0000-0003-2610-0600	DFG [KO 4576/1-1]; Deutsche Forschungsgemeinschaft [FOR 885/IRP5]	DFG(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by a grant from the DFG (KO 4576/1-1 to F. Kortum). GR was supported by a grant from the Deutsche Forschungsgemeinschaft (FOR 885/IRP5). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander A, 1998, Front Biosci, V3, pd729; Bagrodia S, 1998, J BIOL CHEM, V273, P23633, DOI 10.1074/jbc.273.37.23633; Bagrodia S, 1999, J BIOL CHEM, V274, P22393, DOI 10.1074/jbc.274.32.22393; Baird D, 2005, CURR BIOL, V15, P1, DOI 10.1016/j.cub.2004.12.040; Bitler BG, 2010, J CELL SCI, V123, P1716, DOI 10.1242/jcs.062661; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; Daniels RH, 1999, J BIOL CHEM, V274, P6047, DOI 10.1074/jbc.274.10.6047; Di Cesare A, 2000, NAT CELL BIOL, V2, P521, DOI 10.1038/35019561; Dikic I, 2003, BIOCHEM SOC T, V31, P1178; Dikic I, 2003, CELL MOL LIFE SCI, V60, P1805, DOI 10.1007/s00018-003-3029-4; Donaldson JG, 2011, NAT REV MOL CELL BIO, V12, P362, DOI 10.1038/nrm3117; Eden ER, 2012, TRAFFIC, V13, P329, DOI 10.1111/j.1600-0854.2011.01305.x; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Feng QY, 2006, NAT CELL BIOL, V8, P945, DOI 10.1038/ncb1453; Feng QY, 2004, EMBO J, V23, P3492, DOI 10.1038/sj.emboj.7600331; Feng QY, 2002, J BIOL CHEM, V277, P5644, DOI 10.1074/jbc.M107704200; Flanders JA, 2003, FEBS LETT, V550, P119, DOI 10.1016/S0014-5793(03)00853-6; Frank SR, 2008, SEMIN CELL DEV BIOL, V19, P234, DOI 10.1016/j.semcdb.2008.01.002; Grant BD, 2009, NAT REV MOL CELL BIO, V10, P597, DOI 10.1038/nrm2755; Gringel A, 2006, J CELL PHYSIOL, V209, P568, DOI 10.1002/jcp.20777; Grovdal LM, 2008, EXP CELL RES, V314, P1292, DOI 10.1016/j.yexcr.2007.12.017; Gruenberg J, 2004, NAT REV MOL CELL BIO, V5, P317, DOI 10.1038/nrm1360; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Hoefen RJ, 2006, J CELL SCI, V119, P1469, DOI 10.1242/jcs.02925; Hua KT, 2011, CANCER CELL, V19, P218, DOI 10.1016/j.ccr.2010.11.010; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Koh CG, 2001, J CELL SCI, V114, P4239; Kong KF, 2014, NAT IMMUNOL, V15, P465, DOI 10.1038/ni.2866; Korthals M, 2014, J IMMUNOL, V192, P3228, DOI 10.4049/jimmunol.1302585; Kutsche K, 2000, NAT GENET, V26, P247, DOI 10.1038/80002; Li Z, 2003, CELL, V114, P215, DOI 10.1016/S0092-8674(03)00559-2; Lin Q, 2006, METHOD ENZYMOL, V406, P614, DOI 10.1016/S0076-6879(06)06048-4; Llavero F, 2015, J BIOL CHEM, V290, P9171, DOI 10.1074/jbc.M114.608414; Manser E, 1998, MOL CELL, V1, P183, DOI 10.1016/S1097-2765(00)80019-2; Matafora V, 2001, J CELL SCI, V114, P4509; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Mazaki Y, 2006, NAT IMMUNOL, V7, P724, DOI 10.1038/ni1349; Missy K, 2008, MOL CELL BIOL, V28, P3776, DOI 10.1128/MCB.00507-07; Node-Langlois R, 2006, J CELL SCI, V119, P4986, DOI 10.1242/jcs.03273; Phee H, 2005, NAT IMMUNOL, V6, P608, DOI 10.1038/ni1199; Platta HW, 2011, CURR OPIN CELL BIOL, V23, P393, DOI 10.1016/j.ceb.2011.03.008; Prelich G, 2012, GENETICS, V190, P841, DOI 10.1534/genetics.111.136911; Premont RT, 2000, J BIOL CHEM, V275, P22373, DOI 10.1074/jbc.275.29.22373; Qualmann B, 2003, BIOCHEM J, V371, P233, DOI 10.1042/bj20030139; Ramakers GJA, 2012, HUM MOL GENET, V21, P268, DOI 10.1093/hmg/ddr457; Ridley AJ, 2006, TRENDS CELL BIOL, V16, P522, DOI 10.1016/j.tcb.2006.08.006; Roepstorff K, 2008, HISTOCHEM CELL BIOL, V129, P563, DOI 10.1007/s00418-008-0401-3; Roepstorff K, 2009, TRAFFIC, V10, P1115, DOI 10.1111/j.1600-0854.2009.00943.x; Rosenberger G, 2006, EUR J CELL BIOL, V85, P265, DOI 10.1016/j.ejcb.2005.10.007; Rosenberger G, 2005, J BIOL CHEM, V280, P6879, DOI 10.1074/jbc.M412119200; Rosenberger G, 2003, HUM MOL GENET, V12, P155, DOI 10.1093/hmg/ddg019; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Schlenker O, 2009, J MOL BIOL, V386, P280, DOI 10.1016/j.jmb.2008.12.050; Schmidt MHH, 2006, ONCOGENE, V25, P3071, DOI 10.1038/sj.onc.1209329; Schmidt MHH, 2005, NAT REV MOL CELL BIO, V6, P907, DOI 10.1038/nrm1762; Schmidt Mirko H. H., 2006, V327, P131; Scita G, 2010, NATURE, V463, P464, DOI 10.1038/nature08910; Seong MW, 2014, BIOCHEM BIOPH RES CO, V455, P153, DOI 10.1016/j.bbrc.2014.10.129; Shtiegman K, 2007, ONCOGENE, V26, P6968, DOI 10.1038/sj.onc.1210503; Sigismund S, 2012, PHYSIOL REV, V92, P273, DOI 10.1152/physrev.00005.2011; Sorkin A, 2010, CURR PROTOC CELL BIO, DOI [10. 1002/0471143030. cb1514s46, DOI 10.1002/0471143030.CB1514S46]; Sorkin A, 2009, NAT REV MOL CELL BIO, V10, P609, DOI 10.1038/nrm2748; Sorkin A, 2009, EXP CELL RES, V315, P683, DOI [10.1016/j.yexcr.2008.07.029, 10.1016/j.yexcr.2008.08.013]; Staub O, 2006, PHYSIOL REV, V86, P669, DOI 10.1152/physrev.00020.2005; Stofega MR, 2004, MOL BIOL CELL, V15, P2965, DOI 10.1091/mbc.E03-08-0604; Swaminathan G, 2006, J CELL PHYSIOL, V209, P21, DOI 10.1002/jcp.20694; Thien CBF, 2005, GROWTH FACTORS, V23, P161, DOI 10.1080/08977190500153763; Thien CBF, 2001, NAT REV MOL CELL BIO, V2, P294, DOI 10.1038/35067100; Totaro A, 2012, BIOL CELL, DOI [10.1111/boc.201200006, DOI 10.1111/BOC.201200006]; Turner CE, 1999, J CELL BIOL, V145, P851, DOI 10.1083/jcb.145.4.851; Turvy D N, 2001, Curr Protoc Immunol, VChapter 18, DOI 10.1002/0471142735.im1807s36; Valdes JL, 2011, J BIOL CHEM, V286, P39403, DOI 10.1074/jbc.M111.260802; van Weert AWM, 2000, EUR J CELL BIOL, V79, P394, DOI 10.1078/0171-9335-00062; Vitale N, 2000, J BIOL CHEM, V275, P13901, DOI 10.1074/jbc.275.18.13901; Waterman H, 1999, J BIOL CHEM, V274, P22151, DOI 10.1074/jbc.274.32.22151; Weissman AM, 2001, NAT REV MOL CELL BIO, V2, P169, DOI 10.1038/35056563; Wiley HS, 2001, TRAFFIC, V2, P12, DOI 10.1034/j.1600-0854.2001.020103.x; Wong RWC, 2004, CYTOKINE GROWTH F R, V15, P147, DOI 10.1016/j.cytogfr.2004.01.004; Wu WJ, 2003, CELL, V114, P715, DOI 10.1016/S0092-8674(03)00688-3; Yarden Y, 2001, EUR J CANCER, V37, pS3; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Yokota T, 2006, ACTA NEUROPATHOL, V111, P29, DOI 10.1007/s00401-005-1085-6; Yoshii S, 1999, ONCOGENE, V18, P5680, DOI 10.1038/sj.onc.1202936; Yoshii S, 2001, MOL CELL BIOL, V21, P6796, DOI 10.1128/MCB.21.20.6796-6807.2001; Yoshimi R, 2006, J IMMUNOL, V176, P3611, DOI 10.4049/jimmunol.176.6.3611; Zhao ZS, 2000, MOL CELL BIOL, V20, P6354, DOI 10.1128/MCB.20.17.6354-6363.2000	87	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132737	10.1371/journal.pone.0132737	http://dx.doi.org/10.1371/journal.pone.0132737			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177020	Green Submitted, Green Published, gold			2022-12-26	WOS:000358197600147
J	Li, GQ; Du, S; Guo, K				Li, Guoqing; Du, Sheng; Guo, Ke			Evaluation of Limiting Climatic Factors and Simulation of a Climatically Suitable Habitat for Chinese Sea Buckthorn	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; POTENTIAL GEOGRAPHICAL-DISTRIBUTION; LANTANA-CAMARA; DISTRIBUTIONS; PREDICTION; CLIMEX; TREE; SOIL; QUEENSLAND; IMPACTS	Chinese sea buckthorn (Hippophae rhamnoides subsp. sinensis) has considerable economic potential and plays an important role in reclamation and soil and water conservation. For scientific cultivation of this species across China, we identified the key climatic factors and explored climatically suitable habitat in order to maximize survival of Chinese sea buckthorn using MaxEnt and GIS tools, based on 98 occurrence records from herbarium and publications and 13 climatic factors from Bioclim, Holdridge life zone and Kria' index variables. Our simulation showed that the MaxEnt model performance was significantly better than random, with an average test AUC value of 0.93 with 10-fold cross validation. A jackknife test and the regularized gain change, which were applied to the training algorithm, showed that precipitation of the driest month (PDM), annual precipitation (AP), coldness index (CI) and annual range of temperature (ART) were the most influential climatic factors in limiting the distribution of Chinese sea buckthorn, which explained 70.1% of the variation. The predicted map showed that the core of climatically suitable habitat was distributed from the southwest to northwest of Gansu, Ningxia, Shaanxi and Shanxi provinces, where the most influential climate variables were PDM of 1.0-7.0 mm, AP of 344.0-1089.0 mm, CI of -47.7-0.0 degrees C, and ART of 26.1-45.0 degrees C. We conclude that the distribution patterns of Chinese sea buckthorn are related to the northwest winter monsoon, the southwest summer monsoon and the southeast summer monsoon systems in China.	[Li, Guoqing; Du, Sheng] Northwest A&F Univ, State Key Lab Soil Eros & Dryland Farming Loess P, Yangling 712100, Peoples R China; [Guo, Ke] Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing 100093, Peoples R China; [Li, Guoqing; Du, Sheng] Chinese Acad Sci & Minist Water Resources, Inst Soil & Water Conservat, Yangling 712100, Peoples R China	Northwest A&F University - China; Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; Institute of Soil & Water Conservation (ISWC), CAS; Ministry of Water Resources	Guo, K (corresponding author), Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing 100093, Peoples R China.	guoke@ibcas.ac.cn	DU, SHENG/A-7528-2008	DU, SHENG/0000-0002-5580-399X; Li, Guoqing/0000-0003-1767-3052	National Nature Science Foundation of China [31300407]; Public Welfare Scientific Research Project, Ministry of Environmental Protection of China [201209028]; Institute of Soil and Water Conservation, Chinese Academy of Sciences and Ministry of Water Resources [A315021441]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Public Welfare Scientific Research Project, Ministry of Environmental Protection of China; Institute of Soil and Water Conservation, Chinese Academy of Sciences and Ministry of Water Resources	The project was supported financially by the National Nature Science Foundation of China (No. 31300407), http://www.nsfc.gov.cn/; Public Welfare Scientific Research Project, Ministry of Environmental Protection of China (No. 201209028), http://www.zhb.gov.cn/; and Institute of Soil and Water Conservation, Chinese Academy of Sciences and Ministry of Water Resources (A315021441), http://www.iswc.ac.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An BL, 2004, GLOBAL SEABUCK RES D, V2, P12; BOOTH TH, 1988, FOREST ECOL MANAG, V23, P47, DOI 10.1016/0378-1127(88)90013-8; Booth TH, 2014, DIVERS DISTRIB, V20, P1, DOI 10.1111/ddi.12144; Brambilla M, 2012, J ANIM ECOL, V81, P781, DOI 10.1111/j.1365-2656.2012.01970.x; CARPENTER G, 1993, BIODIVERS CONSERV, V2, P667, DOI 10.1007/BF00051966; Chen X L, 2007, HIPPOPHAE, V20, P1; Chen YM, 2004, SCI SOIL WATER CONSE, V2, P88; Delectis Florae Reipublicae Popularis Sinicae Agendae Academiae Sinicae Edita, 1994, FLORA REIPUBLICAE PO; Editorial Committee for Physical Geography of China, 1985, PHYS GEOGR CHIN; Editorial Committee for Vegetation Atlas of China, 2001, 1 100 MILL VEG ATL C; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2010, METHODS ECOL EVOL, V1, P330, DOI 10.1111/j.2041-210X.2010.00036.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; ESRI, 2012, ARCGIS 9 3; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Franklin J, 2009, MAPPING SPECIES DIST; Gaston A, 2014, NEW FOREST, V45, P641, DOI 10.1007/s11056-014-9427-7; Gormley AM, 2011, J APPL ECOL, V48, P25, DOI 10.1111/j.1365-2664.2010.01911.x; Gu H, 2008, INT RES DEVEL SEABUC, V6, P10; Guisan A, 2013, ECOL LETT, V16, P1424, DOI 10.1111/ele.12189; Guisan A, 2011, J BIOGEOGR, V38, P1433, DOI 10.1111/j.1365-2699.2011.02550.x; Guo K, 2010, FOREST ECOL MANAG, V259, P2197, DOI 10.1016/j.foreco.2009.11.034; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hirzel AH, 2008, J APPL ECOL, V45, P1372, DOI 10.1111/j.1365-2664.2008.01524.x; Hodder DP, 2014, WILDLIFE BIOL, V20, P238, DOI 10.2981/wlb.00037; HOLDRIDGE LR, 1947, SCIENCE, V105, P367, DOI 10.1126/science.105.2727.367; HOU HY, 1983, ANN MO BOT GARD, V70, P509, DOI 10.2307/2992085; Kira T., 1945, NEW CLASSIFICATION C; Li GQ, 2014, FORESTS, V5, P2773, DOI 10.3390/f5112773; [李国庆 Li Guoqing], 2013, [生态学报, Acta Ecologica Sinica], V33, P4827; Li GQ, 2012, ECOL RES, V27, P427, DOI 10.1007/s11284-011-0914-4; Li T. S. C., 1996, HortTechnology, V6, P370; Lian Y, 1996, HIPPOPHAE, V9, P15; Lian YS, 1992, ACTA PHYTOTAX SINICA, V30, P349; Liu HY, 2015, APPL VEG SCI, V18, P43, DOI 10.1111/avsc.12139; Liu HY, 2002, PLANT ECOL, V158, P139, DOI 10.1023/A:1015515332254; Macfadyen S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040313; McKenzie D, 2003, J BIOGEOGR, V30, P1093, DOI 10.1046/j.1365-2699.2003.00921.x; Navarro-Cerrillo RM, 2011, APPL VEG SCI, V14, P256, DOI 10.1111/j.1654-109X.2010.01112.x; Nazeri M, 2014, ECOL INFORM, V20, P27, DOI 10.1016/j.ecoinf.2014.01.006; Nazeri M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048104; Nori J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025718; Pattison RR, 2008, GLOBAL CHANGE BIOL, V14, P813, DOI 10.1111/j.1365-2486.2007.01528.x; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Peterson AT, 2011, ECOLOGICAL NICHES GE; Petitpierre B, 2012, SCIENCE, V335, P1344, DOI 10.1126/science.1215933; Phillips S.J, 2004, P 21 INT C MACH LEAR, P83, DOI [10.1145/1015330.1015412, DOI 10.1145/1015330.1015412]; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2013, ECOLOGY, V94, P1409, DOI 10.1890/12-1520.1; Poutsma J, 2008, BIOCONTROL, V53, P103, DOI 10.1007/s10526-007-9140-y; Shabani F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083404; Shabani F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048021; Small E, 1996, BIODIVERISTY, V3, P25; Stockwell D, 1999, INT J GEOGR INF SCI, V13, P143, DOI 10.1080/136588199241391; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Taylor S, 2012, WEED RES, V52, P391, DOI 10.1111/j.1365-3180.2012.00930.x; Taylor S, 2013, J ENVIRON MANAGE, V114, P414, DOI 10.1016/j.jenvman.2012.10.039; Taylor S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035565; Toledo M, 2011, J ECOL, V99, P254, DOI 10.1111/j.1365-2745.2010.01741.x; Wellenreuther M, 2012, ECOLOGY, V93, P1353; Wisz MS, 2008, DIVERS DISTRIB, V14, P763, DOI 10.1111/j.1472-4642.2008.00482.x; Woodward F.I., 1987, CLIMATE PLANT DISTRI; Worldclim, 2014, GLOB CLIM DAT FREE C; Xiong B.Q., 2004, CHIN WILD PLANT RES, V23, P25; Xu W., 1985, CHINESE J ECOL, V3, P35; Yonow T, 1998, AUST J AGR RES, V49, P935, DOI 10.1071/A97152	66	27	28	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0131659	10.1371/journal.pone.0131659	http://dx.doi.org/10.1371/journal.pone.0131659			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177033	gold, Green Published			2022-12-26	WOS:000358197600057
J	Monteagudo, A; Santos, J				Monteagudo, Angel; Santos, Jose			Treatment Analysis in a Cancer Stem Cell Context Using a Tumor Growth Model Based on Cellular Automata	PLOS ONE			English	Article							THERAPEUTIC IMPLICATIONS; RESISTANCE; PERSPECTIVES; STRATEGIES; HALLMARKS; DYNAMICS	Cancer can be viewed as an emergent behavior in terms of complex system theory and artificial life, Cellular Automata (CA) being the tool most used for studying and characterizing the emergent behavior. Different approaches with CA models were used to model cancer growth. The use of the abstract model of acquired cancer hallmarks permits the direct modeling at cellular level, where a cellular automaton defines the mitotic and apoptotic behavior of cells, and allows for an analysis of different dynamics of the cellular system depending on the presence of the different hallmarks. A CA model based on the presence of hallmarks in the cells, which includes a simulation of the behavior of Cancer Stem Cells (CSC) and their implications for the resultant growth behavior of the multicellular system, was employed. This modeling of cancer growth, in the avascular phase, was employed to analyze the effect of cancer treatments in a cancer stem cell context. The model clearly explains why, after treatment against non-stem cancer cells, the regrowth capability of CSCs generates a faster regrowth of tumor behavior, and also shows that a continuous low-intensity treatment does not favor CSC proliferation and differentiation, thereby allowing an unproblematic control of future tumor regrowth. The analysis performed indicates that, contrary to the current attempts at CSC control, trying to make CSC proliferation more difficult is an important point to consider, especially in the immediate period after a standard treatment for controlling non-stem cancer cell proliferation.	[Monteagudo, Angel; Santos, Jose] Univ A Coruna, Dept Comp Sci, La Coruna 15071, Spain	Universidade da Coruna	Santos, J (corresponding author), Univ A Coruna, Dept Comp Sci, Campus Elvina S-N, La Coruna 15071, Spain.	santos@udc.es	Santos, Jose/H-8569-2014	Santos, Jose/0000-0002-4212-1367	Ministry of Economy and Competitiveness of Spain [TIN2013-40981-R]	Ministry of Economy and Competitiveness of Spain(Spanish Government)	This work was supported by Ministry of Economy and Competitiveness of Spain (project TIN2013-40981-R) (JS).	Abbott RG, 2006, ARTIF LIFE, V12, P617, DOI 10.1162/artl.2006.12.4.617; Adami C., 1998, INTRO ARTIFICIAL LIF; Basanta D, 2011, MATH BIOSCI, V229, P22, DOI 10.1016/j.mbs.2010.10.005; Chen K, 2013, ACTA PHARMACOL SIN, V34, P732, DOI 10.1038/aps.2013.27; Cortes-Dericks L, 2010, INT J ONCOL, V37, P437, DOI 10.3892/ijo_00000692; De Pillis LG, 2003, MATH COMPUT MODEL, V37, P1221, DOI 10.1016/S0895-7177(03)00133-X; Eisen MM, 1977, MATH MODELS CELL BIO; Enderling H, 2011, PROG BIOPHYS MOL BIO, V106, P391, DOI 10.1016/j.pbiomolbio.2011.03.007; Enderling H, 2010, ACTA BIOTHEOR, V58, P341, DOI 10.1007/s10441-010-9111-z; Gardner S.N., 2000, J THEOR MED, V2, P215, DOI [DOI 10.1080/10273660008833047, 10.1080/10273660008833047]; Gerlee P, 2007, J THEOR BIOL, V246, P583, DOI 10.1016/j.jtbi.2007.01.027; Gevertz JL, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/3/036010; Gibbs WW, 2003, SCI AM, V289, P56, DOI 10.1038/scientificamerican0703-56; Gil J, 2008, J APPL GENET, V49, P193, DOI 10.1007/BF03195612; Han L, 2013, ACTA PHARM SIN B, V3, P65, DOI 10.1016/j.apsb.2013.02.006; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hillen T, 2013, B MATH BIOL, V75, P161, DOI 10.1007/s11538-012-9798-x; Ilachinski A, 2001, CELLULAR AUTOMATA DE; Isaeva OG, 2009, COMPUT MATH METHOD M, V10, P253, DOI 10.1080/17486700802536054; Korkaya H, 2008, ONCOGENE, V27, P6120, DOI 10.1038/onc.2008.207; LANGTON CG, 1992, SFI S SCI C, V10, P41; Lavi O, 2012, DRUG RESIST UPDATE, V15, P90, DOI 10.1016/j.drup.2012.01.003; Monteagudo Angel, 2013, Natural and Artificial Computation in Engineering and Medical Applications. 5th International Work-Conference on the Interplay Between Natural and Artificial Computation, IWINAC 2013. Proceedings: LNCS 7931, P21, DOI 10.1007/978-3-642-38622-0_3; Monteagudo A, 2014, BIOSYSTEMS, V115, P46, DOI 10.1016/j.biosystems.2013.11.001; Morton CI, 2011, THEOR BIOL MED MODEL, V8, DOI 10.1186/1742-4682-8-48; NORTON L, 1977, CANCER TREAT REP, V61, P1307; Patel M, 2010, UNDERST COMPLEX SYST, P1, DOI 10.1007/978-3-642-15603-8; Rejniak KA, 2011, WIRES SYST BIOL MED, V3, P115, DOI 10.1002/wsbm.102; Ribba B, 2004, LECT NOTES COMPUT SC, V3305, P444; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Santos Jose, 2012, Parallel Problem Solving from Nature - PPSN XII. Proceedings of the 12th International Conference, P489, DOI 10.1007/978-3-642-32937-1_49; Santos J, 2015, IET SYST BIOL, V9, P75, DOI 10.1049/iet-syb.2014.0015; Savage N, 2012, NATURE, V491, pS62, DOI 10.1038/491S62a; Seluanov A, 2009, P NATL ACAD SCI USA, V106, P19352, DOI 10.1073/pnas.0905252106; Simon R, 2006, NAT CLIN PRACT ONCOL, V3, P406, DOI 10.1038/ncponc0560; Sottoriva A, 2010, CANCER RES, V70, P46, DOI 10.1158/0008-5472.CAN-09-3663; Spencer SL, 2006, PLOS COMPUT BIOL, V2, P939, DOI 10.1371/journal.pcbi.0020108; SWAN GW, 1990, MATH BIOSCI, V101, P237, DOI 10.1016/0025-5564(90)90021-P; Swierniak A, 1996, CELL PROLIFERAT, V29, P117, DOI 10.1046/j.1365-2184.1996.00995.x; Swierniak A, 2009, EUR J PHARMACOL, V625, P108, DOI 10.1016/j.ejphar.2009.08.041; Vainstein V, 2012, J THEOR BIOL, V298, P32, DOI 10.1016/j.jtbi.2011.12.016; Wodarz D, 2012, TRENDS GENET, V23, P32; Yap IKS, 2013, IEJSME, V7, pS19	44	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132306	10.1371/journal.pone.0132306	http://dx.doi.org/10.1371/journal.pone.0132306			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176702	Green Published, gold, Green Submitted			2022-12-26	WOS:000358197600098
J	Rogers, RL; Cridland, JM; Shao, L; Hu, TT; Andolfatto, P; Thornton, KR				Rogers, Rebekah L.; Cridland, Julie M.; Shao, Ling; Hu, Tina T.; Andolfatto, Peter; Thornton, Kevin R.			Tandem Duplications and the Limits of Natural Selection in Drosophila yakuba and Drosophila simulans	PLOS ONE			English	Article							PARALLEL MOLECULAR EVOLUTION; COPY-NUMBER POLYMORPHISM; AMINO-ACID SUBSTITUTIONS; CONVERGENT EVOLUTION; GENETIC ARCHITECTURE; RAPID EVOLUTION; GENOME ANALYSIS; PATTERNS; DNA; DIVERGENCE	Tandem duplications are an essential source of genetic novelty, and their variation in natural populations is expected to influence adaptive walks. Here, we describe evolutionary impacts of recently-derived, segregating tandem duplications in Drosophila yakuba and Drosophila simulans. We observe an excess of duplicated genes involved in defense against pathogens, insecticide resistance, chorion development, cuticular peptides, and lipases or endopeptidases associated with the accessory glands across both species. The observed agreement is greater than expectations on chance alone, suggesting large amounts of convergence across functional categories. We document evidence of widespread selection on the D. simulans X, suggesting adaptation through duplication is common on the X. Despite the evidence for positive selection, duplicates display an excess of low frequency variants consistent with largely detrimental impacts, limiting the variation that can effectively facilitate adaptation. Standing variation for tandem duplications spans less than 25% of the genome in D. yakuba and D. simulans, indicating that evolution will be strictly limited by mutation, even in organisms with large population sizes. Effective whole gene duplication rates are low at 1.17 x 10(-9) per gene per generation in D. yakuba and 6.03 x 10(-10) per gene per generation in D. simulans, suggesting long wait times for new mutations on the order of thousands of years for the establishment of sweeps. Hence, in cases where adaptation depends on individual tandem duplications, evolution will be severely limited by mutation. We observe low levels of parallel recruitment of the same duplicated gene in different species, suggesting that the span of standing variation will define evolutionary outcomes in spite of convergence across gene ontologies consistent with rapidly evolving phenotypes.	[Rogers, Rebekah L.] Univ Calif Berkeley, Ecol & Evolutionary Biol, Berkeley, CA 94720 USA; [Cridland, Julie M.] Univ Calif Davis, Ecol & Evolutionary Biol, Davis, CA 95616 USA; [Shao, Ling; Thornton, Kevin R.] Univ Calif Irvine, Ecol & Evolutionary Biol, Irvine, CA USA; [Hu, Tina T.; Andolfatto, Peter] Princeton Univ, Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Hu, Tina T.; Andolfatto, Peter] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA	University of California System; University of California Berkeley; University of California System; University of California Davis; University of California System; University of California Irvine; Princeton University; Princeton University	Rogers, RL (corresponding author), Univ Calif Berkeley, Ecol & Evolutionary Biol, Berkeley, CA 94720 USA.	bekah@berkeley.edu		Andolfatto, Peter/0000-0003-3393-4574; Thornton, Kevin/0000-0003-0743-4445	NIH Ruth Kirschstein National Research Service Award [F32-GM099377]; NIH [R01-GM085183, R01-GM083228]; National Cancer Institute of the National Institutes of Health [P30CA062203]; NATIONAL CANCER INSTITUTE [P30CA062203] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085183, F32GM099377, R01GM083228] Funding Source: NIH RePORTER	NIH Ruth Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	RLR is supported by NIH Ruth Kirschstein National Research Service Award F32-GM099377 (http://www.nih.gov/). Research funds were provided by NIH grant R01-GM085183 to KRT and R01-GM083228 to PA. All sequencing was performed at the UC Irvine High Throughput Genomics facility, which is supported by the National Cancer Institute of the National Institutes of Health under Award Number P30CA062203. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andolfatto P, 2007, GENOME RES, V17, P1755, DOI 10.1101/gr.6691007; Andolfatto P, 2011, GENOME BIOL EVOL, V3, P114, DOI 10.1093/gbe/evq086; Bachtrog D, 2006, EVOLUTION, V60, P292, DOI 10.1111/j.0014-3820.2006.tb01107.x; Bass C, 2011, PEST MANAG SCI, V67, P886, DOI 10.1002/ps.2189; Beckerman AP, 2013, ECOL EVOL, V3, P5119, DOI 10.1002/ece3.766; Begun DJ, 2007, PLOS BIOL, V5, P2534, DOI 10.1371/journal.pbio.0050310; Bhutkar A, 2008, GENETICS, V179, P1657, DOI 10.1534/genetics.107.086108; Brodie ED, 2010, CURR BIOL, V20, pR152, DOI 10.1016/j.cub.2009.12.029; Burke MK, 2010, NATURE, V467, P587, DOI 10.1038/nature09352; Cardoso-Moreira M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002340; Carneiro M, 2010, P NATL ACAD SCI USA, V107, P1747, DOI 10.1073/pnas.0906192106; Chan YF, 2010, SCIENCE, V327, P302, DOI 10.1126/science.1182213; CHAO A, 1984, SCAND J STAT, V11, P265; CHARLESWORTH B, 1993, GENETICS, V134, P1289; Chen LB, 1997, P NATL ACAD SCI USA, V94, P3817, DOI 10.1073/pnas.94.8.3817; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Claycomb JM, 2005, TRENDS GENET, V21, P149, DOI 10.1016/j.tig.2005.01.009; Clemente F, 2012, J EVOLUTION BIOL, V25, P1975, DOI 10.1111/j.1420-9101.2012.02580.x; Colosimo PF, 2005, SCIENCE, V307, P1928, DOI 10.1126/science.1107239; Conant GC, 2008, NAT REV GENET, V9, P938, DOI 10.1038/nrg2482; Coop G, 2012, GENETICS, V192, P205, DOI 10.1534/genetics.112.141861; Cridland JM, 2010, GENOME BIOL EVOL, V2, P83, DOI 10.1093/gbe/evq001; Cui Y, 2002, P NATL ACAD SCI USA, V99, P809, DOI 10.1073/pnas.022240299; Dopman EB, 2007, P NATL ACAD SCI USA, V104, P19920, DOI 10.1073/pnas.0709888104; Emerson JJ, 2008, SCIENCE, V320, P1629, DOI 10.1126/science.1158078; EWENS WJ, 1974, THEOR POPUL BIOL, V6, P143, DOI 10.1016/0040-5809(74)90020-3; Eyre-Walker A, 2002, MOL BIOL EVOL, V19, P2142, DOI 10.1093/oxfordjournals.molbev.a004039; ffrench-Constant RH, 2004, TRENDS GENET, V20, P163, DOI 10.1016/j.tig.2004.01.003; Gillespie J.H., 1991, CAUSES MOL EVOLUTION, P232; Giver L, 1998, CURR OPIN CHEM BIOL, V2, P335, DOI 10.1016/S1367-5931(98)80006-9; GOULD SJ, 1979, PROC R SOC SER B-BIO, V205, P581, DOI 10.1098/rspb.1979.0086; Haag-Liautard C, 2007, NATURE, V445, P82, DOI 10.1038/nature05388; Haddrill PR, 2008, MOL BIOL EVOL, V25, P1825, DOI 10.1093/molbev/msn125; Hahn MW, 2007, PLOS GENET, V3, P2135, DOI 10.1371/journal.pgen.0030197; Haldane JBS, 1927, P CAMB PHILOS SOC, V23, P838, DOI 10.1017/S0305004100015644; Halligan DL, 2006, GENOME RES, V16, P875, DOI 10.1101/gr.5022906; Hartl DL., 2007, PRINCIPLES POPULATIO, V4th Edition, P652; Hermisson J, 2005, GENETICS, V169, P2335, DOI 10.1534/genetics.104.036947; Hu TT, 2013, GENOME RES, V23, P89, DOI 10.1101/gr.141689.112; Jensen JD, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000198; Jones CD, 2005, P NATL ACAD SCI USA, V102, P11373, DOI 10.1073/pnas.0503528102; KAPLAN NL, 1989, GENETICS, V123, P887; Karasov T, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000924; Katju V, 2006, MOL BIOL EVOL, V23, P1056, DOI 10.1093/molbev/msj114; Khadjeh S, 2012, P NATL ACAD SCI USA, V109, P4921, DOI 10.1073/pnas.1116421109; KREITMAN M, 1983, NATURE, V304, P412, DOI 10.1038/304412a0; Lazarro BP, 2012, RAPIDLY EVOLVING GEN; LEMEUNIER F, 1976, PROC R SOC SER B-BIO, V193, P275, DOI 10.1098/rspb.1976.0046; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Llopart A, 2005, GENETICS, V171, P197, DOI 10.1534/genetics.104.033597; LONG MY, 1993, SCIENCE, V260, P91, DOI 10.1126/science.7682012; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Lynch M., 2007, ORIGINS GENOME ARCHI, P494; Lynch Michael, 2003, Journal of Structural and Functional Genomics, V3, P35, DOI 10.1023/A:1022696612931; Mackay TFC, 2012, NATURE, V482, P173, DOI 10.1038/nature10811; Magwire MM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002337; Martin A, 2012, P NATL ACAD SCI USA, V109, P12632, DOI 10.1073/pnas.1204800109; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Moxon ER, 1998, PERSPECT BIOL MED, V42, P154; Nielsen R, 2005, PLOS BIOL, V3, P976, DOI 10.1371/journal.pbio.0030170; Ohno S., 1970, EVOLUTION GENE DUPLI; Orozco-TerWengel P, 2012, MOL ECOL, V21, P4931, DOI 10.1111/j.1365-294X.2012.05673.x; Panhuis TM, 2006, PHILOS T R SOC B, V361, P261, DOI 10.1098/rstb.2005.1793; Parsch J, 2010, MOL BIOL EVOL, V27, P1226, DOI 10.1093/molbev/msq046; Presgraves DC, 2008, TRENDS GENET, V24, P336, DOI 10.1016/j.tig.2008.04.007; Reinhardt JA, 2014, GENETICS, V197, P361, DOI 10.1534/genetics.114.161463; Riehle MM, 2001, P NATL ACAD SCI USA, V98, P525, DOI 10.1073/pnas.021448998; Rogers RL, 2014, MOL BIOL EVOL, V31, P1750, DOI 10.1093/molbev/msu124; Rogers RL, 2012, MOL BIOL EVOL, V29, P517, DOI 10.1093/molbev/msr184; Rogers RL, 2009, GENETICS, V181, P313, DOI 10.1534/genetics.108.091538; Rosenberg NA, 2003, EVOLUTION, V57, P1465, DOI 10.1554/03-012; Schmidt JM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000998; Shapiro MD, 2009, CURR BIOL, V19, P1140, DOI 10.1016/j.cub.2009.05.029; Shih HJ, 2008, GENETICS, V180, P1261, DOI 10.1534/genetics.108.090068; SMITH JM, 1971, J THEOR BIOL, V30, P319, DOI 10.1016/0022-5193(71)90058-0; Smith JM, 2007, GENET RES, V89, P391, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; Stern DL, 2013, NAT REV GENET, V14, P751, DOI 10.1038/nrg3483; TAJIMA F, 1989, GENETICS, V123, P585; TAJIMA F, 1983, GENETICS, V105, P437; Tamura K, 2004, MOL BIOL EVOL, V21, P36, DOI 10.1093/molbev/msg236; Tanaka K, 2009, P NATL ACAD SCI USA, V106, P4764, DOI 10.1073/pnas.0807875106; Tenaillon O, 2012, SCIENCE, V335, P457, DOI 10.1126/science.1212986; Thornton K, 2005, MOL BIOL EVOL, V22, P273, DOI 10.1093/molbev/msi015; Thornton K, 2003, BIOINFORMATICS, V19, P2325, DOI 10.1093/bioinformatics/btg316; Thornton K, 2002, MOL BIOL EVOL, V19, P918, DOI 10.1093/oxfordjournals.molbev.a004149; Van Valen L., 1973, EVOL THEORY, V1, P1, DOI DOI 10.1038/344864A0; Wakeley J., 2009, COALESCENT THEORY IN, P97; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Wittkopp PJ, 2003, P NATL ACAD SCI USA, V100, P1808, DOI 10.1073/pnas.0336368100; Woods R, 2006, P NATL ACAD SCI USA, V103, P9107, DOI 10.1073/pnas.0602917103; Zhang JM, 2004, P NATL ACAD SCI USA, V101, P16246, DOI 10.1073/pnas.0407066101; Zhang YE, 2010, GENOME RES, V20, P1526, DOI 10.1101/gr.107334.110; Zhen Y, 2012, SCIENCE, V337, P1634, DOI 10.1126/science.1226630; Zhou Q, 2008, GENOME RES, V18, P1446, DOI 10.1101/gr.076588.108; Zichner T, 2013, GENOME RES, V23, P568, DOI 10.1101/gr.142646.112	95	17	17	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132184	10.1371/journal.pone.0132184	http://dx.doi.org/10.1371/journal.pone.0132184			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176952	gold, Green Submitted, Green Published			2022-12-26	WOS:000358197600086
J	Zhang, PZ; Howell, K; Krstic, M; Herderich, M; Barlow, EWR; Fuentes, S				Zhang, Pangzhen; Howell, Kate; Krstic, Mark; Herderich, Markus; Barlow, Edward William R.; Fuentes, Sigfredo			Environmental Factors and Seasonality Affect the Concentration of Rotundone in Vitis vinifera L. cv. Shiraz Wine	PLOS ONE			English	Article							NINO-SOUTHERN-OSCILLATION; RED WINE; SURFACE-TEMPERATURE; SENSORY ATTRIBUTES; VINEYARD VARIATION; WINEGRAPE QUALITY; BERRY DEVELOPMENT; WITHIN-VINEYARD; AROMA COMPOUND; CLIMATE-CHANGE	Rotundone is a sesquiterpene that gives grapes and wine a desirable 'peppery' aroma. Previous research has reported that growing grapevines in a cool climate is an important factor that drives rotundone accumulation in grape berries and wine. This study used historical data sets to investigate which weather parameters are mostly influencing rotundone concentration in grape berries and wine. For this purpose, wines produced from 15 vintages from the same Shiraz vineyard (The Old Block, Mount Langi Ghiran, Victoria, Australia) were analysed for rotundone concentration and compared to comprehensive weather data and minimal temperature information. Degree hours were obtained by interpolating available temperature information from the vineyard site using a simple piecewise cubic hermite interpolating polynomial method (PCHIP). Results showed that the highest concentrations of rotundone were consistently found in wines from cool and wet seasons. The Principal Component Analysis (PCA) showed that the concentration of rotundone in wine was negatively correlated with daily solar exposure and grape bunch zone temperature, and positively correlated with vineyard water balance. Finally, models were constructed based on the Gompertz function to describe the dynamics of rotundone concentration in berries through the ripening process according to phenological and thermal times. This characterisation is an important step forward to potentially predict the final quality of the resultant wines based on the evolution of specific compounds in berries according to critical environmental and micrometeorological variables. The modelling techniques described in this paper were able to describe the behaviour of rotundone concentration based on seasonal weather conditions and grapevine phenological stages, and could be potentially used to predict the final rotundone concentration early in future growing seasons. This could enable the adoption of precision irrigation and canopy management strategies to effectively mitigate adverse impacts related to climate change and microclimatic variability, such as heat waves, within a vineyard on wine quality.	[Zhang, Pangzhen; Howell, Kate; Barlow, Edward William R.; Fuentes, Sigfredo] Univ Melbourne, Dept Agr & Food Syst, Parkville, Vic 3052, Australia; [Krstic, Mark] Australian Wine Res Inst, Port Melbourne, Vic, Australia; [Herderich, Markus] Australian Wine Res Inst, Urrbrae, SA, Australia	University of Melbourne; Australian Wine Research Institute; Australian Wine Research Institute	Fuentes, S (corresponding author), Univ Melbourne, Dept Agr & Food Syst, Parkville, Vic 3052, Australia.	sfuentes@unimelb.edu.au	Howell, Kate/M-2370-2013; Fuentes, Sigfredo/J-6238-2015	Howell, Kate/0000-0001-6498-0472; Fuentes, Sigfredo/0000-0002-0377-5085; Zhang, Pangzhen/0000-0002-9794-2269	Rathbone Wine Group; University of Melbourne; Australian Wine Research Institute (AWRI); Australia Grape and Wine Authority; Australian Government [GWR Ph1203]; Faculty of Veterinary and Agricultural Sciences, University of Melbourne; Australian Wine Research Institute	Rathbone Wine Group; University of Melbourne(University of Melbourne); Australian Wine Research Institute (AWRI); Australia Grape and Wine Authority(Australian Grape and Wine Authority); Australian Government(Australian GovernmentCGIAR); Faculty of Veterinary and Agricultural Sciences, University of Melbourne; Australian Wine Research Institute	This work was jointly sponsored by the Rathbone Wine Group, The University of Melbourne, The Australian Wine Research Institute (AWRI) and Australia Grape and Wine Authority. The work was performed at University of Melbourne and AWRI, and supported by Australia's grape growers and winemakers through their investment body, the Australia Grape and Wine Authority, with matching funds from the Australian Government (Grant number: GWR Ph1203). Funding was also received from the Faculty of Veterinary and Agricultural Sciences, University of Melbourne. Co-authors Mark Krstic and Markus Herderich are employed by Australian Wine Research Institute. Australian Wine Research Institute provided support in the form of salaries for authors MK and MH, and provided support in data collection, but did not have any additional role in the study design, data analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. Rathbone Wine Group had a role in data collection, but had no role in study design, data analysis, decision to publish, or preparation of the manuscript. Australia Grape and Wine Authority had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bramley RGV, 2011, AUST J GRAPE WINE R, V17, P217, DOI 10.1111/j.1755-0238.2011.00136.x; Bramley RGV, 2004, AUST J GRAPE WINE R, V10, P32, DOI 10.1111/j.1755-0238.2004.tb00006.x; Capone DL, 2012, J AGR FOOD CHEM, V60, P2281, DOI 10.1021/jf204499h; Chaves MM, 2007, ANN APPL BIOL, V150, P237, DOI 10.1111/j.1744-7348.2006.00123.x; Chiew FHS, 1998, J HYDROL, V204, P138, DOI 10.1016/S0022-1694(97)00121-2; CSIRO and Bureau of Meteorology, 2015, TECHNICAL REPORT; DEARDORFF JW, 1978, J GEOPHYS RES-OCEANS, V83, P1889, DOI 10.1029/JC083iC04p01889; Deluc LG, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-212; Downey MO, 2004, AUST J GRAPE WINE R, V10, P55, DOI 10.1111/j.1755-0238.2004.tb00008.x; Geffroy O, 2014, AUST J GRAPE WINE R, V20, P401, DOI 10.1111/ajgw.12084; Gholami M., 1995, Australian Journal of Grape and Wine Research, V1, P19, DOI 10.1111/j.1755-0238.1995.tb00073.x; Gil M, 2012, PHYTOCHEMISTRY, V77, P89, DOI 10.1016/j.phytochem.2011.12.011; Gladstones J, 2004, VITICULTURE RESOURCE, V1, P90; Gladstones J. S., 1992, VITICULTURE ENV STUD; Gowan E, 1995, J CHEM ECOL, V21, P1781, DOI 10.1007/BF02033676; Herderich MJ., 2012, ACS SYM SER, V1104, P3, DOI DOI 10.1021/BK-2012-1104.CH001; Huang AC, 2014, J AGR FOOD CHEM, V62, P10809, DOI 10.1021/jf504693e; Jeffery D. W., 2009, TECHNICAL REV, V180, P11; Jones DA, 2000, INT J CLIMATOL, V20, P697, DOI 10.1002/1097-0088(20000615)20:7&lt;697::AID-JOC499&gt;3.0.CO;2-A; Jones DA, 2009, AUST METEOROL OCEAN, V58, P233, DOI 10.22499/2.5804.003; LINACRE ET, 1977, AGR METEOROL, V18, P409, DOI 10.1016/0002-1571(77)90007-3; Marais J., 2001, South African Journal of Enology and Viticulture, V22, P22; May B, 2012, FLAVOUR FRAG J, V27, P280, DOI 10.1002/ffj.3096; Murphy BF, 2008, INT J CLIMATOL, V28, P859, DOI 10.1002/joc.1627; Ou CR, 2010, J AGR FOOD CHEM, V58, P12890, DOI 10.1021/jf102587x; Pieterse CMJ, 2012, ANNU REV CELL DEV BI, V28, P489, DOI 10.1146/annurev-cellbio-092910-154055; Pudney S, 2004, SOIL IRRIGATION NUTR, P148; Scarlett NJ, 2014, AUST J GRAPE WINE R, V20, P214, DOI 10.1111/ajgw.12075; Siebert T. E, 2010, P 14 AUSTR WIN IND T; Siebert TE, 2008, J AGR FOOD CHEM, V56, P3745, DOI 10.1021/jf800184t; Skinkis PA, 2010, AM J ENOL VITICULT, V61, P147; SMART RE, 1985, AM J ENOL VITICULT, V36, P230; Soar CJ, 2008, AUST J GRAPE WINE R, V14, P78, DOI 10.1111/j.1755-0238.2008.00011.x; Turgeon R, 2004, PLANT PHYSIOL, V136, P3795, DOI 10.1104/pp.104.042036; Webb LB, 2008, CLIM RES, V36, P89, DOI 10.3354/cr00739; Webb LB, 2008, CLIM RES, V36, P99, DOI 10.3354/cr00740; Webb LB, 2013, AUST J GRAPE WINE R, V19, P331, DOI 10.1111/ajgw.12045; Williamson PO, 2012, AUST J GRAPE WINE R, V18, P256, DOI 10.1111/j.1755-0238.2012.00201.x; Winter E, 2010, VERAISON HARVEST GRO; Wood C, 2008, J AGR FOOD CHEM, V56, P3738, DOI 10.1021/jf800183k; Zhang HH, 2014, FOOD CHEM, V164, P242, DOI 10.1016/j.foodchem.2014.05.012; Zhang PZ, 2015, J AGR FOOD CHEM, V63, P4276, DOI 10.1021/acs.jafc.5b00590	42	30	30	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0133137	10.1371/journal.pone.0133137	http://dx.doi.org/10.1371/journal.pone.0133137			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176692	gold, Green Published			2022-12-26	WOS:000358197600218
J	Zhou, YY; Ji, XF; Fu, JP; Zhu, XJ; Li, RH; Mu, CK; Wang, CL; Song, WW				Zhou, Yue-Yue; Ji, Xiong-Fei; Fu, Jian-Ping; Zhu, Xiao-Juan; Li, Rong-Hua; Mu, Chang-Kao; Wang, Chun-Lin; Song, Wei-Wei			Gene Transcriptional and Metabolic Profile Changes in Mimetic Aging Mice Induced by D-Galactose	PLOS ONE			English	Article							AMELIORATES COGNITION DEFICITS; ATTENUATES OXIDATIVE DAMAGE; SMOOTH-MUSCLE-CELLS; CARDIOVASCULAR-DISEASE; LYSOPHOSPHATIDIC ACID; JAGGED1 EXPRESSION; INSULIN-RESISTANCE; ADVANCED GLYCATION; ENDOTHELIAL-CELLS; MEMORY IMPAIRMENT	D-galactose injection has been shown to induce many changes in mice that represent accelerated aging. This mouse model has been widely used for pharmacological studies of anti-aging agents. The underlying mechanism of D-galactose induced aging remains unclear, however, it appears to relate to glucose and 1ipid metabolic disorders. Currently, there has yet to be a study that focuses on investigating gene expression changes in D-galactose aging mice. In this study, integrated analysis of gas chromatography/mass spectrometry- based metabonomics and gene expression profiles was used to investigate the changes in transcriptional and metabolic profiles in mimetic aging mice injected with D-galactose. Our findings demonstrated that 48 mRNAs were differentially expressed between control and D-galactose mice, and 51 potential biomarkers were identified at the metabolic level. The effects of D-galactose on aging could be attributed to glucose and 1ipid metabolic disorders, oxidative damage, accumulation of advanced glycation end products (AGEs), reduction in abnormal substance elimination, cell apoptosis, and insulin resistance.	[Zhou, Yue-Yue; Ji, Xiong-Fei; Fu, Jian-Ping; Zhu, Xiao-Juan; Li, Rong-Hua; Mu, Chang-Kao; Wang, Chun-Lin; Song, Wei-Wei] Ningbo Univ, Key Lab Minist Educ Appl Marine Biotechnol, Ningbo 315211, Zhejiang, Peoples R China; [Zhou, Yue-Yue; Ji, Xiong-Fei; Fu, Jian-Ping; Zhu, Xiao-Juan; Li, Rong-Hua; Mu, Chang-Kao; Wang, Chun-Lin; Song, Wei-Wei] Ningbo Univ, Collaborat Innovat Ctr Zhejiang Marine High Effic, Ningbo 315211, Zhejiang, Peoples R China	Ningbo University; Ningbo University	Wang, CL (corresponding author), Ningbo Univ, Sch Marine Sci, Ningbo 315211, Zhejiang, Peoples R China.	wangchunlin@nbu.edu.cn; songweiwei@nbu.edu.cn			National Natural Science Foundation of China [41176124, 41206114]; Zhejiang Province Science and Technology Hall [LQ12C19002, ZX2013000403]; Zhejiang Province Department of Education [Y201224605]; Ningbo University [XKL11D2102, XYL12005]; K. C. Wong Magana Fund, Ningbo University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Province Science and Technology Hall; Zhejiang Province Department of Education; Ningbo University; K. C. Wong Magana Fund, Ningbo University	Funding provided by 41176124, National Natural Science Foundation of China to WWS, 41206114, National Natural Science Foundation of China to WWS, LQ12C19002, Zhejiang Province Science and Technology Hall to WWS, ZX2013000403, Zhejiang Province Science and Technology Hall to WWS, Y201224605, Zhejiang Province Department of Education to WWS, XKL11D2102, Ningbo University to WWS, XYL12005, Ningbo University to WWS, and K. C. Wong Magana Fund, Ningbo University to WWS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed MH, 2014, SCAND J GASTROENTERO, V49, P521, DOI 10.3109/00365521.2014.894119; Anderson DH, 2010, PROG RETIN EYE RES, V29, P95, DOI 10.1016/j.preteyeres.2009.11.003; Beger RD, 2010, TOXICOL APPL PHARM, V243, P154, DOI 10.1016/j.taap.2009.11.019; Bektas M, 2005, J CELL BIOL, V169, P801, DOI 10.1083/jcb.200407123; Bosch AM, 2006, J INHERIT METAB DIS, V29, P516, DOI 10.1007/s10545-006-0382-0; Christensen K, 2006, NAT REV GENET, V7, P436, DOI 10.1038/nrg1871; Cui X, 2004, BIOGERONTOLOGY, V5, P317, DOI 10.1007/s10522-004-2570-3; Cuvillier O, 2002, BBA-MOL CELL BIOL L, V1585, P153, DOI 10.1016/S1388-1981(02)00336-0; Deng HB, 2006, BIOMED ENVIRON SCI, V19, P432; Du ZY, 2011, LIPIDS, V46, P647, DOI 10.1007/s11745-011-3569-6; ETHIER MF, 1989, MECH AGEING DEV, V50, P159, DOI 10.1016/0047-6374(89)90011-0; FRATTALI AL, 1994, CLIN CHEM, V40, P1991; Furukawa T, 2003, AM J PATHOL, V162, P1807, DOI 10.1016/S0002-9440(10)64315-5; Hao L, 2014, NEUROSCI LETT, V571, P45, DOI 10.1016/j.neulet.2014.04.038; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Ho SC, 2003, BIOGERONTOLOGY, V4, P15, DOI 10.1023/A:1022417102206; Imam MU, 2014, J FUNCT FOODS, V8, P193, DOI 10.1016/j.jff.2014.03.013; Katiyar SK, 2007, FREE RADICAL BIO MED, V42, P299, DOI 10.1016/j.freeradbiomed.2006.10.049; Kawatani M, 2008, P NATL ACAD SCI USA, V105, P11691, DOI 10.1073/pnas.0712239105; LaRocca TJ, 2013, MECH AGEING DEV, V134, P314, DOI 10.1016/j.mad.2013.04.004; Leclercq IA, 2007, J HEPATOL, V47, P142, DOI 10.1016/j.jhep.2007.04.002; Lightle SA, 2000, MECH AGEING DEV, V120, P111, DOI 10.1016/S0047-6374(00)00191-3; Liu CT, 1998, CANCER GENE THER, V5, P3; Loomes KM, 1999, HUM MOL GENET, V8, P2443, DOI 10.1093/hmg/8.13.2443; Lu J, 2006, BEHAV BRAIN RES, V171, P251, DOI 10.1016/j.bbr.2006.03.043; Lu J, 2007, BIOCHEM PHARMACOL, V74, P1078, DOI 10.1016/j.bcp.2007.07.007; Lundwall A, 2008, CELL MOL LIFE SCI, V65, P2019, DOI 10.1007/s00018-008-8024-3; Madeo F, 2010, AUTOPHAGY, V6, P160, DOI 10.4161/auto.6.1.10600; McCubrey JA, 2006, ANTIOXID REDOX SIGN, V8, P1775, DOI 10.1089/ars.2006.8.1775; Melon I, 2009, NEUROSCIENCE, V159, P657, DOI 10.1016/j.neuroscience.2008.11.056; Mobley AS, 2014, TRENDS NEUROSCI, V37, P77, DOI 10.1016/j.tins.2013.11.004; Moran O, 2003, Pediatr Diabetes, V4, P101, DOI 10.1034/j.1399-5448.2003.00017.x; Morishita K, 2001, J NUTR, V131, P3182, DOI 10.1093/jn/131.12.3182; Nass N, 2007, Z GERONTOL GERIATR, V40, P349, DOI 10.1007/s00391-007-0484-9; Nguyen LN, 2014, NATURE, V509, P503, DOI 10.1038/nature13241; Nicholson JK, 2008, NATURE, V455, P1054, DOI 10.1038/4551054a; Nicholson JK, 1999, XENOBIOTICA, V29, P1181, DOI 10.1080/004982599238047; Nicholson JK, 2002, NAT REV DRUG DISCOV, V1, P153, DOI 10.1038/nrd728; Qian DH, 2011, INT J MOL MED, V28, P207, DOI 10.3892/ijmm.2011.671; Racape M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019321; Rothschild SC, 2007, DEV DYNAM, V236, P295, DOI 10.1002/dvdy.21005; SALGANIK RI, 1994, BIOCHEM BIOPH RES CO, V199, P726, DOI 10.1006/bbrc.1994.1289; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; SHANG F, 1995, BIOCHEM J, V307, P297, DOI 10.1042/bj3070297; Shimizu K, 1999, J BIOL CHEM, V274, P32961, DOI 10.1074/jbc.274.46.32961; Shimokata H., 2012, ANTIAGING MED, V9, P185; Song X, 1999, MECH AGEING DEV, V108, P239, DOI 10.1016/S0047-6374(99)00022-6; Sotiropoulou G, 2009, J BIOL CHEM, V284, P32989, DOI 10.1074/jbc.R109.027946; Spiegel S, 1998, ANN NY ACAD SCI, V845, P11, DOI 10.1111/j.1749-6632.1998.tb09658.x; Sugiura T, 2002, J LIPID RES, V43, P2049, DOI 10.1194/jlr.M200242-JLR200; Sun JH, 2015, MOL NEUROBIOL, V51, P947, DOI 10.1007/s12035-014-8749-y; Takeda E, 2004, BIOFACTORS, V21, P345, DOI 10.1002/biof.552210167; Tian ES, 2013, FOOD DRUG, V15, P168; Toroser D, 2007, BIOCHEM J, V405, P583, DOI 10.1042/BJ20061868; Vina J, 2013, ANTIOXID REDOX SIGN, V19, P779, DOI 10.1089/ars.2012.5111; Waggoner DW, 2004, J BIOL CHEM, V279, P38228, DOI 10.1074/jbc.M405932200; Weinert BT, 2003, J APPL PHYSIOL, V95, P1706, DOI 10.1152/japplphysiol.00288.2003; Willems L, 2003, EXP GERONTOL, V38, P1169, DOI 10.1016/j.exger.2003.08.003; Wu XJ, 2008, CARDIOVASC RES, V77, P800, DOI 10.1093/cvr/cvm105; Yang SH, 2005, J CHENGDE MED COLL, V22, P99; Yang ZH, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-120; Yoder JA, 2002, GENOMICS, V79, P750, DOI 10.1006/geno.2002.6768; Yu X, 2011, EMBO J, V30, P3754, DOI 10.1038/emboj.2011.277; Zanger UM, 2013, PHARMACOL THERAPEUT, V138, P103, DOI 10.1016/j.pharmthera.2012.12.007; Zhang D, 2006, J ETHNOPHARMACOL, V104, P250, DOI 10.1016/j.jep.2005.09.010; Zhang XL, 2007, PHARMACOL BIOCHEM BE, V88, P64, DOI 10.1016/j.pbb.2007.07.004; Zhang ZF, 2009, FOOD CHEM TOXICOL, V47, P496, DOI 10.1016/j.fct.2008.12.005; Zhong C, 2012, INT J PHARM MED, V18, P1844; Zhong Y, 2007, CHINESE REMEDIES CLI, V7, P576; Zhu Ya-zhen, 2007, Fudan Xuebao (Yixueban), V34, P617	70	35	37	3	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132088	10.1371/journal.pone.0132088	http://dx.doi.org/10.1371/journal.pone.0132088			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176541	Green Published, gold, Green Submitted			2022-12-26	WOS:000358197600081
J	Carvalho, MS; Coeli, CM; Chor, D; Pinheiro, RS; da Fonseca, MDM; Carvalho, LCD				Carvalho, Marilia Sa; Coeli, Claudia Medina; Chor, Dora; Pinheiro, Rejane Sobrino; Mendes da Fonseca, Maria de Jesus; de Sa Carvalho, Luiz Carlos			The Challenge of Cardiovascular Diseases and Diabetes to Public Health: A Study Based on Qualitative Systemic Approach	PLOS ONE			English	Article							SOCIOECONOMIC POSITION; BLOOD-PRESSURE; SOCIAL-PARTICIPATION; WORK CHARACTERISTICS; AMERICAN-COLLEGE; ADVERSE EVENTS; AIR-POLLUTION; CARE; LIFE; RISK	The most common modeling approaches to understanding incidence, prevalence and control of chronic diseases in populations, such as statistical regression models, are limited when it comes to dealing with the complexity of those problems. Those complex adaptive systems have characteristics such as emerging properties, self-organization and feedbacks, which structure the system stability and resistance to changes. Recently, system science approaches have been proposed to deal with the range, complexity, and multifactor nature of those public health problems. In this paper we applied a multilevel systemic approach to create an integrated, coherent, and increasingly precise conceptual framework, capable of aggregating different partial or specialized studies, based on the challenges of the Longitudinal Study of Adult Health - ELSA-Brasil. The failure to control blood pressure found in several of the study's subjects was discussed, based on the proposed model, analyzing different loops, time lags, and feedback that influence this outcome in a population with high educational level, with reasonably good health services access. We were able to identify the internal circularities and cycles that generate the system's resistance to change. We believe that this study can contribute to propose some new possibilities of the research agenda and to the discussion of integrated actions in the field of public health.	[Carvalho, Marilia Sa] Fundacao Oswaldo Cruz, Comp Sci Program, Antiga Residencia Oficial, Rio De Janeiro, RJ, Brazil; [Coeli, Claudia Medina; Pinheiro, Rejane Sobrino] Univ Fed Rio de Janeiro, Inst Studies Collect Health, Rio De Janeiro, RJ, Brazil; [Chor, Dora; Mendes da Fonseca, Maria de Jesus] Fundacao Oswaldo Cruz, Dept Epidemiol, Natl Sch Publ Hlth, Rio De Janeiro, RJ, Brazil; [de Sa Carvalho, Luiz Carlos] Pontificia Univ Catolica Rio de Janeiro, Rio De Janeiro, RJ, Brazil	Fundacao Oswaldo Cruz; Universidade Federal do Rio de Janeiro; Fundacao Oswaldo Cruz; Pontificia Universidade Catolica do Rio de Janeiro	Carvalho, MS (corresponding author), Fundacao Oswaldo Cruz, Comp Sci Program, Antiga Residencia Oficial, Rio De Janeiro, RJ, Brazil.	carvalho@fiocruz.br	Pinheiro, Rejane S/J-5129-2015; CARVALHO, MARILIA S/C-3425-2013; CARVALHO, MARILIA/AAD-8283-2020; Coeli, Claudia M/P-4214-2016	Pinheiro, Rejane S/0000-0002-3361-3626; CARVALHO, MARILIA/0000-0002-9566-0284; Coeli, Claudia M/0000-0003-1757-3940	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [309692/2013-0, 300694/2010-5, 309728/2012-6]; FAPERJ - Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro [E_26/2014-203577]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERJ - Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	MSC, DC and RSP received a grant from the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (http://www.cnpq.br/) under award numbers 309692/2013-0, 300694/2010-5 and 309728/2012-6, respectively. MSC received a grant from FAPERJ - Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (http://www.faperj.br/) E_26/2014-203577.	Ackoff R, 2010, DIFFERENCES THAT MAK; Adler N, 2012, P NATL ACAD SCI USA, V109, P17154, DOI 10.1073/pnas.1121399109; Amico KR, 2011, J HEALTH PSYCHOL, V16, P1071, DOI 10.1177/1359105311398727; ANDERSEN RM, 1995, J HEALTH SOC BEHAV, V36, P1, DOI 10.2307/2137284; Anderson CA, 2002, SCIENCE, V295, P2377, DOI 10.1126/science.1070765; Annagur BB, 2014, PAIN MED, V15, P772, DOI 10.1111/pme.12390; [Anonymous], 2010, B WORLD HEALTH ORGAN, V88, P646, DOI 10.2471/BLT.10.020910; [Anonymous], NETWORKS AN INTRODUC; [Anonymous], DOENCAS ISENTAM APOS; Anthony David, 2014, FP Essent, V421, P11; Appleton AA, 2013, CIRCULATION, V127, P905, DOI 10.1161/CIRCULATIONAHA.112.115782; Aquino EML, 2012, AM J EPIDEMIOL, V175, P315, DOI 10.1093/aje/kwr294; Atkinson RW, 2014, THORAX, V69, P660, DOI 10.1136/thoraxjnl-2013-204492; Auchincloss AH, 2011, AM J PREV MED, V40, P303, DOI 10.1016/j.amepre.2010.10.033; Axon RN, 2010, AM J HYPERTENS, V23, P30, DOI 10.1038/ajh.2009.199; Babisch W, 2014, ENVIRON HEALTH PERSP, V122, P492, DOI 10.1289/ehp.1306981; Barclay KJ, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-784; Barros AJD, 2011, CAD SAUDE PUBLICA, V27, pS254, DOI 10.1590/S0102-311X2011001400012; Bateson G, 1972, STEPS TO AN ECOLOGY; Berkman LF, 2004, EPIDEMIOL REV, V26, P2, DOI 10.1093/epirev/mxh012; Berkman LE, 2009, ANNU REV PUBL HEALTH, V30, P27, DOI 10.1146/annurev.publhealth.031308.100310; Blackett PR, 2013, J CLIN LIPIDOL, V7, P65, DOI 10.1016/j.jacl.2012.04.079; Bossel H, 2007, SYSTEMS AND MODELS C; Braveman P, 2011, ANNU REV PUBL HEALTH, V32, P381, DOI 10.1146/annurev-publhealth-031210-101218; Brook RD, 2009, HYPERTENSION, V54, P659, DOI 10.1161/HYPERTENSIONAHA.109.130237; Carrington MJ, 2013, J HYPERTENS, V31, P1265, DOI 10.1097/HJH.0b013e3283606bc7; Gomes FDC, 2014, CAD SAUDE PUBLICA, V30, P31, DOI 10.1590/0102-311X00176812; Chekland P, 1998, SOFT SYSTEMS METHODO; Chen H, 2014, INT J ENV RES PUB HE, V11, P5170, DOI 10.3390/ijerph110505170; Cheng JJ, 2013, INT J PUBLIC HEALTH, V58, P305, DOI 10.1007/s00038-012-0422-5; Cornelissen E, 2014, HEALTH POLICY, V117, P266, DOI 10.1016/j.healthpol.2014.04.010; de Camargo KR, 2013, REV SAUDE PUBL, V47, DOI 10.1590/S0034-8910.2013047004777; De F, 2014, J SCI FOOD AGR, V94, P1958, DOI [10.1002/jsfa.6163, DOI 10.1002/JSFA.6163]; Pinto JMD, 2012, CIENC SAUDE COLETIVA, V17, P521, DOI 10.1590/S1413-81232012000200025; de Vries EN, 2008, QUAL SAF HEALTH CARE, V17, P216, DOI 10.1136/qshc.2007.023622; de Water HV, 2007, J OPER RES SOC, V58, P271, DOI 10.1057/palgrave.jors.2602156; Descartes R, 2001, DISCOURSE ON THE MET; Diez-Roux AV, 2000, ANNU REV PUBL HEALTH, V21, P171, DOI 10.1146/annurev.publhealth.21.1.171; Dobelli R, 2013, GUARDIAN; Donihi AC, 2006, QUAL SAF HEALTH CARE, V15, P89, DOI 10.1136/qshc.2005.014381; Dooris M, 2013, J URBAN HEALTH, V90, pS74, DOI 10.1007/s11524-011-9623-0; Egede LE, 2010, GEN HOSP PSYCHIAT, V32, P563, DOI 10.1016/j.genhosppsych.2010.08.002; Eijkenaar F, 2013, HEALTH POLICY, V110, P115, DOI 10.1016/j.healthpol.2013.01.008; El-Sayed Abdulrahman M, 2012, Epidemiol Perspect Innov, V9, P1, DOI 10.1186/1742-5573-9-1; Ellaway A, 2007, SOC SCI MED, V64, P1384, DOI 10.1016/j.socscimed.2006.11.022; Engum A, 2007, J PSYCHOSOM RES, V62, P31, DOI 10.1016/j.jpsychores.2006.07.009; EVANS RG, 1990, SOC SCI MED, V31, P1347, DOI 10.1016/0277-9536(90)90074-3; Fontbonne A, 2013, CAD SAUDE PUBLICA, V29, P1195, DOI 10.1590/S0102-311X2013001000016; Freudenberg N, 2014, LETHAL BUT LEGAL COR; Freudenberg N, 2009, HEALTH EDUC BEHAV, V36, P230, DOI 10.1177/1090198107301330; Galea S, 2008, HANDBOOK OF URBAN HE; Galea S, 2007, MACROSOCIAL DETERMIN; Ganster DC, 2013, J MANAGE, V39, P1085, DOI 10.1177/0149206313475815; Glasgow RE, 2012, AM J PUBLIC HEALTH, V102, P1274, DOI 10.2105/AJPH.2012.300755; Glass TA, 2013, ANNU REV PUBL HEALTH, V34, P61, DOI 10.1146/annurev-publhealth-031811-124606; Greer S, 2014, PREV CHRONIC DIS, V11, DOI 10.5888/pcd11.130340; Gruenewald TL, 2012, SOC SCI MED, V74, P75, DOI 10.1016/j.socscimed.2011.09.037; Haluza D, 2014, INT J ENV RES PUB HE, V11, P5445, DOI 10.3390/ijerph110505445; Hammond RA, 2012, P NATL ACAD SCI USA, V109, P12356, DOI 10.1073/pnas.0913003109; Hawkley LC, 2003, J PERS SOC PSYCHOL, V85, P105, DOI 10.1037/0022-3514.85.1.105; Herder C, 2014, DIABETOLOGIA, V57, P16, DOI 10.1007/s00125-013-3061-3; Holt-Lunstad J, 2014, INT J PSYCHOPHYSIOL, V93, P381, DOI 10.1016/j.ijpsycho.2014.05.014; Holt-Lunstad J, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000316; Hoven H, 2013, OCCUP ENVIRON MED, V70, P663, DOI 10.1136/oemed-2012-101331; International Diabetes Federation, 2013, IDF DIABETES ATLAS; Iriart C, 2011, GLOBALIZATION HEALTH, V7, DOI 10.1186/1744-8603-7-2; Jeffers AJ, 2013, EAT BEHAV, V14, P468, DOI 10.1016/j.eatbeh.2013.08.007; Joyce K, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008009.pub2; Kaplan GA, 1999, PREV MED, V29, pS30, DOI 10.1006/pmed.1999.0540; Kawachi I, 2007, GLOBALIZATION AND HE; Keeling MJ, 2011, MODELING INFECTIOUS; Kenney WL, 2014, MED SCI SPORT EXER, V46, P1891, DOI 10.1249/MSS.0000000000000325; Kjellstrom T, 2010, INT J PUBLIC HEALTH, V55, P97, DOI 10.1007/s00038-009-0090-2; Klir G, 2001, FACETS OF SYSTEMS SC; Klir George J, 2001, FACETS OF SYSTEMS SC; Koestler A., 1978, JANUS A SUMMING UP; Krieger N, 1996, EPIDEMIOLOGY, V7, P107, DOI 10.1097/00001648-199601000-00020; Kullo IJ, 2014, MAYO CLIN PROC, V89, P1244, DOI 10.1016/j.mayocp.2014.06.018; Landen R, 2013, MODERN HEALTHCARE, V43; Langefors B, 1973, THEORETICAL ANALYSIS; Larsson SC, 2014, NEUROLOGY, V83, P1699, DOI 10.1212/WNL.0000000000000954; Lee PP, 1999, ARCH OPHTHALMOL-CHIC, V117, P100; Lehrer J, 2012, WIRED, V20, P102; Lehrer J, 2012, WILLNCE BLOGS; Lima SML, 2009, CAD SAUDE PUBLICA, V25, P2001, DOI 10.1590/S0102-311X2009000900014; LINK BG, 1995, J HEALTH SOC BEHAV, V35, P80, DOI 10.2307/2626958; Lovasi GS, 2011, PUBLIC HEALTH REV, V33, P484, DOI 10.1007/BF03391647; Luepker RV, 2011, ANNU REV PUBL HEALTH, V32, P1, DOI 10.1146/annurev-publhealth-112810-151726; Luke DA, 2012, ANNU REV PUBL HEALTH, V33, P357, DOI 10.1146/annurev-publhealth-031210-101222; Lynch J, 2005, ANNU REV PUBL HEALTH, V26, P1, DOI 10.1146/annurev.publhealth.26.021304.144505; Machado AF, 2012, CAD SAUDE PUBLICA, V28, P758, DOI 10.1590/S0102-311X2012000400015; Maciel-Lima Sandra Mara, 2004, Cad. Saúde Pública, V20, P502, DOI 10.1590/S0102-311X2004000200018; Mann BS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089168; Marchon SG, 2014, CAD SAUDE PUBLICA, V30, P1815, DOI 10.1590/0102-311X00114113; Marmot MG., 2006, SOCIAL DETERMINANTS; Matthews RA, 2014, J APPL PSYCHOL, V99, P1173, DOI 10.1037/a0036674; McAlister FA, 2011, CAN MED ASSOC J, V183, P1007, DOI 10.1503/cmaj.101767; McClellan MB, 2008, EVIDENCE BASED MEDIC; McHorney CA, 2012, PATIENT PREFER ADHER, V6, P789, DOI 10.2147/PPA.S36535; McMichael AJ, 1999, AM J EPIDEMIOL, V149, P887; Meadows DH, 2008, THINKING IN SYSTEMS; Mechanic D, 2007, MILBANK Q, V85, P533, DOI 10.1111/j.1468-0009.2007.00498.x; Mesarovic MD, 1970, THEORY OF HIERARCHIC; Mestre AM, 2015, EUR J OPER RES, V240, P791, DOI 10.1016/j.ejor.2014.07.024; Midgley G, 2006, AM J PUBLIC HEALTH, V96, P466, DOI 10.2105/AJPH.2005.067660; MITKA M, 2010, JAMA-J AM MED ASSOC, V303, P929, DOI DOI 10.1001/JAMA.2010.230; Moerenhout T, 2013, PATIENT PREFER ADHER, V7, P489, DOI 10.2147/PPA.S45777; Monteiro CA, 2011, PUBLIC HEALTH NUTR, V14, P5, DOI 10.1017/S1368980010003241; Mooney SJ, 2014, AM J EPIDEMIOL, V180, P626, DOI 10.1093/aje/kwu180; Moore LV, 2012, AM J EPIDEMIOL, V175, P1037, DOI 10.1093/aje/kwr445; Morin E., 2008, ON COMPLEXITY; Morin E, 1999, LINTELLIGENCE DA LA; Motivala SJ, 2011, ANN BEHAV MED, V42, P141, DOI 10.1007/s12160-011-9280-2; Murray ET, 2011, ANN EPIDEMIOL, V21, P589, DOI 10.1016/j.annepidem.2011.04.005; Murray J, 2013, BMC CARDIOVASC DISOR, V13, DOI 10.1186/1471-2261-13-48; Murray J, 2012, BMC CARDIOVASC DISOR, V12, DOI 10.1186/1471-2261-12-120; Ness RB, 2007, ANN EPIDEMIOL, V17, P564, DOI 10.1016/j.annepidem.2006.10.014; O'Brien-Pallas L, 2011, J CLIN NURS, V20, P1640, DOI 10.1111/j.1365-2702.2010.03391.x; Oakes JM, 2006, METHODS IN SOCIAL EP; Papanicolas I, 2013, HEALTH POLICY, V112, P1, DOI 10.1016/j.healthpol.2013.07.018; Pastor M, 2014, HEALTH AFFAIR, V33, P1890, DOI 10.1377/hlthaff.2014.0640; Paternotte E, 2015, PATIENT EDUC COUNS, V98, P420, DOI 10.1016/j.pec.2014.11.018; Peacock W Frank, 2013, Crit Pathw Cardiol, V12, P116, DOI 10.1097/HPC.0b013e31828940e3; Pearce N, 1996, AM J PUBLIC HEALTH, V86, P678, DOI 10.2105/AJPH.86.5.678; Resnicow K, 2008, AM J PUBLIC HEALTH, V98, P1382, DOI 10.2105/AJPH.2007.129460; Ribeiro ST, 2010, J AM GERIATR SOC, V58, P383, DOI 10.1111/j.1532-5415.2009.02690.x; Richman LS, 2009, PSYCHOL HEALTH, V24, P919, DOI 10.1080/08870440802108926; Rickles D, 2007, J EPIDEMIOL COMMUN H, V61, P933, DOI 10.1136/jech.2006.054254; Rooks RN, 2012, SOC SCI MED, V74, P176, DOI 10.1016/j.socscimed.2011.09.040; Roux AVD, 2008, J EPIDEMIOL COMMUN H, V62, P957, DOI 10.1136/jech.2007.064311; Roux AVD, 2012, ANNU REV PUBL HEALTH, V33, P41, DOI 10.1146/annurev-publhealth-031811-124534; Roux AVD, 2011, AM J PUBLIC HEALTH, V101, P1627, DOI 10.2105/AJPH.2011.300149; Rowan CG, 2014, PHARMACOEPIDEM DR S, V23, P1294, DOI 10.1002/pds.3694; Sa Carvalho LC., 1993, REFLEXOES EMPIRICAS; Sa E, 2014, OCCUP ENVIRON MED SU, V71, pA102, DOI [10.1136/oemed-2014-102362.319, DOI 10.1136/OEMED-2014-102362.319]; Sanders JL, 2011, J AM GERIATR SOC, V59, P1581, DOI 10.1111/j.1532-5415.2011.03557.x; Sanderson K, 2013, AUST FAM PHYSICIAN, V42, P172; Santos MS, 2012, BEST PRACT RES CL EN, V26, P581, DOI 10.1016/j.beem.2012.03.003; Santos-Pinto CD, 2011, CIENC SAUDE COLETIVA, V16, P2963, DOI 10.1590/S1413-81232011000600034; Schaefer DR, 2013, HEALTH EDUC BEHAV, V40, p24S, DOI 10.1177/1090198113493091; Scheffer M, 2011, INTERFACE-BOTUCATU, V15, P947, DOI 10.1590/S1414-32832011000300030; Schmidt M. I., 2011, Lancet (British edition), V377, P1949, DOI 10.1016/S0140-6736(11)60135-9; Schofield D, 2013, INT J CARDIOL, V166, P68, DOI 10.1016/j.ijcard.2011.09.066; Senge P., 1990, 5 DISCIPLINE; Silvers JB, 2013, ANN FAM MED, V11, P402, DOI 10.1370/afm.1567; Sixsmith R, 2010, HEALTH PROMOT INT, V25, P24, DOI 10.1093/heapro/dap045; Smith BT, 2011, AM J EPIDEMIOL, V173, P438, DOI 10.1093/aje/kwq379; Soderberg M, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1102; Sterman JD, 2006, AM J PUBLIC HEALTH, V96, P505, DOI 10.2105/AJPH.2005.066043; STERN MP, 1995, DIABETES, V44, P369, DOI 10.2337/diabetes.44.4.369; Strasburger V.C., 2013, CHILDREN ADOLESCENTS; Sturm R, 2014, J MENT HEALTH POLICY, V17, P19; Sundquist K, 2004, SOC SCI MED, V58, P615, DOI 10.1016/S0277-9536(03)00229-6; Taal HR, 2012, HYPERTENSION, V59, P241, DOI 10.1161/HYPERTENSIONAHA.111.179481; Taylor RS, 2013, COCHRANE DATABASE OF; Tekola-Ayele F, 2013, PROG CARDIOVASC DIS, V56, P251, DOI 10.1016/j.pcad.2013.09.013; Thomas B, 2013, J LAW MED ETHICS, V41, P16, DOI 10.1111/jlme.12002; Travassos Claudia, 2004, Cad. Saúde Pública, V20, pS190; Tsouros A, 2013, J URBAN HEALTH, V90, pS4, DOI 10.1007/s11524-013-9825-8; Umberson D, 2010, ANNU REV SOCIOL, V36, P139, DOI 10.1146/annurev-soc-070308-120011; Valerdi R, 2010, WHEN SYSTEMS THINKIN, P184, DOI [10.1109/SYSTEMS.2010.5482446, DOI 10.1109/SYSTEMS.2010.5482446]; van de Vijver S, 2013, GLOBAL HEALTH ACTION, V6, DOI 10.3402/gha.v6i0.22510; Van Laethem M, 2013, SCAND J WORK ENV HEA, V39, P535, DOI 10.5271/sjweh.3376; Vandenbroeck P, 2007, FORESIGHT TACKLING O; Varghese MJ, 2014, ANN PEDIAT CARDIOL, V7, P107, DOI 10.4103/0974-2069.132478; Viberg N, 2013, HEALTH POLICY, V112, P53, DOI 10.1016/j.healthpol.2013.06.013; Voelker R, 2012, JAMA-J AM MED ASSOC, V308, P1514, DOI 10.1001/jama.2012.13712; WHO Commission on Social Determinants of Health World Health Organization, 2008, CLOSING THE GAP IN A; Witt J, 2012, PATIENT EDUC COUNS, V88, P256, DOI 10.1016/j.pec.2012.03.002; World Health Organization, WHO FRAMEWORK CONVEN; World Health Organization, 2012, HEALTH POLICY AND SY; Yamin A E, 2000, Health Hum Rights, V5, P116, DOI 10.2307/4065225; Yang YC, 2015, J AGING HEALTH, V27, P403, DOI 10.1177/0898264314551172; Young D, 2010, AM J PUBLIC HEALTH, V100, P1208, DOI 10.2105/AJPH.2009.184705	174	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132216	10.1371/journal.pone.0132216	http://dx.doi.org/10.1371/journal.pone.0132216			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1QN	26171854	Green Published, Green Submitted, gold			2022-12-26	WOS:000358194900035
J	Jia, Z; Johnson, AC; Wang, XX; Guo, ZB; Dreisbach, AW; Lewin, JR; Kyle, PB; Garrett, MR				Jia, Zhen; Johnson, Ashley C.; Wang, Xuexiang; Guo, Zibiao; Dreisbach, Albert W.; Lewin, Jack R.; Kyle, Patrick B.; Garrett, Michael R.			Allelic Variants in Arhgef11 via the Rho-Rock Pathway Are Linked to Epithelial-Mesenchymal Transition and Contributes to Kidney Injury in the Dahl Salt-Sensitive Rat	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; STRESS-FIBER FORMATION; TGF-BETA ANTIBODY; RENAL INJURY; MYOFIBROBLAST DIFFERENTIATION; GENETIC-VARIANTS; S RATS; DISEASE; KINASE; HYPERTENSION	Previously, genetic analyses identified that variants in Arhgef11 may influence kidney injury in the Dahl salt-sensitive (S) rat, a model of hypertensive chronic kidney disease. To understand the potential mechanism by which altered expression and/or protein differences in Arhgef11 could play a role in kidney injury, stably transduced Arhgef11 knockdown cell lines as well as primary cultures of proximal tubule cells were studied. Genetic knockdown of Arhgef11 in HEK293 and NRK resulted in reduced RhoA activity, decreased activation of Rho-ROCK pathway, and less stress fiber formation versus control, similar to what was observed by pharmacological inhibition (fasudil). Primary proximal tubule cells (PTC) cultured from the S exhibited increased expression of Arhgef11, increased RhoA activity, and up regulation of Rho-ROCK signaling compared to control (small congenic). The cells were also more prone (versus control) to TGF beta-1 induced epithelial-mesenchymal transition (EMT), a hallmark feature of the development of renal interstitial fibrosis, and characterized by development of spindle shape morphology, gene expression changes in EMT markers (Col1a3, Mmp9, Bmp7, and Ocln) and increased expression of N-Cadherin and Vimentin. S derived PTC demonstrated a decreased ability to uptake FITC-albumin compared to the small congenic in vitro, which was confirmed by assessment of albumin re-uptake in vivo by infusion of FITC-albumin and immunofluorescence imaging. In summary, these studies suggest that genetic variants in the S form of Arhgef11 via increased expression and/or protein activity play a role in promoting kidney injury in the S rat through changes in cell morphology (Rho-Rock and/or EMT) that impact the function of tubule cells.	[Jia, Zhen; Johnson, Ashley C.; Wang, Xuexiang; Guo, Zibiao; Garrett, Michael R.] Univ Mississippi, Med Ctr, Dept Pharmacol & Toxicol, Jackson, MS 39216 USA; [Dreisbach, Albert W.; Garrett, Michael R.] Univ Mississippi, Med Ctr, Dept Med Nephrol, Jackson, MS 39216 USA; [Guo, Zibiao] Univ Mississippi, Med Ctr, Mol & Genom Core Facil, Jackson, MS 39216 USA; [Lewin, Jack R.; Kyle, Patrick B.] Univ Mississippi, Med Ctr, Dept Pathol, Jackson, MS 39216 USA	University of Mississippi; University of Mississippi Medical Center; University of Mississippi; University of Mississippi Medical Center; University of Mississippi; University of Mississippi Medical Center; University of Mississippi; University of Mississippi Medical Center	Garrett, MR (corresponding author), Univ Mississippi, Med Ctr, Dept Pharmacol & Toxicol, Jackson, MS 39216 USA.	mrgarrett@umc.edu		Wang, Xuexiang/0000-0002-4091-8196	National Institutes of Health/National Heart, Lung, and Blood Institute [HL094446]; Robert M. Hearin Foundation; Mississippi IDeA Network of Biomedical Research Excellence [P20GM103476]; Center for Psychiatric Neuroscience (CPN)-Centers of Biomedical Research Excellence [P30GM103328]; Obesity, Cardiorenal and Metabolic Diseases- Centers of Biomedical Research Excellence [P20GM104357]; National Institute of General Medical Sciences of the National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094446] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103476, P20GM104357, P30GM103328] Funding Source: NIH RePORTER	National Institutes of Health/National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Robert M. Hearin Foundation; Mississippi IDeA Network of Biomedical Research Excellence; Center for Psychiatric Neuroscience (CPN)-Centers of Biomedical Research Excellence; Obesity, Cardiorenal and Metabolic Diseases- Centers of Biomedical Research Excellence; National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	MRG is supported by National Institutes of Health/National Heart, Lung, and Blood Institute (HL094446) and Robert M. Hearin Foundation. The work performed through the UMMC Molecular and Genomics Facility is supported, in part, by funds from the National Institute of General Medical Sciences of the National Institutes of Health, including Mississippi IDeA Network of Biomedical Research Excellence (P20GM103476), Center for Psychiatric Neuroscience (CPN)-Centers of Biomedical Research Excellence (P30GM103328) and Obesity, Cardiorenal and Metabolic Diseases- Centers of Biomedical Research Excellence (P20GM104357). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbate M, 2006, J AM SOC NEPHROL, V17, P2974, DOI 10.1681/ASN.2006040377; Akiyama K, 2010, J HUM GENET, V55, P656, DOI 10.1038/jhg.2010.82; Benigni A, 2003, J AM SOC NEPHROL, V14, P1816, DOI 10.1097/01.ASN.0000074238.61967.B7; Boger CA, 2011, KIDNEY BLOOD PRESS R, V34, P225, DOI 10.1159/000326901; Budzyn K, 2006, TRENDS PHARMACOL SCI, V27, P97, DOI 10.1016/j.tips.2005.12.002; Chai JY, 2007, GUT, V56, P621, DOI 10.1136/gut.2006.106674; Chen CCA, 2013, PHYSIOL GENOMICS, V45, P110, DOI 10.1152/physiolgenomics.00119.2012; Chen S, 2003, BIOCHEM BIOPH RES CO, V300, P16, DOI 10.1016/S0006-291X(02)02708-0; Erkan E, 2013, PEDIATR NEPHROL, V28, P1049, DOI 10.1007/s00467-012-2335-1; Fu M, 2007, DIABETES, V56, P1363, DOI 10.2337/db06-1421; Garrett MR, 2007, PHYSIOL GENOMICS, V30, P322, DOI 10.1152/physiolgenomics.00001.2007; Garrett MR, 2006, PHYSIOL GENOMICS, V25, P39, DOI 10.1152/physiolgenomics.00150.2005; Garrett MR, 2003, J AM SOC NEPHROL, V14, P1175, DOI 10.1097/01.ASN.0000060572.13794.58; Guillemot L, 2008, MOL BIOL CELL, V19, P4442, DOI 10.1091/mbc.E08-06-0558; Guillemot L, 2014, MOL BIOL CELL, V25, P1995, DOI 10.1091/mbc.E13-11-0680; Itoh M, 2012, P NATL ACAD SCI USA, V109, P9905, DOI 10.1073/pnas.1115063109; Jin Qing Song, 2010, Korean Diabetes J, V34, P368, DOI 10.4093/kdj.2010.34.6.368; Kawanabe Y, 2002, MOL PHARMACOL, V61, P277, DOI 10.1124/mol.61.2.277; Laliberte F, 2009, J MANAGE CARE PHARM, V15, P312, DOI 10.18553/jmcp.2009.15.4.312; Levey AS, 2010, KIDNEY INT, V78, P19, DOI 10.1038/ki.2010.115; Loeffler I, 2014, NEPHROL DIAL TRANSPL, V29, pI37, DOI 10.1093/ndt/gft267; Gorriz JL, 2012, TRANSPLANT REV-ORLAN, V26, P3, DOI 10.1016/j.trre.2011.10.002; Mattson DL, 2014, AM J PHYSIOL-RENAL, V307, pF499, DOI 10.1152/ajprenal.00258.2014; Mizuki Y, 2014, HUM PSYCHOPHARM CLIN, V29, P552, DOI 10.1002/hup.2435; Murphy SR, 2012, AM J PHYSIOL-REG I, V303, pR57, DOI 10.1152/ajpregu.00263.2011; Nishikimi T, 2004, J HYPERTENS, V22, P1787, DOI 10.1097/00004872-200409000-00024; Nishikimi T, 2007, J HYPERTENS, V25, P1053, DOI 10.1097/HJH.0b013e3280825440; Packard M, 2009, AM J PHYSIOL-RENAL, V296, pF839, DOI 10.1152/ajprenal.90370.2008; Park JW, 2011, J PHARMACOL EXP THER, V338, P271, DOI 10.1124/jpet.111.179457; Rangel A, 2013, J AM SOC NEPHROL, V24, P283, DOI 10.1681/ASN.2012090927; Rankinen T, 2008, HYPERTENS RES, V31, P1651, DOI 10.1291/hypres.31.1651; Renshaw MW, 1996, J BIOL CHEM, V271, P21691, DOI 10.1074/jbc.271.36.21691; Sah VP, 2000, ANNU REV PHARMACOL, V40, P459, DOI 10.1146/annurev.pharmtox.40.1.459; Said Sarmad, 2014, J Nephropathol, V3, P99, DOI 10.12860/jnp.2014.19; Sakai N, 2013, FASEB J, V27, P1830, DOI 10.1096/fj.12-219378; Sandbo N, 2011, AM J PHYSIOL-LUNG C, V301, pL656, DOI 10.1152/ajplung.00166.2011; Smith DH, 2004, J AM SOC NEPHROL, V15, P1300, DOI 10.1097/01.ASN.0000125670.64996.BB; Tsou PS, 2014, AM J PHYSIOL-CELL PH, V307, pC2, DOI 10.1152/ajpcell.00060.2014; van der Sijde MR, 2014, BBA-MOL BASIS DIS, V1842, P1903, DOI 10.1016/j.bbadis.2014.04.025; Wang X, 2014, J AM SOC NEPHROLOGY; Westbrook L, 2014, J AM SOC NEPHROL, V25, P2499, DOI 10.1681/ASN.2013070786; Williams JM, 2012, HYPERTENSION, V60, P1157, DOI 10.1161/HYPERTENSIONAHA.112.199240; Zhu J, 2013, INT J OPHTHALMOL-CHI, V6, P8, DOI 10.3980/j.issn.2222-3959.2013.01.02; Zicha J, 2012, PHYSIOL RES, V61, pS35, DOI 10.33549/physiolres.932363	44	11	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132553	10.1371/journal.pone.0132553	http://dx.doi.org/10.1371/journal.pone.0132553			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26172442	Green Published, gold, Green Submitted			2022-12-26	WOS:000358194900057
J	Matsui, A; Stephens, D; Kantarci, A; Rittling, SR				Matsui, Aritsune; Stephens, Danielle; Kantarci, Alpdogan; Rittling, Susan R.			Early Cytokine Response to Infection with Pathogenic vs Non-Pathogenic Organisms in a Mouse Model of Endodontic Infection	PLOS ONE			English	Article							PERIAPICAL BONE DESTRUCTION; RESORPTION IN-VIVO; EXPERIMENTAL PERIODONTITIS; INTERLEUKIN-6 DEFICIENCY; DIFFERENT PATTERNS; MICE; INFLAMMATION; RECEPTOR; SUSCEPTIBILITY; RECRUITMENT	Using the subcutaneous chamber model of infection, we showed previously that a mixture of four endodontic pathogens (EP: P. intermedia, F. nucleatum, S. intermedius and P. micra) are able to persist without clearance for up to seven days, while a non-pathogenic oral species, S. mitis, was substantially cleared in this time. Here we have compared the cytokine response inside the chambers against these microorganisms. A majority of cytokines tested (17/24) showed different patterns of expression. Several cytokines had a peak of expression at 2 h after infection in response to the EP, while none showed this pattern in S. mitis infections. Chemokines were uniformly present at similar or higher levels in response to S. mitis, with redundant expression of CXCR2 ligands, while several growth/survival factors were present at higher levels in EP infections. Protease activity expressed by EP may be responsible for the lower levels of some chemokines. T-cell associated cytokines were in general expressed at extremely low levels, and did not differ between the two infections. The inflammatory markers IL-6, IL-1 alpha and IL1-beta were expressed at similar levels in both infections at early times, while TNF alpha was preferentially present in S. mitis infections. In EP infected chambers, reciprocal changes in levels of IL-6 and IL-1 alpha were observed at later times suggesting a switch in the inflammatory response. Analysis of the cytokine response to infection with the individual species from the EP mix suggests that P. intermedia drives this inflammatory switch. Together these results show a surprising level of divergence of the host response to pathogenic and non-pathogenic organisms associated with oral infections, and supports a dominant effect of P. intermedia in polymicrobial endodontic infections.	[Matsui, Aritsune; Stephens, Danielle; Kantarci, Alpdogan; Rittling, Susan R.] Forsyth Inst, Cambridge, MA 02142 USA; [Matsui, Aritsune; Kantarci, Alpdogan; Rittling, Susan R.] Harvard Univ, Sch Dent Med, Boston, MA 02115 USA	Harvard University; Forsyth Institute; Harvard University; Harvard School of Dental Medicine	Rittling, SR (corresponding author), Forsyth Inst, Cambridge, MA 02142 USA.	srittling@forsyth.org			National Institute of Dental and Craniofacial Research of the National Institutes of Health [RO1-DE22380]; Harvard Clinical and Translational Science Center (National Center for Advancing Translational Sciences, National Institutes of Health) [UL1 TR001102]; Harvard University and its affiliated academic healthcare centers; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001102] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE022380] Funding Source: NIH RePORTER	National Institute of Dental and Craniofacial Research of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Harvard Clinical and Translational Science Center (National Center for Advancing Translational Sciences, National Institutes of Health); Harvard University and its affiliated academic healthcare centers; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	Research reported in this publication was supported by the National Institute of Dental and Craniofacial Research of the National Institutes of Health under award number #RO1-DE22380 to SRR. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript. www.nidcr.nih.gov. Support for statistical analysis was provided through The Harvard Clinical and Translational Science Center (National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health Award UL1 TR001102) and financial contributions from Harvard University and its affiliated academic healthcare centers. The content is solely the responsibility of the authors and does not necessarily represent the official views of Harvard Catalyst, Harvard University and its affiliated academic healthcare centers, or the National Institutes of Health.	AlShwaimi E, 2013, J IMMUNOL, V191, P1785, DOI 10.4049/jimmunol.1202194; Balamayooran G, 2012, J IMMUNOL, V189, P5849, DOI 10.4049/jimmunol.1200585; Balto K, 2001, INFECT IMMUN, V69, P744, DOI 10.1128/IAI.69.2.744-750.2001; Biondo C, 2014, MBIO, V5, DOI 10.1128/mBio.01428-14; Bizzarri C, 2006, PHARMACOL THERAPEUT, V112, P139, DOI 10.1016/j.pharmthera.2006.04.002; BLAND JM, 1995, BRIT MED J, V310, P170, DOI 10.1136/bmj.310.6973.170; Byrne DP, 2010, BIOCHEM J, V425, P257, DOI 10.1042/BJ20090343; Chae P, 2002, INFECT IMMUN, V70, P3164, DOI 10.1128/IAI.70.6.3164-3169.2002; Davies LC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2877; Herbold W, 2010, INFECT IMMUN, V78, P2620, DOI 10.1128/IAI.01169-09; Hessle CC, 2005, CYTOKINE, V30, P311, DOI 10.1016/j.cyto.2004.05.008; Hou L, 2000, INFECT IMMUN, V68, P4681, DOI 10.1128/IAI.68.8.4681-4687.2000; Huang GTJ, 2001, ORAL SURG ORAL MED O, V92, P83, DOI 10.1067/moe.2001.115025; Kawashima N, 1999, ARCH ORAL BIOL, V44, P55, DOI 10.1016/S0003-9969(98)00094-6; Lqhal MK, 2008, J ENDODONT, V34, P519, DOI 10.1016/j.joen.2008.01.002; Marton IJ, 2000, ORAL MICROBIOL IMMUN, V15, P139, DOI 10.1034/j.1399-302x.2000.150301.x; Matsui A, 2014, INFECT IMMUN, V82, P4068, DOI 10.1128/IAI.02256-14; Polak D, 2009, J CLIN PERIODONTOL, V36, P406, DOI 10.1111/j.1600-051X.2009.01393.x; Potempa M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000316; Quinton LJ, 2012, J IMMUNOL, V188, P6300, DOI 10.4049/jimmunol.1200256; Rittling SR, 2010, IMMUNOLOGY, V129, P105, DOI 10.1111/j.1365-2567.2009.03159.x; Sasaki H, 2000, J IMMUNOL, V165, P3626, DOI 10.4049/jimmunol.165.7.3626; Sasaki H, 2004, CLIN DIAGN LAB IMMUN, V11, P106, DOI 10.1128/CDLI.11.1.106-110.2004; Siqueira JF, 2009, J DENT RES, V88, P969, DOI 10.1177/0022034509346549; Skovbjerg S, 2010, J INTERF CYTOK RES, V30, P23, DOI 10.1089/jir.2009.0033; Stashenko P, 1998, CRIT REV ORAL BIOL M, V9, P498, DOI 10.1177/10454411980090040701; Teles R, 1997, INFECT IMMUN, V65, P3781, DOI 10.1128/IAI.65.9.3781-3787.1997; ULICH TR, 1994, AM J PHYSIOL-LUNG C, V267, pL442, DOI 10.1152/ajplung.1994.267.4.L442; WANG CY, 1993, ORAL MICROBIOL IMMUN, V8, P50, DOI 10.1111/j.1399-302X.1993.tb00543.x; Wilensky A, 2009, J CLIN PERIODONTOL, V36, P915, DOI 10.1111/j.1600-051X.2009.01464.x; Wuyts A, 1999, J IMMUNOL, V163, P6155; Ye RD, 2009, PHARMACOL REV, V61, P119, DOI 10.1124/pr.109.001578	32	2	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132752	10.1371/journal.pone.0132752	http://dx.doi.org/10.1371/journal.pone.0132752			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26171605	Green Published, gold, Green Submitted			2022-12-26	WOS:000358194900081
J	Smith, RAS; Nabok, A; Blakeman, BJF; Xue, WF; Abell, B; Smith, DP				Smith, Rachel A. S.; Nabok, Aleksey; Blakeman, Ben J. F.; Xue, Wei-Feng; Abell, Benjamin; Smith, David P.			Analysis of Toxic Amyloid Fibril Interactions at Natively Derived Membranes by Ellipsometry	PLOS ONE			English	Article							COMMON MECHANISM; SPECTROSCOPIC ELLIPSOMETRY; ALZHEIMERS-DISEASE; OLIGOMERS IMPLIES; ALPHA-SYNUCLEIN; BETA PEPTIDE; AGGREGATION; CYTOTOXICITY; ASSOCIATION; DISRUPTION	There is an ongoing debate regarding the culprits of cytotoxicity associated with amyloid disorders. Although small pre-fibrillar amyloid oligomers have been implicated as the primary toxic species, the fibrillar amyloid material itself can also induce cytotoxicity. To investigate membrane disruption and cytotoxic effects associated with intact and fragmented fibrils, the novel in situ spectroscopic technique of Total Internal Reflection Ellipsometry (TIRE) was used. Fibril lipid interactions were monitored using natively derived whole cell membranes as a model of the in vivo environment. We show that fragmented fibrils have an increased ability to disrupt these natively derived membranes by causing a loss of material from the deposited surface when compared with unfragmented fibrils. This effect was corroborated by observations of membrane disruption in live cells, and by dye release assay using synthetic liposomes. Through these studies we demonstrate the use of TIRE for the analysis of protein-lipid interactions on natively derived lipid surfaces, and provide an explanation on how amyloid fibrils can cause a toxic gain of function, while entangled amyloid plaques exert minimal biological activity.	[Smith, Rachel A. S.; Abell, Benjamin; Smith, David P.] Sheffield Hallam Univ, Biomed Res Ctr, Sheffield S1 1WB, S Yorkshire, England; [Nabok, Aleksey] Sheffield Hallam Univ, Mat & Engn Res Inst, Sheffield S1 1WB, S Yorkshire, England; [Blakeman, Ben J. F.; Xue, Wei-Feng] Univ Kent, Sch Biosci, Canterbury, Kent, England	Sheffield Hallam University; Sheffield Hallam University; University of Kent	Smith, DP (corresponding author), Sheffield Hallam Univ, Biomed Res Ctr, Sheffield S1 1WB, S Yorkshire, England.	d.p.smith@shu.ac.uk	Nabok, Alexei/AAW-5758-2020	Xue, Wei-Feng/0000-0002-6504-0404; Smith, David/0000-0001-5177-8574	Biomedical Research Centre at Sheffield Hallam University; University of Kent [EP/H000275/1]; Royal Society project Grant [RG2010R1]; BBSRC research grant [BB/J008001/1]; BBSRC [BB/J008001/1] Funding Source: UKRI; EPSRC [EP/H000275/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/J008001/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/H000275/1] Funding Source: researchfish	Biomedical Research Centre at Sheffield Hallam University; University of Kent; Royal Society project Grant; BBSRC research grant(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by the Biomedical Research Centre at Sheffield Hallam University (http://www.shu.ac.uk/research/bmrc/) who funded RASS, BMA and DPS. The University of Kent funded BJFB Equipment was purchased via Engineering and Physical Sciences Research Council (www.epsrc.ac.uk) Engineering for Life research grant (No. EP/H000275/1) and from a Royal Society (https://royalsociety.org/) project Grant (RG2010R1) and a BBSRC(www.bbsrc.ac.uk/) research grant (No. BB/J008001/1, awarded to WFX).	Babenko V, 2013, FEBS LETT, V587, P625, DOI 10.1016/j.febslet.2013.02.010; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Ciccotosto GD, 2004, J BIOL CHEM, V279, P42528, DOI 10.1074/jbc.M406465200; Conway KA, 1998, NAT MED, V4, P1318, DOI 10.1038/3311; Eisenberg D, 2012, CELL, V148, P1188, DOI 10.1016/j.cell.2012.02.022; Fandrich M, 2002, EMBO J, V21, P5682, DOI 10.1093/emboj/cdf573; Finot E, 2013, COLLOID SURFACE B, V104, P289, DOI 10.1016/j.colsurfb.2012.12.013; Fredenburg RA, 2007, BIOCHEMISTRY-US, V46, P7107, DOI 10.1021/bi7000246; Gharibyan AL, 2007, J MOL BIOL, V365, P1337, DOI 10.1016/j.jmb.2006.10.101; Glabe CG, 2006, NEUROLOGY, V66, pS74, DOI 10.1212/01.wnl.0000192103.24796.42; Jakhria T, 2014, J BIOL CHEM, V289, P35781, DOI 10.1074/jbc.M114.586222; Kang LJ, 2011, J AM CHEM SOC, V133, P13465, DOI 10.1021/ja203979j; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kayed R, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-18; Knight JD, 2004, J MOL BIOL, V341, P1175, DOI 10.1016/j.jmb.2004.06.086; Knowles TPJ, 2014, NAT REV MOL CELL BIO, V15, P384, DOI 10.1038/nrm3810; Kriechbaumer V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046221; Kriechbaumer V, 2011, BIOPHYS J, V101, P504, DOI 10.1016/j.bpj.2011.06.011; Lee YJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020244; Li J, 2001, BIOCHEMISTRY-US, V40, P11604, DOI 10.1021/bi010616g; Martins IC, 2008, EMBO J, V27, P224, DOI 10.1038/sj.emboj.7601953; Milanesi L, 2012, P NATL ACAD SCI USA, V109, P20455, DOI 10.1073/pnas.1206325109; Mossuto MF, 2010, J MOL BIOL, V402, P783, DOI 10.1016/j.jmb.2010.07.005; Mustafa MK, 2010, BIOSENS BIOELECTRON, V26, P1332, DOI 10.1016/j.bios.2010.07.042; Nabok A, 2008, THIN SOLID FILMS, V516, P8993, DOI 10.1016/j.tsf.2007.11.077; Ow SY, 2013, SOFT MATTER, V9, P9692, DOI 10.1039/c3sm51671g; Petty M.C., 1996, LANGMUIR BLODGETT FI, DOI 10.1017/CBO9780511622519; Reynolds NP, 2011, J AM CHEM SOC, V133, P19366, DOI 10.1021/ja2029848; Smith DP, 2008, BIOCHEMISTRY-US, V47, P1425, DOI 10.1021/bi701522m; Soto C, 2003, NAT REV NEUROSCI, V4, P49, DOI 10.1038/nrn1007; Stefani M, 2003, J MOL MED, V81, P678, DOI 10.1007/s00109-003-0464-5; Stefani M, 2012, PROG NEUROBIOL, V99, P226, DOI 10.1016/j.pneurobio.2012.03.002; Stefani M, 2010, FEBS J, V277, P4602, DOI 10.1111/j.1742-4658.2010.07889.x; STRIEBEL C, 1994, BIOSENS BIOELECTRON, V9, P139, DOI 10.1016/0956-5663(94)80105-3; Suleman M, 2014, ANTIMICROB AGENTS CH, V58, P2156, DOI 10.1128/AAC.01350-13; Tofoleanu F, 2012, PRION, V6, P339, DOI 10.4161/pri.21022; Woollam J. A., 2002, GUIDE USING WVASE32; Xue WF, 2008, P NATL ACAD SCI USA, V105, P8926, DOI 10.1073/pnas.0711664105; Xue WF, 2013, BIOPHYS J, V105, P2811, DOI 10.1016/j.bpj.2013.10.034; Xue WF, 2010, PRION, V4, P20, DOI 10.4161/pri.4.1.11378; Xue WF, 2009, J BIOL CHEM, V284, P34272, DOI 10.1074/jbc.M109.049809	41	7	7	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132309	10.1371/journal.pone.0132309	http://dx.doi.org/10.1371/journal.pone.0132309			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26172440	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000358194900041
J	Zhou, J; Chen, L; Li, J; Li, HJ; Hong, ZW; Xie, M; Chen, SR; Yao, B				Zhou, Ji; Chen, Li; Li, Jie; Li, Hongjun; Hong, Zhiwei; Xie, Min; Chen, Shengrong; Yao, Bing			The Semen pH Affects Sperm Motility and Capacitation	PLOS ONE			English	Article							HUMAN SPERMATOZOA; REGULATORY MECHANISMS; MEMBRANE INTEGRITY; FOLLICULAR-FLUID; INTRACELLULAR PH; BOAR SPERMATOZOA; ALPHA-4 ISOFORM; PLASMA-MEMBRANE; HAMSTER SPERM; NA,K-ATPASE	As the chemical environment of semen can have a profound effect on sperm quality, we examined the effect of pH on the motility, viability and capacitation of human sperm. The sperm in this study was collected from healthy males to avoid interference from other factors. The spermatozoa cultured in sperm nutrition solution at pH 5.2, 6.2, 7.2 and 8.2 were analyzed for sperm total motility, progressive motility (PR), hypo-osmotic swelling (HOS) rate, and sperm penetration. Our results showed that these parameters were similar in pH 7.2 and 8.2 sperm nutrition solutions, but decreased in pH 5.2 and 6.2 solutions. The HOS rate exhibited positive correlation with the sperm total motility and PR. In addition, the sperm Na+/K+-ATPase activity at different pHs was measured, and the enzyme activity was significantly lower in pH 5.2 and 6.2 media, comparing with that in pH 8.2 and pH 7.2 solutions. Using flow cytometry (FCM) and laser confocal scanning microscopy (LCSM) analysis, the intracellular Ca2+ concentrations of sperm cultured in sperm capacitation solution at pH 5.2, 6.2, 7.2 and 8.2 were determined. Compared with that at pH 7.2, the mean fluorescence intensity of sperm in pH 5.2 and 6.2 media decreased significantly, while that of pH 8.2 group showed no difference. Our results suggested that the declined Na+/K+-ATPase activity at acidic pHs result in decreased sperm movement and capacitation, which could be one of the mechanisms of male infertility.	[Zhou, Ji; Chen, Li; Hong, Zhiwei; Xie, Min; Chen, Shengrong; Yao, Bing] Nanjing Univ, Ctr Reprod Med, Jinling Hosp, Clin Sch,Med Coll, Nanjing 210008, Jiangsu, Peoples R China; [Li, Jie] Nanjing Univ, Dept Neurosurg, Jinling Hosp, Clin Sch,Med Coll, Nanjing 210008, Jiangsu, Peoples R China; [Li, Hongjun] Chinese Acad Med Sci, Dept Urol, Peking Union Med Coll Hosp, Beijing 100730, Peoples R China; [Li, Hongjun] Peking Union Med Coll, Beijing 100021, Peoples R China	Nanjing University; Nanjing University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Yao, B (corresponding author), Nanjing Univ, Ctr Reprod Med, Jinling Hosp, Clin Sch,Med Coll, Nanjing 210008, Jiangsu, Peoples R China.	yaobing@nju.edu.cn			State Key Development Program for Basic Research of China [2013CB945200]	State Key Development Program for Basic Research of China(State Key Development Program for Basic Research of China)	This work was supported by the State Key Development Program for Basic Research of China (2013CB945200) http://www.973.gov.cn/Default_3.aspx, http://jcyxy.njmu.edu.cn/s/59/t/230/8f/58/info36696.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alavi SMH, 2004, REPRODUCTION, V128, P819, DOI 10.1530/rep.1.00244; Amer Soc Reprod Med Collaboration, 2008, FERTIL STERIL, V90, pS74, DOI 10.1016/j.fertnstert.2008.08.092; Andrzej C, 2002, T AM FISH SOC, V131, P9; [Anonymous], 2002, J PRACTICAL MED TECH, V9, P1; [Anonymous], 2006, J SHENYANG MED COLL, V8, P2; ASHIZAWA K, 1994, J REPROD FERTIL, V101, P593, DOI 10.1530/jrf.0.1010593; ASHIZAWA K, 1987, J REPROD FERTIL, V81, P495, DOI 10.1530/jrf.0.0810495; ASHRAF M, 1982, BIOCHEM BIOPH RES CO, V107, P1273, DOI 10.1016/S0006-291X(82)80135-6; BABCOCK DF, 1983, P NATL ACAD SCI-BIOL, V80, P1327, DOI 10.1073/pnas.80.5.1327; Banjoko SO, 2013, J CLIN DIAGN RES, V7, P2483, DOI 10.7860/JCDR/2013/6194.3585; Barna J, 1996, Acta Vet Hung, V44, P221; Blanco G, 2000, J HISTOCHEM CYTOCHEM, V48, P1023, DOI 10.1177/002215540004800801; Bonato M, 2012, ANIM REPROD SCI, V133, P123, DOI 10.1016/j.anireprosci.2012.06.008; Cincik M, 2007, ARCH ANDROLOGY, V53, P25, DOI 10.1080/01485010600888912; Crambert G, 2000, J BIOL CHEM, V275, P1976, DOI 10.1074/jbc.275.3.1976; Donders GGG, 2007, EUR J OBSTET GYN R B, V134, P220, DOI 10.1016/j.ejogrb.2006.07.016; Gandini L, 1999, HUM REPROD, V14, P1022, DOI 10.1093/humrep/14.4.1022; Garcia MA, 1999, MOL REPROD DEV, V52, P189, DOI 10.1002/(SICI)1098-2795(199902)52:2<189::AID-MRD10>3.0.CO;2-D; GATTI JL, 1993, J REPROD FERTIL, V98, P439, DOI 10.1530/jrf.0.0980439; Holm L, 1998, ANIM REPROD SCI, V54, P45, DOI 10.1016/S0378-4320(98)00142-0; Huang R, 2001, J FUZHOU TEACHERS CO, V20, P5; James PF, 1999, MOL CELL, V3, P555, DOI 10.1016/S1097-2765(00)80349-4; Jimenez T, 2010, REPRODUCTION, V139, P835, DOI 10.1530/REP-09-0495; Kaplan JH, 2002, ANNU REV BIOCHEM, V71, P511, DOI 10.1146/annurev.biochem.71.102201.141218; King LM, 2000, J ANDROL, V21, P65; Kocak-Toker N, 2002, INT J ANDROL, V25, P180, DOI 10.1046/j.1365-2605.2002.00346.x; L G H, 2013, CONT MED, V19, P2; Laurent C, 1995, ENVIRON BIOL FISH, V43, P9; Lin MH, 1998, FERTIL STERIL, V70, P1148, DOI 10.1016/S0015-0282(98)00351-3; LINDEMANN CB, 1988, CELL MOTIL CYTOSKEL, V10, P420, DOI 10.1002/cm.970100309; Liu, 2010, FUJIAN PROVINCE ANIM, V32, P4; Liu BJ, 2014, CELL PHYSIOL BIOCHEM, V33, P142, DOI 10.1159/000356657; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; Moubasher AE, 2013, ANDROLOGIA, V45, P135, DOI 10.1111/j.1439-0272.2012.01310.x; MRSNY RJ, 1984, BIOL REPROD, V30, P573, DOI 10.1095/biolreprod30.3.573; Munire Mirihasimu, 2004, Journal of Medical and Dental Sciences, V51, P99; Nallella KP, 2006, FERTIL STERIL, V85, P629, DOI 10.1016/j.fertnstert.2005.08.024; Ostermeier GC, 2002, LANCET, V360, P772, DOI 10.1016/S0140-6736(02)09899-9; SASE I, 1995, J CELL BIOL, V131, P963, DOI 10.1083/jcb.131.4.963; SKOU JC, 1988, METHOD ENZYMOL, V156, P1; Sorensen MB, 1999, MOL HUM REPROD, V5, P331, DOI 10.1093/molehr/5.4.331; SUAREZ SS, 1993, P NATL ACAD SCI USA, V90, P4660, DOI 10.1073/pnas.90.10.4660; THOMAS P, 1989, BIOCHEM J, V264, P539, DOI 10.1042/bj2640539; THOMAS P, 1988, GAMETE RES, V20, P397, DOI 10.1002/mrd.1120200402; Ting D, 2015, CHIN J CLIN LAB SCI, V33, P3; URAYAMA O, 1989, J BIOL CHEM, V264, P8271; Wang L, 2010, ASIAN J ANDROL, V12, P667, DOI 10.1038/aja.2010.79; WISHART GJ, 1986, BRIT POULTRY SCI, V27, P97, DOI 10.1080/00071668608416859; WOLTERSEVERHARDT E, 1986, FERTIL STERIL, V46, P114; WONG PYD, 1981, EXP CELL RES, V131, P97, DOI 10.1016/0014-4827(81)90410-9; Woo AL, 2000, J BIOL CHEM, V275, P20693, DOI 10.1074/jbc.M002323200; YANAGIMA.R, 1970, J REPROD FERTIL, V23, P193, DOI 10.1530/jrf.0.0230193; Zeng Y, 1996, DEV BIOL, V173, P510, DOI 10.1006/dbio.1996.0044; Zhao C, 2007, FERTIL STERIL, V87, P436, DOI 10.1016/j.fertnstert.2006.06.057	54	46	49	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132974	10.1371/journal.pone.0132974	http://dx.doi.org/10.1371/journal.pone.0132974			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26173069	Green Published, gold, Green Submitted			2022-12-26	WOS:000358194900110
J	He, Q; Li, L; Yang, TT; Li, RJ; Li, AY				He, Qiang; Li, Le; Yang, Tingting; Li, Ruijuan; Li, Aiying			Functional Characterization of a Ketoreductase-Encoding Gene med-ORF12 Involved in the Formation of a Stereospecific Pyran Ring during the Biosynthesis of an Antitumor Antibiotic Medermycin	PLOS ONE			English	Article							STREPTOMYCES SP; GENOME SEQUENCE; ACTINORHODIN; CLUSTER; EXPRESSION; STRATEGIES; INHIBITORS; DISCOVERY; AM-7161; CLONING	Medermycin, a polyketide antibiotic, possesses strong bioactivity against a variety of tumors through a novel mechanism and is structurally featured with a pyran ring containing two chiral centers (3Sand 15R). By far the biosynthetic origin of such enantiomerical conformations still remains obscure. In the present study, we reported the functional characterization of a proposed ketoreductase Med-ORF12 encoded by medermycin biosynthetic cluster and revealed its involvement in the stereochemical control at C3 center of medermycin. Firstly, bioinformatics analysis of Med-ORF12 suggested that it belongs to a group of stereospecific ketoreductases. Next, a Med-ORF12-deficient mutant was obtained and LC/MS measurements demonstrated that medermycin production was completely abolished in this mutant. Meanwhile, it was found that two shunt products were accumulated at the absence of Med-ORF12. Finally, the reintroduction of Med-ORF12 into this mutant could restore the production of medermycin. In a conclusion, these data supported that Med-ORF12 is essential for the biosynthesis of medermycin and performs its role as a stereospecifc ketoreductase in the tailoring steps of medermycin biosynthetic pathway.	[He, Qiang; Li, Le; Yang, Tingting; Li, Ruijuan; Li, Aiying] Shandong Univ, State Key Lab Microbial Technol, Sch Life Sci, Helmholtz Inst Biotechnol, Jinan 250100, Peoples R China; [He, Qiang; Li, Le; Yang, Tingting; Li, Aiying] Cent China Normal Univ, Sch Life Sci, Wuhan, Peoples R China	Shandong University; Central China Normal University	Li, AY (corresponding author), Shandong Univ, State Key Lab Microbial Technol, Sch Life Sci, Helmholtz Inst Biotechnol, Jinan 250100, Peoples R China.	aiyli@126.com			National Natural Science Foundation of China [31170050, 30770036]; Fundamental Research Funds for the Central University [CCNU10A02011]; Xinjiang Production & Construction Corps Key Laboratory of Protection and Utilization of Biological Resources in Tarim Basin [BRZD1401]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central University; Xinjiang Production & Construction Corps Key Laboratory of Protection and Utilization of Biological Resources in Tarim Basin	Thanks for financial supports by the National Natural Science Foundation of China (No. 31170050 and 30770036), the Fundamental Research Funds for the Central University (No. CCNU10A02011), and Xinjiang Production & Construction Corps Key Laboratory of Protection and Utilization of Biological Resources in Tarim Basin (No. BRZD1401).	Barycki JJ, 1999, BIOCHEMISTRY-US, V38, P5786, DOI 10.1021/bi9829027; Blin K, 2013, NUCLEIC ACIDS RES, V41, pW204, DOI 10.1093/nar/gkt449; Challis GL, 2008, J MED CHEM, V51, P2618, DOI 10.1021/jm700948z; Donner CD, 2013, TETRAHEDRON, V69, P377, DOI 10.1016/j.tet.2012.10.012; FEHR T, 1989, J ANTIBIOT, V42, P897, DOI 10.7164/antibiotics.42.897; Hopwood DA, 1997, CHEM REV, V97, P2465, DOI 10.1021/cr960034i; Ichinose K, 2003, MICROBIOL-SGM, V149, P1633, DOI 10.1099/mic.0.26310-0; Ichinose K, 1998, CHEM BIOL, V5, P647, DOI 10.1016/S1074-5521(98)90292-7; Ichinose K., 1998, ACTINOMYCETOL, V12, P99; Itoh T, 2007, BIOCHEMISTRY-US, V46, P8181, DOI 10.1021/bi700190p; Kieser T., 2000, PRACTICAL STREPTOMYC, DOI DOI 10.2436/im.v3i4.9291; Kim HJ, 2014, J BIOL CHEM, V289, P34557, DOI 10.1074/jbc.M114.602334; Klassen JL, 2011, J BACTERIOL, V193, P6999, DOI 10.1128/JB.06257-11; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li AY, 2005, BIOORGAN MED CHEM, V13, P6856, DOI 10.1016/j.bmc.2005.07.060; LI Z, 1989, J ANTIBIOT, V42, P577, DOI 10.7164/antibiotics.42.577; MADDURI K, 1995, J BACTERIOL, V177, P3879, DOI 10.1128/jb.177.13.3879-3884.1995; MCDANIEL R, 1993, SCIENCE, V262, P1546, DOI 10.1126/science.8248802; Metsa-Ketela M, 2013, CURR OPIN CHEM BIOL, V17, P562, DOI 10.1016/j.cbpa.2013.06.032; Novakova R, 2010, FOLIA MICROBIOL, V55, P119, DOI 10.1007/s12223-010-0018-5; Novakova R, 2002, GENE, V297, P197, DOI 10.1016/S0378-1119(02)00889-2; Ogasawara Y, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.00114-15; Okamoto S, 2009, CHEM BIOL, V16, P226, DOI 10.1016/j.chembiol.2009.01.015; Omura S, 2001, P NATL ACAD SCI USA, V98, P12215, DOI 10.1073/pnas.211433198; Persson B, 2013, CHEM-BIOL INTERACT, V202, P111, DOI 10.1016/j.cbi.2012.11.009; Rix U, 2002, NAT PROD REP, V19, P542, DOI 10.1039/b103920m; Sambrook J., 2001, MOL CLONING LAB MANU; Sun Rui, 2012, Weishengwu Xuebao, V52, P60; Sun YH, 2009, APPL MICROBIOL BIOT, V82, P303, DOI 10.1007/s00253-008-1793-7; Taguchi T, 2004, BIOORGAN MED CHEM, V12, P5917, DOI 10.1016/j.bmc.2004.08.026; Taguchi T, 2000, J ANTIBIOT, V53, P144, DOI 10.7164/antibiotics.53.144; TAKANO S, 1976, J ANTIBIOT, V29, P765, DOI 10.7164/antibiotics.29.765; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Toral-Barza L, 2007, MOL CANCER THER, V6, P3028, DOI 10.1158/1535-7163.MCT-07-0211	37	7	7	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132431	10.1371/journal.pone.0132431	http://dx.doi.org/10.1371/journal.pone.0132431			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26162081	Green Published, Green Submitted, gold			2022-12-26	WOS:000358162300135
J	Sindato, C; Pfeiffer, DU; Karimuribo, ED; Mboera, LEG; Rweyemamu, MM; Paweska, JT				Sindato, Calvin; Pfeiffer, Dirk U.; Karimuribo, Esron D.; Mboera, Leonard E. G.; Rweyemamu, Mark M.; Paweska, Janusz T.			A Spatial Analysis of Rift Valley Fever Virus Seropositivity in Domestic Ruminants in Tanzania	PLOS ONE			English	Article							LINKED-IMMUNOSORBENT-ASSAY; IGG-SANDWICH; OUTBREAK; ANTIBODY; ELISA; SEROPREVALENCE; CIRCULATION; VALIDATION; LIVESTOCK; SHEEP	Rift Valley fever (RVF) is an acute arthropod-borne viral zoonotic disease primarily occurring in Africa. Since RVF-like disease was reported in Tanzania in 1930, outbreaks of the disease have been reported mainly from the eastern ecosystem of the Great Rift Valley. This cross-sectional study was carried out to describe the variation in RVF virus (RVFV) seropositivity in domestic ruminants between selected villages in the eastern and western Rift Valley ecosystems in Tanzania, and identify potential risk factors. Three study villages were purposively selected from each of the two Rift Valley ecosystems. Serum samples from randomly selected domestic ruminants (n = 1,435) were tested for the presence of specific immunoglobulin G (IgG) and M (IgM), using RVF enzyme-linked immunosorbent assay methods. Mixed effects logistic regression modelling was used to investigate the association between potential risk factors and RVFV seropositivity. The overall RVFV seroprevalence (n = 1,435) in domestic ruminants was 25.8% and speciesspecific seroprevalence was 29.7%, 27.7% and 22.0% in sheep (n = 148), cattle (n = 756) and goats (n = 531), respectively. The odds of seropositivity were significantly higher in animals sampled from the villages in the eastern than those in the western Rift Valley ecosystem (OR = 1.88, CI: 1.41, 2.51; p < 0.001), in animals sampled from villages with soils of good than those with soils of poor water holding capacity (OR = 1.97; 95% CI: 1.58, 3.02; p < 0.001), and in animals which had been introduced than in animals born within the herd (OR = 5.08, CI: 2.74, 9.44; p < 0.001). Compared with animals aged 1-2 years, those aged 3 and 4-5 years had 3.40 (CI: 2.49, 4.64; p < 0.001) and 3.31 (CI: 2.27, 4.82, p < 0.001) times the odds of seropositivity. The findings confirm exposure to RVFV in all the study villages, but with a higher prevalence in the study villages from the eastern Rift Valley ecosystem.	[Sindato, Calvin] Natl Inst Med Res, Tabora, Tanzania; [Sindato, Calvin; Karimuribo, Esron D.] Sokoine Univ Agr, Dept Vet Med & Publ Hlth, Morogoro, Tanzania; [Sindato, Calvin; Karimuribo, Esron D.; Rweyemamu, Mark M.] South African Ctr Infect Dis Surveillance, Morogoro, Tanzania; [Pfeiffer, Dirk U.] Univ London Royal Vet Coll, Econ & Publ Hlth Grp, Vet Epidemiol, London, England; [Mboera, Leonard E. G.] Natl Inst Med Res, Dar Es Salaam, Tanzania; [Paweska, Janusz T.] Ctr Emerging & Zoonot Dis, Natl Inst Communicable Dis, Natl Hlth Lab Serv, Johannesburg, South Africa; [Paweska, Janusz T.] Univ Witwatersrand, Fac Hlth Sci, Sch Pathol, Johannesburg, South Africa	Sokoine University of Agriculture; University of London; University of London Royal Veterinary College; National Institute of Medical Research; National Health Laboratory Service; National Institute for Communicable Diseases (NICD); University of Witwatersrand	Sindato, C (corresponding author), Natl Inst Med Res, Tabora, Tanzania.	calvin.sindato@sacids.org	Pfeiffer, Dirk U/C-5002-2009	Pfeiffer, Dirk U/0000-0001-7000-0530	Wellcome Trust [WT087546MA]; Global Alliance for Livestock Veterinary Medicines, United Kingdom [SUO-R33A0297]	Wellcome Trust(Wellcome TrustEuropean Commission); Global Alliance for Livestock Veterinary Medicines, United Kingdom	This study forms part of the PhD study by CS under the Wellcome Trust Grant WT087546MA and was co-funded by the Global Alliance for Livestock Veterinary Medicines (SUO-R33A0297), United Kingdom. The funders had no role in study design, data collection and analysis or preparation of the manuscript.	Abdo-Salem S, 2006, ANN NY ACAD SCI, P1081; Adam AA, 2010, INT J INFECT DIS, V14, pE179, DOI 10.1016/j.ijid.2009.03.029; Al-Afaleq AI, 2011, VECTOR-BORNE ZOONOT, V11, P1513, DOI 10.1089/vbz.2010.0245; [Anonymous], 2011, TERRESTRIAL ANIMAL H; Anyamba A, 2000, PHOTOGRAM ENG REMOTE, V68, P137; Aradaib IE, 2013, EMERG INFECT DIS, V19, P246, DOI 10.3201/eid1902.120834; Archer BN, 2011, SAMJ S AFR MED J, V101, P263, DOI 10.7196/SAMJ.4544; Balk DL, 2006, ADV PARASIT, V62, P119, DOI 10.1016/S0065-308X(05)62004-0; Balkhy HH, 2003, INT J ANTIMICROB AG, V21, P153, DOI 10.1016/S0924-8579(02)00295-9; Chen X, 2010, LOGISTIC REGRESSION; Daubney R, 1931, J PATHOL BACTERIOL, V34, P545, DOI 10.1002/path.1700340418; Davies F Glyn, 2006, Vet Ital, V42, P31; DAVIES FG, 1992, EPIDEMIOL INFECT, V108, P185, DOI 10.1017/S0950268800049633; EFSA, 2005, EFSA J, V3, P1, DOI DOI 10.2903/J.EFSA.2005.238; El Mamy ABO, 2011, EMERG INFECT DIS, V17, P1894, DOI 10.3201/eid1710.110397; EVANS A, 2007, EPIDEMIOL INFECT, V11, P1; Fafetine J, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002065; Fyumagwa RD, 2011, TANZANIA J HLTH R S1, V13; GAD AM, 1986, J TROP MED HYG, V89, P233; Hartley DM, 2011, EMERG INFECT DIS; Heinrich N, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001557; ILCA, 1990, LIVESTOCK SYSTEMS RE, P287; Jeanmaire EM, 2011, VECTOR-BORNE ZOONOT, V11, P395, DOI 10.1089/vbz.2009.0249; Kamal SA, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-532; Kifaro EG, 2014, ONDERSTEPOORT J VET, V81, DOI 10.4102/ojvr.v81i2.717; LINTHICUM KJ, 1985, J HYG-CAMBRIDGE, V95, P197, DOI 10.1017/S0022172400062434; Linthicum KJ, 1999, SCIENCE, V285, P397, DOI 10.1126/science.285.5426.397; Martin V, 2007, GEOSPATIAL HEALTH, V2, P3, DOI 10.4081/gh.2007.250; Ministry of Health and Social Welfare United Republic of Tanzania, 2011, NATL INTEGRATED DIS; Mlingano Agricultural Research Institute Department of Research and Training Ministry of Agriculture Food Security and Co-Operatives Tanga Tanzania, 2006, SOILS TANZANIA POTEN; Monaco F, 2013, EMERG INFECT DIS, V19, P2025, DOI 10.3201/eid1912.130593; MORLEY CK, 1999, ACTA VULCANOLOGICA, V11, P1; Munyua P, 2010, AM J TROP MED HYG, V83, P58, DOI 10.4269/ajtmh.2010.09-0292; Murphy FA, 1999, VET VIROLOGY, P469; National Institute for Communicable Diseases. Special Pathogens Unit and Outbreak Response Unit, 2011, COMMUNICABLE DIS SUR, V9, P22; NIKLASSON B, 1983, J CLIN MICROBIOL, V17, P1026, DOI 10.1128/JCM.17.6.1026-1031.1983; NIKLASSON B, 1984, J CLIN MICROBIOL, V19, P225, DOI 10.1128/JCM.19.2.225-229.1984; Paweska JT, 2007, J VIROL METHODS, V146, P119, DOI 10.1016/j.jviromet.2007.06.006; Paweska JT, 2005, J VIROL METHODS, V127, P10, DOI 10.1016/j.jviromet.2005.02.008; Paweska JT, 2005, J VIROL METHODS, V124, P173, DOI 10.1016/j.jviromet.2004.11.020; Paweska JT, 2003, J VIROL METHODS, V113, P103, DOI 10.1016/S0166-0934(03)00228-3; Pourrut X, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000763; Rich KM, 2010, AM J TROP MED HYG, V83, P52, DOI 10.4269/ajtmh.2010.09-0291; Shoemaker T, 2002, EMERG INFECT DIS, V8, P1415, DOI 10.3201/eid0812.020195; Sindato C, 2011, TANZANIA J HLTH R S1, V13; Sindato C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088897; Sissoko D, 2009, EMERG INFECT DIS, V15, P568, DOI 10.3201/eid1504.081045; Sumaye RD, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002356; Swai ES, 2009, VECTOR-BORNE ZOONOT, V9, P579, DOI 10.1089/vbz.2008.0108; Swanepoel R., 2004, INFECT DIS LIVESTOCK, V2, P1037; THIONGANE Y, 1991, RES VIROLOGY, V142, P67, DOI 10.1016/0923-2516(91)90029-3; Thonnon J, 1999, TROP MED INT HEALTH, V4, P580, DOI 10.1046/j.1365-3156.1999.00437.x; Versteirt V, SUPPORNTING PUBLICAT, P59; *WHO, 2007, WKLY EPIDEMIOL REC, V82, P169; Woods CW, 2002, EMERG INFECT DIS, V8, P138, DOI 10.3201/eid0802.010023; World Health Organization, 2010, WEEKLY EPIDEMIOLOGIC, V21, P185; Zaki A, 2006, J VIROL METHODS, V131, P34, DOI 10.1016/j.jviromet.2005.07.002	57	19	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0131873	10.1371/journal.pone.0131873	http://dx.doi.org/10.1371/journal.pone.0131873			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26162089	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000358162300069
J	Tervonen, TA; Belitskin, D; Pant, SM; Englund, JI; Marques, E; Ala-Hongisto, H; Nevalaita, L; Sihto, H; Heikkila, P; Leidenius, M; Hewitson, K; Ramachandra, M; Moilanen, A; Joensuu, H; Kovanen, PE; Poso, A; Klefstrom, J				Tervonen, T. A.; Belitskin, D.; Pant, S. M.; Englund, J. I.; Marques, E.; Ala-Hongisto, H.; Nevalaita, L.; Sihto, H.; Heikkila, P.; Leidenius, M.; Hewitson, K.; Ramachandra, M.; Moilanen, A.; Joensuu, H.; Kovanen, P. E.; Poso, A.; Klefstrom, J.			Deregulated hepsin protease activity confers oncogenicity by concomitantly augmenting HGF/MET signalling and disrupting epithelial cohesion	ONCOGENE			English	Article							HEPATOCYTE GROWTH-FACTOR; FACTOR ACTIVATOR INHIBITOR-1; BREAST-CANCER; MATRIPTASE ACTIVATION; IN-VITRO; PROSTATE; IDENTIFICATION; PROGRESSION; SUBSTRATE; CELLS	Hepsin belongs to a family of cell-surface serine proteases, which have sparked interest as therapeutic targets because of the accessibility of extracellular protease domain for inhibitors. Hepsin is frequently amplified and/or overexpressed in epithelial cancers, but it is not clear how enhanced hepsin expression confers a potential for oncogenicity. We show that hepsin is consistently overexpressed in more than 40% of examined breast cancers, including all major biological subtypes. The effects of doxycycline-induced hepsin overexpression were examined in mammary epithelial organoids, and we found that induced hepsin acutely downmodulates its cognate inhibitor, hepatocyte growth factor (HGF) activator inhibitor type 1 (HAI-1). Hepsin-induced depletion of cellular HAI-1 led to a sharp increase in pericellular serine protease activity. The derepressed hepsin proteolytically activated downstream serine proteases, augmented HGF/MET signalling and caused deterioration of desmosomes and hemidesmosomes; structures important for cell cohesion and cell-basement membrane interaction. Moreover, chronic induction of hepsin considerably shortened the latency of Myc-dependent tumourigenesis in the mouse mammary gland. The serine protease and uPA system inhibitor WX-UK1, identified as a micromolar range hepsin inhibitor, prevented hepsin from augmenting HGF/MET signalling and disrupting desmosomes and hemidesmosomes. The findings suggest that the oncogenic activity of hepsin arises not only from elevated expression level but also from depletion of HAI-1, events which together trigger gain-of-function activity impacting HGF/MET signalling and epithelial cohesion. Thus, hepsin overexpression is a major oncogenic conferrer to a serine protease activity involved in breast cancer dissemination.	[Tervonen, T. A.; Belitskin, D.; Pant, S. M.; Englund, J. I.; Marques, E.; Ala-Hongisto, H.; Nevalaita, L.; Klefstrom, J.] Univ Helsinki, Translat Canc Biol & Inst Biomed, Res Programs Unit, Canc Cell Circuitry Lab, FIN-00014 Helsinki, Finland; [Sihto, H.; Joensuu, H.] Univ Helsinki, Dept Oncol, FIN-00014 Helsinki, Finland; [Sihto, H.; Joensuu, H.] Helsinki Univ Cent Hosp, Helsinki, Finland; [Heikkila, P.; Kovanen, P. E.] Helsinki Univ Cent Hosp, HUSLAB, Dept Pathol, Helsinki, Finland; [Heikkila, P.; Kovanen, P. E.] Helsinki Univ Cent Hosp, Haartman Inst, Helsinki, Finland; [Heikkila, P.; Kovanen, P. E.] Univ Helsinki, FIN-00014 Helsinki, Finland; [Leidenius, M.] Helsinki Univ Cent Hosp, Breast Surg Unit, Helsinki, Finland; [Hewitson, K.] Helsinki Innovat Serv Ltd, Tukholmankatu 8A, Helsinki 00290, Finland; [Ramachandra, M.] Aurigene Discovery Technol Ltd, 39-40 KIADB Ind Area,Elect City Phase 2, Bangalore, Karnataka, India; [Moilanen, A.] Orion Pharma, Orion Corp, Turku, Finland; [Poso, A.] Univ Eastern Finland, Sch Pharm, Kuopio, Finland; [Poso, A.] Finnish Inst Mol Med, Helsinki, Finland	University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Aurigene Discovery Technologies Limited; Orion Corporation; University of Eastern Finland	Klefstrom, J (corresponding author), Univ Helsinki, Canc Cell Circuitry Lab, Translat Canc Biol Res Program, Haartmaninkatu 8,Room B507,POB 63, FIN-00014 Helsinki, Finland.	Juha.Klefstrom@helsinki.fi	Englund, Johanna/GYJ-7086-2022; Sihto, Harri J/B-3432-2015; Englund, Johanna/ABG-6420-2021	Sihto, Harri J/0000-0001-5265-5509; Englund, Johanna/0000-0001-9637-6843; Poso, Antti/0000-0003-4196-4204; Belitskin, Denis/0000-0002-0032-2769; Ramachandra, Murali/0000-0003-4039-1491; Joensuu, Heikki/0000-0003-0281-2507	Academy of Finland; Sigrid Juselius Foundation; Finnish Cancer Society; Research Funds of the Helsinki University Central Hospital; Jane and Aatos Erkko Foundation; Helsinki Graduate Program in Biotechnology and Molecular Biology and Innovative Medicines Initiative Joint Undertaking [115188]	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Finnish Cancer Society; Research Funds of the Helsinki University Central Hospital; Jane and Aatos Erkko Foundation; Helsinki Graduate Program in Biotechnology and Molecular Biology and Innovative Medicines Initiative Joint Undertaking	We thank all the members of Klefstrom laboratory for discussions and critical comments on the manuscript. T Raatikainen and T Valimaki are thanked for technical assistance. Biomedicum Imaging Unit and Biomedicum Functional Genomics Unit are acknowledged for core services and technical support. This study was funded by the Academy of Finland, Sigrid Juselius Foundation, the Finnish Cancer Society, the Research Funds of the Helsinki University Central Hospital, Jane and Aatos Erkko Foundation, and Helsinki Graduate Program in Biotechnology and Molecular Biology and Innovative Medicines Initiative Joint Undertaking under grant agreement no 115188.	Antalis TM, 2010, BIOCHEM J, V428, P325, DOI 10.1042/BJ20100046; Benaud C, 2001, EUR J BIOCHEM, V268, P1439, DOI 10.1046/j.1432-1327.2001.02016.x; Buzza MS, 2013, J BIOL CHEM, V288, P10328, DOI 10.1074/jbc.M112.443432; Chen MQ, 2010, MOL CELL BIOCHEM, V337, P259, DOI 10.1007/s11010-009-0307-y; Chen YW, 2010, J BIOL CHEM, V285, P31755, DOI 10.1074/jbc.M110.150367; Chevillet JR, 2008, MOL CANCER THER, V7, P3343, DOI 10.1158/1535-7163.MCT-08-0446; Dang CV, 2012, CELL, V149, P22, DOI 10.1016/j.cell.2012.03.003; Domoto T, 2012, CANCER SCI, V103, P448, DOI 10.1111/j.1349-7006.2011.02162.x; Fan B, 2005, J BIOL CHEM, V280, P34513, DOI 10.1074/jbc.M502119200; Friis S, 2013, J BIOL CHEM, V288, P19028, DOI 10.1074/jbc.M113.469932; Ganesan R, 2012, PROTEIN ENG DES SEL, V25, P127, DOI 10.1093/protein/gzr067; Ganesan R, 2011, MOL CANCER RES, V9, P1175, DOI 10.1158/1541-7786.MCR-11-0004; Gastaldi S, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2617; Gherardi E, 2012, NAT REV CANCER, V12, P89, DOI 10.1038/nrc3205; Godiksen S, 2008, BIOCHEM J, V413, P251, DOI 10.1042/BJ20071496; Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304; Goswami R, 2013, ACS MED CHEM LETT, V4, P1152, DOI 10.1021/ml400213v; Guerin-Dubiard C, 2006, J AGR FOOD CHEM, V54, P3901, DOI 10.1021/jf0529969; Heinemann V, 2013, BRIT J CANCER, V108, P766, DOI 10.1038/bjc.2013.62; Herter S, 2005, BIOCHEM J, V390, P125, DOI 10.1042/BJ20041955; Kaipparettu BA, 2008, BIOTECHNIQUES, V45, P165, DOI 10.2144/000112883; Kiyomiya KI, 2006, AM J PHYSIOL-CELL PH, V291, pC40, DOI 10.1152/ajpcell.00351.2005; Klezovitch O, 2004, CANCER CELL, V6, P185, DOI 10.1016/j.ccr.2004.07.008; Koschubs T, 2012, BIOCHEM J, V442, P483, DOI 10.1042/BJ20111317; Li W, 2009, CANCER RES, V69, P8395, DOI 10.1158/0008-5472.CAN-09-1995; Li Y, 2005, BBA-GENE STRUCT EXPR, V1681, P157, DOI 10.1016/j.bbaexp.2004.11.003; List K, 2005, GENE DEV, V19, P1934, DOI 10.1101/gad.1300705; Marchant DJ, 2014, NAT MED, V20, P497, DOI 10.1038/nm.3508; Meerbrey KL, 2011, P NATL ACAD SCI USA, V108, P3665, DOI 10.1073/pnas.1019736108; Miao JY, 2008, INT J CANCER, V123, P2041, DOI 10.1002/ijc.23726; Moran P, 2006, J BIOL CHEM, V281, P30439, DOI 10.1074/jbc.M605440200; Nandana S, 2010, PROSTATE, V70, P591, DOI 10.1002/pros.21093; Partanen JI, 2007, P NATL ACAD SCI USA, V104, P14694, DOI 10.1073/pnas.0704677104; Partanen JI, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0111; Partanen JI, 2012, P NATL ACAD SCI USA, V109, pE388, DOI 10.1073/pnas.1120421109; Peters DE, 2014, J BIOL CHEM, V289, P14740, DOI 10.1074/jbc.M113.541318; Pulaski B A, 2001, Curr Protoc Immunol, VChapter 20, DOI 10.1002/0471142735.im2002s39; Shimomura T, 1999, J BIOCHEM-TOKYO, V126, P821, DOI 10.1093/oxfordjournals.jbchem.a022522; Szabo R, 2007, ONCOGENE, V26, P1546, DOI 10.1038/sj.onc.1209966; Szabo R, 2008, INT J BIOCHEM CELL B, V40, P1297, DOI 10.1016/j.biocel.2007.11.013; Tang X, 2014, ONCOTARGET, V5, P1352, DOI 10.18632/oncotarget.1817; Tripathi M, 2008, J BIOL CHEM, V283, P30576, DOI 10.1074/jbc.M802312200; Trusolino L, 2002, NAT REV CANCER, V2, P289, DOI 10.1038/nrc779; Xing P, 2011, J INVEST MED, V59, P803, DOI 10.2310/JIM.0b013e31821451a1; Xuan JA, 2006, CANCER RES, V66, P3611, DOI 10.1158/0008-5472.CAN-05-2983; Yue J, 2012, CANCER MICROENVIRON, V5, P275, DOI 10.1007/s12307-012-0101-3	46	30	30	2	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 7	2016	35	14					1832	1846		10.1038/onc.2015.248	http://dx.doi.org/10.1038/onc.2015.248			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DI6LM	26165838				2022-12-26	WOS:000373610400009
J	Chernysh, S; Gordya, N; Suborova, T				Chernysh, Sergey; Gordya, Natalia; Suborova, Tatyana			Insect Antimicrobial Peptide Complexes Prevent Resistance Development in Bacteria	PLOS ONE			English	Article							HOST-DEFENSE PEPTIDES; CALLIPHORA-VICINA; EVOLUTION; MECHANISMS	In recent decades much attention has been paid to antimicrobial peptides (AMPs) as natural antibiotics, which are presumably protected from resistance development in bacteria. However, experimental evolution studies have revealed prompt resistance increase in bacteria to any individual AMP tested. Here we demonstrate that naturally occurring compounds containing insect AMP complexes have clear advantage over individual peptide and small molecule antibiotics in respect of drug resistance development. As a model we have used the compounds isolated from bacteria challenged maggots of Calliphoridae flies. The compound isolated from blow fly Calliphora vicina was found to contain three distinct families of cell membrane disrupting/permeabilizing peptides (defensins, cecropins and diptericins), one family of proline rich peptides and several unknown antimicrobial substances. Resistance changes under long term selective pressure of the compound and reference antibiotics cefotaxime, meropenem and polymyxin B were tested using Escherichia coli, Klebsiella pneumonia and Acinetobacter baumannii clinical strains. All the strains readily developed resistance to the reference antibiotics, while no signs of resistance growth to the compound were registered. Similar results were obtained with the compounds isolated from 3 other fly species. The experiments revealed that natural compounds containing insect AMP complexes, in contrast to individual AMP and small molecule antibiotics, are well protected from resistance development in bacteria. Further progress in the research of natural AMP complexes may provide novel solutions to the drug resistance problem.	[Chernysh, Sergey; Gordya, Natalia] St Petersburg State Univ, Fac Biol, Lab Insect Biopharmacol & Immunol, St Petersburg 199034, Russia; [Suborova, Tatyana] Kirov Mil Med Acad, Res Ctr, St Petersburg, Russia	Saint Petersburg State University	Chernysh, S (corresponding author), St Petersburg State Univ, Fac Biol, Lab Insect Biopharmacol & Immunol, St Petersburg 199034, Russia.	sichernysh1951@gmail.com	Tulin, Dmitry/N-1039-2013	Tulin, Dmitry/0000-0001-6357-0228	St.Petersburg State University [1.39.323.2014]	St.Petersburg State University	This work was supported by St.Petersburg State University (URL http://spbu.ru), grant number 1.39.323.2014 - SC, NG. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell G, 2003, MICROBIOL-SGM, V149, P1367, DOI 10.1099/mic.0.26265-0; BULET P, 1991, J BIOL CHEM, V266, P24520; Bulet P, 2005, PROTEIN PEPTIDE LETT, V12, P3, DOI 10.2174/0929866053406011; Chernysh S, 2002, P NATL ACAD SCI USA, V99, P12628, DOI 10.1073/pnas.192301899; Chernysh SI, 2011, J EVOL BIOCHEM PHYS+, V47, P524, DOI 10.1134/S0022093011060032; Chernysh S.I., 2010, INFEKTS KHIRURG, V8, P47; Chernysh Sergey I., 2000, Entomological Science, V3, P139; CHERNYSH SI, 1995, EUR J ENTOMOL, V92, P203; Davies J, 2010, MICROBIOL MOL BIOL R, V74, P417, DOI 10.1128/MMBR.00016-10; Dobson AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076521; Fehri LF, 2005, ANTIMICROB AGENTS CH, V49, P4154, DOI 10.1128/AAC.49.10.4154-4165.2005; Ge YG, 1999, ANTIMICROB AGENTS CH, V43, P782, DOI 10.1128/AAC.43.4.782; Giacometti A, 1999, J ANTIMICROB CHEMOTH, V44, P641, DOI 10.1093/jac/44.5.641; Gordon NC, 2010, INT J ANTIMICROB AG, V35, P219, DOI 10.1016/j.ijantimicag.2009.10.024; Gueguen Y, 2009, MOL IMMUNOL, V46, P516, DOI 10.1016/j.molimm.2008.07.021; Habets MGJL, 2012, BIOL LETTERS, V8, P416, DOI 10.1098/rsbl.2011.1203; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Hegreness M, 2008, P NATL ACAD SCI USA, V105, P13977, DOI 10.1073/pnas.0805965105; Kaur G, 2011, MICROB DRUG RESIST, V17, P197, DOI 10.1089/mdr.2010.0054; KEPPI E, 1989, ARCH INSECT BIOCHEM, V10, P229, DOI 10.1002/arch.940100306; Lambert RJW, 2004, J APPL MICROBIOL, V97, P699, DOI 10.1111/j.1365-2672.2004.02345.x; Laxminarayan R, 2013, LANCET INFECT DIS, V13, P1057, DOI 10.1016/S1473-3099(13)70318-9; Leonard SN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042103; Lewis K, 2013, NAT REV DRUG DISCOV, V12, P371, DOI 10.1038/nrd3975; Lin MF, 2014, WORLD J CLIN CASES, V2, P787, DOI 10.12998/wjcc.v2.i12.787; Michel JB, 2008, P NATL ACAD SCI USA, V105, P14918, DOI 10.1073/pnas.0800944105; Napier BA, 2013, MBIO, V4, DOI 10.1128/mBio.00021-13; NESIN AP, 1995, APPL ENTOMOL ZOOL, V30, P351; Nicolas P, 2009, FEBS J, V276, P6483, DOI 10.1111/j.1742-4658.2009.07359.x; Nizet V, 2006, CURR ISSUES MOL BIOL, V8, P11; Perron GG, 2006, P ROY SOC B-BIOL SCI, V273, P251, DOI 10.1098/rspb.2005.3301; Peschel A, 2006, NAT REV MICROBIOL, V4, P529, DOI 10.1038/nrmicro1441; U.S. department of health and human services, 2013, ANT RES THEATS US; Vinogradova EB, 1984, BLOWFLY CALLIPHORA V; Wiesner J, 2011, BIOL INSPIR SYST, V2, P29, DOI 10.1007/978-90-481-9641-8_3; Wilmes M, 2011, NAT PROD REP, V28, P1350, DOI 10.1039/c1np00022e; World Health Organization, 2014, ANT RES GLOB REP SUR; Yeaman MR, 2003, PHARMACOL REV, V55, P27, DOI 10.1124/pr.55.1.2; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	39	52	60	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0130788	10.1371/journal.pone.0130788	http://dx.doi.org/10.1371/journal.pone.0130788			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177023	Green Published, gold, Green Submitted			2022-12-26	WOS:000358197600027
J	Nicholson, DB; Mayhew, PJ; Ross, AJ				Nicholson, David B.; Mayhew, Peter J.; Ross, Andrew J.			Changes to the Fossil Record of Insects through Fifteen Years of Discovery	PLOS ONE			English	Article							PERMIAN WELLINGTON FORMATION; EOCENE BALTIC AMBER; CZECH-REPUBLIC INSECTA; HEMIPTERA FULGOROMORPHA FULGOROIDEA; CRETACEOUS BEETLES COLEOPTERA; 1ST GLOSSELYTRODEA INSECTA; FORMATION BERMEJO BASIN; MUSEUM-FUR-NATURKUNDE; FAM. NOV INSECTA; NEW-SOUTH-WALES	The first and last occurrences of hexapod families in the fossil record are compiled from publications up to end-2009. The major features of these data are compared with those of previous datasets (1993 and 1994). About a third of families (>400) are new to the fossil record since 1994, over half of the earlier, existing families have experienced changes in their known stratigraphic range and only about ten percent have unchanged ranges. Despite these significant additions to knowledge, the broad pattern of described richness through time remains similar, with described richness increasing steadily through geological history and a shift in dominant taxa, from Palaeoptera and Polyneoptera to Paraneoptera and Holometabola, after the Palaeozoic. However, after detrending, described richness is not well correlated with the earlier datasets, indicating significant changes in shorter-term patterns. There is reduced Palaeozoic richness, peaking at a different time, and a less pronounced Permian decline. A pronounced Triassic peak and decline is shown, and the plateau from the mid Early Cretaceous to the end of the period remains, albeit at substantially higher richness compared to earlier datasets. Origination and extinction rates are broadly similar to before, with a broad decline in both through time but episodic peaks, including end-Permian turnover. Origination more consistently exceeds extinction compared to previous datasets and exceptions are mainly in the Palaeozoic. These changes suggest that some inferences about causal mechanisms in insect macroevolution are likely to differ as well.	[Nicholson, David B.; Mayhew, Peter J.] Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England; [Nicholson, David B.; Ross, Andrew J.] Natl Museum Scotland, Dept Nat Sci, Edinburgh, Midlothian, Scotland	University of York - UK	Nicholson, DB (corresponding author), Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England.	david.nicholson@nhm.ac.uk	; Mayhew, Peter John/I-6363-2012	Nicholson, David/0000-0002-1296-5673; Mayhew, Peter John/0000-0002-7346-6560	Natural Environment Research Council [NE/G524236/1]	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	DBN was supported by a Natural Environment Research Council studentship grant NE/G524236/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrain JM, 2000, SCIENCE, V289, P110, DOI 10.1126/science.289.5476.110; Alonso J, 2000, J PALEONTOL, V74, P158, DOI 10.1666/0022-3360(2000)074<0158:ANFRWB>2.0.CO;2; Alroy J, 2000, GEOLOGY, V28, P1023, DOI 10.1130/0091-7613(2000)28<1023:SAODCT>2.0.CO;2; Alroy J, 2004, EVOL ECOL RES, V6, P1; Alroy J, 2010, SCIENCE, V329, P1191, DOI 10.1126/science.1189910; Alroy J, 2000, PALEOBIOLOGY, V26, P707, DOI 10.1666/0094-8373(2000)026<0707:NMFQMP>2.0.CO;2; Alroy J, 2001, P NATL ACAD SCI USA, V98, P6261, DOI 10.1073/pnas.111144698; Alroy J, 2010, PALEONTOLOGICAL SOC, V16, P55, DOI [10.1017/S1089332600001819, DOI 10.1017/S1089332600001819]; Alroy J, 2008, P NATL ACAD SCI USA, V105, P11536, DOI 10.1073/pnas.0802597105; Alroy J, 2008, SCIENCE, V321, P97, DOI 10.1126/science.1156963; Amorim DD, 2006, SYST ENTOMOL, V31, P508, DOI 10.1111/j.1365-3113.2006.00326.x; AMORIM DD, 2008, NEOTROPICAL DIPTERA, V4, P1; Andersen N.M., 1998, BIOL SKRIFTER, V50, P1; Andersen NM, 2001, INSECT SYST EVOL, V32, P381; Andersen S, 2001, INSECT SYST EVOL, V32, P419, DOI 10.1163/187631201X00290; [Anonymous], 2004, J SYST PALAEONTOL, V2, P133, DOI 10.1017/S1477201904001191; [Anonymous], 2004, J SYST PALAEONTOL, V2, P109, DOI 10.1017/S1477201904001166; [Anonymous], 1998, PALEONTOLOGICAL J; [Anonymous], 2014, R LANG ENV STAT COMP; [Anonymous], 1998, AMURIAN ZOOLOGICAL J, V72, P281; [Anonymous], OSNABRUCKER NATURWIS; Ansorge J, 2001, NEUES JAHRB GEOL P-M, P553; ANSORGE J, 1952, PALAEONTOL Z, V70, P475; Ansorge Joerg, 2002, Nova Supplementa Entomologica, V15, P55; Ansorge Joerg, 1995, Palaeontologische Zeitschrift, V69, P167; Ansorge Joerg, 2002, Studia Dipterologica, V9, P21; Ansorge Joerg, 2003, Acta Zoologica Cracoviensia, V46, P285; Ansorge Joerg, 1993, Palaeontologische Zeitschrift, V67, P287; Ansorge Jorg, 2003, Acta Zoologica Cracoviensia, V46, P291; Ansorge Jorg, 1999, Stuttgarter Beitraege zur Naturkunde Serie B (Geologie und Palaeontologie), V275, P1; Ansorge Jorg, 1996, Neue Palaeontologische Abhandlungen, V2, P1; Archibald SB, 2006, ANN ENTOMOL SOC AM, V99, P487, DOI 10.1603/0013-8746(2006)99[487:BAOTEO]2.0.CO;2; Archibald SB, 2009, ZOOTAXA, P51, DOI 10.11646/zootaxa.2249.1.5; Archibald SB, 2005, CAN J EARTH SCI, V42, P119, DOI 10.1139/E04-073; Archibald SB, 2005, ANN ENTOMOL SOC AM, V98, P503, DOI 10.1603/0013-8746(2005)098[0503:EADOCE]2.0.CO;2; Arillo Antonio, 2005, Stuttgarter Beitraege zur Naturkunde Serie B (Geologie und Palaeontologie), V352, P1; Arillo A, 2006, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2006)3539[1:RCIBAN]2.0.CO;2; Arillo A, 2009, ZOOTAXA, P33, DOI 10.11646/zootaxa.2026.1.3; Aristov DS, 2008, PALEONTOL J+, V42, P269, DOI 10.1134/S0031030108030088; Aristov DS, 2008, PALEONTOL J+, V42, P159, DOI 10.1134/S0031030108020068; Aristov DS, 2006, PALEONTOL J+, V40, P79, DOI 10.1134/S0031030106010096; Aristov D.S., 2009, Far Eastern Entomologist, V192, P1; Aristov D.S., 2008, Far Eastern Entomologist, V188, P1; Aristov D.S., 2000, Far Eastern Entomologist, V85, P1; Aristov DS, 2009, AFR INVERTEBR, V50, P279, DOI 10.5733/afin.050.0205; Aristov DS, 2009, PALEONTOL J+, V43, P643, DOI 10.1134/S0031030109060070; Aristov DS, 2009, PALEONTOL J+, V43, P418, DOI 10.1134/S0031030109040091; Aristov DS, 2009, PALEONTOL J+, V43, P272, DOI 10.1134/S0031030109030046; Aristov DS, 2009, PALEONTOL J+, V43, P178, DOI 10.1134/S0031030109020087; Aristov Danil S., 2009, Russian Entomological Journal, V18, P257; Aristov Danil S., 2008, Russian Entomological Journal, V17, P327; Aristov DS, 2005, PALEONTOL J+, V39, P173; Aristov DS, 2004, PALEONTOL J+, V38, P514; Aristov DS, 2004, PALEONTOL J+, V38, pS80; Aristov DS, 2004, PALEONTOL J+, V38, pS146; ARISTOV DS, 2000, PALEONTOL J, V34, P519; Aspock U, 2004, SYST ENTOMOL, V29, P11, DOI 10.1111/j.1365-3113.2004.00245.x; Azar D, 2004, ANN SOC ENTOMOL FR, V40, P185, DOI 10.1080/00379271.2004.10697415; Azar D, 2007, CR PALEVOL, V6, P151, DOI 10.1016/j.crpv.2006.10.004; Azar D, 2008, ANN SOC ENTOMOL FR, V44, P459, DOI 10.1080/00379271.2008.10697581; Azar D, 2008, ANN SOC ENTOMOL FR, V44, P451, DOI 10.1080/00379271.2008.10697580; Azar D, 2009, GEODIVERSITAS, V31, P117, DOI 10.5252/g2009n1a10; Bambach RK, 1999, GEOBIOS-LYON, V32, P131, DOI 10.1016/S0016-6995(99)80025-4; Barraclough David A., 2006, African Invertebrates, V47, P117; Basibuyuk HH, 2002, INSECT SYST EVOL, V33, P23, DOI 10.1163/187631202X00037; Baz A, 2000, ANN ENTOMOL SOC AM, V93, P367, DOI 10.1603/0013-8746(2000)093[0367:AANFOP]2.0.CO;2; Baz A, 2001, CRETACEOUS RES, V22, P575, DOI 10.1006/cres.2001.0275; Beattie R, 2007, AFR INVERTEBR, V48, P41; Bechly G., 1998, International Journal of Odonatology, V1, P33; Bechly G, 1998, ODONATOLOGICA, V27, P149; Bechly G., 2007, CRATO FOSSIL BEDS BR, P239; BECHLY G, JURACORDULIA SCHIEME; BECHLY G, 2007, CRATO FOSSIL BEDS BR, P387; Bechly G, 2007, CRATO FOSSIL BEDS BR, P313; BECHLY G, 2005, STUTTG BEITR NATUR B, P1; Bechly G., 2007, CRATO FOSSIL BEDS BR, P184; Bechly G., 2007, CRATO FOSSIL BEDS BR, P249; Bechly Guenter, 2002, Stuttgarter Beitraege zur Naturkunde Serie B (Geologie und Palaeontologie), V328, P1; Bechly Guenter, 2000, Stuttgarter Beitraege zur Naturkunde Serie B (Geologie und Palaeontologie), V289, P1; Bechly Guenter, 2001, Neue Palaeontologische Abhandlungen, V4, P1; Bechly Guenter, 2003, Stuttgarter Beitraege zur Naturkunde Serie B (Geologie und Palaeontologie), V339, P1; Bechly Guenter, 2000, Stuttgarter Beitraege zur Naturkunde Serie B (Geologie und Palaeontologie), V296, P1; Bechly Guenter, 2008, Palaeodiversity, P37; Bechly Gunter, 1998, Stuttgarter Beitraege zur Naturkunde Serie B (Geologie und Palaeontologie), V264, P1; Bechly Gunter, 1996, Petalura Special-Volume, V2, P1; Bechly Gunter, 1997, Rivista del Museo Civico di Scienze Naturali "Enrico Caffi", V19, P31; Beckemeyer RJ, 2004, J KANSAS ENTOMOL SOC, V77, P215, DOI 10.2317/0309.04.1; Beckemeyer RJ, 2004, J KANSAS ENTOMOL SOC, V77, P132, DOI 10.2317/0306.12.1; Beckemeyer RJ, 2009, COLEOPTERISTS B, V112, P45; Beckemeyer Roy J., 2009, Transactions of the Kansas Academy of Science, V112, P45, DOI 10.1660/062.112.0207; Beckemeyer Roy J., 2009, Transactions of the Kansas Academy of Science, V112, P103, DOI 10.1660/062.112.0213; Beckemeyer Roy J., 2000, Kansas School Naturalist, V46, P1; Beckemeyer RJ, 2009, J KANSAS ENTOMOL SOC, V82, P300, DOI 10.2317/JKES809.30.1; Beckemeyer Roy J., 2007, Transactions of the Kansas Academy of Science, V110, P23, DOI 10.1660/0022-8443(2007)110[23:PITIHP]2.0.CO;2; Bennett Daniel J., 2005, Acta Zoologica Cracoviensia, V48B, P1, DOI 10.3409/173491505783995608; Bennett DJ, 2006, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2006)3529[1:ANMWID]2.0.CO;2; Benson RBJ, 2012, BIOL LETTERS, V8, P127, DOI 10.1098/rsbl.2011.0460; Benton M. J., 2003, LIFE NEARLY DIED GRE; Benton MJ, 2009, SCIENCE, V323, P728, DOI 10.1126/science.1157719; BENTON MJ, 1995, SCIENCE, V268, P52, DOI 10.1126/science.7701342; BENTON MJ, 1991, NUMERICAL PALAEOBIOL, P249; Berger H., 2001, Annalen des Naturhistorischen Museums in Wien Serie B Botanik und Zoologie, V103B, P301; Bernard EL, 2010, ACTA PALAEONTOL POL, V55, P229, DOI 10.4202/app.2009.0025; Bethoux O, 2008, J IBER GEOL, V34, P109; Bethoux O., 2002, Journal of Orthoptera Research, V11, P223, DOI 10.1665/1082-6467(2002)011[0223:NDOTP]2.0.CO;2; Bethoux O, 2007, ALCHERINGA, V31, P285, DOI 10.1080/03115510701484739; Bethoux O., 2003, Journal of Orthoptera Research, V12, P57, DOI 10.1665/1082-6467(2003)012[0057:PDBALB]2.0.CO;2; Bethoux O, 2005, J SYST PALAEONTOL, V3, P403, DOI 10.1017/S147720190500163X; Bethoux O, 2005, J PALEONTOL, V79, P125, DOI 10.1666/0022-3360(2005)079<0125:NDOPGI>2.0.CO;2; Bethoux O, 2004, PALAIOS, V19, P408, DOI 10.1669/0883-1351(2004)019<0408:EEOIEO>2.0.CO;2; Bethoux O, 2004, ANN ZOOL, V54, P289; Bethoux O, 2004, PALAEONTOLOGY, V47, P13, DOI 10.1111/j.0031-0239.2004.00344.x; Bethoux O, 2003, EUR J ENTOMOL, V100, P581, DOI 10.14411/eje.2003.087; Bethoux O, 2003, J PALEONTOL, V77, P1016, DOI 10.1666/0022-3360(2003)077<1016:RODSAN>2.0.CO;2; Bethoux O, 2003, GEOBIOS-LYON, V36, P275, DOI 10.1016/S0016-6995(03)00030-5; Bethoux O, 2003, GEOBIOS-LYON, V36, P131, DOI 10.1016/S0016-6995(03)00002-0; Bethoux O, 2002, GEOBIOS-LYON, V35, P293, DOI 10.1016/S0016-6995(02)00027-X; Bethoux O, 2002, EUR J ENTOMOL, V99, P111, DOI 10.14411/eje.2002.019; Bethoux O, 2001, GEOBIOS-LYON, V34, P405, DOI 10.1016/S0016-6995(01)80004-8; BETHOUX O, 1911, B PEABODY MUS NAT HI, V47, P29; Bethoux O., 2002, ZOOTAXA, V96, P1, DOI DOI 10.11646/ZOOTAXA.96.1.1; BETHOUX O, 2009, ALAVESIA, V3, P81; Bethoux O., 2005, J SYSTEMATIC PALAEON, V2, P285, DOI DOI 10.1017/; Bethoux O, 2009, EUR J ENTOMOL, V106, P145, DOI 10.14411/eje.2009.017; Bethoux Oliver, 2007, Alavesia, V1, P41; Bethoux Olivier, 2007, Arthropod Systematics & Phylogeny, V65, P135; Bethoux O, 2008, SYST ENTOMOL, V33, P529, DOI 10.1111/j.1365-3113.2008.00419.x; Bethoux O, 2007, GEOBIOS-LYON, V40, P181, DOI 10.1016/j.geobios.2006.04.001; Bethoux Olivier, 2003, Bulletin de la Societe Entomologique de France, V108, P237; Bethoux Olivier, 2007, Alavesia, V1, P49; Bethoux O, 2009, J PALEONTOL, V83, P931, DOI 10.1666/08-158.1; Bethoux O, 2009, ZOOL J LINN SOC-LOND, V156, P79, DOI 10.1111/j.1096-3642.2008.00485.x; Bethoux Olivier, 2008, Arthropod Systematics & Phylogeny, V66, P145; Bethoux Olivier, 2007, Alavesia, V1, P3; Beutel RG, 2008, J ZOOL SYST EVOL RES, V46, P346, DOI 10.1111/j.1439-0469.2008.00473.x; Bitsch J, 1999, ANN SOC ENTOMOL FR, V35, P17; Blagoderov V, 2004, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2004)433<0001:FSDICA>2.0.CO;2; Blagoderov V. A., 2002, HIST INSECTS, P227; Blagoderov V.A., 1998, AMBA PROJECTS, P11; Blagoderov V, 2007, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2007)509[1:HTFFFD]2.0.CO;2; Blagoderov VV, 2001, GEOBIOS-LYON, V34, P63, DOI 10.1016/S0016-6995(01)80045-0; Blank SM, 2009, ZOOTAXA, P1; Bocher J., 1995, MONOGRAPH FOSSIL INS, V33, P1; Bocher Jens, 1995, Meddelelser om Gronland Geoscience, V33, P1; Bolton H., 1912, Quarterly Journal of the Geological Society of London, V68; Bordy EM, 2009, S AFR J SCI, V105, P356; Borkent A, 2008, ZOOTAXA, P1; Borkent Art, 1997, Stuttgarter Beitraege zur Naturkunde Serie B (Geologie und Palaeontologie), V249, P1; Borner C., 1904, ZOOLOGISCHER ANZEIGE, V27, P511; Bouchard P, 2011, ZOOKEYS, P1, DOI 10.3897/zookeys.88.807; Bourgoin T, 2002, ANN ZOOL, V52, P583; Bourgoin T, 2008, B INSECTOL, V61, P107; Braby MF, 2005, INVERTEBR SYST, V19, P113, DOI 10.1071/IS04020; Brasero Nicolas, 2009, Denisia, P41; Brauckmann C., 2001, Boletin Geologico y Minero (Madrid), V112, P57; Brauckmann C., 1993, Jahresberichte des Naturwissenschaftlichen Vereins in Wuppertal, V46, P115; Brauckmann C., 1985, Geologie und Palaeontologie in Westfalen, V3, P1; Brauckmann C., 1980, Palaeontologische Zeitschrift, V54, P301; Brauckmann C., 1996, NEUES JB GEOLOGIE PA, V1996, P17; BRAUCKMANN C, 2003, GEOLOGIE PALAONTOLOG, V59, P5; Brauckmann Carsten, 1991, Osnabruecker Naturwissenschaftliche Mitteilungen, V17, P25; Brauckmann Carsten, 2005, Courier Forschungsinstitut Senckenberg, V254, P87; Bridges C.A., 1994, CATALOGUE FAMILY GRO; Britt BB, 2008, ICHNOS, V15, P59, DOI 10.1080/10420940701193284; Brodsky A. K., 1994, EVOLUTION INSECT FLI; Brongniart C., 1885, Bulletin de la Societe Rouen, P50; BRONGNIART C, 1893, THESIS FACULTE SCI P, V821, P495; BROOKS DR, 1995, J PARASITOL, V81, P762, DOI 10.2307/3283969; Brothers Denis J., 2003, Acta Zoologica Cracoviensia, V46, P101; Brothers Denis J., 2008, Alavesia, V2, P73; Brothers DJ, 2003, AFR ENTOMOL, V11, P221; Brothers DJ, 2003, EXPEDITION SCI MOREE, V46, P101; BRUES CT, 1915, KEY FAMILIES N AM IN; Brusatte SL, 2008, SCIENCE, V321, P1485, DOI 10.1126/science.1161833; Burmeister H, 1838, HDB ENTOMOLOGIE; BUTSCHLI O, 1889, KLASSEN ORDNUNGEN TH, V1, P1842; Bybee SM, 2008, CLADISTICS, V24, P477, DOI 10.1111/j.1096-0031.2007.00191.x; Cairncross B., 1995, South African Journal of Geology, V98, P452; Carle F. L., 1995, Odonatologica, V24, P383; CARPENTER F. M., 1963, PSYCHE, V70, P240, DOI 10.1155/1963/59263; CARPENTER F. M., 1951, JOUR PALEONTOL, V25, P336; CARPENTER F M, 1991, Psyche (Cambridge), V98, P87, DOI 10.1155/1991/45391; CARPENTER F M, 1985, Psyche (Cambridge), V92, P575, DOI 10.1155/1985/62623; CARPENTER F. M., 1963, PSYCHE, V70, P44, DOI 10.1155/1963/10721; Carpenter FM, 1951, TREATISE INVERTEBR R, V25, P336; Carpenter Frank M., 1997, P184; CARPENTER FRANK M., 1950, PROC AMER ACAD ARTS AND SCI, V78, P187, DOI 10.2307/20023577; Carpenter Frank M., 1992, Psyche (Cambridge), V99, P141, DOI 10.1155/1992/31052; CARVALHO J C M, 1985, Revista Brasileira de Biologia, V45, P249; Chandler P, 2002, ANN SOC ENTOMOL FR, V38, P101; Chang HL, 2009, ANN ZOOL, V59, P7, DOI 10.3161/000345409X432547; CHEN S, 1973, Acta Entomologica Sinica, V16, P169; Christiansen K, 2002, CRETACEOUS RES, V23, P165, DOI 10.1006/cres.2002.0313; Christiansen K, 2006, CRETACEOUS RES, V27, P318, DOI 10.1016/j.cretres.2005.07.003; Cifuentes-Ruiz P, 2006, GEOL CARPATH, V57, P347; CLIFFORD E, 1994, P DORSET NATURAL HIS, V115, P143; Coram R., 2000, Paleontological Journal, V34, pS370; Coram RA, 1999, CRETACEOUS RES, V20, P853, DOI 10.1006/cres.1999.0186; Coram Robert A., 2009, Palaeodiversity, P205; Costa C, 2006, ANN ENTOMOL SOC AM, V99, P409, DOI 10.1603/0013-8746(2006)99[409:ROTFBC]2.0.CO;2; Dalgleish RC, 2006, SYST ENTOMOL, V31, P648, DOI 10.1111/j.1365-3113.2006.00342.x; Damgaard J, 2008, MOL PHYLOGENET EVOL, V47, P443, DOI 10.1016/j.ympev.2008.01.026; Damgaard Jakob, 2008, Acta Entomologica Musei Nationalis Pragae, V48, P251; Damgaard J, 2008, INSECT SYST EVOL, V39, P431, DOI 10.1163/187631208788784264; Davis RB, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-252; De Geer C., 1773, MEMOIRES SERVIR HIST, V3; de Jong Rienk, 2007, Tijdschrift voor Entomologie, V150, P319; Delclos X, 2008, NEUES JAHRB GEOL P-A, V247, P353, DOI 10.1127/0077-7749/2008/0247-0353; Delclos X, 2007, CR PALEVOL, V6, P135, DOI 10.1016/j.crpv.2006.09.003; Dikow T, 2009, B AM MUS NAT HIST, P1, DOI 10.1206/603.1; Dmitriev V.Yu., 1988, P208; EFRON B, 1987, J AM STAT ASSOC, V82, P171, DOI 10.2307/2289144; Engel M. S., 2006, Vestnik Zoologii, V40, P175; Engel M.S., 2004, BIODIVERSIDAD TAXONO, VIV, P175; Engel MS, 2008, J KANSAS ENTOMOL SOC, V81, P168, DOI 10.2317/JKES-712.11.1; Engel Michael S., 2006, Polskie Pismo Entomologiczne, V75, P443; Engel MS, 2006, J KANSAS ENTOMOL SOC, V79, P359, DOI 10.2317/0604.26.1; Engel Michael S., 2004, Transactions of the Kansas Academy of Science, V107, P119, DOI 10.1660/0022-8443(2004)107[0119:TAOKMS]2.0.CO;2; Engel Michael S., 2003, Transactions of the Kansas Academy of Science, V106, P115, DOI 10.1660/0022-8443(2003)106[0115:TEOKWA]2.0.CO;2; Engel Michael S., 2008, Alavesia, V2, P233; Engel Michael S., 2008, Alavesia, V2, P215; Engel Michael S., 2009, Transactions of the Kansas Academy of Science, V112, P1, DOI 10.1660/062.112.0201; Engel Michael S., 2008, Acta Entomologica Slovenica, V16, P127; Engel MS, 2007, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2007)475[1:CSAPOT]2.0.CO;2; Engel Michael S., 2006, American Museum Novitates, V3514, P1, DOI 10.1206/0003-0082(2006)3514[1:TEWIE]2.0.CO;2; Engel MS, 2006, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2006)3515[1:TFCSWH]2.0.CO;2; Engel Michael S., 2009, Transactions of the Kansas Academy of Science, V112, P40, DOI 10.1660/062.112.0206; Engel MS, 2009, AM MUS NOVIT, P1, DOI 10.1206/651.1; Engel MS, 2007, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2007)3587[1:TNFODA]2.0.CO;2; Engel MS, 2007, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2007)539[1:FNFED]2.0.CO;2; Engel Michael S., 2009, Denisia, P53; Engel MS, 2009, ZOOKEYS, P61, DOI 10.3897/zookeys.25.267; Engel Michael S., 2008, Nova Supplementa Entomologica, V20, P1; Engel Michael S., 2006, Transactions of the Kansas Academy of Science, V109, P236, DOI 10.1660/0022-8443(2006)109[236:ANOTRS]2.0.CO;2; Engel Michael S., 2005, Memoirs of the Queensland Museum, V51, P558; Engel Michael S., 2007, Transactions of the Kansas Academy of Science, V110, P159, DOI 10.1660/0022-8443(2007)110[159:NFFWIC]2.0.CO;2; Engel Michael S., 2000, American Museum Novitates, V3296, P1, DOI 10.1206/0003-0082(2000)3296<0001:ANIOTO>2.0.CO;2; Engel MS, 2005, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2005)485[0001:PNAICA]2.0.CO;2; Engel MS, 2004, J PALEONTOL, V78, P1192, DOI 10.1666/0022-3360(2004)078<1192:TFMSWH>2.0.CO;2; Engel MS, 2004, J PALEONTOL, V78, P1018, DOI 10.1666/0022-3360(2004)078<1018:APEICA>2.0.CO;2; Engel MS, 2003, J KANSAS ENTOMOL SOC, V76, P616; Engel MS, 2003, CAN ENTOMOL, V135, P63; Engel MS, 2002, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2002)363<0001:TSSRMA>2.0.CO;2; Engel MS, 2001, B AM MUS NAT HIST, P1, DOI 10.1206/0003-0090(2001)259<0001:AMOTBA>2.0.CO;2; ENGEL MS, 2007, STUTTG BEITR NA 1228, P1; Etter W, 2000, PALAEONTOLOGY, V43, P967, DOI 10.1111/1475-4983.00157; EVANS J. W., 1956, AUSTRALIAN JOUR ZOOL, V4, P165, DOI 10.1071/ZO9560165; Evenhuis N.L., 2002, ENTOMOLOGICAE SYSTEM, V10, P1; Evenhuis N.L., 1994, CATALOGUE FOSSIL FLI; Evenhuis Neal L., 2002, Bishop Museum Bulletins in Entomology, V10, P1; Ezard THG, 2011, SCIENCE, V332, P349, DOI 10.1126/science.1203060; Fernandez-Rubio Fidel, 2000, Boletin de la SEA, V27, P7; Fernandez-Rubio Fidel, 1999, Boletin de la SEA, V26, P521; Fitzgerald PC, 2006, PALEOBIOLOGY, V32, P367, DOI 10.1666/05029.1; Fleck G, 2004, GEODIVERSITAS, V26, P33; Fleck G, 2003, ANN SOC ENTOMOL FR, V39, P55, DOI 10.1080/00379271.2003.10697363; Fleck G, 2001, INSECT SYST EVOL, V32, P285, DOI 10.1163/187631201X00227; Fleck G, 1999, CRETACEOUS RES, V20, P655, DOI 10.1006/cres.1999.0166; Fleck G, 2009, ZOOTAXA, P52, DOI 10.11646/zootaxa.1985.1.5; Fleck Guenther, 2003, Zoologica (Stuttgart), V153, P1; Fleck Guenther, 2008, Palaeodiversity, P19; FOLDI I, 2005, ANN SOC ENTOMOLOGIQU, V41, P18; Foote M, 2000, PALEOBIOLOGY, V26, P74, DOI 10.1666/0094-8373(2000)26[74:OAECOT]2.0.CO;2; Fujiyama Ienori, 1994, Natural History Research, V3, P1; Gaimari S.D., 2000, Bulletin of the Natural History Museum Geology Series, V56, P43; Gall JC, 2005, CR PALEVOL, V4, P637, DOI 10.1016/j.crpv.2005.04.007; GALL LF, 1983, SCIENCE, V219, P507, DOI 10.1126/science.219.4584.507; Gao TP, 2009, ANN ENTOMOL SOC AM, V102, P588, DOI 10.1603/008.102.0402; Garrouste R, 2009, CR PALEVOL, V8, P49, DOI 10.1016/j.crpv.2008.11.008; Geertsema H., 2002, Palaeontologia Africana, V38, P19; Gentilini G, 2006, INSTRUMENTAS BIODIVE, V7, P85; Gentilini Giuseppe, 2002, Studi e Ricerche sui Giacimenti Terziari di Bolca, V9, P7; Gibson GAP, 2007, J HYMENOPT RES, V16, P51; Gibson Gary A.P., 2008, Zootaxa, V1730, P1; Godunko RJ, 2006, ANN ZOOL, V56, P175; Godunko RJ, 2008, ANN ZOOL, V58, P105; Godunko RJ, 2006, ANN ZOOL, V56, P785; Godunko RJ, 2009, AQUAT INSECT, V31, P125, DOI 10.1080/01650420802611187; GOLDENBERG CF, 1877, FAUNA SARAEPONTANA 2; Golub VB, 2008, PALEONTOL J+, V42, P86, DOI 10.1134/S0031030108010140; Golub Viktor B., 2003, Acta Zoologica Cracoviensia, V46, P109; Golub Viktor B., 2000, P231; Gonzalez JAC, 2006, ZOOTAXA, P1; Gorjunova R.V., 1988, NOVYYE NOV, P10; Gorochov AV, 2007, PALEONTOL J+, V41, P621, DOI 10.1134/S0031030107060056; Gorochov A.V., 1988, Trudy Zoologicheskogo Instituta, V178, P32; Gorochov AV, 2006, PALEONTOL J+, V40, P646, DOI 10.1134/S0031030106060074; Gorochov A.V., 1994, Zoosystematica Rossica, V3, P53; Gorochov A.V., 1986, Trudy Zoologicheskogo Instituta, V143, P65; Gorochov A.V., 1988, Paleontologicheskii Zhurnal, V1988, P54; Gorochov A.V., 1987, Vestnik Zoologii, V1987, P20; Gorochov A.V., 1995, P ZOOLOGICAL I RAS, V260, P1; Gorochov A.V., 1985, PALEONTOL J, V19, P56; Gorochov A.V., 1988, CRETACEOUS BIOCOENOT, P145; Gorochov A.V, 2000, PALEONTOL J+, V34, P295; Gorochov AV, 2006, CRETACEOUS RES, V27, P641, DOI 10.1016/j.cretres.2006.03.007; Gorochov AV, 2005, PALEONTOL J+, V39, P272; Gorochov AV., 2002, HIST INSECTS, P293, DOI DOI 10.1007/0-306-47577-4; Gorokhov A.V., 1987, Vestnik Zoologii, V1987, P18; GOROKHOV AV, 1995, ZOOL ZH, V74, P39; Gorokhov AV., 2006, PALEONTOL J, V40, P646; Gratshev V.G., 1994, Paleontological Journal, V27, P148; Gratshev Vadim G., 2003, Acta Zoologica Cracoviensia, V46, P129; Grazia J, 2008, CLADISTICS, V24, P932, DOI 10.1111/j.1096-0031.2008.00224.x; Greenwood DR, 2005, CAN J EARTH SCI, V42, P167, DOI 10.1139/E04-100; Grimaldi D, 1999, B AM MUS NAT HIST, P1; Grimaldi D, 2006, P ROY SOC B-BIOL SCI, V273, P625, DOI 10.1098/rspb.2005.3337; Grimaldi D, 2005, INSECT SYST EVOL, V36, P443, DOI 10.1163/187631205794761021; Grimaldi D, 2005, INSECT SYST EVOL, V36, P1, DOI 10.1163/187631205788912787; Grimaldi D, 2004, J PALEONTOL, V78, P941, DOI 10.1666/0022-3360(2004)078<0941:MTAEEO>2.0.CO;2; Grimaldi D, 1999, ANN MO BOT GARD, V86, P373, DOI 10.2307/2666181; Grimaldi D, 2003, J PALEONTOL, V77, P368, DOI 10.1666/0022-3360(2003)077<0368:TMFADI>2.0.CO;2; Grimaldi D, 2003, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2003)412<0001:AROCMA>2.0.CO;2; Grimaldi D.A., 2007, CRATO FOSSIL BEDS BR, P234; Grimaldi DA, 2003, INSECT SYST EVOL, V34, P329, DOI 10.1163/187631203788964746; Grimaldi DA, 2002, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2002)361<0001:FCAFMB>2.0.CO;2; Grimaldi David, 2005, pi; Grimaldi David, 2008, Alavesia, V2, P259; Grimaldi D, 2006, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2006)3523[1:EFOTGF]2.0.CO;2; Grimaldi DA, 2008, P ENTOMOL SOC WASH, V110, P543, DOI 10.4289/07-072.1; Grimaldi DA, 2008, AM MUS NOVIT, P1, DOI 10.1206/616.1; Grimaldi DA, 2008, AM MUS NOVIT, P1, DOI 10.1206/610.1; Grimaldi DA, 2008, AM MUS NOVIT, P1, DOI 10.1206/602.1; Grimaldi DA, 2008, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2008)3611[1:AUPPIH]2.0.CO;2; Grimaldi DA, 2009, ZOOTAXA, P34, DOI 10.11646/zootaxa.2078.1.2; Gumovsky Alex V., 2005, Entomological Problems, V35, P123; Gumovsky Alex V., 2001, Phegea, V29, P125; Gutierrez PR, 2000, AMEGHINIANA, V37, P375; Haas F., 2007, CRATO FOSSIL BEDS BR, P222; HAECKEL E, 1896, ZWEITER THEIL SYSTEM; Haenni Jean-Paul, 2003, Acta Zoologica Cracoviensia, V46, P407; Haliday A. H., 1836, ENTOMOLOGICAL MAGAZI, V3, P439; Hall JPW, 2004, P ROY SOC B-BIOL SCI, V271, P797, DOI 10.1098/rspb.2004.2691; Hamilton K.G.A., 1990, B AM MUS NAT HIST, V195, P82; HAMILTON KGA, 1992, ANN ENTOMOL SOC AM, V85, P423, DOI 10.1093/aesa/85.4.423; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Handlirsch A, 1911, AM J SCI, V31, P297; Handlirsch A., 1906, Proceedings of the United States National Museum Smithsonian Institution Washington, V29; Handlirsch A., 1937, ANN NATURHISTORISCHE, V48, P1; Handlirsch A., 1939, ANN NATURHISTORISCHE, V49, P1; Handlirsch A., 1906, HDB PALAONTOLOGEN ZO; Handlirsch A, 1906, MATH NATURWISSENSCHA, V29, P661; Hannisdal B, 2011, SCIENCE, V334, P1121, DOI 10.1126/science.1210695; Harbach RE, 2007, ZOOTAXA, P591; Harris AC, 2002, J ROY SOC NEW ZEAL, V32, P457, DOI 10.1080/03014223.2002.9517704; Hauser M, 2007, ANN ENTOMOL SOC AM, V100, P152, DOI 10.1603/0013-8746(2007)100[152:ANFGOS]2.0.CO;2; Hava J., 2006, ACTA SOC ZOOLOGICAE, V69, P281; Heads SW, 2008, PALAEONTOLOGY, V51, P499, DOI 10.1111/j.1475-4983.2008.00756.x; Heads Sam W., 2009, Denisia, P75; Heads Sam W., 2009, Denisia, P69; Heads Sam W., 2008, British Journal of Entomology and Natural History, V21, P247; Heie O.E., 1987, World Crop Pests, V2A, P367; Heie OE, 2000, ANN ENTOMOL SOC AM, V93, P1222, DOI 10.1603/0013-8746(2000)093[1222:TNSOAF]2.0.CO;2; HEIE OE, 1992, CAN ENTOMOL, V124, P1027, DOI 10.4039/Ent1241027-6; Heie OE, 1985, AMBA PROJECTS, P101; HEIE OE, 1985, EVOLUTION BIOSYSTEMA, P101; Heie Olee, 1998, Annals of the Upper Silesian Museum in Bytom Entomology, V8-9, P159; Heraty JM, 2009, ZOOTAXA, P1; Herczek A, 2001, GEOLOGICAL B CHINA, V10-11, P121; Herczek Aleksander, 2001, Annals of the Upper Silesian Museum in Bytom Entomology, V10-11, P121; Herd K.J., 2006, OSNABRUCKER NATURWIS, V30, P19; Hong Y., 1980, Geological Review (Beijing), V26, P89; HONG Y, 1985, Entomotaxonomia, V7, P83; Hong Y.-c., 1990, P44; Hong Y.-c., 1984, Acta Palaeontologica Sinica, V23, P782; Hong Y.-c., 1980, Acta Zootaxonomica Sinica, V5, P63; Hong Y. C., 1983, MIDDLE JURASSIC FOSS; Hong Y.C, 2002, ATLAS AMBER INSECTS; Hong Y.C., 2002, AMBER INSECTS CHINA; HONG YC, 2003, ACTA ZOOTAXON SIN, V28, P715; Hong You-chong, 2006, Dizhi Tongbao, V25, P560; [Hong You-chong 洪友崇], 2009, [地质通报, Geological Bulletin of China], V28, P11; Hong You-Chong, 2009, Acta Zootaxonomica Sinica, V34, P423; Hong You-Chong, 2007, Acta Zootaxonomica Sinica, V32, P875; Hong You-Chong, 2007, Entomotaxonomia, V29, P26; Hong You-Chong, 2007, Acta Entomologica Sinica, V50, P271; Hong You-Chong, 2007, Acta Zootaxonomica Sinica, V32, P261; Hong You-Chong, 2004, Acta Zootaxonomica Sinica, V29, P224; Hong Youchong, 1998, Geoscience, V12, P40; Hong YC, 2009, J PALEONTOL, V83, P826, DOI 10.1666/07-135.1; Hong Youchong, 1998, Entomologia Sinica, V5, P283; Hornschemeyer T, 2001, NEUES JAHRB GEOL P-A, V221, P81; HORNSCHEMEYER T, 1998, AMBA PROJECTS, V1999, P57; Hornschemeyer T., 2005, HDB ZOOLOGIE, P29; HORNSCHEMEYER T, 1999, TERRA NOSTRA SCHRIFT, V8, P98; Huang DY, 2009, CRETACEOUS RES, V30, P429, DOI 10.1016/j.cretres.2008.08.005; Huang DY, 2008, NATURWISSENSCHAFTEN, V95, P947, DOI 10.1007/s00114-008-0412-x; Huang DY, 2008, GEOBIOS-LYON, V41, P461, DOI 10.1016/j.geobios.2007.11.003; Huang DY, 2008, ZOOL J LINN SOC-LOND, V152, P17, DOI 10.1111/j.1096-3642.2007.00351.x; Huang DY, 2007, EUR J ENTOMOL, V104, P837, DOI 10.14411/eje.2007.104; Huang DY, 2007, NEUES JAHRB GEOL P-A, V246, P63, DOI 10.1127/0077-7749/2007/0246-0063; Huang DY, 2009, ZOOL J LINN SOC-LOND, V156, P889, DOI 10.1111/j.1096-3642.2008.00499.x; Huang Di-ying, 2007, Bulletin de la Societe Entomologique de France, V112, P179; Huang D, 2008, PALAEONTOLOGY, V51, P715, DOI 10.1111/j.1475-4983.2008.00773.x; Huang DY, 2003, CRETACEOUS RES, V24, P141, DOI 10.1016/S0195-6671(03)00027-2; Huang Jian-Dong, 2007, Acta Zootaxonomica Sinica, V32, P391; HUBBARD MD, 1987, FOSSILIUM CATALOGUS, V129, P1; Huber John T., 2005, Acta Societatis Zoologicae Bohemicae, V69, P167; Huguet A, 2002, GEOBIOS-LYON, V35, P537, DOI 10.1016/S0016-6995(02)00071-2; Hyatt A., 1890, GUIDES SCI TEACHING; Ivanov V., 2006, ENTOMOL REV, V86, P568, DOI [10.1134/S0013873806050083, DOI 10.1134/S0013873806050083]; Ivanov VD, 2006, PALEONTOL J+, V40, P178, DOI 10.1134/S0031030106020080; Ivanov V.D., 2002, HIST INSECTS, P194; Ivanov V.D., 1992, PALEONTOL J+, V26, P36; Jablonski D, 2003, SCIENCE, V300, P1133, DOI 10.1126/science.1083246; Jacobus LM, 2008, T AM ENTOMOL SOC, V134, P185, DOI 10.3157/0002-8320(2008)134[185:ROEGE]2.0.CO;2; Jacobus LM, 2006, T AM ENTOMOL SOC, V132, P81; Jakobsen, 2008, DANEKRAE DANMARKS BE; JARZEMBOWSKI E A, 1990, Odonatologica, V19, P27; Jarzembowski EA, 2007, GEOL MAG, V144, P449, DOI 10.1017/S0016756807003421; Jarzembowski EA, 1996, CRETACEOUS RES, V17, P67, DOI 10.1006/cres.1996.0005; Jarzembowski EA, 1998, CRETACEOUS RES, V19, P403, DOI 10.1006/cres.1997.0113; Jarzembowski EA, 2002, P GEOLOGIST ASSOC, V113, P165, DOI 10.1016/S0016-7878(02)80018-9; Jarzembowski EA, 1995, CRETACEOUS RES, V16, P695, DOI 10.1006/cres.1995.1043; Jarzembowski EA, 1996, GEOL SOC SPEC PUBL, V102, P65, DOI 10.1144/GSL.SP.1996.001.01.05; JARZEMBOWSKI EA, 1996, P DORSET NATURAL HIS, V1996, P119; Jarzembowski EA, 1996, P DORSET NATURAL HIS, V1996, P119; Jarzembowski Ed. A., 1999, Palaeontological Association Field Guides to Fossils, V9, P149; Jaschhof M, 2007, PALEONTOL J+, V41, P103, DOI 10.1134/S003103010701011X; JASCHHOF M., 2002, STUDIA DIPTEROLOGI S, V11, P1; Jell P. A., 2004, Memoirs of the Queensland Museum, V50, P1; Jennings JT, 2009, INSECT SYST EVOL, V40, P201, DOI 10.1163/187631209X440069; Jepson JE, 2007, PALAEOGEOGR PALAEOCL, V248, P109, DOI 10.1016/j.palaeo.2006.11.015; Jepson James E., 2008, Alavesia, V2, P193; Jepson JE, 2009, CRETACEOUS RES, V30, P1325, DOI 10.1016/j.cretres.2009.07.012; Johnson NF, 2001, INSECT SYST EVOL, V32, P191, DOI 10.1163/187631201X00146; Johnson NF, 2008, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2008)3603[1:TCSGPB]2.0.CO;2; Kaddumi H.F., 2005, AMBER JORDAN OLDEST; KALUGINA NS, 1985, 2 WINGED INSECTS JUR; Kania Iwona, 2008, Monografie Faunistyczne, V25, P5; KEVAN DKM, 1981, CAN J EARTH SCI, V18, P1824, DOI 10.1139/e81-170; KINZELBACH R, 1984, Palaeontologische Zeitschrift, V58, P247; Kirby W, 1815, T LINNEAN SOC LONDON, V11, P86, DOI [10.1111/j.1096-3642.1813.tb00040.x, DOI 10.1111/J.1096-3642.1813.TB00040.X]; KIRBY W, 1815, INTRO ENTOMOLOGY, V1; Kirejtshuk A.G., 2008, Zoosystematica Rossica, V17, P107; Kirejtshuk A. G., 1994, PALAEONTOGICAL J, V28, P69; Kirejtshuk AG, 2006, P ENTOMOL SOC WASH, V108, P155; Kirejtshuk Alexander G., 2009, Denisia, P119; Kirejtshuk Alexander G., 2009, Denisia, P103; Kirejtshuk Alexander G., 2009, Denisia, P99; Kirejtshuk Alexander G., 2008, Alavesia, V2, P15; Kirejtshuk AG, 2008, ANN SOC ENTOMOL FR, V44, P419, DOI 10.1080/00379271.2008.10697578; Kirejtshuk AG, 2009, SYST ENTOMOL, V34, P101, DOI 10.1111/j.1365-3113.2008.00442.x; Kirk-Spriggs AH, 2007, MITTEILUNGEN GEOLOGI, V6, P13; KIRKSPRIGGS AH, 1937, ANN E CAPE MUSEUMS, V6, P13; Klass KD, 2002, SCIENCE, V296, P1456, DOI 10.1126/science.1069397; Klimaszewski SM, 1997, HIST INSECTS, V80, P151; Kluge N.J., 2004, PHYLOGENETIC SYSTEM; Kluge N. J., 1996, ZOOSYSTEMATICA ROSSI, V4, P71; Kluge N. J., 1996, PALEONTOL J, V4, P71; Kluge NJ, 2006, ANN ZOOL, V56, P181; Kocak Ahmet Omer, 2008, Centre for Entomological Studies Miscellaneous Papers, V141, P1; Kopylov D, 2009, PALEONTOL J+, V43, P83, DOI 10.1134/S0031030109010092; KOTEJA J, 1989, Annales Zoologici (Warsaw), V43, P77; Koteja J, 2001, P ENTOMOL SOC WASH, V103, P356; Koteja Jan, 2008, Alavesia, V2, P133; Koteja Jan, 2008, Prace Muzeum Ziemi, V49, P19; Koteja Jan, 2000, Polskie Pismo Entomologiczne, V69, P187; Koteja Jan, 2000, P147; Kotrba M, 2009, SPIXIANA, V32, P187; Kozlov M.V., 2002, HIST INSECTS, P220; Kozlov M. V., 1988, CRETACEOUS BIOCOENOT, P16; Kraemer MMS, 2007, PALAEONTOGR ABT A, V282, P1; Krassilov VA, 2007, AFR INVERTEBR, V48, P13; KRELL FT, 2007, 20078 DENV MUS NAT S; Krishna K, 2003, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2003)390<0001:TFCRIA>2.0.CO;2; Kristensen N.P., 1999, BITTERFELDER BERNSTE, V1, P7; Kristensen Niels P., 1999, Handbuch der Zoologie (Berlin), V4, P7; Krzeminska E, 2009, MONOGRAPH OF FOSSIL TRICHOCERIDAE (DIPTERA): OVER 180 MILLION YEARS OF EVOLUTION, P9; Krzeminska Ewa, 1993, Acta Zoologica Cracoviensia, V35, P581; Krzeminski W, 2002, ANN ZOOL, V52, P211; KRZEMINSKI W, 1992, Mitteilungen der Schweizerischen Entomologischen Gesellschaft, V65, P39; KRZEMINSKI W, 1992, Acta Zoologica Cracoviensia, V35, P45; Krzeminski W, 2001, RIV ITAL PALEONTOL S, V107, P69, DOI 10.13130/2039-4942/5424; Krzeminski W, 1992, AFRICAN INVERTEBRATE, V65, P39; Krzeminski W, 2005, POL PISMO ENTOMOL, V74, P369; KRZEMINSKI W, 2000, CONTRIBUTIONS MANUAL, V1, P535; Krzeminski Wieslaw, 2005, Polskie Pismo Entomologiczne, V74, P369; Krzeminski Wieslaw, 2003, Acta Zoologica Cracoviensia, V46, P153; Krzeminski Wieslaw, 1994, Acta Zoologica Cracoviensia, V37, P95; Krzeminski Wieslaw, 1993, Acta Zoologica Cracoviensia, V35, P593; Ksepka DT, 2012, PALEOBIOLOGY, V38, P112, DOI 10.1666/10059.1; Kubisz Daniel, 2000, Polskie Pismo Entomologiczne, V69, P225; KUKALOVA J, 1969, Psyche (Cambridge), V76, P163, DOI 10.1155/1969/74019; Kukalova J., 1964, PALEONTOLOGIE 2, V3, P39; KUKALOVA J, 1969, PSYCHE, V76, P349; KUKALOVA-PECK J, 1975, Psyche (Cambridge), V82, P1, DOI 10.1155/1975/78215; KUKALOVAPECK J, 1985, CAN J ZOOL, V63, P933, DOI 10.1139/z85-139; KUKALOVAPECK J, 1990, CAN J ZOOL, V68, P1104, DOI 10.1139/z90-163; KUKALOVAPECK J, 1992, CAN J ZOOL, V70, P229, DOI 10.1139/z92-036; KUKALOVAPECK J, 1987, CAN J ZOOL, V65, P2327, DOI 10.1139/z87-352; Kumar Prabhat, 2004, Journal of the Palaeontological Society of India, V49, P159; Kupryjanowicz J., 2001, AMBER TREASURE TRO 1, P19; Kusnezov N, 1903, REV RUSSE ENTOMOLOGI, V3, P208; Kvacek Zlatko, 2004, Journal of the Czech Geological Society, V49, P1; Labandeira CC, 2002, P NATL ACAD SCI USA, V99, P2061, DOI 10.1073/pnas.042492999; Labandeira Conrad C., 1994, Milwaukee Public Museum Contributions in Biology and Geology, V88, P1; Loveridge, 2007, CRATO FOSSIL BEDS BR, P265; 1998, ARCHAEOPTERYX, V16, P29; 1998, PALAONTOLOGISCHE Z, V72, P281; [Anonymous], 1998, PALEONTOL J+; [Anonymous], [No title captured]; Brunner C. De Wattenwyl, 1893, Annali del Museo Genova, V(2), P1; Brunner von Wattenwyl K., 1882, PRODROMUS EUROPAISCH; Klopy Popov YA., 1990, ANN NATURHISTORISC A, V239, P20; Labandeira C.C., 2014, EVOLUTIONARY BIOL GE, P261, DOI DOI 10.1007/978-3-319-07623-2_13; LABANDEIRA CC, 1993, SCIENCE, V261, P310, DOI 10.1126/science.11536548; LABANDEIRA CC, 2001, PALAEOBIOLOGY, V2, P82; Labandeira CC, 2007, TAXON, V56, P663, DOI 10.2307/25065853; Labandeira Conrad C., 2002, Rocky Mountain Geology, V37, P31, DOI 10.2113/gsrocky.37.1.31; Labandeira Conrad C., 2005, American Entomologist, V51, P14; Latreille P.A., 1802, ORTHOPTERA, V3, P267, DOI 10.5962/bhl.title.15764; Latreille P.A., 1825, FAMILLES NATURELLES, DOI DOI 10.5962/BHL.TITLE.16094; Laurentiaux D., 1986, ANN SOC GEOLOGIQUE N, V105, P187; Laurentiaux-Vieira F, 1986, ANNOTATED CHECKLIST, V105, P187; Lawrence JF, 2008, ANN ZOOL, V58, P689, DOI 10.3161/000345408X396620; Lefebvre F, 2004, FOSSIL PLANTHOPPERS; Legalov A.A., 2009, Amurskii Zoologicheskii Zhurnal, V1, P200; Legalov A.A., 2009, Amurskii Zoologicheskii Zhurnal, V1, P117; LEWIS SE, 1977, P ENTOMOL SOC WASH, V79, P583; Li TT, 2009, PROG NAT SCI-MATER, V19, P1837, DOI 10.1016/j.pnsc.2009.06.011; [李祥辉 Li Xianghui], 2009, [地学前缘, Earth Science Frontiers], V16, P63; Li YL, 2008, ZOOTAXA, P38, DOI 10.11646/zootaxa.1929.1.2; Li Z, 2007, ZOOTAXA, P53, DOI 10.11646/zootaxa.1660.1.4; Liang Jun-Hui, 2006, Acta Zootaxonomica Sinica, V31, P102; Liang JH, 2009, ZOOTAXA, P17; Lienhard C., 2002, Psocoptera (Insecta): world catalogue and bibliography; Lin Q, 2004, ODONATOLOGICA, V33, P437; Lin Q.-b., 1992, Acta Palaeontologica Sinica, V31, P313; Lin Q.B., 1980, DIVISION CORRELATION, P211; LIN QB, 1994, CRETACEOUS RES, V15, P305, DOI 10.1006/cres.1994.1019; Lin QB, 2008, ANN ZOOL, V58, P521, DOI 10.3161/000345408X364346; Lin Qi-Bin, 2007, Zootaxa, V1469, P59; Lin QB, 2006, PROG NAT SCI-MATER, V16, P303; Linnaeus C, 1766, SYSTEMA NATURAE REGN; Liu M, 2008, CRETACEOUS RES, V29, P445, DOI 10.1016/j.cretres.2008.01.006; Liu YS, 2009, PALEONTOL J+, V43, P183, DOI 10.1134/S0031030109020099; Liu Yu-Shuang, 2006, Acta Zootaxonomica Sinica, V31, P758; Liu YS, 2008, PROG NAT SCI-MATER, V18, P1039, DOI 10.1016/j.pnsc.2008.03.014; Liu YS, 2008, ACTA GEOL SIN-ENGL, V82, P249; Liu YS, 2007, CRETACEOUS RES, V28, P322, DOI 10.1016/j.cretres.2006.08.003; Liu YS, 2006, ANN ZOOL, V56, P549; Liu Z, 2007, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2007)3583[1:PAGHOT]2.0.CO;2; Lopez-Vaamonde C, 2006, J EVOLUTION BIOL, V19, P1314, DOI 10.1111/j.1420-9101.2005.01070.x; Lopez-Vaamonde C, 2009, MOL PHYLOGENET EVOL, V52, P715, DOI 10.1016/j.ympev.2009.05.028; LUBBOCK JW, 1871, NOTES THYSANURA 4, V27, P277; Lukashevich ED, 2008, PALEONTOL J+, V42, P66, DOI 10.1134/S0031030108010115; Lukashevich E.D., 2000, Paleontological Journal, V34, pS352; Lukashevich Elena D., 2006, Studia Dipterologica, V13, P127; Lukashevitch ED., 2000, AMBA PROJECTS, V34, pS352; Lukashevitch ED., 2008, PALEONTOL J, V42, P66; MacLeay W.S, 1825, ANNULOSA JAVANICA AT; Makarkin V.N., 1990, Annales de la Societe Entomologique de France, V26, P125; Makarkin V. N., 1999, NEUES JB GEOLOGIE PA, V1999, P705; Makarkin VN, 2007, CRETACEOUS RES, V28, P743, DOI 10.1016/j.cretres.2006.11.003; Makarkin Vladimir N., 1998, Tertiary Research, V18, P77; Makarkin VN, 2010, ANN SOC ENTOMOL FR, V46, P254, DOI 10.1080/00379271.2010.10697666; Makarkin VN, 2009, ANN ENTOMOL SOC AM, V102, P964, DOI 10.1603/008.102.0606; Makarkin Vladimjr N., 2009, Denisia, P137; Makarkin VN, 2005, CRETACEOUS RES, V26, P801, DOI 10.1016/j.cretres.2005.05.009; Makarkin VN, 2005, ZOOTAXA, P15; Makarkin VN, 2003, ANN ENTOMOL SOC AM, V96, P171, DOI 10.1603/0013-8746(2003)096[0171:FAOTGP]2.0.CO;2; Manley DG, 2003, P ENTOMOL SOC WASH, V105, P1069; Marchal-Papier F., 2000, Acta Geologica Hispanica, V35, P5; Marshall SA, 2009, ZOOTAXA, P1; MARTILL DM, 2007, CRATO FOSSIL BEDS BR, P582; Martin Sarah K., 2008, Alavesia, V2, P253; Martins Neto Rafael Gioia, 2005, Arquivos do Museu Nacional Rio de Janeiro, V63, P471; MARTINS-NETO R G, 1989, Revista Brasileira de Entomologia, V33, P367; Martins-Neto RG, 2007, AFR INVERTEBR, V48, P87; Martins-Neto R.G., 2007, CRATO FOSSIL BEDS BR, P328; Martins-Neto R. G, 2005, GAEA, V1, P68; Martins-Neto Rafael G., 2008, Alavesia, V2, P47; Martins-Neto Rafael Gioia, 1992, Revista Brasileira de Entomologia, V36, P803; Martins-Neto RG, 2007, ALCHERINGA, V31, P199, DOI 10.1080/03115510701305173; Martins-Neto RG, 2006, AMEGHINIANA, V43, P591; Martins-Neto Rafael Gioia, 2003, Acta Zoologica Cracoviensia, V46, P205; Martins-Neto Rafael Gioia, 1995, Revista Brasileira de Entomologia, V39, P311; Martins-Neto Rafael Gioia, 2009, Gaea, V5, P15; Martins-Neto Rafael Gioia, 1995, Revista Brasileira de Entomologia, V39, P321; Martins-Neto Rafael Gioia, 2007, Gaea, V3, P3; Martins-Neto RG, 2009, ZOOTAXA, P21, DOI 10.11646/zootaxa.2080.1.2; Martins-Neto Rafael Giola, 2006, Polskie Pismo Entomologiczne, V75, P185; Martins-Neto RG, 2005, AMEGHINIANA, V42, P705; Martins-Neto RG., 2002, ACTA GEOLOGICA LEOPO, V25, P35; Martins-Neto RG, 2001, ACTA GEOLOGICA LEOPO, V24, P115; MARTYNOV A. B., 1927, ZOOL ANZ, V72, P99; MARTYNOV A. V., 1938, IZVESTIIA AKADEMII NAUK SSSR OTDELENIE MATEMATICHESKIKH I ESTESTVENNYKH NAUK SERIIA BIOL [BULL ACAD SCI URSS CL SCI MATH ET NAT SER BIOL], V1938, P187; MAXWELL WD, 1990, PALEOBIOLOGY, V16, P322, DOI 10.1017/S0094837300010022; Mayhew PJ, 2008, P ROY SOC B-BIOL SCI, V275, P47, DOI 10.1098/rspb.2007.1302; Mayhew PJ, 2007, BIOL REV, V82, P425, DOI 10.1111/j.1469-185X.2007.00018.x; Mayhew PJ, 2012, P NATL ACAD SCI USA, V109, P15141, DOI 10.1073/pnas.1200844109; Mayhew PJ, 2002, P ROY SOC B-BIOL SCI, V269, P969, DOI 10.1098/rspb.2002.1957; Mazzarolo LA, 2000, INSECT SYST EVOL, V31, P91, DOI 10.1163/187631200X00336; McCafferty W. P., 1997, Bulletin de la Societe d'Histoire Naturelle de Toulouse, V133, P77; McCafferty WP, 2008, ENTOMOL NEWS, V119, P492, DOI 10.3157/0013-872X-119.5.492; McCafferty WP, 2004, ENTOMOL NEWS, V115, P84; MCCAFFERTY WP, 1991, ANN ENTOMOL SOC AM, V84, P343, DOI 10.1093/aesa/84.4.343; MCCAFFERTY WP, 1990, B AM MUS NAT HIST, V195, P25; McKellar RC, 2008, CAN J EARTH SCI, V45, P1061, DOI 10.1139/E08-049; Melnitsky SI, 2009, PALEONTOL J+, V43, P296, DOI 10.1134/S0031030109030071; Mendes LF, 2004, P ENTOMOL SOC WASH, V106, P102; Menon F, 2007, CRATO FOSSIL BEDS BR, P283; Menon F, 2008, PALAEONTOLOGY, V51, P149, DOI 10.1111/j.1475-4983.2007.00740.x; Mey Eberhard, 2005, Anzeiger des Vereins Thueringer Ornithologen, V5, P201; Meyer H.W, 2003, FOSSILFLORISSANT; MICHELSEN V, 2009, STUDIA DIPTEROLOGICA, V15, P211; Michelsen V, 2009, AMBA PROJECTS, V15, P211; Michelsen Verner, 2000, Studia Dipterologica, V7, P11; Michez D, 2007, ZOOL J LINN SOC-LOND, V150, P701, DOI 10.1111/j.1096-3642.2007.00307.x; Michez D, 2009, ZOOL SCR, V38, P171, DOI 10.1111/j.1463-6409.2008.00362.x; Mockford EL, 2006, J NEW YORK ENTOMOL S, V114, P108, DOI 10.1664/0028-7199(2007)114[108:SOPFNA]2.0.CO;2; Mostovski M. B., 2003, Journal of Systematic Palaeontology, V1, P59, DOI 10.1017/S1477201903001020; Mostovski MB, 2003, PALEONTOL J+, V37, P162; MOSTOVSKI MB, 1997, PALEONTOL J, V31, P72; Mostovski Mike B., 2009, Palaeontologia Africana, V44, P121; Mostovski Mikhail B., 2000, Entomological Problems, V31, P137; Mostovsky M.B., 1995, Paleontologicheskii Zhurnal, V4, P86; Mound LA, 2007, ZOOTAXA, P395; NAGATOMI A, 1994, ACTA ZOOL HUNG, V40, P203; NAGATOMI A, 1991, ZOOL SCI, V8, P579; Nagatomi Akira, 1998, Entomologist's Monthly Magazine, V134, P95; NAUMANN ID, 1985, AUST J ZOOL, V33, P761, DOI 10.1071/ZO9850761; Navas L., 1916, MEMORIAS REAL ACAD C, V12, P507; Nazarenko VY, 2009, PALEONTOL J+, V43, P1097, DOI 10.1134/S003103010909010X; Nel A, 2007, CRETACEOUS RES, V28, P1039, DOI 10.1016/j.cretres.2007.02.002; Nel A, 2005, J SYST PALAEONTOL, V3, P371, DOI 10.1017/S1477201905001598; Nel A, 2005, ANN SOC ENTOMOL FR, V41, P29, DOI 10.1080/00379271.2005.10697440; Nel A, 2005, NEUES JAHRB GEOL P-A, V235, P343; Nel A, 2005, GEOBIOS-LYON, V38, P219, DOI 10.1016/j.geobios.2003.10.007; Nel A, 2005, NEUES JAHRB GEOL P-A, V235, P51; Nel A, 2004, DEUT ENTOMOL Z, V51, P253; Nel A, 2004, ANN SOC ENTOMOL FR, V40, P31, DOI 10.1080/00379271.2004.10697402; Nel A, 2004, ACTA PALAEONTOL POL, V49, P283; Nel A, 2004, EUR J ENTOMOL, V101, P145, DOI 10.14411/eje.2004.019; Nel A, 2003, ECLOGAE GEOL HELV, V96, P503, DOI 10.1007/s00015-003-1104-3; Nel A, 2002, ORG DIVERS EVOL, V2, P313, DOI 10.1078/1439-6092-00053; Nel A, 1999, PALAEONTOLOGY, V42, P83, DOI 10.1111/1475-4983.00063; Nel A, 1999, GEOBIOS-LYON, V32, P63, DOI 10.1016/S0016-6995(99)80083-7; Nel A, 1999, GEOBIOS-LYON, V32, P883, DOI 10.1016/S0016-6995(99)80870-5; Nel A., 2005, Bulletin de la Societe Entomologique de France, V110, P185; Nel A, 2001, ANN SOC ENTOMOL FR, V37, P501; Nel A, 1998, CRETACEOUS RES, V19, P393, DOI 10.1006/cres.1998.0110; Nel A, 1996, EUR J ENTOMOL, V93, P223; Nel A., 1992, B SOC ENTOMOLOGIQUE, V97, P381; NEL A, 1918, ANN PALEONTOL, V88, P189; Nel A., 1993, NUMERO HORS SERIE, V3, P1; NEL A, 1907, B MUSEUM NATL HI 4 C, V11, P15; Nel A, 2008, ACTA PALAEONTOL POL, V53, P163; Nel Andre, 1994, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V194, P143; Nel A, 2007, ANN SOC ENTOMOL FR, V43, P349, DOI 10.1080/00379271.2007.10697531; Nel A, 2006, ANN SOC ENTOMOL FR, V42, P179, DOI 10.1080/00379271.2006.10700621; Nel Andre, 2003, Geodiversitas, V25, P109; Nel A, 2013, NATURE, V503, P257, DOI 10.1038/nature12629; Nel Andre, 1994, Annales de Paleontologie, V80, P1; Nel Andre, 2001, Revue Francaise d'Entomologie (Nouvelle Serie), V23, P257; Nel Andre, 2009, Palaeodiversity, P209; Nel Andre, 2009, Palaeodiversity, P199; Nel Andre, 1992, Nouvelle Revue d'Entomologie, V9, P305; Nel Andre, 2001, Stuttgarter Beitraege zur Naturkunde Serie B (Geologie und Palaeontologie), V314, P1; Nel Andre, 1998, Paleontologia Lombarda, V10, P1; Nel Andre, 1996, Paleontologia Lombarda, V5, P25; Nel A, 2009, ANN ZOOL, V59, P281, DOI 10.3161/000345409X476350; Nel A, 2009, PALAEONTOGR ABT A, V289, P89; Nel Andre, 2005, Journal of Systematic Palaeontology, V3, P187, DOI 10.1017/S1477201905001549; Nel A, 2009, J NAT HIST, V43, P57, DOI 10.1080/00222930802528182; Nel Andre, 1994, Nouvelle Revue d'Entomologie, V11, P321; Nel Andre, 2006, Bulletin de la Societe Entomologique de France, V111, P190; Nel P, 2007, CRETACEOUS RES, V28, P1033, DOI 10.1016/j.cretres.2007.02.003; NELSON C R, 1987, Psyche (Cambridge), V94, P309, DOI 10.1155/1987/52032; Neto Rafael Gioia Martins, 2006, Journal of the Entomological Research Society, V8, P63; Nicholson DB, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1823; Novokschonov Viktor, 1997, Palaontologische Zeitschrift, V71, P89; Novokshonov V.G., 2000, Paleontological Journal, V34, pS284; Novokshonov V.G., 1992, PALEONTOL J+, V26, P136; Novokshonov V.G., 2002, PALEONTOL J+, V36, P157; Novokshonov V.G., 1994, PALEONTOL J+, V28, P79; Novokshonov VG, 2004, PALEONTOL J+, V38, pS204; Novokshonov VG, 2004, PALEONTOL J+, V38, pS173; Novokshonov VG, 2004, PALEONTOL J+, V38, P60; Novokshonov VG, 2002, PALEONTOL J, V36, P644; NOVOKSHONOV VG, 2000, PALEONTOL J, V34, P513; Novokshonov VG, 2002, PALEONTOL J, V36, P157; Novokshonov VG., 1992, PALEONTOL J, V26, P136; Novokshonov VG, 2000, PALEONTOL J, V34, pS284; Novokshonov VG, 1997, PALEONTOL J, V71, P89; Novokshonov VG, 1997, PALEONTOL J, V31, P383; Novokshonov VG, 1997, PALEONTOL J, V31, P65; Novokshonov VG, 1998, PALEONTOL J, V32, P46; NOVOKSHONOV VG, 1994, PALEONTOL J, V27, P90; Nyman T, 2006, SYST ENTOMOL, V31, P569, DOI 10.1111/j.1365-3113.2006.00336.x; Oberprieler RG, 2007, CONCISE GEOLOGIC TIM, V1668, P419, DOI DOI 10.1017/S0016756809006207; OBERPRIELER RG, 2007, ZOOTAXA, V1668, P419; Ogden TH, 2009, SYST ENTOMOL, V34, P616, DOI 10.1111/j.1365-3113.2009.00488.x; Ogg JG, 2008, ENCY METHODIQUE DICT, DOI 10.1017/S0016756809006207; Ohl M, 2004, J KANSAS ENTOMOL SOC, V77, P332, DOI 10.2317/E12.1; Ortega-Blanco J, 2008, ZOOTAXA, P39, DOI 10.11646/zootaxa.1937.1.3; Osten T., 2007, CRATO FOSSIL BEDS BR, P350, DOI [10.1017/S0016756808005657, DOI 10.1017/S0016756808005657]; Ozdikmen Huseyin, 2008, Munis Entomology & Zoology, V3, P745; Ozdikmen Huseyin, 2008, Munis Entomology & Zoology, V3, P731; Packard A.S., 1886, NEW ARRANGEMENT ORDE, V20, P808; Papier Francine, 1997, Palaontologische Zeitschrift, V71, P71; Papier Francine, 2001, Palaeontologische Zeitschrift, V74, P533; Penalver E, 2006, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2006)3519[1:NDOMBI]2.0.CO;2; Penalver Enrique, 1996, Treballs del Museu de Geologia de Barcelona, V5, P15; Penalver Enrique, 2007, Alavesia, V1, P63; Penalver Enrique, 1999, Revista Espanola de Paleontologia, V14, P231; Peng Decheng, 2005, Dizhi Tongbao, V24, P219; Perez Daniel E., 1997, Journal of Orthoptera Research, V6, P139; Perez-Gelabert Daniel E., 2006, Journal of Orthoptera Research, V15, P241, DOI 10.1665/1082-6467(2006)15[241:FIOHEG]2.0.CO;2; Perez-Gelabert DE, 2008, ZOOTAXA, P1; Perkovsky EE, 2007, AFR INVERTEBR, V48, P229; Perkovsky E.E., 2001, Vestnik Zoologii, V35, P79; Perkovsky Evgeny E., 2003, Russian Entomological Journal, V12, P119; Perrichot V, 2004, EUR J ENTOMOL, V101, P577, DOI 10.14411/eje.2004.081; Perrichot V., 2004, Geologica Acta, V2, P9; Perrichot V, 2003, GEOL MAG, V140, P669, DOI 10.1017/S0016756803008355; Perrichot V, 2002, CRETACEOUS RES, V23, P307, DOI 10.1006/cres.2002.1011; Perrichot V, 2009, ZOOL SCR, V38, P79, DOI 10.1111/j.1463-6409.2008.00358.x; Perrichot V, 2008, NEUES JAHRB GEOL P-A, V248, P91, DOI 10.1127/0077-7749/2008/0248-0091; Perrichot V, 2007, AFR INVERTEBR, V48, P213; Perrichot V, 2006, ZOOTAXA, P57; Perrichot Vincent, 2009, Paleontological Contributions, P1; Perrichot Vincent, 2008, Alavesia, V2, P203; Perrichot V, 2007, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2007)3598[1:ECSLIA]2.0.CO;2; Perrichot V, 2009, GEODIVERSITAS, V31, P7, DOI 10.5252/g2009n1a1; Pescador ML, 2009, AQUAT INSECT, V31, P137, DOI 10.1080/01650420903148519; Peters SE, 2005, P NATL ACAD SCI USA, V102, P12326, DOI 10.1073/pnas.0502616102; Peters SE, 2001, PALEOBIOLOGY, V27, P583, DOI 10.1666/0094-8373(2001)027<0583:BITPAR>2.0.CO;2; Petrulevicius JF, 2004, PALAEONTOLOGY, V47, P109, DOI 10.1111/j.0031-0239.2004.00350.x; Petrulevicius JF, 2003, J NAT HIST, V37, P2909, DOI 10.1080/0022293021000007543; Petrulevicius JF, 2003, CRETACEOUS RES, V24, P31, DOI 10.1016/S0195-6671(03)00025-9; Petrulevicius JF, 1999, PALAEONTOLOGY, V42, P677, DOI 10.1111/1475-4983.00091; Petrulevicius JF, 2002, PALAEONTOLOGY, V45, P751, DOI 10.1111/1475-4983.00258; Petrulevicius JF, 2009, J PALEONTOL, V83, P994, DOI 10.1666/08-073.1; Petrulevicius Julian F., 2007, Alavesia, V1, P15; Petrulevicius JF, 2009, CR PALEVOL, V8, P385, DOI 10.1016/j.crpv.2008.12.004; Petrulevicius JF, 2007, ANN SOC ENTOMOL FR, V43, P341, DOI 10.1080/00379271.2007.10697530; Petrulevicus JF, 2005, J PALEONTOL, V79, P658, DOI 10.1666/0022-3360(2005)079[0658:AANFOD]2.0.CO;2; Pinto I. D, 1986, PESQUISAS ZOOLOGIA, V18, P23; Pinto I.D., 1996, NEUES JB GEOL PALAON, P43; PINTO ID, 1999, AMBA PROJECTS AM PFI, P117; PINTO ID, 1991, PESQUISAS, V18, P93; Pinto Iraja Damiani, 1995, Universidade Federal do Rio Grande do Sul Instituto de Geociencias Pesquisas, V21, P85; Pionar G, 2008, WHAT BUGGED THE DINOSAURS INSECTS, DISEASE, AND DEATH IN THE CRETACEOUS, P1; Pohl H, 2005, ZOOL SCR, V34, P57, DOI 10.1111/j.1463-6409.2005.00173.x; Pohl H, 2009, INSECT SYST EVOL, V40, P333, DOI 10.1163/139956009X12470378015541; Poinar G, 2005, P ENTOMOL SOC WASH, V107, P835; Poinar G.O., 2001, LEBANESE AMBER OLDES; Poinar GO, 2006, SCIENCE, V314, P614, DOI 10.1126/science.1134103; Poinar G. O. Jr., 2000, Acta Geologica Hispanica, V35, P119; Poinar G, 2007, P ENTOMOL SOC WASH, V109, P649; Poinar G, 2006, P ENTOMOL SOC WASH, V108, P734; Poinar G, 2009, CRETACEOUS RES, V30, P1000, DOI 10.1016/j.cretres.2009.03.003; Poinar G, 2009, P ENTOMOL SOC WASH, V111, P38, DOI 10.4289/0013-8797-111.1.38; Poinar G, 2009, PALAEONTOLOGY, V52, P483, DOI 10.1111/j.1475-4983.2008.00840.x; Poinar GO, 2009, PARASITE VECTOR, V2, DOI 10.1186/1756-3305-2-12; Poinar GO., 1992, LIFE AMBER; Poinar Jr. G.O., 1999, AMBER FOREST; POLHEMUS JT, 2000, BULLETIN, V16, P284; Ponomarenko A, 2008, PALEONTOL J+, V42, P600, DOI 10.1134/S0031030108060051; Ponomarenko A.G., 2000, Paleontological Journal, V34, pS312; Ponomarenko AG, 2009, PALEONTOL J+, V43, P282, DOI 10.1134/S003103010903006X; Ponomarenko A.G., 2000, Paleontological Journal, V34, pS309; Ponomarenko A.G., 1985, Annalen des Naturhistorischen Museums in Wien Serie A Mineralogie und Petrographie Geologie und Palaeontologie Anthropologie und Praehistorie, V87, P135; Ponomarenko A.G, 2002, HIST INSECTS, P164; Ponomarenko A.G., 2002, HIST INSECTS, P176; Ponomarenko A. G., 1996, RUSS ENTOMOL J, V4, P73; Ponomarenko AG, 2004, PALEONTOL J+, V38, pS197; PONOMARENKO AG, 1992, PALEONTOL J, V26, P56; PONOMARENKO AG, 1994, PALEONTOL J, V27, P182; Ponomarenko AG, 2000, JOINT SOVIET MONGOLI, V34, pS309; Ponomarenko AG, 1986, PALEONTOL J, V28, P84, DOI DOI 10.1134/S0031030109020154; Ponomarenko Aleksandr G., 2003, Annals of the Upper Silesian Museum in Bytom Entomology, V12, P87; Ponomarenko Alexandr G., 2005, African Invertebrates, V46, P253; Ponomarenko Alexandr G., 2003, Acta Zoologica Cracoviensia, V46, P319; Popov Y, 2007, CRATO FOSSIL BEDS BR, P317; Popov Y.A., 1991, Geologica et Palaeontologica, V25, P215; Popov Y. A., 1994, T JOINT SOVIET MONGO, V5, P307; Popov Yu.A., 1990, Trudy Paleontologicheskogo Instituta, V239, P20; Popov YA, 2007, PALAEONTOL Z, V81, P429, DOI 10.1007/BF02990254; Popov Yuri A., 1994, Genus (Wroclaw), V5, P307; Popov Yuri A., 2008, Acta Entomologica Musei Nationalis Pragae, V48, P497; PRESTON FW, 1948, ECOLOGY, V29, P254, DOI 10.2307/1930989; Pritykina LN, 2006, PALEONTOL J+, V40, P636, DOI 10.1134/S0031030106060062; PRITYKINA L N, 1986, Odonatologica, V15, P169; Prokop J, 2005, GEOBIOS-LYON, V38, P383, DOI 10.1016/j.geobios.2003.11.006; Prokop J, 2004, EUR J ENTOMOL, V101, P583, DOI 10.14411/eje.2004.082; Prokop J, 2004, GEOL CARPATH, V55, P469; PROKOP J, 2007, ACTA MUSEI NATL PR B, V63, P209; Prokop J, 2007, AFR INVERTEBR, V48, P77; Prokop J, 2007, EUR J ENTOMOL, V104, P267, DOI 10.14411/eje.2007.041; Prokop J, 2006, CR PALEVOL, V5, P867, DOI 10.1016/j.crpv.2006.03.008; Prokop J, 2009, SYST ENTOMOL, V34, P610, DOI 10.1111/j.1365-3113.2009.00495.x; Puchalski SS, 2008, AM MALACOL BULL, V25, P87, DOI 10.4003/0740-2783-25.1.87; Pulawski Wojciech J., 2000, Journal of Hymenoptera Research, V9, P34; Putz A, 2004, INSECT SYST EVOL, V35, P329, DOI 10.1163/187631204788920257; Rainford JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109085; Rainford JL, 2014, HIST INSECTS, V9, DOI 10.1371/journal.pone.0109085; Rasnitsyn AP, 2006, PALEONTOL J+, V40, pS679, DOI 10.1134/S003103010612001X; Rasnitsyn A.P., 2002, P437; Rasnitsyn A.P., 1988, Vestnik Zoologii, V1988, P18; Rasnitsyn A. P., 2008, Russian Entomological Journal, V17, P299; Rasnitsyn A. P., 2000, Acta Geologica Hispanica, V35, P65; Rasnitsyn A.P., 2000, Bulletin of the Natural History Museum Geology Series, V56, P21; Rasnitsyn A.P., 2002, HIST INSECTS, P194; Rasnitsyn A.P., 2002, HIST INSECTS, P69; Rasnitsyn A. P., 2002, HIST INSECTS, P75; Rasnitsyn A. P., 2002, HIST INSECTS, P256; Rasnitsyn AP, 2009, AFR INVERTEBR, V50, P191, DOI 10.5733/afin.050.0108; Rasnitsyn AP, 2006, PALAEONTOLOGY, V49, P907, DOI 10.1111/j.1475-4983.2006.00574.x; Rasnitsyn AP, 2007, AFR INVERTEBR, V48, P193; Rasnitsyn Alexandr P., 1996, Memoirs of the Entomological Society of Washington, V17, P183; Rasnitsyn Alexandr P., 2003, Acta Zoologica Cracoviensia, V46, P85; Rasnitsyn AR, 2006, INSECT SYST EVOL, V37, P179, DOI 10.1163/187631206788831137; Rasnitsyn AP, 2005, PALEONTOL J+, V39, P404; Rasnitsyn AP, 2004, PALAEONTOLOGY, V47, P1507, DOI 10.1111/j.0031-0239.2004.00416.x; RASNITSYN AP, 1990, DOKL AKAD NAUK SSSR+, V310, P973; Rasnitsyn AP, 2004, INSECT SYST EVOL, V35, P123, DOI 10.1163/187631204788912391; Rasnitsyn AP, 1998, CRETACEOUS RES, V19, P329; Rasnitsyn AP, 2004, PALEONTOL J+, V38, pS158; Rasnitsyn AP, 2003, NEUES JAHRB GEOL P-A, V227, P321; Rasnitsyn AP, 2000, CONTRIB ZOOL, V69, P251, DOI 10.1163/18759866-06904003; RASNITSYN AP, 1938, HIST INSECTS, P254; Rasnitsyn AP, 1975, HIST INSECTS, V174, P1; Rasnitsyn AP, 2002, RUSSIAN ENTOMOLOGICA, P242; Rasnitsyn AP, 1925, HIST INSECTS, P106; Rasnitsyn AP, 2002, HIST INSECTS, DOI [10.1007/0-306-47577-4, DOI 10.1007/0-306-47577-4]; Rasnitsyn AP, 2002, RUSSIAN ENTOMOLOGICA, P256; RASNITSYN AP, 1975, T PALEONTOLOGICHESKO, V174, P1; RASNITSYN AP, 2004, NEW MEXICO MUSEUM NA, V25, P215; Rasnitsyn AP, 2002, HIST INSECTS, P128; RASNITSYN AP, 2002, HIST INSECTS, P161; Rasnitsyn AP, 2002, HIST INSECTS, P161; Rasnitsyn AP., 2002, PSYCHE, P88; RAUP DM, 1982, SCIENCE, V215, P1501, DOI 10.1126/science.215.4539.1501; Rehn AC, 2003, SYST ENTOMOL, V28, P181, DOI 10.1046/j.1365-3113.2003.00210.x; Ren D., 2010, SILENT STORIES INSEC; Ren D, 2008, J KANSAS ENTOMOL SOC, V81, P161, DOI 10.2317/JKES-0804.15.1; Ren D, 2008, INSECT SYST EVOL, V39, P223, DOI 10.1163/187631208788784075; Ren Dong, 2003, Acta Entomologica Sinica, V46, P622; Ren D, 2007, ANN ZOOL, V57, P211; Ren Dong, 2002, Acta Entomologica Sinica, V45, P234; [任东 Ren Dong], 2002, [地质通报, Geological Bulletin of China], V21, P584; Ren Dong, 2002, Entomologia Sinica, V9, P53; Ren Dong, 1998, Acta Zootaxonomica Sinica, V23, P65; Ren Dong, 1995, Entomologia Sinica, V2, P300; Ren D, 2009, SCIENCE, V326, P840, DOI 10.1126/science.1178338; Ren D, 2009, CRETACEOUS RES, V30, P1217, DOI 10.1016/j.cretres.2009.06.004; Ren Dong, 1998, Acta Zootaxonomica Sinica, V23, P281; Ren Dong, 2005, Acta Zootaxonomica Sinica, V30, P275; Resh VH, 2009, ZOOTAXA; Resh VH., 2009, ENCY INSECTS; RIEK E F, 1976, Palaeontologia Africana, V19, P141; Rindal DSAE, 2007, FUNDAMENTALS PALEONT, V1535, P1; Rognes K, 1997, CLADISTICS, V13, P27, DOI 10.1111/j.1096-0031.1997.tb00240.x; Rohdendorf BB, 1991, T ROY SOC EDINBURGH, V9; Ross A.J., 1993, P363; Ross A.J., 2000, Bulletin of the Natural History Museum Geology Series, V56, P11; Ross AJ., 2010, 2 INT C PAL, P90; Ross AJ, 1993, BULLETIN, P363; Ross AJ, 2004, 5 INT C FOSS INS 4 W, V94, P319; Ross Andrew, 2010, P208; Ross Andrew J., 2013, Bulletin of Zoological Nomenclature, V70, P291; Ross Andrew J., 2000, P288, DOI 10.1017/CBO9780511535505.020; ROSS ES, 2003, OCCASIONAL PAPERS CA, V154, P1; Rust J, 2008, PALAEONTOLOGY, V51, P709, DOI 10.1111/j.1475-4983.2008.00780.x; Rust J, 2010, P NATL ACAD SCI USA, V107, P18360, DOI 10.1073/pnas.1007407107; Rust Jes, 1998, Palaeontologische Zeitschrift, V72, P41; Sabrosky Curtis W., 1999, Myia, V10, P1; Schliephake Gert, 2001, Mitteilungen aus dem Geologisch-Palaeontologischen Institut der Universitaet Hamburg, V85, P197; Schluter Thomas, 2003, Acta Zoologica Cracoviensia, V46, P345; Schmied H, 2009, ZOOTAXA, P17, DOI 10.11646/zootaxa.1993.1.2; Schneider J., 1983, FREIBERGER FORSCH C, V382, P106; Schneider J.W., 1984, FREIBERGER FORSCH C, V391, P5; Schneider Joerg W., 2006, Geological Society Special Publication, V265, P325, DOI 10.1144/GSL.SP.2006.265.01.15; Schneider JW., 2004, NEW MEXICO MUSEUM NA, V25, P247; Schultz, 1982, GEOLOGICAL SOC AM SP, V190, P291, DOI DOI 10.1130/SPE190-P291; Selden Paul A., 2009, Contributions to Natural History (Bern), V12, P1269; SEPKOSKI JJ, 1993, PALEOBIOLOGY, V19, P43, DOI 10.1017/S0094837300012306; Sharov A.G., 1977, Paleontologicheskii Zhurnal, V1977, P48; Shcherbakov DE, 2008, PALEONTOL J+, V42, P15, DOI 10.1134/S0031030108010036; SHCHERBAKOV D E, 1991, Psyche (Cambridge), V98, P81, DOI 10.1155/1991/87106; Shcherbakov D.E., 2000, Bulletin of the Natural History Museum Geology Series, V56, P29; Shcherbakov D. E., 2008, Russian Entomological Journal, V17, P343; Shcherbakov D. E., 2007, Russian Entomological Journal, V16, P401; Shcherbakov D. E., 2000, PALEONTOL J, V3, P251; Shcherbakov D.E., 1995, INT J DIPTEROLOGICAL, V6, P75; Shcherbakov D.E., 2002, HIST INSECTS, P152; Shcherbakov D. Y., 2007, Russian Entomological Journal, V16, P47; Shcherbakov D. Ye., 2002, HIST INSECTS, P288; Shcherbakov DE, 1992, N JB GEOL PALAONT MH, V1992, P39; SHCHERBAKOV DE, 1988, T JOINT SOVIET MONGO, V33, P60; Shcherbakov Dmitry E., 2006, Russian Entomological Journal, V15, P315; Shcherbakov Dmitry E., 2008, Alavesia, V2, P125; Shcherbakov Dmitry E., 2009, Russian Entomological Journal, V18, P7; Shcherbakov Dmitry E., 2008, Alavesia, V2, P113; Shcherbakov Dmitry E., 2007, Russian Entomological Journal, V16, P259; Shcherbakov Dmitry E., 2007, Russian Entomological Journal, V16, P139; Shi GH, 2012, CRETACEOUS RES, V37, P155, DOI 10.1016/j.cretres.2012.03.014; Shih CK, 2009, ANN ENTOMOL SOC AM, V102, P20, DOI 10.1603/008.102.0103; Shmakov AS, 2008, PALEONTOL J+, V42, P47, DOI 10.1134/S0031030108010073; Shmakov AS, 2009, PALEONTOL J+, V43, P428, DOI 10.1134/S003103010904011X; Silvestri F., 1913, BOLL LAB ZOOL GEN AG, V7, P193; Simon E., 1886, Annales de la Societe Entomologique de France, V(6), P393; SIMON E., 1879, ANN SOC ENTOMOLOGIQU, V22, P183; Simon E, 1886, PALEONTOL J, V6, P393; Simutnik S. A., 2006, Vestnik Zoologii, V40, P283; Sinitshenkova N.D., 2000, Bulletin of the Natural History Museum Geology Series, V56, P25; Sinitshenkova N.D., 2002, P388; Sinitshenkova N.D., 2000, Paleontological Journal, V34, pS275; Sinitshenkova N.D., 1981, Byulleten' Moskovskogo Obshchestva Ispytatelei Prirody Otdel Geologicheskii, V56, P116; Sinitshenkova N.D., 1987, Trudy Paleontologicheskogo Instituta, V221, P1; Sinitshenkova N.D., 1990, PALEONTOL ZH, V24, P62; Sinitshenkova N.D., 1992, PALEONTOL J+, V26, P43; Sinitshenkova N.D., 1998, PALEONTOL J+, V32, P167; Sinitshenkova N. D., 2002, HIST INSECTS, P281; Sinitshenkova N.D, 1989, PALEONTOL J+, V23, P26; Sinitshenkova ND, 2004, PALEONTOL J+, V38, pS164; Sinitshenkova ND, 2002, PALEONTOL J, V35, P270; Sinitshenkova ND, 2002, PALEONTOL J, P388; Sinitshenkova ND, 2000, PALEONTOL J, V34, pS275; Sinitshenkova ND., 2002, HIST INSECTS, P115; Sinitshenkova Nina D., 2005, Palaeontologische Zeitschrift, V79, P377; Sinitshenkova Nina D., 2000, P111; Sinitshenkova Nina D., 2003, Acta Zoologica Cracoviensia, V46, P381; Skalski Andrzej W., 1992, Nota Lepidopterologica Supplement, V4, P144; Smith AB, 2007, PALEOBIOLOGY, V33, P310, DOI 10.1666/06073.1; Smith VS, 2007, SYST ENTOMOL, V32, P196, DOI 10.1111/j.1365-3113.2007.00371.x; Sobczyk Thomas, 2009, Nota Lepidopterologica, V32, P13; Soriano C, 2006, CR PALEVOL, V5, P779, DOI 10.1016/j.crpv.2006.03.006; Soriano C, 2006, CRETACEOUS RES, V27, P555, DOI 10.1016/j.cretres.2005.10.015; Soriano Carmen, 2007, Alavesia, V1, P81; Soriano C, 2009, GEODIVERSITAS, V31, P99, DOI 10.5252/g2009n1a8; SPAHR U, 1990, Stuttgarter Beitraege zur Naturkunde Serie B (Geologie und Palaeontologie), P1; Spahr U, 1992, CRATO FOSSIL BEDS BR, V194, P1; Spahr U, 1992, STUTTG BEITR NATUR B, V194, P1; Staniczek AH., 2007, PALEONTOL J, P163; Staniczek AH, 2007, CRATO FOSSIL BEDS BR, P163; Storozhenko, 1992, PALEONTOL J, V26, P85; STOROZHENKO S, 1992, ENTOMOL FENNICA, V3, P21, DOI 10.33338/ef.83569; STOROZHENKO S, 1992, Spixiana, V15, P67; Storozhenko S.Y., 1995, Far Eastern Entomologist, V19, P1; Storozhenko S. Yu., 1997, Far Eastern Entomologist, V42, P1; Storozhenko S. Yu, 1996, Far Eastern Entomologist, V26, P18; Storozhenko Sergey, 1994, Spixiana, V17, P27; Storozhenko Sergey, 1996, Spixiana, V19, P115; Storozhenko SY., 1988, PALEONTOL J, V22, P45; Storozhenko SYu., 2002, HIST INSECTS, P278; Stuke Jens-Hermann, 2003, Studia Dipterologica, V10, P91; Stuke JH, 2003, PALEONTOL J, V10, P91; Sturm H, 1998, DEUT ENTOMOL Z, V45, P43; Sukacheva I.D., 2000, Paleontological Journal, V34, pS347; Sukacheva ID, 2004, PALEONTOL J+, V38, P182; Sukatsheva ID, 2001, CRETACEOUS RES, V22, P685, DOI 10.1006/cres.2001.0292; Sukatsheva ID, 2007, AFR INVERTEBR, V48, P245; Sun Jian-Hai, 2007, Acta Zootaxonomica Sinica, V32, P881; Sun Jian-Hai, 2007, Acta Zootaxonomica Sinica, V32, P865; Svenson GJ, 2009, CLADISTICS, V25, P468, DOI 10.1111/j.1096-0031.2009.00263.x; SYu Storozhenko, 1996, RUSSIAN ENTOMOLOGICA, V19, P115; Szwedo J, 2007, CRATO FOSSIL BEDS BR, P297; Szwedo J, 2007, AFR INVERTEBR, V48, P127; Szwedo J, 2008, B INSECTOL, V61, P111; Szwedo J, 2008, B INSECTOL, V61, P109; Szwedo J, 2006, ANN ZOOL, V56, P555; Szwedo J, 2009, ZOOTAXA, P40, DOI 10.11646/zootaxa.2281.1.3; Szwedo Jacek, 2008, Palaeodiversity, P75; Szwedo J, 2009, GEODIVERSITAS, V31, P105, DOI 10.5252/g2009n1a9; Szwedo J, 2008, ENTOMOL GEN, V31, P231; Szwedo Jacek, 2006, Russian Entomological Journal, V15, P327; Tan J.J., 2009, MESOZOIC ARCHOSTEMAT; Tan JJ, 2007, ANN ENTOMOL SOC AM, V100, P666, DOI 10.1603/0013-8746(2007)100[666:TEWCCA]2.0.CO;2; Tan JJ, 2007, ANN ZOOL, V57, P231; TASCH P, 1962, J PALEONTOL, V36, P1319; THOMSON C. G., 1859, SKANDINAVIENS COLEOP, VI; TILGNER E, 2001, INSECT SYST EVOL, V31, P473, DOI DOI 10.1163/187631200X00507; van Dijk D.E., 1999, Annals of the Natal Museum, V40, P137; van Dijk DE, 2004, AFR ENTOMOL, V12, P268; Vasilenko DV, 2007, PALEONTOL J+, V41, P1156, DOI 10.1134/S0031030107110147; Vasilenko DV, 2005, PALEONTOL J+, V39, P280; Vilhelmsen L, 2004, BIOL J LINN SOC, V82, P139, DOI 10.1111/j.1095-8312.2004.00327.x; von Tschirnhaus Michael, 2009, Denisia, P171; Vrsansky P., 2000, Paleontological Journal, V34, pS374; Vrsansky P, 2001, CRETACEOUS RES, V22, P157, DOI 10.1006/cres.2000.0244; Vrsansky P, 2002, HIST INSECTS, P263; Vrsansky P, 2008, DEUT ENTOMOL Z, V55, P215, DOI 10.1002/mmnd.200800022; Vrsansky Peter, 2008, Acta Palaeontologica Polonica, V53, P129, DOI 10.4202/app.2008.0109; Vrsansky P, 2007, AFR INVERTEBR, V48, P103; Vrsansky P, 2007, BIOLOGIA, V62, P588, DOI 10.2478/s11756-007-0116-2; Vrsansky Peter, 2005, Entomological Problems, V35, P163; Vrsansky P, 2008, ZOOTAXA, P41, DOI 10.11646/zootaxa.1958.1.4; Vrsansky Peter, 2002, AMBA Projekty, V6; Vrsansky P, 2009, GEOL CARPATH, V60, P449, DOI 10.2478/v10096-009-0033-0; Vrsansky P, 2009, GEODIVERSITAS, V31, P73, DOI 10.5252/g2009n1a7; Vrsanskyy P., 2007, ENTOMOLOGICAL PROBLE, V62, P588; Vrsanskyy P., 2003, AMBA PROJEKTY, V32, P51; Wagner R, 2000, SYST ENTOMOL, V25, P115, DOI 10.1046/j.1365-3113.2000.025001115.x; Wagner R, 2008, HYDROBIOLOGIA, V595, P489, DOI 10.1007/s10750-007-9127-9; Wang B, 2009, PALEONTOL J+, V43, P652, DOI 10.1134/S0031030109060082; [No title captured]; Wang Bo, 2006, Palaeoworld, V15, P115, DOI 10.1016/j.palwor.2006.03.006; Wang B, 2009, SCI CHINA SER D, V52, P1953, DOI 10.1007/s11430-009-0160-6; Wang B, 2009, PALAEONTOLOGY, V52, P53, DOI 10.1111/j.1475-4983.2008.00826.x; Wang MX, 2009, PROG NAT SCI-MATER, V19, P1427, DOI 10.1016/j.pnsc.2009.01.012; Wang Ying, 2006, Acta Zootaxonomica Sinica, V31, P294; Wappler T, 2004, P ROY SOC B-BIOL SCI, V271, pS255, DOI 10.1098/rsbl.2003.0158; Wappler T., 2003, MAINZER NATURWISSENS, V27, P1; Wappler Torsten, 2005, Polskie Pismo Entomologiczne, V74, P227; Wappler T, 2009, P ROY SOC B-BIOL SCI, V276, P4271, DOI 10.1098/rspb.2009.1255; Wappler Torsten, 2007, Alavesia, V1, P69; Wappler T, 2008, ACTA PALAEONTOL POL, V53, P627, DOI 10.4202/app.2008.0407; Ware JL, 2008, SYST ENTOMOL, V33, P429, DOI 10.1111/j.1365-3113.2008.00424.x; Wedmann S, 2007, ZOOL J LINN SOC-LOND, V149, P701, DOI 10.1111/j.1096-3642.2007.00273.x; Wedmann S, 2007, P NATL ACAD SCI USA, V104, P565, DOI 10.1073/pnas.0606937104; Wegierek P, 2002, GEOBIOS-LYON, V35, P745, DOI 10.1016/S0016-6995(02)00086-4; Wegierek P., 1991, Paleontologicheskii Zhurnal, V1991, P114; WEGIEREK P, 1989, PALEONTOL J, V23, P40; Wegrzynowicz P, 2007, ANN ZOOL, V57, P757; Weitschat W., 2002, ATLAS PLANTS ANIMALS; Whalley P.E.S., 1985, Bulletin of the British Museum (Natural History) Geology, V39, P107; Whalley P.E.S., 1988, Bulletin of the British Museum (Natural History) Geology, V44, P45; Whalley P.E.S., 1985, Bulletin of the British Museum (Natural History) Geology, V38, P381; White Russell D., 1995, Postilla, V209, P1; Whiting MF, 2008, CLADISTICS, V24, P677, DOI 10.1111/j.1096-0031.2008.00211.x; Wichard W, 2005, INSECT SYST EVOL, V36, P279, DOI 10.1163/187631205788838410; Wichard W., 2009, AQUATIC INSECTS BALT; WICHARD W, 2003, MITT GEOL PALAONTOL, V87, P162; Wichard W, 2006, ZOOTAXA, P37, DOI 10.11646/zootaxa.1378.1.3; Wichard Wilfried, 1996, Entomologische Mitteilungen aus dem Loebbecke Museum und Aquazoo Beiheft, V4, P1; Wilkommen J., 2007, CRATO FOSSIL BEDS BR, P369; Willmann R, 1989, ABH SENCKENB NAT, V544, P1; Willmann R, 1978, FOSS CAT ANIM, V124, P1; Willmann Rainer, 1998, Palaeontologische Zeitschrift, V72, P281; Wills MA, 2001, GEOL J, V36, P187, DOI 10.1002/gj.882; Wilson HM, 2001, PALAEONTOLOGY, V44, P1025, DOI 10.1111/1475-4983.00213; Winkler J.R., 1987, Mitteilungen Muenchener Entomologischen Gesellschaft, V77, P51; Wolf-Schwenninger K., 2007, CRATO FOSSIL BEDS BR, P340; Wootton RJ, 2000, BIOL REV, V75, P129, DOI 10.1017/S0006323199005459; Yang AS, 2001, EVOL DEV, V3, P59, DOI 10.1046/j.1525-142x.2001.003002059.x; Yao Yun-Zhi, 2004, Acta Zootaxonomica Sinica, V29, P33; Yao YZ, 2007, EUR J ENTOMOL, V104, P827, DOI 10.14411/eje.2007.103; Yao Y, 2006, ZOOTAXA, P41; Yao YZ, 2006, ZOOTAXA, P1; YOSHIMOTO CM, 1975, CAN ENTOMOL, V107, P499, DOI 10.4039/Ent107499-5; Yoshimoto CM, 1975, DOKL AKAD NAUK SSSR, V107, P499; Yunzhi Y, 2008, ACTA GEOL SIN-ENGL, V82, P35; Zajic Jaroslav, 2004, Acta Musei Reginaehradecensis Series A Scientiae Naturales, V30, P5; Zalessky G, 1955, MITTEILUNGSBLATT ENT, V104, P630; Zamboni J.C., 2001, ACTA GEOL LEOPOLD, V24, P129; ZESSIN W, 2005, MITTEILUNGSBLATT ENT, V8, P54; Zessin Wolfgang, 2009, Virgo, V12, P22; Zessin Wolfgang, 1997, Veroeffentlichungen des Naturkundemuseums Erfurt, V16, P172; Zessin Wolfgang, 2006, Virgo, V9, P37; Zhang Guangxue, 1999, Entomologia Sinica, V6, P127; Zhang HC, 2010, SCI CHINA EARTH SCI, V53, P1908, DOI 10.1007/s11430-010-4098-5; Zhang HC, 2008, J SYST PALAEONTOL, V6, P463, DOI 10.1017/S1477201907002428; Zhang JF, 2006, PALEONTOL J+, V40, P553, DOI 10.1134/S0031030106050091; Zhang J.-f., 1986, Acta Palaeontologica Sinica, V25, P49; Zhang J.F., 1994, MIOCENE INSECTS SPID; Zhang JF, 2005, CRETACEOUS RES, V26, P783, DOI 10.1016/j.cretres.2005.05.004; Zhang JF, 2005, GEOBIOS-LYON, V38, P865, DOI 10.1016/j.geobios.2004.05.003; Zhang JF, 2004, CRETACEOUS RES, V25, P797, DOI 10.1016/j.cretres.2004.08.001; Zhang JF, 2004, GEOBIOS-LYON, V37, P687, DOI 10.1016/j.geobios.2003.04.007; Zhang JF, 2007, ORIENT INSECTS, V41, P351, DOI 10.1080/00305316.2007.10417519; Zhang JF, 2006, ORIENT INSECTS, V40, P115, DOI 10.1080/00305316.2006.10417463; Zhang Jun-feng, 1993, Acta Palaeontologica Sinica, V32, P141; Zhang Jun-feng, 2002, Acta Micropalaeontologica Sinica, V19, P348; Zhang JF, 2007, CRETACEOUS RES, V28, P302, DOI 10.1016/j.cretres.2006.05.012; Zhang JF, 2007, CRETACEOUS RES, V28, P289, DOI 10.1016/j.cretres.2006.05.009; Zhang JF, 2007, CRETACEOUS RES, V28, P281, DOI 10.1016/j.cretres.2006.05.008; Zhang KY, 2008, ZOOTAXA, P61, DOI 10.11646/zootaxa.1879.1.7; Zhang KY, 2007, ZOOTAXA, P27; Zhang KY, 2009, ZOOTAXA, P61, DOI 10.11646/zootaxa.1984.1.4; ZHANG XW, 2009, ACTA GEOL SINICA, V84, P38; Zhang Zhi-Qiang, 2002, Fauna of China, V4, P77; [张志军 Zhang Zhijun], 2003, [地质通报, Geological Bulletin of China], V22, P452; Zhang ZL, 1997, SEDIMENT GEOL, V112, P123, DOI 10.1016/S0037-0738(97)00029-8; Zhang ZQ., 2002, ACTA PALAEONTOLOGICA, V4, P77; Zherikhin V.V., 2000, Paleontological Journal, V34, pS333; Zherikhin V.V., 1994, Paleontological Journal, V27, P50; Zherikhin V.V., 2002, P331; ZHERIKHIN V. V., 2002, HIST INSECTS, P273, DOI [10.1007/0-306-47577-4, DOI 10.1007/0-306-47577-4]; Zherikhin V.V., 1993, T PALEONTOLOGICHESKO, V252, P20; Zherikhin VV, 2004, PALEONTOL J+, V38, P528; Zherikin V. V., 2002, HIST INSECTS, P133; Zhou CF, 2003, FLA ENTOMOL, V86, P345, DOI 10.1653/0015-4040(2003)086[0345:TNOSCA]2.0.CO;2; ZLOBIN V, 2007, INT J DIPTEROLOGICAL, V18, P129; Zompro Oliver, 2005, Mitteilungen aus dem Geologisch-Palaeontologischen Institut der Universitaet Hamburg, V89, P85; Zompro Oliver, 2001, Mitteilungen aus dem Geologisch-Palaeontologischen Institut der Universitaet Hamburg, V85, P229	1089	46	46	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0128554	10.1371/journal.pone.0128554	http://dx.doi.org/10.1371/journal.pone.0128554			61	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176667	gold, Green Published, Green Submitted, Green Accepted			2022-12-26	WOS:000358197600008
J	Stitt, CA; Harker, NJ; Hallam, KR; Paraskevoulakos, C; Banos, A; Rennie, S; Jowsey, J; Scott, TB				Stitt, C. A.; Harker, N. J.; Hallam, K. R.; Paraskevoulakos, C.; Banos, A.; Rennie, S.; Jowsey, J.; Scott, T. B.			An Investigation on the Persistence of Uranium Hydride during Storage of Simulant Nuclear Waste Packages	PLOS ONE			English	Article							WATER-VAPOR; CORROSION; MECHANISMS; KINETICS; OXYGEN; METAL; TEMPERATURES; SYNCHROTRON; INCLUSIONS	Synchrotron X-rays have been used to study the oxidation of uranium and uranium hydride when encapsulated in grout and stored in de-ionised water for 10 months. Periodic synchrotron X-ray tomography and X-ray powder diffraction have allowed measurement and identification of the arising corrosion products and the rates of corrosion. The oxidation rates of the uranium metal and uranium hydride were slower than empirically derived rates previously reported for each reactant in an anoxic water system, but without encapsulation in grout. This was attributed to the grout acting as a physical barrier limiting the access of oxidising species to the uranium surface. Uranium hydride was observed to persist throughout the 10 month storage period and industrial consequences of this observed persistence are discussed.	[Stitt, C. A.; Hallam, K. R.; Paraskevoulakos, C.; Banos, A.; Rennie, S.; Scott, T. B.] Univ Bristol, HH Wills Phys Lab, Interface Anal Ctr, Bristol BS8 1TL, Avon, England; [Harker, N. J.] European Synchrotron Radiat Facil, F-38043 Grenoble, Rhone Alpes, France; [Jowsey, J.] Sellafield Ltd, Seascale, Cumbria, England	University of Bristol; European Synchrotron Radiation Facility (ESRF); Sellafield Ltd	Scott, TB (corresponding author), Univ Bristol, HH Wills Phys Lab, Interface Anal Ctr, Tyndall Ave, Bristol BS8 1TL, Avon, England.	T.B.Scott@bristol.ac.uk	Paraskevoulakos, Charilaos/HCI-1395-2022	Paraskevoulakos, Charilaos/0000-0003-4445-500X; Banos, Antonios/0000-0001-8688-2865; Stitt, Camilla/0000-0002-5507-3501	Sellafield Ltd; Centre of Expertise for Uranium and Reactive Metals; EPSRC-NDA grant [EP/I036397/1]; EPSRC [EP/I036397/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [1338575, EP/I036397/1] Funding Source: researchfish	Sellafield Ltd; Centre of Expertise for Uranium and Reactive Metals; EPSRC-NDA grant(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work is primarily supported by a jointly funded EPSRC-NDA grant (EP/I036397/1) entitled 'In situ time-dependent characterisation of corrosion processes in nuclear waste storage and GDF environments' with TBS as the CoI and lead for the part of the project focused on uranium corrosion. Much of the project has been conducted by PhD student CAS. The materials and additional financial support for this project has come from Sellafield Ltd as part of a platform grant associated with the Centre of Expertise for Uranium and Reactive Metals. In the writing of this paper both Sellafield and the NDA (now RWM Ltd) have had input and provided permission to publish.	BAKER MM, 1966, T FARADAY SOC, V62, P2513, DOI 10.1039/tf9666202513; Bloch J, 1997, J ALLOY COMPD, V253, P529, DOI 10.1016/S0925-8388(96)03070-8; BLOCH J, 1981, J LESS-COMMON MET, V81, P301, DOI 10.1016/0022-5088(81)90036-9; COLMENARES CA, 1984, PROG SOLID STATE CH, V15, P257, DOI 10.1016/0079-6786(84)90003-7; Cordfunke EHP, 1969, CHEM URANIUM LLC; Danon A, 1999, LANGMUIR, V15, P5913, DOI 10.1021/la981210g; Delegard C. H., 2008, URANIUM METAL REACTI; Dinh LN, 2011, J NUCL MATER, V408, P171, DOI 10.1016/j.jnucmat.2010.11.026; Divsholi BS, 2014, INT J CONCR STRUCT M, V8, P157, DOI 10.1007/s40069-013-0063-y; Golovich E. C., 2011, SUMMARY URANIUM SOLU; Grenthe I., 2003, CHEM THERMODYN, V2nd; Harker NJ, 2013, SOLID STATE IONICS, V241, P46, DOI 10.1016/j.ssi.2013.04.004; Hart ML, 2013, J APPL CRYSTALLOGR, V46, P1249, DOI 10.1107/S0021889813022437; Haschke J. M., 1995, REACTIONS PLUTONIUM; HASCHKE JM, 1987, J LESS-COMMON MET, V133, P155, DOI 10.1016/0022-5088(87)90469-3; Haschke JM, 1998, J ALLOY COMPD, V278, P149, DOI 10.1016/S0925-8388(98)00639-2; Haschke JM, 2001, J ALLOY COMPD, V314, P78, DOI 10.1016/S0925-8388(00)01222-6; LANGMUIR D, 1978, GEOCHIM COSMOCHIM AC, V42, P547, DOI 10.1016/0016-7037(78)90001-7; Le Guyadec F, 2010, J NUCL MATER, V396, P294, DOI 10.1016/j.jnucmat.2009.11.007; Loui A., 2012, HYDROGEN CORROSION U; Macphee DE, 2011, MRS P, V127, P475; MULFORD RNR, 1954, J AM CHEM SOC, V76, P297, DOI 10.1021/ja01630a094; NDA, 2014, RADIOACTIVE WASTES U; NEWTON AS, 1949, NUCLEONICS, V4, P17; Powell GL, 2004, MINER MET MAT SOC; RITCHIE AG, 1984, J LESS-COMMON MET, V98, P193, DOI 10.1016/0022-5088(84)90294-7; RITCHIE AG, 1981, J NUCL MATER, V102, P170, DOI 10.1016/0022-3115(81)90557-2; RUNDLE RE, 1948, J AM CHEM SOC, V70, P99, DOI 10.1021/ja01181a029; Scott TB, 2011, J HAZARD MATER, V195, P115, DOI 10.1016/j.jhazmat.2011.08.011; Stitt CA, 2015, J HAZARD MATER, V285, P221, DOI 10.1016/j.jhazmat.2014.11.035; Totemeier TC, 2000, J NUCL MATER, V278, P301, DOI 10.1016/S0022-3115(99)00245-7; WOOD DH, 1994, J NUCL MATER, V209, P113, DOI 10.1016/0022-3115(94)90253-4	32	17	17	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132284	10.1371/journal.pone.0132284	http://dx.doi.org/10.1371/journal.pone.0132284			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176551	Green Published, Green Submitted, gold			2022-12-26	WOS:000358197600096
J	Tsuda, S; Sakakura, T; Fujii, S; Suzuki, H; Yomo, T				Tsuda, Soichiro; Sakakura, Tatsuya; Fujii, Satoshi; Suzuki, Hiroaki; Yomo, Tetsuya			Shape Transformations of Lipid Vesicles by Insertion of Bulky-Head Lipids	PLOS ONE			English	Article							UNILAMELLAR VESICLES; PHOSPHOLIPID-VESICLES; GENE-EXPRESSION; GIANT VESICLES; LIPOSOMES; MEMBRANES; MICELLES; STABILITY; DYNAMICS; FISSION	Lipid vesicles, in particular Giant Unilamellar Vesicles (GUVs), have been increasingly important as compartments of artificial cells to reconstruct living cell-like systems in a bottom-up fashion. Here, we report shape transformations of lipid vesicles induced by polyethylene glycol-lipid conjugate (PEG lipids). Statistical analysis of deformed vesicle shapes revealed that shapes vesicles tend to deform into depended on the concentration of the PEG lipids. When compared with theoretically simulated vesicle shapes, those shapes were found to be more energetically favorable, with lower membrane bending energies than other shapes. This result suggests that the vesicle shape transformations can be controlled by externally added membrane molecules, which can serve as a potential method to control the replications of artificial cells.	[Tsuda, Soichiro; Fujii, Satoshi; Suzuki, Hiroaki; Yomo, Tetsuya] Japan Sci & Technol Agcy, ERATO, Yomo Dynam Microscale React Environm Project, Suita, Osaka 5650871, Japan; [Sakakura, Tatsuya; Suzuki, Hiroaki; Yomo, Tetsuya] Osaka Univ, Grad Sch Informat Sci & Technol, Suita, Osaka 5650871, Japan; [Yomo, Tetsuya] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan	Japan Science & Technology Agency (JST); Osaka University; Osaka University	Yomo, T (corresponding author), Japan Sci & Technol Agcy, ERATO, Yomo Dynam Microscale React Environm Project, 1-5 Yamadaoka, Suita, Osaka 5650871, Japan.	yomo@ist.osaka-u.ac.jp	Suzuki, Hiroaki/T-8989-2019; LARIJANI, Professor Banafshe/H-3909-2015	Suzuki, Hiroaki/0000-0002-8899-0955; LARIJANI, Professor Banafshe/0000-0003-4735-1169	Japan Society for the Promotion of Science (JSPS) [24740290]; YOMO Dynamical Micro-scale Reaction Environment, The Exploratory Research for Advanced Technology (ERATO) from Japan Science and Technology Agency (JST); Grants-in-Aid for Scientific Research [26289038] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); YOMO Dynamical Micro-scale Reaction Environment, The Exploratory Research for Advanced Technology (ERATO) from Japan Science and Technology Agency (JST); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by following: Grant-in-Aid for Young Scientists (B) No. 24740290 from Japan Society for the Promotion of Science (JSPS) https://www.jsps.go.jp/english/ and YOMO Dynamical Micro-scale Reaction Environment, The Exploratory Research for Advanced Technology (ERATO) research funding program from Japan Science and Technology Agency (JST) http://www.jst.go.jp/erato/en/about/index.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andes-Koback M, 2011, J AM CHEM SOC, V133, P9545, DOI 10.1021/ja202406v; Ashok B, 2004, J PHARM SCI-US, V93, P2476, DOI 10.1002/jps.20150; Baumgart T, 2007, BBA-BIOMEMBRANES, V1768, P2182, DOI 10.1016/j.bbamem.2007.05.012; BERNDL K, 1990, EUROPHYS LETT, V13, P659, DOI 10.1209/0295-5075/13/7/015; BROWN RE, 1992, BIOCHIM BIOPHYS ACTA, V1113, P375, DOI 10.1016/0304-4157(92)90007-W; Caschera F, 2011, LANGMUIR, V27, P13082, DOI 10.1021/la202648h; DOBEREINER HG, 1993, BIOPHYS J, V65, P1396; Fujii S, 2013, P NATL ACAD SCI USA, V110, P16796, DOI 10.1073/pnas.1314585110; Hatzakis NS, 2009, NAT CHEM BIOL, V5, P835, DOI 10.1038/nchembio.213; Ishikawa K, 2004, FEBS LETT, V576, P387, DOI 10.1016/j.febslet.2004.09.046; KAS J, 1991, BIOPHYS J, V60, P825, DOI 10.1016/S0006-3495(91)82117-8; Kastantin M, 2009, LANGMUIR, V25, P7279, DOI 10.1021/la900310k; Khairy K, 2011, SOFT MATTER, V7, P2138, DOI 10.1039/c0sm01193b; Kita H, 2008, CHEMBIOCHEM, V9, P2403, DOI 10.1002/cbic.200800360; Kurihara K, 2011, NATURE CHEM, P3; McPhee CI, 2013, BIOPHYS J, V105, P1414, DOI 10.1016/j.bpj.2013.07.048; Nishikawa T, 2012, ANAL CHEM; Nishimura K, 2009, LANGMUIR, V25, P10439, DOI 10.1021/la902237y; Noireaux V, 2004, P NATL ACAD SCI USA, V101, P17669, DOI 10.1073/pnas.0408236101; Nomura S, 2003, CHEMBIOCHEM, V4, P1172, DOI 10.1002/cbic.200300630; Pautot S, 2003, P NATL ACAD SCI USA, V100, P10718, DOI 10.1073/pnas.1931005100; Pautot S, 2003, LANGMUIR, V19, P2870, DOI 10.1021/la026100v; Sakakura T, 2012, ANAL METHODS-UK, V4, P1648, DOI 10.1039/c2ay25105a; Sakashita A, 2012, SOFT MATTER, V8, P8569, DOI 10.1039/c2sm25759a; Seifert U., 1995, P403; Seifert U, 1997, ADV PHYS, V46, P13, DOI 10.1080/00018739700101488; Shiomi H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101820; Soga H, 2014, ACS SYNTH BIOL, V3, P372, DOI 10.1021/sb400094c; Stepniewski M, 2011, LANGMUIR, V27, P7788, DOI 10.1021/la200003n; Sunami T, 2010, LANGMUIR, V26, P15098, DOI 10.1021/la102689v; SVETINA S, 1989, EUR BIOPHYS J BIOPHY, V17, P101, DOI 10.1007/BF00257107; Tanaka T, 2004, LANGMUIR, V20, P9526, DOI 10.1021/la049481g; Terasawa H, 2012, P NATL ACAD SCI US; Tsuda S, 2014, SOFT MATTER, V10, P6038, DOI 10.1039/c4sm00992d; Ueda, 2014, ANGEW CHEM, V126, P7665, DOI [10.1002/ange.201403929, DOI 10.1002/ANGE.201403929]; Vukovic L, 2011, J AM CHEM SOC, V133, P13481, DOI 10.1021/ja204043b; WIMLEY WC, 1991, BIOCHEMISTRY-US, V30, P1702, DOI 10.1021/bi00220a036; Yanagisawa M, 2012, SOFT MATTER, V8, P488, DOI 10.1039/c1sm06381b; Yu Y, 2010, J AM CHEM SOC, V132, P195, DOI 10.1021/ja9059014; Zhu TF, 2009, J AM CHEM SOC, V131, P5705, DOI 10.1021/ja900919c	40	9	9	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132963	10.1371/journal.pone.0132963	http://dx.doi.org/10.1371/journal.pone.0132963			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176953	gold, Green Accepted, Green Published, Green Submitted			2022-12-26	WOS:000358197600191
J	Chung, YC; Kuo, JF; Wei, WC; Chang, KJ; Chao, WT				Chung, Yuan-Chiang; Kuo, Jang-Fang; Wei, Wan-Chen; Chang, King-Jen; Chao, Wei-Ting			Caveolin-1 Dependent Endocytosis Enhances the Chemosensitivity of HER-2 Positive Breast Cancer Cells to Trastuzumab Emtansine (T-DM1)	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; PHASE-II TRIAL; DRUG CONJUGATE; TUMOR-GROWTH; RECEPTOR; INHIBITION; EXPRESSION; TRAFFICKING; SITE; IDENTIFICATION	The humanized monoclonal antibody-drug conjugate trastuzumab emtansine (T-DM1, Kadcyla) has been approved by the U.S. FDA to treat human epidermal growth factor receptor 2 (HER-2)-positive metastatic breast cancer. Despite its effectiveness in most patients, some are initially resistant or develop resistance. No biomarker of drug resistance to T-DM1 has been identified. Antibody-drug efficacy is associated with antibody internalization in the cell; therefore, cellular sensitivity of cells to the drug may be linked to cellular vesicle trafficking systems. Caveolin-1 is a 22 KD protein required for caveolae formation and endocytic membrane transport. In this study, the relationship between caveolin-1 expression and the chemosensitivity of HER-2-positive breast cancer cells to T-DM1 was investigated. Samples from 32 human breast cancer biopsy and normal tissue specimens were evaluated immunohistochemically for caveolin-1 expression. Caveolin-1 was shown to be expressed in 68% (22/32) of the breast cancer specimens. In addition, eight (72.7%, 8/11) HER-2 positive breast cancer specimens had a higher caveolin-1 expression than normal tissues. HER-2-positive BT-474 and SKBR-3 breast cancer cells that express low and moderate levels of caveolin-1, respectively, were treated with trastuzumab or its conjugate T-DM1. Cell viability and molecular localizations of caveolin-1, antibody and its conjugate were examined. Confocal microscopy showed that T-DM1 and caveolin-1 colocalized in SKBR-3 cells, which also were five times more sensitive to the conjugate in terms of cell survival than BT-474 cells, although T-DM1 also showed improved drug efficacy in BT-474 cells than trastuzumab treatment. Caveolin-1 expression in these lines was manipulated by transfection of GFP-tagged caveolin-1 or caveolin-1 siRNA. BT-474 cells overexpressing caveolin-1 were more sensitive to T-DM1 treatment than mock-transfected cells, whereas the siRNA-transfected SKBR-3 cells had decreased sensitivity to T-DM1 than mock-transfected SKBR-3 cells. The expression of caveolin-1 could mediate endocytosis and promote the internalization of T-DM1 into HER-2 positive cancer cells. Thus, caveolin-1 protein may be an effective predictor for determining the outcome of T-DM1 treatment in breast cancer patients.	[Chung, Yuan-Chiang; Wei, Wan-Chen; Chang, King-Jen] Cheng Ching Gen Hosp, Chungkang Branch, Dept Surg, Taichung, Taiwan; [Kuo, Jang-Fang] Cheng Ching Gen Hosp, Chungkang Branch, Dept Pathol, Taichung, Taiwan; [Wei, Wan-Chen; Chao, Wei-Ting] Tunghai Univ, Dept Life Sci, Taichung 40704, Taiwan	Tunghai University	Chao, WT (corresponding author), Tunghai Univ, Dept Life Sci, Taichung 40704, Taiwan.	wtchao@thu.edu.tw	Tan, Ming/ABD-5847-2021	Tan, Ming/0000-0003-2007-9898; Chang, King jen/0000-0001-9811-3422	Cheng-Ching hospital [CH10100152]	Cheng-Ching hospital	This work was supported by a grant from Cheng-Ching hospital (CH10100152) to WTC. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin CD, 2004, MOL BIOL CELL, V15, P5268, DOI 10.1091/mbc.E04-07-0591; Barok M, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3621; Barok M, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2868; Ben-Kasus T, 2009, P NATL ACAD SCI USA, V106, P3294, DOI 10.1073/pnas.0812059106; Bouras T, 2004, CANCER BIOL THER, V3, P931, DOI 10.4161/cbt.3.10.1147; Chia S, 2006, J CLIN ONCOL, V24, P2773, DOI 10.1200/JCO.2005.03.8331; Chiu WT, 2011, CANCER RES, V71, P4932, DOI 10.1158/0008-5472.CAN-10-4249; Chung YC, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-587; Elzagheid A, 2006, WORLD J GASTROENTERO, V12, P4304, DOI 10.3748/wjg.v12.i27.4304; Fiucci G, 2002, ONCOGENE, V21, P2365, DOI 10.1038/sj.onc.1205300; Goetz JG, 2008, CANCER METAST REV, V27, P715, DOI 10.1007/s10555-008-9160-9; Gornstein E, 2014, NEUROPHARMACOLOGY, V76, P175, DOI 10.1016/j.neuropharm.2013.08.016; HAYASHI T, 1988, J PHARMACOBIO-DYNAM, V11, P146, DOI 10.1248/bpb1978.11.146; Hudis CA, 2007, NEW ENGL J MED, V357, P39, DOI 10.1056/NEJMra043186; Hurvitz SA, 2013, J CLIN ONCOL, V31, P1157, DOI 10.1200/JCO.2012.44.9694; Khan EM, 2006, J BIOL CHEM, V281, P14486, DOI 10.1074/jbc.M509332200; KOLESKE AJ, 1995, P NATL ACAD SCI USA, V92, P1381, DOI 10.1073/pnas.92.5.1381; Kovtun YV, 2007, CANCER LETT, V255, P232, DOI 10.1016/j.canlet.2007.04.010; Krop IE, 2014, LANCET ONCOL, V15, P689, DOI 10.1016/S1470-2045(14)70178-0; Lee SW, 1998, ONCOGENE, V16, P1391, DOI 10.1038/sj.onc.1201661; LoRusso PM, 2011, CLIN CANCER RES, V17, P6437, DOI 10.1158/1078-0432.CCR-11-0762; Ma XL, 2013, BREAST, V22, P462, DOI 10.1016/j.breast.2013.03.005; Marty M, 2005, J CLIN ONCOL, V23, P4265, DOI 10.1200/JCO.2005.04.173; Menard S, 2003, ONCOGENE, V22, P6570, DOI 10.1038/sj.onc.1206779; Mercier I, 2012, ADV EXP MED BIOL, V729, P83, DOI 10.1007/978-1-4614-1222-9_6; Mosesson Y, 2008, NAT REV CANCER, V8, P835, DOI 10.1038/nrc2521; Muthuswamy SK, 2011, NAT MED, V17, P416, DOI 10.1038/nm0411-416; Panowski S, 2014, MABS-AUSTIN, V6, P34, DOI 10.4161/mabs.27022; Parachoniak CA, 2012, TRENDS CELL BIOL, V22, P231, DOI 10.1016/j.tcb.2012.02.002; Park SS, 2005, HISTOPATHOLOGY, V47, P625, DOI 10.1111/j.1365-2559.2005.02303.x; Pelkmans L, 2004, CELL, V118, P767, DOI 10.1016/j.cell.2004.09.003; Phillips GDL, 2008, CANCER RES, V68, P9280, DOI 10.1158/0008-5472.CAN-08-1776; Rao X, 2013, ONCOGENE, V32, P4519, DOI 10.1038/onc.2012.474; Ritchie M, 2013, MABS-AUSTIN, V5, P13, DOI 10.4161/mabs.22854; Robert N, 2006, J CLIN ONCOL, V24, P2786, DOI 10.1200/JCO.2005.04.1764; ROTHBERG KG, 1992, CELL, V68, P673, DOI 10.1016/0092-8674(92)90143-Z; ROTIN D, 1992, EMBO J, V11, P559, DOI 10.1002/j.1460-2075.1992.tb05087.x; Rubin I, 2001, ANN ONCOL, V12, P3, DOI 10.1023/A:1011195320446; Savage K, 2007, CLIN CANCER RES, V13, P90, DOI 10.1158/1078-0432.CCR-06-1371; Seidman A, 2002, J CLIN ONCOL, V20, P1215, DOI 10.1200/JCO.20.5.1215; Sekhar SC, 2013, J CANCER, V4, P391, DOI 10.7150/jca.6470; Shaughnessy R, 2014, FEBS J, V281, P2172, DOI 10.1111/febs.12770; Shvets E, 2014, CURR OPIN CELL BIOL, V29, P99, DOI 10.1016/j.ceb.2014.04.011; Sigismund S, 2005, P NATL ACAD SCI USA, V102, P2760, DOI 10.1073/pnas.0409817102; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Sloan EK, 2004, ONCOGENE, V23, P7893, DOI 10.1038/sj.onc.1208062; Sloan EK, 2009, AM J PATHOL, V174, P2035, DOI 10.2353/ajpath.2009.080924; Sorkin A, 2009, EXP CELL RES, V315, P683, DOI [10.1016/j.yexcr.2008.07.029, 10.1016/j.yexcr.2008.08.013]; Subik K, 2010, BREAST CANCER-BASIC, V4, P35; Tian JJ, 2012, HEAD NECK ONCOL, V4, DOI 10.1186/1758-3284-4-7; Verma S, 2012, NEW ENGL J MED, V367, P1783, DOI 10.1056/NEJMoa1209124; Wang Z., 2012, MUTUAL REGULATION RE; Williams TM, 2005, AM J PHYSIOL-CELL PH, V288, pC494, DOI 10.1152/ajpcell.00458.2004; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073	55	28	29	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0133072	10.1371/journal.pone.0133072	http://dx.doi.org/10.1371/journal.pone.0133072			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26172389	Green Submitted, Green Published, gold			2022-12-26	WOS:000358194900120
J	Wu, Y; Feng, G; Song, JL; Zhang, YY; Yu, Y; Huang, L; Zheng, LL; Deng, F				Wu, Yan; Feng, Ge; Song, Jinlin; Zhang, Yuanyuan; Yu, Yong; Huang, Lan; Zheng, Leilei; Deng, Feng			TrAmplification of Human Dental Follicle Cells by piggyBac Transposon - Mediated Reversible Immortalization System	PLOS ONE			English	Article							HEPATIC PROGENITOR CELLS; OSTEOGENIC DIFFERENTIATION; MAMMALIAN-CELLS; T-ANTIGEN; STEM-CELLS; GENOME; SV40; REGENERATION; REPLICATION; THERAPY	Dental follicle cells (DFCs) are the precursor cells of periodontium. Under certain differentiation conditions, DFCs can be induced to differentiate into chondrogenic, osteogenic and adipogenic cells. However, DFCs has limited lifespan in vitro, so it's difficult to harvest enough cells for basic research and translational application. pMPH86 is a piggyBac transposon-mediated vector which contains SV40 T-Ag cassette that can be removed by flippase recognition target (FRT) recombinase. Here we demonstrated the pMPH86 can effectively amplify human DFCs through reversible immortalization. The immortalized DFCs (iDFCs) exhibit higher proliferate activity, which can be reversed to its original level before immortalization when deimmortalized by FLP recombinase. The iDFCs and deimmortalized DFCs (dDFCs) express most DFC markers and maintain multiple differentiation potential in vitro as they can be induced by BMP9 to differentiate into chondrogenic, osteogenic and adipogenic cells evidenced by gene expression and protein marker. We also proved telomerase activity of iDFCs are significantly increased and maintained at a high level, while the telomerase activity of primary DFCs was relatively low and decreased with every passage. After SV40 T-Ag was removed to deimmortalize the cells, telomerase activity was reduced to its original level before immortalization and decreased with passages just the same as primary DFCs. These results suggest that piggyBac immortalization system could be a potential strategy to amplify primary cells, which is critical for regenerative research and further clinical application.	[Wu, Yan; Feng, Ge; Song, Jinlin; Yu, Yong; Huang, Lan; Zheng, Leilei; Deng, Feng] Chongqing Med Univ, Dept Orthodont, Stomatol Hosp, Chongqing, Peoples R China; [Wu, Yan; Feng, Ge; Song, Jinlin; Yu, Yong; Huang, Lan; Zheng, Leilei; Deng, Feng] Chongqing Key Lab Oral Dis & Biomed Sci, Chongqing, Peoples R China; [Wu, Yan; Feng, Ge; Song, Jinlin; Yu, Yong; Huang, Lan; Zheng, Leilei; Deng, Feng] Chongqing Municipal Key Lab Oral Biomed Engn High, Chongqing, Peoples R China; [Zhang, Yuanyuan] Wake Forest Univ Hlth Sci, Wake Forest Inst Regenerat Med, Winston Salem, NC USA	Chongqing Medical University; Wake Forest University; Wake Forest University School of Medicine	Deng, F (corresponding author), Chongqing Med Univ, Dept Orthodont, Stomatol Hosp, Chongqing, Peoples R China.	deng63@263.com	zhang, yuanyuan/GYA-4428-2022	Huang, Lan/0000-0001-9594-4722	Natural Science Foundation of China [81271183, 81300914, 81470772]; Program for Innovation Team Building at Institutions of Higher Education in Chongqing; Chongqing Municipal Key Laboratory of Oral Biomedical Engineering of Higher Education	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Innovation Team Building at Institutions of Higher Education in Chongqing; Chongqing Municipal Key Laboratory of Oral Biomedical Engineering of Higher Education	This project was supported by a research grant from the Natural Science Foundation of China (no. 81271183 to FD who designed the study), a research grant from the Natural Science Foundation of China (no. 81300914 to LH who help to prepare the manucript), a research grant from the Natural Science Foundation of China (no. 81470772 to LLZ who helped to write the manuscript), The Program for Innovation Team Building at Institutions of Higher Education in Chongqing, and Chongqing Municipal Key Laboratory of Oral Biomedical Engineering of Higher Education.	AARONSON SA, 1968, J CELL PHYSIOL, V72, P141, DOI 10.1002/jcp.1040720208; Bi Y, 2009, J CELL BIOCHEM, V108, P295, DOI 10.1002/jcb.22254; BOROWIEC JA, 1990, CELL, V60, P181, DOI 10.1016/0092-8674(90)90730-3; Bosshardt DD, 1996, ANAT RECORD, V245, P267; Cheng HW, 2003, J BONE JOINT SURG AM, V85A, P1544, DOI 10.2106/00004623-200308000-00017; Di Matteo Mario, 2012, Methods Mol Biol, V859, P241, DOI 10.1007/978-1-61779-603-6_14; Ding S, 2005, CELL, V122, P473, DOI 10.1016/j.cell.2005.07.013; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; FRASER MJ, 1983, J VIROL, V47, P287, DOI 10.1128/JVI.47.2.287-300.1983; Galvan DL, 2009, J IMMUNOTHER, V32, P837, DOI 10.1097/CJI.0b013e3181b2914c; Guo LJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062332; Guo SJ, 2013, CELL TRANSPLANT, V22, P1061, DOI 10.3727/096368912X656036; He BC, 2010, CLIN CANCER RES, V16, P2235, DOI 10.1158/1078-0432.CCR-09-2499; Honda MJ, 2010, JPN DENT SCI REV, V46, P54, DOI 10.1016/j.jdsr.2009.10.006; Honda Masaki J, 2010, J Oral Sci, V52, P541, DOI 10.2334/josnusd.52.541; Honda MJ, 2011, ORAL SURG ORAL MED O, V111, P700, DOI 10.1016/j.tripleo.2010.08.004; Huang EY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032428; Huang JY, 2009, LIVER INT, V29, P1569, DOI 10.1111/j.1478-3231.2009.02111.x; Ivics Z, 2009, NAT METHODS, V6, P415, DOI [10.1038/NMETH.1332, 10.1038/nmeth.1332]; Kang Q, 2004, GENE THER, V11, P1312, DOI 10.1038/sj.gt.3302298; Kang Q, 2009, STEM CELLS DEV, V18, P545, DOI 10.1089/scd.2008.0130; Kim A, 2011, MOL CELL BIOCHEM, V354, P301, DOI 10.1007/s11010-011-0832-3; Li MA, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr764; Li M, 2013, INT J MED SCI, V10, P1035, DOI 10.7150/ijms.6639; Li XH, 2013, P NATL ACAD SCI USA, V110, pE2279, DOI 10.1073/pnas.1305987110; Meir YJJ, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-28; Meir Yaa-Jyuhn James, 2011, Chang Gung Med J, V34, P565; Morsczeck C, 2005, MATRIX BIOL, V24, P155, DOI 10.1016/j.matbio.2004.12.004; Morsczeck C, 2010, CLIN ORAL INVEST, V14, P433, DOI 10.1007/s00784-009-0310-4; Nakao K, 2007, NAT METHODS, V4, P227, DOI 10.1038/nmeth1012; PRIVES C, 1990, CELL, V61, P735, DOI 10.1016/0092-8674(90)90179-I; Rostovskaya M, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks643; Saito M, 2005, J BONE MINER RES, V20, P50, DOI 10.1359/jbmr.041006; Sharff KA, 2009, J BIOL CHEM, V284, P649, DOI 10.1074/jbc.M806389200; Tang N, 2009, J CELL MOL MED, V13, P2448, DOI 10.1111/j.1582-4934.2008.00569.x; Tsuchiya S, 2010, CONNECT TISSUE RES, V51, P197, DOI 10.3109/03008200903267542; Volponi AA, 2010, TRENDS CELL BIOL, V20, P715, DOI 10.1016/j.tcb.2010.09.012; vom Brocke J, 2006, CARCINOGENESIS, V27, P2141, DOI 10.1093/carcin/bg1101; Wang N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097316; Wang XJ, 2014, J BIOMED MATER RES A, V102, P1017, DOI 10.1002/jbm.a.34764; Westerman KA, 1996, P NATL ACAD SCI USA, V93, P8971, DOI 10.1073/pnas.93.17.8971; Wilson MH, 2007, MOL THER, V15, P139, DOI 10.1038/sj.mt.6300028; Wu JY, 2012, J ENDODONT, V38, P614, DOI 10.1016/j.joen.2012.01.014; Wu SCY, 2006, P NATL ACAD SCI USA, V103, P15008, DOI 10.1073/pnas.0606979103; Yang B, 2012, BIOMATERIALS, V33, P2449, DOI 10.1016/j.biomaterials.2011.11.074; Yang K, 2012, J INVEST DERMATOL, V132, P2479, DOI 10.1038/jid.2012.145; Yao S, 2011, CELL PROLIFERAT, V44, P486, DOI 10.1111/j.1365-2184.2011.00778.x; Yusa K, 2011, P NATL ACAD SCI USA, V108, P1531, DOI 10.1073/pnas.1008322108; Zhang WL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011917; ZHU JY, 1991, J VIROL, V65, P6872, DOI 10.1128/JVI.65.12.6872-6880.1991	50	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0130937	10.1371/journal.pone.0130937	http://dx.doi.org/10.1371/journal.pone.0130937			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26172849	gold, Green Published, Green Submitted			2022-12-26	WOS:000358194900011
J	Zhao, JZ; Li, HJ; Zhou, RJ; Ma, G; Dekker, JD; Tucker, HO; Yao, ZJ; Guo, XZ				Zhao, Jianzhi; Li, Hanjun; Zhou, Rujiang; Ma, Gang; Dekker, Joseph D.; Tucker, Haley O.; Yao, Zhengju; Guo, Xizhi			Foxp1 Regulates the Proliferation of Hair Follicle Stem Cells in Response to Oxidative Stress during Hair Cycling	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; SELF-RENEWAL; SKIN; MORPHOGENESIS; EXPRESSION; CANCER; NICHE; P53; ROS; PREVENTION	Hair follicle stem cells (HFSCs) in the bugle circularly generate outer root sheath (ORS) through linear proliferation within limited cycles during anagen phases. However, the mechanisms controlling the pace of HFSC proliferation remain unclear. Here we revealed that Foxp1, a transcriptional factor, was dynamically relocated from the nucleus to the cytoplasm of HFSCs in phase transitions from anagen to catagen, coupled with the rise of oxidative stress. Mass spectrum analyses revealed that the S468 phosphorylation of Foxp1 protein was responsive to oxidative stress and affected its nucleocytoplasmic translocation. Foxp1 deficiency in hair follicles led to compromised ROS accrual and increased HFSC proliferation. And more, NAC treatment profoundly elongated the anagen duration and HFSC proliferation in Foxp1-deficient background. Molecularly, Foxp1 augmented ROS levels through suppression of Trx1-mediated reductive function, thereafter imposing the cell cycle arrest by modulating the activity of p19/p53 pathway. Our findings identify a novel role for Foxp1 in controlling HFSC proliferation with cellular dynamic location in response to oxidative stress during hair cycling.	[Zhao, Jianzhi; Li, Hanjun; Zhou, Rujiang; Ma, Gang; Yao, Zhengju; Guo, Xizhi] Shanghai Jiao Tong Univ, Bio X Inst, Key Lab Genet Dev & Neuropsychiat Disorders, Minist Educ, Shanghai 200240, Peoples R China; [Dekker, Joseph D.; Tucker, Haley O.] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA	Shanghai Jiao Tong University; University of Texas System; University of Texas Austin	Guo, XZ (corresponding author), Shanghai Jiao Tong Univ, Bio X Inst, Key Lab Genet Dev & Neuropsychiat Disorders, Minist Educ, Shanghai 200240, Peoples R China.	xzguo2005@sjtu.edu.cn	Dekker, Joseph D/G-4924-2013	Dekker, Joseph D/0000-0002-2068-3529; Guo, Xizhi/0000-0001-8047-6049; Li, Hanjun/0000-0002-7017-8782	973 program of China [2014CB942902, 2012CB966903]; NSFC [31171396, 31271553, 81421061, 31100624]; NIH [R01CA31534, CPRIT RP100612]; NATIONAL CANCER INSTITUTE [R01CA031534] Funding Source: NIH RePORTER	973 program of China(National Basic Research Program of China); NSFC(National Natural Science Foundation of China (NSFC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by grants from the 973 program of China (2014CB942902 and 2012CB966903), NSFC (31171396, 31271553, 81421061 and 31100624) (http://www.nsfc.gov.cn/) and NIH (R01CA31534, CPRIT RP100612).	Alonso L, 2003, GENE DEV, V17, P1189, DOI 10.1101/gad.1086903; Arck PC, 2006, FASEB J, V20, P1567, DOI 10.1096/fj.05-4039fje; Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; Blanpain C, 2006, ANNU REV CELL DEV BI, V22, P339, DOI 10.1146/annurev.cellbio.22.010305.104357; Brownell I, 2011, CELL STEM CELL, V8, P552, DOI 10.1016/j.stem.2011.02.021; Duverger O, 2014, SEMIN CELL DEV BIOL, V25, P22, DOI 10.1016/j.semcdb.2013.12.006; Eijkelenboom A, 2013, NAT REV MOL CELL BIO, V14, P83, DOI 10.1038/nrm3507; Enshell-Seijffers D, 2010, DEV CELL, V18, P633, DOI 10.1016/j.devcel.2010.01.016; Feng J, 2012, AM J CLIN PATHOL, V138, P230, DOI 10.1309/AJCPDHQFNYJZ01YG; Feng XM, 2010, BLOOD, V115, P510, DOI 10.1182/blood-2009-07-232694; Folgueras AR, 2013, CELL STEM CELL, V13, P314, DOI 10.1016/j.stem.2013.06.018; Giatromanolaki A, 2006, MODERN PATHOL, V19, P9, DOI 10.1038/modpathol.3800494; Godic A, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/860479; Guerriero G, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00056; Hancock WW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007890; Horsley V, 2008, CELL, V132, P299, DOI 10.1016/j.cell.2007.11.047; Hsu YC, 2014, CELL, V157, P935, DOI 10.1016/j.cell.2014.02.057; Hsu YC, 2011, CELL, V144, P92, DOI 10.1016/j.cell.2010.11.049; Hu CR, 2013, ACTA HISTOCHEM, V115, P137, DOI 10.1016/j.acthis.2012.06.001; Hu H, 2006, NAT IMMUNOL, V7, P819, DOI 10.1038/ni1358; Ijichi N, 2013, VITAM HORM, V93, P203, DOI 10.1016/B978-0-12-416673-8.00006-X; Jang YY, 2007, BLOOD, V110, P3056, DOI 10.1182/blood-2007-05-087759; Jung K, 2008, SPECTROCHIM ACTA A, V69, P1423, DOI 10.1016/j.saa.2007.09.029; Juntilla MM, 2010, BLOOD, V115, P4030, DOI 10.1182/blood-2009-09-241000; Kimura-Ueki M, 2012, J INVEST DERMATOL, V132, P1338, DOI 10.1038/jid.2011.490; Le Belle JE, 2011, CELL STEM CELL, V8, P59, DOI 10.1016/j.stem.2010.11.028; Leishman E, 2013, DEVELOPMENT, V140, P3809, DOI 10.1242/dev.097477; Lewandowski D, 2010, BLOOD, V115, P443, DOI 10.1182/blood-2009-05-222711; Li YX, 2004, ONCOGENE, V23, P7355, DOI 10.1038/sj.onc.1207957; Lim X, 2013, COLD SPRING HARB PER, V5; Liu B, 2008, FREE RADICAL BIO MED, V44, P1529, DOI 10.1016/j.freeradbiomed.2008.01.011; Mitra D, 2012, NATURE, V491, P449, DOI 10.1038/nature11624; Miyamoto K, 2007, CELL STEM CELL, V1, P101, DOI 10.1016/j.stem.2007.02.001; Moore L, 2003, ONCOGENE, V22, P7831, DOI 10.1038/sj.onc.1206985; Morimoto H, 2013, CELL STEM CELL, V12, P774, DOI 10.1016/j.stem.2013.04.001; Nguyen H, 2006, CELL, V127, P171, DOI 10.1016/j.cell.2006.07.036; Nguyen H, 2009, NAT GENET, V41, P1068, DOI 10.1038/ng.431; Nowak Jonathan A., 2009, V482, P215, DOI 10.1007/978-1-59745-060-7_14; Plikus MV, 2008, NATURE, V451, P340, DOI 10.1038/nature06457; Rendl M, 2008, GENE DEV, V22, P543, DOI 10.1101/gad.1614408; Rhee H, 2006, SCIENCE, V312, P1946, DOI 10.1126/science.1128004; Seemann S, 2005, ONCOGENE, V24, P3853, DOI 10.1038/sj.onc.1208549; Sherr CJ, 2001, NAT REV MOL CELL BIO, V2, P731, DOI 10.1038/35096061; Sotiropoulou PA, 2010, NAT CELL BIOL, V12, P572, DOI 10.1038/ncb2059; Takahashi A, 2006, NAT CELL BIOL, V8, P1291, DOI 10.1038/ncb1491; Takayama K, 2008, BIOCHEM BIOPH RES CO, V374, P388, DOI 10.1016/j.bbrc.2008.07.056; Terada LS, 2006, J CELL BIOL, V174, P615, DOI 10.1083/jcb.200605036; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; Vidal VPI, 2005, CURR BIOL, V15, P1340, DOI 10.1016/j.cub.2005.06.064; Wlodarska I, 2005, LEUKEMIA, V19, P1299, DOI 10.1038/sj.leu.2403813; Woo WM, 2012, GENE DEV, V26, P1235, DOI 10.1101/gad.187401.112; Zhang YX, 2012, J CLIN PATHOL, V65, P528, DOI 10.1136/jclinpath-2011-200547; Zhang YZ, 2010, GENE DEV, V24, P1746, DOI 10.1101/gad.1929210; Zschauer TC, 2013, ANTIOXID REDOX SIGN, V18, P1053, DOI 10.1089/ars.2012.4822	54	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0131674	10.1371/journal.pone.0131674	http://dx.doi.org/10.1371/journal.pone.0131674			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26171970	Green Submitted, Green Published, gold			2022-12-26	WOS:000358194900020
J	Zoccola, E; Delamare-Deboutteville, J; Barnes, AC				Zoccola, Emmanuelle; Delamare-Deboutteville, Jerome; Barnes, Andrew C.			Identification of Barramundi (Lates calcarifer) DC-SCRIPT, a Specific Molecular Marker for Dendritic Cells in Fish	PLOS ONE			English	Article							STREPTOCOCCUS-INIAE; LIPOPOLYSACCHARIDE LPS; EXPRESSION; RESPONSES; CULTURES; EVOLUTION; SOFTWARE; RECEPTOR; TLR4; PCR	Antigen presentation is a critical step bridging innate immune recognition and specific immune memory. In mammals, the process is orchestrated by dendritic cells (DCs) in the lymphatic system, which initiate clonal proliferation of antigen-specific lymphocytes. However, fish lack a classical lymphatic system and there are currently no cellular markers for DCs in fish, thus antigen-presentation in fish is poorly understood. Recently, antigen-presenting cells similar in structure and function to mammalian DCs were identified in various fish, including rainbow trout (Oncorhynchus mykiss) and zebrafish (Danio rerio). The present study aimed to identify a potential molecular marker for DCs in fish and therefore targeted DC-SCRIPT, a well-conserved zinc finger protein that is preferentially expressed in all sub-types of human DCs. Putative dendritic cells were obtained in culture by maturation of spleen and pronephros-derived monocytes. DC-SCRIPT was identified in barramundi by homology using RACE PCR and genome walking. Specific expression of DC-SCRIPT was detected in barramundi cells by Stellaris mRNA FISH, in combination with MHCII expression when exposed to bacterial derived peptidoglycan, suggesting the presence of DCs in L. calcarifer. Moreover, morphological identification was achieved by light microscopy of cytospins prepared from these cultures. The cultured cells were morphologically similar to mammalian and trout DCs. Migration assays determined that these cells have the ability to move towards pathogens and pathogen associated molecular patterns, with a preference for peptidoglycans over lipopolysaccharides. The cells were also strongly phagocytic, engulfing bacteria and rapidly breaking them down. Barramundi DCs induced significant proliferation of responder populations of T-lymphocytes, supporting their role as antigen presenting cells. DC-SCRIPT expression in head kidney was higher 6 and 24 h following intraperitoneal challenge with peptidoglycan and lipopolysaccharide and declined after 3 days relative to PBS-injected controls. Relative expression was also lower in the spleen at 3 days post challenge but increased again at 7 days. As DC-SCRIPT is a constitutively expressed nuclear receptor, independent of immune activation, this may indicate initial migration of immature DCs from head kidney and spleen to the injection site, followed by return to the spleen for maturation and antigen presentation. DC-SCRIPT may be a valuable tool in the investigation of antigen presentation in fish and facilitate optimisation of vaccines and adjuvants for aquaculture.	[Barnes, Andrew C.] Univ Queensland, Sch Biol Sci, Brisbane, Qld 4072, Australia; Univ Queensland, Ctr Marine Sci, Brisbane, Qld 4072, Australia	University of Queensland; University of Queensland	Barnes, AC (corresponding author), Univ Queensland, Sch Biol Sci, Brisbane, Qld 4072, Australia.	a.barnes@uq.edu.au	Zoccola, Emmanuelle/E-6898-2017; Zoccola, Emmanuelle/Y-8435-2019; Barnes, Andrew/J-9012-2014	Zoccola, Emmanuelle/0000-0002-5984-1774; Zoccola, Emmanuelle/0000-0002-5984-1774; Barnes, Andrew/0000-0002-3990-8070; Delamare Deboutteville, Jerome/0000-0003-4169-2456				Agnew W, 2007, VET MICROBIOL, V122, P1, DOI 10.1016/j.vetmic.2007.03.002; Arthur R, 2007, FAO FISHERIES P, V9, P271; Aviles F, 2013, VET MICROBIOL, V162, P151, DOI 10.1016/j.vetmic.2012.08.018; Bachrach G, 2001, APPL ENVIRON MICROB, V67, P3756, DOI 10.1128/AEM.67.8.3756-3758.2001; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Barnes AC, 2003, DIS AQUAT ORGAN, V53, P241, DOI 10.3354/dao053241; Bassity E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033196; Bone Q., 2008, BIOL FISHES, DOI [10.1201/9781134186310, DOI 10.1201/9781134186310]; Broere F, 2011, PRINCIPLES IMMUNOPHA, P15, DOI [DOI 10.1007/978-3-0346-0136-8_2, 10.1007/978-3-0346-0136-8_2]; CHELSKY D, 1989, MOL CELL BIOL, V9, P2487, DOI 10.1128/MCB.9.6.2487; Chettri JK, 2011, DEV COMP IMMUNOL, V35, P476, DOI 10.1016/j.dci.2010.12.001; Clark GJ, 2000, MICROBES INFECT, V2, P257, DOI 10.1016/S1286-4579(00)00302-6; De Santis C, 2011, MAR BIOTECHNOL, V13, P170, DOI 10.1007/s10126-010-9277-z; Dos Santos NMS, 2001, FISH SHELLFISH IMMUN, V11, P317, DOI 10.1006/fsim.2000.0320; Dowling D, 2008, CYTOKINE, V41, P254, DOI 10.1016/j.cyto.2007.11.020; Eyngor M, 2008, APPL ENVIRON MICROB, V74, P6892, DOI 10.1128/AEM.00853-08; Fierro-Castro C, 2012, FISH SHELLFISH IMMUN, V33, P389, DOI 10.1016/j.fsi.2012.05.019; Flajnik MF, 2010, NAT REV GENET, V11, P47, DOI 10.1038/nrg2703; Ganassin RC, 1996, FISH SHELLFISH IMMUN, V6, P17, DOI 10.1006/fsim.1996.0003; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Hontelez S, 2013, J IMMUNOL, V190, P3172, DOI 10.4049/jimmunol.1201776; Hontelez S, 2012, J IMMUNOL, V189, P138, DOI 10.4049/jimmunol.1103709; Jondal M, 1996, IMMUNITY, V5, P295, DOI 10.1016/S1074-7613(00)80255-1; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; KERMAN R, 1976, IMMUNOL COMMUN, V5, P685, DOI 10.3109/08820137609033876; Klein Jan, 1997, P271, DOI 10.1016/B978-012417540-2/50017-8; Lackie J.M., 2013, DICT CELL MOL BIOL; Levraud JP, 2009, M S-MED SCI, V25, P405, DOI 10.1051/medsci/2009254405; Lovy J, 2009, FISH SHELLFISH IMMUN, V27, P365, DOI 10.1016/j.fsi.2009.01.006; LU L, 1995, IMMUNOLOGY, V84, P127; Lugo-Villarino G, 2010, P NATL ACAD SCI USA, V107, P15850, DOI 10.1073/pnas.1000494107; MADSEN M, 1980, J IMMUNOL METHODS, V33, P323, DOI 10.1016/0022-1759(80)90003-4; Mak TW, 2006, IMMUNE RESPONSE: BASIC AND CLINICAL PRINCIPLES, P1; Millard CM, 2012, APPL ENVIRON MICROB, V78, P8219, DOI 10.1128/AEM.02216-12; Nafarnda WD, 2011, J ADV SCI RES; Nagai Y, 2002, NAT IMMUNOL, V3, P667, DOI 10.1038/ni809; Pettersen EF, 2008, FISH SHELLFISH IMMUN, V25, P809, DOI 10.1016/j.fsi.2008.08.014; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Sepulcre MP, 2007, MOL IMMUNOL, V44, P2009, DOI 10.1016/j.molimm.2006.09.022; Sepulcre MP, 2009, J IMMUNOL, V182, P1836, DOI 10.4049/jimmunol.0801755; STEINMAN RM, 1979, J EXP MED, V149, P1, DOI 10.1084/jem.149.1.1; Tort L., 2003, Inmunologia, V22, P277; Triantis V, 2006, J IMMUNOL, V176, P1081, DOI 10.4049/jimmunol.176.2.1081; Triantis V, 2006, J LEUKOCYTE BIOL, V79, P1083, DOI 10.1189/jlb.1005588; Tumbol RA, 2009, AQUACULTURE, V292, P180, DOI 10.1016/j.aquaculture.2009.04.030; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; WEAVER CT, 1990, IMMUNOL TODAY, V11, P49; Wilson HL, 2000, EXP HEMATOL, V28, P193, DOI 10.1016/S0301-472X(99)00146-0; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311; Yanagawa Y, 2007, J IMMUNOL, V178, P6173, DOI 10.4049/jimmunol.178.10.6173	50	17	20	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132687	10.1371/journal.pone.0132687	http://dx.doi.org/10.1371/journal.pone.0132687			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26173015	Green Published, Green Submitted, gold			2022-12-26	WOS:000358194900077
J	Camacho, M; Quintana, MD; Calabuig, P; Luzardo, OP; Boada, LD; Zumbado, M; Oros, J				Camacho, Maria; del Pino Quintana, Maria; Calabuig, Pascual; Luzardo, Octavio P.; Boada, Luis D.; Zumbado, Manuel; Oros, Jorge			Acid-Base and Plasma Biochemical Changes Using Crystalloid Fluids in Stranded Juvenile Loggerhead Sea Turtles (Caretta caretta)	PLOS ONE			English	Article							RESPIRATORY STATUS; TEMPERATURE; RESPONSES; BALANCE; STRESS; GAS	Aim The aim of this study was to compare the efficacy and effects on acid-base and electrolyte status of several crystalloid fluids in 57 stranded juvenile loggerhead turtles. Methods Within a rehabilitation program four different crystalloid fluids were administered (0.9% Na Cl solution; 5% dextrose + 0.9% Na Cl solutions 1:1; 0.9% Na Cl + lactated Ringer's solutions 1:1; lactated Ringer's solution). Crystalloid fluids were intracoelomically administered during three days (20 ml/kg/day). Animals were sampled at three different moments: Upon admission for evaluating the type of acid-base or biochemical disorder, post-fluid therapy treatment for controlling the evolution of the disorder, and post-recovery period for obtaining the baseline values for rehabilitated loggerhead turtles. Each sample was analyzed with a portable electronic blood analyzer for pH, pO(2), pCO(2), lactate, sodium, potassium, chloride, glucose, and BUN concentration. Admission and post-fluid therapy treatment values were compared with those obtained for each turtle immediately before release. Results The highest percentage of acid-base recovery and electrolyte balance was observed in turtles treated with mixed saline-lactated Ringer's solution (63.6%), followed by turtles treated with physiological saline solution (55%), lactated Ringer's solution (33.3%), and dextrose-saline solutions (10%). Most turtles treated with lactated Ringer's solution had lower lactate concentrations compared with their initial values; however, 66.6% of turtles treated with lactated Ringer's solution had metabolic alkalosis after therapy. Significant higher concentrations of glucose were detected after saline-dextrose administration compared with all the remaining fluids. Conclusions This is the first study evaluating the effects of several crystalloid fluids on the acid-base status and plasma biochemical values in stranded loggerhead sea turtles. Reference convalescent venous blood gas, acid-base, and plasma biochemical values, useful for veterinary surgeons involved in sea turtle conservation, are also provided.	[Camacho, Maria; Luzardo, Octavio P.; Boada, Luis D.; Zumbado, Manuel; Oros, Jorge] Univ Las Palmas Gran Canaria, Fac Vet, Arucas, Las Palmas, Spain; [del Pino Quintana, Maria] Univ Las Palmas Gran Canaria, Dept Math, Las Palmas Gran Canaria, Spain; [Calabuig, Pascual] Cabildo Gran Canaria, Tafira Wildlife Rehabil Ctr, Tafira Baja Las Palmas D, Spain	Universidad de Las Palmas de Gran Canaria; Universidad de Las Palmas de Gran Canaria	Oros, J (corresponding author), Univ Las Palmas Gran Canaria, Fac Vet, Arucas, Las Palmas, Spain.	jorge.oros@ulpgc.es	Luzardo, Octavio P./H-3045-2019; Calabuig, Pascual/AAB-1723-2019; Zumbado, Manuel/AAN-8373-2020; Zumbado, Manuel/B-4495-2010; Dominguez-Boada, Luis/L-5577-2015; Orós, Jorge/G-8824-2015; CAMACHO, MARIA/H-5085-2015; Staffieri, Francesco/K-4230-2016	Luzardo, Octavio P./0000-0002-4153-3028; Zumbado, Manuel/0000-0002-1534-7758; Dominguez-Boada, Luis/0000-0002-0195-4565; Orós, Jorge/0000-0002-8346-5393; CAMACHO, MARIA/0000-0003-2891-1474; Staffieri, Francesco/0000-0002-2085-376X; Quintana Montesdeoca, Maria del Pino/0000-0003-1276-7594				AGUIRRE AA, 1995, PHYSIOL ZOOL, V68, P831, DOI 10.1086/physzool.68.5.30163934; ASHWOOD ER, 1983, CLIN CHEM, V29, P1877; Bjorndal KA, 2001, FISH B-NOAA, V99, P240; Camacho M, 2013, JAVMA-J AM VET MED A, V242, P396, DOI 10.2460/javma.242.3.396; Casal AB, 2009, VET REC, V164, P663, DOI 10.1136/vr.164.21.663; Casal AB, 2009, VET CLIN PATH, V38, P213, DOI 10.1111/j.1939-165X.2008.00106.x; Chittick EJ, 2002, J AM VET MED ASSOC, V221, P1019, DOI 10.2460/javma.2002.221.1019; Chrisman CL, 1997, J AM VET MED ASSOC, V211, P1043; DiBartola SP., 2006, FLUID ELECTROLYTE, P325, DOI [10.1016/B0-72-163949-6/50017-5, DOI 10.1016/B0-72-163949-6/50017-5]; Flint M, 2010, J WILDLIFE DIS, V46, P731, DOI 10.7589/0090-3558-46.3.731; Gregory LF, 2001, GEN COMP ENDOCR, V124, P66, DOI 10.1006/gcen.2001.7683; Harms CA, 2003, J WILDLIFE DIS, V39, P366, DOI 10.7589/0090-3558-39.2.366; Innis CJ, 2007, J COMP PHYSIOL B, V177, P623, DOI 10.1007/s00360-007-0160-9; IUCN SSC, 2014, IUCN RED LIST THREAT; Jacobson ER, 2006, DIS AQUAT ORGAN, V70, P139, DOI 10.3354/dao070139; Kelly TR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115739; KRAUS DR, 1980, AM J PHYSIOL, V239, pR254, DOI 10.1152/ajpregu.1980.239.3.R254; LUTZ PL, 1989, J EXP BIOL, V144, P155; Mader D, 2006, REPTILE MED SURG 2 E, P533, DOI DOI 10.1016/B0-72-169327-X/50035-3; Martinez-Jimenez David, 2007, Veterinary Clinics of North America Exotic Animal Practice, V10, P557, DOI 10.1016/j.cvex.2007.02.003; Michell AR., 1989, VET FLUID THERAPY, P55; Mitchell M.A., 2006, REPTILE MED SURG, P631; Monzon-Arguello C, 2009, J EXP MAR BIOL ECOL, V373, P79, DOI 10.1016/j.jembe.2009.03.007; Norton Terry M., 2012, P239; Norton TM, 2005, SEMIN AVIAN EXOT PET, V14, P106, DOI 10.1053/j.saep.2005.04.005; Oros J, 2011, DIS AQUAT ORGAN, V95, P163, DOI 10.3354/dao02351; Prezant RM, 1997, PROCEEDINGS OF THE FOURTH ANNUAL CONFERENCE OF THE ASSOCIATION OF REPTILIAN AND AMPHIBIAN VETERINARIANS, P83; Seminoff Jeffrey A., 2004, Herpetological Review, V35, P24; STABENAU EK, 1991, COMP BIOCHEM PHYS A, V99, P107, DOI 10.1016/0300-9629(91)90243-6; Stabenau EK, 2003, FISH B-NOAA, V101, P889; STABENAU EK, 1993, J EXP BIOL, V180, P311; Stahl S., 2006, REPTILE MED SURG, V2e, P822; Wellman ML., 2006, FLUID ELECTROLYTE, P3, DOI [DOI 10.1016/B0-72-163949-6/50004-7, 10.1016/B0-72-163949-6/50004-7]; Whitaker Brent R., 1999, P217; Wilkinson R, 2004, MED SURG TORTOISES T, P481; Wyneken JE., 2006, REPTILE MED SURG, P972	36	14	15	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0132217	10.1371/journal.pone.0132217	http://dx.doi.org/10.1371/journal.pone.0132217			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26167930	Green Published, gold			2022-12-26	WOS:000358193100029
J	Ge, JP; An, Q; Song, SS; Gao, DN; Ping, WX				Ge, Jingping; An, Qi; Song, Shanshan; Gao, Dongni; Ping, Wenxiang			Construction of Recombinant Baculoviruses Expressing Infectious Bursal Disease Virus Main Protective Antigen and Their Immune Effects on Chickens	PLOS ONE			English	Article							VP2 PROTEIN; VACCINE; IMMUNIZATION; RESPONSES	In order to overcome the limitations of conventional vaccines for infectious bursal disease virus (IBDV), we constructed recombinant dual expression system baculoviruses with VP2 and VP2/4/3, the main protective antigens of IBDV. We compared the immune effects of the baculoviruses in avian cells and detected their control effects on chickens with infectious bursal disease. We used Western blot analysis to measure VP2 protein and VP2/4/3 polyprotein expression in avian cells infected using the Bac-to-Bac baculovirus expression system. The recombinant baculoviruses were used to vaccinate specific pathogen-free chickens, which produced specific protective antibodies and strong cellular immune responses. The results of the virus challenge experiment revealed that the protective efficiency of VP2 and VP2/4/3 virus vaccines were 95.8% and 100%, respectively, both of which were higher than the vaccine group (87.5%), and significantly higher than the control group (50%). The results demonstrated that the immune effect of BV-S-ITRs-VP2/4/3 was superior to that of BV-S-ITRs-VP2. Compared with traditional attenuated vaccine and genetically engineered live vector vaccine, the dual expression viral vector vaccine has good bio-safety. The results of this study provide a foundation for the further development of poultry vaccines, in addition to providing a useful reference for developing non-replicating live vaccines against other viral diseases.	[Ge, Jingping; An, Qi; Song, Shanshan; Gao, Dongni; Ping, Wenxiang] Heilongjiang Univ, Key Lab Microbiol, Coll Life Sci, Harbin 150080, Peoples R China	Heilongjiang University	Ping, WX (corresponding author), Heilongjiang Univ, Key Lab Microbiol, Coll Life Sci, Harbin 150080, Peoples R China.	wenxiangp@aliyun.com			National Natural Science Foundation of China [31470537, 31270534, 31270143]; National Science Foundation for Distinguished Young Scholars of China [31300355]; High-level Talents (Innovation Team) Projects of Heilongjiang University [Hdtd2010-17]; Innovation Team in Science and Technology of Heilongjiang Province (the Fermentation Technology of Agricultural Microbiology) [2012td009]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Foundation for Distinguished Young Scholars of China(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); High-level Talents (Innovation Team) Projects of Heilongjiang University; Innovation Team in Science and Technology of Heilongjiang Province (the Fermentation Technology of Agricultural Microbiology)	This work was supported by grants from the National Natural Science Foundation of China (31470537), the National Natural Science Foundation of China (31270534), the National Natural Science Foundation of China (31270143), the National Science Foundation for Distinguished Young Scholars of China (31300355), the High-level Talents (Innovation Team) Projects of Heilongjiang University (Hdtd2010-17), and the Innovation Team in Science and Technology of Heilongjiang Province (the Fermentation Technology of Agricultural Microbiology, 2012td009).	Cheng Tong, 2007, Sheng Wu Gong Cheng Xue Bao, V23, P546; Francois A, 2004, VACCINE, V22, P2351, DOI 10.1016/j.vaccine.2003.10.039; He F, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-238; Hu YC, 2008, CURR GENE THER, V8, P54, DOI 10.2174/156652308783688509; Huang ZH, 2004, J VIROL, V78, P10054, DOI 10.1128/JVI.78.18.10054-10063.2004; Li JR, 2003, VIRUS RES, V98, P63, DOI 10.1016/j.virusres.2003.08.017; Li YM, 2009, J GENE MED, V11, P57, DOI 10.1002/jgm.1271; Mahonen AJ, 2007, J BIOTECHNOL, V131, P1, DOI 10.1016/j.jbiotec.2007.05.022; Mao Qun-ying, 2012, Chinese Journal of Biologicals, V25, P725; Muller H, 2012, AVIAN PATHOL, V41, P133, DOI 10.1080/03079457.2012.661403; Muller H, 2003, VET MICROBIOL, V97, P153, DOI 10.1016/j.vetmic.2003.08.005; Mundt E, 2003, VACCINE, V21, P4616, DOI 10.1016/S0264-410X(03)00448-1; Pradhan SN, 2012, VET IMMUNOL IMMUNOP, V148, P293, DOI 10.1016/j.vetimm.2012.06.019; RONG J, 2002, VACCINE, V23, P4822; Sakaguchi M, 1998, VACCINE, V16, P472, DOI 10.1016/S0264-410X(97)80001-1; Song KH, 2000, ACTA BIOCH BIOPH SIN, V32, P281; TUKAMOTO K, 2002, VIROLOGY, V76, P5637; Xu XG, 2011, AVIAN DIS, V55, P223, DOI 10.1637/9597-111210-Reg.1; Yuwen YQ, 2008, AVIAN DIS, V52, P284, DOI 10.1637/8175-111707-Reg.1	19	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0132993	10.1371/journal.pone.0132993	http://dx.doi.org/10.1371/journal.pone.0132993			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26167907	Green Published, gold			2022-12-26	WOS:000358193100100
J	Martinez-Olivan, J; Fraga, H; Arias-Moreno, X; Ventura, S; Sancho, J				Martinez-Olivan, Juan; Fraga, Hugo; Arias-Moreno, Xabier; Ventura, Salvador; Sancho, Javier			Intradomain Confinement of Disulfides in the Folding of Two Consecutive Modules of the LDL Receptor	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN RECEPTOR; LIGAND-BINDING DOMAIN; CYSTEINE-RICH REPEAT; FAMILIAL HYPERCHOLESTEROLEMIA; 3-DIMENSIONAL STRUCTURE; DIFFERENT PROTEINS; BACKBONE DYNAMICS; HUMAN FIBROBLASTS; NMR STRUCTURE; CHOLESTEROL	The LDL receptor internalizes circulating LDL and VLDL particles for degradation. Its extracellular binding domain contains ten (seven LA and three EGF) cysteine-rich modules, each bearing three disulfide bonds. Despite the enormous number of disulfide combinations possible, LDLR oxidative folding leads to a single native species with 30 unique intradomain disulfides. Previous folding studies of the LDLR have shown that non native disulfides are initially formed that lead to compact species. Accordingly, the folding of the LDLR has been described as a "coordinated nonvectorial" reaction, and it has been proposed that early compaction funnels the reaction toward the native structure. Here we analyze the oxidative folding of LA4 and LA5, the modules critical for ApoE binding, isolated and in the LA45 tandem. Compared to LA5, LA4 folding is slow and inefficient, resembling that of LA5 disease-linked mutants. Without Ca++, it leads to a mixture of many two-disulfide scrambled species and, with Ca++, to the native form plus two three-disulfide intermediates. The folding of the LA45 tandem seems to recapitulate that of the individual repeats. Importantly, although the folding of the LA45 tandem takes place through formation of scrambled isomers, no interdomain disulfides are detected, i.e. the two adjacent modules fold independently without the assistance of interdomain covalent interactions. Reduction of incredibly large disulfide combinatorial spaces, such as that in the LDLR, by intradomain confinement of disulfide bond formation might be also essential for the efficient folding of other homologous disulfide-rich receptors.	[Martinez-Olivan, Juan; Arias-Moreno, Xabier; Sancho, Javier] Univ Zaragoza, Biocomputat & Complex Syst Phys Inst BIFI, Joint Unit BIFI IQFR, CSIC, Zaragoza, Spain; [Martinez-Olivan, Juan; Arias-Moreno, Xabier; Sancho, Javier] Univ Zaragoza, Dept Bioquim & Biol Mol & Cellular, Zaragoza, Spain; [Fraga, Hugo; Ventura, Salvador] Univ Autonoma Barcelona, Inst Biotecnol & Biomed, Bellaterra, Spain; [Fraga, Hugo; Ventura, Salvador] Univ Autonoma Barcelona, Dept Bioquim & Biol Mol, Bellaterra, Spain; [Fraga, Hugo] Univ Porto, Fac Med, Dept Bioquim, P-4100 Oporto, Portugal	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR); University of Zaragoza; University of Zaragoza; Autonomous University of Barcelona; Autonomous University of Barcelona; Universidade do Porto	Ventura, S (corresponding author), Univ Zaragoza, Biocomputat & Complex Syst Phys Inst BIFI, Joint Unit BIFI IQFR, CSIC, Zaragoza, Spain.	salvador.ventura@uab.es; jsancho@unizar.es	Sancho, javier/AAA-1225-2019; Mobli, Mehdi/O-7244-2014; MORENO, XABIER ARIAS/AAA-1176-2021; Ventura, Salvador/AAY-3170-2021; Ventura, Salvador/C-7021-2008; Fraga, Hugo/X-4850-2019	Sancho, javier/0000-0002-2879-9200; Mobli, Mehdi/0000-0003-2420-4262; MORENO, XABIER ARIAS/0000-0001-8601-9092; Ventura, Salvador/0000-0002-9652-6351; Ventura, Salvador/0000-0002-9652-6351; Fraga, Hugo/0000-0001-7677-4086	Ministerio de Ciencia e Innovacion (Spain) [BFU2010-14901, BFU2010-16297]; MINECO (Spain) [BFU2013-47064-P, BFU2013-44763-P]; AGAUR (Generalitat de Catalunya) [2009-SGR-760]; Diputacion General de Aragon, Spain [PI078/08]; Investigador FCT starting grant, Portugal	Ministerio de Ciencia e Innovacion (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); MINECO (Spain)(Spanish Government); AGAUR (Generalitat de Catalunya)(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)Generalitat de Catalunya); Diputacion General de Aragon, Spain(Gobierno de Aragon); Investigador FCT starting grant, Portugal	The authors acknowledge financial support from grants BFU2010-14901 and BFU2010-16297 from Ministerio de Ciencia e Innovacion (Spain), BFU2013-47064-P and BFU2013-44763-P from MINECO (Spain), 2009-SGR-760 from AGAUR (Generalitat de Catalunya) and PI078/08 from (Diputacion General de Aragon, Spain). HF has been granted an Investigador FCT starting grant, Portugal.	Arias-Moreno X, 2008, J BIOL CHEM, V283, P22670, DOI 10.1074/jbc.M802153200; Arias-Moreno X, 2008, J BIOL CHEM, V283, P13627, DOI 10.1074/jbc.M800755200; Beglova N, 2001, BIOCHEMISTRY-US, V40, P2808, DOI 10.1021/bi0027276; BROWN MS, 1975, J CLIN INVEST, V55, P783, DOI 10.1172/JCI107989; BROWN MS, 1976, SCIENCE, V191, P150, DOI 10.1126/science.174194; Cheek S, 2006, J MOL BIOL, V359, P215, DOI 10.1016/j.jmb.2006.03.017; DALY NL, 1995, BIOCHEMISTRY-US, V34, P14474, DOI 10.1021/bi00044a025; DALY NL, 1995, P NATL ACAD SCI USA, V92, P6334, DOI 10.1073/pnas.92.14.6334; ESSER V, 1988, J BIOL CHEM, V263, P13282; Fass D, 1997, NATURE, V388, P691, DOI 10.1038/41798; Fass D, 2012, ANNU REV BIOPHYS, V41, P63, DOI 10.1146/annurev-biophys-050511-102321; Fisher C, 2004, BIOCHEMISTRY-US, V43, P1037, DOI 10.1021/bi035529y; Fisher C, 2006, MOL CELL, V22, P277, DOI 10.1016/j.molcel.2006.02.021; FLORY PJ, 1956, J AM CHEM SOC, V78, P5222, DOI 10.1021/ja01601a025; Fraga H, 2014, ANTIOXID REDOX SIGN, V21, P368, DOI 10.1089/ars.2013.5543; Gerasimenko JV, 1998, CURR BIOL, V8, P1335, DOI 10.1016/S0960-9822(07)00565-9; Go Gwang-woong, 2012, Yale Journal of Biology and Medicine, V85, P19; GOLDSTEIN JL, 1974, J BIOL CHEM, V249, P5153; Guttman M, 2011, BIOCHEMISTRY-US, V50, P11001, DOI 10.1021/bi2014486; Guttman M, 2010, BIOCHEMISTRY-US, V49, P1207, DOI 10.1021/bi9017208; Hogg PJ, 2003, TRENDS BIOCHEM SCI, V28, P210, DOI 10.1016/S0968-0004(03)00057-4; Huang S, 2010, J LIPID RES, V51, P297, DOI 10.1194/jlr.M000422; Jansens A, 2002, SCIENCE, V298, P2401, DOI 10.1126/science.1078376; Jeon H, 2005, ANNU REV BIOCHEM, V74, P535, DOI 10.1146/annurev.biochem.74.082803.133354; Jeon H, 2001, NAT STRUCT BIOL, V8, P499, DOI 10.1038/88556; Kurniawan ND, 2000, PROTEIN SCI, V9, P1282, DOI 10.1110/ps.9.7.1282; Kurniawan ND, 2001, J MOL BIOL, V311, P341, DOI 10.1006/jmbi.2001.4867; Levinthal C., 1969, MOSSB SPECTR BIOL SY, P22; Martinez-Olivan J, 2014, FEBS J, V281, P2638, DOI 10.1111/febs.12811; Martinez-Olivan J, 2014, FEBS J, V281, P1534, DOI 10.1111/febs.12721; North CL, 2000, BIOCHEMISTRY-US, V39, P2564, DOI 10.1021/bi992087a; Oka OBV, 2013, MOL CELL, V50, P793, DOI 10.1016/j.molcel.2013.05.014; Pena F, 2010, J BIOL CHEM, V285, P8656, DOI 10.1074/jbc.M110.105718; Ranganathan S, 2011, J NEUROSCI, V31, P10836, DOI 10.1523/JNEUROSCI.5065-10.2011; Rudenko G, 2002, SCIENCE, V298, P2353, DOI 10.1126/science.1078124; RUSSELL DW, 1989, J BIOL CHEM, V264, P21682; Sherwood MW, 2007, P NATL ACAD SCI USA, V104, P5674, DOI 10.1073/pnas.0700951104; SUDHOF TC, 1985, SCIENCE, V228, P815, DOI 10.1126/science.2988123; Wilkins MR, 1999, METH MOL B, V112, P531; Willnow TE, 1999, NAT CELL BIOL, V1, pE157, DOI 10.1038/14109; Zhao ZZ, 2011, BBA-MOL CELL BIOL L, V1811, P397, DOI 10.1016/j.bbalip.2011.04.002	41	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0132141	10.1371/journal.pone.0132141	http://dx.doi.org/10.1371/journal.pone.0132141			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26168158	Green Published, Green Submitted, gold			2022-12-26	WOS:000358193100023
J	Viales, RR; Eichstaedt, CA; Ehlken, N; Fischer, C; Lichtblau, M; Grunlg, E; Hinderhofer, K				Viales, Rebecca Rodriguez; Eichstaedt, Christina A.; Ehlken, Nicola; Fischer, Christine; Lichtblau, Mona; Gruenlg, Ekkehard; Hinderhofer, Katrin			Mutation in BMPR2 Promoter: A 'Second Hit' for Manifestation of Pulmonary Arterial Hypertension?	PLOS ONE			English	Article							DOMINANT RETINITIS-PIGMENTOSA; INCOMPLETE PENETRANCE; EXERCISE; GENE; POLYMORPHISM; GENOMICS; MODIFIER; FORMS; D85N	Background Hereditary pulmonary arterial hypertension (HPAH) can be caused by autosomal dominant inherited mutations of TGF-beta genes, such as the bone morphogenetic protein receptor 2 (BMPR2) and Endoglin (ENG) gene. Additional modifier genes may play a role in disease manifestation and severity. In this study we prospectively assessed two families with known BMPR2 or ENG mutations clinically and genetically and screened for a second mutation in the BMPR2 promoter region. Methods We investigated the BMPR2 promoter region by direct sequencing in two index-patients with invasively confirmed diagnosis of HPAH, carrying a mutation in the BMPR2 and ENG gene, respectively. Sixteen family members have been assessed clinically by non-invasive methods and genetically by direct sequencing. Results In both index patients with a primary BMPR2 deletion (exon 2 and 3) and Endoglin missense variant (c. 1633G> A, p.(G545S)), respectively, we detected a second mutation (c.669G> A) in the promoter region of the BMPR2 gene. The index patients with 2 mutations/ variants were clinically severely affected at early age, whereas further family members with only one mutation had no manifest HPAH. Conclusion The finding of this study supports the hypothesis that additional mutations may lead to an early and severe manifestation of HPAH. This study shows for the first time that in the regulatory region of the BMPR2 gene the promoter may be important for disease penetrance.Further studies are needed to assess the incidence and clinical relevance of mutations of the BMPR2 promoter region in a larger patient cohort.	[Viales, Rebecca Rodriguez; Eichstaedt, Christina A.; Ehlken, Nicola; Lichtblau, Mona; Gruenlg, Ekkehard] Univ Heidelberg Hosp, Ctr Pulm Hypertens, Thoraxclin Heidelberg, Heidelberg, Germany; [Viales, Rebecca Rodriguez; Fischer, Christine; Hinderhofer, Katrin] Heidelberg Univ, Inst Human Genet, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Hinderhofer, K (corresponding author), Heidelberg Univ, Inst Human Genet, Heidelberg, Germany.	Katrin.Hinderhofer@med.uni-heidelberg.de	Benjamin, Nicola/AAJ-4360-2021	Lichtblau, Mona/0000-0003-4485-1758; Rodriguez Viales, Rebecca/0000-0003-3739-7438				Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Aldred MA, 2007, AM J RESP CRIT CARE, V176, P819, DOI 10.1164/rccm.200701-164OC; Austin ED, 2013, SEMIN RESP CRIT CARE, V34, P568, DOI 10.1055/s-0033-1355443; Austin ED, 2012, CIRC-CARDIOVASC GENE, V5, P336, DOI 10.1161/CIRCGENETICS.111.961888; Brakensiek K, 2008, CLIN GENET, V74, P171, DOI 10.1111/j.1399-0004.2008.01029.x; Chaouat A, 2004, THORAX, V59, P446, DOI 10.1136/thx.2003.11890; Cogan JD, 2006, AM J RESP CRIT CARE, V174, P590, DOI 10.1164/rccm.200602-165OC; De Cruz R, 2012, BRIT J DERMATOL, V166, P20, DOI 10.1111/j.1365-2133.2012.10861.x; Dunmore BJ, 2013, HUM MOL GENET, V22, P3667, DOI 10.1093/hmg/ddt216; Eyries M, 2014, NAT GENET, V46, P65, DOI 10.1038/ng.2844; Giudicessi JR, 2013, TRANSL RES, V161, P1, DOI 10.1016/j.trsl.2012.08.005; Grunig E, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3883; Grunig E, 2012, EUR RESPIR J, V40, P84, DOI 10.1183/09031936.00123711; Grunig E, 2011, RESPIRATION, V81, P394, DOI 10.1159/000322475; Grunig E, 2009, CIRCULATION, V119, P1747, DOI 10.1161/CIRCULATIONAHA.108.800938; Hamid R, 2009, HUM MUTAT, V30, P649, DOI 10.1002/humu.20922; Hasegawa K, 2014, J ARRYTHM, V30, P161, DOI 10.1016/j.joa.2013.08.004; Hinderhofer K, 2013, PLOS ONE UNDER MINOR; Hinderhofer K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091374; Kapplinger JD, 2009, HEART RHYTHM, V6, P1297, DOI 10.1016/j.hrthm.2009.05.021; Lahtinen AM, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-11; Layeneziana P, 2014, EUR RESPIR J, V44, P1069, DOI 10.1183/09031936.00088914; LOYD JE, 1995, AM J RESP CRIT CARE, V152, P93, DOI 10.1164/ajrccm.152.1.7599869; LOYD JE, 1984, AM REV RESPIR DIS, V129, P194; Ma L, 2013, NEW ENGL J MED, V369, P351, DOI 10.1056/NEJMoa1211097; Machado RD, 2009, J AM COLL CARDIOL, V54, pS32, DOI 10.1016/j.jacc.2009.04.015; Machado RD, 2001, AM J HUM GENET, V68, P92, DOI 10.1086/316947; Maloney JP, 2012, AM J PHYSIOL-LUNG C, V302, pL541, DOI 10.1152/ajplung.00282.2011; Mathe E, 2006, NUCLEIC ACIDS RES, V34, P1317, DOI 10.1093/nar/gkj518; Maubaret CG, 2011, INVEST OPHTH VIS SCI, V52, P9304, DOI 10.1167/iovs.11-8372; Pfarr N, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-99; Phillips JA, 2008, GENET MED, V10, P359, DOI 10.1097/GIM.0b013e318172dcdf; Pousada G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100261; Rabinovitch M, 2012, J CLIN INVEST, V122, P4306, DOI 10.1172/JCI60658; Remillard CV, 2007, AM J PHYSIOL-CELL PH, V292, pC1837, DOI 10.1152/ajpcell.00405.2006; Rosenzweig EB, 2008, J HEART LUNG TRANSPL, V27, P668, DOI 10.1016/j.healun.2008.02.009; Saini S, 2012, EXP EYE RES, V104, P82, DOI 10.1016/j.exer.2012.09.010; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Shintani M, 2009, J MED GENET, V46, P331, DOI 10.1136/jmg.2008.062703; Simonneau G, 2009, J AM COLL CARDIOL, V54, pS43, DOI [10.1016/j.jacc.2009.04.012, 10.1016/j.jacc.2013.10.029]; Soubrier F, 2013, J AM COLL CARDIOL, V62, pD13, DOI 10.1016/j.jacc.2013.10.035; Tester DJ, 2005, HEART RHYTHM, V2, P507, DOI 10.1016/j.hrthm.2005.01.020; Trembath R. C., 2001, Journal of Heart and Lung Transplantation, V20, P175, DOI 10.1016/S1053-2498(00)00352-1; Upton PD, 2009, J BIOL CHEM, V284, P15794, DOI 10.1074/jbc.M109.002881; Velankar S, 2013, NUCLEIC ACIDS RES, V41, pD483, DOI 10.1093/nar/gks1258; Wang GL, 2014, INT J CARDIOL, V177, pE167, DOI 10.1016/j.ijcard.2014.08.124; Wang H, 2009, EUR J HUM GENET, V17, P1063, DOI 10.1038/ejhg.2009.3; Westenskow P, 2004, CIRCULATION, V109, P1834, DOI 10.1161/01.CIR.0000125524.34234.13; Wooderchak-Donahue WL, 2013, AM J HUM GENET, V93, P530, DOI 10.1016/j.ajhg.2013.07.004	49	14	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0133042	10.1371/journal.pone.0133042	http://dx.doi.org/10.1371/journal.pone.0133042			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26167679	Green Published, gold, Green Submitted			2022-12-26	WOS:000358193100106
J	Zhou, B; Lindsay, SA; Wasserman, SA				Zhou, Bo; Lindsay, Scott A.; Wasserman, Steven A.			Alternative NF-kappa B Isoforms in the Drosophila Neuromuscular Junction and Brain	PLOS ONE			English	Article							REGULATED NUCLEAR IMPORT; IMMUNE-RESPONSE; DORSOVENTRAL PATTERN; DORSAL PROTEIN; REL PROTEINS; CACTUS; LOCALIZATION; DIF; MELANOGASTER; GENE	The Drosophila NF-kappa B protein Dorsal is expressed at the larval neuromuscular junction, where its expression appears unrelated to known Dorsal functions in embryonic patterning and innate immunity. Using confocal microscopy with domain-specific antisera, we demonstrate that larval muscle expresses only the B isoform of Dorsal, which arises by intron retention. We find that Dorsal B interacts with and stabilizes Cactus at the neuromuscular junction, but exhibits Cactus independent localization and an absence of detectable nuclear translocation. We further find that the Dorsal-related immune factor Dif encodes a B isoform, reflecting a conservation of B domains across a range of insect NF-kappa B proteins. Carrying out mutagenesis of the Dif locus via a site-specific recombineering approach, we demonstrate that Dif B is the major, if not sole, Dif isoform in the mushroom bodies of the larval brain. The Dorsal and Dif B isoforms thus share a specific association with nervous system tissues as well as an alternative protein structure.	[Zhou, Bo; Lindsay, Scott A.; Wasserman, Steven A.] Univ Calif San Diego, Div Biol Sci, Sect Cell & Dev Biol, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Wasserman, SA (corresponding author), Univ Calif San Diego, Div Biol Sci, Sect Cell & Dev Biol, La Jolla, CA 92093 USA.	stevenw@ucsd.edu			National Institutes of Health [RO1 GM050545]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050545] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health, grant RO1 GM050545 to SW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAEUERLE PA, 1988, CELL, V53, P211, DOI 10.1016/0092-8674(88)90382-0; BELVIN MP, 1995, GENE DEV, V9, P783, DOI 10.1101/gad.9.7.783; Belvin MP, 1996, ANNU REV CELL DEV BI, V12, P393, DOI 10.1146/annurev.cellbio.12.1.393; Beremendi A, 2005, NEUROSCIENCE, V134, P397, DOI 10.1016/j.neuroscience.2005.04.046; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Bolatto C, 2003, J NEUROBIOL, V54, P525, DOI 10.1002/neu.10179; Brown JB, 2014, NATURE, V512, P393, DOI 10.1038/nature12962; Budnik V, 1996, NEURON, V17, P627, DOI 10.1016/S0896-6273(00)80196-8; Cammarato A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018497; Cantera R, 1999, J NEUROBIOL, V38, P16, DOI 10.1002/(SICI)1097-4695(199901)38:1<16::AID-NEU2>3.0.CO;2-0; Cantera R, 1999, MOL CELL NEUROSCI, V13, P131, DOI 10.1006/mcne.1999.0739; GEISLER R, 1992, CELL, V71, P613, DOI 10.1016/0092-8674(92)90595-4; GHOSH S, 1990, CELL, V62, P1019, DOI 10.1016/0092-8674(90)90276-K; GILLESPIE SKH, 1994, MOL CELL BIOL, V14, P3559, DOI 10.1128/MCB.14.6.3559; Govind S, 1996, MOL CELL BIOL, V16, P1103; GOVIND S, 1993, DEVELOPMENT, V117, P135; Gross I, 1999, GENE, V228, P233, DOI 10.1016/S0378-1119(98)00595-2; Heckscher ES, 2007, NEURON, V55, P859, DOI 10.1016/j.neuron.2007.08.005; IP YT, 1993, CELL, V75, P753, DOI 10.1016/0092-8674(93)90495-C; JAN LY, 1982, P NATL ACAD SCI-BIOL, V79, P2700, DOI 10.1073/pnas.79.8.2700; KIDD S, 1992, CELL, V71, P623, DOI 10.1016/0092-8674(92)90596-5; Kosugi S, 2009, J BIOL CHEM, V284, P478, DOI 10.1074/jbc.M807017200; Kumar V, 2009, MOL BIOL CELL, V20, P2254, DOI 10.1091/mbc.E08-10-1072; Li Q, 2007, NAT REV NEUROSCI, V8, P819, DOI 10.1038/nrn2237; Lindsay SA, 2014, DEV COMP IMMUNOL, V42, P16, DOI 10.1016/j.dci.2013.04.011; Manfruelli P, 1999, EMBO J, V18, P3380, DOI 10.1093/emboj/18.12.3380; Meng XJ, 1999, GENE DEV, V13, P792, DOI 10.1101/gad.13.7.792; Ni JQ, 2011, NAT METHODS, V8, P405, DOI [10.1038/NMETH.1592, 10.1038/nmeth.1592]; Nusslein-Volhard C., 1979, MATERNAL EFFECT MUTA; Paschinger K, 2009, GLYCOCONJUGATE J, V26, P385, DOI 10.1007/s10719-008-9155-3; Razzaq A, 2001, GENE DEV, V15, P2967, DOI 10.1101/gad.207801; Reach M, 1996, DEV BIOL, V180, P353, DOI 10.1006/dbio.1996.0308; REICHHART JM, 1993, CR ACAD SCI III-VIE, V316, P1218; ROTH S, 1989, CELL, V59, P1189, DOI 10.1016/0092-8674(89)90774-5; RUSHLOW CA, 1989, CELL, V59, P1165, DOI 10.1016/0092-8674(89)90772-1; Rutschmann S, 2000, IMMUNITY, V12, P569, DOI 10.1016/S1074-7613(00)80208-3; SCHUPBACH T, 1989, GENETICS, V121, P101; SCOTT ML, 1993, GENE DEV, V7, P1266, DOI 10.1101/gad.7.7a.1266; Shin SW, 2005, J BIOL CHEM, V280, P16499, DOI 10.1074/jbc.M500711200; St Johnston D, 2013, WIRES DEV BIOL, V2, P587, DOI 10.1002/wdev.101; STEWARD R, 1989, CELL, V59, P1179, DOI 10.1016/0092-8674(89)90773-3; STEWARD R, 1987, SCIENCE, V238, P692, DOI 10.1126/science.3118464; TATEI K, 1995, MOL CELL BIOL, V15, P3627; Thomas U, 2000, CURR BIOL, V10, P1108, DOI 10.1016/S0960-9822(00)00696-5; Ursic-Bedoya R, 2009, INSECT MOL BIOL, V18, P681, DOI 10.1111/j.1365-2583.2009.00909.x; Venken KJT, 2007, DEVELOPMENT, V134, P3571, DOI 10.1242/dev.005686; Venken KJT, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn486; Wang W, 2011, DEV BIOL, V350, P414, DOI 10.1016/j.ydbio.2010.12.002; WHALEN AM, 1993, J CELL BIOL, V123, P523, DOI 10.1083/jcb.123.3.523; Wu LP, 1998, NATURE, V392, P93, DOI 10.1038/32195	50	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0132793	10.1371/journal.pone.0132793	http://dx.doi.org/10.1371/journal.pone.0132793			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26167685	Green Published, gold			2022-12-26	WOS:000358193100082
J	Al-Ahmad, A; Bucher, M; Anderson, AC; Tennert, C; Hellwig, E; Wittmer, A; Vach, K; Karygianni, L				Al-Ahmad, A.; Bucher, M.; Anderson, A. C.; Tennert, C.; Hellwig, E.; Wittmer, A.; Vach, K.; Karygianni, L.			Antimicrobial Photoinactivation Using Visible Light Plus Water-Filtered Infrared-A (VIS plus wIRA) Alters In Situ Oral Biofilms	PLOS ONE			English	Article							PHOTODYNAMIC THERAPY; FUSOBACTERIUM-NUCLEATUM; METHYLENE-BLUE; CLINICAL-TRIAL; IRRADIATION; BACTERIA; VIVO; HYBRIDIZATION; COMMUNICATION; INFECTIONS	Recently, growing attention has been paid to antimicrobial photodynamic therapy (aPDT) in dentistry. Changing the microbial composition of initial and mature oral biofilm by aPDT using visible light plus water-filtered infrared-A wavelengths (VIS + wIRA) has not yet been investigated. Moreover, most aPDT studies have been conducted on planktonic bacterial cultures. Therefore, in the present clinical study we cultivated initial and mature oral biofilms in six healthy volunteers for 2 hours or 3 days, respectively. The biofilms were treated with aPDT using VIS+wIRA (200 mW cm(-2)), toluidine blue (TB) and chlorine e6 (Ce6) for 5 minutes. Chlorhexidine treated biofilm samples served as positive controls, while untreated biofilms served as negative controls. After aPDT treatment the colony forming units (CFU) of the biofilm samples were quantified, and the surviving bacteria were isolated in pure cultures and identified using MALDI-TOF, biochemical tests and 16S rDNA-sequencing. aPDT killed more than 99.9% of the initial viable bacterial count and 95% of the mature oral biofilm in situ, independent of the photosensitizer. The number of surviving bacterial species was highly reduced to 6 (TB) and 4 (Ce6) in the treated initial oral biofilm compared to the 20 different species of the untreated biofilm. The proportions of surviving bacterial species were also changed after TB-and Ce6-mediated aPDT of the mature oral biofilm, resulting in a shift in the microbial composition of the treated biofilm compared to that of the control biofilm. In conclusion, aPDT using VIS + wIRA showed a remarkable potential to eradicate both initial and mature oral biofilms, and also to markedly alter the remaining biofilm. This encourages the clinical use of aPDT with VIS + wIRA for the treatment of periimplantitis and periodontitis.	[Al-Ahmad, A.; Bucher, M.; Anderson, A. C.; Tennert, C.; Hellwig, E.; Karygianni, L.] Univ Freiburg, Ctr Dent Med, Dept Operat Dent & Periodontol, D-79106 Freiburg, Germany; [Wittmer, A.] Univ Freiburg, Inst Med Microbiol & Hyg, D-79106 Freiburg, Germany; [Vach, K.] Univ Freiburg, Ctr Med Biometry & Med Informat, Inst Med Biometry & Stat, D-79106 Freiburg, Germany	University of Freiburg; University of Freiburg; University of Freiburg	Al-Ahmad, A (corresponding author), Univ Freiburg, Ctr Dent Med, Dept Operat Dent & Periodontol, Hugstetter Str 55, D-79106 Freiburg, Germany.	ali.al-ahmad@uniklinik-freiburg.de	Vach, Kirstin/AAI-4643-2020; Vach, Kirstin/GQP-0449-2022	Vach, Kirstin/0000-0001-9278-2203; Vach, Kirstin/0000-0001-9278-2203	Swiss Dr. Braun Science Foundation; German Research Foundation (DFG) [AL 1179/2-1]	Swiss Dr. Braun Science Foundation; German Research Foundation (DFG)(German Research Foundation (DFG))	This study was supported by the Swiss Dr. Braun Science Foundation and in part by the German Research Foundation (DFG, AL 1179/2-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Ahmad A, 2013, ARCH ORAL BIOL, V58, P1139, DOI 10.1016/j.archoralbio.2013.04.011; Al-Ahmad A, 2013, J MED MICROBIOL, V62, P467, DOI 10.1099/jmm.0.048843-0; Al-Ahmad A, 2007, J MED MICROBIOL, V56, P681, DOI 10.1099/jmm.0.47094-0; Al-Ahmad A, 2009, J MED MICROBIOL, V58, P1359, DOI 10.1099/jmm.0.011213-0; Anderson AC, 2014, BMC MICROBIOL, V14, DOI 10.1186/s12866-014-0312-5; Anderson AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049576; Beighton D, 2009, Adv Dent Res, V21, P69, DOI 10.1177/0895937409335641; Chambless JD, 2006, APPL ENVIRON MICROB, V72, P2005, DOI 10.1128/AEM.72.3.2005-2013.2006; Cieplik F, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00405; Cieplik F, 2014, CLIN ORAL INVEST, V18, P1763, DOI 10.1007/s00784-013-1151-8; de Oliveira RR, 2007, J PERIODONTOL, V78, P965, DOI 10.1902/jop.2007.060494; Dewhirst FE, 2010, J BACTERIOL, V192, P5002, DOI 10.1128/JB.00542-10; Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002; Filoche S, 2010, J DENT RES, V89, P8, DOI 10.1177/0022034509351812; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Garcez AS, 2010, J ENDODONT, V36, P1463, DOI 10.1016/j.joen.2010.06.001; Griffen AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019051; Gursoy H, 2013, CLIN ORAL INVEST, V17, P1113, DOI 10.1007/s00784-012-0845-7; Hannig C, 2009, CLIN ORAL INVEST, V13, P123, DOI 10.1007/s00784-008-0243-3; Hartel M, 2006, BRIT J SURG, V93, P952, DOI 10.1002/bjs.5429; Hoffmann G, 2009, GMS HYG INFECT CONTR, V4, DOI 10.3205/dgkh000137; Jakubovics NS, 2010, MOL ORAL MICROBIOL, V25, P4, DOI 10.1111/j.2041-1014.2009.00563.x; Jori G, 2006, LASER SURG MED, V38, P468, DOI 10.1002/lsm.20361; Jung T, 2012, ANN NY ACAD SCI, V1259, P33, DOI 10.1111/j.1749-6632.2012.06581.x; Karygianni L, 2014, APPL ENVIRON MICROB, V80, P7324, DOI 10.1128/AEM.02490-14; Kharkwal GB, 2011, LASER SURG MED, V43, P755, DOI 10.1002/lsm.21080; Kolenbrander PE, 2006, PERIODONTOL 2000, V42, P47, DOI 10.1111/j.1600-0757.2006.00187.x; Kolenbrander PE, 2010, NAT REV MICROBIOL, V8, P471, DOI 10.1038/nrmicro2381; Kolenbrander PE, 2002, MICROBIOL MOL BIOL R, V66, P486, DOI 10.1128/MMBR.66.3.486-505.2002; Kunzli BM, 2013, ANN SURG, V258, P887, DOI 10.1097/SLA.0000000000000235; Kumar PS, 2006, J CLIN MICROBIOL, V44, P3665, DOI 10.1128/JCM.00317-06; Leprince J, 2010, OPER DENT, V35, P220, DOI 10.2341/09-203-L; Lewis K, 2001, ANTIMICROB AGENTS CH, V45, P999, DOI 10.1128/AAC.45.4.999-1007.2001; Liu B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037919; Madianos PN, 2005, J CLIN PERIODONTOL, V32, P57, DOI 10.1111/j.1600-051X.2005.00821.x; Moon YH, 2009, ONCOL REP, V22, P1085, DOI 10.3892/or_00000540; Nagata JY, 2012, PHOTODIAGN PHOTODYN, V9, P122, DOI 10.1016/j.pdpdt.2011.11.006; Nogueira AC, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.5.055004; Paul S, 2013, J FLUORESC, V23, P283, DOI 10.1007/s10895-012-1146-x; Piazena H, 2010, PHOTOCHEM PHOTOBIOL, V86, P687, DOI 10.1111/j.1751-1097.2010.00729.x; Rickard AH, 2003, TRENDS MICROBIOL, V11, P94, DOI 10.1016/S0966-842X(02)00034-3; Rickard AH, 2013, ORAL MICROBIAL ECOLOGY: CURRENT RESEARCH AND NEW PERSPECTIVES, P97; Sigusch BW, 2010, J PERIODONTOL, V81, P975, DOI 10.1902/jop.2010.090246; Usacheva MN, 2003, J PHOTOCH PHOTOBIO B, V71, P87, DOI 10.1016/j.jphotobiol.2003.06.002; Usacheva MN, 2001, LASER SURG MED, V29, P165, DOI 10.1002/lsm.1105; von Felbert V, 2010, BRIT J DERMATOL, V163, P607, DOI 10.1111/j.1365-2133.2010.09817.x; von Felbert Verena, 2008, GMS Krankenhhyg Interdiszip, V2, pDoc52; Voos AC, 2014, LASER SURG MED, V46, P235, DOI 10.1002/lsm.22217; Wainwright M, 2010, LETT APPL MICROBIOL, V50, P486, DOI 10.1111/j.1472-765X.2010.02825.x; Zijnge V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009321	50	22	23	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132107	10.1371/journal.pone.0132107	http://dx.doi.org/10.1371/journal.pone.0132107			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26162100	gold, Green Published, Green Submitted			2022-12-26	WOS:000358162300093
J	Gibson-Reinemer, DK; Rahel, FJ				Gibson-Reinemer, Daniel K.; Rahel, Frank J.			Inconsistent Range Shifts within Species Highlight Idiosyncratic Responses to Climate Warming	PLOS ONE			English	Article							ELEVATIONAL GRADIENT; DYNAMICS; IMPACTS; COMMUNITIES; MIGRATION	Climate in part determines species' distributions, and species' distributions are shifting in response to climate change. Strong correlations between the magnitude of temperature changes and the extent of range shifts point to warming temperatures as the single most influential factor causing shifts in species' distributions species. However, other abiotic and biotic factors may alter or even reverse these patterns. The importance of temperature relative to these other factors can be evaluated by examining range shifts of the same species in different geographic areas. When the same species experience warming in different geographic areas, the extent to which they show range shifts that are similar in direction and magnitude is a measure of temperature's importance. We analyzed published studies to identify species that have documented range shifts in separate areas. For 273 species of plants, birds, mammals, and marine invertebrates with range shifts measured in multiple geographic areas, 42-50% show inconsistency in the direction of their range shifts, despite experiencing similar warming trends. Inconsistency of within-species range shifts highlights how biotic interactions and local, non-thermal abiotic conditions may often supersede the direct physiological effects of temperature. Assemblages show consistent responses to climate change, but this predictability does not appear to extend to species considered individually.	Univ Wyoming, Program Ecol, Laramie, WY 82071 USA; Univ Wyoming, Dept Zool & Physiol, Laramie, WY 82071 USA	University of Wyoming; University of Wyoming	Gibson-Reinemer, DK (corresponding author), Illinois Nat Hist Survey, Havana, IL 62644 USA.	danielkgr@gmail.com						Araujo MB, 2011, ECOGRAPHY, V34, P897, DOI 10.1111/j.1600-0587.2011.06919.x; Archaux F, 2004, IBIS, V146, P138, DOI 10.1111/j.1474-919X.2004.00246.x; Bassler C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065842; Bodin J, 2013, J VEG SCI, V24, P269, DOI 10.1111/j.1654-1103.2012.01456.x; Boulangeat I, 2012, ECOL LETT, V15, P584, DOI 10.1111/j.1461-0248.2012.01772.x; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; Chen IC, 2009, P NATL ACAD SCI USA, V106, P1479, DOI 10.1073/pnas.0809320106; Comte L, 2013, ECOGRAPHY, V36, P1236, DOI 10.1111/j.1600-0587.2013.00282.x; Davis AJ, 1998, NATURE, V391, P783, DOI 10.1038/35842; Felde VA, 2012, ECOGRAPHY, V35, P922, DOI 10.1111/j.1600-0587.2011.07057.x; Foden W, 2007, DIVERS DISTRIB, V13, P245; Gibson-Reinemer DK, 2015, ECOL EVOL, V5, P2340, DOI 10.1002/ece3.1518; Graham RW, 1996, SCIENCE, V272, P1601; Hansen BB, 2013, SCIENCE, V339, P313, DOI 10.1126/science.1226766; Holzinger B, 2008, PLANT ECOL, V195, P179, DOI 10.1007/s11258-007-9314-9; IPCC, 2007, CLIMATE CHANGE 2007; Lenoir J, 2008, SCIENCE, V320, P1768, DOI 10.1126/science.1156831; Lenoir J, 2010, ECOGRAPHY, V33, P295, DOI 10.1111/j.1600-0587.2010.06279.x; MacArthur R.H., 1972, pvii; MORAN PAP, 1953, AUST J ZOOL, V1, P291, DOI 10.1071/ZO9530291; Moritz C, 2008, SCIENCE, V322, P261, DOI 10.1126/science.1163428; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 1999, NATURE, V399, P579, DOI 10.1038/21181; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Parolo G, 2008, BASIC APPL ECOL, V9, P100, DOI 10.1016/j.baae.2007.01.005; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Perry AL, 2005, SCIENCE, V308, P1912, DOI 10.1126/science.1111322; Pinsky ML, 2013, SCIENCE, V341, P1239, DOI 10.1126/science.1239352; Pitt NR, 2010, MAR FRESHWATER RES, V61, P963, DOI 10.1071/MF09225; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Poloczanska ES, 2011, J EXP MAR BIOL ECOL, V400, P145, DOI 10.1016/j.jembe.2011.02.018; Popy S, 2010, J BIOGEOGR, V37, P57, DOI 10.1111/j.1365-2699.2009.02197.x; Post E, 2002, NATURE, V420, P168, DOI 10.1038/nature01064; Przeslawski R, 2012, ESTUAR COAST SHELF S, V113, P205, DOI 10.1016/j.ecss.2012.08.005; R Core Development Team, 2013, R LANG ENV STAT COMP; Rowe RJ, 2010, GLOBAL CHANGE BIOL, V16, P2930, DOI 10.1111/j.1365-2486.2009.02150.x; Storlie C, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2014.0576; Suttle KB, 2007, SCIENCE, V315, P640, DOI 10.1126/science.1136401; Tingley MW, 2012, GLOBAL CHANGE BIOL, V18, P3279, DOI 10.1111/j.1365-2486.2012.02784.x; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Williams JW, 2007, FRONT ECOL ENVIRON, V5, P475, DOI 10.1890/070037	41	34	35	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132103	10.1371/journal.pone.0132103	http://dx.doi.org/10.1371/journal.pone.0132103			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26162013	Green Published, Green Submitted, gold			2022-12-26	WOS:000358162300092
J	Gong, Y; Li, J; Sun, Y; Fu, ZJ; Liu, CH; Evans, L; Tian, K; Saba, N; Fredrick, T; Morss, P; Chen, J; Smith, LEH				Gong, Yan; Li, Jie; Sun, Ye; Fu, Zhongjie; Liu, Chi-Hsiu; Evans, Lucy; Tian, Katherine; Saba, Nicholas; Fredrick, Thomas; Morss, Peyton; Chen, Jing; Smith, Lois E. H.			Optimization of an Image-Guided Laser-Induced Choroidal Neovascularization Model in Mice	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; MACULAR DEGENERATION; MURINE MODEL; AGE; ANGIOGENESIS; SEVERITY; DYSFUNCTION; MECHANISMS; MOUSE	The mouse model of laser-induced choroidal neovascularization (CNV) has been used in studies of the exudative form of age-related macular degeneration using both the conventional slit lamp and a new image-guided laser system. A standardized protocol is needed for consistent results using this model, which has been lacking. We optimized details of laser-induced CNV using the image-guided laser photocoagulation system. Four lesions with similar size were consistently applied per eye at approximately double the disc diameter away from the optic nerve, using different laser power levels, and mice of various ages and genders. After 7 days, the mice were sacrificed and retinal pigment epithelium/choroid/sclera was flat-mounted, stained with Isolectin B4, and imaged. Quantification of the area of the laser-induced lesions was performed using an established and constant threshold. Exclusion criteria are described that were necessary for reliable data analysis of the laser-induced CNV lesions. The CNV lesion area was proportional to the laser power levels. Mice at 12-16 weeks of age developed more severe CNV than those at 6-8 weeks of age, and the gender difference was only significant in mice at 12-16 weeks of age, but not in those at 6-8 weeks of age. Dietary intake of omega-3 long-chain polyunsaturated fatty acid reduced laser-induced CNV in mice. Taken together, laser-induced CNV lesions can be easily and consistently applied using the image-guided laser platform. Mice at 6-8 weeks of age are ideal for the laser-induced CNV model.	[Gong, Yan; Li, Jie; Sun, Ye; Fu, Zhongjie; Liu, Chi-Hsiu; Evans, Lucy; Tian, Katherine; Saba, Nicholas; Fredrick, Thomas; Morss, Peyton; Chen, Jing; Smith, Lois E. H.] Harvard Univ, Sch Med, Dept Ophthalmol, Boston Childrens Hosp, Boston, MA 02138 USA; [Li, Jie] Sichuan Prov Hosp, Dept Ophthalmol, Chengdu, Sichuan, Peoples R China; [Li, Jie] Sichuan Acad Med Sci, Chengdu, Sichuan, Peoples R China	Harvard University; Boston Children's Hospital; Harvard Medical School; Sichuan Provincial People's Hospital	Smith, LEH (corresponding author), Harvard Univ, Sch Med, Dept Ophthalmol, Boston Childrens Hosp, Boston, MA 02138 USA.	lois.smith@childrens.harvard.edu		Gong, Yan/0000-0002-4805-0459; Sun, Ye/0000-0002-7674-9056; FU, ZHONGJIE/0000-0002-8182-2983; Morss-Walton, Peyton/0000-0002-9200-9939	National Institutes of Health/National Eye Institute [R01 EY022275, R01 EY017017, P01 HD18655, R01 EY024963]; Lowy Medical Research Institute; European Commission FP7 [305485]; Ministry of Science and Technology, Taiwan, R.O.C. [104-2917-I-564-026]; China Scholarship Council [201306240082]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY022275, R01EY017017, R01EY024963] Funding Source: NIH RePORTER	National Institutes of Health/National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Lowy Medical Research Institute; European Commission FP7(European CommissionEuropean Commission Joint Research Centre); Ministry of Science and Technology, Taiwan, R.O.C.(Ministry of Science and Technology, Taiwan); China Scholarship Council(China Scholarship Council); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institutes of Health/National Eye Institute (https://www.nei.nih.gov/, R01 EY022275, R01 EY017017, P01 HD18655), Lowy Medical Research Institute (http://www.lmri.net/), European Commission FP7 (http://cordis.europa.eu/fp7/home_en.html) project 305485 PREVENT-ROP (LEHS), National Institutes of Health/National Eye Institute (https://www.nei.nih.gov/, R01 EY024963, JC), Ministry of Science and Technology, Taiwan, R.O.C. (http://www.most.gov.tw/mp.aspx?mp=7) Postdoctoral Research Abroad Program (104-2917-I-564-026, CHL), and China Scholarship Council (http://en.csc.edu.cn/) State Scholarship Fund (201306240082, JL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht ED, 2003, FRONT BIOSCI-LANDMRK, V8, pD416, DOI 10.2741/1001; Apte RS, 2006, PLOS MED, V3, P1371, DOI 10.1371/journal.pmed.0030310; Ashcroft GS, 2002, J CLIN INVEST, V110, P615, DOI 10.1172/JCI200215704; Connor KM, 2007, NAT MED, V13, P868, DOI 10.1038/nm1591; de Jong PTVM, 2006, NEW ENGL J MED, V355, P1474, DOI 10.1056/NEJMra062326; Espinosa-Heidmann DG, 2005, EXP EYE RES, V80, P413, DOI 10.1016/j.exer.2004.10.008; Espinosa-Heidmann DG, 2003, INVEST OPHTH VIS SCI, V44, P3586, DOI 10.1167/iovs.03-0038; Espinosa-Heidmann DG, 2002, INVEST OPHTH VIS SCI, V43, P1567; Framme C, 2008, OPHTHALMOLOGICA, V222, P254, DOI 10.1159/000136903; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P564; Garvin S, 2003, CANCER RES, V63, P8742; Giani A, 2011, INVEST OPHTH VIS SCI, V52, P3880, DOI 10.1167/iovs.10-6266; He Q, 2014, J BONE MINER RES, V29, P1217, DOI 10.1002/jbmr.2114; Imamura Y, 2006, P NATL ACAD SCI USA, V103, P11282, DOI 10.1073/pnas.0602131103; Jost M, 2007, AM J PATHOL, V171, P1369, DOI 10.2353/ajpath.2007.070074; Krzystolik MG, 2002, ARCH OPHTHALMOL-CHIC, V120, P338; Lambert V, 2013, NAT PROTOC, V8, P2197, DOI 10.1038/nprot.2013.135; Li J, 2014, INVEST OPHTH VIS SCI, V55, P8267, DOI 10.1167/iovs.14-15623; Moghaddam-Taaheri S., 2011, J CLIN EXP OPHTHALMO, V2; Nagai N, 2014, INVEST OPHTH VIS SCI, V55, P3709, DOI 10.1167/iovs.14-13989; Noel A, 2007, TRENDS MOL MED, V13, P345, DOI 10.1016/j.molmed.2007.06.005; Pennesi ME, 2012, MOL ASPECTS MED, V33, P487, DOI 10.1016/j.mam.2012.06.003; Poor SH, 2014, INVEST OPHTH VIS SCI, V55, P6525, DOI 10.1167/iovs.14-15067; Ryan S J, 1979, Trans Am Ophthalmol Soc, V77, P707; Sakurai E, 2003, INVEST OPHTH VIS SCI, V44, P3578, DOI 10.1167/iovs.03-0097; Shi YY, 2011, GRAEF ARCH CLIN EXP, V249, P1667, DOI 10.1007/s00417-011-1699-4; Tobe T, 1998, AM J PATHOL, V153, P1641, DOI 10.1016/S0002-9440(10)65753-7; Zhou JH, 2005, MOL VIS, V11, P414; Zhu YJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094743	29	50	54	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132643	10.1371/journal.pone.0132643	http://dx.doi.org/10.1371/journal.pone.0132643			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161975	Green Published, gold, Green Submitted			2022-12-26	WOS:000358162300164
J	Huang, ASE; Chen, WC; Huang, WT; Huang, ST; Lo, YC; Wei, SH; Kuo, HW; Chan, PC; Hung, MN; Liu, YL; Mu, JJ; Yang, JY; Liu, DP; Chou, JH; Chuang, JH; Chang, FY				Huang, Angela Song-En; Chen, Wan-Chin; Huang, Wan-Ting; Huang, Shih-Tse; Lo, Yi-Chun; Wei, Sung-Hsi; Kuo, Hung-Wei; Chan, Pei-Chun; Hung, Min-Nan; Liu, Yu-Lun; Mu, Jung-Jung; Yang, Jyh-Yuan; Liu, Ding-Ping; Chou, Jih-Haw; Chuang, Jen-Hsiang; Chang, Feng-Yee			Public Health Responses to Reemergence of Animal Rabies, Taiwan, July 16-December 28, 2013	PLOS ONE			English	Article							REAL-TIME PCR; VIRUS; ASSAY; TAQMAN; VACCINATION; INFECTION; DIAGNOSIS; DESIGN; DNA	Taiwan had been free of indigenous human and animal rabies case since canine rabies was eliminated in 1961. In July 2013, rabies was confirmed among three wild ferret-badgers, prompting public health response to prevent human rabies cases. This descriptive study reports the immediate response to the reemergence of rabies in Taiwan. Response included enhanced surveillance for human rabies cases by testing stored cerebrospinal fluids (CSF) from patients with encephalitides of unknown cause by RT-PCR, prioritizing vaccine use for postexposure prophylaxis (PEP) during periods of vaccine shortage and subsequent expansion of PEP, surveillance of animal bites using information obtained from vaccine application, roll out of preexposure prophylaxis (PrEP) with vaccine stock restoration, surveillance for adverse events following immunization (AEFI), and ensuring surge capacity to respond to general public inquiries by phone and training for healthcare professionals. Enhanced surveillance for human rabies found no cases after testing 205 stored CSF specimens collected during January 2010-July 2013. During July 16 to December 28, 2013, we received 8,241 rabies PEP application; 6,634 (80.5%) were consistent with recommendations. Among the 6,501persons who received at least one dose of rabies vaccine postexposure, 4,953 (76.2%) persons who were bitten by dogs; only 59 (0.9%) persons were bitten by ferret-badgers. During the study period, 6,247 persons received preexposure prophylaxis. There were 23 reports of AEFI; but no anaphylaxis, Guillain-Barre syndrome, or acute disseminated encephalomyelitis were found. During the study period, there were 40,312 calls to the Taiwan Centers for Disease Control hotline, of which, 8,692 (22%) were related to rabies. Recent identification of rabies among ferret-badgers in a previously rabies-free country prompted rapid response. To date, no human rabies has been identified. Continued multifaceted surveillance and interministerial collaboration are crucial to achieve the goal of rabies-free status in Taiwan.	[Huang, Angela Song-En; Chen, Wan-Chin; Huang, Wan-Ting; Huang, Shih-Tse; Lo, Yi-Chun; Wei, Sung-Hsi; Chan, Pei-Chun; Hung, Min-Nan; Liu, Yu-Lun] Ctr Dis Control, Off Prevent Med, Taipei, Taiwan; [Kuo, Hung-Wei; Liu, Ding-Ping] Ctr Dis Control, Epidem Intelligence Ctr, Taipei, Taiwan; [Mu, Jung-Jung; Yang, Jyh-Yuan] Ctr Dis Control, Ctr Res & Diagnost, Taipei, Taiwan; [Chou, Jih-Haw; Chuang, Jen-Hsiang] Ctr Dis Control, Off Deputy Director, Taipei, Taiwan; [Chang, Feng-Yee] Triserv Gen Hosp, Natl Def Med Ctr, Taipei, Taiwan	Centers For Disease Control - Taiwan; Centers For Disease Control - Taiwan; Centers For Disease Control - Taiwan; Centers For Disease Control - Taiwan; National Defense Medical Center; Tri-Service General Hospital	Chuang, JH (corresponding author), Ctr Dis Control, Off Deputy Director, Taipei, Taiwan.	jhchuang@cdc.gov.tw; fychang@ndmctsgh.edu.tw	Huang, Wan-Ting/E-3497-2010; Chuang, Jen-Hsiang/G-4356-2010	Huang, Wan-Ting/0000-0002-4344-9567; Chuang, Jen-Hsiang/0000-0002-7114-3418; Liu, Ding-Ping/0000-0002-8596-3572; Chen, Wan-Chin/0000-0002-2278-6193				[Anonymous], 2013, MEDICAL DICTIONARY F; [Anonymous], 2014, ANIMAL RABIES SURVEI; [Anonymous], 2008, SURV BAT RAB TAIW; Bonzel L, 2008, PEDIATR INFECT DIS J, V27, P589, DOI 10.1097/INF.0b013e3181694fb9; Callahan JD, 2001, J CLIN MICROBIOL, V39, P4119, DOI 10.1128/JCM.39.11.4119-4124.2001; Chen Y, 2011, J CLIN MICROBIOL, V49, P1653, DOI 10.1128/JCM.02184-10; Chidlow GR, 2009, VIRUSES-BASEL, V1, P42, DOI 10.3390/v1010042; Chiou HY, 2014, EMERG INFECT DIS, V20, P790, DOI 10.3201/eid2005.131389; Chou CY WH, 2013, TAIWAN EPIDEMIOLOGY, V29, P30; Crepin P, 1998, J CLIN MICROBIOL, V36, P1117, DOI 10.1128/JCM.36.4.1117-1121.1998; Edwards CJ, 2007, J CLIN VIROL, V39, P271, DOI 10.1016/j.jcv.2007.05.008; Feyssaguet M, 2007, VACCINE, V25, P2244, DOI 10.1016/j.vaccine.2006.12.012; Fooks AR, 2014, LANCET, V384, P1389, DOI 10.1016/S0140-6736(13)62707-5; Funahashi Y, 2010, J CLIN MICROBIOL, V48, P825, DOI 10.1128/JCM.01699-09; Guillaume V, 2004, J VIROL, V78, P834, DOI 10.1128/JVI.78.2.834-840.2004; Heaton PR, 1997, J CLIN MICROBIOL, V35, P2762, DOI 10.1128/JCM.35.11.2762-2766.1997; Hsu Yung-Hsiang, 2006, Kaohsiung Journal of Medical Sciences, V22, P94, DOI 10.1016/S1607-551X(09)70227-X; Huang WT, 2010, VACCINE, V28, P7161, DOI 10.1016/j.vaccine.2010.08.069; Knoll A, 2002, J MED VIROL, V67, P259, DOI 10.1002/jmv.2216; Lardon Z, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000723; Lee SH CK, 2003, ANIMAL HLTH RES I RE, V39, P19; Lee SH CK, 2006, ANIMAL HLTH RES I RE, V41, P11; Lee SH TK, 2004, ANIMAL HLTH RES I RE, V40, P51; Maertzdorf J, 2004, J CLIN MICROBIOL, V42, P981, DOI 10.1128/JCM.42.3.981-986.2004; Ministry of Health and Welfare EY Taiwan, PHARMACOVIGILANCE IN; Noordhoek GT, 2008, J CLIN VIROL, V41, P75, DOI 10.1016/j.jcv.2007.09.011; Shirato K, 2005, J VIROL METHODS, V126, P119, DOI 10.1016/j.jviromet.2005.02.001; Smith IL, 2001, J VIROL METHODS, V98, P33, DOI 10.1016/S0166-0934(01)00354-8; Sugita S, 2008, BRIT J OPHTHALMOL, V92, P928, DOI 10.1136/bjo.2007.133967; Taiwan Animal Health Research Institute, 2013, SURV RAB AN BRAIN TI; Taiwan Centers for Disease Control, 2013, RABIES POSTEXPOSURE; Taiwan Centers for Disease Control, 2013, MIN HLTH WELF COUNC; Taiwan Centers for Disease Control, 2013, RESP ONG RAB SIT; Tuan YC HM, 2013, TAIWAN EPIDEMIOLOGY, V29, P201; U.S. Centers for Disease Control and Prevention, 2011, COST OF RABIES PREVE; Ward CL, 2004, J CLIN VIROL, V29, P179, DOI 10.1016/S1386-6532(03)00122-7; Weng HY, 2010, VET RES, V41, DOI 10.1051/vetres/2009059; World Health Organization, 2012, WORLD RABIES DAY 201; World Health Organization, 2013, WHO TECHN REP SER, V2nd; World Health Organization, 2014, RABIES GUIDE FOR POS; World Organization for Animal Health, 2013, WEEKLY DIS INFO 0801; World Organization for Animal Health, 2013, WEEKLY DIS INFO 0906; World Organization for Animal Health, 2013, WEEKLY DIS INFO 0718	43	13	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132160	10.1371/journal.pone.0132160	http://dx.doi.org/10.1371/journal.pone.0132160			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26162074	Green Submitted, Green Published, gold			2022-12-26	WOS:000358162300099
J	Damasio, LDA; Lopes, PFM; Guariento, RD; Carvalho, AR				Alves Damasio, Ludmila de Melo; Lopes, Priscila F. M.; Guariento, Rafael D.; Carvalho, Adriana R.			Matching Fishers' Knowledge and Landing Data to Overcome Data Missing in Small-Scale Fisheries	PLOS ONE			English	Article							DEVELOPING-COUNTRIES; RESOURCE-MANAGEMENT; TRENDS; INFORMATION; ABUNDANCE; ECOSYSTEM; IMPROVE; CATCH	Background In small-scale fishery, information provided by fishers has been useful to complement current and past lack of knowledge on species and environment. Methodology Through interviews, 82 fishers from the largest fishing communities on the north and south borders of a Brazilian northeastern coastal state provided estimates of the catch per unit effort (CPUE) and rank of species abundance of their main target fishes for three time points: current year (2013 at the time of the research), 10, and 20 years past. This information was contrasted to other available data sources: scientific sampling of fish landing (2013), governmental statistics (2003), and information provided by expert fishers (1993), respectively. Principal Findings Fishers were more accurate when reporting information about their maximum CPUE for 2013, but except for three species, which they estimated accurately, fishers overestimated their mean CPUE per species. Fishers were also accurate at establishing ranks of abundance of their main target species for all periods. Fishers' beliefs that fish abundance has not changed over the last 10 years (2003-2013) were corroborated by governmental and scientific landing data. Conclusions The comparison between official and formal landing records and fishers' perceptions revealed that fishers are accurate when reporting maximum CPUE, but not when reporting mean CPUE. Moreover, fishers are less precise the less common a species is in their catches, suggesting that they could provide better information for management purposes on their current target species.	[Alves Damasio, Ludmila de Melo] Univ Fed Rio Grande do Norte, UFRN, Graduat Program Dev & Environm, BR-59072970 Natal, RN, Brazil; [Lopes, Priscila F. M.; Carvalho, Adriana R.] Univ Fed Rio Grande do Norte, UFRN, Dept Ecol, BR-59072970 Natal, RN, Brazil; [Lopes, Priscila F. M.] Fisheries & Food Inst, Santos, SP, Brazil; [Guariento, Rafael D.] Univ Mato Grosso Sul, UFMS, Ctr Biol & Hlth Sci, Campo Grande, MS, Brazil	Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte; Universidade Federal de Mato Grosso do Sul	Damasio, LDA (corresponding author), Univ Fed Rio Grande do Norte, UFRN, Graduat Program Dev & Environm, BR-59072970 Natal, RN, Brazil.	ludmila.damasio@hotmail.com	Guariento, Rafael Dettogni/Q-3602-2019; Lopes, Priscila/H-2028-2012; Carvalho, Adriana Rosa/E-2382-2016; GUARIENTO, RAFAEL DETTOGNI/J-1211-2014	Guariento, Rafael Dettogni/0000-0003-2035-2030; Lopes, Priscila/0000-0002-6774-5117; 	Coordination for the Improvement of Higher Education Personnel (CAPES); Rio Grande do Norte Research Foundation, through the First Research Program Call	Coordination for the Improvement of Higher Education Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Rio Grande do Norte Research Foundation, through the First Research Program Call	LMAD received a masters' grant from Coordination for the Improvement of Higher Education Personnel (CAPES) (http://www.capes.gov.br/). PFML received a research grant from Rio Grande do Norte Research Foundation, through the First Research Program Call (http://www.fapern.rn.gov.br/).	Andrew NL, 2007, FISH FISH, V8, P227, DOI 10.1111/j.1467-2679.2007.00252.x; Bene C, 2010, DEV POLICY REV, V28, P325, DOI 10.1111/j.1467-7679.2010.00486.x; Carvalho AR, 2009, FISH RES, V96, P119, DOI 10.1016/j.fishres.2008.08.017; Christophe Bene, 2005, SMALL SCALE FISHERIE, P46; Cisneros-Montemayor AM, 2013, MAR POLICY, V39, P283, DOI 10.1016/j.marpol.2012.12.003; Daw TM, 2010, ANIM CONSERV, V13, P534, DOI 10.1111/j.1469-1795.2010.00418.x; Eddy TD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013670; Food and Agriculture Organization (FAO), 2012, STATE WORLD FISHERIE; Fortibuoni T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015502; Garcia-Allut A., 2007, COASTAL MANAGEMENT S, V4, P227; Hallwass G, 2013, ECOL APPL, V23, P392, DOI 10.1890/12-0429.1; Hood GM, 2010, POPTOOLS; JOHANNES RE, 1981, B MAR SCI, V31, P673; Johannes RE, 1998, TRENDS ECOL EVOL, V13, P243, DOI 10.1016/S0169-5347(98)01384-6; Johannes RE, 2000, FISH FISH, V1, P257, DOI 10.1046/j.1467-2979.2000.00019.x; Johnson TR, 2007, ICES J MAR SCI, V64, P834, DOI 10.1093/icesjms/fsm014; Karper MAM, 2014, MAR POLICY, V44, P457, DOI 10.1016/j.marpol.2013.10.012; Kleisner K, 2014, MAR ECOL PROG SER, V512, P185, DOI 10.3354/meps10949; Le Fur J, 2011, CAN J FISH AQUAT SCI, V68, P1454, DOI 10.1139/F2011-061; Leitao F, 2014, FISH RES, V155, P33, DOI 10.1016/j.fishres.2014.02.012; Matlin MW, 2004, COGNITIVE ILLUSIONS: A HANDBOOK ON FALLACIES AND BIASES IN THINKING, JUDGEMENT AND MEMORY, P255; Ministerio da Pesca e Aquicultura-MPA, 2011, B EST PESC AQ, P60; MMA (Ministerio do Meio Ambiente, 2006, REL FIN PROJ MON AT REL FIN PROJ MON AT, P328; PAULY D, 1995, TRENDS ECOL EVOL, V10, P430, DOI 10.1016/S0169-5347(00)89171-5; Pauly D, 2013, NATURE, V494, P303, DOI 10.1038/494303a; PITCHER TJ, 1997, P 2 WORLD FISH C, V2, P143; Poizat G, 1997, ENVIRON BIOL FISH, V50, P435, DOI 10.1023/A:1007317423165; Rochet MJ, 2008, ICES J MAR SCI, V65, P1057, DOI 10.1093/icesjms/fsn062; Rosa R, 2014, OCEAN COAST MANAGE, V102, P258, DOI 10.1016/j.ocecoaman.2014.10.004; Silvius, 2009, P 42 HAW INT C SYST, P1; Teh LSL, 2011, FISH RES, V110, P450, DOI 10.1016/j.fishres.2011.06.001; Tesfamichael D, 2014, ECOL SOC, V19, DOI 10.5751/ES-06151-190118; VASCONCELOS EMS, 2003, B TECNICO CIENTIFICO, V11, P277; Williams A, 2007, FISHERS KNOWLEDGE FI, P41; Zeller D, 2015, CORAL REEFS, V34, P25, DOI 10.1007/s00338-014-1219-1; Zeller D, 2011, FISH RES, V108, P356, DOI 10.1016/j.fishres.2010.10.024; Zeller D, 2006, MAR RESOUR ECON, V21, P355, DOI DOI 10.1086/MRE.21.4.42629521	37	40	41	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0133122	10.1371/journal.pone.0133122	http://dx.doi.org/10.1371/journal.pone.0133122			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176538	Green Published, gold, Green Submitted			2022-12-26	WOS:000358197600216
J	Fern, EB; Watzke, H; Barclay, DV; Roulin, A; Drewnowski, A				Fern, Edward B.; Watzke, Heribert; Barclay, Denis V.; Roulin, Anne; Drewnowski, Adam			The Nutrient Balance Concept: A New Quality Metric for Composite Meals and Diets	PLOS ONE			English	Article							NUTRITIONAL QUALITY; RICH FOODS; INDIVIDUAL FOODS; ENERGY COSTS; VALIDATION; DENSITY; INDEX; PROFESSIONALS; TOOL	Background Combinations of foods that provide suitable levels of nutrients and energy are required for optimum health. Currently, however, it is difficult to define numerically what are 'suitable levels'. Objective To develop new metrics based on energy considerations-the Nutrient Balance Concept (NBC)-for assessing overall nutrition quality when combining foods and meals. Method The NBC was developed using the USDA Food Composition Database (Release 27) and illustrated with their MyPlate 7-day sample menus for a 2000 calorie food pattern. The NBC concept is centered on three specific metrics for a given food, meal or diet-a Qualifying Index (QI), a Disqualifying Index (DI) and a Nutrient Balance (NB). The QI and DI were determined, respectively, from the content of 27 essential nutrients and 6 nutrients associated with negative health outcomes. The third metric, the Nutrient Balance (NB), was derived from the Qualifying Index (QI) and provided key information on the relative content of qualifying nutrients in the food. Because the Qualifying and Disqualifying Indices (QI and DI) were standardized to energy content, both become constants for a given food/meal/diet and a particular consumer age group, making it possible to develop algorithms for predicting nutrition quality when combining different foods. Results Combining different foods into composite meals and daily diets led to improved nutrition quality as seen by QI values closer to unity (indicating nutrient density was better equilibrated with energy density), DI values below 1.0 (denoting an acceptable level of consumption of disqualifying nutrients) and increased NB values (signifying complementarity of foods and better provision of qualifying nutrients). Conclusion The Nutrient Balance Concept (NBC) represents a new approach to nutrient profiling and the first step in the progression from the nutrient evaluation of individual foods to that of multiple foods in the context of meals and total diets.	[Fern, Edward B.; Watzke, Heribert; Barclay, Denis V.; Roulin, Anne] Nestec Ltd, Int Headquarters, Vevey, Switzerland; [Drewnowski, Adam] Univ Washington, Ctr Publ Hlth Nutr, Seattle, WA 98195 USA	Nestle SA; University of Washington; University of Washington Seattle		ed.fern@bluewin.ch; adamdrew@uw.edu	Drewnowski, Adam/HCI-4117-2022		Nestec Ltd. (part of the Nestle Group); Nestec Ltd.	Nestec Ltd. (part of the Nestle Group); Nestec Ltd.(Nestle SA)	Nestec Ltd. (part of the Nestle Group) was the commercial funder of this research study. The funder provided support in the form of salaries for the following authors: Edward Fern, Heribert Watzke, Denis Barclay and Anne Roulin. The fifth author Adam Drewnowski is a consultant to Nestle and has received consulting fees from Nestec Ltd. The funder Nestec did not have any additional role in the study design, data collection and analysis, the decision to publish, or the preparation of the manuscript.	AFSSA, 2008, DEF PROF NUTR ACC AL; Arambepola C, 2008, VALIDATING NUTR PROF; Arsenault JE, 2012, J ACAD NUTR DIET, V112, P1968, DOI 10.1016/j.jand.2012.08.032; Azais-Braesco V, 2006, PUBLIC HEALTH NUTR, V9, P613, DOI 10.1079/PHN2006966; Darmon N, 2005, J AM DIET ASSOC, V105, P1881, DOI 10.1016/j.jada.2005.09.005; Darmon N, 2009, AM J CLIN NUTR, V89, P1227, DOI 10.3945/ajcn.2008.26465; Drewnowski A, 2005, AM J CLIN NUTR, V82, P721, DOI 10.1093/ajcn/82.4.721; Drewnowski A, 2004, AM J CLIN NUTR, V79, P6; Drewnowski A, 2008, NUTR REV, V66, P23, DOI 10.1111/j.1753-4887.2007.00003.x; Drewnowski A, 2011, J AM DIET ASSOC, V111, P280, DOI 10.1016/j.jada.2010.10.045; Drewnowski A, 2009, J AM COLL NUTR, V28, p421S, DOI 10.1080/07315724.2009.10718106; Friday J, 2008, MYPYRAMID EQUIVALENT; Fulgoni VL, 2009, J NUTR, V139, P1549, DOI 10.3945/jn.108.101360; Global Alliance for Improved Nutrition, 2013, ACC NUTR IND; Institute of Medicine (US) Food and Nutrition Board, 1998, DIET REF INT RISK AS; Labouze E, 2007, PUBLIC HEALTH NUTR, V10, P690, DOI 10.1017/S1368980007382505; Maillot M, 2008, J NUTR, V138, P1107, DOI 10.1093/jn/138.6.1107; Maillot M, 2007, J NUTR, V137, P1815, DOI 10.1093/jn/137.7.1815; Maillot M, 2011, J NUTR, V141, P333, DOI 10.3945/jn.110.131920; Maillot M, 2010, PUBLIC HEALTH NUTR, V13, P1178, DOI 10.1017/S1368980009993028; Nijman CAJ, 2007, EUR J CLIN NUTR, V61, P461, DOI 10.1038/sj.ejcn.1602548; Saxholt E, 2009, DANISH FOOD COMPOSIT; Scarborough P, 2007, PUBLIC HEALTH NUTR, V10, P337, DOI 10.1017/S1368980007666671; Scarborough P, 2007, PUBLIC HEALTH NUTR, V10, P346, DOI 10.1017/S1368980007666683; Tetens I, 2007, EUR J NUTR, V46, P4, DOI 10.1007/s00394-007-2003-6; U.S. Department of Agriculture, 2012, SAMPL MEN 2000 CAL F; U.S. Department of Agriculture, 2014, DIET REF INT; US Department of Agriculture and US Department of Health and Human Services, 2010, DIET GUID AM 2010; USDA, 2014, NAT NUTR DAT STAND R; Volatier JL, 2007, EUR J NUTR, V46, P29, DOI 10.1007/s00394-007-2004-5	30	38	38	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0130491	10.1371/journal.pone.0130491	http://dx.doi.org/10.1371/journal.pone.0130491			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176770	Green Submitted, Green Published, gold			2022-12-26	WOS:000358197600024
J	Fuess, LE; Eisenlord, ME; Closek, CJ; Tracy, AM; Mauntz, R; Gignoux-Wolfsohn, S; Moritsch, MM; Yoshioka, R; Burge, CA; Harvell, CD; Friedman, CS; Hewson, I; Hershberger, PK; Roberts, SB				Fuess, Lauren E.; Eisenlord, Morgan E.; Closek, Collin J.; Tracy, Allison M.; Mauntz, Ruth; Gignoux-Wolfsohn, Sarah; Moritsch, Monica M.; Yoshioka, Reyn; Burge, Colleen A.; Harvell, C. Drew; Friedman, Carolyn S.; Hewson, Ian; Hershberger, Paul K.; Roberts, Steven B.			Up in Arms: Immune and Nervous System Response to Sea Star Wasting Disease	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; ARACHIDONIC-ACID METABOLISM; STRONGYLOCENTROTUS-PURPURATUS; EXPRESSION ANALYSIS; CONNECTIVE-TISSUE; SIGNALING PATHWAY; GENE-EXPRESSION; BINDING LECTIN; URCHIN GENOME; DROSOPHILA	Echinoderms, positioned taxonomically at the base of deuterostomes, provide an important system for the study of the evolution of the immune system. However, there is little known about the cellular components and genes associated with echinoderm immunity. The 2013-2014 sea star wasting disease outbreak is an emergent, rapidly spreading disease, which has led to large population declines of asteroids in the North American Pacific. While evidence suggests that the signs of this disease, twisting arms and lesions, may be attributed to a viral infection, the host response to infection is still poorly understood. In order to examine transcriptional responses of the sea star Pycnopodia helianthoides to sea star wasting disease, we injected a viral sized fraction (0.2 mu m) homogenate prepared from symptomatic P. helianthoides into apparently healthy stars. Nine days following injection, when all stars were displaying signs of the disease, specimens were sacrificed and coelomocytes were extracted for RNA-seq analyses. A number of immune genes, including those involved in Toll signaling pathways, complement cascade, melanization response, and arachidonic acid metabolism, were differentially expressed. Furthermore, genes involved in nervous system processes and tissue remodeling were also differentially expressed, pointing to transcriptional changes underlying the signs of sea star wasting disease. The genomic resources presented here not only increase understanding of host response to sea star wasting disease, but also provide greater insight into the mechanisms underlying immune function in echinoderms.	[Fuess, Lauren E.] Univ Texas Arlington, Dept Biol, Arlington, TX 76019 USA; [Eisenlord, Morgan E.; Tracy, Allison M.; Yoshioka, Reyn; Burge, Colleen A.; Harvell, C. Drew] Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY USA; [Closek, Collin J.] Penn State Univ, Dept Biol, University Pk, PA 16802 USA; [Mauntz, Ruth] Donald P Shiley Biosci Ctr, San Diego, CA USA; [Gignoux-Wolfsohn, Sarah] Northeastern Univ, Ctr Marine Sci, Nahant, MA 01908 USA; [Moritsch, Monica M.] Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA; [Burge, Colleen A.; Friedman, Carolyn S.; Roberts, Steven B.] Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA; [Hewson, Ian] Cornell Univ, Dept Microbiol, Ithaca, NY USA; [Hershberger, Paul K.] US Geol Survey, Western Fisheries Res Ctr, Marrowstone Marine Field Stn, Nordland, WA USA	University of Texas System; University of Texas Arlington; Cornell University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Northeastern University; University of California System; University of California Santa Cruz; University of Washington; University of Washington Seattle; Cornell University; United States Department of the Interior; United States Geological Survey	Fuess, LE (corresponding author), Univ Texas Arlington, Dept Biol, Arlington, TX 76019 USA.	fuess@uta.edu	Fuess, Lauren E/S-6456-2019	Fuess, Lauren E/0000-0003-0197-7326; Gignoux-Wolfsohn, Sarah/0000-0002-9037-1088; Roberts, Steven/0000-0001-8302-1138; Moritsch, Monica/0000-0002-3890-1264; Mauntz, Ruth/0000-0003-0376-3313; Eisenlord, Morgan/0000-0002-9353-6642; Closek, Collin/0000-0003-4431-221X	National Science Foundation (OCE) [1215977]; Division Of Ocean Sciences [1215977] Funding Source: National Science Foundation	National Science Foundation (OCE)(National Science Foundation (NSF)); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was completed as part of the Ecology of Infectious Marine Diseases Research Coordination Network Workshop, funded by the National Science Foundation (OCE #1215977; http://www.eeb.cornell.edu/ecologymarinedisease/Home/Home.html; http://www.nsf.gov/funding/pgm_summ.jsp?pims_id=11691&org=OCE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; [Anonymous], 2013, UNPRECEDENTED SEA ST; [Anonymous], 2014, SEA STAR WAST DIS SA; ARAKI M, 2009, RECENT RES DEV NEURO, V3, P111; Bates AE, 2009, DIS AQUAT ORGAN, V86, P245, DOI 10.3354/dao02125; Beck G, 1996, CYTOKINE, V8, P507, DOI 10.1006/cyto.1996.0069; Belvin MP, 1996, ANNU REV CELL DEV BI, V12, P393, DOI 10.1146/annurev.cellbio.12.1.393; Bettler B, 2004, PHYSIOL REV, V84, P835, DOI 10.1152/physrev.00036.2003; Blair JE, 2005, MOL BIOL EVOL, V22, P2275, DOI 10.1093/molbev/msi225; BOISE LH, 1993, CELL, V74, P597, DOI 10.1016/0092-8674(93)90508-N; Bulgakov AA, 2013, MAR BIOTECHNOL, V15, P73, DOI 10.1007/s10126-012-9460-5; Burke RD, 2006, DEV BIOL, V300, P434, DOI 10.1016/j.ydbio.2006.08.007; Cameron RA, 2009, NUCLEIC ACIDS RES, V37, pD750, DOI 10.1093/nar/gkn887; CANICATTI C, 1989, J INVERTEBR PATHOL, V53, P152, DOI 10.1016/0022-2011(89)90002-5; Cerenius L, 2004, IMMUNOL REV, V198, P116, DOI 10.1111/j.0105-2896.2004.00116.x; Chi ZK, 2012, DEV CELL, V22, P707, DOI 10.1016/j.devcel.2012.02.011; Cuadrado A, 2014, J BIOL CHEM, V289, P15244, DOI 10.1074/jbc.M113.540633; DAVIES P, 1984, ANNU REV IMMUNOL, V2, P335, DOI 10.1146/annurev.immunol.2.1.335; DAYTON PK, 1975, ECOL MONOGR, V45, P137, DOI 10.2307/1942404; Dheilly NM, 2013, DEV COMP IMMUNOL, V40, P35, DOI 10.1016/j.dci.2013.01.007; Dorsam RT, 2007, NAT REV CANCER, V7, P79, DOI 10.1038/nrc2069; DUGGINS DO, 1983, ECOLOGY, V64, P1610, DOI 10.2307/1937514; Eckert GL., 1999, P 5 CAL ISL S SANT B, P390; Elenkov IJ, 1998, J IMMUNOL, V161, P2586; Elphick MR, 2001, J EXP BIOL, V204, P875; Finberg RW, 2007, REV MED VIROL, V17, P35, DOI 10.1002/rmv.525; Franco CF, 2011, PROTEOMICS, V11, P3587, DOI 10.1002/pmic.201000745; Franzenburg S, 2012, P NATL ACAD SCI USA, V109, P19374, DOI 10.1073/pnas.1213110109; Gowda NM, 2013, J FLUORESC, V23, P1147, DOI 10.1007/s10895-013-1244-4; Gudenkauf BM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128150; Hewson I, 2014, P NATL ACAD SCI USA, V111, P17278, DOI 10.1073/pnas.1416625111; Hibino T, 2006, DEV BIOL, V300, P349, DOI 10.1016/j.ydbio.2006.08.065; HIDAKA M, 1983, J EXP BIOL, V103, P1; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; HULTMARK D, 1994, BIOCHEM BIOPH RES CO, V199, P144, DOI 10.1006/bbrc.1994.1206; Janeway Jr C.A., 2001, IMMUNOBIOLOGY IMMUNE, V5th; Katow H, 2008, INT J DEV BIOL, V52, P1077, DOI 10.1387/ijdb.082684hk; Kemper C, 2008, P NATL ACAD SCI USA, V105, P9023, DOI 10.1073/pnas.0801015105; Krishnan A, 2013, GENE, V526, P122, DOI 10.1016/j.gene.2013.05.005; Li C, 2010, DEV COMP IMMUNOL, V34, P959, DOI 10.1016/j.dci.2010.04.004; Li HM, 2013, NAT CELL BIOL, V15, P773, DOI 10.1038/ncb2791; Libro S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081821; Ma JX, 2002, BIOCHEM PHARMACOL, V64, P1447, DOI 10.1016/S0006-2952(02)01393-X; Matsushita M, 2000, J IMMUNOL, V164, P2281, DOI 10.4049/jimmunol.164.5.2281; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Messier-Solek C, 2010, SEMIN IMMUNOL, V22, P39, DOI 10.1016/j.smim.2009.11.007; Miller DJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r59; Mogilenko DA, 2010, MOL BIOL+, V44, P67, DOI 10.1134/S0026893310010097; Moreira R, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-267; Nair SV, 2005, PHYSIOL GENOMICS, V22, P33, DOI 10.1152/physiolgenomics.00052.2005; NEEDLEMAN P, 1986, ANNU REV BIOCHEM, V55, P69, DOI 10.1146/annurev.biochem.55.1.69; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; PAINE R T, 1974, Oecologia (Berlin), V15, P93, DOI 10.1007/BF00345739; PAINE RT, 1966, AM NAT, V100, P65, DOI 10.1086/282400; Quinones JL, 2002, DEV BIOL, V250, P181, DOI 10.1006/dbio.2002.0778; Rast JP, 2006, SCIENCE, V314, P952, DOI 10.1126/science.1134301; Rauta PR, 2014, IMMUNOL LETT, V158, P14, DOI 10.1016/j.imlet.2013.11.013; Ribeiro AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049016; Roberts S, 2015, EIMD SSWD V1 0 SUPPL; SCOTT WA, 1982, J EXP MED, V155, P1148, DOI 10.1084/jem.155.4.1148; Smith LC, 2010, DIS MODEL MECH, V3, P274, DOI 10.1242/dmm.004697; Smith LC, 1999, IMMUNOPHARMACOLOGY, V42, P107, DOI 10.1016/S0162-3109(99)00009-0; SMITH VJ, 1991, DEV COMP IMMUNOL, V15, P251, DOI 10.1016/0145-305X(91)90018-T; Sugni M, 2014, MAR ENVIRON RES, V93, P123, DOI 10.1016/j.marenvres.2013.07.010; Sun HJ, 2013, FISH SHELLFISH IMMUN, V34, P147, DOI 10.1016/j.fsi.2012.10.014; Todgham AE, 2009, J EXP BIOL, V212, P2579, DOI 10.1242/jeb.032540; Valanne S, 2011, J IMMUNOL, V186, P649, DOI 10.4049/jimmunol.1002302; WAITE M, 1979, BIOCHEM BIOPH RES CO, V90, P984, DOI 10.1016/0006-291X(79)91924-7; Wang PH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024773; Ward JR, 2004, PLOS BIOL, V2, P542, DOI 10.1371/journal.pbio.0020120; Yamaguchi Y, 2010, J INVEST DERMATOL, V130, P645, DOI 10.1038/jid.2009.378; Zambon RA, 2005, P NATL ACAD SCI USA, V102, P7257, DOI 10.1073/pnas.0409181102	75	29	29	1	124	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0133053	10.1371/journal.pone.0133053	http://dx.doi.org/10.1371/journal.pone.0133053			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176852	Green Submitted, Green Published, gold			2022-12-26	WOS:000358197600205
J	Fujii, H; Luo, ZJ; Kim, HJ; Newbigging, S; Gassas, A; Keating, A; Egeler, RM				Fujii, Hisaki; Luo, Zhi-Juan; Kim, Hye Jin; Newbigging, Susan; Gassas, Adam; Keating, Armand; Egeler, R. Maarten			Humanized Chronic Graft-versus-Host Disease in NOD-SCID il2r gamma-/- (NSG) Mice with G-CSF-Mobilized Peripheral Blood Mononuclear Cells following Cyclophosphamide and Total Body Irradiation	PLOS ONE			English	Article							CONSENSUS DEVELOPMENT PROJECT; WORKING GROUP-REPORT; BONE-MARROW; CLINICAL-TRIALS; CHRONIC GVHD; MOUSE MODEL; STEM-CELLS; CRITERIA; IMATINIB; LIVER	Chronic graft-versus-host disease (cGvHD) is the major source of late phase morbidity and mortality after allogeneic hematopoietic stem cell transplantation. Humanized acute GvHD (aGvHD) in vivo models using NOD-SCID il2r gamma-/-(NSG) mice are well described and are important tools for investigating pathogenicity of human cells in vivo. However, there have been only few reported humanized cGvHD mouse models. We evaluated if prolonged inflammation driven by low dose G-CSF-mobilized human PBMCs (G-hPBMCs) would lead to cGvHD following cyclophosphamide (CTX) administration and total body irradiation (TBI) in NSG mice. Engraftment was assessed in peripheral blood (PB) and in specific target organs by either flow cytometry or immunohistochemistry (IHC). Tissue samples were harvested 56 days post transplantation and were evaluated by a pathologist. Some mice were kept for up to 84 days to evaluate the degree of fibrosis. Mice that received CTX at 20mg/kg did not show aGvHD with stable expansion of human CD45(+) CD3(+) T-cells in PB (mean; 5.8 to 23.2%). The pathology and fibrosis scores in the lung and the liver were significantly increased with aggregation of T-cells and hCD68(+) macrophages. There was a correlation between liver pathology score and the percentage of hCD68(+) cells, suggesting the role of macrophage in fibrogenesis in NSG mice. In order to study long-term survival, 6/9 mice who survived more than 56 days showed increased fibrosis in the lung and liver at the endpoint, which suggests the infiltrating hCD68(+) macrophages may be pathogenic. It was shown that the combination of CTX and TBI with a low number of G-hPBMCs (1x10(6)) leads to chronic lung and liver inflammation driven by a high infiltration of human macrophage and mature human T cells from the graft, resulting in fibrosis of lung and liver in NSG mice. In conclusion this model may serve as an important pre-clinical model to further current understanding of the roles of human macrophages in cGvHD.	[Fujii, Hisaki; Gassas, Adam; Egeler, R. Maarten] Hosp Sick Children, Hematol Oncol BMT, Toronto, ON M5G 1X8, Canada; [Fujii, Hisaki; Luo, Zhi-Juan; Kim, Hye Jin; Egeler, R. Maarten] Hosp Sick Children, Dev Stem Cell Biol, Toronto, ON M5G 1X8, Canada; [Newbigging, Susan] Toronto Ctr Phenogen, Toronto, ON, Canada; [Keating, Armand] Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre	Egeler, RM (corresponding author), Hosp Sick Children, Hematol Oncol BMT, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	maarten.egeler@sickkids.ca		Keating, Armand/0000-0002-7676-6059	David Smyth fellowship from Canadian Blood and Marrow Transplantation Grou; Sears Cancer Research Fellowship; Garron Family Cancer Centre Research Fellowship	David Smyth fellowship from Canadian Blood and Marrow Transplantation Grou; Sears Cancer Research Fellowship; Garron Family Cancer Centre Research Fellowship	HF is supported by David Smyth fellowship from Canadian Blood and Marrow Transplantation Group, a Sears Cancer Research Fellowship and a Garron Family Cancer Centre Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044219; Anasetti C, 2012, NEW ENGL J MED, V367, P1487, DOI 10.1056/NEJMoa1203517; Arai S, 2011, BLOOD, V118, P4242, DOI 10.1182/blood-2011-03-344390; Blazar BR, 1998, BLOOD, V92, P3949, DOI 10.1182/blood.V92.10.3949.422k26_3949_3959; Chen GL, 2011, BLOOD, V118, P4070, DOI 10.1182/blood-2011-03-341693; Cooke KR, 1996, BLOOD, V88, P3230, DOI 10.1182/blood.V88.8.3230.bloodjournal8883230; Duffield JS, 2005, J CLIN INVEST, V115, P56, DOI 10.1172/JCI200522675; Filipovich AH, 2005, BIOL BLOOD MARROW TR, V11, P945, DOI 10.1016/j.bbmt.2005.09.004; Fujii H, 2008, BLOOD, V111, P3276, DOI 10.1182/blood-2007-08-106286; Fuschiotti P, 2013, ARTHRITIS RHEUM-US, V65, P236, DOI 10.1002/art.37706; Greenblatt MB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044664; Gregoire-Gauthier J, 2012, BONE MARROW TRANSPL, V47, P439, DOI 10.1038/bmt.2011.93; Hirayama M, 2013, HAEMATOL-HEMATOL J, V98, P41, DOI 10.3324/haematol.2012.069815; Holtick U, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010189.pub2; Inamoto Y, 2011, CURR OPIN HEMATOL, V18, P414, DOI 10.1097/MOH.0b013e32834ba87d; Ishikawa F, 2005, BLOOD, V106, P1565, DOI 10.1182/blood-2005-02-0516; King MA, 2009, CLIN EXP IMMUNOL, V157, P104, DOI 10.1111/j.1365-2249.2009.03933.x; Lockridge JL, 2013, BIOL BLOOD MARROW TR, V19, P1310, DOI 10.1016/j.bbmt.2013.06.007; Malard F, 2014, BONE MARROW TRANSPL, V49, P539, DOI 10.1038/bmt.2013.215; Nishiwaki S, 2009, BLOOD, V114, P3113, DOI 10.1182/blood-2009-03-209635; Notta F, 2010, BLOOD, V115, P3704, DOI 10.1182/blood-2009-10-249326; Olivieri A, 2013, BLOOD, V122, P4111, DOI 10.1182/blood-2013-05-494278; Quaglia A, 2007, HISTOPATHOLOGY, V50, P727, DOI 10.1111/j.1365-2559.2007.02679.x; Sato M, 2006, J ORAL PATHOL MED, V35, P33, DOI 10.1111/j.1600-0714.2005.00372.x; Schroeder MA, 2011, DIS MODEL MECH, V4, P318, DOI 10.1242/dmm.006668; SCHULTZ KR, 1995, BONE MARROW TRANSPL, V16, P289; Shulman HM, 2006, BIOL BLOOD MARROW TR, V12, P31, DOI 10.1016/j.bbmt.2005.10.023; Stadler M, 2009, BLOOD, V114, P3718, DOI 10.1182/blood-2009-07-231159; van Rijn RS, 2003, BLOOD, V102, P2522, DOI 10.1182/blood-2002-10-3241; Zorn E, 2005, BLOOD, V106, P2903, DOI 10.1182/blood-2005-03-1257	30	7	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0133216	10.1371/journal.pone.0133216	http://dx.doi.org/10.1371/journal.pone.0133216			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176698	Green Submitted, Green Published, gold			2022-12-26	WOS:000358197600233
J	Joo, YH; Lee, SS; Han, KD; Park, KH				Joo, Young-Hoon; Lee, Seong-Soo; Han, Kyung-do; Park, Kyung-Ho			Association between Chronic Laryngitis and Particulate Matter Based on the Korea National Health and Nutrition Examination Survey 2008-2012	PLOS ONE			English	Article							AIR-POLLUTION EXPOSURE; CIGARETTE-SMOKING; INFECTION; CHILDREN; ASTHMA; SIZE	Background Chronic laryngitis (CL) has been described as chronic inflammation of the larynx. CL have various causes such as long-term smoking, acid reflux, voice overuse, bronchitis, allergies, pneumonia, excessive exposure to toxic chemicals and complications from the flu or a chronic cold. However, the prevalence of CL and role of air pollution in the etiology is uncertain. Objective The aim of this study was to investigate the relationship between CL and particulate matter with aerodynamic diameter less than 10 mu m (PM10) in South Korea using data from the Korea National Health and Nutrition Examination Surveys (KNHANES) during 2008-2012. Methods KNHANES is a cross-sectional survey of the civilian, non-institutionalized population of South Korea (n = 21,116). A field survey team that included an otolaryngologist moved with a mobile examination unit and performed interviews and physical examinations. The mean annual concentrations of ambient PM10, SO2, O3, NO2, and CO levels in Korea were determined from monitoring station data. Multiple logistic regression was used to examine the relationship of air pollution to CL. Results Among the population >= 19 years of age, the weighted prevalence of CL was 3.37 +/- 0.30% (95% confidence interval, 2.79-3.95%). CL was more prevalent in men, current smokers, and those with lower household income and prevalence increased with age. A significant decrease over time was observed in the prevalence of CL (P for trend = 0.0049) and the annual average concentrations of PM10 (P for trend < 0.0001) from 2008 to 2012. In a multivariate model, the factors associated with CL included PM10 (odds ratio [OR], 1.378, p = 0.0457), age (OR, 1.020, p<0.0001), sex (OR, 0.734, p = 0.0179), and smoking status (OR, 1.438, p = 0.0054). Conclusion Elevated PM10 exposures could be associated with increased risk of CL in South Koreans. Further epidemiological and experimental studies are necessary to clarify the impact of chronic PM10 exposure on CL.	[Joo, Young-Hoon; Park, Kyung-Ho] Catholic Univ Korea, Coll Med, Dept Otolaryngol Head & Neck Surg, Seoul, South Korea; [Lee, Seong-Soo] Catholic Univ Korea, Coll Med, Dept Endocrinol, Seoul, South Korea; [Han, Kyung-do] Catholic Univ Korea, Coll Med, Dept Biostat, Seoul, South Korea	Catholic University of Korea; Catholic University of Korea; Catholic University of Korea	Park, KH (corresponding author), Catholic Univ Korea, Coll Med, Dept Otolaryngol Head & Neck Surg, Seoul, South Korea.	khpent@catholic.ac.kr	Joo, Young Hoon/AAU-7285-2020	Joo, Young Hoon/0000-0002-4662-1916				Arcavi L, 2004, ARCH INTERN MED, V164, P2206, DOI 10.1001/archinte.164.20.2206; Baletic N, 2005, IND HEALTH, V43, P302, DOI 10.2486/indhealth.43.302; Bitar K, 2011, NEUROGASTROENT MOTIL, V23, P490, DOI 10.1111/j.1365-2982.2011.01678.x; Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1; Calderon-Garciduenas L, 2008, TOXICOL PATHOL, V36, P289, DOI 10.1177/0192623307313011; Carvalho-Oliveira R, 2005, ENVIRON RES, V98, P349, DOI 10.1016/j.envres.2004.10.002; Chen HK, 2012, AUSTRALAS MED J, V5, P175, DOI 10.4066/AMJ.2012.1101; Coyle SM, 2001, J VOICE, V15, P424, DOI 10.1016/S0892-1997(01)00043-1; Delfino RJ, 1997, ENVIRON HEALTH PERSP, V105, P622, DOI 10.2307/3433608; Dua K, 2002, GUT, V51, P771, DOI 10.1136/gut.51.6.771; Dworkin JP, 2008, OTOLARYNG CLIN N AM, V41, P419, DOI 10.1016/j.otc.2007.11.011; Fukuda K, 2011, AUST NZ J PUBL HEAL, V35, P163, DOI 10.1111/j.1753-6405.2010.00620.x; Joo YH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131247; Kelly FJ, 2012, ATMOS ENVIRON, V60, P504, DOI 10.1016/j.atmosenv.2012.06.039; Kim KH, 2015, ENVIRON INT, V74, P136, DOI 10.1016/j.envint.2014.10.005; Kim Yangho, 2013, J Prev Med Public Health, V46, P96, DOI 10.3961/jpmph.2013.46.2.96; Korean Association of Smoking and Health, NAT SMOK PREV SURV; MARCY TW, 1987, CLIN CHEST MED, V8, P381; Merati AL, 2010, CUMMINGS OTOLARYNGOL, V5th, P901; Murin S, 2005, CLEV CLIN J MED, V72, P916, DOI 10.3949/ccjm.72.10.916; Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397; Neupane B, 2010, AM J RESP CRIT CARE, V181, P47, DOI [10.1164/rccm.200901-0160oc, 10.1164/rccm.200901-0160OC]; Ostro B, 2001, EPIDEMIOLOGY, V12, P200, DOI 10.1097/00001648-200103000-00012; Park SU, 2004, ATMOS ENVIRON, V38, P2155, DOI 10.1016/j.atmosenv.2004.01.024; Soukup JM, 2000, INHAL TOXICOL, V12, P401; Stanek LW, 2011, TOXICOL SCI, V120, pS8, DOI 10.1093/toxsci/kfq367; Stein DJ, 2013, ANN OTO RHINOL LARYN, V122, P771, DOI 10.1177/000348941312201207; Sun QH, 2010, CIRCULATION, V121, P2755, DOI 10.1161/CIRCULATIONAHA.109.893461	28	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0133180	10.1371/journal.pone.0133180	http://dx.doi.org/10.1371/journal.pone.0133180			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177353	Green Submitted, gold, Green Published			2022-12-26	WOS:000358197600226
J	Marcotuli, I; Houston, K; Waugh, R; Fincher, GB; Burton, RA; Blanco, A; Gadaleta, A				Marcotuli, Ilaria; Houston, Kelly; Waugh, Robbie; Fincher, Geoffrey B.; Burton, Rachel A.; Blanco, Antonio; Gadaleta, Agata			Genome Wide Association Mapping for Arabinoxylan Content in a Collection of Tetraploid Wheats	PLOS ONE			English	Article							CANDIDATE GENES; GRAIN; IDENTIFICATION	Background Arabinoxylans (AXs) are major components of plant cell walls in bread wheat and are important in bread-making and starch extraction. Furthermore, arabinoxylans are components of soluble dietary fibre that has potential health-promoting effects in human nutrition. Despite their high value for human health, few studies have been carried out on the genetics of AX content in durum wheat. Results The genetic variability of AX content was investigated in a set of 104 tetraploid wheat genotypes and regions attributable to AX content were identified through a genome wide association study (GWAS). The amount of arabinoxylan, expressed as percentage (w/w) of the dry weight of the kernel, ranged from 1.8% to 5.5% with a mean value of 4.0%. The GWAS revealed a total of 37 significant marker-trait associations (MTA), identifying 19 quantitative trait loci (QTL) associated with AX content. The highest number of MTAs was identified on chromosome 5A (seven), where three QTL regions were associated with AX content, while the lowest number of MTAs was detected on chromosomes 2B and 4B, where only one MTA identified a single locus. Conservation of synteny between SNP marker sequences and the annotated genes and proteins in Brachypodium distachyon, Oryza sativa and Sorghum bicolor allowed the identification of nine QTL coincident with candidate genes. These included a glycosyl hydrolase GH35, which encodes Gal7 and a glucosyltransferase GT31 on chromosome 1A; a cluster of GT1 genes on chromosome 2B that includes TaUGT1 and cisZog1; a glycosyl hydrolase that encodes a CelC gene on chromosome 3A; Ugt12887 and TaUGT1 genes on chromosome 5A; a (1,3)-beta-D-glucan synthase (Gsl12 gene) and a glucosyl hydrolase (Cel8 gene) on chromosome 7A. Conclusions This study identifies significant MTAs for the AX content in the grain of tetraploid wheat genotypes. We propose that these may be used for molecular breeding of durum wheat varieties with higher soluble fibre content.	[Marcotuli, Ilaria; Blanco, Antonio; Gadaleta, Agata] Univ Bari Aldo Moro, Sect Genet & Plant Breeding, Dept Soil Plant & Food Sci, Bari, Italy; [Houston, Kelly; Waugh, Robbie] James Hutton Inst, Dundee, Scotland; [Fincher, Geoffrey B.; Burton, Rachel A.] Univ Adelaide, Australian Res Council, Ctr Excellence Plant Cell Walls, Sch Agr Food & Wine, Glen Osmond, SA, Australia	Universita degli Studi di Bari Aldo Moro; James Hutton Institute; University of Adelaide	Gadaleta, A (corresponding author), Univ Bari Aldo Moro, Sect Genet & Plant Breeding, Dept Soil Plant & Food Sci, Via G Amendola 165-A, Bari, Italy.	agata.gadaleta@uniba.it	Gadaleta, Agata/H-2627-2012; Burton, Rachel A/C-4441-2011	Gadaleta, Agata/0000-0002-6312-249X; Burton, Rachel A/0000-0002-0638-4709; Marcotuli, Ilaria/0000-0002-0146-5286; , Kelly/0000-0003-2136-245X	Ministero dell'Istruzione, dell'Universita' e della Ricerca ['PON-01_01145]; BBSRC [BB/J014869/1]; Australian Research Council; South Australia-Puglia Awards scheme of South Australia; BBSRC [BB/L026317/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/L026317/1, BB/J014869/1] Funding Source: researchfish	Ministero dell'Istruzione, dell'Universita' e della Ricerca(Ministry of Education, Universities and Research (MIUR)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Australian Research Council(Australian Research Council); South Australia-Puglia Awards scheme of South Australia; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The research project was supported by grants from Ministero dell'Istruzione, dell'Universita' e della Ricerca, project 'PON-01_01145 "ISCOCEM' and from BBSRC responsive mode scheme (BB/J014869/1). Additional support was received from the Australian Research Council and the South Australia-Puglia Awards scheme of South Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhunov E, 2009, THEOR APPL GENET, V119, P507, DOI 10.1007/s00122-009-1059-5; Alan Dabney JDS, 2010, QVALUE Q VALUE ESTIM; Burton RA, 2011, PLANT BIOTECHNOL J, V9, P117, DOI 10.1111/j.1467-7652.2010.00532.x; Charmet G, 2009, EUPHYTICA, V170, P155, DOI 10.1007/s10681-009-0019-0; Ciccoritti R, 2011, INT J MOL SCI, V12, P4536, DOI 10.3390/ijms12074536; Colasuonno P, 2014, MOL BREEDING, V34, P1563, DOI 10.1007/s11032-014-0183-3; Collins HM, 2010, CEREAL CHEM, V87, P272, DOI 10.1094/CCHEM-87-4-0272; Courtin CM, 2002, J CEREAL SCI, V35, P225, DOI 10.1006/jcrs.2001.0433; Coutinho PM, 1999, ROY SOC CH, P3; Crossa J, 2007, GENETICS, V177, P1889, DOI 10.1534/genetics.107.078659; Gupta PK, 2005, PLANT MOL BIOL, V57, P461, DOI 10.1007/s11103-005-0257-z; Izydorczyk MS, 1995, CARBOHYD POLYM, V28, P33, DOI 10.1016/0144-8617(95)00077-1; Laido G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067280; Lempereur I, 1997, J CEREAL SCI, V25, P103, DOI 10.1006/jcrs.1996.0090; Lovegrove A, 2013, PLANT PHYSIOL, V163, P95, DOI 10.1104/pp.113.222653; Martinant JP, 1998, THEOR APPL GENET, V97, P1069, DOI 10.1007/s001220050993; Mitchell RAC, 2007, PLANT PHYSIOL, V144, P43, DOI 10.1104/pp.106.094995; Pellny TK, 2012, PLANT PHYSIOL, V158, P612, DOI 10.1104/pp.111.189191; Quraishi UM, 2011, FUNCT INTEGR GENOMIC, V11, P71, DOI 10.1007/s10142-010-0183-2; Saulnier L, 2007, J CEREAL SCI, V46, P261, DOI 10.1016/j.jcs.2007.06.014; Sears E.R., 1954, MISSOURI AGR EXP STA, V572, P1; Shewry PR, 2012, TRENDS FOOD SCI TECH, V25, P70, DOI 10.1016/j.tifs.2012.01.003; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Nguyen VL, 2011, CROP SCI, V51, P1143, DOI 10.2135/cropsci2010.08.0484; Wang SC, 2014, PLANT BIOTECHNOL J, V12, P787, DOI 10.1111/pbi.12183; Xiao J, 1996, THEOR APPL GENET, V92, P230, DOI 10.1007/BF00223380; Zondervan KT, 2004, NAT REV GENET, V5, P89, DOI 10.1038/nrg1270	27	30	32	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132787	10.1371/journal.pone.0132787	http://dx.doi.org/10.1371/journal.pone.0132787			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176552	Green Submitted, gold, Green Published			2022-12-26	WOS:000358197600156
J	Selga, E; Campuzano, O; Pinsach-Abuin, ML; Perez-Serra, A; Mademont-Soler, I; Riuro, H; Pico, F; Coll, M; Iglesias, A; Pagans, S; Sarquella-Brugada, G; Berne, P; Benito, B; Brugada, J; Porres, JM; Zea, ML; Castro-Urda, V; Fernandez-Lozano, I; Brugada, R				Selga, Elisabet; Campuzano, Oscar; Lina Pinsach-Abuin, Mel; Perez-Serra, Alexandra; Mademont-Soler, Irene; Riuro, Helena; Pico, Ferran; Coll, Monica; Iglesias, Anna; Pagans, Sara; Sarquella-Brugada, Georgia; Berne, Paola; Benito, Begona; Brugada, Josep; Porres, Jose M.; Lopez Zea, Matilde; Castro-Urda, Victor; Fernandez-Lozano, Ignacio; Brugada, Ramon			Comprehensive Genetic Characterization of a Spanish Brugada Syndrome Cohort	PLOS ONE			English	Article							SUDDEN CARDIAC DEATH; LONG QT SYNDROME; SCN5A MUTATIONS; PREVALENCE; SPECTRUM; VARIANTS; DISEASE; RISK	Background Brugada syndrome (BrS) is a rare genetic cardiac arrhythmia that can lead to sudden cardiac death in patients with a structurally normal heart. Genetic variations in SCN5A can be identified in approximately 20-25% of BrS cases. The aim of our work was to determine the spectrum and prevalence of genetic variations in a Spanish cohort diagnosed with BrS. Methodology/ Principal Findings We directly sequenced fourteen genes reported to be associated with BrS in 55 unrelated patients clinically diagnosed. Our genetic screening allowed the identification of 61 genetic variants. Of them, 20 potentially pathogenic variations were found in 18 of the 55 patients (32.7% of the patients, 83.3% males). Nineteen of them were located in SCN5A, and had either been previously reported as pathogenic variations or had a potentially pathogenic effect. Regarding the sequencing of the minority genes, we discovered a potentially pathogenic variation in SCN2B that was described to alter sodium current, and one nonsense variant of unknown significance in RANGRF. In addition, we also identified 40 single nucleotide variations which were either synonymous variants (four of them had not been reported yet) or common genetic variants. We next performed MLPA analysis of SCN5A for the 37 patients without an identified genetic variation, and no major rearrangements were detected. Additionally, we show that being at the 30-50 years range or exhibiting symptoms are factors for an increased potentially pathogenic variation discovery yield. Conclusions In summary, the present study is the first comprehensive genetic evaluation of 14 BrS-susceptibility genes and MLPA of SCN5A in a Spanish BrS cohort. The mean pathogenic variation discovery yield is higher than that described for other European BrS cohorts (32.7% vs 20-25%, respectively), and is even higher for patients in the 30-50 years age range.	[Selga, Elisabet; Campuzano, Oscar; Lina Pinsach-Abuin, Mel; Perez-Serra, Alexandra; Mademont-Soler, Irene; Riuro, Helena; Pico, Ferran; Coll, Monica; Iglesias, Anna; Pagans, Sara; Brugada, Ramon] Inst Invest Biomed Girona IDIBGi, Cardiovasc Genet Ctr, Girona, Spain; [Selga, Elisabet; Campuzano, Oscar; Lina Pinsach-Abuin, Mel; Perez-Serra, Alexandra; Mademont-Soler, Irene; Riuro, Helena; Pico, Ferran; Coll, Monica; Iglesias, Anna; Pagans, Sara; Brugada, Ramon] Univ Girona UdG, Sch Med, Girona, Spain; [Sarquella-Brugada, Georgia] Univ Barcelona, Hosp St Joan de Deu, Dept Cardiol, Paediat Arrhythmia Unit, Barcelona, Spain; [Berne, Paola; Benito, Begona; Brugada, Josep] Univ Barcelona, Hosp Clin Barcelona, Arrhythmia Unit, Barcelona, Spain; [Porres, Jose M.] Hosp Univ Donostia, Arrhythmia Unit, San Sebastian, Spain; [Lopez Zea, Matilde] Hosp Ramon & Cajal, Pediat Cardiol Serv, E-28034 Madrid, Spain; [Castro-Urda, Victor; Fernandez-Lozano, Ignacio] Hosp Puerta Hierro, Arrhythmia Unit, Madrid, Spain; [Brugada, Ramon] Hosp Josep Trueta, Girona, Spain	Universitat de Girona; Girona University Hospital Dr. Josep Trueta; Institut d'Investigacio Biomedica de Girona (IDIBGI); Universitat de Girona; University of Barcelona; University of Barcelona; Hospital Clinic de Barcelona; Hospital Universitario Ramon y Cajal; Hospital Puerta de Hierro-Majadahonda; Universitat de Girona; Girona University Hospital Dr. Josep Trueta	Brugada, R (corresponding author), Inst Invest Biomed Girona IDIBGi, Cardiovasc Genet Ctr, Girona, Spain.	rbrugada@idibgi.org	Pinsach, Mel·lina/AAB-5293-2019; campuzano, oscar/J-1968-2014; Pagans, Sara/G-3407-2015; Selga, Elisabet/H-9007-2015; Stefanadis, Christodoulos/ABH-2232-2020; Sarquella-Brugada, Georgia/W-9278-2018; Berne, Paola/HHM-4858-2022	Pinsach, Mel·lina/0000-0001-7199-512X; campuzano, oscar/0000-0001-5298-5276; Pagans, Sara/0000-0003-0772-6982; Selga, Elisabet/0000-0002-4290-8370; Stefanadis, Christodoulos/0000-0001-5974-6454; Sarquella-Brugada, Georgia/0000-0002-6857-8904; Castro, Victor/0000-0002-8325-1379; Mademont-Soler, Irene/0000-0002-6501-9250; Fernandez Lozano, Ignacio/0000-0002-3092-8761; Berne, Paola/0000-0003-1160-4064	Obra social "la Caixa"; Centro Nacional de Investigaciones Cardiovasculares [CNIC-03-2008]; Instituto de Salud Carlos III [FIS-PI08/1800]; Instituto de Salud Carlos III (Fondo Europeo de Desarrollo Regional)	Obra social "la Caixa"(La Caixa Foundation); Centro Nacional de Investigaciones Cardiovasculares; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Instituto de Salud Carlos III (Fondo Europeo de Desarrollo Regional)	This work was supported by Obra social "la Caixa" (www.obrasocial.lacaixa.es/), Centro Nacional de Investigaciones Cardiovasculares (CNIC-03-2008; www.cnic.es/), and Instituto de Salud Carlos III (FIS-PI08/1800 and Fondo Europeo de Desarrollo Regional; www.isciii.es/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman MJ, 2011, EUROPACE, V13, P1077, DOI 10.1093/europace/eur245; Ackerman MJ, 2004, HEART RHYTHM, V1, P600, DOI 10.1016/j.hrthm.2004.07.013; Berne P, 2012, CIRC J, V76, P1563, DOI 10.1253/circj.CJ-12-0717; BRUGADA P, 1992, J AM COLL CARDIOL, V20, P1391, DOI 10.1016/0735-1097(92)90253-J; Campuzano O, 2014, CARDIOL J, V21, P121, DOI 10.5603/CJ.a2013.0125; Chen QY, 1998, NATURE, V392, P293, DOI 10.1038/32675; Cordeiro JM, 2006, CIRCULATION, V114, P2026, DOI 10.1161/CIRCULATIONAHA.106.627489; Crotti L, 2012, J AM COLL CARDIOL, V60, P1410, DOI 10.1016/j.jacc.2012.04.037; Eastaugh LJ, 2011, J CARDIOVASC ELECTR, V22, P1073, DOI 10.1111/j.1540-8167.2010.02003.x; Garcia-Castro M, 2010, REV ESP CARDIOL, V63, P856, DOI 10.1016/S0300-8932(10)70189-5; Garcia-Molina E, 2012, CLIN GENET; Giudicessi JR, 2013, TRANSL RES, V161, P1, DOI 10.1016/j.trsl.2012.08.005; Gollob MH, 2011, CAN J CARDIOL, V27, P232, DOI 10.1016/j.cjca.2010.12.078; Gouas L, 2005, EUR J HUM GENET, V13, P1213, DOI 10.1038/sj.ejhg.5201489; Hedley PL, 2009, HUM MUTAT, V30, P1486, DOI 10.1002/humu.21106; Hedley PL, 2009, HUM MUTAT, V30, P1256, DOI 10.1002/humu.21066; Holst AG, 2010, CARDIOLOGY, V115, P311, DOI 10.1159/000312747; Hong K, 2004, J CARDIOVASC ELECTR, V15, P64, DOI 10.1046/j.1540-8167.2004.03341.x; Kapplinger JD, 2010, HEART RHYTHM, V7, P33, DOI 10.1016/j.hrthm.2009.09.069; Kapplinger JD, 2009, HEART RHYTHM, V6, P1297, DOI 10.1016/j.hrthm.2009.05.021; Koopmann TT, 2007, HEART RHYTHM, V4, P752, DOI 10.1016/j.hrthm.2007.02.021; Kotta CM, 2010, INT J CARDIOL, V145, P45, DOI 10.1016/j.ijcard.2009.03.134; Lizotte E, 2009, J CARDIOVASC ELECTR, V20, P1137, DOI 10.1111/j.1540-8167.2009.01508.x; Makiyama T, 2005, J AM COLL CARDIOL, V46, P2100, DOI 10.1016/j.jacc.2005.08.043; Mizusawa Y, 2012, CIRC-ARRHYTHMIA ELEC, V5, P606, DOI 10.1161/CIRCEP.111.964577; Mok N. S., 2004, Hong Kong Medical Journal, V10, P32; Nakajima T, 2011, INT HEART J, V52, P27, DOI 10.1536/ihj.52.27; Napolitano C, 2005, JAMA-J AM MED ASSOC, V294, P2975, DOI 10.1001/jama.294.23.2975; Nielsen MW, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00179; Nunez L, 2013, HEART RHYTHM, V10, P264, DOI 10.1016/j.hrthm.2012.10.025; Olesen MS, 2011, CAN J CARDIOL, V27, DOI 10.1016/j.cjca.2011.01.003; Priori SG, 2002, CIRCULATION, V105, P1342, DOI 10.1161/hc1102.105288; Risgaard B, 2013, CLIN GENET, V84, P489, DOI 10.1111/cge.12126; Riuro H, 2013, HUM MUTAT, V34, P961, DOI 10.1002/humu.22328; Tarradas A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053220; Taschner PEM, 2011, HUM MUTAT, V32, P507, DOI 10.1002/humu.21427; Vatta M, 2002, HUM MOL GENET, V11, P337, DOI 10.1093/hmg/11.3.337; Watanabe H, 2011, CIRC-ARRHYTHMIA ELEC, V4, P874, DOI 10.1161/CIRCEP.111.963983; Wildeman M, 2008, HUM MUTAT, V29, P6, DOI 10.1002/humu.20654; Yokoi H, 2005, HEART RHYTHM, V2, P285, DOI 10.1016/j.hrthm.2004.11.022	40	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132888	10.1371/journal.pone.0132888	http://dx.doi.org/10.1371/journal.pone.0132888			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26173111	Green Submitted, Green Published, gold			2022-12-26	WOS:000358194900095
J	Campbell-Palmer, R; Del Pozo, J; Gottstein, B; Girling, S; Cracknell, J; Schwab, G; Rosell, F; Pizzi, R				Campbell-Palmer, Roisin; Del Pozo, Jorge; Gottstein, Bruno; Girling, Simon; Cracknell, John; Schwab, Gerhard; Rosell, Frank; Pizzi, Romain			Echinococcus multilocularis Detection in Live Eurasian Beavers (Castor fiber) Using a Combination of Laparoscopy and Abdominal Ultrasound under Field Conditions	PLOS ONE			English	Article							EUROPEAN BEAVER; RISK; INTRAPERITONEAL; ESTABLISHMENT; IMPLANTATION; POPULATION; PREVALENCE; DOGS	Echinococcus multilocularis is an important pathogenic zoonotic parasite of health concern, though absent in the United Kingdom. Eurasian beavers (Castor fiber) may act as a rare intermediate host, and so unscreened wild caught individuals may pose a potential risk of introducing this parasite to disease-free countries through translocation programs. There is currently no single definitive ante-mortem diagnostic test in intermediate hosts. An effective non-lethal diagnostic, feasible under field condition would be helpful to minimise parasite establishment risk, where indiscriminate culling is to be avoided. This study screened live beavers (captive, n = 18 or wild-trapped in Scotland, n = 12) and beaver cadavers (wild Scotland, n = 4 or Bavaria, n = 11), for the presence of E. multilocularis. Ultrasonography in combination with minimally invasive surgical examination of the abdomen by laparoscopy was viable under field conditions for real-time evaluation in beavers. Laparoscopy alone does not allow the operator to visualize the parenchyma of organs such as the liver, or inside the lumen of the gastrointestinal tract, hence the advantage of its combination with abdominal ultrasonography. All live beavers and Scottish cadavers were largely unremarkable in their haematology and serum biochemistry with no values suspicious for liver pathology or potentially indicative of E. multilocularis infection. This correlated well with ultrasound, laparoscopy, and immunoblotting, which were unremarkable in these individuals. Two wild Bavarian individuals were suspected E. multilocularis positive at post-mortem, through the presence of hepatic cysts. Sensitivity and specificity of a combination of laparoscopy and abdominal ultrasonography in the detection of parasitic liver cyst lesions was 100% in the subset of cadavers (95% Confidence Intervals 34.24-100%, and 86.7-100% respectively). For abdominal ultrasonography alone sensitivity was only 50% (95% CI 9.590.6%), with specificity being 100% (95% CI 79.2-100%). For laparoscopy alone sensitivity was 100% (95% CI 34.2-100%), with specificity also being 100% (95% CI 77.2-100%). Further immunoblotting, PCR and histopathological examination revealed one individual positive for E. multilocularis, whilst the other individual was positive for Taenia martis.	[Campbell-Palmer, Roisin; Girling, Simon; Pizzi, Romain] Royal Zool Soc Scotland, Vet Dept & Conservat Programmes, Edinburgh, Midlothian, Scotland; [Del Pozo, Jorge] Univ Edinburgh, Royal Dick Sch Vet Studies, Dept Vet Pathol, Edinburgh EH9 1QH, Midlothian, Scotland; [Gottstein, Bruno] Univ Bern, Vetsuisse Fac, Inst Parasitol, Bern, Switzerland; [Cracknell, John] Longleat Safari & Adventure Pk, Warminster, England; [Schwab, Gerhard] Bund Naturschutz Bayern eV, Deggendorf, Germany; [Campbell-Palmer, Roisin; Rosell, Frank] Telemark Univ Coll, Dept Environm & Hlth Studies, Bo, Norway; [Pizzi, Romain] Natl Wildlife Rescue Ctr, Scottish Soc Prevent Cruelty Animals, Fishcross, Scotland	University of Edinburgh; University of Bern; University College of Southeast Norway	Campbell-Palmer, R (corresponding author), Royal Zool Soc Scotland, Vet Dept & Conservat Programmes, Edinburgh, Midlothian, Scotland.	rcampbellpalmer@rzss.org.uk	Pizzi, Romain/AAW-6360-2020	Pizzi, Romain/0000-0002-9030-9559; Girling, Simon/0000-0001-9927-9491	Scottish Natural Heritage; examination of the Scottish beavers; Swiss National Science Foundation [31003A-125990]	Scottish Natural Heritage; examination of the Scottish beavers; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	Funding was recieved from Scottish Natural Heritage for the trapping and examination of the Scottish beavers (RCP, RP, SG). Payment was recieved for the screening of the captive collection animals, as a private client (RCP, RP). Royal Zoological Society of Scotland, Telemark University College and Zoological Medicine Ltd provided funding in the form of staff wages and expenses for screening work of Bavarian animals (RCP, SG, RP, FR). Molecular investigations were funded by Swiss National Science Foundation - grant no 31003A-125990. Longleat Safari and Adventure Park provided support in the form of salaries for authors [JC], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldred J., 2014, GUARDIAN; Bailey JE, 1999, VETERINARY ENDOSURGERY, P24; Barlow AM, 2011, VET REC, V169, DOI 10.1136/vr.d4673; Campbell RD, 2014, 540 SCOTT NAT HER; Campbell-Palmer R, 2015, 681 SCOTT NAT HER; Campbell-Palmer R, 2013, HUSBANDRY GUIDELINES; Campbell-Palmer R, 2012, VET REC, V170, P235, DOI 10.1136/vr.e1508; Cirovic D, 2012, VET REC, V171, DOI 10.1136/vr.100879; Coles B.J, 2006, BEAVERS BRITAINS; Cook Robert A., 1999, P30; Cronstedt-Fell A, 2010, 9 EWDA C VLIEL 2010; Davidson R, 2010, ANN REPORT 2009 NATL; DEFRA, 2012, QUAL RISK ASS; Deplazes P, 1999, J PARASITOL, V85, P115, DOI 10.2307/3285713; Dinkel A, 1998, J CLIN MICROBIOL, V36, P1871, DOI 10.1128/JCM.36.7.1871-1876.1998; Dore F, 2014, VET PARASITOL, V203, P59, DOI 10.1016/j.vetpar.2014.03.016; Eckert J, 2001, WHO/OIE MANUAL ON ECHINOCOCCOSIS IN HUMANS AND ANIMALS: A PUBLIC HEALTH PROBLEM OF GLOBAL CONCERN, P100; Eckert J., 1997, Parassitologia (Rome), V39, P337; Eckert J, 2000, INT J PARASITOL, V30, P1283, DOI 10.1016/S0020-7519(00)00130-2; FREEMAN LJ, 1999, VET ENDOSURGERY; Goodman G, 2012, J WILDLIFE DIS, V48, P971, DOI 10.7589/2011-06-153; Gottstein B, 2001, EMERG INFECT DIS, V7, P408; Gottsteina B, 2014, VET PARASITOL, V205, P113, DOI 10.1016/j.vetpar.2014.06.017; Gurnell J, 2009, ENV SOCIAL IMPACTS F, P109; Halley D, 2009, 457 NINA; Halley DJ, 2002, MAMMAL REV, V32, P153, DOI 10.1046/j.1365-2907.2002.00106.x; Halley D, 2012, BALT FOR, V18, P168; Janovsky M, 2002, J WILDLIFE DIS, V38, P618, DOI 10.7589/0090-3558-38.3.618; Kalema-Zikusoka G, 2001, J ZOO WILDLIFE MED, V32, P509, DOI 10.1638/1042-7260(2001)032[0509:RPIAFR]2.0.CO;2; Kapel CMO, 2006, INT J PARASITOL, V36, P79, DOI 10.1016/j.ijpara.2005.08.012; Kern P, 2010, CURR OPIN INFECT DIS, V23, P505, DOI 10.1097/QCO.0b013e32833d7516; Kosmider R, 2013, VET REC, V172, DOI 10.1136/vr.101572; Lhermette P, 2008, BSAVA MANUAL ENDOSCO, P1; McEwing R, 2015, 686 SCOTT NAT HER; Moons CPH, 2007, LAB ANIM-UK, V41, P262, DOI 10.1258/002367707780378177; Nolet BA, 1998, BIOL CONSERV, V83, P165, DOI 10.1016/S0006-3207(97)00066-9; Osterman Lind E, 2011, EURO SURVEILL, V16, DOI 19836; Pizzi R, 2011, VET REC, V169, DOI 10.1136/vr.d4985; Pizzi R., 2014, ZOO WILD ANIMAL MED, V8, P688; Pizzi Romain, 2011, Veterinary Medicine International, V2011, P1, DOI 10.4061/2011/131368; Pizzi R, 2012, VET REC, V170, P293, DOI 10.1136/vr.e2041; Quinn JH, 2010, J ZOO WILDLIFE MED, V41, P174, DOI 10.1638/2009-0125.1; Ranheim B, 2004, WILDLIFE BIOL, V10, P11, DOI 10.2981/wlb.2004.004; Romig T, 2006, PARASITOL INT, V55, pS187, DOI 10.1016/j.parint.2005.11.028; Rosell F, 2001, WILDLIFE SOC B, V29, P269; Saitoh T, 1998, RES POPUL ECOL, V40, P97, DOI 10.1007/BF02765225; Sergeant E., 2015, EPITOOLS EPIDEMIOLOG; Simpson V, 2011, VET REC, V169, P689, DOI 10.1136/vr.d8249; Torgerson PR, 2009, VET REC, V165, P366, DOI 10.1136/vr.165.13.366; Torgerson PR, 2009, TRENDS PARASITOL, V25, P164, DOI 10.1016/j.pt.2008.12.008; Toth B, 2010, CHANG LIK ECH MULT A, P29; Vuitton DA, 2003, PARASITOLOGY, V127, pS87, DOI 10.1017/S0031182003004153; Wahlstrom H, 2011, ACTA VET SCAND, V53, DOI 10.1186/1751-0147-53-9; Wimmershoff J, 2012, P JOINT WDA EWDA C L, P37; Woodford MH., 2001, OFFICE INT EPIZOOTIE	55	14	14	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0130842	10.1371/journal.pone.0130842	http://dx.doi.org/10.1371/journal.pone.0130842			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26167927	Green Published, gold			2022-12-26	WOS:000358193100005
J	Charbonnier, L; van der Laan, LN; Viergever, MA; Smeets, PAM				Charbonnier, Lisette; van der Laan, Laura N.; Viergever, Max A.; Smeets, Paul A. M.			Functional MRI of Challenging Food Choices: Forced Choice between Equally Liked High- and Low-Calorie Foods in the Absence of Hunger	PLOS ONE			English	Article							SUPERIOR TEMPORAL SULCUS; ORBITOFRONTAL CORTEX; UNRESTRAINED EATERS; PREFRONTAL CORTEX; DECISION-MAKING; EATING BEHAVIOR; REWARD; BRAIN; ACTIVATION; ATTENTION	We are continuously exposed to food and during the day we make many food choices. These choices play an important role in the regulation of food intake and thereby in weight management. Therefore, it is important to obtain more insight into the mechanisms that underlie these choices. While several food choice functional MRI (fMRI) studies have been conducted, the effect of energy content on neural responses during food choice has, to our knowledge, not been investigated before. Our objective was to examine brain responses during food choices between equally liked high-and low-calorie foods in the absence of hunger. During a 10-min fMRI scan 19 normal weight volunteers performed a forced-choice task. Food pairs were matched on individual liking but differed in perceived and actual caloric content (high-low). Food choice compared with non-food choice elicited stronger unilateral activation in the left insula, superior temporal sulcus, posterior cingulate gyrus and (pre) cuneus. This suggests that the food stimuli were more salient despite subject's low motivation to eat. The right superior temporal sulcus (STS) was the only region that exhibited greater activation for high versus low calorie food choices between foods matched on liking. Together with previous studies, this suggests that STS activation during food evaluation and choice may reflect the food's biological relevance independent of food preference. This novel finding warrants further research into the effects of hunger state and weight status on STS, which may provide a marker of biological relevance.	[Charbonnier, Lisette; van der Laan, Laura N.; Viergever, Max A.; Smeets, Paul A. M.] Univ Med Ctr Utrecht, Image Sci Inst, Utrecht, Netherlands; [Smeets, Paul A. M.] Wageningen Univ, Div Human Nutr, NL-6700 AP Wageningen, Netherlands	Utrecht University; Utrecht University Medical Center; Wageningen University & Research	Charbonnier, L (corresponding author), Univ Med Ctr Utrecht, Image Sci Inst, Utrecht, Netherlands.	lisette@isi.uu.nl	Viergever, Max A/J-1215-2014; Smeets, Paul AM/B-7979-2010	Smeets, Paul AM/0000-0002-8695-9612; van der Laan, Laura Nynke/0000-0003-4307-0888	European Union [266408]	European Union(European Commission)	This study was part of the Full4Health project (www.full4health.eu), funded by the European Union Seventh Framework Program (FP7/2007-2013) under grant agreement number 266408.	Baecke S., 2008, J CONSUM BEHAV, V7, P342, DOI [DOI 10.1002/cb.256, 10.1002/cb.256]; Ballard K, 2009, NEUROIMAGE, V45, P143, DOI 10.1016/j.neuroimage.2008.11.004; Berthoud HR, 2006, OBESITY, V14, P197; Born JM, 2011, AM J CLIN NUTR, V94, P392, DOI 10.3945/ajcn.111.012161; Castellanos EH, 2009, INT J OBESITY, V33, P1063, DOI 10.1038/ijo.2009.138; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Coletta M, 2009, J ABNORM PSYCHOL, V118, P598, DOI 10.1037/a0016201; Epstein LH, 2006, APPETITE, V46, P22, DOI 10.1016/j.appet.2005.04.006; Fedoroff I, 2003, APPETITE, V41, P7, DOI 10.1016/S0195-6663(03)00026-6; Finlayson G, 2008, APPETITE, V50, P120, DOI 10.1016/j.appet.2007.06.007; Finlayson G, 2007, PHYSIOL BEHAV, V90, P36, DOI 10.1016/j.physbeh.2006.08.020; Fisher JO, 2002, AM J CLIN NUTR, V76, P226, DOI 10.1093/ajcn/76.1.226; FitzGerald THB, 2009, J NEUROSCI, V29, P8388, DOI 10.1523/JNEUROSCI.0717-09.2009; Frank S, 2010, BRAIN RES, V1350, P159, DOI 10.1016/j.brainres.2010.04.030; Grabenhorst F, 2013, NEUROIMAGE, V74, P152, DOI 10.1016/j.neuroimage.2013.02.012; Grabenhorst F, 2011, TRENDS COGN SCI, V15, P56, DOI 10.1016/j.tics.2010.12.004; Griffioen-Roose S, 2010, APPETITE, V55, P648, DOI 10.1016/j.appet.2010.09.018; Hare TA, 2011, J NEUROSCI, V31, P11077, DOI 10.1523/JNEUROSCI.6383-10.2011; Heekeren HR, 2003, NEUROREPORT, V14, P1215, DOI 10.1097/00001756-200307010-00005; Hein G, 2008, J COGNITIVE NEUROSCI, V20, P2125, DOI 10.1162/jocn.2008.20148; Kang MJ, 2011, J NEUROSCI, V31, P461, DOI 10.1523/JNEUROSCI.1583-10.2011; Killgore WDS, 2003, NEUROIMAGE, V19, P1381, DOI 10.1016/S1053-8119(03)00191-5; Kim H, 2011, CEREB CORTEX, V21, P769, DOI 10.1093/cercor/bhq145; Klein S, 2010, IEEE T MED IMAGING, V29, P196, DOI 10.1109/TMI.2009.2035616; Knutson B, 2003, NEUROIMAGE, V18, P263, DOI 10.1016/S1053-8119(02)00057-5; Knutson B, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0002.2001; Knutson B, 2007, NEURON, V53, P147, DOI 10.1016/j.neuron.2006.11.010; LaBar KS, 2001, BEHAV NEUROSCI, V115, P493, DOI 10.1037//0735-7044.115.2.493; Levy DJ, 2011, J NEUROSCI, V31, P14693, DOI 10.1523/JNEUROSCI.2218-11.2011; Lieberman MD, 2009, SOC COGN AFFECT NEUR, V4, P423, DOI 10.1093/scan/nsp052; Linder NS, 2010, NEUROIMAGE, V53, P215, DOI 10.1016/j.neuroimage.2010.05.077; McLellan F, 2002, LANCET, V359, P1412, DOI 10.1016/S0140-6736(02)08397-6; Mela DJ, 2006, APPETITE, V47, P10, DOI 10.1016/j.appet.2006.02.006; Narumoto J, 2001, COGNITIVE BRAIN RES, V12, P225, DOI 10.1016/S0926-6410(01)00053-2; Nijs IMT, 2010, APPETITE, V54, P243, DOI 10.1016/j.appet.2009.11.004; Paulus MP, 2006, BIOL PSYCHIAT, V60, P383, DOI 10.1016/j.biopsych.2006.03.042; Pessoa L, 2002, P NATL ACAD SCI USA, V99, P11458, DOI 10.1073/pnas.172403899; Peters J C, 2002, Obes Rev, V3, P69, DOI 10.1046/j.1467-789X.2002.00059.x; Piech RM, 2010, BRAIN COGNITION, V72, P282, DOI 10.1016/j.bandc.2009.09.012; Plassmann H, 2007, J NEUROSCI, V27, P9984, DOI 10.1523/JNEUROSCI.2131-07.2007; Plassmann H, 2010, J NEUROSCI, V30, P10799, DOI 10.1523/JNEUROSCI.0788-10.2010; Rothemund Y, 2007, NEUROIMAGE, V37, P410, DOI 10.1016/j.neuroimage.2007.05.008; Saper CB, 2002, NEURON, V36, P199, DOI 10.1016/S0896-6273(02)00969-8; Shomaker LB, 2010, AM J CLIN NUTR, V92, P697, DOI 10.3945/ajcn.2010.29812; Siep N, 2009, BEHAV BRAIN RES, V198, P149, DOI 10.1016/j.bbr.2008.10.035; Simmons WK, 2005, CEREB CORTEX, V15, P1602, DOI 10.1093/cercor/bhi038; Smeets PAM, 2013, BEHAV BRAIN RES, V248, P41, DOI 10.1016/j.bbr.2013.03.041; Smeets PAM, 2012, P NUTR SOC, V71, P511, DOI 10.1017/S0029665112000808; Stoeckel LE, 2008, NEUROIMAGE, V41, P636, DOI 10.1016/j.neuroimage.2008.02.031; Toepel U, 2010, FAT DETECTION TASTE; Toepel U, 2009, NEUROIMAGE, V44, P967, DOI 10.1016/j.neuroimage.2008.10.005; Uher R, 2006, BEHAV BRAIN RES, V169, P111, DOI 10.1016/j.bbr.2005.12.008; van der Laan LN, 2011, NEUROIMAGE, V55, P296, DOI 10.1016/j.neuroimage.2010.11.055; Van der Laan LN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041738; VANSTRIEN T, 1986, INT J EAT DISORDER, V5, P295, DOI 10.1002/1098-108X(198602)5:2<295::AID-EAT2260050209>3.0.CO;2-T	55	33	34	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0131727	10.1371/journal.pone.0131727	http://dx.doi.org/10.1371/journal.pone.0131727			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1PW	26167916	Green Published, Green Submitted, gold			2022-12-26	WOS:000358193100013
J	Zhao, J; Zhong, Q; Zhao, Y; Hu, YX; Zhang, GZ				Zhao, Jing; Zhong, Qi; Zhao, Ye; Hu, Yan-xin; Zhang, Guo-zhong			Pathogenicity and Complete Genome Characterization of Fowl Adenoviruses Isolated from Chickens Associated with Inclusion Body Hepatitis and Hydropericardium Syndrome in China	PLOS ONE			English	Article							MOLECULAR CHARACTERIZATION; GIZZARD EROSIONS; OUTBREAKS; SEQUENCE; STRAINS; INFECTION	In this study, we determined and genetically characterized three fowl adenoviruses isolated from chickens with inclusion body hepatitis (IBH) and hydropericardium syndrome (HPS) in China and assessed their pathogenicity. The full genome of HBQ12, BJH13 and JSJ13 was found to be 44,081, 43,966 and 43,756 nucleotides long, respectively. Sequence alignment and phylogenetic analysis revealed that strain HBQ12 and BJH13 were clustered together belonging to fowl adenoviruses D species and serotyped as FAdV-11, whereas strain JSJ13 was classified into fowl adenoviruses C species and serotyped as FAdV-4. To our knowledge, this is the first report of FAdV-4 strain circulating in China. The pathogenicity test showed that mortality for chickens infected with HBQ12 and JSJ13 within 21 days post infection (dpi) was 8.6% and 28.6%, respectively. Necropsy displayed mild or severe hepatitis and hydropericardium at 3 and 5 dpi as well as dead chickens. Viral DNA was detected in almost all tissues sampled from dead chickens. These results revealed that fowl adenovirus strains HBQ12 and JSJ13 are capable of causing IBH and HPS in chickens, indicating that preventive measures against FAdV infection on poultry farms should be implemented in China.	[Zhao, Jing; Zhong, Qi; Zhao, Ye; Hu, Yan-xin; Zhang, Guo-zhong] China Agr Univ, Minist Agr, Coll Vet Med, Key Lab Anim Epidemiol & Zoonosis, Beijing 100094, Peoples R China	China Agricultural University; Ministry of Agriculture & Rural Affairs	Zhang, GZ (corresponding author), China Agr Univ, Minist Agr, Coll Vet Med, Key Lab Anim Epidemiol & Zoonosis, Beijing 100094, Peoples R China.	zhanggz@cau.edu.cn			China Agriculture Research System Poultry-related Science and Technology Innovation Team of Peking (CARS-PSTP)	China Agriculture Research System Poultry-related Science and Technology Innovation Team of Peking (CARS-PSTP)	This study was supported by the China Agriculture Research System Poultry-related Science and Technology Innovation Team of Peking (CARS-PSTP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarado IR, 2007, AVIAN DIS, V51, P27, DOI 10.1637/0005-2086(2007)051[0027:GCPAPS]2.0.CO;2; Chiocca S, 1996, J VIROL, V70, P2939, DOI 10.1128/JVI.70.5.2939-2949.1996; Choi KS, 2012, POULTRY SCI, V91, P2502, DOI 10.3382/ps.2012-02296; Dahiya S, 2002, AVIAN DIS, V46, P230, DOI 10.1637/0005-2086(2002)046[0230:FASAWO]2.0.CO;2; Domanska-Blicharz K, 2011, POULTRY SCI, V90, P983, DOI 10.3382/ps.2010-01214; Gjevre AG, 2013, AVIAN PATHOL, V42, P297, DOI 10.1080/03079457.2013.817665; Grgic H, 2014, VIRUS GENES, V48, P74, DOI 10.1007/s11262-013-0995-y; Grgic H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077601; Harrach B, 2012, VIRUS TAXONOMY, V9, P125, DOI DOI 10.1016/B978-0-12-384684-6.00009-4; Harrach B., 2011, SPRINGER INDEX VIRUS; Hess M, 2000, AVIAN PATHOL, V29, P195, DOI 10.1080/03079450050045440; Kajan GL, 2013, VET MICROBIOL, V167, P357, DOI 10.1016/j.vetmic.2013.09.025; Kim JN, 2008, AVIAN DIS, V52, P526, DOI 10.1637/8178-112207-Case; Li HaiYing, 2010, Chinese Veterinary Science / Zhongguo Shouyi Kexue, V40, P722; Marek A, 2013, VET MICROBIOL, V166, P250, DOI 10.1016/j.vetmic.2013.05.017; Marek A, 2010, J VET DIAGN INVEST, V22, P937, DOI 10.1177/104063871002200613; Mase M, 2012, J VET MED SCI, V74, P1087, DOI 10.1292/jvms.11-0443; Mazaheri A, 1998, AVIAN PATHOL, V27, P269, DOI 10.1080/03079459808419335; Mendelson C, 1995, AVIAN PATHOL, V24, P693, DOI 10.1080/03079459508419108; Mittal Dinesh, 2014, Indian Journal of Virology, V25, P114, DOI 10.1007/s13337-013-0183-7; Nakamura K, 1999, AVIAN DIS, V43, P414, DOI 10.2307/1592638; Ojkic D, 2000, J GEN VIROL, V81, P1833, DOI 10.1099/0022-1317-81-7-1833; Ojkic D, 2001, VIROLOGY, V283, P197, DOI 10.1006/viro.2000.0890; Ojkic D, 2008, AVIAN PATHOL, V37, P95, DOI 10.1080/03079450701805324; Okuda Y, 2004, J VET MED SCI, V66, P1561, DOI 10.1292/jvms.66.1561; REED L. J., 1938, AMER JOUR HYG, V27, P493; Schachner A, 2014, VACCINE, V32, P1086, DOI 10.1016/j.vaccine.2013.12.056; Schonewille E, 2008, VET IMMUNOL IMMUNOP, V121, P130, DOI 10.1016/j.vetimm.2007.09.017; Senne DA., 1989, LAB MANUAL ISOLATION, V3rd Edit, P176; Steer PA, 2015, AVIAN PATHOL, V44, P106, DOI 10.1080/03079457.2015.1007919; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Toro H, 2002, AVIAN DIS, V46, P547, DOI 10.1637/0005-2086(2002)046[0547:POIBHH]2.0.CO;2; WELLS RJH, 1974, VET REC, V94, P481, DOI 10.1136/vr.94.21.481	33	76	107	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0133073	10.1371/journal.pone.0133073	http://dx.doi.org/10.1371/journal.pone.0133073			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26167857	gold, Green Published			2022-12-26	WOS:000358193100107
J	Kingston, AW; Roussel-Rossin, C; Dupont, C; Raleigh, EA				Kingston, Anthony W.; Roussel-Rossin, Chloe; Dupont, Claire; Raleigh, Elisabeth A.			Novel recA-Independent Horizontal Gene Transfer in Escherichia coli K-12	PLOS ONE			English	Article							FUNCTIONAL INTERACTION; BIOFILM FORMATION; DNA; RECOMBINATION; EVOLUTION; SEQUENCE; PROTEIN; IDENTIFICATION; REPAIR; RESTRICTION	In bacteria, mechanisms that incorporate DNA into a genome without strand-transfer proteins such as RecA play a major role in generating novelty by horizontal gene transfer. We describe a new illegitimate recombination event in Escherichia coli K-12: RecA-independent homologous replacements, with very large (megabase-length) donor patches replacing recipient DNA. A previously uncharacterized gene (yjiP) increases the frequency of RecA-independent replacement recombination. To show this, we used conjugal DNA transfer, combining a classical conjugation donor, HfrH, with modern genome engineering methods and whole genome sequencing analysis to enable interrogation of genetic dependence of integration mechanisms and characterization of recombination products. As in classical experiments, genomic DNA transfer begins at a unique position in the donor, entering the recipient via conjugation; antibiotic resistance markers are then used to select recombinant progeny. Different configurations of this system were used to compare known mechanisms for stable DNA incorporation, including homologous recombination, F'-plasmid formation, and genome duplication. A genome island of interest known as the immigration control region was specifically replaced in a minority of recombinants, at a frequency of 3 X 10(-12) CFU/recipient per hour.	[Kingston, Anthony W.; Roussel-Rossin, Chloe; Dupont, Claire; Raleigh, Elisabeth A.] New England Biolabs Inc, Ipswich, MA 01938 USA	New England Biolabs	Raleigh, EA (corresponding author), New England Biolabs Inc, Ipswich, MA 01938 USA.	raleigh@neb.com		Raleigh, Elisabeth A./0000-0003-0745-9925	New England Biolabs	New England Biolabs	New England Biolabs provided financial support in the form of salaries for authors AWK, CD, CRR, EAR, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	ACHTMAN M, 1978, J BACTERIOL, V135, P1053, DOI 10.1128/JB.135.3.1053-1061.1978; AMUNDSEN SK, 1986, P NATL ACAD SCI USA, V83, P5558, DOI 10.1073/pnas.83.15.5558; Andersson DI, 2009, ANNU REV GENET, V43, P167, DOI 10.1146/annurev-genet-102108-134805; Babic A, 2008, SCIENCE, V319, P1533, DOI 10.1126/science.1153498; BACHMANN BJ, 1972, BACTERIOL REV, V36, P525, DOI 10.1128/MMBR.36.4.525-557.1972; BACHMANN BJ, 1976, BACTERIOL REV, V40, P116, DOI 10.1128/MMBR.40.1.116-167.1976; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; BLAKELY G, 1993, CELL, V75, P351, DOI 10.1016/0092-8674(93)80076-Q; Bzymek M, 2001, P NATL ACAD SCI USA, V98, P8319, DOI 10.1073/pnas.111008398; Chaudhuri RR, 2012, INFECT GENET EVOL, V12, P214, DOI 10.1016/j.meegid.2012.01.005; Chayot R, 2010, P NATL ACAD SCI USA, V107, P2141, DOI 10.1073/pnas.0906355107; Cox MM, 2000, PROG NUCLEIC ACID RE, V63, P311, DOI 10.1016/S0079-6603(08)60726-6; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Darmon E, 2014, MICROBIOL MOL BIOL R, V78, P1, DOI 10.1128/MMBR.00035-13; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; de la Cruz F, 2000, TRENDS MICROBIOL, V8, P128, DOI 10.1016/S0966-842X(00)01703-0; Didelot X, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-256; Dordet-Frisoni E, 2014, MBIO, V5, DOI 10.1128/mBio.01958-14; Dutra BE, 2007, P NATL ACAD SCI USA, V104, P216, DOI 10.1073/pnas.0608293104; Grainge I, 2011, NUCLEIC ACIDS RES, V39, P5140, DOI 10.1093/nar/gkr078; Guglielmini J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002222; Haft DH, 2001, NUCLEIC ACIDS RES, V29, P41, DOI 10.1093/nar/29.1.41; HANAHAN D, 1991, METHOD ENZYMOL, V204, P63; Herzberg M, 2006, J BACTERIOL, V188, P587, DOI 10.1128/JB.188.2.587-598.2006; Kosinski J, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-172; KOWALCZYKOWSKI SC, 1991, BIOCHIMIE, V73, P289, DOI 10.1016/0300-9084(91)90216-N; Kuzminov A, 1999, GENE DEV, V13, P345, DOI 10.1101/gad.13.3.345; LANKA E, 1995, ANNU REV BIOCHEM, V64, P141, DOI 10.1146/annurev.bi.64.070195.001041; Lawrence Jeffrey G., 2009, V532, P29, DOI 10.1007/978-1-60327-853-9_3; Lesic B, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002529; LLOYD RG, 1995, GENETICS, V139, P1123; Luo CW, 2011, P NATL ACAD SCI USA, V108, P7200, DOI 10.1073/pnas.1015622108; Ma NJ, 2014, NAT PROTOC, V9, P2285, DOI 10.1038/nprot.2014.081; Madsen JS, 2012, FEMS IMMUNOL MED MIC, V65, P183, DOI 10.1111/j.1574-695X.2012.00960.x; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; MASSON L, 1986, NUCLEIC ACIDS RES, V14, P5693, DOI 10.1093/nar/14.14.5693; MCCLAIN MS, 1991, J BACTERIOL, V173, P5308, DOI 10.1128/jb.173.17.5308-5314.1991; McCusker MP, 2008, MOL MICROBIOL, V67, P171, DOI 10.1111/j.1365-2958.2007.06037.x; Merkel WK, 1996, FEMS MICROBIOL LETT, V143, P247, DOI 10.1016/0378-1097(96)00321-7; Milkman R, 2003, GENETICS, V163, P475; Murray NE, 2002, MICROBIOL-SGM, V148, P3, DOI 10.1099/00221287-148-1-3; PIEKAROWICZ A, 1991, NUCLEIC ACIDS RES, V19, P1831, DOI 10.1093/nar/19.8.1831; Puymege A, 2015, MOL GENET GENOMICS; Ragan MA, 2009, PHILOS T R SOC B, V364, P2241, DOI 10.1098/rstb.2009.0031; RALEIGH EA, 1992, MOL MICROBIOL, V6, P1079, DOI 10.1111/j.1365-2958.1992.tb01546.x; Rasko DA, 2008, J BACTERIOL, V190, P6881, DOI 10.1128/JB.00619-08; SCHLAKE T, 1994, BIOCHEMISTRY-US, V33, P12746, DOI 10.1021/bi00209a003; Schubert S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000257; Sibley MH, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1085; Sibley MH, 2004, NUCLEIC ACIDS RES, V32, P522, DOI 10.1093/nar/gkh194; Singleton MR, 2004, NATURE, V432, P187, DOI 10.1038/nature02988; Steczkiewicz K, 2012, NUCLEIC ACIDS RES, V40, P7016, DOI 10.1093/nar/gks382; STERNBERG NL, 1991, METHOD ENZYMOL, V204, P18; Switt AIM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041247; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Tamames J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-136; Tenaillon O, 2010, NAT REV MICROBIOL, V8, P207, DOI 10.1038/nrmicro2298; Touchon M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000344; Travers KJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq543; Vieira G, 2011, J BACTERIOL, V193, P1461, DOI 10.1128/JB.01192-10; Wellington EMH, 2013, LANCET INFECT DIS, V13, P155, DOI 10.1016/S1473-3099(12)70317-1; Wiles TJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003175; WILLETTS NS, 1969, J BACTERIOL, V97, P244, DOI 10.1128/JB.97.1.244-249.1969; Yates J, 2006, MOL MICROBIOL, V59, P1754, DOI 10.1111/j.1365-2958.2005.05033.x; Zhang ZG, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000689; Zhou JD, 2013, NUCLEIC ACIDS RES, V41, pD613, DOI 10.1093/nar/gks1235	66	11	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0130813	10.1371/journal.pone.0130813	http://dx.doi.org/10.1371/journal.pone.0130813			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26162088	Green Published, Green Submitted, gold			2022-12-26	WOS:000358162300021
J	Paik, JS; Jung, SK; Han, KD; Kim, SD; Park, YM; Yang, SW				Paik, Ji-Sun; Jung, Su-Kyung; Han, Kyung-Do; Kim, Sang-Duck; Park, Yong-Moon; Yang, Suk-Woo			Obesity as a Potential Risk Factor for Blepharoptosis: The Korea National Health and Nutrition Examination Survey 2008-2010	PLOS ONE			English	Article							METABOLIC SYNDROME; DYSLIPIDEMIA	Purpose To examine obesity parameters as potential risk factors associated with blepharoptosis in a representative Korean population. Methods We analyzed the Korea National Health and Nutrition Examination Survey (KNHANES), conducted between 2008 and 2010. 10,285 Korean adults (4,441 men and 5,844 women) aged 40 years or older was enrolled. We compared body mass index (BMI), waist circumference (WC) and percentage body fat (BF), according to the severity of blepharoptosis. Multiple logistic regression analysis was conducted to examine the associations of each obesity parameter with blepharoptosis. Results The overall prevalence of age-related blepharoptosis was 14.8 % in South Korea. There were significant and graded associations between increasing blepharoptosis severity and the mean value of obesity parameters (P for trend < 0.05). As marginal reflex distance 1 (MRD1) decreased, the prevalence of general obesity and overweight status increased (P for trend=0.121 in men and < 0.001 in women); the prevalence of abdominal obesity increased (P for trend < 0.001 for both genders); the prevalence of highest quartile of percentage BF increased (P for trend <= 0.001 for both genders). Blepharoptosis was significantly associated with general obesity in women (adjusted odds ratio (aOR), 2.14; 95% confidence intervals (CI), 1.32-3.47); and with the highest quartile of percentage BF in men (aOR, 2.01; 95% CI, 1.34-2.97) and in women (aOR, 1.52; 95% CI, 1.06-2.3317, after adjusting for age, smoking exercise, drinking alcohol, total energy intake, fat intake, total cholesterol, and high density lipoprotein cholesterol, diabetes, hypertension, and family history of eye disease. Conclusions The etiology of age-related blepharoptosis may be multifactorial and is unclear. Our results suggest that obesity parameters such as BMI, WC and percentage BF might be potential risk factors for age-related blepharoptosis in a representative Korean population.	[Paik, Ji-Sun; Jung, Su-Kyung; Yang, Suk-Woo] Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Dept Ophthalmol & Visual Sci, Seoul, South Korea; [Han, Kyung-Do] Catholic Univ Korea, Coll Med, Dept Biostat, Seoul, South Korea; [Kim, Sang-Duck] Wonkwang Univ, Coll Med, Dept Ophthalmol, Iksan, South Korea; [Park, Yong-Moon] Univ S Carolina, Arnold Sch Publ Hlth, Dept Epidemiol & Biostat, Columbia, SC 29208 USA	Catholic University of Korea; Seoul St. Mary's Hospital; Catholic University of Korea; Wonkwang University; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Park, YM (corresponding author), Univ S Carolina, Arnold Sch Publ Hlth, Dept Epidemiol & Biostat, 800 Sumter St, Columbia, SC 29208 USA.	markYMpark@gmail.com; yswoph@catholic.ac.kr	PARK, YONG-MOON ("MARK")/ABA-2765-2021	PARK, YONG-MOON ("MARK")/0000-0002-5879-6879	National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2013R1A1A3007696]	National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of Korea)	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2013R1A1A3007696). The authors discussed with Epidemiologic Survey Committee of the Korean Ophthalmologic Society to deal with national data correctly and accurately.	Ahmadi AJ, 2005, OPHTHAL PLAST RECONS, V21, P46, DOI 10.1097/01.IOP.0000151275.88977.84; Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; Bastiaensen L A, 1985, Ophthalmology, V92, p63A; BASTIAENSEN LAK, 1983, DOC OPHTHALMOL, V56, P5, DOI 10.1007/BF00154702; Bosco D, 2009, J NEUROL SCI, V284, P24, DOI 10.1016/j.jns.2009.03.017; Cahill K V, 1986, Ophthalmic Plast Reconstr Surg, V2, P213, DOI 10.1097/00002341-198601070-00008; Choi JY, 2013, MENOPAUSE, V20, P85, DOI 10.1097/gme.0b013e31825d26b6; COLLIN JRO, 1986, AUST NZ J OPHTHALMOL, V14, P109, DOI 10.1111/j.1442-9071.1986.tb00020.x; Cuillet C, 2005, DIABETES METAB, V31, p5S20; DORTZBACH RK, 1980, ARCH OPHTHALMOL-CHIC, V98, P2045, DOI 10.1001/archopht.1980.01020040897022; Kalpakian B, 1986, J Pediatr Ophthalmol Strabismus, V23, P170; Kantaputra PN, 2001, AM J MED GENET, V103, P283, DOI 10.1002/ajmg.1572; Kim David W, 2007, Facial Plast Surg Clin North Am, V15, P327, DOI 10.1016/j.fsc.2007.04.008; Kim MK, 2014, CLIN ENDOCRINOL, V80, P214, DOI 10.1111/cen.12162; Ko SH, 2014, DIABETES METAB J, V38, P51, DOI 10.4093/dmj.2014.38.1.51; Misra A, 2013, NUTRIENTS, V5, P2708, DOI 10.3390/nu5072708; Nam GE, 2013, PREV MED, V57, P304, DOI 10.1016/j.ypmed.2013.06.008; NETLAND PA, 1994, OPHTHALMOLOGY, V101, P174; Oh SW, 2011, DIABETES METAB J, V35, P561, DOI 10.4093/dmj.2011.35.6.561; Park YH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085068; REAVEN GM, 1993, J CLIN INVEST, V92, P141, DOI 10.1172/JCI116541; Shirado M, 2012, J PLAST RECONSTR AES, V65, pE146, DOI 10.1016/j.bjps.2012.01.009; SHORE JW, 1984, AM J OPHTHALMOL, V98, P21, DOI 10.1016/0002-9394(84)90183-1; Small R G, 1989, Ophthalmic Plast Reconstr Surg, V5, P171; Wong TY, 2004, INVEST OPHTH VIS SCI, V45, P2949, DOI 10.1167/iovs.04-0069; World Health Organisation IAftS of Obesity IOT, 2000, AISA PACIFIC PERSPEC; Yoon Kyung-Chul, 2011, Korean J Ophthalmol, V25, P421, DOI 10.3341/kjo.2011.25.6.421	27	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0131427	10.1371/journal.pone.0131427	http://dx.doi.org/10.1371/journal.pone.0131427			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26162079	Green Submitted, gold, Green Published			2022-12-26	WOS:000358162300039
J	Zhang, YW; Nasto, RE; Varghese, R; Jablonski, SA; Serebriiskii, IG; Surana, R; Calvert, VS; Bebu, I; Murray, J; Jin, L; Johnson, M; Riggins, R; Ressom, H; Petricoin, E; Clarke, R; Golemis, EA; Weiner, LM				Zhang, Y-W; Nasto, R. E.; Varghese, R.; Jablonski, S. A.; Serebriiskii, I. G.; Surana, R.; Calvert, V. S.; Bebu, I.; Murray, J.; Jin, L.; Johnson, M.; Riggins, R.; Ressom, H.; Petricoin, E.; Clarke, R.; Golemis, E. A.; Weiner, L. M.			Acquisition of estrogen independence induces TOB1-related mechanisms supporting breast cancer cell proliferation	ONCOGENE			English	Article							INTERACTING PROTEINS; SIGNALING PATHWAYS; RECEPTOR PATHWAY; ER-ALPHA; RESISTANCE; TOB; DATABASE; MUTATIONS; COMPLEXES; APOPTOSIS	Resistance to therapies targeting the estrogen pathway remains a challenge in the treatment of estrogen receptor-positive breast cancer. To address this challenge, a systems biology approach was used. A library of small interfering RNAs targeting an estrogen receptor (ER)- and aromatase-centered network identified 46 genes that are dispensable in estrogen-dependent MCF7 cells, but are selectively required for the survival of estrogen-independent MCF7-derived cells and multiple additional estrogen-independent breast cancer cell lines. Integration of this information identified a tumor suppressor gene TOB1 as a critical determinant of estrogen-independent ER-positive breast cell survival. Depletion of TOB1 selectively promoted G1 phase arrest and sensitivity to AKT and mammalian target of rapmycin (mTOR) inhibitors in estrogen-independent cells but not in estrogen-dependent cells. Phosphoproteomic profiles from reverse-phase protein array analysis supported by mRNA profiling identified a significant signaling network reprogramming by TOB1 that differed in estrogen-sensitive and estrogen-resistant cell lines. These data support a novel function for TOB1 in mediating survival of estrogen-independent breast cancers. These studies also provide evidence for combining TOB1 inhibition and AKT/mTOR inhibition as a therapeutic strategy, with potential translational significance for the management of patients with ER-positive breast cancers.	[Zhang, Y-W; Nasto, R. E.; Varghese, R.; Jablonski, S. A.; Surana, R.; Murray, J.; Jin, L.; Johnson, M.; Riggins, R.; Ressom, H.; Clarke, R.; Weiner, L. M.] Georgetown Univ, Sch Med, Dept Oncol, Georgetown Lombardi Comprehens Canc Ctr, Res Bldg E501,3970 Reservoir Rd NW, Washington, DC 20057 USA; [Nasto, R. E.; Serebriiskii, I. G.; Golemis, E. A.] Fox Chase Canc Ctr, Program Dev Therapeut, 7701 Burholme Ave, Philadelphia, PA 19111 USA; [Nasto, R. E.] Drexel Univ, Sch Biomed Engn Sci & Hlth Syst, Philadelphia, PA 19104 USA; [Serebriiskii, I. G.] Kazan Fed Univ, Kazan, Russia; [Calvert, V. S.; Petricoin, E.] George Mason Univ, Ctr Appl Prote & Mol Med, Manassas, VA USA; [Bebu, I.] George Washington Univ, Biostat Ctr, Washington, DC USA	Georgetown University; Fox Chase Cancer Center; Drexel University; Kazan Federal University; George Mason University; George Washington University	Weiner, LM (corresponding author), Georgetown Univ, Sch Med, Dept Oncol, Georgetown Lombardi Comprehens Canc Ctr, Res Bldg E501,3970 Reservoir Rd NW, Washington, DC 20057 USA.	weinerl@georgetown.edu	Clarke, Robert/A-6485-2008; Riggins, Rebecca/GQH-4466-2022	Clarke, Robert/0000-0002-9278-0854; Golemis, Erica/0000-0003-3618-3673	NIH/NCI grant [P30-CA051008]; Russian Government;  [R01CA050633];  [CA51880];  [U54 CA149147];  [R01CA63366];  [R21CA181287]; NATIONAL CANCER INSTITUTE [R01CA050633, R21CA181287, R01CA063366, U54CA149147, P30CA006927, U01CA051880, T32CA009686, P30CA051008] Funding Source: NIH RePORTER	NIH/NCI grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Russian Government; ; ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are grateful to the Flow Cytometry and Cell Sorting Shared Resource at the Lombardi Comprehensive Cancer Center, which is partially supported by NIH/NCI grant P30-CA051008. We also thank Wei Xu, Alan Zwart, David Goldstein, Annie Zuo and Yuri Gusev for their technical assistance. This study was supported by R01CA050633, CA51880, U54 CA149147 (to LMW), R01CA63366 and R21CA181287 (to EAG), and by the subsidy of the Russian Government to support the program of competitive growth of Kazan Federal University (to IS).	Acevedo ML, 2003, MOL CELL BIOL, V23, P335, DOI 10.1128/MCB.23.1.335-348.2003; American Cancer Society, 2013, CANC FACTS FIG 2013; Astsaturov I, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001083; Bader GD, 2000, BIOINFORMATICS, V16, P465, DOI 10.1093/bioinformatics/16.5.465; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bostner J, 2013, BREAST CANCER RES TR, V137, P397, DOI 10.1007/s10549-012-2376-y; Britton DJ, 2006, BREAST CANCER RES TR, V96, P131, DOI 10.1007/s10549-005-9070-2; Brunner N, 1997, CANCER RES, V57, P3486; Caravatta L, 2008, J CELL PHYSIOL, V214, P192, DOI 10.1002/jcp.21186; Childs BG, 2014, EMBO REP, V15, P1139, DOI 10.15252/embr.201439245; Chitre M, 2014, CLINICOECONOMIC OUTC, V6, P331, DOI 10.2147/CEOR.S57214; Clarke R, 2003, ONCOGENE, V22, P7316, DOI 10.1038/sj.onc.1206937; CLARKE R, 1989, P NATL ACAD SCI USA, V86, P3649, DOI 10.1073/pnas.86.10.3649; Fox EM, 2011, CANCER RES, V71, P6773, DOI 10.1158/0008-5472.CAN-11-1295; Garcia-Becerra R, 2013, INT J MOL SCI, V14, P108, DOI 10.3390/ijms14010108; Gritsch David, 2011, J Exp Ther Oncol, V9, P37; Helms MW, 2009, CANCER RES, V69, P5049, DOI 10.1158/0008-5472.CAN-08-4154; Hennessy BT, 2005, NAT REV DRUG DISCOV, V4, P988, DOI 10.1038/nrd1902; Huang DW, 2007, NUCLEIC ACIDS RES, V35, pW169, DOI 10.1093/nar/gkm415; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jansen MPHM, 2013, CANCER RES, V73, P6632, DOI 10.1158/0008-5472.CAN-13-0704; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Kim B, 2015, ONCOGENE, V34, P1083, DOI 10.1038/onc.2014.51; Kim SY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008979; Levin ER, 2009, J PHYSIOL-LONDON, V587, P5019, DOI 10.1113/jphysiol.2009.177097; Licata L, 2012, NUCLEIC ACIDS RES, V40, pD857, DOI 10.1093/nar/gkr930; Luo B, 2008, P NATL ACAD SCI USA, V105, P20380, DOI 10.1073/pnas.0810485105; Marcotte R, 2012, CANCER DISCOV, V2, P172, DOI 10.1158/2159-8290.CD-11-0224; Matsuda S, 1996, ONCOGENE, V12, P705; Mishra GR, 2006, NUCLEIC ACIDS RES, V34, pD411, DOI 10.1093/nar/gkj141; Nair BC, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2929; Nehra R, 2010, FASEB J, V24, P2040, DOI 10.1096/fj.09-138305; O'Malley S, 2009, INT J CANCER, V125, P1805, DOI 10.1002/ijc.24490; Orchard S, 2014, NUCLEIC ACIDS RES, V42, pD358, DOI 10.1093/nar/gkt1115; Porter AC, 1998, ONCOGENE, V17, P1343, DOI 10.1038/sj.onc.1202171; Redon CE, 2010, CLIN CANCER RES, V16, P4532, DOI 10.1158/1078-0432.CCR-10-0523; Robinson DR, 2013, NAT GENET, V45, P1446, DOI 10.1038/ng.2823; Saj A, 2010, DEV CELL, V18, P862, DOI 10.1016/j.devcel.2010.03.013; Scaltriti M, 2006, CLIN CANCER RES, V12, P5268, DOI 10.1158/1078-0432.CCR-05-1554; Solimini NL, 2012, SCIENCE, V337, P104, DOI 10.1126/science.1219580; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Sun M, 2001, CANCER RES, V61, P5985; Suzuki T, 2002, GENE DEV, V16, P1356, DOI 10.1101/gad.962802; Suzuki T, 2001, GENES CELLS, V6, P131, DOI 10.1046/j.1365-2443.2001.00406.x; Suzuki T, 2012, J BIOL CHEM, V287, P40256, DOI 10.1074/jbc.M112.353805; Tang SH, 2004, NUCLEIC ACIDS RES, V32, pD533, DOI 10.1093/nar/gkh083; Tarcea VG, 2009, NUCLEIC ACIDS RES, V37, pD642, DOI 10.1093/nar/gkn722; Tateishi Y, 2004, EMBO J, V23, P4813, DOI 10.1038/sj.emboj.7600472; Toy W, 2013, NAT GENET, V45, P1439, DOI 10.1038/ng.2822; Xenarios I, 2002, NUCLEIC ACIDS RES, V30, P303, DOI 10.1093/nar/30.1.303; Xia WL, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3480; Yoshida Y, 2003, GENE DEV, V17, P1201, DOI 10.1101/gad.1088003; Zhang YW, 2009, J BIOL CHEM, V284, P18085, DOI 10.1074/jbc.M109.003020	54	22	23	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 31	2016	35	13					1643	1656		10.1038/onc.2015.226	http://dx.doi.org/10.1038/onc.2015.226			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DH8RP	26165839	Green Accepted			2022-12-26	WOS:000373064200004
J	Iwelunmor, J; Plange-Rhule, J; Airhihenbuwa, CO; Ezepue, C; Ogedegbe, O				Iwelunmor, Juliet; Plange-Rhule, Jacob; Airhihenbuwa, Collins O.; Ezepue, Chizoba; Ogedegbe, Olugbenga			A Narrative Synthesis of the Health Systems Factors Influencing Optimal Hypertension Control in Sub-Saharan Africa	PLOS ONE			English	Article							SOUTH-AFRICA; HUMAN-RESOURCES; BLOOD-PRESSURE; PRIMARY-CARE; MANAGEMENT; BARRIERS; DISEASE; PROFESSIONALS; DETERMINANTS; FACILITIES	Introduction In sub-Saharan Africa (SSA), an estimated 74.7 million individuals are hypertensive. Reducing the growing burden of hypertension in sub-Saharan Africa will require a variety of strategies one of which is identifying the extent to which actions originating at the health systems level improves optimal management and control. Methods and Results We conducted a narrative synthesis of available papers examining health systems factors influencing optimal hypertension in SSA. Eligible studies included those that analyzed the impact of health systems on hypertension awareness, treatment, control and medication adherence. Twenty-five articles met the inclusion criteria and the narrative synthesis identified the following themes: 1) how physical resources influence mechanisms supportive of optimal hypertension control; 2) the role of human resources with enabling and/or inhibiting hypertension control goals; 3) the availability and/or use of intellectual resources; 4) how health systems financing facilitate and/or compromise access to products necessary for optimal hypertension control. Conclusion The findings highlight the need for further research on the health systems factors that influence management and control of hypertension in the region.	[Iwelunmor, Juliet] Univ Illinois, Dept Kinesiol & Community Hlth, Urbana, IL 61801 USA; [Plange-Rhule, Jacob] Kwame Nkrumah Univ Sci & Technol, Coll Hlth Sci, Sch Med Sci, Kumasi, Ghana; [Airhihenbuwa, Collins O.] Penn State Univ, Dept Biobehav Hlth, University Pk, PA 16802 USA; [Ezepue, Chizoba] Georgia Regents Univ, Dept Neurol, Augusta, GA USA; [Ogedegbe, Olugbenga] NYU, Dept Med, Langone Med Ctr, Ctr Healthful Behav Change,Div Gen Internal Med, New York, NY 10016 USA	University of Illinois System; University of Illinois Urbana-Champaign; Kwame Nkrumah University Science & Technology; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University System of Georgia; Augusta University; New York University; NYU Langone Medical Center	Iwelunmor, J (corresponding author), Univ Illinois, Dept Kinesiol & Community Hlth, Urbana, IL 61801 USA.	jiwez@illinois.edu			Fogarty International Center (NIH/FIC) [D43TW009140]; National Heart Lung and Blood Institute (NIH/NHLBI) [U01HL114198]; FOGARTY INTERNATIONAL CENTER [D43TW009140] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K24HL111315, U01HL114198] Funding Source: NIH RePORTER	Fogarty International Center (NIH/FIC); National Heart Lung and Blood Institute (NIH/NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by Grant D43TW009140 (PI: Gbenga Ogedegbe) funded by the Fogarty International Center (NIH/FIC) and grant U01HL114198 funded by the National Heart Lung and Blood Institute (NIH/NHLBI).	Adair-Rohani H, 2013, GLOB HEALTH-SCI PRAC, V1, P249, DOI 10.9745/GHSP-D-13-00037; Ali MK, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005121; Ambaw AD, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-282; Betancourt J R, 1999, Curr Hypertens Rep, V1, P482, DOI 10.1007/BF03215777; Bradley HA, 2007, ETHNIC DIS, V17, P49; Buabeng KO, 2004, J PHARM PHARM SCI, V7, P350; Daniels A, 2000, S AFR MED J, V90, P1206; Dennison CR, 2007, ETHNIC DIS, V17, P484; DeSavigny D, 2009, SYSTEMS THINKING FOR HEALTH SYSTEMS STRENGTHENING, P1; Dzudie A, 2011, BMJ OPEN, V2, P17; Frenk J, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000089; Gombet T R, 2009, Med Trop (Mars), V69, P45; Hagopian Amy, 2004, Hum Resour Health, V2, P17, DOI 10.1186/1478-4491-2-17; Hendriks M, 2011, PLOS ONE, V7; Hendriks ME, 2014, JAMA INTERN MED, V174, P555, DOI 10.1001/jamainternmed.2013.14458; IJsselmuiden C, 2012, SAMJ S AFR MED J, V102, P228; Ilesanmi OS, 2012, PAN AFR MED J, V12; Iwelunmor J, 2014, GLOBALIZATION HEALTH, V10, DOI 10.1186/1744-8603-10-42; Kagee A, 2007, J HEALTH PSYCHOL, V12, P444, DOI 10.1177/1359105307076232; Kalk A, 2010, TROP MED INT HEALTH, V15, P94, DOI 10.1111/j.1365-3156.2009.02424.x; Kaufman J, 1992, ETHNIC DIS, V3, pS83; Kengne AP, 2009, J CLIN HYPERTENS, V11, P564, DOI 10.1111/j.1751-7176.2009.00165.x; Kmet L.M., 2004, STANDARD QUALITY ASS; Labhardt ND, 2011, TROP MED INT HEALTH, V16, P1276, DOI 10.1111/j.1365-3156.2011.02827.x; Labhardt ND, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-339; Maimaris W, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001490; Mayosi BM, 2013, HEART; Mbacke CSM, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-S2-S15; Mbouemboue OP, 2012, INT J COLLAB RES INT, V4, P1663; McCord GC, 2013, B WORLD HEALTH ORGAN, V91, P244, DOI 10.2471/BLT.12.109660; Meessen B, 2011, HEALTH POLICY PLANN, V26, pII16, DOI 10.1093/heapol/czr062; Mendis S, 2004, J HYPERTENS, V22, P59, DOI 10.1097/00004872-200401000-00013; Mills A, 2012, LANCET, V380, P126, DOI 10.1016/S0140-6736(12)60357-2; Mounier-Jack S, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-278; Musinguzi G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062236; Mutale W, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-S2-S9; Ndou T, 2013, GLOBAL HLTH ACTION, V6; Ngoungou EB, 2012, ARCH CARDIOVASC DIS, V105, P77, DOI 10.1016/j.acvd.2011.12.005; Odedosu T, 2012, CLEV CLIN J MED, V79, P46, DOI 10.3949/ccjm.79a.11068; Ogah OS, 2013, HEART; Ogedegbe G, 2008, J CLIN HYPERTENS, V10, P644, DOI 10.1111/j.1751-7176.2008.08329.x; OLUBODUN JOB, 1995, INT J CARDIOL, V51, P193, DOI 10.1016/0167-5273(95)02409-P; Ono Agbani Ejaife, 2006, Sao Paulo Med. J., V124, P105, DOI 10.1590/S1516-31802006000200011; Osamor PE, 2011, J HEALTH POPUL NUTR, V29, P619; Pang T, 2002, BMJ-BRIT MED J, V324, P499, DOI 10.1136/bmj.324.7336.499; Parker A, 2011, CARDIOVASC J AFR, V22, P186, DOI 10.5830/CVJA-2010-066; Peck R, 2014, LANCET GLOB HEALTH, V2, pE285, DOI 10.1016/S2214-109X(14)70033-6; Popay J., 2006, GUIDANCE CONDUCT NAR; Rayner B, 2010, NEPHRON CLIN PRACT, V116, pC269, DOI 10.1159/000318788; Rayner B, 2009, CARDIOVASC J AFR, V20, P224; Reich MR, 2009, LANCET, V373, P508, DOI 10.1016/S0140-6736(08)61899-1; Rispel LC, 2010, SAMJ S AFR MED J, V100, P801, DOI 10.7196/SAMJ.4439; Salako B L, 2003, East Afr Med J, V80, P529; Schneider H, 2006, REPROD HEALTH MATTER, V14, P12, DOI 10.1016/S0968-8080(06)27232-X; Steyn Krisela, 1999, Ethnicity and Disease, V9, P441; Thorogood M, 2007, SCAND J PUBLIC HEALT, V35, P52, DOI 10.1080/14034950701355411; Webster J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065437; Yusuff KB, 2005, J PHARM PHARM SCI, V8, P235	58	17	17	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0130193	10.1371/journal.pone.0130193	http://dx.doi.org/10.1371/journal.pone.0130193			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176223	Green Published, gold, Green Submitted			2022-12-26	WOS:000358197600020
J	Li, J; He, NP; Wei, XH; Gao, Y; Zuo, Y				Li, Jie; He, Nianpeng; Wei, Xuehong; Gao, Yang; Zuo, Yao			Changes in Temperature Sensitivity and Activation Energy of Soil Organic Matter Decomposition in Different Qinghai-Tibet Plateau Grasslands	PLOS ONE			English	Article							CARBON DECOMPOSITION; MICROBIAL BIOMASS; CO2 PRODUCTION; RESPIRATION; NITROGEN; CLIMATE; QUALITY; DEPENDENCE; FEEDBACKS; RESPONSES	Qinghai-Tibet Plateau grasslands are unique geographical regions and store substantial soil organic matter (SOM) in the soil surface, which make them very sensitive to global climate change. Here, we focused on three main grassland types (alpine meadow, steppe, and desert) and conducted a soil incubation experiment at five different temperatures (5, 10, 15, 20, and 25 degrees C) to investigate SOM decomposition rates (R), temperature sensitivity (Q(10)), and activation energy (E-a). The results showed that grassland type and incubation temperature had significant impact on R (P < 0.001), and the values of R were exponential correlated with incubation temperature in three alpine grasslands. At the same temperature, R was in the following order: alpine meadow > alpinesteppe > alpine desert. The Q(10) values differed significantly among different grasslands, and the overall trends were as follows: alpine meadow (1.56 +/- 0.09) < alpine steppe (1.88 +/- 0.23) < alpine desert (2.39 +/- 0.32). Moreover, the E-a values differed significantly across different grassland types (P < 0.001) and increased with increasing incubation time. The exponential negative correlations between E-a and R at 20 degrees C across all grassland types (all Ps < 0.001) indicated that the substrate-quality temperature hypothesis is applicable to the alpine grasslands. Our findings provide new insights for understanding the responses of SOM decomposition and storage to warming scenarios in this Plateau.	[Li, Jie; He, Nianpeng; Gao, Yang; Zuo, Yao] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Key Lab Ecosyst Network Observat & Modeling, Beijing 100101, Peoples R China; [Li, Jie] NE Normal Univ, Inst Grassland Sci, Changchun 130024, Peoples R China; [Li, Jie] Minist Educ, Key Lab Vegetat Ecol, Changchun 130024, Peoples R China; [Wei, Xuehong] Tibet Univ, Agr & Anim Husb Coll, Linzhi 860000, Peoples R China	Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS; Northeast Normal University - China; Tibet University	He, NP (corresponding author), Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Key Lab Ecosyst Network Observat & Modeling, Beijing 100101, Peoples R China.	henp@igsnrr.ac.cn; wxueh@yahoo.com.cn	Gao, Yang/A-4128-2017	Gao, Yang/0000-0002-2053-0418; he, nianpeng/0000-0002-0458-5953	Natural Science Foundation of China [31470506, 31270519]; Chinese Academy of Sciences Strategic Priority Research Program [XDA05050702]; Program for Kezhen Distinguished Talents in Institute of Geographic Sciences and Natural Resources Research, CAS [2013RC102]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences Strategic Priority Research Program; Program for Kezhen Distinguished Talents in Institute of Geographic Sciences and Natural Resources Research, CAS	Funding for this work came from the Natural Science Foundation of China (31470506, 31270519), the Chinese Academy of Sciences Strategic Priority Research Program (XDA05050702), and the Program for Kezhen Distinguished Talents in Institute of Geographic Sciences and Natural Resources Research, CAS (2013RC102). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agren GI, 2002, SOIL BIOL BIOCHEM, V34, P129, DOI 10.1016/S0038-0717(01)00156-0; Akatsuka T, 2011, LIMNOLOGY, V12, P127, DOI 10.1007/s10201-010-0329-x; [Anonymous], 2007, AGENDA; Avery B.W., 1974, SOIL SURVEY LAB METH; Balser TC, 2009, GLOBAL CHANGE BIOL, V15, P2935, DOI 10.1111/j.1365-2486.2009.01946.x; Bekku YS, 2003, APPL SOIL ECOL, V22, P205, DOI 10.1016/S0929-1393(02)00158-0; Billings SA, 2013, GLOBAL CHANGE BIOL, V19, P90, DOI 10.1111/gcb.12029; Bosatta E, 1999, SOIL BIOL BIOCHEM, V31, P1889, DOI 10.1016/S0038-0717(99)00105-4; Cheng GD, 2007, J GEOPHYS RES-EARTH, V112, DOI 10.1029/2006JF000631; Conant RT, 2008, ECOLOGY, V89, P2384, DOI 10.1890/08-0137.1; Conant RT, 2008, GLOBAL CHANGE BIOL, V14, P868, DOI 10.1111/j.1365-2486.2008.01541.x; Conant RT, 2011, GLOBAL CHANGE BIOL, V17, P3392, DOI 10.1111/j.1365-2486.2011.02496.x; Craine J, 2010, SOIL BIOL BIOCHEM, V42, P373, DOI 10.1016/j.soilbio.2009.10.024; Craine JM, 2013, BIOGEOCHEMISTRY, V113, P359, DOI 10.1007/s10533-012-9762-8; Craine JM, 2010, NAT GEOSCI, V3, P854, DOI [10.1038/ngeo1009, 10.1038/NGEO1009]; Dalias P, 2001, GLOBAL CHANGE BIOL, V7, P181, DOI 10.1046/j.1365-2486.2001.00386.x; Davidson EA, 2006, NATURE, V440, P165, DOI 10.1038/nature04514; De Nobili M, 2006, SOIL BIOL BIOCHEM, V38, P2871, DOI 10.1016/j.soilbio.2006.04.044; Dijkstra FA, 2006, SOIL BIOL BIOCHEM, V38, P2519, DOI 10.1016/j.soilbio.2006.02.020; Eliasson PE, 2005, GLOBAL CHANGE BIOL, V11, P167, DOI 10.1111/j.1365-2486.2004.00878.x; Fang C, 2001, SOIL BIOL BIOCHEM, V33, P155, DOI 10.1016/S0038-0717(00)00125-5; Fang CM, 2005, NATURE, V433, P57, DOI 10.1038/nature03138; Feng XJ, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2008JG000743; Fierer N, 2005, ECOLOGY, V86, P320, DOI 10.1890/04-1254; Fierer N, 2003, GLOBAL CHANGE BIOL, V9, P1322, DOI 10.1046/j.1365-2486.2003.00663.x; Fierer N, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2005GB002644; Fisk MC, 2003, SOIL BIOL BIOCHEM, V35, P591, DOI 10.1016/S0038-0717(03)00053-1; Flanagan LB, 2005, AGR FOREST METEOROL, V130, P237, DOI 10.1016/j.agrformet.2005.04.002; GALLAHER RN, 1976, SOIL SCI SOC AM J, V40, P887, DOI 10.2136/sssaj1976.03615995004000060026x; Gershenson A, 2009, GLOBAL CHANGE BIOL, V15, P176, DOI 10.1111/j.1365-2486.2008.01827.x; Haddix ML, 2011, SOIL SCI SOC AM J, V75, P56, DOI 10.2136/sssaj2010.0118; Hartley IP, 2008, SOIL BIOL BIOCHEM, V40, P1567, DOI 10.1016/j.soilbio.2008.01.007; He NP, 2013, ECOL EVOL, V3, P5045, DOI 10.1002/ece3.881; Iqbal J, 2010, AGR ECOSYST ENVIRON, V137, P294, DOI 10.1016/j.agee.2010.02.015; Ise T, 2006, BIOGEOCHEMISTRY, V80, P217, DOI 10.1007/s10533-006-9019-5; Jing X, 2014, BIOGEOCHEMISTRY, V117, P39, DOI 10.1007/s10533-013-9844-2; Jones CD, 2003, TELLUS B, V55, P642, DOI 10.1034/j.1600-0889.2003.01440.x; Kirschbaum MUF, 2006, SOIL BIOL BIOCHEM, V38, P2510, DOI 10.1016/j.soilbio.2006.01.030; Knorr W, 2005, NATURE, V433, P298, DOI 10.1038/nature03226; Larionova AA, 2007, BIOGEOSCIENCES, V4, P1073, DOI 10.5194/bg-4-1073-2007; Leifeld J, 2005, BIOGEOCHEMISTRY, V75, P433, DOI 10.1007/s10533-005-2237-4; Leifeld J, 2014, BIOL FERT SOILS, V50, P147, DOI 10.1007/s00374-013-0822-6; Lorenz K, 2007, GEODERMA, V142, P1, DOI 10.1016/j.geoderma.2007.07.013; McGuire AD, 1992, GLOBAL BIOGEOCHEM CY, V6, P101, DOI 10.1029/92GB00219; Melillo JM, 2002, SCIENCE, V298, P2173, DOI 10.1126/science.1074153; Min K, 2014, SOIL BIOL BIOCHEM, V76, P193, DOI 10.1016/j.soilbio.2014.05.021; Qi Y, 2002, ECOL MODEL, V153, P131, DOI 10.1016/S0304-3800(01)00506-3; Shan JY, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00599; Sharkhuu A, 2013, BIOGEOCHEMISTRY, V115, P333, DOI 10.1007/s10533-013-9839-z; Sokolov AP, 2008, J CLIMATE, V21, P3776, DOI 10.1175/2008JCLI2038.1; Song MH, 2010, EUR J SOIL BIOL, V46, P375, DOI 10.1016/j.ejsobi.2010.09.003; Sun SH, 2013, PLANT SOIL, V372, P597, DOI 10.1007/s11104-013-1758-1; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P703, DOI 10.1016/0038-0717(87)90052-6; Wagai R, 2013, GLOBAL CHANGE BIOL, V19, P1114, DOI 10.1111/gcb.12112; Wang GX, 2008, GEODERMA, V143, P143, DOI 10.1016/j.geoderma.2007.10.023; Wang SQ, 2013, PLANT SOIL, V363, P243, DOI 10.1007/s11104-012-1304-6; Wetterstedt JAM, 2010, GLOBAL CHANGE BIOL, V16, P1806, DOI 10.1111/j.1365-2486.2009.02112.x; Xiang W, 2009, ENVIRON GEOL, V58, P499, DOI 10.1007/s00254-008-1523-6; Xu X, 2012, SOIL BIOL BIOCHEM, V50, P142, DOI 10.1016/j.soilbio.2012.03.007; Yang YH, 2008, GLOBAL CHANGE BIOL, V14, P1592, DOI 10.1111/j.1365-2486.2008.01591.x; Zhang QG, 2006, CHINESE GEOGR SCI, V16, P351, DOI 10.1007/s11769-006-0351-4; Zhou YC, 2013, SCI CHINA EARTH SCI, V56, P311, DOI 10.1007/s11430-012-4498-9	62	20	20	7	90	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132795	10.1371/journal.pone.0132795	http://dx.doi.org/10.1371/journal.pone.0132795			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176705	Green Published, gold, Green Submitted			2022-12-26	WOS:000358197600158
J	Tao, YF; Li, ZH; Xu, LX; Fang, F; Lu, J; Li, G; Cao, L; Wang, NN; Du, XJ; Sun, LC; Zhao, WL; Xiao, PF; Zhao, H; Su, GH; Li, YH; Li, YP; Xu, YY; Zhou, HT; Wu, Y; Jin, MF; Liu, L; Ni, J; Hu, SY; Zhu, XM; Feng, X; Wang, J; Pan, J				Tao Yan-Fang; Li Zhi-Heng; Xu Li-Xiao; Fang Fang; Lu Jun; Li Gang; Cao Lan; Wang Na-Na; Du Xiao-Juan; Sun Li-Chao; Zhao Wen-Li; Xiao Pei-Fang; Zhao He; Su Guang-Hao; Li Yan-Hong; Li Yi-Ping; Xu Yun-Yun; Zhou Hui-Ting; Wu Yi; Jin Mei-Fang; Liu Lin; Ni Jian; Hu Shao-Yan; Zhu Xue-Ming; Feng Xing; Wang Jian; Pan Jian			Molecular Mechanism of the Cell Death Induced by the Histone Deacetylase Pan Inhibitor LBH589 (Panobinostat) in Wilms Tumor Cells	PLOS ONE			English	Article							SUBEROYLANILIDE HYDROXAMIC ACID; PHASE-I TRIAL; GASTRIC-CANCER; HDAC INHIBITOR; COLORECTAL-CANCER; MULTIPLE-MYELOMA; LUNG-CANCER; EXPRESSION; REPRIMO; APOPTOSIS	Background Wilms tumor (WT) is an embryonic kidney cancer, for which histone acetylation might be a therapeutic target. LBH589, a novel targeted agent, suppresses histone deacetylases in many tumors. This study investigated the antitumor activity of LBH589 in SK-NEP-1 and G401 cells. Methods SK-NEP-1 and G401 cell growth was assessed by CCK-8 and in nude mice experiments. Annexin V/propidium iodide staining followed by flow cytometry detected apoptosis in cell culture. Gene expressions of LBH589-treated tumor cells were analyzed using an Arraystar Human LncRNA Array. The Multi Experiment View cluster software analyzed the expression data. Differentially expressed genes from the cluster analyses were imported into the Ingenuity Pathway Analysis tool. Results LBH589 inhibited cell proliferation of SK-NEP-1 and G401 cells in a dose-dependent manner. Annexin V, TUNEL and Hochest 33342 staining analysis showed that LBH589-treated cells showed more apoptotic features compared with the control. LBH589 treatment inhibited the growth of SK-NEP-1 xenograft tumors in nude mice. Arraystar Human LncRNA Array analysis of genes and lncRNAs regulated by LBH589 identified 6653 mRNAs and 8135 lncRNAs in LBH589-treated SK-NEP-1 cells. The most enriched gene ontology terms were those involved in nucleosome assembly. KEGG pathway analysis identified cell cycle proteins, including CCNA2, CCNB2, CCND1, CCND2, CDK4, CDKN1B and HDAC2, etc. Ingenuity Pathway Analysis identified important upstream molecules: HIST2H3C, HIST1H4A, HIST1A, HIST1C, HIST1D, histone H1, histone H3, RPRM, HSP70 and MYC. Conclusions LBH589 treatment caused apoptosis and inhibition of cell proliferation of SK-NEP-1 and G401 cells. LBH589 had a significant effect and few side effects on SK-NEP-1 xenograft tumors. Expression profiling, and GO, KEGG and IPA analyses identified new targets and a new "network" of genes responding to LBH589 treatment in SK-NEP-1 cells. RPRM, HSP70 and MYC may be important regulators during LBH589 treatment. Our results provide new clues to the proapoptotic mechanism of LBH589.	[Tao Yan-Fang; Li Zhi-Heng; Xu Li-Xiao; Fang Fang; Lu Jun; Li Gang; Cao Lan; Wang Na-Na; Zhao Wen-Li; Xiao Pei-Fang; Zhao He; Su Guang-Hao; Li Yan-Hong; Li Yi-Ping; Xu Yun-Yun; Zhou Hui-Ting; Wu Yi; Jin Mei-Fang; Liu Lin; Hu Shao-Yan; Zhu Xue-Ming; Feng Xing; Wang Jian; Pan Jian] Soochow Univ, Dept Hematol & Oncol, Childrens Hosp, Suzhou, Peoples R China; [Du Xiao-Juan] 5th Hosp Chinese PLA, Dept Gastroenterol, Yin Chuan, Peoples R China; [Sun Li-Chao] Chinese Acad Med Sci, Peking Union Med Coll, Dept Cell & Mol Biol, Canc Inst Hosp, Beijing 100730, Peoples R China; [Ni Jian] Nanjing Med Univ, Hosp 2, Translat Res Ctr, Sch Clin 2, Nanjing, Peoples R China	Soochow University - China; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Peking Union Medical College; Nanjing Medical University	Wang, J (corresponding author), Soochow Univ, Dept Hematol & Oncol, Childrens Hosp, Suzhou, Peoples R China.	wj196312@vip.163.com; panjian2008@163.com			National Key Basic Research Program [2010CB933902]; key medical subjects of Jiangsu Province [XK201120]; Innovative team of Jiangsu Province [LJ201114, LJ201126]; Special Clinical Medical Science and Technology of Jiangsu Province [BL2012050, BL2013014]; Key Laboratory of Suzhou [SZS201108, SZS201307]; National Natural Science Foundation [81100371, 81370627, 81300423, 81272143]; Natural Science Foundation of Jiangsu Province [BK2011308]; Universities Natural Science Foundation of Jiangsu Province [11KJB320014]; Talent's subsidy project in science and education of Department of Public Health of Suzhou City [SWKQ1020]; Major Scientific and Technological Special Project for "significant new drugs creation" [2012ZX09103301-040]	National Key Basic Research Program(National Basic Research Program of China); key medical subjects of Jiangsu Province; Innovative team of Jiangsu Province; Special Clinical Medical Science and Technology of Jiangsu Province; Key Laboratory of Suzhou; National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Universities Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Talent's subsidy project in science and education of Department of Public Health of Suzhou City; Major Scientific and Technological Special Project for "significant new drugs creation"	This work was supported by grants from the National Key Basic Research Program No. 2010CB933902, grants from key medical subjects of Jiangsu Province (XK201120), Innovative team of Jiangsu Province (LJ201114, LJ201126), Special Clinical Medical Science and Technology of Jiangsu Province (BL2012050, BL2013014), Key Laboratory of Suzhou (SZS201108, SZS201307), National Natural Science Foundation (81100371, 81370627, 81300423, 81272143), Natural Science Foundation of Jiangsu Province No. BK2011308, Universities Natural Science Foundation of Jiangsu Province No. 11KJB320014, Talent's subsidy project in science and education of Department of Public Health of Suzhou City No. SWKQ1020, and Major Scientific and Technological Special Project for "significant new drugs creation" No. 2012ZX09103301-040. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahari-Javan S, 2012, J NEUROSCI, V32, P5062, DOI 10.1523/JNEUROSCI.0079-12.2012; Beasley WD, 2008, INT J COLORECTAL DIS, V23, P375, DOI 10.1007/s00384-007-0435-3; Bellucci L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054102; Bernal C, 2008, CLIN CANCER RES, V14, P6264, DOI 10.1158/1078-0432.CCR-07-4522; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Brilli LL, 2013, PEDIATR NEPHROL, V28, P1909, DOI 10.1007/s00467-012-2320-8; Chou CW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018087; Chuang MJ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0073401, 10.1371/journal.pone.0083116]; Crump M, 2008, ANN ONCOL, V19, P964, DOI 10.1093/annonc/mdn031; Darzynkiewicz Z, 2008, METHODS, V44, P250, DOI 10.1016/j.ymeth.2007.11.008; Davenport KP, 2012, SURG CLIN N AM, V92, P745, DOI 10.1016/j.suc.2012.03.004; de Marinis F, 2013, J THORAC ONCOL, V8, P1091, DOI 10.1097/JTO.0b013e318293d88c; Fortunati N, 2014, INT J ONCOL, V44, P700, DOI 10.3892/ijo.2013.2218; Ghobrial IM, 2013, BLOOD, V121, P1296, DOI 10.1182/blood-2012-06-439307; Gotze S, 2014, INT J ONCOL, V45, P1715, DOI 10.3892/ijo.2014.2550; Graham C, 2006, CLIN CANCER RES, V12, P223, DOI 10.1158/1078-0432.CCR-05-1225; Hrabeta J, 2014, BIOMED PAP, V158, P161, DOI 10.5507/bp.2013.085; Hsieh YJ, 2014, J NUCL MED, V55, P678, DOI 10.2967/jnumed.113.126573; Jeon YJ, 2013, INT J MOL MED, V32, P860, DOI 10.3892/ijmm.2013.1451; Juengel E, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-152; Kroesen M, 2014, ONCOTARGET; Lemaire M, 2012, CLIN CANCER RES, V18, P2230, DOI 10.1158/1078-0432.CCR-11-1764; Li XY, 2014, CURR DRUG TARGETS, V15, P622, DOI 10.2174/1389450115666140306152642; Ma YY, 2011, TAIWAN J OBSTET GYNE, V50, P165, DOI 10.1016/j.tjog.2011.01.022; Mithraprabhu S, 2013, BRIT J HAEMATOL, V162, P559, DOI 10.1111/bjh.12388; Nakagawa M, 2007, ONCOL REP, V18, P769; Oehme I, 2009, CLIN CANCER RES, V15, P91, DOI 10.1158/1078-0432.CCR-08-0684; Ohki R, 2000, J BIOL CHEM, V275, P22627, DOI 10.1074/jbc.C000235200; Ooki A, 2013, MOL CANCER RES, V11, P1362, DOI 10.1158/1541-7786.MCR-13-0091; Ren J, 2014, CURR PHARM DESIGN, V20, P1847, DOI 10.2174/13816128113199990528; Richardson P, 2008, LEUKEMIA LYMPHOMA, V49, P502, DOI 10.1080/10428190701817258; Russo D, 2013, EXPERT OPIN THER TAR, V17, P179, DOI 10.1517/14728222.2013.740013; Scuto A, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.159; Scuto A, 2008, BLOOD, V111, P5093, DOI 10.1182/blood-2007-10-117762; Shi BW, 2013, DRUG DISCOV THER, V7, P129, DOI 10.5582/ddt.2013.v7.4.129; Smith MA, 2008, PEDIATR BLOOD CANCER, V50, P703, DOI 10.1002/pbc.21099; Song J, 2005, APMIS, V113, P264, DOI 10.1111/j.1600-0463.2005.apm_04.x; Song X, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-114; Tao YF, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-619; Tarhini AA, 2013, ANTICANCER RES, V33, P4475; Valente S, 2014, EXPERT OPIN THER PAT, V24, P401, DOI 10.1517/13543776.2014.877446; Wang G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076662; Wang L., 2014, DISCRETE DYN NAT SOC, V2014, P1, DOI DOI 10.1002/ASL2.454; Wegert J, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-136; Weichert W, 2008, CLIN CANCER RES, V14, P1669, DOI 10.1158/1078-0432.CCR-07-0990; West AC, 2014, J CLIN INVEST, V124, P30, DOI 10.1172/JCI69738; Woods DM, 2013, MELANOMA RES, V23, P341, DOI 10.1097/CMR.0b013e328364c0ed; Xiao WW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074253; Xu M, 2012, ENDOCRINOLOGY, V153, P2963, DOI 10.1210/en.2011-2021; Xu Miqing, 2013, Nan Fang Yi Ke Da Xue Xue Bao, V33, P1409; Yan SF, 2014, CURR PHARM DESIGN, V20, P1604, DOI 10.2174/13816128113199990544; Yasui W, 2003, ANN NY ACAD SCI, V983, P220, DOI 10.1111/j.1749-6632.2003.tb05977.x; Yu G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042377; Zhao YX, 2014, INT J ONCOL, V44, P451, DOI 10.3892/ijo.2013.2193; Zhu P, 2004, CANCER CELL, V5, P455, DOI 10.1016/S1535-6108(04)00114-X	55	17	18	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0126566	10.1371/journal.pone.0126566	http://dx.doi.org/10.1371/journal.pone.0126566			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176219	Green Published, gold, Green Submitted			2022-12-26	WOS:000358197600005
J	van Havre, Z; White, N; Rousseau, J; Mengersen, K				van Havre, Zoe; White, Nicole; Rousseau, Judith; Mengersen, Kerrie			Overfitting Bayesian Mixture Models with an Unknown Number of Components	PLOS ONE			English	Article							CHAIN-MONTE-CARLO; DENSITY-ESTIMATION; MARGINAL LIKELIHOOD; INFERENCE	This paper proposes solutions to three issues pertaining to the estimation of finite mixture models with an unknown number of components: the non-identifiability induced by overfitting the number of components, the mixing limitations of standard Markov Chain Monte Carlo (MCMC) sampling techniques, and the related label switching problem. An overfitting approach is used to estimate the number of components in a finite mixture model via a Zmix algorithm. Zmix provides a bridge between multidimensional samplers and test based estimation methods, whereby priors are chosen to encourage extra groups to have weights approaching zero. MCMC sampling is made possible by the implementation of prior parallel tempering, an extension of parallel tempering. Zmix can accurately estimate the number of components, posterior parameter estimates and allocation probabilities given a sufficiently large sample size. The results will reflect uncertainty in the final model and will report the range of possible candidate models and their respective estimated probabilities from a single run. Label switching is resolved with a computationally light-weight method, Zswitch, developed for overfitted mixtures by exploiting the intuitiveness of allocation-based relabelling algorithms and the precision of label-invariant loss functions. Four simulation studies are included to illustrate Zmix and Zswitch, as well as three case studies from the literature. All methods are available as part of the R package Zmix, which can currently be applied to univariate Gaussian mixture models.	[van Havre, Zoe; White, Nicole] Queensland Univ Technol, Sch Math Sci, Brisbane, Qld 4001, Australia; [van Havre, Zoe; Rousseau, Judith; Mengersen, Kerrie] Univ Paris 09, CEREMADE, F-75775 Paris, France	Queensland University of Technology (QUT); UDICE-French Research Universities; PSL Research University Paris; Universite Paris-Dauphine	van Havre, Z (corresponding author), Queensland Univ Technol, Sch Math Sci, Brisbane, Qld 4001, Australia.	zoe.vanhavre@qut.edu.au	Mengersen, Kerrie/AHC-4096-2022; Rousseau, Judith/A-8625-2018	Mengersen, Kerrie/0000-0001-8625-9168; van Havre, Zoe/0000-0002-4418-226X; White, Nicole/0000-0002-9292-0773; Rousseau, Judith/0000-0002-0998-6174	Australian Postgraduate Award; Australian Research Council	Australian Postgraduate Award(Australian Government); Australian Research Council(Australian Research Council)	This study was partially funded by an Australian Postgraduate Award and the Australian Research Council.	Aitkin M, 2001, STAT MODEL, V1, P287, DOI 10.1177/1471082X0100100404; Altekar G, 2004, BIOINFORMATICS, V20, P407, DOI 10.1093/bioinformatics/btg427; [Anonymous], 2013, TEXTS STAT SCI SERIE; Baragatti M, 2013, STAT COMPUT, V23, P535, DOI 10.1007/s11222-012-9328-6; BECHTEL YC, 1993, CLIN PHARMACOL THER, V54, P134, DOI 10.1038/clpt.1993.124; Cameron E, 2014, STAT SCI, V29, P397, DOI 10.1214/13-STS465; CARLIN BP, 1995, J ROY STAT SOC B MET, V57, P473; Celeux G, 2000, J AM STAT ASSOC, V95, P957, DOI 10.2307/2669477; Celeux G., 1998, COMPSTAT 98, P227; Chib S, 1995, J AM STAT ASSOC, V90, P1313, DOI 10.2307/2291521; CRAWFORD SL, 1994, J AM STAT ASSOC, V89, P259, DOI 10.2307/2291222; da Silva ARF, 2007, MED IMAGE ANAL, V11, P169, DOI 10.1016/j.media.2006.12.002; Earl DJ, 2005, PHYS CHEM CHEM PHYS, V7, P3910, DOI 10.1039/b509983h; ESCOBAR MD, 1995, J AM STAT ASSOC, V90, P577, DOI 10.2307/2291069; Fruhwirth-Schnatter S., 2006, FINITE MIXTURE MARKO; Gelfand A. E., 1996, MARKOV CHAIN MONTE C; GELFAND AE, 1990, J AM STAT ASSOC, V85, P398, DOI 10.2307/2289776; Green PJ, 1995, BIOMETRIKA, V82, P711, DOI 10.2307/2337340; Grun B, 2009, J MULTIVARIATE ANAL, V100, P851, DOI 10.1016/j.jmva.2008.09.006; Heckman J J, 1994, Stat Methods Med Res, V3, P279, DOI 10.1177/096228029400300306; Hurn M, 2003, J COMPUT GRAPH STAT, V12, P55, DOI 10.1198/1061860031329; Jasra A, 2005, STAT SCI, V20, P50, DOI 10.1214/088342305000000016; Lewin A, 2007, STAT APPL GENET MOL, V6, DOI 10.2202/1544-6115.1314; Lin TI, 2007, STAT SINICA, V17, P909; Marin JM, 2005, HANDB STAT, V25, P459, DOI 10.1016/S0169-7161(05)25016-2; McLachlan G., 2000, WILEY SER PROB STAT; Nobile A., 2007, ARXIV07110458; Phillips DV, 1996, MARKOV CHAIN MONTE C, P215; REYNOLDS DA, 1995, IEEE T SPEECH AUDI P, V3, P72, DOI 10.1109/89.365379; Richardson S, 1997, J ROY STAT SOC B MET, V59, P731, DOI 10.1111/1467-9868.00095; Robert C, 2011, STAT SCI, V26, P102, DOI 10.1214/10-STS351; Robert E., 1997, JOURNAL OF THE ROYAL, V59, P731, DOI 10.1111/1467-9868.00095; Roeder K, 1997, J AM STAT ASSOC, V92, P894, DOI 10.2307/2965553; Rousseau J, 2011, J R STAT SOC B, V73, P689, DOI 10.1111/j.1467-9868.2011.00781.x; Stauffer C., 1999, Proceedings. 1999 IEEE Computer Society Conference on Computer Vision and Pattern Recognition (Cat. No PR00149), P246, DOI 10.1109/CVPR.1999.784637; Stephens M, 2000, ANN STAT, V28, P40, DOI 10.1214/aos/1016120364; Stephens M, 2000, J ROY STAT SOC B, V62, P795, DOI 10.1111/1467-9868.00265; SWENDSEN RH, 1986, PHYS REV LETT, V57, P2607, DOI 10.1103/PhysRevLett.57.2607; TANNER MA, 1987, J AM STAT ASSOC, V82, P528, DOI 10.2307/2289457; White N, 2010, STAT METHODS MED RES	42	21	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0131739	10.1371/journal.pone.0131739	http://dx.doi.org/10.1371/journal.pone.0131739			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177375	Green Published, gold			2022-12-26	WOS:000358197600061
J	Yang, CW; Li, CI; Li, TC; Liu, CS; Lin, CH; Lin, WY; Lin, CC				Yang, Chuan-Wei; Li, Chia-Ing; Li, Tsai-Chung; Liu, Chiu-Shong; Lin, Chih-Hsueh; Lin, Wen-Yuan; Lin, Cheng-Chieh			Association of Sarcopenic Obesity with Higher Serum High-Sensitivity C-Reactive Protein Levels in Chinese Older Males - A Community-Based Study (Taichung Community Health Study-Elderly, TCHS-E)	PLOS ONE			English	Article							SKELETAL-MUSCLE MASS; NECROSIS-FACTOR-ALPHA; PHYSICAL-ACTIVITY; METABOLIC SYNDROME; BODY-COMPOSITION; WOMEN; STRENGTH; MEN; INTERLEUKIN-6; PERFORMANCE	The prevalence of obesity and sarcopenia is high among the elderly. The simultaneous occurrence of these two disorders results in sarcopenic obesity. Research suggests that inflammation has an important role in the pathogenesis of obesity and sarcopenia. This study explores the impact of sarcopenic obesity on inflammatory markers, including interleukin-6 (IL-6), high-sensitivity C-reactive protein (hs-CRP), and tumor necrosis factoralpha (TNF-alpha). This study is a community-based cross-sectional study. The study sample consisted of 844 community-dwelling people aged 65 years and older (448 men and 396 women). Sarcopenia was characterized by low muscle mass (skeletal muscle index < 6.87 and 5.46 kg/m(2) for men and women, respectively), and obesity was characterized by excess body fat (body fat percentage greater than the 60th percentile of the study sample by sex [27.82% in men and 37.61% in women]). Older individuals identified with sarcopenic obesity were those who had both sarcopenia and obesity. Inflammatory markers such as IL-6, hs-CRP, and TNF-alpha were measured. The prevalence rates of obesity only, sarcopenia only, and sarcopenic obesity were 32.94%, 11.85%, and 7.23%, respectively. No difference was observed in the serum levels of IL-6 and TNF-alpha among the four groups of combined sarcopenia and obesity status. After multivariate adjustment, the serum hs-CRP levels in the obesity only and in the sarcopenic obesity groups were 0.14 and 0.16 mg/dL among males, respectively, which were significantly higher than that in the normal group (P=0.012 and 0.036). Our results provide evidence that obesity and sarcopenic obesity are associated with increased levels of serum hs-CRP among males.	[Yang, Chuan-Wei; Lin, Cheng-Chieh] China Med Univ, PhD Program Aging, Coll Med, Taichung, Taiwan; [Yang, Chuan-Wei; Li, Chia-Ing; Liu, Chiu-Shong; Lin, Cheng-Chieh] China Med Univ Hosp, Dept Med Res, Taichung, Taiwan; [Li, Chia-Ing; Liu, Chiu-Shong; Lin, Chih-Hsueh; Lin, Wen-Yuan; Lin, Cheng-Chieh] China Med Univ, Coll Med, Sch Med, Taichung, Taiwan; [Li, Tsai-Chung] China Med Univ, Coll Publ Hlth, Grad Inst Biostat, Taichung, Taiwan; [Lin, Cheng-Chieh] Asia Univ, Coll Hlth Sci, Dept Healthcare Adm, Taichung, Taiwan; [Liu, Chiu-Shong; Lin, Chih-Hsueh; Lin, Wen-Yuan; Lin, Cheng-Chieh] China Med Univ Hosp, Dept Family Med, Taichung, Taiwan	China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; Asia University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Lin, CC (corresponding author), China Med Univ, PhD Program Aging, Coll Med, Taichung, Taiwan.	cclin@mail.cmuh.org.tw	Lin, Cheng-Chieh/P-2564-2015; Li, Tsai-Chung/P-2052-2015	Lin, Cheng-Chieh/0000-0002-9625-6216; Li, Tsai-Chung/0000-0002-3346-7462	Taiwan National Health Research Institutes [NHRI-EX100-9838PI]; Taiwan Department of Health Clinical Trial and Research Center of Excellence [DOH100-TD-B-111-004]	Taiwan National Health Research Institutes; Taiwan Department of Health Clinical Trial and Research Center of Excellence	This study was supported by grants from Taiwan National Health Research Institutes (NHRI-EX100-9838PI) and Taiwan Department of Health Clinical Trial and Research Center of Excellence (DOH100-TD-B-111-004).	Atkins JL, 2014, J AM GERIATR SOC, V62, P253, DOI 10.1111/jgs.12652; Baumgartner RN, 2004, OBES RES, V12, P1995, DOI 10.1038/oby.2004.250; Bouchard DR, 2009, OBESITY, V17, P2082, DOI 10.1038/oby.2009.109; Brien SE, 2006, APPL PHYSIOL NUTR ME, V31, P40, DOI 10.1139/H05-024; Brooks GC, 2010, AM J CARDIOL, V106, P56, DOI 10.1016/j.amjcard.2010.02.017; Castillo EM, 2003, AM J PREV MED, V25, P226, DOI 10.1016/S0749-3797(03)00197-1; Chang PC, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-193; Clark BC, 2008, J GERONTOL A-BIOL, V63, P829, DOI 10.1093/gerona/63.8.829; DiGirolamo N, 1997, J LEUKOCYTE BIOL, V61, P667, DOI 10.1002/jlb.61.6.667; Flores MBS, 2012, GASTROENTEROLOGY, V143, P741, DOI 10.1053/j.gastro.2012.05.045; Gale CR, 2007, INT J EPIDEMIOL, V36, P228, DOI 10.1093/ije/dyl224; GOODMAN MN, 1991, AM J PHYSIOL, V260, pE727, DOI 10.1152/ajpendo.1991.260.5.E727; GOODMAN MN, 1994, P SOC EXP BIOL MED, V205, P182; Henry CJK, 2000, EUR J CLIN NUTR, V54, pS77, DOI 10.1038/sj.ejcn.1601029; Huang CF, 2010, HEPATOL INT, V4, P621, DOI 10.1007/s12072-010-9200-8; Illan-Gomez F, 2012, OBES SURG, V22, P950, DOI 10.1007/s11695-012-0643-y; Isasi CR, 2003, PEDIATRICS, V111, P332, DOI 10.1542/peds.111.2.332; Janssen I, 2002, J AM GERIATR SOC, V50, P889, DOI 10.1046/j.1532-5415.2002.50216.x; Kasapis C, 2005, J AM COLL CARDIOL, V45, P1563, DOI 10.1016/j.jacc.2004.12.077; Kim J, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-624; Kim TN, 2009, INT J OBESITY, V33, P885, DOI 10.1038/ijo.2009.130; Kim TN, 2013, CLIN ENDOCRINOL, V78, P525, DOI 10.1111/j.1365-2265.2012.04433.x; Kleppinger A, 2010, J WOMENS HEALTH, V19, P1651, DOI 10.1089/jwh.2009.1853; Lafortuna CL, 2005, INT J OBESITY, V29, P833, DOI 10.1038/sj.ijo.0802955; Landi F, 1999, J AM GERIATR SOC, V47, P1072, DOI 10.1111/j.1532-5415.1999.tb05229.x; Lazzer S, 2010, OBESITY, V18, P71, DOI 10.1038/oby.2009.162; Lee JSW, 2007, GERONTOLOGY, V53, P404, DOI 10.1159/000107355; Martel GF, 2006, EXP PHYSIOL, V91, P457, DOI 10.1113/expphysiol.2005.032771; McDade TW, 2008, J NUTR, V138, P2442, DOI 10.3945/jn.108.092700; Moran LJ, 2007, J CLIN ENDOCR METAB, V92, P2944, DOI 10.1210/jc.2006-2336; Obisesan TO, 2004, ARTERIOSCL THROM VAS, V24, P1874, DOI 10.1161/01.ATV.0000140060.13203.22; Pahor M, 2006, J GERONTOL A-BIOL, V61, P1157; Pedrero-Chamizo R, 2015, J NUTR HEALTH AGING, V19, P211, DOI 10.1007/s12603-014-0530-4; Ridker PM, 1999, CIRCULATION, V100, P230, DOI 10.1161/01.CIR.100.3.230; Rolland Y, 2009, AM J CLIN NUTR, V89, P1895, DOI 10.3945/ajcn.2008.26950; ROSENBERG IH, 1989, AM J CLIN NUTR, V50, P1231, DOI 10.1093/ajcn/50.5.1231; Sanada K, 2010, EUR J APPL PHYSIOL, V110, P57, DOI 10.1007/s00421-010-1473-z; Sayer AA, 2005, DIABETES CARE, V28, P2541, DOI 10.2337/diacare.28.10.2541; Schaap LA, 2006, AM J MED, V119, DOI 10.1016/j.amjmed.2005.10.049; Scheller J, 2011, BBA-MOL CELL RES, V1813, P878, DOI 10.1016/j.bbamcr.2011.01.034; Schrager MA, 2007, J APPL PHYSIOL, V102, P919, DOI 10.1152/japplphysiol.00627.2006; Stenholm S, 2008, CURR OPIN CLIN NUTR, V11, P693, DOI 10.1097/MCO.0b013e328312c37d; Stenholm S, 2008, J AM GERIATR SOC, V56, P462, DOI 10.1111/j.1532-5415.2007.01567.x; Szulc P, 2004, AM J CLIN NUTR, V80, P496, DOI 10.1093/ajcn/80.2.496; Taaffe DR, 2000, J GERONTOL A-BIOL, V55, pM709, DOI 10.1093/gerona/55.12.M709; Thompson D, 1999, STRUCTURE, V7, P169, DOI 10.1016/S0969-2126(99)80023-9; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Visser M, 2005, J GERONTOL A-BIOL, V60, P324, DOI 10.1093/gerona/60.3.324; Visser M, 1998, J GERONTOL A-BIOL, V53, pM214, DOI 10.1093/gerona/53A.3.M214; Visser M, 2002, J GERONTOL A-BIOL, V57, pM326, DOI 10.1093/gerona/57.5.M326; Visser M, 2002, J AM GERIATR SOC, V50, P897, DOI 10.1046/j.1532-5415.2002.50217.x; Xing Z, 1998, J CLIN INVEST, V101, P311, DOI 10.1172/JCI1368; Yang XL, 2008, MED SCI SPORT EXER, V40, P1424, DOI 10.1249/MSS.0b013e318172ced4; Yeh CJ, 2011, ASIA PAC J CLIN NUTR, V20, P292; Zamboni M, 2008, NUTR METAB CARDIOVAS, V18, P388, DOI 10.1016/j.numecd.2007.10.002	55	26	27	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132908	10.1371/journal.pone.0132908	http://dx.doi.org/10.1371/journal.pone.0132908			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1RL	26177029	Green Published, gold			2022-12-26	WOS:000358197600177
J	Kim, E; Park, Y; Kim, Y				Kim, Eunseong; Park, Youngjin; Kim, Yonggyun			A Transformed Bacterium Expressing Double-Stranded RNA Specific to Integrin beta 1 Enhances Bt Toxin Efficacy against a Polyphagous Insect Pest, Spodoptera exigua	PLOS ONE			English	Article							BEET ARMYWORM; GENE-EXPRESSION; INTERFERENCE; DSRNA; INGESTION; RESPONSES; MOSQUITO; DELIVERY; RECEPTOR; REVEALS	Background Oral toxicity of double-stranded RNA (dsRNA) specific to integrin beta 1 subunit (SeINT) was known in a polyphagous insect pest, Spodoptera exigua. For an application of the dsRNA to control the insect pest, this study prepared a transformed Escherichia coli expressing dsRNA specific to SeINT. Principal Findings The dsRNA expression was driven by T7 RNA polymerase overexpressed by an inducer in the transformed E. coli. The produced dsRNA amount was proportional to the number of the cultured bacteria. The transformed bacteria gave a significant oral toxicity to S. exigua larvae with a significant reduction of the SeINT expression. The resulting insect mortality increased with the fed number of the bacteria. Pretreatment with an ultra-sonication to disrupt bacterial cell wall/membrane significantly increased the insecticidal activity of the transformed bacteria. The larvae treated with the transformed bacteria suffered tissue damage in the midgut epithelium, which exhibited a marked loss of cell-cell contacts and underwent a remarkable cell death. Moreover, these treated larvae became significantly susceptible to a Cry toxin derived from Bacillus thuringiensis (Bt). Conclusions This study provides a novel and highly efficient application technique to use dsRNA specific to an integrin gene by mixing with a biopesticide, Bt.	[Kim, Eunseong; Park, Youngjin; Kim, Yonggyun] Andong Natl Univ, Dept Bioresource Sci, Andong 760749, South Korea	Andong National University	Kim, Y (corresponding author), Andong Natl Univ, Dept Bioresource Sci, Andong 760749, South Korea.	hosanna@andong.ac.kr			iPET (Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries), Ministry of Agriculture, Food and Rural Affairs	iPET (Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries), Ministry of Agriculture, Food and Rural Affairs	This research was supported by iPET (Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries), Ministry of Agriculture, Food and Rural Affairs to YK. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen ML, 2012, J INSECT PHYSIOL, V58, P391, DOI 10.1016/j.jinsphys.2011.12.014; Attasart P, 2013, VIRUS RES, V171, P252, DOI 10.1016/j.virusres.2012.11.012; Bachman PM, 2013, TRANSGENIC RES, V22, P1207, DOI 10.1007/s11248-013-9716-5; Barandoc K, 2009, J MICROBIOL BIOTECHN, V19, P610, DOI 10.4014/jmb.0808.495; Baum JA, 2007, NAT BIOTECHNOL, V25, P1322, DOI 10.1038/nbt1359; Bolognesi R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047534; Bravo A, 2011, INSECT BIOCHEM MOLEC, V41, P423, DOI 10.1016/j.ibmb.2011.02.006; Broderick NA, 2006, P NATL ACAD SCI USA, V103, P15196, DOI 10.1073/pnas.0604865103; Chen J, 2010, PLOS ONE, V5; Chen X, 2008, B ENTOMOL RES, V98, P613, DOI 10.1017/S0007485308005932; Christiaens O, 2014, PEPTIDES, V53, P307, DOI 10.1016/j.peptides.2013.12.014; DELORME R, 1988, PESTIC BIOCHEM PHYS, V32, P240, DOI 10.1016/0048-3575(88)90107-1; GOH H G, 1991, Korean Journal of Applied Entomology, V30, P111; GOH H G, 1990, Korean Journal of Applied Entomology, V29, P180; Hwang J, 2011, J INVERTEBR PATHOL, V108, P194, DOI 10.1016/j.jip.2011.09.003; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Kim J, 2012, ARCH INSECT BIOCHEM, V81, P214, DOI 10.1002/arch.21051; KIM Y, 1999, KOR J APPL ENTOMOL, V38, P56; Liu JS, 2013, J INSECT PHYSIOL, V59, P646, DOI 10.1016/j.jinsphys.2013.03.013; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Merzendorfer H, 2003, J EXP BIOL, V206, P4393, DOI 10.1242/jeb.00709; MOAR WJ, 1995, APPL ENVIRON MICROB, V61, P2086, DOI 10.1128/AEM.61.6.2086-2092.1995; Park Y, 2013, J INVERTEBR PATHOL, V114, P285, DOI 10.1016/j.jip.2013.09.006; Park Y, 2013, J EXP BIOL, V216, P4196, DOI 10.1242/jeb.092031; SAS Institute Inc, 1989, SAS STAT US GUID, V2; Scott JG, 2013, J INSECT PHYSIOL, V59, P1212, DOI 10.1016/j.jinsphys.2013.08.014; Shrestha S, 2011, J INSECT PHYSIOL, V57, P1568, DOI 10.1016/j.jinsphys.2011.08.010; Shrestha S, 2011, COMP BIOCHEM PHYS B, V158, P216, DOI 10.1016/j.cbpb.2010.11.007; Singh AD, 2013, J INSECT SCI, V13, DOI 10.1673/031.013.6901; SMITS PH, 1987, ENTOMOL EXP APPL, V43, P67, DOI 10.1007/BF00350377; Srikanth K, 2011, ARCH INSECT BIOCHEM, V78, P145, DOI 10.1002/arch.20450; Surakasi VP, 2011, J INSECT PHYSIOL, V57, P1537, DOI 10.1016/j.jinsphys.2011.08.006; Terenius O, 2011, J INSECT PHYSIOL, V57, P231, DOI 10.1016/j.jinsphys.2010.11.006; Thakur N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087235; Tian HG, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0006225, 10.1371/journal.pone.0005157]; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Upgadhyay SK, 2011, J BIOSCIENCE, V36, P153; Xiong YH, 2013, INT J BIOL SCI, V9, P370, DOI 10.7150/ijbs.5929; Yu N, 2013, INSECT SCI, V20, P4, DOI 10.1111/j.1744-7917.2012.01534.x; Yu R, 2014, INT J BIOL SCI, V10, P1171, DOI 10.7150/ijbs.9598; Zhang X, 2010, INSECT MOL BIOL, V19, P683, DOI 10.1111/j.1365-2583.2010.01029.x; Zhu F, 2011, PEST MANAG SCI, V67, P175, DOI 10.1002/ps.2048; Zhuang S, 2008, DEV COMP IMMUNOL, V32, P365, DOI 10.1016/j.dci.2007.07.007	44	26	30	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132631	10.1371/journal.pone.0132631	http://dx.doi.org/10.1371/journal.pone.0132631			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26171783	gold, Green Published, Green Submitted			2022-12-26	WOS:000358194900066
J	Lin, X; Li, JS; Luo, JW; Wu, XP; Tian, Y; Wang, W				Lin, Xin; Li, Junsheng; Luo, Jianwu; Wu, Xiaopu; Tian, Yu; Wang, Wei			Precipitation Mediates the Response of Carbon Cycle to Rising Temperature in the Mid-to-High Latitudes of the Northern Hemisphere	PLOS ONE			English	Article							DIFFERENCE VEGETATION INDEX; DROUGHT-INDUCED REDUCTION; SOIL RESPIRATION; ECOSYSTEM CARBON; ATMOSPHERIC CO2; PLANT-GROWTH; TERRESTRIAL ECOSYSTEMS; PHOTOSYNTHETIC TRENDS; SEASONAL CYCLE; BOREAL FOREST	Over the past decades, rising air temperature has been accompanied by changes in precipitation. Despite relatively robust literature on the temperature sensitivity of carbon cycle at continental to global scales, less is known about the way this sensitivity is affected by precipitation. In this study we investigate how precipitation mediates the response of the carbon cycle to warming over the mid-to-high latitudes in the Northern Hemisphere (north of 30 degrees N). Based on atmospheric CO2 observations at Point Barrow (BRW) in Alaska, satellite-derived NDVI (a proxy of vegetation productivity), and temperature and precipitation data, we analyzed the responses of carbon cycle to temperature change in wet and dry years (with precipitation above or below the multiyear average). The results suggest that, over the past three decades, the net seasonal atmospheric CO2 changes at BRW were significantly correlated with temperature in spring and autumn, yet only weakly correlated with temperature and precipitation during the growing season. We further found that responses of the net CO2 changes to warming in spring and autumn vary with precipitation levels, with the absolute temperature sensitivity in wet years roughly twice that in dry years. The analyses of NDVI and climate data also identify higher sensitivity of vegetation growth to warming in wet years for the growing season, spring and summer. The different temperature sensitivities in wet versus dry years probably result from differences in soil moisture and/or nutrient availability, which may enhance (inhibit) the responsiveness of carbon assimilation and/or decomposition to warming under high (low) precipitation levels. The precipitation-mediated response of the terrestrial carbon cycle to warming reported here emphasizes the important role of precipitation in assessing the temporal variations of carbon budgets in the past as well as in the future. More efforts are required to reduce uncertainty in future precipitation projections, and to better represent the nonlinearity of carbon cycle responses to climate in current state-of-the-art land surface models.	[Lin, Xin] Beijing Normal Univ, Coll Water Sci, Beijing 100875, Peoples R China; [Lin, Xin; Li, Junsheng; Luo, Jianwu; Wu, Xiaopu; Tian, Yu; Wang, Wei] Chinese Res Inst Environm Sci, State Key Lab Environm Criteria & Risk Assessment, Beijing, Peoples R China	Beijing Normal University; Chinese Research Academy of Environmental Sciences	Li, JS (corresponding author), Chinese Res Inst Environm Sci, State Key Lab Environm Criteria & Risk Assessment, Beijing, Peoples R China.	lijsh@craes.org.cn	Lin, Xin/GRJ-1583-2022	wang, wei/0000-0002-3864-4931; Lin, Xin/0000-0002-0605-6430	Environmental Protection Public Service Project of China [201209028]	Environmental Protection Public Service Project of China	This study was supported by the Environmental Protection Public Service Project of China (201209028) (URL: http://kjs.mep.gov.cn/gyxhykyzx/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Angert A, 2005, P NATL ACAD SCI USA, V102, P10823, DOI 10.1073/pnas.0501647102; Barber VA, 2000, NATURE, V405, P668, DOI 10.1038/35015049; Bauerle WL, 2012, P NATL ACAD SCI USA, V109, P8612, DOI 10.1073/pnas.1119131109; Beier C, 2012, ECOL LETT, V15, P899, DOI 10.1111/j.1461-0248.2012.01793.x; Bousquet P, 2000, SCIENCE, V290, P1342, DOI 10.1126/science.290.5495.1342; Bunn AG, 2006, EARTH INTERACT, V10; Chapin FS, 2006, ECOSYSTEMS, V9, P1041, DOI 10.1007/s10021-005-0105-7; CIAIS P, 1995, SCIENCE, V269, P1098, DOI 10.1126/science.269.5227.1098; D'Arrigo RD, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2004GB002249; Davidson EA, 2006, NATURE, V440, P165, DOI 10.1038/nature04514; Dukes JS, 2005, PLOS BIOL, V3, P1829, DOI 10.1371/journal.pbio.0030319; Fabricante I, 2009, J ARID ENVIRON, V73, P745, DOI 10.1016/j.jaridenv.2009.02.006; Friedlingstein P, 2006, J CLIMATE, V19, P3337, DOI 10.1175/JCLI3800.1; Goetz SJ, 2005, P NATL ACAD SCI USA, V102, P13521, DOI 10.1073/pnas.0506179102; Gong DY, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002300; Graven HD, 2013, SCIENCE, V341, P1085, DOI 10.1126/science.1239207; Hickler T, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024370; Hoeppner SS, 2012, GLOBAL CHANGE BIOL, V18, P1754, DOI 10.1111/j.1365-2486.2011.02626.x; HOLBEN BN, 1986, INT J REMOTE SENS, V7, P1417, DOI 10.1080/01431168608948945; IPCC, 2007, CONTRIBUTION WORKING; Janssens IA, 2003, GLOBAL CHANGE BIOL, V9, P911, DOI 10.1046/j.1365-2486.2003.00636.x; Keeling CD, 1996, NATURE, V382, P146, DOI 10.1038/382146a0; Lapenis A, 2005, GLOBAL CHANGE BIOL, V11, P2090, DOI 10.1111/j.1365-2486.2005.001069.x; Le Quere C, 2009, NAT GEOSCI, V2, P831, DOI 10.1038/ngeo689; Lucht W, 2002, SCIENCE, V296, P1687, DOI 10.1126/science.1071828; Luo YQ, 2008, GLOBAL CHANGE BIOL, V14, P1986, DOI 10.1111/j.1365-2486.2008.01629.x; Ma ZH, 2012, P NATL ACAD SCI USA, V109, P2423, DOI 10.1073/pnas.1111576109; Mitchell TD, 2005, INT J CLIMATOL, V25, P693, DOI 10.1002/joc.1181; Myneni RB, 1997, NATURE, V386, P698, DOI 10.1038/386698a0; Myneni RB, 2001, P NATL ACAD SCI USA, V98, P14784, DOI 10.1073/pnas.261555198; Niu SL, 2008, NEW PHYTOL, V177, P209, DOI 10.1111/j.1469-8137.2007.02237.x; Owe M, 2008, J GEOPHYS RES-EARTH, V113, DOI 10.1029/2007JF000769; Pan YD, 2011, SCIENCE, V333, P988, DOI 10.1126/science.1201609; Park HS, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD012752; Peng SS, 2013, NATURE, V501, P88, DOI 10.1038/nature12434; Peng SS, 2013, AGR FOREST METEOROL, V178, P46, DOI 10.1016/j.agrformet.2013.02.002; Peng SS, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/4/044027; Penuelas J, 2004, ECOSYSTEMS, V7, P598, DOI 10.1007/s10021-004-0179-7; PETERSON JT, 1986, J ATMOS CHEM, V4, P491, DOI 10.1007/BF00053848; PETERSON JT, 1982, TELLUS, V34, P166, DOI 10.1111/j.2153-3490.1982.tb01804.x; Piao SL, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL028205; Piao SL, 2008, NATURE, V451, P49, DOI 10.1038/nature06444; Piao SL, 2013, GLOBAL CHANGE BIOL, V19, P2117, DOI 10.1111/gcb.12187; Piao SL, 2011, GLOBAL CHANGE BIOL, V17, P3228, DOI 10.1111/j.1365-2486.2011.02419.x; Piao SL, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003339; Piao SL, 2009, NATURE, V458, P1009, DOI 10.1038/nature07944; Piao SL, 2004, J VEG SCI, V15, P219, DOI 10.1658/1100-9233(2004)015[0219:VIASVI]2.0.CO;2; Qi Y, 2002, ECOL MODEL, V153, P131, DOI 10.1016/S0304-3800(01)00506-3; Qian HF, 2010, GLOBAL CHANGE BIOL, V16, P641, DOI 10.1111/j.1365-2486.2009.01989.x; Randerson JT, 1999, GEOPHYS RES LETT, V26, P2765, DOI 10.1029/1999GL900500; Randerson JT, 1997, GLOBAL BIOGEOCHEM CY, V11, P535, DOI 10.1029/97GB02268; Reich PB, 2010, SCIENCE, V329, P774, DOI 10.1126/science.1194353; Richardson AD, 2010, PHILOS T R SOC B, V365, P3227, DOI 10.1098/rstb.2010.0102; Rustad LE, 2001, OECOLOGIA, V126, P543, DOI 10.1007/s004420000544; Schaeffer SM, 2013, GLOBAL CHANGE BIOL, V19, P3529, DOI 10.1111/gcb.12318; Schulze ED, 2006, BIOGEOSCIENCES, V3, P147, DOI 10.5194/bg-3-147-2006; Shaw MR, 2002, SCIENCE, V298, P1987, DOI 10.1126/science.1075312; Slayback DA, 2003, GLOBAL CHANGE BIOL, V9, P1, DOI 10.1046/j.1365-2486.2003.00507.x; Suni T, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002381; Suseela V, 2014, SOIL BIOL BIOCHEM, V75, P102, DOI 10.1016/j.soilbio.2014.03.022; Swenson S, 2008, WATER RESOUR RES, V44, DOI 10.1029/2007WR006057; THONING KW, 1989, J GEOPHYS RES-ATMOS, V94, P8549, DOI 10.1029/JD094iD06p08549; Tucker CJ, 2001, INT J BIOMETEOROL, V45, P184, DOI 10.1007/s00484-001-0109-8; Tucker CJ, 2005, INT J REMOTE SENS, V26, P4485, DOI 10.1080/01431160500168686; Vesala T, 2010, BIOGEOSCIENCES, V7, P163, DOI 10.5194/bg-7-163-2010; Wang XH, 2014, NATURE, V506, P212, DOI 10.1038/nature12915; Welp LR, 2007, AGR FOREST METEOROL, V147, P172, DOI 10.1016/j.agrformet.2007.07.010; Weltzin JF, 2003, BIOSCIENCE, V53, P941, DOI 10.1641/0006-3568(2003)053[0941:ATROTE]2.0.CO;2; Yang YH, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035408; Zhang K, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2007JG000621; Zhao MS, 2010, SCIENCE, V329, P940, DOI 10.1126/science.1189590; Zhou L, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002510; Zhou LM, 2001, J GEOPHYS RES-ATMOS, V106, P20069, DOI 10.1029/2000JD000115	73	1	2	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132663	10.1371/journal.pone.0132663	http://dx.doi.org/10.1371/journal.pone.0132663			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26172277	Green Published, gold, Green Submitted			2022-12-26	WOS:000358194900071
J	Lu, P; Zheng, XP				Lu, Peng; Zheng, Xiaoping			Social Stratification and Cooperative Behavior in Spatial Prisoners' Dilemma Games	PLOS ONE			English	Article							PUBLIC-GOODS GAME; PROMOTES COOPERATION; PUNISHMENT; SELECTION; REPUTATION; DIVERSITY; DYNAMICS	It has been a long-lasting pursuit to promote cooperation, and this study aims to promote cooperation via the combination of social stratification and the spatial prisoners' dilemma game. It is previously assumed that agents share the identical payoff matrix, but the stratification or diversity exists and exerts influences in real societies. Thus, two additional classes, elites and scoundrels, derive from and coexist with the existing class, commons. Three classes have different payoff matrices. We construct a model where agents play the prisoners' dilemma game with neighbors. It indicates that stratification and temptation jointly influence cooperation. Temptation permanently reduces cooperation; elites play a positive role in promoting cooperation while scoundrels undermine it. As the temptation getting larger and larger, elites play a more and more positive and critical role while scoundrels' negative effect becomes weaker and weaker, and it is more obvious when temptation goes beyond its threshold.	[Lu, Peng; Zheng, Xiaoping] Tsinghua Univ, Dept Automat, Beijing 100084, Peoples R China; [Lu, Peng] Tsinghua Univ, Dept Sociol, Beijing 100084, Peoples R China	Tsinghua University; Tsinghua University	Zheng, XP (corresponding author), Tsinghua Univ, Dept Automat, Beijing 100084, Peoples R China.	asean@mail.tsinghua.edu.cn	Lu, Peng/G-4766-2015	Lu, Peng/0000-0003-1195-1816	National Science Fund for Distinguished Young Scholars [71225007]; National Basic Research Program of China (973 Program) [2011CB706900]; National Natural Science Foundation of China [91224008]	National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by the National Science Fund for Distinguished Young Scholars (Grant no. 71225007, URL: http://www.nsfc.gov.cn), National Basic Research Program of China (973 Program) (Grant no.2011CB706900, URL: http://www.973.gov.cn), and the National Natural Science Foundation of China (Grant No. 91224008, URL: http://www.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn TK, 2009, J POLIT, V71, P398, DOI 10.1017/S0022381609090355; Anderson SP, 1998, J PUBLIC ECON, V70, P297, DOI 10.1016/S0047-2727(98)00035-8; Bian YJ, 2002, ANNU REV SOCIOL, V28, P91, DOI 10.1146/annurev.soc.28.110601.140823; Cao XB, 2010, PHYSICA A, V389, P1273, DOI 10.1016/j.physa.2009.11.044; Charness G, 2014, GAME ECON BEHAV, V87, P322, DOI 10.1016/j.geb.2014.05.002; Choi JK, 2013, J ECON PSYCHOL, V35, P17, DOI 10.1016/j.joep.2013.01.001; Croson RTA, 2007, ECON INQ, V45, P199, DOI 10.1111/j.1465-7295.2006.00006.x; Dercole F, 2013, J THEOR BIOL, V326, P70, DOI 10.1016/j.jtbi.2012.11.034; Fu F, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.016104; Gao J, 2012, PHYSICA A, V391, P4111, DOI 10.1016/j.physa.2012.03.027; Giddens A, 1993, CLASS STRUCTURE ADV; Goldthorpe John H., 1987, SOCIAL MOBILITY CLAS; Jaramillo JJ, 2010, AD HOC NETW, V8, P416, DOI 10.1016/j.adhoc.2009.10.002; Karagonlar G, 2013, ORGAN BEHAV HUM DEC, V120, P228, DOI 10.1016/j.obhdp.2012.07.006; Kwon K, 2007, MERRILL PALMER QUART, V53, P216, DOI 10.1353/mpq.2007.0012; McIntosh C, 2013, J ECON BEHAV ORGAN, V95, P270, DOI 10.1016/j.jebo.2012.09.013; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Ohtsuki H, 2007, J THEOR BIOL, V244, P518, DOI 10.1016/j.jtbi.2006.08.018; Parks CD, 2013, PSYCHOL SCI PUBL INT, V14, P119, DOI 10.1177/1529100612474436; Power C, 2009, JASSS-J ARTIF SOC S, V12; Raub W, 2013, SOC NETWORKS, V35, P720, DOI 10.1016/j.socnet.2013.05.006; Rezaei G, 2012, PHYSICA A, V391, P6199, DOI 10.1016/j.physa.2012.06.071; Rivas MF, 2011, ECON LETT, V112, P176, DOI 10.1016/j.econlet.2011.04.007; Santos FC, 2008, NATURE, V454, P213, DOI 10.1038/nature06940; Santos MD, 2012, J THEOR BIOL, V315, P81, DOI 10.1016/j.jtbi.2012.09.001; Shi DM, 2009, PHYSICA A, V388, P4646, DOI 10.1016/j.physa.2009.07.031; Szolnoki A, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.036101; Tan FF, 2008, ECONOMIST-NETHERLAND, V156, P269, DOI 10.1007/s10645-008-9094-1; Tepe S, 2007, MEDITERR Q, V18, P107, DOI 10.1215/10474552-2007-008; Van Vugt M, 2010, GROUP PROCESS INTERG, V13, P101, DOI 10.1177/1368430209342258; Volk S, 2011, PERS INDIV DIFFER, V50, P810, DOI 10.1016/j.paid.2011.01.001; Wang XF, 2013, CHAOS SOLITON FRACT, V56, P181, DOI 10.1016/j.chaos.2013.07.019; Wang Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040218; Wiegard A, 2013, CEA CRITIC, V75, P224; Wu T, 2014, PHYSICA A, V413, P86, DOI 10.1016/j.physa.2014.06.040; Xianyu B, 2014, JASSS-J ARTIF SOC S, V15, P3; Yang ZH, 2013, PHYSICA A, V392, P2038, DOI 10.1016/j.physa.2012.11.024; Zhang HF, 2014, PHYSICA A, V414, P86, DOI 10.1016/j.physa.2014.07.013; Zhu CJ, 2014, PHYSICA A, V406, P145, DOI 10.1016/j.physa.2014.03.035	39	8	9	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0131005	10.1371/journal.pone.0131005	http://dx.doi.org/10.1371/journal.pone.0131005			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1QN	26173029	gold, Green Published, Green Submitted			2022-12-26	WOS:000358194900013
J	Sauter, TC; Lindner, G; Ahmad, SS; Leichtle, AB; Fiedler, GM; Exadaktylos, AK; Haider, DG				Sauter, Thomas C.; Lindner, Gregor; Ahmad, Sufian S.; Leichtle, Alexander Benedikt; Fiedler, Georg-Martin; Exadaktylos, Aristomenis K.; Haider, Dominik G.			Calcium Disorders in the Emergency Department: Independent Risk Factors for Mortality	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; RENAL-INSUFFICIENCY; HEART-FAILURE; HYPERCALCEMIA; HYPOCALCEMIA; POPULATION; PREVALENCE; MALIGNANCY; MODERATE; OUTCOMES	Background Calcium disorders are common in both intensive care units and in patients with chronic kidney disease and are associated with increased morbidity and mortality. It is unknown whether calcium abnormalities in unselected emergency department admissions have an impact on in-hospital mortality. Methods This cross-sectional analysis included all admissions to the Emergency Department at the Inselspital Bern, Switzerland from 2010 to 2011. For hyper- and hypocalcaemic patients with a Mann-Whitney U-test, the differences between subgroups divided by age, length of hospital stay, creatinine, sodium, chloride, phosphate, potassium and magnesium were compared. Associations between calcium disorders and 28-day in-hospital mortality were assessed using the Cox proportional hazard regression model. Results 8,270 patients with calcium measurements were included in our study. Overall 264 (3.2%) patients died. 150 patients (6.13%) with hypocalcaemia and 7 patients with hypercalcaemia (6.19%) died, in contrast to 104 normocalcaemic patients (1.82%). In univariate analysis, calcium serum levels were associated with sex, mortality and pre-existing diuretic therapy (all p<0.05). In multivariate Cox regression analysis, hypocalcaemia and hypercalcaemia were independent risk factors for mortality (HR 2.00 and HR 1.88, respectively; both p<0.01). Conclusion Both hypocalcaemia and hypercalcaemia are associated with increased 28-day in-hospital mortality in unselected emergency department admissions.	[Sauter, Thomas C.; Lindner, Gregor; Ahmad, Sufian S.; Exadaktylos, Aristomenis K.; Haider, Dominik G.] Univ Hosp Bern, Dept Emergency Med, Inselspital, CH-3010 Bern, Switzerland; [Leichtle, Alexander Benedikt; Fiedler, Georg-Martin] Univ Hosp Bern, Ctr Lab Med, Inselspital, CH-3010 Bern, Switzerland	University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern	Sauter, TC (corresponding author), Univ Hosp Bern, Dept Emergency Med, Inselspital, Freiburgstr, CH-3010 Bern, Switzerland.	thomas.sauter@insel.ch	Leichtle, Alexander/C-7262-2011; Ahmad, Sufian S/H-3881-2014; Fiedler, Georg Martin/C-8341-2011; Lindner, Gregor/AAR-6761-2020	Ahmad, Sufian S/0000-0001-9763-092X; Fiedler, Georg Martin/0000-0001-5689-4574; Lindner, Gregor/0000-0001-5551-8227; Sauter, Thomas C/0000-0002-6646-5789				Catalano A, 2012, AGING CLIN EXP RES, V24, P400; DESAI TK, 1988, AM J MED, V84, P209, DOI 10.1016/0002-9343(88)90415-9; Donovan PJ, 2015, J CLIN ENDOCR METAB; Drey N, 2003, AM J KIDNEY DIS, V42, P677, DOI 10.1016/S0272-6386(03)00916-8; Garg AX, 2002, KIDNEY INT, V61, P1486, DOI 10.1046/j.1523-1755.2002.00270.x; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Gromadzinski L, 2014, J CARDIOL, V63, P198, DOI 10.1016/j.jjcc.2013.08.003; Hurley K, 2005, J EMERG MED, V28, P155, DOI 10.1016/j.jemermed.2004.06.014; Kazmi AS, 2007, AM J MED SCI, V333, P226, DOI 10.1097/MAJ.0b013e318039b9c6; Kumar Shankar, 2014, World J Nephrol, V3, P143, DOI 10.5527/wjn.v3.i4.143; Lamy O, 2001, J INTERN MED, V250, P73, DOI 10.1046/j.1365-2796.2001.00859.x; Lee CT, 2006, AM J MED SCI, V331, P119, DOI 10.1097/00000441-200603000-00002; Lim LM, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-183; Lindner G, 2013, AM J EMERG MED, V31, P657, DOI 10.1016/j.ajem.2012.11.010; Lu X, 2014, PLOS ONE, V13; Muntner P, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133745; Ross L, 2013, INT J CLIN PRACT, V67, P4, DOI 10.1111/ijcp.12069; Royer AM, 2014, AM SURGEON, V80, P732; SHEK CC, 1990, Q J MED, V77, P1277, DOI 10.1093/qjmed/77.3.1277; Vinas-Rios JM, 2014, NEUROL RES, V36, P102, DOI 10.1179/1743132813Y.0000000272; Vroonhof K, 2005, CLIN CHEM LAB MED, V43, P536, DOI 10.1515/CCLM.2005.093; WYSOLMERSKI JJ, 1994, ANNU REV MED, V45, P189, DOI 10.1146/annurev.med.45.1.189; Zhang Z, 2014, PLOS ONE, V15; Zivin JR, 2001, AM J KIDNEY DIS, V37, P689, DOI 10.1016/S0272-6386(01)80116-5	24	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132788	10.1371/journal.pone.0132788	http://dx.doi.org/10.1371/journal.pone.0132788			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26172117	gold, Green Published, Green Submitted			2022-12-26	WOS:000358194900086
J	Woo, HJ; Qin, Y; Park, SY; Park, SK; Cho, YG; Shin, KS; Lim, MH; Cho, HS				Woo, Hee-Jong; Qin, Yang; Park, Soo-Yun; Park, Soon Ki; Cho, Yong-Gu; Shin, Kong-Sik; Lim, Myung-Ho; Cho, Hyun-Suk			Development of Selectable Marker-Free Transgenic Rice Plants with Enhanced Seed Tocopherol Content through FLP/FRT-Mediated Spontaneous Auto-Excision	PLOS ONE			English	Article							VITAMIN-E; DNA EXCISION; SYSTEM; GENE; TRANSFORMATION; RECOMBINATION; STRATEGIES; RESISTANCE; EVOLUTION; PROMOTER	Development of marker-free transgenic plants is a technical alternative for avoiding concerns about the safety of selectable marker genes used in genetically modified (GM) crops. Here, we describe the construction of a spontaneous self-excision binary vector using an oxidative stress-inducible modified FLP/FRT system and its successful application to produce marker-free transgenic rice plants with enhanced seed tocopherol content. To generate selectable marker-free transgenic rice plants, we constructed a binary vector using the hpt selectable marker gene and the rice codon-optimized FLP (mFLP) gene under the control of an oxidative stress-inducible promoter between two FRT sites, along with multiple cloning sites for convenient cloning of genes of interest. Using this pCMF binary vector with the NtTC gene, marker-free T-1 transgenic rice plants expressing NtTC were produced by Agrobacterium-mediated stable transformation using hygromycin as a selective agent, followed by segregation of selectable marker genes. Furthermore, alpha-, gamma-, and total tocopherol levels were significantly increased in seeds of the marker-free transgenic TC line compared with those of wild-type plants. Thus, this spontaneous auto-excision system, incorporating an oxidative stress-inducible mFLP/FRT system to eliminate the selectable marker gene, can be easily adopted and used to efficiently generate marker-free transgenic rice plants. Moreover, nutritional enhancement of rice seeds through elevation of tocopherol content coupled with this marker-free strategy may improve human health and public acceptance of GM rice.	[Woo, Hee-Jong; Qin, Yang; Park, Soo-Yun; Shin, Kong-Sik; Lim, Myung-Ho; Cho, Hyun-Suk] Rural Dev Adm, Natl Acad Agr Sci, Biosafety Div, Jeonju, South Korea; [Park, Soon Ki] Kyungpook Natl Univ, Sch Appl Biosci, Daegu, South Korea; [Cho, Yong-Gu] Chungbuk Natl Univ, Dept Crop Sci, Cheongju, South Korea	Rural Development Administration (RDA); Kyungpook National University; Chungbuk National University	Woo, HJ (corresponding author), Rural Dev Adm, Natl Acad Agr Sci, Biosafety Div, Jeonju, South Korea.	woo001@korea.kr	Cho, Yong-Gu/AAV-1904-2021		Research Program for Agricultural Science & Technology Development of the National Academy of Agricultural Science [PJ010902]; Next-Generation BioGreen 21 Program (Plant Molecular Breeding Center), Rural Development Administration, Republic of Korea [PJ008021]	Research Program for Agricultural Science & Technology Development of the National Academy of Agricultural Science; Next-Generation BioGreen 21 Program (Plant Molecular Breeding Center), Rural Development Administration, Republic of Korea	This study was supported by a grant from the Research Program for Agricultural Science & Technology Development (Project No. PJ010902) of the National Academy of Agricultural Science and the Next-Generation BioGreen 21 Program (Plant Molecular Breeding Center No. PJ008021), Rural Development Administration, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bramley PM, 2000, J SCI FOOD AGR, V80, P913, DOI [10.1002/(SICI)1097-0010(20000515)80:7<913::AID-JSFA600>3.0.CO;2-3, 10.1002/(SICI)1097-0010(20000515)80:7&lt;913::AID-JSFA600&gt;3.0.CO;2-3]; CHAN MT, 1993, PLANT MOL BIOL, V22, P491, DOI 10.1007/BF00015978; Cheng M, 1997, PLANT PHYSIOL, V115, P971, DOI 10.1104/pp.115.3.971; Christou P, 1995, METHOD CELL BIOL, V50, P375, DOI 10.1016/S0091-679X(08)61044-4; Cuellar W, 2006, PLANT MOL BIOL, V62, P71, DOI 10.1007/s11103-006-9004-3; Darbani Behrooz, 2007, Biotechnology Journal, V2, P83, DOI 10.1002/biot.200600182; Delseny M, 2003, CURR OPIN PLANT BIOL, V6, P101, DOI 10.1016/S1369-5266(03)00010-4; deRijk MC, 1997, ARCH NEUROL-CHICAGO, V54, P762, DOI 10.1001/archneur.1997.00550180070015; Falk J, 2010, J EXP BOT, V61, P1549, DOI 10.1093/jxb/erq030; Fladung M, 2010, PLANT BIOLOGY, V12, P334, DOI 10.1111/j.1438-8677.2009.00293.x; Gelvin SB, 2003, MICROBIOL MOL BIOL R, V67, P16, DOI 10.1128/MMBR.67.1.16-37.2003; Gidoni D, 2008, IN VITRO CELL DEV-PL, V44, P457, DOI 10.1007/s11627-008-9140-3; Guo XY, 2007, FEBS LETT, V581, P1015, DOI 10.1016/j.febslet.2007.01.088; HAYASHIMOTO A, 1990, PLANT PHYSIOL, V93, P857, DOI 10.1104/pp.93.3.857; Heinemann RJB, 2008, CEREAL CHEM, V85, P243, DOI 10.1094/CCHEM-85-2-0243; Hoff T, 2001, PLANT MOL BIOL, V45, P41, DOI 10.1023/A:1006402308365; Khattri A, 2011, J BIOSCIENCES, V36, P37, DOI 10.1007/s12038-011-9010-8; Kim KY, 2003, PLANT MOL BIOL, V51, P831, DOI 10.1023/A:1023045218815; Kopertekh L., 2012, TRANSGENIC PLANTS AD, P449; Kumar R, 2005, FEBS LETT, V579, P1357, DOI 10.1016/j.febslet.2005.01.030; Lyznik LA, 1996, NUCLEIC ACIDS RES, V24, P3784, DOI 10.1093/nar/24.19.3784; MEYDANI SN, 1990, AM J CLIN NUTR, V52, P557, DOI 10.1093/ajcn/52.3.557; Miki B, 2004, J BIOTECHNOL, V107, P193, DOI 10.1016/j.jbiotec.2003.10.011; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Park SY, 2012, PLANT BIOTECHNOL REP, V6, P29, DOI 10.1007/s11816-011-0192-1; Puchta H, 2003, PLANT CELL TISS ORG, V74, P123, DOI 10.1023/A:1023934807184; Sambrook J., 2001, MOL CLONING LAB MANU; Schneider C, 2005, MOL NUTR FOOD RES, V49, P7, DOI 10.1002/mnfr.200400049; SHARP PM, 1989, J MOL EVOL, V28, P398, DOI 10.1007/BF02603075; Sreekala C, 2005, PLANT CELL REP, V24, P86, DOI 10.1007/s00299-004-0909-5; STAMPFER MJ, 1993, NEW ENGL J MED, V328, P1444, DOI 10.1056/NEJM199305203282003; Toki S, 2006, PLANT J, V47, P969, DOI 10.1111/j.1365-313X.2006.02836.x; Wang Y, 2005, TRANSGENIC RES, V14, P605, DOI 10.1007/s11248-005-0884-9; Woo HJ, 2014, PLANT CELL TISS ORG, V119, P257, DOI 10.1007/s11240-014-0530-4; Woo HJ, 2011, BIOTECHNOL BIOPROC E, V16, P1053, DOI 10.1007/s12257-011-0519-3; Woo HJ, 2009, TRANSGENIC RES, V18, P455, DOI 10.1007/s11248-008-9236-x; Yau YY, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-36; Zhang GY, 2013, TRANSGENIC RES, V22, P89, DOI 10.1007/s11248-012-9630-2; Zhang W, 2003, THEOR APPL GENET, V107, P1157, DOI 10.1007/s00122-003-1368-z; Zhang Y, 2009, TRANSGENIC RES, V18, P607, DOI 10.1007/s11248-009-9251-6; Zhang YY, 2006, BIOTECHNOL LETT, V28, P1247, DOI 10.1007/s10529-006-9081-z; Zuo JR, 2001, NAT BIOTECHNOL, V19, P157, DOI 10.1038/84428	42	19	20	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132667	10.1371/journal.pone.0132667	http://dx.doi.org/10.1371/journal.pone.0132667			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26172549	Green Submitted, Green Published, gold			2022-12-26	WOS:000358194900074
J	Zhang, HT; Chai, M; Liu, CZ; Sun, JJ; Huang, CC; Yu, XY; Tian, Y; Luo, HL				Zhang, Haitao; Chai, Meng; Liu, Chaozhong; Sun, Jinjin; Huang, Congchun; Yu, Xinya; Tian, Yi; Luo, Huilan			Endoplasmic Reticulum Is Involved in Myocardial Injury in a Miniature Swine Model of Coronary Artery Stenosis Exposed to Acceleration-Associated Stress	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; OXIDATIVE STRESS; ISCHEMIA/REPERFUSION INJURY; INDUCED APOPTOSIS; FIGHTER PILOTS; AORTIC INDEXES; PLUS GZ; FORCES; RATS; CARVEDILOL	This study aimed to investigate the effects of myocardial injury in a minimally-invasive miniature swine model with different levels of coronary artery stenosis (CAS) and exposed to maximal tolerated +Gz. Proximal left anterior descending branch was ligated in 20 swine. Five swine underwent a sham operation. A trapezoid acceleration curve was used for +Gz stress. Pathological changes of myocardial tissue were detected by H&E staining. Apoptotic cardiomyocytes were detected by TUNEL. GRP78 and CHOP were investigated by immunohistochemistry and western blot. CAS models were successful in 18 animals. Compared with the sham-operated group (+8.00 +/- 0.71 Gz), the maximal tolerated +Gz values of the moderate stenosis (+6.00 +/- 0.89 Gz, P<0.05) and severe stenosis groups (+5.20 +/- 0.84 Gz, P<0.05) were decreased. Compared with sham animals (12.16 +/- 1.25%), after exposure to maximum +Gz, apoptotic cells of the moderate (43.53 +/- 8.42%, P<0.05) and severe stenosis group (60.50 +/- 9.35%, P<0.05) were increased, MDA content was increased (1.89 and 4.91 folds, respectively, P<0.05), and SOD activity was reduced (-13.66% and -21.71%, respectively). After exposure to maximum +Gz, GRP78 protein expression was low in the sham-operated (0.29 +/- 0.05) and mild stenosis groups (0.35 +/- 0.04), while expression was high in the moderate (0.72 +/- 0.04, P<0.05) and severe stenosis groups (0.65 +/- 0.07, P<0.05). CHOP protein expression was not observed in the sham-operated group, while expression was high in the moderate and severe stenosis groups. These results indicated that Under maximum exposure to +Gz stress, different levels of CAS led to different levels of myocardial injury. Endoplasmic reticulum response is involved in the apoptosis of cardiomyocytes after +Gz stress.	[Zhang, Haitao; Sun, Jinjin; Huang, Congchun; Yu, Xinya; Luo, Huilan] PLA, Gen Hosp Air Force, Dept Cardiol, Beijing 100142, Peoples R China; [Chai, Meng] Capital Med Univ, Beijing Anzhen Hosp, Dept Cardiol, Beijing 100029, Peoples R China; [Chai, Meng] Minist Educ, Inst Heart Lung & Blood Vessel Dis, Beijing 100029, Peoples R China; [Liu, Chaozhong] PLA, Gen Hosp Air Force, Beijing 100142, Peoples R China; [Tian, Yi] Fuwai Hosp, Natl Heart Ctr China, Ctr Expt Anim, Beijing 100037, Peoples R China	Capital Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS	Luo, HL (corresponding author), PLA, Gen Hosp Air Force, Dept Cardiol, Beijing 100142, Peoples R China.	luohui_lansci@126.com	Tian, Yi/AFQ-7590-2022		'The twelfth five-year plan' momentous project of PLA [BWS11J054]	'The twelfth five-year plan' momentous project of PLA	The work was supported by the 'The twelfth five-year plan' momentous project of PLA (No.: BWS11J054). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbas H, 2005, J INT MED RES, V33, P528, DOI 10.1177/147323000503300508; Assa A, 2011, J AM SOC ECHOCARDIOG, V24, P1163, DOI 10.1016/j.echo.2011.06.001; Bhandary B, 2013, INT J MOL SCI, V14, P434, DOI 10.3390/ijms14010434; Bonjour J, 2011, EUR J APPL PHYSIOL, V111, P2907, DOI 10.1007/s00421-011-1917-0; BRAUN M, 1993, PROTOPLASMA, V174, P50, DOI 10.1007/BF01404042; Brunelle JK, 2009, J CELL SCI, V122, P437, DOI 10.1242/jcs.031682; Chen LE, 2014, CHIN J INTEGR MED; Chen LE, 2013, J PHYSIOL SCI, V63, P457, DOI 10.1007/s12576-013-0282-7; Convertino V A, 1998, J Gravit Physiol, V5, pP51; Fang SJ, 2010, CHINESE MED J-PEKING, V123, P3597, DOI 10.3760/cma.j.issn.0366-6999.2010.24.018; Feng SF, 2010, NEUROSCI LETT, V478, P150, DOI 10.1016/j.neulet.2010.05.006; Fong K. L., 1997, Annals Academy of Medicine Singapore, V26, P94; Ge CJ, 2012, CHINESE MED J-PEKING, V125, P2472, DOI 10.3760/cma.j.issn.0366-6999.2012.14.014; Gotoh T, 2004, CELL DEATH DIFFER, V11, P390, DOI 10.1038/sj.cdd.4401369; Grossman A, 2011, AVIAT SPACE ENVIR MD, V82, P901, DOI 10.3357/ASEM.2962.2011; Hiss DC, 2009, EXPERT OPIN DRUG DIS, V4, P799, DOI 10.1517/17460440903052559; HOIBERG A, 1985, AVIAT SPACE ENVIR MD, V56, P397; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Kim HS, 2012, BIOMED RES-INDIA, V23, P375; Liao YH, 2012, J AM COLL CARDIOL, V59, P420, DOI 10.1016/j.jacc.2011.10.863; Lim WS, 2008, CIRCULATION, V117, P940, DOI 10.1161/CIRCULATIONAHA.107.711275; Lin JH, 2008, ANNU REV PATHOL-MECH, V3, P399, DOI 10.1146/annurev.pathmechdis.3.121806.151434; Liu H J, 2001, Space Med Med Eng (Beijing), V14, P137; Lu WH, 2008, AVIAT SPACE ENVIR MD, V79, P1086, DOI 10.3357/ASEM.2353.2008; Malhotra JD, 2007, ANTIOXID REDOX SIGN, V9, P2277, DOI 10.1089/ars.2007.1782; Martin DS, 1999, AVIAT SPACE ENVIR MD, V70, P1197; Netticadan T, 1999, AM J PHYSIOL-CELL PH, V277, pC384, DOI 10.1152/ajpcell.1999.277.3.C384; Parlaktas BS, 2014, INT BRAZ J UROL, V40, P109, DOI 10.1590/S1677-5538.IBJU.2014.01.16; Pendergast DR, 2012, AVIAT SPACE ENVIR MD, V83, P488, DOI 10.3357/ASEM.3127.2012; Reimers B, 1997, CATHETER CARDIO DIAG, V40, P343, DOI 10.1002/(SICI)1097-0304(199704)40:4<343::AID-CCD3>3.0.CO;2-9; Rickards CA, 2005, AVIAT SPACE ENVIR MD, V76, P496; Sajdel-Sulkowska EV, 2007, ADV SPACE RES, V40, P1414, DOI 10.1016/j.asr.2007.08.004; Srichai MB, 2012, WORLD J RADIOL, V4, P258, DOI 10.4329/wjr.v4.i6.258; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; Zawadzka-Bartczak E, 2005, Indian J Med Sci, V59, P471; Zhan H, 1999, Space Med Med Eng (Beijing), V12, P1; Zhang X, 1991, BASIC CLIN RES AVIAT	37	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0132654	10.1371/journal.pone.0132654	http://dx.doi.org/10.1371/journal.pone.0132654			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26167928	Green Submitted, Green Published, gold			2022-12-26	WOS:000358193100062
J	Al-Sawalha, N; Pokkunuri, I; Omoluabi, O; Kim, H; Thanawala, VJ; Hernandez, A; Bond, RA; Knoll, BJ				Al-Sawalha, Nour; Pokkunuri, Indira; Omoluabi, Ozozoma; Kim, Hosu; Thanawala, Vaidehi J.; Hernandez, Adrian; Bond, Richard A.; Knoll, Brian J.			Epinephrine Activation of the beta(2)-Adrenoceptor Is Required for IL-13-Induced Mucin Production in Human Bronchial Epithelial Cells	PLOS ONE			English	Article							N-TERMINAL KINASE; PROTEIN-KINASES; AIRWAY HYPERRESPONSIVENESS; ASTHMA PHENOTYPE; GENE-EXPRESSION; BETA-BLOCKER; MURINE MODEL; INFLAMMATION; INTERLEUKIN-13; HYPERPLASIA	Mucus hypersecretion by airway epithelium is a hallmark of inflammation in allergic asthma and results in airway narrowing and obstruction. Others have shown that administration a T(H)2 cytokine, IL-13 is sufficient to cause mucus hypersecretion in vivo and in vitro. Asthma therapy often utilizes beta(2)-adrenoceptor (beta(2)AR) agonists, which are effective acutely as bronchodilators, however chronic use may lead to a worsening of asthma symptoms. In this study, we asked whether beta(2)AR signaling in normal human airway epithelial (NHBE) cells affected mucin production in response to IL-13. This cytokine markedly increased mucin production, but only in the presence of epinephrine. Mucin production was blocked by ICI-118,551, a preferential beta(2)AR antagonist, but not by CGP-20712A, a preferential beta 1AR antagonist. Constitutive beta(2)AR activity was not sufficient for IL-13 induced mucin production and beta-agonist-induced signaling is required. A clinically important long-acting beta-agonist, formoterol, was as effective as epinephrine in potentiating IL-13 induced MUC5AC transcription. IL-13 induced mucin production in the presence of epinephrine was significantly reduced by treatment with selective inhibitors of ERK1/2 (FR180204), p38 (SB203580) and JNK (SP600125). Replacement of epinephrine with forskolin + IBMX resulted in a marked increase in mucin production in NHBE cells in response to IL-13, and treatment with the inhibitory cAMP analogue Rp-cAMPS decreased mucin levels induced by epinephrine + IL-13. Our findings suggest that beta 2AR signaling is required for mucin production in response to IL-13, and that mitogen activated protein kinases and cAMP are necessary for this effect. These data lend support to the notion that beta 2AR-agonists may contribute to asthma exacerbations by increasing mucin production via activation of beta 2ARs on epithelial cells.	[Al-Sawalha, Nour; Pokkunuri, Indira; Kim, Hosu; Thanawala, Vaidehi J.; Bond, Richard A.; Knoll, Brian J.] Univ Houston, Dept Pharmacol & Pharmaceut Sci, Houston, TX 77204 USA; [Omoluabi, Ozozoma; Hernandez, Adrian; Bond, Richard A.; Knoll, Brian J.] Univ Houston, Dept Biol & Biochem, Houston, TX 77204 USA	University of Houston System; University of Houston; University of Houston System; University of Houston	Knoll, BJ (corresponding author), Univ Houston, Dept Pharmacol & Pharmaceut Sci, 4800 Calhoun Rd, Houston, TX 77204 USA.	bknoll@Central.UH.edu		Al-Sawalha, Nour/0000-0002-7401-8065	National Institutes of Health [RO1A179236]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	BJK and RAB were supported by National Institutes of Health RO1A179236. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIKAWA T, 1992, CHEST, V101, P916, DOI 10.1378/chest.101.4.916; Atherton HC, 2003, AM J PHYSIOL-LUNG C, V285, pL730, DOI 10.1152/ajplung.00089.2003; Bai TR, 2005, CLIN SCI, V108, P463, DOI 10.1042/CS20040342; Baker JG, 2005, BRIT J PHARMACOL, V144, P317, DOI 10.1038/sj.bjp.0706048; Bennett BL, 2006, EUR RESPIR J, V28, P651, DOI 10.1183/09031936.06.00012106; BOND RA, 1995, NATURE, V374, P272, DOI 10.1038/374272a0; Chesley A, 2000, CIRC RES, V87, P1172, DOI 10.1161/01.RES.87.12.1172; Chu HW, 2004, AM J PATHOL, V165, P1097, DOI 10.1016/S0002-9440(10)63371-8; Chung KF, 2011, CHEST, V139, P1470, DOI 10.1378/chest.10-1914; DAVIS PB, 1990, AM J PHYSIOL, V258, pC71, DOI 10.1152/ajpcell.1990.258.1.C71; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; DOSTMANN WRG, 1995, FEBS LETT, V375, P231, DOI 10.1016/0014-5793(95)01201-O; Doukas J, 2009, J PHARMACOL EXP THER, V328, P758, DOI 10.1124/jpet.108.144311; Duan W, 2005, INT IMMUNOPHARMACOL, V5, P495, DOI 10.1016/j.intimp.2004.10.015; Evans CM, 2009, CURR OPIN PULM MED, V15, P4, DOI 10.1097/MCP.0b013e32831da8d3; Fujisawa T, 2008, RESPIROLOGY, V13, P191, DOI 10.1111/j.1440-1843.2008.01237.x; Fujisawa T, 2009, J IMMUNOL, V183, P6236, DOI 10.4049/jimmunol.0900614; Grunig G, 1998, SCIENCE, V282, P2261, DOI 10.1126/science.282.5397.2261; Hanania NA, 2008, PULM PHARMACOL THER, V21, P134, DOI 10.1016/j.pupt.2007.07.002; Holgate ST, 2003, EUR RESPIR J, V22, p24S, DOI 10.1183/09031936.03.00000803; Hollingsworth JW, 2010, AM J RESP CELL MOL, V43, P269, DOI 10.1165/rcmb.2009-0198OC; Jiang Y, 1997, J BIOL CHEM, V272, P30122, DOI 10.1074/jbc.272.48.30122; Karmouty-Quintana H, 2013, J MOL MED, V91, P173, DOI 10.1007/s00109-013-0997-1; Kono Y, 2010, PULM PHARMACOL THER, V23, P36, DOI 10.1016/j.pupt.2009.10.005; Kuperman DA, 2002, NAT MED, V8, P885, DOI 10.1038/nm734; Kwak YG, 2003, J CLIN INVEST, V111, P1083, DOI 10.1172/JCI200316440; Lambrecht BN, 2012, NAT MED, V18, P684, DOI 10.1038/nm.2737; Leopoldt D, 1998, J BIOL CHEM, V273, P7024, DOI 10.1074/jbc.273.12.7024; Licona-Limon P, 2013, NAT IMMUNOL, V14, P536, DOI 10.1038/ni.2617; Lim DH, 2009, AM J PHYSIOL-LUNG C, V296, pL210, DOI 10.1152/ajplung.90275.2008; Lin HX, 2007, J PHARM SCI-US, V96, P341, DOI 10.1002/jps.20803; Liu WM, 2008, J ALLERGY CLIN IMMUN, V121, P893, DOI 10.1016/j.jaci.2008.02.004; Lu Q, 2013, AM J PHYSIOL-LUNG C, V304, pL361, DOI 10.1152/ajplung.00161.2012; Ma Jing Ying, 2008, J Asthma Allergy, V1, P31; Myou S, 2003, J EXP MED, V198, P1573, DOI 10.1084/jem.20030298; Nath P, 2005, EUR J PHARMACOL, V506, P273, DOI 10.1016/j.ejphar.2004.11.040; Nguyen LP, 2008, AM J RESP CELL MOL, V38, P256, DOI 10.1165/rcmb.2007-0279RC; Nguyen LP, 2009, P NATL ACAD SCI USA, V106, P2435, DOI 10.1073/pnas.0810902106; Nichols HL, 2012, P NATL ACAD SCI USA, V109, P16660, DOI 10.1073/pnas.1208881109; Ordonez CL, 2001, AM J RESP CRIT CARE, V163, P517, DOI 10.1164/ajrccm.163.2.2004039; Park SW, 2005, CHEST, V128, P1921, DOI 10.1378/chest.128.4.1921; Pelaia G, 2005, J CELL PHYSIOL, V202, P642, DOI 10.1002/jcp.20169; Piccotti L, 2012, METHODS MOL BIOL, V842, P279, DOI 10.1007/978-1-61779-513-8_17; Rose MC, 2006, PHYSIOL REV, V86, P245, DOI 10.1152/physrev.00010.2005; Shiraishi Y, 2009, J ALLERGY CLIN IMMUN, V123, pS56, DOI 10.1016/j.jaci.2008.11.047; Stangherlin A, 2012, AM J PHYSIOL-HEART C, V302, pH379, DOI 10.1152/ajpheart.00766.2011; Thai P, 2008, ANNU REV PHYSIOL, V70, P405, DOI 10.1146/annurev.physiol.70.113006.100441; Thanawala VJ, 2013, AM J RESP CELL MOL, V48, P220, DOI 10.1165/rcmb.2012-0364OC; Williams OW, 2006, AM J RESP CELL MOL, V34, P527, DOI 10.1165/rcmb.2005-0436SF; Wills-Karp M, 1998, SCIENCE, V282, P2258, DOI 10.1126/science.282.5397.2258; Wisler JW, 2007, P NATL ACAD SCI USA, V104, P16657, DOI 10.1073/pnas.0707936104; Yasuo M, 2006, RESPIRATION, V73, P347, DOI 10.1159/000091391; Yoshisue H, 2004, BIOSCI BIOTECH BIOCH, V68, P2024, DOI 10.1271/bbb.68.2024; Young HWJ, 2007, AM J RESP CELL MOL, V37, P273, DOI 10.1165/rcmb.2005-0460OC; Zhen GH, 2007, AM J RESP CELL MOL, V36, P244, DOI 10.1165/rcmb.2006-0180OC	55	10	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132559	10.1371/journal.pone.0132559	http://dx.doi.org/10.1371/journal.pone.0132559			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161982	Green Published, Green Submitted, gold			2022-12-26	WOS:000358162300152
J	Fisher, MB; Williams, AR; Jalloh, MF; Saquee, G; Bain, RES; Bartram, JK				Fisher, Michael B.; Williams, Ashley R.; Jalloh, Mohamed F.; Saquee, George; Bain, Robert E. S.; Bartram, Jamie K.			Microbiological and Chemical Quality of Packaged Sachet Water and Household Stored Drinking Water in Freetown, Sierra Leone	PLOS ONE			English	Article							ACCRA; HEALTH; SOLD	Packaged drinking water (PW) sold in bottles and plastic bags/sachets is widely consumed in low-and middle-income countries (LMICs), and many urban users in sub-Saharan Africa (SSA) rely on packaged sachet water (PSW) as their primary source of water for consumption. However, few rigorous studies have investigated PSW quality in SSA, and none have compared PSW to stored household water for consumption (HWC). A clearer understanding of PSW quality in the context of alternative sources is needed to inform policy and regulation. As elsewhere in SSA, PSW is widely consumed in Sierra Leone, but government oversight is nearly nonexistent. This study examined the microbiological and chemical quality of a representative sample of PSW products in Freetown, Sierra Leone at packaged water manufacturing facilities (PWMFs) and at points of sale (POSs). Samples of HWC were also analyzed for comparison. The study did not find evidence of serious chemical contamination among the parameters studied. However, 19% of 45 PSW products sampled at the PWMF contained detectable Escherichia coli (EC), although only two samples exceeded 10 CFU/100 mL. Concentrations of total coliforms (TC) in PSW (but not EC) increased along the supply chain. Samples of HWC from 60 households in Freetown were significantly more likely to contain EC and TC than PSW at the point of production (p<0.01), and had significantly higher concentrations of both bacterial indicators (p<0.01). These results highlight the need for additional PSW regulation and surveillance, while demonstrating the need to prioritize the safety of HWC. At present, PSW may be the least unsafe option for many households.	[Fisher, Michael B.; Williams, Ashley R.; Bain, Robert E. S.; Bartram, Jamie K.] Univ N Carolina, Water Inst, Dept Environm Sci & Engn, Chapel Hill, NC 27599 USA; [Jalloh, Mohamed F.; Saquee, George] FOCUS 1000, Freetown, Sierra Leone	University of North Carolina; University of North Carolina Chapel Hill	Fisher, MB (corresponding author), Univ N Carolina, Water Inst, Dept Environm Sci & Engn, Chapel Hill, NC 27599 USA.	mbfisher@gmail.com; jbartram@email.unc.edu		Bartram, Jamie/0000-0002-6542-6315	National Institute of Environmental Health Sciences [T32ES007018]; Adam Smith International [13-2097]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007018] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Adam Smith International; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Adam Smith International (http://www.adamsmithinternational.com) Proposal 13-2097, "Improving the Regulation, Monitoring, and Quality of the Packaged (Sachet and Bottled) Water Industry in Sierra Leone and Sensitising the Customer Base." This grant provided support for MBF ARW MFJ GS JKB. This work was also supported in part by a grant from the National Institute of Environmental Health Sciences (http://www.niehs.nih.gov) Grant T32ES007018. This grant provided support for MBF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd El-Salam Magda M, 2008, J Egypt Public Health Assoc, V83, P468; Ackah M, 2012, ADV APPL SCI RES, V3; Addo K, 2009, AFRICAN J FOOD, V9; Ajayi A, 2008, AFRICAN J BIOMEDICAL, V11; Ajayi OS, 2009, IRAN J RADIAT RES, V7, P151; Alhassan M. M., 2012, British Journal of Applied Science and Technology, V2, P146; Alli J, 2011, NEW YORK SCI J, V4; Bain R, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001644; Barrell R A, 2000, Commun Dis Public Health, V3, P8; Beverage Marketing Corporation, 2012, 2011 GLOBAL BOTTLED; Cabral D, 2002, INT J FOOD MICROBIOL, V72, P73, DOI 10.1016/S0168-1605(01)00628-6; Dada AC, 2009, AFR J MICROBIOL RES, V3, P15; Dada AC, 2011, GLOBAL HLTH, V10, P1744; Egwari L, 2005, E AFRICAN MED J, V82; Ejechi EO, 2008, SOC INDIC RES, V85, P211, DOI 10.1007/s11205-007-9086-6; Fujikawa H, 1997, J APPL MICROBIOL, V82, P287, DOI 10.1046/j.1365-2672.1997.00353.x; Ghana Statistical Service, 2011, GHANA MULTIPLE INDIC; Herath AT, 2012, J FOOD SCI, V77, pM160, DOI 10.1111/j.1750-3841.2011.02588.x; Hunter PR, 2009, SCI TOTAL ENVIRON, V407, P2621, DOI 10.1016/j.scitotenv.2009.01.018; Kwakye-Nuako G, 2007, GHANA MED J, V41; LECHEVALLIER MW, 1990, J AM WATER WORKS ASS, V82, P74, DOI 10.1002/j.1551-8833.1990.tb07054.x; MCFETERS GA, 1986, APPL ENVIRON MICROB, V51, P1; MINTZ ED, 1995, JAMA-J AM MED ASSOC, V273, P948, DOI 10.1001/jama.273.12.948; Nunes SAP, 2008, J FOOD PROTECT, V71, P1253, DOI 10.4315/0362-028X-71.6.1253; Obiri-Danso K, 2003, LETT APPL MICROBIOL, V37, P334, DOI 10.1046/j.1472-765X.2003.01403.x; Oluwafemi F., 2012, OPEN J MED MICROBIOL, V2, P115, DOI [DOI 10.4236/ojmm.2012.23017, 10.4236/ojmm.2012.23017, DOI 10.4236/OJMM.2012.23017]; Opatunji O, 2011, 35 WEDC INT C LOUGHB; Orisakwe OE, 2006, ARCH ENVIRON OCCUP H, V61, P209, DOI 10.3200/AEOH.61.5.209-213; Osei AS, 2013, FOOD CONTROL, V31, P172, DOI 10.1016/j.foodcont.2012.08.025; Oshiro, 2002, 1604 US EPA; Pope ML, 2003, APPL ENVIRON MICROB, V69, P6201, DOI 10.1128/AEM.69.10.6201-6207.2003; Pruss A, 2002, ENVIRON HEALTH PERSP, V110, P537, DOI 10.1289/ehp.02110537; Shields K, ENVIRONMENTAL HLTH P; Stoler J, 2014, AM J TROP MED HYG, V90, P272, DOI 10.4269/ajtmh.13-0461; Stoler J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067257; Stoler J, 2012, J WATER SANIT HYG DE, V2, P223, DOI 10.2166/washdev.2012.104; Stoler J, 2012, HEALTH PLACE, V18, P250, DOI 10.1016/j.healthplace.2011.09.020; UNICEF, 2010, SIERRA LEONE MULTIPL; Vantarakis A, 2013, FOOD CONTROL, V33, P63, DOI 10.1016/j.foodcont.2013.01.034; Vapnek J, 2014, LEGISLATIVE REV RECO; WHO, 2011, MANGANESE DRINKING W; WHO, 2011, GUID DRINK WAT QUAL; Williams AR, 2014, IMPROVIN REGULATION	43	35	35	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0131772	10.1371/journal.pone.0131772	http://dx.doi.org/10.1371/journal.pone.0131772			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26162082	Green Published, Green Submitted, gold			2022-12-26	WOS:000358162300057
J	Lee, S; Kim, W; Ko, C; Ryu, WS				Lee, S.; Kim, W.; Ko, C.; Ryu, W-S			Hepatitis B virus X protein enhances Myc stability by inhibiting SCFSkp2 ubiquitin E3 ligase-mediated Myc ubiquitination and contributes to oncogenesis	ONCOGENE			English	Article							BOX RNA HELICASE; C-MYC; HEPATOCELLULAR-CARCINOMA; TRANSGENIC MICE; F-BOX; CANCER-CELLS; HBX GENE; DEGRADATION; SKP2; HEPATOCARCINOGENESIS	The stability of Myc oncoprotein is regulated by Skp/cullin/F-box (SCF) ubiquitin E3 ligase, in particular, via either SCFSkp2 or SCFFbw7 ubiquitin E3 ligases. An earlier study has shown that hepatitis B virus X protein (HBx) augments Myc stability via a mechanism involving the inhibition of Myc ubiquitination. However, the underlying mechanism by which HBx inhibits Myc ubiquitination remained to be elucidated. Moreover, to what extent HBx-mediated Myc stabilization contributes to viral oncogenesis is unknown. First, we corroborated the physiological significance of HBx-mediated Myc stabilization in HBV-replicating cells by demonstrating that (1) the elevation of Myc level in a HBV-replicating HepG2.2.15 cell compared to parental cells; (2) HBx-mediated Myc stabilization in a HBV replicon transfected cells; and (3) the inhibition of Myc ubiquitination by HBx in a HBV replicon transfected cells. Then, the molecular interaction between HBx and Myc protein was revealed via coimmunoprecipitation and immunofluorescence experiments. Subsequent analysis indicated that HBx stabilizes Myc oncoprotein by blocking Skp2, as opposed to Fbw7, -mediated Myc ubiquitination. Next, we defined the Myc-binding region to four residues (VFVL) near the C-terminus of HBx polypeptide. An HBx variant with mutated VFVL consistently failed to not only interact with Myc but also suppress Myc ubiquitination. Importantly, the VFVL mutant lost the ability to transform NIH3T3 cells in concert with Ras, implying that the HBx-Myc interaction is critical for viral oncogenesis. Consistently, immunohistochemistry of liver biopsies revealed that Myc protein is elevated in HBV-infected tissues. We concluded that HBx stabilizes Myc oncoprotein by inhibiting SCFSkp2 ubiquitin E3 ligase-mediated Myc ubiquitination, and the HBx-mediated Myc stabilization greatly contributes to viral oncogenesis.	[Lee, S.; Kim, W.; Ko, C.; Ryu, W-S] Yonsei Univ, Dept Biochem, 50 Yonsei Ro, Seoul 120749, South Korea	Yonsei University	Ryu, WS (corresponding author), Yonsei Univ, Dept Biochem, 50 Yonsei Ro, Seoul 120749, South Korea.	wsryu@yonsei.ac.kr		Ryu, Wang-Shick/0000-0002-0383-5666	National Research Foundation of Korea (NRF) grant - Korean government (MSIP) [NRF-2012R1A2A2A01007811]; BK21 PLUS program	National Research Foundation of Korea (NRF) grant - Korean government (MSIP); BK21 PLUS program	This work was supported by a National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIP; NRF-2012R1A2A2A01007811). SL and WK are fellowship awardee by BK21 PLUS program.	Bajaj BG, 2008, J VIROL, V82, P4082, DOI 10.1128/JVI.02500-07; Baresova P, 2012, J BIOL CHEM, V287, P16199, DOI 10.1074/jbc.M111.335216; Barry Michele, 2006, Sci STKE, V2006, ppe21; Benhenda S, 2009, ADV CANCER RES, V103, P75, DOI 10.1016/S0065-230X(09)03004-8; Bouchard MJ, 2004, J VIROL, V78, P12725, DOI 10.1128/JVI.78.23.12725-12734.2004; Cha MY, 2009, J GEN VIROL, V90, P978, DOI 10.1099/vir.0.009928-0; Cho HS, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2074; Choi SH, 2010, GENE DEV, V24, P1236, DOI 10.1101/gad.1920310; El-Serag HB, 2012, GASTROENTEROLOGY, V142, P1264, DOI 10.1053/j.gastro.2011.12.061; Farazi PA, 2006, NAT REV CANCER, V6, P674, DOI 10.1038/nrc1934; Flinn EM, 1998, MOL CELL BIOL, V18, P5961, DOI 10.1128/MCB.18.10.5961; Geng X, 2012, P NATL ACAD SCI USA, V109, P18471, DOI 10.1073/pnas.1204668109; Gregory MA, 2000, MOL CELL BIOL, V20, P2423, DOI 10.1128/MCB.20.7.2423-2435.2000; Hu ZY, 1999, J VIROL, V73, P7231, DOI 10.1128/JVI.73.9.7231-7240.1999; Kalra N, 2006, FEBS LETT, V580, P431, DOI 10.1016/j.febslet.2005.12.034; Kaposi-Novak P, 2009, CANCER RES, V69, P2775, DOI 10.1158/0008-5472.CAN-08-3357; KIM CM, 1991, NATURE, V351, P317, DOI 10.1038/351317a0; Kim S, 2010, J VIROL, V84, P52, DOI 10.1128/JVI.01232-09; Kim S, 2007, J VIROL, V81, P1714, DOI 10.1128/JVI.01863-06; Kim SY, 2003, MOL CELL, V11, P1177, DOI 10.1016/S1097-2765(03)00173-4; Kim YC, 2001, ONCOGENE, V20, P16, DOI 10.1038/sj.onc.1203840; Ko C, 2014, J VIROL, V88, P13689, DOI 10.1128/JVI.02035-14; Kusunoki H, 2014, BIOCHEM BIOPH RES CO, V450, P741, DOI 10.1016/j.bbrc.2014.06.042; Lakhtakia R, 2003, J GASTROEN HEPATOL, V18, P80, DOI 10.1046/j.1440-1746.2003.02902.x; LEE TH, 1990, J VIROL, V64, P5939, DOI 10.1128/JVI.64.12.5939-5947.1990; Li T, 2010, NAT STRUCT MOL BIOL, V17, P105, DOI 10.1038/nsmb.1719; Ma NF, 2008, CLIN CANCER RES, V14, P5061, DOI 10.1158/1078-0432.CCR-07-5082; Madden CR, 2001, J VIROL, V75, P3851, DOI 10.1128/JVI.75.8.3851-3858.2001; Murakami S, 2001, J GASTROENTEROL, V36, P651, DOI 10.1007/s005350170027; Neuveut C, 2010, J HEPATOL, V52, P594, DOI 10.1016/j.jhep.2009.10.033; Ng SA, 2011, J GASTROENTEROL, V46, P974, DOI 10.1007/s00535-011-0415-9; Oishi N, 2007, CANCER SCI, V98, P1540, DOI 10.1111/j.1349-7006.2007.00579.x; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Popov N, 2007, NAT CELL BIOL, V9, P765, DOI 10.1038/ncb1601; Reifenberg K, 1997, J HEPATOL, V26, P119, DOI 10.1016/S0168-8278(97)80018-9; Salghetti SE, 1999, EMBO J, V18, P717, DOI 10.1093/emboj/18.3.717; Shachaf CM, 2004, NATURE, V431, P1112, DOI 10.1038/nature03043; Slagle BL, 2015, HEPATOLOGY, V61, P1416, DOI 10.1002/hep.27360; Slagle BL, 1996, MOL CARCINOGEN, V15, P261, DOI 10.1002/(SICI)1098-2744(199604)15:4<261::AID-MC3>3.0.CO;2-J; Sze KMF, 2013, HEPATOLOGY, V57, P131, DOI 10.1002/hep.25979; Terradillos O, 1997, ONCOGENE, V14, P395, DOI 10.1038/sj.onc.1200850; Thomas LR, 2011, ADV CANCER RES, V110, P77, DOI 10.1016/B978-0-12-386469-7.00004-9; Thorgeirsson SS, 2002, NAT GENET, V31, P339, DOI 10.1038/ng0802-339; Tu H, 2001, CANCER RES, V61, P7803; Utku Y, 2006, MOL BIOSYST, V2, P312, DOI 10.1039/b603229j; von der Lehr N, 2003, MOL CELL, V11, P1189, DOI 10.1016/S1097-2765(03)00193-X; Wang H, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000986; Wang HF, 2009, J VIROL, V83, P5815, DOI 10.1128/JVI.00011-09; Welcker M, 2004, P NATL ACAD SCI USA, V101, P9085, DOI 10.1073/pnas.0402770101	49	33	36	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 7	2016	35	14					1857	1867		10.1038/onc.2015.251	http://dx.doi.org/10.1038/onc.2015.251			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DI6LM	26165841				2022-12-26	WOS:000373610400011
J	Sin, WC; Aftab, Q; Bechberger, JF; Leung, JH; Chen, H; Naus, CC				Sin, W. C.; Aftab, Q.; Bechberger, J. F.; Leung, J. H.; Chen, H.; Naus, C. C.			Astrocytes promote glioma invasion via the gap junction protein connexin43	ONCOGENE			English	Article							C-TERMINAL REGION; MALIGNANT GLIOMA; MICROENVIRONMENTAL REGULATION; INTERCELLULAR COMMUNICATION; REACTIVE ASTROCYTES; GENE-EXPRESSION; DIRECTED INACTIVATION; GROWTH-FACTOR; MICE LACKING; TUMOR-CELLS	Reactive astrocytes are integral to the glioma microenvironment. Connexin43 (Cx43) is a major gap junction protein in astrocytes and its expression is enhanced significantly in glioma-associated astrocytes, especially at the peri-tumoral region. Although downregulation of Cx43-mediated intercellular communication is associated with increased malignancy in tumor cells, the role of Cx43 in stromal cells in glioma progression is not defined. Using a mouse model consisting of syngeneic intracranial implantation of GL261 glioma cells into Nestin-Cre: Cx43(fl/fl) mice where Cx43 was eliminated in astrocytes, we demonstrate a role of astrocytic Cx43 in the dissemination of glioma cells from the tumor core. To determine whether heterocellular communication between astrocytes and glioma cells is essential for reduced invasion in the absence of astrocytic Cx43, we abolished channel formation between glioma cells and astrocytes by either knocking down Cx43 in glioma cells with short hairpin RNA (shRNA) or overexpressing a dominant-negative channel-defective Cx43-T154A mutant in these cells. Although Cx43shRNA in glioma cells reduced invasion, expression of Cx43-T154A had no effect on glioma invasion, suggesting tumoral Cx43 may influence motility independently from its channel function. Alteration in astrocytic Cx43 function, such as by replacing the wild-type allele with a C-terminal truncated Cx43 mutant exhibiting reduced intercellular coupling, is sufficient to reduce glioma spreading into the brain parenchyma. Our results reveal a novel role of astrocytic Cx43 in the formation of an invasive niche and raise the possibility to control glioma progression by manipulating the microenvironment.	[Sin, W. C.; Aftab, Q.; Bechberger, J. F.; Leung, J. H.; Chen, H.; Naus, C. C.] Univ British Columbia, Dept Cellular & Physiol Sci, Inst Life Sci, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada	University of British Columbia	Sin, WC; Naus, CC (corresponding author), Univ British Columbia, Dept Cellular & Physiol Sci, Inst Life Sci, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	wcsin@mail.ubc.ca; cnaus@mail.ubc.ca			Canadian Institutes of Health Research [MOP-102489, MOP-93572]; National Sciences and Engineering Research Council of Canada	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	We thank Lina Wang, Elodie Montaudon, Kushal Kolar, Xu Qiu Guo, Aishah Tul-Firdaus Binte Abdul Khalid and Jose Luis Vega for providing technical support for this project. We also wish to thank Maxence Le Vasseur for critical review of the manuscript. This study was supported by two operating grants (MOP-102489 and MOP-93572) to WCS and CCN from the Canadian Institutes of Health Research. CCN holds a Canada Research Chair. QA was supported by a postgraduate scholarship from the National Sciences and Engineering Research Council of Canada.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Aronica E, 2001, ACTA NEUROPATHOL, V101, P449; Baklaushev VP, 2011, DRUG DELIV, V18, P331, DOI 10.3109/10717544.2010.549527; Bates DC, 2007, GLIA, V55, P1554, DOI 10.1002/glia.20569; Beahm DL, 2006, J BIOL CHEM, V281, P7994, DOI 10.1074/jbc.M506533200; Behrens J, 2010, EUR J CELL BIOL, V89, P828, DOI 10.1016/j.ejcb.2010.06.003; Berube NG, 2005, J CLIN INVEST, V115, P258, DOI 10.1172/JCI200522329; Brennan C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007752; Buffo A, 2010, BIOCHEM PHARMACOL, V79, P77, DOI 10.1016/j.bcp.2009.09.014; Burda JE, 2014, NEURON, V81, P229, DOI 10.1016/j.neuron.2013.12.034; Caltabiano R, 2010, ACTA HISTOCHEM, V112, P529, DOI 10.1016/j.acthis.2009.05.008; Candolfi M, 2007, J NEURO-ONCOL, V85, P133, DOI 10.1007/s11060-007-9400-9; Casper KB, 2006, MOL CELL NEUROSCI, V31, P676, DOI 10.1016/j.mcn.2005.12.006; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; CHARLES AC, 1992, J CELL BIOL, V118, P195, DOI 10.1083/jcb.118.1.195; Charles NA, 2011, GLIA, V59, P1169, DOI 10.1002/glia.21136; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Cina C, 2009, J NEUROSCI, V29, P2009, DOI 10.1523/JNEUROSCI.5025-08.2009; Cotrina ML, 2008, GLIA, V56, P1791, DOI 10.1002/glia.20728; Cotrina ML, 1998, P NATL ACAD SCI USA, V95, P15735, DOI 10.1073/pnas.95.26.15735; Crespin S, 2010, J CELL BIOCHEM, V110, P589, DOI 10.1002/jcb.22554; De Bock M, 2014, BBA-MOL CELL RES, V1843, P2211, DOI 10.1016/j.bbamcr.2014.04.016; Dermietzel R, 2000, BRAIN RES REV, V32, P45, DOI 10.1016/S0165-0173(99)00067-3; di Tomaso E, 2011, CANCER RES, V71, P19, DOI 10.1158/0008-5472.CAN-10-2602; Di Virgilio F, 2012, CANCER RES, V72, P5441, DOI 10.1158/0008-5472.CAN-12-1600; Dubois NC, 2006, GENESIS, V44, P355, DOI 10.1002/dvg.20226; EDDLESTON M, 1993, NEUROSCIENCE, V54, P15, DOI 10.1016/0306-4522(93)90380-X; Edwards LA, 2011, JNCI-J NATL CANCER I, V103, P1162, DOI 10.1093/jnci/djr224; Elias LAB, 2007, NATURE, V448, P901, DOI 10.1038/nature06063; Fidler IJ, 2010, MOL CELLS, V30, P93, DOI 10.1007/s10059-010-0133-9; Fitzgerald DP, 2008, CLIN EXP METASTAS, V25, P799, DOI 10.1007/s10585-008-9193-z; Fonseca CG, 2002, BRAIN RES, V929, P105, DOI 10.1016/S0006-8993(01)03289-9; Frisch C, 2003, EUR J NEUROSCI, V18, P2313, DOI 10.1046/j.1460-9568.2003.02971.x; Gagliano N, 2009, ONCOL REP, V22, P1349, DOI 10.3892/or_00000574; Giaume C, 2012, METHODS MOL BIOL, V814, P283, DOI 10.1007/978-1-61779-452-0_19; Gielen PR, 2013, NEUROPHARMACOLOGY, V75, P539, DOI 10.1016/j.neuropharm.2013.05.002; Goldberg GS, 1999, NAT CELL BIOL, V1, P457, DOI 10.1038/15693; Graeber MB, 2002, GLIA, V40, P252, DOI 10.1002/glia.10147; Herculano-Houzel S, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.031.2009; Herve JC, 2004, BBA-BIOMEMBRANES, V1662, P22, DOI 10.1016/j.bbamem.2003.10.022; HOCHBERG FH, 1980, NEUROLOGY, V30, P907, DOI 10.1212/WNL.30.9.907; Hodge DR, 2005, EUR J CANCER, V41, P2502, DOI 10.1016/j.ejca.2005.08.016; Holland EC, 2000, P NATL ACAD SCI USA, V97, P6242, DOI 10.1073/pnas.97.12.6242; HOLNESS CL, 1993, BLOOD, V81, P1607; Homkajorn B, 2010, NEUROSCI LETT, V486, P197, DOI 10.1016/j.neulet.2010.09.051; HOSSAIN MZ, 1994, BRAIN RES, V652, P311, DOI 10.1016/0006-8993(94)90242-9; HOZUMI I, 1990, BRAIN RES, V524, P64, DOI 10.1016/0006-8993(90)90492-T; Hu M, 2008, CURR OPIN GENET DEV, V18, P27, DOI 10.1016/j.gde.2007.12.006; Iacobas DA, 2004, NEUROCHEM INT, V45, P243, DOI 10.1016/j.neuint.2003.12.008; Iacobas DA, 2003, PHYSIOL GENOMICS, V15, P177, DOI 10.1152/physiolgenomics.00062.2003; Jacobs VL, 2011, ASN NEURO, V3, DOI 10.1042/AN20110014; Jones TS, 2012, ONCOGENE, V31, P1995, DOI 10.1038/onc.2011.398; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Kang J, 2008, J NEUROSCI, V28, P4702, DOI 10.1523/JNEUROSCI.5048-07.2008; Karpuk N, 2011, J NEUROSCI, V31, P414, DOI 10.1523/JNEUROSCI.5247-10.2011; Katz AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032453; Kim SJ, 2011, NEOPLASIA, V13, P286, DOI 10.1593/neo.11112; Kleihues P, 2002, J NEUROPATH EXP NEUR, V61, P215, DOI 10.1093/jnen/61.3.215; Kolar K, 2015, J NEUROPATH EXP NEUR, V74, P64, DOI 10.1097/NEN.0000000000000150; Kozoriz MG, 2010, J NEUROPATH EXP NEUR, V69, P196, DOI 10.1097/NEN.0b013e3181cd44df; Lathia JD, 2011, CELL STEM CELL, V8, P482, DOI 10.1016/j.stem.2011.04.013; Le DM, 2003, J NEUROSCI, V23, P4034; Le HT, 2014, J BIOL CHEM, V289, P1345, DOI 10.1074/jbc.M113.508390; Lee IH, 2005, J COMP NEUROL, V489, P1, DOI 10.1002/cne.20567; Lee J, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-9; Lin JHC, 2002, J NEUROSCI, V22, P4302, DOI 10.1523/JNEUROSCI.22-11-04302.2002; Maass K, 2004, MOL BIOL CELL, V15, P4597, DOI 10.1091/mbc.E04-04-0324; Maass K, 2007, CIRC RES, V101, P1283, DOI 10.1161/CIRCRESAHA.107.162818; Markovic DS, 2009, P NATL ACAD SCI USA, V106, P12530, DOI 10.1073/pnas.0804273106; Markovic DS, 2005, J NEUROPATH EXP NEUR, V64, P754, DOI 10.1097/01.jnen.0000178445.33972.a9; Matsuuchi L, 2013, BBA-BIOMEMBRANES, V1828, P94, DOI 10.1016/j.bbamem.2012.05.014; Mesnil M, 2005, BBA-BIOMEMBRANES, V1719, P125, DOI 10.1016/j.bbamem.2005.11.004; Moreno AP, 2005, BBA-BIOMEMBRANES, V1711, P164, DOI 10.1016/j.bbamem.2005.02.016; Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165; Nagy JI, 1996, BRAIN RES, V717, P173, DOI 10.1016/0006-8993(95)01526-4; Nagy JI, 1999, NEUROSCIENCE, V88, P447, DOI 10.1016/S0306-4522(98)00191-2; Nakase T, 2004, AM J PATHOL, V164, P2067, DOI 10.1016/S0002-9440(10)63765-0; Naus CCG, 1997, J NEUROSCI RES, V49, P528, DOI 10.1002/(SICI)1097-4547(19970901)49:5<528::AID-JNR3>3.0.CO;2-D; Naus CC, 2010, NAT REV CANCER, V10, P435, DOI 10.1038/nrc2841; Newcomb EW, 2009, CNS CANC MODELS MARK, V12, P227, DOI DOI 10.1007/978-1-60327-553-8; O'Carroll SJ, 2013, METHODS MOL BIOL, V1037, P519, DOI 10.1007/978-1-62703-505-7_31; OCHALSKI PAY, 1995, GLIA, V14, P279, DOI 10.1002/glia.440140405; Oliveira R, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-7; Olk S, 2010, GLIA, V58, P494, DOI 10.1002/glia.20942; Olk S, 2009, CELL MOTIL CYTOSKEL, V66, P1000, DOI 10.1002/cm.20404; Pekny M, 2014, PHYSIOL REV, V94, P1077, DOI 10.1152/physrev.00041.2013; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Ponsaerts R, 2010, FASEB J, V24, P4378, DOI 10.1096/fj.09-153007; Quail DF, 2013, NAT MED, V19, P1423, DOI 10.1038/nm.3394; Rath BH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054752; Rhee DY, 2009, DEVELOPMENT, V136, P3185, DOI 10.1242/dev.032334; Ridet JL, 1997, TRENDS NEUROSCI, V20, P570, DOI 10.1016/S0166-2236(97)01139-9; Rivera-Zengotita M, 2012, ADV ANAT PATHOL, V19, P239, DOI 10.1097/PAP.0b013e31825c6a04; Rong Y, 2006, J NEUROPATH EXP NEUR, V65, P529, DOI 10.1097/00005072-200606000-00001; Rozental R, 2000, BRAIN RES REV, V32, P11, DOI 10.1016/S0165-0173(99)00095-8; Saez JC, 2005, BBA-BIOMEMBRANES, V1711, P215, DOI 10.1016/j.bbamem.2005.01.014; Sansone P, 2011, CURR OPIN GENET DEV, V21, P80, DOI 10.1016/j.gde.2010.11.001; Scemes E, 1998, GLIA, V24, P65, DOI 10.1002/(SICI)1098-1136(199809)24:1<65::AID-GLIA7>3.0.CO;2-#; Scemes E, 2000, J NEUROSCI, V20, P1435; Schajnovitz A, 2011, NAT IMMUNOL, V12, P391, DOI 10.1038/ni.2017; Schalper KA, 2008, MOL BIOL CELL, V19, P3501, DOI 10.1091/mbc.E07-12-1240; Scheckenbach KEL, 2011, J VASC RES, V48, P91, DOI 10.1159/000316942; Seike T, 2011, CLIN EXP METASTAS, V28, P13, DOI 10.1007/s10585-010-9354-8; Shintani-Ishida K, 2007, AM J PHYSIOL-HEART C, V293, pH1714, DOI 10.1152/ajpheart.00022.2007; Silver DJ, 2013, J NEUROSCI, V33, P15603, DOI 10.1523/JNEUROSCI.3004-12.2013; Simon AM, 1998, TRENDS CELL BIOL, V8, P477, DOI 10.1016/S0962-8924(98)01372-5; Sin WC, 2012, BBA-BIOMEMBRANES, V1818, P2058, DOI 10.1016/j.bbamem.2011.10.022; Sofroniew MV, 2014, NEUROSCIENTIST, V20, P160, DOI 10.1177/1073858413504466; Stout CE, 2002, J BIOL CHEM, V277, P10482, DOI 10.1074/jbc.M109902200; Strale PO, 2012, MOL CARCINOGEN, V51, P845, DOI 10.1002/mc.20853; Tafani M, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-32; Theis M, 2001, CELL COMMUN ADHES, V8, P383, DOI 10.3109/15419060109080758; Theis M, 2004, GLIA, V46, P130, DOI 10.1002/glia.10350; Theis M, 2003, J NEUROSCI, V23, P766; Theodoric N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047311; Toyofuku T, 1998, J BIOL CHEM, V273, P1519, DOI 10.1074/jbc.273.3.1519; Wang L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080933; Watters JJ, 2005, J NEUROSCI RES, V81, P447, DOI 10.1002/jnr.20485; Williams SP, 2011, CANCER RES, V71, P5374, DOI 10.1158/0008-5472.CAN-10-3026; Yang CZ, 2012, P NATL ACAD SCI USA, V109, P6963, DOI 10.1073/pnas.1118754109; Ye ZC, 2003, J NEUROSCI, V23, P3588, DOI 10.1523/jneurosci.23-09-03588.2003; Zagzag D, 2008, AM J PATHOL, V173, P545, DOI 10.2353/ajpath.2008.071197; Zhang W, 2003, J NEUROSURG, V99, P1039, DOI 10.3171/jns.2003.99.6.1039; Zhang W, 1999, CANCER RES, V59, P1994; Zhuo L, 2001, GENESIS, V31, P85, DOI 10.1002/gene.10008	125	87	96	1	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 24	2016	35	12					1504	1516		10.1038/onc.2015.210	http://dx.doi.org/10.1038/onc.2015.210			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DH8RJ	26165844				2022-12-26	WOS:000373063600004
J	Samejima, K; Platani, M; Wolny, M; Ogawa, H; Vargiu, G; Knight, PJ; Peckham, M; Earnshaw, WC				Samejima, Kumiko; Platani, Melpomeni; Wolny, Marcin; Ogawa, Hiromi; Vargiu, Giulia; Knight, Peter J.; Peckham, Michelle; Earnshaw, William C.			The Inner Centromere Protein (INCENP) Coil Is a Single -Helix (SAH) Domain That Binds Directly to Microtubules and Is Important for Chromosome Passenger Complex (CPC) Localization and Function in Mitosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						centromere; microtubule; mitosis; mutant; protein structure; CPC; INCENP; chromosome passenger complex; coiled coil; single -helix	AURORA-B-KINASE; PHOSPHORYLATED HISTONE H3; CENTRAL SPINDLE; ALPHA-HELIX; FORCE; PHOSPHOSITEPLUS; ARCHITECTURE; ORIENTATION; ACTIVATION; MUTATIONS	Background: INCENP is predicted to have a coiled coil domain. Results: The coil is actually a stable single -helix (SAH) domain that is highly extendable and directly binds microtubules. Conclusion: This flexible dog leash may allow Aurora B to associate with dynamic targets in the outer kinetochore. Significance: The SAH domain allows CPC flexibility without requiring complex dimerization. The chromosome passenger complex (CPC) is a master regulator of mitosis. Inner centromere protein (INCENP) acts as a scaffold regulating CPC localization and activity. During early mitosis, the N-terminal region of INCENP forms a three-helix bundle with Survivin and Borealin, directing the CPC to the inner centromere where it plays essential roles in chromosome alignment and the spindle assembly checkpoint. The C-terminal IN box region of INCENP is responsible for binding and activating Aurora B kinase. The central region of INCENP has been proposed to comprise a coiled coil domain acting as a spacer between the N- and C-terminal domains that is involved in microtubule binding and regulation of the spindle checkpoint. Here we show that the central region (213 residues) of chicken INCENP is not a coiled coil but a approximate to 32-nm-long single -helix (SAH) domain. The N-terminal half of this domain directly binds to microtubules in vitro. By analogy with previous studies of myosin 10, our data suggest that the INCENP SAH might stretch up to approximate to 80 nm under physiological forces. Thus, the INCENP SAH could act as a flexible dog leash, allowing Aurora B to phosphorylate dynamic substrates localized in the outer kinetochore while at the same time being stably anchored to the heterochromatin of the inner centromere. Furthermore, by achieving this flexibility via an SAH domain, the CPC avoids a need for dimerization (required for coiled coil formation), which would greatly complicate regulation of the proximity-induced trans-phosphorylation that is critical for Aurora B activation.	[Samejima, Kumiko; Platani, Melpomeni; Ogawa, Hiromi; Vargiu, Giulia; Earnshaw, William C.] Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Edinburgh EH9 3BF, Midlothian, Scotland; [Wolny, Marcin; Knight, Peter J.; Peckham, Michelle] Univ Leeds, Astbury Ctr Struct Mol Biol, Leeds LS2 9JT, W Yorkshire, England	University of Edinburgh; University of Leeds	Samejima, K (corresponding author), Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Kings Bldg, Edinburgh EH9 3BF, Midlothian, Scotland.	kumiko.samejima@ed.ac.uk; bill.earnshaw@ed.ac.uk	Peckham, Michelle/J-4991-2015; Earnshaw, William/AAY-7438-2020	Peckham, Michelle/0000-0002-3754-2028; Wolny, Marcin/0000-0003-1030-7607; Platani, Melpomeni/0000-0001-6408-4774; Earnshaw, William/0000-0002-7191-0621	Wellcome Trust Centre for Cell Biology [077707, 092076]; BBSRC [BB/I007423/1, BB/M009114/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I007423/1, BB/M009114/1] Funding Source: researchfish	Wellcome Trust Centre for Cell Biology(Wellcome Trust); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank Drs. Alba Abad and Jeyaprakash Arulanandam for advice on the microtubule binding assays. We also thank Drs. Julie P. I. Welburn and Iain M. Cheeseman for anti-phospho-DSN1 antibody and Professor Hiroshi Kimura for anti-phospho-H3Ser<SUP>28</SUP> antibody. The Wellcome Trust Centre for Cell Biology is supported by Core Grants 077707 and 092076.	Abad MA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms3964; Adams RR, 2000, CURR BIOL, V10, P1075, DOI 10.1016/S0960-9822(00)00673-4; Akiyoshi B, 2010, NATURE, V468, P576, DOI 10.1038/nature09594; Baboolal TG, 2009, P NATL ACAD SCI USA, V106, P22193, DOI [10.1073/pnas.0909851106, 10.1073/pnas.09098S1106]; Batchelor M, 2015, BIOCHEM SOC T, V43, P58, DOI 10.1042/BST20140302; Bishop JD, 2002, J BIOL CHEM, V277, P27577, DOI 10.1074/jbc.C200307200; Bishop JD, 2005, MOL BIOL CELL, V16, P742, DOI 10.1091/mbc.E04-08-0682; Carmena M, 2012, NAT REV MOL CELL BIO, V13, P789, DOI 10.1038/nrm3474; Carmena M, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001250; Cheeseman IM, 2006, CELL, V127, P983, DOI 10.1016/j.cell.2006.09.039; Ciferri C, 2005, J BIOL CHEM, V280, P29088, DOI 10.1074/jbc.M504070200; COOKE CA, 1987, J CELL BIOL, V105, P2053, DOI 10.1083/jcb.105.5.2053; Cormier A, 2013, J BIOL CHEM, V288, P23203, DOI 10.1074/jbc.M113.491480; DeLuca JG, 2006, CELL, V127, P969, DOI 10.1016/j.cell.2006.09.047; DeLuca KF, 2011, J CELL SCI, V124, P622, DOI 10.1242/jcs.072629; EARNSHAW WC, 1991, J CELL SCI, V98, P443; EARNSHAW WC, 1991, CHROMOSOMA, V100, P139, DOI 10.1007/BF00337241; GREENFIE.N, 1969, BIOCHEMISTRY-US, V8, P4108, DOI 10.1021/bi00838a031; Grishchuk EL, 2005, NATURE, V438, P384, DOI 10.1038/nature04132; Hayashi-Takanaka Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106271; Hornbeck PV, 2015, NUCLEIC ACIDS RES, V43, pD512, DOI 10.1093/nar/gku1267; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Hudson DF, 2008, MOL BIOL CELL, V19, P3070, DOI 10.1091/mbc.E08-01-0057; Hummer S, 2009, CURR BIOL, V19, P607, DOI 10.1016/j.cub.2009.02.046; Jeyaprakash AA, 2012, MOL CELL, V46, P274, DOI 10.1016/j.molcel.2012.03.005; Jeyaprakash AA, 2011, STRUCTURE, V19, P1625, DOI 10.1016/j.str.2011.09.002; Kang JS, 2001, J CELL BIOL, V155, P763, DOI 10.1083/jcb.200105029; Kelly AE, 2007, DEV CELL, V12, P31, DOI 10.1016/j.devcel.2006.11.001; Kelly AE, 2010, SCIENCE, V330, P235, DOI 10.1126/science.1189505; Knight PJ, 2005, J BIOL CHEM, V280, P34702, DOI 10.1074/jbc.M504887200; Liu D, 2009, SCIENCE, V323, P1350, DOI 10.1126/science.1167000; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; MACKAY AM, 1993, J CELL BIOL, V123, P373, DOI 10.1083/jcb.123.2.373; Maresca TJ, 2009, J CELL BIOL, V184, P373, DOI 10.1083/jcb.200808130; Noujaim M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086786; Peckham M, 2011, BIOCHEM SOC T, V39, P1142, DOI 10.1042/BST0391142; Peckham M, 2009, SOFT MATTER, V5, P2493, DOI 10.1039/b822339d; Pereira G, 2003, SCIENCE, V302, P2120, DOI 10.1126/science.1091936; Platani M, 2009, MOL BIOL CELL, V20, P5260, DOI 10.1091/mbc.E09-05-0377; Rosasco-Nitcher SE, 2008, SCIENCE, V319, P469, DOI 10.1126/science.1148980; Samejima K, 2008, P NATL ACAD SCI USA, V105, P2457, DOI 10.1073/pnas.0712083105; Sandall S, 2006, CELL, V127, P1179, DOI 10.1016/j.cell.2006.09.049; Santaguida S, 2009, EMBO J, V28, P2511, DOI 10.1038/emboj.2009.173; SCHOLTZ JM, 1992, ANNU REV BIOPH BIOM, V21, P95, DOI 10.1146/annurev.bb.21.060192.000523; Schwaiger I, 2002, NAT MATER, V1, P232, DOI 10.1038/nmat776; Sivaramakrishnan S, 2008, P NATL ACAD SCI USA, V105, P13356, DOI 10.1073/pnas.0806256105; Suveges D, 2009, PROTEINS, V74, P905, DOI 10.1002/prot.22183; Suzuki A, 2014, DEV CELL, V30, P717, DOI 10.1016/j.devcel.2014.08.003; Suzuki A, 2011, J CELL BIOL, V193, P125, DOI 10.1083/jcb.201012050; Swedlow JR, 2009, ANNU REV BIOPHYS, V38, P327, DOI 10.1146/annurev.biophys.050708.133641; Tanaka TU, 2002, CELL, V108, P317, DOI 10.1016/S0092-8674(02)00633-5; Tseng BS, 2010, DEV CELL, V18, P903, DOI 10.1016/j.devcel.2010.05.018; Uchida KSK, 2009, J CELL BIOL, V184, P383, DOI 10.1083/jcb.200811028; Vader G, 2007, MOL BIOL CELL, V18, P4553, DOI 10.1091/mbc.E07-04-0328; van der Horst A, 2014, CHROMOSOMA, V123, P25, DOI 10.1007/s00412-013-0437-6; Wang FW, 2010, SCIENCE, V330, P231, DOI 10.1126/science.1189435; Welburn JPI, 2010, MOL CELL, V38, P383, DOI 10.1016/j.molcel.2010.02.034; Wheatley SP, 2001, EXP CELL RES, V262, P122, DOI 10.1006/excr.2000.5088; Wolny M, 2014, J BIOL CHEM, V289, P27825, DOI 10.1074/jbc.M114.585679; Wolny M, 2013, J BIOL CHEM, V288, P31952, DOI 10.1074/jbc.M113.513291; Xu ZJ, 2009, J CELL BIOL, V187, P637, DOI 10.1083/jcb.200906053; Yamagishi Y, 2010, SCIENCE, V330, P239, DOI 10.1126/science.1194498; Yusko EC, 2014, MOL BIOL CELL, V25, P3717, DOI 10.1091/mbc.E13-12-0707	63	46	47	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2015	290	35					21460	21472		10.1074/jbc.M115.645317	http://dx.doi.org/10.1074/jbc.M115.645317			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ5IS	26175154	hybrid, Green Published, Green Accepted			2022-12-26	WOS:000360637600022
J	Skerrett, R; Pellegrino, MP; Casali, BT; Taraboanta, L; Landreth, GE				Skerrett, Rebecca; Pellegrino, Mateus P.; Casali, Brad T.; Taraboanta, Laura; Landreth, Gary E.			Combined Liver X Receptor/Peroxisome Proliferator-activated Receptor Agonist Treatment Reduces Amyloid Levels and Improves Behavior in Amyloid Precursor Protein/Presenilin 1 Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alzheimer disease; amyloid (A); apolipoprotein E (apoE); microglia; peroxisome proliferator-activated receptor (PPAR); liver X receptor (LXR)	ALZHEIMERS-DISEASE; PPAR-GAMMA; A-BETA; TRANSGENIC MICE; NUCLEAR RECEPTORS; APOLIPOPROTEIN-E; MOUSE MODEL; MEMORY DEFICITS; LXR AGONIST; COGNITIVE DEFICITS	Background: In the brain, the type II nuclear receptors LXR and PPAR control cholesterol efflux and inflammation, key processes in Alzheimer disease pathology. Results: Combining the LXR and PPAR agonists decreases the levels of A and inflammation, resulting in improved cognition. Conclusion: The LXR and PPAR agonists complement each other, possibly by modulating microglial function. Significance: Targeting multiple nuclear receptors expands the therapeutic opportunities for AD treatment. Alzheimer disease (AD) is characterized by the extracellular accumulation of amyloid (A), which is accompanied by a robust inflammatory response in the brain. Both of these pathogenic processes are regulated by nuclear receptors, including the liver X receptors (LXRs) and peroxisome-proliferator receptor (PPAR). Agonists of LXRs have been demonstrated previously to reduce A levels and improve cognitive deficits in AD mouse models by inducing the transcription and lipidation of apolipoprotein E (apoE). Agonists targeting PPAR reduce the microglial expression of proinflammatory genes and have also been shown to modulate apoE expression. Here we investigate whether a combination therapy with both LXR and PPAR agonists results in increased benefits in an AD mouse model. We found that the LXR agonist GW3965 and the PPAR agonist pioglitazone were individually able to increase the levels of apoE and related genes, decrease the expression of proinflammatory genes, and facilitate A decreases in the hippocampus. Combined treatment with both agonists provoked a further increase in the expression of apoE and a decrease in the soluble and deposited forms of A. The decrease in plaques was associated with increased colocalization between microglia and plaques. In addition, the PPAR agonist in the combined treatment paradigm was able to counteract the elevation in plasma triglycerides that is a side effect of LXR agonist treatment. These results suggest that combined LXR/PPAR agonist treatment merits further investigation for the treatment of AD.	[Skerrett, Rebecca; Casali, Brad T.; Taraboanta, Laura; Landreth, Gary E.] Case Western Reserve Univ, Dept Neurosci, Cleveland, OH 44106 USA; [Pellegrino, Mateus P.] Univ Estadual Campinas, Sch Med, BR-13083887 Campinas, SP, Brazil	Case Western Reserve University; Universidade Estadual de Campinas	Landreth, GE (corresponding author), Case Western Reserve Univ, Sch Med, Dept Neurosci, 10900 Euclid Ave, Cleveland, OH 44106 USA.	gel2@case.edu	Regan, Clinton/E-6250-2012	Paquesse Pellegrino, Mateus/0000-0001-5629-435X	National Institutes of Health [R01 AG030482, 5T32NS067431-13]; Gail and Elliott Schlang Philanthropic Fund; CAPES Foundation [5758/12-2]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS067431] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG030482] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gail and Elliott Schlang Philanthropic Fund; CAPES Foundation(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AG030482 (to G. E. L.) and 5T32NS067431-13 (to R. R. S.). This work was also supported by the Gail and Elliott Schlang Philanthropic Fund and CAPES Foundation Grant 5758/12-2 (to M. P. P.). The authors declare that they have no conflicts of interest with the contents of this article.	A-Gonzalez N, 2009, IMMUNITY, V31, P245, DOI 10.1016/j.immuni.2009.06.018; Bales KR, 2009, J NEUROSCI, V29, P6771, DOI 10.1523/JNEUROSCI.0887-09.2009; Baranowski M, 2008, J PHYSIOL PHARMACOL, V59, P31; Bensinger SJ, 2008, NATURE, V454, P470, DOI 10.1038/nature07202; Beyer TP, 2004, J PHARMACOL EXP THER, V309, P861, DOI 10.1124/jpet.103.064535; Burns MP, 2006, J NEUROCHEM, V98, P792, DOI 10.1111/j.1471-4159.2006.03925.x; Castellano JM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002156; Chawla A, 2010, CIRC RES, V106, P1559, DOI 10.1161/CIRCRESAHA.110.216523; Chinetti-Gbaguidi G, 2011, CURR OPIN LIPIDOL, V22, P365, DOI 10.1097/MOL.0b013e32834a77b4; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Cramer PE, 2012, SCIENCE, V335, P1503, DOI 10.1126/science.1217697; Cui W, 2012, NEUROSCIENCE, V210, P200, DOI 10.1016/j.neuroscience.2012.02.047; Daniel B, 2014, GENE DEV, V28, P1562, DOI 10.1101/gad.242685.114; Deane R, 2008, J CLIN INVEST, V118, P4002, DOI 10.1172/JCI36663; Denner LA, 2012, J NEUROSCI, V32, P16725, DOI 10.1523/JNEUROSCI.2153-12.2012; Donkin JJ, 2010, J BIOL CHEM, V285, P34144, DOI 10.1074/jbc.M110.108100; Escribano L, 2010, NEUROPSYCHOPHARMACOL, V35, P1593, DOI 10.1038/npp.2010.32; Evans RM, 2004, NAT MED, V10, P355, DOI 10.1038/nm1025; Fitz NF, 2014, J ALZHEIMERS DIS, V41, P535, DOI 10.3233/JAD-132789; Fitz NF, 2010, J NEUROSCI, V30, P6862, DOI 10.1523/JNEUROSCI.1051-10.2010; Ghisletti S, 2007, MOL CELL, V25, P57, DOI 10.1016/j.molcel.2006.11.022; Gosselin D, 2014, IMMUNOL REV, V262, P96, DOI 10.1111/imr.12213; Heneka MT, 2010, J NEURAL TRANSM, V117, P919, DOI 10.1007/s00702-010-0438-z; Heneka MT, 2005, BRAIN, V128, P1442, DOI 10.1093/brain/awh452; Hickman SE, 2008, J NEUROSCI, V28, P8354, DOI 10.1523/JNEUROSCI.0616-08.2008; Holtzman DM, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006312; Hong C, 2014, NAT REV DRUG DISCOV, V13, P433, DOI 10.1038/nrd4280; Hu J, 2015, MOL NEURODEGENER, V10, DOI 10.1186/s13024-015-0001-3; Hu Y, 2013, J MED CHEM, V56, P6033, DOI 10.1021/jm301913k; Jiang Q, 2008, NEURON, V58, P681, DOI 10.1016/j.neuron.2008.04.010; Koldamova T, 2005, J BIOL CHEM, V280, P4079, DOI 10.1074/jbc.M411420200; Kruit JK, 2005, GASTROENTEROLOGY, V128, P147, DOI 10.1053/j.gastro.2004.10.006; Lacombe P, 2004, J NEUROINFLAMM, V1, DOI 10.1186/1742-2094-1-11; Lee CYD, 2012, J BIOL CHEM, V287, P2032, DOI 10.1074/jbc.M111.295451; Lefterov I, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-20; Lehmann JM, 1997, J BIOL CHEM, V272, P3137, DOI 10.1074/jbc.272.6.3137; Li AC, 2004, J LIPID RES, V45, P2161, DOI 10.1194/jlr.R400010-JLR200; Mandrekar-Colucci S, 2012, J NEUROSCI, V32, P10117, DOI 10.1523/JNEUROSCI.5268-11.2012; Mandrekar-Colucci S, 2010, CNS NEUROL DISORD-DR, V9, P156, DOI 10.2174/187152710791012071; Masciopinto F, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.189; Mawuenyega KG, 2010, SCIENCE, V330, P1774, DOI 10.1126/science.1197623; Miao B, 2004, J LIPID RES, V45, P1410, DOI 10.1194/jlr.M300450-JLR200; Nicolakakis N, 2008, J NEUROSCI, V28, P9287, DOI 10.1523/JNEUROSCI.3348-08.2008; O'Reilly JA, 2012, J NEUROIMMUNE PHARM, V7, P140, DOI 10.1007/s11481-011-9282-7; Papadopoulos P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068612; Pedersen WA, 2006, EXP NEUROL, V199, P265, DOI 10.1016/j.expneurol.2006.01.018; Quinet EM, 2006, MOL PHARMACOL, V70, P1340, DOI 10.1124/mol.106.022608; Riddell DR, 2007, MOL CELL NEUROSCI, V34, P621, DOI 10.1016/j.mcn.2007.01.011; Rodriguez-Rivera J, 2011, BEHAV BRAIN RES, V216, P255, DOI 10.1016/j.bbr.2010.08.002; Saijo K, 2013, GLIA, V61, P104, DOI 10.1002/glia.22423; Sastre M, 2006, P NATL ACAD SCI USA, V103, P443, DOI 10.1073/pnas.0503839103; Savage JC, 2015, J NEUROSCI, V35, P6532, DOI 10.1523/JNEUROSCI.4586-14.2015; SCHMECHEL DE, 1993, P NATL ACAD SCI USA, V90, P9649, DOI 10.1073/pnas.90.20.9649; Schoonjans K, 1996, EMBO J, V15, P5336, DOI 10.1002/j.1460-2075.1996.tb00918.x; Searcy JL, 2012, J ALZHEIMERS DIS, V30, P943, DOI 10.3233/JAD-2012-111661; SHEN CL, 1995, BIOPHYS J, V69, P640, DOI 10.1016/S0006-3495(95)79940-4; Skerrett R, 2014, NEUROBIOL DIS, V72, P104, DOI 10.1016/j.nbd.2014.05.019; Tall AR, 2008, J INTERN MED, V263, P256, DOI 10.1111/j.1365-2796.2007.01898.x; Terwel D, 2011, J NEUROSCI, V31, P7049, DOI 10.1523/JNEUROSCI.6546-10.2011; Toledo EM, 2010, MOL PSYCHIATR, V15, P272, DOI 10.1038/mp.2009.72; van der Hoorn JWA, 2011, BRIT J PHARMACOL, V162, P1553, DOI 10.1111/j.1476-5381.2010.01168.x; Vanmierlo T, 2011, NEUROBIOL AGING, V32, P1262, DOI 10.1016/j.neurobiolaging.2009.07.005; Wahrle SE, 2008, J CLIN INVEST, V118, P671, DOI 10.1172/JCI33622; Wesson DW, 2011, J NEUROSCI, V31, P15962, DOI 10.1523/JNEUROSCI.2085-11.2011; Wildsmith KR, 2013, ALZHEIMERS RES THER, V5, DOI 10.1186/alzrt187; Yamanaka M, 2012, J NEUROSCI, V32, P17321, DOI 10.1523/JNEUROSCI.1569-12.2012; Yan Q, 2003, J NEUROSCI, V23, P7504; Ye JM, 2001, DIABETES, V50, P411, DOI 10.2337/diabetes.50.2.411; Yue L, 2009, J BIOL CHEM, V284, P10453, DOI 10.1074/jbc.M808482200; Zelcer N, 2007, P NATL ACAD SCI USA, V104, P10601, DOI 10.1073/pnas.0701096104	70	62	63	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2015	290	35					21591	21602		10.1074/jbc.M115.652008	http://dx.doi.org/10.1074/jbc.M115.652008			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ5IS	26163517	Green Published, hybrid			2022-12-26	WOS:000360637600032
J	Bowyer, JF; Tranter, KM; Hanig, JP; Crabtree, NM; Schleimer, RP; George, NI				Bowyer, John F.; Tranter, Karen M.; Hanig, Joseph P.; Crabtree, Nathaniel M.; Schleimer, Robert P.; George, Nysia I.			Evaluating the Stability of RNA-Seq Transcriptome Profiles and Drug-Induced Immune-Related Expression Changes in Whole Blood	PLOS ONE			English	Article							GENE-EXPRESSION; DENDRITIC CELLS; INFLAMMATION; MOLECULES; DISEASE; HYPERTHERMIA; PATHOGENESIS; MACROPHAGES; ACTIVATION; MECHANISMS	Methods were developed to evaluate the stability of rat whole blood expression obtained from RNA sequencing (RNA-seq) and assess changes in whole blood transcriptome profiles in experiments replicated over time. Expression was measured in globin-depleted RNA extracted from the whole blood of Sprague-Dawley rats, given either saline (control) or neurotoxic doses of amphetamine (AMPH). The experiment was repeated four times (paired control and AMPH groups) over a 2-year span. The transcriptome of the control and AMPH-treated groups was evaluated on: 1) transcript levels for ribosomal protein subunits; 2) relative expression of immune-related genes; 3) stability of the control transcriptome over 2 years; and 4) stability of the effects of AMPH on immune-related genes over 2 years. All, except one, of the 70 genes that encode the 80s ribosome had levels that ranked in the top 5% of all mean expression levels. Deviations in sequencing performance led to significant changes in the ribosomal transcripts. The overall expression profile of immune-related genes and genes specific to monocytes, T-cells or B-cells were well represented and consistent within treatment groups. There were no differences between the levels of ribosomal transcripts in time-matched control and AMPH groups but significant differences in the expression of immune-related genes between control and AMPH groups. AMPH significantly increased expression of some genes related to monocytes but down-regulated those specific to T-cells. These changes were partially due to changes in the two types of leukocytes present in blood, which indicate an activation of the innate immune system by AMPH. Thus, the stability of RNA-seq whole blood transcriptome can be verified by assessing ribosomal protein subunits and immune-related gene expression. Such stability enables the pooling of samples from replicate experiments to carry out differential expression analysis with acceptable power.	[Bowyer, John F.; Tranter, Karen M.; Crabtree, Nathaniel M.] US FDA, Natl Ctr Toxicol Res, Div Neurotoxicol, Jefferson, AR 72079 USA; [George, Nysia I.] US FDA, Natl Ctr Toxicol Res, Div Bioinformat & Biostat, Jefferson, AR 72079 USA; [Hanig, Joseph P.] US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD USA; [Schleimer, Robert P.] Northwestern Feinberg Sch Med, Div Allergy & Immunol, Chicago, IL USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA); US Food & Drug Administration (FDA); Northwestern University; Feinberg School of Medicine	Bowyer, JF (corresponding author), US FDA, Natl Ctr Toxicol Res, Div Neurotoxicol, Jefferson, AR 72079 USA.	john.bowyer@fda.hhs.gov			NCTR/FDA [E7295, E7519]; National Institute of General Medical Sciences under the Institutional Development Award (IDeA) Program of the National Institutes of Health (NIH); NIH [R37HL068546, R01HL078860, U19AI106683]; Ernest S. Bazley Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL068546, R01HL078860] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI106683] Funding Source: NIH RePORTER	NCTR/FDA; National Institute of General Medical Sciences under the Institutional Development Award (IDeA) Program of the National Institutes of Health (NIH); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ernest S. Bazley Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Research animals, their housing and reagents were funded under NCTR/FDA protocols E7295 and E7519. Nathan Crabtree is a graduate student in Bioinformatics, Department of Information Science, at the University of Arkansas Little Rock and his research is supported by E7519 and Arkansas IDeA Network of Biomedical Research Excellence (Arkansas INBRE) which received funds from the National Institute of General Medical Sciences under the Institutional Development Award (IDeA) Program of the National Institutes of Health (NIH). Dr. Schleimer was supported by NIH grants R37HL068546, R01HL078860 and U19AI106683 from the NIH and by the Ernest S. Bazley Foundation.	Akira S, 2013, DIABETES OBES METAB, V15, P10, DOI 10.1111/dom.12151; Amulic B, 2012, ANNU REV IMMUNOL, V30, P459, DOI 10.1146/annurev-immunol-020711-074942; Aronesty E., 2013, OPEN BIOINFORM J, V7, P1, DOI 10.2174/1875036201307010001; Bellinger DL, 2014, AUTON NEUROSCI-BASIC, V182, P15, DOI 10.1016/j.autneu.2014.01.006; BIERER BE, 1988, FASEB J, V2, P2584, DOI 10.1096/fasebj.2.10.2838364; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Boles KS, 2001, IMMUNOL REV, V181, P234, DOI 10.1034/j.1600-065X.2001.1810120.x; Borrego F, 2013, BLOOD, V121, P1951, DOI 10.1182/blood-2012-09-435057; Bowyer JF, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-147; Bowyer JF, 2008, ANN NY ACAD SCI, V1139, P127, DOI 10.1196/annals.1432.005; Broderick G, 2013, BRAIN BEHAV IMMUN, V28, P159, DOI 10.1016/j.bbi.2012.11.007; Brouard S, 2007, P NATL ACAD SCI USA, V104, P15448, DOI 10.1073/pnas.0705834104; Cai JH, 2007, BIOTECHNIQUES, V42, P503, DOI 10.2144/000112400; COOK DN, 1995, SCIENCE, V269, P1583, DOI 10.1126/science.7667639; Di Santo JP, 2014, IMMUNOL REV, V261, P169, DOI 10.1111/imr.12202; Dorr C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125045; FELTEN DL, 1987, IMMUNOL REV, V100, P225, DOI 10.1111/j.1600-065X.1987.tb00534.x; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; George NI, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125224; George NI, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-92; Hendgen-Cotta UB, 2010, J EXP BIOL, V213, P2734, DOI 10.1242/jeb.041178; Horcher M, 2001, IMMUNITY, V14, P779, DOI 10.1016/S1074-7613(01)00153-4; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Kam SHY, 2012, J ASTHMA, V49, P219, DOI 10.3109/02770903.2011.654300; Kim Y, 2013, PSYCHIAT RES, V210, P287, DOI 10.1016/j.psychres.2013.05.026; Kioussis D, 2002, NAT REV IMMUNOL, V2, P909, DOI 10.1038/nri952; Krause SW, 2000, BIOCHEM J, V346, P729, DOI 10.1042/0264-6021:3460729; Kupfer DM, 2013, BMC MED GENOMICS, V6, DOI 10.1186/1755-8794-6-26; Lauvau G, 2014, CELL IMMUNOL, V291, P32, DOI 10.1016/j.cellimm.2014.07.007; Lehning EJ, 2002, NEUROTOXICOLOGY, V23, P397, DOI 10.1016/S0161-813X(02)00083-9; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li S, 2014, NAT BIOTECHNOL, V32, P915, DOI 10.1038/nbt.2972; Locke BA, 2014, CLIN REV ALLERG IMMU, V46, P154, DOI 10.1007/s12016-014-8412-4; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mahajan SD, 2006, MOL DIAGN THER, V10, P257, DOI 10.1007/BF03256465; Mansson R, 2012, P NATL ACAD SCI USA, V109, P21028, DOI 10.1073/pnas.1211427109; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Martinez-Beamonte R, 2011, J BIOTECHNOL, V151, P325, DOI 10.1016/j.jbiotec.2010.12.017; Mastrokolias A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-28; Menard-Katcher C, 2014, DIGEST DIS, V32, P102, DOI 10.1159/000357295; Merzaban JS, 2011, BLOOD, V118, P1774, DOI 10.1182/blood-2010-11-320705; Mirantes C, 2014, EXP CELL RES; MIYAKE K, 1995, J IMMUNOL, V154, P3333; Mohr S, 2007, TRENDS MOL MED, V13, P422, DOI 10.1016/j.molmed.2007.08.003; Moretta A, 2001, ANNU REV IMMUNOL, V19, P197, DOI 10.1146/annurev.immunol.19.1.197; MORETTA A, 1989, IMMUNOL REV, V111, P145, DOI 10.1111/j.1600-065X.1989.tb00545.x; Nance DM, 2007, BRAIN BEHAV IMMUN, V21, P736, DOI 10.1016/j.bbi.2007.03.008; O'Loughlin A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-250; Painter MW, 2011, J IMMUNOL, V186, P3047, DOI 10.4049/jimmunol.1002695; Rabinovitch M, 2014, CIRC RES, V115, P165, DOI 10.1161/CIRCRESAHA.113.301141; Raghavachari N, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-28; Raghavachari N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006484; Safaee M, 2013, INT J ONCOL, V43, P1343, DOI 10.3892/ijo.2013.2075; Sheridan C, 2014, NAT BIOTECHNOL, V32, P111, DOI [10.1038/nbt0214-115a, 10.1038/nbt0214-111]; Shin H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091041; Sigal LH, 2012, JCR-J CLIN RHEUMATOL, V18, P443, DOI 10.1097/RHU.0b013e31827732f1; Signorelli SS, 2014, INT J MOL MED, V33, P777, DOI 10.3892/ijmm.2014.1657; SONSALLA PK, 1989, SCIENCE, V243, P398, DOI 10.1126/science.2563176; Subrahmanyam YVBK, 2001, BLOOD, V97, P2457, DOI 10.1182/blood.V97.8.2457; TEDDER TF, 1995, FASEB J, V9, P866, DOI 10.1096/fasebj.9.10.7542213; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Visconti L, 2014, BIOMARK MED, V8, P297, DOI 10.2217/bmm.13.122; Wiseman S, 2014, CEREBROVASC DIS, V37, P64, DOI 10.1159/000356789; Wu DD, 2014, J ASTHMA, V51, P847, DOI 10.3109/02770903.2014.917659; Yusupova G, 2014, ANNU REV BIOCHEM, V83, P467, DOI 10.1146/annurev-biochem-060713-035445; Zhao SR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0078644	66	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0133315	10.1371/journal.pone.0133315	http://dx.doi.org/10.1371/journal.pone.0133315			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177368	Green Submitted, Green Published, gold			2022-12-26	WOS:000358197600241
J	Chen, JQ; Zheng, FZ; Guo, RX				Chen, Jianqiu; Zheng, Fengzhu; Guo, Ruixin			Algal Feedback and Removal Efficiency in a Sequencing Batch Reactor Algae Process (SBAR) to Treat the Antibiotic Cefradine	PLOS ONE			English	Article							WASTE-WATER TREATMENT; ENVIRONMENTAL RISK-ASSESSMENT; TANDEM MASS-SPECTROMETRY; VETERINARY ANTIBIOTICS; AQUATIC ORGANISMS; SURFACE-WATER; DEGRADATION; TOXICITY; PRODUCTS; GENES	Many previous studies focused on the removal capability for contaminants when the algae grown in an unexposed, unpolluted environment and ignored whether the feedback of algae to the toxic stress influenced the removal capability in a subsequent treatment batch. The present research investigated and compared algal feedback and removal efficiency in a sequencing batch reactor algae process (SBAR) to remove cefradine. Three varied pollution load conditions (10, 30 and 60 mg/L) were considered. Compared with the algal characteristics in the first treatment batch at 10 and 30 mg/L, higher algal growth inhibition rates were observed in the second treatment batch (11.23% to 20.81%). In contrast, algae produced more photosynthetic pigments in response to cefradine in the second treatment batch. A better removal efficiency (76.02%) was obtained during 96 h when the alga treated the antibiotic at 60 mg/L in the first treatment batch and at 30 mg/L in the second treatment batch. Additionally, the removal rate per unit algal density was also improved when the alga treated the antibiotic at 30 or 60 mg/L in the first treatment batch, respectively and at 30 mg/L in the second treatment batch. Our result indicated that the green algae were also able to adapt to varied pollution loads in different treatment batches.	[Chen, Jianqiu; Zheng, Fengzhu; Guo, Ruixin] China Pharmaceut Univ, Dept Environm Sci, Nanjing 210009, Jiangsu, Peoples R China	China Pharmaceutical University	Guo, RX (corresponding author), China Pharmaceut Univ, Dept Environm Sci, Nanjing 210009, Jiangsu, Peoples R China.	grxcpu@163.com						Abdel-Aty AM, 2013, J ADV RES, V4, P367, DOI 10.1016/j.jare.2012.07.004; Alcock RE, 1999, CHEMOSPHERE, V38, P2247, DOI 10.1016/S0045-6535(98)00444-5; Beale SI, 2005, TRENDS PLANT SCI, V10, P309, DOI 10.1016/j.tplants.2005.05.005; Boxall ABA, 2003, ENVIRON SCI TECHNOL, V37, p286A, DOI 10.1021/es032519b; Brown KD, 2006, SCI TOTAL ENVIRON, V366, P772, DOI 10.1016/j.scitotenv.2005.10.007; Cha JM, 2006, J CHROMATOGR A, V1115, P46, DOI 10.1016/j.chroma.2006.02.086; Chen JQ, 2012, J HAZARD MATER, V209, P520, DOI 10.1016/j.jhazmat.2012.01.041; Chen JQ, 2015, CHEMOSPHERE, V119, P318, DOI 10.1016/j.chemosphere.2014.06.073; Daughton CG, 1999, ENVIRON HEALTH PERSP, V107, P907, DOI 10.2307/3434573; de Godos I, 2012, J HAZARD MATER, V229, P446, DOI 10.1016/j.jhazmat.2012.05.106; Ebert I, 2011, ENVIRON TOXICOL CHEM, V30, P2786, DOI 10.1002/etc.678; Gartiser S, 2007, CHEMOSPHERE, V67, P604, DOI 10.1016/j.chemosphere.2006.08.038; Gonzalez-Pleiter M, 2013, WATER RES, V47, P2050, DOI 10.1016/j.watres.2013.01.020; Guo RX, 2015, CHEM ENG J, V260, P550, DOI 10.1016/j.cej.2014.09.053; Hernando MD, 2006, TALANTA, V69, P334, DOI 10.1016/j.talanta.2005.09.037; Jiang MX, 2010, CHEMOSPHERE, V80, P1399, DOI 10.1016/j.chemosphere.2010.05.048; Jin ZP, 2012, CHEMOSPHERE, V87, P278, DOI 10.1016/j.chemosphere.2011.12.071; Jonsson CM, 2007, CHEMOSPHERE, V69, P849, DOI 10.1016/j.chemosphere.2007.06.024; Kemper N, 2008, ECOL INDIC, V8, P1, DOI 10.1016/j.ecolind.2007.06.002; Koussevitzky S, 2007, SCIENCE, V316, P715, DOI 10.1126/science. 1140516; Kummerer K, 2009, CHEMOSPHERE, V75, P417, DOI 10.1016/j.chemosphere.2008.11.086; Lai HT, 2009, ECOTOX ENVIRON SAFE, V72, P329, DOI 10.1016/j.ecoenv.2008.03.005; Li R, 2009, ECOTOX ENVIRON SAFE, V72, P321, DOI 10.1016/j.ecoenv.2008.05.012; Liu BY, 2011, J ENVIRON SCI-CHINA, V23, P1558, DOI 10.1016/S1001-0742(10)60608-0; Liu Y, 2012, ECOTOX ENVIRON SAFE, V86, P23, DOI 10.1016/j.ecoenv.2012.09.004; Martinez JL, 2008, SCIENCE, V321, P365, DOI 10.1126/science.1159483; Sekomo CB, 2012, ECOL ENG, V44, P102, DOI 10.1016/j.ecoleng.2012.03.003; Tamtam F, 2008, SCI TOTAL ENVIRON, V393, P84, DOI 10.1016/j.scitotenv.2007.12.009; Watkinson AJ, 2009, SCI TOTAL ENVIRON, V407, P2711, DOI 10.1016/j.scitotenv.2008.11.059; Wollenberger L, 2000, CHEMOSPHERE, V40, P723, DOI 10.1016/S0045-6535(99)00443-9; Xu WH, 2007, ENVIRON POLLUT, V145, P672, DOI 10.1016/j.envpol.2006.05.038; Yue XiaLi, 2007, Agricultural Sciences in China, V6, P316, DOI 10.1016/S1671-2927(07)60051-0; Zhang SA, 2011, ECOTOXICOLOGY, V20, P337, DOI 10.1007/s10646-010-0583-z; Zhang Z.S., 1991, METHOD STUDY FRESHWA	34	27	27	8	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0133273	10.1371/journal.pone.0133273	http://dx.doi.org/10.1371/journal.pone.0133273			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177093	gold, Green Published, Green Submitted			2022-12-26	WOS:000358197600238
J	Kurose, T; Hashimoto, M; Ozawa, J; Kawamata, S				Kurose, Tomoyuki; Hashimoto, Masakazu; Ozawa, Junya; Kawamata, Seiichi			Analysis of Gene Expression in Experimental Pressure Ulcers in the Rat with Special Reference to Inflammatory Cytokines	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; SUBCUTANEOUS CONNECTIVE-TISSUE; MODEL; SKIN	Pressure ulcers have been investigated in a few animal models, but the molecular mechanisms of pressure ulcers are not well understood. We hypothesized that pressure results in up-regulation of inflammatory cytokines and those cytokines contribute to the formation of pressure ulcers. We measured genome-wide changes in transcript levels after compression, and focused especially on inflammatory cytokines. The abdominal wall of rats was compressed at 100 mmHg for 4 hours by two magnets. Specimens were obtained 12 hours, 1, or 3 days after compression, and analyzed by light microscopy, microarray, Real-Time PCR, and ELISA. The skin and subcutaneous tissue in the compressed area were markedly thickened. The microarray showed that numerous genes were up-regulated after the compression. Up-regulated genes were involved in apoptosis, inflammation, oxidative stress, proteolysis, hypoxia, and so on. Real-Time PCR showed the up-regulation of granulocyte-macrophage colony stimulating factor (GM-CSF), interferon. (IFN-gamma), interleukin 1 beta (IL-1 beta), interleukin 1 receptor antagonist gene (IL1Ra), interleukin 6 (IL-6), interleukin 10 (IL-10), matrix metalloproteinase 3 (MMP-3), tissue inhibitor of metalloproteinase 1 (TIMP-1), and tumor necrosis factor a (TNF-alpha) at 12 hours, IFN-gamma, IL-6, IL-10, MMP-3, and TIMP-1 at 1 day, and IFN-gamma, IL-6, and MMP-3 at 3 days. Some genes from subcutaneous tissue were up-regulated temporarily, and others were kept at high levels of expression. ELISA data showed that the concentrations of IL-1 beta and IL-6 proteins were most notably increased following compression. Prolonged up-regulation of IL-1 beta, and IL-6 might enhance local inflammation, and continuous local inflammation may contribute to the pressure ulcer formation. In addition, GM-CSF, IFN-gamma, MMP-3, and TIMP-1 were not reported previously in the wound healing process, and those genes may have a role in development of the pressure ulcers. Expression data from Real-Time PCR were generally in good agreement with those of the microarray. Our microarray data were useful for identifying genes involved in pressure ulcer formation. However, the expression levels of the genes didn't necessarily correspond with protein production. As such, the functions of these cytokines need to be further investigated.	[Kurose, Tomoyuki; Hashimoto, Masakazu; Kawamata, Seiichi] Hiroshima Univ, Inst Biomed & Hlth Sci, Hiroshima, Japan; [Ozawa, Junya] Hiroshima Int Univ, Fac Hlth Sci, Hiroshima, Japan	Hiroshima University	Kurose, T (corresponding author), Hiroshima Univ, Inst Biomed & Hlth Sci, Hiroshima, Japan.	kurose@hiroshima-u.ac.jp			Japan Society for the Promotion of Science [19592492, 19700435, 22500461]; Grants-in-Aid for Scientific Research [26350645] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants in Aid from the Japan Society for the Promotion of Science (Nos. 19592492, 19700435, 22500461).	Bronneberg D, 2006, ANN BIOMED ENG, V34, P506, DOI 10.1007/s10439-005-9062-8; Chen L, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-471; Daitoku D, 2007, ARCH HISTOL CYTOL, V70, P29, DOI 10.1679/aohc.70.29; Dallegri F, 1997, INFLAMM RES, V46, P382, DOI 10.1007/s000110050208; Dalton SJ, 2007, J INVEST DERMATOL, V127, P958, DOI 10.1038/sj.jid.5700651; Feldmann M, 2000, CYTOKINE REFERENCE C, P291; Furuichi K, 2003, J AM SOC NEPHROL, V14, P1066, DOI 10.1097/01.ASN.0000059339.14780.E4; Furuichi K, 2006, CRIT CARE MED, V34, P2447, DOI 10.1097/01.CCM.0000233878.36340.10; Goldstein B, 1998, ARCH PHYS MED REHAB, V79, P265, DOI 10.1016/S0003-9993(98)90005-3; Gomez-Cambronero J, 2003, J IMMUNOL, V171, P6846, DOI 10.4049/jimmunol.171.12.6846; Hashimoto M, 2008, ARCH HISTOL CYTOL, V71, P303, DOI 10.1679/aohc.71.303; Kawamata S, 2003, ARCH HISTOL CYTOL, V66, P273, DOI 10.1679/aohc.66.273; Kawamata S, ARCH HISTOL IN PRESS; King A, 2014, ADV WOUND CARE, V3, P315, DOI 10.1089/wound.2013.0461; KOSIAK M, 1959, Arch Phys Med Rehabil, V40, P62; Langevin HM, 2005, AM J PHYSIOL-CELL PH, V288, pC747, DOI 10.1152/ajpcell.00420.2004; METCALF D, 1987, EXP HEMATOL, V15, P1; Peirce SM, 2000, WOUND REPAIR REGEN, V8, P68, DOI 10.1046/j.1524-475x.2000.00068.x; Reid RR, 2004, J SURG RES, V116, P172, DOI 10.1016/S0022-4804(03)00227-0; Saito Y, 2008, J INVEST DERMATOL, V128, P1838, DOI 10.1038/sj.jid.5701258; Salcido R, 1994, Adv Wound Care, V7, P23; Salcido R, 1994, ADV WOUND CARE, V4, P28; Salcido R, 1994, ADV WOUND CARE, V4, P26; Salcido R, 2007, J SPINAL CORD MED, V30, P107, DOI 10.1080/10790268.2007.11753921; Sato Y, 1999, BIOCHEM BIOPH RES CO, V265, P194, DOI 10.1006/bbrc.1999.1455; SMITH JW, 1992, J CLIN ONCOL, V10, P1141, DOI 10.1200/JCO.1992.10.7.1141; Stojadinovic O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069223; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Yanai H., 2011, STATCEL USEFUL ADD I, P172	29	20	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132622	10.1371/journal.pone.0132622	http://dx.doi.org/10.1371/journal.pone.0132622			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177082	gold, Green Published, Green Submitted			2022-12-26	WOS:000358197600133
J	Osterman, CJD; Lynch, JC; Leaf, P; Gonda, A; Bennit, HRF; Griffiths, D; Wall, NR				Osterman, Carlos J. Diaz; Lynch, James C.; Leaf, Patrick; Gonda, Amber; Bennit, Heather R. Ferguson; Griffiths, Duncan; Wall, Nathan R.			Curcumin Modulates Pancreatic Adenocarcinoma Cell-Derived Exosomal Function	PLOS ONE			English	Article							FACTOR-KAPPA-B; CANCER-CELL; LIPOSOMAL CURCUMIN; TUMOR-GROWTH; EXTRACELLULAR VESICLES; DOWN-REGULATION; GEMCITABINE; PROLIFERATION; INHIBITION; DELIVERY	Pancreatic cancer has the highest mortality rates of all cancer types. One potential explanation for the aggressiveness of this disease is that cancer cells have been found to communicate with one another using membrane-bound vesicles known as exosomes. These exosomes carry pro-survival molecules and increase the proliferation, survival, and metastatic potential of recipient cells, suggesting that tumor-derived exosomes are powerful drivers of tumor progression. Thus, to successfully address and eradicate pancreatic cancer, it is imperative to develop therapeutic strategies that neutralize cancer cells and exosomes simultaneously. Curcumin, a turmeric root derivative, has been shown to have potent anti-cancer and anti-inflammatory effects in vitro and in vivo. Recent studies have suggested that exosomal curcumin exerts anti-inflammatory properties on recipient cells. However, curcumin's effects on exosomal pro-tumor function have yet to be determined. We hypothesize that curcumin will alter the pro-survival role of exosomes from pancreatic cancer cells toward a pro-death role, resulting in reduced cell viability of recipient pancreatic cancer cells. The main objective of this study was to determine the functional alterations of exosomes released by pancreatic cancer cells exposed to curcumin compared to exosomes from untreated pancreatic cancer cells. We demonstrate, using an in vitro cell culture model involving pancreatic adenocarcinoma cell lines PANC-1 and MIA PaCa-2, that curcumin is incorporated into exosomes isolated from curcumin-treated pancreatic cancer cells as observed by spectral studies and fluorescence microscopy. Furthermore, curcumin is delivered to recipient pancreatic cancer cells via exosomes, promoting cytotoxicity as demonstrated by Hoffman modulation contrast microscopy as well as AlamarBlue and Trypan blue exclusion assays. Collectively, these data suggest that the efficacy of curcumin may be enhanced in pancreatic cancer cells through exosomal facilitation.	[Osterman, Carlos J. Diaz; Lynch, James C.; Leaf, Patrick; Bennit, Heather R. Ferguson; Wall, Nathan R.] Loma Linda Univ, Div Biochem, Ctr Hlth Dispar & Mol Med, Loma Linda, CA 92350 USA; [Gonda, Amber] Loma Linda Univ, Sch Med, Dept Anat, Loma Linda, CA 92350 USA; [Griffiths, Duncan] Malvern Instruments Inc, Rancho Cucamonga, CA USA	Loma Linda University; Loma Linda University	Wall, NR (corresponding author), Loma Linda Univ, Div Biochem, Ctr Hlth Dispar & Mol Med, Loma Linda, CA 92350 USA.	nwall@llu.edu	Wall, Nathan R./H-7368-2015	Wall, Nathan R./0000-0002-3235-4386	National Institute of Health Disparities and Minority Health of the National Institutes of Health [p20MD0016321, P20MD006988, 2R25 GM060507]; Department of the Army [DAMD17-97-2-7016]; Malvern Instruments Inc.; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM060507] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [P20MD006988] Funding Source: NIH RePORTER	National Institute of Health Disparities and Minority Health of the National Institutes of Health; Department of the Army; Malvern Instruments Inc.; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	Research reported in this publication was supported by the National Institute of Health Disparities and Minority Health of the National Institutes of Health under award numbers p20MD0016321, P20MD006988 and 2R25 GM060507. a National Merit Test Bed (NMTB) award sponsored by the Department of the Army under Cooperative Agreement Number DAMD17-97-2-7016 (NRW). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The PI's personal funds have also contributed to this work. The contribution by Malvern's associate, Mr. Duncan Griffiths was to supply us with the use of their nanosight instrument to detect and measure exosomes in our samples and modest interpretation of the data we collected using their instrument. Malvern Instruments Inc. also provided support in the form of a salary for author DG, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	American Cancer Society, 2013, CANCER FACTS FIGURES; American Cancer Society, 2015, CANCER FACTS FIGURES; Anand P, 2007, MOL PHARMACEUT, V4, P807, DOI 10.1021/mp700113r; Atai NA, 2013, J NEURO-ONCOL, V115, P343, DOI 10.1007/s11060-013-1235-y; Atay Safinur, 2014, Commun Integr Biol, V7, pe28231, DOI 10.4161/cib.28231; Beckler MD, 2013, MOL CELL PROTEOMICS, V12, P343, DOI 10.1074/mcp.M112.022806; Bimonte S, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/810423; Christianson HC, 2013, P NATL ACAD SCI USA, V110, P17380, DOI 10.1073/pnas.1304266110; Dhillon N, 2008, CLIN CANCER RES, V14, P4491, DOI 10.1158/1078-0432.CCR-08-0024; Diaz Osterman CJ, 2015, PANCREAS IN PRESS; Epelbaum R, 2010, NUTR CANCER, V62, P1137, DOI 10.1080/01635581.2010.513802; Feig C, 2012, CLIN CANCER RES, V18, P4266, DOI 10.1158/1078-0432.CCR-11-3114; Ferrucci LM, 2010, ASIAN PAC J CANCER P, V11, P1621; Franzen CA, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/619829; Ghalandarlaki N, 2014, NANOTECHNOLOGY APPLI, V2014, DOI [10.1155/2014/394264, DOI 10.1155/2014/394264]; Glienke W, 2010, CANCER INVEST, V28, P166, DOI 10.3109/07357900903287006; Gupta SC, 2013, MOL NUTR FOOD RES, V57, P1510, DOI 10.1002/mnfr.201100741; Gupta SC, 2013, AAPS J, V15, P195, DOI 10.1208/s12248-012-9432-8; Gupta V, 2009, INT J NANOMED, V4, P115; Jung T, 2009, NEOPLASIA, V11, P1093, DOI 10.1593/neo.09822; Jutooru I, 2010, J BIOL CHEM, V285, P25332, DOI 10.1074/jbc.M109.095240; Kanai M, 2014, WORLD J GASTROENTERO, V20, P9384, DOI 10.3748/wjg.v20.i28.9384; Kanai M, 2013, CANCER CHEMOTH PHARM, V71, P1521, DOI 10.1007/s00280-013-2151-8; Kanai M, 2012, CANCER CHEMOTH PHARM, V69, P65, DOI 10.1007/s00280-011-1673-1; Kanai M, 2011, CANCER CHEMOTH PHARM, V68, P157, DOI 10.1007/s00280-010-1470-2; Khan S, 2009, BRIT J CANCER, V100, P1073, DOI 10.1038/sj.bjc.6604978; Khan S, 2011, APOPTOSIS, V16, P1, DOI 10.1007/s10495-010-0534-4; Kharaziha P, 2012, BBA-REV CANCER, V1826, P103, DOI 10.1016/j.bbcan.2012.03.006; Kunnumakkara AB, 2007, CANCER RES, V67, P3853, DOI 10.1158/0008-5472.CAN-06-4257; Kunwar A, 2008, BBA-GEN SUBJECTS, V1780, P673, DOI 10.1016/j.bbagen.2007.11.016; Kunwar A, 2006, BBA-GEN SUBJECTS, V1760, P1513, DOI 10.1016/j.bbagen.2006.06.012; Lancaster GI, 2005, J BIOL CHEM, V280, P23349, DOI 10.1074/jbc.M502017200; Lev-Ari S, 2007, CANCER INVEST, V25, P411, DOI 10.1080/07357900701359577; Li L, 2005, CANCER-AM CANCER SOC, V104, P1322, DOI 10.1002/cncr.21300; Li L, 2004, CANCER-AM CANCER SOC, V101, P2351, DOI 10.1002/cncr.20605; Lin YG, 2007, CLIN CANCER RES, V13, P3423, DOI 10.1158/1078-0432.CCR-06-3072; Martinez-Lorenzo MJ, 2004, EXP CELL RES, V295, P315, DOI 10.1016/j.yexcr.2003.12.024; Matabudul D, 2012, ANTICANCER RES, V32, P4359; Nardo L, 2011, J FLUORESC, V21, P627, DOI 10.1007/s10895-010-0750-x; Neoptolemos JP, 2011, EUR J CANCER, V47, pS378, DOI 10.1016/S0959-8049(11)70210-6; Ramachandran C, 2010, ONCOL REP, V23, P1529, DOI 10.3892/or_00000792; Rana S, 2013, NEOPLASIA, V15, P281, DOI 10.1593/neo.122010; Ranjan AP, 2013, ANTICANCER RES, V33, P3603; Rieu S, 2000, EUR J BIOCHEM, V267, P583, DOI 10.1046/j.1432-1327.2000.01036.x; Ryan DP, 2014, NEW ENGL J MED, V371, P2140, DOI 10.1056/NEJMc1412266; Sahu A, 2008, ACTA BIOMATER, V4, P1752, DOI 10.1016/j.actbio.2008.04.021; Sasaki H, 2011, BIOL PHARM BULL, V34, P660, DOI 10.1248/bpb.34.660; Savina A, 2003, J BIOL CHEM, V278, P20083, DOI 10.1074/jbc.M301642200; Shaikh J, 2009, EUR J PHARM SCI, V37, P223, DOI 10.1016/j.ejps.2009.02.019; Shehzad A, 2013, BIOFACTORS, V39, P56, DOI 10.1002/biof.1068; Shehzad A, 2010, ARCH PHARM, V343, P489, DOI 10.1002/ardp.200900319; Shi HS, 2012, INT J NANOMED, V7, P2601, DOI 10.2147/IJN.S31439; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Sun DM, 2010, MOL THER, V18, P1606, DOI 10.1038/mt.2010.105; Taylor D D, 1986, Dev Biol (N Y 1985), V3, P33; Taylor DD, 2002, GYNECOL ONCOL, V84, P443, DOI 10.1006/gyno.2001.6551; van der Meel R, 2014, J CONTROL RELEASE, V195, P72, DOI 10.1016/j.jconrel.2014.07.049; Yallapu MM, 2013, MOL CANCER THER, V12, P1471, DOI 10.1158/1535-7163.MCT-12-1227; Yang CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037960; Youns M, 2013, J CELL BIOCHEM, V114, P2654, DOI 10.1002/jcb.24612	60	67	69	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132845	10.1371/journal.pone.0132845	http://dx.doi.org/10.1371/journal.pone.0132845			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177391	Green Published, gold, Green Submitted			2022-12-26	WOS:000358197600166
J	Yip, JLY; Khawaja, AP; Chan, MPY; Broadway, DC; Peto, T; Tufail, A; Luben, R; Hayat, S; Bhaniani, A; Wareham, NJ; Khaw, KT; Foster, PJ				Yip, Jennifer L. Y.; Khawaja, Anthony P.; Chan, Michelle P. Y.; Broadway, David C.; Peto, Tunde; Tufail, Adnan; Luben, Robert; Hayat, Shabina; Bhaniani, Amit; Wareham, Nicholas J.; Khaw, Kay-Tee; Foster, Paul J.			Cross Sectional and Longitudinal Associations between Cardiovascular Risk Factors and Age Related Macular Degeneration in the EPIC-Norfolk Eye Study	PLOS ONE			English	Article							C-REACTIVE PROTEIN; POSTINFARCTION PATIENTS; POOLED FINDINGS; TERM INCIDENCE; PREVALENCE; DISEASE; MACULOPATHY; HYPERTENSION; POLYMORPHISM; CHOLESTEROL	Purpose To examine the cross sectional and longitudinal relationship between cardiovascular risk factors and age-related macular degeneration (AMD) in a large British cohort study. Methods The EPIC Norfolk Eye study is nested in a larger prospective cohort study. Data on cardiovascular risk factors were collected at baseline (1993-1997) and follow up (2006-2011) via clinical examination, validated lifestyle questionnaires and serum blood samples. AMD was ascertained using standardised grading of fundus photographs at the follow up. Logistic regression was used to examine associations between baseline and follow up risk factors with AMD. Results 5,344 pairs (62.0% of total 8623) of fundus photographs were of sufficient quality for grading of AMD in participants with mean age of 67.4 years old (range 44-91) at diagnosis. There were 28 cases of late AMD (0.5%, 95% confidence interval (CI)=0.3-0.8%) and 645 cases of early AMD (12.1%, 95%CI=11.2-13.0.%). In multivariable analysis, older people with higher levels of baseline high density lipoprotein-cholesterol (HDL-C) and C-reactive protein (CRP) were more likely to have any signs of AMD, after adjusting for sex, education, smoking, and systolic blood pressure. In cross sectional analysis, only older age and higher HDL were significantly associated with AMD. Conclusions We have found that older age and higher levels of CRP and HDL-C were associated with increased odds of AMD in this population in the longitudinal analysis, but older age and HDL-C, not CRP was significantly associated with AMD in the cross sectional analysis. The prevalence of AMD in this cohort was low compared to other cohorts in Europe, the US and Australia, and probably reflects the some selection biases in follow up participation as well as the low rate of smoking among our healthy participants.	[Yip, Jennifer L. Y.; Khawaja, Anthony P.; Luben, Robert; Hayat, Shabina; Bhaniani, Amit; Khaw, Kay-Tee] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England; [Yip, Jennifer L. Y.; Khawaja, Anthony P.; Chan, Michelle P. Y.; Peto, Tunde; Tufail, Adnan; Foster, Paul J.] Moorfields Eye Hosp, NIHR Biomed Res Ctr, London, England; [Yip, Jennifer L. Y.; Khawaja, Anthony P.; Chan, Michelle P. Y.; Peto, Tunde; Tufail, Adnan; Foster, Paul J.] UCL Inst Ophthalmol, London, England; [Broadway, David C.] Norfolk & Norwich Univ Hosp, Dept Ophthalmol, Norwich, Norfolk, England; [Wareham, Nicholas J.] Univ Cambridge, MRC, Epidemiol Unit, Sch Clin Med, Cambridge, England	University of Cambridge; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of London; University College London; Norfolk & Norwich University Hospitals NHS Foundation Trust; Norfolk & Norwich University Hospital; University of Cambridge	Yip, JLY (corresponding author), Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England.	jlyy2@medschl.cam.ac.uk	Peto, Tunde/G-8812-2018; Luben, Robert N/H-5519-2015; Khaw, Kay-Tee/AAZ-3209-2021; Foster, Paul/V-7288-2019	Peto, Tunde/0000-0001-6265-0381; Luben, Robert N/0000-0002-5088-6343; Foster, Paul/0000-0002-4755-177X; Yip, Jennifer Lai Yee/0000-0003-3788-7170; Tufail, Adnan/0000-0001-6131-7640; Khawaja, Anthony/0000-0001-6802-8585	Medical Research Council [G0401527]; Cancer Research UK [C864/A8257]; Age UK Research into Ageing grant [262]; International Glaucoma Association; Richard Desmond Charitable Trust (via Fight for Sight); Department for Health through the NIHR to Moorfields Eye Hospital; University College London (UCL) Institute of Ophthalmology for a specialist Biomedical Research Centre for Ophthalmology; MRC [G1001939, MC_UU_12015/1] Funding Source: UKRI; Medical Research Council [G1001939, MC_UU_12015/1, G1000143, MC_U106179471] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10114, CL-2010-14-004, NF-SI-0512-10135] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Age UK Research into Ageing grant; International Glaucoma Association; Richard Desmond Charitable Trust (via Fight for Sight); Department for Health through the NIHR to Moorfields Eye Hospital; University College London (UCL) Institute of Ophthalmology for a specialist Biomedical Research Centre for Ophthalmology; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	EPIC-Norfolk infrastructure and core functions are supported by grants from the Medical Research Council (G0401527) and Cancer Research UK (C864/A8257). The clinic for the third health examination was funded by Age UK Research into Ageing grant (262). Dr. Yip is a National Institute for Health Research (NIHR) Clinical Lecturer. Dr. Khawaja is a Wellcome Trust Clinical Research Fellow. Michelle Chan is an MRC/RCOphth Clinical Training Fellow and has received additional support from the International Glaucoma Association. Professor Foster has received additional support from the Richard Desmond Charitable Trust (via Fight for Sight). Professor Foster and Tunde Peto received funding from the Department for Health through the award made by the NIHR to Moorfields Eye Hospital and the University College London (UCL) Institute of Ophthalmology for a specialist Biomedical Research Centre for Ophthalmology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BIRD AEC, 1995, SURV OPHTHALMOL, V39, P367, DOI 10.1016/S0039-6257(05)80092-X; Cackett P, 2008, AM J OPHTHALMOL, V146, P960, DOI 10.1016/j.ajo.2008.06.026; Chakravarthy U, 2010, BMC OPHTHALMOL, V10, DOI 10.1186/1471-2415-10-31; Corsetti JP, 2006, ATHEROSCLEROSIS, V187, P191, DOI 10.1016/j.atherosclerosis.2005.09.012; Corsetti JP, 2010, ARTERIOSCL THROM VAS, V30, P1657, DOI 10.1161/ATVBAHA.110.207977; Cougnard-Gregoire A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090973; Day N, 1999, BRIT J CANCER, V80, P95; Delcourt C, 2001, Ophthalmic Epidemiol, V8, P237, DOI 10.1076/opep.8.4.237.1613; Fagerness JA, 2009, EUR J HUM GENET, V17, P100, DOI 10.1038/ejhg.2008.140; Fraser-Bell S, 2008, AM J OPHTHALMOL, V145, P308, DOI 10.1016/j.ajo.2007.10.007; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P564; Gold B, 2006, NAT GENET, V38, P458, DOI 10.1038/ng1750; Hageman GS, 2001, PROG RETIN EYE RES, V20, P705, DOI 10.1016/S1350-9462(01)00010-6; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Hayat SA, 2014, INT J EPIDEMIOL, V43, P1063, DOI 10.1093/ije/dyt086; Hogg RE, 2008, OPHTHALMOLOGY, V115, P1046, DOI 10.1016/j.ophtha.2007.07.031; Hong T, 2011, SURV OPHTHALMOL, V56, P184, DOI 10.1016/j.survophthal.2010.08.007; Hyman L, 2000, ARCH OPHTHALMOL-CHIC, V118, P351, DOI 10.1001/archopht.118.3.351; Khaw KT, 2006, INT J EPIDEMIOL, V35, P1034, DOI 10.1093/ije/dyl079; Khawaja AP, 2013, BMJ OPEN, P3; Klein R, 2003, OPHTHALMOLOGY, V110, P636, DOI 10.1016/S0161-6420(02)01448-3; KLEIN R, 1992, OPHTHALMOLOGY, V99, P933; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Klein R, 2007, AM J OPHTHALMOL, V143, P473, DOI 10.1016/j.ajo.2006.11.058; Klein R, 2010, ARCH OPHTHALMOL-CHIC, V128, P750, DOI 10.1001/archophthalmol.2010.92; Lim LS, 2012, LANCET, V379, P1728, DOI 10.1016/S0140-6736(12)60282-7; Maller JB, 2007, NAT GENET, V39, P1200, DOI 10.1038/ng2131; MITCHELL P, 1995, OPHTHALMOLOGY, V102, P1450; Mitta VP, 2013, JAMA OPHTHALMOL, V131, P507, DOI 10.1001/jamaophthalmol.2013.2303; Navab M, 2011, NAT REV CARDIOL, V8, P222, DOI 10.1038/nrcardio.2010.222; Neale BM, 2010, P NATL ACAD SCI USA, V107, P7395, DOI 10.1073/pnas.0912019107; Owen CG, 2012, BRIT J OPHTHALMOL, V96, P752, DOI 10.1136/bjophthalmol-2011-301109; Pascolini D, 2012, BRIT J OPHTHALMOL, V96, P614, DOI 10.1136/bjophthalmol-2011-300539; Reynolds R, 2010, OPHTHALMOLOGY, V117, P1989, DOI 10.1016/j.ophtha.2010.07.009; Seddon JM, 2006, HUM HERED, V61, P157, DOI 10.1159/000094141; Smith W, 2001, OPHTHALMOLOGY, V108, P697, DOI 10.1016/S0161-6420(00)00580-7; Sun C, 2009, OPHTHALMOLOGY, V116, P1913, DOI 10.1016/j.ophtha.2009.03.046; Tan JSL, 2007, OPHTHALMOLOGY, V114, P1143, DOI 10.1016/j.ophtha.2006.09.033; Tomany SC, 2004, OPHTHALMOLOGY, V111, P1280, DOI 10.1016/j.ophtha.2003.11.010; van Leeuwen R, 2004, AM J OPHTHALMOL, V137, P750, DOI 10.1016/S0002-9394(03)01089-4; VINGERLING JR, 1995, OPHTHALMOLOGY, V102, P205; Wong TY, 2006, ANN INTERN MED, V145, P98, DOI 10.7326/0003-4819-145-2-200607180-00007	42	26	27	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132565	10.1371/journal.pone.0132565	http://dx.doi.org/10.1371/journal.pone.0132565			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176222	gold, Green Accepted, Green Published, Green Submitted			2022-12-26	WOS:000358197600125
J	Kondraskov, P; Schutz, N; Schussler, C; de Sequeira, MM; Guerra, AS; Caujape-Castells, J; Jaen-Molina, R; Marrero-Rodriguez, A; Koch, MA; Linder, P; Kovar-Eder, J; Thiv, M				Kondraskov, Paulina; Schuetz, Nicole; Schuessler, Christina; Menezes de Sequeira, Miguel; Santos Guerra, Arnoldo; Caujape-Castells, Juli; Jaen-Molina, Ruth; Marrero-Rodriguez, Aguedo; Koch, Marcus A.; Linder, Peter; Kovar-Eder, Johanna; Thiv, Mike			Biogeography of Mediterranean Hotspot Biodiversity: Re-Evaluating the 'Tertiary Relict' Hypothesis of Macaronesian Laurel Forests	PLOS ONE			English	Article							MOLECULAR PHYLOGENY; PLANT RECORD; EVOLUTION; HISTORY; VEGETATION; LAURACEAE; ANGIOSPERMS; NEOGENE; L.; DIVERSIFICATION	The Macaronesian laurel forests (MLF) are dominated by trees with a laurophyll habit comparable to evergreen humid forests which were scattered across Europe and the Mediterranean in the Paleogene and Neogene. Therefore, MLF are traditionally regarded as an old, 'Tertiary relict' vegetation type. Here we address the question if key taxa of the MLF are relictual. We evaluated the relict hypothesis consulting fossil data and analyses based on molecular phylogenies of 18 representative species. For molecular dating we used the program BEAST, for ancestral trait reconstructions BayesTraits and Lagrange to infer ancestral areas. Our molecular dating showed that the origins of four species date back to the Upper Miocene while 14 originated in the Plio-Pleistocene. This coincides with the decline of fossil laurophyllous elements in Europe since the middle Miocene. Ancestral trait and area reconstructions indicate that MLF evolved partly from pre-adapted taxa from the Mediterranean, Macaronesia and the tropics. According to the fossil record laurophyllous taxa existed in Macaronesia since the Plio- and Pleistocene. MLF are composed of species with a heterogeneous origin. The taxa dated to the Pleistocene are likely not 'Tertiary relicts'. Some species may be interpreted as relictual. In this case, the establishment of most species in the Plio-Pleistocene suggests that there was a massive species turnover before this time. Alternatively, MLF were largely newly assembled through global recruitment rather than surviving as relicts of a once more widespread vegetation. This process may have possibly been triggered by the intensification of the trade winds at the end of the Pliocene as indicated by proxy data.	[Kondraskov, Paulina; Schuetz, Nicole; Schuessler, Christina; Kovar-Eder, Johanna; Thiv, Mike] State Museum Nat Hist Stuttgart, Dept Bot, Stuttgart, Germany; [Menezes de Sequeira, Miguel] Univ Madeira, Ctr Ciencias Vida, Funchal, Madeira, Portugal; [Santos Guerra, Arnoldo] Unidad Bot ICIA, Tenerife, Spain; [Caujape-Castells, Juli; Jaen-Molina, Ruth; Marrero-Rodriguez, Aguedo] CSIC, Jardin Bot Canario Viera y Clavijo Unidad Asociad, Las Palmas Gran Canaria, Spain; [Kondraskov, Paulina; Koch, Marcus A.] Heidelberg Univ, Dept Biodivers & Plant Systemat, Heidelberg, Germany; [Linder, Peter] Univ Zurich, Inst Systemat Bot, Zurich, Switzerland	Universidade da Madeira; Consejo Superior de Investigaciones Cientificas (CSIC); Ruprecht Karls University Heidelberg; University of Zurich	Thiv, M (corresponding author), State Museum Nat Hist Stuttgart, Dept Bot, Stuttgart, Germany.	mike.thiv@smns-bw.de	Koch, Marcus A/A-4924-2011; Caujapé-Castells, Juli/J-8938-2015	Koch, Marcus A/0000-0002-1693-6829; Caujapé-Castells, Juli/0000-0003-0600-1496; Buerki, Sven/0000-0002-8299-6539; Sequeira, Miguel/0000-0001-9728-465X; Eder, Johanna/0000-0001-8039-5441; Schussler, Christina/0000-0002-9935-7426				Aigoin DA, 2009, EVOLUTION, V63, P3248, DOI 10.1111/j.1558-5646.2009.00787.x; Arroyo-Garcia R, 2001, EUPHYTICA, V122, P155, DOI 10.1023/A:1012654514381; Bell CD, 2005, AM J BOT, V92, P284, DOI 10.3732/ajb.92.2.284; Bell CD, 2010, AM J BOT, V97, P1296, DOI 10.3732/ajb.0900346; Borges PAV, 1999, BIOL J LINN SOC, V66, P373, DOI 10.1111/j.1095-8312.1999.tb01897.x; Carine MA, 2010, SPEC SYST, V3, P101; Chao YS, 2014, ANN BOT-LONDON, V114, P109, DOI 10.1093/aob/mcu086; Coiffard C, 2009, PALAEONTOLOGY, V52, P323, DOI 10.1111/j.1475-4983.2009.00845.x; Comes Hans Peter, 2004, New Phytol, V164, P11, DOI 10.1111/j.1469-8137.2004.01194.x; Contreras-Diaz HG, 2007, MOL PHYLOGENET EVOL, V42, P687, DOI 10.1016/j.ympev.2006.10.007; Crisp MD, 2009, NATURE, V458, P754, DOI 10.1038/nature07764; CRONK QCB, 1992, BIOL J LINN SOC, V46, P91, DOI 10.1111/j.1095-8312.1992.tb00852.x; Desamore A, 2012, J BIOGEOGR, V39, P574, DOI 10.1111/j.1365-2699.2011.02622.x; Desamore A, 2011, J BIOGEOGR, V38, P164, DOI 10.1111/j.1365-2699.2010.02387.x; Donoghue MJ, 2008, P NATL ACAD SCI USA, V105, P11549, DOI 10.1073/pnas.0801962105; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Estrada-Ruiz E, 2012, INT J PLANT SCI, V173, P412, DOI 10.1086/664714; FERGUSON DK, 1974, BOT J LINN SOC, V68, P51, DOI 10.1111/j.1095-8339.1974.tb01747.x; Galley C, 2006, J BIOGEOGR, V33, P236, DOI 10.1111/j.1365-2699.2005.01376.x; Garcia-Maroto F, 2009, MOL PHYLOGENET EVOL, V52, P563, DOI 10.1016/j.ympev.2009.04.009; Garcia-Verdugo C, 2013, MOL ECOL, V22, P1546, DOI 10.1111/mec.12194; Geldmacher J, 2001, J VOLCANOL GEOTH RES, V111, P55, DOI 10.1016/S0377-0273(01)00220-7; Gonzalez J, 2009, J ORNITHOL, V150, P357, DOI 10.1007/s10336-008-0360-4; Heer O., 1857, NEUE DENKSCHR ALLG S, VXV, P1; Hooker J.D., 1867, GARDENERS CHRONICLE, V27, P6; Huguet V, 2005, MOL PHYLOGENET EVOL, V34, P557, DOI 10.1016/j.ympev.2004.11.018; Kay KM, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-36; Kovar-Eder J, 2008, PALAIOS, V23, P97, DOI 10.2110/palo.2006.p06-039r; Kovar-Eder J, 2006, PALAEOGEOGR PALAEOCL, V238, P321, DOI 10.1016/j.palaeo.2006.03.031; Li L, 2011, AM J BOT, V98, P1520, DOI 10.3732/ajb.1100006; Anderson CL, 2009, J BIOGEOGR, V36, P2189, DOI 10.1111/j.1365-2699.2009.02222.x; Losch R, 1990, DISS BOT, P146; MAI DH, 1989, PLANT SYST EVOL, V162, P79, DOI 10.1007/BF00936911; Manen JF, 2010, MOL PHYLOGENET EVOL, V57, P961, DOI 10.1016/j.ympev.2010.09.006; Fernandez-Palacios JM, 2011, J BIOGEOGR, V38, P226, DOI 10.1111/j.1365-2699.2010.02427.x; MARTINETTO E, 2014, ALP MEDITERR QUAT, V27; Martinetto E, 2009, QUATERN INT, V204, P20, DOI 10.1016/j.quaint.2008.11.014; Medail F, 1997, ANN MO BOT GARD, V84, P112, DOI 10.2307/2399957; Moreno A, 2001, QUATERNARY SCI REV, V20, P1327, DOI 10.1016/S0277-3791(00)00184-0; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Ortiz JE, 2006, J QUATERNARY SCI, V21, P287, DOI 10.1002/jqs.962; OVERPECK JT, 1992, GEOLOGY, V20, P1071, DOI 10.1130/0091-7613(1992)020<1071:MENAVC>2.3.CO;2; Pagel M, 2013, BAYES TRAITS V2 TUTO; Paradis E, 2006; Ree RH, 2008, SYSTEMATIC BIOL, V57, P4, DOI 10.1080/10635150701883881; Ree RH, 2009, J BIOGEOGR, V36, P1211, DOI 10.1111/j.1365-2699.2008.02068.x; Rivas-Martinez S., 1993, ITINERA GEOBOT, V7, P169; Rodriguez-Sanchez F, 2009, J BIOGEOGR, V36, P1270, DOI 10.1111/j.1365-2699.2009.02091.x; Rohwer J. G., 1993, FAMILIES GENERA VASC, V2, P366, DOI DOI 10.1007/978-3-662-02899-5_46; RStudio, 2013, RSTUDIO INT DEV ENV; Salvo G, 2010, SYST BIOL, V59, P705, DOI 10.1093/sysbio/syq046; Schuettpelz E, 2006, SYST BIOL, V55, P485, DOI 10.1080/10635150600755438; Trauth MH, 2009, QUATERNARY SCI REV, V28, P399, DOI 10.1016/j.quascirev.2008.11.003; von Balthazar M, 2007, AM J BOT, V94, P2041, DOI 10.3732/ajb.94.12.2041; Wagner WL, 1995, HAWAIIAN BIOGEOGRAPH; Walther GR, 2009, TRENDS ECOL EVOL, V24, P686, DOI 10.1016/j.tree.2009.06.008; Wikstrom N, 2001, P ROY SOC B-BIOL SCI, V268, P2211, DOI 10.1098/rspb.2001.1782; Worobiec Grzegorz, 2007, Acta Palaeobotanica, V47, P203	58	57	58	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132091	10.1371/journal.pone.0132091	http://dx.doi.org/10.1371/journal.pone.0132091			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26173113	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000358194900031
J	Paulukonis, ST; Roberts, EM; Valle, JP; Collins, NN; English, PB; Kaye, WE				Paulukonis, Susan T.; Roberts, Eric M.; Valle, Jhaqueline P.; Collins, Natalie N.; English, Paul B.; Kaye, Wendy E.			Survival and Cause of Death among a Cohort of Confirmed Amyotrophic Lateral Sclerosis Cases	PLOS ONE			English	Article							UNITED-STATES; PROGNOSTIC-FACTORS; ALS; MORTALITY; CERTIFICATES; DIAGNOSIS; ACCURACY; CRITERIA	Introduction Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder. Estimates of survival from disease onset range from 20 to 48 months and have been generated using clinical populations or death records alone. Methods Data on a cohort of ALS cases diagnosed between 2009-2011 were collected as part of the Los Angeles and San Francisco Bay Area Metropolitan ALS Surveillance projects; death records 2009-2013 were linked to these confirmed cases to determine survival post diagnosis and factors associated with survival time. Results There were 618 cases identified and 283 of these died during the follow up time period. Median age at death was 64.3 years, and median survival time post-diagnosis was 2.6 years. Age at diagnosis and year of diagnosis were predictors of survival time in adjusted models; those diagnosed at age 80 or older had shorter survival than those diagnosed at age 50 or younger. Most (92%) had ALS noted as a cause of death. Discussion Survival post-diagnosis may be improved compared with previous reports. Age at diagnosis continues to be the strongest predictor of prognosis; recall case reporting bias may play a role in estimates of survival time.	[Paulukonis, Susan T.; Roberts, Eric M.; Valle, Jhaqueline P.; Collins, Natalie N.] Inst Publ Hlth, Calif Environm Hlth Tracking Program, Richmond, CA 94804 USA; [English, Paul B.] Calif Dept Publ Hlth, Calif Environm Hlth Tracking Program, Richmond, CA USA; [Kaye, Wendy E.] McKing Consulting Corp, Atlanta, GA USA	Public Health Institute; California Department of Public Health	Paulukonis, ST (corresponding author), Inst Publ Hlth, Calif Environm Hlth Tracking Program, Richmond, CA 94804 USA.	susan.paulukonis@phi.org	English, Paul/GQB-1018-2022; Paulukonis, Susan/AAH-7635-2021		McKing Consulting Corporation - federal Agency for Toxic Substances and Disease Registry [200-2010-F-36614]; McKing Consulting Corporation	McKing Consulting Corporation - federal Agency for Toxic Substances and Disease Registry; McKing Consulting Corporation	This project was funded by McKing Consulting Corporation through a contract funded by the federal Agency for Toxic Substances and Disease Registry (Contract #200-2010-F-36614). Co-author WK is employed by McKing Consulting Corporation. McKing Consulting Corporation provided support in the form of salary for author WK, and oversaw study design and data collection, but did not have any additional role in and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.	Akaike H, 1999, PRACTICE TIME SERIES; [Anonymous], 2013, 12 ANN NE ALS CONS M; Antao VC, 2012, J ENVIRON HEALTH, V75, P28; Brooks BR, 2000, AMYOTROPH LATERAL SC, V1, P293, DOI 10.1080/146608200300079536; Byrne S, 2011, J NEUROL NEUROSUR PS, V82, P623, DOI 10.1136/jnnp.2010.224501; CDC, 1998, AM J FOREN MED PATH, V19, P234; CHIO A, 1992, J EPIDEMIOL COMMUN H, V46, P517, DOI 10.1136/jech.46.5.517; Chio A, 2009, AMYOTROPH LATERAL SC, V10, P310, DOI 10.3109/17482960802566824; Conde Crystal, 2012, Tex Med, V108, P45; del Aguila MA, 2003, NEUROLOGY, V60, P813, DOI 10.1212/01.WNL.0000049472.47709.3B; Elamin M, 2011, NEUROLOGY, V76, P1263, DOI 10.1212/WNL.0b013e318214359f; Forbes RB, 2004, AGE AGEING, V33, P131, DOI 10.1093/ageing/afh013; Gordon PH, 2012, J NEUROL, V259, P1788, DOI 10.1007/s00415-011-6403-4; Hanzlick R, 1995, Leg Med, P117; Hirtz D, 2007, NEUROLOGY, V68, P326, DOI 10.1212/01.wnl.0000252807.38124.a3; Hoffman P M, 1970, Trans Am Neurol Assoc, V95, P261; Hoyert DL, 2005, PUBLIC HEALTH REP, V120, P288, DOI 10.1177/003335490512000312; Kurian KM, 2009, J NEUROL NEUROSUR PS, V80, P84, DOI 10.1136/jnnp.2008.149708; LEE JRJ, 1995, J NEUROL SCI, V132, P207, DOI 10.1016/0022-510X(95)00154-T; Marin B, 2011, NEUROEPIDEMIOLOGY, V36, P29, DOI 10.1159/000321930; Mehal JM, 2013, AMYOTROPH LAT SCL FR, V14, P346, DOI 10.3109/21678421.2013.787629; Noonan CW, 2005, NEUROLOGY, V64, P1215, DOI 10.1212/01.WNL.0000156518.22559.7F; Phukan J, 2012, J NEUROL NEUROSUR PS, V83, P102, DOI 10.1136/jnnp-2011-300188; Ragonese P, 2004, NEUROEPIDEMIOLOGY, V23, P73, DOI 10.1159/000073978; Sejvar JJ, 2005, NEUROEPIDEMIOLOGY, V25, P144, DOI 10.1159/000086679; Sorenson EJ, 2007, NEUROLOGY, V68, P600, DOI 10.1212/01.wnl.0000254501.58158.e7; Testa D, 2004, AMYOTROPH LATERAL SC, V5, P208, DOI 10.1080/14660820410021311; Traynor BJ, 2003, J NEUROL NEUROSUR PS, V74, P1258, DOI 10.1136/jnnp.74.9.1258; Valle J, 2015, AMYOTROPHIC LATERAL, P1; Wexelman BA, 2013, PREV CHRONIC DIS, V10, DOI 10.5888/pcd10.120288; Zoccolella S, 2008, J NEUROL NEUROSUR PS, V79, P33, DOI 10.1136/jnnp.2007.118018	31	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0131965	10.1371/journal.pone.0131965	http://dx.doi.org/10.1371/journal.pone.0131965			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26172548	gold, Green Submitted, Green Published			2022-12-26	WOS:000358194900026
J	Polo, J; Rodriguez, C; Rodenas, J; Russell, LE; Campbell, JM; Crenshaw, JD; Torrallardona, D; Pujols, J				Polo, Javier; Rodriguez, Carmen; Rodenas, Jesus; Russell, Louis E.; Campbell, Joy M.; Crenshaw, Joe D.; Torrallardona, David; Pujols, Joan			Ultraviolet Light (UV) Inactivation of Porcine Parvovirus in Liquid Plasma and Effect of UV Irradiated Spray Dried Porcine Plasma on Performance of Weaned Pigs	PLOS ONE			English	Article							RESPIRATORY SYNDROME; CIRCOVIRUS TYPE-2; DIARRHEA VIRUS; ANIMAL PLASMA; WEANLING PIGS; RADIATION; BACTERIA; PSEUDORABIES; EFFICACY	A novel ultraviolet light irradiation (UV-C, 254 nm) process was designed as an additional safety feature for manufacturing of spray dried porcine plasma (SDPP). In Exp. 1, three 10-L batches of bovine plasma were inoculated with 10(5.2 +/- 0.12) tissue culture infectious dose 50 (TCID50) of porcine parvovirus (PPV) per mL of plasma and subjected to UV-C ranging from 0 to 9180 J/L. No viable PPV was detected in bovine plasma by micro-titer assay in SK6 cell culture after UV-C at 2295 J/L. In Exp. 2, porcine plasma was subjected to UV-C (3672 J/L), then spray dried and mixed in complete mash diets. Diets were a control without SDPP (Control), UV-C SDPP either at 3% (UVSDPP3) or 6% (UVSDPP6) and non-UV-C SDPP at 3% (SDPP3) or 6% (SDPP6). Diets were fed ad libitum to 320 weaned pigs (26 d of age; 16 pens/diet; 4 pigs/pen) for 14 d after weaning and a common diet was fed d 15 to 28. During d 0 to 14, pigs fed UVSDPP3, UVSDPP6, or SDPP6 had higher (P < 0.05) weight gain and feed intake than control. During d 0 to 28, pigs fed UVSDPP3 and UVSDPP6 had higher (P < 0.05) weight gain and feed intake than control and SDPP3, and SDPP6 had higher (P < 0.05) feed intake than control. Also, pigs fed UVSDPP had higher (P < 0.05) weight gain than pigs fed SDPP. In conclusion, UV-C inactivated PPV in liquid plasma and UVSDPP used in pig feed had no detrimental effects on pig performance.	[Polo, Javier; Rodriguez, Carmen; Rodenas, Jesus] APC EUROPE, E-08403 Granollers, Spain; [Russell, Louis E.; Campbell, Joy M.; Crenshaw, Joe D.] APC Inc, Ankeny, IA 50021 USA; [Torrallardona, David] Inst Recerca & Tecnol Agroalimentaries, Monogastr Nutr, Mas de Bover, Constanti, Spain; [Pujols, Joan] Inst Recerca & Tecnol Agroalimentaries, Ctr Recerca Sanitat Anim CReSA, Barcelona 08193, Spain	IRTA; IRTA	Polo, J (corresponding author), APC EUROPE, SA Avda St Julia 246-258 Pol Ind El Congost, E-08403 Granollers, Spain.	javier.polo@ampc-europe.com	Torrallardona, David/L-3604-2017; Pujols, Joan/S-1141-2018; Pujols, Joan/K-9693-2015; Pujols, Joan/AAV-6427-2020	Torrallardona, David/0000-0001-7814-2939; Pujols, Joan/0000-0002-6940-1529; Pujols, Joan/0000-0002-6940-1529	APC, Inc., Ankeny, Iowa, United States of America; Spanish Government [IDI-20080591, IDI-20101014]; APC EUROPE; APC Inc.	APC, Inc., Ankeny, Iowa, United States of America; Spanish Government(Spanish GovernmentEuropean Commission); APC EUROPE; APC Inc.	Funding for this study was provided in part by APC, Inc., Ankeny, Iowa, United States of America. This study was also partially financed by the programs CDTI (IDI-20080591 and IDI-20101014) of the Spanish Government. APC EUROPE and APC Inc., provided support in the form of salaries for authors JP, CR, JR, LER, JMC and JDC retrospectively, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Burleson FG, 1997, VIROLOGY LAB MANUAL, P53; Caillet-Fauquet P, 2004, J VIROL METHODS, V118, P131, DOI 10.1016/j.jviromet.2004.02.002; Caruso C, 2014, J VIROL METHODS, V208, P79, DOI 10.1016/j.jviromet.2014.07.032; Coffey R. D., 2001, Pig News and Information, V22, p39N; CPMP, 1996, CPMPBWP26895 EUR AG; Darnell MER, 2004, J VIROL METHODS, V121, P85, DOI 10.1016/j.jviromet.2004.06.006; Dee S, 2011, VET MICROBIOL, V150, P96, DOI 10.1016/j.vetmic.2011.01.014; DeRouchey JM, 2004, J ANIM SCI, V82, P250; DeRouchey JM, 2003, J ANIM SCI, V81, P1799; Donaghy J, 2009, LETT APPL MICROBIOL, V49, P217, DOI 10.1111/j.1472-765X.2009.02644.x; Fredericks IN, 2011, FOOD MICROBIOL, V28, P510, DOI 10.1016/j.fm.2010.10.018; Groesbeck CN, 2009, J ANIM SCI, V87, P3997, DOI 10.2527/jas.2008-1156; Hijnen WAM, 2006, WATER RES, V40, P3, DOI 10.1016/j.watres.2005.10.030; Keyser M, 2008, INNOV FOOD SCI EMERG, V9, P348, DOI 10.1016/j.ifset.2007.09.002; Koutchma TN, 2009, CONTEMP FOOD ENG, P1; Mancini G., 1965, J IMMUNOCHEM, V2, P235; Matak KE, 2005, J FOOD PROTECT, V68, P2212, DOI 10.4315/0362-028X-68.10.2212; Opriessnig T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104766; Polo J, 2005, J ANIM SCI, V83, P1933; Polo J, 2004, J AOAC INT, V87, P78; Polo J, 2002, P 48 INT C MEAT SCI, V1, P194; Pujols J, 2008, VET REC, V163, P536, DOI 10.1136/vr.163.18.536; Pujols J., 2007, AM ASS SWINE VET, P281; Pujols J, 2011, VET J, V190, P16; Pujols J, 2014, VET MICROBIOL, V174, P427, DOI 10.1016/j.vetmic.2014.10.021; Remington KM, 2013, BIORESEARCH ON LINE; Royer RL, 2001, J SWINE HEALTH PROD, V9, P281; Schoborg RV, 2014, FRONT CELL INFECT MI, V4, DOI [10.3389/fcimb.2014.00097, 10.3389/fcimb.2014.00020]; Shen HG, 2011, J ANIM SCI, V89, P1930, DOI 10.2527/jas.2010-3502; Torrallardona D, 2010, ASIAN AUSTRAL J ANIM, V23, P131; Unluturk S, 2008, J FOOD ENG, V85, P561, DOI 10.1016/j.jfoodeng.2007.08.017; Wang J, 2004, VOX SANG, V86, P230, DOI 10.1111/j.0042-9007.2004.00485.x; Wyk R, 2011, IUVA NEWS, V13, P13	33	10	10	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0133008	10.1371/journal.pone.0133008	http://dx.doi.org/10.1371/journal.pone.0133008			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26171968	Green Submitted, gold, Green Published			2022-12-26	WOS:000358194900116
J	Akhtar, S; Al-Zaid, B; El-Hashim, AZ; Chandrasekhar, B; Attur, S; Yousif, MHM; Benter, IF				Akhtar, Saghir; Al-Zaid, Bashayer; El-Hashim, Ahmed Z.; Chandrasekhar, Bindu; Attur, Sreeja; Yousif, Mariam H. M.; Benter, Ibrahim F.			Cationic Polyamidoamine Dendrimers as Modulators of EGFR Signaling In Vitro and In Vivo	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; DRUG-DELIVERY SYSTEMS; PAMAM DENDRIMERS; GENE-EXPRESSION; POLY(AMIDOAMINE) DENDRIMERS; DIABETIC-NEPHROPATHY; TOXICOGENOMICS; MECHANISMS; POLYMERS; TRANSACTIVATION	Cationic polyamidoamine (PAMAM) dendrimers are branch-like spherical polymers being investigated for a variety of applications in nanomedicine including nucleic acid drug delivery. Emerging evidence suggests they exhibit intrinsic biological and toxicological effects but little is known of their interactions with signal transduction pathways. We previously showed that the activated (fragmented) generation (G) 6 PAMAM dendrimer, Superfect (SF), stimulated epidermal growth factor receptor (EGFR) tyrosine kinase signaling-an important signaling cascade that regulates cell growth, survival and apoptosis-in cultured human embryonic kidney (HEK 293) cells. Here, we firstly studied the in vitro effects of Polyfect (PF), a non-activated (intact) G6 PAMAM dendrimer, on EGFR tyrosine kinase signaling via extracellular-regulated kinase 1/2 (ERK1/2) and p38 mitogen-activated protein kinase (MAPK) in cultured HEK 293 cells and then compared the in vivo effects of a single administration (10mg/kg i.p) of PF or SF on EGFR signaling in the kidneys of normal and diabetic male Wistar rats. Polyfect exhibited a dose- and time-dependent inhibition of EGFR, ERK1/2 and p38 MAPK phosphorylation in HEK-293 cells similar to AG1478, a selective EGFR inhibitor. Administration of dendrimers to non-diabetic or diabetic animals for 24h showed that PF inhibited whereas SF stimulated EGFR phosphorylation in the kidneys of both sets of animals. PF-mediated inhibition of EGFR phosphorylation as well as SF or PF-mediated apoptosis in HEK 293 cells could be significantly reversed by co-treatment with antioxidants such as tempol implying that both these effects involved an oxidative stress-dependent mechanism. These results show for the first time that SF and PF PAMAM dendrimers can differentially modulate the important EGFR signal transduction pathway in vivo and may represent a novel class of EGFR modulators. These findings could have important clinical implications for the use of PAMAM dendrimers in nanomedicine.	[Akhtar, Saghir; Al-Zaid, Bashayer; Chandrasekhar, Bindu; Attur, Sreeja; Yousif, Mariam H. M.; Benter, Ibrahim F.] Kuwait Univ, Fac Med, Dept Pharmacol & Toxicol, Safat 13110, Jabriya, Kuwait; [El-Hashim, Ahmed Z.] Kuwait Univ, Fac Pharm, Dept Pharmacol & Therapeut, Safat 13110, Jabriya, Kuwait; [Benter, Ibrahim F.] Eastern Mediterranean Univ, Fac Med, Gazimagusa, North Cyprus, Cyprus	Kuwait University; Kuwait University; Eastern Mediterranean University	Akhtar, S (corresponding author), Kuwait Univ, Fac Med, Dept Pharmacol & Toxicol, Safat 13110, Jabriya, Kuwait.	Saghir@hsc.edu.kw	Benter, Ibrahim Fadil/AAY-2527-2020	Akhtar, Saghir/0000-0003-3177-946X; Yousif, Mariam/0000-0002-6464-031X	Research Administration/Sector at Kuwait University [MR01/13]; OMICS Research Unit/RCF; General Facility Grant [SRUL02/13]	Research Administration/Sector at Kuwait University; OMICS Research Unit/RCF; General Facility Grant	This research is funded by a grant from the Research Administration/Sector at Kuwait University (MR01/13). The authors also acknowledge support from the OMICS Research Unit/RCF and the General Facility Grant (SRUL02/13).	Advani A, 2011, NEPHROLOGY, V16, P573, DOI 10.1111/j.1440-1797.2011.01451.x; Akhtar S, 2006, GENE THER, V13, P739, DOI 10.1038/sj.gt.3302692; Akhtar S, 2007, J CLIN INVEST, V117, P3623, DOI 10.1172/JCI33494; Akhtar S, 2007, ADV DRUG DELIVER REV, V59, P164, DOI 10.1016/j.addr.2007.03.010; Akhtar S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067813; Akhtar S, 2013, INT J PHARMACEUT, V448, P239, DOI 10.1016/j.ijpharm.2013.03.039; Akhtar S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039066; Akhtar S, 2012, BRIT J PHARMACOL, V165, P1390, DOI 10.1111/j.1476-5381.2011.01613.x; Akhtar S, 2010, EXPERT OPIN DRUG MET, V6, P1347, DOI 10.1517/17425255.2010.518611; Alaoui-Jamali M, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00017; Albertazzi L, 2010, MOL PHARMACEUT, V7, P680, DOI 10.1021/mp9002464; Arkhipov A, 2013, CELL, V152, P557, DOI 10.1016/j.cell.2012.12.030; Avaritt BR, 2014, PHARM RES-DORDR, V31, P2429, DOI 10.1007/s11095-014-1338-y; Benter IF, 2009, VASC PHARMACOL, V51, P101, DOI 10.1016/j.vph.2009.04.004; Benter IF, 2005, BRIT J PHARMACOL, V145, P829, DOI 10.1038/sj.bjp.0706238; Chauhan AS, 2009, BIOMACROMOLECULES, V10, P1195, DOI 10.1021/bm9000298; Conti DS, 2014, MOL PHARMACEUT, V11, P1808, DOI 10.1021/mp4006358; Cui J, 2014, TUMOR BIOL, V35, P11701, DOI 10.1007/s13277-014-2660-z; Dhomen Nathalie S., 2012, Critical Reviews in Oncogenesis, V17, P31; Duncan R, 2005, ADV DRUG DELIVER REV, V57, P2215, DOI 10.1016/j.addr.2005.09.019; Duran-Lara E, 2013, EUR J MED CHEM, V69, P601, DOI 10.1016/j.ejmech.2013.08.047; Endres NF, 2014, TRENDS BIOCHEM SCI, V39, P437, DOI 10.1016/j.tibs.2014.08.001; Forstner P, 2014, BIOMACROMOLECULES, V15, P2461, DOI 10.1021/bm500328v; Francois H, 2004, FASEB J, V18, P926, DOI 10.1096/fj.03-0702fje; Han JY, 2012, THER DELIV, V3, P263, DOI 10.4155/TDE.11.151; Hollins AJ, 2007, J DRUG TARGET, V15, P83, DOI 10.1080/10611860601151860; Hong SP, 2006, BIOCONJUGATE CHEM, V17, P728, DOI 10.1021/bc060077y; Jain S, 2012, P NATL ACAD SCI USA, V109, P12938, DOI 10.1073/pnas.1204928109; Jones CF, 2012, MOL PHARMACEUT, V9, P1599, DOI 10.1021/mp2006054; Juliano RL, 2013, J DRUG TARGET, V21, P27, DOI 10.3109/1061186X.2012.740674; Kabanov AV, 2006, ADV DRUG DELIVER REV, V58, P1597, DOI 10.1016/j.addr.2006.09.019; Kanwar YS, 2008, EXP BIOL MED, V233, P4, DOI 10.3181/0705-MR-134; Kovacs E, 2015, ANNU REV BIOCHEM, V84, P739, DOI 10.1146/annurev-biochem-060614-034402; Kuo JHS, 2010, MOL PHARMACEUT, V7, P805, DOI 10.1021/mp900303s; Labieniec M, 2010, BIOCHIMIE, V92, P1296, DOI 10.1016/j.biochi.2010.06.002; Labieniec Magdalena, 2008, Int J Pharm, V364, P142, DOI 10.1016/j.ijpharm.2008.08.001; Labieniec-Watala M, 2015, J PHARM SCI-US, V104, P2, DOI 10.1002/jps.24222; Labieniec-Watala M, 2014, INT J PHARMACEUT, V464, P152, DOI 10.1016/j.ijpharm.2014.01.011; Lee JH, 2009, TOXICOL LETT, V190, P202, DOI 10.1016/j.toxlet.2009.07.018; Lemmon MA, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a020768; Li Y, 2014, NANOTOXICOLOGY, V8, P36, DOI 10.3109/17435390.2013.855827; Lill NL, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003341; Luo K, 2014, BIOTECHNOL ADV, V32, P818, DOI 10.1016/j.biotechadv.2013.12.008; Movassaghian S, 2011, J DRUG TARGET, V19, P925, DOI 10.3109/1061186X.2011.628396; Mukherjee SP, 2010, TOXICOL APPL PHARM, V248, P259, DOI 10.1016/j.taap.2010.08.016; Mukherjee SP, 2010, TOXICOL IN VITRO, V24, P169, DOI 10.1016/j.tiv.2009.09.014; Naha PC, 2010, TOXICOL APPL PHARM, V246, P91, DOI 10.1016/j.taap.2010.04.014; Nyitrai G, 2013, BBA-BIOMEMBRANES, V1828, P1873, DOI 10.1016/j.bbamem.2013.04.004; Omerovic J, 2012, J PROTEOME RES, V11, P5157, DOI 10.1021/pr3007304; Omidi Y, 2003, J DRUG TARGET, V11, P311, DOI 10.1080/10611860310001636908; Pettit MW, 2011, THER DELIV, V2, P907, DOI 10.4155/TDE.11.55; Price KAR, 2015, ORAL ONCOL, V51, P399, DOI 10.1016/j.oraloncology.2015.01.018; Roskoski R, 2014, PHARMACOL RES, V79, P34, DOI 10.1016/j.phrs.2013.11.002; Sadekar S, 2012, ADV DRUG DELIVER REV, V64, P571, DOI 10.1016/j.addr.2011.09.010; Sadekar S, 2011, BIOMACROMOLECULES, V12, P88, DOI 10.1021/bm101046d; Seib FP, 2007, J CONTROL RELEASE, V117, P291, DOI 10.1016/j.jconrel.2006.10.020; Shakhbazau A, 2010, INT J PHARMACEUT, V383, P228, DOI 10.1016/j.ijpharm.2009.09.020; Shcharbin D, 2014, J CONTROL RELEASE, V181, P40, DOI 10.1016/j.jconrel.2014.02.021; Shcharbin D, 2013, EXPERT OPIN DRUG DEL, V10, P1687, DOI 10.1517/17425247.2013.853661; Siddiqui S, 2012, INT J ENDOCRINOL, V2012, DOI 10.1155/2012/739428; Sun Y, 2015, PART FIBRE TOXICOL, V12, DOI 10.1186/s12989-015-0080-x; Sur S, 2014, CURR VASC PHARMACOL, V12, P190, DOI 10.2174/1570161112666140226123745; Tang MX, 1997, GENE THER, V4, P823, DOI 10.1038/sj.gt.3300454; Tang MX, 1996, BIOCONJUGATE CHEM, V7, P703, DOI 10.1021/bc9600630; Tang Y, 2015, BIOMACROMOLECULES, V16, P174, DOI 10.1021/bm501390d; Tomalia DA, 2007, BIOCHEM SOC T, V35, P61, DOI 10.1042/BST0350061; Wilcox CS, 2010, PHARMACOL THERAPEUT, V126, P119, DOI 10.1016/j.pharmthera.2010.01.003; Zhang MZ, 2014, DIABETES, V63, P2063, DOI 10.2337/db13-1279; Zhang Y, 2012, PHARM RES-DORDR, V29, P1627, DOI 10.1007/s11095-012-0676-x	69	18	18	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0132215	10.1371/journal.pone.0132215	http://dx.doi.org/10.1371/journal.pone.0132215			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26167903	gold, Green Published, Green Submitted			2022-12-26	WOS:000358193100028
J	Haarindraprasad, R; Hashim, U; Gopinath, SCB; Kashif, M; Veeradasan, P; Balakrishnan, SR; Foo, KL; Poopalan, P				Haarindraprasad, R.; Hashim, U.; Gopinath, Subash C. B.; Kashif, Mohd; Veeradasan, P.; Balakrishnan, S. R.; Foo, K. L.; Poopalan, P.			Low Temperature Annealed Zinc Oxide Nanostructured Thin Film-Based Transducers: Characterization for Sensing Applications	PLOS ONE			English	Article							SOL-GEL METHOD; SEED LAYER THICKNESS; OPTICAL-PROPERTIES; ZNO NANOSTRUCTURES; REFRACTIVE-INDEX; BULK MODULUS; PHOTOLUMINESCENCE PROPERTIES; INTERATOMIC SEPARATION; PRESSURE-DEPENDENCE; THERMAL-EXPANSION	The performance of sensing surfaces highly relies on nanostructures to enhance their sensitivity and specificity. Herein, nanostructured zinc oxide (ZnO) thin films of various thicknesses were coated on glass and p-type silicon substrates using a sol-gel spin-coating technique. The deposited films were characterized for morphological, structural, and optoelectronic properties by high-resolution measurements. X-ray diffraction analyses revealed that the deposited films have a c-axis orientation and display peaks that refer to ZnO, which exhibits a hexagonal structure with a preferable plane orientation (002). The thicknesses of ZnO thin films prepared using 1, 3, 5, and 7 cycles were measured to be 40, 60, 100, and 200 nm, respectively. The increment in grain size of the thin film from 21 to 52 nm was noticed, when its thickness was increased from 40 to 200 nm, whereas the band gap value decreased from 3.282 to 3.268 eV. Band gap value of ZnO thin film with thickness of 200 nm at pH ranging from 2 to 10 reduces from 3.263eV to 3.200 eV. Furthermore, to evaluate the transducing capacity of the ZnO nanostructure, the refractive index, optoelectric constant, and bulk modulus were analyzed and correlated. The highest thickness (200 nm) of ZnO film, embedded with an interdigitated electrode that behaves as a pH-sensing electrode, could sense pH variations in the range of 2-10. It showed a highly sensitive response of 444 mu AmM-1cm-2 with a linear regression of R-2 = 0.9304. The measured sensitivity of the developed device for pH per unit is 3.72 mu A/pH.	[Haarindraprasad, R.; Hashim, U.; Gopinath, Subash C. B.; Kashif, Mohd; Veeradasan, P.; Balakrishnan, S. R.; Foo, K. L.] Inst Nano Elect Engn, Biomed Nano Diagnost Res Grp, Kangar, Perlis, Malaysia; [Gopinath, Subash C. B.] Univ Malaysia Perlis, Sch Bioproc Engn, Kangar, Perlis, Malaysia; [Poopalan, P.] Univ Malaysia Perlis, Sch Microelect Engn, Kuala Perlis, Perlis, Malaysia	Universiti Malaysia Perlis; Universiti Malaysia Perlis	Hashim, U (corresponding author), Inst Nano Elect Engn, Biomed Nano Diagnost Res Grp, Kangar, Perlis, Malaysia.	uda@unimap.edu.my	Foo, Kai Loong/D-2035-2015; Gopinath, Subash/D-2953-2015; Kashif, Muhammad/AAX-8659-2020; Balakrishnan, Sharma Rao/G-4561-2015; Balakrishnan, Sharma Rao/AAP-2889-2021	Foo, Kai Loong/0000-0001-6009-860X; Gopinath, Subash/0000-0002-8347-4687; Kashif, Muhammad/0000-0002-9874-0992; Balakrishnan, Sharma Rao/0000-0002-6796-2277; Balakrishnan, Sharma Rao/0000-0002-6796-2277; Perumal, Veeradasan/0000-0003-4492-0282; POOPALAN, PRABAKARAN/0000-0003-1698-0632	Universiti Malaysia Perlis (UniMAP); Ministry of Higher Education Malaysia through MTUN-COE grant [9016-00004]	Universiti Malaysia Perlis (UniMAP); Ministry of Higher Education Malaysia through MTUN-COE grant	The authors would like to thank Universiti Malaysia Perlis (UniMAP), and Ministry of Higher Education Malaysia for the financial support through MTUN-COE grant 9016-00004 to conduct the research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Douri Y, 2004, MATER CHEM PHYS, V87, P14, DOI 10.1016/j.matchemphys.2003.11.043; Al-Douri Y, 2010, SOL ENERGY, V84, P1979, DOI 10.1016/j.solener.2010.10.006; Al-Douri Y, 2008, SOLID STATE COMMUN, V148, P521, DOI 10.1016/j.ssc.2008.09.055; Ali SMU, 2011, MICRO NANO LETT, V6, P609, DOI 10.1049/mnl.2011.0310; Ba-Abbad MM, 2013, J IND ENG CHEM, V19, P99, DOI 10.1016/j.jiec.2012.07.010; Balakrishnan SR, 2014, SENSOR ACTUAT A-PHYS, V220, P101, DOI 10.1016/j.sna.2014.09.027; Balzaretti NM, 1996, SOLID STATE COMMUN, V99, P943, DOI 10.1016/0038-1098(96)00341-9; Batista PD, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2084319; Boudjouan F, 2015, J LUMIN, V158, P32, DOI 10.1016/j.jlumin.2014.09.026; Caglar Y, 2010, J SOL-GEL SCI TECHN, V53, P372, DOI 10.1007/s10971-009-2105-0; Charifi Z, 2007, PHYS STATUS SOLIDI B, V244, P3154, DOI 10.1002/pssb.200642471; Chen Y, 2012, J PHYS CHEM SOLIDS, V73, P1259, DOI 10.1016/j.jpcs.2012.06.007; COHEN ML, 1985, PHYS REV B, V32, P7988, DOI 10.1103/PhysRevB.32.7988; Degen A, 2000, J EUR CERAM SOC, V20, P667, DOI 10.1016/S0955-2219(99)00203-4; Fabbri F, 2014, SCI REP-UK, V4, DOI 10.1038/srep05158; Foo KL, 2014, CERAM INT, V40, P753, DOI 10.1016/j.ceramint.2013.06.065; Gedamu D, 2014, ADV MATER, V26, P1541, DOI 10.1002/adma.201304363; Ghayour H, 2011, VACUUM, V86, P101, DOI 10.1016/j.vacuum.2011.04.025; GHOSH DK, 1986, INFRARED PHYS, V26, P111, DOI 10.1016/0020-0891(86)90031-X; Godlewski M, 2009, THIN SOLID FILMS, V518, P1145, DOI 10.1016/j.tsf.2009.04.066; GUPTA VP, 1980, PHYS STATUS SOLIDI B, V100, P715, DOI 10.1002/pssb.2221000240; Hassan NK, 2012, INT J ELECTROCHEM SC, V7, P4625; He A, 2001, PHYS STATUS SOLIDI B, V223, P767, DOI 10.1002/1521-3951(200102)223:3<767::AID-PSSB767>3.0.CO;2-X; HERVE P, 1994, INFRARED PHYS TECHN, V35, P609, DOI 10.1016/1350-4495(94)90026-4; HERVE PJL, 1995, J APPL PHYS, V77, P5476, DOI 10.1063/1.359248; Hilt JZ, 2003, BIOMED MICRODEVICES, V5, P177, DOI 10.1023/A:1025786023595; Hrkac V, 2013, J APPL CRYSTALLOGR, V46, P396, DOI 10.1107/S0021889812051333; Ikizler B, 2014, THIN SOLID FILMS, V558, P149, DOI 10.1016/j.tsf.2014.03.019; Jaiswal AK, 2015, MATER CHEM PHYS, V154, P16, DOI 10.1016/j.matchemphys.2015.01.031; Janotti A, 2009, REP PROG PHYS, V72, DOI 10.1088/0034-4885/72/12/126501; Jin X, 2013, ADV MATER, V25, P1342, DOI 10.1002/adma.201203849; Kao CH, 2014, J APPL PHYS, V115, DOI 10.1063/1.4874182; Kashif M, 2012, MICRO NANO LETT, V7, P163, DOI 10.1049/mnl.2011.0681; Kashif M, 2012, PHYS STATUS SOLIDI A, V209, P143, DOI 10.1002/pssa.201127357; KUMAR M, 1995, PHYSICA B, V205, P175, DOI 10.1016/0921-4526(94)00292-4; KUMAR M, 1994, PHYS STATUS SOLIDI B, V181, P55, DOI 10.1002/pssb.2221810106; LAM PK, 1987, PHYS REV B, V35, P9190, DOI 10.1103/PhysRevB.35.9190; Lee CT, 2014, IEEE SENS J, V14, P490, DOI 10.1109/JSEN.2013.2285488; Liu YC, 2008, J PHYS CHEM B, V112, P6484, DOI 10.1021/jp710399d; Maiolo L, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4894805; Mishra YK, 2014, KONA POWDER PART J, P92; Mishra YK, 2011, ANTIVIR RES, V92, P305, DOI 10.1016/j.antiviral.2011.08.017; MOSS TS, 1950, P PHYS SOC LOND B, V63, P167, DOI 10.1088/0370-1301/63/3/302; Pandey RK, 1998, J PHYS CHEM SOLIDS, V59, P1157, DOI 10.1016/S0022-3697(97)00164-9; PENN DR, 1962, PHYS REV, V128, P2093, DOI 10.1103/PhysRev.128.2093; Perumal V., 2013, APPL BIOMED, V11, P1, DOI DOI 10.1016/J.JAB.2013.02.001; Phillips J, 2012, BONDS BANDS SEMICOND; Rani S, 2008, SOL ENERG MAT SOL C, V92, P1639, DOI 10.1016/j.solmat.2008.07.015; RAVINDRA NM, 1979, PHYS STATUS SOLIDI B, V93, pK155, DOI 10.1002/pssb.2220930257; Rouhi J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123433; SAMARA GA, 1983, PHYS REV B, V27, P3494, DOI 10.1103/PhysRevB.27.3494; SHERRY AM, 1991, J PHYS CHEM SOLIDS, V52, P1145, DOI 10.1016/0022-3697(91)90047-4; Singh A, 2014, MAT SCI SEMICON PROC, V27, P934, DOI 10.1016/j.mssp.2014.08.029; Singh A, 2015, J ALLOY COMPD, V618, P475, DOI 10.1016/j.jallcom.2014.08.190; Singh S, 2014, MATER LETT, V131, P31, DOI 10.1016/j.matlet.2014.05.167; Sivakumar K, 2012, B MATER SCI, V35, P327, DOI 10.1007/s12034-012-0305-7; Tak M, 2014, BIOSENS BIOELECTRON, V59, P200, DOI 10.1016/j.bios.2014.03.036; TALLON JL, 1980, J PHYS CHEM SOLIDS, V41, P837, DOI 10.1016/0022-3697(80)90028-1; Tcheliebou F, 1997, THIN SOLID FILMS, V299, P14, DOI 10.1016/S0040-6090(96)09187-0; Thandavan TMK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121756; VANVECHTEN JA, 1969, PHYS REV, V182, P891, DOI 10.1103/PhysRev.182.891; Wang KXZ, 2014, ENERG ENVIRON SCI, V7, P2725, DOI 10.1039/c4ee00839a; Wang MR, 2006, MATER CHEM PHYS, V97, P219, DOI 10.1016/j.matchemphys.2005.07.072; Westermeier C, 2013, ADV MATER, V25, P5719, DOI 10.1002/adma.201300958; Willander M, 2009, METHODS MOL BIOL, V544, P187, DOI 10.1007/978-1-59745-483-4_13; Xu D, 2012, T NONFERR METAL SOC, V22, pS110, DOI 10.1016/S1003-6326(12)61693-8; Xu LH, 2014, J ALLOY COMPD, V583, P560, DOI 10.1016/j.jallcom.2013.09.009; Xu LH, 2012, APPL SURF SCI, V258, P7760, DOI 10.1016/j.apsusc.2012.04.137; Xu LH, 2011, APPL SURF SCI, V257, P4031, DOI 10.1016/j.apsusc.2010.11.170; Xu LH, 2010, J CRYST GROWTH, V312, P851, DOI 10.1016/j.jcrysgro.2009.12.062; Yang HY, 2010, APPL SURF SCI, V256, P6117, DOI 10.1016/j.apsusc.2010.03.129; Yoshino Y, 2000, VACUUM, V59, P403, DOI 10.1016/S0042-207X(00)00294-3; Zeng HB, 2008, ACS NANO, V2, P1661, DOI 10.1021/nn800353q; Zeng HB, 2008, J PHYS CHEM C, V112, P19620, DOI 10.1021/jp807309s; Zhong AH, 2011, APPL SURF SCI, V257, P4051, DOI 10.1016/j.apsusc.2010.11.173; Zhu YZ, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.245209	76	46	46	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0132755	10.1371/journal.pone.0132755	http://dx.doi.org/10.1371/journal.pone.0132755			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26167853	Green Published, gold, Green Submitted			2022-12-26	WOS:000358193100075
J	Li, M; Song, QB; Li, H; Lou, Y; Wang, LL				Li, Min; Song, Qinbin; Li, Hang; Lou, Yi; Wang, Lili			Circulating miR-25-3p and miR-451a May Be Potential Biomarkers for the Diagnosis of Papillary Thyroid Carcinoma	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION; MICRORNA PROFILES; MOLECULAR MARKERS; PROGNOSTIC-FACTOR; TUMOR-SUPPRESSOR; UP-REGULATION; CANCER; SERUM; TISSUE	Objective There is no effective and reliable biomarker to distinguish benign thyroid nodules from papillary thyroid carcinomas (PTC). This study aimed at examining the levels of plasma miRNAs in patients with PTC or benign nodules to explore the potential miRNA biomarkers for PTC. Patients and Methods Genome-wide plasma miRNA expression profiles were determined by the miRNA Microarray and the significantly higher levels of miRNAs were validated in plasma and tissues by quantitative RT-PCR. The levels of two miRNAs were further tested in seven patients before and after tumor excision and the potential values for the diagnosis of PTC were evaluated by receiver operating characteristic curve (ROC). Results In comparison with that in the patients with benign nodules, eight significantly higher and three lower levels of plasma miRNAs were detected in the PTC patients. Further validation indicated that the levels of plasma miR-25-3p, miR-451a, miR-140-3p and let-7i were significantly higher in the PTC cases than in those with benign nodules or the healthy controls. Significantly higher levels of miR-25-3p and miR-451a were detected in the thyroid tissues from the PTC patients. The levels of plasma miR-25-3p and miR-451a in seven patients significantly decreased after tumor excision. ROC analyses revealed that the levels of plasma miR-25-3p at cut-off 1.41 and miR-451a at 1.38 had sensitivity of 92.8% and 88.9%, and specificity of 68.8% and 66.7% for distinguishing PTC from benign nodules, respectively. Conclusion Our findings suggest that the levels of plasma miR-25-3p and miR-451a may be valuable for the diagnosis of PTC.	[Li, Min] China Med Univ, Affiliated Hosp 1, Dept Endocrinol, Shenyang 110001, Peoples R China; [Song, Qinbin; Li, Hang] China Med Univ, Affiliated Hosp 1, Dept Thyroid Surg, Shenyang 110001, Peoples R China; [Lou, Yi] China Med Univ, Dept Genet, Shenyang 110001, Peoples R China; [Wang, Lili] China Med Univ, Shengjing Hosp, Med Res Ctr, Shenyang 110004, Peoples R China	China Medical University; China Medical University; China Medical University; China Medical University	Song, QB (corresponding author), China Med Univ, Affiliated Hosp 1, Dept Thyroid Surg, Shenyang 110001, Peoples R China.	sqb1966@163.com	wang, lili/HDL-7210-2022		Liaoning Provincial Natural Science Foundation of China [20102270, 20082077, 20082083]	Liaoning Provincial Natural Science Foundation of China	This work was supported by the Liaoning Provincial Natural Science Foundation of China (20102270, 20082077, 20082083). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldini E, 2014, INT J SURG, V12, pS52, DOI 10.1016/j.ijsu.2014.05.054; Barut F, 2010, ENDOCR PATHOL, V21, P80, DOI 10.1007/s12022-010-9114-y; Brase JC, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-306; Brenner B, 2011, WORLD J GASTROENTERO, V17, P3976, DOI 10.3748/wjg.v17.i35.3976; Cantara S, 2014, J CLIN ENDOCR METAB, V99, P4190, DOI 10.1210/jc.2014-1923; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Cooper DS, 2009, THYROID, V19, P1167, DOI 10.1089/thy.2009.0110; Esposito F, 2012, J CLIN ENDOCR METAB, V97, pE710, DOI 10.1210/jc.2011-3068; Fryknas M, 2006, TUMOR BIOL, V27, P211, DOI 10.1159/000093056; He HL, 2005, P NATL ACAD SCI USA, V102, P19075, DOI 10.1073/pnas.0509603102; Hu ZB, 2012, CARCINOGENESIS, V33, P828, DOI 10.1093/carcin/bgs030; Huang ZH, 2010, INT J CANCER, V127, P118, DOI 10.1002/ijc.25007; Konishi H, 2012, BRIT J CANCER, V106, P740, DOI 10.1038/bjc.2011.588; Lee JC, 2013, CANCER-AM CANCER SOC, V119, P4358, DOI 10.1002/cncr.28254; Li A, 2010, CANCER RES, V70, P5226, DOI 10.1158/0008-5472.CAN-09-4227; Li LM, 2010, CANCER RES, V70, P9798, DOI 10.1158/0008-5472.CAN-10-1001; Li Q, 2013, CANCER LETT, V335, P168, DOI 10.1016/j.canlet.2013.02.029; Liu R, 2011, EUR J CANCER, V47, P784, DOI 10.1016/j.ejca.2010.10.025; Luo JH, 2014, MOL MED REP, V10, P785, DOI 10.3892/mmr.2014.2274; Mehanna HM, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b733; Nan Y, 2010, BRAIN RES, V1359, P14, DOI 10.1016/j.brainres.2010.08.074; Nishida N, 2012, CLIN CANCER RES, V18, P3054, DOI 10.1158/1078-0432.CCR-11-1078; Pallante P, 2006, ENDOCR-RELAT CANCER, V13, P497, DOI 10.1677/erc.1.01209; Razumilava N, 2012, HEPATOLOGY, V55, P465, DOI 10.1002/hep.24698; Sethi Kruttibas, 2010, J Exp Ther Oncol, V8, P341; Song QB, 2011, DIAGN PATHOL, V6, DOI 10.1186/1746-1596-6-126; Tan A, 2011, ANN DIAGN PATHOL, V15, P108, DOI 10.1016/j.anndiagpath.2010.11.005; Tetzlaff MT, 2007, ENDOCR PATHOL, V18, P163, DOI 10.1007/s12022-007-0023-7; Wang X, 2014, CLIN TRANSL ONCOL, V16, P954, DOI 10.1007/s12094-014-1178-6; Wang ZH, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0577-9; Wu CY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092292; Xu FX, 2014, ASIAN PAC J CANCER P, V15, P1197, DOI 10.7314/APJCP.2014.15.3.1197; Yu S, 2012, J CLIN ENDOCR METAB, V97, P2084, DOI 10.1210/jc.2011-3059; Zhang J, 2013, INT J MED SCI, V10, P585, DOI 10.7150/ijms.5794; Zhang YJ, 2014, LIFE SCI, V118, P39, DOI 10.1016/j.lfs.2014.09.025; Zhao HY, 2014, MOL CELL BIOCHEM, V385, P207, DOI 10.1007/s11010-013-1829-x	36	45	48	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0132403	10.1371/journal.pone.0132403	http://dx.doi.org/10.1371/journal.pone.0132403			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26168287	Green Published, Green Submitted, gold			2022-12-26	WOS:000358193100041
J	Li, Y; Wu, ZY; Zhang, SL; Chen, S; Li, P; Li, J; Cao, CW; Liu, B; Zhang, FC; Li, YZ				Li, Yuan; Wu, Ziyan; Zhang, Shulan; Chen, Si; Li, Ping; Li, Jing; Cao, Chongwei; Liu, Bin; Zhang, Fengchun; Li, Yongzhe			Genetic Variants of I kappa B Kinase beta (IKBKB) and Polymerase beta (POLB) Were Not Associated with Systemic Lupus Erythematosus Risk in a Chinese Han Population	PLOS ONE			English	Article							DNA-DAMAGE; RHEUMATOID-ARTHRITIS; POLYMORPHISMS; DISEASE; REPAIR; XRCC1; SUSCEPTIBILITY; NEUTROPHILS	A previous large-scale replication study validation of a genome wide association study (GWAS) identified I kappa B kinase beta (IKBKB) single nucleotide polymorphisms (SNPs) as a risk factor associated with systemic lupus erythematosus (SLE) in a Chinese Han population. IKBKB SNPs were associated with polymerase beta (POLB) SNPs and reduced POLB expression, and this was proposed to be an underlying cause of human SLE development. In the current case-control study, we evaluated IKBKB (rs12676482 and rs2272733) and POLB (rs3136717 and rs3136744) SNPs in 946 SLE patients and 961 healthy controls. We investigated the possible association of these four SNPs with SLE in a Chinese Han population using the polymerase chain reaction-ligation detection reaction (PCR-LDR) technique. The differences in the frequencies of the four SNP alleles and the genotypes and haplotypes of the POLB polymorphisms were statistically insignificant when the SLE patients were compared with the controls in the Chinese Han population enrolled in this study (all, p > 0.05). Furthermore, no associations were detected using different genetic models (additive, dominant, and recessive; all, p > 0.05). Our findings indicate that the IKBKB (rs12676482 and rs2272733) and POLB (rs3136717, rs3136744) SNPs confer no genetic predisposition to SLE risk in this Chinese Han population.	[Li, Yuan; Liu, Bin] Qingdao Univ, Affiliated Hosp, Dept Rheumatol, Qingdao 266071, Peoples R China; [Li, Yuan; Wu, Ziyan; Zhang, Shulan; Chen, Si; Li, Ping; Li, Jing; Cao, Chongwei; Zhang, Fengchun; Li, Yongzhe] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Rheumatol & Clin Immunol, Beijing 100730, Peoples R China; [Li, Yuan; Wu, Ziyan; Zhang, Shulan; Chen, Si; Li, Ping; Li, Jing; Cao, Chongwei; Zhang, Fengchun; Li, Yongzhe] Peking Union Med Coll, Key Lab Rheumatol & Clin Immunol, Minist Educ, Beijing 100021, Peoples R China	Qingdao University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Liu, B (corresponding author), Qingdao Univ, Affiliated Hosp, Dept Rheumatol, Qingdao 266071, Peoples R China.	binliu72314@163.com; yongzhelipumch@126.com	zhang, shulan/AAS-6912-2020		Research Special Fund for Public Welfare Industry of Health [201202004]; National Natural Science Foundation of China [81072486, 81172857, 81373188]; Natural Sciences Foundation of China [81241094]; Technology program of basic research projects of Qingdao city [13-1-4-138-jch]	Research Special Fund for Public Welfare Industry of Health; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Technology program of basic research projects of Qingdao city	This work was supported by funding from the Research Special Fund for Public Welfare Industry of Health No. 201202004 (to FCZ), and the National Natural Science Foundation of China Grants 81072486, 81172857, 81373188 (to YZL) and the Natural Sciences Foundation of China No. 81241094 (to BL) and Technology program of basic research projects of Qingdao city No. 13-1-4-138-jch (BL).	Bassi CL, 2008, LUPUS, V17, P988, DOI 10.1177/0961203308093461; Courtney PA, 1999, ANN RHEUM DIS, V58, P309, DOI 10.1136/ard.58.5.309; Da SFA, 2013, GENE, V527, P435, DOI [10.1016/j.gene.2013.06.074, DOI 10.1016/J.GENE.2013.06.074]; Danchenko N, 2006, LUPUS, V15, P308, DOI 10.1191/0961203306lu2305xx; Dogliotti E, 2001, PROG NUCLEIC ACID RE, V68, P3; Friedberg EC, 2003, NATURE, V421, P436, DOI 10.1038/nature01408; Graessler J, 2005, J RHEUMATOL, V32, P1654; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Hur JW, 2008, RHEUMATOL INT, V28, P783, DOI 10.1007/s00296-007-0509-0; Koyama A, 2006, RHEUMATOL INT, V26, P749, DOI 10.1007/s00296-005-0066-3; Lin YJ, 2010, J CLIN IMMUNOL, V30, P643, DOI 10.1007/s10875-010-9427-0; Mandel M, 2004, CLIN EXP IMMUNOL, V138, P164, DOI 10.1111/j.1365-2249.2004.02587.x; Martens HA, 2009, SCAND J RHEUMATOL, V38, P256, DOI 10.1080/03009740802552469; McConnell JR, 2002, CLIN EXP RHEUMATOL, V20, P653; McCurdy D, 1997, RADIAT RES, V147, P48, DOI 10.2307/3579442; Miceli-Richard C, 2015, JOINT BONE SPINE, V82, P90, DOI 10.1016/j.jbspin.2014.03.004; Mok CC, 2003, J CLIN PATHOL, V56, P481, DOI 10.1136/jcp.56.7.481; Moser KL, 2009, GENES IMMUN, V10, P373, DOI 10.1038/gene.2009.39; Narayan S, 1996, J BIOL CHEM, V271, P18508, DOI 10.1074/jbc.271.31.18508; Rahman A, 2008, NEW ENGL J MED, V358, P929, DOI 10.1056/NEJMra071297; Senejani AG, 2014, CELL REP, V6, P1, DOI 10.1016/j.celrep.2013.12.017; Sheng YJ, 2011, RHEUMATOLOGY, V50, P682, DOI 10.1093/rheumatology/keq313; Thomas G, 2004, ELECTROPHORESIS, V25, P1668, DOI 10.1002/elps.200405886; Warchol T, 2012, DNA CELL BIOL, V31, P50, DOI 10.1089/dna.2011.1246; Yi P, 2009, PRENATAL DIAG, V29, P217, DOI 10.1002/pd.2072; Zeller T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010693; Zeng QY, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2368; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	28	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0132556	10.1371/journal.pone.0132556	http://dx.doi.org/10.1371/journal.pone.0132556			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26167925	Green Published, Green Submitted, gold			2022-12-26	WOS:000358193100054
J	Emmrich, S; Engeland, F; El-Khatib, M; Henke, K; Obulkasim, A; Schoning, J; Katsman-Kuipers, JE; Zwaan, CM; Pich, A; Stary, J; Baruchel, A; de Haas, V; Reinhardt, D; Fornerod, M; van den Heuvel-Eibrink, MM; Klusmann, JH				Emmrich, S.; Engeland, F.; El-Khatib, M.; Henke, K.; Obulkasim, A.; Schoening, J.; Katsman-Kuipers, J. E.; Zwaan, C. Michel; Pich, A.; Stary, J.; Baruchel, A.; de Haas, V.; Reinhardt, D.; Fornerod, M.; van den Heuvel-Eibrink, M. M.; Klusmann, J. H.			miR-139-5p controls translation in myeloid leukemia through EIF4G2	ONCOGENE			English	Article							DOWN-REGULATION; MALIGNANT-TRANSFORMATION; PROTEIN-SYNTHESIS; POOR-PROGNOSIS; UP-REGULATION; EXPRESSION; BTG3; PHOSPHORYLATION; PROLIFERATION; METHYLATION	MicroRNAs (miRNAs) are crucial components of homeostatic and developmental gene regulation. In turn, dysregulation of miRNA expression is a common feature of different types of cancer, which can be harnessed therapeutically. Here we identify miR-139-5p suppression across several cytogenetically defined acute myeloid leukemia (AML) subgroups. The promoter of mir-139 was transcriptionally silenced and could be reactivated by histone deacetylase inhibitors in a dose-dependent manner. Restoration of mir-139 expression in cell lines representing the major AML subgroups (t[8;21], inv[16], mixed lineage leukemia-rearranged and complex karyotype AML) caused cell cycle arrest and apoptosis in vitro and in xenograft mouse models in vivo. During normal hematopoiesis, mir-139 is exclusively expressed in terminally differentiated neutrophils and macrophages. Ectopic expression of mir-139 repressed proliferation of normal CD34(+)-hematopoietic stem and progenitor cells and perturbed myelomonocytic in vitro differentiation. Mechanistically, mir-139 exerts its effects by repressing the translation initiation factor EIF4G2, thereby reducing overall protein synthesis while specifically inducing the translation of cell cycle inhibitor p27(Kip1). Knockdown of EIF4G2 recapitulated the effects of mir-139, whereas restoring EIF4G2 expression rescued the mir-139 phenotype. Moreover, elevated miR-139-5p expression is associated with a favorable outcome in a cohort of 165 pediatric patients with AML. Thus, mir-139 acts as a global tumor suppressor-miR in AML by controlling protein translation. As AML cells are dependent on high protein synthesis rates controlling the expression of mir-139 constitutes a novel path for the treatment of AML.	[Emmrich, S.; Engeland, F.; El-Khatib, M.; Henke, K.; Schoening, J.; Klusmann, J. H.] Hannover Med Sch, Dept Pediat Hematol & Oncol, Carl Neuberg St 1, D-30625 Hannover, Germany; [Obulkasim, A.; Katsman-Kuipers, J. E.; Zwaan, C. Michel; Fornerod, M.; van den Heuvel-Eibrink, M. M.] Erasmus MC Sophia Childrens Hosp, Dept Pediat Oncol Hematol, Rotterdam, Netherlands; [Pich, A.] Hannover Med Sch, Inst Toxicol, D-30625 Hannover, Germany; [Stary, J.] Charles Univ Prague, Dept Pediat Hematol Oncol, Prague, Czech Republic; [Stary, J.] Univ Hosp Motol, Prague, Czech Republic; [Baruchel, A.] Hop Univ St Louis, St Louis Hosp, Dept Hematol, Paris, France; [de Haas, V.] Stichting Kinderoncol Nederland SKION, Dutch Childhood Oncol Grp, The Hague, Netherlands; [Reinhardt, D.] Univ Hosp Essen, Clin Pediat 3, Essen, Germany; [Fornerod, M.] Erasmus MC Sophia Childrens Hosp, Dept Biochem, Rotterdam, Netherlands	Hannover Medical School; Erasmus University Rotterdam; Erasmus MC; Hannover Medical School; Charles University Prague; Motol University Hospital; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Dutch Childhood Oncology Group; University of Duisburg Essen; Erasmus University Rotterdam; Erasmus MC	Klusmann, JH (corresponding author), Hannover Med Sch, Dept Pediat Hematol & Oncol, Carl Neuberg St 1, D-30625 Hannover, Germany.	klusmann.jan-henning@mh-hannover.de	Stary, Jan/AAB-9635-2020; Reinhardt, Dirk/N-7003-2016; Klusmann, Jan-Henning/M-9655-2015	Reinhardt, Dirk/0000-0002-7027-4483; Klusmann, Jan-Henning/0000-0002-1070-0727; Fornerod, Maarten/0000-0002-6166-3030	Children Cancer Free Foundation (KIKA) [49, 109]; KIKA project [109]; DFG [KL-2374/2-1]	Children Cancer Free Foundation (KIKA); KIKA project; DFG(German Research Foundation (DFG))	The authors thank Drs K Weber, B Fehse and D Heckl for providing plasmids; Dr M Ballmaier for sorting. SE, FE and KH were supported by the Hannover Biomedical Research School. JEK-K was supported by the Children Cancer Free Foundation (KIKA, project 49). JHK is a fellow of the Emmy Noether-Programme from the German Research Foundation (DFG; KL-2374/2-1). A.O. was supported by KIKA project 109. This work was supported by grants to CMZ and MMvdH-E from the Children Cancer Free Foundation (KIKA, projects 49 and 109) and to JHK from the DFG (KL-2374/2-1).	Alemdehy MF, 2015, BLOOD; Avdulov S, 2004, CANCER CELL, V5, P553, DOI 10.1016/j.ccr.2004.05.024; Bao W, 2011, GASTROENTEROLOGY, V141, P2076, DOI 10.1053/j.gastro.2011.08.050; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Berindan-Neagoe I, 2014, CA-CANCER J CLIN, V64, P311, DOI 10.3322/caac.21244; Boussemart L, 2014, NATURE, V513, P105, DOI 10.1038/nature13572; Breinbauer R, 2003, CHEMBIOCHEM, V4, P1147, DOI 10.1002/cbic.200300705; Caron S, 2004, MOL CELL BIOL, V24, P4920, DOI 10.1128/MCB.24.11.4920-4928.2004; Chen P, 2013, P NATL ACAD SCI USA, V110, P11511, DOI 10.1073/pnas.1310144110; Cheng JJ, 2013, CELL REP, V5, P471, DOI 10.1016/j.celrep.2013.08.050; Cheng YC, 2013, P NATL ACAD SCI USA, V110, P5993, DOI 10.1073/pnas.1220635110; Clemens MJ, 2004, ONCOGENE, V23, P3180, DOI 10.1038/sj.onc.1207544; Creutzig U, 2012, BLOOD, V120, P3187, DOI 10.1182/blood-2012-03-362608; Deng BY, 2013, TUMOR BIOL, V34, P2617, DOI 10.1007/s13277-013-0811-2; Dou L, 2012, ONCOGENE, V31, P507, DOI 10.1038/onc.2011.248; Emmrich S, 2014, LEUKEMIA, V28, P1022, DOI 10.1038/leu.2013.357; Fan Q, 2013, CELL BIOCHEM FUNCT, V31, P319, DOI 10.1002/cbf.2902; FukuchiShimogori T, 1997, CANCER RES, V57, P5041; Gradi A, 1998, MOL CELL BIOL, V18, P334, DOI 10.1128/MCB.18.1.334; Gu W, 2014, ONCOL REP, V31, P397, DOI 10.3892/or.2013.2831; Hariri F, 2013, LEUKEMIA, V27, P2047, DOI 10.1038/leu.2013.73; Henis-Korenblit S, 2002, P NATL ACAD SCI USA, V99, P5400, DOI 10.1073/pnas.082102499; Hinnebusch AG, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011544; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; Imataka H, 1998, EMBO J, V17, P7480, DOI 10.1093/emboj/17.24.7480; Jiang H, 2011, CELL, V144, P513, DOI 10.1016/j.cell.2011.01.020; Kar AN, 2013, J NEUROSCI, V33, P7165, DOI 10.1523/JNEUROSCI.2040-12.2013; Klein U, 2010, CANCER CELL, V17, P28, DOI 10.1016/j.ccr.2009.11.019; Krishnan K, 2013, RNA, V19, P1767, DOI 10.1261/rna.042143.113; LAZARISKARATZAS A, 1990, NATURE, V345, P544, DOI 10.1038/345544a0; Lee DW, 2012, ONCOGENE, V31, P4085, DOI 10.1038/onc.2011.579; Lee SH, 2006, EMBO J, V25, P4008, DOI 10.1038/sj.emboj.7601268; Li RY, 2013, CNS NEUROSCI THER, V19, P477, DOI 10.1111/cns.12089; Li ZJ, 2012, BLOOD, V119, P2314, DOI 10.1182/blood-2011-10-386235; Lin TY, 2012, ONCOGENE, V31, P3287, DOI 10.1038/onc.2011.491; Luo HN, 2014, MED ONCOL, V31, DOI 10.1007/s12032-013-0789-z; Marash L, 2008, MOL CELL, V30, P447, DOI 10.1016/j.molcel.2008.03.018; Martelli AM, 2006, LEUKEMIA, V20, P911, DOI 10.1038/sj.leu.2404245; Masaki S, 2007, BIOCHEM BIOPH RES CO, V364, P509, DOI 10.1016/j.bbrc.2007.10.077; Mazan-Mamczarz K, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004105; Nousch M, 2007, RNA, V13, P374, DOI 10.1261/rna.372307; Placke T, 2014, BLOOD, V124, P13, DOI 10.1182/blood-2014-02-558114; Qin H, 2003, J BIOL CHEM, V278, P48570, DOI 10.1074/jbc.M308781200; Sanders MA, 2013, CURR OPIN HEMATOL, V20, P79, DOI 10.1097/MOH.0b013e32835d821c; Scheicher R, 2015, BLOOD, V125, P90, DOI 10.1182/blood-2014-06-584417; Shen K, 2014, FEBS J, V281, P3609, DOI 10.1111/febs.12880; Solh M, 2014, AM J HEMATOL, V89, P1121, DOI 10.1002/ajh.23821; Srivastava T, 2012, J NEUROSCI, V32, P5620, DOI 10.1523/JNEUROSCI.0030-12.2012; Stankov MV, 2014, LEUKEMIA, V28, P577, DOI 10.1038/leu.2013.264; Tamburini J, 2009, CELL CYCLE, V8, P3893, DOI 10.4161/cc.8.23.10091; Tu LX, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-78; Vardiman JW, 2009, BLOOD, V114, P937, DOI 10.1182/blood-2009-03-209262; Vinther J, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl590; Virgili G, 2013, STRUCTURE, V21, P517, DOI 10.1016/j.str.2013.01.015; Wang ZY, 2013, MOL CELL BIOCHEM, V383, P59, DOI 10.1007/s11010-013-1754-z; Weber K, 2008, MOL THER, V16, P698, DOI 10.1038/mt.2008.6; Wong CCL, 2011, GASTROENTEROLOGY, V140, P322, DOI 10.1053/j.gastro.2010.10.006; YANAGISAWA K, 1991, BLOOD, V78, P451; Yu JW, 2008, GENE EXPRESSION, V14, P173; Zhang LJ, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-124	60	42	44	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 7	2016	35	14					1822	1831		10.1038/onc.2015.247	http://dx.doi.org/10.1038/onc.2015.247			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DI6LM	26165837				2022-12-26	WOS:000373610400008
J	Altarelli, F; Braunstein, A; Dall'Asta, L				Altarelli, Fabrizio; Braunstein, Alfredo; Dall'Asta, Luca			Statics and Dynamics of Selfish Interactions in Distributed Service Systems	PLOS ONE			English	Article							CONGESTION GAMES; EQUILIBRIA	We study a class of games which models the competition among agents to access some service provided by distributed service units and which exhibits congestion and frustration phenomena when service units have limited capacity. We propose a technique, based on the cavity method of statistical physics, to characterize the full spectrum of Nash equilibria of the game. The analysis reveals a large variety of equilibria, with very different statistical properties. Natural selfish dynamics, such as best-response, usually tend to large-utility equilibria, even though those of smaller utility are exponentially more numerous. Interestingly, the latter actually can be reached by selecting the initial conditions of the best-response dynamics close to the saturation limit of the service unit capacities. We also study a more realistic stochastic variant of the game by means of a simple and effective approximation of the average over the random parameters, showing that the properties of the average-case Nash equilibria are qualitatively similar to the deterministic ones.	[Altarelli, Fabrizio; Braunstein, Alfredo; Dall'Asta, Luca] Politecn Torino, Dept Appl Sci & Technol, Turin, Italy; [Altarelli, Fabrizio; Braunstein, Alfredo; Dall'Asta, Luca] Politecn Torino, Ctr Computat Sci, Turin, Italy; [Altarelli, Fabrizio; Braunstein, Alfredo; Dall'Asta, Luca] Coll Carlo Alberto, Moncalieri, Italy; [Braunstein, Alfredo] Human Genet Fdn, Turin, Italy	Polytechnic University of Turin; Polytechnic University of Turin; Collegio Carlo Alberto	Braunstein, A (corresponding author), Politecn Torino, Dept Appl Sci & Technol, Turin, Italy.	alfredo.braunstein@polito.it; luca.dallasta@polito.it	Braunstein, Alfredo/E-6924-2012	Braunstein, Alfredo/0000-0002-4562-3610	European Grant ERC Advanced Grant [267915]; Italian Futuro in Ricerca-FIRB [RBFR10QUW4]	European Grant ERC Advanced Grant; Italian Futuro in Ricerca-FIRB	The authors acknowledge the European Grant ERC Advanced Grant, Project No. 267915, http://erc.europa.eu; and the Italian Futuro in Ricerca 2010"-FIRB, Project No. RBFR10QUW4, http://futuroinricerca.miur.it/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann H, 2006, LECT NOTES COMPUT SC, V4286, P50; Altarelli F, 2013, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2013/09/P09011; Altarelli F, 2009, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2009/07/P07002; Altman E, 2006, COMPUT OPER RES, V33, P286, DOI 10.1016/j.cor.2004.06.005; Anderson SP, 2007, J ECON BEHAV ORGAN, V63, P120, DOI 10.1016/j.jebo.2005.05.006; [Anonymous], 2010, SOCIAL EC NETWORKS; Anshelevich E, 2008, SIAM J COMPUT, V38, P1602, DOI 10.1137/070680096; Baldassi C, 2013, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2013/12/P12013; Bhawalkar K, 2010, LECT NOTES COMPUT SC, V6347, P17, DOI 10.1007/978-3-642-15781-3_2; Braunstein A, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.030201; Challet, 2013, MINORITY GAMES INTER; Correa JR, 2004, MATH OPER RES, V29, P961, DOI 10.1287/moor.1040.0098; Culyer AJ., 1990, COMPETITION HLTH CAR; Czumaj A, 2008, ACM T ALGORITHMS, V4, DOI 10.1145/1367064.1367071; Dall'Asta L, 2011, J PUBLIC ECON THEORY, V13, P885, DOI 10.1111/j.1467-9779.2011.01523.x; Dall'Asta L, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.061136; Gourves Laurent, 2012, Algorithmic Game Theory. Proceedings 5th International Symposium, SAGT 2012, P204, DOI 10.1007/978-3-642-33996-7_18; Koutsoupias E, 1999, LECT NOTES COMPUT SC, V1563, P404; Kuhn R, 1996, Z PHYS B CON MAT, V100, P231, DOI 10.1007/s002570050117; Lakemeyer G., 2003, EXPLORING ARTIFICIAL, P239; Levy G, 2005, Q J ECON, V120, P1507, DOI 10.1162/003355305775097489; Lijesen M, 2007, PUBLIC PRIVATE ROLES, P146; Liu MY, 2008, ANN ALLERTON CONF, P1146; Mavronicolas M, 2007, LECT NOTES COMPUT SC, V4708, P633; Mezard M, 2003, J STAT PHYS, V111, P1, DOI 10.1023/A:1022221005097; Mezard M, 2001, EUR PHYS J B, V20, P217, DOI 10.1007/PL00011099; Mezard M., 2009, INFORM PHYS COMPUTAT, pp 584, DOI [10.1093/acprof:oso/9780198570837.001.0001, DOI 10.1093/ACPROF:OSO/9780198570837.001, DOI 10.1093/ACPROF:OSO/9780198570837.001.0001]; Milchtaich I, 1996, GAME ECON BEHAV, V13, P111, DOI 10.1006/game.1996.0027; Monderer D, 1996, GAME ECON BEHAV, V14, P124, DOI 10.1006/game.1996.0044; MORITA T, 1964, J MATH PHYS, V5, P1401, DOI 10.1063/1.1704075; Nisan N, 2007, ALGORITHMIC GAME THEORY, P1, DOI 10.1017/CBO9780511800481; Ostrom E, 2008, TRAGEDY COMMONS NEW, P3573; Panagopoulou PN, 2007, J EXPT ALGORITHMICS, V11; Ramezanpour A, 2011, EUR PHYS J B, V81, P327, DOI 10.1140/epjb/e2011-10963-x; Rhim H, 2003, EUR J OPER RES, V149, P211, DOI 10.1016/S0377-2217(02)00445-9; Rosenthal R. W., 1973, International Journal of Game Theory, V2, P65, DOI 10.1007/BF01737559; Roughgarden T, 2004, GAME ECON BEHAV, V47, P389, DOI 10.1016/j.geb.2003.06.004; Roughgarden T, 2002, J ACM, V49, P236, DOI 10.1145/506147.506153; Suri S., 2004, P 16 ANN ACM S PAR A, P188; Yedidia JS, 2000, ADV NEURAL INFORM PR, V13, P689	40	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0119286	10.1371/journal.pone.0119286	http://dx.doi.org/10.1371/journal.pone.0119286			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177449	gold, Green Published, Green Submitted			2022-12-26	WOS:000358197600002
J	Chen, ML; Wu, YK; Narimatsu, H; Li, XQ; Wang, CM; Luo, JY; Zhao, GM; Chen, ZW; Xu, WH				Chen, Mingling; Wu, Yikang; Narimatsu, Hiroto; Li, Xueqing; Wang, Chunmei; Luo, Jianyong; Zhao, Genming; Chen, Zhongwen; Xu, Wanghong			Socioeconomic Status and Physical Activity in Chinese Adults: A Report from a Community-Based Survey in Jiaxing, China	PLOS ONE			English	Article							HEALTH; PATTERNS; LEISURE; COMPENDIUM; INACTIVITY; OBESITY; BURDEN; UPDATE; URBAN; AGE	Objectives This study examines the associations of socioeconomic status (SES) with intensity of different types of physical activity (PA) in Chinese adults, aimed at outlining and projecting socioeconomic disparities in PA among the population undergoing a rapid nutrition transition. Methods A community-based survey was conducted among 3,567 residents aged 30-65 years old in Jiaxing, China, in 2010. SES and PA were assessed by a structured questionnaire. SES was assessed as socioeconomic index (SEI) score based on self-reported educational attainment, household income and occupation. Metabolic equivalents (METs) were calculated for each subject to quantify the total amount of PA from occupation, exercise, transportation and housework. Results Intensity of overall PA in this population was 165 MET-hours/week, in which energy expenditure in occupational PA accounted for 82%. Both types and intensity of PA were significantly different by SES: middle SES groups had higher intensity of occupational activities; lower SES subjects engaged in more household work; whereas higher SES subjects were more likely to exercise, more active during commuting and had longer sedentary time. All the three components of SES, education attainment, income and occupation, contributed to socioeconomic disparities in PA in this population. Conclusions Our results suggest an overall insufficiency and socioeconomic inequalities in PA among Chinese adults in Jiaxing, a typical city experiencing a rapid urbanization in China. There is an urgent need to promote leisure-time activities in this population.	[Chen, Mingling; Zhao, Genming; Xu, Wanghong] Fudan Univ, Dept Epidemiol, Sch Publ Hlth, Shanghai 200433, Peoples R China; [Chen, Mingling; Zhao, Genming; Xu, Wanghong] Fudan Univ, Key Lab Publ Hlth Safety, Shanghai 200433, Peoples R China; [Wu, Yikang; Li, Xueqing; Luo, Jianyong; Chen, Zhongwen] Jiaxing Ctr Dis Control & Prevent, Jiaxing, Peoples R China; [Narimatsu, Hiroto] Yamagata Univ, Grad Sch Med, Dept Publ Hlth, Yamagata 990, Japan; [Wang, Chunmei] Tongxiang Ctr Dis Control & Prevent, Tongxiang, Peoples R China	Fudan University; Fudan University; Yamagata University	Chen, ZW (corresponding author), Jiaxing Ctr Dis Control & Prevent, Jiaxing, Peoples R China.	czw2007@sohu.com; wanghong.xu@fudan.edu.cn	Narimatsu, Hiroto/ABC-9150-2021	Narimatsu, Hiroto/0000-0002-5302-5872; xu, wanghong/0000-0003-2045-2218; Chen, Mingling/0000-0001-7992-1838	Consulting Service for Center of Excellence in Global Health Policy Development and Governance in China [GHSP-CS-OP3-02]; Bureau of Science and Technology in Jiaxing, Zhejiang Province [2013AY21051-2]	Consulting Service for Center of Excellence in Global Health Policy Development and Governance in China; Bureau of Science and Technology in Jiaxing, Zhejiang Province	This work was supported by funding provided by the Consulting Service for Center of Excellence in Global Health Policy Development and Governance in China (No. GHSP-CS-OP3-02) and the Bureau of Science and Technology in Jiaxing, Zhejiang Province (No. 2013AY21051-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AINSWORTH BE, 1993, MED SCI SPORT EXER, V25, P71, DOI 10.1249/00005768-199301000-00011; Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; [Anonymous], 2007, CIRCULATION, DOI DOI 10.1161/CIRCULATIONAHA.107.185649; Beenackers MA, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-116; Borodulin K, 2008, J PHYS ACT HEALTH, V5, P242, DOI 10.1123/jpah.5.2.242; Cerin E, 2008, SOC SCI MED, V66, P2596, DOI 10.1016/j.socscimed.2008.02.012; Chen CM, 2006, GUIDELINE PREVENTING; Chen J, 2007, CATENA, V69, P1, DOI 10.1016/j.catena.2006.04.019; Cleland V, 2012, SOC SCI MED, V74, P1578, DOI 10.1016/j.socscimed.2012.01.031; Duncan O., 1961, SOCIOECONOMIC INDEX, P109; El-Sayed AM, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-18; Farrell L, 2013, SOCIOECONOMIC GRADIE; Finger JD, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1079; Gidlow C., 2006, HEALTH EDUC J, V65, P338, DOI DOI 10.1177/0017896906069378; Hamer M, 2012, J EPIDEMIOL COMMUN H, V66, P1110, DOI 10.1136/jech-2011-200505; Hu G, 2002, B WORLD HEALTH ORGAN, V80, P933; Jurj AL, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-213; Kesaniemi YA, 2001, MED SCI SPORT EXER, V33, pS351; Khan KM, 2012, LANCET, V380, P59, DOI 10.1016/S0140-6736(12)60865-4; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; Lee SA, 2007, MED SCI SPORT EXER, V39, P1700, DOI 10.1249/mss.0b013e3181238a52; Li Q, 2010, SOCIAL CLASS CURRENT; Liu HG, 2014, J NE NORMAL U PHILOS, P256; Maria Kamphuis CB, 2008, MED SCI SPORT EXER, V40, P71, DOI 10.1249/mss.0b013e318158e467; MORRIS JN, 1953, LANCET, V265, P1053; National Institute for Health and Clinical Excellence, 2008, PROM CREAT BUILT NAT; Ng SW, 2014, OBES REV, V15, P27, DOI 10.1111/obr.12127; Ng SW, 2012, OBES REV, V13, P659, DOI 10.1111/j.1467-789X.2011.00982.x; Ng SW, 2009, SOC SCI MED, V68, P1305, DOI 10.1016/j.socscimed.2009.01.035; Organization WH, 2009, GLOB HLTH RISKS MORT; Parks SE, 2003, J EPIDEMIOL COMMUN H, V57, P29, DOI 10.1136/jech.57.1.29; Patro BK, 2012, INDIAN J PEDIATR, V79, P395, DOI 10.1007/s12098-011-0517-7; Popkin BM, 2010, INT J EPIDEMIOL, V39, P1435, DOI 10.1093/ije/dyp322; Rachel C, 2009, HLTH SURVEY ENGLAND; Saito Y, 2013, INT J ENV RES PUB HE, V10, P2028, DOI 10.3390/ijerph10052028; Scarborough P, 2011, J PUBLIC HEALTH-UK, V33, P527, DOI 10.1093/pubmed/fdr033; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15; Wilson DK, 2004, ANN BEHAV MED, V28, P20, DOI 10.1207/s15324796abm2801_4; World Health Organization, 2003, GLOB PHYS ACT QUEST; Xu H.Z., 2012, CHIN LAND SCI, V26, P74; Zhang JY, 2012, CONSUMER EC, V28	41	31	33	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132918	10.1371/journal.pone.0132918	http://dx.doi.org/10.1371/journal.pone.0132918			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1RL	26177205	Green Published, gold			2022-12-26	WOS:000358197600179
J	Fan, JB; Chen, K; Amombo, E; Hu, ZR; Chen, L; Fu, JM				Fan, Jibiao; Chen, Ke; Amombo, Erick; Hu, Zhengrong; Chen, Liang; Fu, Jinmin			Physiological and Molecular Mechanism of Nitric Oxide (NO) Involved in Bermudagrass Response to Cold Stress	PLOS ONE			English	Article							STIMULATES SEED-GERMINATION; CHLOROPHYLL FLUORESCENCE; ELECTRON-TRANSPORT; FREEZING TOLERANCE; GENE-EXPRESSION; PLANT; ACCLIMATION; COUNTERACTS; TEMPERATURE; METABOLISM	Bermudagrass is widely utilized in parks, lawns, and golf courses. However, cold is a key factor limiting resource use in bermudagrass. Therefore, it is meaningful to study the mechanism of bermudagrass response to cold. Nitric oxide (NO) is a crucial signal molecule with multiple biological functions. Thus, the objective of this study was to investigate whether NO play roles in bermudagrass response to cold. Sodium nitroprusside (SNP) was used as NO donor, while 2-phenyl-4,4,5,5-tetramentylimidazoline-l-oxyl-3-xide (PTIO) plus NG-nitro-Larginine methyl ester (L-NAME) were applied as NO inhibitor. Wild bermudagrass was subjected to 4 degrees C in a growth chamber under different treatments (Control, SNP, PTIO + L-NAME). The results indicated lower levels of malondialdehyde (MDA) content and electrolyte leakage (EL), higher value for chlorophyll content, superoxide dismutase (SOD) and peroxidase (POD) activities after SNP treatment than that of PTIO plus L-NAME treatments under cold stress. Analysis of Chlorophyll (Chl) a fluorescence transient displayed that the OJIP transient curve was higher after treatment with SNP than that of treated with PTIO plus L-NAME under cold stress. The values of photosynthetic fluorescence parameters were higher after treatment with SNP than that of treated with PTIO plus L-NAME under cold stress. Expression of cold-responsive genes was altered under cold stress after treated with SNP or PTIO plus L-NAME. In summary, our findings indicated that, as an important strategy to protect bermudagrass against cold stress, NO could maintain the stability of cell membrane, up-regulate the antioxidant enzymes activities, recover process of photosystem II (PSII) and induce the expression of cold-responsive genes.	[Fan, Jibiao; Chen, Ke; Amombo, Erick; Hu, Zhengrong; Chen, Liang; Fu, Jinmin] Chinese Acad Sci, Wuhan Bot Garden, Key Lab Plant Germplasm Enhancement & Specialty A, Wuhan 430074, Hubei, Peoples R China; [Fan, Jibiao; Amombo, Erick; Hu, Zhengrong] Univ Chinese Acad Sci, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Wuhan Botanical Garden, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Chen, L (corresponding author), Chinese Acad Sci, Wuhan Bot Garden, Key Lab Plant Germplasm Enhancement & Specialty A, Wuhan 430074, Hubei, Peoples R China.	chenliang1034@126.com; jfu@wbgcas.cn	Amombo, Erick/P-2440-2019		China National Science Foundation (NSFC) [31272194, 31401915]; China-Africa Center for Research and Education [SAJC201325]; Hubei Province National Science Foundation Sciences [ZRY1326]; outstanding young talent program of CAS Key Laboratory of Plant Germplasm Enhancement and Specialty Agriculture [Y452341X01]	China National Science Foundation (NSFC)(National Natural Science Foundation of China (NSFC)); China-Africa Center for Research and Education; Hubei Province National Science Foundation Sciences; outstanding young talent program of CAS Key Laboratory of Plant Germplasm Enhancement and Specialty Agriculture	This work was supported by the China National Science Foundation (NSFC) (Grant Nos. 31272194 and 31401915), China-Africa Center for Research and Education (Grant No. SAJC201325), the Hubei Province National Science Foundation Sciences (Grant No. ZRY1326) and the outstanding young talent program of CAS Key Laboratory of Plant Germplasm Enhancement and Specialty Agriculture (Grant No. Y452341X01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agati G, 1996, J PLANT PHYSIOL, V148, P384, DOI 10.1016/S0176-1617(96)80270-7; Beligni MV, 2002, PLANT CELL ENVIRON, V25, P737, DOI 10.1046/j.1365-3040.2002.00857.x; Beligni MV, 1999, PLANTA, V208, P337, DOI 10.1007/s004250050567; Beligni MV, 2000, PLANTA, V210, P215, DOI 10.1007/PL00008128; Chen LA, 2011, PLANT CELL REP, V30, P463, DOI 10.1007/s00299-010-0952-3; Chinnusamy V, 2007, TRENDS PLANT SCI, V12, P444, DOI 10.1016/j.tplants.2007.07.002; Delledonne M, 1998, NATURE, V394, P585, DOI 10.1038/29087; Fan JB, 2014, J AM SOC HORTIC SCI, V139, P699, DOI 10.21273/JASHS.139.6.699; HETHERINGTON SE, 1989, PLANT PHYSIOL, V90, P1609, DOI 10.1104/pp.90.4.1609; HISCOX JD, 1979, CAN J BOT, V57, P1332, DOI 10.1139/b79-163; Hou Y- D., 2010, PLANT SCI, V5, P125, DOI DOI 10.3923/jps.2010.125.136; Hu LX, 2012, J PLANT PHYSIOL, V169, P146, DOI 10.1016/j.jplph.2011.08.020; Jasid S, 2006, PLANT PHYSIOL, V142, P1246, DOI 10.1104/pp.106.086918; Kopyra M, 2003, PLANT PHYSIOL BIOCH, V41, P1011, DOI 10.1016/j.plaphy.2003.09.003; Le MQ, 2008, CRYOBIOLOGY, V57, P104, DOI 10.1016/j.cryobiol.2008.06.004; Leshem YY, 1998, PLANT PHYSIOL BIOCH, V36, P825, DOI 10.1016/S0981-9428(99)80020-5; Li HY, 2012, J AM SOC HORTIC SCI, V137, P80, DOI 10.21273/JASHS.137.2.80; Medina J, 2011, PLANT SCI, V180, P3, DOI 10.1016/j.plantsci.2010.06.019; Neill SJ, 2003, NEW PHYTOL, V159, P11, DOI 10.1046/j.1469-8137.2003.00804.x; Palavan-Unsal N, 2009, BOT REV, V75, P203, DOI 10.1007/s12229-009-9031-2; Samson G, 1999, PHOTOSYNTHETICA, V37, P163, DOI 10.1023/A:1007095619317; Santa-Cruz DM, 2010, PHYTOCHEMISTRY, V71, P1700, DOI 10.1016/j.phytochem.2010.07.009; Seregelyes C, 2003, PLANT SCI, V165, P541, DOI 10.1016/S0168-9452(03)00213-9; Shao RX, 2010, J PLANT PHYSIOL, V167, P472, DOI 10.1016/j.jplph.2009.10.020; Singh SP, 2009, POSTHARVEST BIOL TEC, V53, P101, DOI 10.1016/j.postharvbio.2009.04.007; Srivastava A, 1997, BBA-BIOENERGETICS, V1320, P95, DOI 10.1016/S0005-2728(97)00017-0; Stitt M, 2002, CURR OPIN PLANT BIOL, V5, P199, DOI 10.1016/S1369-5266(02)00258-3; Strasser BJ, 1995, PHOTOSYNTHESIS: FROM LIGHT TO BIOSPHERE, VOL 5, P977; Strasser R.J., 1999, CROP IMPROVEMENT FOO, P60; Strauss AJ, 2006, ENVIRON EXP BOT, V56, P147, DOI 10.1016/j.envexpbot.2005.01.011; Tao DL, 1998, CRYOBIOLOGY, V37, P38, DOI 10.1006/cryo.1998.2096; Thomashow MF, 1999, ANNU REV PLANT PHYS, V50, P571, DOI 10.1146/annurev.arplant.50.1.571; Uchida A, 2002, PLANT SCI, V163, P515, DOI 10.1016/S0168-9452(02)00159-0; Wang HM, 2013, SCI WORLD J, DOI [10.1155/2013/658793, 10.1155/2013/865645]; Wang L., 2011, HUNAN AGR SCI, V62, P56; Wang L, 2011, HUNAN AGR SCI, V11, P62; Wanner LA, 1999, PLANT PHYSIOL, V120, P391, DOI 10.1104/pp.120.2.391; Wodala B, 2008, PLANT PHYSIOL, V146, P1920, DOI 10.1104/pp.107.110205; Zhang XZ, 2006, CROP SCI, V46, P2598, DOI 10.2135/cropsci2006.02.0108; Zhu JH, 2007, CURR OPIN PLANT BIOL, V10, P290, DOI 10.1016/j.pbi.2007.04.010	40	26	28	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132991	10.1371/journal.pone.0132991	http://dx.doi.org/10.1371/journal.pone.0132991			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177459	Green Submitted, Green Published, gold			2022-12-26	WOS:000358197600197
J	Ochieng, C; Ahenda, P; Vittor, AY; Nyoka, R; Gikunju, S; Wachira, C; Waiboci, L; Umuro, M; Kim, AA; Nderitu, L; Juma, B; Montgomery, JM; Breiman, RF; Fields, B				Ochieng, Caroline; Ahenda, Petronella; Vittor, Amy Y.; Nyoka, Raymond; Gikunju, Stella; Wachira, Cyrus; Waiboci, Lilian; Umuro, Mamo; Kim, Andrea A.; Nderitu, Leonard; Juma, Bonventure; Montgomery, Joel M.; Breiman, Robert F.; Fields, Barry			Seroprevalence of Infections with Dengue, Rift Valley Fever and Chikungunya Viruses in Kenya, 2007	PLOS ONE			English	Article							ARBOVIRAL INFECTIONS; ENTOMOLOGIC INVESTIGATIONS; EPIDEMIC; ISLAND; OUTBREAKS; FEATURES; COMOROS; FRANCE; ADULTS; UNION	Arthropod-borne viruses are a major constituent of emerging infectious diseases worldwide, but limited data are available on the prevalence, distribution, and risk factors for transmission in Kenya and East Africa. In this study, we used 1,091 HIV-negative blood specimens from the 2007 Kenya AIDS Indicator Survey (KAIS 2007) to test for the presence of IgG antibodies to dengue virus (DENV), chikungunya virus (CHIKV) and Rift Valley fever virus (RVFV). The KAIS 2007 was a national population-based survey conducted by the Government of Kenya to provide comprehensive information needed to address the HIV/AIDS epidemic. Antibody testing for arboviruses was performed on stored blood specimens from KAIS 2007 through a two-step sandwich IgG ELISA using either commercially available kits or CDC-developed assays. Out of the 1,091 samples tested, 210 (19.2%) were positive for IgG antibodies against at least one of the three arboviruses. DENV was the most common of the three viruses tested (12.5% positive), followed by RVFV and CHIKV (4.5% and 0.97%, respectively). For DENV and RVFV, the participant's province of residence was significantly associated (P <=.01) with seropositivity. Seroprevalence of DENV and RVFV increased with age, while there was no correlation between province of residence/age and seropositivity for CHIKV. Females had twelve times higher odds of exposure to CHIK as opposed to DENV and RVFV where both males and females had the same odds of exposure. Lack of education was significantly associated with a higher odds of previous infection with either DENV or RVFV (p < 0.01). These data show that a number of people are at risk of arbovirus infections depending on their geographic location in Kenya and transmission of these pathogens is greater than previously appreciated. This poses a public health risk, especially for DENV.	[Ochieng, Caroline; Ahenda, Petronella; Gikunju, Stella; Wachira, Cyrus] Kenya Govt Med Res Ctr, Ctr Global Hlth Res, Nairobi, Kenya; [Nyoka, Raymond; Kim, Andrea A.; Juma, Bonventure; Montgomery, Joel M.; Breiman, Robert F.; Fields, Barry] US Ctr Dis Control & Prevent, Global Dis Detect Program, Nairobi, Kenya; [Vittor, Amy Y.] Univ Florida, Emerging Pathogens Inst, Div Infect Dis & Global Med, Gainesville, FL USA; [Umuro, Mamo] Minist Publ Hlth & Sanitat, Nairobi, Kenya; [Breiman, Robert F.] Emory Univ, Atlanta, GA 30322 USA; [Waiboci, Lilian] Univ Nairobi, Nairobi, Kenya; [Nderitu, Leonard] Africa Biomed Labs, Nairobi, Kenya	Kenya Medical Research Institute; State University System of Florida; University of Florida; Emory University; University of Nairobi	Ochieng, C (corresponding author), Kenya Govt Med Res Ctr, Ctr Global Hlth Res, Nairobi, Kenya.	caochieng@kemricdc.org			United States Department of Defense, Defense Threat Reduction Agency (DTRA) [KE 02]	United States Department of Defense, Defense Threat Reduction Agency (DTRA)	This study was funded by the United States Department of Defense, Defense Threat Reduction Agency (DTRA), grant number KE 02. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anyangu AS, 2010, AM J TROP MED HYG, V83, P14, DOI 10.4269/ajtmh.2010.09-0293; Ayu SM, 2010, AM J TROP MED HYG, V83, P1245, DOI 10.4269/ajtmh.2010.10-0279; BENDEL RB, 1977, J AM STAT ASSOC, V72, P46, DOI 10.2307/2286904; BENNETT S, 1991, World Health Statistics Quarterly, V44, P98; Blaylock JM, 2011, TRAVEL MED INFECT DI, V9, P246, DOI 10.1016/j.tmaid.2011.06.005; Chretien JP, 2007, AM J TROP MED HYG, V76, P405, DOI 10.4269/ajtmh.2007.76.405; Gould EA, 2009, T ROY SOC TROP MED H, V103, P109, DOI 10.1016/j.trstmh.2008.07.025; Grandadam M, 2011, EMERG INFECT DIS, V17, P910, DOI 10.3201/eid1705.101873; JOHNSON BK, 1982, E AFR MED J, V59, P781; Kenya Ministry of Health, 2013, E AFR PUBL HLTH LAB, P1; Kularatne SAM, 2009, POSTGRAD MED J, V85, P342, DOI 10.1136/pgmj.2007.066746; Kuniholm MH, 2006, AM J TROP MED HYG, V74, P1078, DOI 10.4269/ajtmh.2006.74.1078; La Ruche G, 2010, EUROSURVEILLANCE, V15, P2; Leroy EM, 2009, EMERG INFECT DIS, V15, P591, DOI 10.3201/eid1504.080664; Lutomiah J, 2013, J VECTOR ECOL, V38, P134, DOI 10.1111/j.1948-7134.2013.12019.x; Maher-Sturgess SL, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-16; Maina WK, 2014, JAIDS-J ACQ IMM DEF, V66, pS130, DOI 10.1097/QAI.0000000000000123; Mease LE, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-371; MICKEY RM, 1989, AM J EPIDEMIOL, V129, P125, DOI 10.1093/oxfordjournals.aje.a115101; Nguku PM, 2010, AM J TROP MED HYG, V83, P5, DOI 10.4269/ajtmh.2010.09-0288; Ochieng C, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-140; Pincus LB, 2008, J AM ACAD DERMATOL, V58, P308, DOI 10.1016/j.jaad.2007.08.042; Powers AM, 2007, J GEN VIROL, V88, P2363, DOI 10.1099/vir.0.82858-0; Renault P, 2007, AM J TROP MED HYG, V77, P727; Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6; Saifur RGM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030919; Sang R, 2010, AM J TROP MED HYG, V83, P28, DOI 10.4269/ajtmh.2010.09-0319; Sang RC, 2008, AM J TROP MED HYG, V78, P77; Sergon K, 2008, AM J TROP MED HYG, V78, P333, DOI 10.4269/ajtmh.2008.78.333; Sergon K, 2007, AM J TROP MED HYG, V76, P1189, DOI 10.4269/ajtmh.2007.76.1189; Sutherland LJ, 2011, AM J TROP MED HYG, V85, P158, DOI 10.4269/ajtmh.2011.10-0203; Turell MJ, 2005, J MED ENTOMOL, V42, P57, DOI 10.1603/0022-2585(2005)042[0057:AUOTPO]2.0.CO;2; Wang WK, 2006, CLIN INFECT DIS, V43, P1023, DOI 10.1086/507635	33	48	49	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132645	10.1371/journal.pone.0132645	http://dx.doi.org/10.1371/journal.pone.0132645			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177451	Green Submitted, Green Published, gold			2022-12-26	WOS:000358197600137
J	Poldervaart, JM; Rottger, E; Dekker, MS; Zuithoff, NPA; Verheggen, PWHM; de Vrey, EA; Wildbergh, TX; van 't Hof, AWJ; Mosterd, A; Hoes, AW				Poldervaart, Judith M.; Rottger, Emma; Dekker, Marieke S.; Zuithoff, Nicolaas P. A.; Verheggen, Peter W. H. M.; de Vrey, Evelyn A.; Wildbergh, Thierry X.; van 't Hof, Arnoud W. J.; Mosterd, Arend; Hoes, Arno W.			No Added Value of Novel Biomarkers in the Diagnostic Assessment of Patients Suspected of Acute Coronary Syndrome	PLOS ONE			English	Article							GROWTH-DIFFERENTIATION FACTOR-15; RISK STRATIFICATION; MYOCARDIAL-INFARCTION; UNIVERSAL DEFINITION; TROPONIN-T; RAPID RULE; COPEPTIN	Background Despite the availability of high-sensitive troponin (hs-cTnT), there is still room for improvement in the diagnostic assessment of patients suspected of acute coronary syndrome (ACS). Apart from serial biomarker testing, which is time-consuming, novel biomarkers like copeptin have been proposed to expedite the early diagnosis of suspected ACS in addition to hs-cTnT. We determined whether placenta derived growth factor (PlGF), soluble Fms-like tyrosine kinase 1 (sFlt-1), myoglobin, N-terminal prohormone B-type Natriuretic Peptide (NT-proBNP), growth-differentiation factor 15 (GDF-15) and copeptin improved early assessment of chest pain patients. Methods This prospective, single centre diagnostic FAME-ER study included patients presenting to the ED with symptoms suggestive of ACS. Blood was collected to measure biomarkers, notably, hs-cTnT was retrospectively assessed. Added value of markers was judged by increase in AUC using multivariable logistic regression. Results Of 453 patients enrolled, 149 (33%) received a final diagnosis of ACS. Hs-cTnT had the highest diagnostic value in both univariable and multivariable analysis. PPVs of the biomarkers ranged from 23.5% (PlGF) to 77.9% (hs-cTnT), NPVs from 67.0% (PlGF) to 86.4% (hs-cTnT). Only myoglobin yielded diagnostic value in addition to clinical symptoms and electrocardiography (ECG) (AUC of clinical model 0.80) with AUC of 0.84 (p<0.001). However, addition of hs-cTnT was superior (AUC 0.89, p<0.001). Addition of the biomarkers to our clinical model and hs-cTnT did not or only marginally (GDF-15) improved diagnostic performance. Conclusion When assessing patients suspected of ACS, only myoglobin had added diagnostic value beyond clinical symptoms and ECG. However, when combined with hs-cTnT, it yields no additional diagnostic value. PlGF, sFlt-1, NT-proBNP, GDF-15 and copeptin had no added value to the clinical model or hs-cTnT.	[Poldervaart, Judith M.; Zuithoff, Nicolaas P. A.; Hoes, Arno W.] Univ Med Ctr, Julius Ctr Hlth Sci & Primary Care, NL-3584 CG Utrecht, Netherlands; [Rottger, Emma] Univ Utrecht, Fac Med, NL-3584 CG Utrecht, Netherlands; [Dekker, Marieke S.; van 't Hof, Arnoud W. J.] Isala Clin, Dept Cardiol, NL-8025 AB Zwolle, Netherlands; [Dekker, Marieke S.; Verheggen, Peter W. H. M.; de Vrey, Evelyn A.; Wildbergh, Thierry X.; Mosterd, Arend] Meander Med Ctr, Dept Cardiol, NL-3813 TZ Amersfoort, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Isala Clinics; Meander Medisch Centrum	Poldervaart, JM (corresponding author), Univ Med Ctr, Julius Ctr Hlth Sci & Primary Care, Univ Weg 100, NL-3584 CG Utrecht, Netherlands.	j.poldervaart@umcutrecht.nl						Apple FS, 2009, CLIN CHEM, V55, P93, DOI 10.1373/clinchem.2008.102905; Bassand JP, 2007, EUR HEART J, V28, P1598, DOI 10.1093/eurheartj/ehm161; Bertens LCM, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001531; Bohyn E, 2013, AM J EMERG MED, V3, P829; Bossuyt PM, 2003, CLIN CHEM, V49, P1, DOI 10.1373/49.1.1; Bossuyt PM, 2003, ANN INTERN MED, V138, P40, DOI 10.7326/0003-4819-138-1-200301070-00010; Dekker MS, 2010, HEART, V96, P1001, DOI 10.1136/hrt.2009.189886; Donders ART, 2006, J CLIN EPIDEMIOL, V59, P1087, DOI 10.1016/j.jclinepi.2006.01.014; Eggers KM, 2008, EUR HEART J, V29, P2327, DOI 10.1093/eurheartj/ehn339; Eggers KM, 2012, CLIN CHIM ACTA, V413, P1135, DOI 10.1016/j.cca.2012.03.011; Giannitsis E, 2011, CLIN CHEM, V57, P1452, DOI 10.1373/clinchem.2010.161265; Guder G, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-13; Hamm CW, 2011, EUR HEART J, V32, P2999, DOI 10.1093/eurheartj/ehr236; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Heeschen C, 2004, JAMA-J AM MED ASSOC, V291, P435, DOI 10.1001/jama.291.4.435; Hochholzer W, 2011, EUR HEART J, V32, P326, DOI 10.1093/eurheartj/ehq429; Kehl DW, 2012, TRANSL RES, V159, P252, DOI 10.1016/j.trsl.2011.11.002; Keller T, 2009, NEW ENGL J MED, V361, P868, DOI 10.1056/NEJMoa0903515; Kurz K, 2011, CLIN RES CARDIOL, V100, P209, DOI 10.1007/s00392-010-0230-y; Maisel A, 2013, J AM COLL CARDIOL, V62, P150, DOI 10.1016/j.jacc.2013.04.011; Matveeva EG, 2005, J IMMUNOL METHODS, V302, P26, DOI 10.1016/j.jim.2005.04.020; Meune C, 2011, ARCH CARDIOVASC DIS, V104, P4, DOI 10.1016/j.acvd.2010.11.002; Mockel M, 2015, EUR HEART J, V36, P369, DOI 10.1093/eurheartj/ehu178; Moons KGM, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b375; Moons KGM, 2002, J CLIN EPIDEMIOL, V55, P633, DOI 10.1016/S0895-4356(02)00408-0; Morgenthaler Nils G, 2010, Congest Heart Fail, V16 Suppl 1, pS37, DOI 10.1111/j.1751-7133.2010.00177.x; Morrow DA, 2003, CIRCULATION, V108, P250, DOI 10.1161/01.CIR.0000078080.37974.D2; Ottenbacher KJ, 2004, J CLIN EPIDEMIOL, V57, P1147, DOI 10.1016/j.jclinepi.2003.05.003; Reichlin T, 2009, NEW ENGL J MED, V361, P858, DOI 10.1056/NEJMoa0900428; Reichlin T, 2009, J AM COLL CARDIOL, V54, P60, DOI 10.1016/j.jacc.2009.01.076; Schaub N, 2012, CLIN CHEM, V58, P441, DOI 10.1373/clinchem.2011.173310; Thygesen K, 2007, CIRCULATION, V116, P2634, DOI 10.1161/CIRCULATIONAHA.107.187397; Thygesen K, 2012, J AM COLL CARDIOL, V60, P1581, DOI 10.1016/j.jacc.2012.08.001; Thygesen K, 2012, EUR HEART J, V33, P2252, DOI 10.1093/eurheartj/ehs154; Wu AHB, 2007, BIOMARK MED, V1, P45, DOI 10.2217/17520363.1.1.45	36	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132000	10.1371/journal.pone.0132000	http://dx.doi.org/10.1371/journal.pone.0132000			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177390	Green Published, Green Submitted, gold			2022-12-26	WOS:000358197600076
J	Reguero, BG; Losada, IJ; Diaz-Simal, P; Mendez, FJ; Beck, MW				Reguero, Borja G.; Losada, Inigo J.; Diaz-Simal, Pedro; Mendez, Fernando J.; Beck, Michael W.			Effects of Climate Change on Exposure to Coastal Flooding in Latin America and the Caribbean	PLOS ONE			English	Article							STORM SURGES; FUTURE	This study considers and compares several of the most important factors contributing to coastal flooding in Latin American and the Caribbean (LAC) while accounting for the variations of these factors with location and time. The study assesses the populations, the land areas and the built capital exposed at present and at the middle and end of the 21st century for a set of scenarios that include both climatic and non-climatic drivers. Climatic drivers include global mean sea level, natural modes of climate variability such as El Nino, natural subsidence, and extreme sea levels resulting from the combination of projected local sea-level rise, storm surges and wave setup. Population is the only human-related driver accounted for in the future. Without adaptation, more than 4 million inhabitants will be exposed to flooding from relative sea-level rise by the end of the century, assuming the 8.5 Wm(-2) trajectory of the Representative Concentration Pathways (RCPs), or RCP8.5. However, the contributions from El Nino events substantially raise the threat in several Pacific-coast countries of the region and sooner than previously anticipated. At the tropical Pacific coastlines, the exposure by the mid-century for an event similar to El Nino 1998 would be comparable to that of the RCP4.5 relative sea-level rise by the end of the century. Furthermore, more than 7.5 million inhabitants, 42,600 km(2) and built capital valued at 334 billion USD are currently situated at elevations below the 100-year extreme sea level. With sea levels rising and the population increasing, it is estimated that more than 9 million inhabitants will be exposed by the end of the century for either of the RCPs considered. The spatial distribution of exposure and the comparison of scenarios and timeframes can serve as a guide in future adaptation and risk reduction policies in the region.	[Reguero, Borja G.; Losada, Inigo J.; Diaz-Simal, Pedro; Mendez, Fernando J.] Univ Cantabria, Environm Hydraul Inst IH Cantabria, E-39005 Santander, Cantabria, Spain; [Reguero, Borja G.; Beck, Michael W.] Univ Calif Santa Cruz, Inst Marine Sci, Santa Cruz, CA 95064 USA; [Reguero, Borja G.; Beck, Michael W.] US Amer & Nat Conservancy, Arlington, VA USA	Universidad de Cantabria; IHCantabria - Instituto de Hidraulica Ambiental de la Universidad de Cantabria; University of California System; University of California Santa Cruz; Nature Conservancy	Losada, IJ (corresponding author), Univ Cantabria, Environm Hydraul Inst IH Cantabria, E-39005 Santander, Cantabria, Spain.	losadai@unican.es	Diaz-Simal, Pedro/P-5873-2015; Losada, Iñigo J/F-9001-2012; Beck, Michael W./AAB-2844-2019; Reguero, Borja/L-8621-2014	Diaz-Simal, Pedro/0000-0002-8645-952X; Losada, Iñigo J/0000-0002-9651-9709; Beck, Michael W./0000-0002-5107-9973; Reguero, Borja/0000-0001-5526-7157				Barros V, 2005, CAMBIO CLIMATICO RIO, P41; Bojanowski A, 2011, NAT GEOSCI, V4, P657, DOI 10.1038/ngeo1280; Brown S., 2013, COASTAL HAZARDS, P117, DOI [10.1007/978-94-007-5234-4, DOI 10.1007/978-94-007-5234-4_5]; Center for International Earth Science Information Network [CIESIN], 2011, GLOB RUR URB MAPP PR; Church JA, 2011, SURV GEOPHYS, V32, P585, DOI 10.1007/s10712-011-9119-1; D'Onofrio EE, 2008, J COASTAL RES, V24, P260, DOI 10.2112/05-0588.1; Dasgupta S, 2011, CLIMATIC CHANGE, V106, P567, DOI 10.1007/s10584-010-9959-6; Dodman D., 2009, POPULATION DYNAMICS, P64; ECLAC, 2013, STAT YB LAT AM CAR; Field C.B., 2014, CLIM CHANG 2014 IMP, P1, DOI [DOI 10.1038/446727A, 10.1017/CBO9781107415379]; Fiore MME, 2009, CONT SHELF RES, V29, P1643, DOI 10.1016/j.csr.2009.05.004; Garcia-Herrera R, 2000, NINO CLIMATOLOGIA EF; Gitay H, 2013, BUILDING RESILIENCE; Hallegatte S, 2013, NAT CLIM CHANGE, V3, P802, DOI [10.1038/nclimate1979, 10.1038/NCLIMATE1979]; Hardoy J, 2011, CURR OPIN ENV SUST, V3, P158, DOI 10.1016/j.cosust.2011.01.004; Hinkel J, 2014, P NATL ACAD SCI USA, V111, P3292, DOI 10.1073/pnas.1222469111; Hinkel J, 2009, GLOBAL ENVIRON CHANG, V19, P384, DOI 10.1016/j.gloenvcha.2009.03.002; Intergov Panel Clim Chg, 2012, MANAGING THE RISKS OF EXTREME EVENTS AND DISASTERS TO ADVANCE CLIMATE CHANGE ADAPTATION, P1, DOI 10.1017/CBO9781139177245; Jenks G.F., 1967, INT YB CARTOGR, V7, P186; Jongman B, 2012, GLOBAL ENVIRON CHANG, V22, P823, DOI 10.1016/j.gloenvcha.2012.07.004; Kelman I, 2015, INT J DISAST RISK SC, V6, P21, DOI 10.1007/s13753-015-0038-5; Kron W, 2013, NAT HAZARDS, V66, P1363, DOI 10.1007/s11069-012-0215-4; Losada IJ, 2013, GLOBAL PLANET CHANGE, V104, P34, DOI 10.1016/j.gloplacha.2013.02.006; McGranahan G, 2007, ENVIRON URBAN, V19, P17, DOI 10.1177/0956247807076960; Menendez M, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC005997; Mondal P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048191; Neumann B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118571; Nicholls RJ, 2004, GLOBAL ENVIRON CHANG, V14, P69, DOI 10.1016/j.gloenvcha.2003.10.007; Nurse LA, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT B: REGIONAL ASPECTS, P1613; Peltier WR., 2000, INT ASS GEOD S 2000; Pielke RA, 2005, SCIENCE, V310, P1615; Rabus B, 2003, ISPRS J PHOTOGRAMM, V57, P241, DOI 10.1016/S0924-2716(02)00124-7; Reguero BG, 2013, GLOBAL PLANET CHANGE, V100, P70, DOI 10.1016/j.gloplacha.2012.09.005; Satterthwaite D, 2009, HUMAN SETTLEMENTS DI; Seneviratne SI, 2012, MANAGING THE RISKS OF EXTREME EVENTS AND DISASTERS TO ADVANCE CLIMATE CHANGE ADAPTATION, P109; Slangen ABA, 2014, CLIMATIC CHANGE, V124, P317, DOI 10.1007/s10584-014-1080-9; Smolka M. O., 2008, NEW GLOBAL FRONTIER, P99; Stocker T.F., 2013, PHYS SCI BASIS, P1535, DOI [10.1017/CBO9781107415324, DOI 10.1017/CB09781107415324, DOI 10.1017/CBO9781107415324]; UNFPA United Nations Fund for Population Activities, 2012, LINK POP DYN URB PRO; Vargas G, 2011, ANDEAN GEOL, V38, P219, DOI 10.5027/andgeoV38n1-a12; Walsh KJE, 2012, GLOBAL PLANET CHANGE, V80-81, P149; Wong PP, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, P361	42	52	52	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0133409	10.1371/journal.pone.0133409	http://dx.doi.org/10.1371/journal.pone.0133409			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177285	gold, Green Published, Green Submitted			2022-12-26	WOS:000358197600255
J	Sek, AC; Xie, ZH; Terai, K; Long, LM; Nelson, C; Dudek, AZ; Druey, KM				Sek, Albert C.; Xie, Zhihui; Terai, Kaoru; Long, Lauren M.; Nelson, Celeste; Dudek, Arkadiusz Z.; Druey, Kirk M.			Endothelial Expression of Endothelin Receptor A in the Systemic Capillary Leak Syndrome	PLOS ONE			English	Article							VON-WILLEBRAND-FACTOR; CELLS; ESTABLISHMENT; PERMEABILITY; DISEASE; EDEMA	Idiopathic systemic capillary leak syndrome (SCLS) is a rare and potentially fatal vascular disorder characterized by reversible bouts of hypotension and edema resulting from fluid and solute escape into soft tissues. Although spikes in permeability-inducing factors have been linked to acute SCLS flares, whether or not they act on an inherently dysfunctional endothelium is unknown. To assess the contribution of endothelial-intrinsic mechanisms in SCLS, we derived blood-outgrowth endothelial cells (BOEC) from patients and healthy controls and examined gene expression patterns. Ednra, encoding Endothelin receptor A (ETA)-the target of Endothelin 1 (ET-1)-was significantly increased in SCLS BOEC compared to healthy controls. Although vasoconstriction mediated by ET-1 through ETA activation on vascular smooth muscle cells has been well characterized, the expression and function of ETA receptors in endothelial cells (ECs) has not been described. To determine the role of ETA and its ligand ET-1 in SCLS, if any, we examined ET-1 levels in SCLS sera and functional effects of endothelial ETA expression. ETA overexpression in EAhy926 endothelioma cells led to ET-1-induced hyper-permeability through canonical mechanisms. Serum ET-1 levels were elevated in acute SCLS sera compared to remission and healthy control sera, suggesting a possible role for ET-1 and ETA in SCLS pathogenesis. However, although ET-1 alone did not induce hyper-permeability of patient-derived BOEC, an SCLS-related mediator (CXCL10) increased Edrna quantities in BOEC, suggesting a link between SCLS and endothelial ETA expression. These results demonstrate that ET-1 triggers classical mechanisms of vascular barrier dysfunction in ECs through ETA. Further studies of the ET-1-ETA axis in SCLS and in more common plasma leakage syndromes including sepsis and filovirus infection would advance our understanding of vascular integrity mechanisms and potentially uncover new treatment strategies.	[Sek, Albert C.; Xie, Zhihui; Long, Lauren M.; Nelson, Celeste; Druey, Kirk M.] NIAID, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Terai, Kaoru; Dudek, Arkadiusz Z.] Univ Illinois, Dept Med, Div Hematol Oncol, Chicago, IL USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Druey, KM (corresponding author), NIAID, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	kdruey@niaid.nih.gov	Dudek, Arkadiusz Zbigniew/HGD-1339-2022; Sek, Albert/Q-6543-2019	Dudek, Arkadiusz Zbigniew/0000-0002-9114-8945; Sek, Albert/0000-0002-8170-3749	Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health [AI001083]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001083] Funding Source: NIH RePORTER	Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded by the Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health (AI001083 to KMD) (http://www.niaid.nih.gov/Pages/default.aspx.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker SM, 2008, FEBS LETT, V582, P4039, DOI 10.1016/j.febslet.2008.10.043; CLARKSON B, 1960, AM J MED, V29, P193, DOI 10.1016/0002-9343(60)90018-8; Druey KM, 2010, ANN INTERN MED, V153, P90, DOI 10.7326/0003-4819-153-2-201007200-00005; Dudek AZ, 2007, BRIT J CANCER, V97, P513, DOI 10.1038/sj.bjc.6603883; Dunmore BJ, 2013, HUM MOL GENET, V22, P3667, DOI 10.1093/hmg/ddt216; Erbilgin A, 2013, ARTERIOSCL THROM VAS, V33, P2509, DOI 10.1161/ATVBAHA.113.301989; Galie N, 2004, CARDIOVASC RES, V61, P227, DOI 10.1016/j.cardiores.2003.11.026; Gavard J, 2006, NAT CELL BIOL, V8, P1223, DOI 10.1038/ncb1486; Gousseff M, 2011, ANN INTERN MED, V154, DOI 10.7326/0003-4819-154-7-201104050-00004; Horinouchi T, 2007, EUR J PHARMACOL, V566, P28, DOI 10.1016/j.ejphar.2007.03.019; Horinouchi T, 2013, J PHARMACOL SCI, V123, P85, DOI 10.1254/jphs.13R02CR; Kapoor P, 2010, MAYO CLIN PROC, V85, P905, DOI 10.4065/mcp.2010.0159; Kawabe S, 2002, INTERNAL MED, V41, P211, DOI 10.2169/internalmedicine.41.211; Kitazawa T, 2011, GENE EXPR PATTERNS, V11, P371, DOI 10.1016/j.gep.2011.04.001; Komarova Y, 2010, ANNU REV PHYSIOL, V72, P463, DOI 10.1146/annurev-physiol-021909-135833; Kuklin V, 2005, CRIT CARE, V9, pR677, DOI 10.1186/cc3882; Lambert M, 2008, CRIT CARE MED, V36, P2184, DOI 10.1097/CCM.0b013e31817d7c71; Martin-Ramirez J, 2012, NAT PROTOC, V7, P1709, DOI 10.1038/nprot.2012.093; Mazzuca MQ, 2012, BIOCHEM PHARMACOL, V84, P147, DOI 10.1016/j.bcp.2012.03.020; Medina RJ, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/346735; Medina RJ, 2010, INVEST OPHTH VIS SCI, V51, P5906, DOI 10.1167/iovs.09-4951; Meier LA, 2014, J CARDIOVASC TRANSL, V7, P242, DOI 10.1007/s12265-013-9539-z; Middleton J, 2005, J PATHOL, V206, P260, DOI 10.1002/path.1788; Milbauer LC, 2008, BLOOD, V111, P3872, DOI 10.1182/blood-2007-06-097188; Niu J, 2015, MOL MED REP, V11, P3981, DOI 10.3892/mmr.2014.3138; Rautureau Y, 2012, CURR OPIN NEPHROL HY, V21, P128, DOI 10.1097/MNH.0b013e32834f0092; Rodriguez-Pascual F, 2011, PHARMACOL RES, V63, P463, DOI 10.1016/j.phrs.2011.01.014; Rossi P, 2004, SHOCK, V21, P543, DOI 10.1097/01.shk.0000126147.76311.18; Sakamoto TM, 2013, MICROVASC RES, V90, P173, DOI 10.1016/j.mvr.2013.10.002; Somani A, 2007, TRANSL RES, V150, P30, DOI 10.1016/j.trsl.2007.02.002; Wang JW, 2013, BLOOD, V121, P2762, DOI 10.1182/blood-2012-06-434373; Wang JB, 2012, PEPTIDES, V38, P457, DOI 10.1016/j.peptides.2012.09.007; Xie ZH, 2013, RARE DIS, V1, DOI 10.4161/rdis.27445; Xie ZH, 2015, AM J MED, V128, P91, DOI 10.1016/j.amjmed.2014.08.015; Xie ZH, 2014, AM J RESP CRIT CARE, V189, P1145, DOI 10.1164/rccm.201310-1746LE; Xie ZH, 2012, BLOOD, V119, P4321, DOI 10.1182/blood-2011-08-375816; Yang Z, 2012, AM J RESP CELL MOL, V46, P823, DOI 10.1165/rcmb.2011-0110OC	37	20	20	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0133266	10.1371/journal.pone.0133266	http://dx.doi.org/10.1371/journal.pone.0133266			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176954	gold, Green Published, Green Submitted			2022-12-26	WOS:000358197600236
J	Smith, T; Codrea, V				Smith, Thierry; Codrea, Vlad			Red Iron-Pigmented Tooth Enamel in a Multituberculate Mammal from the Late Cretaceous Transylvanian "Hateg Island"	PLOS ONE			English	Article							EVOLUTION; DINOSAUR; EXTINCT; BASIN; VERTEBRATES; MORPHOLOGY; PALEOCENE; RADIATION; TEETH; VENOM	Mammals that inhabit islands are characterized by peculiar morphologies in comparison to their mainland relatives. Here we report the discovery of a partial skull associated with the lower jaws of a Late Cretaceous (approximate to 70 Ma) multituberculate mammal from the Carpathian "Hateg Island" of Transylvania, Romania. The mammal belongs to the Kogaionidae, one of the rare families that survived the Cretaceous-Paleogene mass extinction in Europe. The excellent preservation of this specimen allows for the first time description of the complete dentition of a kogaionid and demonstration that the enigmatic Barbatodon transylvanicus presents a mosaic of primitive and derived characters, and that it is phylogenetically basal among the Cimolodonta. Another peculiarity is the presence of red pigmentation in its tooth enamel. The red coloration is present on the anterior side of the incisors and on the cusps of most of the teeth. Energy-dispersive X-ray spectrometry (EDS) analysis reveals that the pigmented enamel contains iron, as in living placentals. Such a red pigmentation is known in living soricine shrews and many families of rodents, where it is thought to increase the resistance of the enamel to the abrasion that occurs during "grinding" mastication. The extended pattern of red pigment distribution in Barbatodon is more similar to that in eulipotyplan insectivores than to that in rodents and suggests a very hard diet and, importantly, demonstrates that its grasping incisors were not ever-growing. As inferred for other endemic Transylvanian vertebrates such as dwarf herbivorous dinosaurs and unusual theropod dinosaurs, insularity was probably the main factor of survival of such a primitive mammalian lineage relative to other mainland contemporaries of the Northern hemisphere.	[Smith, Thierry] Royal Belgian Inst Nat Sci, Directorate Earth & Hist Life, Brussels, Belgium; [Codrea, Vlad] Univ Babes Bolyai, Fac Biol & Geol, R-3400 Cluj Napoca, Romania	Royal Belgian Institute of Natural Sciences; Babes Bolyai University from Cluj	Smith, T (corresponding author), Royal Belgian Inst Nat Sci, Directorate Earth & Hist Life, Brussels, Belgium.	thierry.smith@naturalsciences.be	Codrea, Vlad/C-2721-2011	Codrea, Vlad/0000-0002-5575-4139; Smith, Thierry/0000-0002-1795-2564; Codrea, Vlad Aurel/0000-0002-3992-955X	Royal Belgian Institute of Natural Sciences; Fonds National de la Recherche; Belgian Science Policy Office [MO/36/001-004]; Romanian National Research Council CNCS grant [PN-II-ID-PCE-2011-3-0381]	Royal Belgian Institute of Natural Sciences; Fonds National de la Recherche(Luxembourg National Research Fund); Belgian Science Policy Office(Belgian Federal Science Policy Office); Romanian National Research Council CNCS grant(Consiliul National al Cercetarii Stiintifice (CNCS))	Fieldwork was supported by the Royal Belgian Institute of Natural Sciences and by travel grants from the Fonds National de la Recherche (to TS). Field vehicles and technical equipments were kindly supplied by Belgian companies Fabricom and Ford Motor. Funding for this research was provided by the Belgian Science Policy Office Projects MO/36/001-004 (to Pierre Bultynck and TS) and the Romanian National Research Council CNCS grant PN-II-ID-PCE-2011-3-0381 (to VC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agenbroad Larry D., 2009, P 7 CAL ISL S, P15; Akersten William A., 2002, Journal of Vertebrate Paleontology, V22, p31A; Asher RJ, 2002, B AM MUS NAT HIST, P1; Benton MJ, 2010, PALAEOGEOGR PALAEOCL, V293, P438, DOI 10.1016/j.palaeo.2010.01.026; Blanco A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115837; Brooker LR, 2012, ADVANCED TOPICS IN BIOMINERALIZATION, P65; Brown P, 2004, NATURE, V431, P1055, DOI 10.1038/nature02999; CARLSON S J, 1985, Contributions from the Museum of Paleontology University of Michigan, V27, P1; Codrea AV., 2005, STUD U BABES-BOL GEO, V50, P19, DOI [10.5038/1937-8602.50.1.3, DOI 10.5038/1937-8602.50.1.3]; Codrea V, 2002, CR PALEVOL, V1, P173, DOI 10.1016/S1631-0683(02)00021-0; Codrea VA, 2008, CR PALEVOL, V7, P289, DOI 10.1016/j.crpv.2008.03.008; Codrea Vlad A., 2012, P570; Codrea VA, 2014, CR PALEVOL, V13, P489, DOI 10.1016/j.crpv.2014.01.003; Csiki Z, 2000, ACTA PALAEONTOL POL, V45, P85; Csiki Z., 2001, ACTA PALAEONTOL ROM, V3, P87; Csiki Z, 2010, P NATL ACAD SCI USA, V107, P15357, DOI 10.1073/pnas.1006970107; Csiki Zoltan, 2005, Acta Palaeontologica Romaniae, V5, P73; Csiki-Sava Z, 2015, ZOOKEYS, P1, DOI 10.3897/zookeys.469.8439; Csontos L, 2004, PALAEOGEOGR PALAEOCL, V210, P1, DOI 10.1016/j.palaeo.2004.02.033; Delfino M, 2008, J VERTEBR PALEONTOL, V28, P111, DOI 10.1671/0272-4634(2008)28[111:ACSOAP]2.0.CO;2; Dercourt J., 2000, PALAEOGEOGRAPHICAL M; DOTSCH C, 1978, Z SAUGETIERKD, V43, P65; Dumont M, 2014, J STRUCT BIOL, V186, P38, DOI 10.1016/j.jsb.2014.02.006; Feild TS, 2011, P NATL ACAD SCI USA, V108, P8363, DOI 10.1073/pnas.1014456108; Folinsbee KE, 2013, CR PALEVOL, V12, P531, DOI 10.1016/j.crpv.2013.05.004; Fosse G, 2001, ACTA PALAEONTOL POL, V46, P437; FOSTER JB, 1964, NATURE, V202, P234, DOI 10.1038/202234a0; Fox RC, 2005, NATURE, V435, P1091, DOI 10.1038/nature03646; Freudenthal M., 1972, Scripta geol, V14, P1; Gheerbrant E, 1999, ECLOGAE GEOL HELV, V92, P517; Goloboff P, 2003, CLADISTICS, V24, P1; Gordon LM, 2015, SCIENCE, V347, P746, DOI 10.1126/science.1258950; Goswami A, 2011, P NATL ACAD SCI USA, V108, P16333, DOI 10.1073/pnas.1108723108; Grellet-Tinner G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032051; Grigorescu D., 1987, Geologica et Palaeontologica, V21, P237; Jordana X, 2012, P ROY SOC B-BIOL SCI, V279, P3339, DOI 10.1098/rspb.2012.0689; Kielan-Jaworowska Z, 2001, PALAEONTOLOGY, V44, P389, DOI 10.1111/1475-4983.00185; Kielan-Jaworowska Z., 2005, MAMMALS AGE DINOSAUR; KOZAWA Y, 1988, HISTOCHEMISTRY, V90, P61, DOI 10.1007/BF00495708; Krause DW, 2014, NATURE, V515, P512, DOI 10.1038/nature13922; KRAUSE DW, 1987, J MAMMAL, V68, P755, DOI 10.2307/1381552; KRAUSE DW, 1982, PALEOBIOLOGY, V8, P265, DOI 10.1017/S0094837300006989; Leinders J.J.M., 1984, SCRIPTA GEOLOGICA, V70, P1; Mao F.-Y., ACTA PALAEO IN PRESS; Mao FY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128243; Miao Desui, 1986, Contributions to Geology University of Wyoming, V24, P65; MOTTA PJ, 1987, CAN J ZOOL, V65, P106, DOI 10.1139/z87-016; Nopcsa F., 1914, VERHANDLUNGEN ZOOLOG, V54, P12; PALOMBO MR, 2001, WORLD ELEPHANTS, P486; PANAIOTU C, 2002, 7 EUR WORKSH VERT PA, P61; Panaiotu CG, 2010, PALAEOGEOGR PALAEOCL, V293, P343, DOI 10.1016/j.palaeo.2009.11.017; Pelaez-Campomanes P, 2000, J PALEONTOL, V74, P701, DOI 10.1666/0022-3360(2000)074<0701:TEMOTE>2.0.CO;2; Radulescu C., 1996, ANUARUL INSTITUTULUI, V69, P177; Radulescu C., 1986, CR HEBD ACAD SCI, V304, P1825; RANDALL M, 1966, NATURE, V210, P1325, DOI 10.1038/2101325a0; Repenning C. A., 1967, Professional Papers US Geological Survey, V565, P1; ROUGIER GW, 1997, AM MUS NOVIT, P1; RUNHAM NW, 1969, Z ZELLFORSCH MIK ANA, V99, P608, DOI 10.1007/BF00340948; SELVIG KA, 1975, SCAND J DENT RES, V83, P88; SHELLIS RP, 1976, J ZOOL, V180, P69; Smith Thierry, 2002, Studia Universitatis Babes-Bolyai Geologia, P321; Smith T, 2010, NATURWISSENSCHAFTEN, V97, P417, DOI 10.1007/s00114-010-0651-5; Stein K, 2010, P NATL ACAD SCI USA, V107, P9258, DOI 10.1073/pnas.1000781107; Strait SG, 2006, J MAMMAL, V87, P700, DOI 10.1644/05-MAMM-A-265R4.1; Van Itterbeeck J, 2005, GEOL CARPATH, V56, P137; VIANEY-LIAUD M, 1986, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V191, P85; Vianey-Liaud M., 1979, Palaeovertebrata (Montpellier), V9, P117; vonKoenigswald W, 1997, TOOTH ENAMEL MICROSTRUCTURE, P137; Wall C.E., 1992, Journal of Vertebrate Paleontology, V12, P172; Weil A, 2008, EVOLUTION OF TERTIARY MAMMALS OF NORTH AMERICA, VOL 2, P19; Weishampel DB, 2010, PALAEOGEOGR PALAEOCL, V293, P419, DOI 10.1016/j.palaeo.2010.03.024; Wilson GP, 2012, NATURE, V483, P457, DOI 10.1038/nature10880; Worthy TH, 2006, P NATL ACAD SCI USA, V103, P19419, DOI 10.1073/pnas.0605684103; Wu SY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046445; Yuan CX, 2013, SCIENCE, V341, P779, DOI 10.1126/science.1237970	75	24	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132550	10.1371/journal.pone.0132550	http://dx.doi.org/10.1371/journal.pone.0132550			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177465	Green Submitted, gold, Green Published			2022-12-26	WOS:000358197600122
J	Torres, M; Palomares, O; Quiralte, J; Pauli, G; Rodriguez, R; Villalba, M				Torres, Maria; Palomares, Oscar; Quiralte, Joaquin; Pauli, Gabrielle; Rodriguez, Rosalia; Villalba, Mayte			An Enzymatically Active beta-1,3-Glucanase from Ash Pollen with Allergenic Properties: A Particular Member in the Oleaceae Family	PLOS ONE			English	Article							LATEX-FRUIT SYNDROME; YEAST PICHIA-PASTORIS; OLIVE POLLEN; MAJOR ALLERGEN; CROSS-REACTIVITY; BETA-GLUCANASES; MOLECULAR-BASIS; CHE A-3; BINDING; 1,3-BETA-GLUCANASE	Endo-beta-1,3-glucanases are widespread enzymes with glycosyl hydrolitic activity involved in carbohydrate remodelling during the germination and pollen tube growth. Although members of this protein family with allergenic activity have been reported, their effective contribution to allergy is little known. In this work, we identified Fra e 9 as a novel allergenic beta-1,3-glucanase from ash pollen. We produced the catalytic and carbohydrate-binding domains as two independent recombinant proteins and characterized them from structural, biochemical and immunological point of view in comparison to their counterparts from olive pollen. We showed that despite having significant differences in biochemical activity Fra e 9 and Ole e 9 display similar IgE-binding capacity, suggesting that beta-1,3-glucanases represent an heterogeneous family that could display intrinsic allergenic capacity. Specific cDNA encoding Fra e 9 was cloned and sequenced. The full-length cDNA encoded a polypeptide chain of 461 amino acids containing a signal peptide of 29 residues, leading to a mature protein of 47760.2 Da and a pI of 8.66. An N-terminal catalytic domain and a C-terminal carbohydrate-binding module are the components of this enzyme. Despite the phylogenetic proximity to the olive pollen beta-1,3-glucanase, Ole e 9, there is only a 39% identity between both sequences. The N- and C-terminal domains have been produced as independent recombinant proteins in Escherichia coli and Pichia pastoris, respectively. Although a low or null enzymatic activity has been associated to long alpha-1,3-glucanases, the recombinant N-terminal domain has 200-fold higher hydrolytic activity on laminarin than reported for Ole e 9. The C-terminal domain of Fra e 9, a cysteine-rich compact structure, is able to bind laminarin. Both molecules retain comparable IgE-binding capacity when assayed with allergic sera. In summary, the structural and functional comparison between these two closely phylogenetic related enzymes provides novel insights into the complexity of alpha-1,3-glucanases, representing a heterogeneous protein family with intrinsic allergenic capacity.	[Torres, Maria; Palomares, Oscar; Rodriguez, Rosalia; Villalba, Mayte] Univ Madrid, Biochem & Mol Biol Dept Complutense, Madrid 3, Spain; [Quiralte, Joaquin] Virgen del Rocio Univ, Hosp Seville, Seville, Spain; [Pauli, Gabrielle] Hop Univ Strasbourg, Hop Lyautey, Strasbourg, France	CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Villalba, M (corresponding author), Univ Madrid, Biochem & Mol Biol Dept Complutense, Madrid 3, Spain.	mvillalb@quim.ucm.es	Palomares, Oscar/ABG-5229-2020; IBIS, ALERGICAS/C-1733-2016; Villalba, María Teresa/AAW-1067-2020; Torres, Maria/GVU-3391-2022; RODRIGUEZ, ROSALIA/K-4993-2014	Villalba, María Teresa/0000-0002-0042-9953; RODRIGUEZ, ROSALIA/0000-0002-4280-3691; Palomares, Oscar/0000-0003-4516-0369	PROYECTOS DE INVESTIGACION FUNDAMENTAL NO ORIENTADA (SAF) [2008-04053, 2011-26716]	PROYECTOS DE INVESTIGACION FUNDAMENTAL NO ORIENTADA (SAF)	PROYECTOS DE INVESTIGACION FUNDAMENTAL NO ORIENTADA (SAF) (2008-04053) RR, PROYECTOS DE INVESTIGACION FUNDAMENTAL NO ORIENTADA (SAF) (2011-26716) MV.	ALENIUS H, 1995, CLIN EXP ALLERGY, V25, P659, DOI 10.1111/j.1365-2222.1995.tb01114.x; Andersson K, 2003, INT ARCH ALLERGY IMM, V130, P87, DOI 10.1159/000069013; Barber D, 2008, ALLERGY, V63, P1550, DOI 10.1111/j.1398-9995.2008.01807.x; Barderas R, 2006, ANN ALLERG ASTHMA IM, V96, P557, DOI 10.1016/S1081-1206(10)63550-8; Barderas R, 2004, J ALLERGY CLIN IMMUN, V113, P1192, DOI 10.1016/j.jaci.2003.12.587; Barral P, 2005, PROTEIN EXPRES PURIF, V44, P147, DOI 10.1016/j.pep.2005.04.012; Barral P, 2005, BIOCHEM J, V390, P77, DOI 10.1042/BJ20050456; Barre A, 2009, MOL IMMUNOL, V46, P1595, DOI 10.1016/j.molimm.2008.12.007; Batanero E, 1996, EUR J BIOCHEM, V241, P772, DOI 10.1111/j.1432-1033.1996.00772.x; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; CHEN L, 1995, J BIOL CHEM, V270, P8093, DOI 10.1074/jbc.270.14.8093; Dahl R, 2004, RESP MED, V98, P398, DOI 10.1016/j.rmed.2003.11.015; DAMATO G, 1988, CLIN ALLERGY, V18, P541, DOI 10.1111/j.1365-2222.1988.tb02905.x; El-Katatny MH, 2001, APPL MICROBIOL BIOT, V56, P137, DOI 10.1007/s002530100646; Fuchs KP, 2003, MICROBIOL-SGM, V149, P1021, DOI 10.1099/mic.0.26153-0; Garcia BE, 2011, J INVEST ALLERG CLIN, V21, P34; Guillen D, 2010, APPL MICROBIOL BIOT, V85, P1241, DOI 10.1007/s00253-009-2331-y; HIRD DL, 1993, PLANT J, V4, P1023, DOI 10.1046/j.1365-313X.1993.04061023.x; Huecas S, 1999, EUR J BIOCHEM, V261, P539, DOI 10.1046/j.1432-1327.1999.00307.x; Huecas S, 2001, J BIOL CHEM, V276, P27959, DOI 10.1074/jbc.M103041200; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mas S, 2014, J ALLERGY CLIN IMMUN, V133, P923, DOI 10.1016/j.jaci.2013.10.061; MEMELINK J, 1990, PLANT MOL BIOL, V14, P119, DOI 10.1007/BF00018553; Nelson N, 1944, J BIOL CHEM, V153, P375; Palomares O, 2003, BIOCHEM J, V369, P593, DOI 10.1042/BJ20020423; Palomares O, 2005, CLIN EXP ALLERGY, V35, P345, DOI 10.1111/j.1365-2222.2004.02186.x; Palomares O, 2006, ANN ALLERG ASTHMA IM, V97, P61, DOI 10.1016/S1081-1206(10)61371-3; Peumans WJ, 2000, EUR J BIOCHEM, V267, P1188, DOI 10.1046/j.1432-1327.2000.01117.x; Popolo L, 2008, J BIOL CHEM, V283, P18553, DOI 10.1074/jbc.M801562200; Receveur-Brechot V, 2006, PROTEINS, V63, P235, DOI 10.1002/prot.20876; Rodriguez R, 2007, J INVEST ALLERG CLIN, V17, P4; Salamanca G, 2010, FEBS J, V277, P2729, DOI 10.1111/j.1742-4658.2010.07689.x; SOMOGYI M, 1952, J BIOL CHEM, V195, P19; Thomas BR, 2000, INT J BIOL MACROMOL, V27, P145, DOI 10.1016/S0141-8130(00)00110-0; Thomas BR, 2000, INT J BIOL MACROMOL, V27, P139, DOI 10.1016/S0141-8130(00)00109-4; Trevino MA, 2008, PROTEIN SCI, V17, P371, DOI 10.1110/ps.073230008; van Loon LC, 2006, ANNU REV PHYTOPATHOL, V44, P135, DOI 10.1146/annurev.phyto.44.070505.143425; Verdino P, 2008, J IMMUNOL, V180, P2313, DOI 10.4049/jimmunol.180.4.2313; Verma DPS, 2005, TRENDS PLANT SCI, V10, P159, DOI 10.1016/j.tplants.2005.02.004; VOGELILANGE R, 1994, PLANT MOL BIOL, V25, P299, DOI 10.1007/BF00023245; Wagner S, 2004, CLIN EXP ALLERGY, V34, P1739, DOI 10.1111/j.1365-2222.2004.02103.x; WARD ER, 1991, PLANT PHYSIOL, V96, P390, DOI 10.1104/pp.96.2.390; WATANABE T, 1992, J BACTERIOL, V174, P186, DOI 10.1128/jb.174.1.186-190.1992; Wojtkowiak A, 2012, ACTA CRYSTALLOGR D, V68, P713, DOI 10.1107/S090744491200995X; WORRALL D, 1992, PLANT CELL, V4, P759, DOI 10.1105/tpc.4.7.759; Yi SY, 1997, MOL CELLS, V7, P408	46	19	19	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0133066	10.1371/journal.pone.0133066	http://dx.doi.org/10.1371/journal.pone.0133066			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177095	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000358197600208
J	Folayan, MO; Adebajo, S; Adeyemi, A; Ogungbemi, M				Folayan, Morenike Oluwatoyin; Adebajo, Sylvia; Adeyemi, Adedayo; Ogungbemi, Micheal			Differences in Sexual Practices, Sexual Behavior and HIV Risk Profile between Adolescents and Young Persons in Rural and Urban Nigeria	PLOS ONE			English	Article							PREVALENCE; HEALTH; WOMEN	Introduction We aimed to determine differences in sexual practices, HIV sexual risk behaviors, and HIV risk profile of adolescents and young persons' in rural and urban Nigeria. Methodology We recruited 772 participants 15 to 24 years old from urban and rural townships in Nigeria through a household survey. Information on participants' socio-demographic profile (age sex, residential area, number of meals taken per day), sexual practices (vagina, oral and anal sex; heterosexual and homosexual sex; sex with spouse, casual acquaintances, boy/girlfriend and commercial sex workers), sexual behavior (age of sexual debut, use of condom, multiple sex partners, transactional sex and age of sexual partner), and other HIV risk factors (use of alcohol and psychoactive substances, reason for sexual debut, knowledge of HIV prevention and HIV transmission, report of STI symptoms) were collected through an interviewer administered questionnaire. Differences in sexual behavior and sexual practices of adolescents and HIV risk profile of adolescents and young persons resident in urban and rural areas were determined. Results More than half (53.5%) of the respondents were sexually active, with more residing in the rural than urban areas (64.9% vs 44.1%; p<0.001) and more resident in the rural area reporting having more than one sexual partner (29.5% vs 20.4%; p = 0.04). Also, 97.3% of sexually active respondents reported having vaginal sex, 8.7% reported oral sex and 1.9% reported anal sex. More male than female respondents in the urban area used condoms during the last vaginal sexual intercourse (69.1% vs 51.9%; p = 0.02), and reported sex with casual partners (7.0% vs 15.3%; p = 0.007). More female than male respondents residing in the rural area engaged in transactional sex (1.0% vs 6.7%; p = 0.005). More females than males in both rural (3.6% vs 10.2%; p = 0.04) and urban (4.7% vs 26.6%; p<0.001) areas self-reported a history of discharge. More females than males in both rural (1.4% vs 17.0%; p = 0.04) and urban (15.0% vs 29.1%; p<0.001) areas self-reported a history of itching. Conclusion There are differences in the sexual behavior and practices of adolescents and young persons' residing in the urban and rural area with implication for HIV prevention programming.	[Folayan, Morenike Oluwatoyin] Obafemi Awolowo Univ, Inst Publ Hlth, Ife, Nigeria; [Folayan, Morenike Oluwatoyin] Obafemi Awolowo Univ, Dept Child Dent Hlth, Ife, Nigeria; [Adebajo, Sylvia] Populat Council, Abuja, Nigeria; [Adeyemi, Adedayo] MEASURE, Asokoro, Abuja, Nigeria; [Ogungbemi, Micheal] Natl Agcy Control AIDS, Strateg Knowledge Management Unit, Abuja, Nigeria	Obafemi Awolowo University; Obafemi Awolowo University	Folayan, MO (corresponding author), Obafemi Awolowo Univ, Inst Publ Hlth, Ife, Nigeria.	toyinukpong@yahoo.co.uk	Folayan, Morenike/A-8632-2018	Folayan, Morenike/0000-0002-9008-7730	Africa Initiative	Africa Initiative	Funding for this study was obtained through a grant support from Africa Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboki H, 2014, AFR J REPROD HEALTH, V18, P109; Bamidele James Olusegun, 2009, Int J Adolesc Med Health, V21, P387, DOI 10.1515/IJAMH.2009.21.3.387; Brody S, 2005, PLOS MED, V2, P458, DOI 10.1371/journal.pmed.0020137; Brown JD, 2009, COMMUN RES, V36, P129, DOI 10.1177/0093650208326465; Darj E, 2010, SEX REPROD HEALTHC, V1, P111, DOI 10.1016/j.srhc.2010.03.001; Dodoo FNA, 2007, SOC SCI MED, V64, P1019, DOI 10.1016/j.socscimed.2006.10.007; Federal Ministry of Health, 2005, NAT HIV AIDS REPR HL; Federal Ministry of Health, 2007, NAT HIV AIDS REPR HL; Federal Ministry of Health, 2010, 2010 NAT HIV SER SEN; Federal Ministry of Health, 2010, HIV STI INT BIOL BEH; Federal Ministry of Health, 2008, HIV STI INT BIOL BEH; Folayan MO, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-83; Folayan MO, 2014, GLOBAL HEALTH ACTION, V7, DOI 10.3402/gha.v7.25583; Halperin DT, 1999, AIDS PATIENT CARE ST, V13, P717, DOI 10.1089/apc.1999.13.717; L'Engle KL, 2006, J ADOLESCENT HEALTH, V38, P186, DOI 10.1016/j.jadohealth.2005.03.020; Mmari K, 2014, ARCH DIS CHILD, V99, P778, DOI 10.1136/archdischild-2013-304072; National Agency for the Control of AIDS, 2014, GLOB AIDS RESP COUNT; National Agency for the Control of AIDS, 2008, MOD HIV TRANSM NIG A; Ogungbemi K, 2014, NIGERIAN J HLTH SCI, V14, P16; Okpani A O, 2000, Afr J Reprod Health, V4, P40, DOI 10.2307/3583241; UNAIDS, 2012, FACTSH; Voeten HACM, 2004, SEX TRANSM DIS, V31, P481, DOI 10.1097/01.olq.0000135989.14131.9d; WebMD, HIGH RISK SEX BEH TO	23	20	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0129106	10.1371/journal.pone.0129106	http://dx.doi.org/10.1371/journal.pone.0129106			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1QN	26171859	Green Published, gold, Green Submitted			2022-12-26	WOS:000358194900003
J	Tsuzuki, T; Shinozaki, S; Nakamoto, H; Kaneki, M; Goto, S; Shimokado, K; Kobayashi, H; Naito, H				Tsuzuki, Takamasa; Shinozaki, Shohei; Nakamoto, Hideko; Kaneki, Masao; Goto, Sataro; Shimokado, Kentaro; Kobayashi, Hiroyuki; Naito, Hisashi			Voluntary Exercise Can Ameliorate Insulin Resistance by Reducing iNOS-Mediated S-Nitrosylation of Akt in the Liver in Obese Rats	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; HYPERPHAGIC OLETF RATS; PROTEIN-KINASE-B/AKT; SKELETAL-MUSCLE; ADIPOSE-TISSUE; ENDURANCE EXERCISE; METABOLIC SYNDROME; RECEPTOR SUBSTRATE-1; GLUCOSE-HOMEOSTASIS; NITROSATIVE STRESS	Voluntary exercise can ameliorate insulin resistance. The underlying mechanism, however, remains to be elucidated. We previously demonstrated that inducible nitric oxide synthase (iNOS) in the liver plays an important role in hepatic insulin resistance in the setting of obesity. In this study, we tried to verify our hypothesis that voluntary exercise improves insulin resistance by reducing the expression of iNOS and subsequent S-nitrosylation of key molecules of glucose metabolism in the liver. Twenty-one Otsuka Long-Evans Tokushima Fatty (OLETF) rats, a model of type 2 diabetes mellitus, and 18 non-diabetic control Long-Evans Tokushima Otsuka (LETO) rats were randomly assigned to a sedentary group or exercise group subjected to voluntary wheel running for 20 weeks. The voluntary exercise significantly reduced the fasting blood glucose and HOMA-IR in the OLETF rats. In addition, the exercise decreased the amount of iNOS mRNA in the liver in the OLETF rats. Moreover, exercise reduced the levels of S-nitrosylated Akt in the liver, which were increased in the OLETF rats, to those observed in the LETO rats. These findings support our hypothesis that voluntary exercise improves insulin resistance, at least partly, by suppressing the iNOS expression and subsequent S-nitrosylation of Akt, a key molecule of the signal transduction pathways in glucose metabolism in the liver.	[Tsuzuki, Takamasa; Kobayashi, Hiroyuki; Naito, Hisashi] Juntendo Univ, Grad Sch Hlth & Sports Sci, Chiba, Japan; [Tsuzuki, Takamasa] Japan Soc Promot Sci, Tokyo, Japan; [Shinozaki, Shohei] Tokyo Med & Dent Univ, Grad Sch Med, Dept Arteriosclerosis & Vasc Biol, Tokyo, Japan; [Nakamoto, Hideko; Goto, Sataro] Juntendo Univ, Grad Sch Hlth & Sports Sci, Inst Hlth & Sports Sci & Med, Chiba, Japan; [Kaneki, Masao] Harvard Univ, Sch Med, Shriners Hosp Children, Dept Anesthesia Crit Care & Pain Med,Massachusett, Charlestown, MA USA; [Shimokado, Kentaro] Tokyo Med & Dent Univ, Grad Sch Med, Dept Geriatr & Vasc Med, Tokyo, Japan; [Kobayashi, Hiroyuki] Tsukuba Univ Hosp, Mito Med Ctr, Dept Gen Med, Ibaraki, Japan	Juntendo University; Japan Society for the Promotion of Science; Tokyo Medical & Dental University (TMDU); Juntendo University; Harvard University; Tokyo Medical & Dental University (TMDU); University of Tsukuba	Naito, H (corresponding author), Juntendo Univ, Grad Sch Hlth & Sports Sci, Chiba, Japan.	hnaitou@juntendo.ac.jp	Tsuzuki, Takamasa/S-3563-2019; Shinozaki, Shohei/AAT-3018-2021; Naito, Hisashi/F-5655-2011	Tsuzuki, Takamasa/0000-0002-0241-1183; Naito, Hisashi/0000-0002-0522-9512; Andrews, Zane B./0000-0002-9097-7944	MEXT-Supported Program for the Strategic Research Foundation at Private Universities [S1101008]; JSPS [13J10819]; JSPS KANKENHI [25860231]; Kato Memorial Bioscience Foundation; Takeda Science Foundation; Japan Atherosclerosis Research Foundation	MEXT-Supported Program for the Strategic Research Foundation at Private Universities(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS KANKENHI; Kato Memorial Bioscience Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); Japan Atherosclerosis Research Foundation	This work was supported by grants from the MEXT-Supported Program for the Strategic Research Foundation at Private Universities (S1101008) to H. Naito, a Grant-in-Aid for JSPS Fellows (13J10819) to T. Tsuzuki, JSPS KANKENHI (25860231), Kato Memorial Bioscience Foundation and Takeda Science Foundation to S. Shinozaki and the Japan Atherosclerosis Research Foundation to K. Shimokado. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Anand P, 2012, J MOL MED, V90, P233, DOI 10.1007/s00109-012-0878-z; Benhar M, 2009, NAT REV MOL CELL BIO, V10, P721, DOI 10.1038/nrm2764; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Bruning JC, 1998, MOL CELL, V2, P559, DOI 10.1016/S1097-2765(00)80155-0; Carvalho MA, 2005, DIABETES, V54, P959, DOI 10.2337/diabetes.54.4.959; Carvalho MA, 2009, DIABETOLOGIA, V52, P2425, DOI 10.1007/s00125-009-1498-1; Chang YS, 2005, J LIPID RES, V46, P2624, DOI 10.1194/jlr.M500154-JLR200; Copps KD, 2010, CELL METAB, V11, P84, DOI 10.1016/j.cmet.2009.11.003; Crissey JM, 2014, AM J PHYSIOL-REG I, V306, pR596, DOI 10.1152/ajpregu.00493.2013; Dallaire P, 2008, DIABETES, V57, P1999, DOI 10.2337/db08-0540; Eghbalzadeh K, 2014, NITRIC OXIDE-BIOL CH, V37, P28, DOI 10.1016/j.niox.2013.12.009; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fontana L, 2010, AGE, V32, P97, DOI 10.1007/s11357-009-9118-z; Frank LL, 2005, OBES RES, V13, P615, DOI 10.1038/oby.2005.66; Fujimoto M, 2005, DIABETES, V54, P1340, DOI 10.2337/diabetes.54.5.1340; Galbo T, 2013, P NATL ACAD SCI USA, V110, P12780, DOI 10.1073/pnas.1311176110; GOODYEAR LJ, 1992, J APPL PHYSIOL, V72, P143, DOI 10.1152/jappl.1992.72.1.143; GOODYEAR LJ, 1992, DIABETES, V41, P1091, DOI 10.2337/diabetes.41.9.1091; Hardie DG, 1998, ANNU REV BIOCHEM, V67, P821, DOI 10.1146/annurev.biochem.67.1.821; He CC, 2012, NATURE, V481, P511, DOI 10.1038/nature10758; Herrema H, 2014, BIOCHEM BIOPH RES CO, V443, P689, DOI 10.1016/j.bbrc.2013.12.023; Hilder TL, 2003, FEBS LETT, V553, P63, DOI 10.1016/S0014-5793(03)00972-4; HILL JO, 1983, PHYSIOL BEHAV, V31, P133, DOI 10.1016/0031-9384(83)90107-5; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; Jenkins NT, 2012, J APPL PHYSIOL, V113, P1873, DOI 10.1152/japplphysiol.00936.2012; Jung TW, 2014, MOL CELL ENDOCRINOL, V391, P30, DOI 10.1016/j.mce.2014.04.012; Kaneki M, 2007, ANTIOXID REDOX SIGN, V9, P319, DOI 10.1089/ars.2006.1464; Kano Y, 2011, AM J PHYSIOL-REG I, V301, pR1350, DOI 10.1152/ajpregu.00294.2011; KAWANO K, 1992, DIABETES, V41, P1422, DOI 10.2337/diabetes.41.11.1422; Lakka TA, 2007, APPL PHYSIOL NUTR ME, V32, P76, DOI [10.1139/H06-113, 10.1139/h06-113]; Laye MJ, 2009, J PHYSIOL-LONDON, V587, P3729, DOI 10.1113/jphysiol.2009.172601; Lee YH, 2003, J BIOL CHEM, V278, P2896, DOI 10.1074/jbc.M208359200; Linden MA, 2013, AM J PHYSIOL-REG I, V304, pR763, DOI 10.1152/ajpregu.00537.2012; Liu QL, 2012, FREE RADICAL BIO MED, V53, P250, DOI 10.1016/j.freeradbiomed.2012.05.012; Louche K, 2013, J CLIN ENDOCR METAB, V98, P4863, DOI 10.1210/jc.2013-2058; Lu XM, 2013, INT J MOL MED, V31, P740, DOI 10.3892/ijmm.2013.1241; Malhotra D, 2011, J CLIN INVEST, V121, P4289, DOI 10.1172/JCI45144; McGillicuddy FC, 2013, AM J PHYSIOL-ENDOC M, V305, pE834, DOI 10.1152/ajpendo.00297.2013; Michael MD, 2000, MOL CELL, V6, P87, DOI 10.1016/S1097-2765(00)00010-1; Minamino T, 2009, NAT MED, V15, P1082, DOI 10.1038/nm.2014; Morris PJ, 2003, OBES RES, V11, P1333, DOI 10.1038/oby.2003.180; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Park YH, 2013, BIOCHEM BIOPH RES CO, V435, P244, DOI 10.1016/j.bbrc.2013.04.071; Pauli JR, 2008, J PHYSIOL-LONDON, V586, P659, DOI 10.1113/jphysiol.2007.142414; Pereira SMP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031132; Radak Z, 2004, FASEB J, V18, P749, DOI 10.1096/fj.03-0509fje; Rector RS, 2008, AM J PHYSIOL-GASTR L, V294, pG619, DOI 10.1152/ajpgi.00428.2007; Rector RS, 2011, AM J PHYSIOL-GASTR L, V300, pG874, DOI 10.1152/ajpgi.00510.2010; Rector RS, 2010, AM J PHYSIOL-ENDOC M, V298, pE1179, DOI 10.1152/ajpendo.00703.2009; Ruas JL, 2012, CELL, V151, P1319, DOI 10.1016/j.cell.2012.10.050; Salanova M, 2013, REDOX BIOL, V1, P514, DOI 10.1016/j.redox.2013.10.006; Schattenberg JM, 2006, HEPATOLOGY, V43, P163, DOI 10.1002/hep.20999; Schroeder M, 2010, HORM BEHAV, V57, P496, DOI 10.1016/j.yhbeh.2010.02.008; Sheldon RD, 2014, J APPL PHYSIOL, V116, P1156, DOI 10.1152/japplphysiol.01275.2013; SHIMA K, 1993, METABOLISM, V42, P971, DOI 10.1016/0026-0495(93)90009-D; Shinozaki S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075249; Shinozaki S, 2011, J BIOL CHEM, V286, P34959, DOI 10.1074/jbc.M110.187666; Sugita M, 2012, METABOLISM, V61, P127, DOI 10.1016/j.metabol.2011.06.001; Ueki K, 1998, J BIOL CHEM, V273, P5315, DOI 10.1074/jbc.273.9.5315; Wagh Arati, 2004, Expert Rev Cardiovasc Ther, V2, P213, DOI 10.1586/14779072.2.2.213; Yasukawa T, 2005, J BIOL CHEM, V280, P7511, DOI 10.1074/jbc.M411871200; Yatsuya H, 2014, OBES RES CLIN PRACT, V8, pE350, DOI 10.1016/j.orcp.2013.08.002; Zhang BC, 2004, CELL SIGNAL, V16, P837, DOI 10.1016/j.cellsig.2004.01.001	64	22	24	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132029	10.1371/journal.pone.0132029	http://dx.doi.org/10.1371/journal.pone.0132029			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26172834	Green Published, Green Submitted, gold			2022-12-26	WOS:000358194900027
J	Zhao, DJ; Lin, MY; Chen, J; Pedrosa, E; Hrabovsky, A; Fourcade, HM; Zheng, DY; Lachman, HM				Zhao, Dejian; Lin, Mingyan; Chen, Jian; Pedrosa, Erika; Hrabovsky, Anastasia; Fourcade, H. Matthew; Zheng, Deyou; Lachman, Herbert M.			MicroRNA Profiling of Neurons Generated Using Induced Pluripotent Stem Cells Derived from Patients with Schizophrenia and Schizoaffective Disorder, and 22q11.2 Del	PLOS ONE			English	Article							CARDIO-FACIAL SYNDROME; AUTISM SPECTRUM DISORDER; DELETION SYNDROME; VELOCARDIOFACIAL SYNDROME; SYNAPTIC-TRANSMISSION; EXPRESSION PATTERNS; PREFRONTAL CORTEX; SIGNALING PATHWAY; RISK-FACTOR; GENE	We are using induced pluripotent stem cell (iPSC) technology to study neuropsychiatric disorders associated with 22q11.2 microdeletions (del), the most common known schizophrenia (SZ)-associated genetic factor. Several genes in the region have been implicated; a promising candidate is DGCR8, which codes for a protein involved in microRNA (miRNA) biogenesis. We carried out miRNA expression profiling (miRNA-seq) on neurons generated from iPSCs derived from controls and SZ patients with 22q11.2 del. Using thresholds of p<0.01 for nominal significance and 1.5-fold differences in expression, 45 differentially expressed miRNAs were detected (13 lower in SZ and 32 higher). Of these, 6 were significantly down-regulated in patients after correcting for genome wide significance (FDR<0.05), including 4 miRNAs that map to the 22q11.2 del region. In addition, a nominally significant increase in the expression of several miRNAs was found in the 22q11.2 neurons that were previously found to be differentially expressed in autopsy samples and peripheral blood in SZ and autism spectrum disorders (e.g., miR-34, miR-4449, miR-146b-3p, and miR-23a-5p). Pathway and function analysis of predicted mRNA targets of the differentially expressed miRNAs showed enrichment for genes involved in neurological disease and psychological disorders for both up and down regulated miRNAs. Our findings suggest that: i. neurons with 22q11.2 del recapitulate the miRNA expression patterns expected of 22q11.2 haploinsufficiency, ii. differentially expressed miRNAs previously identified using autopsy samples and peripheral cells, both of which have significant methodological problems, are indeed disrupted in neuropsychiatric disorders and likely have an underlying genetic basis.	[Zhao, Dejian; Zheng, Deyou] Albert Einstein Coll Med, Dept Neurol, Bronx, NY 10467 USA; [Lin, Mingyan; Zheng, Deyou; Lachman, Herbert M.] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10467 USA; [Chen, Jian; Pedrosa, Erika; Hrabovsky, Anastasia; Fourcade, H. Matthew; Lachman, Herbert M.] Albert Einstein Coll Med, Dept Psychiat & Behav Sci, Bronx, NY 10467 USA; [Zheng, Deyou; Lachman, Herbert M.] Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10467 USA; [Lachman, Herbert M.] Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Zheng, DY (corresponding author), Albert Einstein Coll Med, Dept Neurol, 1300 Morris Pk Ave, Bronx, NY 10467 USA.	deyou.zheng@einstein.yu.edu; herb.lachman@einstein.yu.edu	lin, mingyan/HDL-9420-2022; Zhao, Dejian/C-8321-2009	Zhao, Dejian/0000-0002-2105-3799; Zheng, Deyou/0000-0003-4354-5337	National Institute of Mental Health [MH087840, MH099427, MH093869, MH099452]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH099427, R21MH093869, R21MH099452, R21MH087840, R33MH087840] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by National Institute of Mental Health grants MH087840, MH099427, MH093869 and MH099452. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Elneel K, 2008, NEUROGENETICS, V9, P153, DOI 10.1007/s10048-008-0133-5; Ahn K, 2014, MOL PSYCHIATR, V19, P568, DOI 10.1038/mp.2013.59; Aneja A, 2007, J CHILD ADOL PSYCHOP, V17, P105, DOI 10.1089/cap.2006.0023; Antshel KM, 2007, J AUTISM DEV DISORD, V37, P1776, DOI 10.1007/s10803-006-0308-6; Aoto J, 2013, CELL, V154, P75, DOI 10.1016/j.cell.2013.05.060; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bassett Anne S, 2008, Curr Psychiatry Rep, V10, P148; Belkaya S, 2013, J BIOL CHEM, V288, P30752, DOI 10.1074/jbc.M113.503532; Beveridge NJ, 2010, MOL PSYCHIATR, V15, P1176, DOI 10.1038/mp.2009.84; Beveridge NJ, 2014, SCHIZOPHRENIA BULL, V40, P399, DOI 10.1093/schbul/sbs198; Binns D, 2009, BIOINFORMATICS, V25, P3045, DOI 10.1093/bioinformatics/btp536; Brennand KJ, 2011, NATURE, V473, P221, DOI 10.1038/nature09915; Brzustowicz Linda M., 2012, Frontiers in Genetics, V3, P291, DOI 10.3389/fgene.2012.00291; Carlson C, 1997, AM J HUM GENET, V61, P620, DOI 10.1086/515508; Carlson C, 1997, AM J HUM GENET, V60, P851; Chamberlain SJ, 2010, P NATL ACAD SCI USA, V107, P17668, DOI 10.1073/pnas.1004487107; Cheung ENM, 2014, GENET MED, V16, P40, DOI 10.1038/gim.2013.71; Chiang CH, 2011, MOL PSYCHIATR, V16, P358, DOI 10.1038/mp.2011.13; Chitwood DH, 2010, NATURE, V467, P415, DOI 10.1038/nature09351; Clarke MC, 2012, BIOL PSYCHIAT, V71, P836, DOI 10.1016/j.biopsych.2012.01.011; Clarke RA, 2009, CASE REP MED, V2009, DOI 10.1155/2009/361518; Clipperton-Allen AE, 2014, HUM MOL GENET, V23, P3490, DOI 10.1093/hmg/ddu057; Das S, 2012, DEV DYNAM, V241, P1260, DOI 10.1002/dvdy.23811; de la Morena MT, 2013, CLIN IMMUNOL, V147, P11, DOI 10.1016/j.clim.2013.01.011; DeRosa BA, 2012, NEUROSCI LETT, V516, P9, DOI 10.1016/j.neulet.2012.02.086; Doherty JL, 2012, CLIN GENET, V81, P103, DOI 10.1111/j.1399-0004.2011.01773.x; Drerup CM, 2009, DEVELOPMENT, V136, P2623, DOI 10.1242/dev.030577; DRISCOLL DA, 1992, AM J MED GENET, V44, P261, DOI 10.1002/ajmg.1320440237; Earls LR, 2012, J NEUROSCI, V32, P14132, DOI 10.1523/JNEUROSCI.1312-12.2012; Edelmann L, 1999, HUM MOL GENET, V8, P1157, DOI 10.1093/hmg/8.7.1157; Farra N, 2012, MOL PSYCHIATR, V17, P1261, DOI 10.1038/mp.2011.180; Forstner AJ, 2014, J PSYCHIATR NEUROSCI, V39, P386, DOI 10.1503/jpn.130189; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Garbett KA, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.24; Gasso P, 2014, J PSYCHIATR RES, V48, P94, DOI 10.1016/j.jpsychires.2013.09.017; Ghanizadeh A, 2011, INT J HYPERTHER, V27, P737, DOI 10.3109/02656736.2011.604665; Gothelf D, 2013, J AM ACAD CHILD PSY, V52, P1192, DOI 10.1016/j.jaac.2013.08.008; Green GH, 2007, STAT APPL GENET MOL, V6, DOI 10.2202/1544-6115.1302; Green MJ, 2013, MOL PSYCHIATR, V18, P774, DOI 10.1038/mp.2012.84; Guo R, 2012, MOLECULES, V17, P14733, DOI 10.3390/molecules171214733; Ha M, 2014, NAT REV MOL CELL BIO, V15, P509, DOI 10.1038/nrm3838; Hall J., 2014, BIOL PSYCHIAT; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Henshall DC, 2014, CURR OPIN NEUROL, V27, P199, DOI 10.1097/WCO.0000000000000079; Hiramoto T, 2011, HUM MOL GENET, V20, P4775, DOI 10.1093/hmg/ddr404; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Hsiao EY, 2012, P NATL ACAD SCI USA, V109, P12776, DOI 10.1073/pnas.1202556109; Hsu R, 2012, MOL CELL NEUROSCI, V50, P283, DOI 10.1016/j.mcn.2012.06.002; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Isserlin Ruth, 2014, F1000Res, V3, P141, DOI 10.12688/f1000research.4536.1; Isshiki M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5742; Ivanov D, 2003, BRIT J PSYCHIAT, V183, P409, DOI 10.1192/bjp.183.5.409; Jimenez-Mateos EM, 2012, NAT MED, V18, P1087, DOI 10.1038/nm.2834; Karayiorgou M, 2004, MOL BRAIN RES, V132, P95, DOI 10.1016/j.molbrainres.2004.09.029; Kates WR, 2007, AM J MED GENET A, V143A, P2642, DOI 10.1002/ajmg.a.32012; Kates WR, 2006, J AM ACAD CHILD PSY, V45, P587, DOI 10.1097/01.chi.0000205704.33077.4a; Kim AH, 2012, SCHIZOPHR RES, V141, P60, DOI 10.1016/j.schres.2012.06.038; Kim AH, 2010, SCHIZOPHR RES, V124, P183, DOI 10.1016/j.schres.2010.07.002; Kim KY, 2012, TRENDS MOL MED, V18, P463, DOI 10.1016/j.molmed.2012.06.002; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Konopka W, 2010, J NEUROSCI, V30, P14835, DOI 10.1523/JNEUROSCI.3030-10.2010; Krichevsky AM, 2003, RNA, V9, P1274, DOI 10.1261/rna.5980303; Kumarasinghe N, 2013, INT J NEUROPSYCHOPH, V16, P1483, DOI 10.1017/S1461145713000035; Kwon E, 2013, MOL PSYCHIATR, V18, P11, DOI 10.1038/mp.2011.170; Lachman HM, 1996, AM J MED GENET, V67, P468, DOI 10.1002/(SICI)1096-8628(19960920)67:5<468::AID-AJMG5>3.0.CO;2-G; Lai CY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021635; Lambert TJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015182; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Leblond CS, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004580; Lepagnol-Bestel AM, 2013, MOL CELL NEUROSCI, V54, P84, DOI 10.1016/j.mcn.2013.01.006; Lett TA, 2013, MOL PSYCHIATR, V18, P443, DOI 10.1038/mp.2013.17; Li T, 2008, AM J MED GENET B, V147B, P654, DOI 10.1002/ajmg.b.30648; Lin MY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094968; Lin MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044017; Lin MY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023356; Lionel AC, 2013, HUM MOL GENET, V22, P2055, DOI 10.1093/hmg/ddt056; Liu J, 2012, STEM CELL REV REP, V8, P1129, DOI 10.1007/s12015-012-9411-6; Liu T, 2015, MOL NEUROBIOL, V51, P1053, DOI 10.1007/s12035-014-8770-1; Liu YF, 2013, STAT INTERFACE, V6, P1; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lv JW, 2013, NEUROSCI BULL, V29, P773, DOI 10.1007/s12264-013-1382-3; Maekawa M, 2014, BIOL PSYCHIAT; Marchetto MCN, 2010, CELL, V143, P527, DOI 10.1016/j.cell.2010.10.016; Merico D, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00238; Merscher S, 2001, CELL, V104, P619, DOI 10.1016/S0092-8674(01)00247-1; Meza-Sosa KF, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00175; Migliore C, 2008, CANCER RES, V68, P10128, DOI 10.1158/0008-5472.CAN-08-2148; Missler M, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005694; Montojo CA, 2013, CEREB CORTEX; Moreau MP, 2011, BIOL PSYCHIAT, V69, P188, DOI 10.1016/j.biopsych.2010.09.039; Morgado AL, 2015, MOL NEUROBIOL, V51, P1168, DOI 10.1007/s12035-014-8794-6; Muenthaisong S, 2012, EXP CELL RES, V318, P2482, DOI 10.1016/j.yexcr.2012.07.014; Murdoch JD, 2013, CURR OPIN GENET DEV, V23, P310, DOI 10.1016/j.gde.2013.02.003; Murphy KC, 2001, BRIT J PSYCHIAT, V179, P397, DOI 10.1192/bjp.179.5.397; Na KS, 2014, PROG NEURO-PSYCHOPH, V48, P277, DOI 10.1016/j.pnpbp.2012.10.022; Okita K, 2011, NAT METHODS, V8, P409, DOI [10.1038/NMETH.1591, 10.1038/nmeth.1591]; Pal R, 2013, J BIOSCI BIOENG, V115, P200, DOI 10.1016/j.jbiosc.2012.08.018; Pantano L, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1127; Papolos DF, 1998, MOL PSYCHIATR, V3, P346, DOI 10.1038/sj.mp.4000410; Parker-Athill EC, 2010, NEUROSIGNALS, V18, P113, DOI 10.1159/000319828; Penzes P, 2013, J NEUROCHEM, V126, P165, DOI 10.1111/jnc.12261; Pietrzykowski AZ, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00389; Porteous D, 2009, NEURON, V63, P711, DOI 10.1016/j.neuron.2009.09.017; Raver-Shapira N, 2007, MOL CELL, V26, P731, DOI 10.1016/j.molcel.2007.05.017; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Ripke S, 2011, NAT GENET, V43, P969, DOI 10.1038/ng.940; Robertson MM, 2006, J PSYCHOSOM RES, V61, P365, DOI 10.1016/j.jpsychores.2006.06.011; Saito R, 2012, NAT METHODS, V9, P1069, DOI [10.1038/nmeth.2212, 10.1038/NMETH.2212]; Santarelli DM, 2011, BIOL PSYCHIAT, V69, P180, DOI 10.1016/j.biopsych.2010.09.030; Sarachana T, 2013, MOL AUTISM, V4, DOI 10.1186/2040-2392-4-14; SCAMBLER PJ, 1992, LANCET, V339, P1138, DOI 10.1016/0140-6736(92)90734-K; Schneider M, 2014, AM J PSYCHIAT, V171, P627, DOI 10.1176/appi.ajp.2013.13070864; Schofield CM, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-11; Schulte LN, 2013, NUCLEIC ACIDS RES, V41, P542, DOI 10.1093/nar/gks1030; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Seno MMG, 2011, BRAIN RES, V1380, P85, DOI 10.1016/j.brainres.2010.09.046; Shaham L, 2015, BLOOD, V125, P1292, DOI 10.1182/blood-2014-06-581892; Sheedy FJ, 2008, ANN RHEUM DIS, V67, P50, DOI 10.1136/ard.2008.100289; Sheridan SD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026203; SHPRINTZEN RJ, 1978, CLEFT PALATE J, V15, P56; Simao I, 2013, J PEDIATR ENDOCR MET, V26, P381, DOI 10.1515/jpem-2012-0348; Slezak-Prochazka I, 2010, RNA, V16, P1087, DOI 10.1261/rna.1804410; Smalheiser NR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086469; Smalheiser NR, 2009, NEUROMOL MED, V11, P133, DOI 10.1007/s12017-009-8065-2; Sonkoly E, 2008, SEMIN CANCER BIOL, V18, P131, DOI 10.1016/j.semcancer.2008.01.005; Stappert L, 2015, CELL TISSUE RES, V359, P47, DOI 10.1007/s00441-014-1981-y; Stark KL, 2008, NAT GENET, V40, P751, DOI 10.1038/ng.138; Strange A, 2012, BIOL PSYCHIAT, V72, P620, DOI 10.1016/j.biopsych.2012.05.035; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tian Y, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0075-5; Tsai NP, 2012, CELL, V151, P1581, DOI 10.1016/j.cell.2012.11.040; Urdinguio RG, 2010, EPIGENETICS-US, V5, P656, DOI 10.4161/epi.5.7.13055; Vaishnavi V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056781; van Spronsen M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074907; Vergoulis T, 2014, BIOINFORMATICS; Vlachos IS, 2015, NUCLEIC ACIDS RES, V43, pD153, DOI 10.1093/nar/gku1215; Wang LG, 2015, GENE, V554, P1, DOI 10.1016/j.gene.2014.10.032; Wei HG, 2012, BBA-MOL BASIS DIS, V1822, P831, DOI 10.1016/j.bbadis.2012.01.011; Wen ZX, 2014, NATURE, V515, P414, DOI 10.1038/nature13716; Xiao FF, 2009, NUCLEIC ACIDS RES, V37, pD105, DOI 10.1093/nar/gkn851; Xu B, 2013, CELL, V152, P262, DOI 10.1016/j.cell.2012.11.052; Xu B, 2011, NAT GENET, V43, P864, DOI 10.1038/ng.902; Yao JJ, 2013, AM J PHYSIOL-CELL PH, V305, pC197, DOI 10.1152/ajpcell.00041.2013; Zerbo O, 2013, J AUTISM DEV DISORD, V43, P25, DOI 10.1007/s10803-012-1540-x; Zhang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072652; Zhao WN, 2012, J BIOMOL SCREEN, V17, P1252, DOI 10.1177/1087057112456876	147	63	65	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132387	10.1371/journal.pone.0132387	http://dx.doi.org/10.1371/journal.pone.0132387			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26173148	gold, Green Submitted, Green Published			2022-12-26	WOS:000358194900048
J	Gil-Alonso, S; Jauregizar, N; Eraso, E; Quindos, G				Gil-Alonso, Sandra; Jauregizar, Nerea; Eraso, Elena; Quindos, Guillermo			Postantifungal Effect of Micafungin against the Species Complexes of Candida albicans and Candida parapsilosis	PLOS ONE			English	Article							IN-VITRO ACTIVITY; TIME-KILL; ANTIFUNGAL SUSCEPTIBILITY; AMPHOTERICIN-B; C. PARAPSILOSIS; ECHINOCANDINS; ANIDULAFUNGIN; CASPOFUNGIN; GLABRATA; ORTHOPSILOSIS	Micafungin is an effective antifungal agent useful for the therapy of invasive candidiasis. Candida albicans is the most common cause of invasive candidiasis; however, infections due to non-C. albicans species, such as Candida parapsilosis, are rising. Killing and postantifungal effects (PAFE) are important factors in both dose interval choice and infection outcome. The aim of this study was to determinate the micafungin PAFE against 7 C. albicans strains, 5 Candida dubliniensis, 2 Candida Africana, 3 C. parapsilosis, 2 Candida metapsilosis and 2 Candida orthopsilosis. For PAFE studies, cells were exposed to micafungin for 1 h at concentrations ranging from 0.12 to 8 mu g/ml. Time-kill experiments (TK) were conducted at the same concentrations. Samples were removed at each time point (0-48 h) and viable counts determined. Micafungin (2 mu g/ml) was fungicidal (>= 3 log(10) reduction) in TK against 5 out of 14 (36%) strains of C. albicans complex. In PAFE experiments, fungicidal endpoint was achieved against 2 out of 14 strains (14%). In TK against C. parapsilosis, 8 mu g/ml of micafungin turned out to be fungicidal against 4 out 7 (57%) strains. Conversely, fungicidal endpoint was not achieved in PAFE studies. PAFE results for C. albicans complex (41.83 +/- 2.18 h) differed from C. parapsilosis complex (8.07 +/- 4.2 h) at the highest tested concentration of micafungin. In conclusion, micafungin showed significant differences in PAFE against C. albicans and C. parapsilosis complexes, being PAFE for the C. albicans complex longer than for the C. parapsilosis complex.	[Gil-Alonso, Sandra; Eraso, Elena; Quindos, Guillermo] Univ Basque Country, Euskal Herriko Unibertsitatea, Fac Med & Odontol, Dept Inmunol Microbiol & Parasitol,Unidad Formac, E-48080 Bilbao, Bizkaia, Spain; [Gil-Alonso, Sandra; Jauregizar, Nerea] Univ Basque Country, Euskal Herriko Unibertsitatea, Fac Med & Odontol, Dept Farmacol,Unidad Formac & Invest Multidiscipl, E-48080 Bilbao, Bizkaia, Spain	University of Basque Country; University of Basque Country	Quindos, G (corresponding author), Univ Basque Country, Euskal Herriko Unibertsitatea, Fac Med & Odontol, Dept Inmunol Microbiol & Parasitol,Unidad Formac, E-48080 Bilbao, Bizkaia, Spain.	guillermo.quindos@ehu.eus	Jauregizar, Nerea/AAD-4042-2020; Quindós, Guillermo/I-2577-2015; Eraso, Elena/K-5443-2013	Quindós, Guillermo/0000-0003-0438-2248; Eraso, Elena/0000-0002-9043-9265; Gil-Alonso, Sandra/0000-0002-1470-4442	Consejeria de Educacion, Universidades e Investigacion [GIC12 210-IT-696-13]; Departamento de Industria, Comercio y Turismo of Gobierno Vasco-Eusko Jaurlaritza [S-PR12UN002, S-PE13UN025, S-PE13UN121]; UPV/EHU [UFI 11/25]; Fondo de Investigacion Sanitaria [FIS PI11/00203]	Consejeria de Educacion, Universidades e Investigacion; Departamento de Industria, Comercio y Turismo of Gobierno Vasco-Eusko Jaurlaritza; UPV/EHU; Fondo de Investigacion Sanitaria(Instituto de Salud Carlos III)	This work was supported by Consejeria de Educacion, Universidades e Investigacion (GIC12 210-IT-696-13), the Departamento de Industria, Comercio y Turismo (S-PR12UN002, S-PE13UN025) of Gobierno Vasco-Eusko Jaurlaritza, and UPV/EHU (UFI 11/25). Elena Eraso and Guillermo Quindos have received grant support from Consejeria de Educacion, Universidades e Investigacion (GIC12 210-IT-696-13) and Departamento de Industria, Comercio y Turismo (S-PR12UN002, S-PE13UN121) of Gobierno Vasco-Eusko Jaurlaritza, Fondo de Investigacion Sanitaria (FIS PI11/00203), and UPV/EHU (UFI 11/25).	Canton E, 2004, ANTIMICROB AGENTS CH, V48, P2477, DOI 10.1128/AAC.48.7.2477-2482.2004; Canton E, 2013, J ANTIMICROB CHEMOTH, V68, P864, DOI 10.1093/jac/dks489; Canton E, 2010, ANTIMICROB AGENTS CH, V54, P2194, DOI 10.1128/AAC.01538-09; Gonzalez MC, 2008, REV IBEROAM MICOL, V25, P92, DOI 10.1016/S1130-1406(08)70026-3; Clancy CJ, 2006, ANTIMICROB AGENTS CH, V50, P2569, DOI 10.1128/AAC.00291-06; Clinical and Laboratory Standards Institute, 2012, M27A3S4 CLIN LAB STA; Clinical and Laboratory Standards Institute, 2008, M27A3 CLIN LAB STAND; Denning DW, 2003, LANCET, V362, P1142, DOI 10.1016/S0140-6736(03)14472-8; Ellepola ANB, 2015, J INVESTIG CLIN DENT, V6, P186, DOI 10.1111/jicd.12095; Ellepola ANB, 2014, MYCOSES, V57, P56, DOI 10.1111/myc.12102; Emri T, 2013, APPL MICROBIOL BIOT, V97, P3267, DOI 10.1007/s00253-013-4761-9; Ernst EJ, 2000, ANTIMICROB AGENTS CH, V44, P1108, DOI 10.1128/AAC.44.4.1108-1111.2000; Ernst EJ, 2002, ANTIMICROB AGENTS CH, V46, P3846, DOI 10.1128/AAC.46.12.3846-3853.2002; Gil-Alonso S, 2015, DIAGN MICR INFEC DIS, V82, P57, DOI 10.1016/j.diagmicrobio.2015.01.010; Kovacs R, 2014, MYCOPATHOLOGIA, V178, P197, DOI 10.1007/s11046-014-9799-4; Lewis RE, 2002, J ANTIMICROB CHEMOTH, V49, P345, DOI 10.1093/jac/49.2.345; Lockhart SR, 2008, J CLIN MICROBIOL, V46, P2659, DOI 10.1128/JCM.00803-08; Manavathu EK, 2004, J ANTIMICROB CHEMOTH, V53, P386, DOI 10.1093/jac/dkh066; Miranda-Zapico I, 2011, J ANTIMICROB CHEMOTH, V66, P2315, DOI 10.1093/jac/dkr298; Moriyama B, 2012, FUTURE MICROBIOL, V7, P565, DOI [10.2217/fmb.12.31, 10.2217/FMB.12.31]; Moudgal V, 2005, ANTIMICROB AGENTS CH, V49, P767, DOI 10.1128/AAC.49.2.767-769.2005; Nguyen KT, 2010, INT J ANTIMICROB AG, V35, P80, DOI 10.1016/j.ijantimicag.2009.09.003; Nguyen KT, 2009, ANTIMICROB AGENTS CH, V53, P3347, DOI 10.1128/AAC.01480-08; Oz Y, 2013, MED MYCOL, V51, P60, DOI 10.3109/13693786.2012.697198; Peman J, 2012, J ANTIMICROB CHEMOTH, V67, P1181, DOI 10.1093/jac/dks019; Pfaller MA, 2008, J CLIN MICROBIOL, V46, P150, DOI 10.1128/JCM.01901-07; Pfaller MA, 2014, ANTIMICROB AGENTS CH, V58, P916, DOI 10.1128/AAC.02020-13; Quindos G, 2014, REV IBEROAM MICOL, V31, P42, DOI 10.1016/j.riam.2013.10.001; Quindos G, 2009, REV IBEROAM MICOL, V26, P35, DOI 10.1016/S1130-1406(09)70006-3; Smith RP, 2011, DIAGN MICR INFEC DIS, V71, P131, DOI 10.1016/j.diagmicrobio.2011.06.018; Tavanti A, 2005, J CLIN MICROBIOL, V43, P284, DOI 10.1128/JCM.43.1.284-292.2005	31	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0132730	10.1371/journal.pone.0132730	http://dx.doi.org/10.1371/journal.pone.0132730			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26168269	Green Published, gold, Green Submitted			2022-12-26	WOS:000358193100072
J	Jabbari, E; Sarvestani, SK; Daneshian, L; Moeinzadeh, S				Jabbari, Esmaiel; Sarvestani, Samaneh K.; Daneshian, Leily; Moeinzadeh, Seyedsina			Optimum 3D Matrix Stiffness for Maintenance of Cancer Stem Cells Is Dependent on Tissue Origin of Cancer Cells	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; MARROW STROMAL CELLS; BREAST-CANCER; COLORECTAL-CANCER; MOLECULAR SUBTYPE; EXPRESSION; MICROENVIRONMENT; DIFFERENTIATION; PHENOTYPE; HYDROGEL	Introduction The growth and expression of cancer stem cells (CSCs) depend on many factors in the tumor microenvironment. The objective of this work was to investigate the effect of cancer cells' tissue origin on the optimum matrix stiffness for CSC growth and marker expression in a model polyethylene glycol diacrylate (PEGDA) hydrogel without the interference of other factors in the microenvironment. Methods Human MCF7 and MDA-MB-231 breast carcinoma, HCT116 colorectal and AGS gastric carcinoma, and U2OS osteosarcoma cells were used. The cells were encapsulated in PEGDA gels with compressive moduli in the 2-70 kPa range and optimized cell seeding density of 0.6x10(6) cells/mL. Micropatterning was used to optimize the growth of encapsulated cells with respect to average tumorsphere size. The CSC sub-population of the encapsulated cells was characterized by cell number, tumorsphere size and number density, and mRNA expression of CSC markers. Results The optimum matrix stiffness for growth and marker expression of CSC sub-population of cancer cells was 5 kPa for breast MCF7 and MDA231, 25 kPa for colorectal HCT116 and gastric AGS, and 50 kPa for bone U2OS cells. Conjugation of a CD44 binding peptide to the gel stopped tumorsphere formation by cancer cells from different tissue origin. The expression of YAP/TAZ transcription factors by the encapsulated cancer cells was highest at the optimum stiffness indicating a link between the Hippo transducers and CSC growth. The optimum average tumorsphere size for CSC growth and marker expression was 50 mu m. Conclusion The marker expression results suggest that the CSC sub-population of cancer cells resides within a niche with optimum stiffness which depends on the cancer cells' tissue origin.	[Jabbari, Esmaiel; Sarvestani, Samaneh K.; Daneshian, Leily; Moeinzadeh, Seyedsina] Univ S Carolina, Dept Chem Engn, Biomimet Mat & Tissue Engn Lab, Columbia, SC 29208 USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Jabbari, E (corresponding author), Univ S Carolina, Dept Chem Engn, Biomimet Mat & Tissue Engn Lab, Columbia, SC 29208 USA.	jabbari@mailbox.sc.edu	Jabbari, Esmaiel/AAJ-2369-2020	Jabbari, Esmaiel/0000-0001-6548-5422	National Science Foundation [CBET1403545]; National Institutes of Health [AR063745]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R56AR063745] Funding Source: NIH RePORTER; Div Of Chem, Bioeng, Env, & Transp Sys [1403545] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Div Of Chem, Bioeng, Env, & Transp Sys(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This work was supported by research grants to EJ from the National Science Foundation under grant No. CBET1403545 and the National Institutes of Health under grant No. AR063745. The funding agencies did not have any role in designing experiments or in preparation of this manuscript.	Abu-Ali S, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-47; Baker EL, 2010, BIOPHYS J, V99, P2048, DOI 10.1016/j.bpj.2010.07.051; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Biddle A, 2012, CANCER METAST REV, V31, P285, DOI 10.1007/s10555-012-9345-0; Boyd NF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100937; Britton KM, 2012, CANCER LETT, V323, P97, DOI 10.1016/j.canlet.2012.03.041; Chen L, 2012, BIOMATERIALS, V33, P1437, DOI 10.1016/j.biomaterials.2011.10.056; Chen Z, 2009, J SURG ONCOL, V99, P414, DOI 10.1002/jso.21270; Cordenonsi M, 2011, CELL, V147, P759, DOI 10.1016/j.cell.2011.09.048; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Engberg K, 2011, BIOMED MATER, V6, DOI 10.1088/1748-6041/6/5/055006; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Fang YT, 2012, ONCOL REP, V28, P2115, DOI 10.3892/or.2012.2054; Fenner A, 2012, NAT REV UROL, V9, P473, DOI [10.1038/nrurol.2012.126, 10.1038/nrurol.2012.13, 10.1038/nrurol.2012.139, 10.1038/nrurol.2012.168, 10.1038/nrurol.2012.190, 10.1038/nrurol.2012.119]; Ferraro JT, 2004, AM J PHYSIOL-CELL PH, V286, pC831, DOI 10.1152/ajpcell.00224.2003; Fessler E, 2013, CANCER LETT, V341, P97, DOI 10.1016/j.canlet.2012.10.015; Fillmore CM, 2010, P NATL ACAD SCI USA, V107, P21737, DOI 10.1073/pnas.1007863107; Flecha FLG, 2003, BIOCHEM MOL BIOL EDU, V31, P319; Hale NA, 2010, ACS APPL MATER INTER, V2, P2317, DOI 10.1021/am100346k; He XZ, 2008, LANGMUIR, V24, P12508, DOI 10.1021/la802447v; He XZ, 2012, LANGMUIR, V28, P5387, DOI 10.1021/la205005h; Henderson JA, 2008, MACROMOL BIOSCI, V8, P499, DOI 10.1002/mabi.200700127; Hibino S, 2004, CANCER RES, V64, P4810, DOI 10.1158/0008-5472.CAN-04-0129; Hiraga T, 2011, ONCOL REP, V25, P289, DOI 10.3892/or_00001073; Holliday DL, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2889; Jaggupilli A, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/708036; Jamal M, 2012, NEOPLASIA, V14, P150, DOI 10.1593/neo.111794; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Liu TJ, 2013, ONCOGENE, V32, P544, DOI 10.1038/onc.2012.85; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Louie E, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2773; Lu J, 2013, CANCER CELL, V23, P171, DOI 10.1016/j.ccr.2012.12.021; Lynn AD, 2010, J BIOMED MATER RES A, V93A, P941, DOI 10.1002/jbm.a.32595; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Medema JP, 2013, NAT CELL BIOL, V15, P338, DOI 10.1038/ncb2717; Meyer JS, 2009, P NATL ACAD SCI USA, V106, P16698, DOI 10.1073/pnas.0905245106; Mylona E., 2008, EUR S BIOMED ENG, P1; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Pattabiraman DR, 2014, NAT REV DRUG DISCOV, V13, P497, DOI 10.1038/nrd4253; Pek YS, 2010, BIOMATERIALS, V31, P385, DOI 10.1016/j.biomaterials.2009.09.057; Peppas N.A., 1986, HYDROGELS MED PHARM, DOI DOI 10.1016/80142-9612(03)00332-6; Ricardo S, 2011, J CLIN PATHOL, V64, P937, DOI 10.1136/jcp.2011.090456; Roy Sanchita, 2012, J Mol Signal, V7, P11, DOI 10.1186/1750-2187-7-11; Sakai K, 2011, BIOSCI TRENDS, V5, P10, DOI 10.5582/bst.2011.v5.1.10; Scheel C, 2011, CELL, V145, P926, DOI 10.1016/j.cell.2011.04.029; Soofi SS, 2009, J STRUCT BIOL, V167, P216, DOI 10.1016/j.jsb.2009.05.005; Staubach S, 2011, EXPERT REV PROTEOMIC, V8, P263, DOI [10.1586/EPR.11.2, 10.1586/epr.11.2]; Stokes ME, 2008, VALUE HEALTH, V11, P213, DOI 10.1111/j.1524-4733.2007.00226.x; Subik K, 2010, BREAST CANCER-BASIC, V4, P35; Sun YR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005498; Tang X, 2010, BIOPHYS J, V99, P2460, DOI 10.1016/j.bpj.2010.08.034; Tilghman RW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012905; Tirino V, 2011, FASEB J, V25, P2022, DOI 10.1096/fj.10-179036; Tobin NP, 2015, ANN ONCOL, V26, P81, DOI 10.1093/annonc/mdu498; Tsai WS, 2011, INT J COLORECTAL DIS, V26, P1329, DOI 10.1007/s00384-011-1214-8; Tse HTK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038986; Xie SP, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-40; Yamamoto M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3299; Yan J, 2009, BIOSENS BIOELECTRON, V24, P2604, DOI 10.1016/j.bios.2009.01.029; Yang XM, 2013, TISSUE ENG PT A, V19, P669, DOI [10.1089/ten.TEA.2012.0333, 10.1089/ten.tea.2012.0333]; Yang XM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059147; Ye J, 2014, TUMOR BIOL, V35, P3945, DOI 10.1007/s13277-013-1561-x; Yu F, 2011, ONCOGENE, V30, P2161, DOI 10.1038/onc.2010.591; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183	66	78	79	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0132377	10.1371/journal.pone.0132377	http://dx.doi.org/10.1371/journal.pone.0132377			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26168187	Green Published, gold, Green Submitted			2022-12-26	WOS:000358193100039
J	Skovgaard, A; Castro-Mejia, JL; Hansen, LH; Nielsen, DS				Skovgaard, Alf; Castro-Mejia, Josue Leonardo; Hansen, Lars Hestbjerg; Nielsen, Dennis Sandris			Host-Specific and pH-Dependent Microbiomes of Copepods in an Extensive Rearing System	PLOS ONE			English	Article							MARINE PLANKTONIC COPEPOD; VIBRIO-CHOLERAE; BACTERIAL COMMUNITY; GUT MICROBIOTA; FECAL PELLETS; MICROORGANISMS; ZOOPLANKTON; DEGRADATION; AEROMONAS; ABUNDANCE	Copepods are to an increasing extent cultivated as feed for mariculture fish larvae with variable production success. In the temperate climate zone, this production faces seasonal limitation due to changing abiotic factors, in particular temperature and light. Furthermore, the production of copepods may be influenced by biotic factors of the culture systems, such as competing microorganisms, harmful algae, or other eukaryotes and prokaryotes that may be non-beneficial for the copepods. In this study, the composition of bacteria associated with copepods was investigated in an extensive outdoor copepod production system. Light microscopy and scanning electron microscopy revealed that bacteria were primarily found attached to the exoskeleton of copepods although a few bacteria were also found in the gut as well as internally in skeletal muscle tissue. Through 16S rRNA gene-targeted denaturing gradient gel electrophoresis (DGGE) analysis, a clear difference was found between the microbiomes of the two copepod species, Acartia tonsa and Centropages hamatus, present in the system. This pattern was corroborated through 454/FLX-based 16S rRNA gene amplicon sequencing of copepod microbiomes, which furthermore showed that the abiotic parameters pH and oxygen concentration in rearing tank water were the key factors influencing composition of copepod microbiomes.	[Skovgaard, Alf] Univ Copenhagen, Dept Vet Dis Biol, DK-1870 Frederiksberg, Denmark; [Castro-Mejia, Josue Leonardo; Nielsen, Dennis Sandris] Univ Copenhagen, Dept Food Sci, DK-1958 Frederiksberg, Denmark; [Hansen, Lars Hestbjerg] Aarhus Univ, Dept Environm Sci, DK-4000 Roskilde, Denmark	University of Copenhagen; University of Copenhagen; Aarhus University	Skovgaard, A (corresponding author), Univ Roskilde, Dept Environm Social & Spatial Change, DK-4000 Roskilde, Denmark.	alf@sund.ku.dk	Skovgaard, Alf/B-5684-2009; Nielsen, Dennis/A-9769-2015; Castro-Mejia, Josue L./P-5649-2014	Nielsen, Dennis/0000-0001-8121-1114; Hestbjerg Hansen, Lars/0000-0003-0027-1524; Castro-Mejia, Josue L./0000-0002-1416-8205	IMPAQ, IMProvement of AQuaculture high quality fish fry production; Danish Council for Strategic Research [10-093522]; AMPHICOP, Acartia tonsa Molecular PHysiology-Implementation of novel and fast tools to assess COPepod physiological states; Villum Foundation [8960]; University of Copenhagen Excellence; Villum Fonden [00008689] Funding Source: researchfish	IMPAQ, IMProvement of AQuaculture high quality fish fry production; Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF)); AMPHICOP, Acartia tonsa Molecular PHysiology-Implementation of novel and fast tools to assess COPepod physiological states; Villum Foundation(Villum Fonden); University of Copenhagen Excellence; Villum Fonden(Villum Fonden)	AS was supported through the projects IMPAQ, IMProvement of AQuaculture high quality fish fry production, funded by the Danish Council for Strategic Research (grant no. 10-093522), and AMPHICOP, Acartia tonsa Molecular PHysiology-Implementation of novel and fast tools to assess COPepod physiological states, funded by the Villum Foundation (project no. 8960). JLC-M was supported by a University of Copenhagen Excellence grant for interdisciplinary research (CALM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMANN RI, 1990, APPL ENVIRON MICROB, V56, P1919, DOI 10.1128/AEM.56.6.1919-1925.1990; BERTHE FCJ, 1995, DIS AQUAT ORGAN, V21, P151, DOI 10.3354/dao021151; Bojesen AM, 2003, J CLIN MICROBIOL, V41, P5167, DOI 10.1128/JCM.41.11.5167-5172.2003; Brandt P, 2010, HELGOLAND MAR RES, V64, P331, DOI 10.1007/s10152-010-0188-1; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Carman KR, 1997, MICROSC RES TECHNIQ, V37, P116, DOI 10.1002/(SICI)1097-0029(19970415)37:2<116::AID-JEMT2>3.0.CO;2-M; Colwell R, 2001, HYDROBIOLOGIA, V460, P141, DOI 10.1023/A:1013111016642; Cripps G, 2014, J PLANKTON RES, V36, P1165, DOI 10.1093/plankt/fbu052; De Corte D, 2014, AQUAT MICROB ECOL, V72, P215, DOI 10.3354/ame01696; Drillet G, 2011, AQUACULTURE, V315, P155, DOI 10.1016/j.aquaculture.2011.02.027; Dumontet S, 1996, COMP IMMUNOL MICROB, V19, P245, DOI 10.1016/0147-9571(96)00012-4; Dziallas C, 2013, ARCT ANTARCT ALP RES, V45, P471, DOI 10.1657/1938-4246.45.4.471; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Gerdts G, 2013, HELGOLAND MAR RES, V67, P757, DOI 10.1007/s10152-013-0361-4; Grossart HP, 2010, P NATL ACAD SCI USA, V107, P11959, DOI 10.1073/pnas.1000668107; Grossart HP, 2005, ENVIRON MICROBIOL, V7, P860, DOI 10.1111/j.1462-2920.2005.00759.x; Gugliandolo C, 2008, MAR POLLUT BULL, V56, P600, DOI 10.1016/j.marpolbul.2007.12.001; Hansen B, 1996, J PLANKTON RES, V18, P257, DOI 10.1093/plankt/18.2.257; Hansen B, 1996, J PLANKTON RES, V18, P275, DOI 10.1093/plankt/18.2.275; Hansen CHF, 2012, DIABETOLOGIA, V55, P2285, DOI 10.1007/s00125-012-2564-7; Hansen PJ, 2002, AQUAT MICROB ECOL, V28, P279, DOI 10.3354/ame028279; Heidelberg JF, 2002, APPL ENVIRON MICROB, V68, P5498, DOI 10.1128/AEM.68.11.5498-5507.2002; Hufeldt MR, 2010, LAB ANIM-UK, V44, P283, DOI 10.1258/la.2010.010058; Hufeldt MR, 2010, COMPARATIVE MED, V60, P336; HUNTER JR, 1981, MARINE FISH LARVAE M, P34; HUQ A, 1983, APPL ENVIRON MICROB, V45, P275, DOI 10.1128/AEM.45.1.275-283.1983; IANORA A, 1990, J PLANKTON RES, V12, P249, DOI 10.1093/plankt/12.2.249; Khimmakthong U, 2013, MICROB PATHOGENESIS, V59-60, P33, DOI 10.1016/j.micpath.2013.03.001; KOIE M, 1990, J HELMINTHOL, V64, P193, DOI 10.1017/S0022149X00012165; Krause E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047035; Krych L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062578; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Meibom KL, 2004, P NATL ACAD SCI USA, V101, P2524, DOI 10.1073/pnas.0308707101; Melo RCN, 2007, MICRON, V38, P714, DOI 10.1016/j.micron.2007.05.002; Moller EF, 2007, AQUAT MICROB ECOL, V47, P99, DOI 10.3354/ame047099; NAGASAWA S, 1989, SCI PROG, V73, P169; NAGASAWA S, 1985, MAR BIOL, V87, P61, DOI 10.1007/BF00397006; NAGASAWA S, 1987, J PLANKTON RES, V9, P749, DOI 10.1093/plankt/9.4.749; NATION JL, 1983, STAIN TECHNOL, V58, P347, DOI 10.3109/10520298309066811; Ovreas L, 1997, APPL ENVIRON MICROB, V63, P3367; Skovgaard A, 2006, MAR ECOL PROG SER, V327, P37, DOI 10.3354/meps327037; Skovgaard A, 2011, J PLANKTON RES, V33, P1311, DOI 10.1093/plankt/fbr027; SOCHARD MR, 1979, APPL ENVIRON MICROB, V37, P750, DOI 10.1128/AEM.37.4.750-759.1979; Souissi A, 2013, J EXP MAR BIOL ECOL, V445, P38, DOI 10.1016/j.jembe.2013.04.002; Stottrup JG, 1997, AQUACULTURE, V155, P231, DOI 10.1016/S0044-8486(97)00120-8; Svitil AL, 1997, APPL ENVIRON MICROB, V63, P408, DOI 10.1128/AEM.63.2.408-413.1997; Tang K, 2009, BIOL LETTERS, V5, P549, DOI 10.1098/rsbl.2009.0076; Tang KW, 2006, AQUAT MICROB ECOL, V45, P219, DOI 10.3354/ame045219; Tang KW, 2011, ENVIRON MICROBIOL, V13, P378, DOI 10.1111/j.1462-2920.2010.02335.x; Tang KW, 2005, AQUAT MICROB ECOL, V38, P31, DOI 10.3354/ame038031; THEODORIDES J, 1989, ADV MAR BIOL, V25, P117; Toranzo AE, 2005, AQUACULTURE, V246, P37, DOI 10.1016/j.aquaculture.2005.01.002; Verity PG, 1996, MAR ECOL PROG SER, V130, P277, DOI 10.3354/meps130277; Vezzulli L, 2010, ENV MICROBIOL REP, V2, P27, DOI 10.1111/j.1758-2229.2009.00128.x; Winther G, 2015, ACTA NEUROPSYCHIATR, V27, P168, DOI 10.1017/neu.2015.7; Zhu Xu-fen, 2007, Journal of Zhejiang University-Science B, V8, P831, DOI 10.1631/jzus.2007.B0831	57	16	17	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0132516	10.1371/journal.pone.0132516	http://dx.doi.org/10.1371/journal.pone.0132516			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26167852	Green Published, gold, Green Submitted			2022-12-26	WOS:000358193100051
J	Bouton, C; Geldreich, A; Ramel, L; Ryabova, LA; Dimitrova, M; Keller, M				Bouton, Clement; Geldreich, Angele; Ramel, Laetitia; Ryabova, Lyubov A.; Dimitrova, Maria; Keller, Mario			Cauliflower mosaic virus Transcriptome Reveals a Complex Alternative Splicing Pattern	PLOS ONE			English	Article							APHID TRANSMISSION FACTOR; PRE-MESSENGER-RNAS; READING FRAME-III; MOVEMENT PROTEIN; REVERSE TRANSCRIPTION; NUCLEOTIDE-SEQUENCE; HELPER COMPONENT; GENE-EXPRESSION; NUCLEAR EXPORT; VI PRODUCT	The plant pararetrovirus Cauliflower mosaic virus (CaMV) uses alternative splic-ing to generate several isoforms from its polycistronic pregenomic 35S RNA. This pro-cess has been shown to be essential for infectivity. Previous works have identified four splice donor sites and a single splice acceptor site in the 35S RNA 5' region and sug-gested that the main role of CaMV splicing is to downregulate expression of open read-ing frames (ORFs) I and II. In this study, we show that alternative splicing is a conserved process among CaMV isolates. In Cabb B-JI and Cabb-S isolates, splicing frequently leads to different fusion between ORFs, particularly between ORF I and II. The corresponding P1P2 fusion proteins expressed in E. coli interact with viral proteins P2 and P3 in vitro. However, they are detected neither during infection nor upon transient expression in planta, which suggests rapid degradation after synthesis and no important biological role in the CaMV infectious cycle. To gain a better understanding of the functional relevance of 35S RNA alternative splicing in CaMV infectivity, we inactivated the previously described splice sites. All the splicing mutants were as pathogenic as the corresponding wild-type isolate. Through RT-PCR-based analysis we demonstrate that CaMV 35S RNA exhibits a complex splicing pattern, as we identify new splice donor and acceptor sites whose selection leads to more than thirteen 35S RNA isoforms in infected turnip plants. Inactivating splice donor or acceptor sites is not lethal for the virus, since disrupted sites are systematically rescued by the activation of cryptic and/or seldom used splice sites. Taken together, our data depict a conserved, complex and flexible process, involving multiple sites, that ensures splicing of 35S RNA.	[Bouton, Clement; Geldreich, Angele; Ramel, Laetitia; Ryabova, Lyubov A.; Dimitrova, Maria; Keller, Mario] Univ Strasbourg, CNRS, Inst Biol Mol Plantes, Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Dimitrova, M (corresponding author), Univ Strasbourg, CNRS, Inst Biol Mol Plantes, Strasbourg, France.	maria.dimitrova@ibmp-cnrs.unistra.fr; mario.keller@ibmp-cnrs.unistra.fr		Bouton, Clement/0000-0001-9607-6533	French Ministere de l'Education Nationale, de l'Enseignement Superieur et de la Recherche	French Ministere de l'Education Nationale, de l'Enseignement Superieur et de la Recherche	CB was supported by a PhD fellowship from the French Ministere de l'Education Nationale, de l'Enseignement Superieur et de la Recherche. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMOUR SL, 1983, VIROLOGY, V129, P25, DOI 10.1016/0042-6822(83)90392-6; ASHE MP, 1995, GENE DEV, V9, P3008, DOI 10.1101/gad.9.23.3008; Baek JM, 2008, PLANT MOL BIOL, V67, P499, DOI 10.1007/s11103-008-9334-4; Bayliss J, 2013, J HEPATOL, V59, P1022, DOI 10.1016/j.jhep.2013.06.018; Blevins T, 2006, NUCLEIC ACIDS RES, V34, P6233, DOI 10.1093/nar/gkl886; Chen WN, 2010, J GEN VIROL, V91, P2592, DOI 10.1099/vir.0.022517-0; Christie M, 2011, PLANT SIGNAL BEHAV, V6, P2035, DOI 10.4161/psb.6.12.18238; Christie M, 2011, PLANT J, V68, P159, DOI 10.1111/j.1365-313X.2011.04676.x; Damgaard CK, 2008, MOL CELL, V29, P271, DOI 10.1016/j.molcel.2007.11.035; DAUTEL S, 1994, VIROLOGY, V202, P1043, DOI 10.1006/viro.1994.1435; DELSENY M, 1983, PLASMID, V9, P31, DOI 10.1016/0147-619X(83)90029-X; ESPINOZA AM, 1991, VIROLOGY, V185, P337, DOI 10.1016/0042-6822(91)90781-6; FRANCK A, 1980, CELL, V21, P285, DOI 10.1016/0092-8674(80)90136-1; Froissart R, 2004, J GEN VIROL, V85, P2719, DOI 10.1099/vir.0.80029-0; FUTTERER J, 1994, VIROLOGY, V198, P663, DOI 10.1006/viro.1994.1078; Gamazon ER, 2014, HUM GENET, V133, P679, DOI 10.1007/s00439-013-1411-3; GOODALL GJ, 1989, CELL, V58, P473, DOI 10.1016/0092-8674(89)90428-5; GUILLEY H, 1983, EMBO J, V2, P277, DOI 10.1002/j.1460-2075.1983.tb01417.x; Haas M, 2005, PLANT CELL, V17, P927, DOI 10.1105/tpc.104.029017; Haas M, 2002, MOL PLANT PATHOL, V3, P419, DOI 10.1046/j.1364-3703.2002.00136.x; Hapiak M, 2008, VIRUS RES, V138, P119, DOI 10.1016/j.virusres.2008.09.002; Hebrard E, 2001, J VIROL, V75, P8538, DOI 10.1128/JVI.75.18.8538-8546.2001; HIROCHIKA H, 1985, EMBO J, V4, P1673, DOI 10.1002/j.1460-2075.1985.tb03836.x; HOWARTH AJ, 1981, VIROLOGY, V112, P678, DOI 10.1016/0042-6822(81)90313-5; INGLIS SC, 1981, NUCLEIC ACIDS RES, V9, P2727, DOI 10.1093/nar/9.12.2727; Kaida D, 2010, NATURE, V468, P664, DOI 10.1038/nature09479; Karsies A, 2001, PLANT J, V27, P335, DOI 10.1046/j.1365-313x.2001.01093.x; Khelifa M, 2010, VIROLOGY, V396, P238, DOI 10.1016/j.virol.2009.09.032; KISSLASZLO Z, 1995, EMBO J, V14, P3552, DOI 10.1002/j.1460-2075.1995.tb07361.x; KissLaszlo Z, 1996, TRENDS MICROBIOL, V4, P480, DOI 10.1016/S0966-842X(97)82909-5; Langemeier J, 2013, RNA BIOL, V10, P180, DOI 10.4161/rna.23314; Lee GH, 2008, VIRUS RES, V136, P1, DOI 10.1016/j.virusres.2008.05.007; Leh V, 2000, VIROLOGY, V266, P1, DOI 10.1006/viro.1999.0073; Leh V, 1999, EMBO J, V18, P7077, DOI 10.1093/emboj/18.24.7077; Leh V, 2001, J VIROL, V75, P100, DOI 10.1128/JVI.75.1.100-106.2001; Lutz L, 2012, VIRUS RES, V170, P150, DOI 10.1016/j.virusres.2012.08.017; MESNARD JM, 1993, BIOCHIMIE, V75, P645, DOI 10.1016/0300-9084(93)90094-9; Moissiard G, 2006, P NATL ACAD SCI USA, V103, P19593, DOI 10.1073/pnas.0604627103; Nakagawa T, 2007, J BIOSCI BIOENG, V104, P34, DOI 10.1263/jbb.104.34; OLSZEWSKI NE, 1983, NUCLEIC ACIDS RES, V11, P8901, DOI 10.1093/nar/11.24.8901; Park GS, 2008, VIRUS RES, V136, P166, DOI 10.1016/j.virusres.2008.05.005; PERBAL MC, 1993, VIROLOGY, V195, P281, DOI 10.1006/viro.1993.1375; PFEIFFER P, 1983, CELL, V33, P781, DOI 10.1016/0092-8674(83)90020-X; Qiu SG, 1997, VIROLOGY, V227, P180, DOI 10.1006/viro.1996.8314; Reddy ASN, 2007, ANNU REV PLANT BIOL, V58, P267, DOI 10.1146/annurev.arplant.58.032806.103754; RICHARDS KE, 1981, FEBS LETT, V134, P67, DOI 10.1016/0014-5793(81)80552-2; Roberts K, 2007, NEW PHYTOL, V175, P707, DOI 10.1111/j.1469-8137.2007.02136.x; Roy B, 2013, CURR GENOMICS, V14, P182, DOI 10.2174/1389202911314030004; Ryabova LA, 2006, VIRUS RES, V119, P52, DOI 10.1016/j.virusres.2005.10.017; Sajic R, 2007, NUCLEIC ACIDS RES, V35, P247, DOI 10.1093/nar/gkl022; Sanchez-Navarro J, 2010, J VIROL, V84, P4109, DOI 10.1128/JVI.02543-09; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SCHOLTHOF HB, 1991, VIROLOGY, V184, P290, DOI 10.1016/0042-6822(91)90845-3; Schrom EM, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-55; Shivaprasad PV, 2008, NUCLEIC ACIDS RES, V36, P5896, DOI 10.1093/nar/gkn590; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sommer G, 2008, FRONT BIOSCI-LANDMRK, V13, P5533; Soussan P, 2003, J HEPATOL, V38, P343, DOI 10.1016/S0168-8278(02)00422-1; Stavolone L, 2005, P NATL ACAD SCI USA, V102, P6219, DOI 10.1073/pnas.0407731102; THOMAS CL, 1995, PLANT CELL, V7, P561, DOI 10.1105/tpc.7.5.561; Valencia P, 2008, P NATL ACAD SCI USA, V105, P3386, DOI 10.1073/pnas.0800250105; Voinnet O, 2003, PLANT J, V33, P949, DOI 10.1046/j.1365-313X.2003.01676.x; Wright EA, 1997, PLANT J, V12, P1285, DOI 10.1046/j.1365-313x.1997.12061285.x; XIONG C, 1982, EMBO J, V1, P971, DOI 10.1002/j.1460-2075.1982.tb01280.x; XIONG C, 1984, P NATL ACAD SCI-BIOL, V81, P6608, DOI 10.1073/pnas.81.21.6608; Yasaka R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085641; Zheng ZM, 2010, INT J BIOL SCI, V6, P730	67	11	11	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132665	10.1371/journal.pone.0132665	http://dx.doi.org/10.1371/journal.pone.0132665			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26162084	Green Published, gold, Green Submitted			2022-12-26	WOS:000358162300165
J	Erickson, NA; Nystrom, EEL; Mundhenk, L; Arike, L; Glauben, R; Heimesaat, MM; Fischer, A; Bereswill, S; Birchenough, GMH; Gruber, AD; Johansson, MEV				Erickson, Nancy A.; Nystrom, Elisabeth E. L.; Mundhenk, Lars; Arike, Liisa; Glauben, Rainer; Heimesaat, Markus M.; Fischer, Andre; Bereswill, Stefan; Birchenough, George M. H.; Gruber, Achim D.; Johansson, Malin E. V.			The Goblet Cell Protein Clca1 (Alias mClca3 or Gob-5) Is Not Required for Intestinal Mucus Synthesis, Structure and Barrier Function in Naive or DSS-Challenged Mice	PLOS ONE			English	Article							ACTIVATED CHLORIDE CHANNEL; MOUSE STOMACH; MUCIN; EXPRESSION; GENE; LAYERS; FAMILY; INFLAMMATION; BACTERIA; COLITIS	The secreted, goblet cell-derived protein Clca1 (chloride channel regulator, calcium-activated-1) has been linked to diseases with mucus overproduction, including asthma and cystic fibrosis. In the intestine Clca1 is found in the mucus with an abundance and expression pattern similar to Muc2, the major structural mucus component. We hypothesized that Clca1 is required for the synthesis, structure or barrier function of intestinal mucus and therefore compared wild type and Clca1-deficient mice under naive and at various time points of DSS (dextran sodium sulfate)-challenged conditions. The mucus phenotype in Clca1-deficient compared to wild type mice was systematically characterized by assessment of the mucus protein composition using proteomics, immunofluorescence and expression analysis of selected mucin genes on mRNA level. Mucus barrier integrity was assessed in-vivo by analysis of bacterial penetration into the mucus and translocation into sentinel organs combined analysis of the fecal microbiota and ex-vivo by assessment of mucus penetrability using beads. All of these assays revealed no relevant differences between wild type and Clca1-deficient mice under steady state or DSS-challenged conditions in mouse colon. Clca1 is not required for mucus synthesis, structure and barrier function in the murine colon.	[Erickson, Nancy A.; Mundhenk, Lars; Gruber, Achim D.] Free Univ Berlin, Dept Vet Pathol, Berlin, Germany; [Nystrom, Elisabeth E. L.; Arike, Liisa; Birchenough, George M. H.; Johansson, Malin E. V.] Univ Gothenburg, Dept Med Biochem, Gothenburg, Sweden; [Glauben, Rainer] Charite, Div Gastroenterol Infectiol & Rheumatol, Dept Med, D-13353 Berlin, Germany; [Heimesaat, Markus M.; Fischer, Andre; Bereswill, Stefan] Charite, Dept Microbiol & Hyg, D-13353 Berlin, Germany	Free University of Berlin; University of Gothenburg; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Johansson, MEV (corresponding author), Univ Gothenburg, Dept Med Biochem, Gothenburg, Sweden.	malin.johansson@medkem.gu.se	Gruber, Achim D./ABA-4514-2021; Arike, Liisa/AAF-7698-2020; Johansson, Malin E. V./HCH-7451-2022	Arike, Liisa/0000-0002-2184-0960; Johansson, Malin E. V./0000-0002-4237-6677; Heimesaat, Markus/0000-0001-6399-651X	Swedish Research Council [22220-01-5]; Wilhelm and Martina Lundgren's Foundation; Assar Gabrielsson's Foundation; Clas Groschinskys Foundation; National Institute of Allergy and Infectious Diseases [U01AI095776-03:9006862]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI095776, U01AI095473] Funding Source: NIH RePORTER	Swedish Research Council(Swedish Research CouncilEuropean Commission); Wilhelm and Martina Lundgren's Foundation; Assar Gabrielsson's Foundation; Clas Groschinskys Foundation; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Swedish Research Council (no. 22220-01-5, http://www.vr.se/, to MEVJ), the Wilhelm and Martina Lundgren's Foundation (http://www.wmlundgren.se/, to MEVJ), the Assar Gabrielsson's Foundation (http://www.agfond.se/, to MEVJ), the Clas Groschinskys Foundation (http://www.groschinsky.org/, to MEVJ) and the National Institute of Allergy and Infectious Diseases (U01AI095776-03:9006862, http://www.niaid.nih.gov/Pages/default.aspx, to MEVJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnel M, 1999, FEBS LETT, V455, P295, DOI 10.1016/S0014-5793(99)00891-1; Al-Jumaily Mohammed, 2007, Neurosci Bull, V23, P293, DOI 10.1007/s12264-007-0044-8; Alevy YG, 2012, J CLIN INVEST, V122, P4555, DOI 10.1172/JCI64896; Ambort D., 2012, COLD SPRING HARB PER, V2; Bereswill S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015099; Bothe M, 2011, MOL CELLS, V32, P535, DOI 10.1007/s10059-011-0158-8; Braun J, 2010, J CYST FIBROS, V9, P351, DOI 10.1016/j.jcf.2010.06.003; Brouillard F, 2005, MOL CELL PROTEOMICS, V4, P1762, DOI 10.1074/mcp.M500098-MCP200; Buisine MP, 2001, GUT, V49, P544, DOI 10.1136/gut.49.4.544; Byrnes JJ, 2009, INFLAMM RES, V58, P819, DOI 10.1007/s00011-009-0053-3; Carvalho FA, 2012, CELL HOST MICROBE, V12, P139, DOI 10.1016/j.chom.2012.07.004; Ching JCH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083130; Corfield AP, 2000, GUT, V47, P589, DOI 10.1136/gut.47.4.589; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Deplancke B, 2001, AM J CLIN NUTR, V73, p1131S; Desseyn JL, 2003, GENOMICS, V81, P433, DOI 10.1016/S0888-7543(03)00036-3; Dietert K, 2015, HISTOCHEM CELL BIOL, V143, P277, DOI 10.1007/s00418-014-1279-x; Dietert K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102606; Ermund A, 2013, AM J PHYSIOL-GASTR L, V305, pG341, DOI 10.1152/ajpgi.00046.2013; Escande F, 2004, BBA-GENE STRUCT EXPR, V1676, P240, DOI 10.1016/j.bbaexp.2004.01.001; Fu JX, 2011, J CLIN INVEST, V121, P1657, DOI 10.1172/JCI45538; Gibson A, 2005, J BIOL CHEM, V280, P27205, DOI 10.1074/jbc.M504654200; Giulietti A, 2001, METHODS, V25, P386, DOI 10.1006/meth.2001.1261; Gruber AD, 1998, GENOMICS, V54, P200, DOI 10.1006/geno.1998.5562; Gustafsson JK, 2012, AM J PHYSIOL-GASTR L, V302, pG430, DOI [10.1152/ajpgi.00405.2011, 10.1152/ajpgi.00405.2011.]; Hasnain SZ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001856; Hauber HP, 2004, EUR RESPIR J, V23, P846, DOI 10.1183/09031936.04.00096504; Hegab AE, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.012484; Heimesaat MM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000662; Heimesaat MM, 2006, J IMMUNOL, V177, P8785, DOI 10.4049/jimmunol.177.12.8785; Heimesaat MM, 2010, GUT, V59, P1079, DOI 10.1136/gut.2009.197434; Hoebler C, 2006, DIGEST DIS SCI, V51, P381, DOI 10.1007/s10620-006-3142-y; Hoshino M, 2002, AM J RESP CRIT CARE, V165, P1132, DOI 10.1164/ajrccm.165.8.2107068; HUANG S, 1992, AM J PATHOL, V141, P981; Johansson MEV, 2014, GUT, V63, P281, DOI 10.1136/gutjnl-2012-303207; Johansson MEV, 2013, NAT REV GASTRO HEPAT, V10, P352, DOI 10.1038/nrgastro.2013.35; Johansson MEV, 2012, METHODS MOL BIOL, V842, P229, DOI 10.1007/978-1-61779-513-8_13; Johansson MEV, 2011, CELL MOL LIFE SCI, V68, P3635, DOI 10.1007/s00018-011-0822-3; Johansson MEV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012238; Johansson MEV, 2009, J PROTEOME RES, V8, P3549, DOI 10.1021/pr9002504; Johansson MEV, 2008, P NATL ACAD SCI USA, V105, P15064, DOI 10.1073/pnas.0803124105; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Larsson JMH, 2011, INFLAMM BOWEL DIS, V17, P2299, DOI 10.1002/ibd.21625; Leverkoehne I, 2002, J HISTOCHEM CYTOCHEM, V50, P829, DOI 10.1177/002215540205000609; Lupp C, 2007, CELL HOST MICROBE, V2, P119, DOI 10.1016/j.chom.2007.06.010; Luster AD, 1998, NEW ENGL J MED, V338, P436, DOI 10.1056/NEJM199802123380706; Mahler M, 2014, LAB ANIM-UK, V48, P178, DOI 10.1177/0023677213516312; Mukherjee S, 2011, AM J PATHOL, V179, P248, DOI 10.1016/j.ajpath.2011.03.003; Mundhenk L, 2006, J BIOL CHEM, V281, P30072, DOI 10.1074/jbc.M606489200; Mundhenk L, 2012, AM J RESP CELL MOL, V47, P87, DOI 10.1165/rcmb.2010-0508OC; Nakanishi A, 2001, P NATL ACAD SCI USA, V98, P5175, DOI 10.1073/pnas.081510898; Norris MD, 2000, MED PEDIATR ONCOL, V35, P585, DOI 10.1002/1096-911X(20001201)35:6<585::AID-MPO20>3.3.CO;2-G; OKAYASU I, 1990, GASTROENTEROLOGY, V98, P694, DOI 10.1016/0016-5085(90)90290-H; Patel AC, 2006, PHYSIOL GENOMICS, V25, P502, DOI 10.1152/physiolgenomics.00321.2005; Patel AC, 2009, ANNU REV PHYSIOL, V71, P425, DOI 10.1146/annurev.physiol.010908.163253; Pawlowski K, 2006, PROTEINS, V63, P424, DOI 10.1002/prot.20887; Perse M, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/718617; Plog S, 2009, J HISTOCHEM CYTOCHEM, V57, P1169, DOI 10.1369/jhc.2009.954594; Range F, 2007, VET PATHOL, V44, P901, DOI 10.1354/vp.44-6-901; Rausch S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074026; Robichaud A, 2005, AM J RESP CELL MOL, V33, P303, DOI 10.1165/rcmb.2004-0372OC; Rodriguez-Pineiro AM, 2013, AM J PHYSIOL-GASTR L, V305, pG348, DOI 10.1152/ajpgi.00047.2013; Rose MC, 2006, PHYSIOL REV, V86, P245, DOI 10.1152/physrev.00010.2005; Sala-Rabanal M, 2015, ELIFE, V4, DOI 10.7554/eLife.05875; Song LQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082367; Tetaert D, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-39; Thoene-Reineke C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113406; Toda M, 2002, J ALLERGY CLIN IMMUN, V109, P246, DOI 10.1067/mai.2002.121555; Tytgat KMAJ, 1996, BIOCHEM BIOPH RES CO, V224, P397, DOI 10.1006/bbrc.1996.1039; van der Doef HPJ, 2010, J PEDIATR GASTR NUTR, V50, P347, DOI 10.1097/MPG.0b013e3181afce6c; van der Post S, 2014, MOL CELL PROTEOMICS, V13, P2277, DOI 10.1074/mcp.M114.040204; Van der Sluis M, 2006, GASTROENTEROLOGY, V131, P117, DOI 10.1053/j.gastro.2006.04.020; van Klinken BJW, 1998, AM J PHYSIOL-GASTR L, V274, pG871, DOI 10.1152/ajpgi.1998.274.5.G871; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Whittaker CA, 2002, MOL BIOL CELL, V13, P3369, DOI 10.1091/mbc.E02-05-0259; Wirtz S, 2007, NAT PROTOC, V2, P541, DOI 10.1038/nprot.2007.41; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Yang B, 2015, CANCER; Yang B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060861; Young FD, 2007, GASTROENTEROLOGY, V133, P1928, DOI 10.1053/j.gastro.2007.10.007; Yurtsever Z, 2012, J BIOL CHEM, V287, P42138, DOI 10.1074/jbc.M112.410282; Zhou YH, 2001, AM J RESP CELL MOL, V25, P486, DOI 10.1165/ajrcmb.25.4.4578	82	15	15	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0131991	10.1371/journal.pone.0131991	http://dx.doi.org/10.1371/journal.pone.0131991			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26162072	Green Published, gold, Green Submitted			2022-12-26	WOS:000358162300081
J	Dong, Y; Chen, J; Chen, ZQ; Tian, CY; Lu, HS; Ruan, JG; Yang, WJ				Dong, Ying; Chen, Jing; Chen, Zhiqiang; Tian, Chaoyong; Lu, Huaisheng; Ruan, Jigang; Yang, Wenjun			Evaluating the Association of Eight Polymorphisms with Cancer Susceptibility in a Han Chinese Population	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SQUAMOUS-CELL CARCINOMA; LOCI; PLCE1; C20ORF54; STAT3; RISK	Background The identification of susceptibility genes for specific types of cancer can provide necessary information for the complete characterization of cancer syndromes. Eight single nucleotide polymorphisms (SNPs), rs465498, rs17728461, rs4488809, rs753955, rs13361707, rs9841504, rs2274223, and rs13042395, were reported by genome wide association studies (GWASs) to be closely related to the susceptibility of lung cancer (LC), gastric cancer (GC) or esophageal cancer (EC) in Han population from northern or southern China. However, Chinese Han people from different geographic areas may have different genetic backgrounds. This study aims to assess the genetic associations of the eight SNPs mentioned above with three cancers risk in a Han population from northwest China. Methods A total of 186 cancer-free controls and 436 cases with non-small cell lung cancer (NSCLC) (159 cases), non-cardia GC (167 cases) or EC (110 cases) were enrolled in this study. Chi-square test and polytomous logistic regression analyses were used to estimate the association between eight cancer-related SNPs and three cancers in a Han Chinese population from northwest China. The logistic regression results were adjusted for confounding factors and Benjamini and Hochberg False Discovery Rate (FDR) method was used to adjust the multiple hypothesis tests. Association analyses by cigarette smoking or alcohol drinking status were analyzed by crossover analyses. Results One of the eight SNPs, rs17728461 was associated with NSCLC susceptibility (in a heterozygous model, OR = 0.44, 95% CI = 0.27-0.72, p = 0.001). Two SNPs, rs753955 and rs13042395, were associated with the risk of non-cardia GC in different genetic models (p < 0.05). No SNPs were associated with EC. The crossover analyses showed that the rs13042395 CT genotype, combined with cigarette smoking or alcohol drinking, could further increase the risk for non-cardia GC (p < 0.05). Conclusions These results indicated that rs17728461 may be specifically associated with the risk of NSCLC. rs753955 and rs13042395 were specifically associated with susceptibility to non-cardia GC in Ningxia Han Chinese. Susceptibility-associated polymorphisms in the northwestern Han Chinese were not very consistent with those in the northern Han Chinese or southern Han Chinese. The validation of these findings with a functional evaluation and a larger population is still required.	[Dong, Ying; Yang, Wenjun] Ningxia Med Univ, Dept Med Oncol, Gen Hosp, Ningxia, Peoples R China; [Dong, Ying; Chen, Jing; Tian, Chaoyong; Yang, Wenjun] Ningxia Med Univ, Key Lab Ningxia Reprod & Hered, Ningxia, Peoples R China; [Chen, Zhiqiang] Ningxia Med Univ, Dept Radiol, Gen Hosp, Ningxia, Peoples R China; [Lu, Huaisheng] Ningxia Peoples Hosp, Dept Pathol, Ningxia, Peoples R China; [Ruan, Jigang] Ningxia Med Univ, Gen Hosp, Digest Dept, Ningxia, Peoples R China	Ningxia Medical University; Ningxia Medical University; Ningxia Medical University; Ningxia Medical University	Yang, WJ (corresponding author), Ningxia Med Univ, Dept Med Oncol, Gen Hosp, Ningxia, Peoples R China.	yw001@nxmu.edu.cn	小建, 于/N-3224-2015	Yang, Wenjun/0000-0001-5671-1344	National Natural Science Foundation of China [81460434, 81160249, 81260339, 81301886, 81160252]; Ningxia Natural Science Foundation [NZ13057]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ningxia Natural Science Foundation	This work was supported by the National Natural Science Foundation of China (grant numbers 81460434, 81160249, 81260339, 81301886, and 81160252 to WJY, JC, and HSL; http://www.nsfc.gov.cn/), the Ningxia Natural Science Foundation (grant number NZ13057 to WJY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen BF, 2014, J MOL NEUROSCI, V52, P481, DOI 10.1007/s12031-013-0160-z; Chen YL, 2010, CANCER RES, V70, P8917, DOI 10.1158/0008-5472.CAN-10-0518; Chew A, 2000, GENOMICS, V65, P104, DOI 10.1006/geno.2000.6162; Dura P, 2013, EUR J CANCER PREV, V22, P417, DOI 10.1097/CEJ.0b013e32835c7f53; Ferlay J, 2012, IARC CANCERBASE; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Gu HY, 2012, MOL BIOL REP, V39, P9105, DOI 10.1007/s11033-012-1782-x; Hu ZB, 2011, NAT GENET, V43, P792, DOI 10.1038/ng.875; Hutter CM, 2011, CANCER EPIDEM BIOMAR, V20, P1950, DOI 10.1158/1055-9965.EPI-11-0524; Karafet T, 2001, AM J HUM GENET, V69, P615, DOI 10.1086/323299; Manolio TA, 2010, NEW ENGL J MED, V363, P166, DOI 10.1056/NEJMra0905980; Palmer AJ, 2012, EUR J CANCER PREV, V21, P541, DOI 10.1097/CEJ.0b013e3283529b79; Piao JM, J 0B013E3283529B79; Shi YY, 2011, NAT GENET, V43, P1215, DOI 10.1038/ng.978; Walker CL, 2012, NAT REV CANCER, V12, P479, DOI 10.1038/nrc3220; Wang LD, 2010, NAT GENET, V42, P759, DOI 10.1038/ng.648; Wen B, 2004, NATURE, V431, P302, DOI 10.1038/nature02878; Xu SH, 2009, AM J HUM GENET, V85, P762, DOI 10.1016/j.ajhg.2009.10.015; Yao YG, 2002, AM J PHYS ANTHROPOL, V118, P63, DOI 10.1002/ajpa.10052; Yao YG, 2002, AM J HUM GENET, V70, P635, DOI 10.1086/338999; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734	21	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132797	10.1371/journal.pone.0132797	http://dx.doi.org/10.1371/journal.pone.0132797			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176862	Green Submitted, Green Published, gold			2022-12-26	WOS:000358197600160
J	el Din, FA; Patri, S; Thoreau, V; Rodriguez-Ballesteros, M; Hamade, E; Bailly, S; Gilbert-Dussardier, B; Abou Merhi, R; Kitzis, A				el Din, Ferdos Alaa; Patri, Sylvie; Thoreau, Vincent; Rodriguez-Ballesteros, Montserrat; Hamade, Eva; Bailly, Sabine; Gilbert-Dussardier, Brigitte; Abou Merhi, Raghida; Kitzis, Alain			Functional and splicing defect analysis of 23 ACVRL1 mutations in a cohort of patients affected by Hereditary Hemorrhagic Telangiectasia	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; TGF-BETA; JUVENILE POLYPOSIS; I RECEPTORS; ALK1; ANGIOGENESIS; ACTIVIN; IDENTIFICATION; MECHANISMS; BMP9	Hereditary Hemorrhagic Telangiectasia syndrome (HHT) or Rendu-Osler-Weber (ROW) syndrome is an autosomal dominant vascular disorder. Two most common forms of HHT, HHT1 and HHT2, have been linked to mutations in the endoglin (ENG) and activin receptor-like kinase 1 (ACVRL1 or ALK1) genes respectively. This work was designed to examine the pathogenicity of 23 nucleotide variations in ACVRL1 gene detected in more than 400 patients. Among them, 14 missense mutations and one intronic variant were novels, and 8 missense mutations were previously identified with questionable implication in HHT2. The functionality of missense mutations was analyzed in response to BMP9 (specific ligand of ALK1), the maturation of the protein products and their localization were analyzed by western blot and fluorescence microscopy. The splicing impairment of the intronic and of two missense mutations was examined by minigene assay. Functional analysis showed that 18 out of 22 missense mutations were defective. Splicing analysis revealed that one missense mutation (c. 733A>G, p.Ile245Val) affects the splicing of the harboring exon 6. Similarly, the intronic mutation outside the consensus splicing sites (c. 1048+5G>A in intron 7) was seen pathogenic by splicing study. Both mutations induce a frame shift creating a premature stop codon likely resulting in mRNA degradation by NMD surveillance mechanism. Our results confirm the haploinsufficiency model proposed for HHT2. The affected allele of ACVRL1 induces mRNA degradation or the synthesis of a protein lacking the receptor activity. Furthermore, our data demonstrate that functional and splicing analyses together, represent two robust diagnostic tools to be used by geneticists confronted with novel or conflicted ACVRL1 mutations.	[el Din, Ferdos Alaa; Patri, Sylvie; Thoreau, Vincent; Rodriguez-Ballesteros, Montserrat; Gilbert-Dussardier, Brigitte; Kitzis, Alain] Univ Poitiers, Genet Rare Dis, Poitiers, France; [Patri, Sylvie; Rodriguez-Ballesteros, Montserrat; Gilbert-Dussardier, Brigitte; Kitzis, Alain] Univ Hosp Poitiers, Dept Genet, Poitiers, France; [el Din, Ferdos Alaa; Hamade, Eva; Abou Merhi, Raghida] Fac Sci EDST, Hadath, Lebanon; [Bailly, Sabine] CEA Grenoble, INSERM, U1036, F-38054 Grenoble, France; [Gilbert-Dussardier, Brigitte] Univ Hosp Poitiers, Competence Ctr Rendu Osler, Poitiers, France	Universite de Poitiers; CHU Poitiers; Universite de Poitiers; CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Poitiers; Universite de Poitiers	Patri, S (corresponding author), Univ Poitiers, Genet Rare Dis, Poitiers, France.	sylvie.patri@chu-poitiers.fr; raboumerhi@ul.edu.lb	bailly, sabine/G-3540-2013	bailly, sabine/0000-0003-1043-7030; GILBERT-DUSSARDIER, Brigitte/0000-0001-7182-9914; Hamade, Eva/0000-0001-5152-913X	LASER LIBANESE UNIVERSITY; Association francaise Maladie de Rendu Osler Weber (AMRO)	LASER LIBANESE UNIVERSITY; Association francaise Maladie de Rendu Osler Weber (AMRO)	This work was supported by LASER LIBANESE UNIVERSITY: FAD, and the Association francaise Maladie de Rendu Osler Weber (AMRO) to AK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdalla SA, 2006, J MED GENET, V43, P97, DOI 10.1136/jmg.2005.030833; Ali BR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026206; ATTISANO L, 1993, CELL, V75, P671, DOI 10.1016/0092-8674(93)90488-C; Bayrak-Toydemir P, 2006, AM J MED GENET A, V140A, P2155, DOI 10.1002/ajmg.a.31450; Bernabeu C, 2010, J APPL BIOMED, V8, P169, DOI 10.2478/v10136-009-0020-x; Bobik A, 2006, ARTERIOSCL THROM VAS, V26, P1712, DOI 10.1161/01.ATV.0000225287.20034.2c; Chen YG, 1999, J BIOL CHEM, V274, P3672, DOI 10.1074/jbc.274.6.3672; Cole SG, 2005, J MED GENET, V42, P577, DOI 10.1136/jmg.2004.028712; David L, 2008, CIRC RES, V102, P914, DOI 10.1161/CIRCRESAHA.107.165530; David L, 2007, BLOOD, V109, P1953, DOI 10.1182/blood-2006-07-034124; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Fernandez-L A, 2006, CLIN MED RES, V4, P66, DOI 10.3121/cmr.4.1.66; Gallione C, 2010, AM J MED GENET A, V152A, P333, DOI 10.1002/ajmg.a.33206; Gallione CJ, 2004, LANCET, V363, P852, DOI 10.1016/S0140-6736(04)15732-2; Goumans MJ, 2002, EMBO J, V21, P1743, DOI 10.1093/emboj/21.7.1743; Goumans MJ, 2003, TRENDS CARDIOVAS MED, V13, P301, DOI 10.1016/S1050-1738(03)00142-7; Govani FS, 2009, EUR J HUM GENET, V17, P860, DOI 10.1038/ejhg.2009.35; Gu Y, 2006, BLOOD, V107, P1951, DOI 10.1182/blood-2005-05-1834; GUTTMACHER AE, 1995, NEW ENGL J MED, V333, P918, DOI 10.1056/NEJM199510053331407; Harrison RE, 2003, J MED GENET, V40, P865, DOI 10.1136/jmg.40.12.865; Hume AN, 2013, MOL CELL BIOCHEM, V373, P247, DOI 10.1007/s11010-012-1496-3; Johnson DW, 1995, 2 LOCUS HEREDITARY H, P21; Johnson DW, 1996, MUTATIONS ACTIVIN RE, P189; Kjeldsen AD, 1999, J INTERN MED, V245, P31, DOI 10.1046/j.1365-2796.1999.00398.x; Klaus Daniel J., 1998, Human Mutation, V12, P137, DOI 10.1002/(SICI)1098-1004(1998)12:2<137::AID-HUMU15>3.0.CO;2-M; Korchynskyi O, 2002, J BIOL CHEM, V277, P4883, DOI 10.1074/jbc.M111023200; Lamouille S, 2002, BLOOD, V100, P4495, DOI 10.1182/blood.V100.13.4495; Lesca Gaetan, 2006, Hum Mutat, V27, P598, DOI 10.1002/humu.9421; Mallet C, 2014, HUM MOL GENET; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; MCALLISTER KA, 1994, J MED GENET, V31, P927, DOI 10.1136/jmg.31.12.927; McAllister KA, 1994, ENDOGLIN TGF BETA BI, V1, P345; McDonald J, 2010, MOL DIAGNOSIS HEREDI, P335; Nielsen KB, 2007, AM J HUM GENET, V80, P416, DOI 10.1086/511992; Novoyatleva T, 2006, PROG MOLEC, V44, P27; Oh SP, 2000, P NATL ACAD SCI USA, V97, P2626, DOI 10.1073/pnas.97.6.2626; Pagani F, 2005, P NATL ACAD SCI USA, V102, P6368, DOI 10.1073/pnas.0502288102; Ricard N, 2010, BLOOD, V116, P1604, DOI 10.1182/blood-2010-03-276881; Scharpfenecker M, 2007, J CELL SCI, V120, P964, DOI 10.1242/jcs.002949; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Shovlin CL, 2000, AM J MED GENET, V91, P66, DOI 10.1002/(SICI)1096-8628(20000306)91:1<66::AID-AJMG12>3.0.CO;2-P; Shovlin CL, 2010, BLOOD REV, V24, P203, DOI 10.1016/j.blre.2010.07.001; Tang Y, 2005, ANAL ALTERNATIVE SPL, P755; ten Dijke P, 2008, ANGIOGENESIS, V11, P79, DOI 10.1007/s10456-008-9101-9; WEISBERG RA, 1983, J MOL BIOL, V170, P319, DOI 10.1016/S0022-2836(83)80151-X; Wooderchak-Donahue WL, 2013, AM J HUM GENET, V93, P530, DOI 10.1016/j.ajhg.2013.07.004; Wrighton KH, 2009, J BIOL CHEM, V284, P9755, DOI 10.1074/jbc.M809223200	47	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132111	10.1371/journal.pone.0132111	http://dx.doi.org/10.1371/journal.pone.0132111			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176610	Green Published, gold, Green Submitted			2022-12-26	WOS:000358197600082
J	Kim, J; Nadella, P; Kim, DJ; Brodmerkel, C; da Rosa, JC; Krueger, JG; Suarez-Farinas, M				Kim, Jaehwan; Nadella, Pranay; Kim, Dong Joo; Brodmerkel, Carrie; da Rosa, Joel Correa; Krueger, James G.; Suarez-Farinas, Mayte			Histological Stratification of Thick and Thin Plaque Psoriasis Explores Molecular Phenotypes with Clinical Implications	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIALS; TO-SEVERE PSORIASIS; GENE-EXPRESSION; MONOCLONAL-ANTIBODY; DISEASE SEVERITY; TNF-ALPHA; ARTHRITIS; MODERATE; METAANALYSIS; USTEKINUMAB	Psoriasis, which presents as red, scaly patches on the body, is a common, autoimmune skin disease that affects 2 to 3 percent of the world population. To leverage recent molecular findings into the personalized treatment of psoriasis, we need a strategy that integrates clinical stratification with molecular phenotyping. In this study, we sought to stratify psoriasis patients by histological measurements of epidermal thickness, and to compare their molecular characterizations by gene expression, serum cytokines, and response to biologics. We obtained histological measures of epidermal thickness in a cohort of 609 psoriasis patients, and identified a mixture of two subpopulations-thick and thin plaque psoriasis-from which they were derived. This stratification was verified in a subcohort of 65 patients from a previously published study with significant differences in inflammatory cell infiltrates in the psoriatic skin. Thick and thin plaque psoriasis shared 84.8% of the meta-analysis-derived psoriasis transcriptome, but a stronger dysregulation of the meta-analysis-derived psoriasis transcriptome was seen in thick plaque psoriasis on microarray. RT-PCR revealed that gene expression in thick and thin plaque psoriasis was different not only within psoriatic lesional skin but also in peripheral non-lesional skin. Additionally, differences in circulating cytokines and their changes in response to biologic treatments were found between the two subgroups. All together, we were able to integrate histological stratification with molecular phenotyping as a way of exploring clinical phenotypes with different expression levels of the psoriasis transcriptome and circulating cytokines.	[Kim, Jaehwan; Nadella, Pranay; Kim, Dong Joo; Krueger, James G.] Rockefeller Univ, Invest Dermatol Lab, New York, NY 10021 USA; [Nadella, Pranay] Harvard Univ, Cambridge, MA 02138 USA; [Kim, Dong Joo] SUNY Stony Brook, Sch Med, Stony Brook, NY 11794 USA; [Brodmerkel, Carrie] Janssen Res & Dev, Immunol & Biomarkers, Radnor, PA USA; [da Rosa, Joel Correa; Suarez-Farinas, Mayte] Rockefeller Univ, Ctr Clin & Translat Sci, New York, NY 10021 USA; [Suarez-Farinas, Mayte] Icahn Sch Med Mt Sinai, New York, NY 10029 USA	Rockefeller University; Harvard University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Rockefeller University; Icahn School of Medicine at Mount Sinai	Krueger, JG (corresponding author), Rockefeller Univ, Invest Dermatol Lab, 1230 York Ave, New York, NY 10021 USA.	kruegej@rockefeller.edu; farinam@rockefeller.edu	Da Rosa, Joel/AAU-1238-2020; Correa da Rosa, Joel/Q-4753-2017	Da Rosa, Joel/0000-0003-4221-1976; Correa da Rosa, Joel/0000-0003-4221-1976; Nadella, Pranay/0000-0003-3002-1200; Kim, Jaehwan/0000-0002-7586-1425	Janssen Research Development	Janssen Research Development	Janssen Research & Development provided support in the form of data collection and salaries for author C.B. The specific roles of these authors are articulated in the 'author contributions' section.	Ainali C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-472; Arican O, 2005, MEDIAT INFLAMM, P273, DOI 10.1155/MI.2005.273; Bhalerao J, 1998, HUM MOL GENET, V7, P1537, DOI 10.1093/hmg/7.10.1537; Boehncke WH, 2011, EXP DERMATOL, V20, P303, DOI 10.1111/j.1600-0625.2011.01261.x; Bowcock AM, 2001, HUM MOL GENET, V10, P1793, DOI 10.1093/hmg/10.17.1793; Chandran V, 2010, J AUTOIMMUN, V34, pJ314, DOI 10.1016/j.jaut.2009.12.001; Christensen TE, 2006, J INVEST DERMATOL, V126, P2397, DOI 10.1038/sj.jid.5700489; Christophers E, 2014, BRIT J DERMATOL, V170, P59, DOI 10.1111/bjd.12631; Cohen AD, 2008, ISR MED ASSOC J, V10, P419; DEMPSTER WJ, 1977, JPN HEART J, V18, P491; Devrimci-Ozguven H, 2000, J EUR ACAD DERMATOL, V14, P267, DOI 10.1046/j.1468-3083.2000.00085.x; Garlanda C, 2013, IMMUNITY, V39, P1003, DOI 10.1016/j.immuni.2013.11.010; Gladman DD, 2005, ANN RHEUM DIS, V64, P14, DOI 10.1136/ard.2004.032482; Gottlieb A, 2009, LANCET, V373, P633, DOI 10.1016/S0140-6736(09)60140-9; Griffiths CEM, 2010, NEW ENGL J MED, V362, P118, DOI 10.1056/NEJMoa0810652; Gudjonsson JE, 2009, J INVEST DERMATOL, V129, P2795, DOI 10.1038/jid.2009.173; Hanzelmann S, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-7; Jabbari A, 2012, J INVEST DERMATOL, V132, P246, DOI 10.1038/jid.2011.267; Johnston A, 2011, J IMMUNOL, V186, P2613, DOI 10.4049/jimmunol.1003162; Keermann M, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1508-2; Kim J, 2015, DERMATOL CLIN, V33, P13, DOI 10.1016/j.det.2014.09.002; Koo J, 1996, DERMATOL CLIN, V14, P485, DOI 10.1016/S0733-8635(05)70376-4; Krueger GG, 2007, NEW ENGL J MED, V356, P580, DOI 10.1056/NEJMoa062382; Leavy O., 2012, NAT REV IMMUNOL, V12, P322; Lee E, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000217; McLachlan GJ, 2004, FINITE MIXTURE MODEL, DOI [10.1002/0471721182, DOI 10.1002/0471721182]; Mussi A, 1996, J BIOL REGULATORS HO, V11, P115; Neimann AL, 2006, J AM ACAD DERMATOL, V55, P829, DOI 10.1016/j.jaad.2006.08.040; Rasband W, 2009, IMAGEJ; Reich K, 2012, BRIT J DERMATOL, V166, P179, DOI 10.1111/j.1365-2133.2011.10583.x; Schmitt J, 2008, BRIT J DERMATOL, V159, P513, DOI 10.1111/j.1365-2133.2008.08732.x; Schon MP, 2005, LANCET, V366, P1333, DOI 10.1016/S0140-6736(05)67542-3; Suarez-Farinas M, 2012, J INVESTIGATIVE DERM; Suarez-Farinas M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010247; Swindell WR, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-527; Swindell WR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034594; Tian SY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044274; Weinblatt ME, 1999, NEW ENGL J MED, V340, P253, DOI 10.1056/NEJM199901283400401; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Yao YH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002737	40	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132454	10.1371/journal.pone.0132454	http://dx.doi.org/10.1371/journal.pone.0132454			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176783	Green Submitted, gold, Green Published			2022-12-26	WOS:000358197600114
J	Yamashita, JM; de Moura-Grec, PG; de Freitas, AR; Sales-Peres, A; Groppo, FC; Ceneviva, R; Sales-Peres, SHD				Yamashita, Joselene Martinelli; de Moura-Grec, Patrcia Garcia; de Freitas, Adriana Rodrigues; Sales-Peres, Arsenio; Groppo, Francisco Carlos; Ceneviva, Reginaldo; de Carvalho Sales-Peres, Silvia Helena			Assessment of Oral Conditions and Quality of Life in Morbid Obese and Normal Weight Individuals: A Cross-Sectional Study	PLOS ONE			English	Article							GASTROESOPHAGEAL-REFLUX DISEASE; BARIATRIC SURGERY; PERIODONTAL-DISEASE; DENTAL-CARIES; BODY-WEIGHT; TOOTH WEAR; FLOW-RATE; ASSOCIATION; HEALTH; PREVALENCE	The aim of this study was to identify the impact of oral disease on the quality of life of morbid obese and normal weight individuals. Cohort was composed of 100 morbid-obese and 50 normal-weight subjects. Dental caries, community periodontal index, gingival bleeding on probing (BOP), calculus, probing pocket depth, clinical attachment level, dental wear, stimulated salivary flow, and salivary pH were used to evaluate oral diseases. Socioeconomic and the oral impacts on daily performances (OIDP) questionnaires showed the quality of life in both groups. Unpaired Student, Fisher's Exact, Chi-Square, Mann-Whitney, and Multiple Regression tests were used (p<0.05). Obese showed lower socio-economic level than control group, but no differences were found considering OIDP. No significant differences were observed between groups considering the number of absent teeth, bruxism, difficult mastication, calculus, initial caries lesion, and caries. However, saliva flow was low, and the salivary pH was changed in the obese group. Enamel wear was lower and dentine wear was higher in obese. More BOP, insertion loss, and periodontal pocket, especially the deeper ones, were found in obese subjects. The regression model showed gender, smoking, salivary pH, socio-economic level, periodontal pocket, and periodontal insertion loss significantly associated to obesity. However, both OIDP and BOP did not show significant contribution to the model. The quality of life of morbid obese was more negatively influenced by oral disease and socio-economic factors than in normal weight subjects.	[Yamashita, Joselene Martinelli; de Moura-Grec, Patrcia Garcia; de Freitas, Adriana Rodrigues; Sales-Peres, Arsenio; de Carvalho Sales-Peres, Silvia Helena] Univ Sao Paulo, Bauru Sch Dent, Dept Pediat Dent Orthodont & Publ Hlth, Bauru, SP, Brazil; [Groppo, Francisco Carlos] Univ Sao Paulo, Sch Med Ribeirao Preto, Dept Surg & Anat, Ribeirao Preto, SP, Brazil; [Ceneviva, Reginaldo] Univ Estadual Campinas, Dept Physiol Sci, Piracicaba Dent Sch, Piracicaba, SP, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Estadual de Campinas	Sales-Peres, SHD (corresponding author), Univ Sao Paulo, Bauru Sch Dent, Dept Pediat Dent Orthodont & Publ Hlth, Bauru, SP, Brazil.	shcperes@usp.br	Sales-Peres, SILVIA/C-2714-2012; groppo, francisco carlos/HIK-2053-2022	Sales-Peres, SILVIA/0000-0003-3811-7899; groppo, francisco carlos/0000-0002-8513-773X	CNPq; CAPES; FAPESP [558366/2010-4, 2014/09550-6]	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	The authors would like to thank CNPq, CAPES, and FAPESP for financial support through grants 558366/2010-4 and 2014/09550-6. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adulyanon S., 1997, MEASURING ORAL HLTH, P151; Al-Zahrani MS, 2003, J PERIODONTOL, V74, P610, DOI 10.1902/jop.2003.74.5.610; Al-Zarea Bader K, 2012, ISRN Dent, V2012, P161565, DOI 10.5402/2012/161565; Amar S, 2013, MOL ORAL MICROBIOL, V28, P331, DOI 10.1111/omi.12035; Atlantis E, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b3868; Baceviciene M, 2009, MEDICINA-LITHUANIA, V45, P565, DOI 10.3390/medicina45070075; Barron Robert P, 2003, J Can Dent Assoc, V69, P84; Bastos A, 2005, BRAZILIAN RES PEDIAT, V5, P57; Biccas Beatriz N., 2009, Arq. Gastroenterol., V46, P15, DOI 10.1590/S0004-28032009000100008; Caballero B, 2007, EPIDEMIOL REV, V29, P1, DOI 10.1093/epirev/mxm012; Cnop M, 2002, DIABETES, V51, P1005, DOI 10.2337/diabetes.51.4.1005; Curran AE, 2010, J AM DENT ASSOC, V141, P1307, DOI 10.14219/jada.archive.2010.0075; Sales-Peres SHD, 2008, PUBLIC HEALTH, V122, P942, DOI 10.1016/j.puhe.2007.12.008; de Moura-Grec PG, 2012, EUR J GASTROEN HEPAT, V24, P84, DOI 10.1097/MEG.0b013e32834bebb3; Dodson MV, 2011, J LIPIDS, V2011, DOI 10.1155/2011/721686; Dodson MV, 2013, EXP BIOL MED, V238, P491, DOI 10.1177/1535370213477603; El-Serag HB, 2005, GUT, V54, P11, DOI 10.1136/gut.2004.040337; Fenoll-Palomares C, 2004, REV ESP ENFERM DIG, V96, P773; Ferreira J, 2005, DIAGNOSTICO TRATAMEN, P161; Figueiredo Wagner, 2005, Ciênc. saúde coletiva, V10, P105, DOI 10.1590/S1413-81232005000100017; Gordon NF, 1997, AM J CARDIOL, V79, P763, DOI 10.1016/S0002-9149(96)00864-8; Graciano MIG, 1980, SERV SOCIAL SOC, V1, P181; Grisius MM, 2001, ORAL SURG ORAL MED O, V92, P156, DOI 10.1067/moe.2001.116601; Gugliucci Alejandro, 2000, Journal of the American Osteopathic Association, V100, P621; Ibiyemi O, 2012, ETHIOP J HEALTH SCI, V22, P189; Isaksson H, 2013, SWEDISH DENT J S, P1; Ismail AI, 2007, COMMUNITY DENT ORAL, V35, P170, DOI 10.1111/j.1600-0528.2007.00347.x; Jung RT, 1997, BRIT MED BULL, V53, P307, DOI 10.1093/oxfordjournals.bmb.a011615; Kolotkin R L, 2001, Obes Rev, V2, P219, DOI 10.1046/j.1467-789X.2001.00040.x; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Kozlowski F., 2001, THESIS U ESTADUAL CA; Krebs N, 2014, J TRACE ELEM MED BIO, V28, P1, DOI 10.1016/j.jtemb.2013.09.006; Levine R, 2012, BRIT DENT J, V213, P453, DOI 10.1038/sj.bdj.2012.1009; Lussi A, 2012, CARIES RES, V46, P507, DOI 10.1159/000339783; Lussi Adrian, 2004, Oral Health Prev Dent, V2 Suppl 1, P321; Marmot MG, 1997, LANCET, V350, P235, DOI 10.1016/S0140-6736(97)04244-X; Marsicano JA, 2013, EUR J GASTROEN HEPAT, V25, P135, DOI 10.1097/MEG.0b013e32835ae8f7; Mathier MA, 2008, CHEST, V134, P670, DOI 10.1378/chest.08-1518; McMahon FG, 2002, J HUM HYPERTENS, V16, P5, DOI 10.1038/sj.jhh.1001298; Meneghim MD, 2007, CIENC SAUDE COLETIVA, V12, P523, DOI 10.1590/S1413-81232007000200028; Mirijello A, 2015, J AFFECT DISORDERS, V179, P95, DOI 10.1016/j.jad.2015.03.030; Moazzez R, 2004, J DENT, V32, P489, DOI 10.1016/j.jdent.2004.03.004; Modeer T, 2010, OBESITY, V18, P2367, DOI 10.1038/oby.2010.63; Moura-Grec PG, 2012, ABCD-ARQ BRAS CIR DI, V25, P173, DOI 10.1590/S0102-67202012000300008; Organization WH, 1998, WELLB MEAS PRIM HLTH; Ostberg AL, 2012, BMC ORAL HEALTH, V12, DOI 10.1186/1472-6831-12-50; Pataro AL, 2012, CLIN ORAL INVEST, V16, P727, DOI 10.1007/s00784-011-0554-7; Pataro AL, 2012, J PERIODONTOL, V83, P257, DOI 10.1902/jop.2011.100782; Pischon N, 2007, J DENT RES, V86, P400, DOI 10.1177/154405910708600503; Serratine ACP, 2009, PESQUI BRAS ODONTOPE, V9, P217, DOI 10.4034/1519.0501.2009.0092.0014; Saito T, 2005, J PERIODONTAL RES, V40, P346, DOI 10.1111/j.1600-0765.2005.00813.x; Samnieng P, 2012, COMMUNITY DENT HLTH, V29, P117, DOI 10.1922/CDH_2690Ueno07; Sarlati F, 2008, INT DENT J, V58, P36; Sutin AR, 2010, J RES PERS, V44, P402, DOI 10.1016/j.jrp.2010.03.006; Suvan J, 2013, J DENT RES; Touger-Decker R, 2010, J AM DENT ASSOC, V141, P167, DOI 10.14219/jada.archive.2010.0135; Tremblay M, 2012, BMC ORAL HEALTH, V12, DOI 10.1186/1472-6831-12-40; Trombelli L, 2013, Minerva Stomatol, V62, P207; Turner MD, 2007, J AM DENT ASSOC, V138, p15S, DOI 10.14219/jada.archive.2007.0358; WHO, 2003, DIET NUTR PREVENTION, V916; World Health Organization, 1997, WHO OR HLTH SURV BAS, V4th; World Health Organization, 2000, WHO TECHN REP SER, V894; Ylostalo P, 2008, J CLIN PERIODONTOL, V35, P297, DOI 10.1111/j.1600-051X.2008.01203.x; Yuan JCC, 2012, J DENT EDUC, V76, P1129	65	19	21	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0129687	10.1371/journal.pone.0129687	http://dx.doi.org/10.1371/journal.pone.0129687			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1RL	26177268	Green Published, Green Submitted, gold			2022-12-26	WOS:000358197600015
J	Dettmer, AM; Rosenberg, KL; Suomi, SJ; Meyer, JS; Novak, MA				Dettmer, Amanda M.; Rosenberg, Kendra L.; Suomi, Stephen J.; Meyer, Jerrold S.; Novak, Melinda A.			Associations between Parity, Hair Hormone Profiles during Pregnancy and Lactation, and Infant Development in Rhesus Monkeys (Macaca mulatta)	PLOS ONE			English	Article							MATERNAL CORTISOL-LEVELS; LUTEINIZING-HORMONE; POSTNATAL ESTRADIOL; PSYCHOSOCIAL STRESS; NONHUMAN-PRIMATES; PRENATAL EXPOSURE; RELOCATION STRESS; STEROID-HORMONES; DOMINANCE RANK; LIFE-HISTORY	Studies examining hormones throughout pregnancy and lactation in women have been limited to single, or a few repeated, short-term measures of endocrine activity. Furthermore, potential differences in chronic hormonal changes across pregnancy/lactation between first-time and experienced mothers are not well understood, especially as they relate to infant development. Hormone concentrations in hair provide long-term assessments of hormone production, and studying these measures in non-human primates allows for repeated sampling under controlled conditions that are difficult to achieve in humans. We studied hormonal profiles in the hair of 26 female rhesus monkeys (Macaca mulatta, n=12 primiparous), to determine the influences of parity on chronic levels of cortisol ( hair cortisol concentration, HCC) and progesterone (hair progesterone concentration, HPC) during early-to mid-pregnancy (PREG1), in late pregnancy/early lactation (PREG2/LACT1), and in peak lactation (LACT2). We also assessed infants' neurobehavioral development across the first month of life. After controlling for age and stage of pregnancy at the first hair sampling period, we found that HCCs overall peaked in PREG2/LACT1 (p=0.02), but only in primiparous monkeys (p<0.001). HPCs declined across pregnancy and lactation for all monkeys (p<0.01), and primiparous monkeys had higher HPCs overall than multiparous monkeys (p=0.02). Infants of primiparous mothers had lower sensorimotor reflex scores (p=0.02) and tended to be more irritable (p=0.05) and less consolable (p=0.08) in the first month of life. Moreover, across all subjects, HCCs in PREG2/LACT1 were positively correlated with irritability (r((s))=0.43, p=0.03) and negatively correlated with sensorimotor scores (r((s))=-0.41, p=0.04). Together, the present results indicate that primiparity influences both chronic maternal hormonal profiles and infant development. These effects may, in part, reflect differential reproductive and maternal effort in mothers with varied caretaking experience. In addition, infant exposure to relatively higher levels of maternal cortisol during the late fetal and early postnatal periods is predictive of poorer developmental outcomes.	[Dettmer, Amanda M.; Suomi, Stephen J.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Comparat Ethol Lab, NIH, Poolesville, MD 20837 USA; [Rosenberg, Kendra L.; Meyer, Jerrold S.; Novak, Melinda A.] Univ Massachusetts, Dept Psychol & Brain Sci, Amherst, MA USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of Massachusetts System; University of Massachusetts Amherst	Dettmer, AM (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Comparat Ethol Lab, NIH, Poolesville, MD 20837 USA.	dettmera@mail.nih.gov		Meyer, Jerrold/0000-0002-8382-7075; Novak, Melinda/0000-0002-4224-2396	Eunice Kennedy Shriver National Institute of Child Health & Human Development Division of Intramural Research Grant [HD001106]; National Institutes of Health [OD011180]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001107] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R24OD011180] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health & Human Development Division of Intramural Research Grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	SJS: Eunice Kennedy Shriver National Institute of Child Health & Human Development Division of Intramural Research Grant #HD001106 https://dir.nichd.nih.gov/dirweb/home.html. MAN: National Institutes of Health Grant #OD011180 http://www.nih.gov/about/almanac/organization/NCRR.htm.	Albrecht ED, 1999, PLACENTA, V20, P129, DOI 10.1053/plac.1998.0359; ALTEMUS M, 1995, J CLIN ENDOCR METAB, V80, P2954, DOI 10.1210/jc.80.10.2954; Altmann J, 2004, AM J PRIMATOL, V64, P95, DOI 10.1002/ajp.20064; Bacci ML, 2014, REPROD BIOL, V14, P218, DOI 10.1016/j.repbio.2014.06.001; Bastian ML, 2003, DEV PSYCHOBIOL, V42, P44, DOI 10.1002/dev.10091; Bechshoft TO, 2011, SCI TOTAL ENVIRON, V409, P831, DOI 10.1016/j.scitotenv.2010.10.047; Bergman K, 2010, BIOL PSYCHIAT, V67, P1026, DOI 10.1016/j.biopsych.2010.01.002; Brazelton T. B., 1995, NEONATAL BEHAV ASSES; Bridges RS, 2015, FRONT NEUROENDOCRIN, V36, P178, DOI 10.1016/j.yfrne.2014.11.007; BRINKER RP, 1994, AM J MENT RETARD, V98, P463; Brouwers EPM, 2001, INFANT BEHAV DEV, V24, P95, DOI 10.1016/S0163-6383(01)00062-5; Bryan HM, 2015, FUNCT ECOL, V29, P347, DOI 10.1111/1365-2435.12354; CHALLIS JRG, 1971, J ENDOCRINOL, V51, P333, DOI 10.1677/joe.0.0510333; CHENAULT JR, 1975, J DAIRY SCI, V58, P709, DOI 10.3168/jds.S0022-0302(75)84632-7; CONCANNON PW, 1978, BIOL REPROD, V19, P1113, DOI 10.1095/biolreprod19.5.1113; D'Anna-Hernandez KL, 2011, PHYSIOL BEHAV, V104, P348, DOI 10.1016/j.physbeh.2011.02.041; Davenport MD, 2008, BIOL PSYCHIAT, V63, P990, DOI 10.1016/j.biopsych.2007.10.025; Davenport MD, 2006, GEN COMP ENDOCR, V147, P255, DOI 10.1016/j.ygcen.2006.01.005; Davis EP, 2010, CHILD DEV, V81, P131, DOI 10.1111/j.1467-8624.2009.01385.x; Davis EP, 2007, J AM ACAD CHILD PSY, V46, P737, DOI 10.1097/chi.0b013e318047b775; de Weerth C, 2003, EARLY HUM DEV, V74, P139, DOI 10.1016/S0378-3782(03)00088-4; Dettenborn L, 2012, STRESS, V15, P348, DOI [10.3109/10253890.2011.619239, 10.3109/10253890.2012.654479]; Dettmer AM, 2014, PSYCHONEUROENDOCRINO, V42, P59, DOI 10.1016/j.psyneuen.2014.01.002; Dettmer AM, 2012, PSYCHONEUROENDOCRINO, V37, P191, DOI 10.1016/j.psyneuen.2011.06.003; Endo N, 2012, ANIM REPROD SCI, V134, P112, DOI 10.1016/j.anireprosci.2012.08.018; Essex MJ, 2002, BIOL PSYCHIAT, V52, P776, DOI 10.1016/S0006-3223(02)01553-6; Fairbanks LA, 2011, PSYCHONEUROENDOCRINO, V36, P1201, DOI 10.1016/j.psyneuen.2011.02.013; Fessler DMT, 2005, AM J PHYS ANTHROPOL, V127, P95, DOI 10.1002/ajpa.20039; Fleming AS, 1999, NEUROSCI BIOBEHAV R, V23, P673, DOI 10.1016/S0149-7634(99)00011-1; FOLMAN Y, 1973, J REPROD FERTIL, V34, P267, DOI 10.1530/jrf.0.0340267; Fooden J, 2000, FIELDIANA ZOOL, V96, P1, DOI DOI 10.5962/BHL.TITLE.7192; FUJIEDA K, 1982, J CLIN ENDOCR METAB, V54, P89, DOI 10.1210/jcem-54-1-89; Gameiro S, 2009, J REPROD INFANT PSYC, V27, P269, DOI 10.1080/02646830802350898; Gao W, 2013, J CHROMATOGR B, V928, P1, DOI 10.1016/j.jchromb.2013.03.008; Glynn LM, 2007, EARLY HUM DEV, V83, P675, DOI 10.1016/j.earlhumdev.2007.01.003; Grant KS, 2014, NEUROTOXICOL TERATOL, V43, P91, DOI 10.1016/j.ntt.2014.04.050; Grey KR, 2013, PSYCHONEUROENDOCRINO, V38, P1178, DOI 10.1016/j.psyneuen.2012.11.002; Hamosh M, 2001, PEDIATR CLIN N AM, V48, P69, DOI 10.1016/S0031-3955(05)70286-8; Hart S, 2004, INFANT BEHAV DEV, V27, P101, DOI 10.1016/j.infbeh.2003.06.002; Hinde K, 2009, AM J PHYS ANTHROPOL, V138, P148, DOI 10.1002/ajpa.20911; Hinde K, 2009, AM J HUM BIOL, V21, P512, DOI 10.1002/ajhb.20917; Hinde K, 2015, BEHAV ECOL, V26, P269, DOI 10.1093/beheco/aru186; Hobel CJ, 2008, CLIN OBSTET GYNECOL, V51, P333, DOI 10.1097/GRF.0b013e31816f2709; HODGEN GD, 1977, AM J OBSTET GYNECOL, V127, P581, DOI 10.1016/0002-9378(77)90352-0; HOOLEY J M, 1981, Primates, V22, P379; Hung CH, 2007, KAOHSIUNG J MED SCI, V23, P352, DOI 10.1016/S1607-551X(09)70421-8; Jarcho MR, 2012, AM J PRIMATOL, V74, P462, DOI 10.1002/ajp.22003; Kapoor A, 2014, PEDIATR RES, V75, P476, DOI 10.1038/pr.2014.1; Kirschbaum C, 2009, PSYCHONEUROENDOCRINO, V34, P32, DOI 10.1016/j.psyneuen.2008.08.024; Koren L, 2002, ANIM BEHAV, V63, P403, DOI 10.1006/anbe.2001.1907; Lipkin EW, 2001, BONE, V29, P249, DOI 10.1016/S8756-3282(01)00508-7; Liu X. Y., 1988, International Journal of Animal Sciences, V3, P123; Macbeth BJ, 2010, CAN J ZOOL, V88, P935, DOI 10.1139/Z10-057; MAEDA KI, 1991, J REPROD FERTIL, V92, P371, DOI 10.1530/jrf.0.0920371; MAGNUS P, 1985, EARLY HUM DEV, V12, P49, DOI 10.1016/0378-3782(85)90136-7; Martin RD, 2007, YEARB PHYS ANTHROPOL, V50, P59, DOI 10.1002/ajpa.20734; Mas-Rivera A, 2008, AM J PRIMATOL, V70, P1047, DOI 10.1002/ajp.20596; Meyer JS, 2014, ILAR J, V55, P347, DOI 10.1093/ilar/ilu023; Meyer JS, 2012, ENDOCRINOLOGY, V153, P4120, DOI 10.1210/en.2012-1226; MITCHELL G, 1968, Developmental Psychobiology, V1, P280, DOI 10.1002/dev.420010411; MOLTZ H, 1970, PHYSIOL BEHAV, V5, P1373, DOI 10.1016/0031-9384(70)90122-8; Novak MA, 2014, J AM ASSOC LAB ANIM, V53, P261; Novak MA, 2013, APPL ANIM BEHAV SCI, V143, P135, DOI 10.1016/j.applanim.2012.10.012; Novak MFSX., 2006, DEV PRIMATOLOGY PROG, P513; Pang WW, 2007, J MAMMARY GLAND BIOL, V12, P211, DOI 10.1007/s10911-007-9054-4; PARVIZI N, 1976, J ENDOCRINOL, V69, P193, DOI 10.1677/joe.0.0690193; PATERSON JY, 1974, J ENDOCRINOL, V62, P371, DOI 10.1677/joe.0.0620371; PEPE GJ, 1995, ENDOCR REV, V16, P608, DOI 10.1210/er.16.5.608; Pereg D, 2011, STRESS, V14, P73, DOI 10.3109/10253890.2010.511352; Rawlins RG., 1986, CAYO SANTIAGO MACAQU; ROSENBERG M, 1977, J REPROD FERTIL, V51, P363, DOI 10.1530/jrf.0.0510363; ROUSSEL JD, 1983, THERIOGENOLOGY, V19, P535, DOI 10.1016/0093-691X(83)90174-7; Rutherford JN, 2013, BUILDING BABIES PRIM, P27, DOI DOI 10.1007/978-1-4614-4060-4_2; Saltzman W, 2011, PHYSIOL BEHAV, V104, P446, DOI 10.1016/j.physbeh.2011.05.005; SCHNEIDER ML, 1992, INFANT BEHAV DEV, V15, P155, DOI 10.1016/0163-6383(92)80021-L; Scholl T O, 1992, Ann Epidemiol, V2, P565; SEAY B, 1966, FOLIA PRIMATOL, V4, P146, DOI 10.1159/000155049; SMITH VG, 1973, J ANIM SCI, V36, P391; STERN JM, 1973, NEUROENDOCRINOLOGY, V12, P179, DOI 10.1159/000122167; Suarez-Jimenez B, 2013, AM J PRIMATOL, V75, P65, DOI 10.1002/ajp.22081; Sullivan EC, 2011, DEV PSYCHOBIOL, V53, P96, DOI 10.1002/dev.20483; Thompson ME, 2012, BEHAV ECOL, V23, P1234, DOI 10.1093/beheco/ars107; Trotter A, 2001, J CLIN ENDOCR METAB, V86, P601, DOI 10.1210/jc.86.2.601; Trotter A, 1999, J CLIN ENDOCR METAB, V84, P4531, DOI 10.1210/jc.84.12.4531; Tu MT, 2006, PSYCHONEUROENDOCRINO, V31, P812, DOI 10.1016/j.psyneuen.2006.03.006; TURNBULL AC, 1974, LANCET, V1, P101; Van Esch E, 2008, TOXICOL PATHOL, V36, p171S, DOI 10.1177/0192623308327415; VANWAGENEN G, 1956, AM J PHYS ANTHROPOL, V14, P245, DOI 10.1002/ajpa.1330140219; vom Saal F.S., 1988, P2351; Wallner B, 2011, PRIMATES, V52, P69, DOI 10.1007/s10329-010-0221-7; Weinstock M, 2008, NEUROSCI BIOBEHAV R, V32, P1073, DOI 10.1016/j.neubiorev.2008.03.002; WILSON ME, 1992, J ENDOCRINOL, V134, P493, DOI 10.1677/joe.0.1340493; Yang HZ, 1998, J STEROID BIOCHEM, V67, P447, DOI 10.1016/S0960-0760(98)00120-4	93	30	30	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0131692	10.1371/journal.pone.0131692	http://dx.doi.org/10.1371/journal.pone.0131692			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26172048	Green Published, Green Submitted, gold			2022-12-26	WOS:000358194900021
J	Muller, P; Doliva, R; Busch, M; Philippeit, C; Stephan, H; Dunker, N				Mueller, Patrick; Doliva, Rebekka; Busch, Maike; Philippeit, Claudia; Stephan, Harald; Duenker, Nicole			Additive Effects of Retinoic Acid (RA) and Bone Morphogenetic Protein 4 (BMP-4) Apoptosis Signaling in Retinoblastoma Cell Lines	PLOS ONE			English	Article							ACUTE PROMYELOCYTIC LEUKEMIA; BREAST-CANCER CELLS; EMBRYONAL CARCINOMA-CELLS; RECEPTOR-BETA; LUNG-CANCER; X-RECEPTORS; GROWTH-INHIBITION; NUCLEAR RECEPTOR; MAMMALIAN-CELLS; ACTIVATION	Retinoids have been shown to serve promising therapeutic agents for human cancers, e.g. the treatment of neuroblastoma. Synthetic retinoids, specific for particular retinoic acid (RA) receptors, are tested as new therapy strategies. In the present study, application of recombinant retinoic acid (RA) lowers retinoblastoma (RB) cell viability and induces apoptosis in RB cell lines. Combined treatment of RA and bone morphogenetic protein 4 (BMP-4) increases the pro-apoptotic effect of RA in the RB cells lines WERI-Rb1, Y-79, RB355, RBL-30 and RBL-15, indicating an additive effect. We could show that in WERI-Rb1 cells RA/BMP-4 mediated cell death is at least partially caspase-dependent, whereby RA and BMP-4 additively increased (i) Apaf-1 mRNA levels, (ii) caspase-9 cleavage activity and (iii) the number of activated, cleaved caspase-3 positive cells. Compared to single application of RA and BMP-4, combined RA/BMP-4 treatment significantly augments mRNA levels of the retinoic acid receptors (RARs) RAR alpha and RAR beta and the retinoic X receptor (RXR) RXR gamma suggesting an interaction in the induction of these RA receptor subtypes in WERI-Rb1 cells. Agonist studies revealed that both, RARs and RXRs are involved in RA/BMP-4 mediated apoptosis in WERI-Rb1 retinoblastoma cells. Employing specific RAR subtype antagonists and a RXR beta and RXR gamma knockdown, we proved that RA/BMP-4 apoptosis signaling in WERI-Rb1 cells requires the RA receptor subtypes RAR alpha, RAR beta, RXR beta and RXR gamma. Deciphering signaling mechanisms underlying apoptosis induction of RA and BMP-4 in WERI-Rb1 cells, our study provides useful starting-points for future retinoid-based therapy strategies in retinoblastoma.	[Mueller, Patrick; Doliva, Rebekka; Busch, Maike; Philippeit, Claudia; Duenker, Nicole] Univ Duisburg Essen, Inst Anat, Fac Med, Dept Neuroanat, Essen, Germany; [Stephan, Harald] Univ Duisburg Essen, Childrens Hosp, Div Haematol & Oncol, Essen, Germany	University of Duisburg Essen; University of Duisburg Essen	Dunker, N (corresponding author), Univ Duisburg Essen, Inst Anat, Fac Med, Dept Neuroanat, Essen, Germany.	nicole.duenker@uk-essen.de	Busch, Maike Anna/AGI-3929-2022; Stephan, Harald/AAT-6802-2021	Busch, Maike Anna/0000-0001-9651-031X; Dunker, Nicole/0000-0003-1273-0644	Else Kroner Fresenius foundation	Else Kroner Fresenius foundation	PM and RD were funded by the Else Kroner Fresenius foundation (http://www.ekfs.de/de/aktuell/promotionskolleg-2011.html).	ALLEGRETTO EA, 1993, J BIOL CHEM, V268, P26625; Brandebourg TD, 2005, J ANIM SCI, V83, P98; Bratton SB, 2010, J CELL SCI, V123, P3209, DOI 10.1242/jcs.073643; Bushue N, 2010, ADV DRUG DELIVER REV, V62, P1285, DOI 10.1016/j.addr.2010.07.003; CASTAIGNE S, 1990, BLOOD, V76, P1704; Chi HT, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-165; Decensi A, 2000, J CELL BIOCHEM, P84; DETHE H, 1989, EMBO J, V8, P429, DOI 10.1002/j.1460-2075.1989.tb03394.x; Donato LJ, 2005, CANCER RES, V65, P8193, DOI 10.1158/0008-5472.CAN-05-1177; Ferrari N, 1998, MOL CELL BIOL, V18, P6482, DOI 10.1128/MCB.18.11.6482; Fujita E, 1999, CELL DEATH DIFFER, V6, P1109, DOI 10.1038/sj.cdd.4400585; Gilardi F, 2014, SUBCELL BIOCHEM, V70, P75, DOI 10.1007/978-94-017-9050-5_5; Glozak MA, 1996, DEV BIOL, V179, P458, DOI 10.1006/dbio.1996.0275; GRIEGEL S, 1990, INT J CANCER, V46, P125, DOI 10.1002/ijc.2910460123; HARMON MA, 1995, P NATL ACAD SCI USA, V92, P6157, DOI 10.1073/pnas.92.13.6157; Hartmann L, 2010, AM J HUM GENET, V87, P480, DOI 10.1016/j.ajhg.2010.08.016; Haubold M, 2010, INT J BIOL SCI, V6, P700; HEYMAN RA, 1992, CELL, V68, P397, DOI 10.1016/0092-8674(92)90479-V; HOULE B, 1991, GENE CHROMOSOME CANC, V3, P358, DOI 10.1002/gcc.2870030506; HU L, 1991, CANCER RES, V51, P3972; HUANG ME, 1988, BLOOD, V72, P567, DOI 10.1182/blood.V72.2.567.567; HUGGENVIK JI, 1995, PHARMACOL TOXICOL, V76, P17, DOI 10.1111/j.1600-0773.1995.tb00096.x; Kim DG, 1996, CANCER LETT, V107, P149, DOI 10.1016/0304-3835(96)04407-2; KOK K, 1987, NATURE, V330, P578, DOI 10.1038/330578a0; KYRITSIS A, 1984, JNCI-J NATL CANCER I, V73, P649; le Maire A, 2014, SUBCELL BIOCHEM, V70, P37, DOI 10.1007/978-94-017-9050-5_3; le Maire A, 2012, CURR TOP MED CHEM, V12, P505, DOI 10.2174/156802612799436687; Li AM, 2003, INVEST OPHTH VIS SCI, V44, P996, DOI 10.1167/iovs.02-0434; Li ML, 2014, CRIT REV ONCOL HEMAT, V91, P271, DOI 10.1016/j.critrevonc.2014.04.001; Li Y, 1999, J BIOL CHEM, V274, P15360, DOI 10.1074/jbc.274.22.15360; Li Y, 1998, INT J CANCER, V75, P88, DOI 10.1002/(SICI)1097-0215(19980105)75:1<88::AID-IJC14>3.0.CO;2-9; Lin BZ, 2000, MOL CELL BIOL, V20, P957, DOI 10.1128/MCB.20.3.957-970.2000; LIPPMAN SM, 1987, CANCER TREAT REP, V71, P493; Liu Y, 1996, MOL CELL BIOL, V16, P1138; Lu Tai-Ying, 2010, Zhonghua Zhong Liu Za Zhi, V32, P892; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; MANGELSDORF DJ, 1991, CELL, V66, P555, DOI 10.1016/0092-8674(81)90018-0; MANGELSDORF DJ, 1990, NATURE, V345, P224, DOI 10.1038/345224a0; Mangiarotti R, 1998, BRIT J CANCER, V77, P186, DOI 10.1038/bjc.1998.32; Masetti R, 2012, ADV THER, V29, P747, DOI 10.1007/s12325-012-0047-3; MCFALL RC, 1977, CANCER RES, V37, P1003; NAGY L, 1995, MOL CELL BIOL, V15, P3540; Nichol JN, 2014, BEST PRACT RES CL HA, V27, P19, DOI 10.1016/j.beha.2014.04.009; Piskunov A, 2014, SUBCELL BIOCHEM, V70, P103, DOI 10.1007/978-94-017-9050-5_6; Poulaki V, 2005, INVEST OPHTH VIS SCI, V46, P358, DOI 10.1167/iovs.04-0324; REID TW, 1974, J NATL CANCER I, V53, P347, DOI 10.1093/jnci/53.2.347; ROBERTS AB, 1984, RETINOIDS, V2, P209; Somenzi G, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000836; Stegmeier F, 2005, P NATL ACAD SCI USA, V102, P13212, DOI 10.1073/pnas.0506306102; SWISSHELM K, 1994, CELL GROWTH DIFFER, V5, P133; Yuan SJ, 2013, STRUCTURE, V21, P501, DOI 10.1016/j.str.2013.02.024	51	4	4	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0131467	10.1371/journal.pone.0131467	http://dx.doi.org/10.1371/journal.pone.0131467			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26173116	Green Submitted, Green Published, gold			2022-12-26	WOS:000358194900015
J	Poggi, C; Giusti, B; Gozzini, E; Sereni, A; Romagnuolo, I; Kura, A; Pasquini, E; Abbate, R; Dani, C				Poggi, Chiara; Giusti, Betti; Gozzini, Elena; Sereni, Alice; Romagnuolo, Ilaria; Kura, Ada; Pasquini, Elisabetta; Abbate, Rosanna; Dani, Carlo			Genetic Contributions to the Development of Complications in Preterm Newborns	PLOS ONE			English	Article							INHALED NITRIC-OXIDE; ENDOTHELIAL GROWTH-FACTOR; ANGIOTENSIN-CONVERTING ENZYME; SYNTHASE GENE; RESPIRATORY-DISTRESS; INSERTION/DELETION POLYMORPHISM; PULMONARY-HYPERTENSION; HEME OXYGENASE-1; LUNG GROWTH; INFANTS	Aim We aimed to identify specific polymorphisms of genes encoding for vascular endothelial growth factor A (VEGFA), endothelial nitric oxide synthase (eNOS), renin-angiotensin system (angiotensinogen gene [AGT], angiotensinogen type 1 receptor [AGTR1], angiotensin-converting enzyme [ACE]), and heme oxygenase-1 (HMOX-1) in a cohort of preterm infants and correlate their presence with the development of respiratory distress syndrome (RDS) requiring mechanical ventilation (MV), bronchopulmonary dysplasia (BPD), intraventricular hemorrhage (IVH) and retinopathy of prematurity (ROP). Study Design We carried out a retrospective study to evaluate the allele frequency and genotype distribution of polymorphisms of VEGFA, eNOS, AGT, AGTR1, ACE, and HMOX-1 in a population of preterm neonates (n=342) with a gestational age <= 28 weeks according to the presence or absence of RDS requiring MV, BPD, IVH, or ROP. Moreover, we evaluated through the haplotype reconstruction analysis whether combinations of the selected polymorphisms are related to the occurrence of RDS, BPD, IVH and ROP. Results In our population 157 infants developed RDS requiring MV, 71 BPD, 70 IVH, and 43 ROP. We found that TC+CC rs2070744 eNOS (41.7 vs. 25.4%, p=0.01) and GT+TT rs1799983 eNOS (51.8 vs. 35.2%, p=0.01) polymorphisms are independent risk factors for BPD. Haplotype reconstruction showed that haplotypes in VEGF and eNOS are significantly associated with different effects on RDS, BPD, IVH, and ROP in our population. Conclusions We found that TC+CC rs2070744 eNOS and GT+TT rs1799983 eNOS polymorphisms are independent predictors of an increased risk of developing BPD. Haplotypes of VEGFA and eNOS may be independent protective or risk markers for prematurity complications.	[Poggi, Chiara; Gozzini, Elena] Careggi Univ Hosp Florence, Div Neonatol, Florence, Italy; [Giusti, Betti; Sereni, Alice; Romagnuolo, Ilaria; Kura, Ada; Abbate, Rosanna] Univ Florence, Dept Expt & Clin Med, Atherothrombot Dis Ctr, Careggi Univ Hosp Florence, Florence, Italy; [Romagnuolo, Ilaria] Univ Florence, Dept Informat Engn, Florence, Italy; [Pasquini, Elisabetta] Meyer Childrens Hosp, Clin Pediat Neurol, Metab & Muscular Unit, Florence, Italy; [Dani, Carlo] Careggi Univ Hosp Florence, Dept Neurosci Psychol Drug Res & Child Hlth, Florence, Italy	University of Florence; Azienda Ospedaliero Universitaria Careggi; University of Florence; Azienda Ospedaliero Universitaria Careggi; University of Florence; University of Florence; Azienda Ospedaliera Universitaria (AOU) MEYER; University of Florence; Azienda Ospedaliero Universitaria Careggi	Dani, C (corresponding author), Careggi Univ Hosp Florence, Dept Neurosci Psychol Drug Res & Child Hlth, Florence, Italy.	cdani@unifi.It	Giusti, Betti/K-6978-2016; Sereni, Alice/K-6350-2016	Giusti, Betti/0000-0002-8708-9444; Sereni, Alice/0000-0002-6976-1110	Ente Cassa di Risparmio di Firenze	Ente Cassa di Risparmio di Firenze(Fondazione Cassa Risparmio Firenze)	The study was funded by Ente Cassa di Risparmio di Firenze to Fiorgen Foundation, Florence, Italy.	Abdel-Aziz TA, 2013, MOL BIOL REP, V40, P3065, DOI 10.1007/s11033-012-2380-7; Ballard RA, 2006, NEW ENGL J MED, V355, P343, DOI 10.1056/NEJMoa061088; Bassan H, 2009, CLIN PERINATOL, V36, P737, DOI 10.1016/j.clp.2009.07.014; Becker T, 2005, ANN HUM GENET, V69, P747, DOI 10.1111/j.1529-8817.2005.00198.x; BELL MJ, 1978, ANN SURG, V187, P1, DOI 10.1097/00000658-197801000-00001; Bhatt AJ, 2001, AM J RESP CRIT CARE, V164, P1971, DOI 10.1164/ajrccm.164.10.2101140; Colomba Daniela, 2008, Immun Ageing, V5, P4, DOI 10.1186/1742-4933-5-4; Dani C, 2008, NEONATOLOGY, V94, P87, DOI 10.1159/000119719; Dani C, 2011, J MATERN-FETAL NEO M, V24, P1427, DOI 10.3109/14767058.2011.572203; Davis JM, 1999, NEONATOLOGY, P509; DEVRIES LS, 1992, BEHAV BRAIN RES, V49, P1, DOI 10.1016/S0166-4328(05)80189-5; Ehrenkranz RA, 2005, PEDIATRICS, V116, P1353, DOI 10.1542/peds.2005-0249; Fatini C, 2004, AM HEART J, V147, P516, DOI 10.1016/j.ahj.2003.10.032; Gole GA, 2005, ARCH OPHTHALMOL-CHIC, V123, P991, DOI 10.1001/archopht.123.7.991; Good WV, 2005, PEDIATRICS, V116, P15, DOI 10.1542/peds.2004-1413; Haider MZ, 2002, BIOL NEONATE, V82, P84, DOI 10.1159/000063092; Hollegaard MV, 2013, MOL GENET METAB, V110, P65, DOI 10.1016/j.ymgme.2013.06.004; Kazzi SNJ, 2005, J PEDIATR-US, V147, P818, DOI 10.1016/j.jpeds.2005.07.029; Koch W, 2005, CLIN CHEM, V51, P1547, DOI 10.1373/clinchem.2005.051656; Lassus P, 2001, AM J RESP CRIT CARE, V164, P1981, DOI 10.1164/ajrccm.164.10.2012036; Liu PL, 2012, MOL BIOL REP, V39, P10731, DOI 10.1007/s11033-012-1964-6; McCurnin DC, 2005, AM J PHYSIOL-LUNG C, V288, pL450, DOI 10.1152/ajplung.00347.2004; Mohamed S, 2009, PEDIATR RES, V65, P193, DOI 10.1203/PDR.0b013e31818d1dbd; PAPILE LA, 1978, J PEDIATR-US, V92, P529, DOI 10.1016/S0022-3476(78)80282-0; PIERCE MR, 1995, PEDIATR PULM, V19, P371, DOI 10.1002/ppul.1950190611; Rubaltelli FF, 1998, ACTA PAEDIATR, V87, P1261, DOI 10.1080/080352598750030951; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Sivasli E, 2007, TURKISH J PEDIATR, V49, P69; Spiegler J, 2010, NEONATOLOGY, V97, P10, DOI 10.1159/000226602; Taha H, 2010, ARTERIOSCL THROM VAS, V30, P1634, DOI 10.1161/ATVBAHA.110.207316; Tang JR, 2007, AM J PHYSIOL-LUNG C, V293, pL1271, DOI 10.1152/ajplung.00224.2007; Tang JR, 2004, AM J PHYSIOL-LUNG C, V287, pL344, DOI 10.1152/ajplung.00291.2003; Tesauro M, 2000, P NATL ACAD SCI USA, V97, P2832, DOI 10.1073/pnas.97.6.2832; Vannemreddy P, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2009.10.FOCUS09143; Vazquez-Armenta G, 2013, TOHOKU J EXP MED, V231, P201, DOI 10.1620/tjem.231.201; Veldman BA, 2002, J HYPERTENS, V20, P2023, DOI 10.1097/00004872-200210000-00022; Wang MY, 2013, BIOMED REP, V1, P144, DOI 10.3892/br.2012.23; Yanamandra Krishna, 2004, BMC Pediatr, V4, P26, DOI 10.1186/1471-2431-4-26	38	24	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0131741	10.1371/journal.pone.0131741	http://dx.doi.org/10.1371/journal.pone.0131741			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26172140	Green Submitted, Green Published, gold			2022-12-26	WOS:000358194900022
J	Shi, W; Wang, VB; Zhao, CE; Zhang, QC; Loo, SCJ; Yang, L; Xu, CJ				Shi, Wei; Wang, Victor Bochuan; Zhao, Cui-E; Zhang, Qichun; Loo, Say Chye Joachim; Yang, Liang; Xu, Chenjie			Anditalea andensis ANESC-S-T- An Alkaliphilic Halotolerant Bacterium Capable of Electricity Generation under Alkaline-Saline Conditions	PLOS ONE			English	Article							MICROBIAL FUEL-CELLS; WASTE-WATER TREATMENT; EXTRACELLULAR ELECTRON-TRANSFER; CONJUGATED OLIGOELECTROLYTES; ELECTROCHEMICAL TECHNOLOGIES; PERFORMANCE; BIOELECTRICITY; REMOVAL; BIOFILM; ENERGY	A great challenge in wastewater bioremediation is the sustained activity of viablemicroorganisms, which can contribute to the breakdown of waste contaminants, especially in alkaline pH conditions. Identification of extremophiles with bioremediation capability can improve the efficiency of wastewater treatment. Here, we report the discovery of an electrochemically active alkaliphilic halotolerant bacterium, Anditalea andensis ANESC-S-T (=CICC10485T=NCCB 100412(T)), which is capable of generating bioelectricity in alkaline-saline conditions. A. andensis ANESC-S-T was shown to grow in alkaline conditions between pH 7.0-11.0 and also under high salt condition (up to 4 wt% NaCl). Electrical output was further demonstrated in microbial fuel cells (MFCs) with an average current density of similar to 0.5 mu A/cm(2), even under the harsh condition of 4 wt% NaCl and pH 9.0. Subsequent introduction of secreted extracellular metabolites into MFCs inoculated with Escherichia coli or Pseudomonas aeruginosa yielded enhanced electrical output. The ability of A. andensis ANESC-S-T to generate energy under alkalinesaline conditions points towards a solution for bioelectricity recovery fromalkaline-saline wastewater. This is the first report of A. andensis ANESC-S-T producing bioelectricity at high salt concentration and pH.	[Shi, Wei; Xu, Chenjie] Nanyang Technol Univ, Sch Chem & Biomed Engn, Singapore 637551, Singapore; [Wang, Victor Bochuan; Loo, Say Chye Joachim; Yang, Liang] Nanyang Technol Univ, Singapore Ctr Environm Life Sci Engn, Singapore 637551, Singapore; [Wang, Victor Bochuan; Zhao, Cui-E; Zhang, Qichun; Loo, Say Chye Joachim] Nanyang Technol Univ, Sch Mat Sci & Engn, Singapore 639798, Singapore; [Yang, Liang] Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore; [Shi, Wei] Nanjing Tech Univ, Natl Jiangsu Synergist Innovat Ctr Adv Mat, Key Lab Flexible Elect, Nanjing 211816, Jiangsu, Peoples R China; [Shi, Wei] Nanjing Tech Univ, Natl Jiangsu Synergist Innovat Ctr Adv Mat, Inst Adv Mat, Nanjing 211816, Jiangsu, Peoples R China	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Nanjing Tech University; Nanjing Tech University	Yang, L (corresponding author), Nanyang Technol Univ, Singapore Ctr Environm Life Sci Engn, Singapore 637551, Singapore.	yangliang@ntu.edu.sg; cjxu@ntu.edu.sg	xu, chenjie/E-4075-2012; Yang, Liang/C-8487-2011; Loo, Say Chye Joachim/A-2234-2011; Qichun, Zhang/A-2253-2011	Yang, Liang/0000-0002-2362-0128; Loo, Say Chye Joachim/0000-0001-5300-1275; Qichun, Zhang/0000-0003-1854-8659; Xu, Chenjie/0000-0002-8278-3912	SMART Ignition Grant [ING137064-BIO]; Singapore Centre on Environmental Life Sciences Engineering (SCELSE) [M4330001.C70.703012]; School of Materials Science and Engineering [M020070110]; NTU-National Healthcare Group (NTU-NHG) [ARG/14012]	SMART Ignition Grant; Singapore Centre on Environmental Life Sciences Engineering (SCELSE); School of Materials Science and Engineering; NTU-National Healthcare Group (NTU-NHG)	This work was partially supported by SMART Ignition Grant (ING137064-BIO to C Xu). SCJ Loo and VBC Wang would also like to acknowledge the financial support from the Singapore Centre on Environmental Life Sciences Engineering (SCELSE) (M4330001.C70.703012), the School of Materials Science and Engineering (M020070110), and the NTU-National Healthcare Group (NTU-NHG) grant (ARG/14012).	Chen GH, 2004, SEP PURIF TECHNOL, V38, P11, DOI 10.1016/j.seppur.2003.10.006; Freguia S, 2009, BIOELECTROCHEMISTRY, V76, P14, DOI 10.1016/j.bioelechem.2009.04.001; Fricke K, 2008, ENERG ENVIRON SCI, V1, P144, DOI 10.1039/b802363h; Garner LE, 2012, ENERG ENVIRON SCI, V5, P9449, DOI 10.1039/c2ee22839d; Garner LE, 2010, J AM CHEM SOC, V132, P10042, DOI 10.1021/ja1016156; Huang YX, 2011, CHEM COMMUN, V47, P5795, DOI 10.1039/c1cc10159e; Jung S, 2007, APPL MICROBIOL BIOT, V77, P393, DOI 10.1007/s00253-007-1162-y; Kim BH, 2003, BIOTECHNOL LETT, V25, P541, DOI 10.1023/A:1022891231369; Lefebvre O, 2006, WATER RES, V40, P3671, DOI 10.1016/j.watres.2006.08.027; Li WW, 2014, ENERG ENVIRON SCI, V7, P911, DOI 10.1039/c3ee43106a; Logan BE, 2012, SCIENCE, V337, P686, DOI 10.1126/science.1217412; Marshall CW, 2009, ENERG ENVIRON SCI, V2, P699, DOI 10.1039/b823237g; Marsili E, 2008, P NATL ACAD SCI USA, V105, P3968, DOI 10.1073/pnas.0710525105; Meng XM, 2008, FUEL PROCESS TECHNOL, V89, P851, DOI 10.1016/j.fuproc.2008.02.006; Murata K, 2009, ENERG ENVIRON SCI, V2, P1280, DOI 10.1039/b912915d; Newton GJ, 2009, APPL ENVIRON MICROB, V75, P7674, DOI 10.1128/AEM.01142-09; Nielsen ME, 2008, ENERG ENVIRON SCI, V1, P584, DOI 10.1039/b811899j; O'Sullivan LA, 2006, INT J SYST EVOL MICR, V56, P169, DOI 10.1099/ijs.0.63941-0; Ha PT, 2012, ENVIRON SCI TECHNOL, V46, P3022, DOI 10.1021/es203861v; Pokhrel D, 2004, SCI TOTAL ENVIRON, V333, P37, DOI 10.1016/j.scitotenv.2004.05.017; Qiao Y, 2010, ENERG ENVIRON SCI, V3, P544, DOI 10.1039/b923503e; Rabaey K, 2005, ENVIRON SCI TECHNOL, V39, P3401, DOI 10.1021/es048563o; Rinaldi A, 2008, ENERG ENVIRON SCI, V1, P417, DOI 10.1039/b806498a; Ringeisen BR, 2006, ENVIRON SCI TECHNOL, V40, P2629, DOI 10.1021/es052254w; Shi W, 2012, ANTON LEEUW INT J G, V102, P703, DOI 10.1007/s10482-012-9770-7; Wang VB, 2014, CHEM COMMUN, V50, P8223, DOI 10.1039/c4cc02784a; Wang VB, 2014, BIORESOURCE TECHNOL, V155, P71, DOI 10.1016/j.biortech.2013.12.078; Wang VB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063129; Wang VB, 2013, PHYS CHEM CHEM PHYS, V15, P5867, DOI 10.1039/c3cp50437a; Werner CM, 2013, J MEMBRANE SCI, V428, P116, DOI 10.1016/j.memsci.2012.10.031; Yang L, 2007, MICROBIOL-SGM, V153, P1318, DOI 10.1099/mic.0.2006/004911-0; Zhang LX, 2008, ELECTROCHEM COMMUN, V10, P1641, DOI 10.1016/j.elecom.2008.08.030; Zhao C, 2013, J MATER CHEM A, V1, P12587, DOI 10.1039/c3ta12947k	33	8	8	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132766	10.1371/journal.pone.0132766	http://dx.doi.org/10.1371/journal.pone.0132766			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26171779	Green Published, gold			2022-12-26	WOS:000358194900082
J	Shih, YY; Hung, CC; Gong, GC; Chung, WC; Wang, YH; Lee, IH; Chen, KS; Ho, CY				Shih, Yung-Yen; Hung, Chin-Chang; Gong, Gwo-Ching; Chung, Wan-Chen; Wang, Yu-Huai; Lee, I-Huan; Chen, Kuo-Shu; Ho, Chuang-Yi			Enhanced Particulate Organic Carbon Export at Eddy Edges in the Oligotrophic Western North Pacific Ocean	PLOS ONE			English	Article							EAST CHINA SEA; MESOSCALE EDDIES; FIELD OBSERVATIONS; PARTICLE EXPORT; SEDIMENT TRAPS; FLUX; TH-234; KUROSHIO; CHLOROPHYLL; NITRATE	Mesoscale eddies in the subtropical oligotrophic ocean are ubiquitous and play an important role in nutrient supply and oceanic primary production. However, it is still unclear whether these mesoscale eddies can efficiently transfer CO2 from the atmosphere to deep waters via biological pump because of the sampling difficulty due to their transient nature. In 2007, particulate organic carbon (POC) fluxes, measured below the euphotic zone at the edge of warm eddy were 136-194 mg-C m(-2) d(-1) which was greatly elevated over that (POC flux = 26-35 mg-C m(-2) d(-1)) determined in the nutrient-depleted oligotrophic waters in the Western North Pacific (WNP). In 2010, higher POC fluxes (83-115 mg-C m(-2) d(-1)) were also observed at the boundary of mesoscale eddies in the WNP. The enhanced POC flux at the edge of eddies was mainly attributed to both large denuded diatom frustules and zooplankton fecal pellets based on scanning electron microscopy (SEM) examination. The result suggests that mesoscale eddies in the oligotrophic waters in the subtropical WNP can efficiently increase the oceanic carbon export flux and the eddy edge is a crucial conduit in carbon sequestration to deep waters.	[Shih, Yung-Yen; Hung, Chin-Chang; Wang, Yu-Huai; Lee, I-Huan; Chen, Kuo-Shu; Ho, Chuang-Yi] Natl Sun Yat Sen Univ, Dept Oceanog, Kaohsiung 80424, Taiwan; [Gong, Gwo-Ching; Chung, Wan-Chen] Natl Taiwan Ocean Univ, Inst Marine Environm Chem & Ecol, Keelung 20224, Taiwan	National Sun Yat Sen University; National Taiwan Ocean University	Hung, CC (corresponding author), Natl Sun Yat Sen Univ, Dept Oceanog, Kaohsiung 80424, Taiwan.	cchung@mail.nsysu.edu.tw			Top University Program; Ministry of Science and Technology of Taiwan [NSC101-2611-M-110-015-MY3, NSC100-2119-M-110-003]	Top University Program; Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan)	This research was supported by the Top University Program and the Ministry of Science and Technology (NSC101-2611-M-110-015-MY3, NSC100-2119-M-110-003) of Taiwan.	Behrenfeld MJ, LIMNOLOGY OCEANOGRAP, V42, P1; Benitez-Nelson CR, 2007, SCIENCE, V316, P1017, DOI 10.1126/science.1136221; Bidigare RR, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016393; BIGGS DC, 1992, J GEOPHYS RES-OCEANS, V97, P2143, DOI 10.1029/90JC02020; Boyd PW, 1999, DEEP-SEA RES PT I, V46, P63, DOI 10.1016/S0967-0637(98)00066-1; Buesseler KO, 2008, DEEP-SEA RES PT II, V55, P1426, DOI 10.1016/j.dsr2.2008.02.007; Buesseler KO, 2007, J MAR RES, V65, P345, DOI 10.1357/002224007781567621; Chang J, 2003, DEEP-SEA RES PT II, V50, P1265, DOI 10.1016/S0967-0645(03)00022-5; Chang J, 1996, MAR ECOL PROG SER, V140, P199, DOI 10.3354/meps140199; Chang MH, 2013, J GEOPHYS RES-OCEANS, V118, P1508, DOI 10.1002/jgrc.20151; Chelton DB, 2011, SCIENCE, V334, P328, DOI 10.1126/science.1208897; Chen KS, 2013, GEOPHYS RES LETT, V40, P5728, DOI 10.1002/2013GL058300; Chen YLL, 2003, MAR ECOL PROG SER, V259, P47, DOI 10.3354/meps259047; Chen YLL, 2008, LIMNOL OCEANOGR, V53, P1705, DOI 10.4319/lo.2008.53.5.1705; Chen YLL, 2007, J OCEANOGR, V63, P671, DOI 10.1007/s10872-007-0059-9; Chiang KP, 2002, CONT SHELF RES, V22, P3, DOI 10.1016/S0278-4343(01)00067-X; GARDNER WD, 1980, J MAR RES, V38, P41; Gong GC, 2003, CONT SHELF RES, V23, P213, DOI 10.1016/S0278-4343(02)00166-8; Gong GC, 1999, DEEP-SEA RES PT I, V46, P93, DOI 10.1016/S0967-0637(98)00057-0; Gong GC, 1992, THESIS NATL TAIWAN U, P1; Guo LD, 2002, MAR CHEM, V78, P103, DOI 10.1016/S0304-4203(02)00012-9; Hung CC, 2010, BIOGEOSCIENCES, V7, P3007, DOI 10.5194/bg-7-3007-2010; Hung CC, 2004, GEOCHEM J, V38, P601, DOI 10.2343/geochemj.38.601; Hung CC, 2000, LIMNOL OCEANOGR, V45, P836, DOI 10.4319/lo.2000.45.4.0836; Hung CC, 2012, GEOCHIM COSMOCHIM AC, V91, P60, DOI 10.1016/j.gca.2012.05.017; Hung CC, 2010, MAR CHEM, V121, P132, DOI 10.1016/j.marchem.2010.03.011; Hung CC, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030236; Hung CC, 2009, MAR CHEM, V113, P19, DOI 10.1016/j.marchem.2008.11.004; Kameda T, 2005, J OCEANOGR, V61, P663, DOI 10.1007/s10872-005-0074-7; Kara AB, 2000, J GEOPHYS RES-OCEANS, V105, P16803, DOI 10.1029/2000JC900072; Karl DM, 1989, OCEANOGRAPHY, V2, P32, DOI DOI 10.5670/OCEANOG.1989.28; Lalande C, 2013, PROG OCEANOGR, V109, P70, DOI 10.1016/j.pocean.2012.09.006; Lee C., 1988, OCEANOGRAPHY, V1, P34, DOI [DOI 10.2307/43924419, 10.5670/oceanog.1988.06, DOI 10.5670/OCEANOG.1988.06]; Letelier RM, 2004, LIMNOL OCEANOGR, V49, P508, DOI 10.4319/lo.2004.49.2.0508; Malone T.C., 1980, Studies in Ecology, V7, P433; Maranon E, 2003, MAR ECOL PROG SER, V257, P1, DOI 10.3354/meps257001; MICHAELS AF, 1988, DEEP-SEA RES, V35, P473, DOI 10.1016/0198-0149(88)90126-4; Michaels AF, 2007, SCIENCE, V316, P992, DOI 10.1126/science.1140059; Moutin T, 2012, BIOGEOSCIENCES, V9, P3817, DOI 10.5194/bg-9-3817-2012; Santschi PH, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016046; Shih YY, 2013, TERR ATMOS OCEAN SCI, V24, P899, DOI 10.3319/TAO.2013.05.23.01(Oc); Sweeney EN, 2003, DEEP-SEA RES PT II, V50, P3017, DOI 10.1016/j.dsr2.2003.07.008; Verdeny E, 2008, DEEP-SEA RES PT II, V55, P1461, DOI 10.1016/j.dsr2.2008.02.009; Wakeham SG, 1997, GEOCHIM COSMOCHIM AC, V61, P5363, DOI 10.1016/S0016-7037(97)00312-8; WARD BB, 1989, LIMNOL OCEANOGR, V34, P493, DOI 10.4319/lo.1989.34.3.0493; Wei CL, 2011, BIOGEOSCIENCES, V8, P3793, DOI 10.5194/bg-8-3793-2011; Wormuth John H., 2000, Gulf of Mexico Science, V18, P23; Xiu P, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006800; Zhou KB, 2013, EARTH PLANET SC LETT, V381, P198, DOI 10.1016/j.epsl.2013.07.039	49	28	28	3	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0131538	10.1371/journal.pone.0131538	http://dx.doi.org/10.1371/journal.pone.0131538			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26171611	gold, Green Submitted, Green Published			2022-12-26	WOS:000358194900017
J	Bach, JP; Gold, M; Mengel, D; Hattesohl, A; Lubbe, D; Schmid, S; Tackenberg, B; Rieke, J; Maddula, S; Baumbach, JI; Nell, C; Boeselt, T; Michelis, J; Alferink, J; Heneka, M; Oertel, W; Jessen, F; Janciauskiene, S; Vogelmeier, C; Dodel, R; Koczulla, AR				Bach, Jan-Philipp; Gold, Maike; Mengel, David; Hattesohl, Akira; Lubbe, Dirk; Schmid, Severin; Tackenberg, Bjoern; Rieke, Juergen; Maddula, Sasidhar; Baumbach, Joerg Ingo; Nell, Christoph; Boeselt, Tobias; Michelis, Joan; Alferink, Judith; Heneka, Michael; Oertel, Wolfgang; Jessen, Frank; Janciauskiene, Sabina; Vogelmeier, Claus; Dodel, Richard; Koczulla, Andreas Rembert			Measuring Compounds in Exhaled Air to Detect Alzheimer's Disease and Parkinson's Disease	PLOS ONE			English	Article							ELECTRONIC NOSE; LUNG-CANCER; DIAGNOSIS; BREATH; CSF; DISCRIMINATION; DEMENTIA; COPD	Background Alzheimer's disease (AD) is diagnosed based upon medical history, neuropsychiatric examination, cerebrospinal fluid analysis, extensive laboratory analyses and cerebral imaging. Diagnosis is time consuming and labour intensive. Parkinson's disease (PD) is mainly diagnosed on clinical grounds. Objective The primary aim of this study was to differentiate patients suffering from AD, PD and healthy controls by investigating exhaled air with the electronic nose technique. After demonstrating a difference between the three groups the secondary aim was the identification of specific substances responsible for the difference(s) using ion mobility spectroscopy. Thirdly we analysed whether amyloid beta (A beta) in exhaled breath was causative for the observed differences between patients suffering from AD and healthy controls. Methods We employed novel pulmonary diagnostic tools (electronic nose device/ion-mobility spectrometry) for the identification of patients with neurodegenerative diseases. Specifically, we analysed breath pattern differences in exhaled air of patients with AD, those with PD and healthy controls using the electronic nose device (eNose). Using ion mobility spectrometry (IMS), we identified the compounds responsible for the observed differences in breath patterns. We applied ELISA technique to measure A beta in exhaled breath condensates. Results The eNose was able to differentiate between AD, PD and HC correctly. Using IMS, we identified markers that could be used to differentiate healthy controls from patients with AD and PD with an accuracy of 94%. In addition, patients suffering from PD were identified with sensitivity and specificity of 100%. Altogether, 3 AD patients out of 53 participants were misclassified. Although we found A beta in exhaled breath condensate from both AD and healthy controls, no significant differences between groups were detected. Conclusion These data may open a new field in the diagnosis of neurodegenerative disease such as Alzheimer's disease and Parkinson's disease. Further research is required to evaluate the significance of these pulmonary findings with respect to the pathophysiology of neurodegenerative disorders.	[Bach, Jan-Philipp] Rhein Westfal TH Aachen, Dept Neurol, D-52074 Aachen, Germany; [Gold, Maike; Mengel, David; Tackenberg, Bjoern; Rieke, Juergen; Oertel, Wolfgang; Dodel, Richard] Univ Marburg, Dept Neurol, D-35043 Marburg, Germany; [Hattesohl, Akira; Schmid, Severin; Nell, Christoph; Boeselt, Tobias; Vogelmeier, Claus; Koczulla, Andreas Rembert] Univ Marburg, Div Pulm Dis, Dept Internal Med, D-35043 Marburg, Germany; [Lubbe, Dirk] Univ Giessen, Div Methodol & Stat, Dept Psychol, D-35394 Giessen, Germany; [Maddula, Sasidhar; Baumbach, Joerg Ingo] Reutlingen Univ, Fac Appl Chem, D-72762 Reutlingen, Germany; [Michelis, Joan; Heneka, Michael] Univ Bonn, Dept Neurol, Clin Neurosci Unit, D-53105 Bonn, Germany; [Michelis, Joan; Alferink, Judith; Jessen, Frank] Univ Bonn, Dept Psychiat, D-53105 Bonn, Germany; [Alferink, Judith] Univ Munster, Dept Psychiat, D-48149 Munster, Germany; [Heneka, Michael; Jessen, Frank] German Ctr Neurodegenerat Dis DZNE, D-53105 Bonn, Germany; [Janciauskiene, Sabina] Leibniz Univ Hannover, Dept Internal Med, D-30625 Hannover, Germany	RWTH Aachen University; Philipps University Marburg; Philipps University Marburg; Justus Liebig University Giessen; University of Bonn; University of Bonn; University of Munster; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Leibniz University Hannover	Dodel, R (corresponding author), Univ Marburg, Dept Neurol, D-35043 Marburg, Germany.	dodel@med.uni-marburg.de	Boeselt, Tobias/HHM-5170-2022; Jessen, Frank/AAK-6170-2020; Boeselt, Tobias/AAE-8908-2021; Hattesohl, Akira/AAB-1341-2022; Heneka, Michael/AAE-8011-2019; Heneka, Michael/E-8072-2015	Schmid, Severin/0000-0001-8077-082X; Michelis, Joan Philipp/0000-0002-6349-7654; alferink, judith/0000-0002-3251-6584; Heneka, Michael/0000-0003-4996-1630	Behring Rontgen Initiative [56-0036]	Behring Rontgen Initiative	This work was financed by a research grant from the Behring Rontgen Initiative awarded to ARK and JPB (Behring Rontgen Stiftung, Grant title: non-invasive diagnostic in patients with AD, Grant number: 56-0036). The funding source was not involved in study design, the collection, analysis and interpretation of the data, in writing of the report, and in the decision to submit the article for publication.	Barth S, 2005, FORTSCHR NEUROL PSYC, V73, P568, DOI 10.1055/s-2004-830249; Baumbach JI, 2009, J BREATH RES, V3, DOI 10.1088/1752-7155/3/3/034001; Cummings JL, 2004, NEW ENGL J MED, V351, P56, DOI 10.1056/NEJMra040223; de Leon MJ, 2007, ANN NY ACAD SCI, V1097, P114, DOI 10.1196/annals.1379.012; Dragonieri S, 2009, LUNG CANCER, V64, P166, DOI 10.1016/j.lungcan.2008.08.008; Dubois B, 2007, LANCET NEUROL, V6, P734, DOI 10.1016/S1474-4422(07)70178-3; Fens N, 2009, AM J RESP CRIT CARE, V180, P1076, DOI 10.1164/rccm.200906-0939OC; Goldman SM, 2012, ANN NEUROL, V71, P776, DOI 10.1002/ana.22629; Hattesohl ADM, 2011, RESPIROLOGY, V16, P1258, DOI 10.1111/j.1440-1843.2011.02047.x; Hoglund K, 2008, NEURODEGENER DIS, V5, P268, DOI 10.1159/000119457; Holtzman DM, 2011, NEUROBIOL AGING, V32, pS4, DOI 10.1016/j.neurobiolaging.2011.09.003; Huttmann EM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027467; Hughes A, 1992, J NEUROL NEUROSUR PS, V66, P181, DOI DOI 10.1136/JNNP.55.3.181; Lewis NS, 2004, ACCOUNTS CHEM RES, V37, P663, DOI 10.1021/ar030120m; MASTERS CL, 1985, EMBO J, V4, P2757, DOI 10.1002/j.1460-2075.1985.tb04000.x; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Peng G, 2010, BRIT J CANCER, V103, P542, DOI 10.1038/sj.bjc.6605810; Peng G, 2009, NAT NANOTECHNOL, V4, P669, DOI 10.1038/nnano.2009.235; Peng G, 2009, NANO LETT, V9, P1362, DOI 10.1021/nl8030218; Thaler ER, 2005, EXPERT REV MED DEVIC, V2, P559, DOI 10.1586/17434440.2.5.559; Tisch U, 2013, NANOMEDICINE-UK, V8, P43, DOI [10.2217/nnm.12.105, 10.2217/NNM.12.105]; Trojanowski JQ, 2010, ALZHEIMERS DEMENT, V6, P230, DOI 10.1016/j.jalz.2010.03.008; Weiner Michael W, 2012, Alzheimers Dement, V8, pS1, DOI [10.1016/j.jalz.2013.05.1769, 10.1016/j.jalz.2011.09.172]; Westhoff M, 2009, THORAX, V64, P744, DOI 10.1136/thx.2008.099465; Wiltfang J, 2005, WORLD J BIOL PSYCHIA, V6, P69, DOI 10.1080/15622970510029786	25	33	35	0	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0132227	10.1371/journal.pone.0132227	http://dx.doi.org/10.1371/journal.pone.0132227			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26168044	Green Published, gold			2022-12-26	WOS:000358193100030
J	Domingueti, CP; Dusse, LMS; Foscolo, RB; Reis, JS; Annichino-Bizzacchi, JM; Orsi, FLD; Mazetto, BD; Carvalho, MD; Gomes, KB; Fernandes, AP				Domingueti, Caroline Pereira; Dusse, Luci Maria S.; Foscolo, Rodrigo Bastos; Reis, Janice Sepulveda; Annichino-Bizzacchi, Joyce Maria; de Andrade Orsi, Fernanda Loureiro; Mazetto, Bruna de Moraes; Carvalho, Maria das Gracas; Gomes, Karina Braga; Fernandes, Ana Paula			Von Willebrand Factor, ADAMTS13 and D-Dimer Are Correlated with Different Levels of Nephropathy in Type 1 Diabetes Mellitus	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; ENDOTHELIAL DYSFUNCTION; CARDIOVASCULAR-DISEASE; MICROALBUMINURIA; INFLAMMATION; RISK	We have investigated whether von Willebrand factor, ADAMTS13 (a disintegrin and metalloproteinase with thrombospondin type 1 motif, member 13), and D-Dimer were associated with different levels of renal function in patients with type 1 diabetes. Patients were classified according to level of renal function through estimated glomerular filtration rate: >= 90 and <130mL/min/1,73m(2), n=52 (control group), >= 60 and <90mL/min/1,73m(2), n=29 (mild renal dysfunction group), <60mL/min/1,73m(2), n=28 (severe renal dysfunction group); and through urinary albumin excretion: normoalbuminuria, microalbuminuria and macroalbuminuria. Von Willebrand factor, ADAMTS13, and D-Dimer plasma levels were determined by enzyme-linked immunosorbent assay. ADAMTS13 activity was determined by fluorescence resonance energy transfer assay. Von Willebrand factor levels were increased in patients with mild (P=0.001) and severe (P<0.001) renal dysfunction as compared to the control group. ADAMTS13 levels were also increased in mild (P=0.029) and severe (P=0.002) renal dysfunction groups in comparison to the control group, while ADAMTS13 activity was increased only in the severe renal dysfunction group as compared to the control group (P=0.006). No significant differences were observed among the groups regarding vonWillebrand factor/ADAMTS13 ratio. ADAMTS13 activity/ADAMTS13 levels ratio was reduced in patients with mild (P=0.013) and severe (P=0.015) renal dysfunction as compared to the control group. D-Dimer levels were increased in patients with mild (P=0.006) and severe (P<0.001) renal dysfunction as compared to the control group; it was also higher in patients with severe renal dysfunction as compared to the mild renal dysfunction group (P=0.019). Similar results were found for albuminuria classification. Increased von Willebrand factor, ADAMTS13, and D-Dimer levels and decreased ADAMTS13 activity/ADAMTS13 levels ratio are associated with renal dysfunction in patients with type 1 diabetes, suggesting that endothelial dysfunction and hypercoagulability are associated with nephropathy in type 1 diabetes.	[Domingueti, Caroline Pereira; Dusse, Luci Maria S.; Carvalho, Maria das Gracas; Gomes, Karina Braga; Fernandes, Ana Paula] Univ Fed Minas Gerais, Dept Clin & Toxicol Anal, Fac Pharm, Belo Horizonte, MG, Brazil; [Foscolo, Rodrigo Bastos] Univ Fed Minas Gerais, Dept Clin Med, Fac Med, Belo Horizonte, MG, Brazil; [Reis, Janice Sepulveda] Inst Educ & Res Santa Casa Belo Horizonte, Dept Endocrinol & Metab, Belo Horizonte, MG, Brazil; [Annichino-Bizzacchi, Joyce Maria; de Andrade Orsi, Fernanda Loureiro; Mazetto, Bruna de Moraes] Univ Estadual Campinas, Hemoctr Campinas, Lab Hemostasis, Sao Paulo, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Insper; Instituto de Ensino Superior e Pesquisa da Santa Casa; Universidade Estadual de Campinas	Fernandes, AP (corresponding author), Univ Fed Minas Gerais, Dept Clin & Toxicol Anal, Fac Pharm, Belo Horizonte, MG, Brazil.	apfernandes.ufmg@gmail.com	Mazetto Fonseca, Bruna de Moraes/AIE-7685-2022; Carvalho, Maria das Graças/AAY-1619-2021; Orsi, Fernanda L.A./H-1203-2014	Orsi, Fernanda L.A./0000-0002-7908-9073; Dusse, Luci/0000-0002-7484-1684	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Pesquisa (CNPq/Brazil)	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Pesquisa (CNPq/Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG) - APF; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) - APF; Conselho Nacional de Pesquisa (CNPq/Brazil) - APF. The funders have no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams NB, 2013, J THROMB HAEMOST, V11, P1078, DOI 10.1111/jth.12223; Almquist T, 2012, NEPHROL DIAL TRANSPL, V27, P3540, DOI 10.1093/ndt/gfs183; American Diabetes Association, 2013, DIABETES CARE, V36, pdc13; Bastos MG, 2010, REV ASSOC MED BRAS, V56, P248, DOI 10.1590/S0104-42302010000200028; Bernardo A, 2004, BLOOD, V104, P100, DOI 10.1182/blood-2004-01-0107; Chan NN, 2003, MED SCI MONITOR, V9, P297; Deckert T, 1996, BRIT MED J, V312, P871; Domingueti CP, 2013, CLIN CHIM ACTA, V415, P279, DOI 10.1016/j.cca.2012.10.061; El Asrar Mohamed A, 2012, Pediatr Endocrinol Rev, V9, P657; Frankel DS, 2008, CIRCULATION, V118, P2533, DOI 10.1161/CIRCULATIONAHA.108.792986; Fuller JH, 2001, DIABETOLOGIA, V44, pS54, DOI 10.1007/PL00002940; Goldberg RB, 2009, J CLIN ENDOCR METAB, V94, P3171, DOI 10.1210/jc.2008-2534; Gross JL, 2005, DIABETES CARE, V28, P164, DOI 10.2337/diacare.28.1.164; Jenkins PV, 2006, TRANSFUSION, V46, P1836, DOI 10.1111/j.1537-2995.2006.00975.x; Karnib HH, 2010, DIABETES RES CLIN PR, V89, P201, DOI 10.1016/j.diabres.2010.05.022; Kassimatis TI, 2014, PHARMACOL RES, V88, P62, DOI 10.1016/j.phrs.2014.06.011; Kato S, 2010, J THROMB THROMBOLYS, V30, P281, DOI 10.1007/s11239-010-0442-z; Kessler L, 1998, DIABETES METAB, V24, P327; Kim WY, 2007, CIRCULATION, V115, P228, DOI 10.1161/CIRCULATIONAHA.106.633339; Levey AS, 2000, J AM SOC NEPHROL, V11, p155A; Lip GYH, 1997, CARDIOVASC RES, V34, P255, DOI 10.1016/S0008-6363(97)00039-4; Long Zhao-feng, 2001, Hunan Yike Daxue Xuebao, V26, P434; Marshall SM, 2004, POSTGRAD MED J, V80, P624, DOI 10.1136/pgmj.2004.021287; Murussi M, 2008, ARQ BRAS ENDOCRINOL, V52, P442, DOI 10.1590/S0004-27302008000300004; Nwose EU, 2007, PATHOLOGY, V39, P252, DOI 10.1080/00313020701230658; Reininger AJ, 2008, HAEMOPHILIA, V14, P11, DOI 10.1111/j.1365-2516.2008.01848.x; Rurali E, 2013, DIABETES, V62, P3599, DOI 10.2337/db13-0530; Scaldaferri F, 2007, J CLIN INVEST, V117, P1951, DOI 10.1172/JCI31027; Scheiflinger F, 2003, BLOOD, V102, P3241, DOI 10.1182/blood-2003-05-1616; Soares AL, 2010, CLIN APPL THROMB-HEM, V16, P204, DOI 10.1177/1076029609334626; STEHOUWER CDA, 1991, DIABETES, V40, P971, DOI 10.2337/diabetes.40.8.971; STEHOUWER CDA, 1995, DIABETES, V44, P561, DOI 10.2337/diabetes.44.5.561; Valmadrid CT, 2000, ARCH INTERN MED, V160, P1093, DOI 10.1001/archinte.160.8.1093; Wakabayashi I, 2009, J THROMB THROMBOLYS, V27, P29, DOI 10.1007/s11239-007-0155-0; WEKSLER BB, 1983, NEW ENGL J MED, V308, P800, DOI 10.1056/NEJM198304073081402	35	16	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0132784	10.1371/journal.pone.0132784	http://dx.doi.org/10.1371/journal.pone.0132784			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26168189	Green Published, gold, Green Submitted			2022-12-26	WOS:000358193100080
J	Han, X; Adames, K; Sykes, EME; Srayko, M				Han, Xue; Adames, Kelly; Sykes, Ellen M. E.; Srayko, Martin			The KLP-7 Residue S546 Is a Putative Aurora Kinase Site Required for Microtubule Regulation at the Centrosome in C. elegans	PLOS ONE			English	Article							CENTROMERE-ASSOCIATED KINESIN; CAENORHABDITIS-ELEGANS; MITOTIC SPINDLE; CHROMOSOME SEGREGATION; A KINASE; DEPENDENT PHOSPHORYLATION; GENETIC INTERFERENCE; PROTEIN; MCAK; MEIOSIS	Regulation of microtubule dynamics is essential for many cellular processes, including proper assembly and function of the mitotic spindle. The kinesin-13 microtubule-depolymerizing enzymes provide one mechanism to regulate microtubule behaviour temporally and spatially. Vertebrate MCAK locates to chromatin, kinetochores, spindle poles, microtubule tips, and the cytoplasm, implying that the regulation of kinesin-13 activity and subcellular targeting is complex. Phosphorylation of kinesin-13 by Aurora kinase inhibits microtubule depolymerization activity and some Aurora phosphorylation sites on kinesin-13 are required for subcellular localization. Herein, we determine that a C. elegans deletion mutant klp-7 (tm2143) causes meiotic and mitotic defects that are consistent with an increase in the amount of microtubules in the cytoplasmic and spindle regions of meiotic embryos, and an increase in microtubules emanating from centrosomes. We show that KLP-7 is phosphorylated by Aurora A and Aurora B kinases in vitro, and that the phosphorylation by Aurora A is stimulated by TPXL-1. Using a structure-function approach, we establish that one putative Aurora kinase site, S546, within the C-terminal part of the core domain is required for the function, but not subcellular localization, of KLP-7 in vivo. Furthermore, FRAP analysis reveals microtubule-dependent differences in the turnover of KLP-7(S546A) and KLP-7 (S546E) mutant proteins at the centrosome, suggesting a possible mechanism for the regulation of KLP-7 by Aurora kinase.	[Han, Xue; Adames, Kelly; Sykes, Ellen M. E.; Srayko, Martin] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada	University of Alberta	Srayko, M (corresponding author), Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada.	srayko@ualberta.ca	Srayko, Martin/A-3755-2014	Avila-Sykes, Ellen/0000-0002-1010-5151; Srayko, Martin/0000-0003-0196-0364	Canadian Institutes of Health Research (CIHR); Alberta Innovates Scholar; CIHR New Investigator awards; National Science and Engineering Research Council post-graduate scholarship	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Alberta Innovates Scholar; CIHR New Investigator awards(Canadian Institutes of Health Research (CIHR)); National Science and Engineering Research Council post-graduate scholarship	This work was funded by grants from Canadian Institutes of Health Research (CIHR); M.S. was supported by Alberta Innovates Scholar and CIHR New Investigator awards; X.H. was supported by a National Science and Engineering Research Council post-graduate scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertson DG, 1993, CHROMOSOME RES, V1, P15, DOI 10.1007/BF00710603; Andrews PD, 2003, CURR OPIN CELL BIOL, V15, P672, DOI 10.1016/j.ceb.2003.10.013; Andrews PD, 2004, DEV CELL, V6, P253, DOI 10.1016/S1534-5807(04)00025-5; Bajaj M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071889; Bayliss R, 2003, MOL CELL, V12, P851, DOI 10.1016/S1097-2765(03)00392-7; Bishop JD, 2002, J BIOL CHEM, V277, P27577, DOI 10.1074/jbc.C200307200; BRENNER S, 1974, GENETICS, V77, P71; Brouhard GJ, 2008, CELL, V132, P79, DOI 10.1016/j.cell.2007.11.043; Carvalho A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024656; CHAN CSM, 1993, GENETICS, V135, P677; Colombo K, 2003, SCIENCE, V300, P1957, DOI 10.1126/science.1084146; Desai A, 1999, CELL, V96, P69, DOI 10.1016/S0092-8674(00)80960-5; Dumont J, 2010, NAT CELL BIOL, V12, P894, DOI 10.1038/ncb2093; Encalada SE, 2005, MOL BIOL CELL, V16, P1056, DOI 10.1091/mbc.E04-08-0712; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; GARD DL, 1987, J CELL BIOL, V105, P2203, DOI 10.1083/jcb.105.5.2203; GLOVER DM, 1995, CELL, V81, P95, DOI 10.1016/0092-8674(95)90374-7; Gopalan G, 1997, J CELL BIOL, V138, P643, DOI 10.1083/jcb.138.3.643; Gotta M, 2003, CURR BIOL, V13, P1029, DOI 10.1016/S0960-9822(03)00371-3; Grill SW, 2001, NATURE, V409, P630, DOI 10.1038/35054572; Grill SW, 2003, SCIENCE, V301, P518, DOI 10.1126/science.1086560; Gusnowski EM, 2011, J CELL BIOL, V194, P377, DOI 10.1083/jcb.201103128; Hannak E, 2001, J CELL BIOL, V155, P1109, DOI 10.1083/jcb.200108051; Harris TW, 2014, NUCLEIC ACIDS RES, V42, pD789, DOI 10.1093/nar/gkt1063; HODGKIN J, 1979, GENETICS, V91, P67; Hunter AW, 2003, MOL CELL, V11, P445, DOI 10.1016/S1097-2765(03)00049-2; Illingworth C, 2010, DEVELOPMENT, V137, P2133, DOI 10.1242/dev.048306; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Kaitna S, 2002, CURR BIOL, V12, P798, DOI 10.1016/S0960-9822(02)00820-5; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; Kline-Smith SL, 2004, MOL BIOL CELL, V15, P1146, DOI 10.1091/mbc.E03-08-0581; Knowlton AL, 2006, CURR BIOL, V16, P1705, DOI 10.1016/j.cub.2006.07.057; Kozlowski C, 2007, CELL, V129, P499, DOI 10.1016/j.cell.2007.03.027; Kufer TA, 2002, J CELL BIOL, V158, P617, DOI 10.1083/jcb.200204155; Lampson MA, 2011, TRENDS CELL BIOL, V21, P133, DOI 10.1016/j.tcb.2010.10.007; Lan WJ, 2004, CURR BIOL, V14, P273, DOI 10.1016/j.cub.2004.01.055; Maney T, 1998, J CELL BIOL, V142, P787, DOI 10.1083/jcb.142.3.787; Mennella V, 2009, J CELL BIOL, V186, P481, DOI 10.1083/jcb.200902113; Moore A, 2004, TRENDS CELL BIOL, V14, P537, DOI 10.1016/j.tcb.2004.09.001; Moores CA, 2006, J CELL SCI, V119, P3905, DOI 10.1242/jcs.03224; Oegema K, 2001, J CELL BIOL, V153, P1209, DOI 10.1083/jcb.153.6.1209; Ogawa T, 2004, CELL, V116, P591, DOI 10.1016/S0092-8674(04)00129-1; Ohi R, 2004, MOL BIOL CELL, V15, P2895, DOI 10.1091/mbc.E04-02-0082; Ozlu N, 2005, DEV CELL, V9, P237, DOI 10.1016/j.devcel.2005.07.002; Pakala SB, 2012, J BIOL CHEM, V287, P40560, DOI 10.1074/jbc.M112.399576; Praitis V, 2001, GENETICS, V157, P1217; Rapsomaniki MA, 2012, BIOINFORMATICS, V28, P1800, DOI 10.1093/bioinformatics/bts241; Rogers E, 2002, J CELL BIOL, V157, P219, DOI 10.1083/jcb.200110045; Sanhaji M, 2010, MOL CELL BIOL, V30, P2594, DOI 10.1128/MCB.00098-10; Schlaitz AL, 2007, CELL, V128, P115, DOI 10.1016/j.cell.2006.10.050; Schumacher JM, 1998, DEVELOPMENT, V125, P4391; Schumacher JM, 1998, J CELL BIOL, V143, P1635, DOI 10.1083/jcb.143.6.1635; Severson AF, 2000, CURR BIOL, V10, P1162, DOI 10.1016/S0960-9822(00)00715-6; Srayko M, 2005, DEV CELL, V9, P223, DOI 10.1016/j.devcel.2005.07.003; Srayko M, 2003, CURR BIOL, V13, P1506, DOI 10.1016/S0960-9822(03)00597-9; Srinivasan DG, 2003, GENE DEV, V17, P1225, DOI 10.1101/gad.1081203; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Walczak CE, 1996, CELL, V84, P37, DOI 10.1016/S0092-8674(00)80991-5; Walczak CE, 2002, CURR BIOL, V12, P1885, DOI 10.1016/S0960-9822(02)01227-7; Widlund PO, 2011, P NATL ACAD SCI USA, V108, P2741, DOI 10.1073/pnas.1016498108; Woehlke G, 1997, CELL, V90, P207, DOI 10.1016/S0092-8674(00)80329-3; Woollard A, 1999, MECH DEVELOP, V82, P95, DOI 10.1016/S0925-4773(99)00020-9; WORDEMAN L, 1995, J CELL BIOL, V128, P95, DOI 10.1083/jcb.128.1.95; Zhang LY, 2011, J BIOL CHEM, V286, P3033, DOI 10.1074/jbc.M110.165340; Zhang X, 2008, MOL BIOL CELL, V19, P2752, DOI 10.1091/mbc.E08-02-0198; Zhang X, 2007, MOL BIOL CELL, V18, P3264, DOI 10.1091/mbc.E07-01-0086; Zhou FF, 2004, BIOCHEM BIOPH RES CO, V325, P1443, DOI 10.1016/j.bbrc.2004.11.001	69	18	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0132593	10.1371/journal.pone.0132593	http://dx.doi.org/10.1371/journal.pone.0132593			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26168236	gold, Green Published, Green Submitted			2022-12-26	WOS:000358193100057
J	Mackay, DS; Bennett, TM; Shiels, A				Mackay, Donna S.; Bennett, Thomas M.; Shiels, Alan			Exome Sequencing Identifies a Missense Variant in EFEMP1 Co-Segregating in a Family with Autosomal Dominant Primary Open-Angle Glaucoma	PLOS ONE			English	Article							HONEYCOMB RETINAL DYSTROPHY; MACULAR DEGENERATION; R345W MUTATION; DRUSEN; GENE; ASSOCIATION; MICE; PATHOPHYSIOLOGY; POPULATIONS; EXPRESSION	Primary open-angle glaucoma (POAG) is a clinically important and genetically heterogeneous cause of progressive vision loss as a result of retinal ganglion cell death. Here we have utilized trio-based, whole-exome sequencing to identify the genetic defect underlying an autosomal dominant form of adult-onset POAG segregating in an African-American family. Exome sequencing identified a novel missense variant (c.418C>T, p.Arg140Trp) in exon-5 of the gene coding for epidermal growth factor (EGF) containing fibulin-like extracellular matrix protein 1 (EFEMP1) that co-segregated with disease in the family. Linkage and haplotype analyses with microsatellite markers indicated that the disease interval overlapped a known POAG locus (GLC1H) on chromosome 2p. The p.Arg140Trp substitution was predicted in silico to have damaging effects on protein function and transient expression studies in cultured cells revealed that the Trp140-mutant protein exhibited increased intracellular accumulation compared with wild-type EFEMP1. In situ hybridization of the mouse eye with oligonucleotide probes detected the highest levels of EFEMP1 transcripts in the ciliary body, cornea, inner nuclear layer of the retina, and the optic nerve head. The recent finding that a common variant near EFEMP1 was associated with optic nerve-head morphology supports the possibility that the EFEMP1 variant identified in this POAG family may be pathogenic.	[Mackay, Donna S.; Bennett, Thomas M.; Shiels, Alan] Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63110 USA	Washington University (WUSTL)	Shiels, A (corresponding author), Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63110 USA.	shiels@vision.wustl.edu		Mackay, Donna/0000-0002-2499-1203	National Institutes of Health (NIH) [EY012284, EY02687]; Research to Prevent Blindness (RPB); NIH [P30 CA91842, UL1 TR000448]; NATIONAL CANCER INSTITUTE [P30CA091842] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY012284, P30EY002687] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness (RPB)(Research to Prevent Blindness (RPB)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institutes of Health (NIH) grants EY012284 (to A.S.) and EY02687 (Core Grant for Vision Research), and by an unrestricted grant to the Department of Ophthalmology and Visual Sciences from Research to Prevent Blindness (RPB). The Genome Technology Access Center (GTAC) at Washington University School of Medicine is partially supported by NIH grants P30 CA91842, and UL1 TR000448. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alapati A, 2014, INVEST OPHTH VIS SCI, V55, P5510, DOI 10.1167/iovs.14-14359; Nguyen A, 2015, EXP EYE RES, V130, P66, DOI 10.1016/j.exer.2014.12.002; Balasubbu S, 2012, INVEST OPHTH VIS SCI, V53, P1861, DOI 10.1167/iovs.11-8602; Boon CJF, 2013, PROG RETIN EYE RES, V37, P90, DOI 10.1016/j.preteyeres.2013.08.003; Chen LJ, 2012, MOL VIS, V18, P1629; de Vega S, 2009, CELL MOL LIFE SCI, V66, P1890, DOI 10.1007/s00018-009-8632-6; Djokic J, 2013, J BIOL CHEM, V288, P22821, DOI 10.1074/jbc.M112.439158; Fan BJ, 2010, J CLIN INVEST, V120, P3064, DOI 10.1172/JCI43085; Fu L, 2007, HUM MOL GENET, V16, P2411, DOI 10.1093/hmg/ddm198; Fuchshofer R, 2009, EXP EYE RES, V88, P1020, DOI 10.1016/j.exer.2009.01.002; Gemenetzi M, 2012, EYE, V26, P355, DOI 10.1038/eye.2011.309; Hulleman JD, 2011, MOL BIOL CELL, V22, P4765, DOI 10.1091/mbc.E11-08-0695; Janssen SF, 2013, PROG RETIN EYE RES, V37, P31, DOI 10.1016/j.preteyeres.2013.09.001; Jiao XD, 2009, P NATL ACAD SCI USA, V106, P17105, DOI 10.1073/pnas.0907564106; Kobayashi N, 2007, J BIOL CHEM, V282, P11805, DOI 10.1074/jbc.M611029200; Lin Y, 2008, MOL VIS, V14, P739; Liu T, 2012, MOL VIS, V18, P2119; Liu YT, 2013, INVEST OPHTH VIS SCI, V54, P6248, DOI 10.1167/iovs.13-12779; Liu YT, 2011, EXP EYE RES, V93, P331, DOI 10.1016/j.exer.2011.08.007; Liu YT, 2010, P NATL ACAD SCI USA, V107, pE61, DOI 10.1073/pnas.0913838107; Marmorstein LY, 2007, HUM MOL GENET, V16, P2423, DOI 10.1093/hmg/ddm199; Matsumoto M, 2001, AM J OPHTHALMOL, V131, P810, DOI 10.1016/S0002-9394(00)00926-0; McLaughlin PJ, 2007, HUM MOL GENET, V16, P3059, DOI 10.1093/hmg/ddm264; Rezaie T, 2002, SCIENCE, V295, P1077, DOI 10.1126/science.1066901; Roybal CN, 2005, INVEST OPHTH VIS SCI, V46, P3973, DOI 10.1167/iovs.05-0070; Springelkamp H, 2015, GENET EPIDEMIOL, V39, P207, DOI 10.1002/gepi.21886; Stone EM, 1999, NAT GENET, V22, P199, DOI 10.1038/9722; Suriyapperuma SP, 2007, ARCH OPHTHALMOL-CHIC, V125, P86, DOI 10.1001/archopht.125.1.86; Takamoto M, 2014, JPN J OPHTHALMOL, V58, P1, DOI 10.1007/s10384-013-0286-0; Takeuchi T, 2010, INVEST OPHTH VIS SCI, V51, P1643, DOI 10.1167/iovs.09-4497; Tarttelin EE, 2001, J MED GENET, V38, P381, DOI 10.1136/jmg.38.6.381; Templeton JP, 2013, INVEST OPHTH VIS SCI, V54, P2599, DOI 10.1167/iovs.12-11175; Tham YC, 2014, OPHTHALMOLOGY, V121, P2081, DOI 10.1016/j.ophtha.2014.05.013; Weinreb RN, 2014, JAMA-J AM MED ASSOC, V311, P1901, DOI 10.1001/jama.2014.3192; Wiggs JL, 2007, ARCH OPHTHALMOL-CHIC, V125, P30, DOI 10.1001/archopht.125.1.30; Williams SEI, 2015, SCI REP-UK, V5, DOI 10.1038/srep08378; Zhang T, 2014, RETINA-J RET VIT DIS, V34, P2462, DOI 10.1097/IAE.0000000000000259	37	24	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132529	10.1371/journal.pone.0132529	http://dx.doi.org/10.1371/journal.pone.0132529			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26162006	Green Published, gold, Green Submitted			2022-12-26	WOS:000358162300146
J	Gao, CH; Wang, JY; Zhang, S; Yang, YT; Wang, Y				Gao, Chun-hua; Wang, Jun-yun; Zhang, Song; Yang, Yue-tao; Wang, Yong			Survey of Wild and Domestic Mammals for Infection with Leishmania infantum following an Outbreak of Desert Zoonotic Visceral Leishmaniasis in Jiashi, People's Republic of China	PLOS ONE			English	Article							RABBITS ORYCTOLAGUS-CUNICULUS; CANINE LEISHMANIASIS; RESERVOIR HOSTS; CATS	In 2008 and 2009, an outbreak of desert-subtype zoonotic visceral leishmaniasis occurred in Jiashi county, Xinjiang, China. So far, no animal reservoir has been identified for this type of visceral leishmaniasis. Therefore, we surveyed the most common mammals (wild and domestic) for Leishmania infections during the outbreak in 2008 and 2009 in order to identify the source of the visceral leishmaniasis in this region. Spleen, liver, bone marrow and blood samples collected from 86 wood mice (Apodemus sylvaticus), 61 midday jirds (Meriones meridianus) and 27 Yarkand hares (Lepus yarkandensis) were tested for the presence of Leishmania by microscopy, culture and PCR. All of the animals were found to be negative for Leishmania infections; On the other hand, Leishmania DNA was detected in blood samples collected from livestock reared in the outbreak area: 30.36% (17/56) of sheep, 21.57% (11/51) of goats, 17.78% (8/45) of cattle, and 21.62 (8/37) of donkeys were positive for Leishmania DNA by PCR. The amplified kDNA sequences from the livestock samples matched Leishmania DNA sequences isolated from patients with visceral leishmaniasis in the study area. We suggest that these domestic mammals are a possible reservoir host for Leishmania infantum in the outbreak area.	[Gao, Chun-hua; Wang, Jun-yun; Yang, Yue-tao] Chinese Minist Hlth, Natl Inst Parasit Dis, Chinese Ctr Dis Control & Prevent,WHO Collaborati, Key Lab Parasite & Vector Biol,Natl Ctr Int Res T, Shanghai 200025, Peoples R China; [Zhang, Song] Ctr Dis Control & Prevent Xinjiang Uygur Autonomo, Urumqi 830002, Peoples R China; [Wang, Yong] Cent S Univ, Sch Basic Med Sci, Dept Immunol, Changsha 410013, Hunan, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute of Parasitic Diseases, Chinese Center for Disease Control & Prevention; Central South University	Wang, JY (corresponding author), Chinese Minist Hlth, Natl Inst Parasit Dis, Chinese Ctr Dis Control & Prevent,WHO Collaborati, Key Lab Parasite & Vector Biol,Natl Ctr Int Res T, Shanghai 200025, Peoples R China.	wang_junyun@yahoo.com			China's National S & T Major Program [2008ZX10004-011, 2012ZX10004-220]	China's National S & T Major Program	This work was supported by China's National S & T Major Program (grant nos. 2008ZX10004-011 and 2012ZX10004-220).	Alvar J, 2006, TRENDS PARASITOL, V22, P552, DOI 10.1016/j.pt.2006.09.004; Ashford RW, 1996, CLIN DERMATOL, V14, P523, DOI 10.1016/0738-081X(96)00041-7; AYDOGDU I, 1995, TROP GEOGR MED, V47, P231; Banuls AL, 2007, ADV PARASIT, V64, P1, DOI 10.1016/S0065-308X(06)64001-3; Bhattarai NR, 2010, EMERG INFECT DIS, V16, P231, DOI 10.3201/eid1602.090623; Carrillo E, 2013, TRENDS PARASITOL, V29, P579, DOI 10.1016/j.pt.2013.10.007; Diaz-Saez V, 2014, VET PARASITOL, V202, P119, DOI 10.1016/j.vetpar.2014.03.029; Elnaiem DA, 2001, PARASITOLOGY, V122, P531, DOI 10.1017/S0031182001007594; GUAN L-R, 1991, Southeast Asian Journal of Tropical Medicine and Public Health, V22, P291; GUAN LR, 1991, B WORLD HEALTH ORGAN, V69, P595; Jimenez M, 2014, VET PARASITOL, V202, P296, DOI 10.1016/j.vetpar.2014.03.027; Maia C, 2010, VET PARASITOL, V174, P336, DOI 10.1016/j.vetpar.2010.08.030; Maia C, 2008, VECTOR-BORNE ZOONOT, V8, P555, DOI 10.1089/vbz.2007.0247; Maia C, 2011, TRENDS PARASITOL, V27, P341, DOI 10.1016/j.pt.2011.03.008; Molina R, 2012, VET PARASITOL, V190, P268, DOI 10.1016/j.vetpar.2012.05.006; Moreno I, 2014, VET PARASITOL, V199, P264, DOI 10.1016/j.vetpar.2013.10.010; Moreno J, 2002, TRENDS PARASITOL, V18, P399, DOI 10.1016/S1471-4922(02)02347-4; Palatnik-de-Sousa CB, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-197; Prina E, 2007, MICROBES INFECT, V9, P1307, DOI 10.1016/j.micinf.2007.06.005; Quinnell RJ, 2009, PARASITOLOGY, V136, P1915, DOI 10.1017/S0031182009991156; Reithinger Richard, 2002, Trends in Parasitology, V18, P289, DOI 10.1016/S1471-4922(02)02296-1; Sastre N, 2008, VET PARASITOL, V158, P117, DOI 10.1016/j.vetpar.2008.08.008; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Wang JY, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-31; Wang JY, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-69; Wang JY, 2010, PARASITOL INT, V59, P331, DOI 10.1016/j.parint.2010.04.002; Wang JunYun, 2006, Chinese Journal of Zoonoses, V22, P734; WHO, 2010, CONTR LEISHM, P186	28	9	10	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132493	10.1371/journal.pone.0132493	http://dx.doi.org/10.1371/journal.pone.0132493			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177101	Green Submitted, Green Published, gold			2022-12-26	WOS:000358197600118
J	Hillson, R; Alejandre, JD; Jacobsen, KH; Ansumana, R; Bockarie, AS; Bangura, U; Lamin, JM; Stenger, DA				Hillson, Roger; Alejandre, Joel D.; Jacobsen, Kathryn H.; Ansumana, Rashid; Bockarie, Alfred S.; Bangura, Umaru; Lamin, Joseph M.; Stenger, David A.			Stratified Sampling of Neighborhood Sections for Population Estimation: A Case Study of Bo City, Sierra Leone	PLOS ONE			English	Article								There is a need for better estimators of population size in places that have undergone rapid growth and where collection of census data is difficult. We explored simulated estimates of urban population based on survey data from Bo, Sierra Leone, using two approaches: (1) stratified sampling from across 20 neighborhoods and (2) stratified single-stage cluster sampling of only four randomly-sampled neighborhoods. The stratification variables evaluated were (a) occupants per individual residence, (b) occupants per neighborhood, and (c) residential structures per neighborhood. For method (1), stratification variable (a) yielded the most accurate re-estimate of the current total population. Stratification variable (c), which can be estimated from aerial photography and zoning type verification, and variable (b), which could be ascertained by surveying a limited number of households, increased the accuracy of method (2). Small household-level surveys with appropriate sampling methods can yield reasonably accurate estimations of urban populations.	[Hillson, Roger; Alejandre, Joel D.] Naval Res Lab, Div Informat Technol, Washington, DC USA; [Jacobsen, Kathryn H.] George Mason Univ, Dept Global & Community Hlth, Fairfax, VA 22030 USA; [Ansumana, Rashid; Bockarie, Alfred S.] Njala Univ, Bo, Sierra Leone; [Ansumana, Rashid; Bockarie, Alfred S.; Bangura, Umaru; Lamin, Joseph M.] Mercy Hosp Res Lab, Bo, Sierra Leone; [Stenger, David A.] Naval Res Lab, Ctr Biomol Sci & Engn, Washington, DC 20375 USA	United States Department of Defense; United States Navy; Naval Research Laboratory; George Mason University; Njala University; United States Department of Defense; United States Navy; Naval Research Laboratory	Stenger, DA (corresponding author), Naval Res Lab, Ctr Biomol Sci & Engn, Washington, DC 20375 USA.	david.stenger@nrl.navy.mil	Ansumana, Rashid/AGQ-7401-2022; Jacobsen, Kathryn H./B-5857-2008	Jacobsen, Kathryn H./0000-0002-4198-6246	Defense Threat Reduction Agency, Joint Science and Technology Office; NRL; George Mason University	Defense Threat Reduction Agency, Joint Science and Technology Office(United States Department of DefenseDefense Threat Reduction Agency); NRL; George Mason University	This work was funded by the Defense Threat Reduction Agency, Joint Science and Technology Office (http://www.dvidshub.net/unit/DTRA-CB#.UoUqZ9wo5zk) via contract to myself at the Naval Research Laboratory. A subcontract from NRL with George Mason University was used to provide support for contractors (Rashid Ansumana, Alfred Bockarie, Umaru Bangura and Joseph Lamin) working at Mercy Hospital Research Laboratory in Bo, Sierra Leone. There is no past, present or future Intellectual Property associated with the work described in the paper, and none of the authors have any financial interests or conflicts in the outcome of the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansumana R, 2013, PAN AFR MED J, V15, DOI 10.11604/pamj.2013.15.34.2291; Ansumana R, 2010, INT J HEALTH GEOGR, V9, DOI 10.1186/1476-072X-9-56; Archer BN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049482; Baillargeon S, 2012, PACKAGE STRATIFICATI; Baillargeon S, 2011, SURV METHODOL, V37, P53; Checchi F, 2013, INT J HEALTH GEOGR, V12, DOI 10.1186/1476-072X-12-4; Croarkin C, 2015, NIST SEMATECH E HDB; Dalgaard P., 2013, INTRO STAT R; Fox J, 2014, PACKAGE CAR COMPANIO; Glasser J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012777; Gomez-Elipe A, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-129; Hay SI, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000048; Hethcote HW, 2000, SIAM REV, V42, P599, DOI 10.1137/S0036144500371907; HIDIROGLOU MA, 1993, J BUS ECON STAT, V11, P397, DOI 10.2307/1391630; Hillson R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112241; Hinkley DV, 1997, BOOTSTRAP METHODS AN, DOI 10.2307/1271471; Jacobsen KH, 2012, INT HEALTH, V4, P307, DOI 10.1016/j.inhe.2012.09.004; Jacobsen KH, 2012, ACTA OBSTET GYN SCAN, V91, P750, DOI 10.1111/j.1600-0412.2012.01384.x; Kozak M., 2004, STAT TRANSITION, V6, P797; Kozak M.R., 2006, SURV METHODOL, V32, P157; Lavallee P., 1988, SURV METHODOL, V14, P33; Levey PS, 2008, SAMPLING POPULATION; Magalhaes RJS, 2011, ADV PARASIT, V74, P267, DOI 10.1016/B978-0-12-385897-9.00005-7; MCGILL R, 1978, AM STAT, V32, P12, DOI 10.2307/2683468; OVERTON WS, 1995, AM STAT, V49, P261, DOI 10.2307/2684196; Quatember A, 2014, AUST J STAT, V43, P93, DOI 10.17713/ajs.v43i2.10; Ripley B, 2013, PACKAGE BOOT BOOTSTR; Tille Y, PACKAGE SAMPLING R S; Tille Y, 2010, ICOTS; White LF, 2008, STAT MED, V27, P2999, DOI 10.1002/sim.3136	30	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132850	10.1371/journal.pone.0132850	http://dx.doi.org/10.1371/journal.pone.0132850			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177479	Green Published, Green Submitted, gold			2022-12-26	WOS:000358197600167
J	Fu, C; Chen, D; Chen, RJ; Hu, QS; Wang, GH				Fu, Cheng; Chen, Dong; Chen, Ruijie; Hu, Qingsong; Wang, Guanghui			The Schizophrenia-Related Protein Dysbindin-1A Is Degraded and Facilitates NF-Kappa B Activity in the Nucleus	PLOS ONE			English	Article							SDY MUTANT MICE; SUSCEPTIBILITY GENE; SYNAPTIC PLASTICITY; NEURITE OUTGROWTH; UBIQUITIN LIGASE; MEMORY FORMATION; WORKING-MEMORY; SPATIAL MEMORY; DTNBP1; EXPRESSION	Dystrobrevin-binding protein 1 (DTNBP1), a gene encoding dysbindin-1, has been identified as a susceptibility gene for schizophrenia. Functioning with partners in synapses or the cytoplasm, this gene regulates neurite outgrowth and neurotransmitter release. Loss of dysbindin-1 affects schizophrenia pathology. Dysbindin-1 is also found in the nucleus, however, the characteristics of dysbindin in the nucleus are not fully understood. Here, we found that dysbindin-1A is degraded in the nucleus via the ubiquitin-proteasome system and that amino acids 2-41 at the N-terminus are required for this process. By interacting with p65, dysbindin-1A promotes the transcriptional activity of NF-kappa B in the nucleus and positively regulates MMP-9 expression. Taken together, the data obtained in this study demonstrate that dysbindin-1A protein levels are highly regulated in the nucleus and that dysbindin-1A regulates transcription factor NF-kappa B activity to promote the expression of MMP-9 and TNF-alpha.	[Fu, Cheng; Wang, Guanghui] Univ Sci & Technol China, Chinese Acad Sci, Key Lab Brain Funct & Dis, Lab Mol Neuropathol, Hefei 230026, Anhui, Peoples R China; [Fu, Cheng; Wang, Guanghui] Univ Sci & Technol China, Chinese Acad Sci, Sch Life Sci, Hefei 230026, Anhui, Peoples R China; [Chen, Dong; Hu, Qingsong; Wang, Guanghui] Soochow Univ, Jiangsu Key Lab Translat Res & Therapy Neuropsyco, Lab Mol Neuropathol, Suzhou, Jiangsu, Peoples R China; [Chen, Dong; Hu, Qingsong; Wang, Guanghui] Soochow Univ, Coll Pharmaceut Sci, Suzhou, Jiangsu, Peoples R China; [Chen, Ruijie] Wenzhou Med Univ, Affiliated Hosp 2, Dept Clin Pharm & Pharmacol, Wenzhou, Zhejiang, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Soochow University - China; Soochow University - China; Wenzhou Medical University	Wang, GH (corresponding author), Univ Sci & Technol China, Chinese Acad Sci, Key Lab Brain Funct & Dis, Lab Mol Neuropathol, Hefei 230026, Anhui, Peoples R China.	wghui@ustc.edu.cn	Wang, Guanghui/U-3979-2017	Wang, Guanghui/0000-0001-8551-6468; Lim, Kah-Leong/0000-0002-5440-2588	National High-tech Research and Development program of China 973-projects [2012CB947602]; National Natural Sciences Foundation of China [31330030, 81371393]; Jiangsu Key Laboratory of Translational Research and Therapy for Neuro-Psycho-Diseases [BM2013003]	National High-tech Research and Development program of China 973-projects(National Basic Research Program of China); National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Key Laboratory of Translational Research and Therapy for Neuro-Psycho-Diseases	The National High-tech Research and Development program of China 973-projects (2012CB947602, http://www.most.gov.cn/), the National Natural Sciences Foundation of China (Nos. 31330030 and 81371393, http://www.nsfc.gov.cn/) and Jiangsu Key Laboratory of Translational Research and Therapy for Neuro-Psycho-Diseases (BM2013003, http://www.jstd.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn HJ, 2008, LEARN MEMORY, V15, P539, DOI 10.1101/lm.866408; Alvarez-Castelao B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055999; Ao Li X, 2009, BDM PUB COMPUTATIONA; Boersma MCH, 2011, J NEUROSCI, V31, P5414, DOI 10.1523/JNEUROSCI.2456-10.2011; Burdick KE, 2007, SCHIZOPHR RES, V89, P169, DOI 10.1016/j.schres.2006.09.008; Burdick KE, 2006, HUM MOL GENET, V15, P1563, DOI 10.1093/hmg/ddi481; Chen XW, 2008, J CELL BIOL, V181, P791, DOI 10.1083/jcb.200711021; Cox MM, 2009, GENES BRAIN BEHAV, V8, P390, DOI 10.1111/j.1601-183X.2009.00477.x; Dash PK, 2005, J NEUROCHEM, V93, P269, DOI 10.1111/j.1471-4159.2004.03016.x; Denis-Donini S, 2008, J NEUROSCI, V28, P3911, DOI 10.1523/JNEUROSCI.0148-08.2008; Dziembowska M, 2012, INT J BIOCHEM CELL B, V44, P709, DOI 10.1016/j.biocel.2012.01.023; Fei EK, 2010, J BIOL CHEM, V285, P38630, DOI 10.1074/jbc.M110.107912; Feng YQ, 2008, SCHIZOPHR RES, V106, P218, DOI 10.1016/j.schres.2008.07.018; Ghiani CA, 2010, MOL PSYCHIATR, V15, P204, DOI 10.1038/mp.2009.58; Gutierrez H, 2005, DEVELOPMENT, V132, P1713, DOI 10.1242/dev.01702; Hattori S, 2008, BIOCHEM BIOPH RES CO, V373, P298, DOI 10.1016/j.bbrc.2008.06.016; HOUGH R, 1986, J BIOL CHEM, V261, P2400; Iizuka Y, 2007, J NEUROSCI, V27, P12390, DOI 10.1523/JNEUROSCI.1689-07.2007; Ito H, 2010, MOL PSYCHIATR, V15, P976, DOI [10.1038/mp.2010.69, 10.1038/mp.2010.93]; Jia JM, 2014, J NEUROSCI, V34, P13725, DOI 10.1523/JNEUROSCI.0184-14.2014; Kaltschmidt B, 2006, MOL CELL BIOL, V26, P2936, DOI 10.1128/MCB.26.8.2936-2946.2006; Karlsgodt KH, 2011, BIOL PSYCHIAT, V69, P28, DOI 10.1016/j.biopsych.2010.09.012; Kubota K, 2009, BIOCHEM BIOPH RES CO, V379, P191, DOI 10.1016/j.bbrc.2008.12.017; Kudryashova E, 2005, J MOL BIOL, V354, P413, DOI 10.1016/j.jmb.2005.09.068; Lingbeck JM, 2003, J BIOL CHEM, V278, P1817, DOI 10.1074/jbc.M208815200; Locke M, 2009, HUM MOL GENET, V18, P2344, DOI 10.1093/hmg/ddp167; Ma X, 2011, MOL PSYCHIATR, V16, P1105, DOI 10.1038/mp.2011.43; Meffert MK, 2003, NAT NEUROSCI, V6, P1072, DOI 10.1038/nn1110; Nagy V, 2006, J NEUROSCI, V26, P1923, DOI 10.1523/JNEUROSCI.4359-05.2006; Numakawa T, 2004, HUM MOL GENET, V13, P2699, DOI 10.1093/hmg/ddh280; Okuda H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008773; Oyama S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004199; Radivojac P, 2010, PROTEINS, V78, P365, DOI 10.1002/prot.22555; Roussos P, 2013, NEUROPSYCHOPHARMACOL, V38, P533, DOI 10.1038/npp.2012.215; Takao K, 2008, MOL BRAIN, V1, DOI 10.1186/1756-6606-1-11; Talbot K, 2004, J CLIN INVEST, V113, P1353, DOI 10.1172/JCI200420425; Tang TTT, 2009, P NATL ACAD SCI USA, V106, P21395, DOI 10.1073/pnas.0910499106; Trausch-Azar J, 2010, J BIOL CHEM, V285, P40192, DOI 10.1074/jbc.M110.131615; Vawter MP, 2002, MOL PSYCHIATR, V7, P571, DOI 10.1038/sj.mp.4001158; von Mikecz A, 2006, J CELL SCI, V119, P1977, DOI 10.1242/jcs.03008; Weickert CS, 2004, ARCH GEN PSYCHIAT, V61, P544, DOI 10.1001/archpsyc.61.6.544; Yap MYA, 2014, NEUROCHEM INT, V79, P65, DOI 10.1016/j.neuint.2014.10.001; Yeh SH, 2002, J BIOL CHEM, V277, P46720, DOI 10.1074/jbc.M206258200	43	15	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132639	10.1371/journal.pone.0132639	http://dx.doi.org/10.1371/journal.pone.0132639			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26171858	Green Submitted, gold, Green Published			2022-12-26	WOS:000358194900067
J	Han, K; Chao, AC; Chang, FC; Chung, CP; Hsu, HY; Sheng, WY; Wu, J; Hu, HH				Han, Ke; Chao, A-Ching; Chang, Feng-Chi; Chung, Chih-Ping; Hsu, Hung-Yi; Sheng, Wen-Yung; Wu, Jiang; Hu, Han-Hwa			Obstruction of Venous Drainage Linked to Transient Global Amnesia	PLOS ONE			English	Article							INTERNAL JUGULAR-VEIN; CEREBRAL-CIRCULATION; COMPRESSION SYNDROME; MULTIPLE-SCLEROSIS; VALVE INCOMPETENCE; CAVERNOUS SINUS; CT ANGIOGRAPHY; BASAL VEIN; MR; OUTFLOW	Abnormal extracranial venous drainage modality has been considered an etiology of transient global amnesia (TGA). Evidence suggests that the transmission of the intrathoracic/intraabdominal pressure during a Valsalva maneuver (VM) is mainly through the vertebral venous system, and patency of internal jugular vein (IJV) is essential for venous drainage and pressure releasing. We hypothesize that obstruction of IJV venous drainage is a contributing factor in TGA pathogenesis. A magnetic resonance (MR) imaging protocol was used in 45 TGA patients and 45 age-and sex-matched controls to assess the morphologies of IJV, brachiocephalic vein (BCV) and asymmetry of transverse sinus (TS). The IJV was divided into the upper-and middle-IJV segments. Compared to the controls, TGA patients had significantly higher rates of moderate and severe compression/stenosis at the bilateral upper-IJV segment (left: 37.8% vs. 17.8%, P = 0.0393; right: 57.8% vs. 15.6%, P<0.0012), in left BCV (60% vs. 8.9%, P<0.0004), and in TS hypoplasia (53.3%% vs. 31.1%, P = 0.0405). The prevalence of at least one site of venous compression/stenosis in IJV or BCV was significantly higher in patients than in controls (91.1% vs. 33.3%, P<0.0004). The diameter of the left TS in MRV, but not in T1 contrast imaging, was significantly smaller in TGA patients than in controls (0.31 +/- 0.21 vs. 0.41 +/- 0.19, P = 0.0290), which was compatible with downstream venous stenosis/obstruction. TGA patients have a higher prevalence of compression/stenosis of the bilateral IJV and the left BCV and TS hypoplasia, which is new evidence that supports the role of extracranial veins in TGA pathogenesis.	[Han, Ke; Wu, Jiang] Jilin Univ, Hosp 1, Dept Neurol, Changchun 130023, Jilin Province, Peoples R China; [Chao, A-Ching] Kaohsiung Med Univ, Dept Neurol, Coll Med, Kaohsiung, Taiwan; [Chao, A-Ching] Kaohsiung Med Univ Hosp, Dept Neurol, Kaohsiung, Taiwan; [Chang, Feng-Chi] Taipei Vet Gen Hosp, Dept Radiol, Taipei, Taiwan; [Chang, Feng-Chi; Chung, Chih-Ping; Sheng, Wen-Yung] Natl Yang Ming Univ, Taipei 112, Taiwan; [Chung, Chih-Ping; Sheng, Wen-Yung] Taipei Vet Gen Hosp, Dept Neurol, Taipei, Taiwan; [Hsu, Hung-Yi] Chung Shan Med Univ, Tungs Taichung Metro Harbor Hosp, Dept Neurol, Taichung, Taiwan; [Hsu, Hung-Yi] Chung Shan Med Univ, Dept Neurol, Sch Med, Taichung, Taiwan; [Hu, Han-Hwa] Taipei Med Univ & Hosp, Coll Med, Grad Inst Clin Med, Taipei, Taiwan; [Hu, Han-Hwa] Taipei Med Univ & Hosp, Dept Neurol, Coll Med, Taipei, Taiwan	Jilin University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Chung Shan Medical University; Chung Shan Medical University; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University Hospital	Wu, J (corresponding author), Jilin Univ, Hosp 1, Dept Neurol, Changchun 130023, Jilin Province, Peoples R China.	doctorwujiang@sina.cn; hanhwa@hotmail.com		Chung, Chih-Ping/0000-0001-9419-9070	Taiwan National Science Council Research Grant [NSC101-2314-B-037-069-MY2]	Taiwan National Science Council Research Grant	This work was supported by the Taiwan National Science Council Research Grant (NSC101-2314-B-037-069-MY2); The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baracchini C, 2012, STROKE, V43, P2289, DOI 10.1161/STROKEAHA.112.654087; BOK B, 1978, EUR J NUCL MED, V3, P63; Cejas C, 2010, STROKE, V41, P67, DOI 10.1161/STROKEAHA.109.566315; Cheng CY, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-94; Chung CP, 2006, NEUROLOGY, V66, P1873, DOI 10.1212/01.wnl.0000219620.69618.9d; Chung CP, 2007, ULTRASOUND MED BIOL, V33, P1727, DOI 10.1016/j.ultrasmedbio.2007.05.018; Chung JI, 2005, INTERV NEURORADIOL, V11, P123, DOI 10.1177/159101990501100202; Dashti SR, 2012, NEUROSURGERY, V70, pE795, DOI 10.1227/NEU.0b013e3182333859; EPSTEIN HM, 1970, ANESTHESIOLOGY, V32, P332, DOI 10.1097/00000542-197004000-00007; Feng W, 2012, REV RECENT CLIN TRIA, V7, P117, DOI 10.2174/157488712800100206; Fofi L, 2012, HEADACHE, V52, P1254, DOI 10.1111/j.1526-4610.2012.02154.x; Frydrychowski AF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048245; Gianesini S, 2014, PHLEBOLOGY, V29, P632, DOI 10.1177/0268355513489549; Gisolf J, 2004, J PHYSIOL-LONDON, V560, P317, DOI 10.1113/jphysiol.2004.070409; GUERCI AD, 1985, CIRC RES, V56, P20, DOI 10.1161/01.RES.56.1.20; HODGES JR, 1990, J NEUROL NEUROSUR PS, V53, P834, DOI 10.1136/jnnp.53.10.834; Hsu HY, 2008, ANN NEUROL, V63, P247, DOI 10.1002/ana.21299; Jayaraman MV, 2012, AM J NEURORADIOL, V33, P1247, DOI 10.3174/ajnr.A2953; Kim BS, 2009, NEURORADIOLOGY, V51, P327, DOI 10.1007/s00234-009-0500-4; Law M, 2004, RADIOLOGY, V231, P645, DOI 10.1148/radiol.2313030996; Lewis SL, 1998, LANCET, V352, P397, DOI 10.1016/S0140-6736(98)01442-1; Lin CJ, 2014, AM J NEURORADIOL, V35, P1132, DOI 10.3174/ajnr.A3838; Liu MJ, 2015, J VASC SURG, V61, P1511, DOI 10.1016/j.jvs.2014.02.021; Lo CP, 2007, CLIN RADIOL, V62, P185, DOI 10.1016/j.crad.2006.09.019; Lochner P, 2014, J NEUROIMAGING, V24, P479, DOI 10.1111/jon.12042; MCHEDLISHVILI GI, 1964, CIRCULATION, V30, P597, DOI 10.1161/01.CIR.30.4.597; Modabbernia A, 2012, ACTA NEUROL BELG, V112, P237, DOI 10.1007/s13760-012-0072-7; Niggemann P, 2011, CENT EUR NEUROSURG, V72, P32, DOI 10.1055/s-0030-1253348; Paksoy Y, 2003, AM J NEURORADIOL, V24, P1364; Parkinson D, 2000, J NEUROSURG, V92, P585, DOI 10.3171/jns.2000.92.4.0585; Quinette P, 2006, BRAIN, V129, P1640, DOI 10.1093/brain/awl105; Schreiber SJ, 2005, J NEUROL NEUROSUR PS, V76, P509, DOI 10.1136/jnnp.2004.043844; STEINBACH JJ, 1976, J NUCL MED, V17, P61; Suzuki Y, 2001, AM J NEURORADIOL, V22, P670; Takahashi S, 2005, EUR RADIOL, V15, P1694, DOI 10.1007/s00330-004-2597-5; TANAKA T, 1993, RADIOLOGY, V188, P355, DOI 10.1148/radiology.188.2.8327678; Valdueza JM, 2000, LANCET, V355, P200; Velasco R, 2008, REV NEUROLOGIA, V47, P301, DOI 10.33588/rn.4706.2008112; Yu WG, 2009, STROKE, V40, P3736, DOI 10.1161/STROKEAHA.109.563080; Zaharchuk G, 2011, AM J NEURORADIOL, V32, P1482, DOI 10.3174/ajnr.A2549; Zamboni P, 2009, CURR NEUROVASC RES, V6, P204, DOI 10.2174/156720209788970054; ZOUAOUI A, 1988, ACTA ANAT, V133, P318	42	17	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132893	10.1371/journal.pone.0132893	http://dx.doi.org/10.1371/journal.pone.0132893			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26173146	Green Published, Green Submitted, gold			2022-12-26	WOS:000358194900096
J	Szalonek, M; Sierpien, B; Rymaszewski, W; Gieczewska, K; Garstka, M; Lichocka, M; Sass, L; Paul, K; Vass, I; Vankova, R; Dobrev, P; Szczesny, P; Marczewski, W; Krusiewicz, D; Strzelczyk-Zyta, D; Hennig, J; Konopka-Postupolska, D				Szalonek, Michal; Sierpien, Barbara; Rymaszewski, Wojciech; Gieczewska, Katarzyna; Garstka, Maciej; Lichocka, Malgorzata; Sass, Laszlo; Paul, Kenny; Vass, Imre; Vankova, Radomira; Dobrev, Peter; Szczesny, Pawel; Marczewski, Waldemar; Krusiewicz, Dominika; Strzelczyk-Zyta, Danuta; Hennig, Jacek; Konopka-Postupolska, Dorota			Potato Annexin STANN1 Promotes Drought Tolerance and Mitigates Light Stress in Transgenic Solanum tuberosum L. Plants	PLOS ONE			English	Article							MEDIATED OXIDATIVE STRESS; BRASSICA-JUNCEA ANNEXIN-3; REDOX SIGNALING PATHWAYS; SALICYLIC-ACID; ASCORBATE PEROXIDASE; ABIOTIC STRESS; HYDROGEN-PEROXIDE; TOBACCO PLANTS; PHOTOOXIDATIVE STRESS; PROTEOMIC IDENTIFICATION	Annexins are a family of calcium-and membrane-binding proteins that are important for plant tolerance to adverse environmental conditions. Annexins function to counteract oxidative stress, maintain cell redox homeostasis, and enhance drought tolerance. In the present study, an endogenous annexin, STANN1, was overexpressed to determine whether crop yields could be improved in potato (Solanum tuberosum L.) during drought. Nine potential potato annexins were identified and their expression characterized in response to drought treatment. STANN1 mRNA was constitutively expressed at a high level and drought treatment strongly increased transcription levels. Therefore, STANN1 was selected for overexpression analysis. Under drought conditions, transgenic potato plants ectopically expressing STANN1 were more tolerant to water deficit in the root zone, preserved more water in green tissues, maintained chloroplast functions, and had higher accumulation of chlorophyll b and xanthophylls (especially zeaxanthin) than wild type (WT). Droughtinduced reductions in the maximum efficiency and the electron transport rate of photosystem II (PSII), as well as the quantum yield of photosynthesis, were less pronounced in transgenic plants overexpressing STANN1 than in the WT. This conferred more efficient non-photochemical energy dissipation in the outer antennae of PSII and probably more efficient protection of reaction centers against photooxidative damage in transgenic plants under drought conditions. Consequently, these plants were able to maintain effective photosynthesis during drought, which resulted in greater productivity than WT plants despite water scarcity. Although the mechanisms underlying this stress protection are not yet clear, annexin-mediated photoprotection is probably linked to protection against light-induced oxidative stress.	[Szalonek, Michal; Sierpien, Barbara; Rymaszewski, Wojciech; Lichocka, Malgorzata; Szczesny, Pawel; Hennig, Jacek; Konopka-Postupolska, Dorota] Polish Acad Sci, Inst Biochem & Biophys, Plant Pathogenesis Lab, Warsaw, Poland; [Gieczewska, Katarzyna; Garstka, Maciej] Univ Warsaw, Dept Metab Regulat, Warsaw, Poland; [Sass, Laszlo; Paul, Kenny; Vass, Imre] Hungarian Acad Sci, Biol Res Ctr, Lab Mol Stress & Photobiol, H-6701 Szeged, Hungary; [Vankova, Radomira; Dobrev, Peter] Inst Expt Bot AS CR, Lab Hormonal Regulat Plants, Prague, Czech Republic; [Marczewski, Waldemar; Krusiewicz, Dominika; Strzelczyk-Zyta, Danuta] Natl Res Inst, Plant Breeding & Acclimatizat Inst, Dept Potato Genet & Parental Lines, Mlochow, Poland	Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences; University of Warsaw; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center; Czech Academy of Sciences; Institute of Experimental Botany of the Czech Academy of Sciences; Institute of Plant Breeding & Acclimatization	Konopka-Postupolska, D (corresponding author), Polish Acad Sci, Inst Biochem & Biophys, Dept Plant Biochem, Warsaw, Poland.	konopka@ibb.waw.pl	Vass, Imre/AAS-6171-2021; Gieczewska, Katarzyna B./ABI-6264-2020; Lichocka, Małgorzata/ABF-2236-2020; Garstka, Maciej Z/T-4962-2018; Konopka-Postupolska, Dorota/AAE-9134-2020; Konopka-Postupolska, Dorota M/H-1916-2012	Vass, Imre/0000-0003-4987-7842; Lichocka, Małgorzata/0000-0002-9894-8195; Garstka, Maciej Z/0000-0001-7141-505X; Paul, Kenny/0000-0003-4948-765X; Marczewski, Waldemar/0000-0002-1424-7325; Hennig, Jacek/0000-0003-0156-1320; Gieczewska, Katarzyna/0000-0001-5400-868X; Konopka-Postupolska, Dorota/0000-0002-3181-5478	Transnational Access Capacities of the European Plant Phenotyping Network (EPPN) - FP7 Research Infrastructures Program of the European Union [284443]; Ministry of Science and Higher Education [N N301 567540, PBZMNiSW-213/2006/5]; European Union - the European Regional Development Fund within the Operational Programme "Innovative economy"	Transnational Access Capacities of the European Plant Phenotyping Network (EPPN) - FP7 Research Infrastructures Program of the European Union; Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); European Union - the European Regional Development Fund within the Operational Programme "Innovative economy"	This work was supported by Transnational Access Capacities of the European Plant Phenotyping Network (EPPN, grant agreement no 284443) - FP7 Research Infrastructures Program of the European Union, http://cordis.europa.eu/fp7/ict/e-infrastructure/ (to MS); Grant N N301 567540 Ministry of Science and Higher Education, http://www.nauka.gov.pl/en/ (to DKP); Grant PBZMNiSW-213/2006/5 - Ministry of Science and Higher Education, http://www. nauka.gov.pl/en/ (to JH); and the use of CePT infrastructure was financed by the European Union - the European Regional Development Fund within the Operational Programme "Innovative economy" for 2007-2013, https://cept.wum.edu.pl/ (MG and KG)	Aghaei K, 2008, J PROTEOME RES, V7, P4858, DOI 10.1021/pr800460y; Aimar D, 2011, PLANTS ENV; Argueso CT, 2009, PLANT CELL ENVIRON, V32, P1147, DOI 10.1111/j.1365-3040.2009.01940.x; Asada K, 1999, ANNU REV PLANT PHYS, V50, P601, DOI 10.1146/annurev.arplant.50.1.601; Asada K, 2006, PLANT PHYSIOL, V141, P391, DOI 10.1104/pp.106.082040; Asselbergh B, 2008, MOL PLANT MICROBE IN, V21, P709, DOI 10.1094/MPMI-21-6-0709; Baebler S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029009; Baier M, 2005, J EXP BOT, V56, P1449, DOI 10.1093/jxb/eri161; Bartoli CG, 2013, ENVIRON EXP BOT, V94, P73, DOI 10.1016/j.envexpbot.2012.05.003; BAULCOMBE DC, 1986, NATURE, V321, P446, DOI 10.1038/321446a0; Baxter A, 2014, J EXP BOT, V65, P1229, DOI 10.1093/jxb/ert375; Bhargava A, 2013, PLANT PHYSIOL, V162, P272, DOI 10.1104/pp.113.217026; Bhargava S, 2013, PLANT BREEDING, V132, P21, DOI 10.1111/pbr.12004; Bick JA, 2001, BIOCHEMISTRY-US, V40, P9040, DOI 10.1021/bi010518v; Broin M, 2003, PLANT PHYSIOL, V132, P1335, DOI 10.1104/pp.103.021626; Caplan JF, 2004, J BIOL CHEM, V279, P7740, DOI 10.1074/jbc.M313049200; Chaves I, 2009, PROTEOMICS, V9, P4154, DOI 10.1002/pmic.200700649; Chen SG, 2010, BBA-BIOENERGETICS, V1797, P391, DOI 10.1016/j.bbabio.2009.12.007; Chen Z, 2008, J BIOL CHEM, V283, P21347, DOI 10.1074/jbc.M802601200; CHEN ZX, 1993, P NATL ACAD SCI USA, V90, P9533, DOI 10.1073/pnas.90.20.9533; Chow B, 2004, J EXP BOT, V55, P247, DOI 10.1093/jxb/erh032; Chu P, 2012, PLANTA, V235, P1271, DOI 10.1007/s00425-011-1573-y; Clark G, 2010, PLANT SIGNAL BEHAV, V5, P303, DOI 10.4161/psb.5.3.10835; Clark GB, 2012, NEW PHYTOL, V196, P695, DOI 10.1111/j.1469-8137.2012.04308.x; Cortleven A, 2014, PLANT PHYSIOL, V164, P1470, DOI 10.1104/pp.113.224667; Dalal A, 2014, PLANT SCI, V219, P9, DOI 10.1016/j.plantsci.2013.12.016; Dalal A, 2014, FEBS LETT, V588, P584, DOI 10.1016/j.febslet.2014.01.006; DalCorso G, 2008, CELL, V132, P273, DOI 10.1016/j.cell.2007.12.028; Davies Julia M., 2014, Plants-Basel, V3, P128, DOI 10.3390/plants3010128; Davletova S, 2005, PLANT CELL, V17, P268, DOI 10.1105/tpc.104.026971; de Carvalho MHC, 2008, PLANT SIGNAL BEHAV, V3, P156, DOI 10.4161/psb.3.3.5536; Dempsey D'Maris Amick, 2011, Arabidopsis Book, V9, pe0156, DOI 10.1199/tab.0156; Divya K, 2010, PLANT MOL BIOL, V73, P293, DOI 10.1007/s11103-010-9615-6; Dobrev Petre I, 2012, Methods Mol Biol, V913, P251, DOI 10.1007/978-1-61779-986-0_17; Dobrev PI, 2002, J CHROMATOGR A, V950, P21, DOI 10.1016/S0021-9673(02)00024-9; DURNER J, 1995, P NATL ACAD SCI USA, V92, P11312, DOI 10.1073/pnas.92.24.11312; Durner J, 1996, J BIOL CHEM, V271, P28492, DOI 10.1074/jbc.271.45.28492; Finkelstein Ruth, 2013, Arabidopsis Book, V11, pe0166, DOI 10.1199/tab.0166; Folgado R, 2013, INT J MOL SCI, V14, P4912, DOI 10.3390/ijms14034912; Fotopoulos V, 2008, J EXP BOT, V59, P729, DOI 10.1093/jxb/erm359; Foyer CH, 2005, PLANT CELL, V17, P1866, DOI 10.1105/tpc.105.033589; FOYER CH, 1994, PHYSIOL PLANTARUM, V92, P696, DOI 10.1111/j.1399-3054.1994.tb03042.x; Foyer CH, 2013, ANTIOXID REDOX SIGN, V18, P2087, DOI 10.1089/ars.2013.5278; Foyer CH, 2012, J EXP BOT, V63, P1637, DOI 10.1093/jxb/ers013; Foyer CH, 2011, PLANT PHYSIOL, V155, P2, DOI 10.1104/pp.110.167569; Foyer CH, 2011, PLANT PHYSIOL, V155, P93, DOI 10.1104/pp.110.166181; Gajdosova S, 2011, J EXP BOT, V62, P2827, DOI 10.1093/jxb/erq457; Gao Q, 2008, J PLANT PHYSIOL, V165, P138, DOI 10.1016/j.jplph.2007.04.002; Gidrol X, 1996, P NATL ACAD SCI USA, V93, P11268, DOI 10.1073/pnas.93.20.11268; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; Gomez LD, 2004, PLANT PHYSIOL, V134, P1662, DOI 10.1104/pp.103.033027; Gorecka KM, 2005, BIOCHEM BIOPH RES CO, V336, P868, DOI 10.1016/j.bbrc.2005.08.181; Ha S, 2012, TRENDS PLANT SCI, V17, P172, DOI 10.1016/j.tplants.2011.12.005; Halim VA, 2007, MOL PLANT MICROBE IN, V20, P1346, DOI 10.1094/MPMI-20-11-1346; Hassanpanah D, 2010, POTATO RES, V53, P383, DOI 10.1007/s11540-010-9179-5; Havaux M, 2005, PLANT CELL, V17, P3451, DOI 10.1105/tpc.105.037036; Havaux M, 2000, PLANT PHYSIOL, V124, P273, DOI 10.1104/pp.124.1.273; Havlova M, 2008, PLANT CELL ENVIRON, V31, P341, DOI 10.1111/j.1365-3040.2007.01766.x; Hipkins MF, 1986, SPECTROSCOPY, P51; Hodges DM, 1999, PLANTA, V207, P604, DOI 10.1007/s004250050524; Hoekstra AY, 2005, GLOBAL ENVIRON CHANG, V15, P45, DOI 10.1016/j.gloenvcha.2004.06.004; Hortensteiner S, 2006, ANNU REV PLANT BIOL, V57, P55, DOI 10.1146/annurev.arplant.57.032905.105212; Hoser R, 2013, NEW PHYTOL, V200, P158, DOI 10.1111/nph.12347; Hossain M. A., 2011, Frontiers of Agriculture in China, V5, P1, DOI 10.1007/s11703-010-1070-2; Hossain M.A., 2013, J PLANT SCI MOL BREE, V2, P2, DOI [10.7243/2050-2389-2-2, DOI 10.7243/2050-2389-2-2]; Ishibashi Y, 2012, PLANT PHYSIOL, V158, P1705, DOI 10.1104/pp.111.192740; Jahns P, 2009, BBA-BIOENERGETICS, V1787, P3, DOI 10.1016/j.bbabio.2008.09.013; Jami SK, 2012, PLANT CELL REP, V31, P813, DOI 10.1007/s00299-011-1201-0; Jami SK, 2008, PLANT PHYSIOL BIOCH, V46, P1019, DOI 10.1016/j.plaphy.2008.07.006; Janda T, 2014, ACTA PHYSIOL PLANT, V36, P2537, DOI 10.1007/s11738-014-1620-y; JEFFERIES RA, 1993, ANN APPL BIOL, V122, P105, DOI 10.1111/j.1744-7348.1993.tb04018.x; Jeon J, 2010, J BIOL CHEM, V285, P23369, DOI 10.1074/jbc.M109.096644; Joo JH, 2005, PLANT CELL, V17, P957, DOI 10.1105/tpc.104.029603; Kitajima S, 2008, PHOTOCHEM PHOTOBIOL, V84, P1404, DOI 10.1111/j.1751-1097.2008.00452.x; Konopka-Postupolska D, 2011, PLANT SCI, V181, P230, DOI 10.1016/j.plantsci.2011.05.013; Konopka-Postupolska D, 2009, PLANT PHYSIOL, V150, P1394, DOI 10.1104/pp.109.135228; Koornneef A, 2008, PLANT PHYSIOL, V147, P1358, DOI 10.1104/pp.108.121392; Kwak JM, 2006, PLANT PHYSIOL, V141, P323, DOI 10.1104/pp.106.079004; Kwak JM, 2003, EMBO J, V22, P2623, DOI 10.1093/emboj/cdg277; Kwon M, 2005, J BIOL CHEM, V280, P23584, DOI 10.1074/jbc.M504325200; Labudda M, 2014, ACTA SOC BOT POL, V83, P3, DOI 10.5586/asbp.2014.003; Laohavisit A, 2013, PLANT PHYSIOL, V163, P253, DOI 10.1104/pp.113.217810; Laohavisit A, 2011, NEW PHYTOL, V189, P40, DOI 10.1111/j.1469-8137.2010.03533.x; Laohavisit A, 2010, PLANT PHYSIOL, V152, P1824, DOI 10.1104/pp.109.145458; Laohavisit A, 2009, PLANT CELL, V21, P479, DOI 10.1105/tpc.108.059550; Lascano Ramiro, 2011, P135; Lehesranta SJ, 2005, PLANT PHYSIOL, V138, P1690, DOI 10.1104/pp.105.060152; Li ZR, 2012, PLANT PHYSIOL, V158, P313, DOI 10.1104/pp.111.181230; Lim PO, 2007, ANNU REV PLANT BIOL, V58, P115, DOI 10.1146/annurev.arplant.57.032905.105316; Lin F, 2009, J EXP BOT, V60, P3221, DOI 10.1093/jxb/erp157; Lindermayr C, 2005, PLANT PHYSIOL, V137, P921, DOI 10.1104/pp.104.058719; Lu YG, 2012, GENE, V499, P14, DOI 10.1016/j.gene.2012.03.026; Mac A, 2004, CELL MOL BIOL LETT, V9, P843; Mackova H, 2013, J EXP BOT, V64, P2805, DOI 10.1093/jxb/ert131; Madureira PA, 2013, INT J MOL SCI, V14, P3568, DOI 10.3390/ijms14023568; Madureira PA, 2011, ONCOTARGET, V2, P1075, DOI 10.18632/oncotarget.375; Mano J, 2001, BBA-BIOENERGETICS, V1504, P275, DOI 10.1016/S0005-2728(00)00256-5; Masip L, 2006, ANTIOXID REDOX SIGN, V8, P753, DOI 10.1089/ars.2006.8.753; Mateo A, 2006, J EXP BOT, V57, P1795, DOI 10.1093/jxb/erj196; Maughan SC, 2010, P NATL ACAD SCI USA, V107, P2331, DOI 10.1073/pnas.0913689107; Merewitz EB, 2011, J EXP BOT, V62, P5311, DOI 10.1093/jxb/err166; Merewitz EB, 2010, J AM SOC HORTIC SCI, V135, P230, DOI 10.21273/JASHS.135.3.230; Mhamdi A, 2010, J EXP BOT, V61, P4197, DOI 10.1093/jxb/erq282; Mhamdi A, 2010, PLANT PHYSIOL, V153, P1144, DOI 10.1104/pp.110.153767; Miller G, 2008, PHYSIOL PLANTARUM, V133, P481, DOI 10.1111/j.1399-3054.2008.01090.x; Miller G, 2007, PLANT PHYSIOL, V144, P1777, DOI 10.1104/pp.107.101436; Miller G, 2010, PLANT CELL ENVIRON, V33, P453, DOI 10.1111/j.1365-3040.2009.02041.x; Mittler R, 2006, TRENDS PLANT SCI, V11, P15, DOI 10.1016/j.tplants.2005.11.002; Mittler R, 2010, ANNU REV PLANT BIOL, V61, P443, DOI 10.1146/annurev-arplant-042809-112116; Miura K, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00004; Monneveux P, 2013, PLANT SCI, V205, P76, DOI 10.1016/j.plantsci.2013.01.011; Mortimer JC, 2008, J EXP BOT, V59, P533, DOI 10.1093/jxb/erm344; Mortimer JC, 2009, PLANT SIGNAL BEHAV, V4, P428, DOI [10.4161/psb.4.5.8297, 10.1105/tpc.108.059550]; Muller-Moule P, 2002, PLANT PHYSIOL, V128, P970, DOI 10.1104/pp.010924; Munne-Bosch S, 2003, PLANTA, V217, P758, DOI 10.1007/s00425-003-1037-0; Murphy JP, 2010, PROTEOMICS, V10, P4258, DOI 10.1002/pmic.200900718; Muthuramalingam M, 2013, FRONT PLANT SCI, V4, DOI [10.3389/fpls.2013.00089, 10.3389/fpls.2013.00054]; Navarre DA, 2004, PHYSIOL MOL PLANT P, V64, P179, DOI 10.1016/j.pmpp.2004.09.001; Nicot N, 2005, J EXP BOT, V56, P2907, DOI 10.1093/jxb/eri285; Noctor G, 2012, ANN BOT, V89, P841; O'Brien JA, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00451; Pal AK, 2013, BIOL PLANTARUM, V57, P359, DOI 10.1007/s10535-012-0277-x; Pasternak M, 2008, PLANT J, V53, P999, DOI 10.1111/j.1365-313X.2007.03389.x; Pastori GM, 2003, PLANT CELL, V15, P939, DOI 10.1105/tpc.010538; PERL A, 1993, THEOR APPL GENET, V85, P568, DOI 10.1007/BF00220915; Pfannschmidt T, 2000, EUR J BIOCHEM, V267, P253, DOI 10.1046/j.1432-1327.2000.00991.x; Pinheiro C, 2011, J EXP BOT, V62, P869, DOI 10.1093/jxb/erq340; Plieth C, 2012, PLANT SIGNAL BEHAV, V7, P650, DOI 10.4161/psb.20065; Prochazkova D, 2008, CELL BIOCHEM FUNCT, V26, P582, DOI 10.1002/cbf.1481; Queval G, 2007, PLANT J, V52, P640, DOI 10.1111/j.1365-313X.2007.03263.x; Queval G, 2011, PLANT CELL ENVIRON, V34, P21, DOI 10.1111/j.1365-3040.2010.02222.x; Queval G, 2009, MOL PLANT, V2, P344, DOI 10.1093/mp/ssp002; Rahantaniaina MS, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00477; Rashotte AM, 2003, PLANT PHYSIOL, V132, P1998, DOI 10.1104/pp.103.021436; Raspor M, 2012, J PLANT GROWTH REGUL, V31, P460, DOI 10.1007/s00344-011-9255-3; Reynolds M, 2008, CURR OPIN PLANT BIOL, V11, P171, DOI 10.1016/j.pbi.2008.02.005; Richards SL, 2014, PLANT J, V77, P136, DOI 10.1111/tpj.12372; Rivero RM, 2007, P NATL ACAD SCI USA, V104, P19631, DOI 10.1073/pnas.0709453104; Rivero RM, 2010, PLANT CELL PHYSIOL, V51, P1929, DOI 10.1093/pcp/pcq143; Rivero RM, 2009, PLANT PHYSIOL, V150, P1530, DOI 10.1104/pp.109.139378; Rizhsky L, 2004, PLANT PHYSIOL, V134, P1683, DOI 10.1104/pp.103.033431; Rizhsky L, 2002, PLANT J, V32, P329, DOI 10.1046/j.1365-313X.2002.01427.x; Salekdeh GH, 2009, TRENDS PLANT SCI, V14, P488, DOI 10.1016/j.tplants.2009.07.007; Sanchez G, 2010, MOL PLANT MICROBE IN, V23, P394, DOI 10.1094/MPMI-23-4-0394; Sareddy GR, 2013, J CANC SCI THER, V5, P256; Schmidt R, 2015, BBA-GEN SUBJECTS, V1850, P1497, DOI 10.1016/j.bbagen.2014.12.020; Schmitz G, 2010, MOL PLANT MICROBE IN, V23, P1584, DOI 10.1094/MPMI-02-10-0045; Schraudner M, 1998, PLANT J, V16, P235, DOI 10.1046/j.1365-313x.1998.00294.x; Seregelyes C, 2003, PLANT SCI, V165, P541, DOI 10.1016/S0168-9452(03)00213-9; Shao HB, 2008, INT J BIOL SCI, V4, P8; Sharma P., 2012, APPL ENVIRON SOIL SC, V2012, P1, DOI [10.1155/2012/217037, DOI 10.1155/2012/650206]; Sies H, 1999, FREE RADICAL BIO MED, V27, P916, DOI 10.1016/S0891-5849(99)00177-X; Sobrino-Plata J, 2014, PLANT SOIL, V377, P369, DOI 10.1007/s11104-013-2006-4; Steiner S, 2011, PLANT PHYSIOL, V157, P1043, DOI 10.1104/pp.111.184515; Su D, 2014, FREE RADICAL BIO MED, V67, P460, DOI 10.1016/j.freeradbiomed.2013.12.004; Suzuki N, 2012, FREE RADICAL BIO MED, V53, P2269, DOI 10.1016/j.freeradbiomed.2012.10.538; Tang L, 2006, PLANT CELL REP, V25, P1380, DOI 10.1007/s00299-006-0199-1; Tripathy BC, 2012, PLANT SIGNAL BEHAV, V7, P1621, DOI 10.4161/psb.22455; Urbany C, 2012, J PROTEOME RES, V11, P703, DOI 10.1021/pr2006186; Vasquez-Robinet C, 2008, J EXP BOT, V59, P2109, DOI 10.1093/jxb/ern073; Veljovic-Jovanovic SD, 2001, PLANT PHYSIOL, V127, P426, DOI 10.1104/pp.010141; Voss I, 2013, PLANT BIOLOGY, V15, P713, DOI 10.1111/j.1438-8677.2012.00710.x; Xia XJ, 2015, J EXP BOT, V66, P2839, DOI 10.1093/jxb/erv089; Xie YJ, 2011, PLANT J, V66, P280, DOI 10.1111/j.1365-313X.2011.04488.x; Xue LJ, 2013, PLANT CELL, V25, P2714, DOI 10.1105/tpc.113.112839; Yang YN, 2004, PLANT J, V40, P909, DOI 10.1111/j.1365-313X.2004.02267.x; Yuan S, 2008, Z NATURFORSCH C, V63, P313; Zaffagnini M, 2012, PLANT SCI, V185, P86, DOI 10.1016/j.plantsci.2012.01.005; Zagorchev L, 2013, INT J MOL SCI, V14, P7405, DOI 10.3390/ijms14047405; Zechmann B, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00566; Zhu JE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102407; Zhu JG, 2014, MOL PLANT, V7, P751, DOI 10.1093/mp/sst171; Zingaretti SM, RESPONSES ORGANISMS	173	49	50	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132683	10.1371/journal.pone.0132683	http://dx.doi.org/10.1371/journal.pone.0132683			38	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26172952	Green Submitted, gold, Green Published			2022-12-26	WOS:000358194900076
J	Welsh, JQ; Bellwood, DR				Welsh, Justin Q.; Bellwood, David R.			Simulated Macro-Algal Outbreak Triggers a Large-Scale Response on Coral Reefs	PLOS ONE			English	Article							HOME-RANGE SIZE; HABITAT UTILIZATION; HERBIVOROUS FISHES; SEED DISPERSAL; MOBILE LINKS; SUCCESSION; PATTERNS; EXPLOITATION; RESILIENCE; DIVERSITY	Ecosystem degradation has become common throughout the world. On coral reefs, macroalgal outbreaks are one of the most widely documented signs of degradation. This study simulated local-scale degradation on a healthy coral reef to determine how resident taxa, with the potential to reverse algal outbreaks, respond. We utilized a combination of acoustic and video monitoring to quantify changes in the movements and densities, respectively, of coral reef herbivores following a simulated algal outbreak. We found an unprecedented accumulation of functionally important herbivorous taxa in response to algal increases. Herbivore densities increased by 267% where algae were present. The increase in herbivore densities was driven primarily by an accumulation of the browsing taxa Naso unicornis and Kyphosus vaigiensis, two species which are known to be important in removing macroalgae and which may be capable of reversing algal outbreaks. However, resident individuals at the site of algal increase exhibited no change in their movements. Instead, analysis of the size classes of the responding individuals indicates that large functionally-important nonresident individuals changed their movement patterns to move in and feed on the algae. This suggests that local-scale reef processes may not be sufficient to mitigate the effects of local degradation and highlights the importance of mobile links and cross-scale interactions.	[Welsh, Justin Q.] MSci Pty Ltd, Perth, WA, Australia; [Welsh, Justin Q.; Bellwood, David R.] James Cook Univ, Australian Res Council Ctr Excellence Coral Reef, Townsville, Qld 4811, Australia; [Welsh, Justin Q.; Bellwood, David R.] James Cook Univ, Coll Marine & Environm Sci, Townsville, Qld 4811, Australia	James Cook University; James Cook University	Welsh, JQ (corresponding author), MSci Pty Ltd, Perth, WA, Australia.	Justin.Welsh@my.jcu.edu.au			Australian Museum, Lizard Island Doctoral Fellowship; Australian Research Council-Centres of Excellence ARC Centre of Excellence	Australian Museum, Lizard Island Doctoral Fellowship; Australian Research Council-Centres of Excellence ARC Centre of Excellence(Australian Research Council)	JQW received funding from the Australian Museum, Lizard Island Doctoral Fellowship. (URL: http://australianmuseum.net.au/doctoral-fellowships) DRB received funding from Australian Research Council-Centres of Excellence ARC Centre of Excellence for Integrated Coral Reef Studies. (URL: http://www.coralcoe.org.au) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonso P, 2009, MAR ECOL PROG SER, V381, P273, DOI 10.3354/meps07946; Bejarano S, 2013, MAR ECOL PROG SER, V482, P197, DOI 10.3354/meps10270; Bellwood DR, 2006, CURR BIOL, V16, P2434, DOI 10.1016/j.cub.2006.10.030; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Bellwood DR, 2011, P ROYAL SOC B; Brandl SJ, 2013, J FISH BIOL, V82, P2031, DOI 10.1111/jfb.12131; BRUGGEMANN JH, 1994, MAR ECOL PROG SER, V112, P51, DOI 10.3354/meps112051; Burgess SC, 2006, CORAL REEFS, V25, P390, DOI 10.1007/s00338-006-0108-7; Burkepile DE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008963; Ceccarelli DM, 2011, J EXP MAR BIOL ECOL, V399, P60, DOI 10.1016/j.jembe.2011.01.019; Cheal A, 2012, MAR BIOL, V159, P1143, DOI 10.1007/s00227-012-1893-x; Chong-Seng KM, 2014, CORAL REEFS, V33, P409, DOI 10.1007/s00338-014-1134-5; Chong-Seng KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042167; Couvreur M, 2004, APPL VEG SCI, V7, P229, DOI 10.1111/j.1654-109X.2004.tb00614.x; COX PA, 1991, CONSERV BIOL, V5, P448, DOI 10.1111/j.1523-1739.1991.tb00351.x; Cvitanovic C, 2009, CORAL REEFS, V28, P127, DOI 10.1007/s00338-008-0433-0; Duncan RS, 1999, ECOL APPL, V9, P998, DOI 10.1890/1051-0761(1999)009[0998:SDAPFS]2.0.CO;2; Eristhee N, 2001, J FISH BIOL, V59, P129, DOI 10.1006/jfbi.2001.1754; Fox RJ, 2011, FUNCT ECOL, V25, P1096, DOI 10.1111/j.1365-2435.2011.01874.x; Friedlander AM, 2007, MAR ECOL PROG SER, V351, P221, DOI 10.3354/meps07112; Graham NAJ, 2006, P NATL ACAD SCI USA, V103, P8425, DOI 10.1073/pnas.0600693103; Green A.L., 2009, MONITORING FUNCTIONA; HAY ME, 1981, AM NAT, V118, P520, DOI 10.1086/283845; Henry M, 2007, J ANIM ECOL, V76, P801, DOI 10.1111/j.1365-2656.2007.01258.x; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hoey AS, 2010, MAR ECOL PROG SER, V411, P299, DOI 10.3354/meps08660; Hoey AS, 2011, ECOL LETT, V14, P267, DOI 10.1111/j.1461-0248.2010.01581.x; Hoey AS, 2009, ECOSYSTEMS, V12, P1316, DOI 10.1007/s10021-009-9291-z; Hughes TP, 2007, CURR BIOL, V17, P360, DOI 10.1016/j.cub.2006.12.049; Ishii HT, 2004, FOREST SCI, V50, P342; Khalil MT, 2013, ENVIRON BIOL FISH, V96, P1065, DOI 10.1007/s10641-012-0103-5; Lefevre CD, 2010, MAR BIOL, V157, P955, DOI 10.1007/s00227-009-1376-x; LEWIS SM, 1985, J EXP MAR BIOL ECOL, V87, P215, DOI 10.1016/0022-0981(85)90206-0; Long SP, 2013, GLOBAL CHANGE BIOL, V19, P1, DOI 10.1111/gcb.12101; Lundberg J, 2003, ECOSYSTEMS, V6, P87, DOI 10.1007/s10021-002-0150-4; Marshell A, 2011, CORAL REEFS, V30, P631, DOI 10.1007/s00338-011-0770-2; McClanaban TR, 1999, CORAL REEFS, V18, P195, DOI 10.1007/s003380050181; McKinney JA, 2012, MAR ECOL PROG SER, V458, P199, DOI 10.3354/meps09777; Meyer CG, 2005, ENVIRON BIOL FISH, V73, P201, DOI 10.1007/s10641-005-0559-7; Muscarella R, 2007, BIOL REV, V82, P573, DOI 10.1111/j.1469-185X.2007.00026.x; Nash KL, 2013, ECOL APPL, V23, P1632, DOI 10.1890/12-2031.1; Nathan R, 2006, SCIENCE, V313, P786, DOI 10.1126/science.1124975; Olds AD, 2012, J APPL ECOL, V49, P1195, DOI 10.1111/jpe.12002; Pardini R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013666; Polovina JJ, 1996, FISH OCEANOGR, V5, P114, DOI 10.1111/j.1365-2419.1996.tb00110.x; Pomilla C, 2005, BIOL LETTERS, V1, P476, DOI 10.1098/rsbl.2005.0351; Rasher DB, 2013, ECOLOGY, V94, P1347, DOI 10.1890/12-0389.1; Verges A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017115; Welsh JQ, 2014, CORAL REEFS, V33, P303, DOI 10.1007/s00338-014-1124-7; Welsh JQ, 2012, CORAL REEFS, V31, P693, DOI 10.1007/s00338-012-0892-1; Welsh JQ, 2012, CORAL REEFS, V31, P55, DOI 10.1007/s00338-011-0813-8; Wilson SK, 2008, GLOBAL CHANGE BIOL, V14, P2796, DOI 10.1111/j.1365-2486.2008.01696.x; Wismer S, 2009, MAR ECOL PROG SER, V376, P45, DOI 10.3354/meps07790; Wunderle JM, 1997, FOREST ECOL MANAG, V99, P223, DOI 10.1016/S0378-1127(97)00208-9	54	9	9	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132895	10.1371/journal.pone.0132895	http://dx.doi.org/10.1371/journal.pone.0132895			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26171788	Green Submitted, gold, Green Accepted, Green Published			2022-12-26	WOS:000358194900098
J	Zhang, H; Wang, WQ; Liu, SJ; Moller, IM; Song, SQ				Zhang, Hong; Wang, Wei-Qing; Liu, Shu-Jun; Moller, Ian Max; Song, Song-Quan			Proteome Analysis of Poplar Seed Vigor	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; RIPARIAN COTTONWOODS; EXPRESSION ANALYSIS; INSTREAM FLOWS; ACTIVE OXYGEN; GENE FAMILY; ARABIDOPSIS; GERMINATION; DETERIORATION; GLUTATHIONE	Seed vigor is a complex property that determines the seed's potential for rapid uniform emergence and subsequent growth. However, the mechanism for change in seed vigor is poorly understood. The seeds of poplar (Populus x Canadensis Moench), which are short-lived, were stored at 30 degrees C and 75 +/- 5% relative humidity for different periods of time (0-90 days) to obtain different vigor seeds (from 95 to 0% germination). With decreasing seed vigor, the temperature range of seed germination became narrower; the respiration rate of the seeds decreased markedly, while the relative electrolyte leakage increased markedly, both levelling off after 45 days. A total of 81 protein spots showed a significant change in abundance (>= 1.5-fold, P < 0.05) when comparing the proteomes among seeds with different vigor. Of the identified 65 proteins, most belonged to the groups involved in metabolism (23%), protein synthesis and destination (22%), energy (18%), cell defense and rescue (17%), and storage protein (15%). These proteins accounted for 95% of all the identified proteins. During seed aging, 53 and 6 identified proteins consistently increased and decreased in abundance, respectively, and they were associated with metabolism (22%), protein synthesis and destination (22%), energy (19%), cell defense and rescue (19%), storage proteins (15%), and cell growth and structure (3%). These data show that the decrease in seed vigor (aging) is an energy-dependent process, which requires protein synthesis and degradation as well as cellular defense and rescue.	[Zhang, Hong; Wang, Wei-Qing; Liu, Shu-Jun; Song, Song-Quan] Chinese Acad Sci, Inst Bot, Key Lab Plant Resources, Beijing, Peoples R China; [Moller, Ian Max] Aarhus Univ, Dept Mol Biol & Genet, Slagelse, Denmark	Chinese Academy of Sciences; Institute of Botany, CAS; Aarhus University	Song, SQ (corresponding author), Chinese Acad Sci, Inst Bot, Key Lab Plant Resources, Beijing, Peoples R China.	sqsong@ibcas.ac.cn			National Science Foundation of China [31300529, 31171624]; National Science and Technology Support Program [2012BAC01B05]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Support Program	Funds for this study were provided by the National Science Foundation of China (31300529, 31171624) and the National Science and Technology Support Program (2012BAC01B05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, INT RUL SEED TEST; Aylott MJ, 2008, NEW PHYTOL, V178, P358, DOI 10.1111/j.1469-8137.2008.02396.x; Bailly C, 2004, SEED SCI RES, V14, P93, DOI 10.1079/SSR2004159; Bailly C, 2001, J EXP BOT, V52, P701, DOI 10.1093/jexbot/52.357.701; Bailly C, 1996, PHYSIOL PLANTARUM, V97, P104, DOI 10.1111/j.1399-3054.1996.tb00485.x; Bevan M, 1998, NATURE, V391, P485, DOI 10.1038/35140; Bewley J. D., 2013, SEEDS, DOI [10.1017/S0960258513000287, DOI 10.1007/978-1-4614-4693-4_1]; Bleicheret F, 2010, CRIT REV BIOCHEM MOL, V45, P331, DOI 10.3109/10409238.2010.496772; Borset O., 1960, Scottish Forestry, V14, P68; Bove J, 2005, PLANT MOL BIOL, V57, P593, DOI 10.1007/s11103-005-0953-8; Braatne JH, 2007, RIVER RES APPL, V23, P247, DOI 10.1002/rra.978; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Campanini B, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/353270; Catusse J, 2011, PROTEOMICS, V11, P1569, DOI 10.1002/pmic.201000586; Cheng HY, 2008, J INTEGR PLANT BIOL, V50, P1549, DOI 10.1111/j.1744-7909.2008.00723.x; Cheng LB, 2010, MOL BREEDING, V26, P1, DOI 10.1007/s11032-009-9371-y; Chepyshko H, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-309; Chu P, 2012, PLANTA, V235, P1271, DOI 10.1007/s00425-011-1573-y; DELOUCHE J C, 1973, Seed Science and Technology, V1, P427; Dixon DP, 2011, BIOCHEM J, V438, P63, DOI 10.1042/BJ20101884; DURE L, 1993, PLANT J, V3, P363, DOI 10.1046/j.1365-313X.1993.t01-18-00999.x; Gallardo K, 2001, PLANT PHYSIOL, V126, P835, DOI 10.1104/pp.126.2.835; Ginting EL, 2014, PREP BIOCHEM BIOTECH, V44, P480, DOI 10.1080/10826068.2013.833114; Gonzalez E, 2010, TREES-STRUCT FUNCT, V24, P151, DOI 10.1007/s00468-009-0388-y; Hayano T, 2003, J BIOL CHEM, V278, P34309, DOI 10.1074/jbc.M304304200; He XMM, 2002, ANNU REV BIOCHEM, V71, P701, DOI 10.1146/annurev.biochem.71.110601.135339; Hendry George A. F., 1993, Seed Science Research, V3, P141, DOI 10.1017/S0960258500001720; HEYDECKER W, 1973, NATURE, V246, P42, DOI 10.1038/246042a0; Huang H, 2009, J INTEGR PLANT BIOL, V51, P67, DOI 10.1111/j.1744-7909.2008.00772.x; Huang H, 2012, J PROTEOMICS, V75, P1247, DOI 10.1016/j.jprot.2011.10.036; Hyndman D, 2003, CHEM-BIOL INTERACT, V143, P621, DOI 10.1016/S0009-2797(02)00193-X; Jin Y, 2007, ANNU REV PHARMACOL, V47, P263, DOI 10.1146/annurev.pharmtox.47.120505.105337; Job C, 2005, PLANT PHYSIOL, V138, P790, DOI 10.1104/pp.105.062778; Kalemba EM, 2008, ENVIRON EXP BOT, V63, P274, DOI 10.1016/j.envexpbot.2007.12.011; Karrenberg S, 2003, AM J BOT, V90, P749, DOI 10.3732/ajb.90.5.749; Kawai K, 2010, PLANT BIOTECHNOL-NAR, V27, P75, DOI 10.5511/plantbiotechnology.27.75; Kermode Allison R., 2002, P149, DOI 10.1079/9780851995342.0149; Kermode AR., 1997, SEED SCI RES; Kim HM, 2011, BBA-GENE REGUL MECH, V1809, P67, DOI 10.1016/j.bbagrm.2010.08.008; Kupper M, 2014, FEMS MICROBIOL LETT, V353, P1, DOI 10.1111/1574-6968.12390; Mazorra-Manzano MA, 2010, PHYTOCHEMISTRY, V71, P515, DOI 10.1016/j.phytochem.2009.12.005; McDonald MB, 1999, SEED SCI TECHNOL, V27, P177; McDonald MB, 2000, SEED TECHNOLOGY ITS, P287; Miernyk JA, 2011, J PROTEOMICS, V74, P389, DOI 10.1016/j.jprot.2010.12.004; Miyazono K, 2009, NATURE, V462, P609, DOI 10.1038/nature08583; Moller IM, 2007, ANNU REV PLANT BIOL, V58, P459, DOI 10.1146/annurev.arplant.58.032806.103946; Moss EH, 1937, BOT GAZ, V99, P529; Nambara E, 2010, SEED SCI RES, V20, P55, DOI 10.1017/S0960258510000012; Noctor G, 1998, ANNU REV PLANT PHYS, V49, P249, DOI 10.1146/annurev.arplant.49.1.249; Nonogaki H, 2010, PLANT SCI, V179, P574, DOI 10.1016/j.plantsci.2010.02.010; Ohta D, 2000, PLANT PHYSIOL, V122, P907, DOI 10.1104/pp.122.3.907; Pedreno S, 2012, BIOCHEMISTRY-US, V51, P8027, DOI 10.1021/bi300808b; Priestley D.A., 1986, SEED AGING IMPLICATI; Prieto-Dapena P, 2006, PLANT PHYSIOL, V142, P1102, DOI 10.1104/pp.106.087817; Rabbani N, 2014, BIOCHEM SOC T, V42, P419, DOI 10.1042/BST20140008; Rajjou L, 2007, SEEDS: BIOLOGY, DEVELOPMENT AND ECOLOGY, P324, DOI 10.1079/9781845931971.0324; Rajjou L, 2008, PLANT PHYSIOL, V148, P620, DOI 10.1104/pp.108.123141; Rajjou L, 2006, PLANT PHYSIOL, V141, P910, DOI 10.1104/pp.106.082057; Rajjou L, 2012, ANNU REV PLANT BIOL, V63, P507, DOI 10.1146/annurev-arplant-042811-105550; ROOD SB, 1995, CAN J BOT, V73, P1250, DOI 10.1139/b95-136; Sanhewe AJ, 1996, J EXP BOT, V47, P949, DOI 10.1093/jxb/47.7.949; Schiltz S, 2004, PLANT PHYSIOL, V135, P2241, DOI 10.1104/pp.104.041947; Schimoler-O'Rourke R, 2001, APPL ENVIRON MICROB, V67, P2365, DOI 10.1128/AEM.67.5.2365-2366.2001; Seabra AR, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-137; Sun WN, 2002, BBA-GENE STRUCT EXPR, V1577, P1, DOI 10.1016/S0167-4781(02)00417-7; Taiz L., 2014, PLANT PHYSL DEV, V6th; Tekrony DM, 1997, CURR PLANT SCI BIOT, V30, P593; Tiwari S, 2008, PLANT CELL, V20, P2387, DOI 10.1105/tpc.108.061929; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; VIERLING E, 1991, ANNU REV PLANT PHYS, V42, P579, DOI 10.1146/annurev.pp.42.060191.003051; Walters C., 2006, ENCY SEEDS SCI TECHN, P137; Wang LQ, 2012, J PROTEOMICS, V75, P2109, DOI 10.1016/j.jprot.2012.01.007; Wang WQ, 2015, PLANT PHYSIOL BIOCH, V86, P1, DOI 10.1016/j.plaphy.2014.11.003; Wang WQ, 2014, J PROTEOME RES, V13, P606, DOI 10.1021/pr4007574; Wang WQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062868; Weitbrecht K, 2011, J EXP BOT, V62, P3289, DOI 10.1093/jxb/err030; Wu HM, 2012, BIOLOGIA, V67, P48, DOI 10.2478/s11756-011-0164-5; Xin X, 2011, PHYSIOL PLANTARUM, V143, P126, DOI 10.1111/j.1399-3054.2011.01497.x; Yacoubi R, 2011, J PROTEOME RES, V10, P3891, DOI 10.1021/pr101274f; Zhao Y, 1996, PLANT PHYSIOL, V111, P1299, DOI 10.1104/pp.111.4.1299	80	28	31	4	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132509	10.1371/journal.pone.0132509	http://dx.doi.org/10.1371/journal.pone.0132509			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26172265	Green Published, gold, Green Submitted			2022-12-26	WOS:000358194900055
J	Ma, XY; Zhang, Y; Zhu, D; Lu, Y; Zhou, GD; Liu, W; Cao, YL; Zhang, WJ				Ma, Xiao Yun; Zhang, Yun; Zhu, Dan; Lu, Yang; Zhou, Guangdong; Liu, Wei; Cao, Yilin; Zhang, Wen Jie			Corneal Stroma Regeneration with Acellular Corneal Stroma Sheets and Keratocytes in a Rabbit Model	PLOS ONE			English	Article							PENETRATING KERATOPLASTY; SCAFFOLDS; TRANSPLANTATION; RECONSTRUCTION; CONSTRUCTION; CELLS	Acellular corneal stroma matrix has been used for corneal stroma engineering. However, because of its compact tissue structure, regrowth of keratocytes into the scaffold is difficult. Previously, we developed a sandwich model for cartilage engineering using acellular cartilage sheets. In the present study, we tested this model for corneal stroma regeneration using acellular porcine corneal stroma (APCS) sheets and keratocytes. Porcine corneas were decellularized by NaCl treatment, and the APCS was cut into 20-mu m-thick sheets. A rabbit corneal stroma defect model was created by lamellar keratoplasty and repaired by transplantation of five pieces of APCS sheets with keratocytes. Six months after transplantation, transparent corneas were present in the experimental group, which were confirmed by anterior segment optical coherence tomography examination and transmittance examination. The biomechanical properties in the experimental group were similar to those of normal cornea. Histological analyses showed an even distribution of keratocytes and well-oriented matrix in the stroma layer in the experimental group. Together, these results demonstrated that the sandwich model using acellular corneal stroma sheets and keratocytes could be potentially useful for corneal stroma regeneration.	[Ma, Xiao Yun; Lu, Yang; Zhou, Guangdong; Liu, Wei; Cao, Yilin; Zhang, Wen Jie] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 9, Sch Med,Natl Tissue Engn Ctr China, Dept Plast & Reconstruct Surg,Shanghai Key Lab Ti, Shanghai 200030, Peoples R China; [Ma, Xiao Yun; Zhang, Yun; Zhu, Dan] Shanghai Guanghua Integrat Med Hosp, Dept Ophthalmol, Shanghai, Peoples R China	Shanghai Jiao Tong University	Cao, YL (corresponding author), Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 9, Sch Med,Natl Tissue Engn Ctr China, Dept Plast & Reconstruct Surg,Shanghai Key Lab Ti, Shanghai 200030, Peoples R China.	yilincao@yahoo.com; wenjieboshi@aliyun.cn		Ljubimov, Alexander/0000-0003-2398-5319	Major State Basic Research Development Program of China [2011CB964704]; National Basic Research Program of China [30800231, 31170944]	Major State Basic Research Development Program of China(National Basic Research Program of China); National Basic Research Program of China(National Basic Research Program of China)	This work was supported by the Major State Basic Research Development Program of China (2011CB964704), and the National Basic Research Program of China (30800231, 31170944).	Ahearne M, 2008, TOP TISSUE ENG, V4, P1; Builles N, 2010, BIOMATERIALS, V31, P8313, DOI 10.1016/j.biomaterials.2010.07.066; Deshpande P, 2010, REGEN MED, V5, P395, DOI [10.2217/rme.10.16, 10.2217/RME.10.16]; Engelmayr GC, 2008, NAT MATER, V7, P1003, DOI 10.1038/nmat2316; Espandar L, 2013, J OPHTHALMOL, V2013, DOI 10.1155/2013/894319; Fagerholm P, 2014, BIOMATERIALS, V35, P2420, DOI 10.1016/j.biomaterials.2013.11.079; Fu Y, 2010, CELLS TISSUES ORGANS, V191, P193, DOI 10.1159/000235680; Germain L, 2000, PROG RETIN EYE RES, V19, P497, DOI 10.1016/S1350-9462(00)00005-7; Gong YY, 2011, BIOMATERIALS, V32, P2265, DOI 10.1016/j.biomaterials.2010.11.078; Gonzalez-Andrades M, 2011, INVEST OPHTH VIS SCI, V52, P215, DOI 10.1167/iovs.09-4773; Guan L, 2013, CELLS TISSUES ORGANS, V198, P190, DOI 10.1159/000355944; Hashimoto Y, 2010, BIOMATERIALS, V31, P3941, DOI 10.1016/j.biomaterials.2010.01.122; Javadi MA, 2010, CORNEA, V29, P365, DOI 10.1097/ICO.0b013e3181b81b71; Kadakia Arpita, 2008, Critical Reviews in Biomedical Engineering, V36, P441, DOI 10.1615/CritRevBiomedEng.v36.i5-6.50; KIM EY, 2014, INFLAMM REGEN, V34, P4; Liu W, 2003, TISSUE ENG, V9, pS17; Lynch AP, 2013, EXP EYE RES, V108, P42, DOI 10.1016/j.exer.2012.12.012; Meek KM, 2003, EYE, V17, P927, DOI 10.1038/sj.eye.6700574; Melles GRJ, 1999, BRIT J OPHTHALMOL, V83, P327, DOI 10.1136/bjo.83.3.327; Menon NG, 2003, ANN PLAS SURG, V50, P523, DOI 10.1097/01.SAP.0000044252.76804.6B; Myung D, 2008, BIOTECHNOL PROGR, V24, P735, DOI 10.1021/bp070476n; Oliva MS, 2012, INDIAN J OPHTHALMOL, V60, P423, DOI 10.4103/0301-4738.100540; Marquez SP, 2009, ACTA BIOMATER, V5, P1839, DOI 10.1016/j.actbio.2009.02.011; Schwab IR, 2000, CORNEA, V19, P421, DOI 10.1097/00003226-200007000-00003; Shah A, 2008, PEDIATR RES, V63, P535, DOI 10.1203/PDR.0b013e31816bdf54; SONODA Y, 1992, TRANSPLANTATION, V54, P694, DOI 10.1097/00007890-199210000-00026; Tan DTH, 2012, LANCET, V379, P1749, DOI 10.1016/S0140-6736(12)60437-1; Uzunalli G, 2014, ACTA BIOMATER, V10, P1156, DOI 10.1016/j.actbio.2013.12.002; Whitcher JP, 2001, B WORLD HEALTH ORGAN, V79, P214; Williams KA, 2010, CLIN EXP OPHTHALMOL, V38, P93, DOI 10.1111/j.1442-9071.2009.02179.x; Wilson SL, 2013, J FUNCT BIOMATER, V4, P114, DOI 10.3390/jfb4030114; Wu Z, 2009, BIOMATERIALS, V30, P3513, DOI 10.1016/j.biomaterials.2009.03.003; Xiao JH, 2011, BIOMATERIALS, V32, P6962, DOI 10.1016/j.biomaterials.2011.05.084; Xie LX, 2007, CORNEA, V26, P1070, DOI 10.1097/ICO.0b013e318093de07; Yang ZQ, 2010, TISSUE ENG PART C-ME, V16, P865, DOI [10.1089/ten.tec.2009.0444, 10.1089/ten.TEC.2009.0444]; Zhang YQ, 2008, TISSUE ENG PT A, V14, P295, DOI 10.1089/tea.2007.0200	36	16	16	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0132705	10.1371/journal.pone.0132705	http://dx.doi.org/10.1371/journal.pone.0132705			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26167895	Green Submitted, Green Published, gold			2022-12-26	WOS:000358193100068
J	Ota, RR; Message, HJ; da Graca, WJ; Pavanelli, CS				Ota, Renata Rubia; Message, Hugo Jose; da Graca, Weferson Junio; Pavanelli, Carla Simone			Neotropical Siluriformes as a Model for Insights on Determining Biodiversity of Animal Groups	PLOS ONE			English	Article							ECOLOGY; FISHES	We performed an analysis of the descriptions of new species of Neotropical Siluriformes (catfishes) to estimate the number of new species that remain to be described for a complete knowledge on biodiversity of this order, to verify the effectiveness of taxonomic support, and to identify trends and present relevant information for future policies. We conducted a literature review of species descriptions between January 1990 and August 2014. The following metadata were recorded from each article: year of publication, number of species, journal and impact factor, family(s) of the described species, number of authors, age of the authors and coauthors, country of the first author's institution and ecoregion of the type-locality. From accumulation of descriptions, we built an estimate model for number of species remaining to be described. We found 595 described species in 402 articles. The data demonstrated that there has been an increased understanding of the diversity of Siluriformes over the last 25 years in the Neotropical region, although 35% of the species still remain to be described. The model estimated that with the current trends and incentives, the biodiversity will be known in almost seven decades. We have reinforced the idea that greater joint efforts should be made by society and the scientific community to obtain this knowledge in a shorter period of time through enhanced programs for promoting science, training and the advancement of professionals before undiscovered species become extinct. The model built in this study can be used for similar estimates of other groups of animals.	[Ota, Renata Rubia; Message, Hugo Jose; da Graca, Weferson Junio; Pavanelli, Carla Simone] Univ Estadual Maringa, Res Ctr Limnol Ichthyol & Aquaculture, Nupelia, Maringa, Parana, Brazil; [da Graca, Weferson Junio] Univ Estadual Maringa, Dept Biol, Maringa, Parana, Brazil	Universidade Estadual de Maringa; Universidade Estadual de Maringa	Ota, RR (corresponding author), Univ Estadual Maringa, Res Ctr Limnol Ichthyol & Aquaculture, Nupelia, Maringa, Parana, Brazil.	renata_ota@yahoo.com.br	Fapesp, Biota/F-8655-2017; Pavanelli, Carla/G-6399-2012; Graca, Weferson/D-8358-2013	Fapesp, Biota/0000-0002-9887-8449; Pavanelli, Carla/0000-0003-4059-984X; Graca, Weferson/0000-0002-8925-5629	National Counsel of Technological and Scientific Development (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq); Brazilian Federal Agency for Support and Evaluation of Graduate Education (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES/Proex)	National Counsel of Technological and Scientific Development (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Brazilian Federal Agency for Support and Evaluation of Graduate Education (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES/Proex)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The authors thank the National Counsel of Technological and Scientific Development (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq http://www.cnpq.br/) for granting scholarship and providing grant to RRO and CSP, respectively. The authors also thank the Brazilian Federal Agency for Support and Evaluation of Graduate Education (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES/Proex http://www.capes.gov.br/) for providing a scholarship to HJM and the Araucaria Foundation	Abell R, 2008, BIOSCIENCE, V58, P403, DOI 10.1641/B580507; Agostinho A.A., 2004, STRUCTURE FUNCTIONIN; Agostinho CS, 2009, RESERVATORIO PEIXE A; Albert JS, 2011, HISTORICAL BIOGEOGRAPHY OF NEOTROPICAL FRESHWATER FISHES, P3; [Anonymous], 2002, NATURE, V419, P863, DOI 10.1038/419863a; Armbruster JW, 2011, AM FISH S S, V77, P15; BOHLKE J E, 1978, Acta Amazonica, V8, P657; Braga RR, 2012, REV FISH BIOL FISHER, V22, P915, DOI 10.1007/s11160-012-9273-7; Brown J. H., 1998, BIOGEOGRAPHY; Castro RMC, 2004, BIOTA NEOTROP, P4; Costello MJ, 2011, GLOBAL ECOL BIOGEOGR, V20, P319, DOI 10.1111/j.1466-8238.2010.00603.x; De Carvalho MR, 2014, CLADISTICS, V30, P322, DOI 10.1111/cla.12045; de Carvalho MR, 2005, SCIENCE, V307, P353; Dubois Alain, 2010, Taprobanica, V2, P6; Ebach MC, 2011, CLADISTICS, V27, P550, DOI 10.1111/j.1096-0031.2011.00348.x; Eschmeyer W.N., 2014, CATALOG FISHES GENER; Eschmeyer WN, 2014, SPECIES FISHES FAMIL; Ferraris Carl J. Jr., 2007, Zootaxa, V1418, P1; Ferraris Jr. Carl J., 2005, Neotrop. ichthyol., V3, P453, DOI 10.1590/S1679-62252005000400001; Fontaine B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036881; Froese R., 2014, FISHBASE; Ghazzi MS., 2007, CATALOGO ESPECIES PE; Gotelli NJ, 2008, PRIMER ECOLOGY, V4th; Joppa LN, 2011, TRENDS ECOL EVOL, V26, P551, DOI 10.1016/j.tree.2011.07.010; Kullander S.O., 2003, CHECK LIST FRESHWATE, P605; Langeani F., 2007, BIOTA NEOTROP, V7, P1, DOI DOI 10.1590/S1676-06032007000300020; Leveque C, 2008, HYDROBIOLOGIA, V595, P545, DOI 10.1007/s10750-007-9034-0; Linnaeus C, 1758, SYSTEMA NATURAE; Lohrmann V, 2012, TAXONOMISCHE FORSCHU; Lomolino M.V., 2010, BIOGEOGRAPHY, Vfourth; Lomolino MV, 2004, FRONTIERS OF BIOGEOGRAPHY: NEW DIRECTIONS IN THE GEOGRAPHY OF NATURE, P1; Lundberg JG, 2000, ANN MO BOT GARD, V87, P26, DOI 10.2307/2666207; Man JP, 2004, EUR J EPIDEMIOL, V19, P811; Marques Antonio Carlos, 2006, Pap. Avulsos Zool. (São Paulo), V46, P139, DOI 10.1590/S0031-10492006001300001; Menezes NA, 2007, PEIXES AGUA DOCE MAT; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Pavanelli CS., 2007, PEIXES PLANICIE INUN; R Core Team, 2021, R LANGUAGE ENV STAT; Sabaj Perez MH, 2003, ALL CATFISH SPECIES; Santos G. M., 2004, PEIXES BAIXO RIO TOC; Thomaz SM, 2004, BIO INL WAT, P75; Vari Richard P., 1998, P1; Wheeler QD, 2004, SCIENCE, V303, P285, DOI 10.1126/science.303.5656.285	43	31	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0132913	10.1371/journal.pone.0132913	http://dx.doi.org/10.1371/journal.pone.0132913			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26168270	Green Published, Green Submitted, gold			2022-12-26	WOS:000358193100097
J	Mayer, C; Bergholdt, R; Cucak, H; Rolin, BC; Sams, A; Rosendahl, A				Mayer, Christopher; Bergholdt, Regine; Cucak, Helena; Rolin, Bidda Charlotte; Sams, Anette; Rosendahl, Alexander			Neutralizing Anti-IL20 Antibody Treatment Significantly Modulates Low Grade Inflammation without Affecting HbA1c in Type 2 Diabetic db/db Mice	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; BETA-CELLS; OBESITY; IL-20; MACROPHAGES; EXPRESSION; INSULIN; GLUCOSE; INTERLEUKIN-20; HEMOGLOBIN	Low grade inflammation is present in pre-clinical and human type 2 diabetes. In this process, several cytokines like IL-1 beta and inflammatory cells like macrophages are activated and demonstrated to participate to the disease initiation and progression. IL-20 is a cytokine known to play non-redundant roles in progression of several inflammatory diseases. To address the therapeutic effect of inhibiting the IL-20 pathway in diabetes, diabetic db/db mice were treated with neutralizing anti-IL20 antibodies in vivo and both metabolic and inflammatory parameters were followed. Diabetic islets expressed the IL-20 cytokine and all IL-20 receptor components in elevated levels compared to resting non-diabetic islets. Islets were responsive to ex vivo IL-20 stimulation measured as SOCS induction and KC and IL-6 production. Neutralizing anti-IL20 treatment in vivo had no effect on HbA1c or weight although the slope of blood glucose increase was lowered. In contrast, anti-IL20 treatment significantly reduced the systemic low-grade inflammation and modulated the local pancreatic immunity. Significant reduction of the systemic IL-1 beta and MCP-1 was demonstrated upon anti-IL20 treatment which was orchestrated with a reduced RANTES, IL-16 and IL-2 but increased TIMP-1, MCP-1 and IL-6 protein expression locally in the pancreas. Interestingly, anti-IL20 treatment induced an expansion of the myeloid suppressor CD11bGr1(int) macrophage while reducing the number of CD8 T cells. Taken together, anti-IL20 treatment showed moderate effects on metabolic parameters, but significantly altered the low grade local and systemic inflammation. Hence, future combination therapies with anti-IL20 may provide beneficial therapeutic effects in type 2 diabetes through a reduction of inflammation.	[Mayer, Christopher; Bergholdt, Regine; Cucak, Helena; Sams, Anette; Rosendahl, Alexander] Novo Nordisk AS, Global Res, Dept Diabet Complicat Biol, Malov, Denmark; [Rolin, Bidda Charlotte] Novo Nordisk AS, Global Res, Dept Translat Pharmacol, Malov, Denmark	Novo Nordisk; Novo Nordisk	Rosendahl, A (corresponding author), Novo Nordisk AS, Dept Biopharmaceut New Haemophilia, DK-2820 Gentofte, Denmark.	alexander.rosendahl.axrd@gmail.com	Sams, Anette/R-1764-2016	Sams, Anette/0000-0002-9203-4333	Novo Nordisk	Novo Nordisk(Novo Nordisk)	Novo Nordisk provided support in the form of salaries for authors [BCR, CM, HC, RB, AS, AR], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	ANDERSEN L, 1993, CLIN CHEM, V39, P578; Arora M, 2011, INT IMMUNOPHARMACOL, V11, P827, DOI 10.1016/j.intimp.2011.01.034; Blumberg H, 2001, CELL, V104, P9, DOI 10.1016/S0092-8674(01)00187-8; Boni-Schnetzler M, 2008, J CLIN ENDOCR METAB, V93, P4065, DOI 10.1210/jc.2008-0396; Calderon B, 2008, J IMMUNOL, V181, P6964, DOI 10.4049/jimmunol.181.10.6964; Chen L, 2012, NAT REV ENDOCRINOL, V8, P228, DOI 10.1038/nrendo.2011.183; Chen WY, 2006, ARTERIOSCL THROM VAS, V26, P2090, DOI 10.1161/01.ATV.0000232502.88144.6f; Chiu YS, 2014, HEPATOLOGY, V60, P1003, DOI 10.1002/hep.27189; Cohen RM, 2008, CURR OPIN CLIN NUTR, V11, P512, DOI 10.1097/MCO.0b013e32830467bd; COLEMAN DL, 1982, DIABETES, V31, P1; Cucak H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107140; Cucak H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090685; Cucak H, 2014, J LEUKOCYTE BIOL, V95, P149, DOI 10.1189/jlb.0213075; De Filippo K, 2008, J IMMUNOL, V180, P4308, DOI 10.4049/jimmunol.180.6.4308; Eguchi K, 2012, CELL METAB, V15, P518, DOI 10.1016/j.cmet.2012.01.023; Ehses JA, 2009, P NATL ACAD SCI USA, V106, P13998, DOI 10.1073/pnas.0810087106; Fink LN, 2013, DIABETOLOGIA, V56, P1623, DOI 10.1007/s00125-013-2897-x; Fonseca VA, 2009, DIABETES CARE, V32, pS151, DOI 10.2337/dc09-S301; Hammer T, 2009, MICROVASC RES, V78, P25, DOI 10.1016/j.mvr.2009.02.007; Hempe JM, 2002, J DIABETES COMPLICAT, V16, P313, DOI 10.1016/S1056-8727(01)00227-6; Herder C, 2006, EUR J ENDOCRINOL, V154, P311, DOI 10.1530/eje.1.02090; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; HOTAMISLIGIL GS, 1994, DIABETES, V43, P1271, DOI 10.2337/diabetes.43.11.1271; Hsieh MY, 2006, GENES IMMUN, V7, P234, DOI 10.1038/sj.gene.6364291; Jenkins JK, 2002, AM J MED SCI, V323, P197, DOI 10.1097/00000441-200204000-00006; Jiang HW, 2007, DIABETES, V56, P49, DOI 10.2337/db06-0710; Kilpatrick ES, 1998, DIABETES CARE, V21, P261, DOI 10.2337/diacare.21.2.261; Kunz S, 2006, EXP DERMATOL, V15, P991, DOI 10.1111/j.1600-0625.2006.00516.x; Liu L, 2003, BLOOD, V102, P3206, DOI 10.1182/blood-2003-05-1419; Mandrup-Poulsen Thomas, 2012, Rev Diabet Stud, V9, P338, DOI 10.1900/RDS.2012.9.338; Meier JJ, 2006, DIABETOLOGIA, V49, P83, DOI 10.1007/s00125-005-0069-3; Musah S, 2012, TOXICOLOGY, V299, P125, DOI 10.1016/j.tox.2012.05.014; Packham DK, 2012, AM J KIDNEY DIS, V59, P75, DOI 10.1053/j.ajkd.2011.09.017; Shaul ME, 2010, DIABETES, V59, P1171, DOI 10.2337/db09-1402; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Simpson RJ, 1997, PROTEIN SCI, V6, P929, DOI 10.1002/pro.5560060501; Tritsaris K, 2007, P NATL ACAD SCI USA, V104, P15364, DOI 10.1073/pnas.0707302104; Tschopp J, 2003, NAT REV MOL CELL BIO, V4, P95, DOI 10.1038/nrm1019; Turnquist HR, 2011, J IMMUNOL, V187, P4598, DOI 10.4049/jimmunol.1100519; Uto-Konomi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040343; Vassiliou EK, 2009, LIPIDS HEALTH DIS, V8, DOI 10.1186/1476-511X-8-25; Virtue MA, 2004, DIABETES CARE, V27, P931, DOI 10.2337/diacare.27.4.931; Volk Hans-Dieter, 2001, Trends in Immunology, V22, P414, DOI 10.1016/S1471-4906(01)01985-8; Waight JD, 2013, J CLIN INVEST, V123, P4464, DOI 10.1172/JCI68189; Welsh N, 2005, DIABETES, V54, P3238, DOI 10.2337/diabetes.54.11.3238	45	6	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0131306	10.1371/journal.pone.0131306	http://dx.doi.org/10.1371/journal.pone.0131306			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26162095	Green Published, gold, Green Submitted			2022-12-26	WOS:000358162300033
J	Kraus, A; Anson, KJ; Raymond, LD; Martens, C; Groveman, BR; Dorward, DW; Caughey, B				Kraus, Allison; Anson, Kelsie J.; Raymond, Lynne D.; Martens, Craig; Groveman, Bradley R.; Dorward, David W.; Caughey, Byron			Prion Protein Prolines 102 and 105 and the Surrounding Lysine Cluster Impede Amyloid Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						amyloid; prion; prion disease; protein folding; protein structure; GSS; lysine; proline	IN-VITRO; TRANSGENIC MICE; HYDROGEN/DEUTERIUM EXCHANGE; ALZHEIMERS-DISEASE; PRP AMYLOIDS; MOUSE-BRAIN; SCRAPIE; MUTATION; CONFORMATION; MECHANISM	Background: We investigated how pathogenic prion protein mutations P102L and P105L lead to misfolding. Results: Mutations of these proline and adjacent lysine residues accelerated in vitro formation of amyloid with properties reminiscent of PrPSc. Conclusion: Specific proline and lysine residues might delay spontaneous prion disease by hindering PrP conversion into amyloid. Significance: These findings suggest mechanisms for genetic prion diseases. Human prion diseases can have acquired, sporadic, or genetic origins, each of which results in the conversion of prion protein (PrP) to transmissible, pathological forms. The genetic prion disease Gerstmann-Straussler-Scheinker syndrome can arise from point mutations of prolines 102 or 105. However, the structural effects of these two prolines, and mutations thereof, on PrP misfolding are not well understood. Here, we provide evidence that individual mutations of Pro-102 or Pro-105 to noncyclic aliphatic residues such as the Gerstmann-Straussler-Scheinker-linked leucines can promote the in vitro formation of PrP amyloid with extended protease-resistant cores reminiscent of infectious prions. This effect was enhanced by additional charge-neutralizing mutations of four nearby lysine residues comprising the so-called central lysine cluster. Substitution of these proline and lysine residues accelerated PrP conversion such that spontaneous amyloid formation was no longer slower than scrapie-seeded amyloid formation. Thus, Pro-102 and Pro-105, as well as the lysines in the central lysine cluster, impede amyloid formation by PrP, implicating these residues as key structural modulators in the conversion of PrP to disease-associated types of amyloid.	[Kraus, Allison; Anson, Kelsie J.; Raymond, Lynne D.; Groveman, Bradley R.; Caughey, Byron] NIAID, Persistent Viral Dis Lab, NIH, Hamilton, MT 59840 USA; [Martens, Craig; Dorward, David W.] NIAID, Res Technol Branch, Rocky Mt Labs, NIH, Hamilton, MT 59840 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Caughey, B (corresponding author), NIAID, Persistent Viral Dis Lab, NIH, Hamilton, MT 59840 USA.	bcaughey@nih.gov			National Institutes of Health Intramural Research Program of the NIAID; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000580, ZICAI001052] Funding Source: NIH RePORTER	National Institutes of Health Intramural Research Program of the NIAID; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Intramural Research Program of the NIAID. The authors declare that they have no conflicts of interest with the contents of this article.	Abalos GC, 2008, J BIOL CHEM, V283, P34021, DOI 10.1074/jbc.M804475200; Adzhubei AA, 2013, J MOL BIOL, V425, P2100, DOI 10.1016/j.jmb.2013.03.018; Biljan I, 2011, J MOL BIOL, V412, P660, DOI 10.1016/j.jmb.2011.07.067; Cappai R, 1999, BIOCHEMISTRY-US, V38, P3280, DOI 10.1021/bi982328z; CAUGHEY B, 1991, J VIROL, V65, P6597, DOI 10.1128/JVI.65.12.6597-6603.1991; CAUGHEY B, 1988, P NATL ACAD SCI USA, V85, P4657, DOI 10.1073/pnas.85.13.4657; CHOU PY, 1978, ANNU REV BIOCHEM, V47, P251, DOI 10.1146/annurev.bi.47.070178.001343; Cobb NJ, 2007, P NATL ACAD SCI USA, V104, P18946, DOI 10.1073/pnas.0706522104; Deleault NR, 2007, P NATL ACAD SCI USA, V104, P9741, DOI 10.1073/pnas.0702662104; Deleault NR, 2012, P NATL ACAD SCI USA, V109, P8546, DOI 10.1073/pnas.1204498109; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eichner T, 2011, MOL CELL, V41, P161, DOI 10.1016/j.molcel.2010.11.028; Eichner T, 2009, J MOL BIOL, V386, P1312, DOI 10.1016/j.jmb.2009.01.013; Fox Brian G, 2009, Curr Protoc Protein Sci, VChapter 5, DOI 10.1002/0471140864.ps0523s56; GHETTI B, 2003, NEURODEGENERATION MO, P318; Groveman BR, 2015, J BIOL CHEM, V290, P1119, DOI 10.1074/jbc.M114.619627; Groveman BR, 2014, J BIOL CHEM, V289, P24129, DOI 10.1074/jbc.M114.578344; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; HOPE J, 1988, EUR J BIOCHEM, V172, P271, DOI 10.1111/j.1432-1033.1988.tb13883.x; HSIAO KK, 1994, P NATL ACAD SCI USA, V91, P9126, DOI 10.1073/pnas.91.19.9126; HSIAO KK, 1990, SCIENCE, V250, P1587, DOI 10.1126/science.1980379; Ilc G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011715; Inouye H, 2000, J MOL BIOL, V300, P1283, DOI 10.1006/jmbi.2000.3926; IRONSIDE JW, 2008, GREENFIELDS NEUROPAT, P1197; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; Jones EM, 2006, J BIOL CHEM, V281, P8190, DOI 10.1074/jbc.M513417200; Kaneko K, 2000, J MOL BIOL, V295, P997, DOI 10.1006/jmbi.1999.3386; Lu PJ, 1999, NATURE, V399, P784; Lu XJ, 2007, P NATL ACAD SCI USA, V104, P1510, DOI 10.1073/pnas.0608447104; Manson JC, 1999, EMBO J, V18, P6855, DOI 10.1093/emboj/18.23.6855; Miller MB, 2013, STRUCTURE, V21, P2061, DOI 10.1016/j.str.2013.08.025; Nakamura K, 2012, CELL, V149, P232, DOI 10.1016/j.cell.2012.02.016; Noble GP, 2015, BIOCHEMISTRY-US, V54, P1180, DOI 10.1021/bi501495j; Pastorino L, 2006, NATURE, V440, P528, DOI 10.1038/nature04543; PRUSINER SB, 1984, CELL, V38, P127, DOI 10.1016/0092-8674(84)90533-6; Rauscher S, 2006, STRUCTURE, V14, P1667, DOI 10.1016/j.str.2006.09.008; Rogaeva E, 2006, ARCH NEUROL-CHICAGO, V63, P1016, DOI 10.1001/archneur.63.7.1016; Shen Y, 2010, J BIOMOL NMR, V46, P199, DOI 10.1007/s10858-009-9395-y; Smirnovas V, 2011, NAT STRUCT MOL BIOL, V18, P504, DOI 10.1038/nsmb.2035; Smirnovas V, 2009, J BIOL CHEM, V284, P24233, DOI 10.1074/jbc.M109.036558; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Tunnell E, 2008, NEUROLOGY, V71, P1431, DOI 10.1212/01.wnl.0000330237.94742.fa; Wan W, 2015, BIOPHYS J, V108, P1548, DOI 10.1016/j.bpj.2015.01.008; Wang F, 2010, BIOCHEMISTRY-US, V49, P8169, DOI 10.1021/bi101146v; Wang F, 2010, SCIENCE, V327, P1132, DOI 10.1126/science.1183748; Wilham JM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001217; Zahn R, 2000, P NATL ACAD SCI USA, V97, P145, DOI 10.1073/pnas.97.1.145	47	17	17	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2015	290	35					21510	21522		10.1074/jbc.M115.665844	http://dx.doi.org/10.1074/jbc.M115.665844			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ5IS	26175152	Green Published, hybrid			2022-12-26	WOS:000360637600026
J	Lung, RI; Suciu, M; Gasko, N; Dumitrescu, D				Lung, Rodica Ioana; Suciu, Mihai; Gasko, Noemi; Dumitrescu, D.			Characterization and Detection of epsilon-Berge-Zhukovskii Equilibria	PLOS ONE			English	Article							NASH; COMMUNITY; BEHAVIOR; EXISTENCE; LONG	The Berge-Zhukovskii equilibrium is an alternate solution concept in non-cooperative game theory that formalizes cooperation in a noncooperative setting. In this paper, the epsilon-Berge-Zhukovskii equilibrium is introduced and characterized by using a generative relation. The generative relation also provides a solution to the problem of computing the epsilon-Berge-Zhukovskii equilibrium for large games, by using evolutionary algorithms. Numerical examples illustrate the approach and provide a possible application for this equilibrium concept.	[Lung, Rodica Ioana] Univ Babes Bolyai, Fac Econ & Business Adm, R-3400 Cluj Napoca, Romania; [Suciu, Mihai; Gasko, Noemi; Dumitrescu, D.] Univ Babes Bolyai, Fac Math & Comp Sci, R-3400 Cluj Napoca, Romania	Babes Bolyai University from Cluj; Babes Bolyai University from Cluj	Gasko, N (corresponding author), Univ Babes Bolyai, Fac Econ & Business Adm, R-3400 Cluj Napoca, Romania.	gaskonomi@cs.ubbcluj.ro	lung, rodica ioana I/C-4716-2011; Suciu, Mihai/B-4564-2014; Gaskó, Noémi/C-6210-2012	Suciu, Mihai/0000-0003-0659-4594; Gasko, Noemi/0000-0002-3915-8986; Lung, Rodica Ioana/0000-0002-5572-8141	OPEN-RES Academic Writing project [212/2012]	OPEN-RES Academic Writing project	This work was supported by OPEN-RES Academic Writing project 212/2012 (http://econ.ubbcluj.ro/similar to rodica.lung/openres/).	Abalo K, 2005, APPL MATH COMPUT, V169, P624, DOI 10.1016/j.amc.2004.09.080; Abalo KY, 2006, APPL MATH COMPUT, V182, P1840, DOI 10.1016/j.amc.2006.06.021; Berge Claude, 1957, THEORIE GEN JEUX PER; Bochet O, 2006, J ECON BEHAV ORGAN, V60, P11, DOI 10.1016/j.jebo.2003.06.006; Colman AM, 2011, J MATH PSYCHOL, V55, P166, DOI 10.1016/j.jmp.2011.02.001; Courtois P, 2015, ECON PHILOS, V31, P123, DOI 10.1017/S026626711400042X; De Jong Kenneth A., 2006, EVOLUTIONARY COMPUTA, DOI 10.1145/1274000.1274109; Deb K, 2002, IEEE T EVOLUT COMPUT, V6, P182, DOI 10.1109/4235.996017; Dumitrescu D, 2009, LECT NOTES COMPUT SC, V5484, P253, DOI 10.1007/978-3-642-01129-0_29; Dumitrescu D., 2009, P 11 ANN C GENETIC E, P1507; Eiben AE, 2003, INTRO EVOLUTIONARY C, DOI 10.1007/978-3-662-44874-8; Fischbacher U, 2001, ECON LETT, V71, P397, DOI 10.1016/S0165-1765(01)00394-9; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Gasko N, 2011, COMPUTATIONAL INTELL; Gasko N, 2011, STUD COMPUT INTELL, V387, P149; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Lancichinetti A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018961; Lancichinetti A, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.016118; Lancichinetti A, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/3/033015; Larbani M, 2008, MATH SOC SCI, V55, P258, DOI 10.1016/j.mathsocsci.2007.07.004; Lung RI, 2008, INT J COMPUT COMMUN, V3, P364; Lung RI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086891; Lung RI, 2011, STUD COMPUT INTELL, V387, P195; Lung RI, 2011, STUD COMPUT INTELL, V387, P121; Lusseau D, 2003, BEHAV ECOL SOCIOBIOL, V54, P396, DOI 10.1007/s00265-003-0651-y; Muller L, 2008, J ECON BEHAV ORGAN, V67, P782, DOI 10.1016/j.jebo.2007.09.001; Murphy RO, 2006, EXP ECON, V9, P147, DOI 10.1007/s10683-006-7049-4; Musy O, 2012, INT GAME THEORY REV, V14, DOI 10.1142/S0219198912500053; NASH J, 1951, ANN MATH, V54, P286, DOI 10.2307/1969529; Nessah R, 2007, APPL MATH LETT, V20, P926, DOI 10.1016/j.aml.2006.09.005; Nessah R, 2014, J MATH ANAL APPL, V414, P871, DOI 10.1016/j.jmaa.2014.01.030; RADNER R, 1980, J ECON THEORY, V22, P136, DOI 10.1016/0022-0531(80)90037-X; Rosvall M, 2008, P NATL ACAD SCI USA, V105, P1118, DOI 10.1073/pnas.0706851105; Sales-Pardo M, 2007, P NATL ACAD SCI USA, V104, P15224, DOI 10.1073/pnas.0703740104; Van Veldhuizen D. A., 2007, EVOLUTIONARY ALGORIT, V5; ZACHARY WW, 1977, J ANTHROPOL RES, V33, P452, DOI 10.1086/jar.33.4.3629752; Zhukovskii Vladislav I., 1994, LINEAR QUADRATIC DIF	37	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0131983	10.1371/journal.pone.0131983	http://dx.doi.org/10.1371/journal.pone.0131983			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177217	gold, Green Published, Green Submitted			2022-12-26	WOS:000358197600074
J	Mundiyanapurath, S; Mohlenbruch, M; Ringleb, PA; Bosel, J; Wick, W; Bendszus, M; Radbruch, A				Mundiyanapurath, S.; Moehlenbruch, M.; Ringleb, P. A.; Boesel, J.; Wick, W.; Bendszus, M.; Radbruch, A.			Posterior Circulation Acute Stroke Prognosis Early Computed Tomography Score Using Hypointense Vessels on Susceptibility Weighted Imaging Independently Predicts Outcome in Patients with Basilar Artery Occlusion	PLOS ONE			English	Article							DIFFUSION LESION REVERSAL; MRI; THROMBOLYSIS; ANGIOGRAPHY	Purpose Appearance of hypointense vessels on susceptibility weighted imaging (SWI) has been reported to correlate with outcome in patients with ischemia of the anterior circulation. This study investigates the correlation between the appearance of hypointense vessels on SWI after recanalization therapy and outcome in patients with basilar artery occlusion. Methods Patients with basilar artery occlusion who were treated with endovascular recanalization or intravenous alteplase and received an MRI including SWI after therapy were retrieved from the hospital database for retrospective analysis. Posterior circulation Acute Stroke Prognosis Early Computed Tomography Score (pcASPECTS) was calculated based on regions displaying hypointense vessels on SWI and compared to lesions on diffusion weighted imaging (DWI). Subsequently, SWI based pcASPECTS was correlated with outcome determined with modified Rankin Scale (mRS), categorized as favorable outcome (mRS 0-2) or unfavorable outcome (3-6). Results Twenty-two MRI of patients with basilar artery occlusion were analyzed. In seven out of eight areas of the pcASPECTS hypointense vessels on SWI were significantly correlated to areas of restricted diffusion on DWI. In univariate analysis median pcASPECTS on SWI was significantly higher in patients with favorable outcome (7.5 vs. 5, p=0.02). In a multivariate analysis pcASPECTS on SWI was an independent predictor of favorable outcome (OR 2.02; CI [1.02; 3,99]; p=0.04). Conclusion pcASPECTS based on hypointense vessels on SWI after therapy predicts outcome in patients with basilar artery occlusion and might potentially be used as an additional imaging biomarker in the management of patients with stroke in the posterior circulation. This needs to be confirmed in larger prospective clinical trials.	[Mundiyanapurath, S.; Ringleb, P. A.; Boesel, J.; Wick, W.] Univ Heidelberg Hosp, Dept Neurol, Heidelberg, Germany; [Moehlenbruch, M.; Bendszus, M.; Radbruch, A.] Univ Heidelberg Hosp, Dept Neuroradiol, Heidelberg, Germany; [Radbruch, A.] German Canc Res Ctr, Dept Radiol, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ)	Radbruch, A (corresponding author), Univ Heidelberg Hosp, Dept Neuroradiol, Heidelberg, Germany.	a.radbruch@dkfz.de	Wick, Wolfgang/AAA-2545-2020; Radbruch, Alexander/ABA-6277-2021	Wick, Wolfgang/0000-0002-6171-634X; Radbruch, Alexander/0000-0001-6238-6525; Mundiyanapurath, Sibu/0000-0003-4637-4641				Hacke W, 2008, NEW ENGL J MED, V359, P1317, DOI 10.1056/NEJMoa0804656; Kim SJ, 2010, CEREBROVASC DIS, V29, P382, DOI 10.1159/000286340; Kohrmann M, 2009, STROKE, V40, P1897, DOI 10.1161/STROKEAHA.108.532838; Labeyrie MA, 2012, STROKE, V43, P2986, DOI 10.1161/STROKEAHA.112.661009; Lescher S, 2014, AM J NEURORADIOL, V35, P1942, DOI 10.3174/ajnr.A3981; Lindsberg PJ, 2012, ANN NY ACAD SCI, V1268, P35, DOI 10.1111/j.1749-6632.2012.06687.x; Lou M, 2014, AM J NEURORADIOL, V35, P2061, DOI 10.3174/ajnr.A4017; Mattle HP, 2011, LANCET NEUROL, V10, P1002, DOI 10.1016/S1474-4422(11)70229-0; Mittal S, 2009, AM J NEURORADIOL, V30, P232, DOI 10.3174/ajnr.A1461; Morita N, 2008, CEREBROVASC DIS, V26, P367, DOI 10.1159/000151640; Mucke J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120801; Nagel S, 2012, INT J STROKE, V7, P282, DOI 10.1111/j.1747-4949.2011.00705.x; Puetz V, 2008, STROKE, V39, P2485, DOI 10.1161/STROKEAHA.107.511162; Radbruch A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063459; Reichenbach JR, 2001, NMR BIOMED, V14, P453, DOI 10.1002/nbm.722; Reichenbach JR, 1997, RADIOLOGY, V204, P272, DOI 10.1148/radiology.204.1.9205259; Rochon J, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-81; Santhosh K, 2009, CLIN RADIOL, V64, P74, DOI 10.1016/j.crad.2008.04.022; Sehgal V, 2005, J MAGN RESON IMAGING, V22, P439, DOI 10.1002/jmri.20404; Soize S, 2015, STROKE, V46, P704, DOI 10.1161/STROKEAHA.114.008322; Sun W, 2014, EUR J NEUROL, V21, P1411, DOI 10.1111/ene.12510; Tisserand M, 2014, STROKE, V45, P1167, DOI 10.1161/STROKEAHA.113.004000; Xia S, 2014, MAGN RESON IMAGING, V32, P1272, DOI 10.1016/j.mri.2014.08.012	23	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132587	10.1371/journal.pone.0132587	http://dx.doi.org/10.1371/journal.pone.0132587			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176682	Green Submitted, Green Published, gold			2022-12-26	WOS:000358197600128
J	Rogowski, I; Creveaux, T; Triquigneaux, S; Mace, P; Gauthier, F; Sevrez, V				Rogowski, Isabelle; Creveaux, Thomas; Triquigneaux, Sylvain; Mace, Pierre; Gauthier, Fabien; Sevrez, Violaine			Tennis Racket Vibrations and Shock Transmission to the Wrist during Forehand Drive	PLOS ONE			English	Article							DAMPERS; IMPACTS; FOREARM; PERFORMANCE	This study aimed to investigate the effects of two different racket models and two different forehand drive velocities on the three-dimensional vibration behavior of the racket and shock transmission to the player's wrist under real playing conditions. Nine tennis players performed a series of crosscourt flat forehand drives at two velocities, using a lightly and a highly vibrant racket. Two accelerometers were fixed on the racket frame and the player's wrist. The analysis of vibration signals in both time and frequency domains showed no interaction effect of velocity and racket conditions either on the racket vibration behavior or on shock transmission. An increase in playing velocity enlarged the amount of vibrations at the racket and wrist, but weakly altered their frequency content. As compared to a racket perceived as highly vibrating, a racket perceived as lightly vibrating damped longer in the out-of-plane axis of the racket and shorter on the other axis of the racket and on the wrist, and displayed a lower amount of energy in the high frequency of the vibration signal at the racket and wrist. These findings indicated that the playing velocity must be controlled when investigating the vibration loads due to the racket under real playing conditions. Similarly, a reduced perception of vibration by the tennis player would be linked to decreased amplitude of the racket vibration signal, which may concentrate the signal energy in the low frequencies.	[Rogowski, Isabelle; Creveaux, Thomas; Sevrez, Violaine] Univ Lyon 1, Ctr Rech & Innovat Sport, EA 647, UFRSTAPS, F-69622 Villeurbanne, France; [Triquigneaux, Sylvain; Mace, Pierre; Gauthier, Fabien] Babolat VS, Lyon, France	UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Rogowski, I (corresponding author), Univ Lyon 1, Ctr Rech & Innovat Sport, EA 647, UFRSTAPS, F-69622 Villeurbanne, France.	isabelle.rogowski@univ-lyon1.fr		SEVREZ, Violaine/0000-0003-4697-3468	Agence Nationale pour la Recherche; "Pole de Competitivite Sporaltec" [ANR ACE] [2010-BLANC-901]; Babolat VS	Agence Nationale pour la Recherche(French National Research Agency (ANR)); "Pole de Competitivite Sporaltec" [ANR ACE](French National Research Agency (ANR)); Babolat VS	This work was funded by Agence Nationale pour la Recherche (www.agence-nationale-recherche.fr). Additional support was received from the "Pole de Competitivite Sporaltec" [ANR ACE no 2010-BLANC-901]. Co-authors Sylvain Triquigneaux, Pierre Mace and Fabien Gauthier are employed by Babolat VS. Babolat VS provided support in the form of salaries for authors ST, PM and FG, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Banwell G, 2012, TOPICS MOD ANAL, V6, P649; BRODY H, 1989, INT J SPORT BIOMECH, V5, P451, DOI 10.1123/ijsb.5.4.451; BRODY H, 1987, INT J SPORT BIOMECH, V3, P293, DOI 10.1123/ijsb.3.3.293; Creveaux T, 2014, COMPUT METHOD BIOMEC, V17, P150, DOI 10.1080/10255842.2014.931610; CROSS R, 1998, SPORTS ENG, V1, P63, DOI DOI 10.1046/J.1460-2687.1999.00011.X; Ferrara L, 2013, PROCEDIA ENGINEER, V60, P397, DOI 10.1016/j.proeng.2013.07.015; Genevois C, 2013, J STRENGTH COND RES, V27, P677, DOI 10.1519/JSC.0b013e31825c3290; HENNIG EM, 1992, MED SCI SPORT EXER, V24, P1134; Hennig EM, 2007, EXERC SPORT SCI REV, V35, P62; Howell DC, 2013, STAT METHOD PSYCHOL, P457; KNUDSON DV, 1991, J SPORT MED PHYS FIT, V31, P527; Li FX, 2004, J SPORT SCI, V22, P1041, DOI 10.1080/02640410410001729982; Nass D, 1998, P 16 INT S BIOM SPOR, P229; Sarvazyan A, 2014, MED HYPOTHESES, V83, P6, DOI 10.1016/j.mehy.2014.04.020; Stroede CL, 1999, J SPORT SCI, V17, P379, DOI 10.1080/026404199365894; Timme N, 2009, J ACOUST SOC AM, V125, P3650, DOI 10.1121/1.3126343; Wei SH, 2006, CLIN J SPORT MED, V16, P129, DOI 10.1097/00042752-200603000-00008	17	9	10	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132925	10.1371/journal.pone.0132925	http://dx.doi.org/10.1371/journal.pone.0132925			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177373	gold, Green Published, Green Submitted			2022-12-26	WOS:000358197600181
J	Vassbakk-Brovold, K; Berntsen, S; Fegran, L; Lian, H; Mjaland, O; Mjaland, S; Seiler, S; Kersten, C				Vassbakk-Brovold, Karianne; Berntsen, Sveinung; Fegran, Liv; Lian, Henrik; Mjaland, Odd; Mjaland, Svein; Seiler, Stephen; Kersten, Christian			Individualized Comprehensive Lifestyle Intervention in Patients Undergoing Chemotherapy with Curative or Palliative Intent: Who Participates?	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; CANCER-PATIENTS; BREAST; CARE	Objective Knowledge about determinants of participation in lifestyle interventions in cancer patients undergoing chemotherapy, particularly with palliative intent, remains poor. The objective of the present study was to identify determinants of participating in a 12 month individualized, comprehensive lifestyle intervention, focusing on diet, physical activity, mental stress and smoking cessation, in cancer patients receiving chemotherapy with curative or palliative intent. The secondary objective was to identify participation determinants 4 months into the study. Methods Newly diagnosed cancer patients starting chemotherapy at the cancer center in Kristiansand/Norway (during a 16 month inclusion period) were screened. Demographic and medical data (age, sex, body mass index, education level, marital status, smoking status, Eastern Cooperative Oncology Group performance status (ECOG), diagnosis, tumor stage and treatment intention) was analyzed for screened patients. Results 100 of 161 invited patients participated. There were more females (69 vs. 48%; P = 0.004), breast cancer patients (46 vs. 25%; P = 0.007), non-smokers (87 vs. 74%; P = 0.041), younger (mean age 60 vs. 67 yrs; P < 0.001) and fitter (82 vs. 64% with EGOC 0; P = 0.036) participants vs. non-participants included. In multivariate logistic regression analyses, age (Odds Ratio 0.94, 95% Confidence Interval 0.91, 0.97) and smoking (0.42, 0.18, 0.99) were negatively associated with participation. After 4 months, 63 participants were still participating. Cancer type, smoking and age increased the probability of dropping out. Multivariate logistic regression revealed that age was the only significant determinant of 4 month participation (0.95, 0.91, 0.99). Patients aged > 70 years were less likely to participate at baseline and 4 months. Conclusion Individualized lifestyle interventions in cancer patients undergoing chemotherapy appear to facilitate a high participation rate that declines with increasing age; both during the enrollment process and completing the intervention. Neither oncologic nor socioeconomic variables deterred participation.	[Vassbakk-Brovold, Karianne; Mjaland, Svein; Kersten, Christian] Southern Hosp Trust, Dept Oncol, Kristiansand, Norway; [Vassbakk-Brovold, Karianne; Berntsen, Sveinung; Seiler, Stephen] Univ Agder, Fac Hlth Sport Sci, Dept Publ Hlth Sport & Nutr, Kristiansand, Norway; [Fegran, Liv] Univ Agder, Fac Hlth & Sport Sci, Dept Hlth & Nursing Sci, Kristiansand, Norway; [Lian, Henrik] Southern Hosp Trust, Dept Phys Med & Prevent, Kristiansand, Norway; [Mjaland, Odd] Southern Hosp Trust, Dept Surg, Kristiansand, Norway	University of Agder; University of Agder	Vassbakk-Brovold, K (corresponding author), Southern Hosp Trust, Dept Oncol, Kristiansand, Norway.	karianne.vassbakk.brovold@sshf.no	fegran, liv/AAW-2160-2020	Fegran, Liv/0000-0001-5470-8686	Oddrun Mjaland Foundation for Cancer Research	Oddrun Mjaland Foundation for Cancer Research	The salary of the PhD-student was funded by the Oddrun Mjaland Foundation for Cancer Research (KVB). Grant number or URL to funders website is NA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamsen L, 2006, SUPPORT CARE CANCER, V14, P116, DOI 10.1007/s00520-005-0864-x; Adamsen L, 2009, BMJ, V339; Brubaker PH, 2014, CURR GERIATR REP, V3, P291, DOI 10.1007/s13670-014-0104-7; Buffart LM, 2014, CANCER TREAT REV, V40, P327, DOI 10.1016/j.ctrv.2013.06.007; Cancer Registry of Norway, 2013, CANC NORW 2011 CANC; Courneya K, 2008, INT J BEHAV NUTR PHY, V5; Courneya KS, 2008, MED SCI SPORT EXER, V40, P1180, DOI 10.1249/MSS.0b013e318168da45; Courneya KS, 2008, ANN BEHAV MED, V35, P116, DOI 10.1007/s12160-007-9009-4; Courneya KS, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/s12966-014-0085-0; Courneya KS, 2015, RES Q EXERC SPORTS, P1; DiaGraphIT AS-Clinical monitoring software, 2012, DIAGRAPHIT AS CLIN M; George SM, 2011, CANCER CAUSE CONTROL, V22, P589, DOI 10.1007/s10552-011-9732-9; Gibson TM, 2010, SEMIN ONCOL, V37, P282, DOI 10.1053/j.seminoncol.2010.05.011; Helsedirektoratet (The Norwegian Directorate of Health), 2011, KOSTR FREMM FOLK FOR; Helsedirektoratet (The Norwegian Directorate of Health), 2012, HELS PLAN SYST KUNNS; Hosmer DavidW., 2000, APPL LOGISTIC REGRES; Husebo AML, 2013, J CLIN NURS, V22, P4, DOI 10.1111/j.1365-2702.2012.04322.x; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kim HS, 2002, CANCER NURS, V25, P425, DOI 10.1097/00002820-200212000-00004; Kreftregisteret (Cancer Registry of Norway), 2014, FAKT OM KREFT; Lutgendorf SK, 2010, J CLIN ONCOL, V28, P4094, DOI 10.1200/JCO.2009.26.9357; Meyerhardt JA, 2006, J CLIN ONCOL, V24, P3535, DOI 10.1200/JCO.2006.06.0863; Midtgaard M, 2009, EUR J ONCOL NURS, V13, P116, DOI 10.1016/j.ejon.2009.01.006; Moller T, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003556; NIoP Health, 2010, SMOK SMOK TOB NORW F; Nordin K, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-167; Oldervoll Line M, 2005, Palliat Support Care, V3, P281; Oldervoll LM, 2006, J PAIN SYMPTOM MANAG, V31, P421, DOI 10.1016/j.jpainsymman.2005.10.004; Ornish D, 2008, LANCET ONCOL, V9, P1048, DOI 10.1016/S1470-2045(08)70234-1; Pekmezi DW, 2011, ACTA ONCOL, V50, P167, DOI 10.3109/0284186X.2010.529822; Rock Cheryl L, 2012, CA Cancer J Clin, V62, P243, DOI 10.3322/caac.21142; Rubin H, 2013, P NATL ACAD SCI USA, V110, P13927, DOI 10.1073/pnas.1312831110; Sallis J F, 1990, Exerc Sport Sci Rev, V18, P307; Schulz MD, 2014, NATURE, V514, P508, DOI 10.1038/nature13398; Shiels MS, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju294; Thomsen TG, 2010, J CLIN NURS, V19, P3410, DOI 10.1111/j.1365-2702.2009.03154.x; Tsianakas V, 2012, SUPPORT CARE CANCER, V20, P2639, DOI 10.1007/s00520-012-1470-3; Voerman B, 2007, PSYCHO-ONCOL, V16, P1092, DOI 10.1002/pon.1160; WHO, 2014, OB OV	39	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0131355	10.1371/journal.pone.0131355	http://dx.doi.org/10.1371/journal.pone.0131355			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1RL	26176950	Green Submitted, Green Published, gold			2022-12-26	WOS:000358197600041
J	Wormsbecker, AE; Wang, J; Rosella, LC; Kwong, JC; Seo, CY; Crowcroft, NS; Deeks, SL				Wormsbecker, Anne E.; Wang, Jun; Rosella, Laura C.; Kwong, Jeffrey C.; Seo, Chi Yon; Crowcroft, Natasha S.; Deeks, Shelley L.			Twenty Years of Medically-Attended Pediatric Varicella and Herpes Zoster in Ontario, Canada: A Population-Based Study	PLOS ONE			English	Article							VACCINATION PROGRAM; ACTIVE SURVEILLANCE; CARE OUTCOMES; UNITED-STATES; CHILDREN; EPIDEMIOLOGY; IMPACT; HOSPITALIZATIONS; IMPLEMENTATION; ADOLESCENTS	Objective To determine if reductions in medically-attended pediatric varicella and herpes zoster occurred in Ontario, Canada, after publicly-funded varicella immunization was implemented in 2004. Methods For fiscal years (FY) 1992-2011, we examined data on varicella and herpes zoster physician office visits, emergency department (ED) visits, hospitalizations (including for varicella-associated skin and soft tissue infections [SSTI]), and intensive care unit (ICU) admissions, among those aged < 18 years. The pre-vaccine, privately-available, and vaccine program eras were FY1992-1998, FY1999-2003, and FY2004-2011, respectively. We used Poisson regression and Kruskal-Wallis tests (all at the p<0.05 level of significance), and compared rates using incidence rate ratios (IRRs) and 95% confidence intervals (CIs). Results Incidence of varicella office visits declined over the study period from a high of 25.1/1,000 in FY1994 to a low of 3.2/1,000 in FY2011. ED visits and hospitalizations followed similar patterns of decreasing rates later in the study period. IRRs comparing the vaccine program versus pre-vaccine eras were 0.29 (95% CI: 0.26-0.32) for office visits, 0.29 (95% CI: 0.21-0.40) for ED visits, and 0.41 (95% CI: 0.10-1.69) for hospitalizations. Annual declines in varicella office visits were 7.7%, 9.1%, 8.4%, and 8.4% per year among children aged < 1 year, 1-4 years, 5-11 years, and >= 12 years, respectively (all p< 0.001). Age-specific rates of varicella-associated SSTI declined significantly among children < 12 years (p< 0.001) and rates of ICU admissions decreased significantly for children < 1 year (p = 0.02). (p<0.001) over the study period. For children aged 5-17 years, herpes zoster office visits decreased whereas ED visits increased (both p<0.001) and there was a small, non-significant (p = 0.07), decrease in hospitalizations. Conclusion Medically-attended varicella decreased during the study period, particularly since varicella vaccine was publicly-funded. Results suggest immunization program-related changes in varicella epidemiology, including herd effects, demonstrated by reductions in varicella in program-ineligible age groups. We did not observe a consistent impact on herpes zoster.	[Wormsbecker, Anne E.; Wang, Jun; Rosella, Laura C.; Kwong, Jeffrey C.; Seo, Chi Yon; Crowcroft, Natasha S.; Deeks, Shelley L.] Publ Hlth Ontario, Toronto, ON, Canada; [Wormsbecker, Anne E.] Hosp Sick Children, Div Paediat Med, Toronto, ON M5G 1X8, Canada; [Rosella, Laura C.; Kwong, Jeffrey C.; Crowcroft, Natasha S.; Deeks, Shelley L.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Rosella, Laura C.; Kwong, Jeffrey C.] Inst Clin Evaluat Sci, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto	Deeks, SL (corresponding author), Publ Hlth Ontario, Toronto, ON, Canada.	shelley.deeks@oahpp.ca			Public Health Ontario	Public Health Ontario	Public Health Ontario provided the funding. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI), 2010, ACS8 NACI, V36; Baxter R, 2013, PEDIATRICS, V131, pE1389, DOI 10.1542/peds.2012-3303; Chaves SS, 2011, PEDIATRICS, V128, P1071, DOI 10.1542/peds.2011-0017; Civen R, 2009, PEDIATR INFECT DIS J, V28, P954, DOI 10.1097/INF.0b013e3181a90b16; Eneli I, 2007, J PEDIATR-US, V151, P79, DOI 10.1016/j.jpeds.2007.02.019; French B, 2008, STAT MED, V27, P5005, DOI 10.1002/sim.3340; Galil K, 2002, NEW ENGL J MED, V347, P1909, DOI 10.1056/NEJMoa021662; Gil-Prieto R, 2014, VACCINE, V32, P7043, DOI 10.1016/j.vaccine.2014.10.076; Goldman GS, 2013, VACCINE, V31, P1680, DOI 10.1016/j.vaccine.2012.05.050; GUESS HA, 1985, PEDIATRICS, V76, P512; Guris D, 2008, J INFECT DIS, V197, pS71, DOI 10.1086/522156; Izurieta HS, 1997, JAMA-J AM MED ASSOC, V278, P1495, DOI 10.1001/jama.278.18.1495; Juurlink D, 2006, CANADIAN I HLTH INFO; Kwong JC, 2008, VACCINE, V26, P6006, DOI 10.1016/j.vaccine.2008.08.016; Lopez AS, 2006, PEDIATRICS, V117, pE1070, DOI 10.1542/peds.2005-2085; Marshall HS, 2013, PEDIATR INFECT DIS J, V32, P530, DOI 10.1097/INF.0b013e31827e92b7; Ontario Agency for Health Protection and Promotion, 2014, IMM COV REP SCH PUP; Ontario Ministry Health and Long-Term Care Corporate Services Division Supply Chain and Facilities Branch Ontario Government Pharmaceutical and Medical Supply Service, COMP ASS MAT MAN SYS; Pierik JGJ, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-110; Russell ML, 2014, VACCINE, V32, P6319, DOI 10.1016/j.vaccine.2013.09.018; Scales DC, 2006, J CLIN EPIDEMIOL, V59, P802, DOI 10.1016/j.jclinepi.2005.11.015; Scales DC, 2008, CRIT CARE, V12, DOI 10.1186/cc6923; Seo CY, 2013, ONT PUBL HLTH C APR; Seward JF, 2008, J INFECT DIS, V197, pS82, DOI 10.1086/522145; Statistics Canada, 2013, POP EST POP PROJ; Tan B, 2012, PEDIATR INFECT DIS J, V31, P956, DOI 10.1097/INF.0b013e318260cc4d; Tanuseputro P, 2011, VACCINE, V29, P8580, DOI 10.1016/j.vaccine.2011.09.024; Waye A, 2013, VACCINE, V31, P4744, DOI 10.1016/j.vaccine.2013.08.022	28	9	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0129483	10.1371/journal.pone.0129483	http://dx.doi.org/10.1371/journal.pone.0129483			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177077	Green Submitted, Green Published, gold			2022-12-26	WOS:000358197600013
J	Allain, EP; Boudreau, LH; Flamand, N; Surette, ME				Allain, Eric P.; Boudreau, Luc H.; Flamand, Nicolas; Surette, Marc E.			The Intracellular Localisation and Phosphorylation Profile of the Human 5-Lipoxygenase Delta 13 Isoform Differs from That of Its Full Length Counterpart	PLOS ONE			English	Article							COACTOSIN-LIKE PROTEIN; BASOPHILIC LEUKEMIA-CELLS; LEUKOTRIENE BIOSYNTHESIS; NUCLEAR IMPORT; ARACHIDONIC-ACID; POLYMORPHONUCLEAR LEUKOCYTES; ALVEOLAR MACROPHAGES; HUMAN NEUTROPHILS; ENZYME-ACTIVITY; TRANSLOCATION	5-Lipoxygenase (5-LO) catalyzes leukotriene (LT) biosynthesis by a mechanism that involves interactions with 5-lipoxygenase activating protein (FLAP) and coactosin-like protein (CLP). 5-LO splice variants were recently identified in human myeloid and lymphoid cells, including the catalytically inactive Delta 13 isoform (5-LO Delta 13) whose transcript lacks exon 13.5-LO Delta 13 inhibits 5-LO product biosynthesis when co-expressed with active full length 5-LO (5-LO1). The objective of this study was to investigate potential mechanisms by which 5-LO Delta 13 interferes with 5-LO product biosynthesis in transfected HEK293 cells. When co-expressed with 5-LO1, 5-LO Delta 13 inhibited LT but not 5-hydroxyeicosatetraenoic acid (5-HETE) biosynthesis. This inhibition was independent of 5-LO Delta 13-FLAP interactions since it occurred in cells expressing FLAP or not. In cell-free assays CLP enhances 5-LO activity through interactions with tryptophan-102 of 5-LO. In the current study, the requirement for W102 was extended to whole cells, as cells expressing the 5-LO1-W102A mutant produced little 5-LO products. W102A mutants of 5-LO Delta 13 inhibited 5-LO product biosynthesis as effectively as 5-LO Delta 13 suggesting that inhibition is independent of interactions with CLP. Confocal microscopy showed that 5-LO1 was primarily in the nucleoplasm whereas W102A mutants showed a diffuse cellular expression. Despite the retention of known nuclear localisation sequences, 5-LO Delta 13 was cytosolic and concentrated in ER-rich perinuclear regions where its effect on LT biosynthesis may occur. W102A mutants of 5-LO Delta 13 showed the same pattern. Consistent with subcellular distribution patterns, 5-LO Delta 13 was hyper-phosphorylated on S523 and S273 compared to 5-LO1. Together, these results reveal a role for W102 in nuclear targeting of 5-LO1 suggesting that interactions with CLP are required for nuclear localization of 5-LO1, and are an initial characterisation of the 5-LO Delta 13 isoform whose inhibition of LT biosynthesis appears independent of interactions with CLP and FLAP. Better knowledge of the regulation and properties of alternative 5-LO isoforms will contribute to understanding the complex regulation of LT biosynthesis.	[Allain, Eric P.; Boudreau, Luc H.; Surette, Marc E.] Univ Moncton, Dept Chim & Biochim, Moncton, NB E1A 3E9, Canada; [Flamand, Nicolas] Univ Laval, Dept Med, Inst Univ Cardiol & Pneumol Quebec, Ctr Rech, Quebec City, PQ G1K 7P4, Canada; [Flamand, Nicolas] Univ Laval, Fac Med, Quebec City, PQ G1K 7P4, Canada	University of Moncton; Laval University; Laval University	Surette, ME (corresponding author), Univ Moncton, Dept Chim & Biochim, Moncton, NB E1A 3E9, Canada.	marc.surette@umoncton.ca	Flamand, Nicolas/H-5823-2019; Surette, Marc/AAW-1078-2021	Flamand, Nicolas/0000-0001-5944-7200; Allain, Eric/0000-0003-4283-6060; Boudreau, Luc H/0000-0002-3674-5026	Heart and Stroke Foundation of Canada; Natural Sciences and Engineering Research Council of Canada; Canada Research Chairs Program; Fonds de recherche du Quebec-Sante; New Brunswick Health Research Foundation	Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Research Chairs Program(Canada Research Chairs); Fonds de recherche du Quebec-Sante(Fonds de la Recherche en Sante du Quebec); New Brunswick Health Research Foundation	This work was supported by grants from the Heart and Stroke Foundation of Canada (to MES), and the Natural Sciences and Engineering Research Council of Canada (to NF). MES was supported by the Canada Research Chairs Program. NF is the recipient of a salary award from the Fonds de recherche du Quebec-Sante. EA was supported by a graduate student scholarship from the New Brunswick Health Research Foundation. LHB was the recipient of a fellowship from the Fonds de recherche du Quebec-Sante. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMOVITZ M, 1993, EUR J BIOCHEM, V215, P105, DOI 10.1111/j.1432-1033.1993.tb18012.x; Basavarajappa D, 2014, P NATL ACAD SCI USA, V111, P11371, DOI 10.1073/pnas.1410983111; Bhatia B, 2003, J BIOL CHEM, V278, P25091, DOI 10.1074/jbc.M301920200; Bishayee K, 2013, ACTA BIOCH BIOPH SIN, V45, P709, DOI 10.1093/abbs/gmt064; BOADO RJ, 1992, P NATL ACAD SCI USA, V89, P9044, DOI 10.1073/pnas.89.19.9044; BORGEAT P, 1990, METHOD ENZYMOL, V187, P98; BORGEAT P, 1979, P NATL ACAD SCI USA, V76, P2148, DOI 10.1073/pnas.76.5.2148; Boudreau LH, 2011, FASEB J, V25, P1097, DOI 10.1096/fj.10-173856; BROCK TG, 1995, ADV PROSTAG THROMB L, V23, P151; Brock TG, 1997, J BIOL CHEM, V272, P8276, DOI 10.1074/jbc.272.13.8276; Brock TG, 1999, J IMMUNOL, V162, P1669; BROCK TG, 1995, J BIOL CHEM, V270, P21652, DOI 10.1074/jbc.270.37.21652; Chen M, 2006, J EXP MED, V203, P837, DOI 10.1084/jem.20052371; CHEN XS, 1995, J BIOL CHEM, V270, P17993, DOI 10.1074/jbc.270.30.17993; Chen XS, 1998, J BIOL CHEM, V273, P31237, DOI 10.1074/jbc.273.47.31237; Chu J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070991; DIXON RAF, 1990, NATURE, V343, P282, DOI 10.1038/343282a0; Esser J, 2010, BIOCHEM J, V425, P265, DOI 10.1042/BJ20090856; Fanning LB, 2013, ANN ALLERG ASTHMA IM, V111, P155, DOI 10.1016/j.anai.2013.06.031; Flamand N, 2006, J BIOL CHEM, V281, P129, DOI 10.1074/jbc.M506513200; Flamand N, 2009, J BIOL CHEM, V284, P306, DOI 10.1074/jbc.M805593200; Gerstmeier J, 2014, BBA-GEN SUBJECTS, V1840, P2961, DOI 10.1016/j.bbagen.2014.05.016; Hafner AK, 2011, BIOL CHEM, V392, P1097, DOI [10.1515/BC.2011.200, 10.1515/BC-2011-200]; Haeggstrom JZ, 2011, CHEM REV, V111, P5866, DOI 10.1021/cr200246d; Hammarberg T, 2001, BIOCHEMISTRY-US, V40, P6371, DOI 10.1021/bi001595d; Hammarberg T, 2000, J BIOL CHEM, V275, P38787, DOI 10.1074/jbc.M006136200; Jones SM, 2003, J BIOL CHEM, V278, P10257, DOI 10.1074/jbc.M211021200; Jones SM, 2002, J BIOL CHEM, V277, P38550, DOI 10.1074/jbc.M206070200; Luo M, 2005, J BIOL CHEM, V280, P40609, DOI 10.1074/jbc.M507045200; OCHI K, 1983, J BIOL CHEM, V258, P5754; Ochs MJ, 2014, BASIC CLIN PHARMACOL, V114, P78, DOI 10.1111/bcpt.12115; Ochs MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031363; Peters-Golden M, 2007, NEW ENGL J MED, V357, P1841, DOI 10.1056/NEJMra071371; Plante H, 2006, BIOCHEM J, V393, P211, DOI 10.1042/BJ20060669; Provost P, 2001, BIOCHEM J, V359, P255, DOI 10.1042/0264-6021:3590255; Radmark O, 2010, BIOCHEM BIOPH RES CO, V396, P105, DOI 10.1016/j.bbrc.2010.02.173; Rakonjac M, 2006, P NATL ACAD SCI USA, V103, P13150, DOI 10.1073/pnas.0605150103; Woods J. W., 1993, J EXP MED, V178, P1935; WOODS JW, 1995, J CLIN INVEST, V95, P2035, DOI 10.1172/JCI117889; Zhang YY, 2000, BIOCHEM J, V351, P697, DOI 10.1042/0264-6021:3510697	40	15	15	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132607	10.1371/journal.pone.0132607	http://dx.doi.org/10.1371/journal.pone.0132607			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26173130	gold, Green Submitted, Green Published			2022-12-26	WOS:000358194900064
J	Guo, X; Zhao, D; Jung, DW; Li, Q; Kong, LF; Ni, G; Nakano, T; Matsukuma, A; Kim, S; Park, C; Lee, HJ; Park, JK				Guo, Xiang; Zhao, Dan; Jung, Daewui; Li, Qi; Kong, Ling-Feng; Ni, Gang; Nakano, Tomoyuki; Matsukuma, Akihiko; Kim, Sanghee; Park, Chungoo; Lee, Hyuk Je; Park, Joong-Ki			Phylogeography of the Rock Shell Thais clavigera (Mollusca): Evidence for Long-Distance Dispersal in the Northwestern Pacific	PLOS ONE			English	Article							GENETIC DIFFERENTIATION; POPULATION EXPANSION; MARGINAL SEAS; PLEISTOCENE ISOLATION; LARVAL DISPERSAL; MARINE; DIVERGENCE; MODEL; MURICIDAE; SOFTWARE	The present-day genetic structure of a species reflects both historical demography and patterns of contemporary gene flow among populations. To precisely understand how these factors shape current population structure of the northwestern (NW) Pacific marine gastropod, Thais clavigera, we determined the partial nucleotide sequences of the mitochondrial COI gene for 602 individuals sampled from 29 localities spanning almost the whole distribution of T. clavigera in the NW Pacific Ocean (similar to 3,700 km). Results from population genetic and demographic analyses (AMOVA, phi(ST)-statistics, haplotype networks, Tajima's D, Fu's F-S, mismatch distribution, and Bayesian skyline plots) revealed a lack of genealogical branches or geographical clusters, and a high level of genetic (haplotype) diversity within each of studied population. Nevertheless, low but significant genetic structuring was detected among some geographical populations separated by the Changjiang River, suggesting the presence of geographical barriers to larval dispersal around this region. Several lines of evidence including significant negative Tajima's D and Fu's FS statistics values, the unimodally shaped mismatch distribution, and Bayesian skyline plots suggest a population expansion at marine isotope stage 11 (MIS 11; 400 ka), the longest and warmest interglacial interval during the Pleistocene epoch. The lack of genetic structure among the great majority of the NW Pacific T. clavigera populations may be attributable to high gene flow by current- driven long-distance dispersal of prolonged planktonic larval phase of this species.	[Guo, Xiang; Park, Joong-Ki] Ewha Womans Univ, Div EcoSci, Seoul 120750, South Korea; [Zhao, Dan; Li, Qi; Kong, Ling-Feng; Ni, Gang; Matsukuma, Akihiko] Ocean Univ China, Key Lab Mariculture, Minist Educ, Qingdao 266003, Peoples R China; [Jung, Daewui] Chungbuk Natl Univ, Coll Med, Program Cell Biol & Genet, Cheongju 361763, South Korea; [Jung, Daewui] Chungbuk Natl Univ, Coll Med, Dept Parasitol, Cheongju 361763, South Korea; [Nakano, Tomoyuki] Kyoto Univ, Seto Marine Biol Lab, Shirahama, Wakayama Prefec, Japan; [Kim, Sanghee] Korea Polar Res Inst, Inchon 406840, South Korea; [Park, Chungoo] Chonnam Natl Univ, Sch Biol Sci & Technol, Kwangju 500757, South Korea; [Lee, Hyuk Je] Sangji Univ, Dept Biol Sci, Coll Sci & Engn, Wonju 220702, South Korea	Ewha Womans University; Ocean University of China; Chungbuk National University; Chungbuk National University; Kyoto University; Korea Institute of Ocean Science & Technology (KIOST); Korea Polar Research Institute (KOPRI); Chonnam National University; Sangji University	Li, Q (corresponding author), Ocean Univ China, Key Lab Mariculture, Minist Educ, Qingdao 266003, Peoples R China.	qili66@ouc.edu.cn; jkpark@ewha.ac.kr	Park, Joong-Ki/S-8855-2019; Kong, Lingfeng/AAJ-3402-2021; Kong, Lingfeng/AAG-2473-2019	Kong, Lingfeng/0000-0001-5263-1697	Marine Biotechnology Program (Genome Analysis of Marine Organisms and Development of Functional Applications and Marine Mollusk Resource Bank of Korea) [PJT200620]; National Natural Science Foundation of China [41276138]; Ministry of Oceans and Fisheries, Korea	Marine Biotechnology Program (Genome Analysis of Marine Organisms and Development of Functional Applications and Marine Mollusk Resource Bank of Korea); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Oceans and Fisheries, Korea	This research was supported by a grant from Marine Biotechnology Program (PJT200620, Genome Analysis of Marine Organisms and Development of Functional Applications and Marine Mollusk Resource Bank of Korea) to J-KP and funded by the Ministry of Oceans and Fisheries, Korea, and National Natural Science Foundation of China (41276138) to QL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addison JA, 2008, MOL ECOL, V17, P4222, DOI 10.1111/j.1365-294X.2008.03905.x; [Anonymous], 2014, TRACER V1 6; ArisBrosou S, 1996, MOL BIOL EVOL, V13, P494, DOI 10.1093/oxfordjournals.molbev.a025610; Avise JC, 2004, MOL MARKERS NATURAL, P248; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Candy I, 2014, EARTH-SCI REV, V128, P18, DOI 10.1016/j.earscirev.2013.09.006; Cardenas L, 2009, J BIOGEOGR, V36, P969, DOI 10.1111/j.1365-2699.2008.02056.x; Cheang CC, 2012, J BIOGEOGR, V39, P1819, DOI 10.1111/j.1365-2699.2012.02742.x; Cox LN, 2014, J BIOGEOGR, V41, P615, DOI 10.1111/jbi.12217; Dong Yu-lin, 2012, PLoS One, V7, pe34435, DOI 10.1371/journal.pone.0034435; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; FOIGHIL DO, 1989, MAR BIOL, V103, P349; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fu YX, 1997, GENETICS, V147, P915; Guo EM, 2012, MOL BIOL REP, V39, P1453, DOI 10.1007/s11033-011-0882-3; Guo ZT, 2000, GEOPHYS RES LETT, V27, P1751, DOI 10.1029/1999GL008419; Hayashi T, 1999, ZOOL SCI, V16, P81, DOI 10.2108/zsj.16.81; Hearty Paul J., 2002, Pacific Science, V56, P65, DOI 10.1353/psc.2002.0004; Hearty PJ, 1999, GEOLOGY, V27, P375, DOI 10.1130/0091-7613(1999)027<0375:AMMPSL>2.3.CO;2; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; Hoffman JI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032415; Hsieh Y-C, 2001, THESIS NATL SUN YAT; Hu J., 2000, J OCEANOGR, V56, P607, DOI DOI 10.1023/A:1011117531252; Huang J-R, 2013, THESIS XIAMEN U; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Ito Toshimichi, 1995, Journal of Oceanography, V51, P267, DOI 10.1007/BF02285165; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Kang JH, 2012, GENET MOL RES, V11, P3988, DOI 10.4238/2012.November.21.2; Kariya C, 2010, QUATERNARY SCI REV, V29, P1863, DOI 10.1016/j.quascirev.2010.04.005; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kinlan BP, 2003, ECOLOGY, V84, P2007, DOI 10.1890/01-0622; Lambeck K, 2002, NATURE, V419, P199, DOI 10.1038/nature01089; Lee HJ, 2003, DEEP-SEA RES PT II, V50, P1065, DOI 10.1016/S0967-0645(03)00010-9; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liu JY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0057473, 10.1371/journal.pone.0050719, 10.1371/journal.pone.0064143]; Liu JX, 2007, MOL ECOL, V16, P275, DOI 10.1111/j.1365-294X.2006.03140.x; Liu Y, 2009, HYDROBIOLOGIA, V618, P125, DOI 10.1007/s10750-008-9570-2; Maggs CA, 2008, ECOLOGY, V89, pS108, DOI 10.1890/08-0257.1; Marko PB, 2010, MOL ECOL, V19, P146, DOI 10.1111/j.1365-294X.2009.04417.x; Ni G, 2014, MOL ECOL, V23, P534, DOI 10.1111/mec.12620; Ni G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049487; Nunes FLD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022298; 이순목, 2011, [Korean Journal of Food and Cookery Science, 한국식품조리과학회지], V27, P1; Polzin T, 2003, OPER RES LETT, V31, P12, DOI 10.1016/S0167-6377(02)00185-2; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Purcell JFH, 2006, P ROY SOC B-BIOL SCI, V273, P1483, DOI 10.1098/rspb.2006.3470; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Romero MS, 2004, MAR BIOL, V145, P681, DOI 10.1007/s00227-004-1368-9; SCHELTEMA RS, 1971, BIOL BULL-US, V140, P284, DOI 10.2307/1540075; Shanks AL, 2009, BIOL BULL-US, V216, P373; Song N, 2010, J FISH BIOL, V77, P388, DOI 10.1111/j.1095-8649.2010.02694.x; Stamatis C, 2004, MOL ECOL, V13, P1377, DOI 10.1111/j.1365-294X.2004.02165.x; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tan KS, 2001, ZOOL SCI, V18, P1275, DOI 10.2108/zsj.18.1275; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; TONG L K Y, 1988, Asian Marine Biology, V5, P65; Tsang LM, 2008, MOL ECOL, V17, P4151, DOI 10.1111/j.1365-294X.2008.03907.x; Wang PX, 1999, MAR GEOL, V156, P5, DOI 10.1016/S0025-3227(98)00172-8; Wang X, 2013, THESIS ZHEJIANG OCEA; Xiao YS, 2009, ENVIRON BIOL FISH, V85, P303, DOI 10.1007/s10641-009-9497-0; Xu JW, 2009, MOL PHYLOGENET EVOL, V52, P45, DOI 10.1016/j.ympev.2009.02.007; Xue DX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095436; York KL, 2008, MOL ECOL, V17, P1948, DOI 10.1111/j.1365-294X.2008.03735.x; You ZJ, 2010, J ZHEJIANG OCEAN U N, V29, P306; Zane L, 2006, MOL ECOL, V15, P4499, DOI 10.1111/j.1365-294X.2006.03105.x	68	30	31	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0129715	10.1371/journal.pone.0129715	http://dx.doi.org/10.1371/journal.pone.0129715			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26171966	gold, Green Published, Green Submitted			2022-12-26	WOS:000358194900004
J	Sekine, J; Nakatani, E; Ohira, K; Hideshima, K; Kanno, T; Nariai, Y; Kagimura, T; Urano, T				Sekine, Joji; Nakatani, Eiji; Ohira, Koichiro; Hideshima, Katsumi; Kanno, Takahiro; Nariai, Yoshiki; Kagimura, Tatsuo; Urano, Takeshi			Nucleus Accumbens-Associated Protein 1 Expression Has Potential as a Marker for Distinguishing Oral Epithelial Dysplasia and Squamous Cell Carcinoma	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; MALIGNANT-TRANSFORMATION; CANCER; PLURIPOTENCY; PROGNOSIS; NETWORK; NACL	Background Oral epithelial dysplasia (OED) and carcinoma in situ (CIS) are defined by dysplastic cells in the epithelium. Over a third of oral squamous cell carcinoma (OSCC) patients present with associated OED. However, accurate histopathological diagnosis of such lesions is difficult. Nucleus accumbens-associated protein 1 (NAC1) is a member of the Pox virus and Zinc finger/Bric-a-brac Tramtrack Broad complex family of proteins, and is overexpressed in OSCC. This study aimed to determine whether NAC1 has the potential to be used as a marker to distinguish OED and OSCC. Methods and Findings The study included 114 patients (64 men, 50 women). There were 67, 10, and 37 patients with OED, CIS, and OSCC, respectively. NAC1 labeling indices (LIs) and immunoreactivity intensities (IRI) were evaluated. The patients' pathological classification was significantly associated with age, sex, NAC1 LIs, and NAC1 IRI (p = 0.025, p = 0.022, p < 0.001, and p < 0.001, respectively). As a result of multivariate analysis, a predictive model was made; this identified the NAC1 LIs (OR [95% CI] 1.18 [1.11-1.28], p < 0.001) and NAC1 IRI (0.78 [0.68-0.86], p < 0.001) as predictive factors for CIS/OSCC. The NAC1 LIs/IRI cut-off values which discriminated between OED and CIS/OSCC were 50%/124 pixels. For NAC1 LIs with > 50% positivity the sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) were 0.766, 0.910, 0.857, and 0.847, respectively. For NAC1 IRI with <= 124 positive pixels, the sensitivity, specificity, PPV, and NPV were 0.787, 0.866, 0.804, and 0.853, respectively. Though there are several potential limitations to this study and the results were obtained from a retrospective analysis of a single site cohort, the data suggest that the NAC1 LIs/IRI is a strong predictor of CIS/OSCC. Conclusions NAC1 has potential as a marker for distinguishing OED from CIS/OSCC.	[Sekine, Joji; Ohira, Koichiro; Hideshima, Katsumi; Kanno, Takahiro; Nariai, Yoshiki] Shimane Univ, Fac Med, Dept Oral & Maxillofacial Surg, Izumo, Shimane, Japan; [Nakatani, Eiji; Kagimura, Tatsuo] Fdn Biomed Res & Innovat, Translat Res Informat Ctr, Kobe, Hyogo, Japan; [Urano, Takeshi] Shimane Univ, Fac Med, Dept Biochem, Izumo, Shimane, Japan	Shimane University; Institute for Biomedical Research & Innovation (IBRI); Shimane University	Sekine, J (corresponding author), Shimane Univ, Fac Med, Dept Oral & Maxillofacial Surg, Izumo, Shimane, Japan.	georges@med.shimane-u.ac.jp	Nakatani, Eiji/O-2782-2013	Nakatani, Eiji/0000-0002-4876-446X	research budget of the Department of Oral and Maxillofacial Surgery, Shimane University Faculty of Medicine	research budget of the Department of Oral and Maxillofacial Surgery, Shimane University Faculty of Medicine	This study was not supported by a national grant but was supported by the research budget of the Department of Oral and Maxillofacial Surgery, Shimane University Faculty of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes L., 2005, WHO CLASSIFICATION T; Cawson RA, 2001, ORAL DIS; Dost F, 2014, OR SURG OR MED OR PA, V117, P343, DOI 10.1016/j.oooo.2013.09.017; El Hallani S, 2013, ORAL ONCOL, V49, P582, DOI 10.1016/j.oraloncology.2013.01.009; Garcia-de Marcos JA, 2014, INT J ORAL MAX SURG, V43, P274, DOI 10.1016/j.ijom.2013.10.016; Kaur J, 2014, INT J CANCER, V134, P1379, DOI 10.1002/ijc.28473; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Nakabayashi M, 2014, ONCOL LETT, V7, P750, DOI 10.3892/ol.2013.1775; Nakayama K, 2010, GYNECOL ONCOL, V119, P469, DOI 10.1016/j.ygyno.2010.08.031; Nankivell P, 2013, BRIT J CANCER, V109, P2864, DOI 10.1038/bjc.2013.600; Nevill BW, 2001, ORAL MAXILLOFACIAL P, P315; Ohira K, 2015, SHIMANE J MED SCI, V31, P29; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Rahman MT, 2012, BRIT J CANCER, V107, P300, DOI 10.1038/bjc.2012.246; Ramasubramanian Abilasha, 2013, J Nat Sci Biol Med, V4, P349, DOI 10.4103/0976-9668.117011; Sankaranarayanan R, 1998, ANTICANCER RES, V18, P4779; Stogios PJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-10-r82; van Zyl AW, 2012, HEAD NECK PATHOL, V6, P322, DOI 10.1007/s12105-012-0352-9; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Wittekindt C, 2012, GMS CURR TOP OTORHIN, V11, pDoc09, DOI DOI 10.3205/CTO000091	20	7	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0131752	10.1371/journal.pone.0131752	http://dx.doi.org/10.1371/journal.pone.0131752			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26172271	Green Published, Green Submitted, gold			2022-12-26	WOS:000358194900023
J	Sobral, M; Veiga, T; Dominguez, P; Guitian, JA; Guitian, P; Guitian, JM				Sobral, Mar; Veiga, Tania; Dominguez, Paula; Guitian, Javier A.; Guitian, Pablo; Guitian, Jose M.			Selective Pressures Explain Differences in Flower Color among Gentiana lutea Populations	PLOS ONE			English	Article							MIMULUS-AURANTIACUS; NATURAL-SELECTION; FLORAL-COLOR; WILD RADISH; POLLINATORS; HERBIVORES; ANTHOCYANINS; PIGMENTATION; CAROTENOIDS; MAINTENANCE	Flower color variation among plant populations might reflect adaptation to local conditions such as the interacting animal community. In the northwest Iberian Peninsula, flower color of Gentiana lutea varies longitudinally among populations, ranging from orange to yellow. We explored whether flower color is locally adapted and the role of pollinators and seed predators as agents of selection by analyzing the influence of flower color on (i) pollinator visitation rate and (ii) escape from seed predation and (iii) by testing whether differences in pollinator communities correlate with flower color variation across populations. Finally, (iv) we investigated whether variation in selective pressures explains flower color variation among 12 G. lutea populations. Flower color influenced pollinator visits and differences in flower color among populations were related to variation in pollinator communities. Selective pressures on flower color vary among populations and explain part of flower color differences among populations of G. lutea. We conclude that flower color in G. lutea is locally adapted and that pollinators play a role in this adaptation.	[Sobral, Mar; Guitian, Jose M.] Univ Santiago de Compostela, Area Ecol, Santiago De Compostela 15782, Galicia, Spain; [Sobral, Mar] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Veiga, Tania; Dominguez, Paula; Guitian, Javier A.; Guitian, Pablo] Univ Santiago de Compostela, Dept Bot, Santiago De Compostela 15782, Galicia, Spain	Universidade de Santiago de Compostela; Stanford University; Universidade de Santiago de Compostela	Sobral, M (corresponding author), Univ Santiago de Compostela, Area Ecol, Santiago De Compostela 15782, Galicia, Spain.	sobral.bernal.mar@gmail.com	Sobral, Mar/Q-9812-2017	Sobral, Mar/0000-0001-6995-0491	Ministerio de Ciencia [CGL2009-08959]; Plan Galego de Investigacion e Crecemento (Plan I2C), Conselleria de Educacion e Ordenacion Universitaria e Innovacion	Ministerio de Ciencia(Spanish Government); Plan Galego de Investigacion e Crecemento (Plan I2C), Conselleria de Educacion e Ordenacion Universitaria e Innovacion	This work was financed by the Plan Nacional de I + D + I (2008-2011), CGL2009-08959 Ministerio de Ciencia. T.V. was supported by a PhD grant from the Plan Galego de Investigacion e Crecemento 2011/2015 (Plan I2C), Conselleria de Educacion e Ordenacion Universitaria e Innovacion.	Alarcon M, 2012, MOL PHYLOGENET EVOL, V63, P866, DOI 10.1016/j.ympev.2012.02.031; Alcantara JM, 2010, J EVOLUTION BIOL, V23, P1218, DOI 10.1111/j.1420-9101.2010.01981.x; Arista M, 2013, J ECOL, V101, P1613, DOI 10.1111/1365-2745.12151; Borghesi E, 2011, J AGR FOOD CHEM, V59, P11676, DOI 10.1021/jf2021623; Briscoe AD, 2001, ANNU REV ENTOMOL, V46, P471, DOI 10.1146/annurev.ento.46.1.471; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Carlson JE, 2013, OECOLOGIA, V171, P905, DOI 10.1007/s00442-012-2453-2; Caruso CM, 2010, INT J PLANT SCI, V171, P1020, DOI 10.1086/656511; Chittka L, 1997, ISRAEL J PLANT SCI, V45, P169, DOI 10.1080/07929978.1997.10676682; Conner J. K., 2004, PRIMER ECOLOGICAL GE; Fenster CB, 2004, ANNU REV ECOL EVOL S, V35, P375, DOI 10.1146/annurev.ecolsys.34.011802.132347; Frey FM, 2004, EVOLUTION, V58, P2426, DOI 10.1111/j.0014-3820.2004.tb00872.x; Gonzalez-Lopez O, 2014, INT J MOL SCI, V15, P10052, DOI 10.3390/ijms150610052; Herrera C.M., 2006, ECOLOGY EVOLUTION FL, P278; Irwin RE, 2003, ECOLOGY, V84, P1733, DOI 10.1890/0012-9658(2003)084[1733:TROHIT]2.0.CO;2; Kawecki TJ, 2004, ECOL LETT, V7, P1225, DOI 10.1111/j.1461-0248.2004.00684.x; Kingsolver JG, 2001, AM NAT, V157, P245, DOI 10.1086/319193; Kohlein F, 1991, GENTIANS; Kolb A, 2007, PERSPECT PLANT ECOL, V9, P79, DOI 10.1016/j.ppees.2007.09.001; Kugler H., 1943, ERG BIOL, V19, P323; LANDE R, 1983, EVOLUTION, V37, P1210, DOI 10.1111/j.1558-5646.1983.tb00236.x; Ma JF, 2001, TRENDS PLANT SCI, V6, P273, DOI 10.1016/S1360-1385(01)01961-6; Manzaneda AJ, 2008, ECOGRAPHY, V31, P583, DOI 10.1111/j.0906-7590.2008.05345.x; Saiz JCM, 2013, J BIOGEOGR, V40, P90, DOI 10.1111/j.1365-2699.2012.02774.x; Newman E, 2012, P ROY SOC B-BIOL SCI, V279, P2309, DOI 10.1098/rspb.2011.2375; PEITSCH D, 1992, J COMP PHYSIOL A, V170, P23, DOI 10.1007/BF00190398; Rausher MD, 2008, INT J PLANT SCI, V169, P7, DOI 10.1086/523358; RAUSHER MD, 1992, EVOLUTION, V46, P616, DOI 10.1111/j.1558-5646.1992.tb02070.x; Renoult JP, 2013, J EVOLUTION BIOL, V26, P2415, DOI 10.1111/jeb.12234; Rodriguez-Girones MA, 2004, PLOS BIOL, V2, P1515, DOI 10.1371/journal.pbio.0020350; Rossi M, 2014, FLORA, V209, P164, DOI 10.1016/j.flora.2014.02.002; Schemske DW, 2007, EVOLUTION, V61, P2528, DOI 10.1111/j.1558-5646.2007.00219.x; Stewart JR, 2010, P ROY SOC B-BIOL SCI, V277, P661, DOI 10.1098/rspb.2009.1272; Stinchcombe JR, 2002, AM NAT, V160, P511, DOI 10.1086/342069; Strauss S.Y., 2006, ECOLOGY EVOLUTION FL, P120; Strauss SY, 2004, J ECOL, V92, P132, DOI 10.1111/j.1365-2745.2004.00843.x; Streisfeld MA, 2007, J EVOLUTION BIOL, V20, P122, DOI 10.1111/j.1420-9101.2006.01216.x; Streisfeld MA, 2005, EVOLUTION, V59, P2548, DOI 10.1111/j.0014-3820.2005.tb00968.x; Struwe L, 2002, GENTIANACEAE SYSTEMA; Tanaka Y, 2008, PLANT J, V54, P733, DOI 10.1111/j.1365-313X.2008.03447.x; Thompson JD., 1994, COEVOLUTIONARY PROCE; Veiga T, 2015, EVOL ECOL, V29, P451, DOI 10.1007/s10682-014-9751-6; Yoshida K, 2003, PLANT CELL PHYSIOL, V44, P262, DOI 10.1093/pcp/pcg033; Zhu CF, 2002, PLANT MOL BIOL, V48, P277, DOI 10.1023/A:1013383120392; Zhu CF, 2010, ARCH BIOCHEM BIOPHYS, V504, P132, DOI 10.1016/j.abb.2010.07.028; Zhua CF, 2003, BBA-GENE STRUCT EXPR, V1625, P305, DOI 10.1016/S0167-4781(03)00017-4	46	30	31	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132522	10.1371/journal.pone.0132522	http://dx.doi.org/10.1371/journal.pone.0132522			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26172378	Green Published, gold, Green Submitted			2022-12-26	WOS:000358194900056
J	Farahani, F; Shariatpanahi, E; Jahanshahi, J; Poorolajal, J				Farahani, Farhad; Shariatpanahi, Elnaz; Jahanshahi, Javane; Poorolajal, Jalal			Diagnostic Performance of Endoscopic and Microscopic Procedures for Identifying Different Middle Ear Structures and Remaining Disease in Patients with Chronic Otitis Media: A Prospective Cohort Study	PLOS ONE			English	Article							CHOLESTEATOMA; MANAGEMENT; TYMPANOPLASTY	Background The diagnostic performance of endoscopic and microscopic procedures for detecting diseases of the middle ear in patients with chronic otitis media (COM) has rarely been investigated. This study was conducted to compare the performance of these procedures for identifying middle ear structures and their associated diseases in COM patients. Methods In this prospective cohort study, 58 patients with chronic COM, who were candidates for tympanoplasty with or without a mastoidectomy, were enrolled. Before the surgical intervention, the middle ear was examined via an operating microscope and then through an endoscope to identify the middle ear structures as well as diseases associated with the middle ear. Results The patients were 15 years of age or older. The anatomical parts of the middle ear - the epitympanic, posterior mesotympanic, and hypotympanic structures - were more visible through an endoscope than through a microscope. In addition, the various segments of the mesotympanum, oval window, round window, and Eustachian tube were more visible via endoscopy. The post-operative endoscopic reevaluation of the middle ear revealed that a cholesteatoma had remained in four of 13 patients after surgery. Conclusion According to the results of this study, in cases in which there is poor visibility with the operating microscope or the surgeon suspects remaining disease within the middle ear, endoscopy could be utilized to improve the evaluation of more hidden middle ear pits and structures, particularly if there is a potentially recrudescent pathology.	[Farahani, Farhad; Shariatpanahi, Elnaz; Jahanshahi, Javane] Hamadan Univ Med Sci, Sch Med, Dept Otolaryngol, Hamadan, Iran; [Poorolajal, Jalal] Hamadan Univ Med Sci, Sch Publ Hlth, Dept Epidemiol, Modeling Noncommunicable Dis Res Ctr, Hamadan, Iran		Poorolajal, J (corresponding author), Hamadan Univ Med Sci, Sch Publ Hlth, Dept Epidemiol, Modeling Noncommunicable Dis Res Ctr, Hamadan, Iran.	poorolajal@umsha.ac.ir	farahani, farhad/N-5865-2018; jahanshahi, javaneh/H-1440-2017; Poorolajal, Jalal/D-3506-2013; Shariatpanahi, Elnaz/P-5763-2017	farahani, farhad/0000-0001-7977-089X; jahanshahi, javaneh/0000-0002-0064-7408; Shariatpanahi, Elnaz/0000-0003-0218-5689	Hamadan University of Medical Sciences	Hamadan University of Medical Sciences	This article was part of the MD thesis in Otolaryngology which was funded by Hamadan University of Medical Sciences.	Ayache S, 2008, OTOL NEUROTOL, V29, P1085, DOI 10.1097/MAO.0b013e318188e8d7; Badr-el-Dine M, 2002, OTOL NEUROTOL, V23, P631, DOI 10.1097/00129492-200209000-00004; BOTTRILL ID, 1995, AM J OTOL, V16, P158; Campbell AP, 2010, LARYNGOSCOPE, V120, P1619, DOI 10.1002/lary.20979; El-Begermy M, 2003, INT C SERIES, V1240, P919; El-Begermy MA, 2003, INT C SERIES, V1240, P907; Flint PW, 2010, COMMINGS OTOLARYNGOL; Fritsch MH, 2009, OTOLARYNGOLOGIC CLIN, V48, P8; GLASSCOCK ME, 1976, LARYNGOSCOPE, V86, P1639, DOI 10.1288/00005537-197611000-00005; Junior JFN, 2009, INT OTORHINOLOGY, V13, P46; Liu Y, 2010, CHINESE MED J-PEKING, V123, P291, DOI 10.3760/cma.j.issn.0366-6999.2010.03.007; Marchioni D, 2010, LARYNGOSCOPE, V120, P1847, DOI 10.1002/lary.21069; Marchioni D, 2010, LARYNGOSCOPE, V120, P1880, DOI 10.1002/lary.20995; Poe DS, 1992, OPER TECH OTOLAYNGOL, V3, P239; Snyderman CH, 2006, OP TECH OTOLARYNGOL, V17, P168; Tarabichi M, 1999, ANN OTO RHINOL LARYN, V108, P39, DOI 10.1177/000348949910800106; Tarabichi M, 1997, AM J OTOL, V18, P544; Tarabichi M, 2000, OTOLARYNG HEAD NECK, V122, P874, DOI 10.1016/S0194-5998(00)70017-9; Tarabichi M., 2004, LARYNGOSCOPE, V114, P1157; Tarabichi M, 2010, OTOL NEUROTOL, V31, P580, DOI 10.1097/MAO.0b013e3181db72f8; Wang JL, 2010, ACTAOTOLARYNG, V96, P72; Yadav SPS, 2009, SINGAP MED J, V50, P510	22	12	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0132890	10.1371/journal.pone.0132890	http://dx.doi.org/10.1371/journal.pone.0132890			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26167935	gold, Green Published, Green Submitted			2022-12-26	WOS:000358193100094
J	Chen, ST; Okada, M; Nakato, R; Izumi, K; Bando, M; Shirahige, K				Chen, Shu-Ting; Okada, Maiko; Nakato, Ryuichiro; Izumi, Kosuke; Bando, Masashige; Shirahige, Katsuhiko			The Deubiquitinating Enzyme USP7 Regulates Androgen Receptor Activity by Modulating Its Binding to Chromatin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						androgen receptor; gene transcription; prostate cancer; transcriptional coactivator; ubiquitin-dependent protease	UBIQUITIN-SPECIFIC PROTEASE; RESISTANT PROSTATE-CANCER; TRANSCRIPTIONAL ACTIVITY; NUCLEAR RECEPTORS; AR COREGULATORS; HAUSP; NETWORK; ACTIVATION; EXPRESSION; DISEASE	Background: The androgen receptor (AR) plays a key role in prostate cancer progression. Results: USP7 is required for binding of the AR to chromatin. Conclusion: USP7 is a novel AR co-regulator that mediates AR activity. Significance: Pharmacological inhibition of USP7 represents a compelling therapeutic strategy for the treatment of prostate cancer. The androgen receptor (AR), a nuclear receptor superfamily transcription factor, plays a key role in prostate cancer. AR signaling is the principal target for prostate cancer treatment, but current androgen-deprivation therapies cannot completely abolish AR signaling because of the heterogeneity of prostate cancers. Therefore, unraveling the mechanism of AR reactivation in androgen-depleted conditions can identify effective prostate cancer therapeutic targets. Increasing evidence indicates that AR activity is mediated by the interplay of modifying/demodifying enzymatic co-regulators. To better understand the mechanism of AR transcriptional activity regulation, we used antibodies against AR for affinity purification and identified the deubiquitinating enzyme ubiquitin-specific protease 7, USP7 as a novel AR co-regulator in prostate cancer cells. We showed that USP7 associates with AR in an androgen-dependent manner and mediates AR deubiquitination. Sequential ChIP assays indicated that USP7 forms a complex with AR on androgen-responsive elements of target genes upon stimulation with the androgen 5-dihydrotestosterone. Further investigation indicated that USP7 is necessary to facilitate androgen-activated AR binding to chromatin. Transcriptome profile analysis of USP7-knockdown LNCaP cells also revealed the essential role of USP7 in the expression of a subset of androgen-responsive genes. Hence, inhibition of USP7 represents a compelling therapeutic strategy for the treatment of prostate cancer.	[Chen, Shu-Ting; Nakato, Ryuichiro; Izumi, Kosuke; Bando, Masashige; Shirahige, Katsuhiko] Univ Tokyo, Inst Mol & Cellular Biosci, Res Ctr Epigenet Dis, Tokyo 1130032, Japan; [Okada, Maiko] St Marianna Univ, Grad Sch Med, Dept Translat Oncol, Kawasaki, Kanagawa 2168511, Japan	University of Tokyo; Saint Marianna University	Shirahige, K (corresponding author), Univ Tokyo, Inst Mol & Cellular Biosci, Res Ctr Epigenet Dis, Tokyo 1130032, Japan.	kshirahi@iam.u-tokyo.ac.jp	Nakato, Ryuichiro/AAV-6405-2020	Nakato, Ryuichiro/0000-0003-3019-5817; Shirahige, Katsuhiko/0000-0002-7862-1144	Research Program of Innovative Cell Biology by Innovative Technology; Japan Society for the Promotion of Science KAKENHI Grant [24-5985]	Research Program of Innovative Cell Biology by Innovative Technology; Japan Society for the Promotion of Science KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research from the Research Program of Innovative Cell Biology by Innovative Technology, Grant-in-Aid for Scientific Research (to K. S.) (category S), Grant-in-Aid for Scientific Research (to M. B.) (category B) and Japan Society for the Promotion of Science KAKENHI Grant Number 24-5985. The authors declare no competing financial interests.	Becker K, 2007, CELL DEATH DIFFER, V14, P1350, DOI 10.1038/sj.cdd.4402126; Burska UL, 2013, J BIOL CHEM, V288, P32641, DOI 10.1074/jbc.M113.485912; Cheng CD, 2013, ONCOL REP, V29, P1730, DOI 10.3892/or.2013.2342; Chng KR, 2012, EMBO J, V31, P2810, DOI 10.1038/emboj.2012.112; Chymkowitch P, 2011, EMBO J, V30, P468, DOI 10.1038/emboj.2010.337; Coffey K, 2012, J ENDOCRINOL, V215, P221, DOI 10.1530/JOE-12-0238; Colleran A, 2013, P NATL ACAD SCI USA, V110, P618, DOI 10.1073/pnas.1208446110; Deardorff MA, 2012, NATURE, V489, P313, DOI 10.1038/nature11316; Dirac AMG, 2010, MOL CANCER RES, V8, P844, DOI 10.1158/1541-7786.MCR-09-0424; Draker R, 2011, NUCLEIC ACIDS RES, V39, P3529, DOI 10.1093/nar/gkq1352; Everett RD, 1997, EMBO J, V16, P1519, DOI 10.1093/emboj/16.7.1519; Faus H, 2005, MOL CELL ENDOCRINOL, V245, P138, DOI 10.1016/j.mce.2005.11.011; Feldman BJ, 2001, NAT REV CANCER, V1, P34, DOI 10.1038/35094009; Felten A, 2013, ONCOGENE, V32, P4981, DOI 10.1038/onc.2012.503; Gaughan L, 2005, NUCLEIC ACIDS RES, V33, P13, DOI 10.1093/nar/gki141; Heemers HV, 2007, ENDOCR REV, V28, P778, DOI 10.1210/er.2007-0019; Heemers HV, 2009, CANCER CELL, V15, P245, DOI 10.1016/j.ccr.2009.03.009; Heinlein CA, 2002, ENDOCR REV, V23, P175, DOI 10.1210/er.23.2.175; Helsen C, 2014, MOL CELL ENDOCRINOL, V382, P97, DOI 10.1016/j.mce.2013.09.009; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; KEMPPAINEN JA, 1992, J BIOL CHEM, V267, P968; Kon N, 2010, ONCOGENE, V29, P1270, DOI 10.1038/onc.2009.427; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lecona E, 2015, MOL CELL BIOL, V35, P1157, DOI 10.1128/MCB.01197-14; Lee HJ, 2003, CELL MOL LIFE SCI, V60, P1613, DOI 10.1007/s00018-003-2309-3; Li MY, 2002, NATURE, V416, P648, DOI 10.1038/nature737; Li MY, 2004, MOL CELL, V13, P879, DOI 10.1016/S1097-2765(04)00157-1; Lin HK, 2002, EMBO J, V21, P4037, DOI 10.1093/emboj/cdf406; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Masuya D, 2006, J PATHOL, V208, P724, DOI 10.1002/path.1931; Matsumoto T, 2013, ANNU REV PHYSIOL, V75, P201, DOI 10.1146/annurev-physiol-030212-183656; McKenna NJ, 2002, CELL, V108, P465, DOI 10.1016/S0092-8674(02)00641-4; Nelson WG, 2003, NEW ENGL J MED, V349, P366, DOI 10.1056/NEJMra021562; Nicholson B, 2011, CELL BIOCHEM BIOPHYS, V60, P61, DOI 10.1007/s12013-011-9185-5; Qi JF, 2013, CANCER CELL, V23, P332, DOI 10.1016/j.ccr.2013.02.016; R Core Team, 2013, LANG ENV STAT COMP; Ramos-Montoya A, 2014, EMBO MOL MED, V6, P651, DOI 10.1002/emmm.201303581; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Song MS, 2008, NATURE, V455, P813, DOI 10.1038/nature07290; Sramkoski RM, 1999, IN VITRO CELL DEV-AN, V35, P403; Taplin ME, 2007, NAT CLIN PRACT ONCOL, V4, P236, DOI 10.1038/ncponc0765; Tepper CG, 2002, CANCER RES, V62, P6606; van der Horst A, 2006, NAT CELL BIOL, V8, P1064, DOI 10.1038/ncb1469; van der Knaap JA, 2005, MOL CELL, V17, P695, DOI 10.1016/j.molcel.2005.02.013; van der Steen T, 2013, INT J MOL SCI, V14, P14833, DOI 10.3390/ijms140714833; Wang QB, 2005, MOL CELL, V19, P631, DOI 10.1016/j.molcel.2005.07.018; Wang QB, 2007, MOL CELL, V27, P380, DOI 10.1016/j.molcel.2007.05.041; Whitfield GK, 1999, J CELL BIOCHEM, P110; WILSON JD, 1983, AUST J BIOL SCI, V36, P101; Xu KX, 2009, CANCER CELL, V15, P270, DOI 10.1016/j.ccr.2009.02.021	50	43	45	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2015	290	35					21713	21723		10.1074/jbc.M114.628255	http://dx.doi.org/10.1074/jbc.M114.628255			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ5IS	26175158	Green Published, hybrid			2022-12-26	WOS:000360637600042
J	Beraud, G; Kazmercziak, S; Beutels, P; Levy-Bruhl, D; Lenne, X; Mielcarek, N; Yazdanpanah, Y; Boelle, PY; Hens, N; Dervaux, B				Beraud, Guillaume; Kazmercziak, Sabine; Beutels, Philippe; Levy-Bruhl, Daniel; Lenne, Xavier; Mielcarek, Nathalie; Yazdanpanah, Yazdan; Boelle, Pierre-Yves; Hens, Niel; Dervaux, Benoit			The French Connection: The First Large Population-Based Contact Survey in France Relevant for the Spread of Infectious Diseases	PLOS ONE			English	Article							SOCIAL CONTACTS; PANDEMIC INFLUENZA; MIXING PATTERNS; TRANSMISSION; MODELS; SCHOOL; BEHAVIOR; IMPACT; VIRUS	Background Empirical social contact patterns are essential to understand the spread of infectious diseases. To date, no such data existed for France. Although infectious diseases are frequently seasonal, the temporal variation of contact patterns has not been documented hitherto. Methods COMES-F is the first French large-scale population survey, carried out over 3 different periods (February-March, April, April-May) with some participants common to the first and the last period. Participants described their contacts for 2 consecutive days, and reported separately on professional contacts when typically over 20 per day. Results 2033 participants reported 38 881 contacts (weighted median [first quartile-third quartile]: 8[5-14] per day), and 54 378 contacts with supplementary professional contacts (9[5-17]). Contrary to age, gender, household size, holidays, weekend and occupation, period of the year had little influence on the number of contacts or the mixing patterns. Contact patterns were highly assortative with age, irrespective of the location of the contact, and gender, with women having 8% more contacts than men. Although most contacts occurred at home and at school, the inclusion of professional contacts modified the structure of the mixing patterns. Holidays and weekends reduced dramatically the number of contacts, and as proxies for school closure, reduced R-0 by 33% and 28%, respectively. Thus, school closures could have an important impact on the spread of close contact infections in France. Conclusions Despite no clear evidence for temporal variation, trends suggest that more studies are needed. Age and gender were found important determinants of the mixing patterns. Gender differences in mixing patterns might help explain gender differences in the epidemiology of infectious diseases.	[Beraud, Guillaume] Ctr Hosp Poitiers, Med Interne & Malad Infect, Poitiers, France; [Beraud, Guillaume; Dervaux, Benoit] Univ Lille 2, EA2694, Lille, France; [Beraud, Guillaume; Hens, Niel] Hasselt Univ, Interuniv Inst Biostat & Stat Bioinformat, Hasselt, Belgium; [Kazmercziak, Sabine] Univ Catholique Lille, CRESGE, Lille, France; [Beutels, Philippe; Hens, Niel] Univ Antwerp, Vaccine & Infect Dis Inst, Ctr Hlth Econ Res & Modeling Infect Dis, B-2020 Antwerp, Belgium; [Levy-Bruhl, Daniel] InVS, Dept Malad Infect, St Maurice, France; [Lenne, Xavier] Univ Lille Nord, CHU Lille, Dept Informat Med, Lille, France; [Mielcarek, Nathalie] Inst Pasteur, Ctr Infect & Immun Lille, F-59019 Lille, France; [Mielcarek, Nathalie] INSERM, U1019, F-59045 Lille, France; [Mielcarek, Nathalie] Inst Pasteur, Ctr Immunol & Biol Parasitaire, CNRS, UMR8204, F-59019 Lille, France; [Mielcarek, Nathalie] Univ Lille Nord France, Lille, France; [Yazdanpanah, Yazdan] Hop Bichat Claude Bernard, Serv Malad Infect & Trop, F-75877 Paris 18, France; [Boelle, Pierre-Yves] INSERM, UMR S 707, Paris, France; [Dervaux, Benoit] CHU Lille, DRCI, F-59037 Lille, France	Universite de Poitiers; Universite de Lille - ISITE; Universite de Lille; Hasselt University; Universite Catholique de Lille; University of Antwerp; Institute of Public Health Surveillance; Universite de Lille - ISITE; CHU Lille; Universite de Lille; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; CHU Lille	Beraud, G (corresponding author), Ctr Hosp Poitiers, Med Interne & Malad Infect, Poitiers, France.	beraudguillaume@gmail.com	Calmette, Albert/Q-2318-2016; Beutels, Philippe/A-1919-2010; Béraud, Guillaume/O-6062-2017; Hens, Niel/M-4445-2017; Dervaux, Benoit/O-6002-2016	Calmette, Albert/0000-0002-1852-0122; Beutels, Philippe/0000-0001-5034-3595; Béraud, Guillaume/0000-0002-4705-0916; Hens, Niel/0000-0003-1881-0637; Levy-Bruhl, Daniel/0000-0002-4246-0932; Dervaux, Benoit/0000-0002-8429-2404; Mielcarek, Nathalie/0000-0002-5968-9442	GlaxoSmithKline; Hasselt University [BOF14BL07]	GlaxoSmithKline(GlaxoSmithKline); Hasselt University	GlaxoSmithKline provided an unconditional grant to Universite Catholique de Lille to which belong SK. GB acknowledges support from a bilateral special research fund from Hasselt University (BOF14BL07). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbara AM, 2012, CAN J PUBLIC HEALTH, V103, P69, DOI 10.1007/BF03404072; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Chan TC, 2015, EPIDEMIOL INFECT, V143, P440, DOI 10.1017/S0950268814000843; Chowell G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008164; Cowling BJ, 2008, EPIDEMIOL INFECT, V136, P562, DOI 10.1017/S0950268807008722; De Cao E, 2014, BIOSTATISTICS, V15, P470, DOI 10.1093/biostatistics/kxu008; DeStefano F, 2011, EPIDEMIOL INFECT, V139, P1181, DOI 10.1017/S095026881000230X; DIEKMANN O, 1990, J MATH BIOL, V28, P365; Eshima N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042261; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; France AM, 2010, J INFECT DIS, V201, P984, DOI 10.1086/651145; Fu YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045113; Fumanelli L, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002673; Germann TC, 2006, P NATL ACAD SCI USA, V103, P5935, DOI 10.1073/pnas.0601266103; Glass RJ, 2006, EMERG INFECT DIS, V12, P1671, DOI 10.3201/eid1211.060255; Grijalva CG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118457; Gustafson PE, 1998, RISK ANAL, V18, P805, DOI 10.1023/B:RIAN.0000005926.03250.c0; Haslam N, 2014, J ROY SOC MED, V107, P157, DOI 10.1177/0141076813519439; Hens N, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-187; Hens N, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-5; Horby P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016965; INSEE: National Institute of Statistics and Economic Studies, 2009, REC POP; Keeling MJ., 2011, MODELING INFECT DIS, DOI [10.2307/j.ctvcm4gk0, DOI 10.2307/J.CTVCM4GK0]; Keogh-Brown MR, 2010, EUR J HEALTH ECON, V11, P543, DOI 10.1007/s10198-009-0210-1; Klein SL, 2012, J LEUKOCYTE BIOL, V92, P67, DOI 10.1189/jlb.0811427; Lapidus N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060127; Lowen AC, 2007, PLOS PATHOG, V3, P1470, DOI 10.1371/journal.ppat.0030151; Markel H, 2007, JAMA-J AM MED ASSOC, V298, P644, DOI 10.1001/jama.298.6.644; McCaw JM, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-345; Melegaro A, 2011, EPIDEMICS-NETH, V3, P143, DOI 10.1016/j.epidem.2011.04.001; Metcalf CJE, 2009, P ROY SOC B-BIOL SCI, V276, P4111, DOI 10.1098/rspb.2009.1058; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; Ogunjimi B, 2009, MATH BIOSCI, V218, P80, DOI 10.1016/j.mbs.2008.12.009; Read JM, 2008, J R SOC INTERFACE, V5, P1001, DOI 10.1098/rsif.2008.0013; Read JM, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0268; Rohani P, 2010, SCIENCE, V330, P982, DOI 10.1126/science.1194134; Smieszek T, 2012, EPIDEMIOL INFECT, V140, P744, DOI 10.1017/S0950268811001130; Stehle J, 2013, SOC NETWORKS, V35, P604, DOI 10.1016/j.socnet.2013.08.003; te Beest DE, 2014, EPIDEMICS-NETH, V7, P1, DOI 10.1016/j.epidem.2014.02.001; Vandendijck Y, ANN APPL STAT; Wallinga J, 2006, AM J EPIDEMIOL, V164, P936, DOI 10.1093/aje/kwj317; Williams LJ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0036161, 10.1371/journal.pone.0048695]; Wood SN, 2006, GEN ADDITIVE MODELS; World Health Organization, 2010, SEX GEND INFL; Zagheni E, 2008, AM J EPIDEMIOL, V168, P1082, DOI 10.1093/aje/kwn220	45	94	94	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0133203	10.1371/journal.pone.0133203	http://dx.doi.org/10.1371/journal.pone.0133203			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1RL	26176549	Green Published, Green Submitted, gold			2022-12-26	WOS:000358197600231
J	Hao, JJ; Hao, C; Zhang, LJ; Liu, X; Zhou, XL; Dun, YL; Li, HH; Li, GS; Zhao, XL; An, YY; Liu, JK; Yu, GL				Hao, Jiejie; Hao, Cui; Zhang, Lijuan; Liu, Xin; Zhou, Xiaolin; Dun, Yunlou; Li, Haihua; Li, Guangsheng; Zhao, Xiaoliang; An, Yuanyuan; Liu, Jiankang; Yu, Guangli			OM2, a Novel Oligomannuronate-Chromium (III) Complex, Promotes Mitochondrial Biogenesis and Lipid Metabolism in 3T3-L1 Adipocytes via the AMPK-PGC1 alpha Pathway	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; ADIPOSE-TISSUE; SKELETAL-MUSCLE; ENERGY SENSOR; OLIGOSACCHARIDE; RATS; AMPK; FAT; ROSIGLITAZONE; PGC-1-ALPHA	Background In our previous studies, we prepared novel oligomannuronate-chromium(III) complexes (OM2, OM4) from marine alginate, and found that these compounds sensitize insulin action better than oligomannuronate(OM), chromium, and metformin in C2C12 skeletal muscle cells. In the present study, we studied their effects on mitochondrial biogenesis, lipid metabolism, and the underlying molecular mechanisms in differentiated 3T3-L1 adipocytes. Methodology/Principal Findings We firstly used the pGL3-PGC1 alpha and pGL3-ATGL promoter plasmids to compare their effects on PGC1 alpha and ATGL transcription activities. Then mitochondrial biogenesis was quantified by transmission electron microscopy and MitoTracker staining. Mitochondrial oxygen consumption and fatty acid oxidation were measured by an oxygen biosensor system and H-3-labelled water scintillation. The mitochondrial DNA and mRNA involved in mitochondrial biogenesis and lipid oxidation were evaluated by real-time PCR. AMPK together with other protein expression levels were measured by western blotting. The inhibitor compound C and siRNA of PGC1 alpha were used to inhibit the OM2-induced AMPK-PGC1 alpha signaling pathway. And we found that OM2 stimulated AMPK-PGC1 alpha pathway in the 3T3-L1 adipocytes, which were correlated with induced mitochondrial biogenesis, improved mitochondrial function, and reduced lipid accumulation by enhanced fatty acid beta-oxidation and augmented ATGL protein expression. Conclusions/Significance Our data indicated that the marine oligosaccharide-derived OM2 might represent a novel class of molecules that could be useful for type 2 diabetes prevention and treatment by upregulating AMPK-PGC1 alpha signaling pathway.	[Hao, Jiejie; Hao, Cui; Zhang, Lijuan; Liu, Xin; Zhou, Xiaolin; Dun, Yunlou; Li, Haihua; Li, Guangsheng; Zhao, Xiaoliang; An, Yuanyuan; Yu, Guangli] Ocean Univ China, Minist Educ, Key Lab Marine Drugs, Qingdao 266003, Peoples R China; [Hao, Jiejie; Hao, Cui; Zhang, Lijuan; Liu, Xin; Zhou, Xiaolin; Dun, Yunlou; Li, Haihua; Li, Guangsheng; Zhao, Xiaoliang; An, Yuanyuan; Yu, Guangli] Ocean Univ China, Shandong Prov Key Lab Glycosci & Glycotechnol, Qingdao 266003, Peoples R China; [Liu, Jiankang] Xi An Jiao Tong Univ, Ctr Mitochondrial Biol & Med, Key Lab Biomed Informat Engn, Minist Educ,Sch Life Sci & Technol, Xian 710049, Peoples R China; [Liu, Jiankang] Xi An Jiao Tong Univ, Frontier Inst Sci & Technol, Xian 710049, Peoples R China	Ocean University of China; Ocean University of China; Xi'an Jiaotong University; Xi'an Jiaotong University	Yu, GL (corresponding author), Ocean Univ China, Minist Educ, Key Lab Marine Drugs, 5 Yushan Rd, Qingdao 266003, Peoples R China.	glyu@ouc.edu.cn	Zhang, Li/GWM-7501-2022; Rui, Zhenhua/J-8195-2019; Liu, Jiankang/A-1610-2011	Rui, Zhenhua/0000-0001-6088-0845; 	NSFC-Shandong Joint Fund for Marine Science Research Centers [U1406402]; NSFC [81402982]; Special Fund for Marine Scientific Research in the Public Interest [201005024]; National Key Technology R&D Program of the Ministry of Science and Technology [2013BAB01B02]; 973 Program [2015CB553602]	NSFC-Shandong Joint Fund for Marine Science Research Centers; NSFC(National Natural Science Foundation of China (NSFC)); Special Fund for Marine Scientific Research in the Public Interest; National Key Technology R&D Program of the Ministry of Science and Technology(National Key Technology R&D Program); 973 Program(National Basic Research Program of China)	This study was supported by NSFC-Shandong Joint Fund for Marine Science Research Centers (U1406402), the NSFC (81402982), the Special Fund for Marine Scientific Research in the Public Interest (201005024), the National Key Technology R&D Program of the Ministry of Science and Technology (2013BAB01B02), and the 973 Program (2015CB553602). No potential conflicts of interest relevant to this article were reptorted. The funders had no role in the design and conduct of the study, in the collection, analysis, and interpretation of data, or in the preparation, review, or approval of the manuscript.	Agheli N, 1998, J NUTR, V128, P1283, DOI 10.1093/jn/128.8.1283; An QD, 2009, J APPL MICROBIOL, V106, P161, DOI 10.1111/j.1365-2672.2008.03988.x; Bolten CW, 2007, GENE REGUL SYST BIO, V1, P73; Canto C, 2010, CELL MOL LIFE SCI, V67, P3407, DOI 10.1007/s00018-010-0454-z; Canto C, 2009, CURR OPIN LIPIDOL, V20, P98, DOI 10.1097/MOL.0b013e328328d0a4; Chau MDL, 2010, P NATL ACAD SCI USA, V107, P12553, DOI 10.1073/pnas.1006962107; Chen WL, 2012, DIABETOLOGIA, V55, P1824, DOI 10.1007/s00125-012-2530-4; [陈秀敏 CHEN Xiumin], 2003, [中国生化药物杂志, Chinese Journal of Biochemical Pharmaceutics], V24, P1; Choi D, 2009, APPL BIOCHEM BIOTECH, V159, P438, DOI 10.1007/s12010-008-8514-7; Choo HJ, 2006, DIABETOLOGIA, V49, P784, DOI 10.1007/s00125-006-0170-2; Dogra C, 2007, FASEB J, V21, P1857, DOI 10.1096/fj.06-7537com; Flachs P, 2005, DIABETOLOGIA, V48, P2365, DOI 10.1007/s00125-005-1944-7; Fruhbeck G, 2001, FASEB J, V15, P1996, DOI 10.1096/fj.00-0829hyp; Fruhbeck Gema, 2008, V456, P1, DOI 10.1007/978-1-59745-245-8_1; Gaidhu MP, 2009, J LIPID RES, V50, P704, DOI 10.1194/jlr.M800480-JLR200; Gauthier MS, 2008, J BIOL CHEM, V283, P16514, DOI 10.1074/jbc.M708177200; Geng M, 2004, China Patent, Patent No. [10023827.0, 10023827]; Gratia S, 2012, CARDIOVASC RES, V95, P290, DOI 10.1093/cvr/cvs134; Guan H, 2006, China Patent, Patent No. [200610044581.4, 200610044581]; Haemmerle G, 2011, NAT MED, V17, P1076, DOI 10.1038/nm.2439; Hao C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024598; Hao JJ, 2010, J NUTR BIOCHEM, V21, P634, DOI 10.1016/j.jnutbio.2009.03.012; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Hardie DG, 2011, GENE DEV, V25, P1895, DOI 10.1101/gad.17420111; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Kim JN, 2009, ISLETS, V1, P111, DOI 10.4161/isl.1.2.9143; Krol E, 2010, FOOD CHEM TOXICOL, V48, P2791, DOI 10.1016/j.fct.2010.07.008; Langelueddecke C, 2012, CELL PHYSIOL BIOCHEM, V29, P75, DOI 10.1159/000337589; Langin D, 2006, PHARMACOL RES, V53, P482, DOI 10.1016/j.phrs.2006.03.009; Ma JG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003774; Manabe N, DIS ESOPHAGUS; Morak M, 2012, MOL CELL PROTEOMICS, V11, P1777, DOI 10.1074/mcp.M111.015743; Moreira PI, 2011, HANDB EXP PHARMACOL, V203, P331, DOI 10.1007/978-3-642-17214-4_14; Nisoli E, 2005, SCIENCE, V310, P314, DOI 10.1126/science.1117728; Phielix E, 2010, DIABETOLOGIA, V53, P1714, DOI 10.1007/s00125-010-1764-2; Reznick RM, 2006, J PHYSIOL-LONDON, V574, P33, DOI 10.1113/jphysiol.2006.109512; Rong JX, 2007, DIABETES, V56, P1751, DOI 10.2337/db06-1135; Sahin K, 2011, BIOL TRACE ELEM RES, V143, P1018, DOI 10.1007/s12011-010-8905-9; Shimabukuro M, 1997, P NATL ACAD SCI USA, V94, P4637, DOI 10.1073/pnas.94.9.4637; Short KR, 2003, DIABETES, V52, P1888, DOI 10.2337/diabetes.52.8.1888; Strugala V, 2009, J PHARM PHARMACOL, V61, P1021, DOI 10.1211/jpp/61.08.0005; Szendroedi J, 2009, DIABETES CARE, V32, P677, DOI 10.2337/dc08-2078; Toseland CDN, 2001, DIABETES OBES METAB, V3, P163, DOI 10.1046/j.1463-1326.2001.00117.x; Tusi SK, 2011, BIOMATERIALS, V32, P5438, DOI 10.1016/j.biomaterials.2011.04.024; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Yuan WP, 2009, WORLD J GASTROENTERO, V15, P1339, DOI 10.3748/wjg.15.1339; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747	47	13	17	4	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0131930	10.1371/journal.pone.0131930	http://dx.doi.org/10.1371/journal.pone.0131930			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176781	Green Published, gold, Green Submitted			2022-12-26	WOS:000358197600069
J	Kuhle, S; Maguire, B; Ata, N; Hamilton, D				Kuhle, Stefan; Maguire, Bryan; Ata, Nicole; Hamilton, David			Percentile Curves for Anthropometric Measures for Canadian Children and Youth	PLOS ONE			English	Article							TO-HEIGHT RATIO; WAIST CIRCUMFERENCE PERCENTILES; CARDIOVASCULAR RISK-FACTORS; BODY-MASS INDEX; ABDOMINAL OBESITY; SKINFOLD THICKNESSES; GROWTH REFERENCE; FAT DISTRIBUTION; CENTILE CURVES; METABOLIC RISK	Body mass index (BMI) is commonly used to assess a child's weight status but it does not provide information about the distribution of body fat. Since the disease risks associated with obesity are related to the amount and distribution of body fat, measures that assess visceral or subcutaneous fat, such as waist circumference (WC), waist-to-height ratio (WHtR), or skinfolds thickness may be more suitable. The objective of this study was to develop percentile curves for BMI, WC, WHtR, and sum of 5 skinfolds (SF5) in a representative sample of Canadian children and youth. The analysis used data from 4115 children and adolescents between 6 and 19 years of age that participated in the Canadian Health Measures Survey Cycles 1 (2007/2009) and 2 (2009/2011). BMI, WC, WHtR, and SF5 were measured using standardized procedures. Age-and sex-specific centiles were calculated using the LMS method and the percentiles that intersect the adult cutpoints for BMI, WC, and WHtR at age 18 years were determined. Percentile curves for all measures showed an upward shift compared to curves from the pre-obesity epidemic era. The adult cutoffs for overweight and obesity corresponded to the 72nd and 91st percentile, respectively, for both sexes. The current study has presented for the first time percentile curves for BMI, WC, WHtR, and SF5 in a representative sample of Canadian children and youth. The percentile curves presented are meant to be descriptive rather than prescriptive as associations with cardiovascular disease markers or outcomes were not assessed.	[Kuhle, Stefan; Maguire, Bryan] Dalhousie Univ, Dept Pediat, Halifax, NS, Canada; [Kuhle, Stefan; Maguire, Bryan] Dalhousie Univ, Dept Obstet & Gynaecol, Halifax, NS, Canada; [Maguire, Bryan; Hamilton, David] Dalhousie Univ, Dept Math & Stat, Halifax, NS, Canada; [Ata, Nicole] Dalhousie Univ, Sch Hlth & Human Performance, Halifax, NS, Canada	Dalhousie University; Dalhousie University; Dalhousie University; Dalhousie University	Kuhle, S (corresponding author), Dalhousie Univ, Dept Pediat, Halifax, NS, Canada.	stefan.kuhle@dal.ca	Kuhle, Stefan/X-5815-2019	Kuhle, Stefan/0000-0001-9417-3727	IWK Health Centre Establishment Grant award [09020]	IWK Health Centre Establishment Grant award	This work was supported by an IWK Health Centre (http://www.iwk.nshealth.ca) Establishment Grant awarded to Dr. Stefan Kuhle (# 09020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addo OY, 2010, AM J CLIN NUTR, V91, P635, DOI 10.3945/ajcn.2009.28385; [Anonymous], 2014, R LANG ENV STAT COMP; Anzo M, 2014, ANN HUM BIOL, P1; Ashwell M, 2012, OBES REV, V13, P275, DOI 10.1111/j.1467-789X.2011.00952.x; Brambilla P, 2006, INT J OBESITY, V30, P23, DOI 10.1038/sj.ijo.0803163; Brannsether B, 2011, ACTA PAEDIATR, V100, P1576, DOI 10.1111/j.1651-2227.2011.02370.x; Canadian Society for Exercise Physiology, 2003, CAN PHYS ACT FITN LI; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; COLE TJ, 1992, STAT MED, V11, P1305, DOI 10.1002/sim.4780111005; Daniels SR, 1999, CIRCULATION, V99, P541, DOI 10.1161/01.CIR.99.4.541; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; Frankenfield DC, 2001, NUTRITION, V17, P26, DOI 10.1016/S0899-9007(00)00471-8; Freedman DS, 2009, PEDIATRICS, V124, pS23, DOI 10.1542/peds.2008-3586E; FREEDMAN DS, 1985, JAMA-J AM MED ASSOC, V254, P515, DOI 10.1001/jama.254.4.515; Freedman DS, 1999, AM J CLIN NUTR, V69, P308; Gonzalez AS, 2007, NUTRITION, V23, P36, DOI 10.1016/j.nut.2006.08.019; Gruson E, 2010, HEART, V96, P136, DOI 10.1136/hrt.2009.171447; Hsieh SD, 2003, INT J OBESITY, V27, P610, DOI 10.1038/sj.ijo.0802259; JAMES WPT, 1988, EUR J CLIN NUTR, V42, P969; Katzmarzyk PT, 2004, EUR J CLIN NUTR, V58, P1011, DOI 10.1038/sj.ejcn.1601924; Kromeyer-Hauschild K, 2013, OBESITY FACTS, V6, P165, DOI 10.1159/000351066; Kromeyer-Hauschild K, 2011, INT J PEDIATR OBES, V6, pE129, DOI 10.3109/17477166.2010.490267; Kuczmarski RJ., 2002, VITAL HLTH STAT, V11, P1, DOI DOI 10.1016/J.BBRC.2015.06.114; LEAN MEJ, 1995, BRIT MED J, V311, P158, DOI 10.1136/bmj.311.6998.158; Lee CMY, 2008, J CLIN EPIDEMIOL, V61, P646, DOI 10.1016/j.jclinepi.2007.08.012; Maffeis C, 2001, OBES RES, V9, P179, DOI 10.1038/oby.2001.19; Maffeis C, 2008, J PEDIATR-US, V152, P207, DOI 10.1016/j.jpeds.2007.09.021; MARKS GC, 1989, AM J EPIDEMIOL, V130, P578, DOI 10.1093/oxfordjournals.aje.a115372; McCarthy HD, 2006, INT J OBESITY, V30, P988, DOI 10.1038/sj.ijo.0803226; McCarthy HD, 2001, EUR J CLIN NUTR, V55, P902, DOI 10.1038/sj.ejcn.1601240; Neuhauser H, 2011, REFERENZPERZENTILE A; Nooyens ACJ, 2007, AM J CLIN NUTR, V85, P1533, DOI 10.1093/ajcn/85.6.1533; Reilly JJ, 2003, ARCH DIS CHILD, V88, P748, DOI 10.1136/adc.88.9.748; Rigby RA, 2005, J R STAT SOC C-APPL, V54, P507, DOI 10.1111/j.1467-9876.2005.00510.x; Rigby RA, 2004, STAT MED, V23, P3053, DOI 10.1002/sim.1861; Rigby RA, 2006, STAT MODEL, V6, P209, DOI 10.1191/1471082X06st122oa; Romero-Corral A, 2008, INT J OBESITY, V32, P959, DOI 10.1038/ijo.2008.11; Savva SC, 2000, INT J OBESITY, V24, P1453, DOI 10.1038/sj.ijo.0801401; Statistics Canada, 2013, CAN HLTH MEAS SURV C; Statistics Canada, 2011, CAN HLTH MEAS SURV C; Statistics Canada, 2012, CAN HLTH MEAS SURV C; Ulijaszek SJ, 1999, BRIT J NUTR, V82, P165, DOI 10.1017/S0007114599001348; van Buuren S, 2001, STAT MED, V20, P1259, DOI 10.1002/sim.746; World Health Organization, 1995, PHYS STAT US INT ANT	44	13	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132891	10.1371/journal.pone.0132891	http://dx.doi.org/10.1371/journal.pone.0132891			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176769	Green Published, gold, Green Submitted			2022-12-26	WOS:000358197600174
J	Lian, M; Luo, WJ; Sui, YH; Li, ZP; Hua, J				Lian, Min; Luo, Wenjing; Sui, Yongheng; Li, Zhiping; Hua, Jing			Dietary n-3 PUFA Protects Mice from Con A Induced Liver Injury by Modulating Regulatory T Cells and PPAR-gamma Expression	PLOS ONE			English	Article							ACTIVATED RECEPTOR-GAMMA; POLYUNSATURATED FATTY-ACIDS; FISH-OIL; SYSTEMIC INFLAMMATION; ADIPOSE-TISSUE; IMMUNOREGULATION; GENERATION; RESPONSES; ROLES; RICH	Background Dietary n-3 polyunsaturated fatty acids (PUFA) exert anti-inflammatory and immunoregulatory effects through down-regulating the innate and adoptive immune response. However, the effect of dietary n-3 PUFA on CD4(+)CD25(+) regulatory T cells (Tregs) is unclear. Aims The current study was to examine the relationship between n-3 PUFA and Tregs as well as their immunoregulatory effect in immune-mediated liver injury. Methods The mice model feeding with n-3 PUFA-enriched diet was established and Tregs were analyzed. Effect of docosahexaenoic acid (DHA) on Tregs proliferation and induction was determined in vitro. The potential immunotherapeutic effect of dietary n-3 PUFA was investigated through Con A-induced hepatitis model. Results Long-term administration of dietary n-3 PUFA significantly increased hepatic Tregs and modulated their phenotype. n-3 PUFA or DHA directly increased natural Tregs (nTreg) proliferation but didn't increase inducible Tregs (iTreg). In addition, the expression of peroxisome proliferator activated receptor gamma (PPAR-gamma), transforming growth factor beta (TGF beta) and interleukin (IL)-10 were significantly up-regulated in n-3 PUFA-enriched diet-fed mice. Finally, n-3 PUFA-enriched diet alleviated liver injury induced by Con A and down-regulated pro-inflammatory cytokines expression, accompanied by increased PPAR-gamma expression. Conclusion Dietary n-3 PUFA enhanced Tregs generation through up-regulating PPAR-gamma and TGF-beta expression, and protected mice from Con A-induced liver injury. This finding provides a promising potential therapeutic method in treating inflammatory and autoimmune disease.	[Lian, Min; Luo, Wenjing; Sui, Yongheng; Hua, Jing] Shanghai Jiao Tong Univ, Shanghai Inst Digest Dis, Div Gastroenterol & Hepatol, Ren Ji Hosp,Sch Med, Shanghai 200030, Peoples R China; [Li, Zhiping] Johns Hopkins Univ, Dept Med, Baltimore, MD USA	Shanghai Jiao Tong University; Johns Hopkins University	Hua, J (corresponding author), Shanghai Jiao Tong Univ, Shanghai Inst Digest Dis, Div Gastroenterol & Hepatol, Ren Ji Hosp,Sch Med, Shanghai 200030, Peoples R China.	hua-jing88@hotmail.com			National Natural Science Foundation of China [81170374, 81470842]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (JH, NO. 81170374, NO. 81470842). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anz D, 2011, INT J CANCER, V129, P2417, DOI 10.1002/ijc.25902; Asseman C, 1999, J EXP MED, V190, P995, DOI 10.1084/jem.190.7.995; Belluzzi A, 2000, AM J CLIN NUTR, V71, p339S, DOI 10.1093/ajcn/71.1.339s; Bensinger SJ, 2008, NATURE, V454, P470, DOI 10.1038/nature07202; BERGMEYER HU, 1978, CLIN CHEM, V24, P58; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Camuesco D, 2005, J NUTR, V135, P687, DOI 10.1093/jn/135.4.687; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Cipolletta D, 2012, NATURE, V486, P549, DOI 10.1038/nature11132; Clark RB, 2000, J IMMUNOL, V164, P1364, DOI 10.4049/jimmunol.164.3.1364; Daynes RA, 2002, NAT REV IMMUNOL, V2, P748, DOI 10.1038/nri912; Ferramosca A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038797; Galli C, 2009, ANN NUTR METAB, V55, P123, DOI 10.1159/000228999; Gosset P, 2001, EUR J IMMUNOL, V31, P2857, DOI 10.1002/1521-4141(2001010)31:10<2857::AID-IMMU2857>3.0.CO;2-X; Hammad H, 2004, AM J PATHOL, V164, P263, DOI 10.1016/S0002-9440(10)63116-1; Han SC, 2012, BMC IMMUNOL, V13, DOI 10.1186/1471-2172-13-44; Hara M, 2001, J IMMUNOL, V166, P3789, DOI 10.4049/jimmunol.166.6.3789; Hontecillas R, 2007, J IMMUNOL, V178, P2940, DOI 10.4049/jimmunol.178.5.2940; Hudert CA, 2006, P NATL ACAD SCI USA, V103, P11276, DOI 10.1073/pnas.0601280103; Itariu BK, 2012, AM J CLIN NUTR, V96, P1137, DOI 10.3945/ajcn.112.037432; Iwami D, 2009, AM J TRANSPLANT, V9, P1294, DOI 10.1111/j.1600-6143.2009.02641.x; Iwami D, 2011, INT IMMUNOPHARMACOL, V11, P384, DOI 10.1016/j.intimp.2010.11.035; Jaudszus A, 2013, J LIPID RES, V54, P923, DOI 10.1194/jlr.P031260; Li CC, 2014, J NUTR BIOCHEM, V25, P19, DOI 10.1016/j.jnutbio.2013.08.010; Li J, 2014, MOL ENDOCRINOL, V28, P1316, DOI 10.1210/me.2014-1011; Li ZP, 2005, HEPATOLOGY, V42, P880, DOI 10.1002/hep.20826; Longhi MS, 2006, J IMMUNOL, V176, P4484, DOI 10.4049/jimmunol.176.7.4484; Longhi MS, 2004, J HEPATOL, V41, P31, DOI 10.1016/j.jhep.2004.03.008; Nakamura K, 2001, J EXP MED, V194, P629, DOI 10.1084/jem.194.5.629; Nakamura K, 2004, J IMMUNOL, V172, P834, DOI 10.4049/jimmunol.172.2.834; Sakaguchi S, 2009, INT IMMUNOL, V21, P1105, DOI 10.1093/intimm/dxp095; Shevach EM, 2009, IMMUNITY, V30, P636, DOI 10.1016/j.immuni.2009.04.010; Volker D, 2000, J RHEUMATOL, V27, P2343; Wan YSY, 2006, IMMUNOL REV, V212, P114, DOI 10.1111/j.0105-2896.2006.00407.x; Wei HX, 2008, J IMMUNOL, V181, P7221, DOI 10.4049/jimmunol.181.10.7221; Wohlfert EA, 2007, J IMMUNOL, V178, P4129, DOI 10.4049/jimmunol.178.7.4129; Yang XH, 2006, J HEPATOL, V45, P254, DOI 10.1016/j.jhep.2006.01.036; Yates CM, 2014, PHARMACOL THERAPEUT, V141, P272, DOI 10.1016/j.pharmthera.2013.10.010; Yessoufou A, 2009, J LIPID RES, V50, P2377, DOI 10.1194/jlr.M900101-JLR200; Zhao WP, 2013, CLIN IMMUNOL, V149, P119, DOI 10.1016/j.clim.2013.07.002	40	32	32	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132741	10.1371/journal.pone.0132741	http://dx.doi.org/10.1371/journal.pone.0132741			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177196	Green Published, gold, Green Submitted			2022-12-26	WOS:000358197600149
J	Song, CG; Wang, JC; Mo, CP; Mu, SH; Jiang, XG; Li, XY; Zhong, SZ; Zhao, ZF; Zhou, GQ				Song, Chengang; Wang, Jiachuan; Mo, Cuiping; Mu, Shuhua; Jiang, Xiaogang; Li, Xiaoyun; Zhong, Shizhen; Zhao, Zhenfu; Zhou, Guangqian			Use of Ferritin Expression, Regulated by Neural Cell-Specific Promoters in Human Adipose Tissue-Derived Mesenchymal Stem Cells, to Monitor Differentiation with Magnetic Resonance Imaging In Vitro	PLOS ONE			English	Article							IRON-OXIDE; TRACKING; VIVO; TRANSPLANTATION; OVEREXPRESSION; SURVIVAL; REPORTER; HEART; MODEL; GENE	The purpose of this study was to establish a method for monitoring the neural differentiation of stem cells using ferritin transgene expression, under the control of a neural-differentiation-inducible promoter, and magnetic resonance imaging (MRI). Human adipose tissue-derived mesenchymal stem cells (hADMSCs) were transduced with a lentivirus containing the human ferritin heavy chain 1 (FTH1) gene coupled to one of three neural cell-specific promoters: human synapsin 1 promoter (SYN1p, for neurons), human glial fibrillary acidic protein promoter (GFAPp, for astrocytes), and human myelin basic protein promoter (MBPp, for oligodendrocytes). Three groups of neural-differentiation-inducible ferritin-expressing (NDIFE) hADMSCs were established: SYN1p-FTH1, GFAPp-FTH1, and MBPp-FTH1. The proliferation rate of the NDIFE hADMSCs was evaluated using a Cell Counting Kit-8 assay. Ferritin expression was assessed with western blotting and immunofluorescent staining before and after the induction of differentiation in NDIFE hADMSCs. The intracellular iron content was measured with Prussian blue iron staining and inductively coupled plasma mass spectrometry. R2 relaxation rates were measured with MRI in vitro. The proliferation rates of control and NDIFE hADMSCs did not differ significantly (P > 0.05). SYN1p-FTH1, GFAPp-FTH1, and MBPp-FTH1 hADMSCs expressed specific markers of neurons, astrocytes, and oligodendrocytes, respectively, after neural differentiation. Neural differentiation increased ferritin expression twofold, the intracellular iron content threefold, and the R2 relaxation rate two-to threefold in NDIFE hADMSCs, resulting in notable hypointensity in T2-weighted images (P < 0.05). These results were cross-validated. Thus, a link between neural differentiation and MRI signals (R2 relaxation rate) was established in hADMSCs. The use of MRI and neural-differentiation-inducible ferritin expression is a viable method for monitoring the neural differentiation of hADMSCs.	[Song, Chengang; Zhong, Shizhen] Southern Med Univ, Inst Clin Anat, Dept Anat, Guangzhou, Guangdong, Peoples R China; [Wang, Jiachuan; Mo, Cuiping; Mu, Shuhua; Zhao, Zhenfu; Zhou, Guangqian] Shenzhen Univ, Sch Med, Shenzhen, Peoples R China; [Wang, Jiachuan] Guangzhou Univ Tradit Chinese Med, Dept Pathol, Shenzhen Affiliated Hosp, Shenzhen, Peoples R China; [Jiang, Xiaogang] Southern Med Univ, Dept Pathol, Guangzhou, Guangdong, Peoples R China; [Li, Xiaoyun] S China Normal Univ, Guangdong Prov Key Lab Biotechnol Plant Dev, Coll Life Sci, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Shenzhen University; Guangzhou University of Chinese Medicine; Southern Medical University - China; South China Normal University	Zhong, SZ (corresponding author), Southern Med Univ, Inst Clin Anat, Dept Anat, Guangzhou, Guangdong, Peoples R China.	zhszh@fimmu.com; zhb@szu.edu.cn; gqzhou@szu.edu.cn	MU, shuhua/CAG-2304-2022; 王, 家传/ACG-4186-2022	王, 家传/0000-0001-9517-924X; mu, shuhua/0000-0002-4457-6795	Shenzhen Key Laboratory foundation [ZDSYS 20140509100746679]; Natural Science Foundation of Shenzhen University [201119]; Medical Science Foundation of Guangdong Province [A2014511]; science technology and innovation committee of Shenzhen for basic research projects [JYJC20130327093948937, JCYJ20130401164750005]	Shenzhen Key Laboratory foundation; Natural Science Foundation of Shenzhen University; Medical Science Foundation of Guangdong Province; science technology and innovation committee of Shenzhen for basic research projects	The Shenzhen Key Laboratory foundation (No. ZDSYS 20140509100746679), the Natural Science Foundation of Shenzhen University (No. 201119), the Medical Science Foundation of Guangdong Province (No. A2014511), and the science technology and innovation committee of Shenzhen for basic research projects (Grant Nos. JYJC20130327093948937 and JCYJ20130401164750005).	Bahat-Stroomza M, 2009, J MOL NEUROSCI, V39, P199, DOI 10.1007/s12031-008-9166-3; BARRES BA, 1993, DEVELOPMENT, V118, P283; Campan M, 2011, AM J PHYSIOL-HEART C, V300, pH2238, DOI 10.1152/ajpheart.00935.2010; Cecchi C, 2011, J ALZHEIMERS DIS, V27, P651, DOI 10.3233/JAD-2011-110590; Choong PF, 2007, CYTOTHERAPY, V9, P170, DOI 10.1080/14653240701196829; Guan M, 2014, EUR CYTOKINE NETW, V25, P58, DOI 10.1684/ecn.2014.0357; Guan YM, 2014, BMC NEUROSCI, V15, DOI 10.1186/1471-2202-15-41; Hill PJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025409; Hou ZL, 2013, CELL ADHES MIGR, V7, P404, DOI 10.4161/cam.26941; Janowski M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097631; Kuroda H, 2008, J GENE MED, V10, P1163, DOI 10.1002/jgm.1249; Lee JH, 2012, BIOMATERIALS, V33, P4861, DOI 10.1016/j.biomaterials.2012.03.035; Leite C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111059; Liu J, 2009, TISSUE ENG PART C-ME, V15, P739, DOI 10.1089/ten.TEC.2008.0678; Naumova AV, 2014, J CARDIOVASC PHARM T, V19, P358, DOI 10.1177/1074248414525999; Naumova AV, 2010, MOL IMAGING, V9, P201, DOI 10.2310/7290.2010.00020; Park HW, 2007, PROTEOMICS, V7, P2881, DOI 10.1002/pmic.200700089; Stacpoole SRL, 2013, STEM CELL REP, V1, P437, DOI 10.1016/j.stemcr.2013.09.006; Wang FF, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-52; WRABETZ L, 1993, J NEUROSCI RES, V36, P455, DOI 10.1002/jnr.490360412; Yan YF, 2014, NEURAL REGEN RES, V9, P798, DOI 10.4103/1673-5374.131596; Yin XF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105118	22	6	8	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132480	10.1371/journal.pone.0132480	http://dx.doi.org/10.1371/journal.pone.0132480			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176961	Green Submitted, gold, Green Published			2022-12-26	WOS:000358197600116
J	Wu, JX; Zhang, ZG; Zhang, Q; Liu, YY; Zhu, BT; Cao, J; Li, ZP; Han, LZ; Jia, JZ; Zhao, GY; Sun, XH				Wu, Jinxia; Zhang, Zhiguo; Zhang, Qian; Liu, Yayun; Zhu, Butuo; Cao, Jian; Li, Zhanpeng; Han, Longzhi; Jia, Jizeng; Zhao, Guangyao; Sun, Xuehui			Generation of Wheat Transcription Factor FOX Rice Lines and Systematic Screening for Salt and Osmotic Stress Tolerance	PLOS ONE			English	Article							FULL-LENGTH CDNA; ABIOTIC STRESSES; FUNCTIONAL-ANALYSIS; EXPRESSION SYSTEM; DRAFT SEQUENCE; HUNTING SYSTEM; OF-FUNCTION; T-DNA; GENE; GENOME	Transcription factors (TFs) play important roles in plant growth, development, and responses to environmental stress. In this study, we collected 1,455 full-length (FL) cDNAs of TFs, representing 45 families, from wheat and its relatives Triticum urartu, Aegilops speltoides, Aegilops tauschii, Triticum carthlicum, and Triticum aestivum. More than 15,000 T-0 TF FOX (Full-length cDNA Over-eXpressing) rice lines were generated; of these, 10,496 lines set seeds. About 14.88% of the T-0 plants showed obvious phenotypic changes. T-1 lines (5,232 lines) were screened for salt and osmotic stress tolerance using 150 mM NaCl and 20% (v/v) PEG-4000, respectively. Among them, five lines (591, 746, 1647, 1812, and J4065) showed enhanced salt stress tolerance, five lines (591, 746, 898, 1078, and 1647) showed enhanced osmotic stress tolerance, and three lines (591, 746, and 1647) showed both salt and osmotic stress tolerance. Further analysis of the T-DNA flanking sequences showed that line 746 over-expressed TaEREB1, line 898 over-expressed TabZIPD, and lines 1812 and J4065 over-expressed TaOBF1a and TaOBF1b, respectively. The enhanced salt and osmotic stress tolerance of lines 898 and 1812 was confirmed by retransformation of the respective genes. Our results demonstrate that a heterologous FOX system may be used as an alternative genetic resource for the systematic functional analysis of the wheat genome.	[Wu, Jinxia; Zhang, Zhiguo; Zhang, Qian; Liu, Yayun; Zhu, Butuo; Li, Zhanpeng; Sun, Xuehui] Chinese Acad Agr Sci, Biotechnol Res Inst, Natl Key Facil Gene Resources & Gene Improvement, Beijing 100081, Peoples R China; [Cao, Jian; Han, Longzhi; Jia, Jizeng; Zhao, Guangyao] Chinese Acad Agr Sci, Inst Crop Sci, Chinese Natl Key Facil Gene Resources & Gene Impr, Beijing 100081, Peoples R China	Chinese Academy of Agricultural Sciences; Biotechnology Research Institute, CAAS; Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS	Zhao, GY (corresponding author), Chinese Acad Agr Sci, Inst Crop Sci, Chinese Natl Key Facil Gene Resources & Gene Impr, Beijing 100081, Peoples R China.	zhaoguangyao@caas.cn; sunxuehui@caas.cn			National Special Grant for Transgenic Crops [ZX08001-003, ZX08009-24B]	National Special Grant for Transgenic Crops	This research was funded by National Special Grant for Transgenic Crops (ZX08001-003 and ZX08009-24B).	Albinsky D, 2010, MOL PLANT, V3, P125, DOI 10.1093/mp/ssp069; Baloglu MC, 2014, GENE, V550, P117, DOI 10.1016/j.gene.2014.08.025; Brenchley R, 2012, NATURE, V491, P705, DOI 10.1038/nature11650; Chen RM, 2005, PLANT SCI, V169, P1146, DOI 10.1016/j.plantsci.2005.07.018; Chen WQJ, 2004, TRENDS PLANT SCI, V9, P591, DOI 10.1016/j.tplants.2004.10.007; Dubouzet JG, 2011, PLANT BIOTECHNOL J, V9, P466, DOI 10.1111/j.1467-7652.2010.00568.x; Goff SA, 2002, SCIENCE, V296, P92, DOI 10.1126/science.1068275; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; Higuchi M, 2012, METHODS MOL BIOL, V847, P75, DOI 10.1007/978-1-61779-558-9_8; Higuchi M, 2011, METHODS MOL BIOL, V678, P77, DOI 10.1007/978-1-60761-682-5_7; Higuchi-Takeuchi M, 2013, INT J DEV BIOL, V57, P517, DOI 10.1387/ijdb.130176mm; Higuchi-Takeuchi M, 2011, PLANT PHYSIOL, V157, P96, DOI 10.1104/pp.111.181248; Huang XY, 2009, GENE DEV, V23, P1805, DOI 10.1101/gad.1812409; Jia JZ, 2013, NATURE, V496, P91, DOI 10.1038/nature12028; Kobayashi F, 2008, J EXP BOT, V59, P891, DOI 10.1093/jxb/ern014; Kovalchuk N, 2013, PLANT BIOTECHNOL J, V11, P659, DOI 10.1111/pbi.12056; Kuromori T, 2009, PLANT CELL PHYSIOL, V50, P1215, DOI 10.1093/pcp/pcp078; Lin R, 2007, PHYSIOL MOL PLANT P, V70, P60, DOI 10.1016/j.pmpp.2007.06.002; Ling HQ, 2013, NATURE, V496, P87, DOI 10.1038/nature11997; Mao X, 2014, PLOS ONE, V10; Marcolino-Gomes J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062294; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Nakamura H, 2007, PLANT MOL BIOL, V65, P357, DOI 10.1007/s11103-007-9243-y; Peng H, 2005, PLANT SCI, V168, P1571, DOI 10.1016/j.plantsci.2005.02.011; Rong W, 2014, PLANT BIOTECHNOL J, V12, P468, DOI 10.1111/pbi.12153; Sakurai T, 2011, PLANT CELL PHYSIOL, V52, P265, DOI 10.1093/pcp/pcq190; Wan SY, 2009, PLANT MOL BIOL, V69, P69, DOI 10.1007/s11103-008-9406-5; Wang YH, 2009, PLANT MOL BIOL REP, V27, P454, DOI 10.1007/s11105-009-0111-6; Yang YZ, 2004, PLANT SCI, V167, P281, DOI 10.1016/j.plantsci.2004.03.026; Yi N, 2010, PLANTA, V232, P743, DOI 10.1007/s00425-010-1212-z; Yu J, 2002, SCIENCE, V296, P79, DOI 10.1126/science.1068037; Zhang GY, 2009, J EXP BOT, V60, P3781, DOI 10.1093/jxb/erp214; Zhang LC, 2014, PLANT CELL PHYSIOL, V55, P1802, DOI 10.1093/pcp/pcu109; Zhang LN, 2015, PHYSIOL PLANTARUM, V153, P538, DOI 10.1111/ppl.12261	34	10	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132314	10.1371/journal.pone.0132314	http://dx.doi.org/10.1371/journal.pone.0132314			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176782	gold, Green Submitted, Green Published			2022-12-26	WOS:000358197600099
J	Adhi, M; Ferrara, D; Mullins, RF; Baumal, CR; Mohler, KJ; Kraus, MF; Liu, J; Badaro, E; Alasil, T; Hornegger, J; Fujimoto, JG; Duker, JS; Waheed, NK				Adhi, Mehreen; Ferrara, Daniela; Mullins, Robert F.; Baumal, Caroline R.; Mohler, Kathrin J.; Kraus, Martin F.; Liu, Jonathan; Badaro, Emmerson; Alasil, Tarek; Hornegger, Joachim; Fujimoto, James G.; Duker, Jay S.; Waheed, Nadia K.			Characterization of Choroidal Layers in Normal Aging Eyes Using Enface Swept-Source Optical Coherence Tomography	PLOS ONE			English	Article							NERVE-FIBER LAYER; HEALTHY EYES; MACULAR DEGENERATION; THICKNESS; CHORIOCAPILLARIS; FEATURES	Purpose To characterize qualitative and quantitative features of the choroid in normal eyes using enface swept-source optical coherence tomography (SS-OCT). Methods Fifty-two eyes of 26 consecutive normal subjects were prospectively recruited to obtain multiple three-dimensional 12x12mm volumetric scans using a long-wavelength high-speed SS-OCT prototype. A motion-correction algorithm merged multiple SS-OCT volumes to improve signal. Retinal pigment epithelium (RPE) was segmented as the reference and enface images were extracted at varying depths every 4.13 mu m intervals. Systematic analysis of the choroid at different depths was performed to qualitatively assess the morphology of the choroid and quantify the absolute thicknesses as well as the relative thicknesses of the choroidal vascular layers including the choroidal microvasculature (choriocapillaris, terminal arterioles and venules; CC) and choroidal vessels (CV) with respect to the subfoveal total choroidal thickness (TC). Subjects were divided into two age groups: younger (<40 years) and older (>= 40 years). Results Mean age of subjects was 41.92 (24-66) years. Enface images at the level of the RPE, CC, CV, and choroidal-scleral interface were used to assess specific qualitative features. In the younger age group, the mean absolute thicknesses were: TC 379.4 mu m (SD +/- 75.7 mu m), CC 81.3 mu m (SD +/- 21.2 mu m) and CV 298.1 mu m (SD +/- 63.7 mu m). In the older group, the mean absolute thicknesses were: TC 305.0 mu m (SD +/- 50.9 mu m), CC 56.4 mu m (SD +/- 12.1 mu m) and CV 248.6 mu m (SD +/- 49.7 mu m). In the younger group, the relative thicknesses of the individual choroidal layers were: CC 21.5% (SD +/- 4.0%) and CV 78.4% (SD +/- 4.0%). In the older group, the relative thicknesses were: CC 18.9% (SD +/- 4.5%) and CV 81.1% (SD +/- 4.5%). The absolute thicknesses were smaller in the older age group for all choroidal layers (TC p=0.006, CC p=0.0003, CV p=0.03) while the relative thickness was smaller only for the CC (p=0.04). Conclusions Enface SS-OCT at 1050nm enables a precise qualitative and quantitative characterization of the individual choroidal layers in normal eyes. Only the CC is relatively thinner in the older eyes. In-vivo evaluation of the choroid at variable depths may be potentially valuable in understanding the natural history of age-related posterior segment disease.	[Adhi, Mehreen; Ferrara, Daniela; Baumal, Caroline R.; Badaro, Emmerson; Alasil, Tarek; Duker, Jay S.; Waheed, Nadia K.] Tufts Med Ctr, New England Eye Ctr, Dept Ophthalmol, Boston, MA 02111 USA; [Adhi, Mehreen; Mohler, Kathrin J.; Kraus, Martin F.; Liu, Jonathan; Fujimoto, James G.] MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA; [Adhi, Mehreen; Mohler, Kathrin J.; Kraus, Martin F.; Liu, Jonathan; Fujimoto, James G.] MIT, Elect Res Lab, Cambridge, MA 02139 USA; [Mullins, Robert F.] Univ Iowa, Dept Ophthalmol & Visual Sci, Iowa City, IA USA; [Mohler, Kathrin J.] Univ Munich, Fac Phys, Munich, Germany; [Kraus, Martin F.; Hornegger, Joachim] Univ Erlangen Nurnberg, Pattern Recognit Lab, D-91054 Erlangen, Germany; [Kraus, Martin F.; Hornegger, Joachim] Univ Erlangen Nurnberg, Grad Sch Adv Opt Technol, D-91054 Erlangen, Germany	Tufts Medical Center; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); University of Iowa; University of Munich; University of Erlangen Nuremberg; University of Erlangen Nuremberg	Waheed, NK (corresponding author), Tufts Med Ctr, New England Eye Ctr, Dept Ophthalmol, Boston, MA 02111 USA.	nadiakwaheed@gmail.com	Mullins, Robert F/I-6717-2013; Adhi, Mehreen/AAS-9733-2021; Hornegger, Joachim/H-2465-2017	Hornegger, Joachim/0000-0002-1834-8844; Mullins, Robert/0000-0002-5006-0891	National Institute of Health [R01-EY011289-27, R44EY022864-01, R01-CA075289-16]; Air Force Office of Scientific Research [FA9550-10-1-0551, FA9550-10-1-0063]; Research to Prevent Blindness; Massachusetts Lions Clubs; DFG German Science Foundation [DFG-GSC80-SAOT]; NATIONAL CANCER INSTITUTE [R01CA075289] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY011289, R44EY022864] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Massachusetts Lions Clubs; DFG German Science Foundation(German Research Foundation (DFG)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by funding from National Institute of Health (R01-EY011289-27, R44EY022864-01, R01-CA075289-16) to JGF; Air Force Office of Scientific Research (FA9550-10-1-0551 and FA9550-10-1-0063) to JGF; Research to Prevent Blindness unrestricted grant to the New England Eye Center (JSD); Massachusetts Lions Clubs (JSD); DFG German Science Foundation (DFG-GSC80-SAOT) to JH. The funding organizations had no role in design or conduct of this research.	Adhi M, 2014, AM J OPHTHALMOL, V157, P1272, DOI 10.1016/j.ajo.2014.02.034; Alizadeh Yousef, 2014, J Ophthalmic Vis Res, V9, P38; ANSI, 2007, Z136 ANSI; Branchini LA, 2013, OPHTHALMOLOGY, V120, P1901, DOI 10.1016/j.ophtha.2013.01.066; CARPEL EF, 1981, AM J OPHTHALMOL, V91, P588, DOI 10.1016/0002-9394(81)90056-8; Esmaeelpour M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099690; Ferrara D, 2014, OPHTHALMOLOGY, V121, P719, DOI 10.1016/j.ophtha.2013.10.014; Flores-Moreno I, 2013, AM J OPHTHALMOL, V155, P314, DOI 10.1016/j.ajo.2012.07.015; Gurses-Ozden R, 2004, J GLAUCOMA, V13, P238; HAYREH SS, 1990, EYE, V4, P273, DOI 10.1038/eye.1990.39; HAYREH SS, 1975, BRIT J OPHTHALMOL, V59, P631, DOI 10.1136/bjo.59.11.631; Hsu SY, 2008, J GLAUCOMA, V17, P30, DOI 10.1097/IJG.0b013e31811243b4; Ikuno Y, 2010, INVEST OPHTH VIS SCI, V51, P2173, DOI 10.1167/iovs.09-4383; Kim SW, 2011, RETINA-J RET VIT DIS, V31, P1904, DOI 10.1097/IAE.0b013e31821801c5; Kraus MF, 2012, BIOMED OPT EXPRESS, V3, P1182, DOI 10.1364/BOE.3.001182; Lopes FSS, 2014, BMC OPHTHALMOL, V14, DOI 10.1186/1471-2415-14-72; Lutty G, 1999, MOL VIS, V5; Manjunath V, 2011, AM J OPHTHALMOL, V152, P663, DOI 10.1016/j.ajo.2011.03.008; Margolis R, 2009, AM J OPHTHALMOL, V147, P811, DOI 10.1016/j.ajo.2008.12.008; McLeod DS, 2009, INVEST OPHTH VIS SCI, V50, P4982, DOI 10.1167/iovs.09-3639; MCLEOD DS, 1994, INVEST OPHTH VIS SCI, V35, P3799; Motaghiannezam R, 2012, INVEST OPHTH VIS SCI, V53, P2337, DOI 10.1167/iovs.11-7823; Mullins RF, 2005, MOL VIS, V11, P509; Mullins RE, 2011, INVEST OPHTH VIS SCI, V52, P1606, DOI 10.1167/iovs.10-6476; Mullins RF, 2014, AM J PATHOL, V184, P3142, DOI 10.1016/j.ajpath.2014.07.017; Potsaid B, 2010, OPT EXPRESS, V18, P20029, DOI 10.1364/OE.18.020029; RAMRATTAN RS, 1994, INVEST OPHTH VIS SCI, V35, P2857; Sohn EH, 2014, INVEST OPHTH VIS SCI, V55, P1352, DOI 10.1167/iovs.13-13754; Sohrab M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048631; Spaide RF, 2008, AM J OPHTHALMOL, V146, P496, DOI 10.1016/j.ajo.2008.05.032; Spaide RF, 2009, AM J OPHTHALMOL, V147, P801, DOI 10.1016/j.ajo.2008.12.010; Srinivasan VJ, 2008, INVEST OPHTH VIS SCI, V49, P5103, DOI 10.1167/iovs.08-2127; Unterhuber A, 2005, OPT EXPRESS, V13, P3252, DOI 10.1364/OPEX.13.003252; Wei WB, 2013, OPHTHALMOLOGY, V120, P175, DOI 10.1016/j.ophtha.2012.07.048	34	40	40	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0133080	10.1371/journal.pone.0133080	http://dx.doi.org/10.1371/journal.pone.0133080			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26172550	Green Published, gold, Green Submitted			2022-12-26	WOS:000358194900122
J	Cona, G; Cavazzana, A; Paoli, A; Marcolin, G; Grainer, A; Bisiacchi, PS				Cona, Giorgia; Cavazzana, Annachiara; Paoli, Antonio; Marcolin, Giuseppe; Grainer, Alessandro; Bisiacchi, Patrizia Silvia			It's a Matter of Mind! Cognitive Functioning Predicts the Athletic Performance in Ultra-Marathon Runners	PLOS ONE			English	Article							ATTENTIONAL FOCUS; EXERCISE; TASK; EMOTIONS; BASEBALL; FITNESS	The present study was aimed at exploring the influence of cognitive processes on performance in ultra-marathon runners, providing an overview of the cognitive aspects that characterize outstanding runners. Thirty runners were administered a battery of computerized tests right before their participation in an ultra-marathon. Then, they were split according to the race rank into two groups (i.e., faster runners and slower runners) and their cognitive performance was compared. Faster runners outperformed slower runners in trials requiring motor inhibition and were more effective at performing two tasks together, successfully suppressing the activation of the information for one of the tasks when was not relevant. Furthermore, slower runners took longer to remember to execute pre-defined actions associated with emotional stimuli when such stimuli were presented. These findings suggest that cognitive factors play a key role in running an ultra-marathon. Indeed, if compared with slower runners, faster runners seem to have a better inhibitory control, showing superior ability not only to inhibit motor response but also to suppress processing of irrelevant information. Their cognitive performance also appears to be less influenced by emotional stimuli. This research opens new directions towards understanding which kinds of cognitive and emotional factors can discriminate talented runners from less outstanding runners.	[Cona, Giorgia; Cavazzana, Annachiara; Bisiacchi, Patrizia Silvia] Univ Padua, Dept Gen Psychol, Padua, Italy; [Cona, Giorgia] Univ Padua, Dept Neurosci, Padua, Italy; [Paoli, Antonio; Marcolin, Giuseppe; Grainer, Alessandro] Univ Padua, Dept Biomed Sci, Padua, Italy; [Bisiacchi, Patrizia Silvia] Univ Padua, Ctr Cognit Neurosci, Padua, Italy	University of Padua; University of Padua; University of Padua; University of Padua	Cona, G (corresponding author), Univ Padua, Dept Gen Psychol, Padua, Italy.	giorgia.cona@unipd.it	Marcolin, Giuseppe/ABD-5831-2020; Paoli, Antonio/A-6151-2015	Paoli, Antonio/0000-0003-0474-4229; Marcolin, Giuseppe/0000-0002-2768-3257; bisiacchi, patrizia/0000-0003-2760-8000; , Giorgia/0000-0003-1844-9327; Cavazzana, Annachiara/0000-0003-2947-5424	University of Padova (Strategic Grant NEURAT) [STPD11B8HM_004]	University of Padova (Strategic Grant NEURAT)	This study was supported by a grant from the University of Padova (Strategic Grant NEURAT; STPD11B8HM_004) to P.B. The funder did not have any role in study, data collection or analysis, decision to publish, or preparation of the manuscript.	Ali A, 2011, SCAND J MED SCI SPOR, V21, P170, DOI 10.1111/j.1600-0838.2010.01256.x; Alves H, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00036; Amodio P, 2010, GASTROENTEROLOGY, V139, P510, DOI 10.1053/j.gastro.2010.04.057; Bate D., 1996, SCI SOCCER; Beilock SL, 2002, J EXP PSYCHOL-APPL, V8, P6, DOI 10.1037/1076-898X.8.1.6; Bisiacchi P, 2014, METAB BRAIN DIS, V29, P945, DOI 10.1007/s11011-014-9529-0; Castaneda B, 2007, J SPORT EXERCISE PSY, V29, P60, DOI 10.1123/jsep.29.1.60; Colcombe SJ, 2004, P NATL ACAD SCI USA, V101, P3316, DOI 10.1073/pnas.0400266101; Cona G, 2015, NEUROSCI BIOBEHAV R, V52, P21, DOI 10.1016/j.neubiorev.2015.02.007; Cona G, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00010; Cona G, 2014, CLIN NEUROPHYSIOL, V125, P1138, DOI 10.1016/j.clinph.2013.10.048; Cona G, 2013, NEUROPSYCHOLOGY, V27, P378, DOI 10.1037/a0032708; Di Russo F, 2006, NEUROSCI LETT, V408, P113, DOI 10.1016/j.neulet.2006.08.085; Erickson KI, 2011, P NATL ACAD SCI USA, V108, P3017, DOI 10.1073/pnas.1015950108; Ericsson K. A., 2003, ADV RES SPORT EXPERT, P371; Hayes SM, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00031; Hillman CH, 2008, NAT REV NEUROSCI, V9, P58, DOI 10.1038/nrn2298; Holyoak K. J., 1991, GEN THEORY EXPERTISE, V301; Jackson RC, 2006, J SPORT EXERCISE PSY, V28, P49, DOI 10.1123/jsep.28.1.49; Jansen P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048620; Lang P. J., 2005, A6 U FLOR, DOI DOI 10.1027/0269-8803/A000147; Lazarus RS, 2000, SPORT PSYCHOL; Masters KS, 1998, SPORT PSYCHOL, V12, P253, DOI 10.1123/tsp.12.3.253; Morgan W P, 1977, Ann N Y Acad Sci, V301, P382, DOI 10.1111/j.1749-6632.1977.tb38215.x; Nakamoto H, 2008, PERCEPT MOTOR SKILL, V106, P163, DOI 10.2466/PMS.106.1.163-170; Neil R, 2011, PSYCHOL SPORT EXERC, V12, P460, DOI 10.1016/j.psychsport.2011.02.001; NOAKES TD, 1988, MED SCI SPORT EXER, V20, P319, DOI 10.1249/00005768-198808000-00001; Pontifex MB, 2011, J COGNITIVE NEUROSCI, V23, P1332, DOI 10.1162/jocn.2010.21528; Robazza C, 2004, PSYCHOL SPORT EXERC, V5, P379, DOI 10.1016/S1469-0292(03)00034-7; Robazza C, 2004, J APPL SPORT PSYCHOL, V16, P151, DOI 10.1080/10413200490437679; Schucker L, 2009, J SPORT SCI, V27, P1241, DOI 10.1080/02640410903150467; Sheppard JM, 2006, J SPORT SCI, V24, P919, DOI 10.1080/02640410500457109; Starkes JL, 1993, COGNITIVE ISSUES MOT, P365; Verburgh L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091254; Vestberg T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034731; Voss MW, 2010, APPL COGNITIVE PSYCH, V24, P812, DOI 10.1002/acp.1588; Wang CH, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0055773, 10.1371/journal.pone.0073985]; Williams A. M., 1999, VISUAL PERCEPTION AC; Wulf G., 2007, E J BEWEG TRAIN, V1, P1	39	60	60	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132943	10.1371/journal.pone.0132943	http://dx.doi.org/10.1371/journal.pone.0132943			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1QN	26172546	Green Published, Green Submitted, gold			2022-12-26	WOS:000358194900106
J	Haun, AM; Peli, E				Haun, Andrew M.; Peli, Eli			Similar Sensitivity to Ladder Contours in Macular Degeneration Patients and Controls	PLOS ONE			English	Article							CORTICAL REORGANIZATION; INTEGRATION	Purpose To determine whether people with central field loss (CFL) from macular degeneration have improved ability to recognize a particularly difficult spatial configuration embedded in noise, the peripherally-viewed 'ladder contour'. The visibility of these configuration has been linked to general contour integration ability and crowding limitations in peripheral vision. Methods We used a trial-based yes-no task. CFL patients and normally-sighted controls performed the task, looking for ladder contours embedded in a field of randomly oriented Gabor patches, at a range of stimulus presentation times (varying stimulus difficulty). Viewing eccentricity in CFL patients was set by their preferred retinal loci (PRLs) and matched artificially in the control group. The contours were presented so as to be tangent to the CFL region, given a patient's PRL location. Results CFL and normally-sighted groups performed similarly on the task. The only significant determinant of performance was the viewing eccentricity. Conclusions CFL patients do not seem to develop any improved ability to recognize ladder contours with their parafoveal retina, which suggests that there is no underlying improvement in contour integration or reduction in crowding limitations in the region of the PRL despite extended daily use.	[Haun, Andrew M.] Univ Wisconsin, Dept Psychol, Madison, WI 53706 USA; [Peli, Eli] Harvard Univ, Sch Med, Dept Ophthalmol, Schepens Eye Res Inst,Mass Eye & Ear, Boston, MA USA	University of Wisconsin System; University of Wisconsin Madison; Harvard University; Harvard Medical School; Schepens Eye Research Institute	Haun, AM (corresponding author), Univ Wisconsin, Dept Psychol, 1202 W Johnson St, Madison, WI 53706 USA.	amhaun01@gmail.com	; Haun, Andrew/I-4956-2012	Peli, Eli/0000-0002-1340-9257; Haun, Andrew/0000-0001-9458-8957	 [NIH EY05957]; NATIONAL EYE INSTITUTE [R01EY005957] Funding Source: NIH RePORTER	; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	NIH EY05957	Baker CI, 2005, J NEUROSCI, V25, P614, DOI 10.1523/JNEUROSCI.3476-04.2005; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Chakravarthi R, 2011, J VIS, P11; Cheung SH, 2005, VISUAL NEUROSCI, V22, P187, DOI 10.1017/S0952523805222071; Chung STL, 2013, J NEUROSCI, V33, P18080, DOI 10.1523/JNEUROSCI.2764-13.2013; Chung STL, 2011, INVEST OPHTH VIS SCI, V52, P1164, DOI 10.1167/iovs.10-6034; Dilks DD, 2007, J NEUROSCI, V27, P9585, DOI 10.1523/JNEUROSCI.2650-07.2007; Dilks DD, 2009, J NEUROSCI, V29, P2768, DOI 10.1523/JNEUROSCI.5258-08.2009; FIELD DJ, 1993, VISION RES, V33, P173, DOI 10.1016/0042-6989(93)90156-Q; Masuda Y, 2008, CEREB CORTEX, V18, P2483, DOI 10.1093/cercor/bhm256; May KA, 2007, J VISION, V7, DOI 10.1167/7.12.13; Nandy AS, 2012, NAT NEUROSCI, V15, P463, DOI 10.1038/nn.3021; Nugent AK, 2003, VISION RES, V43, P2427, DOI 10.1016/S0042-6989(03)00434-6; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Pelli DG, 2004, J VISION, V4, P1136, DOI 10.1167/4.12.12; Schumacher EH, 2008, RESTOR NEUROL NEUROS, V26, P391; TIMBERLAKE GT, 1986, INVEST OPHTH VIS SCI, V27, P1137; WHITE JM, 1990, INVEST OPHTH VIS SCI, V31, P1149; WHITTAKER SG, 1991, VISION RES, V31, P2209, DOI 10.1016/0042-6989(91)90173-3; Xiao LQ, 2008, CURR BIOL, V18, P1922, DOI 10.1016/j.cub.2008.10.030; Yu DY, 2010, VISION RES, V50, P860, DOI 10.1016/j.visres.2010.02.006	21	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0128119	10.1371/journal.pone.0128119	http://dx.doi.org/10.1371/journal.pone.0128119			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26171784	Green Published, gold, Green Submitted			2022-12-26	WOS:000358194900002
J	Musinguzi, G; Bastiaens, H; Matovu, JKB; Nuwaha, F; Mujisha, G; Kiguli, J; Arinaitwe, J; Van Geertruyden, JP; Wanyenze, RK				Musinguzi, Geofrey; Bastiaens, Hilde; Matovu, Joseph K. B.; Nuwaha, Fred; Mujisha, Geoffrey; Kiguli, Juliet; Arinaitwe, Jim; Van Geertruyden, Jean-Pierre; Wanyenze, Rhoda K.			Barriers to Condom Use among High Risk Men Who Have Sex with Men in Uganda: A Qualitative Study	PLOS ONE			English	Article							HIV TRANSMISSION RISK; ANAL INTERCOURSE; YOUNG MEN; BEHAVIORS; HIV/AIDS; PERCEPTIONS; WORKERS; NONUSE; GAY	Background Unprotected sexual intercourse is a major risk factor for HIV transmission. Men who have sex with men (MSM) face challenges in accessing HIV prevention services, including condoms. However, there is limited in-depth assessment and documentation of the barriers to condom use among MSM in sub-Saharan Africa. In this paper, we examine the barriers to condom use among MSM in Uganda. Methods The data for this study were extracted from a larger qualitative study conducted among 85 self-identified adult (> 18 years) MSM in 11 districts in Uganda between July and December 2013. Data on sexual behaviours and access and barriers to condom use were collected using semi-structured interviews. All interviews were audio-recorded and transcribed verbatim. This paper presents an analysis of data for 33 MSM who did not use condoms at last sex, with a focus on barriers to condom use. Analysis was conducted using the content analysis approach. Results Six major barriers to condom use were identified: Difficulties with using condoms, access challenges, lack of knowledge and misinformation about condom use, partner and relationship related issues, financial incentives and socio-economic vulnerability, and alcohol consumption. Conclusion The findings suggest that several reasons account for lack of condom use among high-risk MSM. The findings are valuable to inform interventions needed to increase condom use among MSM.	[Musinguzi, Geofrey; Nuwaha, Fred; Wanyenze, Rhoda K.] Makerere Univ, Sch Publ Hlth, Dis Control & Environm Hlth, Kampala, Uganda; [Musinguzi, Geofrey; Van Geertruyden, Jean-Pierre] Univ Antwerp, Int Hlth, B-2020 Antwerp, Belgium; [Bastiaens, Hilde] Univ Antwerp, Primary & Interdisciplinary Care, B-2020 Antwerp, Belgium; [Matovu, Joseph K. B.; Kiguli, Juliet] Makerere Univ, Sch Publ Hlth, Community Hlth & Behav Sci, Kampala, Uganda; [Mujisha, Geoffrey] MARPS Network, Kampala, Uganda; [Arinaitwe, Jim] Minist Hlth, Kampala, Uganda	Makerere University; University of Antwerp; University of Antwerp; Makerere University	Musinguzi, G (corresponding author), Makerere Univ, Sch Publ Hlth, Dis Control & Environm Hlth, Kampala, Uganda.	mgeof@musph.ac.ug	Van geertruyden, Jean-Pierre/K-6425-2014; Van geertruyden, Jean-Pierre/S-3254-2019; Matovu, Joseph/AAO-5790-2020	Van geertruyden, Jean-Pierre/0000-0001-5006-6364; Van geertruyden, Jean-Pierre/0000-0001-5006-6364; Bastiaens, Hilde/0000-0002-5509-3406	Global Fund; VLIR-UOS	Global Fund; VLIR-UOS	The study was funded by the Global Fund to RW. Geofrey Musinguzi received a short research stay support by VLIR-UOS and used the data to draft this manuscript.	Adams J, 2009, QUAL HEALTH RES, V19, P1669, DOI 10.1177/1049732309353046; Alexander M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088858; Baggaley RF, 2010, INT J EPIDEMIOL, V39, P1048, DOI 10.1093/ije/dyq057; Baral S, 2007, PLOS MED, V4, P1901, DOI 10.1371/journal.pmed.0040339; Blake SM, 2001, AM J PUBLIC HEALTH, V91, P940, DOI 10.2105/AJPH.91.6.940; CarballoDieguez A, 1996, AM J PUBLIC HEALTH, V86, P1619, DOI 10.2105/AJPH.86.11.1619; Dudley MG, 2004, AIDS EDUC PREV, V16, P328, DOI 10.1521/aeap.16.4.328.40397; Fields EL, 2012, J ADOLESCENT HEALTH, V50, P296, DOI 10.1016/j.jadohealth.2011.07.007; Geofrey Musinguzi HB, 2014, BARRIERS TO AND OPPO; Gysels M, 2001, AIDS CARE, V13, P373, DOI 10.1080/09540120120044026; Hladik W, 2008, AIDS, V22, P503, DOI 10.1097/QAD.0b013e3282f470be; Hladik W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038143; Jin FY, 2010, AIDS, V24, P907, DOI 10.1097/QAD.0b013e3283372d90; King R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082937; Koblin BA, 2003, AM J PUBLIC HEALTH, V93, P926, DOI 10.2105/AJPH.93.6.926; Li HC, 2010, AIDS CARE, V22, P1481, DOI 10.1080/09540121.2010.482121; Lightfoot M, 2005, JAIDS-J ACQ IMM DEF, V38, P61, DOI 10.1097/00126334-200501010-00012; Mishra SR, 2013, HIV AIDS-RES PALLIAT, V5, P81, DOI 10.2147/HIV.S42795; Morse JM, 2008, QUAL HEALTH RES, V18, P727, DOI 10.1177/1049732308314930; Musinguzi G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085646; Okal J, 2009, CULT HEALTH SEX, V11, P811, DOI 10.1080/13691050902906488; Ostergren JE, 2011, CULT HEALTH SEX, V13, P123, DOI 10.1080/13691058.2010.520168; Pando MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039834; Patel P, 2014, AIDS, V28, P1509, DOI 10.1097/QAD.0000000000000298; Raymond HF, 2009, AIDS BEHAV, V13, P677, DOI 10.1007/s10461-009-9557-7; SAGE Publications I, ENCYCLOPEDIA OF SOCI; Smith AD, 2009, LANCET, V374, P416, DOI 10.1016/S0140-6736(09)61118-1; Tucker Saroj, 2012, Indian J Sex Transm Dis AIDS, V33, P9, DOI 10.4103/0253-7184.93787; Vaismoradi M, 2013, NURS HEALTH SCI, V15, P398, DOI 10.1111/nhs.12048; Varga C A, 1997, Afr J Reprod Health, V1, P74, DOI 10.2307/3583277; Vittinghoff E, 1999, AM J EPIDEMIOL, V150, P306, DOI 10.1093/oxfordjournals.aje.a010003; World Health Organization, 2013, GLOBAL REPORT UNAIDS	32	33	33	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132297	10.1371/journal.pone.0132297	http://dx.doi.org/10.1371/journal.pone.0132297			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1QN	26172374	Green Submitted, Green Published, gold			2022-12-26	WOS:000358194900040
J	Popp, M; Thielmann, I; Nieswandt, B; Stegner, D				Popp, Michael; Thielmann, Ina; Nieswandt, Bernhard; Stegner, David			Normal Platelet Integrin Function in Mice Lacking Hydrogen Peroxide-Induced Clone-5 (Hic-5)	PLOS ONE			English	Article							IN-VIVO; ACTIVATION; ADHESION; AGGREGATION; BINDING; HEMOSTASIS; MECHANISMS; THROMBOSIS; COLLAGEN; PROTEIN	Integrin alpha IIb beta 3 plays a central role in the adhesion and aggregation of platelets and thus is essential for hemostasis and thrombosis. Integrin activation requires the transmission of a signal from the small cytoplasmic tails of the a or beta subunit to the large extracellular domains resulting in conformational changes of the extracellular domains to enable ligand binding. Hydrogen peroxide-inducible clone-5 (Hic-5), a member of the paxillin family, serves as a focal adhesion adaptor protein associated with alpha IIb beta 3 at its cytoplasmic tails. Previous studies suggested Hic-5 as a novel regulator of integrin alpha IIb beta 3 activation and platelet aggregation in mice. To assess this in more detail, we generated Hic-5-null mice and analyzed activation and aggregation of their platelets in vitro and in vivo. Surprisingly, lack of Hic-5 had no detectable effect on platelet integrin activation and function in vitro and in vivo under all tested conditions. These results indicate that Hic-5 is dispensable for integrin alpha IIb beta 3 activation and consequently for arterial thrombosis and hemostasis in mice.	[Stegner, David] Univ Wurzburg, Univ Hosp, Dept Expt Biomed Vasc Med, D-97070 Wurzburg, Germany; Univ Wurzburg, Rudolf Virchow Ctr, D-97070 Wurzburg, Germany	University of Wurzburg; University of Wurzburg	Stegner, D (corresponding author), Univ Wurzburg, Univ Hosp, Dept Expt Biomed Vasc Med, D-97070 Wurzburg, Germany.	stegner@virchow.uni-wuerzburg.de	Stegner, David/AAA-4948-2019	Stegner, David/0000-0003-1059-9865	Rudolf Virchow Center; Deutsche Forschungsgemeinschaft [SFB688]; German Research Foundation (DFG); University of Wuerzburg	Rudolf Virchow Center; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Research Foundation (DFG)(German Research Foundation (DFG)); University of Wuerzburg	This work was supported by the Rudolf Virchow Center and the Deutsche Forschungsgemeinschaft (SFB688). This publication was funded by the German Research Foundation (DFG) and the University of Wuerzburg in the funding programme Open Access Publishing.	Cheli Y, 2008, BLOOD, V111, P1266, DOI 10.1182/blood-2007-09-111369; Ginsberg MH, 2005, CURR OPIN CELL BIOL, V17, P509, DOI 10.1016/j.ceb.2005.08.010; Grosse J, 2007, J CLIN INVEST, V117, P3540, DOI 10.1172/JCI32312; Hagmann J, 1998, J CELL SCI, V111, P2181; Kim-Kaneyama JR, 2012, J THROMB HAEMOST, V10, P1867, DOI 10.1111/j.1538-7836.2012.04856.x; Knight CG, 1999, CARDIOVASC RES, V41, P450, DOI 10.1016/S0008-6363(98)00306-X; Legate KR, 2009, J CELL SCI, V122, P187, DOI 10.1242/jcs.041624; Lei XF, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000747; LENTER M, 1993, P NATL ACAD SCI USA, V90, P9051, DOI 10.1073/pnas.90.19.9051; Ma YQ, 2008, J CELL BIOL, V181, P439, DOI 10.1083/jcb.200710196; Morgenstern E, 1990, BLOOD COAGUL FIBRIN, V1, P547; Moser M, 2008, NAT MED, V14, P325, DOI 10.1038/nm1722; Nieswandt B, 2011, J THROMB HAEMOST, V9, P92, DOI 10.1111/j.1538-7836.2011.04361.x; Nieswandt B, 2003, BLOOD, V102, P449, DOI 10.1182/blood-2002-12-3882; Nieswandt B, 2007, J EXP MED, V204, P3113, DOI 10.1084/jem.20071827; Petrich BG, 2007, J EXP MED, V204, P3103, DOI 10.1084/jem.20071800; Pleines I, 2010, BLOOD, V115, P3364, DOI 10.1182/blood-2009-09-242271; Rathore VB, 2007, BIOCHEM J, V403, P275, DOI 10.1042/BJ20061618; Ruggeri ZM, 2002, NAT MED, V8, P1227, DOI 10.1038/nm1102-1227; Sakata A, 2014, THROMB J, V12, DOI 10.1186/1477-9560-12-1; SCHALLER MD, 1995, J CELL BIOL, V130, P1181, DOI 10.1083/jcb.130.5.1181; Shattil SJ, 2004, BLOOD, V104, P1606, DOI 10.1182/blood-2004-04-1257; Shattil SJ, 1998, BLOOD, V91, P2645, DOI 10.1182/blood.V91.8.2645.2645_2645_2657; SHIBANUMA M, 1994, J BIOL CHEM, V269, P26767; Stritt S, 2015, BLOOD, V125, P219, DOI 10.1182/blood-2014-08-597542; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; Tumbarello DA, 2007, J CELL PHYSIOL, V211, P736, DOI 10.1002/jcp.20991	27	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0133429	10.1371/journal.pone.0133429	http://dx.doi.org/10.1371/journal.pone.0133429			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26172113	Green Published, Green Submitted, gold			2022-12-26	WOS:000358194900150
J	Roedgaard, M; Fredsoe, J; Pedersen, JM; Bjergbaek, L; Andersen, AH				Roedgaard, Morten; Fredsoe, Jacob; Pedersen, Jakob Madsen; Bjergbaek, Lotte; Andersen, Anni Hangaard			DNA Topoisomerases Are Required for Preinitiation Complex Assembly during GAL Gene Activation	PLOS ONE			English	Article							NUCLEOSOME OCCUPANCY; POL II; YEAST; CHROMATIN; TRANSCRIPTION; REPLICATION; GALACTOSE; PROTEIN; EXPRESSION; BINDING	To investigate the importance of topoisomerases for transcription of the galactose induced genes, we have studied the expression of GAL1, GAL2, GAL7 and GAL10 in Saccharomyces cerevisiae cells deficient for topoisomerases I and II. We find that topoisomerases are required for transcriptional activation of the GAL genes, but are dispensable for ongoing transcription, eliminating a role of the enzymes in transcriptional elongation. Furthermore, we demonstrate that promoter chromatin remodeling of the GAL genes is unaffected in the topoisomerase deficient strain. However, the cells fail to successfully recruit RNA polymerase II due to an inability of the TATA-binding protein (TBP) to bind to the TATA box in these promoters. We therefore argue that topoisomerases are required for accurate assembly of the preinitiation complex at the promoters of the GAL genes.	[Roedgaard, Morten; Fredsoe, Jacob; Pedersen, Jakob Madsen; Bjergbaek, Lotte; Andersen, Anni Hangaard] Aarhus Univ, Dept Mol Biol & Genet, Lab Genome Res, DK-8000 Aarhus C, Denmark	Aarhus University	Andersen, AH (corresponding author), Aarhus Univ, Dept Mol Biol & Genet, Lab Genome Res, CF Mollers Alle 3, DK-8000 Aarhus C, Denmark.	aha@mbg.au.dk	Bjergbæk, Lotte/AAW-6302-2021; Fredsøe, Jacob/AAD-6677-2019; Andersen, Anni/O-1162-2017	Fredsøe, Jacob/0000-0002-7319-2467; Bjergbaek, Lotte/0000-0002-8233-3356; Andersen, Anni/0000-0001-7194-3258	Danish Natural Science Research Council; Novo Nordisk Foundation; Karen Elise Jensen Foundation; Gangsted Foundation; Simon Fougner Hartmanns Foundation; Dagmar Marshalls Foundation; Astrid Thaysens Foundation; Villum Kann Rasmussen Foundation	Danish Natural Science Research Council(Danish Natural Science Research Council); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Karen Elise Jensen Foundation; Gangsted Foundation; Simon Fougner Hartmanns Foundation; Dagmar Marshalls Foundation; Astrid Thaysens Foundation; Villum Kann Rasmussen Foundation(Villum Fonden)	This work was supported by the Danish Natural Science Research Council, the Novo Nordisk Foundation, the Karen Elise Jensen Foundation, the Gangsted Foundation, the Simon Fougner Hartmanns Foundation, the Dagmar Marshalls Foundation, the Astrid Thaysens Foundation, and the Villum Kann Rasmussen Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramczyk D, 2012, EUKARYOT CELL, V11, P334, DOI 10.1128/EC.05294-11; Bancaud A, 2006, NAT STRUCT MOL BIOL, V13, P444, DOI 10.1038/nsmb1087; Bermejo R, 2007, GENE DEV, V21, P1921, DOI 10.1101/gad.432107; Bermejo R, 2009, CELL, V138, P870, DOI 10.1016/j.cell.2009.06.022; BRILL SJ, 1987, NATURE, V326, P414, DOI 10.1038/326414a0; Bryant GO, 2008, PLOS BIOL, V6, P2928, DOI 10.1371/journal.pbio.0060317; CLARK DJ, 1991, EMBO J, V10, P387, DOI 10.1002/j.1460-2075.1991.tb07960.x; Durand-Dubief M, 2010, EMBO J, V29, P2126, DOI 10.1038/emboj.2010.109; Garinther WI, 1997, MOL CELL BIOL, V17, P3520, DOI 10.1128/MCB.17.7.3520; Greger IH, 1998, EMBO J, V17, P4771, DOI 10.1093/emboj/17.16.4771; Hamiche A, 1996, P NATL ACAD SCI USA, V93, P7588, DOI 10.1073/pnas.93.15.7588; Jiang FL, 2009, MOL CELL BIOL, V29, P5604, DOI 10.1128/MCB.00632-09; Joshi RS, 2012, NUCLEIC ACIDS RES, V40, P7907, DOI 10.1093/nar/gks626; Joshi RS, 2010, EMBO J, V29, P740, DOI 10.1038/emboj.2009.391; Kahn JD, 2000, BIOCHEMISTRY-US, V39, P3520, DOI 10.1021/bi992263f; Kouzine F, 2008, NAT STRUCT MOL BIOL, V15, P146, DOI 10.1038/nsmb.1372; Kouzine F, 2013, NAT STRUCT MOL BIOL, V20, P396, DOI 10.1038/nsmb.2517; Laine JP, 2009, GENE DEV, V23, P2604, DOI 10.1101/gad.1823609; Larschan E, 2001, GENE DEV, V15, P1946, DOI 10.1101/gad.911501; Lee W, 2007, NAT GENET, V39, P1235, DOI 10.1038/ng2117; LIU LF, 1987, P NATL ACAD SCI USA, V84, P7024, DOI 10.1073/pnas.84.20.7024; LOHR D, 1995, FASEB J, V9, P777, DOI 10.1096/fasebj.9.9.7601342; LUE NF, 1987, MOL CELL BIOL, V7, P3446, DOI 10.1128/MCB.7.10.3446; Martinez E, 2002, PLANT MOL BIOL, V50, P925, DOI 10.1023/A:1021258713850; Nikolaou C, 2013, NUCLEIC ACIDS RES, V41, P9243, DOI 10.1093/nar/gkt707; NIKOLOV DB, 1995, NATURE, V377, P119, DOI 10.1038/377119a0; PARVIN JD, 1993, CELL, V73, P533, DOI 10.1016/0092-8674(93)90140-L; Pedersen JM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003128; Pilauri V, 2005, GENETICS, V169, P1903, DOI 10.1534/genetics.104.036723; Platt A, 1998, EMBO J, V17, P4086, DOI 10.1093/emboj/17.14.4086; Salceda J, 2006, EMBO J, V25, P2575, DOI 10.1038/sj.emboj.7601142; Sarge KD, 2005, TRENDS BIOCHEM SCI, V30, P605, DOI 10.1016/j.tibs.2005.09.004; Sellick CA, 2008, INT REV CEL MOL BIO, V269, P111, DOI 10.1016/S1937-6448(08)01003-4; Sil AK, 1999, MOL CELL BIOL, V19, P7828; Sperling AS, 2011, P NATL ACAD SCI USA, V108, P12693, DOI 10.1073/pnas.1106834108; SVAREN J, 1994, EMBO J, V13, P4856, DOI 10.1002/j.1460-2075.1994.tb06812.x; TABUCHI H, 1993, BIOCHEM BIOPH RES CO, V192, P1432, DOI 10.1006/bbrc.1993.1576; Traven A, 2006, EMBO REP, V7, P496, DOI 10.1038/sj.embor.7400679; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; Wang YL, 2002, P NATL ACAD SCI USA, V99, P5860, DOI 10.1073/pnas.092538799	40	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132739	10.1371/journal.pone.0132739	http://dx.doi.org/10.1371/journal.pone.0132739			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26173127	Green Published, gold, Green Submitted			2022-12-26	WOS:000358194900080
J	Roh, HW; Hong, CH; Lee, Y; Oh, BH; Lee, KS; Chang, KJ; Kang, DR; Kim, J; Lee, S; Back, JH; Chung, YK; Lim, KY; Noh, JS; Kim, D; Son, SJ				Roh, Hyun Woong; Hong, Chang Hyung; Lee, Yunhwan; Oh, Byoung Hoon; Lee, Kang Soo; Chang, Ki Jung; Kang, Dae Ryong; Kim, Jinhee; Lee, SooJin; Back, Joung Hwan; Chung, Young Ki; Lim, Ki Young; Noh, Jai Sung; Kim, Dongsoo; Son, Sang Joon			Participation in Physical, Social, and Religious Activity and Risk of Depression in the Elderly: A Community-Based Three-Year Longitudinal Study in Korea	PLOS ONE			English	Article							OLDER-ADULTS; MENTAL-HEALTH; PSYCHOSOCIAL INTERVENTIONS; SYMPTOMS; SUPPORT; PEOPLE; SPIRITUALITY; ASSOCIATION; PREDICTORS; PREVENTION	Background We examined the longitudinal association between participation in individual or combinations of physical, social, and religious activity and risk of depression in the elderly. Methods Elderly subjects aged >= 60 years who completed the Living Profiles of Older People Survey in Korea (n = 6,647) were included. The baseline assessment, Wave 1, was conducted in 2008, and a follow-up assessment, Wave 2, was conducted in 2011. We defined participation in frequent physical activity as >= 3 times weekly (at least 30 minutes per activity). Frequent participation in social and religious activity was defined as >= 1 activity weekly. The primary outcome was depression at 3-year follow up. Results Multivariable logistic regression analysis showed that subjects who participated in frequent physical, social, and religious activity had an adjusted odds ratio of 0.81 (95% confidence interval [CI], 0.69-0.96), 0.87 (95% CI, 0.75-1.00), and 0.78 (95% CI, 0.67-0.90), respectively, compared with participants who did not participate in each activity. Participants who participated in only one type of activity frequently and participants who participated in two or three types of activities frequently had an adjusted odds ratio of 0.86 (95% CI, 0.75-0.98) and 0.64 (95% CI, 0.52-0.79), respectively, compared with participants who did not participate in any type of physical, social, and religious activity frequently. Conclusion Participation in physical, social, and religious activity was associated with decreased risk of depression in the elderly. In addition, risk of depression was much lower in the elderly people who participated in two or three of the above-mentioned types of activity than that in the elderly who did not.	[Roh, Hyun Woong; Hong, Chang Hyung; Chang, Ki Jung; Chung, Young Ki; Lim, Ki Young; Noh, Jai Sung; Kim, Dongsoo; Son, Sang Joon] Ajou Univ, Sch Med, Dept Psychiat, Suwon 441749, South Korea; [Roh, Hyun Woong; Hong, Chang Hyung; Lee, Yunhwan; Chang, Ki Jung; Kim, Jinhee; Son, Sang Joon] Ajou Univ, Inst Aging, Med Ctr, Suwon 441749, South Korea; [Lee, Yunhwan; Kim, Jinhee] Ajou Univ, Dept Prevent Med & Publ Hlth, Sch Med, Suwon 441749, South Korea; [Oh, Byoung Hoon] Yonsei Univ, Coll Med, Dept Psychiat, Seoul, South Korea; [Oh, Byoung Hoon] Yonsei Univ, Coll Med, Inst Behav Sci Med, Seoul, South Korea; [Lee, Kang Soo] CHA Univ, Dept Psychiat, Sch Med, CHA Hosp, Gangnam, South Korea; [Kang, Dae Ryong] Ajou Univ, Dept Med Humanities & Social Med, Off Biostat, Sch Med, Suwon 441749, South Korea; [Lee, SooJin] Backseok Arts Univ, Dept Medicare Adm, Seoul, South Korea; [Back, Joung Hwan] Natl Hlth Insurance Serv, Seoul, South Korea	Ajou University; Ajou University; Ajou University; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Pochon Cha University; Ajou University; National Health Insurance Service	Son, SJ (corresponding author), Ajou Univ, Sch Med, Dept Psychiat, Suwon 441749, South Korea.	sjsonpsy@ajou.ac.kr	Lee, Yunhwan/F-4967-2010	Lee, Yunhwan/0000-0001-8484-4750	Haesong Geriatric Psychiatry Research Fund from the Korean Mental Health Foundation	Haesong Geriatric Psychiatry Research Fund from the Korean Mental Health Foundation	This study was supported by a Haesong Geriatric Psychiatry Research Fund from the Korean Mental Health Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth BE, 2011, MED SCI SPORT EXER, V43, P1575, DOI 10.1249/MSS.0b013e31821ece12; Arean PA, 2005, BIOL PSYCHIAT, V58, P277, DOI 10.1016/j.biopsych.2005.03.037; Bac JN, 2004, J PSYCHOSOM RES, V57, P297, DOI 10.1016/j.jpsychores.2004.01.004; Braam AW, 2004, J AGING HEALTH, V16, P467, DOI 10.1177/0898264304265765; Bridle C, 2012, BRIT J PSYCHIAT, V201, P180, DOI 10.1192/bjp.bp.111.095174; Bruce ML, 2002, BIOL PSYCHIAT, V52, P175, DOI 10.1016/S0006-3223(02)01410-5; Chen HT, 2007, INT J GERIATR PSYCH, V22, P144, DOI 10.1002/gps.1704; Chiao C, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-292; Cruwys T, 2013, SOC SCI MED, V98, P179, DOI 10.1016/j.socscimed.2013.09.013; Dickens AP, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-647; Erickson Kirk I, 2013, Dialogues Clin Neurosci, V15, P99; Forsman AK, 2011, HEALTH PROMOT INT, V26, pI85, DOI 10.1093/heapro/dar074; Forsman AK, 2011, J AGING HEALTH, V23, P387, DOI 10.1177/0898264310378041; Guerra M, 2009, BRIT J PSYCHIAT, V195, P510, DOI 10.1192/bjp.bp.109.064055; Hahn CY, 2004, INT J GERIATR PSYCH, V19, P1148, DOI 10.1002/gps.1204; Han ES, 2014, INT PSYCHOGERIATR, V26, P155, DOI 10.1017/S1041610213001841; Harris T, 2003, AGE AGEING, V32, P510, DOI 10.1093/ageing/afg087; Hayward RD, 2012, AM J GERIAT PSYCHIAT, V20, P188, DOI 10.1097/JGP.0b013e31822ccd51; 이성찬, 2013, [Journal of Korean Geriatirc Psychiatry, 노인정신의학], V17, P36; Kim KHC, 2004, PUBLIC HEALTH NUTR, V7, P773, DOI 10.1079/PHN2004601; Koenig HG, 2007, AM J GERIAT PSYCHIAT, V15, P282, DOI 10.1097/01.JGP.0000246875.93674.0c; Koenig HG, 1997, AM J GERIAT PSYCHIAT, V5, P131; Krause Neal, 2003, J Gerontol B Psychol Sci Soc Sci, V58, pS160; 이동영, 2002, [JOURNAL OF THE KOREAN NEUROPSYCHIATRIC ASSOCIATION, 신경정신의학], V41, P508; Lee Kang Soo, 2009, [JOURNAL OF THE KOREAN NEUROPSYCHIATRIC ASSOCIATION, 신경정신의학], V48, P61; Lee Y, 2014, GERONTOLOGY, V60, P475, DOI 10.1159/000362330; Lucas M, 2011, AM J EPIDEMIOL, V174, P1017, DOI 10.1093/aje/kwr218; Correa AAM, 2011, REV BRAS PSIQUIATR, V33, P157, DOI 10.1590/S1516-44462011000200011; Maki Y, 2012, J AM GERIATR SOC, V60, P1590, DOI 10.1111/j.1532-5415.2012.04091.x; Manning LK, 2013, QUAL HEALTH RES, V23, P568, DOI 10.1177/1049732312471730; MEEUSEN R, 1995, SPORTS MED, V20, P160, DOI 10.2165/00007256-199520030-00004; Miller L, 2014, JAMA PSYCHIAT, V71, P128, DOI 10.1001/jamapsychiatry.2013.3067; Miller L, 2012, AM J PSYCHIAT, V169, P89, DOI 10.1176/appi.ajp.2011.10121823; Mura Gioia, 2013, Clin Pract Epidemiol Ment Health, V9, P125, DOI 10.2174/1745017901309010125; Oyama H, 2006, PSYCHIAT CLIN NEUROS, V60, P110, DOI 10.1111/j.1440-1819.2006.01468.x; Park J.E., 2014, INT J GERIATR PSYCHI; Pasco JA, 2011, INT PSYCHOGERIATR, V23, P292, DOI 10.1017/S1041610210001833; Razafsha M, 2012, METHODS MOL BIOL, V829, P49, DOI 10.1007/978-1-61779-458-2_3; Sarris J, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-107; Schwarzbach M, 2014, INT J GERIATR PSYCH, V29, P1, DOI 10.1002/gps.3971; Shankar A, 2011, HEALTH PSYCHOL, V30, P377, DOI 10.1037/a0022826; SHEIKH J I, 1986, Clinical Gerontologist, V5, P165; Son J, 2008, J HEALTH SOC BEHAV, V49, P104, DOI 10.1177/002214650804900108; Sugihara Y, 2008, J GERONTOL B-PSYCHOL, V63, pP227, DOI 10.1093/geronb/63.4.P227; Teo AR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062396; Uebelacker LA, 2013, SOC PSYCH PSYCH EPID, V48, P1971, DOI 10.1007/s00127-013-0693-z; Wassink-Vossen S, 2014, J AFFECT DISORDERS, V161, P65, DOI 10.1016/j.jad.2014.03.001; who, ACT AG POL FRAM; Won C.W., 2002, J KOREAN GERIATRICS, V6, P273; Won CW, 2002, J KOREAN GERIATR SOC, V6, P107, DOI DOI 10.1037/T06803-000]; Zou JX, 2014, SOC PSYCH PSYCH EPID, V49, P911, DOI 10.1007/s00127-013-0785-9	51	64	68	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132838	10.1371/journal.pone.0132838	http://dx.doi.org/10.1371/journal.pone.0132838			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1QN	26172441	Green Published, gold, Green Submitted			2022-12-26	WOS:000358194900089
J	Hunter, MO; Keller, M; Morton, D; Cook, B; Lefsky, M; Ducey, M; Saleska, S; de Oliveira, RC; Schietti, J				Hunter, Maria O.; Keller, Michael; Morton, Douglas; Cook, Bruce; Lefsky, Michael; Ducey, Mark; Saleska, Scott; de Oliveira, Raimundo Cosme, Jr.; Schietti, Juliana			Structural Dynamics of Tropical Moist Forest Gaps	PLOS ONE			English	Article							RAIN-FOREST; PHASE REGENERATION; TREE DIVERSITY; CANOPY GAPS; AMAZONIAN FOREST; STEADY-STATE; FIRME FOREST; LEAF-AREA; DISTURBANCE; LIDAR	Gap phase dynamics are the dominant mode of forest turnover in tropical forests. However, gap processes are infrequently studied at the landscape scale. Airborne lidar data offer detailed information on three-dimensional forest structure, providing a means to characterize fine-scale (1 m) processes in tropical forests over large areas. Lidar-based estimates of forest structure (top down) differ from traditional field measurements (bottom up), and necessitate clear-cut definitions unencumbered by the wisdom of a field observer. We offer a new definition of a forest gap that is driven by forest dynamics and consistent with precise ranging measurements from airborne lidar data and tall, multi-layered tropical forest structure. We used 1000 ha of multi-temporal lidar data (2008, 2012) at two sites, the Tapajos National Forest and Ducke Reserve, to study gap dynamics in the Brazilian Amazon. Here, we identified dynamic gaps as contiguous areas of significant growth, that correspond to areas > 10 m(2), with height < 10 m. Applying the dynamic definition at both sites, we found over twice as much area in gap at Tapajos National Forest (4.8 %) as compared to Ducke Reserve (2.0 %). On average, gaps were smaller at Ducke Reserve and closed slightly more rapidly, with estimated height gains of 1.2 m y(-1) versus 1.1 m y(-1) at Tapajos. At the Tapajos site, height growth in gap centers was greater than the average height gain in gaps (1.3 m y(-1) versus 1.1 m y(-1)). Rates of height growth between lidar acquisitions reflect the interplay between gap edge mortality, horizontal ingrowth and gap size at the two sites. We estimated that approximately 10% of gap area closed via horizontal ingrowth at Ducke Reserve as opposed to 6 % at Tapajos National Forest. Height loss (interpreted as repeat damage and/or mortality) and horizontal ingrowth accounted for similar proportions of gap area at Ducke Reserve (13% and 10 %, respectively). At Tapajos, height loss had a much stronger signal (23 % versus 6 %) within gaps. Both sites demonstrate limited gap contagiousness defined by an increase in the likelihood of mortality in the immediate vicinity (similar to 6 m) of existing gaps.	[Hunter, Maria O.] Univ New Hampshire, Earth Sci Res Ctr, Durham, NH 03824 USA; [Keller, Michael] USDA Forest Serv, Int Inst Trop Forestry, San Juan, PR USA; [Keller, Michael] EMBRAPA Monitoramento Satelite, Campinas, SP, Brazil; [Morton, Douglas; Cook, Bruce] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Lefsky, Michael] Colorado State Univ, Nat Resource Ecol Lab, Ft Collins, CO 80523 USA; [Ducey, Mark] Univ New Hampshire, Dept Nat Resources, Durham, NH 03824 USA; [Saleska, Scott] Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ USA; [de Oliveira, Raimundo Cosme, Jr.] EMBRAPA Amazonia Oriental, Belem, Para, Brazil; [Schietti, Juliana] Inst Nacl de Pesquisas da Amazonia, Manaus, Amazonas, Brazil	University System Of New Hampshire; University of New Hampshire; United States Department of Agriculture (USDA); United States Forest Service; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Colorado State University; University System Of New Hampshire; University of New Hampshire; University of Arizona; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Institute Nacional de Pesquisas da Amazonia	Hunter, MO (corresponding author), Univ New Hampshire, Earth Sci Res Ctr, Durham, NH 03824 USA.	Hunter.maria@gmail.com	Schietti, Juliana/AAV-7451-2020; Saleska, Scott R/K-1733-2016; Keller, Michael/A-8976-2012; Morton, Douglas C/D-5044-2012; Schietti, Juliana/B-8226-2015; Ducey, Mark/K-1101-2016	Schietti, Juliana/0000-0002-1687-4373; Saleska, Scott R/0000-0002-4974-3628; Keller, Michael/0000-0002-0253-3359; Schietti, Juliana/0000-0002-1687-4373; 	NASA [NNX09AO46H, NNG06GE11A, NNX09AI33G, NNG04G073G, NNX06AH36G]; NSF [DEB0721140]; USAid Sustainable Landscapes	NASA(National Aeronautics & Space Administration (NASA)); NSF(National Science Foundation (NSF)); USAid Sustainable Landscapes(United States Agency for International Development (USAID))	Funding provided by NASA Grant NNX09AO46H, NASA grant NNG06GE11A, NASA grant NNX09AI33G, NASA grant NNG04G073G, NASA grant NNX06AH36G, NSF grant DEB0721140, USAid Sustainable Landscapes (www.nasa.gov,www.nsf.gov,www.usaid.gov/climate/sustainablelandscapes). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asner GP, 2003, REMOTE SENS ENVIRON, V87, P521, DOI 10.1016/j.rse.2003.08.006; Asner GP, 2002, REMOTE SENS ENVIRON, V80, P483, DOI 10.1016/S0034-4257(01)00326-1; Asner GP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060875; BORMANN FH, 1979, AM SCI, V67, P660; Boyd DS, 2013, ECOL APPL, V23, P1588, DOI 10.1890/12-0371.1; Brokaw N, 2000, TRENDS ECOL EVOL, V15, P183, DOI 10.1016/S0169-5347(00)01822-X; BROKAW NVL, 1982, BIOTROPICA, V14, P158, DOI 10.2307/2387750; BROKAW NVL, 1987, J ECOL, V75, P9, DOI 10.2307/2260533; BROKAW NVL, 1985, ECOLOGY, V66, P682, DOI 10.2307/1940529; Chambers JQ, 2013, P NATL ACAD SCI USA, V110, P3949, DOI 10.1073/pnas.1202894110; Chambers JQ, 2009, ECOL LETT, V12, pE22, DOI 10.1111/j.1461-0248.2009.01398.x; Chao KJ, 2009, J VEG SCI, V20, P260, DOI 10.1111/j.1654-1103.2009.05755.x; CHAUVEL A, 1987, EXPERIENTIA, V43, P234, DOI 10.1007/BF01945546; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Cochrane MA, 2003, NATURE, V421, P913, DOI 10.1038/nature01437; Cook BD, 2013, REMOTE SENS-BASEL, V5, P4045, DOI 10.3390/rs5084045; de Castilho CV, 2006, FOREST ECOL MANAG, V234, P85, DOI 10.1016/j.foreco.2006.06.024; de Toledo JJ, 2012, FOREST ECOL MANAG, V263, P253, DOI 10.1016/j.foreco.2011.09.017; DENSLOW JS, 1987, ANNU REV ECOL SYST, V18, P431, DOI 10.1146/annurev.es.18.110187.002243; DESTEVEN D, 1988, J TROP ECOL, V4, P407, DOI 10.1017/S0266467400003084; Doughty CE, 2008, J GEOPHYS RES-BIOGEO, V113, DOI [10.1029/2007JG000632, 10.1029/2007JG000590]; Drake JB, 2002, REMOTE SENS ENVIRON, V79, P305, DOI 10.1016/S0034-4257(01)00281-4; Efron B, 1994, INTRO BOOTSTRAP; Espirito-Santo FDB, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043146; Espirito-Santo FDB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4434; Espirito-Santo FDB, 2014, PLANT ECOL DIVERS, V7, P305, DOI 10.1080/17550874.2013.795629; Ferry B, 2010, J ECOL, V98, P106, DOI 10.1111/j.1365-2745.2009.01604.x; Franklin JF, 2002, FOREST ECOL MANAG, V155, P399, DOI 10.1016/S0378-1127(01)00575-8; Frazer GW, 2005, FOREST ECOL MANAG, V214, P65, DOI 10.1016/j.foreco.2005.03.056; Gale N, 2001, J VEG SCI, V12, P337, DOI 10.2307/3236847; Gale N, 1999, J TROP ECOL, V15, P415, DOI 10.1017/S0266467499000929; Gaulton R, 2010, INT J REMOTE SENS, V31, P1193, DOI 10.1080/01431160903380565; Gloor M, 2009, GLOBAL CHANGE BIOL, V15, P2418, DOI 10.1111/j.1365-2486.2009.01891.x; Hubbell S. P., 1986, PLANT ECOL, P77; Hubbell SP, 1999, SCIENCE, V283, P554, DOI 10.1126/science.283.5401.554; Hunter MO, 2013, BIOGEOSCIENCES, V10, P8385, DOI 10.5194/bg-10-8385-2013; JANS L, 1993, BIOTROPICA, V25, P258, DOI 10.2307/2388784; Jansen PA, 2008, ECOLOGY, V89, P3490, DOI 10.1890/07-1682.1; KAPOS V, 1990, BIOTROPICA, V22, P218, DOI 10.2307/2388531; Keller M, 2004, ECOL APPL, V14, pS3, DOI 10.1890/03-6003; Kellner JR, 2014, ECOL LETT, V17, P556, DOI 10.1111/ele.12256; Kellner JR, 2009, ECOL LETT, V12, P887, DOI 10.1111/j.1461-0248.2009.01345.x; Kellner JR, 2009, ECOL LETT, V12, P155, DOI 10.1111/j.1461-0248.2008.01274.x; Laurance WF, 1998, ECOLOGY, V79, P2032, DOI 10.1890/0012-9658(1998)079[2032:RFFATD]2.0.CO;2; LAWTON RO, 1988, ECOLOGY, V69, P764, DOI 10.2307/1941025; Lefsky MA, 2002, BIOSCIENCE, V52, P19, DOI 10.1641/0006-3568(2002)052[0019:LRSFES]2.0.CO;2; LIEBERMAN D, 1985, J ECOL, V73, P915, DOI 10.2307/2260157; Lloyd J, 2009, ECOL LETT, V12, pE19, DOI 10.1111/j.1461-0248.2009.01326.x; Lobo E, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3218; Luizao F.J., 1989, GEOJOURNAL, V19, P407, DOI [DOI 10.1007/BF00176910, 10.1007/BF00176910]; LUIZAO FJ, 1987, EXPERIENTIA, V43, P259, DOI 10.1007/BF01945549; Malhado ACM, 2009, FOREST ECOL MANAG, V258, P1161, DOI 10.1016/j.foreco.2009.06.002; Molino JF, 2001, SCIENCE, V294, P1702, DOI 10.1126/science.1060284; Muller-Landau HC, 2006, ECOL LETT, V9, P589, DOI 10.1111/j.1461-0248.2006.00915.x; Nath CD, 2006, J BIOSCIENCES, V31, P651, DOI 10.1007/BF02708418; Negron-Juarez RI, 2011, REMOTE SENS ENVIRON, V115, P3322, DOI 10.1016/j.rse.2011.07.015; Oliver C.D., 1996, FOREST STAND DYNAMIC; Palace M, 2007, FOREST ECOL MANAG, V238, P309, DOI 10.1016/j.foreco.2006.10.026; POORTER L, 1994, J TROP ECOL, V10, P385, DOI 10.1017/S0266467400008063; PUTZ FE, 1983, BIOTROPICA, V15, P185, DOI 10.2307/2387827; Pyle EH, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2007JG000592; Ray D, 2005, ECOL APPL, V15, P1664, DOI 10.1890/05-0404; RUNKLE JR, 1981, ECOLOGY, V62, P1041, DOI 10.2307/1937003; RUNKLE JR, 1987, ECOLOGY, V68, P417, DOI 10.2307/1939273; Schliemann SA, 2011, FOREST ECOL MANAG, V261, P1143, DOI 10.1016/j.foreco.2011.01.011; Silver WL, 2000, ECOSYSTEMS, V3, P193, DOI 10.1007/s100210000019; St-Onge B, 2004, POWER, V140, p200uJ; Stark SC, 2012, ECOL LETT, V15, P1406, DOI 10.1111/j.1461-0248.2012.01864.x; Thompson J, 1998, FOREST ECOL MANAG, V102, P305, DOI 10.1016/S0378-1127(97)00171-0; vanderMeer PJ, 1996, VEGETATIO, V126, P167, DOI 10.1007/BF00045602; VANDERMEER PJ, 1994, ACTA OECOL, V15, P701; Vepakomma U, 2008, REMOTE SENS ENVIRON, V112, P2326, DOI 10.1016/j.rse.2007.10.001; Vepakomma U, 2011, ECOL APPL, V21, P99, DOI 10.1890/09-0896.1; Vieira S, 2004, OECOLOGIA, V140, P468, DOI 10.1007/s00442-004-1598-z; Whitmore TC, 1996, PHILOS T R SOC B, V351, P1195, DOI 10.1098/rstb.1996.0102; WHITMORE TC, 1993, J TROP ECOL, V9, P131, DOI 10.1017/S0266467400007112; YOUNG TP, 1991, ECOLOGY, V72, P1464, DOI 10.2307/1941119; Zhang KQ, 2003, IEEE T GEOSCI REMOTE, V41, P872, DOI 10.1109/TGRS.2003.810682	78	21	22	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0132144	10.1371/journal.pone.0132144	http://dx.doi.org/10.1371/journal.pone.0132144			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26168242	Green Published, Green Submitted, gold			2022-12-26	WOS:000358193100024
J	Shi, Y; Zhao, QP; Fan, HF; Liu, Q				Shi, Yang; Zhao, Qinpei; Fan, Hongfei; Liu, Qin			Secure Obfuscation for Encrypted Group Signatures	PLOS ONE			English	Article							IDENTITY-BASED ENCRYPTION; PRIVACY; SCHEME; AUTHENTICATION; SYSTEM	In recent years, group signature techniques are widely used in constructing privacy-preserving security schemes for various information systems. However, conventional techniques keep the schemes secure only in normal black-box attack contexts. In other words, these schemes suppose that (the implementation of) the group signature generation algorithm is running in a platform that is perfectly protected from various intrusions and attacks. As a complementary to existing studies, how to generate group signatures securely in a more austere security context, such as a white-box attack context, is studied in this paper. We use obfuscation as an approach to acquire a higher level of security. Concretely, we introduce a special group signature functionality-an encrypted group signature, and then provide an obfuscator for the proposed functionality. A series of new security notions for both the functionality and its obfuscator has been introduced. The most important one is the average-case secure virtual black-box property w.r.t. dependent oracles and restricted dependent oracles which captures the requirement of protecting the output of the proposed obfuscator against collision attacks from group members. The security notions fit for many other specialized obfuscators, such as obfuscators for identity-based signatures, threshold signatures and key-insulated signatures. Finally, the correctness and security of the proposed obfuscator have been proven. Thereby, the obfuscated encrypted group signature functionality can be applied to variants of privacy-preserving security schemes and enhance the security level of these schemes.	[Shi, Yang; Zhao, Qinpei; Fan, Hongfei; Liu, Qin] Tongji Univ, Sch Software Engn, Shanghai 200092, Peoples R China	Tongji University	Liu, Q (corresponding author), Tongji Univ, Sch Software Engn, Shanghai 200092, Peoples R China.	qin.liu@tongji.edu.cn			National Natural Science Foundation of China [61202382]; Fundamental Research Funds for the Central Universities [2013KJ033]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Science Foundation of China (No. 61202382, www.nsfc.gov.cn) and the Fundamental Research Funds for the Central Universities (No. 2013KJ033, www.moe.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barak B., 2001, Advances in Cryptology - CRTPTO 2001. 21st Annual International Cryptology Conference, Proceedings (Lecture Notes in Computer Science Vol.2139), P1; Barak B, 2014, LECT NOTES COMPUT SC, V8441, P221, DOI 10.1007/978-3-642-55220-5_13; Barak B, 2012, J ACM, V59, DOI 10.1145/2160158.2160159; Bellare M, 2003, LECT NOTES COMPUT SC, V2656, P614; Bitansky N, 2013, STOC'13: PROCEEDINGS OF THE 2013 ACM SYMPOSIUM ON THEORY OF COMPUTING, P241; Boneh D, 2004, LECT NOTES COMPUT SC, V3152, P41, DOI 10.1007/978-3-540-28628-8_3; Boyen X, 2007, LECT NOTES COMPUT SC, V4450, P1; Boyen X, 2006, LECT NOTES COMPUT SC, V4117, P290; Brakerski Z., 2014, INNOVATIONS THEORETI, P235; Brakerski Z, 2014, LECT NOTES COMPUT SC, V8349, P1, DOI 10.1007/978-3-642-54242-8_1; Canetti R, 1997, LECT NOTES COMPUT SC, V1294, P455; Chandran N, 2014, LECT NOTES COMPUT SC, V8383, P95, DOI 10.1007/978-3-642-54631-0_6; Chandran N, 2012, LECT NOTES COMPUT SC, V7194, P404, DOI 10.1007/978-3-642-28914-9_23; Chaum D, 1991, GROUP SIGNATURES, P257; Chen L., 1995, LNCS, V950, P171; Chen MT, 2012, INT J INNOV COMPUT I, V8, P4469; Chen YY, 2013, INT J COMPUT MATH, V90, P2614, DOI 10.1080/00207160.2013.807916; Cheng R, 2011, LECT NOTES COMPUT SC, V6980, P188, DOI 10.1007/978-3-642-24316-5_14; Dodis Y, 2003, LECT NOTES COMPUT SC, V2567, P130; Elahi G, GOAL ORIENTED MODELI; Feng X, 2014, SECURE OBFUSCATOR EN, P311; Garg S, 2013, ANN IEEE SYMP FOUND, P40, DOI 10.1109/FOCS.2013.13; Goldwasser S, 2005, ANN IEEE SYMP FOUND, P553, DOI 10.1109/SFCS.2005.60; Goldwasser S, 2014, J CRYPTOL, V27, P480, DOI 10.1007/s00145-013-9151-z; Guo LK, 2012, INT CON DISTR COMP S, P224, DOI 10.1109/ICDCS.2012.45; Hada S, 2010, LECT NOTES COMPUT SC, V6110, P92; Hofheinz D, 2012, LECT NOTES COMPUT SC, V7417, P590, DOI 10.1007/978-3-642-32009-5_35; Hofheinz D, 2010, J CRYPTOL, V23, P121, DOI 10.1007/s00145-009-9046-1; Hohenberger S, 2011, J CRYPTOL, V24, P694, DOI 10.1007/s00145-010-9077-7; Hsu CL, 2012, J MED SYST, V36, P3637, DOI 10.1007/s10916-012-9838-y; Hwang SO, 2009, IEEE T BROADCAST, V55, P686, DOI 10.1109/TBC.2009.2029911; Jensen M, 2010, ANONYMOUS ACCESS CON, P540; Li C, 2012, COMM COM INF SC, V345, P680; Lian B, 2014, INT J INF SECUR, V13, P271, DOI 10.1007/s10207-014-0240-2; Liang XH, 2011, J COMMUN NETW-S KOR, V13, P102, DOI 10.1109/JCN.2011.6157409; Liu XF, 2013, IEEE T PARALL DISTR, V24, P1182, DOI 10.1109/TPDS.2012.331; Tornos JL, 2013, 2013 IFIP/IEEE INTERNATIONAL SYMPOSIUM ON INTEGRATED NETWORK MANAGEMENT (IM 2013), P1346; Lynn B, 2004, LECT NOTES COMPUT SC, V3027, P20; Mejri MN, 2014, VEH COMMUN, V1, P53, DOI 10.1016/j.vehcom.2014.05.001; Nishimaki R., 2014, DESIGN CODE CRYPTOGR, P1; Nishimoto Y, 2009, IEEE T BROADCAST, V55, P419, DOI 10.1109/TBC.2009.2016496; Razzaque M. A., 2013, WIRELESS NETWORKS SE, P107, DOI DOI 10.1007/978-3-642-36169-2_4; Regev O, 2009, J ACM, V56, DOI 10.1145/1568318.1568324; Rong Cheng, 2013, 2013 5th International Conference on Intelligent Networking and Collaborative Systems, P30, DOI 10.1109/INCoS.2013.15; Shamir A., 1984, LECT NOTES COMPUTER, P47, DOI [DOI 10.1007/3-540-39568-7, 10.1007/3-540-39568-7_5]; Shen E, 2009, LECT NOTES COMPUT SC, V5444, P457; Shi Y, 2013, APPL MATH INFORM SCI, V7, P823, DOI 10.12785/amis/070254; Shi Y, 2011, J INTERNET TECHNOL, V12, P981; Sookhak M, 2014, J NETW COMPUT APPL, V43, P121, DOI 10.1016/j.jnca.2014.04.011; Tague P, 2009, IEEE T MOBILE COMPUT, V8, P1221, DOI 10.1109/TMC.2009.33; Wang BY, 2013, IEEE ICC, DOI 10.1109/ICC.2013.6654808; Waters B, 2005, LECT NOTES COMPUT SC, V3494, P114; Wee H., 2005, 37 ANN ACM S THEORY, P523, DOI DOI 10.1145/1060590.1060669; Wei X, 2013, 2013 9TH INTERNATIONAL CONFERENCE ON COMPUTATIONAL INTELLIGENCE AND SECURITY (CIS), P589, DOI 10.1109/CIS.2013.130; Yager RR, 2013, IEEE T FUZZY SYST, V21, P672, DOI 10.1109/TFUZZ.2012.2227263; Yang W, 2013, WIRELESS NETWORK SEC, P95; Yu Y, 2014, FUTURE GENER COMP SY, V30, P127, DOI 10.1016/j.future.2013.05.005; Yum DH, 2012, IEEE T WIREL COMMUN, V11, P1638, DOI 10.1109/TWC.2012.031212.110887; Zhang K, 2014, INFORM SCIENCES, V284, P130, DOI 10.1016/j.ins.2014.06.011; Zhu LH, 2012, SENSOR LETT, V10, P1785, DOI 10.1166/sl.2012.2631; Zhu XY, 2014, IEEE T VEH TECHNOL, V63, P907, DOI 10.1109/TVT.2013.2294032	61	7	7	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0131550	10.1371/journal.pone.0131550	http://dx.doi.org/10.1371/journal.pone.0131550			40	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26167686	Green Published, gold, Green Submitted			2022-12-26	WOS:000358193100010
J	Shringarpure, KS; Isaakidis, P; Sagili, KD; Baxi, RK				Shringarpure, Kalpita S.; Isaakidis, Petros; Sagili, Karuna D.; Baxi, R. K.			Loss-To-Follow-Up on Multidrug Resistant Tuberculosis Treatment in Gujarat, India: The WHEN and WHO of It	PLOS ONE			English	Article							TREATMENT OUTCOMES; DEFAULT; METAANALYSIS	Background Multidrug-resistant Tuberculosis (MDR-TB) is a rising global threat to public health and concerted efforts for its treatment are diluted if the outcomes are not successful, loss to follow up (LFU) being one of them. It is therefore necessary to know the proportion and the associated reasons for LFU and devise effective patient-centered strategies to improve retention in care. Methods A retrospective cohort study was conducted at the MDR-TB treatment site (DR-TB Site) in Central Gujarat among all patients registered from February 2010 to June 2013. LFU patients were defined as those whose treatment was interrupted for two or more consecutive months for any reason. Descriptive statistics, survival analysis and multivariate modeling were used to determine the proportion of patients LFU and to assess associations between LFU and selected demographic and clinical factors. Results A total of 796 patients were enrolled during the study period; 71.9% were male and the median age was 35 years [Interquartile range (IQR) 27-45]. The overall proportion of LFU patients was 153/796 (19.2%). The majority of LFU patients (133/153 i.e. 87%) were lost within the first 6 months of treatment. Ambulatory treatment initiation (adjusted Hazards ratio aHR=2.63, CI: 1.01-6.86), different providers in IP and CP (aHR=1.27, CI: 1.18-1.38) and culture conversion after more than 4 months of treatment(aHR=1.34, CI: 1.21-1.49) were found to be significantly associated with LFU in multivariate models. Conclusions A high proportion of LFU among patients on MDR-TB treatment was found in a programmatic setting in India. Clinical but equally important programmatic factors were associated with LFU, accounting for one-fifth of all the outcomes of MDR-TB treatment. Proper training for DOT providers and aggressive counseling and health system strengthening with patient friendly follow up services may help reduce LFU.	[Shringarpure, Kalpita S.; Baxi, R. K.] Govt Med Coll, Dept Prevent Social Med, Baroda, Gujarat, India; [Isaakidis, Petros] Med Sans Frontieres, Operat Res Unit, Mumbai, Maharashtra, India; [Sagili, Karuna D.] Union, South East Asia Off, New Delhi, India	Maharaja Sayajirao University Baroda	Shringarpure, KS (corresponding author), Govt Med Coll, Dept Prevent Social Med, Baroda, Gujarat, India.	kshringarpure@gmail.com		Isaakidis, Petros/0000-0002-7881-1554	American People through the United States Agency for International Development (USAID); State RNTCP Cell, Gandhinagar	American People through the United States Agency for International Development (USAID)(United States Agency for International Development (USAID)); State RNTCP Cell, Gandhinagar	Funding for the operational research course was made possible by the support of the American People through the United States Agency for International Development (USAID). Funding for the project was made possible through support of the State RNTCP Cell, Gandhinagar. Funders had no role in study design, data collection, analysis and interpretation of data, decision to publish or preparation of the manuscript. The contents of this paper do not necessarily reflect the views of USAID, the United States Government, International Union Against Tuberculosis and Lung Disease (The Union) or the State RNTCP cell, Gujarat.	Ahuja SD, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001300; Cavanaugh JS, 2012, INT J TUBERC LUNG D, V16, P1069, DOI 10.5588/ijtld.11.0696; Chiang CY, 2006, EUR RESPIR J, V28, P980, DOI 10.1183/09031936.06.00125705; Chiang CY, 2010, RESPIROLOGY, V15, P413, DOI 10.1111/j.1440-1843.2010.01738.x; Datta BS, 2008, MULTIDRUG RESISTANT, P15; Government of India, 2014, TB INDIA 2014 REVISE; Hasker E, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-97; Holtz TH, 2006, INT J TUBERC LUNG D, V10, P649; Isaakidis P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068869; Isaakidis P, 2013, TROP MED INT HEALTH, V18, P1128, DOI 10.1111/tmi.12146; Jeon DS, 2011, J KOREAN MED SCI, V26, P33, DOI 10.3346/jkms.2011.26.1.33; Johnston JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006914; Orenstein EW, 2009, LANCET INFECT DIS, V9, P153, DOI 10.1016/S1473-3099(09)70041-6; Revised National Tuberculosis Control Programme, 2012, GUIDELINES ON PROGRA; Sahu GB, 2011, ECONOMICAND POLITICA, VXLVI; Santha T, 2002, INT J TUBERC LUNG D, V6, P780; Singla R, 2009, INT J TUBERC LUNG D, V13, P976; State Health Society (RNTCP Sub Committee) CoH; Medical Services and Medical Education (HS), ANNUAL STATUS REPORT; World Health Organization, 2013, ZHURNAL EKSPERIMENTA	19	18	19	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0132543	10.1371/journal.pone.0132543	http://dx.doi.org/10.1371/journal.pone.0132543			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26167891	Green Published, Green Submitted, gold			2022-12-26	WOS:000358193100052
J	Wu, BX; Fan, J; Boyer, NP; Jenkins, RW; Koutalos, Y; Hannun, YA; Crosson, CE				Wu, Bill X.; Fan, Jie; Boyer, Nicholas P.; Jenkins, Russell W.; Koutalos, Yiannis; Hannun, Yusuf A.; Crosson, Craig E.			Lack of Acid Sphingomyelinase Induces Age-Related Retinal Degeneration	PLOS ONE			English	Article							NIEMANN-PICK-DISEASE; PIGMENT EPITHELIAL-CELLS; MACULAR DEGENERATION; DEFICIENT MICE; DRUSEN FORMATION; AUTOPHAGY; LIGHT; NEURONS; SPHINGOLIPIDS; INTERMEDIATE	Background Mutations of acid sphingomyelinase (ASMase) cause Niemann-Pick diseases type A and B, which are fatal inherited lipid lysosomal storage diseases, characterized with visceral organ abnormalities and neurodegeneration. However, the effects of suppressing retinal ASMase expression are not understood. The goal of this study was to determine if the disruption of ASMase expression impacts the retinal structure and function in the mouse, and begin to investigate the mechanisms underlying these abnormalities. Methods Acid sphingomyelinase knockout (ASMase KO) mice were utilized to study the roles of this sphingolipid metabolizing enzyme in the retina. Electroretinogram and morphometric analysis were used to assess the retinal function and structure at various ages. Sphingolipid profile was determined by liquid chromatography-mass spectrometry. Western blots evaluated the level of the autophagy marker LC3-II. Results When compared to control animals, ASMase KO mice exhibited significant age-dependent reduction in ERG a- and b-wave amplitudes. Associated with these functional deficits, morphometric analysis revealed progressive thinning of retinal layers; however, the most prominent degeneration was observed in the photoreceptor and outer nuclear layer. Additional analyses of ASMase KO mice revealed early reduction in ERG c-wave amplitudes and increased lipofuscin accumulation in the retinal pigment epithelium (RPE). Sphingolipid analyses showed abnormal accumulation of sphingomyelin and sphingosine in ASMase KO retinas. Western blot analyses showed a higher level of the autophagosome marker LC3- II. Conclusions These studies demonstrate that ASMase is necessary for the maintenance of normal retinal structure and function. The early outer retinal dysfunction, outer segment degeneration, accumulation of lipofuscin and autophagosome markers provide evidence that disruption of lysosomal function contributes to the age-dependent retinal degeneration exhibited by ASMase KO mice.	[Wu, Bill X.; Jenkins, Russell W.; Hannun, Yusuf A.] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Fan, Jie; Boyer, Nicholas P.; Koutalos, Yiannis; Crosson, Craig E.] Med Univ S Carolina, Storm Eye Inst, Dept Ophthalmol, Charleston, SC 29425 USA; [Hannun, Yusuf A.] SUNY Stony Brook, Stony Brook Canc Ctr, Stony Brook, NY 11794 USA; [Hannun, Yusuf A.] SUNY Stony Brook, Dept Med, Stony Brook, NY 11794 USA	Medical University of South Carolina; Medical University of South Carolina; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Fan, J (corresponding author), Med Univ S Carolina, Storm Eye Inst, Dept Ophthalmol, Charleston, SC 29425 USA.	fan@musc.edu			National Institutes of Health (NIH) [EY021368, CA 097132]; South Carolina Clinical & Translational Research (SCTR) institute with an academic home at the Medical University of South Carolina CTSA, NIH/NCATS [UL1TR000062]; National Center for Research Resources; Office of the Director of the National Institutes of Health [C06 RR018823]; Research to Prevent Blindness (RPB) (New York, NY); NATIONAL CANCER INSTITUTE [P01CA097132] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000062] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY021368] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM043825] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); South Carolina Clinical & Translational Research (SCTR) institute with an academic home at the Medical University of South Carolina CTSA, NIH/NCATS; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Office of the Director of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness (RPB) (New York, NY)(Research to Prevent Blindness (RPB)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was supported by the following: 1. National Institutes of Health (NIH) Grant EY021368 (C.E.C.), http://www.nih.gov/. This funder had roles in study design, data collection and analysis, decision to publish and preparation of the manuscript. 2. National Institutes of Health (NIH) Grant CA 097132 (Y.A.H.), http://www.nih.gov/. This funder had roles in data collection and analysis. 3. South Carolina Clinical & Translational Research (SCTR) institute, with an academic home at the Medical University of South Carolina CTSA, NIH/NCATS grant number UL1TR000062, http://academicdepartments.musc.edu/sctr/index.htm. This funder had roles in study design, data collection and analysis. 4. National Center for Research Resources and the Office of the Director of the National Institutes of Health through Grant Number C06 RR018823, http://www.nih.gov/. This funder had roles in data collection and analysis. 5. Unrestricted grant to the Department of Ophthalmology, Storm Eye Institute, Medical University of South Carolina, from Research to Prevent Blindness (RPB) (New York, NY), http://www.rpbusa.org/rpb/. This funder had no role in study design, data collection and analysis, decision to publish and preparation of the manuscript	Abrahan CE, 2010, INVEST OPHTH VIS SCI, V51, P1171, DOI 10.1167/iovs.09-3909; Bazan NG, 2010, J LIPID RES, V51, P2018, DOI 10.1194/jlr.R001131; Bazan NG, 2009, PROSTAG LEUKOTR ESS, V81, P205, DOI 10.1016/j.plefa.2009.05.024; Bielawski J, 2006, METHODS, V39, P82, DOI 10.1016/j.ymeth.2006.05.004; Boini KM, 2011, AM J PATHOL, V179, P2210, DOI 10.1016/j.ajpath.2011.07.019; Boyer NP, 2012, J BIOL CHEM, V287, P22276, DOI 10.1074/jbc.M111.329235; BROWNSTEIN S, 1978, ARCH OPHTHALMOL-CHIC, V96, P864, DOI 10.1001/archopht.1978.03910050466015; Chalfant CE, 2005, J CELL SCI, V118, P4605, DOI 10.1242/jcs.02637; Chen H, 2012, ADV EXP MED BIOL, V723, P553, DOI 10.1007/978-1-4614-0631-0_70; Ledesma MD, 2011, J NEUROCHEM, V116, P779, DOI 10.1111/j.1471-4159.2010.07034.x; Fan J, 2010, J NEUROSCI, V30, P2496, DOI 10.1523/JNEUROSCI.6254-09.2010; Filling-Katz M R, 1992, Metab Pediatr Syst Ophthalmol (1985), V15, P16; Fliesler SJ, 2010, J LIPID RES, V51, P3399, DOI 10.1194/jlr.R010538; Friedman JS, 2010, P NATL ACAD SCI USA, V107, P15523, DOI 10.1073/pnas.1002897107; Gabande-Rodriguez E, 2014, CELL DEATH DIFFER, V21, P864, DOI 10.1038/cdd.2014.4; Galvan C, 2008, MOL BIOL CELL, V19, P509, DOI 10.1091/mbc.E07-05-0439; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; HORINOUCHI K, 1995, NAT GENET, V10, P288, DOI 10.1038/ng0795-288; Jenkins RW, 2011, J BIOL CHEM, V286, P13292, DOI 10.1074/jbc.M110.163378; Kaarniranta K, 2009, AGEING RES REV, V8, P128, DOI 10.1016/j.arr.2009.01.001; Kim JY, 2013, CELL, V154, P365, DOI 10.1016/j.cell.2013.06.012; Klettner A, 2013, INT J BIOCHEM CELL B, V45, P1457, DOI 10.1016/j.biocel.2013.04.013; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Krohne TU, 2010, EXP EYE RES, V90, P465, DOI 10.1016/j.exer.2009.12.011; Kuemmel TA, 1997, J NEUROPATH EXP NEUR, V56, P171, DOI 10.1097/00005072-199702000-00008; Li CP, 2013, BIOCHEM BIOPH RES CO, V438, P739, DOI 10.1016/j.bbrc.2013.07.097; McGovern MM, 2004, OPHTHALMOLOGY, V111, P1424, DOI 10.1016/j.ophtha.2003.10.034; Merrill AH, 2011, CHEM REV, V111, P6387, DOI 10.1021/cr2002917; Neale BM, 2010, P NATL ACAD SCI USA, V107, P7395, DOI 10.1073/pnas.0912019107; Opreanu M, 2011, DIABETES, V60, P2370, DOI 10.2337/db10-0550; OTTERBACH B, 1995, CELL, V81, P1053, DOI 10.1016/S0092-8674(05)80010-8; Rajala RVS, 2010, MOL NEUROBIOL, V42, P39, DOI 10.1007/s12035-010-8130-8; ROBB RM, 1973, INVEST OPHTH VISUAL, V12, P366; Rodriguez-Muela N, 2013, AGING CELL, V12, P478, DOI 10.1111/acel.12072; Rotstein NP, 2010, J LIPID RES, V51, P1247, DOI 10.1194/jlr.R003442; Ryhanen T, 2009, J CELL MOL MED, V13, P3616, DOI 10.1111/j.1582-4934.2008.00577.x; Sango K, 2008, OPHTHALMIC RES, V40, P241, DOI 10.1159/000127831; Sparrow JR, 2012, PROG RETIN EYE RES, V31, P121, DOI 10.1016/j.preteyeres.2011.12.001; Sparrow JR, 2010, J LIPID RES, V51, P247, DOI 10.1194/jlr.R000687; Toops KA, 2015, MOL BIOL CELL, V26, P1, DOI 10.1091/mbc.E14-05-1028; Wang AL, 2009, AUTOPHAGY, V5, P563, DOI 10.4161/auto.5.4.8163; Wang AL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004160; Wasserstein MP, 2006, J PEDIATR-US, V149, P554, DOI 10.1016/j.jpeds.2006.06.034; Yu Y, 2011, INVEST OPHTH VIS SCI, V52, P4663, DOI 10.1167/iovs.10-7070; Zeidan YH, 2006, J BIOL CHEM, V281, P24695, DOI 10.1074/jbc.M604713200; Zhao ZY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019456	46	18	19	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0133032	10.1371/journal.pone.0133032	http://dx.doi.org/10.1371/journal.pone.0133032			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26168297	Green Submitted, Green Published, gold			2022-12-26	WOS:000358193100105
J	Wu, MN; Matsubara, JH; Gordon, KE				Wu, Mengnan; Matsubara, Jesse H.; Gordon, Keith E.			General and Specific Strategies Used to Facilitate Locomotor Maneuvers	PLOS ONE			English	Article							ANTICIPATORY POSTURAL ADJUSTMENTS; INCREASED ROTATIONAL INERTIA; LOCAL DYNAMIC STABILITY; CENTER-OF-MASS; FRONTAL PLANE; LATERAL STABILIZATION; STEPPING STRATEGIES; WALKING; BALANCE; GAIT	People make anticipatory changes in gait patterns prior to initiating a rapid change of direction. How they prepare will change based on their knowledge of the maneuver. To investigate specific and general strategies used to facilitate locomotor maneuvers, we manipulated subjects' ability to anticipate the direction of an upcoming lateral "lane-change" maneuver. To examine specific anticipatory adjustments, we observed the four steps immediately preceding a maneuver that subjects were instructed to perform at a known time in a known direction. We hypothesized that to facilitate a specific change of direction, subjects would proactively decrease margin of stability in the future direction of travel. Our results support this hypothesis: subjects significantly decreased lateral margin of stability by 69% on the side ipsilateral to the maneuver during only the step immediately preceding the maneuver. This gait adaptation may have improved energetic efficiency and simplified the control of the maneuver. To examine general anticipatory adjustments, we observed the two steps immediately preceding the instant when subjects received information about the direction of the maneuver. When the maneuver direction was unknown, we hypothesized that subjects would make general anticipatory adjustments that would improve their ability to actively initiate a maneuver in multiple directions. This second hypothesis was partially supported as subjects increased step width and stance phase hip flexion during these anticipatory steps. These modifications may have improved subjects' ability to generate forces in multiple directions and maintain equilibrium during the onset and execution of the rapid maneuver. However, adapting these general anticipatory strategies likely incurred an additional energetic cost.	[Wu, Mengnan; Matsubara, Jesse H.; Gordon, Keith E.] Northwestern Univ, Feinberg Sch Med, Dept Phys Therapy & Human Movement Sci, Chicago, IL 60611 USA; [Gordon, Keith E.] Edward Hines Jr VA Hosp, Res Serv, Hines, IL USA	Northwestern University; Feinberg School of Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Edward Hines Jr. VA Hospital	Wu, MN (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Phys Therapy & Human Movement Sci, Chicago, IL 60611 USA.	mengnan.mary.wu@gmail.com		Gordon, Keith/0000-0001-6057-7651	United States Department of Veterans Affairs, Rehabilitation Research and Development Service [1 IK2 RX000717-01]; National Institutes of Health [T32HD057845]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD057845] Funding Source: NIH RePORTER	United States Department of Veterans Affairs, Rehabilitation Research and Development Service; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	KG received funding from Career Development Award #1 IK2 RX000717-01 from the United States Department of Veterans Affairs, Rehabilitation Research and Development Service, http://www.rehab.research.va.gov/.JM received funding from the National Institutes of Health, T32HD057845, http://www.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauby CE, 2000, J BIOMECH, V33, P1433, DOI 10.1016/S0021-9290(00)00101-9; Bertram JEA, 2001, J THEOR BIOL, V209, P445, DOI 10.1006/jtbi.2001.2279; BIEWENER AA, 1989, SCIENCE, V245, P45, DOI 10.1126/science.2740914; Bingham JT, 2011, J NEUROPHYSIOL, V106, P437, DOI 10.1152/jn.00010.2011; Blum Y, 2011, J THEOR BIOL, V281, P97, DOI 10.1016/j.jtbi.2011.04.029; Bruijn SM, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0999; Cao C, 1997, J GERONTOL A-BIOL, V52, pM88, DOI 10.1093/gerona/52A.2.M88; Chang CL, 2008, J BIOMECH, V41, P1317, DOI 10.1016/j.jbiomech.2008.01.023; Collins S, 2005, SCIENCE, V307, P1082, DOI 10.1126/science.1107799; Dean JC, 2007, IEEE T BIO-MED ENG, V54, P1919, DOI 10.1109/TBME.2007.901031; Dickinson MH, 2000, SCIENCE, V288, P100, DOI 10.1126/science.288.5463.100; Dingwell JB, 2006, J BIOMECH, V39, P444, DOI 10.1016/j.jbiomech.2004.12.014; Donelan JM, 2001, P ROY SOC B-BIOL SCI, V268, P1985, DOI 10.1098/rspb.2001.1761; Glaister BC, 2007, GAIT POSTURE, V25, P289, DOI 10.1016/j.gaitpost.2006.04.003; Gordon KE, 2009, ARCH PHYS MED REHAB, V90, P136, DOI 10.1016/j.apmr.2008.07.014; Hak L, 2013, CLIN BIOMECH, V28, P1041, DOI 10.1016/j.clinbiomech.2013.10.010; Hak L, 2013, J BIOMECH, V46, P905, DOI 10.1016/j.jbiomech.2012.12.017; HIROKAWA S, 1989, J BIOMED ENG, V11, P449, DOI 10.1016/0141-5425(89)90038-1; Hof AL, 2005, J BIOMECH, V38, P1, DOI 10.1016/j.jbiomech.2004.03.025; Hof AL, 2007, GAIT POSTURE, V25, P250, DOI 10.1016/j.gaitpost.2006.04.013; Hollands KL, 2010, NEUROREHAB NEURAL RE, V24, P358, DOI 10.1177/1545968309348508; Houck JR, 2006, GAIT POSTURE, V24, P314, DOI 10.1016/j.gaitpost.2005.10.005; Hurt CP, 2015, J BIOMECH, V48, P592, DOI 10.1016/j.jbiomech.2015.01.003; Huxham F, 2008, MOVEMENT DISORD, V23, P817, DOI 10.1002/mds.21932; Kubow TM, 1999, PHILOS T ROY SOC B, V354, P849, DOI 10.1098/rstb.1999.0437; Kuo AD, 1999, INT J ROBOT RES, V18, P917, DOI 10.1177/02783649922066655; Le Pellec A, 2000, J ELECTROMYOGR KINES, V10, P171, DOI 10.1016/S1050-6411(00)00006-7; Lee DV, 2001, J EXP BIOL, V204, P3927; Lemay JF, 2014, J ELECTROMYOGR KINES, V24, P739, DOI 10.1016/j.jelekin.2014.04.013; Liechti M, 2008, CLIN NEUROPHYSIOL, V119, P2804, DOI 10.1016/j.clinph.2008.05.033; Lyon IN, 1997, EXP BRAIN RES, V115, P345, DOI 10.1007/PL00005703; MACKINNON CD, 1993, J BIOMECH, V26, P633, DOI 10.1016/0021-9290(93)90027-C; Matsubara JH, 2015, GAIT POSTURE, V41, P646, DOI 10.1016/j.gaitpost.2015.01.015; Matsusaka N., 1985, BIOMECHANICS A, P427; Musselman KE, 2007, J REHABIL MED, V39, P567, DOI 10.2340/16501977-0090; Patla AE, 2003, IEEE ENG MED BIOL, V22, P48, DOI 10.1109/MEMB.2003.1195695; PATLA AE, 1991, J EXP PSYCHOL HUMAN, V17, P603, DOI 10.1037/0096-1523.17.3.603; Patla AE, 1999, EXP BRAIN RES, V129, P629, DOI 10.1007/s002210050932; Patton J, 2008, TOP STROKE REHABIL, V15, P131, DOI 10.1310/tsr1502-131; Qiao M, 2014, J EXP BIOL, V217, P432, DOI 10.1242/jeb.087569; Rosenblatt NJ, 2010, GAIT POSTURE, V31, P380, DOI 10.1016/j.gaitpost.2010.01.002; Sadeghi H, 2000, GAIT POSTURE, V12, P34, DOI 10.1016/S0966-6362(00)00070-9; Sefati S, 2013, P NATL ACAD SCI USA, V110, P18798, DOI 10.1073/pnas.1309300110; Strike SC, 2009, GAIT POSTURE, V29, P597, DOI 10.1016/j.gaitpost.2008.12.015; Thigpen MT, 2009, GAIT POSTURE, V29, P113, DOI 10.1016/j.gaitpost.2008.07.009; Thigpen MT, 2000, PHYS THER, V80, P1174, DOI 10.1093/ptj/80.12.1174; Toebes MJP, 2012, GAIT POSTURE, V36, P527, DOI 10.1016/j.gaitpost.2012.05.016; van Hedel HJA, 2005, SPINAL CORD, V43, P593, DOI 10.1038/sj.sc.3101768; Webb PW, 2006, FISH PHYSIOL, V23, P281, DOI 10.1016/S1546-5098(05)23008-X; Xu DL, 2004, J MOTOR BEHAV, V36, P316, DOI 10.3200/JMBR.36.3.316-326; Young PMM, 2012, J BIOMECH, V45, P1053, DOI 10.1016/j.jbiomech.2011.12.027	51	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0132707	10.1371/journal.pone.0132707	http://dx.doi.org/10.1371/journal.pone.0132707			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26167931	Green Published, gold, Green Submitted			2022-12-26	WOS:000358193100069
J	Antonczak, AK; Mullee, LI; Wang, Y; Comartin, D; Inoue, T; Pelletier, L; Morrison, CG				Antonczak, A. K.; Mullee, L. I.; Wang, Y.; Comartin, D.; Inoue, T.; Pelletier, L.; Morrison, C. G.			Opposing effects of pericentrin and microcephalin on the pericentriolar material regulate CHK1 activation in the DNA damage response	ONCOGENE			English	Article							CENTROSOME AMPLIFICATION; MITOTIC ENTRY; CHECKPOINT; SPINDLE; PHOSPHORYLATION; ORGANIZATION; SURVIVAL; DEFECTS; CELLS	Genotoxic stresses lead to centrosome amplification, a frequently-observed feature in cancer that may contribute to genome instability and to tumour cell invasion. Here we have explored how the centrosome controls DNA damage responses. For most of the cell cycle, centrosomes consist of two centrioles embedded in the proteinaceous pericentriolar material (PCM). Recent data indicate that the PCM is not an amorphous assembly of proteins, but actually a highly organised scaffold around the centrioles. The large coiled-coil protein, pericentrin, participates in PCM assembly and has been implicated in the control of DNA damage responses (DDRs) through its interactions with checkpoint kinase 1 (CHK1) and microcephalin (MCPH1). CHK1 is required for DNA damage-induced centrosome amplification, whereas MCPH1 deficiency greatly increases the amplification seen after DNA damage. We found that the PCM showed a marked expansion in volume and a noticeable change in higher-order organisation after ionising radiation treatment. PCM expansion was dependent on CHK1 kinase activity and was potentiated by MCPH1 deficiency. Furthermore, pericentrin deficiency or mutation of a separase cleavage site blocked DNA damage-induced PCM expansion. The extent of nuclear CHK1 activation after DNA damage reflected the level of PCM expansion, with a reduction in pericentrin-deficient or separase cleavage site mutant-expressing cells, and an increase in MCPH1-deficient cells that was suppressed by the loss of pericentrin. Deletion of the nuclear export signal of CHK1 led to its hyperphosphorylation after irradiation and reduced centrosome amplification. Deletion of the nuclear localisation signal led to low CHK1 activation and low centrosome amplification. From these data, we propose a feedback loop from the PCM to the nuclear DDR in which CHK1 regulates pericentrin-dependent PCM expansion to control its own activation.	[Antonczak, A. K.; Mullee, L. I.; Wang, Y.; Morrison, C. G.] Natl Univ Ireland Galway, Sch Nat Sci, Ctr Chromosome Biol, Galway, Ireland; [Comartin, D.; Pelletier, L.] Univ Toronto, Lunenfeld Tanenbaum Res Inst, Toronto, ON, Canada; [Inoue, T.] Johns Hopkins Univ, Dept Cell Biol, Baltimore, MD USA	Ollscoil na Gaillimhe-University of Galway; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Johns Hopkins University	Morrison, CG (corresponding author), Natl Univ Ireland Galway, Ctr Chromosome Biol, Biosci Bldg, Galway, Ireland.	Ciaran.Morrison@nuigalway.ie	Pelletier, Laurence/F-8858-2013; Morrison, Ciaran/AAH-2034-2019; Morrison, Ciaran/B-6568-2008	Morrison, Ciaran/0000-0003-2401-7029; Morrison, Ciaran/0000-0003-2401-7029	EMBO Long-term Postdoctoral Fellowship; Journal of Cell Science; National University of Ireland; Science Foundation Ireland [08/IN.1/B1029, 10/IN.1/B2972]	EMBO Long-term Postdoctoral Fellowship(European Molecular Biology Organization (EMBO)); Journal of Cell Science; National University of Ireland; Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	We are grateful to Alex Bird, David Drechsel, Fanni Gergely, Andreas Merdes and Eric Tippmann for reagents and to Brian McStay and Noel Lowndes for critically reading the manuscript. AKA received an EMBO Long-term Postdoctoral Fellowship and a Travelling Fellowship from the Journal of Cell Science. LIM received a Travelling Studentship from the National University of Ireland. This work was supported by Science Foundation Ireland Principal Investigator awards 08/IN.1/B1029 and 10/IN.1/B2972.	Agircan FG, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004672; Alderton GK, 2006, NAT CELL BIOL, V8, P725, DOI 10.1038/ncb1431; Anderhub SJ, 2012, CANCER LETT, V322, P8, DOI 10.1016/j.canlet.2012.02.006; Barr AR, 2010, J CELL BIOL, V189, P23, DOI 10.1083/jcb.200912163; Bartek J, 2003, CANCER CELL, V3, P421, DOI 10.1016/S1535-6108(03)00110-7; Bekker-Jensen S, 2006, J CELL BIOL, V173, P195, DOI 10.1083/jcb.200510130; Bird AW, 2008, J CELL BIOL, V182, P289, DOI 10.1083/jcb.200802005; Bourke E, 2010, ONCOGENE, V29, P616, DOI 10.1038/onc.2009.340; Bourke E, 2007, EMBO REP, V8, P603, DOI 10.1038/sj.embor.7400962; Brown JAL, 2010, ONCOGENE, V29, P5537, DOI 10.1038/onc.2010.302; D'Assoro AB, 2002, ONCOGENE, V21, P6146, DOI 10.1038/sj.onc.1205772; Dammermann A, 2002, J CELL BIOL, V159, P255, DOI 10.1083/jcb.200204023; Dictenberg JB, 1998, J CELL BIOL, V141, P163, DOI 10.1083/jcb.141.1.163; Duensing S, 2000, P NATL ACAD SCI USA, V97, P10002, DOI 10.1073/pnas.170093297; Fu JY, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120104; Ganem NJ, 2009, NATURE, V460, P278, DOI 10.1038/nature08136; Godinho SA, 2014, NATURE, V510, P167, DOI 10.1038/nature13277; Griffith E, 2008, NAT GENET, V40, P232, DOI 10.1038/ng.2007.80; Kramer A, 2004, NAT CELL BIOL, V6, P884, DOI 10.1038/ncb1165; Kushner EJ, 2014, J CELL BIOL, V206, P257, DOI 10.1083/jcb.201311013; Lawo S, 2012, NAT CELL BIOL, V14, P1148, DOI 10.1038/ncb2591; Lee K, 2012, CELL CYCLE, V11, P2476, DOI 10.4161/cc.20878; Lee K, 2011, J CELL BIOL, V195, P1093, DOI 10.1083/jcb.201106093; Lingle WL, 1998, P NATL ACAD SCI USA, V95, P2950, DOI 10.1073/pnas.95.6.2950; Loffler H, 2013, ONCOGENE, V32, P2963, DOI 10.1038/onc.2012.310; Loffler H, 2007, CELL CYCLE, V6, P2541; Loncarek J, 2008, NAT CELL BIOL, V10, P322, DOI 10.1038/ncb1694; Matsuo K, 2012, CURR BIOL, V22, P915, DOI 10.1016/j.cub.2012.03.048; Matsuyama M, 2011, J CELL SCI, V124, P2113, DOI 10.1242/jcs.086488; Mennella V, 2012, NAT CELL BIOL, V14, P1159, DOI 10.1038/ncb2597; Nigg EA, 2002, NAT REV CANCER, V2, P815, DOI 10.1038/nrc924; Nigg EA, 2009, CELL, V139, P663, DOI 10.1016/j.cell.2009.10.036; Niida H, 2007, MOL CELL BIOL, V27, P2572, DOI 10.1128/MCB.01611-06; Palazzo RE, 2000, CURR TOP DEV BIOL, V49, P449; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Pihan GA, 2001, CANCER RES, V61, P2212; Prosser SL, 2012, J CELL SCI, V125, P5353, DOI 10.1242/jcs.106096; Prosser SL, 2009, MOL CELL BIOL, V29, P1760, DOI 10.1128/MCB.01124-08; Robinson HMR, 2007, CELL CYCLE, V6, P982, DOI 10.4161/cc.6.8.4111; Sonnen KF, 2012, BIOL OPEN, V1, P965, DOI 10.1242/bio.20122337; Stephan AK, 2011, MOL CELL BIOL, V31, P1369, DOI 10.1128/MCB.00786-10; Tibelius A, 2009, J CELL BIOL, V185, P1149, DOI 10.1083/jcb.200810159; Wang Y- D, 2006, REV PROTOCOLS DT40 R, P439; Wang YF, 2013, CELL CYCLE, V12, P635, DOI 10.4161/cc.23516; Wilsker D, 2008, P NATL ACAD SCI USA, V105, P20752, DOI 10.1073/pnas.0806917106; Zachos G, 2003, EMBO J, V22, P713, DOI 10.1093/emboj/cdg060; Zachos G, 2007, DEV CELL, V12, P247, DOI 10.1016/j.devcel.2007.01.003	47	18	18	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 14	2016	35	15					2003	2010		10.1038/onc.2015.257	http://dx.doi.org/10.1038/onc.2015.257			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DJ2CC	26165835				2022-12-26	WOS:000374010300013
J	Mir, R; Pradhan, SJ; Patil, P; Mulherkar, R; Galande, S				Mir, R.; Pradhan, S. J.; Patil, P.; Mulherkar, R.; Galande, S.			Wnt/beta-catenin signaling regulated SATB1 promotes colorectal cancer tumorigenesis and progression	ONCOGENE			English	Article							CHROMATIN ORGANIZER SATB1; TUMOR PROGRESSION; GENE-EXPRESSION; GASTRIC-CANCER; UP-REGULATION; IN-VITRO; METASTASIS; GROWTH; CARCINOMA; GENOME	The chromatin organizer SATB1 has been implicated in the development and progression of multiple cancers including breast and colorectal cancers. However, the regulation and role of SATB1 in colorectal cancers is poorly understood. Here, we demonstrate that expression of SATB1 is induced upon hyperactivation of Wnt/beta-catenin signaling and repressed upon depletion of TCF7L2 (TCF4) and beta-catenin. Using several colorectal cancer cell line models and the APC min mutant zebrafish in vivo model, we established that SATB1 is a novel target of Wnt/beta-catenin signaling. We show that direct binding of TCF7L2/beta-catenin complex on Satb1 promoter is required for the regulation of SATB1. Moreover, SATB1 is sufficient to regulate the expression of beta-catenin, members of TCF family, multiple downstream effectors and mediators of Wnt pathway. SATB1 potentiates the cellular changes and expression of key cancer-associated genes in non-aggressive colorectal cells, promotes their aggressive phenotype and tumorigenesis in vivo. Conversely, depletion of SATB1 from aggressive cells reprograms the expression of cancer-associated genes, reverses their cancer phenotype and reduces the potential of these cells to develop tumors in vivo. We also show that SATB1 and beta-catenin bind to the promoters of TCF7L2 and the downstream targets of Wnt signaling and regulate their expression. Our findings suggest that SATB1 shares a feedback regulatory network with TCF7L2/beta-catenin signaling and is required for Wnt signaling-dependent regulation of beta-catenin. Collectively, these results provide unequivocal evidence to establish that SATB1 reprograms the expression of tumor growth-and metastasis-associated genes to promote tumorigenesis and functionally overlaps with Wnt signaling critical for colorectal cancer tumorigenesis.	[Mir, R.; Pradhan, S. J.; Galande, S.] Indian Inst Sci Educ & Res, Pune, Maharashtra, India; [Patil, P.] Tata Mem Hosp, Mumbai 400012, Maharashtra, India; [Mulherkar, R.] Adv Ctr Treatment Res & Educ Canc, Kharghar, Navi Mumbai, India; [Galande, S.] Natl Ctr Cell Sci, Pune, Maharashtra, India	Indian Institute of Science Education & Research (IISER) Pune; Tata Memorial Centre (TMC); Tata Memorial Hospital; Tata Memorial Centre (TMC); Advance Centre for Treatment, Research & Education in Cancer (ACTREC); Department of Biotechnology (DBT) India; National Centre for Cell Science, Pune (NCCS)	Galande, S (corresponding author), Indian Inst Sci Educ & Res, Ctr Excellence Epigenet, Dr Homi Bhabha Rd, Pune 411008, Maharashtra, India.	sanjeev@iiserpune.ac.in		Patil, Prachi/0000-0002-5809-6282	Centre of Excellence in Epigenetics program of the Department of Biotechnology; Department of Science and Technology, Government of India; University Grants Commission, India	Centre of Excellence in Epigenetics program of the Department of Biotechnology; Department of Science and Technology, Government of India(Department of Science & Technology (India)); University Grants Commission, India(University Grants Commission, India)	We thank the staff of the experimental animal facility and in vivo imaging facility of NCCS. Work was supported by grants from the Centre of Excellence in Epigenetics program of the Department of Biotechnology and the Swarnajayanti Fellowship from the Department of Science and Technology, Government of India to SG. RM is supported by fellowship from the University Grants Commission, India. We thank Mahendra Sonawane for providing RNA and whole cell lysates from APC min mutant Zebrafish.	Aguilera O, 2006, ONCOGENE, V25, P4116, DOI 10.1038/sj.onc.1209439; Azzolin L, 2012, CELL, V151, P1443, DOI 10.1016/j.cell.2012.11.027; Bienz M, 2000, CELL, V103, P311, DOI 10.1016/S0092-8674(00)00122-7; Cai ST, 2006, NAT GENET, V38, P1278, DOI 10.1038/ng1913; Cheng C, 2010, APMIS, V118, P855, DOI 10.1111/j.1600-0463.2010.02673.x; Chu SH, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-149; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Frietze S, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r52; Fromberg A, 2014, INT J CANCER, V135, P2537, DOI 10.1002/ijc.28895; Galande S, 2007, CURR OPIN GENET DEV, V17, P408, DOI 10.1016/j.gde.2007.08.003; Galande S, 2002, CURR CANCER DRUG TAR, V2, P157, DOI 10.2174/1568009023333917; Gonzalex-Sancho JM, 2005, ONCOGENE, V24, P1098, DOI 10.1038/sj.onc.1208303; Han HJ, 2008, NATURE, V452, P187, DOI 10.1038/nature06781; Karmodiya K, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-424; Kohwi-Shigematsu T, 2013, SEMIN CANCER BIOL, V23, P72, DOI 10.1016/j.semcancer.2012.06.009; LEIBOVITZ A, 1976, CANCER RES, V36, P4562; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Lu XM, 2010, ONCOL REP, V24, P981, DOI 10.3892/or_00000945; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; McInnes N, 2012, ONCOGENE, V31, P1045, DOI 10.1038/onc.2011.293; Meng WJ, 2012, INT J COLORECTAL DIS, V27, P143, DOI 10.1007/s00384-011-1302-9; Meng WJ, 2011, MED HYPOTHESES, V76, P277, DOI 10.1016/j.mehy.2010.10.022; Mir R, 2012, CURR DRUG TARGETS, V13, P1603, DOI 10.2174/138945012803530008; Najdi Rani, 2011, J Carcinog, V10, P5, DOI 10.4103/1477-3163.78111; Nodin B, 2012, DIAGN PATHOL, V7, DOI 10.1186/1746-1596-7-115; Notani D, 2011, J BIOSCIENCES, V36, P461, DOI 10.1007/s12038-011-9091-4; Notani D, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000296; Ordinario E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051786; Thorne CA, 2010, NAT CHEM BIOL, V6, P829, DOI 10.1038/NCHEMBIO.453; Tu W, 2012, LIVER INT, V32, P1064, DOI 10.1111/j.1478-3231.2012.02815.x; Valenta T, 2012, EMBO J, V31, P2714, DOI 10.1038/emboj.2012.150; vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X; Wagner RT, 2010, STEM CELLS, V28, P1794, DOI 10.1002/stem.502; Wang S, 2009, J PATHOL, V219, P114, DOI 10.1002/path.2575; Xiang JD, 2012, ONCOL LETT, V3, P865, DOI 10.3892/ol.2012.571; Zhang J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0047902; Zhang LZ, 2004, MOL CELL BIOL, V24, P2169, DOI 10.1128/MCB.24.5.2169-2180.2004; Zhang Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100413; Zhao F, 2005, NUCLEIC ACIDS RES, V33, pD103, DOI 10.1093/nar/gki004	40	62	66	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 31	2016	35	13					1679	1691		10.1038/onc.2015.232	http://dx.doi.org/10.1038/onc.2015.232			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DH8RP	26165840				2022-12-26	WOS:000373064200007
J	Dai, C; Miao, CX; Xu, XM; Liu, LJ; Gu, YF; Zhou, D; Chen, LS; Lin, G; Lu, GX				Dai, Can; Miao, Cong-Xiu; Xu, Xiao-Ming; Liu, Lv-Jun; Gu, Yi-Fan; Zhou, Di; Chen, Lian-Sheng; Lin, Ge; Lu, Guang-Xiu			Transcriptional Activation of Human CDCA8 Gene Regulated by Transcription Factor NF-Y in Embryonic Stem Cells and Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTI-APOPTOSIS GENE; EXPRESSION; SURVIVIN; BOREALIN; PROGNOSIS; PROTEIN; CYCLE; IDENTIFICATION; ACCUMULATION; CARCINOMAS	The cell division cycle associated 8 (CDCA8) gene plays an important role in mitosis. Overexpression of CDCA8 was reported in some human cancers and is required for cancer growth and progression. We found CDCA8 expression was also high in human ES cells (hESCs) but dropped significantly upon hESC differentiation. However, the regulation of CDCA8 expression has not yet been studied. Here, we characterized the CDCA8 promoter and identified its cis-elements and transcription factors. Three transcription start sites were identified. Reporter gene assays revealed that the CDCA8 promoter was activated in hESCs and cancer cell lines. The promoter drove the reporter expression specifically to pluripotent cells during early mouse embryo development and to tumor tissues in tumor-bearing mice. These results indicate that CDCA8 is transcriptionally activated in hESCs and cancer cells. Mechanistically, two key activation elements, bound by transcription factor NF-Y and CREB1, respectively, were identified in the CDCA8 basic promoter by mutation analyses and electrophoretic motility shift assays. NF-Y binding is positively correlated with promoter activities in different cell types. Interestingly, the NF-YA subunit, binding to the promoter, is primarily a short isoform in hESCs and a long isoform in cancer cells, indicating a different activation mechanism of the CDCA8 transcription between hESCs and cancer cells. Finally, enhanced CDCA8 promoter activities by NF-Y overexpression and reduced CDCA8 transcription by NF-Y knockdown further verified that NF-Y is a positive regulator of CDCA8 transcription. Our study unearths the molecular mechanisms underlying the activation of CDCA8 expression in hESCs and cancer cells, which provides a better understanding of its biological functions.	[Dai, Can; Miao, Cong-Xiu; Xu, Xiao-Ming; Liu, Lv-Jun; Gu, Yi-Fan; Zhou, Di; Lin, Ge; Lu, Guang-Xiu] Cent S Univ, Inst Reprod & Stem Cell Engn, Changsha 410078, Hunan, Peoples R China; [Dai, Can; Chen, Lian-Sheng; Lin, Ge; Lu, Guang-Xiu] Natl Engn & Res Ctr Human Stem Cell, Changsha 410205, Hunan, Peoples R China; [Dai, Can; Gu, Yi-Fan] Cent S Univ, Sch Basic Med Sci, Changsha 410013, Hunan, Peoples R China	Central South University; Central South University	Lin, G (corresponding author), Cent S Univ, Inst Reprod & Stem Cell Engn, Changsha 410078, Hunan, Peoples R China.	linge_csu@yahoo.com; lugxdirector@aliyun.com			National Basic Research Program of China 973 Program [2011CB964900, 2012CB944901]; Hunan Provincial Natural Science Foundation of China [13JJ4012]; Post-doctoral Foundation of Central South University [105378]	National Basic Research Program of China 973 Program(National Basic Research Program of China); Hunan Provincial Natural Science Foundation of China(Natural Science Foundation of Hunan Province); Post-doctoral Foundation of Central South University	This work was supported by National Basic Research Program of China 973 Program, Grants 2011CB964900 and 2012CB944901, the Hunan Provincial Natural Science Foundation of China Grant 13JJ4012, and the Post-doctoral Foundation of Central South University Grant 105378. The authors declare that they have no conflicts of interest with the contents of this article.	Adida C, 1998, LANCET, V351, P882, DOI 10.1016/S0140-6736(05)70294-4; Araki K, 2004, J NEURO-ONCOL, V67, P53, DOI 10.1023/B:NEON.0000021784.33421.05; Chang JL, 2006, EXP CELL RES, V312, P962, DOI 10.1016/j.yexcr.2005.12.015; Chen JS, 2004, CANCER GENE THER, V11, P740, DOI 10.1038/sj.cgt.7700752; Date DA, 2007, CELL BIOL INT, V31, P1470, DOI 10.1016/j.cellbi.2007.06.013; Dolfini D, 2012, STEM CELLS, V30, P2450, DOI 10.1002/stem.1232; Du Juan, 2004, Acta Genetica Sinica, V31, P956; Du Lili, 2009, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V34, P1157; Gassmann R, 2004, J CELL BIOL, V166, P179, DOI 10.1083/jcb.200404001; Ge YB, 2002, BBA-GENE STRUCT EXPR, V1579, P73, DOI 10.1016/S0167-4781(02)00509-2; Gerlach U, 2006, J PATHOL, V208, P462, DOI 10.1002/path.1914; Goodarzi H, 2009, MOL CELL, V36, P900, DOI 10.1016/j.molcel.2009.11.016; Grskovic M, 2007, PLOS GENET, V3, P1524, DOI 10.1371/journal.pgen.0030145; Hayama S, 2007, CANCER RES, V67, P4113, DOI 10.1158/0008-5472.CAN-06-4705; Higuchi T, 2003, NATURE, V426, P780, DOI 10.1038/426780a; Ju W, 2009, ONCOL RES, V18, P47, DOI 10.3727/096504009789954672; LI XY, 1992, J BIOL CHEM, V267, P8984; Lin G, 2009, CELL STEM CELL, V5, P461, DOI 10.1016/j.stem.2009.10.009; Liu X, 2014, J BIOL CHEM, V289, P20638, DOI 10.1074/jbc.M114.572842; Lu CD, 1998, CANCER RES, V58, P1808; Monzo M, 1999, J CLIN ONCOL, V17, P2100, DOI 10.1200/JCO.1999.17.7.2100; Narayan G, 2007, GENE CHROMOSOME CANC, V46, P373, DOI 10.1002/gcc.20418; Nelson JD, 2006, NAT PROTOC, V1, P179, DOI 10.1038/nprot.2006.27; Sorrentino R, 2005, J CLIN ENDOCR METAB, V90, P928, DOI 10.1210/jc.2004-1518; Tanaka K, 2000, CLIN CANCER RES, V6, P127; Templeton NS, 1997, NAT BIOTECHNOL, V15, P647, DOI 10.1038/nbt0797-647; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Wiederschain D, 2009, CELL CYCLE, V8, P498, DOI 10.4161/cc.8.3.7701; Xie PY, 2014, STEM CELLS, V32, P391, DOI 10.1002/stem.1558; Zhang QJ, 2009, MOL BIOL REP, V36, P603, DOI 10.1007/s11033-008-9220-9; Zhu J, 2005, P NATL ACAD SCI USA, V102, P11728, DOI 10.1073/pnas.0503405102; Zhu J, 2003, BLOOD, V102, P2420, DOI 10.1182/blood-2003-01-0251	32	48	50	0	41	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2015	290	37					22423	22434		10.1074/jbc.M115.642710	http://dx.doi.org/10.1074/jbc.M115.642710			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR2PB	26170459	hybrid, Green Published			2022-12-26	WOS:000361171500009
J	Carthy, JM; Meredith, AJ; Boroomand, S; Abraham, T; Luo, ZS; Knight, D; McManus, BM				Carthy, Jon M.; Meredith, Anna J.; Boroomand, Seti; Abraham, Thomas; Luo, Zongshu; Knight, Darryl; McManus, Bruce M.			Versican V1 Overexpression Induces a Myofibroblast-Like Phenotype in Cultured Fibroblasts	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; RICH PERICELLULAR MATRIX; GROWTH-FACTOR-BETA; IN-VITRO; INDUCED APOPTOSIS; PROSTATE-CANCER; PG-M/VERSICAN; HYALURONAN; EXPRESSION; DECORIN	Background Versican, a chondroitin sulphate proteoglycan, is one of the key components of the provisional extracellular matrix expressed after injury. The current study evaluated the hypothesis that a versican-rich matrix alters the phenotype of cultured fibroblasts. Methods and Results The full-length cDNA for the V1 isoform of human versican was cloned and the recombinant proteoglycan was expressed in murine fibroblasts. Versican expression induced a marked change in fibroblast phenotype. Functionally, the versican-expressing fibroblasts proliferated faster and displayed enhanced cell adhesion, but migrated slower than control cells. These changes in cell function were associated with greater N-cadherin and integrin beta 1 expression, along with increased FAK phosphorylation. The versican-expressing fibroblasts also displayed expression of smooth muscle alpha-actin, a marker of myofibroblast differentiation. Consistent with this observation, the versican fibroblasts displayed increased synthetic activity, as measured by collagen III mRNA expression, as well as a greater capacity to contract a collagen lattice. These changes appear to be mediated, at least in part, by an increase in active TGF-beta signaling in the versican expressing fibroblasts, and this was measured by phosphorylation and nuclear accumulation of SMAD2. Conclusions Collectively, these data indicate versican expression induces a myofibroblast-like phenotype in cultured fibroblasts.	[Carthy, Jon M.; Meredith, Anna J.; Boroomand, Seti; Abraham, Thomas; Luo, Zongshu; Knight, Darryl; McManus, Bruce M.] Univ British Columbia, Dept Pathol & Lab Med, Providence Hlth Care, UBC James Hogg Res Ctr,Inst Heart Lung Hlth, Vancouver, BC, Canada	University of British Columbia	McManus, BM (corresponding author), Univ British Columbia, Dept Pathol & Lab Med, Providence Hlth Care, UBC James Hogg Res Ctr,Inst Heart Lung Hlth, Vancouver, BC, Canada.	bruce.mcmanus@hli.ubc.ca	Abraham, Thomas/AAJ-7950-2020; Abraham, Thomas/J-7080-2014	Abraham, Thomas/0000-0003-0750-8774	Heart and Stroke Foundation of British Columbia and Yukon [F08-00086]	Heart and Stroke Foundation of British Columbia and Yukon	This work was supported by a grant-in-aid from the Heart and Stroke Foundation of British Columbia and Yukon entitled "Regulation of mesenchymal cell behaviour by versican: Implications for arterial remodeling" F08-00086.(www.heartandstroke.ca) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baarsma HA, 2011, AM J PHYSIOL-LUNG C, V301, pL956, DOI 10.1152/ajplung.00123.2011; Bensadoun ES, 1997, EUR RESPIR J, V10, P2731, DOI 10.1183/09031936.97.10122731; Bensadoun ES, 1996, AM J RESP CRIT CARE, V154, P1819, DOI 10.1164/ajrccm.154.6.8970376; Cardoso LEM, 2010, J BIOL CHEM, V285, P6987, DOI 10.1074/jbc.M109.088674; Carthy JM, 2012, CARDIOVASC PATHOL, V21, P74, DOI 10.1016/j.carpath.2011.03.003; Carthy JM, 2012, LAB INVEST, V92, P246, DOI 10.1038/labinvest.2011.164; Carthy JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019809; Choocheep K, 2010, J BIOL CHEM, V285, P21114, DOI 10.1074/jbc.M109.096479; Evanko SP, 1999, ARTERIOSCL THROM VAS, V19, P1004, DOI 10.1161/01.ATV.19.4.1004; Evanko SP, 1998, AM J PATHOL, V152, P533; Evanko SP, 2001, ARCH BIOCHEM BIOPHYS, V394, P29, DOI 10.1006/abbi.2001.2507; Farb A, 2004, CIRCULATION, V110, P940, DOI 10.1161/01.CIR.0000139337.56084.30; Geary RL, 1998, J VASC SURG, V27, P96, DOI 10.1016/S0741-5214(98)70296-4; Gupta V, 2009, CARDIOVASC PATHOL, V18, P191, DOI 10.1016/j.carpath.2008.05.001; Hattori N, 2011, J BIOL CHEM, V286, P34298, DOI 10.1074/jbc.M111.254938; Hinz B, 2007, AM J PATHOL, V170, P1807, DOI 10.2353/ajpath.2007.070112; Hinz B, 2012, AM J PATHOL, V180, P1340, DOI 10.1016/j.ajpath.2012.02.004; Hirose J, 2001, J BIOL CHEM, V276, P5228, DOI 10.1074/jbc.M007542200; Huang R, 2006, CIRC RES, V98, P370, DOI 10.1161/01.RES.0000202051.28319.c8; KAHARI VM, 1991, J BIOL CHEM, V266, P10608; Keire PA, 2014, J BIOL CHEM, V289, P34089, DOI 10.1074/jbc.M114.607168; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Lin H, 1996, J HEART LUNG TRANSPL, V15, P1233; Merrilees MJ, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-41; Mjaatvedt CH, 1998, DEV BIOL, V202, P56, DOI 10.1006/dbio.1998.9001; Nara Y, 1997, HISTOCHEM J, V29, P21, DOI 10.1023/A:1026460700592; Nikitovic D, 2006, IUBMB LIFE, V58, P47, DOI 10.1080/15216540500531713; Rahmani M, 2005, J BIOL CHEM, V280, P13019, DOI 10.1074/jbc.M411766200; Rezai N, 2005, LAB INVEST, V85, P982, DOI 10.1038/labinvest.3700302; Ricciardelli C, 1998, CLIN CANCER RES, V4, P963; Ricciardelli C, 2007, J BIOL CHEM, V282, P10814, DOI 10.1074/jbc.M606991200; Rudnicki M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044891; Sheng W, 2006, MOL BIOL CELL, V17, P2009, DOI 10.1091/mbc.E05-10-0951; Sheng W, 2005, MOL BIOL CELL, V16, P1330, DOI 10.1091/mbc.e04-04-0295; Toeda K, 2005, MOL CELL BIOCHEM, V280, P47, DOI 10.1007/s11010-005-8051-4; Van Bockstal Mieke, 2014, Oncoscience, V1, P634; Wang JF, CONNECT TISSUE RES, P195; Wang JF, 2008, LAB INVEST, V88, P1278, DOI 10.1038/labinvest.2008.101; Wu YJ, 2005, CELL RES, V15, P483, DOI 10.1038/sj.cr.7290318; Wu YJ, 2005, MATRIX BIOL, V24, P3, DOI 10.1016/j.matbio.2004.11.007; Wu YJ, 2002, J BIOL CHEM, V277, P12294, DOI 10.1074/jbc.M110748200; Xiang YY, 2006, J BIOL CHEM, V281, P19358, DOI 10.1074/jbc.M512980200; Yeung TL, 2013, CANCER RES, V73, P5016, DOI 10.1158/0008-5472.CAN-13-0023	43	22	22	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0133056	10.1371/journal.pone.0133056	http://dx.doi.org/10.1371/journal.pone.0133056			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176948	gold, Green Submitted, Green Published			2022-12-26	WOS:000358197600206
J	Chang, WX; Asakawa, S; Toyoki, D; Nemoto, Y; Morimoto, C; Tamura, Y; Ota, T; Shibata, S; Fujigaki, Y; Shen, ZY; Uchida, S				Chang, Wen Xiu; Asakawa, Shinichiro; Toyoki, Daigo; Nemoto, Yoshikazu; Morimoto, Chikayuki; Tamura, Yoshifuru; Ota, Tatsuru; Shibata, Shigeru; Fujigaki, Yoshihide; Shen, Zhong Yang; Uchida, Shunya			Predictors and the Subsequent Risk of End-Stage Renal Disease - Usefulness of 30% Decline in Estimated GFR over 2 Years	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; DIABETIC-NEPHROPATHY; PROGRESSION; CKD; MORTALITY; FAILURE; POPULATION; THERAPY; HYPOXIA; INJURY	Background A goal of searching risk factors for chronic kidney disease (CKD) is to halt progressing to end-stage renal disease (ESRD) by potential intervention. To predict the future ESRD, 30% decline in estimated GFR over 2 years was examined in comparison with other time-dependent predictors. Methods CKD patients who had measurement of serum creatinine at baseline and 2 years were enrolled (n = 701) and followed up to 6 years. Time-dependent parameters were calculated as time-averaged values over 2 years by a trapezoidal rule. Risk factors affecting the incidence of ESRD were investigated by the extended Cox proportional hazard model with baseline dataset and 2-year time-averaged dataset. Predictive significance of 30% decline in estimated GFR over 2 years for ESRD was analyzed. Results For predicting ESRD, baseline estimated GFR and proteinuria were the most influential risk factors either with the baseline dataset or the 2-year time-averaged dataset. Using the 2-year time-averaged dataset, 30% decline in estimated GFR over 2 years by itself showed the highest HR of 31.6 for ESRD whereas addition of baseline estimated GFR, proteinuria, serum albumin and hemoglobin yielded a better model by a multivariate Cox regression model. This novel surrogate was mostly associated with time-averaged proteinuria over 2 years with the cut-off of similar to 1 g/g creatinine. Conclusion These results suggest that decline in estimated GFR and proteinuria are the risk factors while serum albumin and hemoglobin are the protective factors by the time-to-event analysis. Future incidence of ESRD is best predicted by 30% decline in eGFR over 2 years that can be modified by intervention to proteinuria, hemoglobin, uric acid, phosphorus, blood pressure and use of renin-angiotensin system inhibitors in the follow-up of 2 years.	[Chang, Wen Xiu; Asakawa, Shinichiro; Toyoki, Daigo; Nemoto, Yoshikazu; Morimoto, Chikayuki; Tamura, Yoshifuru; Ota, Tatsuru; Shibata, Shigeru; Fujigaki, Yoshihide; Uchida, Shunya] Teikyo Univ, Sch Med, Dept Internal Med, Tokyo 173, Japan; [Chang, Wen Xiu] Tianjin First Cent Hosp, Dept Nephrol, Tianjin, Peoples R China; [Shen, Zhong Yang] Tianjin First Cent Hosp, Dept Organ Transplantat, Tianjin, Peoples R China	Teikyo University; Tianjin Medical University; Tianjin Medical University	Uchida, S (corresponding author), Teikyo Univ, Sch Med, Dept Internal Med, Tokyo 173, Japan.	s_uchida@netjoy.ne.jp		Shibata, Shigeru/0000-0002-6868-0626; , wen xiu/0000-0001-6269-5694	Ministry of Health, Labour and Welfare of Japan; Gout Research Foundation	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Gout Research Foundation	This study was supported in part by a Grant-in-Aid for Progressive Renal Diseases Research, Research on Rare and Intractable Disease, from the Ministry of Health, Labour and Welfare of Japan (to SU) and Gout Research Foundation (to SU). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbate M, 2006, J AM SOC NEPHROL, V17, P2974, DOI 10.1681/ASN.2006040377; Bantis LE, 2014, BIOMETRICS, V70, P212, DOI 10.1111/biom.12107; Bouma-de Krijger A, 2014, NEPHROL DIAL TRANSPL, V29, P88, DOI 10.1093/ndt/gft456; Cancela AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036883; Coresh J, 2014, JAMA-J AM MED ASSOC, V311, P2518, DOI 10.1001/jama.2014.6634; Covic A, 2014, AM J NEPHROL, V40, P263, DOI 10.1159/000366025; de Brito-Ashurst I, 2009, J AM SOC NEPHROL, V20, P2075, DOI 10.1681/ASN.2008111205; Drueke TB, 2006, NEW ENGL J MED, V355, P2071, DOI 10.1056/NEJMoa062276; Erickson KF, 2013, CLIN J AM SOC NEPHRO, V8, P75, DOI 10.2215/CJN.03340412; George B, 2014, J NUCL CARDIOL, V21, P686, DOI 10.1007/s12350-014-9908-2; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hoefield RA, 2010, AM J KIDNEY DIS, V56, P1072, DOI 10.1053/j.ajkd.2010.06.010; Inker LA, 2014, AM J KIDNEY DIS, V63, P713, DOI 10.1053/j.ajkd.2014.01.416; Inoue T, 2011, INTERNAL MED, V50, P1273, DOI 10.2169/internalmedicine.50.4059; Johnson ES, 2011, BMC NEPHROL, V12, DOI 10.1186/1471-2369-12-17; LEWIS EJ, 1993, NEW ENGL J MED, V329, P1456, DOI 10.1056/NEJM199311113292004; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Nacak H, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-91; Nangaku M, 2006, J AM SOC NEPHROL, V17, P17, DOI 10.1681/ASN.2005070757; Ni ZH, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-194; Pfeffer MA, 2009, NEW ENGL J MED, V361, P2019, DOI 10.1056/NEJMoa0907845; Portoles J, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-2; Rahman M, 2014, CLIN J AM SOC NEPHRO, V9, P1190, DOI 10.2215/CJN.09320913; Rocco MV, 2012, AM J KIDNEY DIS, V60, P857, DOI 10.1053/j.ajkd.2012.07.005; Seiler S, 2013, CLIN J AM SOC NEPHRO, V8, P1764, DOI 10.2215/CJN.13021212; Shoji K, 2014, CURR OPIN NEPHROL HY, V23, P161, DOI 10.1097/01.mnh.0000441049.98664.6c; Sim JJ, 2013, AM J MED, V126, P311, DOI 10.1016/j.amjmed.2012.08.018; Steinman TI, 2000, SEMIN DIALYSIS, V13, P404, DOI 10.1046/j.1525-139x.2000.00110.x; Tangri N, 2011, JAMA-J AM MED ASSOC, V305, P1553, DOI 10.1001/jama.2011.451; Torlen K, 2012, CLIN J AM SOC NEPHRO, V7, P1272, DOI 10.2215/CJN.00960112; Turin TC, 2012, NEPHROL DIAL TRANSPL, V27, P3835, DOI 10.1093/ndt/gfs263; Van Pottelbergh G, 2012, NEPHROL DIAL TRANSPL, V27, P2297, DOI 10.1093/ndt/gfr659; Varshney A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017230; Xie JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038904; Yang W, 2014, AM J KIDNEY DIS, V63, P236, DOI 10.1053/j.ajkd.2013.08.028; Zhuo L, 2013, EUR J MED RES, V18, DOI 10.1186/2047-783X-18-4; Zoja C, 2015, NEPHROL DIAL TRANSPL, V30, P706, DOI 10.1093/ndt/gfu261	37	30	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132927	10.1371/journal.pone.0132927	http://dx.doi.org/10.1371/journal.pone.0132927			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177463	Green Submitted, Green Published, gold			2022-12-26	WOS:000358197600182
J	Lee, JW; Kang, JH; Yim, YR; Kim, JE; Wen, L; Lee, KE; Park, DJ; Kim, TJ; Park, YW; Lee, SS				Lee, Jeong-Won; Kang, Ji-Hyoun; Yim, Yi-Rang; Kim, Ji-Eun; Wen, Lihui; Lee, Kyung-Eun; Park, Dong-Jin; Kim, Tae-Jong; Park, Yong-Wook; Lee, Shin-Seok			Predictors of Switching Anti-Tumor Necrosis Factor Therapy in Patients with Ankylosing Spondylitis	PLOS ONE			English	Article							PLACEBO-CONTROLLED TRIAL; ANTI-TNF AGENTS; EFFICACY; ARTHRITIS; SPONDYLOARTHRITIS; IMMUNOGENICITY; ANTAGONISTS; ADALIMUMAB; INHIBITORS; INFLIXIMAB	The aim of this study was to investigate the potential predictors of switching tumor necrosis factor (TNF)-alpha inhibitors in Korean patients with ankylosing spondylitis (AS). The patients who had been treated with TNF-alpha inhibitors were divided into two groups depending on whether they had switched TNF-alpha inhibitors. Demographic, clinical, laboratory, and treatment data at the time of initiation of TNF-alpha inhibitor treatment were compared between switchers and non-switchers, and within switchers according to the reasons for switching. Of the 269 patients, 70 (23%) had switched TNF-alpha inhibitors once; of these, 11 switched again. The median follow-up time was 52.7 months. Three-and five-year drug survival rates were 52%/48% for infliximab, 62%/42% for etanercept, and 71%/51% for adalimumab, respectively. Switchers were more likely to be prescribed disease-modifying anti-rheumatic drugs than non-switchers. A history of joint surgery and complete ankylosis of the sacroiliac joint was more frequent in switchers. Multivariate Cox's proportional hazard analysis showed that the use of adalimumab as the first TNF-alpha inhibitor was less likely to lead to switching and complete ankylosis of the sacroiliac joints was more likely to lead to switching. The principal reasons for switching were drug inefficacy and adverse events, but the differences in the clinical data of these two groups of switchers were not significant. In AS patients who are candidates for TNF-alpha inhibitor therapy, switching may improve the therapeutic outcome based on clinical information.	[Lee, Jeong-Won; Kang, Ji-Hyoun; Yim, Yi-Rang; Kim, Ji-Eun; Wen, Lihui; Lee, Kyung-Eun; Park, Dong-Jin; Kim, Tae-Jong; Park, Yong-Wook; Lee, Shin-Seok] Chonnam Natl Univ, Med Sch & Hosp, Dept Rheumatol, Gwangju, South Korea	Chonnam National University	Lee, SS (corresponding author), Chonnam Natl Univ, Med Sch & Hosp, Dept Rheumatol, Gwangju, South Korea.	shinseok@chonnam.ac.kr	Lee, Shin-Seok/AAC-6779-2021	Kim, Tae-Jong/0000-0002-2871-1635; Wen, Lihui/0000-0002-6385-0825	Chonnam National University Hospital Biomedical Research Institute [BCRI 14001-52]	Chonnam National University Hospital Biomedical Research Institute	This study was supported by a grant (BCRI 14001-52) from Chonnam National University Hospital Biomedical Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson PJ, 2005, SEMIN ARTHRITIS RHEU, V34, P19, DOI 10.1016/j.semarthrit.2005.01.005; Bartelds GM, 2011, JAMA-J AM MED ASSOC, V305, P1460, DOI 10.1001/jama.2011.406; Braun J, 2006, ANN RHEUM DIS, V65, P316, DOI 10.1136/ard.2005.040758; Busquets N, 2011, RHEUMATOLOGY, V50, P1999, DOI 10.1093/rheumatology/ker281; Dadoun S, 2011, CLIN EXP RHEUMATOL, V29, P1010; Davis JC, 2005, ANN RHEUM DIS, V64, P1557, DOI 10.1136/ard.2004.035105; Glintborg B, 2013, ANN RHEUM DIS, V72, P1149, DOI 10.1136/annrheumdis-2012-201933; Gomez-Reino JJ, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1881; Haberhauer G, 2010, WIEN MED WOCHENSCHR, V160, P220, DOI 10.1007/s10354-010-0795-0; Kristensen LE, 2010, ARTHRIT CARE RES, V62, P1362, DOI 10.1002/acr.20258; Lie E, 2011, ANN RHEUM DIS, V70, P157, DOI 10.1136/ard.2010.131797; Lukas C, 2007, J RHEUMATOL, V34, P862; Paccou J, 2011, RHEUMATOLOGY, V50, P714, DOI 10.1093/rheumatology/keq377; Plasencia C, 2012, ANN RHEUM DIS, V71, P1955, DOI 10.1136/annrheumdis-2011-200828; Radstake TRDJ, 2009, ANN RHEUM DIS, V68, P1739, DOI 10.1136/ard.2008.092833; Soliman MM, 2011, ANN RHEUM DIS, V70, P583, DOI 10.1136/ard.2010.139774; van der Heijde D, 2005, ARTHRITIS RHEUM-US, V52, P582, DOI 10.1002/art.20852; van der Heijde D, 2006, ARTHRITIS RHEUM-US, V54, P2136, DOI 10.1002/art.21913; VANDERLINDEN S, 1984, ARTHRITIS RHEUM, V27, P361	19	15	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0131864	10.1371/journal.pone.0131864	http://dx.doi.org/10.1371/journal.pone.0131864			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176701	Green Published, Green Submitted, gold			2022-12-26	WOS:000358197600068
J	Meireles, AL; Xavier, CC; Andrade, ACD; Proietti, FA; Caiaffa, WT				Meireles, Adriana Lucia; Xavier, Cesar Coelho; de Souza Andrade, Amanda Cristina; Proietti, Fernando Augusto; Caiaffa, Waleska Teixeira			Self-Rated Health among Urban Adolescents: The Roles of Age, Gender, and Their Associated Factors	PLOS ONE			English	Article							SCHOOL; FAMILY; PREDICTORS; COMPLAINTS; MORTALITY; STRESS; ADULTS	Health status is often analyzed in population surveys. Self-rated health (SRH) is a single-item summary measure of the perception of one's health. In Brazil, studies on the SRH of adolescents remain scarce, especially those aiming to understand the domains that compose this construct. Therefore, the aim of this study is to determine the prevalence of poor SRH and its associated factors among 11- to 13-year-olds and 14- to 17-year-olds living in a large urban center in Brazil. This cross-sectional study was conducted using a household survey across Belo Horizonte that included 1,042 adolescents. Stratified logistic regression models were used for each age group to assess the associations between worse SRH and the following variables: socio-demographic, social and family support, lifestyles, psychological health, and anthropometry. Approximately 11% (95% CIs = 8.7-13.6) of the studied adolescents rated their health as poor, and SHR decreased with age among males and females. This trend was more pronounced among girls (from 6.9% among 11- to 13-year-old girls to 16.9% among 14- to 17-year-old girls) than boys (from 8.3% among 11- to 13-year-old boys to 11% among 14- to 17-year-old boys). Worse SRH was associated with family support (as assessed by the absence of parent-adolescent conversations; odds ratio [OR] = 3.5 among 11- to 13-year-olds), family structure (OR = 2.8 among 14- to 17-year-olds), and argument reporting (OR = 8.2 among 14- to 17-year-olds). Among older adolescents, the consumption of fruit fewer than five times per week (OR = 2.4), life dissatisfaction (OR = 2.8), underweight status (OR = 6.7), and overweight status (OR = 2.7) were associated with poor SRH. As adolescents age, their universe expands from their relationship with their parents to include more complex issues, such as their lifestyles and life satisfaction. Therefore, these results suggest the importance of evaluating SRH across adolescent age groups and demonstrate the influence of the family environment (in addition to other factors) on negative health assessments, particularly among 14- to 17-year-olds.	[Meireles, Adriana Lucia] Univ Fed Rio Grande do Norte, Nutr, Fac Ciencias Saude Trairi, BR-59072970 Natal, RN, Brazil; [Meireles, Adriana Lucia; Xavier, Cesar Coelho; de Souza Andrade, Amanda Cristina; Proietti, Fernando Augusto; Caiaffa, Waleska Teixeira] Univ Fed Minas Gerais, Observ Urban Hlth Belo Horizonte, Sch Med, Belo Horizonte, MG, Brazil; [Xavier, Cesar Coelho; Proietti, Fernando Augusto] Fac Saude & Ecol Humana, Med, Vespasiano, MG, Brazil	Universidade Federal do Rio Grande do Norte; Universidade Federal de Minas Gerais	Meireles, AL (corresponding author), Univ Fed Rio Grande do Norte, Nutr, Fac Ciencias Saude Trairi, BR-59072970 Natal, RN, Brazil.	dri_meireles@yahoo.com.br		Cristina de Souza Andrade, Amanda/0000-0002-3366-4423	National Health Fund of the Ministry of Health [25000.102984/2006-97]; CNPq [475004/2006-0, 409688/2006-1, 479392/2008-0, 481113/2010-0]; FAPEMIG [APQ-00975-08]	National Health Fund of the Ministry of Health; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	Funding sources are: 1. MOVE BH Project: funded by the National Health Fund of the Ministry of Health (Process 25000.102984/2006-97) and CNPq (Process 475004/2006-0); 2. Social Determinants of Health Project: funded by CNPq (Process 409688/2006-1); 3. Well-being of adolescents, funded by FAPEMIG (Process APQ-00975-08) and CNPq (Process 479392/2008-0 and Process 481113/2010-0).	[Anonymous], 2004, YOUNG PEOPLES HLTH C; da Silva RA, 2007, CAD SAUDE PUBLICA, V23, P1113, DOI 10.1590/S0102-311X2007000500013; Bailis DS, 2003, SOC SCI MED, V56, P203, DOI 10.1016/S0277-9536(02)00020-5; Baker AJL, 1999, FUTURE CHILD, V9, P116, DOI 10.2307/1602724; Boardman JD, 2006, J ADOLESCENT HEALTH, V38, P401, DOI 10.1016/j.jadohealth.2005.01.006; BRASIL. Ministerio da Saude. Secretaria de Atencao a Saude. Departamento de Atencao Basica. Programa Saude na Escola, 2014, OR GER AC PROM SEG A; Pavao ALB, 2013, CAD SAUDE PUBLICA, V29, P723, DOI 10.1590/S0102-311X2013000800010; Breidablik HJ, 2008, SCAND J PUBLIC HEALT, V36, P12, DOI 10.1177/1403494807085306; Centro de Pesquisas Epidemiologicas/Universidade Federal de Pelotas (CPE/UFPel), EST COORT NASCI 1993; Cheng JR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117940; Currie C, 2012, HLTH BEHAV SCH AGED; Friche AAD, 2013, J URBAN HEALTH, V90, P246, DOI 10.1007/s11524-012-9737-z; Farias Junior JC, 2012, REV BRAS ATIV FIS SA, V17, P174; Finnell SME, 2014, APPL CLIN INFORM, V5, P651, DOI 10.4338/ACI-2014-02-RA-0012; Foti K, 2010, PUBLIC HEALTH REP, V125, P771, DOI 10.1177/003335491012500522; Franks P, 2003, SOC SCI MED, V56, P2505, DOI 10.1016/S0277-9536(02)00281-2; Galan I, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002644; Gerencia de Epidemiologia e Informacao Secretaria Municipal de Saude de Belo Horizonte, 2003, IND VULN SAUD; Hallal Pedro Curi, 2006, Cad. Saúde Pública, V22, P1277, DOI 10.1590/S0102-311X2006000600017; Haugland S, 2001, EUR J PUBLIC HEALTH, V11, P4, DOI 10.1093/eurpub/11.1.4; Heard HE, 2008, POPUL RES POLICY REV, V27, P773, DOI 10.1007/s11113-008-9090-9; Herrenkohl TI, 2009, J ADOLESCENT HEALTH, V44, P146, DOI 10.1016/j.jadohealth.2008.07.005; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Instituto Brasileiro de Geografia e Estatistica [Brazilian Institute of Geography and Statistics] (IBGE), 2011, SIN DO CENS DEM 2010; Jerden L, 2011, J ADOLESCENT HEALTH, V48, P143, DOI 10.1016/j.jadohealth.2010.06.005; Karademas EC, 2008, J HEALTH PSYCHOL, V13, P1012, DOI 10.1177/1359105308097965; Lima-Costa MF, 2012, AM J EPIDEMIOL, V175, P228, DOI 10.1093/aje/kwr290; Malta Deborah Carvalho, 2014, Rev. bras. epidemiol., V17, P77, DOI 10.1590/1809-4503201400050007; Manor O, 2000, INT J EPIDEMIOL, V29, P149, DOI 10.1093/ije/29.1.149; McDaid O, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002571; McDowell I., 1996, MEASURING HLTH GUIDE; MECHANIC D, 1987, J HEALTH SOC BEHAV, V28, P364, DOI 10.2307/2136790; Meireles AL, 2010, THESIS FEDERAL U MIN; Peres MA, 2010, REV SAUDE PUBL, V44, DOI 10.1590/S0034-89102010000500016; Pratta Elisângela Maria Machado, 2007, Psicol. Estud., V12, P247, DOI 10.1590/S1413-73722007000200005; Richter M, 2009, SOC SCI MED, V69, P396, DOI 10.1016/j.socscimed.2009.05.023; Schlesselman JJ, 1982, CASE CONTROL STUDIES; Shooshtari S, 2007, RES AGING, V29, P512, DOI 10.1177/0164027507305729; Simões Anna Maria Azevedo, 2004, Cad. Saúde Pública, V20, P1169, DOI 10.1590/S0102-311X2004000500010; Sousa Thiago Ferreira de, 2010, Rev. paul. pediatr., V28, P333; Souza EM, 2006, COMUN CIENC SAUDE, V17, P9; VILHJALMSSON R, 1994, J YOUTH ADOLESCENCE, V23, P437, DOI 10.1007/BF01538038; Vingilis E, 1998, J ADOLESCENCE, V21, P83, DOI 10.1006/jado.1997.0131; Vingilis ER, 2002, CAN J PUBLIC HEALTH, V93, P193, DOI 10.1007/BF03404999; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15; Wiklund M, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-993; World Health Organization (WHO), 2007, GRWOTH REF DAT 5 19	47	20	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132254	10.1371/journal.pone.0132254	http://dx.doi.org/10.1371/journal.pone.0132254			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1RL	26177464	Green Submitted, Green Published, gold			2022-12-26	WOS:000358197600092
J	Sartori, L; Camperio-Ciani, A; Bulgheroni, M; Castiello, U				Sartori, Luisa; Camperio-Ciani, Andrea; Bulgheroni, Maria; Castiello, Umberto			Intersegmental Coordination in the Kinematics of Prehension Movements of Macaques	PLOS ONE			English	Article							MEDIAL PARIETOOCCIPITAL CORTEX; OBJECT SIZE; SELECTION; MONKEY	The most popular model to explain how prehensile movements are organized assumes that they comprise two "components", the reaching component encoding information regarding the object's spatial location and the grasping component encoding information on the object's intrinsic properties such as size and shape. Comparative kinematic studies on grasping behavior in the humans and in macaques have been carried out to investigate the similarities and differences existing across the two species. Although these studies seem to favor the hypothesis that macaques and humans share a number of kinematic features it remains unclear how the reaching and grasping components are coordinated during prehension movements in free-ranging macaque monkeys. Twelve hours of video footage was filmed of the monkeys as they snatched food items from one another (i.e., snatching) or collect them in the absence of competitors (i.e., unconstrained). The video samples were analyzed frame-by-frame using digitization techniques developed to perform two-dimensional post-hoc kinematic analyses of the two types of actions. The results indicate that only for the snatching condition when the reaching variability increased there was an increase in the amplitude of maximum grip aperture. Besides, the start of a break-point along the deceleration phase of the velocity profile correlated with the time at which maximum grip aperture occurred. These findings suggest that macaques can spatially and temporally couple the reaching and the grasping components when there is pressure to act quickly. They offer a substantial contribution to the debate about the nature of how prehensile actions are programmed.	[Sartori, Luisa; Castiello, Umberto] Univ Padua, Dipartimento Psicol Gen, Padua, Italy; [Sartori, Luisa; Castiello, Umberto] Univ Padua, Cognit Neurosci Ctr, Padua, Italy; [Camperio-Ciani, Andrea] Univ Padua, Dipartimento FISSPA, Padua, Italy; [Bulgheroni, Maria] Ab Acus, Milan, Italy; [Castiello, Umberto] Acad Lincei, Ctr Linceo Interdisciplinare Beniamino Segre, Rome, Italy	University of Padua; University of Padua; University of Padua	Castiello, U (corresponding author), Univ Padua, Dipartimento Psicol Gen, Padua, Italy.	umberto.castiello@unipd.it	Ciani, Andrea Camperio/A-8290-2013	Ciani, Andrea Camperio/0000-0002-4689-1799; Bulgheroni, Maria/0000-0001-8484-9834; Sartori, Luisa/0000-0002-3838-8958; Castiello, Umberto/0000-0003-0629-1286	MIUR [287713]; FP7: REWIRE project; Progetto Strategico, Universita di Padova [2010XPMFW4]; Ab.Acus	MIUR(Ministry of Education, Universities and Research (MIUR)); FP7: REWIRE project; Progetto Strategico, Universita di Padova; Ab.Acus	This work was supported by a grant from the MIUR (N. 287713), the FP7: REWIRE project and the Progetto Strategico, Universita di Padova (N. 2010XPMFW4) to Umberto Castiello. Ab.Acus provided support in the form of salaries for authors [MB], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Castiello U, 2005, NAT REV NEUROSCI, V6, P726, DOI 10.1038/nrn1744; Castiello U, 1996, J EXP PSYCHOL HUMAN, V22, P582, DOI 10.1037/0096-1523.22.3.582; CHIEFFI S, 1993, EXP BRAIN RES, V94, P471; Christel MI, 2002, BEHAV BRAIN RES, V131, P169, DOI 10.1016/S0166-4328(01)00372-2; Ciani AC, 2005, BIOL CONSERV, V121, P635, DOI 10.1016/j.biocon.2004.06.009; DAMICO M, 1990, MED BIOL ENG COMPUT, V28, P407, DOI 10.1007/BF02441963; Fa J. E, 1984, BARBARY MACAQUE CASE; Fattori P, 2005, EUR J NEUROSCI, V22, P956, DOI 10.1111/j.1460-9568.2005.04288.x; Fattori P, 2010, J NEUROSCI, V30, P342, DOI 10.1523/JNEUROSCI.3800-09.2010; Filimon F, 2010, NEUROSCIENTIST, V16, P388, DOI 10.1177/1073858410375468; FOGASSI L, 1991, B SOC ITAL BIOL SPER, V7, P715; GENTILUCCI M, 1991, NEUROPSYCHOLOGIA, V29, P361, DOI 10.1016/0028-3932(91)90025-4; Hildebrand M., 1985, P38; JAKOBSON LS, 1991, EXP BRAIN RES, V86, P199; JEANNEROD M, 1984, J MOTOR BEHAV, V16, P235; Jeannerod M., 1981, ATTENTION PERFORM, P153; Jindrich DL, 2011, EXP BRAIN RES, V209, P35, DOI 10.1007/s00221-010-2514-x; Mouna M, 1999, SEL P 1 INT C BIOD N, P91; Roy AC, 2006, EXP BRAIN RES, V169, P182, DOI 10.1007/s00221-005-0133-8; Roy AC, 2002, J NEUROPHYSIOL, V88, P1491, DOI 10.1152/jn.2002.88.3.1491; Roy AC, 2000, BEHAV BRAIN RES, V117, P75, DOI 10.1016/S0166-4328(00)00284-9; Sacrey LAR, 2009, BEHAV BRAIN RES, V204, P153, DOI 10.1016/j.bbr.2009.05.035; Sartori L, 2014, EXP BRAIN RES, V232, P919, DOI 10.1007/s00221-013-3804-x; Sartori L, 2014, SCI REP-UK, V4, DOI 10.1038/srep04019; Sartori L, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00114; Sartori L, 2013, EXP BRAIN RES, V224, P119, DOI 10.1007/s00221-012-3294-2; Smeets JBJ, 1999, MOTOR CONTROL, V3, P237, DOI 10.1123/mcj.3.3.237; Walker JA, 1998, J EXP BIOL, V201, P981; Wallace SA, JMB, V20, P81; WING AM, 1986, J MOTOR BEHAV, V18, P245	31	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132937	10.1371/journal.pone.0132937	http://dx.doi.org/10.1371/journal.pone.0132937			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176232	gold, Green Published, Green Submitted			2022-12-26	WOS:000358197600185
J	Velasquez, J; Sanchez, JA				Velasquez, Johanna; Sanchez, Juan A.			Octocoral Species Assembly and Coexistence in Caribbean Coral Reefs	PLOS ONE			English	Article							PHYLOGENETIC COMMUNITY STRUCTURE; NEUTRAL THEORY; ECOLOGY; PATTERNS; LIGHT; BIODIVERSITY; ENVIRONMENT; ORGANISMS; SIGNAL; SIZE	Background What are the determinant factors of community assemblies in the most diverse ecosystem in the ocean? Coral reefs can be divided in continental (i.e., reefs that develop on the continental shelf, including siliciclastic reefs) and oceanic (i.e., far off the continental shelf, usually on volcanic substratum); whether or not these habitat differences impose community-wide ecological divergence or species exclusion/coexistence with evolutionary consequences, is unknown. Methods Studying Caribbean octocorals as model system, we determined the phylogenetic community structure in a coral reef community, making emphasis on species coexistence evidenced on trait evolution and environmental feedbacks. Forty-nine species represented in five families constituted the species pool from which a phylogenetic tree was reconstructed using mtDNA. We included data from 11 localities in the Western Caribbean (Colombia) including most reef types. To test diversity-environment and phenotype-environment relationships, phylogenetic community structure and trait evolution we carried out comparative analyses implementing ecological and evolutionary approaches. Results Phylogenetic inferences suggest clustering of oceanic reefs (e.g., atolls) contrasting with phylogenetic overdispersion of continental reefs (e.g., reefs banks). Additionally, atolls and barrier reefs had the highest species diversity (Shannon index) whereas phylogenetic diversity was higher in reef banks. The discriminant component analysis supported this differentiation between oceanic and continental reefs, where continental octocoral species tend to have greater calyx apertures, thicker branches, prominent calyces and azooxanthellate species. This analysis also indicated a clear separation between the slope and the remaining habitats, caused by the presence or absence of Symbiodinium. K statistic analysis showed that this trait is conserved as well as the branch shape. Discussion There was strong octocoral community structure with opposite diversity and composition patterns between oceanic and continental reefs. Even habitats with similar depths and overall environmental conditions did not share similar communities between oceanic and continental reefs. This indicates a strong regional influence over the local communities, probably due to water transparency differences between major reef types, i.e., oceanic vs. continental shelf-neritic. This was supported by contrasting patterns found in morphology, composition and evolutionary history of the species between atolls and reef banks.	[Velasquez, Johanna; Sanchez, Juan A.] Univ Los Andes, Fac Ciencias, Lab Biol Mol Marina BIOMMAR, Dept Ciencias Biol, Bogota 111711, Colombia	Universidad de los Andes (Colombia)	Sanchez, JA (corresponding author), Univ Los Andes, Fac Ciencias, Lab Biol Mol Marina BIOMMAR, Dept Ciencias Biol, Carrera 1E 18A-10, Bogota 111711, Colombia.	juansanc@uniandes.edu	sanchez, juan/GSD-8167-2022	Sanchez, Juan Armando/0000-0001-7149-8369	Facultad de Ciencias-Departamento de Ciencias Biologicas and Vicerrectoria de Investigaciones, Universidad de los Andes	Facultad de Ciencias-Departamento de Ciencias Biologicas and Vicerrectoria de Investigaciones, Universidad de los Andes	This study was funded by Facultad de Ciencias-Departamento de Ciencias Biologicas and Vicerrectoria de Investigaciones, Universidad de los Andes.	Ackerly DD, 2003, INT J PLANT SCI, V164, pS1, DOI 10.1086/374729; Andrefouet S, 2015, GLOBAL CHANGE BIOL, V21, P195, DOI 10.1111/gcb.12699; [Anonymous], 1961, SHALLOW WATER OCTOCO; Anthony KRN, 2004, LIMNOL OCEANOGR, V49, P2201, DOI 10.4319/lo.2004.49.6.2201; Beeravolu CR, 2009, ECOL MODEL, V220, P2603, DOI 10.1016/j.ecolmodel.2009.06.041; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Botero L., 1987, Anales del Instituto de Investigaciones Marinas de Punta de Betin, V17, P61; Cavender-Bares J, 2009, ECOL LETT, V12, P693, DOI 10.1111/j.1461-0248.2009.01314.x; COFFROTH MA, 1992, MAR BIOL, V114, P317, DOI 10.1007/BF00349534; Connolly SR, 2005, SCIENCE, V309, P1363, DOI 10.1126/science.1113281; DAHLGREN EJ, 1989, B MAR SCI, V45, P678; Darwin C., 1842, STRUCTURE DISTRIBUTI; Darwin C, 1859, ORIGIN SPECIES MEANS, DOI [10.1007/s12064-009-0058-z, DOI 10.1007/S12064-009-0058-Z]; Diaz M, 2011, CORAL REEFS, V30, P73, DOI 10.1007/s00338-010-0668-4; Diaz-Pulido G, 2004, REV ACAD COLOMB CIEN, V28, P337; Dornelas M, 2006, NATURE, V440, P80, DOI 10.1038/nature04534; Dornelas M, 2014, SCIENCE, V344, P296, DOI 10.1126/science.1248484; ELTON C, 1946, J ANIM ECOL, V15, P54, DOI 10.2307/1625; Emerson BC, 2008, TRENDS ECOL EVOL, V23, P619, DOI 10.1016/j.tree.2008.07.005; Etnoyer Peter J, 2010, PLoS One, V5, pe10668, DOI 10.1371/journal.pone.0010668; Fabricius KE, 2008, ECOLOGY, V89, P3163, DOI 10.1890/08-0005.1; Fabricius KE, 2005, MAR POLLUT BULL, V50, P125, DOI 10.1016/j.marpolbul.2004.11.028; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Gardner JPA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087971; Geister J, 1975, STUTTGARTER BEITRA B, V15, P1; Grajales A, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-90; GRAUS RR, 1989, CORAL REEFS, V8, P9, DOI 10.1007/BF00304687; Hardy OJ, 2007, J ECOL, V95, P493, DOI 10.1111/j.1365-2745.2007.01222.x; Harrison P.L., 1990, P133; HilleRisLambers J, 2012, ANNU REV ECOL EVOL S, V43, P227, DOI 10.1146/annurev-ecolsys-110411-160411; Hoogenboom MO, 2009, ECOLOGY, V90, P767, DOI 10.1890/07-2010.1; Hubbell SP, 2005, FUNCT ECOL, V19, P166, DOI 10.1111/j.0269-8463.2005.00965.x; Hubbell Stephen P., 2001, V32, pi; HUGHES RN, 1983, BIOL J LINN SOC, V20, P39, DOI 10.1111/j.1095-8312.1983.tb01588.x; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Ives AR, 2010, AM NAT, V176, pE128, DOI 10.1086/656486; Kaandorp JA, 1999, MAR BIOL, V134, P295, DOI 10.1007/s002270050547; Lasker HR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074587; LASKER HR, 1983, MAR ECOL PROG SER, V13, P21, DOI 10.3354/meps013021; Losos JB, 2008, ECOL LETT, V11, P995, DOI 10.1111/j.1461-0248.2008.01229.x; Marchinko KB, 2004, ECOL LETT, V7, P114, DOI 10.1046/j.1461-0248.2003.00557.x; Marshall DJ, 2010, ECOL LETT, V13, P128, DOI 10.1111/j.1461-0248.2009.01408.x; Mayfield MM, 2010, ECOL LETT, V13, P1085, DOI 10.1111/j.1461-0248.2010.01509.x; Montaggioni LF, 2009, DEV MARINE GEOL; PORTER JW, 1976, AM NAT, V110, P731, DOI 10.1086/283100; Prada C, 2010, CORAL REEFS, V29, P41, DOI 10.1007/s00338-009-0547-z; Prada C, 2013, P NATL ACAD SCI USA, V110, P3961, DOI 10.1073/pnas.1208931110; Prada C, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-47; Ricklefs RE, 2004, ECOL LETT, V7, P1, DOI 10.1046/j.1461-0248.2003.00554.x; Ricklefs Robert E., 2005, P16; Ricklefs RE, 2008, AM NAT, V172, P741, DOI 10.1086/593002; Rosen B.R., 2002, P255; Ryan-Mishkin K, 2009, CARIBB J SCI, V45, P151; Sanchez JA, 2005, CARIBB J SCI, V41, P508; Sanchez JA, 2004, HYDROBIOLOGIA, V530, P283, DOI 10.1007/s10750-004-2684-2; Sanchez JA, 1999, B MAR SCI, V65, P215; Sanchez JA, 2003, MAR BIOL, V142, P975, DOI 10.1007/s00227-003-1018-7; Sanchez JA, 1997, B MAR SCI, V61, P453; Sanchez JA, 2005, EVALUATING CORAL REE; Sanchez JA, 2009, ZOOLOGICAL J LINNEAN; Sanchez Juan A., 1998, Caribbean Journal of Science, V34, P250; Sanchez JA, 2010, REV BIOL TROP, V58, P145; Swofford DL, 2002, PAUP 4 0B10 PHYLOGEN; Tilman D., 1982, Monographs in Population Biology, pi; Vamosi JC, 2007, DIVERS DISTRIB, V13, P1, DOI 10.1111/j.1472-4642.2006.00299.x; Vamosi SM, 2009, MOL ECOL, V18, P572, DOI 10.1111/j.1365-294X.2008.04001.x; Vernette G, 1986, THESIS MEM I GEOL BA, V20, P1; Volkov I, 2007, NATURE, V450, P45, DOI 10.1038/nature06197; Webb CO, 2008, BIOINFORMATICS, V24, P2098, DOI 10.1093/bioinformatics/btn358; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; Wiens JJ, 2004, TRENDS ECOL EVOL, V19, P639, DOI 10.1016/j.tree.2004.09.011	71	15	16	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0129609	10.1371/journal.pone.0129609	http://dx.doi.org/10.1371/journal.pone.0129609			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177191	Green Published, Green Submitted, gold			2022-12-26	WOS:000358197600014
J	Yang, Y; Jiang, M; Hu, J; Lv, X; Yu, LX; Qian, XP; Liu, BR				Yang, Yang; Jiang, Man; Hu, Jing; Lv, Xin; Yu, Lixia; Qian, Xiaoping; Liu, Baorui			Enhancement of Radiation Effects by Ursolic Acid in BGC-823 Human Adenocarcinoma Gastric Cancer Cell Line	PLOS ONE			English	Article							GAMBOGIC ACID; TUMORIGENESIS; RADIOTHERAPY; EXPRESSION; DOCETAXEL	Recent research has suggested that certain plant-derived polyphenols, i.e., ursolic acid (UA), which are reported to have antitumor activities, might be used to sensitize tumor cells to radiation therapy by inhibiting pathways leading to radiation therapy resistance. This experiment was designed to investigate the effects and possible mechanism of radiosensitization by UA in BGC-823 cell line from human adenocarcinoma gastric cancer in vitro. UA caused cytotoxicity in a dose-dependent manner, and we used a sub-cytotoxicity concentration of UA to test radioenhancement efficacy with UA in gastric cancer. Radiosensitivity was determined by clonogenic survival assay. Surviving fraction of the combined group with irradiation and sub-cytotoxicity UA significantly decreased compared with the irradiation group. The improved radiosensitization efficacy was associated with enhanced G2/M arrest, increased reactive oxygen species (ROS), down-regulated Ki-67 level and improved apoptosis. In conclusion, as UA demonstrated potent antiproliferation effect and synergistic effect, it could be used as a potential drug sensitizer for the application of radiotherapy.	[Qian, Xiaoping] Nanjing Univ, Sch Med, Drum Tower Hosp, Ctr Comprehens Canc, Nanjing 210008, Jiangsu, Peoples R China; Nanjing Univ, Clin Canc Inst, Nanjing 210008, Jiangsu, Peoples R China	Nanjing University; Nanjing University	Qian, XP (corresponding author), Nanjing Univ, Sch Med, Drum Tower Hosp, Ctr Comprehens Canc, Nanjing 210008, Jiangsu, Peoples R China.	qianxiaoping211@hotmail.com; baoruiliu@nju.edu.cn			National Natural Science Foundation of China [81172094]; Top Six Talents Project of Jiangsu Province [2011ws005]; Medical Science and Technology Development Projects of Nanjing [ZKX10011]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Top Six Talents Project of Jiangsu Province; Medical Science and Technology Development Projects of Nanjing	Supported by grants from the National Natural Science Foundation of China (Grant No. 81172094), Top Six Talents Project of Jiangsu Province (Grant No. 2011ws005), and Medical Science and Technology Development Projects of Nanjing (Grant No. ZKX10011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai KK, 2011, BIOORGAN MED CHEM, V19, P4043, DOI 10.1016/j.bmc.2011.05.017; Barcellos-Hoff MH, 2005, NAT REV CANCER, V5, P867, DOI 10.1038/nrc1735; Cha HJ, 1996, CANCER RES, V56, P2281; Creane M, 1999, INT J RADIAT BIOL, V75, P731, DOI 10.1080/095530099140078; Garg AK, 2005, ANTIOXID REDOX SIGN, V7, P1630, DOI 10.1089/ars.2005.7.1630; Goishi H, 2000, ONCOL REP, V7, P713; Hartgrink HH, 2009, LANCET, V374, P477, DOI 10.1016/S0140-6736(09)60617-6; HUANG MT, 1994, CANCER RES, V54, P701; LEE HY, 1994, J CANCER RES CLIN, V120, P513, DOI 10.1007/BF01221027; Liu YP, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1093/ecam/nep175; Mita T, 2001, J GASTROENTEROL, V36, P661, DOI 10.1007/s005350170028; Moran JM, 2005, LANCET ONCOL, V6, P51; RILEY PA, 1994, INT J RADIAT BIOL, V65, P27, DOI 10.1080/09553009414550041; SHON KH, 1995, CANCER LETT, V94, P213, DOI 10.1016/0304-3835(95)03856-R; TOKUDA H, 1986, CANCER LETT, V33, P279, DOI 10.1016/0304-3835(86)90067-4; Valentini V, 2007, EXPERT REV ANTICANC, V7, P1379, DOI 10.1586/14737140.7.10.1379; Valentini V, 2009, RADIOTHER ONCOL, V92, P176, DOI 10.1016/j.radonc.2009.06.014; Zhang W, 1996, CLIN CANCER RES, V2, P843; Zou ZY, 2012, CANCER BIOTHER RADIO, V27, P299, DOI 10.1089/cbr.2010.0943; Zou ZY, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-58	20	15	16	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0133169	10.1371/journal.pone.0133169	http://dx.doi.org/10.1371/journal.pone.0133169			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177078	Green Published, Green Submitted, gold			2022-12-26	WOS:000358197600223
J	Fourrier, J; Deschamps, M; Droin, L; Alaux, C; Fortini, D; Beslay, D; Le Conte, Y; Devillers, J; Aupinel, P; Decourtye, A				Fourrier, Julie; Deschamps, Matthieu; Droin, Lea; Alaux, Cedric; Fortini, Dominique; Beslay, Dominique; Le Conte, Yves; Devillers, James; Aupinel, Pierrick; Decourtye, Axel			Larval Exposure to the Juvenile Hormone Analog Pyriproxyfen Disrupts Acceptance of and Social Behavior Performance in Adult Honeybees	PLOS ONE			English	Article							APIS-MELLIFERA WORKERS; DIVISION-OF-LABOR; RISK-ASSESSMENT; AGE POLYETHISM; BEE LARVAE; HYMENOPTERA; DIFFERENTIATION; MELANIZATION; INSECTICIDES; RECOGNITION	Background Juvenile hormone (JH) plays an important role in honeybee development and the regulation of age-related division of labor. However, honeybees can be exposed to insect growth regulators (IGRs), such as JH analogs developed for insect pest and vector control. Although their side effects as endocrine disruptors on honeybee larval or adult stages have been studied, little is known about the subsequent effects on adults of a sublethal larval exposure. We therefore studied the impact of the JH analog pyriproxyfen on larvae and resulting adults within a colony under semi-field conditions by combining recent laboratory larval tests with chemical analysis and behavioral observations. Oral and chronic larval exposure at cumulative doses of 23 or 57 ng per larva were tested. Results Pyriproxyfen-treated bees emerged earlier than control bees and the highest dose led to a significant rate of malformed adults (atrophied wings). Young pyriproxyfen-treated bees were more frequently rejected by nestmates from the colony, inducing a shorter life span. This could be linked to differences in cuticular hydrocarbon (CHC) profiles between control and pyriproxyfen-treated bees. Finally, pyriproxyfen-treated bees exhibited fewer social behaviors (ventilation, brood care, contacts with nestmates or food stocks) than control bees. Conclusion Larval exposure to sublethal doses of pyriproxyfen affected several life history traits of the honeybees. Our results especially showed changes in social integration (acceptance by nestmates and social behaviors performance) that could potentially affect population growth and balance of the colony.	[Fourrier, Julie; Deschamps, Matthieu; Droin, Lea] ACTA, ICB VETAGROSUP, F-69280 Marcy Letoile, France; [Alaux, Cedric; Beslay, Dominique; Le Conte, Yves] INRA, UR Abeilles & Environm 406, F-84914 Avignon 9, France; [Alaux, Cedric; Beslay, Dominique; Le Conte, Yves; Decourtye, Axel] UMT PrADE, Avignon, France; [Fortini, Dominique; Aupinel, Pierrick] INRA, UE1255, UE Entomol, Stn Magneraud, F-17700 Surgeres, France; [Devillers, James] CTIS, F-69140 Rillieux La Pape, France; [Decourtye, Axel] ACTA, F-84914 Avignon 9, France; [Decourtye, Axel] ITSAP Inst Abeille, Avignon, France	INRAE; INRAE	Fourrier, J (corresponding author), ACTA, ICB VETAGROSUP, 1 Ave C Bourgelat, F-69280 Marcy Letoile, France.	julie.fourrier@acta.asso.fr	Le Conte, Yves/AAP-2379-2021; Alaux, Cedric/B-4667-2013; Le Conte, Yves M/B-3246-2016; Le Conte, Yves/M-4442-2018; Aupinel, Pierrick/Y-5436-2019; Rueppell, Olav/G-2679-2010	Le Conte, Yves/0000-0002-8466-5370; Alaux, Cedric/0000-0002-3045-2599; Le Conte, Yves M/0000-0002-8466-5370; Le Conte, Yves/0000-0002-8466-5370; Rueppell, Olav/0000-0001-5370-4229	French Ministry of Ecology, Environment and Sustainable Development for the National Research Program on Endocrine Disruptors (PNRPE program); CTIS	French Ministry of Ecology, Environment and Sustainable Development for the National Research Program on Endocrine Disruptors (PNRPE program); CTIS	This work was supported by grants from the French Ministry of Ecology, Environment and Sustainable Development for the National Research Program on Endocrine Disruptors (PNRPE program). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Co-author James Devillers is employed by CTIS. CTIS provided support in the form of salary for author JD, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Amdam GV, 2003, P NATL ACAD SCI USA, V100, P1799, DOI 10.1073/pnas.0333979100; [Anonymous], 2010, R LANG ENV STAT COMP; Aupinel Merrick, 2007, Redia, V90, P91; Aupinel P, 2007, PEST MANAG SCI, V63, P1090, DOI 10.1002/ps.1446; Aupinel Pierrick, 2005, Bulletin of Insectology, V58, P107; Babendreier D, 2004, APIDOLOGIE, V35, P293, DOI 10.1051/apido:2004016; Baracchi D, 2012, J INSECT PHYSIOL, V58, P1589, DOI 10.1016/j.jinsphys.2012.09.014; Bates D., 2013, LME4 LINEAR MIXED EF; Beshers SN, 2001, J THEOR BIOL, V213, P461, DOI 10.1006/jtbi.2001.2427; Bitondi MMG, 1998, J INSECT PHYSIOL, V44, P499, DOI 10.1016/S0022-1910(97)00113-3; BREED MD, 1985, P NATL ACAD SCI USA, V82, P3058, DOI 10.1073/pnas.82.9.3058; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; Devillers J, 2013, QSAR ENVIRON HEALTH, P127; Devillers J, 2014, IN SILICO BEES, P179; DOULL K M, 1976, Apidologie, V7, P61, DOI 10.1051/apido:19760104; Elekonich MM, 2003, J INSECT PHYSIOL, V49, P359, DOI 10.1016/S0022-1910(03)00020-9; Fernandez FC, 2012, MICROSC RES TECHNIQ, V75, P844, DOI 10.1002/jemt.22003; Heimken C, 2009, J EXP BIOL, V212, P1032, DOI 10.1242/jeb.022582; HERBERS JM, 1983, ANIM BEHAV, V31, P759, DOI 10.1016/S0003-3472(83)80233-4; Howard RW, 2005, ANNU REV ENTOMOL, V50, P371, DOI 10.1146/annurev.ento.50.071803.130359; HUANG ZY, 1992, P NATL ACAD SCI USA, V89, P11726, DOI 10.1073/pnas.89.24.11726; HUANG ZY, 1995, J COMP PHYSIOL B, V165, P18, DOI 10.1007/BF00264682; HUANG ZY, 1994, J COMP PHYSIOL A, V174, P731, DOI 10.1007/BF00192722; HUANG ZY, 1991, J INSECT PHYSIOL, V37, P733, DOI 10.1016/0022-1910(91)90107-B; HUSSEIN MH, 1978, Z ANGEW ENTOMOL, V87, P109; JAYCOX ER, 1974, ANN ENTOMOL SOC AM, V67, P529, DOI 10.1093/aesa/67.4.529; Kamakura M, 2011, NATURE, V473, P478, DOI 10.1038/nature10093; KOLMES SA, 1984, J APICULT RES, V23, P189, DOI 10.1080/00218839.1984.11100631; Lambert O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067007; LE CONTE Y, 1995, J ECON ENTOMOL, V88, P798, DOI 10.1093/jee/88.4.798; Le Conte Y, 2008, ANNU REV ENTOMOL, V53, P523, DOI 10.1146/annurev.ento.52.110405.091434; Liang D, 2000, NATURWISSENSCHAFTEN, V87, P412, DOI 10.1007/s001140050752; Mattila HR, 2006, APIDOLOGIE, V37, P533, DOI 10.1051/apido:2006037; McDonnell CM, 2013, BMC ECOL, V13, DOI 10.1186/1472-6785-13-25; Mullin CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009754; Nelson CM, 2007, PLOS BIOL, V5, P673, DOI 10.1371/journal.pbio.0050062; OEPP/EPPO, 2010, B OEPP EPPO B, V40, P323; Pinto LZ, 2000, J INSECT PHYSIOL, V46, P153, DOI 10.1016/S0022-1910(99)00111-0; RACHINSKY A, 1990, J INSECT PHYSIOL, V36, P189, DOI 10.1016/0022-1910(90)90121-U; RACHINSKY A, 1990, GEN COMP ENDOCR, V79, P31, DOI 10.1016/0016-6480(90)90085-Z; REMBOLD H, 1987, INSECT BIOCHEM, V17, P1003, DOI 10.1016/0020-1790(87)90110-7; Reyment RA, 1989, TERRA NOVA, V1, P29, DOI 10.1111/j.1365-3121.1989.tb00322.x; Richard FJ, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-50; Richard FJ, 2004, CHEMOECOLOGY, V14, P9, DOI 10.1007/s00049-003-0251-3; Richard FJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-558; ROBINSON GE, 1992, ANNU REV ENTOMOL, V37, P637, DOI 10.1146/annurev.en.37.010192.003225; ROBINSON GE, 1987, BEHAV ECOL SOCIOBIOL, V20, P329, DOI 10.1007/BF00300679; ROBINSON GE, 1989, SCIENCE, V246, P109, DOI 10.1126/science.246.4926.109; Robinson GE, 1997, ARCH INSECT BIOCHEM, V35, P559, DOI 10.1002/(SICI)1520-6327(1997)35:4<559::AID-ARCH13>3.0.CO;2-9; ROBINSON GE, 1985, J INSECT PHYSIOL, V31, P277, DOI 10.1016/0022-1910(85)90003-4; Rortais A, 2005, APIDOLOGIE, V36, P71, DOI 10.1051/apido:2004071; Salvy M, 2001, PARASITOLOGY, V122, P145, DOI 10.1017/S0031182001007181; Sanchez-Bayo F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094482; SEELEY TD, 1982, BEHAV ECOL SOCIOBIOL, V11, P287, DOI 10.1007/BF00299306; Sullivan JP, 2000, HORM BEHAV, V37, P1, DOI 10.1006/hbeh.1999.1552; Tasei JN, 2001, APIDOLOGIE, V32, P527, DOI 10.1051/apido:2001102; Thompson HM, 2007, PEST MANAG SCI, V63, P1081, DOI 10.1002/ps.1457; Thompson HM, 2005, ECOTOXICOLOGY, V14, P757, DOI 10.1007/s10646-005-0024-6; Thompson HM, 2003, ECOTOXICOLOGY, V12, P317, DOI 10.1023/A:1022575315413; Villa S, 2000, ECOTOXICOLOGY, V9, P287, DOI 10.1023/A:1026522112328; Winston M. L., 1987, The biology of the honey bee.; Yang E. C., 2010, P INT SEM ENH FUNCT; Zhu WY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0077547; Zufelato MS, 2000, ARTHROPOD STRUCT DEV, V29, P111, DOI 10.1016/S1467-8039(00)00023-2	64	27	27	1	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132985	10.1371/journal.pone.0132985	http://dx.doi.org/10.1371/journal.pone.0132985			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26171610	Green Published, gold, Green Submitted			2022-12-26	WOS:000358194900113
J	Juzenas, S; Salteniene, V; Kupcinskas, J; Link, A; Kiudelis, G; Jonaitis, L; Jarmalaite, S; Kupcinskas, L; Malfertheiner, P; Skieceviciene, J				Juzenas, Simonas; Salteniene, Violeta; Kupcinskas, Juozas; Link, Alexander; Kiudelis, Gediminas; Jonaitis, Laimas; Jarmalaite, Sonata; Kupcinskas, Limas; Malfertheiner, Peter; Skieceviciene, Jurgita			Analysis of Deregulated microRNAs and Their Target Genes in Gastric Cancer	PLOS ONE			English	Article							CELL-PROLIFERATION; PCR DATA; EXPRESSION; QUANTIFICATION; NORMALIZATION; METASTASIS; SIGNATURE	Background MicroRNAs (miRNAs) are widely studied non-coding RNAs that modulate gene expression. MiRNAs are deregulated in different tumors including gastric cancer (GC) and have potential diagnostic and prognostic implications. The aim of our study was to determine miRNA profile in GC tissues, followed by evaluation of deregulated miRNAs in plasma of GC patients. Using available databases and bioinformatics methods we also aimed to evaluate potential target genes of confirmed differentially expressed miRNA and validate these findings in GC tissues. Methods The study included 51 GC patients and 51 controls. Initially, we screened miRNA expression profile in 13 tissue samples of GC and 12 normal gastric tissues with TaqMan low density array (TLDA). In the second stage, differentially expressed miRNAs were validated in a replication cohort using qRT-PCR in tissue and plasma samples. Subsequently, we analyzed potential target genes of deregulated miRNAs using bioinformatics approach, determined their expression in GC tissues and performed correlation analysis with targeting miRNAs. Results Profiling with TLDA revealed 15 deregulated miRNAs in GC tissues compared to normal gastric mucosa. Replication analysis confirmed that miR-148a-3p, miR-204-5p, miR-223-3p and miR-375 were consistently deregulated in GC tissues. Analysis of GC patients' plasma samples showed significant down-regulation of miR-148a-3p, miR-375 and up-regulation of miR-223-3p compared to healthy subjects. Further, using bioinformatic tools we identified targets of replicated miRNAs and performed disease-associated gene enrichment analysis. Ultimately, we evaluated potential target gene BCL2 and DNMT3B expression by qRT-PCR in GC tissue, which correlated with targeting miRNA expression. Conclusions Our study revealed miRNA profile in GC tissues and showed that miR-148a-3p, miR-223-3p and miR-375 are deregulated in GC plasma samples, but these circulating miRNAs showed relatively weak diagnostic performance as sole biomarkers. Target gene analysis demonstrated that BCL2 and DNMT3B expression in GC tissue correlated with their targeting miRNA expression.	[Juzenas, Simonas; Salteniene, Violeta; Kupcinskas, Juozas; Kiudelis, Gediminas; Jonaitis, Laimas; Kupcinskas, Limas; Skieceviciene, Jurgita] Lithuanian Univ Hlth Sci, Inst Digest Res, Kaunas, Lithuania; [Kupcinskas, Juozas; Kiudelis, Gediminas; Jonaitis, Laimas; Kupcinskas, Limas] Lithuanian Univ Hlth Sci, Dept Gastroenterol, Kaunas, Lithuania; [Link, Alexander; Malfertheiner, Peter] Univ Magdeburg, Dept Gastroenterol Hepatol & Infect Dis, D-39106 Magdeburg, Germany; [Jarmalaite, Sonata] Vilnius State Univ, Fac Nat Sci, Res Ctr, Div Human Genome, Vilnius, Lithuania	Lithuanian University of Health Sciences; Lithuanian University of Health Sciences; Otto von Guericke University; Vilnius University	Kupcinskas, J (corresponding author), Lithuanian Univ Hlth Sci, Inst Digest Res, Kaunas, Lithuania.	j_kupcinskas@yahoo.com	Juzenas, Simonas/F-3187-2018; Jarmalaite, Sonata/CAF-4301-2022; Kupcinskas, Juozas/AAU-6968-2021	Juzenas, Simonas/0000-0001-9293-0691; 	European Social Fund [VP1-3.1-SMM-07-K-01-156]; German Federal Ministry of Education and Research in the frame of ERA-Net PathoGenoMics [BMBF-0315905D]	European Social Fund(European Social Fund (ESF)); German Federal Ministry of Education and Research in the frame of ERA-Net PathoGenoMics	This work of JK, LJ, SiJu, LK, JS was supported by the European Social Fund No. VP1-3.1-SMM-07-K-01-156. The work of PM is supported by German Federal Ministry of Education and Research in the frame of ERA-Net PathoGenoMics. Grant No: BMBF-0315905D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmedin J., 2014, CA-CANCER J CLIN, V61, P69; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Bae IS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122554; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bass AJ, 2014, NATURE, V513, P202, DOI 10.1038/nature13480; Benz F, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.81; Bornschein J, 2014, FRONT BIOSCI-LANDMRK, V19, P312, DOI 10.2741/4210; Bornschein J, 2011, HELICOBACTER, V16, P45, DOI 10.1111/j.1523-5378.2011.00880.x; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Ding L, 2010, CELL RES, V20, P784, DOI 10.1038/cr.2010.79; Dvinge H, 2009, BIOINFORMATICS, V25, P3325, DOI 10.1093/bioinformatics/btp578; Fujimoto D, 2013, INT J ONCOL, V42, P565, DOI 10.3892/ijo.2012.1738; Genovesi Laura A, 2012, BMC Res Notes, V5, P507, DOI 10.1186/1756-0500-5-507; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Guo SL, 2011, INT J BIOL SCI, V7, P567, DOI 10.7150/ijbs.7.567; Han TS, 2015, GUT, V64, P203, DOI 10.1136/gutjnl-2013-306640; Hashimoto Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062589; Jia CY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027008; Kang W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033919; Kim CH, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-79; Kim SY, 2013, J MOL DIAGN, V15, P661, DOI 10.1016/j.jmoldx.2013.04.004; Kutmon M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082160; Lamba Vishal, 2014, BMC Res Notes, V7, P129, DOI 10.1186/1756-0500-7-129; LAUREN P, 1965, ACTA PATHOL MIC SC, V64, P31, DOI 10.1111/apm.1965.64.1.31; Lauss M, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-532; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Li GR, 2011, INVEST OPHTH VIS SCI, V52, P2999, DOI 10.1167/iovs.10-6708; Li XH, 2010, GUT, V59, P579, DOI 10.1136/gut.2008.175497; Li XH, 2011, ONCOL REP, V26, P1431, DOI 10.3892/or.2011.1437; Linhart HG, 2007, GENE DEV, V21, P3110, DOI 10.1101/gad.1594007; Link A, 2015, SCI REP-UK, V5, DOI 10.1038/srep08270; Link A, 2013, ADV CLIN CHEM, V62, P221, DOI 10.1016/B978-0-12-800096-0.00006-8; Link A, 2012, DIGEST DIS, V30, P255, DOI 10.1159/000336919; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lujambio A, 2012, NATURE, V482, P347, DOI 10.1038/nature10888; Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64; Minn YK, 2014, INT J ONCOL, V45, P2403, DOI 10.3892/ijo.2014.2680; Perkins JR, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-296; Petrocca F, 2008, CANCER CELL, V13, P272, DOI 10.1016/j.ccr.2008.02.013; Sacconi A, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.160; Shen ZY, 2014, EXP THER MED, V7, P1757, DOI 10.3892/etm.2014.1627; Shrestha S, 2014, CANCER MED-US, V3, P878, DOI 10.1002/cam4.246; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Steponaitiene R, 2016, MOL CARCINOGEN, V55, P376, DOI 10.1002/mc.22287; Tang B, 2010, FEBS LETT, V584, P1481, DOI 10.1016/j.febslet.2010.02.063; Ueda T, 2010, LANCET ONCOL, V11, P136, DOI 10.1016/S1470-2045(09)70343-2; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113401; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Xiang MQ, 2014, BIOCHEM BIOPH RES CO, V454, P210, DOI 10.1016/j.bbrc.2014.10.064; Xiao B, 2009, J INFECT DIS, V200, P916, DOI 10.1086/605443; Xu YJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099516; Yamakuchi M, 2010, P NATL ACAD SCI USA, V107, P6334, DOI 10.1073/pnas.0911082107; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Zheng GX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083025; Zhou XY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101457; Zhu C, 2014, BRIT J CANCER, V110, P2291, DOI 10.1038/bjc.2014.119	57	40	43	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132327	10.1371/journal.pone.0132327	http://dx.doi.org/10.1371/journal.pone.0132327			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26172537	Green Published, Green Submitted, gold			2022-12-26	WOS:000358194900042
J	Ketema, T; Bacha, K; Alemayehu, E; Ambelu, A				Ketema, Tsige; Bacha, Ketema; Alemayehu, Esayas; Ambelu, Argaw			Incidence of Severe Malaria Syndromes and Status of Immune Responses among Khat Chewer Malaria Patients in Ethiopia	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; CATHA-EDULIS; BLOOD-PRESSURE; URIC-ACID; CIGARETTE-SMOKING; CLINICAL MALARIA; IN-VITRO; IMMUNOGLOBULIN; THROMBOCYTOPENIA; ANTIBODIES	Although more emphasis has been given to the genetic and environmental factors that determine host vulnerability to malaria, other factors that might have a crucial role in burdening the disease have not been evaluated yet. Therefore, this study was designed to assess the effect of khat chewing on the incidence of severe malaria syndromes and immune responses during malaria infection in an area where the two problems co-exist. Clinical, physical, demographic, hematological, biochemical and immunological data were collected from Plasmodium falciparum mono-infected malaria patients (age >= 10 years) seeking medication in Halaba Kulito and Jimma Health Centers. In addition, incidences of severe malaria symptoms were assessed. The data were analyzed using SPSS (version 20) software. Prevalence of current khat chewer malaria patients was 57.38% (95% CI = 53-61.56%). Malaria symptoms such as hyperpyrexia, prostration and hyperparasitemia were significantly lower (P<0.05) among khat chewer malaria patients. However, relative risk to jaundice and renal failure were significantly higher (P<0.05) in khat chewers than in non-khat chewer malaria patients. Longer duration of khat use was positively associated with incidence of anemia. IgM and IgG antibody titers were significantly higher (P<0.05) among khat chewer malaria patients than among malaria positive non-chewers. Although levels of IgG subclasses in malaria patients did not show significant differences (P>0.05), IgG3 antibody was significantly higher (P<0.001) among khat chewer malaria patients. Moreover, IgM, IgG, IgG1 and IgG3 antibodies had significant negative association (P<0.001) with parasite burden and clinical manifestations of severe malaria symptoms, but not with severe anemia and hypoglycemia. Additionally, a significant increment (P<0.05) in CD4(+) T-lymphocyte population was observed among khat users. Khat might be an important risk factor for incidence of some severe malaria complications. Nevertheless, it can enhance induction of humoral immune response and CD4(+) T-lymphocyte population during malaria infection. This calls for further investigation on the effect of khat on parasite or antigen-specifc protective malaria immunity and analysis of cytokines released upon malaria infection among khat chewers.	[Ketema, Tsige; Ambelu, Argaw] Jimma Univ, Dept Environm Hlth Sci & Technol, Coll Hlth Sci, Jimma, Ethiopia; [Ketema, Tsige; Bacha, Ketema] Jimma Univ, Dept Biol, Coll Nat Sci, Jimma, Ethiopia; [Alemayehu, Esayas] Jimma Univ, Inst Technol, Sch Civil & Environm Engn, Jimma, Ethiopia	Jimma University; Jimma University; Jimma University	Ketema, T (corresponding author), Jimma Univ, Dept Environm Hlth Sci & Technol, Coll Hlth Sci, Jimma, Ethiopia.	tsigeketema@gmail.com	Ambelu, Argaw/V-8317-2018; Prof., Esayas Alemayehu/AAK-1907-2020; Ambelu, Argaw/GQA-6114-2022	Ambelu, Argaw/0000-0003-1898-4100; Ambelu, Argaw/0000-0003-1898-4100; /0000-0002-6286-5689; Alemayehu, Esayas/0000-0001-8843-1136	L'Oreal UNESCO; DAAD; Jimma University	L'Oreal UNESCO(L'Oreal Group); DAAD(Deutscher Akademischer Austausch Dienst (DAAD)); Jimma University	The study was financially supported by L'Oreal UNESCO, DAAD, and Jimma University.	Abdul Manan Junejo, 2006, J Ayub Med Coll Abbottabad, V18, P47; Abuye C, 2005, J CLIN IMMUNOL, V25, P127, DOI 10.1007/s10875-005-2818-y; ACMD, 2005, KHAT QAT ASS RISK IN; Adhanom TDW, 2006, EPIDEMIOLOGY ECOLOGY, P556; Al-Hashem FH, 2011, BAHRAIN MED B, V33; Al-hebshi N, 2006, ARCH ORAL BIOL, V51, P183, DOI 10.1016/j.archoralbio.2005.08.001; Al-Hebshi NN, 2005, ADDICT BIOL, V10, P299, DOI 10.1080/13556210500353020; Al-Mamary M, 2002, PHYTOTHER RES, V16, P127, DOI 10.1002/ptr.835; ALMESHAL IA, 1986, AGENTS ACTIONS, V17, P379, DOI 10.1007/BF01982654; Alsalahi A, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/829401; Alsanosy RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065504; ANAND A C, 1992, National Medical Journal of India, V5, P59; [Anonymous], 2006, 34 WHO ECDD; [Anonymous], 2012, MAN SEV MAL PRACT HD; Aucan C, 2000, INFECT IMMUN, V68, P1252, DOI 10.1128/IAI.68.3.1252-1258.2000; Balint EE, 2009, WIEN KLIN WOCHENSCHR, V121, P604, DOI 10.1007/s00508-009-1259-7; BOUHAROUNTAYOUN H, 1990, J EXP MED, V172, P1633, DOI 10.1084/jem.172.6.1633; Cheesbrough M, 2005, DISTRICT LAB PRACTIC, P462; Christian R, 1998, ENCY PSYCHOACTIVE PL; Clark IA, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-85; Corkery JM, 2011, ANN I SUPER SANITA, V47, P445, DOI 10.4415/ANN_11_04_17; Cox D, 2010, CELL MOL LIFE SCI, V67, P557, DOI 10.1007/s00018-009-0211-3; Cox G, 2003, ADV PSYCHIAT TREAT, V9, P456, DOI [10.1192/apt.9.6.456, DOI 10.1192/APT.9.6.456]; Damena T, 2011, ETHIOP J HEALTH SCI, V21, P37; Deressa W, 2003, B WORLD HEALTH ORGAN, V81, P261; Dhaifalah Ishraq, 2004, Biomedical Papers (Olomouc), V148, P11; Elhag H, 1999, ANT CYT ACT EXTR KHA, P463; Felix K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082755; FIEVET N, 1993, CLIN EXP IMMUNOL, V91, P63, DOI 10.1111/j.1365-2249.1993.tb03355.x; Fitzgerald J, 2009, KHAT LIT REV; FMOH (Federal Ministry of Health of Ethiopia), 2007, P ANN REV M MAL PREV; FMOH (Federal Ministry of Health of Ethiopia), 2007, ENT PROF MAL ETH; FMOH (Federal ministry of Health of Ethiopia), 2012, NAT MAL GUID; FMOH (Federal Ministry of Health of Ethiopia), 1999, MAL OTH VECT BORN DI; Friedman JF, 2003, J INFECT DIS, V188, P449, DOI 10.1086/376596; Gelaw Y, 2004, ETHIOP J HEALTH DEV, V18, P179; Getahun W, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-390; Graeme B, 2010, AUST J MED HERBAL, V22, P107; Hassan NA, 2005, SAUDI MED J, V26, P537; Hassan NAGM, 2000, TROP DOCT, V30, P107, DOI 10.1177/004947550003000219; Iman R, 2013, EGYPT J INTERN MED, V25, P37; Ishani A, 2006, J AM SOC NEPHROL, V17, P1444, DOI 10.1681/ASN.2005091012; Johnson RJ, 2003, HYPERTENSION, V41, P1183, DOI 10.1161/01.HYP.0000069700.62727.C5; KABILAN L, 1987, CLIN EXP IMMUNOL, V68, P288; KALIX P, 1987, BRIT J ADDICT, V82, P47; Kang DH, 2002, J AM SOC NEPHROL, V13, P2888, DOI 10.1097/01.ASN.0000034910.58454.FD; KELTON JG, 1983, J CLIN INVEST, V71, P832, DOI 10.1172/JCI110836; Ketema T, 2015, J BIOL CHEM RES, V32, P374; Kour K, 2011, J PHARM PHARMACOL, V63, P267, DOI 10.1111/j.2042-7158.2010.01195.x; Kwiatkowski DP, 2005, AM J HUM GENET, V77, P171, DOI 10.1086/432519; Laswar AKN, 2009, SAUDI J KIDNEY DIS T, V20, P862; Lee SH, 1997, THROMB HAEMOSTASIS, V77, P289; Mark L, 2003, BASIC REFERENCE, V28, P217; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; Murdoch C, 2011, J ETHNOPHARMACOL, V138, P780, DOI 10.1016/j.jep.2011.10.030; Nebie I, 2008, INFECT IMMUN, V76, P759, DOI 10.1128/IAI.01147-07; Nutt D, 2007, LANCET, V369, P1047, DOI 10.1016/S0140-6736(07)60464-4; Odenwald M, 2010, J ETHNOPHARMACOL, V132, P615, DOI 10.1016/j.jep.2009.11.005; Opal SM, 2000, CHEST, V117, P1162, DOI 10.1378/chest.117.4.1162; Orengo JM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000013; Orengo JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005194; Otten M, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-14; Parroche P, 2007, P NATL ACAD SCI USA, V104, P1919, DOI 10.1073/pnas.0608745104; Piguet PF, 2002, APOPTOSIS, V7, P91, DOI 10.1023/A:1014341611412; Polley SD, 2006, VACCINE, V24, P4233, DOI 10.1016/j.vaccine.2005.06.030; Schumann RR, 2007, P NATL ACAD SCI USA, V104, P1743, DOI 10.1073/pnas.0610874104; Siddiqui R, 2012, J BACTERIOL PARASITO, V3, P1; Stanisic DI, 2009, INFECT IMMUN, V77, P1165, DOI 10.1128/IAI.01129-08; Tongren JE, 2006, INFECT IMMUN, V74, P257, DOI 10.1128/IAI.74.1.257-264.2006; Tulu NA, 1993, ECOLOGY HLTH DIS ETH, P341; UN-OCHA, 2003, CRIT EM SIT KAMB TAM; VANDERHEYDE HC, 1994, J IMMUNOL, V152, P4557; Wassmer SC, 2006, J IMMUNOL, V176, P1180, DOI 10.4049/jimmunol.176.2.1180; White NJ, 2008, CLIN INFECT DIS, V46, P172, DOI 10.1086/524889; WHO/UNICEF, 2005, WORLD MAL REP; WHO (World Health Organization), 2004, THE LANCET, P157; Wickramasinghe SN, 2000, BEST PRACT RES CL HA, V13, P277, DOI 10.1053/beha.1999.0072; World Health Organization, 2010, BAS MAL MICR 1; Yamaguchi S, 1997, AM J HEMATOL, V56, P183, DOI 10.1002/(SICI)1096-8652(199711)56:3&lt;183::AID-AJH9&gt;3.0.CO;2-U	79	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0131212	10.1371/journal.pone.0131212	http://dx.doi.org/10.1371/journal.pone.0131212			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26173100	Green Submitted, Green Published, gold			2022-12-26	WOS:000358194900014
J	Baikara, BT; Zholdybayeva, EV; Rakhimova, SE; Nigmatullina, NB; Momynaliev, KT; Ramanculov, YM				Baikara, Barshagul T.; Zholdybayeva, Elena V.; Rakhimova, Saule E.; Nigmatullina, Nazym B.; Momynaliev, Kuvat T.; Ramanculov, Yerlan M.			A Novel Mutation in a Kazakh Family with X-Linked Alport Syndrome	PLOS ONE			English	Article							PHENOTYPE CORRELATIONS; IV COLLAGEN; GENE	Alport syndrome is a genetic condition that results in hematuria, progressive renal impairment, hearing loss, and occasionally lenticonus and retinopathy. Approximately 80% of Alport syndrome cases are caused by X-linked mutations in the COL4A5 gene encoding type IV collagen. The objective of this study was to define the SNP profiles for COL4A5 in patients with hereditary nephritis and hematuria. For this, we examined four subjects from one Kazakh family clinically affected with X-linked Alport syndrome due to COL4A5 gene mutations. All 51 exons of the COL4A5 gene were screened by linkage analysis and direct DNA sequencing, resulting in the identification of a novel mutation (G641E) in exon 25. The mutation was found only in two affected family individuals but was not present in healthy family members or 200 unrelated healthy controls. This result demonstrates that this novel mutation is pathogenic and has meaningful implications for the diagnosis of patients with Alport syndrome.	[Baikara, Barshagul T.; Zholdybayeva, Elena V.; Rakhimova, Saule E.; Momynaliev, Kuvat T.; Ramanculov, Yerlan M.] Natl Biotechnol Ctr, Astana, Kazakhstan; [Rakhimova, Saule E.] Nazarbayev Univ, Ctr Sci, Astana, Kazakhstan; [Nigmatullina, Nazym B.] Natl Res Ctr Maternal & Child Hlth, Astana, Kazakhstan; [Ramanculov, Yerlan M.] Nazarbayev Univ, Sch Sci & Technol, Astana, Kazakhstan	National Center for Biotechnology (NCB); Nazarbayev University; Nazarbayev University	Baikara, BT (corresponding author), Natl Biotechnol Ctr, Astana, Kazakhstan.	baikara.barshagul@gmail.com	Ramankulov, Yerlan/AAG-7450-2019; Baikara, Barshagul/AAQ-7756-2020; Rakhimova, Saule Eslamovna/N-4602-2017; Zholdybayeva, Elena/AAB-1509-2020; Momynaliev, Kuvat/ADR-6456-2022	Ramankulov, Yerlan/0000-0001-6786-3028; Zholdybayeva, Elena/0000-0002-9677-008X; Momynaliev, Kuvat/0000-0003-4656-1025; Ramanculov, Erlan/0000-0001-6791-4497; Rakhimova, Saule/0000-0002-8245-2400	Ministry of Education and Science of the Republic of Kazakhstan; National Center for Biotechnology	Ministry of Education and Science of the Republic of Kazakhstan(Government of the Republic of KazakhstanMinistry of Education and Science of the Republic of Kazakhstan); National Center for Biotechnology	This study was supported by the Ministry of Education and Science of the Republic of Kazakhstan. The National Center for Biotechnology received this grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alport AC, 1927, BMJ-BRIT MED J, V1927, P504, DOI 10.1136/bmj.1.3454.504; Arrondel C, 2004, KIDNEY INT, V65, P2030, DOI 10.1111/j.1523-1755.2004.00622.x; BARKER DF, 1990, SCIENCE, V248, P1224, DOI 10.1126/science.2349482; Deltas C, 2012, PEDIATR NEPHROL, V27, P1221, DOI 10.1007/s00467-011-1935-5; Gross O, 2002, NEPHROL DIAL TRANSPL, V17, P1218, DOI 10.1093/ndt/17.7.1218; Haas M, 2009, ARCH PATHOL LAB MED, V133, P224, DOI 10.1043/1543-2165-133.2.224; Hertz JM, 2012, EUR J HUM GENET, V20, DOI 10.1038/ejhg.2011.237; Hertz JM, 2009, DAN MED BULL, V56, P105; Jais JP, 2000, J AM SOC NEPHROL, V11, P649, DOI 10.1681/ASN.V114649; Kalluri R, 1997, J CLIN INVEST, V99, P2470, DOI 10.1172/JCI119431; Kashtan CE, 2009, PEDIATR NEPHROL, V24, P1951, DOI 10.1007/s00467-007-0622-z; LEMMINK HH, 1994, HUM MOL GENET, V3, P1269, DOI 10.1093/hmg/3.8.1269; Liapis H, 2002, HUM PATHOL, V33, P836, DOI 10.1053/hupa.2002.125374; Longo I, 2002, KIDNEY INT, V61, P1947, DOI 10.1046/j.1523-1755.2002.00379.x; Persikov AV, 2004, HUM MUTAT, V24, P330, DOI 10.1002/humu.20091; Spear G S, 1973, Clin Nephrol, V1, P336; Wang YF, 2004, BIOCHEM BIOPH RES CO, V316, P1143, DOI 10.1016/j.bbrc.2004.02.168	17	2	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0132010	10.1371/journal.pone.0132010	http://dx.doi.org/10.1371/journal.pone.0132010			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26168235	Green Submitted, gold, Green Published			2022-12-26	WOS:000358193100017
J	George, NM; Whitaker, J; Vieira, G; Geronimo, JT; Bellinger, DA; Fletcher, CA; Garner, JP				George, Nneka M.; Whitaker, Julia; Vieira, Giovana; Geronimo, Jerome T.; Bellinger, Dwight A.; Fletcher, Craig A.; Garner, Joseph P.			Antioxidant Therapies for Ulcerative Dermatitis: A Potential Model for Skin Picking Disorder	PLOS ONE			English	Article							OXIDATIVE STRESS; N-ACETYLCYSTEINE; C57BL/6 MICE; TRICHOTILLOMANIA; GLUTATHIONE; BEHAVIORS; MODULATOR	Skin Picking Disorder affects 4% of the general population, with serious quality of life impacts, and potentially life threatening complications. Standard psychoactive medications do not help most patients. Similarly, Mouse Ulcerative Dermatitis (skin lesions caused by excessive abnormal grooming behavior) is very common in widely used inbred strains of mice, and represents a serious animal welfare issue and cause of mortality. Treatment options for Ulcerative Dermatitis are largely palliative and ineffective. We have proposed mouse Ulcerative Dermatitis as a model for human Skin Picking Disorder based on similar epidemiology, behavior, and its comorbidity and mechanistic overlap with hair pulling (trichotillomania). We predicted that mouse Ulcerative Dermatitis would be treated by N-Acetylcysteine, as this compound is highly effective in treating both Skin Picking Disorder and Trichotillomania. Furthermore, we hypothesized that N-Acetylcysteine's mode of action is as a precursor to the production of the endogenous antioxidant glutathione in the brain, and therefore intranasal glutathione would also treat Ulcerative Dermatitis. Accordingly, we show in a heterogenous prospective trial, the significant reduction in Ulcerative Dermatitis lesion severity in mice receiving either N-acetylcysteine (oral administration) or glutathione (intranasal). The majority of mice treated with N-acetylcysteine improved slowly throughout the course of the study. Roughly half of the mice treated with glutathione showed complete resolution of lesion within 2-4 weeks, while the remainder did not respond. These findings are the first to show that the use of N-acetylcysteine and Glutathione can be curative for mouse Ulcerative Dermatitis. These findings lend additional support for mouse Ulcerative Dermatitis as a model of Skin Picking Disorder and also support oxidative stress and glutathione synthesis as the mechanism of action for these compounds. As N-Acetylcysteine is poorly tolerated by many patients, intranasal glutathione warrants further study as potential therapy in Skin Picking, trichotillomania and other body-focused repetitive behavior disorders.	[George, Nneka M.; Whitaker, Julia; Bellinger, Dwight A.; Fletcher, Craig A.] Univ N Carolina, Div Lab Anim Med, Dept Pathol & Lab Med, Chapel Hill, NC 27514 USA; [Vieira, Giovana] Purdue Univ, Dept Anim Sci, W Lafayette, IN 47907 USA; [Geronimo, Jerome T.; Garner, Joseph P.] Stanford Univ, Dept Comparat Med, Stanford, CA 94305 USA; [Garner, Joseph P.] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA	University of North Carolina; University of North Carolina Chapel Hill; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Stanford University; Stanford University	George, NM (corresponding author), Univ N Carolina, Div Lab Anim Med, Dept Pathol & Lab Med, Chapel Hill, NC 27514 USA.	ngeorge@email.unc.edu	Garner, Joseph P/C-8422-2009	Bader, Michael/0000-0003-4780-4164	Timothy Foundation	Timothy Foundation	NMG JW DB and CAF received no specific funding for this work. JPG and JG were supported in part by the Timothy Foundation, a private nonprofit fund, whose strategic funding of Trichotillomania research is inspired by the prior head and founder of TLC, Christina Pearson, in recognition of her continuing dedication to reducing the suffering of those with Trichotillomania. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afshar H, 2012, J CLIN PSYCHOPHARM, V32, P797, DOI 10.1097/JCP.0b013e318272677d; ANDREWS AG, 1994, VET PATHOL, V31, P293, DOI 10.1177/030098589403100301; Bachmanov AA, 2002, BEHAV GENET, V32, P435, DOI 10.1023/A:1020884312053; Bechard A, 2011, J AM ASSOC LAB ANIM, V50, P171; Berman AE, 2011, ANN NEUROL, V69, P509, DOI 10.1002/ana.22162; Camfield DA, 2011, PROG NEURO-PSYCHOPH, V35, P887, DOI 10.1016/j.pnpbp.2011.02.011; Dufour BD, 2010, NEUROBIOLOGY GROOMIN; Dufour BD, 2010, NUTR NEUROSCI, V13, P256, DOI 10.1179/147683010X12611460764688; Ezell PC, 2012, J AM ASSOC LAB ANIM, V51, P609; Garner JP, 2011, BEHAV BRAIN RES, V219, P189, DOI 10.1016/j.bbr.2011.01.002; Garner JP, 2004, COMPARATIVE MED, V54, P216; Gaskill BN, 2011, THERMAL COMFORT MICE; Grant JE, 2012, AM J PSYCHIAT, V169, P1143, DOI 10.1176/appi.ajp.2012.12040508; Grant JE, 2009, ARCH GEN PSYCHIAT, V66, P756, DOI 10.1001/archgenpsychiatry.2009.60; Inagaki N, 2010, EUR J PHARMACOL, V626, P283, DOI 10.1016/j.ejphar.2009.09.043; Kassed CA, 2004, BEHAV BRAIN RES, V154, P577, DOI 10.1016/j.bbr.2004.03.026; Kastenmayer RJ, 2006, J AM ASSOC LAB ANIM, V45, P8; Mader JR, 2010, SCAND J LAB ANIM SCI, V37, P253; Miller JL, 2014, AM J MED GENET A, V164, P421, DOI 10.1002/ajmg.a.36306; Mischley LK, 2013, J ALTERN COMPLEM MED, V19, P459, DOI 10.1089/acm.2011.0673; Mischley LK, 2011, J ORTHOMOL MED, V26; Neuhaus B, 2012, EXP DERMATOL, V21, P712, DOI 10.1111/j.1600-0625.2012.01558.x; Ng F, 2008, INT J NEUROPSYCHOPH, V11, P851, DOI 10.1017/S1461145707008401; Odlaug BL, 2008, GEN HOSP PSYCHIAT, V30, P61, DOI 10.1016/j.genhosppsych.2007.07.009; Odlaug BL, 2007, J CLIN PSYCHOPHARM, V27, P227, DOI 10.1097/01.jcp.0000264976.86990.00; Odlaug BL, 2013, GEN HOSP PSYCHIAT, V35, P168, DOI 10.1016/j.genhosppsych.2012.08.006; Odlaug BL, 2010, AM J DRUG ALCOHOL AB, V36, P296, DOI 10.3109/00952991003747543; Ohmura T, 2004, EUR J PHARMACOL, V491, P191, DOI 10.1016/j.ejphar.2004.03.047; Perkins SN, 1998, J INVEST DERMATOL, V111, P292, DOI 10.1046/j.1523-1747.1998.00270.x; Richter SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016461; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Sims NR, 2004, J BIOENERG BIOMEMBR, V36, P329, DOI 10.1023/B:JOBB.0000041763.63958.e7; SUNDBERG JP, 1994, HDB MOUSE MUTATIONS, P485; Sundberg JP, 1996, PATHOBIOLOGY AGING M, P325; Tayebati SK, 2013, CURR PHARM DESIGN, V19, P510; Ullman-Cullere MH, 1999, LAB ANIM SCI, V49, P319; Vieira L.T. G., 2014, PREVENTING TREATING; Williams LK, 2012, COMPARATIVE MED, V62, P166; Williams-Fritze MJ, 2011, J AM ASSOC LAB ANIM, V50, P221	39	12	13	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0132092	10.1371/journal.pone.0132092	http://dx.doi.org/10.1371/journal.pone.0132092			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26167859	Green Published, Green Submitted, gold			2022-12-26	WOS:000358193100019
J	Hagel, KR; Beriont, J; Tessier, CR				Hagel, Kimberly R.; Beriont, Jane; Tessier, Charles R.			Drosophila Cbp53E Regulates Axon Growth at the Neuromuscular Junction	PLOS ONE			English	Article							CALCIUM-BINDING PROTEIN; CALRETININ-IMMUNOREACTIVE NEURONS; MENTAL-RETARDATION PROTEIN; MICE LACKING CALRETININ; MOTOR COORDINATION; ALZHEIMERS-DISEASE; CALBINDIN D28K; DENTATE GYRUS; CELLS; PARVALBUMIN	Calcium is a primary second messenger in all cells that functions in processes ranging from cellular proliferation to synaptic transmission. Proper regulation of calcium is achieved through numerous mechanisms involving channels, sensors, and buffers notably containing one or more EF-hand calcium binding domains. The Drosophila genome encodes only a single 6 EF-hand domain containing protein, Cbp53E, which is likely the prototypic member of a small family of related mammalian proteins that act as calcium buffers and calcium sensors. Like the mammalian homologs, Cbp53E is broadly though discretely expressed throughout the nervous system. Despite the importance of calcium in neuronal function and growth, nothing is known about Cbp53E's function in neuronal development. To address this deficiency, we generated novel null alleles of Drosophila Cbp53E and examined neuronal development at the well-characterized larval neuromuscular junction. Loss of Cbp53E resulted in increases in axonal branching at both peptidergic and glutamatergic neuronal terminals. This overgrowth could be completely rescued by expression of exogenous Cbp53E. Overexpression of Cbp53E, however, only affected the growth of peptidergic neuronal processes. These findings indicate that Cbp53E plays a significant role in neuronal growth and suggest that it may function in both local synaptic and global cellular mechanisms.	[Hagel, Kimberly R.; Beriont, Jane] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA; [Tessier, Charles R.] Indiana Univ Sch Med, Dept Med & Mol Genet, South Bend, IN 46617 USA	University of Notre Dame; Indiana University System; Indiana University South Bend	Tessier, CR (corresponding author), Indiana Univ Sch Med, Dept Med & Mol Genet, South Bend, IN 46617 USA.	crtessie@iupui.edu			Biomedical Research Enhancement Grant from Indiana University School of Medicine; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD018537] Funding Source: NIH RePORTER	Biomedical Research Enhancement Grant from Indiana University School of Medicine; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by a Biomedical Research Enhancement Grant from Indiana University School of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airaksinen MS, 1997, P NATL ACAD SCI USA, V94, P1488, DOI 10.1073/pnas.94.4.1488; Bachstetter AD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105191; Bastianelli E, 2003, CEREBELLUM, V2, P242, DOI 10.1080/14734220310022289; Bellido T, 2000, J BIOL CHEM, V275, P26328, DOI 10.1074/jbc.M003600200; Berggard T, 2002, J BIOL CHEM, V277, P16662, DOI 10.1074/jbc.M200415200; Bronner F, 2001, ScientificWorldJournal, V1, P919; CHARD PS, 1993, J PHYSIOL-LONDON, V472, P341, DOI 10.1113/jphysiol.1993.sp019950; Cheron G, 2000, PROG BRAIN RES, V124, P299; Choi JC, 2004, J NEUROPHYSIOL, V91, P2353, DOI 10.1152/jn.01115.2003; Coffee RL, 2010, DIS MODEL MECH, V3, P471, DOI 10.1242/dmm.004598; Craig AM, 2007, CURR OPIN NEUROBIOL, V17, P43, DOI 10.1016/j.conb.2007.01.011; Cukier HN, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000179; Diaz-Balzac CA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032689; Fahandejsaadi A, 2004, NEUROREPORT, V15, P443, DOI 10.1097/00001756-200403010-00012; FONSECA M, 1995, BRAIN RES, V691, P83, DOI 10.1016/0006-8993(95)00622-W; Franco B, 2004, J NEUROSCI, V24, P6573, DOI 10.1523/JNEUROSCI.1580-04.2004; Gall D, 2003, J NEUROSCI, V23, P9320; Gartner W, 2007, AM J PHYSIOL-ENDOC M, V293, pE347, DOI 10.1152/ajpendo.00055.2007; Gartner W, 2001, CEREB CORTEX, V11, P1161, DOI 10.1093/cercor/11.12.1161; Gilabert JA, 2012, ADV EXP MED BIOL, V740, P483, DOI 10.1007/978-94-007-2888-2_20; Goldberg JH, 2005, TRENDS NEUROSCI, V28, P158, DOI 10.1016/j.tins.2005.01.005; GORCZYCA M, 1993, J NEUROSCI, V13, P3692; Gulyas AI, 1996, J NEUROSCI, V16, P3397; Gurden H, 1998, EUR J NEUROSCI, V10, P3029, DOI 10.1111/j.1460-9568.1998.00373.x; Hofbauer A, 2009, J NEUROGENET, V23, P78, DOI 10.1080/01677060802471627; JOHANSEN J, 1989, J NEUROSCI, V9, P710; Kavalali ET, 2015, NAT REV NEUROSCI, V16, P5, DOI 10.1038/nrn3875; Keshishian H, 1996, ANNU REV NEUROSCI, V19, P545, DOI 10.1146/annurev.ne.19.030196.002553; Menon KP, 2013, WIRES DEV BIOL, V2, P647, DOI 10.1002/wdev.108; Metaxakis A, 2005, GENETICS, V171, P571, DOI 10.1534/genetics.105.041848; Miller DL, 2012, J NEUROSCI, V32, P13776, DOI 10.1523/JNEUROSCI.0508-12.2012; MONASTIRIOTI M, 1995, J COMP NEUROL, V356, P275, DOI 10.1002/cne.903560210; MOUATTPRIGENT A, 1994, BRAIN RES, V668, P62, DOI 10.1016/0006-8993(94)90511-8; Muqit MMK, 2002, NAT REV NEUROSCI, V3, P237, DOI 10.1038/nrn751; Odero GL, 2010, NEUROSCIENCE, V169, P532, DOI 10.1016/j.neuroscience.2010.04.004; PIKE CJ, 1995, BRAIN RES, V671, P293, DOI 10.1016/0006-8993(94)01354-K; REIFEGERSTE R, 1993, J NEUROSCI, V13, P2186; Rivlin PK, 2004, J COMP NEUROL, V468, P596, DOI 10.1002/cne.10977; ROGERS JH, 1992, BRAIN RES, V587, P147, DOI 10.1016/0006-8993(92)91439-L; Schiffmann SN, 1999, P NATL ACAD SCI USA, V96, P5257, DOI 10.1073/pnas.96.9.5257; Schwaller B, 1997, J BIOL CHEM, V272, P29663, DOI 10.1074/jbc.272.47.29663; Schwaller B, 2009, CELL MOL LIFE SCI, V66, P275, DOI 10.1007/s00018-008-8564-6; Schwaller Beat, 2002, Cerebellum, V1, P241, DOI 10.1080/147342202320883551; Schwaller B, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a004051; SLOVITER RS, 1991, J COMP NEUROL, V308, P381, DOI 10.1002/cne.903080306; Suo D, 2015, J NEUROSCI, V35, P3893, DOI 10.1523/JNEUROSCI.4402-14.2015; Tessier CR, 2008, DEVELOPMENT, V135, P1547, DOI 10.1242/dev.015867; Waites CL, 2011, TRENDS NEUROSCI, V34, P326, DOI 10.1016/j.tins.2011.03.004; Westerink RHS, 2012, BRAIN RES, V1450, P1, DOI 10.1016/j.brainres.2012.02.036; Wu Y, 2008, P NATL ACAD SCI USA, V105, P12399, DOI 10.1073/pnas.0805291105; Yuan HH, 2013, MOL NEUROBIOL, V47, P117, DOI 10.1007/s12035-012-8332-3; Zhang YQ, 2001, CELL, V107, P591, DOI 10.1016/S0092-8674(01)00589-X	52	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0132636	10.1371/journal.pone.0132636	http://dx.doi.org/10.1371/journal.pone.0132636			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26167908	gold, Green Published, Green Submitted			2022-12-26	WOS:000358193100060
J	Nagaoka, K; Matoba, T; Mao, YJ; Nakano, Y; Ikeda, G; Egusa, S; Tokutome, M; Nagahama, R; Nakano, K; Sunagawa, K; Egashira, K				Nagaoka, Kazuhiro; Matoba, Tetsuya; Mao, Yajing; Nakano, Yasuhiro; Ikeda, Gentaro; Egusa, Shizuka; Tokutome, Masaki; Nagahama, Ryoji; Nakano, Kaku; Sunagawa, Kenji; Egashira, Kensuke			A New Therapeutic Modality for Acute Myocardial Infarction: Nanoparticle-Mediated Delivery of Pitavastatin Induces Cardioprotection from Ischemia-Reperfusion Injury via Activation of PI3K/Akt Pathway and Anti-Inflammation in a Rat Model	PLOS ONE			English	Article							MITOCHONDRIAL PERMEABILITY TRANSITION; GLYCOGEN-SYNTHASE KINASE-3-BETA; INDUCED CARDIOMYOCYTE APOPTOSIS; CELLULAR BIOLOGY; OXIDATIVE STRESS; EUROPEAN-SOCIETY; WORKING GROUP; MICE; ISCHEMIA/REPERFUSION; MONOCYTES	Aim There is an unmet need to develop an innovative cardioprotective modality for acute myocardial infarction (AMI), for which the effectiveness of interventional reperfusion therapy is hampered by myocardial ischemia-reperfusion (IR) injury. Pretreatment with statins before ischemia is shown to reduce MI size in animals. However, no benefit was found in animals and patients with AMI when administered at the time of reperfusion, suggesting insufficient drug targeting into the IR myocardium. Here we tested the hypothesis that nanoparticle-mediated targeting of pitavastatin protects the heart from IR injury. Methods and Results In a rat IR model, poly(lactic acid/glycolic acid) (PLGA) nanoparticle incorporating FITC accumulated in the IR myocardium through enhanced vascular permeability, and in CD11b-positive leukocytes in the IR myocardium and peripheral blood after intravenous treatment. Intravenous treatment with PLGA nanoparticle containing pitavastatin (Pitavastatin-NP, 1 mg/kg) at reperfusion reduced MI size after 24 hours and ameliorated left ventricular dysfunction 4-week after reperfusion; by contrast, pitavastatin alone (as high as 10 mg/kg) showed no therapeutic effects. The therapeutic effects of Pitavastatin-NP were blunted by a PI3K inhibitor wortmannin, but not by a mitochondrial permeability transition pore inhibitor cyclosporine A. Pitavastatin-NP induced phosphorylation of Akt and GSK3 beta, and inhibited inflammation and cardiomyocyte apoptosis in the IR myocardium. Conclusions Nanoparticle-mediated targeting of pitavastatin induced cardioprotection from IR injury by activation of PI3K/Akt pathway and inhibition of inflammation and cardiomyocyte death in this model. This strategy can be developed as an innovative cardioprotective modality that may advance currently unsatisfactory reperfusion therapy for AMI.	[Nagaoka, Kazuhiro; Matoba, Tetsuya; Mao, Yajing; Nakano, Yasuhiro; Ikeda, Gentaro; Tokutome, Masaki; Sunagawa, Kenji; Egashira, Kensuke] Kyushu Univ, Grad Sch Med Sci, Dept Cardiovasc Med, Fukuoka 812, Japan; [Egusa, Shizuka; Nagahama, Ryoji; Nakano, Kaku; Egashira, Kensuke] Kyushu Univ, Grad Sch Med Sci, Dept Cardiovasc Res Dev & Translat Med, Fukuoka 812, Japan	Kyushu University; Kyushu University	Egashira, K (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Cardiovasc Med, Fukuoka 812, Japan.	egashira@cardiol.med.kyushu-u.ac.jp	Ikeda, Gentaro/AAC-4164-2022	Ikeda, Gentaro/0000-0003-4019-8990; Matoba, Tetsuya/0000-0003-4563-304X	Ministry of Education, Science, and Culture, Tokyo, Japan; Health Science Research Grants (Research on Translational Research, Intractable Diseases, and Nanomedicine) from the Ministry of Health Labor and Welfare, Tokyo, Japan; Japanese Government; Sentan Medical Inc	Ministry of Education, Science, and Culture, Tokyo, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Health Science Research Grants (Research on Translational Research, Intractable Diseases, and Nanomedicine) from the Ministry of Health Labor and Welfare, Tokyo, Japan; Japanese Government; Sentan Medical Inc	This study was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Science, and Culture, Tokyo, Japan and by Health Science Research Grants (Research on Translational Research, Intractable Diseases, and Nanomedicine) from the Ministry of Health Labor and Welfare, Tokyo, Japan. Dr. Egashira reports grant support from the Japanese Government as mentioned above to conduct this study, and personal fees from Sentan Medical Inc outside the submitted work. The specific roles of these authors are articulated in the 'author contributions' section.	Acharya S, 2011, ADV DRUG DELIVER REV, V63, P170, DOI 10.1016/j.addr.2010.10.008; Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Becatti M, 2012, CELL MOL LIFE SCI, V69, P2245, DOI 10.1007/s00018-012-0925-5; Bergmann MW, 2004, J MOL CELL CARDIOL, V37, P681, DOI 10.1016/j.yjmcc.2004.05.025; Chen L, 2011, HYPERTENSION, V57, P343, DOI 10.1161/HYPERTENSIONAHA.110.157032; DAUBER IM, 1990, CIRC RES, V66, P986, DOI 10.1161/01.RES.66.4.986; Downey JM, 2009, CIRC J, V73, P1171, DOI 10.1253/circj.CJ-09-0338; Egashira K, 2003, HYPERTENSION, V41, P834, DOI 10.1161/01.HYP.0000051642.65283.36; Frangogiannis NG, 2002, CARDIOVASC RES, V53, P31, DOI 10.1016/S0008-6363(01)00434-5; Gomez L, 2008, CIRCULATION, V117, P2761, DOI 10.1161/CIRCULATIONAHA.107.755066; Gong R, 2008, AM J TRANSPLANT, V8, P1852, DOI 10.1111/j.1600-6143.2008.02319.x; Hausenloy DJ, 2013, CARDIOVASC RES, V98, P7, DOI 10.1093/cvr/cvt004; Hayasaki T, 2006, CIRC J, V70, P342, DOI 10.1253/circj.70.342; Jones SP, 2002, J AM COLL CARDIOL, V40, P1172, DOI 10.1016/S0735-1097(02)02115-0; Jones SP, 2001, ARTERIOSCL THROM VAS, V21, P2059, DOI 10.1161/hq1201.099509; Juhaszova M, 2004, J CLIN INVEST, V113, P1535, DOI 10.1172/JCI200419906; Katsuki S, 2014, CIRCULATION, V129, P896, DOI 10.1161/CIRCULATIONAHA.113.002870; Kawaguchi M, 2011, CIRCULATION, V123, P594, DOI 10.1161/CIRCULATIONAHA.110.982777; Kim AH, 2001, MOL CELL BIOL, V21, P893, DOI 10.1128/MCB.21.3.893-901.2001; Kimura S, 2008, CIRCULATION, V118, pS65, DOI 10.1161/CIRCULATIONAHA.107.740613; Kimura S, 2009, HYPERTENSION, V53, P877, DOI 10.1161/HYPERTENSIONAHA.108.121418; Kinugawa S, 2000, CIRC RES, V87, P392; Kocsis GF, 2008, AM J PHYSIOL-HEART C, V294, pH2406, DOI 10.1152/ajpheart.00862.2007; Kubo M, 2009, ARTERIOSCL THROM VAS, V29, P796, DOI 10.1161/ATVBAHA.108.182584; Lal H, 2012, CIRCULATION, V125, P65, DOI 10.1161/CIRCULATIONAHA.111.050666; Lefer AM, 1999, CIRCULATION, V100, P178, DOI 10.1161/01.CIR.100.2.178; Leuschner F, 2011, NAT BIOTECHNOL, V29, P1005, DOI 10.1038/nbt.1989; Lewis EF, 2003, J AM COLL CARDIOL, V42, P1446, DOI 10.1016/S0735-1097(03)01057-X; Lin MJ, 2013, ELIFE, V2, DOI 10.7554/eLife.01295; Linseman DA, 2004, J NEUROSCI, V24, P9993, DOI 10.1523/JNEUROSCI.2057-04.2004; Matsuki A, 2006, CIRC J, V70, P1643, DOI 10.1253/circj.70.1643; Monceau V, 2006, AM J PHYSIOL-HEART C, V291, pH965, DOI 10.1152/ajpheart.01053.2005; Nagahama R, 2012, ARTERIOSCLER THROMB; Nahrendorf M, 2010, CIRCULATION, V121, P2437, DOI 10.1161/CIRCULATIONAHA.109.916346; Nakano K, 2009, JACC-CARDIOVASC INTE, V2, P277, DOI 10.1016/j.jcin.2008.08.023; Oda S, 2010, J VASC SURG, V52, P412, DOI 10.1016/j.jvs.2010.03.020; Okumura H, 2004, CIRCULATION, V109, P242, DOI 10.1161/01.CIR.0000109214.30211.7C; Ovize M, 2010, CARDIOVASC RES, V87, P406, DOI 10.1093/cvr/cvq129; Patti G, 2007, J AM COLL CARDIOL, V49, P1272, DOI 10.1016/j.jacc.2007.02.025; Post S, 2012, CATHETER CARDIOVASC; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Sanada S, 2004, CIRCULATION, V110, P2143, DOI 10.1161/01.CIR.0000143830.59419.73; Sitniewska EM, 2001, REGUL PEPTIDES, V96, P105, DOI 10.1016/S0167-0115(00)00131-2; Steffens S, 2009, THROMB HAEMOSTASIS, V102, P240, DOI 10.1160/TH08-12-0837; Takahama H, 2009, J AM COLL CARDIOL, V53, P709, DOI 10.1016/j.jacc.2008.11.014; Tsukie N, 2013, J ATHEROSCLER THROMB, V20, P32, DOI 10.5551/jat.13862; Tuuminen R, 2011, CIRCULATION, V124, P1138, DOI 10.1161/CIRCULATIONAHA.110.005249; Wang XL, 2007, APOPTOSIS, V12, P1209, DOI 10.1007/s10495-007-0055-y; Xi JK, 2009, EUR J PHARMACOL, V604, P111, DOI 10.1016/j.ejphar.2008.12.024; Yellon DM, 2007, NEW ENGL J MED, V357, P1121, DOI 10.1056/NEJMra071667; Zhai PY, 2011, CIRC RES, V109, P502, DOI 10.1161/CIRCRESAHA.111.249532; Zhao ZQ, 2001, APOPTOSIS, V6, P279, DOI 10.1023/A:1011335525219	52	66	69	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0132451	10.1371/journal.pone.0132451	http://dx.doi.org/10.1371/journal.pone.0132451			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26167913	gold, Green Published, Green Accepted, Green Submitted			2022-12-26	WOS:000358193100044
J	Oliveira, A; Leite, M; Kluskens, LD; Santos, SB; Melo, LDR; Azeredo, J				Oliveira, Ana; Leite, Marta; Kluskens, Leon D.; Santos, Slvio B.; Melo, Luis D. R.; Azeredo, Joana			The First Paenibacillus larvae Bacteriophage Endolysin (PlyPl23) with High Potential to Control American Foulbrood	PLOS ONE			English	Article							HONEY-BEES; AGENT	Endolysins, which are peptidoglycan-degrading enzymes expressed during the terminal stage of the reproduction cycle of bacteriophages, have great potential to control Gram-positive pathogens. This work describes the characterization of a novel endolysin (PlyPl23) encoded on the genome of Paenibacillus larvae phage phiIBB_Pl23 with high potential to control American foulbrood. This bacterial disease, caused by P. larvae, is widespread in North America and Europe and causes important economic losses in apiculture. The restriction to antibiotic residues in honey imposed by the EU legislation hinders its therapeutic use to combat American foulbrood and enforces the development of alternative antimicrobial methods. The new endolysin described herein has an N-acetylmuramoyl-L-alanine amidase catalytic domain and exhibits a broad-spectrum activity against common P. larvae genotypes. Moreover, the enzyme displays high antimicrobial activity in a range of pH that matches environmental conditions (pH between 5.0 and 7.0), showing its feasible application in the field. At pH 7.0, a concentration of 0.2 mu M of enzyme was enough to lyse 10(4) CFU.mL(-1) of P. larvae in no more than 2 h. The presence of sucrose and of the substances present in the larvae gut content did not affect the enzyme activity. Interestingly, an increase of activity was observed when PlyPl23 was previously incubated in royal jelly. Furthermore, in vivo safety evaluation assays demonstrated that this enzyme is not toxic to the bee larvae. The present work describes for the first time an endolysin encoded in a P. larvae phage that presents high potential to integrate a commercial product to control the problematic American foulbrood.	[Oliveira, Ana; Leite, Marta; Kluskens, Leon D.; Santos, Slvio B.; Melo, Luis D. R.; Azeredo, Joana] Univ Minho, CEB Ctr Biol Engn, P-4710057 Braga, Portugal	Universidade do Minho	Oliveira, A (corresponding author), Univ Minho, CEB Ctr Biol Engn, P-4710057 Braga, Portugal.	anaoliveira@deb.uminho.pt	Santos, Silvio/O-5491-2015; Melo, Luís/O-5488-2015; Kluskens, Leon/J-3019-2013	Santos, Silvio/0000-0003-0801-8080; Melo, Luís/0000-0002-6865-6044; Leite, Marta/0000-0002-4438-4662; Azeredo, Joana/0000-0002-5180-7133; Oliveira, Ana/0000-0002-6477-5345; Kluskens, Leon/0000-0002-0070-7837	Portuguese FCT-Foundation for Science and Technology [UID/BIO/04469/2013]; European Community fund FEDER [FCOMP-01-0124-FEDER-007025 (PTDC/AMB/68393/2006), PEst-OE/EQB/LA0023/2013, PEST-C/FIS/UI607/2013, RECI/BBB-EBI/0179/2012 (FCOMP-01-0124-FEDER-027462)]; FCT-Fundacao para a Ciencia e Tecnologia [SFRH/BPD/69356/2010, SFRH/BPD/75311/2010]; Fundação para a Ciência e a Tecnologia [RECI/BBB-EBI/0179/2012, PTDC/AMB/68393/2006] Funding Source: FCT	Portuguese FCT-Foundation for Science and Technology(Portuguese Foundation for Science and Technology); European Community fund FEDER(European Commission); FCT-Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and Technology); Fundação para a Ciência e a Tecnologia	This study was supported by the Portuguese FCT-Foundation for Science and Technology (http://www.fct.pt) strategic funding of UID/BIO/04469/2013 unit and the European Community fund FEDER, through Program COMPETE, under the scope of the Projects FCOMP-01-0124-FEDER-007025 (PTDC/AMB/68393/2006), PEst-OE/EQB/LA0023/2013, PEST-C/FIS/UI607/2013, RECI/BBB-EBI/0179/2012 (FCOMP-01-0124-FEDER-027462). Ana Oliveira was supported by the grant SFRH/BPD/69356/2010 and Silvio B. Santos was supported by the grant SFRH/BPD/75311/2010, both from the FCT-Fundacao para a Ciencia e Tecnologia (http://www.fct.pt). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Alvarado I, 2013, J BACTERIOL, V195, P1005, DOI 10.1128/JB.01958-12; Aupinel Pierrick, 2005, Bulletin of Insectology, V58, P107; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Beynen AC, 2003, PRINCIPLES LAB ANIMA, P219; Bilikova K, 2001, APIDOLOGIE, V32, P275, DOI 10.1051/apido:2001129; Bogdanov S., 2014, BEE PRODUCT SCI, P1; BROUWERS EVM, 1987, J APICULT RES, V26, P11, DOI 10.1080/00218839.1987.11100729; Dobbelaere W, 2001, APIDOLOGIE, V32, P363, DOI 10.1051/apido:2001136; Fischetti VA, 2005, TRENDS MICROBIOL, V13, P491, DOI 10.1016/j.tim.2005.08.007; Fischetti VA, 2008, CURR OPIN MICROBIOL, V11, P393, DOI 10.1016/j.mib.2008.09.012; Fischetti VA, 2006, NAT BIOTECHNOL, V24, P1508, DOI 10.1038/nbt1206-1508; Forsgren E, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.1.12; Forsgren E, 2010, APIDOLOGIE, V41, P99, DOI 10.1051/apido/2009065; Genersch E, 2003, APIDOLOGIE, V34, P195, DOI 10.1051/apido:2003025; Genersch E, 2010, J INVERTEBR PATHOL, V103, pS10, DOI 10.1016/j.jip.2009.06.015; Gerova M, 2011, FEMS MICROBIOL LETT, V321, P83, DOI 10.1111/j.1574-6968.2011.02312.x; Hansen H, 1999, BEE WORLD, V80, P5, DOI 10.1080/0005772X.1999.11099415; Hildebrand A, 2009, PROTEINS, V77, P128, DOI 10.1002/prot.22499; Il'iasov R A, 2012, Zh Evol Biokhim Fiziol, V48, P425; Kaftanoglu O, 2011, J INSECT SCI, V11, DOI 10.1673/031.011.9601; Kochansky J, 2001, APIDOLOGIE, V32, P215, DOI 10.1051/apido:2001123; Marchler-Bauer A, 2013, NUCLEIC ACIDS RES, V41, pD348, DOI 10.1093/nar/gks1243; Merrill BD, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-745; Oliveira A, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00438-13; Oliveira H, 2013, J VIROL, V87, P4558, DOI 10.1128/JVI.03277-12; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pujirahayu N., 2014, INT J PHARM PHARM SC, V6, P338; SACKS LE, 1961, J BACTERIOL, V82, P331, DOI 10.1128/JB.82.3.331-341.1961; Schaeffer A B, 1933, Science, V77, P194, DOI 10.1126/science.77.1990.194; Schmelcher M, 2012, FUTURE MICROBIOL, V7, P1147, DOI [10.2217/fmb.12.97, 10.2217/FMB.12.97]; Schuch R, 2002, NATURE, V418, P884, DOI 10.1038/nature01026; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Titera D, 2003, APIACTA, V38, P131; Turck M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030403; Viuda-Martos M, 2008, J FOOD SCI, V73, pR117, DOI 10.1111/j.1750-3841.2008.00966.x; WALLER GD, 1972, ANN ENTOMOL SOC AM, V65, P857, DOI 10.1093/aesa/65.4.857; Walmagh M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036991; Yue D, 2008, ENVIRON MICROBIOL, V10, P1612, DOI 10.1111/j.1462-2920.2008.01579.x	39	20	21	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0132095	10.1371/journal.pone.0132095	http://dx.doi.org/10.1371/journal.pone.0132095			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26167894	Green Published, gold, Green Submitted			2022-12-26	WOS:000358193100020
J	Tilson, SG; Haley, EM; Triantafillu, UL; Dozier, DA; Langford, CP; Gillespie, GY; Kim, Y				Tilson, Samantha G.; Haley, Elizabeth M.; Triantafillu, Ursula L.; Dozier, David A.; Langford, Catherine P.; Gillespie, G. Yancey; Kim, Yonghyun			ROCK Inhibition Facilitates In Vitro Expansion of Glioblastoma Stem-Like Cells	PLOS ONE			English	Article							RHO/ROCK PATHWAY; SELF-RENEWAL; MODELS; MAINTENANCE; APOPTOSIS; SURVIVAL; TUMORS; LINES	Due to their stem-like characteristics and their resistance to existing chemo-and radiation therapies, there is a growing appreciation that cancer stem cells (CSCs) are the root cause behind cancer metastasis and recurrence. However, these cells represent a small subpopulation of cancer cells and are difficult to propagate in vitro. Glioblastoma is an extremely deadly form of brain cancer that is hypothesized to have a subpopulation of CSCs called glioblastoma stem cells (GSCs; also called brain tumor initiating cells, BTICs). We propose the use of selective Rho-kinase (ROCK) inhibitors, Y-27632 and fasudil, to promote GSC/BTIC-like cell survival and propagation in vitro. ROCK inhibitors have been implicated in suppressing apoptosis, and it was hypothesized that they would increase the number of GSC/BTIC-like cells grown in vitro and improve cloning efficiencies. Indeed, our data demonstrate that transient and continuous supplementation of non-toxic concentrations of Y-27632 and fasudil inhibited apoptosis, enhanced the cells' ability to form spheres, and increased stem cell marker expressing GSC/BTIC-like cell subpopulation. Our data indicated that pharmacological and genetic (siRNA) inhibitions of the ROCK pathway facilitates in vitro expansion of GSC/BTIC-like cells. Thus, ROCK pathway inhibition shows promise for future optimization of CSC culture media.	[Tilson, Samantha G.; Haley, Elizabeth M.; Triantafillu, Ursula L.; Dozier, David A.; Kim, Yonghyun] Univ Alabama, Dept Chem & Biol Engn, Tuscaloosa, AL 35401 USA; [Langford, Catherine P.; Gillespie, G. Yancey] Univ Alabama Birmingham, Dept Neurosurg, Birmingham, AL USA	University of Alabama System; University of Alabama Tuscaloosa; University of Alabama System; University of Alabama Birmingham	Kim, Y (corresponding author), Univ Alabama, Dept Chem & Biol Engn, Tuscaloosa, AL 35401 USA.	ykim@eng.ua.edu	Kim, John/A-7234-2008	Kim, John/0000-0001-6344-1258; Muccilli, Samantha/0000-0001-6318-5784; Gillespie, George/0000-0001-6436-9542	National Science Foundation [1342388]; National Institutes of Health [P20 CA151129]; Howard Hughes Medical Institute Undergraduate Science Education grant; Directorate For Engineering [1342388] Funding Source: National Science Foundation; NATIONAL CANCER INSTITUTE [P20CA151129] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute Undergraduate Science Education grant; Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This material is based upon work supported by the National Science Foundation (http://www.nsf.gov) Grant 1342388 (YK) and National Institutes of Health (http://www.nih.gov) Grant P20 CA151129 (GYG). Any opinions, findings, and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the National Science Foundation or the National Institutes of Health. The authors are also grateful for the support from the 2010 Howard Hughes Medical Institute Undergraduate Science Education grant to The University of Alabama (http://bsc.ua.edu/howard-hughes-medical-institute-program/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2004, CURR OPIN GENET DEV, V14, P43, DOI 10.1016/j.gde.2003.11.007; Asin L, 2012, PHARM RES-DORDR, V29, P1319, DOI 10.1007/s11095-012-0710-z; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Carlson Brett L, 2011, Curr Protoc Pharmacol, VChapter 14, DOI 10.1002/0471141755.ph1416s52; Castro DJ, 2013, STEM CELLS, V31, P12, DOI 10.1002/stem.1224; Cho KJ, 2008, CLIN CANCER RES, V14, P1310, DOI 10.1158/1078-0432.CCR-07-1441; Domcke S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3126; Flavahan WA, 2013, NAT NEUROSCI, V16, P1373, DOI 10.1038/nn.3510; Friedman GK, 2009, J NEURO-ONCOL, V95, P199, DOI 10.1007/s11060-009-9926-0; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Gangemi RMR, 2009, STEM CELLS, V27, P40, DOI 10.1634/stemcells.2008-0493; Heddleston JM, 2011, CURR PHARM DESIGN, V17, P2386; Hulikova A, 2013, J CELL PHYSIOL, V228, P743, DOI 10.1002/jcp.24221; Joo KM, 2013, CELL REP, V3, P260, DOI 10.1016/j.celrep.2012.12.013; Kim Yonghyun, 2009, Int J Stem Cells, V2, P109; Kim Y, 2012, LAB INVEST, V92, P466, DOI 10.1038/labinvest.2011.161; Koyanagi M, 2008, J NEUROSCI RES, V86, P270, DOI 10.1002/jnr.21502; Krawetz RJ, 2009, BIOESSAYS, V31, P336, DOI 10.1002/bies.200800157; Lau CL, 2011, BRIT J PHARMACOL, V163, P533, DOI 10.1111/j.1476-5381.2011.01259.x; Lau CL, 2012, J CELL PHYSIOL, V227, P1199, DOI 10.1002/jcp.22838; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Merchant TE, 2008, PEDIATR BLOOD CANCER, V51, P110, DOI 10.1002/pbc.21530; Ohata H, 2012, CANCER RES, V72, P5101, DOI 10.1158/0008-5472.CAN-11-3812; Ohgushi M, 2010, CELL STEM CELL, V7, P225, DOI 10.1016/j.stem.2010.06.018; Rattan R, 2006, J NEUROSCI RES, V83, P243, DOI 10.1002/jnr.20707; Rich JN, 2007, CANCER RES, V67, P8980, DOI 10.1158/0008-5472.CAN-07-0895; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Routhier A, 2010, ONCOL REP, V23, P861, DOI 10.3892/or_00000708; Santini R, 2014, ONCOGENE, V33, P4697, DOI 10.1038/onc.2014.71; Singh SK, 2004, ONCOGENE, V23, P7267, DOI 10.1038/sj.onc.1207946; Singh SK, 2003, CANCER RES, V63, P5821; Vanner RJ, 2014, CANCER CELL, V26, P33, DOI 10.1016/j.ccr.2014.05.005; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Zhang LJ, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0028432, 10.1371/journal.pone.0020963, 10.1371/journal.pone.0026129, 10.1371/journal.pone.0028953]; Zohrabian VM, 2009, ANTICANCER RES, V29, P119	35	23	25	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0132823	10.1371/journal.pone.0132823	http://dx.doi.org/10.1371/journal.pone.0132823			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26167936	gold, Green Published, Green Submitted			2022-12-26	WOS:000358193100085
J	Schmidt, T; Brodesser, A; Schnitzler, N; Gruger, T; Brandenburg, K; Zinserling, J; Zundorf, J				Schmidt, Thomas; Brodesser, Alva; Schnitzler, Norbert; Grueger, Thomas; Brandenburg, Kerstin; Zinserling, Joerg; Zuendorf, Josef			CD66b Overexpression and Loss of C5a Receptors as Surface Markers for Staphylococcus aureus-Induced Neutrophil Dysfunction	PLOS ONE			English	Article							PERIPHERAL-BLOOD NEUTROPHILS; LIPOTEICHOIC ACID; INNATE IMMUNITY; SEVERE SEPSIS; GENE FAMILY; ACTIVATION; EXPRESSION; PEPTIDOGLYCAN; GRANULOCYTE; INTEGRINS	Neutrophil granulocytes constitute the main component of innate immunity in the clearance of bacterial infections. However, during systemic inflammation, immunoparalysis may occur resulting in neutrophil dysfunction. This study presents a new in vitro model for analyzing the dysfunction of human peripheral blood neutrophils resulting from the interaction with Staphylococcus aureus components in whole blood. After induction of a massive complement activation by S. aureus supernatant, the neutrophils exhibit a reduced phagocytic capacity resulting in a dramatic reduction of the antibacterial activity similar to that of neutrophils isolated from septic patients. The number of phagocytozing neutrophils is drastically reduced as well as the phagocytic capacity designated by a significantly lower number of ingested microbes. This dysfunction correlates with the loss of complement component 5a receptor 1 from the neutrophil cell surface and can be further characterized by a C5a-induced CD66b overexpression. The presented in vitro model offers a new platform for preclinical testing of immunosuppressive drugs and delivers new information for the understanding of neutrophil dysfunctions under the conditions described.	[Schmidt, Thomas] Univ Marburg, Dept Dermatol, Marburg, Germany; [Brodesser, Alva; Grueger, Thomas; Brandenburg, Kerstin; Zuendorf, Josef] Fed Inst Drugs & Med Devices, Biosafety Lab L2, Bonn, Germany; [Schnitzler, Norbert] Gesundheitsamt Kreises Duren, Duren, Germany; [Zinserling, Joerg] Fed Inst Drugs & Med Devices, Biostat Unit, Bonn, Germany	Philipps University Marburg	Zundorf, J (corresponding author), Fed Inst Drugs & Med Devices, Biosafety Lab L2, Bonn, Germany.	josef.zuendorf@bfarm.de			BfArM, Bonn, Germany	BfArM, Bonn, Germany	This work was entirely funded by BfArM, Bonn, Germany.	Adib-Conquy M, 2007, FEBS LETT, V581, P3723, DOI 10.1016/j.febslet.2007.03.074; Alves JC, 2005, MEM I OSWALDO CRUZ, V100, P223, DOI 10.1590/S0074-02762005000900038; Alves JC, 2010, SHOCK, V34, P15, DOI 10.1097/SHK.0b013e3181e7e61b; Bamberg CE, 2010, J BIOL CHEM, V285, P7633, DOI 10.1074/jbc.M109.092106; Borregaard N, 1997, BLOOD, V89, P3503, DOI 10.1182/blood.V89.10.3503.3503_3503_3521; DEKIMPE SJ, 1995, P NATL ACAD SCI USA, V92, P10359, DOI 10.1073/pnas.92.22.10359; DUCKER TP, 1992, J LEUKOCYTE BIOL, V52, P11, DOI 10.1002/jlb.52.1.11; ELSAKKA N, 2006, CRIT CARE SHOCK, V9, P9; FASANO MB, 1991, J CLIN INVEST, V88, P1452, DOI 10.1172/JCI115454; Fukuoka Y, 1998, BIOCHEM BIOPH RES CO, V242, P663, DOI 10.1006/bbrc.1997.8034; Furebring M, 2006, SCAND J IMMUNOL, V63, P208, DOI 10.1111/j.1365-3083.2006.01724.x; Furebring M, 2002, CRIT CARE, V6, P363, DOI 10.1186/cc1524; GRANOWITZ EV, 1994, J INFECT DIS, V169, P480, DOI 10.1093/infdis/169.2.480; Gruger T, 2012, CHEMOTHERAPY, V58, P206, DOI 10.1159/000338390; Guo RF, 2003, FASEB J, V17, P1889, DOI 10.1096/fj.03-0009fje; Guo RF, 2005, ANNU REV IMMUNOL, V23, P821, DOI 10.1146/annurev.immunol.23.021704.115835; Hawkins PT, 2010, CURR TOP MICROBIOL, V346, P183, DOI 10.1007/82_2010_40; Hoarau C, 2007, J IMMUNOL, V179, P4754, DOI 10.4049/jimmunol.179.7.4754; Huber-Lang M, 2001, J IMMUNOL, V166, P1193, DOI 10.4049/jimmunol.166.2.1193; Huber-Lang MS, 2002, J IMMUNOL, V169, P3223, DOI 10.4049/jimmunol.169.6.3223; Kaufmann I, 2006, SHOCK, V26, P254, DOI 10.1097/01.shk.0000223131.64512.7a; Kobold ACM, 2000, INTENS CARE MED, V26, P883, DOI 10.1007/s001340051277; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Marc MM, 2010, SCAND J IMMUNOL, V71, P386, DOI 10.1111/j.1365-3083.2010.02385.x; Martins PS, 2008, CRIT CARE, V12, DOI 10.1186/cc6801; Morris AC, 2011, BLOOD, V117, P5178, DOI 10.1182/blood-2010-08-304667; Morris AC, 2009, AM J RESP CRIT CARE, V180, P19, DOI 10.1164/rccm.200812-1928OC; NAKAE H, 1994, RES COMMUN CHEM PATH, V84, P189; Paulsen J, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0849-4; Presneill JJ, 2002, AM J RESP CRIT CARE, V166, P138, DOI 10.1164/rccm.2009005; Reddy RC, 2008, BLOOD, V112, P4250, DOI 10.1182/blood-2007-12-128967; Rittirsch D, 2008, NAT REV IMMUNOL, V8, P776, DOI 10.1038/nri2402; Schmidt T, 2013, CLIN MICROBIOL INFEC, V19, P279, DOI 10.1111/j.1469-0691.2012.03775.x; Schmidt T, 2012, J LEUKOCYTE BIOL, V91, P791, DOI 10.1189/jlb.0911483; Schnitzler N, 1999, NAT MED, V5, P231, DOI 10.1038/5597; Schwandner R, 1999, J BIOL CHEM, V274, P17406, DOI 10.1074/jbc.274.25.17406; Scola AM, 2009, MOL IMMUNOL, V46, P1149, DOI 10.1016/j.molimm.2008.11.001; Tan SM, 2012, BIOSCIENCE REP, V32, P241, DOI 10.1042/BSR20110101; TELLADO JM, 1991, J LEUKOCYTE BIOL, V50, P547, DOI 10.1002/jlb.50.6.547; THOMPSON JA, 1991, J CLIN LAB ANAL, V5, P344, DOI 10.1002/jcla.1860050510; Torsteinsdottir I, 1999, SCAND J IMMUNOL, V50, P433, DOI 10.1046/j.1365-3083.1999.00602.x; van den Berg CW, 2014, J IMMUNOL, V192, P1787, DOI 10.4049/jimmunol.1301920; Ward PA, 2010, J INNATE IMMUN, V2, P439, DOI 10.1159/000317194; Zhou GQ, 2001, GENE, V264, P105, DOI 10.1016/S0378-1119(00)00595-3	44	15	16	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132703	10.1371/journal.pone.0132703	http://dx.doi.org/10.1371/journal.pone.0132703			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176669	Green Submitted, gold, Green Published			2022-12-26	WOS:000358197600143
J	Ayaru, L; Ypsilantis, PP; Nanapragasam, A; Choi, RCH; Thillanathan, A; Min-Ho, L; Montana, G				Ayaru, Lakshmana; Ypsilantis, Petros-Pavlos; Nanapragasam, Abigail; Choi, Ryan Chang-Ho; Thillanathan, Anish; Min-Ho, Lee; Montana, Giovanni			Prediction of Outcome in Acute Lower Gastrointestinal Bleeding Using Gradient Boosting	PLOS ONE			English	Article							MANAGEMENT; MORTALITY; VALIDATION; HEMORRHAGE; IMPACT; RISK	Background There are no widely used models in clinical care to predict outcome in acute lower gastrointestinal bleeding (ALGIB). If available these could help triage patients at presentation to appropriate levels of care/intervention and improve medical resource utilisation. We aimed to apply a state-of-the-art machine learning classifier, gradient boosting (GB), to predict outcome in ALGIB using non-endoscopic measurements as predictors. Methods Non-endoscopic variables from patients with ALGIB attending the emergency departments of two teaching hospitals were analysed retrospectively for training/internal validation (n=170) and external validation (n=130) of the GB model. The performance of the GB algorithm in predicting recurrent bleeding, clinical intervention and severe bleeding was compared to a multiple logic regression (MLR) model and two published MLR-based prediction algorithms (BLEED and Strate prediction rule). Results The GB algorithm had the best negative predictive values for the chosen outcomes (>88%). On internal validation the accuracy of the GB algorithm for predicting recurrent bleeding, therapeutic intervention and severe bleeding were (88%, 88% and 78% respectively) and superior to the BLEED classification (64%, 68% and 63%), Strate prediction rule (78%, 78%, 67%) and conventional MLR (74%, 74% 62%). On external validation the accuracy was similar to conventional MLR for recurrent bleeding (88% vs. 83%) and therapeutic intervention (91% vs. 87%) but superior for severe bleeding (83% vs. 71%). Conclusion The gradient boosting algorithm accurately predicts outcome in patients with acute lower gastrointestinal bleeding and outperforms multiple logistic regression based models. These may be useful for risk stratification of patients on presentation to the emergency department.	[Ayaru, Lakshmana; Nanapragasam, Abigail; Choi, Ryan Chang-Ho; Thillanathan, Anish; Min-Ho, Lee] Imperial Coll Healthcare NHS Trust, Charing Cross Hosp, Dept Gastroenterol, London, England; [Ayaru, Lakshmana; Nanapragasam, Abigail; Choi, Ryan Chang-Ho; Thillanathan, Anish; Min-Ho, Lee] Imperial Coll Healthcare NHS Trust, Hammersmith Hosp, London, England; [Ypsilantis, Petros-Pavlos; Montana, Giovanni] Kings Coll London, Dept Biomed Engn, London, England	Imperial College London; Imperial College London; University of London; King's College London	Ayaru, L (corresponding author), Imperial Coll Healthcare NHS Trust, Charing Cross Hosp, Dept Gastroenterol, London, England.	Lakshmana.ayaru@imperial.nhs.uk; giovanni.montana@kcl.ac.uk						Aoki T, 2015, CLIN GASTROENTEROL H, V13, P488, DOI 10.1016/j.cgh.2014.06.023; Austin PC, 2012, BIOMETRICAL J, V54, P657, DOI 10.1002/bimj.201100251; Barnert J, 2009, NAT REV GASTRO HEPAT, V6, P637, DOI 10.1038/nrgastro.2009.167; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L, 2001, STAT SCI, V16, P199, DOI 10.1214/ss/1009213726; Breiman L., 2017, CLASSIFICATION REGRE; Casanova R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098587; Chen HY, 2007, NEW ENGL J MED, V356, P11, DOI 10.1056/NEJMoa060096; Chen YF, 2013, COMPUT MATH METHOD M, V2013, DOI 10.1155/2013/873595; Chu A, 2008, ARTIF INTELL MED, V42, P247, DOI 10.1016/j.artmed.2007.10.003; Das A, 2003, LANCET, V362, P1261, DOI 10.1016/S0140-6736(03)14568-0; Dodd S, 2014, J AFFECT DISORDERS, V168, P284, DOI 10.1016/j.jad.2014.05.014; Dworzynski K, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e3412; Farrell JJ, 2005, ALIMENT PHARM THER, V21, P1281, DOI 10.1111/j.1365-2036.2005.02485.x; Friedman JH, 2001, ANN STAT, V29, P1189, DOI 10.1214/aos/1013203451; Gurm HS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096385; Hastie T., 2009, ELEMENTS STAT LEARNI, V2nd ed.; Jianjun Xie, 2010, Statistical Analysis and Data Mining, V3, P253, DOI 10.1002/sam.10079; Kalai A, 2003, P 35 ANN ACM S THEOR, P195, DOI [10.1145/780542.780573, DOI 10.1145/780542.780573]; Kollef MH, 1997, CRIT CARE MED, V25, P1125, DOI 10.1097/00003246-199707000-00011; Lanas A, 2009, AM J GASTROENTEROL, V104, P1633, DOI 10.1038/ajg.2009.164; Maroco Joao, 2011, BMC Res Notes, V4, P299, DOI 10.1186/1756-0500-4-299; Martin R, 2006, PHARMACOGENOMICS, V7, P1003, DOI 10.2217/14622416.7.7.1003; Parker Donna R, 2011, J Med Econ, V14, P279, DOI 10.3111/13696998.2011.571328; Peng SY, 2010, EUR J NEUROL, V17, P945, DOI 10.1111/j.1468-1331.2010.02955.x; Strate LL, 2008, CLIN GASTROENTEROL H, V6, P1004, DOI 10.1016/j.cgh.2008.03.021; Strate LL, 2010, CLIN GASTROENTEROL H, V8, P333, DOI 10.1016/j.cgh.2009.12.017; Strate LL, 2005, AM J GASTROENTEROL, V100, P1821, DOI 10.1111/j.1572-0241.2005.41755.x; Strate LL, 2003, ARCH INTERN MED, V163, P838, DOI 10.1001/archinte.163.7.838; Velayos FS, 2004, CLIN GASTROENTEROL H, V2, P485, DOI 10.1016/S1542-3565(04)00167-3; Venkatesh PGK, 2014, INT J COLORECTAL DIS, V29, P953, DOI 10.1007/s00384-014-1915-x; Weiss JC, 2012, P INN APPL ART INT C	32	32	34	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132485	10.1371/journal.pone.0132485	http://dx.doi.org/10.1371/journal.pone.0132485			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26172121	gold, Green Published, Green Submitted			2022-12-26	WOS:000358194900054
J	Hsieh, HM; Gu, SM; Shin, SJ; Kao, HY; Lin, YC; Chiu, HC				Hsieh, Hui-Min; Gu, Song-Mao; Shin, Shyi-Jang; Kao, Hao-Yun; Lin, Yi-Chieh; Chiu, Herng-Chia			Cost-Effectiveness of a Diabetes Pay-For-Performance Program in Diabetes Patients with Multiple Chronic Conditions	PLOS ONE			English	Article							PREFERENCE-BASED MEASURE; HEALTH-CARE UTILIZATION; METABOLIC SYNDROME; QUALITY; COMPLICATIONS; MORTALITY; OUTCOMES; TAIWAN; MULTIMORBIDITY; COMORBIDITY	Pay for performance (P4P) has been used as a strategy to improve quality for patients with chronic illness. Little was known whether care provided to individuals with multiple chronic conditions in a P4P program were cost-effective. This study investigated cost effectiveness of a diabetes P4P program for caring patients with diabetes alone (DM alone) and diabetes with comorbid hypertension and hyperlipidemia (DMHH) from a single payer perspective in Taiwan. Analyzing data using population-based longitudinal databases, we compared costs and effectiveness between P4P and non-P4P diabetes patient groups in two cohorts. Propensity score matching (PSM) was used to match comparable control groups for intervention groups. Outcomes included life-years, quality-adjusted life-years (QALYs), program intervention costs, cost-savings and incremental cost-effectiveness ratios (ICERs). QALYs for P4P patients and non-P4P patients were 2.80 and 2.71 for the DM alone cohort and 2.74 and 2.66 for the DMHH patient cohort. The average incremental intervention costs per QALYs was TWD$167,251 in the DM alone cohort and TWD$145,474 in the DMHH cohort. The average incremental all-cause medical costs saved by the P4P program per QALYs were TWD$434,815 in DM alone cohort and TWD$506,199 in the DMHH cohort. The findings indicated that the P4P program for both cohorts were cost-effective and the resulting return on investment (ROI) was 2.60:1 in the DM alone cohort and 3.48:1 in the DMHH cohort. We conclude that the diabetes P4P program in both cohorts enabled the long-term cost-effective use of resources and cost-savings, especially for patients with multiple comorbid conditions.	[Hsieh, Hui-Min] Kaohsiung Med Univ, Dept Publ Hlth, Kaohsiung, Taiwan; [Gu, Song-Mao] Ctr Dis Control, Div HIV AIDS & TB, Taipei, Taiwan; [Shin, Shyi-Jang] Kaohsiung Med Univ, Ctr Lipid & Glycomed Res, Kaohsiung, Taiwan; [Shin, Shyi-Jang] Kaohsiung Med Univ, Coll Med, Kaohsiung, Taiwan; [Shin, Shyi-Jang] Kaohsiung Med Univ Hosp, Div Endocrinol & Metab, Kaohsiung, Taiwan; [Kao, Hao-Yun; Lin, Yi-Chieh; Chiu, Herng-Chia] Kaohsiung Med Univ, Dept Healthcare Adm & Med Informat, Kaohsiung, Taiwan; [Chiu, Herng-Chia] Natl Sun Yat Sen Univ, Dept Business Adm, Kaohsiung 80424, Taiwan	Kaohsiung Medical University; Centers For Disease Control - Taiwan; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; National Sun Yat Sen University	Chiu, HC (corresponding author), Kaohsiung Med Univ, Dept Healthcare Adm & Med Informat, Kaohsiung, Taiwan.	chiu@kmu.edu.tw	Kao, Hao-Yun/AAZ-5597-2021; Hao-Yun, Kao/AGD-6394-2022	Kao, Hao-Yun/0000-0002-9390-9314; 	National Institutes of Health Grant [HD049888]; Research to Prevent Blindness; NIH Cancer Center Support (CORE) grant [CA21765]; ALSAC; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD049888] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NIH Cancer Center Support (CORE) grant; ALSAC(American Lebanese Syrian Associated Charities (ALSAC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a National Institutes of Health Grant HD049888, Research to Prevent Blindness (Unrestricted Grant), a NIH Cancer Center Support (CORE) grant CA21765, and ALSAC.	Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS14, DOI 10.2337/dc14-S014; Austin PC, 2008, STAT MED, V27, P2037, DOI 10.1002/sim.3150; Boyd CM, 2005, JAMA-J AM MED ASSOC, V294, P716, DOI 10.1001/jama.294.6.716; Boyd CM, 2010, PUBLIC HEALTH REV, V32, P451, DOI 10.1007/BF03391611; Brazier J, 2002, J HEALTH ECON, V21, P271, DOI 10.1016/S0167-6296(01)00130-8; Brazier JE, 2004, MED CARE, V42, P851, DOI 10.1097/01.mlr.0000135827.18610.0d; Campbell SM, 2009, NEW ENGL J MED, V361, P368, DOI 10.1056/NEJMsa0807651; Chen CC, 2013, MED CARE, V51, P231, DOI 10.1097/MLR.0b013e31827da5b9; Chen TT, 2011, HEALTH SERV RES, V46, P47, DOI 10.1111/j.1475-6773.2010.01182.x; Cheng SH, 2012, MED CARE, V50, P109, DOI 10.1097/MLR.0b013e31822d5d36; Cromwell J, 2011, PAY PERFORMANC EHLTH; Curtin K, 2006, J HEALTHC MANAG, V51, P365, DOI 10.1097/00115514-200611000-00005; de Bruin SR, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-272; Dehejia RH, 2002, REV ECON STAT, V84, P151, DOI 10.1162/003465302317331982; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Eijkenaar F, 2013, HEALTH POLICY, V110, P115, DOI 10.1016/j.healthpol.2013.01.008; Emmert M, 2012, EUR J HEALTH ECON, V13, P755, DOI 10.1007/s10198-011-0329-8; Gillam SJ, 2012, ANN FAM MED, V10, P461, DOI 10.1370/afm.1377; Glasziou P, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-21; Gold MR, 1996, COST EFFECTIVENESS H; Greene J, 2013, HEALTH SERV RES, V48, P1415, DOI 10.1111/1475-6773.12033; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Hsieh HM, 2015, MED CARE, V53, P106, DOI 10.1097/MLR.0000000000000264; Isomaa B, 2001, DIABETES CARE, V24, P683, DOI 10.2337/diacare.24.4.683; Isomaa B, 2001, DIABETOLOGIA, V44, P1148, DOI 10.1007/s001250100615; Lee TT, 2010, AM J MANAG CARE, V16, P65; Lee TA, 2007, J GEN INTERN MED, V22, P403, DOI 10.1007/s11606-007-0277-2; Lehnert T, 2011, MED CARE RES REV, V68, P387, DOI 10.1177/1077558711399580; Mangin D, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3526; Meacock R, 2014, HEALTH ECON, V23, P1, DOI 10.1002/hec.2978; Meduru P, 2007, J GEN INTERN MED, V22, P408, DOI 10.1007/s11606-007-0310-5; Nahra TA, 2006, MED CARE RES REV, V63, p49S, DOI 10.1177/1077558705283629; Parekh AK, 2010, JAMA-J AM MED ASSOC, V303, P1303, DOI 10.1001/jama.2010.381; Petersen LA, 2006, ANN INTERN MED, V145, P265, DOI 10.7326/0003-4819-145-4-200608150-00006; Pham HH, 2007, NEW ENGL J MED, V356, P1130, DOI 10.1056/NEJMsa063979; Pickard A Simon, 2005, Health Qual Life Outcomes, V3, P11, DOI 10.1186/1477-7525-3-11; Piette JD, 2006, DIABETES CARE, V29, P725, DOI 10.2337/diacare.29.03.06.dc05-2078; Tan ECH, 2014, QUAL LIFE RES, V23, P689, DOI 10.1007/s11136-013-0502-x; Tinetti ME, 2012, JAMA-J AM MED ASSOC, V307, P2493, DOI 10.1001/jama.2012.5265; Torrance GW, 1987, METHODS EC EVALUATIO; Tseng LN, 2012, J FORMOS MED ASSOC, V111, P625, DOI 10.1016/j.jfma.2012.09.010; Vaghela P, 2009, DIABETES CARE, V32, P427, DOI 10.2337/dc08-1999; Weintraub WS, 2009, CIRC-CARDIOVASC QUAL, V2, P55, DOI 10.1161/CIRCOUTCOMES.108.812321; Wolff JL, 2002, ARCH INTERN MED, V162, P2269, DOI 10.1001/archinte.162.20.2269; Young BA, 2008, AM J MANAG CARE, V14, P15	45	24	24	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0133163	10.1371/journal.pone.0133163	http://dx.doi.org/10.1371/journal.pone.0133163			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1QN	26173086	Green Submitted, Green Published, gold			2022-12-26	WOS:000358194900142
J	Ma, XL; Sheng, ZZ; Huang, B; Qi, LH; Li, YF; Yu, KX; Liu, CX; Qin, ZM; Wang, D; Song, MX; Li, F				Ma, Xiuli; Sheng, Zizhang; Huang, Bing; Qi, Lihong; Li, Yufeng; Yu, Kexiang; Liu, Cunxia; Qin, Zhuoming; Wang, Dan; Song, Minxun; Li, Feng			Molecular Evolution and Genetic Analysis of the Major Capsid Protein VP1 of Duck Hepatitis A Viruses: Implications for Antigenic Stability	PLOS ONE			English	Article							GENOMIC SEQUENCE; SEROTYPE	The duck hepatitis A virus (DHAV), a member of the family Picornaviridae, is the major cause of outbreaks with high mortality rates in young ducklings. It has three distinctive serotypes and among them, serotypes 1 (DHAV-1) and 3 (DHAV-3) were recognized in China. To investigate evolutionary and antigenic properties of the major capsid protein VP1 of these two serotypes, a primary target of neutralizing antibodies, we determined the VP1 coding sequences of 19 DHAV-1 (spanning 2000-2012) and 11 DHAV-3 isolates (spanning 2008-2014) associated with disease outbreaks. By bioinformatics analysis of VP1 sequences of these isolates and other DHAV strains reported previously, we demonstrated that DHAV-1 viruses evolved into two genetic lineages, while DHAV-3 viruses exhibited three distinct lineages. The rate of nucleotide substitution for DHAV-1 VP1 genes was estimated to be 5.57 x 10(-4) per site per year, which was about one-third times slower than that for DHAV-3 VP1 genes. The population dynamics analysis showed an upward trend for infection of DHAV-1 viruses over time with little change observed for DHAV-3 viruses. Antigenic study of representative DHAV-1 and DHAV-3 strains covering all observed major lineages revealed no detectable changes in viral neutralization properties within the serotype, despite the lack of cross-neutralization between serotypes 1 and 3 strains. Structural analysis identified VP1 mutations in DHAV-1 and DHAV-3 viruses that underpin the observed antigenic phenotypes. Results of our experiments described here shall give novel insights into evolution and antigenicity of duck picornaviruses.	[Ma, Xiuli; Huang, Bing; Qi, Lihong; Li, Yufeng; Yu, Kexiang; Liu, Cunxia; Qin, Zhuoming; Song, Minxun; Li, Feng] Shandong Acad Agr Sci, Inst Poultry Sci, Jinan 250023, Shandong, Peoples R China; [Sheng, Zizhang] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10027 USA; [Huang, Bing; Wang, Dan; Li, Feng] S Dakota State Univ, Dept Biol & Microbiol, Brookings, SD 57007 USA; [Huang, Bing; Li, Feng] S Dakota State Univ, Dept Vet & Biomed Sci, Brookings, SD 57007 USA	Shandong Academy of Agricultural Sciences; Columbia University; South Dakota State University; South Dakota State University	Song, MX (corresponding author), Shandong Acad Agr Sci, Inst Poultry Sci, 1 Jiaoxiao Rd, Jinan 250023, Shandong, Peoples R China.	mxsong@aliyun.com; feng.li@sdstate.edu	Li, yu/HHZ-5236-2022; Qi, LI/AAF-3389-2019; Sheng, Zizhang/AFR-8049-2022	Sheng, Zizhang/0000-0002-3253-3309; Wang, Dan/0000-0002-7263-8420; Li, Feng/0000-0002-8904-2893	Shandong Provincial Natural Science Foundation [BS2009YY019]; Shandong Modern Agricultural Technology & Industry System [SDAIT-13-011-01]; Youth Scientific Research Foundation of Shandong Academy of Agricultural Sciences [2014QNZ06]; Taishan Scholar Program to Institute of Poultry Science, Chinese National Science foundation [31172355/C1806]; Agro-scientific research in the public interest [201003012]; Office of Integrative Activities [1355423] Funding Source: National Science Foundation	Shandong Provincial Natural Science Foundation(Natural Science Foundation of Shandong Province); Shandong Modern Agricultural Technology & Industry System; Youth Scientific Research Foundation of Shandong Academy of Agricultural Sciences; Taishan Scholar Program to Institute of Poultry Science, Chinese National Science foundation; Agro-scientific research in the public interest; Office of Integrative Activities(National Science Foundation (NSF)NSF - Office of the Director (OD))	The study was partially supported by funds from Shandong Provincial Natural Science Foundation (BS2009YY019), Shandong Modern Agricultural Technology & Industry System (SDAIT-13-011-01), the Youth Scientific Research Foundation of Shandong Academy of Agricultural Sciences (2014QNZ06), the Taishan Scholar Program to Institute of Poultry Science, Chinese National Science foundation (31172355/C1806), and Agro-scientific research in the public interest (201003012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baele G, 2013, MOL BIOL EVOL, V30, P239, DOI 10.1093/molbev/mss243; Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537; Ding CY, 2007, VIROLOGY, V361, P9, DOI 10.1016/j.virol.2007.01.007; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Fan W, 2011, ANIMAL HUSBANDRY VET, V43, P65; Fu Y, 2008, VET MICROBIOL, V131, P247, DOI 10.1016/j.vetmic.2008.03.011; Gray RR, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-131; He R, 2009, GUANGDONG J ANIMAL V, V34, P34; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kim MC, 2007, ARCH VIROL, V152, P2059, DOI 10.1007/s00705-007-1023-0; Kim MC, 2006, J GEN VIROL, V87, P3307, DOI 10.1099/vir.0.81804-0; Lemey P, 2006, AIDS REV, V8, P125; Liu Guang-qing, 2007, Virologica Sinica, V22, P353, DOI 10.1007/s12250-007-0032-1; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Pan M, 2009, CHINESE J VET MED, V45, P13; Racaniello V.R., 2001, FIELDS VIROLOGY, P455; Sanjuan R, 2010, J VIROL, V84, P9733, DOI 10.1128/JVI.00694-10; Shi Shaohua, 2009, Weishengwu Xuebao, V49, P309; Su Jing-liang, 2002, Chinese Journal of Veterinary Science & Technology, V32, P15; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tseng CH, 2007, VIRUS RES, V126, P19, DOI 10.1016/j.virusres.2007.01.012; Tseng CH, 2007, VIRUS RES, V123, P190, DOI 10.1016/j.virusres.2006.09.007; Wang P, 1980, ACTA SCICENTIARUM NA, P55; Woolcock PR., 2003, DIS POULTRY CHAPTER, V11, P343, DOI DOI 10.1111/1750-3841.12436; Xu Qian, 2013, Bing Du Xue Bao, V29, P522; Yuan ShuaiZhen, 2010, Zhongguo Yufang Shouyi Xuebao / Chinese Journal of Preventive Veterinary Medicine, V32, P507	26	10	11	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132982	10.1371/journal.pone.0132982	http://dx.doi.org/10.1371/journal.pone.0132982			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26173145	Green Submitted, Green Published, gold			2022-12-26	WOS:000358194900112
J	Osman, A; Hitzler, WE; Ameur, A; Provost, P				Osman, Abdimajid; Hitzler, Walter E.; Ameur, Adam; Provost, Patrick			Differential Expression Analysis by RNA-Seq Reveals Perturbations in the Platelet mRNA Transcriptome Triggered by Pathogen Reduction Systems	PLOS ONE			English	Article							PROTEIN; INACTIVATION	Platelet concentrates (PCs) are prepared at blood banks for transfusion to patients in certain clinical conditions associated with a low platelet count. To prevent transfusion-transmitted infections via PCs, different pathogen reduction (PR) systems have been developed that inactivate the nucleic acids of contaminating pathogens by chemical cross-linking, a mechanism that may also affect platelets' nucleic acids. We previously reported that treatment of stored platelets with the PR system Intercept significantly reduced the level of half of the microRNAs that were monitored, induced platelet activation and compromised the platelet response to physiological agonists. Using genome-wide differential expression (DE) RNA sequencing (RNA-Seq), we now report that Intercept markedly perturbs the mRNA transcriptome of human platelets and alters the expression level of >800 mRNAs (P<0.05) compared to other PR systems and control platelets. Of these, 400 genes were deregulated with DE corresponding to fold changes (FC) >= 2. At the p-value < 0.001, as many as 147 genes were deregulated by >= 2-fold in Intercept-treated platelets, compared to none in the other groups. Finally, integrated analysis combining expression data for microRNA (miRNA) and mRNA, and involving prediction of miRNA-mRNA interactions, disclosed several positive and inverse correlations between miRNAs and mRNAs in stored platelets. In conclusion, this study demonstrates that Intercept markedly deregulates the platelet mRNA transcriptome, concomitant with reduced levels of mRNA-regulatory miRNAs. These findings should enlighten authorities worldwide when considering the implementation of PR systems, that target nucleic acids and are not specific to pathogens, for the management of blood products.	[Osman, Abdimajid] Dept Clin Chem, Linkoping, Sweden; [Osman, Abdimajid] Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden; [Hitzler, Walter E.] Johannes Gutenberg Univ Mainz, Transfus Ctr, Univ Med Ctr, D-55122 Mainz, Germany; [Ameur, Adam] Uppsala Univ, Dept Immunol Genet & Pathol, Sci Life Lab, Uppsala, Sweden; [Provost, Patrick] Univ Laval, CHUQ Res Ctr, CHUL, Quebec City, PQ, Canada	Linkoping University; Johannes Gutenberg University of Mainz; Uppsala University; Laval University	Osman, A (corresponding author), Dept Clin Chem, Ingang 64, Linkoping, Sweden.	majid.osman@liu.se	Ameur, Adam/E-6207-2011; Provost, Patrick/G-2786-2010	Ameur, Adam/0000-0001-6085-6749; Provost, Patrick/0000-0002-6099-6562; Osman, Abdimajid/0000-0002-5143-8315	Regional Council of Ostergotland, Sweden [LIO-353011]; Canadian Blood Services/Canadian Institutes of Health Research (CIHR) Blood Utilization and Conservation Initiative via Health Canada [293933]	Regional Council of Ostergotland, Sweden; Canadian Blood Services/Canadian Institutes of Health Research (CIHR) Blood Utilization and Conservation Initiative via Health Canada	This work was supported by grant no. LIO-353011 from the Regional Council of Ostergotland, Sweden (to A.O.), and grant no. 293933 from the Canadian Blood Services/Canadian Institutes of Health Research (CIHR) Blood Utilization and Conservation Initiative via Health Canada (to W.E.H and P.P.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, 101A HER BUND JUST, V62; BOOYSE FM, 1968, BIOCHIM BIOPHYS ACTA, V166, P689, DOI 10.1016/0005-2787(68)90376-6; Butler C, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009072.pub2; Gnatenko DV, 2003, BLOOD, V101, P2285, DOI 10.1182/blood-2002-09-2797; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kerkhoffs JLH, 2010, BRIT J HAEMATOL, V150, P209, DOI 10.1111/j.1365-2141.2010.08227.x; KIEFFER N, 1987, EUR J BIOCHEM, V164, P189, DOI 10.1111/j.1432-1033.1987.tb11010.x; Kissopoulou A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081809; Landry P, 2009, NAT STRUCT MOL BIOL, V16, P961, DOI 10.1038/nsmb.1651; Londin ER, 2014, BIOL DIRECT, V9, DOI 10.1186/1745-6150-9-3; McCloskey C, 2010, J PHYSIOL-LONDON, V588, P1399, DOI 10.1113/jphysiol.2010.188136; McCullough J, 2004, BLOOD, V104, P1534, DOI 10.1182/blood-2003-12-4443; McRedmond JP, 2004, MOL CELL PROTEOMICS, V3, P133, DOI 10.1074/mcp.M300063-MCP200; Osman A, 2015, PLATELETS, V26, P154, DOI 10.3109/09537104.2014.898178; Ple H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050746; Rodeghiero F, 2009, BLOOD, V113, P2386, DOI 10.1182/blood-2008-07-162503; Rowley JW, 2011, BLOOD, V118, pE101, DOI 10.1182/blood-2011-03-339705; Sales G, 2010, NUCLEIC ACIDS RES, V38, pW352, DOI 10.1093/nar/gkq423; Schubert S, 2014, BLOOD, V124, P493, DOI 10.1182/blood-2014-04-512756; Teruel-Montoya R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102259; TSAO CH, 1971, SCAND J HAEMATOL, V8, P134; Weyrich AS, 1998, P NATL ACAD SCI USA, V95, P5556, DOI 10.1073/pnas.95.10.5556; Wollowitz S, 2001, SEMIN HEMATOL, V38, P4, DOI 10.1053/shem.2001.29495; Zhang JD, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-565; Zimmerman GA, 2008, ARTERIOSCL THROM VAS, V28, pS17, DOI 10.1161/ATVBAHA.107.160218	25	27	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0133070	10.1371/journal.pone.0133070	http://dx.doi.org/10.1371/journal.pone.0133070			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26172280	gold, Green Published, Green Submitted			2022-12-26	WOS:000358194900119
J	Beringhelli, T; Gianazza, E; Maggioni, D; Scanu, S; Parravicini, C; Sensi, C; Monaco, HL; Eberini, I				Beringhelli, Tiziana; Gianazza, Elisabetta; Maggioni, Daniela; Scanu, Sandra; Parravicini, Chiara; Sensi, Cristina; Monaco, Hugo L.; Eberini, Ivano			All-Purpose Containers? Lipid-Binding Protein - Drug Interactions	PLOS ONE			English	Article							HUMAN SERUM-ALBUMIN; BOVINE BETA-LACTOGLOBULIN; FATTY-ACID; BILE-ACIDS; ALPHA-1-ACID GLYCOPROTEIN; MAGNETIC-RESONANCE; SEX-DIFFERENCES; PHARMACOKINETICS; NMR; PHARMACODYNAMICS	The combined use of in vitro (F-19-NMR) and in silico (molecular docking) procedures demonstrates the affinity of a number of human calycins (lipid-binding proteins from ileum, liver, heart, adipose tissue and epidermis, and retinol-binding protein from intestine) for different drugs (mainly steroids and vastatins). Comparative evaluations on the complexes outline some of the features relevant for interaction (non-polar character of the drugs; amino acids and water molecules in the protein calyx most often involved in binding). Dissociation constants (K-i) for drugs typically lie in the same range as K-i for natural ligands; in most instances (different proteins and docking conditions), vastatins are the strongest interactors, with atorvastatin ranking top in half of the cases. The affinity of some calycins for some of the vastatins is in the order of magnitude of the drug C-max after systemic administration in humans. The possible biological implications of this feature are discussed in connection with drug delivery parameters (route of administration, binding to carrier proteins, distribution to, and accumulation in, human tissues).	[Beringhelli, Tiziana; Maggioni, Daniela; Scanu, Sandra] Politecn Milan, Dipartimento Chim, I-20133 Milan, Italy; [Gianazza, Elisabetta] Univ Milan, Dipartimento Sci Farmacol & Biomol, Grp Studio Prote & Struttura Prot, Sez Sci Farmacol, I-20133 Milan, Italy; [Parravicini, Chiara; Sensi, Cristina; Eberini, Ivano] Univ Milan, Lab Biochim & Biofis Computaz, Dipartimento Sci Farmacol & Biomol, Sez Biochim Biofis Fisiol & Immunopatol, I-20134 Milan, Italy; [Monaco, Hugo L.] Univ Verona, Dipartimento Biotecnol, I-37134 Verona, Italy	Polytechnic University of Milan; University of Milan; University of Milan; University of Verona	Gianazza, E (corresponding author), Univ Milan, Dipartimento Sci Farmacol & Biomol, Grp Studio Prote & Struttura Prot, Sez Sci Farmacol, Via Balzaretti 9, I-20133 Milan, Italy.	elisabetta.gianazza@unimi.it	Maggioni, Daniela/A-5932-2012	Maggioni, Daniela/0000-0001-5201-4824; Monaco, Hugo L./0000-0002-2067-0365	intramural grant for young researchers (Fondo di Sviluppo UNIMI, Linea B)	intramural grant for young researchers (Fondo di Sviluppo UNIMI, Linea B)	This work was supported by an intramural grant for young researchers (Fondo di Sviluppo UNIMI, Linea B) to Ivano Eberini. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerstrom B, 2000, BBA-PROTEIN STRUCT M, V1482, P1, DOI 10.1016/S0167-4838(00)00137-0; Assfalg M, 2007, J MED CHEM, V50, P5257, DOI 10.1021/jm070397i; Barbiroli A, 2010, BIOL CHEM, V391, P21, DOI 10.1515/BC.2010.008; BARRE J, 1983, INT J CLIN PHARM RES, V3, P215; Bellosta S, 2004, CIRCULATION, V109, P50, DOI 10.1161/01.CIR.0000131519.15067.1f; Beringhelli T, 2001, BIOCHEMISTRY-US, V40, P12604, DOI 10.1021/bi011009w; Capaldi S, 2009, J MOL BIOL, V385, P99, DOI 10.1016/j.jmb.2008.10.007; Chuang S, 2008, J MED CHEM, V51, P3755, DOI 10.1021/jm701192w; Eberini I, 2008, PROTEINS, V71, P1889, DOI 10.1002/prot.21875; Eberini I, 2008, J MOL GRAPH MODEL, V26, P1004, DOI 10.1016/j.jmgm.2007.08.006; Eberini I, 2006, PROTEINS, V65, P555, DOI 10.1002/prot.21109; Elzoghby AO, 2012, J CONTROL RELEASE, V157, P168, DOI 10.1016/j.jconrel.2011.07.031; Fanali G, 2012, MOL ASPECTS MED, V33, P209, DOI 10.1016/j.mam.2011.12.002; Flower DR, 2000, BBA-PROTEIN STRUCT M, V1482, P9, DOI 10.1016/S0167-4838(00)00148-5; Gambacorti-Passerini C, 2000, JNCI-J NATL CANCER I, V92, P1641, DOI 10.1093/jnci/92.20.1641; Gandhi M, 2004, ANNU REV PHARMACOL, V44, P499, DOI [10.1146/annurev.pharmtox.44.101802.121453, 10.2165/00003088-200948030-00001]; Ghuman J, 2005, J MOL BIOL, V353, P38, DOI 10.1016/j.jmb.2005.07.075; Guariento M, 2010, BIOCHEM J, V425, P413, DOI 10.1042/BJ20091209; Hackett MJ, 2013, ADV DRUG DELIVER REV, V65, P1331, DOI 10.1016/j.addr.2012.07.012; He Y, 2007, BIOCHEMISTRY-US, V46, P12543, DOI 10.1021/bi701092r; He Y, 2011, BIOCHEMISTRY-US, V50, P1283, DOI 10.1021/bi101307h; Huang ZQ, 2013, CURR DRUG METAB, V14, P226; Israili ZH, 2001, DRUG METAB REV, V33, P161, DOI 10.1081/DMR-100104402; Kosa T, 1997, PHARMACEUT RES, V14, P1607, DOI 10.1023/A:1012138604016; Kratz F, 2012, J CONTROL RELEASE, V161, P429, DOI 10.1016/j.jconrel.2011.11.028; Kratz F, 2008, J CONTROL RELEASE, V132, P171, DOI 10.1016/j.jconrel.2008.05.010; Krenzel ES, 2013, BIOCHEMISTRY-US, V52, P1559, DOI 10.1021/bi301458b; Lan H, 2011, J LIPID RES, V52, P646, DOI 10.1194/jlr.M012757; Maeda K, 2005, CELL METAB, V1, P107, DOI 10.1016/j.cmet.2004.12.008; Matsumoto Kazuaki, 2002, Drug Metab Pharmacokinet, V17, P300, DOI 10.2133/dmpk.17.300; Nichesola D, 2004, BIOCHEMISTRY-US, V43, P14072, DOI 10.1021/bi0489661; Niwa T, 2011, MASS SPECTROM REV, V30, P510, DOI 10.1002/mas.20323; NOTARIANNI LJ, 1990, CLIN PHARMACOKINET, V18, P20, DOI 10.2165/00003088-199018010-00002; Perduca M, 2000, ELECTROPHORESIS, V21, P2316, DOI 10.1002/1522-2683(20000701)21:12<2316::AID-ELPS2316>3.0.CO;2-0; Ricchiuto P, 2008, J MOL RECOGNIT, V21, P347, DOI 10.1002/jmr.908; Richter A, 2014, FEBS LETT, V588, P213, DOI 10.1016/j.febslet.2013.11.006; Ross GA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032036; SCAPIN G, 1988, FEBS LETT, V240, P196, DOI 10.1016/0014-5793(88)80367-3; Schiefner A, 2015, ACCOUNTS CHEM RES, V48, P976, DOI 10.1021/ar5003973; SCHIEVANO E, 1994, BIOPOLYMERS, V34, P879, DOI 10.1002/bip.360340707; Sharma A, 2011, J BIOL CHEM, V286, P31924, DOI 10.1074/jbc.M111.270165; Skerra A, 2000, BBA-PROTEIN STRUCT M, V1482, P337, DOI 10.1016/S0167-4838(00)00145-X; Skerra A, 2008, FEBS J, V275, P2677, DOI 10.1111/j.1742-4658.2008.06439.x; Sleep D, 2013, BBA-GEN SUBJECTS, V1830, P5526, DOI 10.1016/j.bbagen.2013.04.023; Smathers Rebecca L., 2011, Human Genomics, V5, P170; Soldin OP, 2009, CLIN PHARMACOKINET, V48, P143, DOI 10.2165/00003088-200948030-00001; Storch J, 2010, J BIOL CHEM, V285, P32679, DOI 10.1074/jbc.R110.135210; Sulsky R, 2007, BIOORG MED CHEM LETT, V17, P3511, DOI 10.1016/j.bmcl.2006.12.044; Takamura N, 1997, CLIN CHEM, V43, P2274; Tochtrop GP, 2002, P NATL ACAD SCI USA, V99, P1847, DOI 10.1073/pnas.012379199; Tomaselli S, 2007, PROTEINS, V69, P177, DOI 10.1002/prot.21517; Tornaselli S, 2008, J MED CHEM, V51, P6782, DOI 10.1021/jm800820b; Vallianatou T, 2013, EXPERT OPIN DRUG DIS, V8, P583, DOI 10.1517/17460441.2013.777424; Weiss GA, 2000, CHEM BIOL, V7, pR177; Yamasaki K, 2013, BBA-GEN SUBJECTS, V1830, P5435, DOI 10.1016/j.bbagen.2013.05.005; Zhang MM, 2014, MED CHEM, V10, P339, DOI 10.2174/15734064113096660045; Zsila F, 2011, BIOINFORMATICS, V27, P1806, DOI 10.1093/bioinformatics/btr284	57	3	3	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0132096	10.1371/journal.pone.0132096	http://dx.doi.org/10.1371/journal.pone.0132096			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26167932	gold, Green Published, Green Submitted			2022-12-26	WOS:000358193100021
J	Nissi, MJ; Toth, F; Wang, LN; Carlson, CS; Ellermann, JM				Nissi, Mikko J.; Toth, Ferenc; Wang, Luning; Carlson, Cathy S.; Ellermann, Jutta M.			Improved Visualization of Cartilage Canals Using Quantitative Susceptibility Mapping	PLOS ONE			English	Article							HIGH-FIELD MRI; HUMAN BRAIN; IN-VIVO; EX-VIVO; PHASE; CONTRAST; VENOGRAPHY; TESLA; OSTEOCHONDROSIS; IMAGES	Purpose Cartilage canal vessels are critical to the normal function of epiphyseal (growth) cartilage and damage to these vessels is demonstrated or suspected in several important developmental orthopaedic diseases. High-resolution, three-dimensional (3-D) visualization of cartilage canals has recently been demonstrated using susceptibility weighted imaging (SWI). In the present study, a quantitative susceptibility mapping (QSM) approach is evaluated for 3-D visualization of the cartilage canals. It is hypothesized that QSM post-processing improves visualization of the cartilage canals by resolving artifacts present in the standard SWI post-processing while retaining sensitivity to the cartilage canals. Methods Ex vivo distal femoral specimens from 3- and 8-week-old piglets and a 1-month-old human cadaver were scanned at 9.4 T with a 3-D gradient recalled echo sequence suitable for SWI and QSM post-processing. The human specimen and the stifle joint of a live, 3-week-old piglet also were scanned at 7.0 T. Datasets were processed using the standard SWI method and truncated k-space division QSM approach. To compare the post-processing methods, minimum/maximum intensity projections and 3-D reconstructions of the processed datasets were generated and evaluated. Results Cartilage canals were successfully visualized using both SWI and QSM approaches. The artifactual splitting of the cartilage canals that occurs due to the dipolar phase, which was present in the SWI post-processed data, was eliminated by the QSM approach. Thus, orientation-independent visualization and better localization of the cartilage canals was achieved with the QSM approach. Combination of GRE with a mask based on QSM data further improved visualization. Conclusions Improved and artifact-free 3-D visualization of the cartilage canals was demonstrated by QSM processing of the data, especially by utilizing susceptibility data as an enhancing mask. Utilizing tissue-inherent contrast, this method allows noninvasive assessment of the vasculature in the epiphyseal cartilage in the developing skeleton and potentially increases the opportunity to diagnose disease of this tissue in the preclinical stages, when treatment likely will have increased efficacy.	[Nissi, Mikko J.; Wang, Luning; Ellermann, Jutta M.] Univ Minnesota, Dept Radiol, Ctr Magnet Resonance Res, Minneapolis, MN 55455 USA; [Nissi, Mikko J.; Wang, Luning] Univ Minnesota, Dept Orthopaed Surg, Minneapolis, MN 55455 USA; [Nissi, Mikko J.] Univ Oulu, Res Grp Med Imaging Phys & Technol, Fac Med, Oulu, Finland; [Nissi, Mikko J.] Oulu Univ Hosp, Med Res Ctr Oulu, Oulu, Finland; [Nissi, Mikko J.] Univ Oulu, Oulu, Finland; [Nissi, Mikko J.] Univ Eastern Finland, Dept Appl Phys, Kuopio, Finland; [Toth, Ferenc; Ellermann, Jutta M.] Univ Minnesota, Coll Vet Med, Dept Vet Populat Med, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Oulu; University of Oulu; University of Oulu; University of Eastern Finland; University of Minnesota System; University of Minnesota Twin Cities	Nissi, MJ (corresponding author), Univ Minnesota, Dept Radiol, Ctr Magnet Resonance Res, Minneapolis, MN 55455 USA.	mikko.nissi@uef.fi	Wang, Luning/B-2780-2016	Nissi, Mikko/0000-0002-5678-0689; Toth, Ferenc/0000-0002-6615-389X; Ellermann, Jutta/0000-0002-7109-9656	National Institutes of Health [T32 OD010993, K18 OD010468, P41 EB015894, S10 RR026783, R21 EB009138]; Academy of Finland grant [260321]; W. M. Keck Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026783] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015894, R21EB009138] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [K18OD010468, T32OD010993] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Academy of Finland grant(Academy of Finland); W. M. Keck Foundation(W.M. Keck Foundation); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health (http://www.nih.gov/): grants T32 OD010993 (CSC), K18 OD010468 (CSC), P41 EB015894, S10 RR026783, R21 EB009138; Academy of Finland (http://www.aka.fi/): grant 260321; and W. M. Keck Foundation (http://www.wmkeck.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abduljalil AM, 2003, J MAGN RESON IMAGING, V18, P284, DOI 10.1002/jmri.10362; Abosch A, 2010, NEUROSURGERY, V67, P1745, DOI 10.1227/NEU.0b013e3181f74105; Barnes SRS, 2009, MAGN RESON IMAGING C, V17, P47, DOI 10.1016/j.mric.2008.12.002; Bilgic B, 2014, MAGN RESON MED, V72, P1444, DOI 10.1002/mrm.25029; Duyn JH, 2007, P NATL ACAD SCI USA, V104, P11796, DOI 10.1073/pnas.0610821104; Fan AP, 2014, MAGN RESON MED, V72, P149, DOI 10.1002/mrm.24918; Gho SM, 2014, MAGN RESON MED, V72, P337, DOI 10.1002/mrm.24920; Haacke EM, 2010, J MAGN RESON IMAGING, V32, P663, DOI 10.1002/jmri.22276; Haacke EM, 2009, AM J NEURORADIOL, V30, P19, DOI 10.3174/ajnr.A1400; Haacke EM, 2004, MAGN RESON MED, V52, P612, DOI 10.1002/mrm.20198; Haines RW, 1933, J ANAT, V68, P45; Jaramillo D, 2004, AM J ROENTGENOL, V182, P353, DOI 10.2214/ajr.182.2.1820353; Lehto LJ, 2012, NEUROIMAGE, V61, P761, DOI 10.1016/j.neuroimage.2012.03.002; Liu SF, 2014, J MAGN RESON IMAGING, V40, P698, DOI 10.1002/jmri.24413; Metzger GJ, 2013, MAGN RESON MED, V69, P114, DOI 10.1002/mrm.24237; Nissi MJ, 2014, MAGN RESON MED, V71, P2197, DOI 10.1002/mrm.24863; Nissi MJ, 2013, T ORTHOP RES SOC; Nissi MJ, 2013, P INT SOC MAG RESON; Reichenbach JR, 1997, RADIOLOGY, V204, P272, DOI 10.1148/radiology.204.1.9205259; Reichenbach JR, 2000, J COMPUT ASSIST TOMO, V24, P949, DOI 10.1097/00004728-200011000-00023; Rosset A, 2004, J DIGIT IMAGING, V17, P205, DOI 10.1007/s10278-004-1014-6; Schweser F, 2013, MAGN RESON MED, V69, P1581, DOI 10.1002/mrm.24405; Schweser F, 2011, NEUROIMAGE, V54, P2789, DOI 10.1016/j.neuroimage.2010.10.070; Shmueli K, 2009, MAGN RESON MED, V62, P1510, DOI 10.1002/mrm.22135; Toth F, 2013, J ORTHOP RES, V31, P2006, DOI 10.1002/jor.22449; Van De Moortele PF, 2005, MAGN RESON MED, V54, P1503, DOI 10.1002/mrm.20708; Wang MY, 2011, MAGN RESON IMAGING, V29, P365, DOI 10.1016/j.mri.2010.10.016; Wang Y, 2000, J MAGN RESON IMAGING, V12, P661, DOI 10.1002/1522-2586(200011)12:5<661::AID-JMRI2>3.3.CO;2-C; Wharton S, 2010, NEUROIMAGE, V53, P515, DOI 10.1016/j.neuroimage.2010.06.070; Wharton S, 2010, MAGN RESON MED, V63, P1292, DOI 10.1002/mrm.22334; Yao B, 2009, NEUROIMAGE, V44, P1259, DOI 10.1016/j.neuroimage.2008.10.029; Ytrehus B, 2007, VET PATHOL, V44, P429, DOI 10.1354/vp.44-4-429	32	27	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0132167	10.1371/journal.pone.0132167	http://dx.doi.org/10.1371/journal.pone.0132167			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26168296	Green Submitted, Green Published, gold			2022-12-26	WOS:000358193100025
J	Smith, CE; Bowen, N; Graham, WJ; Goellner, EM; Srivatsan, A; Kolodner, RD				Smith, Catherine E.; Bowen, Nikki; Graham, William J.; Goellner, Eva M.; Srivatsan, Anjana; Kolodner, Richard D.			Activation of Saccharomyces cerevisiae Mlh1-Pms1 Endonuclease in a Reconstituted Mismatch Repair System	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA recombination; DNA repair; DNA replication; mutagenesis; proliferating cell nuclear antigen (PCNA); replication factor C (RFC); yeast genetics; exonuclease 1; genome instability; Msh2-Msh6	CELL NUCLEAR ANTIGEN; REPLICATION FACTOR-C; HUMAN EXONUCLEASE-I; MUTL-ALPHA; MSH2-MSH6 COMPLEX; ESCHERICHIA-COLI; MISPAIR-BINDING; DOMINANT MUTATIONS; COLORECTAL-CANCER; DNA-REPLICATION	Background: Biochemical analysis of S. cerevisiae MMR mutants has been limited by a lack of reconstituted MMR reactions. Results: 3 nick-directed Mlh1-Pms1-dependent endonuclease and reconstituted MMR reactions were developed. Conclusion: 3 nick-directed MMR required the Mlh1-Pms1 endonuclease and was eliminated by mutations inactivating Exo1-independent MMR. Significance: The reconstituted MMR reactions facilitated analysis of uncharacterized MMR mutants and the mechanism of Exo1-independent MMR. Previous studies reported the reconstitution of an Mlh1-Pms1-independent 5 nick-directed mismatch repair (MMR) reaction using Saccharomyces cerevisiae proteins. Here we describe the reconstitution of a mispair-dependent Mlh1-Pms1 endonuclease activation reaction requiring Msh2-Msh6 (or Msh2-Msh3), proliferating cell nuclear antigen (PCNA), and replication factor C (RFC) and a reconstituted Mlh1-Pms1-dependent 3 nick-directed MMR reaction requiring Msh2-Msh6 (or Msh2-Msh3), exonuclease 1 (Exo1), replication protein A (RPA), RFC, PCNA, and DNA polymerase . Both reactions required Mg2+ and Mn2+ for optimal activity. The MMR reaction also required two reaction stages in which the first stage required incubation of Mlh1-Pms1 with substrate DNA, with or without Msh2-Msh6 (or Msh2-Msh3), PCNA, and RFC but did not require nicking of the substrate, followed by a second stage in which other proteins were added. Analysis of different mutant proteins demonstrated that both reactions required a functional Mlh1-Pms1 endonuclease active site, as well as mispair recognition and Mlh1-Pms1 recruitment by Msh2-Msh6 but not sliding clamp formation. Mutant Mlh1-Pms1 and PCNA proteins that were defective for Exo1-independent but not Exo1-dependent MMR in vivo were partially defective in the Mlh1-Pms1 endonuclease and MMR reactions, suggesting that both reactions reflect the activation of Mlh1-Pms1 seen in Exo1-independent MMR in vivo. The availability of this reconstituted MMR reaction should now make it possible to better study both Exo1-independent and Exo1-dependent MMR.	[Smith, Catherine E.; Bowen, Nikki; Graham, William J.; Goellner, Eva M.; Srivatsan, Anjana; Kolodner, Richard D.] Univ Calif San Diego, Ludwig Inst Canc Res, Sch Med, La Jolla, CA 92093 USA; [Kolodner, Richard D.] Univ Calif San Diego, Dept Cellular & Mol Med, Sch Med, La Jolla, CA 92093 USA; [Kolodner, Richard D.] Univ Calif San Diego, Moores UCSD Canc Ctr, Sch Med, La Jolla, CA 92093 USA; [Kolodner, Richard D.] Univ Calif San Diego, Inst Genom Med, Sch Med, La Jolla, CA 92093 USA	Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Kolodner, RD (corresponding author), Univ Calif San Diego, Ludwig Inst Canc Res, Sch Med, La Jolla, CA 92093 USA.	rkolodner@ucsd.edu	Srivatsan, Anjana/S-1518-2017; Regan, Clinton/E-6250-2012; Srivatsan, Anjana/Q-6312-2017; Classen, Scott/AAY-8176-2020	Srivatsan, Anjana/0000-0003-1645-7075; Srivatsan, Anjana/0000-0003-1645-7075; 	National Institutes of Health [R01 GM50006, P01 CA92584, F32 GM106598]; NATIONAL CANCER INSTITUTE [P01CA092584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050006, F32GM106598] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM50006 and P01 CA92584 (to R. D. K.) and F32 GM106598 (to E. M. G.). The authors declare that they have no conflicts of interest with the contents of this article.	Abdel-Rahman WM, 2001, P NATL ACAD SCI USA, V98, P2538, DOI 10.1073/pnas.041603298; Acharya S, 1996, P NATL ACAD SCI USA, V93, P13629, DOI 10.1073/pnas.93.24.13629; ALANI E, 1994, GENETICS, V137, P19; Amin NS, 2001, MOL CELL BIOL, V21, P5142, DOI 10.1128/MCB.21.15.5142-5155.2001; Antony E, 2003, BIOCHEMISTRY-US, V42, P7682, DOI 10.1021/bi034602h; AU KG, 1992, J BIOL CHEM, V267, P12142; Ban C, 1998, CELL, V95, P541, DOI 10.1016/S0092-8674(00)81621-9; Ban C, 1999, CELL, V97, P85, DOI 10.1016/S0092-8674(00)80717-5; Ban C, 1998, EMBO J, V17, P1526, DOI 10.1093/emboj/17.5.1526; Blackwell LJ, 2001, J BIOL CHEM, V276, P33233, DOI 10.1074/jbc.M105076200; Bowen N, 2013, P NATL ACAD SCI USA, V110, P18472, DOI 10.1073/pnas.1318971110; Bowers J, 1999, J BIOL CHEM, V274, P16115, DOI 10.1074/jbc.274.23.16115; Campbell CS, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004327; Constantin N, 2005, J BIOL CHEM, V280, P39752, DOI 10.1074/jbc.M509701200; Das Gupta R, 2000, NAT GENET, V24, P53, DOI 10.1038/71684; Datta A, 1996, MOL CELL BIOL, V16, P1085; de la Chapelle A, 2004, NAT REV CANCER, V4, P769, DOI 10.1038/nrc1453; FIEN K, 1992, MOL CELL BIOL, V12, P155, DOI 10.1128/MCB.12.1.155; Flores-Rozas H, 2000, NAT GENET, V26, P375, DOI 10.1038/81708; Flores-Rozas H, 1998, P NATL ACAD SCI USA, V95, P12404, DOI 10.1073/pnas.95.21.12404; Fortune JM, 2006, NUCLEIC ACIDS RES, V34, P4335, DOI 10.1093/nar/gkl403; Genschel J, 1998, J BIOL CHEM, V273, P19895, DOI 10.1074/jbc.273.31.19895; Genschel J, 2003, MOL CELL, V12, P1077, DOI 10.1016/S1097-2765(03)00428-3; Genschel J, 2002, J BIOL CHEM, V277, P13302, DOI 10.1074/jbc.M111854200; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Goellner EM, 2014, MOL CELL, V55, P291, DOI 10.1016/j.molcel.2014.04.034; Gomes XV, 2000, J BIOL CHEM, V275, P14541, DOI 10.1074/jbc.275.19.14541; Gradia S, 1999, MOL CELL, V3, P255, DOI 10.1016/S1097-2765(00)80316-0; Gueneau E, 2013, NAT STRUCT MOL BIOL, V20, P461, DOI 10.1038/nsmb.2511; Harfe BD, 2000, CURR BIOL, V10, P145, DOI 10.1016/S0960-9822(00)00314-6; Harfe BD, 2000, ANNU REV GENET, V34, P359, DOI 10.1146/annurev.genet.34.1.359; Hargreaves VV, 2010, J BIOL CHEM, V285, P9301, DOI 10.1074/jbc.M109.096388; Hess MT, 2006, P NATL ACAD SCI USA, V103, P558, DOI 10.1073/pnas.0510078103; Hess MT, 2002, J BIOL CHEM, V277, P25545, DOI 10.1074/jbc.M202282200; Hombauer H, 2011, CELL, V147, P1040, DOI 10.1016/j.cell.2011.10.025; Iyer RR, 2008, J BIOL CHEM, V283, P13310, DOI 10.1074/jbc.M800606200; Iyer RR, 2010, J BIOL CHEM, V285, P11730, DOI 10.1074/jbc.M110.104125; Iyer RR, 2006, CHEM REV, V106, P302, DOI 10.1021/cr0404794; Jagmohan-Changur S, 2003, CANCER RES, V63, P154; Jeong C, 2011, NAT STRUCT MOL BIOL, V18, P379, DOI 10.1038/nsmb.2009; Jiricny J, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012633; Kadyrov FA, 2007, J BIOL CHEM, V282, P37181, DOI 10.1074/jbc.M707617200; Kadyrov FA, 2006, CELL, V126, P297, DOI 10.1016/j.cell.2006.05.039; Kadyrov FA, 2009, P NATL ACAD SCI USA, V106, P8495, DOI 10.1073/pnas.0903654106; Kleczkowska HE, 2001, GENE DEV, V15, P724, DOI 10.1101/gad.191201; Kolodner RD, 1999, CURR OPIN GENET DEV, V9, P89, DOI 10.1016/S0959-437X(99)80013-6; Kosinski J, 2008, J MOL BIOL, V382, P610, DOI 10.1016/j.jmb.2008.06.056; Lau PJ, 2002, MOL CELL BIOL, V22, P6669, DOI 10.1128/MCB.22.19.6669-6680.2002; Lee SD, 2007, J MOL BIOL, V366, P53, DOI 10.1016/j.jmb.2006.10.099; LI GM, 1995, P NATL ACAD SCI USA, V92, P1950, DOI 10.1073/pnas.92.6.1950; Li GM, 2008, CELL RES, V18, P85, DOI 10.1038/cr.2007.115; Lin YL, 1998, J BIOL CHEM, V273, P1453, DOI 10.1074/jbc.273.3.1453; Marsischky GT, 1999, J BIOL CHEM, V274, P26668, DOI 10.1074/jbc.274.38.26668; Marsischky GT, 1996, GENE DEV, V10, P407, DOI 10.1101/gad.10.4.407; Mendillo ML, 2005, J BIOL CHEM, V280, P22245, DOI 10.1074/jbc.M407545200; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nakagawa T, 2001, J BIOL CHEM, V276, P31487, DOI 10.1074/jbc.M104003200; Palombo F, 1996, CURR BIOL, V6, P1181, DOI 10.1016/S0960-9822(02)70685-4; Peltomaki P, 2003, J CLIN ONCOL, V21, P1174, DOI 10.1200/JCO.2003.04.060; Pluciennik A, 2010, P NATL ACAD SCI USA, V107, P16066, DOI 10.1073/pnas.1010662107; Plys AJ, 2012, J MOL BIOL, V422, P192, DOI 10.1016/j.jmb.2012.05.030; PROLLA TA, 1994, SCIENCE, V265, P1091, DOI 10.1126/science.8066446; Putnam CD, 2009, NATURE, V460, P984, DOI 10.1038/nature08217; RAYSSIGUIER C, 1989, NATURE, V342, P396, DOI 10.1038/342396a0; REENAN RAG, 1992, GENETICS, V132, P975; Sacho EJ, 2008, MOL CELL, V29, P112, DOI 10.1016/j.molcel.2007.10.030; Schmutte C, 1998, CANCER RES, V58, P4537; Shell SS, 2007, P NATL ACAD SCI USA, V104, P10956, DOI 10.1073/pnas.0704148104; Shell SS, 2007, MOL CELL, V26, P565, DOI 10.1016/j.molcel.2007.04.024; Sia EA, 1997, MOL CELL BIOL, V17, P2851, DOI 10.1128/MCB.17.5.2851; Smith CE, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003869; Spies M, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a022657; Srivatsan A, 2014, J BIOL CHEM, V289, P9352, DOI 10.1074/jbc.M114.552190; Tishkoff DX, 1998, CANCER RES, V58, P5027; Tishkoff DX, 1997, P NATL ACAD SCI USA, V94, P7487, DOI 10.1073/pnas.94.14.7487; Tomer G, 2002, J BIOL CHEM, V277, P21801, DOI 10.1074/jbc.M111342200; Tran HT, 1999, MOL CELL BIOL, V19, P2000; Tran PT, 2000, MOL CELL BIOL, V20, P6390, DOI 10.1128/MCB.20.17.6390-6398.2000; Tran PT, 2004, DNA REPAIR, V3, P1549, DOI 10.1016/j.dnarep.2004.05.015; Tran PT, 2001, P NATL ACAD SCI USA, V98, P9760, DOI 10.1073/pnas.161175998; Wang TF, 1999, P NATL ACAD SCI USA, V96, P13914, DOI 10.1073/pnas.96.24.13914; Wei KC, 2003, GENE DEV, V17, P603, DOI 10.1101/gad.1060603; Wilson T, 1999, J BIOL CHEM, V274, P21659, DOI 10.1074/jbc.274.31.21659; Zhang YB, 2005, CELL, V122, P693, DOI 10.1016/j.cell.2005.06.027	84	22	22	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2015	290	35					21580	21590		10.1074/jbc.M115.662189	http://dx.doi.org/10.1074/jbc.M115.662189			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ5IS	26170454	Green Published, hybrid			2022-12-26	WOS:000360637600031
J	Birken, CS; Lebovic, G; Anderson, LN; McCrindle, BW; Mamdani, M; Kandasamy, S; Khovratovich, M; Parkin, PC; Maguire, JL				Birken, Catherine S.; Lebovic, Gerald; Anderson, Laura N.; McCrindle, Brian W.; Mamdani, Muhammad; Kandasamy, Sharmilaa; Khovratovich, Marina; Parkin, Patricia C.; Maguire, Jonathon L.		TARGet Kids Collaboration	Association between Vitamin D and Circulating Lipids in Early Childhood	PLOS ONE			English	Article							CARDIOVASCULAR RISK-FACTORS; SERUM 25-HYDROXYVITAMIN D; METABOLIC SYNDROME; CARDIOMETABOLIC RISK; YOUNG-ADULTS; D DEFICIENCY; US CHILDREN; ADOLESCENTS; PREVALENCE; DISEASE	Vitamin D is associated with established cardiovascular risk factors such as low density lipoprotein (LDL) in adults. It is unknown whether these associations are present in early childhood. To determine whether serum 25-hydroxyvitamin D (25(OH) D) is associated with serum non-high density lipoprotein (non-HDL) cholesterol during early childhood we conducted a cross-sectional study of children aged 1 to 5 years. Healthy children were recruited through the TARGet Kids! practice based research network from 2008-2011 (n=1,961). The associations between 25(OH) D and non-fasting non-HDL cholesterol (the primary endpoint), total cholesterol, triglycerides, HDL, and low density lipoprotein (LDL) cholesterol, were evaluated using multiple linear regression adjusted for age, sex, skin pigmentation, milk intake, vitamin D supplementation, season, body mass index, outdoor play, and screen time. Each 10 nmol/L increase in 25(OH) D was associated with a decrease in non-HDL cholesterol concentration of -0.89 mg/dl (95% CI: -1.16,-0.50), total cholesterol of -1.08 mg/dl (95% CI: -1.49,-0.70), and triglycerides of -2.34 mg/dl (95% CI: -3.23,-1.45). The associations between 25(OH) D and LDL and HDL were not statistically significant. 25(OH) D concentrations were inversely associated with circulating lipids in early childhood, suggesting that vitamin D exposure in early life may be an early modifiable risk factor for cardiovascular disease.	[Birken, Catherine S.; Anderson, Laura N.; Khovratovich, Marina; Parkin, Patricia C.; Maguire, Jonathon L.] Hosp Sick Children, Dept Paediat, Div Paediat Med, Pediat Outcomes Res Team, Toronto, ON M5G 1X8, Canada; [Birken, Catherine S.; McCrindle, Brian W.; Parkin, Patricia C.; Maguire, Jonathon L.] Univ Toronto, Fac Med, Dept Pediat, Toronto, ON, Canada; [Birken, Catherine S.; Lebovic, Gerald; Parkin, Patricia C.; Maguire, Jonathon L.] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Lebovic, Gerald; Anderson, Laura N.; Mamdani, Muhammad; Kandasamy, Sharmilaa; Maguire, Jonathon L.] St Michaels Hosp, Li Ka Shing Knowledge Inst, Appl Hlth Res Ctr, Toronto, ON M5B 1W8, Canada; [McCrindle, Brian W.] Hosp Sick Children, Div Cardiol, Toronto, ON M5G 1X8, Canada; [Mamdani, Muhammad] Univ Toronto, Leslie Dan Fac Pharm, Toronto, ON, Canada; [Maguire, Jonathon L.] St Michaels Hosp, Dept Pediat, Toronto, ON M5B 1W8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	Birken, CS (corresponding author), Hosp Sick Children, Dept Paediat, Div Paediat Med, Pediat Outcomes Res Team, Toronto, ON M5G 1X8, Canada.	catherine.birken@sickkids.ca	Anderson, Laura/K-4707-2019	Anderson, Laura/0000-0002-6106-5073; Borkhoff, Cornelia/0000-0003-3420-1866; Lebovic, Gerald/0000-0003-3540-3339	Canadian Institutes of Health Research (CIHR); St. Michael's Hospital Foundation; Hospital for Sick Children Foundation	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); St. Michael's Hospital Foundation; Hospital for Sick Children Foundation	This work was supported by the Canadian Institutes of Health Research (CIHR), as well as the St. Michael's Hospital Foundation. The Pediatric Outcomes Research Team is supported by a grant from the Hospital for Sick Children Foundation. Funding agencies had no role in the design, collection, analyses or interpretation of data, the writing of the report, or the decision to submit the manuscript for publication.	American Heart Association, 2006, HEART DIS STROK STAT; [Anonymous], REGRESSION MODELING; [Anonymous], 2011, DIET REF INT CALC VI; Arnberg K, 2011, ACTA PAEDIATR, V100, P1244, DOI 10.1111/j.1651-2227.2011.02273.x; Ashraf AP, 2011, OBESITY, V19, P2214, DOI 10.1038/oby.2011.110; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berenson GS, 1998, NEW ENGL J MED, V338, P1650, DOI 10.1056/NEJM199806043382302; Carsley S, 2015, INT J EPIDEMIOL, V44, P776, DOI 10.1093/ije/dyu123; de Onis Mercedes, 2003, Forum Nutr, V56, P238; Delvin EE, 2010, J NUTR, V140, P987, DOI 10.3945/jn.109.112250; Dietitians of Canada, 2010, Can J Diet Pract Res, V71, pe1; DUAN N, 1983, J AM STAT ASSOC, V78, P605, DOI 10.2307/2288126; Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents, 2011, Pediatrics, V128 Suppl 5, pS213, DOI 10.1542/peds.2009-2107C; FITZPATRICK TB, 1988, ARCH DERMATOL, V124, P869, DOI 10.1001/archderm.124.6.869; Ford ES, 2005, DIABETES CARE, V28, P1228, DOI 10.2337/diacare.28.5.1228; Ganji V, 2011, AM J CLIN NUTR, V94, P225, DOI 10.3945/ajcn.111.013516; Johnson MD, 2010, J PEDIATR-US, V156, P444, DOI 10.1016/j.jpeds.2009.09.070; Jorde R, 2011, PROG LIPID RES, V50, P303, DOI 10.1016/j.plipres.2011.05.001; Khera AV, 2012, ARCH INTERN MED, V172, P1710, DOI 10.1001/2013.jamainternmed.263; Kumar J, 2009, PEDIATRICS, V124, pE362, DOI 10.1542/peds.2009-0051; LAUER RM, 1990, JAMA-J AM MED ASSOC, V264, P3034, DOI 10.1001/jama.264.23.3034; Maunsell Z, 2005, CLIN CHEM, V51, P1683, DOI 10.1373/clinchem.2005.052936; Norman PE, 2014, CIRC RES, V114, P379, DOI 10.1161/CIRCRESAHA.113.301241; Pacifico L, 2011, EUR J ENDOCRINOL, V165, P603, DOI 10.1530/EJE-11-0545; Pilz S, 2011, CLIN ENDOCRINOL, V75, P575, DOI 10.1111/j.1365-2265.2011.04147.x; Raitakari OT, 2003, JAMA-J AM MED ASSOC, V290, P2277, DOI 10.1001/jama.290.17.2277; Rajakumar K, 2011, J CLIN ENDOCR METAB, V96, P1560, DOI 10.1210/jc.2010-2388; Sacheck J, 2011, J PEDIATR-US, V159, P945, DOI 10.1016/j.jpeds.2011.06.001; Schnatz PF, 2014, CLIN CHEM, V60, P600, DOI 10.1373/clinchem.2013.211037; Singh RJ, 2006, J CLIN ENDOCR METAB, V91, P3055, DOI 10.1210/jc.2006-0710; Skaaby T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057647; Steiner MJ, 2011, PEDIATRICS, V128, P463, DOI 10.1542/peds.2011-0844; Strong JP, 1999, JAMA-J AM MED ASSOC, V281, P727, DOI 10.1001/jama.281.8.727; Wang L, 2012, CIRC-CARDIOVASC QUAL, V5, P819, DOI 10.1161/CIRCOUTCOMES.112.967604; Warnick GR, 2008, CLIN CHEM, V54, P14, DOI 10.1373/clinchem.2007.098863; Williams DM, 2012, J CLIN ENDOCR METAB, V97, P1563, DOI 10.1210/jc.2011-2335; Williams DM, 2011, HEART, V97, P315, DOI 10.1136/hrt.2010.203224	37	18	19	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0131938	10.1371/journal.pone.0131938	http://dx.doi.org/10.1371/journal.pone.0131938			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176958	gold, Green Published, Green Submitted			2022-12-26	WOS:000358197600071
J	Kojima, N; Kim, M; Saito, K; Yoshida, H; Yoshida, Y; Hirano, H; Obuchi, S; Shimada, H; Suzuki, T; Kim, H				Kojima, Narumi; Kim, Miji; Saito, Kyoko; Yoshida, Hideyo; Yoshida, Yuko; Hirano, Hirohiko; Obuchi, Shuichi; Shimada, Hiroyuki; Suzuki, Takao; Kim, Hunkyung			Lifestyle-Related Factors Contributing to Decline in Knee Extension Strength among Elderly Women: A Cross-Sectional and Longitudinal Cohort Study	PLOS ONE			English	Article							MUSCLE STRENGTH; PHYSICAL PERFORMANCE; SERUM-ALBUMIN; FUNCTIONAL-CAPACITY; PROTEIN-INTAKE; GRIP STRENGTH; OLDER WOMEN; COMMUNITY; VITAMIN; EXERCISE	This cross-sectional and 4-year longitudinal cohort study aimed to clarify how various lifestyle-related variables affect knee extension strength in elderly Japanese women. The participants were community-dwelling women (n = 575) living in the Itabashi Ward of Tokyo, Japan aged 75-85 years at baseline (in 2008) who returned for a follow-up examination 4 years later (in 2012). Maximum isometric knee extension strength in the dominant leg was measured during comprehensive medical check-ups at baseline and follow-up. Interviews with participants included questions on their history of 11 diseases and lifestyle-related factors such as physical activity as well as dietary, smoking, and drinking habits. Cross-sectional and longitudinal analyses yielded inconsistent results regarding the associations between lifestyle-related factors and knee extension strength. While going out more frequently and regular physical exercise positively affected baseline knee extension strength, they did not affect knee extension strength in the longitudinal analysis. The longitudinal analysis revealed that more frequent intake of soy products or green and yellow vegetables at baseline decreased age-related knee extension strength decline. The inconsistent results from the cross-sectional and longitudinal analyses indicate that conducting both types of analyses is crucial for researching this type of subject. The present study demonstrates that the age-related decline in muscle strength is lower in those who frequently eat soy products or green and yellow vegetables. Thus, recommending higher intake of soy products, and green and yellow vegetables for the elderly might help maintain their muscle health.	[Kojima, Narumi; Kim, Miji; Yoshida, Hideyo; Yoshida, Yuko; Hirano, Hirohiko; Obuchi, Shuichi; Kim, Hunkyung] Tokyo Metropolitan Inst Gerontol, Itabashi Ku, Tokyo, Japan; [Saito, Kyoko] Yokohama City Univ, Grad Sch Med, Kanazawa Ku, Yokohama, Kanagawa 232, Japan; [Shimada, Hiroyuki; Suzuki, Takao] Natl Ctr Geriatr & Gerontol, Res Inst, Obu, Aichi, Japan	Tokyo Metropolitan Institute of Gerontology; Yokohama City University; National Center for Geriatrics & Gerontology	Kojima, N (corresponding author), Tokyo Metropolitan Inst Gerontol, Itabashi Ku, Tokyo, Japan.	nkojima@tmig.or.jp		Kojima, Narumi/0000-0001-5742-0389				[Anonymous], 1997, JAMA-J AM MED ASSOC, V277, P925; Azegami M, 2007, NURS HEALTH SCI, V9, P168, DOI 10.1111/j.1442-2018.2007.00317.x; Bischoff HA, 1999, ARCH PHYS MED REHAB, V80, P54, DOI 10.1016/S0003-9993(99)90307-6; Cesari M, 2004, AM J CLIN NUTR, V79, P289; Cote MP, 2014, HUM FACTORS, V56, P228, DOI 10.1177/0018720813518220; Ekino S, 2007, J NEUROL SCI, V262, P131, DOI 10.1016/j.jns.2007.06.036; FIATARONE MA, 1994, NEW ENGL J MED, V330, P1769, DOI 10.1056/NEJM199406233302501; Forrest KYZ, 2007, GERONTOLOGY, V53, P140, DOI 10.1159/000097979; Hughes VA, 2001, J GERONTOL A-BIOL, V56, pB209, DOI 10.1093/gerona/56.5.B209; Imai E, 2014, J AM GERIATR SOC, V62, P426, DOI 10.1111/jgs.12690; Kaneki M, 2001, NUTRITION, V17, P315, DOI 10.1016/S0899-9007(00)00554-2; Katsuyama H, 2004, J NUTR SCI VITAMINOL, V50, P114, DOI 10.3177/jnsv.50.114; Kim H, 2013, ARCH GERONTOL GERIAT, V57, P352, DOI 10.1016/j.archger.2013.06.008; Kim H, 2013, GERIATR GERONTOL INT, V13, P458, DOI 10.1111/j.1447-0594.2012.00923.x; Kimura M, 2013, BMC GERIATR, V13, DOI 10.1186/1471-2318-13-8; Kitamura Kaori, 2012, Environmental Health and Preventive Medicine, V17, P164, DOI 10.1007/s12199-011-0233-y; Kojima N, 2014, GERIATR GERONTOL INT, V14, P674, DOI 10.1111/ggi.12158; Kumagai Shu, 2003, Nihon Koshu Eisei Zasshi, V50, P1117; Kwon J, 2006, EUR J CLIN NUTR, V60, P305, DOI 10.1038/sj.ejcn.1602314; Lands LC, 1999, J APPL PHYSIOL, V87, P1381, DOI 10.1152/jappl.1999.87.4.1381; Lauretani F, 2008, J GERONTOL A-BIOL, V63, P376, DOI 10.1093/gerona/63.4.376; Michelon E, 2006, J GERONTOL A-BIOL, V61, P600, DOI 10.1093/gerona/61.6.600; Mizushige T, 2010, BIOMED RES-TOKYO, V31, P347, DOI 10.2220/biomedres.31.347; Mori Mari, 2004, Clin Exp Pharmacol Physiol, V31 Suppl 2, pS44, DOI 10.1111/j.1440-1681.2004.04118.x; Mori Mari, 2004, Clin Exp Pharmacol Physiol, V31 Suppl 2, pS39, DOI 10.1111/j.1440-1681.2004.04117.x; Okamura T, 2008, J AM GERIATR SOC, V56, P529, DOI 10.1111/j.1532-5415.2007.01549.x; Rantanen T, 1998, J APPL PHYSIOL, V85, P2047, DOI 10.1152/jappl.1998.85.6.2047; Rantanen Taina, 2002, Aging Clin Exp Res, V14, P10; Renzoni A, 1998, ENVIRON RES, V77, P68, DOI 10.1006/enrs.1998.3832; Robinson SM, 2008, J AM GERIATR SOC, V56, P84, DOI 10.1111/j.1532-5415.2007.01478.x; Saito K, 2012, J GERONTOL A-BIOL, V67, P295, DOI 10.1093/gerona/glr174; Semba RD, 2003, AGING CLIN EXP RES, V15, P482, DOI 10.1007/BF03327377; Semba RD, 2007, ARCH BIOCHEM BIOPHYS, V458, P141, DOI 10.1016/j.abb.2006.11.025; Snyder CK, 2012, J AM GERIATR SOC, V60, P1663, DOI 10.1111/j.1532-5415.2012.04115.x; Stenholm S, 2012, J AM GERIATR SOC, V60, P77, DOI 10.1111/j.1532-5415.2011.03779.x	35	10	10	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132523	10.1371/journal.pone.0132523	http://dx.doi.org/10.1371/journal.pone.0132523			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1RL	26177292	Green Published, Green Submitted, gold			2022-12-26	WOS:000358197600120
J	Magrach, A; Ghazoul, J				Magrach, Ainhoa; Ghazoul, Jaboury			Climate and Pest-Driven Geographic Shifts in Global Coffee Production: Implications for Forest Cover, Biodiversity and Carbon Storage	PLOS ONE			English	Article							LAND; CONSERVATION; ADAPTATION	Coffee is highly sensitive to temperature and rainfall, making its cultivation vulnerable to geographic shifts in response to a changing climate. This could lead to the establishment of coffee plantations in new areas and potential conflicts with other land covers including natural forest, with consequent implications for biodiversity and ecosystem services. We project areas suitable for future coffee cultivation based on several climate scenarios and expected responses of the coffee berry borer, a principle pest of coffee crops. We show that the global climatically-suitable area will suffer marked shifts from some current major centres of cultivation. Most areas will be suited to Robusta coffee, demand for which could be met without incurring forest encroachment. The cultivation of Arabica, which represents 70% of consumed coffee, can also be accommodated in the future, but only by incurring some natural forest loss. This has corresponding implications for carbon storage, and is likely to affect areas currently designated as priority areas for biodiversity. Where Arabica coffee does encroach on natural forests, we project average local losses of 35% of threatened vertebrate species. The interaction of climate and coffee berry borer greatly influences projected outcomes.	[Magrach, Ainhoa; Ghazoul, Jaboury] ETH, Inst Terr Ecosyst, CH-8092 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Magrach, A (corresponding author), ETH, Inst Terr Ecosyst, CHN G 73-1 Univ Str 16, CH-8092 Zurich, Switzerland.	ainhoa.magrach@usys.ethz.chmailto	Ghazoul, Jaboury/B-2121-2018		Eidgenossische Technische Hochschule Zurich-Marie Curie CoFund [FEL-04 13-1]; ETH-Marie Curie postdoctoral fellowship	Eidgenossische Technische Hochschule Zurich-Marie Curie CoFund; ETH-Marie Curie postdoctoral fellowship	This study was funded by an Eidgenossische Technische Hochschule Zurich-Marie Curie CoFund (FEL-04 13-1). AM was funded by an ETH-Marie Curie postdoctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], ENV FACTORS SUITABLE; Araujo MB, 2006, J BIOGEOGR, V33, P1677, DOI 10.1111/j.1365-2699.2006.01584.x; Avelino J, 2015, FOOD SECUR, V7, P303, DOI 10.1007/s12571-015-0446-9; Baek HJ, 2013, ASIA-PAC J ATMOS SCI, V49, P603, DOI 10.1007/s13143-013-0053-7; Bartholome E, 2005, INT J REMOTE SENS, V26, P1959, DOI 10.1080/01431160412331291297; Battisti DS, 2009, SCIENCE, V323, P240, DOI 10.1126/science.1164363; Bhagwat SA, 2005, CONSERV BIOL, V19, P1853, DOI 10.1111/j.1523-1739.2005.00248.x; Bryant D., 1997, LAST FRONTIER FOREST; Bunn C, 2015, CLIMATIC CHANGE, V129, P89, DOI 10.1007/s10584-014-1306-x; Butchart Stuart H M, 2012, PLoS One, V7, pe32529, DOI 10.1371/journal.pone.0032529; CABI, HYP HAMP; CIAT, 2012, FUT CLIM SCEN VIETN; DaMatta Fábio M., 2006, Braz. J. Plant Physiol., V18, P55, DOI 10.1590/S1677-04202006000100006; Davis AS, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0047149, 10.1371/journal.pone.0047981]; DeFries RS, 2010, NAT GEOSCI, V3, P178, DOI 10.1038/NGEO756; Dossa EL, 2008, AGROFOREST SYST, V72, P103, DOI 10.1007/s10457-007-9075-4; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; FAO, 2006, DIG SOIL MAP WORLD D; FAO, 2014, FAOSTAT STAT DAT DAT; Fernandes FL, 2011, J ECON ENTOMOL, V104, P1909, DOI 10.1603/EC11032; Gibbs HK, 2010, P NATL ACAD SCI USA, V107, P16732, DOI 10.1073/pnas.0910275107; Haggar J., 2012, COFFEE CLIMATE CHANG; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hoekstra JM, 2005, ECOL LETT, V8, P23, DOI 10.1111/j.1461-0248.2004.00686.x; ICO. International Coffee Organization, 2014, HIST DAT; Intergovernmental Panel on Climate Change (IPCC), 2013, CLIM CHANG 2013 PHYS; Jaramillo J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051815; Jaramillo J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024528; Jarvis A., 2008, HOLE FILLED SRTM GLO; Koh LP, 2010, P NATL ACAD SCI USA, V107, P11140, DOI 10.1073/pnas.1000530107; Laderach P, 2011, CLIM CHANG MANAG, P703, DOI 10.1007/978-3-642-14776-0_42; Lan C.C., 2004, COFFEE CROWING PROCE, P459; Lobell DB, 2008, SCIENCE, V319, P607, DOI 10.1126/science.1152339; Mayer A, 2013, BIOSCIENCE, V63, P781, DOI 10.1525/bio.2013.63.10.2; Meyfroidt P, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/7/074012; Mittermeier RA, 2003, P NATL ACAD SCI USA, V100, P10309, DOI 10.1073/pnas.1732458100; Mittermeier Russell A., 2004, P1; Monfreda C, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB002947; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; NatureServe and BirdLife International, 2014, BIRD SPEC DISTR MAPS; O'Brien TG, 2003, SCIENCE, V300, P587, DOI 10.1126/science.1082328; Olson DM, 1998, CONSERV BIOL, V12, P502, DOI 10.1046/j.1523-1739.1998.012003502.x; Olson DM, 2002, ANN MO BOT GARD, V89, P199, DOI 10.2307/3298564; Parolo G, 2008, J APPL ECOL, V45, P1410, DOI 10.1111/j.1365-2664.2008.01516.x; Perfecto I, 2005, ECOL ECON, V54, P435, DOI 10.1016/j.ecolecon.2004.10.009; Peters VE, 2012, AGROFOREST SYST, V85, P95, DOI 10.1007/s10457-011-9476-2; Power S, 2013, NATURE, V502, P541, DOI 10.1038/nature12580; Raes N, 2007, ECOGRAPHY, V30, P727, DOI 10.1111/j.2007.0906-7590.05041.x; Ramankutty N, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB002952; Ramirez-Villegas J, 2012, CLIMATIC CHANGE, V115, P611, DOI 10.1007/s10584-012-0500-y; Ruesch A., 2008, NEW IPCC TIER 1 GLOB; Sanderson EW, 2002, BIOSCIENCE, V52, P891, DOI 10.1641/0006-3568(2002)052[0891:THFATL]2.0.CO;2; Schipper J, 2008, SCIENCE, V322, P225, DOI 10.1126/science.1165115; Stattersfield A.J., 1998, ENDEMIC BIRD AREAS W, V115, P1089, DOI 10.2307/4089533; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Tscharntke T, 2011, J APPL ECOL, V48, P619, DOI 10.1111/j.1365-2664.2010.01939.x; USAID, 2013, UG CLIM CHANG VULN A; USDA, 2012, PROD SUPPL DISTR ONL; Vermeulen SJ, 2013, P NATL ACAD SCI USA, V110, P8357, DOI 10.1073/pnas.1219441110; Weyant J, 2009, REPORT OF 2 6 VERSUS; WorldClim, 2013, WORLDCLIM GLOB CLIM	61	62	63	1	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0133071	10.1371/journal.pone.0133071	http://dx.doi.org/10.1371/journal.pone.0133071			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177201	Green Published, Green Submitted, gold			2022-12-26	WOS:000358197600209
J	Miles, WTS; Mavor, R; Riddiford, NJ; Harvey, PV; Riddington, R; Shaw, DN; Parnaby, D; Reid, JM				Miles, Will T. S.; Mavor, Roddy; Riddiford, Nick J.; Harvey, Paul V.; Riddington, Roger; Shaw, Deryk N.; Parnaby, David; Reid, Jane M.			Decline in an Atlantic Puffin Population: Evaluation of Magnitude and Mechanisms	PLOS ONE			English	Article							SKUAS STERCORARIUS-SKUA; GREAT SKUAS; FRATERCULA-ARCTICA; CATHARACTA-SKUA; LONG-TERM; FOOD AVAILABILITY; ADULT SURVIVAL; ENVIRONMENTAL VARIABILITY; RELATIVE IMPORTANCE; AMMODYTES-MARINUS	Determining which demographic and ecological parameters contribute to variation in population growth rate is crucial to understanding the dynamics of declining populations. This study aimed to evaluate the magnitude and mechanisms of an apparent major decline in an Atlantic Puffin Fratercula arctica population. This was achieved using a 27-year dataset to estimate changes in population size and in two key demographic rates: adult survival and breeding success. Estimated demographic variation was then related to two ecological factors hypothesised to be key drivers of demographic change, namely the abundance of the main predator at the study site, the Great Skua Stercorarius skua, and Atlantic Puffin chick food supply, over the same 27-year period. Using a population model, we assessed whether estimated variation in adult survival and reproductive success was sufficient to explain the population change observed. Estimates of Atlantic Puffin population size decreased considerably during the study period, approximately halving, whereas Great Skua population estimates increased, approximately trebling. Estimated adult Atlantic Puffin survival remained high across all years and did not vary with Great Skua abundance; however, Atlantic Puffin breeding success and quantities of fish prey brought ashore by adults both decreased substantially through the period. A population model combining best possible demographic parameter estimates predicted rapid population growth, at odds with the long-term decrease observed. To simulate the observed decrease, population models had to incorporate low immature survival, high immature emigration, or increasingly high adult non-breeding rates. We concluded that reduced recruitment of immatures into the breeding population was the most likely cause of population decrease. This study showed that increase in the size of a predator population does not always impact on the survival of adult prey and that reduced recruitment can be a crucial determinant of seabird population size but can easily go undetected.	[Miles, Will T. S.; Reid, Jane M.] Univ Aberdeen, Inst Biol & Environm Sci, Aberdeen, Aberdeen, Scotland; [Mavor, Roddy] Joint Nat Conservat Comm, Aberdeen, Aberdeen, Scotland; [Riddiford, Nick J.; Shaw, Deryk N.; Parnaby, David] Fair Isle Bird Observ, Fair Isle, Shetland, Scotland; [Harvey, Paul V.] Shetland Amen Trust, Shetland Biol Records Ctr, Lerwick, Shetland, Scotland; [Riddington, Roger] Spindrift, Virkie, Shetland, Scotland	University of Aberdeen	Miles, WTS (corresponding author), Univ Aberdeen, Inst Biol & Environm Sci, Aberdeen, Aberdeen, Scotland.	w.miles@abdn.ac.uk			Fair Isle Bird Observatory Trust; Fair Isle Bird Observatory	Fair Isle Bird Observatory Trust; Fair Isle Bird Observatory	This study was funded annually by Fair Isle Bird Observatory Trust (www.fairislebirdobs.co.uk) with contributions from the Joint Nature Conservation Committee (jncc.defra.gov.uk). Funding was received from these two sources by Fair Isle Bird Observatory from 1986 to 2013. The Joint Nature Conservation Committee and Fair Isle Bird Observatory Trust supplied guidance on study design, data collection, analyses, preparation of the manuscript and the decision to publish.	Bergallo HG, 1999, J MAMMAL, V80, P472, DOI 10.2307/1383294; Birkhead, 1993, GREAT AUK ISLANDS; Bogdanova MI, 2011, P ROY SOC B-BIOL SCI, V278, P2412, DOI 10.1098/rspb.2010.2601; Bradley JS, 2000, J ANIM ECOL, V69, P639, DOI 10.1046/j.1365-2656.2000.00422.x; BRAULT S, 1993, ECOLOGY, V74, P1444, DOI 10.2307/1940073; Bretagnolle V, 1998, BEHAVIOUR, V135, P1161, DOI 10.1163/156853998792913555; Breton AR, 2014, IBIS, V156, P35, DOI 10.1111/ibi.12100; Breton AR, 2006, ECOL MONOGR, V76, P133, DOI 10.1890/05-0704; Breton AR, 2005, AUK, V122, P773, DOI 10.1642/0004-8038(2005)122[0773:ASEFTA]2.0.CO;2; Brinkhof MWG, 1997, P ROY SOC B-BIOL SCI, V264, P291, DOI 10.1098/rspb.1997.0041; Brooke M, 1994, ALBATROSSES PETRELS; Buche BI, 2013, SEABIRD MONITO UNPUB; Burnham KP, 2002, J APPL STAT, V29, P245, DOI 10.1080/02664760120108755; Burnham KP, 1998, MODEL SELECTION INF; Caswell, 2000, MATRIX POPULATION MO; Chen LH, 2014, HYDROBIOLOGIA, V726, P179, DOI 10.1007/s10750-013-1763-7; Chu CJ, 2014, J ECOL, V102, P531, DOI 10.1111/1365-2745.12212; Clutton-Brock T. H., 1989, RED DEER HIGHLANDS; Cook ASCP, 2014, ECOL INDIC, V38, P1, DOI 10.1016/j.ecolind.2013.10.027; Coulson J.C., 2011, THE KITTIWAKE; COULSON JC, 1984, IBIS, V126, P525, DOI 10.1111/j.1474-919X.1984.tb02078.x; Coulson T, 2001, SCIENCE, V292, P1528, DOI 10.1126/science.292.5521.1528; Croxall J.P., 1991, Oxford Ornithology Series, P272; Croxall JP., 1987, SEABIRDS FEEDING ECO; Daunt F, 2006, BEHAV ECOL SOCIOBIOL, V59, P381, DOI 10.1007/s00265-005-0061-4; Daunt F, 2008, CAN J FISH AQUAT SCI, V65, P362, DOI 10.1139/F07-164; Dawson NM, 2011, IBIS, V153, P143, DOI 10.1111/j.1474-919X.2010.01065.x; Doxa A, 2013, ANIM CONSERV, V16, P684, DOI 10.1111/acv.12048; Edgar GJ, 2014, NATURE, V506, P216, DOI 10.1038/nature13022; Erikstad KE, 1998, ECOLOGY, V79, P1781; Espin S, 2012, MAR POLLUT BULL, V64, P2461, DOI 10.1016/j.marpolbul.2012.07.045; Finney SK, 2003, J APPL ECOL, V40, P545, DOI 10.1046/j.1365-2664.2003.00810.x; Foster S, 2012, BIODIVERSITY SEABIRD; Franklin AB, 2002, J APPL STAT, V29, P267, DOI 10.1080/02664760120108719; Frederiksen M, 2004, J APPL ECOL, V41, P1129, DOI 10.1111/j.0021-8901.2004.00966.x; Frederiksen M, 2006, J ANIM ECOL, V75, P1259, DOI 10.1111/j.1365-2656.2006.01148.x; Furness R. W., 1987, SKUAS; Furness RW, 2003, SCI MAR, V67, P33, DOI 10.3989/scimar.2003.67s233; FURNESS RW, 1981, J ZOOL, V195, P1, DOI 10.1111/j.1469-7998.1981.tb01890.x; Furness RW, 1997, ICES J MAR SCI, V54, P726, DOI 10.1006/jmsc.1997.0243; Gaillard JM, 1998, TRENDS ECOL EVOL, V13, P58, DOI 10.1016/S0169-5347(97)01237-8; Gaston A.J., 2004, SEABIRDS NATURAL HIS; HARRIS M P, 1982, Scottish Birds, V12, P11; Harris Michael P., 2012, Ringing & Migration, V27, P43; HARRIS MP, 1983, IBIS, V125, P109, DOI 10.1111/j.1474-919X.1983.tb03088.x; Harris MP, 2005, MAR ECOL PROG SER, V297, P283, DOI 10.3354/meps297283; Harris MP, 1997, J AVIAN BIOL, V28, P287, DOI 10.2307/3676941; Harris MP, 1989, 941 NCC CSD; Harris P, 2011, THE PUFFIN; Heath M, 2009, MARINE CLIMATE CHANG, P1; Heppell SS, 2000, ECOLOGY, V81, P654, DOI 10.1890/0012-9658(2000)081[0654:LHAEPP]2.0.CO;2; Hooper T, 2014, MAR POLICY, V43, P295, DOI 10.1016/j.marpol.2013.06.011; Horswill C, 2014, J ANIM ECOL, V83, P1057, DOI 10.1111/1365-2656.12229; Hoyt E., 1981, ORCA WHALE CALLED KI, P175; Jenouvrier S, 2005, ECOLOGY, V86, P2889, DOI 10.1890/05-0514; Jenouvrier S, 2013, GLOBAL CHANGE BIOL, V19, P2036, DOI 10.1111/gcb.12195; Jones IL, 2013, IBIS, V155, P1, DOI 10.1111/ibi.12015; Jones IL, 2002, OECOLOGIA, V133, P38, DOI 10.1007/s00442-002-0991-8; Kappes PJ, 2014, BIODIVERS CONSERV, V23, P503, DOI 10.1007/s10531-013-0608-z; Le Corre M, 2008, NATURE, V451, P134, DOI 10.1038/451134a; LEBRETON JD, 1992, ECOL MONOGR, V62, P67, DOI 10.2307/2937171; Lescroel A, 2009, J ANIM ECOL, V78, P798, DOI 10.1111/j.1365-2656.2009.01542.x; Loison A, 2002, J APPL STAT, V29, P289, DOI 10.1080/02664760120108665; Louis M, 2014, MOL ECOL, V23, P857, DOI 10.1111/mec.12653; Maciejewski W, 2014, J THEOR BIOL, V340, P285, DOI 10.1016/j.jtbi.2013.09.032; McDonald David B., 1993, Current Ornithology, V10, P139; Mech D., 2003, WOLVES BEHAV ECOLOGY; Miles WTS, 2013, IBIS, V155, P16, DOI 10.1111/ibi.12007; Miles WTS, 2010, THESIS U GLASGOW GLA; Mitchell PI, 2004, SEABIRD POPULATIONS; MONAGHAN P, 1992, ARDEA, V80, P70; Mougeot F, 1998, J ZOOL, V244, P429, DOI 10.1017/S0952836998003136; Mougeot F, 2000, J AVIAN BIOL, V31, P376, DOI 10.1034/j.1600-048X.2000.310314.x; Mougeot F, 2000, ANIM BEHAV, V60, P647, DOI 10.1006/anbe.2000.1491; Mulder CPH, 2011, SEABIRD ISLANDS ECOL; Newson S.E., 2008, Seabird, V21, P77; Oro D, 2005, J ZOOL, V265, P421, DOI 10.1017/S0952836905006515; Oro D, 2002, ECOLOGY, V83, P2516; Oro D, 1999, OECOLOGIA, V118, P438, DOI 10.1007/s004420050746; Parsons M, 2008, ICES J MAR SCI, V65, P1520, DOI 10.1093/icesjms/fsn155; Perez-Ramirez E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046418; Pfister CA, 1998, P NATL ACAD SCI USA, V95, P213, DOI 10.1073/pnas.95.1.213; Phillips RA, 1999, J APPL ECOL, V36, P218, DOI 10.1046/j.1365-2664.1999.00391.x; Phillips RA, 1999, BIRD STUDY, V46, P174, DOI 10.1080/00063659909461129; Planas M, 2012, J EXP MAR BIOL ECOL, V438, P154, DOI 10.1016/j.jembe.2012.10.003; Pradel R, 1997, BIOMETRICS, V53, P60, DOI 10.2307/2533097; R Development Core Team, 2012, R LANG ENV STAT COMP; Reid JM, 2004, J ANIM ECOL, V73, P777, DOI 10.1111/j.0021-8790.2004.00854.x; Reid JM, 2003, J ANIM ECOL, V72, P36, DOI 10.1046/j.1365-2656.2003.00673.x; Reid T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058230; Ricklefs R.E., 1973, P366; Rodway MS, 1996, BIOL CONSERV, V76, P311, DOI 10.1016/0006-3207(94)00118-9; Saether BE, 1997, TRENDS ECOL EVOL, V12, P143, DOI 10.1016/S0169-5347(96)10068-9; Saether BE, 2000, ECOLOGY, V81, P642, DOI 10.2307/177366; Sandvik H, 2005, J ANIM ECOL, V74, P817, DOI 10.1111/j.1365-2656.2005.00981.x; Sandvik H, 2008, AUK, V125, P723, DOI 10.1525/auk.2008.07059; Sandvik H, 2012, MAR ECOL PROG SER, V454, P273, DOI 10.3354/meps09558; Schwartz MW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083809; Selig ER, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082898; Sibly RM, 2002, PHILOS T R SOC B, V357, P1153, DOI 10.1098/rstb.2002.1117; SILVERTOWN J, 1993, J ECOL, V81, P465, DOI 10.2307/2261525; SONERUD GA, 1992, OIKOS, V63, P223, DOI 10.2307/3545382; TAOKA M, 1989, AUK, V106, P471; van Deurs M, 2009, MAR ECOL PROG SER, V381, P249, DOI 10.3354/meps07960; Votier SC, 2004, J APPL ECOL, V41, P1117, DOI 10.1111/j.0021-8901.2004.00974.x; Votier SC, 2004, CONDOR, V106, P275, DOI 10.1650/7261; Votier SC, 2004, NATURE, V427, P727, DOI 10.1038/nature02315; Votier SC, 2003, POLAR BIOL, V26, P20, DOI 10.1007/s00300-002-0446-z; Votier SC, 2001, BIRD STUDY, V48, P373, DOI 10.1080/00063650109461237; Votier SC, 2007, J AVIAN BIOL, V38, P234, DOI 10.1111/j.0908-8857.2007.03893.x; Votier SC, 2006, J ORNITHOL, V147, P405, DOI 10.1007/s10336-005-0021-9; Votier SC, 2011, MAR BIOL, V158, P355, DOI 10.1007/s00227-010-1563-9; Walsh P.M., 1995, SEABIRD MONITORING H; Wanless S, 2004, MAR ECOL PROG SER, V279, P237, DOI 10.3354/meps279237; Wanless S, 2005, MAR ECOL PROG SER, V294, P1, DOI 10.3354/meps294001; Weimerskirch H, 2001, BEHAV ECOL, V12, P22, DOI 10.1093/oxfordjournals.beheco.a000374; White G. C., 2012, PROGRAM MARK VERSION; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Wilson JR, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0053383, DOI 10.1371/JOURNAL.PONE.0053383]; Wright PJ, 1996, AQUATIC PREDATORS AND THEIR PREY, P154	120	8	11	7	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0131527	10.1371/journal.pone.0131527	http://dx.doi.org/10.1371/journal.pone.0131527			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177461	gold, Green Submitted, Green Published			2022-12-26	WOS:000358197600047
J	Yang, C; Fei, YD; Qin, YL; Luo, D; Yang, SF; Kou, XY; Zi, YX; Deng, TT; Jin, M				Yang, Chao; Fei, Yuda; Qin, Yali; Luo, Dan; Yang, Shufei; Kou, Xinyun; Zi, Yingxin; Deng, Tingting; Jin, Ming			Bacterial Flora Changes in Conjunctiva of Rats with Streptozotocin-Induced Type I Diabetes	PLOS ONE			English	Article							KOCURIA-KRISTINAE; GUT MICROBIOTA	Background The microbiota of both humans and animals plays an important role in their health and the development of disease. Therefore, the bacterial flora of the conjunctiva may also be associated with some diseases. However, there are no reports on the alteration of bacterial flora in conjunctiva of diabetic rats in the literature. Therefore, we investigated the changes in bacterial flora in bulbar conjunctiva of rats with streptozotocin (STZ)-induced type I diabetes. Methods A high dose of STZ (60 mg/kg, i.p.) was injected into Sprague-Dawley (SD) rats to induce type I diabetes mellitus (T1DM). The diabetic rats were raised in the animal laboratory and at 8 months post-injection of STZ swab samples were taken from the bulbar conjunctiva for cultivation of aerobic bacteria. The bacterial isolates were identified by Gram staining and biochemical features. The identified bacteria from both diabetic and healthy rats were then compared. Results The diabetic and healthy rats had different bacterial flora present in their bulbar conjunctiva. In total, 10 and 8 bacterial species were found in the STZ and control groups, respectively, with only three species (Enterococcus faecium, Enterococcus gallinarum and Escherichia coli) shared between the two groups. Gram-positive bacteria were common in both groups and the most abundant was Enterococcus faecium. However, after the development of T1DM, the bacterial flora in the rat bulbar conjunctiva changed considerably, with a reduced complexity evident. Conclusions STZ-induced diabetes caused alterations of bacterial flora in the bulbar conjunctiva in rats, with some bacterial species disappearing and others emerging. Our results indicate that the conjunctival bacterial flora in diabetic humans should be surveyed for potential diagnostic markers or countermeasures to prevent eye infections in T1DM patients.	[Yang, Chao; Qin, Yali; Luo, Dan; Yang, Shufei; Kou, Xinyun; Zi, Yingxin; Deng, Tingting; Jin, Ming] Sino Japan Hosp, Beijing 100029, Peoples R China; [Yang, Chao] Beijing Hosp Tradit Chinese Med TCM, Beijing 100010, Peoples R China; [Fei, Yuda] China Acad Chinese Med Sci, Hosp Eye, Beijing 100040, Peoples R China	China Academy of Chinese Medical Sciences	Jin, M (corresponding author), Sino Japan Hosp, 1 Yinghua East St, Beijing 100029, Peoples R China.	jinming57@163.com		FEI, Yuda/0000-0002-9648-7911	Natural Science Foundation Committee of China [81373693]	Natural Science Foundation Committee of China(National Natural Science Foundation of China (NSFC))	This research was supported by Natural Science Foundation Committee of China (contract number 81373693). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayramoglu G, 2014, CYTOTECHNOLOGY, V66, P251, DOI 10.1007/s10616-013-9563-5; Bellenger J, 2011, DIABETES, V60, P1090, DOI 10.2337/db10-0901; Citro R, 2013, J MED MICROBIOL, V62, P932, DOI 10.1099/jmm.0.054536-0; de Goffau MC, 2014, DIABETOLOGIA, V57, P1569, DOI 10.1007/s00125-014-3274-0; Dong QF, 2011, INVEST OPHTH VIS SCI, V52, P5408, DOI 10.1167/iovs.10-6939; Ermis SS, 2004, EYE, V18, P249, DOI 10.1038/sj.eye.6700631; Everard A, 2013, BEST PRACT RES CL GA, V27, P73, DOI 10.1016/j.bpg.2013.03.007; Gomes AC, 2014, NUTR J, V13, DOI 10.1186/1475-2891-13-60; Jin YL, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/259368; Liu YC, 2014, J CELL MOL MED, V18, P1203, DOI 10.1111/jcmm.12267; Moore K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086570; Moreno-Indias I, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00190; Nara N, 2013, CLIN IMMUNOL, V146, P112, DOI 10.1016/j.clim.2012.12.001; Nejabat M, 2014, JUNDISHAPUR J MICROB, V7, DOI 10.5812/jjm.9678; NEMA HV, 1964, BRIT J OPHTHALMOL, V48, P690, DOI 10.1136/bjo.48.12.690; Okamoto T, 2008, EXP ANIM TOKYO, V57, P335, DOI 10.1538/expanim.57.335; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Reddy SC, 2013, INT J OPHTHALMOL-CHI, V6, P632, DOI 10.3980/j.issn.2222-3959.2013.05.14; Sambhav K, 2011, J MED MICROBIOL, V60, P670, DOI 10.1099/jmm.0.016675-0; Tewari R, 2013, J CLIN DIAGN RES, V7, P1692, DOI 10.7860/JCDR/2013/6077.3247; Vaarala Outi, 2012, Rev Diabet Stud, V9, P251, DOI 10.1900/RDS.2012.9.251; Verga Falzacappa C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019839; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; Woo PCY, 2004, J CLIN MICROBIOL, V42, P919, DOI 10.1128/JCM.42.2.919-922.2004; Yang R, 2015, INFECT DIS T MED, V1, P16, DOI 10.11979/idtm.201501006; Zhang Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep05654; Zhou M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061516	27	15	15	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0133021	10.1371/journal.pone.0133021	http://dx.doi.org/10.1371/journal.pone.0133021			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176548	gold, Green Published, Green Submitted			2022-12-26	WOS:000358197600201
J	Brooks, GR; Larson, RA; Schwing, PT; Romero, I; Moore, C; Reichart, GJ; Jilbert, T; Chanton, JP; Hastings, DW; Overholt, WA; Marks, KP; Kostka, JE; Holmes, CW; Hollander, D				Brooks, Gregg R.; Larson, Rebekka A.; Schwing, Patrick T.; Romero, Isabel; Moore, Christopher; Reichart, Gert-Jan; Jilbert, Tom; Chanton, Jeff P.; Hastings, David W.; Overholt, Will A.; Marks, Kala P.; Kostka, Joel E.; Holmes, Charles W.; Hollander, David			Sedimentation Pulse in the NE Gulf of Mexico following the 2010 DWH Blowout	PLOS ONE			English	Article							HORIZON OIL-SPILL; ORGANIC-MATTER; EQUATORIAL PACIFIC; ACCUMULATION RATES; NORTHEASTERN GULF; WATER; PB-210; TRANSPORT; MISSISSIPPI; TH-234	The objective of this study was to investigate the impacts of the Deepwater Horizon (DWH) oil discharge at the seafloor as recorded in bottom sediments of the DeSoto Canyon region in the northeastern Gulf of Mexico. Through a close coupling of sedimentological, geochemical, and biological approaches, multiple independent lines of evidence from 11 sites sampled in November/December 2010 revealed that the upper similar to 1 cm depth interval is distinct from underlying sediments and results indicate that particles originated at the sea surface. Consistent dissimilarities in grain size over the surficial similar to 1 cm of sediments correspond to excess Th-234 depths, which indicates a lack of vertical mixing (bioturbation), suggesting the entire layer was deposited within a 4-5 month period. Further, a time series from four deep-sea sites sampled up to three additional times over the following two years revealed that excess Th-234 depths, accumulation rates, and Th-234 inventories decreased rapidly, within a few to several months after initial coring. The interpretation of a rapid sedimentation pulse is corroborated by stratification in solid phase Mn, which is linked to diagenesis and redox change, and the dramatic decrease in benthic formanifera density that was recorded in surficial sediments. Results are consistent with a brief depositional pulse that was also reported in previous studies of sediments, and marine snow formation in surface waters closer to the wellhead during the summer and fall of 2010. Although sediment input from the Mississippi River and advective transport may influence sedimentation on the seafloor in the DeSoto Canyon region, we conclude based on multidisciplinary evidence that the sedimentation pulse in late 2010 is the product of marine snow formation and is likely linked to the DWH discharge.	[Brooks, Gregg R.; Larson, Rebekka A.; Moore, Christopher; Hastings, David W.] Eckerd Coll, Dept Marine Sci, St Petersburg, FL 33733 USA; [Larson, Rebekka A.; Schwing, Patrick T.; Romero, Isabel; Hollander, David] Univ S Florida, Coll Marine Sci, St Petersburg, FL 33701 USA; [Reichart, Gert-Jan; Jilbert, Tom] Univ Utrecht, Dept Earth Sci, Utrecht, Netherlands; [Reichart, Gert-Jan] Royal Netherlands Inst Sea Res, Marine Geol Dept, Texel, Netherlands; [Chanton, Jeff P.] Florida State Univ, Dept Earth Ocean & Atmospher Sci, Tallahassee, FL 32306 USA; [Overholt, Will A.; Marks, Kala P.; Kostka, Joel E.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Kostka, Joel E.] Georgia Inst Technol, Sch Earth, Atlanta, GA 30332 USA; [Kostka, Joel E.] Georgia Inst Technol, Sch Atmospher Sci, Atlanta, GA 30332 USA; [Holmes, Charles W.] Environchron, Bradenton, FL USA	State University System of Florida; University of South Florida; Utrecht University; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); State University System of Florida; Florida State University; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology	Brooks, GR (corresponding author), Eckerd Coll, Dept Marine Sci, St Petersburg, FL 33733 USA.	brooksgr@eckerd.edu	Schwing, Patrick/AAK-8593-2020; Jilbert, Tom/AAL-2273-2021; Reichart, Gert-Jan/N-6308-2018; Overholt, Will/X-2461-2019	Schwing, Patrick/0000-0001-8466-4952; Reichart, Gert-Jan/0000-0002-7256-2243; Overholt, Will/0000-0002-2897-6991; Romero, Isabel C./0000-0002-8590-5989	Gulf of Mexico Research Initiative through the Florida Institute of Oceanography; Center for Integrated Modeling and Analysis of Gulf Ecosystems; Deepsea to Coast Connectivity in the Eastern Gulf of Mexico consortia; Environchron	Gulf of Mexico Research Initiative through the Florida Institute of Oceanography; Center for Integrated Modeling and Analysis of Gulf Ecosystems; Deepsea to Coast Connectivity in the Eastern Gulf of Mexico consortia; Environchron	Funding was provided by the Gulf of Mexico Research Initiative (http://gulfresearchinitiative.org) through the Florida Institute of Oceanography (http://www.fio.usf.edu), Center for Integrated Modeling and Analysis of Gulf Ecosystems (http://www.marine.usf.edu/c-image/), and Deepsea to Coast Connectivity in the Eastern Gulf of Mexico (http://deep-c.org) consortia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Environchron provided support in the form of salaries for authors C.W.H., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	8272 EM, 2007, 8272 EM, P1; Aeppli C, 2014, ENVIRON SCI TECHNOL, V48, P6726, DOI 10.1021/es500825q; Alexander CR, 2010, MAR GEOL, V270, P213, DOI 10.1016/j.margeo.2009.10.015; ANDERS MH, 1987, J GEOL, V95, P1, DOI 10.1086/629103; [Anonymous], [No title captured]; APPLEBY PG, 1983, HYDROBIOLOGIA, V103, P29, DOI 10.1007/BF00028424; Balsam WL, 2003, DEEP-SEA RES PT I, V50, P1421, DOI 10.1016/j.dsr.2003.06.001; Barron MG, 2012, TOXICOL PATHOL, V40, P315, DOI 10.1177/0192623311428474; Baskaran M, 2002, CONT SHELF RES, V22, P1493, DOI 10.1016/S0278-4343(02)00017-1; Bianchi TS, 2011, MAR ENVIRON RES, V72, P248, DOI 10.1016/j.marenvres.2011.09.007; Binford, 1990, J PALEOLIMNOL, V3, P253, DOI DOI 10.1007/BF00219461; Bokulich NA, 2013, NAT METHODS, V10, P57, DOI [10.1038/nmeth.2276, 10.1038/NMETH.2276]; BONNETT PJP, 1991, HYDROBIOLOGIA, V214, P71, DOI 10.1007/BF00050934; Brooks GR, 2012, AGU ASLO OC SCI M FE; BURDIGE DJ, 1993, EARTH-SCI REV, V35, P249, DOI 10.1016/0012-8252(93)90040-E; Camilli R, 2010, SCIENCE, V330, P201, DOI 10.1126/science.1195223; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chanton J, 2015, ENVIRON SCI TECHNOL, V49, P847, DOI 10.1021/es5046524; Choi YH, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2004GB002261; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Crusius J, 2007, ESTUAR COAST SHELF S, V71, P537, DOI 10.1016/j.ecss.2006.09.006; CUTSHALL NH, 1983, NUCL INSTRUM METHODS, V206, P309, DOI 10.1016/0167-5087(83)91273-5; DEAN WE, 1974, J SEDIMENT PETROL, V44, P242; Dell'Amore C, 2010, NATL GEOGRAPHIC 0923; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Diercks A, 2013, 2013 MOSSFA M OCT 22; Dietrich JC, 2012, CONT SHELF RES, V41, P17, DOI 10.1016/j.csr.2012.03.015; DOYLE LJ, 1980, J SEDIMENT PETROL, V50, P905; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; EMILIANI C, 1975, SCIENCE, V189, P1083, DOI 10.1126/science.189.4208.1083; Finney BP, 1988, PALEOCEANOGRAPHY, V3, P169, DOI 10.1029/PA003i002p00169; Folk R. L., 1965, PETROLOGY SEDIMENTAR; FROELICH PN, 1979, GEOCHIM COSMOCHIM AC, V43, P1075, DOI 10.1016/0016-7037(79)90095-4; Garcia-Pineda O, 2013, OCEANOGRAPHY, V26, P124, DOI 10.5670/oceanog.2013.38; GARDNER WD, 1985, MAR GEOL, V65, P199, DOI 10.1016/0025-3227(85)90057-X; Gould HR, 1956, SEPM SPEC PUBL, V3, P2; Graham WM, 2010, ENVIRON RES LETT, V5, DOI 10.1088/1748-9326/5/4/045301; GRIFFIN GM, 1962, GEOL SOC AM BULL, V73, P737, DOI 10.1130/0016-7606(1962)73[737:RCFOWI]2.0.CO;2; HARBISON RN, 1968, J GEOPHYS RES, V73, P5175, DOI 10.1029/JB073i016p05175; Herndl G J, 1999, Ann Ist Super Sanita, V35, P405; Hollander DJ, 2012, 2012 OC SCI M FEB 23; Holmes CW., 2001, SHORT LIVED ISOTOPES; Hussain N, 1996, APPL RADIAT ISOTOPES, V47, P473, DOI 10.1016/0969-8043(95)00319-3; Joye SB, 2014, BIOSCIENCE, V64, P766, DOI 10.1093/biosci/biu121; Joye SB, 2011, NAT GEOSCI, V4, P160, DOI [10.1038/ngeo1067, 10.1038/NGEO1067]; KITTO ME, 1991, APPL RADIAT ISOTOPES, V42, P835, DOI 10.1016/0883-2889(91)90221-L; Lubchenco J, 2012, P NATL ACAD SCI USA, V109, P20212, DOI 10.1073/pnas.1204729109; MCKEE BA, 1983, GEOLOGY, V11, P631, DOI 10.1130/0091-7613(1983)11<631:COSDAA>2.0.CO;2; Milliman J. D., 1974, MARINE CARBONATES; Nurnberg D, 2008, EARTH PLANET SC LETT, V272, P278, DOI 10.1016/j.epsl.2008.04.051; Olsson IU, 1986, HDB HOLOCENE PALAEOE, P298; Passow U, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/3/035301; Passow U., 2014, DEEP SEA RES 2; PENNA N, 1993, WATER RES, V27, P1767, DOI 10.1016/0043-1354(93)90115-X; Pope RH, 1996, DEEP-SEA RES PT II, V43, P1339, DOI 10.1016/0967-0645(96)00009-4; Price BA, 1998, THESIS UCSD; PRINCE RC, 1994, ENVIRON SCI TECHNOL, V28, P142, DOI 10.1021/es00050a019; Romero IC, 2010, PLOS ONE; Rowe G., 2009, NO GULF MEXICO CONTI; Ryerson TB, 2012, P NATL ACAD SCI USA, V109, P20246, DOI 10.1073/pnas.1110564109; SADLER PM, 1981, J GEOL, V89, P569, DOI 10.1086/628623; Santschi PH, 2001, MAR CHEM, V73, P125, DOI 10.1016/S0304-4203(00)00101-8; Schwing PT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120565; Sionneau T, 2008, QUATERNARY SCI REV, V27, P1740, DOI 10.1016/j.quascirev.2008.07.001; Spier C, 2013, ENVIRON POLLUT, V173, P224, DOI 10.1016/j.envpol.2012.10.019; STACHOWITSCH M, 1990, PSZNI MAR ECOL, V11, P327, DOI 10.1111/j.1439-0485.1990.tb00387.x; STUIVER M, 1977, RADIOCARBON, V19, P355, DOI 10.1017/S0033822200003672; Thibodeaux LJ, 2011, ENVIRON ENG SCI, V28, P87, DOI 10.1089/ees.2010.0276; Tjallingii R, 2007, GEOCHEM GEOPHY GEOSY, V8, DOI 10.1029/2006GC001393; Valentine DL, 2014, P NATL ACAD SCI USA, V111, P15906, DOI 10.1073/pnas.1414873111; Valentine DL, 2010, SCIENCE, V330, P208, DOI 10.1126/science.1196830; VOGEL JS, 1984, NUCL INSTRUM METH B, V5, P289, DOI 10.1016/0168-583X(84)90529-9; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Yeager KM, 2004, MAR CHEM, V91, P1, DOI 10.1016/j.marchem.2004.03.016; Ziervogel K, 2014, DEEP SEA RES 2; Ziervogel K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034816	77	66	66	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132341	10.1371/journal.pone.0132341	http://dx.doi.org/10.1371/journal.pone.0132341			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26172639	Green Submitted, Green Published, gold			2022-12-26	WOS:000358194900043
J	Humphrey, B; McLeod, N; Turner, C; Sutton, JM; Dark, PM; Warhurst, G				Humphrey, Bruce; McLeod, Neil; Turner, Carrie; Sutton, J. Mark; Dark, Paul M.; Warhurst, Geoffrey			Removal of Contaminant DNA by Combined UV-EMA Treatment Allows Low Copy Number Detection of Clinically Relevant Bacteria Using Pan-Bacterial Real-Time PCR	PLOS ONE			English	Article							PROPIDIUM MONOAZIDE; ETHIDIUM MONOAZIDE; ULTRAPURE WATER; RIBOSOMAL DNA; BLOOD; IDENTIFICATION; ELIMINATION; INDUSTRIAL; REAGENTS; SEPSIS	Background More than two decades after its discovery, contaminant microbial DNA in PCR reagents continues to impact the sensitivity and integrity of broad-range PCR diagnostic techniques. This is particularly relevant to their use in the setting of human sepsis, where a successful diagnostic on blood samples needs to combine universal bacterial detection with sensitivity to 1-2 genome copies, because low levels of a broad range of bacteria are implicated. Results We investigated the efficacy of ethidium monoazide (EMA) and propidium monoazide (PMA) treatment as emerging methods for the decontamination of PCR reagents. Both treatments were able to inactivate contaminating microbial DNA but only at concentrations that considerably affected assay sensitivity. Increasing amplicon length improved EMA/PMA decontamination efficiency but at the cost of assay sensitivity. The same was true for UV exposure as an alternative decontamination strategy, likely due to damage sustained by oligonucleotide primers which were a significant source of contamination. However, a simple combination strategy with UV-treated PCR reagents paired with EMA-treated primers produced an assay capable of two genome copy detection and a <5% contamination rate. This decontamination strategy could have important utility in developing improved pan-bacterial assays for rapid diagnosis of low pathogen burden conditions such as in the blood of patients with suspected blood stream infection.	[Humphrey, Bruce; Dark, Paul M.; Warhurst, Geoffrey] Univ Manchester, Fac Med & Human Sci, Inst Inflammat & Repair, Manchester, Lancs, England; [Humphrey, Bruce; Dark, Paul M.; Warhurst, Geoffrey] Salford Royal NHS Fdn Trust, Infect Injury & Inflammat Res Grp, Salford, Lancs, England; [McLeod, Neil; Turner, Carrie; Sutton, J. Mark] Publ Hlth England, Microbiol Serv Div, Salisbury, Wilts, England	University of Manchester; Salford Royal NHS Foundation Trust; Public Health England	Humphrey, B (corresponding author), Univ Manchester, Fac Med & Human Sci, Inst Inflammat & Repair, Manchester, Lancs, England.	bruce.humphrey@manchester.ac.uk		Dark, Paul/0000-0003-3309-0164	Technology Strategy Board UK grant [101187]	Technology Strategy Board UK grant	This work was funded by Technology Strategy Board UK grant #101187. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biedenbach DJ, 2004, DIAGN MICR INFEC DIS, V50, P59, DOI 10.1016/j.diagmicrobio.2004.05.003; Carroll NM, 1999, J CLIN MICROBIOL, V37, P3402, DOI 10.1128/JCM.37.10.3402-3404.1999; Champlot S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013042; Chang SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020303; Corless CE, 2000, J CLIN MICROBIOL, P38; Dark P, 2015, INTENS CARE MED, V41, P21, DOI 10.1007/s00134-014-3553-8; Emmadi R, 2011, J MOL DIAGN, V13, P583, DOI 10.1016/j.jmoldx.2011.05.011; Gomila M, 2007, INT J SYST EVOL MICR, V57, P2629, DOI 10.1099/ijs.0.65149-0; Goto M, 2005, FEMS MICROBIOL LETT, V246, P33, DOI 10.1016/j.femsle.2005.03.042; Hein I, 2007, J MICROBIOL METH, V71, P336, DOI 10.1016/j.mimet.2007.09.005; Heininger A, 2003, J CLIN MICROBIOL, V41, P1763, DOI 10.1128/JCM.41.4.1763-1765.2003; Huggett Jim F, 2008, BMC Res Notes, V1, P70, DOI 10.1186/1756-0500-1-70; Kulakov LA, 2002, APPL ENVIRON MICROB, V68, P1548, DOI 10.1128/AEM.68.4.1548-1555.2002; MEIER A, 1993, J CLIN MICROBIOL, V31, P646, DOI 10.1128/JCM.31.3.646-652.1993; Mennerat A, 2014, MICROB ECOL, V68, P834, DOI 10.1007/s00248-014-0453-y; Millar BC, 2002, J CLIN MICROBIOL, V40, P1575, DOI 10.1128/JCM.40.5.1575-1580.2002; Mohammadi T, 2003, J CLIN MICROBIOL, V41, P4796, DOI 10.1128/JCM.41.10.4796-4798.2003; Nogami T, 1998, ANAL CHEM, V70, P5296, DOI 10.1021/ac9805854; Ozbak H, 2012, J MOL DIAGN, V14, P176, DOI 10.1016/j.jmoldx.2011.12.004; Patel P, 2012, TRANSFUSION, V52, P1423, DOI 10.1111/j.1537-2995.2011.03484.x; Philipp S, 2010, TRANSFUS MED HEMOTH, V37, P21, DOI 10.1159/000265571; PRINCE AM, 1992, BIOTECHNIQUES, V12, P358; RAND KH, 1990, MOL CELL PROBE, V4, P445, DOI 10.1016/0890-8508(90)90003-I; Rueckert A, 2007, J MICROBIOL METH, V68, P596, DOI 10.1016/j.mimet.2006.11.006; SARKAR G, 1990, NATURE, V343, P27, DOI 10.1038/343027a0; Schnetzinger F, 2013, APPL MICROBIOL BIOT, V97, P2153, DOI 10.1007/s00253-013-4711-6; Singh SK, 1998, CHEM COMMUN, P455, DOI 10.1039/a708608c; van Dongen WFD, 2013, BMC ECOL, V13, DOI 10.1186/1472-6785-13-11; YAGUPSKY P, 1990, CLIN MICROBIOL REV, V3, P269, DOI 10.1128/CMR.3.3.269-279.1990	29	11	11	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132954	10.1371/journal.pone.0132954	http://dx.doi.org/10.1371/journal.pone.0132954			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26172943	Green Published, Green Submitted, gold			2022-12-26	WOS:000358194900108
J	Zhao, YF; Liu, LJ; Huang, J; Shi, SF; Lv, JC; Liu, G; Zhao, MH; Zhang, H				Zhao, Yanfeng; Liu, Lijun; Huang, Jing; Shi, Sufang; Lv, Jicheng; Liu, Gang; Zhao, Minghui; Zhang, Hong			Plasma Soluble Urokinase Receptor Level Is Correlated with Podocytes Damage in Patients with IgA Nephropathy	PLOS ONE			English	Article							FOCAL-SEGMENTAL GLOMERULOSCLEROSIS; OXFORD CLASSIFICATION; GLOMERULAR-FILTRATION; SUPAR; VALIDATION; PREDICTORS; EXPRESSION	Background Focal segmental glomerulosclerosis (FSGS) lesions are similar in characteristics to S lesions of the Oxford classification of IgA nephropathy (IgAN) and may predict poor prognosis. In the present study, we aimed to explore the association between plasma soluble urokinase receptor (suPAR) levels and S lesions and podocytes damage in IgAN patients. Methods We enrolled 569 IgAN patients with follow-up data and detected plasma suPAR levels at renal biopsy by enzyme-linked immunosorbent assay. Results Plasma suPAR levels in IgAN patients with or without S lesions did not differ significantly (P = 0.411). However, suPAR levels were positively correlated with proteinuria (r = 0.202, P < 0.001), and negatively correlated with estimated glomerular filtration rate (eGFR, r = -0.236, P < 0.001). In the partial correlation to adjust for eGFR, plasma suPAR levels remained positively correlated with proteinuria (r = 0.112, P = 0.023). In a Cox proportional hazards model, higher levels of plasma suPAR were not associated with poor renal outcome. Plasma suPAR levels of IgAN and primary FSGS patients with nephrotic syndrome were not significantly different (P = 0.306). Plasma suPAR levels in patients with extensive effacement of the epithelial cell foot processes of glomerular podocytes were significantly higher than those with segmental effacement on the basis of comparable eGFR (P = 0.036). Conclusions In IgAN patients, plasma suPAR levels were not associated with S lesions. However, they were positively associated with proteinuria and negatively associated with eGFR. In addition, plasma suPAR levels were positively associated with the effacement degree of the foot processes, which might partially contribute to the development of proteinuria in patients with IgAN.	[Zhao, Yanfeng; Liu, Lijun; Huang, Jing; Shi, Sufang; Lv, Jicheng; Liu, Gang; Zhao, Minghui; Zhang, Hong] Peking Univ, Div Renal, Dept Med, Hosp 1, Beijing 100871, Peoples R China; [Zhao, Yanfeng; Liu, Lijun; Huang, Jing; Shi, Sufang; Lv, Jicheng; Liu, Gang; Zhao, Minghui; Zhang, Hong] Peking Univ, Inst Nephrol, Beijing 100871, Peoples R China; [Zhao, Yanfeng; Liu, Lijun; Huang, Jing; Shi, Sufang; Lv, Jicheng; Liu, Gang; Zhao, Minghui; Zhang, Hong] Minist Hlth China, Key Lab Renal Dis, Beijing, Peoples R China; [Zhao, Yanfeng; Liu, Lijun; Huang, Jing; Shi, Sufang; Lv, Jicheng; Liu, Gang; Zhao, Minghui; Zhang, Hong] Peking Univ, Key Lab Chron Kidney Dis Prevent & Treatment, Minist Educ, Beijing 100871, Peoples R China	Peking University; Peking University; Peking University	Liu, LJ (corresponding author), Peking Univ, Div Renal, Dept Med, Hosp 1, Beijing 100871, Peoples R China.	lijun.liu@medmail.com.cn			National Natural Science Foundation of China [81100503, 81370809, 81021004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants from the National Natural Science Foundation of China (No. 81100503), the National Natural Science Foundation of China (No. 81370809) and Natural Science Foundation of China to the Innovation Research Group (81021004).	[Anonymous], 1982, KIDNEY INT, V22, P643; Blasi F, 2002, NAT REV MOL CELL BIO, V3, P932, DOI 10.1038/nrm977; Cattran DC, 2009, KIDNEY INT, V76, P534, DOI 10.1038/ki.2009.243; Coppo R, 2014, KIDNEY INT, V86, P828, DOI 10.1038/ki.2014.63; D'Amico G, 2000, AM J KIDNEY DIS, V36, P227, DOI 10.1053/ajkd.2000.8966; DAMICO G, 1987, Q J MED, V64, P709; Deegens JK, 2014, NAT REV NEPHROL, V10, P431, DOI 10.1038/nrneph.2014.113; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; El Karoui K, 2011, KIDNEY INT, V79, P643, DOI 10.1038/ki.2010.460; Haas M, 1997, AM J KIDNEY DIS, V29, P829, DOI 10.1016/S0272-6386(97)90456-X; Haas M, 1996, AM J KIDNEY DIS, V28, P365, DOI 10.1016/S0272-6386(96)90493-X; Harita Y, 2014, PEDIATR NEPHROL, V29, P1553, DOI 10.1007/s00467-014-2808-5; Huang J, 2013, KIDNEY INT, V84, P366, DOI 10.1038/ki.2013.55; Kidney Diseases Improving Global Outcomes (KDIGO), 2012, KIDNEY INT S, V2, P259, DOI DOI 10.1038/KISUP.2012.30; Lee JH, 2014, KOREAN J INTERN MED, V29, P176, DOI 10.3904/kjim.2014.29.2.176; LEE SMK, 1982, HUM PATHOL, V13, P314, DOI 10.1016/S0046-8177(82)80221-9; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Lv JC, 2013, AM J KIDNEY DIS, V62, P891, DOI 10.1053/j.ajkd.2013.04.021; Meijers B, 2014, KIDNEY INT, V85, P636, DOI 10.1038/ki.2013.505; Musetti C, 2014, J NEPHROL; Packham DK, 1996, CLIN NEPHROL, V46, P225; Roberts ISD, 2009, KIDNEY INT, V76, P546, DOI 10.1038/ki.2009.168; Shi SF, 2011, CLIN J AM SOC NEPHRO, V6, P2175, DOI 10.2215/CJN.11521210; Shushakova N, 2005, J CELL SCI, V118, P2743, DOI 10.1242/jcs.02409; Sinha A, 2014, KIDNEY INT, V85, P649, DOI 10.1038/ki.2013.546; Sinniah R, 1984, Contrib Nephrol, V40, P156; Smith HW, 2010, NAT REV MOL CELL BIO, V11, P23, DOI 10.1038/nrm2821; Spinale JM, 2014, KIDNEY INT; Spinale JM, 2015, KIDNEY INT, V87, P564, DOI 10.1038/ki.2014.346; Trachtman H, 2014, NAT REV NEPHROL, V10, P610, DOI 10.1038/nrneph.2014.113-c1; Weber CL, 2009, NEPHROL DIAL TRANSPL, V24, P483, DOI 10.1093/ndt/gfn513; Wei CL, 2011, NAT MED, V17, P952, DOI 10.1038/nm.2411; Zeng CH, 2012, AM J KIDNEY DIS, V60, P812, DOI 10.1053/j.ajkd.2012.06.011	33	13	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0132869	10.1371/journal.pone.0132869	http://dx.doi.org/10.1371/journal.pone.0132869			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26167688	Green Published, Green Submitted, gold			2022-12-26	WOS:000358193100090
J	Arriagada, RA; Sills, EO; Ferraro, PJ; Pattanayak, SK				Arriagada, R. A.; Sills, E. O.; Ferraro, P. J.; Pattanayak, S. K.			Do Payments Pay Off? Evidence from Participation in Costa Rica's PES Program	PLOS ONE			English	Article							ENVIRONMENTAL SERVICES; ECOSYSTEM SERVICES; MULTIPLE IMPUTATION; FOREST CONSERVATION; BIODIVERSITY; IMPLEMENTATION; MANAGEMENT; EFFICIENCY; MECHANISM; STANDARDS	Payments for environmental services (PES) are often viewed as a way to simultaneously improve conservation outcomes and the wellbeing of rural households who receive the payments. However, evidence for such win-win outcomes has been elusive. We add to the growing literature on conservation program impacts by using primary household survey data to evaluate the socioeconomic impacts of participation in Costa Rica's PES program. Despite the substantial cash transfers to voluntary participants in this program, we do not detect any evidence of impacts on their wealth or self-reported well-being using a quasi-experimental design. These results are consistent with the common claim that voluntary PES do not harm participants, but they beg the question of why landowners participate if they do not benefit. Landowners in our sample voluntarily renewed their contracts after five years in the program and thus are unlikely to have underestimated their costs of participation. They apparently did not invest additional income from the program in farm inputs such as cattle or hired labor, since both decreased as a result of participation. Nor do we find evidence that participation encouraged moves off-farm. Instead, semi-structured interviews suggest that participants joined the program to secure their property rights and contribute to the public good of forest conservation. Thus, in order to understand the social impacts of PES, we need to look beyond simple economic rationales and material outcomes.	[Arriagada, R. A.] Pontificia Univ Catolica Chile, Dept Agr Econ, Ctr Appl Ecol & Sustainabil CAPES, Millennium Nucl Ctr Socioecon Impact Environm, Santiago, Chile; [Sills, E. O.] N Carolina State Univ, Dept Forestry & Environm Resources, Raleigh, NC 27695 USA; [Ferraro, P. J.] Georgia State Univ, Dept Econ, Andrew Young Sch Policy Studies, Atlanta, GA 30303 USA; [Pattanayak, S. K.] Duke Univ, Sanford Sch Publ Policy, Durham, NC USA; [Pattanayak, S. K.] Duke Univ, Nicholas Sch Environm, Durham, NC USA	Pontificia Universidad Catolica de Chile; University of North Carolina; North Carolina State University; University System of Georgia; Georgia State University; Duke University; Duke University	Arriagada, RA (corresponding author), Pontificia Univ Catolica Chile, Dept Agr Econ, Ctr Appl Ecol & Sustainabil CAPES, Millennium Nucl Ctr Socioecon Impact Environm, Ave Vicuna Mackenna 4860, Santiago, Chile.	rarriagadac@uc.cl	Ferraro, Paul J/B-4435-2014	Ferraro, Paul J/0000-0002-4777-5108; Sills, Erin/0000-0001-8289-0489	National Science Foundation [SES-0519194]; Fondo Nacional de Financiamiento Forestal (FONAFIFO-Costa Rica)	National Science Foundation(National Science Foundation (NSF)); Fondo Nacional de Financiamiento Forestal (FONAFIFO-Costa Rica)	This work was supported by the National Science Foundation (SES-0519194) (EOS), and Fondo Nacional de Financiamiento Forestal (FONAFIFO-Costa Rica) (EOS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarca P, 2007, INDICE DESARROLLO SO; Alix-Garcia JM, 2012, LAND ECON, V88, P613, DOI 10.3368/le.88.4.613; Andam KS, 2010, P NATL ACAD SCI USA, V107, P9996, DOI 10.1073/pnas.0914177107; [Anonymous], 2003, REV INCOME WEALTH; Arriagada R. A., 2009, Journal of Sustainable Forestry, V28, P343, DOI 10.1080/10549810802701192; Arriagada RA, 2008, THESIS N CAROLINA ST; Arriagada RA, 2012, LAND ECON, V88, P382, DOI 10.3368/le.88.2.382; Baser O, 2006, VALUE HEALTH, V9, P377, DOI 10.1111/j.1524-4733.2006.00130.x; Bauch SC, 2014, WORLD DEV, V64, pS135, DOI 10.1016/j.worlddev.2014.03.009; Blackman A, 2010, ECOL ECON, V69, P1626, DOI 10.1016/j.ecolecon.2010.03.004; Cole RJ, 2010, INT J SUST DEV WORLD, V17, P208, DOI 10.1080/13504501003729085; Daniels AE, 2010, ECOL ECON, V69, P2116, DOI 10.1016/j.ecolecon.2010.06.011; Engel S, 2008, ECOL ECON, V65, P663, DOI 10.1016/j.ecolecon.2008.03.011; Ferraro PJ, 2008, ECOL ECON, V65, P810, DOI 10.1016/j.ecolecon.2007.07.029; Ferraro PJ, 2012, REV ENV ECON POLICY, V6, P20, DOI 10.1093/reep/rer019; Ferraro PJ, 2002, LAND ECON, V78, P339, DOI 10.2307/3146894; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Fisher B, 2007, ECOL ECON, V62, P93, DOI 10.1016/j.ecolecon.2006.05.020; Greiner R, 2013, LAND USE POLICY, V31, P4, DOI 10.1016/j.landusepol.2011.11.012; Grieg-Gran M, 2005, WORLD DEV, V33, P1511, DOI 10.1016/j.worlddev.2005.05.002; Hartshorn G., 2005, EVALUATION WORLD BAN; Ho DE, 2007, POLIT ANAL, V15, P199, DOI 10.1093/pan/mpl013; Imbens G., 2009, J ECON LIT, V48, P399; Imbens GW, 2009, J ECON LIT, V47, P5, DOI 10.1257/jel.47.1.5; Ingram JC, 2014, ECOSYST SERV, V7, P10, DOI 10.1016/j.ecoser.2013.12.003; Kolenikov S, 2009, REV INCOME WEALTH, V55, P128, DOI 10.1111/j.1475-4991.2008.00309.x; Larigauderie A, 2012, CURR OPIN ENV SUST, V4, P101, DOI 10.1016/j.cosust.2012.01.007; Legrand T, 2013, FOREST POLICY ECON, V37, P115, DOI 10.1016/j.forpol.2013.06.016; Locatelli B, 2008, FOREST POLICY ECON, V10, P275, DOI 10.1016/j.forpol.2007.11.007; Mainka SA, 2008, ENVIRONMENT, V50, P42, DOI 10.3200/ENVT.50.2.42-55; McGinley K, 2003, FOREST POLICY ECON, V5, P421, DOI 10.1016/S1389-9341(03)00040-6; Milder JC, 2010, ECOL SOC, V15; Miranda M., 2003, SOCIAL IMPACTS PAYME; Miteva DA, 2012, OXFORD REV ECON POL, V28, P69, DOI 10.1093/oxrep/grs009; Montgomery MR, 2000, DEMOGRAPHY, V37, P155, DOI 10.2307/2648118; Mullan K, 2014, FIELD METHOD, V26, P223, DOI 10.1177/1525822X13510370; Munoz Calvo R, 2004, THESIS U COSTA RICA; Muradian R, 2010, ECOL ECON, V69, P1202, DOI 10.1016/j.ecolecon.2009.11.006; Ortiz E, 1992, INFORME AVANCE ESTRA; Ortiz E., 2004, KUR REV FORESTAL, V1, P1; Pagiola S, 2008, ECOL ECON, V65, P712, DOI 10.1016/j.ecolecon.2007.07.033; Pagiola S, 2010, ENVIRON RESOUR ECON, V47, P371, DOI 10.1007/s10640-010-9383-4; Pannell DJ, 2008, LAND ECON, V84, P225, DOI 10.3368/le.84.2.225; Pattanayak SK, 2010, REV ENV ECON POLICY, V4, P254, DOI 10.1093/reep/req006; Persson UM, 2013, WORLD DEV, V43, P124, DOI 10.1016/j.worlddev.2012.10.006; Pfaff A, 2012, OXFORD REV ECON POL, V28, P164, DOI 10.1093/oxrep/grs012; Porras I., 2013, LEARNING 20 YEARS PA; Robalino J, 2013, LAND ECON, V89, P432, DOI 10.3368/le.89.3.432; Robalino JA, 2007, ENVIRON DEV ECON, V12, P521, DOI 10.1017/S1355770X07003671; Robalino JA, 2012, J DEV ECON, V97, P427, DOI 10.1016/j.jdeveco.2011.06.003; Royston P, 2011, J STAT SOFTW, V45, P1, DOI 10.18637/jss.v045.i04; Rubin DB, 2004, MULTIPLE IMPUTATION; Samii C., 2014, CAMPBELL SYSTEMATIC, V11; Sanchez-Azofeifa GA, 2007, CONSERV BIOL, V21, P1165, DOI 10.1111/j.1523-1739.2007.00751.x; Sierra R, 2006, ECOL ECON, V59, P131, DOI 10.1016/j.ecolecon.2005.10.010; Snider AG, 2003, J FOREST, V101, P18; Sunderlin WD, 2008, ECOL SOC, V13; Uchida E, 2009, AM J AGR ECON, V91, P70, DOI 10.1111/j.1467-8276.2008.01184.x; Van Buuren S, 1999, STAT MED, V18, P681, DOI 10.1002/(SICI)1097-0258(19990330)18:6<681::AID-SIM71>3.0.CO;2-R; Weber JG, 2011, LAND ECON, V87, P661, DOI 10.3368/le.87.4.661; Wunder S, 2007, CONSERV BIOL, V21, P48, DOI 10.1111/j.1523-1739.2006.00559.x; Zbinden S, 2005, WORLD DEV, V33, P255, DOI 10.1016/j.worlddev.2004.07.012; Zhang W, 2011, ENVIRON CONSERV, V38, P406, DOI 10.1017/S0376892911000555; Zilberman D, 2008, ENVIRON DEV ECON, V13, P255, DOI 10.1017/S1355770X08004294	64	55	55	1	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0131544	10.1371/journal.pone.0131544	http://dx.doi.org/10.1371/journal.pone.0131544			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1FD	26162000	Green Published, gold			2022-12-26	WOS:000358162300044
J	Gouleme, N; Gerard, CL; Bucci, MP				Gouleme, Nathalie; Gerard, Christophe-Loic; Bucci, Maria Pia			The Effect of Training on Postural Control in Dyslexic Children	PLOS ONE			English	Article							DEVELOPMENTAL DYSLEXIA; BALANCE; PERFORMANCE; PARAMETERS; PLATFORM; GAIT	The aim of this study was to explore whether a short postural training period could affect postural stability in dyslexic children. Postural performances were evaluated using Multitest Equilibre from Framiral. Posture was recorded in three different viewing conditions (eyes open fixating a target, eyes closed and eyes open with perturbed vision) and in two different postural conditions (on stable and unstable support). Two groups of dyslexic children participated in the study, i.e. G1:16 dyslexic participants (mean age 9.9 +/- 0.3 years) who performed short postural training and G2: 16 dyslexic participants of similar ages (mean age 9.1 +/- 0.3 years) who did not perform any short postural training. Findings showed that short postural training improved postural stability on unstable support surfaces with perturbed vision: indeed the surface, the mean velocity of CoP and the spectral power indices in both directions decreased significantly, and the cancelling time in the antero-posterior direction improved significantly. Such improvement could be due to brain plasticity, which allows better performance in sensory process and cerebellar integration.	[Gouleme, Nathalie; Bucci, Maria Pia] Paris Diderot Univ, UMR 1141, INSERM, Robert Debre Hosp, Paris, France; [Gerard, Christophe-Loic] Hop Robert Debre, Child & Adolescent Psychiat Dept, F-75019 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite	Gouleme, N (corresponding author), Paris Diderot Univ, UMR 1141, INSERM, Robert Debre Hosp, Paris, France.	gouleme.nathalie@gmail.com		Gouleme, Nathalie/0000-0002-0246-973X	Fondation Cotrel / Institut de France	Fondation Cotrel / Institut de France	The authors are grateful to the Fondation Cotrel / Institut de France for their financial support.	Abd El-Kafy EM, 2014, AM J PHYS MED REHAB, V93, P938, DOI 10.1097/PHM.0000000000000109; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Angulo-Barroso RM, 2013, RES DEV DISABIL, V34, P3629, DOI 10.1016/j.ridd.2013.07.037; Barela JA, 2011, RES DEV DISABIL, V32, P1814, DOI 10.1016/j.ridd.2011.03.011; Barge L, 2007, EXPLORATION REEDUCAT, P8; Bernard-Demanze L, 2009, Curr Aging Sci, V2, P139; Brandt T, 2003, VERTIGO ITS MULTISEN, P503; Bucci MP, 2012, EXP BRAIN RES, V222, P21, DOI 10.1007/s00221-012-3192-7; Bucci M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057801; Burciu RG, 2013, J NEUROSCI, V33, P4594, DOI 10.1523/JNEUROSCI.3381-12.2013; Chevrie-Muller C, 1997, BATTERIE LANGUAGE OR; Chiari L, 2002, CLIN BIOMECH, V17, P666, DOI 10.1016/S0268-0033(02)00107-9; Eckert MA, 2003, BRAIN, V126, P482, DOI 10.1093/brain/awg026; Faigenbaum AD, 2013, J STRENGTH COND RES, V27, P323, DOI 10.1519/JSC.0b013e31827e135b; Fawcett A, 1999, REV ELECT INVEST PSI, V2, P35; GEURTS ACH, 1993, ARCH PHYS MED REHAB, V74, P1144; Ghulyan V, 2005, ACTA OTO-LARYNGOL, V125, P607, DOI 10.1080/00016480510026908; Gouleme N, 2015, CLIN NEUROPHYSIOL, V126, P1370, DOI 10.1016/j.clinph.2014.10.016; Ilg W, 2009, NEUROLOGY, V73, P1823, DOI 10.1212/WNL.0b013e3181c33adf; Ilg W, 2010, MOVEMENT DISORD, V25, P2239, DOI 10.1002/mds.23222; Ionescu E, 2006, INT J PEDIATR OTORHI, V70, P1457, DOI 10.1016/j.ijporl.2006.03.012; Katz-Leurer M, 2009, CLIN REHABIL, V23, P714, DOI 10.1177/0269215509335293; KohenRaz R, 1996, PERCEPT MOTOR SKILL, V82, P547, DOI 10.2466/pms.1996.82.2.547; Konczak J, 2005, BRAIN, V128, P1428, DOI 10.1093/brain/awh385; Lacour M, 2008, NEUROPHYSIOL CLIN, V38, P411, DOI 10.1016/j.neucli.2008.09.005; Legrand A, 2021, PLOS ONE, V7, P1; MAKI BE, 1990, J AM GERIATR SOC, V38, P1, DOI 10.1111/j.1532-5415.1990.tb01588.x; Miyai I, 2012, NEUROREHAB NEURAL RE, V26, P515, DOI 10.1177/1545968311425918; Moe-Nilssen R, 2003, EXP BRAIN RES, V150, P237, DOI 10.1007/s00221-003-1450-4; Naschner LN, 2008, PROGR BRAIN RES, V1979, P177; Nicolson RI, 2007, TRENDS NEUROSCI, V30, P135, DOI 10.1016/j.tins.2007.02.003; O'Hare Anne, 2002, Dyslexia, V8, P234, DOI 10.1002/dys.230; Paillard T, 2002, BRIT J SPORT MED, V36, P304, DOI 10.1136/bjsm.36.4.304; Perennou D, 2006, EFFICIENCE DEFICIENC, P65; Pozzo T, 2006, NEUROSCI LETT, V403, P211, DOI 10.1016/j.neulet.2006.03.049; Rae C, 1998, LANCET, V351, P1849, DOI 10.1016/S0140-6736(97)99001-2; Reynolds D, 2003, DYSLEXIA, V9, P48, DOI 10.1002/dys.235; Sehm B, 2014, NEUROBIOL AGING, V35, P232, DOI 10.1016/j.neurobiolaging.2013.06.021; Stoodley CJ, 2005, EXP BRAIN RES, V167, P370, DOI 10.1007/s00221-005-0042-x; Taubert M, 2010, J NEUROSCI, V30, P11670, DOI 10.1523/JNEUROSCI.2567-10.2010; Viana AR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072719; Vieira S, 2009, NEUROSCI LETT, V462, P125, DOI 10.1016/j.neulet.2009.06.093; Woollacott MH, 1989, DEV POSTURE GAIT LIF, P77; YAP RL, 1994, J LEARN DISABIL, V27, P660, DOI 10.1177/002221949402701006; Zech A, 2014, EUR J APPL PHYSIOL, V114, P395, DOI 10.1007/s00421-013-2786-5	45	8	9	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0130196	10.1371/journal.pone.0130196	http://dx.doi.org/10.1371/journal.pone.0130196			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1FD	26162071	gold, Green Published, Green Submitted			2022-12-26	WOS:000358162300015
J	Li, WB; Wang, PP; Li, YG; Zhang, KX; Ding, FQ; Nie, TK; Yang, X; Lv, QX; Zhao, L				Li, Wenbin; Wang, Pengpeng; Li, Yongguang; Zhang, Kexin; Ding, Fuquan; Nie, Tengkun; Yang, Xue; Lv, Qingxue; Zhao, Lin			Identification of MicroRNAs in Response to Different Day Lengths in Soybean Using High-Throughput Sequencing and qRT-PCR	PLOS ONE			English	Article							SHOOT APICAL MERISTEM; GAMYB-LIKE GENES; SMALL RNAS; TRANSLATIONAL INHIBITION; FLORAL DEVELOPMENT; CIRCADIAN CLOCK; FLOWERING TIME; TARGET GENES; ARABIDOPSIS; EXPRESSION	MicroRNAs (miRNAs) are short, non-coding single-strand RNA molecules that play important roles in plant growth, development and stress responses. Flowering time affects the seed yield and quality of soybean. However, the miRNAs involved in the regulation of flowering time in soybean have not been reported until recently. Here, high-throughput sequencing and qRT-PCR were used to identify miRNAs involved in soybean photoperiodic pathways. The first trifoliate leaves of soybean that receive the signal of light treatment were used to construct six libraries (0, 8, and 16 h under short-day (SD) treatment and 0, 8, and 16 h under long-day (LD) treatment). The libraries were sequenced using Illumina Solexa. A total of 318 known plant miRNAs belonging to 163 miRNA families and 81 novel predicted miRNAs were identified. Among these, 23 miRNAs at 0 h, 65 miRNAs at 8 h and 83 miRNAs at 16 h, including six novel predicted miRNAs at 8 h and six novel predicted miRNAs at 16 h, showed differences in abundance between LD and SD treatments. Furthermore, the results of GO and KEGG analyses indicated that most of the miRNA targets were transcription factors. Seven miRNAs at 0 h, 23 miRNAs (including four novel predicted miRNAs) at 8 h, 16 miRNAs (including one novel predicted miRNA) at 16 h and miRNA targets were selected for qRT-PCR analysis to assess the accuracy of the sequencing and target prediction. The results indicated that the expression patterns of the selected miRNAs and miRNA targets showed no differences between the qRT-PCR and sequencing results. In addition, 23 miRNAs at 0 h, 65 miRNAs at 8 h and 83 miRNAs at 16 h responded to day length changes in soybean, including six novel predicted miRNAs at 8 h and six novel predicted miRNAs at 16 h. These results provided an important molecular basis to understand the regulation of flowering time through photoperiodic pathways in soybean.	[Li, Wenbin; Wang, Pengpeng; Li, Yongguang; Zhang, Kexin; Ding, Fuquan; Nie, Tengkun; Yang, Xue; Lv, Qingxue; Zhao, Lin] Northeast Agr Univ, Chinese Educ Minist, Key Lab Biol & Genet & Breeding Soybean Northeast, Key Lab Soybean Biol, Harbin 150030, Peoples R China	Northeast Agricultural University - China	Zhao, L (corresponding author), Northeast Agr Univ, Chinese Educ Minist, Key Lab Biol & Genet & Breeding Soybean Northeast, Key Lab Soybean Biol, Harbin 150030, Peoples R China.	zhaolinneau@126.com	zhang, ke/AAH-8217-2019; Li, Yongguang/ACM-0755-2022	Li, Yongguang/0000-0002-9171-2729	National 863 project [2013AA102602]; Chinese National Natural Science Foundation [31271748]; National education Ministry; Chinese Key Projects of Soybean Transformation [2014ZX08004-005]; Hei Longjiang Province Natural Science Foundation [C2015009]; Youth Backbone Research program of Provincial Education Department [1253G010]; "Young Talents" Project of Northeast Agricultural University [14QC23]; Northeast Agricultural University Innovation Foundation [yjscx14047]	National 863 project(National High Technology Research and Development Program of China); Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National education Ministry; Chinese Key Projects of Soybean Transformation; Hei Longjiang Province Natural Science Foundation(Natural Science Foundation of Heilongjiang Province); Youth Backbone Research program of Provincial Education Department; "Young Talents" Project of Northeast Agricultural University; Northeast Agricultural University Innovation Foundation	The project was financially supported by National 863 project (2013AA102602), Chinese National Natural Science Foundation (31271748), National education Ministry for the teams of soybean molecular design, Chinese Key Projects of Soybean Transformation (2014ZX08004-005), Hei Longjiang Province Natural Science Foundation (C2015009), Youth Backbone Research program of Provincial Education Department (1253G010), "Young Talents" Project of Northeast Agricultural University (14QC23) Northeast Agricultural University Innovation Foundation For Postgraduate (yjscx14047).	Achard P, 2004, DEVELOPMENT, V131, P3357, DOI 10.1242/dev.01206; Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Aukerman MJ, 2003, PLANT CELL, V15, P2730, DOI 10.1105/tpc.016238; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Blazquez MA, 2000, NATURE, V404, P889, DOI 10.1038/35009125; Boss PK, 2004, PLANT CELL, V16, pS18, DOI 10.1105/tpc.015958; Brodersen P, 2008, SCIENCE, V320, P1185, DOI 10.1126/science.1159151; Cardon G, 1999, GENE, V237, P91, DOI 10.1016/S0378-1119(99)00308-X; Chen R, 2009, J INTEGR PLANT BIOL, V51, P1071, DOI 10.1111/j.1744-7909.2009.00887.x; Chen XM, 2005, FEBS LETT, V579, P5923, DOI 10.1016/j.febslet.2005.07.071; Chen XM, 2004, SCIENCE, V303, P2022, DOI 10.1126/science.1088060; Dai XB, 2011, NUCLEIC ACIDS RES, V39, pW155, DOI 10.1093/nar/gkr319; Fornara F, 2009, CELL, V138, P625, DOI 10.1016/j.cell.2009.08.011; Gandikota M, 2007, PLANT J, V49, P683, DOI 10.1111/j.1365-313X.2006.02983.x; Garcia D, 2006, CURR BIOL, V16, P933, DOI 10.1016/j.cub.2006.03.064; Gocal GFW, 2001, PLANT PHYSIOL, V127, P1682, DOI 10.1104/pp.010442; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Hagen G, 2002, PLANT MOL BIOL, V49, P373, DOI 10.1023/A:1015207114117; Hao QN, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-525; Hayama R, 2003, CURR OPIN PLANT BIOL, V6, P13, DOI 10.1016/S1369-5266(02)00011-0; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Joshi T, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S1-S14; Jung JH, 2007, PLANT CELL, V19, P2736, DOI 10.1105/tpc.107.054528; Jung J, 2007, PLANTA, V225, P575, DOI 10.1007/s00425-006-0373-2; Khraiwesh Basel, 2012, Biochim Biophys Acta, V1819, P137, DOI 10.1016/j.bbagrm.2011.05.001; Kim VN, 2004, TRENDS CELL BIOL, V14, P156, DOI 10.1016/j.tcb.2004.02.006; Kulcheski FR, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-307; Kulcheski FR, 2010, ANAL BIOCHEM, V406, P185, DOI 10.1016/j.ab.2010.07.020; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Li MY, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-242; Liang G, 2010, PLANT J, V62, P1046, DOI 10.1111/j.1365-313X.2010.04216.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu C, 2006, GENOME RES, V16, P1276, DOI 10.1101/gr.5530106; Martinez G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019523; Meng YJ, 2010, J EXP BOT, V61, P3833, DOI 10.1093/jxb/erq209; Meyers BC, 2008, PLANT CELL, V20, P3186, DOI 10.1105/tpc.108.064311; Millar AA, 2005, PLANT CELL, V17, P705, DOI 10.1105/tpc.104.027920; Mouradov A, 2002, PLANT CELL, V14, pS111, DOI 10.1105/tpc.001362; Mutum RD, 2013, FEBS J, V280, P1717, DOI 10.1111/febs.12186; Nogueira FTS, 2007, GENE DEV, V21, P750, DOI 10.1101/gad.1528607; Okamuro JK, 1997, P NATL ACAD SCI USA, V94, P7076, DOI 10.1073/pnas.94.13.7076; Putterill J, 2004, BIOESSAYS, V26, P363, DOI 10.1002/bies.20021; Schmid M, 2003, DEVELOPMENT, V130, P6001, DOI 10.1242/dev.00842; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Schwarz S, 2008, PLANT MOL BIOL, V67, P183, DOI 10.1007/s11103-008-9310-z; Sha AH, 2012, J PLANT BIOL, V55, P268, DOI 10.1007/s12374-011-0255-4; Song CNA, 2010, BMC GENOMICS, V11, DOI [10.1186/1471-2164-11-431, 10.1186/1471-2164-11-261]; Song QX, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-5; Suarez-Lopez P, 2001, NATURE, V410, P1116, DOI 10.1038/35074138; Subramanian S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-160; Sunkar R, 2007, TRENDS PLANT SCI, V12, P301, DOI 10.1016/j.tplants.2007.05.001; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Turck F, 2008, ANNU REV PLANT BIOL, V59, P573, DOI 10.1146/annurev.arplant.59.032607.092755; Vaucheret H, 2004, GENE DEV, V18, P1187, DOI 10.1101/gad.1201404; Wang JW, 2009, CELL, V138, P738, DOI 10.1016/j.cell.2009.06.014; Wang YW, 2009, BIOCHEM BIOPH RES CO, V378, P799, DOI 10.1016/j.bbrc.2008.11.140; Wong CE, 2011, J EXP BOT, V62, P2495, DOI 10.1093/jxb/erq437; Wu G, 2006, DEVELOPMENT, V133, P3539, DOI 10.1242/dev.02521; Xu ZH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028009; Yang ZF, 2008, GENE, V407, P1, DOI 10.1016/j.gene.2007.02.034; Yanovsky MJ, 2002, NATURE, V419, P308, DOI 10.1038/nature00996; Zeng QY, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-182; Zhao JP, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0047811, 10.1371/journal.pone.0048131]; Zhou CM, 2013, J GENET GENOMICS, V40, P211, DOI 10.1016/j.jgg.2012.12.003; Zhou LG, 2010, J EXP BOT, V61, P4157, DOI 10.1093/jxb/erq237; Zhu HL, 2011, CELL, V145, P242, DOI 10.1016/j.cell.2011.03.024	70	13	13	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132621	10.1371/journal.pone.0132621	http://dx.doi.org/10.1371/journal.pone.0132621			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26162069	gold, Green Published, Green Submitted			2022-12-26	WOS:000358162300159
J	Sorensen, MJ; Kjaersgaard, MIS; Pedersen, HS; Vestergaard, M; Christensen, J; Olsen, J; Parner, E; Pedersen, LH; Bech, BH				Sorensen, Merete Juul; Kjaersgaard, Maiken Ina Siegismund; Pedersen, Henrik Sondergaard; Vestergaard, Mogens; Christensen, Jacob; Olsen, Jorn; Parner, Erik; Pedersen, Lars Henning; Bech, Bodil Hammer			Risk of Fetal Death after Treatment with Antipsychotic Medications during Pregnancy	PLOS ONE			English	Article							POSTMARKETING SURVEILLANCE; WOMEN; SCHIZOPHRENIA; OUTCOMES; POPULATION; EXPERIENCE; OLANZAPINE; DISORDERS; REGISTER; EXPOSURE	Background Antipsychotic medications are increasingly used during pregnancy. Nevertheless, fetal risks are still not fully studied. It is currently unclear whether the antipsychotic treatment might induce a higher risk of fetal death. We aimed to determine if use of antipsychotic medication during pregnancy is associated with an increased risk of spontaneous abortion or stillbirth. Methods In a historical cohort study, we identified all clinically recognized pregnancies registered in the nationwide Danish registries from 1997 to 2008 (N = 1,005,319). Exposure was defined as any prescription of antipsychotic medications redeemed by the pregnant women during the exposure window, and recorded in the Danish National Prescription Register. Outcome was defined as any spontaneous abortion or stillbirth recorded in the Danish National Hospital Register and the Danish Medical Birth Register respectively. Results Women exposed to antipsychotic medications during pregnancy had a 34% higher risk of spontaneous abortion (adjusted relative risk = 1.34; 95% confidence interval = 1.22; 1.46) compared to unexposed women, but a similar risk compared to women exposed prior to (but not during) pregnancy (adjusted relative risk = 1.04; 95% confidence interval = 0.93; 1.17). The risk of spontaneous abortion was not increased in exposed pregnancies when compared to unexposed pregnancies in the same women (adjusted hazard ratio = 1.11; 95% CI = 0.94; 1.31). A twofold higher risk of stillbirth was found in women exposed to antipsychotic medications compared with unexposed women (relative risk = 2.27; 95% confidence interval = 1.45; 3.55) and compared with women exposed only prior to pregnancy (relative risk = 2.06; 95% confidence interval = 1.01; 4.19). Conclusions The increased risk of spontaneous abortion found in women treated with antipsychotic medications during pregnancy is most likely due to confounding factors. The risk of stillbirth was twofold higher in pregnancies exposed to antipsychotic medication during pregnancy. Treatment with antipsychotic medications during pregnancy requires careful consideration.	[Sorensen, Merete Juul] Aarhus Univ Hosp, Reg Ctr Child & Adolescent Psychiat, DK-8000 Aarhus, Denmark; [Kjaersgaard, Maiken Ina Siegismund; Parner, Erik] Aarhus Univ, Dept Publ Hlth, Biostat Sect, Aarhus, Denmark; [Pedersen, Henrik Sondergaard; Vestergaard, Mogens] Aarhus Univ, Res Unit Gen Practice, Dept Publ Hlth, Aarhus, Denmark; [Vestergaard, Mogens] Aarhus Univ, Sect Gen Med Practice, Dept Publ Hlth, Aarhus, Denmark; [Christensen, Jacob] Aarhus Univ Hosp, Dept Neurol, DK-8000 Aarhus, Denmark; [Christensen, Jacob] Aarhus Univ Hosp, Dept Clin Pharmacol, DK-8000 Aarhus, Denmark; [Olsen, Jorn; Pedersen, Lars Henning; Bech, Bodil Hammer] Aarhus Univ, Dept Publ Hlth, Epidemiol Sect, Aarhus, Denmark; [Pedersen, Lars Henning] Aarhus Univ, Inst Clin Med Obstet & Gynaecol, Aarhus, Denmark	Aarhus University; Aarhus University; Aarhus University; Aarhus University; Aarhus University; Aarhus University; Aarhus University; Aarhus University	Sorensen, MJ (corresponding author), Aarhus Univ Hosp, Reg Ctr Child & Adolescent Psychiat, DK-8000 Aarhus, Denmark.	meresoer@rm.dk	Bech, Bodil Hammer/B-9646-2016; Parner, Erik Thorlund/F-5532-2010	Bech, Bodil Hammer/0000-0002-0287-3687; Parner, Erik Thorlund/0000-0003-3661-1922; Christensen, Jakob/0000-0002-9385-6435	Regional Center for Child and Adolescent Psychiatry, Aarhus University Hospital, Risskov, Denmark	Regional Center for Child and Adolescent Psychiatry, Aarhus University Hospital, Risskov, Denmark	The Regional Center for Child and Adolescent Psychiatry, Aarhus University Hospital, Risskov, Denmark, contributed with funding to the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander GC, 2011, PHARMACOEPIDEM DR S, V20, P177, DOI 10.1002/pds.2082; Andersen TF, 1999, DAN MED BULL, V46, P263; Bennedsen BE, 2001, ARCH GEN PSYCHIAT, V58, P674, DOI 10.1001/archpsyc.58.7.674; Biswas PN, 2001, J PSYCHOPHARMACOL, V15, P265, DOI 10.1177/026988110101500405; Coppola D, 2007, DRUG SAFETY, V30, P247, DOI 10.2165/00002018-200730030-00006; Diav-Citrin O, 2005, J CLIN PSYCHIAT, V66, P317, DOI 10.4088/JCP.v66n0307; Gentile S, 2010, SCHIZOPHRENIA BULL, V36, P518, DOI 10.1093/schbul/sbn107; Gissler M, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-383; Goldstein DJ, 2000, J CLIN PSYCHOPHARM, V20, P399, DOI 10.1097/00004714-200008000-00002; Habermann F, 2013, J CLIN PSYCHOPHARM, V33, P453, DOI 10.1097/JCP.0b013e318295fe12; Hironaka M, 2011, J OBSTET GYNAECOL RE, V37, P1283, DOI 10.1111/j.1447-0756.2010.01512.x; Howard LM, 2003, BRIT J PSYCHIAT, V182, P63, DOI 10.1192/bjp.182.1.63; Johnson KC, 2012, ARCH GEN PSYCHIAT, V69, P787, DOI 10.1001/archgenpsychiatry.2012.160; Kildemoes HW, 2011, SCAND J PUBLIC HEALT, V39, P38, DOI 10.1177/1403494810394717; King-Hele S, 2009, ARCH DIS CHILD-FETAL, V94, pF105, DOI 10.1136/adc.2007.135459; Knudsen LB, 1998, DAN MED BULL, V45, P320; Lin HC, 2010, SCHIZOPHR RES, V116, P55, DOI 10.1016/j.schres.2009.10.011; McKenna K, 2005, J CLIN PSYCHIAT, V66, P444, DOI 10.4088/JCP.v66n0406; MunkJorgensen P, 1997, DAN MED BULL, V44, P82; Newport DJ, 2007, AM J PSYCHIAT, V164, P1214, DOI 10.1176/appi.ajp.2007.06111886; Nilsson E, 2002, SCHIZOPHR RES, V58, P221, DOI 10.1016/S0920-9964(01)00370-X; Olesen C, 2001, EPIDEMIOLOGY, V12, P497, DOI 10.1097/00001648-200109000-00006; Peng M, 2013, PSYCHOPHARMACOLOGY, V228, P577, DOI 10.1007/s00213-013-3060-6; Reis M, 2008, J CLIN PSYCHOPHARM, V28, P279, DOI 10.1097/JCP.0b013e318172b8d5; Sadowski A, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003062; Stephenson CP, 2013, AUST NZ J PSYCHIAT, V47, P74, DOI 10.1177/0004867412466595; Twaites BR, 2007, J PSYCHOPHARMACOL, V21, P392, DOI 10.1177/0269881107073257; Vigod SN, 2012, SCHIZOPHR RES, V139, P169, DOI 10.1016/j.schres.2012.05.010; World Health Organization, 1993, THE ICD 10 CLASSIFIC	29	12	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132280	10.1371/journal.pone.0132280	http://dx.doi.org/10.1371/journal.pone.0132280			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1FD	26162087	Green Submitted, gold, Green Published			2022-12-26	WOS:000358162300111
J	Xu, JL; Wang, Y; Zhang, F; Wu, Y; Zheng, TQ; Wang, YH; Zhao, XQ; Cui, YR; Chen, K; Zhang, Q; Lin, HX; Li, JY; Li, ZK				Xu, Jian-Long; Wang, Yun; Zhang, Fan; Wu, Yuan; Zheng, Tian-Qing; Wang, Yong-Hong; Zhao, Xiu-Qin; Cui, Yan-Ru; Chen, Kai; Zhang, Qiang; Lin, Hong-Xuan; Li, Jia-Yang; Li, Zhi-Kang			SS1 (NAL1)- and SS2-Mediated Genetic Networks Underlying Source-Sink and Yield Traits in Rice (Oryza sativa L.)	PLOS ONE			English	Article							ADVANCED BACKCROSS POPULATION; OVERDOMINANT EPISTATIC LOCI; GRAIN-YIELD; INBREEDING DEPRESSION; MOLECULAR DISSECTION; INTROGRESSION LINES; NATURAL VARIATION; INCREASES YIELD; COMPLEX TRAITS; HEADING DATE	Source leaf/sink capacity (SS) traits are important determinants of grain yield (GY) of rice. To understand the genetic basis of the SS relationship in rice, five SS and GY traits of rice were genetically dissected using two reciprocal introgression populations. Seventy-three QTL affecting the SS and GY traits were identified, most of which were detected in one of the parental genetic backgrounds (GBs). Two major QTL at bins 4.7 (SS1) and 3.12 (SS2) were associated consistently with all measured SS and yield traits in both GBs across two contrasting environments. Strong interactions between SS1/SS2 and the detected QTL led us to the discovery of genetic networks affecting the SS and GY traits. The SS1 acted as a regulator controlling two groups of downstream QTL affecting the source leaf width and grain number per panicle (GNP). SS2 functioned as a regulator positively regulating different groups of downstream QTL affecting the source leaf length, GNP, grain weight, and GY. Map-based cloning of SS1 indicates that SS1 is NAL1 involved in polar auxin/IAA transport. Different alleles at NAL1 were apparently able to qualitatively and/or quantitatively control the IAA transport from the apical meristem to different plant tissues and thus regulate those downstream loci/pathways controlling different SS traits of rice. There was a functional allele and a non-functional mutation in the parents at each of the QTL downstream of SS1 or SS2, which were detectable only in the presence of the functional allele of SS1 or SS2. Our results provided direct evidence that SS and yield traits in rice are controlled by complex signaling pathways and suggest further improvement of rice yield potential with enhanced and balanced SS relationships can be achieved by accurately manipulating allelic combinations at loci in the SS1 and SS2 mediated pathways.	[Xu, Jian-Long; Zhang, Fan; Zheng, Tian-Qing; Zhao, Xiu-Qin; Cui, Yan-Ru; Chen, Kai; Zhang, Qiang; Li, Zhi-Kang] Chinese Acad Agr Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Inst Crop Sci, Beijing 100081, Peoples R China; [Xu, Jian-Long; Li, Zhi-Kang] Chinese Acad Agr Sci, Shenzhen Inst Innovat Breeding, Shenzhen 518120, Peoples R China; [Wang, Yun] Shenyang Agr Univ, Rice Inst, Minist Agr, Key Lab Crop Physiol Ecol Genet & Breeding, Shenyang 110866, Peoples R China; [Wu, Yuan; Lin, Hong-Xuan] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Shanghai 200032, Peoples R China; [Wang, Yong-Hong; Li, Jia-Yang] Chinese Acad Sci, Inst Genet & Dev Biol, Beijing 100101, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Chinese Academy of Agricultural Sciences; Ministry of Agriculture & Rural Affairs; Shenyang Agricultural University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS	Li, ZK (corresponding author), Chinese Acad Agr Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Inst Crop Sci, 12 South Zhong Guan Cun St, Beijing 100081, Peoples R China.	lizhikang@caas.cn	Xu, Jianlong/AAI-8310-2020; Lin, Hong-Xuan/AEQ-6607-2022; Li, Jiayang/AAG-4377-2020	Lin, Hong-Xuan/0000-0002-2818-023X; 	National Natural Science Foundation [31261140369, 31071061]; Chinese Transgenic Key Project [2009ZX08009-124B]; Chinese Ministry of Science Technology; "948" Project [2011-G2B]; Chinese Ministry of Agriculture; Project of International S&T Cooperation Program of China [2012DFB32280]; 863 key Project [2014AA10A601]; "Green Super Rice" Project from Chinese Ministry of Science Technology [OR1393]; Bill & Melinda Gates Foundation; Shenzhen Peacock Plan [20130415095710361]; CAAS Innovative Team Award	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Chinese Transgenic Key Project; Chinese Ministry of Science Technology(Ministry of Science and Technology, China); "948" Project(Ministry of Agriculture & Rural Affairs); Chinese Ministry of Agriculture(Ministry of Agriculture & Rural Affairs); Project of International S&T Cooperation Program of China; 863 key Project(National High Technology Research and Development Program of China); "Green Super Rice" Project from Chinese Ministry of Science Technology; Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Shenzhen Peacock Plan; CAAS Innovative Team Award	This research was funded by the National Natural Science Foundation (31261140369 to JLX, 31071061 to YW, http://www.nsfc.gov.cn), the Chinese Transgenic Key Project to JLX (2009ZX08009-124B, http://www.most.gov.cn) from the Chinese Ministry of Science & Technology, the "948" Project to ZKL (2011-G2B, http://www.moa.gov.cn/) from the Chinese Ministry of Agriculture, the Project of International S&T Cooperation Program of China to ZKL (2012DFB32280, http://www.istcp.org.cn/), 863 key Project to JLX (2014AA10A601, http://www.most.gov.cn) and the "Green Super Rice" Project to ZKL (OR1393) from the Chinese Ministry of Science & Technology (http://www.most.gov.cn) and Bill & Melinda Gates Foundation (http://www.gatesfoundation.org/), and the Shenzhen Peacock Plan (20130415095710361, http://www.szsti.gov.cn/) and the CAAS Innovative Team Award (http://www.caas.cn/) to ZK Li's team. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BELFORD RK, 1991, FIELD CROP RES, V26, P221, DOI 10.1016/0378-4290(91)90037-V; Chen HD, 2011, THEOR APPL GENET, V123, P869, DOI 10.1007/s00122-011-1633-5; Cheng LR, 2013, CROP SCI, V53, P1437, DOI 10.2135/cropsci2013.02.0075; Cho SH, 2014, PLANT MOL BIOL REP, V32, P270, DOI 10.1007/s11105-013-0675-z; Cui KH, 2003, THEOR APPL GENET, V106, P649, DOI 10.1007/s00122-002-1113-z; Ding XP, 2011, THEOR APPL GENET, V123, P815, DOI 10.1007/s00122-011-1629-1; DONALD CM, 1968, EUPHYTICA, V17, P385, DOI 10.1007/BF00056241; ESHED Y, 1995, GENETICS, V141, P1147; Fan CH, 2006, THEOR APPL GENET, V112, P1164, DOI 10.1007/s00122-006-0218-1; FOYER CH, 1987, PLANT PHYSIOL BIOCH, V25, P649; Frazer KA, 2009, NAT REV GENET, V10, P241, DOI 10.1038/nrg2554; Fujita D, 2013, P NATL ACAD SCI USA, V110, P20431, DOI 10.1073/pnas.1310790110; GLADUN IV, 1993, RUSS PLANT PHYSIOL+, V40, P215; Guo YA, 2010, J GENET GENOMICS, V37, P533, DOI 10.1016/S1673-8527(09)60073-4; Huang YX, 2003, WORLD SCI TECH R D, V12, P1; Iliadi KG, 2009, EXP GERONTOL, V44, P546, DOI 10.1016/j.exger.2009.05.008; Khush GS, 2001, NAT REV GENET, V2, P815, DOI 10.1038/35093585; LAFITTE HR, 1984, CROP SCI, V24, P447, DOI 10.2135/cropsci1984.0011183X002400030004x; Li YB, 2011, NAT GENET, V43, P1266, DOI 10.1038/ng.977; Li Z., 2013, GENETICS GENOMICS RI, P349, DOI [10.1007/978-1-4614-7903-1_23, DOI 10.1007/978-1-4614-7903-1_23]; Li ZK, 2013, CURR OPIN PLANT BIOL, V16, P261, DOI 10.1016/j.pbi.2013.03.008; Li ZK, 1997, GENETICS, V145, P453; Li ZK, 2003, THEOR APPL GENET, V108, P141, DOI 10.1007/s00122-003-1401-2; Li ZK, 2001, GENETICS, V158, P1737; Li ZK, 1998, MOL BREEDING, V4, P419, DOI 10.1023/A:1009608128785; Li ZK, 1997, MOL DISSECTION COMPL, P119; Liao CY, 2001, THEOR APPL GENET, V103, P104, DOI 10.1007/s001220000528; Lin HX, 1996, THEOR APPL GENET, V92, P920, DOI 10.1007/BF00224031; Luo LJ, 2001, GENETICS, V158, P1755; Mather K, 1982, BIOMETRICAL GENETICS; Mei HW, 2006, THEOR APPL GENET, V112, P648, DOI 10.1007/s00122-005-0167-0; Mohammad Ashraf, 1994, Genetic improvement of field crops., P413; Moncada P, 2001, THEOR APPL GENET, V102, P41, DOI 10.1007/s001220051616; Monforte AJ, 2000, GENOME, V43, P803, DOI 10.1139/gen-43-5-803; Qi J, 2008, PLANT PHYSIOL, V147, P1947, DOI 10.1104/pp.108.118778; SAS Institute, 2008, SAS STAT US GUID; Septiningsih EM, 2003, THEOR APPL GENET, V107, P1419, DOI 10.1007/s00122-003-1373-2; Shomura A, 2008, NAT GENET, V40, P1023, DOI 10.1038/ng.169; Song XJ, 2007, NAT GENET, V39, P623, DOI 10.1038/ng2014; Takai T, 2013, SCI REP-UK, V3, DOI 10.1038/srep02149; Thomson MJ, 2003, THEOR APPL GENET, V107, P479, DOI 10.1007/s00122-003-1270-8; Wang E, 2008, NAT GENET, V40, P1370, DOI 10.1038/ng.220; Wang P, 2012, MOL BREEDING, V29, P903, DOI 10.1007/s11032-011-9679-2; Wang P, 2012, MOL BREEDING, V29, P99, DOI 10.1007/s11032-010-9529-7; Wang W, 2015, PLANT GENOME, DOI [10.3835/plantgenome2014.10.0078, DOI 10.3835/PLANTGENOME2014.10.0078]; Wang Yun, 2009, Acta Agronomica Sinica, V35, P1386; Weng JF, 2008, CELL RES, V18, P1199, DOI 10.1038/cr.2008.307; Wu B, 2013, GENETICS GENOMICS RI, P35; Wu RL, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-84; Xie XB, 2006, THEOR APPL GENET, V113, P885, DOI 10.1007/s00122-006-0348-5; Xie XueWen, 2008, Acta Agronomica Sinica, V34, P1885, DOI 10.1016/S1875-2780(09)60013-4; Xu JL, 2006, J EXP BOT, V57, P2815, DOI 10.1093/jxb/erl046; Xu JL, 2005, THEOR APPL GENET, V111, P1642, DOI 10.1007/s00122-005-0099-8; Xu JL, 2004, PLANT BREEDING, V123, P43, DOI 10.1046/j.1439-0523.2003.00936.x; Xu ZhengJin, 1998, Acta Agronomica Sinica, V24, P47; Xue WY, 2008, NAT GENET, V40, P761, DOI 10.1038/ng.143; Yang Jing, 2009, Acta Agronomica Sinica, V35, P974, DOI 10.3724/SP.J.1006.2009.00974; Yoshida S, 1981, FUNDAMENTALS RICE CR; Yuan L.P., 1997, HYBRID RICE, V12, P1, DOI DOI 10.16267/J.CNKI.1005-3956.1997.06.001; Yue Bing, 2006, Acta Genetica Sinica, V33, P824, DOI 10.1016/S0379-4172(06)60116-9; Zhang F, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-55; Zhang F, 2013, THEOR APPL GENET, V126, P1011, DOI 10.1007/s00122-012-2033-1; Zhang F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014541; Zhang GH, 2014, MOL PLANT, V7, P1350, DOI 10.1093/mp/ssu055; Zhang YS, 2009, THEOR APPL GENET, V118, P1035, DOI 10.1007/s00122-008-0960-7; Zheng TQ, 2011, CROP SCI, V51, P2525, DOI 10.2135/cropsci2011.05.0259	66	13	17	7	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132060	10.1371/journal.pone.0132060	http://dx.doi.org/10.1371/journal.pone.0132060			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26162098	Green Submitted, Green Published, gold			2022-12-26	WOS:000358162300087
J	Larsson, H; Tegern, M; Monnier, A; Skoglund, J; Helander, C; Persson, E; Malm, C; Broman, L; Aasa, U				Larsson, Helena; Tegern, Matthias; Monnier, Andreas; Skoglund, Jorgen; Helander, Charlotte; Persson, Emelie; Malm, Christer; Broman, Lisbet; Aasa, Ulrika			Content Validity Index and Intra- and Inter-Rater Reliability of a New Muscle Strength/Endurance Test Battery for Swedish Soldiers	PLOS ONE			English	Article							PHYSICAL PERFORMANCE TESTS; BODY-MASS BIAS; LOAD-CARRIAGE; PREMATURE DISCHARGE; FITNESS; OUTCOMES; ARMY; STANDARDS; PROGRAM; GENDER	The objective of this study was to examine the content validity of commonly used muscle performance tests in military personnel and to investigate the reliability of a proposed test battery. For the content validity investigation, thirty selected tests were those described in the literature and/or commonly used in the Nordic and North Atlantic Treaty Organization (NATO) countries. Nine selected experts rated, on a four-point Likert scale, the relevance of these tests in relation to five different work tasks: lifting, carrying equipment on the body or in the hands, climbing, and digging. Thereafter, a content validity index (CVI) was calculated for each work task. The result showed excellent CVI (>= 0.78) for sixteen tests, which comprised of one or more of the military work tasks. Three of the tests; the functional lower-limb loading test (the Ranger test), dead-lift with kettlebells, and back extension, showed excellent content validity for four of the work tasks. For the development of a new muscle strength/endurance test battery, these three tests were further supplemented with two other tests, namely, the chins and side-bridge test. The inter-rater reliability was high (intraclass correlation coefficient, ICC2,1 0.99) for all five tests. The intra-rater reliability was good to high (ICC3,1 0.82-0.96) with an acceptable standard error of mean (SEM), except for the side-bridge test (SEM%>15). Thus, the final suggested test battery for a valid and reliable evaluation of soldiers' muscle performance comprised the following four tests; the Ranger test, dead-lift with kettlebells, chins, and back extension test. The criterion-related validity of the test battery should be further evaluated for soldiers exposed to varying physical workload.	[Larsson, Helena; Tegern, Matthias; Monnier, Andreas; Broman, Lisbet; Aasa, Ulrika] Karolinska Inst, Div Physiotherapy, Dept Neurobiol Care Sci & Soc, SE-14183 Huddinge, Sweden; [Larsson, Helena; Monnier, Andreas] Swedish Armed Forces, SE-10785 Stockholm, Sweden; [Tegern, Matthias; Skoglund, Jorgen; Helander, Charlotte; Aasa, Ulrika] Umea Univ, Dept Community Med & Rehabil, SE-90187 Umea, Sweden; [Persson, Emelie; Malm, Christer] Umea Univ, Dept Surg & Perioperat Sci, SE-90887 Umea, Sweden	Karolinska Institutet; Umea University; Umea University	Larsson, H (corresponding author), Karolinska Inst, Div Physiotherapy, Dept Neurobiol Care Sci & Soc, SE-14183 Huddinge, Sweden.	elena.larsson.2@ki.se	Malm, Christer B/O-3458-2014	Malm, Christer B/0000-0002-8436-2476; Aasa, Ulrika/0000-0002-3383-0540; Monnier, Andreas/0000-0001-8923-1670; Tegern, Matthias/0000-0001-6871-1341				ALTMAN DG, 1986, J EPIDEMIOL COMMUN H, V40, P274, DOI 10.1136/jech.40.3.274; BIERINGSORENSEN F, 1984, SPINE, V9, P106, DOI 10.1097/00007632-198403000-00002; Bilzon JLJ, 2001, OCCUP MED-OXFORD, V51, P357, DOI 10.1093/occmed/51.5.357; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Brown LE, 2007, STRENGTH TRAINING; CICCHETTI DV, 1981, AM J MENT DEF, V86, P127; Currier D, 1990, ELEMENTS RES PHYS TH; Dean C, 2003, MODERN WARRIORS COMB; Evans K, 2007, J SCI MED SPORT, V10, P447, DOI 10.1016/j.jsams.2006.09.003; Feuerstein M, 1997, J OCCUP ENVIRON MED, V39, P68, DOI 10.1097/00043764-199701000-00013; Frohm A, 2012, SCAND J MED SCI SPOR, V22, P306, DOI 10.1111/j.1600-0838.2010.01267.x; Harman EA, 2008, MIL MED, V173, P36, DOI 10.7205/MILMED.173.1.36; Hopkins WG, 2000, SPORTS MED, V30, P1, DOI 10.2165/00007256-200030010-00001; Jaenen S, 2009, 019 NATO RES TECHN G; KNAPIK J, 1989, MIL MED, V154, P326; Knapik JJ, 2004, MIL MED, V169, P45, DOI 10.7205/MILMED.169.1.45; Knapik JJ, 2006, MIL MED, V171, P45, DOI 10.7205/MILMED.171.1.45; Knapik JJ, 2004, INJURY PREV, V10, P37, DOI 10.1136/ip.2003.002808; Knapik JJ, 2007, MIL MED, V172, P115, DOI 10.7205/MILMED.172.2.115; Larsson H, 2009, THESIS KAROLINSKA I; Larsson H, 2006, MIL MED, V171, P1065, DOI 10.7205/MILMED.171.11.1065; Larsson H, 2012, WORK, V42, P241, DOI 10.3233/WOR-2012-1347; Larsson H, 2009, MIL MED, V174, P9, DOI 10.7205/MILMED-D-03-7407; Lexell JE, 2005, AM J PHYS MED REHAB, V84, P719, DOI 10.1097/01.phm.0000176452.17771.20; LYNN MR, 1986, NURS RES, V35, P382; Malmberg J, 2011, PHYS FITN TEST NORD; Milligan GS, 2013, EXTREME PHYSIOL MED, V2, DOI 10.1186/2046-7648-2-14; Optimizing Operational Physical Fitness, 2009, 019 NATO RES TECHN O; Pandorf Clay E, 2002, Work, V18, P179; Payne W, 2010, ERGONOMICS, V53, P858, DOI 10.1080/00140139.2010.489964; Polit DF, 2007, RES NURS HEALTH, V30, P459, DOI 10.1002/nur.20199; Portney L, 2000, FDN CLIN RES APPL PR, P223; Rayson M, 2000, ERGONOMICS, V43, P73, DOI 10.1080/001401300184675; Ropponen A, 2005, J ORTHOP SPORT PHYS, V35, P437, DOI 10.2519/jospt.2005.35.7.437; Sharp M, 2009, 019 NATO RES TECHN O; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Vanderburgh PM, 2008, MED SCI SPORT EXER, V40, P1538, DOI 10.1249/MSS.0b013e31817323ee; Vanderburgh PM, 2011, MIL MED, V176, P1032, DOI 10.7205/MILMED-D-11-00069; Williams AG, 2006, ERGONOMICS, V49, P661, DOI 10.1080/00140130500497447	39	37	37	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132185	10.1371/journal.pone.0132185	http://dx.doi.org/10.1371/journal.pone.0132185			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1RL	26177030	Green Published, gold, Green Submitted			2022-12-26	WOS:000358197600087
J	Panja, AS; Bandopadhyay, B; Maiti, S				Panja, Anindya Sundar; Bandopadhyay, Bidyut; Maiti, Smarajit			Protein Thermostability Is Owing to Their Preferences to Non-Polar Smaller Volume Amino Acids, Variations in Residual Physico-Chemical Properties and More Salt-Bridges	PLOS ONE			English	Article							STRUCTURAL DIFFERENCES; THERMAL-STABILITY; GENE-EXPRESSION; PEPTIDE-BONDS; PHOSPHORYLATION; DYNAMICS; PATTERNS; CIS; CONFORMATION; SUBSTITUTION	Introduction Protein thermostability is an important field for its evolutionary perspective of mesophilic versus thermophilic relationship and for its industrial/therapeutic applications. Methods Presently, a total 400 (200 thermophilic and 200 mesophilic homologue) proteins were studied utilizing several software/databases to evaluate their amino acid preferences. Randomly selected 50 homologous proteins with available PDB-structure of each group were explored for the understanding of the protein charges, isoelectric-points, hydrophilicity, hydrophobicity, tyrosine phosphorylation and salt-bridge occurrences. These 100 proteins were further probed to generate Ramachandran plot/data for the gross secondary structure prediction in and comparison between the thermophilic and mesophilic proteins. Results Present results strongly suggest that nonpolar smaller volume amino acids Ala (chi(2) = 238.54, p<0.001) and Gly (chi(2) = 73.35, p<0.001) are highly and Val moderately (chi(2) = 144.43, p<0.001) occurring in the 85% of thermophilic proteins. Phospho-regulated Tyr and redox-sensitive Cys are also moderately distributed (chi(2)similar to 20.0, p<0.01) in a larger number of thermophilic proteins. A consistent lower distribution of thermophilicity and discretely higher distribution of hydrophobicity is noticed in a large number of thermophilic versus their mesophilic protein homolog. The mean differences of isoelectric points and charges are found to be significantly less (7.11 vs. 6.39, p<0.05 and 1 vs. -0.6, p<0.01, respectively) in thermophilic proteins compared to their mesophilic counterpart. The possible sites for Tyr phosphorylation are noticed to be 25% higher (p<0.05) in thermophilic proteins. The 60% thermophiles are found with higher number of salt bridges in this study. The average percentage of salt-bridge of thermophiles is found to be higher by 20% than their mesophilic homologue. The GLU-HIS and GLU-LYS salt-bridge dyads are calculated to be significantly higher (p<0.05 and p<0.001, respectively) in thermophilic and GLU-ARG is higher in the mesophilic proteins. The Ramachandran plot/data suggest a higher abundance of the helix, left-handed helix, sheet, nonplanar peptide and lower occurrence of cis peptide, loop/turn and outlier in thermophiles. Pearson's correlation result suggests that the isoelectric points of mesophilic and thermophilic proteins are positively correlated (r = 0.93 and 0.84, respectively; p<0.001) to their corresponding charges. And their hydrophilicity is negatively associated with the corresponding hydrophobicity (r = -0.493, p<0.001 and r = -0.324, p<0.05) suggesting their reciprocal evolvement. Conclusions Present results for the first time with this large amount of datasets and multiple contributing factors suggest the greater occurrence of hydrophobicity, salt-bridges and smaller volume nonpolar residues (Gly, Ala and Val) and lesser occurrence of bulky polar residues in the thermophilic proteins. A more stoichiometric relationship amongst these factors minimized the hindrance due to side chain burial and increased compactness and secondary structural stability in thermophilic proteins.	[Panja, Anindya Sundar; Bandopadhyay, Bidyut] Vidyasagar Univ, Oriental Inst Sci & Technol, Post Grad Dept Biotechnol, Midnapore 721102, W Bengal, India; [Maiti, Smarajit] Vidyasagar Univ, Oriental Inst Sci & Technol, Post Grad Dept Biochem & Biotechnol, Cell & Mol Therapeut Lab, Midnapore 721102, W Bengal, India	Vidyasagar University; Vidyasagar University	Maiti, S (corresponding author), Vidyasagar Univ, Oriental Inst Sci & Technol, Post Grad Dept Biochem & Biotechnol, Cell & Mol Therapeut Lab, Midnapore 721102, W Bengal, India.	maitism@rediffmail.com	Panja, Anindya Sundar/AAB-2621-2020	Panja, Anindya Sundar/0000-0003-2823-9948				Arrigo AP, 1999, FREE RADICAL BIO MED, V27, P936, DOI 10.1016/S0891-5849(99)00175-6; Bakaysa DL, 1996, PROTEIN SCI, V5, P2521, DOI 10.1002/pro.5560051215; Balbach J., 2000, MECH PROTEIN FOLDING, P212; Banerjee R, 2012, J BIOL CHEM, V287, P4397, DOI 10.1074/jbc.R111.287995; Berkholz DS, 2012, P NATL ACAD SCI USA, V109, P449, DOI 10.1073/pnas.1107115108; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; BROCK TD, 1969, J BACTERIOL, V98, P289, DOI 10.1128/JB.98.1.289-297.1969; Butterwick JA, 2006, PROTEIN SCI, V15, P2697, DOI 10.1110/ps.062398606; Chan CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030296; Chang CEA, 2008, P NATL ACAD SCI USA, V105, P7456, DOI 10.1073/pnas.0800452105; Das Rajdeep, 2000, Functional and Integrative Genomics, V1, P76, DOI 10.1007/s101420050009; Dodson G, 1998, TRENDS BIOCHEM SCI, V23, P347, DOI 10.1016/S0968-0004(98)01254-7; Edison AS, 2001, NAT STRUCT BIOL, V8, P201, DOI 10.1038/84921; Friedman R, 2004, GENETICS, V167, P1507, DOI 10.1534/genetics.104.026344; Fujiwara K, 2012, BMC STRUCT BIOL, V12, DOI 10.1186/1472-6807-12-18; Han JDJ, 2008, CELL RES, V18, P224, DOI 10.1038/cr.2008.16; Haney PJ, 1999, P NATL ACAD SCI USA, V96, P3578, DOI 10.1073/pnas.96.7.3578; HASELMEIER R, 1995, J PHYS CHEM-US, V99, P2243, DOI 10.1021/j100008a001; HEADGORDON T, 1991, J AM CHEM SOC, V113, P5989, DOI 10.1021/ja00016a010; Ho PS, 1998, PRINCIPLES PHYS BIOC, P18; Ibrahim BS, 2004, BIOCHEM BIOPH RES CO, V325, P1082, DOI 10.1016/j.bbrc.2004.10.128; Joseph AP, 2012, AMINO ACIDS, V43, P1369, DOI 10.1007/s00726-011-1211-9; Karplus PA, 1996, PROTEIN SCI, V5, P1406, DOI 10.1002/pro.5560050719; Kawamura S, 1997, J BIOCHEM-TOKYO, V121, P448; Kaytor MD, 1999, J BIOL CHEM, V274, P37507, DOI 10.1074/jbc.274.53.37507; Kiraga J, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-163; Kleywegt GJ, 1996, STRUCTURE, V4, P1395, DOI 10.1016/S0969-2126(96)00147-5; Kreil DP, 2001, NUCLEIC ACIDS RES, V29, P1608, DOI 10.1093/nar/29.7.1608; Kumar Vijay, 2014, J Amino Acids, V2014, P475839, DOI 10.1155/2014/475839; Lee NR, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-61; Liao SM, 2013, CHEM CENT J, V7, DOI 10.1186/1752-153X-7-44; Lieph R, 2006, TRENDS MICROBIOL, V14, P423, DOI 10.1016/j.tim.2006.08.004; Lopez-Maury L, 2008, NAT REV GENET, V9, P583, DOI 10.1038/nrg2398; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; MacArthur MW, 1996, J MOL BIOL, V264, P1180, DOI 10.1006/jmbi.1996.0705; Meruelo AD, 2012, PROTEIN SCI, V21, P1746, DOI 10.1002/pro.2157; Miseta A, 2000, MOL BIOL EVOL, V17, P1232, DOI 10.1093/oxfordjournals.molbev.a026406; Moreira IS, 2013, BBA-PROTEINS PROTEOM, V1834, P404, DOI 10.1016/j.bbapap.2012.07.005; Mrozek A, 2003, J MOL STRUCT, V655, P397, DOI 10.1016/S0022-2860(03)00282-5; Olson-Manning CF, 2012, NAT REV GENET, V13, P867, DOI 10.1038/nrg3322; Pack SP, 2013, APPL BIOCHEM BIOTECH, V171, P1212, DOI 10.1007/s12010-013-0195-1; Persidis A, 1998, NAT BIOTECHNOL, V16, P593, DOI 10.1038/nbt0698-593; RAMACHANDRAN GN, 1973, BIOCHIM BIOPHYS ACTA, V303, P8, DOI 10.1016/0005-2795(73)90142-6; RAMAKRISHNAN C, 1965, BIOPHYS J, V5, P909, DOI 10.1016/S0006-3495(65)86759-5; Razvi A, 2006, PROTEIN SCI, V15, P1569, DOI 10.1110/ps.062130306; Sadeghi M, 2006, BIOPHYS CHEM, V119, P256, DOI 10.1016/j.bpc.2005.09.018; Sawle L, 2011, BIOPHYS J, V101, P217, DOI 10.1016/j.bpj.2011.05.059; Scandurra R, 1998, BIOCHIMIE, V80, P933, DOI 10.1016/S0300-9084(00)88890-2; Shaw KL, 2001, PROTEIN SCI, V10, P1206, DOI 10.1110/ps.440101; Shi ZS, 2006, CHEM REV, V106, P1877, DOI 10.1021/cr040433a; Singer GAC, 2003, GENE, V317, P39, DOI 10.1016/S0378-1119(03)00660-7; STEWART DE, 1990, J MOL BIOL, V214, P253, DOI 10.1016/0022-2836(90)90159-J; Szilagyi A, 2000, STRUCTURE, V8, P493, DOI 10.1016/S0969-2126(00)00133-7; Tanner JJ, 1996, BIOCHEMISTRY-US, V35, P2597, DOI 10.1021/bi951988q; Taylor TJ, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-S1-S5; Tehei M, 2007, FEBS J, V274, P4034, DOI 10.1111/j.1742-4658.2007.05953.x; Tina KG, 2007, NUCLEIC ACIDS RES, V35, pW473, DOI 10.1093/nar/gkm423; Udgaonkar JB, 2013, ARCH BIOCHEM BIOPHYS, V531, P24, DOI 10.1016/j.abb.2012.10.003; van Bentem SD, 2008, J PROTEOME RES, V7, P2458, DOI 10.1021/pr8000173; van Bentem SD, 2009, TRENDS PLANT SCI, V14, P71, DOI 10.1016/j.tplants.2008.11.003; van den Burg B, 2003, CURR OPIN MICROBIOL, V6, P213, DOI 10.1016/S1369-5274(03)00060-2; Van den Burg B, 1998, P NATL ACAD SCI USA, V95, P2056, DOI 10.1073/pnas.95.5.2056; Verghese J, 2012, MICROBIOL MOL BIOL R, V76, P115, DOI 10.1128/MMBR.05018-11; Vogt G, 1997, J MOL BIOL, V269, P631, DOI 10.1006/jmbi.1997.1042; Voigt CA, 2001, ADV PROTEIN CHEM, V55, P79; Warren GL, 1995, PROTEIN ENG, V8, P905, DOI 10.1093/protein/8.9.905; Yamakura F, 2006, NITRIC OXIDE-BIOL CH, V14, P152, DOI 10.1016/j.niox.2005.07.009; Yoda T, 2010, BIOPHYS J, V99, P1637, DOI 10.1016/j.bpj.2010.06.045; Yokota K, 2006, SCI TECHNOL ADV MAT, V7, P255, DOI 10.1016/j.stam.2006.03.003; Zeldovich KB, 2008, ANNU REV PHYS CHEM, V59, P105, DOI 10.1146/annurev.physchem.58.032806.104449; Zeldovich KB, 2007, P NATL ACAD SCI USA, V104, P16152, DOI 10.1073/pnas.0705366104; Zhou XX, 2008, AMINO ACIDS, V34, P25, DOI 10.1007/s00726-007-0589-x; ZIMMERMAN SS, 1976, MACROMOLECULES, V9, P408, DOI 10.1021/ma60051a005	73	46	49	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0131495	10.1371/journal.pone.0131495	http://dx.doi.org/10.1371/journal.pone.0131495			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177372	gold, Green Submitted, Green Published			2022-12-26	WOS:000358197600046
J	Plenge, E; Klein, SS; Niessen, WJ; Meijering, E				Plenge, Esben; Klein, Stefan S.; Niessen, Wiro J.; Meijering, Erik			Multiple Sparse Representations Classification	PLOS ONE			English	Article							IMAGE SUPERRESOLUTION; SEGMENTATION; HIPPOCAMPUS; ALGORITHM; LUMEN	Sparse representations classification (SRC) is a powerful technique for pixelwise classification of images and it is increasingly being used for a wide variety of image analysis tasks. The method uses sparse representation and learned redundant dictionaries to classify image pixels. In this empirical study we propose to further leverage the redundancy of the learned dictionaries to achieve a more accurate classifier. In conventional SRC, each image pixel is associated with a small patch surrounding it. Using these patches, a dictionary is trained for each class in a supervised fashion. Commonly, redundant/overcomplete dictionaries are trained and image patches are sparsely represented by a linear combination of only a few of the dictionary elements. Given a set of trained dictionaries, a new patch is sparse coded using each of them, and subsequently assigned to the class whose dictionary yields the minimum residual energy. We propose a generalization of this scheme. The method, which we call multiple sparse representations classification (mSRC), is based on the observation that an overcomplete, class specific dictionary is capable of generating multiple accurate and independent estimates of a patch belonging to the class. So instead of finding a single sparse representation of a patch for each dictionary, we find multiple, and the corresponding residual energies provides an enhanced statistic which is used to improve classification. We demonstrate the efficacy of mSRC for three example applications: pixelwise classification of texture images, lumen segmentation in carotid artery magnetic resonance imaging (MRI), and bifurcation point detection in carotid artery MRI. We compare our method with conventional SRC, K-nearest neighbor, and support vector machine classifiers. The results show that mSRC outperforms SRC and the other reference methods. In addition, we present an extensive evaluation of the effect of the main mSRC parameters: patch size, dictionary size, and sparsity level.	[Plenge, Esben; Klein, Stefan S.; Niessen, Wiro J.; Meijering, Erik] Erasmus Univ, Med Ctr, Biomed Imaging Grp Rotterdam, Dept Med Informat, Rotterdam, Netherlands; [Plenge, Esben; Klein, Stefan S.; Niessen, Wiro J.; Meijering, Erik] Erasmus Univ, Dept Radiol, Med Ctr, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Plenge, E (corresponding author), Technion Israel Inst Technol, Div Comp Sci, Haifa, Israel.	esben.plenge@gmail.com	Meijering, Erik/AAL-8143-2020	Klein, Stefan/0000-0003-4449-6784; Niessen, Wiro/0000-0002-5822-1995	Medical Delta (HST-Klein project); NWO, The Netherlands Organization of Scientific Research	Medical Delta (HST-Klein project); NWO, The Netherlands Organization of Scientific Research	This research was funded by Medical Delta (HST-Klein project) (EM), and by NWO, The Netherlands Organization of Scientific Research. In addition, the authors thank SURFsara (www.surfsara.nl) for the support in using the Lisa Compute Cluster. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharon M, 2006, IEEE T SIGNAL PROCES, V54, P4311, DOI 10.1109/TSP.2006.881199; Buades A, 2005, PROC CVPR IEEE, P60, DOI 10.1109/cvpr.2005.38; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Cheriyadat AM, 2014, IEEE T GEOSCI REMOTE, V52, P439, DOI 10.1109/TGRS.2013.2241444; Coupe P, 2012, NEUROIMAGE, V59, P3736, DOI 10.1016/j.neuroimage.2011.10.080; Coupe P, 2011, NEUROIMAGE, V54, P940, DOI 10.1016/j.neuroimage.2010.09.018; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; Elad M, 2006, IEEE T IMAGE PROCESS, V15, P3736, DOI 10.1109/TIP.2006.881969; Elad M, 2010, SPARSE AND REDUNDANT REPRESENTATIONS, P3, DOI 10.1007/978-1-4419-7011-4_1; Elad M, 2009, IEEE T INFORM THEORY, V55, P4701, DOI 10.1109/TIT.2009.2027565; Gao YZ, 2012, MED PHYS, V39, P6372, DOI 10.1118/1.4754304; Guha T, 2012, IEEE T PATTERN ANAL, V34, P1576, DOI 10.1109/TPAMI.2011.253; Hameeteman K, 2013, PHYS MED BIOL, V58, P1605, DOI 10.1088/0031-9155/58/5/1605; Herredesvela J, 2005, WORKSH SIGN PROC AD, pTS1; Li ST, 2012, IEEE T BIO-MED ENG, V59, P417, DOI 10.1109/TBME.2011.2173935; Mairal J, 2008, PROC CVPR IEEE, P2415; Manjon JV, 2010, INT J BIOMED IMAGING, V2010, DOI 10.1155/2010/425891; Peyre G, 2009, J MATH IMAGING VIS, V34, P17, DOI 10.1007/s10851-008-0120-3; Plenge E, 2013, LECT NOTES COMPUT SC, V8151, P123, DOI 10.1007/978-3-642-40760-4_16; RAMIREZ I, 2010, PROC CVPR IEEE, P3501, DOI DOI 10.1109/CVPR.2010.5539964; Randen T, 1999, IEEE T PATTERN ANAL, V21, P291, DOI 10.1109/34.761261; Rousseau F, 2011, IEEE T MED IMAGING, V30, P1852, DOI 10.1109/TMI.2011.2156806; Rousseau F, 2010, MED IMAGE ANAL, V14, P594, DOI 10.1016/j.media.2010.04.005; Rubinstein R, 2010, P IEEE, V98, P1045, DOI 10.1109/JPROC.2010.2040551; Skretting K, 2006, EURASIP J APPL SIG P, DOI 10.1155/ASP/2006/52561; Tong T, 2013, NEUROIMAGE, V76, P11, DOI 10.1016/j.neuroimage.2013.02.069; Tropp JA, 2007, IEEE T INFORM THEORY, V53, P4655, DOI 10.1109/TIT.2007.909108; Tustison NJ, 2010, IEEE T MED IMAGING, V29, P1310, DOI 10.1109/TMI.2010.2046908; van 't Klooster R, 2012, J MAGN RESON IMAGING, V35, P156, DOI 10.1002/jmri.22809; Wright J, 2009, IEEE T PATTERN ANAL, V31, P210, DOI 10.1109/TPAMI.2008.79; Yang JC, 2010, IEEE T IMAGE PROCESS, V19, P2861, DOI 10.1109/TIP.2010.2050625; Yang M, 2011, IEEE I CONF COMP VIS, P543, DOI 10.1109/ICCV.2011.6126286; Yuan C, 1999, MAGN RESON IMAGING, V17, P257, DOI 10.1016/S0730-725X(98)00162-3; ZONTAK M, 2011, PROC CVPR IEEE, P977, DOI DOI 10.1109/CVPR.2011.5995401; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	35	9	9	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0131968	10.1371/journal.pone.0131968	http://dx.doi.org/10.1371/journal.pone.0131968			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177106	Green Published, Green Submitted, gold			2022-12-26	WOS:000358197600073
J	Rudqvist, N; Spetz, J; Schuler, E; Parris, TZ; Langen, B; Helou, K; Forssell-Aronsson, E				Rudqvist, Nils; Spetz, Johan; Schuler, Emil; Parris, Toshima Z.; Langen, Britta; Helou, Khalil; Forssell-Aronsson, Eva			Transcriptional Response in Mouse Thyroid Tissue after At-211 Administration: Effects of Absorbed Dose, Initial Dose-Rate and Time after Administration	PLOS ONE			English	Article							GENE-EXPRESSION; ASTATINE-211; DOSIMETRY; EXPOSURE; RADIOTHERAPY; IRRADIATION; I-125(-); ANTIBODY; I-131; MICE	Background At-211-labeled radiopharmaceuticals are potentially useful for tumor therapy. However, a limitation has been the preferential accumulation of released At-211 in the thyroid gland, which is a critical organ for such therapy. The aim of this study was to determine the effect of absorbed dose, dose-rate, and time after At-211 exposure on genome-wide transcriptional expression in mouse thyroid gland. Methods BALB/c mice were i.v. injected with 1.7, 7.5 or 100 kBq At-211. Animals injected with 1.7 kBq were killed after 1, 6, or 168 h with mean thyroid absorbed doses of 0.023, 0.32, and 1.8 Gy, respectively. Animals injected with 7.5 and 100 kBq were killed after 6 and 1 h, respectively; mean thyroid absorbed dose was 1.4 Gy. Total RNA was extracted from pooled thyroids and the Illumina RNA microarray platform was used to determine mRNA levels. Differentially expressed transcripts and enriched GO terms were determined with adjusted p-value <0.01 and fold change >1.5, and p-value <0.05, respectively. Results In total, 1232 differentially expressed transcripts were detected after At-211 administration, demonstrating a profound effect on gene regulation. The number of regulated transcripts increased with higher initial dose-rate/absorbed dose at 1 or 6 h. However, the number of regulated transcripts decreased with mean absorbed dose/time after 1.7 kBq At-211 administration. Furthermore, similar regulation profiles were seen for groups administered 1.7 kBq. Interestingly, few previously proposed radiation responsive genes were detected in the present study. Regulation of immunological processes were prevalent at 1, 6, and 168 h after 1.7 kBq administration (0.023, 0.32, 1.8 Gy).	[Rudqvist, Nils; Spetz, Johan; Schuler, Emil; Langen, Britta; Forssell-Aronsson, Eva] Univ Gothenburg, Inst Clin Sci, Dept Radiat Phys, Sahlgrenska Canc Ctr,Sahlgrenska Acad, Gothenburg, Sweden; [Parris, Toshima Z.; Helou, Khalil] Univ Gothenburg, Inst Clin Sci, Dept Oncol, Sahlgrenska Canc Ctr,Sahlgrenska Acad, Gothenburg, Sweden	University of Gothenburg; University of Gothenburg	Rudqvist, N (corresponding author), Columbia Univ, Ctr Radiol Res, Med Ctr, New York, NY 10032 USA.	nils.rudqvist@radfys.gu.se	Spetz, Johan/P-1662-2017; Parris, Toshima/Q-5427-2018	Spetz, Johan/0000-0002-5216-9786; Parris, Toshima/0000-0003-0834-5540; Forssell-Aronsson, Eva/0000-0002-7558-4368; Langen, Britta/0000-0002-3713-6169; Rudqvist, Nils/0000-0002-9720-3124	European Commission FP7 Collaborative Project TARCC [HEALTH-F2-2007-201962]; Swedish Research Council [21073]; Swedish Cancer Society [3427]; BioCARE - a National Strategic Research Program at the University of Gothenburg; Swedish Radiation Safety Authority; King Gustav V Jubilee Clinic Cancer Research Foundation; Sahlgrenska University Hospital Research Funds; Wilhelm and Martina Lundgren foundation; Assar Gabrielsson Cancer Research Foundation	European Commission FP7 Collaborative Project TARCC; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); BioCARE - a National Strategic Research Program at the University of Gothenburg; Swedish Radiation Safety Authority; King Gustav V Jubilee Clinic Cancer Research Foundation; Sahlgrenska University Hospital Research Funds; Wilhelm and Martina Lundgren foundation; Assar Gabrielsson Cancer Research Foundation	This study was supported by grants from the European Commission FP7 Collaborative Project TARCC HEALTH-F2-2007-201962, the Swedish Research Council (grant no. 21073), the Swedish Cancer Society (grant no. 3427), BioCARE - a National Strategic Research Program at the University of Gothenburg, the Swedish Radiation Safety Authority, the King Gustav V Jubilee Clinic Cancer Research Foundation, the Sahlgrenska University Hospital Research Funds, the Wilhelm and Martina Lundgren foundation, and the Assar Gabrielsson Cancer Research Foundation. EFA received all funding except from the Wilhelm and Martina Lundgren foundation and the Assar Gabrielsson Cancer Research Foundation of which NR was the receiver. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abend M, 2013, BR J CANC; Amundson SA, 2001, RADIAT PROT DOSIM, V97, P11, DOI 10.1093/oxfordjournals.rpd.a006632; Amundson SA, 2008, RADIAT ENVIRON BIOPH, V47, P25, DOI 10.1007/s00411-007-0140-1; Andersson H, 2009, J NUCL MED, V50, P1153, DOI 10.2967/jnumed.109.062604; Bentzen SM, 2006, NAT REV CANCER, V6, P702, DOI 10.1038/nrc1950; Bolch WE, 2009, J NUCL MED, V50, P477, DOI 10.2967/jnumed.108.056036; BROWN I, 1986, APPL RADIAT ISOTOPES, V37, P789, DOI 10.1016/0883-2889(86)90273-X; Chaudhry MA, 2008, J BIOMED SCI, V15, P557, DOI 10.1007/s11373-008-9253-z; Filiano AN, 2011, RADIAT RES, V176, P49, DOI 10.1667/RR2419.1; GARG PK, 1990, CANCER RES, V50, P3514; Hauck ML, 1998, BRIT J CANCER, V77, P753, DOI 10.1038/bjc.1998.123; ICRU, 1984, ICRU REPORT 37; Jodal L, 2009, ACTA ONCOL, V48, P308, DOI 10.1080/02841860802245163; Josefsson A, 2014, THESIS; Josefsson A, 2012, EJNMMI RES, V2, DOI 10.1186/2191-219X-2-29; LANCE GN, 1967, COMPUT J, V10, P271, DOI 10.1093/comjnl/10.3.271; Langen B, 2013, J NUCL MED, V54, P990, DOI 10.2967/jnumed.112.114462; Lindegren S, 2001, APPL RADIAT ISOTOPES, V55, P157, DOI 10.1016/S0969-8043(01)00044-6; Lindencrona U, 2001, NUCL MED BIOL, V28, P41, DOI 10.1016/S0969-8051(00)00179-7; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Rudqvist N, 2014, NUCLEAR MEDICINE AND; Rudqvist N., 2015, THESIS; Rudqvist N, 2012, EJNMMI RES, V2, DOI 10.1186/2191-219X-2-32; Saal LH, 2002, GENOME BIOL, V3; Schuler E, 2014, NUCL MED BIOL, V41, P825, DOI 10.1016/j.nucmedbio.2014.07.010; Schuler E, 2014, NUCL MED BIOL, V41, P238, DOI 10.1016/j.nucmedbio.2013.12.001; Schuler E, 2011, EJNMMI RES, V1, DOI 10.1186/2191-219X-1-29; Snyder AR, 2004, CANCER METAST REV, V23, P259, DOI 10.1023/B:CANC.0000031765.17886.fa; Spetz J, 2013, CANCER BIOTHER RADIO, V28, P657, DOI 10.1089/cbr.2013.1483; Vairapandi M, 2002, J CELL PHYSIOL, V192, P327, DOI 10.1002/jcp.10140; Weber D. A., 1989, MIRD RADIONUCLIDE DA; Zalutsky MR, 2007, NUCL MED BIOL, V34, P779, DOI 10.1016/j.nucmedbio.2007.03.007	32	11	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0131686	10.1371/journal.pone.0131686	http://dx.doi.org/10.1371/journal.pone.0131686			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177204	Green Published, Green Submitted, gold			2022-12-26	WOS:000358197600059
J	Ssengooba, W; Cobelens, FG; Nakiyingi, L; Mboowa, G; Armstrong, DT; Manabe, YC; Joloba, ML; de Jong, BC				Ssengooba, Willy; Cobelens, Frank G.; Nakiyingi, Lydia; Mboowa, Gerald; Armstrong, Derek T.; Manabe, Yukari C.; Joloba, Moses L.; de Jong, Bouke C.			High Genotypic Discordance of Concurrent Mycobacterium tuberculosis Isolates from Sputum and Blood of HIV-Infected Individuals	PLOS ONE			English	Article							EXTRAPULMONARY TUBERCULOSIS; PULMONARY TUBERCULOSIS; MULTIDRUG-RESISTANT; GENETIC DIVERSITY; MULTIPLE STRAINS; MIRU-VNTRPLUS; RABBIT MODEL; IDENTIFICATION; DISEASE; AFRICA	Background Among HIV-infected individuals with CD4 less than 200 cells/mm(3), tuberculosis often has an atypical presentation, is more likely to be disseminated and is diagnostically challenging. We sought to understand the genotypic discordance of concurrent sputum and blood M. tuberculosis (MTB) isolates from HIV-infected individuals. Methods From a prospective diagnostic accuracy study with 182 HIV-infected culture-positive TB adults, isolates were obtained from 51 of 66 participants who were MTB culture-positive by both sputum and blood. Isolates were subjected to susceptibility testing to 1st line drugs, spoligotyping and 24 locus-MIRU-VNTR. Results The median age of the participants was 31 (IQR; 27-38) years and 51% were male. The median CD4 count was 29 (IQR; 10-84) cells/mm(3) with 20% taking ART; 8.0% were previously treated for TB, and 63% were AFB smear-negative. The isolates belonged to two of the main global MTB-lineages; East-African-Indian (L3) 17 (16.7%) and Euro-American (L4) 85 (83.3%). We identified 26 (51.0%) participants with discordant MTB-genotypes between sputum and blood, including two patients with evidence of mixed infection in either compartment. Having discordant MTB-genotypes was not predicted by the MTB-lineage in either blood or sputum, CD4 cell count, or any other clinical characteristic. Conclusions There is a high genotypic discordance among M. tuberculosis concurrently isolated from sputum and blood of HIV-infected individuals. These findings suggest that infection with more than one strain of M. tuberculosis occurs in at least half of patients with advanced HIV infection.	[Ssengooba, Willy; Mboowa, Gerald; Joloba, Moses L.] Makerere Univ, Coll Hlth Sci, Dept Med Microbiol, Kampala, Uganda; [Ssengooba, Willy; Cobelens, Frank G.] Univ Amsterdam, Acad Med Ctr, Dept Global Hlth, NL-1105 AZ Amsterdam, Netherlands; [Ssengooba, Willy; Cobelens, Frank G.] Univ Amsterdam, Acad Med Ctr, Amsterdam Inst Global Hlth & Dev, NL-1105 AZ Amsterdam, Netherlands; [Ssengooba, Willy; de Jong, Bouke C.] Inst Trop Med, Unit Mycobacteriol, B-2000 Antwerp, Belgium; [Cobelens, Frank G.] KNCV TB Fdn, The Hague, Netherlands; [Nakiyingi, Lydia; Manabe, Yukari C.; Joloba, Moses L.] Makerere Univ, Infect Dis Inst, Coll Hlth Sci, Kampala, Uganda; [Armstrong, Derek T.; Manabe, Yukari C.] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [de Jong, Bouke C.] NYU, Div Infect Dis, New York, NY USA	Makerere University; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Institute of Tropical Medicine (ITM); KNCV Tuberculosis Foundation; Makerere University; Johns Hopkins University; New York University	de Jong, BC (corresponding author), Inst Trop Med, Unit Mycobacteriol, B-2000 Antwerp, Belgium.	bdejong@itg.be	Ssengooba, Willy/AAG-1202-2020; Ssengooba, Willy/ABE-2168-2020; de Jong, Bouke/A-3636-2013; Nakiyingi, Lydia/ABG-7669-2020; Mboowa, Gerald/K-9976-2018	Ssengooba, Willy/0000-0002-1643-110X; Ssengooba, Willy/0000-0002-1643-110X; de Jong, Bouke/0000-0002-1017-4675; Nakiyingi, Lydia/0000-0001-7263-3198; Mboowa, Gerald/0000-0001-8445-9414; Joloba, Moses/0000-0002-0334-9983; Cobelens, Frank/0000-0002-4367-1133	Erasmus Mundus Joint Doctorate Program of the European Union; European Research Council-INTERRUPTB starting grant [311725]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI094189] Funding Source: NIH RePORTER	Erasmus Mundus Joint Doctorate Program of the European Union; European Research Council-INTERRUPTB starting grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported with financial support from the Erasmus Mundus Joint Doctorate Program of the European Union through a training grant to WS and the European Research Council-INTERRUPTB starting grant (nr. 311725) to BdJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams LV, 2012, J CLIN MICROBIOL, V50, P2645, DOI 10.1128/JCM.00624-12; Allix-Beguec C, 2008, J CLIN MICROBIOL, V46, P2692, DOI 10.1128/JCM.00540-08; Aminian M, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/398484; Andrade MKN, 2009, BRAZ J MED BIOL RES, V42, P433, DOI 10.1590/S0100-879X2009000500006; Asiimwe BB, 2008, INT J TUBERC LUNG D, V12, P386; Barrios-Payan J, 2012, J INFECT DIS, V206, P1194, DOI 10.1093/infdis/jis381; Behr MA, 2004, AM J RESP CRIT CARE, V169, P554, DOI 10.1164/rccm.2401001; Behr MA, 2014, LANCET INFECT DIS, V14, P250, DOI 10.1016/S1473-3099(13)70253-6; Brudey K, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-23; Caws M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000034; Click ES, 2012, CLIN INFECT DIS, V54, P211, DOI 10.1093/cid/cir788; Comas I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007815; Crump JA, 2012, CLIN INFECT DIS, V55, P242, DOI 10.1093/cid/cis409; Das S, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-404; Dickman KR, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-349; Gomes T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074517; Harries AD, 2001, LANCET, V357, P1519, DOI 10.1016/S0140-6736(00)04639-0; Heysell SK, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-344; Jacob ST, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070305; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Lari N, 2009, CLIN MICROBIOL INFEC, V15, P538, DOI 10.1111/j.1469-0691.2009.02712.x; Leeds IL, 2012, CLIN INFECT DIS, V55, P75, DOI 10.1093/cid/cis303; Lukoye D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070763; Manabe YC, 2003, INFECT IMMUN, V71, P6004, DOI 10.1128/IAI.71.10.6004-6011.2003; Manabe YC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101459; Martin A, 2010, TUBERCULOSIS, V90, P201, DOI 10.1016/j.tube.2010.03.012; Mudenda V, 2012, J INFECT DIS, V205, pS340, DOI 10.1093/infdis/jir859; Muhumuza J, 2006, INT J TUBERC LUNG D, V10, P1262; Nakiyingi L, 2014, JAIDS-J ACQ IMM DEF, V66, P270, DOI 10.1097/QAI.0000000000000151; Niemann S, 2000, EMERG INFECT DIS, V6, P548, DOI 10.3201/eid0605.000518; Pando RH, 2010, TUBERCULOSIS, V90, P268, DOI 10.1016/j.tube.2010.05.002; Perez-Lago L, 2014, J INFECT DIS, V209, P98, DOI 10.1093/infdis/jit439; Scott LE, 2014, J CLIN MICROBIOL, V52, P1818, DOI 10.1128/JCM.03553-13; Shin SS, 2015, J INFECT DIS, V211, P347, DOI 10.1093/infdis/jiu421; Srilohasin P, 2014, J CLIN MICROBIOL, V52, P4267, DOI 10.1128/JCM.01467-14; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; Tsenova L, 2005, J INFECT DIS, V192, P98, DOI 10.1086/430614; Uchiya K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071831; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993; von Reyn CF, 2011, INT J TUBERC LUNG D, V15, P1087, DOI 10.5588/ijtld.10.0517; Weniger T, 2010, NUCLEIC ACIDS RES, V38, pW326, DOI 10.1093/nar/gkq351; World Health Organization, 2013, TUB DIAGN XP MTB RIF; Wright A, 2009, LANCET, V373, P1861, DOI 10.1016/S0140-6736(09)60331-7; Zetola NM, 2014, J CLIN MICROBIOL, V52, P2422, DOI 10.1128/JCM.02489-13; Zetola NM, 2014, J INFECT DIS, V209, P1754, DOI 10.1093/infdis/jiu040	45	7	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132581	10.1371/journal.pone.0132581	http://dx.doi.org/10.1371/journal.pone.0132581			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176604	gold, Green Submitted, Green Published			2022-12-26	WOS:000358197600127
J	Valente, M; Denis, J; Grenier, N; Arvers, P; Foucher, B; Desangles, F; Martigne, P; Chaussard, H; Drouet, M; Abend, M; Herodin, F				Valente, Marco; Denis, Josiane; Grenier, Nancy; Arvers, Philippe; Foucher, Barbara; Desangles, Francois; Martigne, Patrick; Chaussard, Herve; Drouet, Michel; Abend, Michael; Herodin, Francis			Revisiting Biomarkers of Total-Body and Partial-Body Exposure in a Baboon Model of Irradiation	PLOS ONE			English	Article							RADIATION MODEL; DOSIMETRY; PLASMA; DAMAGE	In case of a mass casualty radiation event, there is a need to distinguish total-body irradiation (TBI) and partial-body irradiation (PBI) to concentrate overwhelmed medical resources to the individuals that would develop an acute radiation syndrome (ARS) and need hematologic support (i.e., mostly TBI victims). To improve the identification and medical care of TBI versus PBI individuals, reliable biomarkers of exposure could be very useful. To investigate this issue, pairs of baboons (n = 18) were exposed to different situations of TBI and PBI corresponding to an equivalent of either 5 Gy Co-60 gamma irradiation (5 Gy TBI; 7.5 Gy left hemibody/2.5 right hemibody TBI; 5.55 Gy 90% PBI; 6.25 Gy 80% PBI; 10 Gy 50% PBI, 15 Gy 30% PBI) or 2.5 Gy (2.5 Gy TBI; 5 Gy 50% PBI). More than fifty parameters were evaluated before and after irradiation at several time points up to 200 days. A partial least square discriminant analysis showed a good distinction of TBI from PBI situations that were equivalent to 5 Gy. Furthermore, all the animals were pooled in two groups, TBI (n = 6) and PBI (n = 12), for comparison using a logistic regression and a non parametric statistical test. Nine plasmatic biochemical markers and most of hematological parameters turned out to discriminate between TBI and PBI animals during the prodromal phase and the manifest illness phase. The most significant biomarkers were aspartate aminotransferase, creatine kinase, lactico dehydrogenase, urea, Flt3-ligand, iron, C-reactive protein, absolute neutrophil count and neutrophil-to-lymphocyte ratio for the early period, and Flt3-ligand, iron, platelet count, hemoglobin, monocyte count, absolute neutrophil count and neutrophil-tolymphocyte ratio for the ARS phase. These results suggest that heterogeneity could be distinguished within a range of 2.5 to 5 Gy TBI.	[Valente, Marco; Denis, Josiane; Grenier, Nancy; Arvers, Philippe; Desangles, Francois; Martigne, Patrick; Chaussard, Herve; Drouet, Michel; Herodin, Francis] IRBA, Dept Effets Biol Rayonnements EBR, Bretigny Sur Orge, France; [Foucher, Barbara] Hop Instruct Armees Desgenettes, Lab Serv, Lyon, France; [Abend, Michael] Bundeswehr Inst Radiobiol, Munich, Germany		Valente, M (corresponding author), IRBA, Dept Effets Biol Rayonnements EBR, Bretigny Sur Orge, France.	marco.valente@live.fr	Valente, Marco/A-8833-2018	FOUCHER, Barbara/0000-0002-2634-2098	French Ministry of Defense	French Ministry of Defense	Financial support was provided by the French Ministry of Defense.	Bertho JM, 2001, INT J RADIAT BIOL, V77, P703, DOI 10.1080/09553000110043711; Blakely WF, 2014, RADIAT PROT DOSIM, V159, P46, DOI 10.1093/rpd/ncu127; Blakely WF, 2010, HEALTH PHYS, V98, P153, DOI 10.1097/HP.0b013e3181b0306d; CHAUDHURI JP, 1979, ACTA RADIOL ONCOL, V18, P155, DOI 10.3109/02841867909128202; Deperas J, 2007, RADIAT PROT DOSIM, V124, P115, DOI 10.1093/rpd/ncm137; Dolphin G. W., 1969, BIOL DOSIMETRY PARTI, P215; Friesecke I, 2001, BRIT J RADIOL, V74, P121, DOI 10.1259/bjr.74.878.740121; Herodin F, 2005, EXP HEMATOL, V33, P1071, DOI 10.1016/j.exphem.2005.04.007; Herodin F, 2014, HEALTH PHYS, V106, P750, DOI 10.1097/HP.0000000000000059; Herodin F, 2012, HEALTH PHYS, V103, P143, DOI 10.1097/HP.0b013e3182475e54; Huchet A, 2003, INT J RADIAT ONCOL, V57, P508, DOI 10.1016/S0360-3016(03)00584-4; Norol F, 2000, BRIT J HAEMATOL, V109, P162, DOI 10.1046/j.1365-2141.2000.01995.x; Ossetrova NI, 2011, RADIAT MEAS, V46, P1019, DOI 10.1016/j.radmeas.2011.05.021; Ossetrova NI, 2009, INT J RADIAT BIOL, V85, P837, DOI 10.3109/09553000903154799; Palma Carlo-Rojas, 2009, TMT HDB TRIAGE MONIT; Prasanna Pataje G S, 2010, Radiat Res, V173, P245, DOI 10.1667/RR1993.1; Prasanna PGS, 2010, HEALTH PHYS, V98, P244, DOI 10.1097/01.HP.0000348020.14969.4; Trott KR, 2012, RADIOTHER ONCOL, V105, P79, DOI 10.1016/j.radonc.2012.05.008	18	36	36	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132194	10.1371/journal.pone.0132194	http://dx.doi.org/10.1371/journal.pone.0132194			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177207	Green Published, gold, Green Submitted			2022-12-26	WOS:000358197600089
J	Smaldino, PJ; Routh, ED; Kim, JH; Giri, B; Creacy, SD; Hantgan, RR; Akman, SA; Vaughn, JP				Smaldino, Philip J.; Routh, Eric D.; Kim, Jung H.; Giri, Banabihari; Creacy, Steven D.; Hantgan, Roy R.; Akman, Steven A.; Vaughn, James P.			Mutational Dissection of Telomeric DNA Binding Requirements of G4 Resolvase 1 Shows that G4-Structure and Certain 3 '-Tail Sequences Are Sufficient for Tight and Complete Binding	PLOS ONE			English	Article							G-QUADRUPLEX STRUCTURES; DEAH-BOX HELICASE; K+ SOLUTION; TETRAMOLECULAR QUADRUPLEX; TEMPLATE BOUNDARY; MAJOR SOURCE; HUMAN GENOME; IN-VITRO; RNA; EXTENSION	Ends of human chromosomes consist of the six nucleotide repeat d[pTTAGGG](n) known as telomeric DNA, which protects chromosomes. We have previously shown that the DHX36 gene product, G4 Resolvase 1 (G4R1), binds parallel G-quadruplex (G4) DNA with an unusually tight apparent K-d. Recent work associates G4R1 with the telomerase holoenzyme, which may allow it to access telomeric G4-DNA. Here we show that G4R1 can tightly bind telomeric G4-DNA, and in the context of the telomeric sequence, we determine length, sequence, and structural requirements sufficient for tight G4R1 telomeric binding. Specifically, G4R1 binds telomeric DNA in the K+-induced "3+1" G4-topology with an apparent K-d = 10 +/- 1.9 pM, a value similar as previously found for binding to unimolecular parallel G4-DNA. G4R1 binds to the Na+-induced "2+2" basket G4-structure formed by the same DNA sequence with an apparent K-d = 71 +/- 2.2 pM. While the minimal G4-structure is not sufficient for G4R1 binding, a 5' G4-structure with a 3' unstructured tail containing a guanine flanked by adenine(s) is sufficient for maximal binding. Mutations directed to disrupt G4-structure similarly disrupt G4R1 binding; secondary mutations that restore G4-structure also restore G4R1 binding. We present a model showing that a replication fork disrupting a T-loop could create a 5' quadruplex with an opened 3' tail structure that is recognized by G4R1.	[Smaldino, Philip J.; Routh, Eric D.; Kim, Jung H.; Creacy, Steven D.; Vaughn, James P.] Wake Forest Sch Med, Dept Canc Biol, Winston Salem, NC 27157 USA; [Giri, Banabihari] Furman Univ, Dept Chem, Greenville, SC 29613 USA; [Creacy, Steven D.] Harmonyx Diagnost, Cordova, TN 38016 USA; [Hantgan, Roy R.] Wake Forest Sch Med, Dept Biochem, Winston Salem, NC 27157 USA; [Akman, Steven A.] Roper St Francis Hosp, Dept Hematol & Oncol, Charleston, SC 29401 USA	Wake Forest University; Wake Forest University	Vaughn, JP (corresponding author), Wake Forest Sch Med, Dept Canc Biol, Winston Salem, NC 27157 USA.	jpvaughn@nanomedica.com	Smaldino, Philip/AAX-4203-2020	Routh, Eric/0000-0002-7371-1802	National Institutes of Health [P30-CA12197, T32-CA079448]; NATIONAL CANCER INSTITUTE [T32CA079448, P30CA012197] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The National Institutes of Health (Grant P30-CA12197) and the National Institutes of Health (Grant T32-CA079448 (to P.J.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrus A, 2006, NUCLEIC ACIDS RES, V34, P2723, DOI 10.1093/nar/gkl348; Arimondo PB, 2000, NUCLEIC ACIDS RES, V28, P4832, DOI 10.1093/nar/28.24.4832; Bidzinska J, 2013, MOLECULES, V18, P12368, DOI 10.3390/molecules181012368; Biffi G, 2013, NAT CHEM, V5, P182, DOI [10.1038/NCHEM.1548, 10.1038/nchem.1548]; Booy EP, 2012, NUCLEIC ACIDS RES, V40, P4110, DOI 10.1093/nar/gkr1306; Burge S, 2006, NUCLEIC ACIDS RES, V34, P5402, DOI 10.1093/nar/gkl655; Campbell Nancy, 2012, Curr Protoc Nucleic Acid Chem, VChapter 17, DOI 10.1002/0471142700.nc1706s50; Cech TR, 2004, CELL, V116, P273, DOI 10.1016/S0092-8674(04)00038-8; Chen JL, 2003, GENE DEV, V17, P2747, DOI 10.1101/gad.1140303; Chen MC, 2015, NUCLEIC ACIDS RES, V43, P2223, DOI 10.1093/nar/gkv051; Creacy SD, 2008, J BIOL CHEM, V283, P34626, DOI 10.1074/jbc.M806277200; Dai JX, 2008, BIOCHIMIE, V90, P1172, DOI 10.1016/j.biochi.2008.02.026; Doherty KM, 2006, RECENT PAT ANTI-CANC, V1, P185, DOI 10.2174/157489206777442232; Enokizono Y, 2005, J BIOL CHEM, V280, P18862, DOI 10.1074/jbc.M411822200; Fletcher TM, 1998, BIOCHEMISTRY-US, V37, P5536, DOI 10.1021/bi972681p; Giri B, 2011, NUCLEIC ACIDS RES, V39, P7161, DOI 10.1093/nar/gkr234; Gomez DE, 2012, INT J ONCOL, V41, P1561, DOI 10.3892/ijo.2012.1611; Guedin A, 2010, NUCLEIC ACIDS RES, V38, P7858, DOI 10.1093/nar/gkq639; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; Huang WW, 2012, NUCLEIC ACIDS RES, V40, P1033, DOI 10.1093/nar/gkr849; Huppert JL, 2005, NUCLEIC ACIDS RES, V33, P2908, DOI 10.1093/nar/gki609; Hwang H, 2012, STRUCTURE, V20, P1872, DOI 10.1016/j.str.2012.08.018; Kamath-Loeb A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030189; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Lai JC, 2012, BLOOD, V119, P4291, DOI 10.1182/blood-2011-08-362954; Lattmann S, 2011, NUCLEIC ACIDS RES, V39, P9390, DOI 10.1093/nar/gkr630; Lipps HJ, 2009, TRENDS CELL BIOL, V19, P414, DOI 10.1016/j.tcb.2009.05.002; Luu KN, 2006, J AM CHEM SOC, V128, P9963, DOI 10.1021/ja062791w; McElligott R, 1997, EMBO J, V16, P3705, DOI 10.1093/emboj/16.12.3705; Mohaghegh P, 2001, NUCLEIC ACIDS RES, V29, P2843, DOI 10.1093/nar/29.13.2843; O'Sullivan RJ, 2010, NAT REV MOL CELL BIO, V11, P171, DOI 10.1038/nrm2848; Oeseburg H, 2010, PFLUG ARCH EUR J PHY, V459, P259, DOI 10.1007/s00424-009-0728-1; Oganesian L, 2006, EMBO J, V25, P1148, DOI 10.1038/sj.emboj.7601006; Oganesian L, 2007, BIOESSAYS, V29, P155, DOI 10.1002/bies.20523; Patel DJ, 2007, NUCLEIC ACIDS RES, V35, P7429, DOI 10.1093/nar/gkm711; Phan AT, 2006, NUCLEIC ACIDS RES, V34, P5715, DOI 10.1093/nar/gkl726; Qin Y, 2008, BIOCHIMIE, V90, P1149, DOI 10.1016/j.biochi.2008.02.020; Sanders CM, 2010, BIOCHEM J, V430, P119, DOI 10.1042/BJ20100612; Schaffitzel C, 2001, P NATL ACAD SCI USA, V98, P8572, DOI 10.1073/pnas.141229498; Sexton AN, 2011, MOL CELL BIOL, V31, P736, DOI 10.1128/MCB.01033-10; Singh V, 2012, CHEM COMMUN, V48, P8258, DOI 10.1039/c2cc32012f; Smith JS, 2011, NAT STRUCT MOL BIOL, V18, P478, DOI 10.1038/nsmb.2033; Stegle O, 2009, BIOINFORMATICS, V25, pI374, DOI 10.1093/bioinformatics/btp210; Sun H, 1998, J BIOL CHEM, V273, P27587, DOI 10.1074/jbc.273.42.27587; Sun H, 2001, P NATL ACAD SCI USA, V98, P12444, DOI 10.1073/pnas.231479198; Sun HX, 2012, ANALYST, V137, P862, DOI 10.1039/c2an15870a; Tran H, 2004, MOL CELL, V13, P101, DOI 10.1016/S1097-2765(03)00481-7; Vaughn JP, 2005, J BIOL CHEM, V280, P38117, DOI 10.1074/jbc.C500348200; Viglasky V, 2010, BIOCHEMISTRY-US, V49, P2110, DOI 10.1021/bi902099u; Wang F, 2012, P NATL ACAD SCI USA, V109, P20413, DOI 10.1073/pnas.1200232109; Wang Q, 2011, NUCLEIC ACIDS RES, V39, P6229, DOI 10.1093/nar/gkr164; WANG Y, 1993, STRUCTURE, V1, P263, DOI 10.1016/0969-2126(93)90015-9; Wu YL, 2008, MOL CELL BIOL, V28, P4116, DOI 10.1128/MCB.02210-07; Wu YL, 2012, J BIOL CHEM, V287, P1007, DOI 10.1074/jbc.M111.276022; Wu YL, 2010, FEBS J, V277, P3470, DOI 10.1111/j.1742-4658.2010.07760.x; Xu Y, 2006, BIOORGAN MED CHEM, V14, P5584, DOI 10.1016/j.bmc.2006.04.033; ZAHLER AM, 1991, NATURE, V350, P718, DOI 10.1038/350718a0; Zaug AJ, 2005, P NATL ACAD SCI USA, V102, P10864, DOI 10.1073/pnas.0504744102; Zhang QS, 2006, RNA, V12, P1116, DOI 10.1261/rna.58806	59	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132668	10.1371/journal.pone.0132668	http://dx.doi.org/10.1371/journal.pone.0132668			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26172836	gold, Green Published, Green Submitted			2022-12-26	WOS:000358194900075
J	Feitosa, EL; Sampaio, VS; Salinas, JL; Queiroz, AM; da Silva, IM; Gomes, AA; Sachett, J; Siqueira, AM; Ferreira, LCL; dos Santos, MC; Lacerda, M; Monteiro, W				Feitosa, Esau L.; Sampaio, Vanderson S.; Salinas, Jorge L.; Queiroz, Amanda M.; da Silva, Iran Mendonca; Gomes, Andre A.; Sachett, Jacqueline; Siqueira, Andre M.; Ferreira, Luiz Carlos L.; dos Santos, Maria Cristina; Lacerda, Marcus; Monteiro, Wuelton			Older Age and Time to Medical Assistance Are Associated with Severity and Mortality of Snakebites in the Brazilian Amazon: A Case-Control Study	PLOS ONE			English	Article							ACUTE KIDNEY INJURY; BOTHROPS; BITES; ACCIDENTS; SNAKES; STATE; PROFILE; STROKE; NORTH; INDIA	The Amazon region reports the highest incidence of snakebite envenomings in Brazil. We aimed to describe the epidemiology of snakebites in the state of Amazonas and to investigate factors associated with disease severity and lethality. We used a nested case-control study, in order to identify factors associated with snakebite severity and mortality using official Brazilian reporting systems, from 2007 to 2012. Patients evolving to severity or death were considered cases and those with non-severe bites were included in the control group. During the study period, 9,191 snakebites were recorded, resulting in an incidence rate of 52.8 cases per 100,000 person/years. Snakebites mostly occurred in males (79.0%) and in rural areas (70.2%). The most affected age group was between 16 and 45 years old (54.6%). Fifty five percent of the snakebites were related to work activities. Age <= 15 years [OR=1.26 (95% CI=1.03-1.52); (p=0.018)], age >= 65 years [OR=1.53 (95% CI=1.09-2.13); (p=0.012)], work related bites [OR=1.39 (95% CI=1.17-1.63); (p<0.001)] and time to medical assistance >6 hours [OR=1.73 (95% CI=1.45-2.07); (p<0.001)] were independently associated with the risk of severity. Age >= 65 years [OR=3.19 (95% CI=1.40-7.25); (p=0.006)] and time to medical assistance >6 hours [OR=2.01 (95% CI=1.15-3.50); (p=0.013)] were independently associated with the risk of death. Snakebites represent an occupational health problem for rural populations in the Brazilian Amazon with a wide distribution. These results highlight the need for public health strategies aiming to reduce occupational injuries. Most cases of severe disease occurred in the extremes of age, in those with delays in medical attention and those caused by Micrurus bites. These features of victims of snakebite demand adequate management according to well-defined protocols, including prompt referral to tertiary centres when necessary, as well as an effective response from surveillance systems and policy makers for these vulnerable groups.	[Feitosa, Esau L.; Sampaio, Vanderson S.; Queiroz, Amanda M.; da Silva, Iran Mendonca; Gomes, Andre A.; Sachett, Jacqueline; Ferreira, Luiz Carlos L.; Lacerda, Marcus; Monteiro, Wuelton] Fdn Med Trop Doutor Heitor Vieira Dourado, Dept Ensino & Pesquisa, Manaus, Amazonas, Brazil; [Feitosa, Esau L.; Sampaio, Vanderson S.; Queiroz, Amanda M.; da Silva, Iran Mendonca; Gomes, Andre A.; Sachett, Jacqueline; Ferreira, Luiz Carlos L.; Lacerda, Marcus; Monteiro, Wuelton] Univ Estado Amazonas, Escola Super Ciencias Saude, Manaus, Amazonas, Brazil; [Sampaio, Vanderson S.] Fundacao Vigilancia Saude Amazonas, Nucleo Sistemas Informacao, Manaus, Amazonas, Brazil; [Salinas, Jorge L.] Emory Univ, Dept Med, Atlanta, GA 30322 USA; [Siqueira, Andre M.] Fundacao Oswaldo Cruz, Inst Nacl Infectol Evandro Chagas, Rio De Janeiro, Brazil; [dos Santos, Maria Cristina] Univ Fed Amazonas, Inst Ciencias Biol, Manaus, Amazonas, Brazil; [Lacerda, Marcus] Fundacao Oswaldo Cruz, Inst Leonidas & Maria Deane, Manaus, Amazonas, Brazil	Universidade do Estado do Amazonas; Emory University; Fundacao Oswaldo Cruz; Universidade Federal de Amazonas; Fundacao Oswaldo Cruz	Monteiro, W (corresponding author), Fdn Med Trop Doutor Heitor Vieira Dourado, Dept Ensino & Pesquisa, Manaus, Amazonas, Brazil.	wueltonmm@gmail.com	Sampaio, Vanderson/AAQ-1418-2020; Salinas, Jorge/ABC-7735-2021; Sachett, Jacqueline/I-5642-2017; Siqueira, Andre M/G-1340-2010; Sampaio, Vanderson/M-4337-2015	Sampaio, Vanderson/0000-0001-7307-8851; Salinas, Jorge/0000-0002-9193-820X; Sachett, Jacqueline/0000-0001-5723-9977; Siqueira, Andre M/0000-0003-2208-0294; Sampaio, Vanderson/0000-0001-7307-8851; Dos-Santos, Maria Cristina/0000-0002-1504-2647	PPSUS Public Call (FAPEAM/SUSAM-SES-AM/MS/CNPq) [001/2013]	PPSUS Public Call (FAPEAM/SUSAM-SES-AM/MS/CNPq)	This study was supported by the PPSUS Public Call (FAPEAM/SUSAM-SES-AM/MS/CNPq number 001/2013). JLS is a fellow from Fogarty Global Health [R25TW009337]. MCS is a level 2 fellow from CNPq. MVGL is a level 1 fellow from CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albuquerque PLMM, 2014, NEPHROLOGY, V19, P764, DOI 10.1111/nep.12327; Albuquerque PLMM, 2013, REV INST MED TROP SP, V55, P295, DOI 10.1590/S0036-46652013000500001; AMARAL CFS, 1986, REV I MED TROP, V28, P220, DOI 10.1590/S0036-46651986000400003; [Anonymous], 2007, REV PARAENSE MED, DOI DOI 10.5123/S0101-59072007000300012; Bard R, 1994, REV I MED TROP SAO P, V36; Bernarde Paulo Sérgio, 2012, Acta Amaz., V42, P65, DOI 10.1590/S0044-59672012000100008; Borges C. C., 1999, Revista da Sociedade Brasileira de Medicina Tropical, V32, P637, DOI 10.1590/S0037-86821999000600005; Brazilian Ministry of Health, 2009, GUIA VIG EP CAD 14 A; Brazilian Ministry of Health, 2014, SIST INF AGR NOT SIN; Chippaux JP, 1998, B WORLD HEALTH ORGAN, V76, P515; David S, 2012, J MED TOXICOL, V8, P118, DOI 10.1007/s13181-011-0204-0; de Carvalho M A, 1998, Cad Saude Publica, V14, P753, DOI 10.1590/S0102-311X1998000400017; Pardal PPD, 2010, REV INST MED TROP SP, V52, P333, DOI 10.1590/S0036-46652010000600009; Dharod Mrudul V, 2013, N Am J Med Sci, V5, P594, DOI 10.4103/1947-2714.120795; ENNIK F, 1980, WESTERN J MED, V133, P463; Feitosa ES, 2015, REV SOC BRA IN PRESS; Feitosa R F, 1997, Rev Soc Bras Med Trop, V30, P295, DOI 10.1590/S0037-86821997000400004; Fiszon Judith Tiomny, 2008, Rev. bras. epidemiol., V11, P114; Gutierrez JM, 2009, J PROTEOMICS, V72, P165, DOI 10.1016/j.jprot.2009.01.008; Habib AG, 2011, INT HEALTH, V3, P50, DOI 10.1016/j.inhe.2010.08.001; Harrison RA, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000569; INSTITUTO BRASILEIRO DE GEOGRAFIA E ESTATISTICA, 2010, CENS DEM 2010; Kalantri S, 2006, TROP MED INT HEALTH, V11, P22, DOI 10.1111/j.1365-3156.2005.01535.x; Kasturiratne A, 2008, PLOS MED, V5, P1591, DOI 10.1371/journal.pmed.0050218; Kim Jae Seok, 2008, Korean Journal of Internal Medicine, V23, P94, DOI 10.3904/kjim.2008.23.2.94; Lima JS, 2009, REV SOC BRAS MED TRO, V42, P561, DOI 10.1590/S0037-86822009000500015; Machado AS, 2010, REV SOC BRAS MED TRO, V43, P602, DOI 10.1590/S0037-86822010000500029; Mohapatra B, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001018; Moreno E, 2005, REV SOC BRAS MED TRO, V38, P15, DOI 10.1590/S0037-86822005000100004; Mosquera A, 2003, NEUROLOGY, V60, P1577, DOI 10.1212/01.WNL.0000061614.52580.A1; Nascimento S P, 2000, Cad Saude Publica, V16, P271, DOI 10.1590/S0102-311X2000000100031; Ogunfowokan O, 2011, West Afr J Med, V30, P348; Pinho FMO, 2008, SEMIN NEPHROL, V28, P354, DOI 10.1016/j.semnephrol.2008.04.004; Otero R, 2002, TOXICON, V40, P1107, DOI 10.1016/S0041-0101(02)00104-6; Ozay G, 2005, PEDIATR INT, V47, P669, DOI 10.1111/j.1442-200x.2005.02134.x; Pardal PPD, 2004, T ROY SOC TROP MED H, V98, P28, DOI 10.1016/S0035-9203(03)00005-1; Pierini SV, 1996, TOXICON, V34, P225, DOI 10.1016/0041-0101(95)00125-5; Pinho FMO, 2005, KIDNEY INT, V67, P659, DOI 10.1111/j.1523-1755.2005.67122.x; Ribeiro L A, 1998, Rev Assoc Med Bras (1992), V44, P312, DOI 10.1590/S0104-42301998000400010; Ribeiro LA, 2008, REV SOC BRAS MED TRO, V41, P46, DOI 10.1590/S0037-86822008000100009; Sa-Neto R P, 1995, REV SOC BRASILEIRA M, V28, P171; Sa-Neto RP, 1995, REV SOC BRAS MED TRO, V28, P173; Sankar J, 2013, ARCH DIS CHILD, V98, P596, DOI 10.1136/archdischild-2012-303025; Santos MC, 2003, ANIMAS PECONHENTOS B, P115; Santos-Soares PC, 2007, ARQ NEURO-PSIQUIAT, V65, P341, DOI 10.1590/S0004-282X2007000200030; Saravu K, 2012, INDIAN J CRIT CARE M, V16, P187, DOI 10.4103/0972-5229.106499; Sharma SK, 2013, AM J TROP MED HYG, V89, P145, DOI 10.4269/ajtmh.12-0750; Sharma SK, 2004, AM J TROP MED HYG, V71, P234, DOI 10.4269/ajtmh.2004.71.234; Sharma SK, 2004, TROP DOCT, V34, P20, DOI 10.1177/004947550403400108; Lima ACSF, 2009, REV SOC BRAS MED TRO, V42, P329, DOI 10.1590/S0037-86822009000300017; Souza A, 2000, REV PATOL TROP, V31, P259; Suchithra N, 2008, EMERG MED J, V25, P200, DOI 10.1136/emj.2007.051136; Waldez Fabiano, 2009, Acta Amaz., V39, P681, DOI 10.1590/S0044-59672009000300025; Wen FH, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003701; Williams D, 2010, LANCET, V375, P89, DOI 10.1016/S0140-6736(09)61159-4; World Health Organisation, 2015, NEGL TROP DIS	56	56	58	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0132237	10.1371/journal.pone.0132237	http://dx.doi.org/10.1371/journal.pone.0132237			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26168155	Green Published, gold, Green Submitted			2022-12-26	WOS:000358193100031
J	Labrie, M; Vladoiu, M; Leclerc, BG; Grosset, AA; Gaboury, L; Stagg, J; St-Pierre, Y				Labrie, Marilyne; Vladoiu, Maria; Leclerc, Bruno G.; Grosset, Andree-Anne; Gaboury, Louis; Stagg, John; St-Pierre, Yves			A Mutation in the Carbohydrate Recognition Domain Drives a Phenotypic Switch in the Role of Galectin-7 in Prostate	PLOS ONE			English	Article							CARCINOMA CELL-LINE; BREAST-CANCER CELLS; BETA-CATENIN; EXPRESSION; OVEREXPRESSION; IDENTIFICATION; KERATINOCYTES; ASSOCIATION; SUPPRESSION; PROGRESSION	The observation that galectin-7 (gal-7) is specifically expressed in mammary myoepithelial (basal) cells prompted us to investigate whether this protein is expressed in the basal cells of other tissues. Given that breast and prostate cancer have remarkable underlying biological similarities and given the important roles of basal cells in prostate cancer, we examined the expression patterns and role of gal-7 in human prostate cancer. Using tissue microarray, we found that although gal-7 is readily expressed in basal cells in normal prostate tissue, it is downregulated in prostate cancer (PCa) cells. De novo expression of gal-7 in prostate cancer cells increases their sensitivity to apoptosis in response to etoposide and cisplatin. The assessment of a carbohydrate-recognition domain (CRD)-defective mutant form of gal7 (R7S) showed that the ability of this protein to modulate apoptosis was independent of its CRD activity. This activity was also independent of its ability to translocate to the mitochondrial and nuclear compartments. However, CRD activity was necessary to inhibit the invasive behaviors of prostate cancer cells. In vivo, gal-7 overexpression in PCa cells led to a modest yet significant reduction in tumor size, while its CRD-defective mutant form significantly increased tumor growth compared to controls. Taken together, these results suggest that although de novo expression of gal-7 may be an interesting means of increasing the tumorigenic phenotypes of PCa cells, alterations in the CRD activity of this protein drive a phenotypic switch in its role in PCa cells. This CRD-independent activity represents a paradigm shift in our understanding of the functions of galectin. The R74S model will be useful to distinguish CRD-dependent and CRD-independent functions of gal-7 in cancer progression.	[Labrie, Marilyne; Vladoiu, Maria; Grosset, Andree-Anne; St-Pierre, Yves] Inst Armand Frappier, INRS, Laval, PQ, Canada; [Leclerc, Bruno G.; Stagg, John] Ctr Hosp Univ Montreal, Ctr Rech, Montreal, PQ, Canada; [Grosset, Andree-Anne; Gaboury, Louis] Inst Rech Immunol & Cancerol, Montreal, PQ, Canada	University of Quebec; Institut national de la recherche scientifique (INRS); Universite de Montreal; Universite de Montreal	St-Pierre, Y (corresponding author), Inst Armand Frappier, INRS, Laval, PQ, Canada.	yves.st-pierre@iaf.inrs.ca		St-Pierre, Yves/0000-0002-1948-2041; Labrie, Marilyne/0000-0003-3957-5533	Canadian Institutes for Health Research [MOP-89697]	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	This study was supported by the Canadian Institutes for Health Research (Grant No. MOP-89697) to YSP (http://www.cihr-irsc.gc.ca/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman SJ, 2002, J BIOL CHEM, V277, P14859, DOI 10.1074/jbc.M200221200; Akahani S, 1997, CANCER RES, V57, P5272; Alves PM, 2011, PATHOL RES PRACT, V207, P236, DOI 10.1016/j.prp.2011.02.004; Bernerd F, 1999, P NATL ACAD SCI USA, V96, P11329, DOI 10.1073/pnas.96.20.11329; Blixt O, 2004, P NATL ACAD SCI USA, V101, P17033, DOI 10.1073/pnas.0407902101; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Califice S, 2004, ONCOGENE, V23, P7527, DOI 10.1038/sj.onc.1207997; Campion CG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095087; Campion CG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072468; Cao ZY, 2002, J BIOL CHEM, V277, P42299, DOI 10.1074/jbc.M200981200; Davids MS, 2012, J CLIN ONCOL, V30, P3127, DOI 10.1200/JCO.2011.37.0981; Demers M, 2010, AM J PATHOL, V176, P3023, DOI 10.2353/ajpath.2010.090876; Demers M, 2009, BIOCHEM BIOPH RES CO, V387, P425, DOI 10.1016/j.bbrc.2009.07.015; Ellerhorst JA, 2002, PROSTATE, V50, P64, DOI 10.1002/pros.10033; Gendronneau G, 2008, MOL BIOL CELL, V19, P5541, DOI 10.1091/mbc.E08-02-0166; GIBAS Z, 1984, CANCER GENET CYTOGEN, V11, P399, DOI 10.1016/0165-4608(84)90020-7; Goldstein AS, 2010, SCIENCE, V329, P568, DOI 10.1126/science.1189992; Grosset AA, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-801; KAIGHN ME, 1979, INVEST UROL, V17, P16; Kim SJ, 2013, ONCOTARGET, V4, P1461, DOI 10.18632/oncotarget.1219; Kim SJ, 2011, CLIN EXP METASTAS, V28, P743, DOI 10.1007/s10585-011-9406-8; Kuwabara I, 2002, J BIOL CHEM, V277, P3487, DOI 10.1074/jbc.M109360200; Labrie M, 2014, ONCOTARGET, V5, P7705, DOI 10.18632/oncotarget.2299; Lazebnik YA, 1995, J CELL SCI, P41; Magnaldo T, 1998, DIFFERENTIATION, V63, P159, DOI 10.1046/j.1432-0436.1998.6330159.x; MAGNALDO T, 1995, DEV BIOL, V168, P259, DOI 10.1006/dbio.1995.1078; Nakahara S, 2005, APOPTOSIS, V10, P267, DOI 10.1007/s10495-005-0801-y; Pacis RA, 2000, PROSTATE, V44, P118; Park JW, 2001, NUCLEIC ACIDS RES, V29, P3595, DOI 10.1093/nar/29.17.3595; Risbridger GP, 2010, NAT REV CANCER, V10, P205, DOI 10.1038/nrc2795; Rondanino C, 2011, AM J PHYSIOL-RENAL, V301, pF622, DOI 10.1152/ajprenal.00134.2011; Saussez S, 2006, ANN SURG ONCOL, V13, P999, DOI 10.1245/ASO.2006.08.033; Shimura T, 2004, CANCER RES, V64, P6363, DOI 10.1158/0008-5472.CAN-04-1816; Song SM, 2009, CANCER RES, V69, P1343, DOI 10.1158/0008-5472.CAN-08-4153; Song YK, 2002, AM J PATHOL, V160, P1069, DOI 10.1016/S0002-9440(10)64927-9; STONE KR, 1978, INT J CANCER, V21, P274, DOI 10.1002/ijc.2910210305; Ueda S, 2004, CANCER RES, V64, P5672, DOI 10.1158/0008-5472.CAN-04-0985; Valenta T, 2012, EMBO J, V31, P2714, DOI 10.1038/emboj.2012.150; van den Brule FA, 2000, INT J CANCER, V89, P361, DOI 10.1002/1097-0215(20000720)89:4<361::AID-IJC8>3.3.CO;2-L; Villeneuve C, 2011, MOL BIOL CELL, V22, P999, DOI 10.1091/mbc.E10-06-0534; Vladoiu MC, 2014, INT J ONCOL, V44, P1001, DOI 10.3892/ijo.2014.2267; Weinberger PM, 2007, ARCH OTOLARYNGOL, V133, P503, DOI 10.1001/archotol.133.5.503; Zhu X, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-290	43	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0131307	10.1371/journal.pone.0131307	http://dx.doi.org/10.1371/journal.pone.0131307			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26168167	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000358193100007
J	Lam, E; Ramke, M; Warnecke, G; Schrepfer, S; Kopfnagel, V; Dobner, T; Heim, A				Lam, Elena; Ramke, Mirja; Warnecke, Gregor; Schrepfer, Sonja; Kopfnagel, Verena; Dobner, Thomas; Heim, Albert			Effective Apical Infection of Differentiated Human Bronchial Epithelial Cells and Induction of Proinflammatory Chemokines by the Highly Pneumotropic Human Adenovirus Type 14p1	PLOS ONE			English	Article							ACUTE RESPIRATORY-DISEASE; CILIATED AIRWAY EPITHELIA; INFLAMMATORY MEDIATORS; RECEPTOR; RECRUITS; LOCALIZATION; ATTACHMENT; EXPRESSION; PNEUMONIA; RESPONSES	Background Only a few pneumotropic types of the human adenoviruses (e.g. type B14p1) cause severe lower respiratory tract infections like pneumonia and acute respiratory distress syndrome (ARDS) even in immunocompetent patients. By contrast, many other human adenovirus (HAdV) types (e.g. HAdV-C5) are associated mainly with upper respiratory tract infections. This is in accordance with a highly physiological cell culture system consisting of differentiated primary human bronchial epithelial cells which are little susceptible for apical HAdV-C5 infections. Objective and Methods We hypothesized that a pneumotropic and highly pathogenic HAdV type infects differentiated human bronchial epithelial cells efficiently from the apical surface and also induces proinflammatory cytokines in order to establish ARDS and pneumonia. Therefore, the apical infection of differentiated primary human bronchial epithelial cells with the pneumotropic and virulent type HAdV-B14p1 was investigated in comparison to the less pneumotropic HAdV-C5 as a control. Results Binding of HAdV-B14p1 to the apical surface of differentiated human bronchial epithelial cells and subsequent internalization of HAdV DNA was 10 fold higher (p<0.01) compared to the less-pneumotropic HAdV-C5 one hour after infection. Overall, the replication cycle of HAdV-B14p1 following apical infection and including apical release of infectious virus progeny was about 1000-fold more effective compared to the non-pneumotropic HAdV-C5 (p<0.001). HAdV-B14p1 infected cells expressed desmoglein 2 (DSG2), which has been described as potential receptor for HAdV-B14p1. Moreover, HAdV-B14p1 induced proinflammatory chemokines IP-10 and I-Tac as potential virulence factors. Interestingly, IP-10 has already been described as a marker for severe respiratory infections e.g. by influenza virus A H5N1. Conclusions The efficient "apical to apical" replication cycle of HAdV-B14p1 can promote endobronchial dissemination of the infection from the upper to the lower respiratory tract. Simultaneous induction of proinflammatory cytokines probably contributes to the high virulence of HAdV-B14p1.	[Lam, Elena; Ramke, Mirja; Heim, Albert] Hannover Med Sch, Inst Virol, Hannover, Germany; [Lam, Elena; Dobner, Thomas] Heinrich Pette Inst, Dept Viral Transformat, Hamburg, Germany; [Warnecke, Gregor] Hannover Med Sch, Dept Cardiothorac Transplantat & Vasc Surg, Hannover, Germany; [Schrepfer, Sonja] Univ Klinikum Eppendorf, Univ Heart Ctr Hamburg, Transplant & Stem Cell Immunobiol Lab, Hamburg, Germany; [Kopfnagel, Verena] Hannover Med Sch, Dept Dermatol, Hannover, Germany	Hannover Medical School; Heinrich Pette Institute; Hannover Medical School; University of Hamburg; University Medical Center Hamburg-Eppendorf; Hannover Medical School	Heim, A (corresponding author), Hannover Med Sch, Inst Virol, Hannover, Germany.	heim.albert@mh-hannover.de		Mittermaier, Mirja/0000-0003-0678-6676	Robert Koch Institut (RKI) [FKZ 1369-380, 1369-461]	Robert Koch Institut (RKI)	This work was supported in part by Robert Koch Institut (RKI) grants FKZ 1369-380 and 1369-461. Elena Lam received Hannover biomedical research school stipend funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barraza EM, 1999, J INFECT DIS, V179, P1531, DOI 10.1086/314772; Bergelson JM, 1999, BIOCHEM PHARMACOL, V57, P975, DOI 10.1016/S0006-2952(98)00332-3; Borgland SL, 2000, J VIROL, V74, P3941, DOI 10.1128/JVI.74.9.3941-3947.2000; Chan MCW, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-135; DUDDING BA, 1972, AM J EPIDEMIOL, V95, P140, DOI 10.1093/oxfordjournals.aje.a121378; Excoffon KJDA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009909; Fein AM, 2000, CRIT CARE CLIN, V16, P289, DOI 10.1016/S0749-0704(05)70111-1; Ganzenmueller T, 2012, REV MED VIROL, V22, P194, DOI 10.1002/rmv.724; Girouard G, 2013, EMERG INFECT DIS, V19, P119, DOI 10.3201/eid1901.120423; Heim A, 2003, J MED VIROL, V70, P228, DOI 10.1002/jmv.10382; Huang GH, 2013, INFLUENZA OTHER RESP, V7, P1048, DOI 10.1111/irv.12118; Karp Philip H, 2002, Methods Mol Biol, V188, P115; KENDALL EJC, 1957, BRIT MED J, V2, P131, DOI 10.1136/bmj.2.5037.131; Kiehl MG, 1998, CRIT CARE MED, V26, P1194, DOI 10.1097/00003246-199807000-00019; Lai CY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053614; Lama E, 2011, J VIROL METHODS, V178, P117, DOI 10.1016/j.jviromet.2011.08.025; Louie JK, 2008, CLIN INFECT DIS, V46, P421, DOI 10.1086/525261; Metzgar D, 2007, J INFECT DIS, V196, P1465, DOI 10.1086/522970; Moro MR, 2009, PEDIATR INFECT DIS J, V28, P376, DOI 10.1097/INF.0b013e31819075a6; O'Flanagan D, 2009, 1 REPORTED CASES HUM, P16; Parcell BJ, 2014, J PUBLIC HLTH OXF; PEREIRA HG, 1958, VIROLOGY, V6, P601, DOI 10.1016/0042-6822(58)90109-0; PRINCE GA, 1993, J VIROL, V67, P101, DOI 10.1128/JVI.67.1.101-111.1993; Ryu JS, 2003, YONSEI MED J, V44, P732, DOI 10.3349/ymj.2003.44.4.732; SCHRADER E, 1981, J VIROL METHODS, V2, P321, DOI 10.1016/0166-0934(81)90055-0; Short JJ, 2006, VIRUS RES, V122, P144, DOI 10.1016/j.virusres.2006.07.009; Sirena D, 2004, J VIROL, V78, P4454, DOI 10.1128/JVI.78.9.4454-4462.2004; Sumino KC, 2010, THORAX, V65, P639, DOI 10.1136/thx.2009.132480; TOP FH, 1971, AM J EPIDEMIOL, V94, P142, DOI 10.1093/oxfordjournals.aje.a121306; TOP FH, 1971, J INFECT DIS, V124, P148, DOI 10.1093/infdis/124.2.148; VANDERVEEN J, 1957, AM J HYG, V65, P119; Walters RW, 1999, J BIOL CHEM, V274, P10219, DOI 10.1074/jbc.274.15.10219; Walters RW, 2002, CELL, V110, P789, DOI 10.1016/S0092-8674(02)00912-1; Wang HJ, 2011, NAT MED, V17, P96, DOI 10.1038/nm.2270; Wu WX, 2010, J GEN VIROL, V91, P1155, DOI 10.1099/vir.0.017905-0; Yoon JS, 2007, PEDIATR PULM, V42, P277, DOI 10.1002/ppul.20574; Young AM, 2012, MOL THER, V20, P1676, DOI 10.1038/mt.2012.116; Zabner J, 1997, J CLIN INVEST, V100, P1144, DOI 10.1172/JCI119625; Zabner J, 1996, J VIROL, V70, P6994, DOI 10.1128/JVI.70.10.6994-7003.1996	39	12	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0131201	10.1371/journal.pone.0131201	http://dx.doi.org/10.1371/journal.pone.0131201			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26168049	Green Published, Green Submitted, gold			2022-12-26	WOS:000358193100006
J	de Garibay, GR; Herranz, C; Llorente, A; Boni, J; Serra-Musach, J; Mateo, F; Aguilar, H; Gomez-Baldo, L; Petit, A; Vidal, A; Climent, F; Hernandez-Losa, J; Cordero, A; Gonzalez-Suarez, E; Sanchez-Mut, JV; Esteller, M; Llatjos, R; Varela, M; Lopez, JI; Garcia, N; Extremera, AI; Guma, A; Ortega, R; Pla, MJ; Fernandez, A; Pernas, S; Falo, C; Morilla, I; Campos, M; Gil, M; Roman, A; Molina-Molina, M; Ussetti, P; Laporta, R; Valenzuela, C; Ancochea, J; Xaubet, A; Casanova, A; Pujana, MA				Ruiz de Garibay, Gorka; Herranz, Carmen; Llorente, Alicia; Boni, Jacopo; Serra-Musach, Jordi; Mateo, Francesca; Aguilar, Helena; Gomez-Baldo, Laia; Petit, Anna; Vidal, August; Climent, Fina; Hernandez-Losa, Javier; Cordero, Alex; Gonzalez-Suarez, Eva; Vicente Sanchez-Mut, Jose; Esteller, Manel; Llatjos, Roger; Varela, Mar; Ignacio Lopez, Jose; Garcia, Nadia; Extremera, Ana I.; Guma, Anna; Ortega, Raul; Jesus Pla, Maria; Fernandez, Adela; Pernas, Sonia; Falo, Catalina; Morilla, Idoia; Campos, Miriam; Gil, Miguel; Roman, Antonio; Molina-Molina, Maria; Ussetti, Piedad; Laporta, Rosalia; Valenzuela, Claudia; Ancochea, Julio; Xaubet, Antoni; Casanova, Alvaro; Angel Pujana, Miguel			Lymphangioleiomyomatosis Biomarkers Linked to Lung Metastatic Potential and Cell Stemness	PLOS ONE			English	Article							TUBEROUS SCLEROSIS COMPLEX; SPORADIC PULMONARY LYMPHANGIOLEIOMYOMATOSIS; HUMAN BREAST-CANCER; DUCTAL CARCINOMA; SELF-RENEWAL; ID PROTEINS; GENE TSC2; EXPRESSION; TRANSPLANTATION; ACTIVATION	Lymphangioleiomyomatosis (LAM) is a rare lung-metastasizing neoplasm caused by the proliferation of smooth muscle-like cells that commonly carry loss-of-function mutations in either the tuberous sclerosis complex 1 or 2 (TSC1 or TSC2) genes. While allosteric inhibition of the mechanistic target of rapamycin (mTOR) has shown substantial clinical benefit, complementary therapies are required to improve response and/or to treat specific patients. However, there is a lack of LAM biomarkers that could potentially be used to monitor the disease and to develop other targeted therapies. We hypothesized that the mediators of cancer metastasis to lung, particularly in breast cancer, also play a relevant role in LAM. Analyses across independent breast cancer datasets revealed associations between low TSC1/2 expression, altered mTOR complex 1 (mTORC1) pathway signaling, and metastasis to lung. Subsequently, immunohistochemical analyses of 23 LAM lesions revealed positivity in all cases for the lung metastasis mediators fascin 1 (FSCN1) and inhibitor of DNA binding 1 (ID1). Moreover, assessment of breast cancer stem or luminal progenitor cell biomarkers showed positivity in most LAM tissue for the aldehyde dehydrogenase 1 (ALDH1), integrin-beta 3 (ITGB3/CD61), and/or the sex-determining region Y-box 9 (SOX9) proteins. The immunohistochemical analyses also provided evidence of heterogeneity between and within LAM cases. The analysis of Tsc2-deficient cells revealed relative over-expression of FSCN1 and ID1; however, Tsc2-deficient cells did not show higher sensitivity to ID1-based cancer inhibitors. Collectively, the results of this study reveal novel LAM biomarkers linked to breast cancer metastasis to lung and to cell stemness, which in turn might guide the assessment of additional or complementary therapeutic opportunities for LAM.	[Ruiz de Garibay, Gorka; Herranz, Carmen; Llorente, Alicia; Boni, Jacopo; Serra-Musach, Jordi; Mateo, Francesca; Aguilar, Helena; Gomez-Baldo, Laia; Garcia, Nadia; Extremera, Ana I.; Angel Pujana, Miguel] Bellvitge Inst Biomed Res IDIBELL, Catalan Inst Oncol ICO, Program Canc Therapeut Resistance ProCURE, Breast Canc & Syst Biol, Lhospitalet Del Llobrega, Catalonia, Spain; [Petit, Anna; Vidal, August; Climent, Fina; Llatjos, Roger; Varela, Mar] Univ Hosp Bellvitge, Bellvitge Inst Biomed Res IDIBELL, Dept Pathol, Lhospitalet Del Llobrega, Catalonia, Spain; [Hernandez-Losa, Javier] Vall dHebron Hosp, Dept Pathol, Barcelona, Catalonia, Spain; [Cordero, Alex; Gonzalez-Suarez, Eva; Vicente Sanchez-Mut, Jose; Esteller, Manel] Bellvitge Inst Biomed Res IDIBELL, Canc Epigenet & Biol Program, Lhospitalet Del Llobrega, Catalonia, Spain; [Esteller, Manel] Univ Barcelona, Sch Med, Dept Physiol Sci 2, Barcelona, Catalonia, Spain; [Esteller, Manel] Inst Catalana Recerca & Estudis Avancats, Barcelona, Catalonia, Spain; [Ignacio Lopez, Jose] Univ Basque Country, BioCruces Res Inst, Cruces Univ Hosp, Baracaldo, Spain; [Guma, Anna; Ortega, Raul] Univ Hosp Bellvitge, Bellvitge Inst Biomed Res IDIBELL, Dept Radiol, Lhospitalet Del Llobrega, Catalonia, Spain; [Jesus Pla, Maria] Univ Hosp Bellvitge, Bellvitge Inst Biomed Res IDIBELL, Catalan Inst Oncol ICO, Dept Gynecol,Breast Canc Unit, Lhospitalet Del Llobrega, Catalonia, Spain; [Fernandez, Adela; Pernas, Sonia; Falo, Catalina; Morilla, Idoia; Campos, Miriam; Gil, Miguel] Bellvitge Inst Biomed Res IDIBELL, Catalan Inst Oncol ICO, Breast Canc Unit, Dept Med Oncol, Lhospitalet Del Llobrega, Catalonia, Spain; [Roman, Antonio] Vall dHebron Univ Hosp, Lymphangioleiomyomatosis LAM Clin, Lung Transplant Unit, Dept Pulmonol, Barcelona, Catalonia, Spain; [Molina-Molina, Maria] Univ Hosp Bellvitge, Bellvitge Inst Biomed Res IDIBELL, Dept Pneumol, Lhospitalet Del Llobrega, Catalonia, Spain; [Molina-Molina, Maria; Xaubet, Antoni] Biomed Res Ctr Network Resp Dis CIBERES, Madrid, Spain; [Ussetti, Piedad; Laporta, Rosalia] Univ Hosp Clin Puerta Hierro, Dept Pneumol, Madrid, Spain; [Valenzuela, Claudia; Ancochea, Julio] Hosp La Princesa, Inst Invest Sanitaria La Princesa, Dept Pneumol, Madrid, Spain; [Xaubet, Antoni] Hosp Clin Barcelona, Agusti Pi Suner Biomed Res Inst IDIBAPS, Dept Pneumol, Barcelona, Catalonia, Spain; [Casanova, Alvaro] Henares Hosp, Dept Pneumol, Madrid, Spain	Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; Hospital Universitari Vall d'Hebron; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; ICREA; Hospital Universitario Cruces; University of Basque Country; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Hospital Universitari Vall d'Hebron; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; CIBERESP; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Pujana, MA (corresponding author), Bellvitge Inst Biomed Res IDIBELL, Catalan Inst Oncol ICO, Program Canc Therapeut Resistance ProCURE, Breast Canc & Syst Biol, Lhospitalet Del Llobrega, Catalonia, Spain.	mapujana@iconcologia.net	Laporta Hernandez, Rosalía/AFP-1538-2022; Casanovas, Alex Cordero/AAA-8157-2020; Sanchez-Mut, Jose V./A-8651-2019; de Garibay, Gorka Ruiz/AAB-6579-2020; Boni, Jacopo/I-9587-2016; Varela, Mar/J-1814-2016; Javier, Hernandez Losa/C-1173-2008; Esteller, Manel/L-5956-2014; Ussetti, Piedad/B-3853-2014; Herranz Ors, Carmen/K-1043-2017; Mateo, Francesca/K-7746-2015; Pujana, Miquel Angel/N-3127-2014; Vidal, August/N-4662-2016; Morilla, Idoia/P-6155-2019; Lopez, Jose Ignacio/L-3884-2019; Gonzalez-Suarez, Eva/L-6298-2014; Petit, Anna/GYU-5229-2022	Laporta Hernandez, Rosalía/0000-0002-8326-6626; Sanchez-Mut, Jose V./0000-0002-9292-8521; de Garibay, Gorka Ruiz/0000-0001-9936-8419; Varela, Mar/0000-0002-2129-6336; Javier, Hernandez Losa/0000-0003-1526-3201; Esteller, Manel/0000-0003-4490-6093; Ussetti, Piedad/0000-0002-3439-5536; Herranz Ors, Carmen/0000-0002-2866-0321; Mateo, Francesca/0000-0002-2342-7010; Pujana, Miquel Angel/0000-0003-3222-4044; Vidal, August/0000-0001-5727-2099; Morilla, Idoia/0000-0001-8237-5073; Lopez, Jose Ignacio/0000-0003-0842-5348; Gonzalez-Suarez, Eva/0000-0003-0858-8171; Extremera, Ana Isabel/0000-0002-3731-4367; Climent, Fina/0000-0002-4360-8388; Boni, Jacopo/0000-0003-2626-9393; Ancochea, julio/0000-0001-7451-4133; valenzuela, claudia/0000-0002-0856-6290; MOLINA MOLINA, MARIA/0000-0002-1852-1723; Llorente, Alicia/0000-0002-6056-0566; Cordero Casanovas, Alejandro/0000-0002-2224-7122	Government of Catalonia [SGR 2014-364]; Red Tematica de Investigacion Colaborativa en Cancer [RD12/0036/0008]; Telemaraton "Todos Somos Raros, Todos Somos Unicos [P35]; Spanish Ministry of Health "Instituto de Salud Carlos III Fondo de Investigacion Sanitaria" [PI12/01528]; Spanish Society of Pneumology and Thoracic Surgery (Sociedad Espanola de Neumologia y Cirugia Toracica, SEPAR); ICREA Funding Source: Custom	Government of Catalonia(Generalitat de Catalunya); Red Tematica de Investigacion Colaborativa en Cancer; Telemaraton "Todos Somos Raros, Todos Somos Unicos; Spanish Ministry of Health "Instituto de Salud Carlos III Fondo de Investigacion Sanitaria"(Instituto de Salud Carlos IIISpanish Government); Spanish Society of Pneumology and Thoracic Surgery (Sociedad Espanola de Neumologia y Cirugia Toracica, SEPAR); ICREA(ICREA)	This work was funded by the Government of Catalonia grant SGR 2014-364, the "Red Tematica de Investigacion Colaborativa en Cancer" grant RD12/0036/0008, the Telemaraton 2014 "Todos Somos Raros, Todos Somos Unicos" grant P35, the Spanish Ministry of Health "Instituto de Salud Carlos III Fondo de Investigacion Sanitaria" grant PI12/01528, and a Spanish Society of Pneumology and Thoracic Surgery (Sociedad Espanola de Neumologia y Cirugia Toracica, SEPAR) grant for 2012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anton E, 2009, SARCOIDOSIS VASC DIF, V26, P85; Astrinidis A, 2000, J MED GENET, V37, P55, DOI 10.1136/jmg.37.1.55; Badri KR, 2013, AM J RESP CRIT CARE, V187, P663, DOI 10.1164/ajrccm.187.6.663; Bittmann I, 2003, HUM PATHOL, V34, P95, DOI 10.1053/hupa.2003.50; Blei F, 2011, LYMPHAT RES BIOL, V9, P185, DOI 10.1089/lrb.2011.0020; Boecker W, 2002, J PATHOL, V198, P458, DOI 10.1002/path.1241; BONETTI F, 1989, AM J CLIN PATHOL, V92, P491, DOI 10.1093/ajcp/92.4.491; Cai XO, 2010, AM J RESP CRIT CARE, V182, P1410, DOI 10.1164/rccm.201003-0489OC; Carsillo T, 2000, P NATL ACAD SCI USA, V97, P6085, DOI 10.1073/pnas.97.11.6085; Chakravarty G, 2011, EXP BIOL MED, V236, P145, DOI 10.1258/ebm.2010.010086; Chu SC, 1999, CHEST, V115, P1041, DOI 10.1378/chest.115.4.1041; Crino PB, 2006, NEW ENGL J MED, V355, P1345, DOI 10.1056/NEJMra055323; Crooks DM, 2004, P NATL ACAD SCI USA, V101, P17462, DOI 10.1073/pnas.0407971101; Delaney SP, 2014, FRONT CELL DEV BIOL, V2, DOI 10.3389/fcell.2014.00069; Ferrer I, 2014, J PATHOL, V233, P247, DOI 10.1002/path.4343; Finlay G, 2004, AM J PHYSIOL-LUNG C, V286, pL690, DOI 10.1152/ajplung.00311.2003; Fu NY, 2014, CURR TOP DEV BIOL, V107, P133, DOI 10.1016/B978-0-12-416022-4.00005-6; Gan B, 2008, P NATL ACAD SCI USA, V105, P19384, DOI 10.1073/pnas.0810584105; Gao L, 2014, VIRCHOWS ARCH, V464, P495, DOI 10.1007/s00428-014-1559-9; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Gomez-Baldo L, 2010, CELL CYCLE, V9, P1143, DOI 10.4161/cc.9.6.11018; Guo WJ, 2012, CELL, V148, P1015, DOI 10.1016/j.cell.2012.02.008; Hancock DB, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003098; Hashimoto Y, 2011, J PATHOL, V224, P289, DOI 10.1002/path.2894; Hasskarl J, 2002, CANCER BIOL THER, V1, P91, DOI 10.4161/cbt.50; Hohman DW, 2008, EUR J INTERN MED, V19, P319, DOI 10.1016/j.ejim.2007.10.015; Honeth G, 2015, STEM CELL REP, V4, P699, DOI 10.1016/j.stemcr.2015.02.013; Hsieh AC, 2012, NATURE, V485, P55, DOI 10.1038/nature10912; Jiang WG, 2005, EUR J CANCER, V41, P1628, DOI 10.1016/j.ejca.2005.03.023; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Karbowniczek M, 2003, AM J RESP CRIT CARE, V167, P976, DOI 10.1164/rccm.200208-969OC; Kobayashi E, 2010, MOL CANCER THER, V9, P535, DOI 10.1158/1535-7163.MCT-09-0774; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Landemaine T, 2008, CANCER RES, V68, P6092, DOI 10.1158/0008-5472.CAN-08-0436; Li CG, 2014, J EXP MED, V211, P15, DOI 10.1084/jem.20131080; Li ZD, 2009, FEBS LETT, V583, P1999, DOI 10.1016/j.febslet.2009.05.013; Lin HJ, 2005, BRIT J CANCER, V93, P1372, DOI 10.1038/sj.bjc.6602862; Lo PK, 2012, ONCOGENE, V31, P2614, DOI [10.1038/onc.2011.439, 10.1038/onc.2012.147]; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Matsui K, 2000, AM J RESP CRIT CARE, V161, P1002, DOI 10.1164/ajrccm.161.3.9904009; McAllister SD, 2011, BREAST CANCER RES TR, V129, P37, DOI 10.1007/s10549-010-1177-4; McCormack FX, 2008, CHEST, V133, P507, DOI 10.1378/chest.07-0898; McCormack FX, 2012, AM J RESP CRIT CARE, V186, P1210, DOI 10.1164/rccm.201205-0848OE; McCormack FX, 2011, NEW ENGL J MED, V364, P1595, DOI 10.1056/NEJMoa1100391; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Mistry H, 2013, MOL CANCER THER, V12, P2651, DOI 10.1158/1535-7163.MCT-13-0103-T; Muzykewicz DA, 2009, J MED GENET, V46, P465, DOI 10.1136/jmg.2008.065342; Nasr Z, 2013, ONCOGENE, V32, P861, DOI 10.1038/onc.2012.105; Nishiyama K, 2007, J BIOL CHEM, V282, P17200, DOI 10.1074/jbc.M611609200; Pacheco-Rodriguez G, 2010, CRIT REV IMMUNOL, V30, P387, DOI 10.1615/CritRevImmunol.v30.i4.40; Perk J, 2005, NAT REV CANCER, V5, P603, DOI 10.1038/nrc1673; Romero-Lanman EE, 2012, STEM CELLS DEV, V21, P384, DOI 10.1089/scd.2011.0428; Russell RC, 2011, DEVELOPMENT, V138, P3343, DOI 10.1242/dev.058230; Sato T, 2002, J HUM GENET, V47, P20, DOI 10.1007/s10038-002-8651-8; Seyama K, 2010, LYMPHAT RES BIOL, V8, P21, DOI 10.1089/lrb.2009.0018; Smid M, 2008, CANCER RES, V68, P3108, DOI 10.1158/0008-5472.CAN-07-5644; Soroceanu L, 2013, CANCER RES, V73, P1559, DOI 10.1158/0008-5472.CAN-12-1943; Steagall WK, 2015, AM J RESP CRIT CARE, V191, P854, DOI 10.1164/rccm.201412-2170LE; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Taveira-DaSilva Angelo M, 2006, Cancer Control, V13, P276; Taveira-DaSilva AM, 2010, LYMPHAT RES BIOL, V8, P9, DOI 10.1089/lrb.2009.0024; Tobin NP, 2015, ANN ONCOL, V26, P81, DOI 10.1093/annonc/mdu498; Treutlein B, 2014, NATURE, V509, P371, DOI 10.1038/nature13173; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; Wagner SN, 1997, CANCER IMMUNOL IMMUN, V44, P239, DOI 10.1007/s002620050379; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Yu J, 2010, LYMPHAT RES BIOL, V8, P43, DOI 10.1089/lrb.2009.0020; Zhou JB, 2007, P NATL ACAD SCI USA, V104, P16158, DOI 10.1073/pnas.0702596104; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	70	13	13	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0132546	10.1371/journal.pone.0132546	http://dx.doi.org/10.1371/journal.pone.0132546			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26167915	Green Published, Green Submitted, gold			2022-12-26	WOS:000358193100053
J	Mouchet, M; Levers, C; Zupan, L; Kuemmerle, T; Plutzar, C; Erb, K; Lavorel, S; Thuiller, W; Haberl, H				Mouchet, Maud; Levers, Christian; Zupan, Laure; Kuemmerle, Tobias; Plutzar, Christoph; Erb, Karlheinz; Lavorel, Sandra; Thuiller, Wilfried; Haberl, Helmut			Testing the Effectiveness of Environmental Variables to Explain European Terrestrial Vertebrate Species Richness across Biogeographical Scales	PLOS ONE			English	Article							NET PRIMARY PRODUCTION; LAND-USE; LATITUDINAL GRADIENTS; BIOTIC INTERACTIONS; HUMAN APPROPRIATION; LANDSCAPE STRUCTURE; PLANT DIVERSITY; GLOBAL PATTERNS; CLIMATE; ENERGY	We compared the effectiveness of environmental variables, and in particular of land-use indicators, to explain species richness patterns across taxonomic groups and biogeographical scales (i.e. overall pan-Europe and ecoregions within pan-Europe). Using boosted regression trees that handle non-linear relationships, we compared the relative influence (as a measure of effectiveness) of environmental variables related to climate, landscape (or habitat heterogeneity), land-use intensity or energy availability to explain European vertebrate species richness (birds, amphibians, and mammals) at the continental and ecoregion scales. We found that dominant land cover and actual evapotranspiration that relate to energy availability were the main correlates of vertebrate species richness over Europe. At the ecoregion scale, we identified four distinct groups of ecoregions where species richness was essentially associated to (i) seasonality of temperature, (ii) actual evapotranspiration and/or mean annual temperature, (iii) seasonality of precipitation, actual evapotranspiration and land cover) and (iv) and an even combination of the environmental variables. This typology of ecoregions remained valid for total vertebrate richness and the three vertebrate groups taken separately. Despite the overwhelming influence of land cover and actual evapotranspiration to explain vertebrate species richness patterns at European scale, the ranking of the main correlates of species richness varied between regions. Interestingly, landscape and land-use indicators did not stand out at the continental scale but their influence greatly increased in southern ecoregions, revealing the long-lasting human footprint on land-use-land-cover changes. Our study provides one of the first multi-scale descriptions of the variability in the ranking of correlates across several taxa.	[Mouchet, Maud; Zupan, Laure; Lavorel, Sandra; Thuiller, Wilfried] Univ Grenoble Alpes, Lab Ecol Alpine LECA, F-38000 Grenoble, France; [Mouchet, Maud; Zupan, Laure; Lavorel, Sandra; Thuiller, Wilfried] CNRS, Lab Ecol Alpine LECA, F-38000 Grenoble, France; [Levers, Christian; Kuemmerle, Tobias] Humboldt Univ, Dept Geog, D-10099 Berlin, Germany; [Plutzar, Christoph; Erb, Karlheinz; Haberl, Helmut] Alpen Adria Univ Klagenfurt, Inst Social Ecol Vienna, A-1070 Vienna, Austria; [Kuemmerle, Tobias; Haberl, Helmut] Humboldt Univ, Integrat Res Inst Transformat Human Environm Syst, D-10099 Berlin, Germany	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Universite de Savoie; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Universite de Savoie; Humboldt University of Berlin; University of Klagenfurt; Humboldt University of Berlin	Mouchet, M (corresponding author), MNHN, CESCO, UMR7204, 55 Rue Buffon, F-75005 Paris, France.	maud.mouchet@mnhn.fr	Levers, Christian/L-9204-2013; Mouchet, Maud A/D-4145-2013; Haberl, Helmut/G-3679-2013; Erb, Karlheinz/F-1282-2016; Plutzar, Christoph/J-6055-2015; Thuiller, Wilfried/G-3283-2010; Kuemmerle, Tobias/B-4340-2008	Levers, Christian/0000-0003-4810-9024; Mouchet, Maud A/0000-0001-5939-6802; Haberl, Helmut/0000-0003-2104-5446; Erb, Karlheinz/0000-0002-8335-4159; Plutzar, Christoph/0000-0003-2041-6399; Thuiller, Wilfried/0000-0002-5388-5274; Kuemmerle, Tobias/0000-0002-9775-142X	EU project VOLANTE (Visions of Land use Transitions in Europe) [FP7-ENV-2010-265104]; European Research Council grant ("LUISE") [ERC-2010-stg-263522]	EU project VOLANTE (Visions of Land use Transitions in Europe); European Research Council grant ("LUISE")	This research was funded by the EU project VOLANTE (Visions of Land use Transitions in Europe) FP7-ENV-2010-265104. Karlheinz Erb is supported by a European Research Council grant (ERC-2010-stg-263522 "LUISE").	Aggemyr E, 2012, J BIOGEOGR, V39, P1645, DOI 10.1111/j.1365-2699.2012.02733.x; Allen AP, 2006, ECOL LETT, V9, P947, DOI 10.1111/j.1461-0248.2006.00946.x; [Anonymous], 2001, PLANT STRATEGIES VEG; Araujo MB, 2007, GLOBAL ECOL BIOGEOGR, V16, P743, DOI 10.1111/j.1466-8238.2007.00359.x; Aronson MFJ, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3330; Atauri JA, 2001, LANDSCAPE ECOL, V16, P147, DOI 10.1023/A:1011115921050; BAZZAZ FA, 1975, ECOLOGY, V56, P485, DOI 10.2307/1934981; Belmaker J, 2011, GLOBAL ECOL BIOGEOGR, V20, P464, DOI 10.1111/j.1466-8238.2010.00615.x; Breiman L, 2001, STAT SCI, V16, P199, DOI 10.1214/ss/1009213726; BROWN JH, 1981, AM ZOOL, V21, P877; Buckley LB, 2008, P NATL ACAD SCI USA, V105, P17836, DOI 10.1073/pnas.0803524105; Clarke A, 2006, P ROY SOC B-BIOL SCI, V273, P2257, DOI 10.1098/rspb.2006.3545; Currie DJ, 2004, ECOL LETT, V7, P1121, DOI 10.1111/j.1461-0248.2004.00671.x; Cusens J, 2012, ECOLOGY, V93, P2241, DOI 10.1890/11-1861.1; Davies RG, 2007, P ROY SOC B-BIOL SCI, V274, P1189, DOI 10.1098/rspb.2006.0061; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; Dullinger S, 2013, P NATL ACAD SCI USA, V110, P7342, DOI 10.1073/pnas.1216303110; Eglington SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030407; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; Evans KL, 2005, P ROY SOC B-BIOL SCI, V272, P2155, DOI 10.1098/rspb.2005.3209; Evans KL, 2005, BIOL REV, V80, P1, DOI 10.1017/S1464793104006517; Falcucci A, 2007, LANDSCAPE ECOL, V22, P617, DOI 10.1007/s10980-006-9056-4; Field R, 2009, J BIOGEOGR, V36, P132, DOI 10.1111/j.1365-2699.2008.01963.x; Flojgaard C, 2011, GLOBAL ECOL BIOGEOGR, V20, P218, DOI 10.1111/j.1466-8238.2010.00604.x; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Foster D, 2003, BIOSCIENCE, V53, P77, DOI 10.1641/0006-3568(2003)053[0077:TIOLUL]2.0.CO;2; Friedman JH, 2001, ANN STAT, V29, P1189, DOI 10.1214/aos/1013203451; Friedman JH, 2003, STAT MED, V22, P1365, DOI 10.1002/sim.1501; Gaston KJ, 2000, NATURE, V405, P220, DOI 10.1038/35012228; Gaston KJ, 2003, STRUCT DYNAMICS GEOG; Gerstner K, 2014, J APPL ECOL, V51, P1690, DOI 10.1111/1365-2664.12329; Gotelli NJ, 2010, P NATL ACAD SCI USA, V107, P5030, DOI 10.1073/pnas.0914089107; Haberl H, 2007, P NATL ACAD SCI USA, V104, P12942, DOI 10.1073/pnas.0704243104; Hagemeijer E.J.M., 1997, EBCC ATLAS EUROPEAN; Hastie TJ, 2011, ELEMENTS STAT LEARNI; Hawkins BA, 2005, AM NAT, V166, pE140, DOI 10.1086/491686; Hawkins BA, 2003, ECOLOGY, V84, P3105, DOI 10.1890/03-8006; Heikinheimo H, 2012, J BIOGEOGR, V39, P1633, DOI 10.1111/j.1365-2699.2012.02723.x; Heikkinen RK, 2007, GLOBAL ECOL BIOGEOGR, V16, P754, DOI 10.1111/j.1466-8238.2007.00345.x; Helm A, 2006, ECOL LETT, V9, P72, DOI 10.1111/j.1461-0248.2005.00841.x; Hijmans R.J., 2013, DISMO SPECIES DISTRI, V0, P8; Hortal J, 2008, J BIOGEOGR, V35, P1202, DOI 10.1111/j.1365-2699.2007.01850.x; Kerr JT, 1998, ECOSCIENCE, V5, P448, DOI 10.1080/11956860.1998.11682483; Kozak KH, 2012, ECOLOGY, V93, pS167, DOI 10.1890/11-0542.1; Krausmann F, 2013, P NATL ACAD SCI USA, V110, P10324, DOI 10.1073/pnas.1211349110; Krauss J, 2010, ECOL LETT, V13, P597, DOI 10.1111/j.1461-0248.2010.01457.x; Levers C, 2014, FOREST ECOL MANAG, V315, P160, DOI 10.1016/j.foreco.2013.12.030; Lindborg R, 2004, ECOLOGY, V85, P1840, DOI 10.1890/04-0367; Lomolino MV, 2001, GLOBAL ECOL BIOGEOGR, V10, P3, DOI 10.1046/j.1466-822x.2001.00229.x; MAC ARTHUR ROBERT H., 1967; Maiorano L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074989; Metzger MJ, 2005, GLOBAL ECOL BIOGEOGR, V14, P549, DOI 10.1111/j.1466-822x.2005.00190.x; Mucher CA, 2009, LANDSCAPE URBAN PLAN, V92, P148, DOI 10.1016/j.landurbplan.2009.04.003; Muller D, 2013, AGR SYST, V117, P66, DOI 10.1016/j.agsy.2012.12.010; O'Brien EM, 1998, ECOGRAPHY, V21, P495, DOI 10.1111/j.1600-0587.1998.tb00441.x; PIANKA ER, 1966, AM NAT, V100, P33, DOI 10.1086/282398; Pimm SL, 2004, SCIENCE, V304, P831, DOI 10.1126/science.1095332; Plutzar C, 2016, REG ENVIRON CHANGE, V16, P1225, DOI 10.1007/s10113-015-0820-3; R Development Core Team, 2012, R LANG ENV STAT COMP; Rahbek C, 2007, P ROY SOC B-BIOL SCI, V274, P165, DOI 10.1098/rspb.2006.3700; Ricklefs RE, 2004, ECOL LETT, V7, P1, DOI 10.1046/j.1461-0248.2003.00554.x; Riley S.J., 1999, INTERMOUNTAIN J SCI, V5, P23, DOI DOI 10.1016/j.geomorph.2010.11.003; Rodriguez MA, 2005, ACTA OECOL, V28, P65, DOI 10.1016/j.actao.2005.02.006; Sol D, 2014, ECOL LETT, V17, P942, DOI 10.1111/ele.12297; Spehn EM, 2011, PLANT ECOL DIVERS, V4, P301, DOI 10.1080/17550874.2012.698660; Tews J, 2004, J BIOGEOGR, V31, P79, DOI 10.1046/j.0305-0270.2003.00994.x; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thuiller W, 2006, ECOGRAPHY, V29, P733, DOI 10.1111/j.0906-7590.2006.04674.x; Tscharntke T, 2012, BIOL REV, V87, P661, DOI 10.1111/j.1469-185X.2011.00216.x; Whittaker RJ, 2001, J BIOGEOGR, V28, P453, DOI 10.1046/j.1365-2699.2001.00563.x; Whitton FJS, 2012, GLOBAL ECOL BIOGEOGR, V21, P179, DOI 10.1111/j.1466-8238.2011.00660.x; Yamaura Y, 2011, OIKOS, V120, P427, DOI 10.1111/j.1600-0706.2010.18764.x	72	18	19	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0131924	10.1371/journal.pone.0131924	http://dx.doi.org/10.1371/journal.pone.0131924			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161981	Green Published, gold, Green Submitted			2022-12-26	WOS:000358162300074
J	Li, QL; Li, YW; Gu, BN; Fang, L; Zhou, PB; Bao, SL; Huang, L; Dai, X				Li, Qiuling; Li, Yuewei; Gu, Bingnan; Fang, Lei; Zhou, Pengbo; Bao, Shilai; Huang, Lan; Dai, Xing			Akt Phosphorylates Wnt Coactivator and Chromatin Effector Pygo2 at Serine 48 to Antagonize Its Ubiquitin/Proteasome-mediated Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						E3 ubiquitin ligase; phosphorylation; ubiquitin ligase; ubiquitylation (ubiquitination); Wnt signaling; Akt; Cul4; DDB1; Pygo2	GLYCOGEN-SYNTHASE KINASE-3; DNA-DAMAGE RESPONSE; BETA-CATENIN; PROTEIN-KINASE; UBIQUITIN LIGASE; GENE-EXPRESSION; STEM-CELLS; SIGNALING PATHWAY; BINDING PROTEIN; ACTIVATION	Background: Pygo2 is a chromatin effector of the Wnt signaling pathway that regulates cell growth and differentiation. Results: Pygo2 is degraded through the ubiquitin/proteasome pathway and is stabilized by Akt phosphorylation at its serine 48. Conclusion: Stabilizing phosphorylation by Akt regulates Pygo2 protein expression. Significance: Pygo2 is a common nodule downstream of Wnt and Akt pathways. Pygopus 2 (Pygo2/PYGO2) is an evolutionarily conserved coactivator and chromatin effector in the Wnt/-catenin signaling pathway that regulates cell growth and differentiation in various normal and malignant tissues. Although PYGO2 is highly overexpressed in a number of human cancers, the molecular mechanism underlying its deregulation is largely unknown. Here we report that Pygo2 protein is degraded through the ubiquitin/proteasome pathway and is posttranslationally stabilized through phosphorylation by activated phosphatidylinositol 3-kinase/Akt signaling. Specifically, Pygo2 is stabilized upon inhibition of the proteasome, and its intracellular level is regulated by Cullin 4 (Cul4) and DNA damage-binding protein 1 (DDB1), components of the Cul4-DDB1 E3 ubiquitin ligase complex. Furthermore, Pygo2 is phosphorylated at multiple residues, and Akt-mediated phosphorylation at serine 48 leads to its decreased ubiquitylation and increased stability. Finally, we provide evidence that Akt and its upstream growth factors act in parallel with Wnt to stabilize Pygo2. Taken together, our findings highlight chromatin regulator Pygo2 as a common node downstream of oncogenic Wnt and Akt signaling pathways and underscore posttranslational modification, particularly phosphorylation and ubiquitylation, as a significant mode of regulation of Pygo2 protein expression.	[Li, Qiuling; Gu, Bingnan; Dai, Xing] Univ Calif Irvine, Dept Biol Chem, Sch Med, Irvine, CA 92697 USA; [Fang, Lei; Huang, Lan] Univ Calif Irvine, Dept Physiol & Biophys, Sch Med, Irvine, CA 92697 USA; [Li, Qiuling; Bao, Shilai] Chinese Acad Sci, Inst Genet & Dev Biol, Ctr Dev Biol, State Key Lab Mol & Dev Biol, Beijing 100101, Peoples R China; [Li, Yuewei; Zhou, Pengbo] Weill Cornell Med Coll, Dept Pathol & Lab Med, New York, NY 10065 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Cornell University	Huang, L (corresponding author), Univ Calif Irvine, Dept Physiol & Biophys, Sch Med, D233 Med Sci 1, Irvine, CA 92697 USA.	lanhuang@uci.edu; xdai@uci.edu	Regan, Clinton/E-6250-2012	Fang, Lei/0000-0002-2582-4845; Dai, Xing/0000-0001-8134-1365	National Institutes of Health [R01-GM083089, R21CA161807, R01GM074830]; Susan G. Komen Grant [KG110897]; California Breast Cancer Research Program Postdoctoral Fellowship [14FB-0129]; NATIONAL CANCER INSTITUTE [R21CA161807] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074830, R01GM083089] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Susan G. Komen Grant(Susan G. Komen Breast Cancer Foundation); California Breast Cancer Research Program Postdoctoral Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-GM083089 (to X. D.) and R21CA161807 and R01GM074830 (to L. H.). This work was also supported by Susan G. Komen Grant KG110897 (to X. D.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by California Breast Cancer Research Program Postdoctoral Fellowship 14FB-0129.	Agarwal A, 2005, ONCOGENE, V24, P1021, DOI 10.1038/sj.onc.1208296; Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Almeida M, 2005, J BIOL CHEM, V280, P41342, DOI 10.1074/jbc.M502168200; Andrews PGP, 2007, INT J ONCOL, V30, P357; Andrews PGP, 2009, BIOCHEM J, V422, P493, DOI 10.1042/BJ20090134; Angers S, 2006, NATURE, V443, P590, DOI 10.1038/nature05175; Bader AG, 2005, NAT REV CANCER, V5, P921, DOI 10.1038/nrc1753; BALL RK, 1988, EMBO J, V7, P2089, DOI 10.1002/j.1460-2075.1988.tb03048.x; Belenkaya TY, 2002, DEVELOPMENT, V129, P4089; Berlato C, 2009, ENDOCRINOLOGY, V150, P2924, DOI 10.1210/en.2008-0668; Brembeck FH, 2011, GASTROENTEROLOGY, V141, P1359, DOI 10.1053/j.gastro.2011.06.039; Cajanek L, 2010, J CELL BIOCHEM, V111, P1077, DOI 10.1002/jcb.22771; Chan TO, 1999, ANNU REV BIOCHEM, V68, P965, DOI 10.1146/annurev.biochem.68.1.965; Chandrasekaran S, 2011, MOL CELL BIOL, V31, P4405, DOI 10.1128/MCB.06163-11; Chen JK, 2010, MOL CELL BIOL, V30, P5621, DOI 10.1128/MCB.00465-10; Chen YY, 2011, MED ONCOL, V28, P631, DOI 10.1007/s12032-010-9488-1; Choi DW, 2013, MOL CELL, V51, P374, DOI 10.1016/j.molcel.2013.06.010; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Desbois-Mouthon C, 2001, ONCOGENE, V20, P252, DOI 10.1038/sj.onc.1204064; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Ding VW, 2000, J BIOL CHEM, V275, P32475, DOI 10.1074/jbc.M005342200; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Fang DX, 2007, J BIOL CHEM, V282, P11221, DOI 10.1074/jbc.M611871200; Fang L, 2012, MOL CELL PROTEOMICS, V11, P138, DOI 10.1074/mcp.M111.016352; Fiedler M, 2008, MOL CELL, V30, P507, DOI 10.1016/j.molcel.2008.03.011; Fukumoto S, 2001, J BIOL CHEM, V276, P17479, DOI 10.1074/jbc.C000880200; Gu BN, 2013, CELL STEM CELL, V13, P48, DOI 10.1016/j.stem.2013.04.012; Gu BN, 2012, CELL CYCLE, V11, P79, DOI 10.4161/cc.11.1.18402; Gu BN, 2009, J CELL BIOL, V185, P811, DOI 10.1083/jcb.200810133; Guenatri M, 2004, J CELL BIOL, V166, P493, DOI 10.1083/jcb.200403109; He XC, 2007, NAT GENET, V39, P189, DOI 10.1038/ng1928; Hemmings BA, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011189; Hirsch HA, 2009, CANCER RES, V69, P7507, DOI 10.1158/0008-5472.CAN-09-2994; Iliopoulos D, 2010, MOL CELL, V39, P493, DOI 10.1016/j.molcel.2010.07.023; Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014; Imami K, 2008, ANAL SCI, V24, P161, DOI 10.2116/analsci.24.161; JACKSON DA, 1988, J CELL SCI, V90, P365; Jessen S, 2008, BIOESSAYS, V30, P448, DOI 10.1002/bies.20757; Kerzendorfer C, 2010, HUM MOL GENET, V19, P1324, DOI 10.1093/hmg/ddq008; Kessler R, 2009, MECH DEVELOP, V126, P752, DOI 10.1016/j.mod.2009.04.003; KIRSCHNER RH, 1977, J CELL BIOL, V72, P118, DOI 10.1083/jcb.72.1.118; Klebba JE, 2013, CURR BIOL, V23, P2255, DOI 10.1016/j.cub.2013.09.019; Kobielak K, 2007, P NATL ACAD SCI USA, V104, P10063, DOI 10.1073/pnas.0703004104; Korkaya H, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000121; Kramps T, 2002, CELL, V109, P47, DOI 10.1016/S0092-8674(02)00679-7; Lee J, 2007, MOL CELL, V26, P775, DOI 10.1016/j.molcel.2007.06.001; Lee JM, 2012, MOL CELL, V48, P572, DOI 10.1016/j.molcel.2012.09.004; Li B, 2007, GENESIS, V45, P318, DOI 10.1002/dvg.20299; Li T, 2006, CELL, V124, P105, DOI 10.1016/j.cell.2005.10.033; Lin YJ, 2012, MOL CELL, V48, P627, DOI 10.1016/j.molcel.2012.08.030; Liu LR, 2012, CELL RES, V22, P1258, DOI 10.1038/cr.2012.48; Liu LR, 2009, MOL CELL, V34, P451, DOI 10.1016/j.molcel.2009.04.020; Liu PX, 2009, NAT REV DRUG DISCOV, V8, P627, DOI 10.1038/nrd2926; Liu Y, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-346; Lydeard JR, 2013, EMBO REP, V14, P1050, DOI 10.1038/embor.2013.173; MacDonald BT, 2007, CELL, V131, DOI 10.1016/j.cell.2007.11.036; Meijer L, 2003, CHEM BIOL, V10, P1255, DOI 10.1016/j.chembiol.2003.11.010; Mesquita B, 2013, BREAST CANCER RES TR, V138, P37, DOI 10.1007/s10549-013-2408-2; Mosimann C, 2009, NAT REV MOL CELL BIO, V10, P276, DOI 10.1038/nrm2654; Nair M, 2008, DEV BIOL, V320, P446, DOI 10.1016/j.ydbio.2008.05.553; Nakagawa T, 2011, MOL CELL, V43, P381, DOI 10.1016/j.molcel.2011.05.033; Ng SW, 2009, J BIOL CHEM, V284, P24767, DOI 10.1074/jbc.M109.011692; O'Connell BC, 2007, CURR OPIN CELL BIOL, V19, P206, DOI 10.1016/j.ceb.2007.02.014; Parker DS, 2002, DEVELOPMENT, V129, P2565; Popadiuk CM, 2006, CLIN CANCER RES, V12, P2216, DOI 10.1158/1078-0432.CCR-05-2433; POWIS G, 1994, CANCER RES, V54, P2419; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Rochat A, 2004, MOL BIOL CELL, V15, P4544, DOI 10.1091/mbc.E03-11-0816; Ryves WJ, 2001, BIOCHEM BIOPH RES CO, V280, P720, DOI 10.1006/bbrc.2000.4169; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Schrofelbauer B, 2007, P NATL ACAD SCI USA, V104, P4130, DOI 10.1073/pnas.0610167104; Schultze SM, 2012, EXPERT REV MOL MED, V14, DOI 10.1017/S1462399411002109; Schwab KR, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-15; Shadeo A, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1370; Sharma M, 2002, J BIOL CHEM, V277, P30935, DOI 10.1074/jbc.M201919200; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Song MS, 2012, NAT REV MOL CELL BIO, V13, P283, DOI 10.1038/nrm3330; Song N, 2007, DEVELOPMENT, V134, P1873, DOI 10.1242/dev.001495; Stokoe D, 1997, SCIENCE, V277, P567, DOI 10.1126/science.277.5325.567; Sun P, 2014, P NATL ACAD SCI USA, V111, P10215, DOI 10.1073/pnas.1311395111; Thompson B, 2002, NAT CELL BIOL, V4, P367, DOI 10.1038/ncb786; Thorne CA, 2010, NAT CHEM BIOL, V6, P829, DOI 10.1038/NCHEMBIO.453; Tobin AB, 2002, TRENDS PHARMACOL SCI, V23, P337, DOI 10.1016/S0165-6147(02)02043-6; Townsley FM, 2004, J BIOL CHEM, V279, P5177, DOI 10.1074/jbc.M309722200; Tripathi R, 2007, J BIOSCIENCES, V32, P1133, DOI 10.1007/s12038-007-0114-0; Tzenov YR, 2013, MOL CANCER RES, V11, P19, DOI 10.1158/1541-7786.MCR-12-0510; Verma R, 1997, SCIENCE, V278, P455, DOI 10.1126/science.278.5337.455; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wang XN, 2011, CELL, V147, P893, DOI 10.1016/j.cell.2011.10.018; Wang ZX, 2010, J NEURO-ONCOL, V100, P31, DOI 10.1007/s11060-010-0144-6; Watanabe K, 2014, ONCOGENE, V33, P632, DOI 10.1038/onc.2012.620; Watanabe K, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002436; Xu C, 2009, CELL CYCLE, V8, P4032, DOI 10.4161/cc.8.24.10111; Zhang Y, 2003, EMBO J, V22, P6057, DOI 10.1093/emboj/cdg577	97	6	7	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2015	290	35					21553	21567		10.1074/jbc.M115.639419	http://dx.doi.org/10.1074/jbc.M115.639419			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ5IS	26170450	hybrid, Green Published			2022-12-26	WOS:000360637600029
J	Aboalela, N; Lyon, D; Elswick, RK; Kelly, DL; Brumelle, J; Bear, HD; Jackson-Cook, C				Aboalela, Noran; Lyon, Debra; Elswick, R. K., Jr.; Kelly, Debra Lynch; Brumelle, Jenni; Bear, Harry D.; Jackson-Cook, Colleen			Perceived Stress Levels, Chemotherapy, Radiation Treatment and Tumor Characteristics Are Associated with a Persistent Increased Frequency of Somatic Chromosomal Instability in Women Diagnosed with Breast Cancer: A One Year Longitudinal Study	PLOS ONE			English	Article							PERIPHERAL-BLOOD LYMPHOCYTES; DNA-DAMAGE; IN-VIVO; MICRONUCLEUS FREQUENCIES; MOLECULAR PORTRAITS; IONIZING-RADIATION; AFRICAN-AMERICAN; TELOMERE LENGTH; TRISOMY 7; CELLS	While advances in therapeutic approaches have resulted in improved survival rates for women diagnosed with breast cancer, subsets of these survivors develop persistent psychoneurological symptoms (fatigue, depression/anxiety, cognitive dysfunction) that compromise their quality of life. The biological basis for these persistent symptoms is unclear, but could reflect the acquisition of soma-wide chromosomal instability following the multiple biological/psychological exposures associated with the diagnosis/treatment of breast cancer. An essential first step toward testing this hypothesis is to determine if these cancer-related exposures are indeed associated with somatic chromosomal instability frequencies. Towards this end, we longitudinally studied 71 women (ages 23-71) with early-stage breast cancer and quantified their somatic chromosomal instability levels using a cytokinesis-blocked micronuclear/cytome assay at 4 timepoints: before chemotherapy (baseline); four weeks after chemotherapy initiation; six months after chemotherapy (at which time some women received radiotherapy); and one year following chemotherapy initiation. Overall, a significant change in instability frequencies was observed over time, with this change differing based on whether the women received radiotherapy (p=0.0052). Also, significantly higher instability values were observed one year after treatment initiation compared to baseline for the women who received: sequential taxotere/doxorubicin/cyclophosphamide (p<0.001) or taxotere/cyclophosphamide (p=0.014). Significant predictive associations for acquired micronuclear/cytome abnormality frequencies were also observed for race (p=0.0052), tumor type [luminal B tumors] (p=0.0053), and perceived stress levels (p=0.0129). The impact of perceived stress on micronuclear/cytome frequencies was detected across all visits, with the highest levels of stress being reported at baseline (p=0.0024). These findings suggest that the cancer-related exposome has an impact on both healthy somatic cells and tumor cells, and may lead to persistent chromosomal instability. In addition, stress was a significant predictor of chromosomal instability; thus, interventions that aim to reduce stress may reduce acquired soma-wide chromosomal instability for cancer survivors.	[Aboalela, Noran; Jackson-Cook, Colleen] Virginia Commonwealth Univ, Dept Human & Mol Genet, Richmond, VA 23284 USA; [Lyon, Debra; Elswick, R. K., Jr.; Kelly, Debra Lynch] Virginia Commonwealth Univ, Sch Nursing, Family & Community Hlth Nursing, Richmond, VA USA; [Brumelle, Jenni; Jackson-Cook, Colleen] Virginia Commonwealth Univ, Dept Pathol, Richmond, VA USA; [Bear, Harry D.] Virginia Commonwealth Univ, Div Surg Oncol, Richmond, VA USA; [Bear, Harry D.; Jackson-Cook, Colleen] Virginia Commonwealth Univ, Massey Canc Ctr, Richmond, VA USA	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University	Jackson-Cook, C (corresponding author), Virginia Commonwealth Univ, Dept Human & Mol Genet, Richmond, VA 23284 USA.	ccook@mcvh-vcu.edu	Lyon, Deb/ABF-7547-2021		National Institute of Nursing Research, National Institutes of Health (multi-PIs) [R01NR012667]; NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR012667] Funding Source: NIH RePORTER	National Institute of Nursing Research, National Institutes of Health (multi-PIs); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))	This research was supported by Award Number R01NR012667 from the National Institute of Nursing Research, National Institutes of Health (multi-PIs: DL CJC). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Nursing Research or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abut YC, 2012, SAUDI J ANAESTH, V6, P46, DOI 10.4103/1658-354X.93059; Ahire V, 2014, J ENVIRON PATHOL TOX, V33, P69, DOI 10.1615/JEnvironPatholToxicolOncol.2014010743; Andreou E, 2011, INT J ENV RES PUB HE, V8, P3287, DOI 10.3390/ijerph8083287; [Anonymous], 2013, AM CANC SOC BREAST C; Aristei C, 2009, CANCER GENET CYTOGEN, V192, P24, DOI 10.1016/j.cancergencyto.2009.02.019; Badger T, 2007, NURS RES, V56, P44, DOI 10.1097/00006199-200701000-00006; Berger AM, 2010, SUPPORT CARE CANCER, V18, P105, DOI 10.1007/s00520-009-0636-0; Braybrooke JP, 2015, EUR J CANCER CARE, V24, P650, DOI 10.1111/ecc.12222; Broberg K, 1998, CYTOGENET CELL GENET, V83, P30, DOI 10.1159/000015160; Brown, 2006, APPL MIXED MODELS ME; Cardinale F, 2012, BRIT J CANCER, V106, P780, DOI 10.1038/bjc.2011.567; Carey LA, 2013, MOL INTRINSIC SUBTYP; Carey LA, 2006, JAMA-J AM MED ASSOC, V295, P2492, DOI 10.1001/jama.295.21.2492; Castellanos MV, 2004, OSTEOARTHR CARTILAGE, V12, P982, DOI 10.1016/j.joca.2004.08.011; Ceppi M, 2011, MUTAGENESIS, V26, P247, DOI 10.1093/mutage/geq060; Clarke SJ, 1999, CLIN PHARMACOKINET, V36, P99, DOI 10.2165/00003088-199936020-00002; Cleeland CS, 2003, CANCER-AM CANCER SOC, V97, P2919, DOI 10.1002/cncr.11382; Clynes RA, 2000, NAT MED, V6, P443, DOI 10.1038/74704; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; Dahlen A, 2001, CANCER GENET CYTOGEN, V131, P19, DOI 10.1016/S0165-4608(01)00488-5; Dantzer R, 2001, BRAIN BEHAV IMMUN, V15, P7, DOI 10.1006/brbi.2000.0613; Dhillon VS, 2011, MUTAGENESIS, V26, P33, DOI 10.1093/mutage/geq076; EASTMOND DA, 1989, ENVIRON MOL MUTAGEN, V13, P34, DOI 10.1002/em.2850130104; Elmore LW, 2002, J BIOL CHEM, V277, P35509, DOI 10.1074/jbc.M205477200; Elsendoorn TJ, 2001, MUTAT RES-GEN TOX EN, V498, P145, DOI 10.1016/S1383-5718(01)00278-9; Faggioli F, 2011, MECH AGEING DEV, V132, P429, DOI 10.1016/j.mad.2011.04.008; Fan C, 2006, NEW ENGL J MED, V355, P560, DOI 10.1056/NEJMoa052933; Fenech M, 2000, MUTAT RES-FUND MOL M, V455, P81, DOI 10.1016/S0027-5107(00)00065-8; Fenech M, 2003, MUTAT RES-GEN TOX EN, V534, P65, DOI 10.1016/S1383-5718(02)00249-8; Fenech M, 2007, NAT PROTOC, V2, P1084, DOI 10.1038/nprot.2007.77; Fenech M, 2011, MUTAGENESIS, V26, P43, DOI 10.1093/mutage/geq050; Fenech M, 2011, MUTAGENESIS, V26, P239, DOI 10.1093/mutage/geq051; Fumaz CR, 2012, BRAIN BEHAV IMMUN, V26, P568, DOI 10.1016/j.bbi.2012.01.001; Gamulin M, 2010, J ENVIRON SCI HEAL A, V45, P292, DOI 10.1080/10934520903467881; Gewirtz DA, 1999, BIOCHEM PHARMACOL, V57, P727, DOI 10.1016/S0006-2952(98)00307-4; Guerreiro PS, 2013, MUTAT RES-GEN TOX EN, V757, P140, DOI 10.1016/j.mrgentox.2013.08.003; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Hu ZY, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-96; Hudis CA, 2007, NEW ENGL J MED, V357, P39, DOI 10.1056/NEJMra043186; Huen K, 2006, ENVIRON MOL MUTAGEN, V47, P236, DOI 10.1002/em.20193; Ingle JN, 2013, J HUM GENET, V58, P306, DOI 10.1038/jhg.2013.35; Jagetia GC, 2001, MUTAT RES-GEN TOX EN, V491, P9, DOI 10.1016/S1383-5718(00)00132-7; Jones KH, 2011, MUTAGENESIS, V26, P745, DOI 10.1093/mutage/ger042; Khan F, 2009, J ENVIRON BIOL, V30, P409; Kinne RW, 2001, ARTHRITIS RES, V3, P319, DOI 10.1186/ar322; Kirsch-Volders M, 2011, ARCH TOXICOL, V85, P873, DOI 10.1007/s00204-011-0691-4; Knox RJ, 1986, CANC RES 2, V46, P1972; Koppelmans V, 2012, BREAST CANCER RES TR, V132, P1099, DOI 10.1007/s10549-011-1888-1; Leach NT, 2001, MUTAT RES-GEN TOX EN, V495, P11, DOI 10.1016/S1383-5718(01)00194-2; Lee BN, 2004, NEUROIMMUNOMODULAT, V11, P279, DOI 10.1159/000079408; Lee K, 2004, SLEEP MED REV, V8, P199, DOI 10.1016/j.smrv.2003.10.001; Lee SL, 2015, ENVIRON MOL MUTAGEN, V56, P32, DOI 10.1002/em.21890; Li P, 2012, INT J BIOCHEM CELL B, V44, P1531, DOI 10.1016/j.biocel.2012.06.020; Lien EA, 2013, BREAST CANCER RES TR, V141, P243, DOI 10.1007/s10549-013-2677-9; Lyon D, 2014, BIOL RES NURS, V16, P160, DOI 10.1177/1099800413483545; Machiela MJ, 2015, AM J HUM GENET, V96, P487, DOI 10.1016/j.ajhg.2015.01.011; McClelland SE, 2009, CELL CYCLE, V8, P3262, DOI 10.4161/cc.8.20.9690; Menzies V, 2013, NURS RES PRACT, V2013, DOI 10.1155/2013/795784; Mertens F, 1996, HUM GENET, V98, P651, DOI 10.1007/s004390050278; Milosevic-Djordjevic O, 2011, J BUON, V16, P437; Minicucci EM, 2008, CLIN EXP MED, V8, P79, DOI 10.1007/s10238-008-0161-3; Minotti G, 2004, PHARMACOL REV, V56, P185, DOI 10.1124/pr.56.2.6; Morath J, 2014, PSYCHOTHER PSYCHOSOM, V83, P289, DOI 10.1159/000362739; Nagar S, 2010, ADV EXP MED BIOL, V678, P124; Park SB, 2013, CA-CANCER J CLIN, V63, P419, DOI 10.3322/caac.21204; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Phan VH, 2009, EXPERT OPIN DRUG MET, V5, P243, DOI [10.1517/17425250902800153, 10.1517/17425250902800153 ]; POWIS G, 1987, CANCER CHEMOTH PHARM, V20, P219, DOI 10.1007/BF00570489; Province MA, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/djt379; Quinlan J, 2014, SYST REV-LONDON, V3, DOI 10.1186/2046-4053-3-40; Ramos DL, 2011, MUTAT RES-GEN TOX EN, V724, P28, DOI 10.1016/j.mrgentox.2011.04.013; Robinson TJW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078641; Rohena CC, 2014, NAT PROD REP, V31, P335, DOI 10.1039/c3np70092e; Sacharczuk M, 2003, MUTAT RES-GEN TOX EN, V535, P95, DOI 10.1016/S1383-5718(02)00290-5; Sanchenkov A, 2001, JNCI-J NATL CANCER I, V93, P347, DOI 10.1093/jnci/93.5.347; Santos RA, 2010, CLIN EXP MED, V10, P87, DOI 10.1007/s10238-009-0079-4; Selfe TK, 2012, EVID BASED COMPLEMEN; Shalev C, 2013, PSYCHONEUROENDOCRINO, V38, P1835, DOI 10.1016/j.psyneuen.2013.03.010; Starkweather AR, 2014, NURS RES, V63, P36, DOI 10.1097/NNR.0000000000000009; Surtees PG, 2011, J GERONTOL A-BIOL, V66, P1152, DOI 10.1093/gerona/glr112; Swain SM, 2013, J CLIN ONCOL, V31, P3197, DOI 10.1200/JCO.2012.48.1275; Vu T, 2012, FRONT ONCOL, V2, P1, DOI 10.3389/fonc.2012.00062; Troester MA, 2004, CANCER RES, V64, P4218, DOI 10.1158/0008-5472.CAN-04-0107; Utne I, 2010, J PALLIAT MED, V13, P311, DOI 10.1089/jpm.2009.0294; Valeberg BT, 2008, EUR J PAIN, V12, P582, DOI 10.1016/j.ejpain.2007.09.004; Voduc KD, 2010, J CLIN ONCOL, V28, P1684, DOI 10.1200/JCO.2009.24.9284; Vral A, 2011, MUTAGENESIS, V26, P11, DOI 10.1093/mutage/geq078; Watters JL, 2007, CANCER EPIDEM BIOMAR, V16, P1428, DOI 10.1158/1055-9965.EPI-06-1030; Wefel JS, 2011, LANCET ONCOL, V12, P703, DOI 10.1016/S1470-2045(10)70294-1; Westbrook K, 2013, PHARMACOL THERAPEUT, V139, P1, DOI 10.1016/j.pharmthera.2013.03.001; Wu SM, 2014, PSYCHOSOM MED, V76, P252, DOI 10.1097/PSY.0000000000000060; Yang F, 2014, BBA-REV CANCER, V1845, P84, DOI 10.1016/j.bbcan.2013.12.002; York TP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055337	93	14	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0133380	10.1371/journal.pone.0133380	http://dx.doi.org/10.1371/journal.pone.0133380			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177092	Green Published, Green Submitted, gold			2022-12-26	WOS:000358197600253
J	Cordero, OJ; Varela-Calvino, R; Lopez-Gonzalez, T; Calvino-Sampedro, C; Vinuela, JE; Mourino, C; Hernandez-Rodriguez, I; Rodriguez-Lopez, M; de la Iglesia, BA; Pego, JM				Cordero, Oscar J.; Varela-Calvino, Ruben; Lopez-Gonzalez, Tania; Calvino-Sampedro, Cristina; Vinuela, Juan E.; Mourino, Coral; Hernandez-Rodriguez, Inigo; Rodriguez-Lopez, Marina; Aspe de la Iglesia, Bruno; Maria Pego, Jose			CD26 Expression on T Helper Populations and sCD26 Serum Levels in Patients with Rheumatoid Arthritis	PLOS ONE			English	Article							DIPEPTIDYL-PEPTIDASE-IV; SYNOVIAL-FLUID; SOLUBLE CD26; CELLS; INTERLEUKIN-12; TH17; AUTOANTIBODIES; ASSOCIATION; MEMORY	We studied dipeptidyl peptidase IV (DPP-IV, CD26) expression in different T helper cells and serum soluble DPP-IV/sCD26 levels in rheumatoid arthritis (RA) patients, correlated these with disease activity score (DAS), and examined how they were affected by different therapies, conventional or biological (anti-TNF, anti-CD20 and anti-IL6R or Ig-CTLA4). The percentage of CD4(+)CD45R0(+)CD26(-) cells was greatly reduced in patients (up to 50%) when compared with healthy subjects. Three other subsets of CD4 cells, including a CD26high Th1-associated population, changed variably with therapies. Data from these subsets (frequency and staining density) significantly correlated with DAS28 or DAS28 components but different in each group of patients undergoing the different therapies. Th17 and Th22 subsets were implicated in RA as independent CCR4(+) and CCR4(-) populations each, with distinct CD26 expression, and were targeted with varying efficiency by each therapy. Serum DPP-IV activity rather than sCD26 levels was lower in RA patients compared to healthy donors. DPP-IV and sCD26 serum levels were found related to specific T cell subsets but not to disease activity. We conclude that, according to their CD26 expression, different cell subsets could serve to monitor RA course, and an uncharacterized T helper CD26(-) subset, not targeted by therapies, should be monitored for early diagnosis.	[Cordero, Oscar J.; Varela-Calvino, Ruben; Lopez-Gonzalez, Tania; Calvino-Sampedro, Cristina] Univ Santiago de Compostela, Dept Biochem & Mol Biol, Santiago De Compostela, Spain; [Vinuela, Juan E.] Univ Hosp Complex Santiago de Compostela, Serv Immunol, Santiago De Compostela, Spain; [Mourino, Coral; Hernandez-Rodriguez, Inigo; Rodriguez-Lopez, Marina; Aspe de la Iglesia, Bruno; Maria Pego, Jose] Univ Hosp Complex Vigo, Serv Rheumatol, Vigo, Spain; [Mourino, Coral; Rodriguez-Lopez, Marina; Maria Pego, Jose] Xerencia Xest Integrada SERGAS, Inst Invest Biomed, IRIDIS Invest Rheumatol & Immunomediated Dis Grp, Vigo, Spain	Universidade de Santiago de Compostela	Cordero, OJ (corresponding author), Univ Santiago de Compostela, Dept Biochem & Mol Biol, Santiago De Compostela, Spain.	oscarj.cordero@usc.es	RODRIGUEZ, CORAL MOURIÑO/ABG-1819-2020; Varela-Calvino, Ruben/ABF-9910-2020; Sampedro Torres Quevedo, Cristina/GVW-1493-2022; Calviño Sampedro, Cristina/AAC-3301-2021; Cordero, Oscar J/K-5415-2015	Varela-Calvino, Ruben/0000-0002-4978-661X; Calviño Sampedro, Cristina/0000-0002-5121-0265; Cordero, Oscar J/0000-0003-1026-124X; Vinuela, Juan Evaristo/0000-0001-7778-901X	Pfizer Spain; European Union [316265]	Pfizer Spain(Pfizer); European Union(European Commission)	This work was supported by an unrestricted medical grant from Pfizer Spain to OJC and JMP. European Union Seventh Framework Programme [FP7/REGPOT-2012-2013.1] under grant agreement no 316265, BIOCAPS, supports to JMP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aletaha D, 2010, ARTHRITIS RHEUM-US, V62, P2569, DOI 10.1002/art.27584; Annunziato F, 2009, BLOOD, V114, P2213, DOI 10.1182/blood-2009-03-209189; Bayes HK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090263; Bengsch B, 2012, J IMMUNOL, V188, P5438, DOI 10.4049/jimmunol.1103801; Biswas S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056246; Buljevic S, 2013, RHEUMATOL INT, V33, P2867, DOI 10.1007/s00296-013-2823-z; Busso N, 2005, AM J PATHOL, V166, P433, DOI 10.1016/S0002-9440(10)62266-3; Cordero OJ, 1997, IMMUNOBIOLOGY, V197, P522, DOI 10.1016/S0171-2985(97)80084-8; Cordero OJ, 2001, RHEUMATOL INT, V21, P69, DOI 10.1007/s002960100134; Cordero OJ, 2009, CANCER IMMUNOL IMMUN, V58, P1725, DOI 10.1007/s00262-009-0728-1; Cuchacovich M, 2001, CLIN EXP RHEUMATOL, V19, P673; De Chiara L, 2009, DIS MARKERS, V27, P311, DOI [10.3233/DMA-2009-0679, 10.1155/2009/986295]; Ellingsen T, 2007, SCAND J IMMUNOL, V66, P451, DOI 10.1111/j.1365-3083.2007.01966.x; Eyerich S, 2009, J CLIN INVEST, V119, P3573, DOI 10.1172/JCI40202; Gerlag DM, 2012, ANN RHEUM DIS, V71, P638, DOI 10.1136/annrheumdis-2011-200990; GOTOH H, 1989, CLIN CHEM, V35, P1016; HAGIHARA M, 1987, CLIN CHEM, V33, P1463; Hashimoto M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098202; Havre PA, 2009, BRIT J CANCER, V101, P983, DOI 10.1038/sj.bjc.6605236; Havre PA, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-517; Ibegbu CC, 2009, IMMUNOLOGY, V126, P346, DOI 10.1111/j.1365-2567.2008.02899.x; Kobayashi H, 2002, J RHEUMATOL, V29, P1858; Krakauer M, 2006, J NEUROIMMUNOL, V181, P157, DOI 10.1016/j.jneuroim.2006.09.006; Lambeir AM, 2003, CRIT REV CL LAB SCI, V40, P209, DOI 10.1080/713609354; Mavropoulos JC, 2005, J RHEUMATOL, V32, P2116; MUSCAT C, 1994, CLIN EXP IMMUNOL, V98, P252; Narducci MG, 2006, BLOOD, V107, P1108, DOI 10.1182/blood-2005-04-1492; Proost P., 2003, METH MOL B, V239, P27; Salgado FJ, 2003, J BIOL CHEM, V278, P24849, DOI 10.1074/jbc.M212978200; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Sanchez-Otero N, 2014, SCI REP-UK, V4, DOI 10.1038/srep03999; Sromova L, 2010, CLIN CHIM ACTA, V411, P1046, DOI 10.1016/j.cca.2010.03.034; STANCIKOVA M, 1992, CLIN EXP RHEUMATOL, V10, P381; Tejera-Alhambra M, 2014, CLIN IMMUNOL, V150, P170, DOI 10.1016/j.clim.2013.11.011; Truchetet ME, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3486; Uematsu T, 2004, ANTICANCER RES, V24, P619; van Eden W, 2002, ANN RHEUM DIS, V61, P25; Wan Q, 2011, J EXP MED, V208, P1875, DOI 10.1084/jem.20102516; WOLFE F, 1988, J RHEUMATOL, V15, P1480; Zhang L, 2012, J ENG FIBER FABR, V7, P7; Zhao F, 2012, J IMMUNOL, V188, P6055, DOI 10.4049/jimmunol.1102918	41	19	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0131992	10.1371/journal.pone.0131992	http://dx.doi.org/10.1371/journal.pone.0131992			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177310	Green Published, gold, Green Submitted			2022-12-26	WOS:000358197600075
J	Kim, SY; Zhang, QY; Brunmeir, R; Han, WP; Xu, F				Kim, Sun-Yee; Zhang, Qiongyi; Brunmeir, Reinhard; Han, Weiping; Xu, Feng			SIRT1 Interacts with and Deacetylates ATP6V1B2 in Mature Adipocytes	PLOS ONE			English	Article							FATTY-ACID OXIDATION; LYSINE ACETYLATION; 2-DIMENSIONAL ELECTROPHORESIS; CELL-SURVIVAL; PGC-1-ALPHA; METABOLISM; SIRTUINS; ACETYLTRANSFERASE; INFLAMMATION; ACTIVATION	SIRT1 plays a key role in maintaining metabolic homeostasis in mammals by directly modulating the activities of various transcription factors and metabolic enzymes through lysine deacetylation. White adipose tissue plays a key role in lipid storage and metabolism. To identify novel molecular targets of SIRT1 in fat cells, we used a non-biased proteomic approach. We identified a number of proteins whose acetylation status was significantly affected by SIRT1 modulator treatment in 3T3-L1 adipocytes. Among them, ATP6V1B2, a subunit of the vacuolar (H+)-ATPase, was further shown to be associated with SIRT1 by co-immunoprecipitation assay. Moreover, SIRT1 deacetylates ATP6V1B2 in vitro and in vivo. Taken together, our study demonstrates that ATP6V1B2 is a molecular target of SIRT1 in fat cells and the role of SIRT1 and ATP6V1B2 acetylation in the vacuolar (H+)-ATPase function warrants further investigation.	[Kim, Sun-Yee; Zhang, Qiongyi; Brunmeir, Reinhard; Xu, Feng] ASTAR, Singapore Inst Clin Sci, Singapore, Singapore; [Han, Weiping] ASTAR, Singapore Bioimaging Consortium, Lab Metab Med, Singapore, Singapore; [Han, Weiping; Xu, Feng] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117595, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Institute for Clinical Sciences (SICS); Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Bioengineering & Bioimaging (IBB); A*STAR - Singapore Bioimaging Consortium (SBIC); National University of Singapore	Xu, F (corresponding author), ASTAR, Singapore Inst Clin Sci, Singapore, Singapore.	xu_feng@sics.a-star.edu.sg		Xu, Feng/0000-0003-2016-7521; Brunmeir, Reinhard/0000-0001-7545-2819; KIM, Sun-Yee/0000-0002-8061-2271	Academic Center of Excellence Research Grant from GSK [100019545]; Industry Alignment Fund from the Agency for Science, Technology and Research (A*STAR) of Singapore [IAF111002]; A*STAR of Singapore	Academic Center of Excellence Research Grant from GSK; Industry Alignment Fund from the Agency for Science, Technology and Research (A*STAR) of Singapore(Agency for Science Technology & Research (A*STAR)); A*STAR of Singapore(Agency for Science Technology & Research (A*STAR))	This work was supported by the Academic Center of Excellence Research Grant (No. 100019545) from GSK and the Industry Alignment Fund (IAF111002) from the Agency for Science, Technology and Research (A*STAR) of Singapore to F.X. Funding for the open-access charge was provided by A*STAR of Singapore. GSK provided the SIRT1 modulators for this study and performed the non-biased proteomic analysis to identify novel SIRT1 targets. Other than that, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLFREY VG, 1964, P NATL ACAD SCI USA, V51, P786, DOI 10.1073/pnas.51.5.786; Aquilano K, 2010, J BIOL CHEM, V285, P21590, DOI 10.1074/jbc.M109.070169; Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; Brownell JE, 1996, CELL, V84, P843, DOI 10.1016/S0092-8674(00)81063-6; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; BURGESSCASSLER A, 1989, CLIN CHEM, V35, P2297; Canto C, 2009, TRENDS ENDOCRIN MET, V20, P325, DOI 10.1016/j.tem.2009.03.008; Chalkiadaki A, 2012, CELL METAB, V16, P180, DOI 10.1016/j.cmet.2012.07.003; Chen Y, 2012, MOL CELL PROTEOMICS, V11, P1048, DOI 10.1074/mcp.M112.019547; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Dai H, 2010, J BIOL CHEM, V285, P32695, DOI 10.1074/jbc.M110.133892; Dobbin MM, 2013, NAT NEUROSCI, V16, P1008, DOI 10.1038/nn.3460; Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633; Gerhart-Hines Z, 2011, MOL CELL, V44, P851, DOI 10.1016/j.molcel.2011.12.005; Gertz M, 2013, P NATL ACAD SCI USA, V110, pE2772, DOI 10.1073/pnas.1303628110; Guarente L, 2005, CELL, V120, P473, DOI 10.1016/j.cell.2005.01.029; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; Hallows WC, 2006, P NATL ACAD SCI USA, V103, P10230, DOI 10.1073/pnas.0604392103; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Lerin C, 2006, CELL METAB, V3, P429, DOI 10.1016/j.cmet.2006.04.013; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Moynihan KA, 2005, CELL METAB, V2, P105, DOI 10.1016/j.cmet.2005.07.001; Nishi T, 2002, NAT REV MOL CELL BIO, V3, P94, DOI 10.1038/nrm729; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Purushotham A, 2009, CELL METAB, V9, P327, DOI 10.1016/j.cmet.2009.02.006; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Solomon JM, 2006, MOL CELL BIOL, V26, P28, DOI 10.1128/MCB.26.1.28-38.2006; Stevens TH, 1997, ANNU REV CELL DEV BI, V13, P779, DOI 10.1146/annurev.cellbio.13.1.779; Sun C, 2007, CELL METAB, V6, P307, DOI 10.1016/j.cmet.2007.08.014; Tanno M, 2007, J BIOL CHEM, V282, P6823, DOI 10.1074/jbc.M609554200; Vaquero A, 2004, MOL CELL, V16, P93, DOI 10.1016/j.molcel.2004.08.031; Yang HH, 2012, SCI WORLD J, P1, DOI 10.1100/2012/149132; Zhang QY, 2012, CELL CYCLE, V11, P4310, DOI 10.4161/cc.22224; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689	36	8	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0133448	10.1371/journal.pone.0133448	http://dx.doi.org/10.1371/journal.pone.0133448			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177453	gold, Green Published, Green Submitted			2022-12-26	WOS:000358197600257
J	Madera, L; Greenshields, A; Coombs, MRP; Hoskin, DW				Madera, Laurence; Greenshields, Anna; Coombs, Melanie R. Power; Hoskin, David W.			4T1 Murine Mammary Carcinoma Cells Enhance Macrophage-Mediated Innate Inflammatory Responses	PLOS ONE			English	Article							TUMOR-ASSOCIATED MACROPHAGES; BREAST-CANCER; TNF-ALPHA; IMMUNE SUPPRESSION; METASTASIS; MICROENVIRONMENT; RECEPTOR; DISTINCT; MODEL; OLIGODEOXYNUCLEOTIDES	Tumor progression and the immune response are intricately linked. While it is known that cancers alter macrophage inflammatory responses to promote tumor progression, little is known regarding how cancers affect macrophage-dependent innate host defense. In this study, murine bone-marrow-derived macrophages (BMDM) were exposed to murine carcinoma-conditioned media prior to assessment of the macrophage inflammatory response. BMDMs exposed to 4T1 mammary carcinoma-conditioned medium demonstrated enhanced production of pro-inflammatory cytokines tumor necrosis factor alpha, interleukin-6, and CCL2 in response to lipopolysaccharide (LPS) while production of interleukin-10 remained unchanged. The increased LPS-induced production of pro-inflammatory cytokines was transient and correlated with enhanced cytokine production in response to other Toll-like receptor agonists, including peptidoglycan and flagellin. In addition, 4T1-conditioned BMDMs exhibited strengthened LPS-induced nitric oxide production and enhanced phagocytosis of Escherichia coli. 4T1-mediated augmentation of macrophage responses to LPS was partially dependent on the NF kappa B pathway, macrophage-colony stimulating factor, and actin polymerization, as well as the presence of 4T1-secreted extracellular vesicles. Furthermore, peritoneal macrophages obtained from 4T1 tumor-bearing mice displayed enhanced pro-inflammatory cytokine production in response to LPS. These results suggest that uptake of 4T1-secreted factors and actin-mediated ingestion of 4T1-secreted exosomes by macrophages cause a transient enhancement of innate inflammatory responses. Mammary carcinoma-mediated regulation of innate immunity may have significant implications for our understanding of host defense and cancer progression.	[Madera, Laurence; Hoskin, David W.] Dalhousie Univ, Dept Microbiol & Immunol, Halifax, NS, Canada; [Greenshields, Anna; Coombs, Melanie R. Power; Hoskin, David W.] Dalhousie Univ, Dept Pathol, Halifax, NS, Canada; [Hoskin, David W.] Dalhousie Univ, Dept Surg, Halifax, NS B3H 4H2, Canada	Dalhousie University; Dalhousie University; Dalhousie University	Madera, L (corresponding author), Dalhousie Univ, Dept Microbiol & Immunol, Halifax, NS, Canada.	Laurence.madera@dal.ca	Coombs, Melanie/GQH-9000-2022		Canadian Breast Cancer Foundation-Atlantic Region; Cancer Research Training Program as part of The Terry Fox Foundation Strategic Health Research Training Program in Cancer Research at CIHR	Canadian Breast Cancer Foundation-Atlantic Region; Cancer Research Training Program as part of The Terry Fox Foundation Strategic Health Research Training Program in Cancer Research at CIHR	This work was supported by funding from the Canadian Breast Cancer Foundation-Atlantic Region. D. Hoskin holds the Canadian Breast Cancer Foundation-Atlantic Region Endowed Chair in Breast Cancer Research. L. Madera is supported by a fellowship from the Canadian Breast Cancer Foundation-Atlantic Region, as well as a trainee award from the Cancer Research Training Program as part of The Terry Fox Foundation Strategic Health Research Training Program in Cancer Research at CIHR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizadeh D, 2010, CLIN CANCER RES, V16, P3399, DOI 10.1158/1078-0432.CCR-09-3087; Alokail MS, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0038-0; Azmi AS, 2013, CANCER METAST REV, V32, P623, DOI 10.1007/s10555-013-9441-9; Balkwill FR, 2012, J CELL SCI, V125, P5591, DOI 10.1242/jcs.116392; Ben-Baruch A, 2003, BREAST CANCER RES, V5, P31, DOI 10.1186/bcr554; Bhatelia K, 2014, CELL SIGNAL, V26, P2350, DOI 10.1016/j.cellsig.2014.07.035; Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164; Biswas SK, 2006, BLOOD, V107, P2112, DOI 10.1182/blood-2005-01-0428; Biswas SK, 2008, J IMMUNOL, V180, P2011, DOI 10.4049/jimmunol.180.4.2011; Bonapace L, 2014, NATURE, V515, DOI 10.1038/nature13862; Broomfield SA, 2009, J IMMUNOL, V182, P5217, DOI 10.4049/jimmunol.0803826; Brown KL, 2011, J IMMUNOL, V186, P5497, DOI 10.4049/jimmunol.1002508; Cho HJ, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3195; Chow A, 2014, SCI REP-UK, V4, DOI 10.1038/srep05750; Davis MJ, 2013, MBIO, V4, DOI 10.1128/mBio.00264-13; Ewens A, 2005, ANTICANCER RES, V25, P3905; Gajewski TF, 2006, J IMMUNOTHER, V29, P233, DOI 10.1097/01.cji.0000199193.29048.56; Holloway RW, 2012, J BIOL CHEM, V287, P39171, DOI 10.1074/jbc.M112.404293; Imtiyaz HZ, 2010, J CLIN INVEST, V120, P2699, DOI 10.1172/JCI39506; Kawarada Y, 2001, J IMMUNOL, V167, P5247, DOI 10.4049/jimmunol.167.9.5247; Kim S, 2009, NATURE, V457, P102, DOI 10.1038/nature07623; Laoui D, 2011, INT J DEV BIOL, V55, P861, DOI 10.1387/ijdb.113371dl; Lin HH, 2005, J EXP MED, V201, P1615, DOI 10.1084/jem.20042307; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Mantovani A, 2013, J PATHOL, V229, P176, DOI 10.1002/path.4133; Pena OM, 2013, PLOS ONE, P8; Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138; REGO SL, 2014, BREAST TUMOR CELL TA, V17, P573, DOI DOI 10.1007/S10456-013-9405-2; Roby KF, 2000, CARCINOGENESIS, V21, P585, DOI 10.1093/carcin/21.4.585; Sinha P, 2005, CANCER IMMUNOL IMMUN, V54, P1137, DOI 10.1007/s00262-005-0703-4; Solinas G, 2009, J LEUKOCYTE BIOL, V86, P1065, DOI 10.1189/jlb.0609385; Tang XQ, 2013, CANCER LETT, V332, P3, DOI 10.1016/j.canlet.2013.01.024; Tripsianis G, 2014, NEOPLASMA, V61, P205, DOI 10.4149/neo_2014_026; Vacchelli E, 2012, ONCOIMMUNOLOGY, V1, P894, DOI 10.4161/onci.20931; Weigel BJ, 2003, CLIN CANCER RES, V9, P3105; Yu L, 2013, BBA-REV CANCER, V1835, P144, DOI 10.1016/j.bbcan.2012.10.006; Yu MX, 2013, CANCER RES, V73, P4061, DOI 10.1158/0008-5472.CAN-12-3946; Zhang Xia, 2008, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1401s83	38	12	12	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0133385	10.1371/journal.pone.0133385	http://dx.doi.org/10.1371/journal.pone.0133385			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177198	Green Published, gold, Green Submitted			2022-12-26	WOS:000358197600254
J	Tian, HQ; Chen, XY; Lu, Y; Lu, WM; Wang, ML; Zhao, HL; Lu, MP; Zhou, H; Chen, RX; Zhang, ZD; Shen, C; Cheng, L				Tian, Hui-Qin; Chen, Xin-Yuan; Lu, Ying; Lu, Wen-Min; Wang, Mei-Lin; Zhao, Hai-Long; Lu, Mei-Ping; Zhou, Han; Chen, Ruo-Xi; Zhang, Zheng-Dong; Shen, Chong; Cheng, Lei			Association of VDR and CYP2R1 Polymorphisms with Mite-Sensitized Persistent Allergic Rhinitis in a Chinese Population	PLOS ONE			English	Article							VITAMIN-D-RECEPTOR; GENE POLYMORPHISMS; IMMUNE-SYSTEM; D PATHWAY; ASTHMA; IMPACT; SUSCEPTIBILITY; ORGANIZATION; CHILDREN; DISEASE	As recent studies have described an association between vitamin D and allergic rhinitis, we hypothesized that vitamin D pathway-related genes may be candidate genes for susceptibility to allergic rhinitis. Thus, we sought to evaluate whether polymorphisms in the vitamin D receptor (VDR) and CYP2R1 genes are associated with mite-sensitized persistent allergic rhinitis (PER) in a Han Chinese population. A hospital-based case-control study consisting of 519 patients with mite-sensitized PER and 447 healthy controls was conducted. Five single nucleotide polymorphisms (SNPs) in VDR and CYP2R1 were selected for genotyping. The genotype and allele frequencies of rs9729, rs2228570, rs1544410, and rs731236 in VDR as well as rs2060793 in CYP2R1 were not significantly associated with susceptibility to mite-sensitized PER. After stratification analyses, however, both the CT and CT/TT genotypes of rs2228570 in VDR exhibited a significantly decreased risk (CT: adjusted odds ratio (OR)=0.58, 95% confidence intervals (CI)=0.37-0.91; CT/TT: adjusted OR=0.61, 95% CI=0.40-0.93) of mite-sensitized PER, while the AA genotype of rs2060793 in CYP2R1 exhibited a significantly increased risk (adjusted OR=1.85, 95% CI=1.03-3.34) of PER in the age subgroup of <16 years old. Both the AG and AG/GG genotypes of rs731236 in VDR exhibited a significantly decreased risk (AG: adjusted OR=0.43, 95% CI=0.21-0.89; AG/GG: adjusted OR=0.46, 95% CI=0.23-0.94) of PER in the female subgroup. Analysis of the locus-locus interactions of VDR and CYP2R1 revealed two models that involved combined SNPs of VDR and CYP2R1 were statistically significant (P<0.05). Our data suggest that age and gender may have an impact on the association of three SNPs (rs2228570, rs731236, and rs2060793) in genes of the vitamin D pathway with the risk of mite-sensitized PER in this Chinese population. The VDR and CYP2R1 variants may be involved in genetic interactions in the pathogenesis of PER.	[Tian, Hui-Qin; Chen, Xin-Yuan; Lu, Wen-Min; Lu, Mei-Ping; Zhou, Han; Chen, Ruo-Xi; Cheng, Lei] Nanjing Med Univ, Affiliated Hosp 1, Dept Otorhinolaryngol, Nanjing, Jiangsu, Peoples R China; [Lu, Ying] Nanjing Med Univ, Affiliated Hosp 1, Dept Grp Healthcare, Nanjing, Jiangsu, Peoples R China; [Wang, Mei-Lin; Zhang, Zheng-Dong] Nanjing Med Univ, Sch Publ Hlth, Dept Mol & Genet Toxicol, Nanjing, Jiangsu, Peoples R China; [Zhao, Hai-Long; Shen, Chong] Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Nanjing, Jiangsu, Peoples R China; [Cheng, Lei] Nanjing Med Univ, Int Ctr Allergy Res, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Cheng, L (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Otorhinolaryngol, Nanjing, Jiangsu, Peoples R China.	jspent@126.com	Lu, Wen-Min/K-9831-2019; zhang, zheng/HCH-9684-2022; Lu, Wen-Min/A-2837-2012; Cheng, Lei/AAT-2690-2021; LU, WEN-MIN/GRR-5111-2022	Lu, Wen-Min/0000-0003-2410-8502; Lu, Wen-Min/0000-0003-2410-8502; Cheng, Lei/0000-0001-6541-7702; 	National Natural Science Foundation of China [81300834, 81200747]; Health Promotion Project of Jiangsu Province, China [XK200719, RC2007065, RC2011071]; Priority Academic Program Development of Jiangsu Higher Education Institutions, China [JX10231801]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Health Promotion Project of Jiangsu Province, China; Priority Academic Program Development of Jiangsu Higher Education Institutions, China	This work was supported by the National Natural Science Foundation of China (No. 81300834 to HQT and No. 81200747 to MPL). LC was supported by grants Nos. XK200719, RC2007065 and RC2011071 from the Health Promotion Project of Jiangsu Province, China, and grant No. JX10231801 from the Priority Academic Program Development of Jiangsu Higher Education Institutions, China, for Nanjing Medical University.	Bener A, 2014, J FAM COMMUNITY MED, V21, P154, DOI 10.4103/2230-8229.142967; Boonstra A, 2001, J IMMUNOL, V167, P4974, DOI 10.4049/jimmunol.167.9.4974; Bosse Y, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-98; Bousquet J, 2008, ALLERGY, V63, P8, DOI 10.1111/j.1398-9995.2007.01620.x; Bousquet J, 2012, J ALLERGY CLIN IMMUN, V130, P1049, DOI 10.1016/j.jaci.2012.07.053; Bousquet J, 2001, J ALLERGY CLIN IMMUN, V108, pS147, DOI 10.1067/mai.2001.118891; Chanock S, 2001, DIS MARKERS, V17, P89, DOI 10.1155/2001/858760; Chen RX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095033; Cheng JB, 2003, J BIOL CHEM, V278, P38084, DOI 10.1074/jbc.M307028200; Cheng L, 2004, CLIN EXP ALLERGY, V34, P1192, DOI 10.1111/j.1365-2222.2004.02008.x; Gross C, 1996, J BONE MINER RES, V11, P1850; Hitchon CA, 2012, J RHEUMATOL, V39, P1792, DOI 10.3899/jrheum.120387; Kamen DL, 2010, J MOL MED, V88, P441, DOI 10.1007/s00109-010-0590-9; Li F, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-103; Lu MP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027363; Maalmi H, 2013, HUM IMMUNOL, V74, P234, DOI 10.1016/j.humimm.2012.11.005; Mai XM, 2014, ALLERGY, V69, P488, DOI 10.1111/all.12365; Miyake Y, 2012, HUM IMMUNOL, V73, P1046, DOI 10.1016/j.humimm.2012.07.339; Miyamoto K, 1997, MOL ENDOCRINOL, V11, P1165, DOI 10.1210/me.11.8.1165; Moran-Auth Y, 2013, J STEROID BIOCHEM, V136, P83, DOI 10.1016/j.jsbmb.2013.02.005; Mostowska A, 2013, MOL BIOL REP, V40, P803, DOI 10.1007/s11033-012-2118-6; Norman AW, 2008, AM J CLIN NUTR, V88, p491S, DOI 10.1093/ajcn/88.2.491S; Ramos-Lopez E, 2006, ANN NY ACAD SCI, V1079, P327, DOI 10.1196/annals.1375.050; Tizaoui K, 2014, LUNG, V192, P955, DOI 10.1007/s00408-014-9648-8; Toda M, 2002, IMMUNOLOGY, V106, P1, DOI 10.1046/j.1365-2567.2002.01407.x; van Etten E, 2007, EUR J IMMUNOL, V37, P395, DOI 10.1002/eji.200636043; Wang SS, 2014, ALLERGY, V69, P118, DOI 10.1111/all.12337; Wang YJ, 2012, ARCH BIOCHEM BIOPHYS, V523, P123, DOI 10.1016/j.abb.2012.04.001; Wei X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057981; Wjst M, 2007, ALLERGY, V62, P1085, DOI 10.1111/j.1398-9995.2007.01437.x	30	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0133162	10.1371/journal.pone.0133162	http://dx.doi.org/10.1371/journal.pone.0133162			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177022	gold, Green Published, Green Submitted			2022-12-26	WOS:000358197600222
J	Wu, AP; Li, ZL; He, FF; Wang, YH; Dong, M				Wu, Ai-Ping; Li, Zi-Li; He, Fei-Fei; Wang, Yan-Hong; Dong, Ming			Screening Allelochemical-Resistant Species of the Alien Invasive Mikania micrantha for Restoration in South China	PLOS ONE			English	Article							MUSTARD BRASSICA-NIGRA; SEED-GERMINATION; BIOLOGICAL INVASIONS; LONICERA-MAACKII; ROOT EXTRACTS; GROWTH; PLANTS; RICE; LEAF; ESTABLISHMENT	To screen allelochemical-resistant species of the alien invasive weed Mikania micrantha, we studied the allelopathic inhibition effects of the leaf aqueous extract (LAE) of Mikania on seed germination and seedling growth of the 26 species native or naturalized in the invaded region in South China. Seed germination was more strongly negatively affected by LAE than seedling growth. Responses of seed germination and seed growth to LAE differed differently among the target species. LAE more strongly negatively affected seed germination, but less strongly negatively affected seedling growth, in non-legume species than in legume species. LAE more strongly negatively affected seed germination and seedling growth in native species than naturalized exotic species. Therefore, naturalized exotic non-legume seedlings are more suitable than seeds of native legume species for restoration of Mikania-invaded habitats.	[Wu, Ai-Ping; Li, Zi-Li] Hunan Agr Univ, Inst Ecol, Dept Ecol, Coll Biosci & Biotechnol, Changsha 410128, Hunan, Peoples R China; [He, Fei-Fei] Yunnan Univ, Sch Agr, Kunming 650091, Peoples R China; [Wang, Yan-Hong] Zhejiang Agr & Forestry Univ, Sch Forestry & Biotechnol, Hangzhou 311300, Zhejiang, Peoples R China; [Dong, Ming] Hangzhou Normal Univ, Coll Life & Environm Sci, Hangzhou 310036, Zhejiang, Peoples R China	Hunan Agricultural University; Yunnan University; Zhejiang A&F University; Hangzhou Normal University	Wu, AP (corresponding author), Hunan Agr Univ, Inst Ecol, Dept Ecol, Coll Biosci & Biotechnol, Changsha 410128, Hunan, Peoples R China.	wuaip8101@126.com; dongming@hznu.edu.cn	wang, yan/GSE-6489-2022; wang, yi/GVT-8516-2022; Wang, Yanbo/HFZ-8018-2022; Wu, Aiping/AAU-8710-2020		National Natural Science Foundation of China [31301725]; Zhejiang Provincial Natural Science Foundation of China [LQ12C03002]; State Key Laboratory of Vegetation and Environmental Change [LVEC-2012kf05]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); State Key Laboratory of Vegetation and Environmental Change	This research was financially supported by the National Natural Science Foundation of China (No. 31301725), Zhejiang Provincial Natural Science Foundation of China (No. LQ12C03002) and State Key Laboratory of Vegetation and Environmental Change (No. LVEC-2012kf05).	Ahn JK, 2000, AGRON J, V92, P1162, DOI 10.2134/agronj2000.9261162x; Alford ER, 2009, RESTOR ECOL, V17, P506, DOI 10.1111/j.1526-100X.2008.00405.x; Allaie RR, 2006, J AGRON CROP SCI, V192, P186, DOI 10.1111/j.1439-037X.2006.00205.x; Barnum Kimberly, 2013, International Journal of Plant Biology, V4, P8, DOI 10.4081/pb.2013.e2; Bauer JT, 2012, PLANT ECOL, V213, P1907, DOI 10.1007/s11258-012-0036-2; Bousquet-Melou A, 2005, CHEMOECOLOGY, V15, P193, DOI 10.1007/s00049-005-0311-y; Callaway RM, 2006, TRENDS ECOL EVOL, V21, P369, DOI 10.1016/j.tree.2006.04.008; Callaway RM, 2000, SCIENCE, V290, P521, DOI 10.1126/science.290.5491.521; Catford JA, 2012, GLOBAL CHANGE BIOL, V18, P44, DOI 10.1111/j.1365-2486.2011.02549.x; DemmigAdams B, 1996, PHYSIOL PLANTARUM, V98, P253, DOI 10.1034/j.1399-3054.1996.980206.x; Djurdjevic L, 2004, BIOCHEM SYST ECOL, V32, P533, DOI 10.1016/j.bse.2003.10.001; Dorning M, 2006, PLANT ECOL, V184, P287, DOI 10.1007/s11258-005-9073-4; Ebana K, 2001, AGRON J, V93, P12, DOI 10.2134/agronj2001.93112x; El-Darier SM, 2000, ANN APPL BIOL, V136, P273, DOI 10.1111/j.1744-7348.2000.tb00035.x; Emeterio LS, 2004, GRASS FORAGE SCI, V59, P107; Escudero A, 1999, J ECOL, V87, P290, DOI 10.1046/j.1365-2745.1999.00356.x; Fitter A, 2003, SCIENCE, V301, P1337, DOI 10.1126/science.1089291; FOWLER N, 1986, ANNU REV ECOL SYST, V17, P89, DOI 10.1146/annurev.es.17.110186.000513; Harrod RJ, 2001, NORTHWEST SCI, V75, P85; Hickman JE, 2010, P NATL ACAD SCI USA, V107, P10115, DOI 10.1073/pnas.0912279107; Hulme PE, 2009, SCIENCE, V324, P40, DOI 10.1126/science.1171111; Hunter ME, 2002, AM J BOT, V89, P1113, DOI 10.3732/ajb.89.7.1113; Inderjit, 2003, PLANTA, V217, P529, DOI 10.1007/s00425-003-1054-z; Inderjit, 2001, AGRON J, V93, P79; Ismail B. S., 2002, Weed Biology and Management, V2, P31, DOI 10.1046/j.1445-6664.2002.00045.x; Jefferson LV, 2003, J ARID ENVIRON, V55, P275, DOI 10.1016/S0140-1963(03)00028-4; Kaur R, 2012, BIOL FERT SOILS, V48, P481, DOI 10.1007/s00374-011-0645-2; Li JM, 2009, BIOL INVASIONS, V11, P687, DOI 10.1007/s10530-008-9283-5; Li WH, 2006, PLANT SOIL, V281, P309, DOI 10.1007/s11104-005-9641-3; Limpens E, 2003, CURR OPIN PLANT BIOL, V6, P343, DOI 10.1016/S1369-5266(03)00068-2; Lind EM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010429; Lorenzo P, 2013, SOIL BIOL BIOCHEM, V57, P156, DOI 10.1016/j.soilbio.2012.08.018; Mack MC, 1998, TRENDS ECOL EVOL, V13, P195, DOI 10.1016/S0169-5347(97)01286-X; Mao JA, 2006, SOIL BIOL BIOCHEM, V38, P201, DOI 10.1016/j.soilbio.2005.04.030; Myers JH, 2000, TRENDS ECOL EVOL, V15, P316, DOI 10.1016/S0169-5347(00)01914-5; Ni GY, 2007, ALLELOPATHY J, V19, P287; Ni GY, 2006, ALLELOPATHY J, V17, P247; Orr SP, 2005, PLANT ECOL, V181, P153, DOI 10.1007/s11258-005-5698-6; Parvez SS, 2004, PLANT GROWTH REGUL, V42, P245, DOI 10.1023/B:GROW.0000026493.95805.a5; Perry LG, 2005, RESTOR ECOL, V13, P725, DOI 10.1111/j.1526-100X.2005.00092.x; Saxena A, 1996, J ARID ENVIRON, V33, P255, DOI 10.1006/jare.1996.0061; Shao H, 2005, J CHEM ECOL, V31, P1657, DOI 10.1007/s10886-005-5805-0; Simons SB, 1999, SOUTHWEST NAT, V44, P256; Spehn EM, 2002, OIKOS, V98, P205, DOI 10.1034/j.1600-0706.2002.980203.x; Tawaha AM, 2003, J AGRON CROP SCI, V189, P298, DOI 10.1046/j.1439-037X.2003.00047.x; Turk M. A., 2003, Weed Biology and Management, V3, P37, DOI 10.1046/j.1445-6664.2003.00079.x; Turk MA, 2003, CROP PROT, V22, P673, DOI 10.1016/S0261-2194(02)00241-7; Tyrer SJ, 2007, RANGELAND ECOL MANAG, V60, P604, DOI 10.2111/06-147R2.1; Uddin MN, 2014, AM J BOT, V101, P479, DOI 10.3732/ajb.1400021; Vidotto F, 2013, CROP PROT, V54, P161, DOI 10.1016/j.cropro.2013.08.009; Vila M, 2011, ECOL LETT, V14, P702, DOI 10.1111/j.1461-0248.2011.01628.x; Vila M, 2010, FRONT ECOL ENVIRON, V8, P135, DOI 10.1890/080083; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Vivanco JM, 2004, ECOL LETT, V7, P285, DOI 10.1111/j.1461-0248.2004.00576.x; Wang BS, 2004, INVASION ECOLOGY MAN, P80; Wardle DA, 1998, BIOL REV, V73, P305, DOI 10.1017/S0006323198005192; Weiner J, 1997, OIKOS, V79, P85, DOI 10.2307/3546093; Wetzel RG, 1999, AQUAT BOT, V64, P111, DOI 10.1016/S0304-3770(99)00013-3; Wilcove DS, 1998, BIOSCIENCE, V48, P607, DOI 10.2307/1313420; Wu AP, 2009, TREES-STRUCT FUNCT, V23, P11, DOI 10.1007/s00468-008-0249-0; Wu AP, 2010, ALLELOPATHY J, V25, P503; Wu Z, 2013, BIOL INVASIONS, V15, P2755, DOI 10.1007/s10530-013-0490-3; Yu H, 2011, BIOL INVASIONS, V13, P747, DOI 10.1007/s10530-010-9865-x; Zalba SM, 2000, BIOL CONSERV, V93, P203, DOI 10.1016/S0006-3207(99)00146-9	64	8	9	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132967	10.1371/journal.pone.0132967	http://dx.doi.org/10.1371/journal.pone.0132967			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177031	gold, Green Published, Green Submitted			2022-12-26	WOS:000358197600192
J	Patyka, M; Malamud, D; Weissman, D; Abrams, WR; Kurago, Z				Patyka, Mariia; Malamud, Daniel; Weissman, Drew; Abrams, William R.; Kurago, Zoya			Periluminal Distribution of HIV-Binding Target Cells and Gp340 in the Oral, Cervical and Sigmoid/Rectal Mucosae: A Mapping Study	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; DENDRITIC CELLS; GENITAL-TRACT; DC-SIGN; INFECTION; TRANSMISSION; RECEPTOR; EPITHELIUM; PROTEIN; TYPE-1	Studies have shown that the transmission of HIV is most likely to occur via rectal or vaginal routes, and rarely through oral exposure. However, the mechanisms of virus entry at mucosal surfaces remain incompletely understood. Prophylactic strategies against HIV infection may be attainable once gaps in current knowledge are filled. To address these gaps, we evaluated essentially normal epithelial surfaces and mapped the periluminal distribution of CD4(+) HIV target cells, including T cells and antigen-presenting cells, and an HIV-binding molecule gp340 that can be expressed by epithelial cells in secreted and cell-associated forms. Immunohistochemistry for CD4, CD16, CD3, CD1a and gp340 in human oral, rectal/sigmoid and cervical mucosal samples from HIV-negative subjects demonstrated that periluminal HIV target cells were more prevalent at rectal/sigmoid and endocervical surfaces lined by simple columnar epithelium, than at oral and ectocervical surfaces covered by multilayered stratified squamous epithelium (p<0.001). gp340 expression patterns at these sites were also distinct and strong in oral minor salivary gland acini and ducts, including ductal saliva, in individual rectum/sigmoid and endocervix periluminar columnar cells, and in ectocervix squamous cells. Only weak expression was noted in the oral non-ductal squamous epithelium. We conclude that periluminal HIV target cells, together with periluminal epithelial cell-associated gp340 appear to be most accessible for HIV transmission at rectal/sigmoid and endocervical surfaces. Our data help define vulnerable structural features of mucosal sites exposed to HIV.	[Patyka, Mariia] McGill Univ, Fac Med, Div Expt Med, Montreal, PQ, Canada; [Malamud, Daniel; Abrams, William R.] NYU, Coll Dent, Dept Basic Sci, HIV AIDS Res Program, New York, NY USA; [Malamud, Daniel] NYU, Sch Med, Infect Dis, New York, NY USA; [Weissman, Drew] Univ Penn, Med Infect Dis, Perelman Sch Med, Philadelphia, PA 19104 USA; [Kurago, Zoya] Georgia Regents Univ, Coll Dent Med, Oral Hlth & Diagnost Sci, Augusta, GA 30912 USA	McGill University; New York University; New York University; University of Pennsylvania; Pennsylvania Medicine; University System of Georgia; Augusta University	Kurago, Z (corresponding author), Georgia Regents Univ, Coll Dent Med, Oral Hlth & Diagnost Sci, Augusta, GA 30912 USA.	zkurago@gru.edu	Abrams, William R/A-5782-2008	Malamud, Daniel/0000-0002-9094-4122	National Center for Research Resources, National Institutes of Health [UL1RR029893]; National Cancer Institute [5P30CA016087-32]; NYU Master's Program in Biology; Fulbright Graduate Student Program grant - United States Department of State, Bureau of Educational and Cultural Affairs; Department of Oral and Maxillofacial Pathology, Radiology and Medicine (NYUCD);  [U19DE018385];  [AI094599];  [AI082701]; NATIONAL CANCER INSTITUTE [P30CA016087] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001445] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029893] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI094599, R21AI082701, R33AI082701, P30AI045008] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [U19DE018385] Funding Source: NIH RePORTER	National Center for Research Resources, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NYU Master's Program in Biology; Fulbright Graduate Student Program grant - United States Department of State, Bureau of Educational and Cultural Affairs; Department of Oral and Maxillofacial Pathology, Radiology and Medicine (NYUCD); ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	The NYU BRC is supported in part by grant UL1RR029893 from the National Center for Research Resources, National Institutes of Health and grant 5P30CA016087-32 from the National Cancer Institute. The study was supported by U19DE018385, AI094599 and AI082701, as well as the NYU Master's Program in Biology, by the Fulbright Graduate Student Program grant, Sponsored by the United States Department of State, Bureau of Educational and Cultural Affairs (Mariia Patyka, Sep. 2010 - May 2012), and the Department of Oral and Maxillofacial Pathology, Radiology and Medicine (NYUCD).	Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Bergamaschi A, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-31; Cannon G, 2008, J IMMUNOL, V181, P2065, DOI 10.4049/jimmunol.181.3.2065; Cavarelli M, 2013, EMBO MOL MED, V5, P776, DOI 10.1002/emmm.201202232; Collin M, 2013, IMMUNOLOGY, V140, P22, DOI 10.1111/imm.12117; Cummins JE, 2006, AIDS RES HUM RETROV, V22, P788, DOI 10.1089/aid.2006.22.788; de Witte L, 2007, P NATL ACAD SCI USA, V104, P19464, DOI 10.1073/pnas.0703747104; de Witte L, 2007, NAT MED, V13, P367, DOI 10.1038/nm1541; Dimitrov DS, 1997, CELL, V91, P721, DOI 10.1016/S0092-8674(00)80460-2; Engering A, 2002, BLOOD, V100, P1780, DOI 10.1182/blood-2001-12-0179; Frappart L, 2004, INTRO ANATOMY UTERIN; Fukui H, 2011, INFLAMM BOWEL DIS, V17, P1177, DOI 10.1002/ibd.21473; Galvin SR, 2004, NAT REV MICROBIOL, V2, P33, DOI 10.1038/nrmicro794; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Geijtenbeek TBH, 2000, CELL, V100, P575, DOI 10.1016/S0092-8674(00)80693-5; GOLDACRE MJ, 1978, BRIT MED J, V1, P748, DOI 10.1136/bmj.1.6115.748; Gorry Paul R, 2011, Curr HIV/AIDS Rep, V8, P45, DOI 10.1007/s11904-010-0069-x; Haase AT, 2010, NATURE, V464, P217, DOI 10.1038/nature08757; Herzberg M C, 2011, Adv Dent Res, V23, P38, DOI 10.1177/0022034511399283; Hirbod T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025551; Jakobsen MR, 2010, FUTURE VIROL, V5, P219, DOI 10.2217/FVL.09.77; Jens Madsen JM, 2010, INNATE IMMUN, P1; Klijn AJ, 2004, J UROLOGY, V172, P1986, DOI 10.1097/01.ju.0000142686.09532.46; Kumar RB, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-25; Kurago ZB, 2008, HEAD NECK PATHOL, V2, P1, DOI 10.1007/s12105-007-0038-x; Ligtenberg AJM, 2010, INT J MOL SCI, V11, P5213, DOI 10.3390/ijms1112521; Malamud D, 2010, AIDS, V24, P5, DOI 10.1097/QAD.0b013e328333525f; Marlin R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005971; Matiluko AA, 2007, J FAM PLAN REPROD H, V33, P277, DOI 10.1783/147118907782101724; McElrath MJ, 2013, JAIDS-J ACQ IMM DEF, V63, P263, DOI 10.1097/QAI.0b013e3182898392; MOSS GB, 1991, J INFECT DIS, V164, P588, DOI 10.1093/infdis/164.3.588; Nagashunmugam T, 1998, J INFECT DIS, V178, P1635, DOI 10.1086/314511; Nazli A, 2013, J IMMUNOL, V191, P4246, DOI 10.4049/jimmunol.1301482; Page-Shafer K, 2006, Adv Dent Res, V19, P152; Page-Shafer K, 2002, AIDS, V16, P2350, DOI 10.1097/00002030-200211220-00022; Qin SX, 1998, J CLIN INVEST, V101, P746, DOI 10.1172/JCI1422; Romas LM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100820; Schust DJ, 2012, CURR HIV RES, V10, P218, DOI 10.2174/157016212800618093; Sellors J.W., 2003, COLPOSCOPY AND TREAT; Shaw George M, 2012, Cold Spring Harb Perspect Med, V2, DOI 10.1101/cshperspect.a006965; Shugars DC, 2002, ORAL DIS, V8, P169, DOI 10.1034/j.1601-0825.8.s2.7.x; Sterjovski J, 2010, VIROLOGY, V404, P269, DOI 10.1016/j.virol.2010.05.006; Stoddard E, 2007, J IMMUNOL, V179, P3126, DOI 10.4049/jimmunol.179.5.3126; Stoddard E, 2009, J VIROL, V83, P8596, DOI 10.1128/JVI.00744-09; TAKANO K, 1991, ANAT REC, V230, P307, DOI 10.1002/ar.1092300303; TSOUKAS CM, 1988, J ACQ IMMUN DEF SYND, V1, P505; Wahl S M, 1997, Oral Dis, V3 Suppl 1, pS64; WALKER L, 1992, AIDS RES HUM RETROV, V8, P1083, DOI 10.1089/aid.1992.8.1083; WILEN CB, 2012, CSH PERSPECT MED, V2, P8191, DOI DOI 10.1101/CSHPERSPECT.A006866; Wood LF, 2013, IMMUNOL REV, V254, P34, DOI 10.1111/imr.12078; Wu ZW, 2004, AIDS RES HUM RETROV, V20, P600, DOI 10.1089/0889222041217400; Wu ZW, 2003, J INFECT DIS, V188, P1473, DOI 10.1086/379248; Yi TJ, 2013, AM J REPROD IMMUNOL, V69, P74, DOI 10.1111/aji.12035	53	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132942	10.1371/journal.pone.0132942	http://dx.doi.org/10.1371/journal.pone.0132942			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26172445	Green Published, Green Submitted, gold			2022-12-26	WOS:000358194900105
J	Di, HY; Duan, Z; Luo, K; Zhang, DY; Wu, F; Zhang, JY; Liu, WX; Wang, YR				Di, Hongyan; Duan, Zhen; Luo, Kai; Zhang, Daiyu; Wu, Fan; Zhang, Jiyu; Liu, Wenxian; Wang, Yanrong			Interspecific Phylogenic Relationships within Genus Melilotus Based on Nuclear and Chloroplast DNA	PLOS ONE			English	Article							MOLECULAR PHYLOGENY; ASTERACEAE; RDNA; AMPLIFICATION; PRIMERS; MODEL; MATK	Melilotus comprises 19 species, while the phylogenetic relationships between species remain unclear. In the present work, three chloroplast genes, rbcL, matK, tmL-F, and one nuclear region, ITS (internal transcribed spacer) belonging to 48 populations of 18 species of Melilotus were sequenced and phylogenetic trees were constructed to study their interspecific relationships. Based on the phylogenetic tree generated in this study using rbcL analysis, the Melilotusgenus is clearly monophyletic in the legume family. Both Bayesian and maximum-parsimony approaches were used to analyze the data. The nrDNA ITS provided more informative characteristics (9.8%) than cpDNA (3.0%). Melilotus contains two closely related groups, clade I and clade II. M. spicatus, M. indicusand M. segetalis have a close relationship. M. infestus, M. siculus and M. sulcatus are closely related. The comparing between molecular phylogeny and flower color classification in Melilotusshowed that the flower color is not much informative for phylogenetics of this genus.	[Di, Hongyan; Duan, Zhen; Luo, Kai; Zhang, Daiyu; Wu, Fan; Zhang, Jiyu; Liu, Wenxian; Wang, Yanrong] Lanzhou Univ, Coll Pastoral Agr Sci & Technol, State Key Lab Grassland Agroecosyst, Lanzhou 730000, Peoples R China; [Di, Hongyan; Duan, Zhen; Luo, Kai; Zhang, Daiyu; Wu, Fan; Zhang, Jiyu; Liu, Wenxian; Wang, Yanrong] Lanzhou Univ, Coll Pastoral Agr Sci & Technol, Lanzhou 730000, Peoples R China	Lanzhou University; Lanzhou University	Zhang, JY (corresponding author), Lanzhou Univ, Coll Pastoral Agr Sci & Technol, State Key Lab Grassland Agroecosyst, Lanzhou 730000, Peoples R China.	zhangjy@lzu.edu.cn	Zhang, Jiyu/AAG-3452-2021	Zhang, Jiyu/0000-0002-3642-373X	Ministry of Agriculture, China [20120304205]; Ministry of ST, China [31101759]; Department of Agriculture and Animal Husbandry, Gansu province [GNSW-2011-16]	Ministry of Agriculture, China(Ministry of Agriculture & Rural Affairs); Ministry of ST, China; Department of Agriculture and Animal Husbandry, Gansu province	This research was supported by grants from Ministry of Agriculture, China (20120304205), Ministry of S&T, China (31101759), the Department of Agriculture and Animal Husbandry, Gansu province (GNSW-2011-16).	Aboel-Atta AI, 2009, INT J PLANT SCI, V2, P113, DOI [10.1038/s41598-018-35947-7, DOI 10.1038/s41598-018-37737-7]; Al Sherif EA, 2009, FLORA, V204, P737, DOI 10.1016/j.flora.2008.10.004; ARNHEIM N, 1980, P NATL ACAD SCI-BIOL, V77, P7323, DOI 10.1073/pnas.77.12.7323; Bowman G, 1998, SUSTAINABLE AGR NETW, V15, P100; Brenner DM, 1970, NEWSLETTER, V141, P51; Cardoso D, 2013, AM J BOT, V100, P403, DOI 10.3732/ajb.1200276; Clarke A.E., 1934, NUMBER MORPHOLOGY CH; CLARKE ALFRED E., 1935, JOUR AMER SOC AGRON, V27, P492; Clevinger JA, 2000, AM J BOT, V87, P565, DOI 10.2307/2656600; Cong JM, 2012, J ANHUI AGR SCI, V5, P2962; Conn JS, 2011, ARCT ANTARCT ALP RES, V43, P343, DOI 10.1657/1938-4246-43.3.343; Degnan JH, 2009, TRENDS ECOL EVOL, V24, P332, DOI 10.1016/j.tree.2009.01.009; Dong WP, 2014, MOL ECOL RESOUR, V14, P336, DOI 10.1111/1755-0998.12185; DOYLE JJ, 1992, SYST BOT, V17, P144, DOI 10.2307/2419070; Fior S, 2006, AM J BOT, V93, P399, DOI 10.3732/ajb.93.3.399; Fordyce JA, 2008, ANN ENTOMOL SOC AM, V101, P794, DOI 10.1603/0013-8746(2008)101[794:POGVBT]2.0.CO;2; Hamby RK, 1992, MOL SYSTEMATICS PLAN, DOI DOI 10.1086/661633; Hao JS, 2012, COMP FUNCT GENOM, DOI 10.1155/2012/328049; HILLIS DM, 1991, Q REV BIOL, V66, P411, DOI 10.1086/417338; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Isely D, 1969, P IOWA ACAD SCI, V61, P119; Jenks AA, 2013, J PLANT RES, V126, P483, DOI 10.1007/s10265-012-0543-1; Kass E, 1997, MOL PHYLOGENET EVOL, V8, P65, DOI 10.1006/mpev.1997.0410; KITA F., 1965, Journal of the Faculty of Agriculture, Hokkaido University, V54, P23; Klebesadel LJ, 1954, MORPHOLOGICAL PHYSL; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee CS, 2012, J PLANT BIOL, V55, P165, DOI 10.1007/s12374-011-9201-8; Linder CR, 2000, MOL PHYLOGENET EVOL, V14, P285, DOI 10.1006/mpev.1999.0706; Lindner DL, 2011, MYCOLOGIA, V103, P731, DOI 10.3852/10-331; Liu JQ, 2006, MOL PHYLOGENET EVOL, V38, P31, DOI 10.1016/j.ympev.2005.09.010; Maddison WP, 2006, SYST BIOL, V55, P21, DOI 10.1080/10635150500354928; Maddison WP, 1997, SYST BIOL, V46, P523, DOI 10.2307/2413694; Mitsui Y, 2008, ANN BOT-LONDON, V101, P111, DOI 10.1093/aob/mcm267; Moussavi S. M., 2001, Rostaniha, V2, P57; Nuin P, 2005, MRMTGUI 10 VERSION 1; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Reinhardt AC, 2008, APPL VEG SCI, V11, P131, DOI [10.3170/2007-7-18335, 10.1111/j.1654-109X.2008.tb00211.x]; Rogers ME, 2008, PLANT SOIL, V304, P89, DOI 10.1007/s11104-007-9523-y; Scarcelli N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019954; [单志 SHAN Zhi], 2011, [广东农业科学, Guangdong Agricultural Sciences], V38, P113; STEVENSO.GA, 1969, CAN J PLANT SCI, V49, P1, DOI 10.4141/cjps69-001; STEVENSON T. M., 1935, Scientific Agriculture, V15, P580; STICKLER F. C, 1959, AGRON JOUR, V51, P135; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Van Riper LC, 2009, PLANT ECOL, V200, P129, DOI 10.1007/s11258-008-9438-6; Yu J, 2011, J SYST EVOL, V49, P176, DOI 10.1111/j.1759-6831.2011.00134.x; Zhang W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098133; Zimmer EA, 1991, P NATL ACAD SCI USA, V77, P2158	50	22	25	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0132596	10.1371/journal.pone.0132596	http://dx.doi.org/10.1371/journal.pone.0132596			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26167689	Green Published, Green Submitted, gold			2022-12-26	WOS:000358193100058
J	Gundlapalli, AV; Nelson, RE; Haroldsen, C; Carter, ME; LaFleur, J				Gundlapalli, Adi V.; Nelson, Richard E.; Haroldsen, Candace; Carter, Marjorie E.; LaFleur, Joanne			Correlates of Initiation of Treatment for Chronic Hepatitis C Infection in United States Veterans, 2004-2009	PLOS ONE			English	Article							VIRUS-INFECTION; US VETERANS; PEGYLATED-INTERFERON; ANTIVIRAL THERAPY; HOMELESS ADULTS; PREVALENCE; ADHERENCE; PATIENT; PREDICTORS; RIBAVIRIN	We describe the rates and predictors of initiation of treatment for chronic hepatitis C (HCV) infection in a large cohort of HCV positive Veterans seen in U.S. Department of Veterans Affairs (VA) facilities between January 1, 2004 and December 31, 2009. In addition, we identify the relationship between homelessness among these Veterans and treatment initiation. Univariate and multivariable Cox Proportional Hazards regression models with time-varying covariates were used to identify predictors of initiation of treatment with pegylated interferon alpha plus ribavirin. Of the 101,444 HCV treatment-naive Veterans during the study period, rates of initiation of treatment among homeless and non-homeless Veterans with HCV were low and clinically similar (6.2% vs. 7.4%, p<0.0001). For all U.S. Veterans, being diagnosed with genotype 2 or 3, black or other/unknown race, having Medicare or other insurance increased the risk of treatment. Veterans with age >= 50 years, drug abuse, diabetes, and hemoglobin <10 g/dL showed lower rates of treatment. Initiation of treatment for HCV in homeless Veterans is low; similar factors predicted initiation of treatment. Additionally, exposure to treatment with medications for diabetes predicted lower rates of treatment. As newer therapies become available for HCV, these results may inform further studies and guide strategies to increase treatment rates in all U.S. Veterans and those who experience homelessness.	[Gundlapalli, Adi V.; Nelson, Richard E.; Haroldsen, Candace; Carter, Marjorie E.; LaFleur, Joanne] VA Salt Lake City Hlth Care Syst, Informat Decis Enhancement & Surveillance IDEAS, Salt Lake City, UT 84108 USA; [Gundlapalli, Adi V.; Nelson, Richard E.; Haroldsen, Candace; Carter, Marjorie E.] Univ Utah, Sch Med, Salt Lake City, UT USA; [LaFleur, Joanne] Univ Utah, Coll Pharm, Salt Lake City, UT 84112 USA	US Department of Veterans Affairs; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Gundlapalli, AV (corresponding author), VA Salt Lake City Hlth Care Syst, Informat Decis Enhancement & Surveillance IDEAS, Salt Lake City, UT 84108 USA.	adi.gundlapalli@hsc.utah.edu			Genentech; U.S. Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Health Services Research and Development [HIR 10-002]; VA Salt Lake City Health Care System (IDEAS Center)	Genentech(Roche HoldingGenentech); U.S. Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Health Services Research and Development(US Department of Veterans Affairs); VA Salt Lake City Health Care System (IDEAS Center)	Funding for this project was provided by a grant from Genentech (PI: JL); additional funding was provided by U.S. Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Health Services Research and Development Project #HIR 10-002 (PI: AVG). Resources and administrative support were provided by the VA Salt Lake City Health Care System (IDEAS Center).	Armstrong GL, 2006, ANN INTERN MED, V144, P705, DOI 10.7326/0003-4819-144-10-200605160-00004; Backus LI, 2006, J VIRAL HEPATITIS, V13, P799, DOI 10.1111/j.1365-2893.2006.00751.x; Badiaga S, 2012, COMP IMMUNOL MICROB, V35, P39, DOI 10.1016/j.cimid.2011.09.008; Baggett TP, 2013, JAMA INTERN MED, V173, P189, DOI 10.1001/jamainternmed.2013.1604; Beste LA, 2015, EPIDEMIOL REV, V37, P131, DOI 10.1093/epirev/mxu002; Bini EJ, 2005, AM J GASTROENTEROL, V100, P1772, DOI 10.1111/j.1572-0241.2005.41860.x; Butt AA, 2007, GUT, V56, P385, DOI 10.1136/gut.2006.099150; Cacoub P, 2008, WORLD J GASTROENTERO, V14, P6195, DOI 10.3748/wjg.14.6195; Cawthorne CH, 2002, AM J GASTROENTEROL, V97, P149, DOI 10.1111/j.1572-0241.2002.05439.x; Chak E, 2011, LIVER INT, V31, P1090, DOI 10.1111/j.1478-3231.2011.02494.x; Cheung RC, 2002, J CLIN GASTROENTEROL, V34, P476, DOI 10.1097/00004836-200204000-00021; Clark BT, 2012, PATIENT PREFER ADHER, V6, P285, DOI 10.2147/PPA.S30111; Desai RA, 2003, SOC PSYCH PSYCH EPID, V38, P396, DOI 10.1007/s00127-003-0639-y; Dominitz JA, 2005, HEPATOLOGY, V41, P88, DOI 10.1002/hep.20502; Gelberg L, 2012, PUBLIC HEALTH REP, V127, P407, DOI 10.1177/003335491212700409; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Gish RG, 2005, CLIN GASTROENTEROL H, V3, P311, DOI 10.1016/S1542-3565(04)00666-4; Groom H, 2008, J CLIN GASTROENTEROL, V42, P97, DOI 10.1097/MCG.0b013e31802dc56f; Hellard M, 2009, CLIN INFECT DIS, V49, P561, DOI 10.1086/600304; Holmberg SD, 2013, NEW ENGL J MED, V368, P1859, DOI 10.1056/NEJMp1302973; Hussein Mohamed, 2010, Qual Manag Health Care, V19, P25, DOI 10.1097/QMH.0b013e3181ccbc7a; Hwang EW, 2013, J CLIN GASTROENTEROL, V47, P264, DOI 10.1097/MCG.0b013e31827035cf; Hwang SW, 2014, LANCET, V384, P1541, DOI 10.1016/S0140-6736(14)61133-8; Kanwal F, 2007, HEPATOLOGY, V46, P1741, DOI 10.1002/hep.21927; Kim WR, 2002, HEPATOLOGY, V36, pS30, DOI 10.1053/jhep.2002.36791; LaFleur Joanne, 2014, BMC Res Notes, V7, P266, DOI 10.1186/1756-0500-7-266; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; McHutchison JG, 2002, GASTROENTEROLOGY, V123, P1061, DOI 10.1053/gast.2002.35950; Muir AJ, 2002, J CLIN GASTROENTEROL, V34, P268, DOI 10.1097/00004836-200203000-00015; Nelson RE, 2014, ANN PHARMACOTHER, V48, P826, DOI 10.1177/1060028014531724; Nelson RE, 2012, J RURAL HEALTH, V28, P192, DOI 10.1111/j.1748-0361.2011.00387.x; Sloan KL, 2004, J CLIN GASTROENTEROL, V38, P279, DOI 10.1097/00004836-200403000-00016; Smith Bryce D., 2012, Morbidity and Mortality Weekly Report, V61, P1; Talal AH, 2013, ALIMENT PHARM THER, V37, P473, DOI 10.1111/apt.12200; U.S. Department of Veterans Affairs Office of Inspector Genial, 2012, HOM INC RISK FACT BE; U.S. Department ofVeteranAffairs, CHRON HEP C VIR HCV; US Department of Veterans Affairs, 2010, STAT CAR VET CHRON H; Webster DP, 2015, LANCET, V385, P1124, DOI [10.1016/S0140-6736(14)62401-6, 10.1016/S0140-6736(14)61932-2]; Weiss JJ, 2009, ALIMENT PHARM THER, V30, P14, DOI 10.1111/j.1365-2036.2009.04004.x	39	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0132056	10.1371/journal.pone.0132056	http://dx.doi.org/10.1371/journal.pone.0132056			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26167690	Green Published, gold, Green Submitted			2022-12-26	WOS:000358193100018
J	Svanes, O; Skorge, TD; Johannessen, A; Bertelsen, RJ; Bratveit, M; Forsberg, B; Gislason, T; Holm, M; Janson, C; Jogi, R; Macsali, F; Norback, D; Omenaas, ER; Real, FG; Schlunssen, V; Sigsgaard, T; Wieslander, G; Zock, JP; Aasen, T; Dratva, J; Svanes, C				Svanes, Oistein; Skorge, Trude Duelien; Johannessen, Ane; Bertelsen, Randi Jacobsen; Bratveit, Magne; Forsberg, Bertil; Gislason, Thorarin; Holm, Mathias; Janson, Christer; Joegi, Rain; Macsali, Ferenc; Norback, Dan; Omenaas, Ernst Reidar; Real, Francisco Gomez; Schlunssen, Vivi; Sigsgaard, Torben; Wieslander, Gunilla; Zock, Jan-Paul; Aasen, Tor; Dratva, Julia; Svanes, Cecilie			Respiratory Health in Cleaners in Northern Europe: Is Susceptibility Established in Early Life?	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; LUNG-FUNCTION; OCCUPATIONAL EXPOSURES; CHRONIC-BRONCHITIS; ASTHMA; POPULATION; CHILDHOOD; SMOKING; WORK; COPD	Rationale There is some evidence that maternal smoking increases susceptibility to personal smoking's detrimental effects. One might question whether early life disadvantage might influence susceptibility to occupational exposure. Objectives In this cross-sectional study we investigated respiratory symptoms, asthma and self-reported chronic obstructive pulmonary disease (COPD) as related to working as a cleaner in Northern European populations, and whether early life factors influenced susceptibility to occupational cleaning's unhealthy effects. Methods The RHINE III questionnaire study assessed occupational cleaning in 13,499 participants. Associations with respiratory symptoms, asthma and self-reported COPD were analysed with multiple logistic regressions, adjusting for sex, age, smoking, educational level, parent's educational level, BMI and participating centre. Interaction of occupational cleaning with early life disadvantage (maternal smoking, severe respiratory infection < 5 years, born during winter months, maternal age at birth > 35 years) was investigated. Main Results Among 2138 ever-cleaners the risks of wheeze (OR 1.4, 95% CI 1.3-1.6), adult-onset asthma (1.5 [1.2-1.8]) and self-reported COPD (1.7 [1.3-2.2]) were increased. The risk increased with years in occupational cleaning (adult-onset asthma: <= 1 year 0.9 [0.7-1.3]; 1-4 years 1.5 [1.1-2.0]; >= 4 years 1.6 [1.2-2.1]). The association of wheeze with cleaning activity >= 4 years was significantly stronger for those with early life disadvantage than in those without (1.8 [1.5-2.3] vs. 1.3 [0.96-1.8]; pinteraction 0.035). Conclusions Occupational cleaners had increased risk of asthma and self-reported COPD. Respiratory symptom risk was particularly increased in persons with factors suggestive of early life disadvantage. We hypothesize that early life disadvantage may increase airway vulnerability to harmful exposure from cleaning agents later in life.	[Svanes, Oistein; Real, Francisco Gomez] Univ Bergen, Dept Clin Sci, Bergen, Norway; [Svanes, Oistein] Haukeland Hosp, Dept Thorac Med, N-5021 Bergen, Norway; [Svanes, Oistein; Skorge, Trude Duelien; Bertelsen, Randi Jacobsen; Aasen, Tor; Svanes, Cecilie] Haukeland Hosp, Dept Occupat Med, N-5021 Bergen, Norway; [Johannessen, Ane; Omenaas, Ernst Reidar] Haukeland Hosp, Clin Res Ctr, N-5021 Bergen, Norway; [Bratveit, Magne] Univ Bergen, Dept Publ Hlth & Primary Hlth Care, Bergen, Norway; [Forsberg, Bertil] Umea Univ, Occupat & Environm Med, Umea, Sweden; [Gislason, Thorarin] Natl Univ Hosp Iceland, Dept Resp Med & Sleep, Reykjavik, Iceland; [Holm, Mathias] Univ Gothenburg, Dept Occupat & Environm Med, Gothenburg, Sweden; [Janson, Christer; Norback, Dan; Wieslander, Gunilla] Uppsala Univ, Dept Med Sci Occupat & Environm Med, Uppsala, Sweden; [Joegi, Rain] Tartu Univ Hosp, Lung Clin, Tartu, Estonia; [Macsali, Ferenc; Real, Francisco Gomez] Haukeland Hosp, Dept Gynecol & Obstet, N-5021 Bergen, Norway; [Schlunssen, Vivi; Sigsgaard, Torben] Aarhus Univ, Dept Publ Hlth, Sect Environm Occupat & Hlth, Aarhus, Denmark; [Zock, Jan-Paul] Ctr Res Environm Epidemiol CREAL, Barcelona, Spain; [Dratva, Julia] Univ Basel, Swiss Trop & Publ Hlth Inst SwissTPH, Basel, Switzerland; [Svanes, Cecilie] Univ Bergen, Ctr Int Hlth, Bergen, Norway	University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen; Haukeland University Hospital; University of Bergen; Haukeland University Hospital; University of Bergen; Umea University; Landspitali National University Hospital; University of Gothenburg; Uppsala University; University of Bergen; Haukeland University Hospital; Aarhus University; Pompeu Fabra University; University of Basel; Swiss Tropical & Public Health Institute; University of Bergen	Svanes, O (corresponding author), Univ Bergen, Dept Clin Sci, Bergen, Norway.	oistein.svanes@k2.uib.no	Bertelsen, Randi J/N-6917-2017; Sigsgaard, Torben/AAC-1292-2020; Zock, Jan-Paul/P-5034-2018; Svanes, Cecilie/N-7556-2017; Aasen, Tor/P-4452-2017	Bertelsen, Randi J/0000-0001-5319-525X; Sigsgaard, Torben/0000-0002-2043-7571; Zock, Jan-Paul/0000-0002-2941-6259; Svanes, Cecilie/0000-0001-8512-5192; Norback, Dan/0000-0002-5174-6668; Aasen, Tor/0000-0002-1043-5193; Schlunssen, Vivi/0000-0003-4915-1734; Johannessen, Ane/0000-0003-3269-8354; Gomez Real, Francisco/0000-0001-5407-3270	Norwegian Research Council [214123]; Bergen Medical Research Foundation; Western Norwegian Regional Health Authorities [911 892, 911 631]; Norwegian Labour Inspection; Norwegian Asthma and Allergy Association; Faculty of Health of Aarhus University [240008]; Wood Dust Foundation [444508795]; Danish Lung Association; Swedish Heart and Lung Foundation; Vardal Foundation for Health Care Science and Allergy Research; Swedish Council for Working Life and Social Research; Bror Hjerpstedt Foundation; Swedish Asthma and Allergy Association; Icelandic Research Council; Landspitali University Hospital Research Fund; University of Iceland; Estonian Science Foundation [4350]	Norwegian Research Council(Research Council of NorwayEuropean Commission); Bergen Medical Research Foundation; Western Norwegian Regional Health Authorities; Norwegian Labour Inspection; Norwegian Asthma and Allergy Association; Faculty of Health of Aarhus University; Wood Dust Foundation; Danish Lung Association; Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Vardal Foundation for Health Care Science and Allergy Research; Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Bror Hjerpstedt Foundation; Swedish Asthma and Allergy Association; Icelandic Research Council; Landspitali University Hospital Research Fund; University of Iceland; Estonian Science Foundation	The RHINE III was supported financially by the Norwegian Research Council (Grant No. 214123), the Bergen Medical Research Foundation, the Western Norwegian Regional Health Authorities (Grant No. 911 892 and 911 631), the Norwegian Labour Inspection, the Norwegian Asthma and Allergy Association, the Faculty of Health of Aarhus University, (Project No. 240008), The Wood Dust Foundation (Project No. 444508795), the Danish Lung Association, the Swedish Heart and Lung Foundation, the Vardal Foundation for Health Care Science and Allergy Research, the Swedish Council for Working Life and Social Research, the Bror Hjerpstedt Foundation, the Swedish Asthma and Allergy Association, the Icelandic Research Council, the Landspitali University Hospital Research Fund, the University of Iceland and the Estonian Science Foundation (Grant No. 4350). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameille J, 2006, REV MAL RESPIR, V23, P726, DOI 10.1016/S0761-8425(06)72085-X; Arif AA, 2003, AM J IND MED, V44, P368, DOI 10.1002/ajim.10291; Bello A, 2010, ENV HLTH, V9, P1; Blanc PD, 2009, EUR RESPIR J, V33, P298, DOI 10.1183/09031936.00118808; Blanc PD, 2012, J ASTHMA, V49, P2, DOI 10.3109/02770903.2011.611957; CELLI BR, 1995, AM J RESP CRIT CARE, V152, pS77; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dharmage SC, 2009, EUR RESPIR J, V33, P237, DOI 10.1183/09031936.00062907; Dumas O, 2013, OCCUP ENVIRON MED, V70, P603, DOI 10.1136/oemed-2013-101362; Guerra S, 2013, THORAX, V68, P1021, DOI 10.1136/thoraxjnl-2013-203538; Halbert RJ, 2006, EUR RESPIR J, V28, P523, DOI 10.1183/09031936.06.00124605; Holm M, 2012, INT J TUBERC LUNG D, V16, P553, DOI 10.5588/ijtld.11.0288; Jaakkola JJK, 2006, CURR OPIN ALLERGY CL, V6, P85, DOI 10.1097/01.all.0000216849.64828.55; Johannessen A, 2014, BMC PULM MED, V14, DOI 10.1186/1471-2466-14-63; Kogevinas M, 1999, LANCET, V353, P1750, DOI 10.1016/S0140-6736(98)07397-8; Kogevinas M, 2007, LANCET, V370, P336, DOI 10.1016/S0140-6736(07)61164-7; Lemiere C, 1997, EUR RESPIR J, V10, P241, DOI 10.1183/09031936.97.10010241; LIBERATOS P, 1988, EPIDEMIOL REV, V10, P87, DOI 10.1093/oxfordjournals.epirev.a036030; Maestrelli P, 2009, J ALLERGY CLIN IMMUN, V123, P531, DOI 10.1016/j.jaci.2009.01.057; Makela R, 2011, OCCUP MED-OXFORD, V61, P121, DOI 10.1093/occmed/kqq192; Mehta AJ, 2012, AM J RESP CRIT CARE, V185, P1292, DOI 10.1164/rccm.201110-1917OC; Mirabelli MC, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-24; Pekkanen J, 2005, EUR RESPIR J, V26, P28, DOI 10.1183/09031936.05.00120104; Quirce S, 2010, J INVEST ALLERG CLIN, V20, P542; Santos R, 2014, PEDIAT CARDIOL; Siracusa A, 2013, ALLERGY, V68, P1532, DOI 10.1111/all.12279; Svanes C, 2008, INDOOR AIR, V18, P84, DOI 10.1111/j.1600-0668.2008.00523.x; Svanes C, 2004, THORAX, V59, P295, DOI 10.1136/thx.2003.009746; Svanes C, 2010, THORAX, V65, P14, DOI 10.1136/thx.2008.112136; van den Boom G, 1998, AM J RESP CRIT CARE, V158, P1730, DOI 10.1164/ajrccm.158.6.9709003; Waatevik M, 2013, RESP MED, V107, P1037, DOI 10.1016/j.rmed.2013.04.008; Zock JP, 2007, AM J RESP CRIT CARE, V176, P735, DOI 10.1164/rccm.200612-1793OC; Zock JP, 2010, CURR OPIN ALLERGY CL, V10, P114, DOI 10.1097/ACI.0b013e32833733fe; Zock JP, 2001, AM J RESP CRIT CARE, V163, P1572, DOI 10.1164/ajrccm.163.7.2004195	34	31	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0131959	10.1371/journal.pone.0131959	http://dx.doi.org/10.1371/journal.pone.0131959			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26168149	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000358193100016
J	Zhao, Y; Peng, L; Yang, LC; Xu, XD; Li, WJ; Luo, XM; Jin, X				Zhao, Yun; Peng, Lu; Yang, Li-chao; Xu, Xu-dong; Li, Wei-jie; Luo, Xiu-mei; Jin, Xin			Wedelolactone Regulates Lipid Metabolism and Improves Hepatic Steatosis Partly by AMPK Activation and Up-Regulation of Expression of PPAR alpha/LPL and LDLR	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN RECEPTOR; INDUCED HYPERLIPIDEMIC RATS; HIGH-FAT DIET; OXIDATIVE STRESS; TRITON WR-1339; PROTEIN-KINASE; MICE; ANTIOXIDANT; EXTRACT; LIVER	Hyperlipidemia is considered one of the greatest risk factors of cardiovascular diseases. We investigated the anti-hyperlipidemic effect and the underlying mechanism of wedelolactone, a plant-derived coumestan, in HepG2 cells and high-fat diet (HFD)-induced hyperlipidemic hamsters. We showed that in cultured HepG2 cells, wedelolactone up-regulated protein levels of adenosine monophosphate activated protein kinase (AMPK) and peroxisome proliferator-activated receptor-alpha (PPAR alpha) as well as the gene expression of AMPK, PPAR alpha, lipoprotein lipase (LPL), and the low-density lipoprotein receptor (LDLR). Meanwhile, administration of wedelolactone for 4 weeks decreased the lipid profiles of plasma and liver in HFD-induced hyperlipidemic hamsters, including total cholesterol (TC), triglycerides (TG), and low-density lipoprotein-cholesterol (LDL-C). The activation of AMPK and up-regulation of PPAR alpha was also observed with wedelolactone treatment. Furthermore, wedelolactone also increased the activities of superoxidase dismutase (SOD) and glutathione peroxidase (GSH-Px) and decreased the level of the lipid peroxidation product malondialdehyde (MDA) in the liver, therefore decreasing the activity of alanine aminotransferase (ALT). In conclusion, we provide novel experimental evidence that wedelolactone possesses lipid-lowering and steatosis-improving effects, and the underlying mechanism is, at least in part, mediated by the activation of AMPK and the up-regulation of PPAR alpha/LPL and LDLR.	[Zhao, Yun; Peng, Lu; Yang, Li-chao; Li, Wei-jie; Luo, Xiu-mei; Jin, Xin] Xiamen Univ, Coll Med, Dept Basic Med Sci, Xiamen, Fujian, Peoples R China; [Zhao, Yun; Peng, Lu; Yang, Li-chao; Li, Wei-jie; Jin, Xin] Xiamen Key Lab Chiral Drugs, Xiamen, Fujian, Peoples R China; [Xu, Xu-dong] Zhongshan Hosp, Dept Cardiol, Xiamen, Fujian, Peoples R China	Xiamen University	Jin, X (corresponding author), Xiamen Univ, Coll Med, Dept Basic Med Sci, Xiamen, Fujian, Peoples R China.	xinjin@xmu.edu.cn	li, wj/HGD-7322-2022; Yang, Lichao/HDM-6210-2022		Research Fund of Strait (Xiamen) Technology Platform in Traditional Chinese Medicine [3502Z20100006]	Research Fund of Strait (Xiamen) Technology Platform in Traditional Chinese Medicine	This study was supported by grants from the Research Fund of Strait (Xiamen) Technology Platform in Traditional Chinese Medicine (No. 3502Z20100006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barroso E, 2011, ENDOCRINOLOGY, V152, P1848, DOI 10.1210/en.2010-1468; Davies BSJ, 2012, CURR OPIN LIPIDOL, V23, P35, DOI 10.1097/MOL.0b013e32834d0b33; Do GM, 2011, BRIT J NUTR, V106, P1855, DOI 10.1017/S000711451100256X; Dyroy E, 2007, ARTERIOSCL THROM VAS, V27, P628, DOI 10.1161/01.ATV.0000255950.70774.d5; Ebrahimzadeh MA, 2010, PAK J PHARM SCI, V23, P29; Esposito K, 2002, CIRCULATION, V106, P2067, DOI 10.1161/01.CIR.0000034509.14906.AE; Fernandez-Alvarez A, 2011, J BIOL CHEM, V286, P21466, DOI 10.1074/jbc.M110.209973; Guo P, 2010, J PHARMACOL SCI, V113, P395, DOI 10.1254/jphs.10041FP; Harnafi H, 2007, J ETHNOPHARMACOL, V109, P156, DOI 10.1016/j.jep.2006.09.017; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Hou XY, 2010, BIOCHEM BIOPH RES CO, V394, P653, DOI 10.1016/j.bbrc.2010.03.043; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Keating GM, 2011, AM J CARDIOVASC DRUG, V11, P227, DOI 10.2165/11207690-000000000-00000; Kim DI, 2008, NUTR RES, V28, P550, DOI 10.1016/j.nutres.2008.05.003; Kim DY, 2009, J AGR FOOD CHEM, V57, P1532, DOI 10.1021/jf802867b; Kobori M, 2004, CELL DEATH DIFFER, V11, P123, DOI 10.1038/sj.cdd.4401325; Kumar D, 2012, PHARMACOGN MAG, V8, P314, DOI 10.4103/0973-1296.103663; Lage R, 2008, TRENDS MOL MED, V14, P539, DOI 10.1016/j.molmed.2008.09.007; Lee W, 2012, AM J CHINESE MED, V40, P1217, DOI 10.1142/S0192415X12500905; Li Y, 2011, CELL METAB, V13, P376, DOI 10.1016/j.cmet.2011.03.009; Liu YQ, 2014, J ETHNOPHARMACOL, V157, P206, DOI 10.1016/j.jep.2014.09.033; Manvar D, 2012, J ETHNOPHARMACOL, V144, P545, DOI 10.1016/j.jep.2012.09.036; Peschel D, 2007, J NUTR BIOCHEM, V18, P113, DOI 10.1016/j.jnutbio.2006.03.007; Rakhshandehroo M, 2007, PPAR RES, V2007, DOI 10.1155/2007/26839; Ricci D, 2005, J ETHNOPHARMACOL, V98, P195, DOI 10.1016/j.jep.2005.01.022; Rony KA, 2014, ENVIRON TOXICOL PHAR, V37, P482, DOI 10.1016/j.etap.2014.01.004; Rull A, 2014, J PROTEOME RES, V13, P1731, DOI 10.1021/pr401230s; Schafer HL, 2012, ACTA PHARMACOL SIN, V33, P82, DOI 10.1038/aps.2011.165; Schoonjans K, 1996, EMBO J, V15, P5336, DOI 10.1002/j.1460-2075.1996.tb00918.x; Sharma N, 2009, INDIAN J BIOCHEM BIO, V46, P99; Slack C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047699; SPADY DK, 1986, P NATL ACAD SCI USA, V83, P1916, DOI 10.1073/pnas.83.6.1916; STAELS B, 1992, DEVELOPMENT, V115, P1035; Tang JJ, 2011, CELL METAB, V13, P44, DOI 10.1016/j.cmet.2010.12.004; Werz O, 2007, PLANTA MED, V73, P1331, DOI 10.1055/s-2007-990242; Xia YZ, 2013, EUR J PHARMACOL, V714, P105, DOI 10.1016/j.ejphar.2013.06.012; Yan F, 2004, PLOS ONE, V9; Yao N, 2014, CHIN J INTEGR MED, V20, P31, DOI 10.1007/s11655-012-1243-3; Yashiro T, 2012, ATHEROSCLEROSIS, V220, P369, DOI 10.1016/j.atherosclerosis.2011.11.006; Yin JJ, 2014, J ETHNOPHARMACOL, V154, P229, DOI 10.1016/j.jep.2014.04.011; Yin SN, 2014, ENDOCR RES, V39, P67, DOI 10.3109/07435800.2013.828741; Youn JY, 2014, DIABETES, V63, P2344, DOI 10.2337/db13-0719; Zhang XP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061922	43	28	28	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0132720	10.1371/journal.pone.0132720	http://dx.doi.org/10.1371/journal.pone.0132720			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26168156	gold, Green Submitted, Green Published			2022-12-26	WOS:000358193100071
J	Ligasova, A; Liboska, R; Rosenberg, I; Koberna, K				Ligasova, Anna; Liboska, Radek; Rosenberg, Ivan; Koberna, Karel			The Fingerprint of Anti-Bromodeoxyuridine Antibodies and Its Use for the Assessment of Their Affinity to 5-Bromo-2 '-Deoxyuridine in Cellular DNA under Various Conditions	PLOS ONE			English	Article							PANCREATIC DEOXYRIBONUCLEASE-A; DIFFERENT BIVALENT METALS; NUCLEAR-ORGANIZATION; REPLICATION SITES; IN-VIVO; MAMMALIAN-CELLS; CLICK CHEMISTRY; LIVING CELLS; EDU; PROLIFERATION	We have developed a simple system for the analysis of the affinity of anti-bromodeoxyuridine antibodies. The system is based on the anchored oligonucleotides containing 5-bromo-2'-deoxyuridine (BrdU) at three different positions. It allows a reliable estimation of the reactivity of particular clones of monoclonal anti-bromodeoxyuridine antibodies with BrdU in fixed and permeabilized cells. Using oligonucleotide probes and four different protocols for the detection of BrdU incorporated in cellular DNA, we identified two antibody clones that evinced sufficient reactivity to BrdU in all the tested protocols. One of these clones exhibited higher reactivity to 5-iodo-2'-deoxyuridine (IdU) than to BrdU. It allowed us to increase the sensitivity of the used protocols without a negative effect on the cell physiology as the cytotoxicity of IdU was comparable with BrdU and negligible when compared to 5-ethynyl-2'-deoxyuridine. The combination of IdU and the improved protocol for oxidative degradation of DNA provided a sensitive and reliable approach for the situations when the low degradation of DNA and high BrdU signal is a priority.	[Ligasova, Anna; Koberna, Karel] Palacky Univ, Fac Med, Inst Mol & Translat Med, CR-77147 Olomouc, Czech Republic; [Liboska, Radek; Rosenberg, Ivan] CAS, Inst Organ Chem & Biochem, Oligonucleotide Grp, Vvi, Prague, Czech Republic	Palacky University Olomouc; Czech Academy of Sciences; Institute of Organic Chemistry & Biochemistry of the Czech Academy of Sciences	Ligasova, A (corresponding author), Palacky Univ, Fac Med, Inst Mol & Translat Med, CR-77147 Olomouc, Czech Republic.	anna.ligasova@upol.cz	Ligasová, Anna/P-5460-2015; KOBERNA, Karel/G-5551-2019	Ligasová, Anna/0000-0002-1564-3768; KOBERNA, Karel/0000-0002-7375-4298	Technology Agency of the Czech Republic [TA03010598, TA03010719, TE02000058]; Ministry of Health of the Czech Republic [AZV 15-31604A]; Ministry of Education, Youth and Sports [LO1304]	Technology Agency of the Czech Republic; Ministry of Health of the Czech Republic(Ministry of Health, Czech Republic); Ministry of Education, Youth and Sports(Ministry of Education, Youth & Sports - Czech Republic)	This work was supported by the Technology Agency of the Czech Republic [TA03010598, TA03010719 and TE02000058], the Ministry of Health of the Czech Republic [AZV 15-31604A] and the Ministry of Education, Youth and Sports [LO1304]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGENO M, 1969, BIOPHYS J, V9, P1281, DOI 10.1016/S0006-3495(69)86452-0; AHMADZADEH C, 1971, IMMUNOLOGY, V21, P1065; ATEN JA, 1992, HISTOCHEM J, V24, P251, DOI 10.1007/BF01046839; Barbie DA, 2004, MOL CELL BIOL, V24, P595, DOI 10.1128/MCB.24.2.595-607.2004; CAMPBELL VW, 1980, J BIOL CHEM, V255, P3726; Cristofoli WA, 2007, J MED CHEM, V50, P2851, DOI 10.1021/jm0701472; Diermeier-Daucher S, 2009, CYTOM PART A, V75A, P535, DOI 10.1002/cyto.a.20712; Dimitrova DS, 2002, J CELL SCI, V115, P4037, DOI 10.1242/jcs.00087; Dimitrova DS, 1999, MOL CELL, V4, P983, DOI 10.1016/S1097-2765(00)80227-0; Dimitrova DS, 1999, J CELL BIOL, V146, P709, DOI 10.1083/jcb.146.4.709; Freshney RI, 2005, CULTURE ANIMAL CELLS, P365; Hong V, 2010, BIOCONJUGATE CHEM, V21, P1912, DOI 10.1021/bc100272z; Jackson DA, 1998, J CELL BIOL, V140, P1285, DOI 10.1083/jcb.140.6.1285; JUNOWICZ E, 1973, BIOCHIM BIOPHYS ACTA, V312, P85, DOI 10.1016/0005-2787(73)90054-3; JUNOWICZ E, 1973, BIOCHIM BIOPHYS ACTA, V312, P72, DOI 10.1016/0005-2787(73)90053-1; Kennedy BK, 2000, GENE DEV, V14, P2855, DOI 10.1101/gad.842600; Koberna K, 1999, CHROMOSOMA, V108, P325, DOI 10.1007/s004120050384; Kohlmeier F, 2013, CHROMOSOME RES, V21, P87, DOI 10.1007/s10577-013-9340-5; Liboska R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051679; Ligasova A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117459; Ligasova A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066864; Ligasova A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052584; Ligasova A, 2009, J STRUCT BIOL, V165, P204, DOI 10.1016/j.jsb.2008.11.004; Loschberger A, 2014, BIOTECHNOL J, V9, P693, DOI 10.1002/biot.201400026; Meneni S, 2007, BIOORGAN MED CHEM, V15, P3082, DOI 10.1016/j.bmc.2007.01.048; PEPPERKOK R, 1995, METHOD MOL CELL BIOL, V5, P112; Ross HH, 2011, J NEURO-ONCOL, V105, P485, DOI 10.1007/s11060-011-0621-6; Salic A, 2008, P NATL ACAD SCI USA, V105, P2415, DOI 10.1073/pnas.0712168105; Sokol AM, 2013, SCI REP-UK, V3, DOI 10.1038/srep03277; Sporbert A, 2002, MOL CELL, V10, P1355, DOI 10.1016/S1097-2765(02)00729-3; Stanek D, 2001, CHROMOSOMA, V110, P460, DOI 10.1007/s00412-001-0172-2; Stanojcic S, 2008, MOL CELL BIOL, V28, P5265, DOI 10.1128/MCB.00181-08; Tang XB, 2007, J NEUROSCI, V27, P5837, DOI 10.1523/JNEUROSCI.5048-06.2007; Zhao H, 2013, CYTOM PART A, V83, P979, DOI 10.1002/cyto.a.22396; Zink D, 1998, HUM GENET, V102, P241, DOI 10.1007/s004390050686	35	5	6	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132393	10.1371/journal.pone.0132393	http://dx.doi.org/10.1371/journal.pone.0132393			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161977	Green Submitted, Green Published, gold			2022-12-26	WOS:000358162300128
J	Zhang, JC; Gao, Y; Yu, MY; Wu, HB; Ai, ZY; Wu, YY; Liu, HL; Du, J; Guo, ZK; Zhang, Y				Zhang, Jingcheng; Gao, Yang; Yu, Mengying; Wu, Haibo; Ai, Zhiying; Wu, Yongyan; Liu, Hongliang; Du, Juan; Guo, Zekun; Zhang, Yong			Retinoic Acid Induces Embryonic Stem Cell Differentiation by Altering Both Encoding RNA and microRNA Expression	PLOS ONE			English	Article							ONE-CARBON METABOLISM; DNA-METHYLATION; HISTONE DEACETYLASES; MAMMALIAN DEVELOPMENT; MOUSE EMBRYOS; SELF-RENEWAL; VISCERAL ENDODERM; PROGENITOR CELLS; GENE-REGULATION; MESSENGER-RNA	Retinoic acid (RA) is a vitamin A metabolite that is essential for early embryonic development and promotes stem cell neural lineage specification; however, little is known regarding the impact of RA on mRNA transcription and microRNA levels on embryonic stem cell differentiation. Here, we present mRNA microarray and microRNA high-output sequencing to clarify how RA regulates gene expression. Using mRNA microarray analysis, we showed that RA repressed pluripotency-associated genes while activating ectoderm markers in mouse embryonic stem cells (mESCs). Moreover, RA modulated the DNA methylation of mESCs by altering the expression of epigenetic-associated genes such as Dnmt3b and Dnmt3l. Furthermore, H3K4me2, a pluripotent histone modification, was repressed by RA stimulation. From microRNA sequence data, we identified two downregulated microRNAs, namely, miR200b and miR-200c, which regulated the pluripotency of stem cells. We found that miR-200b or miR-200c deficiency suppressed the expression of pluripotent genes, including Oct4 and Nanog, and activated the expression of the ectodermal marker gene Nestin. These results demonstrate that retinoid induces mESCs to differentiate by regulating miR-200b/200c. Our findings provide the landscapes of mRNA and microRNA gene networks and indicate the crucial role of miR-200b/200c in the RA-induced differentiation of mESCs.	[Zhang, Jingcheng; Gao, Yang; Yu, Mengying; Wu, Haibo; Wu, Yongyan; Liu, Hongliang; Guo, Zekun; Zhang, Yong] Northwest A&F Univ, Coll Vet Med, Yangling 712100, Shaanxi, Peoples R China; [Zhang, Jingcheng; Gao, Yang; Yu, Mengying; Wu, Haibo; Ai, Zhiying; Wu, Yongyan; Liu, Hongliang; Du, Juan; Guo, Zekun; Zhang, Yong] Northwest A&F Univ, Minist Agr, Key Lab Anim Biotechnol, Yangling 712100, Shaanxi, Peoples R China; [Ai, Zhiying; Du, Juan] Northwest A&F Univ, Coll Life Sci, Yangling 712100, Shaanxi, Peoples R China; [Zhang, Jingcheng] China Agr Univ, Coll Vet Med, Beijing 100094, Peoples R China	Northwest A&F University - China; Ministry of Agriculture & Rural Affairs; Northwest A&F University - China; Northwest A&F University - China; China Agricultural University	Guo, ZK (corresponding author), Northwest A&F Univ, Coll Vet Med, Yangling 712100, Shaanxi, Peoples R China.	gzk@nwsuaf.edu.cn; zhy1956@263.net	Wu, Yongyan/AAH-1471-2019; Zhang, Yong/K-7945-2016	Wu, Yongyan/0000-0003-1669-3860; Zhang, Yong/0000-0001-8642-4071	National High Technology Research and Development Program of China (863 Program) [2011AA100303]; National Natural Science Foundation of China [31172279]; Key Science and Technology Innovation Team in Shaanxi Province [2014KCT-26]	National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Science and Technology Innovation Team in Shaanxi Province	This work was supported by the National High Technology Research and Development Program of China (863 Program) (No. 2011AA100303) (http://www.863.gov.cn/), partly by a grant from the National Natural Science Foundation of China (No. 31172279) (http://www.nsfc.gov.cn/), and Key Science and Technology Innovation Team in Shaanxi Province (2014KCT-26) (http://www.sninfo.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agger K, 2007, NATURE, V449, P731, DOI 10.1038/nature06145; Ajamian F, 2003, NEUROSCI LETT, V346, P57, DOI 10.1016/S0304-3940(03)00545-7; Alison M, 2014, J BIOL CHEM; Anderson OS, 2012, J NUTR BIOCHEM, V23, P853, DOI 10.1016/j.jnutbio.2012.03.003; Buganim Y, 2013, NAT REV GENET, V14, P427, DOI 10.1038/nrg3473; Castelo-Branco G, 2014, STEM CELL REP, V3, P502, DOI 10.1016/j.stemcr.2014.07.008; Chen CC, 2012, J BIOL CHEM, V287, P33116, DOI 10.1074/jbc.C112.406975; Chew JL, 2005, MOL CELL BIOL, V25, P6031, DOI 10.1128/MCB.25.14.6031-6046.2005; Choi I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065771; CONLON RA, 1995, TRENDS GENET, V11, P314, DOI 10.1016/S0168-9525(00)89089-7; Dokmanovic M, 2007, MOL CANCER RES, V5, P981, DOI 10.1158/1541-7786.MCR-07-0324; Friso S, 2005, CURR DRUG METAB, V6, P37, DOI 10.2174/1389200052997339; Gadue P, 2006, P NATL ACAD SCI USA, V103, P16806, DOI 10.1073/pnas.0603916103; Golebiewska A, 2009, STEM CELLS, V27, P1298, DOI 10.1002/stem.59; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; HAWLEY SHB, 1995, GENE DEV, V9, P2923, DOI 10.1101/gad.9.23.2923; HO AM, 1994, J BIOL CHEM, V269, P28181; Holland LZ, 2007, NATURE, V447, P153, DOI 10.1038/447153a; Houbaviy HB, 2003, DEV CELL, V5, P351, DOI 10.1016/S1534-5807(03)00227-2; Hough SR, 2006, STEM CELLS, V24, P1467, DOI 10.1634/stemcells.2005-0475; Howe EN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049987; Huang HN, 2014, STEM CELL RES, V12, P338, DOI 10.1016/j.scr.2013.11.009; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Jirmanova L, 2002, ONCOGENE, V21, P5515, DOI 10.1038/sj.onc.1205728; Jones PA, 2001, SCIENCE, V293, P1068, DOI 10.1126/science.1063852; Kawasaki H, 2000, NEURON, V28, P31, DOI 10.1016/S0896-6273(00)00083-0; Kim JB, 2008, NATURE, V454, P646, DOI 10.1038/nature07061; Koh KP, 2011, CELL STEM CELL, V8, P200, DOI 10.1016/j.stem.2011.01.008; Kraushaar DC, 2012, J BIOL CHEM, V287, P22691, DOI 10.1074/jbc.M112.368241; Kuo LT, 2007, NEUROSCIENCE, V147, P491, DOI 10.1016/j.neuroscience.2007.04.023; Li E, 2002, NAT REV GENET, V3, P662, DOI 10.1038/nrg887; Li TY, 2014, MITOCHONDR DNA, P1; Liu Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068990; Loebel DAF, 2003, DEV BIOL, V264, P1, DOI 10.1016/S0012-1606(03)00390-7; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Melton C, 2010, NATURE, V463, P621, DOI 10.1038/nature08725; Mill J, 2008, AM J HUM GENET, V82, P696, DOI 10.1016/j.ajhg.2008.01.008; Morrisey EE, 1998, GENE DEV, V12, P3579, DOI 10.1101/gad.12.22.3579; Nakatake Y, 2006, MOL CELL BIOL, V26, P7772, DOI 10.1128/MCB.00468-06; Neri F, 2013, CELL, V155, P121, DOI 10.1016/j.cell.2013.08.056; Ng HH, 2011, NAT CELL BIOL, V13, P490, DOI 10.1038/ncb0511-490; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Okada Y, 2004, DEV BIOL, V275, P124, DOI 10.1016/j.ydbio.2004.07.038; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Paterson EL, 2008, THESCIENTIFICWORLDJO, V8, P901, DOI 10.1100/tsw.2008.115; Pearson JC, 2005, NAT REV GENET, V6, P893, DOI 10.1038/nrg1726; Perea-Gomez A, 2001, DEVELOPMENT, V128, P753; Pesce M, 1998, BIOESSAYS, V20, P722, DOI 10.1002/(SICI)1521-1878(199809)20:9&lt;722::AID-BIES5&gt;3.0.CO;2-I; Peter ME, 2009, CELL CYCLE, V8, P843, DOI 10.4161/cc.8.6.7907; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Ross SA, 2000, PHYSIOL REV, V80, P1021, DOI 10.1152/physrev.2000.80.3.1021; RUBERTE E, 1991, DEVELOPMENT, V111, P45; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Semba RD, 1998, NUTR REV, V56, pS38, DOI 10.1111/j.1753-4887.1998.tb01643.x; Simandi Z, 2010, FEBS LETT, V584, P3123, DOI 10.1016/j.febslet.2010.05.052; Smith AG, 2001, ANNU REV CELL DEV BI, V17, P435, DOI 10.1146/annurev.cellbio.17.1.435; Smith ZD, 2014, NATURE, V511, P611, DOI 10.1038/nature13581; Spallotta F, 2010, STEM CELLS, V28, P431, DOI 10.1002/stem.300; Sun GQ, 2007, P NATL ACAD SCI USA, V104, P15282, DOI 10.1073/pnas.0704089104; Tang F, 2007, GENE DEV, V21, P644, DOI 10.1101/gad.418707; Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299; Terling C, 1995, INT J DEV BIOL, V39, P947; Waltregny D, 2005, FASEB J, V19, P966, DOI 10.1096/fj.04-2303fje; Wang GY, 2013, P NATL ACAD SCI USA, V110, P2858, DOI 10.1073/pnas.1212769110; Watanabe D, 2002, MECH DEVELOP, V118, P187, DOI 10.1016/S0925-4773(02)00242-3; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; Wendling O, 2001, DEVELOPMENT, V128, P2031; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; WINNIER G, 1995, GENE DEV, V9, P2105, DOI 10.1101/gad.9.17.2105; Wu Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029043; Yang J, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0095-z; Yasuda S, 2006, GENES CELLS, V11, P1115, DOI 10.1111/j.1365-2443.2006.01000.x; Zeng LF, 2006, J CELL BIOL, V174, P1059, DOI 10.1083/jcb.200605113; Zhang J, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S8-S5	76	41	43	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132566	10.1371/journal.pone.0132566	http://dx.doi.org/10.1371/journal.pone.0132566			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26162091	gold, Green Published, Green Submitted			2022-12-26	WOS:000358162300153
J	Bonnemaison, ML; Back, N; Duffy, ME; Ralle, M; Mains, RE; Eipper, BA				Bonnemaison, Mathilde L.; Back, Nils; Duffy, Megan E.; Ralle, Martina; Mains, Richard E.; Eipper, Betty A.			Adaptor Protein-1 Complex Affects the Endocytic Trafficking and Function of Peptidylglycine alpha-Amidating Monooxygenase, a Luminal Cuproenzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adaptor protein; copper; peptide biosynthesis; pituitary gland; secretion; AtT-20; Atp7a; PAM; amidation	GRANULE-ASSOCIATED PROTEINS; AMYLOID PRECURSOR PROTEIN; SECRETORY GRANULE; MEMBRANE-PROTEIN; ATT-20 CELLS; ADRENOCORTICOTROPIN-ENDORPHIN; COPPER TRANSPORTER; JOINING PEPTIDE; MEDNIK SYNDROME; RECEPTOR SORLA	Background: Trafficking of Atp7a, a copper pump, and PAM-1, a cuproenzyme, depends on adaptor protein-1 complex (AP-1). Results: Disruption of AP-1-dependent late endosomal trafficking diminishes the ability of PAM to retain copper and produce amidated peptides. Conclusion: Impaired AP-1 function alters luminal copper delivery to PAM. Significance: Altered luminal cuproenzyme function may contribute to diseases associated with diminished AP-1 function. The adaptor protein-1 complex (AP-1), which transports cargo between the trans-Golgi network and endosomes, plays a role in the trafficking of Atp7a, a copper-transporting P-type ATPase, and peptidylglycine -amidating monooxygenase (PAM), a copper-dependent membrane enzyme. Lack of any of the four AP-1 subunits impairs function, and patients with MEDNIK syndrome, a rare genetic disorder caused by lack of expression of the sigma 1A subunit, exhibit clinical and biochemical signs of impaired copper homeostasis. To explore the role of AP-1 in copper homeostasis in neuroendocrine cells, we used corticotrope tumor cells in which AP-1 function was diminished by reducing expression of its 1A subunit. Copper levels were unchanged when AP-1 function was impaired, but cellular levels of Atp7a declined slightly. The ability of PAM to function was assessed by monitoring 18-kDa fragment-NH2 production from proopiomelanocortin. Reduced AP-1 function made 18-kDa fragment amidation more sensitive to inhibition by bathocuproine disulfonate, a cell-impermeant Cu(I) chelator. The endocytic trafficking of PAM was altered, and PAM-1 accumulated on the cell surface when AP-1 levels were reduced. Reduced AP-1 function increased the Atp7a presence in early/recycling endosomes but did not alter the ability of copper to stimulate its appearance on the plasma membrane. Co-immunoprecipitation of a small fraction of PAM and Atp7a supports the suggestion that copper can be transferred directly from Atp7a to PAM, a process that can occur only when both proteins are present in the same subcellular compartment. Altered luminal cuproenzyme function may contribute to deficits observed when the AP-1 function is compromised.	[Bonnemaison, Mathilde L.; Eipper, Betty A.] Univ Connecticut, Ctr Hlth, Dept Mol Biol & Biophys, Farmington, CT 06030 USA; [Mains, Richard E.; Eipper, Betty A.] Univ Connecticut, Ctr Hlth, Dept Neurosci, Farmington, CT 06030 USA; [Back, Nils] Univ Helsinki, Fac Med, Dept Anat, FIN-00014 Helsinki, Finland; [Duffy, Megan E.; Ralle, Martina] Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portland, OR 97239 USA	University of Connecticut; University of Connecticut; University of Helsinki; Oregon Health & Science University	Eipper, BA (corresponding author), Univ Connecticut, Ctr Hlth, Dept Mol Biol & Biophys, 263 Farmington Ave, Farmington, CT 06030 USA.	eipper@uchc.edu	Regan, Clinton/E-6250-2012; Ralle, Martina/H-2936-2019	Back, Nils/0000-0001-9992-3726	National Institutes of Health [DK-32949, GM-090016, S10-RR-025512]; Perklen and Liv och Halsa Foundations; Finska Lakaresallskapet; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR025512] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK032949, R37DK032949, R01DK032949] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM090016] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Perklen and Liv och Halsa Foundations; Finska Lakaresallskapet; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK-32949 (to B. A. E.), GM-090016 (to M. R.), and S10-RR-025512 (to M. R.). This work was also supported by grants from the Perklen and Liv och Halsa Foundations and Finska Lakaresallskapet (to N. B.). The authors declare that they have no conflicts of interest with the contents of this article.	Acevedo KM, 2014, J BIOL CHEM, V289, P11007, DOI 10.1074/jbc.M113.538710; Back N, 2010, TRAFFIC, V11, P972, DOI 10.1111/j.1600-0854.2010.01066.x; Barry AN, 2011, J BIOL CHEM, V286, P26585, DOI 10.1074/jbc.M111.229039; Bell J, 2003, BIOCHEMISTRY-US, V42, P7133, DOI 10.1021/bi034247v; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Bonnemaison M, 2014, TRAFFIC, V15, P1099, DOI 10.1111/tra.12194; Bousquet-Moore D, 2009, ENDOCRINOLOGY, V150, P1739, DOI 10.1210/en.2008-1202; Canuel M, 2008, BIOCHEM BIOPH RES CO, V366, P724, DOI 10.1016/j.bbrc.2007.12.015; Cobbold C, 2002, HUM MOL GENET, V11, P2855, DOI 10.1093/hmg/11.23.2855; CULLEN EI, 1987, MOL ENDOCRINOL, V1, P583, DOI 10.1210/mend-1-9-583; Czyzyk TA, 2005, DEV BIOL, V287, P301, DOI 10.1016/j.ydbio.2005.09.001; D'Souza RS, 2014, CURR BIOL, V24, P1187, DOI 10.1016/j.cub.2014.04.003; De M, 2007, J BIOL CHEM, V282, P23362, DOI 10.1074/jbc.M702891200; Dodani SC, 2011, P NATL ACAD SCI USA, V108, P5980, DOI 10.1073/pnas.1009932108; EIPPER BA, 1986, J BIOL CHEM, V261, P8686; El Meskini R, 2003, J BIOL CHEM, V278, P12278, DOI 10.1074/jbc.M211413200; Francone VP, 2010, MOL ENDOCRINOL, V24, P1543, DOI 10.1210/me.2009-0381; Gaier ED, 2013, J NEUROSCI RES, V91, P2, DOI 10.1002/jnr.23143; Hamza I, 2003, P NATL ACAD SCI USA, V100, P1215, DOI 10.1073/pnas.0336230100; Heldwein EE, 2004, P NATL ACAD SCI USA, V101, P14108, DOI 10.1073/pnas.0406102101; Hellman NE, 2002, ANNU REV NUTR, V22, P439, DOI 10.1146/annurev.nutr.22.012502.114457; Hirokawa N, 2009, NAT REV MOL CELL BIO, V10, P682, DOI 10.1038/nrm2774; Holloway ZG, 2013, MOL BIOL CELL, V24, P1735, DOI 10.1091/mbc.E12-08-0625; Huotari J, 2011, EMBO J, V30, P3481, DOI 10.1038/emboj.2011.286; Jiang N, 2000, DEV BIOL, V226, P118, DOI 10.1006/dbio.2000.9832; Luck AN, 2012, CURR TOP MEMBR, V69, P3, DOI 10.1016/B978-0-12-394390-3.00001-X; MAINS RE, 1978, J BIOL CHEM, V253, P651; MALTESE JY, 1992, MOL ENDOCRINOL, V6, P1998, DOI 10.1210/me.6.12.1998; Martinelli D, 2014, ANN NY ACAD SCI, V1314, P55, DOI 10.1111/nyas.12426; Martinelli D, 2013, BRAIN, V136, P872, DOI 10.1093/brain/awt012; MAY V, 1986, ENDOCRINOLOGY, V118, P1284, DOI 10.1210/endo-118-4-1284; Meskini RE, 2000, ENDOCRINOLOGY, V141, P3020; Meyer C, 2001, J CELL SCI, V114, P4469; Meyer C, 2000, EMBO J, V19, P2193, DOI 10.1093/emboj/19.10.2193; Milgram SL, 1996, J BIOL CHEM, V271, P17526, DOI 10.1074/jbc.271.29.17526; MILGRAM SL, 1994, J CELL BIOL, V124, P33, DOI 10.1083/jcb.124.1.33; MILGRAM SL, 1992, J CELL BIOL, V117, P717, DOI 10.1083/jcb.117.4.717; Milgram SL, 1997, J CELL SCI, V110, P695; MILGRAM SL, 1994, J CELL SCI, V107, P737; Montpetit A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000296; Nakagawa T, 2000, CELL, V103, P569, DOI 10.1016/S0092-8674(00)00161-6; Niciu MJ, 2006, NEUROSCIENCE, V139, P947, DOI 10.1016/j.neuroscience.2006.01.044; Niciu MJ, 2007, NEUROBIOL DIS, V27, P278, DOI 10.1016/j.nbd.2007.05.004; Nielsen MS, 2007, MOL CELL BIOL, V27, P6842, DOI 10.1128/MCB.00815-07; Nose Y, 2010, J BIOL CHEM, V285, P32385, DOI 10.1074/jbc.M110.143826; Orzech E, 2001, J BIOL CHEM, V276, P31340, DOI 10.1074/jbc.M101054200; Otoikhian A, 2012, J AM CHEM SOC, V134, P10458, DOI 10.1021/ja301221s; Perrin L, 2013, J CELL SCI, V126, P4950, DOI 10.1242/jcs.130575; Rae TD, 1999, SCIENCE, V284, P805, DOI 10.1126/science.284.5415.805; Rajagopal C, 2010, J BIOL CHEM, V285, P34632, DOI 10.1074/jbc.M110.145334; Robinson MS, 2010, DEV CELL, V18, P324, DOI 10.1016/j.devcel.2009.12.015; SCHNABEL E, 1989, MOL ENDOCRINOL, V3, P1223, DOI 10.1210/mend-3-8-1223; Setty SRG, 2008, NATURE, V454, P1142, DOI 10.1038/nature07163; Steveson TC, 2003, ENDOCRINOLOGY, V144, P188, DOI 10.1210/en.2002-220716; Tanaka S, 1997, J HISTOCHEM CYTOCHEM, V45, P425, DOI 10.1177/002215549704500310; Traikov S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109372; Willnow TE, 2013, J CELL SCI, V126, P2751, DOI 10.1242/jcs.125393; YUN HY, 1993, ARCH BIOCHEM BIOPHYS, V301, P77, DOI 10.1006/abbi.1993.1117; Zizioli D, 1999, J BIOL CHEM, V274, P5385, DOI 10.1074/jbc.274.9.5385	59	5	5	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2015	290	35					21264	21279		10.1074/jbc.M115.641027	http://dx.doi.org/10.1074/jbc.M115.641027			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ5IS	26170456	hybrid, Green Published			2022-12-26	WOS:000360637600007
J	Shashikanth, N; Petrova, YI; Park, S; Chekan, J; Maiden, S; Spano, M; Ha, T; Gumbiner, BM; Leckband, DE				Shashikanth, Nitesh; Petrova, Yuliya I.; Park, Seongjin; Chekan, Jillian; Maiden, Stephanie; Spano, Martha; Ha, Taekjip; Gumbiner, Barry M.; Leckband, Deborah E.			Allosteric Regulation of E-Cadherin Adhesion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						allosteric regulation; cadherin-1 (CDH1) (epithelial cadherin) (E-cadherin); catenin; cell adhesion; kinetics	LIGAND BINDING-KINETICS; CELL-ADHESION; ALPHA-CATENIN; LATERAL DIMERIZATION; TISSUE MORPHOGENESIS; P120 CATENIN; MUTATIONS; DOMAIN; PHOSPHORYLATION; CONFORMATIONS	Background: Measured binding kinetics between Colo 205 cells tested the postulate that E-cadherin adhesion is allosterically regulated. Results: p120 catenin dephosphorylation or cell treatment with activating anti-E-cadherin antibody increased E-cadherin binding affinities by 2-3-fold. Conclusion: Perturbations that do not directly affect the binding site enhanced the adhesive function of E-cadherin. Significance: These biophysical measurements demonstrated that E-cadherin is allosterically regulated. Cadherins are transmembrane adhesion proteins that maintain intercellular cohesion in all tissues, and their rapid regulation is essential for organized tissue remodeling. Despite some evidence that cadherin adhesion might be allosterically regulated, testing of this has been hindered by the difficulty of quantifying altered E-cadherin binding affinity caused by perturbations outside the ectodomain binding site. Here, measured kinetics of cadherin-mediated intercellular adhesion demonstrated quantitatively that treatment with activating, anti-E-cadherin antibodies or the dephosphorylation of a cytoplasmic binding partner, p120(ctn), increased the homophilic binding affinity of E-cadherin. Results obtained with Colo 205 cells, which express inactive E-cadherin and do not aggregate, demonstrated that four treatments, which induced Colo 205 aggregation and p120(ctn) dephosphorylation, triggered quantitatively similar increases in E-cadherin affinity. Several processes can alter cell aggregation, but these results directly demonstrated the allosteric regulation of cell surface E-cadherin by p120(ctn) dephosphorylation.	[Shashikanth, Nitesh; Ha, Taekjip; Leckband, Deborah E.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA; [Park, Seongjin; Ha, Taekjip] Univ Illinois, Dept Phys, Urbana, IL 61801 USA; [Chekan, Jillian; Leckband, Deborah E.] Univ Illinois, Dept Chem & Biomol Engn, Urbana, IL 61801 USA; [Petrova, Yuliya I.; Maiden, Stephanie; Spano, Martha; Gumbiner, Barry M.] Univ Virginia, Sch Med, Dept Cell Biol, Charlottesville, VA 22908 USA; [Ha, Taekjip] Howard Hughes Med Inst, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Virginia; Howard Hughes Medical Institute	Leckband, DE (corresponding author), Dept Chem & Biomol Engn, 600 S Mathews Ave, Urbana, IL 61801 USA.	leckband@illinois.edu	Regan, Clinton/E-6250-2012; Ha, Taekjip/B-9506-2009; Park, Seongjin/AAU-9963-2020	Ha, Taekjip/0000-0003-2195-6258; Shashikanth, Nitesh/0000-0003-4114-8178; Maiden, Stephanie/0000-0002-5144-386X	National Institutes of Health [RO1 GM097443, R01 GM106659]; National Science Foundation (NSF) [CMMI 10-29871, PHY-1147498]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097443, R01GM106659] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF)(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 GM097443 (to D.E.L.) and R01 GM106659 (to B.M.G.). This work was also supported by National Science Foundation (NSF) Grants CMMI 10-29871 (to D.E.L.) and PHY-1147498 (to T.H.). The authors declare that they have no conflicts of interest with the contents of this article.	Aono S, 1999, J CELL BIOL, V145, P551, DOI 10.1083/jcb.145.3.551; Barry AK, 2014, J CELL SCI, V127, P1779, DOI 10.1242/jcs.139014; Berx G, 1998, HUM MUTAT, V12, P226, DOI 10.1002/(SICI)1098-1004(1998)12:4<226::AID-HUMU2>3.0.CO;2-D; Quang BAT, 2013, CURR BIOL, V23, P2197, DOI 10.1016/j.cub.2013.09.015; Brieher WM, 1996, J CELL BIOL, V135, P487, DOI 10.1083/jcb.135.2.487; Chen W, 2008, CELL MOL BIOENG, V1, P276, DOI 10.1007/s12195-008-0024-8; Chen X, 2006, J CELL BIOL, V174, P301, DOI 10.1083/jcb.200602062; Chen XJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008411; Chesla SE, 1998, BIOPHYS J, V75, P1553, DOI 10.1016/S0006-3495(98)74074-3; Chien YH, 2008, J BIOL CHEM, V283, P1848, DOI 10.1074/jbc.M708044200; Chu YS, 2004, J CELL BIOL, V167, P1183, DOI 10.1083/jcb.200403043; Ciesiolka M, 2004, J CELL SCI, V117, P4325, DOI 10.1242/jcs.01298; COOPER A, 1984, EUR BIOPHYS J BIOPHY, V11, P103, DOI 10.1007/BF00276625; Daneshjou N, 2015, J CELL BIOL, V208, P23, DOI 10.1083/jcb.201409108; Daszykowski M, 2002, J CHEM INF COMP SCI, V42, P500, DOI 10.1021/ci010384s; Emond MR, 2011, J CELL BIOL, V195, P1115, DOI 10.1083/jcb.201108115; Evans EA, 2007, SCIENCE, V316, P1148, DOI 10.1126/science.1137592; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; Harrison OJ, 2011, STRUCTURE, V19, P244, DOI 10.1016/j.str.2010.11.016; Hedgepeth CM, 1997, DEV BIOL, V185, P82, DOI 10.1006/dbio.1997.8552; Hong S, 2013, J CELL BIOL, V201, P131, DOI 10.1083/jcb.201211054; Huang B, 2008, SCIENCE, V319, P810, DOI 10.1126/science.1153529; Huang J, 2007, J IMMUNOL, V179, P7653, DOI 10.4049/jimmunol.179.11.7653; Huang J, 2010, NATURE, V464, P932, DOI 10.1038/nature08944; Huber O, 1999, J CELL SCI, V112, P4415; Hunter R., 1989, FDN COLLOID SCI, P440; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ireton RC, 2002, J CELL BIOL, V159, P465, DOI 10.1083/jcb.200205115; Itoh K, 2010, P NATL ACAD SCI USA, V107, P7775, DOI 10.1073/pnas.0912978107; Jiang N, 2011, IMMUNITY, V34, P13, DOI 10.1016/j.immuni.2010.12.017; Kaibuchi K, 1999, ANNU REV BIOCHEM, V68, P459, DOI 10.1146/annurev.biochem.68.1.459; Kardash E, 2010, NAT CELL BIOL, V12, P47, DOI 10.1038/ncb2003; Kern D, 2003, CURR OPIN STRUC BIOL, V13, P748, DOI 10.1016/j.sbi.2003.10.008; Kitov PI, 2003, J AM CHEM SOC, V125, P16271, DOI 10.1021/ja038223n; Klingelhofer J, 2002, MOL CELL BIOL, V22, P7449, DOI 10.1128/MCB.22.21.7449-7458.2002; KOFLER R, 1977, J IMMUNOL METHODS, V16, P201, DOI 10.1016/0022-1759(77)90198-3; Langer MD, 2012, J CELL SCI, V125, P2478, DOI 10.1242/jcs.101147; Law SM, 2014, P NATL ACAD SCI USA, V111, P12067, DOI 10.1073/pnas.1405831111; Long M, 2001, ANN BIOMED ENG, V29, P935, DOI 10.1114/1.1415529; Lu CF, 2001, P NATL ACAD SCI USA, V98, P2393, DOI 10.1073/pnas.041618598; Luo BH, 2004, J BIOL CHEM, V279, P10215, DOI 10.1074/jbc.M312732200; Maitre JL, 2012, SCIENCE, V338, P253, DOI 10.1126/science.1225399; Mammen M, 1998, ANGEW CHEM INT EDIT, V37, P2755; Manning ML, 2010, P NATL ACAD SCI USA, V107, P12517, DOI 10.1073/pnas.1003743107; Motlagh HN, 2014, NATURE, V508, P331, DOI 10.1038/nature13001; NAGAFUCHI A, 1994, J CELL BIOL, V127, P235, DOI 10.1083/jcb.127.1.235; Nelson WJ, 2008, BIOCHEM SOC T, V36, P149, DOI 10.1042/BST0360149; OZAWA M, 1990, MECH DEVELOP, V33, P49, DOI 10.1016/0925-4773(90)90134-8; Ozawa M, 2002, J BIOL CHEM, V277, P19600, DOI 10.1074/jbc.M202029200; Ozawa M, 1998, J CELL BIOL, V142, P1605, DOI 10.1083/jcb.142.6.1605; Petrova YI, 2012, MOL BIOL CELL, V23, P2092, DOI 10.1091/mbc.E11-12-1060; Prakasam A, 2006, BIOCHEMISTRY-US, V45, P6930, DOI 10.1021/bi060213m; Rakshit S, 2012, P NATL ACAD SCI USA, V109, P18815, DOI 10.1073/pnas.1208349109; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Shapiro L, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003053; Sotomayor M, 2008, BIOPHYS J, V94, P4621, DOI 10.1529/biophysj.107.125591; Stambolic V, 1996, CURR BIOL, V6, P1664, DOI 10.1016/S0960-9822(02)70790-2; Tabdili H, 2012, J CELL SCI, V125, P4362, DOI 10.1242/jcs.105775; Tabdili H, 2012, J CELL SCI, V125, P3299, DOI 10.1242/jcs.087395; Thomas WA, 2013, J BIOL CHEM, V288, P4957, DOI 10.1074/jbc.M112.403774; Thoumine O, 2005, BIOPHYS J, V89, pL40, DOI 10.1529/biophysj.105.071688; Tsuiji H, 2007, J BIOL CHEM, V282, P12871, DOI 10.1074/jbc.M611725200; Vorup-Jensen T, 2003, P NATL ACAD SCI USA, V100, P1873, DOI 10.1073/pnas.0237387100; Waschke J, 2004, AM J PHYSIOL-HEART C, V286, pH394, DOI 10.1152/ajpheart.00221.2003; Weber GF, 2012, DEV CELL, V22, P104, DOI 10.1016/j.devcel.2011.10.013; Wessel F, 2014, NAT IMMUNOL, V15, P223, DOI 10.1038/ni.2824; Williams TE, 2000, BIOPHYS J, V79, P1858, DOI 10.1016/S0006-3495(00)76435-6; Wu J, 1998, HYBRIDOMA, V17, P175, DOI 10.1089/hyb.1998.17.175; Wu Y, 2015, DEV CELL, V32, P139, DOI 10.1016/j.devcel.2014.12.003; Wu YH, 2011, NATURE, V475, P510, DOI 10.1038/nature10183; Wu YH, 2010, P NATL ACAD SCI USA, V107, P17592, DOI 10.1073/pnas.1011247107; Xia XB, 2004, HYBRIDOMA HYBRIDOM, V23, P343, DOI 10.1089/hyb.2004.23.343; Xia XB, 2003, BIOCHEMISTRY-US, V42, P9195, DOI 10.1021/bi034597h; Xia XB, 2006, EXP CELL RES, V312, P3336, DOI 10.1016/j.yexcr.2006.07.007; Yap AS, 1998, J CELL BIOL, V141, P779, DOI 10.1083/jcb.141.3.779; Yap AS, 1997, CURR BIOL, V7, P308, DOI 10.1016/S0960-9822(06)00154-0; Zhang YD, 2013, SCI WORLD J, DOI 10.1155/2013/130134; Zhong Y, 1999, J CELL BIOL, V144, P351, DOI 10.1083/jcb.144.2.351	78	31	31	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2015	290	35					21749	21761		10.1074/jbc.M115.657098	http://dx.doi.org/10.1074/jbc.M115.657098			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ5IS	26175155	hybrid, Green Published			2022-12-26	WOS:000360637600046
J	Chugh, D; Ali, I; Bakochi, A; Bahonjic, E; Etholm, L; Ekdahl, CT				Chugh, Deepti; Ali, Idrish; Bakochi, Anahita; Bahonjic, Elma; Etholm, Lars; Ekdahl, Christine T.			Alterations in Brain Inflammation, Synaptic Proteins, and Adult Hippocampal Neurogenesis during Epileptogenesis in Mice Lacking Synapsin2	PLOS ONE			English	Article							TEMPORAL-LOBE EPILEPSY; CELL-ADHESION MOLECULE; I-DEFICIENT MICE; KNOCK-OUT MICE; INHIBITORY SYNAPSES; STATUS EPILEPTICUS; RECEPTOR SUBUNITS; DENTATE GYRUS; NEUROTRANSMITTER RELEASE; COTRANSPORTER KCC2	Synapsins are pre-synaptic vesicle-associated proteins linked to the pathogenesis of epilepsy through genetic association studies in humans. Deletion of synapsins causes an excitatory/inhibitory imbalance, exemplified by the epileptic phenotype of synapsin knock-out mice. These mice develop handling-induced tonic-clonic seizures starting at the age of about 3 months. Hence, they provide an opportunity to study epileptogenic alterations in a temporally controlled manner. Here, we evaluated brain inflammation, synaptic protein expression, and adult hippocampal neurogenesis in the epileptogenic (1 and 2 months of age) and tonic-clonic (3.5-4 months) phase of synapsin 2 knockout mice using immunohistochemical and biochemical assays. In the epileptogenic phase, region-specific microglial activation was evident, accompanied by an increase in the chemokine receptor CX3CR1, interleukin-6, and tumor necrosis factor-alpha, and a decrease in chemokine keratinocyte chemoattractant/ growth-related oncogene. Both post-synaptic density-95 and gephyrin, scaffolding proteins at excitatory and inhibitory synapses, respectively, showed a significant up-regulation primarily in the cortex. Furthermore, we observed an increase in the inhibitory adhesion molecules neuroligin-2 and neurofascin and potassium chloride co-transporter KCC2. Decreased expression of gamma-aminobutyric acid receptor-delta subunit and cholecystokinin was also evident. Surprisingly, hippocampal neurogenesis was reduced in the epileptogenic phase. Taken together, we report molecular alterations in brain inflammation and excitatory/inhibitory balance that could serve as potential targets for therapeutics and diagnostic biomarkers. In addition, the regional differences in brain inflammation and synaptic protein expression indicate an epileptogenic zone from where the generalized seizures in synapsin 2 knockout mice may be initiated or spread.	[Chugh, Deepti; Ali, Idrish; Bakochi, Anahita; Ekdahl, Christine T.] Lund Univ, Div Clin Neurophysiol, Inflammat & Stem Cell Therapy Grp, SE-22184 Lund, Sweden; [Chugh, Deepti; Ali, Idrish; Bakochi, Anahita; Ekdahl, Christine T.] Lund Univ, Lund Epilepsy Ctr, SE-22184 Lund, Sweden; [Bahonjic, Elma; Etholm, Lars] Univ Oslo, Inst Basic Med Sci, Dept Physiol, Oslo, Norway; [Etholm, Lars] Oslo Univ Hosp, Clin Neurophysiol Sect, Dept Neurol, Oslo, Norway	Lund University; Lund University; University of Oslo; University of Oslo	Ekdahl, CT (corresponding author), Lund Univ, Div Clin Neurophysiol, Inflammat & Stem Cell Therapy Grp, SE-22184 Lund, Sweden.	Christine.Ekdahl_Clementson@med.lu.se	Ali, Idrish/P-4989-2018; Ali, Idrish/K-1706-2015	Ali, Idrish/0000-0002-0971-4654; Ali, Idrish/0000-0002-0971-4654; Bakochi, Anahita/0000-0001-8144-8525	Swedish Research Council; ALF Grant; Zoega's Foundation; O. E. and Edla Johanssons Scientific Foundation; Tore Nilson's Foundation; Ahlen's Foundation; European Union's Seventh Framework Programme (FP7) [602102]	Swedish Research Council(Swedish Research CouncilEuropean Commission); ALF Grant; Zoega's Foundation; O. E. and Edla Johanssons Scientific Foundation; Tore Nilson's Foundation; Ahlen's Foundation; European Union's Seventh Framework Programme (FP7)	This work was supported by the Swedish Research Council, ALF Grant for funding for medical training and research, Zoega's Foundation, O. E. and Edla Johanssons Scientific Foundation, Tore Nilson's Foundation, and Ahlen's Foundation. The research leading to these results has received funding from the European Union's Seventh Framework Programme (FP7/2007-2013) under grant agreement no602102 (EPITARGET). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali I, 2015, NEUROBIOL DIS, V74, P194, DOI 10.1016/j.nbd.2014.11.009; Avdic U, 2014, CELLULAR MOLECULAR I; Avoli M, 1996, J NEUROSCI, V16, P3912; Baldelli P, 2007, J NEUROSCI, V27, P13520, DOI 10.1523/JNEUROSCI.3151-07.2007; Bengzon J, 1997, P NATL ACAD SCI USA, V94, P10432, DOI 10.1073/pnas.94.19.10432; Bonde S, 2006, EUR J NEUROSCI, V23, P965, DOI 10.1111/j.1460-9568.2006.04635.x; Chiappalone M, 2009, CEREB CORTEX, V19, P1422, DOI 10.1093/cercor/bhn182; CHIN LS, 1995, P NATL ACAD SCI USA, V92, P9230, DOI 10.1073/pnas.92.20.9230; Chugh D, 2013, EXP NEUROL, V250, P176, DOI 10.1016/j.expneurol.2013.09.005; Corradi A, 2008, J CELL SCI, V121, P3042, DOI 10.1242/jcs.035063; Dalva MB, 2007, NAT REV NEUROSCI, V8, P206, DOI 10.1038/nrn2075; Delattre V, 2013, SCI REP-UK, V3, DOI 10.1038/srep02897; Ekdahl CT, 2003, P NATL ACAD SCI USA, V100, P13632, DOI 10.1073/pnas.2234031100; Etholm L, 2013, EXP NEUROL, V247, P59, DOI 10.1016/j.expneurol.2013.03.025; Etholm L, 2012, EPILEPSY RES, V99, P252, DOI 10.1016/j.eplepsyres.2011.12.004; Etholm L, 2011, BRAIN RES, V1383, P270, DOI 10.1016/j.brainres.2011.01.070; Etholm L, 2009, EPILEPSY BEHAV, V14, P582, DOI 10.1016/j.yebeh.2009.02.021; Ferreira A, 1998, MOL MED, V4, P22, DOI 10.1007/BF03401726; Fritschy JM, 2008, FRONT MOL NEUROSCI, V1, DOI 10.3389/neuro.02.005.2008; Garcia CC, 2004, J MED GENET, V41, P183, DOI 10.1136/jmg.2003.013680; Gitler D, 2004, J NEUROSCI, V24, P11368, DOI 10.1523/JNEUROSCI.3795-04.2004; GONZALEZ M, 2013, PUBMED CENTRAL, P85234, DOI DOI 10.3389/FNCEL.2013.00113; Gonzalez MI, 2013, EPILEPSIA, V54, P616, DOI 10.1111/epi.12063; Greco B, 2013, BEHAV BRAIN RES, V251, P65, DOI 10.1016/j.bbr.2012.12.015; Harrison JK, 1998, P NATL ACAD SCI USA, V95, P10896, DOI 10.1073/pnas.95.18.10896; Hefft S, 2005, NAT NEUROSCI, V8, P1319, DOI 10.1038/nn1542; Hilfiker S, 1999, PHILOS T ROY SOC B, V354, P269, DOI 10.1098/rstb.1999.0378; Hines RM, 2008, J NEUROSCI, V28, P6055, DOI 10.1523/JNEUROSCI.0032-08.2008; Jackson J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035557; Jedlicka P, 2013, BRAIN STRUCTURE FUNC; Jedlicka P, 2011, CEREB CORTEX, V21, P357, DOI 10.1093/cercor/bhq100; Kao HT, 2008, J COMP NEUROL, V507, P1860, DOI 10.1002/cne.21643; Keith D, 2008, FRONT MOL NEUROSCI, V1, DOI 10.3389/neuro.02.004.2008; Ketzef M, 2011, NEUROSCIENCE, V189, P108, DOI 10.1016/j.neuroscience.2011.05.030; Knuesel I, 2001, EUR J NEUROSCI, V13, P1113, DOI 10.1046/j.0953-816x.2001.01476.x; Kriebel M, 2011, J BIOL CHEM, V286, P24385, DOI 10.1074/jbc.M110.212191; Lakhan R, 2010, SYNAPSE, V64, P403, DOI 10.1002/syn.20740; Lehrmann E, 1997, J COMP NEUROL, V386, P461; Li H, 2007, NEURON, V56, P1019, DOI 10.1016/j.neuron.2007.10.039; LI L, 1995, P NATL ACAD SCI USA, V92, P9235, DOI 10.1073/pnas.92.20.9235; Limatola C, 2000, P NATL ACAD SCI USA, V97, P6197, DOI 10.1073/pnas.090105997; Medrihan L, 2014, CEREBRAL CORTEX; Medrihan L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2515; Mohapel P, 2004, NEUROBIOL DIS, V15, P196, DOI 10.1016/j.nbd.2003.11.010; Murashima YL, 2010, EPILEPSIA, V51, P131, DOI 10.1111/j.1528-1167.2010.02627.x; Noda M, 2011, J BIOL CHEM, V286, P2308, DOI 10.1074/jbc.M110.169839; Omari KM, 2009, AM J PATHOL, V174, P164, DOI 10.2353/ajpath.2009.080350; Parent JM, 1997, J NEUROSCI, V17, P3727; Pitkanen A, 2009, EPILEPSY BEHAV, V14, P16, DOI 10.1016/j.yebeh.2008.09.023; Pitkanen A, 2002, LANCET NEUROL, V1, P173, DOI 10.1016/S1474-4422(02)00073-X; Pitkanen A, 2014, NEUROTHERAPEUTICS, V11, P231, DOI 10.1007/s13311-014-0257-2; Poduri A, 2011, CURR OPIN GENET DEV, V21, P325, DOI 10.1016/j.gde.2011.01.005; Rivera C, 1999, NATURE, V397, P251, DOI 10.1038/16697; Rivera C, 2002, J CELL BIOL, V159, P747, DOI 10.1083/jcb.200209011; ROSAHL TW, 1995, NATURE, V375, P488, DOI 10.1038/375488a0; Roseti C, 2013, EPILEPSIA, V54, P1834, DOI 10.1111/epi.12354; Schmued LC, 1997, BRAIN RES, V751, P37, DOI 10.1016/S0006-8993(96)01387-X; Schuele SU, 2008, LANCET NEUROL, V7, P514, DOI 10.1016/S1474-4422(08)70108-X; Song JY, 1999, P NATL ACAD SCI USA, V96, P1100, DOI 10.1073/pnas.96.3.1100; STALEY KJ, 1995, SCIENCE, V269, P977, DOI 10.1126/science.7638623; Sun CC, 2013, MOL BRAIN, V6, DOI 10.1186/1756-6606-6-23; Tretter V, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00023; Turtzo LC, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-82; Varoqueaux F, 2004, EUR J CELL BIOL, V83, P449, DOI 10.1078/0171-9335-00410; Vezzani A, 2011, NAT REV NEUROL, V7, P31, DOI 10.1038/nrneurol.2010.178; Wood JC, 2011, EXP NEUROL, V229, P484, DOI 10.1016/j.expneurol.2011.03.019; Yeo SI, 2011, J NEUROIMMUNOL, V234, P93, DOI 10.1016/j.jneuroim.2011.03.005; Ying Z, 2004, EPILEPSIA, V45, P314, DOI 10.1111/j.0013-9580.2004.37703.x; Yu TS, 2014, NEUROSCIENTIST REV J	69	20	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132366	10.1371/journal.pone.0132366	http://dx.doi.org/10.1371/journal.pone.0132366			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177381	Green Published, gold			2022-12-26	WOS:000358197600106
J	Croes, M; Oner, FC; Kruyt, MC; Blokhuis, TJ; Bastian, O; Dhert, WJA; Alblas, J				Croes, Michiel; Oner, F. Cumhur; Kruyt, Moyo C.; Blokhuis, Taco J.; Bastian, Okan; Dhert, Wouter J. A.; Alblas, Jacqueline			Proinflammatory Mediators Enhance the Osteogenesis of Human Mesenchymal Stem Cells after Lineage Commitment	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; TOLL-LIKE RECEPTORS; ACTIVATED PROTEIN-KINASE; MARROW STROMAL CELLS; TNF-ALPHA; IN-VITRO; OSTEOBLAST DIFFERENTIATION; BONE REGENERATION; TISSUE REGENERATION; ENGINEERED BONE	Several inflammatory processes underlie excessive bone formation, including chronic inflammation of the spine, acute infections, or periarticular ossifications after trauma. This suggests that local factors in these conditions have osteogenic properties. Mesenchymal stem cells (MSCs) and their differentiated progeny contribute to bone healing by synthesizing extracellular matrix and inducing mineralization. Due to the variation in experimental designs used in vitro, there is controversy about the osteogenic potential of proinflammatory factors on MSCs. Our goal was to determine the specific conditions allowing the pro-osteogenic effects of distinct inflammatory stimuli. Human bone marrow MSCs were exposed to tumor necrosis factor alpha (TNF-alpha) and lipopolysaccharide (LPS). Cells were cultured in growth medium or osteogenic differentiation medium. Alternatively, bone morphogenetic protein 2 (BMP-2) was used as osteogenic supplement to simulate the conditions in vivo. Alkaline phosphatase activity and calcium deposition were indicators of osteogenicity. To elucidate lineage commitment-dependent effects, MSCs were pre-differentiated prior treatment. Our results show that TNF-a and LPS do not affect the expression of osteogenic markers by MSCs in the absence of an osteogenic supplement. In osteogenic differentiation medium or together with BMP-2 however, these mediators highly stimulated their alkaline phosphatase activity and subsequent matrix mineralization. In pre-osteoblasts, matrix mineralization was significantly increased by these mediators, but irrespective of the culture conditions. Our study shows that inflammatory factors potently enhance the osteogenic capacity of MSCs. These properties may be harnessed in bone regenerative strategies. Importantly, the commitment of MSCs to the osteogenic lineage greatly enhances their responsiveness to inflammatory signals.	[Croes, Michiel; Oner, F. Cumhur; Kruyt, Moyo C.; Dhert, Wouter J. A.; Alblas, Jacqueline] Univ Med Ctr Utrecht, Dept Orthoped, Utrecht, Netherlands; [Blokhuis, Taco J.; Bastian, Okan] Univ Med Ctr Utrecht, Dept Surg, Utrecht, Netherlands; [Dhert, Wouter J. A.] Univ Utrecht, Fac Vet Med, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University	Alblas, J (corresponding author), Univ Med Ctr Utrecht, Dept Orthoped, Utrecht, Netherlands.	j.alblas@umcutrecht.nl		Alblas, Jacqueline/0000-0002-2996-9697; Dhert, Wouter/0000-0001-9150-6143; Croes, Michiel/0000-0002-0270-8905				Arrington ED, 1996, CLIN ORTHOP RELAT R, P300, DOI 10.1097/00003086-199608000-00037; AUPHAN N, 1995, SCIENCE, V270, P286, DOI 10.1126/science.270.5234.286; Balboni TA, 2006, INT J RADIAT ONCOL, V65, P1289, DOI 10.1016/j.ijrobp.2006.03.053; Bandow K, 2010, BIOCHEM BIOPH RES CO, V402, P755, DOI 10.1016/j.bbrc.2010.10.103; Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890; Cho HH, 2006, STEM CELLS, V24, P2744, DOI 10.1634/stemcells.2006-0189; Cho HH, 2010, J CELL PHYSIOL, V223, P168, DOI 10.1002/jcp.22024; Cho TJ, 2002, J BONE MINER RES, V17, P513, DOI 10.1359/jbmr.2002.17.3.513; Claes L, 2012, NAT REV RHEUMATOL, V8, P133, DOI 10.1038/nrrheum.2012.1; Crisostomo PR, 2008, AM J PHYSIOL-CELL PH, V294, pC675, DOI 10.1152/ajpcell.00437.2007; Curran JM, 2006, BIOMATERIALS, V27, P4783, DOI 10.1016/j.biomaterials.2006.05.001; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Ding J, 2009, LIFE SCI, V84, P499, DOI 10.1016/j.lfs.2009.01.013; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Eijken M, 2006, MOL CELL ENDOCRINOL, V248, P87, DOI 10.1016/j.mce.2005.11.034; Gawlitta D, 2012, TISSUE ENG PT A, V18, P208, DOI [10.1089/ten.tea.2010.0731, 10.1089/ten.TEA.2010.0731]; Geiger M, 2003, ADV DRUG DELIVER REV, V55, P1613, DOI 10.1016/j.addr.2003.08.010; Gerstenfeld LC, 2003, J BONE MINER RES, V18, P1584, DOI 10.1359/jbmr.2003.18.9.1584; Geusens P, 2013, CURRENT OPINION RHEU; Gilbert L, 2002, J BIOL CHEM, V277, P2695, DOI 10.1074/jbc.M106339200; Hess K, 2009, BONE, V45, P367, DOI 10.1016/j.bone.2009.04.252; Huang H, 2011, CELL PROLIFERAT, V44, P420, DOI 10.1111/j.1365-2184.2011.00769.x; Jaiswal N, 1997, J CELL BIOCHEM, V64, P295, DOI 10.1002/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.0.CO;2-I; Jaiswal RK, 2000, J BIOL CHEM, V275, P9645, DOI 10.1074/jbc.275.13.9645; Lacey DC, 2009, OSTEOARTHR CARTILAGE, V17, P735, DOI 10.1016/j.joca.2008.11.011; Langenbach F, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt328; LeGeros RZ, 2002, CLIN ORTHOP RELAT R, P81; Li CH, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt456; Lories RJU, 2012, RHEUM DIS CLIN N AM, V38, P555, DOI 10.1016/j.rdc.2012.08.003; Lu ZF, 2012, STEM CELLS DEV, V21, P2420, DOI 10.1089/scd.2011.0589; Mo IFY, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-52; Mountziaris PM, 2008, TISSUE ENG PART B-RE, V14, P179, DOI 10.1089/ten.teb.2008.0038; Mountziaris PM, 2011, TISSUE ENG PART B-RE, V17, P393, DOI [10.1089/ten.teb.2011.0182, 10.1089/ten.TEB.2011.0182]; Osyczka AM, 2004, CELLS TISSUES ORGANS, V176, P109, DOI 10.1159/000075032; Petite H, 2000, NAT BIOTECHNOL, V18, P959, DOI 10.1038/79449; Prins HJ, 2014, STEM CELL RES, V12, P428, DOI 10.1016/j.scr.2013.12.001; Rundle CH, 2006, BONE, V38, P521, DOI 10.1016/j.bone.2005.09.015; Ryoo HM, 2006, GENE, V366, P51, DOI 10.1016/j.gene.2005.10.011; Schmidt-Bleek K, 2014, EXPERT OPIN BIOL TH, V14, P247, DOI 10.1517/14712598.2014.857653; Takayanagi H, 2009, NAT REV RHEUMATOL, V5, P667, DOI 10.1038/nrrheum.2009.217; Tomchuck SL, 2008, STEM CELLS, V26, P99, DOI 10.1634/stemcells.2007-0563; Vincent C, 2009, J BONE MINER RES, V24, P1434, DOI [10.1359/jbmr.090305, 10.1359/JBMR.090305]; Yang X, 2007, BONE, V41, P928, DOI 10.1016/j.bone.2007.07.022	43	53	57	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132781	10.1371/journal.pone.0132781	http://dx.doi.org/10.1371/journal.pone.0132781			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176237	Green Published, gold, Green Submitted			2022-12-26	WOS:000358197600155
J	Zhan, XY; Zhang, L; Zhou, BK; Zhu, P; Zhang, SX; Xu, MG				Zhan, Xiaoying; Zhang, Li; Zhou, Baoku; Zhu, Ping; Zhang, Shuxiang; Xu, Minggang			Changes in Olsen Phosphorus Concentration and Its Response to Phosphorus Balance in Black Soils under Different Long-Term Fertilization Patterns	PLOS ONE			English	Article							MAIZE CROPPING SYSTEMS; AVAILABLE PHOSPHORUS; DYNAMICS; ACCUMULATION; MANAGEMENT; RHIZOSPHERE; EFFICIENCY; DEPLETION; SORPTION; RELEASE	The Olsen phosphorus (P) concentration of a soil is a key index that can be used to evaluate the P supply capacity of the soil and to estimate the optimal P fertilization rate. A study of the relationship between the soil Olsen P concentration and the P balance (P input minus P output) and their variations among different fertilization patterns will help to provide useful information for proper management of P fertilization. In this paper, the two investigated long-term experiments were established on black soils in the northeast region of China. Six fertilization treatments were selected: (1) unfertilized (CK); (2) nitrogen only (N); (3) nitrogen and potassium (NK); (4) nitrogen and phosphorus (NP); (5) nitrogen, phosphorus, and potassium (NPK); and (6) nitrogen, phosphorus, potassium and manure (NPKM). The results showed that the average Olsen P concentrations in the black soils at Gongzhuling and Harbin (16-and 31-year study periods, respectively), decreased by 0.49 and 0.56 mg kg(-1) a(-1), respectively, without P addition and increased by 3.17 and 1.78 mg kg(-1) a(-1), respectively, with P fertilization. The changes in soil Olsen P concentrations were significantly (P<0.05) correlated with the P balances at both sites except for the NP and NPK treatments at Gongzhuling. Under an average deficit of 100 kg ha(-1) P, the soil Olsen P concentration at both sites decreased by 1.36 similar to 3.35 mg kg(-1) in the treatments without P addition and increased by 4.80 similar to 16.04 mg kg(-1) in the treatments with 100 kg ha-1 of P accumulation. In addition, the changes in Olsen P concentrations in the soil with 100 kg ha(-1)of P balance were significantly correlated with the P activation coefficient (PAC, percentage of Olsen P to total P, r=0.99, P<0.01) and soil organic matter content (r=0.91, P<0.01). A low pH was related to large changes of Olsen P by 1 kg ha(-1) of P balance. These results indicated that soil organic matter and pH have important effects on the change in soil Olsen P by 1 kg ha(-1)of P balance.	[Zhan, Xiaoying; Zhang, Li; Zhang, Shuxiang; Xu, Minggang] Chinese Acad Agr Sci, Inst Agr Resources & Reg Planning, Natl Engn Lab Improving Qual Arable Land, Beijing 100081, Peoples R China; [Zhou, Baoku] Heilongjiang Acad Agr Sci, Soil & Fertilizer Inst, Harbin 150086, Heilongjiang, Peoples R China; [Zhu, Ping] Jilin Acad Agr Sci, Ctr Agr Environm & Resources, Gongzhuling 136100, Jilin, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Agricultural Resources & Regional Planning, CAAS; Heilongjiang Academy of Agricultural Sciences; Jilin Academy of Agricultural Sciences	Zhang, SX (corresponding author), Chinese Acad Agr Sci, Inst Agr Resources & Reg Planning, Natl Engn Lab Improving Qual Arable Land, Beijing 100081, Peoples R China.	zhangshuxiang@caas.cn			National Science Foundation of China [41471249]; Agro-scientific Research in the Public Interest of China [201203030]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Agro-scientific Research in the Public Interest of China	This work is supported by the National Science Foundation of China http://www.nsfc.gov.cn/ (41471249) and by the Special Fund for Agro-scientific Research in the Public Interest of China http://www.moa.gov.cn/ (201203030). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson R, 2001, CHEMOSPHERE, V42, P161, DOI 10.1016/S0045-6535(00)00121-1; [Anonymous], 2005, NUTR CONT ORG FERT; [Anonymous], 1999, CHINA ORGANIC FERTIL, P5; Arai Y, 2007, ADV AGRON, V94, P135, DOI 10.1016/S0065-2113(06)94003-6; Aulakh MS, 2007, SOIL USE MANAGE, V23, P417, DOI 10.1111/j.1475-2743.2007.00124.x; Bai ZH, 2013, PLANT SOIL, V372, P27, DOI 10.1007/s11104-013-1696-y; Cao N, 2012, NUTR CYCL AGROECOSYS, V94, P161, DOI 10.1007/s10705-012-9530-0; Colomb B, 2007, EUR J AGRON, V26, P154, DOI 10.1016/j.eja.2006.09.004; Dobermann A, 2002, SOIL SCI SOC AM J, V66, P652, DOI 10.2136/sssaj2002.0652; *FAO, 2004, FAO FERT PLANT NUTR, V15; Fu XL, 2009, CATENA, V77, P200, DOI 10.1016/j.catena.2008.12.017; GAHOONIA TS, 1992, PLANT SOIL, V143, P185, DOI 10.1007/BF00007872; Garg S, 2008, BIORESOURCE TECHNOL, V99, P5773, DOI 10.1016/j.biortech.2007.10.063; Guo JH, 2010, SCIENCE, V327, P1008, DOI 10.1126/science.1182570; Hinsinger P, 2003, PLANT SOIL, V248, P43, DOI 10.1023/A:1022371130939; HINSINGER P, 1995, AUST J SOIL RES, V33, P477, DOI 10.1071/SR9950477; Huang CY, 2000, SOIL SCI, P32; Johnston A E., 2000, SOIL PLANT PHOSPHATE, P27; Li XM, 1994, CHINESE J SOIL SCI, V25, P259; Liu Jianling, 2000, Yingyong Shengtai Xuebao, V11, P365; Lookman R, 1996, GEODERMA, V69, P265, DOI 10.1016/0016-7061(95)00068-2; Lu R. K., 1996, CHINESE J SOIL SCI, V27, P241; Lu R.K, 2000, ANAL METHOD SOIL AGR; Ma YB, 2009, FIELD CROP RES, V110, P207, DOI 10.1016/j.fcr.2008.08.007; Malik MA, 2012, SOIL BIOL BIOCHEM, V49, P106, DOI 10.1016/j.soilbio.2012.02.013; Meng HQ, 2013, J INTEGR AGR, V12, P2092, DOI 10.1016/S2095-3119(13)60398-6; Messiga AJ, 2010, SOIL USE MANAGE, V26, P354, DOI 10.1111/j.1475-2743.2010.00287.x; Pei RuiNa, 2010, Scientia Agricultura Sinica, V43, P4008; Qu JunFeng, 2008, Plant Nutrition and Fertilizer Science, V14, P90; [曲均峰 Qu Junfeng], 2008, [生态环境, Ecology and Environment], V17, P2068; Selles F, 2011, CAN J SOIL SCI, V91, P39, DOI 10.4141/CJSS10049; Shafqat MN, 2013, CHEMOSPHERE, V90, P691, DOI 10.1016/j.chemosphere.2012.09.050; Sheldrick WF, 2002, NUTR CYCL AGROECOSYS, V62, P61, DOI 10.1023/A:1015124930280; Shen JB, 2011, PLANT PHYSIOL, V156, P997, DOI 10.1104/pp.111.175232; Shen P, 2014, THESIS CHINESE ACAD; Shen P, 2014, CATENA, V118, P20, DOI 10.1016/j.catena.2014.01.020; Shen P, 2014, J INTEGR AGR, V13, P597, DOI 10.1016/S2095-3119(13)60717-0; Shepherd MA, 1999, NUTR CYCL AGROECOSYS, V54, P233, DOI 10.1023/A:1009744706679; Siddique MT, 2003, J ENVIRON QUAL, V32, P1114, DOI 10.2134/jeq2003.1114; Song C, 2007, BIOL FERT SOILS, V44, P37, DOI 10.1007/s00374-007-0176-z; Sugihara S, 2012, AGR ECOSYST ENVIRON, V162, P101, DOI 10.1016/j.agee.2012.07.019; Tang X, 2008, FIELD CROP RES, V108, P231, DOI 10.1016/j.fcr.2008.05.007; TATE KR, 1988, BIOGEOCHEMISTRY, V5, P99, DOI 10.1007/BF02180319; Tian K, 2015, AGR ECOSYST ENVIRON, V204, P40, DOI 10.1016/j.agee.2015.02.008; Xu YF, 2015, CHEM ENG J, V267, P260, DOI 10.1016/j.cej.2015.01.037; [张继光 Zhang Jiguang], 2010, [土壤, Soils], V42, P364; [周宝库 Zhou Baoku], 2005, [植物营养与肥料学报, Plant nutrition and fertitizer science], V11, P143	47	26	35	2	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0131713	10.1371/journal.pone.0131713	http://dx.doi.org/10.1371/journal.pone.0131713			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177293	Green Published, Green Submitted, gold			2022-12-26	WOS:000358197600060
J	Doskey, CM; van't Erve, TJ; Wagner, BA; Buettner, GR				Doskey, Claire M.; van't Erve, Thomas J.; Wagner, Brett A.; Buettner, Garry R.			Moles of a Substance per Cell Is a Highly Informative Dosing Metric in Cell Culture	PLOS ONE			English	Article							NOMINAL EFFECTIVE CONCENTRATIONS; SUPEROXIDE-DISMUTASE ACTIVITY; COMPOUNDS IN-VITRO; HYDROGEN-PEROXIDE; INDUCED CYTOTOXICITY; ADDUCT FORMATION; DNA-DAMAGE; GLUTATHIONE; H2O2; TOXICITY	Background The biological consequences upon exposure of cells in culture to a dose of xenobiotic are not only dependent on biological variables, but also the physical aspects of experiments e.g. cell number and media volume. Dependence on physical aspects is often overlooked due to the unrecognized ambiguity in the dominant metric used to express exposure, i.e. initial concentration of xenobiotic delivered to the culture medium over the cells. We hypothesize that for many xenobiotics, specifying dose as moles per cell will reduce this ambiguity. Dose as moles per cell can also provide additional information not easily obtainable with traditional dosing metrics. Methods Here, 1,4-benzoquinone and oligomycin A are used as model compounds to investigate moles per cell as an informative dosing metric. Mechanistic insight into reactions with intracellular molecules, differences between sequential and bolus addition of xenobiotic and the influence of cell volume and protein content on toxicity are also investigated. Results When the dose of 1,4-benzoquinone or oligomycin A was specified as moles per cell, toxicity was independent of the physical conditions used (number of cells, volume of medium). When using moles per cell as a dose-metric, direct quantitative comparisons can be made between biochemical or biological endpoints and the dose of xenobiotic applied. For example, the toxicity of 1,4-benzoquinone correlated inversely with intracellular volume for all five cell lines exposed (C6, MDA-MB231, A549, MIA PaCa-2, and HepG2). Conclusions Moles per cell is a useful and informative dosing metric in cell culture. This dosing metric is a scalable parameter that: can reduce ambiguity between experiments having different physical conditions; provides additional mechanistic information; allows direct comparison between different cells; affords a more uniform platform for experimental design; addresses the important issue of repeatability of experimental results, and could increase the translatability of information gained from in vitro experiments.	[Doskey, Claire M.; van't Erve, Thomas J.; Buettner, Garry R.] Univ Iowa, Interdisciplinary Grad Program Human Toxicol, Iowa City, IA 52242 USA; [Wagner, Brett A.; Buettner, Garry R.] Univ Iowa, Dept Radiat Oncol, Free Radical & Radiat Biol Program, Iowa City, IA 52242 USA	University of Iowa; University of Iowa	Buettner, GR (corresponding author), Univ Iowa, Interdisciplinary Grad Program Human Toxicol, Iowa City, IA 52242 USA.	garry-buettner@uiowa.edu		Buettner, Garry/0000-0002-5594-1903; van 't Erve, Thomas/0000-0002-3260-6627	United States National Institutes of Health [R01 GM073929, R01 CA169046, P30 ES005605, P42 ES013661, NIH P30 CA086862]; NATIONAL CANCER INSTITUTE [P30CA086862, R01CA169046] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES005605, P42ES013661] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073929] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The United States National Institutes of Health Supported for this work with grants R01 GM073929 (GRB), R01 CA169046 (GRB), P30 ES005605 (GRB), P42 ES013661 (GRB, TJvE, CMD), NIH P30 CA086862 (GRB).	Abernethy DJ, 2004, TOXICOL SCI, V79, P82, DOI 10.1093/toxsci/kfh095; Aebi H, 1984, Methods Enzymol, V105, P121; Antunes F, 2001, FREE RADICAL BIO MED, V30, P1008, DOI 10.1016/S0891-5849(01)00493-2; Antunes F, 2000, FEBS LETT, V475, P121, DOI 10.1016/S0014-5793(00)01638-0; BANNISTER JV, 1973, FEBS LETT, V32, P303, DOI 10.1016/0014-5793(73)80859-2; Buettner GR, 2013, CELL BIOCHEM BIOPHYS, V67, P477, DOI 10.1007/s12013-011-9320-3; Codreanu SG, 2014, MOL CELL PROTEOMICS, V13, P849, DOI 10.1074/mcp.M113.032953; Coecke S, 2013, TOXICOL IN VITRO, V27, P1570, DOI 10.1016/j.tiv.2012.06.012; CUNNINGHAM CC, 1975, J BIOL CHEM, V250, P2036; ESMANN M, 1991, BIOCHIM BIOPHYS ACTA, V1064, P31, DOI 10.1016/0005-2736(91)90408-Z; Groothuis FA, 2015, TOXICOLOGY, V332, P30, DOI 10.1016/j.tox.2013.08.012; Gulden M, 2010, FREE RADICAL BIO MED, V49, P1298, DOI 10.1016/j.freeradbiomed.2010.07.015; Gulden M, 2005, AQUAT TOXICOL, V72, P327, DOI 10.1016/j.aquatox.2005.02.002; Gulden M, 2003, TOXICOLOGY, V189, P211, DOI 10.1016/S0300-483X(03)00146-X; Gulden M, 2002, TOXICOLOGY, V175, P201, DOI 10.1016/S0300-483X(02)00085-9; Gulden M, 2001, TOXICOL IN VITRO, V15, P233, DOI 10.1016/S0887-2333(01)00008-X; Halsey LG, 2015, NAT METHODS, V12, P179, DOI 10.1038/nmeth.3288; Johnson KM, 2006, ACS CHEM BIOL, V1, P304, DOI 10.1021/cb600143j; Lamore SD, 2010, CELL STRESS CHAPERON, V15, P309, DOI 10.1007/s12192-009-0145-6; Landar A, 2006, AM J PHYSIOL-HEART C, V290, pH1777, DOI 10.1152/ajpheart.01087.2005; LAWRENCE RA, 1976, BIOCHEM BIOPH RES CO, V71, P952, DOI 10.1016/0006-291X(76)90747-6; LEA DE, 1946, BRIT MED BULL, V4, P24, DOI 10.1093/oxfordjournals.bmb.a072663; LEES MB, 1972, ANAL BIOCHEM, V47, P184, DOI 10.1016/0003-2697(72)90291-6; Monks Terrence J, 2002, Curr Drug Metab, V3, P425, DOI 10.2174/1389200023337388; Munshi A, 2005, METH MOLEC MED, V110, P21; Nakamura J, 2003, NUCLEIC ACIDS RES, V31, P1790, DOI 10.1093/nar/gkg263; OBERLEY LW, 1984, METHOD ENZYMOL, V105, P457; OBRIEN PJ, 1991, CHEM-BIOL INTERACT, V80, P1, DOI 10.1016/0009-2797(91)90029-7; Oh JY, 2008, BIOCHEM J, V411, P297, DOI [10.1042/BJ20071189, 10.1042/bj20071189]; Park HJ, 2010, ANAL BIOCHEM, V407, P151, DOI 10.1016/j.ab.2010.08.012; Rawal M, 2013, CANCER RES, V73, P5232, DOI 10.1158/0008-5472.CAN-13-0470; Riss TL, 2004, ASSAY DRUG DEV TECHN, V2, P51, DOI 10.1089/154065804322966315; RUSSELL W. M. S., 1959; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Seibert H, 2002, TOXICOL IN VITRO, V16, P289, DOI 10.1016/S0887-2333(02)00014-0; Sheridan AM, 1996, KIDNEY INT, V49, P88, DOI 10.1038/ki.1996.12; Sobotta MC, 2013, FREE RADICAL BIO MED, V60, P325, DOI 10.1016/j.freeradbiomed.2013.02.017; Song Y, 2010, FREE RADICAL BIO MED, V49, P919, DOI 10.1016/j.freeradbiomed.2010.05.009; Song Y, 2009, P NATL ACAD SCI USA, V106, P9725, DOI 10.1073/pnas.0810352106; SPITZ DR, 1990, ARCH BIOCHEM BIOPHYS, V279, P249, DOI 10.1016/0003-9861(90)90489-L; Stagg RB, 1997, BIOELECTROMAGNETICS, V18, P230, DOI 10.1002/(SICI)1521-186X(1997)18:3<230::AID-BEM5>3.0.CO;2-3; Strober Warren, 2015, Curr Protoc Immunol, V111, DOI 10.1002/0471142735.ima03bs111; Valdiglesias V, 2011, J ENVIRON MONITOR, V13, P1831, DOI 10.1039/c0em00771d; van 't Erve TJ, 2013, FREE RADICAL BIO MED, V65, P742, DOI 10.1016/j.freeradbiomed.2013.08.002; Wagner BA, 2013, REDOX BIOL, V1, P210, DOI 10.1016/j.redox.2013.01.011; Wagner BA, 2011, FREE RADICAL BIO MED, V51, P700, DOI 10.1016/j.freeradbiomed.2011.05.024; Wang XH, 2006, P NATL ACAD SCI USA, V103, P3604, DOI 10.1073/pnas.0510962103; Wetmore BA, 2012, TOXICOL SCI, V125, P157, DOI 10.1093/toxsci/kfr254; Yang F, 2010, J TOXICOL ENV HEAL A, V73, P483, DOI 10.1080/15287390903523402	49	35	36	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132572	10.1371/journal.pone.0132572	http://dx.doi.org/10.1371/journal.pone.0132572			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26172833	Green Published, Green Submitted, gold			2022-12-26	WOS:000358194900059
J	Kawashima-Goto, S; Imamura, T; Tomoyasu, C; Yano, M; Yoshida, H; Fujiki, A; Tamura, S; Osone, S; Ishida, H; Morimoto, A; Kuroda, H; Hosoi, H				Kawashima-Goto, Sachiko; Imamura, Toshihiko; Tomoyasu, Chihiro; Yano, Mio; Yoshida, Hideki; Fujiki, Atsushi; Tamura, Shinichi; Osone, Shinya; Ishida, Hiroyuki; Morimoto, Akira; Kuroda, Hiroshi; Hosoi, Hajime			BCL2 Inhibitor (ABT-737): A Restorer of Prednisolone Sensitivity in Early T-Cell Precursor-Acute Lymphoblastic Leukemia with High MEF2C Expression?	PLOS ONE			English	Article							PROGENITORS; MECHANISMS	Early T-cell precursor-acute lymphoblastic leukemia (ETP-ALL) has been identified as a high-risk subtype of pediatric T-cell acute lymphoblastic leukemia (T-ALL). Conventional chemotherapy is not fully effective for this subtype of leukemia; therefore, potential therapeutic targets need to be explored. Analysis of the gene expression patterns of the transcription factors in pediatric T-ALL revealed that MEF2C and FLT3 were expressed at higher levels in ETP-ALL than typical T-ALL. Using human T-ALL and BaF3 cell lines with high expression levels of MEF2C, the present study tested whether the BCL2 inhibitor (ABT-737) restores the sensitivity to prednisolone (PSL), because MEF2C causes PSL resistance, possibly by augmenting the anti-apoptotic activity of BCL2. Treatment with PSL and ABT-737 caused a significant reduction in the IC50 of PSL in the MEF2C-expressing LOUCY cells, in addition to the MEF2C-transduced BaF3 cells, but not in the non-MEF2C-expressing Jurkat cells. The combination treatment significantly accelerated the killing of primary leukemic blast cells of ETP-ALL with high expression levels of MEF2C, which were co-cultured with murine stromal cells. These findings suggest that BCL2 inhibitors may be a therapeutic candidate in vivo for patients with ETP-ALL with high expression levels of MEF2C.	[Imamura, Toshihiko] Kyoto Prefectural Univ Med, Dept Pediat, Grad Sch Med Sci, Kyoto 602, Japan; [Kawashima-Goto, Sachiko; Imamura, Toshihiko; Tomoyasu, Chihiro; Yano, Mio; Yoshida, Hideki; Osone, Shinya; Ishida, Hiroyuki; Hosoi, Hajime] Kyoto Prefectural Univ Med, Dept Pediat, Grad Sch Med Sci, Kyoto 602, Japan; [Fujiki, Atsushi; Ishida, Hiroyuki] Matsushita Mem Hosp, Dept Pediat, Moriguchi, Osaka, Japan; [Tamura, Shinichi; Kuroda, Hiroshi] Kyoto City Hosp, Dept Pediat, Kyoto, Japan; [Morimoto, Akira] Jichi Med Univ, Sch Med, Dept Pediat, Shimotuke, Japan	Kyoto Prefectural University of Medicine; Kyoto Prefectural University of Medicine; Kyoto City Hospital; Jichi Medical University	Imamura, T (corresponding author), Kyoto Prefectural Univ Med, Dept Pediat, Grad Sch Med Sci, Kyoto 602, Japan.	imamura@koto.kpu-m.ac.jp			Japanese Ministry of Health, Labor, and Welfare; Japanese Ministry of Education, Culture, Sports, Science and Technology	Japanese Ministry of Health, Labor, and Welfare(Ministry of Health, Labour and Welfare, Japan); Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants for Clinical Cancer Research and Research on Measures for Intractable Diseases from the Japanese Ministry of Health, Labor, and Welfare, by grants-in-aid for scientific research from the Japanese Ministry of Education, Culture, Sports, Science and Technology, and by grants for the Japan Foundation for Pediatric Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aifantis I, 2008, NAT REV IMMUNOL, V8, P380, DOI 10.1038/nri2304; Bell JJ, 2008, NATURE, V452, P764, DOI 10.1038/nature06840; Black BL, 1998, ANNU REV CELL DEV BI, V14, P167, DOI 10.1146/annurev.cellbio.14.1.167; Bonapace L, 2010, J CLIN INVEST, V120, P1310, DOI 10.1172/JCI39987; Buitenhuis M, 2005, BLOOD, V105, P4272, DOI 10.1182/blood-2004-12-4883; Cante-Barrett K, 2014, ONCOGENE, V33, P403, DOI 10.1038/onc.2013.56; CHEN ZX, 1994, CANCER RES, V54, P3494; Coustan-Smith E, 2009, LANCET ONCOL, V10, P147, DOI 10.1016/S1470-2045(08)70314-0; Ferrando AA, 2002, CANCER CELL, V1, P75, DOI 10.1016/S1535-6108(02)00018-1; Homminga I, 2011, CANCER CELL, V19, P484, DOI 10.1016/j.ccr.2011.02.008; ITOH K, 1989, EXP HEMATOL, V17, P145; Kikushige Y, 2008, J IMMUNOL, V180, P7358, DOI 10.4049/jimmunol.180.11.7358; Konopleva M, 2006, CANCER CELL, V10, P375, DOI 10.1016/j.ccr.2006.10.006; Lavau C, 2000, P NATL ACAD SCI USA, V97, P10984, DOI 10.1073/pnas.190167297; MCNIECE IK, 1982, CELL BIOL INT REP, V6, P243, DOI 10.1016/0309-1651(82)90076-5; Moll UM, 2006, ONCOGENE, V25, P4725, DOI 10.1038/sj.onc.1209601; Moore VD, 2008, BLOOD, V111, P2300, DOI 10.1182/blood-2007-06-098012; Moore VD, 2007, J CLIN INVEST, V117, P112, DOI 10.1172/JCI28281; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Nagel S, 2008, LEUKEMIA, V22, P600, DOI 10.1038/sj.leu.2405067; Neumann M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053190; Peirs S, 2014, BLOOD, V124, P3738, DOI 10.1182/blood-2014-05-574566; Schrappe M, 2011, BLOOD, V118, P2077, DOI 10.1182/blood-2011-03-338707; Stehling-Sun S, 2009, NAT IMMUNOL, V10, P289, DOI 10.1038/ni.1694; Wolfler A, 2010, BLOOD, V116, P4116, DOI 10.1182/blood-2010-03-275404; Yamaji K, 2010, PEDIATR BLOOD CANCER, V55, P1287, DOI 10.1002/pbc.22620; Zenatti PP, 2011, NAT GENET, V43, P932, DOI 10.1038/ng.924; Zhang JH, 2012, NATURE, V481, P157, DOI 10.1038/nature10725; Zuurbier L, 2014, HAEMATOLOGICA, V99, P94, DOI 10.3324/haematol.2013.090233	29	17	20	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132926	10.1371/journal.pone.0132926	http://dx.doi.org/10.1371/journal.pone.0132926			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26172269	gold, Green Submitted, Green Published			2022-12-26	WOS:000358194900103
J	Ke, CC; Lin, CS; Yeh, CC; Chung, CL; Hung, CJ; Liao, CC; Chen, TL				Ke, Chi-Chen; Lin, Chao-Shun; Yeh, Chun-Chieh; Chung, Chi-Li; Hung, Chih-Jen; Liao, Chien-Chang; Chen, Ta-Liang			Adverse Outcomes after Non-Chest Surgeries in Patients with Pulmonary Tuberculosis: A Nationwide Study	PLOS ONE			English	Article							NONCARDIAC SURGERY; UNITED-STATES; POSTOPERATIVE OUTCOMES; RETROSPECTIVE COHORT; RISK-FACTORS; INFECTION; FAILURE; EPIDEMICS; MORTALITY; CARE	Background The association between pulmonary tuberculosis (TB) and postoperative outcomes remains unknown. This study investigated outcomes following non-chest surgeries in patients with previous pulmonary TB. Methods Using Taiwan's National Health Insurance Research Database, we analyzed 6911 patients (aged >= 20 years) with preoperative diagnosis of pulmonary TB and 6911 propensity score-matched controls receiving non-chest surgeries in 2008-2010. Postoperative outcomes were compared between patients with or without pulmonary TB by calculating adjusted odds ratios (ORs) and 95% confidence intervals (CIs) in the multivariate logistic regressions. Results Surgical patients with pulmonary TB had a significantly higher postoperative complication rates than controls, including septicemia, pneumonia, acute renal failure, deep wound infection, overall complications, and 30-day postoperative mortality (OR 1.41; 95% CI 1.07-1.86). The ORs of patients with low-income status were as high as 2.27 (95% CI 1.03-5.03). Preoperative use of TB drugs and TB-related medical expenditure also associated with higher postoperative mortality among surgical patients with pulmonary TB. Conclusions Surgical patients with pulmonary TB have significantly increased risks of postoperative complications and mortality after non-chest surgeries. This study suggests the need to improve postoperative care for surgical patients with pulmonary TB.	[Ke, Chi-Chen; Hung, Chih-Jen] Taichung Vet Gen Hosp, Dept Anesthesiol, Taichung, Taiwan; [Lin, Chao-Shun; Liao, Chien-Chang; Chen, Ta-Liang] Taipei Med Univ Hosp, Dept Anesthesiol, Taipei, Taiwan; [Lin, Chao-Shun; Liao, Chien-Chang; Chen, Ta-Liang] Taipei Med Univ Hosp, Ctr Hlth Policy Res, Taipei, Taiwan; [Lin, Chao-Shun; Liao, Chien-Chang; Chen, Ta-Liang] Taipei Med Univ, Sch Med, Taipei, Taiwan; [Yeh, Chun-Chieh] China Med Univ Hosp, Dept Surg, Taichung, Taiwan; [Yeh, Chun-Chieh] Univ Illinois, Dept Surg, Chicago, IL 60680 USA; [Chung, Chi-Li] Taipei Med Univ Hosp, Div Pulm Med, Dept Internal Med, Taipei, Taiwan; [Liao, Chien-Chang] China Med Univ, Sch Chinese Med, Taichung, Taiwan	Taichung Veterans General Hospital; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; China Medical University Taiwan; China Medical University Hospital - Taiwan; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Taipei Medical University; Taipei Medical University Hospital; China Medical University Taiwan	Chen, TL (corresponding author), Taipei Med Univ Hosp, Dept Anesthesiol, Taipei, Taiwan.	tlc@tmu.edu.tw	Yeh, Chun Chieh/I-4893-2019	Yeh, Chun Chieh/0000-0001-6753-7564; Hozbor, Daniela/0000-0001-6379-0482	Taiwan's Ministry of Science and Technology [NSC102-2314-B-038-021-MY3]	Taiwan's Ministry of Science and Technology	This study was supported by a grant (NSC102-2314-B-038-021-MY3) from Taiwan's Ministry of Science and Technology. Disclaimer: The funders were not involved with study design, data analysis, or manuscript preparation. The contents of the manuscript are solely the responsibility of the authors.	Ascuntar JM, 2010, INT J TUBERC LUNG D, V14, P1323; Boccia D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020824; Boelaert JR, 2002, LANCET, V360, P1102, DOI 10.1016/S0140-6736(02)11169-X; Cantwell MF, 1998, AM J RESP CRIT CARE, V157, P1016, DOI 10.1164/ajrccm.157.4.9704036; Dobler CC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029563; Donald PR, 2010, LANCET, V375, P1852, DOI 10.1016/S0140-6736(10)60580-6; Dooley KE, 2009, LANCET INFECT DIS, V9, P737, DOI 10.1016/S1473-3099(09)70282-8; Farmer PE, 2013, NEW ENGL J MED, V369, P2424, DOI 10.1056/NEJMsa1310472; Fishman JA, 2007, NEW ENGL J MED, V357, P2601, DOI 10.1056/NEJMra064928; Hansel NN, 2004, CHEST, V126, P1079, DOI 10.1378/chest.126.4.1079; Havlir DV, 2008, JAMA-J AM MED ASSOC, V300, P423, DOI 10.1001/jama.300.4.423; Hernandez AF, 2004, J AM COLL CARDIOL, V44, P1446, DOI 10.1016/j.jacc.2004.06.059; Kempker RR, 2012, LANCET INFECT DIS, V12, P157, DOI 10.1016/S1473-3099(11)70244-4; Kethireddy S, 2013, CHEST, V144, P474, DOI 10.1378/chest.12-1286; Kim YJ, 2008, EUR RESPIR J, V32, P1625, DOI 10.1183/09031936.00070907; Kwara A, 2008, CHEST, V133, P862, DOI 10.1378/chest.07-2024; Lai SW, 2014, CLIN MICROBIOL INFEC, V20, P764, DOI 10.1111/1469-0691.12516; Lawn SD, 2011, LANCET, V378, P57, DOI 10.1016/S0140-6736(10)62173-3; Leung CC, 2002, J AM GERIATR SOC, V50, P1219, DOI 10.1046/j.1532-5415.2002.50308.x; Leung CC, 2012, LANCET, V379, P2008, DOI 10.1016/S0140-6736(12)60235-9; Liao CC, 2013, ANN SURG, V257, P433, DOI 10.1097/SLA.0b013e31827b9b25; Lin CS, 2013, BRIT J SURG, V100, P1784, DOI 10.1002/bjs.9312; Lin CY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063936; Ma ZK, 2010, LANCET, V375, P2100, DOI 10.1016/S0140-6736(10)60359-9; Marais BJ, 2013, LANCET INFECT DIS, V13, P436, DOI 10.1016/S1473-3099(13)70015-X; Meintjes G, 2012, AM J RESP CRIT CARE, V186, P369, DOI 10.1164/rccm.201201-0094OC; Morris MD, 2013, INT J TUBERC LUNG D, V17, P954, DOI 10.5588/ijtld.12.0480; Musallam KM, 2011, LANCET, V378, P1396, DOI 10.1016/S0140-6736(11)61381-0; Oeltmann JE, 2009, ARCH INTERN MED, V169, P189, DOI 10.1001/archinternmed.2008.535; Pasipanodya JG, 2007, CHEST, V131, P1817, DOI 10.1378/chest.06-2949; Peto HM, 2009, CLIN INFECT DIS, V49, P1350, DOI 10.1086/605559; Rabe KF, 2012, LANCET, V380, P623, DOI 10.1016/S0140-6736(12)61306-3; Robinson TN, 2012, J AM COLL SURGEONS, V215, P12, DOI 10.1016/j.jamcollsurg.2012.02.007; Sepkowitz KA, 2002, CLIN INFECT DIS, V34, P1098, DOI 10.1086/339548; Sheu JJ, 2010, STROKE, V41, P244, DOI 10.1161/STROKEAHA.109.567735; Sokolove PE, 2000, ACAD EMERG MED, V7, P1056, DOI 10.1111/j.1553-2712.2000.tb02100.x; Turrentine FE, 2006, J AM COLL SURGEONS, V203, P865, DOI 10.1016/j.jamcollsurg.2006.08.026; Vento S, 2011, LANCET ONCOL, V12, P520, DOI 10.1016/S1470-2045(11)70105-X; Chung WS, 2007, INT J TUBERC LUNG D, V11, P59; Wu YC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118929; Yang ZH, 2004, CLIN INFECT DIS, V38, P199, DOI 10.1086/380644; Yee D, 2003, AM J RESP CRIT CARE, V167, P1472, DOI 10.1164/rccm.200206-626OC; Yeh CC, 2013, DIABETES CARE, V36, P3216, DOI 10.2337/dc13-0770; Zignol M, 2012, B WORLD HEALTH ORGAN, V90, P111, DOI 10.2471/BLT.11.092585; Zumla A, 2013, NEW ENGL J MED, V368, P745, DOI 10.1056/NEJMra1200894	45	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0133064	10.1371/journal.pone.0133064	http://dx.doi.org/10.1371/journal.pone.0133064			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26172153	Green Submitted, gold, Green Published			2022-12-26	WOS:000358194900118
J	Mao, K; Wang, L; Li, YY; Wu, RL				Mao, Ke; Wang, Lina; Li, Yuan-Yuan; Wu, Rongling			Molecular Cloning and Functional Analysis of UV RESISTANCE LOCUS 8 (PeUVR8) from Populus euphratica	PLOS ONE			English	Article							B-INDUCED PHOTOMORPHOGENESIS; BLUE-LIGHT RECEPTORS; PHOTORECEPTOR; COP1; PERCEPTION; GROWTH; ELONGATION; TRYPTOPHAN; EXPRESSION; RADIATION	Ultraviolet-B (UV-B; 280-315 nm) light, which is an integral part of the solar radiation reaching the surface of the Earth, induces a broad range of physiological responses in plants. The UV RESISTANCE LOCUS 8 (UVR8) protein is the first and only light photoreceptor characterized to date that is specific for UV-B light and it regulates various aspects of plant growth and development in response to UV-B light. Despite its involvement in the control of important plant traits, most studies on UV-B photoreceptors have focused on Arabidopsis and no data on UVR8 function are available for forest trees. In this study, we isolated a homologue of the UV receptor UVR8 of Arabidopsis, PeUVR8, from Populus euphratica (Euphrates poplar) and analyzed its structure and function in detail. The deduced PeUVR8 amino acid sequence contained nine well-conserved regulator of chromosome condensation 1 (RCC1) repeats and the region 27 amino acids from the C terminus (C27) that interact with COP1 (CONSTITUTIVELY PHOTOMORPHOGENIC1). Secondary and tertiary structure analysis showed that PeUVR8 shares high similarity with the AtUVR8 protein from Arabidopsis thaliana. Using heterologous expression in Arabidopsis, we showed that PeUVR8 overexpression rescued the uvr8 mutant phenotype. In addition, PeUVR8 overexpression in wild-type background seedlings grown under UV-B light inhibited hypocotyl elongation and enhanced anthocyanin accumulation. Furthermore, we examined the interaction between PeUVR8 and AtCOP1 using a bimolecular fluorescence complementation (BiFC) assay. Our data provide evidence that PeUVR8 plays important roles in the control of photomorphogenesis in planta.	[Mao, Ke; Wang, Lina; Wu, Rongling] Beijing Forestry Univ, Coll Biol Sci & Technol, Ctr Computat Biol, Beijing 100083, Peoples R China; [Li, Yuan-Yuan] Shandong Agr Univ, Coll Hort Sci & Engn, Tai An 271018, Shandong, Peoples R China; [Wu, Rongling] Penn State Univ, Ctr Stat Genet, Hershey, PA 17033 USA	Beijing Forestry University; Shandong Agricultural University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Wu, RL (corresponding author), Beijing Forestry Univ, Coll Biol Sci & Technol, Ctr Computat Biol, Beijing 100083, Peoples R China.	rwu@bjfu.edu.cn			Special Fund for Forest Scientific Research in the Public Welfare [201404102]; Foundation for Outstanding Young Scientist in Shandong Province [BS2013NY001]; National Natural Science Foundation of China [31301763]; "Thousand-Person Plan" Award	Special Fund for Forest Scientific Research in the Public Welfare; Foundation for Outstanding Young Scientist in Shandong Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); "Thousand-Person Plan" Award(Chinese Academy of Sciences)	This work is supported by the Special Fund for Forest Scientific Research in the Public Welfare (201404102), the "Thousand-Person Plan" Award, the Foundation for Outstanding Young Scientist in Shandong Province (BS2013NY001), and the National Natural Science Foundation of China (31301763).	Boccalandro HE, 2001, PLANT PHYSIOL, V126, P780, DOI 10.1104/pp.126.2.780; Briggs WR, 1999, ANNU REV CELL DEV BI, V15, P33, DOI 10.1146/annurev.cellbio.15.1.33; Brown BA, 2005, P NATL ACAD SCI USA, V102, P18225, DOI 10.1073/pnas.0507187102; Canamero RC, 2006, PLANTA, V224, P995, DOI 10.1007/s00425-006-0280-6; Cashmore AR, 1999, SCIENCE, V284, P760, DOI 10.1126/science.284.5415.760; Christie JM, 2012, SCIENCE, V335, P1492, DOI 10.1126/science.1218091; Cloix C, 2012, P NATL ACAD SCI USA, V109, P16366, DOI 10.1073/pnas.1210898109; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Coleman RS, 2004, PHYSIOL PLANTARUM, V122, P362, DOI 10.1111/j.1399-3054.2004.00411.x; Conte M, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-112; Correll MJ, 2005, PLANT CELL PHYSIOL, V46, P317, DOI 10.1093/pcp/pci038; CREED D, 1984, PHOTOCHEM PHOTOBIOL, V39, P537; Eisinger WR, 2003, AM J BOT, V90, P1560, DOI 10.3732/ajb.90.11.1560; Favory JJ, 2009, EMBO J, V28, P591, DOI 10.1038/emboj.2009.4; Folta KM, 2003, PLANT J, V36, P203, DOI 10.1046/j.1365-313X.2003.01870.x; Fritsche E, 2007, P NATL ACAD SCI USA, V104, P8851, DOI 10.1073/pnas.0701764104; GEOURJON C, 1994, PROTEIN ENG, V7, P157, DOI 10.1093/protein/7.2.157; Heijde M, 2012, TRENDS PLANT SCI, V17, P230, DOI 10.1016/j.tplants.2012.01.007; Jenkins GI, 2014, CURR OPIN STRUC BIOL, V29, P52, DOI 10.1016/j.sbi.2014.09.004; Kaiserli E, 2007, PLANT CELL, V19, P2662, DOI 10.1105/tpc.107.053330; Kami C, 2010, CURR TOP DEV BIOL, V91, P29, DOI 10.1016/S0070-2153(10)91002-8; Kim BC, 1998, PLANT J, V15, P667, DOI 10.1046/j.1365-313x.1998.00246.x; Kliebenstein DJ, 2002, PLANT PHYSIOL, V130, P234, DOI 10.1104/pp.005041; Kucera B, 2003, PLANT PHYSIOL, V133, P1445, DOI 10.1104/pp.103.029520; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Leasure CD, 2011, MOL PLANT, V4, P759, DOI 10.1093/mp/ssr033; LEE HS, 1991, J FOOD SCI, V56, P466, DOI 10.1111/j.1365-2621.1991.tb05305.x; Li YY, 2013, PLANT CELL REP, V32, P555, DOI 10.1007/s00299-013-1387-4; Lin CT, 2002, PLANT CELL, V14, pS207, DOI 10.1105/tpc.000646; Ma LG, 2001, PLANT CELL, V13, P2589, DOI 10.1105/tpc.13.12.2589; McKenzie RL, 2007, PHOTOCH PHOTOBIO SCI, V6, P218, DOI 10.1039/b700017k; Morelli G, 2002, TRENDS PLANT SCI, V7, P399, DOI 10.1016/S1360-1385(02)02314-2; O'Hara A, 2012, PLANT CELL, V24, P3755, DOI 10.1105/tpc.112.101451; Oravecz A, 2006, PLANT CELL, V18, P1975, DOI 10.1105/tpc.105.040097; Prilusky J, 2005, BIOINFORMATICS, V21, P3435, DOI 10.1093/bioinformatics/bti537; Quaggiotti S, 2004, PLANT SCI, V167, P107, DOI 10.1016/j.plantsci.2004.03.005; QUAIL PH, 1995, SCIENCE, V268, P675, DOI 10.1126/science.7732376; Rizzini L, 2011, SCIENCE, V332, P103, DOI 10.1126/science.1200660; Rozema J, 1997, TRENDS ECOL EVOL, V12, P22, DOI 10.1016/S0169-5347(96)10062-8; Shinkle JR, 2004, PHYSIOL PLANTARUM, V120, P240, DOI 10.1111/j.0031-9317.2004.0237.x; Sorce C, 2008, J PLANT PHYSIOL, V165, P482, DOI 10.1016/j.jplph.2007.03.012; Suesslin C, 2003, PLANT J, V33, P591, DOI 10.1046/j.1365-313X.2003.01649.x; Sullivan JA, 2003, DEV BIOL, V260, P289, DOI 10.1016/S0012-1606(03)00212-4; SULLIVAN JH, 1988, AM J BOT, V75, P225, DOI 10.2307/2443888; TEVINI M, 1989, PHOTOCHEM PHOTOBIOL, V50, P479, DOI 10.1111/j.1751-1097.1989.tb05552.x; Tong HY, 2008, P NATL ACAD SCI USA, V105, P21039, DOI 10.1073/pnas.0809942106; Ulm R, 2004, P NATL ACAD SCI USA, V101, P1397, DOI 10.1073/pnas.0308044100; Wargent JJ, 2009, NEW PHYTOL, V183, P315, DOI 10.1111/j.1469-8137.2009.02855.x; Wu D, 2012, NATURE, V484, P214, DOI [10.1038/nature10931, 10.1038/nature11685]; Xie XB, 2012, PLANT CELL ENVIRON, V35, P1884, DOI 10.1111/j.1365-3040.2012.02523.x; Yi CL, 2005, TRENDS CELL BIOL, V15, P618, DOI 10.1016/j.tcb.2005.09.007; Yin RH, 2015, PLANT CELL, V27, P202, DOI 10.1105/tpc.114.133868	52	16	20	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132390	10.1371/journal.pone.0132390	http://dx.doi.org/10.1371/journal.pone.0132390			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26171608	Green Published, gold, Green Submitted			2022-12-26	WOS:000358194900049
J	Fjaere, E; Andersen, C; Myrmel, LS; Petersen, RK; Hansen, JB; Tastesen, HS; Mandrup-Poulsen, T; Brunner, N; Kristiansen, K; Madsen, L; Romer, MU				Fjaere, Even; Andersen, Charlotte; Myrmel, Lene Secher; Petersen, Rasmus Koefoed; Hansen, Jakob Bondo; Tastesen, Hanne Sorup; Mandrup-Poulsen, Thomas; Brunner, Nils; Kristiansen, Karsten; Madsen, Lise; Romer, Maria Unni			Tissue Inhibitor Of Matrix Metalloproteinase-1 Is Required for High-Fat Diet-Induced Glucose Intolerance and Hepatic Steatosis in Mice	PLOS ONE			English	Article							ADIPOSE-TISSUE; INDUCED OBESITY; INSULIN; TIMP-1; DYSFUNCTION; PROGRESSION; DEFICIENCY; EXPRESSION; TUMOR	Background Plasma levels of tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) are elevated in obesity and obesity-related disorders, such as steatosis, but the metabolic role of TIMP-1 is unclear. Here we investigated how the presence or absence of TIMP-1 affected the development of diet-induced glucose intolerance and hepatic steatosis using the Timp1 null mice. Methods Timp1 knockout (TKO) and wild type (TWT) mice were fed chow, high-fat diet (HFD) or intermediate fat and sucrose diet (IFSD). We determined body weight, body composition, lipid content of the liver, energy intake, energy expenditure, oral glucose tolerance, as well as insulin tolerance. In addition, the histology of liver and adipose tissues was examined and expression of selected genes involved in lipid metabolism and inflammation in liver and adipose tissues was determined by RT-qPCR. Results TKO mice gained less weight and had lower energy efficiency than TWT mice when fed HFD, but not when fed chow or IFSD. Importantly, TKO mice were protected from development of HFD- as well as IFSD-induced glucose intolerance, hepatic steatosis, and altered expression of genes involved in hepatic lipid metabolism and inflammation. Conclusion Collectively, our results indicate that TIMP-1 contributes to the development of diet-induced hepatic steatosis and glucose intolerance and may be a potential therapeutic target.	[Fjaere, Even; Myrmel, Lene Secher; Petersen, Rasmus Koefoed; Tastesen, Hanne Sorup; Kristiansen, Karsten; Madsen, Lise] Univ Copenhagen, Fac Sci, Dept Biol, Copenhagen, Denmark; [Fjaere, Even; Myrmel, Lene Secher; Madsen, Lise] Natl Inst Nutr & Seafood Res, Bergen, Norway; [Andersen, Charlotte; Hansen, Jakob Bondo; Brunner, Nils; Romer, Maria Unni] Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet Dis Biol, Frederiksberg, Denmark; [Hansen, Jakob Bondo; Mandrup-Poulsen, Thomas] Univ Copenhagen, Fac Hlth & Med Sci, Dept Biomed Sci, Copenhagen, Denmark; [Mandrup-Poulsen, Thomas] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden; [Romer, Maria Unni] Univ Copenhagen, Rigshosp, Dept Clin Physiol Nucl Med & PET, DK-2100 Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen; Karolinska Institutet; Rigshospitalet; University of Copenhagen	Madsen, L (corresponding author), Univ Copenhagen, Fac Sci, Dept Biol, Copenhagen, Denmark.	lmad@nifes.no; maria.unni.romer@gmail.com	Kristiansen, Karsten/J-5148-2014; Madsen, Lise/C-6246-2012	Kristiansen, Karsten/0000-0002-6024-0917; Madsen, Lise/0000-0003-4468-1947; Hansen, Jakob Bondo/0000-0002-6837-0919; Mandrup-Poulsen, Thomas/0000-0002-3215-9273	Danish Natural Science Research Council; Novo Nordisk Foundation; Carlsberg Foundation; Novo Nordisk; Synergy in Human and Animal Research (SHARE LIFE) Initiative; Strategic Research Counsel	Danish Natural Science Research Council(Danish Natural Science Research Council); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Carlsberg Foundation(Carlsberg Foundation); Novo Nordisk(Novo Nordisk); Synergy in Human and Animal Research (SHARE LIFE) Initiative; Strategic Research Counsel	The work was supported by grants to Karsten Kristiansen from the Danish Natural Science Research Council, the Novo Nordisk Foundation, and the Carlsberg Foundation, to Thomas Mandrup-Poulsen from Novo Nordisk and the Novo Nordisk Foundation, to Jakob Bondo Hansen from the Synergy in Human and Animal Research (SHARE LIFE) Initiative and Novo Nordisk and to Nils Brunner from The Strategic Research Counsel. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beaueux JL, 2003, ATHEROSCLEROSIS, V169, P139, DOI 10.1016/S0021-9150(03)00149-7; Boden G, 2008, AM J PHYSIOL-ENDOC M, V295, pE692, DOI 10.1152/ajpendo.90370.2008; Bouloumie A, 2001, DIABETES, V50, P2080, DOI 10.2337/diabetes.50.9.2080; Buler M, 2012, J BIOL CHEM, V287, P1847, DOI 10.1074/jbc.M111.302356; Chavey C, 2003, J BIOL CHEM, V278, P11888, DOI 10.1074/jbc.M209196200; Chirco R, 2006, CANCER METAST REV, V25, P99, DOI 10.1007/s10555-006-7893-x; Derosa G, 2009, CLIN INVEST MED, V32, pE124, DOI 10.25011/cim.v32i2.6030; Duval C, 2010, DIABETES, V59, P3181, DOI 10.2337/db10-0224; Fearnside JF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001668; Feng F, 2008, ENDOCRINOLOGY, V149, P1505, DOI 10.1210/en.2007-1119; Gerin I, 2009, ENDOCRINOLOGY, V150, P1697, DOI 10.1210/en.2008-1409; Gustafson B, 2010, J ATHEROSCLER THROMB, V17, P332, DOI 10.5551/jat.3939; Han X, 2001, DIABETES, V50, P1047, DOI 10.2337/diabetes.50.5.1047; Hansen JB, 2012, CELL METAB, V16, P449, DOI 10.1016/j.cmet.2012.09.001; Harslund J, 2007, AM J PHYSIOL-REG I, V293, pR1630, DOI 10.1152/ajpregu.00380.2007; Jiang HW, 2011, CHINESE MED J-PEKING, V124, P258, DOI 10.3760/cma.j.issn.0366-6999.2011.02.020; KEKOW J, 1988, DIABETES, V37, P321, DOI 10.2337/diabetes.37.3.321; Kralisch S, 2007, EUR J ENDOCRINOL, V156, P257, DOI 10.1530/eje.1.02328; Lee SW, 2005, DIABETES RES CLIN PR, V69, P175, DOI 10.1016/j.diabres.2004.12.010; Lijnen HR, 2003, THROMB HAEMOSTASIS, V89, P249; Lijnen HR, 2002, THROMB HAEMOSTASIS, V87, P530; Lo L, 2011, J HEPATOL, V55, P435, DOI 10.1016/j.jhep.2010.10.039; Malik J, 2005, INT ANGIOL, V24, P300; Maquoi E, 2003, THROMB HAEMOSTASIS, V89, P696, DOI 10.1055/s-0037-1613586; Maury E, 2010, OBESITY, V18, P1503, DOI 10.1038/oby.2009.464; Meissburger B, 2011, DIABETOLOGIA, V54, P1468, DOI 10.1007/s00125-011-2093-9; Miele L, 2009, TRANSL RES, V154, P194, DOI 10.1016/j.trsl.2009.06.007; Miura K, 2010, GASTROENTEROLOGY, V139, P323, DOI 10.1053/j.gastro.2010.03.052; Ono H, 2003, DIABETES, V52, P2905, DOI 10.2337/diabetes.52.12.2905; Papazoglou D, 2010, EXP CLIN ENDOCR DIAB, V118, P730, DOI 10.1055/s-0030-1249671; Pendas AM, 2004, MOL CELL BIOL, V24, P5304, DOI 10.1128/MCB.24.12.5304-5313.2004; Smith BW, 2011, CRIT REV CL LAB SCI, V48, P97, DOI 10.3109/10408363.2011.596521; Soloway PD, 1996, ONCOGENE, V13, P2307; Tilg H, 2008, MOL MED, V14, P222, DOI 10.2119/2007-00119.Tilg; Weiss TW, 2011, INT J CLIN PRACT, V65, P939, DOI 10.1111/j.1742-1241.2011.02717.x; Weyer C, 2000, DIABETOLOGIA, V43, P1498, DOI 10.1007/s001250051560; Younossi ZM, 2011, OBES SURG, V21, P431, DOI 10.1007/s11695-010-0204-1	37	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0132910	10.1371/journal.pone.0132910	http://dx.doi.org/10.1371/journal.pone.0132910			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26168159	Green Submitted, Green Published, gold			2022-12-26	WOS:000358193100096
J	Tadesse, BT; Foster, BA; Berhan, Y				Tadesse, Birkneh Tilahun; Foster, Byron Alexander; Berhan, Yifru			Cross Sectional Characterization of Factors Associated with Pediatric HIV Status Disclosure in Southern Ethiopia	PLOS ONE			English	Article							CHILDREN; DIAGNOSIS; ADOLESCENTS	Background Disclosure of HIV positive status to children and adolescents is a complex process. However, disclosure has been found to be associated with improved outcomes. The objective of the current study was to identify the predictors that facilitate disclosure of HIV status to children and adolescents and to study the reasons for non-disclosure. Methods Interviews of caregivers and reviews of records were done to collect data on caregiver and child information and details regarding the disclosure status of children. Bivariate analysis was done to test the association between HIV status disclosure and different caregiver and child factors. To identify the independent predictors of disclosure, we did multivariable logistic regression. Results A total of 177 children attending an HIV clinic were included. The mean age of the participants was 10.1 years (SD = 2.8), and about half (50.8%) were female. Most caregivers, 137 (77.8%) stated that disclosure of HIV status to children is important and should be done. However, disclosure had only been made to 59 (33.3%) of the participants. Child age more than 10 years [AOR = 6.7; 95% CI: 1.73-26.01], duration of HIV diagnosis of 5 years or more [AOR = 4.4; 95% CI: 1.26-15.06] and taking a zidovudin (AZT) based regimen [AOR = 3.5; 95% CI: 1.31-9.53] predicted HIV positive status disclosure. Additionally, length of treatment of caregivers of more than 14 years [AOR = 3.9; 95% CI: 1.07-14.61], disclosure of caregiver's HIV status to children and/or others [AOR = 4.7; 95% CI: 1.19-18.74], and the child's inquiry about their condition [AOR = 4.5; 95% CI: 1.16-17.43] increased the odds of disclosure. Conclusion The rate of disclosure among HIV infected children in southern Ethiopia is low. Primarily time-based factors were associated with the probability of HIV positive status disclosure and a specific regimen which has not been found previously. Further qualitative research may elucidate more on these factors; educational strategies may address some of these determinants.	[Tadesse, Birkneh Tilahun; Berhan, Yifru] Hawassa Univ, Coll Hlth Sci, Dept Child Hlth, Hawassa, Ethiopia; [Foster, Byron Alexander] Univ Texas Hlth Sci Ctr San Antonio, Dept Pediat, San Antonio, TX 78229 USA	Hawassa University; University of Texas System; University of Texas Health San Antonio	Foster, BA (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Pediat, San Antonio, TX 78229 USA.	fosterba@uthscsa.edu		Tadesse, Birkneh Tilahun/0000-0003-4005-8605	NCATS NIH HHS [KL2 TR001118, UL1 TR001120] Funding Source: Medline; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR001118, UL1TR001120] Funding Source: NIH RePORTER	NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))		Bachanas PJ, 2001, J PEDIATR PSYCHOL, V26, P343, DOI 10.1093/jpepsy/26.6.343; Bhattacharya M, 2011, J TROP PEDIATRICS, V57, P405, DOI 10.1093/tropej/fmq115; Biadgilign S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017572; Ferris M, 2007, AIDS CARE, V19, P1088, DOI 10.1080/09540120701367124; HARDY MS, 1994, J DEV BEHAV PEDIATR, V15, pS49; Heeren GA, 2012, VULNERABLE CHILD YOU, V7, P47, DOI 10.1080/17450128.2012.656733; Hejoaka F, 2009, SOC SCI MED, V69, P869, DOI 10.1016/j.socscimed.2009.05.041; Kallem S, 2011, AIDS BEHAV, V15, P1121, DOI 10.1007/s10461-010-9741-9; Kouyoumdjian FG, 2005, J TROP PEDIATRICS, V51, P285, DOI 10.1093/tropej/fmi014; Menon A, 2007, JAIDS-J ACQ IMM DEF, V46, P349, DOI 10.1097/QAI.0b013e3181565df0; Moodley K, 2006, SAMJ S AFR MED J, V96, pA201; Oberdorfer P, 2006, J PAEDIATR CHILD H, V42, P283, DOI 10.1111/j.1440-1754.2006.00855.x; Petersen I, 2010, AIDS CARE, V22, P970, DOI 10.1080/09540121003623693; UNAIDS, 2010, GLOB AIDS EP UPD REP; Vreeman RC, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18466; WHO, 2014, TREATM CHILDR HIV AI; WHO UNICEF, 2008, SCAL HIV REL PREV DI; Wiener L, 2007, J DEV BEHAV PEDIATR, V28, P155, DOI 10.1097/01.DBP.0000267570.87564.cd; Yang H, 2006, AIDS CARE, V18, P717, DOI 10.1080/09540120500303403	19	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0132691	10.1371/journal.pone.0132691	http://dx.doi.org/10.1371/journal.pone.0132691			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1PW	26167687	Green Published, gold, Green Submitted			2022-12-26	WOS:000358193100066
J	Yin, FF; Zhu, Z; Liu, XP; Hou, DH; Wang, J; Zhang, L; Wang, ML; Kou, Z; Wang, HL; Deng, F; Hu, ZH				Yin, Feifei; Zhu, Zheng; Liu, Xiaoping; Hou, Dianhai; Wang, Jun; Zhang, Lei; Wang, Manli; Kou, Zheng; Wang, Hualin; Deng, Fei; Hu, Zhihong			The Complete Genome of a New Betabaculovirus from Clostera anastomosis	PLOS ONE			English	Article							OS INFECTIVITY FACTOR; SEQUENCE-ANALYSIS; FUNCTIONAL-ANALYSIS; GRANULOSIS-VIRUS; F-PROTEINS; IN-VIVO; BACULOVIRUS; OCCLUSION; IDENTIFICATION; REPLICATION	Clostera anastomosis (Lepidoptera: Notodontidae) is a defoliating forest insect pest. Clostera anastomosis granulovirus-B (ClasGV-B) belonging to the genus Betabaculovirus of family Baculoviridae has been used for biological control of the pest. Here we reported the full genome sequence of ClasGV-B and compared it to other previously sequenced baculoviruses. The circular double-stranded DNA genome is 107,439 bp in length, with a G+C content of 37.8% and contains 123 open reading frames (ORFs) representing 93% of the genome. ClasGV-B contains 37 baculovirus core genes, 25 lepidopteran baculovirus specific genes, 19 betabaculovirus specific genes, 39 other genes with homologues to baculoviruses and 3 ORFs unique to ClasGV-B. Hrs appear to be absent from the ClasGV-B genome, however, two non-hr repeats were found. Phylogenetic tree based on 37 core genes from 73 baculovirus genomes placed ClasGV-B in the clade b of betabaculoviruses and was most closely related to Erinnyis ello GV (ErelGV). The gene arrangement of ClasGV-B also shared the strongest collinearity with ErelGV but differed from Clostera anachoreta GV (ClanGV), Clostera anastomosis GV-A (ClasGV-A, previously also called CaLGV) and Epinotia aporema GV (EpapGV) with a 20 kb inversion. ClasGV-B genome contains three copies of polyhedron envelope protein gene (pep) and phylogenetic tree divides the PEPs of betabaculoviruses into three major clades: PEP-1, PEP-2 and PEP/P10. ClasGV-B also contains three homologues of P10 which all harbor an N-terminal coiled-coli domain and a C-terminal basic sequence. ClasGV-B encodes three fibroblast growth factor (FGF) homologues which are conserved in all sequenced betabaculoviruses. Phylogenetic analysis placed these three FGFs into different groups and suggested that the FGFs were evolved at the early stage of the betabaculovirus expansion. ClasGV-B is different from previously reported ClasGV-A and ClanGV isolated from Notodontidae in sequence and gene arrangement, indicating the virus is a new notodontid betabaculovirus.	[Yin, Feifei; Zhu, Zheng; Liu, Xiaoping; Hou, Dianhai; Wang, Jun; Zhang, Lei; Wang, Manli; Kou, Zheng; Wang, Hualin; Deng, Fei; Hu, Zhihong] Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan 430071, Peoples R China; [Yin, Feifei; Zhu, Zheng; Liu, Xiaoping; Hou, Dianhai; Wang, Jun; Zhang, Lei; Wang, Manli; Kou, Zheng; Wang, Hualin; Deng, Fei; Hu, Zhihong] Chinese Acad Sci, Wuhan Inst Virol, China Ctr Virus Culture Collect, Wuhan 430071, Peoples R China; [Yin, Feifei] Hainan Med Univ, Sch Trop & Lab Med, Haikou 571101, Peoples R China	Chinese Academy of Sciences; Wuhan Institute of Virology, CAS; Chinese Academy of Sciences; Wuhan Institute of Virology, CAS; Hainan Medical University	Hu, ZH (corresponding author), Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan 430071, Peoples R China.	huzh@wh.iov.cn	ZHU, ZHENG/P-2173-2016; Hu, Zhihong/AAS-2215-2020	ZHU, ZHENG/0000-0002-2035-0804; Hu, Zhihong/0000-0002-1560-0928; KOU, Zheng/0000-0003-4758-2872	Strategic Priority Research Program of the Chinese Academy of Sciences [XDB11030400]; National Science Foundation of China [31321001, 31200124, 31460017]	Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Science Foundation of China(National Natural Science Foundation of China (NSFC))	The research was supported in part by the Strategic Priority Research Program of the Chinese Academy of Sciences (Grant No. XDB11030400) and the National Science Foundation of China (31321001, 31200124, 31460017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens CH, 1997, VIROLOGY, V229, P381, DOI 10.1006/viro.1997.8448; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; BLISSARD GW, 1992, J VIROL, V66, P6829, DOI 10.1128/JVI.66.11.6829-6835.1992; Detvisitsakun C, 2006, VIROLOGY, V346, P258, DOI 10.1016/j.virol.2006.01.016; Escasa SR, 2006, J GEN VIROL, V87, P1917, DOI 10.1099/vir.0.81792-0; Fang MG, 2009, J VIROL, V83, P12569, DOI 10.1128/JVI.01141-09; Federici B.A., 1997, BACULOVIRUSES VIRUSE, P33, DOI [10.1007/978-1-4899-1834-5_3, DOI 10.1007/978-1-4899-1834-5_3]; FEDERICI BA, 1990, J INVERTEBR PATHOL, V56, P401, DOI 10.1016/0022-2011(90)90128-S; Friesen PD, 1997, BACULOVIRUSES, P141, DOI [10.1007/978-1-4899-1834-5_6, DOI 10.1007/978-1-4899-1834-5_6]; Harrison RL, 2008, VIRUS GENES, V36, P565, DOI 10.1007/s11262-008-0218-0; Hashimoto Y, 2000, VIROLOGY, V275, P358, DOI 10.1006/viro.2000.0530; Hawtin RE, 1997, VIROLOGY, V238, P243, DOI 10.1006/viro.1997.8816; Hayakawa T, 1999, VIROLOGY, V262, P277, DOI 10.1006/viro.1999.9894; Hayakawa T, 2000, VIROLOGY, V278, P1, DOI 10.1006/viro.2000.0668; Herniou EA, 2003, ANNU REV ENTOMOL, V48, P211, DOI 10.1146/annurev.ento.48.091801.112756; Herniou EA, 2001, J VIROL, V75, P8117, DOI 10.1128/JVI.75.17.8117-8126.2001; Herniou EA, 2007, CURR DRUG TARGETS, V8, P1043, DOI 10.2174/138945007782151306; Hilton S, 2008, ARCH VIROL, V153, P1527, DOI 10.1007/s00705-008-0148-0; Hu ZH, 1998, J GEN VIROL, V79, P2841, DOI 10.1099/0022-1317-79-11-2841; IJkel WFJ, 2000, VIROLOGY, V275, P30, DOI 10.1006/viro.2000.0483; Ikeda M, 2004, VIROLOGY, V321, P359, DOI 10.1016/j.virol.2004.01.002; Ishimwe E, 2015, VIROLOGY, V479, P637, DOI 10.1016/j.virol.2015.01.027; Garavaglia MJ, 2012, J VIROL, V86, P12069, DOI 10.1128/JVI.01873-12; Jehle JA, 2006, VIROLOGY, V346, P180, DOI 10.1016/j.virol.2005.10.032; Jehle JA, 2002, J GEN VIROL, V83, P2025, DOI 10.1099/0022-1317-83-8-2025; Katsuma S, 2006, VIROLOGY, V355, P62, DOI 10.1016/j.virol.2006.07.008; Ko R, 2000, J VIROL, V74, P11240, DOI 10.1128/JVI.74.23.11240-11246.2000; Kuzio J, 1999, VIROLOGY, V253, P17, DOI 10.1006/viro.1998.9469; Lange M, 2003, VIROLOGY, V317, P220, DOI 10.1016/S0042-6822(03)00515-4; Lepore LS, 1996, J INVERTEBR PATHOL, V68, P131, DOI 10.1006/jipa.1996.0070; Ferrelli ML, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-548; Li Hai-xia, 2006, Journal of Forestry Research (Harbin), V17, P50, DOI 10.1007/s11676-006-0012-6; Liang ZP, 2013, ARCH VIROL, V158, P2109, DOI 10.1007/s00705-013-1710-y; Liang ZP, 2011, ARCH VIROL, V156, P1185, DOI 10.1007/s00705-011-0977-0; Lu H, 2014, PROT FORE SCI TECH, V126, P66; Lung O, 2002, J VIROL, V76, P5729, DOI 10.1128/JVI.76.11.5729-5736.2002; Luque T, 2001, J GEN VIROL, V82, P2531, DOI 10.1099/0022-1317-82-10-2531; Miele Solange Ana Belen, 2011, Int J Evol Biol, V2011, P379424, DOI 10.4061/2011/379424; Moscardi F, 2011, MICROBES AND MICROBIAL TECHNOLOGY: AGRICULTURAL AND ENVIRONMENTAL APPLICATIONS, P415, DOI 10.1007/978-1-4419-7931-5_16; Nie YC, 2012, J VIROL, V86, P3985, DOI 10.1128/JVI.06849-11; OReilly D.R., 1997, BACULOVIRUSES, P267, DOI DOI 10.1007/978-1-4899-1834-5_11; Passarelli AL, 2007, CURR DRUG TARGETS, V8, P1103, DOI 10.2174/138945007782151324; Pearson MN, 1998, J VIROL, V72, P9142, DOI 10.1128/JVI.72.11.9142-9149.1998; Peng K, 2010, J VIROL, V84, P9497, DOI 10.1128/JVI.00812-10; Ardisson-Araujo DMP, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-856; Popovici C, 2005, BIOESSAYS, V27, P849, DOI 10.1002/bies.20261; Reichard P, 2002, ARCH BIOCHEM BIOPHYS, V397, P149, DOI 10.1006/abbi.2001.2637; SLACK JM, 1995, J GEN VIROL, V76, P1091, DOI 10.1099/0022-1317-76-5-1091; Solovyev VV, 1999, NUCLEIC ACIDS RES, V27, P248, DOI 10.1093/nar/27.1.248; Sparks WO, 2011, VIROLOGY, V409, P69, DOI 10.1016/j.virol.2010.09.027; Sun Xiulian, 1998, Virologica Sinica, V13, P83; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tang X, 2004, J HUAZHONG AGR, V23, P616; Tatusova TA, 1999, FEMS MICROBIOL LETT, V174, P247, DOI 10.1016/S0378-1097(99)00149-4; van Oers MM, 2007, CURR DRUG TARGETS, V8, P1051, DOI 10.2174/138945007782151333; VanOers MM, 1997, J INVERTEBR PATHOL, V70, P1, DOI 10.1006/jipa.1997.4675; VANOERS MM, 1993, J GEN VIROL, V74, P563, DOI 10.1099/0022-1317-74-4-563; Vaux DL, 1996, P NATL ACAD SCI USA, V93, P2239, DOI 10.1073/pnas.93.6.2239; Wang P, 1997, P NATL ACAD SCI USA, V94, P6977, DOI 10.1073/pnas.94.13.6977; Wheeler DL, 2003, NUCLEIC ACIDS RES, V31, P28, DOI 10.1093/nar/gkg033; WINSTANLEY D, 1999, ENCY VIROLOGY, V1, P140; Wormleaton S, 2003, VIROLOGY, V311, P350, DOI 10.1016/S0042-6822(03)00149-1; Yin FF, 2008, J VIROL, V82, P8922, DOI 10.1128/JVI.00493-08; Yin FF, 2013, VIROLOGY, V436, P59, DOI 10.1016/j.virol.2012.10.017; Zheng M, 1987, GUIZHOU FORES SCI TE, V03, P78; Zhu Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086450	66	13	13	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0132792	10.1371/journal.pone.0132792	http://dx.doi.org/10.1371/journal.pone.0132792			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26168260	Green Submitted, Green Published, gold			2022-12-26	WOS:000358193100081
J	Sacilotto, N; Castillo, J; Riffo-Campos, AL; Flores, JM; Hibbitt, O; Wade-Martins, R; Lopez, C; Rodrigo, MI; Franco, L; Lopez-Rodas, G				Sacilotto, Natalia; Castillo, Josefa; Riffo-Campos, Angela L.; Flores, Juana M.; Hibbitt, Olivia; Wade-Martins, Richard; Lopez, Carlos; Isabel Rodrigo, M.; Franco, Luis; Lopez-Rodas, Gerardo			Growth Arrest Specific 1 (Gas1) Gene Overexpression in Liver Reduces the In Vivo Progression of Murine Hepatocellular Carcinoma and Partially Restores Gene Expression Levels	PLOS ONE			English	Article							INHIBITS TUMOR-GROWTH; VENTRAL SPINAL-CORD; HEDGEHOG; CANCER; CELLS; PROLIFERATION; SHH; METASTASIS; TRANSPORT; PATHWAY	The prognosis of hepatocellular carcinoma patients is usually poor, the size of tumors being a limiting factor for surgical treatments. Present results suggest that the overexpression of Gas1 (growth arrest specific 1) gene reduces the size, proliferating activity and malignancy of liver tumors. Mice developing diethylnitrosamine-induced hepatocellular carcinoma were subjected to hydrodynamic gene delivery to overexpress Gas1 in liver. This treatment significantly (p < 0.05) reduced the number of large tumors, while the difference in the total number of lesions was not significant. Moreover, the number of carcinoma foci in the liver and the number of lung metastases were reduced. These results are related with the finding that overexpression of Gas1 in Hepa 1-6 cells arrests cell cycle before S phase, with a significant (p < 0.01) and concomitant reduction in the expression of cyclin E2 gene. In addition, a triangular analysis of microarray data shows that Gas1 overexpression restores the transcription levels of 150 genes whose expression was affected in the diethylnitrosamine-induced tumors, thirteen of which are involved in the hedgehog signaling pathway. Since the in vivo Gas1 gene delivery to livers of mice carrying hepatocellular carcinoma reduces the size and proliferating activity of tumors, partially restoring the transcriptional profile of the liver, the present study opens promising insights towards a therapeutic approach for hepatocellular carcinoma.	[Sacilotto, Natalia; Castillo, Josefa; Riffo-Campos, Angela L.; Isabel Rodrigo, M.; Franco, Luis; Lopez-Rodas, Gerardo] Univ Valencia, Dept Biochem & Mol Biol, Valencia, Spain; [Castillo, Josefa; Riffo-Campos, Angela L.; Isabel Rodrigo, M.; Franco, Luis] Inst Hlth Res INCLIVA, Valencia, Spain; [Flores, Juana M.] Univ Complutense, Dept Med & Anim Surg, E-28040 Madrid, Spain; [Hibbitt, Olivia; Wade-Martins, Richard] Univ Oxford, Dept Physiol Anat & Genet, Oxford, England; [Lopez, Carlos] Univ Valencia, Dept Cell Biol, Valencia, Spain	University of Valencia; Complutense University of Madrid; University of Oxford; University of Valencia	Franco, L (corresponding author), Univ Valencia, Dept Biochem & Mol Biol, Valencia, Spain.	luis.franco@uv.es	Riffo-Campos, Angela L./AAX-8637-2021; LOPEZ-RODAS, GERARDO/I-1349-2015	Riffo-Campos, Angela L./0000-0001-6300-3338; Wade-Martins, Richard/0000-0001-6691-580X; LOPEZ-RODAS, GERARDO/0000-0001-8367-653X; Castillo Aliaga, Josefa/0000-0002-4092-0085; Franco, Luis/0000-0001-9610-6448	Consolider-Ingenio program (Ministerio de Educacion, Spain); Generalitat Valenciana; Prometeo (Generalitat Valenciana)	Consolider-Ingenio program (Ministerio de Educacion, Spain); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); Prometeo (Generalitat Valenciana)(Center for Forestry Research & Experimentation (CIEF))	This work was supported by Consolider-Ingenio program (Ministerio de Educacion, Spain) to G.L-R (http://www.mecd.gob.es/educacion-mecd/ACOM2010/133); Generalitat Valenciana to G.L.-R (http://www.cece.gva.es/es/); Prometeo 2013/2014 (Generalitat Valenciana) to L.F. (http://www.cece.gva.es/es/).	Allen BL, 2011, DEV CELL, V20, P775, DOI 10.1016/j.devcel.2011.04.018; Annenkov A, 2009, MOL NEUROBIOL, V40, P195, DOI 10.1007/s12035-009-8081-0; Avanesov A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002503; Ayrault O, 2010, CANCER RES, V70, P5618, DOI 10.1158/0008-5472.CAN-09-3740; Benitez JA, 2007, CANCER GENE THER, V14, P836, DOI 10.1038/sj.cgt.7701076; Bhoori S, 2010, TRANSPL INT, V23, P712, DOI 10.1111/j.1432-2277.2010.01111.x; Bolstad B.M, 2001, PROBE LEVEL QUANTILE; Cabrera JR, 2006, J BIOL CHEM, V281, P14330, DOI 10.1074/jbc.M509572200; Chaya T, 2014, EMBO J, V33, P1227, DOI 10.1002/embj.201488175; Chen X, 2014, AM J PATHOL, V184, P912, DOI 10.1016/j.ajpath.2013.12.002; Chenna V, 2012, MOL CANCER THER, V11, P165, DOI 10.1158/1535-7163.MCT-11-0341; Das SK, 2015, J CELL PHYSIOL, V230, P259, DOI 10.1002/jcp.24791; DELSAL G, 1994, P NATL ACAD SCI USA, V91, P1848, DOI 10.1073/pnas.91.5.1848; DELSAL G, 1992, CELL, V70, P595, DOI 10.1016/0092-8674(92)90429-G; DELSAL G, 1995, MOL CELL BIOL, V15, P7152; Dentice M, 2005, NAT CELL BIOL, V7, P698, DOI 10.1038/ncb1272; Evdokiou A, 1998, EXP CELL RES, V240, P359, DOI 10.1006/excr.1998.4011; EVDOKIOU A, 1993, GENOMICS, V18, P731, DOI 10.1016/S0888-7543(05)80388-X; Fan LL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046472; Fernandez C, 2010, DEV NEUROSCI-BASEL, V32, P59, DOI 10.1159/000274458; Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0; Genethliou N, 2009, BIOCHEM BIOPH RES CO, V382, P69, DOI 10.1016/j.bbrc.2009.02.134; Ghanipour A, 2009, CANCER EPIDEM BIOMAR, V18, P2949, DOI 10.1158/1055-9965.EPI-09-0456; Gialmanidis IP, 2013, LUNG, V191, P511, DOI 10.1007/s00408-013-9490-4; Gobeil S, 2008, GENE DEV, V22, P2932, DOI 10.1101/gad.1714608; Grossi M, 1998, ONCOGENE, V17, P1629, DOI 10.1038/sj.onc.1202090; Hager-Theodorides AL, 2009, J IMMUNOL, V183, P3023, DOI 10.4049/jimmunol.0900152; Izzi L, 2011, DEV CELL, V20, P788, DOI 10.1016/j.devcel.2011.04.017; Jiang Z, 2011, HUM PATHOL, V42, P361, DOI 10.1016/j.humpath.2010.03.009; Jimenez A, 2014, EXP CELL RES, V327, P307, DOI 10.1016/j.yexcr.2014.06.016; Justilien V, 2015, CLIN CANCER RES, V21, P505, DOI 10.1158/1078-0432.CCR-14-0507; Kawakubo T, 2007, CANCER RES, V67, P10869, DOI 10.1158/0008-5472.CAN-07-2048; KYRIAZIS AP, 1974, CANCER RES, V34, P2881; Lapouge G, 2005, CELL MOL LIFE SCI, V62, P53, DOI 10.1007/s00018-004-4329-z; Lee CS, 2001, P NATL ACAD SCI USA, V98, P11347, DOI 10.1073/pnas.201418298; Liu AM, 2005, DEVELOPMENT, V132, P3103, DOI 10.1242/dev.01894; Liu F, 1999, GENE THER, V6, P1258, DOI 10.1038/sj.gt.3300947; Liu JH, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003884; Madhala-Levy D, 2012, J CELL PHYSIOL, V227, P1455, DOI 10.1002/jcp.22861; Moon H, 2014, P NATL ACAD SCI USA, V111, P8541, DOI 10.1073/pnas.1323161111; Ng RCL, 2014, CELL DEATH DIFFER, V21, P978, DOI 10.1038/cdd.2014.20; Nguyen AT, 2008, J SURG RES, V148, P60, DOI 10.1016/j.jss.2008.02.016; Ocbina PJR, 2011, NAT GENET, V43, P547, DOI 10.1038/ng.832; Oishi N, 2014, LIVER CANCER, V3, P71, DOI 10.1159/000343863; Omenetti A, 2011, J HEPATOL, V54, P366, DOI 10.1016/j.jhep.2010.10.003; Pfaffl MW., 2004, REAL TIME PCR, P63; Pollard KS, 2005, STAT BIOL HEALTH, P249; Qin JA, 2011, P NATL ACAD SCI USA, V108, P1456, DOI 10.1073/pnas.1011410108; Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412; Rizzi F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003617; Sala M, 2004, HEPATOLOGY, V40, P1352, DOI 10.1002/hep.20465; Sanchez-Arrones L, 2012, INT J BIOCHEM CELL B, V44, P698, DOI 10.1016/j.biocel.2012.01.019; Sanchez-Hernandez D, 2012, DEVELOPMENT, V139, P3849, DOI 10.1242/dev.080028; SCHNEIDER C, 1988, CELL, V54, P787, DOI 10.1016/S0092-8674(88)91065-3; Sebestyen MG, 2006, J GENE MED, V8, P852, DOI 10.1002/jgm.921; Stebel M, 2000, FEBS LETT, V481, P152, DOI 10.1016/S0014-5793(00)02004-4; Touahri Y, 2012, J NEUROSCI, V32, P18018, DOI 10.1523/JNEUROSCI.3553-12.2012; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; van Roeyen CRC, 2013, KIDNEY INT, V83, P251, DOI 10.1038/ki.2012.400; Varas A, 2008, J LEUKOCYTE BIOL, V83, P1476, DOI 10.1189/jlb.1107792; VARNER JA, 1995, MOL BIOL CELL, V6, P725, DOI 10.1091/mbc.6.6.725; VESSELINOVITCH SD, 1983, CANCER RES, V43, P4253; Wang HH, 2012, FEBS J, V279, P3652, DOI 10.1111/j.1742-4658.2012.08726.x; Witt RM, 2013, J BIOL CHEM, V288, P26275, DOI 10.1074/jbc.M112.438937; Xu CR, 2009, MOL CANCER RES, V7, P1937, DOI 10.1158/1541-7786.MCR-09-0333; Zamorano A, 2004, NEUROBIOL DIS, V15, P483, DOI 10.1016/j.nbd.2003.11.022; Zamorano A, 2003, J NEUROSCI RES, V71, P256, DOI 10.1002/jnr.10461; Zarco N, 2012, APOPTOSIS, V17, P627, DOI 10.1007/s10495-011-0696-8	68	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132477	10.1371/journal.pone.0132477	http://dx.doi.org/10.1371/journal.pone.0132477			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161998	Green Submitted, gold, Green Published			2022-12-26	WOS:000358162300140
J	Thedja, MD; Muljono, DH; Ie, SI; Sidarta, E; Turyadi; Verhoef, J; Marzuki, S				Thedja, Meta Dewi; Muljono, David Handojo; Ie, Susan Irawati; Sidarta, Erick; Turyadi; Verhoef, Jan; Marzuki, Sangkot			Genogeography and Immune Epitope Characteristics of Hepatitis B Virus Genotype C Reveals Two Distinct Types: Asian and Papua-Pacific	PLOS ONE			English	Article							T-CELL EPITOPE; SURFACE-ANTIGEN; GENETIC DIVERSITY; PHYLOGENETIC RELATEDNESS; NUCLEOTIDE-SEQUENCE; BLOOD-DONORS; CORE GENE; SUBGENOTYPES; DISEASE; IDENTIFICATION	Distribution of hepatitis B virus (HBV) genotypes/subgenotypes is geographically and ethnologically specific. In the Indonesian archipelago, HBV genotype C (HBV/C) is prevalent with high genome variability, reflected by the presence of 13 of currently existing 16 subgenotypes. We investigated the association between HBV/C molecular characteristics with host ethnicity and geographical distribution by examining various subgenotypes of HBV/C isolates from the Asia and Pacific region, with further analysis on the immune epitope characteristics of the core and surface proteins. Phylogenetic tree was constructed based on complete HBV/C genome sequences from Asia and Pacific region, and genetic distance between isolates was also examined. HBV/C surface and core immune epitopes were analyzed and grouped by comparing the amino acid residue characteristics and geographical origins. Based on phylogenetic tree and geographical origins of isolates, two major groups of HBV/C isolates-East-Southeast Asia and Papua-Pacific-were identified. Analysis of core and surface immune epitopes supported these findings with several amino acid substitutions distinguishing the East-Southeast Asia isolates from the Papua-Pacific isolates. A west-to-east gradient of HBsAg subtype distribution was observed with adrq+ prominent in the East and Southeast Asia and adrq-in the Pacific, with several adrq-indeterminate subtypes observed in Papua and Papua New Guinea (PNG). This study indicates that HBV/C isolates can be classified into two types, the Asian and the Papua-Pacific, based on the virus genome diversity, immune epitope characteristics, and geographical distribution, with Papua and PNG as the molecular evolutionary admixture region in the switching from adrq+ to adrq-.	[Thedja, Meta Dewi; Muljono, David Handojo; Ie, Susan Irawati; Sidarta, Erick; Turyadi; Marzuki, Sangkot] Eijkman Inst Mol Biol, Jakarta, Indonesia; [Thedja, Meta Dewi; Verhoef, Jan] Univ Med Ctr UMC Utrecht, Eijkman Winkler Inst, Utrecht, Netherlands; [Muljono, David Handojo] Hasanuddin Univ, Fac Med, Makassar, Indonesia; [Muljono, David Handojo] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia; [Marzuki, Sangkot] Monash Univ, Monash Med Ctr, Dept Med, Clayton, Vic, Australia	Eijkman Institute; Universitas Hasanuddin; University of Sydney; Monash University	Muljono, DH (corresponding author), Eijkman Inst Mol Biol, Jakarta, Indonesia.	davidhm@eijkman.go.id	Muljono, David Handojo/AAR-6270-2021; Muljono, David Handojo/H-5477-2019	Muljono, David Handojo/0000-0002-5542-106X; Ie, Susan Irawati/0000-0001-8469-932X; , Turyadi/0000-0002-1388-4920; Thedja, Meta Dewi/0000-0002-2948-4905				Abdulla MA, 2009, SCIENCE, V326, P1541, DOI 10.1126/science.1177074; BELLWOOD P, 1997, PREHISTORY INDOMALAY, P96; BERTOLETTI A, 1994, J EXP MED, V180, P933, DOI 10.1084/jem.180.3.933; Bertoletti A, 1997, HEPATOLOGY, V26, P1027, DOI 10.1002/hep.510260435; Carman WF, 1997, J INFECT DIS, V175, P1093, DOI 10.1086/516447; Carman WF, 2005, VIRAL HEPATITIS, 3RD EDITION, P225, DOI 10.1002/9780470987131.ch14; Cavinta L, 2009, J MED VIROL, V81, P983, DOI 10.1002/jmv.21475; Chan HLY, 2005, J INFECT DIS, V191, P2022, DOI 10.1086/430324; Chisari FV, 2000, AM J PATHOL, V156, P1117, DOI 10.1016/S0002-9440(10)64980-2; COUROUCEPAUTY AM, 1978, VOX SANG, V35, P304, DOI 10.1111/j.1423-0410.1978.tb02939.x; Deka R, 2001, GENETIC LINGUISTIC A, P135; EHATA T, 1992, J CLIN INVEST, V89, P332, DOI 10.1172/JCI115581; EHATA T, 1991, J GASTROEN HEPATOL, V6, P292, DOI 10.1111/j.1440-1746.1991.tb01481.x; FERRARI C, 1991, J CLIN INVEST, V88, P214, DOI 10.1172/JCI115280; Friedlaender JS, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040019; Huy TTT, 2008, J VIROL, V82, P5657, DOI 10.1128/JVI.02556-07; Huy TTT, 2008, VIRUS GENES, V36, P299, DOI 10.1007/s11262-008-0205-5; Huy TTT, 2004, J GEN VIROL, V85, P283, DOI 10.1099/vir.0.19633-0; Jazayeri M, 2004, J VIRAL HEPATITIS, V11, P488, DOI 10.1111/j.1365-2893.2004.00534.x; Jazayeri MS, 2004, J HEPATOL, V41, P139, DOI 10.1016/j.jhep.2004.03.025; Jazayeri SM, 2005, HEPAT MON, V5, P133; Kao JH, 2000, GASTROENTEROLOGY, V118, P554, DOI 10.1016/S0016-5085(00)70261-7; Kim HJ, 2007, LIVER INT, V27, P633, DOI 10.1111/j.1478-3231.2007.01481.x; Kramvis A, 2014, INTERVIROLOGY, V57, P141, DOI 10.1159/000360947; Kurbanov F, 2010, HEPATOL RES, V40, P14, DOI 10.1111/j.1872-034X.2009.00601.x; Lavanchy D, 2004, J VIRAL HEPATITIS, V11, P97, DOI 10.1046/j.1365-2893.2003.00487.x; Liu CJ, 2013, SEMIN LIVER DIS, V33, P97, DOI 10.1055/s-0033-1345716; Lusida MI, 2008, J CLIN MICROBIOL, V46, P2160, DOI 10.1128/JCM.01681-07; Marzuki S, 2003, ADV EXP MED BIOL, P5313; MCMAHON G, 1992, HEPATOLOGY, V15, P757, DOI 10.1002/hep.1840150503; Min WP, 1996, HUM IMMUNOL, V46, P93, DOI 10.1016/0198-8859(96)00009-2; Mohamadkhani A, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-209; Mulyanto, 2012, VIRUS RES, V163, P129, DOI 10.1016/j.virusres.2011.09.002; Mulyanto, 2011, J MED VIROL, V83, P54, DOI 10.1002/jmv.21931; Mulyanto, 2010, ARCH VIROL, V155, P705, DOI 10.1007/s00705-010-0628-x; Mulyanto, 1997, ARCH VIROL, V142, P2121, DOI 10.1007/s007050050230; Mulyanto, 2009, ARCH VIROL, V154, P1047, DOI 10.1007/s00705-009-0406-9; NAYERSINA R, 1993, J IMMUNOL, V150, P4659; NORDER H, 1992, J GEN VIROL, V73, P3141, DOI 10.1099/0022-1317-73-12-3141; Norder H, 2004, INTERVIROLOGY, V47, P289, DOI 10.1159/000080872; NORDER H, 1994, VIROLOGY, V198, P489, DOI 10.1006/viro.1994.1060; Nurainy N, 2008, ARCH VIROL, V153, P1057, DOI 10.1007/s00705-008-0092-z; OKAMOTO H, 1987, J VIROL, V61, P3030, DOI 10.1128/JVI.61.10.3030-3034.1987; OKAMOTO H, 1988, J GEN VIROL, V69, P2575, DOI 10.1099/0022-1317-69-10-2575; Okamoto H, 1992, NONB NONC NONG HEPAT; Orito E, 2001, HEPATOLOGY, V33, P218, DOI 10.1053/jhep.2001.20532; Pairan A, 2009, J VIROL, V83, P11616, DOI 10.1128/JVI.01178-09; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sakamoto T, 2006, J GEN VIROL, V87, P1873, DOI 10.1099/vir.0.81714-0; SASTROSOEWIGNJO RI, 1991, J GASTROEN HEPATOL, V6, P491, DOI 10.1111/j.1440-1746.1991.tb00894.x; Sugauchi F, 2001, J GEN VIROL, V82, P883, DOI 10.1099/0022-1317-82-4-883; Tai PC, 1997, J VIROL, V71, P4852, DOI 10.1128/JVI.71.6.4852-4856.1997; Tan AT, 2008, J VIROL, V82, P10986, DOI 10.1128/JVI.01124-08; Tatematsu K, 2009, J VIROL, V83, P10538, DOI 10.1128/JVI.00462-09; Thedja MD, 2010, HEPATOL INT, V4, P608, DOI 10.1007/s12072-010-9203-5; Thedja MD, 2011, ARCH VIROL, V156, P855, DOI 10.1007/s00705-011-0926-y; Thursz M, 2011, SEMIN LIVER DIS, V31, P115, DOI 10.1055/s-0031-1276642; TIOLLAIS P, 1985, NATURE, V317, P489, DOI 10.1038/317489a0; Tryon D. T., 1995, AUSTRONESIANS HIST C, P17; Yang HI, 2008, JNCI-J NATL CANCER I, V100, P1134, DOI 10.1093/jnci/djn243; Zeng G, 2005, J VIRAL HEPATITIS, V12, P609, DOI 10.1111/j.1365-2893.2005.00657.x	61	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132533	10.1371/journal.pone.0132533	http://dx.doi.org/10.1371/journal.pone.0132533			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26162099	gold, Green Published, Green Submitted			2022-12-26	WOS:000358162300147
J	Brehove, M; Wang, T; North, J; Luo, Y; Dreher, SJ; Shimko, JC; Ottesen, JJ; Luger, K; Poirier, MG				Brehove, Matthew; Wang, Tao; North, Justin; Luo, Yi; Dreher, Sarah J.; Shimko, John C.; Ottesen, Jennifer J.; Luger, Karolin; Poirier, Michael G.			Histone Core Phosphorylation Regulates DNA Accessibility	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-ANGLE SCATTERING; EMBRYONIC STEM-CELLS; NUCLEOSOME DYNAMICS; POSTTRANSLATIONAL MODIFICATIONS; CHROMATIN-STRUCTURE; CRYSTAL-STRUCTURE; HIGH-RESOLUTION; LYSINE 56; H3; ACETYLATION	Nucleosome unwrapping dynamics provide transient access to the complexes involved in DNA transcription, repair, and replication, whereas regulation of nucleosome unwrapping modulates occupancy of these complexes. Histone H3 is phosphorylated at tyrosine 41 (H3Y41ph) and threonine 45 (H3T45ph). H3Y41ph is implicated in regulating transcription, whereas H3T45ph is involved in DNA replication and apoptosis. These modifications are located in the DNA-histone interface near where the DNA exits the nucleosome, and are thus poised to disrupt DNA-histone interactions. However, the impact of histone phosphorylation on nucleosome unwrapping and accessibility is unknown. We find that the phosphorylation mimics H3Y41E and H3T45E, and the chemically correct modification, H3Y41ph, significantly increase nucleosome unwrapping. This enhances DNA accessibility to protein binding by 3-fold. H3K56 acetylation(H3K56ac) is also located in the same DNA-histone interface and increases DNA unwrapping. H3K56ac is implicated in transcription regulation, suggesting that H3Y41ph and H3K56ac could function together. We find that the combination of H3Y41ph with H3K56ac increases DNA accessibility by over an order of magnitude. These results suggest that phosphorylation within the nucleosome DNA entry-exit region increases access to DNA binding complexes and that the combination of phosphorylation with acetylation has the potential to significantly influence DNA accessibility to transcription regulatory complexes.	[Brehove, Matthew; Poirier, Michael G.] Ohio State Univ, Dept Phys, Columbus, OH 43210 USA; [North, Justin] Ohio State Univ, Dept Microbiol, Columbus, OH 43210 USA; [Luo, Yi; Ottesen, Jennifer J.; Poirier, Michael G.] Ohio State Univ, Biophys Grad Program, Columbus, OH 43210 USA; [Dreher, Sarah J.; Shimko, John C.; Ottesen, Jennifer J.; Poirier, Michael G.] Ohio State Univ, Ohio State Biochem Program, Columbus, OH 43210 USA; [Shimko, John C.; Ottesen, Jennifer J.; Poirier, Michael G.] Ohio State Univ, Dept Chem & Biochem, Columbus, OH 43210 USA; [Luger, Karolin] Colorado State Univ, Howard Hughes Med Inst, Ft Collins, CO 80523 USA; [Wang, Tao; Luger, Karolin] Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Colorado State University; Howard Hughes Medical Institute; Colorado State University	Poirier, MG (corresponding author), Ohio State Univ, Dept Phys, 191 W Woodruff Ave, Columbus, OH 43214 USA.	mpoirier@mps.ohio-state.edu	Poirier, Michael Guy/B-5378-2012	, Yi/0000-0001-9279-9726; SCHNIZER-LUGER, KAROLINE/0000-0001-5136-5331; Wang, Tao/0000-0002-9641-6558; Ottesen, Jennifer/0000-0003-3323-6290	DOE Office of Biological and Environmental Research; National Institute of Health MINOS [R01GM105404]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM105404, R01GM096192, P01GM088409, R01GM083055] Funding Source: NIH RePORTER	DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institute of Health MINOS; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Poirier, Ottesen, and Luger laboratories for helpful discussions. We are grateful to Cody Alsaker, Mark van der Woerd, and F. Jay Breidt for help with the statistical analysis of the SAXS data. SAXS data collection in this work was conducted at the Advanced Light Source (ALS), a national user facility operated by Lawrence Berkeley National Laboratory on behalf of the Department of Energy, Office of Basic Energy Sciences, through the Integrated Diffraction Analysis Technologies (IDAT) program, supported by DOE Office of Biological and Environmental Research. Additional support comes from the National Institute of Health project MINOS (R01GM105404).	Arnaudo AM, 2013, EPIGENET CHROMATIN, V6, DOI 10.1186/1756-8935-6-24; Avvakumov N, 2011, MOL CELL, V41, P502, DOI 10.1016/j.molcel.2011.02.013; Baker SP, 2010, NAT CELL BIOL, V12, P294, DOI 10.1038/ncb2030; Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Bartholomew B, 2014, ANNU REV BIOCHEM, V83, P671, DOI 10.1146/annurev-biochem-051810-093157; Bowman GD, 2015, CHEM REV, V115, P2274, DOI 10.1021/cr500350x; Casadio F, 2013, P NATL ACAD SCI USA, V110, P14894, DOI 10.1073/pnas.1312925110; Chen CC, 2008, CELL, V134, P231, DOI 10.1016/j.cell.2008.06.035; CLEGG RM, 1992, METHOD ENZYMOL, V211, P353; Cosgrove MS, 2004, NAT STRUCT MOL BIOL, V11, P1037, DOI 10.1038/nsmb851; Das C, 2010, TRENDS BIOCHEM SCI, V35, P476, DOI 10.1016/j.tibs.2010.04.001; Das C, 2009, NATURE, V459, P113, DOI 10.1038/nature07861; Dawson MA, 2012, CELL REP, V2, P470, DOI 10.1016/j.celrep.2012.08.016; Dawson MR, 2009, NATURE, V461, pE4, DOI 10.1038/nature08254; Dechassa ML, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1320; Dyer PN, 2004, METHOD ENZYMOL, V375, P23; Forties RA, 2011, NUCLEIC ACIDS RES, V39, P8306, DOI 10.1093/nar/gkr422; Griffiths DS, 2011, NAT CELL BIOL, V13, P13, DOI 10.1038/ncb2135; Guinier A., 1955, J POLYM SCI, V19, P594, DOI [10.1002/pol.1956.120199326, DOI 10.1002/POL.1956.120199326]; Hall MA, 2009, NAT STRUCT MOL BIOL, V16, P124, DOI 10.1038/nsmb.1526; Hurd PJ, 2009, J BIOL CHEM, V284, P16575, DOI 10.1074/jbc.M109.005421; Jang SM, 2014, EMBO REP, V15, P686, DOI 10.15252/embr.201338356; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Li G, 2004, NAT STRUCT MOL BIOL, V11, P763, DOI 10.1038/nsmb801; Li Q, 2008, CELL, V134, P244, DOI 10.1016/j.cell.2008.06.018; LITTLE JW, 1994, METHOD ENZYMOL, V244, P266; Lo KA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019778; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Loyola A, 2004, BBA-GENE STRUCT EXPR, V1677, P3, DOI 10.1016/j.bbaexp.2003.09.012; Luger K, 2006, CHROMOSOME RES, V14, P5, DOI 10.1007/s10577-005-1026-1; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Mahto SK, 2011, CHEMBIOCHEM, V12, P2488, DOI 10.1002/cbic.201100472; Manohar M, 2009, J BIOL CHEM, V284, P23312, DOI 10.1074/jbc.M109.003202; Narlikar GJ, 2013, CELL, V154, P490, DOI 10.1016/j.cell.2013.07.011; Neumann H, 2009, MOL CELL, V36, P153, DOI 10.1016/j.molcel.2009.07.027; Ngo TTM, 2015, CELL, V160, P1135, DOI 10.1016/j.cell.2015.02.001; North JA, 2014, NUCLEIC ACIDS RES, V42, P4922, DOI 10.1093/nar/gku150; North JA, 2012, NUCLEIC ACIDS RES, V40, P10215, DOI 10.1093/nar/gks747; North JA, 2011, NUCLEIC ACIDS RES, V39, P6465, DOI 10.1093/nar/gkr304; POLACH KJ, 1995, J MOL BIOL, V254, P130, DOI 10.1006/jmbi.1995.0606; Ranjith P, 2007, P NATL ACAD SCI USA, V104, P13649, DOI 10.1073/pnas.0701459104; Rothbart SB, 2014, BBA-GENE REGUL MECH, V1839, P627, DOI 10.1016/j.bbagrm.2014.03.001; Ryan DP, 2011, CURR OPIN CHEM BIOL, V15, P649, DOI 10.1016/j.cbpa.2011.07.022; Schnitzler G, 1998, CELL, V94, P17, DOI 10.1016/S0092-8674(00)81217-9; Shimko John C, 2013, Methods Mol Biol, V981, P177, DOI 10.1007/978-1-62703-305-3_14; Shimko JC, 2011, J MOL BIOL, V408, P187, DOI 10.1016/j.jmb.2011.01.003; Simon M, 2011, P NATL ACAD SCI USA, V108, P12711, DOI 10.1073/pnas.1106264108; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Tachiwana H, 2011, NATURE, V476, P232, DOI 10.1038/nature10258; Tan YL, 2013, P NATL ACAD SCI USA, V110, P11493, DOI 10.1073/pnas.1309914110; Tropberger P, 2013, NAT STRUCT MOL BIOL, V20, P657, DOI 10.1038/nsmb.2581; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wang XD, 2008, MOL CELL BIOL, V28, P227, DOI 10.1128/MCB.01245-07; Widom J, 1998, ANNU REV BIOPH BIOM, V27, P285, DOI 10.1146/annurev.biophys.27.1.285; Xie W, 2009, MOL CELL, V33, P417, DOI 10.1016/j.molcel.2009.02.004; Xu F, 2005, CELL, V121, P375, DOI 10.1016/j.cell.2005.03.011; Yang CH, 2011, NUCLEIC ACIDS RES, V39, P4122, DOI 10.1093/nar/gkr005; Zentner GE, 2013, NAT STRUCT MOL BIOL, V20, P259, DOI 10.1038/nsmb.2470	61	61	63	1	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2015	290	37					22612	22621		10.1074/jbc.M115.661363	http://dx.doi.org/10.1074/jbc.M115.661363			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR2PB	26175159	Green Published, hybrid			2022-12-26	WOS:000361171500027
J	Brosseau, N; Andreev, E; Ramotar, D				Brosseau, Nicolas; Andreev, Emil; Ramotar, Dindial			Complementation of the Yeast Model System Reveals that Caenorhabditis elegans OCT-1 Is a Functional Transporter of Anthracyclines	PLOS ONE			English	Article							ORGANIC CATION TRANSPORTER; ACUTE MYELOID-LEUKEMIA; CALCIUM SIGNALING PATHWAY; GENOME-WIDE SCREEN; SACCHAROMYCES-CEREVISIAE; CARNITINE TRANSPORTER; POLYAMINE UPTAKE; DRUG-RESISTANCE; GROUP-B; DOXORUBICIN	The yeast plasma membrane protein Agp2 belongs to the family of amino acid transporters. It acts as a regulator that controls the expression of several uptake transporter genes such as DUR3 and SAM3 encoding two high-affinity polyamine permeases. agp2 Delta mutants display extreme resistance to several cationic compounds including polyamines, the anticancer agent bleomycin, and cationic antifungal peptides. We propose that Agp2 might be involved in regulating the uptake of other cationic anticancer drugs. To date, an uptake transporter has not been reported for anthracyclines, a family of chemotherapeutic agents that are used for treating adult patients with acute myeloid leukemia. Herein, we develop assay conditions to monitor the uptake of the anthracycline doxorubicin into yeast cells and demonstrate for the first time that Agp2 is required for the drug uptake. Deletion of both the DUR3 and SAM3 genes reduced doxorubicin uptake, but not the deletion of either gene alone, while theagp2 Delta mutant was severely compromised, suggesting that Agp2 controls the drug uptake via Dur3 and Sam3 and at least one additional transporter. Overexpression of DUR3 or SAM3 from the endogenous promoter rescued doxorubicin uptake into the sam3 Delta dur3 Delta double mutant, consistent with a role for these transporters in the uptake of anthracyclines. We further show by cross-species complementation analysis that expression of the Caenorhabditis elegans oct-1 gene encoding an organic cation transporter restored full doxorubicin uptake in the agp2D mutant. Four separate variants of CeOCT-1 derived by substituting the amino acid residues Gln15, Cys31, Gln109 and Lys300 with alanine were stably expressed, but did not mediate doxorubicin uptake into the agp2D mutant. Moreover, we show that overexpression of CeOCT-1 sensitized parent yeast cells to doxorubicin, suggesting that CeOCT-1 related members might be key transporters to facilitate entry of anthracyclines into human cells.	[Brosseau, Nicolas; Andreev, Emil; Ramotar, Dindial] Univ Montreal, Res Ctr, Maisonneuve Rosemont Hosp, Dept Med, Montreal, PQ, Canada	Universite de Montreal	Ramotar, D (corresponding author), Univ Montreal, Res Ctr, Maisonneuve Rosemont Hosp, Dept Med, 5415 Boul Assompt, Montreal, PQ, Canada.	dindial.ramotar@umontreal.ca			Canadian Institute of Health Research [MOP-93573, RGPIN/202432-2012]; Natural Science and Engineering Research Council of Canada	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by research grants (MOP-93573 and RGPIN/202432-2012) to D. R. from the Canadian Institute of Health Research and the Natural Science and Engineering Research Council of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aouida M, 2005, J BIOL CHEM, V280, P24267, DOI 10.1074/jbc.M503071200; Aouida M, 2004, CANCER RES, V64, P1102, DOI 10.1158/0008-5472.CAN-03-2729; Aouida M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065717; Becker ML, 2009, PHARMACOGENOMICS J, V9, P242, DOI 10.1038/tpj.2009.15; Bleackley MR, 2014, ANTIMICROB AGENTS CH, V58, P2688, DOI 10.1128/AAC.02087-13; Byrd JC, 2002, BLOOD, V100, P4325, DOI 10.1182/blood-2002-03-0772; Chauncey TR, 2001, CURR OPIN ONCOL, V13, P21, DOI 10.1097/00001622-200101000-00005; Cheah IK, 2013, FREE RADICAL RES, V47, P1036, DOI 10.3109/10715762.2013.848354; CHEN G, 1994, CANCER RES, V54, P4980; Cunningham KW, 2011, CELL CALCIUM, V50, P129, DOI 10.1016/j.ceca.2011.01.010; Cyert MS, 2003, BIOCHEM BIOPH RES CO, V311, P1143, DOI 10.1016/S0006-291X(03)01552-3; Dean M, 2001, J LIPID RES, V42, P1007; Dohner H, 2010, BLOOD, V115, P453, DOI 10.1182/blood-2009-07-235358; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; Gottesman MM, 1995, ANNU REV GENET, V29, P607, DOI 10.1146/annurev.ge.29.120195.003135; Hillgren KM, 2013, CLIN PHARMACOL THER, V94, P52, DOI 10.1038/clpt.2013.74; Koepsell H, 2013, MOL ASPECTS MED, V34, P413, DOI 10.1016/j.mam.2012.10.010; Kolitz JE, 2010, BLOOD, V116, P1413, DOI 10.1182/blood-2009-07-229492; Lavina WA, 2013, J BIOSCI BIOENG, V115, P138, DOI 10.1016/j.jbiosc.2012.08.022; Marie JP, 2001, CURR OPIN ONCOL, V13, P463, DOI 10.1097/00001622-200111000-00008; Nigam SK, 2015, NAT REV DRUG DISCOV, V14, P29, DOI 10.1038/nrd4461; Nikitovic D, 2014, CHEST, V146, P1123, DOI 10.1378/chest.14-0460; Okabe M, 2005, BIOCHEM BIOPH RES CO, V333, P754, DOI 10.1016/j.bbrc.2005.05.174; Sinclair CJ, 2000, J LIPID RES, V41, P1841; Stefan CP, 2013, EUKARYOT CELL, V12, P204, DOI 10.1128/EC.00299-12; Swietach P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035949; Tamai I, 1998, J BIOL CHEM, V273, P20378, DOI 10.1074/jbc.273.32.20378; Uemura T, 2007, J BIOL CHEM, V282, P7733, DOI 10.1074/jbc.M611105200; van Roermund CWT, 1999, EMBO J, V18, P5843, DOI 10.1093/emboj/18.21.5843; Westmoreland TJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005830; White DL, 2010, LEUKEMIA, V24, P1962, DOI 10.1038/leu.2010.188; Wu X, 1999, BBA-BIOMEMBRANES, V1418, P239, DOI 10.1016/S0005-2736(99)00020-6; Xia L, 2007, CANCER RES, V67, P11411, DOI 10.1158/0008-5472.CAN-07-2399; Yoshimoto H, 2002, J BIOL CHEM, V277, P31079, DOI 10.1074/jbc.M202718200	34	11	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0133182	10.1371/journal.pone.0133182	http://dx.doi.org/10.1371/journal.pone.0133182			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177450	Green Published, gold, Green Submitted			2022-12-26	WOS:000358197600227
J	Cao, LQ; Xie, BH; Yang, XW; Liang, HH; Jiang, XF; Zhang, DW; Xue, P; Chen, D; Shao, ZL				Cao, Liangqi; Xie, Binhui; Yang, Xuewei; Liang, Huihong; Jiang, Xiaofeng; Zhang, Dawei; Xue, Ping; Chen, De; Shao, Zili			MiR-324-5p Suppresses Hepatocellular Carcinoma Cell Invasion by Counteracting ECM Degradation through Post-Transcriptionally Downregulating ETS1 and SP1	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; PROSTATE-CANCER; BREAST-CANCER; MATRIX METALLOPROTEINASE-2; VASCULAR INVASION; EXPRESSION; MMP-9; MICRORNAS; PROMOTES; METASTASIS	Hepatocellular carcinoma (HCC) is one of the common malignancies, which is highly metastatic and the third common cause of cancer deaths in the world. The invasion and metastasis of cancer cells is a multistep and complex process which is mainly initiated by extracellular matrix (ECM) degradation. Aberrant expression of microRNA has been investigated in HCC and shown to play essential roles during HCC progression. In the present study, we found that microRNA-324-5p (miR-324-5p) was downregulated in both HCC cell lines and tissues. Ectopic miR-324-5p led to the reduction of HCC cells invasive and metastatic capacity, whereas inhibition of miR-324-5p promoted the invasion of HCC cells. Matrix metalloproteinase 2 (MMP2) and MMP9, the major regulators of ECM degradation, were found to be downregulated by ectopic miR-324-5p, while upregulated by miR-324-5p inhibitor. E26 transformation-specific 1 (ETS1) and Specificity protein 1 (SP1), both of which could modulate MMP2 and MMP9 expression and activity, were presented as the direct targets of and downregulated by miR-324-5p. Downregulation of ETS1 and SP1 mediated the inhibitory function of miR-324-5p on HCC migration and invasion. Our study demonstrates that miR-324-5p suppresses hepatocellular carcinoma cell invasion and might provide new clues to invasive HCC therapy.	[Cao, Liangqi; Yang, Xuewei; Liang, Huihong; Jiang, Xiaofeng; Zhang, Dawei; Xue, Ping; Chen, De; Shao, Zili] Guangzhou Med Univ, Affiliated Hosp 2, Dept Hepatobiliary Surg, Guangzhou, Guangdong, Peoples R China; [Xie, Binhui] Gannan Med Univ, Affiliated Hosp 1, Dept Gen Surg, Ganzhou, Peoples R China	Guangzhou Medical University; Gannan Medical University	Shao, ZL (corresponding author), Guangzhou Med Univ, Affiliated Hosp 2, Dept Hepatobiliary Surg, Guangzhou, Guangdong, Peoples R China.	43478443@qq.com			Science & Technology Project in Guangzhou City-Zhujiang Science & Technology New Star [2012J2200039]; Natural Science Foundation of Jiangxi Province [2012ZBAB205001]; Science and Technology Projects Foundation of Jiangxi Province [20112BBG70037]	Science & Technology Project in Guangzhou City-Zhujiang Science & Technology New Star; Natural Science Foundation of Jiangxi Province(Natural Science Foundation of Jiangxi Province); Science and Technology Projects Foundation of Jiangxi Province	This work was financially supported by the Science & Technology Project in Guangzhou City-Zhujiang Science & Technology New Star (2012J2200039), Natural Science Foundation of Jiangxi Province (2012ZBAB205001), and Science and Technology Projects Foundation of Jiangxi Province (20112BBG70037).	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Behrens P, 2001, J PATHOL, V194, P43, DOI 10.1002/path.844; Behrens P, 2001, INT J MOL MED, V8, P149; Black AR, 2001, J CELL PHYSIOL, V188, P143, DOI 10.1002/jcp.1111; Bourboulia D, 2010, SEMIN CANCER BIOL, V20, P161, DOI 10.1016/j.semcancer.2010.05.002; Budhu A, 2008, HEPATOLOGY, V47, P897, DOI 10.1002/hep.22160; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Calli AO, 2011, PATHOL RES PRACT, V207, P628, DOI 10.1016/j.prp.2011.07.010; Chang WC, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-94; Chen D, 2012, INT J MOL SCI, V13, P10594, DOI 10.3390/ijms130810594; Chen KL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072927; Chen RX, 2012, ANN SURG ONCOL, V19, pS375, DOI 10.1245/s10434-011-1836-7; Dittmer Jurgen, 2003, Mol Cancer, V2, P29, DOI 10.1186/1476-4598-2-29; Fan HX, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-90; Farazi TA, 2013, ADV EXP MED BIOL, V774, P1, DOI 10.1007/978-94-007-5590-1_1; Folgueras AR, 2004, INT J DEV BIOL, V48, P411, DOI 10.1387/ijdb.041811af; Fromigue O, 2008, J BIOL CHEM, V283, P30549, DOI 10.1074/jbc.M801436200; Fujimoto J, 2002, ANN ONCOL, V13, P1598, DOI 10.1093/annonc/mdf248; Guan HY, 2012, INT J CANCER, V130, P593, DOI 10.1002/ijc.26049; Hahn WC, 2002, MOL CELL BIOL, V22, P2111, DOI 10.1128/MCB.22.7.2111-2123.2002; Hahne JC, 2005, ONCOGENE, V24, P5384, DOI 10.1038/sj.onc.1208761; Hsu TI, 2012, ONCOGENE, V31, P3973, DOI 10.1038/onc.2011.568; Ito Y, 2000, AM J CLIN PATHOL, V114, P719, DOI 10.1309/RAVV-8NM1-CJB7-GJFR; Jacob A, 2013, J CELL SCI, V126, P4647, DOI 10.1242/jcs.126573; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jiang LL, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-406; Jiang NY, 2008, CANCER EPIDEM BIOMAR, V17, P1648, DOI 10.1158/1055-9965.EPI-07-2791; Jonas S, 2001, HEPATOLOGY, V33, P1080, DOI 10.1053/jhep.2001.23561; Kondo S, 2007, J CELL SCI, V120, P849, DOI 10.1242/jcs.03388; Kousidou OC, 2004, ANTICANCER RES, V24, P4025; Ladeiro Y, 2008, HEPATOLOGY, V47, P1955, DOI 10.1002/hep.22256; Li LM, 2010, CANCER RES, V70, P9798, DOI 10.1158/0008-5472.CAN-10-1001; Moroz A, 2013, BIOCHEM BIOPH RES CO, V430, P1319, DOI 10.1016/j.bbrc.2012.12.031; Murthy S, 2012, BIOCHEM J, V445, P229, DOI 10.1042/BJ20120053; Naito S, 2000, PATHOL RES PRACT, V196, P103, DOI 10.1016/S0344-0338(00)80041-2; Okuducu AF, 2006, HISTOPATHOLOGY, V48, P836, DOI 10.1111/j.1365-2559.2006.02432.x; Pande P, 1999, J PATHOL, V189, P40, DOI 10.1002/(SICI)1096-9896(199909)189:1<40::AID-PATH405>3.0.CO;2-#; Park KS, 2011, J GASTROEN HEPATOL, V26, P391, DOI 10.1111/j.1440-1746.2010.06504.x; Pavelic SK, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-22; Pazzaglia L, 2004, ANTICANCER RES, V24, P967; Peltier HJ, 2008, RNA, V14, P844, DOI 10.1261/rna.939908; Sahai E, 2005, CURR OPIN GENET DEV, V15, P87, DOI 10.1016/j.gde.2004.12.002; Sankpal UT, 2011, MED CHEM, V7, P518; Sementchenko VI, 2000, ONCOGENE, V19, P6533, DOI 10.1038/sj.onc.1204034; Shaikhibrahim Z, 2012, INT J ONCOL, V40, P1748, DOI 10.3892/ijo.2012.1380; Shukla Girish C, 2011, Mol Cell Pharmacol, V3, P83; Somiari SB, 2006, INT J CANCER, V119, P1403, DOI 10.1002/ijc.21989; Span PN, 2002, ONCOGENE, V21, P8506, DOI 10.1038/sj.onc.1206040; Takai N, 2002, INT J MOL MED, V9, P287; Teo EK, 2001, DIGEST DIS, V19, P263, DOI 10.1159/000050692; Thuluvath PJ, 2009, J CLIN GASTROENTEROL, V43, P101, DOI 10.1097/MCG.0b013e318191e64f; Venook AP, 2010, ONCOLOGIST, V15, P5, DOI 10.1634/theoncologist.2010-S4-05; Ventura A, 2009, CELL, V136, P586, DOI 10.1016/j.cell.2009.02.005; Westermarck J, 1999, FASEB J, V13, P781, DOI 10.1096/fasebj.13.8.781; Xia L, 2001, GENE, V268, P77, DOI 10.1016/S0378-1119(01)00429-2; Zhang J, 2013, EUR REV MED PHARMACO, V17, P2372; Zhao WN, 2013, INT J MOL SCI, V14, P13577, DOI 10.3390/ijms140713577; Zhou CF, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-102; Zhou J, 2011, J CLIN ONCOL, V29, P4781, DOI 10.1200/JCO.2011.38.2697	60	58	61	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0133074	10.1371/journal.pone.0133074	http://dx.doi.org/10.1371/journal.pone.0133074			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177288	Green Published, gold, Green Submitted			2022-12-26	WOS:000358197600210
J	Cipriani, S; Renga, B; D'Amore, C; Simonetti, M; De Tursi, AA; Carino, A; Monti, MC; Sepe, V; Zampella, A; Fiorucci, S				Cipriani, Sabrina; Renga, Barbara; D'Amore, Claudio; Simonetti, Michele; De Tursi, Antonio Angelo; Carino, Adriana; Monti, Maria Chiara; Sepe, Valentina; Zampella, Angela; Fiorucci, Stefano			Impaired Itching Perception in Murine Models of Cholestasis Is Supported by Dysregulation of GPBAR1 Signaling	PLOS ONE			English	Article							FARNESOID-X RECEPTOR; BILE-ACID RECEPTOR; PRIMARY SCLEROSING CHOLANGITIS; LIVER-DISEASES; TGR5; EXPRESSION; PRURITUS; AGONIST; FXR; DETOXIFICATION	Background & Aims In cholestatic syndromes, body accumulation of bile acids is thought to cause itching. However, the mechanisms supporting this effect remain elusive. Recently, GPBAR1 (TGR5) a G-protein coupled receptor has been shown to mediate itching caused by intradermal administration of DCA and LCA. 6 alpha-ethyl-3 alpha, 7 alpha-dihydroxy-24-nor-5 beta-cholan-23-ol (BAR502) is a non-bile acid dual ligand for FXR and GPBAR1. Methods Cholestasis was induced in wild type and GPBAR1(-/-) mice by administration of alpha-naphthylisothiocyanate (ANIT) or 17 alpha-ethynylestradiol. Results. In naive mice skin application of DCA, TLCA, 6-ECDCA, oleanolic and betulinic acid induces a GPBAR1 dependent pruritogenic response that could be desensitized by re-challenging the mice with the same GPBAR1 agonist. In wild type and GPBAR1(-/-) mice cholestasis induced by ANIT fails to induce spontaneous itching and abrogates scratching behavior caused by intradermal administration of DCA. In this model, co-treatment with BAR502 increases survival, attenuates serum alkaline phosphatase levels and robustly modulates the liver expression of canonical FXR target genes including OSTa, BSEP, SHP and MDR1, without inducing pruritus. Betulinic acid, a selective GPBAR1 ligand, failed to rescue wild type and GPBAR1(-/-) mice from ANIT cholestasis but did not induced itching. In the 17 alpha-ethynylestradiol model BAR502 attenuates cholestasis and reshapes bile acid pool without inducing itching. Conclusions The itching response to intradermal injection of GPBAR1 agonists desensitizes rapidly and is deactivated in models of cholestasis, explain the lack of correlation between bile acids levels and itching severity in cholestatic syndromes. In models of non-obstructive cholestasis, BAR502 attenuates liver injury without causing itching.	[Cipriani, Sabrina] Univ Perugia, Dept Med, I-06100 Perugia, Italy; [Renga, Barbara; D'Amore, Claudio; Simonetti, Michele; De Tursi, Antonio Angelo; Carino, Adriana; Fiorucci, Stefano] Univ Perugia, Dept Surg & Biomed Sci, I-06100 Perugia, Italy; [Monti, Maria Chiara] Univ Salerno, Dept Pharm, I-84100 Salerno, Italy; [Sepe, Valentina; Zampella, Angela] Univ Naples Federico II, Dept Pharm, Naples, Italy	University of Perugia; University of Perugia; University of Salerno; University of Naples Federico II	Fiorucci, S (corresponding author), Univ Perugia, Dept Surg & Biomed Sci, I-06100 Perugia, Italy.	Stefano.Fiorucci@unipg.it	Sepe, Valentina/F-5994-2010	Carino, Adriana/0000-0003-2341-9528; Sepe, Valentina/0000-0002-0169-4441; D'Amore, Claudio/0000-0001-9217-9404	BAR Pharmaceuticals; PSC seeking a cure	BAR Pharmaceuticals; PSC seeking a cure	This study was partially supported by a grant form BAR Pharmaceuticals and by a grant from "PSC seeking a cure". BAR502 was provided by BAR Pharmaceuticals. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This does not alter the authors' adherence to all PLOS ONE policies on sharing data and materials.	Alemi F, 2013, J CLIN INVEST, V123, P1513, DOI 10.1172/JCI64551; Braz J, 2014, NEURON, V82, P522, DOI 10.1016/j.neuron.2014.01.018; D'Amore C, 2014, J MED CHEM, V57, P937, DOI 10.1021/jm401873d; Eaton JE, 2013, GASTROENTEROLOGY, V145, P521, DOI 10.1053/j.gastro.2013.06.052; Fagan E A, 1999, Clin Liver Dis, V3, P603, DOI 10.1016/S1089-3261(05)70087-8; Festa C, 2014, J MED CHEM, V57, P8477, DOI 10.1021/jm501273r; Fiorucci S, 2005, J PHARMACOL EXP THER, V313, P604, DOI 10.1124/jpet.104.079665; Fiorucci S, 2011, MINI-REV MED CHEM, V11, P753, DOI 10.2174/138955711796355258; Fiorucci S, 2004, GASTROENTEROLOGY, V127, P1497, DOI 10.1053/j.gastro.2004.08.001; Fiorucci S, 2014, EXPERT OPIN THER TAR, V18, P1449, DOI 10.1517/14728222.2014.956087; Fiorucci S, 2010, PROG LIPID RES, V49, P171, DOI 10.1016/j.plipres.2009.11.001; Fiorucci S, 2009, TRENDS PHARMACOL SCI, V30, P570, DOI 10.1016/j.tips.2009.08.001; Fiorucci S, 2009, CURR OPIN GASTROEN, V25, P252, DOI 10.1097/MOG.0b013e328324f87e; Hirschfield GM, 2013, GASTROENTEROLOGY, V144, P1357, DOI 10.1053/j.gastro.2013.03.053; Jensen DD, 2013, J BIOL CHEM, V288, P22942, DOI 10.1074/jbc.M113.455774; Jonker JW, 2012, J STEROID BIOCHEM, V130, P147, DOI 10.1016/j.jsbmb.2011.06.012; Kawamata Y, 2003, J BIOL CHEM, V278, P9435, DOI 10.1074/jbc.M209706200; Keitel V, 2008, BIOCHEM BIOPH RES CO, V372, P78, DOI 10.1016/j.bbrc.2008.04.171; Keitel V, 2009, HEPATOLOGY, V50, P861, DOI 10.1002/hep.23032; KIRBY J, 1974, BMJ-BRIT MED J, V4, P693, DOI 10.1136/bmj.4.5946.693; Kowdley KV, 2011, J HEPATOL, V54, pS13, DOI 10.1016/S0168-8278(11)60030-5; Kremer AE, 2010, GASTROENTEROLOGY, V139, P1008, DOI 10.1053/j.gastro.2010.05.009; LaMotte RH, 2014, NAT REV NEUROSCI, V15, P19, DOI 10.1038/nrn3641; Leva FS, 2013, J MED CHEM, V56, P4701, DOI [10.1021/jm400419e, DOI 10.1021/JM400419E]; Li TT, 2011, MOL ENDOCRINOL, V25, P1066, DOI 10.1210/me.2010-0460; Lieu T, 2014, GASTROENTEROLOGY, V147, P1417, DOI 10.1053/j.gastro.2014.08.042; Marschall HU, 2006, J LIPID RES, V47, P582, DOI 10.1194/jlr.M500427-JLR200; Maruyama T, 2002, BIOCHEM BIOPH RES CO, V298, P714, DOI 10.1016/S0006-291X(02)02550-0; Mela M, 2003, ALIMENT PHARM THER, V17, P857, DOI 10.1046/j.1365-2036.2003.01458.x; Mencarelli A, 2013, DIABETES, V62, P3384, DOI 10.2337/db13-0299; Pellicciari R, 2002, J MED CHEM, V45, P3569, DOI 10.1021/jm025529g; Poupon R, 2012, CLIN RES HEPATOL GAS, V36, pS3, DOI 10.1016/S2210-7401(12)70015-3; Renga B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030443; Renga B, 2011, BBA-GENE REGUL MECH, V1809, P157, DOI 10.1016/j.bbagrm.2011.01.008; Ruparel NB, 2011, MOL PHARMACOL, V80, P117, DOI 10.1124/mol.110.068940; SCHOENFI.LJ, 1967, NATURE, V213, P93, DOI 10.1038/213093b0; Sinakos E, 2013, INFLAMM BOWEL DIS, V19, P1004, DOI 10.1097/MIB.0b013e3182802893; Stedman C, 2006, P NATL ACAD SCI USA, V103, P11323, DOI 10.1073/pnas.0604772103; Tabibian JH, 2013, EXPERT REV GASTROENT, V7, P103, DOI [10.1586/egh.12.80, 10.1586/EGH.12.80]; VARADI DP, 1974, ARCH DERMATOL, V109, P678, DOI 10.1001/archderm.109.5.678; Wagner M, 2003, GASTROENTEROLOGY, V125, P825, DOI 10.1016/S0016-5085(03)01068-0; Wang L, 2002, DEV CELL, V2, P721, DOI 10.1016/S1534-5807(02)00187-9; Zollner G, 2007, LIVER INT, V27, P920, DOI 10.1111/j.1478-3231.2007.01506.x	43	33	34	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0129866	10.1371/journal.pone.0129866	http://dx.doi.org/10.1371/journal.pone.0129866			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177448	gold, Green Published, Green Submitted			2022-12-26	WOS:000358197600017
J	Cleuren, ACA; Blankevoort, VT; van Diepen, JA; Verhoef, D; Voshol, PJ; Reitsma, PH; van Vlijmen, BJM				Cleuren, Audrey C. A.; Blankevoort, Vicky T.; van Diepen, Janna A.; Verhoef, Daniel; Voshol, Peter J.; Reitsma, Pieter H.; van Vlijmen, Bart J. M.			Changes in Dietary Fat Content Rapidly Alters the Mouse Plasma Coagulation Profile without Affecting Relative Transcript Levels of Coagulation Factors	PLOS ONE			English	Article							ORAL-CONTRACEPTIVE USE; WEIGHT-LOSS; OBESE MICE; THROMBIN GENERATION; VENOUS THROMBOSIS; ENDOTHELIAL-CELLS; GENE-EXPRESSION; FACTOR-VIII; RISK; ADAPTATION	Background Obesity is associated with a hypercoagulable state and increased risk for thrombotic cardiovascular events. Objective Establish the onset and reversibility of the hypercoagulable state during the development and regression of nutritionally-induced obesity in mice, and its relation to transcriptional changes and clearance rates of coagulation factors as well as its relation to changes in metabolic and inflammatory parameters. Methods Male C57BL/6J mice were fed a low fat (10% kcal as fat; LFD) or high fat diet (45% kcal as fat; HFD) for 2, 4, 8 or 16 weeks. To study the effects of weight loss, mice were fed the HFD for 16 weeks and switched to the LFD for 1, 2 or 4 weeks. For each time point analyses of plasma and hepatic mRNA levels of coagulation factors were performed after overnight fasting, as well as measurements of circulating metabolic and inflammatory parameters. Furthermore, in vivo clearance rates of human factor (F) VII, FVIII and FIX proteins were determined after 2 weeks of HFD-feeding. Results HFD feeding gradually increased the body and liver weight, which was accompanied by a significant increase in plasma glucose levels from 8 weeks onwards, while insulin levels were affected after 16 weeks. Besides a transient rise in cytokine levels at 2 weeks after starting the HFD, no significant effect on inflammation markers was present. Increased plasma levels of fibrinogen, FII, FVII, FVIII, FIX, FXI and FXII were observed in mice on a HFD for 2 weeks, which in general persisted throughout the 16 weeks of HFD-feeding. Interestingly, with the exception of FXI the effects on plasma coagulation levels were not paralleled by changes in relative transcript levels in the liver, nor by decreased clearance rates. Switching from HFD to LFD reversed the HFD-induced procoagulant shift in plasma, again not coinciding with transcriptional modulation. Conclusions Changes in dietary fat content rapidly alter the mouse plasma coagulation profile, thereby preceding plasma metabolic changes, which cannot be explained by changes in relative expression of coagulation factors or decreased clearance rates.	[Cleuren, Audrey C. A.; Blankevoort, Vicky T.; Verhoef, Daniel; Reitsma, Pieter H.; van Vlijmen, Bart J. M.] Leiden Univ, Med Ctr, Einthoven Lab Expt Vasc Med, Dept Thrombosis & Hemostasis, Leiden, Netherlands; [van Diepen, Janna A.; Voshol, Peter J.] Leiden Univ, Med Ctr, Einthoven Lab Expt Vasc Med, Dept Endocrinol, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	van Vlijmen, BJM (corresponding author), Leiden Univ, Med Ctr, Einthoven Lab Expt Vasc Med, Dept Thrombosis & Hemostasis, Leiden, Netherlands.	b.j.m.van_vlijmen@lumc.nl	van Diepen, Janna/E-9485-2010; Cleuren, Audrey/AAV-3684-2021	van Diepen, Janna/0000-0001-9091-1075; Cleuren, Audrey/0000-0003-1384-4651	Leducq Foundation (Paris, France); Netherlands Heart Foundation [2006B045]	Leducq Foundation (Paris, France)(Leducq Foundation); Netherlands Heart Foundation(Netherlands Heart Foundation)	This study was supported by the Leducq Foundation (Paris, France; LINAT project) and grant 2006B045 from the Netherlands Heart Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdollahi M, 2003, THROMB HAEMOSTASIS, V89, P493, DOI 10.1055/s-0037-1613379; Ay L, 2010, J THROMB HAEMOST, V8, P759, DOI 10.1111/j.1538-7836.2010.03766.x; Cleuren ACA, 2010, J THROMB HAEMOST, V8, P1838, DOI 10.1111/j.1538-7836.2010.03930.x; Cleuren ACA, 2009, THROMB HAEMOSTASIS, V102, P993, DOI 10.1160/TH09-03-0169; Do GM, 2011, MOL NUTR FOOD RES, V55, pS173, DOI 10.1002/mnfr.201100064; Everett LA, 2014, BLOOD, V123, P3697, DOI 10.1182/blood-2014-02-554501; Fahs SA, 2014, BLOOD, V123, P3706, DOI 10.1182/blood-2014-02-555151; FOLSOM AR, 1993, ARTERIOSCLER THROMB, V13, P162, DOI 10.1161/01.ATV.13.2.162; Godsland IF, 2005, J CLIN ENDOCR METAB, V90, P190, DOI 10.1210/jc.2004-1292; HAUS E, 1990, CHRONOBIOL INT, V7, P203, DOI 10.3109/07420529009056976; Kaji N, 2013, J VET MED SCI, V75, P1245, DOI 10.1292/jvms.13-0029; Mertens I, 2002, Obes Rev, V3, P85, DOI 10.1046/j.1467-789X.2002.00056.x; Muller M, 2003, NAT REV GENET, V4, P315, DOI 10.1038/nrg1047; Nagai N, 2008, THROMB RES, V122, P549, DOI 10.1016/j.thromres.2007.12.017; Oishi K, 2006, J THROMB HAEMOST, V4, P1774, DOI 10.1111/j.1538-7836.2006.02032.x; Pomp ER, 2007, BRIT J HAEMATOL, V139, P289, DOI 10.1111/j.1365-2141.2007.06780.x; Radonjic M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006646; Rosito GA, 2004, THROMB HAEMOSTASIS, V91, P683, DOI 10.1160/TH03-01-0014; Samad F, 1999, THROMB HAEMOSTASIS, V82, P742, DOI 10.1055/s-0037-1615906; Sanchez C, 2012, ARTERIOSCL THROM VAS, V32, P2394, DOI 10.1161/ATVBAHA.112.250332; Sola E, 2009, THROMB RES, V123, P697, DOI 10.1016/j.thromres.2008.07.017	21	11	12	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0131859	10.1371/journal.pone.0131859	http://dx.doi.org/10.1371/journal.pone.0131859			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176620	gold, Green Published, Green Submitted			2022-12-26	WOS:000358197600067
J	Kao, HW; Lee, KW; Kuo, CL; Huang, CS; Tseng, WM; Liu, CS; Lin, CP				Kao, Hung-Wen; Lee, Kwo-Whei; Kuo, Chen-Ling; Huang, Ching-Shan; Tseng, Wan-Min; Liu, Chin-San; Lin, Ching-Po			Interleukin-6 as a Prognostic Biomarker in Ruptured Intracranial Aneurysms	PLOS ONE			English	Article							ENDOTHELIN RECEPTOR ANTAGONIST; SUBARACHNOID HEMORRHAGE; CEREBRAL VASOSPASM; DOUBLE-BLIND; CLAZOSENTAN; CYTOKINES; ISCHEMIA; IL-6; ASSOCIATION; INCREASE	Background Interleukin-6 (IL-6), a proinflammatory cytokine, was found to surge in the cerebral spinal fluid after aneurysmal subarachnoid hemorrhage (SAH). We hypothesized that the plasma level of IL-6 could be an independent biomarker in predicting clinical outcome of patients with ruptured intracranial aneurysm. Methods We prospectively included 53 consecutive patients treated with platinum coil embolization of the ruptured intracranial aneurysm. Plasma IL-6 levels were measured in the blood samples at the orifices of the aneurysms and from peripheral veins. The outcome measure was the modified Rankin Scale one month after SAH. Multiple logistic regression analyses were used to evaluate the associations between the plasma IL-6 levels and the neurological outcome. Results Significant risk factors for the poor outcome were old age, low Glasgow Coma Scale (GCS) on day 0, high Fisher grades, and high aneurysmal and venous IL-6 levels in univariate analyses. Aneurysmal IL-6 levels showed modest to moderate correlations with GCS on day 0, vasospasm grade and Fisher grade. A strong correlation was found between the aneurysmal and the corresponding venous IL-6 levels (rho = 0.721; P<0.001). In the multiple logistic regression models, the poor 30-day mRS was significantly associated with high aneurysmal IL-6 level (OR, 17.97; 95% CI, 1.51-214.33; P = 0.022) and marginally associated with high venous IL-6 level (OR, 12.71; 95% CI, 0.90-180.35; P = 0.022) after adjusting for dichotomized age, GCS on day 0, and vasospasm and Fisher grades. Conclusions The plasma level of IL-6 is an independent prognostic biomarker that could be used to aid in the identification of patients at high-risk of poor neurological outcome after rupture of the intracranial aneurysm.	[Kao, Hung-Wen] Natl Def Med Ctr, Tri Serv Gen Hosp, Dept Radiol, Taipei, Taiwan; [Kao, Hung-Wen; Lin, Ching-Po] Natl Yang Ming Univ, Dept Biomed Imaging & Radiol Sci, Taipei 112, Taiwan; [Lee, Kwo-Whei] Changhua Christian Hosp, Dept Med Imaging, Changhua, Taiwan; [Lee, Kwo-Whei; Kuo, Chen-Ling; Huang, Ching-Shan; Tseng, Wan-Min; Liu, Chin-San] Changhua Christian Hosp, Vasc & Genom Ctr, Changhua, Taiwan; [Liu, Chin-San] Changhua Christian Hosp, Dept Neurol, Changhua, Taiwan; [Liu, Chin-San] China Med Univ, Grad Inst Integrat Med, Taichung, Taiwan; [Lin, Ching-Po] Natl Yang Ming Univ, Sch Life Sci, Inst Neurosci, Taipei 112, Taiwan	National Defense Medical Center; Tri-Service General Hospital; National Yang Ming Chiao Tung University; Changhua Christian Hospital; Changhua Christian Hospital; Changhua Christian Hospital; China Medical University Taiwan; National Yang Ming Chiao Tung University	Lee, KW (corresponding author), Changhua Christian Hosp, Dept Med Imaging, Changhua, Taiwan.	94692@cch.org.tw; liu48111@gmail.com			Changhua Christian Hospital, Changhua, Taiwan [98-CCH-IRP-34, 101-CCH-IRP-84]	Changhua Christian Hospital, Changhua, Taiwan	This work was supported by Changhua Christian Hospital, Changhua, Taiwan under grants 98-CCH-IRP-34 and 101-CCH-IRP-84.	BROWN JM, 1989, SURG GYNECOL OBSTET, V169, P568; Cesari M, 2003, CIRCULATION, V108, P2317, DOI 10.1161/01.CIR.0000097109.90783.FC; Chalouhi N, 2013, STROKE, V44, P2594, DOI 10.1161/STROKEAHA.113.002361; Dhar R, 2008, NEUROCRIT CARE, V8, P253, DOI 10.1007/s12028-007-9020-4; Dorhout SM, 2012, STROKE, V43, P2126, DOI 10.1161/STROKEAHA.111.639690; Dumont AS, 2003, NEUROSURGERY, V53, P123, DOI 10.1227/01.NEU.0000068863.37133.9E; Fassbender K, 2001, J NEUROL NEUROSUR PS, V70, P534, DOI 10.1136/jnnp.70.4.534; FASSBENDER K, 1994, J NEUROL SCI, V122, P135, DOI 10.1016/0022-510X(94)90289-5; FISHER CM, 1980, NEUROSURGERY, V6, P1, DOI 10.1227/00006123-198001000-00001; Folsom AR, 2006, ARCH INTERN MED, V166, P1368, DOI 10.1001/archinte.166.13.1368; Heikkila K, 2008, EUR J CANCER, V44, P937, DOI 10.1016/j.ejca.2008.02.047; Hendryk S, 2004, NEUROENDOCRINOL LETT, V25, P141; Jones KG, 2001, CIRCULATION, V103, P2260; KASSELL NF, 1985, STROKE, V16, P562, DOI 10.1161/01.STR.16.4.562; LE JM, 1989, LAB INVEST, V61, P588; LJUNGGREN B, 1985, J NEUROSURG, V62, P547, DOI 10.3171/jns.1985.62.4.0547; Macdonald RL, 2008, STROKE, V39, P3015, DOI 10.1161/STROKEAHA.108.519942; Macdonald RL, 2013, ACTA NEUROCHIR SUPPL, V115, P27, DOI 10.1007/978-3-7091-1192-5_7; Macdonald RL, 2011, LANCET NEUROL, V10, P618, DOI 10.1016/S1474-4422(11)70108-9; Macdonald RL, 2010, NEUROCRIT CARE, V13, P416, DOI 10.1007/s12028-010-9433-3; McMahon CJ, 2013, J NEUROINTERV SURG, V5, P512, DOI 10.1136/neurintsurg-2012-010386; Meyers PM, 2011, NAT REV NEUROL, V7, P660, DOI 10.1038/nrneurol.2011.168; Minambres E, 2003, CRIT CARE MED, V31, P933, DOI 10.1097/01.CCM.0000055370.66389.59; PAKARINEN S, 1967, ACTA NEUROL SCAND, VS 43, P9; Rose MJ, 2011, CURR OPIN ANESTHESIO, V24, P500, DOI 10.1097/ACO.0b013e32834ad45b; Rosengart AJ, 2007, STROKE, V38, P2315, DOI 10.1161/STROKEAHA.107.484360; Sarrafzadeh A, 2010, NEUROCRIT CARE, V13, P339, DOI 10.1007/s12028-010-9432-4; Schoch B, 2007, NEUROSURGERY, V60, P828, DOI 10.1227/01.NEU.0000255440.21495.80; Vlak MHM, 2011, LANCET NEUROL, V10, P626, DOI 10.1016/S1474-4422(11)70109-0; Wermer MJH, 2007, STROKE, V38, P1404, DOI 10.1161/01.STR.0000260955.51401.cd; Yalamanchili K, 1998, AM J NEURORADIOL, V19, P553	31	29	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132115	10.1371/journal.pone.0132115	http://dx.doi.org/10.1371/journal.pone.0132115			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176774	gold, Green Published, Green Submitted			2022-12-26	WOS:000358197600084
J	Kimura, M; Cutler, S; Isobe, S				Kimura, Mitsuhiro; Cutler, Sean; Isobe, Sachiko			A Novel Phenolic Compound, Chloroxynil, Improves Agrobacterium-Mediated Transient Transformation in Lotus japonicus	PLOS ONE			English	Article							MODEL LEGUME; FLORAL-DIP; GENETIC-TRANSFORMATION; PLANT TRANSFORMATION; TRANSGENIC PLANTS; MIYAKOJIMA MG-20; TUMEFACIENS; EFFICIENCY; EXPRESSION; TISSUE	Agrobacterium-mediated transformation is a commonly used method for plant genetic engineering. However, the limitations of Agrobacterium host-plant interactions and the complexity of plant tissue culture often make the production of transgenic plants difficult. Transformation efficiency in many legume species, including soybean and the common bean, has been reported to be quite low. To improve the transformation procedure in legumes, we screened for chemicals that increase the transformation efficiency of Lotus japonicus, a model legume species. A Chemical library was screened and chemicals that increase in transient transformation efficiency of L. japonicus accession, Miyakojima MG-20 were identified. The transient transformation efficiency was quantified by reporter activity in which an intron-containing reporter gene produces the GUS protein only when the T-DNA is expressed in the plant nuclei. We identified a phenolic compound, chloroxynil, which increased the genetic transformation of L. japonicus by Agrobacterium tumefaciens strain EHA105. Characterization of the mode of chloroxynil action indicated that it enhanced Agrobacterium-mediated transformation through the activation of the Agrobacterium vir gene expression, similar to acetosyringone, a phenolic compound known to improve Agrobacterium-mediated transformation efficiency. Transient transformation efficiency of L. japonicus with 5 mu M chloroxynil was 60- and 6-fold higher than that of the control and acetosyringone treatment, respectively. In addition, transgenic L. japonicus lines were successfully generated by 5 mu M chloroxynil treatment. Furthermore, we show that chloroxynil improves L. japonicus transformation by Agrobacterium strain GV3101 and rice transformation. Our results demonstrate that chloroxynil significantly improves Agrobacterium tumefaciens-mediated transformation efficiency of various agriculturally important crops.	[Kimura, Mitsuhiro; Isobe, Sachiko] Kazusa DNA Res Inst, Dept Frontier Res, Chiba, Japan; [Cutler, Sean] Univ Calif Riverside, Dept Bot & Plant Sci, Ctr Plant Cell Biol, Riverside, CA 92521 USA; [Cutler, Sean] Univ Calif Riverside, Dept Bot & Plant Sci, Inst Integrat Genome Biol, Riverside, CA 92521 USA	Kazusa DNA Research Institute; University of California System; University of California Riverside; University of California System; University of California Riverside	Kimura, M (corresponding author), Okayama Univ, Grad Sch Nat Sci & Technol, Okayama 7008530, Japan.	mitsukimu@okayama-u.ac.jp			Kazusa DNA Research Institute Foundation	Kazusa DNA Research Institute Foundation	The research was supported by the Kazusa DNA Research Institute Foundation. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki T, 2002, PLANT CELL REP, V21, P238, DOI 10.1007/s00299-002-0494-4; Brookes Graham, 2013, GM CROPS GLOBAL SOCI; Buzas DM, 2005, PLANT CELL PHYSIOL, V46, P1202, DOI 10.1093/pcp/pci129; CANADAY CH, 1986, PLANT DIS, V70, P863, DOI 10.1094/PD-70-863; Cheng M, 1997, PLANT PHYSIOL, V115, P971, DOI 10.1104/pp.115.3.971; Cheng M, 1996, PLANT CELL REP, V15, P653, DOI 10.1007/BF00231918; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Colebatch G, 2004, PLANT J, V39, P487, DOI 10.1111/j.1365-313X.2004.02150.x; Curtis IS, 2001, TRANSGENIC RES, V10, P363, DOI 10.1023/A:1016600517293; Cutler SR, 2005, BMC PLANT BIOL, V5, DOI 10.1186/1471-2229-5-4; Dam S, 2009, PLANT PHYSIOL, V149, P1325, DOI 10.1104/pp.108.133405; de Groot MJA, 1998, NAT BIOTECHNOL, V16, P839, DOI 10.1038/nbt0998-839; Dellaporta SL, 1983, PLANT MOL BIOL REP, V1, P19, DOI DOI 10.1007/BF02712670; Desbrosses GG, 2005, PLANT PHYSIOL, V137, P1302, DOI 10.1104/pp.104.054957; Fukai E, 2012, PLANT J, V69, P720, DOI 10.1111/j.1365-313X.2011.04826.x; Gelvin SB, 2003, MICROBIOL MOL BIOL R, V67, P16, DOI 10.1128/MMBR.67.1.16-37.2003; HANDBERG K, 1992, PLANT J, V2, P487, DOI 10.1111/j.1365-313X.1992.00487.x; Hiei Y, 1997, PLANT MOL BIOL, V35, P205, DOI 10.1023/A:1005847615493; Imaizumi R, 2005, J PLANT RES, V118, P391, DOI 10.1007/s10265-005-0231-5; Ishida Y, 1996, NAT BIOTECHNOL, V14, P745, DOI 10.1038/nbt0696-745; JEFFERSON RA, 1987, EMBO J, V6, P3901; Johal GS, 2009, EUR J AGRON, V31, P144, DOI 10.1016/j.eja.2009.04.004; Kato T, 2005, J BIOSCI BIOENG, V99, P165, DOI 10.1263/jbb.99.165; Kawaguchi M, 2000, J PLANT RES, V113, P507, DOI 10.1007/PL00013961; Kouchi H, 2004, DNA RES, V11, P263, DOI 10.1093/dnares/11.4.263; KRAMER MG, 1994, EUPHYTICA, V79, P293, DOI 10.1007/BF00022530; Kunik T, 2001, P NATL ACAD SCI USA, V98, P1871, DOI 10.1073/pnas.041327598; MANSUR EA, 1993, PLANT SCI, V89, P93, DOI 10.1016/0168-9452(93)90174-X; McCullen CA, 2006, ANNU REV CELL DEV BI, V22, P101, DOI 10.1146/annurev.cellbio.22.011105.102022; Nadolska-Orczyk A, 2000, MOL BREEDING, V6, P185, DOI 10.1023/A:1009679908948; Peters NK, MOL PLANT MICROBE IN, V3, P4; Piers KL, 1996, P NATL ACAD SCI USA, V93, P1613, DOI 10.1073/pnas.93.4.1613; Pitzschke A, 2010, EMBO J, V29, P1021, DOI 10.1038/emboj.2010.8; Polowick PL, 2000, PLANT SCI, V153, P161, DOI 10.1016/S0168-9452(99)00267-8; Rashid H, 1996, PLANT CELL REP, V15, P727, DOI 10.1007/BF00232216; Rohini VK, 2000, PLANT SCI, V150, P41, DOI 10.1016/S0168-9452(99)00160-0; Sato S, 2008, DNA RES, V15, P227, DOI 10.1093/dnares/dsn008; Shimmen T, 2012, J PLANT RES, V125, P749, DOI 10.1007/s10265-012-0487-5; Shimmen T, 2010, J PLANT RES, V123, P715, DOI 10.1007/s10265-009-0297-6; STACHEL SE, 1985, NATURE, V318, P624, DOI 10.1038/318624a0; Stiller J, 1997, J EXP BOT, V48, P1357, DOI 10.1093/jxb/48.7.1357; Takanashi K, 2012, MOL PLANT MICROBE IN, V25, P869, DOI 10.1094/MPMI-01-12-0011-R; Toki S, 2006, PLANT J, V47, P969, DOI 10.1111/j.1365-313X.2006.02836.x; Urbanski DF, 2012, PLANT J, V69, P731, DOI 10.1111/j.1365-313X.2011.04827.x; Wenck AR, 1999, PLANT MOL BIOL, V39, P407, DOI 10.1023/A:1006126609534; Yoshioka M, 2006, J BIOL CHEM, V281, P21660, DOI 10.1074/jbc.M602896200; Zale JM, 2009, PLANT CELL REP, V28, P903, DOI 10.1007/s00299-009-0696-0	47	6	7	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0131626	10.1371/journal.pone.0131626	http://dx.doi.org/10.1371/journal.pone.0131626			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176780	Green Submitted, Green Published, gold			2022-12-26	WOS:000358197600054
J	Naundrup, PJ; Svenning, JC				Naundrup, Pernille Johansen; Svenning, Jens-Christian			A Geographic Assessment of the Global Scope for Rewilding with Wild-Living Horses (Equus ferus)	PLOS ONE			English	Article							BUTTERFLY DISTRIBUTION MAPS; ANCIENT FEEDING ECOLOGY; LAND-COVER DATA; FERAL HORSES; SPECIES DISTRIBUTIONS; PLEISTOCENE EXTINCTIONS; HABITAT SELECTION; CLIMATE-CHANGE; SAMPLING BIAS; EVOLUTIONARY HISTORY	Megafaunas worldwide have been decimated during the late Quaternary. Many extirpated species were keystone species, and their loss likely has had large effects on ecosystems. Therefore, it is increasingly considered how megafaunas can be restored. The horse (Equus ferus) is highly relevant in this context as it was once extremely widespread and, despite severe range contraction, survives in the form of domestic, feral, and originally wild horses. Further, it is a functionally important species, notably due to its ability to graze coarse, abrasive grasses. Here, we used species distribution modelling to link locations of wild-living E. ferus populations to climate to estimate climatically suitable areas for wild-living E. ferus. These models were combined with habitat information and past and present distributions of equid species to identify areas suitable for rewilding with E. ferus. Mean temperature in the coldest quarter, precipitation in the coldest quarter, and precipitation in the driest quarter emerged as the best climatic predictors. The distribution models estimated the climate to be suitable in large parts of the Americas, Eurasia, Africa, and Australia and, combined with habitat mapping, revealed large areas to be suitable for rewilding with horses within its former range, including up to 1.5 million ha within five major rewilding areas in Europe. The widespread occurrence of suitable climates and habitats within E. ferus' former range together with its important functions cause it to be a key candidate for rewilding in large parts of the world. Successful re-establishment of wild-living horse populations will require handling the complexity of human-horse relations, for example, potential conflicts with ranchers and other agriculturalists or with other conservation aims, perception as a non-native invasive species in some regions, and coverage by legislation for domestic animals.	[Naundrup, Pernille Johansen; Svenning, Jens-Christian] Aarhus Univ, Sect Ecoinformat & Biodivers, Dept Biosci, Aarhus C, Denmark	Aarhus University	Naundrup, PJ (corresponding author), Aarhus Univ, Sect Ecoinformat & Biodivers, Dept Biosci, Aarhus C, Denmark.	Samic1988@gmail.com; svenning@bios.au.dk	Svenning, Jens-Christian/C-8977-2012	Svenning, Jens-Christian/0000-0002-3415-0862	Aarhus University; Aarhus University Research Foundation under the AU IDEAS program	Aarhus University; Aarhus University Research Foundation under the AU IDEAS program	We would like to thank Peder Klith Bocher for his assistance in ArcGIS and Jonas Nuchel for help with MAXENT. JCS considers this study a contribution to Center for Informatics Research on Complexity in Ecology, CIRCE (funded by Aarhus University and Aarhus University Research Foundation under the AU IDEAS program) and the Danish National Research Foundation Niels Bohr professorship project, Aarhus University Research on the Anthropocene (AURA).	Achilli A, 2012, P NATL ACAD SCI USA, V109, P2449, DOI 10.1073/pnas.1111637109; Agerskov U, 2012, STAT YB 2012; Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; Alroy J, 2001, SCIENCE, V292, P1893, DOI 10.1126/science.1059342; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; Arino O, 2008, ESA BULL-EUR SPACE, P24; AZZAROLI A, 1991, ANN ZOOL FENN, V28, P151; Ballesteros-Mejia L, 2013, GLOBAL ECOL BIOGEOGR, V22, P586, DOI 10.1111/geb.12039; Bennett D, 1992, WORLD ANIMAL SCI S C; Bennett D., 1999, MAMMAL SPECIES, V628, P1; Berger J., 1986, WILD HORSES GREAT BA; Bhattacharyya J, 2011, HUM ECOL, V39, P613, DOI 10.1007/s10745-011-9416-9; Bignon O, 2005, J ARCHAEOL SCI, V32, P375, DOI 10.1016/j.jas.2004.02.016; Boakes EH, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000385; Bocherens H, 1999, J ARCHAEOL SCI, V26, P599, DOI 10.1006/jasc.1998.0377; Bonde AM, 2013, PALEOECOLOGY LATE PA; Buckley AW, 1983, PUB LAND L REV, V4, P29; Burke A, 2003, QUATERNARY RES, V59, P459, DOI 10.1016/S0033-5894(03)00059-0; Buttenschon RM, 2007, GREASNING OG HOSLET; Cameron EZ, 2001, POPULATIONS DYNAMICS; Caro T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4535; Caro T, 2009, NATURE, V462, P985, DOI 10.1038/462985b; Carpenter D, 2012, BIODIVERS CONSERV, V21, P3385, DOI 10.1007/s10531-012-0369-0; Chapron G, 2014, SCIENCE, V346, P1517, DOI 10.1126/science.1257553; Churcher CS, 1999, PALAEOGEOGR PALAEOCL, V154, P301, DOI 10.1016/S0031-0182(99)00104-2; Clutton-Brock J, 1999, NATURAL HIST DOMESTI; Colbert E. H., 1940, American Museum Novitates, Vno. 1099; Cothran EG, 2001, J S AFR VET ASSOC, V72, P18; Cran KK, 1997, J RANGE MANAGE, V50, P374, DOI 10.2307/4003303; Cromsigt JPGM, 2012, DIVERS DISTRIB, V18, P1253, DOI 10.1111/j.1472-4642.2012.00927.x; Csurhes S., 2009, PEST ANIMAL RISK ASS; Davies KW, 2014, ECOSPHERE, V5, DOI 10.1890/ES14-00171.1; Dawson M, 2006, P NATL FER HORS MAN; Dennis RLH, 2000, J INSECT CONSERV, V4, P73, DOI 10.1023/A:1009690919835; Dennis RLH, 1999, J INSECT CONSERV, V3, P33, DOI 10.1023/A:1009678422145; Diedrich Cajus G., 2006, Bulletin of Geosciences, V81, P237; Dirzo R, 2014, SCIENCE, V345, P401, DOI 10.1126/science.1251817; Dobbie W. R., 1993, MANAGING VERTEBRATE; Domingo L, 2012, QUATERNARY SCI REV, V55, P103, DOI 10.1016/j.quascirev.2012.08.017; DUNCAN P, 1983, J ANIM ECOL, V52, P93, DOI 10.2307/4590; Edwards WE, 1967, P 7 C INT ASS QUART; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Farber O, 2003, ECOL MODEL, V160, P115, DOI 10.1016/S0304-3800(02)00327-7; Feranec R, 2010, PALAEOGEOGR PALAEOCL, V297, P263, DOI 10.1016/j.palaeo.2010.08.006; Ferrusquia-Villafranca I, 2010, QUATERN INT, V217, P53, DOI 10.1016/j.quaint.2009.11.036; Forsten A, 1998, GEOBIOS-LYON, V31, P545, DOI 10.1016/S0016-6995(98)80125-3; FORSTEN A, 1986, J MAMMAL, V67, P422, DOI 10.2307/1380904; FORSTEN A, 1988, PALAEOGEOGR PALAEOCL, V65, P23, DOI 10.1016/0031-0182(88)90109-5; Fox-Dobbs K, 2008, PALAEOGEOGR PALAEOCL, V261, P30, DOI 10.1016/j.palaeo.2007.12.011; Freeman EA, 2008, ECOL MODEL, V217, P48, DOI 10.1016/j.ecolmodel.2008.05.015; GANSKOPP D, 1987, NORTHWEST SCI, V61, P74; GARROTT RA, 1991, J WILDLIFE MANAGE, V55, P641, DOI 10.2307/3809513; Girard TL, 2013, RANGELAND ECOL MANAG, V66, P428, DOI 10.2111/REM-D-12-00081.1; Girard TL, 2013, ENVIRON MANAGE, V51, P435, DOI [10.1007/s00267-012-9987-2, 10.1007/s00267-012-9987-]; GOODLOE RB, 1991, J WILDLIFE MANAGE, V55, P412, DOI 10.2307/3808969; Greyling T, 2007, S AFR J BOT, V73, P328, DOI 10.1016/j.sajb.2007.02.161; Greyling T, 2005, FACTORS AFFECTING PO; Griffiths CJ, 2010, CONSERV BIOL, V24, P645, DOI 10.1111/j.1523-1739.2010.01511.x; Groves CP, 1974, HORSES ASSESS ZEBRAS; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Haile J, 2009, P NATL ACAD SCI USA, V106, P22352, DOI 10.1073/pnas.0912510106; Hampson BA, 2010, EQUINE VET J, V42, P582, DOI 10.1111/j.2042-3306.2010.00203.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hu J, 2010, J ZOOL, V282, P54, DOI 10.1111/j.1469-7998.2010.00715.x; Hughes FMR, 2011, J NAT CONSERV, V19, P245, DOI 10.1016/j.jnc.2011.02.003; IUCN, 2013, IUCN RED LIST THREAT; Jelinek A, 1967, 7 C INT ASS QUART RE; Kerley GIH, 2012, ECOGRAPHY, V35, P519, DOI 10.1111/j.1600-0587.2011.07146.x; Klein RG, 1984, QUARTERNARY EXTINCTI; Klimov V, 1985, MUSTANGS MANYCH LAKE; Kuemmerle T, 2011, ECOL APPL, V21, P830, DOI 10.1890/10-0073.1; Kurten B., 1980, PLEISTOCENE MAMMALS; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Latif QS, 2013, ECOL EVOL, V3, P4348, DOI 10.1002/ece3.790; Leitao PJ, 2011, INT J GEOGR INF SCI, V25, P439, DOI 10.1080/13658816.2010.531020; Levin PS, 2002, CONSERV BIOL, V16, P1364, DOI 10.1046/j.1523-1739.2002.01167.x; Linklater WL, 2000, NEW ZEAL J ECOL, V24, P139; Linnartz L., 2014, REWILDING HORSES EUR; Lippold S, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-328; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Lomolino MV., 2010, BIOGEOGRAPHY, P137; Long JL, 2003, INTRO MAMMALS WORLD; Loydi A, 2010, NAT AREA J, V30, P148, DOI 10.3375/043.030.0203; MacFadden BJ, 1999, SCIENCE, V283, P824, DOI 10.1126/science.283.5403.824; MacFadden BJ, 1997, PALEOBIOLOGY, V23, P77, DOI 10.1017/S0094837300016651; MacFadden BJ, 1999, GLOBAL ECOL BIOGEOGR, V8, P137, DOI 10.1046/j.1466-822X.1999.00127.x; MacFadden BJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059277; Martin PS, 1967, P 7 C INT ASS QUAT R; Martinez-Meyer E, 2004, GLOBAL ECOL BIOGEOGR, V13, P305, DOI 10.1111/j.1466-822X.2004.00107.x; Menard C, 2002, J APPL ECOL, V39, P120, DOI 10.1046/j.1365-2664.2002.00693.x; Mihlbachler MC, 2011, SCIENCE, V331, P1178, DOI 10.1126/science.1196166; MILLER R, 1983, J RANGE MANAGE, V36, P195, DOI 10.2307/3898161; Moehlman P.D., 2002, EQUIDS ZEBRAS ASSES; Morueta-Holme N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010360; National Research Counsil, 1980, WILD FREE ROAM HORS; Nimmo DG, 2007, WILDLIFE RES, V34, P408, DOI 10.1071/WR06102; Oliveira-Santos LGR, 2010, CONSERV BIOL, V24, P4, DOI 10.1111/j.1523-1739.2009.01379.x; Orlando L, 2008, J MOL EVOL, V66, P533, DOI 10.1007/s00239-008-9100-x; Orlando L, 2009, P NATL ACAD SCI USA, V106, P21754, DOI 10.1073/pnas.0903672106; Ostermann-Kelm Stacey D., 2009, BMC Ecology, V9, P22, DOI 10.1186/1472-6785-9-22; Ottaviani D, 2009, ECOL MODEL, V220, P111, DOI 10.1016/j.ecolmodel.2008.09.014; Outram AK, 2009, SCIENCE, V323, P1332, DOI 10.1126/science.1168594; OWENSMITH N, 1987, PALEOBIOLOGY, V13, P351; Palmqvist P, 2003, PALEOBIOLOGY, V29, P205, DOI 10.1666/0094-8373(2003)029<0205:PROALP>2.0.CO;2; Pearson RG, 2004, ECOGRAPHY, V27, P285, DOI 10.1111/j.0906-7590.2004.03740.x; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; Pearson RG, 2006, J BIOGEOGR, V33, P1704, DOI 10.1111/j.1365-2699.2006.01460.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Politis GG, 1998, LAT AM ANTIQ, V9, P111, DOI 10.2307/971990; Prado Jose L., 2011, BMC Ecology, V11, P15, DOI 10.1186/1472-6785-11-15; PRATT RM, 1986, J APPL ECOL, V23, P539, DOI 10.2307/2404035; Pratt-Phillips SE, 2011, J EQUINE VET SCI, V31, P640, DOI 10.1016/j.jevs.2011.05.012; Reddy S, 2003, J BIOGEOGR, V30, P1719, DOI 10.1046/j.1365-2699.2003.00946.x; Rheinhardt RD, 2004, J RANGE MANAGE, V57, P253, DOI 10.2307/4003793; Richmond OMW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012899; Rivals F, 2012, PALEOGEOGR PALEOCLIM; ROGERS GM, 1991, NEW ZEAL J ECOL, V15, P49; ROGERS PM, 1980, J APPL ECOL, V17, P545, DOI 10.2307/2402636; Rubenstein D.I., 1986, P282; Rubenstein DR, 2006, BIOL CONSERV, V132, P232, DOI 10.1016/j.biocon.2006.04.003; Saastamoinen MT, 2012, FORAGES GRAZING HORS, V132, DOI [10.3920/978-90-8686-755-4, DOI 10.3920/978-90-8686-755-4]; SALTER RE, 1979, J RANGE MANAGE, V32, P221, DOI 10.2307/3897127; Sanchez B, 2006, AMEGHINIANA, V43, P427; Sandom C., 2013, KEY TOPICS CONSERVAT, V2, P430, DOI DOI 10.1002/9781118520178.ch23; Sandom CJ, 2014, P NATL ACAD SCI USA, V111, P4162, DOI 10.1073/pnas.1311014111; Scorolli Alberto L., 2006, Mastozool. neotrop., V13, P255; Seddon PJ, 2014, SCIENCE, V345, P406, DOI 10.1126/science.1251818; Smith CI, 2005, NATURE, V437, P318, DOI 10.1038/437318a; Solomonov N G, 2009, Dokl Biol Sci, V427, P358; Solow AR, 2006, P NATL ACAD SCI USA, V103, P7351, DOI 10.1073/pnas.0509480103; Sommer RS, 2011, J QUATERNARY SCI, V26, P805, DOI 10.1002/jqs.1509; Soule M, 1998, WILD EARTH, V8; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; The Department of Conservation, KAIM WILD HORS PLAN; Thuiller W, 2004, J BIOGEOGR, V31, P353, DOI 10.1046/j.0305-0270.2003.00991.x; Turner JW, 2001, SOUTHWEST NAT, V46, P183, DOI 10.2307/3672527; van Asperen EN, 2010, PALAEOGEOGR PALAEOCL, V297, P584, DOI 10.1016/j.palaeo.2010.09.007; van Beest FM, 2014, J ANIM ECOL, V83, P147, DOI 10.1111/1365-2656.12115; van de Vlasakker JWG., 2006, EVALUATION NATURAL G; van Klink R, 2015, BIOL REV, V90, P347, DOI 10.1111/brv.12113; VanDierendonck MC, 1996, CONSERV BIOL, V10, P728, DOI 10.1046/j.1523-1739.1996.10030728.x; vanDierendonck MC, 1996, APPL ANIM BEHAV SCI, V50, P95, DOI 10.1016/0168-1591(96)01089-1; Vera Frans W.M., 2009, British Wildlife, V20, P28; Verbruggen H., 2012, OCCURRENCETHINNER VE; Waring G.H., 1983, BEHAV TRAITS ADAPTAT; Warmuth V, 2012, P NATL ACAD SCI USA, V109, P8202, DOI 10.1073/pnas.1111122109; Warmuth V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018194; Weinstock J, 2005, PLOS BIOL, V3, P1373, DOI 10.1371/journal.pbio.0030241; Wisz MS, 2013, BIOL REV, V88, P15, DOI 10.1111/j.1469-185X.2012.00235.x; Yang WJ, 2013, J BIOGEOGR, V40, P1415, DOI 10.1111/jbi.12108; Zalba SM, 2004, ANIM CONSERV, V7, P35, DOI 10.1017/S1367943003001094; Zeigenfuss LC, 2014, WEST N AM NATURALIST, V74, P286, DOI 10.3398/064.074.0304	154	33	33	1	120	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132359	10.1371/journal.pone.0132359	http://dx.doi.org/10.1371/journal.pone.0132359			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177104	Green Published, Green Submitted, gold			2022-12-26	WOS:000358197600103
J	Rashed, L; Hay, RA; Hay, RA; Hasan, N; Zahra, A; Fayez, S				Rashed, Laila; Hay, Rania Abdel; Hay, Rania Abdel; Hasan, Nermeen; Zahra, Amr; Fayez, Salwa			Association of Angiotensin-Converting Enzyme (ACE) Gene Polymorphism with Inflammation and Cellular Cytotoxicity in Vitiligo Patients	PLOS ONE			English	Article							GLUTATHIONE-PEROXIDASE ACTIVITIES; GENERALIZED VITILIGO; AUTOIMMUNE-DISEASES; HUMAN MELANOCYTES; I/D POLYMORPHISM; GRAVES-DISEASE; NITRIC-OXIDE; CELLS; SERUM; INSERTION/DELETION	Background Vitiligo is a disorder with profound heterogeneity in its aetio-pathophysiology. Angiotensin converting enzyme (ACE) plays an important role in the physiology of the vasculature, blood pressure and inflammation. An insertion/deletion (I/D) polymorphism of the ACE gene was reported be associated with the development of vitiligo. Objective Our aim was to evaluate the ACE I/D polymorphism in vitiligo patients and controls. Our second aim was to find a possible association between ACE gene polymorphism and inflammatory mediators (as interleukin (IL)-6) and/or cellular cytotoxicity induced by serum nitrite (as a breakdown product of the cytotoxic nitric oxide) in vitiligo patients. Methods This case-control study included 74 vitiligo patients and 75 apparently healthy controls. The distribution of ACE gene I/D genotype was investigated using PCR. Serum ACE, IL-6 and nitrite were measured by colorimetric method, ELISA and Griess assay respectively. Results The ACE allele frequency was significantly different between vitiligo patients and healthy controls (P = 0.026). However there was no significant difference between the ACE genotyping frequency in both groups (P = 0.115). There were statistically significant higher VIDA score (P = 0.007), and serum IL-6 (P < 0.001) in patients with the DD genotype when compared to other genotypes. Serum nitrite in patients with the DD genotype was significantly higher (P = 0.007) when compared to patients with II genotype. Serum levels of ACE, IL-6 and nitrite in vitiligo patients were statistically significantly higher than those in controls. Conclusion As a conclusion, ACE gene polymorphism might grant susceptibility to develop vitiligo. Serum IL-6 and nitrite levels might have an important role in the pathogenesis of vitiligo. Targeting these two factors might have an implication in the treatment of some resistant cases.	[Rashed, Laila; Hasan, Nermeen; Fayez, Salwa] Cairo Univ, Fac Med, Dept Biochem, Cairo, Egypt; [Hay, Rania Abdel] Cairo Univ, Dept Dermatol, Fac Med, Cairo, Egypt; [Hay, Rania Abdel; Zahra, Amr] Fayoum Univ, Dept Biochem, Al Fayyum, Egypt	Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); Fayoum University	Hay, RA (corresponding author), Fayoum Univ, Dept Biochem, Al Fayyum, Egypt.	raniahosnibiochemistry@gmail.com	Hay, Rania Abdel/E-7472-2010	Hay, Rania Abdel/0000-0002-3280-0796; Zahra, Amr/0000-0001-5983-3507				Alkhateeb A, 2003, PIGM CELL RES, V16, P208, DOI 10.1034/j.1600-0749.2003.00032.x; Beazley WD, 1999, BRIT J DERMATOL, V141, P301; Behl P N, 1999, Indian J Dermatol Venereol Leprol, V65, P161; CZERNOBILSKY H, 1985, KLIN WOCHENSCHR, V63, P518, DOI 10.1007/BF01747982; Deeba F, 2009, INT J MED MED SCI, V1; Hazneci E, 2005, INT J DERMATOL, V44, P636, DOI 10.1111/j.1365-4632.2004.02027.x; Jagannath C, 1998, NITRIC OXIDE-BIOL CH, V2, P174, DOI 10.1006/niox.1998.9999; Jin SY, 2004, PIGM CELL RES, V17, P84, DOI 10.1046/j.1600-0749.2003.00105.x; KASAHARA Y, 1981, CLIN CHEM, V27, P1922; Kemp EH, 1997, J INVEST DERMATOL, V109, P69, DOI 10.1111/1523-1747.ep12276556; KIRNBAUER R, 1992, J INVEST DERMATOL, V98, P320, DOI 10.1111/1523-1747.ep12499793; Lv YJ, 2013, ARCH DERMATOL RES, V305, P365, DOI 10.1007/s00403-013-1315-z; Marz P, 1998, P NATL ACAD SCI USA, V95, P3251, DOI 10.1073/pnas.95.6.3251; Miranda KM, 2000, NITRIC OXIDE BIOL PA, P49; Moretti S, 2002, PIGM CELL RES, V15, P87, DOI 10.1034/j.1600-0749.2002.1o049.x; Nickoloff BJ, 2004, J CLIN INVEST, V113, P1664, DOI 10.1172/JCI200422147; NORRIS DA, 1988, J INVEST DERMATOL, V90, P783, DOI 10.1111/1523-1747.ep12461505; OCHI Y, 1969, ANN INTERN MED, V71, P935, DOI 10.7326/0003-4819-71-5-935; Onay H, 2007, EUR J DERMATOL, V17, P146, DOI 10.1684/ejd.2007.0128; Papadopoulos KI, 2000, J INTERN MED, V247, P71, DOI 10.1046/j.1365-2796.2000.00575.x; Patwardhan M, 2013, BRIT J DERMATOL, V168, P1195, DOI 10.1111/bjd.12177; Pehlivan S, 2009, EUR J DERMATOL, V19, P126, DOI 10.1684/ejd.2008.0578; RIGAT B, 1992, NUCLEIC ACIDS RES, V20, P1433, DOI 10.1093/nar/20.6.1433-a; Rocha IM, 2001, ARCH DERMATOL RES, V293, P245; SCHALLREUTER KU, 1994, SCIENCE, V263, P1444, DOI 10.1126/science.8128228; Singh Suman, 2012, Indian J Dermatol, V57, P12, DOI 10.4103/0019-5154.92668; Song GG, 2015, J RENIN-ANGIO-ALDO S, V16, P195, DOI 10.1177/1470320313478285; Spritz RA, 2007, PIGM CELL RES, V20, P271, DOI 10.1111/j.1600-0749.2007.00384.x; Takahashi T, 2000, ANN NY ACAD SCI, V902, P283; Tippisetty S, 2011, EUR J DERMATOL, V21, P173, DOI 10.1684/ejd.2011.1279; Vrijman C, 2013, BRIT J DERMATOL, V168, P1003, DOI 10.1111/bjd.12162; Weger W, 2007, EXP DERMATOL, V16, P993, DOI 10.1111/j.1600-0625.2007.00620.x; Yildirim M, 2004, J EUR ACAD DERMATOL, V18, P683, DOI 10.1111/j.1468-3083.2004.01080.x; Yildirim M, 2003, J DERMATOL, V30, P104, DOI 10.1111/j.1346-8138.2003.tb00356.x; Yu HS, 1997, J INVEST DERMATOL, V108, P527, DOI 10.1111/1523-1747.ep12289743	35	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132915	10.1371/journal.pone.0132915	http://dx.doi.org/10.1371/journal.pone.0132915			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177100	Green Published, gold, Green Submitted			2022-12-26	WOS:000358197600178
J	Yang, XX; Wang, J; Sun, J; Liu, R				Yang, Xiaoxia; Wang, Jia; Sun, Jun; Liu, Rong			SNBRFinder: A Sequence-Based Hybrid Algorithm for Enhanced Prediction of Nucleic Acid-Binding Residues	PLOS ONE			English	Article							PROTEIN-STRUCTURE ALIGNMENT; STRUCTURAL INFORMATION; RNA INTERFACE; DNA; SITES; SERVER; FEATURES; CONSERVATION; EVOLUTIONARY; ACCURATE	Protein-nucleic acid interactions are central to various fundamental biological processes. Automated methods capable of reliably identifying DNA-and RNA-binding residues in protein sequence are assuming ever-increasing importance. The majority of current algorithms rely on feature-based prediction, but their accuracy remains to be further improved. Here we propose a sequence-based hybrid algorithm SNBRFinder (Sequence-based Nucleic acid-Binding Residue Finder) by merging a feature predictor SNBRFinder(F) and a template predictor SNBRFinder(T). SNBRFinder(F) was established using the support vector machine whose inputs include sequence profile and other complementary sequence descriptors, while SNBRFinder(T) was implemented with the sequence alignment algorithm based on profile hidden Markov models to capture the weakly homologous template of query sequence. Experimental results show that SNBRFinder(F) was clearly superior to the commonly used sequence profile-based predictor and SNBRFinder(T) can achieve comparable performance to the structure-based template methods. Leveraging the complementary relationship between these two predictors, SNBRFinder reasonably improved the performance of both DNA-and RNA-binding residue predictions. More importantly, the sequence-based hybrid prediction reached competitive performance relative to our previous structure-based counterpart. Our extensive and stringent comparisons show that SNBRFinder has obvious advantages over the existing sequence-based prediction algorithms. The value of our algorithm is highlighted by establishing an easy-to-use web server that is freely accessible at http://ibi.hzau.edu.cn/SNBRFinder.	[Yang, Xiaoxia; Wang, Jia; Sun, Jun; Liu, Rong] Huazhong Agr Univ, Coll Informat, Agr Bioinformat Key Lab Hubei Prov, Wuhan, Hubei, Peoples R China	Huazhong Agricultural University	Liu, R (corresponding author), Huazhong Agr Univ, Coll Informat, Agr Bioinformat Key Lab Hubei Prov, Wuhan, Hubei, Peoples R China.	liurong116@mail.hzau.edu.cn		Yang, Catherine/0000-0001-6040-6393; Sun, Jun/0000-0003-1190-3937	National Natural Science Foundation of China [31301091]; Fundamental Research Funds for the Central Universities [2014JC003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Science Foundation of China (31301091) and the Fundamental Research Funds for the Central Universities (2014JC003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-33; Ahmad S, 2004, BIOINFORMATICS, V20, P477, DOI 10.1093/bioinformatics/btg432; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Capra JA, 2007, BIOINFORMATICS, V23, P1875, DOI 10.1093/bioinformatics/btm270; Carson MB, 2010, NUCLEIC ACIDS RES, V38, pW431, DOI 10.1093/nar/gkq361; Chen K, 2012, BIOINFORMATICS, V28, P331, DOI 10.1093/bioinformatics/btr657; Chen Y, 2005, FEBS J, V272, P2088, DOI 10.1111/j.1742-4658.2005.04650.x; Chen YC, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gkt1299; Chen YC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn008; Dey S, 2012, NUCLEIC ACIDS RES, V40, P7150, DOI 10.1093/nar/gks405; Dror I, 2012, PROTEINS, V80, P482, DOI 10.1002/prot.23214; Fan RE, 2005, J MACH LEARN RES, V6, P1889; Faraggi E, 2012, J COMPUT CHEM, V33, P259, DOI 10.1002/jcc.21968; Gangloff S, 2000, NAT GENET, V25, P192, DOI 10.1038/76055; Gao M, 2008, NUCLEIC ACIDS RES, V36, P3978, DOI 10.1093/nar/gkn332; Hwang S, 2007, BIOINFORMATICS, V23, P634, DOI 10.1093/bioinformatics/btl672; Kawashima S, 2008, NUCLEIC ACIDS RES, V36, pD202, DOI 10.1093/nar/gkm998; Kim OTP, 2006, NUCLEIC ACIDS RES, V34, P6450, DOI 10.1093/nar/gkl819; Kumar M, 2008, PROTEINS, V71, P189, DOI 10.1002/prot.21677; Kuznetsov IB, 2006, PROTEINS, V64, P19, DOI 10.1002/prot.20977; Li SL, 2014, NUCLEIC ACIDS RES, V42, P10086, DOI 10.1093/nar/gku681; Liu R, 2013, PROTEINS, V81, P1885, DOI 10.1002/prot.24330; Liu ZP, 2010, BIOINFORMATICS, V26, P1616, DOI 10.1093/bioinformatics/btq253; Ma X, 2011, PROTEINS, V79, P1230, DOI 10.1002/prot.22958; Maetschke SR, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-341; Murakami Y, 2010, NUCLEIC ACIDS RES, V38, pW412, DOI 10.1093/nar/gkq474; Nagarajan R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091140; Nagarajan R, 2013, NUCLEIC ACIDS RES, V41, P7606, DOI 10.1093/nar/gkt544; Perez-Cano L, 2010, PROTEINS, V78, P25, DOI 10.1002/prot.22527; Puton T, 2012, J STRUCT BIOL, V179, P261, DOI 10.1016/j.jsb.2011.10.001; Remmert M, 2012, NAT METHODS, V9, P173, DOI [10.1038/NMETH.1818, 10.1038/nmeth.1818]; ROST B, 1994, PROTEINS, V20, P216, DOI 10.1002/prot.340200303; SHENKIN PS, 1991, PROTEINS, V11, P297, DOI 10.1002/prot.340110408; Si JN, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-S1-S7; Stawiski EW, 2003, J MOL BIOL, V326, P1065, DOI 10.1016/S0022-2836(03)00031-7; Terribilini M, 2007, NUCLEIC ACIDS RES, V35, pW578, DOI 10.1093/nar/gkm294; Tjong H, 2007, NUCLEIC ACIDS RES, V35, P1465, DOI 10.1093/nar/gkm008; Towfic F, 2010, INT J DATA MIN BIOIN, V4, P21, DOI 10.1504/IJDMB.2010.030965; Tsuchiya Y, 2004, PROTEINS, V55, P885, DOI 10.1002/prot.20111; Walia RR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097725; Walia RR, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-89; Wang K, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-385; Wang LJ, 2006, NUCLEIC ACIDS RES, V34, pW243, DOI 10.1093/nar/gkl298; Wang LJ, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-S1-S3; Wang LJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-S1-S1; Ward JJ, 2004, BIOINFORMATICS, V20, P2138, DOI 10.1093/bioinformatics/bth195; Wu JS, 2009, BIOINFORMATICS, V25, P30, DOI 10.1093/bioinformatics/btn583; Xiong Y, 2011, PROTEINS, V79, P509, DOI 10.1002/prot.22898; Yan CH, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-262; Yang XX, 2014, PROTEINS, V82, P2455, DOI 10.1002/prot.24610; Yang YD, 2012, PROTEINS, V80, P2080, DOI 10.1002/prot.24100; Zhang Y, 2005, NUCLEIC ACIDS RES, V33, P2302, DOI 10.1093/nar/gki524; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhao HY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096694; Zhao HY, 2011, RNA BIOL, V8, P988, DOI 10.4161/rna.8.6.17813; Zhao HY, 2011, NUCLEIC ACIDS RES, V39, P3017, DOI 10.1093/nar/gkq1266; Zhao HY, 2010, BIOINFORMATICS, V26, P1857, DOI 10.1093/bioinformatics/btq295; Zhu XL, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt617	59	16	16	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0133260	10.1371/journal.pone.0133260	http://dx.doi.org/10.1371/journal.pone.0133260			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176857	Green Published, gold, Green Submitted			2022-12-26	WOS:000358197600235
J	Olkkola, S; Kovanen, S; Roine, J; Hanninen, ML; Hielm-Bjorkman, A; Kivisto, R				Olkkola, Satu; Kovanen, Sara; Roine, Johanna; Hanninen, Marja-Liisa; Hielm-Bjorkman, Anna; Kivisto, Rauni			Population Genetics and Antimicrobial Susceptibility of Canine Campylobacter Isolates Collected before and after a Raw Feeding Experiment	PLOS ONE			English	Article							SEQUENCE TYPING SYSTEM; THERMOPHILIC CAMPYLOBACTER; RISK-FACTORS; RPSL GENE; PET DOGS; MYCOBACTERIUM-TUBERCULOSIS; STREPTOMYCIN RESISTANCE; PCR ASSAY; C. COLI; JEJUNI	In recent years, increasing numbers of consumers have become interested in feeding raw food for their pet dogs as opposed to commercial dry food, in the belief of health advantages. However, raw meat and internal organs, possibly contaminated by pathogens such as Campylobacter spp., may pose a risk of transmission of zoonoses to the pet owners. Campylobacter jejuni is the leading cause of bacterial gastroenteritis in humans but C. upsaliensis has also been associated with human disease. In this study we investigated the effect of different feeding strategies on the prevalence of Campylobacter spp. in Finnish dogs. We further characterized the isolates using multilocus sequence typing (MLST), whole-genome (wg) MLST and antimicrobial susceptibility testing. Dogs were sampled before and after a feeding period consisting of commercial raw feed or dry pellet feed. Altogether 56% (20/36) of the dogs yielded at least one Campylobacter-positive fecal sample. C. upsaliensis was the major species detected from 39% of the dogs before and 30% after the feeding period. Two C. jejuni isolates were recovered, both from raw-fed dogs after the dietary regimen. The isolates represented the same genotype (ST-1326), suggesting a common infection source. However, no statistically significant correlation was found between the feeding strategies and Campylobacter spp. carriage. The global genealogy of MLST types of dog and human C. upsaliensis isolates revealed weakly clonal population structure as most STs were widely dispersed. Major antimicrobial resistance among C. upsaliensis isolates was against streptomycin (STR MIC > 4mg/l). Apart from that, all isolates were highly susceptible against the antimicrobials tested. Mutations were found in the genes rpsL or rpsL and rsmG in streptomycin resistant isolates. In conclusion, increasing trend to feed dogs with raw meat warrants more studies to evaluate the risk associated with raw feeding of pets in transmission of zoonoses to humans.	[Olkkola, Satu; Kovanen, Sara; Hanninen, Marja-Liisa; Kivisto, Rauni] Univ Helsinki, Fac Vet Med, Dept Food Hyg & Environm Hlth, Helsinki, Finland; [Roine, Johanna; Hielm-Bjorkman, Anna] Univ Helsinki, Fac Vet Med, Dept Equine & Small Anim Med, Helsinki, Finland	University of Helsinki; University of Helsinki	Olkkola, S (corresponding author), Univ Helsinki, Fac Vet Med, Dept Food Hyg & Environm Hlth, Helsinki, Finland.	satu.olkkola@helsinki.fi		Kivisto, Rauni/0000-0001-9533-2259; Hielm-Bjorkman, Anna/0000-0003-1343-3473; Olkkola, Satu/0000-0001-6966-7151	Finnish Foundation of Veterinary Research	Finnish Foundation of Veterinary Research	SO received funding from the Finnish Foundation of Veterinary Research (no specific grant number) for conducting this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarestrup FM, 2001, VET RES, V32, P311, DOI 10.1051/vetres:2001127; Acke E, 2009, FOODBORNE PATHOG DIS, V6, P705, DOI 10.1089/fpd.2008.0225; Amar C, 2014, VET MICROBIOL, V168, P124, DOI 10.1016/j.vetmic.2013.10.006; Baily JL, 2015, MOL ECOL, V24, P208, DOI 10.1111/mec.13001; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Benford D, 2014, EFSA J, V12, DOI [10.2903/j.efsa.2014.3802, 10.2903/j.efsa.2015.4260]; Benitez-Paez A, 2014, BIOMEDICA, V34, P41, DOI [10.7705/biomedica.v34i0.1702, 10.1590/S0120-41572014000500006]; Billinghurst I., 2001, BARF DIET RAW FEEDIN; Blaser MJ, 2008, CAMPYLOBACTER, 3RD EDITION, P99; Carbonero A, 2012, COMP IMMUNOL MICROB, V35, P505, DOI 10.1016/j.cimid.2012.05.002; Chaban B, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-73; Couturier BA, 2012, J CLIN MICROBIOL, V50, P3792, DOI 10.1128/JCM.01807-12; Denis M, 1999, LETT APPL MICROBIOL, V29, P406, DOI 10.1046/j.1472-765X.1999.00658.x; Didelot X, 2007, GENETICS, V175, P1251, DOI 10.1534/genetics.106.063305; Dingle KE, 2001, J CLIN MICROBIOL, V39, P14, DOI 10.1128/JCM.39.1.14-23.2001; Edwards DS, 2014, EPIDEMIOL INFECT, V142, P352, DOI 10.1017/S0950268813001222; Engvall EO, 2003, SCAND J INFECT DIS, V35, P713, DOI 10.1080/00365540310014558; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Fouts DE, 2005, PLOS BIOL, V3, P72, DOI 10.1371/journal.pbio.0030015; Francisco AP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-87; Francisco AP, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-152; Fukuda M, 1999, J ANTIMICROB CHEMOTH, V43, P281, DOI 10.1093/jac/43.2.281; FUNATSU G, 1972, J MOL BIOL, V68, P547, DOI 10.1016/0022-2836(72)90108-8; GOOSSENS H, 1995, J INFECT DIS, V172, P1298, DOI 10.1093/infdis/172.5.1298; Gras LM, 2013, EPIDEMIOL INFECT, V141, P2526, DOI 10.1017/S0950268813000356; Hald B, 2004, J CLIN MICROBIOL, V42, P2003, DOI 10.1128/JCM.42.5.2003-2012.2004; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Jesse TW, 2006, J APPL MICROBIOL, V100, P682, DOI 10.1111/j.1365-2672.2005.02796.x; KAPPERUD G, 1992, J CLIN MICROBIOL, V30, P3117, DOI 10.1128/JCM.30.12.3117-3121.1992; Katzav M, 2008, FOOD MICROBIOL, V25, P908, DOI 10.1016/j.fm.2008.05.010; Kittl S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081796; Kivisto RI, 2014, GENOME BIOL EVOL, V6, P2424, DOI 10.1093/gbe/evu194; Lawson AJ, 1997, J APPL MICROBIOL, V83, P375, DOI 10.1046/j.1365-2672.1997.00240.x; Lenz J, 2009, CAN VET J, V50, P637; Llarena AK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116585; Luo N, 2003, ANTIMICROB AGENTS CH, V47, P390, DOI 10.1128/AAC.47.1.390-394.2003; Meier A, 1996, ANTIMICROB AGENTS CH, V40, P2452, DOI 10.1128/AAC.40.11.2452; Miller WG, 2005, J CLIN MICROBIOL, V43, P2315, DOI 10.1128/JCM.43.5.2315-2329.2005; Nirdnoy W, 2005, ANTIMICROB AGENTS CH, V49, P2454, DOI 10.1128/AAC.49.6.2454-2459.2005; Nishimura K, 2007, J BACTERIOL, V189, P6068, DOI 10.1128/JB.00558-07; Noormohamed A, 2013, INT J ENV RES PUB HE, V10, P2058, DOI 10.3390/ijerph10052058; Okamoto S, 2007, MOL MICROBIOL, V63, P1096, DOI 10.1111/j.1365-2958.2006.05585.x; Olkkola S, 2010, MICROB DRUG RESIST, V16, P105, DOI 10.1089/mdr.2009.0128; Parsons BN, 2012, VET MICROBIOL, V157, P391, DOI 10.1016/j.vetmic.2011.12.035; Parsons BN, 2010, VET J, V184, P66, DOI 10.1016/j.tvjl.2009.01.009; Parsons BN, 2009, J CLIN MICROBIOL, V47, P3466, DOI 10.1128/JCM.01046-09; Procter TD, 2014, ZOONOSES PUBLIC HLTH, V61, P208, DOI 10.1111/zph.12062; Qin SS, 2012, ANTIMICROB AGENTS CH, V56, P5332, DOI 10.1128/AAC.00809-12; Revez J, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-768; Rossi M, 2008, VET MICROBIOL, V129, P304, DOI 10.1016/j.vetmic.2007.11.014; Sandberg M, 2002, PREV VET MED, V55, P241, DOI 10.1016/S0167-5877(02)00095-8; Sasaki Y, 2013, JPN J INFECT DIS, V66, P161, DOI 10.7883/yoken.66.161; Shimizu Y, 2012, CASE REP NEPHROL DIA, V2, P145, DOI 10.1159/000343499; Strohmeyer RA, 2006, JAVMA-J AM VET MED A, V228, P537, DOI 10.2460/javma.228.4.537; Torii N, 2003, MUTAT RES-GEN TOX EN, V535, P141, DOI 10.1016/S1383-5718(02)00292-9; Trokhymchuk A, 2014, J FOOD PROTECT, V77, P2106, DOI 10.4315/0362-028X.JFP-14-247; Tsai HJ, 2007, VET RES COMMUN, V31, P931, DOI 10.1007/s11259-007-0009-4; Vandenberg O, 2006, J ANTIMICROB CHEMOTH, V57, P908, DOI 10.1093/jac/dkl080; WANG Y, 1993, ANTIMICROB AGENTS CH, V37, P457, DOI 10.1128/AAC.37.3.457; Weese JS, 2005, CAN VET J, V46, P513; Workman SN, 2005, J CLIN MICROBIOL, V43, P2642, DOI 10.1128/JCM.43.6.2642-2650.2005; Zanoni RG, 2007, INT J FOOD MICROBIOL, V116, P168, DOI 10.1016/j.ijfoodmicro.2006.12.007; Zhang J, 2015, J CLIN MICROBIOL, V53, P1765, DOI 10.1128/JCM.00051-15	63	15	15	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132660	10.1371/journal.pone.0132660	http://dx.doi.org/10.1371/journal.pone.0132660			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26172151	Green Published, gold, Green Submitted			2022-12-26	WOS:000358194900070
J	Tzeng, YM; Kao, LT; Lin, HC; Huang, CY				Tzeng, Ya-Mei; Kao, Li-Ting; Lin, Herng-Ching; Huang, Chao-Yuan			A Population-Based Study on the Association between Benign Prostatic Enlargement and Rheumatoid Arthritis	PLOS ONE			English	Article							INFLAMMATION; CYTOKINES; HYPERPLASIA; DISEASES	Benign prostatic hyperplasia is one of the chronic inflammatory conditions in ageing male populations. Rheumatoid arthritis (RA) is a major autoimmune disease and is also regarded as a chronic inflammatory disorder. Although RA and benign prostatic enlargement (BPE) may share the same underlying etiologies, almost no study has ever attempted to explore the relationship between RA and BPE. The aim of this study was to explore the relationship between RA and BPE using a population-based dataset. This case-control study used data retrieved from the Taiwan Longitudinal Health Insurance Database 2005. This study comprised 18,716 patients with BPE and 18,716 age-matched patients without BPE. Conditional logistic regression analyses were performed to calculate the odds ratio (OR) for having been previously diagnosed with RA between patients with BPE and comparison patients. In total, 485 of the 37,432 sampled patients (1.3%) had received a prior RA diagnosis. There was a significant difference in the prevalence of prior RA between cases and controls (1.6% vs. 1.0%, p<0.001). After adjusting for patient's urbanization level, monthly income, geographic region, and obesity, the adjusted OR was 1.54 (95% CI = 1.28 similar to 1.85) for patients with BPE compared to comparison patients. In addition, the sensitivity analysis showed that BPE was consistently and significantly associated with a prior RA diagnosis even after excluding subjects diagnosed with RA within 1, 2, or 3 years prior to the index date (the adjusted ORs were 1.46, 1.50, and 1.42, respectively). We concluded that there was a significant association between prior RA and BPE. Further large-scale longitudinal studies are suggested to clarify the causal relationship between RA and BPE.	[Tzeng, Ya-Mei] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Tzeng, Ya-Mei; Lin, Herng-Ching] Taipei Med Univ Hosp, Sleep Res Ctr, Taipei, Taiwan; [Kao, Li-Ting] Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan; [Huang, Chao-Yuan] Natl Taiwan Univ, Natl Taiwan Univ Hosp, Dept Urol, Coll Med, Taipei 10764, Taiwan; [Huang, Chao-Yuan] Taipei Med Univ, Sch Publ Hlth, Taipei, Taiwan	National Defense Medical Center; Taipei Medical University; Taipei Medical University Hospital; National Defense Medical Center; National Taiwan University; National Taiwan University Hospital; Taipei Medical University	Huang, CY (corresponding author), Natl Taiwan Univ, Natl Taiwan Univ Hosp, Dept Urol, Coll Med, Taipei 10764, Taiwan.	cyh540909@yahoo.com.tw	Kao, Li-Ting/W-9287-2018	Kao, Li-Ting/0000-0003-0692-7408; HUANG, CHAO-YUAN/0000-0002-9322-6062				Abdollah F, 2011, KOREAN J UROL, V52, P507, DOI 10.4111/kju.2011.52.8.507; Al-Shukaili AK, 2006, SAUDI MED J, V27, P1642; Berhane N, 2012, MOL BIOL REP, V39, P11125, DOI 10.1007/s11033-012-2020-2; Briganti A, 2010, EUR UROL, V57, P551, DOI 10.1016/j.eururo.2009.12.023; Chen YC, 2011, SCIENTOMETRICS, V86, P365, DOI 10.1007/s11192-010-0289-2; Ficarra V, 2013, EUR UROL SUPPL, V12, P110, DOI 10.1016/j.eursup.2013.08.002; Filkova M, 2015, CYTOKINE, V73, P36, DOI 10.1016/j.cyto.2015.01.019; Klareskog L, 2009, LANCET, V373, P659, DOI 10.1016/S0140-6736(09)60008-8; Koskimaki J, 2001, SCAND J UROL NEPHROL, V35, P377; Kramer G, 2006, CURR OPIN UROL, V16, P25; Kramer G, 2002, PROSTATE, V52, P43, DOI 10.1002/pros.10084; Nickel JC, 2008, UROL CLIN N AM, V35, P109, DOI 10.1016/j.ucl.2007.09.012; Siebert S, 2015, PHARMACOL REV, V67, P280, DOI 10.1124/pr.114.009639	13	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0133013	10.1371/journal.pone.0133013	http://dx.doi.org/10.1371/journal.pone.0133013			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26172054	Green Published, Green Submitted, gold			2022-12-26	WOS:000358194900117
J	Ren, GR; Hauser, F; Rewitz, KF; Kondo, S; Engelbrecht, AF; Didriksen, AK; Schjott, SR; Sembach, FE; Li, SZ; Sogaard, KC; Sondergaard, L; Grimmelikhuijzen, CJP				Ren, Guilin R.; Hauser, Frank; Rewitz, Kim F.; Kondo, Shu; Engelbrecht, Alexander F.; Didriksen, Anders K.; Schjott, Suzanne R.; Sembach, Frederikke E.; Li, Shizhong; Sogaard, Karen C.; Sondergaard, Leif; Grimmelikhuijzen, Cornelis J. P.			CCHamide-2 Is an Orexigenic Brain-Gut Peptide in Drosophila	PLOS ONE			English	Article							FOOD-INTAKE; DEVELOPMENTAL CONTROL; NEUROPEPTIDES; BEHAVIOR; NEURONS; GENOME; GROWTH; CELLS	The neuroendocrine peptides CCHamide-1 and -2, encoded by the genes ccha1 and -2, are produced by endocrine cells in the midgut and by neurons in the brain of Drosophila melanogaster. Here, we used the CRISPR/Cas9 technique to disrupt the ccha1 and -2 genes and identify mutant phenotypes with a focus on ccha-2 mutants. We found that both larval and adult ccha2 mutants showed a significantly reduced food intake as measured in adult flies by the Capillary Feeding (CAFE) assay (up to 72% reduced food intake compared to wild-type). Locomotion tests in adult flies showed that ccha2 mutants had a significantly reduced locomotor activity especially around 8 a.m. and 8 p.m., where adult Drosophila normally feeds (up to 70% reduced locomotor activity compared to wild-type). Reduced larval feeding is normally coupled to a delayed larval development, a process that is mediated by insulin. Accordingly, we found that the ccha2 mutants had a remarkably delayed development, showing pupariation 70 hours after the pupariation time point of the wild-type. In contrast, the ccha-1 mutants were not developmentally delayed. We also found that the ccha2 mutants had up to 80% reduced mRNA concentrations coding for the Drosophila insulin-like-peptides-2 and -3, while these concentrations were unchanged for the ccha1 mutants. From these experiments we conclude that CCHamide-2 is an orexigenic peptide and an important factor for controlling developmental timing in Drosophila.	[Ren, Guilin R.; Hauser, Frank; Engelbrecht, Alexander F.; Didriksen, Anders K.; Schjott, Suzanne R.; Sembach, Frederikke E.; Li, Shizhong; Sogaard, Karen C.; Sondergaard, Leif; Grimmelikhuijzen, Cornelis J. P.] Univ Copenhagen, Ctr Funct & Comparat Insect Genom, Dept Biol, Copenhagen, Denmark; [Ren, Guilin R.; Hauser, Frank; Rewitz, Kim F.; Engelbrecht, Alexander F.; Didriksen, Anders K.; Schjott, Suzanne R.; Sembach, Frederikke E.; Li, Shizhong; Sogaard, Karen C.; Sondergaard, Leif; Grimmelikhuijzen, Cornelis J. P.] Univ Copenhagen, Dept Biol, Sect Cell & Neurobiol, DK-2100 Copenhagen, Denmark; [Kondo, Shu] Natl Inst Genet, Genet Strains Res Ctr, Mishima, Shizuoka 411, Japan	University of Copenhagen; University of Copenhagen; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan	Grimmelikhuijzen, CJP (corresponding author), Univ Copenhagen, Ctr Funct & Comparat Insect Genom, Dept Biol, Copenhagen, Denmark.	cgrimmelikhuijzen@bio.ku.dk	Hauser, Frank/M-2952-2014; Rewitz, Kim F/M-6012-2014; Kondo, Shu/AAH-8921-2020	Hauser, Frank/0000-0001-5563-2345; Rewitz, Kim F/0000-0002-4409-9941; Kondo, Shu/0000-0002-4625-8379; Grimmelikhuijzen, Cornelis Johannes Pieter/0000-0001-6486-2046	Lundbeck Foundation; Lundbeck Foundation [R83-2011-7610] Funding Source: researchfish; Novo Nordisk Fonden [NNF14OC0010929] Funding Source: researchfish	Lundbeck Foundation(Lundbeckfonden); Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported by the Lundbeck Foundation to CJPG: (http://www.lundbeckfoundation.com/About-the-Foundation.25.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chipman AD, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1002005; Chiu Joanna C, 2010, J Vis Exp, DOI 10.3791/2157; Christie AE, 2015, GEN COMP ENDOCR, V210, P63, DOI 10.1016/j.ygcen.2014.10.005; Christie AE, 2014, GEN COMP ENDOCR, V206, P235, DOI 10.1016/j.ygcen.2014.04.015; Deshpande SA, 2014, NAT METHODS, V11, P535, DOI [10.1038/NMETH.2899, 10.1038/nmeth.2899]; Dircksen H, 2011, J PROTEOME RES, V10, P4478, DOI 10.1021/pr200284e; EIPPER BA, 1992, ANNU REV NEUROSCI, V15, P57, DOI 10.1146/annurev.ne.15.030192.000421; Erion R, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00353; Galagovsky D, 2014, MOL BIOL CELL, V25, P916, DOI 10.1091/mbc.E13-04-0213; Geminard C, 2009, CELL METAB, V10, P199, DOI 10.1016/j.cmet.2009.08.002; Hansen KK, 2011, BIOCHEM BIOPH RES CO, V404, P184, DOI 10.1016/j.bbrc.2010.11.089; Hergarden AC, 2012, P NATL ACAD SCI USA, V109, P3967, DOI 10.1073/pnas.1200778109; Ida Takanori, 2012, Front Endocrinol (Lausanne), V3, P177, DOI 10.3389/fendo.2012.00177; Kondo S, 2014, GENES GENET SYST, V89, P3, DOI 10.1266/ggs.89.3; Kondo S, 2013, GENETICS, V195, P715, DOI 10.1534/genetics.113.156737; Lee KS, 2004, J BIOL CHEM, V279, P50781, DOI 10.1074/jbc.M407842200; Li SZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076131; Mirth Christen Kerry, 2012, Front Endocrinol (Lausanne), V3, P49, DOI 10.3389/fendo.2012.00049; Nassel DR, 2011, PEPTIDES, V32, P1335, DOI 10.1016/j.peptides.2011.03.013; Nijhout HF, 2014, WIRES DEV BIOL, V3, P113, DOI 10.1002/wdev.124; Nygaard S, 2011, GENOME RES, V21, P1339, DOI 10.1101/gr.121392.111; Park S, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004555; Parker J, 2011, EVOL DEV, V13, P304, DOI 10.1111/j.1525-142X.2011.00481.x; Poulsen M, 2014, P NATL ACAD SCI USA, V111, P14500, DOI 10.1073/pnas.1319718111; Reiher W, 2011, J PROTEOME RES, V10, P1881, DOI 10.1021/pr101116g; Ro J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101107; Roller L, 2008, INSECT BIOCHEM MOLEC, V38, P1147, DOI 10.1016/j.ibmb.2008.04.009; Rulifson EJ, 2002, SCIENCE, V296, P1118, DOI 10.1126/science.1070058; Sano H, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005209; Schoofs A, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001893; Soderberg Jeannette A E, 2012, Front Endocrinol (Lausanne), V3, P109, DOI 10.3389/fendo.2012.00109; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Veenstra JA, 2014, CELL TISSUE RES, V357, P607, DOI 10.1007/s00441-014-1880-2; Veenstra JA, 2009, CELL TISSUE RES, V336, P309, DOI 10.1007/s00441-009-0769-y; Wong R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006063; Wu Q, 2003, NEURON, V39, P147, DOI 10.1016/S0896-6273(03)00396-9; Zdarek J, 2000, J INSECT PHYSIOL, V46, P213, DOI 10.1016/S0022-1910(99)00114-6; Zoephel J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041543	38	65	67	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0133017	10.1371/journal.pone.0133017	http://dx.doi.org/10.1371/journal.pone.0133017			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26168160	Green Published, gold, Green Submitted			2022-12-26	WOS:000358193100103
J	Leitan, ND; Williams, B; Murray, G				Leitan, N. D.; Williams, B.; Murray, G.			Look Up for Healing: Embodiment of the Heal Concept in Looking Upward	PLOS ONE			English	Article							DIFFUSION-MODEL; READING FLUENCY; VERTICAL SPACE; FMRI EVIDENCE; REPRESENTATION; KNOWLEDGE; COGNITION; MEMORY; POWER; ACTIVATION	Objective Conceptual processing may not be restricted to the mind. The heal concept has been metaphorically associated with an "up" bodily posture. Perceptual Symbol Systems (PSS) theory suggests that this association is underpinned by bodily states which occur during learning and become instantiated as the concept. Thus the aim of this study was to examine whether processing related to the heal concept is promoted by priming the bodily state of looking upwards. Method We used a mixed 2x2 priming paradigm in which 58 participants were asked to evaluate words as either related to the heal concept or not after being primed to trigger the concept of looking up versus down (Direction - within subjects). A possible dose-response effect of priming was investigated via allocating participants to two 'strengths' of prime, observing an image of someone whose gaze was upward/downward (low strength) and observing an image of someone whose gaze was upward/downward while physically tilting their head upwards or downwards in accord with the image (high strength) (Strength - between subjects). Results Participants responded to words related to heal faster than words unrelated to heal across both "Strength" conditions. There was no evidence that priming was stronger in the high strength condition. Conclusion The present study found that, consistent with a PSS view of cognition, the heal concept is embodied in looking upward, which has important implications for cognition, general health, health psychology, health promotion and therapy.	[Leitan, N. D.; Williams, B.; Murray, G.] Swinburne Univ Technol, Fac Hlth Arts & Design, Melbourne, Vic, Australia	Swinburne University of Technology	Leitan, ND (corresponding author), Swinburne Univ Technol, Fac Hlth Arts & Design, Melbourne, Vic, Australia.	nleitan@swin.edu.au	Murray, Greg/N-8933-2017	Murray, Greg/0000-0001-7208-5603				[Anonymous], 2014, SENSORIA J MIND BRAI; Barsalou Lawrence, 2005, HDB CATEGORIZATION C, P620; Barsalou LW, 2008, ANNU REV PSYCHOL, V59, P617, DOI 10.1146/annurev.psych.59.103006.093639; Barsalou LW, 1999, BEHAV BRAIN SCI, V22, P577, DOI 10.1017/S0140525X99532147; Barsalou LW, 2003, PSYCHOL LEARN MOTIV, V43, P43, DOI 10.1016/S0079-7421(03)01011-9; Burns MK, 2011, PSYCHOL SCHOOLS, V48, P124, DOI 10.1002/pits.20531; Chandler J, 2009, J EXP SOC PSYCHOL, V45, P123, DOI 10.1016/j.jesp.2008.06.012; Chang ACS, 2013, READ FOREIGN LANG, V25, P126; COLLINS AM, 1975, PSYCHOL REV, V82, P407, DOI 10.1037/0033-295X.82.6.407; Crawford LE, 2006, COGNITION EMOTION, V20, P1153, DOI 10.1080/02699930500347794; Crawford LE, 2009, EMOT REV, V1, P129, DOI 10.1177/1754073908100438; Ernst MO, 2002, J VISION, V2, DOI [10.1167/2.10.126, DOI 10.1167/2.10.126]; Faw B, 2009, J CONSCIOUSNESS STUD, V16, P45; Fodor J. A., 1975, LANGUAGE THOUGHT; Gallese V, 2005, COGN NEUROPSYCHOL, V22, P455, DOI 10.1080/02643290442000310; Gangi C, 2011, PSYCHOL HEALTH, V26, P1006, DOI 10.1080/08870446.2010.520714; Ghane A, 2013, HEALTH PSYCHOL REV, V7, pS159, DOI 10.1080/17437199.2012.706988; Harris J, 2003, WORDCOUNT2003; Henning J, 2010, BASIC ENGLISH WORD L; Howell D.C., 2010, STAT METHODS PSYCHOL, V7; Hung IW, 2011, J CONSUM RES, V37, P1046, DOI 10.1086/657240; Jostmann NB, 2009, PSYCHOL SCI, V20, P1169, DOI 10.1111/j.1467-9280.2009.02426.x; Kan IP, 2003, COGN NEUROPSYCHOL, V20, P525, DOI 10.1080/02643290244000257; Kellenbach ML, 2001, COGN AFFECT BEHAV NE, V1, P207, DOI 10.3758/CABN.1.3.207; Kirmayer LJ, 2008, TRANSCULT PSYCHIATRY, V45, P318, DOI 10.1177/1363461508089769; Lakens D, 2011, SOC PSYCHOL-GERMANY, V42, P205, DOI 10.1027/1864-9335/a000064; Lakoff George, 2003, METAPHOR WE LIVE BY; Landauer TK, 1997, PSYCHOL REV, V104, P211, DOI 10.1037/0033-295X.104.2.211; Lavidor M, 2001, COGNITIVE BRAIN RES, V12, P265, DOI 10.1016/S0926-6410(01)00056-8; Marques JF, 2006, MEM COGNITION, V34, P60, DOI 10.3758/BF03193386; McClelland J. L., 1986, PARALLEL DISTRIBUTED, V2; Meier BP, 2006, J RES PERS, V40, P451, DOI 10.1016/j.jrp.2005.03.001; Meier BP, 2004, PSYCHOL SCI, V15, P243, DOI 10.1111/j.0956-7976.2004.00659.x; Meier BP, 2007, J PERS SOC PSYCHOL, V93, P699, DOI 10.1037/0022-3514.93.5.699; Michalak J, 2014, CLIN PSYCHOL PSYCHOT, V21, P519, DOI 10.1002/cpp.1890; Michalak J, 2009, PSYCHOSOM MED, V71, P580, DOI 10.1097/PSY.0b013e3181a2515c; Monsell S., 1991, BASIC PROCESSES READ, P148; Nation ISP, 2005, PASAA, V36, P21; Pecher D, 2004, PSYCHON B REV, V11, P164, DOI 10.3758/BF03206477; Pecher D, 2003, PSYCHOL SCI, V14, P119, DOI 10.1111/1467-9280.t01-1-01429; PEPER E, 2012, BIOFEEDBACK, V40, P125, DOI DOI 10.5298/1081-5937-40.3.01; Pylyshyn Z., 1984, COMPUTATION COGNITIO; Ratcliff R, 2002, PSYCHON B REV, V9, P438, DOI 10.3758/BF03196302; Scheffe H., 1999, ANAL VARIANCE; Schubert TW, 2009, J EXP SOC PSYCHOL, V45, P828, DOI 10.1016/j.jesp.2009.02.003; Schubert TW, 2005, J PERS SOC PSYCHOL, V89, P1, DOI 10.1037/0022-3514.89.1.1; Schubert TW, 2004, PERS SOC PSYCHOL B, V30, P757, DOI 10.1177/0146167204263780; Shapiro L, 2007, PHILOS COMPASS, V2, P338, DOI 10.1111/j.1747-9991.2007.00064.x; Sherman DK, 2010, J EXP SOC PSYCHOL, V46, P461, DOI 10.1016/j.jesp.2009.12.008; Simmons WK, 2008, J PHYSIOL-PARIS, V102, P106, DOI 10.1016/j.jphysparis.2008.03.014; Simmons WK, 2003, COGN NEUROPSYCHOL, V20, P451, DOI 10.1080/02643290342000032; Slocomb D, 2009, J PSYCHOLINGUIST RES, V38, P43, DOI 10.1007/s10936-008-9082-2; Stage SA, 2001, SCHOOL PSYCHOL REV, V30, P407; TEASDALE JD, 1993, BEHAV RES THER, V31, P339, DOI 10.1016/0005-7967(93)90092-9; Vacharkulksemsuk T, 2012, J EXP SOC PSYCHOL, V48, P399, DOI 10.1016/j.jesp.2011.07.015; Wagenmakers EJ, 2008, J MEM LANG, V58, P140, DOI 10.1016/j.jml.2007.04.006; Wells AJ, 1998, COGNITIVE SCI, V22, P269, DOI 10.1207/s15516709cog2203_1; White C, 2009, COGNITION EMOTION, V23, P181, DOI 10.1080/02699930801976770; Wilson-Mendenhall CD, 2013, J COGNITIVE NEUROSCI, V25, P920, DOI 10.1162/jocn_a_00361; Wu LL, 2009, ACTA PSYCHOL, V132, P173, DOI 10.1016/j.actpsy.2009.02.002	60	6	6	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132427	10.1371/journal.pone.0132427	http://dx.doi.org/10.1371/journal.pone.0132427			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1FD	26161967	Green Published, gold			2022-12-26	WOS:000358162300134
J	Chagas, BS; Comar, M; Gurgel, APAD; Paiva, S; Seraceni, S; de Freitas, AC; Crovella, S				Chagas, Barbara Simas; Comar, Manola; Almeida Diniz Gurgel, Ana Pavla; Paiva, Sergio; Seraceni, Silva; de Freitas, Antonio Carlos; Crovella, Sergio			Association Study between Cervical Lesions and Single or Multiple Vaccine-Target and Non-Vaccine Target Human Papillomavirus (HPV) Types in Women from Northeastern Brazil	PLOS ONE			English	Article							HPV-16/18 AS04-ADJUVANTED VACCINE; CROSS-PROTECTIVE EFFICACY; OF-STUDY ANALYSIS; HIGH-RISK; CONCURRENT INFECTIONS; VARIANT LINEAGES; E7 ONCOGENES; E6 VARIANTS; CANCER; PREVALENCE	We performed an association between high-grade squamous intraepithelial lesions (HSIL), low-grade squamous intraepithelial lesions (LSIL) and single or multiple vaccine-target as well as non-vaccine target Human papillomavirus (HPV) types. Using bead-based HPV genotyping, 594 gynecological samples were genotyped. An association between squamous intraepithelial lesion (SIL) and presence of HPV16, 18, 31, 58 and 56 types were calculated. The risk was estimated by using odds ratio (OR) and 95% of confidence intervals (CI). A total of 370 (62.3%) women were HPV positive. Among these, 157 (42.7%) presented a single HPV infection, and 212 (57.3%) were infected by more than one HPV type. HPV31 was the most prevalent genotype, regardless single and multiple HPV infections. Single infection with HPV31 was associated with LSIL (OR=2.32; 95% CI: 1.01 to 5.32; p=0.04); HPV31 was also associated with LSIL (OR=3.28; 95% CI: 1.74 to 6.19; p=0.0002) and HSIL (OR=3.82; 95% CI: 2.10 to 6.97; p<0.001) in multiple HPV infections. Risk to harbor cervical lesions was observed in multiple HPV infections with regard to the HPV56 (OR=5.39; 95% CI: 2.44 to 11.90; p<0.001 for LSIL; OR=5.37; 95% CI: 2.71 to 10.69; p<0.001) and HPV58 (OR=3.29; 95% CI: 1.34 to 8.09; p=0.0091 for LSIL; OR=3.55; 95% CI: 1.56 to 8.11; p=0.0026) genotypes. In addition, women coinfected with HPV16/31/56 types had 6 and 5-fold increased risk of HSIL (OR=6.46; 95% CI: 1.89 to 22.09; p=0.002) and LSIL (OR=5.22; 95% CI: 1.10 to 24.70; p=0.03), respectively. Multiple HPV infections without HPV16/18 has 2-fold increased risk of HSIL (OR=2.57; 95% CI: 1.41 to 4.70; p=0.002) and LSIL OR=2.03; 95% CI: 1.08 to 3.79; p=0.02). The results of this study suggest that single and multiple vaccine target as well as non-vaccine target HPV types are associated with LSIL and HSIL. These finding should be taken into consideration in the design of HPV vaccination strategies.	[Chagas, Barbara Simas; Almeida Diniz Gurgel, Ana Pavla; Paiva, Sergio; de Freitas, Antonio Carlos] Univ Fed Pernambuco, Dept Genet, Lab Mol Studies & Expt Therapy, Caruaru, PE, Brazil; [Comar, Manola; Seraceni, Silva; Crovella, Sergio] IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, Trieste, Italy; [Seraceni, Silva; Crovella, Sergio] Univ Trieste, Trieste, Italy	Universidade Federal de Pernambuco; IRCCS Burlo Garofolo; University of Trieste	de Freitas, AC (corresponding author), Univ Fed Pernambuco, Dept Genet, Lab Mol Studies & Expt Therapy, Caruaru, PE, Brazil.	acf_ufpe@yahoo.com.br	Comar, Manola/K-4613-2016; Chagas, Bárbara/M-9327-2019; Freitas, Antonio/G-1843-2012; Crovella, Sergio/K-5050-2016; COMAR, Manola/K-4613-2016	Comar, Manola/0000-0001-6310-3320; Freitas, Antonio/0000-0002-4957-9549; Crovella, Sergio/0000-0001-8493-1168; Simas Chagas, Barbara/0000-0003-3917-9055; COMAR, Manola/0000-0002-9487-861X; Gurgel, Ana Pavla A.D./0000-0001-5848-6419	Brazilian Institute CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico); Brazilian Institute FACEPE (Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco); Brazilian Institute PPSUS (Programa Pesquisa para o Sistema Unico de Saude); Brazilian Institute CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)	Brazilian Institute CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Brazilian Institute FACEPE (Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco); Brazilian Institute PPSUS (Programa Pesquisa para o Sistema Unico de Saude); Brazilian Institute CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)	This work was supported by Brazilian Institutes CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico), - FACEPE (Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco), PPSUS (Programa Pesquisa para o Sistema Unico de Saude), CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior).	Ah Lee S, 2003, CANC LETT, V198, P187, DOI 10.1016/S0304-3835(03)00312-4; Alencar TR, 2007, VIRUS GENES, V35, P1, DOI 10.1007/s11262-006-0040-5; Gurgel APAD, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/546354; Gurgel APAD, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/130828; Arbyn M, 2011, ANN ONCOL, V22, P2675, DOI 10.1093/annonc/mdr015; Baldez da Silva M F P T, 2009, Genet Mol Res, V8, P1437, DOI 10.4238/vol8-4gmr677; da Silva MFPTB, 2012, GENET MOL RES, V11, P462, DOI 10.4238/2012.March.1.3; Beca F, 2014, DIAGN CYTOPATHOL, V42, P919, DOI 10.1002/dc.23143; Berumen J, 2001, JNCI-J NATL CANCER I, V93, P1325, DOI 10.1093/jnci/93.17.1325; Burk RD, 2003, CANCER RES, V63, P7215; Burk RD, 2013, VIROLOGY, V445, P232, DOI 10.1016/j.virol.2013.07.018; Burroni E, 2013, J MED VIROL, V85, P83, DOI 10.1002/jmv.23417; Carozzi F, 2012, EUR J CANCER, V48, P1633, DOI 10.1016/j.ejca.2011.10.010; Castro MM, 2011, GENET MOL RES, V10, P186, DOI 10.4238/vol10-1gmr992; Chagas BS, 2011, GYNECOL ONCOL, V123, P284, DOI 10.1016/j.ygyno.2011.07.008; Chagas BS, 2013, INFECT GENET EVOL, V16, P13, DOI 10.1016/j.meegid.2013.02.001; Chang YJ, 2011, INT J CANCER, V129, P965, DOI 10.1002/ijc.25724; Chansaenroj J, 2012, ASIAN PAC J CANCER P, V13, P599, DOI 10.7314/APJCP.2012.13.2.599; Chaturvedi AK, 2011, J INFECT DIS, V203, P910, DOI 10.1093/infdis/jiq139; Comar M, 2012, J CLIN MICROBIOL, V50, P4041, DOI 10.1128/JCM.02105-12; Combita A, 2013, REV COLOMB CANCEROL, V17, P103, DOI 10.1016/S0123-9015(13)70012-X; Cornet I, 2013, INFECT AGENTS CANCER, V8, DOI 10.1186/1750-9378-8-4; Cornet I, 2012, J VIROL, V86, P6855, DOI 10.1128/JVI.00483-12; Cruz MR, 2004, MEM I OSWALDO CRUZ, V99, P281, DOI 10.1590/S0074-02762004000300007; Cuschieri KS, 2004, J CLIN PATHOL, V57, P68, DOI 10.1136/jcp.57.1.68; Resende LSDA, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-214; de Freitas AC, 2012, GYNECOL ONCOL, V126, P304, DOI 10.1016/j.ygyno.2012.03.047; Fernandes TAADM, 2008, BRAZ J MICROBIOL, V39, P573, DOI [10.1590/S1517-83822008000300031, 10.1590/S1517-838220080003000031]; de Sanjose S, 2007, LANCET INFECT DIS, V7, P453, DOI 10.1016/S1473-3099(07)70158-5; de Sanjose S, 2010, LANCET ONCOL, V11, P1048, DOI 10.1016/S1470-2045(10)70230-8; De Vincenzo R, 2013, GYNECOL ONCOL, V130, P642, DOI 10.1016/j.ygyno.2013.05.033; Dickson EL, 2014, GYNECOL ONCOL, V133, P405, DOI 10.1016/j.ygyno.2014.03.552; Dickson EL, 2013, INT J GYNECOL CANCER, V23, P1295, DOI 10.1097/IGC.0b013e31829e9fb4; Fernandes Jose V, 2010, BMC Res Notes, V3, P96, DOI 10.1186/1756-0500-3-96; Fernandes JV, 2011, MOL MED REP, V4, P1321, DOI 10.3892/mmr.2011.579; Freitas LB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100746; Gheit T, 2006, J CLIN MICROBIOL, V44, P2025, DOI 10.1128/JCM.02305-05; Gheit T, 2011, CANCER EPIDEM BIOMAR, V20, P1315, DOI 10.1158/1055-9965.EPI-10-1187; Goldstone SE, 2013, VACCINE, V31, P3849, DOI 10.1016/j.vaccine.2013.06.057; Hildesheim A, 2014, VACCINE, V32, P5087, DOI 10.1016/j.vaccine.2014.06.038; Kahn JA, 2012, PEDIATRICS, V130, pE249, DOI 10.1542/peds.2011-3587; Kavanagh K, 2014, BRIT J CANCER, V110, P2804, DOI 10.1038/bjc.2014.198; Lehtinen M, 2012, LANCET ONCOL, V13, P89, DOI 10.1016/S1470-2045(11)70286-8; Li N, 2011, INT J CANCER, V128, P927, DOI 10.1002/ijc.25396; Londesborough P, 1996, INT J CANCER, V69, P364; Malagon T, 2012, LANCET INFECT DIS, V12, P781, DOI 10.1016/S1473-3099(12)70187-1; Mejlhede N, 2009, APMIS, V117, P108, DOI 10.1111/j.1600-0463.2008.00019.x; Munagala R, 2009, INT J ONCOL, V34, P263, DOI 10.3892/ijo_00000148; Nielsen A, 2008, SEX TRANSM DIS, V35, P276, DOI 10.1097/OLQ.0b013e31815ac5c7; Orlando PA, 2012, J INFECT DIS, V205, P272, DOI 10.1093/infdis/jir717; Pista A, 2011, CLIN MICROBIOL INFEC, V17, P941, DOI 10.1111/j.1469-0691.2010.03387.x; Quint KD, 2010, GYNECOL ONCOL, V117, P297, DOI 10.1016/j.ygyno.2010.02.003; Schiffman M, 2010, CANCER RES, V70, P3159, DOI 10.1158/0008-5472.CAN-09-4179; Schmitt M, 2006, J CLIN MICROBIOL, V44, P504, DOI 10.1128/JCM.44.2.504-512.2006; Sichero L, 2007, INT J CANCER, V120, P1763, DOI 10.1002/ijc.22481; Tabrizi SN, 2014, LANCET INFECT DIS, V14, P958, DOI 10.1016/S1473-3099(14)70841-2; Trottier H, 2006, VACCINE, V24, P4, DOI 10.1016/j.vaccine.2005.09.054; Trottier H, 2006, CANCER EPIDEM BIOMAR, V15, P1274, DOI 10.1158/1055-9965.EPI-06-0129; Villa LL, 2000, J GEN VIROL, V81, P2959, DOI 10.1099/0022-1317-81-12-2959; Wheeler CM, 2012, LANCET ONCOL, V13, P100, DOI 10.1016/S1470-2045(11)70287-X; XI LF, 1995, J INFECT DIS, V172, P747, DOI 10.1093/infdis/172.3.747; Xi LF, 2006, J NATL CANCER I, V98, P1045, DOI 10.1093/jnci/djj297; Yamada T, 1997, J VIROL, V71, P2463, DOI 10.1128/JVI.71.3.2463-2472.1997; Zehbe I, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-77; Zuna RE, 2011, INFECT AGENTS CANCER, V6, DOI 10.1186/1750-9378-6-19; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798; zur Hausen H, 2009, VIROLOGY, V384, P260, DOI 10.1016/j.virol.2008.11.046	67	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132570	10.1371/journal.pone.0132570	http://dx.doi.org/10.1371/journal.pone.0132570			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176537	Green Published, gold, Green Submitted			2022-12-26	WOS:000358197600126
J	Eisermann, K; Dar, JA; Dong, J; Wang, D; Masoodi, KZ; Wang, Z				Eisermann, Kurtis; Dar, Javid A.; Dong, Jun; Wang, Dan; Masoodi, Khalid Z.; Wang, Zhou			Poly (A) Binding Protein Cytoplasmic 1 Is a Novel Co-Regulator of the Androgen Receptor	PLOS ONE			English	Article							ADVANCED PROSTATE-CANCER; N-TERMINAL DOMAIN; GENE-EXPRESSION; POLY(A)-BINDING PROTEIN-1; INCREASED SURVIVAL; PAXILLIN; BICALUTAMIDE; ACTIVATION; VARIANTS; GENOMICS	The androgen receptor (AR) is a member of the steroid receptor superfamily that regulates gene expression in a ligand-dependent manner. The NTD of the AR plays a key role in AR transactivation including androgen-independent activation of the AR in castration-resistant prostate cancer (CRPC) cells. We recently reported that amino acids (a. a.) 50-250 of the NTD are capable of modulating AR nucleocytoplasmic trafficking. To further explore the mechanism associated with a. a. 50-250, GFP pull-down assays were performed in C4-2 CRPC cells transfected with GFP tagged a. a. 50-250 of the AR. Mass spectrometry analysis of the pulled down proteins identified poly (A) binding protein cytoplasmic 1 (PABPC1) interaction with this region of the AR. In silicoanalysis of gene expression data revealed PABPC1 up-regulation in prostate cancer tissue specimens and this up-regulation correlates to increased disease recurrence. Co-immunoprecipitation assays confirmed the association of PABPC1 with a. a. 50-250 of the NTD of the AR. Knockdown of PABPC1 decreased nuclear AR protein levels and inhibited androgen activation of the AR target PSA in LNCaP and C4-2 cells. Additionally, knockdown of PABPC1 inhibited transactivation of the PSA promoter by NAR (AR lacking the LBD) and attenuated proliferation of AR-positive prostate cancer cells. These findings suggest that PABPC1 is a novel co-regulator of the AR and may be a potential target for blocking activation of the AR in CRPC.	[Eisermann, Kurtis; Dar, Javid A.; Dong, Jun; Wang, Dan; Masoodi, Khalid Z.; Wang, Zhou] Univ Pittsburgh, Sch Med, Dept Urol, Pittsburgh, PA 15260 USA; [Wang, Zhou] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA USA; [Wang, Zhou] Univ Pittsburgh, Sch Med, Inst Canc, Pittsburgh, PA USA; [Dar, Javid A.] King Saud Univ, Coll Sci, Cent Lab, Riyadh 11451, Saudi Arabia; [Masoodi, Khalid Z.] Sher e Kashmir Univ Agr Sci & Technol, Div Biotechnol, Srinagar, Jammu & Kashmir, India	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; King Saud University; Sher-e-Kashmir University of Agricultural Sciences & Technology of Kashmir (SKUAST Kashmir)	Wang, Z (corresponding author), Univ Pittsburgh, Sch Med, Dept Urol, Pittsburgh, PA 15260 USA.	wangz2@upmc.edu	Masoodi, KhalidZ./ABG-5492-2021; Masoodi, Khalid Z/F-1787-2015; Dar, Javid/D-6276-2015	Masoodi, KhalidZ./0000-0002-4889-5558; Masoodi, Khalid Z/0000-0002-4889-5558; Dar, Javid/0000-0002-4102-6202	National Institutes of Health [R01 CA186780, R01 DK088793, T32 DK007774, P30 CA047904]; NATIONAL CANCER INSTITUTE [R01CA186780, P30CA047904] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088793, T32DK007774] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded in part by National Institutes of Health grants R01 CA186780, R01 DK088793, T32 DK007774, and P30 CA047904 (ZW). KE is a postdoctoral scholar supported by T32 DK007774. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonina E, 1998, J BIOL CHEM, V273, P13015, DOI 10.1074/jbc.273.21.13015; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chan SC, 2012, J BIOL CHEM, V287, P19736, DOI 10.1074/jbc.M112.352930; Claessens Frank, 2008, Nucl Recept Signal, V6, pe008, DOI 10.1621/nrs.06008; Cleutjens KBJM, 1997, MOL ENDOCRINOL, V11, P148, DOI 10.1210/me.11.2.148; Dar JA, 2014, J STEROID BIOCHEM, V139, P16, DOI 10.1016/j.jsbmb.2013.09.013; De Bono JS, 2011, NEW ENGL J MED, V364, P1995, DOI 10.1056/NEJMoa1014618; Dehm SM, 2011, ENDOCR-RELAT CANCER, V18, pR183, DOI 10.1530/ERC-11-0141; Eisermann K, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-7; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; JENSTER G, 1995, J BIOL CHEM, V270, P7341, DOI 10.1074/jbc.270.13.7341; Klotz Laurence, 2005, Clin Prostate Cancer, V3, P215, DOI 10.3816/CGC.2005.n.002; LABRIE F, 1993, CLIN INVEST MED, V16, P499; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo JH, 2002, MOL CARCINOGEN, V33, P25, DOI 10.1002/mc.10018; Mangus DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-223; McEwan Iain J, 2007, Nucl Recept Signal, V5, pe001; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Schellhammer Paul F, 2002, Expert Opin Pharmacother, V3, P1313, DOI 10.1517/14656566.3.9.1313; Scher HI, 1997, J CLIN ONCOL, V15, P2928, DOI 10.1200/JCO.1997.15.8.2928; Scher HI, 2012, NEW ENGL J MED, V367, P1187, DOI 10.1056/NEJMoa1207506; See WA, 2002, J UROLOGY, V168, P429, DOI 10.1016/S0022-5347(05)64652-6; Sen A, 2012, J CLIN INVEST, V122, P2469, DOI 10.1172/JCI62044; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Singh D, 2002, CANCER CELL, V1, P203, DOI 10.1016/S1535-6108(02)00030-2; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Thomas MA, 2010, BIOCHEM J, V425, P575, DOI 10.1042/BJ20091109; Ueda T, 2002, J BIOL CHEM, V277, P7076, DOI 10.1074/jbc.M108255200; Vanaja DK, 2003, CANCER RES, V63, P3877; Woods AJ, 2002, J BIOL CHEM, V277, P6428, DOI 10.1074/jbc.M109446200; Woods AJ, 2005, MOL CELL BIOL, V25, P3763, DOI 10.1128/MCB.25.9.3763-3773.2005; Yu YP, 2004, J CLIN ONCOL, V22, P2790, DOI 10.1200/JCO.2004.05.158	33	11	11	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0128495	10.1371/journal.pone.0128495	http://dx.doi.org/10.1371/journal.pone.0128495			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176602	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000358197600007
J	Gu, RP; Fu, LL; Jiang, CH; Xu, YF; Wang, X; Yu, J				Gu, R. P.; Fu, L. L.; Jiang, C. H.; Xu, Y. F.; Wang, X.; Yu, J.			Retina Is Protected by Neuroserpin from Ischemic/Reperfusion-Induced Injury Independent of Tissue-Type Plasminogen Activator	PLOS ONE			English	Article							RECEPTOR-RELATED PROTEIN; ISCHEMIA-REPERFUSION INJURY; BLOOD-BRAIN-BARRIER; NERVOUS-SYSTEM; RAT RETINA; INHIBITOR NEUROSERPIN; CELL-DEATH; STROKE; TPA; MODEL	The purpose of the present study was to investigate the potential neuroprotective effect of neuroserpin (NSP) on acute retinal ischemic/reperfusion-induced (IR) injury. An IR injury model was established by elevating intraocular pressure (IOP) for 60 minutes in wild type and tPA-deficient (tPA-/-) mice. Prior to IR injury, 1 mu L of 20 mu mol/L NSP or an equal volume of bovine serum albumin (BSA) was intravitreally administered. Retinal function was evaluated by electroretinograph (ERG) and the number of apoptotic neurons was determined via TUNEL labeling. Caspase-3, -8, -9, poly (ADP-ribose) polymerase (PARP) and their cleaved forms were subsequently analyzed. It was found that IR injury significantly damaged retinal function, inducing apoptosis in the retina, while NSP attenuated the loss of retinal function and significantly reduced the number of apoptotic neurons in both wild type and tPA-/-mice. The levels of cleaved caspase-3, cleaved PARP (the substrate of caspase-3) and caspase-9 (the modulator of the caspase-3), which had increased following IR injury, were significantly inhibited by NSP in both wild type and tPA(-/-)mice. NSP increased ischemic tolerance in the retina at least partially by inhibiting the intrinsic cell death signaling pathway of caspase-3. It was therefore concluded that the protective effect of neuroserpin maybe independent from its canonical interaction with a tissue-type plasminogen activator.	[Gu, R. P.; Jiang, C. H.; Xu, Y. F.; Wang, X.; Yu, J.] Fudan Univ, Shanghai Med Coll, Eye & ENT Hosp, Dept Ophthalmol & Vis Sci,State Hlth Minist, Shanghai 200031, Peoples R China; [Gu, R. P.; Jiang, C. H.; Xu, Y. F.; Wang, X.; Yu, J.] Fudan Univ, Shanghai Med Coll, Eye & ENT Hosp, Key Lab Myopia,State Hlth Minist, Shanghai 200031, Peoples R China; [Fu, L. L.] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Ophthalmol, Wuhan 430074, Peoples R China; [Jiang, C. H.] 5 Peoples Hosp Shanghai, Dept Ophthalmol, Shanghai 200240, Peoples R China	Fudan University; Fudan University; Huazhong University of Science & Technology	Jiang, CH (corresponding author), Fudan Univ, Shanghai Med Coll, Eye & ENT Hosp, Dept Ophthalmol & Vis Sci,State Hlth Minist, Shanghai 200031, Peoples R China.	chhjiang70@163.com			Science and Technology Ministry of China [2012YQ12008003]; National Major Scientific Equipment program [2012YQ120080]; Shanghai Key Laboratory of Visual Impairment and Restoration; Shanghai Science and Technology Committee program [13430710500]	Science and Technology Ministry of China(Ministry of Science and Technology, China); National Major Scientific Equipment program; Shanghai Key Laboratory of Visual Impairment and Restoration; Shanghai Science and Technology Committee program	The present study was supported by a project of the Science and Technology Ministry of China (2012YQ12008003), the National Major Scientific Equipment program (2012YQ120080), Shanghai Key Laboratory of Visual Impairment and Restoration, and Shanghai Science and Technology Committee program (13430710500). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barber AJ, 2001, J BIOL CHEM, V276, P32814, DOI 10.1074/jbc.M104738200; Benchenane K, 2007, J CELL SCI, V120, P578, DOI 10.1242/jcs.03354; BU GJ, 1993, J BIOL CHEM, V268, P13002; Chen FT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064262; Chen SN, 2003, OPHTHALMOLOGY, V110, P704, DOI 10.1016/S0161-6420(02)01979-6; Cinelli P, 2001, MOL CELL NEUROSCI, V18, P443, DOI 10.1006/mcne.2001.1028; D'Onofrio PM, 2013, ACTA PHARMACOL SIN, V34, P91, DOI 10.1038/aps.2012.165; DENT MAR, 1993, EUR J NEUROSCI, V5, P633, DOI 10.1111/j.1460-9568.1993.tb00529.x; Gelderblom M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063118; Gonzalez RG, 2013, STROKE, V44, P3109, DOI 10.1161/STROKEAHA.113.001938; Hanninen VA, 2002, CURR EYE RES, V25, P389; Hastings GA, 1997, J BIOL CHEM, V272, P33062, DOI 10.1074/jbc.272.52.33062; Hattenbach LO, 1999, RETINA-J RET VIT DIS, V19, P383, DOI 10.1097/00006982-199909000-00003; Hill RM, 2001, PROTEIN EXPRES PURIF, V22, P406, DOI 10.1006/prep.2001.1463; Hsiao Y, 2008, J GASTROEN HEPATOL, V23, pE258, DOI 10.1111/j.1440-1746.2007.05100.x; Huang P, 2013, EXP EYE RES, V115, P131, DOI 10.1016/j.exer.2013.06.015; HUGHES WF, 1991, EXP EYE RES, V53, P573, DOI 10.1016/0014-4835(91)90215-Z; Husain S, 2011, INVEST OPHTH VIS SCI, V52, P2577, DOI 10.1167/iovs.10-5629; JOHNSON RN, 1989, ARCH OPHTHALMOL-CHIC, V107, P891, DOI 10.1001/archopht.1989.01070010913040; Kermer P, 2000, MOL BRAIN RES, V85, P144, DOI 10.1016/S0169-328X(00)00256-4; Kim YR, 2013, INT J MOL MED, V32, P1303, DOI 10.3892/ijmm.2013.1511; Krueger SR, 1997, J NEUROSCI, V17, P8984; Lee TW, 2008, J NEUROSCI RES, V86, P1243, DOI 10.1002/jnr.21592; London A, 2013, NAT REV NEUROL, V9, P44, DOI 10.1038/nrneurol.2012.227; Ma J, 2012, BIOL RES, V45, P357, DOI 10.4067/S0716-97602012000400005; Makarova A, 2003, J BIOL CHEM, V278, P50250, DOI 10.1074/jbc.M309150200; Millard WB, 2013, ANN EMERG MED, V62, p13A, DOI 10.1016/j.annemergmed.2013.05.010; Mitka M, 2013, JAMA-J AM MED ASSOC, V310, P1111, DOI 10.1001/jama.2013.278292; Mohr S, 2002, DIABETES, V51, P1172, DOI 10.2337/diabetes.51.4.1172; NYKJAER A, 1992, J BIOL CHEM, V267, P14543; Osterwalder T, 1996, EMBO J, V15, P2944, DOI 10.1002/j.1460-2075.1996.tb00657.x; Parathath SR, 2006, J CELL SCI, V119, P339, DOI 10.1242/jcs.02734; Rodriguez-Gonzalez R, 2011, THROMB HAEMOSTASIS, V105, P421, DOI 10.1160/TH10-09-0621; Rodriguez-Gonzalez R, 2011, NEUROCHEM INT, V58, P337, DOI 10.1016/j.neuint.2010.12.006; Shima C, 2012, OPHTHALMIC RES, V48, P199, DOI 10.1159/000340059; Shu Q, 2014, J MOL NEUROSCI; SUMI Y, 1992, DEVELOPMENT, V116, P625; Sun D, 2007, J COMP NEUROL, V505, P114, DOI 10.1002/cne.21481; Tian Y, 2014, INT J MOL SCI, V15, P3172, DOI 10.3390/ijms15023172; Vote BJ, 2004, RETINA-J RET VIT DIS, V24, P808, DOI 10.1097/00006982-200410000-00024; White BC, 2000, J NEUROL SCI, V179, P1, DOI 10.1016/S0022-510X(00)00386-5; Wu B, 2004, AM J PHYSIOL-GASTR L, V286, pG580, DOI 10.1152/ajpgi.00335.2003; Wu JL, 2010, AM J PATHOL, V177, P2576, DOI 10.2353/ajpath.2010.100466; Yamamoto T, 2008, GRAEF ARCH CLIN EXP, V246, P509, DOI 10.1007/s00417-007-0670-x; Yang Y, 2011, INT J OPHTHALMOL-CHI, V4, P259, DOI 10.3980/j.issn.2222-3959.2011.03.09; Yepes M, 2004, EXP BIOL MED, V229, P1097, DOI 10.1177/153537020422901103; Yepes M, 2004, TRENDS CARDIOVAS MED, V14, P173, DOI 10.1016/j.tcm.2004.03.004; Yepes M, 2003, J CLIN INVEST, V112, P1533, DOI 10.1172/JCI200319212; Yepes M, 2002, J CLIN INVEST, V109, P1571, DOI 10.1172/JCI200214308; Yepes M, 2000, BLOOD, V96, P569; Zhang ZG, 2002, CIRCULATION, V106, P740, DOI 10.1161/01.CIR.0000023942.10849.41	51	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0130440	10.1371/journal.pone.0130440	http://dx.doi.org/10.1371/journal.pone.0130440			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176694	Green Submitted, gold, Green Published			2022-12-26	WOS:000358197600023
J	Oh, YJ; An, JN; Kim, CT; Yang, SH; Lee, H; Kim, DK; Joo, KW; Paik, JH; Kang, SW; Park, JT; Lim, CS; Kim, YS; Lee, JP				Oh, Yun Jung; An, Jung Nam; Kim, Clara Tammy; Yang, Seung Hee; Lee, Hajeong; Kim, Dong Ki; Joo, Kwon Wook; Paik, Jin Ho; Kang, Shin-Wook; Park, Jung Tak; Lim, Chun Soo; Kim, Yon Su; Lee, Jung Pyo			Circulating Tumor Necrosis Factor a Receptors Predict the Outcomes of Human IgA Nephropathy: A Prospective Cohort Study	PLOS ONE			English	Article							EXPERIMENTAL CRESCENTIC GLOMERULONEPHRITIS; CHRONIC-RENAL-FAILURE; TNF-ALPHA; KIDNEY-FUNCTION; GLOMERULAR-DISEASES; EPITHELIAL-CELLS; INFLAMMATION; PROGRESSION; DYSFUNCTION; EXPRESSION	The circulating tumor necrosis factor receptors (TNFRs) could predict the long-term renal outcome in diabetes, but the role of circulating TNFRs in other chronic kidney disease has not been reported. Here, we investigated the correlation between circulating TNFRs and renal histologic findings on kidney biopsy in IgA nephropathy (IgAN) and assessed the notion that the circulating TNFRs could predict the clinical outcome. 347 consecutive biopsy-proven IgAN patients between 2006 and 2012 were prospectively enrolled. Concentrations of circulating TNFRs were measured using serum samples stored at the time of biopsy. The primary clinical endpoint was the decline of estimated glomerular filtration rate (eGFR; >= 30% decline compared to baseline). Mean eGFR decreased and proteinuria worsened proportionally as circulating TNFR1 and TNFR2 increased (P < 0.001). Tubuloin-terstitial lesions such as interstitial fibrosis and tubular atrophy were significantly more severe as concentrations of circulating TNFRs increased, regardless of eGFR levels. The risks of reaching the primary endpoint were significantly higher in the highest quartile of TNFRs compared with other quartiles by the Cox proportional hazards model (TNFR1; hazard ratio 7.48, P < 0.001, TNFR2; hazard ratio 2.51, P = 0.021). In stratified analysis according to initial renal function classified by the eGFR levels of 60 mL/min/1.73 m(2), TNFR1 and TNFR2 were significant predictors of renal progression in both subgroups. In conclusion, circulating TNFRs reflect the histology and clinical severity of IgAN. Moreover, elevated concentrations of circulating TNFRs at baseline are early biomarkers for subsequent renal progression in IgAN patients.	[Oh, Yun Jung] Cheju Halla Gen Hosp, Dept Internal Med, Jeju, South Korea; [An, Jung Nam; Lim, Chun Soo; Lee, Jung Pyo] Seoul Natl Univ, Dept Internal Med, Boramae Med Ctr, Seoul, South Korea; [An, Jung Nam; Lee, Hajeong; Kim, Dong Ki; Joo, Kwon Wook; Lim, Chun Soo; Kim, Yon Su; Lee, Jung Pyo] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea; [Kim, Clara Tammy] Seoul Natl Univ, Grad Sch Publ Hlth, Seoul, South Korea; [Yang, Seung Hee] Seoul Natl Univ, Kidney Res Inst, Seoul, South Korea; [Paik, Jin Ho] Seoul Natl Univ, Coll Med, Dept Pathol, Seoul 151, South Korea; [Kang, Shin-Wook; Park, Jung Tak] Yonsei Univ, Coll Med, Dept Internal Med, Severance Biomed Sci Inst, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Yonsei University; Yonsei University Health System	Lee, JP (corresponding author), Seoul Natl Univ, Dept Internal Med, Boramae Med Ctr, Seoul, South Korea.	nephrolee@gmail.com	Kim, Dong Ki/J-5389-2012	Kim, Dong Ki/0000-0002-5195-7852; Kim, Clara Tammy/0000-0001-7381-7044; Park, Jung Tak/0000-0002-2325-8982	Korea Healthcare Technology R&D Project, Ministry for Health, Welfare and Family Affairs, Republic of Korea [A070001]	Korea Healthcare Technology R&D Project, Ministry for Health, Welfare and Family Affairs, Republic of Korea	This study was funded by the Korea Healthcare Technology R&D Project, Ministry for Health, Welfare and Family Affairs, Republic of Korea (A070001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Lamki RS, 2005, FASEB J, V19, P1637, DOI 10.1096/fj.05-3841com; Al-Lamki RS, 2001, LAB INVEST, V81, P1503, DOI 10.1038/labinvest.3780364; ALAMARTINE E, 1991, AM J KIDNEY DIS, V18, P12, DOI 10.1016/S0272-6386(12)80284-8; Bartosik LP, 2001, AM J KIDNEY DIS, V38, P728, DOI 10.1053/ajkd.2001.27689; BERTANI T, 1989, AM J PATHOL, V134, P419; Berthoux F, 2011, J AM SOC NEPHROL, V22, P752, DOI 10.1681/ASN.2010040355; BEUKHOF JR, 1986, KIDNEY INT, V29, P549, DOI 10.1038/ki.1986.33; Bolton CH, 2001, NEPHROL DIAL TRANSPL, V16, P1189, DOI 10.1093/ndt/16.6.1189; Carlsson AC, 2014, J AM SOC NEPHROL, V25, P1313, DOI 10.1681/ASN.2013080860; Chan LYY, 2005, KIDNEY INT, V67, P602, DOI 10.1111/j.1523-1755.2005.67116.x; Chang JH, 2009, NEPHROL DIAL TRANSPL, V24, P2406, DOI 10.1093/ndt/gfp091; DAMICO G, 1995, AM J KIDNEY DIS, V26, P124, DOI 10.1016/0272-6386(95)90165-5; Donadio JV, 2002, NEW ENGL J MED, V347, P738, DOI 10.1056/NEJMra020109; Ernandez T, 2009, KIDNEY INT, V76, P262, DOI 10.1038/ki.2009.142; Feldmann M, 2006, J AM SOC NEPHROL, V17, P1243, DOI 10.1681/ASN.2005121359; Frimat L, 1997, NEPHROL DIAL TRANSPL, V12, P2569; Gohda T, 2012, J AM SOC NEPHROL, V23, P516, DOI 10.1681/ASN.2011060628; Grell M, 1998, EUR J IMMUNOL, V28, P257, DOI 10.1002/(SICI)1521-4141(199801)28:01<257::AID-IMMU257>3.0.CO;2-G; Guo GJ, 1999, AM J PHYSIOL-RENAL, V277, pF766, DOI 10.1152/ajprenal.1999.277.5.F766; Hasegawa M, 2009, NEPHRON CLIN PRACT, V113, pC222, DOI 10.1159/000235242; Idasiak-Piechocka I, 2010, NEPHROL DIAL TRANSPL, V25, P3948, DOI 10.1093/ndt/gfq310; ISHA N, 1989, J IMMUNOL, V142, P3083; Julian B A, 1999, Adv Nephrol Necker Hosp, V29, P53; Karkar AM, 2001, NEPHROL DIAL TRANSPL, V16, P518, DOI 10.1093/ndt/16.3.518; Keller C, 2008, BMC NEPHROL, V9, DOI 10.1186/1471-2369-9-9; Khan SB, 2005, KIDNEY INT, V67, P1812, DOI 10.1111/j.1523-1755.2005.00279.x; Knight EL, 2004, J AM SOC NEPHROL, V15, P1897, DOI 10.1097/01.asn.0000128966.55133.69; Kollias G, 2002, CYTOKINE GROWTH F R, V13, P315, DOI 10.1016/S1359-6101(02)00019-9; Krolewski AS, 2014, DIABETES CARE, V37, P226, DOI 10.2337/dc13-0985; Lai KN, 2008, AM J PHYSIOL-RENAL, V294, pF945, DOI 10.1152/ajprenal.00423.2007; Lee H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051225; Lee HS, 2005, NEPHROL DIAL TRANSPL, V20, P342, DOI 10.1093/ndt/gfh633; Lee JP, 2011, AM J PHYSIOL-RENAL, V300, pF1283, DOI 10.1152/ajprenal.00733.2010; Lee SM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104354; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Lopes-Virella MF, 2013, DIABETES CARE, V36, P2317, DOI 10.2337/dc12-2521; Miyazawa I, 2011, DIABETES RES CLIN PR, V92, P174, DOI 10.1016/j.diabres.2011.01.008; NEALE TJ, 1995, AM J PATHOL, V146, P1444; NICHOLLS KM, 1984, Q J MED, V53, P227; Niewczas MA, 2012, J AM SOC NEPHROL, V23, P507, DOI 10.1681/ASN.2011060627; Niewczas MA, 2009, CLIN J AM SOC NEPHRO, V4, P62, DOI 10.2215/CJN.03010608; PEREIRA BJG, 1994, KIDNEY INT, V45, P890, DOI 10.1038/ki.1994.117; Pfeffer K, 2003, CYTOKINE GROWTH F R, V14, P185, DOI 10.1016/S1359-6101(03)00022-4; Radford MG, 1997, J AM SOC NEPHROL, V8, P199; Richter C, 2012, MOL CELL BIOL, V32, P2515, DOI 10.1128/MCB.06458-11; Sonoda Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122212; Speeckaert MM, 2012, AM J NEPHROL, V36, P261, DOI 10.1159/000342333; Upadhyay A, 2011, NEPHROL DIAL TRANSPL, V26, P920, DOI 10.1093/ndt/gfq471; Vielhauer V, 2005, J CLIN INVEST, V115, P1199, DOI 10.1172/JCI200523348; Wu TF, 2007, J IMMUNOL, V179, P7166, DOI 10.4049/jimmunol.179.10.7166; Wu TF, 2007, ARTHRITIS RHEUM-US, V56, P949, DOI 10.1002/art.22556; Xie JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038904; Zhu L, 2009, LUPUS, V18, P116, DOI 10.1177/0961203308094764	53	19	20	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132826	10.1371/journal.pone.0132826	http://dx.doi.org/10.1371/journal.pone.0132826			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177311	Green Published, gold, Green Submitted			2022-12-26	WOS:000358197600165
J	Pan, LY; Weng, HB; Li, H; Liu, ZZ; Xu, YY; Zhou, CJ; Lu, XX; Su, XY; Zhang, YY; Chen, DF				Pan, Lingyu; Weng, Hongbo; Li, Hong; Liu, Zhenzhen; Xu, Yanyan; Zhou, Chunjiao; Lu, Xiaoxiao; Su, Xiaoyu; Zhang, Yunyi; Chen, Daofeng			Therapeutic Effects of Bupleurum Polysaccharides in Streptozotocin Induced Diabetic Mice	PLOS ONE			English	Article							TRADITIONAL CHINESE MEDICINE; OXIDATIVE STRESS; CATATHELASMA-VENTRICOSUM; HYPERGLYCEMIA; INFLAMMATION; SELENIUM; INSULIN; ROOTS	Diabetes mellitus is related to low-grade chronic inflammation and oxidative stress. Bupleurum Polysaccharides (BPs), isolated from Bupleurum smithii var. parvifolium has anti-inflammatory and anti-oxidative properties. However, little is known about its therapeutic effects on diabetes. In this experiment, the effects of BPs on alleviation of diabetes and the underlying mechanisms were investigated. Diabetic mice model was established via successive intraperitoneal injections of streptozotocin (100 mg/kg body weight) for two days. Mice with blood glucose levels higher than 16.8mmol/L were selected for experiments. The diabetic mice were orally administered with BPs (30 and 60 mg/kg) once a day for 35 days. BPs not only significantly decreased levels of blood glucose, but also increased those of serum insulin and liver glycogen in diabetic mice compared to model mice. Additionally, BPs adminstration improved the insulin expression and suppressed the apoptosis in pancreas of the diabetic mice. Histopathological observations further demonstrated that BPs protected the pancreas and liver from oxidative and inflammatory damages. These results suggest that BPs protect pancreatic beta cells and liver hepatocytes and ameliorate diabetes, which is associated with its anti-oxidative and anti-inflammatory properties.	[Pan, Lingyu; Weng, Hongbo; Li, Hong; Liu, Zhenzhen; Xu, Yanyan; Zhou, Chunjiao; Lu, Xiaoxiao; Su, Xiaoyu; Zhang, Yunyi] Fudan Univ, Sch Pharm, Dept Pharmacol, Shanghai 200433, Peoples R China; [Chen, Daofeng] Fudan Univ, Sch Pharm, Dept Pharmacognosy, Shanghai 200433, Peoples R China	Fudan University; Fudan University	Li, H (corresponding author), Fudan Univ, Sch Pharm, Dept Pharmacol, Shanghai 200433, Peoples R China.	lxzhang@shmu.edu.cn; dfchen@shmu.edu.cn	hong, li/T-6392-2019		National Natural Science Foundation of China [30925042, 81330089, 81274165]; State Key Program for New Drugs from the Ministry of Science and Technology, China [2012ZX09301001-003]; Science and Technology Commission of Shanghai Municipality [10XD1405900, 12JC1400800]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Program for New Drugs from the Ministry of Science and Technology, China; Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This work was supported by the National Natural Science Foundation of China (Grant No. 30925042, 81330089, 81274165), the State Key Program for New Drugs from the Ministry of Science and Technology, China (Grant No. 2012ZX09301001-003), and the Science and Technology Commission of Shanghai Municipality (Grant No. 10XD1405900, 12JC1400800). The authors are fully responsible for the content of this report. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronoff S.L, 2004, DIABETES SPECTR, V17, P183, DOI [DOI 10.2337/DIASPECT.17.3.183, 10.2337/diaspect.17.3.183]; Baynes JW, 1999, DIABETES, V48, P1, DOI 10.2337/diabetes.48.1.1; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHEN V, 1982, CAN J PHYSIOL PHARM, V60, P1251, DOI 10.1139/y82-183; Cheng XQ, 2010, J ETHNOPHARMACOL, V130, P363, DOI 10.1016/j.jep.2010.05.019; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Ehses JA, 2009, P NATL ACAD SCI USA, V106, P13998, DOI 10.1073/pnas.0810087106; Formigare A, 2007, COMP BIOCHEM PHYS C, V146, P443, DOI 10.1016/j.cbpc.2007.07.010; Garcia-Ruiz I, 2006, HEPATOLOGY, V44, P581, DOI 10.1002/hep.21313; Goodman L, 1941, ANESTHESIOLOGY, V2, P341; He K, 2011, J ETHNOPHARMACOL, V137, P1135, DOI 10.1016/j.jep.2011.07.033; Hu FD, 2010, CAN J PHYSIOL PHARM, V88, P64, DOI 10.1139/Y09-098; Jia W, 2003, PHYTOTHER RES, V17, P1127, DOI 10.1002/ptr.1398; Jiang YW, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/842928; Kajimoto Y, 2004, ANN NY ACAD SCI, V1011, P168, DOI 10.1196/annals.1293.017; KATZ J, 1979, BIOCHEM J, V180, P389, DOI 10.1042/bj1800389; Kawahito S, 2009, WORLD J GASTROENTERO, V15, P4137, DOI 10.3748/wjg.15.4137; Kowluru RA, 2007, EXP DIABETES RES, DOI 10.1155/2007/43603; Leckstrom A, 1996, PANCREAS, V13, P259, DOI 10.1097/00006676-199610000-00008; Li WL, 2004, J ETHNOPHARMACOL, V92, P1, DOI 10.1016/j.jep.2003.12.031; Li YG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065892; Lin B, 2010, CHINESE JOURNEY CLIN, P6; Liu M, 2010, J ETHNOPHARMACOL, V127, P32, DOI 10.1016/j.jep.2009.09.055; Liu YT, 2013, FOOD CHEM TOXICOL, V62, P285, DOI 10.1016/j.fct.2013.08.082; Liu YT, 2013, FOOD CHEM TOXICOL, V57, P39, DOI 10.1016/j.fct.2013.03.001; Lontchi-Yimagou E, 2013, CURR DIABETES REP, V13, P435, DOI 10.1007/s11892-013-0375-y; Ma SW, 2008, DIABETES OBES METAB, V10, P1125, DOI 10.1111/j.1463-1326.2008.00858.x; Okada S, 2003, DIABETES, V52, P2586, DOI 10.2337/diabetes.52.10.2586; Pitocco D, 2013, INT J MOL SCI, V14, P21525, DOI 10.3390/ijms141121525; PRESTON AM, 1985, NUTR RES, V5, P435, DOI 10.1016/S0271-5317(85)80228-1; Rotondo F, IMMUNOHISTOCHEMICAL, P303; Ryu M, 2008, J ETHNOPHARMACOL, V115, P184, DOI 10.1016/j.jep.2007.09.027; Serrano-Martin X, 2006, ANTIMICROB AGENTS CH, V50, P4214, DOI 10.1128/AAC.00617-06; Wang Z, 2009, J ETHNOPHARMACOL, V124, P481, DOI 10.1016/j.jep.2009.05.013; Wu J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078051; Xie W, 2011, DIABETES OBES METAB, V13, P289, DOI 10.1111/j.1463-1326.2010.01336.x; Xu H, 2007, INT IMMUNOPHARMACOL, V7, P175, DOI 10.1016/j.intimp.2006.09.006; Yang SJ, 2014, EUR J PHARMACOL, V736, P26, DOI 10.1016/j.ejphar.2014.04.031; Zeng JH, 2009, J NUTR BIOCHEM, V20, P530, DOI 10.1016/j.jnutbio.2008.05.012; Zhang TT, 2012, EXPERT OPIN INV DRUG, V21, P1625, DOI 10.1517/13543784.2012.713937; Zhang T, 2014, INT J BIOL MACROMOL, V65, P436, DOI 10.1016/j.ijbiomac.2014.01.063; Zhang ZG, 2008, MOL ENDOCRINOL, V22, P186, DOI 10.1210/me.2007-0119; Zhao LY, 2011, PHYTOMEDICINE, V18, P661, DOI 10.1016/j.phymed.2011.01.001; Zhen Z, 2011, AM J CHINESE MED, V39, P53, DOI 10.1142/S0192415X11008646	44	10	10	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0133212	10.1371/journal.pone.0133212	http://dx.doi.org/10.1371/journal.pone.0133212			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176625	Green Published, Green Submitted, gold			2022-12-26	WOS:000358197600232
J	Vickers, TW; Sanchez, JN; Johnson, CK; Morrison, SA; Botta, R; Smith, T; Cohen, BS; Huber, PR; Ernest, HB; Boyce, WM				Vickers, T. Winston; Sanchez, Jessica N.; Johnson, Christine K.; Morrison, Scott A.; Botta, Randy; Smith, Trish; Cohen, Brian S.; Huber, Patrick R.; Ernest, Holly B.; Boyce, Walter M.			Survival and Mortality of Pumas (Puma concolor) in a Fragmented, Urbanizing Landscape	PLOS ONE			English	Article							MOUNTAIN LION POPULATION; GENETIC RESTORATION; CONSERVATION; COUGARS; CONNECTIVITY; CARNIVORES; DYNAMICS; GROWTH; MODEL	Wide-ranging large carnivores pose myriad challenges for conservation, especially in highly fragmented landscapes. Over a 13-year period, we combined monitoring of radio collared pumas (Puma concolor) with complementary multi-generational genetic analyses to inform puma conservation in southern California, USA. Our goals were to generate survivorship estimates, determine causes of mortality, identify barriers to movement, and determine the genetic and demographic challenges to puma persistence among >20,000,000 people and extensive urban, suburban, and exurban development. Despite protection from hunting, annual survival for radio collared pumas was surprisingly low (55.8%), and humans caused the majority of puma deaths. The most common sources of mortality were vehicle collisions (28% of deaths), and mortalities resulting from depredation permits issued after pumas killed domestic animals (17% of deaths). Other human-caused mortalities included illegal shootings, public safety removals, and human-caused wildfire. An interstate highway (I-15) bisecting this study area, and associated development, have created a nearly impermeable barrier to puma movements, resulting in severe genetic restriction and demographic isolation of the small puma population (n similar to 17-27 adults) in the Santa Ana Mountains west of I-15. Highways that bisect habitat or divide remaining "conserved" habitat, and associated ongoing development, threaten to further subdivide this already fragmented puma population and increase threats to survival. This study highlights the importance of combining demographic and genetic analyses, and illustrates that in the absence of effective measures to reduce mortality and enhance safe movement across highways, translocation of pumas, such as was done with the endangered Florida panther (P. c. coryi), may ultimately be necessary to prevent further genetic decline and ensure persistence of the Santa Ana Mountains population.	[Vickers, T. Winston; Sanchez, Jessica N.; Johnson, Christine K.; Ernest, Holly B.; Boyce, Walter M.] Univ Calif Davis, Sch Vet Med, Karen C Drayer Wildlife Hlth Ctr, Davis, CA 95616 USA; [Morrison, Scott A.; Smith, Trish; Cohen, Brian S.] Nature Conservancy, San Francisco, CA USA; [Botta, Randy] Calif Dept Fish & Wildlife, Valley Ctr, CA USA; [Huber, Patrick R.] Univ Calif Davis, Environm Informat Ctr, Davis, CA 95616 USA	University of California System; University of California Davis; Nature Conservancy; University of California System; University of California Davis	Vickers, TW (corresponding author), Univ Calif Davis, Sch Vet Med, Karen C Drayer Wildlife Hlth Ctr, Davis, CA 95616 USA.	twvickers@ucdavis.edu; wmboyce@ucdavis.edu	; Ernest, Holly/D-5731-2012	Sanchez, Jessica/0000-0002-7689-0324; Ernest, Holly/0000-0002-0205-8818	California State Department of Parks and Recreation; California Department of Fish and Wildlife; Nature Conservancy; McBeth Foundation; Anza Borrego Foundation; Nature Reserve of Orange County; National Science Foundation; Foothill/Eastern Transportation Corridor Agency; San Diego County Association of Governments Environmental Mitigation Program; San Diego Foundation; Felidae Conservation Fund; Mountain Lion Foundation; Santa Rosa Plateau Foundation; Institute for Wildlife Studies; private donors	California State Department of Parks and Recreation; California Department of Fish and Wildlife; Nature Conservancy; McBeth Foundation; Anza Borrego Foundation; Nature Reserve of Orange County; National Science Foundation(National Science Foundation (NSF)); Foothill/Eastern Transportation Corridor Agency; San Diego County Association of Governments Environmental Mitigation Program; San Diego Foundation; Felidae Conservation Fund; Mountain Lion Foundation; Santa Rosa Plateau Foundation; Institute for Wildlife Studies; private donors	The work was supported by the following: California State Department of Parks and Recreation (WMB; http://www.parks.ca.gov/), California Department of Fish and Wildlife (WMB; https://www.dfg.ca.gov/), The Nature Conservancy (WMB, TWV, SAM, HBE; http://www.nature.org/), The McBeth Foundation (WMB, TWV; http://mcbethfoundation.com/), The Anza Borrego Foundation (WMB; http://theabf.org/), The Nature Reserve of Orange County (TWV, HBE, WMB; http://www.naturereserveoc.org/), The National Science Foundation (WMB; http://www.nsf.gov/), The Foothill/Eastern Transportation Corridor Agency (TWV, WMB, PRH; https://www.thetollroads.com/), San Diego County Association of Governments Environmental Mitigation Program (TWV, WMB; http://www.sandag.org/index.asp?classid=17&projectid=263&fuseaction=projects.detail), The San Diego Foundation (TWV; http://www.sdfoundation.org/), Felidae Conservation Fund (WMB, TWV; http://www.felidaefund.org/), The Mountain Lion Foundation (TWV; Http://www.mountainlion.org/), the Santa Rosa Plateau Foundation (TWV; http://www.srpf.org/), the Institute for Wildlife Studies (TWV; http://www.iws.org), and private donors. The Nature Conservancy (SAM, TS) helped with study design, as well as sample collection, analysis, and preparation of the manuscript (SAM, TS, BSC). California Department of Fish and Wildlife (RB), helped with sample and data collection. Otherwise, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambient Communities, 2014, VILL W; ANDERSEN PK, 1982, ANN STAT, V10, P1100, DOI 10.1214/aos/1176345976; Arnold TW, 2010, J WILDLIFE MANAGE, V74, P1175, DOI 10.2193/2009-367; Ashman D, 1983, W4815 NEV FISH GAM D; Bauer JW, 2005, SOUTHWEST NAT, V50, P466, DOI 10.1894/0038-4909(2005)050[0466:SBIP]2.0.CO;2; Beier P, 2006, J WILDLIFE MANAGE, V70, P236, DOI 10.2193/0022-541X(2006)70[236:ESIATF]2.0.CO;2; BEIER P, 1995, J WILDLIFE MANAGE, V59, P228, DOI 10.2307/3808935; Beier P, 1993, COUGAR SANTA ANA MOU; Boucly C, 2013, ORANGE COUNTY REGIST; BRESLOW N, 1974, BIOMETRICS, V30, P89, DOI 10.2307/2529620; Burdett CL, 2010, ECOSPHERE, V1, DOI 10.1890/ES10-00005.1; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; California Department of Fish and Wildlife, 2014, NAT COMM CONS PLANN; California Department of Fish and Wildlife, 2014, MOUNT LION DEPR STAT; California Department of Fish and Wildlife, 2014, KEEP ME WILD; Clark Tim W., 2005, P211; Clevenger AP, 2006, ANAL WILDLIFE UNPUB; Conservation Biology Institute, 2004, CAL BIN CONS I UNPUB; Corlatti L, 2009, CONSERV BIOL, V23, P548, DOI 10.1111/j.1523-1739.2008.01162.x; Cougar Management Guidelines Working Group, 2005, COUG MAN GUID; Crooks K. R., 2006, CONNECTIVITY CONSERV; Crooks KR, 2002, CONSERV BIOL, V16, P488, DOI 10.1046/j.1523-1739.2002.00386.x; Dickson BG, 2005, J WILDLIFE MANAGE, V69, P264, DOI 10.2193/0022-541X(2005)069&lt;0264:IOVTAR&gt;2.0.CO;2; Ernest HB, 2003, CONSERV GENET, V4, P353, DOI 10.1023/A:1024069014911; Ernest HB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107985; Galetti M, 2013, BIOL CONSERV, V163, P1, DOI 10.1016/j.biocon.2013.04.020; Grinnell J., 1937, FUR BEARING MAMMALS; HEISEY DM, 1985, J WILDLIFE MANAGE, V49, P668, DOI 10.2307/3801692; Hostetler JA, 2013, J ANIM ECOL, V82, P608, DOI 10.1111/1365-2656.12033; Johnson CJ, 2004, J WILDLIFE MANAGE, V68, P966, DOI 10.2193/0022-541X(2004)068[0966:MSAOTA]2.0.CO;2; Johnson WE, 2010, SCIENCE, V329, P1641, DOI 10.1126/science.1192891; Kertson BN, 2013, J MAMMAL, V94, P269, DOI 10.1644/12-MAMM-A-051.1; Kunkel KE, 2013, ANIM CONSERV, V16, P32, DOI 10.1111/j.1469-1795.2012.00568.x; LaPoint S, 2013, LANDSCAPE ECOL, V28, P1615, DOI 10.1007/s10980-013-9910-0; Laundre JW, 2002, J WILDLIFE MANAGE, V66, P849, DOI 10.2307/3803149; Laundre JW, 2000, WILDLIFE SOC B, V28, P963; Logan K.A., 2001, DESERT PUMA EVOLUTIO; Logan KA, 1999, WILDLIFE SOC B, V27, P201; LOGAN KA, 1986, J WILDLIFE MANAGE, V50, P648, DOI 10.2307/3800975; Luke C, 2004, LINKAGE DESIGN UNPUB; McRae BH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052604; Miotto RA, 2012, BIOTROPICA, V44, P98, DOI 10.1111/j.1744-7429.2011.00772.x; Mondol S, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0496; Morrison SA, 2009, CONSERV BIOL, V23, P275, DOI 10.1111/j.1523-1739.2008.01079.x; Mountain Lion Foundation, 2014, DEF MOUNT DEPR CAL; Noss R, 2006, EVALUATION COAL CANY; Nowell K, 1996, STATUS SURVEY CONSER; Orange County Transportation Corridor Agency, 2013, FOOTH E TRANSP CORR; Ordenana MA, 2010, J MAMMAL, V91, P1322, DOI 10.1644/09-MAMM-A-312.1; Packer C, 2013, ECOL LETT, V16, P635, DOI 10.1111/ele.12091; Packer C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005941; Peters M, 2014, NOTICE PREPARATION D; Riley SPD, 2006, MOL ECOL, V15, P1733, DOI 10.1111/j.1365-294X.2006.02907.x; Riley SPD, 2014, CURR BIOL, V24, P1989, DOI 10.1016/j.cub.2014.07.029; Riley Seth P.D., 2010, P121; ROELKE ME, 1993, CURR BIOL, V3, P340, DOI 10.1016/0960-9822(93)90197-V; Schwab AC, 2011, APPL GEOGR, V31, P859, DOI 10.1016/j.apgeog.2010.10.015; Spencer WD, 2001, GLOBAL REGIONAL ECOL; Storer T. I, 1996, CALIFORNIA GRIZZLY; Teel TL, 2005, 58 CO COL STAT U HUM, P58; Theobald DM, 2005, ECOL SOC, V10; United States Department of Transportation, 2014, MOST TRAV URB HIGHW; US Census Bureau, 2010, 2010 CENS POP HOUS S; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Winterbach HEK, 2013, MAMMAL REV, V43, P89, DOI 10.1111/j.1365-2907.2011.00209.x; Wolfe ML, 2015, BIOL CONSERV, V182, P187, DOI 10.1016/j.biocon.2014.12.008	66	57	57	1	165	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0131490	10.1371/journal.pone.0131490	http://dx.doi.org/10.1371/journal.pone.0131490			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177290	Green Published, Green Submitted, gold			2022-12-26	WOS:000358197600045
J	Kovell, LC; Juraschek, SP; Russell, SD				Kovell, Lara C.; Juraschek, Stephen P.; Russell, Stuart D.			Stage A Heart Failure Is Not Adequately Recognized in US Adults: Analysis of the National Health and Nutrition Examination Surveys, 2007-2010	PLOS ONE			English	Article							SOCIOECONOMIC-STATUS; CARDIOVASCULAR EVENTS; MYOCARDIAL-INFARCTION; HIGH-RISK; DISEASE; HYPERTENSION; MORBIDITY; MORTALITY; CORONARY; UPDATE	Background Stage A heart failure (HF) is defined as people without HF symptoms or structural heart disease, but with predisposing conditions for HF. This classification is used to identify high risk patients to prevent progression to symptomatic HF. While guidelines exist for managing HF risk factors, achievement of treatment goals in the United States (US) population is unknown. Methods We examined all adults with Stage A HF (>= 20 years, N = 4,470) in the National Health and Nutrition Examination Surveys (NHANES) 2007-2010, a nationally representative sample. Stage A HF was defined by coronary heart disease (CHD), hypertension, diabetes mellitus, or chronic kidney disease. We evaluated whether nationally accepted guidelines for risk factor control were achieved in Stage A patients, including sodium intake, body mass index, hemoglobin A1c (HbA1c), cholesterol, and blood pressure (BP). Pharmacologic interventions and socioeconomic factors associated with guideline compliance were also assessed. Results Over 75 million people, or 1 in 3 US adults, have Stage A HF. The mean age of the Stage A population was 56.9 years and 51.5% were women. Seventy-two percent consume >= 2g sodium/day and 49.2% are obese. Of those with CHD, 58.6% were on a statin and 51.8% were on a beta-blocker. In people with diabetes, 43.6% had HbA1c >= 7%, with Mexican Americans more likely to have HbA1c >= 7%. Of those with hypertension, 30.8% had a systolic BP >= 140 or diastolic BP >= 90 mm Hg. Having health insurance was associated with controlled blood pressure, both in those with hypertension and diabetes. In CHD patients, income >=$20,000/year and health insurance were inversely associated with LDL >= 100mg/dL with prevalence ratio (PR) of 0.58 (P=0.03) and 0.56 (P=0.03), respectively. Conclusions One-third of the US adult population has Stage A HF. Prevention efforts should focus on those with poorly controlled comorbid disease.	[Kovell, Lara C.; Russell, Stuart D.] Johns Hopkins Univ, Sch Med, Dept Med, Div Cardiol, Baltimore, MD 21205 USA; [Juraschek, Stephen P.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Kovell, LC (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Div Cardiol, Baltimore, MD 21205 USA.	lkovell1@jhmi.edu		Juraschek, Stephen/0000-0003-4168-2696; Chamberlain, Alanna/0000-0003-1888-9584; Kovell, Lara C/0000-0002-7919-2361	NIH/NHLBI [T32HL007024]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007024] Funding Source: NIH RePORTER	NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	SPJ is supported by a NIH/NHLBI T32HL007024 Cardiovascular Epidemiology Training Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali MK, 2013, NEW ENGL J MED, V368, P1613, DOI 10.1056/NEJMsa1213829; AMBROSIONI E, 1995, NEW ENGL J MED, V332, P80, DOI 10.1056/NEJM199501123320203; Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS14, DOI 10.2337/dc14-S014; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS11, DOI 10.2337/dc13-S011; Arnold JMO, 2003, CIRCULATION, V107, P1284, DOI 10.1161/01.CIR.0000054165.93055.42; Behrens T, 2004, METHOD INFORM MED, V43, P505; Blair AS, 2002, J FAM PRACTICE, V51, P169; Braunwald E, 2013, JACC-HEART FAIL, V1, P1, DOI 10.1016/j.jchf.2012.10.002; Brenner BM, 2001, NEW ENGL J MED, V345, P861, DOI 10.1056/NEJMoa011161; Centers for Disease Control, 2010, NHANES NHANES 1999 2; Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251, DOI 10.1161/01.HYP.9.2_PT_2.II36, DOI 10.1161/01.HYP.0000107251.49515.C2]; Colucci WS, 2007, CIRCULATION, V116, P49, DOI 10.1161/CIRCULATIONAHA.106.666016; Djousse L, 2009, JAMA-J AM MED ASSOC, V302, P394, DOI 10.1001/jama.2009.1062; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Hawkins NM, 2012, EUR J HEART FAIL, V14, P138, DOI 10.1093/eurjhf/hfr168; He J, 2001, ARCH INTERN MED, V161, P996, DOI 10.1001/archinte.161.7.996; Heidenreich PA, 2013, CIRC-HEART FAIL, V6, P606, DOI 10.1161/HHF.0b013e318291329a; Ho JE, 2013, CIRC-HEART FAIL, V6, P279, DOI 10.1161/CIRCHEARTFAILURE.112.972828; Hunt SA, 2009, J AM COLL CARDIOL, V53, pE1, DOI 10.1016/j.jacc.2008.11.013; Iribarren C, 2001, CIRCULATION, V103, P2668; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; Kenchaiah S, 2002, NEW ENGL J MED, V347, P305, DOI 10.1056/NEJMoa020245; Kjekshus J, 1997, J Card Fail, V3, P249, DOI 10.1016/S1071-9164(97)90022-1; Levy D, 1996, JAMA-J AM MED ASSOC, V275, P1557, DOI 10.1001/jama.275.20.1557; Lindholm LH, 2002, LANCET, V359, P1004, DOI 10.1016/S0140-6736(02)08090-X; Lloyd-Jones DM, 2010, CIRCULATION, V121, P586, DOI 10.1161/CIRCULATIONAHA.109.192703; Masoudi FA, 2007, AM J CARDIOL, V99, p113B, DOI 10.1016/j.amjcard.2006.11.013; National Kidney Foundation, 2004, AM J KIDNEY DIS S, V43, pS1, DOI [DOI 10.1053/J.AJKD.2004.03.003, 10.1053/j.ajkd.2004.03.003]; PFEFFER MA, 1992, NEW ENGL J MED, V327, P669, DOI 10.1056/NEJM199209033271001; Quatromoni J, 2008, INT J CLIN PRACT, V62, P1910, DOI 10.1111/j.1742-1241.2008.01943.x; Salomaa V, 2001, J EPIDEMIOL COMMUN H, V55, P475, DOI 10.1136/jech.55.7.475; Shepherd J, 2008, J AM COLL CARDIOL, V51, P1448, DOI 10.1016/j.jacc.2007.11.072; Smith SC, 2006, J AM COLL CARDIOL, V47, P2130, DOI 10.1016/j.jacc.2006.04.026; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; Toto RD, 2005, SEMIN NEPHROL, V25, P435, DOI 10.1016/j.semnephrol.2005.05.016; Tsai J, 2012, ADDICT BEHAV, V37, P78, DOI 10.1016/j.addbeh.2011.09.002; Vaur L, 2003, DIABETES CARE, V26, P855, DOI 10.2337/diacare.26.3.855; Yusuf S, 2008, LANCET, V372, P1174, DOI 10.1016/S0140-6736(08)61242-8; Yusuf S, 2008, NEW ENGL J MED, V358, P1547, DOI 10.1056/NEJMoa0801317	42	14	16	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132228	10.1371/journal.pone.0132228	http://dx.doi.org/10.1371/journal.pone.0132228			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26171960	Green Published, Green Submitted, gold			2022-12-26	WOS:000358194900036
J	Kubler, JE; Dudgeon, SR				Kuebler, Janet E.; Dudgeon, Steven R.			Predicting Effects of Ocean Acidification and Warming on Algae Lacking Carbon Concentrating Mechanisms	PLOS ONE			English	Article							INORGANIC CARBON; CHONDRUS-CRISPUS; RED MACROALGA; OXYGEN-UPTAKE; ULVA-RIGIDA; CO2; LIGHT; PHOTOSYNTHESIS; ACQUISITION; TEMPERATURE	Seaweeds that lack carbon-concentrating mechanisms are potentially inorganic carbon-limited under current air equilibrium conditions. To estimate effects of increased atmospheric carbon dioxide concentration and ocean acidification on photosynthetic rates, we modeled rates of photosynthesis in response to pCO(2), temperature, and their interaction under limiting and saturating photon flux densities. We synthesized the available data for photosynthetic responses of red seaweeds lacking carbon-concentrating mechanisms to light and temperature. The model was parameterized with published data and known carbonate system dynamics. The model predicts that direction and magnitude of response to pCO(2) and temperature, depend on photon flux density. At sub-saturating light intensities, photosynthetic rates are predicted to be low and respond positively to increasing pCO(2), and negatively to increasing temperature. Consequently, pCO(2) and temperature are predicted to interact antagonistically to influence photosynthetic rates at low PFD. The model predicts that pCO(2) will have a much larger effect than temperature at sub-saturating light intensities. However, photosynthetic rates under low light will not increase proportionately as pCO(2) in seawater continues to rise. In the range of light saturation (I-k), both CO2 and temperature have positive effects on photosynthetic rate and correspondingly strong predicted synergistic effects. At saturating light intensities, the response of photosynthetic rates to increasing pCO(2) approaches linearity, but the model also predicts increased importance of thermal over pCO(2) effects, with effects acting additively. Increasing boundary layer thickness decreased the effect of added pCO(2) and, for very thick boundary layers, overwhelmed the effect of temperature on photosynthetic rates. The maximum photosynthetic rates of strictly CO2-using algae are low, so even large percentage increases in rates with climate change will not contribute much to changing primary production in the habitats where they commonly live.	[Kuebler, Janet E.; Dudgeon, Steven R.] Calif State Univ Northridge, Dept Biol, Northridge, CA 91330 USA	California State University System; California State University Northridge	Kubler, JE (corresponding author), Calif State Univ Northridge, Dept Biol, Northridge, CA 91330 USA.	janet.kubler@csun.edu	/AAL-3738-2021		National Science Foundation Ocean Sciences Program [OCE-1316198]	National Science Foundation Ocean Sciences Program	This work was supported by the National Science Foundation Ocean Sciences Program, OCE-1316198 to JE Kubler and SR Dudgeon.	Badger MR, 1998, CAN J BOT, V76, P1052, DOI 10.1139/b98-074; BRECHIGNAC F, 1985, PLANT PHYSIOL, V78, P545, DOI 10.1104/pp.78.3.545; BRECHIGNAC F, 1984, PLANT PHYSIOL, V75, P919, DOI 10.1104/pp.75.4.919; Burnham KP, 2002, MODEL SELECTION MULT, V2nd, DOI [DOI 10.1007/B97636, 10.1007/978-1-4757-2917-7, DOI 10.1007/978-1-4757-2917-7]; Comeau S, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2374; Cornwall CE, 2015, PHOTOSYNTH RES, V124, P181, DOI 10.1007/s11120-015-0114-0; Cornwall CE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097235; DAVISON IR, 1991, J PHYCOL, V27, P2, DOI 10.1111/j.0022-3646.1991.00002.x; Dickson AG, 2007, CARBON DIOXIDE ANAL; Falkowski P.G., 2007, AQUATIC PHOTOSYNTHES; Gordillo FJL, 2003, PLANTA, V218, P315, DOI 10.1007/s00425-003-1087-3; Gordillo FJL, 2001, PLANTA, V213, P64, DOI 10.1007/s004250000468; Hendriks IE, 2010, ESTUAR COAST SHELF S, V86, P157, DOI 10.1016/j.ecss.2009.11.022; Hill R, 1955, WHITTINGHAM CP PHOTO; Hurd CL, 2014, SEAWEED ECOLOGY AND PHYSIOLOGY, 2ND EDITION, P1, DOI 10.1017/CBO9781139192637; JOHNSTON AM, 1992, OECOLOGIA, V92, P317, DOI 10.1007/BF00317457; JOHNSTON AM, 1986, J PHYCOL, V22, P78, DOI 10.1111/j.1529-8817.1986.tb02518.x; Kleypas JA, 1999, SCIENCE, V284, P118, DOI 10.1126/science.284.5411.118; Kroeker KJ, 2010, ECOL LETT, V11, P1304; Kroeker KJ, 2013, GLOBAL CHANGE BIOL, V19, P1884, DOI 10.1111/gcb.12179; KUBLER JE, 1994, MAR ECOL PROG SER, V110, P203, DOI 10.3354/meps110203; Kubler JE, 1996, HYDROBIOLOGIA, V327, P401; KUBLER JE, 1993, MAR BIOL, V117, P327, DOI 10.1007/BF00345678; KUBLER JE, 1995, EUR J PHYCOL, V30, P189, DOI 10.1080/09670269500650971; Kubler JE, 1999, PLANT CELL ENVIRON, V22, P1303, DOI 10.1046/j.1365-3040.1999.00492.x; KUBLER JE, 1995, J PHYCOL, V31, P369, DOI 10.1111/j.0022-3646.1995.00369.x; KUEBLER JE, 1991, BRIT PHYCOL J, V26, P9, DOI 10.1080/00071619100650021; Lueker TJ, 2000, MAR CHEM, V70, P105, DOI 10.1016/S0304-4203(00)00022-0; MABERLY SC, 1992, OECOLOGIA, V91, P481, DOI 10.1007/BF00650320; MACFARLANE JJ, 1985, J EXP BOT, V36, P610, DOI 10.1093/jxb/36.4.610; MACFARLANE JJ, 1989, J EXP BOT, V40, P321, DOI 10.1093/jxb/40.3.321; MACFARLANE JJ, 1990, PLANT CELL ENVIRON, V13, P1, DOI 10.1111/j.1365-3040.1990.tb01294.x; Mazerolle M. J., 2013, MODEL SELECTION MULT; MILLHOUSE J, 1986, J EXP BOT, V37, P965, DOI 10.1093/jxb/37.7.965; MOOK WG, 1974, EARTH PLANET SC LETT, V22, P169, DOI 10.1016/0012-821X(74)90078-8; Morel F, 2010, NATL STRATEGY MEET C; Olischlager M, 2013, J EXP BOT, V64, P5587, DOI 10.1093/jxb/ert329; Post E, 1999, ECOLOGY, V80, P1322, DOI 10.1890/0012-9658(1999)080[1322:CVPPAN]2.0.CO;2; R Core Development Team, 2013, R LANG ENV STAT COMP; Raven J, 2005, OCEAN ACIDIFICATION; Raven JA, 1997, ADV BOT RES, V27, P85; Raven JA, 2005, CAN J BOT, V83, P879, DOI 10.1139/B05-074; Raven JA, 2002, ANN BOT-LONDON, V90, P525, DOI 10.1093/aob/mcf171; Raven JA, 2002, FUNCT PLANT BIOL, V29, P355, DOI 10.1071/PP01201; Raven JA, 1987, PLANT LIFE AQUATIC A; Robbins L.L., 2010, CO2CALC USER FRIENDL, DOI 10.3133/ofr20101280; Sarker MY, 2013, BOT MAR, V56, P63, DOI 10.1515/bot-2012-0143; Sett S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088308; Sherlock JA, 2001, BOT J SCOTLAND, V113, P301; Uemura K, 1997, BIOCHEM BIOPH RES CO, V233, P568, DOI 10.1006/bbrc.1997.6497; WIENCKE C, 1990, MAR ECOL PROG SER, V65, P283, DOI 10.3354/meps065283; Zeebe RE, 2011, GEOCHIM COSMOCHIM AC, V75, P2483, DOI 10.1016/j.gca.2011.02.010	52	25	25	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132806	10.1371/journal.pone.0132806	http://dx.doi.org/10.1371/journal.pone.0132806			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26172263	Green Submitted, gold, Green Published			2022-12-26	WOS:000358194900087
J	Sills, EO; Herrera, D; Kirkpatrick, AJ; Brandao, A; Dickson, R; Hall, S; Pattanayak, S; Shoch, D; Vedoveto, M; Young, L; Pfaff, A				Sills, Erin O.; Herrera, Diego; Kirkpatrick, A. Justin; Brandao, Amintas, Jr.; Dickson, Rebecca; Hall, Simon; Pattanayak, Subhrendu; Shoch, David; Vedoveto, Mariana; Young, Luisa; Pfaff, Alexander			Estimating the Impacts of Local Policy Innovation: The Synthetic Control Method Applied to Tropical Deforestation	PLOS ONE			English	Article							LAND-USE; REDUCE	Quasi-experimental methods increasingly are used to evaluate the impacts of conservation interventions by generating credible estimates of counterfactual baselines. These methods generally require large samples for statistical comparisons, presenting a challenge for evaluating innovative policies implemented within a few pioneering jurisdictions. Single jurisdictions often are studied using comparative methods, which rely on analysts' selection of best case comparisons. The synthetic control method (SCM) offers one systematic and transparent way to select cases for comparison, from a sizeable pool, by focusing upon similarity in outcomes before the intervention. We explain SCM, then apply it to one local initiative to limit deforestation in the Brazilian Amazon. The municipality of Paragominas launched a multi-pronged local initiative in 2008 to maintain low deforestation while restoring economic production. This was a response to having been placed, due to high deforestation, on a federal "blacklist" that increased enforcement of forest regulations and restricted access to credit and output markets. The local initiative included mapping and monitoring of rural land plus promotion of economic alternatives compatible with low deforestation. The key motivation for the program may have been to reduce the costs of blacklisting. However its stated purpose was to limit deforestation, and thus we apply SCM to estimate what deforestation would have been in a (counterfactual) scenario of no local initiative. We obtain a plausible estimate, in that deforestation patterns before the intervention were similar in Paragominas and the synthetic control, which suggests that after several years, the initiative did lower deforestation (significantly below the synthetic control in 2012). This demonstrates that SCM can yield helpful land-use counterfactuals for single units, with opportunities to integrate local and expert knowledge and to test innovations and permutations on policies that are implemented in just a few locations.	[Sills, Erin O.] N Carolina State Univ, Dept Forestry & Environm Resources, Raleigh, NC 27695 USA; [Herrera, Diego; Kirkpatrick, A. Justin; Pattanayak, Subhrendu; Pfaff, Alexander] Duke Univ, Sanford Sch Publ Policy, Durham, NC USA; [Sills, Erin O.; Brandao, Amintas, Jr.] Amazon Inst People & Environm, IMAZON, Belem, Para, Brazil; [Dickson, Rebecca; Shoch, David] TerraCarbon LLC, Charlottesville, VA USA; [Hall, Simon] Natl Wildlife Federat, Washington, DC USA; [Vedoveto, Mariana] Yale Univ, Sch Forestry & Environm Studies, New Haven, CT 06511 USA; [Young, Luisa] Clark Univ, Dept Geog, Worcester, MA 01610 USA	University of North Carolina; North Carolina State University; Duke University; Yale University; Clark University	Sills, EO (corresponding author), N Carolina State Univ, Dept Forestry & Environm Resources, Raleigh, NC 27695 USA.	sills@ncsu.edu; alex.pfaff@duke.edu		Sills, Erin/0000-0001-8289-0489	American people through the United States Agency for International Development (USAID); Duke University's Graduate School	American people through the United States Agency for International Development (USAID)(United States Agency for International Development (USAID)); Duke University's Graduate School	This study is made possible by the generous support of the American people through the United States Agency for International Development (USAID). The contents are the responsibility of the authors and do not necessarily reflect the views of USAID or the United States Government. Funding was also provided by Duke University's Graduate School. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadie A, 2003, AM ECON REV, V93, P113, DOI 10.1257/000282803321455188; Abadie A, 2015, AM J POLIT SCI, V59, P495, DOI 10.1111/ajps.12116; Abadie A, 2011, J STAT SOFTW, V42, P1; Abadie A, 2010, J AM STAT ASSOC, V105, P493, DOI 10.1198/jasa.2009.ap08746; Arima EY, 2014, LAND USE POLICY, V41, P465, DOI 10.1016/j.landusepol.2014.06.026; Arima EY, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/2/024010; AssuncAo J, 2014, GETTING GREENER GOIN; Billmeier A, 2013, REV ECON STAT, V95, P983, DOI 10.1162/REST_a_00324; Bohn S, 2014, REV ECON STAT, V96, P258, DOI 10.1162/REST_a_00429; Brito B., 2010, EVERYTHING IS CONNEC, P29; Campos NF, 2014, IZA DISCUSSION PAPER; Cavallo E, 2013, REV ECON STAT, V95, P1549, DOI 10.1162/REST_a_00413; Coffman M, 2012, ENVIRON DEV ECON, V17, P187, DOI 10.1017/S1355770X11000350; Collier D, 1993, POLITICAL SCI STATE, P105; Dorsett R, 2013, EUR J POLIT ECON, V29, P119, DOI 10.1016/j.ejpoleco.2012.10.003; Dube A, POOLED SYNT IN PRESS; Hansen MC, 2010, P NATL ACAD SCI USA, V107, P8650, DOI 10.1073/pnas.0912668107; Heim BT, 2014, SMALL BUS ECON, V43, P917, DOI 10.1007/s11187-014-9572-6; Instituto Nacional de Pesquisas Espaciais (INPE) Database, PROJ PROD MON FLOR A; Keele L, 2013, LEGIS STUD QUART, V38, P291, DOI 10.1111/lsq.12016; Kirkpatrick AJ, 2014, J ENVIRON ECON MANAG, V68, P357, DOI 10.1016/j.jeem.2014.05.001; Lapola DM, 2010, P NATL ACAD SCI USA, V107, P3388, DOI 10.1073/pnas.0907318107; LIJPHART A, 1971, AM POLIT SCI REV, V65, P682, DOI 10.2307/1955513; Mooney CZ, 1993, QUANTITATIVE APPL SO; Morton DC, 2006, P NATL ACAD SCI USA, V103, P14637, DOI 10.1073/pnas.0606377103; Nepstad D, 2014, SCIENCE, V344, P1118, DOI 10.1126/science.1248525; Nepstad DC, 2008, PHILOS T R SOC B, V363, P1737, DOI 10.1098/rstb.2007.0036; Neves Estela Maria Souza Costa, 2012, Estud. av., V26, P137, DOI 10.1590/S0103-40142012000100010; Ostrom E, 2010, GLOBAL ENVIRON CHANG, V20, P550, DOI 10.1016/j.gloenvcha.2010.07.004; Sampaio B, 2014, TRANSPORTMETRICA A, V10, P1, DOI 10.1080/18128602.2012.688073; Sanso-Navarro M, 2011, JCMS-J COMMON MARK S, V49, P463, DOI 10.1111/j.1468-5965.2010.02124.x; Seawright J, 2008, POLIT RES QUART, V61, P294, DOI 10.1177/1065912907313077; Trandafir M, 2014, DEMOGRAPHY, V51, P317, DOI 10.1007/s13524-013-0248-7; Verissimo A, 2002, EXPANSAO MADEIREIRA, V2nd; Villela M, 2010, PARAGOMINAS AINDA PO	35	57	57	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132590	10.1371/journal.pone.0132590	http://dx.doi.org/10.1371/journal.pone.0132590			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1QN	26173108	Green Published, gold, Green Submitted			2022-12-26	WOS:000358194900063
J	Spear, GT; McKenna, M; Landay, AL; Makinde, H; Hamaker, B; French, AL; Lee, BH				Spear, Greg T.; McKenna, Mary; Landay, Alan L.; Makinde, Hadijat; Hamaker, Bruce; French, Audrey L.; Lee, Byung-Hoo			Effect of pH on Cleavage of Glycogen by Vaginal Enzymes	PLOS ONE			English	Article							BACTERIAL VAGINOSIS; LACTOBACILLI; FLUID; FLORA; RISK	Glycogen expressed by the lower genital tract epithelium is believed to support Lactobacillus growth in vivo, although most genital isolates of Lactobacillus are not able to use glycogen as an energy source in vitro. We recently reported that alpha-amylase is present in the genital fluid of women and that it breaks down glycogen into small carbohydrates that support growth of lactobacilli. Since the pH of the lower genital tract can be very low, we determined how low pH affects glycogen processing by alpha-amylase. alpha-amylase in saliva degraded glycogen similarly at pH 6 and 7, but activity was reduced by 52% at pH 4. The glycogen degrading activity in nine genital samples from seven women showed a similar profile with an average reduction of more than 50% at pH 4. However, two samples collected from one woman at different times had a strikingly different pH profile with increased glycogen degradation at pH 4, 5 and 6 compared to pH 7. This second pH profile did not correlate with levels of human alpha-acid glucosidase or human intestinal maltase glucoamylase. High-performance anion-exchange chromatography showed that mostly maltose was produced from glycogen by samples with the second pH profile in contrast to genital a-amylase that yielded maltose, maltotriose and maltotetraose. These studies show that at low pH, alpha-amylase activity is reduced to low but detectable levels, which we speculate helps maintain Lactobacillus growth at a limited but sustained rate. Additionally, some women have a genital enzyme distinct from alpha-amylase with higher activity at low pH. Further studies are needed to determine the identity and distribution of this second enzyme, and whether its presence influences the makeup of genital microbiota.	[Spear, Greg T.; McKenna, Mary; Landay, Alan L.; Makinde, Hadijat] Rush Univ, Med Ctr, Dept Immunol Microbiol, Chicago, IL 60612 USA; [Hamaker, Bruce] Purdue Univ, Dept Food Sci, Whistler Ctr Carbohydrate Res, W Lafayette, IN 47907 USA; [French, Audrey L.] Rush Univ, Med Ctr, Dept Med, CORE Ctr Cook Cty Hlth & Hosp Syst, Chicago, IL 60612 USA; [Lee, Byung-Hoo] Gachon Univ, Coll BioNano Technol, Dept Food Sci & Biotechnol, Songnam, South Korea	Rush University; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Rush University; Gachon University	Spear, GT (corresponding author), Rush Univ, Med Ctr, Dept Immunol Microbiol, Chicago, IL 60612 USA.	gspear@rush.edu	Yoo, Sang-Ho/AAI-4446-2020	Makinde, Hadijat-Kubura/0000-0001-8492-4187	NIH [AI082971]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI034993, P01AI082971] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding was provided by NIH grant AI082971.	Aframian DJ, 2006, ORAL DIS, V12, P420, DOI 10.1111/j.1601-0825.2005.01217.x; AMSEL R, 1983, AM J MED, V74, P14, DOI 10.1016/0002-9343(83)91112-9; Birse KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079505; Boskey ER, 1999, INFECT IMMUN, V67, P5170, DOI 10.1128/IAI.67.10.5170-5175.1999; Cherpes TL, 2008, SEX TRANSM DIS, V35, P78, DOI 10.1097/OLQ.0b013e318156a5d0; Cruickshank R SA, 1934, J OBSTET GYN BR COMM, V41, P208, DOI DOI 10.1111/J.1471-0528; FOX CA, 1973, J REPROD FERTIL, V33, P69; Fredricks DN, 2009, J CLIN MICROBIOL, V47, P721, DOI 10.1128/JCM.01384-08; Hillier SL, 1998, AIDS RES HUM RETROV, V14, pS17; Lee CK, 2008, J AGR FOOD CHEM, V56, P126, DOI 10.1021/jf072508s; Ma LY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070716; Martin HL, 1999, J INFECT DIS, V180, P1863, DOI 10.1086/315127; Martin R, 2009, INT MICROBIOL, V11, P261, DOI 10.2436/20.1501.01.70; MIRMONSEF P, 2014, MENOPAUSE, V22, P1, DOI DOI 10.1097/GME.0000000000000397; Mirmonsef P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102467; Mirmonsef P, 2014, AM J REPROD IMMUNOL, V71, P531, DOI 10.1111/aji.12232; MORRIS DL, 1946, J BIOL CHEM, V166, P199; O'Hanlon DE, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-120; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Spear GT, 2014, J INFECT DIS, V210, P1019, DOI 10.1093/infdis/jiu231; Srinivasan S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010197; STEWARTT.DE, 1964, AM J OBSTET GYNECOL, V88, P676, DOI 10.1016/0002-9378(64)90898-1; WYLIE JG, 1969, J MED MICROBIOL, V2, P363, DOI 10.1099/00222615-2-3-363	23	19	19	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132646	10.1371/journal.pone.0132646	http://dx.doi.org/10.1371/journal.pone.0132646			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26171967	gold, Green Submitted, Green Published			2022-12-26	WOS:000358194900068
J	Wang, TC; Lin, CC; Lin, CD; Chung, HK; Wang, CY; Tsai, MH; Kao, CH				Wang, Tang-Chuan; Lin, Che-Chen; Lin, Chia-Der; Chung, Hsiung-Kwang; Wang, Ching-Yuang; Tsai, Ming-Hsui; Kao, Chia-Hung			Increased Acquired Cholesteatoma Risk in Patients with Osteoporosis: A Retrospective Cohort Study	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; MIDDLE-EAR CHOLESTEATOMA; CHRONIC OTITIS-MEDIA; BONE-RESORPTION; FACTOR-ALPHA; OSTEOCLAST; INTERLEUKIN-1-ALPHA; DIAGNOSIS; PRESSURE; BIOLOGY	Objective Clinically, we found the increased incidence of acquired colesteatoma in the patients with osteoporosis. In this study, we used a retrospective cohort to examine this association and to investigate the possible mechanism. Methods We conducted a population-based retrospective cohort study by using the National Health Insurance Research Database (NHIRD). We identified an osteoporosis cohort comprising 37 124 patients newly diagnosed with osteoporosis aged 20 years or older. Patients in the comparison cohort had no history of osteoporosis and were frequency matched with the patients in the osteoporosis cohort according to sex, age, and index year. Results The acquired cholesteatoma incidence rates for the osteoporosis and comparison cohorts were 1.12 and 0.83 per 1000 person-years, respectively. After we adjusted for confounding factors, the osteoporosis cohort exhibited a 1.32-fold increased acquired cholesteatoma risk relative to the comparison cohort (hazard ratio [HR] = 1.32, 95% confidence interval [CI] = 1.11-1.57). In addition, patients with no history of otitis media (HR = 1.33, 95% CI = 1.11-1.59), cancer (HR = 1.34, 95% CI = 1.12-1.60), or COPD (HR = 1.26, 95% CI = 1.05-1.52) in the osteoporosis cohort exhibited an increased risk of subsequent acquired cholesteatoma relative to those in the comparison cohort. Conclusions Our cohort study indicated that patients with osteoporosis had a 1.31-fold increased acquired cholesteatoma risk relative to the comparison cohort. This risk was further increased in patients with comorbid otitis media. Hence, we recommend that otolaryngologists evaluate the condition of the middle ear of patients with osteoporosis.	[Wang, Tang-Chuan; Lin, Chia-Der; Chung, Hsiung-Kwang; Wang, Ching-Yuang; Tsai, Ming-Hsui] China Med Univ Hosp, Dept Otolaryngol Head & Neck Surg, Taichung, Taiwan; [Wang, Tang-Chuan] Univ Iowa Hosp, Dept Otolaryngol Head & Neck Surg, Iowa City, IA USA; [Lin, Che-Chen] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan; [Lin, Che-Chen] China Med Univ, Coll Med, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ, Coll Med, Grad Inst Clin Med Sci, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ, Coll Med, Sch Med, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ Hosp, Dept Nucl Med, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ Hosp, PET Ctr, Taichung, Taiwan	China Medical University Taiwan; China Medical University Hospital - Taiwan; University of Iowa; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Kao, CH (corresponding author), China Med Univ, Coll Med, Grad Inst Clin Med Sci, Taichung, Taiwan.	d10040@mail.cmuh.org.tw			Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [MOHW104-TDU-B-212-113002]; China Medical University Hospital, Academia Sinica Taiwan Biobank, Stroke Biosignature Project [BM104010092]; NRPB Stroke Clinical Trial Consortium [MOST 103-2325-B-039-006]; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan; CMU under the Aim for Top University Plan of the Ministry of Education, Taiwan	Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence; China Medical University Hospital, Academia Sinica Taiwan Biobank, Stroke Biosignature Project; NRPB Stroke Clinical Trial Consortium; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan; CMU under the Aim for Top University Plan of the Ministry of Education, Taiwan	This study is supported in part by Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW104-TDU-B-212-113002); China Medical University Hospital, Academia Sinica Taiwan Biobank, Stroke Biosignature Project (BM104010092); NRPB Stroke Clinical Trial Consortium (MOST 103-2325-B-039-006); Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan, and CMU under the Aim for Top University Plan of the Ministry of Education, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Akimoto R, 2000, ORL J OTO-RHINO-LARY, V62, P257, DOI 10.1159/000027756; Albino AP, 1998, AM J OTOL, V19, P7; Albino AP, 1998, AM J OTOL, V19, P266; Amar MS, 1996, J LARYNGOL OTOL, V110, P534, DOI 10.1017/S002221510013419X; Bujia J, 1996, EUR ARCH OTO-RHINO-L, V253, P152, DOI 10.1007/BF00615113; Bujia J, 1996, EUR ARCH OTO-RHINO-L, V253, P252; CHESHIRE IM, 1991, LANCET, V338, P1041, DOI 10.1016/0140-6736(91)91902-7; Chole RA, 1997, ANN NY ACAD SCI, V830, P95, DOI 10.1111/j.1749-6632.1997.tb51882.x; CHOLE RA, 1984, LARYNGOSCOPE, V94, P76, DOI 10.1002/lary.5540940117; CHOLE RA, 1985, ANN OTO RHINOL LARYN, V94, P165, DOI 10.1177/000348948509400214; Hamzei M, 2003, LARYNGOSCOPE, V113, P436, DOI 10.1097/00005537-200303000-00009; Ho KY, 2013, INT J MOL SCI, V14, P14439, DOI 10.3390/ijms140714439; IINO Y, 1990, ACTA OTO-LARYNGOL, V110, P410, DOI 10.3109/00016489009107462; Jung JY, 2002, ORL-J OTO-RHIN-LARYN, V64, P95, DOI 10.1159/000057787; Kanis JA, 2002, LANCET, V359, P1929, DOI 10.1016/S0140-6736(02)08761-5; Karmody CS, 2012, OTOL NEUROTOL, V33, P42, DOI 10.1097/MAO.0b013e31823c919c; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; ORISEK BS, 1987, ARCH OTOLARYNGOL, V113, P386; Roodman GD, 1999, EXP HEMATOL, V27, P1229, DOI 10.1016/S0301-472X(99)00061-2; Spears M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071460; Spilsbury K, 2010, LARYNGOSCOPE, V120, P625, DOI 10.1002/lary.20765; Tanaka Y, 1999, LARYNGOSCOPE, V109, P1102, DOI 10.1097/00005537-199907000-00017; Thorsteinsson AL, 2014, OSTEOPOROSIS INT, V25, P1937, DOI 10.1007/s00198-014-2684-7; Tsai LT, 2010, NEURORADIOL J, V23, P307, DOI 10.1177/197140091002300308; Warriner AH, 2013, ORTHOP CLIN N AM, V44, P125, DOI 10.1016/j.ocl.2013.01.005; WOLFMAN DE, 1986, ARCH OTOLARYNGOL, V112, P1037; YAN SD, 1991, AM J OTOLARYNG, V12, P83, DOI 10.1016/0196-0709(91)90041-D; Yetiser S, 2002, OTOL NEUROTOL, V23, P647, DOI 10.1097/00129492-200209000-00007	28	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132447	10.1371/journal.pone.0132447	http://dx.doi.org/10.1371/journal.pone.0132447			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26171780	gold, Green Published, Green Submitted			2022-12-26	WOS:000358194900050
J	Han, SY; Tsou, MH; Clarke, KC				Han, Su Yeon; Tsou, Ming-Hsiang; Clarke, Keith C.			Do Global Cities Enable Global Views? Using Twitter to Quantify the Level of Geographical Awareness of US Cities	PLOS ONE			English	Article								Dynamic social media content, such as Twitter messages, can be used to examine individuals' beliefs and perceptions. By analyzing Twitter messages, this study examines how Twitter users exchanged and recognized toponyms (city names) for different cities in the United States. The frequency and variety of city names found in their online conversations were used to identify the unique spatiotemporal patterns of "geographical awareness" for Twitter users. A new analytic method, Knowledge Discovery in Cyberspace for Geographical Awareness (KDCGA), is introduced to help identify the dynamic spatiotemporal patterns of geographic awareness among social media conversations. Twitter data were collected across 50 U.S. cities. Thousands of city names around the world were extracted from a large volume of Twitter messages (over 5 million tweets) by using the Twitter Application Programming Interface (APIs) and Python language computer programs. The percentages of distant city names (cities located in distant states or other countries far away from the locations of Twitter users) were used to estimate the level of global geographical awareness for Twitter users in each U.S. city. A Global awareness index (GAI) was developed to quantify the level of geographical awareness of Twitter users from within the same city. Our findings are that: (1) the level of geographical awareness varies depending on when and where Twitter messages are posted, yet Twitter users from big cities are more aware of the names of international cities or distant US cities than users from mid-size cities; (2) Twitter users have an increased awareness of other city names far away from their home city during holiday seasons; and (3) Twitter users are more aware of nearby city names than distant city names, and more aware of big city names rather than small city names.	[Han, Su Yeon; Tsou, Ming-Hsiang] San Diego State Univ, Dept Geog, San Diego, CA 92182 USA; [Han, Su Yeon; Clarke, Keith C.] Univ Calif Santa Barbara, Dept Geog, Santa Barbara, CA 93106 USA	California State University System; San Diego State University; University of California System; University of California Santa Barbara	Tsou, MH (corresponding author), San Diego State Univ, Dept Geog, San Diego, CA 92182 USA.	mtsou@mail.sdsu.edu	Clarke, Keith/L-8641-2019; Clarke, Keith C/E-1863-2011; Tsou, Ming-Hsiang/B-2357-2015	Clarke, Keith/0000-0001-5805-6056; Clarke, Keith C/0000-0001-5805-6056; Tsou, Ming-Hsiang/0000-0003-3421-486X	National Science Foundation [1028177, 1416509]; Division Of Computer and Network Systems [1028177] Funding Source: National Science Foundation; SBE Off Of Multidisciplinary Activities [1416509] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Division Of Computer and Network Systems(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE)); SBE Off Of Multidisciplinary Activities(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	This material is based upon work supported by the National Science Foundation under Grant No. 1028177, project titled "CDI-Type II: Mapping Cyberspace to Realspace: Visualizing and Understanding the Spatiotemporal Dynamics of Global Diffusion of Ideas and the Semantic Web" and Grant No. 1416509, project titled, "Spatiotemporal Modeling of Human Dynamics Across Social Media and Social Networks". Any opinions, findings, and conclusions or recommendations expressed in this material are those of the author(s) and do not necessarily reflect the views of the National Science Foundation.	[Anonymous], 2001, FOREIGN POLICY, P56; [Anonymous], 2011, SCIENCE, DOI [DOI 10.21055/0370-1069-2020-1-51-60, DOI 10.1016/j.jocs.2010.12.007]; Aslam AA, 2014, J MED INTERNET RES, V16, DOI 10.2196/jmir.3532; BEATTY WW, 1987, SEX ROLES, V16, P565, DOI 10.1007/BF00300374; Bo Pang, 2008, Foundations and Trends in Information Retrieval, V2, P1, DOI 10.1561/1500000001; Brunn SD, 1991, COLLAPSING SPACE TIM; Cairncross F., 2001, DEATH DISTANCE COMMU; CHIODO JJ, 1993, J GEOGR, V92, P110, DOI 10.1080/00221349308979633; Clarke KC, 2015, MAPS WEB MAPPING; Downs RM, 1970, PROGR GEOGRAPHY, V2, P65; Dreher A, 2006, APPL ECON, V38, P1091, DOI 10.1080/00036840500392078; Fellmann JD, 2007, HUMAN GEOGRAPHY, P66; Ford CM., 2011, TWITTER FACEBOOK 10; Ghosh D, 2013, CARTOGR GEOGR INF SC, V40, P90, DOI 10.1080/15230406.2013.776210; Huberman BA, 2008, P INT C COMP SUPP CO; Kamvar Sepandar D., 2011, P 4 ACM INT C WEB SE; Lerman K, 2010, ICWSM, V10, P90, DOI DOI 10.1146/ANNUREV.AN.03.100174.001431; Leskovec J., 2008, INT C WORLD WIDE WEB, DOI DOI 10.1145/1367497.1367620; Li LN, 2013, CARTOGR GEOGR INF SC, V40, P61, DOI 10.1080/15230406.2013.777139; Maceachren A.M., 2011, 25 INT CART C; Manovich Lev, 2011, TRENDING PROMISES CH, P460; Martens P, 2009, INTEGRATED ASSESSMEN, V9; Martens P., 2014, GLOBALIZATIONS, V12, P1; Mislove A, 2011, P INT AAAI C WEB SOC; Montello D. R., 2009, INT ENCY HUMAN GEOGR, P160, DOI DOI 10.1016/B978-008044910-4.00668-4; Nader, 2012, USING SOCIAL MEDIA G; Nagel AC, 2013, J MED INTERNET RES, V15, P263, DOI 10.2196/jmir.2705; OConnor B., 2010, ICWSM, P122; Padmanabhan A., 2013, P C EXTR SCI ENG DIS; Randolph J, 2001, G INDEX GLOBALISATIO; Ressler S., 2006, HOMELAND SECURITY AF, V2, P1; Rodrigue JP., 2013, GEOGRAPHY TRANSPORT, DOI DOI 10.4324/9781315618159-2; Sakaki T., 2010, P 19 INT C WORLD WID; Shook E, 2012, E SCI E SCI 2012 IEE; Signorini A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019467; Spitzberg B. H., 2013, STUDIES MEDIA COMMUN, V1, P101, DOI 10.11114/smc.v1i1.64; Thelwall M, 2011, J AM SOC INF SCI TEC, V62, P406, DOI 10.1002/asi.21462; TOBLER WR, 1970, ECON GEOGR, V46, P234, DOI 10.2307/143141; Tsou M-H, 2013, GOLDEN OPPORTUNITY M; Tsou MH, 2013, CARTOGR GEOGR INF SC, V40, P337, DOI 10.1080/15230406.2013.799738; Tsou MH, 2013, CARTOGR GEOGR INF SC, V40, P55, DOI 10.1080/15230406.2013.776754; Wallace R, 1997, SOC SCI MED, V44, P935, DOI 10.1016/S0277-9536(96)00197-9; Wang W, 2012, PRIV SEC RISK TRUST; Wong DWS, 2005, STAT ANAL GEOGRAPHIC; Xu C, 2013, CARTOGR GEOGR INF SC, V40, P103, DOI 10.1080/15230406.2013.776212; Zywietz D., 2006, J INT DEV, V18, P331, DOI DOI 10.1002/JID.1223	46	19	19	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0132464	10.1371/journal.pone.0132464	http://dx.doi.org/10.1371/journal.pone.0132464			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1PW	26167942	gold, Green Published, Green Submitted			2022-12-26	WOS:000358193100045
J	Burkhalter, RJ; Westfall, SD; Liu, YY; Stack, MS				Burkhalter, Rebecca J.; Westfall, Suzanne D.; Liu, Yueying; Stack, M. Sharon			Lysophosphatidic Acid Initiates Epithelial to Mesenchymal Transition and Induces beta-Catenin-mediated Transcription in Epithelial Ovarian Carcinoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WNT/BETA-CATENIN; SIGNALING PATHWAY; SEROUS CARCINOMA; GROWTH-FACTOR; CANCER CELLS; WNT PATHWAY; INTEGRIN; LPA; ACTIVATION; TARGET	During tumor progression, epithelial ovarian cancer (EOC) cells undergo epithelial-to-mesenchymal transition (EMT), which influences metastatic success. Mutation-dependent activation of Wnt/beta-catenin signaling has been implicated in gain of mesenchymal phenotype and loss of differentiation in several solid tumors; however, similar mutations are rare in most EOC histotypes. Nevertheless, evidence for activated Wnt/beta-catenin signaling in EOC has been reported, and immunohistochemical analysis of human EOC tumors demonstrates nuclear staining in all histotypes. This study addresses the hypothesis that the bioactive lipid lysophosphatidic acid (LPA), prevalent in the EOC microenvironment, functions to regulate EMT in EOC. Our results demonstrate that LPA induces loss of junctional beta-catenin, stimulates clustering of beta 1 integrins, and enhances the conformationally active population of surface beta 1 integrins. Furthermore, LPA treatment initiates nuclear translocation of beta-catenin and transcriptional activation of Wnt/beta-catenin target genes resulting in gain of mesenchymal marker expression. Together these data suggest that LPA initiates EMT in ovarian tumors through beta 1-integrin-dependent activation of Wnt/beta-catenin signaling, providing a novel mechanism for mutation-independent activation of this pathway in EOC progression.	[Burkhalter, Rebecca J.] Univ Missouri, Dept Med Pharmacol & Physiol, Columbia, MO 65212 USA; [Westfall, Suzanne D.] Univ Missouri, Dept Pathol & Anat Sci, Columbia, MO 65212 USA; [Burkhalter, Rebecca J.; Liu, Yueying; Stack, M. Sharon] Univ Notre Dame, Harper Canc Res Inst, South Bend, IN 46617 USA; [Liu, Yueying; Stack, M. Sharon] Univ Notre Dame, Dept Chem & Biochem, South Bend, IN 46617 USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Notre Dame; University of Notre Dame	Stack, MS (corresponding author), Univ Notre Dame, Dept Chem & Biochem, Harper Canc Res Inst, 1234 Notre Dame Ave,A200E Harper Hall, South Bend, IN 46617 USA.	sstack@nd.edu			National Institutes of Health from the NCI [RO1 CA109545, RO1 CA086984]; Leo and Ann Albert Charitable Trust;  [CA086984-11S1]; NATIONAL CANCER INSTITUTE [R01CA109545, R01CA086984] Funding Source: NIH RePORTER	National Institutes of Health from the NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Leo and Ann Albert Charitable Trust; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 CA109545 (to M. S. S.) and RO1 CA086984 (to M. S. S.) from the NCI and Research Supplement to Promote Diversity CA086984-11S1 (to R. J. B.). This work was also supported by the Leo and Ann Albert Charitable Trust (to M. S. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Ahmed AA, 2010, J PATHOL, V221, P49, DOI 10.1002/path.2696; Alam N, 2007, J CELL PHYSIOL, V213, P649, DOI 10.1002/jcp.21278; *AM CANC SOC, 2010, CANC FACTS FIG; Arend RC, 2014, GYNECOL ONCOL, V134, P112, DOI 10.1016/j.ygyno.2014.04.005; Auersperg N, 1998, SEMIN ONCOL, V25, P281; AUERSPERG N, 1995, OVARIAN CANC, V3, P157; Auersperg N, 2011, INT J GYNECOL PATHOL, V30, P12, DOI 10.1097/PGP.0b013e3181f45f3e; Barbolina MV, 2007, J BIOL CHEM, V282, P4924, DOI 10.1074/jbc.M608428200; Barbolina MV, 2013, J BIOL CHEM, V288, P141, DOI 10.1074/jbc.M112.431411; Barbolina MV, 2011, BIOCHEM J, V437, P1, DOI 10.1042/BJ20110112; Barker Nick, 2008, V468, P5, DOI 10.1007/978-1-59745-249-6_1; Bian YS, 2000, AM J CLIN PATHOL, V114, P583, DOI 10.1309/3QLC-5MF1-JYXU-A5XX; Blechschmidt K, 2008, BRIT J CANCER, V98, P489, DOI 10.1038/sj.bjc.6604115; Burkhalter RJ, 2011, J BIOL CHEM, V286, P23467, DOI 10.1074/jbc.M110.199539; Cannistra SA, 2004, NEW ENGL J MED, V351, P2519, DOI 10.1056/NEJMra041842; Cavallo RA, 1998, NATURE, V395, P604, DOI 10.1038/26982; Chamorro MN, 2005, EMBO J, V24, P73, DOI 10.1038/sj.emboj.7600460; Choi JW, 2010, ANNU REV PHARMACOL, V50, P157, DOI 10.1146/annurev.pharmtox.010909.105753; Choudhury M, 2008, ALCOHOL CLIN EXP RES, V32, P829, DOI 10.1111/j.1530-0277.2008.00630.x; Davidowitz RA, 2014, J CLIN INVEST, V124, P2611, DOI 10.1172/JCI69815; Dempke W, 2001, J CANCER RES CLIN, V127, P411, DOI 10.1007/s004320000225; Do TV, 2007, MOL CANCER RES, V5, P121, DOI 10.1158/1541-7786.MCR-06-0319; FAGOTTO F, 1994, DEVELOPMENT, V120, P3667; Fishman DA, 2001, CANCER RES, V61, P3194; Ford CE, 2014, GYNECOL ONCOL, V134, P338, DOI 10.1016/j.ygyno.2014.06.004; Fukushima N, 2001, PROSTAG OTH LIPID M, V64, P21, DOI 10.1016/S0090-6980(01)00105-8; Gardi NL, 2014, CLIN CANCER RES, V20, P87, DOI 10.1158/1078-0432.CCR-13-2063; Gilcrease MZ, 2004, CANCER RES, V64, P7395, DOI 10.1158/0008-5472.CAN-04-1809; Guo LL, 2015, CELL SIGNAL, V27, P961, DOI 10.1016/j.cellsig.2015.02.005; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harburger DS, 2009, J CELL SCI, V122, P159, DOI 10.1242/jcs.018093; Hudson LG, 2008, CLIN EXP METASTAS, V25, P643, DOI 10.1007/s10585-008-9171-5; Jiang YH, 2011, CANCER RES, V71, P2959, DOI 10.1158/0008-5472.CAN-10-4077; Jin HY, 2010, INT J CANCER, V126, P2102, DOI 10.1002/ijc.24901; Jourquin J, 2006, J CELL PHYSIOL, V206, P337, DOI 10.1002/jcp.20470; Kam Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004580; Kim A, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-14; Kim J, 2012, P NATL ACAD SCI USA, V109, P3921, DOI 10.1073/pnas.1117135109; Krieghoff E, 2006, J CELL SCI, V119, P1453, DOI 10.1242/jcs.02864; Kurman RJ, 2011, HUM PATHOL, V42, P918, DOI 10.1016/j.humpath.2011.03.003; Kurman RJ, 2010, AM J SURG PATHOL, V34, P433, DOI 10.1097/PAS.0b013e3181cf3d79; Latifi A, 2011, J CELL BIOCHEM, V112, P2850, DOI 10.1002/jcb.23199; Lee Y, 2007, J PATHOL, V211, P26, DOI 10.1002/path.2091; Lepourcelet M, 2004, CANCER CELL, V5, P91, DOI 10.1016/S1535-6108(03)00334-9; Lili LN, 2013, J OVARIAN RES, V6, DOI 10.1186/1757-2215-6-49; Liu YY, 2012, J ONCOL, V2012, DOI 10.1155/2012/501492; Lowry WE, 2005, GENE DEV, V19, P1596, DOI 10.1101/gad.1324905; Luo JY, 2007, LAB INVEST, V87, P97, DOI 10.1038/labinvest.3700509; Luu HH, 2004, CURR CANCER DRUG TAR, V4, P653, DOI 10.2174/1568009043332709; Marchini S, 2013, EUR J CANCER, V49, P520, DOI 10.1016/j.ejca.2012.06.026; McDonald SL, 2009, BRIT J CANCER, V101, P209, DOI 10.1038/sj.bjc.6605174; Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Ripka S, 2007, CARCINOGENESIS, V28, P1178, DOI 10.1093/carcin/bgl255; ROZENGURT E, 1995, CANCER SURV, V24, P81; Sakai T, 1999, J BIOL CHEM, V274, P15480, DOI 10.1074/jbc.274.22.15480; Seidman JD, 2004, INT J GYNECOL PATHOL, V23, P41, DOI 10.1097/01.pgp.0000101080.35393.16; Shen ZZ, 1998, GYNECOL ONCOL, V71, P364, DOI 10.1006/gyno.1998.5193; Shih IM, 2004, AM J PATHOL, V164, P1511, DOI 10.1016/S0002-9440(10)63708-X; Smicun Y, 2007, GYNECOL ONCOL, V107, P298, DOI 10.1016/j.ygyno.2007.06.024; Strauss R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016186; Suh EK, 2003, EXP CELL RES, V290, P447, DOI 10.1016/S0014-4827(03)00370-7; Surveillance Research Program NCI, 2014, SEER STAT FACT SHEET; Symowicz J, 2005, CANCER RES, V65, P2234, DOI 10.1158/0008.5472.CAN-04-2781; Symowicz J, 2007, CANCER RES, V67, P2030, DOI 10.1158/0008-5472.CAN-06-2808; Takahashi-Yanaga F, 2007, J PHARMACOL SCI, V104, P293, DOI 10.1254/jphs.CR0070024; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Tuhkanen H, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-289; van Amerongen R, 2009, DEVELOPMENT, V136, P3205, DOI 10.1242/dev.033910; Wells A, 2011, FRONT BIOSCI-LANDMRK, V16, P815, DOI 10.2741/3722; Westermann AM, 1998, ANN ONCOL, V9, P437, DOI 10.1023/A:1008217129273; Wu R, 2007, CANCER CELL, V11, P321, DOI 10.1016/j.ccr.2007.02.016; Xiao YJ, 2001, ANAL BIOCHEM, V290, P302, DOI 10.1006/abio.2001.5000; Xu MY, 2009, AM J PATHOL, V174, P1264, DOI 10.2353/ajpath.2009.080160; Xu Y, 1998, JAMA-J AM MED ASSOC, V280, P719, DOI 10.1001/jama.280.8.719; Xu Y, 1995, CLIN CANCER RES, V1, P1223; Yan XH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063731; Yang M, 2005, P NATL ACAD SCI USA, V102, P6027, DOI 10.1073/pnas.0501535102; Zeng X, 2008, DEVELOPMENT, V135, P367, DOI 10.1242/dev.013540; Zhang B, 2010, P NATL ACAD SCI USA, V107, P6900, DOI 10.1073/pnas.0906764107	81	40	43	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2015	290	36					22143	22154		10.1074/jbc.M115.641092	http://dx.doi.org/10.1074/jbc.M115.641092			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ9XI	26175151	Green Published, hybrid			2022-12-26	WOS:000360968500031
J	Sathe, L; Bolinger, C; Amin-ul Mannan, M; Dever, TE; Dey, M				Sathe, Leena; Bolinger, Cheryl; Amin-ul Mannan, M.; Dever, Thomas E.; Dey, Madhusudan			Evidence That Base-pairing Interaction between Intron and mRNA Leader Sequences Inhibits Initiation of HAC1 mRNA Translation in Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN-RESPONSE; ENDOPLASMIC-RETICULUM; TRANSCRIPTION FACTOR; SECONDARY STRUCTURE; MECHANISM; HELICASE; INDUCTION; RIBOSOMES; LIGASE; ROLES	The Hac1 transcription factor in yeast up-regulates a collection of genes that control protein homeostasis. Base-pairing interactions between sequences in the intron and the 5'-untranslated region (5' UTR) of the HAC1 mRNA represses Hac1 protein production under basal conditions, whereas cytoplasmic splicing of the intron by the Ire1 kinase-endonuclease, activated under endoplasmic reticulum stress conditions, relieves the inhibition and enables Hac1 synthesis. Using a random mutational screen as well as site-directed mutagenesis, we identify point mutations within the 5' UTR-intron interaction site that derepress translation of the unspliced HAC1 mRNA. We also show that insertion of an in-frame AUG start codon upstream of the interaction site releases the translational block, demonstrating that an elongating ribosome can disrupt the interaction. Moreover, overexpression of translation initiation factor eIF4A, a helicase, enhances production of Hac1 from an mRNA containing an upstream AUG start codon at the beginning of the base-paired region. These results suggest that the major block of translation occurs at the initiation stage. Supporting this interpretation, the point mutations that enhanced Hac1 production resulted in an increased percentage of the HAC1 mRNA associating with polysomes versus free ribosomal subunits. Thus, our results provide evidence that the 5' UTR-intron interaction represses translation initiation on the unspliced HAC1 mRNA.	[Sathe, Leena; Amin-ul Mannan, M.; Dey, Madhusudan] Univ Wisconsin, Dept Biol Sci, Milwaukee, WI 53211 USA; [Bolinger, Cheryl; Dever, Thomas E.] Eunice Kennedy Shriver NICHD, NIH, Bethesda, MD 20892 USA	University of Wisconsin System; University of Wisconsin Milwaukee; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Dever, TE (corresponding author), NIH, Bldg 6,Rm 228,6 Ctr Dr, Bethesda, MD 20892 USA.	tdever@nih.gov; deym@uwm.edu	Dever, Thomas/GSE-0966-2022; Mannan, Mohammad Amin-ul/AAT-6203-2021; Regan, Clinton/E-6250-2012	Mannan, Mohammad Amin-ul/0000-0001-7484-6736; Dever, Thomas/0000-0001-7120-9678	National Institutes of Health (NIH) [1R15GM101575-01]; Intramural Research Program of the NIH (NICHD); Research Growth Initiative (UW-Milwaukee Graduate School); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001010] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Research Program of the NIH (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Research Growth Initiative (UW-Milwaukee Graduate School); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by National Institutes of Health (NIH) Grants 1R15GM101575-01 (to M. D.) and by the Intramural Research Program of the N<INF>I</INF>H (NICHD; to T. E. D.). This work was also supported by Research Growth Initiative (UW-Milwaukee Graduate School; to M. D.). The authors declare that they have no conflicts of interest with the contents of this article.	Amin-ul Mannan M, 2013, J MOL BIOL, V425, P2083, DOI 10.1016/j.jmb.2013.02.036; Anshu A, 2015, MOL CELL BIOL, V35, P199, DOI 10.1128/MCB.00981-14; ANTHONY DD, 1992, J BIOL CHEM, V267, P1554; Chapman RE, 1997, CURR BIOL, V7, P850, DOI 10.1016/S0960-9822(06)00373-3; COX JS, 1993, CELL, V73, P1197, DOI 10.1016/0092-8674(93)90648-A; Cox JS, 1997, MOL BIOL CELL, V8, P1805, DOI 10.1091/mbc.8.9.1805; Cox JS, 1996, CELL, V87, P391, DOI 10.1016/S0092-8674(00)81360-4; delaCruz J, 1997, P NATL ACAD SCI USA, V94, P5201, DOI 10.1073/pnas.94.10.5201; Gebauer F, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a012245; Gonzalez TN, 1999, EMBO J, V18, P3119, DOI 10.1093/emboj/18.11.3119; Guydosh NR, 2014, CELL, V156, P950, DOI 10.1016/j.cell.2014.02.006; Hinnebusch AG, 2005, ANNU REV MICROBIOL, V59, P407, DOI 10.1146/annurev.micro.59.031805.133833; Hinnebusch AG, 2014, ANNU REV BIOCHEM, V83, P779, DOI 10.1146/annurev-biochem-060713-035802; Hinnebusch AG, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011544; Hinnebusch AG, 2011, MICROBIOL MOL BIOL R, V75, P434, DOI 10.1128/MMBR.00008-11; Hooks KB, 2011, RNA BIOL, V8, P552, DOI 10.4161/rna.8.4.15396; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Kawahara T, 1997, MOL BIOL CELL, V8, P1845, DOI 10.1091/mbc.8.10.1845; Kozak M, 2005, GENE, V361, P13, DOI 10.1016/j.gene.2005.06.037; KOZAK M, 1991, GENE EXPRESSION, V1, P111; KOZAK M, 1986, P NATL ACAD SCI USA, V83, P2850, DOI 10.1073/pnas.83.9.2850; KOZAK M, 1989, MOL CELL BIOL, V9, P5134, DOI 10.1128/MCB.9.11.5134; KOZAK M, 1991, J BIOL CHEM, V266, P19867; Mendez R, 2001, NAT REV MOL CELL BIO, V2, P521, DOI 10.1038/35080081; Mori K, 2000, P NATL ACAD SCI USA, V97, P4660, DOI 10.1073/pnas.050010197; Mori K, 1996, GENES CELLS, V1, P803, DOI 10.1046/j.1365-2443.1996.d01-274.x; Mori T, 2010, MOL BIOL CELL, V21, P3722, DOI 10.1091/mbc.E10-08-0693; Mukhopadhyay R, 2009, TRENDS BIOCHEM SCI, V34, P324, DOI 10.1016/j.tibs.2009.03.004; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Ozes AR, 2011, J MOL BIOL, V412, P674, DOI 10.1016/j.jmb.2011.08.004; Patil CK, 2004, PLOS BIOL, V2, P1208, DOI 10.1371/journal.pbio.0020246; PAUSE A, 1992, EMBO J, V11, P2643, DOI 10.1002/j.1460-2075.1992.tb05330.x; PELLETIER J, 1985, CELL, V40, P515, DOI 10.1016/0092-8674(85)90200-4; Pestova TV, 2002, GENE DEV, V16, P2906, DOI 10.1101/gad.1020902; Pestova TV, 1998, NATURE, V394, P854, DOI 10.1038/29703; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Ruegsegger U, 2001, CELL, V107, P103, DOI 10.1016/S0092-8674(01)00505-0; SCHMID SR, 1991, MOL CELL BIOL, V11, P3463, DOI 10.1128/MCB.11.7.3463; Sidrauski C, 1997, CELL, V90, P1031, DOI 10.1016/S0092-8674(00)80369-4; Sidrauski C, 1996, CELL, V87, P405, DOI 10.1016/S0092-8674(00)81361-6; SIKORSKI RS, 1989, GENETICS, V122, P19; Takyar S, 2005, CELL, V120, P49, DOI 10.1016/j.cell.2004.11.042; Tarun SZ, 1997, MOL CELL BIOL, V17, P6876, DOI 10.1128/MCB.17.12.6876; TARUN SZ, 1995, GENE DEV, V9, P2997, DOI 10.1101/gad.9.23.2997; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Zhou FJ, 2014, J BIOL CHEM, V289, P1704, DOI 10.1074/jbc.M113.529370	47	19	20	1	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2015	290	36					21821	21832		10.1074/jbc.M115.649335	http://dx.doi.org/10.1074/jbc.M115.649335			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ9XI	26175153	hybrid, Green Published			2022-12-26	WOS:000360968500005
J	Fan, HT; Hahm, J; Diggs, S; Perry, JJP; Blaha, G				Fan, Haitian; Hahm, Joseph; Diggs, Stephen; Perry, J. Jefferson P.; Blaha, Gregor			Structural and Functional Analysis of BipA, a Regulator of Virulence in Enteropathogenic Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELONGATION-FACTOR-G; PATHOGENICITY ISLAND; CRYSTAL-STRUCTURE; DIFFRACTION DATA; EF-G; BINDING; RIBOSOME; GTPASE; PPGPP; EXPRESSION	The translational GTPase BipA regulates the expression of virulence and pathogenicity factors in several eubacteria. BipA-dependent expression of virulence factors occurs under starvation conditions, such as encountered during infection of a host. Under these conditions, BipA associates with the small ribosomal subunit. BipA also has a second function to promote the efficiency of late steps in biogenesis of large ribosomal subunits at low temperatures, presumably while bound to the ribosome. During starvation, the cellular concentration of stress alarmone guanosine-3', 5'-bis pyrophosphate (ppGpp) is increased. This increase allows ppGpp to bind to BipA and switch its binding specificity from ribosomes to small ribosomal subunits. A conformational change of BipA upon ppGpp binding could explain the ppGpp regulation of the binding specificity of BipA. Here, we present the structures of the full-length BipA from Escherichia coli in apo, GDP-, and ppGpp-bound forms. The crystal structure and small-angle x-ray scattering data of the protein with bound nucleotides, together with a thermodynamic analysis of the binding of GDP and of ppGpp to BipA, indicate that the ppGpp-bound form of BipA adopts the structure of the GDP form. This suggests furthermore, that the switch in binding preference only occurs when both ppGpp and the small ribosomal subunit are present. This molecular mechanism would allow BipA to interact with both the ribosome and the small ribosomal subunit during stress response.	[Fan, Haitian; Hahm, Joseph; Diggs, Stephen; Perry, J. Jefferson P.; Blaha, Gregor] Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA	University of California System; University of California Riverside	Blaha, G (corresponding author), Univ Calif Riverside, Dept Biochem, 900 Univ Ave,Boyce Hall 5489, Riverside, CA 92521 USA.	gregor.blaha@ucr.edu	Regan, Clinton/E-6250-2012	Fan, Haitian/0000-0003-4337-665X	NIH [P41 GM103403]; DOE [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103403] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOE(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Kennedy Ngotran, Bryan Peguero, and Carlos Rodriguez for help with sample preparation, Dr. Zhimin Zhang for assistance during data collection, Tim Rowsell and Sarah Radi for critical reading of the manuscript, and Dr. Russ Hille for critical discussions. In addition, we thank the staff of beamlines 5.0.1 and 5.0.2 of the Berkeley Center of Structure Biology at the Advanced Light Source (ALS), of the SIBYLS beamline 12.3.1 at ALS, and of beamline 24-ID-C of the Northeastern Collaborative Access Team (funded by NIH, award P41 GM103403) at the Advanced Photon Source (APS; funded by DOE, award DE-AC02-06CH11357) for their expert support during data collection.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; AEVARSSON A, 1994, EMBO J, V13, P3669, DOI 10.1002/j.1460-2075.1994.tb06676.x; Al-Karadaghi S, 1996, STRUCTURE, V4, P555, DOI 10.1016/S0969-2126(96)00061-5; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; Cashel M., 1996, ESCHERICHIA COLI SAL, P1458; Choudhury P, 2015, J BACTERIOL, V197, P1819, DOI 10.1128/JB.00023-15; Classen S, 2013, J APPL CRYSTALLOGR, V46, P1, DOI 10.1107/S0021889812048698; Czworkowski J, 1997, BIOCHEMISTRY-US, V36, P10327, DOI 10.1021/bi970610k; Dalebroux ZD, 2010, MICROBIOL MOL BIOL R, V74, P171, DOI 10.1128/MMBR.00046-09; deLivron MA, 2008, J BACTERIOL, V190, P5944, DOI 10.1128/JB.00763-08; deLivron MA, 2009, BIOCHEMISTRY-US, V48, P10533, DOI 10.1021/bi901026z; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans RN, 2008, P NATL ACAD SCI USA, V105, P4673, DOI 10.1073/pnas.0801308105; Farris M, 1998, MOL MICROBIOL, V28, P265, DOI 10.1046/j.1365-2958.1998.00793.x; Gagnon MG, 2014, SCIENCE, V345, P684, DOI 10.1126/science.1253525; Grant AJ, 2003, MOL MICROBIOL, V48, P507, DOI 10.1046/j.1365-2958.2003.t01-1-03447.x; Hansson S, 2005, FEBS LETT, V579, P4492, DOI 10.1016/j.febslet.2005.07.016; Hauryliuk V, 2008, P NATL ACAD SCI USA, V105, P15678, DOI 10.1073/pnas.0807912105; Hauryliuk V, 2008, BIOPHYS J, V95, P1704, DOI 10.1529/biophysj.107.127290; Hauryliuk V, 2009, J MOL BIOL, V394, P621, DOI 10.1016/j.jmb.2009.10.015; Krishnan K, 2008, J BACTERIOL, V190, P7675, DOI 10.1128/JB.00835-08; Laurberg M, 2000, J MOL BIOL, V303, P593, DOI 10.1006/jmbi.2000.4168; Leipe DD, 2002, J MOL BIOL, V317, P41, DOI 10.1006/jmbi.2001.5378; Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; Liljas A, 1995, BIOCHEM CELL BIOL, V73, P1209, DOI 10.1139/o95-130; Lin JZ, 2015, CELL, V160, P219, DOI 10.1016/j.cell.2014.11.049; Margus T, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-15; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Milon P, 2006, P NATL ACAD SCI USA, V103, P13962, DOI 10.1073/pnas.0606384103; Mitkevich VA, 2010, J MOL BIOL, V402, P838, DOI 10.1016/j.jmb.2010.08.016; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nakanishi N, 2006, MOL MICROBIOL, V61, P194, DOI 10.1111/j.1365-2958.2006.05217.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Owens RM, 2004, EMBO J, V23, P3375, DOI 10.1038/sj.emboj.7600343; Perry JJP, 2013, METHODS, V59, P363, DOI 10.1016/j.ymeth.2013.01.005; Potrykus K, 2011, ENVIRON MICROBIOL, V13, P563, DOI 10.1111/j.1462-2920.2010.02357.x; Rowe S, 2000, J BACTERIOL, V182, P2741, DOI 10.1128/JB.182.10.2741-2745.2000; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766	39	20	21	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2015	290	34					20856	20864		10.1074/jbc.M115.659136	http://dx.doi.org/10.1074/jbc.M115.659136			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP6QC	26163516	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000360011800022
J	Chen, CM; Tsai, MJ; Wei, PJ; Su, YC; Yang, CJ; Wu, MN; Hsu, CY; Hwang, SJ; Chong, IW; Huang, MS				Chen, Chia-Min; Tsai, Ming-Ju; Wei, Po-Ju; Su, Yu-Chung; Yang, Chih-Jen; Wu, Meng-Ni; Hsu, Chung-Yao; Hwang, Shang-Jyh; Chong, Inn-Wen; Huang, Ming-Shyan			Erectile Dysfunction in Patients with Sleep Apnea - A Nationwide Population-Based Study	PLOS ONE			English	Article							POSITIVE AIRWAY PRESSURE; QUALITY-OF-LIFE; SEXUAL FUNCTION; MEN; ASSOCIATION; SILDENAFIL; THERAPY; DISEASE; RISK; METAANALYSIS	Increased incidence of erectile dysfunction (ED) has been reported among patients with sleep apnea (SA). However, this association has not been confirmed in a large-scale study. We therefore performed a population-based cohort study using Taiwan National Health Insurance (NHI) database to investigate the association of SA and ED. From the database of one million representative subjects randomly sampled from individuals enrolled in the NHI system in 2010, we identified adult patients having SA and excluded those having a diagnosis of ED prior to SA. From these suspected SA patients, those having SA diagnosis after polysomnography were defined as probable SA patients. The dates of their first SA diagnosis were defined as their index dates. Each SA patient was matched to 30 randomly-selected, age-matched control subjects without any SA diagnosis. The control subjects were assigned index dates as their corresponding SA patients, and were ensured having no ED diagnosis prior to their index dates. Totally, 4,835 male patients with suspected SA (including 1,946 probable SA patients) were matched to 145,050 control subjects (including 58,380 subjects matched to probable SA patients). The incidence rate of ED was significantly higher in probable SA patients as compared with the corresponding control subjects (5.7 vs. 2.3 per 1000 patient-year; adjusted incidence rate ratio = 2.0 [95% CI: 1.8-2.2], p<0.0001). The cumulative incidence was also significantly higher in the probable SA patients (p<0.0001). In multivariable Cox regression analysis, probable SA remained a significant risk factor for the development of ED after adjusting for age, residency, income level and comorbidities (hazard ratio = 2.0 [95% CI: 1.5-2.7], p<0.0001). In line with previous studies, this population-based large-scale study confirmed an increased ED incidence in SA patients in Chinese population. Physicians need to pay attention to the possible underlying SA while treating ED patients.	[Chen, Chia-Min; Tsai, Ming-Ju; Wei, Po-Ju; Yang, Chih-Jen; Chong, Inn-Wen; Huang, Ming-Shyan] Kaohsiung Med Univ, Div Pulm & Crit Care Med, Dept Internal Med, Kaohsiung Med Univ Hosp, Kaohsiung, Taiwan; [Tsai, Ming-Ju; Yang, Chih-Jen; Huang, Ming-Shyan] Kaohsiung Med Univ, Grad Inst Med, Coll Med, Kaohsiung, Taiwan; [Tsai, Ming-Ju; Wu, Meng-Ni; Hsu, Chung-Yao] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Sleep Disorders Ctr, Kaohsiung, Taiwan; [Su, Yu-Chung; Yang, Chih-Jen] Kaohsiung Med Univ, Kaohsiung Municipal Ta Tung Hosp, Dept Internal Med, Kaohsiung, Taiwan; [Su, Yu-Chung; Yang, Chih-Jen; Hsu, Chung-Yao; Huang, Ming-Shyan] Kaohsiung Med Univ, Coll Med, Sch Med, Kaohsiung, Taiwan; [Wu, Meng-Ni; Hsu, Chung-Yao] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Neurol, Kaohsiung, Taiwan; [Hwang, Shang-Jyh] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Div Nephrol, Dept Internal Med, Kaohsiung, Taiwan; [Hwang, Shang-Jyh] Kaohsiung Med Univ, Dept Renal Care, Coll Med, Kaohsiung, Taiwan; [Chong, Inn-Wen] Kaohsiung Med Univ, Dept Resp Care, Coll Med, Kaohsiung, Taiwan; [Huang, Ming-Shyan] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Div Geriatr & Gerontol, Dept Internal Med, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Municipal Ta-Tung Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital	Huang, MS (corresponding author), Kaohsiung Med Univ, Div Pulm & Crit Care Med, Dept Internal Med, Kaohsiung Med Univ Hosp, Kaohsiung, Taiwan.	shyan310@gmail.com	Tsai, Ming-Ju/D-5566-2011; Stefanadis, Christodoulos/ABH-2232-2020	Stefanadis, Christodoulos/0000-0001-5974-6454; Chen, Chia Min/0000-0001-7045-1251; Hsu, Chung-Yao/0000-0002-9880-5944				Andersen ML, 2010, SLEEP MED, V11, P1019, DOI 10.1016/j.sleep.2009.08.016; Arzt M, 2005, AM J RESP CRIT CARE, V172, P1447, DOI 10.1164/rccm.200505-702OC; Aytac IA, 1999, BJU INT, V84, P50; Bouloukaki I, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/568951; Budweiser S, 2013, J SEX MED, V10, P524, DOI 10.1111/j.1743-6109.2012.02968.x; Budweiser S, 2009, J SEX MED, V6, P3147, DOI 10.1111/j.1743-6109.2009.01372.x; Chou KT, 2012, AM J MED, V125, P374, DOI 10.1016/j.amjmed.2011.07.003; Chou PS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093081; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Fanfulla F, 2000, SLEEP, V23, P775; Gandaglia G, 2014, EUR UROL, V65, P968, DOI 10.1016/j.eururo.2013.08.023; Goncalves MA, 2005, SLEEP MED, V6, P333, DOI 10.1016/j.sleep.2005.03.001; Heruti R, 2005, J SEX MED, V2, P543, DOI 10.1111/j.1743-6109.2005.00072.x; HIRSHKOWITZ M, 1990, UROLOGY, V36, P232, DOI 10.1016/0090-4295(90)80262-L; Hoekema A, 2007, J SEX MED, V4, P1153, DOI 10.1111/j.1743-6109.2006.00341.x; Hoyos CM, 2015, SLEEP MED REV, V20, P5, DOI 10.1016/j.smrv.2014.03.004; Huang CC, 2013, ANDROLOGY-US, V1, P240, DOI 10.1111/j.2047-2927.2012.00037.x; Huyghe E, 2009, J SEX MED, V6, P1395, DOI 10.1111/j.1743-6109.2008.01169.x; JONLER M, 1995, BRIT J UROL, V75, P651, DOI 10.1111/j.1464-410X.1995.tb07426.x; Kang JH, 2012, UROLOGY, V79, P340, DOI 10.1016/j.urology.2011.08.040; Khafagy AH, 2012, INT J CLIN PRACT, V66, P1204, DOI 10.1111/j.1742-1241.2012.02990.x; Knapp A, 2014, CLIN ENDOCRINOL, V81, P254, DOI 10.1111/cen.12401; Kohler M, 2011, AM J RESP CRIT CARE, V184, P1192, DOI 10.1164/rccm.201106-0964OC; Li XM, 2010, AGING MALE, V13, P82, DOI 10.3109/13685530903406789; Liu K, 2012, J ANDROL, V33, P1186, DOI 10.2164/jandrol.112.016642; Maiorino MI, 2014, DIABET METAB SYND OB, V7, P95, DOI 10.2147/DMSO.S36455; Margel D, 2004, UROLOGY, V63, P545, DOI 10.1016/j.urology.2003.10.016; Meller SM, 2013, J INVASIVE CARDIOL, V25, P313; Myers KA, 2013, JAMA-J AM MED ASSOC, V310, P731, DOI 10.1001/jama.2013.276185; Pastore AL, 2014, INT J CLIN PRACT, V68, P995, DOI 10.1111/ijcp.12463; Perimenis P, 2007, INT UROL NEPHROL, V39, P547, DOI 10.1007/s11255-006-9079-4; Perimenis P, 2007, ASIAN J ANDROL, V9, P259, DOI 10.1111/j.1745-7262.2007.00085.x; Reichmuth KJ, 2005, AM J RESP CRIT CARE, V172, P1590, DOI 10.1164/rccm.200504-637OC; Roizenblatt S, 2006, ARCH INTERN MED, V166, P1763, DOI 10.1001/archinte.166.16.1763; Shin HW, 2008, INT J IMPOT RES, V20, P549, DOI 10.1038/ijir.2008.39; Shin HW, 2013, J SEX MED, V10, P2053, DOI 10.1111/jsm.12128; Soukhova-O'Hare GK, 2008, AM J RESP CRIT CARE, V178, P644, DOI 10.1164/rccm.200801-190OC; Su VYF, 2013, ALLERGY, V68, P440, DOI 10.1111/all.12100; Teloken PE, 2006, UROLOGY, V67, P1033, DOI 10.1016/j.urology.2005.11.040; Vlachopoulos CV, 2013, CIRC-CARDIOVASC QUAL, V6, P99, DOI 10.1161/CIRCOUTCOMES.112.966903; Wu CY, 2012, JAMA-J AM MED ASSOC, V308, P1906, DOI 10.1001/2012.jama.11975; YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704; Zias N, 2009, SLEEP BREATH, V13, P3, DOI 10.1007/s11325-008-0212-8	43	18	18	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132510	10.1371/journal.pone.0132510	http://dx.doi.org/10.1371/journal.pone.0132510			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177206	Green Published, Green Submitted, gold			2022-12-26	WOS:000358197600119
J	Cho, KS; Lee, JH; Park, MK; Park, HK; Yu, HS; Roh, HJ				Cho, Kyu-Sup; Lee, Jung-Hoon; Park, Mi-Kyung; Park, Hye-Kyung; Yu, Hak-Sun; Roh, Hwan-Jung			Prostaglandin E2 and Transforming Growth Factor-beta Play a Critical Role in Suppression of Allergic Airway Inflammation by Adipose-Derived Stem Cells	PLOS ONE			English	Article							T-CELLS; TGF-BETA; ASTHMA; LYMPHOCYTE; SECRETION; RHINITIS; MODEL; GAMMA; E-2	Background The role of soluble factors in the suppression of allergic airway inflammation by adipose-derived stem cells (ASCs) remains to be elucidated. Moreover, the major soluble factors responsible for the immunomodulatory effects of ASCs in allergic airway diseases have not been well documented. We evaluated the effects of ASCs on allergic inflammation in asthmatic mice treated with a prostaglandin E2 (PGE2) inhibitor or transforming growth factor-beta (TGF-beta) neutralizing antibodies. Methods and Findings Asthmatic mice were injected intraperitoneally with a PGE2 inhibitor or TGF-beta neutralizing antibodies at approximately the same time as ASCs injection and were compared with nontreated controls. In asthmatic mice, ASCs significantly reduced airway hyperresponsiveness, the number of total inflammatory cells and eosinophils in the bronchoalveolar lavage fluid (BALF), eosinophilic inflammation, goblet cell hyperplasia, and serum total and allergen-specific IgE and IgG1. ASCs significantly inhibited Th2 cytokines, such as interleukin (IL)-4, IL-5, and IL-1 beta, and enhanced the Th1 cytokine (Interferon-gamma) and regulatory cytokines (IL-10 and TGF-beta) in the BALF and lung draining lymph nodes (LLNs). ASCs engraftment caused significant increases in the regulatory T cell (Treg) and IL-10(+)T cell populations in LLNs. However, blocking PGE2 or TGF-beta eliminated the immunosuppressive effect of ASCs in allergic airway inflammation. Conclusions ASCs are capable of secreting PGE2 and TGF-beta, which may play a role in inducing Treg expansion. Furthermore, treatment with a PGE2 inhibitor or TGF-beta neutralizing antibodies eliminated the beneficial effect of ASCs treatment in asthmatic mice, suggesting that PGE2 and TGF-beta are the major soluble factors responsible for suppressing allergic airway inflammation.	[Cho, Kyu-Sup; Lee, Jung-Hoon] Pusan Natl Univ Hosp, Dept Otorhinolaryngol, Busan, South Korea; [Cho, Kyu-Sup; Lee, Jung-Hoon] Pusan Natl Univ Hosp, Biomed Res Inst, Busan, South Korea; [Park, Mi-Kyung; Yu, Hak-Sun] Pusan Natl Univ, Sch Med, Dept Parasitol, Yangsan, South Korea; [Park, Hye-Kyung] Pusan Natl Univ Hosp, Dept Internal Med, Busan, South Korea; [Roh, Hwan-Jung] Pusan Natl Univ, Yangsan Hosp, Dept Otorhinolaryngol, Yangsan, South Korea; [Roh, Hwan-Jung] Pusan Natl Univ, Yangsan Hosp, Res Inst Convergence Biomed Sci & Technol, Yangsan, South Korea	Pusan National University; Pusan National University Hospital; Pusan National University; Pusan National University Hospital; Pusan National University; Pusan National University Hospital; Pusan National University; Pusan National University Hospital; Pusan National University; Pusan National University Hospital; Pusan National University; Pusan National University Hospital	Roh, HJ (corresponding author), Pusan Natl Univ, Yangsan Hosp, Dept Otorhinolaryngol, Yangsan, South Korea.	rohhj@pusan.ac.kr			Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [HI12C0315]	Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea	This study was supported by a grant of the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (HI12C0315). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Baratelli F, 2005, J IMMUNOL, V175, P1483, DOI 10.4049/jimmunol.175.3.1483; Bonfield TL, 2010, AM J PHYSIOL-LUNG C, V299, pL760, DOI 10.1152/ajplung.00182.2009; Bonfield TL, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-51; Bousquet J, 2008, ALLERGY, V63, P8, DOI 10.1111/j.1398-9995.2007.01620.x; Caterson E, 2002, MOL BIOTECHNOL, V20, P245, DOI 10.1385/MB:20:3:245; Cho KS, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/436476; Cho KS, 2010, CURR STEM CELL RES T, V5, P111, DOI 10.2174/157488810791268681; Cho KS, 2009, STEM CELLS, V27, P259, DOI 10.1634/stemcells.2008-0283; Cohn L, 2004, ANNU REV IMMUNOL, V22, P789, DOI 10.1146/annurev.immunol.22.012703.104716; Cui L, 2007, TISSUE ENG, V13, P1185, DOI 10.1089/ten.2006.0315; English K, 2009, CLIN EXP IMMUNOL, V156, P149, DOI 10.1111/j.1365-2249.2009.03874.x; English K, 2008, IMMUNOL LETT, V115, P50, DOI 10.1016/j.imlet.2007.10.002; Fu QL, 2012, ALLERGY, V67, P1215, DOI [10.1111/j.1398-9995.2012.02875.x, 10.1111/j.1398-9995.2012.02875.x.]; Fu S, 2004, AM J TRANSPLANT, V4, P1614, DOI 10.1111/j.1600-6143.2004.00566.x; Ge XH, 2013, CELL BIOL INT, V37, P675, DOI 10.1002/cbin.10084; Goodwin M, 2011, STEM CELLS, V29, P1137, DOI 10.1002/stem.656; Hartl D, 2007, J ALLERGY CLIN IMMUN, V119, P1258, DOI 10.1016/j.jaci.2007.02.023; Jaffar Z, 2004, J IMMUNOL, V172, P3842, DOI 10.4049/jimmunol.172.6.3842; Kang JH, 2009, AM J RESP CRIT CARE, V179, P875, DOI 10.1164/rccm.200806-893OC; Lee CG, 2004, NAT MED, V10, P1095, DOI 10.1038/nm1105; Mathias LJ, 2013, J IMMUNOL, V191, P5914, DOI 10.4049/jimmunol.1300667; Nemeth K, 2010, P NATL ACAD SCI USA, V107, P5652, DOI 10.1073/pnas.0910720107; Park HK, 2010, STEM CELLS DEV, V19, P1811, DOI 10.1089/scd.2009.0513; Pellaton-Longaretti C, 2011, INT IMMUNOL, V23, P17, DOI 10.1093/intimm/dxq453; Peters-Golden M, 2004, AM J RESP CELL MOL, V31, P3, DOI 10.1165/rcmb.f279; Ryan JM, 2007, CLIN EXP IMMUNOL, V149, P353, DOI 10.1111/j.1365-2249.2007.03422.x; Selmani Z, 2008, STEM CELLS, V26, P212, DOI 10.1634/stemcells.2007-0554; Shi HZ, 2005, ALLERGY, V60, P986, DOI 10.1111/j.1398-9995.2005.00844.x; Shi M, 2011, CLIN EXP IMMUNOL, V164, P1, DOI 10.1111/j.1365-2249.2011.04327.x; Spaggiari GM, 2008, BLOOD, V111, P1327, DOI 10.1182/blood-2007-02-074997; Sun YQ, 2012, STEM CELLS, V30, P2692, DOI 10.1002/stem.1241; Tournoy KG, 2000, CLIN EXP ALLERGY, V30, P79; Uccelli A, 2007, TRENDS IMMUNOL, V28, P219, DOI 10.1016/j.it.2007.03.001; Uccelli A, 2006, EUR J IMMUNOL, V36, P2566, DOI 10.1002/eji.200636416; Wilson MS, 2005, J EXP MED, V202, P1199, DOI 10.1084/jem.20042572	36	28	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0131813	10.1371/journal.pone.0131813	http://dx.doi.org/10.1371/journal.pone.0131813			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176545	Green Published, Green Submitted, gold			2022-12-26	WOS:000358197600066
J	Garavito, NT; Newton, AC; Golicher, D; Oldfield, S				Garavito, Natalia Tejedor; Newton, Adrian C.; Golicher, Duncan; Oldfield, Sara			The Relative Impact of Climate Change on the Extinction Risk of Tree Species in the Montane Tropical Andes	PLOS ONE			English	Article							IUCN RED LIST; DISTRIBUTION MODELS; PLANT DIVERSITY; LAND-USE; BIODIVERSITY; CONSERVATION; HABITAT; DISTRIBUTIONS; FUTURE; FOREST	There are widespread concerns that anthropogenic climate change will become a major cause of global biodiversity loss. However, the potential impact of climate change on the extinction risk of species remains poorly understood, particularly in comparison to other current threats. The objective of this research was to examine the relative impact of climate change on extinction risk of upper montane tree species in the tropical Andes, an area of high biodiversity value that is particularly vulnerable to climate change impacts. The extinction risk of 129 tree species endemic to the region was evaluated according to the IUCN Red List criteria, both with and without the potential impacts of climate change. Evaluations were supported by development of species distribution models, using three methods (generalized additive models, recursive partitioning, and support vector machines), all of which produced similarly high AUC values when averaged across all species evaluated (0.82, 0.86, and 0.88, respectively). Inclusion of climate change increased the risk of extinction of 18-20% of the tree species evaluated, depending on the climate scenario. The relative impact of climate change was further illustrated by calculating the Red List Index, an indicator that shows changes in the overall extinction risk of sets of species over time. A 15% decline in the Red List Index was obtained when climate change was included in this evaluation. While these results suggest that climate change represents a significant threat to tree species in the tropical Andes, they contradict previous suggestions that climate change will become the most important cause of biodiversity loss in coming decades. Conservation strategies should therefore focus on addressing the multiple threatening processes currently affecting biodiversity, rather than focusing primarily on potential climate change impacts.	[Garavito, Natalia Tejedor; Newton, Adrian C.; Golicher, Duncan] Bournemouth Univ, Fac Sci & Technol, Poole BH12 5BB, Dorset, England; [Oldfield, Sara] Bot Garden Conservat Int, Richmond, Surrey, England	Bournemouth University	Newton, AC (corresponding author), Bournemouth Univ, Fac Sci & Technol, Poole BH12 5BB, Dorset, England.	anewton@bournemouth.ac.uk	Golicher, Duncan/B-4240-2009; Tejedor, Natalia/A-5601-2012	Tejedor, Natalia/0000-0002-1140-6263	Bournemouth University studentship; Franklinia Foundation	Bournemouth University studentship; Franklinia Foundation	This research was supported by a Bournemouth University studentship to the senior author, and support from the Franklinia Foundation to BGCI.	Akcakaya HR, 2006, GLOBAL CHANGE BIOL, V12, P2037, DOI 10.1111/j.1365-2486.2006.01253.x; Allen MR, 2000, NATURE, V407, P617, DOI 10.1038/35036559; Anderson EP., 2011, CLIMATE CHANGE BIODI, P1, DOI DOI 10.13140/2.1.3718.4969; Araujo MB, 2011, ECOL LETT, V14, P484, DOI 10.1111/j.1461-0248.2011.01610.x; Barbet-Massin M, 2012, METHODS ECOL EVOL, V3, P327, DOI 10.1111/j.2041-210X.2011.00172.x; Bellard C, 2012, ECOL LETT, V15, P365, DOI 10.1111/j.1461-0248.2011.01736.x; Bomhard B, 2005, GLOBAL CHANGE BIOL, V11, P1452, DOI 10.1111/j.1365-2486.2005.00997.x; Botkin DB, 2007, BIOSCIENCE, V57, P227, DOI 10.1641/B570306; Busch J, 2012, CONSERV BIOL, V26, P408, DOI 10.1111/j.1523-1739.2012.01838.x; Bush M.B., 2007, TROPICAL RAINFOREST, P59, DOI DOI 10.1007/978-3-540-48842-2; Butchart SHM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000140; Campbell A., 2009, TECHNICAL SERIES, V42, P124; Cayuela L, 2009, TROP CONSERV SCI, V2, P319, DOI 10.1177/194008290900200304; Cubasch U, 2001, CLIMATE CHANGE 2001: THE SCIENTIFIC BASIS, P525; Dawson TP, 2011, SCIENCE, V332, P53, DOI 10.1126/science.1200303; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; FAO, 2020, GLOBAL FOREST RESOUR; Feeley KJ, 2011, J BIOGEOGR, V38, P783, DOI 10.1111/j.1365-2699.2010.02444.x; Franklin J, 2009, MAPPING SPECIES DIST; Garavito N. T., 2014, REGIONAL RED LIST MO; Garavito N.T., 2012, ECOSISTEMAS, P1; Golicher DJ, 2012, BIOTROPICA, V44, P284, DOI 10.1111/j.1744-7429.2011.00815.x; Gu WD, 2004, BIOL CONSERV, V116, P195, DOI 10.1016/S0006-3207(03)00190-3; Guisan A, 2007, DIVERS DISTRIB, V13, P332, DOI 10.1111/j.1472-4642.2007.00342.x; HASTIE T, 2008, GAM GEN ADDITIVE MOD; He FL, 2011, NATURE, V473, P368, DOI 10.1038/nature09985; Hernandez PA, 2006, ECOGRAPHY, V29, P773, DOI 10.1111/j.0906-7590.2006.04700.x; Hilbert DW, 2004, BIOL CONSERV, V116, P367, DOI 10.1016/S0006-3207(03)00230-1; Ibanez I, 2006, ECOLOGY, V87, P1896, DOI 10.1890/0012-9658(2006)87[1896:PBCOTC]2.0.CO;2; IPCC, 2000, IPCC SPEC REP EM SCE, P20; IUCN, 2012, IUCN RED LIST CATEGO, VSecond edition; IUCN, 2022, GUID US IUCN RED LIS; IUCN U.-W., 2012, WORLD DAT PROT AR WD; Jetz W, 2007, PLOS BIOL, V5, P1211, DOI 10.1371/journal.pbio.0050157; Karatzoglou A, 2013, SUPPORT VECTOR MACHI; Ladle RJ, 2005, INTERDISCIPL SCI REV, V30, P231, DOI 10.1179/030801805X42036; Lamoreux J, 2003, TRENDS ECOL EVOL, V18, P214, DOI 10.1016/S0169-5347(03)00090-9; Laurance WF, 2011, BIOL CONSERV, V144, P548, DOI 10.1016/j.biocon.2010.10.010; Leadley P., 2010, TECHNICAL SERIES SEC, V50, P1; Lobo JM, 2010, ECOGRAPHY, V33, P103, DOI 10.1111/j.1600-0587.2009.06039.x; Loiselle BA, 2008, J BIOGEOGR, V35, P105, DOI 10.1111/j.1365-2699.2007.01779.x; Lomolino MV, 2004, CONSERVATION BIOGEOG, P293; Mace GM, 2008, CONSERV BIOL, V22, P1424, DOI 10.1111/j.1523-1739.2008.01044.x; Malcolm JR, 2006, CONSERV BIOL, V20, P538, DOI 10.1111/j.1523-1739.2006.00364.x; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Olson D.M., 1997, GLOBAL 200 CONSERVIN; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Pearson RG, 2006, J BIOGEOGR, V33, P1704, DOI 10.1111/j.1365-2699.2006.01460.x; Pereira HM, 2010, SCIENCE, V330, P1496, DOI 10.1126/science.1196624; Ponce-Reyes R, 2013, DIVERS DISTRIB, V19, P518, DOI 10.1111/ddi.12064; Pounds JA, 1999, NATURE, V398, P611, DOI 10.1038/19297; R Core Team, 2016, R FDN STAT COMP; Raes N, 2007, ECOGRAPHY, V30, P727, DOI 10.1111/j.2007.0906-7590.05041.x; Ramirez J, 2012, HIGH RESOLUTION STAT; Raxworthy CJ, 2008, GLOBAL CHANGE BIOL, V14, P1703, DOI 10.1111/j.1365-2486.2008.01596.x; Ricketts TH, 2005, P NATL ACAD SCI USA, V102, P18497, DOI 10.1073/pnas.0509060102; Rodrigues ASL, 2006, TRENDS ECOL EVOL, V21, P71, DOI 10.1016/j.tree.2005.10.010; Secretariat of the Convention on Biological Diversity (SCDB), 2010, GLOB BIOD OUTL, V3; Sekercioglu CH, 2008, CONSERV BIOL, V22, P140, DOI 10.1111/j.1523-1739.2007.00852.x; Shoo LP, 2005, BIOL CONSERV, V125, P335, DOI 10.1016/j.biocon.2005.04.003; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Staudt A, 2013, FRONT ECOL ENVIRON, V11, P494, DOI 10.1890/120275; Stein BA, 2013, FRONT ECOL ENVIRON, V11, P502, DOI 10.1890/120277; Swab RM, 2012, J BIOGEOGR, V39, P1266, DOI 10.1111/j.1365-2699.2012.02690.x; Therneau T., 2013, RPART RECURSIVE PART; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thuiller W, 2005, P NATL ACAD SCI USA, V102, P8245, DOI 10.1073/pnas.0409902102; Thuiller W, 2011, NATURE, V470, P531, DOI 10.1038/nature09705; Tovar C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063634; Tsoar A, 2007, DIVERS DISTRIB, V13, P397, DOI 10.1111/j.1472-4642.2007.00346.x; Urrutia R, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2008JD011021; Van Bogaert E., 2012, GLOBAL LAND COVER MA; van Vuuren DP, 2006, ECOL SOC, V11; Vuille M, 2000, GEOPHYS RES LETT, V27, P3885, DOI 10.1029/2000GL011871; Williams JW, 2007, P NATL ACAD SCI USA, V104, P5738, DOI 10.1073/pnas.0606292104; Williams SE, 2003, P ROY SOC B-BIOL SCI, V270, P1887, DOI 10.1098/rspb.2003.2464; Yang LH, 2010, ECOL LETT, V13, P1, DOI 10.1111/j.1461-0248.2009.01402.x; Young KR, 2007, PHYS GEOGRAPHY S AM, P200	80	10	11	2	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0131388	10.1371/journal.pone.0131388	http://dx.doi.org/10.1371/journal.pone.0131388			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177097	Green Published, gold, Green Accepted			2022-12-26	WOS:000358197600043
J	Li, SW; Shi, RF; Leng, Y				Li, Shi-Weng; Shi, Rui-Fang; Leng, Yan			De Novo Characterization of the Mung Bean Transcriptome and Transcriptomic Analysis of Adventitious Rooting in Seedlings Using RNA-Seq	PLOS ONE			English	Article							GENE-EXPRESSION; GENOME ANNOTATION; HYDROGEN-PEROXIDE; IN-VITRO; AUXIN; PLANT; ARABIDOPSIS; LIGNIN; ACID; IDENTIFICATION	Adventitious rooting is the most important mechanism underlying vegetative propagation and an important strategy for plant propagation under environmental stress. The present study was conducted to obtain transcriptomic data and examine gene expression using RNA-Seq and bioinformatics analysis, thereby providing a foundation for understanding the molecular mechanisms controlling adventitious rooting. Three cDNA libraries constructed from mRNA samples from mung bean hypocotyls during adventitious rooting were sequenced. These three samples generated a total of 73 million, 60 million, and 59 million 100-bp reads, respectively. These reads were assembled into 78,697 unigenes with an average length of 832 bp, totaling 65 Mb. The unigenes were aligned against six public protein databases, and 29,029 unigenes (36.77%) were annotated using BLASTx. Among them, 28,225 (35.75%) and 28,119 (35.62%) unigenes had homologs in the TrEMBL and NCBI non-redundant (Nr) databases, respectively. Of these unigenes, 21,140 were assigned to gene ontology classes, and a total of 11,990 unigenes were classified into 25 KOG functional categories. A total of 7,357 unigenes were annotated to 4,524 KOs, and 4,651 unigenes were mapped onto 342 KEGG pathways using BLAST comparison against the KEGG database. A total of 11,717 unigenes were differentially expressed (fold change>2) during the root induction stage, with 8,772 unigenes down-regulated and 2,945 unigenes up-regulated. A total of 12,737 unigenes were differentially expressed during the root initiation stage, with 9,303 unigenes down-regulated and 3,434 unigenes up-regulated. A total of 5,334 unigenes were differentially expressed between the root induction and initiation stage, with 2,167 unigenes down-regulated and 3,167 unigenes up-regulated. qRT-PCR validation of the 39 genes with known functions indicated a strong correlation (92.3%) with the RNA-Seq data. The GO enrichment, pathway mapping, and gene expression profiles reveal molecular traits for root induction and initiation. This study provides a platform for functional genomic research with this species.	[Li, Shi-Weng; Shi, Rui-Fang; Leng, Yan] Lanzhou Jiaotong Univ, Sch Chem & Biol Engn, Key Lab Extreme Environm Microbial Resources & En, Lanzhou 730070, Peoples R China	Lanzhou Jiaotong University	Li, SW (corresponding author), Lanzhou Jiaotong Univ, Sch Chem & Biol Engn, Key Lab Extreme Environm Microbial Resources & En, 88 West Anning Rd, Lanzhou 730070, Peoples R China.	lishweng@mail.lzjtu.cn	Li, Shi-Weng/J-6005-2019	Li, Shi Weng/0000-0002-2584-0562	National Natural Science Foundation of China [31260090]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (31260090).	Alvarez S, 2008, PLANT CELL ENVIRON, V31, P325, DOI 10.1111/j.1365-3040.2007.01770.x; Annadurai RS, 2012, BMC GENOMICS, V13, P1, DOI 10.1186/1471-2164-13-663; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Bai XG, 2012, PLANT PHYSIOL, V158, P725, DOI 10.1104/pp.111.185769; Barrero RA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-600; Batish DR, 2008, J PLANT PHYSIOL, V165, P297, DOI 10.1016/j.jplph.2007.05.003; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BOUDET AM, 1995, NEW PHYTOL, V129, P203, DOI 10.1111/j.1469-8137.1995.tb04292.x; Braun N, 2008, PLANT CELL, V20, P2746, DOI 10.1105/tpc.108.059048; Brinker M, 2004, PLANT PHYSIOL, V135, P1526, DOI 10.1104/pp.103.032235; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Chapman EJ, 2009, ANNU REV GENET, V43, P265, DOI 10.1146/annurev-genet-102108-134148; Cho M, 2007, PLANT CELL, V19, P3930, DOI 10.1105/tpc.107.054288; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cosgrove DJ, 2005, NAT REV MOL CELL BIO, V6, P850, DOI 10.1038/nrm1746; Davin LB, 2008, NAT PROD REP, V25, P1015, DOI 10.1039/b510386j; De Klerk GJ, 1999, IN VITRO CELL DEV-PL, V35, P189, DOI 10.1007/s11627-999-0076-z; DEKLERK GJ, 1995, J EXP BOT, V46, P965, DOI 10.1093/jxb/46.8.965; DeKlerk GJ, 1997, BIOL PLANTARUM, V39, P53, DOI 10.1023/A:1000304922507; Feng C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-19; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gutierrez L, 2009, PLANT CELL, V21, P3119, DOI 10.1105/tpc.108.064758; Hand SC, 2011, ANNU REV PHYSIOL, V73, P115, DOI 10.1146/annurev-physiol-012110-142203; Hatzilazarou SP, 2006, J PLANT PHYSIOL, V163, P827, DOI 10.1016/j.jplph.2005.06.018; Holmes P, 2010, FUNCT PLANT BIOL, V37, P1117, DOI 10.1071/FP10159; Holmes P, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-21; Huang HH, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-648; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Jian B, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-59; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li SW, 2014, ENVIRON SCI POLLUT R, V21, P525, DOI 10.1007/s11356-013-1942-0; Li SW, 2009, ENVIRON EXP BOT, V66, P442, DOI 10.1016/j.envexpbot.2009.03.005; Li SW, 2009, BOT REV, V75, P230, DOI 10.1007/s12229-009-9029-9; Li SW, 2009, ENVIRON EXP BOT, V65, P63, DOI 10.1016/j.envexpbot.2008.06.004; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mao XZ, 2005, BIOINFORMATICS, V21, P3787, DOI 10.1093/bioinformatics/bti430; Metaxas DJ, 2004, PLANT GROWTH REGUL, V44, P257, DOI 10.1007/s10725-004-5931-7; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; MYLONA P, 1994, PLANT MOL BIOL, V26, P39, DOI 10.1007/BF00039518; Negi S, 2010, PLANT J, V61, P3, DOI 10.1111/j.1365-313X.2009.04027.x; Qiu Q, 2011, TREE PHYSIOL, V31, P452, DOI 10.1093/treephys/tpr015; Ramirez-Carvajal GA, 2010, PLANT SIGNAL BEHAV, V5, P281, DOI 10.4161/psb.5.3.10705; Ramirez-Carvajal GA, 2009, PLANT PHYSIOL, V150, P759, DOI 10.1104/pp.109.137505; Rigal A, 2012, PLANT PHYSIOL, V160, P1996, DOI 10.1104/pp.112.204453; Rorat T, 2006, CELL MOL BIOL LETT, V11, P536, DOI 10.2478/s11658-006-0044-0; Macedo ES, 2012, PLANT CELL REP, V31, P1581, DOI 10.1007/s00299-012-1272-6; Schafleitner R, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1556-7; Shin R, 2007, PLANT CELL, V19, P2440, DOI 10.1105/tpc.107.050963; Sorin C, 2006, PLANT PHYSIOL, V140, P349, DOI 10.1104/pp.105.067868; Sweetman C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-691; Tamagnone L, 1998, PLANT CELL, V10, P1801, DOI 10.1105/tpc.10.11.1801; Tromas A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006648; Turktas M, 2015, TURK J AGRIC FOR, V39, P361, DOI 10.3906/tar-1409-93; Vidoz ML, 2010, PLANT J, V63, P551, DOI 10.1111/j.1365-313X.2010.04262.x; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wang WX, 2003, PLANTA, V218, P1, DOI 10.1007/s00425-003-1105-5; Wei K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107201; WIESMAN Z, 1988, PHYSIOL PLANTARUM, V74, P556, DOI 10.1111/j.1399-3054.1988.tb02018.x; Wong MML, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-342; Xu DL, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-133; Yang W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084580; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zazimalova E, 2007, CELL MOL LIFE SCI, V64, P1621, DOI 10.1007/s00018-007-6566-4	66	32	36	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132969	10.1371/journal.pone.0132969	http://dx.doi.org/10.1371/journal.pone.0132969			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177103	gold, Green Submitted, Green Published			2022-12-26	WOS:000358197600193
J	Pont-Sunyer, C; Iranzo, A; Gaig, C; Fernandez-Arcos, A; Vilas, D; Valldeoriola, F; Compta, Y; Fernandez-Santiago, R; Fernandez, M; Bayes, A; Calopa, M; Casquero, P; de Fabregues, O; Jauma, S; Puente, V; Salamero, M; Marti, MJ; Santamaria, J; Tolosa, E				Pont-Sunyer, Claustre; Iranzo, Alex; Gaig, Carles; Fernandez-Arcos, Ana; Vilas, Dolores; Valldeoriola, Francesc; Compta, Yaroslau; Fernandez-Santiago, Ruben; Fernandez, Manel; Bayes, Angels; Calopa, Matilde; Casquero, Pilar; de Fabregues, Oriol; Jauma, Serge; Puente, Victor; Salamero, Manel; Marti, Maria Jose; Santamaria, Joan; Tolosa, Eduard			Sleep Disorders in Parkinsonian and Nonparkinsonian LRRK2 Mutation Carriers	PLOS ONE			English	Article							EXCESSIVE DAYTIME SLEEPINESS; RESTLESS LEGS SYNDROME; QUALITY-OF-LIFE; BEHAVIOR DISORDER; REM-SLEEP; G2019S MUTATION; DIAGNOSTIC-CRITERIA; DISEASE PATIENTS; RATING-SCALE; PENETRANCE	Objective In idiopathic Parkinson disease (IPD) sleep disorders are common and may antedate the onset of parkinsonism. Based on the clinical similarities between IPD and Parkinson disease associated with LRRK2 gene mutations (LRRK2-PD), we aimed to characterize sleep in parkinsonian and nonmanifesting LRRK2 mutation carriers (NMC). Methods A comprehensive interview conducted by sleep specialists, validated sleep scales and questionnaires, and video-polysomnography followed by multiple sleep latency test (MSLT) assessed sleep in 18 LRRK2-PD (17 carrying G2019S and one R1441G mutations), 17 NMC (11 G2019S, three R1441G, three R1441C), 14 non-manifesting non-carriers (NMNC) and 19 unrelated IPD. Results Sleep complaints were frequent in LRRK2-PD patients; 78% reported poor sleep quality, 33% sleep onset insomnia, 56% sleep fragmentation and 39% early awakening. Sleep onset insomnia correlated with depressive symptoms and poor sleep quality. In LRRK2-PD, excessive daytime sleepiness (EDS) was a complaint in 33% patients and short sleep latencies on the MSLT, which are indicative of objective EDS, were found in 71%. Sleep attacks occurred in three LRRK2-PD patients and a narcoleptic phenotype was not observed. REM sleep behavior disorder (RBD) was diagnosed in three LRRK2-PD. EDS and RBD were always reported to start after the onset of parkinsonism in LRRK2-PD. In NMC, EDS was rarely reported and RBD was absent. When compared to IPD, sleep onset insomnia was more significantly frequent, EDS was similar, and RBD was less significantly frequent and less severe in LRRK2-PD. In NMC, RBD was not detected and sleep complaints were much less frequent than in LRRK2-PD. No differences were observed in sleep between NMC and NMNC. Conclusions Sleep complaints are frequent in LRRK2-PDand show a pattern that when compared to IPD is characterized by more frequent sleep onset insomnia, similar EDS and less prominent RBD. Unlike in IPD, RBD and EDS seem to be not markers of the prodromal stage of LRRK2-PD.	[Pont-Sunyer, Claustre; Vilas, Dolores; Valldeoriola, Francesc; Compta, Yaroslau; Marti, Maria Jose; Tolosa, Eduard] Univ Barcelona, Inst Invest Biomed August Pi I Sunyer IDIBAPS, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Hosp Clin Barcelona,Neurol Serv,Parkinsons Dis &, Barcelona, Spain; [Iranzo, Alex; Gaig, Carles; Fernandez-Arcos, Ana; Santamaria, Joan] Univ Barcelona, Inst Invest Biomed August Pi I Sunyer IDIBAPS, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Hosp Clin Barcelona,Neurol Serv,Multidisciplinary, Barcelona, Spain; [Fernandez-Santiago, Ruben; Fernandez, Manel] Univ Barcelona, Inst Invest Biomed August Pi I Sunyer IDIBAPS, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Dept Clin & Expt Neurol,Hosp Clin Barcelona,Lab N, Barcelona, Spain; [Bayes, Angels] Unidad Parkinson Teknon, Barcelona, Spain; [Calopa, Matilde; Jauma, Serge] Hosp Univ Bellvitge, Neurol Serv, Barcelona, Spain; [Casquero, Pilar] Hosp Mateu Orfila, Mao, Menorca, Spain; [de Fabregues, Oriol] Hosp Univ Vall DHebron, Neurol Serv, Barcelona, Spain; [Puente, Victor] Hosp Del Mar, Neurol Serv, Barcelona, Spain; [Salamero, Manel] Hosp Clin Barcelona, Psychol Serv, Barcelona, Spain	CIBERNED; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBERNED; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBERNED; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; Hospital Mateu Orfila; Hospital Universitari Vall d'Hebron; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; University of Barcelona; Hospital Clinic de Barcelona	Iranzo, A (corresponding author), Univ Barcelona, Inst Invest Biomed August Pi I Sunyer IDIBAPS, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Hosp Clin Barcelona,Neurol Serv,Multidisciplinary, Barcelona, Spain.	airanzo@clinic.ub.es	Vilas, Dolores/AAB-7244-2019; Fernández-Santiago, Rubén/K-3808-2014; De Fabregues, Oriol/AAG-7420-2020; Compta, Yaroslau/U-8298-2017; Bayés, Àngels/AAB-3873-2019; Fernandez, Manel/AAC-2447-2020	Fernández-Santiago, Rubén/0000-0002-4582-0702; De Fabregues, Oriol/0000-0002-3518-5338; Compta, Yaroslau/0000-0001-6443-0104; Fernandez, Manel/0000-0002-8558-9920; Calopa, Matilde/0000-0002-6943-3707; Pont-Sunyer, Claustre/0000-0003-1102-7746	"La Fundacio la Marato de TV3" [061130/31]	"La Fundacio la Marato de TV3"	This manuscript received support through the grant number 061130/31 from "La Fundacio la Marato de TV3" to Eduard Tolosa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott RD, 2005, NEUROLOGY, V65, P1442, DOI 10.1212/01.wnl.0000183056.89590.0d; Alcalay RN, 2013, MOVEMENT DISORD, V28, P1966, DOI 10.1002/mds.25647; Allen RP, 2003, SLEEP MED, V4, P101, DOI 10.1016/S1389-9457(03)00010-8; [Anonymous], 2014, INT CLASSIFICATION S, V3rd; Arnulf I, 2002, NEUROLOGY, V58, P1019, DOI 10.1212/WNL.58.7.1019; Ataide Marcelo, 2014, Sleep Disord, V2014, P767181, DOI 10.1155/2014/767181; Belarbi S, 2010, PARKINSONISM RELAT D, V16, P676, DOI 10.1016/j.parkreldis.2010.09.003; Berg D, 2005, BRAIN, V128, P3000, DOI 10.1093/brain/awh666; Brockmann K, 2011, MOVEMENT DISORD, V26, P2335, DOI 10.1002/mds.23991; Buskova J, 2011, J NEUROL, V258, P2254, DOI 10.1007/s00415-011-6109-7; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; CARSKADON MA, 1986, SLEEP, V9, P519, DOI 10.1093/sleep/9.4.519; Chahine LM, 2013, MOVEMENT DISORD, V28, P1146, DOI 10.1002/mds.25438; De Cock VC, 2008, NAT CLIN PRACT NEURO, V4, P254, DOI 10.1038/ncpneuro0775; De Cock VC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107278; Emre M, 2007, MOVEMENT DISORD, V22, P1689, DOI 10.1002/mds.21507; Frauscher B, 2012, SLEEP, V35, P835, DOI 10.5665/sleep.1886; Gaig C, 2006, ARCH NEUROL-CHICAGO, V63, P377, DOI 10.1001/archneur.63.3.377; Gaig C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108982; Gaig CI A, 2013, J NEUROL S1, pS32; Gallego ML., 2009, ALZHEIMER REAL INVES, V43, P4; Gao JJ, 2011, AM J EPIDEMIOL, V173, P1032, DOI 10.1093/aje/kwq478; Goetz CG, 2008, MOVEMENT DISORD, V23, P2129, DOI 10.1002/mds.22340; Goldwurm S, 2006, PARKINSONISM RELAT D, V12, P410, DOI 10.1016/j.parkreldis.2006.04.001; Healy DG, 2008, LANCET NEUROL, V7, P583, DOI 10.1016/S1474-4422(08)70117-0; Hobson DE, 2002, JAMA-J AM MED ASSOC, V287, P455, DOI 10.1001/jama.287.4.455; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Iber C., 2007, AASM MANUAL SCORING; Iranzo A, 2005, NEUROLOGY, V65, P247, DOI 10.1212/01.wnl.0000168864.97813.e0; Iranzo A, 2005, SLEEP, V28, P203, DOI 10.1093/sleep/28.2.203; Iranzo A, 2013, LANCET NEUROL, V12, P443, DOI 10.1016/S1474-4422(13)70056-5; Iranzo A, 2011, J NEUROL SCI, V310, P283, DOI 10.1016/j.jns.2011.07.049; JANKOVIC J, 1990, NEUROLOGY, V40, P1529, DOI 10.1212/WNL.40.10.1529; Johansen KK, 2011, PARKINSONISM RELAT D, V17, P528, DOI 10.1016/j.parkreldis.2011.04.014; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kalia LV, 2015, JAMA NEUROL, V72, P100, DOI 10.1001/jamaneurol.2014.2704; Marras C, 2011, NEUROLOGY, V77, P325, DOI 10.1212/WNL.0b013e318227042d; Martinez-Martin P, 1998, J NEUROL, V245, pS34, DOI 10.1007/PL00007737; Martinez-Martin P, 2011, J NEUROL SCI, V310, P12, DOI 10.1016/j.jns.2011.05.006; Merino-Andreu M, 2003, NEUROLOGY, V60, P1553, DOI 10.1212/01.WNL.0000058905.71369.97; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Peever J, 2014, TRENDS NEUROSCI, V37, P279, DOI 10.1016/j.tins.2014.02.009; Plomhause L, 2013, SLEEP MED, V14, P1035, DOI 10.1016/j.sleep.2013.04.018; Prudon B, 2014, MOVEMENT DISORD, V29, P259, DOI 10.1002/mds.25730; Ruiz-Martinez J, 2011, MOVEMENT DISORD, V26, P2026, DOI 10.1002/mds.23773; Santamaria J, 2004, NEUROLOGY, V63, pS21, DOI 10.1212/WNL.63.8_suppl_3.S21; Schwab R.S., 1969, 3 S PARK DIS, P152; Sierra M, 2013, NEUROLOGY, V80, P621, DOI 10.1212/WNL.0b013e31828250d6; Sierra M, 2011, MOVEMENT DISORD, V26, P2343, DOI 10.1002/mds.23965; Stiasny-Kolster K, 2007, MOVEMENT DISORD, V22, P2386, DOI 10.1002/mds.21740; Suzuki K, 2015, ACTA NEUROL SCAND, V131, P426, DOI 10.1111/ane.12347; Tolosa E, 2011, J NEUROL SCI, V310, P4, DOI 10.1016/j.jns.2011.05.027; Tomlinson CL, 2010, MOVEMENT DISORD, V25, P2649, DOI 10.1002/mds.23429; Trenkwalder C, 2011, MOVEMENT DISORD, V26, P644, DOI 10.1002/mds.23476; Valldeoriola F, 2011, J NEUROL, V258, P1126, DOI 10.1007/s00415-010-5896-6; Walters AS, 2003, SLEEP MED, V4, P121, DOI 10.1016/S1389-9457(02)00258-7; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	60	48	48	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132368	10.1371/journal.pone.0132368	http://dx.doi.org/10.1371/journal.pone.0132368			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177462	Green Published, Green Submitted, gold			2022-12-26	WOS:000358197600107
J	Sun, Y; Zhu, DM; Wang, GH; Wang, D; Zhou, HS; Liu, XT; Jiang, ML; Liao, LJ; Zhou, ZG; Hu, JY				Sun, Yi; Zhu, Demao; Wang, Guihua; Wang, Di; Zhou, Huashan; Liu, Xueting; Jiang, Manli; Liao, Lingjuan; Zhou, Zhiguang; Hu, Jinyue			Pro-Inflammatory Cytokine IL-1 beta Up-Regulates CXC Chemokine Receptor 4 via Notch and ERK Signaling Pathways in Tongue Squamous Cell Carcinoma	PLOS ONE			English	Article							LYMPHOID-TISSUE LYMPHOMA; GROWTH IN-VITRO; BREAST-CANCER; HUMAN-PAPILLOMAVIRUS; HELICOBACTER-PYLORI; TUMOR-SUPPRESSOR; GASTRIC-CANCER; BONE-MARROW; EXPRESSION; INTERLEUKIN-1	Chronic inflammation contributes to tumor development through the induction of oncogenic mutations, genomic instability, early tumor promotion, and enhanced angiogenesis. Here, we report that IL-1 receptor 1 (IL-1R1) was expressed in 40 of 41 human tongue squamous cell carcinomas (TSCC). IL-1 beta up-regulated the expression of CXCR4, a CXC chemokine receptor that mediates cancer growth and metastasis, at both mRNA and protein levels in Tca8113 TSCC cells. IL-1 beta treatment of Tca8113 cells promoted migration in response to CXCR4 ligand stromal-derived factor a (SDF-1 alpha). The inhibition of IL-1R1 by its antagonist IL-1Ra or RNA interference significantly reversed the up-regulation of CXCR4 induced by IL-1 beta. IL-1R1 activation also up-regulated the expression of IL-1 beta itself, suggesting a positive feedback regulation of CXCR4 expression. Furthermore, IL-1 beta induced the activation of Notch, which was originally considered a stem cell regulator. Pharmacological inhibition of Notch signaling reversed the up-regulation of CXCR4 induced by IL-1 beta, suggesting that Notch signaling may be involved in the growth and metastasis of cancers via up-regulation of CXCR4. In addition, IL-1 beta induced the activation of extracellular signal regulated kinase (ERK) and ERK inhibition decreased the up-regulation of CXCR4 induced by IL-1 beta, suggesting the involvement of ERK signaling in cancer metastasis. Taken together these data suggest that IL-1 beta and IL-1R1 promote cancer growth and metastasis by up-regulating CXCR4 expression and that CXCR4 may be a link between inflammation and cancer.	[Sun, Yi] Cent S Univ, Xiangya Hosp 2, Dept Pathol, Changsha, Hunan, Peoples R China; [Sun, Yi; Liu, Xueting; Jiang, Manli; Liao, Lingjuan; Hu, Jinyue] Changsha Cent Hosp, Med Res Ctr, Changsha, Hunan, Peoples R China; [Zhu, Demao; Zhou, Huashan] Changsha Cent Hosp, Dept Pathol, Changsha, Hunan, Peoples R China; [Wang, Guihua; Wang, Di] Changsha Cent Hosp, Dept Oncol, Changsha, Hunan, Peoples R China; [Zhou, Zhiguang] Cent S Univ, Xiangya Hosp 2, Inst Metab & Endocrinol, Changsha, Hunan, Peoples R China	Central South University; Central South University	Zhou, ZG (corresponding author), Cent S Univ, Xiangya Hosp 2, Inst Metab & Endocrinol, Changsha, Hunan, Peoples R China.	zhouzg@hotmail.com; jinyueh@yahoo.com		Zhou, Zhiguang/0000-0002-0374-1838	National Natural Science Foundation of China [81172042]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by the National Natural Science Foundation of China (JH, 81172042, www.nsfc.gov.cn).	Asnaghi L, 2012, CLIN CANCER RES, V18, P654, DOI 10.1158/1078-0432.CCR-11-1406; Barber MD, 2000, BRIT J CANCER, V83, P1443, DOI 10.1054/bjoc.2000.1479; Brozovic A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076397; Choi C, 2014, ONCOGENE, V33, P3668, DOI 10.1038/onc.2013.341; Clifford G, 2007, LANCET, V370, P6, DOI 10.1016/S0140-6736(07)61023-X; Gonzalez-Losa MD, 2009, ORAL ONCOL, V45, pE72, DOI 10.1016/j.oraloncology.2009.02.002; Didigu CA, 2014, BLOOD, V123, P61, DOI 10.1182/blood-2013-08-521229; El-Omar EM, 2000, NATURE, V404, P398, DOI 10.1038/35006081; Elango KJ, 2011, ASIAN PAC J CANCER P, V12, P889; Elaraj DM, 2006, CLIN CANCER RES, V12, P1088, DOI 10.1158/1078-0432.CCR-05-1603; Fang ZQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062823; Fox JG, 2007, J CLIN INVEST, V117, P60, DOI 10.1172/JCI30111; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Gromminger S, 2012, BRIT J HAEMATOL, V156, P719, DOI 10.1111/j.1365-2141.2011.09007.x; Guo MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090518; Hasegawa M, 2012, J IMMUNOL, V189, P3085, DOI 10.4049/jimmunol.1200821; Hefler LA, 2005, CLIN CANCER RES, V11, P5718, DOI 10.1158/1078-0432.CCR-05-0001; Hu JY, 2005, CLIN CANCER RES, V11, P4658, DOI 10.1158/1078-0432.CCR-04-1798; Hu ZB, 2006, CANCER LETT, V236, P269, DOI 10.1016/j.canlet.2005.05.015; Ito M, 2014, BLOOD, V123, P1499, DOI 10.1182/blood-2013-09-527739; Kauppila JH, 2013, BRIT J CANCER, V108, P638, DOI 10.1038/bjc.2012.589; Kew MC, 2013, J VIRAL HEPATITIS, V20, P149, DOI 10.1111/jvh.12043; Kikuchi Y, 2014, AM J PATHOL, V184, P859, DOI 10.1016/j.ajpath.2013.11.012; Kochetkova M, 2009, CELL DEATH DIFFER, V16, P664, DOI 10.1038/cdd.2008.190; Lee JH, 2010, CANCER LETT, V290, P68, DOI 10.1016/j.canlet.2009.08.027; Lewis AM, 2006, J TRANSL MED, V4, DOI 10.1186/1479-5876-4-48; Li L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091509; Lindmark F, 2005, BRIT J CANCER, V93, P493, DOI 10.1038/sj.bjc.6602729; Lo KW, 2004, CANCER CELL, V5, P423, DOI 10.1016/S1535-6108(04)00119-9; Marignol L, 2013, NAT REV UROL, V10, P405, DOI 10.1038/nrurol.2013.110; Mirandola L, 2013, LEUKEMIA, V27, P1558, DOI 10.1038/leu.2013.27; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Nakamura S, 2013, WORLD J GASTROENTERO, V19, P8181, DOI 10.3748/wjg.v19.i45.8181; Neufert C, 2013, J CLIN INVEST, V123, P1428, DOI 10.1172/JCI63748; Nicolas M, 2003, NAT GENET, V33, P416, DOI 10.1038/ng1099; Nordfors C, 2013, EUR J CANCER, V49, P2522, DOI 10.1016/j.ejca.2013.03.019; Oh JW, 2001, J IMMUNOL, V166, P2695, DOI 10.4049/jimmunol.166.4.2695; Polk DB, 2010, NAT REV CANCER, V10, P403, DOI 10.1038/nrc2857; Proweller A, 2006, CANCER RES, V66, P7438, DOI 10.1158/0008-5472.CAN-06-0793; Purow BW, 2005, CANCER RES, V65, P2353, DOI 10.1158/0008-5472.CAN-04-1890; Renshaw J, 2013, CLIN CANCER RES, V19, P5940, DOI 10.1158/1078-0432.CCR-13-0850; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; South AP, 2012, SEMIN CELL DEV BIOL, V23, P458, DOI 10.1016/j.semcdb.2012.01.017; Staller P, 2003, NATURE, V425, P307, DOI 10.1038/nature01874; Suman S, 2013, BRIT J CANCER, V109, P2587, DOI 10.1038/bjc.2013.642; Sun RL, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.178798; Takahashi H, 2010, CANCER CELL, V17, P89, DOI 10.1016/j.ccr.2009.12.008; Teicher BA, 2010, CLIN CANCER RES, V16, P2927, DOI 10.1158/1078-0432.CCR-09-2329; Toprak NU, 2006, CLIN MICROBIOL INFEC, V12, P782, DOI 10.1111/j.1469-0691.2006.01494.x; Tsimplaki E, 2014, ANTICANCER RES, V34, P1021; Tu S, 2008, CANCER CELL, V14, P408, DOI 10.1016/j.ccr.2008.10.011; Wang L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007572; Wang N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089991; Wang YC, 2009, J BIOL CHEM, V284, P15993, DOI 10.1074/jbc.M901144200; Weber A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3105cm1; Williams CK, 2008, CANCER RES, V68, P1889, DOI 10.1158/0008-5472.CAN-07-2181; Wu S, 2013, CANCER LETT, V337, P293, DOI 10.1016/j.canlet.2013.04.003; Wundisch T, 2012, GASTROENTEROLOGY, V143, P936, DOI 10.1053/j.gastro.2012.06.035; Xie J, 2013, CELL IMMUNOL, V281, P68, DOI 10.1016/j.cellimm.2013.02.001; Yang YN, 2011, J CLIN INVEST, V121, P1373, DOI 10.1172/JCI42579; Yu T, 2014, ONCOGENE, V33, P5017, DOI 10.1038/onc.2013.448; Zaghloul Mohamed S, 2008, J Egypt Natl Canc Inst, V20, P168; Zhang DP, 2014, CANCER LETT, V348, P100, DOI 10.1016/j.canlet.2014.03.006; Zlotnik A, 2012, IMMUNITY, V36, P705, DOI 10.1016/j.immuni.2012.05.008; Zlotnik A, 2011, NAT REV IMMUNOL, V11, P597, DOI 10.1038/nri3049	65	20	22	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132677	10.1371/journal.pone.0132677	http://dx.doi.org/10.1371/journal.pone.0132677			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176534	Green Published, Green Submitted, gold			2022-12-26	WOS:000358197600141
J	Das Gupta, M; Chan, SKS; Monteiro, A				Das Gupta, Mainak; Chan, Sam Kok Sim; Monteiro, Antonia			Natural Loss of eyeless/Pax6 Expression in Eyes of Bicyclus anynana Adult Butterflies Likely Leads to Exponential Decrease of Eye Fluorescence in Transgenics	PLOS ONE			English	Article							MARKER; TRANSFORMATION; DROSOPHILA; PROTEIN; MORPHOGENESIS; PATTERNS; REPORTER; PAX6; GFP	Commonly used visible markers for transgenesis use fluorescent proteins expressed at the surface of the body, such as in eyes. One commonly used marker is the 3xP3-EGFP cassette containing synthetic binding sites for the eyeless/Pax6 conserved transcription factor. This marker cassette leads to fluorescent eyes in a variety of animals tested so far. Here we show that upon reaching adulthood, transgenic Bicyclus anynana butterflies containing this marker cassette exponentially loose fluorescence in their eyes. After 12 days, transgenic individuals are no longer distinguishable from wild type individuals. The decreased eye fluorescence is likely due to significantly decreased or halted eyeless/Pax6 expression observed in wild type animals upon adult emergence. Implications from these findings include care in screening transgenic animals before these reach adulthood, or shortly thereafter, and in using adult animals of the same age for quantitative screening of likely homozygote and heterozygote individuals.	[Das Gupta, Mainak; Monteiro, Antonia] Natl Univ Singapore, Biol Sci, Singapore 117548, Singapore; [Chan, Sam Kok Sim] Univ Tunku Abdul Rahman, Biol Sci, Kampar, Perak, Malaysia; [Monteiro, Antonia] Yale NUS Coll, Singapore, Singapore	National University of Singapore; Universiti Tunku Abdul Rahman (UTAR); Yale NUS College	Monteiro, A (corresponding author), Natl Univ Singapore, Biol Sci, Singapore 117548, Singapore.	antonia.monteiro@nus.edu.sg	Monteiro, Antonia/J-6452-2013	Monteiro, Antonia/0000-0001-9696-459X; CHAN, KOK SIM/0000-0003-3458-1897	Singapore Ministry of Education [R-154-000-602-112]	Singapore Ministry of Education(Ministry of Education, Singapore)	This research was funded by the Singapore Ministry of Education grant R-154-000-602-112. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berghammer AJ, 1999, NATURE, V402, P370, DOI 10.1038/46463; Chen B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018659; Chiu WL, 1996, CURR BIOL, V6, P325, DOI 10.1016/S0960-9822(02)00483-9; Corish P, 1999, PROTEIN ENG, V12, P1035, DOI 10.1093/protein/12.12.1035; Cornett JC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029486; Fic W, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000253; Gehring WJ, 1999, TRENDS GENET, V15, P371, DOI 10.1016/S0168-9525(99)01776-X; Gonzalez-Estevez C, 2003, P NATL ACAD SCI USA, V100, P14046, DOI 10.1073/pnas.2335980100; IKAWA M, 1995, DEV GROWTH DIFFER, V37, P455, DOI 10.1046/j.1440-169X.1995.t01-2-00012.x; Kokoza V, 2001, INSECT BIOCHEM MOLEC, V31, P1137, DOI 10.1016/S0965-1748(01)00120-5; Kriventseva EV, 2015, NUCLEIC ACIDS RES, V43, pD250, DOI 10.1093/nar/gku1220; Marcus JM, 2004, P ROY SOC B-BIOL SCI, V271, pS263, DOI 10.1098/rsbl.2004.0175; Mishra M, 2010, DEVELOPMENT, V137, P2895, DOI 10.1242/dev.051722; Monteiro A, 2013, J EXP ZOOL PART B, V320B, P321, DOI 10.1002/jez.b.22503; Papatsenko D, 2001, MECH DEVELOP, V101, P143, DOI 10.1016/S0925-4773(00)00581-5; Pavlopoulos A, 2005, P NATL ACAD SCI USA, V102, P7888, DOI 10.1073/pnas.0501101102; Ramos DM, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-55; Sheng GJ, 1997, GENE DEV, V11, P1122, DOI 10.1101/gad.11.9.1122; Thomas JL, 2002, INSECT BIOCHEM MOLEC, V32, P247, DOI 10.1016/S0965-1748(01)00150-3; Tong XL, 2014, DEV BIOL, V394, P357, DOI 10.1016/j.ydbio.2014.08.020; Warren IA, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-86; Yang Y, 2006, EMBO J, V25, P2107, DOI 10.1038/sj.emboj.7601114; YEH E, 1995, P NATL ACAD SCI USA, V92, P7036, DOI 10.1073/pnas.92.15.7036	23	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132882	10.1371/journal.pone.0132882	http://dx.doi.org/10.1371/journal.pone.0132882			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26173066	Green Published, Green Submitted, gold			2022-12-26	WOS:000358194900094
J	Lu, XH; Zang, RG; Huang, JH				Lu, XingHui; Zang, RunGuo; Huang, JiHong			Relationships between Community Level Functional Traits of Trees and Seedlings during Secondary Succession in a Tropical Lowland Rainforest	PLOS ONE			English	Article							LEAF TRAITS; GROWTH-RESPONSES; SHADE TOLERANCE; WOODY-PLANTS; ADULT TREES; LIGHT; PATTERNS; SAPLINGS; NITROGEN; RATES	Most of the previous studies on functional traits focus exclusively on either seedlings or trees. Little knowledge exists on the relationships between community level functional traits of trees and seedlings during succession. Here, we examine variations of the community-level functional traits for trees and seedlings and their correlations along a secondary successional and environmental gradient in a tropical lowland rainforest after shifting cultivation. The results showed that the dynamic patterns in community level functional traits of seedlings were generally consistent with those of the trees during secondary succession. Compared with seedlings, community level traits for trees were less affected by abiotic factors during secondary succession. Correlations between community level functional traits of trees and seedlings were significant for: leaf dry matter content and leaf nitrogen concentration in the 18-year-old fallow; leaf chlorophyll content in the 30-year-old fallow; specific leaf area, leaf dry matter content and leaf nitrogen concentration in the 60-year-old fallow; and leaf nitrogen concentration in old growth. However, these traits except specific leaf area for the tree and seedling communities were all significantly correlated if all the successional stages were combined. Our results suggest that the correlations between community level functional traits of trees and those of seedlings depend on the actual traits and the successional stages examined. However, if all the four successional stages are combined, then four out of five of the community level functional traits for trees could be well predicted by those of the seedlings in the tropical lowland rain forest.	[Lu, XingHui; Zang, RunGuo; Huang, JiHong] Chinese Acad Forestry, Key Lab Forest Ecol & Environm, Inst Forest Ecol, State Forestry Adm, Beijing, Peoples R China; [Lu, XingHui; Zang, RunGuo; Huang, JiHong] Nanjing Forestry Univ, Coinnovat Ctr Sustainable Forestry Southern China, Nanjing, Jiangsu, Peoples R China	Chinese Academy of Forestry; Research Institute of Forest Ecology, Environment and Protection, CAF; Nanjing Forestry University	Zang, RG (corresponding author), Chinese Acad Forestry, Key Lab Forest Ecol & Environm, Inst Forest Ecol, State Forestry Adm, Beijing, Peoples R China.	zangrung@caf.ac.cn	Huang, Jihong/I-8860-2019	Huang, Jihong/0000-0001-7668-3010	Special Fund for Forest Scientific Research in the Public Welfare [201304308]; National natural science foundation of China [30430570]	Special Fund for Forest Scientific Research in the Public Welfare; National natural science foundation of China(National Natural Science Foundation of China (NSFC))	Special Fund for Forest Scientific Research in the Public Welfare (201304308), Runguo Zang, http://www.hymof.net.cn/SystemFrame/wdt_login.aspx; National natural science foundation of China (30430570), Runguo Zang, http://isisn.nsfc.gov.cn/egrantweb/project/rptcompletion/index. The funder played an important role in the study design and preparation of the manuscript.	Adler PB, 2014, P NATL ACAD SCI USA, V111, P740, DOI 10.1073/pnas.1315179111; Adler PB, 2013, ECOL LETT, V16, P1294, DOI 10.1111/ele.12157; Beckage B, 2005, J ECOL, V93, P1177, DOI 10.1111/j.1365-2745.2005.01053.x; Campetella G, 2011, AGR ECOSYST ENVIRON, V145, P38, DOI 10.1016/j.agee.2011.06.025; Cavender-Bares J, 2000, OECOLOGIA, V124, P8, DOI 10.1007/PL00008865; Chen YH, 2013, ECOGRAPHY, V36, P178, DOI 10.1111/j.1600-0587.2011.06833.x; Comita LS, 2008, BIOTROPICA, V40, P251, DOI 10.1111/j.1744-7429.2007.00337.x; Comita LS, 2007, J VEG SCI, V18, P163, DOI 10.1658/1100-9233(2007)18[163:POWPSA]2.0.CO;2; Cornelissen JHC, 2003, J VEG SCI, V14, P311, DOI 10.1111/j.1654-1103.2003.tb02157.x; Diaz S, 2004, J VEG SCI, V15, P295, DOI 10.1111/j.1654-1103.2004.tb02266.x; Dray S, 2014, ECOLOGY, V95, P14, DOI 10.1890/13-0196.1; Ellsworth DS, 1996, ECOLOGY, V77, P581, DOI 10.2307/2265632; Fortunel C, 2014, J ECOL, V102, P145, DOI 10.1111/1365-2745.12160; Gonzalez MA, 2010, J ECOL, V98, P137, DOI 10.1111/j.1365-2745.2009.01607.x; Herault B, 2011, J ECOL, V99, P1431, DOI 10.1111/j.1365-2745.2011.01883.x; Holscher D, 2004, BASIC APPL ECOL, V5, P163, DOI 10.1078/1439-1791-00218; Holste EK, 2011, ECOLOGY, V92, P1828, DOI 10.1890/10-1697.1; Jackson BG, 2013, J ECOL, V101, P1409, DOI 10.1111/1365-2745.12155; Kitajima K, 2010, NEW PHYTOL, V186, P708, DOI 10.1111/j.1469-8137.2010.03212.x; Lebrija-Trejos E, 2010, ECOLOGY, V91, P386, DOI 10.1890/08-1449.1; Lu XH, 2014, BIOTROPICA, V46, P404, DOI 10.1111/btp.12125; Lusk CH, 2004, FUNCT ECOL, V18, P820, DOI 10.1111/j.0269-8463.2004.00897.x; Norden N, 2009, ECOL LETT, V12, P385, DOI 10.1111/j.1461-0248.2009.01292.x; Perez-Harguindeguy N, 2013, AUST J BOT, V61, P167, DOI 10.1071/BT12225; Poorter H, 2009, NEW PHYTOL, V182, P565, DOI 10.1111/j.1469-8137.2009.02830.x; Poorter L, 2008, ECOLOGY, V89, P1908, DOI 10.1890/07-0207.1; Poorter L, 2004, PLANT BIOLOGY, V6, P746, DOI 10.1055/s-2004-821269; Poorter L, 1999, FUNCT ECOL, V13, P396, DOI 10.1046/j.1365-2435.1999.00332.x; Poorter L, 2008, BIOTROPICA, V40, P321, DOI 10.1111/j.1744-7429.2007.00380.x; Rijkers T, 2000, FUNCT ECOL, V14, P77, DOI 10.1046/j.1365-2435.2000.00395.x; Roscher C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036760; Saura-Mas S, 2009, FUNCT ECOL, V23, P103, DOI 10.1111/j.1365-2435.2008.01474.x; Thomas SC, 2002, TREE PHYSIOL, V22, P117, DOI 10.1093/treephys/22.2-3.117	33	2	3	10	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132849	10.1371/journal.pone.0132849	http://dx.doi.org/10.1371/journal.pone.0132849			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26172543	Green Published, gold			2022-12-26	WOS:000358194900090
J	Theilacker, C; Diederich, AK; Otto, A; Sava, IG; Wobser, D; Bao, YY; Hese, K; Broszat, M; Henneke, P; Becher, D; Huebner, J				Theilacker, Christian; Diederich, Ann-Kristin; Otto, Andreas; Sava, Irina G.; Wobser, Dominique; Bao, Yinyin; Hese, Katrin; Broszat, Melanie; Henneke, Philipp; Becher, Doerte; Huebner, Johannes			Enterococcus faecalis Glycolipids Modulate Lipoprotein-Content of the Bacterial Cell Membrane and Host Immune Response	PLOS ONE			English	Article							GROUP-B STREPTOCOCCUS; QUANTITATIVE-ANALYSIS; LIPOTEICHOIC ACID; PROTEOME; FAECIUM; RECOGNITION; EXPRESSION; TLR2; CONTRIBUTES; CLEARANCE	In this study, we investigated the impact of the cell membrane composition of E. faecalis on its recognition by the host immune system. To this end, we employed an E. faecalis deletion mutant (Delta bgsA) that does not synthesize the major cell membrane glycolipid diglycosyl-diacylglycerol (DGlcDAG). Proteomic analysis revealed that 13 of a total of 21 upregulated surface-associated proteins of E. faecalis Delta bgsA were lipoproteins. This led to a total lipoprotein content in the cell membrane of 35.8% in Delta bgsA compared to only 9.4% in wildtype bacteria. Increased lipoprotein content strongly affected the recognition of Delta bgsA by mouse macrophages in vitro with an increased stimulation of TNF-alpha production by heat-fixed bacteria and secreted antigens. Inactivation of the prolipoprotein diacylglycerol transferase (lgt) in Delta bgsA abrogated TNF-alpha induction by a Delta bgsA_lgt double mutant indicating that lipoproteins mediate increased activation of mouse macrophages by Delta bgsA. Heatfixed Delta bgsA bacteria, culture supernatant, or cell membrane lipid extract activated transfected HEK cells in a TLR2-dependent fashion; the same was not true of wild-type bacteria. In mice infected intraperitoneally with a sublethal dose of E. faecalis we observed a 70% greater mortality in mice infected with Delta bgsA compared with wild-type-infected mice. Increased mortality due to Delta bgsA infection was associated with elevated plasma levels of the inflammatory cytokines TNF-alpha, IL-6 and MIP-2. In summary, our results provide evidence that an E. faecalis mutant lacking its major bilayer forming glycolipid DGlcDAG upregulates lipoprotein expression leading to increased activation of the host innate immune system and virulence in vivo.	[Theilacker, Christian; Hese, Katrin; Henneke, Philipp] Univ Med Ctr Freiburg, Ctr Chron Immunodeficiency, Freiburg, Germany; [Theilacker, Christian; Diederich, Ann-Kristin; Wobser, Dominique; Bao, Yinyin; Broszat, Melanie; Huebner, Johannes] Univ Med Ctr Freiburg, Ctr Infect Dis & Travel Med, Freiburg, Germany; [Diederich, Ann-Kristin; Huebner, Johannes] Univ Munich, Dr von Hauner Childrens Hosp, Div Pediat Infect Dis, Munich, Germany; [Otto, Andreas; Becher, Doerte] Ernst Moritz Arndt Univ Greifswald, Inst Microbiol, Dept Microbial Physiol, Greifswald, Germany; [Henneke, Philipp] Univ Med Ctr Freiburg, Ctr Paediat & Adolescent Med, Freiburg, Germany; [Diederich, Ann-Kristin] Univ Freiburg, Dept Microbiol, Fac Biol, D-79106 Freiburg, Germany; [Sava, Irina G.] Tech Univ Munich, Res Ctr Nutr & Food Sci, Freising Weihenstephan, Germany	University of Freiburg; University of Freiburg; University of Munich; Ernst Moritz Arndt Universitat Greifswald; University of Freiburg; University of Freiburg; Technical University of Munich	Theilacker, C (corresponding author), Univ Basel Hosp, Div Infect Dis, Petersgraben 4, CH-4031 Basel, Switzerland.	christian.theilacker@usb.ch	; Becher, Dorte/B-4454-2015	Huebner, Johannes/0000-0003-1232-4646; Theilacker, Christian/0000-0003-0821-9202; Becher, Dorte/0000-0002-9630-5735	German Federal Ministry of Education and Research [BMBF 01 EO 0803]	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This work was supported by the German Federal Ministry of Education and Research (BMBF 01 EO 0803).	Becher D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008176; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brouwer MC, 2009, LANCET INFECT DIS, V9, P31, DOI 10.1016/S1473-3099(08)70261-5; BRUSCA JS, 1994, METHOD ENZYMOL, V228, P182; Bychowska A, 2011, CARBOHYD RES, V346, P2816, DOI 10.1016/j.carres.2011.09.026; Callegan MC, 1999, INFECT IMMUN, V67, P3357, DOI 10.1128/IAI.67.7.3357-3366.1999; Casanova JL, 2011, ANNU REV IMMUNOL, V29, P447, DOI 10.1146/annurev-immunol-030409-101335; Cieslewicz MJ, 2001, J BIOL CHEM, V276, P139, DOI 10.1074/jbc.M005702200; Diederich AK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096295; Dreisbach A, 2008, PROTEOMICS, V8, P2062, DOI 10.1002/pmic.200701081; Echchannaoui H, 2002, J INFECT DIS, V186, P798, DOI 10.1086/342845; Edman M, 2003, J BIOL CHEM, V278, P8420, DOI 10.1074/jbc.M211492200; Gurung M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027958; Hashimoto M, 2006, INT IMMUNOL, V18, P355, DOI 10.1093/intimm/dxh374; Hashimoto M, 2006, J IMMUNOL, V177, P3162, DOI 10.4049/jimmunol.177.5.3162; Henneke P, 2005, J IMMUNOL, V174, P6449, DOI 10.4049/jimmunol.174.10.6449; Henneke P, 2008, J IMMUNOL, V180, P6149, DOI 10.4049/jimmunol.180.9.6149; Hilmi D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096416; Huebner J, 1999, INFECT IMMUN, V67, P1213, DOI 10.1128/IAI.67.3.1213-1219.1999; Hutchings MI, 2009, TRENDS MICROBIOL, V17, P13, DOI 10.1016/j.tim.2008.10.001; Jones CL, 2012, CELL MICROBIOL, V14, P1531, DOI 10.1111/j.1462-5822.2012.01816.x; Jouhet J, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00494; Kang JY, 2009, IMMUNITY, V31, P873, DOI 10.1016/j.immuni.2009.09.018; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Knapp S, 2004, J IMMUNOL, V172, P3132, DOI 10.4049/jimmunol.172.5.3132; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Leendertse M, 2008, J IMMUNOL, V180, P4865, DOI 10.4049/jimmunol.180.7.4865; Leendertse Masja, 2009, Innate Immun, V15, P3, DOI 10.1177/1753425908100238; Leendertse M, 2010, J INFECT DIS, V201, P544, DOI 10.1086/650341; Leendertse M, 2009, INFECT IMMUN, V77, P485, DOI 10.1128/IAI.00863-08; Lind J, 2007, BIOCHEMISTRY-US, V46, P5664, DOI 10.1021/bi700042x; MacCoss MJ, 2003, ANAL CHEM, V75, P6912, DOI 10.1021/ac034790h; Mancuso G, 2004, J IMMUNOL, V172, P6324, DOI 10.4049/jimmunol.172.10.6324; Meiers M, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-12; Mogensen TH, 2009, CLIN MICROBIOL REV, V22, P240, DOI 10.1128/CMR.00046-08; Ness TL, 2003, J IMMUNOL, V171, P3775, DOI 10.4049/jimmunol.171.7.3775; Otto A, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1137; Paoletti LC, 1996, INFECT IMMUN, V64, P1220, DOI 10.1128/IAI.64.4.1220-1226.1996; Park SK, 2008, NAT METHODS, V5, P319, DOI [10.1038/NMETH.1195, 10.1038/nmeth.1195]; Parsons JB, 2013, PROG LIPID RES, V52, P249, DOI 10.1016/j.plipres.2013.02.002; Prados-Rosales R, 2011, J CLIN INVEST, V121, P1471, DOI 10.1172/JCI44261; Reffuveille F, 2012, MICROBIOL-SGM, V158, P816, DOI 10.1099/mic.0.055319-0; Reffuveille F, 2011, MICROBIOL-SGM, V157, P3001, DOI 10.1099/mic.0.053314-0; Sievers S, 2010, PROTEOMICS, V10, P1685, DOI 10.1002/pmic.200900772; Stoll H, 2005, INFECT IMMUN, V73, P2411, DOI 10.1128/IAI.73.4.2411-2423.2005; Theilacker C, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-67; Theilacker C, 2009, MOL MICROBIOL, V71, P1055, DOI [10.1111/j.1365-2958.2008.06587.x, 10.1111/j.1365-2958.2009.06587.x]; Walley KR, 1997, INFECT IMMUN, V65, P3847, DOI 10.1128/IAI.65.9.3847-3851.1997; Wardenburg JB, 2006, P NATL ACAD SCI USA, V103, P13831, DOI 10.1073/pnas.0603072103; Wengner AM, 2008, BLOOD, V111, P42, DOI 10.1182/blood-2007-07-099648; Wikstrom M, 2004, J BIOL CHEM, V279, P10484, DOI 10.1074/jbc.M310183200; Yimin, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074287; Zahringer U, 2008, IMMUNOBIOLOGY, V213, P205, DOI 10.1016/j.imbio.2008.02.005; Zhang Y, 2010, ANAL CHEM, V82, P2272, DOI 10.1021/ac9023999; Zybailov B, 2006, J PROTEOME RES, V5, P2339, DOI 10.1021/pr060161n	55	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132949	10.1371/journal.pone.0132949	http://dx.doi.org/10.1371/journal.pone.0132949			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26172831	Green Published, Green Submitted, gold			2022-12-26	WOS:000358194900107
J	Woo, SJ; Ahn, J; Morrison, MA; Ahn, SY; Lee, J; Kim, KW; DeAngelis, MM; Park, KH				Woo, Se Joon; Ahn, Jeeyun; Morrison, Margaux A.; Ahn, So Yeon; Lee, Jaebong; Kim, Ki Woong; DeAngelis, Margaret M.; Park, Kyu Hyung			Analysis of Genetic and Environmental Risk Factors and Their Interactions in Korean Patients with Age-Related Macular Degeneration	PLOS ONE			English	Article							POLYPOIDAL CHOROIDAL VASCULOPATHY; FACTOR-H GENE; CIGARETTE-SMOKING; LOC387715/HTRA1 POLYMORPHISMS; ASSOCIATION; SUSCEPTIBILITY; POPULATION; PREVALENCE; JAPANESE; CFH	Purpose To investigate the association of genetic and environmental factors, and their interactions in Korean patients with exudative age-related macular degeneration (AMD). Methods A total of 314 robustly characterized exudative AMD patients, including 111 PCV (polypoidal choroidal vasculopathy) and 154 typical choroidal neovascularization (CNV), and 395 control subjects without any evidence of AMD were enrolled. Full ophthalmologic examinations including fluorescein angiography (FA), indocyanine green angiography (ICG) and optical coherence tomography (OCT) were done, according to which patients were divided into either PCV or typical CNV. Standardized questionnaires were used to collect information regarding underlying systemic diseases, dietary habits, smoking history and body mass index (BMI). A total of 86 SNPs from 31 candidate genes were analyzed. Genotype association and logistic regression analyses were done and stepwise regression models to best predict disease for each AMD subtype were constructed. Results Age, spherical equivalent, myopia, and ever smoking were associated with exudative AMD. Age, hypertension, hyperlipidemia, spherical equivalent, and myopia were risk factors for typical CNV, while increased education and ever smoking were significantly associated with PCV (p<.05 for all). Four SNPs, ARMS2/HTRA1 rs10490924, rs11200638, and rs2736911, and CFH rs800292, showed association with exudative AMD. Two of these SNPs, ARMS2/HTRA1 rs10490924 and rs11200638, showed significant association with typical CNV and PCV specifically. There were no significant interactions between environmental and genetic factors. The most predictive disease model for exudative AMD included age, spherical equivalent, smoking, CFH rs800292, and ARMS2 rs10490924 while that for typical CNV included age, hyperlipidemia, spherical equivalent, and ARMS2 rs10490924. Smoking, spherical equivalent, and ARMS2 rs10490924 were the most predictive variables for PCV. When comparing PCV cases to CNV cases, age, BMI, and education were the most predictive risk factors of PCV. Conclusions Only one locus, the ARMS2/HTRA1 was a significant genetic risk factor for Korean exudative AMD, including its subtypes, PCV and typical CNV. Stepwise regression revealed that CFH was important to risk of exudative AMD in general but not to any specific subtype. While increased education was a unique risk factor to PCV when compared to CNV, this association was independent of refractive error in this homogenous population from South Korea. No significant interactions between environmental and genetic risk factors were observed.	[Woo, Se Joon; Ahn, Jeeyun; Park, Kyu Hyung] Seoul Natl Univ, Coll Med, Dept Ophthalmol, Seoul, South Korea; [Woo, Se Joon; Park, Kyu Hyung] Seoul Natl Univ, Bundang Hosp, Dept Ophthalmol, Songnam, South Korea; [Ahn, Jeeyun] Seoul Natl Univ, Seoul Metropolitan Govt, Boramae Med Ctr, Dept Ophthalmol, Seoul, South Korea; [Morrison, Margaux A.; DeAngelis, Margaret M.] Univ Utah, Dept Ophthalmol & Visual Sci, John A Moran Eye Ctr, Salt Lake City, UT 84112 USA; [Ahn, So Yeon; Lee, Jaebong] Seoul Natl Univ, Bundang Hosp, Med Res Collaborating Ctr, Songnam, South Korea; [Kim, Ki Woong] Seoul Natl Univ, Coll Med, Dept Psychiat, Seoul, South Korea; [Kim, Ki Woong] Seoul Natl Univ, Bundang Hosp, Dept Neuropsychiat, Songnam, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Utah System of Higher Education; University of Utah; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	DeAngelis, MM (corresponding author), Univ Utah, Dept Ophthalmol & Visual Sci, John A Moran Eye Ctr, Salt Lake City, UT 84112 USA.	Margaret.DeAngelis@utah.edu; jiani4@snu.ac.kr	DeAngelis, e/J-7863-2015	Ahn, Jeeyun/0000-0001-9017-1652	Seoul National University Bundang Hospital Research Fund [03-2009-008]; National Research Foundation of Korea (NRF) - Ministry of Education, Science, and Technology [2009-0072603, 2012R1A1A2008943]; Research to Prevent Blindness; ALSAM Foundation	Seoul National University Bundang Hospital Research Fund; National Research Foundation of Korea (NRF) - Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of Korea); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); ALSAM Foundation	This study was supported by the Seoul National University Bundang Hospital Research Fund (Grant No. 03-2009-008), National Research Foundation of Korea (NRF) grants funded by the Ministry of Education, Science, and Technology (2009-0072603, 2012R1A1A2008943), an unrestricted grant from Research to Prevent Blindness (http://www.rpbusa.org/rpb/) to the Department of Ophthalmology and Visual Sciences - Moran Eye Center, and the ALSAM Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand R, 2000, OPHTHALMOLOGY, V107, P2224; Arakawa S, 2011, NAT GENET, V43, P1001, DOI 10.1038/ng.938; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BIRD AEC, 1995, SURV OPHTHALMOL, V39, P367, DOI 10.1016/S0039-6257(05)80092-X; Chen HY, 2012, MOL VIS, V18, P816; Chen LJ, 2006, MOL VIS, V12, P1536; Conley YP, 2006, HUM MOL GENET, V15, P3206, DOI 10.1093/hmg/ddl396; DeAngelis MM, 2007, ARCH OPHTHALMOL-CHIC, V125, P49, DOI 10.1001/archopht.125.1.49; DeAngelis MM, 2011, SEMIN OPHTHALMOL, V26, P77, DOI 10.3109/08820538.2011.577129; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Fritsche LG, 2013, NAT GENET, V45, P433, DOI 10.1038/ng.2578; Gorin MB, 2012, MOL ASPECTS MED, V33, P467, DOI 10.1016/j.mam.2012.04.004; Gotoh N, 2006, HUM GENET, V120, P139, DOI 10.1007/s00439-006-0187-0; Gotoh N, 2009, AM J OPHTHALMOL, V147, P1037, DOI 10.1016/j.ajo.2008.12.036; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Imamura Y, 2010, SURV OPHTHALMOL, V55, P501, DOI 10.1016/j.survophthal.2010.03.004; Jhoo JH, 2008, DEMENT GERIATR COGN, V26, P270, DOI 10.1159/000160960; Kabasawa S, 2011, OPHTHALMOLOGY, V118, P1082, DOI 10.1016/j.ophtha.2010.10.012; Keller MC, 2014, BIOL PSYCHIAT, V75, P18, DOI 10.1016/j.biopsych.2013.09.006; Kim NR, 2008, INVEST OPHTH VIS SCI, V49, P2071, DOI 10.1167/iovs.07-1195; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Klein Ronald, 2003, Ophthalmology, V110, P1273, DOI 10.1016/S0161-6420(03)00599-2; Kondo N, 2011, OPHTHALMOLOGY, V118, P339, DOI 10.1016/j.ophtha.2010.06.040; Kondo N, 2009, OPHTHALMOLOGY, V116, P304, DOI 10.1016/j.ophtha.2008.11.011; KyuHyung Park，, 2010, [Journal of The Korean Ophthalmological Society, 대한안과학회지], V51, P516; Lee SJ, 2010, CLIN EXP OPHTHALMOL, V38, P698, DOI 10.1111/j.1442-9071.2010.02316.x; Lim LS, 2012, LANCET, V379, P1728, DOI 10.1016/S0140-6736(12)60282-7; Liu Y, 2007, GRAEF ARCH CLIN EXP, V245, P1441, DOI 10.1007/s00417-007-0575-8; Maruko I, 2007, AM J OPHTHALMOL, V144, P15, DOI 10.1016/j.ajo.2007.03.047; Mori K, 2010, OPHTHALMOLOGY, V117, P928, DOI 10.1016/j.ophtha.2009.10.001; Nakanishi H, 2010, INVEST OPHTH VIS SCI, V51, P6183, DOI 10.1167/iovs.09-4948; Park SJ, 2014, OPHTHALMOLOGY, V121, P1756, DOI 10.1016/j.ophtha.2014.03.022; Ristau T, 2014, INVEST OPHTH VIS SCI, V55, P5228, DOI 10.1167/iovs.14-14299; Sakurada Y, 2013, RETINA-J RET VIT DIS, V33, P841, DOI 10.1097/IAE.0b013e31826ffe9d; Schmidt S, 2006, AM J HUM GENET, V78, P852, DOI 10.1086/503822; Seddon JM, 2009, INVEST OPHTH VIS SCI, V50, P2044, DOI 10.1167/iovs.08-3064; Singerman Lawrence J, 2005, Retina, V25, pS1; Swaroop A, 2009, ANNU REV GENOM HUM G, V10, P19, DOI 10.1146/annurev.genom.9.081307.164350; Tan JSL, 2007, OPHTHALMOLOGY, V114, P1143, DOI 10.1016/j.ophtha.2006.09.033; Thakkinstian A, 2006, HUM MOL GENET, V15, P2784, DOI 10.1093/hmg/ddl220; Tomany SC, 2004, OPHTHALMOLOGY, V111, P1280, DOI 10.1016/j.ophtha.2003.11.010; Ueta T, 2009, OPHTHALMOLOGY, V116, P2400, DOI 10.1016/j.ophtha.2009.06.013	42	32	34	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132771	10.1371/journal.pone.0132771	http://dx.doi.org/10.1371/journal.pone.0132771			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26171855	Green Published, gold, Green Submitted			2022-12-26	WOS:000358194900083
J	Yu, YM; Shin, WG; Lee, JY; Choi, SA; Jo, YH; Youn, SJ; Lee, MS; Choi, KH				Yu, Yun Mi; Shin, Wan Gyoon; Lee, Ju-Yeun; Choi, Soo An; Jo, Yun Hee; Youn, So Jung; Lee, Mo Se; Choi, Kwang Hoon			Patterns of Adverse Drug Reactions in Different Age Groups: Analysis of Spontaneous Reports by Community Pharmacists	PLOS ONE			English	Article							AMBULATORY-CARE; GENDER-DIFFERENCES; EVENTS; PREVALENCE; DIZZINESS; MEDICINE	Purpose To evaluate the clinical manifestations and causative drugs associated with adverse drug reactions (ADRs) spontaneously reported by community pharmacists and to compare the ADRs by age. Methods ADRs reported to the Regional Pharmacovigilance Center of the Korean Pharmaceutical Association by community pharmacists from January 2013 to June 2014 were included. Causality was assessed using the WHO-Uppsala Monitoring Centre system. The patient population was classified into three age groups. We analyzed 31,398 (74.9%) ADRs from 9,705 patients, identified as having a causal relationship, from a total pool of 41,930 ADRs from 9,873 patients. Median patient age was 58.0 years; 66.9% were female. Results Gastrointestinal system (34.4%), nervous system (14.4%), and psychiatric (12.1%) disorders were the most frequent symptoms. Prevalent causative drugs were those for acid-related disorders (11.4%), anti-inflammatory products (10.5%), analgesics (7.2%), and anti-bacterials (7.1%). Comparisons by age revealed diarrhea and antibacterials to be most commonly associated with ADRs in children (p < 0.001), whereas dizziness was prevalent in the elderly (p < 0.001). Anaphylactic reaction was the most frequent serious event (19.7%), mainly associated with cephalosporins and non-steroidal anti-inflammatory drugs. Among 612 ADRs caused by nonprescription drugs, the leading symptoms and causative drugs were skin disorders (29.6%) and non-steroidal anti-inflammatory drugs (16.2%), respectively. Conclusions According to the community pharmacist reports, the leading clinical manifestations and causative drugs associated with ADRs in outpatients differed among age groups.	[Yu, Yun Mi; Shin, Wan Gyoon; Choi, Soo An; Jo, Yun Hee] Seoul Natl Univ, Coll Pharm, Seoul, South Korea; [Yu, Yun Mi; Shin, Wan Gyoon; Choi, Soo An; Jo, Yun Hee] Seoul Natl Univ, Pharmaceut Sci Res Inst, Seoul, South Korea; [Lee, Ju-Yeun] Hanyang Univ, Inst Pharmaceut Sci & Technol, Coll Pharm, Ansan, South Korea; [Youn, So Jung; Lee, Mo Se; Choi, Kwang Hoon] Korean Pharmaceut Assoc, Reg Pharmacovigilance Ctr, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Hanyang University	Shin, WG (corresponding author), Seoul Natl Univ, Coll Pharm, Seoul, South Korea.	wgshin@snu.ac.kr		Yu, Yun Mi/0000-0002-8267-9453	Ministry of Food and Drug Safety to operation of the regional pharmacovigilance center [20140114-000012]	Ministry of Food and Drug Safety to operation of the regional pharmacovigilance center(Ministry of Food & Drug Safety (MFDS), Republic of Korea)	This research was supported by a grant from Ministry of Food and Drug Safety (http://www.mfds.go.kr/index.do) to operation of the regional pharmacovigilance center in 2014 (20140114-000012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Hamid A, 2014, BRIT J CLIN PHARMACO, V78, P202, DOI 10.1111/bcp.12293; Bourgeois FT, 2010, PHARMACOEPIDEM DR S, V19, P901, DOI 10.1002/pds.1984; Byrt T, 1996, EPIDEMIOLOGY, V7, P561, DOI 10.1097/00001648-199609000-00030; Capuano A, 2009, EUR J CLIN PHARMACOL, V65, P721, DOI 10.1007/s00228-009-0641-8; Conforti A, 2012, PHARMACOEPIDEM DR S, V21, P597, DOI 10.1002/pds.3225; D'Incau P, 2014, FUND CLIN PHARMACOL, V28, P342, DOI 10.1111/fcp.12032; Drici MD, 2001, DRUG SAFETY, V24, P575, DOI 10.2165/00002018-200124080-00002; Edwards IR, 2000, LANCET, V356, P1255, DOI 10.1016/S0140-6736(00)02799-9; Gandhi TK, 2003, NEW ENGL J MED, V348, P1556, DOI 10.1056/NEJMsa020703; Inman WHW, 1996, BRIT J CLIN PHARMACO, V41, P434; Kaushal R, 2007, AMBUL PEDIATR, V7, P383, DOI 10.1016/j.ambp.2007.05.005; Kongkaew C, 2013, PHARMACOTHERAPY, V33, P827, DOI 10.1002/phar.1287; Korea Institute of Drug Safefy & Risk Management, 2014, TRENDS DRUG SAF INF; Ladwig KH, 2000, EUR J EPIDEMIOL, V16, P511, DOI 10.1023/A:1007629920752; Lagnaoui R, 2000, EUR J CLIN PHARMACOL, V56, P181, DOI 10.1007/s002280050738; Leone R, 2013, DRUG SAFETY, V36, P267, DOI 10.1007/s40264-013-0028-8; Maarsingh OR, 2010, ANN FAM MED, V8, P196, DOI 10.1370/afm.1116; Mazzitello C, 2013, J PHARMACOL PHARMACO, V4, pS20, DOI 10.4103/0976-500X.120942; McLernon DJ, 2010, DRUG SAFETY, V33, P775, DOI 10.2165/11536510-000000000-00000; Penders J, 2006, PEDIATRICS, V118, P511, DOI 10.1542/peds.2005-2824; Perraudin C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063894; Ribeiro-Vaz I, 2013, EUR J CLIN PHARMACOL, V69, P673, DOI 10.1007/s00228-012-1376-5; Schmiedl S, 2014, DRUG SAFETY, V37, P225, DOI 10.1007/s40264-014-0141-3; Shin YS, 2009, PHARMACOEPIDEM DR S, V18, P910, DOI 10.1002/pds.1796; Sloane PD, 2001, ANN INTERN MED, V134, P823, DOI 10.7326/0003-4819-134-9_Part_2-200105011-00005; Smyth RMD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0024061; Statistics Korea, 2014, STAT DAT KOR STAT IN, VAvailable; Tache SV, 2011, ANN PHARMACOTHER, V45, P977, DOI 10.1345/aph.1P627; Thomsen LA, 2007, ANN PHARMACOTHER, V41, P1411, DOI 10.1345/aph.1H658; Tran C, 1998, J CLIN PHARMACOL, V38, P1003, DOI 10.1177/009127009803801103; van Grootheest A C, 2005, Res Social Adm Pharm, V1, P126, DOI 10.1016/j.sapharm.2004.12.009; van Grootheest K, 2004, PHARMACOEPIDEM DR S, V13, P457, DOI 10.1002/pds.897; Vidaver RM, 2000, J WOMEN HEALTH GEN-B, V9, P495, DOI 10.1089/15246090050073576; Willis A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091157; Wistrom J, 2001, J ANTIMICROB CHEMOTH, V47, P43, DOI 10.1093/jac/47.1.43; World Health Oganization, 2013, AN THER CHEM ATC CLA; World Health Oganization, 2005, WHO ADV REACT TERM W; World Health Organization, 2012, WHO UMC CAUS ASS; World Health Organization, 1972, WHO TECH REP SER, V488, P1	39	28	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132916	10.1371/journal.pone.0132916	http://dx.doi.org/10.1371/journal.pone.0132916			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26172050	Green Published, Green Submitted, gold			2022-12-26	WOS:000358194900101
J	Ortiz-Matamoros, MF; Islas-Flores, T; Voigt, B; Menzel, D; Baluska, F; Villanueva, MA				Fernando Ortiz-Matamoros, Mario; Islas-Flores, Tania; Voigt, Boris; Menzel, Diedrik; Baluska, Frantisek; Villanueva, Marco A.			Heterologous DNA Uptake in Cultured Symbiodinium spp. Aided by Agrobacterium tumefaciens	PLOS ONE			English	Article							MEDIATED TRANSFORMATION; GENETIC-TRANSFORMATION; ARABIDOPSIS-THALIANA; T-DNA; CHLAMYDOMONAS-REINHARDTII; NUCLEAR TRANSFORMATION; PLANT TRANSFORMATION; SYMBIOSIS; EXPRESSION; CELLS	Plant-targeted pCB302 plasmids containing sequences encoding gfp fusions with a microtubule-binding domain; gfp with the fimbrin actin-binding domain 2; and gfp with AtRACK1C from Arabidopsis thaliana, all harbored in Agrobacterium tumefaciens, were used to assay heterologous expression on three different clades of the photosynthetic dinoflagellate, Symbiodinium. Accessibility to the resistant cell wall and through the plasma membrane of these dinoflagellates was gained after brief but vigorous shaking in the presence of glass beads and polyethylene glycol. A resistance gene to the herbicide Basta allowed appropriate selection of the cells expressing the hybrid proteins, which showed a characteristic green fluorescence, although they appeared to lose their photosynthetic pigments and did not further divide. Cell GFP expression frequency measured as green fluorescence emission yielded 839 per every 10(6) cells for Symbiodinium kawagutii, followed by 640 and 460 per every 10(6) cells for Symbiodinium microadriaticum and Symbiodinium sp. Mf11, respectively. Genomic PCR with specific primers amplified the AtRACK1C and gfp sequences after selection in all clades, thus revealing their presence in the cells. RT-PCR from RNA of S. kawagutii co-incubated with A. tumefaciens harboring each of the three vectors with their respective constructs, amplified products corresponding to the heterologous gfp sequence while no products were obtained from three distinct negative controls. The reported procedure shows that mild abrasion followed by co-incubation with A. tumefaciens harboring heterologous plasmids with CaMV35S and nos promoters can lead to expression of the encoded proteins into the Symbiodinium cells in culture. Despite the obvious drawbacks of the procedure, this is an important first step towards a stable transformation of Symbiodinium.	[Fernando Ortiz-Matamoros, Mario; Islas-Flores, Tania; Villanueva, Marco A.] Univ Nacl Autonoma Mexico, Inst Ciencias Mar & Limnol, Unidad Acad Sistemas Arrecifales, Puerto Morelos 77580, Quintana Roo, Mexico; [Fernando Ortiz-Matamoros, Mario] Univ Nacl Autonoma Mexico, Inst Ciencias Mar & Limnol, Posgrado Ciencias Mar & Limnol, Delegacion Coyoacan 04510, DF, Mexico; [Voigt, Boris; Menzel, Diedrik; Baluska, Frantisek] Univ Bonn, Inst Zellular & Mol Bot, D-53115 Bonn, Germany	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; University of Bonn	Villanueva, MA (corresponding author), Univ Nacl Autonoma Mexico, Inst Ciencias Mar & Limnol, Unidad Acad Sistemas Arrecifales, Prol Ave Ninos Heroes S-N, Puerto Morelos 77580, Quintana Roo, Mexico.	marco@cmarl.unam.mx	Islas, Tania/AAN-7790-2020; Baluska, Frantisek/AAQ-1358-2021; Villanueva, Marco A/A-7153-2013	Villanueva, Marco/0000-0001-5369-1026; Islas, Tania/0000-0003-0073-7734	DGAPA-UNAM [PAPIIT IN210514]; National Council of Science and Technology-Mexico (CONACyT) [175951]; CONACyT [131280]	DGAPA-UNAM(Universidad Nacional Autonoma de Mexico); National Council of Science and Technology-Mexico (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by grants PAPIIT IN210514 from DGAPA-UNAM and 175951 from the National Council of Science and Technology-Mexico (CONACyT) to MAV. MFO was supported by a PhD scholarship (No. 131280) from CONACyT. TIF was supported by a postdoctoral fellowship from DGAPA-UNAM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAMA K, 1995, PLANT CELL REP, V14, P450, DOI 10.1007/BF00234053; Apt KE, 1996, MOL GEN GENET, V252, P572, DOI 10.1007/s004380050264; BUNDOCK P, 1995, EMBO J, V14, P3206, DOI 10.1002/j.1460-2075.1995.tb07323.x; Castillo-Medina RE, 2013, PHOTOSYNTH RES, V115, P167, DOI 10.1007/s11120-013-9856-8; Chen MC, 2005, BIOCHEM BIOPH RES CO, V338, P1607, DOI 10.1016/j.bbrc.2005.10.133; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; de Groot MJA, 1998, NAT BIOTECHNOL, V16, P839, DOI 10.1038/nbt0998-839; Dunahay Terri G., 1997, V62, P503; Elliott AR, 1998, AUST J PLANT PHYSIOL, V25, P739, DOI 10.1071/PP98066; Ortiz-Matamoros MF, 2015, CIENC MAR, V41, P21, DOI 10.7773/cm.v41i1.2449; Foret S, 2007, CORAL REEFS, V26, P475, DOI 10.1007/s00338-007-0206-1; Franklin DJ, 2004, MAR ECOL PROG SER, V272, P117, DOI 10.3354/meps272117; GATES RD, 1992, BIOL BULL, V182, P324, DOI 10.2307/1542252; GODWIN I, 1991, PLANT CELL REP, V9, P671, DOI 10.1007/BF00235354; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; HOOYKAAS PJJ, 1992, PLANT MOL BIOL, V19, P15, DOI 10.1007/BF00015604; Ishida Y, 1996, NAT BIOTECHNOL, V14, P745, DOI 10.1038/nbt0696-745; KINDLE KL, 1990, P NATL ACAD SCI USA, V87, P1228, DOI 10.1073/pnas.87.3.1228; Kumar SV, 2004, PLANT SCI, V166, P731, DOI 10.1016/j.plantsci.2003.11.012; Kunik T, 2001, P NATL ACAD SCI USA, V98, P1871, DOI 10.1073/pnas.041327598; Kuo J, 2004, BIOCHEM BIOPH RES CO, V318, P176, DOI 10.1016/j.bbrc.2004.03.191; Lacroix B, 2006, TRENDS GENET, V22, P29, DOI 10.1016/j.tig.2005.10.004; Leggat W, 2007, J PHYCOL, V43, P1010, DOI 10.1111/j.1529-8817.2007.00387.x; Lesser MP, 1996, LIMNOL OCEANOGR, V41, P271, DOI 10.4319/lo.1996.41.2.0271; Loram JE, 2007, MOL ECOL, V16, P4849, DOI 10.1111/j.1365-294X.2007.03491.x; Marc J, 1998, PLANT CELL, V10, P1927, DOI 10.1105/tpc.10.11.1927; Mikosch TSP, 2001, CURR GENET, V39, P35, DOI 10.1007/s002940000178; Miller DJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r59; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Newell CA, 2000, MOL BIOTECHNOL, V16, P53, DOI 10.1385/MB:16:1:53; Rodriguez-Lanetty M, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-23; Schwarz JA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-97; Shoguchi E, 2013, CURR BIOL, V23, P1399, DOI 10.1016/j.cub.2013.05.062; Soffer N., 2008, P 11 INT COR REEF S, P159; ten Lohuis MR, 1998, PLANT J, V13, P427; TRENCH RK, 1993, ENDOCYTOBIOSIS CELL, V9, P135; VALVEKENS D, 1988, P NATL ACAD SCI USA, V85, P5536, DOI 10.1073/pnas.85.15.5536; Voigt B, 2005, EUR J CELL BIOL, V84, P595, DOI 10.1016/j.ejcb.2004.11.011; Voolstra CR, 2009, MOL ECOL, V18, P1823, DOI 10.1111/j.1365-294X.2009.04167.x; Wakefield TS, 2001, BIOL BULL-US, V200, P127, DOI 10.2307/1543306; Wild A, 1990, PESTIC SCI, V30, P22; Wood-Charlson EM, 2006, CELL MICROBIOL, V8, P1985, DOI 10.1111/j.1462-5822.2006.00765.x; Xiang CB, 1999, PLANT MOL BIOL, V40, P711, DOI 10.1023/A:1006201910593	44	23	23	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0132693	10.1371/journal.pone.0132693	http://dx.doi.org/10.1371/journal.pone.0132693			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26167858	Green Submitted, Green Published, gold			2022-12-26	WOS:000358193100067
J	Rapoport, SI; Primiani, CT; Chen, CT; Ahn, K; Ryan, VH				Rapoport, Stanley I.; Primiani, Christopher T.; Chen, Chuck T.; Ahn, Kwangmi; Ryan, Veronica H.			Coordinated Expression of Phosphoinositide Metabolic Genes during Development and Aging of Human Dorsolateral Prefrontal Cortex	PLOS ONE			English	Article							INOSITOL TRISPHOSPHATE RECEPTOR; HUMAN BRAIN; ALZHEIMERS-DISEASE; MESSENGER-RNA; PROTEIN; AGE; TRANSCRIPTION; MYOINOSITOL; ACID; PHOSPHATIDYLINOSITOL	Background Phosphoinositides, lipid-signaling molecules, participate in diverse brain processes within a wide metabolic cascade. Hypothesis Gene transcriptional networks coordinately regulate the phosphoinositide cascade during human brain Development and Aging. Methods We used the public BrainCloud database for human dorsolateral prefrontal cortex to examine age-related expression levels of 49 phosphoinositide metabolic genes during Development (0 to 20+ years) and Aging (21+ years). Results We identified three groups of partially overlapping genes in each of the two intervals, with similar intergroup correlations despite marked phenotypic differences between Aging and Development. In each interval, ITPKB, PLCD1, PIK3R3, ISYNA1, IMPA2, INPPL1, PI4KB, and AKT1 are in Group 1, PIK3CB, PTEN, PIK3CA, and IMPA1 in Group 2, and SACM1L, PI3KR4, INPP5A, SYNJ1, and PLCB1 in Group 3. Ten of the genes change expression non-linearly during Development, suggesting involvement in rapidly changing neuronal, glial and myelination events. Correlated transcription for some gene pairs likely is facilitated by colocalization on the same chromosome band. Conclusions Stable coordinated gene transcriptional networks regulate brain phosphoinositide metabolic pathways during human Development and Aging.	[Rapoport, Stanley I.; Primiani, Christopher T.; Ryan, Veronica H.] NIA, Brain Physiol & Metab Sect, Neurosci Lab, NIH, Bethesda, MD 20892 USA; [Chen, Chuck T.] NIAAA, Sect Nutr Neurosci, NIH, Bethesda, MD USA; [Ahn, Kwangmi] NIMH, Child Psychiat Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Rapoport, SI (corresponding author), NIA, Brain Physiol & Metab Sect, Neurosci Lab, NIH, Bethesda, MD 20892 USA.	sir@nih.gov	Ahn, Kwangmi/GLV-4077-2022	Chen, Chuck/0000-0002-1099-4198; Ryan, Veronica/0000-0001-5121-4672	Intramural Research Programs of the National Institute on Aging, National Institute on Alcohol Abuse and Alcoholism, National Institute of Mental Health; NATIONAL INSTITUTE ON AGING [ZIAAG000428] Funding Source: NIH RePORTER	Intramural Research Programs of the National Institute on Aging, National Institute on Alcohol Abuse and Alcoholism, National Institute of Mental Health; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The Intramural Research Programs of the National Institute on Aging, National Institute on Alcohol Abuse and Alcoholism, National Institute of Mental Health supported this research.	Arai Y, 2001, DEV BRAIN RES, V129, P1, DOI 10.1016/S0165-3806(01)00140-7; BENJAMIN J, 1995, PSYCHOPHARMACOL BULL, V31, P167; BERRIDGE MJ, 1989, JAMA-J AM MED ASSOC, V262, P1834; Carver JD, 2001, BRAIN RES BULL, V56, P79, DOI 10.1016/S0361-9230(01)00551-2; CHUGANI HT, 1991, J NUCL MED, V32, P23; Colantuoni C, 2011, NATURE, V478, P519, DOI 10.1038/nature10524; Cooper J., 2003, BIOCH BASIS NEUROPHA; Cunnane SC, 2014, J HUM EVOL, V77, P88, DOI 10.1016/j.jhevol.2014.05.001; Dai ZM, 2012, NUCLEIC ACIDS RES, V40, P27, DOI 10.1093/nar/gkr689; Dall'Armi C, 2013, CURR BIOL, V23, pR33, DOI 10.1016/j.cub.2012.10.041; Dawson AP, 2003, BIOCHEM J, V370, P621, DOI 10.1042/BJ20021289; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Delgado-Esteban M, 2007, J NEUROCHEM, V102, P194, DOI 10.1111/j.1471-4159.2007.04450.x; Downward J, 2004, SEMIN CELL DEV BIOL, V15, P177, DOI 10.1016/j.semcdb.2004.01.002; Eisen M, 1998, CLUSTER 3 0 MANUAL; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Falkenburger BH, 2010, J PHYSIOL-LONDON, V588, P3179, DOI 10.1113/jphysiol.2010.192153; Fisher SK, 2002, J NEUROCHEM, V82, P736, DOI 10.1046/j.1471-4159.2002.01041.x; FURTH EE, 1988, J BIOL CHEM, V263, P15951; George AA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084394; Grachev ID, 2001, J NEUROCHEM, V77, P292, DOI 10.1046/j.1471-4159.2001.00238.x; GREENWOOD AF, 1995, NEUROSCIENCE, V69, P125, DOI 10.1016/0306-4522(95)00220-D; Griffin RJ, 2005, J NEUROCHEM, V93, P105, DOI 10.1111/j.1471-4159.2004.02949.x; HAUSER G, 1963, J BIOL CHEM, V238, P3224; Hawrylycz MJ, 2012, NATURE, V489, P391, DOI 10.1038/nature11405; Heffron TP, 2012, J MED CHEM, V55, P8007, DOI 10.1021/jm300867c; Hu LH, 2008, BIOPHYS J, V95, P1151, DOI 10.1529/biophysj.108.129825; Huang W, 1999, AM J PSYCHIAT, V156, P1879; HUTTENLOCHER PR, 1984, AM J MENT DEF, V88, P488; Irvine RF, 2003, NAT REV MOL CELL BIO, V4, P586, DOI 10.1038/nrm1152; Ishrat T, 2012, NEUROSCIENCE, V210, P442, DOI 10.1016/j.neuroscience.2012.03.008; JOLLES J, 1993, DEMENTIA, V4, P81, DOI 10.1159/000107301; Kantarci K, 2000, NEUROLOGY, V55, P210, DOI 10.1212/WNL.55.2.210; Kim S, 2011, CELL METAB, V13, P215, DOI 10.1016/j.cmet.2011.01.007; Kitano J, 2002, J NEUROSCI, V22, P1280, DOI 10.1523/JNEUROSCI.22-04-01280.2002; LAPOSATA M, 1987, METHOD ENZYMOL, V141, P350; Law AJ, 2012, P NATL ACAD SCI USA, V109, P12165, DOI 10.1073/pnas.1206118109; Lee JY, 2012, ANN NY ACAD SCI, V1271, P68, DOI 10.1111/j.1749-6632.2012.06725.x; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Lister R, 2013, SCIENCE, V341, P629, DOI 10.1126/science.1237905; Loerch PM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003329; Ma KZ, 2006, NEUROCHEM RES, V31, P759, DOI 10.1007/s11064-006-9080-4; MIYAZAKI S, 1995, CURR OPIN CELL BIOL, V7, P190, DOI 10.1016/0955-0674(95)80027-1; NEUFELD EJ, 1985, J CELL BIOL, V101, P573, DOI 10.1083/jcb.101.2.573; Numata S, 2012, AM J HUM GENET, V90, P260, DOI 10.1016/j.ajhg.2011.12.020; O' Neill C, 2013, EXP GERONTOL, V48, P647, DOI 10.1016/j.exger.2013.02.025; Ohno S., 1970, EVOLUTION GENE DUPLI; Pacheco MA, 1996, PROG NEUROBIOL, V50, P255, DOI 10.1016/S0301-0082(96)00035-4; Persengiev S, 2013, FRONT MOL NEUROSCI, V6, DOI 10.3389/fnmol.2013.00032; Petanjek Z, 2011, P NATL ACAD SCI USA, V108, P13281, DOI 10.1073/pnas.1105108108; Pouwels PJW, 1999, PEDIATR RES, V46, P474, DOI 10.1203/00006450-199910000-00019; Primiani CT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110972; Purdon A.D., 2007, HDB NEUROCHEMISTRY M, P401; Putney JW, 2009, IMMUNOL REV, V231, P10, DOI 10.1111/j.1600-065X.2009.00810.x; RAPOPORT SI, 1990, BRAIN RES REV, V15, P267, DOI 10.1016/0165-0173(90)90004-8; Rapoport SI, 2008, PROSTAG LEUKOTR ESS, V79, P153, DOI 10.1016/j.plefa.2008.09.010; Ryan VH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100858; Saetre P, 2011, SYNAPSE, V65, P971, DOI 10.1002/syn.20933; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Serretti A, 2009, CURR MED CHEM, V16, P1917, DOI 10.2174/092986709788186101; Shankar SK, 2010, INDIAN J PATHOL MICR, V53, P595, DOI 10.4103/0377-4929.71995; SHETTY HU, 1995, J CLIN INVEST, V95, P542, DOI 10.1172/JCI117696; Shetty HU, 1996, BIOCHEM J, V313, P31, DOI 10.1042/bj3130031; Sjoholt G, 2004, MOL PSYCHIATR, V9, P621, DOI 10.1038/sj.mp.4001460; Somel M, 2010, GENOME RES, V20, P1207, DOI 10.1101/gr.106849.110; Sowell ER, 2004, NEUROSCIENTIST, V10, P372, DOI 10.1177/1073858404263960; Sullivan Gail M, 2012, J Grad Med Educ, V4, P279, DOI 10.4300/JGME-D-12-00156.1; Tamarkin-Ben-Harush A, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-688; Venkatesh S, 2015, NAT REV MOL CELL BIO, V16, P178, DOI 10.1038/nrm3941; Voronov SV, 2008, P NATL ACAD SCI USA, V105, P9415, DOI 10.1073/pnas.0803756105; Wang DZ, 2013, ANNU REV MED, V64, P131, DOI 10.1146/annurev-med-112211-154330; Wenk MR, 2004, P NATL ACAD SCI USA, V101, P8262, DOI 10.1073/pnas.0401874101; Yakovlev P. I., 1967, REGIONAL DEV BRAIN E, P3	74	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0132675	10.1371/journal.pone.0132675	http://dx.doi.org/10.1371/journal.pone.0132675			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26168237	Green Published, Green Submitted, gold			2022-12-26	WOS:000358193100065
J	Virgone, C; Lalli, E; Bisogno, G; Lazzari, E; Roma, J; Zin, A; Poli, E; Cecchetto, G; Dall'Igna, P; Alaggio, R				Virgone, Calogero; Lalli, Enzo; Bisogno, Gianni; Lazzari, Elena; Roma, Josep; Zin, Angelica; Poli, Elena; Cecchetto, Giovanni; Dall'Igna, Patrizia; Alaggio, Rita			DAX-1 Expression in Pediatric Rhabdomyosarcomas: Another Immunohistochemical Marker Useful in the Diagnosis of Translocation Positive Alveolar Rhabdomyosarcoma	PLOS ONE			English	Article							NUCLEAR RECEPTOR DAX1; EMBRYONIC STEM-CELLS; FUSION STATUS; INFANTILE RHABDOMYOFIBROSARCOMA; EPITHELIOID RHABDOMYOSARCOMA; INTERGROUP RHABDOMYOSARCOMA; EWS/FLI1 ONCOPROTEIN; WILMS-TUMOR; GENE; CLASSIFICATION	Objectives The aim of this study was to investigate the expression of DAX-1 in a series of pediatric rhabdomyosarcomas (RMS) with known translocation and compare it to Ap2 beta, known to be selectively expressed in ARMS. Design We revised a series of 71 alveolar rhabdomyosarcomas (ARMS), enrolled in the Italian Protocols RMS 79 and 96, and 23 embryonal rhabdomyosarcomas (ERMS) as controls. Before investigating Ap2 beta and DAX-1, ARMS were reviewed and reclassified as 48 ARMS and 23 non-ARMS. Results Translocation positive ARMS showed a characteristic Ap2 beta/DAX-1+ staining pattern in 78% of cases, while 76% of classic ERMS were negative for both. Ap2 beta alone was positive in 3.9% of RMS lacking translocation, whereas DAX-1 alone was positive in 25.4%. Conversely, 9% and 6% of translocation positive ARMS were positive only for DAX-1 or Ap2 beta, respectively. The 23 non-ARMS shared the same phenotype as ERMS but had a higher frequency of DAX-1 expression. Conclusions DAX-1 is less specific than Ap2 beta, however it is a sensitive marker for translocation positive ARMS and can be helpful in their diagnosis if used in combination with Ap2 beta.	[Virgone, Calogero; Cecchetto, Giovanni; Dall'Igna, Patrizia] Univ Hosp Padua, Pediat Surg, Dept Womens & Childrens Hlth, Padua, Italy; [Lalli, Enzo] CNRS, Inst Pharmacol Mol & Cellulaire, Unite Mixte Rech 7275, F-06560 Valbonne, France; [Lalli, Enzo] Univ Nice Sophia Antipolis, Valbonne, France; [Bisogno, Gianni] Univ Hosp Padua, Hematol Oncol, Dept Womens & Childrens Hlth, Padua, Italy; [Lazzari, Elena] San Bortolo Hosp, Pathol Unit, Vicenza, Italy; [Roma, Josep] Univ Autonoma Barcelona, Lab Translat Res Pediat Canc, Vall dHebron Res Inst, E-08193 Barcelona, Spain; [Zin, Angelica; Poli, Elena] Ist Ric Pediat Citta della Speranza, Lab Biol Tumori Solidi, Padua, Italy; [Alaggio, Rita] Univ Padua, Dept Med & Diagnost Sci & Special Therapies, Pathol Unit, Padua, Italy	University of Padua; Azienda Ospedaliera - Universita di Padova; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur; University of Padua; Azienda Ospedaliera - Universita di Padova; ULSS 8 Berica; Ospedale San Bortolo di Vicenza; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Fondazione Citta della Speranza; University of Padua	Virgone, C (corresponding author), Univ Hosp Padua, Pediat Surg, Dept Womens & Childrens Hlth, Padua, Italy.	calogero.virgone@unipd.it	Virgone, Calogero/ABB-7432-2020; alaggio, rita/AAC-2348-2019; Lalli, Enzo/F-7052-2013; Bisogno, Gianni/K-9282-2016	alaggio, rita/0000-0003-3915-3816; Lalli, Enzo/0000-0002-0584-5681; Virgone, Calogero/0000-0002-3651-9416; Dall'Igna, Patrizia/0000-0002-3822-3272; Bisogno, Gianni/0000-0003-4462-5523; Roma, Josep/0000-0001-7692-6123				Barr FG, 2006, J MOL DIAGN, V8, P202, DOI 10.2353/jmoldx.2006.050124; BARR FG, 1991, GENE CHROMOSOME CANC, V3, P153, DOI 10.1002/gcc.2870030212; Barr FG, 2009, GENE CHROMOSOME CANC, V48, P661, DOI 10.1002/gcc.20673; Battista MC, 2005, J CLIN ENDOCR METAB, V90, P5426, DOI 10.1210/jc.2005-0666; Boman F, 1996, PEDIATR PATHOL LAB M, V16, P951, DOI 10.1080/15513819609168718; Davicioni E, 2006, CANCER RES, V66, P6936, DOI 10.1158/0008-5472.CAN-05-4578; Davicioni E, 2009, AM J PATHOL, V174, P550, DOI 10.2353/ajpath.2009.080631; Doghman M, 2007, MOL ENDOCRINOL, V21, P2968, DOI 10.1210/me.2007-0120; Faria P, 1996, AM J SURG PATHOL, V20, P909, DOI 10.1097/00000478-199608000-00001; Fletcher C, 2013, WHO CLASSIFICATION O; Folpe AL, 2002, AM J SURG PATHOL, V26, P1175, DOI 10.1097/00000478-200209000-00008; Garcia-Aragoncillo E, 2008, ONCOGENE, V27, P6034, DOI 10.1038/onc.2008.203; GURNEY JG, 1995, CANCER, V75, P2186, DOI 10.1002/1097-0142(19950415)75:8<2186::AID-CNCR2820750825>3.0.CO;2-F; Jo VY, 2011, AM J SURG PATHOL, V35, P1523, DOI 10.1097/PAS.0b013e31822e0907; Kelly VR, 2011, MOL CELL ENDOCRINOL, V332, P116, DOI 10.1016/j.mce.2010.10.003; Khalfallah O, 2009, STEM CELLS, V27, P1529, DOI 10.1002/stem.78; Kinsey M, 2006, MOL CANCER RES, V4, P851, DOI 10.1158/1541-7786.MCR-06-0090; KODET R, 1991, AM J SURG PATHOL, V15, P257, DOI 10.1097/00000478-199103000-00006; Lalli E, 2010, EXPERT OPIN THER TAR, V14, P169, DOI 10.1517/14728220903531454; LUNDGREN L, 1993, HUM PATHOL, V24, P785, DOI 10.1016/0046-8177(93)90017-B; Mendiola M, 2006, INT J CANCER, V118, P1381, DOI 10.1002/ijc.21578; Mentzel T, 2000, VIRCHOWS ARCH, V436, P305, DOI 10.1007/s004280050451; Miki H, 1999, HUM PATHOL, V30, P1519, DOI 10.1016/S0046-8177(99)90177-6; MUSCATELLI F, 1994, NATURE, V372, P672, DOI 10.1038/372672a0; NEWTON WA, 1995, CANCER-AM CANCER SOC, V76, P1073, DOI 10.1002/1097-0142(19950915)76:6<1073::AID-CNCR2820760624>3.0.CO;2-L; Niakan KK, 2006, MOL GENET METAB, V88, P261, DOI 10.1016/j.ymgme.2005.12.010; Oda T, 2009, AM J PATHOL, V175, P1235, DOI 10.2353/ajpath.2009.090010; Parham DM, 2007, AM J SURG PATHOL, V31, P895, DOI 10.1097/01.pas.0000213436.99492.51; Parham DM, 2013, ADV ANAT PATHOL, V20, P387, DOI 10.1097/PAP.0b013e3182a92d0d; Qualman SJ, 1998, PEDIATR DEVEL PATHOL, V1, P550, DOI 10.1007/s100249900076; Rudzinski ER, 2014, AM J SURG PATHOL, V38, P654, DOI 10.1097/PAS.0000000000000195; Rudzinski Erin R, 2013, Am Soc Clin Oncol Educ Book, P425, DOI 10.1200/EdBook_AM.2013.33.425; Skapek SX, 2013, PEDIATR BLOOD CANCER, V60, P1411, DOI 10.1002/pbc.24532; Tamai KT, 1996, MOL ENDOCRINOL, V10, P1561, DOI 10.1210/me.10.12.1561; Wachtel M, 2006, J CLIN ONCOL, V24, P816, DOI 10.1200/JCO.2005.03.4934; Wachtel M, 2004, CANCER RES, V64, P5539, DOI 10.1158/0008-5472.CAN-04-0844; Wexler Leonard H., 1997, P799; Williamson D, 2010, J CLIN ONCOL, V28, P2151, DOI 10.1200/JCO.2009.26.3814; Xia SJJ, 2002, CANCER BIOL THER, V1, P97, DOI 10.4161/cbt.51; ZANARIA E, 1994, NATURE, V372, P635, DOI 10.1038/372635a0; Zin A, 2014, AM J SURG PATHOL, V38, P273, DOI 10.1097/PAS.0000000000000105; ZUPPAN CW, 1991, ULTRASTRUCT PATHOL, V15, P353, DOI 10.3109/01913129109016244; ZUPPAN CW, 1988, HUM PATHOL, V19, P1199, DOI 10.1016/S0046-8177(88)80152-7	43	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0133019	10.1371/journal.pone.0133019	http://dx.doi.org/10.1371/journal.pone.0133019			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26168243	gold, Green Published, Green Submitted			2022-12-26	WOS:000358193100104
J	Wang, LY; Wang, N; Le, F; Li, L; Lou, HY; Liu, XZ; Zheng, YM; Qian, YQ; Chen, YL; Jiang, XH; Huang, HF; Jin, F				Wang, Li-Ya; Wang, Ning; Le, Fang; Li, Lei; Lou, Hang-Ying; Liu, Xiao-Zhen; Zheng, Ying-Ming; Qian, Ye-Qing; Chen, Yun-Long; Jiang, Xin-Hang; Huang, He-Feng; Jin, Fan			Superovulation Induced Changes of Lipid Metabolism in Ovaries and Embryos and Its Probable Mechanism	PLOS ONE			English	Article							ASSISTED REPRODUCTIVE TECHNOLOGY; ELEMENT-BINDING PROTEIN-1A; LOW-BIRTH-WEIGHT; GRANULOSA-CELLS; FATTY-ACIDS; POSTMENOPAUSAL WOMEN; REPLACEMENT THERAPY; RECEPTOR EXPRESSION; FETAL DEVELOPMENT; HORMONE RECEPTOR	This research was intended to investigate the fetal origins of changed birth weight of the offspring born through assisted reproductive technology (ART). The association between hormone and lipid metabolism or body weight has been generally accepted, and as the basic and specific treatment in ART procedure, gonadotropin stimulation might have potential effects on intrauterine lipid metabolism. In our studies, the mice were superovulated with two doses of gonadotropin. The cholesterol metabolism in ovaries and the triglyceride metabolism in embryos were analyzed. The results showed gonadotropin probably accelerated luteinization and induced a longer time follicle development and ovulation, which resulted in histological and morphological alteration of ovary, and increased the cholesterol content and the expressions of steroidogenesis-related genes. In embryos, gonadotropin increased lipid accumulation and decreased fatty acid synthesis in a dose-dependent manner. Moreover, the changes of fatty acid composition were also shown in superovulation groups. Our studies firstly provided the evidence that the superovulation might affect the maternal and fetal lipid metabolism. These variations of lipid metabolism in our results may be associated with birth weight of ART infants.	[Wang, Li-Ya; Wang, Ning; Le, Fang; Lou, Hang-Ying; Liu, Xiao-Zhen; Zheng, Ying-Ming; Qian, Ye-Qing; Jin, Fan] Zhejiang Univ, Sch Med, Womens Hosp, Ctr Reprod Med, Hangzhou 310006, Zhejiang, Peoples R China; [Wang, Li-Ya; Wang, Ning; Le, Fang; Lou, Hang-Ying; Liu, Xiao-Zhen; Zheng, Ying-Ming; Qian, Ye-Qing; Huang, He-Feng; Jin, Fan] Minist Hlth, Key Lab Reprod Genet Zhejiang, Hangzhou 310006, Zhejiang, Peoples R China; [Li, Lei] Henan Canc Hosp, Dept Gynecol Oncol, Zhengzhou 450003, Peoples R China; [Chen, Yun-Long; Jiang, Xin-Hang] Zhejiang Univ, Coll Life Sci, Hangzhou 310058, Zhejiang, Peoples R China; [Huang, He-Feng] Shanghai Jiao Tong Univ, Sch Med, Int Peace Matern & Child Hlth Hosp, Shanghai 200030, Peoples R China	Zhejiang University; Zhengzhou University; Zhejiang University; Shanghai Jiao Tong University	Jin, F (corresponding author), Zhejiang Univ, Sch Med, Womens Hosp, Ctr Reprod Med, Hangzhou 310006, Zhejiang, Peoples R China.	jinfan@zju.edu.cn	Huang, He-Feng/AAN-7985-2020; Huang, Hefeng/AAR-7184-2021; Huang, Hefeng/ABF-1117-2020	Huang, He-Feng/0000-0003-4344-8019; Wang, Li-Ya/0000-0002-1100-3704	National Basic Research Program of China [2014CB943302, 2012CB944901]; National Science Foundation of China [81370760, 81300532]; Zhejiang Province Natural Science Foundation Projects of China [LZ13H040001]	National Basic Research Program of China(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Province Natural Science Foundation Projects of China	This work was supported by the National Basic Research Program of China (grant numbers 2014CB943302 and 2012CB944901), the National Science Foundation of China (grant numbers 81370760 and 81300532), and the Zhejiang Province Natural Science Foundation Projects of China (grant number LZ13H040001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adair LS, 2009, AM J CLIN NUTR, V89, P1383, DOI 10.3945/ajcn.2008.27139; Andric N, 2010, MOL ENDOCRINOL, V24, P552, DOI 10.1210/me.2009-0450; BARKER DJP, 1989, LANCET, V2, P577; BARKER DJP, 1990, BRIT MED J, V301, P1111, DOI 10.1136/bmj.301.6761.1111; Beltrand J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005343; Berfield AK, 2002, KIDNEY INT, V62, P1229, DOI 10.1111/j.1523-1755.2002.kid578.x; BROOKE OG, 1989, BRIT MED J, V298, P795, DOI 10.1136/bmj.298.6676.795; Christenson LK, 2001, ENDOCRINOLOGY, V142, P28, DOI 10.1210/endo.142.1.7867; Drouineaud V, 2007, MOL HUM REPROD, V13, P373, DOI 10.1093/molehr/gam019; Dunning KR, 2010, BIOL REPROD, V83, P909, DOI 10.1095/biolreprod.110.084145; Farhat A, 2011, J OVARIAN RES, V4, DOI 10.1186/1757-2215-4-3; Gambacciani M, 1997, J CLIN ENDOCR METAB, V82, P414, DOI 10.1210/jc.82.2.414; GREENWALD GS, 1976, J REPROD FERTIL, V48, P313, DOI 10.1530/jrf.0.0480313; Heijmans BT, 2008, P NATL ACAD SCI USA, V105, P17046, DOI 10.1073/pnas.0806560105; HERVEY E, 1967, J ENDOCRINOL, V37, P361, DOI 10.1677/joe.0.0370361; HORROBIN DF, 1980, MED HYPOTHESES, V6, P785, DOI 10.1016/0306-9877(80)90003-1; Huynh K, 2004, BIOL REPROD, V70, P1263, DOI 10.1095/biolreprod.103.022111; JOHNSON MR, 1995, EUR J OBSTET GYN R B, V59, P193, DOI 10.1016/0028-2243(95)02040-Y; Kortelainen ML, 2004, INT J OBESITY, V28, P623, DOI 10.1038/sj.ijo.0802522; KRONE W, 1988, J LIPID RES, V29, P1663; Kuroda H, 2001, INT J CANCER, V91, P309, DOI 10.1002/1097-0215(200002)9999:9999<::AID-IJC1060>3.0.CO;2-0; LAPOLT PS, 1990, ENDOCRINOLOGY, V126, P3277, DOI 10.1210/endo-126-6-3277; Lawson JS, 2001, BREAST CANCER RES, V3, P342, DOI 10.1186/bcr318; Lindsay RS, 2008, INT J EPIDEMIOL, V37, P192, DOI 10.1093/ije/dym256; Lindsay RS, 2007, CLIN ENDOCRINOL, V66, P322, DOI 10.1111/j.1365-2265.2006.02719.x; Liu JY, 1998, BIOL REPROD, V58, P648, DOI 10.1095/biolreprod58.3.648; Liu ZL, 2009, MOL ENDOCRINOL, V23, P649, DOI 10.1210/me.2008-0412; Lopez D, 1999, ENDOCRINOLOGY, V140, P5669, DOI 10.1210/en.140.12.5669; MATTHEWS KA, 1989, NEW ENGL J MED, V321, P641, DOI 10.1056/NEJM198909073211004; Miles EA, 2002, CYTOKINE, V20, P215, DOI 10.1006/cyto.2002.2007; Mzayek F, 2007, AM J EPIDEMIOL, V166, P413, DOI 10.1093/aje/kwm098; Savage DB, 2006, J CLIN INVEST, V116, P817, DOI 10.1172/JCI27300; Schieve LA, 2002, NEW ENGL J MED, V346, P731, DOI 10.1056/NEJMoa010806; Sriraman V, 2000, MOL CELL ENDOCRINOL, V162, P113, DOI 10.1016/S0303-7207(00)00201-X; Sturmey RG, 2009, REPROD DOMEST ANIM, V44, P50, DOI 10.1111/j.1439-0531.2009.01402.x; Van der Auwera I, 2001, HUM REPROD, V16, P1237, DOI 10.1093/humrep/16.6.1237; Wang DH, 2010, AQUAC RES, V41, P1140, DOI 10.1111/j.1365-2109.2009.02401.x; Wang L, 2007, MOL ENDOCRINOL, V21, P2233, DOI 10.1210/me.2007-0102; Wang YA, 2005, FERTIL STERIL, V83, P1650, DOI 10.1016/j.fertnstert.2004.12.033; Watanabe T, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-38; WATERMAN RA, 1988, BIOL REPROD, V38, P605, DOI 10.1095/biolreprod38.3.605; Wilhelms KW, 2006, ENVIRON TOXICOL CHEM, V25, P233, DOI 10.1897/05-039R.1; WU TCJ, 1992, MOL REPROD DEV, V33, P407, DOI 10.1002/mrd.1080330406; Yamashita S, 2005, MOL ENDOCRINOL, V19, P2099, DOI 10.1210/me.2005-0049; Yu Y, 2009, MOL CELL PROTEOMICS, V8, P1490, DOI 10.1074/mcp.M800273-MCP200	45	148	148	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0132638	10.1371/journal.pone.0132638	http://dx.doi.org/10.1371/journal.pone.0132638			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26167919	Green Published, Green Submitted, gold			2022-12-26	WOS:000358193100061
J	Shinderman-Maman, E; Cohen, K; Weingarten, C; Nabriski, D; Twito, O; Baraf, L; Hercbergs, A; Davis, PJ; Werner, H; Ellis, M; Ashur-Fabian, O				Shinderman-Maman, E.; Cohen, K.; Weingarten, C.; Nabriski, D.; Twito, O.; Baraf, L.; Hercbergs, A.; Davis, P. J.; Werner, H.; Ellis, M.; Ashur-Fabian, O.			The thyroid hormone-alpha v beta 3 integrin axis in ovarian cancer: regulation of gene transcription and MAPK-dependent proliferation	ONCOGENE			English	Article							ACTIVATED PROTEIN-KINASE; CELL-SURFACE RECEPTOR; ALPHA-V; ALPHA(V)BETA(3) INTEGRIN; GROWTH-FACTOR; TETRAIODOTHYROACETIC ACID; ALPHA-V-BETA-3 INTEGRIN; HORMONE STIMULATION; PLASMA-MEMBRANE; UP-REGULATION	Ovarian carcinoma is the fifth common cause of cancer death in women, despite advanced therapeutic approaches. alpha v beta 3 integrin, a plasma membrane receptor, binds thyroid hormones (L-thyroxine, T4; 3,5,3'-triiodo-L-thyronine, T3) and is overexpressed in ovarian cancer. We have demonstrated selective binding of fluorescently labeled hormones to alpha v beta 3-positive ovarian cancer cells but not to integrin-negative cells. Physiologically relevant T3 (1 nM) and T4 (100 nM) concentrations in OVCAR-3 (high alpha v beta 3) and A2780 (low alpha v beta 3) cells promoted alpha v and beta 3 transcription in association with basal integrin levels. This transcription was effectively blocked by RGD (Arg-Gly-Asp) peptide and neutralizing alpha v beta 3 antibodies, excluding T3-induced beta 3 messenger RNA, suggesting subspecialization of T3 and T4 binding to the integrin receptor pocket. We have provided support for extracellular regulated kinase (ERK)-mediated transcriptional regulation of the alpha v monomer by T3 and of beta 3 monomer by both hormones and documented a rapid (30-120 min) and dose-dependent (0.1-1000 nM) ERK activation. OVCAR-3 cells and alpha v beta 3-deficient HEK293 cells treated with alpha v beta 3 blockers confirmed the requirement for an intact thyroid hormone-integrin interaction in ERK activation. In addition, novel data indicated that T4, but not T3, controls integrin's outside-in signaling by phosphorylating tyrosine 759 in the beta 3 subunit. Both hormones induced cell proliferation (cell counts), survival (Annexin-PI), viability (WST-1) and significantly reduced the expression of genes that inhibit cell cycle (p21, p16), promote mitochondrial apoptosis (Nix, PUMA) and tumor suppression (GDF-15, IGFBP-6), particularly in cells with high integrin expression. At last, we have confirmed that hypothyroid environment attenuated ovarian cancer growth using a novel experimental platform that exploited paired euthyroid and severe hypothyroid serum samples from human subjects. To conclude, our data define a critical role for thyroid hormones as potent alpha v beta 3-ligands, driving ovarian cancer cell proliferation and suggest that disruption of this axis may present a novel treatment strategy in this aggressive disease.	[Shinderman-Maman, E.; Cohen, K.; Weingarten, C.; Ellis, M.; Ashur-Fabian, O.] Meir Med Ctr, Translat Hematooncol Lab, Inst Hematol, Tchernichovsky 59, IL-6997801 Kefar Sava, NA, Israel; [Shinderman-Maman, E.; Cohen, K.; Weingarten, C.; Ellis, M.; Ashur-Fabian, O.] Meir Med Ctr, Blood Bank, Tchernichovsky 59, IL-6997801 Kefar Sava, NA, Israel; [Shinderman-Maman, E.; Cohen, K.; Weingarten, C.; Werner, H.; Ashur-Fabian, O.] Tel Aviv Univ, Dept Human Mol Genet & Biochem, IL-69978 Tel Aviv, Israel; [Shinderman-Maman, E.; Cohen, K.; Weingarten, C.; Nabriski, D.; Werner, H.; Ellis, M.; Ashur-Fabian, O.] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel; [Nabriski, D.; Twito, O.; Baraf, L.] Meir Med Ctr, Dept Endocrinol, IL-6997801 Kefar Sava, NA, Israel; [Hercbergs, A.] Cleveland Clin, Radiat Oncol, Cleveland, OH 44106 USA; [Davis, P. J.] Albany Med Coll, Dept Med, Albany, NY 12208 USA	Tel Aviv University; Tel Aviv University; Tel Aviv University; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Cleveland Clinic Foundation; Albany Medical College	Ashur-Fabian, O (corresponding author), Meir Med Ctr, Translat Hematooncol Lab, Inst Hematol, Tchernichovsky 59, IL-6997801 Kefar Sava, NA, Israel.; Ashur-Fabian, O (corresponding author), Meir Med Ctr, Blood Bank, Tchernichovsky 59, IL-6997801 Kefar Sava, NA, Israel.	osnataf@gmail.com	Ashur, Osnat/AAC-1417-2020	twito, orit/0000-0002-8865-3860; Ashur-Fabian, Osnat/0000-0001-8624-3182	Li Ka Shing Foundation (LKSF)	Li Ka Shing Foundation (LKSF)	The work of Elena Shinderman Maman and Keren Cohen was done in partial fulfillment of the requirements for a PhD degree and of Chen Weingarten MSc degree from the Sackler Faculty of Medicine, Tel Aviv University, Israel. This work was partially supported by the Li Ka Shing Foundation (LKSF). We are grateful to Professor Jean-Luc Col (Institut Albert Bonniot and Universite Joseph Fourier, France) for HEK293 beta 3 and beta 1 cells.	Auersperg N, 2001, ENDOCR REV, V22, P255, DOI 10.1210/er.22.2.255; Bach LA, 2015, J CELL COMMUN SIGNAL, V9, P189, DOI 10.1007/s12079-015-0288-4; Bassett JHD, 2003, MOL CELL ENDOCRINOL, V213, P1, DOI 10.1016/j.mce.2003.10.033; Beral V, 2007, LANCET, V369, P1703, DOI 10.1016/S0140-6736(07)60534-0; Bergh JJ, 2005, ENDOCRINOLOGY, V146, P2864, DOI 10.1210/en.2005-0102; Blystone SD, 2002, J BIOL CHEM, V277, P46886, DOI 10.1074/jbc.M209506200; Boger C, 2013, APPL IMMUNOHISTO M M, V21, P553, DOI 10.1097/PAI.0b013e318284a03a; Brinton LA, 2007, GYNECOL ONCOL, V107, P487, DOI 10.1016/j.ygyno.2007.08.002; Brix K, 2011, THYROID RES, V4, DOI 10.1186/1756-6614-4-S1-S9; CANNISTRA SA, 1995, GYNECOL ONCOL, V58, P216, DOI 10.1006/gyno.1995.1214; Carduner L, 2014, CLIN EXP METASTAS, V31, P675, DOI 10.1007/s10585-014-9658-1; Chambery D, 2000, GROWTH HORM IGF RES, V10, P349, DOI 10.1054/ghir.2000.0179; Cheng SY, 2010, ENDOCR REV, V31, P139, DOI 10.1210/er.2009-0007; Cody V, 2007, STEROIDS, V72, P165, DOI 10.1016/j.steroids.2006.11.008; Cohen K, 2015, LEUKEMIA LYMPHOMA, V56, P1107, DOI 10.3109/10428194.2014.947612; Cohen K, 2014, ONCOTARGET, V5, P6312, DOI 10.18632/oncotarget.2205; Cohen K, 2011, MOL CANCER RES, V9, P1385, DOI 10.1158/1541-7786.MCR-11-0187; Colombo R, 2012, J MED CHEM, V55, P10460, DOI 10.1021/jm301058f; Courter DL, 2005, J BIOL CHEM, V280, P12145, DOI 10.1074/jbc.M412555200; Cruet-Hennequart S, 2003, ONCOGENE, V22, P1688, DOI 10.1038/sj.onc.1206347; Datta A, 2002, J BIOL CHEM, V277, P3943, DOI 10.1074/jbc.M109536200; Davis FB, 2006, CANCER RES, V66, P7270, DOI 10.1158/0008-5472.CAN-05-4365; Davis PJ, 2015, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00240; Davis PJ, 2014, ONCOTARGETS THER, V7, P1619, DOI 10.2147/OTT.S67393; Davis PJ, 2013, HORM CANCER-US, V4, P335, DOI 10.1007/s12672-013-0156-8; Davis PJ, 2011, ANNU REV PHARMACOL, V51, P99, DOI 10.1146/annurev-pharmtox-010510-100512; Davis PJ, 2000, J BIOL CHEM, V275, P38032, DOI 10.1074/jbc.M002560200; De S, 2005, P NATL ACAD SCI USA, V102, P7589, DOI 10.1073/pnas.0502935102; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; Dijkgraaf I, 2007, INT J CANCER, V120, P605, DOI 10.1002/ijc.22297; Dittrich R, 2011, J REPROD IMMUNOL, V90, P58, DOI 10.1016/j.jri.2011.02.009; Domcke S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3126; Edson MA, 2009, ENDOCR REV, V30, P624, DOI 10.1210/er.2009-0012; Freindorf M, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/959057; Guo WJ, 2004, NAT REV MOL CELL BIO, V5, P816, DOI 10.1038/nrm1490; Hall LC, 2008, J STEROID BIOCHEM, V109, P57, DOI 10.1016/j.jsbmb.2007.12.008; Hanna L, 2006, BEST PRACT RES CL OB, V20, P339, DOI 10.1016/j.bpobgyn.2005.10.016; Hapke S, 2003, BIOL CHEM, V384, P1073, DOI 10.1515/BC.2003.120; Hercbergs A, 2015, ONCOLOGIST, V20, P72, DOI 10.1634/theoncologist.2014-0308; Hercbergs AH, 2010, CURR OPIN ENDOCRINOL, V17, P432, DOI 10.1097/MED.0b013e32833d9710; Huang CY, 2011, J CELL PHYSIOL, V226, P1274, DOI 10.1002/jcp.22455; Huang YC, 2007, BIOCHEM PHARMACOL, V74, P1702, DOI 10.1016/j.bcp.2007.08.025; Illario M, 2005, J CLIN ENDOCR METAB, V90, P2865, DOI 10.1210/jc.2004-1520; Incerpi S, 1999, ENDOCRINOLOGY, V140, P683, DOI 10.1210/en.140.2.683; Incerpi S, 2005, ENDOCRINOLOGY, V146, P2861, DOI 10.1210/en.2005-0394; Janssen ML, 2002, CANCER RES, V62, P6146; Jayson GC, 2014, LANCET, V384, P1376, DOI 10.1016/S0140-6736(13)62146-7; Kang JH, 2013, OBSTET GYNECOL INT, V2013, DOI 10.1155/2013/743721; Krassas GE, 2010, ENDOCR REV, V31, P702, DOI 10.1210/er.2009-0041; Landen CN, 2008, NEOPLASIA, V10, P1259, DOI 10.1593/neo.08740; Liapis H, 1997, HUM PATHOL, V28, P443, DOI 10.1016/S0046-8177(97)90033-2; Lin HY, 2008, CARCINOGENESIS, V29, P62, DOI 10.1093/carcin/bgm239; Lin HY, 2007, STEROIDS, V72, P180, DOI 10.1016/j.steroids.2006.11.014; Lin HY, 2013, FASEB J, V27, P3209, DOI 10.1096/fj.12-227132; Lin HY, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001073; Lin HY, 2009, AM J PHYSIOL-CELL PH, V296, pC980, DOI 10.1152/ajpcell.00305.2008; Lin HY, 1998, J IMMUNOL, V161, P843; Liu J, 2014, CLIN CANCER RES, V20, P5150, DOI 10.1158/1078-0432.CCR-14-1312; Losel R, 2003, NAT REV MOL CELL BIO, V4, P46, DOI 10.1038/nrm1009; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Martinez MB, 2000, ANTICANCER RES, V20, P4141; Miller CR, 2014, GYNECOL ONCOL, V133, P128, DOI 10.1016/j.ygyno.2014.01.008; Moeller LC, 2011, THYROID RES, V4, DOI 10.1186/1756-6614-4-S1-S6; Moriggi G, 2011, ANTICANCER RES, V31, P89; Mousa SA, 2012, LUNG CANCER, V76, P39, DOI 10.1016/j.lungcan.2011.10.003; Ness RB, 2000, EPIDEMIOLOGY, V11, P111, DOI 10.1097/00001648-200003000-00006; Ozols RF, 2004, CANCER CELL, V5, P19, DOI 10.1016/S1535-6108(04)00002-9; Pascual A, 2013, BBA-GEN SUBJECTS, V1830, P3908, DOI 10.1016/j.bbagen.2012.03.012; Rae MT, 2007, J CLIN ENDOCR METAB, V92, P322, DOI 10.1210/jc.2006-1522; Rathinam R, 2010, CANCER METAST REV, V29, P223, DOI 10.1007/s10555-010-9211-x; Saegusa M, 2001, CANCER, V92, P1177, DOI 10.1002/1097-0142(20010901)92:5<1177::AID-CNCR1436>3.0.CO;2-5; Scanlan TS, 2004, NAT MED, V10, P638, DOI 10.1038/nm1051; Scarlett A, 2008, J ENDOCRINOL, V196, P509, DOI 10.1677/JOE-07-0344; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; SIEGRISTKAISER CA, 1990, J BIOL CHEM, V265, P5296; Sterle HA, 2014, J ENDOCRINOL, V222, P243, DOI 10.1530/JOE-14-0159; Storey NM, 2006, P NATL ACAD SCI USA, V103, P5197, DOI 10.1073/pnas.0600089103; Stromblad S, 1996, J CLIN INVEST, V98, P426, DOI 10.1172/JCI118808; Tang HY, 2004, ENDOCRINOLOGY, V145, P3265, DOI 10.1210/en.2004-0308; Theodossiou C, 1999, CANCER, V86, P1596, DOI 10.1002/(SICI)1097-0142(19991015)86:8<1596::AID-CNCR30>3.0.CO;2-C; Verga Falzacappa C, 2006, J CELL PHYSIOL, V206, P309, DOI 10.1002/jcp.20460; Wang XY, 2013, BIOCHEM PHARMACOL, V85, P597, DOI 10.1016/j.bcp.2012.11.025; Wang YF, 2011, INT J MOL SCI, V12, P3409, DOI 10.3390/ijms12063409; Woods D, 2001, MOL CELL BIOL, V21, P3192, DOI 10.1128/MCB.21.9.3192-3205.2001; Wu W, 2013, J LIPID RES, V54, P936, DOI 10.1194/jlr.M031450; Xi XD, 2006, J BIOL CHEM, V281, P29426, DOI 10.1074/jbc.C600039200; Xiong SB, 1998, P NATL ACAD SCI USA, V95, P12260, DOI 10.1073/pnas.95.21.12260; Yalcin M, 2013, HORM CANCER-US, V4, P176, DOI 10.1007/s12672-013-0137-y; Yamauchi M, 2008, MOL ENDOCRINOL, V22, P893, DOI 10.1210/me.2007-0249; Yehuda-Shnaidman E, 2014, ENDOCR REV, V35, P35, DOI 10.1210/er.2013-1006; Yu YC, 2013, ONCOL RES, V21, P217, DOI 10.3727/096504014X13907540404879; Zhang J, 2009, CELL DEATH DIFFER, V16, P939, DOI 10.1038/cdd.2009.16; Zhao YS, 2007, CANCER RES, V67, P5821, DOI 10.1158/0008-5472.CAN-06-4499	93	53	53	0	21	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 14	2016	35	15					1977	1987		10.1038/onc.2015.262	http://dx.doi.org/10.1038/onc.2015.262			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DJ2CC	26165836				2022-12-26	WOS:000374010300010
J	Deguchi, A; Tomita, T; Ohto, U; Takemura, K; Kitao, A; Akashi-Takamura, S; Miyake, K; Maru, Y				Deguchi, A.; Tomita, T.; Ohto, U.; Takemura, K.; Kitao, A.; Akashi-Takamura, S.; Miyake, K.; Maru, Y.			Eritoran inhibits S100A8-mediated TLR4/MD-2 activation and tumor growth by changing the immune microenvironment	ONCOGENE			English	Article							CALCIUM-BINDING PROTEINS; TOLL-LIKE RECEPTORS; NF-KAPPA-B; S100 PROTEINS; SIGNAL-TRANSDUCTION; SUPPRESSOR-CELLS; STRUCTURAL BASIS; MYELOID CELLS; TLR4; EXPRESSION	S100A8/A9 is a major component of the acute phase of inflammation, and appears to regulate cell proliferation, redox regulation and chemotaxis. We previously reported that S100A8/S100A9 are upregulated in the premetastatic lung. However, the detailed mechanisms by which S100A8 contributes to tumor progression have not been elucidated. In this study, we investigated the TLR4/MD-2 dependency by S100A8 on tumor progression. We found that S100A8 (2-89) peptide stimulated cell migration in a manner dependent on TLR4, MD-2 and MyD88. The S100A8 (2-89) peptide also activated p38 and NF-kappa B in TLR4-dependent manner. The peptide induced the upregulation of both IL-6 and Ccl2 in peritoneal macrophages obtained from wild-type mice, but not TLR4-deficient mice. We then investigated the responsible region of S100A8 for TLR4/MD-2 binding by a binding assay, and found that C-terminal region of S100A8 binds to TLR4/MD-2 complex. To further evaluate the TLR4 dependency on tumor microenvironment, Lewis lung carcinoma-bearing mice were treated with Eritoran, an antagonist of TLR4/MD-2 complex. We found that both tumor volume and pulmonary recruitment of myeloid-derived suppressor cells were reduced with the treatment of Eritoran for five consecutive days. Eritoran reduced the development of tumor vasculature, and increased tumor-infiltration of CD8(+) T-cells. Taken together, S100A8 appears to play a crucial role in the activation of the TLR4/MD-2 pathway and the promotion of a tumor growth-enhancing immune microenvironment.	[Deguchi, A.; Tomita, T.; Maru, Y.] Tokyo Womens Med Univ, Dept Pharmacol, Shinjuku Ku, 8-1 Kawada Cho, Tokyo 1628666, Japan; [Ohto, U.] Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo, Japan; [Takemura, K.; Kitao, A.] Univ Tokyo, Inst Mol & Cellular Biosci, Tokyo, Japan; [Akashi-Takamura, S.] Aichi Med Univ, Dept Microbiol & Immunol, Nagakute, Aichi 48011, Japan; [Miyake, K.] Univ Tokyo, Inst Med Sci, Div Infect Genet, Tokyo, Japan	Tokyo Women's Medical University; University of Tokyo; University of Tokyo; Aichi Medical University; University of Tokyo	Deguchi, A; Maru, Y (corresponding author), Tokyo Womens Med Univ, Dept Pharmacol, Shinjuku Ku, 8-1 Kawada Cho, Tokyo 1628666, Japan.	deguchi@research.twmu.ac.jp; ymaru@research.twmu.ac.jp	Kitao, Akio/B-8371-2008	Kitao, Akio/0000-0002-5221-0806; Takemura, Kazuhiro/0000-0001-5946-4502; Tomita, Takeshi/0000-0001-6815-2244	Ministry of Education, Culture, Sports, Science and Technology of Japan [21117008, 24501321, 26440063]; Grants-in-Aid for Scientific Research [15H04357] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank Drs Hiroyuki Aburatani and Akira Watanabe (Genome Science Division, Research Center for Advanced Science and Technology, The University of Tokyo) for providing an expression system for mammalian cell-derived S100A8, and Dr Mihich (Roswell Park Cancer Institute, NY, USA) for providing E0771 cells. We thank Dr Tatsuya Shimizu (Institute of Advanced Biomedical Engineering and Science, Tokyo Women's Medical University) for cell sorting technology. We also thank Dr Sachie Hiratsuka for valuable discussion and Messr. Tsutomu Omori and Taishi Mishima for technical assistance. This work was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to YM, 21117008) (to AD, 24501321) (to TT, 26440063).	Acharyya S, 2012, CELL, V150, P165, DOI 10.1016/j.cell.2012.04.042; Akira S, 2003, CURR OPIN IMMUNOL, V15, P5, DOI 10.1016/S0952-7915(02)00013-4; Andreani V, 2007, CANCER RES, V67, P10519, DOI 10.1158/0008-5472.CAN-07-0079; Asea A, 2002, J BIOL CHEM, V277, P15028, DOI 10.1074/jbc.M200497200; Biragyn A, 2002, SCIENCE, V298, P1025, DOI 10.1126/science.1075565; Bjork P, 2009, PLOS BIOL, V7, P800, DOI 10.1371/journal.pbio.1000097; Chen KQ, 2007, INT IMMUNOPHARMACOL, V7, P1271, DOI 10.1016/j.intimp.2007.05.016; Chen R, 2003, PROTEINS, V52, P80, DOI 10.1002/prot.10389; Deguchi A, 2013, J IMMUNOL, V191, P1856, DOI 10.4049/jimmunol.1201996; Donato R, 1999, BBA-MOL CELL RES, V1450, P191, DOI 10.1016/S0167-4889(99)00058-0; Doyle SL, 2006, BIOCHEM PHARMACOL, V72, P1102, DOI 10.1016/j.bcp.2006.07.010; Eckert RL, 2004, J INVEST DERMATOL, V123, P23, DOI 10.1111/j.0022-202X.2004.22719.x; Ehrchen JM, 2009, J LEUKOCYTE BIOL, V86, P557, DOI 10.1189/jlb.1008647; Ewens A, 2005, ANTICANCER RES, V25, P3905; Fitzgerald KA, 2003, J EXP MED, V198, P1043, DOI 10.1084/jem.20031023; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Ghavami S, 2008, J LEUKOCYTE BIOL, V83, P1484, DOI 10.1189/jlb.0607397; Grimbaldeston MA, 2003, J INVEST DERMATOL, V121, P1168, DOI 10.1046/j.1523-1747.2003.12561.x; Healy AM, 2006, CIRCULATION, V113, P2278, DOI 10.1161/CIRCULATIONAHA.105.607333; HESSIAN PA, 1993, J LEUKOCYTE BIOL, V53, P197, DOI 10.1002/jlb.53.2.197; Hiratsuka S, 2008, NAT CELL BIOL, V10, P1349, DOI 10.1038/ncb1794; Hiratsuka S, 2006, NAT CELL BIOL, V8, P1369, DOI 10.1038/ncb1507; Hiratsuka S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2856; Hsu K, 2005, J IMMUNOL, V174, P2318, DOI 10.4049/jimmunol.174.4.2318; Hsu RYC, 2011, CANCER RES, V71, P1989, DOI 10.1158/0008-5472.CAN-10-2833; Huang YH, 2012, P NATL ACAD SCI USA, V109, P17561, DOI 10.1073/pnas.1215397109; Hunter MJ, 1998, J BIOL CHEM, V273, P12427, DOI 10.1074/jbc.273.20.12427; Ichikawa M, 2011, MOL CANCER RES, V9, P133, DOI 10.1158/1541-7786.MCR-10-0394; Jiang DH, 2005, NAT MED, V11, P1173, DOI 10.1038/nm1315; Johnson GB, 2002, J IMMUNOL, V168, P5233, DOI 10.4049/jimmunol.168.10.5233; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kawasaki K, 2001, J ENDOTOXIN RES, V7, P232, DOI 10.1177/09680519010070030701; Kerkhoff C, 2005, FASEB J, V19, P467, DOI 10.1096/fj.04-2377fje; Kim HM, 2007, CELL, V130, P906, DOI 10.1016/j.cell.2007.08.002; Kitamura T, 2010, P NATL ACAD SCI USA, V107, P13063, DOI 10.1073/pnas.1002372107; Kumar A, 2003, INT ARCH ALLERGY IMM, V132, P40, DOI 10.1159/000073263; Kumar RK, 2001, J LEUKOCYTE BIOL, V70, P59; Mantovani A, 2015, J EXP MED, V212, P435, DOI 10.1084/jem.20150295; McCormick MM, 2005, J BIOL CHEM, V280, P41521, DOI 10.1074/jbc.M509442200; Merline R, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001868; Nagai Y, 2002, NAT IMMUNOL, V3, P667, DOI 10.1038/ni809; Ohto U, 2012, P NATL ACAD SCI USA, V109, P7421, DOI 10.1073/pnas.1201193109; Okamura Y, 2001, J BIOL CHEM, V276, P10229, DOI 10.1074/jbc.M100099200; Omori S, 2013, PROTEINS, V81, P1005, DOI 10.1002/prot.24252; Pal D, 2012, NAT MED, V18, P1279, DOI 10.1038/nm.2851; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Passey RJ, 1999, J IMMUNOL, V163, P2209; Pierce BG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024657; Propper C, 1999, J BIOL CHEM, V274, P183, DOI 10.1074/jbc.274.1.183; Qin H, 2014, NAT MED, V20, P676, DOI 10.1038/nm.3560; Rahimi F, 2005, FEBS J, V272, P2811, DOI 10.1111/j.1742-4658.2005.04703.x; Rajput S, 2013, MOL CANCER THER, V12, P1676, DOI 10.1158/1535-7163.MCT-12-1019; Rammes A, 1997, J BIOL CHEM, V272, P9496; Riva M, 2012, IMMUNOLOGY, V137, P172, DOI 10.1111/j.1365-2567.2012.03619.x; Ryckman C, 2003, J IMMUNOL, V170, P3233, DOI 10.4049/jimmunol.170.6.3233; Schaefer L, 2005, J CLIN INVEST, V115, P2223, DOI 10.1172/JCI23755; Schafer BW, 1996, TRENDS BIOCHEM SCI, V21, P134, DOI 10.1016/S0968-0004(96)80167-8; Shi C, 2011, IMMUNITY, V34, P590, DOI 10.1016/j.immuni.2011.02.016; Smiley ST, 2001, J IMMUNOL, V167, P2887, DOI 10.4049/jimmunol.167.5.2887; Szajnik M, 2009, ONCOGENE, V28, P4353, DOI 10.1038/onc.2009.289; Szczepanski MJ, 2009, CANCER RES, V69, P3105, DOI 10.1158/0008-5472.CAN-08-3838; Tomita T, 2011, ONCOGENE, V30, P3429, DOI 10.1038/onc.2011.53; Turovskaya O, 2008, CARCINOGENESIS, V29, P2035, DOI 10.1093/carcin/bgn188; Vabulas RM, 2001, J BIOL CHEM, V276, P31332, DOI 10.1074/jbc.M103217200; Vogl T, 2004, BLOOD, V104, P4260, DOI 10.1182/blood-2004-02-0446; Vogl T, 2006, BBA-MOL CELL RES, V1763, P1298, DOI 10.1016/j.bbamcr.2006.08.028; Vogl T, 2007, NAT MED, V13, P1042, DOI 10.1038/nm1638; Volk-Draper L, 2014, CANCER RES, V74, P5421, DOI 10.1158/0008-5472.CAN-14-0067; Xu K, 2001, J IMMUNOL, V166, P6358, DOI 10.4049/jimmunol.166.10.6358; Yang HA, 2010, P NATL ACAD SCI USA, V107, P11942, DOI 10.1073/pnas.1003893107; Yen T, 1997, BLOOD, V90, P4812, DOI 10.1182/blood.V90.12.4812.4812_4812_4821; Zreiqat H, 2007, J MOL HISTOL, V38, P381, DOI 10.1007/s10735-007-9117-2	73	40	43	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 17	2016	35	11					1445	1456		10.1038/onc.2015.211	http://dx.doi.org/10.1038/onc.2015.211			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DG6LQ	26165843				2022-12-26	WOS:000372196400010
J	Torres, M; Medinas, DB; Matamala, JM; Woehlbier, U; Cornejo, VH; Solda, T; Andreu, C; Rozas, P; Matus, S; Munoz, N; Vergara, C; Cartier, L; Soto, C; Molinari, M; Hetz, C				Torres, Mauricio; Medinas, Danilo B.; Matamala, Jose Manuel; Woehlbier, Ute; Cornejo, Victor Hugo; Solda, Tatiana; Andreu, Catherine; Rozas, Pablo; Matus, Soledad; Munoz, Natalia; Vergara, Carmen; Cartier, Luis; Soto, Claudio; Molinari, Maurizio; Hetz, Claudio			The Protein-disulfide Isomerase ERp57 Regulates the Steady-state Levels of the Prion Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; TRANSMEMBRANE FORM; PEPTIDE; DISEASE; RETROTRANSLOCATION; ACCUMULATION; TRAFFICKING; MODULATION; TRANSPORT; APOPTOSIS	Although the accumulation of a misfolded and protease-resistant form of the prion protein (PrP) is a key event in prion pathogenesis, the cellular factors involved in its folding and quality control are poorly understood. PrP is a glycosylated and disulfide-bonded protein synthesized at the endoplasmic reticulum (ER). The ER foldase ERp57 (also known as Grp58) is highly expressed in the brain of sporadic and infectious forms of prion-related disorders. ERp57 is a disulfide isomerase involved in the folding of a subset of glycoproteins in the ER as part of the calnexin/calreticulin cycle. Here, we show that levels of ERp57 increase mainly in neurons of Creutzfeldt-Jacob patients. Using gain- and loss-of-function approaches in cell culture, we demonstrate that ERp57 expression controls the maturation and total levels of wild-type PrP and mutant forms associated with human disease. In addition, we found that PrP physically interacts with ERp57, and also with the closest family member PDIA1, but not ERp72. Furthermore, we generated a conditional knock-out mouse for ERp57 in the nervous system and detected a reduction in the steady-state levels of the mono- and nonglycosylated forms of PrP in the brain. In contrast, ERp57 transgenic mice showed increased levels of endogenous PrP. Unexpectedly, ERp57 expression did not affect the susceptibility of cells to ER stress in vitro and in vivo. This study identifies ERp57 as a new modulator of PrP levels and may help with understanding the consequences of ERp57 up-regulation observed in human disease.	[Torres, Mauricio; Medinas, Danilo B.; Matamala, Jose Manuel; Woehlbier, Ute; Cornejo, Victor Hugo; Andreu, Catherine; Rozas, Pablo; Matus, Soledad; Munoz, Natalia; Hetz, Claudio] Univ Chile, Fac Med, Biomed Neurosci Inst, Santiago 8380453, Chile; [Torres, Mauricio; Medinas, Danilo B.; Woehlbier, Ute; Cornejo, Victor Hugo; Andreu, Catherine; Rozas, Pablo; Molinari, Maurizio; Hetz, Claudio] Univ Chile, Ctr Mol Studie Cell, Inst Biomed Sci, Program Cellular & Mol Biol, Santiago 8380453, Chile; [Matamala, Jose Manuel; Vergara, Carmen; Cartier, Luis] Univ Chile, Fac Med, Dept Neurol Sci, Santiago 7500691, Chile; [Solda, Tatiana; Molinari, Maurizio] Inst Biomed Res, CH-6500 Bellinzona, Switzerland; [Matus, Soledad; Munoz, Natalia] CENPAR, Neurounion Biomed Fdn, Santiago 7630614, Chile; [Molinari, Maurizio] Univ Svizzera Italiana, CH-6900 Lugano, Switzerland; [Molinari, Maurizio] Ecole Polytech Fed Lausanne, Sch Life Sci, CH-1015 Lausanne, Switzerland; [Soto, Claudio] Univ Texas Houston, Sch Med, Dept Neurol, Houston, TX 77030 USA; [Hetz, Claudio] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	Universidad de Chile; Universidad de Chile; Universidad de Chile; Universita della Svizzera Italiana; Universita della Svizzera Italiana; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Texas System; University of Texas Health Science Center Houston; Harvard University; Harvard T.H. Chan School of Public Health	Hetz, C (corresponding author), Univ Chile, Fac Med, Inst Biomed Sci, Independencia 1027,POB 70086, Santiago 8380453, Chile.	chetz@med.uchile.cl	Hetz, Claudio/ABD-7514-2021; Medinas, Danilo/ABA-1182-2021; Cornejo, Victor Hugo/ABD-8410-2021; Andreu, Catherine/AAV-6825-2021; Molinari, Maurizio/N-2587-2019; Matus, Soledad/AAA-3857-2020	Andreu, Catherine/0000-0003-2402-0252; Molinari, Maurizio/0000-0002-7636-5829; Torres-Gutierrez, Mauricio Andres/0000-0002-5081-9044; Bilches Medinas, Danilo/0000-0002-1822-1974; Woehlbier, Ute/0000-0003-3114-9708; Matamala, Jose Manuel/0000-0001-9062-5642	FONDECYT [1140549, 1100176, 11121524]; Millennium Institute [P09-015-F]; Ring Initiative [ACT1109]; FONDEF [D11I1007]; CONICYT [USA2013-0003, ECOS-CONICYTC13S02]; Michael J. Fox Foundation for Parkinson Research; Frick Foundation; Amyotrophic Lateral Sclerosis Therapy Alliance; Muscular Dystrophy Association, Foundation Grant COPEC-UC; FONDECYT Postdoctoral Fellowship [3110067, 3130351]; CONICYT; Foundation for Research on Neurodegenerative Diseases; Swiss National Science Foundation; Comel Foundation; Gabriele Foundation; Gelu Foundation	FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Millennium Institute(Takeda Pharmaceutical Company Ltd); Ring Initiative; FONDEF; CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); Michael J. Fox Foundation for Parkinson Research; Frick Foundation; Amyotrophic Lateral Sclerosis Therapy Alliance; Muscular Dystrophy Association, Foundation Grant COPEC-UC(Muscular Dystrophy Association); FONDECYT Postdoctoral Fellowship(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); Foundation for Research on Neurodegenerative Diseases; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Comel Foundation; Gabriele Foundation; Gelu Foundation	This work was supported in part by FONDECYT Grants 1140549 and 1100176, Millennium Institute Grant P09-015-F, Ring Initiative Grant ACT1109, FONDEF Grant D11I1007, CONICYT Grant USA2013-0003, ECOS-CONICYTC13S02, The Michael J. Fox Foundation for Parkinson Research, The Frick Foundation, Amyotrophic Lateral Sclerosis Therapy Alliance, Muscular Dystrophy Association, Foundation Grant COPEC-UC (to C. H.), FONDECYT Grant 11121524 (to S. M.), FONDECYT Postdoctoral Fellowships 3110067 (to U. W.) and 3130351 (to D. B. M.), CONICYT Ph.D. fellowship (to M. T. and V. H. C.), and Master fellowship (to P. R.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by Signora Alessandra, by the Foundation for Research on Neurodegenerative Diseases, the Swiss National Science Foundation, and the Comel, Gabriele, and Gelu Foundations.	Andreu CI, 2012, FEBS LETT, V586, P2826, DOI 10.1016/j.febslet.2012.07.023; Ashok A, 2008, MOL BIOL CELL, V19, P3463, DOI 10.1091/mbc.E08-01-0087; Borchelt DR, 1996, GENET ANAL-BIOMOL E, V13, P159, DOI 10.1016/S1050-3862(96)00167-2; Bremer J, 2010, NAT NEUROSCI, V13, P310, DOI 10.1038/nn.2483; Burgos PV, 2010, DEV CELL, V18, P425, DOI 10.1016/j.devcel.2010.01.015; Capellari S, 1999, J BIOL CHEM, V274, P34846, DOI 10.1074/jbc.274.49.34846; Castillo V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136620; Chiesa R, 1998, NEURON, V21, P1339, DOI 10.1016/S0896-6273(00)80653-4; Coe H, 2010, INT J BIOCHEM CELL B, V42, P796, DOI 10.1016/j.biocel.2010.01.009; Coe H, 2010, J BIOL CHEM, V285, P6725, DOI 10.1074/jbc.M109.054015; Dossena S, 2008, NEURON, V60, P598, DOI 10.1016/j.neuron.2008.09.008; Drisaldi B, 2003, J BIOL CHEM, V278, P21732, DOI 10.1074/jbc.M213247200; Feige MJ, 2011, CURR OPIN CELL BIOL, V23, P167, DOI 10.1016/j.ceb.2010.10.012; Garbi N, 2006, NAT IMMUNOL, V7, P93, DOI 10.1038/ni1288; Garbi N, 2007, CURR OPIN IMMUNOL, V19, P99, DOI 10.1016/j.coi.2006.11.013; Hetz C, 2006, SCIENCE, V312, P572, DOI 10.1126/science.1123480; Hetz C, 2005, J NEUROSCI, V25, P2793, DOI 10.1523/JNEUROSCI.4090-04.2005; Hetz C, 2003, EMBO J, V22, P5435, DOI 10.1093/emboj/cdg537; Hetz CA, 2006, CURR MOL MED, V6, P37, DOI 10.2174/156652406775574578; Hetz C, 2008, P NATL ACAD SCI USA, V105, P757, DOI 10.1073/pnas.0711094105; Hetz C, 2007, J BIOL CHEM, V282, P12725, DOI 10.1074/jbc.M611909200; Hetz C, 2015, NAT CELL BIOL, V17, P829, DOI 10.1038/ncb3184; Hetz C, 2014, NAT REV NEUROSCI, V15, P233, DOI 10.1038/nrn3689; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Hetz C, 2009, GENE DEV, V23, P2294, DOI 10.1101/gad.1830709; Hoffstrom BG, 2010, NAT CHEM BIOL, V6, P900, DOI [10.1038/nchembio.467, 10.1038/NCHEMBIO.467]; Ivanova L, 2001, J BIOL CHEM, V276, P42409, DOI 10.1074/jbc.M106928200; Jessop CE, 2007, EMBO J, V26, P28, DOI 10.1038/sj.emboj.7601505; Jessop CE, 2009, J CELL SCI, V122, P4287, DOI 10.1242/jcs.059154; Jessop CE, 2009, J BIOL CHEM, V284, P2194, DOI 10.1074/jbc.M808054200; Kang SW, 2006, CELL, V127, P999, DOI 10.1016/j.cell.2006.10.032; Li Y, 2004, J CELL BIOL, V164, P35, DOI 10.1083/jcb.200307010; Lisbona F, 2009, MOL CELL, V33, P679, DOI 10.1016/j.molcel.2009.02.017; Lucassen R, 2003, BIOCHEMISTRY-US, V42, P4127, DOI 10.1021/bi027218d; Ma JY, 2001, P NATL ACAD SCI USA, V98, P14955, DOI 10.1073/pnas.011578098; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Moreno J. A., 2013, TRANSL MED, V5; Moreno JA, 2012, NATURE, V485, P507, DOI 10.1038/nature11058; Moya KL, 2005, J NEUROCHEM, V92, P1044, DOI 10.1111/j.1471-4159.2004.02940.x; Nunziante M, 2011, J BIOL CHEM, V286, P33942, DOI 10.1074/jbc.M111.272617; Orsi A, 2006, J BIOL CHEM, V281, P30431, DOI 10.1074/jbc.M605320200; Peaper DR, 2008, P NATL ACAD SCI USA, V105, P10477, DOI 10.1073/pnas.0805044105; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Puig B., 2014, PRION, V8, P1; Quaglio E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019339; Rane NS, 2008, DEV CELL, V15, P359, DOI 10.1016/j.devcel.2008.06.015; Rodriguez DA, 2012, EMBO J, V31, P2322, DOI 10.1038/emboj.2012.84; Rojas-Rivera D, 2012, CELL DEATH DIFFER, V19, P1013, DOI 10.1038/cdd.2011.189; Satpute-Krishnan P, 2014, CELL, V158, P522, DOI 10.1016/j.cell.2014.06.026; Solda T, 2006, J BIOL CHEM, V281, P6219, DOI 10.1074/jbc.M513595200; Soto C, 2011, TRENDS BIOCHEM SCI, V36, P151, DOI 10.1016/j.tibs.2010.11.001; Steele AD, 2007, PRION, V1, P243, DOI 10.4161/pri.1.4.5551; Stewart RS, 2005, J NEUROSCI, V25, P3469, DOI 10.1523/JNEUROSCI.0105-05.2005; Stewart RS, 2001, MOL BIOL CELL, V12, P881, DOI 10.1091/mbc.12.4.881; Tompa P, 2002, BIOPHYS J, V82, P1711, DOI 10.1016/S0006-3495(02)75523-9; Torres M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036159; Torres M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015658; Turano C, 2011, CELL MOL BIOL LETT, V16, P539, DOI 10.2478/s11658-011-0022-z; Uehara T, 2006, NATURE, V441, P513, DOI 10.1038/nature04782; Vey M, 1996, P NATL ACAD SCI USA, V93, P14945, DOI 10.1073/pnas.93.25.14945; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang SB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038221; Wang X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014602; Watts JC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000608; Wearsch PA, 2007, NAT IMMUNOL, V8, P873, DOI 10.1038/ni1485; Welker E, 2001, P NATL ACAD SCI USA, V98, P4334, DOI 10.1073/pnas.071066598; Xu K, 2012, REV NEUROSCIENCE, V23, P79, DOI [10.1515/RNS.2011.062, 10.1515/rns.2011.062]; Yanai A, 1999, FEBS LETT, V460, P11, DOI 10.1016/S0014-5793(99)01316-2; Yedidia Y, 2001, EMBO J, V20, P5383, DOI 10.1093/emboj/20.19.5383; Yoo BC, 2002, NEUROSCI LETT, V334, P196, DOI 10.1016/S0304-3940(02)01071-6	70	41	43	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2015	290	39					23631	23645		10.1074/jbc.M114.635565	http://dx.doi.org/10.1074/jbc.M114.635565			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CS1IF	26170458	hybrid, Green Published			2022-12-26	WOS:000361816500014
J	Carbone, V; Schofield, LR; Zhang, YL; Sang, C; Dey, D; Hannus, IM; Martin, WF; Sutherland-Smith, AJ; Ronimus, RS				Carbone, Vincenzo; Schofield, Linley R.; Zhang, Yanli; Sang, Carrie; Dey, Debjit; Hannus, Ingegerd M.; Martin, William F.; Sutherland-Smith, Andrew J.; Ronimus, Ron S.			Structure and Evolution of the Archaeal Lipid Synthesis Enzyme sn-Glycerol-1-phosphate Dehydrogenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						archaea; dehydrogenase; evolution; lipid synthesis; phylogenetics; structural biology; thermophile; cell membrane; sn-glycerol-1-phosphate dehydrogenase; stereospecific	ENANTIOMERIC GLYCEROPHOSPHATE BACKBONE; DEHYDROQUINATE SYNTHASE; METHANOBACTERIUM-THERMOAUTOTROPHICUM; HYPERTHERMOPHILIC ARCHAEON; 3 DOMAINS; BIOSYNTHESIS; ORIGIN; CELLS; IDENTIFICATION; MEMBRANES	Background: Archaea synthesize glycerol-based membrane lipids of unique stereochemistry, utilizing distinct enzymology. Results: The structure of sn-glycerol-1-phosphate dehydrogenase (G1PDH), the first step in archaeal lipid synthesis, was determined. Conclusion: G1PDH is a member of the iron-dependent alcohol dehydrogenase and dehydroquinate synthase superfamily. Significance: The data contribute to our understanding of the origins of cellular lipids at the divergence of the Archaea and Bacteria. One of the most critical events in the origins of cellular life was the development of lipid membranes. Archaea use isoprenoid chains linked via ether bonds to sn-glycerol 1-phosphate (G1P), whereas bacteria and eukaryotes use fatty acids attached via ester bonds to enantiomeric sn-glycerol 3-phosphate. NAD(P)H-dependent G1P dehydrogenase (G1PDH) forms G1P and has been proposed to have played a crucial role in the speciation of the Archaea. We present here, to our knowledge, the first structures of archaeal G1PDH from the hyperthermophilic methanogen Methanocaldococcus jannaschii with bound substrate dihydroxyacetone phosphate, product G1P, NADPH, and Zn2+ cofactor. We also biochemically characterized the enzyme with respect to pH optimum, cation specificity, and kinetic parameters for dihydroxyacetone phosphate and NAD(P)H. The structures provide key evidence for the reaction mechanism in the stereospecific addition for the NAD(P)H-based pro-R hydrogen transfer and the coordination of the Zn2+ cofactor during catalysis. Structure-based phylogenetic analyses also provide insight into the origins of G1PDH.	[Carbone, Vincenzo; Schofield, Linley R.; Zhang, Yanli; Sang, Carrie; Dey, Debjit; Hannus, Ingegerd M.; Ronimus, Ron S.] AgResearch Ltd, Grasslands Res Ctr, Palmerston North 4442, New Zealand; [Martin, William F.] Univ Dusseldorf, Inst Mol Evolut, D-40225 Dusseldorf, Germany; [Sutherland-Smith, Andrew J.] Massey Univ, Inst Fundamental Sci, Palmerston North 4442, New Zealand	AgResearch - New Zealand; Heinrich Heine University Dusseldorf; Massey University	Ronimus, RS (corresponding author), AgResearch Ltd, Anim Nutr & Hlth, Grasslands Res Ctr, Tennent Dr,Private Bag 11008, Palmerston North 4442, New Zealand.	ron.ronimus@agresearch.co.nz	Martin, William F./O-5446-2015; Sutherland-Smith, Andrew/F-1813-2011	Martin, William F./0000-0003-1478-6449; Sutherland-Smith, Andrew/0000-0001-9485-1428; Sang, Carrie/0000-0003-4368-1558; carbone, vincenzo/0000-0003-4231-2785; Ronimus, Ron/0000-0001-8669-5840; /0000-0001-7288-2792	Pastoral Greenhouse Gas Research Consortium; Royal Society of New Zealand; New Zealand Synchrotron Group; Australian Synchrotron Foundation investor access program	Pastoral Greenhouse Gas Research Consortium; Royal Society of New Zealand(Royal Society of New Zealand); New Zealand Synchrotron Group; Australian Synchrotron Foundation investor access program	This work was supported by the Pastoral Greenhouse Gas Research Consortium, the Royal Society of New Zealand, the New Zealand Synchrotron Group, and the Australian Synchrotron Foundation investor access program. The authors declare no conflicts of interest.	Alarcon DA, 2012, ACTA CRYSTALLOGR F, V68, P1279, DOI 10.1107/S1744309112037736; Boucher Y, 2003, ANNU REV GENET, V37, P283, DOI 10.1146/annurev.genet.37.050503.084247; Boucher Y, 2004, MOL MICROBIOL, V52, P515, DOI 10.1111/j.1365-2958.2004.03992.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carpenter EP, 1998, NATURE, V394, P299, DOI 10.1038/28431; Daiyasu H, 2002, PROTEIN ENG, V15, P987, DOI 10.1093/protein/15.12.987; Dibrova DV, 2014, ENVIRON MICROBIOL, V16, P907, DOI 10.1111/1462-2920.12359; Doolittle WF, 2000, SCI AM, V282, P90, DOI 10.1038/scientificamerican0200-90; Elleuche S, 2013, APPL MICROBIOL BIOT, V97, P8963, DOI 10.1007/s00253-013-4725-0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Gribaldo S, 2006, PHILOS T R SOC B, V361, P1007, DOI 10.1098/rstb.2006.1841; Grochowski LL, 2008, ANN NY ACAD SCI, V1125, P190, DOI 10.1196/annals.1419.001; Guldan H, 2008, BIOCHEMISTRY-US, V47, P7376, DOI 10.1021/bi8005779; Guldan H, 2011, ANGEW CHEM INT EDIT, V50, P8188, DOI 10.1002/anie.201101832; Guy L, 2011, TRENDS MICROBIOL, V19, P580, DOI 10.1016/j.tim.2011.09.002; Hall BG, 2013, MOL BIOL EVOL, V30, P1229, DOI 10.1093/molbev/mst012; Han Jin-Suk, 2005, Archaea, V1, P311, DOI 10.1155/2005/257264; Han JS, 2002, EUR J BIOCHEM, V269, P969, DOI 10.1046/j.0014-2956.2001.02731.x; Holm Liisa, 2006, Curr Protoc Bioinformatics, VChapter 5, DOI 10.1002/0471250953.bi0505s14; Jain S, 2014, CHEM BIOL, V21, P1392, DOI 10.1016/j.chembiol.2014.07.022; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kandler Otto, 1998, P19; Koga Y, 2006, BIOSCI BIOTECH BIOCH, V70, P282, DOI 10.1271/bbb.70.282; Koga Y, 2003, BIOSCI BIOTECH BIOCH, V67, P1605, DOI 10.1271/bbb.67.1605; Koga Y, 1998, J MOL EVOL, V46, P54, DOI 10.1007/PL00006283; Koga Y, 2012, ARCHAEA, V2012, DOI 10.1155/2012/789652; Koga Y, 2014, J MOL EVOL, V78, P234, DOI 10.1007/s00239-014-9613-4; Koga Y, 2011, J MOL EVOL, V72, P274, DOI 10.1007/s00239-011-9428-5; Koonin EV, 2009, ANN NY ACAD SCI, V1178, P47, DOI 10.1111/j.1749-6632.2009.04992.x; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lane N, 2010, BIOESSAYS, V32, P271, DOI 10.1002/bies.200900131; Leatherbarrow R.J., 2009, GRAFIT VERSION 7; Lombard J, 2012, ARCHAEA, V2012, DOI 10.1155/2012/630910; Lombard J, 2012, NAT REV MICROBIOL, V10, P507, DOI 10.1038/nrmicro2815; Lombard J, 2011, MOL BIOL EVOL, V28, P87, DOI 10.1093/molbev/msq177; Marcal D, 2009, J BACTERIOL, V191, P1143, DOI 10.1128/JB.01077-08; Martin W, 2003, PHILOS T R SOC B, V358, P59, DOI 10.1098/rstb.2002.1183; Martin WF, 2014, SCIENCE, V344, P1092, DOI 10.1126/science.1251653; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Mayer F, 2014, FEMS MICROBIOL REV, V38, P449, DOI 10.1111/1574-6976.12043; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; McPhillips TM, 2002, J SYNCHROTRON RADIAT, V9, P401, DOI 10.1107/S0909049502015170; Mittelstadt G, 2013, ARCH BIOCHEM BIOPHYS, V537, P185, DOI 10.1016/j.abb.2013.07.022; Moon JH, 2011, J MOL BIOL, V407, P413, DOI 10.1016/j.jmb.2011.01.045; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nakatani Y, 2014, ORIGINS LIFE EVOL B, V44, P197, DOI 10.1007/s11084-014-9365-6; Nelson-Sathi S, 2015, NATURE, V517, P77, DOI 10.1038/nature13805; NISHIHARA M, 1995, J BIOCHEM-TOKYO, V117, P933, DOI 10.1093/oxfordjournals.jbchem.a124822; Nishihara M, 1997, J BIOCHEM-TOKYO, V122, P572; Nogly P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5169; Pace NR, 2009, MICROBIOL MOL BIOL R, V73, P565, DOI 10.1128/MMBR.00033-09; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Pereto J, 2004, TRENDS BIOCHEM SCI, V29, P469, DOI 10.1016/j.tibs.2004.07.002; Pester M, 2011, CURR OPIN MICROBIOL, V14, P300, DOI 10.1016/j.mib.2011.04.007; Ruzheinikov SN, 2001, STRUCTURE, V9, P789, DOI 10.1016/S0969-2126(01)00645-1; Sciara G, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5068; Soderberg Tim, 2005, Archaea, V1, P347, DOI 10.1155/2005/314760; Sojo V, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001926; Sousa FL, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0088; Stein N, 2008, J APPL CRYSTALLOGR, V41, P641, DOI 10.1107/S0021889808006985; Sugahara M, 2005, PROTEINS, V58, P249, DOI 10.1002/prot.20281; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Treangen TJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001284; Wachtershauser G, 2003, MOL MICROBIOL, V47, P13, DOI 10.1046/j.1365-2958.2003.03267.x; Wedlock DN, 2010, NEW ZEAL VET J, V58, P29, DOI 10.1080/00480169.2010.65058; Williams TA, 2013, NATURE, V504, P231, DOI 10.1038/nature12779; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2	71	13	14	1	44	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2015	290	35					21690	21704		10.1074/jbc.M115.647461	http://dx.doi.org/10.1074/jbc.M115.647461			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ5IS	26175150	Green Published, hybrid			2022-12-26	WOS:000360637600040
J	Huang, YL; Pai, FS; Tsou, YT; Mon, HC; Hsu, TL; Wu, CY; Chou, TY; Yang, WB; Chen, CH; Wong, CH; Hsieh, SL				Huang, Ya-Lang; Pai, Feng-Shuo; Tsou, Yun-Ting; Mon, Hsien-Chen; Hsu, Tsui-Ling; Wu, Chung-Yi; Chou, Teh-Ying; Yang, Wen-Bin; Chen, Chung-Hsuan; Wong, Chi-Huey; Hsieh, Shie-Liang			Human CLEC18 Gene Cluster Contains C-type Lectins with Differential Glycan-binding Specificity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						carbohydrate-binding protein; glycobiology; glycoconjugate; glycolipid; glycoprotein; lectin	CAP SUPERFAMILY; RECOGNITION; MODULATION; PROTEINS	Background: CLEC18 is a novel C-type lectin not being characterized. Results: The amino acid residue in the C-type lectin-like domain of CLEC18 contribute to the differential glycan-binding ability. Conclusion: CLEC18 members are expressed in immune and non-immune cells, and preferentially bind to fucoidan, -glucan, and galactan. Significance: The biochemical features, tissue distribution, and the glycan-binding specificity suggest that CLEC18 may contribute to host immunity against pathogens. The human C-type lectin 18 (clec18) gene cluster, which contains three clec18a, clec18b, and clec18c loci, is located in human chromosome 16q22. Although the amino acid sequences of CLEC18A, CLEC18B, and CLEC18C are almost identical, several amino acid residues located in the C-type lectin-like domain (CTLD) and the sperm-coating protein/Tpx-1/Ag5/PR-1/Sc7 (SCP/TAPS) domain, also known as the cysteine-rich secretory proteins/antigen 5/pathogenesis-related 1 proteins (CAP) domain, are distinct from each other. Genotyping by real-time PCR and sequencing further shows the presence of multiple alleles in clec18a/b/c loci. Flow cytometry analysis demonstrates that CLEC18 (CLEC18A, -B, and -C) are expressed abundantly in human peripheral blood cells. Moreover, CLEC18 expression is further up-regulated when monocytes differentiate into macrophages and dendritic cells. Immunofluorescence staining reveals that CLEC18 are localized in the endoplasmic reticulum, Golgi apparatus, and endosome. Interestingly, CLEC18 are also detectable in human sera and culture supernatants from primary cells and 293T cells overexpressing CLEC18. Moreover, CLEC18 bind polysaccharide in Ca2+-independent manner, and amino acid residues Ser/Arg(339) and Asp/Asn(421) in CTLD domain contribute to their differential binding abilities to polysaccharides isolated from Ganoderma lucidum (GLPS-F3). The Ser(339) (CLEC18A) Arg(339) (CLEC18A-1) mutation completely abolishes CLEC18A-1 binding to GLPS-F3, and a sugar competition assay shows that CLEC18 preferentially binds to fucoidan, -glucans, and galactans. Because proteins with the SCP/TAPS/CAP domain are able to bind sterol and acidic glycolipid, and are involved in sterol transport and -amyloid aggregation, it would be interesting to investigate whether CLEC18 modulates host immunity via binding to glycolipids, and are also involved in glycolipid transportation and protein aggregation in the future.	[Huang, Ya-Lang; Tsou, Yun-Ting; Hsieh, Shie-Liang] Natl Yang Ming Univ, Inst Microbiol & Immunol, Taipei 112, Taiwan; [Pai, Feng-Shuo; Chou, Teh-Ying; Hsieh, Shie-Liang] Natl Yang Ming Univ, Sch Med, Inst Clin Med, Taipei 112, Taiwan; [Mon, Hsien-Chen] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan; [Hsu, Tsui-Ling; Wu, Chung-Yi; Yang, Wen-Bin; Chen, Chung-Hsuan; Wong, Chi-Huey; Hsieh, Shie-Liang] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; [Hsieh, Shie-Liang] Taipei Vet Gen Hosp, Dept Med Res & Educ, Taipei, Taiwan; [Hsieh, Shie-Liang] Taipei Med Univ, Inst Canc Biol & Drug Discovery, Taipei, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Academia Sinica - Taiwan; Taipei Veterans General Hospital; Taipei Medical University	Hsieh, SL (corresponding author), Acad Sinica, Genom Res Ctr, 128 Acad Rd,Sect 2, Taipei 115, Taiwan.	slhsieh@gate.sinica.edu.tw	Wu, Chung-Yi/K-8334-2018; Hsieh, Shie-Liang Edmond/ABA-9184-2021; Hsu, Tsui-Ling/AAE-8821-2019; Hsu, Tsui-Ling/H-6704-2015	Hsu, Tsui-Ling/0000-0002-2912-3261; Hsieh, Shie-Liang/0000-0001-9415-346X	National Institutes of Health NIGMS [GM62116]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM062116] Funding Source: NIH RePORTER	National Institutes of Health NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the BioLegend (R) for their technique support and related antibody preparation. The glycan arrays were provided by the Consortium for the Functional Glycomics funded by National Institutes of Health NIGMS Grant GM62116.	Brown GD, 2001, NATURE, V413, P36, DOI 10.1038/35092620; Cambi A, 2003, CURR OPIN CELL BIOL, V15, P539, DOI 10.1016/j.ceb.2003.08.004; Cantacessi C, 2009, BIOTECHNOL ADV, V27, P376, DOI 10.1016/j.biotechadv.2009.02.005; Chang YC, 2004, J LEUKOCYTE BIOL, V75, P486, DOI 10.1189/jlb.0903448; Chen ST, 2008, NATURE, V453, P672, DOI 10.1038/nature07013; Choudhary V, 2012, P NATL ACAD SCI USA, V109, P16882, DOI 10.1073/pnas.1209086109; Dodd RB, 2001, GLYCOBIOLOGY, V11, p71R, DOI 10.1093/glycob/11.5.71R; Drickamer K, 1999, GLYCOBIOLOGY, V9, P1357, DOI 10.1093/glycob/9.12.1357; Gibbs GM, 2008, ENDOCR REV, V29, P865, DOI 10.1210/er.2008-0032; Hsu TL, 2002, J IMMUNOL, V168, P4846, DOI 10.4049/jimmunol.168.10.4846; Hsu TL, 2009, J BIOL CHEM, V284, P34479, DOI 10.1074/jbc.M109.065961; Kozlov G, 2010, J BIOL CHEM, V285, P38612, DOI 10.1074/jbc.M110.168294; Olrichs NK, 2014, AMYLOID, V21, P88, DOI 10.3109/13506129.2014.882304; Poget SF, 2001, BIOCHEMISTRY-US, V40, P10966, DOI 10.1021/bi002698z; Schneiter Roger, 2013, Biomol Concepts, V4, P519, DOI 10.1515/bmc-2013-0021; Stanley P., 2009, ESSENTIALS GLYCOBIOL, P425; Wang YY, 2002, BIOORGAN MED CHEM, V10, P1057, DOI 10.1016/S0968-0896(01)00377-7; Weis WI, 1998, IMMUNOL REV, V163, P19, DOI 10.1111/j.1600-065X.1998.tb01185.x; Yang CY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065070; Zelensky AN, 2005, FEBS J, V272, P6179, DOI 10.1111/j.1742-4658.2005.05031.x	20	16	19	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2015	290	35					21252	21263		10.1074/jbc.M115.649814	http://dx.doi.org/10.1074/jbc.M115.649814			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ5IS	26170455	Green Published, hybrid			2022-12-26	WOS:000360637600006
J	Samanta, AK; Jayaram, C; Jayapal, N; Sondhi, N; Kolte, AP; Senani, S; Sridhar, M; Dhali, A				Samanta, Ashis Kumar; Jayaram, C.; Jayapal, N.; Sondhi, N.; Kolte, A. P.; Senani, S.; Sridhar, M.; Dhali, A.			Assessment of Fecal Microflora Changes in Pigs Supplemented with Herbal Residue and Prebiotic	PLOS ONE			English	Article							FRAGMENT-LENGTH-POLYMORPHISMS; INTESTINAL MICROFLORA; MICROBIAL DIVERSITY; T-RFLP; 16S; BACTERIUM; ACID; IDENTIFICATION; COMMUNITIES; PERFORMANCE	Antibiotic usage in animals as a growth promoter is considered as public health issue due to its negative impact on consumer health and environment. The present study aimed to evaluate effectiveness of herbal residue (ginger, Zingiber officinale, dried rhizome powder) and prebiotic (inulin) as an alternative to antibiotics by comparing fecal microflora composition using terminal restriction fragment length polymorphism. The grower pigs were offered feed containing antibiotic (tetracycline), ginger and inulin separately and un-supplemented group served as control. The study revealed significant changes in the microbial abundance based on operational taxonomic units (OTUs) among the groups. Presumptive identification of organisms was established based on the fragment length of OTUs generated with three restriction enzymes (MspI, Sau3AI and BsuRI). The abundance of OTUs representing Bacteroides intestinalis, Eubacterium oxidoreducens, Selonomonas sp., Methylobacterium sp. and Denitrobacter sp. was found significantly greater in inulin supplemented pigs. Similarly, the abundance of OTUs representing Bacteroides intestinalis, Selonomonas sp., and Phascolarcobacterium faecium was found significantly greater in ginger supplemented pigs. In contrast, the abundance of OTUs representing pathogenic microorganisms Atopostipes suicloacalis and Bartonella quintana str. Toulouse was significantly reduced in ginger and inulin supplemented pigs. The OTUs were found to be clustered under two major phylotypes; ginger-inulin and control-tetracycline. Additionally, the abundance of OTUs was similar in ginger and inulin supplemented pigs. The results suggest the potential of ginger and prebioticsto replace antibiotics in the diet of grower pig.	[Samanta, Ashis Kumar; Jayaram, C.; Jayapal, N.; Sondhi, N.; Senani, S.] Natl Inst Anim Nutr & Physiol, Feed Addit & Nutraceut Lab, Bangalore 560030, Karnataka, India; [Kolte, A. P.; Dhali, A.] Natl Inst Anim Nutr & Physiol, Omics Lab, Bangalore 560030, Karnataka, India; [Sridhar, M.] Natl Inst Anim Nutr & Physiol, Fermentat Technol Lab, Bangalore 560030, Karnataka, India	Indian Council of Agricultural Research (ICAR); ICAR - National Institute of Animal Nutrition & Physiology; Indian Council of Agricultural Research (ICAR); ICAR - National Institute of Animal Nutrition & Physiology; Indian Council of Agricultural Research (ICAR); ICAR - National Institute of Animal Nutrition & Physiology	Samanta, AK (corresponding author), Natl Inst Anim Nutr & Physiol, Feed Addit & Nutraceut Lab, Hosur Rd, Bangalore 560030, Karnataka, India.	drashiskumarsamanta@gmail.com	Samanta, Ashis Kumar/AAE-6920-2019; Senani, Swaraj/ABD-8567-2020; Chikkerur, Jayaram/ABI-5147-2020	Samanta, Ashis Kumar/0000-0003-1646-294X; Chikkerur, Jayaram/0000-0001-8575-7632	Department of Biotechnology, Ministry of Science and Technology, Government of India [BT/PR13932/AAQ/01/435/2010]	Department of Biotechnology, Ministry of Science and Technology, Government of India(Department of Biotechnology (DBT) IndiaMinistry of Science and Technology, Government of India)	The grant was received by AKS from the Department of Biotechnology, Ministry of Science and Technology, Government of India (www.dbtindia.nic.in) Grant No. BT/PR13932/AAQ/01/435/2010.	Al Jassim RAM, 2003, LETT APPL MICROBIOL, V37, P213, DOI 10.1046/j.1472-765X.2003.01380.x; Apajalahti J, 2005, J APPL POULTRY RES, V14, P444, DOI 10.1093/japr/14.2.444; BRAY J. ROGER, 1957, ECOL MONOGR, V27, P325, DOI 10.2307/1942268; Casewell M, 2003, J ANTIMICROB CHEMOTH, V52, P159, DOI 10.1093/jac/dkg313; Castanon JIR, 2007, POULTRY SCI, V86, P2466, DOI 10.3382/ps.2007-00249; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Costa E, 2009, J MICROBIOL METH, V78, P175, DOI 10.1016/j.mimet.2009.05.011; Costa LB, 2013, S AFR J ANIM SCI, V43, P181, DOI 10.4314/sajas.v43i2.9; de Lange CFM, 2010, LIVEST SCI, V134, P124, DOI 10.1016/j.livsci.2010.06.117; Dicksved J, 2007, APPL ENVIRON MICROB, V73, P2284, DOI 10.1128/AEM.02223-06; Duncan SH, 1998, FEMS MICROBIOL LETT, V164, P283, DOI 10.1111/j.1574-6968.1998.tb13099.x; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Economic and Social Committee of the European Union, 1998, OP RES ANT THREAT PU; Engebretson JJ, 2003, APPL ENVIRON MICROB, V69, P4823, DOI 10.1128/AEM.69.8.4823-4829.2003; Fukuda S, 2006, J APPL MICROBIOL, V100, P787, DOI 10.1111/j.1365-2672.2006.02864.x; Gaggia F, 2010, INT J FOOD MICROBIOL, V141, pS15, DOI 10.1016/j.ijfoodmicro.2010.02.031; Genersch E, 2005, APPL ENVIRON MICROB, V71, P7551, DOI 10.1128/AEM.71.11.7551-7555.2005; Hong PY, 2014, APPL ENVIRON MICROB, V80, P2084, DOI 10.1128/AEM.03176-13; Konstantinov SR, 2004, APPL ENVIRON MICROB, V70, P3821, DOI 10.1128/AEM.70.7.3821-3830.2004; KRUSKAL JB, 1964, PSYCHOMETRIKA, V29, P1, DOI 10.1007/BF02289565; Kverka M, 2011, CLIN EXP IMMUNOL, V163, P250, DOI 10.1111/j.1365-2249.2010.04286.x; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI DOI 10.1007/S00227-012-2133-0; Li JR, 2003, APPL ENVIRON MICROB, V69, P901, DOI 10.1128/AEM.69.2.901-908.2003; Li PF, 2012, ASIAN AUSTRAL J ANIM, V25, P1617, DOI 10.5713/ajas.2012.12292; Liu WT, 1997, APPL ENVIRON MICROB, V63, P4516, DOI 10.1128/AEM.63.11.4516-4522.1997; Loh G, 2006, J NUTR, V136, P1198, DOI 10.1093/jn/136.5.1198; Lynch MB, 2007, ANIMAL, V1, P1112, DOI 10.1017/S1751731107000407; Marsh TL, 1999, CURR OPIN MICROBIOL, V2, P323, DOI 10.1016/S1369-5274(99)80056-3; MOORE LVH, 1987, INT J SYST BACTERIOL, V37, P271, DOI 10.1099/00207713-37-3-271; MUDARRIS M, 1994, INT J SYST BACTERIOL, V44, P447, DOI 10.1099/00207713-44-3-447; MUYZER G, 1995, ARCH MICROBIOL, V164, P165, DOI 10.1007/BF02529967; O'Mahony R, 2005, WORLD J GASTROENTERO, V11, P7499, DOI 10.3748/wjg.v11.i47.7499; Ohl ME, 2000, CLIN INFECT DIS, V31, P131, DOI 10.1086/313890; Oli MW, 1998, DIGEST DIS SCI, V43, P138, DOI 10.1023/A:1018892524790; Patterson JK, 2010, J NUTR, V140, P2158, DOI 10.3945/jn.110.130302; Pedersen R, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-30; Prive F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069076; Samanta AK, 2011, CURR SCI INDIA, V101, P43; Samanta AK, 2012, J MICROBIOL, V50, P218, DOI 10.1007/s12275-012-1362-8; Schutte UME, 2008, APPL MICROBIOL BIOT, V80, P365, DOI 10.1007/s00253-008-1565-4; SHEPARD RN, 1962, PSYCHOMETRIKA, V27, P125, DOI 10.1007/BF02289630; Shyu C, 2007, MICROB ECOL, V53, P562, DOI 10.1007/s00248-006-9106-0; Spear GT, 2010, AIDS RES HUM RETROV, V26, P193, DOI 10.1089/aid.2009.0166; Sun YZ, 2011, J APPL MICROBIOL, V110, P1093, DOI 10.1111/j.1365-2672.2011.04967.x; Suryanarayana M.V.A.N., 2013, J AGR SUSTAIN, V3, P183; Thies JE, 2007, SOIL SCI SOC AM J, V71, P579, DOI 10.2136/sssaj2006.0318; Torok VA, 2008, APPL ENVIRON MICROB, V74, P783, DOI 10.1128/AEM.01384-07; Ueno N, 2011, INFLAMM BOWEL DIS, V17, P2235, DOI 10.1002/ibd.21597; Van Loo J, 2007, J NUTR, V137, p2594S, DOI 10.1093/jn/137.11.2594S; Varley PF, 2010, J SCI FOOD AGR, V90, P2447, DOI 10.1002/jsfa.4105; Watanabe Y, 2012, APPL ENVIRON MICROB, V78, P511, DOI 10.1128/AEM.06035-11; WINTER J, 1989, APPL ENVIRON MICROB, V55, P1203, DOI 10.1128/AEM.55.5.1203-1208.1989; World Health Organization, 1997, MED IMP US ANT FOOD; Yan L, 2012, LIVEST SCI, V145, P189, DOI 10.1016/j.livsci.2012.02.001	55	11	14	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132961	10.1371/journal.pone.0132961	http://dx.doi.org/10.1371/journal.pone.0132961			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176779	Green Published, gold, Green Submitted			2022-12-26	WOS:000358197600189
J	Uno, K; Yoshizaki, K; Iwahashi, M; Yamana, J; Yamana, S; Tanigawa, M; Yagi, K				Uno, Kazuko; Yoshizaki, Kazuyuki; Iwahashi, Mitsuhiro; Yamana, Jiro; Yamana, Seizo; Tanigawa, Miki; Yagi, Katsumi			Pretreatment Prediction of Individual Rheumatoid Arthritis Patients' Response to Anti-Cytokine Therapy Using Serum Cytokine/Chemokine/Soluble Receptor Biomarkers	PLOS ONE			English	Article							ANTITUMOR NECROSIS FACTOR; DISEASE-ACTIVITY; DOUBLE-BLIND; CONCOMITANT METHOTREXATE; MONOCLONAL-ANTIBODY; GENE-EXPRESSION; SOLUBLE IL-6; TOCILIZUMAB; TRIAL; REMISSION	The inability to match rheumatoid arthritis (RA) patients with the anti-cytokine agent most efficacious for them is a major hindrance to patients' speedy recovery and to the clinical use of anti-cytokine therapy. Identifying predictive biomarkers that can assist in matching RA patients with more suitable anti-cytokine treatment was our aim in this report. The sample consisted of 138 RA patients (naive and non-naive) who were administered tocilizumab or etanercept for a minimum of 16 weeks as a prescribed RA treatment. Pretreatment serum samples were obtained from patients and clinical measures of their disease activity were evaluated at baseline and 16 weeks after treatment commenced. Using patients' pretreatment serum, we measured 31 cytokines/chemokines/soluble receptors and used multiple linear regression analysis to identify biomarkers that correlated with patients' symptom levels (DAS28-CRP score) at week 16 and multiple logistic analyses for biomarkers that correlated with patients' final outcome. The results revealed that sgp130, logIL-6, logIL-8, logEotaxin, logIP-10, logVEGF, logsTNFR-I and logsTNFR-II pretreatment serum levels were predictive of the week 16 DAS28-CRP score in naive tocilizumab patients while sgp130, logGM-CSF and logIP-10 were predictive in non-naive patients. Additionally, we found logIL-9, logVEGF and logTNF-alpha to be less reliable at predicting the week 16 DAS28-CRP score in naive etanercept patients. Multiple linear regression and multiple logistic regression analyses identified biomarkers that were predictive of remission/non-remission in tocilizumab and etanercept therapy. Although less reliable than those for tocilizumab, we identified a few possible biomarkers for etanercept therapy. The biomarkers for these two therapies differ suggesting that their efficacy will vary for individual patients. We discovered biomarkers in RA pretreatment serum that predicted their week 16 DAS28-CRP score and clinical outcome to tocilizumab therapy. Most of these biomarkers, especially sgp130, are involved in RA pathogenesis and IL-6 signal transduction, which further suggests that they are highly reliable.	[Uno, Kazuko; Yoshizaki, Kazuyuki; Tanigawa, Miki] Osaka Univ, Inst Sci & Ind Res, Dept Organ Fine Chem, Div Biol & Mol Sci, Suita, Osaka, Japan; [Uno, Kazuko; Yagi, Katsumi] Louis Pasteur Ctr Med Res, Kyoto, Kyoto, Japan; [Iwahashi, Mitsuhiro; Yamana, Jiro; Yamana, Seizo] Higashi Hiroshima Mem Hosp, Higashihiroshima, Hiroshima, Japan; [Yoshizaki, Kazuyuki] Tokushukai Med Corp, Tokyo, Japan	Osaka University	Yoshizaki, K (corresponding author), Osaka Univ, Inst Sci & Ind Res, Dept Organ Fine Chem, Div Biol & Mol Sci, Suita, Osaka, Japan.	kyoshi@sanken.osaka-u.ac.jp			Japan Health Foundation [25460784]	Japan Health Foundation(Japan Health Foundation)	Support was provided by Grants-in-Aid for Scientific Research, the Japan Health Foundation, (No. 25460784).	Aga AB, 2013, ANN RHEUM DIS; Arend WP, 2002, J RHEUMATOL, V29, P16; Bienkowska JR, 2009, GENOMICS, V94, P423, DOI 10.1016/j.ygeno.2009.08.008; Boettger MK, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3079; Burmester GR, 2011, ANN RHEUM DIS, V70, P755, DOI 10.1136/ard.2010.139725; Conaghan PG, 2011, CLIN RHEUMATOL, V30, pS41, DOI 10.1007/s10067-010-1639-4; Emery P, 2008, LANCET, V372, P375, DOI 10.1016/S0140-6736(08)61000-4; Hagihara K, 2004, BIOCHEM BIOPH RES CO, V314, P363, DOI 10.1016/j.bbrc.2003.12.096; Hambardzumyan K, 2014, ANN RHEUM DIS; Inoue E, 2007, ANN RHEUM DIS, V66, P407, DOI 10.1136/ard.2006.054205; Lindstrom TM, 2010, SCAND J CLIN LAB INV, V70, P79, DOI 10.3109/00365513.2010.493406; Maini R, 1999, LANCET, V354, P1932, DOI 10.1016/S0140-6736(99)05246-0; Marotte H, 2010, JOINT BONE SPINE, V77, P297, DOI 10.1016/j.jbspin.2010.02.026; Nakahara H, 2003, ARTHRITIS RHEUM-US, V48, P1521, DOI 10.1002/art.11143; Navarro-Millan I, 2013, CURR OPIN RHEUMATOL, V25, P384, DOI 10.1097/BOR.0b013e32835fc62e; Nishikawa T, 2008, J IMMUNOL, V180, P3492, DOI 10.4049/jimmunol.180.5.3492; Nishimoto N, 2004, ARTHRITIS RHEUM-US, V50, P1761, DOI 10.1002/art.20303; Nishimoto N, 2003, J RHEUMATOL, V30, P1426; Nishimoto N, 2010, MOD RHEUMATOL, V20, P539, DOI 10.1007/s10165-010-0328-0; Nishina N, 2014, ANN RHEUM DIS, V73, P945, DOI 10.1136/annrheumdis-2013-204137; Nowell MA, 2003, J IMMUNOL, V171, P3202, DOI 10.4049/jimmunol.171.6.3202; Ortea I, 2012, J PROTEOMICS, V77, P372, DOI 10.1016/j.jprot.2012.09.011; Rose-John S, 2012, INT J BIOL SCI, V8, P1237, DOI 10.7150/ijbs.4989; Sanayama Y, 2014, ARTHRITIS RHEUMATOL, V66, P1421, DOI 10.1002/art.38400; Serada S, 2014, METHODS MOL BIOL, V1142, P99, DOI 10.1007/978-1-4939-0404-4_12; Smolen JS, 2008, LANCET, V371, P987, DOI 10.1016/S0140-6736(08)60453-5; Smolen JS, 2013, ANN RHEUM DIS; Solomon DH, 2014, ARTHRITIS RHEUMATOL, V66, P775, DOI 10.1002/art.38323; Song SNJ, 2015, EXPERT OPIN DRUG MET, V11, P307, DOI 10.1517/17425255.2015.992779; Song SNJ, 2010, BLOOD, V116, P3627, DOI 10.1182/blood-2010-03-271791; Tanaka T, 2010, EXPERT REV CLIN IMMU, V6, P843, DOI [10.1586/eci.10.70, 10.1586/ECI.10.70]; van den Broek M, 2013, CURR OPIN PHARMACOL, V13, P463, DOI 10.1016/j.coph.2013.03.006; van der Heijde D, 2005, ANN RHEUM DIS, V64, P1582, DOI 10.1136/ard.2004.034371; van der Heijde D, 2010, J RHEUMATOL, V37, P2237, DOI 10.3899/jrheum.100208; van der Kooij SM, 2009, ANN RHEUM DIS, V68, P914, DOI 10.1136/ard.2008.092254; Weinblatt ME, 2003, ARTHRITIS RHEUM-US, V48, P35, DOI 10.1002/art.10697	36	23	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132055	10.1371/journal.pone.0132055	http://dx.doi.org/10.1371/journal.pone.0132055			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176225	Green Published, gold, Green Submitted			2022-12-26	WOS:000358197600080
J	Wang, Z; Li, XF; Jiang, Y; Shao, QZ; Liu, Q; Chen, BY; Huang, DS				Wang, Zhen; Li, Xianfeng; Jiang, Yi; Shao, Qianzhi; Liu, Qi; Chen, BingYu; Huang, Dongsheng			swDMR: A Sliding Window Approach to Identify Differentially Methylated Regions Based on Whole Genome Bisulfite Sequencing	PLOS ONE			English	Article							DNA METHYLATION; METHYLOME; PATTERNS; IDENTIFICATION; MODEL	DNA methylation is a widespread epigenetic modification that plays an essential role in gene expression through transcriptional regulation and chromatin remodeling. The emergence of whole genome bisulfite sequencing (WGBS) represents an important milestone in the detection of DNA methylation. Characterization of differential methylated regions (DMRs) is fundamental as well for further functional analysis. In this study, we present swDMR (http://sourceforge.net/projects/swdmr/) for the comprehensive analysis of DMRs from whole genome methylation profiles by a sliding window approach. It is an integrated tool designed for WGBS data, which not only implements accessible statistical methods to perform hypothesis test adapted to two or more samples without replicates, but false discovery rate was also controlled by multiple test correction. Downstream analysis tools were also provided, including cluster, annotation and visualization modules. In summary, based on WGBS data, swDMR can produce abundant information of differential methylated regions. As a convenient and flexible tool, we believe swDMR will bring us closer to unveil the potential functional regions involved in epigenetic regulation.	[Wang, Zhen; Chen, BingYu; Huang, Dongsheng] Wenzhou Med Univ, Minist Educ, Zhejiang Prov Peoples Hosp, Res Ctr Blood Transfus Med,Key Lab Lab Med, Hangzhou, Zhejiang, Peoples R China; [Li, Xianfeng] Cent S Univ, State Key Lab Med Genet, Changsha, Hunan, Peoples R China; [Jiang, Yi; Shao, Qianzhi; Liu, Qi] Wenzhou Med Univ, Inst Genom Med, Wenzhou, Zhejiang, Peoples R China	Wenzhou Medical University; Zhejiang Provincial People's Hospital; Central South University; Wenzhou Medical University	Chen, BY (corresponding author), Wenzhou Med Univ, Minist Educ, Zhejiang Prov Peoples Hosp, Res Ctr Blood Transfus Med,Key Lab Lab Med, Hangzhou, Zhejiang, Peoples R China.	mmizjpph66@163.com; mmizjpph668@163.com	li, xianfeng/GYD-5825-2022		Traditional Chinese Medicine of Scientific Research [2014ZB007]; outstanding young talent foundation of Zhejiang Province [2014ZQ005]; Natural Science Foundation of Zhejiang Province [LY15C090004]	Traditional Chinese Medicine of Scientific Research; outstanding young talent foundation of Zhejiang Province; Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province)	This work was supported by the Traditional Chinese Medicine of Scientific Research (2014ZB007, BC), outstanding young talent foundation of Zhejiang Province (2014ZQ005, ZW) and the Natural Science Foundation of Zhejiang Province (LY15C090004, ZW).	Aryee MJ, 2011, BIOSTATISTICS, V12, P197, DOI 10.1093/biostatistics/kxq055; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bock C, 2010, NAT BIOTECHNOL, V28, P1106, DOI 10.1038/nbt.1681; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Doi A, 2009, NAT GENET, V41, P1350, DOI 10.1038/ng.471; Fang F, 2012, P NATL ACAD SCI USA, V109, P7332, DOI 10.1073/pnas.1201310109; Feng H, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku154; Hansen KD, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-10-r83, 10.1186/gb-2012-13-10-R83]; Hebestreit K, 2013, BIOINFORMATICS, V29, P1647, DOI 10.1093/bioinformatics/btt263; Hellman A, 2007, SCIENCE, V315, P1141, DOI 10.1126/science.1136352; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kim JH, 2011, GENOME RES, V21, P1028, DOI 10.1101/gr.119347.110; Krueger F, 2012, NAT METHODS, V9, P145, DOI [10.1038/NMETH.1828, 10.1038/nmeth.1828]; Laird PW, 2010, NAT REV GENET, V11, P191, DOI 10.1038/nrg2732; Laurent L, 2010, GENOME RES, V20, P320, DOI 10.1101/gr.101907.109; Li S, 2013, BMC BIOINFORMATICS, P14; Li YR, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000533; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Park Y, 2014, BIOINFORMATICS; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rakyan VK, 2008, GENOME RES, V18, P1518, DOI 10.1101/gr.077479.108; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Rosenbloom KR, 2012, NUCLEIC ACIDS RES, V40, pD912, DOI 10.1093/nar/gkr1012; Saito Y, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gkt1373; Su JZ, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks829; Sun DQ, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r38; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Yagi S, 2008, GENOME RES, V18, P1969, DOI 10.1101/gr.074070.107; Yan Zhou B Z, 2013, METHYLMNM DETECT DIF; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zhang Y, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr053	35	36	38	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132866	10.1371/journal.pone.0132866	http://dx.doi.org/10.1371/journal.pone.0132866			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176536	Green Submitted, gold, Green Published			2022-12-26	WOS:000358197600171
J	Wu, W; Qu, Y; Hu, N; Zeng, YX; Yang, J; Xu, HW; Yin, ZQ				Wu, Wei; Qu, Ya; Hu, Ning; Zeng, Yuxiao; Yang, Jun; Xu, Haiwei; Yin, Zheng Qin			A Cell Electrofusion Chip for Somatic Cells Reprogramming	PLOS ONE			English	Article							EMBRYONIC STEM-CELL; DNA DEMETHYLATION; MICROFLUIDIC DEVICE; TET PROTEINS; IN-VITRO; ES CELLS; 5-HYDROXYMETHYLCYTOSINE; 5-METHYLCYTOSINE; PLURIPOTENCY; FUSION	Cell fusion is a potent approach to explore the mechanisms of somatic cells reprogramming. However, previous fusion methods, such as polyethylene glycol (PEG) mediated cell fusion, are often limited by poor fusion yields. In this study, we developed a simplified cell electrofusion chip, which was based on a micro-cavity/discrete microelectrode structure to improve the fusion efficiency and to reduce multi-cell electrofusion. Using this chip, we could efficiently fuse NIH3T3 cells and mouse embryonic stem cells (mESCs) to induce somatic cells reprogramming. We also found that fused cells demethylated gradually and 5-hydroxy-methylcytosine (5hmC) was involved in the demethylation during the reprogramming. Thus, the cell electrofusion chip would facilitate reprogramming mechanisms research by improving efficiency of cell fusion and reducing workloads.	[Wu, Wei; Qu, Ya; Zeng, Yuxiao; Xu, Haiwei; Yin, Zheng Qin] Third Mil Med Univ, Southwest Hosp, Southwest Eye Hosp, Chongqing, Peoples R China; [Wu, Wei; Qu, Ya; Hu, Ning; Zeng, Yuxiao; Yang, Jun; Xu, Haiwei; Yin, Zheng Qin] Key Lab Visual Damage & Regenerat & Restorat Chon, Chongqing, Peoples R China; [Hu, Ning; Yang, Jun] Chongqing Univ, Bioengn Coll, Chongqing 630044, Peoples R China	Army Medical University; Chongqing University	Xu, HW (corresponding author), Third Mil Med Univ, Southwest Hosp, Southwest Eye Hosp, Chongqing, Peoples R China.	haiweixu2001@163.com; qinzyin@aliyun.com		Wu, Wei/0000-0002-7097-2150	National Basic Research Program of China [2013CB967002]	National Basic Research Program of China(National Basic Research Program of China)	This study was supported by National Basic Research Program of China (No. 2013CB967002) (http://www.973.gov.cn/Default_3.aspx).	Bhutani N, 2011, CELL, V146, P866, DOI 10.1016/j.cell.2011.08.042; Bhutani N, 2010, NATURE, V463, P1042, DOI 10.1038/nature08752; Branco MR, 2012, NAT REV GENET, V13, P7, DOI 10.1038/nrg3080; Clow AL, 2010, BIOMED MICRODEVICES, V12, P777, DOI 10.1007/s10544-010-9432-3; Ficz G, 2011, NATURE, V473, P398, DOI 10.1038/nature10008; Gel M, 2010, BIOMICROFLUIDICS, V4, DOI 10.1063/1.3422544; Guo JU, 2011, CELL, V145, P423, DOI 10.1016/j.cell.2011.03.022; Hamdi FS, 2014, BIOELECTROCHEMISTRY, V100, P27, DOI 10.1016/j.bioelechem.2014.05.004; Hu N, 2013, SENSOR ACTUAT B-CHEM, V178, P63, DOI 10.1016/j.snb.2012.12.034; Hu N, 2012, ELECTROPHORESIS, V33, P1980, DOI 10.1002/elps.201100579; Hu N, 2011, BIOMICROFLUIDICS, V5, DOI 10.1063/1.3630125; Hu N, 2011, ELECTROPHORESIS, V32, P2488, DOI 10.1002/elps.201100082; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Kemna EWM, 2011, ELECTROPHORESIS, V32, P3138, DOI 10.1002/elps.201100227; Kirschbaum M, 2012, LAB CHIP, V12, P443, DOI 10.1039/c1lc20818g; Liang GY, 2013, CELL RES, V23, P49, DOI 10.1038/cr.2012.175; Morganti E, 2011, MICROFLUID NANOFLUID, V10, P1211, DOI 10.1007/s10404-010-0751-8; Piccolo FM, 2013, MOL CELL, V49, P1023, DOI 10.1016/j.molcel.2013.01.032; Pucihar G, 2001, BIOELECTROCHEMISTRY, V54, P107, DOI 10.1016/S1567-5394(01)00117-7; Qu Y, 2011, MICROFLUID NANOFLUID, V11, P633, DOI 10.1007/s10404-011-0829-y; Rajasingh J, 2008, CIRC RES, V102, pE107, DOI 10.1161/CIRCRESAHA.108.176115; Rems L, 2013, SCI REP-UK, V3, DOI 10.1038/srep03382; Sancho M, 2010, BIOMICROFLUIDICS, V4, DOI 10.1063/1.3454129; Silva J, 2006, NATURE, V441, P997, DOI 10.1038/nature04914; Simonsson S, 2004, NAT CELL BIOL, V6, P984, DOI 10.1038/ncb1176; Skelley AM, 2009, NAT METHODS, V6, P147, DOI [10.1038/NMETH.1290, 10.1038/nmeth.1290]; Tada M, 2003, DEV DYNAM, V227, P504, DOI 10.1002/dvdy.10337; Tada M, 2001, CURR BIOL, V11, P1553, DOI 10.1016/S0960-9822(01)00459-6; Tada M, 2006, METH MOL B, V325, P67; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tan L, 2012, DEVELOPMENT, V139, P1895, DOI 10.1242/dev.070771; Tang J, 2008, NEUROSCI RES, V62, P86, DOI 10.1016/j.neures.2008.06.005; Techaumnat B, 2008, IET NANOBIOTECHNOL, V2, P93, DOI 10.1049/iet-nbt:20080008; Tresset G, 2004, BIOMED MICRODEVICES, V6, P213, DOI 10.1023/B:BMMD.0000042050.95246.af; Usaj M, 2012, J MEMBRANE BIOL, V245, P583, DOI 10.1007/s00232-012-9470-2; Wang J, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2402122; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Wossidlo M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1240; Yamanaka S, 2010, NATURE, V465, P704, DOI 10.1038/nature09229; Yamazaki Y, 2006, MOL REPROD DEV, V73, P180, DOI 10.1002/mrd.20411; Yang H, 2010, CELL RES, V20, P1034, DOI 10.1038/cr.2010.97	43	10	10	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0131966	10.1371/journal.pone.0131966	http://dx.doi.org/10.1371/journal.pone.0131966			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177036	Green Published, Green Submitted, gold			2022-12-26	WOS:000358197600072
J	Chen, Z; Wu, WL; Shao, XM; Li, L; Guo, YB; Ding, GC				Chen, Zhu; Wu, Wenliang; Shao, Xiaoming; Li, Li; Guo, Yanbin; Ding, Guochun			Shifts in Abundance and Diversity of Soil Ammonia-Oxidizing Bacteria and Archaea Associated with Land Restoration in a Semi-Arid Ecosystem	PLOS ONE			English	Article							LONG-TERM FERTILIZATION; COMMUNITY STRUCTURE; NITROGEN; NITRIFICATION; RHIZOSPHERE; RESPONSES; POLICIES	The Grain to Green Project (GGP) is an unprecedented land restoration action in China. The project converted large areas (ca 10 million ha) of steep-sloped/degraded farmland and barren land into forest and grassland resulting in ecological benefits such as a reduction in severe soil erosion. It may also affect soil microorganisms involved in ammonia oxidization, which is a key step in the global nitrogen cycle. The methods for restoration that are typically adopted in semi-arid regions include abandoning farmland and growing drought tolerant grass (Lolium perenne L.) or shrubs (Caragana korshinskii Kom.). In the present study, the effects of these methods on the abundance and diversity of ammonia-oxidizing bacteria (AOB) and ammonia-oxidizing archaea (AOA) were evaluated via quantitative real-time PCR, terminal restriction fragment length polymorphism and clone library analysis of amoA genes. Comparisons were made between soil samples from three restored lands and the adjacent farmland in Inner Mongolia. Both the abundance and community composition of AOB were significantly different between the restored lands and the adjacent control. Significantly lower nitrification activity was observed for the restored land. Clone library analysis revealed that all AOB amoA gene sequences were affiliated with Nitrosospira. Abundance of the populations that were associated with Nitrosospira sp. Nv6 which had possibly adapted to high concentrations of inorganic nitrogen, decreased on the restored land. Only a slight difference in the AOB communities was observed between the restored land with and without the shrub (Caragana korshinskii Kom.). A minor effect of land restoration on AOA was observed. In summary, land restoration negatively affected the abundance of AOB and soil nitrification activities, suggesting the potential role of GGP in the leaching of nitrates, and in the emission of N2O in related terrestrial ecosystems.	[Chen, Zhu; Shao, Xiaoming] China Agr Univ, Coll Biol Sci, Beijing 100094, Peoples R China; [Wu, Wenliang; Li, Li; Guo, Yanbin; Ding, Guochun] China Agr Univ, Coll Resources & Environm Sci, Beijing 100094, Peoples R China; [Wu, Wenliang; Li, Li; Guo, Yanbin; Ding, Guochun] China Agr Univ, Beijing Key Lab Biodivers & Organ Farming, Beijing 100094, Peoples R China	China Agricultural University; China Agricultural University; China Agricultural University	Guo, YB (corresponding author), China Agr Univ, Coll Resources & Environm Sci, Beijing 100094, Peoples R China.	guoyb@cau.edu.cn; gc_ding@cau.edu.cn		ding, guo-chun/0000-0002-5468-5979	National Natural Science Foundation of China [31170489, 31400095]; Funds for International Cooperation and Exchange of the National Natural Science Foundation of China [31261140367]; Funds for Science and Technology Bureau of Tibet Autonomous Region [Z2013C02N02]; Chinese Universities Scientific Fund [2015ZH005]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Funds for International Cooperation and Exchange of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Funds for Science and Technology Bureau of Tibet Autonomous Region; Chinese Universities Scientific Fund	This work was supported by the National Natural Science Foundation of China (Grant No. 31170489), the Funds for International Cooperation and Exchange of the National Natural Science Foundation of China (Grant No. 31261140367), the Funds for Science and Technology Bureau of Tibet Autonomous Region (Project no. Z2013C02N02), National Natural Science Foundation of China (Grant No. 31400095), Chinese Universities Scientific Fund (Project no. 2015ZH005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai C, 2013, SOIL BIOL BIOCHEM, V57, P30, DOI 10.1016/j.soilbio.2012.08.003; ALLISON SM, 1991, SOIL BIOL BIOCHEM, V23, P45, DOI 10.1016/0038-0717(91)90161-C; [安萍莉 An Pingli], 2002, [资源科学, Resources science], V24, P35; Babic KH, 2008, ENVIRON MICROBIOL, V10, P2922, DOI 10.1111/j.1462-2920.2008.01762.x; Bissett A, 2011, APPL SOIL ECOL, V51, P66, DOI 10.1016/j.apsoil.2011.08.010; Boyle-Yarwood SA, 2008, ENVIRON MICROBIOL, V10, P2956, DOI 10.1111/j.1462-2920.2008.01600.x; Chen YL, 2013, APPL SOIL ECOL, V68, P36, DOI 10.1016/j.apsoil.2013.03.006; Chu HY, 2007, APPL ENVIRON MICROB, V73, P485, DOI 10.1128/AEM.01536-06; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Deng L, 2012, INT J SEDIMENT RES, V27, P120, DOI 10.1016/S1001-6279(12)60021-3; Di HJ, 2009, NAT GEOSCI, V2, P621, DOI 10.1038/NGEO613; Ding GC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059497; Hatzenpichler R, 2008, P NATL ACAD SCI USA, V105, P2134, DOI 10.1073/pnas.0708857105; Hatzenpichler R, 2012, APPL ENVIRON MICROB, V78, P7501, DOI 10.1128/AEM.01960-12; He J, 2007, ENVIRON MICROBIOL, V9, P2364, DOI 10.1111/j.1462-2920.2007.01358.x; Hu HW, 2015, ENVIRON MICROBIOL, V17, P444, DOI 10.1111/1462-2920.12481; Jia GM, 2010, EUR J SOIL BIOL, V46, P6, DOI 10.1016/j.ejsobi.2009.10.002; Khademi S, 2006, PHYSIOLOGY, V21, P419, DOI 10.1152/physiol.00051.2005; Konneke M, 2005, NATURE, V437, P543, DOI 10.1038/nature03911; Kowalchuk GA, 2000, ENVIRON MICROBIOL, V2, P99, DOI 10.1046/j.1462-2920.2000.00080.x; Kowalchuk GA, 2001, ANNU REV MICROBIOL, V55, P485, DOI 10.1146/annurev.micro.55.1.485; Kurola J, 2005, FEMS MICROBIOL LETT, V250, P33, DOI 10.1016/j.femsle.2005.06.057; Leininger S, 2006, NATURE, V442, P806, DOI 10.1038/nature04983; Liu JG, 2008, P NATL ACAD SCI USA, V105, P9477, DOI 10.1073/pnas.0706436105; Lu L, 2012, ISME J, V6, P1978, DOI 10.1038/ismej.2012.45; McLean E., 1983, METHODS SOIL ANAL PA, V9, P199, DOI DOI 10.2134/AGRONMONOGR9.2.2ED.C12; Murty D, 2002, GLOBAL CHANGE BIOL, V8, P105, DOI 10.1046/j.1354-1013.2001.00459.x; Nicol GW, 2008, ENVIRON MICROBIOL, V10, P2966, DOI 10.1111/j.1462-2920.2008.01701.x; Offre P, 2014, TRENDS MICROBIOL, V22, P665, DOI 10.1016/j.tim.2014.07.007; Olsen SR, 1965, METHODS SOIL ANAL, V9, P920, DOI DOI 10.2134/AGRONMONOGR9.2.C22; Placella SA, 2013, APPL ENVIRON MICROB, V79, P3294, DOI 10.1128/AEM.00404-13; PROSSER JI, 1989, ADV MICROB PHYSIOL, V30, P125; Rotthauwe JH, 1997, APPL ENVIRON MICROB, V63, P4704, DOI 10.1128/AEM.63.12.4704-4712.1997; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shen JP, 2008, ENVIRON MICROBIOL, V10, P1601, DOI 10.1111/j.1462-2920.2008.01578.x; Sheng R, 2013, J SOIL SEDIMENT, V13, P1246, DOI 10.1007/s11368-013-0713-3; Song XZ, 2014, SCI REP-UK, V4, DOI 10.1038/srep04460; Stempfhuber B, 2015, MICROB ECOL, V69, P879, DOI 10.1007/s00248-014-0548-5; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tourna M, 2008, ENVIRON MICROBIOL, V10, P1357, DOI 10.1111/j.1462-2920.2007.01563.x; Tourna M, 2011, P NATL ACAD SCI USA, V108, P8420, DOI 10.1073/pnas.1013488108; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Verhamme DT, 2011, ISME J, V5, P1067, DOI 10.1038/ismej.2010.191; Wang LiWei, 2013, Transactions of the Chinese Society of Agricultural Engineering, V29, P224; Webster G, 2005, ENVIRON MICROBIOL, V7, P676, DOI 10.1111/j.1462-2920.2005.00740.x; Young IM, 2004, SCIENCE, V304, P1634, DOI 10.1126/science.1097394; Zhang JL, 2013, 2012 CHINA FORESTRY; Zhang LM, 2012, ISME J, V6, P1032, DOI 10.1038/ismej.2011.168; Zhao CX, 2006, ARID LAND RES MANAG, V20, P233, DOI 10.1080/15324980600705735	49	10	13	1	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132879	10.1371/journal.pone.0132879	http://dx.doi.org/10.1371/journal.pone.0132879			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26172994	Green Published, gold, Green Submitted			2022-12-26	WOS:000358194900093
J	Huang, X; Park, H; Greene, J; Pao, J; Mulvey, E; Zhou, SX; Albert, CM; Moy, F; Sachdev, D; Yee, D; Rader, C; Hamby, CV; Loeb, DM; Cairo, MS; Zhou, XZ				Huang, Xin; Park, Haein; Greene, Joseph; Pao, James; Mulvey, Erin; Zhou, Sophia X.; Albert, Catherine M.; Moy, Fred; Sachdev, Deepali; Yee, Douglas; Rader, Christoph; Hamby, Carl V.; Loeb, David M.; Cairo, Mitchell S.; Zhou, Xianzheng			IGF1R-and ROR1-Specific CAR T Cells as a Potential Therapy for High Risk Sarcomas	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; CHIMERIC ANTIGEN RECEPTOR; ACUTE LYMPHOBLASTIC-LEUKEMIA; REFRACTORY EWING SARCOMA; FACTOR-I RECEPTOR; BREAST-CANCER; SOLID TUMORS; HEMATOLOGIC MALIGNANCIES; MONOCLONAL-ANTIBODY; IGF-IR	Patients with metastatic or recurrent and refractory sarcomas have a dismal prognosis. Therefore, new targeted therapies are urgently needed. This study was designed to evaluate chimeric antigen receptor (CAR) T cells targeting the type I insulin-like growth factor receptor (IGF1R) or tyrosine kinase-like orphan receptor 1 (ROR1) molecules for their therapeutic potential against sarcomas. Here, we report that IGF1R (15/15) and ROR1 (11/15) were highly expressed in sarcoma cell lines including Ewing sarcoma, osteosarcoma, alveolar or embryonal rhabdomyosarcoma, and fibrosarcoma. IGF1R and ROR1 CAR T cells derived from eight healthy donors using the Sleeping Beauty (SB) transposon system were cytotoxic against sarcoma cells and produced high levels of IFN-gamma, TNF-alpha and IL-13 in an antigen-specific manner. IGF1R and ROR1 CAR T cells generated from three sarcoma patients released significant amounts of IFN-gamma in response to sarcoma stimulation. The adoptive transfer of IGF1R and ROR1 CAR T cells derived from a sarcoma patient significantly reduced tumor growth in pre-established, systemically disseminated and localized osteosarcoma xenograft models in NSG mice. Infusion of IGF1R and ROR1 CAR T cells also prolonged animal survival in a localized sarcoma model using NOD/scid mice. Our data indicate that both IGF1R and ROR1 can be effectively targeted by SB modified CAR T cells and that such CAR T cells may be useful in the treatment of high risk sarcoma patients.	[Huang, Xin; Park, Haein; Cairo, Mitchell S.; Zhou, Xianzheng] New York Med Coll, Dept Pediat, Div Hematol Oncol & Stem Cell Transplantat, Valhalla, NY 10595 USA; [Greene, Joseph] Univ Minnesota, Coll Biol Sci, Minneapolis, MN USA; [Pao, James; Mulvey, Erin] New York Med Coll, Sch Med, Valhalla, NY 10595 USA; [Zhou, Sophia X.; Sachdev, Deepali; Yee, Douglas] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN USA; [Albert, Catherine M.; Loeb, David M.] Johns Hopkins Univ, Div Pediat Oncol, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA; [Moy, Fred; Cairo, Mitchell S.] New York Med Coll, Dept Pathol, Valhalla, NY 10595 USA; [Rader, Christoph] Scripps Res Inst, Dept Canc Biol, Jupiter, FL USA; [Rader, Christoph] Scripps Res Inst, Dept Mol Therapeut, Jupiter, FL USA; [Hamby, Carl V.; Cairo, Mitchell S.; Zhou, Xianzheng] New York Med Coll, Dept Microbiol & Immunol, Valhalla, NY 10595 USA; [Cairo, Mitchell S.; Zhou, Xianzheng] New York Med Coll, Dept Cell Biol & Anat, Valhalla, NY 10595 USA; [Cairo, Mitchell S.] New York Med Coll, Dept Med, Valhalla, NY 10595 USA	New York Medical College; University of Minnesota System; University of Minnesota Twin Cities; New York Medical College; University of Minnesota System; University of Minnesota Twin Cities; Johns Hopkins University; Johns Hopkins Medicine; New York Medical College; Scripps Research Institute; Scripps Research Institute; New York Medical College; New York Medical College; New York Medical College	Zhou, XZ (corresponding author), New York Med Coll, Dept Pediat, Div Hematol Oncol & Stem Cell Transplantat, Valhalla, NY 10595 USA.	xianzheng_zhou@nymc.edu		Rader, Christoph/0000-0001-9955-3454; Yee, Douglas/0000-0002-3387-4009; Greene, Joseph/0000-0003-3482-0958	Karen Wyckoff Rein in Sarcoma Foundation; National Institutes of Health [AI092220]; Pediatric Cancer Research Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI092220] Funding Source: NIH RePORTER	Karen Wyckoff Rein in Sarcoma Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pediatric Cancer Research Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the Karen Wyckoff Rein in Sarcoma Foundation (XZ), National Institutes of Health AI092220 (XZ) and Pediatric Cancer Research Foundation (MSC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed N, 2015, J CLIN ONCOL, V33, P1688, DOI 10.1200/JCO.2014.58.0225; Ahmed N, 2009, MOL THER, V17, P1779, DOI 10.1038/mt.2009.133; Anders K, 2013, CLIN CANCER RES, V19, P320, DOI 10.1158/1078-0432.CCR-12-3017; Baskar S, 2008, CLIN CANCER RES, V14, P396, DOI 10.1158/1078-0432.CCR-07-1823; Baskar S, 2012, MABS-AUSTIN, V4, P349, DOI 10.4161/mabs.19870; Berger C, 2015, CANCER IMMUNOL RES, V3, P206, DOI 10.1158/2326-6066.CIR-14-0163; Bicocca VT, 2012, CANCER CELL, V22, P656, DOI 10.1016/j.ccr.2012.08.027; Brentjens RJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005930; Broome HE, 2011, LEUKEMIA RES, V35, P1390, DOI 10.1016/j.leukres.2011.06.021; Cecil DL, 2013, BREAST CANCER RES TR, V139, P657, DOI 10.1007/s10549-013-2577-z; Chitnis MM, 2008, CLIN CANCER RES, V14, P6364, DOI 10.1158/1078-0432.CCR-07-4879; Cui B, 2013, CANCER RES, V73, P3649, DOI 10.1158/0008-5472.CAN-12-3832; Dave H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052655; Disis ML, 2013, CANCER PREV RES, V6, P1273, DOI 10.1158/1940-6207.CAPR-13-0182; Fedorov VD, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006597; Fukuda T, 2008, P NATL ACAD SCI USA, V105, P3047, DOI 10.1073/pnas.0712148105; Gattenlohner S, 2006, CANCER RES, V66, P24, DOI 10.1158/0008-5472.CAN-05-0542; Hojjat-Farsangi M, 2014, SEMIN CANCER BIOL, V29, P21, DOI 10.1016/j.semcancer.2014.07.005; Huang GX, 2012, CANCER RES, V72, P271, DOI 10.1158/0008-5472.CAN-11-2778; Huang X, 2008, MOL THER, V16, P580, DOI 10.1038/sj.mt.6300404; Hudecek M, 2013, CLIN CANCER RES, V19, P3153, DOI 10.1158/1078-0432.CCR-13-0330; Hudecek M, 2010, BLOOD, V116, P4532, DOI 10.1182/blood-2010-05-283309; Juergens H, 2011, J CLIN ONCOL, V29, P4534, DOI 10.1200/JCO.2010.33.0670; June CH, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3643; Kailayangiri S, 2012, BRIT J CANCER, V106, P1123, DOI 10.1038/bjc.2012.57; Kakarla S, 2014, CANCER J, V20, P151, DOI 10.1097/PPO.0000000000000032; Kusada Y, 2008, J BIOCHEM, V143, P9, DOI 10.1093/jb/mvm192; Langer CJ, 2014, J CLIN ONCOL, V32, P2059, DOI 10.1200/JCO.2013.54.4932; Luo W, 2009, ONCOGENE, V28, P4126, DOI 10.1038/onc.2009.262; Malempati S, 2012, J CLIN ONCOL, V30, P256, DOI 10.1200/JCO.2011.37.4355; Maude SL, 2014, NEW ENGL J MED, V371, P1507, DOI 10.1056/NEJMoa1407222; Maus MV, 2014, BLOOD, V123, P2625, DOI 10.1182/blood-2013-11-492231; Mitsiades CS, 2004, CANCER CELL, V5, P221, DOI 10.1016/S1535-6108(04)00050-9; Owen LA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001965; Pappo AS, 2011, J CLIN ONCOL, V29, P4541, DOI 10.1200/JCO.2010.34.0000; Pollak M, 2012, NAT REV CANCER, V12, P159, DOI 10.1038/nrc3215; Porter DL, 2011, NEW ENGL J MED, V365, P725, DOI 10.1056/NEJMoa1103849; Pule MA, 2008, NAT MED, V14, P1264, DOI 10.1038/nm.1882; Robbins PF, 2011, J CLIN ONCOL, V29, P917, DOI 10.1200/JCO.2010.32.2537; Rosenberg SA, 2009, CURR OPIN IMMUNOL, V21, P233, DOI 10.1016/j.coi.2009.03.002; Sachdev D, 2006, CANCER RES, V66, P2391, DOI 10.1158/0008-5472.CAN-05-3126; Sachdev D, 2003, CANCER RES, V63, P627; Sykulev Y, 1996, IMMUNITY, V4, P565, DOI 10.1016/S1074-7613(00)80483-5; Tammana S, 2010, HUM GENE THER, V21, P75, DOI 10.1089/hum.2009.122; Wagner MJ, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00009; Xue XK, 2009, BLOOD, V114, P1319, DOI 10.1182/blood-2009-03-210005; Yamaguchi T, 2012, CANCER CELL, V21, P348, DOI 10.1016/j.ccr.2012.02.008; Yang JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021018; YEE D, 1990, J CLIN INVEST, V86, P1806, DOI 10.1172/JCI114910; Yee D, 2012, JNCI-J NATL CANCER I, V104, P975, DOI 10.1093/jnci/djs258; Zhang SP, 2014, P NATL ACAD SCI USA, V111, P17266, DOI 10.1073/pnas.1419599111; Zhang SP, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0031127, 10.1371/journal.pone.0046853]; Zhou XZ, 2005, CANCER RES, V65, P1079	53	58	62	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0133152	10.1371/journal.pone.0133152	http://dx.doi.org/10.1371/journal.pone.0133152			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26173023	Green Published, Green Submitted, gold			2022-12-26	WOS:000358194900141
J	Lai, YJJ; Chang, HHD; Lai, HY; Xu, Y; Shiao, F; Huang, NX; Li, LP; Lee, MS; Johnson, MD; Wang, JK; Lin, CY				Lai, Ying-Jung J.; Chang, Hsiang-Hua D.; Lai, Hongyu; Xu, Yuan; Shiao, Frank; Huang, Nanxi; Li, Linpei; Lee, Ming-Shyue; Johnson, Michael D.; Wang, Jehng-Kang; Lin, Chen-Yong			N-Glycan Branching Affects the Subcellular Distribution of and Inhibition of Matriptase by HAI-2/Placental Bikunin	PLOS ONE			English	Article							GROWTH-FACTOR ACTIVATOR; SERINE-PROTEASE INHIBITOR; SQUAMOUS-CELL CARCINOMA; ZYMOGEN; CLONING; LINES; HEAD; NECK	The gene product of SPINT 2, that encodes a transmembrane, Kunitz-type serine protease inhibitor independently designated as HAI-2 or placenta bikunin (PB), is involved in regulation of sodium absorption in human gastrointestinal track. Here, we show that SPINT 2 is expressed as two species of different size (30-40-versus 25-kDa) due to different N-glycans on Asn-57. The N-glycan on 25-kDa HAI-2 appears to be of the oligomannose type and that on 30-40-kDa HAI-2 to be of complex type with extensive terminal N-acetylglucosamine branching. The two different types of N-glycan differentially mask two epitopes on HAI-2 polypeptide, recognized by two different HAI-2 mAbs. The 30-40-kDa form may be mature HAI-2, and is primarily localized in vesicles/granules. The 25-kDa form is likely immature HAI-2, that remains in the endoplasmic reticulum (ER) in the perinuclear regions of mammary epithelial cells. The two different N-glycans could, therefore, represent different maturation stages of N-glycosylation with the 25-kDa likely a precursor of the 30-40-kDa HAI-2, with the ratio of their levels roughly similar among a variety of cells. In breast cancer cells, a significant amount of the 30-40-kDa HAI-2 can translocate to and inhibit matriptase on the cell surface, followed by shedding of the matriptase-HAI-2 complex. The 25-kDa HAI-2 appears to have also exited the ER/Golgi, being localized at the cytoplasmic face of the plasma membrane of breast cancer cells. While the 25-kDa HAI-2 was also detected at the extracellular face of plasma membrane at very low levels it appears to have no role in matriptase inhibition probably due to its paucity on the cell surface. Our study reveals that N-glycan branching regulates HAI-2 through different subcellular distribution and subsequently access to different target proteases.	[Lai, Ying-Jung J.; Chang, Hsiang-Hua D.; Lai, Hongyu; Xu, Yuan; Shiao, Frank; Huang, Nanxi; Li, Linpei; Johnson, Michael D.; Lin, Chen-Yong] Georgetown Univ, Lombardi Comprehens Canc Ctr, Dept Oncol, Washington, DC 20057 USA; [Chang, Hsiang-Hua D.; Wang, Jehng-Kang] Natl Def Med Ctr, Dept Biochem, Taipei 10764, Taiwan; [Li, Linpei] Hunan Tradit Chinese Med Res Inst, Affiliated Hosp, Changsha, Hunan, Peoples R China; [Lee, Ming-Shyue] Natl Taiwan Univ, Coll Med, Grad Inst Biochem & Mol Biol, Taipei 10764, Taiwan	Georgetown University; National Defense Medical Center; National Taiwan University	Lin, CY (corresponding author), Georgetown Univ, Lombardi Comprehens Canc Ctr, Dept Oncol, Washington, DC 20057 USA.	jkwang@ndmctsgh.edu.tw; lincy@georgetown.edu	Lin, Chen/GRR-2799-2022	Shiao, Frank/0000-0001-9258-0396; LEE, MING-SHYUE/0000-0002-8673-5088; johnson, Michael/0000-0001-6260-7586; LEE, MING-SHYUE/0000-0002-5884-4535	National Cancer Institute (NCI) Grant [RO1 CA 123223]; Ministry of Science and Technology (Taiwan) Grant [MOST 103-2320-B-016-022]; Department of Defense (Taiwan) Grant [MAB-104-026]; NIH/NCI grant [P30-CA051008]; NATIONAL CANCER INSTITUTE [P30CA051008, R01CA123223] Funding Source: NIH RePORTER	National Cancer Institute (NCI) Grant; Ministry of Science and Technology (Taiwan) Grant; Department of Defense (Taiwan) Grant; NIH/NCI grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by a National Cancer Institute (NCI) Grant RO1 CA 123223 (to M. Johnson and C.-Y. Lin), and a Ministry of Science and Technology (Taiwan) Grant MOST 103-2320-B-016-022 (to J.-K. Wang) and a Department of Defense (Taiwan) Grant MAB-104-026 (to J.-K. Wang). The authors acknowledge the assistance provided by the Microscopy and Imaging, Tissue Culture, and other Shared Resources within the Lombardi Comprehensive Cancer Center which are partially supported by NIH/NCI grant P30-CA051008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, CLIN DYSMORPHOL; Apweiler R, 1999, BBA-GEN SUBJECTS, V1473, P4, DOI 10.1016/S0304-4165(99)00165-8; Benaud C, 2002, J BIOL CHEM, V277, P10539, DOI 10.1074/jbc.M109064200; Benaud C, 2001, EUR J BIOCHEM, V268, P1439, DOI 10.1046/j.1432-1327.2001.02016.x; Chang HH, 2015, PLOS ONE, V9; Enghild JJ, 1999, BIOCHEMISTRY-US, V38, P11804, DOI 10.1021/bi9908540; Faller N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094267; HEIFETZ A, 1979, BIOCHEMISTRY-US, V18, P2186, DOI 10.1021/bi00578a008; Heinz-Erian P, 2009, AM J HUM GENET, V84, P188, DOI 10.1016/j.ajhg.2009.01.004; HEO DS, 1989, CANCER RES, V49, P5167; Kataoka H, 2000, CANCER LETT, V148, P127, DOI 10.1016/S0304-3835(99)00322-5; Kawaguchi T, 1997, J BIOL CHEM, V272, P27558, DOI 10.1074/jbc.272.44.27558; Larsen BR, 2013, EXP CELL RES, V319, P918, DOI 10.1016/j.yexcr.2013.01.008; Lee MS, 2005, AM J PHYSIOL-CELL PH, V288, pC932, DOI 10.1152/ajpcell.00497.2004; Marlor CW, 1997, J BIOL CHEM, V272, P12202, DOI 10.1074/jbc.272.18.12202; Muller T, 2000, GASTROENTEROLOGY, V119, P1506, DOI 10.1053/gast.2000.20514; Okajima A, 1997, HEPATOLOGY, V25, P97, DOI 10.1002/hep.510250118; SHIMOMURA T, 1993, J BIOL CHEM, V268, P22927; Stampfer MR, P NATL ACAD SCI US, V198, P2394; Szabo R, 2009, DEVELOPMENT, V136, P2653, DOI 10.1242/dev.038430; TEICHER BA, 1987, CANCER RES, V47, P388; Tseng IC, 2010, J BIOL CHEM, V285, P3261, DOI 10.1074/jbc.M109.055640; Xu H, 2012, AM J PHYSIOL-CELL PH, V302, pC453, DOI 10.1152/ajpcell.00344.2011; Xu ZH, 2011, J MED CHEM, V54, P7567, DOI 10.1021/jm200920s; YASUMURA S, 1993, CANCER RES, V53, P1461	25	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132163	10.1371/journal.pone.0132163	http://dx.doi.org/10.1371/journal.pone.0132163			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26171609	gold, Green Published, Green Submitted			2022-12-26	WOS:000358194900033
J	Lei, HM; Chen, Y; Li, RQ; He, DL; Zhang, J				Lei, Hongmei; Chen, Ying; Li, Ruiqi; He, Deli; Zhang, Jiang			Maximum Entropy for the International Division of Labor	PLOS ONE			English	Article							MONOPOLISTIC COMPETITION; INCREASING RETURNS; PRODUCT; SPECIALIZATION	As a result of the international division of labor, the trade value distribution on different products substantiated by international trade flows can be regarded as one country's strategy for competition. According to the empirical data of trade flows, countries may spend a large fraction of export values on ubiquitous and competitive products. Meanwhile, countries may also diversify their exports share on different types of products to reduce the risk. In this paper, we report that the export share distribution curves can be derived by maximizing the entropy of shares on different products under the product's complexity constraint once the international market structure (the country-product bipartite network) is given. Therefore, a maximum entropy model provides a good fit to empirical data. The empirical data is consistent with maximum entropy subject to a constraint on the expected value of the product complexity for each country. One country's strategy is mainly determined by the types of products this country can export. In addition, our model is able to fit the empirical export share distribution curves of nearly every country very well by tuning only one parameter.	[Lei, Hongmei; Chen, Ying; Li, Ruiqi; He, Deli; Zhang, Jiang] Beijing Normal Univ, Sch Syst Sci, Beijing 100875, Peoples R China	Beijing Normal University	Zhang, J (corresponding author), Beijing Normal Univ, Sch Syst Sci, Beijing 100875, Peoples R China.	zhangjiang@bnu.edu.cn	Li, Ruiqi/AAD-2689-2019	Li, Ruiqi/0000-0002-3290-9476	Beijing Higher Education Young Elite Teacher Project [YETP0291]	Beijing Higher Education Young Elite Teacher Project	This work was supported by Beijing Higher Education Young Elite Teacher Project under Grant No. YETP0291 (http://www.bjedu.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, WORLD EC MILLENNIAL; Cover T. M., 1991, ELEMENTS INFORM THEO; DIXIT AK, 1977, AM ECON REV, V67, P297; Golan A., 1996, MAXIMUM ENTROPY ECON; Harte J, 2011, OX ECOL EV, P1, DOI 10.1093/acprof:oso/9780199593415.001.0001; Hausmann R, 2010, HKS FACULTY RES WORK; Hidalgo CA, 2007, SCIENCE, V317, P482, DOI 10.1126/science.1144581; Hidalgo CA, 2009, P NATL ACAD SCI USA, V106, P10570, DOI 10.1073/pnas.0900943106; HOUTHAKKER HS, 1956, KYKLOS, V9, P181, DOI 10.1111/j.1467-6435.1956.tb02717.x; Hu LC, 2012, PHYSICA A, V391, P731, DOI 10.1016/j.physa.2011.08.048; JAYNES ET, 1957, PHYS REV, V106, P620, DOI 10.1103/PhysRev.106.620; KRUGMAN P, 1980, AM ECON REV, V70, P950; KRUGMAN PR, 1979, J INT ECON, V9, P469, DOI 10.1016/0022-1996(79)90017-5; Lei HM, 2014, EPL-EUROPHYS LETT, V105, DOI 10.1209/0295-5075/105/68003; Pritchett L, 1997, J ECON PERSPECT, V11, P3, DOI 10.1257/jep.11.3.3; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Smith A., 1976, INQUIRY NATURE CAUSE; Stigler GJ, 1951, J POLIT ECON, V59, P185, DOI 10.1086/257075; YANG XK, 1991, J POLIT ECON, V99, P460, DOI 10.1086/261762; YANG XK, 1992, AM ECON REV, V82, P392; Young AA, 1928, ECON J, V38, P527, DOI 10.2307/2224097	21	2	2	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0129955	10.1371/journal.pone.0129955	http://dx.doi.org/10.1371/journal.pone.0129955			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1QN	26172052	Green Submitted, Green Published, gold			2022-12-26	WOS:000358194900005
J	Mork-Jansson, A; Bue, AK; Gargano, D; Furnes, C; Reisinger, V; Arnold, J; Kmiec, K; Eichacker, LA				Mork-Jansson, Astrid; Bue, Ann Kristin; Gargano, Daniela; Furnes, Clemens; Reisinger, Veronika; Arnold, Janine; Kmiec, Karol; Eichacker, Lutz Andreas			Lil3 Assembles with Proteins Regulating Chlorophyll Synthesis in Barley	PLOS ONE			English	Article							II REACTION-CENTER; SYNECHOCYSTIS SP PCC-6803; PHOTOSYSTEM-II; PROTOCHLOROPHYLLIDE OXIDOREDUCTASE; HOMOGENTISATE PHYTYLTRANSFERASE; GERANYLGERANYL REDUCTASE; ARABIDOPSIS-THALIANA; ETIOPLAST MEMBRANES; COMPLEX; BIOSYNTHESIS	The light-harvesting-like (LIL) proteins are a family of membrane proteins that share a chlorophyll a/b-binding motif with the major light-harvesting antenna proteins of oxygenic photoautotrophs. LIL proteins have been associated with the regulation of tetrapyrrol biosynthesis, and plant responses to light-stress. Here, it was found in a native PAGE approach that chlorophyllide, and chlorophyllide plus geranylgeraniolpyrophosphate trigger assembly of Lil3 in three chlorine binding fluorescent protein bands, termed F1, F2, and F3. It is shown that light and chlorophyllide trigger accumulation of protochlorophyllide-oxidoreductase, and chlorophyll synthase in band F3. Chlorophyllide and chlorophyll esterified to geranylgeraniol were identified as basis of fluorescence recorded from band F3. A direct interaction between Lil3, CHS and POR was confirmed in a split ubiquitin assay. In the presence of light or chlorophyllide, geranylgeraniolpyrophosphate was shown to trigger a loss of the F3 band and accumulation of Lil3 and geranylgeranyl reductase in F1 and F2. No direct interaction between Lil3 and geranylgeraniolreductase was identified in a split ubiquitin assay; however, accumulation of chlorophyll esterified to phytol in F1 and F2 corroborated the enzymes assembly. Chlorophyll esterified to phytol and the reaction center protein psbD of photosystem II were identified to accumulate together with psb29, and APX in the fluorescent band F2. Data show that Lil3 assembles with proteins regulating chlorophyll synthesis in etioplasts from barley (Hordeum vulgare L.).	[Mork-Jansson, Astrid; Bue, Ann Kristin; Gargano, Daniela; Furnes, Clemens; Reisinger, Veronika; Arnold, Janine; Kmiec, Karol; Eichacker, Lutz Andreas] Univ Stavanger, Ctr Organelle Res, Stavanger, Norway	Universitetet i Stavanger	Eichacker, LA (corresponding author), Univ Stavanger, Ctr Organelle Res, Stavanger, Norway.	lutz.eichacker@uis.no	Vatland, Ann Kristin/ABC-5758-2021	Vatland, Ann Kristin/0000-0002-3296-6120; Mork-Jansson, Astrid Elisabeth/0000-0003-1525-2270	Forskingsradet [192436, 197119]	Forskingsradet	192436, http://www.forskningsradet.no/no/Forsiden/1173185591033, Forskingsradet, DG, VR; 197119, http://www.forskningsradet.no/no/Forsiden/1173185591033, Forskingsradet, JA, AMJ, CF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adra AN, 1998, PHOTOCHEM PHOTOBIOL, V68, P852; ARMSTRONG GA, 1995, PLANT PHYSIOL, V108, P1505, DOI 10.1104/pp.108.4.1505; Barthelemy X, 2000, PHOTOSYNTH RES, V64, P63, DOI 10.1023/A:1026576319029; Chidgey JW, 2014, PLANT CELL, V26, P1267, DOI 10.1105/tpc.114.124495; Collakova E, 2001, PLANT PHYSIOL, V127, P1113, DOI 10.1104/pp.010421; Domanskii VP, 2001, PHOTOSYNTH RES, V68, P131, DOI 10.1023/A:1011817531801; EICHACKER LA, 1990, J BIOL CHEM, V265, P13566; Eichacker LA, 1996, J BIOL CHEM; Granvogl B, 2006, PROTEOMICS, V6, P3681, DOI 10.1002/pmic.200500924; GRIFFITHS WT, 1978, BIOCHEM J, V174, P681, DOI 10.1042/bj1740681; Grzyb JM, 2013, J PLANT PHYSIOL, V170, P1217, DOI 10.1016/j.jplph.2013.04.017; HELFRICH M, 1994, EUR J BIOCHEM, V219, P267, DOI 10.1111/j.1432-1033.1994.tb19938.x; Jansson S, 1999, TRENDS PLANT SCI, V4, P236, DOI 10.1016/S1360-1385(99)01419-3; Keller Y, 1998, EUR J BIOCHEM, V251, P413, DOI 10.1046/j.1432-1327.1998.2510413.x; Keren N, 2005, PLANT CELL, V17, P2768, DOI 10.1105/tpc.105.035048; KIM S, 1992, FEBS LETT, V314, P67, DOI 10.1016/0014-5793(92)81463-V; Knoppova J, 2014, PLANT CELL, V26, P1200, DOI 10.1105/tpc.114.123919; Komenda J, 2004, J BIOL CHEM, V279, P48620, DOI 10.1074/jbc.M405725200; Liu ZF, 2004, NATURE, V428, P287, DOI 10.1038/nature02373; Lopez-Juez E, 2005, INT J DEV BIOL, V49, P557, DOI 10.1387/ijdb.051997el; Muller B, 1999, PLANT CELL, V11, P2365, DOI 10.1105/tpc.11.12.2365; Plucken H, 2002, FEBS LETT, V532, P85, DOI 10.1016/S0014-5793(02)03634-7; Reisinger V, 2008, FEBS LETT, V582, P1547, DOI 10.1016/j.febslet.2008.03.042; Reisinger V, 2008, FEBS J, V275, P1018, DOI 10.1111/j.1742-4658.2008.06268.x; RUDIGER W, 1980, EUR J BIOCHEM, V109, P193, DOI 10.1111/j.1432-1033.1980.tb04784.x; Savidge B, 2002, PLANT PHYSIOL, V129, P321, DOI 10.1104/pp.010747; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Schoefs B, 2008, PHOTOSYNTH RES, V96, P15, DOI 10.1007/s11120-007-9274-x; Seo J, 2006, BIOINFORMATICS, V22, P808, DOI 10.1093/bioinformatics/btk052; Seo J, 2004, UNDERSTANDING CLUSTE; Shpilyov AV, 2013, PLANT J, V73, P336, DOI 10.1111/tpj.12044; SOLL J, 1987, METHOD ENZYMOL, V148, P383; Solymosi K, 2010, PHOTOSYNTH RES, V105, P143, DOI 10.1007/s11120-010-9568-2; Takahashi K, 2014, J BIOL CHEM, V289, P987, DOI 10.1074/jbc.M113.525428; Tanaka R, 1999, PLANT PHYSIOL, V120, P695, DOI 10.1104/pp.120.3.695; Tanaka R, 2010, P NATL ACAD SCI USA, V107, P16721, DOI 10.1073/pnas.1004699107; Towbin H, 1992, Biotechnology, V24, P145; TROST P, 1995, EUR J BIOCHEM, V234, P452, DOI 10.1111/j.1432-1033.1995.452_b.x; Vinti G, 2005, PLANT MOL BIOL, V57, P343, DOI 10.1007/s11103-004-7867-8; Zhou Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075299	40	19	19	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0133145	10.1371/journal.pone.0133145	http://dx.doi.org/10.1371/journal.pone.0133145			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26172838	Green Accepted, Green Submitted, Green Published, gold			2022-12-26	WOS:000358194900139
J	Skinner, DZ				Skinner, Daniel Z.			Genes Upregulated in Winter Wheat (Triticum aestivum L.) during Mild Freezing and Subsequent Thawing Suggest Sequential Activation of Multiple Response Mechanisms	PLOS ONE			English	Article							QUANTITATIVE EXPRESSION ANALYSIS; PLANT COLD-ACCLIMATION; LOW-TEMPERATURE; TOLERANCE; PATHWAY; GLYCOSYLTRANSFERASES; SALINITY; ONTOLOGY; EXPOSURE	Exposing fully cold-acclimated wheat plants to a mild freeze-thaw cycle of -3 degrees C for 24h followed by +3 degrees C for 24 or 48h results in dramatically improved tolerance of subsequent exposure to sub-freezing temperatures. Gene enrichment analysis of crown tissue from plants collected before or after the -3 degrees C freeze or after thawing at +3 degrees C for 24 or 48h revealed that many biological processes and molecular functions were activated during the freeze-thaw cycle in an increasing cascade of responses such that over 150 processes or functions were significantly enhanced by the end of the 48 h, post-freeze thaw. Nearly 2,000 individual genes were upregulated more than 2-fold over the 72 h course of freezing and thawing, but more than 70% of these genes were upregulated during only one of the time periods examined, suggesting a series of genes and gene functions were involved in activation of the processes that led to enhanced freezing tolerance. This series of functions appeared to include extensive cell signaling, activation of stress response mechanisms and the phenylpropanoid biosynthetic pathway, extensive modification of secondary metabolites, and physical restructuring of cell membranes. By identifying plant lines that are especially able to activate these multiple mechanisms it may be possible to develop lines with enhanced winterhardiness.	[Skinner, Daniel Z.] USDA ARS, 209 Johnson Hall, Pullman, WA 99164 USA; [Skinner, Daniel Z.] Washington State Univ, Dept Crop & Soil Sci, Pullman, WA 99164 USA	United States Department of Agriculture (USDA); Washington State University	Skinner, DZ (corresponding author), USDA ARS, 209 Johnson Hall, Pullman, WA 99164 USA.	dan.skinner@ars.usda.gov			US Department of Agriculture intramural project [5348-21000-030-00D]	US Department of Agriculture intramural project	This research was supported by US Department of Agriculture intramural project number 5348-21000-030-00D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Blazejczyk M., 2007, FLEXARRAY STAT DATA; Bowles D, 2005, CURR OPIN PLANT BIOL, V8, P254, DOI 10.1016/j.pbi.2005.03.007; Breton C, 2006, GLYCOBIOLOGY, V16, p29R, DOI 10.1093/glycob/cwj016; Chalker-Scott L, 1999, PHOTOCHEM PHOTOBIOL, V70, P1, DOI 10.1111/j.1751-1097.1999.tb01944.x; Cheynier V, 2011, PLANT PHYSIOL BIOCH, V72, P1; Clark N.R., 2014, PLANT PHYSIOL, V15, P79, DOI DOI 10.1104/PP.107.109561; Clark NR, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-79; Day-Richter J, 2007, BIOINFORMATICS, V23, P2198, DOI 10.1093/bioinformatics/btm112; Demiral T, 2011, ADV BOT RES, V57, P293, DOI 10.1016/B978-0-12-387692-8.00008-4; Dixon RA, 2002, MOL PLANT PATHOL, V3, P371, DOI 10.1046/j.1364-3703.2002.00131.x; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Dussault AA, 2006, BIOL PROCED ONLINE, V8, P1, DOI 10.1251/bpo114; Eckardt NA, 2008, PLANT CELL, V20, P499, DOI [10.1105/tpc.108.200311, 10.1105/tpc.108.059485]; Finkelstein Ruth, 2013, Arabidopsis Book, V11, pe0166, DOI 10.1199/tab.0166; Ganeshan S, 2008, J EXP BOT, V59, P2393, DOI 10.1093/jxb/ern112; Ganeshan S, 2011, PLANT MOL BIOL, V75, P379, DOI 10.1007/s11103-011-9734-8; Ganeshan S, 2009, ENVIRON EXP BOT, V66, P46, DOI 10.1016/j.envexpbot.2008.12.013; Grace SC, 2000, PHILOS T R SOC B, V355, P1499, DOI 10.1098/rstb.2000.0710; Gulick PJ, 2005, GENOME, V48, P913, DOI 10.1139/g05-039; Harper JE, 2004, ANNU REV PLANT BIOL, V55, P263, DOI 10.1146/annurev.arplant.55.031903.141627; Hartung W, 2002, J EXP BOT, V53, P27, DOI 10.1093/jexbot/53.366.27; Herman EM, 2006, J EXP BOT, V57, P3601, DOI 10.1093/jxb/erl111; Jacoby RP, 2011, TRENDS PLANT SCI, V16, P614, DOI 10.1016/j.tplants.2011.08.002; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; KISHA TJ, 1992, CROP SCI, V32, P1292, DOI 10.2135/cropsci1992.0011183X003200050049x; Laudencia-Chingcuanco D, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-299; Le MQ, 2015, PLANT MOL BIOL, V87, P1, DOI 10.1007/s11103-014-0256-z; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Liu H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050785; Monroy AF, 2007, PLANT MOL BIOL, V64, P409, DOI 10.1007/s11103-007-9161-z; Naika M, 2013, MOL BIOSYST, V9, P1888, DOI 10.1039/c3mb70072k; NIEMAN RICHARD H., 1962, BOT GAZ, V123, P279, DOI 10.1086/336163; Palmgren MG, 2001, ANNU REV PLANT PHYS, V52, P817, DOI 10.1146/annurev.arplant.52.1.817; Qi MS, 2005, J CELL SCI, V118, P3569, DOI 10.1242/jcs.02470; Saulescu N. N., 2001, APPL PHYSL WHEAT BRE, P111; Shinozaki K, 2000, CURR OPIN PLANT BIOL, V3, P217, DOI 10.1016/S1369-5266(00)00067-4; Skinner DZ, 2014, METHODS MOL BIOL, V1166, P7, DOI 10.1007/978-1-4939-0844-8_2; Skinner DZ, 2010, PLANT SOIL, V332, P289, DOI 10.1007/s11104-010-0293-6; Skinner DZ, 2009, FUNCT INTEGR GENOMIC, V9, P513, DOI 10.1007/s10142-009-0126-y; Skinner DZ, 2005, CROP SCI, V45, P1858, DOI 10.2135/cropsci2004.0721; Sun YH, 2013, ZOOKEYS, P85, DOI 10.3897/zookeys.258.4108; Thomashow MF, 1999, ANNU REV PLANT PHYS, V50, P571, DOI 10.1146/annurev.arplant.50.1.571; Thomashow MF, 2010, PLANT PHYSIOL, V154, P571, DOI 10.1104/pp.110.161794; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vogt T, 2000, TRENDS PLANT SCI, V5, P380, DOI 10.1016/S1360-1385(00)01720-9; Winfield MO, 2010, PLANT BIOTECHNOL J, V8, P749, DOI 10.1111/j.1467-7652.2010.00536.x; Winfield MO, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-55; Yonekura-Sakakibara K, 2011, PLANT J, V66, P182, DOI 10.1111/j.1365-313X.2011.04493.x; Yoo H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3833	50	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0133166	10.1371/journal.pone.0133166	http://dx.doi.org/10.1371/journal.pone.0133166			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26173115	Green Submitted, Green Published, gold			2022-12-26	WOS:000358194900143
J	Wan, GJ; Wang, WJ; Xu, JJ; Yang, QF; Dai, MJ; Zhang, FJ; Sword, GA; Pan, WD; Chen, FJ				Wan, Gui-Jun; Wang, Wen-Jing; Xu, Jing-Jing; Yang, Quan-Feng; Dai, Ming-Jiang; Zhang, Feng-Jiao; Sword, Gregory A.; Pan, Wei-Dong; Chen, Fa-Jun			Cryptochromes and Hormone Signal Transduction under Near-Zero Magnetic Fields: New Clues to Magnetic Field Effects in a Rice Planthopper	PLOS ONE			English	Article							JUVENILE-HORMONE; BROWN PLANTHOPPER; CIRCADIAN CLOCK; GEOMAGNETIC-FIELD; WING DIMORPHISM; GENES; LONGEVITY; MECHANISM; RHYTHMS; DENSITY	Although there are considerable reports of magnetic field effects (MFE) on organisms, very little is known so far about the MFE-related signal transduction pathways. Here we establish a manipulative near-zero magnetic field (NZMF) to investigate the potential signal transduction pathways involved in MFE. We show that exposure of migratory white-backed planthopper, Sogatella furcifera, to the NZMF results in delayed egg and nymphal development, increased frequency of brachypterous females, and reduced longevity of macropterous female adults. To understand the changes in gene expression underlying these phenotypes, we examined the temporal patterns of gene expression of (i) CRY1 and CRY2 as putative magnetosensors, (ii) JHAMT, FAMeT and JHEH in the juvenile hormone pathway, (iii) CYP307A1 in the ecdysone pathway, and (iv) reproduction-related Vitellogenin (Vg). The significantly altered gene expression of CRY1 and CRY2 under the NZMF suggest their developmental stage-specific patterns and potential upstream location in magnetic response. Gene expression patterns of JHAMT, JHEH and CYP307A1 were consistent with the NZMF-triggered delay in nymphal development, higher proportion of brachypterous female adults, and the shortened longevity of macropterous female adults, which show feasible links between hormone signal transduction and phenotypic MFE. By conducting manipulative NZMF experiments, our study suggests an important role of the geomagnetic field (GMF) in modulating development and physiology of insects, provides new insights into the complexity of MFE-magnetosensitivity interactions, and represents an initial but crucial step forward in understanding the molecular basis of cryptochromes and hormone signal transduction involved in MFE.	[Wan, Gui-Jun; Wang, Wen-Jing; Yang, Quan-Feng; Dai, Ming-Jiang; Zhang, Feng-Jiao; Chen, Fa-Jun] Nanjing Agr Univ, Dept Entomol, Nanjing, Jiangsu, Peoples R China; [Xu, Jing-Jing; Pan, Wei-Dong] Chinese Acad Sci, Inst Elect Engn, Beijing Key Lab Bioelectromaget, Beijing, Peoples R China; [Sword, Gregory A.] Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA	Nanjing Agricultural University; Chinese Academy of Sciences; Institute of Electrical Engineering, CAS; Texas A&M University System; Texas A&M University College Station	Chen, FJ (corresponding author), Nanjing Agr Univ, Dept Entomol, Nanjing, Jiangsu, Peoples R China.	panwd@mail.iee.ac.cn; fajunchen@njau.edu.cn	DAI, M/GPS-8291-2022		National Basic Research Program of China "973" grant [2010CB126200]; National Nature Science Foundations of China [31470454, 31272051, 31170362, 31070755]; Fok Ying Tung Education Foundation [122033]; Qing Lan Project; Jiangsu Province [KYLX_0576]	National Basic Research Program of China "973" grant(National Basic Research Program of China); National Nature Science Foundations of China(National Natural Science Foundation of China (NSFC)); Fok Ying Tung Education Foundation(Fok Ying Tung Education Foundation); Qing Lan Project(Jiangsu Polytech Institute); Jiangsu Province	FJC was funded by the National Basic Research Program of China "973" grant no. 2010CB126200, the National Nature Science Foundations of China grants no. 31470454 and 31272051, the Fok Ying Tung Education Foundation grant no. 122033 and the Qing Lan Project. WDP was funded by the National Nature Science Foundations of China grant no. 31170362 and 31070755. GJW was funded by the Research Grant from the Innovation Project for Graduate Student of Jiangsu Province grant no. KYLX_0576. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMAD M, 1993, NATURE, V366, P162, DOI 10.1038/366162a0; Bajgar A, 2013, P NATL ACAD SCI USA, V110, P4416, DOI 10.1073/pnas.1217060110; Bass J, 2010, SCIENCE, V330, P1349, DOI 10.1126/science.1195027; BERG BN, 1960, J NUTR, V71, P255; BLISS VL, 1976, NATURE, V261, P411, DOI 10.1038/261411a0; Bree RT, 2002, BIOGERONTOLOGY, V3, P195, DOI 10.1023/A:1016299812327; Burger T, 2010, J R SOC INTERFACE, V7, P1275, DOI 10.1098/rsif.2009.0551; Chaves I, 2011, ANNU REV PLANT BIOL, V62, P335, DOI 10.1146/annurev-arplant-042110-103759; Close J, 2012, P ROY SOC B-BIOL SCI, V279, P2081, DOI 10.1098/rspb.2012.0324; CZEISLER CA, 1986, SCIENCE, V233, P667, DOI 10.1126/science.3726555; De Loof A, 2008, GEN COMP ENDOCR, V155, P3, DOI 10.1016/j.ygcen.2007.07.001; De Santis A, 2007, PHYS EARTH PLANET IN, V162, P217, DOI 10.1016/j.pepi.2007.04.011; Dodson CA, 2013, TRENDS BIOCHEM SCI, V38, P435, DOI 10.1016/j.tibs.2013.07.002; Dubrovsky EB, 2005, TRENDS ENDOCRIN MET, V16, P6, DOI 10.1016/j.tem.2004.11.003; Fedele G, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004804; Flatt T, 2013, Q REV BIOL, V88, P185, DOI 10.1086/671484; Foley LE, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1364; Gegear RJ, 2010, NATURE, V463, P804, DOI 10.1038/nature08719; Gilbert LI, 2002, ANNU REV ENTOMOL, V47, P883, DOI 10.1146/annurev.ento.47.091201.145302; Gould JL, 2010, CURR BIOL, V20, pR431, DOI 10.1016/j.cub.2010.03.045; Guerra PA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5164; Henrich VC, 1999, VITAM HORM, V55, P73; Hoffmann KH, 1999, EUR J ENTOMOL, V96, P255; IWANAGA K, 1986, J INSECT PHYSIOL, V32, P585, DOI 10.1016/0022-1910(86)90076-4; Jindra M, 2013, ANNU REV ENTOMOL, V58, P181, DOI 10.1146/annurev-ento-120811-153700; KAWAKAMI A, 1990, SCIENCE, V247, P1333, DOI 10.1126/science.2315701; Lee AA, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.1063; Lohmann KJ, 2010, NATURE, V464, P1140, DOI 10.1038/4641140a; Lohmann KJ, 1996, NATURE, V380, P59, DOI 10.1038/380059a0; Maeda K, 2012, P NATL ACAD SCI USA, V109, P4774, DOI 10.1073/pnas.1118959109; Maffei ME, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00445; Mallis MM, 2005, AVIAT SPACE ENVIR MD, V76, pB94; Marley R, 2014, SCI REP-UK, V4, DOI 10.1038/srep05799; Matsumura M, 1996, HEREDITY, V76, P229, DOI 10.1038/hdy.1996.36; Matsuo T, 2003, SCIENCE, V302, P255, DOI 10.1126/science.1086271; McBrayer Z, 2007, DEV CELL, V13, P857, DOI 10.1016/j.devcel.2007.11.003; Meelkop E, 2011, PROG NEUROBIOL, V93, P125, DOI 10.1016/j.pneurobio.2010.10.004; Mo WC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054775; Mo WC, 2014, SCI CHINA LIFE SCI, V57, P448, DOI 10.1007/s11427-014-4644-z; Monk TH, 2001, PSYCHOSOM MED, V63, P881, DOI 10.1097/00006842-200111000-00005; NISHIO T, 1979, PHYSIOL BEHAV, V23, P763, DOI 10.1016/0031-9384(79)90172-0; Reppert SM, 2006, CELL, V124, P233, DOI 10.1016/j.cell.2006.01.009; Sakai T, 2001, P NATL ACAD SCI USA, V98, P9221, DOI 10.1073/pnas.151443298; Sandrelli F, 2008, INSECT MOL BIOL, V17, P447, DOI 10.1111/j.1365-2583.2008.00832.x; Sehadova H, 2004, J BIOL RHYTHM, V19, P466, DOI 10.1177/0748730404269153; Silver R, 1996, NATURE, V382, P810, DOI 10.1038/382810a0; Sneed A, 2014, SCI AM, V311, P29, DOI 10.1038/scientificamerican1014-29; Stay B, 2000, INSECT BIOCHEM MOLEC, V30, P653, DOI 10.1016/S0965-1748(00)00036-9; Tomioka K, 2010, CELL MOL LIFE SCI, V67, P1397, DOI 10.1007/s00018-009-0232-y; Tufail M, 2014, ENTOMOL SCI, V17, P269, DOI 10.1111/ens.12086; Van Ekert E, 2014, J INSECT PHYSIOL, V70, P143, DOI 10.1016/j.jinsphys.2014.08.001; WALKER MM, 1989, J EXP BIOL, V145, P489; Wan GJ, 2014, J INSECT PHYSIOL, V68, P7, DOI 10.1016/j.jinsphys.2014.06.016; Wiltschko R, 2014, BIOSENSORS-BASEL, V4, P221, DOI 10.3390/bios4030221; Yamanaka N, 2013, SCIENCE, V341, P1113, DOI 10.1126/science.1241210; Yamanaka N, 2013, ANNU REV ENTOMOL, V58, P497, DOI 10.1146/annurev-ento-120811-153608; Yoshii T, 2009, PLOS BIOL, V7, P813, DOI 10.1371/journal.pbio.1000086; Yuan Q, 2007, MOL BIOL EVOL, V24, P948, DOI 10.1093/molbev/msm011; Zamoshchina T A, 2012, Aviakosm Ekolog Med, V46, P17; Zhai YF, 2013, J PROTEOME RES, V12, P5199, DOI 10.1021/pr400561c; Zhou GH, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00270	61	15	22	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132966	10.1371/journal.pone.0132966	http://dx.doi.org/10.1371/journal.pone.0132966			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26173003	Green Published, Green Submitted, gold			2022-12-26	WOS:000358194900109
J	Devi, SG; Fathima, AA; Radha, S; Arunraj, R; Curtis, WR; Ramya, M				Devi, Selvaraju Gayathri; Fathima, Anwar Aliya; Radha, Sudhakar; Arunraj, Rex; Curtis, Wayne R.; Ramya, Mohandass			A Rapid and Economical Method for Efficient DNA Extraction from Diverse Soils Suitable for Metagenomic Applications	PLOS ONE			English	Article							SEDIMENT SAMPLES; PURIFICATION PROCEDURES; MOLECULAR DIVERSITY; BACTERIAL DIVERSITY; COASTAL GUJARAT; SALINE HABITATS; NUCLEIC-ACIDS; GLASS POWDER; PCR; ENVIRONMENT	A rapid, cost effective method of metagenomic DNA extraction from soil is a useful tool for environmental microbiology. The present work describes an improved method of DNA extraction namely "powdered glass method" from diverse soils. The method involves the use of sterile glass powder for cell lysis followed by addition of 1% powdered activated charcoal (PAC) as purifying agent to remove humic substances. The method yielded substantial DNA (5.87 +/- 0.04 mu g/g of soil) with high purity (A(260/280): 1.76 +/- 0.05) and reduced humic substances (A(340): 0.047 +/- 0.03). The quality of the extracted DNA was compared against five different methods based on 16S rDNA PCR amplification, BamHI digestion and validated using quantitative PCR. The digested DNA was used for a metagenomic library construction with the transformation efficiency of 4 X 10(6) CFU mL(-1). Besides providing rapid, efficient and economical extraction of metgenomic DNA from diverse soils, this method's applicability is also demonstrated for cultivated organisms (Gram positive B. subtilis NRRL-B-201, Gram negative E. coli MTCC40, and a microalgae C. sorokiniana UTEX#1666).	[Devi, Selvaraju Gayathri; Fathima, Anwar Aliya; Radha, Sudhakar; Arunraj, Rex; Ramya, Mohandass] SRM Univ, Dept Genet Engn, Kattankulathur, Tamil Nadu, India; [Curtis, Wayne R.] Penn State Univ, Dept Chem Engn, University Pk, PA 16802 USA	SRM Institute of Science & Technology Chennai; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Ramya, M (corresponding author), SRM Univ, Dept Genet Engn, Kattankulathur, Tamil Nadu, India.	ramya.mohandass@gmail.com	Arunraj, Rex/AAS-9159-2020; Wolverton, Christopher/B-7542-2009; Mohandass, Ramya/Q-4185-2016; Selvaraju, Gayathri Devi/ADI-9612-2022; Anwar, Aliya Fathima/AAJ-6312-2021	Mohandass, Ramya/0000-0003-4448-920X; Selvaraju, Gayathri Devi/0000-0001-7500-6181; Curtis, Wayne/0000-0001-6976-0890; Arunraj, Rex/0000-0002-2739-8325				American Public Health Association (APHA), 2005, STANDARD METHODS EXA; ATTAL J, 1995, TRANSGENIC RES, V4, P149, DOI 10.1007/BF01969417; Aziz A, 2007, ANN BIOMED ENG, V35, P2108, DOI 10.1007/s10439-007-9387-6; BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990; Burgmann H, 2001, J MICROBIOL METH, V45, P7, DOI 10.1016/S0167-7012(01)00213-5; Buscot F., 2005, MICROORGANISMS SOILS, P19; Cottrell MT, 2005, ENVIRON MICROBIOL, V7, P1883, DOI 10.1111/j.1462-2920.2005.00762.x; CURTIS WR, 1993, BIOTECHNOL BIOENG, V42, P520, DOI 10.1002/bit.260420416; Doebler RW, 2009, JALA-J LAB AUTOM, V14, P119, DOI 10.1016/j.jala.2009.02.010; Frostegard A, 1999, APPL ENVIRON MICROB, V65, P5409; Gray JP, 1996, APPL ENVIRON MICROB, V62, P4049, DOI 10.1128/AEM.62.11.4049-4059.1996; Harry M, 1999, ANALUSIS, V27, P439, DOI 10.1051/analusis:1999270439; Hussain T, 2014, SAUDI J BIOL SCI, V21, P380, DOI 10.1016/j.sjbs.2013.09.012; JACOBSEN CS, 1992, APPL ENVIRON MICROB, V58, P2458, DOI 10.1128/AEM.58.8.2458-2462.1992; JOHNSTON CG, 1994, APPL ENVIRON MICROB, V60, P2350, DOI 10.1128/AEM.60.7.2350-2354.1994; Kauffmann IM, 2004, APPL MICROBIOL BIOT, V64, P665, DOI 10.1007/s00253-003-1528-8; LaMontagne MG, 2002, J MICROBIOL METH, V49, P255, DOI 10.1016/S0167-7012(01)00377-3; Lee SY, 1996, APPL ENVIRON MICROB, V62, P3787, DOI 10.1128/AEM.62.10.3787-3793.1996; Li L, 2015, J VIROL METHODS, V213, P139, DOI 10.1016/j.jviromet.2014.12.002; LIESACK W, 1992, J BACTERIOL, V174, P5072, DOI 10.1128/JB.174.15.5072-5078.1992; MARKO MA, 1982, ANAL BIOCHEM, V121, P382, DOI 10.1016/0003-2697(82)90497-3; Miller DN, 1999, APPL ENVIRON MICROB, V65, P4715; Nair Harisree P, 2014, Biotechnol Rep (Amst), V4, P134, DOI 10.1016/j.btre.2014.09.008; Poeckh T, 2008, ANAL BIOCHEM, V373, P253, DOI 10.1016/j.ab.2007.10.026; Punekar N.S., 2003, FUNGAL GENET REP, V50, P15; Purohit MK, 2009, LETT APPL MICROBIOL, V49, P338, DOI 10.1111/j.1472-765X.2009.02663.x; Radha S, 2013, J APPL PHYCOL, V25, P609, DOI 10.1007/s10811-012-9895-0; Riesenfeld CS, 2004, ENVIRON MICROBIOL, V6, P981, DOI 10.1111/j.1462-2920.2004.00664.x; Rojas-Herrera R, 2008, MOL BIOTECHNOL, V40, P13, DOI 10.1007/s12033-008-9061-8; Roose-Amsaleg CL, 2001, APPL SOIL ECOL, V18, P47, DOI 10.1016/S0929-1393(01)00149-4; Sagar K, 2014, J MICROBIOL METH, V97, P68, DOI 10.1016/j.mimet.2013.11.008; Seo GT, 2001, WATER SCI TECHNOL, V43, P67, DOI 10.2166/wst.2001.0668; Sharma PK, 2007, MOL BIOTECHNOL, V36, P61, DOI 10.1007/s12033-007-0015-3; Sharma S, 2014, J APPL MICROBIOL, V116, P923, DOI 10.1111/jam.12420; Siddhapura PK, 2010, INT J BIOL MACROMOL, V47, P375, DOI 10.1016/j.ijbiomac.2010.06.004; Tiedje JM, 1999, APPL SOIL ECOL, V13, P109, DOI 10.1016/S0929-1393(99)00026-8; TSAI YL, 1991, APPL ENVIRON MICROB, V57, P1070, DOI 10.1128/AEM.57.4.1070-1074.1991; Verma D, 2011, APPL BIOCHEM BIOTECH, V165, P454, DOI 10.1007/s12010-011-9264-5; Wise MG, 1997, APPL ENVIRON MICROB, V63, P1505, DOI 10.1128/AEM.63.4.1505-1514.1997; Yeates C, 1998, Biol Proced Online, V1, P40, DOI 10.1251/bpo6; Zhang D, 2004, ANAL BIOANAL CHEM, V379, P1025, DOI 10.1007/s00216-004-2653-7; Zhou JZ, 1996, APPL ENVIRON MICROB, V62, P316, DOI 10.1128/AEM.62.2.316-322.1996	42	32	34	2	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0132441	10.1371/journal.pone.0132441	http://dx.doi.org/10.1371/journal.pone.0132441			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26167854	gold, Green Submitted, Green Published			2022-12-26	WOS:000358193100043
J	Salerno, L; Cosentino, C; Morrone, G; Amato, F				Salerno, Luca; Cosentino, Carlo; Morrone, Giovanni; Amato, Francesco			Computational Modeling of a Transcriptional Switch Underlying B-Lymphocyte Lineage Commitment of Hematopoietic Multipotent Cells	PLOS ONE			English	Article							FINGER PROTEIN 521; STEM-CELLS; TERMINAL DIFFERENTIATION; INTERLEUKIN-7 RECEPTOR; PROGENITOR CELLS; GENE-EXPRESSION; PU.1; SPECIFICATION; SYSTEMS; ZFP521	Despite progresses in identifying the cellular mechanisms at the basis of the differentiation of hematopoietic stem/progenitor cells, little is known about the regulatory circuitry at the basis of lineage commitment of hematopoietic multipotent progenitors. To address this issue, we propose a computational approach to give further insights in the comprehension of this genetic mechanism. Differently from T lymphopoiesis, however, there is at present no mathematical model describing lineage restriction of multipotent progenitors to early B-cell precursors. Here, we provide a first model-constructed on the basis of current experimental evidence from literature and of publicly available microarray datasets-of the genetic regulatory network driving the cellular fate determination at the stage of lymphoid lineage commitment, with particular regard to the multipotent-B-cell progenitor transition. By applying multistability analysis methods, we are able to assess the capability of the model to capture the experimentally observed switch-like commitment behavior. These methods allow us to confirm the central role of zinc finger protein 521 (ZNF521) in this process, that we had previously reported, and to identify a novel putative functional interaction for ZNF521, which is essential to realize such characteristic behavior. Moreover, using the devised model, we are able to rigorously analyze the mechanisms underpinning irreversibility of the physiological commitment step and to devise a possible reprogramming strategy, based on the combined modification of the expression of ZNF521 and EBF1.	[Salerno, Luca; Cosentino, Carlo; Amato, Francesco] Magna Graecia Univ Catanzaro, Lab Biomechatron, Dept Expt & Clin Med, Catanzaro, Italy; [Morrone, Giovanni] Magna Graecia Univ Catanzaro, Dept Expt & Clin Med, Lab Mol Haematopoiesis & Stem Cell Biol, Catanzaro, Italy	Magna Graecia University of Catanzaro; Magna Graecia University of Catanzaro	Cosentino, C (corresponding author), Magna Graecia Univ Catanzaro, Lab Biomechatron, Dept Expt & Clin Med, Catanzaro, Italy.	carlo.cosentino@unicz.it	Amato, Francesco/E-8757-2013; Morrone, Giovanni/A-7202-2008; Cosentino, Carlo/C-5677-2011; Salerno, Luca/ABF-9467-2022	Amato, Francesco/0000-0002-9053-3139; Morrone, Giovanni/0000-0002-1978-340X; Cosentino, Carlo/0000-0001-5768-1829; Salerno, Luca/0000-0003-4221-3533	Italian PON project "STAYWELL" [PON04a2_00003]	Italian PON project "STAYWELL"	The post-doc fellowship of L.S. was funded under the Italian PON project "STAYWELL" - PON04a2_00003. The other authors received no specific funding for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS B, 1992, GENE DEV, V6, P1589, DOI 10.1101/gad.6.9.1589; ARPIN C, 1995, SCIENCE, V268, P720, DOI 10.1126/science.7537388; Bates DG, 2011, IET SYST BIOL, V5, P229, DOI 10.1049/iet-syb.2010.0072; Bond HM, 2008, INT J BIOCHEM CELL B, V40, P848, DOI 10.1016/j.biocel.2007.04.006; Bond HM, 2004, BLOOD, V103, P2062, DOI 10.1182/blood-2003-07-2388; Carotta S, 2010, IMMUNITY, V32, P628, DOI 10.1016/j.immuni.2010.05.005; Chickarmane V, 2005, BIOINFORMATICS, V21, P3688, DOI 10.1093/bioinformatics/bti603; Chickarmane V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003478; Chickarmane V, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000268; Corfe SA, 2012, SEMIN IMMUNOL, V24, P198, DOI 10.1016/j.smim.2012.02.001; Correa D, 2010, DEV CELL, V19, P533, DOI 10.1016/j.devcel.2010.09.008; Cosentino C., 2011, FEEDBACK CONTROL SYS; Cross MA, 1997, CURR OPIN GENET DEV, V7, P609, DOI 10.1016/S0959-437X(97)80007-X; Dakic A, 2005, J EXP MED, V201, P1487, DOI 10.1084/jem.20050075; Decker T, 2009, IMMUNITY, V30, P508, DOI 10.1016/j.immuni.2009.01.012; DeKoter RP, 2002, IMMUNITY, V16, P297, DOI 10.1016/S1074-7613(02)00269-8; Dhooge A, 2004, LECT NOTES COMPUT SC, V3037, P42; Dias S, 2008, IMMUNITY, V29, P217, DOI 10.1016/j.immuni.2008.05.015; Fuxa M, 2007, J IMMUNOL, V178, P8221, DOI 10.4049/jimmunol.178.12.8221-a; Gerrits A, 2011, THESIS U LIB GRONING; Graf T, 2002, BLOOD, V99, P3089, DOI 10.1182/blood.V99.9.3089; Grosschedl R, 2013, COLD SPRING HARB SYM, V157, P549; Gurdon JB, 2008, SCIENCE, V322, P1811, DOI 10.1126/science.1160810; Hesse E, 2010, J CELL BIOL, V191, P1271, DOI 10.1083/jcb.201009107; Holmes ML, 2006, GENE DEV, V20, P933, DOI 10.1101/gad.1396206; Hu M, 1997, GENE DEV, V11, P774, DOI 10.1101/gad.11.6.774; Huang S, 2009, ENCY COMPLEXITY SYST, P1180; Huang S, 2007, DEV BIOL, V305, P695, DOI 10.1016/j.ydbio.2007.02.036; Huang S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000380; Kamiya D, 2011, NATURE, V470, P503, DOI 10.1038/nature09726; Kang S, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001433; Kirk P, 2013, CURR OPIN BIOTECH, V24, P767, DOI 10.1016/j.copbio.2013.03.012; Kirstetter P, 2002, EUR J IMMUNOL, V32, P720, DOI 10.1002/1521-4141(200203)32:3<720::AID-IMMU720>3.0.CO;2-P; Kiviranta R, 2013, J EXP MED, V210, P969, DOI 10.1084/jem.20121187; Kwon K, 2008, IMMUNITY, V28, P751, DOI 10.1016/j.immuni.2008.04.014; Laiosa CV, 2006, ANNU REV IMMUNOL, V24, P705, DOI 10.1146/annurev.immunol.24.021605.090742; Laurent M, 1999, TRENDS BIOCHEM SCI, V24, P418, DOI 10.1016/S0968-0004(99)01473-5; Loose M, 2007, CURR OPIN HEMATOL, V14, P307, DOI 10.1097/MOH.0b013e3281900eee; Loose M, 2006, CURR OPIN HEMATOL, V13, P229, DOI 10.1097/01.moh.0000231419.15654.7f; Lukin K, 2008, SEMIN IMMUNOL, V20, P221, DOI 10.1016/j.smim.2008.07.004; Martinez MR, 2012, P NATL ACAD SCI USA, V109, P2672, DOI 10.1073/pnas.1113019109; Matsubara E, 2009, J BIOL CHEM, V284, P3480, DOI 10.1074/jbc.M805874200; McManus S, 2011, EMBO J, V30, P2388, DOI 10.1038/emboj.2011.140; Mega T, 2011, CELL CYCLE, V10, P2129, DOI 10.4161/cc.10.13.16045; Mesuraca M, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/318793; Miller JP, 2002, J EXP MED, V196, P705, DOI 10.1084/jem.20020784; Nechanitzky R, 2013, NAT IMMUNOL, V14, P867, DOI 10.1038/ni.2641; Nodland SE, 2011, BLOOD, V118, P2116, DOI 10.1182/blood-2010-08-302513; Nutt SL, 2007, IMMUNITY, V26, P715, DOI 10.1016/j.immuni.2007.05.010; Riddell J, 2014, CELL, V157, P549, DOI 10.1016/j.cell.2014.04.006; Roeder I, 2006, J THEOR BIOL, V241, P852, DOI 10.1016/j.jtbi.2006.01.021; Roessler S, 2007, MOL CELL BIOL, V27, P579, DOI 10.1128/MCB.01192-06; Schebesta M, 2002, CURR OPIN IMMUNOL, V14, P216, DOI 10.1016/S0952-7915(02)00324-2; Schwickert TA, 2014, NAT IMMUNOL, V15, P283, DOI 10.1038/ni.2828; Sitnicka E, 2003, J EXP MED, V198, P1495, DOI 10.1084/jem.20031152; Spina R, 2013, ONCOTARGET, V4, P1280, DOI 10.18632/oncotarget.1176; Spooner CJ, 2009, IMMUNITY, V31, P576, DOI 10.1016/j.immuni.2009.07.011; Strogatz SH., 1994, NONLINEAR DYNAMICS C, V1; Swiers G, 2006, DEV BIOL, V294, P525, DOI 10.1016/j.ydbio.2006.02.051; van Zelm MC, 2005, J IMMUNOL, V175, P5912, DOI 10.4049/jimmunol.175.9.5912; Yamasaki N, 2010, ONCOGENE, V29, P1963, DOI 10.1038/onc.2009.475; Yoshida T, 2006, NAT IMMUNOL, V7, P382, DOI 10.1038/ni1314; Zhang Q, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-40; Zhu J, 2002, ONCOGENE, V21, P3295, DOI 10.1038/sj.onc.1205318	64	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0132208	10.1371/journal.pone.0132208	http://dx.doi.org/10.1371/journal.pone.0132208			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26167861	Green Submitted, gold, Green Published			2022-12-26	WOS:000358193100027
J	Schmidt, AE; Dybala, KE; Botsford, LW; Eadie, JM; Bradley, RW; Jahncke, J				Schmidt, Annie E.; Dybala, Kristen E.; Botsford, Louis W.; Eadie, John M.; Bradley, Russell W.; Jahncke, Jaime			Shifting Effects of Ocean Conditions on Survival and Breeding Probability of a Long-Lived Seabird	PLOS ONE			English	Article							CLIMATE-CHANGE; POPULATION-DYNAMICS; EL-NINO; REPRODUCTIVE SUCCESS; PACIFIC; VARIABILITY; CALIFORNIA; COSTS; AGE; HYPOTHESES	With a rapidly changing climate, there is an increasing need to predict how species will respond to changes in the physical environment. One approach is to use historic data to estimate the past influence of environmental variation on important demographic parameters and then use these relationships to project the abundance of a population or species under future climate scenarios. However, as novel climate conditions emerge, novel species responses may also appear. In some systems, environmental conditions beyond the range of those observed during the course of most long-term ecological studies are already evident. Yet little attention has been given to how these novel conditions may be influencing previously established environment-species relationships. Here, we model the relationships between ocean conditions and the demography of a long-lived seabird, Brandt's cormorant (Phalacrocorax penicillatusI), in central California and show that these relationships have changed in recent years. Beginning in 2007/2008, the response of Brandt's cormorant, an upper trophic level predator, to ocean conditions shifted, resulting in lower than predicted survival and breeding probability. Survival was generally less variable than breeding probability and was initially best predicted by the basin-scale forcing of the El Nino Southern Oscillation rather than local ocean conditions. The shifting response of Brandt's cormorant to ocean conditions may be just a proximate indication of altered dynamics in the food web and that important forage fish are not responding to the physical ocean environment as expected. These changing relationships have important implications for our ability to project the effects of future climate change for species and communities.	[Schmidt, Annie E.; Dybala, Kristen E.; Botsford, Louis W.; Eadie, John M.] Univ Calif Davis, Dept Wildlife Fish & Conservat Biol, Davis, CA 95616 USA; [Schmidt, Annie E.; Bradley, Russell W.; Jahncke, Jaime] Point Blue Conservat Sci, Petaluma, CA 94954 USA	University of California System; University of California Davis	Schmidt, AE (corresponding author), Point Blue Conservat Sci, Petaluma, CA 94954 USA.	aschmidt@ucdavis.edu	Dybala, Kristen/P-4629-2015	Dybala, Kristen/0000-0002-2787-4600; Schmidt, Annie/0000-0001-6144-9950; Eadie, John/0000-0001-9573-2703	National Science Foundation Graduate Research Fellowship [1148897]; University of California, Davis, Graduate Group in Ecology fellowship; Jastro Shields research fellowship; Selma Herr Fund for Ornithological Research; Baker Trust; Marisla Foundation; Campini Foundation; Kimball Foundation; Mead Foundation	National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); University of California, Davis, Graduate Group in Ecology fellowship; Jastro Shields research fellowship; Selma Herr Fund for Ornithological Research; Baker Trust; Marisla Foundation; Campini Foundation; Kimball Foundation; Mead Foundation	AES was supported by a National Science Foundation Graduate Research Fellowship (grant No. 1148897), a University of California, Davis, Graduate Group in Ecology fellowship, a Jastro Shields research fellowship, and a grant from the Selma Herr Fund for Ornithological Research. No other authors received specific funding for this work. The continued operation of Point Blue's Farallon Research Program is supported by the Baker Trust, Marisla Foundation, Campini Foundation, Kimball Foundation, Mead Foundation, and individual donors. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham CL, 2004, MAR ECOL PROG SER, V274, P235, DOI 10.3354/meps274235; AINLEY DG, 1995, MAR ECOL PROG SER, V118, P69, DOI 10.3354/meps118069; Barbraud C, 2005, ECOLOGY, V86, P682, DOI 10.1890/04-0075; Beaugrand G, 2012, MAR ECOL PROG SER, V445, P293, DOI 10.3354/meps09493; Black BA, 2011, GLOBAL CHANGE BIOL, V17, P2536, DOI 10.1111/j.1365-2486.2011.02422.x; Blois JL, 2013, SCIENCE, V341, P499, DOI 10.1126/science.1237184; BOEKELHEIDE RJ, 1989, AUK, V106, P389; BRIGGS KT, 1987, STUD AVIAN BIOL, V11, P1; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Chenillat F, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2011GL049966; Choquet R, 2009, ECOGRAPHY, V32, P1071, DOI 10.1111/j.1600-0587.2009.05968.x; Di Lorenzo E, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032838; Di Lorenzo E, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL038261; Durant JM, 2009, CLIM RES, V39, P115, DOI 10.3354/cr00798; Dybala KE, 2013, GLOBAL CHANGE BIOL, V19, P2688, DOI 10.1111/gcb.12228; Gaillard JM, 2000, ANNU REV ECOL SYST, V31, P367, DOI 10.1146/annurev.ecolsys.31.1.367; Garcia-Reyes M, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2011JC007629; Grosbois V, 2008, BIOL REV, V83, P357, DOI 10.1111/j.1469-185X.2008.00047.x; Hatch SA, 2013, MAR ECOL PROG SER, V477, P271, DOI 10.3354/meps10161; Hidalgo M, 2012, P ROY SOC B-BIOL SCI, V279, P275, DOI 10.1098/rspb.2011.0750; Jenouvrier S, 2005, OIKOS, V108, P511, DOI 10.1111/j.0030-1299.2005.13351.x; Jenouvrier S, 2012, GLOBAL CHANGE BIOL, V18, P2756, DOI 10.1111/j.1365-2486.2012.02744.x; Jones NM, 2008, WATERBIRDS, V31, P505; Kao HY, 2009, J CLIMATE, V22, P615, DOI 10.1175/2008JCLI2309.1; Kirby RR, 2009, P ROY SOC B-BIOL SCI, V276, P4095, DOI 10.1098/rspb.2009.1320; Laake J. L., 2013, 201301 AFSC; LARGIER JL, 1993, J GEOPHYS RES-OCEANS, V98, P18147, DOI 10.1029/93JC01074; LEBRETON JD, 1992, ECOL MONOGR, V62, P67, DOI 10.2307/2937171; Litzow MA, 2014, PROG OCEANOGR, V120, P110, DOI 10.1016/j.pocean.2013.08.003; Mann KH, 2006, DYNAMICS MARINE ECOS; Mantua NJ, 1997, B AM METEOROL SOC, V78, P1069, DOI 10.1175/1520-0477(1997)078<1069:APICOW>2.0.CO;2; Marinovic BB, 2002, PROG OCEANOGR, V54, P265, DOI 10.1016/S0079-6611(02)00053-8; McNamara JM, 1996, NATURE, V380, P215, DOI 10.1038/380215a0; McPhaden MJ, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051826; Nevoux M, 2010, ECOLOGY, V91, P2416, DOI 10.1890/09-0143.1; NICHOLS JD, 1994, ECOLOGY, V75, P2052, DOI 10.2307/1941610; Nur N, 1999, BIRD STUDY, V46, P92; Oro D, 2010, ECOLOGY, V91, P1205, DOI 10.1890/09-0939.1; Pardo D, 2013, ECOLOGY, V94, P208, DOI 10.1890/12-0215.1; Piatt JF, 2007, MAR ECOL PROG SER, V352, P221, DOI 10.3354/meps07078; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Robert A, 2012, ECOLOGY, V93, P1944, DOI 10.1890/11-1840.1; Schmidt AE, 2014, MAR ECOL PROG SER, V499, P249, DOI 10.3354/meps10629; SCHREIBER RW, 1984, SCIENCE, V225, P713, DOI 10.1126/science.225.4663.713; Skalski JR, 1996, CAN J FISH AQUAT SCI, V53, P196, DOI 10.1139/cjfas-53-1-196; Sydeman WJ, 2014, SCIENCE, V345, P77, DOI [10.1126/science.1251635, 10.1126/science.1250830]; Sydeman WJ, 2013, GLOBAL CHANGE BIOL, V19, P1662, DOI 10.1111/gcb.12165; van de Pol M, 2010, ECOLOGY, V91, P1192, DOI 10.1890/09-0410.1; Warzybok PM, 2012, POPULATION SIZE REPR; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; WILLIAMS GC, 1966, AM NAT, V100, P687, DOI 10.1086/282461; Wolter K., 1998, WEATHER, V53, P315, DOI DOI 10.1002/J.1477-8696.1998.TB06408.X; Wolter K, 2011, INT J CLIMATOL, V31, P1074, DOI 10.1002/joc.2336; Yeh SW, 2009, NATURE, V461, P511, DOI 10.1038/nature08316; Yokomizo H, 2010, THEOR ECOL-NETH, V3, P53, DOI 10.1007/s12080-009-0053-5; [No title captured]; [No title captured]	57	10	10	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0132372	10.1371/journal.pone.0132372	http://dx.doi.org/10.1371/journal.pone.0132372			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26168050	Green Published, Green Submitted, gold			2022-12-26	WOS:000358193100038
J	Tzeng, TD; Pao, YY; Chen, PC; Weng, FCH; Jean, WD; Wang, D				Tzeng, Tzong-Der; Pao, Yueh-Yang; Chen, Po-Cheng; Weng, Francis Cheng-Hsuan; Jean, Wen Dar; Wang, Daryi			Effects of Host Phylogeny and Habitats on Gut Microbiomes of Oriental River Prawn (Macrobrachium nipponense)	PLOS ONE			English	Article							INTESTINAL MICROBIOTA; COMMUNITIES; SHRIMP; DISEASE; TRACT; FISH; CHIMPANZEES; EXPRESSION; PROBIOTICS; DIVERSITY	The gut microbial community is one of the richest and most complex ecosystems on earth, and the intestinal microbes play an important role in host development and health. Next generation sequencing approaches, which rapidly produce millions of short reads that enable the investigation on a culture independent basis, are now popular for exploring microbial community. Currently, the gut microbiome in fresh water shrimp is unexplored. To explore gut microbiomes of the oriental river prawn (Macrobrachium nipponense) and investigate the effects of host genetics and habitats on the microbial composition, 454 pyrosequencing based on the 16S rRNA gene were performed. We collected six groups of samples, including M. nipponense shrimp from two populations, rivers and lakes, and one sister species (M. asperulum) as an out group. We found that Proteobacteria is the major phylum in oriental river prawn, followed by Firmicutes and Actinobacteria. Compositional analysis showed microbial divergence between the two shrimp species is higher than that between the two populations of one shrimp species collected from river and lake. Hierarchical clustering also showed that host genetics had a greater impact on the divergence of gut microbiome than host habitats. This finding was also congruent with the functional prediction from the metagenomic data implying that the two shrimp species still shared the same type of biological functions, reflecting a similar metabolic profile in their gut environments. In conclusion, this study provides the first investigation of the gut microbiome of fresh water shrimp, and supports the hypothesis of host species-specific signatures of bacterial community composition.	[Tzeng, Tzong-Der] Shu Te Univ, Dept Leisure & Tourism Management, Kaohsiung 824, Taiwan; [Pao, Yueh-Yang; Weng, Francis Cheng-Hsuan; Jean, Wen Dar; Wang, Daryi] Acad Sinica, Biodivers Res Ctr, Taipei 115, Taiwan; [Chen, Po-Cheng] Natl Taiwan Univ, Coll Life Sci, Inst Fisheries Sci, Taipei 106, Taiwan; [Weng, Francis Cheng-Hsuan; Wang, Daryi] Acad Sinica, Taiwan Int Grad Program, Biodivers Program, Taipei 115, Taiwan; [Weng, Francis Cheng-Hsuan; Wang, Daryi] Natl Taiwan Normal Univ, Dept Life Sci, Taipei 116, Taiwan	Shu-Te University; Academia Sinica - Taiwan; National Taiwan University; Academia Sinica - Taiwan; National Taiwan Normal University	Jean, WD (corresponding author), Acad Sinica, Biodivers Res Ctr, Taipei 115, Taiwan.	aredarj001@gmail.com; dywang@gate.sinica.edu.tw			National Science Council of Taiwan [MOST 103-2313-B-001-004]; Sustainability Science Research Project, Academia Sinica	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Sustainability Science Research Project, Academia Sinica	This work was supported by the National Science Council of Taiwan (Grant No: MOST 103-2313-B-001-004), and Sustainability Science Research Project, Academia Sinica. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard K, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008599; Balcazar JL, 2006, VET MICROBIOL, V114, P173, DOI 10.1016/j.vetmic.2006.01.009; Bernstein AM, 2010, CIRCULATION, V122, P876, DOI 10.1161/CIRCULATIONAHA.109.915165; Blaser MJ, 2008, CANCER PREV RES, V1, P15, DOI 10.1158/1940-6207.CAPR-08-0024; Cai Y, 2006, RAFFLES B ZOOL, V54, P25; Chaiyapechara S, 2012, MICROB ECOL, V63, P938, DOI 10.1007/s00248-011-9936-2; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; Degnan PH, 2012, P NATL ACAD SCI USA, V109, P13034, DOI 10.1073/pnas.1110994109; Delsuc F, 2014, MOL ECOL, V23, P1301, DOI 10.1111/mec.12501; DG S., 2006, AQUAT INVASIONS, V1, P5; Durso LM, 2010, APPL ENVIRON MICROB, V76, P4858, DOI 10.1128/AEM.00207-10; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Ezenwa VO, 2012, SCIENCE, V338, P198, DOI 10.1126/science.1227412; Flegel TW, 2012, J INVERTEBR PATHOL, V110, P166, DOI 10.1016/j.jip.2012.03.004; Franzenburg S, 2013, P NATL ACAD SCI USA, V110, pE3730, DOI 10.1073/pnas.1304960110; Gomez GD, 2008, FEMS IMMUNOL MED MIC, V52, P145, DOI 10.1111/j.1574-695X.2007.00343.x; Hamdan LJ, 2008, FEMS MICROBIOL ECOL, V65, P15, DOI 10.1111/j.1574-6941.2008.00507.x; HARRIS JM, 1993, MICROB ECOL, V25, P195, DOI 10.1007/BF00171889; He YD, 2014, J VIROL, V88, P1104, DOI 10.1128/JVI.02455-13; Hooper LV, 2002, ANNU REV NUTR, V22, P283, DOI 10.1146/annurev.nutr.22.011602.092259; Ilmberger N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106707; Kongnum K, 2012, FISH SHELLFISH IMMUN, V32, P170, DOI 10.1016/j.fsi.2011.11.008; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Li K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063139; Li M, 2008, P NATL ACAD SCI USA, V105, P2117, DOI 10.1073/pnas.0712038105; Li XM, 2012, J MICROBIOL, V50, P29, DOI 10.1007/s12275-012-1340-1; Linnenbrink M, 2013, MOL ECOL, V22, P1904, DOI 10.1111/mec.12206; Luz-Agostinho KDG, 2006, NEOTROP ICHTHYOL, V4, P61, DOI 10.1590/S1679-62252006000100005; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Mashiko K, 2000, J CRUSTACEAN BIOL, V20, P118, DOI 10.1651/0278-0372(2000)020[0118:DOPWDS]2.0.CO;2; Mashiko K, 2008, J CRUSTACEAN BIOL, V28, P370, DOI 10.1651/0278-0372(2008)028[0370:DOFMAS]2.0.CO;2; McFall-Ngai M, 2013, P NATL ACAD SCI USA, V110, P3229, DOI 10.1073/pnas.1218525110; Moeller AH, 2013, GENOME RES, V23, P1715, DOI 10.1101/gr.154773.113; Ninawe AS, 2009, CRIT REV MICROBIOL, V35, P43, DOI 10.1080/10408410802667202; Ochman H, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000546; Park SJ, 2014, ANAEROBE, V28, P157, DOI 10.1016/j.anaerobe.2014.06.002; Perez T, 2010, MUCOSAL IMMUNOL, V3, P355, DOI 10.1038/mi.2010.12; Qin CB, 2014, FISH SHELLFISH IMMUN, V40, P267, DOI 10.1016/j.fsi.2014.07.010; Quinn RA, 2013, CAN J MICROBIOL, V59, P380, DOI 10.1139/cjm-2012-0679; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Rungrassamee W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091853; Rungrassamee W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060802; Sartor RB, 2008, GASTROENTEROLOGY, V134, P577, DOI 10.1053/j.gastro.2007.11.059; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sekar R, 2006, APPL ENVIRON MICROB, V72, P5963, DOI 10.1128/AEM.00843-06; Shy JY, 1987, J FISH SOC TAIWAN, V14, P14; Stanley D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084290; Sullam KE, 2015, ISME J, V9, P1508, DOI 10.1038/ismej.2014.231; Thompson FL, 2004, MICROBIOL MOL BIOL R, V68, P403, DOI 10.1128/MMBR.68.3.403-431.2004; Tremaroli V, 2012, NATURE, V489, P242, DOI 10.1038/nature11552; Verschuere L, 2000, MICROBIOL MOL BIOL R, V64, P655, DOI 10.1128/MMBR.64.4.655-671.2000; Wong ACN, 2013, ISME J, V7, P1922, DOI 10.1038/ismej.2013.86; Wong JTY, 1994, AQUACULTURE, V88, P5; Wu HM, 2010, COMPUTATIONAL STAT D, V54, P12; Wu SG, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0040727, 10.1371/journal.pone.0030440]; Xing MX, 2013, FEMS MICROBIOL ECOL, V86, P432, DOI 10.1111/1574-6941.12174; Xu J, 2003, P NATL ACAD SCI USA, V100, P10452, DOI 10.1073/pnas.1734063100; Ye L, 2014, ISME J, V8, P541, DOI 10.1038/ismej.2013.181	60	45	51	0	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0132860	10.1371/journal.pone.0132860	http://dx.doi.org/10.1371/journal.pone.0132860			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26168244	gold, Green Published, Green Submitted			2022-12-26	WOS:000358193100088
J	Ware, EB; Riehle, E; Smith, JA; Zhao, W; Turner, ST; Kardia, SLR; Lieske, JC				Ware, Erin B.; Riehle, Ellen; Smith, Jennifer A.; Zhao, Wei; Turner, Stephen T.; Kardia, Sharon L. R.; Lieske, John C.			SLC2A9 Genotype Is Associated with SLC2A9 Gene Expression and Urinary Uric Acid Concentration	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; RENAL HYPOURICEMIA TYPE-2; CALCIUM STONE DISEASE; UNITED-STATES; KIDNEY-STONES; RISK-FACTORS; URATE; NEPHROLITHIASIS; FREQUENCY; POPULATION	Objectives SLC2A9 gene variants have been associated with urinary uric acid (UA) concentration, but little is known about the functional mechanism linking these gene variants with UA. SLC2A9 encodes a UA transporter present in the proximal tubule of the kidney, and gene expression levels of SLC2A9 and other genes in the uricosuric pathway (ABCG2, SLC17A1, SLC17A3, and SLC22A12) could potentially mediate the relationship between SLC2A9 gene variants and urinary UA excretion. Methods The association between urinary UA concentrations and single nucleotide polymorphisms (SNPs) within the SLC2A9 gene region, expression levels of genes in the uricosuric pathway, and dietary protein intake were analyzed for a sample of non-Hispanic white participants from the Genetic Epidemiology Network of Arteriopathy (GENOA) cohort. The SLC2A9 SNP most significantly associated with urinary UA concentration was then tested for associations with gene expression levels from uric acid absorption/secretion associated genes. Models including interactions between dietary protein (total, animal, and vegetable) and genetic factors were also assessed. Results The most significant SLC2A9 SNP associated with urinary UA (rs12509955, corrected p = 0.001) was also associated with SLC2A9 gene expression levels (corrected p = 0.0084); however, SLC2A9 gene expression levels were not significantly associated with urinary UA concentrations (p = 0.509). The interactions between rs12509955 and total dietary protein, and SLC2A9 gene-level gene expression and dietary vegetable protein on the outcome of urinary UA were marginally significant (p = 0.11 and p = 0.07, respectively). Gene expression level of one SLC2A9 transcript had a significant interaction with dietary animal protein (SLC2A9-001 ENST00000506583, p = 0.01) and a marginally significant interaction with total dietary protein (p = 0.07) on urinary UA. Conclusion Our results illustrate that SNPs in the SLC2A9 gene influence SLC2A9 gene expression as well as urinary UA excretion. Evidence is also suggestive that gene-by-diet interactions may disproportionately increase urinary UA in genetically susceptible individuals that consume higher amounts of protein.	[Ware, Erin B.; Riehle, Ellen; Smith, Jennifer A.; Zhao, Wei; Kardia, Sharon L. R.] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA; [Ware, Erin B.] Univ Michigan, Inst Social Res, Ann Arbor, MI USA; [Turner, Stephen T.; Lieske, John C.] Mayo Clin, Div Nephrol & Hypertens, Rochester, MN USA; [Lieske, John C.] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Mayo Clinic; Mayo Clinic	Kardia, SLR (corresponding author), Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA.	skardia@umich.edu	Turner, Stephen/GXM-4654-2022; Lieske, John/ABA-4829-2020	Ware, Erin/0000-0003-4731-8158; Smith, Jennifer Ann/0000-0002-3575-5468	Mayo Clinic O'Brien Urology Research Center from the National Center for Advancing Translational Sciences (NCATS) [U54 DK100227, UL1 TR000135]; National Institutes of Health;  [R01 DK077950];  [R01 DK073537];  [U01 HL054457];  [R01 HL087660];  [R01 HL119443]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000135] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL119443, U01HL054457, R01HL087660] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U54DK100227, R01DK077950, R01DK073537] Funding Source: NIH RePORTER	Mayo Clinic O'Brien Urology Research Center from the National Center for Advancing Translational Sciences (NCATS); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; ; ; ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by R01 DK077950, R01 DK073537, U01 HL054457, R01 HL087660, R01 HL119443, and the Mayo Clinic O'Brien Urology Research Center U54 DK100227, and Grant Number UL1 TR000135 from the National Center for Advancing Translational Sciences (NCATS), all funded by the National Institutes of Health. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, BAS SAS R CAR; Anzai N, 2012, CLIN EXP NEPHROL, V16, P89, DOI 10.1007/s10157-011-0532-z; Augustin R, 2004, J BIOL CHEM, V279, P16229, DOI 10.1074/jbc.M312226200; COE FL, 1978, KIDNEY INT, V13, P418, DOI 10.1038/ki.1978.60; Cunningham F, 2015, NUCLEIC ACIDS RES, V43, pD662, DOI 10.1093/nar/gku1010; Curhan GC, 1997, J AM SOC NEPHROL, V8, P1568; Dehghan A, 2008, LANCET, V372, P1953, DOI 10.1016/S0140-6736(08)61343-4; Dinour D, 2012, NEPHROL DIAL TRANSPL, V27, P1035, DOI 10.1093/ndt/gfr419; Doring A, 2008, NAT GENET, V40, P430, DOI 10.1038/ng.107; Enomoto A, 2002, NATURE, V417, P447, DOI 10.1038/nature742; Gao XY, 2008, GENET EPIDEMIOL, V32, P361, DOI 10.1002/gepi.20310; Gault MH, 2000, J UROLOGY, V164, P302, DOI 10.1016/S0022-5347(05)67345-4; Giannini S, 1999, AM J CLIN NUTR, V69, P267; Griffin DG, 2004, J CLIN PATHOL, V57, P793, DOI 10.1136/jcp.2003.014886; GROVER PK, 1993, CLIN SCI, V85, P303, DOI 10.1042/cs0850303; GUTMAN AB, 1968, AM J MED, V45, P756, DOI 10.1016/0002-9343(68)90209-X; Hamajima N, 2011, MOL GENET METAB, V103, P378, DOI 10.1016/j.ymgme.2011.04.001; Heilberg IP, 2013, ADV CHRONIC KIDNEY D, V20, P165, DOI 10.1053/j.ackd.2012.12.001; Kawamura Y, 2011, NUCLEOS NUCLEOT NUCL, V30, P1105, DOI 10.1080/15257770.2011.623685; Khitan Z, 2013, J NUTR METAB, V2013, DOI 10.1155/2013/682673; Kirejczyk JK, 2014, J PEDIATR UROL, V10, P130, DOI 10.1016/j.jpurol.2013.07.010; Kottgen A, 2013, NAT GENET, V45, P145, DOI 10.1038/ng.2500; Kuo CF, 2015, ANN RHEUM DIS, V74, P369, DOI 10.1136/annrheumdis-2013-204067; Leonetti F, 1998, NEPHROL DIAL TRANSPL, V13, P617, DOI 10.1093/ndt/13.3.617; Lieske JC, 2014, CLIN J AM SOC NEPHRO, V9, P943, DOI 10.2215/CJN.08210813; Lipkowitz MS, 2012, CURR RHEUMATOL REP, V14, DOI 10.1007/s11926-012-0240-z; MANDEL NS, 1989, J UROLOGY, V142, P1513, DOI 10.1016/S0022-5347(17)39144-9; MCGEOWN MG, 1960, CLIN SCI, V19, P465; Mosli HA, 2013, RES REP UROL, V5, P11, DOI 10.2147/RRU.S39581; Pais VM, 2007, J ENDOUROL, V21, P232, DOI 10.1089/end.2007.2218; PAK CYC, 1977, J CLIN INVEST, V59, P426, DOI 10.1172/JCI108656; Park C, 2010, KOREAN J UROL, V51, P50, DOI 10.4111/kju.2010.51.1.50; Patterson RE, 1999, ANN EPIDEMIOL, V9, P178, DOI 10.1016/S1047-2797(98)00055-6; Polasek O, 2010, CROAT MED J, V51, P48, DOI 10.3325/cmj.2010.51.48; Preitner F, 2013, AM J PHYSIOL-RENAL, V305, pF786, DOI 10.1152/ajprenal.00083.2013; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Reddy ST, 2002, AM J KIDNEY DIS, V40, P265, DOI 10.1053/ajkd.2002.34504; Reginato AM, 2012, NAT REV RHEUMATOL, V8, P610, DOI 10.1038/nrrheum.2012.144; RESNICK M, 1968, NEW ENGL J MED, V278, P1313, DOI 10.1056/NEJM196806132782403; ROBERTSON WG, 1978, BRIT J UROL, V50, P449, DOI 10.1111/j.1464-410X.1978.tb06189.x; Roch-Ramel F, 1999, NEWS PHYSIOL SCI, V14, P80; Rule AD, 2011, RHEUMATOLOGY, V50, P871, DOI 10.1093/rheumatology/keq425; Scales CD, 2012, EUR UROL, V62, P160, DOI 10.1016/j.eururo.2012.03.052; SIERAKOWSKI R, 1978, INVEST UROL, V15, P438; Stiburkova B, 2011, MOL GENET METAB, V102, P430, DOI 10.1016/j.ymgme.2010.12.016; Sull JW, 2013, RHEUMATOL INT, V33, P19, DOI 10.1007/s00296-011-2303-2; Tracy CR, 2014, J UROLOGY, V192, P137, DOI 10.1016/j.juro.2014.01.093; TRINCHIERI A, 1988, J UROLOGY, V139, P478, DOI 10.1016/S0022-5347(17)42497-9; Voruganti VS, 2014, EUR J HUM GENET, V22, P938, DOI 10.1038/ejhg.2013.264; Voruganti Venkata Saroja, 2013, Frontiers in Genetics, V4, P279, DOI 10.3389/fgene.2013.00279; Witkowska K, 2012, AM J PHYSIOL-RENAL, V303, pF527, DOI 10.1152/ajprenal.00134.2012; Wright AF, 2010, KIDNEY INT, V78, P446, DOI 10.1038/ki.2010.206	52	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0128593	10.1371/journal.pone.0128593	http://dx.doi.org/10.1371/journal.pone.0128593			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26167684	Green Published, Green Submitted, gold			2022-12-26	WOS:000358193100002
J	Liang, J; Xu, GR; Xie, J; Lee, I; Xiang, L; Wang, HZ; Zhang, GY; Xie, LP; Zhang, RQ				Liang, Jian; Xu, Guangrui; Xie, Jun; Lee, Ilsun; Xiang, Liang; Wang, Hongzhong; Zhang, Guiyou; Xie, Liping; Zhang, Rongqing			Dual Roles of the Lysine-Rich Matrix Protein (KRMP)-3 in Shell Formation of Pearl Oyster, Pinctada fucata	PLOS ONE			English	Article							PRISMATIC LAYER; FRAMEWORK FORMATION; CARBONIC-ANHYDRASE; NACRE; BIOMINERALIZATION; GENE; IDENTIFICATION; MANTLE; CALCIFICATION; PRISMALIN-14	Matrix proteins play important roles in shell formation. Our group firstly isolated three cDNAs encoding lysine-rich matrix protein from Pinctada fucata in 2006. However, the functions of KRMPs are not fully understood. In addition, KRMPs contain two functional domains, the basic domain and the Gly/Tyr domain respectively. Based on the modular organization, the roles of their two domains were poorly characterized. Furthermore, KRMPs were then reported in other two species, P. maxima and P. margaritifera, which indicated that KRMPs might be very important for shell formation. In this study, the characterization and function of KRMP-3 and its two functional domains were studied in vitro through purification of recombinant glutathione S-transferase tagged KRMP-3 and two KRMP-3 deletion mutants. Western blot and immunofluorescence revealed that native KRMP-3 existed in the EDTA-insoluble matrix of the prismatic layer and was located in the organic sheet and the prismatic sheath. Recombinant KRMP-3 (rKRMP-3) bound tightly to chitin and this binding capacity was duo to the Gly/Tyr-rich region. rKRMP-3 inhibited the precipitation of CaCO3, affected the crystal morphology of calcite and inhibited the growth of aragonite in vitro, which was almost entirely attributed to the lysine-rich region. The results present direct evidence of the roles of KRMP-3 in shell biomineralization. The functional rBR region was found to participate in the growth control of crystals and the rGYR region was responsible to bind to chitin.	[Liang, Jian; Xu, Guangrui; Xie, Jun; Lee, Ilsun; Xiang, Liang; Wang, Hongzhong; Zhang, Guiyou; Xie, Liping; Zhang, Rongqing] Tsinghua Univ, Sch Life Sci, Collaborat Innovat Ctr Deep Sea Biol, Inst Marine Biotechnol, Beijing 100084, Peoples R China; [Xie, Liping; Zhang, Rongqing] Tsinghua Univ, Prot Sci Lab, Minist Educ, Beijing 100084, Peoples R China	Tsinghua University; Tsinghua University	Xie, LP (corresponding author), Tsinghua Univ, Sch Life Sci, Collaborat Innovat Ctr Deep Sea Biol, Inst Marine Biotechnol, Beijing 100084, Peoples R China.	lpxie@mail.tsinghua.edu.cn; rqzhang@mail.tsinghua.edu.cn			National Natural Science Foundation of China [31372502, 31172382]; Independent Research Projects of Tsinghua University [20111080964]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Independent Research Projects of Tsinghua University	This work was supported by the National Natural Science Foundation of China Grants 31372502, 31172382 and Independent Research Projects of Tsinghua University Grant 20111080964.	Aizenberg J, 2003, SCIENCE, V299, P1205, DOI 10.1126/science.1079204; Belcher AM, 1996, NATURE, V381, P56, DOI 10.1038/381056a0; Belton D, 2004, J MATER CHEM, V14, P2231, DOI 10.1039/b401882f; Berland S, 2011, CHEMBIOCHEM, V12, P950, DOI 10.1002/cbic.201000667; Boskey AL, 1998, J CELL BIOCHEM, P83, DOI 10.1002/(SICI)1097-4644(1998)72:30/31+<83::AID-JCB12>3.0.CO;2-F; Currey JD, 1999, J EXP BIOL, V202, P3285; Falini G, 1996, SCIENCE, V271, P67, DOI 10.1126/science.271.5245.67; Fan XX, 2004, PLANT PHYSIOL, V136, P3979, DOI 10.1104/pp.104.046326; Fang D, 2012, J BIOL CHEM, V287, P15776, DOI 10.1074/jbc.M112.341594; Farre B, 2009, COMP BIOCHEM PHYS B, V152, P103, DOI 10.1016/j.cbpb.2008.10.003; Freer A, 2014, MAR BIOTECHNOL, V16, P34, DOI 10.1007/s10126-013-9516-1; Fu G, 2005, BIOMACROMOLECULES, V6, P1289, DOI 10.1021/bm049314v; Gardner LD, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-455; Ghatak AS, 2013, INT J MOL SCI, V14, P11842, DOI 10.3390/ijms140611842; Inoue H, 2001, BIOSCI BIOTECH BIOCH, V65, P1840, DOI 10.1271/bbb.65.1840; Jackson DJ, 2010, MOL BIOL EVOL, V27, P591, DOI 10.1093/molbev/msp278; Kong YW, 2009, J BIOL CHEM, V284, P10841, DOI 10.1074/jbc.M808357200; Liu HL, 2007, BIOCHEMISTRY-US, V46, P844, DOI 10.1021/bi061881a; Lowenstam HA, 1989, BIOMINERALIZATION; Marin F, 2005, MAT SCI ENG C-BIO S, V25, P105, DOI 10.1016/j.msec.2005.01.003; Marin F, 2000, J BIOL CHEM, V275, P20667, DOI 10.1074/jbc.M003006200; Marin F, 2008, CURR TOP DEV BIOL, V80, P209, DOI 10.1016/S0070-2153(07)80006-8; McDougall C, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0041; Miyamoto H, 2005, ZOOL SCI, V22, P311, DOI 10.2108/zsj.22.311; Miyamoto H, 1996, P NATL ACAD SCI USA, V93, P9657, DOI 10.1073/pnas.93.18.9657; Patwardhan SV, 2005, CHEM COMMUN, P1113, DOI 10.1039/b416926c; Ramanathan R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017707; REBERS JE, 1988, J MOL BIOL, V203, P411, DOI 10.1016/0022-2836(88)90009-5; Rebers JE, 2001, INSECT BIOCHEM MOLEC, V31, P1083, DOI 10.1016/S0965-1748(01)00056-X; Shechter A, 2008, P NATL ACAD SCI USA, V105, P7129, DOI 10.1073/pnas.0800193105; Shen XY, 1997, J BIOL CHEM, V272, P32472, DOI 10.1074/jbc.272.51.32472; Simkiss K, 1989, BIOMINERALIZATION CE; Sudo S, 1997, NATURE, V387, P563, DOI 10.1038/42391; Suzuki M, 2004, BIOCHEM J, V382, P205, DOI 10.1042/BJ20040319; Suzuki M, 2007, FEBS J, V274, P5158, DOI 10.1111/j.1742-4658.2007.06036.x; Suzuki M, 2007, BIOSCI BIOTECH BIOCH, V71, P1735, DOI 10.1271/bbb.70140; Suzuki M, 2013, CAN J ZOOL, V91, P349, DOI 10.1139/cjz-2012-0333; Takeuchi T, 2008, FEBS LETT, V582, P591, DOI 10.1016/j.febslet.2008.01.026; Watabe N., 1988, P69; Yan ZG, 2007, BIOMACROMOLECULES, V8, P3597, DOI 10.1021/bm0701494; Yano M, 2006, COMP BIOCHEM PHYS B, V144, P254, DOI 10.1016/j.cbpb.2006.03.004; Zhang C, 2006, MAR BIOTECHNOL, V8, P624, DOI 10.1007/s10126-006-6037-1; Zhang C, 2006, BIOCHEM BIOPH RES CO, V344, P735, DOI 10.1016/j.bbrc.2006.03.179; Zhang Y, 2003, COMP BIOCHEM PHYS B, V135, P565, DOI 10.1016/S1096-4959(03)00138-6	44	31	36	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0131868	10.1371/journal.pone.0131868	http://dx.doi.org/10.1371/journal.pone.0131868			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161976	Green Published, Green Submitted, gold			2022-12-26	WOS:000358162300068
J	Kang, CH; Lee, SY; Park, JH; Lee, Y; Jung, HS; Chi, YH; Jung, YJ; Chae, HB; Shin, MR; Kim, WY; Yun, DJ; Lee, SY				Kang, Chang Ho; Lee, Sun Yong; Park, Joung Hun; Lee, Yuno; Jung, Hyun Suk; Chi, Yong Hun; Jung, Young Jun; Chae, Ho Byoung; Shin, Mi Rim; Kim, Woe Yeon; Yun, Dae-Jin; Lee, Sang Yeol			Stress-driven structural and functional switching of Ypt1p from a GTPase to a molecular chaperone mediates thermo tolerance in Saccharomyces cerevisiae	FASEB JOURNAL			English	Article						heat shock; small GTPase; structural change	PLASMA-MEMBRANE FLUIDITY; HEAT-SHOCK RESPONSE; OXIDATIVE STRESS; EXTREMOPHILIC YEASTS; PROTEIN; THIOREDOXIN; ARABIDOPSIS; REDOX; EXPRESSION; REDUCTASE	Guanosine triphosphatases (GTPases) function as molecular switches in signal transduction pathways that enable cells to respond to extracellular stimuli. Saccharomyces cerevisiae yeast protein two 1 protein (Ypt1p) is a monomeric small GTPase that is essential for endoplasmic reticulum-to-Golgi trafficking. By size-exclusion chromatography, SDS-PAGE, and native PAGE, followed by immunoblot analysis with an anti-Ypt1p antibody, we found that Ypt1p structurally changed from low-molecular-weight (LMW) forms to high-molecular-weight (HMW) complexes after heat shock. Based on our results, Ypt1p exhibited dual functions both as a GTPase and a molecular chaperone, and furthermore, heat shock induced a functional switch from that of a GTPase to a molecular chaperone driven by the structural change from LMW to HMW forms. Subsequently, we found, by using a galactose-inducible expression system, that conditional overexpression of YPT1 in yeast cells enhanced the thermotolerance of cells by increasing the survival rate at 55 degrees C by similar to 60%, compared with the control cells expressing YPT1 in the wild-type level. Altogether, our results suggest that Ypt1p is involved in the cellular protection process under heat stress conditions. Also, these findings provide new insight into the in vivo roles of small GTP-binding proteins and have an impact on research and the investigation of human diseases.	[Kang, Chang Ho; Lee, Sun Yong; Park, Joung Hun; Lee, Yuno; Chi, Yong Hun; Jung, Young Jun; Chae, Ho Byoung; Shin, Mi Rim; Kim, Woe Yeon; Yun, Dae-Jin; Lee, Sang Yeol] Gyeongsang Natl Univ, Div Appl Life Sci, 501 Jinju Daero, Jinju 660701, South Korea; [Kang, Chang Ho; Lee, Sun Yong; Park, Joung Hun; Lee, Yuno; Chi, Yong Hun; Jung, Young Jun; Chae, Ho Byoung; Shin, Mi Rim; Kim, Woe Yeon; Yun, Dae-Jin; Lee, Sang Yeol] Gyeongsang Natl Univ, Plant Mol Biol & Biotechnol Res Ctr, Jinju 660701, South Korea; [Jung, Hyun Suk] Korea Basic Sci Inst, Div Electron Microscop Res, Daejeon, South Korea; [Jung, Hyun Suk] Kangwon Natl Univ, Dept Biochem, Coll Nat Sci, Chunchon, South Korea	Gyeongsang National University; Gyeongsang National University; Korea Basic Science Institute (KBSI); Kangwon National University	Lee, SY (corresponding author), Gyeongsang Natl Univ, Div Appl Life Sci, 501 Jinju Daero, Jinju 660701, South Korea.	sylee@gnu.ac.kr		Yun, Dae-Jin/0000-0002-3638-6043; Kang, Chang Ho/0000-0003-4342-5247	Cooperative Research Program for Agriculture Science and Technology Development; Rural Development Administration [PJ007850]; Basic Science Research Program, through the National Research Foundation, Ministry of Education, Science, and Technology (Seoul, South Korea) [2012R1A1A2044337]	Cooperative Research Program for Agriculture Science and Technology Development(Rural Development Administration (RDA), Republic of Korea); Rural Development Administration(Rural Development Administration (RDA), Republic of Korea); Basic Science Research Program, through the National Research Foundation, Ministry of Education, Science, and Technology (Seoul, South Korea)	This work was supported by funds from the Cooperative Research Program for Agriculture Science and Technology Development, Grant PJ007850 from the Rural Development Administration, and Grant 2012R1A1A2044337 from the Basic Science Research Program, through the National Research Foundation, which is funded by the Ministry of Education, Science, and Technology (Seoul, South Korea).	Adesokan AA, 2004, J MED CHEM, V47, P821, DOI 10.1021/jm0301890; Allakhverdiev SI, 2008, PHOTOSYNTH RES, V98, P529, DOI 10.1007/s11120-008-9334-x; Amoros M, 2001, MOL MICROBIOL, V39, P1523, DOI 10.1046/j.1365-2958.2001.02339.x; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; BOLLAG G, 1995, METHOD ENZYMOL, V255, P161; Braun P, 2003, TRENDS BIOTECHNOL, V21, P383, DOI 10.1016/S0167-7799(03)00189-6; Butterfield DA, 1999, METHOD ENZYMOL, V309, P746; Cai YY, 2008, CELL, V133, P1202, DOI 10.1016/j.cell.2008.04.049; Castells-Roca L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017272; Chae HB, 2013, MOL PLANT, V6, P323, DOI 10.1093/mp/sss105; CHAE HZ, 1994, J BIOL CHEM, V269, P27670; Cheong NE, 1999, PLANT MOL BIOL, V40, P825, DOI 10.1023/A:1006271823973; Clement AB, 2010, FREE RADICAL BIO MED, V48, P1236, DOI 10.1016/j.freeradbiomed.2010.02.008; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DAS KP, 1995, FEBS LETT, V369, P321, DOI 10.1016/0014-5793(95)00775-5; Eathiraj S, 2005, NATURE, V436, P415, DOI 10.1038/nature03798; Feldman DE, 2000, CURR OPIN STRUC BIOL, V10, P26, DOI 10.1016/S0959-440X(99)00044-5; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Gaestel A, 2006, HANDB EXP PHARM, V172, P93; Gao HB, 2008, P NATL ACAD SCI USA, V105, P16398, DOI 10.1073/pnas.0808463105; Gitler AD, 2008, P NATL ACAD SCI USA, V105, P145, DOI 10.1073/pnas.0710685105; Hajheidari M, 2007, J PROTEOME RES, V6, P1451, DOI 10.1021/pr060570j; HENDRICK JP, 1993, ANNU REV BIOCHEM, V62, P349, DOI 10.1146/annurev.bi.62.070193.002025; Jang HH, 2004, CELL, V117, P625, DOI 10.1016/j.cell.2004.05.002; JEDD G, 1995, J CELL BIOL, V131, P583, DOI 10.1083/jcb.131.3.583; Jedd G, 1997, J CELL BIOL, V137, P563, DOI 10.1083/jcb.137.3.563; Jelitto-Van Dooren EPWM, 1999, PLANT CELL, V11, P1935, DOI 10.2307/3871088; Kim KS, 2002, FREE RADICAL BIO MED, V32, P544, DOI 10.1016/S0891-5849(02)00741-4; Langlais C, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-64; Lee JR, 2009, P NATL ACAD SCI USA, V106, P5978, DOI 10.1073/pnas.0811231106; Mandell JG, 2001, PROTEIN ENG, V14, P105, DOI 10.1093/protein/14.2.105; Mayer MP, 2012, CELL, V148, P843, DOI 10.1016/j.cell.2012.02.029; Meissner U, 2007, MICRON, V38, P29, DOI 10.1016/j.micron.2006.04.010; Moraitis C, 2004, YEAST, V21, P313, DOI 10.1002/yea.1078; Park JH, 2011, NEW PHYTOL, V191, P692, DOI 10.1111/j.1469-8137.2011.03734.x; Park SK, 2009, PLANT PHYSIOL, V150, P552, DOI 10.1104/pp.109.135426; Richardson CJ, 1998, MOL CELL BIOL, V18, P827, DOI 10.1128/MCB.18.2.827; Scheper W, 2007, NEUROPATH APPL NEURO, V33, P523, DOI 10.1111/j.1365-2990.2007.00846.x; SEGEV N, 1987, MOL CELL BIOL, V7, P2367, DOI 10.1128/MCB.7.7.2367; Seo HS, 2003, J BIOCHEM MOL BIOL, V36, P196; Sharma KK, 1998, J BIOL CHEM, V273, P8965, DOI 10.1074/jbc.273.15.8965; Slavotinek AM, 2001, TRENDS GENET, V17, P528, DOI 10.1016/S0168-9525(01)02413-1; SPAARGAREN M, 1994, P NATL ACAD SCI USA, V91, P12609, DOI 10.1073/pnas.91.26.12609; Suharsono U, 2002, P NATL ACAD SCI USA, V99, P13307, DOI 10.1073/pnas.192244099; Turk M, 2007, FEMS YEAST RES, V7, P550, DOI 10.1111/j.1567-1364.2007.00209.x; Turk M, 2011, FUNGAL BIOL-UK, V115, P950, DOI 10.1016/j.funbio.2011.04.006; Van der Spoel D., 2006, GROMACS USER MANUAL; VANHEEL M, 1981, ULTRAMICROSCOPY, V6, P187, DOI 10.1016/0304-3991(81)90059-0; Verghese J, 2012, MICROBIOL MOL BIOL R, V76, P115, DOI 10.1128/MMBR.05018-11; Vigh L, 2007, TRENDS BIOCHEM SCI, V32, P357, DOI 10.1016/j.tibs.2007.06.009; Watanabe N, 2008, J BIOL CHEM, V283, P3200, DOI 10.1074/jbc.M706659200; Zhang BL, 2001, J BIOL CHEM, V276, P8958, DOI 10.1074/jbc.M008720200	52	7	7	0	21	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2015	29	11					4424	4434		10.1096/fj.15-270140	http://dx.doi.org/10.1096/fj.15-270140			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CV8EZ	26169936				2022-12-26	WOS:000364514700004
J	Goto, R; Nakamura, Y; Takami, T; Sanke, T; Tozuka, Z				Goto, Rieko; Nakamura, Yasushi; Takami, Tomonori; Sanke, Tokio; Tozuka, Zenzaburo			Quantitative LC-MS/MS Analysis of Proteins Involved in Metastasis of Breast Cancer	PLOS ONE			English	Article							TANDEM MASS-SPECTRA; PEPTIDE-IDENTIFICATION; MATRIX PROTEINS; XIV COLLAGEN; SPECTROMETRY; UNDULIN; SEQUEST; VALIDATION; STRATEGIES; BINDING	The purpose of this study was to develop quantitative liquid chromatography-tandem mass spectrometry (LC-MS/MS) methods for the analysis of proteins involved in metastasis of breast cancer for diagnosis and determining disease prognosis, as well as to further our understand of metastatic mechanisms. We have previously demonstrated that the protein type XIV collagen may be specifically expressed in metastatic tissues by two dimensional LC-MS/MS. In this study, we developed quantitative LC-MS/MS methods for type XIV collagen. Type XIV collagen was quantified by analyzing 2 peptides generated by digesting type XIV collagen using stable isotope-labeled peptides. The individual concentrations were equivalent between 2 different peptides of type XIV collagen by evaluation of imprecise transitions and using the best transition for the peptide concentration. The results indicated that type XIV collagen is highly expressed in metastatic tissues of patients with massive lymph node involvement compared to non-metastatic tissues. These findings were validated by quantitative real-time RT-PCR. Further studies on type XIV collagen are desired to verify its role as a prognostic factor and diagnosis marker for metastasis.	[Goto, Rieko; Nakamura, Yasushi; Sanke, Tokio] Wakayama Med Univ, Dept Clin Lab Med, Wakayama, Japan; [Goto, Rieko; Takami, Tomonori] JCL Bioassay Corp, Nishiwaki, Hyogo, Japan; [Tozuka, Zenzaburo] Osaka Univ, Grad Sch Pharmaceut Sci, Suita, Osaka, Japan	Wakayama Medical University; Osaka University	Goto, R (corresponding author), Wakayama Med Univ, Dept Clin Lab Med, Wakayama, Japan.	r.goto@jclbio.com			JCL Bioassay Corporation, Nishiwaki, Hyogo, Japan	JCL Bioassay Corporation, Nishiwaki, Hyogo, Japan	JCL Bioassay Corporation, Nishiwaki, Hyogo, Japan provided support in the form of salaries for authors RG & TT, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbatiello SE, 2010, CLIN CHEM, V56, P291, DOI 10.1373/clinchem.2009.138420; Addona TA, 2009, NAT BIOTECHNOL, V27, P633, DOI 10.1038/nbt.1546; Amelinckx A, 2009, J PROTEOME RES, V8, P3727, DOI 10.1021/pr900294g; Anderson DC, 2003, J PROTEOME RES, V2, P137, DOI 10.1021/pr0255654; Anderson NL, 2004, J PROTEOME RES, V3, P235, DOI 10.1021/pr034086h; Bengtsson E, 2002, J BIOL CHEM, V277, P15061, DOI 10.1074/jbc.M108285200; Dings PJM, 2013, ANN SURG ONCOL, V20, P2607, DOI 10.1245/s10434-013-2932-7; Ehnis T, 1996, EXP CELL RES, V229, P388, DOI 10.1006/excr.1996.0384; Elias JE, 2004, NAT BIOTECHNOL, V22, P214, DOI 10.1038/nbt930; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; GERECKE DR, 1993, J BIOL CHEM, V268, P12177; Goto R, 2014, J WAKAYAMA MED SOC, V65, P84; Goto R, 2006, PCT application, Patent No. [PCT/JP2006/325008, 2006325008]; Kamiie J, 2008, PHARM RES-DORDR, V25, P1469, DOI 10.1007/s11095-008-9532-4; Keshishian H, 2007, MOL CELL PROTEOMICS, V6, P2212, DOI 10.1074/mcp.M700354-MCP200; Kiyonami R, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.002931; LOHR M, 1994, BRIT J CANCER, V69, P144, DOI 10.1038/bjc.1994.24; Lopez-Ferrer D, 2004, ANAL CHEM, V76, P6853, DOI 10.1021/ac049305c; Mathupala SP, 2010, BBA-BIOENERGETICS, V1797, P1225, DOI 10.1016/j.bbabio.2010.03.025; Matuszewski BK, 2003, ANAL CHEM, V75, P3019, DOI 10.1021/ac020361s; Nakamura Y, 2003, CLIN CANCER RES, V9, P5313; Nakamura Y, US patent publication, Patent No. [8030014 (B2), 8030014]; Nakamura Y, EP patent publication, Patent No. [1962094 (A1), 1962094]; NEMOTO T, 1980, CANCER, V45, P2917, DOI 10.1002/1097-0142(19800615)45:12<2917::AID-CNCR2820451203>3.0.CO;2-M; Prakash C, 2007, MASS SPECTROM REV, V26, P340, DOI 10.1002/mas.20128; Razumovskaya J, 2004, PROTEOMICS, V4, P961, DOI 10.1002/pmic.200300656; Reiter L, 2011, NAT METHODS, V8, P430, DOI [10.1038/NMETH.1584, 10.1038/nmeth.1584]; Remane D, 2010, RAPID COMMUN MASS SP, V24, P3103, DOI 10.1002/rcm.4736; Rifai N, 2006, NAT BIOTECHNOL, V24, P971, DOI 10.1038/nbt1235; Rosano C, 1999, STRUCT FOLD DES, V7, P1427, DOI 10.1016/S0969-2126(00)80032-5; Savitski MM, 2005, MOL CELL PROTEOMICS, V4, P1180, DOI 10.1074/mcp.T500009-MCP200; SCHUPPAN D, 1990, J BIOL CHEM, V265, P8823; Troyanovsky B, 2001, J CELL BIOL, V152, P1247, DOI 10.1083/jcb.152.6.1247; TRUEB J, 1992, EUR J BIOCHEM, V207, P549, DOI 10.1111/j.1432-1033.1992.tb17081.x; Wells CD, 2006, CELL, V125, P535, DOI 10.1016/j.cell.2006.02.045	35	12	12	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0130760	10.1371/journal.pone.0130760	http://dx.doi.org/10.1371/journal.pone.0130760			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176947	Green Submitted, Green Published, gold			2022-12-26	WOS:000358197600026
J	Gworek, B; Dmuchowski, W; Gozdowski, D; Koda, E; Osiecka, R; Borzyszkowski, J				Gworek, Barbara; Dmuchowski, Wojciech; Gozdowski, Dariusz; Koda, Eugeniusz; Osiecka, Renata; Borzyszkowski, Jan			Influence of a Municipal Waste Landfill on the Spatial Distribution of Mercury in the Environment	PLOS ONE			English	Article							CONTAMINATION; SOIL; ACCUMULATION; ATMOSPHERE; LEACHATES; TRANSPORT; EMPHASIS; EXCHANGE; SURFACE; WATER	The study investigations were focused on assessing the influence of a 35-year-old municipal waste landfill on environmental mercury pollution. The total Hg content was determined in the soil profile, groundwater, and the plants (Solidago virgaurea and Poaceae sp.) in the landfill area. Environmental pollution near the landfill was relatively low. The topsoil layer, groundwater and the leaves of Solidago virgaurea and Poaceae sp. contained 19-271 mu g kg(-1), 0.36-3.01 mu g l(-1), 19-66 mu g kg(-1) and 8-29 mu g kg(-1) of Hg, respectively. The total Hg content in the soil decreased with the depth. The results are presented as pollution maps of the landfill area based on the total Hg content in the soil, groundwater and plants. Statistical analysis revealed the lack of correlation between the total Hg content in the soil and plants, but a relationship between the total concentration of Hg in groundwater and soil was shown. The landfill is not a direct source of pollution in the area. The type of land morphology did not influence the pollution level. Construction of bentonite cut-off wall bypassing MSW landfill reduces the risk of mercury release into ground-water environment.	[Gworek, Barbara; Osiecka, Renata; Borzyszkowski, Jan] Natl Res Inst, Inst Environm Protection, Warsaw, Poland; [Gworek, Barbara; Dmuchowski, Wojciech; Gozdowski, Dariusz; Koda, Eugeniusz] Warsaw Univ Life Sci SGGW, Warsaw, Poland; [Dmuchowski, Wojciech] Polish Acad Sci, Bot Garden Ctr Biol Div Conservat, Warsaw, Poland	Institute of Environmental Protection - National Research Institute; Warsaw University of Life Sciences; Polish Academy of Sciences	Dmuchowski, W (corresponding author), Warsaw Univ Life Sci SGGW, Warsaw, Poland.	w.dmuchowski@obpan.pl		Gozdowski, Dariusz/0000-0002-7365-7607; Gworek, Barbara/0000-0002-2368-5888; Koda, Eugeniusz/0000-0002-3895-960X				AMAP/UNEP, 2008, GLOBAL MERCURY ASSES; Barringer JL, 2013, WATER AIR SOIL POLL, V224, DOI 10.1007/s11270-013-1475-7; Barzi F, 1996, CONTAMINANTS AND THE SOIL ENVIRONMENT IN THE AUSTRALASIA-PACIFIC REGION, P451; Birke M., 2011, MAPPING CHEM ENV URB, P245, DOI DOI 10.1002/9780470670071.CH17; Boszke L, 2008, ENVIRON GEOL, V55, P1075, DOI 10.1007/s00254-007-1056-4; CARPI A, 1994, J AIR WASTE MANAGE, V44, P669; Cheng HF, 2012, ENVIRON SCI TECHNOL, V46, P593, DOI 10.1021/es2026517; Christensen TH, 2001, APPL GEOCHEM, V16, P659, DOI 10.1016/S0883-2927(00)00082-2; De Temmerman L, 2007, ENVIRON POLLUT, V146, P458, DOI 10.1016/j.envpol.2006.07.002; Ding ZH, 2007, J ENVIRON SCI, V19, P200, DOI 10.1016/S1001-0742(07)60032-1; Dryzalowska A, 2014, ECOTOX ENVIRON SAFE, V107, P97, DOI 10.1016/j.ecoenv.2014.05.020; Earle CDA, 1999, WASTE MANAGE RES, V17, P305, DOI 10.1034/j.1399-3070.1999.00047.x; Ericksen JA, 2006, SCI TOTAL ENVIRON, V366, P851, DOI 10.1016/j.scitotenv.2005.08.019; Falkowska L, 2013, OCEANOL HYDROBIOL ST, V42, P99, DOI 10.2478/s13545-013-0064-0; Fay L, 2007, WATER AIR SOIL POLL, V181, P373, DOI 10.1007/s11270-006-9308-6; Feng XB, 2009, MERCURY FATE AND TRANSPORT IN THE GLOBAL ATMOSPHERE, P67, DOI 10.1007/978-0-387-93958-2_3; Fitzgerald WF, 2005, TREATISE ON GEOCHEMISTRY, VOL 9: ENVIRONMENTAL GEOCHEMISTRY, P107; Golimowski J, 2001, ANN WARSAW AGR U LAN, V32, P17; Gray JE, 2015, ENVIRON GEOCHEM HLTH, V37, P35, DOI 10.1007/s10653-014-9628-1; Ilgen G, 2008, WASTE MANAGE, V28, P1518, DOI 10.1016/j.wasman.2007.06.020; Kabata-Pendias A, 2010, TRACE ELEMENTS SOILS, Vfourth, DOI [DOI 10.1201/B10158, 10.1201/9781420039900]; Khatiwada NR, 2002, WATER SCI TECHNOL, V46, P147, DOI 10.2166/wst.2002.0226; Koda E, 2012, POL J ENVIRON STUD, V21, P929; Kowalski A, 2007, POL J ENVIRON STUD, V16, P67; KRABBENHOFT DP, 1992, WATER RESOUR RES, V28, P3119, DOI 10.1029/92WR01766; Kulikowska D, 2008, BIORESOURCE TECHNOL, V99, P5981, DOI 10.1016/j.biortech.2007.10.015; Li P, 2009, J HAZARD MATER, V168, P591, DOI 10.1016/j.jhazmat.2009.03.031; LIS J, 2005, POL GEOL I SPEC PAPE, V17, P42; Lodenius Martin, 1994, P343; Loska K, 2004, ENVIRON INT, V30, P159, DOI 10.1016/S0160-4120(03)00157-0; Matejczyk M, 2011, CHEMOSPHERE, V82, P1017, DOI 10.1016/j.chemosphere.2010.10.066; Mukherjee AB, 2004, RESOUR CONSERV RECY, V42, P155, DOI 10.1016/j.resconrec.2004.02.009; Mukherjee AB, 2009, MERCURY FATE AND TRANSPORT IN THE GLOBAL ATMOSPHERE, P81, DOI 10.1007/978-0-387-93958-2_4; MURPHY EA, 1994, WATER AIR SOIL POLL, V78, P61, DOI 10.1007/BF00475668; Niu ZC, 2013, ENVIRON SCI POLLUT R, V20, P6337, DOI 10.1007/s11356-013-1691-0; Olivero-Verbel J, 2008, ECOTOX ENVIRON SAFE, V70, P294, DOI 10.1016/j.ecoenv.2007.05.016; Ottesen RT, 2013, APPL GEOCHEM, V33, P1, DOI 10.1016/j.apgeochem.2012.12.013; Oygard JK, 2004, WATER RES, V38, P2851, DOI 10.1016/j.watres.2004.03.036; Pirrone N, 2010, ATMOS CHEM PHYS, V10, P5951, DOI 10.5194/acp-10-5951-2010; Salminen R., 2005, GEOCHEMICAL ATLAS EU; SCHUSTER E, 1991, WATER AIR SOIL POLL, V56, P667, DOI 10.1007/BF00342308; SUSZCYNSKY EM, 1995, ENVIRON TOXICOL CHEM, V14, P61, DOI 10.1002/etc.5620140108; [汤庆合 Tang Qinghe], 2003, [城市环境与城市生态, Urban Environment and Urban Ecology], V16, P15; Tomiyasu T, 2004, ENV SCI, V12, P231; Tsarpali V, 2012, J HAZARD MATER, V233, P163, DOI 10.1016/j.jhazmat.2012.07.007; US EPA, 2005, NAT EM INV NEI; Zhang L, 2007, ENVIRON INT, V33, P108, DOI 10.1016/j.envint.2006.06.022; Zhang XM, 2006, SCI TOTAL ENVIRON, V368, P713, DOI 10.1016/j.scitotenv.2006.01.037; Zhu W, 2013, ATMOS ENVIRON, V79, P188, DOI 10.1016/j.atmosenv.2013.05.083	49	24	25	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0133130	10.1371/journal.pone.0133130	http://dx.doi.org/10.1371/journal.pone.0133130			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176607	gold, Green Submitted, Green Published			2022-12-26	WOS:000358197600217
J	Juel, HB; Faber, C; Munthe-Fog, L; Bastrup-Birk, S; Reese-Petersen, AL; Falk, MK; Singh, A; Sorensen, TL; Garred, P; Nissen, MH				Juel, Helene Baek; Faber, Carsten; Munthe-Fog, Lea; Bastrup-Birk, Simone; Reese-Petersen, Alexander Lynge; Falk, Mads Krueger; Singh, Amardeep; Sorensen, Torben Lykke; Garred, Peter; Nissen, Mogens Holst			Systemic and Ocular Long Pentraxin 3 in Patients with Age-Related Macular Degeneration	PLOS ONE			English	Article							COMPLEMENT FACTOR-H; C-REACTIVE PROTEIN; VISUAL IMPAIRMENT; PLASMA-LEVELS; DRUSEN; ACTIVATION; EXPRESSION; BIOMARKERS; BINDING; CELLS	Age-related macular degeneration (AMD) has been associated with both systemic and ocular alterations of the immune system. In particular dysfunction of complement factor H (CFH), a soluble regulator of the alternative pathway of the complement system, has been implicated in AMD pathogenesis. One of the ligands for CFH is long pentraxin 3 (PTX3), which is produced locally in the retinal pigment epithelium (RPE). To test the hypothesis that PTX3 is relevant to retinal immunohomeostasis and may be associated with AMD pathogenesis, we measured plasma PTX3 protein concentration and analyzed the RPE/choroid PTX3 gene expression in patients with AMD. To measure the ability of RPE cells to secrete PTX3 in vitro, polarized ARPE-19 cells were treated with activated T cells or cytokines (interferon (IFN)-gamma and/or tumor necrosis factor (TNF)-alpha) from the basolateral side; then PTX3 protein concentration in supernatants and PTX3 gene expression in tissue lysates were quantified. Plasma levels of PTX3 were generally low and did not significantly differ between patients and controls (P=0.307). No statistically significant difference was observed between dry and exudative AMD nor was there any correlation with hsCRP or CFH genotype. The gene expression of PTX3 increased in RPE/choroid with age (P=0.0098 macular; P=0.003 extramacular), but did not differ between aged controls and AMD patients. In vitro, ARPE-19 cells increased expression of the PTX3 gene as well PTX3 apical secretions after stimulation with TNF-alpha or activated T cells (P<0.01). These findings indicate that PTX3 expressed in the eye cannot be detected systemically and systemic PTX3 may have little or no impact on disease progression, but our findings do not exclude that locally produced PTX3 produced in the posterior segment of the eye may be part of the AMD immunopathogenesis.	[Juel, Helene Baek; Faber, Carsten; Reese-Petersen, Alexander Lynge; Nissen, Mogens Holst] Univ Copenhagen, Dept Int Hlth Immunol & Microbiol, Eye Res Unit, Copenhagen, Denmark; [Faber, Carsten] Glostrup Cty Hosp, Dept Ophthalmol, Glostrup, Denmark; [Munthe-Fog, Lea; Bastrup-Birk, Simone; Garred, Peter] Copenhagen Univ Hosp, Dept Clin Immunol, Mol Med Lab, Rigshosp, Copenhagen, Denmark; [Falk, Mads Krueger; Singh, Amardeep; Sorensen, Torben Lykke] Copenhagen Univ Hosp, Dept Ophthalmol, Roskilde, Denmark; [Sorensen, Torben Lykke] Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen; University of Copenhagen	Faber, C (corresponding author), Univ Copenhagen, Dept Int Hlth Immunol & Microbiol, Eye Res Unit, Copenhagen, Denmark.	carstenfaber@gmail.com	Singh, Amardeep/ABI-4544-2020; Faber, Carsten/N-3210-2019; Juel, Helene/AAD-2843-2020; Faber, Carsten/I-4150-2013; Nissen, Mogens/B-4825-2008; Bastrup-Birk, Annemarie/K-1937-2016	Faber, Carsten/0000-0002-2517-7270; Faber, Carsten/0000-0002-2517-7270; Nissen, Mogens/0000-0001-7729-8667; Munthe-Fog, Lea/0000-0003-1345-176X; Juel, Helene B/0000-0002-5763-8545; Bastrup Israelsen, Simone/0000-0002-0653-1289; Garred, Peter/0000-0002-2876-8586; Bastrup-Birk, Annemarie/0000-0002-8405-8538	Lundbeck Foundation; Danish Eye Research Foundation; Fight for Sight Denmark; Rigshospitalet; Medical Research Council; Novo Nordisk Research Foundation	Lundbeck Foundation(Lundbeckfonden); Danish Eye Research Foundation; Fight for Sight Denmark; Rigshospitalet; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Novo Nordisk Research Foundation(Novo Nordisk Foundation)	This work was funded by The Lundbeck Foundation, The Danish Eye Research Foundation, Fight for Sight Denmark, Rigshospitalet, The Medical Research Council, and The Novo Nordisk Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansari M, 2013, HUM MOL GENET, V22, P4857, DOI 10.1093/hmg/ddt336; Bastrup-Birk S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073119; Brantley MA, 2012, AM J OPHTHALMOL, V153, P460, DOI 10.1016/j.ajo.2011.08.033; Buch H, 2004, OPHTHALMOLOGY, V111, P53, DOI 10.1016/j.ophtha.2003.05.010; Clark SJ, 2013, J IMMUNOL, V190, P2049, DOI 10.4049/jimmunol.1201751; Crabb JW, 2002, P NATL ACAD SCI USA, V99, P14682, DOI 10.1073/pnas.222551899; Deban L, 2008, J IMMUNOL, V181, P8433, DOI 10.4049/jimmunol.181.12.8433; Doni A, 2012, IMMUNOBIOLOGY, V217, P1122, DOI 10.1016/j.imbio.2012.07.004; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Faber C, 2013, OPHTHALMOLOGY, V120, P2310, DOI 10.1016/j.ophtha.2013.04.014; Faber C, 2012, INVEST OPHTH VIS SCI, V53, P6324, DOI 10.1167/iovs.12-10385; Hageman GS, 2001, PROG RETIN EYE RES, V20, P705, DOI 10.1016/S1350-9462(01)00010-6; Hecker LA, 2010, HUM MOL GENET, V19, P209, DOI 10.1093/hmg/ddp472; Hong T, 2011, SURV OPHTHALMOL, V56, P184, DOI 10.1016/j.survophthal.2010.08.007; Johnson LV, 2001, EXP EYE RES, V73, P887, DOI 10.1006/exer.2001.1094; Juel HB, 2012, INVEST OPHTH VIS SCI, V53, P8472, DOI 10.1167/iovs.12-9963; Juel HB, 2011, EXP EYE RES, V92, P180, DOI 10.1016/j.exer.2011.01.003; Katta S, 2009, J GENET, V88, P425, DOI 10.1007/s12041-009-0064-4; Khandhadia S, 2012, IMMUNOBIOLOGY, V217, P127, DOI 10.1016/j.imbio.2011.07.019; Laine M, 2007, J IMMUNOL, V178, P3831, DOI 10.4049/jimmunol.178.6.3831; Le Fur I, 2010, NEUROBIOL AGING, V31, P165, DOI 10.1016/j.neurobiolaging.2008.03.003; Lee HW, 2011, MOVEMENT DISORD, V26, P2364, DOI 10.1002/mds.23871; Lindekleiv H, 2013, ACTA OPHTHALMOL, V91, P307, DOI 10.1111/j.1755-3768.2012.02399.x; Mihlan M, 2009, CELL DEATH DIFFER, V16, P1630, DOI 10.1038/cdd.2009.103; Miller JW, 2013, AM J OPHTHALMOL, V155, P1, DOI 10.1016/j.ajo.2012.10.018; Mullins RF, 2000, FASEB J, V14, P835, DOI 10.1096/fasebj.14.7.835; Newman AM, 2012, GENOME MED, V4, DOI [10.1186/PREACCEPT-1418491035586234, 10.1186/gm315]; Noma H, 2014, RETINA-J RET VIT DIS, V34, P352, DOI 10.1097/IAE.0b013e3182993d74; Nozaki M, 2006, P NATL ACAD SCI USA, V103, P2328, DOI 10.1073/pnas.0408835103; Okemefuna AI, 2010, J BIOL CHEM, V285, P1053, DOI 10.1074/jbc.M109.044529; Resnikoff S, 2004, B WORLD HEALTH ORGAN, V82, P844; Reynolds R, 2009, INVEST OPHTH VIS SCI, V50, P5818, DOI 10.1167/iovs.09-3928; Robman L, 2010, OPHTHALMOLOGY, V117, P1982, DOI 10.1016/j.ophtha.2010.02.003; Rodrigues EB, 2007, OPHTHALMOLOGICA, V221, P143, DOI 10.1159/000099293; Russell SR, 2000, AM J OPHTHALMOL, V129, P205, DOI 10.1016/S0002-9394(99)00345-1; Scholl HPN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002593; Seddon JM, 2006, OPHTHALMOLOGY, V113, P260, DOI 10.1016/j.ophtha.2005.11.001; Shimada Y, 2014, MOD RHEUMATOL, V24, P78, DOI 10.3109/14397595.2013.852837; Singh A, 2012, AM J OPHTHALMOL, V154, P193, DOI 10.1016/j.ajo.2012.01.036; Smailhodzic D, 2012, OPHTHALMOLOGY, V119, P339, DOI 10.1016/j.ophtha.2011.07.056; Sofat R, 2010, ATHEROSCLEROSIS, V213, P184, DOI 10.1016/j.atherosclerosis.2010.07.021; Trouw LA, 2011, CLIN EXP IMMUNOL, V166, P333, DOI 10.1111/j.1365-2249.2011.04482.x; Uusitalo-Seppala R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053661; Wang HH, 2013, MULT SCLER J, V19, P926, DOI 10.1177/1352458512457845; Wang L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010329; Weismann D, 2011, NATURE, V478, P76, DOI 10.1038/nature10449; Woo JM, 2013, MOL VIS, V19, P303; Xu HP, 2009, PROG RETIN EYE RES, V28, P348, DOI 10.1016/j.preteyeres.2009.06.001	48	11	11	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132800	10.1371/journal.pone.0132800	http://dx.doi.org/10.1371/journal.pone.0132800			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176960	Green Submitted, Green Published, gold			2022-12-26	WOS:000358197600161
J	Tan, SY; Jiang, QY; Zhuo, F; Liu, H; Wang, YT; Li, SS; Ye, ZH; Jing, YX				Tan, Shi-Yun; Jiang, Qiu-Yun; Zhuo, Feng; Liu, Hui; Wang, Yu-Tao; Li, Shao-Shan; Ye, Zhi-Hong; Jing, Yuan-Xiao			Effect of Inoculation with Glomus versiforme on Cadmium Accumulation, Antioxidant Activities and Phytochelatins of Solanum photeinocarpum	PLOS ONE			English	Article							ARBUSCULAR MYCORRHIZAL FUNGI; HEAVY-METAL TOLERANCE; CD-HYPERACCUMULATOR; CONTAMINATED SOILS; HYDROGEN-PEROXIDE; POLLUTED SOILS; L.; GLUTATHIONE; GROWTH; PLANTS	The plant growth, phosphate acquisition, Cd translocation, phytochelatins (PCs) production and antioxidant parameters [superoxide dismutase (SOD), catalase (CAT), guaiacol peroxidase (POD), ascorbate peroxidase (APX), glutathione reductase (GR), glutathione (GSH), ascorbate (ASA) and malonaldehyde (MDA)] were investigated in Cd-hyperaccumulator Solanum photeinocarpum inoculated with Glomus versiforme BGC GD01C (Gv) in Cd-added soils (0, 5, 10, 20, 40 mg Cd kg(-1) soil). Mycorrhizal colonization rates were generally high (from 77% to 94%), and hardly affected by Cd. Gv colonization significantly enhanced P acquisition, growth and total Cd uptakes in both shoots and roots of S. photeinocarpum at all Cd levels. Meanwhile, Gv symbiosis significantly increased Cd concentration in the roots, and decreased Cd concentration in the shoots at all Cd levels, which indicates that Gv could promote phytostabilization by enhancing Cd accumulation in the roots to inhibit its translocation to shoots and the "dilution effects" linked to an increase in plant dry matter yield and a reduced Cd partitioning to shoots. Moreover, the improvement of CAT, POD and APX activities in the leaves of mycorrhizal plants infers that Gv symbiosis helped S. photeinocarpum to relieve oxidative damage to biomolecules in Cd-contaminated soil. The evident decline of MDA content in the leaves of mycorrhizal plants indicates that Gv symbiosis evidently improved antioxidant activities, and the enhancement of PCs production in the leaves of mycorrhizal plants suggests that Gv-inoculated plant may be more efficient to relieve Cd phytotoxicity. Therefore, the possible mechanisms of Cd phytotoxicity alleviation by Gv can be concluded as the decline of Cd concentration in the shoots and the improvement of P acquisition, PCs production and activities of CAT, POD, APX in mycorrhizal plants.	[Tan, Shi-Yun; Jiang, Qiu-Yun; Zhuo, Feng; Liu, Hui; Wang, Yu-Tao; Li, Shao-Shan; Jing, Yuan-Xiao] S China Normal Univ, Coll Life Sci, Key Lab Ecol & Environm Sci Guangdong Higher Educ, Guangzhou, Guangdong, Peoples R China; [Ye, Zhi-Hong] Sun Yat Sen Univ, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China; [Ye, Zhi-Hong] Sun Yat Sen Univ, Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China	South China Normal University; Sun Yat Sen University; Sun Yat Sen University	Jing, YX (corresponding author), S China Normal Univ, Coll Life Sci, Key Lab Ecol & Environm Sci Guangdong Higher Educ, Guangzhou, Guangdong, Peoples R China.	jingyx@scnu.edu.cn			Guangzhou Science and Technology Program [201510010056, 2014J4100053]; Guangdong Natural Science Foundation of China [S2013010012969]	Guangzhou Science and Technology Program; Guangdong Natural Science Foundation of China(National Natural Science Foundation of Guangdong Province)	The work was supported by the Guangzhou Science and Technology Program (201510010056; 2014J4100053) (http://www.gzsi.gov.cn/) and the Guangdong Natural Science Foundation of China (S2013010012969) (http://pro.gdstc.gov.cn/egrantweb/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adediran GA, 2015, J HAZARD MATER, V283, P490, DOI 10.1016/j.jhazmat.2014.09.064; Aebi H, 1984, METHOD ENZYMOL, V6, P105, DOI DOI 10.1016/S0076-6879(84)05016-3; Amir H, 2013, MYCORRHIZA, V23, P585, DOI 10.1007/s00572-013-0499-6; Andrade SAL, 2010, ENVIRON EXP BOT, V68, P198, DOI 10.1016/j.envexpbot.2009.11.009; Azcon R, 2009, APPL SOIL ECOL, V41, P168, DOI 10.1016/j.apsoil.2008.10.008; Arias MSB, 2015, INT J PHYTOREMEDIAT, V17, P405, DOI 10.1080/15226514.2014.898023; BEYER WF, 1987, ANAL BIOCHEM, V161, P559, DOI 10.1016/0003-2697(87)90489-1; Bhargava P, 2005, J PLANT PHYSIOL, V162, P1220, DOI 10.1016/j.jplph.2004.12.006; Bissonnette L, 2010, PLANT SOIL, V332, P55, DOI 10.1007/s11104-009-0273-x; Bolan N, 2014, J HAZARD MATER, V266, P141, DOI 10.1016/j.jhazmat.2013.12.018; CARLBERG I, 1985, METHOD ENZYMOL, V113, P484; Carvalho LM, 2006, PLANT SOIL, V285, P161, DOI 10.1007/s11104-006-9001-y; Chan WF, 2013, J HAZARD MATER, V262, P1116, DOI 10.1016/j.jhazmat.2012.08.020; Chen BD, 2005, ENVIRON SCI POLLUT R, V12, P325, DOI 10.1065/espr2005.06.267; Chen LH, 2015, ECOTOX ENVIRON SAFE, V113, P460, DOI 10.1016/j.ecoenv.2014.12.033; Degola F, 2014, PLANT CELL PHYSIOL, V55, P1884, DOI 10.1093/pcp/pcu117; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Garg N, 2013, J AGRON CROP SCI, V199, P118, DOI 10.1111/j.1439-037X.2012.00533.x; Garg N, 2012, J PLANT GROWTH REGUL, V31, P292, DOI 10.1007/s00344-011-9239-3; Garg N, 2012, PLANT GROWTH REGUL, V66, P9, DOI 10.1007/s10725-011-9624-8; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; Giovannetti M., 1980, New Phytologist, V84, P489, DOI 10.1111/j.1469-8137.1980.tb04556.x; Gupta M, 1998, CHEMOSPHERE, V37, P785, DOI 10.1016/S0045-6535(98)00073-3; HANSON WC, 1950, J SCI FOOD AGR, V1, P172, DOI 10.1002/jsfa.2740010604; He HD, 2013, CHEMOSPHERE, V90, P1960, DOI 10.1016/j.chemosphere.2012.10.057; HEATH RL, 1968, ARCH BIOCHEM BIOPHYS, V125, P189, DOI 10.1016/0003-9861(68)90654-1; Hildebrandt U, 2007, PHYTOCHEMISTRY, V68, P139, DOI 10.1016/j.phytochem.2006.09.023; HISSIN PJ, 1976, ANAL BIOCHEM, V74, P214, DOI 10.1016/0003-2697(76)90326-2; Hu JL, 2014, SCI REP-UK, V4, DOI 10.1038/srep04671; Hu JL, 2013, CHEMOSPHERE, V93, P1359, DOI 10.1016/j.chemosphere.2013.07.089; Jarrah M, 2014, BIOREMEDIAT J, V18, P71, DOI 10.1080/10889868.2013.847401; Jemo M, 2014, SOIL BIOL BIOCHEM, V79, P117, DOI 10.1016/j.soilbio.2014.09.014; Jia L, 2013, ECOTOXICOLOGY, V22, P476, DOI 10.1007/s10646-013-1041-5; Jimenez A, 1997, PLANT PHYSIOL, V114, P275, DOI 10.1104/pp.114.1.275; Kaldorf M, 1999, J PLANT PHYSIOL, V154, P718, DOI 10.1016/S0176-1617(99)80250-8; Latef AAHA, 2011, MYCORRHIZA, V21, P495, DOI 10.1007/s00572-010-0360-0; LAW MY, 1983, BIOCHEM J, V210, P899, DOI 10.1042/bj2100899; Leyval C, 1997, MYCORRHIZA, V7, P139, DOI 10.1007/s005720050174; Liu H, 2015, APPL SOIL ECOL, V89, P44, DOI 10.1016/j.apsoil.2015.01.006; MAEHLY AC, 1954, METHOD BIOCHEM ANAL, V1, P357; Mani D, 2014, INT J ENVIRON SCI TE, V11, P843, DOI 10.1007/s13762-013-0299-8; Meharg AA, 2000, ADV ECOL RES, V30, P69, DOI 10.1016/S0065-2504(08)60017-3; Meier S, 2015, J PLANT NUTR SOIL SC, V178, P126, DOI 10.1002/jpln.201400092; Meier S, 2012, CRIT REV ENV SCI TEC, V42, P741, DOI 10.1080/10643389.2010.528518; Muhling KH, 2003, PLANT SOIL, V253, P219, DOI 10.1023/A:1024517919764; NAKANO Y, 1981, PLANT CELL PHYSIOL, V22, P867; NIELSEN JD, 1983, PLANT SOIL, V70, P165, DOI 10.1007/BF02374777; Orlowska E, 2011, ENVIRON POLLUT, V159, P3730, DOI 10.1016/j.envpol.2011.07.008; PHILLIPS JM, 1970, T BRIT MYCOL SOC, V55, P158, DOI 10.1016/S0007-1536(70)80110-3; Rozpadek P, 2014, CHEMOSPHERE, V112, P217, DOI 10.1016/j.chemosphere.2014.04.023; Singh P, 2014, PLANT PHYSIOL BIOCH, V83, P180, DOI 10.1016/j.plaphy.2014.07.018; Southam CM, 1943, PHYTOPATHOLOGY, V33, P517; Sun RL, 2007, ENVIRON EXP BOT, V60, P468, DOI 10.1016/j.envexpbot.2007.01.004; Trotta A, 2006, CHEMOSPHERE, V65, P74, DOI 10.1016/j.chemosphere.2006.02.048; Vazquez S, 2009, PLANT PHYSIOL BIOCH, V47, P63, DOI 10.1016/j.plaphy.2008.09.010; Vodnik D, 2008, SCI TOTAL ENVIRON, V392, P130, DOI 10.1016/j.scitotenv.2007.11.016; Wei Y, 2014, APPL SOIL ECOL, V82, P11, DOI 10.1016/j.apsoil.2014.05.005; Wu Y, 2014, AQUAT TOXICOL, V148, P122, DOI 10.1016/j.aquatox.2014.01.005; Yuan M, 2014, CHEMOSPHERE, V103, P99, DOI 10.1016/j.chemosphere.2013.11.040; Zan NR, 2013, ENVIRON MONIT ASSESS, V185, P10015, DOI 10.1007/s10661-013-3309-x; Zenk MH, 1996, GENE, V179, P21, DOI 10.1016/S0378-1119(96)00422-2; Zhang XF, 2011, J HAZARD MATER, V189, P414, DOI 10.1016/j.jhazmat.2011.02.053; Zhong WL, 2012, J ENVIRON MONITOR, V14, P2497, DOI 10.1039/c2em30333g	63	33	36	4	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132347	10.1371/journal.pone.0132347	http://dx.doi.org/10.1371/journal.pone.0132347			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176959	Green Published, gold, Green Submitted			2022-12-26	WOS:000358197600101
J	Gradidge, PJL; Norris, SA; Micklesfield, LK; Crowther, NJ				Gradidge, Philippe Jean-Luc; Norris, Shane A.; Micklesfield, Lisa K.; Crowther, Nigel J.			The Role of Lifestyle and Psycho-Social Factors in Predicting Changes in Body Composition in Black South African Women	PLOS ONE			English	Article							NORTH-WEST PROVINCE; PHYSICAL-ACTIVITY; MASS INDEX; HEALTH; DRINKING; OBESITY; IMAGE; WEIGHT; PERCEPTIONS; TRANSITION	Background This study aimed to determine whether lifestyle and psycho-social factors determine changes in body composition over 10 years in a population of black African females with a high prevalence of obesity. Materials and Methods Data were collected from 430 women at baseline and 10-year follow-up. Dual energy x-ray absorptiometry-derived body fat mass and fat free soft tissue mass, and simple anthropometric measures were taken at both time points. Data on physical activity (PA), diet, smoking, and alcohol intake were collected at baseline. Body size dissatisfaction and body size discrepancy were determined at baseline using the feel minus ideal (FID) index and the perceived minus actual weight status discrepancy score (PAD), respectively. Results All body composition measurements increased over 10 years (p<0.0005). Two distinct groups of overweight/obese females were identified using PAD and FID: one that was content with their body size and one that wished to be leaner. Vigorous PA at baseline was inversely associated with absolute changes in all measures of adiposity. In subjects who underestimated their body size at baseline (74.0% of the study population) changes in total and peripheral levels of body fat were less than in subjects who correctly identified their body size. In the group that underestimated body size, more women wanted to be leaner than in the group who knew their body size (60.1% vs 47.5%, p<0.05). Conclusions Underestimation of body size is common and is associated with a lower gain in total body adiposity and a prevalent desire to lose weight.	[Gradidge, Philippe Jean-Luc] Univ Witwatersrand, Ctr Exercise Sci & Sports Med, Fac Hlth Sci, Johannesburg, South Africa; [Gradidge, Philippe Jean-Luc; Norris, Shane A.; Micklesfield, Lisa K.] Univ Witwatersrand, Wits Dev Pathways Hlth Res Unit, MRC, Fac Hlth Sci, Johannesburg, South Africa; [Crowther, Nigel J.] Univ Witwatersrand, Dept Chem Pathol, Natl Hlth Lab Serv, Fac Hlth Sci, Johannesburg, South Africa	University of Witwatersrand; University of Witwatersrand; National Health Laboratory Service; University of Witwatersrand	Gradidge, PJL (corresponding author), Univ Witwatersrand, Ctr Exercise Sci & Sports Med, Fac Hlth Sci, Johannesburg, South Africa.	philippe.gradidge@wits.ac.za	Gradidge, Philippe/ABE-4070-2020; Gradidge, Philippe/R-5183-2017; Norris, Shane/C-4664-2014; Micklesfield, Lisa/AAR-8262-2021	Gradidge, Philippe/0000-0001-5225-1184; Gradidge, Philippe/0000-0001-5225-1184; Norris, Shane/0000-0001-7124-3788; Micklesfield, Lisa/0000-0002-4994-0779; Crowther, Nigel/0000-0002-5766-1745	Wellcome Trust (UK)	Wellcome Trust (UK)(Wellcome Trust)	This research was supported financially by the Wellcome Trust (UK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American College of Sports Medicine, 2010, ACSMS GUID EX TEST P; [Anonymous], STATISTICA; [Anonymous], 2014, J PSYCHIAT, DOI DOI 10.4172/1994-8220.1000101; Bull FC, 2009, J PHYS ACT HEALTH, V6, P790, DOI 10.1123/jpah.6.6.790; CHESLER JULIA, 1961, S AFRICAN MED JOUR, V35, P129; Chiolero A, 2008, AM J CLIN NUTR, V87, P801, DOI 10.1093/ajcn/87.4.801; Cook I, 2012, J PHYS ACT HEALTH, V9, P300, DOI 10.1123/jpah.9.2.300; Crowther NJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048883; Dorn JM, 2003, J NUTR, V133, P2655, DOI 10.1093/jn/133.8.2655; Fitzgibbon ML, 2000, OBES RES, V8, P582, DOI 10.1038/oby.2000.75; Gitau TM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109709; Griffiths PL, 2008, ARCH DIS CHILD, V93, P862, DOI 10.1136/adc.2006.112649; Guthold R, 2008, AM J PREV MED, V34, P486, DOI 10.1016/j.amepre.2008.02.013; Guthold R, 2011, AM J PREV MED, V41, P52, DOI 10.1016/j.amepre.2011.03.008; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; Irving BA, 2008, MED SCI SPORT EXER, V40, P1863, DOI 10.1249/MSS.0b013e3181801d40; Kruger H Salome, 2003, Cardiovasc J S Afr, V14, P16; Kruger HS, 2001, BRIT J NUTR, V86, P733, DOI 10.1079/BJN2001469; Letamo G, 2011, J BIOSOC SCI, V43, P75, DOI 10.1017/S0021932010000519; MacIntyre UE, 2002, NUTR RES, V22, P239, DOI 10.1016/S0271-5317(01)00392-X; Malyutina S, 2002, LANCET, V360, P1448, DOI 10.1016/S0140-6736(02)11470-X; Matoti-Mvalo T, 2011, S AFR J CLIN NUTR, V24, P40; Mayosi BM, 2009, LANCET, V374, P934, DOI 10.1016/S0140-6736(09)61087-4; Mchiza ZJ, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-433; Mciza Z, 2005, PUBLIC HEALTH NUTR, V8, P509, DOI [10.1097/PHN2005814, 10.1079/PHN2005814]; Mfenyana K, 2006, SAMJ S AFR MED J, V96, P323; Mozaffarian D, 2011, NEW ENGL J MED, V364, P2392, DOI 10.1056/NEJMoa1014296; Mvo Z, 1999, Curationis, V22, P27; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Peer N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043336; Philipsen A, 2015, MED SCI SPORT EXER, V47, P983, DOI 10.1249/MSS.0000000000000504; Puoane T, 2005, S AFR J CLIN NUTR, V18, P6; Puoane T, 2002, OBES RES, V10, P1038, DOI 10.1038/oby.2002.141; Puoane T, 2010, ETHNIC DIS, V20, P29; Richter LM, 2004, PAEDIATR PERINAT EP, V18, P290, DOI 10.1111/j.1365-3016.2004.00572.x; Senekal M, 2003, ETHNIC DIS, V13, P109; Shisana O, 2013, S AFRICAN NATL HLTH; Skelton DA, 2008, ADV SPORTS EXERCISE; Steyn NP, 2011, SCAND J PUBLIC HEALT, V39, P88, DOI 10.1177/1403494810384426; Stunkard A J, 1983, Res Publ Assoc Res Nerv Ment Dis, V60, P115; Tolstrup JS, 2008, AM J CLIN NUTR, V87, P957, DOI 10.1093/ajcn/87.4.957; Tolstrup JS, 2005, INT J OBESITY, V29, P490, DOI 10.1038/sj.ijo.0802874; Zaccagni L, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-42	43	17	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132914	10.1371/journal.pone.0132914	http://dx.doi.org/10.1371/journal.pone.0132914			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26171972	gold, Green Published, Green Submitted			2022-12-26	WOS:000358194900100
J	Dumpala, PR; Peterson, BC; Lawrence, ML; Karsi, A				Dumpala, Pradeep R.; Peterson, Brian C.; Lawrence, Mark L.; Karsi, Attila			Identification of Differentially Abundant Proteins of Edwardsiella ictaluri during Iron Restriction	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEINS; ESCHERICHIA-COLI; CHANNEL CATFISH; PSEUDOMONAS-AERUGINOSA; VIBRIO-CHOLERAE; SMALL RNA; EXTRACELLULAR PRODUCTS; PUNCTATUS RAFINESQUE; PATHOGENIC BACTERIA; ENTERIC SEPTICEMIA	Edwardsiella ictaluri is a Gram-negative facultative anaerobe intracellular bacterium that causes enteric septicemia in channel catfish. Iron is an essential inorganic nutrient of bacteria and is crucial for bacterial invasion. Reduced availability of iron by the host may cause significant stress for bacterial pathogens and is considered a signal that leads to significant alteration in virulence gene expression. However, the precise effect of iron-restriction on E. ictaluri protein abundance is unknown. The purpose of this study was to identify differentially abundant proteins of E. ictaluri during in vitro iron-restricted conditions. We applied two-dimensional difference in gel electrophoresis (2D-DIGE) for determining differentially abundant proteins and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI TOF/TOF MS) for protein identification. Gene ontology and pathway-based functional modeling of differentially abundant proteins was also conducted. A total of 50 unique differentially abundant proteins at a minimum of 2-fold (p <= 0.05) difference in abundance due to iron-restriction were detected. The numbers of up-and down-regulated proteins were 37 and 13, respectively. We noted several proteins, including EsrB, LamB, MalM, MalE, FdaA, and TonB-dependent heme/hemoglobin receptor family proteins responded to iron restriction in E. ictaluri.	[Dumpala, Pradeep R.] Rogosin Inst, Xenia Div, Xenia, OH USA; [Peterson, Brian C.] USDA ARS, Warmwater Aquaculture Res Unit, Thad Cochran Natl Warmwater Aquaculture Ctr, Stoneville, MS 38776 USA; [Lawrence, Mark L.; Karsi, Attila] Mississippi State Univ, Coll Vet Med, Dept Basic Sci, Mississippi State, MS 39762 USA	United States Department of Agriculture (USDA); Mississippi State University	Karsi, A (corresponding author), Mississippi State Univ, Coll Vet Med, Dept Basic Sci, Mississippi State, MS 39762 USA.	a.karsi@msstate.edu	Karsi, Attila/AAG-5046-2019	Karsi, Attila/0000-0001-6845-3346	United States Department of Agriculture; College of Veterinary Medicine; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103476] Funding Source: NIH RePORTER	United States Department of Agriculture(United States Department of Agriculture (USDA)); College of Veterinary Medicine; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank the United States Department of Agriculture and College of Veterinary Medicine for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelhamed H, 2013, VET MICROBIOL, V162, P858, DOI 10.1016/j.vetmic.2012.11.006; AINSWORTH AJ, 1990, DEV COMP IMMUNOL, V14, P201, DOI 10.1016/0145-305X(90)90091-R; Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; Antiabong JF, 2015, GENE, V563, P94, DOI 10.1016/j.gene.2015.03.017; Arias CR, 2003, J FISH DIS, V26, P415, DOI 10.1046/j.1365-2761.2003.00475.x; Bader JA, 2004, FISH SHELLFISH IMMUN, V16, P415, DOI 10.1016/j.fsi.2003.07.003; Baldwin Thomas J., 1993, Journal of Aquatic Animal Health, V5, P189, DOI 10.1577/1548-8667(1993)005&lt;0189:POESOC&gt;2.3.CO;2; BINDEREIF A, 1985, J BACTERIOL, V162, P1039, DOI 10.1128/JB.162.3.1039-1046.1985; Binns D, 2009, BIOINFORMATICS, V25, P3045, DOI 10.1093/bioinformatics/btp536; BJORN MJ, 1978, INFECT IMMUN, V19, P785, DOI 10.1128/IAI.19.3.785-791.1978; BJORN MJ, 1979, J BACTERIOL, V138, P193, DOI 10.1128/JB.138.1.193-200.1979; Braun V, 2001, INT J MED MICROBIOL, V291, P67, DOI 10.1078/1438-4221-00103; Caldas TD, 1998, J BIOL CHEM, V273, P11478, DOI 10.1074/jbc.273.19.11478; CALDERWOOD SB, 1987, J BACTERIOL, V169, P4759, DOI 10.1128/jb.169.10.4759-4764.1987; Chaudhary A, 2007, TOXICOL APPL PHARM, V220, P197, DOI 10.1016/j.taap.2006.12.030; Cooper Richard K. Ii, 1996, Journal of Aquatic Animal Health, V8, P319, DOI 10.1577/1548-8667(1996)008&lt;0319:UOAMTT&gt;2.3.CO;2; DAVIES RL, 1992, J GEN MICROBIOL, V138, P909, DOI 10.1099/00221287-138-5-909; DUBOS RJ, 1946, J EXP MED, V84, P143, DOI 10.1084/jem.84.2.143; Dumpala PR, 2009, PROTEOMICS, V9, P1353, DOI 10.1002/pmic.200800652; DYER DW, 1988, INFECT IMMUN, V56, P977, DOI 10.1128/IAI.56.4.977-983.1988; Ernst FD, 2005, J BACTERIOL, V187, P3687, DOI 10.1128/JB.187.11.3687-3692.2005; Ferguson AD, 2007, P NATL ACAD SCI USA, V104, P513, DOI 10.1073/pnas.0609887104; Gaballa A, 2008, P NATL ACAD SCI USA, V105, P11927, DOI 10.1073/pnas.0711752105; Gardy JL, 2005, BIOINFORMATICS, V21, P617, DOI 10.1093/bioinformatics/bti057; GOLDBERG MB, 1990, INFECT IMMUN, V58, P55, DOI 10.1128/IAI.58.1.55-60.1990; Griffiths E, 1999, IRON REGULATORY SIGN; HAWKE JP, 1981, INT J SYST BACTERIOL, V31, P396, DOI 10.1099/00207713-31-4-396; Jacobsen I, 2005, INFECT IMMUN, V73, P226, DOI 10.1128/IAI.73.1.226-234.2005; Jung YS, 2008, CURR MICROBIOL, V57, P593, DOI 10.1007/s00284-008-9248-z; Kaplan J, 2006, BBA-MOL CELL RES, V1763, P646, DOI 10.1016/j.bbamcr.2006.03.008; Kneidinger B, 2002, J BACTERIOL, V184, P363, DOI 10.1128/JB.184.2.363-369.2002; Koebnik R, 2005, TRENDS MICROBIOL, V13, P343, DOI 10.1016/j.tim.2005.06.005; Kunert A, 2007, J IMMUNOL, V179, P2979, DOI 10.4049/jimmunol.179.5.2979; Lawrence ML, 2003, MICROBIOL-SGM, V149, P1409, DOI 10.1099/mic.0.26138-0; Lawrence ML, 2001, J AQUAT ANIM HEALTH, V13, P291, DOI 10.1577/1548-8667(2001)013&lt;0291:PAVOAT&gt;2.0.CO;2; Lawrence ML, 1997, INFECT IMMUN, V65, P4642, DOI 10.1128/IAI.65.11.4642-4651.1997; Lee Y, 2009, FEMS MICROBIOL LETT, V297, P38, DOI 10.1111/j.1574-6968.2009.01650.x; Lenco J, 2007, FEMS MICROBIOL LETT, V269, P11, DOI 10.1111/j.1574-6968.2006.00595.x; Ling E, 2004, CLIN EXP IMMUNOL, V138, P290, DOI 10.1111/j.1365-2249.2004.02628.x; LITWIN CM, 1993, CLIN MICROBIOL REV, V6, P137, DOI 10.1128/CMR.6.2.137-149.1993; Madsen ML, 2006, MICROBIOL-SGM, V152, P937, DOI 10.1099/mic.0.28674-0; Masse E, 2005, TRENDS BIOCHEM SCI, V30, P462, DOI 10.1016/j.tibs.2005.06.005; Masse E, 2005, J BACTERIOL, V187, P6962, DOI 10.1128/JB.187.20.6962-6971.2005; McCarthy FM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-229; McHugh JP, 2003, J BIOL CHEM, V278, P29478, DOI 10.1074/jbc.M303381200; Mey AR, 2005, INFECT IMMUN, V73, P8167, DOI 10.1128/IAI.73.12.8167-8178.2005; MIYAZAKI T, 1985, J FISH DIS, V8, P389, DOI 10.1111/j.1365-2761.1985.tb00961.x; Moore MM, 2002, DIS AQUAT ORGAN, V52, P93, DOI 10.3354/dao052093; NEWTON JC, 1989, J FISH DIS, V12, P335, DOI 10.1111/j.1365-2761.1989.tb00322.x; NEWTON JC, 1990, AM J VET RES, V51, P211; Newton Joseph C., 1993, Journal of Aquatic Animal Health, V5, P246, DOI 10.1577/1548-8667(1993)005&lt;0246:EAICOL&gt;2.3.CO;2; Payne Shelley M., 1993, Trends in Microbiology, V1, P66, DOI 10.1016/0966-842X(93)90036-Q; POOLE K, 1993, J BACTERIOL, V175, P4597, DOI 10.1128/JB.175.15.4597-4604.1993; Ratledge C, 2000, ANNU REV MICROBIOL, V54, P881, DOI 10.1146/annurev.micro.54.1.881; Sabri M, 2006, MICROBIOL-SGM, V152, P745, DOI 10.1099/mic.0.28682-0; Santander J, 2012, INFECT IMMUN, V80, P2689, DOI 10.1128/IAI.00013-12; SCIORTINO CV, 1983, INFECT IMMUN, V42, P990, DOI 10.1128/IAI.42.3.990-996.1983; Sheldon JR, 2014, MOL MICROBIOL, V92, P824, DOI 10.1111/mmi.12593; SHOTTS EB, 1986, CAN J FISH AQUAT SCI, V43, P36, DOI 10.1139/f86-005; SIGEL SP, 1982, J BACTERIOL, V150, P148, DOI 10.1128/JB.150.1.148-155.1982; Skirpstunas RT, 2003, J AQUAT ANIM HEALTH, V15, P92, DOI 10.1577/1548-8667(2003)015&lt;0092:AAASOM&gt;2.0.CO;2; Stanley L. A., 1994, Journal of Aquatic Animal Health, V6, P36, DOI 10.1577/1548-8667(1994)006&lt;0036:EPAWVA&gt;2.3.CO;2; STOEBNER JA, 1988, INFECT IMMUN, V56, P2891, DOI 10.1128/IAI.56.11.2891-2895.1988; Subramanian K, 2008, J APPL MICROBIOL, V105, P715, DOI 10.1111/j.1365-2672.2008.03800.x; Timms P, 2009, J MICROBIOL IMMUNOL, V42, P27; Vasil ML, 2007, BIOMETALS, V20, P587, DOI 10.1007/s10534-006-9067-2; Vassinova N, 2000, MICROBIOL-SGM, V146, P3171, DOI 10.1099/00221287-146-12-3171; VINITNANTHARAT S, 1993, FISH SHELLFISH IMMUN, V3, P401, DOI 10.1006/fsim.1993.1040; WALTMAN WD, 1986, APPL ENVIRON MICROB, V51, P101, DOI 10.1128/AEM.51.1.101-104.1986; Wang QY, 2008, ARCH MICROBIOL, V190, P595, DOI 10.1007/s00203-008-0407-1; Wang X, 2009, FISH SHELLFISH IMMUN, V27, P469, DOI 10.1016/j.fsi.2009.06.013; Wang YF, 1997, J MOL BIOL, V272, P56, DOI 10.1006/jmbi.1997.1224; WEETE JD, 1988, CAN J MICROBIOL, V34, P1224, DOI 10.1139/m88-215; WEINBERG ED, 1993, PERSPECT BIOL MED, V36, P215; Wilderman PJ, 2004, P NATL ACAD SCI USA, V101, P9792, DOI 10.1073/pnas.0403423101; Williams ML, 2005, VET MICROBIOL, V108, P281, DOI 10.1016/j.vetmic.2005.04.017; Williams ML, 2003, J AQUAT ANIM HEALTH, V15, P264, DOI 10.1577/H03-051.1; YOUNG CC, 1991, J BACTERIOL, V173, P3096, DOI 10.1128/JB.173.10.3096-3100.1991; YU F, 1986, J BIOL CHEM, V261, P2284; Yu J, 1999, MICROBES INFECT, V1, P1221, DOI 10.1016/S1286-4579(99)00239-7; Zhang DF, 2008, INT J ANTIMICROB AG, V32, P315, DOI 10.1016/j.ijantimicag.2008.04.015	81	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0132504	10.1371/journal.pone.0132504	http://dx.doi.org/10.1371/journal.pone.0132504			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26168192	Green Published, Green Submitted, gold			2022-12-26	WOS:000358193100047
J	Driebe, EM; Sahl, JW; Roe, C; Bowers, JR; Schupp, JM; Gillece, JD; Kelley, E; Price, LB; Pearson, TR; Hepp, CM; Brzoska, PM; Cummings, CA; Furtado, MR; Andersen, PS; Stegger, M; Engelthaler, DM; Keim, PS				Driebe, Elizabeth M.; Sahl, Jason W.; Roe, Chandler; Bowers, Jolene R.; Schupp, James M.; Gillece, John D.; Kelley, Erin; Price, Lance B.; Pearson, Talima R.; Hepp, Crystal M.; Brzoska, Pius M.; Cummings, Craig A.; Furtado, Manohar R.; Andersen, Paal S.; Stegger, Marc; Engelthaler, David M.; Keim, Paul S.			Using Whole Genome Analysis to Examine Recombination across Diverse Sequence Types of Staphylococcus aureus	PLOS ONE			English	Article							PANTON-VALENTINE LEUKOCIDIN; HORIZONTAL GENE-TRANSFER; MOLECULAR CLOCK; UNITED-STATES; COMMUNITY; VIRULENCE; EVOLUTION; EMERGENCE; PREVALENCE; SOFTWARE	Staphylococcus aureus is an important clinical pathogen worldwide and understanding this organism's phylogeny and, in particular, the role of recombination, is important both to understand the overall spread of virulent lineages and to characterize outbreaks. To further elucidate the phylogeny of S. aureus, 35 diverse strains were sequenced using whole genome sequencing. In addition, 29 publicly available whole genome sequences were included to create a single nucleotide polymorphism (SNP)-based phylogenetic tree encompassing 11 distinct lineages. All strains of a particular sequence type fell into the same clade with clear groupings of the major clonal complexes of CC8, CC5, CC30, CC45 and CC1. Using a novel analysis method, we plotted the homoplasy density and SNP density across the whole genome and found evidence of recombination throughout the entire chromosome, but when we examined individual clonal lineages we found very little recombination. However, when we analyzed three branches of multiple lineages, we saw intermediate and differing levels of recombination between them. These data demonstrate that in S. aureus, recombination occurs across major lineages that subsequently expand in a clonal manner. Estimated mutation rates for the CC8 and CC5 lineages were different from each other. While the CC8 lineage rate was similar to previous studies, the CC5 lineage was 100-fold greater. Fifty known virulence genes were screened in all genomes in silico to determine their distribution across major clades. Thirty-three genes were present variably across clades, most of which were not constrained by ancestry, indicating horizontal gene transfer or gene loss.	[Driebe, Elizabeth M.; Sahl, Jason W.; Roe, Chandler; Bowers, Jolene R.; Schupp, James M.; Gillece, John D.; Kelley, Erin; Price, Lance B.; Engelthaler, David M.; Keim, Paul S.] Translat Genom Res Inst, Pathogen Genom Div, Flagstaff, AZ 85004 USA; [Pearson, Talima R.; Hepp, Crystal M.; Keim, Paul S.] No Arizona Univ, Ctr Microbial Genet & Genom, Flagstaff, AZ 86011 USA; [Brzoska, Pius M.; Cummings, Craig A.; Furtado, Manohar R.] Thermo Fisher Sci, San Francisco, CA USA; [Andersen, Paal S.; Stegger, Marc] Statens Serum Inst, Microbiol & Infect Control, DK-2300 Copenhagen, Denmark	Translational Genomics Research Institute; Northern Arizona University; Thermo Fisher Scientific; Statens Serum Institut	Driebe, EM (corresponding author), Translat Genom Res Inst, Pathogen Genom Div, Flagstaff, AZ 85004 USA.	edriebe@tgen.org	Pearson, Talima/O-7840-2019; Andersen, Paal Skytt/H-2087-2015	Pearson, Talima/0000-0003-3696-041X; Andersen, Paal Skytt/0000-0001-5656-0427; , Jason/0000-0002-2497-0138; Stegger, Marc/0000-0003-0321-1180; Furtado, Manohar/0000-0001-6016-1357	NIH R01 [R01AI090782]; NIH U01 [AI066581]; Thermo Fisher Scientific (Life Technologies); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI101371, R01AI090782, U01AI066581] Funding Source: NIH RePORTER	NIH R01(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH U01(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Thermo Fisher Scientific (Life Technologies); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding for this work was provided in part by NIH R01 grant R01AI090782 and NIH U01 grant AI066581, http://www.niaid.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Thermo Fisher Scientific (Life Technologies) provided support in the form of salaries for authors PMB, CAC and MRF, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [Anonymous], 1961, BMJ-BRIT MED J, V1, P113; [Anonymous], 2014, TRACER V1 6; Bae IG, 2009, J CLIN MICROBIOL, V47, P3952, DOI 10.1128/JCM.01643-09; Baele G, 2013, MOL BIOL EVOL, V30, P239, DOI 10.1093/molbev/mss243; Baele G, 2012, MOL BIOL EVOL, V29, P2157, DOI 10.1093/molbev/mss084; Brauner J, 2013, EUR J CLIN MICROBIOL, V32, P613, DOI 10.1007/s10096-012-1784-6; Chambers HF, 2009, NAT REV MICROBIOL, V7, P629, DOI 10.1038/nrmicro2200; Chua K, 2010, J BACTERIOL, V192, P5556, DOI 10.1128/JB.00878-10; Chua KYL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025887; Coombs GW, 2009, COMMUN DIS INTELL, V33, P10; Diep BA, 2006, J INFECT DIS, V193, P1495, DOI 10.1086/503777; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; Diep BA, 2008, TRENDS MICROBIOL, V16, P361, DOI 10.1016/j.tim.2008.05.002; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Everitt RG, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4956; Faria NR, 2014, SCIENCE, V346, P56, DOI 10.1126/science.1256739; Feil EJ, 2003, J BACTERIOL, V185, P3307, DOI 10.1128/JB.185.11.3307-3316.2003; Gelman A, 1998, STAT SCI, V13, P163; Gorwitz RJ, 2008, J INFECT DIS, V197, P1226, DOI 10.1086/533494; Gray RR, 2011, MOL BIOL EVOL, V28, P1593, DOI 10.1093/molbev/msq319; Hanssen AM, 2005, J CLIN MICROBIOL, V43, P2118, DOI 10.1128/JCM.43.5.2118-2124.2005; Harris SR, 2010, SCIENCE, V327, P469, DOI 10.1126/science.1182395; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hendriksen RS, 2011, MBIO, V2, DOI [10.1128/mBio.00157-11, 10.1128/mBio.00305-11]; Holden MTG, 2013, GENOME RES, V23, P653, DOI 10.1101/gr.147710.112; Holden MTG, 2010, J BACTERIOL, V192, P888, DOI 10.1128/JB.01255-09; Holt DC, 2011, GENOME BIOL EVOL, V3, P881, DOI 10.1093/gbe/evr078; Homer N, 2009, PLOS ONE, V4, pA95, DOI 10.1371/journal.pone.0007767; Jackson CR, 2013, J CLIN MICROBIOL, V51, P1199, DOI 10.1128/JCM.03166-12; Kennedy AD, 2008, P NATL ACAD SCI USA, V105, P1327, DOI 10.1073/pnas.0710217105; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kuroda M, 2001, LANCET, V357, P1225, DOI 10.1016/S0140-6736(00)04403-2; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Larsen AR, 2008, CLIN MICROBIOL INFEC, V14, P611, DOI 10.1111/j.1469-0691.2008.01995.x; Lattar SM, 2012, EUR J CLIN MICROBIOL, V31, P2559, DOI 10.1007/s10096-012-1596-8; Li M, 2009, P NATL ACAD SCI USA, V106, P5883, DOI 10.1073/pnas.0900743106; Lindsay Jodi A., 2006, Functional & Integrative Genomics, V6, P186, DOI 10.1007/s10142-005-0019-7; Long SW, 2014, MBIO, V5, DOI 10.1128/mBio.01692-14; McCarthy AJ, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00006; McCarthy AJ, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-104; McDougal LK, 2003, J CLIN MICROBIOL, V41, P5113, DOI 10.1128/JCM.41.11.5113-5120.2003; Monecke S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017936; Moore CL, 2010, J CLIN MICROBIOL, V48, P2307, DOI 10.1128/JCM.00409-10; Moore PCL, 2001, J CLIN MICROBIOL, V39, P2760, DOI 10.1128/JCM.39.8.2760-2767.2001; Nubel U, 2008, P NATL ACAD SCI USA, V105, P14130, DOI 10.1073/pnas.0804178105; Nubel U, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000855; Pasquale TR, 2013, INT J INFECT DIS, V17, pE398, DOI 10.1016/j.ijid.2012.12.013; Pearson T, 2013, SYST BIOL, V62, P752, DOI 10.1093/sysbio/syt038; Rasko DA, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-2; Robinson DA, 2004, J BACTERIOL, V186, P1060, DOI 10.1128/JB.186.4.1060-1064.2004; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Sahl JW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054287; Sanderson MJ, 1996, HOMOPLASY RECURRENCE, Vxxv; Sanguinetti L, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002668; Stam-Bolink EM, 2007, EUR J CLIN MICROBIOL, V26, P723, DOI 10.1007/s10096-007-0352-y; Sung JML, 2007, ANTIMICROB AGENTS CH, V51, P2189, DOI 10.1128/AAC.01442-06; Takuno S, 2012, MOL BIOL EVOL, V29, P797, DOI 10.1093/molbev/msr249; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tenover FC, 2012, ANTIMICROB AGENTS CH, V56, P1324, DOI 10.1128/AAC.05804-11; Tenover FC, 2009, J CLIN MICROBIOL, V47, P2452, DOI 10.1128/JCM.00476-09; Vandenesch F, 2003, EMERG INFECT DIS, V9, P978; Varshney AK, 2009, APPL ENVIRON MICROB, V75, P6839, DOI 10.1128/AEM.00272-09; Voyich JM, 2006, J INFECT DIS, V194, P1761, DOI 10.1086/509506; Waldron DE, 2006, J BACTERIOL, V188, P5578, DOI 10.1128/JB.00418-06; Witte W, 2005, EUR J CLIN MICROBIOL, V24, P1, DOI 10.1007/s10096-004-1262-x; Xie WG, 2011, SYST BIOL, V60, P150, DOI 10.1093/sysbio/syq085; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	71	31	31	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0130955	10.1371/journal.pone.0130955	http://dx.doi.org/10.1371/journal.pone.0130955			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161978	Green Published, Green Submitted, gold			2022-12-26	WOS:000358162300026
J	Cattaneo, L; Cicconi, R; Mignogna, G; Giorgi, A; Mattei, M; Graziani, G; Ferracane, R; Grosso, A; Aducci, P; Schinina, ME; Marra, M				Cattaneo, Lucia; Cicconi, Rosella; Mignogna, Giuseppina; Giorgi, Alessandra; Mattei, Maurizio; Graziani, Giulia; Ferracane, Rosalia; Grosso, Alessandro; Aducci, Patrizia; Schinina, M. Eugenia; Marra, Mauro			Anti-Proliferative Effect of Rosmarinus officinalis L. Extract on Human Melanoma A375 Cells	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; PROTEIN DISULFIDE-ISOMERASE; TANDEM MASS-SPECTROMETRY; SALVIA-OFFICINALIS; ROSEMARY EXTRACT; CARNOSIC ACID; CYCLE ARREST; ANTIOXIDANT PROPERTIES; MYELOID-LEUKEMIA; BRONCHIAL CELLS	Rosemary (Rosmarinus officinalis L.) has been used since ancient times in traditional medicine, while nowadays various rosemary formulations are increasingly exploited by alternative medicine to cure or prevent a wide range of health disorders. Rosemary's bioproperties have prompted scientific investigation, which allowed us to ascertain antioxidant, anti-inflammatory, cytostatic, and cytotoxic activities of crude extracts or of pure components. Although there is a growing body of experimental work, information about rosemary's anticancer properties, such as chemoprotective or anti-proliferative effects on cancer cells, is very poor, especially concerning the mechanism of action. Melanoma is a skin tumor whose diffusion is rapidly increasing in the world and whose malignancy is reinforced by its high resistance to cytotoxic agents; hence the availability of new cytotoxic drugs would be very helpful to improve melanoma prognosis. Here we report on the effect of a rosemary hydroalcoholic extract on the viability of the human melanoma A375 cell line. Main components of rosemary extract were identified by liquid chromatography coupled to tandem mass spectrometry (LC/ESI-MS/MS) and the effect of the crude extract or of pure components on the proliferation of cancer cells was tested by MTT and Trypan blue assays. The effect on cell cycle was investigated by using flow cytometry, and the alteration of the cellular redox state was evaluated by intracellular ROS levels and protein carbonylation analysis. Furthermore, in order to get information about the molecular mechanisms of cytotoxicity, a comparative proteomic investigation was performed.	[Cattaneo, Lucia; Grosso, Alessandro; Aducci, Patrizia; Marra, Mauro] Univ Roma Tor Vergata, Dept Biol, I-00173 Rome, Italy; [Cicconi, Rosella; Mattei, Maurizio] Univ Roma Tor Vergata, Ctr Serv Interdipartimentale, Staz Tecnol Anim, Rome, Italy; [Mignogna, Giuseppina; Giorgi, Alessandra; Schinina, M. Eugenia] Univ Roma La Sapienza, Dept Biochem Sci, I-00185 Rome, Italy; [Graziani, Giulia; Ferracane, Rosalia] Univ Naples Federico II, Dept Agr & Food Sci, Naples, Italy	University of Rome Tor Vergata; University of Rome Tor Vergata; Sapienza University Rome; University of Naples Federico II	Marra, M (corresponding author), Univ Roma Tor Vergata, Dept Biol, I-00173 Rome, Italy.	marra@uniroma2.it	Graziani, Giulia/AAN-4828-2020; Mattei, Maurizio/AAC-1303-2019	Graziani, Giulia/0000-0003-3070-5389; Mattei, Maurizio/0000-0002-0814-8873; Mignogna, Giuseppina/0000-0001-9238-132X; Ferracane, Rosalia/0000-0002-1323-7715	Italian grant from MIUR [PRIN 2010HEBBB8_002]; Sapienza University grant [C26A124WCR]	Italian grant from MIUR; Sapienza University grant	This work has been partly supported by an Italian grant from MIUR (to MES; grant number PRIN 2010HEBBB8_002) and by a Sapienza University grant (to MES; grant number C26A124WCR).	Al-Sereiti M. R., 1999, Indian Journal of Experimental Biology, V37, P124; Atallah Ehab, 2005, Curr Treat Options Oncol, V6, P185; Bai HH, 2014, SCANNING, V36, P622, DOI 10.1002/sca.21170; Bai NS, 2010, J AGR FOOD CHEM, V58, P5363, DOI 10.1021/jf100332w; Bakirel T, 2008, J ETHNOPHARMACOL, V116, P64, DOI 10.1016/j.jep.2007.10.039; Benham AM, 2012, ANTIOXID REDOX SIGN, V16, P781, DOI 10.1089/ars.2011.4439; Bozin B, 2007, J AGR FOOD CHEM, V55, P7879, DOI 10.1021/jf0715323; Chang IS, 2007, BLOOD, V110, P994, DOI 10.1182/blood-2007-03-078303; Cheung S, 2007, ONCOL REP, V17, P1525; Chiu CC, 2011, CLIN CANCER RES, V17, P4629, DOI 10.1158/1078-0432.CCR-10-2107; Cho NH, 2006, J PROTEOME RES, V5, P643, DOI 10.1021/pr050460x; Choi EJ, 2013, ONCOL LETT, V6, P1784, DOI 10.3892/ol.2013.1601; D'Alessio C, 1999, J BIOL CHEM, V274, P25899, DOI 10.1074/jbc.274.36.25899; Das S, 2012, EXP BIOL MED, V237, P1433, DOI 10.1258/ebm.2012.012148; Dias PC, 2000, J ETHNOPHARMACOL, V69, P57, DOI 10.1016/S0378-8741(99)00133-6; Ding HY, 2010, FOOD CHEM, V123, P254, DOI 10.1016/j.foodchem.2010.04.025; Drenth JPH, 2005, TRENDS MOL MED, V11, P37, DOI 10.1016/j.molmed.2004.11.004; George VC, 2013, ASIAN PAC J CANCER P, V14, P631, DOI 10.7314/APJCP.2013.14.2.631; Gonzalez-Trujano ME, 2007, J ETHNOPHARMACOL, V111, P476, DOI 10.1016/j.jep.2006.12.011; Gutierrez R, 2010, PHYTOTHER RES, V24, P595, DOI 10.1002/ptr.2997; Han W, 2013, J CLIN INVEST, V123, P2103, DOI 10.1172/JCI61820; Herrero M, 2010, J CHROMATOGR A, V1217, P2512, DOI 10.1016/j.chroma.2009.11.032; Higa A, 2014, MOL CELL BIOL, V34, P1839, DOI 10.1128/MCB.01484-13; Hu CE, 2014, BIOCHEM BIOPH RES CO, V448, P437, DOI 10.1016/j.bbrc.2014.04.124; HUANG MT, 1994, CANCER RES, V54, P701; Huang SC, 2005, BIOCHEM PHARMACOL, V69, P221, DOI 10.1016/j.bcp.2004.09.019; Johnson JJ, 2011, CANCER LETT, V305, P1, DOI 10.1016/j.canlet.2011.02.005; Johnson JJ, 2008, PHARM RES-DORDR, V25, P2125, DOI 10.1007/s11095-008-9552-0; Kontogianni VG, 2013, FOOD CHEM, V136, P120, DOI 10.1016/j.foodchem.2012.07.091; Liao Y, 2014, PLOS ONE, V19; Lin Y, 2008, CURR CANCER DRUG TAR, V8, P634, DOI 10.2174/156800908786241050; Lovat PE, 2008, CANCER RES, V68, P5363, DOI 10.1158/0008-5472.CAN-08-0035; Marugame T, 2010, JPN J CLIN ONCOL, V40, P710, DOI 10.1093/jjco/hyq107; Menoret A, 2014, MOL CARCINOGEN, V53, pE11, DOI 10.1002/mc.21986; Molinaro RJ, 2006, NUCLEIC ACIDS RES, V34, P6684, DOI 10.1093/nar/gkl968; Moran AE, 2005, CANCER RES, V65, P1097; OFFORD EA, 1995, CARCINOGENESIS, V16, P2057, DOI 10.1093/carcin/16.9.2057; Offord EA, 1997, CANCER LETT, V114, P275, DOI 10.1016/S0304-3835(97)04680-6; Pappin Darryl J C, 2003, Methods Mol Biol, V211, P211; Park SJ, 2009, BONE, V45, P994, DOI 10.1016/j.bone.2009.07.018; Qu J, 2001, J CHROMATOGR A, V919, P437, DOI 10.1016/S0021-9673(01)00849-4; Rieder CL, 2004, DEV CELL, V7, P637, DOI 10.1016/j.devcel.2004.09.002; Russo A, 2009, NAT PROD COMMUN, V4, P1707; Senorans FJ, 2000, J CHROMATOGR A, V870, P491, DOI 10.1016/S0021-9673(99)00941-3; Shabtay A, 2008, ONCOLOGY-BASEL, V75, P203, DOI 10.1159/000163849; Sharabani H, 2006, INT J CANCER, V118, P3012, DOI 10.1002/ijc.21736; Singletary K, 1996, CANCER LETT, V104, P43, DOI 10.1016/0304-3835(96)04227-9; Singletary KW, 1997, PLANT FOOD HUM NUTR, V50, P47, DOI 10.1007/BF02436042; Sotelo-Felix JI, 2002, J ETHNOPHARMACOL, V81, P145, DOI 10.1016/S0378-8741(02)00090-9; Steiner M, 2001, NUTR CANCER, V41, P135, DOI 10.1207/S15327914NC41-1&amp;2_19; Sun W, 2001, Curr Treat Options Oncol, V2, P193, DOI 10.1007/s11864-001-0033-5; Tawbi Hussein A, 2010, Clin Adv Hematol Oncol, V8, P259; Trombetta ES, 1996, J BIOL CHEM, V271, P27509, DOI 10.1074/jbc.271.44.27509; Ullah MF, 2013, CELL BIOCHEM BIOPHYS, V67, P431, DOI 10.1007/s12013-011-9303-4; Urich-Merzenich G, 2009, PHYTOMEDICINE, V16, P495, DOI 10.1016/j.phymed.2009.04.001; Visanji JM, 2006, CANCER LETT, V237, P130, DOI 10.1016/j.canlet.2005.05.045; Wang F, 2014, DRUG RES; Wei Feng-Xiang, 2008, Zhong Yao Cai, V31, P877; Xavier CPR, 2009, NUTR CANCER, V61, P564, DOI 10.1080/01635580802710733; Xu SL, 2014, DRUG DISCOV TODAY, V19, P222, DOI 10.1016/j.drudis.2013.10.017; Yamamoto J, 2005, NUTRITION, V21, P580, DOI 10.1016/j.nut.2004.09.016; Yang B, 2013, CARBOHYD POLYM, V92, P1308, DOI 10.1016/j.carbpol.2012.10.012; Yesil-Celiktas O, 2010, PLANT FOOD HUM NUTR, V65, P158, DOI 10.1007/s11130-010-0166-4; YU SG, 1995, J NUTR, V125, P2763; Zhang JY, 2014, INT IMMUNOPHARMACOL, V21, P94, DOI 10.1016/j.intimp.2014.04.011; Zhavoronkov A, 2012, J MOL MED, V90, P1361, DOI 10.1007/s00109-012-0962-4	66	51	56	3	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132439	10.1371/journal.pone.0132439	http://dx.doi.org/10.1371/journal.pone.0132439			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176704	Green Published, gold, Green Submitted			2022-12-26	WOS:000358197600113
J	Earl, SC; Rogers, MT; Keen, J; Bland, DM; Houppert, AS; Miller, C; Temple, I; Anderson, DM; Marketon, MM				Earl, Shaun C.; Rogers, Miles T.; Keen, Jennifer; Bland, David M.; Houppert, Andrew S.; Miller, Caitlynn; Temple, Ian; Anderson, Deborah M.; Marketon, Melanie M.			Resistance to Innate Immunity Contributes to Colonization of the Insect Gut by Yersinia pestis	PLOS ONE			English	Article							EARLY-PHASE TRANSMISSION; XENOPSYLLA-CHEOPIS SIPHONAPTERA; PSEUDOMONAS-AERUGINOSA INFECTION; OROPSYLLA-MONTANA SIPHONAPTERA; DROSOPHILA-MELANOGASTER; MODEL HOST; ANTIMICROBIAL PEPTIDES; BIOFILM FORMATION; MURINE TOXIN; STAPHYLOCOCCUS-AUREUS	Yersinia pestis, the causative agent of bubonic and pneumonic plague, is typically a zoonotic vector-borne disease of wild rodents. Bacterial biofilm formation in the proventriculus of the flea contributes to chronic infection of fleas and facilitates efficient disease transmission. However prior to biofilm formation, ingested bacteria must survive within the flea midgut, and yet little is known about vector-pathogen interactions that are required for flea gut colonization. Here we establish a Drosophila melanogaster model system to gain insight into Y. pestis colonization of the insect vector. We show that Y. pestis establishes a stable infection in the anterior midgut of fly larvae, and we used this model system to study the roles of genes involved in biofilm production and/or resistance to gut immunity stressors. We find that PhoP and GmhA both contribute to colonization and resistance to antimicrobial peptides in flies, and furthermore, the data suggest biofilm formation may afford protection against antimicrobial peptides. Production of reactive oxygen species in the fly gut, as in fleas, also serves to limit bacterial infection, and OxyR mediates Y. pestis survival in both insect models. Overall, our data establish the fruit fly as an informative model to elucidate the relationship between Y. pestis and its flea vector.	[Earl, Shaun C.; Rogers, Miles T.; Keen, Jennifer; Houppert, Andrew S.; Miller, Caitlynn; Temple, Ian; Marketon, Melanie M.] Indiana Univ, Dept Biol, Bloomington, IN 47401 USA; [Bland, David M.; Anderson, Deborah M.] Univ Missouri, Dept Vet Pathobiol, Columbia, MO USA	Indiana University System; Indiana University Bloomington; University of Missouri System; University of Missouri Columbia	Marketon, MM (corresponding author), Indiana Univ, Dept Biol, Bloomington, IN 47401 USA.	mmarketo@indiana.edu		Rogers, Miles/0000-0003-2804-880X; Keen, Jennifer/0000-0002-4271-4349; Bland, David/0000-0002-5052-5599	University of Missouri Research Board; Office of the Vice Provost of Research at Indiana University-Bloomington through the Faculty Research Support Program; United States Public Health Service (NIAID) [R21AI101242, P40OD018537]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI101242] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD018537] Funding Source: NIH RePORTER	University of Missouri Research Board; Office of the Vice Provost of Research at Indiana University-Bloomington through the Faculty Research Support Program; United States Public Health Service (NIAID); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	DMA acknowledges the University of Missouri Research Board for partial funding of this work. MMM acknowledges funding for this work by the Office of the Vice Provost of Research at Indiana University-Bloomington through the Faculty Research Support Program and by the grant R21AI101242 from the United States Public Health Service (NIAID; www.niaid.nih.gov). Fly stocks used in this study were obtained from the Bloomington Drosophila Stock Center, which is supported through grant P40OD018537 from the United States Public Health Service (NIAID; www.niaid.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoyagi KL, 2015, MICROBIOL-SGM, V161, P628, DOI 10.1099/mic.0.000018; Apidianakis Y, 2009, NAT PROTOC, V4, P1285, DOI 10.1038/nprot.2009.124; Asare R, 2010, ENVIRON MICROBIOL, V12, P2587, DOI 10.1111/j.1462-2920.2010.02230.x; Bacot A W, 1914, J Hyg (Lond), V13, P423; Barnes A.M., 1982, Symposia of the Zoological Society of London, V50, P237; BIBIKOVA VA, 1977, ANNU REV ENTOMOL, V22, P23, DOI 10.1146/annurev.en.22.010177.000323; Brooke JS, 1996, J BIOL CHEM, V271, P3608; Buchon N, 2013, NAT REV MICROBIOL, V11, P615, DOI 10.1038/nrmicro3074; Buchon N, 2009, CELL HOST MICROBE, V5, P200, DOI 10.1016/j.chom.2009.01.003; Bulet P, 1999, DEV COMP IMMUNOL, V23, P329, DOI 10.1016/S0145-305X(99)00015-4; BURROUGHS AL, 1947, J HYG-CAMBRIDGE, V45, P371, DOI 10.1017/S0022172400014042; Butler T, 2013, AM J TROP MED HYG, V89, P788, DOI 10.4269/ajtmh.13-0191; Chan C, 2004, J BIOL CHEM, V279, P38749, DOI 10.1074/jbc.M406044200; Charroux B, 2010, FLY, V4, P40, DOI 10.4161/fly.4.1.10810; Choi KH, 2005, NAT METHODS, V2, P443, DOI 10.1038/NMETH765; D'Argenio DA, 2001, J BACTERIOL, V183, P1466, DOI 10.1128/JB.183.4.1466-1471.2001; Darby C, 2005, INFECT IMMUN, V73, P7236, DOI 10.1128/IAI.73.11.7236-7242.2005; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dentovskaya SV, 2011, BIOCHEMISTRY-MOSCOW+, V76, P808, DOI 10.1134/S0006297911070121; Dewoody R, 2011, MOL MICROBIOL, V79, P1445, DOI 10.1111/j.1365-2958.2011.07534.x; Dionne MS, 2003, INFECT IMMUN, V71, P3540, DOI 10.1128/IAI.71.6.3540-3550.2003; Drancourt M, 2006, LANCET INFECT DIS, V6, P234, DOI 10.1016/S1473-3099(06)70438-8; Eisen RJ, 2008, J MED ENTOMOL, V45, P1160, DOI 10.1603/0022-2585(2008)45[1160:DOETOY]2.0.CO;2; Eisen RJ, 2008, AM J TROP MED HYG, V78, P949, DOI 10.4269/ajtmh.2008.78.949; Eisen RJ, 2007, J MED ENTOMOL, V44, P678, DOI 10.1603/0022-2585(2007)44[678:ETOYPB]2.0.CO;2; Eisen RJ, 2007, J MED ENTOMOL, V44, P672, DOI 10.1603/0022-2585(2007)44[672:TDOETO]2.0.CO;2; Eisen RJ, 2006, P NATL ACAD SCI USA, V103, P15380, DOI 10.1073/pnas.0606831103; Eisen RJ, 2009, J MED ENTOMOL, V46, P737, DOI 10.1603/033.046.0403; Erickson DL, 2011, MICROB PATHOGENESIS, V51, P389, DOI 10.1016/j.micpath.2011.08.008; Eskey C. R., 1940, PLAGUE W PART US; Ferrandon D, 2007, NAT REV IMMUNOL, V7, P862, DOI 10.1038/nri2194; FETHERSTON JD, 1992, MOL MICROBIOL, V6, P2693, DOI 10.1111/j.1365-2958.1992.tb01446.x; Gabitzsch ES, 2008, AM J TROP MED HYG, V79, P99, DOI 10.4269/ajtmh.2008.79.99; GAGE KL, 2005, ANNU REV ENTOMOL, V50, P505, DOI DOI 10.1146/annurev.ento.50.071803.130337; Ha EM, 2005, SCIENCE, V310, P847, DOI 10.1126/science.1117311; Han YP, 2008, DNA CELL BIOL, V27, P453, DOI 10.1089/dna.2007.0657; Hao ZG, 2003, INSECT BIOCHEM MOLEC, V33, P1155, DOI 10.1016/j.ibmb.2003.07.001; Hinnebusch BJ, 2005, CURR ISSUES MOL BIOL, V7, P197, DOI 10.21775/cimb.007.197; Hinnebusch BJ, 1996, SCIENCE, V273, P367, DOI 10.1126/science.273.5273.367; Hinnebusch BJ, 2002, SCIENCE, V296, P733, DOI 10.1126/science.1069972; Hitchen PG, 2002, MOL MICROBIOL, V44, P1637, DOI 10.1046/j.1365-2958.2002.02990.x; Houppert AS, 2013, INFECT IMMUN, V81, P1186, DOI 10.1128/IAI.01417-12; Houppert AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034039; Hubbart JA, 2011, J VECTOR ECOL, V36, P117, DOI 10.1111/j.1948-7134.2011.00148.x; Jarrett CO, 2004, J INFECT DIS, V190, P783, DOI 10.1086/422695; Johnson TL, 2014, MICROBIOL-SGM, V160, P2517, DOI 10.1099/mic.0.082123-0; Joo H. S., 2015, BIOCH BIOPHYS ACTA; Kim JK, 2014, DEV COMP IMMUNOL, V43, P10, DOI 10.1016/j.dci.2013.10.010; Kim SH, 2008, INFECT IMMUN, V76, P4152, DOI 10.1128/IAI.01637-07; Kingsolver MB, 2013, J MOL BIOL, V425, P4921, DOI 10.1016/j.jmb.2013.10.006; Knirel YA, 2007, ADV EXP MED BIOL, V603, P88; Kounatidis I, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120075; Kurata S, 2010, ADV EXP MED BIOL, V708, P205; Kurata S, 2010, INT IMMUNOL, V22, P143, DOI 10.1093/intimm/dxp128; Lathem WW, 2007, SCIENCE, V315, P509, DOI 10.1126/science.1137195; Lehrer RI, 1999, CURR OPIN IMMUNOL, V11, P23, DOI 10.1016/S0952-7915(99)80005-3; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Mulcahy H, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000213; Nayduch D, 2013, J MED ENTOMOL, V50, P171, DOI 10.1603/ME12189; Needham AJ, 2004, MICROBIOL-SGM, V150, P2347, DOI 10.1099/mic.0.27116-0; Nuri R, 2015, BIOCH BIOPHYS ACTA; Olcott MH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012504; Perry RD, 1997, CLIN MICROBIOL REV, V10, P35, DOI 10.1128/CMR.10.1.35; Rebeil R, 2013, J BACTERIOL, V195, P1920, DOI 10.1128/JB.02000-12; Royet J, 2011, CELL MOL LIFE SCI, V68, P3651, DOI 10.1007/s00018-011-0828-x; Rozen S, 2000, Methods Mol Biol, V132, P365; Rudolph AE, 1999, J BIOL CHEM, V274, P11824, DOI 10.1074/jbc.274.17.11824; Ryu JH, 2006, EMBO J, V25, P3693, DOI 10.1038/sj.emboj.7601233; Shanbhag S, 2005, J MEMBRANE BIOL, V206, P61, DOI 10.1007/s00232-005-0774-1; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shaw AE, 2012, J VIROL, V86, P9015, DOI 10.1128/JVI.00131-12; TAKESHITA S, 1987, GENE, V61, P63, DOI 10.1016/0378-1119(87)90365-9; Tan L, 2006, MOL MICROBIOL, V61, P861, DOI 10.1111/j.1365-2958.2006.05265.x; Tzou P, 2000, IMMUNITY, V13, P737, DOI 10.1016/S1074-7613(00)00072-8; Uliczka F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020425; Uvell H, 2007, TRENDS GENET, V23, P342, DOI 10.1016/j.tig.2007.05.003; Vadyvaloo V, 2015, MICROBIOLOGY; Vadyvaloo V, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000783; Vallet-Gely I, 2008, NAT REV MICROBIOL, V6, P302, DOI 10.1038/nrmicro1870; Vetter SM, 2010, MICROBIOL-SGM, V156, P2216, DOI 10.1099/mic.0.037952-0; Vuong C, 2004, J BIOL CHEM, V279, P54881, DOI 10.1074/jbc.M411374200; Vuong C, 2004, CELL MICROBIOL, V6, P269, DOI 10.1046/j.1462-5822.2004.00367.x; Whitfield GB, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00471; Wigglesworth VB, 1972, PRINCIPLES INSECT PH; Wilder AP, 2008, VECTOR-BORNE ZOONOT, V8, P359, DOI 10.1089/vbz.2007.0181; Wood JW, 2003, HUM BIOL, V75, P427, DOI 10.1353/hub.2003.0067; Zhou W, 2012, J MED ENTOMOL, V49, P364, DOI 10.1603/ME11172	87	14	14	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0133318	10.1371/journal.pone.0133318	http://dx.doi.org/10.1371/journal.pone.0133318			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177454	Green Submitted, Green Published, gold			2022-12-26	WOS:000358197600242
J	Gaitas, A; Kim, G				Gaitas, Angelo; Kim, Gwangseong			Chemically Modified Plastic Tube for High Volume Removal and Collection of Circulating Tumor Cells	PLOS ONE			English	Article							INTRAOPERATIVE BLOOD SALVAGE; CANCER-PATIENTS; DIALYSIS MEMBRANE; DEPLETION; CAPTURE; TRAIL	In this preliminary effort, we use a commercially available and chemically modified tube to selectively capture circulating tumor cells (CTCs) from the blood stream by immobilizing human anti-EpCAM antibodies on the tube's interior surface. We describe the requisite and critical steps required to modify a tube into a cancer cell-capturing device. Using these simple modifications, we were able to capture or entrap about 85% of cancer cells from suspension and 44% of cancer cells from spiked whole blood. We also found that the percentage of cells captured was dependent on the tube's length and also the number of cancer cells present. It is our strong belief that with the utilization of appropriate tube lengths and procedures, we can ensure capture and removal of nearly the entire CTC population in whole blood. Importantly after a patient's entire blood volume has circulated through the tube, the tube can then be trypsinized to release the captured live CTCs for further analysis and testing.	[Gaitas, Angelo; Kim, Gwangseong] Kytaro Inc, Miami, FL 33199 USA; [Gaitas, Angelo; Kim, Gwangseong] Florida Int Univ, Miami, FL 33199 USA	State University System of Florida; Florida International University	Gaitas, A (corresponding author), Kytaro Inc, Miami, FL 33199 USA.	agaitas@fiu.edu		Gaitas, Angelo/0000-0003-4428-3949	NIH [GM084520]; Kytaro, Inc.; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R43GM084520, R44GM084520] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kytaro, Inc.; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was funded by NIH grant #GM084520 (PI: Gaitas) Kytaro, Inc. which provided support in the form of salaries for authors AG and GK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	Adams D, CANC DET DIAGN TECHN, V301, P983; Adams D, 2011, P 102 AACR M; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Draffin JE, 2004, CANCER RES, V64, P5702, DOI 10.1158/0008-5472.CAN-04-0389; Edelman MJ, 1996, UROLOGY, V47, P179, DOI 10.1016/S0090-4295(99)80411-7; Fruhauf NR, 2001, PERFUSION-UK, V16, P51, DOI 10.1177/026765910101600i107; Gertler R, 2003, RECENT RES CANCER, V162, P149; Hu YJ, 2010, CYTOM PART A, V77A, P213, DOI 10.1002/cyto.a.20838; Kemmner W., 2011, J CLIN EXP PATHOL, V40, P1125; Kim G, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2771530; Kim MY, 2009, CELL, V139, P1315, DOI 10.1016/j.cell.2009.11.025; Kim WS, 2007, LANGMUIR, V23, P4732, DOI 10.1021/la070074p; King MR, 2009, J BIONIC ENG, V6, P311, DOI 10.1016/S1672-6529(08)60129-8; King MR, THERAPEUTIC TARGETIN; Lopez-Riquelme N, 2013, APMIS, V121, P1139, DOI 10.1111/apm.12061; Lu J, 2010, INT J CANCER, V126, P669, DOI 10.1002/ijc.24814; Maheswaran S, 2008, NEW ENGL J MED, V359, P366, DOI 10.1056/NEJMoa0800668; Mitchell MJ, 2014, P NATL ACAD SCI USA, V111, P930, DOI 10.1073/pnas.1316312111; Munz M, 2010, CANCER CELL INT, V10, DOI 10.1186/1475-2867-10-44; Nagrath S, 2007, NATURE, V450, P1235, DOI 10.1038/nature06385; Perseghin P, 1997, VOX SANG, V72, P221, DOI 10.1046/j.1423-0410.1997.7240221.x; Racila E, 1998, P NATL ACAD SCI USA, V95, P4589, DOI 10.1073/pnas.95.8.4589; Rana K, 2009, BIOTECHNOL BIOENG, V102, P1692, DOI 10.1002/bit.22204; Ricci SB, 2007, CLIN NEPHROL, V68, P354; Ricci SB, 2012, MED HYPOTHESES, V78, P1, DOI 10.1016/j.mehy.2011.09.026; Ricci SB, 2009, MED HYPOTHESES, V73, P328, DOI 10.1016/j.mehy.2009.03.043; Saucedo-Zeni N, 2012, INT J ONCOL, V41, P1241, DOI 10.3892/ijo.2012.1557; Sieben S, 2001, J MAGN MAGN MATER, V225, P175, DOI 10.1016/S0304-8853(00)01248-8; Sui GD, 2006, ANAL CHEM, V78, P5543, DOI 10.1021/ac060605z; Talasaz AH, 2009, P NATL ACAD SCI USA, V106, P3970, DOI 10.1073/pnas.0813188106; Yoon HJ, 2013, NAT NANOTECHNOL, V8, P735, DOI 10.1038/nnano.2013.194	31	6	6	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0133194	10.1371/journal.pone.0133194	http://dx.doi.org/10.1371/journal.pone.0133194			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176235	Green Published, Green Submitted, gold			2022-12-26	WOS:000358197600230
J	Karmacharya, D; Manandhar, S; Sharma, A; Bhatta, T; Adhikari, P; Sherchan, AM; Shrestha, B; Bista, M; Rajbhandari, R; Oberoi, M; Bisht, K; Hero, JM; Dissanayake, R; Dhakal, M; Hughes, J; Debnath, N				Karmacharya, Dibesh; Manandhar, Sulochana; Sharma, Ajay; Bhatta, Tarka; Adhikari, Pratikshya; Sherchan, Adarsh Man; Shrestha, Bishwo; Bista, Manisha; Rajbhandari, Rajesh; Oberoi, Mohinder; Bisht, Khadak; Hero, Jean-Marc; Dissanayake, Ravi; Dhakal, Maheshwar; Hughes, Jane; Debnath, Nitish			Surveillance of Influenza A Virus and Its Subtypes in Migratory Wild Birds of Nepal	PLOS ONE			English	Article							PATHOGENIC AVIAN INFLUENZA; INFECTION; H5N1; PREVALENCE; PATTERNS; A(H7N9); DUCKS	Nepal boarders India and China and all three countries lie within the Central Asian Flyway for migratory birds. Novel influenza A H7N9 caused human fatalities in China in 2013. Sub-clinical infections of influenza A H7N9 in birds and the potential for virus dispersal by migratory birds prompted this study to assess avian H7N9 viral intrusion into Nepal. Surveillance of influenza A virus in migratory birds was implemented in early 2014 with assistance from the Food and Agricultural Organization (FAO). Of 1811 environmental fecal samples collected from seven wetland migratory bird roosting areas, influenza A H9N2 was found in one sample from a ruddy shelduck in Koshi Tappu Wildlife Reserve located in southern Nepal. Avian H7N9 and other highly pathogenic avian influenza viruses were not detected. This study provides baseline data on the status of avian influenza virus in migratory bird populations in Nepal.	[Karmacharya, Dibesh; Manandhar, Sulochana; Sharma, Ajay; Bhatta, Tarka; Adhikari, Pratikshya; Sherchan, Adarsh Man; Shrestha, Bishwo; Bista, Manisha; Rajbhandari, Rajesh] Ctr Mol Dynam Nepal, Kathmandu, Nepal; [Oberoi, Mohinder; Bisht, Khadak; Dissanayake, Ravi; Debnath, Nitish] Food & Agr Org, Kathmandu, Nepal; [Hero, Jean-Marc; Hughes, Jane] Griffith Univ, Sch Environm, Nathan, Qld 4111, Australia; [Dhakal, Maheshwar] Dept Natl Pk & Wildlife Conservat, Kathmandu, Nepal	Food & Agriculture Organization of the United Nations (FAO); Griffith University	Karmacharya, D (corresponding author), Ctr Mol Dynam Nepal, Thapathali 11, Kathmandu, Nepal.	dibesh@cmdn.org	hughes, jane m/C-5321-2008; Karmacharya, Dibesh/GVU-4782-2022	Karmacharya, Dibesh/0000-0001-5093-6737; Dissanayake, Ravi Bandara/0000-0001-8059-9436	USAID through FAO under H7N9 AIV surveillance program	USAID through FAO under H7N9 AIV surveillance program(United States Agency for International Development (USAID))	This study was funded by USAID through FAO under H7N9 AIV surveillance program.	AAHL (Australian Animal Health Laboratory), 2004, MAN NUCL AC DET DIS; Alexander DJ, 2007, VACCINE, V25, P5637, DOI 10.1016/j.vaccine.2006.10.051; [Anonymous], 2013, MOL DIAGN CSIRO AN F; Chen HY, 2014, LANCET, V383, P714, DOI 10.1016/S0140-6736(14)60111-2; Cui LB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4142; DeLiberto TJ, 2009, INTEGR ZOOL, V4, P426, DOI 10.1111/j.1749-4877.2009.00180.x; Fereidouni SR, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-43; Gaidet N, 2007, EMERG INFECT DIS, V13, P626, DOI 10.3201/eid1304.061011; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Horimoto T, 2001, CLIN MICROBIOL REV, V14, P129, DOI 10.1128/CMR.14.1.129-149.2001; Hoye BJ, 2010, EMERG INFECT DIS, V16, P1827, DOI 10.3201/eid1612.100589; Huang YY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081842; Inskipp C, 1991, GUIDE BIRDS NEPAL; Ip HS, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-71; Karki S, 2014, ZOONOSES PUBLIC HLTH, V61, P442, DOI 10.1111/zph.12097; Lam TTY, 2013, NATURE, V502, P241, DOI 10.1038/nature12515; Leung YHC, 2007, EMERG INFECT DIS, V13, P1380, DOI 10.3201/eid1309.070517; Liu D, 2014, LANCET, V383, P869, DOI 10.1016/S0140-6736(14)60386-X; Liu J, 2005, SCIENCE, V309, P1206, DOI 10.1126/science.1115273; Marinova-Petkova A, 2014, EMERG MICROBES INFEC, V3, DOI 10.1038/emi.2014.11; Munster VJ, 2007, PLOS PATHOG, V3, P630, DOI 10.1371/journal.ppat.0030061; Newman SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030636; Olsen B, 2006, SCIENCE, V312, P384, DOI 10.1126/science.1122438; Olson SH, 2013, EMERG INFECT DIS, V19, P2031, DOI 10.3201/eid1912.130649; Parry J, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2568; Sergeant ESG, 2015, EPITOOLS SURVEY TOOL; Spackman E, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-190; STALLKNECHT DE, 1990, AVIAN DIS, V34, P406, DOI 10.2307/1591428; Takekawa JY, 2013, VIRUSES-BASEL, V5, P2129, DOI 10.3390/v5092129; Tsukamoto K, 2008, J CLIN MICROBIOL, V46, P3048, DOI 10.1128/JCM.02386-07; Vijaykrishna D, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000161; Wallensten A, 2007, EMERG INFECT DIS, V13, P404, DOI 10.3201/eid1303.061130; Wang GH, 2008, J GEN VIROL, V89, P697, DOI 10.1099/vir.0.83419-0; WEBSTER RG, 1978, VIROLOGY, V84, P268, DOI 10.1016/0042-6822(78)90247-7; WEBSTER RG, 1976, J GEN VIROL, V32, P217, DOI 10.1099/0022-1317-32-2-217; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Whitworth D., 2007, WILD BIRDS AVIAN INF; World Health Organization, CUM NUMB CONF HUM CA; World Health Organization, 2006, GUIDE FOR FIELD OPER; World Organization for Animal Health, UPD HIGHL PATH AV IN; Wu AP, 2013, CELL HOST MICROBE, V14, P446, DOI 10.1016/j.chom.2013.09.001; Zhao BH, 2014, EMERG INFECT DIS, V20, P850, DOI 10.3201/eid2005.131707	43	7	7	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0133035	10.1371/journal.pone.0133035	http://dx.doi.org/10.1371/journal.pone.0133035			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176773	Green Published, Green Submitted, gold			2022-12-26	WOS:000358197600204
J	Nerandzic, MM; Sunkesula, VCK; Sankar, CT; Setlow, P; Donskey, CJ				Nerandzic, Michelle M.; Sunkesula, Venkata C. K.; Sankar, Thriveen C.; Setlow, Peter; Donskey, Curtis J.			Unlocking the Sporicidal Potential of Ethanol: Induced Sporicidal Activity of Ethanol against Clostridium difficile and Bacillus Spores under Altered Physical and Chemical Conditions	PLOS ONE			English	Article							HAND HYGIENE; ASYMPTOMATIC CARRIERS; AGENTS; DISINFECTANTS; RESISTANCE; INFECTION; OUTBREAK; EFFICACY; REMOVAL; SOAP	Background Due to their efficacy and convenience, alcohol-based hand sanitizers have been widely adopted as the primary method of hand hygiene in healthcare settings. However, alcohols lack activity against bacterial spores produced by pathogens such as Clostridium difficile and Bacillus anthracis. We hypothesized that sporicidal activity could be induced in alcohols through alteration of physical or chemical conditions that have been shown to degrade or allow penetration of spore coats. Principal Findings Acidification, alkalinization, and heating of ethanol induced rapid sporicidal activity against C. difficile, and to a lesser extent Bacillus thuringiensis and Bacillus subtilis. The sporicidal activity of acidified ethanol was enhanced by increasing ionic strength and mild elevations in temperature. On skin, sporicidal ethanol formulations were as effective as soap and water hand washing in reducing levels of C. difficile spores. Conclusions These findings demonstrate that novel ethanol-based sporicidal hand hygiene formulations can be developed through alteration of physical and chemical conditions.	[Nerandzic, Michelle M.; Sunkesula, Venkata C. K.] Cleveland Vet Affairs Med Ctr, Res Serv, Cleveland, OH 44106 USA; [Sunkesula, Venkata C. K.; Sankar, Thriveen C.; Donskey, Curtis J.] Case Western Reserve Univ, Sch Med, Cleveland, OH USA; [Setlow, Peter] Univ Connecticut, Ctr Hlth, Dept Mol Biol & Biophys, Farmington, CT USA; [Donskey, Curtis J.] Cleveland Vet Affairs Med Ctr, Geriatr Res Educ & Clin Ctr, Cleveland, OH USA	Case Western Reserve University; University of Connecticut; Geriatric Research Education & Clinical Center	Nerandzic, MM (corresponding author), Cleveland Vet Affairs Med Ctr, Res Serv, Cleveland, OH 44106 USA.	michellenerandzi@aim.com			Merit Review Grant from the Department of Veterans Affairs; Veterans Affairs [I01BX002944] Funding Source: NIH RePORTER	Merit Review Grant from the Department of Veterans Affairs(US Department of Veterans Affairs); Veterans Affairs(US Department of Veterans Affairs)	This study was funded by a Merit Review Grant from the Department of Veterans Affairs awarded to Curtis Donskey. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Society for Testing and Materials, 2012, E289712 AM SOC TEST; American Society for Testing and Materials, 2010, E227610 AM SOC TEST; Blaak J, 2011, J COSMETICS DERMATOL, V1, P50, DOI [10.4236/jcdsa.2011.13009, DOI 10.4236/JCDSA.2011.13009]; Boyce JM, 2002, INFECT CONT HOSP EP, V23, pS3, DOI 10.1086/503164; Cubin HK, 1929, BIOCHEM J, V23, P25, DOI 10.1042/bj0230025; Curry SR, 2013, CLIN INFECT DIS, V57, P1094, DOI 10.1093/cid/cit475; DILL KA, 1991, ANNU REV BIOCHEM, V60, P795, DOI 10.1146/annurev.bi.60.070191.004051; Edmonds SL, 2013, INFECT CONT HOSP EP, V34, P302, DOI 10.1086/669521; Girou E, 2002, BRIT MED J, V325, P362, DOI 10.1136/bmj.325.7360.362; GORMAN SP, 1987, J APPL BACTERIOL, V63, P183, DOI 10.1111/j.1365-2672.1987.tb02701.x; GOULD GW, 1963, J GEN MICROBIOL, V33, P413, DOI 10.1099/00221287-33-3-413; Hilburn J, 2003, AM J INFECT CONTROL, V31, P109, DOI 10.1067/mic.2003.15; ISSAHARY G, 1970, J BACTERIOL, V101, P418, DOI 10.1128/JB.101.2.418-422.1970; JONES DS, 1995, INT J PHARM, V119, P247, DOI 10.1016/0378-5173(94)00409-X; Kampf G, 2004, CLIN MICROBIOL REV, V17, P863, DOI 10.1128/CMR.17.4.863-893.2004; Kundrapu S, 2014, INFECT CONT HOSP EP, V35, P204, DOI 10.1086/674859; Lambers H., 2006, International Journal of Cosmetic Science, V28, P359, DOI 10.1111/j.1467-2494.2006.00344.x; Leggett MJ, 2012, J APPL MICROBIOL, V113, P485, DOI 10.1111/j.1365-2672.2012.05336.x; Loo VG, 2005, NEW ENGL J MED, V353, P2442, DOI 10.1056/NEJMoa051639; MACHEBOEUF M, 1953, B SOC CHIM BIOL, V35, P399; McDonnell G, 1999, CLIN MICROBIOL REV, V12, P147, DOI 10.1128/CMR.12.1.147; Muto CA, 2007, CLIN INFECT DIS, V45, P1266, DOI 10.1086/522654; Nerandzic MM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123809; Nerandzic MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068706; Nerandzic MM, 2009, J CLIN MICROBIOL, V47, P397, DOI 10.1128/JCM.01591-08; Nicholson WL., 1990, MOL BIOL METHODS BAC, P391, DOI DOI 10.1111/J.1751-1097.1991.TB02087.X; Oughton MT, 2009, INFECT CONT HOSP EP, V30, P939, DOI 10.1086/605322; Paredes-Sabja D, 2014, TRENDS MICROBIOL, V22, P406, DOI 10.1016/j.tim.2014.04.003; Permpoonpattana P, 2013, J BACTERIOL, V195, P1492, DOI 10.1128/JB.02104-12; Poxton IR, 2001, CLIN MICROBIOL INFEC, V7, P421, DOI 10.1046/j.1198-743x.2001.00287.x; Riggs MM, 2007, CLIN INFECT DIS, V45, P992, DOI 10.1086/521854; Roberts D, 2014, MOL PHARMACEUT, V11, P2475, DOI 10.1021/mp5002334; Rodriguez-Palacios A, 2011, APPL ENVIRON MICROB, V77, P3085, DOI 10.1128/AEM.01589-10; Russell AD, 1999, J HOSP INFECT, V43, pS57, DOI 10.1016/S0195-6701(99)90066-X; Schmidt FC, 1955, BACTERIOL P, V40; Setlow P, 2007, TRENDS MICROBIOL, V15, P172, DOI 10.1016/j.tim.2007.02.004; Sorg JA, 2008, J BACTERIOL, V190, P2505, DOI 10.1128/JB.01765-07; STEERE AC, 1975, ANN INTERN MED, V83, P683, DOI 10.7326/0003-4819-83-5-683; Voss A, 1997, INFECT CONT HOSP EP, V18, P205; Weber DJ, 2003, JAMA-J AM MED ASSOC, V289, P1274, DOI 10.1001/jama.289.10.1274	40	12	12	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132805	10.1371/journal.pone.0132805	http://dx.doi.org/10.1371/journal.pone.0132805			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177038	gold, Green Submitted, Green Published			2022-12-26	WOS:000358197600162
J	Thijs, T; Broos, K; Soenen, SJ; Vandenbulcke, A; Vanhoorelbeke, K; Deckmyn, H; Salles-Crawley, II				Thijs, Tim; Broos, Katleen; Soenen, Stefaan J.; Vandenbulcke, Aline; Vanhoorelbeke, Karen; Deckmyn, Hans; Salles-Crawley, Isabelle I.			Artificial MiRNA Knockdown of Platelet Glycoprotein Ib alpha: A Tool for Platelet Gene Silencing	PLOS ONE			English	Article							BERNARD-SOULIER-SYNDROME; SHORT HAIRPIN RNA; MAMMALIAN-CELLS; IN-VIVO; GPIB-ALPHA; EXPRESSION; MICRORNA; MODEL; INTERFERENCE; SHRNA	In recent years, candidate genes and proteins implicated in platelet function have been identified by various genomic approaches. To elucidate their exact role, we aimed to develop a method to apply miRNA interference in platelet progenitor cells by using GPIb alpha as a proof-of-concept target protein. After in silico and in vitro screening of siRNAs targeting GPIba (siGPIBAs), we developed artificial miRNAs (miGPIBAs), which were tested in CHO cells stably expressing GPIb-IX complex and megakaryoblastic DAMI cells. Introduction of siGPIBAs in CHO GPIb-IX cells resulted in 44 to 75% and up to 80% knockdown of GPIba expression using single or combined siRNAs, respectively. Conversion of siGPIBAs to miGPIBAs resulted in reduced silencing efficiency, which could however be circumvented by tandem integration of two hairpins targeting different regions of GPIBA mRNA where 72% GPIba knockdown was achieved. CHO GPIb-IX cells transfected with the miG-PIBA construct displayed a significant decrease in their ability to aggregate characterized by lower aggregate numbers and size compared to control CHO GPIb-IX cells. More importantly, we successfully silenced GPIba in differentiating megakaryoblastic DAMI cells that exhibited morphological changes associated with actin organization. In conclusion, we here report the successful use of miRNA technology to silence a platelet protein in megakaryoblastic cells and demonstrate its usefulness in functional assays. Hence, we believe that artificial miRNAs are suitable tools to unravel the role of a protein of interest in stem cells, megakaryocytes and platelets, thereby expanding their application to novel fields of basic and translational research.	[Thijs, Tim; Broos, Katleen; Vandenbulcke, Aline; Vanhoorelbeke, Karen; Deckmyn, Hans; Salles-Crawley, Isabelle I.] KU Leuven Kulak, Lab Thrombosis Res, Interdisciplinary Res Facil Life Sci, Kortrijk, Belgium; [Soenen, Stefaan J.] Katholieke Univ Leuven, Dept Imaging & Technol, Biomed MRI, Leuven, Belgium; [Salles-Crawley, Isabelle I.] Univ London Imperial Coll Sci Technol & Med, Ctr Haematol, London, England	KU Leuven; KU Leuven; Imperial College London	Salles-Crawley, II (corresponding author), KU Leuven Kulak, Lab Thrombosis Res, Interdisciplinary Res Facil Life Sci, Kortrijk, Belgium.	i.salles@imperial.ac.uk	Deckmyn, Hans/N-8932-2019; Soenen, Stefaan J/D-7370-2014; Salles, Isabelle/O-1375-2019; Soenen, Stefaan/GLR-3797-2022; Deckmyn, Hans/L-9434-2015	Deckmyn, Hans/0000-0003-3952-5501; Soenen, Stefaan J/0000-0003-2390-3133; Salles, Isabelle/0000-0001-7394-0587; Deckmyn, Hans/0000-0003-3952-5501	Instituut voor de Aanmoediging van Innovatie door Wetenschap en Technologie; Katholieke Universiteit Leuven [GOA09/829, CIF-2]; Fonds voorWetenschappelijk Onderzoek [G.0564.08]; European Union 6th Framework Programme [LSHM-CT-2004-503485]; British Heart Foundation [FS/10/004/28165]; British Heart Foundation [PG/14/90/31219] Funding Source: researchfish	Instituut voor de Aanmoediging van Innovatie door Wetenschap en Technologie; Katholieke Universiteit Leuven(KU Leuven); Fonds voorWetenschappelijk Onderzoek(FWO); European Union 6th Framework Programme(European Commission); British Heart Foundation(British Heart Foundation); British Heart Foundation(British Heart Foundation)	This work was supported by the Instituut voor de Aanmoediging van Innovatie door Wetenschap en Technologie (http://www.iwt.be/) to TT, Katholieke Universiteit Leuven (www.kuleuven.be/), GOA09/829 and CIF-2 to HD, Fonds voorWetenschappelijk Onderzoek (http://www.fwo.be/), G. 0564.08 to HD, European Union 6th Framework Programme, LSHM-CT-2004-503485 to HD, and British Heart Foundation (https://www.bhf.org.uk/), FS/10/004/28165 to IS-C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amendola M, 2009, MOL THER, V17, P1039, DOI 10.1038/mt.2009.48; Arvey A, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.24; Boden D, 2004, NUCLEIC ACIDS RES, V32, P1154, DOI 10.1093/nar/gkh278; Boudreau RL, 2009, MOL THER, V17, P169, DOI 10.1038/mt.2008.231; Burkhart JM, 2014, CIRC RES, V114, P1204, DOI 10.1161/CIRCRESAHA.114.301598; Cauwenberghs N, 2001, BLOOD, V98, P652, DOI 10.1182/blood.V98.3.652; Denis MM, 2005, CELL, V122, P379, DOI 10.1016/j.cell.2005.06.015; DONG JF, 1995, BLOOD, V86, P4175, DOI 10.1182/blood.V86.11.4175.bloodjournal86114175; Falet H, 2010, J EXP MED, V207, P1967, DOI 10.1084/jem.20100222; Gras C, 2013, HUM GENE THER, V24, P1018, DOI 10.1089/hum.2013.074; Grimm D, 2006, NATURE, V441, P537, DOI 10.1038/nature04791; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hong W, 2011, CTS-CLIN TRANSL SCI, V4, P180, DOI 10.1111/j.1752-8062.2011.00279.x; Kanaji T, 2012, BLOOD, V119, P2906, DOI 10.1182/blood-2011-08-376566; Kauskot A, 2013, BLOOD, V121, P5208, DOI 10.1182/blood-2012-10-462887; LOPEZ JA, 1994, BLOOD COAGUL FIBRIN, V5, P479; Lopez JA, 1998, BLOOD, V91, P4397, DOI 10.1182/blood.V91.12.4397.412k42_4397_4418; Lordier L, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1704; Ma HM, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.27; Maczuga P, 2013, MOL THER, V21, P217, DOI 10.1038/mt.2012.160; McBride JL, 2008, P NATL ACAD SCI USA, V105, P5868, DOI 10.1073/pnas.0801775105; Mittal V, 2004, NAT REV GENET, V5, P355, DOI 10.1038/nrg1323; Morrell CN, 2014, BLOOD, V123, P2759, DOI 10.1182/blood-2013-11-462432; Nagalla S, 2011, BLOOD, V117, P5189, DOI 10.1182/blood-2010-09-299719; Ohmori T, 2007, ARTERIOSCL THROM VAS, V27, P2266, DOI 10.1161/ATVBAHA.107.149872; Paddison PJ, 2004, NAT METHODS, V1, P163, DOI 10.1038/nmeth1104-163; Perrault C, 1999, BLOOD, V94, P4186, DOI 10.1182/blood.V94.12.4186.424k24_4186_4194; Poujol CR, 2002, EXP HEMATOL, V30, P352, DOI 10.1016/S0301-472X(02)00774-9; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; Rowley JW, 2011, BLOOD, V118, pE101, DOI 10.1182/blood-2011-03-339705; Saito H, 1997, BAILLIERE CLIN HAEM, V10, P47, DOI 10.1016/S0950-3536(97)80050-9; Sakata A, 2014, THROMB J, V12, DOI 10.1186/1477-9560-12-1; Scherr Michaela, 2009, V506, P207, DOI 10.1007/978-1-59745-409-4_15; Shan ZX, 2010, MOL BIOL REP, V37, P1831, DOI 10.1007/s11033-009-9618-z; Snyder LL, 2008, ANTIVIR RES, V80, P36, DOI 10.1016/j.antiviral.2008.04.001; Stegmeier F, 2005, P NATL ACAD SCI USA, V102, P13212, DOI 10.1073/pnas.0506306102; Sun DQ, 2006, BIOTECHNIQUES, V41, P59, DOI 10.2144/000112203; Thijs T, 2012, BLOOD, V119, P1634, DOI 10.1182/blood-2011-10-381715; Ware J, 2000, P NATL ACAD SCI USA, V97, P2803, DOI 10.1073/pnas.050582097; Watkins NA, 2009, BLOOD, V113, pE1, DOI 10.1182/blood-2008-06-162958; Wu Junzhu, 2009, V487, P205, DOI 10.1007/978-1-60327-547-7_10; Zufferey A, 2011, THROMB HAEMOSTASIS, V106, P466, DOI 10.1160/TH11-04-0226	42	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132899	10.1371/journal.pone.0132899	http://dx.doi.org/10.1371/journal.pone.0132899			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176854	gold, Green Submitted, Green Published, Green Accepted			2022-12-26	WOS:000358197600175
J	Tsukamoto, K; Ozeki, C; Kohda, T; Tsuji, T				Tsukamoto, Kentaro; Ozeki, Chikako; Kohda, Tomoko; Tsuji, Takao			CRISPR/Cas9-Mediated Genomic Deletion of the Beta-1, 4 N-acetylgalactosaminyltransferase 1 Gene in Murine P19 Embryonal Carcinoma Cells Results in Low Sensitivity to Botulinum Neurotoxin Type C	PLOS ONE			English	Article							BIOLOGICAL-ACTIVITY; PROTEIN-RECEPTOR; GANGLIOSIDE; ENTRY; BINDING; SV2	Botulinum neurotoxins produced by Clostridium botulinum cause flaccid paralysis by inhibiting neurotransmitter release at peripheral nerve terminals. Previously, we found that neurons derived from the murine P19 embryonal carcinoma cell line exhibited high sensitivity to botulinum neurotoxin type C. In order to prove the utility of P19 cells for the study of the intracellular mechanism of botulinum neurotoxins, ganglioside-knockout neurons were generated by deletion of the gene encoding beta-1,4 N-acetylgalactosaminyltransferase 1 in P19 cells using the clustered regularly interspaced short palindromic repeats combined with Cas9 (CRISPR/Cas9) system. By using this system, knockout cells could be generated more easily than with previous methods. The sensitivity of the generated beta-1,4 N-acetylgalactosaminyltransferase 1-depleted P19 neurons to botulinum neurotoxin type C was decreased considerably, and the exogenous addition of the gangliosides GD1a, GD1b, and GT1b restored the susceptibility of P19 cells to botulinum neurotoxin type C. In particular, addition of a mixture of these three ganglioside more effectively recovered the sensitivity of knockout cells compared to independent addition of GD1a, GD1b, or GT1b. Consequently, the genome-edited P19 cells generated by the CRISPR/Cas9 system were useful for identifying and defining the intracellular molecules involved in the toxic action of botulinum neurotoxins.	[Tsukamoto, Kentaro; Ozeki, Chikako; Tsuji, Takao] Fujita Hlth Univ, Sch Med, Dept Microbiol, Toyoake, Aichi 47011, Japan; [Kohda, Tomoko] Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Dept Vet Sci, Osaka, Japan	Fujita Health University; Osaka Metropolitan University	Tsukamoto, K (corresponding author), Fujita Hlth Univ, Sch Med, Dept Microbiol, Toyoake, Aichi 47011, Japan.	tsuka-k@fujita-hu.ac.jp	Tsukamoto, Kentaro/AFQ-2771-2022	Tsukamoto, Kentaro/0000-0002-9254-4632	Japan Society for the Promotion of Science (JSPS) KAKENHI [15K08476]; grant of Strategic Research Foundation Grant-aided Project for Private Universities from Ministry of Education, Culture, Sport, Science, and Technology, Japan [S1001035]	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); grant of Strategic Research Foundation Grant-aided Project for Private Universities from Ministry of Education, Culture, Sport, Science, and Technology, Japan	This study was supported by by a Grant-in-Aid for Scientific Research (C) from the Japan Society for the Promotion of Science (JSPS) KAKENHI (15K08476 for KT), and a grant of Strategic Research Foundation Grant-aided Project for Private Universities from Ministry of Education, Culture, Sport, Science, and Technology, Japan (S1001035 for TT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Binz T, 2009, J NEUROCHEM, V109, P1584, DOI 10.1111/j.1471-4159.2009.06093.x; BLASI J, 1993, EMBO J, V12, P4821, DOI 10.1002/j.1460-2075.1993.tb06171.x; Dong M, 2006, SCIENCE, V312, P592, DOI 10.1126/science.1123654; Dong M, 2007, J CELL BIOL, V179, P1511, DOI 10.1083/jcb.200707184; Dong M, 2008, MOL BIOL CELL, V19, P5226, DOI 10.1091/mbc.E08-07-0765; Foran P, 1986, BIOCHEMISTRY-US, V35, P2630; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Fu ZJ, 2009, BIOCHEMISTRY-US, V48, P5631, DOI 10.1021/bi9002138; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Karalewitz APA, 2012, J BIOL CHEM, V287, P40806, DOI 10.1074/jbc.M112.404244; Kozaki S, 1998, MICROB PATHOGENESIS, V25, P91, DOI 10.1006/mpat.1998.0214; KURAZONO H, 1985, FEMS MICROBIOL LETT, V30, P47; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Montal M, 2010, ANNU REV BIOCHEM, V79, P591, DOI 10.1146/annurev.biochem.051908.125345; Nakamura K, 2012, INFECT IMMUN, V80, P2886, DOI 10.1128/IAI.00302-12; Nakamura K, 2010, VET MICROBIOL, V140, P147, DOI 10.1016/j.vetmic.2009.07.023; NISHIKI T, 1994, J BIOL CHEM, V269, P10498; Peng LS, 2012, J CELL SCI, V125, P3233, DOI 10.1242/jcs.103564; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; SIMPSON LL, 1986, ANNU REV PHARMACOL, V26, P427, DOI 10.1146/annurev.pa.26.040186.002235; Soprano DR, 2007, VITAM HORM, V75, P69, DOI 10.1016/S0083-6729(06)75003-8; Strotmeier J, 2011, MOL MICROBIOL, V81, P143, DOI 10.1111/j.1365-2958.2011.07682.x; Tsukamoto K, 2005, J BIOL CHEM, V280, P35164, DOI 10.1074/jbc.M507596200; Tsukamoto K, 2012, MICROBIOL IMMUNOL, V56, P664, DOI 10.1111/j.1348-0421.2012.00490.x	25	7	7	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132363	10.1371/journal.pone.0132363	http://dx.doi.org/10.1371/journal.pone.0132363			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177297	Green Submitted, Green Published, gold			2022-12-26	WOS:000358197600105
J	Warrier, V; Chakrabarti, B; Murphy, L; Chan, A; Craig, I; Mallya, U; Lakatosova, S; Rehnstrom, K; Peltonen, L; Wheelwright, S; Allison, C; Fisher, SE; Baron-Cohen, S				Warrier, Varun; Chakrabarti, Bhismadev; Murphy, Laura; Chan, Allen; Craig, Ian; Mallya, Uma; Lakatosova, Silvia; Rehnstrom, Karola; Peltonen, Leena; Wheelwright, Sally; Allison, Carrie; Fisher, Simon E.; Baron-Cohen, Simon			A Pooled Genome-Wide Association Study of Asperger Syndrome	PLOS ONE			English	Article							AUTISM; DNA; MICROARRAYS; RISK; LOCI; IDENTIFICATION; IMPAIRMENT; OVERLAP; SAMPLES; SNPS	Asperger Syndrome (AS) is a neurodevelopmental condition characterized by impairments in social interaction and communication, alongside the presence of unusually repetitive, restricted interests and stereotyped behaviour. Individuals with AS have no delay in cognitive and language development. It is a subset of Autism Spectrum Conditions (ASC), which are highly heritable and has a population prevalence of approximately 1%. Few studies have investigated the genetic basis of AS. To address this gap in the literature, we performed a genome-wide pooled DNA association study to identify candidate loci in 612 individuals (294 cases and 318 controls) of Caucasian ancestry, using the Affymetrix GeneChip Human Mapping version 6.0 array. We identified 11 SNPs that had a p-value below 1x10(-5). These SNPs were independently genotyped in the same sample. Three of the SNPs (rs1268055, rs7785891 and rs2782448) were nominally significant, though none remained significant after Bonferroni correction. Two of our top three SNPs (rs7785891 and rs2782448) lie in loci previously implicated in ASC. However, investigation of the three SNPs in the ASC genome-wide association dataset from the Psychiatric Genomics Consortium indicated that these three SNPs were not significantly associated with ASC. The effect sizes of the variants were modest, indicating that our study was not sufficiently powered to identify causal variants with precision.	[Warrier, Varun; Chakrabarti, Bhismadev; Murphy, Laura; Chan, Allen; Mallya, Uma; Lakatosova, Silvia; Wheelwright, Sally; Allison, Carrie; Baron-Cohen, Simon] Univ Cambridge, Dept Psychiat, Autism Res Ctr, Cambridge, England; [Chakrabarti, Bhismadev] Univ Reading, Ctr Integrat Neurosci & Neurodynam, Sch Psychol & Clin Language Sci, Reading, Berks, England; [Craig, Ian] Kings Coll London, Inst Psychiat, MRC Ctr Social Genet & Dev Psychiat, London WC2R 2LS, England; [Rehnstrom, Karola; Peltonen, Leena] Wellcome Trust Sanger Inst, Hinxton, Cambs, England; [Fisher, Simon E.] Max Planck Inst Psycholinguist, NL-6500 AH Nijmegen, Netherlands; [Fisher, Simon E.] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands; [Baron-Cohen, Simon] Cambridgeshire & Peterborough NHS Fdn Trust CPFT, CLASS Clin, Cambridge, England	University of Cambridge; University of Reading; University of London; King's College London; Wellcome Trust Sanger Institute; Max Planck Society; Radboud University Nijmegen	Warrier, V (corresponding author), Univ Cambridge, Dept Psychiat, Autism Res Ctr, Cambridge, England.	vw260@medschl.cam.ac.uk; sb205@cam.ac.uk	Fisher, Simon E./E-9130-2012; Craig, Ian/AAF-9167-2019	Fisher, Simon E./0000-0002-3132-1996; Chakrabarti, Bhismadev/0000-0002-6649-7895; Murphy, Laura/0000-0003-0029-0434; Warrier, Varun/0000-0003-4532-8571; Wheelwright, Sally/0000-0003-0657-2483; Baron-Cohen, Simon/0000-0001-9217-2544	Nancy Lurie Marks Family Foundation; Medical Research Council (MRC) UK; Target Autism Genome; Autism Research Trust (ART); Max Planck Society; St. John's College, Cambridge; Cambridge Commonwealth Trust	Nancy Lurie Marks Family Foundation; Medical Research Council (MRC) UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Target Autism Genome; Autism Research Trust (ART); Max Planck Society(Max Planck SocietyFoundation CELLEX); St. John's College, Cambridge; Cambridge Commonwealth Trust	This work was funded by grants to SB-C from the Nancy Lurie Marks Family Foundation, the Medical Research Council (MRC) UK, Target Autism Genome, and the Autism Research Trust (ART). LM and SEF were supported by the Max Planck Society. VW is funded by St. John's College, Cambridge and the Cambridge Commonwealth Trust.	American Psychiatric Association, 1994, DIAGN STAT MAN MENT; [Anonymous], CEREB CORTEX; Baron-Cohen S, 2009, BRIT J PSYCHIAT, V194, P500, DOI 10.1192/bjp.bp.108.059345; Barratt BJ, 2002, ANN HUM GENET, V66, P393, DOI [10.1046/j.1469-1809.2002.00125.x, 10.1017/S0003480002001252]; Bartlett CW, 2004, HUM HERED, V57, P10, DOI 10.1159/000077385; Bartlett CW, 2002, AM J HUM GENET, V71, P45, DOI 10.1086/341095; Bill BR, 2009, CURR OPIN GENET DEV, V19, P271, DOI 10.1016/j.gde.2009.04.004; Butcher LM, 2004, BEHAV GENET, V34, P549, DOI 10.1023/B:BEGE.0000038493.26202.d3; Butcher LM, 2005, HUM MOL GENET, V14, P1315, DOI 10.1093/hmg/ddi142; Chakrabarti B, 2009, AUTISM RES, V2, P157, DOI 10.1002/aur.80; Chelala C, 2009, BIOINFORMATICS, V25, P655, DOI 10.1093/bioinformatics/btn653; Davis OSP, 2009, BIOINFORMATICS, V25, P281, DOI 10.1093/bioinformatics/btn587; Gaugler T, 2014, NAT GENET, V46, P881, DOI 10.1038/ng.3039; Geschwind DH, 2009, ANNU REV MED, V60, P367, DOI 10.1146/annurev.med.60.053107.121225; Hallmayer J, 2011, ARCH GEN PSYCHIAT, V68, P1095, DOI 10.1001/archgenpsychiatry.2011.76; Klei L, 2012, MOL AUTISM, V3, DOI 10.1186/2040-2392-3-9; Lai M-C, 2013, LANCET, V13, P61539; Maestrini E, 2010, MOL PSYCHIATR, V15, P954, DOI 10.1038/mp.2009.34; Mbadiwe Tafari, 2013, Autism Res Treat, V2013, P826156, DOI 10.1155/2013/826156; Meaburn EL, 2008, MOL PSYCHIATR, V13, P729, DOI 10.1038/sj.mp.4002063; Pagnamenta AT, 2010, BIOL PSYCHIAT, V68, P320, DOI 10.1016/j.biopsych.2010.02.002; Persico AM, 2013, BEHAV BRAIN RES, V251, P95, DOI 10.1016/j.bbr.2013.06.012; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Samaco RC, 2005, HUM MOL GENET, V14, P483, DOI 10.1093/hmg/ddi045; Schosser Alexandra, 2010, BMC Res Notes, V3, P274, DOI 10.1186/1756-0500-3-274; Smoller JW, 2013, LANCET, V381, P1371, DOI 10.1016/S0140-6736(12)62129-1; Szelinger S, 2011, METHODS MOL BIOL, V700, P49, DOI 10.1007/978-1-61737-954-3_4; Talebizadeh Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067569; Tian C, 2008, HUM MOL GENET, V17, pR143, DOI 10.1093/hmg/ddn268; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917	30	6	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0131202	10.1371/journal.pone.0131202	http://dx.doi.org/10.1371/journal.pone.0131202			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176695	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000358197600038
J	Maher, M; Churchill, NW; Manoel, ALD; Graham, SJ; Macdonald, RL; Schweizer, TA				Maher, Monica; Churchill, Nathan W.; Manoel, Airton Leonardo de Oliveira; Graham, Simon J.; Macdonald, R. Loch; Schweizer, Tom A.			Altered Resting-State Connectivity within Executive Networks after Aneurysmal Subarachnoid Hemorrhage	PLOS ONE			English	Article							QUALITY-OF-LIFE; SORTING TEST-PERFORMANCE; VERBAL FLUENCY; COGNITIVE DYSFUNCTION; DEPRESSION; STROKE; IMPAIRMENT; VALIDITY; DISEASE; LESIONS	Aneurysmal subarachnoid hemorrhage (aSAH) is associated with significant mortality rates, and most survivors experience significant cognitive deficits across multiple domains, including executive function. It is critical to determine the neural basis for executive deficits in aSAH, in order to better understand and improve patient outcomes. This study is the first examination of resting-state functional Magnetic Resonance Imaging in a group of aSAH patients, used to characterize changes in functional connectivity of the frontoparietal network. We scanned 14 aSAH patients and 14 healthy controls, and divided patients into "impaired" and "unimpaired" groups based on a composite executive function score. Impaired patients exhibited significantly lower quality of life and neuropsychological impairment relative to controls, across multiple domains. Seed-based functional connectivity analysis demonstrated that unimpaired patients were not significantly different from controls, but impaired patients had increased frontoparietal connectivity. Patients evidenced increased frontoparietal connectivity as a function of decreased executive function and decreased mood (i.e. quality of life). In addition, T1 morphometric analysis demonstrated that these changes are not attributable to local cortical atrophy among aSAH patients. These results establish significant, reliable changes in the endogenous brain dynamics of aSAH patients, that are related to cognitive and mood outcomes.	[Maher, Monica] Univ Toronto, Fac Med, Toronto, ON, Canada; [Churchill, Nathan W.; Manoel, Airton Leonardo de Oliveira] St Michaels Hosp, Keenan Res Ctr Biomed Sci, Li Ka Shing Knowledge Inst, Neurosci Res Program, Toronto, ON M5B 1W8, Canada; [Graham, Simon J.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Graham, Simon J.] Sunnybrook Hlth Sci Ctr, Sunnybrook Res Inst, Toronto, ON M4N 3M5, Canada; [Macdonald, R. Loch; Schweizer, Tom A.] St Michaels Hosp, Keenan Res Ctr Biomed Sci, Li Ka Shing Knowledge Inst, 30 Bond St, Toronto, ON M5B 1W8, Canada; [Macdonald, R. Loch; Schweizer, Tom A.] St Michaels Hosp, Div Neurosurg, Toronto, ON M5B 1W8, Canada; [Macdonald, R. Loch; Schweizer, Tom A.] Univ Toronto, Dept Neurosurg, Div Neurosurg, Toronto, ON, Canada	University of Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto	Schweizer, TA (corresponding author), St Michaels Hosp, Keenan Res Ctr Biomed Sci, Li Ka Shing Knowledge Inst, 30 Bond St, Toronto, ON M5B 1W8, Canada.	SchweizerT@smh.ca	de Oliveira Manoel, Airton Leonardo/C-4724-2018	de Oliveira Manoel, Airton Leonardo/0000-0002-9593-1013	Heart and Stroke Foundation of Canada [G-13-0002824]; Heart and Stroke Foundation of Ontario; Ontario Ministry of Research and Innovation; Brain Aneurysm Foundation; Canadian Institutes for Health Research; Heart and Stroke Foundation of Canada; Edge Therapeutics, Inc.	Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Ontario Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario); Brain Aneurysm Foundation; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Edge Therapeutics, Inc.	This work was supported by a Personnel Award from the Heart and Stroke Foundation of Canada, Operating Award from the Heart and Stroke Foundation of Ontario and an Early Researcher Award from the Ontario Ministry of Research and Innovation to TAS. It was also supported in part by grant G-13-0002824 awarded from the Heart and Stroke Foundation of Canada to SJG. RLM receives grant support from the Physicians Services Incorporated Foundation, Brain Aneurysm Foundation, Canadian Institutes for Health Research, and the Heart and Stroke Foundation of Canada. Edge Therapeutics, Inc. supplied support in the form of salary to R. Loch Macdonald, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Al-Khindi T, 2010, STROKE, V41, pE519, DOI 10.1161/STROKEAHA.110.581975; Armitage SG, 1946, PSYCHOL MONOGR, V60, P1; Barch D., 2013, AM J GERIATRIC PSYCH, V20, P682; Baune BT, 2014, PSYCHIAT RES, V219, P25, DOI 10.1016/j.psychres.2014.05.013; BENTON AL, 1968, NEUROPSYCHOLOGIA, V6, P53, DOI 10.1016/0028-3932(68)90038-9; Berg EA, 1948, J GEN PSYCHOL, V39, P15, DOI 10.1080/00221309.1948.9918159; Brodtmann A. P. H. L. Q. L. R. O. L. C. T., 2012, J NEUROLOGICAL SCI, V322; Cannon R., 2014, CLIN EEG NEUROSCI, V45, P1; Chung C. P. A., 2012, HEALTH; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Davidson PSR, 2008, J CLIN EXP NEUROPSYC, V30, P18, DOI 10.1080/13803390601161166; Dean PJ S, 2009, BRAIN BEHAV, V5; Delnooz CCS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062877; Di Pellegrino G. C. E. L. E., 2007, J COGNITIVE NEUROSCI, V19; Dobkin RD, 2007, MOVEMENT DISORD, V22, P946, DOI 10.1002/mds.21455; Doolittle ND, 2013, NEUROLOGY, V81, P84, DOI 10.1212/WNL.0b013e318297eeba; Dumas R, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-87; Egge A, 2005, ACTA NEUROL SCAND, V112, P76, DOI 10.1111/j.1600-0404.2005.00449.x; Ellmore TM, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00179; Fan J, 2002, J COGNITIVE NEUROSCI, V14, P340, DOI 10.1162/089892902317361886; Frontera J., 2013, J NEUROLOGY, P2014; Hackett ML, 2000, NEUROLOGY, V55, P658, DOI 10.1212/WNL.55.5.658; Hadeishi H, 2002, NEUROSURGERY, V50, P741, DOI 10.1097/00006123-200204000-00010; He Y. E. A., 2010, CURRENT OPINION NEUR, V23; Hillis AE, 2000, J NEUROL NEUROSUR PS, V69, P608, DOI 10.1136/jnnp.69.5.608; Hollender KD, 2014, J NEUROSCI NURS, V46, P135, DOI 10.1097/JNN.0000000000000047; Hop JW, 1997, STROKE, V28, P660, DOI 10.1161/01.STR.28.3.660; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Kjaer TW, 2002, NEUROIMAGE, V17, P1080, DOI 10.1006/nimg.2002.1230; Kraemer M. S. T. H. G. Q. B. W. O. S. R., 2004, J NEUROIMAGING, V14; Kreiter KT, 2002, STROKE, V33, P200, DOI 10.1161/hs0102.101080; Lee MH, 2013, AM J NEURORADIOL, V34, P1866, DOI 10.3174/ajnr.A3263; Lou HC, 2004, P NATL ACAD SCI USA, V101, P6827, DOI 10.1073/pnas.0400049101; Mikell CB, 2015, STROKE, V46, P49, DOI 10.1161/STROKEAHA.114.007645; ODONNELL WE, 1993, J CLIN PSYCHOL, V49, P372, DOI 10.1002/1097-4679(199305)49:3<372::AID-JCLP2270490311>3.0.CO;2-K; Ovadia-Caro S, 2014, STROKE, V45, P2818, DOI 10.1161/STROKEAHA.114.003689; Possin KL, 2014, J INT NEUROPSYCH SOC, V20, P20, DOI 10.1017/S1355617713000611; Pugh KG, 2003, J AM GERIATR SOC, V51, P1439, DOI 10.1046/j.1532-5415.2003.51463.x; Rosazza C, 2011, NEUROL SCI, V32, P773, DOI 10.1007/s10072-011-0636-y; Sato K, 2010, J CEREBR BLOOD F MET, V30, P1110, DOI 10.1038/jcbfm.2009.264; Shehzad Z, 2009, CEREB CORTEX, V19, P2209, DOI 10.1093/cercor/bhn256; Smith AB, 2004, HUM BRAIN MAPP, V21, P247, DOI 10.1002/hbm.20007; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Stebbins G. N. D. W. C. C. J. F. S. B. K. e. a., 2008, STROKE, V39; Stuss DT, 2000, NEUROPSYCHOLOGIA, V38, P388, DOI 10.1016/S0028-3932(99)00093-7; Stuss DT, 1998, J INT NEUROPSYCH SOC, V4, P265, DOI 10.1017/S1355617798002653; Stuss DT, 2002, ANNU REV PSYCHOL, V53, P401, DOI 10.1146/annurev.psych.53.100901.135220; Thiel A, 2015, STROKE, V46, P296, DOI 10.1161/STROKEAHA.114.006307; TIDSWELL P, 1995, NEUROLOGY, V45, P875; Troyer AK, 1998, NEUROPSYCHOLOGIA, V36, P499, DOI 10.1016/S0028-3932(97)00152-8; Weschler D, 1997, WESCHLER ADULT INTEL; Williams LS, 1999, STROKE, V30, P1362, DOI 10.1161/01.STR.30.7.1362	52	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0130483	10.1371/journal.pone.0130483	http://dx.doi.org/10.1371/journal.pone.0130483			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26172281	Green Submitted, Green Published, gold			2022-12-26	WOS:000358194900007
J	Steketee, RME; Mutsaerts, HJMM; Bron, EE; van Osch, MJP; Majoie, CBLM; van der Lugt, A; Nederveen, AJ; Smits, M				Steketee, Rebecca M. E.; Mutsaerts, Henri J. M. M.; Bron, Esther E.; van Osch, Matthias J. P.; Majoie, Charles B. L. M.; van der Lugt, Aad; Nederveen, Aart J.; Smits, Marion			Quantitative Functional Arterial Spin Labeling (fASL) MRI - Sensitivity and Reproducibility of Regional CBF Changes Using Pseudo-Continuous ASL Product Sequences	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; PERFUSION MRI; MOTOR ACTIVATION; WHOLE-BRAIN; BOLD; TIME; RELIABILITY; PRECISION; LOCALIZATION; EFFICIENCY	Arterial spin labeling (ASL) magnetic resonance imaging is increasingly used to quantify task-related brain activation. This study assessed functional ASL (fASL) using pseudo-continuous ASL (pCASL) product sequences from two vendors. By scanning healthy participants twice with each sequence while they performed a motor task, this study assessed functional ASL for 1) its sensitivity to detect task-related cerebral blood flow (CBF) changes, and 2) its reproducibility of resting CBF and absolute CBF changes (delta CBF) in the motor cortex. Whole-brain voxel-wise analyses showed that sensitivity for motor activation was sufficient with each sequence, and comparable between sequences. Reproducibility was assessed with within-subject coefficients of variation (wsCV) and intraclass correlation coefficients (ICC). Reproducibility of resting CBF was reasonably good within (wsCV: 14.1-15.7%; ICC: 0.69-0.77) and between sequences (wsCV: 15.1%; ICC: 0.69). Reproducibility of delta CBF was relatively low, both within (wsCV: 182-297%; ICC: 0.04-0.32) and between sequences (wsCV: 185%; ICC: 0.45), while inter-session variation was low. This may be due to delta CBF's small mean effect (0.77-1.32 mL/100g gray matter/min). In conclusion, fASL seems sufficiently sensitive to detect task-related changes on a group level, with acceptable inter-sequence differences. Resting CBF may provide a consistent baseline to compare task-related activation to, but absolute regional CBF changes are more variable, and should be interpreted cautiously when acquired with two pCASL product sequences.	[Steketee, Rebecca M. E.; Bron, Esther E.; van der Lugt, Aad; Smits, Marion] Erasmus MC Univ Med Ctr Rotterdam, Dept Radiol, Rotterdam, Netherlands; [Mutsaerts, Henri J. M. M.; Majoie, Charles B. L. M.; Nederveen, Aart J.] Univ Amsterdam, Acad Med Ctr, Dept Radiol, NL-1105 AZ Amsterdam, Netherlands; [Bron, Esther E.] Erasmus MC Univ Med Ctr Rotterdam, Dept Med Informat, Biomed Imaging Grp Rotterdam, Rotterdam, Netherlands; [van Osch, Matthias J. P.] Leiden Univ, Med Ctr, CJ Gorter Ctr High Field MRI, Leiden, Netherlands	Erasmus University Rotterdam; Erasmus MC; University of Amsterdam; Academic Medical Center Amsterdam; Erasmus University Rotterdam; Erasmus MC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Smits, M (corresponding author), Erasmus MC Univ Med Ctr Rotterdam, Dept Radiol, Rotterdam, Netherlands.	marion.smits@erasmusmc.nl	Smits, Marion/E-4795-2011; Smits, Marion/AAB-3985-2019; Steketee, Rebecca/AAA-4081-2020; Mutsaerts, Henk JMM/T-8656-2017; Van Osch, Matthias/AAV-3876-2021	Smits, Marion/0000-0001-5563-2871; Mutsaerts, Henk JMM/0000-0003-0894-0307; Van Osch, Matthias/0000-0001-7034-8959; Steketee, Rebecca/0000-0003-2689-5490; Bron, Esther/0000-0002-5778-9263; Nederveen, Aart/0000-0002-5477-973X	Dutch non-governmental organization 'Stichting Coolsingel' (Rotterdam, NL);  [179]	Dutch non-governmental organization 'Stichting Coolsingel' (Rotterdam, NL); 	This project was financially supported by the Dutch non-governmental organization 'Stichting Coolsingel' (Rotterdam, NL). The funder had no role in the study design; data collection, analysis or interpretation; writing of the report; or decision to submit the article for publication (grant no. 179, received by MS; http://www.stichtingcoolsingel.nl/).	Aguirre GK, 2002, NEUROIMAGE, V15, P488, DOI 10.1006/nimg.2001.0990; Alsop DC, 2015, MAGN RESON MED, V73, P102, DOI 10.1002/mrm.25197; Alsop DC, 1996, J CEREBR BLOOD F MET, V16, P1236, DOI 10.1097/00004647-199611000-00019; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Aslan S, 2010, MAGN RESON MED, V63, P765, DOI 10.1002/mrm.22245; Bron EE, 2014, HUM BRAIN MAPP, V35, P4916, DOI 10.1002/hbm.22522; Cavusoglu M, 2012, NEUROIMAGE, V59, P4044, DOI 10.1016/j.neuroimage.2011.10.056; Chen YF, 2011, J MAGN RESON IMAGING, V33, P940, DOI 10.1002/jmri.22345; Demeter E, 2011, NEUROIMAGE, V54, P1518, DOI 10.1016/j.neuroimage.2010.09.026; Fernandez-Seara MA, 2007, HUM BRAIN MAPP, V28, P1391, DOI 10.1002/hbm.20366; Floyd TF, 2003, J MAGN RESON IMAGING, V18, P649, DOI 10.1002/jmri.10416; Garcia DM, 2005, MAGN RESON MED, V54, P366, DOI 10.1002/mrm.20556; Gaxiola-Valdez I, 2012, MAGN RESON IMAGING, V30, P1394, DOI 10.1016/j.mri.2012.05.002; Gevers S, 2009, AM J NEURORADIOL, V30, P968, DOI 10.3174/ajnr.A1454; Gevers S, 2011, J CEREBR BLOOD F MET, V31, P1706, DOI 10.1038/jcbfm.2011.10; Gonzalez-At JB, 2000, MAGNET RESON MED, V43, P739, DOI 10.1002/(SICI)1522-2594(200005)43:5<739::AID-MRM17>3.0.CO;2-2; Gousias IS, 2008, NEUROIMAGE, V40, P672, DOI 10.1016/j.neuroimage.2007.11.034; Hammers A, 2003, HUM BRAIN MAPP, V19, P224, DOI 10.1002/hbm.10123; Heijtel DFR, 2014, NEUROIMAGE, V92, P182, DOI 10.1016/j.neuroimage.2014.02.011; Hermes M, 2007, MAGN RESON MATER PHY, V20, P103, DOI 10.1007/s10334-007-0073-3; Hu Y, 2007, MAGN RESON MED, V58, P947, DOI 10.1002/mrm.21328; Jahng GH, 2005, RADIOLOGY, V234, P909, DOI 10.1148/radiol.2343031499; Kemeny S, 2005, HUM BRAIN MAPP, V24, P173, DOI 10.1002/hbm.20078; Klein S, 2010, IEEE T MED IMAGING, V29, P196, DOI 10.1109/TMI.2009.2035616; Klomp A, 2012, NEUROIMAGE, V63, P1695, DOI 10.1016/j.neuroimage.2012.07.038; Lawrence KSS, 2005, MAGN RESON MED, V53, P425, DOI 10.1002/mrm.20364; Lu HZ, 2004, MAGN RESON MED, V52, P679, DOI 10.1002/mrm.20178; Mildner T, 2003, MAGNET RESON MED, V49, P791, DOI 10.1002/mrm.10438; Mutsaerts HJMM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104108; Obata T, 2004, NEUROIMAGE, V21, P144, DOI 10.1016/j.neuroimage.2003.08.040; OGAWA S, 1993, BIOPHYS J, V64, P803, DOI 10.1016/S0006-3495(93)81441-3; Parkes LM, 2004, MAGN RESON MED, V51, P736, DOI 10.1002/mrm.20023; Petersen ET, 2010, NEUROIMAGE, V49, P104, DOI 10.1016/j.neuroimage.2009.07.068; Pfefferbaum A, 2010, PSYCHIAT RES-NEUROIM, V182, P266, DOI 10.1016/j.pscychresns.2010.02.010; Pimentel MAF, 2013, HUM BRAIN MAPP, V34, P96, DOI 10.1002/hbm.21418; Raoult H, 2012, J MAGN RESON IMAGING, V36, P1435, DOI 10.1002/jmri.23782; Raoult H, 2011, NEUROIMAGE, V58, P157, DOI 10.1016/j.neuroimage.2011.06.011; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Tjandra T, 2005, NEUROIMAGE, V27, P393, DOI 10.1016/j.neuroimage.2005.04.021; van Osch MJP, 2007, J MAGN RESON IMAGING, V25, P215, DOI 10.1002/jmri.20823; Vidorreta M, 2013, NEUROIMAGE, V66, P662, DOI 10.1016/j.neuroimage.2012.10.087; Wang JJ, 2003, MAGN RESON MED, V49, P796, DOI 10.1002/mrm.10437; Wang Y, 2011, NEUROIMAGE, V54, P1188, DOI 10.1016/j.neuroimage.2010.08.043; Wu B, 2014, J MAGN RESON IMAGING, V39, P402, DOI 10.1002/jmri.24175; Wu WC, 2011, NEUROIMAGE, V56, P1244, DOI 10.1016/j.neuroimage.2011.02.080; Xu GF, 2010, NMR BIOMED, V23, P286, DOI 10.1002/nbm.1462; Ye FQ, 1999, MAGNET RESON MED, V42, P404, DOI 10.1002/(SICI)1522-2594(199908)42:2<404::AID-MRM23>3.0.CO;2-0; Yen YF, 2002, MAGNET RESON MED, V47, P921, DOI 10.1002/mrm.10140; Yousry TA, 1997, BRAIN, V120, P141, DOI 10.1093/brain/120.1.141	49	17	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132929	10.1371/journal.pone.0132929	http://dx.doi.org/10.1371/journal.pone.0132929			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26172381	Green Published, gold, Green Submitted			2022-12-26	WOS:000358194900104
J	Troegeler, A; Lugo-Villarino, G; Hansen, S; Rasolofo, V; Henriksen, ML; Mori, K; Ohtani, K; Duval, C; Mercier, I; Benard, A; Nigou, J; Hudrisier, D; Wakamiya, N; Neyrolles, O				Troegeler, Anthony; Lugo-Villarino, Geanncarlo; Hansen, Soren; Rasolofo, Voahangy; Henriksen, Maiken Lumby; Mori, Kenichiro; Ohtani, Katsuki; Duval, Carine; Mercier, Ingrid; Benard, Alan; Nigou, Jerome; Hudrisier, Denis; Wakamiya, Nobutaka; Neyrolles, Olivier			Collectin CL-LK Is a Novel Soluble Pattern Recognition Receptor for Mycobacterium tuberculosis	PLOS ONE			English	Article							HUMAN DENDRITIC CELLS; 11 CL-11; COMPLEMENT-SYSTEM; DC-SIGN; CL-K1; BINDING; LECTIN; LIPOARABINOMANNAN; PHAGOCYTOSIS; MACROPHAGES	Understanding the molecular components of immune recognition of the tuberculosis ( TB) bacillus, Mycobacterium tuberculosis, can help designing novel strategies to combat TB. Here, we identify collectin CL-LK as a novel soluble C-type lectin able to bind M. tuberculosis, and characterize mycobacterial mannose-capped lipoarabinomannan as a primary ligand for CL-LK. Mice deficient in CL-K1, one of the CL-LK subunits, do not display altered susceptibility to M. tuberculosis. However, we found that the amount of CL-LK in the serum of patients with active TB is reduced, compared to that in controls, and correlates inversely to the magnitude of the immune response to the pathogen. These findings indicate that CL-LK might be of interest for future diagnostic and treatment monitoring purposes.	[Troegeler, Anthony; Lugo-Villarino, Geanncarlo; Duval, Carine; Mercier, Ingrid; Benard, Alan; Nigou, Jerome; Hudrisier, Denis; Neyrolles, Olivier] CNRS, Inst Pharmacol & Biol Struct, Toulouse, France; [Troegeler, Anthony; Lugo-Villarino, Geanncarlo; Duval, Carine; Mercier, Ingrid; Benard, Alan; Nigou, Jerome; Hudrisier, Denis; Neyrolles, Olivier] Univ Toulouse 3, Inst Pharmacol & Biol Struct, F-31062 Toulouse, France; [Hansen, Soren] Univ Southern Denmark, Inst Mol Med, Dept Canc & Inflammat Res, Odense, Denmark; [Rasolofo, Voahangy] Pasteur Inst Antananarivo, Mycobacteria Unit, Antananarivo, Madagascar; [Mori, Kenichiro; Ohtani, Katsuki; Wakamiya, Nobutaka] Asahikawa Med Univ, Dept Microbiol & Immunochem, Asahikawa, Hokkaido, Japan	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); University of Southern Denmark; Asahikawa Medical College	Neyrolles, O (corresponding author), CNRS, Inst Pharmacol & Biol Struct, Toulouse, France.	olivier.neyrolles@ipbs.fr	Lugo, Geanncarlo/H-4674-2019; Neyrolles, Olivier/AAG-3692-2019; Nigou, Jérôme/D-6802-2019	Lugo, Geanncarlo/0000-0003-4620-8491; Neyrolles, Olivier/0000-0003-0047-5885; Nigou, Jérôme/0000-0002-6233-2487; Hudrisier, Denis/0000-0002-3631-9561; Hansen, Soren/0000-0002-8186-4630	Fondation pour la Recherche Medicale (FRM); European Union (NEWTBVAC project) [241745]; Fondation Bettencourt-Schueller; Centre National de la Recherche Scientifique (CNRS); University of Toulouse; Agence Nationale de la Recherche (ANR)/Programme d'Investissements d'Avenir (PIA grant) [ANR-11-EQUIPEX-0003]; French Ministry of Higher Education and Research [ANR-12-BSV3-0002 B-TB]	Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); European Union (NEWTBVAC project); Fondation Bettencourt-Schueller; Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); University of Toulouse; Agence Nationale de la Recherche (ANR)/Programme d'Investissements d'Avenir (PIA grant)(French National Research Agency (ANR)); French Ministry of Higher Education and Research	This work was supported by Centre National de la Recherche Scientifique (CNRS), University of Toulouse, Agence Nationale de la Recherche (ANR)/Programme d'Investissements d'Avenir (PIA grant number ANR-11-EQUIPEX-0003) and ANR-12-BSV3-0002 B-TB grant, French Ministry of Higher Education and Research (fellowship to A. T.), Fondation pour la Recherche Medicale (FRM fellowships to G.L.V., A.B. and C.D.), European Union (NEWTBVAC project, project no 241745), and Fondation Bettencourt-Schueller. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Degn SE, 2011, AM J HUM GENET, V88, P689, DOI 10.1016/j.ajhg.2011.05.011; Doherty TM, 2005, J IMMUNOL METHODS, V298, P129, DOI 10.1016/j.jim.2005.01.013; Ferguson JS, 2004, INFECT IMMUN, V72, P2564, DOI 10.1128/IAI.72.5.2564-2573.2004; Ferguson JS, 1999, J IMMUNOL, V163, P312; Geijtenbeek TBH, 2003, J EXP MED, V197, P7, DOI 10.1084/jem.20021229; Gouzy A, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003928; Gupta A, 2012, IMMUNOBIOLOGY, V217, P363, DOI 10.1016/j.imbio.2011.07.008; Hakansson K, 2000, PROTEIN SCI, V9, P1607, DOI 10.1110/ps.9.9.1607; Hansen S, 2010, J IMMUNOL, V185, P6096, DOI 10.4049/jimmunol.1002185; Henriksen ML, 2014, J IMMUNOL METHODS, V413, P25, DOI 10.1016/j.jim.2014.07.006; Henriksen ML, 2013, J IMMUNOL, V191, P6117, DOI 10.4049/jimmunol.1302121; Henriksen ML, 2013, MOL IMMUNOL, V56, P757, DOI 10.1016/j.molimm.2013.07.011; Keshi H, 2006, MICROBIOL IMMUNOL, V50, P1001, DOI 10.1111/j.1348-0421.2006.tb03868.x; Lemos MP, 2011, INFECT IMMUN, V79, P1077, DOI 10.1128/IAI.00286-10; Motomura W, 2008, J HISTOCHEM CYTOCHEM, V56, P243, DOI 10.1369/jhc.7A7312.2007; Nigou J, 2001, J IMMUNOL, V166, P7477, DOI 10.4049/jimmunol.166.12.7477; O'Garra A, 2013, ANNU REV IMMUNOL, V31, P475, DOI 10.1146/annurev-immunol-032712-095939; Rakotosamimanana N, 2010, CLIN VACCINE IMMUNOL, V17, P1094, DOI 10.1128/CVI.00049-10; SCHLESINGER LS, 1994, J IMMUNOL, V152, P4070; SCHLESINGER LS, 1993, J IMMUNOL, V150, P2920; Selman L, 2012, J IMMUNOL METHODS, V375, P182, DOI 10.1016/j.jim.2011.10.010; Selman L, 2012, IMMUNOBIOLOGY, V217, P851, DOI 10.1016/j.imbio.2011.12.008; Sidobre S, 2000, J BIOL CHEM, V275, P2415, DOI 10.1074/jbc.275.4.2415; Tailleux L, 2003, J EXP MED, V197, P121, DOI 10.1084/jem.20021468; Torrelles JB, 2008, CURR DRUG TARGETS, V9, P102; Wright JR, 2005, NAT REV IMMUNOL, V5, P58, DOI 10.1038/nri1528; Yoshizaki T, 2012, J BIOCHEM, V151, P57, DOI 10.1093/jb/mvr114; Zumla A, 2013, LANCET, V382, P1765, DOI 10.1016/S0140-6736(13)62078-4	28	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132692	10.1371/journal.pone.0132692	http://dx.doi.org/10.1371/journal.pone.0132692			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26173080	Green Published, Green Submitted, gold			2022-12-26	WOS:000358194900078
J	Guariguata, L; de Beer, I; Hough, R; Mulongeni, P; Feeley, FG; de Wit, TFR				Guariguata, Leonor; de Beer, Ingrid; Hough, Rina; Mulongeni, Pancho; Feeley, Frank G.; de Wit, Tobias F. Rinke			Prevalence and Knowledge Assessment of HIV and Non-Communicable Disease Risk Factors among Formal Sector Employees in Namibia	PLOS ONE			English	Article							SEXUAL-BEHAVIOR; DIABETES-MELLITUS; HEALTH CONDITIONS; BLOOD-PRESSURE; LIFE-STYLES; HYPERTENSION; AWARENESS; PROGRAM; POPULATION; PERCEPTION	Introduction The burden of non-communicable diseases (NCDs) is growing in sub-Saharan Africa combined with an already high prevalence of infectious disease, like HIV. Engaging the formal employment sector may present a viable strategy for addressing both HIV and NCDs in people of working age. This study assesses the presence of three of the most significant threats to health in Namibia among employees in the formal sector: elevated blood pressure, elevated blood glucose, and HIV and assesses the knowledge and self-perceived risk of employees for these conditions. Methods A health and wellness screening survey of employees working in 13 industries in the formal sector of Namibia was conducted including 11,192 participants in the Bophelo! Project in Namibia, from January 2009 to October 2010. The survey combined a medical screening for HIV, blood glucose and blood pressure with an employee-completed survey on knowledge and risk behaviors for those conditions. We estimated the prevalence of the three conditions and compared to self-reported employee knowledge and risk behaviors and possible determinants. Results 25.8% of participants had elevated blood pressure, 8.3% of participants had an elevated random blood glucose measurement, and 8.9% of participants tested positive for HIV. Most participants were not smokers (80%), reported not drinking alcohol regularly (81.2%), and had regular condom use (66%). Most participants could not correctly identify risk factors for hypertension (57.2%), diabetes (57.3%), or high-risk behaviors for HIV infection (59.5%). In multivariate analysis, having insurance (OR: 1.15, 95% CI: 1.03 - 1.28) and a managerial position (OR: 1.29, 95% CI: 1.13 - 1.47) were associated with better odds of knowledge of diabetes. Conclusion The prevalence of elevated blood pressure, elevated blood glucose, and HIV among employees of the Namibian formal sector is high, while risk awareness is low. Attention must be paid to improving the knowledge of health-related risk factors as well as providing care to those with chronic conditions in the formal sector through programs such as work-place wellness.	[Guariguata, Leonor; de Wit, Tobias F. Rinke] PharmAccess Fdn, Amsterdam, Netherlands; [de Beer, Ingrid; Hough, Rina; Mulongeni, Pancho] PharmAccess Fdn, Windhoek, Namibia; [Feeley, Frank G.] Boston Univ, Sch Publ Hlth, Boston, MA USA; [de Wit, Tobias F. Rinke] Univ Amsterdam, Acad Med Ctr, Amsterdam Inst Global Hlth & Dev, NL-1105 AZ Amsterdam, Netherlands	Boston University; University of Amsterdam; Academic Medical Center Amsterdam	Guariguata, L (corresponding author), PharmAccess Fdn, Amsterdam, Netherlands.	leonor.guariguata@gmail.com		Guariguata, Leonor/0000-0003-1682-7160	Namibia Global Fund Program; Dutch Foreign Ministry; Ministry of Health and Social Services; Dutch Postcode Loterij; Dutch Aidsfonds; Stop AIDS Now!; HIVOS; Global Fund	Namibia Global Fund Program; Dutch Foreign Ministry; Ministry of Health and Social Services; Dutch Postcode Loterij; Dutch Aidsfonds; Stop AIDS Now!; HIVOS; Global Fund	The Namibia Global Fund Program provided funding for the HIV screening of the Bophelo! program. The funding for the Bophelo! is provided by The Dutch Foreign Ministry. The Bophelo! Project is a partnership between the PharmAccess Foundation, the Namibian Business Coalition on AIDS, and the Namibian Institute of Pathology, supported by the Ministry of Health and Social Services. The project was initially created using funds from the Dutch Postcode Loterij, through the Dutch Aidsfonds, Stop AIDS Now!, HIVOS and the Global Fund to fight AIDS, TB and Malaria. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abubakari AR, 2013, INT J GEN MED, V6, P617, DOI 10.2147/IJGM.S46649; Akwara PA, 2003, J BIOSOC SCI, V35, P385, DOI 10.1017/S0021932003003857; Albarracin D, 2005, PSYCHOL BULL, V131, P856, DOI 10.1037/0033-2909.131.6.856; Archer W Roodly, 2011, Am J Health Promot, V25, pe12, DOI 10.4278/ajhp.090421-QUAN-144; Clark MJ, 2000, PUBLIC HEALTH NURS, V17, P452, DOI 10.1046/j.1525-1446.2000.00452.x; Collins JJ, 2005, J OCCUP ENVIRON MED, V47, P547, DOI 10.1097/01.jom.0000166864.58664.29; Commodore-Mensah Y, 2014, J HYPERTENS, V32, P464, DOI 10.1097/HJH.0000000000000061; Cooper M, 2012, ETHNIC HEALTH, V17, P597, DOI 10.1080/13557858.2012.740003; Dzudie A, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001217; Fenton KA, 2002, SEX TRANSM INFECT, V78, P241, DOI 10.1136/sti.78.4.241; Fisher HH, 2011, AIDS BEHAV, V15, P1691, DOI 10.1007/s10461-011-9961-7; Freak-Poli R, 2010, J OCCUP ENVIRON MED, V52, P1132, DOI 10.1097/JOM.0b013e3181f8da77; Green EC, 2006, AIDS BEHAV, V10, P335, DOI 10.1007/s10461-006-9073-y; Guariguata L, 2013, DIABETES RES CLIN PR; Guariguata L, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-44; Hall V, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-564; Huang SQ, 2011, HYPERTENS RES, V34, P503, DOI 10.1038/hr.2010.265; Kirigia JM, 2009, BMC INT HEALTH HUM R, V9, DOI 10.1186/1472-698X-9-6; Kolbe-Alexander T, 2014, J OCCUP ENVIRON MED, V56, P1094, DOI 10.1097/JOM.0000000000000236; Lee LL, 2010, INT J NURS STUD, V47, P1545, DOI 10.1016/j.ijnurstu.2010.08.008; Lindstrom J, 2003, J AM SOC NEPHROL, V14, pS108, DOI 10.1097/01.ASN.0000070157.96264.13; Loeppke R, 2008, POPUL HEALTH MANAG, V11, P287, DOI 10.1089/pop.2008.0006; Loprinzi PD, 2015, PREV MED, V73, P37, DOI 10.1016/j.ypmed.2015.01.002; Marseille E, 2006, AIDS, V20, P907, DOI 10.1097/01.aids.0000218556.36661.47; Mayega RW, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-864; Milani RV, 2009, AM J CARDIOL, V104, P1389, DOI 10.1016/j.amjcard.2009.07.007; Namibia Statistics Agency, 2013, NAM LAB WORKF SURV 2; Pegus C, 2002, J OCCUP ENVIRON MED, V44, P228, DOI 10.1097/00043764-200203000-00010; Perez AP, 2009, PREV CHRONIC DIS, V6; Prabhakaran D, 2005, NATL MED J INDIA, V18, P59; Prata N, 2006, INT FAM PLAN PERSPEC, V32, P192, DOI 10.1363/3219206; Rosen S, 2004, AIDS, V18, P317, DOI 10.1097/00002030-200401230-00023; Rula EY, 2010, AM J HEALTH BEHAV, V34, P532; Sarafidis PA, 2004, J HUM HYPERTENS, V18, P623, DOI 10.1038/sj.jhh.1001724; Totsikas C, 2011, J HYPERTENS, V29, P1220, DOI 10.1097/HJH.0b013e3283469910; UNAIDS, NAM COUNTR REP	36	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0131737	10.1371/journal.pone.0131737	http://dx.doi.org/10.1371/journal.pone.0131737			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1PW	26167926	Green Published, Green Submitted, gold			2022-12-26	WOS:000358193100014
J	Kunutsor, SK; Bakker, SJL; Kootstra-Ros, JE; Gansevoort, RT; Gregson, J; Dullaart, RPF				Kunutsor, Setor K.; Bakker, Stephan J. L.; Kootstra-Ros, Jenny E.; Gansevoort, Ronald T.; Gregson, John; Dullaart, Robin P. F.			Serum Alkaline Phosphatase and Risk of Incident Cardiovascular Disease: Interrelationship with High Sensitivity C-Reactive Protein	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; GENERAL-POPULATION; VASCULAR CALCIFICATION; LIVER-ENZYMES; VITAMIN-D; ASSOCIATION; MORTALITY; HEALTH; PREDICTION; FRAMINGHAM	Background Alkaline phosphatase (ALP) has been suggested to be associated with cardiovascular disease (CVD) risk, however, important aspects of the association, such as shape and independence from established risk factors, have yet to be characterized in detail. We assessed the association of ALP with CVD risk and determined its utility for CVD risk prediction. Methods Alkaline phosphatase activity was measured at baseline in the PREVEND prospective cohort involving 6,974 participants aged 28-75 years without pre-existing CVD. Hazard ratios (95% confidence intervals [ CI]) and measures of risk discrimination and reclassification were assessed. Results During a median follow-up of 10.5 years, 737 participants developed CVD. Serum ALP was correlated with several risk markers for CVD, with strongest correlations for age (r = 0.30; P < 0.001), gamma-glutamyltransferase (r = 0.26; P < 0.001), and C-reactive protein (CRP) (r = 0.25; P < 0.001). There was a non-linear "J-shaped" relationship between ALP and CVD risk. In analyses adjusted for conventional risk factors, the hazard ratio (95% CI) for CVD in a comparison of the top quintile versus bottom quintiles 1-4 of ALP values was 1.34 (1.14 to 1.56; P< 0.001), which persisted after additional adjustment for potential confounders 1.33 (1.13 to 1.55; P< 0.001). However, the association was somewhat attenuated after adjustment for CRP 1.24 (1.05 to 1.45; P= 0.009). Addition of information on ALP to a CVD risk prediction model containing established risk factors did not improve the C-index or net reclassification. Conclusions Available evidence suggests a non-linear association between ALP activity and CVD risk, which is partly dependent on CRP. Taking account of conventional	[Kunutsor, Setor K.] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England; [Kunutsor, Setor K.] Univ Bristol, Sch Clin Sci, Bristol, Avon, England; [Bakker, Stephan J. L.; Gansevoort, Ronald T.] Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med, Groningen, Netherlands; [Bakker, Stephan J. L.] Top Inst Food & Nutr, Wageningen, Netherlands; [Kootstra-Ros, Jenny E.] Univ Groningen, Univ Med Ctr Groningen, Dept Clin Chem, Groningen, Netherlands; [Gregson, John] London Sch Hyg & Trop Med, Dept Med Stat, London WC1, England; [Dullaart, Robin P. F.] Univ Groningen, Univ Med Ctr Groningen, Dept Endocrinol, Groningen, Netherlands	University of Cambridge; University of Bristol; University of Groningen; Top Institute Food & Nutrition; University of Groningen; University of London; London School of Hygiene & Tropical Medicine; University of Groningen	Kunutsor, SK (corresponding author), Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England.	skk31@cantab.net	Kunutsor, Setor K/H-9807-2019	Kunutsor, Setor K/0000-0002-2625-0273	Dutch Kidney Foundation [E.033]; Dutch Heart Foundation [2001-005]	Dutch Kidney Foundation; Dutch Heart Foundation(Netherlands Heart Foundation)	The Dutch Kidney Foundation supported the infrastructure of the PREVEND program from 1997 to 2003 (Grant E.033). The University Medical Center Groningen supported the infrastructure from 2003 to 2006 and from 2007 to 2011. Dade Behring, Ausam, Roche, and Abbott financed laboratory equipment and reagents by which various laboratory determinations could be performed. The Dutch Heart Foundation supported studies on lipid metabolism (Grant 2001-005). These sources had no role in design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript.	Abbasi A, 2013, J CLIN ENDOCR METAB, V98, pE1352, DOI 10.1210/jc.2013-1680; Abramowitz M, 2010, CLIN J AM SOC NEPHRO, V5, P1064, DOI 10.2215/CJN.08621209; Ali AT, 2006, ANN CLIN BIOCHEM, V43, P207, DOI 10.1258/000456306776865179; Belozeroff V, 2009, CLIN J AM SOC NEPHRO, V4, P673, DOI 10.2215/CJN.03790808; Borggreve SE, 2007, EUR HEART J, V28, P1012, DOI 10.1093/eurheartj/ehm062; Cheung BMY, 2008, CLIN CHEM LAB MED, V46, P523, DOI 10.1515/CCLM.2008.111; Cook NR, 2012, CIRCULATION, V125, P1748, DOI 10.1161/CIRCULATIONAHA.111.075929; COX DR, 1972, J R STAT SOC B, V34, P187; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; Damera S, 2011, KIDNEY INT, V79, P228, DOI 10.1038/ki.2010.356; Detrano RC, 2000, CURR PROB CARDIOLOGY, V25, P374, DOI 10.1067/mcd.2000.104848; Dullaart RPF, 2010, ATHEROSCLEROSIS, V208, P537, DOI 10.1016/j.atherosclerosis.2009.07.042; Durup D, 2015, J CLIN ENDOCR METAB, V100, P2339, DOI 10.1210/jc.2014-4551; EASTON DF, 1991, STAT MED, V10, P1025, DOI 10.1002/sim.4780100703; Germano G, 2012, EUR HEART J, V33, P137; Greenland P, 2010, CIRCULATION, V122, pE584, DOI 10.1161/CIR.0b013e3182051b4c; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Heeringa SG, 2017, APPL SURVEY DATA ANA, VSecond, DOI DOI 10.1201/9781315153278; Inker LA, 2012, NEW ENGL J MED, V367, P20, DOI 10.1056/NEJMoa1114248; Kalantar-Zadeh K, 2009, CLIN J AM SOC NEPHRO, V4, P1529, DOI 10.2215/CJN.02140309; Kaptoge S, 2010, LANCET, V375, P132, DOI 10.1016/S0140-6736(09)61717-7; Kerner A, 2005, ARTERIOSCL THROM VAS, V25, P193, DOI 10.1161/01.ATV.0000148324.63685.6a; Kunutsor SK, 2014, ATHEROSCLEROSIS, V236, P7, DOI 10.1016/j.atherosclerosis.2014.06.006; Lambers Heerspink HJ, 2008, AM J EPIDEMIOL, V168, P897, DOI 10.1093/aje/kwn209; Lazo M, 2008, ANN INTERN MED, V148, P348, DOI 10.7326/0003-4819-148-5-200803040-00005; Maldonado O, 1998, J CLIN GASTROENTEROL, V27, P342, DOI 10.1097/00004836-199812000-00013; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; Narisawa S, 2007, J BONE MINER RES, V22, P1700, DOI 10.1359/JBMR.070714; O'Neill WC, 2006, CIRC RES, V99, pE2, DOI 10.1161/01.RES.0000234909.24367.a9; Soler EP, 2010, CURR CARDIOL REV, V6, P138, DOI 10.2174/157340310791658785; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Pencina MJ, 2011, STAT MED, V30, P11, DOI 10.1002/sim.4085; PRISMANT, 2002, INV REL NAT MED REG; Ridker PM, 2007, JAMA-J AM MED ASSOC, V297, P611, DOI 10.1001/jama.297.6.611; Ridker PM, 2008, CIRCULATION, V118, P2243, DOI 10.1161/CIRCULATIONAHA.108.814251; Ryu WS, 2010, NEUROLOGY, V75, P1995, DOI 10.1212/WNL.0b013e3181ff966a; Schoppet M, 2008, KIDNEY INT, V73, P989, DOI 10.1038/ki.2008.104; Schumann G, 2011, CLIN CHEM LAB MED, V49, P1439, DOI 10.1515/CCLM.2011.621; Shimizu Y, 2013, J STROKE CEREBROVASC, V22, P1046, DOI 10.1016/j.jstrokecerebrovasdis.2012.06.009; Smith GD, 2003, INT J EPIDEMIOL, V32, P1, DOI 10.1093/ije/dyg070; Stone NJ, 2014, J AM COLL CARDIOL, V63, P2889, DOI 10.1016/j.jacc.2013.11.002; Stricker B H Ch, 2006, Ned Tijdschr Geneeskd, V150, P1916; Tang FT, 2006, CALCIFIED TISSUE INT, V79, P326, DOI 10.1007/s00223-006-0004-8; Therneau T.M., 2000, MODELING SURVIVAL DA; Tonelli M, 2009, CIRCULATION, V120, P1784, DOI 10.1161/CIRCULATIONAHA.109.851873; Wannamethee SG, 2013, ARTERIOSCL THROM VAS, V33, P1070, DOI 10.1161/ATVBAHA.112.300826; Webber M, 2010, CLIN CHEM LAB MED, V48, P167, DOI 10.1515/CCLM.2010.052; WILKINSO.JH, 1970, CLIN CHEM, V16, P733	48	32	33	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0132822	10.1371/journal.pone.0132822	http://dx.doi.org/10.1371/journal.pone.0132822			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26167920	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000358193100084
J	Wei, F; Shang, WJ; Yang, JR; Hu, XP; Xu, XM				Wei, Feng; Shang, Wenjing; Yang, Jiarong; Hu, Xiaoping; Xu, Xiangming			Spatial Pattern of Verticillium dahliae Microsclerotia and Cotton Plants with Wilt Symptoms in Commercial Plantations	PLOS ONE			English	Article							SPORE DISPERSAL GRADIENT; POTATO FIELD SOILS; DISEASE EPIDEMICS; INOCULUM DENSITY; SOUTHERN SPAIN; QUADRAT SIZE; POPULATION; PROPAGULES; TIME; CAULIFLOWER	Spatial patterns of pathogen inoculum in field soils and the resulting patterns of disease may reflect the underlying mechanisms of pathogen dispersal. This knowledge can be used to design more efficient sampling schemes for assessing diseases. Spatial patterns of Verticillium dahliae microsclerotia were characterized in commercial cotton fields through quadrat and point sampling in 1994 and 2013, respectively. Furthermore, cotton plants with wilt symptoms, caused by V. dahliae, were assessed in six commercial cotton fields in 2013. Soil samples were assayed for the density of microsclerotia (expressed as CFU g(-1) of soil) using a wet-sieving plating method and a real-time quantitative PCR method for the 1994 and 2013 study, respectively. The estimated inoculum threshold for causing wilt development on individual plants varied with the three fields: ca. 1.6 CFU g(-1) of soil for one field, and 7.2 CFU g(-1) of soil for the other two. Both quadrat and point sampling spatial analyses showed that aggregation of V. dahliae inoculum in soils was usually not detected beyond 1.0 m. Similarly, the spatial patterns of wilted cotton plants indicated that spatial aggregation of diseased plants were only observed below the scale of 1.0 m in six commercial cotton plantations. Therefore, spatial aggregation of both V. dahliae inoculum and cotton plants with wilt symptoms is not likely to be detected above the scale of 1.0 m for most commercial cotton plantations. When designing schemes for assessing wilt inoculum and wilt development, this scale needs to be taken into consideration.	[Wei, Feng; Shang, Wenjing; Yang, Jiarong; Hu, Xiaoping; Xu, Xiangming] Northwest A&F Univ, Coll Plant Protect, State Key Lab Crop Stress Biol Arid Areas, Yangling, Peoples R China; [Xu, Xiangming] East Malling Res, East Malling, Kent, England	Northwest A&F University - China	Hu, XP (corresponding author), Northwest A&F Univ, Coll Plant Protect, State Key Lab Crop Stress Biol Arid Areas, Yangling, Peoples R China.	xphu@nwsuaf.edu.cn; Xiangming.Xu@emr.ac.uk	FANG, DAVID/AAV-5774-2020; Xu, Xiangming/I-3050-2014	FANG, DAVID/0000-0003-0036-5459; Xu, Xiangming/0000-0002-4567-7117; Wei, Feng/0000-0002-4579-3732	National Natural Science Foundation of China [31371888]; State Key Laboratory of Cotton Biology Open Fund of China [CB2013A20]; Programme of Introducing Talents of Discipline to Universities of China [B07049]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Cotton Biology Open Fund of China; Programme of Introducing Talents of Discipline to Universities of China(Ministry of Education, China - 111 Project)	The study was sponsored by National Natural Science Foundation of China (No. 31371888), and partially by State Key Laboratory of Cotton Biology Open Fund of China (No. CB2013A20) and by the Programme of Introducing Talents of Discipline to Universities of China (No. B07049). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashworth JLJ, 1979, PHYTOPATHOLOGY, V69, P483; Banno S, 2011, J GEN PLANT PATHOL, V77, P282, DOI 10.1007/s10327-011-0335-9; Bilodeau GJ, 2012, PHYTOPATHOLOGY, V102, P331, DOI 10.1094/PHYTO-05-11-0130; Debode J, 2011, PLANT DIS, V95, P1571, DOI 10.1094/PDIS-04-11-0267; Dhanasekaran S, 2010, J IMMUNOL METHODS, V354, P34, DOI 10.1016/j.jim.2010.01.004; DOWER WJ, 1988, NUCLEIC ACIDS RES, V16, P6127, DOI 10.1093/nar/16.13.6127; EASTON GD, 1969, PHYTOPATHOLOGY, V59, P1171; EVANS G, 1980, ANN APPL BIOL, V95, P177, DOI 10.1111/j.1744-7348.1980.tb04736.x; EVANS G, 1967, PHYTOPATHOLOGY, V57, P1250; Franca SC, 2013, CROP PROT, V54, P134, DOI 10.1016/j.cropro.2013.08.008; Garcia-Cabello S, 2012, EUR J PLANT PATHOL, V133, P877, DOI 10.1007/s10658-012-0011-8; GRIFFITHS DA, 1970, ARCH MIKROBIOL, V74, P207, DOI 10.1007/BF00408881; Harris DC, 1996, PLANT PATHOL, V45, P106, DOI 10.1046/j.1365-3059.1996.d01-96.x; HARRIS DC, 1993, PLANT PATHOL, V42, P238, DOI 10.1111/j.1365-3059.1993.tb01496.x; Johnson DA, 2006, PLANT DIS, V90, P789, DOI 10.1094/PD-90-0789; JOHNSON KB, 1988, PLANT DIS, V72, P484, DOI 10.1094/PD-72-0484; KOROLEVA NS, 1986, MIKOL FITOPATOL, V20, P509; Madden L.V., 2007, STUDY PLANT DIS EPID; Mol L, 1996, PLANT PATHOL, V45, P205, DOI 10.1046/j.1365-3059.1996.d01-125.x; Navas-Cortes JA, 2008, PHYTOPATHOLOGY, V98, P167, DOI 10.1094/PHYTO-98-2-0167; Pegg GF, 2002, VERTICILLUM WILTS, DOI [DOI 10.1079/9780851995298.0000, 10.1079/9780851995298.0000]; PULLMAN GS, 1982, PHYTOPATHOLOGY, V72, P549, DOI 10.1094/Phyto-72-549; Sivaganesan M, 2010, WATER RES, V44, P4726, DOI 10.1016/j.watres.2010.07.066; SMITH VL, 1984, PHYTOPATHOLOGY, V74, P553, DOI 10.1094/Phyto-74-553; Wang YL, 2013, PLANT DIS, V97, P1645, DOI 10.1094/PDIS-04-13-0406-RE; Wei F, 2015, PHYTOPATHOLOGY, V105, P220, DOI 10.1094/PHYTO-05-14-0139-R; Wheeler TA, 2000, PLANT DIS, V84, P961, DOI 10.1094/PDIS.2000.84.9.961; WHEELER TA, 1994, PHYTOPATHOLOGY, V84, P843, DOI 10.1094/Phyto-84-843; Xiao CL, 1997, PHYTOPATHOLOGY, V87, P325, DOI 10.1094/PHYTO.1997.87.3.325; Xiao CL, 1998, PHYTOPATHOLOGY, V88, P1108, DOI 10.1094/PHYTO.1998.88.10.1108; Xu XM, 2000, PHYTOPATHOLOGY, V90, P738, DOI 10.1094/PHYTO.2000.90.7.738; Xu XM, 1998, PHYTOPATHOLOGY, V88, P1000, DOI 10.1094/PHYTO.1998.88.10.1000; Zhang WW, 2013, EUR J PLANT PATHOL, V135, P867, DOI 10.1007/s10658-012-0131-1	33	3	3	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0132812	10.1371/journal.pone.0132812	http://dx.doi.org/10.1371/journal.pone.0132812			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26167868	Green Submitted, Green Published, gold			2022-12-26	WOS:000358193100083
J	Erdos, PL; Kiss, SZ; Miklos, I; Soukup, L				Erdos, Peter L.; Kiss, Sandor Z.; Miklos, Istvan; Soukup, Lajos			Approximate Counting of Graphical Realizations	PLOS ONE			English	Article							ALGORITHM	In 1999 Kannan, Tetali and Vempala proposed a MCMC method to uniformly sample all possible realizations of a given graphical degree sequence and conjectured its rapidly mixing nature. Recently their conjecture was proved affirmative for regular graphs (by Cooper, Dyer and Greenhill, 2007), for regular directed graphs (by Greenhill, 2011) and for half-regular bipartite graphs (by Miklos, Erdos and Soukup, 2013). Several heuristics on counting the number of possible realizations exist (via sampling processes), and while they work well in practice, so far no approximation guarantees exist for such an approach. This paper is the first to develop a method for counting realizations with provable approximation guarantee. In fact, we solve a slightly more general problem; besides the graphical degree sequence a small set of forbidden edges is also given. We show that for the general problem (which contains the Greenhill problem and the Miklos, Erdos and Soukup problem as special cases) the derived MCMC process is rapidly mixing. Further, we show that this new problem is self-reducible therefore it provides a fully polynomial randomized approximation scheme (a.k.a. FPRAS) for counting of all realizations.	[Erdos, Peter L.; Miklos, Istvan; Soukup, Lajos] Hungarian Acad Sci, Alfred Renyi Inst Math, Budapest, Hungary; [Kiss, Sandor Z.; Miklos, Istvan] Hungarian Acad Sci, Inst Comp Sci & Control, Budapest, Hungary; [Kiss, Sandor Z.] Univ Technol & Econ, Dept Algebra, Budapest, Hungary	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Alfred Renyi Institute of Mathematics; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Institute for Computer Science & Control; Budapest University of Technology & Economics	Erdos, PL (corresponding author), Realtanoda U 13-5, H-1053 Budapest, Hungary.	erdos.peter@renyi.mta.hu			U.S. Air Force Office of Scientific Research (AFOSR) [FA9550-12-1-0405]; Defense Advanced Research Projects Agency (DARPA); Alexander von Humboldt-Foundation; Hungarian NSF [K77476, NK105645, PD84297, NK 83726]	U.S. Air Force Office of Scientific Research (AFOSR)(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Defense Advanced Research Projects Agency (DARPA)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Alexander von Humboldt-Foundation(Alexander von Humboldt Foundation); Hungarian NSF(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	PLE and IM acknowledge financial support from grant #FA9550-12-1-0405 from the U.S. Air Force Office of Scientific Research (AFOSR) and the Defense Advanced Research Projects Agency (DARPA). PLE was partly supported by the Alexander von Humboldt-Foundation, when this author visited Universitat Hamburg in Fall of 2014. SZK was partly supported by Hungarian NSF, under contract K77476 and NK105645. IM was partly supported by Hungarian NSF, under contract PD84297. LS was partly supported by Hungarian NSF, under contract NK 83726. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cooper C, 2007, COMB PROBAB COMPUT, V16, P557, DOI 10.1017/S0963548306007978; Erdos PL, 2013, COMB PROBAB COMPUT, V22, P366, DOI 10.1017/S0963548313000096; Erdos PL, 2010, ELECTRON J COMB, V17; Gale D., 1957, PAC J MATH, V7, P1073, DOI [10.2140/pjm.1957.7.1073, DOI 10.2140/PJM.1957.7.1073]; Greenhill C., 2011, ELECTRON J COMB, V18, P234; HAKIMI SL, 1962, J SOC IND APPL MATH, V10, P496, DOI 10.1137/0110037; Havel V., 1955, CASOPIS PROPESTOV MA, V80, P477, DOI DOI 10.21136/CPM.1955.108220; Jerrum M, 2004, J ACM, V51, P671, DOI 10.1145/1008731.1008738; JERRUM MR, 1986, THEOR COMPUT SCI, V43, P169, DOI 10.1016/0304-3975(86)90174-X; Kannan R, 1999, RANDOM STRUCT ALGOR, V14, P293, DOI 10.1002/(SICI)1098-2418(199907)14:4<293::AID-RSA1>3.0.CO;2-G; Kim H, 2009, J PHYS A-MATH THEOR, V42, DOI 10.1088/1751-8113/42/39/392001; Kleitman D. J., 1973, Discrete Mathematics, V6, P79, DOI 10.1016/0012-365X(73)90037-X; Miklos I., 2013, ELECRON J COMBIN, V20, P1; Newman M, 2010, NETWORKS INTRO, DOI 10.1093/acprof:oso/9780199206650.001.0001; Newman MEJ, 2006, STRUCTURE DYNAMICS N, P624; Petersen J., 1891, ACTA MATH, P193, DOI DOI 10.1007/BF02392606; Ryser HJ., 1957, CAN J MATH, V9, P371, DOI [10.4153/CJM-1957-044-3, DOI 10.4153/CJM-1957-044-3]; Sinclair A., 1992, COMBINATORICS PROBAB, V1, P351, DOI DOI 10.1017/S0963548300000390; TUTTE WT, 1952, CAN J MATH, V4, P314, DOI 10.4153/CJM-1952-028-2	19	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0131300	10.1371/journal.pone.0131300	http://dx.doi.org/10.1371/journal.pone.0131300			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161994	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000358162300032
J	Markandeya, YS; Phelan, LJ; Woon, MT; Keefe, AM; Reynolds, CR; August, BK; Hacker, TA; Roth, DM; Patel, HH; Balijepalli, RC				Markandeya, Yogananda S.; Phelan, Laura J.; Woon, Marites T.; Keefe, Alexis M.; Reynolds, Courtney R.; August, Benjamin K.; Hacker, Timothy A.; Roth, David M.; Patel, Hemal H.; Balijepalli, Ravi C.			Caveolin-3 Overexpression Attenuates Cardiac Hypertrophy via Inhibition of T-type Ca2+ Current Modulated by Protein Kinase C alpha in Cardiomyocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-SIGNALING COMPONENTS; SOLUBLE GUANYLYL CYCLASE; PATHOLOGICAL HYPERTROPHY; FAILING HUMAN; HEART; CHANNEL; EXPRESSION; MYOCYTES; CALCINEURIN; CONTRACTILE	Pathological cardiac hypertrophy is characterized by subcellular remodeling of the ventricular myocyte with a reduction in the scaffolding protein caveolin-3 (Cav-3), altered Ca2+ cycling, increased protein kinase C expression, and hyperactivation of calcineurin/nuclear factor of activated T cell (NFAT) signaling. However, the precise role of Cav-3 in the regulation of local Ca2+ signaling in pathological cardiac hypertrophy is unclear. We used cardiac-specific Cav-3-overexpressing mice and in vivo and in vitro cardiac hypertrophy models to determine the essential requirement for Cav-3 expression in protection against pharmacologically and pressure overload-induced cardiac hypertrophy. Transverse aortic constriction and angiotensin-II (Ang-II) infusion in wild type (WT) mice resulted in cardiac hypertrophy characterized by significant reduction in fractional shortening, ejection fraction, and a reduced expression of Cav-3. In addition, association of PKC alpha and angiotensin-II receptor, type 1, with Cav-3 was disrupted in the hypertrophic ventricular myocytes. Whole cell patch clamp analysis demonstrated increased expression of T-type Ca2+ current (I-Ca,(T)) in hypertrophic ventricular myocytes. In contrast, the Cav-3-overexpressing mice demonstrated protection from transverse aortic constriction or Ang-II-induced pathological hypertrophy with inhibition of I-Ca,(T) and intact Cav-3-associated macromolecular signaling complexes. siRNA-mediated knockdown of Cav-3 in the neonatal cardiomyocytes resulted in enhanced Ang-II stimulation of I-Ca,(T) mediated by PKC alpha, which caused nuclear translocation of NFAT. Overexpression of Cav-3 in neonatal myocytes prevented a PKC alpha -mediated increase in I-Ca,(T) and nuclear translocation of NFAT. In conclusion, we show that stable Cav-3 expression is essential for protecting the signaling mechanisms in pharmacologically and pressure overload-induced cardiac hypertrophy.	[Markandeya, Yogananda S.; Phelan, Laura J.; Woon, Marites T.; Keefe, Alexis M.; Reynolds, Courtney R.; August, Benjamin K.; Hacker, Timothy A.; Balijepalli, Ravi C.] Univ Wisconsin, Cellular & Mol Arrhythmia Res Program, Dept Med, Madison, WI 53706 USA; [Roth, David M.; Patel, Hemal H.] Vet Affairs San Diego Healthcare Syst, San Diego, CA 92161 USA; [Roth, David M.; Patel, Hemal H.] Univ Calif San Diego, Dept Anesthesiol, La Jolla, CA 92161 USA	University of Wisconsin System; University of Wisconsin Madison; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of California System; University of California San Diego	Balijepalli, RC (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Med, 1111 Highland Ave,Rm 8405 WIMR II, Madison, WI 53706 USA.	rcb@medicine.wisc.edu			National Institutes of Health from NHLBI [HL105713, HL091071, HL107200, HL066941, HL115933]; United States Department of Veterans Affairs (Washington D. C.) [BX001963, BX000783]; American Heart Association [11GRNT7610094]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105713, R01HL091071, P01HL066941, R01HL107200, R01HL115933] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008688] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000783, I01BX001963] Funding Source: NIH RePORTER	National Institutes of Health from NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); United States Department of Veterans Affairs (Washington D. C.)(US Department of Veterans Affairs); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grants HL105713 (to R. C. B.), HL091071 (to H. H. P.), HL107200 (to H. H. P.), HL066941 (to D. M. R.), and HL115933 (to D. M. R.) from NHLBI. This work was also supported by the United States Department of Veterans Affairs (Washington D. C.) Grants BX001963 (to H. H. P.) and BX000783 (to D. M. R.) and American Heart Association Grant-in-aid 11GRNT7610094 (to R. C. B.). The authors declare that they have no conflicts of interest with the contents of this article.	Adebiyi A, 2011, J BIOL CHEM, V286, P4341, DOI 10.1074/jbc.M110.179747; Balijepalli RC, 2006, P NATL ACAD SCI USA, V103, P7500, DOI 10.1073/pnas.0503465103; Balijepalli RC, 2008, PROG BIOPHYS MOL BIO, V98, P149, DOI 10.1016/j.pbiomolbio.2009.01.012; Balijepalli RC, 2003, CARDIOVASC RES, V59, P67, DOI 10.1016/S0008-6363(03)00325-0; Bers DM, 2006, J PHARMACOL SCI, V100, P315, DOI 10.1254/jphs.CPJ06001X; Bkaily G, 2005, PEPTIDES, V26, P1410, DOI 10.1016/j.peptides.2005.03.021; Bowling N, 1999, CIRCULATION, V99, P384, DOI 10.1161/01.CIR.99.3.384; Braz JC, 2004, NAT MED, V10, P248, DOI 10.1038/nm1000; Chen XW, 2011, J MOL CELL CARDIOL, V50, P460, DOI 10.1016/j.yjmcc.2010.11.012; Chiang CS, 2009, CIRC RES, V104, P522, DOI 10.1161/CIRCRESAHA.108.184051; David LS, 2010, CHANNELS, V4, P375, DOI 10.4161/chan.4.5.12874; Feiner EC, 2011, J CARD FAIL, V17, P253, DOI 10.1016/j.cardfail.2010.10.008; Ferron L, 2003, CIRC RES, V93, P1241, DOI 10.1161/01.RES.0000106134.69300.B7; Frey N, 2003, ANNU REV PHYSIOL, V65, P45, DOI 10.1146/annurev.physiol.65.092101.142243; Gao H, 2012, J MOL CELL CARDIOL, V53, P657, DOI 10.1016/j.yjmcc.2012.08.005; Goonasekera SA, 2012, J MOL CELL CARDIOL, V52, P317, DOI 10.1016/j.yjmcc.2011.05.001; Head BP, 2005, J BIOL CHEM, V280, P31036, DOI 10.1074/jbc.M502540200; Horikawa YT, 2011, J AM COLL CARDIOL, V57, P2273, DOI 10.1016/j.jacc.2010.12.032; Houser SR, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.125pe31; Huang BY, 2000, CARDIOVASC RES, V46, P442, DOI 10.1016/S0008-6363(00)00017-1; Huang CH, 2013, FEBS LETT, V587, P1723, DOI 10.1016/j.febslet.2013.04.040; Kinoshita H, 2009, CIRCULATION, V120, P743, DOI 10.1161/CIRCULATIONAHA.109.857011; LEVY D, 1987, AM J CARDIOL, V60, P560, DOI 10.1016/0002-9149(87)90305-5; Liu YH, 2013, J MOL CELL CARDIOL, V60, P72, DOI 10.1016/j.yjmcc.2013.03.019; Lyon AR, 2009, P NATL ACAD SCI USA, V106, P6854, DOI 10.1073/pnas.0809777106; Makarewich CA, 2012, CIRC RES, V110, P669, DOI 10.1161/CIRCRESAHA.111.264028; Markandeya YS, 2011, J BIOL CHEM, V286, P2433, DOI 10.1074/jbc.M110.182550; Martinez ML, 1999, J MOL CELL CARDIOL, V31, P1617, DOI 10.1006/jmcc.1999.0998; Meng XW, 2010, J BIOL CHEM, V285, P888, DOI 10.1074/jbc.M109.057638; Mialet-Perez J, 2012, J MOL CELL CARDIOL, V52, P502, DOI 10.1016/j.yjmcc.2011.07.019; Morishima M, 2009, EUR J PHARMACOL, V609, P105, DOI 10.1016/j.ejphar.2009.03.024; Nakayama H, 2007, J CLIN INVEST, V117, P2431, DOI 10.1172/JCI31060; Nakayama H, 2009, J CLIN INVEST, V119, P3787, DOI 10.1172/JCI39724; Nattel S, 2007, PHYSIOL REV, V87, P425, DOI 10.1152/physrev.00014.2006; Niwa N, 2004, AM J PHYSIOL-HEART C, V286, pH2257, DOI 10.1152/ajpheart.01043.2003; NUSS HB, 1993, CIRC RES, V73, P777, DOI 10.1161/01.RES.73.4.777; Park JY, 2006, J PHYSIOL-LONDON, V577, P513, DOI 10.1113/jphysiol.2006.117440; Patel H. H., 2008, V186, P167, DOI 10.1007/978-3-540-72843-6_7; Perrino C, 2006, J CLIN INVEST, V116, P1547, DOI 10.1172/JCI25397; Pluteanu F, 2009, AM J PHYSIOL-HEART C, V297, pH1304, DOI 10.1152/ajpheart.00528.2009; Rinne A, 2010, AM J PHYSIOL-HEART C, V298, pH2001, DOI 10.1152/ajpheart.01072.2009; ROCKMAN HA, 1991, P NATL ACAD SCI USA, V88, P8277, DOI 10.1073/pnas.88.18.8277; SEN L, 1994, CIRC RES, V75, P149, DOI 10.1161/01.RES.75.1.149; Tsai EJ, 2012, CIRC RES, V110, P295, DOI 10.1161/CIRCRESAHA.111.259242; Tsutsumi YM, 2008, CIRCULATION, V118, P1979, DOI 10.1161/CIRCULATIONAHA.108.788331; Wang F, 2013, J MOL CELL CARDIOL, V62, P122, DOI 10.1016/j.yjmcc.2013.05.016; Wang Y, 2008, J BIOL CHEM, V283, P25524, DOI 10.1074/jbc.M803043200; Wang YG, 2014, TRENDS CARDIOVAS MED, V24, P14, DOI 10.1016/j.tcm.2013.05.004; Wei S, 2010, CIRC RES, V107, P520, DOI 10.1161/CIRCRESAHA.109.212324; Wilkins BJ, 2002, MOL CELL BIOL, V22, P7603, DOI 10.1128/MCB.22.21.7603-7613.2002; Williams TM, 2004, ANN MED, V36, P584, DOI 10.1080/07853890410018899; Wu X, 2010, P NATL ACAD SCI USA, V107, P7000, DOI 10.1073/pnas.1001825107; Yamamoto E, 2010, J HYPERTENS, V28, P1321, DOI 10.1097/HJH.0b013e3283388045; Yasui K, 2005, J PHARMACOL SCI, V99, P205, DOI 10.1254/jphs.FMJ05002X3; Zheng MQ, 2010, J MOL CELL CARDIOL, V48, P131, DOI 10.1016/j.yjmcc.2009.08.032	55	43	43	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2015	290	36					22085	22100		10.1074/jbc.M115.674945	http://dx.doi.org/10.1074/jbc.M115.674945			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ9XI	26170457	Green Published, hybrid			2022-12-26	WOS:000360968500027
J	Buj, I; Caleta, M; Marcic, Z; Sanda, R; Vukic, J; Mrakovcic, M				Buj, Ivana; Caleta, Marko; Marcic, Zoran; Sanda, Radek; Vukic, Jasna; Mrakovcic, Milorad			Different Histories, Different Destinies-Impact of Evolutionary History and Population Genetic Structure on Extinction Risk of the Adriatic Spined Loaches (Genus Cobitis; Cypriniformes, Actinopterygii)	PLOS ONE			English	Article							DINARIDE LAKE SYSTEM; RED LIST CRITERIA; MIDDLE MIOCENE; CONSERVATION; SIZES; DIVERSITY; INFERENCE	The region of Balkans is often considered as an ichthyologic "hot spot", with a great number of species and high portion of endemics living in fresh waters in a relatively small area. The Adriatic watershed in Croatia and Herzegovina is inhabited by six spined loach species (genus Cobitis) whose extinction risk estimations were based solely on their extent of occurrence (and/or area of occupancy) and its fragmentation, and conservation proposals do not consider diversity below species level. In this investigation we employed molecular genetic methods to describe present genetic structure of the Adriatic spined loaches and reveal their demographic history. The divergence of the Adriatic lineages inside the genus Cobitis started in Miocene and lasted until Pleistocene epoch. Geological events responsible for shaping recent diversity of spined loaches in the Adriatic basin are: the Dinarid Mountains upwelling, the evolution of Dinaric Lake system, local tectonic activity, river connections during glaciations and differences in sea level. Even though all the investigated species inhabit karstic rivers located in the same geographic area and that were subject of similar geological events, the results obtained reveal great differences in their genetic diversity and structure and point out the necessity of different conservation measures to ensure their future viability. High level of genetic polymorphism is characteristic for species located more to the south. Two species comprised of more than one population have completely different intraspecific structure; populations of C. illyrica are genetically distinct and represent separate evolutionary significant units, whereas intraspecific structure of C. narentana corresponds to metapopulational pattern. Without population genetic data, evolutionary significant units could be easily misidentified. Furthermore, the obtained results affirm that population genetic measurements are able to detect differences among closely located and related species and estimate extinction risk even more accurately than currently applied IUCN criteria.	[Buj, Ivana; Marcic, Zoran; Mrakovcic, Milorad] Univ Zagreb, Fac Sci, Dept Zool, Zagreb 41000, Croatia; [Caleta, Marko] Univ Zagreb, Fac Teacher Educ, Zagreb 41000, Croatia; [Sanda, Radek] Natl Museum, Prague, Czech Republic; [Vukic, Jasna] Charles Univ Prague, Dept Ecol, Prague, Czech Republic	University of Zagreb; University of Zagreb; National Museum; Charles University Prague	Buj, I (corresponding author), Univ Zagreb, Fac Sci, Dept Zool, Zagreb 41000, Croatia.	ivaradic@biol.pmf.hr	Ćaleta, Marko/AGT-7655-2022; Vukic, Jasna/D-2811-2015	Ćaleta, Marko/0000-0002-4675-556X; Vukic, Jasna/0000-0003-2243-0303	Croatian Ministry of Science, Education and Sport [119-0000000-3184]; Czech Ministry of Culture [DKRVO 2014/14]; Czech Ministry of Culture (National Museum) [00023272]; SYNTHESYS programme project (Museo Nacional de Ciencias Naturales) - European Community [ES-TAF-2061]	Croatian Ministry of Science, Education and Sport(Ministry of Science, Education and Sports, Republic of Croatia); Czech Ministry of Culture; Czech Ministry of Culture (National Museum); SYNTHESYS programme project (Museo Nacional de Ciencias Naturales) - European Community	This investigation was supported by the Croatian Ministry of Science, Education and Sport (project no. 119-0000000-3184), the Czech Ministry of Culture (DKRVO 2014/14, National Museum, 00023272) and the SYNTHESYS programme project (ES-TAF-2061 at the Museo Nacional de Ciencias Naturales) financed by European Community Research Infrastructure Action under the FP7 "Capacities" Programme.	Akcakaya HR, 2006, GLOBAL CHANGE BIOL, V12, P2037, DOI 10.1111/j.1365-2486.2006.01253.x; Alfirevic S, 1965, GEOLOGIJA JADRANA; Allendorf F., 2007, CONSERVATION GENETIC; Allendorf F, 2013, CONSERV GENET, V2nd; Baucic I, 1967, CETINA RAZVOJ RELJEF, V6; Beerli P, 2001, P NATL ACAD SCI USA, V98, P4563, DOI 10.1073/pnas.081068098; Beerli P, 1998, NATO ADV SCI I A-LIF, V306, P39; Beerli Peter, 2009, V17, P42; Bender M. G., 2012, Endangered Species Research, V18, P247, DOI 10.3354/esr00449; Brito D, 2010, BIOL CONSERV, V143, P1154, DOI 10.1016/j.biocon.2010.02.015; Brooks TM, 2006, SCIENCE, V313, P58, DOI 10.1126/science.1127609; Buj I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099833; Coric S, 2009, GEOL CROAT, V62, P31; Doadrio I, 2005, MOL PHYLOGENET EVOL, V37, P484, DOI 10.1016/j.ympev.2005.07.009; Dov Por Francis, 2009, BioRisk, V3, P5; Feulner PGD, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004966; Frankham R, 2005, BIOL CONSERV, V126, P131, DOI 10.1016/j.biocon.2005.05.002; Frankham R., 2010, INTRO CONSERVATION G, DOI DOI 10.1017/CBO9780511809002; Frankham R, 2014, BIOL CONSERV, V170, P56, DOI 10.1016/j.biocon.2013.12.036; Franklin I.R., 1980, CONSERVATION BIOL EV; Fraser DJ, 2001, MOL ECOL, V10, P2741, DOI 10.1046/j.1365-294X.2001.t01-1-01411.x; Gardenfors U, 2001, CONSERV BIOL, V16, P511; Gilpin M.E., 1986, P19; Harzhauser M, 2008, PALAEOGEOGR PALAEOCL, V260, P417, DOI 10.1016/j.palaeo.2007.12.013; Harzhauser M, 2012, HYDROBIOLOGIA, V682, P27, DOI 10.1007/s10750-011-0618-3; Hidasi-Neto J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073431; HUDSON RR, 1992, MOL BIOL EVOL, V9, P138; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jimenez-Moreno G, 2008, REV PALAEOBOT PALYNO, V152, P237, DOI 10.1016/j.revpalbo.2008.05.005; Li WLS, 2012, MOL BIOL EVOL, V29, P751, DOI 10.1093/molbev/msr232; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Mace GM, 2008, CONSERV BIOL, V22, P1424, DOI 10.1111/j.1523-1739.2008.01044.x; Mace GM, 2003, SCIENCE, V300, P1707, DOI 10.1126/science.1085510; Marjanac Lj, 2004, QUATERNARY GLACIATIO; McNeely J. A., 1990, CONSERVING WORLDS BI; Moran P, 2002, ECOL FRESHW FISH, V11, P30, DOI 10.1034/j.1600-0633.2002.110105.x; MORITZ C, 1994, TRENDS ECOL EVOL, V9, P373, DOI 10.1016/0169-5347(94)90057-4; Neubauer TA, 2011, ARCH MOLLUSKENKD, V140, P201, DOI 10.1127/arch.moll/1869-0963/140/201-237; Perdices A, 2001, MOL PHYLOGENET EVOL, V19, P468, DOI 10.1006/mpev.2000.0900; Perdices A, 2008, MOL PHYLOGENET EVOL, V46, P382, DOI 10.1016/j.ympev.2007.05.007; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rodrigues ASL, 2006, TRENDS ECOL EVOL, V21, P71, DOI 10.1016/j.tree.2005.10.010; RYDER OA, 1986, TRENDS ECOL EVOL, V1, P9, DOI 10.1016/0169-5347(86)90059-5; SHAFFER ML, 1981, BIOSCIENCE, V31, P131, DOI 10.2307/1308256; Stephens M, 2005, AM J HUM GENET, V76, P449, DOI 10.1086/428594; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Suric M, 2010, GEOL CROAT, V63, P155, DOI 10.4154/gc.2010.13; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Waples R.S., 1991, MAR FISH REV, V53, P11; Waples RS, 1995, AM FISH S S, V17, P8; Zou JB, 2013, ANN BOT-LONDON, V112, P1829, DOI 10.1093/aob/mct241	51	17	19	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0131580	10.1371/journal.pone.0131580	http://dx.doi.org/10.1371/journal.pone.0131580			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176227	Green Published, Green Submitted, gold			2022-12-26	WOS:000358197600050
J	Cappelli, J; Garcia, A; Ceacero, F; Gomez, S; Luna, S; Gallego, L; Gambin, P; Landete-Castillejos, T				Cappelli, Jamil; Garcia, Andres; Ceacero, Francisco; Gomez, Santiago; Luna, Salvador; Gallego, Laureano; Gambin, Pablo; Landete-Castillejos, Tomas			Manganese Supplementation in Deer under Balanced Diet Increases Impact Energy and Contents in Minerals of Antler Bone Tissue	PLOS ONE			English	Article							MECHANICAL-PROPERTIES; CHEMICAL-COMPOSITION; PHYSIOLOGICAL EFFORT; GLYCOSAMINOGLYCAN; SILICON; GROWTH; WEIGHT; PLANTS	Bone ash, collagen, Ca and P composition, are considered the main factors affecting mechanical properties in bones. However, a series of studies in bone and antler have shown that some trace minerals, such as manganese, may play a role whose importance exceeds what may be expected considering their low content. A previous study showed that a reduction in manganese in antlers during a year of late winter frosts led to generalized antler breakage in Spain, which included a reduction of 30% of cortical thickness, 27% reduction in impact energy, and 10% reduction in work to peak force. Starting for this observation, we experimentally studied the effects of manganese supplementation in adults and yearling (yearlings) red deer under a balanced diet. Subjects were 29 deer of different age classes (adult n = 19, yearlings n = 10) that were divided in a manganese injected group (n = 14) and a control group (n = 15). Antler content in ashes and minerals, intrinsic mechanical properties and cross section structure were examined at 4 points along the antler beam. A one way ANOVA (mean per antler) showed that in yearlings, manganese supplementation only increased its content and that of Fe. However, in adults, Mn supplementation increased the mean content per antler of Ca, Na, P, B, Co, Cu, K, Mn, Ni, Se (while Si content was reduced), and impact work but not Young's modulus of elasticity, bending strength or work to peak force. A GLM series on characteristics in the uppermost part examined in the antler, often showing physiological exhaustion and depletion of body stores, showed also a 16% increase in work to peak force in the antlers of the treated group. Thus, manganese supplementation altered mineral composition of antler and improved structure and some mechanical properties despite animals having a balanced diet.	[Cappelli, Jamil; Garcia, Andres; Gallego, Laureano; Gambin, Pablo; Landete-Castillejos, Tomas] CSIC UCLM JCCM, IREC Sect Albacete, Anim Sci Tech Appl Wildlife Management Res Grp, Albacete, Spain; [Cappelli, Jamil; Garcia, Andres; Gallego, Laureano; Gambin, Pablo; Landete-Castillejos, Tomas] Univ Castilla La Mancha, IDR, Secc Recursos Cineget & Ganaderos, Albacete, Spain; [Cappelli, Jamil; Garcia, Andres; Gallego, Laureano; Gambin, Pablo; Landete-Castillejos, Tomas] Univ Castilla La Mancha, ETSIAM, Dept Ciencia & Tecnol Agroforestal & Genet, Albacete, Spain; [Ceacero, Francisco] Czech Univ Life Sci, Fac Trop AgriSci, Dept Anim Sci & Food Proc, Prague 6, Suchdol, Czech Republic; [Gomez, Santiago] Univ Cadiz, Dept Anat Patol, Cadiz, Spain; [Luna, Salvador] Univ Cadiz, Dept Enfermeria & Fisioterapia, Cadiz, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Castilla-La Mancha; Universidad de Castilla-La Mancha; Universidad de Castilla-La Mancha; Czech University of Life Sciences Prague; Universidad de Cadiz; Universidad de Cadiz	Landete-Castillejos, T (corresponding author), CSIC UCLM JCCM, IREC Sect Albacete, Anim Sci Tech Appl Wildlife Management Res Grp, Campus UCLM, Albacete, Spain.	Tomas.Landete@uclm.es	Ceacero, Francisco/C-1088-2009; Gallego, Laureano/G-9715-2015; Cappelli, Jamil/L-8326-2018; Garcia Diaz, Andres Jose/A-9162-2012	Ceacero, Francisco/0000-0001-9014-147X; Luna Galvez, Salvador/0000-0002-4668-1732; Gallego, Laureano/0000-0001-8219-087X; Landete Castillejos, Tomas/0000-0001-9753-5295; Cappelli, Jamil/0000-0001-5746-5835; Garcia Diaz, Andres Jose/0000-0002-4662-2185	Ministerio de Economia y Competitividad, Government of Spain (MINECO) [AGL2012-38898]; Consejeria de Educacion y Deportes de Castilla-La Mancha [PEII-2014-004-P]	Ministerio de Economia y Competitividad, Government of Spain (MINECO); Consejeria de Educacion y Deportes de Castilla-La Mancha	Funding was provided by Ministerio de Economia y Competitividad, Government of Spain (MINECO): Project AGL2012-38898 to TLC, AG, LG, FC, JC; Consejeria de Educacion y Deportes de Castilla-La Mancha: Project PEII-2014-004-P to LG TLC AG.	Bertassoni LE, 2014, J MECH BEHAV BIOMED, V38, P91, DOI 10.1016/j.jmbbm.2014.06.008; BOLZE MS, 1985, J NUTR, V115, P352, DOI 10.1093/jn/115.3.352; Burr DB, 2014, BASIC AND APPLIED BONE BIOLOGY, P3, DOI 10.1016/B978-0-12-416015-6.00001-0; Ceacero F, 2014, J ANIM SCI, V92, P4130, DOI 10.2527/jas.2014-7716; Ceacero F, 2010, PHYSIOL BEHAV, V100, P122, DOI 10.1016/j.physbeh.2010.02.008; Currey JD, 2009, J EXP BIOL, V212, P3985, DOI 10.1242/jeb.032292; Currey J.D., 2002, BONES STRUCTURE MECH; Currey JD, 2004, P ROY SOC B-BIOL SCI, V271, P517, DOI 10.1098/rspb.2003.2634; CURREY JD, 1979, J BIOMECH, V12, P313, DOI 10.1016/0021-9290(79)90073-3; Davison KS, 2006, SEMIN ARTHRITIS RHEU, V36, P22, DOI 10.1016/j.semarthrit.2006.04.002; Estevez JA, 2009, ACTA THERIOL, V54, P235, DOI 10.4098/j.at.0001-7051.070.2008; FORE H, 1952, BIOCHEM J, V51, P598, DOI 10.1042/bj0510598; Gaspar-Lopez E, 2008, EUR J WILDLIFE RES, V54, P1, DOI 10.1007/s10344-007-0096-0; Gomez Notario R, 2002, 50 ANOS HOMOLOGACION; Gomez S, 2013, BONE, V52, P506, DOI 10.1016/j.bone.2012.09.015; HYVARINEN H, 1977, BRIT J NUTR, V38, P301, DOI 10.1079/BJN19770094; Kierdorf H, 1995, ANN ANAT, V177, P525, DOI 10.1016/S0940-9602(11)80085-3; Klimlis-Zacas D, 2008, CELL BIOL TOXICOL, V24, P341; Krauss S, 2011, J STRUCT BIOL, V175, P457, DOI 10.1016/j.jsb.2011.06.005; Krauss S, 2009, BONE, V44, P1105, DOI 10.1016/j.bone.2009.02.009; Landete-Castilleijos T, 2007, BONE, V41, P794, DOI 10.1016/j.bone.2007.07.013; Landete-Castillejos T, 2007, BONE, V40, P1095, DOI 10.1016/j.bone.2006.11.022; Landete-Castillejos T, 2007, BONE, V40, P230, DOI 10.1016/j.bone.2006.07.009; Landete-Castillejos T, 2012, BONE, V50, P245, DOI 10.1016/j.bone.2011.10.026; Landete-Castillejos T, 2010, BONE, V47, P815, DOI 10.1016/j.bone.2010.07.021; Launey ME, 2010, ACTA BIOMATER, V6, P1505, DOI 10.1016/j.actbio.2009.11.026; LEACH RM, 1969, ARCH BIOCHEM BIOPHYS, V133, P22, DOI 10.1016/0003-9861(69)90483-4; Liang YC, 2007, ENVIRON POLLUT, V147, P422, DOI 10.1016/j.envpol.2006.06.008; Ma JF, 2004, SOIL SCI PLANT NUTR, V50, P11, DOI 10.1080/00380768.2004.10408447; Ma JF, 2006, TRENDS PLANT SCI, V11, P392, DOI 10.1016/j.tplants.2006.06.007; Mobasheri A, 1998, PHYSIOL RES, V47, P47; Olguin CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065461; STRAUSE LG, 1986, J NUTR, V116, P135, DOI 10.1093/jn/116.1.135; SVENSSON O, 1987, CLIN ORTHOP RELAT R, P302; TURNER CH, 1993, BONE, V14, P595, DOI 10.1016/8756-3282(93)90081-K; Wopenka B, 2005, MAT SCI ENG C-BIO S, V25, P131, DOI 10.1016/j.msec.2005.01.008; Xiao JF, 2014, POULTRY SCI, V93, P380, DOI 10.3382/ps.2013-03354; Yang PY, 1998, BIOL TRACE ELEM RES, V64, P275, DOI 10.1007/BF02783343	38	18	18	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132738	10.1371/journal.pone.0132738	http://dx.doi.org/10.1371/journal.pone.0132738			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177083	Green Submitted, Green Published, gold			2022-12-26	WOS:000358197600148
J	Caudrillier, A; Mallavia, B; Rouse, L; Marschner, S; Looney, MR				Caudrillier, Axelle; Mallavia, Benat; Rouse, Lindsay; Marschner, Susanne; Looney, Mark R.			Transfusion of Human Platelets Treated with Mirasol Pathogen Reduction Technology Does Not Induce Acute Lung Injury in Mice	PLOS ONE			English	Article							MOUSE MODEL; LIGHT; INACTIVATION	Pathogen reduction technology (PRT) has been developed in an effort to make the blood supply safer, but there is controversy as to whether it may induce structural or functional changes to platelets that could lead to acute lung injury after transfusion. In this study, we used a commercial PRT system to treat human platelets that were then transfused into immunodeficient mice, and the development of acute lung injury was determined. P-selectin expression was higher in the Mirasol PRT-treated platelets compared to control platelets on storage day 5, but not storage day 1. Transfusion of control vs. Mirasol PRT-treated platelets (day 5 of storage, 109 platelets per mouse) into NOD/SCID mice did not result in lung injury, however transfusion of storage day 5 platelets treated with thrombin receptor-activating peptide increased both extravascular lung water and lung vascular permeability. Transfusion of day 1 platelets did not produce lung injury in any group, and LPS priming 24 hours before transfusion had no effect on lung injury. In a model of transfusion-related acute lung injury, NOD/SCID mice were susceptible to acute lung injury when challenged with H-2Kd monoclonal antibody vs. isotype control antibody. Using lung intravital microscopy, we did not detect a difference in the dynamic retention of platelets in the lung circulation in control vs. Mirasol PRT-treated groups. In conclusion, Mirasol PRT produced an increase in P-selectin expression that is storage-dependent, but transfusion of human platelets treated with Mirasol PRT into immunodeficient mice did not result in greater platelet retention in the lungs or the development of acute lung injury.	[Caudrillier, Axelle; Mallavia, Benat; Looney, Mark R.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Rouse, Lindsay; Marschner, Susanne] Terumo BCT Inc, Lakewood, CO USA; [Looney, Mark R.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Looney, MR (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.	mark.looney@ucsf.edu		Hartson, Lindsay/0000-0002-3131-3507	Terumo BCT, Inc.	Terumo BCT, Inc.	This study was funded by Terumo BCT, Inc. Lindsay Rouse and Susanne Marschner are employees of Terumo BCT, Inc. Terumo BCT, Inc. provided support in the form of salaries for authors LR and SM but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Caudrillier A, 2012, J CLIN INVEST, V122, P2661, DOI 10.1172/JCI61303; Chi X, 2014, TRANSFUSION, V54, P74, DOI 10.1111/trf.12242; Chi X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044829; Cookson P, 2012, TRANSFUSION, V52, P983, DOI 10.1111/j.1537-2995.2011.03388.x; Dwyre DM, 2011, VOX SANG, V100, P92, DOI 10.1111/j.1423-0410.2010.01426.x; Fung YL, 2010, BLOOD, V116, P3073, DOI 10.1182/blood-2010-05-284570; Gelderman MP, 2011, TRANSFUSION, V51, P2343, DOI 10.1111/j.1537-2995.2011.03135.x; Goodrich RP, 2006, TRANSFUS APHER SCI, V35, P5, DOI 10.1016/j.transci.2006.01.007; Looney MR, 2006, J CLIN INVEST, V116, P1615, DOI 10.1172/JCI27238; Looney MR, 2011, NAT METHODS, V8, P91, DOI 10.1038/NMETH.1543; Looney MR, 2009, J CLIN INVEST, V119, P3450, DOI 10.1172/JCI38432; Ortiz-Munoz G, 2014, BLOOD, V124, P2625, DOI 10.1182/blood-2014-03-562876; Schlenke P, 2014, TRANSFUS MED HEMOTH, V41, P309, DOI 10.1159/000365646; SHULTZ LD, 1995, J IMMUNOL, V154, P180; Snyder E, 2005, TRANSFUSION, V45, P1864, DOI 10.1111/j.1537-2995.2005.00639.x; Spinella PC, 2008, CRIT CARE MED, V36, pS340, DOI 10.1097/CCM.0b013e31817e2ef9; Zarbock A, 2006, J CLIN INVEST, V116, P3211, DOI 10.1172/JCI29499	17	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0133022	10.1371/journal.pone.0133022	http://dx.doi.org/10.1371/journal.pone.0133022			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176623	gold, Green Submitted, Green Published			2022-12-26	WOS:000358197600202
J	Lopez-Larraz, E; Montesano, L; Gil-Agudo, A; Minguez, J; Oliviero, A				Lopez-Larraz, Eduardo; Montesano, Luis; Gil-Agudo, Angel; Minguez, Javier; Oliviero, Antonio			Evolution of EEG Motor Rhythms after Spinal Cord Injury: A Longitudinal Study	PLOS ONE			English	Article							SYSTEM FUNCTION; IMAGERY; STROKE; CORTEX; REORGANIZATION; RECOVERY; DESYNCHRONIZATION; MOVEMENTS; FNIRS; TIME	Spinal cord injury (SCI) does not only produce a lack of sensory and motor function caudal to the level of injury, but it also leads to a progressive brain reorganization. Chronic SCI patients attempting to move their affected limbs present a significant reduction of brain activation in the motor cortex, which has been linked to the deafferentation. The aim of this work is to study the evolution of the motor-related brain activity during the first months after SCI. Eighteen subacute SCI patients were recruited to participate in bi-weekly experimental sessions during at least two months. Their EEG was recorded to analyze the temporal evolution of the event-related desynchronization (ERD) over the motor cortex, both during motor attempt and motor imagery of their paralyzed hands. The results show that the a and beta ERD evolution after SCI is negatively correlated with the clinical progression of the patients during the first months after the injury. This work provides the first longitudinal study of the event-related desynchronization during the subacute phase of spinal cord injury. Furthermore, our findings reveal a strong association between the ERD changes and the clinical evolution of the patients. These results help to better understand the brain transformation after SCI, which is important to characterize the neuroplasticity mechanisms involved after this lesion and may lead to new strategies for rehabilitation and motor restoration of these patients.	[Lopez-Larraz, Eduardo; Montesano, Luis; Minguez, Javier] Univ Zaragoza, Dpto Informat & Ingn Sistemas, Zaragoza, Spain; [Lopez-Larraz, Eduardo; Montesano, Luis; Minguez, Javier] Inst Invest Ingn Aragon I3A, Zaragoza, Spain; [Gil-Agudo, Angel] Hosp Nacl Paraplejicos, Biomech & Tech Aids Unit, Toledo, Spain; [Minguez, Javier] Bit&Brain Technol SL, Zaragoza, Spain; [Oliviero, Antonio] Hosp Nacl Paraplejicos, FENNSI Grp, Toledo, Spain	University of Zaragoza; Hospital Nacional de Paraplejicos; Hospital Nacional de Paraplejicos	Lopez-Larraz, E (corresponding author), Univ Zaragoza, Dpto Informat & Ingn Sistemas, Zaragoza, Spain.	edulop@unizar.es	Oliviero, Antonio/ABH-4485-2020; Gil-Agudo, Ángel/ABD-3065-2021; López-Larraz, Eduardo/AAB-9689-2019	Oliviero, Antonio/0000-0001-7723-0478; Gil-Agudo, Ángel/0000-0001-5082-4225; López-Larraz, Eduardo/0000-0001-5482-1347; Minguez Zafra, Javier/0000-0002-2957-0133	Ministerio de Ciencia e Innovacion (Spanish Government) [HYPER-CSD2009-00067]; Diputacion General de Aragon (Spain), DGA-FSE (grupo T04); BitAMP;Brain Technologies SL; Ministerio de Economia y competitividad (Spanish Government) [DPI2011-25892]	Ministerio de Ciencia e Innovacion (Spanish Government)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Diputacion General de Aragon (Spain), DGA-FSE (grupo T04); BitAMP;Brain Technologies SL; Ministerio de Economia y competitividad (Spanish Government)(Spanish Government)	This work was supported by Ministerio de Ciencia e Innovacion (Spanish Government), Project HYPER-CSD2009-00067: ELL, LM, AGA; Ministerio de Economia y competitividad (Spanish Government), Project DPI2011-25892: ELL, LM; and Diputacion General de Aragon (Spain), DGA-FSE (grupo T04): ELL, LM. Bit&Brain Technologies SL, provided support in the form of salaries for author JM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Aguilar J, 2010, J NEUROSCI, V30, P7528, DOI 10.1523/JNEUROSCI.0379-10.2010; Alkadhi H, 2005, CEREB CORTEX, V15, P131, DOI 10.1093/cercor/bhh116; Blokland Y, 2014, IEEE T NEUR SYS REH, V22, P222, DOI 10.1109/TNSRE.2013.2292995; Bruehlmeier M, 1998, EUR J NEUROSCI, V10, P3918, DOI 10.1046/j.1460-9568.1998.00454.x; Castro A, 2013, INT J PSYCHOPHYSIOL, V87, P205, DOI 10.1016/j.ijpsycho.2013.01.012; Catz A, 2007, J REHABIL RES DEV, V44, P65, DOI 10.1682/JRRD.2005.07.0123; Cramer SC, 2005, BRAIN, V128, P2941, DOI 10.1093/brain/awh648; Cramer SC, 2007, EXP BRAIN RES, V177, P233, DOI 10.1007/s00221-006-0662-9; Curt A, 2002, J NEUROTRAUM, V19, P43, DOI 10.1089/089771502753460222; Enzinger C, 2008, EXP BRAIN RES, V190, P215, DOI 10.1007/s00221-008-1465-y; Fawcett JW, 2007, SPINAL CORD, V45, P190, DOI 10.1038/sj.sc.3102007; Feydy A, 2002, STROKE, V33, P1610, DOI 10.1161/01.STR.0000017100.68294.52; Freund P, 2013, LANCET NEUROL, V12, P873, DOI 10.1016/S1474-4422(13)70146-7; Furkiewicz MT, 2007, NEUROREHAB NEURAL RE, V21, P527, DOI 10.1177/1545968307301872; Graimann B, 2006, PROG BRAIN RES, V159, P79, DOI 10.1016/S0079-6123(06)59006-5; Green JB, 1999, NEUROLOGY, V53, P736, DOI 10.1212/WNL.53.4.736; Hotz-Boenden-Naker S, 2008, NEUROIMAGE, V39, P383, DOI 10.1016/j.neuroimage.2007.07.065; Jurkiewicz MT, 2010, NEUROREHAB NEURAL RE, V24, P136, DOI 10.1177/1545968309347680; Jurkiewicz MT, 2006, NEUROLOGY, V66, P762, DOI 10.1212/01.wnl.0000201276.28141.40; Kaiser V, 2014, NEUROIMAGE, V85, P432, DOI 10.1016/j.neuroimage.2013.04.097; Kirshblum SC, 2011, J SPINAL CORD MED, V34, P547, DOI 10.1179/107902611X13186000420242; Kokotilo KJ, 2009, J NEUROTRAUM, V26, P2113, DOI 10.1089/neu.2008.0688; Lopez-Larraz E, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-153; Lopez-Larraz E, 2012, IEEE ENG MED BIO, P1798, DOI 10.1109/EMBC.2012.6346299; Lotze M, 2006, NEUROREHAB NEURAL RE, V20, P14, DOI 10.1177/1545968305282919; Moxon KA, 2014, NEUROSCIENCE, V283, P78, DOI 10.1016/j.neuroscience.2014.06.056; Muller-Putz GR, 2007, BRAIN RES, V1137, P84, DOI 10.1016/j.brainres.2006.12.052; Neuper C, 2005, COGNITIVE BRAIN RES, V25, P668, DOI 10.1016/j.cogbrainres.2005.08.014; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Roiha K, 2011, CLIN NEUROPHYSIOL, V122, P339, DOI 10.1016/j.clinph.2010.06.032; TallonBaudry C, 1997, J NEUROSCI, V17, P722; Tangwiriyasakul C, 2014, CLIN NEUROPHYSIOL, V125, P1112, DOI 10.1016/j.clinph.2013.10.047; Turner JA, 2003, NEUROREHAB NEURAL RE, V17, P37, DOI 10.1177/0888439002250443; Turner JA, 2001, IEEE T NEUR SYS REH, V9, P154, DOI 10.1109/7333.928575; Ward NS, 2004, ANN NEUROL, V55, P829, DOI 10.1002/ana.20099; Ward NS, 2003, BRAIN, V126, P2476, DOI 10.1093/brain/awg245; Wrigley PJ, 2009, CEREB CORTEX, V19, P224, DOI 10.1093/cercor/bhn072; Wyndaele M, 2006, SPINAL CORD, V44, P523, DOI 10.1038/sj.sc.3101893	38	36	37	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0131759	10.1371/journal.pone.0131759	http://dx.doi.org/10.1371/journal.pone.0131759			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177457	Green Published, Green Submitted, gold			2022-12-26	WOS:000358197600062
J	Mahjoub, Y; Malaquin, S; Mourier, G; Lorne, E; Abou Arab, O; Massy, ZA; Dupont, H; Ducancel, F				Mahjoub, Yazine; Malaquin, Stephanie; Mourier, Gilles; Lorne, Emmanuel; Abou Arab, Osama; Massy, Ziad A.; Dupont, Herve; Ducancel, Frederic			Short- versus Long-Sarafotoxins: Two Structurally Related Snake Toxins with Very Different in vivo Haemodynamic Effects	PLOS ONE			English	Article							ENDOTHELIN-LIKE PEPTIDES; LEFT-VENTRICULAR RELAXATION; ATRACTASPIS-ENGADDENSIS; BURROWING ASP; ISOLATED RAT; PRESSURE; RECEPTOR; LUNG; POLYPEPTIDE; PERFORMANCE	Sarafotoxin-m (24 amino acids) from the venom of Atractaspis microlepidota microlepidota was the first long-sarafotoxin to be identified, while sarafotoxin-b (21 aa) is a short-sarafotoxin from Atractaspis engaddensis. Despite the presence of three additional C-terminus residues in sarafotoxin-m, these two peptides display a high sequence homology and share similar three-dimensional structures. However, unlike sarafotoxin-b, sarafotoxin-m shows a very low in vitro affinity for endothelin receptors, but still has a very high in vivo toxicity in mammals, similar to that of sarafotoxin-b. We have previously demonstrated, in vitro, the crucial role of the C-terminus extension in terms of pharmacological profiles and receptor affinities of long-versus short-sarafotoxins. One possible hypothesis to explain the high in vivo toxicity of sarafotoxin-m could be that its C-terminus extension is processed in vivo, resulting in short-like sarafotoxin. To address this possibility, we investigated, in the present study, the in vivo cardiovascular effects of sarafotoxin-b, sarafotoxin-m and sarafotoxin-m -Cter (sarafotoxin-m without the C -terminus extension). Male Wistar rats were anaesthetised and mechanically ventilated. Invasive haemodynamic measurements and echocardiographic measurements of left and right ventricular function were performed. The rats were divided into four groups that respectively received intravenous injections of: saline, sarafotoxin-b (one LD50), sarafotoxin-m (one LD50) or sarafotoxin-m -Cter (one LD50). All measurements were performed at baseline, at 1 minute (+1) and at 6 minutes (+6) after injection. Results: Sarafotoxin-b and sarafotoxin-m-Cter decreased cardiac output and impaired left ventricle systolic and diastolic function, whilst sarafotoxin-m decreased cardiac output, increased airway pressures and led to acute right ventricular dilatation associated with a decreased tricuspid annulus peak systolic velocity. Sarafotoxin-b and sarafotoxin-m -Cter appear to exert toxic effects via impairment of left ventricular function, whilst sarafotoxin-m increases airway pressures and impairs right ventricular function. These results do not support the hypothesis of an in vivo processing of long sarafotoxins.	[Mahjoub, Yazine; Malaquin, Stephanie; Lorne, Emmanuel; Abou Arab, Osama; Dupont, Herve; Ducancel, Frederic] CHU Amiens, Pole Anesthesie Reanimat & Med Urgence, Amiens, France; [Mahjoub, Yazine; Malaquin, Stephanie; Lorne, Emmanuel; Abou Arab, Osama; Massy, Ziad A.; Dupont, Herve] Unite INSERM U1088, Amiens, France; [Ducancel, Frederic] CEA Fontenay aux Roses, Serv Immuno Virol, CEA, iMETI, F-92265 Fontenay Aux Roses, France; [Mourier, Gilles] CEA Saclay, CEA, iBiTec S, Serv Ingn Mol Prot SIMOPRO, F-91191 Gif Sur Yvette, France	Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; Institut National de la Sante et de la Recherche Medicale (Inserm); CEA; UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Universite Paris Saclay	Mahjoub, Y (corresponding author), CHU Amiens, Pole Anesthesie Reanimat & Med Urgence, Amiens, France.	mahjoub.yazine@chu-amiens.fr	Mahjoub, Yazine/AAR-8585-2020; arab, osama abou/J-3073-2019; Dupont, Herve/D-1259-2010	arab, osama abou/0000-0003-3766-716X; 	CHU Amiens; INSERM [U1088]	CHU Amiens; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	This work was funded by institutional funds from CHU Amiens and INSERM U1088 with no specific grant. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Alam M, 2000, AM HEART J, V139, P710, DOI 10.1016/S0002-8703(00)90053-X; ATKINS AR, 1995, BIOCHEMISTRY-US, V34, P2026, DOI 10.1021/bi00006a024; Barton M, 2008, CAN J PHYSIOL PHARM, V86, P485, DOI 10.1139/Y08-059; BDOLAH A, 1989, BIOCHEM PHARMACOL, V38, P3145, DOI 10.1016/0006-2952(89)90606-0; D'Orleans-Juste P, 2002, PHARMACOL THERAPEUT, V95, P221, DOI 10.1016/S0163-7258(02)00235-8; Ducancel F, 2005, CELL MOL LIFE SCI, V62, P2828, DOI 10.1007/s00018-005-5286-x; Ducancel F, 2002, TOXICON, V40, P1541, DOI 10.1016/S0041-0101(02)00159-9; FILEP JG, 1991, BRIT J PHARMACOL, V103, P1633, DOI 10.1111/j.1476-5381.1991.tb09840.x; Fougeres E, 2010, CRIT CARE MED, V38, P802, DOI 10.1097/CCM.0b013e3181c587fd; GLOWER DD, 1985, CIRCULATION, V71, P994, DOI 10.1161/01.CIR.71.5.994; Granstrom B, 2004, ACTA PHYSIOL SCAND, V181, P259, DOI 10.1111/j.1365-201X.2004.01275.x; HAN SP, 1990, LIFE SCI, V46, P767, DOI 10.1016/0024-3205(90)90064-X; Hayashi MAF, 2004, PEPTIDES, V25, P1243, DOI 10.1016/j.peptides.2004.05.010; Jacques D, 2005, PEPTIDES, V26, P1427, DOI 10.1016/j.peptides.2005.03.048; Janosi T, 2008, EXP PHYSIOL, V93, P1210, DOI 10.1113/expphysiol.2008.042481; Jardin F, 1997, CHEST, V111, P209, DOI 10.1378/chest.111.1.209; JARDIN F, 1987, CHEST, V92, P789, DOI 10.1378/chest.92.5.789; KASS DA, 1988, CIRCULATION, V77, P1203, DOI 10.1161/01.CIR.77.6.1203; Khimji AK, 2010, CELL SIGNAL, V22, P1615, DOI 10.1016/j.cellsig.2010.05.002; Kiely DG, 1997, CARDIOVASC RES, V33, P378, DOI 10.1016/S0008-6363(96)00219-2; Konrad D, 2005, AM J PHYSIOL-HEART C, V289, pH1702, DOI 10.1152/ajpheart.00892.2004; Kurnik D, 1999, TOXICON, V37, P223, DOI 10.1016/S0041-0101(98)00166-4; LAL H, 1995, BRIT J PHARMACOL, V115, P653, DOI 10.1111/j.1476-5381.1995.tb14982.x; LOUIE EK, 1995, CIRCULATION, V92, P819, DOI 10.1161/01.CIR.92.4.819; Mahjoub Y, 2012, BRIT J ANAESTH, V108, P211, DOI 10.1093/bja/aer382; Mahjoub Y, 2009, CRIT CARE MED, V37, P2570, DOI 10.1097/CCM.0b013e3181a380a3; Meluzin J, 2001, EUR HEART J, V22, P340, DOI 10.1053/euhj.2000.2296; Mourier G, 2003, MOL PHARMACOL, V63, P26, DOI 10.1124/mol.63.1.26; Mourier G, 2012, BIOCHIMIE, V94, P461, DOI 10.1016/j.biochi.2011.08.014; Pacher P, 2008, NAT PROTOC, V3, P1422, DOI 10.1038/nprot.2008.138; Slama M, 2005, AM J PHYSIOL-HEART C, V289, pH1131, DOI 10.1152/ajpheart.00345.2004; Slama M, 2003, AM J PHYSIOL-HEART C, V284, pH691, DOI 10.1152/ajpheart.00653.2002; SOKOLOVSKY M, 1991, TRENDS BIOCHEM SCI, V16, P261, DOI 10.1016/0968-0004(91)90100-A; TEERLINK JR, 1994, CIRC RES, V74, P105, DOI 10.1161/01.RES.74.1.105; Tei C, 1997, J AM SOC ECHOCARDIOG, V10, P169, DOI 10.1016/S0894-7317(97)70090-7; Vieillard-Baron A, 1999, J APPL PHYSIOL, V87, P1644, DOI 10.1152/jappl.1999.87.5.1644; WEISS JL, 1976, J CLIN INVEST, V58, P751, DOI 10.1172/JCI108522; WOLLBERG Z, 1988, TOXICON, V26, P525, DOI 10.1016/0041-0101(88)90232-2; Xu XL, 2015, CURR TOP MED CHEM, V15, P658, DOI 10.2174/1568026615666150217113835; YANAGISAWA M, 1988, NATURE, V332, P411, DOI 10.1038/332411a0	40	12	12	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132864	10.1371/journal.pone.0132864	http://dx.doi.org/10.1371/journal.pone.0132864			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176218	Green Submitted, Green Published, gold			2022-12-26	WOS:000358197600170
J	Reddig, A; Fatahi, M; Friebe, B; Guttek, K; Hartig, R; Godenschweger, F; Roggenbuck, D; Ricke, J; Reinhold, D; Speck, O				Reddig, Annika; Fatahi, Mahsa; Friebe, Bjoern; Guttek, Karina; Hartig, Roland; Godenschweger, Frank; Roggenbuck, Dirk; Ricke, Jens; Reinhold, Dirk; Speck, Oliver			Analysis of DNA Double-Strand Breaks and Cytotoxicity after 7 Tesla Magnetic Resonance Imaging of Isolated Human Lymphocytes	PLOS ONE			English	Article							PERIPHERAL-BLOOD LYMPHOCYTES; COMET ASSAY; IONIZING-RADIATION; GAMMA-H2AX FOCI; MICRONUCLEUS; DAMAGE; MECHANISMS; BIOMARKER; IMPACT; REPAIR	The global use of magnetic resonance imaging (MRI) is constantly growing and the field strengths increasing. Yet, only little data about harmful biological effects caused by MRI exposure are available and published research analyzing the impact of MRI on DNA integrity reported controversial results. This in vitro study aimed to investigate the genotoxic and cytotoxic potential of 7 T ultra-high-field MRI on isolated human peripheral blood mononuclear cells. Hence, unstimulated mononuclear blood cells were exposed to 7 T static magnetic field alone or in combination with maximum permissible imaging gradients and radiofrequency pulses as well as to ionizing radiation during computed tomography and gamma-ray exposure. DNA double-strand breaks were quantified by flow cytometry and automated microscopy analysis of immunofluorescence stained gamma H2AX. Cytotoxicity was studied by CellTiter-Blue viability assay and [H-3]-thymidine proliferation assay. Exposure of unstimulated mononuclear blood cells to 7 T static magnetic field alone or combined with varying gradient magnetic fields and pulsed radiofrequency fields did not induce DNA double-strand breaks, whereas irradiation with X-and gamma-rays led to a dose-dependent induction of gamma H2AX foci. The viability assay revealed a time-and dose-dependent decrease in metabolic activity only among samples exposed to gamma-radiation. Further, there was no evidence for altered proliferation response after cells were exposed to 7 T MRI or low doses of ionizing radiation (<= 0.2 Gy). These findings confirm the acceptance of MRI as a safe non-invasive diagnostic imaging tool, but whether MRI can induce other types of DNA lesions or DNA double-strand breaks during altered conditions still needs to be investigated.	[Reddig, Annika; Guttek, Karina; Hartig, Roland; Reinhold, Dirk] Otto Von Guericke Univ, Inst Mol & Clin Immunol, Magdeburg, Germany; [Fatahi, Mahsa; Godenschweger, Frank; Speck, Oliver] Otto Von Guericke Univ, Dept Biomed Magnet Resonance, Magdeburg, Germany; [Friebe, Bjoern; Ricke, Jens] Otto Von Guericke Univ, Dept Radiol & Nucl Med, Magdeburg, Germany; [Roggenbuck, Dirk] Medipan GmbH, Dahlewitz Berlin, Germany; [Roggenbuck, Dirk] Brandenburg Univ Technol Cottbus Senftenberg, Fac Nat Sci, Senftenberg, Germany; [Speck, Oliver] Leibniz Inst Neurobiol, Magdeburg, Germany; [Speck, Oliver] Ctr Behav Brain Sci, Magdeburg, Germany; [Speck, Oliver] German Ctr Neurodegenerat Dis, Magdeburg, Germany	Otto von Guericke University; Otto von Guericke University; Otto von Guericke University; Brandenburg University of Technology Cottbus; Leibniz Institut fur Neurobiologie (LIN); Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Reddig, A (corresponding author), Otto Von Guericke Univ, Inst Mol & Clin Immunol, Magdeburg, Germany.	annika.reddig@med.ovgu.de	Speck, Oliver/F-1406-2013	Speck, Oliver/0000-0002-6019-5597; Roggenbuck, Dirk/0000-0002-6861-6827; Reddig, Annika/0000-0001-6587-206X; Hartig, Roland/0000-0002-3706-7458	GA Generic Assays GmbH; Medipan GmbH; HiMR (High Field Magnetic Resonance), an initial training network - FP7 Marie Curie Actions of the European Commission [FP7-PEOPLE-2012-ITN-316716]	GA Generic Assays GmbH; Medipan GmbH; HiMR (High Field Magnetic Resonance), an initial training network - FP7 Marie Curie Actions of the European Commission	Mahsa Fatahi was supported by the HiMR (High Field Magnetic Resonance), an initial training network, funded by the FP7 Marie Curie Actions of the European Commission (FP7-PEOPLE-2012-ITN-316716). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. GA Generic Assays GmbH and Medipan GmbH provided support in the form of salaries for author DR, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Caldecott KW, 2007, DNA REPAIR, V6, P443, DOI 10.1016/j.dnarep.2006.10.006; Carpenter D.O., 2012, PATTYS TOXICOLOGY, P109, DOI DOI 10.1002/0471435139.TOX100.PUB2; Cho S, 2014, DRUG CHEM TOXICOL, V37, P440, DOI 10.3109/01480545.2013.879662; Collins AR, 2008, MUTAGENESIS, V23, P143, DOI 10.1093/mutage/gem051; Collins CM, 2006, ULTRAHIGH FIELD MAGN, P231, DOI [10.1007/978-0-387-49648-1, DOI 10.1007/978-0-387-49648-1]; European Commission-Research Directorate General, 2005, HLTH EL FIELDS EU FU; Fenech M, 2011, MUTAGENESIS, V26, P125, DOI 10.1093/mutage/geq052; Fiechter M, 2013, EUR HEART J, V34, P2340, DOI 10.1093/eurheartj/eht184; Friedrich KM, 2009, SEMIN MUSCULOSKEL R, V13, P74, DOI 10.1055/s-0029-1202942; Ghodbane S, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/602987; Hartmann A, 2001, FOOD CHEM TOXICOL, V39, P843, DOI 10.1016/S0278-6915(01)00031-X; Hartwig V, 2009, INT J ENV RES PUB HE, V6, P1778, DOI 10.3390/ijerph6061778; Hiemann R, 2009, AUTOIMMUN REV, V9, P17, DOI 10.1016/j.autrev.2009.02.033; Ivashkevich A, 2012, CANCER LETT, V327, P123, DOI 10.1016/j.canlet.2011.12.025; Ivashkevich AN, 2011, MUTAT RES-FUND MOL M, V711, P49, DOI 10.1016/j.mrfmmm.2010.12.015; Kimura A, 2013, MUTAGENESIS, V28, P583, DOI 10.1093/mutage/get036; Kuefner MA, 2010, EUR RADIOL, V20, P2917, DOI 10.1007/s00330-010-1873-9; Lee J, 2011, BIOELECTROMAGNETICS, V32, P535, DOI 10.1002/bem.20664; Norimura Toshiyuki, 1993, Journal of UOEH, V15, P103; Onodera H, 2003, RADIAT RES, V159, P775, DOI 10.1667/0033-7587(2003)159[0775:EOTSMF]2.0.CO;2; Phillips J L, 2009, Pathophysiology, V16, P79, DOI 10.1016/j.pathophys.2008.11.005; Redon CE, 2011, AGING-US, V3, P168, DOI 10.18632/aging.100284; Redon CE, 2011, METHODS MOL BIOL, V682, P249, DOI 10.1007/978-1-60327-409-8_18; Redon CE, 2009, ADV SPACE RES, V43, P1171, DOI 10.1016/j.asr.2008.10.011; Rothkamm K, 2002, INT J ONCOL, V21, P433; Rothkamm K, 2007, RADIOLOGY, V242, P244, DOI 10.1148/radiol.2421060171; Runge R, 2012, INT J RADIAT BIOL, V88, P439, DOI 10.3109/09553002.2012.658468; Schwab SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070660; Schwenzer NF, 2007, J MAGN RESON IMAGING, V26, P1308, DOI 10.1002/jmri.21138; Simi S, 2008, MUTAT RES-FUND MOL M, V645, P39, DOI 10.1016/j.mrfmmm.2008.08.011; Speck O, 2012, HIGH FIELD MR IMAGIN, P84, DOI [10.1007/978-3-540-85090-8, DOI 10.1007/978-3-540-85090-8]; Szerencsi A, 2013, INT J RADIAT BIOL, V89, P870, DOI 10.3109/09553002.2013.804962; van Deventer TE, 2005, PROG BIOPHYS MOL BIO, V87, P355, DOI 10.1016/j.pbiomolbio.2004.08.017; van Osch MJP., 2014, CURR RADIOL REP, V2, P61, DOI DOI 10.1007/S40134-014-0061-0; Vijayalaxmi, 2015, MUTAT RES-REV MUTAT, V764, P51, DOI 10.1016/j.mrrev.2015.02.002; Watters GP, 2009, MUTAT RES-GEN TOX EN, V679, P50, DOI 10.1016/j.mrgentox.2009.07.007; WHO, 2006, ENV HLTH CRIT 232 ST; Willitzki A, 2013, CYTOM PART A, V83, P1017, DOI 10.1002/cyto.a.22350; Willitzki A, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/284740; Yildiz S, 2011, CLIN BIOCHEM, V44, P975, DOI 10.1016/j.clinbiochem.2011.05.005; Yu YK, 2006, TOXICOL IN VITRO, V20, P959, DOI 10.1016/j.tiv.2006.01.004	42	25	26	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132702	10.1371/journal.pone.0132702	http://dx.doi.org/10.1371/journal.pone.0132702			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176601	gold, Green Published, Green Submitted			2022-12-26	WOS:000358197600142
J	Reynolds, TH; Banerjee, S; Sharma, VM; Donohue, J; Couldwell, S; Sosinsky, A; Frulla, A; Robinson, A; Puri, V				Reynolds, Thomas H.; Banerjee, Sayani; Sharma, Vishva Mitra; Donohue, Jacob; Couldwell, Sandrine; Sosinsky, Alexandra; Frulla, Ashton; Robinson, Allegra; Puri, Vishwajeet			Effects of a High Fat Diet and Voluntary Wheel Running Exercise on Cidea and Cidec Expression in Liver and Adipose Tissue of Mice	PLOS ONE			English	Article							DEFICIENT MICE; TRANSCRIPTIONAL ACTIVATION; HEPATIC GLUCONEOGENESIS; INSULIN SENSITIVITY; ADIPOCYTE LIPOLYSIS; SKELETAL-MUSCLE; PGC-1-ALPHA; FSP27; COACTIVATOR; RESISTANCE	Cidea and Cidec play an important role in regulating triglyceride storage in liver and adipose tissue. It is not known if the Cidea and Cidec genes respond to a high fat diet (HFD) or exercise training, two interventions that alter lipid storage. The purpose of the present study was to determine the effect of a HFD and voluntary wheel running (WR) on Cidea and Cidec mRNA and protein expression in adipose tissue and liver of mice. A HFD promoted a significant increase in Cidea and Cidec mRNA levels in adipose tissue and liver. The increase in Cidea and Cidec mRNAs in adipose tissue and liver in response to a HFD was prevented by WR. Similar to the changes in Cidea mRNA, Cidea protein levels in adipose tissue significantly increased in response to a HFD, a process that was, again, prevented by WR. However, in adipose tissue the changes in Cidec mRNA did not correspond to the changes in Cidec protein levels, as a HFD decreased Cidec protein abundance. Interestingly, in adipose tissue Cidea protein expression was significantly related to body weight (R=.725), epididymal adipose tissue (EWAT) mass (R=.475) and insulin resistance (R=.706), whereas Cidec protein expression was inversely related to body weight (R=-.787), EWAT mass (R=.706), and insulin resistance (R=-.679). Similar to adipose tissue, Cidea protein expression in liver was significantly related to body weight (R=.660), EWAT mass (R=.468), and insulin resistance (R=.599); however, unlike adipose tissue, Cidec protein levels in liver were not related to body weight or EWAT mass and only moderately associated with insulin resistance (R=-.422, P=0.051). Overall, our findings indicate that Cidea is highly associated with adiposity and insulin resistance, whereas Cidec is related to insulin sensitivity. The present study suggests that Cide proteins might play an important functional role in the development of obesity, hepatic steatosis, as well as the pathogenesis of type 2 diabetes.	[Reynolds, Thomas H.; Donohue, Jacob; Couldwell, Sandrine; Sosinsky, Alexandra; Frulla, Ashton; Robinson, Allegra] Skidmore Coll, Dept Hlth & Exercise Sci, Saratoga Springs, NY 12866 USA; [Banerjee, Sayani; Sharma, Vishva Mitra; Puri, Vishwajeet] Boston Univ, Dept Med, Sect Endocrinol Diabet & Nutr, Boston, MA 02118 USA	Skidmore College; Boston University	Reynolds, TH (corresponding author), Skidmore Coll, Dept Hlth & Exercise Sci, Saratoga Springs, NY 12866 USA.	treynold@skidmore.edu	Sosinsky, Alexandra Z/N-9092-2019; Couldwell, Sandrine/GNH-4078-2022	Sosinsky, Alexandra Z/0000-0003-2051-7333; Reynolds, Thomas/0000-0002-0290-528X	Smith Family Grant; National Institutes of Health [1 R15 DK090722-01]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R15DK090722] Funding Source: NIH RePORTER	Smith Family Grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Smith Family Grant, (THR)and by the National Institutes of Health (grand no. 1 R15 DK090722-01 to THR).	Amer Diabet Assoc, 2013, DIABETES CARE, V36, P1033, DOI 10.2337/dc12-2625; [Anonymous], 2009, NCHS DATA BRIEF; Baar K, 2004, P NUTR SOC, V63, P269, DOI 10.1079/PNS2004334; Bickel PE, 2009, BBA-MOL CELL BIOL L, V1791, P419, DOI 10.1016/j.bbalip.2009.04.002; Boden G, 2011, CURR OPIN ENDOCRINOL, V18, P139, DOI 10.1097/MED.0b013e3283444b09; Centers for Disease Control and Prevention, 2011, NAT DIAB FACT SHEET; Christianson JL, 2010, J LIPID RES, V51, P3455, DOI 10.1194/jlr.M009498; Gong JY, 2011, J CELL BIOL, V195, P953, DOI 10.1083/jcb.201104142; Grahn THM, 2014, J BIOL CHEM, V289, P12029, DOI 10.1074/jbc.M113.539890; Hallberg M, 2008, MOL CELL BIOL, V28, P6785, DOI 10.1128/MCB.00504-08; Hammarstedt A, 2003, BIOCHEM BIOPH RES CO, V301, P578, DOI 10.1016/S0006-291X(03)00014-7; Hancock CR, 2008, P NATL ACAD SCI USA, V105, P7815, DOI 10.1073/pnas.0802057105; Jambunathan S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028614; Jeppesen J, 2012, J PHYSIOL-LONDON, V590, P1059, DOI 10.1113/jphysiol.2011.225011; Kim YJ, 2008, BIOCHEM BIOPH RES CO, V377, P297, DOI 10.1016/j.bbrc.2008.09.129; Larigauderie G, 2006, FEBS J, V273, P3498, DOI 10.1111/j.1742-4658.2006.05357.x; Lira VA, 2010, AM J PHYSIOL-ENDOC M, V299, pE145, DOI 10.1152/ajpendo.00755.2009; Liu K, 2009, AM J PHYSIOL-ENDOC M, V297, pE1395, DOI 10.1152/ajpendo.00188.2009; Matiello R, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-36; Matsusue K, 2008, CELL METAB, V7, P302, DOI 10.1016/j.cmet.2008.03.003; Nian ZQ, 2010, J BIOL CHEM, V285, P9604, DOI 10.1074/jbc.M109.043786; Nishino N, 2008, J CLIN INVEST, V118, P2808, DOI 10.1172/JCI34090; Nordstrom EA, 2005, DIABETES, V54, P1726, DOI 10.2337/diabetes.54.6.1726; Pilegaard H, 2003, J PHYSIOL-LONDON, V546, P851, DOI 10.1113/jphysiol.2002.034850; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Puri V, 2008, P NATL ACAD SCI USA, V105, P7833, DOI 10.1073/pnas.0802063105; Ranjit S, 2011, J LIPID RES, V52, P221, DOI 10.1194/jlr.M008771; Reynolds TH, 2012, AM J PHYSIOL-REG I, V303, pR1186, DOI 10.1152/ajpregu.00358.2012; Reynolds TH, 2009, J APPL PHYSIOL, V107, P1479, DOI 10.1152/japplphysiol.00574.2009; Rubio-Cabezas O, 2009, EMBO MOL MED, V1, P280, DOI 10.1002/emmm.200900037; Sahlin K, 2008, ACTA PHYSIOL, V194, P283, DOI 10.1111/j.1748-1716.2008.01879.x; Sato W, 2006, HEPATOL RES, V34, P256, DOI 10.1016/j.hepres.2006.01.003; Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007; Semple RK, 2004, INT J OBESITY, V28, P176, DOI 10.1038/sj.ijo.0802482; Singh M, 2014, J BIOL CHEM, V289, P14481, DOI 10.1074/jbc.C114.563080; Pauli LSS, 2014, J PHYSIOL-LONDON, V592, P1325, DOI 10.1113/jphysiol.2013.264002; Sun ZQ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2581; Sutherland LN, 2009, J PHYSIOL-LONDON, V587, P1607, DOI 10.1113/jphysiol.2008.165464; Tansey JT, 2001, P NATL ACAD SCI USA, V98, P6494, DOI 10.1073/pnas.101042998; Viswakarma N, 2007, J BIOL CHEM, V282, P18613, DOI 10.1074/jbc.M701983200; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Yonezawa T, 2009, BIOCHEM BIOPH RES CO, V384, P535, DOI 10.1016/j.bbrc.2009.05.012; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Zhang XD, 2014, AM J PHYSIOL-ENDOC M, V307, pE1047, DOI 10.1152/ajpendo.00125.2014; Zhou LK, 2012, HEPATOLOGY, V56, P95, DOI 10.1002/hep.25611; Zhou ZH, 2003, NAT GENET, V35, P49, DOI 10.1038/ng1225	46	23	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0130259	10.1371/journal.pone.0130259	http://dx.doi.org/10.1371/journal.pone.0130259			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176546	gold, Green Submitted, Green Published			2022-12-26	WOS:000358197600021
J	Romero-Lorca, A; Novillo, A; Gaibar, M; Bandres, F; Fernandez-Santander, A				Romero-Lorca, Alicia; Novillo, Apolonia; Gaibar, Maria; Bandres, Fernando; Fernandez-Santander, Ana			Impacts of the Glucuronidase Genotypes UGT1A4, UGT2B7, UGT2B15 and UGT2B17 on Tamoxifen Metabolism in Breast Cancer Patients	PLOS ONE			English	Article							UDP-GLUCURONOSYLTRANSFERASE; HUMAN LIVER; GENETIC POLYMORPHISMS; ESTROGEN-RECEPTOR; N-GLUCURONIDATION; POTENTIAL ROLE; PHASE-I; CYP2D6; RECURRENCE; PHARMACOGENETICS	Tamoxifen is used to prevent and treat estrogen-dependent breast cancer. It is described as a prodrug since most of its antiestrogen effects are exerted through its hydroxylated metabolites 4-OH-tamoxifen and endoxifen. In prior work, we correlated optimal plasma levels of these metabolites with certain genotypes of CYP2D6 and SULT1A2. This descriptive study examines correlations between concentrations of tamoxifen's glucuronide metabolites and genotypes UGT1A4 Pro24Thr, UGT1A4 Leu48Val, UGT2B7 His268Tyr, UGT2B15 Asp85YTyr UGT2B15 Lys523Thrand UGT2B17delin 132 patients with estrogen receptor-positive breast cancer under treatment with tamoxifen. Patients were genotyped by real-time and conventional PCR-RFLP. The glucuronides 4-OH-tamoxifen-N-glucuronide, 4-OH-tamoxifen-O-glucuronide and endoxifen-O-glucuronide were isolated from blood plasma and quantified using a high-pressure liquid chromatography-tandem mass spectrometry system. Individuals who were homozygous for UGT1A4(48VAL) showed significantly lower mean concentrations of both glucuronide metabolites compared to subjects genotyped as wt/wt plus wt/48Val (p=0.037 and p=0.031, respectively). Women homozygous for UGT2B7(268Tyr) also showed mean substrate/product ratios of 4-OH-tamoxifen/4-OH-tamoxifen-O-glucuronide and 4-OH-tamoxifen/4-OH-tamoxifen-N-glucuronide indicative of reduced glucuronidase activity compared to wt homozygotes or to heterozygotes for the polymorphism (p=0.005 and p=0.003, respectively). In contrast, UGT2B15 Lys523Thrand UGT2B17del were associated with possibly increased enzyme activity. Patients with at least one variant allele UGT2B15(523Thr) showed significantly higher 4-OH-tamoxifen-O-glucuronide and endoxifen-glucuronide levels (p=0.023 and p=0.025, respectively) indicating a variant gene-dose effect. Higher 4-OH-tamoxifen-N-glucuronide levels observed in UGT2B17del genotypes (p=0.042) could be attributed to a mechanism that compensates for the greater expression of other genes in UGT2B17 del/del individuals. Our observations suggest that patients carrying mutations UGT1A4(48Val), UGT2B7(268Tyr) or with wt genotypes for UGT2B17(nodel) and UGT2B15(523Lys) could be the best candidates for a good response to tamoxifen therapy in terms of eliciting effective plasma active tamoxifen metabolite levels. However, additional studies examining the effects of UGT genotype on overall patient response to TAM are needed to further examine the role of UGT polymorphisms in the therapeutic efficacy of TAM.	[Romero-Lorca, Alicia; Novillo, Apolonia; Gaibar, Maria; Fernandez-Santander, Ana] Univ Europea Madrid, Dept Basic Biomed Sci, Fac Biomed Sci, Madrid, Spain; [Bandres, Fernando] Fdn Tejerina, Sch Adv Studies, Madrid, Spain	European University of Madrid	Fernandez-Santander, A (corresponding author), Univ Europea Madrid, Dept Basic Biomed Sci, Fac Biomed Sci, Madrid, Spain.	ana.fernandez@uem.es	Novillo, Apolonia/M-7389-2017; Lorca, Alicia Romero/O-4074-2016; Gaibar, Maria/AHA-5931-2022; FERNÁNDEZ SANTANDER, ANA/ABT-4005-2022; Fernandez-Santander, Ana/L-5707-2014	Novillo, Apolonia/0000-0003-0902-0991; Lorca, Alicia Romero/0000-0002-1920-034X; Fernandez-Santander, Ana/0000-0001-7545-1170; , GAIBAR/0000-0003-3881-8345; BANDRES MOYA, FERNANDO/0000-0002-4675-8226	National Natural Science Foundation of China [51404260]; Basic Research Program of Jiangsu Province [BK20140206]; China Postdoctoral Science Foundation [2015M572112]; Priority Academic Program Development of Jiangsu Higher Education Institutions; Fundamental Research Funds for the Central Universities [2013QNB01]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Basic Research Program of Jiangsu Province; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Priority Academic Program Development of Jiangsu Higher Education Institutions; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Science Foundation of China (No. 51404260) (http://www.nsfc.gov.cn), the Basic Research Program of Jiangsu Province (No. BK20140206) (http://www.jskjjh.gov.cn), the China Postdoctoral Science Foundation (No. 2015M572112) (http://res.chinapostdoctor.org.cn/BshWeb/index.shtml), "A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions" (http://www.cumt.edu.cn), and the Fundamental Research Funds for the Central Universities (No. 2013QNB01) (http://www.cumt.edu.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benoit-Biancamano MO, 2009, PHARMACOGENET GENOM, V19, P945, DOI 10.1097/FPC.0b013e3283331637; Blevins-Primeau AS, 2009, CANCER RES, V69, P1892, DOI 10.1158/0008-5472.CAN-08-3708; Breyer-Pfaff U, 2000, DRUG METAB DISPOS, V28, P869; CHEN F, 1993, BIOCHEMISTRY-US, V32, P10648, DOI 10.1021/bi00091a015; Chen G, 2010, CANCER RES, V70, P7543, DOI 10.1158/0008-5472.CAN-09-4582; Chung JY, 2005, CLIN PHARMACOL THER, V77, P486, DOI 10.1016/j.clpt.2005.02.006; Court MH, 2004, J PHARMACOL EXP THER, V310, P656, DOI 10.1124/jpet.104.067660; Damodaran SE, 2012, CANCER CHEMOTH PHARM, V70, P75, DOI 10.1007/s00280-012-1891-1; Ehmer U, 2004, HEPATOLOGY, V39, P970, DOI 10.1002/hep.20131; Fernandez-Santander A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070183; Fisher B, 1996, JNCI-J NATL CANCER I, V88, P1529, DOI 10.1093/jnci/88.21.1529; Gjerde J, 2008, ANN ONCOL, V19, P56, DOI 10.1093/annonc/mdm434; GJERDE J, 2010, BMC CANCER, V21, P10; Green MD, 1998, DRUG METAB DISPOS, V26, P860; GREEN MD, 1994, DRUG METAB DISPOS, V22, P799; Greer AK, 2014, DRUG METAB DISPOS, V42, P1392, DOI 10.1124/dmd.114.058016; He X, 2009, BRIT J CLIN PHARMACO, V68, P721, DOI 10.1111/j.1365-2125.2009.03519.x; Jin Y, 2005, JNCI-J NATL CANCER I, V97, P30, DOI 10.1093/jnci/dji005; Johnson MD, 2004, BREAST CANCER RES TR, V85, P151, DOI 10.1023/B:BREA.0000025406.31193.e8; Kaku T, 2004, BIOCHEM PHARMACOL, V67, P2093, DOI 10.1016/j.bcp.2004.02.014; Kiyotani K, 2010, J CLIN ONCOL, V28, P1287, DOI 10.1200/JCO.2009.25.7246; Lampe JW, 2000, CANCER EPIDEM BIOMAR, V9, P329; Lazarus P, 2009, ANN NY ACAD SCI, V1155, P99, DOI 10.1111/j.1749-6632.2009.04114.x; LIEN EA, 1989, CANCER RES, V49, P2175; LIEN EA, 1988, CANCER RES, V48, P2304; Lim HS, 2007, J CLIN ONCOL, V25, P3837, DOI 10.1200/JCO.2007.11.4850; Murdter TE, 2011, CLIN PHARMACOL THER, V89, P708, DOI 10.1038/clpt.2011.27; Nadeau G, 2011, J CLIN ENDOCR METAB, V96, pE1550, DOI 10.1210/jc.2011-1049; Nishiyama T, 2002, BIOCHEM PHARMACOL, V63, P1817, DOI 10.1016/S0006-2952(02)00994-2; Nowell SA, 2005, BREAST CANCER RES TR, V91, P249, DOI 10.1007/s10549-004-7751-x; POON GK, 1993, DRUG METAB DISPOS, V21, P1119; Rae JM, 2012, JNCI-J NATL CANCER I, V104, P452, DOI 10.1093/jnci/djs126; Saeki Mayumi, 2005, Drug Metab Pharmacokinet, V20, P144, DOI 10.2133/dmpk.20.144; Schulze JJ, 2011, J CLIN ENDOCR METAB, V96, P3440, DOI 10.1210/jc.2011-0521; Schulze JJ, 2008, PHARMACOGENET GENOM, V18, P477, DOI 10.1097/FPC.0b013e3282fad38a; Strahm Emmanuel, 2013, Front Endocrinol (Lausanne), V4, P75, DOI 10.3389/fendo.2013.00075; Sun D, 2007, DRUG METAB DISPOS, V35, P2006, DOI 10.1124/dmd.107.017145; Sun DX, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1539; Turgeon D, 2000, J MOL BIOL, V295, P489, DOI 10.1006/jmbi.1999.3374; Wiener D, 2004, DRUG METAB DISPOS, V32, P72, DOI 10.1124/dmd.32.1.72; Wiener D, 2004, CANCER RES, V64, P1190, DOI 10.1158/0008-5472.CAN-03-3219; Wilson W, 2004, GENOMICS, V84, P707, DOI 10.1016/j.ygeno.2004.06.011; Zhou J, 2011, PHARMACOGENOMICS, V12, P1671, DOI [10.2217/PGS.11.105, 10.2217/pgs.11.105]	43	34	35	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132269	10.1371/journal.pone.0132269	http://dx.doi.org/10.1371/journal.pone.0132269			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176234	Green Published, Green Submitted, gold			2022-12-26	WOS:000358197600095
J	Zhang, KDD; Stoller, ML; Fekete, DM				Zhang, Kaidi D.; Stoller, Michelle L.; Fekete, Donna M.			Expression and Misexpression of the miR-183 Family in the Developing Hearing Organ of the Chicken	PLOS ONE			English	Article							DEVELOPING INNER-EAR; HAIR-CELL-DEVELOPMENT; IN-SITU DETECTION; BASILAR PAPILLA; ACTIN-FILAMENTS; GENE-EXPRESSION; OTIC PLACODE; COCHLEA; MICRORNAS; DIFFERENTIATION	The miR-183 family consists of 3 related microRNAs (miR-183, miR-96, miR-182) that are required to complete maturation of primary sensory cells in the mammalian inner ear. Because the level of these microRNAs is not uniform across hair cell subtypes in the murine cochlea, the question arises as to whether hair cell phenotypes are influenced by microRNA expression levels. To address this, we used the chicken embryo to study expression and misexpression of this gene family. By in situ hybridization, expression of all 3 microRNAs is robust in immature hair cells of both auditory and vestibular organs and is present in the statoacoustic ganglion. The auditory organ, called the basilar papilla, shows a weak radial gradient (highest on the neural side) in prosensory cells near the base on embryonic day 7. About nine days later, the basilar papilla also displays a longitudinal gradient (highest in apical hair cells) for the 3 microRNAs. Tol2-mediated gene delivery was used to ask whether cell phenotypes are malleable when the prosensory epithelium was forced to over-express the miR-183 family. The expression plasmid included EGFP as a reporter located upstream of an intron carrying the microRNA genes. The vectors were electroporated into the otic cup/vesicle, resulting in strong co-expression of EGFP and the miR-183 family that persisted for at least 2 weeks. This manipulation did not generate ectopic hair cells in non-sensory territories of the cochlear duct, although within the basilar papilla, hair cells were over-represented relative to supporting cells. There was no evidence for a change in hair cell phenotypes, such as short-to-tall, or basal-to-apical hair cell features. Therefore, while increasing expression of the miR-183 family was sufficient to influence cell lineage decisions, it did not redirect the differentiation of hair cells towards alternative radial or longitudinal phenotypes.	[Zhang, Kaidi D.; Stoller, Michelle L.; Fekete, Donna M.] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; [Fekete, Donna M.] Purdue Univ, Ctr Canc Res, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Fekete, DM (corresponding author), Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA.	dfekete@purdue.edu	Fekete, Donna M/B-9170-2009	Fekete, Donna M/0000-0003-0662-0246	National Institutes of Health [R01DC002756, F31DC011687, P300CA023168]; NATIONAL CANCER INSTITUTE [P30CA023168] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002756, F31DC011687] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was funded by the National Institutes of Health (http://www.nih.gov/; R01DC002756 to D.M.F.; F31DC011687 to M.L.S.; P300CA023168).	Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; BARTOLAMI S, 1991, J COMP NEUROL, V314, P777, DOI 10.1002/cne.903140410; Battisti AC, 2014, HEARING RES, V310, P1, DOI 10.1016/j.heares.2014.01.003; Bell D, 2008, DEV BIOL, V322, P109, DOI 10.1016/j.ydbio.2008.07.011; Beurg M, 2013, NEURON, V79, P69, DOI 10.1016/j.neuron.2013.05.018; BROWNELL WE, 1990, EAR HEARING, V11, P82, DOI 10.1097/00003446-199004000-00003; Bulankina AV, 2012, PHYSIOLOGY, V27, P100, DOI 10.1152/physiol.00036.2011; Busskamp V, 2014, NEURON, V83, P586, DOI 10.1016/j.neuron.2014.06.020; Chen J, 2014, EUR J NEUROSCI, V39, P744, DOI 10.1111/ejn.12484; Chiang HR, 2010, GENE DEV, V24, P992, DOI 10.1101/gad.1884710; Chrysostomou E, 2012, DEVELOPMENT, V139, P3764, DOI 10.1242/dev.074476; COTANCHE DA, 1983, ARCH OTO-RHINO-LARYN, V237, P191, DOI 10.1007/BF00453723; Dabdoub A, 2008, P NATL ACAD SCI USA, V105, P18396, DOI 10.1073/pnas.0808175105; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; FISCHER FP, 1992, HEARING RES, V61, P167, DOI 10.1016/0378-5955(92)90048-R; Frucht CS, 2011, JARO-J ASSOC RES OTO, V12, P423, DOI 10.1007/s10162-011-0259-2; FUCHS PA, 1988, J NEUROSCI, V8, P2460; GOODYEAR R, 1995, J COMP NEUROL, V351, P81, DOI 10.1002/cne.903510108; Goodyear R, 1997, J NEUROSCI, V17, P6289; Goodyear RJ, 2010, JARO-J ASSOC RES OTO, V11, P573, DOI 10.1007/s10162-010-0231-6; Groves AK, 2013, ANNU REV NEUROSCI, V36, P361, DOI 10.1146/annurev-neuro-062012-170309; Groves AK, 2012, DEVELOPMENT, V139, P245, DOI 10.1242/dev.067074; HAMBURGER V, 1992, DEV DYNAM, V195, P231, DOI 10.1002/dvdy.1001950404; KATAYAMA A, 1989, J COMP NEUROL, V281, P129, DOI 10.1002/cne.902810110; Kawakami K, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-S1-S7; Kloosterman WP, 2006, NAT METHODS, V3, P27, DOI 10.1038/NMETH843; Knowlton VY, 1967, J MORPHOLOGY, V121, P179; Kowalik L, 2011, DEV BIOL, V354, P221, DOI 10.1016/j.ydbio.2011.03.031; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Krol J, 2010, CELL, V141, P618, DOI 10.1016/j.cell.2010.03.039; Kuhn S, 2011, P NATL ACAD SCI USA, V108, P2355, DOI 10.1073/pnas.1016646108; Lewis MA, 2009, NAT GENET, V41, P614, DOI 10.1038/ng.369; Li H, 2010, ROLES MICRORNAS ZEBR; Li HQ, 2010, J NEUROSCI, V30, P3254, DOI 10.1523/JNEUROSCI.4948-09.2010; LIM DJ, 1986, HEARING RES, V22, P117, DOI 10.1016/0378-5955(86)90089-4; LIM DJ, 1980, J ACOUST SOC AM, V67, P1686, DOI 10.1121/1.384295; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lumayag S, 2013, P NATL ACAD SCI USA, V110, pE507, DOI 10.1073/pnas.1212655110; Mann ZF, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4839; Mencia A, 2009, NAT GENET, V41, P609, DOI 10.1038/ng.355; Molea D, 1999, J COMP NEUROL, V406, P183; Neves J, 2007, J COMP NEUROL, V503, P487, DOI 10.1002/cne.21299; Obernosterer G, 2007, NAT PROTOC, V2, P1508, DOI 10.1038/nprot.2007.153; Sanchez-Guardado LO, 2014, DEVELOPMENT, V141, P2302, DOI 10.1242/dev.101667; Powder KE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035111; Sacheli R, 2009, GENE EXPR PATTERNS, V9, P364, DOI 10.1016/j.gep.2009.01.003; Sato Y, 2007, DEV BIOL, V305, P616, DOI 10.1016/j.ydbio.2007.01.043; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Sienknecht UJ, 2008, J COMP NEUROL, V510, P378, DOI 10.1002/cne.21791; Stoller ML, 2013, INT J MOL SCI, V14, P18239, DOI 10.3390/ijms140918239; TANAKA K, 1978, AM J ANAT, V153, P251, DOI 10.1002/aja.1001530206; Thiede BR, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4840; TILNEY LG, 1992, ANNU REV CELL BIOL, V8, P257, DOI 10.1146/annurev.cb.08.110192.001353; TILNEY LG, 1983, J CELL BIOL, V96, P807, DOI 10.1083/jcb.96.3.807; Weston MD, 2006, BRAIN RES, V1111, P95, DOI 10.1016/j.brainres.2006.07.006; Weston MD, 2011, DEV DYNAM, V240, P808, DOI 10.1002/dvdy.22591; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; Xu SB, 2007, J BIOL CHEM, V282, P25053, DOI 10.1074/jbc.M700501200; Zhu QB, 2011, J BIOL CHEM, V286, P31749, DOI 10.1074/jbc.M111.259028	59	9	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132796	10.1371/journal.pone.0132796	http://dx.doi.org/10.1371/journal.pone.0132796			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176784	Green Submitted, Green Published, gold			2022-12-26	WOS:000358197600159
J	Zhao, WW; Chen, F; Wu, MH; Jiang, S; Wu, BB; Luo, HL; Wen, JY; Hu, CH; Yu, SH				Zhao, Weiwei; Chen, Fan; Wu, Menghua; Jiang, Shuai; Wu, Binbin; Luo, Huali; Wen, Jingyi; Hu, Chaohui; Yu, Shihui			Postnatal Identification of Trisomy 21: An Overview of 7,133 Postnatal Trisomy 21 Cases Identified in a Diagnostic Reference Laboratory in China	PLOS ONE			English	Article							DOWN-SYNDROME; MATERNAL AGE; EPIDEMIOLOGIC FINDINGS; AUTOSOMAL ANEUPLOIDY; PRENATAL-DIAGNOSIS; TERMINATION RATES; BIRTH-DEFECTS; UNITED-STATES; SEX-RATIO; PREVALENCE	This study describes the cytogenetic characteristics of 7,133 trisomy 21 (Tri21) identified from 247,818 consecutive postnatal cases karyotyped in a single reference laboratory in China for a period of 4 years. The average detection rate of Tri21 is 2.88% ranging from 3.39% in 2011 to 2.52% in 2014. The decreased detection rates over the years might reflect a possible impact of noninvasive prenatal testing applied rapidly in China and elective termination of affected pregnancies. 95.32% of the Tri21 karyotypes are standard Tri21, 4.53% are Robertsonian Tri21, and less than 1% are other Tri21 forms. There are more mosaic Tri21 in older children and adults, consistent with previous observations that clinical features in individuals with mosaic Tri21 are generally milder and easily missed during perinatal period. The male/female (M/F ratio) for the total 7,133 Tri21 cases and for the 6,671 cases with non-mosaic standard Tri21 are 1.50 and 1.53 respectively, significantly higher than the 0.93 for all the 247,818 cases we karyotyped, the 1.30 for the Down syndrome (DS) identified during perinatal period in China, and the 1.20 for the livebirth in Chinese population. In contrast, the mosaic standard Tri21 case has a significantly lower proportion of males when compared with the non-mosaic standard Tri21, indicating different underlying mechanisms leading to their formations. Opposite M/F ratios in different subtypes of ROB Tri21 were observed. A long list of rare or private karyotypes where Tri21 are concurrently present was identified. The large collection of Tri21 cases with a diversity of clinical findings and a wide age range allowed us to determine the frequency of the different karyotypes of Down syndrome in China, given the fact that this kind of national epidemiological data is lacking currently.	[Zhao, Weiwei; Chen, Fan; Wu, Menghua; Jiang, Shuai; Wu, Binbin; Luo, Huali; Wen, Jingyi; Hu, Chaohui; Yu, Shihui] KingMed Genome Diagnost Lab, Guangzhou, Guangdong, Peoples R China; [Yu, Shihui] Univ Washington, Sch Med, Dept Lab Med, Seattle, WA 98195 USA; [Yu, Shihui] Seattle Childrens Hosp, Seattle, WA USA	University of Washington; University of Washington Seattle; Seattle Children's Hospital	Yu, SH (corresponding author), KingMed Genome Diagnost Lab, Guangzhou, Guangdong, Peoples R China.	shihui.yu@seattlechildrens.org			KingMed Genome Diagnostic Laboratory	KingMed Genome Diagnostic Laboratory	KingMed Genome Diagnostic Laboratory provided support in the form of salaries for authors WWZ, FC, MHW, SJ, BBW, HLL, JYW, and CHH, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Alfarawati S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003025; Antonarakis SE, 2004, NAT REV GENET, V5, P725, DOI 10.1038/nrg1448; Bandyopadhyay R, 2001, CHROMOSOME RES, V9, P235, DOI 10.1023/A:1016652621226; Bornstein E, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2009.01.017; Carothers AD, 1999, J MED GENET, V36, P386; Chen SP, 2013, PRENATAL DIAG, V33, P584, DOI 10.1002/pd.4110; Deng C, 2014, PRENAT DIAGN; Devlin L, 2004, Ulster Med J, V73, P4; Freeman SB, 2008, GENET MED, V10, P173, DOI 10.1097/GIM.0b013e3181634867; Gardner R, 2012, CHROMOSOME ABNORMALI, V4th; Griffin DK, 1996, AM J HUM GENET, V59, P1108; Hecht CA, 1996, AM J MED GENET, V62, P376, DOI 10.1002/(SICI)1096-8628(19960424)62:4<376::AID-AJMG10>3.0.CO;2-L; Hindley D, 2002, ARCH DIS CHILD-FETAL, V87, P220, DOI 10.1136/fn.87.3.F220; Hook EB, 1999, AM J MED GENET, V84, P316, DOI 10.1002/(SICI)1096-8628(19990604)84:4<316::AID-AJMG2>3.3.CO;2-T; Hoshi N, 1999, AM J MED GENET, V84, P340, DOI 10.1002/(SICI)1096-8628(19990604)84:4<340::AID-AJMG6>3.0.CO;2-N; Huether CA, 1996, AM J MED GENET, V63, P492, DOI 10.1002/(SICI)1096-8628(19960614)63:3<492::AID-AJMG15>3.0.CO;2-H; Hulten MA, 2010, CURR GENOMICS, V11, P409, DOI 10.2174/138920210793176056; Hulten MA, 2010, MOL CYTOGENET, V3, DOI 10.1186/1755-8166-3-4; Hulten MA, 2008, MOL CYTOGENET, V1, DOI 10.1186/1755-8166-1-21; Jackson-Cook C, 2011, CLIN LAB MED, V31, P481, DOI 10.1016/j.cll.2011.08.002; Jon HJ, 2005, PRENATAL DIAG, V25, P665, DOI 10.1002/pd.1220; Lai FM, 2002, SINGAP MED J, V43; Loane M, 2013, EUR J HUM GENET, V21, P27, DOI 10.1038/ejhg.2012.94; Mai CT, 2013, BIRTH DEFECTS RES A, V97, P709, DOI 10.1002/bdra.23198; Mandava S, 2010, GENET TEST MOL BIOMA, V14, P499, DOI 10.1089/gtmb.2009.0167; Mansfield C, 1999, PRENATAL DIAG, V19, P808, DOI 10.1002/(SICI)1097-0223(199909)19:9<808::AID-PD637>3.0.CO;2-B; Morris JK, 2012, AM J MED GENET A, V158A, P1151, DOI 10.1002/ajmg.a.35248; Murthy SK, 2007, MED PRIN PRACT, V16, P25, DOI 10.1159/000096136; Mutton D, 1996, J MED GENET, V33, P387, DOI 10.1136/jmg.33.5.387; Natoli JL, 2012, PRENATAL DIAG, V32, P142, DOI 10.1002/pd.2910; NIELSEN J, 1991, HUM GENET, V87, P81, DOI 10.1007/BF01213097; O'Nuallain S, 2007, Ir Med J, V100, P329; Papavassiliou P, 2015, AM J MED GENET A, V167, P26, DOI 10.1002/ajmg.a.36861; Parker SE, 2010, BIRTH DEFECTS RES A, V88, P1008, DOI 10.1002/bdra.20735; Pennington BF, 2003, CHILD DEV, V74, P75, DOI 10.1111/1467-8624.00522; Shin M, 2010, AM J MED GENET A, V152A, P800, DOI 10.1002/ajmg.a.33295; Skotko BG, 2009, PEDIATRICS, V124, pE751, DOI 10.1542/peds.2009-0480; Stoll C, 1998, ANN GENET-PARIS, V41, P44; Zhang H, 2015, ULTRASOUND OBSTET GY; Zhu JL, 2013, GENET MED, V15, P64, DOI 10.1038/gim.2012.93	40	10	10	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0133151	10.1371/journal.pone.0133151	http://dx.doi.org/10.1371/journal.pone.0133151			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176847	Green Submitted, gold, Green Published			2022-12-26	WOS:000358197600220
J	Chiu, SC; Lin, YJ; Huang, SY; Lien, CF; Chen, SP; Pang, CY; Lin, JH; Yang, KT				Chiu, Sheng-Chun; Lin, Yu-Jou; Huang, Sung-Ying; Lien, Chih-Feng; Chen, Shee-Ping; Pang, Cheng-Yoong; Lin, Jian-Hong; Yang, Kun-Ta			The Role of Intermittent Hypoxia on the Proliferative Inhibition of Rat Cerebellar Astrocytes	PLOS ONE			English	Article							ASTROGLIAL CELL-PROLIFERATION; SLEEP-APNEA; POLY(ADP-RIBOSE) POLYMERASE; OXIDATIVE STRESS; REACTIVE OXYGEN; EXPRESSION; BRAIN; GLUTATHIONE; DEATH; DIFFERENTIATION	Sleep apnea syndrome, characterized by intermittent hypoxia (IH), is linked with increased oxidative stress. This study investigates the mechanisms underlying IH and the effects of IH-induced oxidative stress on cerebellar astrocytes. Rat primary cerebellar astrocytes were kept in an incubator with an oscillating O-2 concentration between 20% and 5% every 30 min for 1-4 days. Although the cell loss increased with the duration, the IH incubation didn't induce apoptosis or necrosis, but rather a G0/G1 cell cycle arrest of cerebellar astrocytes was noted. ROS accumulation was associated with cell loss during IH. PARP activation, resulting in p21 activation and cyclin D1 degradation was associated with cell cycle G0/G1 arrest of IH-treated cerebellar astrocytes. Our results suggest that IH induces cell loss by enhancing oxidative stress, PARP activation and cell cycle G0/G1 arrest in rat primary cerebellar astrocytes.	[Chiu, Sheng-Chun] Buddhist Tzu Chi Med Fdn, Taichung Tzu Chi Hosp, Dept Res, Taichung, Taiwan; [Lin, Yu-Jou; Yang, Kun-Ta] Tzu Chi Univ, Sch Med, Physiol & Anat Med, Hualien, Taiwan; [Huang, Sung-Ying] Mackay Mem Hosp, Dept Ophthalmol, Hsinchu, Taiwan; [Lien, Chih-Feng; Pang, Cheng-Yoong] Tzu Chi Univ, Sch Med, Inst Med Sci, Hualien, Taiwan; [Chen, Shee-Ping] Buddhist Tzu Chi Med Fdn, Hualien Tzu Chi Hosp, Tzu Chi Stem Cells Ctr, Hualien, Taiwan; [Pang, Cheng-Yoong] Buddhist Tzu Chi Med Fdn, Hualien Tzu Chi Hosp, Dept Med Res, Hualien, Taiwan; [Lin, Jian-Hong] Tzu Chi Univ, PhD Program Pharmacol & Toxicol, Hualien, Taiwan; [Yang, Kun-Ta] Tzu Chi Univ, Sch Med, Dept Physiol, Hualien, Taiwan	Buddhist Tzu Chi General Hospital; Taichung Tzu Chi Hospital; Tzu Chi University; Mackay Memorial Hospital; Tzu Chi University; Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; Tzu Chi University; Tzu Chi University	Yang, KT (corresponding author), Tzu Chi Univ, Sch Med, Physiol & Anat Med, Hualien, Taiwan.	ktyang@mail.tcu.edu.tw	Pang, Cheng-Yoong/AFO-1562-2022; Pang, Cheng-Yoong/R-4990-2019; Chiu, Sheng-Chun/F-9493-2015; Lin, Jian-Hong/AAX-9667-2021	Pang, Cheng-Yoong/0000-0002-9063-2858; Lin, Jian-Hong/0000-0002-3011-8259; Chiu, Sheng-Chun/0000-0002-5927-8088	Tzu Chi University, Taiwan, ROC [TCRPP100007, TCIRP98002-1, TCIRP 95004-05]	Tzu Chi University, Taiwan, ROC	This research was supported by grants TCRPP100007, TCIRP98002-1 and TCIRP 95004-05 from Tzu Chi University, Taiwan, ROC.	Albrecht PJ, 2002, EXP NEUROL, V173, P46, DOI 10.1006/exnr.2001.7834; Bramanti V, 2015, J NEUROSCI RES, V93, P521, DOI 10.1002/jnr.23506; Bramanti V, 2012, NEUROCHEM RES, V37, P2795, DOI 10.1007/s11064-012-0873-3; Burch PM, 2005, ANTIOXID REDOX SIGN, V7, P741, DOI 10.1089/ars.2005.7.741; Carnevale D., 2007, CNS & Neurological Disorders-Drug Targets, V6, P388; Chiu SC, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-29; Douglas RM, 2010, AM J PHYSIOL-CELL PH, V298, pC1594, DOI 10.1152/ajpcell.00298.2009; Dringen R, 2000, EUR J BIOCHEM, V267, P4912, DOI 10.1046/j.1432-1327.2000.01597.x; Dringen R, 1998, GLIA, V23, P139, DOI 10.1002/(SICI)1098-1136(199806)23:2<139::AID-GLIA5>3.0.CO;2-1; Fasanaro P, 2006, FASEB J, V20, P1242, DOI 10.1096/fj.05-4695fje; Gao C, 2014, NEUROCHEM RES, V39, P2160, DOI 10.1007/s11064-014-1411-2; Grasso S, 2014, J NEUROSCI RES, V92, P86, DOI 10.1002/jnr.23289; Jagtap P, 2005, NAT REV DRUG DISCOV, V4, P421, DOI 10.1038/nrd1718; Kussmaul L, 1999, J NEUROCHEM, V73, P1246, DOI 10.1046/j.1471-4159.1999.0731246.x; Liberto CM, 2004, J NEUROCHEM, V89, P1092, DOI 10.1111/j.1471-4159.2004.02420.x; Macey PM, 2002, AM J RESP CRIT CARE, V166, P1382, DOI 10.1164/rccm.200201-050OC; Magistretti PJ, 2006, J EXP BIOL, V209, P2304, DOI 10.1242/jeb.02208; Martin-Oliva D, 2006, CANCER RES, V66, P5744, DOI 10.1158/0008-5472.CAN-05-3050; MAYFIELD KP, 1994, AM J PHYSIOL, V266, pR1615, DOI 10.1152/ajpregu.1994.266.5.R1615; NAEGELE B, 1995, SLEEP, V18, P43; Nedergaard M, 2005, GLIA, V50, P281, DOI 10.1002/glia.20205; Neubauer JA, 2001, J APPL PHYSIOL, V90, P1593, DOI 10.1152/jappl.2001.90.4.1593; Nieto FJ, 2000, JAMA-J AM MED ASSOC, V283, P1829, DOI 10.1001/jama.283.14.1829; O'Brien LM, 2004, PEDIATR CLIN N AM, V51, P187, DOI 10.1016/S0031-3955(03)00184-6; Pellerin L, 2002, DIABETES NUTR METAB, V15, P268; Rosafio K, 2014, GLIA, V62, P477, DOI 10.1002/glia.22618; ROSENBERG PA, 1989, NEUROSCI LETT, V103, P162, DOI 10.1016/0304-3940(89)90569-7; Song SH, 2002, NATURE, V417, P39, DOI 10.1038/417039a; Tsai KL, 1997, J PHYSIOL-LONDON, V502, P161, DOI 10.1111/j.1469-7793.1997.161bl.x; van Wijk SJL, 2005, FREE RADICAL BIO MED, V39, P81, DOI 10.1016/j.freeadbiomed.2005.03.021; Virag L, 2002, PHARMACOL REV, V54, P375, DOI 10.1124/pr.54.3.375; Wilson JX, 1997, CAN J PHYSIOL PHARM, V75, P1149, DOI 10.1139/cjpp-75-10-11-1149; Wu ML, 1999, J NEUROCHEM, V73, P1318; Xu W, 2004, NEUROSCIENCE, V126, P313, DOI 10.1016/j.neuroscience.2004.03.055	34	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132263	10.1371/journal.pone.0132263	http://dx.doi.org/10.1371/journal.pone.0132263			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26172116	Green Published, gold, Green Submitted			2022-12-26	WOS:000358194900038
J	Grendelmeier, A; Arlettaz, R; Gerber, M; Pasinelli, G				Grendelmeier, Alex; Arlettaz, Raphael; Gerber, Michael; Pasinelli, Gilberto			Reproductive Performance of a Declining Forest Passerine in Relation to Environmental and Social Factors: Implications for Species Conservation	PLOS ONE			English	Article							WARBLER PHYLLOSCOPUS-SIBILATRIX; AKAIKES-INFORMATION-CRITERION; GROUND-NESTING BIRDS; TITS PARUS-MAJOR; CLUTCH SIZE; SITE SELECTION; RECREATIONAL TRAILS; SEASONAL DECLINE; BREEDING SUCCESS; PREDATION RATES	Identifying factors influencing a species' ecological niche and demography is a prerequisite for species conservation. However, our understanding of the interplay between demographic rates and biotic/abiotic factors is still poor for most species of conservation concern. We evaluated relevance of eight hypotheses relating to timing of breeding, temporal nest exposure, nest concealment, topography, tree structure, predation risk and disturbance, density dependence and weather for explaining variation in reproductive performance of the declining wood warbler Phylloscopus sibilatrix in northern Switzerland. Reproductive performance was monitored with cameras at 136 nests from 2010 to 2012 and was associated to temporal exposure, timing of breeding and concealment of nests. Daily nest survival was positively related to the number of grass and sedge tussocks, nest concealment and nest age. Clutch size and number of fledglings decreased, the later in the season a nest was initiated. Nest survival over an average nesting period of 31 days was 46.9 +/- 0.07% (mean +/- SE), daily nest survival rate was 0.976 +/- 0.002. As for many ground-breeding birds, nest predation was the principal cause of nest failure, accounting for 79% of all nest losses. Conservation measures should aim at increasing the area of relatively homogenous forest stands featuring suitable habitats characterized by abundant and accessible grass and sedge tussocks. In managed forests, such conditions can be found in stands of middle age (i.e. pole wood) with little to no shrub layer.	[Grendelmeier, Alex; Pasinelli, Gilberto] Swiss Ornithol Inst, Sempach, Switzerland; [Grendelmeier, Alex; Arlettaz, Raphael] Univ Bern, Inst Ecol & Evolut, Div Conservat Biol, Bern, Switzerland; [Gerber, Michael] BirdLife Schweiz, Schweizer Vogelschutz SVS, Zurich, Switzerland	Swiss Ornithological Institute; University of Bern	Grendelmeier, A (corresponding author), Swiss Ornithol Inst, Sempach, Switzerland.	alex.grendelmeier@vogelwarte.ch	Arlettaz, Raphaël/O-2182-2016	Arlettaz, Raphaël/0000-0001-6360-5339	Swiss National Science Foundation [31003A_143879/1]; Hilfsfonds fur die Schweizerische Vogelwarte Sempach; Styner-Stiftung; Stotzer-Kastli-Stiftung; Lotteriefonds des Kantons Solothurn	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Hilfsfonds fur die Schweizerische Vogelwarte Sempach; Styner-Stiftung; Stotzer-Kastli-Stiftung; Lotteriefonds des Kantons Solothurn	Swiss National Science Foundation (grant no. 31003A_143879/1) www.snf.ch, recipient: GP; Hilfsfonds fur die Schweizerische Vogelwarte Sempach, recipient: GP; Styner-Stiftung, recipient: GP; Stotzer-Kastli-Stiftung, recipient: GP; Lotteriefonds des Kantons Solothurn, https://www.so.ch/verwaltung/departement-des-innern/amt-fuersoziale-sicherheit/non-profit-organisationen/lotterie-sportfonds/lotteriefonds/, recipient: GP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlering MA, 2010, CONDOR, V112, P252, DOI 10.1525/cond.2010.090239; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Arlettaz R, 2007, P R SOC B, V274, P1219, DOI 10.1098/rspb.2006.0434; Arlettaz R, 2010, J ORNITHOL, V151, P889, DOI 10.1007/s10336-010-0527-7; Arlettaz R, 2010, J ORNITHOL, V151, P553, DOI 10.1007/s10336-009-0485-0; Bakermans MH, 2012, J WILDLIFE MANAGE, V76, P1225, DOI 10.1002/jwmg.349; Bates D. M., 2010, LME4 MIXED EFFECTS M; BAXTER GS, 1994, COLON WATERBIRD, V17, P120, DOI 10.2307/1521290; Berec L, 2007, TRENDS ECOL EVOL, V22, P185, DOI 10.1016/j.tree.2006.12.002; BEST LB, 1978, AUK, V95, P9, DOI 10.2307/4085491; Betts MG, 2008, P ROY SOC B-BIOL SCI, V275, P2257, DOI 10.1098/rspb.2008.0217; BirdLifeInternational, 2014, SPEC FACTSH PHYLL SI; Both C, 2006, NATURE, V441, P81, DOI 10.1038/nature04539; BOYLE SA, 1985, WILDLIFE SOC B, V13, P110; Brown CR, 1999, AUK, V116, P467, DOI 10.2307/4089380; Buchanan KL, 1997, P ROY SOC B-BIOL SCI, V264, P521, DOI 10.1098/rspb.1997.0074; Burhans DE, 2002, J WILDLIFE MANAGE, V66, P240, DOI 10.2307/3802890; Burke DM, 2000, ECOL APPL, V10, P1749, DOI 10.1890/1051-0761(2000)010[1749:LAFSEO]2.0.CO;2; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Burton NHK, 2006, J AVIAN BIOL, V37, P312, DOI 10.1111/j.2006.0908-8857.03822.x; Christians JK, 2001, J ANIM ECOL, V70, P1080, DOI 10.1046/j.0021-8790.2001.00566.x; Coch T., 2005, Schweizerische Zeitschrift fur Forstwesen, V156, P59, DOI 10.3188/szf.2005.0059; Courchamp F., 2008, ALLEE EFFECTS ECOLOG, DOI DOI 10.1017/S0376892909005384; de Heij ME, 2006, P ROY SOC B-BIOL SCI, V273, P2353, DOI 10.1098/rspb.2006.3584; DIXON CL, 1978, AUK, V95, P235; Emmering QC, 2011, J ANIM ECOL, V80, P1305, DOI 10.1111/j.1365-2656.2011.01869.x; Flade Martin, 2004, Vogelwelt, V125, P177; Gelman A., 2011, ARM DATA ANAL USING; Gerber M, 2011, THESIS U ZURICH; Glutz von Blotzheim U., 1991, HDB VOGEL MITTELEURO; Grant TA, 2005, AUK, V122, P661, DOI 10.1642/0004-8038(2005)122[0661:TVIPNS]2.0.CO;2; Haff TM, 2011, BIOL LETTERS, V7, P493, DOI 10.1098/rsbl.2010.1125; Haley MP, 2004, BEHAVIOUR, V141, P391, DOI 10.1163/156853904323066702; Hansson B, 2000, ECOLOGY, V81, P319, DOI 10.2307/177429; Hatchwell BJ, 1996, IBIS, V138, P256, DOI 10.1111/j.1474-919X.1996.tb04337.x; Heltzel JM, 2006, CONDOR, V108, P842, DOI 10.1650/0010-5422(2006)108[842:FINSOS]2.0.CO;2; HERREMANS M, 1993, BIRD STUDY, V40, P12, DOI 10.1080/00063659309477124; Hillig F, 2009, VERURSACHEN VERANDER; Hobson KA, 2014, ACTA ORNITHOL, V49, P57, DOI 10.3161/000164514X682896; Holzinger J, 1999, SINGVOGEL; Howlett JS, 1997, WILSON BULL, V109, P643; Huber N, 2013, THESIS U ZURICH; Ibanez-Alamo JD, 2012, IBIS, V154, P5, DOI 10.1111/j.1474-919X.2011.01186.x; Jetz W, 2008, PLOS BIOL, V6, P2650, DOI 10.1371/journal.pbio.0060303; Keller V., 2010, Ornithologische Beobachter, V107, P265; Kirkpatrick C, 2010, WILSON J ORNITHOL, V122, P614, DOI 10.1676/09-166.1; Kruger O, 2002, OECOLOGIA, V133, P474, DOI 10.1007/s00442-002-1053-y; Lack D., 1954, P343; LaHaye WS, 1997, WILSON BULL, V109, P42; Langgemach Torsten, 2005, Vogelwelt, V126, P259; Lippek Wolfgang, 2009, Vogelwelt, V130, P165; Maguire GS, 2006, J AVIAN BIOL, V37, P579, DOI 10.1111/j.2006.0908-8857.03757.x; Mallord JW, 2012, BIRD STUDY, V59, P286, DOI 10.1080/00063657.2012.669359; Marti Jakob, 2007, Ornithologische Beobachter, V104, P45; Martin TE, 2000, P ROY SOC B-BIOL SCI, V267, P2287, DOI 10.1098/rspb.2000.1281; MARTIN TE, 1993, AM NAT, V141, P897, DOI 10.1086/285515; MARTIN TE, 1995, ECOL MONOGR, V65, P101, DOI 10.2307/2937160; Maumary L., 2007, OISEAUX SUISSE; MAYFIELD HAROLD, 1961, WILSON BULL, V73, P255; Mazerolle M. J., 2010, AICCMODAVG MODEL SEL; Mazerolle MJ, 2006, AMPHIBIA-REPTILIA, V27, P169, DOI 10.1163/156853806777239922; Maziarz M, 2010, BIRD STUDY, V57, P540, DOI 10.1080/00063657.2010.512954; MILDENBERGER H., 1940, JOUR ORNITHOL, V88, P537, DOI 10.1007/BF01670583; Miller JR, 2000, LANDSCAPE URBAN PLAN, V50, P227, DOI 10.1016/S0169-2046(00)00091-8; Miller SG, 1998, ECOL APPL, V8, P162, DOI 10.1890/1051-0761(1998)008[0162:IORTOB]2.0.CO;2; Mills L. S., 2012, CONSERVATION WILDLIF; Monaghan P, 1997, TRENDS ECOL EVOL, V12, P270, DOI 10.1016/S0169-5347(97)01094-X; Moreau Gaston, 2001, Alauda, V69, P103; Morrison SA, 2002, OECOLOGIA, V133, P315, DOI 10.1007/s00442-002-1040-3; Muller M, 2005, OECOLOGIA, V143, P37, DOI 10.1007/s00442-004-1770-5; MURPHY MT, 1983, AUK, V100, P326, DOI 10.1093/auk/100.2.326; Naef-Daenzer B, 2001, J ANIM ECOL, V70, P730, DOI 10.1046/j.0021-8790.2001.00533.x; Naef-Daenzer L, 2000, J AVIAN BIOL, V31, P206, DOI 10.1034/j.1600-048X.2000.310212.x; Newell FL, 2011, FOREST ECOL MANAG, V262, P739, DOI 10.1016/j.foreco.2011.05.006; Pasinelli G, 2002, ECOLOGY, V83, P2229, DOI 10.1890/0012-9658(2002)083[2229:SAEFAN]2.0.CO;2; Pasinelli G, 2006, ECOGRAPHY, V29, P721, DOI 10.1111/j.2006.0906-7590.04728.x; Patthey P, 2008, J APPL ECOL, V45, P1704, DOI 10.1111/j.1365-2664.2008.01547.x; Peak RG, 2007, CONDOR, V109, P628, DOI 10.1650/8274.1; Pietz PJ, 2000, J WILDLIFE MANAGE, V64, P71, DOI 10.2307/3802976; R Core Team, 2018, R LANG ENV STAT COMP; Robertson KA, 2005, P ROY SOC B-BIOL SCI, V272, P1541, DOI 10.1098/rspb.2005.3142; Rodriguez C, 2003, J ANIM ECOL, V72, P793, DOI 10.1046/j.1365-2656.2003.00757.x; Roper JJ, 1997, J AVIAN BIOL, V28, P111, DOI 10.2307/3677304; Sanders MD, 2002, BIOL CONSERV, V106, P225, DOI 10.1016/S0006-3207(01)00248-8; Schaub M, 2012, OECOLOGIA, V168, P97, DOI 10.1007/s00442-011-2070-5; Schmidt KA, 2008, ECOLOGY, V89, P635, DOI 10.1890/07-0199.1; Shaffer TL, 2004, AUK, V121, P526, DOI 10.1642/0004-8038(2004)121[0526:AUATAN]2.0.CO;2; Signorell N, 2010, WILDLIFE BIOL, V16, P249, DOI 10.2981/09-028; Skorpilova J, 2007, WOOD WARBLER POPULAT; SLAGSVOLD T, 1984, J ANIM ECOL, V53, P945, DOI 10.2307/4669; Smith JI, 2005, J FIELD ORNITHOL, V76, P383, DOI 10.1648/0273-8570-76.4.383; Spaar R, 2012, ELEMENTE ARTENFORDER; Steven R, 2011, J ENVIRON MANAGE, V92, P2287, DOI 10.1016/j.jenvman.2011.05.005; Storch I, 2005, LANDSCAPE ECOL, V20, P927, DOI 10.1007/s10980-005-7005-2; STRESEMANN ERWIN, 1955, JOUR ORNITHOL, V96, P153, DOI 10.1007/BF01975010; SUAREZ F, 1992, ORNIS SCAND, V23, P24, DOI 10.2307/3676423; SUGIURA N, 1978, COMMUN STAT A-THEOR, V7, P13, DOI 10.1080/03610927808827599; Sutherland WJ, 2004, TRENDS ECOL EVOL, V19, P305, DOI 10.1016/j.tree.2004.03.018; Tarof SA, 2004, AUK, V121, P877, DOI 10.1642/0004-8038(2004)121[0877:HCANPD]2.0.CO;2; VERBEEK NAM, 1981, ORNIS SCAND, V12, P37, DOI 10.2307/3675902; VERHULST S, 1995, ECOLOGY, V76, P2392, DOI 10.2307/2265815; Walankiewicz Wieslaw, 2002, Acta Ornithologica (Warsaw), V37, P21; Weidinger K, 2002, J ANIM ECOL, V71, P424, DOI 10.1046/j.1365-2656.2002.00611.x; WESOLOWSKI T, 1985, ORNIS SCAND, V16, P49, DOI 10.2307/3676575; Wesolowski T, 2005, J AVIAN BIOL, V36, P361, DOI 10.1111/j.0908-8857.2005.03570.x; Wesolowski T, 2009, ACTA ORNITHOL, V44, P69, DOI 10.3161/000164509X464902; Wesolowski T, 2009, BIRD STUDY, V56, P26, DOI 10.1080/00063650802681540; Williams B. K., 2002, ANAL MANAGEMENT ANIM; Yanes M, 1995, ECOGRAPHY, V18, P423, DOI 10.1111/j.1600-0587.1995.tb00145.x; YOUNG HOWARD, 1963, AUK, V80, P145; Zanette LY, 2011, SCIENCE, V334, P1398, DOI 10.1126/science.1210908	111	25	26	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0130954	10.1371/journal.pone.0130954	http://dx.doi.org/10.1371/journal.pone.0130954			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26172954	gold, Green Published			2022-12-26	WOS:000358194900012
J	Kwan, CK; Sanford, E; Long, J				Kwan, Christopher Kent; Sanford, Eric; Long, Jeremy			Copper Pollution Increases the Relative Importance of Predation Risk in an Aquatic Food Web	PLOS ONE			English	Article							DENSITY-DEPENDENT MORTALITY; JUVENILE COHO SALMON; SAN-FRANCISCO BAY; CONSPECIFIC DENSITY; CHEMICAL SIGNALS; MARINE; MECHANISMS; ECOLOGY; INSECTICIDES; CONTAMINANTS	Although the cascading impact of predators depends critically on the relative role of lethal predation and predation risk, we lack an understanding of how human-caused stressors may shift this balance. Emergent evidence suggests that pollution may increase the importance of predator consumptive effects by weakening the effects of fear perceived by prey. However, this oversimplification ignores the possibility that pollution may also alter predator consumptive effects. In particular, contaminants may impair the consumptive effects of predators by altering density-dependent interactions among prey conspecifics. No study has directly compared predator consumptive and non-consumptive effects in polluted versus non-polluted settings. We addressed this issue by using laboratory mesocosms to examine the impact of sublethal doses of copper on tri-trophic interactions among estuarine predator crabs Cancer productus, carnivorous whelk prey Urosalpinx cinerea, and the basal resource barnacles Balanus glandula. We investigated crab consumptive effects (whelks culled without crab chemical cues), non-consumptive effects (whelks not culled with crab chemical cues), and total effects (whelks culled with crab chemical cues) on whelks in copper polluted and non-polluted waters. Realistic copper concentrations suppressed the effects of simulated crab lethal predation (whelk culling) by removing density-dependent feeding by whelks. Specifically, reductions in conspecific density occurring in elevated copper levels did not trigger the normal increase in whelk consumption rates of barnacles. Weakened effects of fear were only observed at extremely high copper levels, suggesting consumptive effects were more sensitive to pollution. Thus, pollution may shape communities by altering the roles of predators and interactions among prey.	[Kwan, Christopher Kent; Long, Jeremy] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; [Kwan, Christopher Kent; Long, Jeremy] San Diego State Univ, Coastal & Marine Inst Lab, San Diego, CA 92182 USA; [Kwan, Christopher Kent; Sanford, Eric] Univ Calif Davis, Bodega Marine Lab, Bodega Bay, CA USA; [Kwan, Christopher Kent; Sanford, Eric] Univ Calif Davis, Dept Ecol & Evolut, Bodega Bay, CA USA	California State University System; San Diego State University; California State University System; San Diego State University; University of California System; University of California Davis; University of California System; University of California Davis	Long, J (corresponding author), San Diego State Univ, Dept Biol, San Diego, CA 92182 USA.	jlong@mail.sdsu.edu			National Science Foundation Coastal, Atmospheric, and Marine Environmental Observing Studies Fellowship; California State University Council on Ocean Affairs, Science and Technology Award	National Science Foundation Coastal, Atmospheric, and Marine Environmental Observing Studies Fellowship; California State University Council on Ocean Affairs, Science and Technology Award	This work was supported by National Science Foundation Coastal, Atmospheric, and Marine Environmental Observing Studies Fellowship to CK and the California State University Council on Ocean Affairs, Science and Technology Award to CK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson TW, 2001, ECOLOGY, V82, P245; Blake AC, 2004, ESTUARIES, V27, P437, DOI 10.1007/BF02803536; BROWN KM, 1994, MAR ECOL PROG SER, V112, P97, DOI 10.3354/meps112097; Brown RJ, 2004, AQUAT TOXICOL, V66, P267, DOI 10.1016/j.aquatox.2003.10.001; BRYAN GW, 1992, ENVIRON POLLUT, V76, P89, DOI 10.1016/0269-7491(92)90099-V; Carlton JT, 1999, MALACOLOGIA, V41, P439; Dew WA, 2012, ENVIRON SCI TECHNOL, V46, P9019, DOI 10.1021/es300670p; ELGAR MA, 1989, BIOL REV, V64, P13, DOI 10.1111/j.1469-185X.1989.tb00636.x; Fernandez-Juricic E, 2004, BEHAV ECOL, V15, P371, DOI 10.1093/beheco/arh017; Fleeger JW, 2003, SCI TOTAL ENVIRON, V317, P207, DOI 10.1016/S0048-9697(03)00141-4; Flegal AR, 2005, ECOTOXICOLOGY, V14, P645, DOI 10.1007/s10646-005-0016-6; Frid A, 2008, OIKOS, V117, P191, DOI 10.1111/j.2007.0030-1299.16134.x; Griffin CAM, 2006, ECOL LETT, V9, P335, DOI 10.1111/j.1461-0248.2005.00880.x; GROSHOLZ ED, 1995, MAR BIOL, V122, P239; Hanazato T, 1999, ENVIRON POLLUT, V105, P137, DOI 10.1016/S0269-7491(98)00203-6; Hawlena D, 2012, SCIENCE, V336, P1434, DOI 10.1126/science.1220097; Hay ME, 2009, ANNU REV MAR SCI, V1, P193, DOI 10.1146/annurev.marine.010908.163708; Hixon MA, 2005, ECOLOGY, V86, P2847, DOI 10.1890/04-1455; Hughes AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044839; Kimbro DL, 2009, OECOLOGIA, V160, P563, DOI 10.1007/s00442-009-1322-0; Letelier ME, 2005, CHEM-BIOL INTERACT, V151, P71, DOI 10.1016/j.cbi.2004.12.004; Linder MC, 1996, AM J CLIN NUTR, V63, P797; Lurling M, 2007, TRENDS ECOL EVOL, V22, P374, DOI 10.1016/j.tree.2007.04.002; Matthysen E, 2005, ECOGRAPHY, V28, P403, DOI 10.1111/j.0906-7590.2005.04073.x; Mccoy MW, 2007, OECOLOGIA, V153, P871, DOI 10.1007/s00442-007-0795-y; McIntyre JK, 2008, ENVIRON SCI TECHNOL, V42, P1352, DOI 10.1021/es071603e; McIntyre JK, 2012, ECOL APPL, V22, P1460, DOI 10.1890/11-2001.1; McPherson CA, 2000, MAR POLLUT BULL, V40, P656, DOI 10.1016/S0025-326X(00)00043-6; MEADOR JP, 1993, ECOL APPL, V3, P139, DOI 10.2307/1941797; MIAO SL, 1991, ECOLOGY, V72, P1634, DOI 10.2307/1940963; Miller LP, 2014, GLOBAL CHANGE BIOL, V20, P3834, DOI 10.1111/gcb.12639; Munday PL, 2009, P NATL ACAD SCI USA, V106, P1848, DOI 10.1073/pnas.0809996106; Neff JM, 1977, POLLUTANT EFFECTS MA, P155; Peacor SD, 2004, ECOLOGY, V85, P2754, DOI 10.1890/03-0662; Peacor SD, 2003, OIKOS, V100, P409, DOI 10.1034/j.1600-0706.2003.12043.x; Peacor SD, 2001, P NATL ACAD SCI USA, V98, P3904, DOI 10.1073/pnas.071061998; PRATT DM, 1974, MAR BIOL, V27, P37, DOI 10.1007/BF00394758; PRATT DM, 1976, J EXP MAR BIOL ECOL, V21, P7, DOI 10.1016/0022-0981(76)90066-6; Puig S, 2002, CURR OPIN CHEM BIOL, V6, P171, DOI 10.1016/S1367-5931(02)00298-3; Rainbow PS, 2002, ENVIRON POLLUT, V120, P497, DOI 10.1016/S0269-7491(02)00238-5; Relyea RA, 2005, ECOL APPL, V15, P618, DOI 10.1890/03-5342; Relyea R, 2006, ECOL LETT, V9, P1157, DOI 10.1111/j.1461-0248.2006.00966.x; Rice A, 2007, J CRUSTACEAN BIOL, V27, P74, DOI 10.1651/S-2668.1; Rohr JR, 2006, TRENDS ECOL EVOL, V21, P606, DOI 10.1016/j.tree.2006.07.002; S-ROZSA K, 1990, Environmental Monitoring and Assessment, V14, P363, DOI 10.1007/BF00677928; Schiff K, 2004, MAR POLLUT BULL, V48, P371, DOI 10.1016/j.marpolbul.2003.08.016; Singhasemanon N., 2009, EH0805 CAL ENV PROT; Stallings CD, 2008, ECOLOGY, V89, P2090, DOI 10.1890/07-1671.1; Trussell GC, 2008, ECOLOGY, V89, P2798, DOI 10.1890/08-0250.1; Trussell GC, 2006, ECOL LETT, V9, P1245, DOI 10.1111/j.1461-0248.2006.00981.x; Weis JS, 2001, BIOSCIENCE, V51, P209, DOI 10.1641/0006-3568(2001)051[0209:EOCOBB]2.0.CO;2; WEISSBURG MJ, 1993, ECOLOGY, V74, P1428, DOI 10.2307/1940072; Woin P, 1998, ECOTOX ENVIRON SAFE, V41, P137, DOI 10.1006/eesa.1998.1694; Wojdak JM, 2005, OIKOS, V111, P592, DOI 10.1111/j.0030-1299.2005.13869.x; Zimmer RK, 1999, ECOLOGY, V80, P1432, DOI 10.1890/0012-9658(1999)080[1432:REOECS]2.0.CO;2	55	12	12	0	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0133329	10.1371/journal.pone.0133329	http://dx.doi.org/10.1371/journal.pone.0133329			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26172044	Green Submitted, gold, Green Published			2022-12-26	WOS:000358194900149
J	Lu, K; Guo, WJ; Lu, JX; Yu, H; Qu, CM; Tang, ZL; Li, JN; Chai, YR; Liang, Y				Lu, Kun; Guo, Wenjin; Lu, Junxing; Yu, Hao; Qu, Cunmin; Tang, Zhanglin; Li, Jiana; Chai, Yourong; Liang, Ying			Genome-Wide Survey and Expression Profile Analysis of the Mitogen-Activated Protein Kinase (MAPK) Gene Family in Brassica rapa	PLOS ONE			English	Article							MAXIMUM-LIKELIHOOD; SALT STRESS; CASCADE; MPK4; CYTOKINESIS; RESISTANCE; IMMUNITY; DATABASE; DEFENSE; CLONING	Mitogen-activated protein kinase (MAPK) cascades are fundamental signal transduction modules in plants, controlling cell division, development, hormone signaling, and biotic and abiotic stress responses. Although MAPKs have been investigated in several plant species, a comprehensive analysis of the MAPK gene family has hitherto not been performed in Brassica rapa. In this study, we identified 32 MAPKs in the B. rapa genome by conducting BLASTP and syntenic block analyses, and screening for the essential signature motif (TDY or TEY) of plant MAPK proteins. Of the 32 BraMAPK genes retrieved from the Brassica Database, 13 exhibited exon splicing errors, excessive splicing of the 5' sequence, excessive retention of the 5' sequence, and sequencing errors of the 3' end. Phylogenetic trees of the 32 corrected MAPKs from B. rapa and of MAPKs from other plants generated by the neighbor-joining and maximum likelihood methods suggested that BraMAPKs could be divided into four groups (groups A, B, C, and D). Gene number expansion was observed for BraMAPK genes in groups A and D, which may have been caused by the tandem duplication and genome triplication of the ancestral genome of the Brassica progenitor. Except for five members of the BraMAPK10 subfamily, the identified BraMAPKs were expressed in most of the tissues examined, including callus, root, stem, leaf, flower, and silique. Quantitative real-time PCR demonstrated that at least six and five BraMAPKs were induced or repressed by various abiotic stresses and hormone treatments, respectively, suggesting their potential roles in the abiotic stress response and various hormone signal transduction pathways in B. rapa. This study provides valuable insight into the putative physiological and biochemical functions of MAPK genes in B. rapa.	[Lu, Kun; Guo, Wenjin; Lu, Junxing; Yu, Hao; Qu, Cunmin; Tang, Zhanglin; Li, Jiana; Chai, Yourong; Liang, Ying] Southwest Univ, Coll Agron & Biotechnol, Chongqing 400715, Peoples R China; [Lu, Kun; Qu, Cunmin; Tang, Zhanglin; Li, Jiana; Chai, Yourong; Liang, Ying] Southwest Univ, Chongqing Rapeseed Engn Res Ctr, Chongqing 400715, Peoples R China; [Lu, Kun; Qu, Cunmin; Tang, Zhanglin; Li, Jiana; Chai, Yourong; Liang, Ying] Southwest Univ, Minist Educ, Engn Res Ctr South Upland Agr, Chongqing 400715, Peoples R China; [Lu, Junxing] Chongqing Normal Univ, Coll Life Sci, Chongqing 401331, Peoples R China	Southwest University - China; Southwest University - China; Southwest University - China; Chongqing Normal University	Lu, K (corresponding author), Southwest Univ, Coll Agron & Biotechnol, Chongqing 400715, Peoples R China.	drlukun@swu.edu.cn; yliang@swu.edu.cn	Lu, Kun/C-2597-2008; Lu, Junxing/GZH-2188-2022	Lu, Kun/0000-0003-1370-8633; Lu, Junxing/0000-0002-1447-2768; Qu, Cunmin/0000-0003-2413-2350	863 Project [2013AA102602]; National Science Foundation of China [31271756, 31171619]; 111 Project [B12006]; 973 Project [2015CB250100]; Chongqing Project of Main Crop Variety Innovation [cstc2012ggB80008]; Fundamental Research Funds for the Central Universities [XDJK2012A009, XDJK2013C031]	863 Project(National High Technology Research and Development Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); 111 Project(Ministry of Education, China - 111 Project); 973 Project(National Basic Research Program of China); Chongqing Project of Main Crop Variety Innovation; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by grants from the 863 Project [2013AA102602, www.most.gov.cn], the National Science Foundation of China [31271756 and 31171619, http://www.nsfc.gov.cn], the 111 Project [B12006, http://www.moe.edu.cn], the 973 Project [2015CB250100, www.most.gov.cn], the Chongqing Project of Main Crop Variety Innovation [cstc2012ggB80008, http://www.cstc.gov.cn], and the Fundamental Research Funds for the Central Universities [XDJK2012A009 and XDJK2013C031, http://www.moe.edu.cn]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal GK, 2003, BIOCHEM BIOPH RES CO, V302, P171, DOI 10.1016/S0006-291X(03)00174-8; Ahmed NU, 2013, SCI HORTIC-AMSTERDAM, V152, P26, DOI 10.1016/j.scienta.2013.01.007; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andreasson E, 2005, EMBO J, V24, P2579, DOI 10.1038/sj.emboj.7600737; Arasan SKT, 2013, PLANT PHYSIOL BIOCH, V67, P144, DOI 10.1016/j.plaphy.2013.02.030; Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; Asif MH, 2014, FUNCT INTEGR GENOMIC, V14, P161, DOI 10.1007/s10142-013-0349-9; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Berriri S, 2012, PLANT CELL, V24, P4281, DOI 10.1105/tpc.112.101253; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chen LH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046744; Cheng F, 2013, PLANT CELL, V25, P1541, DOI 10.1105/tpc.113.110486; Cheng F, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-136; Colcombet J, 2008, BIOCHEM J, V413, P217, DOI 10.1042/BJ20080625; Dan I, 2001, TRENDS CELL BIOL, V11, P220, DOI 10.1016/S0962-8924(01)01980-8; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; Doczi R, 2007, PLANT CELL, V19, P3266, DOI 10.1105/tpc.106.050039; DRUMMOND AJ, 2009, GENEIOUS V4 8; Fang L, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00261; Gao MH, 2008, CELL RES, V18, P1190, DOI 10.1038/cr.2008.300; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Guo An-Yuan, 2007, Yichuan, V29, P1023, DOI 10.1360/yc-007-1023; Hamel LP, 2006, TRENDS PLANT SCI, V11, P192, DOI 10.1016/j.tplants.2006.02.007; Hulskamp M, 1997, DEV BIOL, V187, P114, DOI 10.1006/dbio.1997.8554; Hyun TK, 2010, GENES GENOM, V32, P275, DOI 10.1007/s13258-010-0010-0; Ichimura K, 2000, PLANT J, V24, P655, DOI 10.1046/j.1365-313x.2000.00913.x; Ichimura K, 2006, J BIOL CHEM, V281, P36969, DOI 10.1074/jbc.M605319200; Jammes F, 2009, P NATL ACAD SCI USA, V106, P20520, DOI 10.1073/pnas.0907205106; Jeong MJ, 2006, PLANT CELL TISS ORG, V85, P151, DOI 10.1007/s11240-005-9064-0; Jiang JJ, 2013, MOL GENET GENOMICS, V288, P601, DOI 10.1007/s00438-013-0775-3; Jonak C, 2002, CURR OPIN PLANT BIOL, V5, P415, DOI 10.1016/S1369-5266(02)00285-6; Kong FL, 2012, GENE, V499, P108, DOI 10.1016/j.gene.2012.01.048; Kong Q, 2012, PLANT CELL, V24, P2225, DOI 10.1105/tpc.112.097253; Kosetsu K, 2010, PLANT CELL, V22, P3778, DOI 10.1105/tpc.110.077164; Lamesch P, 2012, NUCLEIC ACIDS RES, V40, pD1202, DOI 10.1093/nar/gkr1090; Larade K, 2006, COMP BIOCHEM PHYS B, V143, P85, DOI 10.1016/j.cbpb.2005.10.008; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee SK, 2011, J BIOSCIENCES, V36, P139, DOI 10.1007/s12038-011-9002-8; Lei B, 2013, MOL BIOL REP, V40, P345, DOI 10.1007/s11033-012-2067-0; Lian WW, 2012, J INTEGR AGR, V11, P1227, DOI 10.1016/S2095-3119(12)60119-1; Liu YK, 2013, PLANT MOL BIOL REP, V31, P1446, DOI 10.1007/s11105-013-0623-y; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu K, 2008, THEOR APPL GENET, V117, P963, DOI 10.1007/s00122-008-0836-x; Meng XZ, 2013, ANNU REV PHYTOPATHOL, V51, P245, DOI 10.1146/annurev-phyto-082712-102314; Mistry J, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt263; Mizoguchi T, 1996, P NATL ACAD SCI USA, V93, P765, DOI 10.1073/pnas.93.2.765; Moustafa K, 2014, PLANT CELL REP, V33, P1217, DOI 10.1007/s00299-014-1629-0; Ohyanagi H, 2006, NUCLEIC ACIDS RES, V34, pD741, DOI 10.1093/nar/gkj094; Ovecka Miroslav, 2009, P51, DOI 10.1007/978-3-540-89228-1_3; Pan JW, 2012, PLANTA, V235, P661, DOI 10.1007/s00425-011-1510-0; Pitzschke A, 2009, CURR OPIN PLANT BIOL, V12, P421, DOI 10.1016/j.pbi.2009.06.008; Qi JN, 2010, PLANT MOL BIOL REP, V28, P597, DOI 10.1007/s11105-010-0185-1; Ramchiary N, 2011, PLANT GENET GENOMICS, V9, P215, DOI 10.1007/978-1-4419-7118-0_8; Rao KP, 2010, DNA RES, V17, P139, DOI 10.1093/dnares/dsq011; Reyna NS, 2006, MOL PLANT MICROBE IN, V19, P530, DOI 10.1094/MPMI-19-0530; Rodriguez MCS, 2010, ANNU REV PLANT BIOL, V61, P621, DOI 10.1146/annurev-arplant-042809-112252; Rohila JS, 2007, J INTEGR PLANT BIOL, V49, P751, DOI 10.1111/j.1744-7909.2007.00501.x; SARASTE M, 1990, TRENDS BIOCHEM SCI, V15, P430, DOI 10.1016/0968-0004(90)90281-F; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Schranz ME, 2006, TRENDS PLANT SCI, V11, P535, DOI 10.1016/j.tplants.2006.09.002; Shi J, 2010, PLANT MOL BIOL, V74, P1, DOI 10.1007/s11103-010-9661-0; Song D, 2006, PLANT BIOLOGY, V8, P587, DOI 10.1055/s-2006-924149; Song FM, 2002, PLANTA, V215, P997, DOI 10.1007/s00425-002-0794-5; Soyano T, 2003, GENE DEV, V17, P1055, DOI 10.1101/gad.1071103; Takahashi Y, 2010, PLANT CELL PHYSIOL, V51, P1766, DOI 10.1093/pcp/pcq135; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tanoue T, 2000, NAT CELL BIOL, V2, P110, DOI 10.1038/35000065; Teige M, 2004, MOL CELL, V15, P141, DOI 10.1016/j.molcel.2004.06.023; Tong CB, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-689; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; U. N., 1935, Japanese Journal of Botany, V7, P389; Wang HC, 2007, PLANT CELL, V19, P63, DOI 10.1105/tpc.106.048298; Wang JX, 2010, J INTEGR PLANT BIOL, V52, P442, DOI 10.1111/j.1744-7909.2010.00906.x; Wang XW, 2011, NAT GENET, V43, P1035, DOI 10.1038/ng.919; Wang Z, 2014, MOL GENET GENOMICS, V289, P1023, DOI 10.1007/s00438-014-0853-1; Wang Z, 2009, MOL PLANT MICROBE IN, V22, P235, DOI 10.1094/MPMI-22-3-0235; Wei CJ, 2014, PLANT PHYSIOL BIOCH, V77, P108, DOI 10.1016/j.plaphy.2014.02.002; Wu J, 2012, MOL GENET GENOMICS, V287, P295, DOI 10.1007/s00438-012-0675-y; Xing Y, 2008, PLANT J, V54, P440, DOI 10.1111/j.1365-313X.2008.03433.x; Yoo SD, 2008, NATURE, V451, P789, DOI 10.1038/nature06543; Zeng QN, 2011, PLANT SIGNAL BEHAV, V6, P1436, DOI 10.4161/psb.6.10.17089; Zeng QN, 2011, PLANT J, V67, P895, DOI 10.1111/j.1365-313X.2011.04642.x; Zhang A, 2010, J EXP BOT, V61, P4399, DOI 10.1093/jxb/erq243; Zhang SZ, 2013, GENE, V531, P377, DOI 10.1016/j.gene.2013.07.107; Zhang XT, 2013, MOL BIOL REP, V40, P1407, DOI 10.1007/s11033-012-2184-9; Zhang ZB, 2012, CELL HOST MICROBE, V11, P253, DOI 10.1016/j.chom.2012.01.015; Zhou CJ, 2009, PLANT PHYSIOL, V150, P167, DOI 10.1104/pp.108.133439	87	39	40	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132051	10.1371/journal.pone.0132051	http://dx.doi.org/10.1371/journal.pone.0132051			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26173020	Green Published, Green Submitted, gold			2022-12-26	WOS:000358194900029
J	Takamatsu, T; Uehara, K; Sasaki, Y; Hidekazu, M; Matsumura, Y; Iwasawa, A; Ito, N; Kohno, M; Azuma, T; Okino, A				Takamatsu, Toshihiro; Uehara, Kodai; Sasaki, Yota; Hidekazu, Miyahara; Matsumura, Yuriko; Iwasawa, Atsuo; Ito, Norihiko; Kohno, Masahiro; Azuma, Takeshi; Okino, Akitoshi			Microbial Inactivation in the Liquid Phase Induced by Multigas Plasma Jet	PLOS ONE			English	Article							ATMOSPHERIC-PRESSURE PLASMA; SINGLET OXYGEN; HELIUM; DAMAGE	Various gas atmospheric nonthermal plasmas were generated using a multigas plasma jet to treat microbial suspensions. Results indicated that carbon dioxide and nitrogen plasma had high sterilization effects. Carbon dioxide plasma, which generated the greatest amount of singlet oxygen than other gas plasmas, killed general bacteria and some fungi. On the other hand, nitrogen plasma, which generated the largest amount of OH radical, killed >= 6 log of 11 species of microorganisms, including general bacteria, fungi, acid-fast bacteria, spores, and viruses in 1-15 min. To identify reactive species responsible for bacterial inactivation, antioxidants were added to bacterial suspensions, which revealed that singlet oxygen and OH radicals had greatest inactivation effects.	[Takamatsu, Toshihiro; Azuma, Takeshi] Kobe Univ, Dept Gastroenterol, Kobe, Hyogo 657, Japan; [Takamatsu, Toshihiro; Uehara, Kodai; Sasaki, Yota; Hidekazu, Miyahara; Okino, Akitoshi] Tokyo Inst Technol, Dept Energy Sci, Yokohama, Kanagawa 227, Japan; [Matsumura, Yuriko; Iwasawa, Atsuo; Kohno, Masahiro] Tokyo Inst Technol, Dept Bioengn, Yokohama, Kanagawa 227, Japan; [Ito, Norihiko] Tottori Univ, Ctr Vet Med, Tottori 680, Japan	Kobe University; Tokyo Institute of Technology; Tokyo Institute of Technology; Tottori University	Takamatsu, T (corresponding author), Kobe Univ, Dept Gastroenterol, Kobe, Hyogo 657, Japan.	tplasma@med.kobe-u.ac.jp	Okino, Akitoshi/O-1804-2013; Ito, Norihiko/ABD-3147-2021	Okino, Akitoshi/0000-0002-8949-294X; 	 [26886009];  [26670382]	; 	This work was supported by Grant-in-Aid for Research Activity Start-up Grant Number 26886009 and Grant-in-Aid for Challenging Exploratory Research Grant Number 26670382. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buonocore G, 2010, SEMIN FETAL NEONAT M, V15, P186, DOI 10.1016/j.siny.2010.04.003; Davies MJ, 2003, BIOCHEM BIOPH RES CO, V305, P761, DOI 10.1016/S0006-291X(03)00817-9; Ehlbeck J, 2011, J PHYS D APPL PHYS, V44, DOI 10.1088/0022-3727/44/1/013002; Ionin AA, 2007, J PHYS D APPL PHYS, V40, pR25, DOI 10.1088/0022-3727/40/2/R01; Iwai T, 2014, J ANAL ATOM SPECTROM, V29, P464, DOI 10.1039/c3ja50321f; Iwasawa A, 2012, BIOCONTROL SCI, V17, P45, DOI 10.4265/bio.17.45; KONG MG, 2009, NEW J PHYS, V11, DOI DOI 10.1088/1367-2630/11/11/115012; Kongmany S, 2013, J PHYS CONF SER, V441, DOI 10.1088/1742-6596/441/1/012006; Laroussi M, 2004, INT J MASS SPECTROM, V233, P81, DOI 10.1016/j.ijms.2003.11.016; Lee K, 2006, J MICROBIOL, V44, P269; Matsumura Y, 2013, CHEM LETT, V42, P1291, DOI 10.1246/cl.130618; Nakamura K, 2012, MICROBIOL IMMUNOL, V56, P48, DOI 10.1111/j.1348-0421.2011.00400.x; Oehmigen K, 2010, PLASMA PROCESS POLYM, V7, P250, DOI 10.1002/ppap.200900077; Oshita T, 2015, IEEE T PLASMA SCI, V43, P1987, DOI 10.1109/TPS.2015.2428696; Surowsky B, 2015, FOOD ENG REV, V7, P82, DOI 10.1007/s12393-014-9088-5; Takamatsu T., 2012, PLASMA MED, V2, P237, DOI DOI 10.1615/PLASMAMED.2014010792; Takamatsu T, 2014, RSC ADV, V4, P39901, DOI 10.1039/c4ra05936k; Takamatsu T, 2014, J TOXICOL SCI, V39, P281, DOI 10.2131/jts.39.281; Takamatsu T, 2013, IEEE T PLASMA SCI, V41, P119, DOI 10.1109/TPS.2012.2227459; Tomaru A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085569; Vakrat-Haglili Y, 2005, J AM CHEM SOC, V127, P6487, DOI 10.1021/ja046210j; van Gils CAJ, 2013, J PHYS D APPL PHYS, V46, DOI 10.1088/0022-3727/46/17/175203; Ziuzina D, 2013, J APPL MICROBIOL, V114, P778, DOI 10.1111/jam.12087	23	48	48	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132381	10.1371/journal.pone.0132381	http://dx.doi.org/10.1371/journal.pone.0132381			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26173107	gold, Green Published			2022-12-26	WOS:000358194900047
J	Zhang, HS; Zhu, MX; Zheng, Y; Li, GL				Zhang, Haoshi; Zhu, Mingxing; Zheng, Yue; Li, Guanglin			Toward Capturing Momentary Changes of Heart Rate Variability by a Dynamic Analysis Method	PLOS ONE			English	Article							TIME-FREQUENCY	The analysis of heart rate variability (HRV) has been performed on long-term electrocardiography (ECG) recordings (12 similar to 24 hours) and short-term recordings (2 similar to 5 minutes), which may not capture momentary change of HRV. In this study, we present a new method to analyze the momentary HRV (mHRV). The ECG recordings were segmented into a series of overlapped HRV analysis windows with a window length of 5 minutes and different time increments. The performance of the proposed method in delineating the dynamics of momentary HRV measurement was evaluated with four commonly used time courses of HRV measures on both synthetic time series and real ECG recordings from human subjects and dogs. Our results showed that a smaller time increment could capture more dynamical information on transient changes. Considering a too short increment such as 10 s would cause the indented time courses of the four measures, a 1-min time increment (4-min overlapping) was suggested in the analysis of mHRV in the study. ECG recordings from human subjects and dogs were used to further assess the effectiveness of the proposed method. The pilot study demonstrated that the proposed analysis of mHRV could provide more accurate assessment of the dynamical changes in cardiac activity than the conventional measures of HRV (without time overlapping). The proposed method may provide an efficient means in delineating the dynamics of momentary HRV and it would be worthy performing more investigations.	[Zhang, Haoshi; Zhu, Mingxing; Zheng, Yue; Li, Guanglin] Chinese Acad Sci, Key Lab Human Machine Intelligence Synergy Syst, Shenzhen Inst Adv Technol, Shenzhen, Guangdong, Peoples R China	Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS	Li, GL (corresponding author), Chinese Acad Sci, Key Lab Human Machine Intelligence Synergy Syst, Shenzhen Inst Adv Technol, Shenzhen, Guangdong, Peoples R China.	gl.li@siat.ac.cn		Li, Guanglin/0000-0001-9016-2617	National Key Basic Research Program of China [2013CB329505]; National Natural Science Foundation of China [61135004]; Shenzhen Governmental Basic Research Grant [JCYJ20130402113127532]; Guangdong Innovation Research Team Fund for Low-cost Healthcare Technologies	National Key Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shenzhen Governmental Basic Research Grant; Guangdong Innovation Research Team Fund for Low-cost Healthcare Technologies	This work was partly supported by the National Key Basic Research Program of China (#2013CB329505), the National Natural Science Foundation of China under grants (#61135004), the Shenzhen Governmental Basic Research Grant (#JCYJ20130402113127532), and the Guangdong Innovation Research Team Fund for Low-cost Healthcare Technologies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKSELROD S, 1981, SCIENCE, V213, P220, DOI 10.1126/science.6166045; Bar KJ, 2007, CLIN NEUROPHYSIOL, V118, P2009, DOI 10.1016/j.clinph.2007.06.012; Bahoura M, 1997, COMPUT METH PROG BIO, V52, P35, DOI 10.1016/S0169-2607(97)01780-X; Bailon R, 2007, P ANN INT IEEE EMBS, P6675; Bernardi L, 2000, J AM COLL CARDIOL, V35, P1462, DOI 10.1016/S0735-1097(00)00595-7; Camm AJ, 1996, CIRCULATION, V93, P1043; CHOI HI, 1989, IEEE T ACOUST SPEECH, V37, P862, DOI 10.1109/ASSP.1989.28057; FRIESEN GM, 1990, IEEE T BIO-MED ENG, V37, P85, DOI 10.1109/10.43620; Goldberger AL, 2000, CIRCULATION, V101, pE215, DOI 10.1161/01.CIR.101.23.e215; Gorman Jack M., 2000, American Heart Journal, V140, pS77; Li HL, 2011, IEEE ACM T COMPUT BI, V8, P1557, DOI 10.1109/TCBB.2011.43; Mainardi LT, 2009, PHILOS T R SOC A, V367, P255, DOI 10.1098/rsta.2008.0188; Peng CK, 1999, INT J CARDIOL, V70, P101, DOI 10.1016/S0167-5273(99)00066-2; Pola S, 1996, IEEE T BIO-MED ENG, V43, P46, DOI 10.1109/10.477700; Toledo E, 2003, AM J PHYSIOL-REG I, V284, pR1079, DOI 10.1152/ajpregu.00287.2002; Vila J, 1997, IEEE ENG MED BIOL, V16, P119, DOI 10.1109/51.620503; Wiklund U, 1997, IEEE ENG MED BIOL, V16, P113, DOI 10.1109/51.620502; Zhong YR, 2004, IEEE T BIO-MED ENG, V51, P255, DOI 10.1109/TBME.2003.820401	18	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0133148	10.1371/journal.pone.0133148	http://dx.doi.org/10.1371/journal.pone.0133148			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26172953	Green Published, Green Submitted, gold			2022-12-26	WOS:000358194900140
J	Brand, HK; Ahout, IML; de Ridder, D; van Diepen, A; Li, Y; Zaalberg, M; Andeweg, A; Roeleveld, N; de Groot, R; Warris, A; Hermans, PWM; Ferwerda, G; Staal, FJT				Brand, H. K.; Ahout, I. M. L.; de Ridder, D.; van Diepen, A.; Li, Y.; Zaalberg, M.; Andeweg, A.; Roeleveld, N.; de Groot, R.; Warris, A.; Hermans, P. W. M.; Ferwerda, G.; Staal, F. J. T.			Olfactomedin 4 Serves as a Marker for Disease Severity in Pediatric Respiratory Syncytial Virus (RSV) Infection	PLOS ONE			English	Article							GENE-EXPRESSION PATTERNS; PROSPECTIVE MULTICENTER; EMERGENCY-DEPARTMENT; HELICOBACTER-PYLORI; BRONCHIOLITIS; CHILDREN; MICROARRAYS; HOSPITALIZATIONS; DIAGNOSTICS; ADMISSION	Background Respiratory viral infections follow an unpredictable clinical course in young children ranging from a common cold to respiratory failure. The transition from mild to severe disease occurs rapidly and is difficult to predict. The pathophysiology underlying disease severity has remained elusive. There is an urgent need to better understand the immune response in this disease to come up with biomarkers that may aid clinical decision making. Methods In a prospective study, flow cytometric and genome-wide gene expression analyses were performed on blood samples of 26 children with a diagnosis of severe, moderate or mild Respiratory Syncytial Virus (RSV) infection. Differentially expressed genes were validated using Q-PCR in a second cohort of 80 children during three consecutive winter seasons. FACS analyses were also performed in the second cohort and on recovery samples of severe cases in the first cohort. Results Severe RSV infection was associated with a transient but marked decrease in CD4+ T, CD8+ T, and NK cells in peripheral blood. Gene expression analyses in both cohorts identified Olfactomedin4 (OLFM4) as a fully discriminative marker between children with mild and severe RSV infection, giving a PAM cross-validation error of 0%. Patients with an OLFM4 gene expression level above -7.5 were 6 times more likely to develop severe disease, after correction for age at hospitalization and gestational age. Conclusion By combining genome-wide expression profiling of blood cell subsets with clinically well-annotated samples, OLFM4 was identified as a biomarker for severity of pediatric RSV infection.	[Brand, H. K.; Ahout, I. M. L.; van Diepen, A.; Zaalberg, M.; Roeleveld, N.; de Groot, R.; Warris, A.; Hermans, P. W. M.; Ferwerda, G.] Radboud Univ Nijmegen, Med Ctr, Lab Pediat Infect Dis, NL-6525 ED Nijmegen, Netherlands; [Brand, H. K.; Ahout, I. M. L.; van Diepen, A.; de Groot, R.; Warris, A.; Hermans, P. W. M.; Ferwerda, G.] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, NL-6525 ED Nijmegen, Netherlands; [de Ridder, D.] Delft Univ Technol, Delft Bioinformat Lab, Fac Elect Engn Math & Comp Sci, Delft, Netherlands; [Li, Y.] Erasmus Univ, Med Ctr, Dept Bioinformat, Rotterdam, Netherlands; [Andeweg, A.] Erasmus Univ, Med Ctr, Dept Virol, Rotterdam, Netherlands; [Roeleveld, N.] Radboud Univ Nijmegen, Med Ctr, Dept Hlth Evidence, NL-6525 ED Nijmegen, Netherlands; [Staal, F. J. T.] Leiden Univ, Med Ctr, Dept Immunohematol & Blood Transfus, Leiden, Netherlands; [Staal, F. J. T.] Erasmus Univ, Med Ctr, Dept Immunol, Rotterdam, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Delft University of Technology; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Radboud University Nijmegen; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Erasmus University Rotterdam; Erasmus MC	Ferwerda, G (corresponding author), Radboud Univ Nijmegen, Med Ctr, Lab Pediat Infect Dis, NL-6525 ED Nijmegen, Netherlands.	Gerben.ferwerda@radboudumc.nl	Ferwerda, J.G./L-4305-2015; Warris, A./L-4745-2015; de Groot, R./H-8039-2014; Roeleveld, Nel/B-4242-2008; Hermans, Peter W.M./H-8042-2014; de Ridder, Dick/F-3169-2010; Ahout, Inge ML/P-8666-2015	Roeleveld, Nel/0000-0002-3390-4466; de Ridder, Dick/0000-0002-4944-4310; Warris, Adilia/0000-0001-6586-3358	VIRGO consortium; Dutch Government [BSIK 03012]	VIRGO consortium; Dutch Government	Statement of financial support: The study was financially supported by the VIRGO consortium, an Innovative Cluster approved by the Netherlands Genomics Initiative and partially funded by the Dutch Government (BSIK 03012). The authors have indicated they have no personal financial relationships relevant to this article to disclose.	Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Allantaz F, 2007, J EXP MED, V204, P2131, DOI 10.1084/jem.20070070; Berger TM, 2009, INFECTION, V37, P109, DOI 10.1007/s15010-008-8130-z; Black Craig Patrick, 2003, Respir Care, V48, P209; Boyce TG, 2000, J PEDIATR-US, V137, P865, DOI 10.1067/mpd.2000.110531; Brand HK, 2010, ADV EXP MED BIOL, V659, P19, DOI 10.1007/978-1-4419-0981-7_2; Chaussabel D, 2008, IMMUNITY, V29, P150, DOI 10.1016/j.immuni.2008.05.012; Chen R, 2012, CELL, V148, P1293, DOI 10.1016/j.cell.2012.02.009; Clemmensen SN, 2012, J LEUKOCYTE BIOL, V91, P495, DOI 10.1189/jlb.0811417; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Gersemann M, 2012, J CROHNS COLITIS, V6, P425, DOI 10.1016/j.crohns.2011.09.013; Grover PK, 2010, CANCER METAST REV, V29, P761, DOI 10.1007/s10555-010-9262-z; Henrickson KJ, 2004, PEDIATR INFECT DIS J, V23, pS11, DOI 10.1097/01.inf.0000108188.37237.48; Hoggatt J, 2011, MOL DIAGN THER, V15, P53, DOI 10.2165/11534880-000000000-00000; Iwane MK, 2004, PEDIATRICS, V113, P1758, DOI 10.1542/peds.113.6.1758; Kim Brand H, 2012, PEDIAT RES; Liu WL, 2012, J IMMUNOL, V189, P2460, DOI 10.4049/jimmunol.1103179; Liu WL, 2010, P NATL ACAD SCI USA, V107, P11056, DOI 10.1073/pnas.1001269107; Lopez Guinea A, 2007, An Pediatr (Barc), V67, P116; Mannick EE, 2004, SCAND J GASTROENTERO, V39, P1192, DOI 10.1080/00365520410003588; Mansbach JM, 2008, PEDIATRICS, V121, P680, DOI 10.1542/peds.2007-1418; Mejias A, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001549; Norwood A, 2010, ACAD EMERG MED, V17, P376, DOI 10.1111/j.1553-2712.2010.00699.x; Openshaw PJM, 2005, CLIN MICROBIOL REV, V18, P541, DOI 10.1128/CMR.18.3.541-555.2005; Parkinson H, 2011, NUCLEIC ACIDS RES, V39, pD1002, DOI 10.1093/nar/gkq1040; Prais D, 2005, CHEST, V128, P2765, DOI 10.1378/chest.128.4.2765; Quinn B, 2010, CLIN PHARMACOL THER, V88, P751, DOI 10.1038/clpt.2010.234; Ramilo O, 2007, BLOOD, V109, P2066, DOI 10.1182/blood-2006-02-002477; Roback MG, 1997, PEDIATR EMERG CARE, V13, P9, DOI 10.1097/00006565-199702000-00003; Robbins AS, 2002, ANN EPIDEMIOL, V12, P452, DOI 10.1016/S1047-2797(01)00278-2; Shay DK, 1999, JAMA-J AM MED ASSOC, V282, P1440, DOI 10.1001/jama.282.15.1440; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Staal FJT, 2010, LEUKEMIA, V24, P491, DOI 10.1038/leu.2009.286; Staal FJT, 2004, J IMMUNOL, V172, P1099, DOI 10.4049/jimmunol.172.2.1099; Templeton KE, 2004, J CLIN MICROBIOL, V42, P1564, DOI 10.1128/JCM.42.4.1564-1569.2004; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; WANG EEL, 1995, J PEDIATR-US, V126, P212, DOI 10.1016/S0022-3476(95)70547-3; Wang YH, 2007, J VIROL, V81, P3904, DOI 10.1128/JVI.01887-06; Zaas AK, 2009, CELL HOST MICROBE, V6, P207, DOI 10.1016/j.chom.2009.07.006; Zhang JC, 2002, GENE, V283, P83, DOI 10.1016/S0378-1119(01)00763-6; Zilliox MJ, 2007, CLIN VACCINE IMMUNOL, V14, P918, DOI 10.1128/CVI.00031-07	42	37	37	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0131927	10.1371/journal.pone.0131927	http://dx.doi.org/10.1371/journal.pone.0131927			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26162090	Green Published, gold, Green Submitted			2022-12-26	WOS:000358162300075
J	Yang, E; Cisowski, J; Nguyen, N; O'Callaghan, K; Xu, J; Agarwal, A; Kuliopulos, A; Covic, L				Yang, E.; Cisowski, J.; Nguyen, N.; O'Callaghan, K.; Xu, J.; Agarwal, A.; Kuliopulos, A.; Covic, L.			Dysregulated protease activated receptor 1 (PAR1) promotes metastatic phenotype in breast cancer through HMGA2	ONCOGENE			English	Article							CELL-PENETRATING PEPDUCINS; THROMBIN-RECEPTOR; MESENCHYMAL TRANSITIONS; EXPRESSION; TRANSCRIPTION; INVASION; DIFFERENTIATION; INTERVENTION; PROGRESSION; COOPERATION	As the majority of patients with basal-like breast carcinoma present with invasive, metastatic disease that do not respond to available therapies, it is essential to identify new therapeutic targets that impact invasion and metastasis. Protease-activated receptor 1 (PAR1), a G-protein coupled receptor has been shown to act as an oncogene, but underlying mechanisms are not well understood. Here, we show that ectopic expression of functionally active PAR1 in MCF-7 cells induced a hormone-refractory, invasive phenotype representative of advanced basal-like breast carcinoma that readily formed metastatic lesions in lungs of mice. PAR1 was found to globally upregulate mesenchymal markers, including vimentin, a direct target of PAR1, and downregulate the epithelial markers including E-cadherin, as well as estrogen receptor. In contrast, non-signaling PAR1 mutant receptor did not lead to an invasive, hormone refractory phenotype. PAR1 expression increased spheroid formation and the level of stemness markers and self-renewal capacity in human breast cancer cells. We identified HMGA2 (high mobility group A2) as an important regulator of PAR1-mediated invasion. Inhibition of PAR1 signaling suppresses HMGA2-driven invasion in breast cancer cells. HMGA2 gene and protein are highly expressed in metastatic breast cancer cells. Overall, our results show that PAR1/HMGA2 pathway may present a novel therapeutic target.	[Yang, E.; Cisowski, J.; Nguyen, N.; O'Callaghan, K.; Xu, J.; Agarwal, A.; Kuliopulos, A.; Covic, L.] Tufts Med Ctr, Mol Oncol Res Inst, Boston, MA USA; [Yang, E.; Kuliopulos, A.; Covic, L.] Dept Biochem, Boston, MA USA; [Yang, E.; Kuliopulos, A.; Covic, L.] Tufts Med Ctr, Boston, MA USA; [Kuliopulos, A.; Covic, L.] Tufts Med Ctr, Div Hematol Oncol, Boston, MA USA; [Kuliopulos, A.; Covic, L.] Tufts Med Ctr, Dept Med, Boston, MA USA	Tufts Medical Center; Tufts Medical Center; Tufts Medical Center; Tufts Medical Center	Covic, L (corresponding author), Tufts Med Ctr, Mol Oncol Res Inst, Div Hematol Oncol, Box 7510,750 Washington St, Boston, MA 02111 USA.	lcovic@tuftsmedicalcenter.org			NIH [CA104406, CA122992, HL64701]; Susan G. Komen [BCTR0706763]; Diane Connolly-Zaniboni Research Scholarship; NNDS [P30 NS047243]; Aid for Cancer Research, Boston, MA	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Susan G. Komen(Susan G. Komen Breast Cancer Foundation); Diane Connolly-Zaniboni Research Scholarship; NNDS; Aid for Cancer Research, Boston, MA	We thank Vishal Trivedi, Chris Parkin, Akiko Hata, Larry Feig and Anna Wronski for their expert advice and Ryan Stevenson for critically reading the manuscript. The microarray analysis was carried out in the Genomics Core of the Tufts Center for Neuroscience Research, Tufts University School of Medicine (supported by NNDS - P30 NS047243). This work was supported by NIH grants CA104406 (LC), Susan G. Komen BCTR0706763, Diane Connolly-Zaniboni Research Scholarship (LC) and a fellowship from Aid for Cancer Research, Boston, MA (EY) by NIH CA122992, HL64701 (to AK).	Agarwal A, 2008, MOL CANCER THER, V7, P2746, DOI 10.1158/1535-7163.MCT-08-0177; Aigner K, 2007, ONCOGENE, V26, P6979, DOI 10.1038/sj.onc.1210508; Becker RC, 2009, LANCET, V373, P919, DOI 10.1016/S0140-6736(09)60230-0; Bergers G, 2000, NAT CELL BIOL, V2, P737, DOI 10.1038/35036374; Boire A, 2005, CELL, V120, P303, DOI 10.1016/j.cell.2004.12.018; Bolos V, 2003, J CELL SCI, V116, P499, DOI 10.1242/jcs.00224; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Chen JQ, 2009, BBA-REV CANCER, V1796, P162, DOI 10.1016/j.bbcan.2009.06.003; Cisowski J, 2011, AM J PATHOL, V179, P513, DOI 10.1016/j.ajpath.2011.03.025; Cleynen I, 2007, MOL CANCER RES, V5, P363, DOI 10.1158/1541-7786.MCR-06-0331; Covic L, 2000, BIOCHEMISTRY-US, V39, P5458, DOI 10.1021/bi9927078; Covic L, 2002, NAT MED, V8, P1161, DOI 10.1038/nm760; Even-Ram S, 1998, NAT MED, V4, P909, DOI 10.1038/nm0898-909; Even-Ram SC, 2001, J BIOL CHEM, V276, P10952, DOI 10.1074/jbc.M007027200; Ferguson M, 2003, NUCLEIC ACIDS RES, V31, P3123, DOI 10.1093/nar/gkg403; Fillmore CM, 2010, P NATL ACAD SCI USA, V107, P21737, DOI 10.1073/pnas.1007863107; Hatziapostolou M, 2008, CANCER RES, V68, P1851, DOI 10.1158/0008-5472.CAN-07-5793; Henrikson KP, 1999, BRIT J CANCER, V79, P401, DOI 10.1038/sj.bjc.6690063; Kamath L, 2001, CANCER RES, V61, P5933; Korkola JE, 2003, CANCER RES, V63, P7167; Kuliopulos A, 1999, BIOCHEMISTRY-US, V38, P4572, DOI 10.1021/bi9824792; Kumar MS, 2014, NATURE, V505, P212, DOI 10.1038/nature12785; Lahat G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010105; Li Y, 2014, CANCER LETT, V355, P130, DOI 10.1016/j.canlet.2014.09.007; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Martin CB, 2001, ONCOGENE, V20, P1953, DOI 10.1038/sj.onc.1204281; Medeiros F, 2007, GENE CHROMOSOME CANC, V46, P981, DOI 10.1002/gcc.20483; Morrow DA, 2012, NEW ENGL J MED, V366, P1404, DOI 10.1056/NEJMoa1200933; NELSON WJ, 1983, MOL CELL BIOL, V3, P1146, DOI 10.1128/MCB.3.6.1146; Nguyen N, 2006, CANCER RES, V66, P2658, DOI 10.1158/0008-5472.CAN-05-2082; Nierodzik ML, 1998, BLOOD, V92, P3694, DOI 10.1182/blood.V92.10.3694.422k40_3694_3700; Pegoraro S, 2013, ONCOTARGET, V4, P1293, DOI 10.18632/oncotarget.1136; Peluso S, 2010, BREAST CARE, V5, P81, DOI 10.1159/000297717; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Reeves R, 2010, BBA-GENE REGUL MECH, V1799, P3, DOI 10.1016/j.bbagrm.2009.09.001; Rudroff C, 2002, CLIN EXP METASTAS, V19, P181, DOI 10.1023/A:1014598904644; Salah Z, 2005, FASEB J, V19, P62, DOI 10.1096/fj.04-2386com; Salah Z, 2012, FASEB J, V26, P2031, DOI 10.1096/fj.11-194704; Satelli A, 2011, CELL MOL LIFE SCI, V68, P3033, DOI 10.1007/s00018-011-0735-1; Sgarra R, 2010, BBA-GENE REGUL MECH, V1799, P37, DOI 10.1016/j.bbagrm.2009.08.009; Sheen YS, 2015, J INVEST DERMATOL, V135, P1065, DOI 10.1038/jid.2014.480; Slofstra SH, 2007, BLOOD, V110, P3176, DOI 10.1182/blood-2007-02-075440; Sun JM, 2005, EXP CELL RES, V302, P96, DOI 10.1016/j.yexcr.2004.08.015; Tallini G, 1999, ADV ANAT PATHOL, V6, P237, DOI 10.1097/00125480-199909000-00001; Tallini G, 1997, AM J PATHOL, V151, P37; Tellez C, 2003, ONCOGENE, V22, P3130, DOI 10.1038/sj.onc.1206453; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Thuault S, 2008, J BIOL CHEM, V283, P33437, DOI 10.1074/jbc.M802016200; Tricoci P, 2012, NEW ENGL J MED, V366, P20, DOI 10.1056/NEJMoa1109719; VU TKH, 1991, CELL, V64, P1057, DOI 10.1016/0092-8674(91)90261-V; WHITEHEAD I, 1995, MOL CELL BIOL, V15, P704; Xi YN, 2014, ASIAN PAC J TROP MED, V7, P289, DOI 10.1016/S1995-7645(14)60040-7; Yang E, 2009, CANCER RES, V69, P6223, DOI 10.1158/0008-5472.CAN-09-0187; Zhang P, 2012, CIRCULATION, V126, P83, DOI 10.1161/CIRCULATIONAHA.112.091918	54	31	31	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 24	2016	35	12					1529	1540		10.1038/onc.2015.217	http://dx.doi.org/10.1038/onc.2015.217			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DH8RJ	26165842	Green Accepted			2022-12-26	WOS:000373063600006
J	Li, RZ; Uttarwar, L; Gao, B; Charbonneau, M; Shi, YX; Chan, JSD; Dubois, CM; Krepinsky, JC				Li, Renzhong; Uttarwar, Lalita; Gao, Bo; Charbonneau, Martine; Shi, Yixuan; Chan, John S. D.; Dubois, Claire M.; Krepinsky, Joan C.			High Glucose Up-regulates ADAM17 through HIF-1 alpha in Mesangial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell signaling; diabetes; epidermal growth factor receptor (EGFR); extracellular matrix; hypoxia-inducible factor (HIF); kidney; diabetic nephropathy	GROWTH-FACTOR RECEPTOR; TUMOR-NECROSIS-FACTOR; HYPOXIA-INDUCIBLE FACTOR; ALPHA-CONVERTING ENZYME/ADAM17; PREVENTS DIABETIC-NEPHROPATHY; ELEMENT-BINDING PROTEIN; EGFR TRANSACTIVATION; FACTOR 1-ALPHA; EXPRESSION; ACTIVATION	Background: ADAM17 is an important promoter of fibrosis in diabetic kidney disease. Results: ADAM17 is transcriptionally up-regulated by glucose through HIF-1 in kidney mesangial cells, associated with enhanced enzymatic activity. Conclusion: ADAM17 induces its own up-regulation, thereby augmenting its activity, in response to glucose. Significance: These studies provide a strong foundation for further evaluation of the role of ADAM17 in the profibrotic response of kidney cells to high glucose. We previously showed that ADAM17 mediates high glucose-induced matrix production by kidney mesangial cells. ADAM17 expression is increased in diabetic kidneys, suggesting that its up-regulation may augment high glucose profibrotic responses. We thus studied the effects of high glucose on ADAM17 gene regulation. Primary rat mesangial cells were treated with high glucose (30 mm) or mannitol as osmotic control. High glucose dose-dependently increased ADAM17 promoter activity, transcript, and protein levels. This correlated with augmented ADAM17 activity after 24 h versus 1 h of high glucose. We tested involvement of transcription factors shown in other settings to regulate ADAM17 transcription. Promoter activation was not affected by NF-B or Sp1 inhibitors, but was blocked by hypoxia-inducible factor-1 (HIF-1) inhibition or down-regulation. This also prevented ADAM17 transcript and protein increases. HIF-1 activation by high glucose was shown by its increased nuclear translocation and activation of the HIF-responsive hypoxia-response element (HRE)-luciferase reporter construct. Assessment of ADAM17 promoter deletion constructs coupled with mutation analysis and ChIP studies identified HIF-1 binding to its consensus element at -607 as critical for the high glucose response. Finally, inhibitors of epidermal growth factor receptor (EGFR) and downstream PI3K/Akt, or ADAM17 itself, prevented high glucose-induced HIF-1 activation and ADAM17 up-regulation. Thus, high glucose induces ADAM17 transcriptional up-regulation in mesangial cells, which is associated with augmentation of its activity. This is mediated by HIF-1 and requires EGFR/ADAM17 signaling, demonstrating the potentiation by ADAM17 of its own up-regulation. ADAM17 inhibition thus provides a potential novel therapeutic strategy for the treatment of diabetic nephropathy.	[Li, Renzhong; Uttarwar, Lalita; Gao, Bo; Krepinsky, Joan C.] McMaster Univ, Div Nephrol, Hamilton, ON L8N 4A6, Canada; [Charbonneau, Martine; Dubois, Claire M.] Univ Sherbrooke, Div Immunol, Sherbrooke, PQ J1H 5N4, Canada; [Shi, Yixuan; Chan, John S. D.] Ctr Hosp Univ Montreal, Ctr Rech, Montreal, PQ H2X 0A9, Canada	McMaster University; University of Sherbrooke; Universite de Montreal	Krepinsky, JC (corresponding author), St Josephs Hosp, 50 Charlton Ave East,Rm T3311, Hamilton, ON L8N 4A6, Canada.	krepinj@mcmaster.ca			Canadian Institutes of Health Research (CIHR) [MOP-258039, MOP-86634, MOP-84363]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This study was supported by the Canadian Institutes of Health Research (CIHR) Grants MOP-258039 (to J. C. K.), MOP-86634 (to C. M. D.), and MOP-84363 (to J. S. D. C.). The authors declare that they have no conflicts of interest with the contents of this article.	Adrain C, 2012, SCIENCE, V335, P225, DOI 10.1126/science.1214400; Advani A, 2011, NEPHROLOGY, V16, P573, DOI 10.1111/j.1440-1797.2011.01451.x; Bzowska M, 2004, EUR J BIOCHEM, V271, P2808, DOI 10.1111/j.1432-1033.2004.04215.x; Chae YM, 2004, BIOCHEM BIOPH RES CO, V319, P550, DOI 10.1016/j.bbrc.2004.05.025; Charbonneau M, 2007, J BIOL CHEM, V282, P33714, DOI 10.1074/jbc.M704041200; Fioretto P, 1998, NEW ENGL J MED, V339, P69, DOI 10.1056/NEJM199807093390202; Fischer Oliver M., 2006, V327, P85; Ford BM, 2013, AM J PHYSIOL-RENAL, V305, pF323, DOI 10.1152/ajprenal.00522.2012; Goldberg HJ, 2006, ENDOCRINOLOGY, V147, P222, DOI 10.1210/en.2005-0523; Haneda M, 1997, DIABETES, V46, P847, DOI 10.2337/diabetes.46.5.847; Huang LE, 2003, J BIOL CHEM, V278, P19575, DOI 10.1074/jbc.R200030200; Hundhausen C, 2003, BLOOD, V102, P1186, DOI 10.1182/blood-2002-12-3775; Hurtado O, 2001, NEUROPHARMACOLOGY, V40, P1094, DOI 10.1016/S0028-3908(01)00035-1; Isoe T, 2010, KIDNEY INT, V78, P48, DOI 10.1038/ki.2010.99; Kenchappa RS, 2010, J BIOL CHEM, V285, P20358, DOI 10.1074/jbc.M109.082834; Kimura K, 2008, AM J PHYSIOL-RENAL, V295, pF1023, DOI 10.1152/ajprenal.90209.2008; Krepinsky JC, 2003, J AM SOC NEPHROL, V14, P2790, DOI 10.1097/01.ASN.0000094085.04161.A7; Lauzier MC, 2007, ENDOCRINOLOGY, V148, P4023, DOI 10.1210/en.2007-0285; LEE YJ, 1995, BIOCHEM BIOPH RES CO, V207, P216, DOI 10.1006/bbrc.1995.1175; Majka S, 2002, INVEST OPHTH VIS SCI, V43, P260; Mason RM, 2003, J AM SOC NEPHROL, V14, P1358, DOI 10.1097/01.ASN.0000065640.77499.D7; Matoba K, 2013, KIDNEY INT, V84, P545, DOI 10.1038/ki.2013.130; Melenhorst WB, 2009, AM J PHYSIOL-RENAL, V297, pF781, DOI 10.1152/ajprenal.90610.2008; Miyazawa T, 2013, KIDNEY INT, V84, P1176, DOI 10.1038/ki.2013.214; Mizui Y, 1999, GENE, V233, P67, DOI 10.1016/S0378-1119(99)00155-9; Moss ML, 2007, ANAL BIOCHEM, V366, P144, DOI 10.1016/j.ab.2007.04.043; Murphy M, 1999, J BIOL CHEM, V274, P5830, DOI 10.1074/jbc.274.9.5830; Murumkar PR, 2010, EXPERT OPIN THER PAT, V20, P31, DOI 10.1517/13543770903465157; Navarro-Gonzalez JF, 2009, CYTOKINE GROWTH F R, V20, P165, DOI 10.1016/j.cytogfr.2009.02.005; Nordquist L, 2015, J AM SOC NEPHROL, V26, P328, DOI 10.1681/ASN.2013090990; Obama T, 2015, AM J HYPERTENS, V28, P10, DOI 10.1093/ajh/hpu094; Page EL, 2002, J BIOL CHEM, V277, P48403, DOI 10.1074/jbc.M209114200; Park MJ, 2014, J BIOL CHEM, V289, P13519, DOI 10.1074/jbc.M113.530139; Portik-Dobos V, 2006, AM J PHYSIOL-REG I, V290, pR435, DOI 10.1152/ajpregu.00300.2005; Prenzel N, 1999, NATURE, V402, P884, DOI 10.1038/47260; Raab G, 1997, BBA-REV CANCER, V1333, pF179, DOI 10.1016/S0304-419X(97)00024-3; Salem ESB, 2014, AM J PHYSIOL-RENAL, V306, pF629, DOI 10.1152/ajprenal.00516.2013; Sang NL, 2003, J BIOL CHEM, V278, P14013, DOI 10.1074/jbc.M209702200; Santiago-Josefat B, 2007, J BIOL CHEM, V282, P8325, DOI 10.1074/jbc.M608826200; Shi YX, 2015, CLIN SCI, V128, P649, DOI 10.1042/CS20140329; Szalad A, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-129; Taniguchi K, 2013, DIABETES, V62, P3874, DOI 10.2337/db12-1010; Thangarajah H, 2010, CELL CYCLE, V9, P75, DOI 10.4161/cc.9.1.10371; Treins C, 2002, J BIOL CHEM, V277, P27975, DOI 10.1074/jbc.M204152200; Uttarwar L, 2011, AM J PHYSIOL-RENAL, V300, pF921, DOI 10.1152/ajprenal.00436.2010; Wassef L, 2004, KIDNEY INT, V66, P1805, DOI 10.1111/j.1523-1755.2004.00955.x; Wu D, 2007, DIABETOLOGIA, V50, P2008, DOI 10.1007/s00125-007-0721-1; Wu D, 2009, AM J PHYSIOL-RENAL, V297, pF822, DOI 10.1152/ajprenal.00054.2009; Wu DC, 2009, J AM SOC NEPHROL, V20, P554, DOI 10.1681/ASN.2008040445; Yoda M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054412; Yu HM, 2012, J APPL TOXICOL, V32, P282, DOI 10.1002/jat.1679; Zhang MZ, 2014, DIABETES, V63, P2063, DOI 10.2337/db13-1279	52	45	48	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2015	290	35					21603	21614		10.1074/jbc.M115.651604	http://dx.doi.org/10.1074/jbc.M115.651604			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ5IS	26175156	Green Published, hybrid			2022-12-26	WOS:000360637600033
J	Mizuguchi, C; Ogata, F; Mikawa, S; Tsuji, K; Baba, T; Shigenaga, A; Shimanouchi, T; Okuhira, K; Otaka, A; Saito, H				Mizuguchi, Chiharu; Ogata, Fuka; Mikawa, Shiho; Tsuji, Kohei; Baba, Teruhiko; Shigenaga, Akira; Shimanouchi, Toshinori; Okuhira, Keiichiro; Otaka, Akira; Saito, Hiroyuki			Amyloidogenic Mutation Promotes Fibril Formation of the N-terminal Apolipoprotein A-I on Lipid Membranes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-SYNUCLEIN AGGREGATION; BIOLOGICAL-MEMBRANES; CHOLESTEROL EFFLUX; HYDROGEN-EXCHANGE; MASS-SPECTROMETRY; CRYSTAL-STRUCTURE; HELICAL SEGMENTS; DOMAIN-STRUCTURE; APOA-I; POLYPEPTIDE	The N-terminal amino acid 1-83 fragment of apolipoprotein A-I (apoA-I) has a strong propensity to form amyloid fibrils at physiological neutral pH. Because apoA-I has an ability to bind to lipid membranes, we examined the effects of the lipid environment on fibril-forming properties of the N-terminal fragment of apoA-I variants. Thioflavin T fluorescence assay as well as fluorescence and transmission microscopies revealed that upon lipid binding, fibril formation by apoA-I 1-83 is strongly inhibited, whereas the G26R mutant still retains the ability to form fibrils. Such distinct effects of lipid binding on fibril formation were also observed for the amyloidogenic prone region-containing peptides, apoA-I 8-33 and 8-33/G26R. This amyloidogenic region shifts from random coil to alpha-helical structure upon lipid binding. The G26R mutation appears to prevent this helix transition because lower helical propensity and more solvent-exposed conformation of the G26R variant upon lipid binding were observed in the apoA-I 1-83 fragment and 8-33 peptide. With a partially alpha-helical conformation induced by the presence of 2,2,2-trifluoroethanol, fibril formation by apoA-I 1-83 was strongly inhibited, whereas the G26R variant can form amyloid fibrils. These findings suggest a new possible pathway for amyloid fibril formation by the N-terminal fragment of apoA-I variants: the amyloidogenic mutations partially destabilize the alpha-helical structure formed upon association with lipid membranes, resulting in physiologically relevant conformations that allow fibril formation.	[Mizuguchi, Chiharu; Ogata, Fuka; Mikawa, Shiho; Tsuji, Kohei; Shigenaga, Akira; Okuhira, Keiichiro; Otaka, Akira; Saito, Hiroyuki] Univ Tokushima, Grad Sch Pharmaceut Sci, Inst Biomed Sci, Tokushima 7708505, Japan; [Baba, Teruhiko] Natl Inst Adv Ind Sci & Technol, Res Ctr Stem Cell Engn SCRC, Tsukuba, Ibaraki 3058565, Japan; [Shimanouchi, Toshinori] Okayama Univ, Grad Sch Environm & Life Sci, Okayama 7008530, Japan	Tokushima University; National Institute of Advanced Industrial Science & Technology (AIST); Okayama University	Saito, H (corresponding author), Univ Tokushima, Grad Sch Pharmaceut Sci, Inst Biomed Sci, 1-78-1 Shomachi, Tokushima 7708505, Japan.	hsaito@tokushima-u.ac.jp	Baba, Teruhiko/J-3351-2018	Baba, Teruhiko/0000-0002-9075-2999; Shigenaga, Akira/0000-0002-6474-5517; Tsuji, Kohei/0000-0003-4773-8793	Japan Society for the Promotion of Science [25293006, 25670014]; Tokushima University	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Tokushima University	This work was supported in part by Grant-in-Aid for Scientific Research 25293006 and 25670014 (to H. S.) from Japan Society for the Promotion of Science, and the research program for development of intelligent Tokushima artificial exosome (iTEX) from Tokushima University. The authors declare that they have no conflicts of interest with the contents of this article.	Abedini A, 2009, PROTEIN ENG DES SEL, V22, P453, DOI 10.1093/protein/gzp036; Abedini A, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/1/015005; Adachi E, 2014, FEBS LETT, V588, P389, DOI 10.1016/j.febslet.2013.11.031; Adachi E, 2013, J BIOL CHEM, V288, P2848, DOI 10.1074/jbc.M112.428052; Anderson VL, 2010, P NATL ACAD SCI USA, V107, P18850, DOI 10.1073/pnas.1012336107; Apostolidou M, 2008, J BIOL CHEM, V283, P17205, DOI 10.1074/jbc.M801383200; Arciello A, 2011, J CELL MOL MED, V15, P2652, DOI 10.1111/j.1582-4934.2011.01271.x; Arnulphi C, 2004, BIOCHEMISTRY-US, V43, P12258, DOI 10.1021/bi036118k; Axelsen PH, 2011, PHYSIOLOGY, V26, P54, DOI 10.1152/physiol.00024.2010; Bucciantini M, 2014, J PHYS CHEM LETT, V5, P517, DOI 10.1021/jz4024354; Butterfield SM, 2010, ANGEW CHEM INT EDIT, V49, P5628, DOI 10.1002/anie.200906670; Bystrom R, 2008, CELL BIOCHEM BIOPHYS, V52, P175, DOI 10.1007/s12013-008-9033-4; Chan GKL, 2015, J BIOL CHEM, V290, P10958, DOI 10.1074/jbc.M114.630442; Chetty PS, 2012, BIOCHEMISTRY-US, V51, P8993, DOI 10.1021/bi300926j; Chetty PS, 2009, P NATL ACAD SCI USA, V106, P19005, DOI 10.1073/pnas.0909708106; Das M, 2014, FEBS J, V281, P2525, DOI 10.1111/febs.12809; Davidson WS, 1996, P NATL ACAD SCI USA, V93, P13605, DOI 10.1073/pnas.93.24.13605; Di Gaetano S, 2006, BIOCHEM BIOPH RES CO, V351, P223, DOI 10.1016/j.bbrc.2006.10.026; Frank PG, 2000, J LIPID RES, V41, P853; Galvagnion C, 2015, NAT CHEM BIOL, V11, P229, DOI [10.1038/NCHEMBIO.1750, 10.1038/nchembio.1750]; Georgieva ER, 2010, J BIOL CHEM, V285, P28261, DOI 10.1074/jbc.M110.157214; Girych M, 2014, J STRUCT BIOL, V185, P116, DOI 10.1016/j.jsb.2013.10.017; Gorbenko GP, 2006, CHEM PHYS LIPIDS, V141, P72, DOI 10.1016/j.chemphyslip.2006.02.006; Griffin MDW, 2008, J MOL BIOL, V375, P240, DOI 10.1016/j.jmb.2007.10.038; Guo C, 2015, J PHYS CHEM B, V119, P3366, DOI 10.1021/jp5111357; Gursky O, 1996, P NATL ACAD SCI USA, V93, P2991, DOI 10.1073/pnas.93.7.2991; Gursky O, 2012, BIOCHEMISTRY-US, V51, P10, DOI 10.1021/bi2017014; Hebda JA, 2009, ANNU REV BIOPHYS, V38, P125, DOI 10.1146/annurev.biophys.050708.133622; Jayasinghe SA, 2005, BIOCHEMISTRY-US, V44, P12113, DOI 10.1021/bi050840w; Jayasinghe SA, 2007, BBA-BIOMEMBRANES, V1768, P2002, DOI 10.1016/j.bbamem.2007.01.022; Jiang ZP, 2013, J AM CHEM SOC, V135, P15970, DOI 10.1021/ja405993r; Joy T, 2003, CLIN BIOCHEM, V36, P641, DOI 10.1016/S0009-9120(03)00110-3; Knight JD, 2006, BIOCHEMISTRY-US, V45, P9496, DOI 10.1021/bi060579z; Koyama M, 2009, BIOCHEMISTRY-US, V48, P2529, DOI 10.1021/bi802317v; Lagerstedt JO, 2007, BIOCHEMISTRY-US, V46, P9693, DOI 10.1021/bi7005493; Lee JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047580; Mei XH, 2011, J BIOL CHEM, V286, P38570, DOI 10.1074/jbc.M111.260422; Mendoza-Espinosa P, 2014, MOL CELL BIOCHEM, V393, P99, DOI 10.1007/s11010-014-2050-2; Mizuguchi C, 2012, BIOCHEMISTRY-US, V51, P5580, DOI 10.1021/bi300672s; Monti DM, 2010, EUR BIOPHYS J BIOPHY, V39, P1289, DOI 10.1007/s00249-010-0582-2; Munishkina LA, 2003, BIOCHEMISTRY-US, V42, P2720, DOI 10.1021/bi027166s; NICHOLS WC, 1988, BIOCHEM BIOPH RES CO, V156, P762, DOI 10.1016/S0006-291X(88)80909-4; Obici L, 2006, AMYLOID, V13, P191, DOI 10.1080/13506120600960288; Okada T, 2007, J MOL BIOL, V371, P481, DOI 10.1016/j.jmb.2007.05.069; Petrlova J, 2014, PROTEIN SCI, V23, P1559, DOI 10.1002/pro.2534; Phillips MC, 2014, J BIOL CHEM, V289, P24020, DOI 10.1074/jbc.R114.583658; Rader DJ, 2009, J LIPID RES, V50, pS189, DOI 10.1194/jlr.R800088-JLR200; RADER DJ, 1992, J LIPID RES, V33, P755; Raimondi S, 2011, J MOL BIOL, V407, P465, DOI 10.1016/j.jmb.2011.01.044; Rosenson RS, 2012, CIRCULATION, V125, P1905, DOI 10.1161/CIRCULATIONAHA.111.066589; Rowczenio D, 2011, AM J PATHOL, V179, P1978, DOI 10.1016/j.ajpath.2011.06.024; Saito H, 2004, PROG LIPID RES, V43, P350, DOI 10.1016/j.plipres.2004.05.002; Saito H, 2004, J BIOL CHEM, V279, P20974, DOI 10.1074/jbc.M402043200; Saito H, 2003, J BIOL CHEM, V278, P23227, DOI 10.1074/jbc.M303365200; Shen L, 2012, J AM CHEM SOC, V134, P14172, DOI 10.1021/ja305398f; Sorci-Thomas MG, 2002, TRENDS CARDIOVAS MED, V12, P121, DOI 10.1016/S1050-1738(01)00163-3; SPARKS DL, 1992, J BIOL CHEM, V267, P25839; Tanaka M, 2006, BIOCHEMISTRY-US, V45, P10351, DOI 10.1021/bi060726t; Tanaka M, 2009, J PEPT SCI, V15, P36, DOI 10.1002/psc.1092; Tartaglia GG, 2008, J MOL BIOL, V380, P425, DOI 10.1016/j.jmb.2008.05.013; Terakawa MS, 2015, J BIOL CHEM, V290, P815, DOI 10.1074/jbc.M114.592527; Tricerri MA, 2000, BIOCHEMISTRY-US, V39, P14682, DOI 10.1021/bi0014251; Varkey J, 2010, J BIOL CHEM, V285, P32486, DOI 10.1074/jbc.M110.139576; VENKATACHALAPATHI YV, 1993, PROTEINS, V15, P349, DOI 10.1002/prot.340150403; Williamson JA, 2009, J MOL BIOL, V393, P383, DOI 10.1016/j.jmb.2009.07.077; Wong YQ, 2012, FEBS LETT, V586, P1754, DOI 10.1016/j.febslet.2012.05.007; Wong YQ, 2010, P NATL ACAD SCI USA, V107, P1977, DOI 10.1073/pnas.0910136107; Yamaguchi K, 2006, J MOL BIOL, V363, P279, DOI 10.1016/j.jmb.2006.08.030; Yanagi K, 2011, J BIOL CHEM, V286, P23959, DOI 10.1074/jbc.M111.226688; Ysselstein D, 2015, NEUROBIOL DIS, V79, P150, DOI 10.1016/j.nbd.2015.04.007; Zhou Z, 2009, J BIOL CHEM, V284, P30148, DOI 10.1074/jbc.M109.002832; Zhu M, 2003, J BIOL CHEM, V278, P16873, DOI 10.1074/jbc.M210136200	72	10	10	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2015	290	34					20947	20959		10.1074/jbc.M115.664227	http://dx.doi.org/10.1074/jbc.M115.664227			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP6QC	26175149	hybrid, Green Published			2022-12-26	WOS:000360011800029
J	Chen, LW; Simonsen, N; Liu, L				Chen, Liwei; Simonsen, Neal; Liu, Li			Racial Differences of Pediatric Hypertension in Relation to Birth Weight and Body Size in the United States	PLOS ONE			English	Article							NUTRITION EXAMINATION SURVEY; BLOOD-PRESSURE DIFFERENCES; NATIONAL-HEALTH; CHILDREN; PREVALENCE; PREHYPERTENSION	Background The prevalence of hypertension is known to differ by racial group in adults in the United States (US), but findings in children are scarce and inconsistent. The objective of this study was to assess the racial differences in pediatric hypertension and to explore whether these differences, if any, can be explained by low birth weight (LBW) and obesity. Methods Analyses were performed for participants aged 8-17 years (N = 9,250) included in the 1999-2010 National Health and Nutrition Examination Survey. Multivariate logistic regressions and weighted analysis were carried out considering the complex survey design. Results Compared to non-Hispanic White youth, the crude prevalence of hypertension was significantly higher in non-Hispanic Blacks (7.1% vs. 5.6%; P = 0.04), but not in Mexican Americans (5.4% vs. 5.6%; P = 0.77). Blacks also had higher rates of LBW (14.6% vs. 5.9%; P < 0.001) and obesity (22.9% vs. 15.8%; P < 0.001) than Whites. In stratified analysis by age-sex groups, the Black-White difference in hypertension prevalence was only significant in boys aged 13-17 (9.6% vs. 6.6%). After controlling for age, Black boys had a 51% higher odds of having hypertension (Odds ratio = 1.51; 95% confidence interval: 1.03, 3.43; P = 0.04) compared to White youth at ages 13-17. This racial difference persisted with additional adjustment for birth weight (odds ratio (OR) = 2.00; P = 0.02) and for current body mass index (OR = 1.50; P = 0.04). Mexican American youth had no difference in hypertension prevalence as compared to White youth after adjusting for age, sex, birth weight and obesity (Odds ratio = 0.82; P = 0.16) and in age-sex stratified subgroups. Conclusions Non-Hispanic Black adolescent boys have a significantly higher hypertension rate than their non-Hispanic White counterparts in the US. This racial difference cannot be explained by LBW and current obesity status within the Black population.	[Chen, Liwei] Clemson Univ, Dept Publ Hlth Sci, Clemson, SC USA; [Simonsen, Neal] Louisiana State Univ, Sch Publ Hlth, Hlth Sci Ctr, New Orleans, LA USA; [Liu, Li] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Populat Family & Reprod Hlth, Baltimore, MD 21205 USA; [Liu, Li] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA	Clemson University; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Liu, L (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Populat Family & Reprod Hlth, Baltimore, MD 21205 USA.	lliu26@jhu.edu	liu, li/HGC-0900-2022		School of Public Health, Louisiana State University Health Sciences Center	School of Public Health, Louisiana State University Health Sciences Center	This research was partly supported by School of Public Health, Louisiana State University Health Sciences Center. The authors received no other specific funding for this work.	Bowers K, 2011, PEDIATRICS, V127, pE1272, DOI 10.1542/peds.2010-2213; BURT VL, 1995, HYPERTENSION, V25, P305, DOI 10.1161/01.HYP.25.3.305; CASEY R, 1992, CLIN PEDIATR, V31, P200, DOI 10.1177/000992289203100402; Chen XL, 2008, CIRCULATION, V117, P3171, DOI 10.1161/CIRCULATIONAHA.107.730366; de Jong F, 2012, HYPERTENSION, V59, P226, DOI 10.1161/HYPERTENSIONAHA.111.181784; Fattal-Valevski A, 2011, ISR MED ASSOC J, V13, P480; Gidding SS, 2008, CIRCULATION, V117, P3163, DOI 10.1161/CIRCULATIONAHA.108.787168; Lo JC, 2013, PEDIATRICS, V131, pE415, DOI 10.1542/peds.2012-1292; McNiece KL, 2007, J PEDIATR-US, V150, P640, DOI 10.1016/j.jpeds.2007.01.052; Mu M, 2012, ARCH CARDIOVASC DIS, V105, P99, DOI 10.1016/j.acvd.2011.10.006; Natl High Blood Pressure Educ Prog, 2004, PEDIATRICS, V114, P555; Ostchega Y, 2009, AM J HYPERTENS, V22, P59, DOI 10.1038/ajh.2008.312; Rosner B, 2000, AM J EPIDEMIOL, V151, P1007, DOI 10.1093/oxfordjournals.aje.a010129; Rosner B, 2013, HYPERTENSION, V62, pE45, DOI 10.1161/HYPERTENSIONAHA.113.02128; Rosner B, 2009, HYPERTENSION, V54, P502, DOI 10.1161/HYPERTENSIONAHA.109.134049; Shay CM, 2013, CIRCULATION, V127, P1369, DOI 10.1161/CIRCULATIONAHA.113.001559; Sorof JM, 2004, PEDIATRICS, V113, P475, DOI 10.1542/peds.113.3.475; Tourangeau R, 2000, SCIENCE OF SELF-REPORT, P29; Wodskou PM, 2010, ACTA OBSTET GYN SCAN, V89, P1134, DOI 10.3109/00016349.2010.500370	19	15	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132606	10.1371/journal.pone.0132606	http://dx.doi.org/10.1371/journal.pone.0132606			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176843	Green Published, Green Submitted, gold			2022-12-26	WOS:000358197600130
J	Jemielita, T; Gerton, GL; Neidell, M; Chillrud, S; Yan, BZ; Stute, M; Howarth, M; Saberi, P; Fausti, N; Penning, TM; Roy, J; Propert, KJ; Panettieri, RA				Jemielita, Thomas; Gerton, George L.; Neidell, Matthew; Chillrud, Steven; Yan, Beizhan; Stute, Martin; Howarth, Marilyn; Saberi, Pounw; Fausti, Nicholas; Penning, Trevor M.; Roy, Jason; Propert, Kathleen J.; Panettieri, Reynold A., Jr.			Unconventional Gas and Oil Drilling Is Associated with Increased Hospital Utilization Rates	PLOS ONE			English	Article							SHALE GAS; OPERATIONS; EXTRACTION	Over the past ten years, unconventional gas and oil drilling (UGOD) has markedly expanded in the United States. Despite substantial increases in well drilling, the health consequences of UGOD toxicant exposure remain unclear. This study examines an association between wells and healthcare use by zip code from 2007 to 2011 in Pennsylvania. Inpatient discharge databases from the Pennsylvania Healthcare Cost Containment Council were correlated with active wells by zip code in three counties in Pennsylvania. For overall inpatient prevalence rates and 25 specific medical categories, the association of inpatient prevalence rates with number of wells per zip code and, separately, with wells per km(2) (separated into quantiles and defined as well density) were estimated using fixed-effects Poisson models. To account for multiple comparisons, a Bonferroni correction with associations of p<0.00096 was considered statistically significant. Cardiology inpatient prevalence rates were significantly associated with number of wells per zip code (p<0.00096) and wells per km(2) (p<0.00096) while neurology inpatient prevalence rates were significantly associated with wells per km(2) (p<0.00096). Furthermore, evidence also supported an association between well density and inpatient prevalence rates for the medical categories of dermatology, neurology, oncology, and urology. These data suggest that UGOD wells, which dramatically increased in the past decade, were associated with increased inpatient prevalence rates within specific medical categories in Pennsylvania. Further studies are necessary to address healthcare costs of UGOD and determine whether specific toxicants or combinations are associated with organ-specific responses.	[Jemielita, Thomas; Roy, Jason; Propert, Kathleen J.] Univ Penn, Perelman Sch Med, Dept Biostat, Philadelphia, PA 19104 USA; [Gerton, George L.; Howarth, Marilyn; Saberi, Pounw; Fausti, Nicholas; Penning, Trevor M.; Panettieri, Reynold A., Jr.] Univ Penn, Ctr Excellence Environm Toxicol, Airways Biol Initiat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Neidell, Matthew] Columbia Univ, Mailman Sch Publ Hlth, Dept Hlth Policy & Management, New York, NY USA; [Chillrud, Steven; Yan, Beizhan] Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Columbia University; Columbia University	Panettieri, RA (corresponding author), Univ Penn, Ctr Excellence Environm Toxicol, Airways Biol Initiat, Perelman Sch Med, Philadelphia, PA 19104 USA.	rap@mail.med.upenn.edu	panettieri, reynold/AAG-9485-2019	Penning, Trevor/0000-0002-3937-1066	National Institute of Environmental Health Sciences [P30-ES013508, P30-ES009089]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL114471] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES013508, P30ES009089] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was funded by grants from the National Institute of Environmental Health Sciences (www.niehs.nih.gov): P30-ES013508 (GLG MH PS NF TMP JR KJP RAP) and P30-ES009089 (GLG MN SC BY MS MH PS NF TMP JR KJP RAP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adgate JL, 2014, ENVIRON SCI TECHNOL, V48, P8307, DOI 10.1021/es404621d; Bernstein AB, 2003, DHHS PUBLICATION, V2004-1031; Colborn T, 2011, HUM ECOL RISK ASSESS, V17, P1039, DOI 10.1080/10807039.2011.605662; Earthworks, EARTHW HYDR FRACT 10, V101; EIA, 2014, ANN EN OUTL 2014; EPA, 2014, PROC HYDR FRACT; Gross SA, 2013, J AIR WASTE MANAGE, V63, P424, DOI 10.1080/10962247.2012.759166; IER, 2012, US LEADS WORLD NAT G; Jackson RB, 2013, P NATL ACAD SCI USA, V110, P11250, DOI 10.1073/pnas.1221635110; Lampe DJ, 2015, J ENVIRON SCI HEAL A, V50, P434, DOI 10.1080/10934529.2015.992653; Lanki T., 2015, ENV HLTH PERSPECT; Macy PG, 2014, ENV HLTH, V13, P82, DOI [10.1186/1476-069X-13-82, DOI 10.1186/1476-069X-13-82]; McKenzie LM, 2014, ENVIRON HEALTH PERSP, V122, P412, DOI 10.1289/ehp.1306722; McKenzie LM, 2012, SCI TOTAL ENVIRON, V424, P79, DOI 10.1016/j.scitotenv.2012.02.018; PA Department of Environmental Protection, 2013, 2013 OIL GAS ANN REP; PA Department of Environmental Protection, 2013, MARC SHAK DEV; Penning TM, 2014, ENVIRON HEALTH PERSP, V122, P1155, DOI 10.1289/ehp.1408207; Rabinowitz PM, 2014, ENV HLTH PERSPECT; Schnoor JL, 2012, ENVIRON SCI TECHNOL, V46, P4686, DOI 10.1021/es3011767; US Government, 2010, 2010 CENS DAT; Warner NR, 2013, ENVIRON SCI TECHNOL, V47, P11849, DOI 10.1021/es402165b; Wooldridge JM, 1999, J ECONOMETRICS, V90, P77, DOI 10.1016/S0304-4076(98)00033-5	22	61	63	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0131093	10.1371/journal.pone.0131093	http://dx.doi.org/10.1371/journal.pone.0131093			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176544	Green Published, Green Submitted, gold			2022-12-26	WOS:000358197600036
J	Megas, Z; Martinez, C; Manzano, S; Garcia, A; Rebolloso-Fuentes, MD; Garrido, D; Valenzuela, JL; Jamilena, M				Megas, Zoraida; Martinez, Cecilia; Manzano, Susana; Garcia, Alicia; del Mar Rebolloso-Fuentes, Maria; Garrido, Dolores; Luis Valenzuela, Juan; Jamilena, Manuel			Individual Shrink Wrapping of Zucchini Fruit Improves Postharvest Chilling Tolerance Associated with a Reduction in Ethylene Production and Oxidative Stress Metabolites	PLOS ONE			English	Article							COLD-STORAGE; SHELF-LIFE; QUALITY; INJURY; MAINTENANCE; TEMPERATURE; SQUASH; FILMS; POLYAMINES; RESPIRATION	We have studied the effect of individual shrink wrapping (ISW) on the postharvest performance of refrigerated fruit from two zucchini cultivars that differ in their sensitivity to cold storage: Sinatra (more sensitive) and Natura (more tolerant). The fruit was individually shrink wrapped before storing at 4 degrees C for 0, 7 and 14 days. Quality parameters, ethylene and CO2 productions, ethylene gene expression, and oxidative stress metabolites were assessed in shrink wrapped and non- wrapped fruit after conditioning the fruit for 6 hours at 20 degrees C. ISW decreased significantly the postharvest deterioration of chilled zucchini in both cultivars. Weight loss was reduced to less than 1%, pitting symptoms were completely absent in ISW fruit at 7 days, and were less than 25% those of control fruits at 14 days of cold storage, and firmness loss was significantly reduced in the cultivar Sinatra. These enhancements in quality of ISW fruit were associated with a significant reduction in cold-induced ethylene production, in the respiration rate, and in the level of oxidative stress metabolites such as hydrogen peroxide and malonyldialdehyde (MDA). A detailed expression analysis of ethylene biosynthesis, perception and signaling genes demonstrated a downregulation of CpACS1 and CpACO1 genes in response to ISW, two genes that are upregulated by cold storage. However, the expression patterns of six other ethylene biosynthesis genes (CpACS2 to CpACS7) and five ethylene signal transduction pathway genes (CpCTR1, CpETR1, CpERS1, CpEIN3.1 and CpEN3.2), suggest that they do not play a major role in response to cold storage and ISW packaging. In conclusion, ISW zucchini packaging resulted in improved tolerance to chilling concomitantly with a reduction in oxidative stress, respiration rate and ethylene production, as well as in the expression of ethylene biosynthesis genes, but not of those involved in ethylene perception and sensitivity.	[Megas, Zoraida; Martinez, Cecilia; Manzano, Susana; Garcia, Alicia; Luis Valenzuela, Juan; Jamilena, Manuel] Univ Almeria, Campus Int Excellence ceiA3, Dept Biol & Geol, Agrifood, Almeria 04120, Spain; [del Mar Rebolloso-Fuentes, Maria] Univ Almeria, Campus Int Excellence ceiA3, Dept Agron, Agrifood, Almeria 04120, Spain; [Garrido, Dolores] Univ Granada, Fac Ciencias, Dept Fisiol Vegetal, E-18071 Granada, Spain	Universidad de Almeria; Universidad de Almeria; University of Granada	Jamilena, M (corresponding author), Univ Almeria, Campus Int Excellence ceiA3, Dept Biol & Geol, Agrifood, La Canada de San Urbano S-N, Almeria 04120, Spain.	mjamille@ual.es	Jamilena, Manuel/ABE-9137-2020; Jamilena, Manuel/K-3331-2014; Valenzuela, Juan Luis/L-6974-2014; Manzano, Susana/M-1372-2015; Martínez, Cecilia/AAA-5090-2020; Garrido, Dolores/K-7475-2017	Jamilena, Manuel/0000-0001-7072-0458; Jamilena, Manuel/0000-0001-7072-0458; Valenzuela, Juan Luis/0000-0002-5726-3464; Garrido, Dolores/0000-0002-0426-7146; Martinez, Cecilia/0000-0003-0464-1828	Spanish Ministry of Science and Innovation [AGL2011-30568-C02/ALI, PTA2011-479-I]; Consejeria de Economia, Innovacion y Ciencia, Junta de Andalucia, Spain [AGR1423]; MEC, Spain	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Consejeria de Economia, Innovacion y Ciencia, Junta de Andalucia, Spain(Junta de Andalucia); MEC, Spain(Spanish Government)	This work was supported by grants AGL2011-30568-C02/ALI from the Spanish Ministry of Science and Innovation, and AGR1423 from the Consejeria de Economia, Innovacion y Ciencia, Junta de Andalucia, Spain. Z.M. acknowledges FPU program scholarships from MEC, Spain. S.M. is funded by grant PTA2011-479-I from the Spanish Ministry of Science and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexieva V, 2001, PLANT CELL ENVIRON, V24, P1337, DOI 10.1046/j.1365-3040.2001.00778.x; Amoros A, 2008, FOOD SCI TECHNOL INT, V14, P95, DOI 10.1177/1082013208089985; Balandran-Quintana RR, 2003, BIOCHEM BIOPH RES CO, V307, P553, DOI 10.1016/S0006-291X(03)01212-9; Begheldo M, 2008, POSTHARVEST BIOL TEC, V48, P84, DOI 10.1016/j.postharvbio.2007.09.023; BENYEHOSHUA S, 1983, PLANT PHYSIOL, V73, P87, DOI 10.1104/pp.73.1.87; BHOWMIK SR, 1989, LEBENSM WISS TECHNOL, V22, P119; Blanca J, 2011, BMC GENOMICS, P12; Cai C, 2006, POSTHARVEST BIOL TEC, V41, P252, DOI 10.1016/j.postharvbio.2006.04.015; Cantwell M.I., 2011, POSTHARVEST TECHNOLO, P407; Carvajal F, 2015, ANN APPL BIOL, V166, P340, DOI 10.1111/aab.12189; Carvajal F, 2011, SCI HORTIC-AMSTERDAM, V130, P90, DOI 10.1016/j.scienta.2011.06.016; Chiriboga MA, 2013, POSTHARVEST BIOL TEC, V86, P212, DOI 10.1016/j.postharvbio.2013.07.003; Choudhury SR, 2008, J PLANT PHYSIOL, V165, P1865, DOI 10.1016/j.jplph.2008.04.012; COLLINS JK, 1990, HORTSCIENCE, V25, P1409, DOI 10.21273/HORTSCI.25.11.1409; Dhall RK, 2012, J FOOD SCI TECH MYS, V49, P495, DOI 10.1007/s13197-011-0284-5; Diaz-Mula HM, 2011, POSTHARVEST BIOL TEC, V61, P103, DOI 10.1016/j.postharvbio.2011.02.010; El-Sharkawy I, 2003, J EXP BOT, V54, P1615, DOI 10.1093/jxb/erg158; Fahmy Khandra, 2014, Environmental Control in Biology, V52, P233, DOI 10.2525/ecb.52.233; Fante CA, 2014, FOOD SCI TECH-BRAZIL, V34, P309, DOI 10.1590/fst.2014.0044; Floros JD, 2005, INNOVATIONS IN FOOD PACKAGING, P159, DOI 10.1016/B978-012311632-1/50042-5; Goulas V, 2014, FOOD CHEM, V155, P227, DOI 10.1016/j.foodchem.2014.01.054; Guillen F, 2013, POSTHARVEST BIOL TEC, V83, P54, DOI 10.1016/j.postharvbio.2013.03.011; Hariyadi P., 1991, Postharvest Biology and Technology, V1, P33, DOI 10.1016/0925-5214(91)90017-6; Hertog MLATM, 1998, POSTHARVEST BIOL TEC, V14, P335, DOI 10.1016/S0925-5214(98)00058-1; Hodges DM, 1999, PLANTA, V207, P604, DOI 10.1007/s004250050524; Ilic ZS, 2012, INT J FOOD SCI TECH, V47, P83, DOI 10.1111/j.1365-2621.2011.02810.x; Lado J, 2015, POSTHARVEST BIOL TEC, V100, P176, DOI 10.1016/j.postharvbio.2014.10.002; LEE DS, 1991, J FOOD SCI, V56, P1580, DOI 10.1111/j.1365-2621.1991.tb08645.x; Lin ZF, 2008, PLANT J, V54, P1083, DOI 10.1111/j.1365-313X.2008.03481.x; Manzano S, 2013, J PLANT GROWTH REGUL, V32, P789, DOI 10.1007/s00344-013-9344-6; Martinez C, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-139; Martinez-Romero D, 2013, POSTHARVEST BIOL TEC, V86, P107, DOI 10.1016/j.postharvbio.2013.06.022; Martinez-Tellez MA, 2002, BIOCHEM BIOPH RES CO, V295, P98, DOI 10.1016/S0006-291X(02)00631-9; Megias Z, 2014, LWT-FOOD SCI TECHNOL, V57, P194, DOI 10.1016/j.lwt.2013.12.044; MENCARELLI F, 1983, J AM SOC HORTIC SCI, V108, P884; Nanda S, 2001, POSTHARVEST BIOL TEC, V22, P61, DOI 10.1016/S0925-5214(00)00181-2; Palma F, 2015, POSTHARVEST BIOL TEC, V99, P131, DOI 10.1016/j.postharvbio.2014.08.010; Palma F, 2014, PLANT PHYSIOL BIOCH, V82, P161, DOI 10.1016/j.plaphy.2014.06.001; Pesis E, 2002, POSTHARVEST BIOL TEC, V26, P157, DOI 10.1016/S0925-5214(02)00024-8; PRETEL MT, 1993, FOOD SCI TECHNOL-LEB, V26, P8, DOI 10.1006/fstl.1993.1002; Rao SDV, 2000, INDIAN FOOD PACK, V54, P65; Rugkong A, 2011, POSTHARVEST BIOL TEC, V61, P1, DOI 10.1016/j.postharvbio.2011.02.009; Serrano M, 2006, POSTHARVEST BIOL TEC, V39, P61, DOI 10.1016/j.postharvbio.2005.08.004; Serrano M, 2005, INNOV FOOD SCI EMERG, V6, P115, DOI 10.1016/j.ifset.2004.09.001; Serrano M, 1998, J AGR FOOD CHEM, V46, P2465, DOI 10.1021/jf970864c; Sevillano L, 2009, J SCI FOOD AGR, V89, P555, DOI 10.1002/jsfa.3468; Sharma P., 2012, APPL ENVIRON SOIL SC, V2012, P1, DOI [10.1155/2012/217037, DOI 10.1155/2012/650206]; Sharma RR, 2013, J FOOD SCI TECH MYS, V50, P590, DOI 10.1007/s13197-011-0332-1; Singh SP, 2005, J FOOD SCI TECH MYS, V42, P523; Sonkar RK, 1999, J FOOD SCI TECH MYS, V36, P273; Tano K, 2007, POSTHARVEST BIOL TEC, V46, P212, DOI 10.1016/j.postharvbio.2007.05.008; WANG CY, 1995, POSTHARVEST BIOL TEC, V5, P67, DOI 10.1016/0925-5214(94)00020-S; Wang CY, 1997, POSTHARVEST BIOL TEC, V10, P195, DOI 10.1016/S0925-5214(97)01405-1; WANG CY, 1989, SCI HORTIC-AMSTERDAM, V39, P1, DOI 10.1016/0304-4238(89)90031-9; Wang P, 2010, J EXP BOT, V61, P179, DOI 10.1093/jxb/erp302; Wong WS, 2001, PLANT SCI, V161, P969, DOI 10.1016/S0168-9452(01)00505-2; Xie XB, 2014, POSTHARVEST BIOL TEC, V97, P1, DOI 10.1016/j.postharvbio.2014.06.002; YANG SF, 1984, ANNU REV PLANT PHYS, V35, P155, DOI 10.1146/annurev.pp.35.060184.001103; Yin XR, 2009, POSTHARVEST BIOL TEC, V52, P9, DOI 10.1016/j.postharvbio.2008.09.016; Zou Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116002	60	14	14	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0133058	10.1371/journal.pone.0133058	http://dx.doi.org/10.1371/journal.pone.0133058			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26177024	Green Published, gold			2022-12-26	WOS:000358197600207
J	Wu, X; Fu, XW; Guo, JL; Zhao, XC; Wu, KM				Wu, Xiao; Fu, Xiaowei; Guo, Jianglong; Zhao, Xincheng; Wu, Kongming			Annual Migration of Cabbage Moth, Mamestra brassicae L. (Lepidoptera: Noctuidae), over the Sea in Northern China	PLOS ONE			English	Article							HELICOVERPA-ARMIGERA LEPIDOPTERA; BOHAI SEA; AUTUMN MIGRATION; CNAPHALOCROCIS-MEDINALIS; SEASONAL MIGRATION; JUVENILE-HORMONE; INSECT MIGRATION; RADAR; FLIGHT; PYRALIDAE	The cabbage moth, Mamestra brassicae L. (Lepidoptera: Noctuidae), is a serious pest of vegetable crops throughout the world. In order to determine whether or not M. brassicae is a migrant, and if yes, what is the pattern of M. brassicae seasonal migration, a long-term study on M. brassicae from April to October in 2003-2014 was carried out by means of a searchlight trap on a small island located in the center of the Bohai Strait. The results show that a large number of M. brassicae were trapped every year on the island, which indicates that M. brassicae is a migrant and migrated at least 40-60 km across the Bohai Strait. The mean migration period of M. brassicae over the sea within one year is 151 +/- 8 d in 2003-2014, with the shortest time span 78 d in 2003 and the longest 189 d in 2014, respectively. The number of M. brassicae captured, however, varies considerably between months or years. The majority of captures were female, with different levels of ovarian development and mating status. Most of the females trapped in May-July during 2010-2014 had a high mating rate and advanced level of ovarian development, suggesting that the migration of this species does not conform to the hypothesis of 'oogenesis-flight syndrome'. The findings of the present study are beneficial to the development of forecasting systems and management strategies of M. brassicae.	[Wu, Xiao; Fu, Xiaowei; Guo, Jianglong; Wu, Kongming] Chinese Acad Agr Sci, State Key Lab Biol Plant Dis & Insect Pests, Inst Plant Protect, Beijing 100193, Peoples R China; [Wu, Xiao; Guo, Jianglong; Zhao, Xincheng] Henan Agr Univ, Coll Plant Protect, Dept Entomol, Zhengzhou 450002, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; Henan Agricultural University	Wu, KM (corresponding author), Chinese Acad Agr Sci, State Key Lab Biol Plant Dis & Insect Pests, Inst Plant Protect, Beijing 100193, Peoples R China.	kmwu@ippcaas.cn			National Natural Science Foundation of China [31321004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was funded by National Natural Science Foundation of China (grant number 31321004) to KMW (http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atmospheric science dictionary editorial committee, 1994, ATMOSPHERIC SCI DICT, P1; BUHLER A, 1983, J INSECT PHYSIOL, V29, P885, DOI 10.1016/0022-1910(83)90051-3; Carde RT, 2008, CURR BIOL, V18, pR1007, DOI 10.1016/j.cub.2008.09.013; Chapman JW, 2011, ANNU REV ENTOMOL, V56, P337, DOI 10.1146/annurev-ento-120709-144820; CUSSON M, 1990, J INSECT PHYSIOL, V36, P139, DOI 10.1016/0022-1910(90)90185-I; Dingle H, 2007, BIOSCIENCE, V57, P113, DOI 10.1641/B570206; DRAKE VA, 1988, ANNU REV ENTOMOL, V33, P183, DOI 10.1146/annurev.en.33.010188.001151; Feng H.Q., 2010, China Patent, Patent No. [CN201020229775.3, 2010202297753, 201020229775.3]; Feng HQ, 2008, ENVIRON ENTOMOL, V37, P774, DOI 10.1603/0046-225X(2008)37[774:AMOMSL]2.0.CO;2; Feng HQ, 2006, ECOL ENTOMOL, V31, P511, DOI 10.1111/j.1365-2311.2006.00813.x; Feng HQ, 2009, J ECON ENTOMOL, V102, P95, DOI 10.1603/029.102.0114; Feng HQ, 2005, J INSECT BEHAV, V18, P335, DOI 10.1007/s10905-005-3694-2; Feng HQ, 2004, J ECON ENTOMOL, V97, P1874, DOI 10.1603/0022-0493-97.6.1874; Feng HQ, 2004, ENVIRON ENTOMOL, V33, P1253, DOI 10.1603/0046-225X-33.5.1253; Feng HQ, 2003, B ENTOMOL RES, V93, P115, DOI 10.1079/BER2002221; Finch S., 1992, P87; Fu XW, 2014, CROP PROT, V64, P143, DOI 10.1016/j.cropro.2014.06.021; Fu XW, 2014, J ECON ENTOMOL, V107, P1399, DOI 10.1603/EC13380; Gan GF, 1997, SUGAR CROPS CHINA, V1, P20; Heinrich B., 1993, HOT BLOODED INSECTS; HUANG L, 2007, ENCY KNOWLEDGE, V7, P4; IBM Corp, 2011, IBM SPSS STAT 20 BRI; JOHNSON CG, 1963, NATURE, V198, P423, DOI 10.1038/198423a0; Johnson CG, 1969, MIGRATION DISPERSAL, P1; KOERWITZ F. L., 1964, J KANS ENTOMOL SOC, V37, P234; Li R.D, 1987, OVARIAN DISSECTION I; Luo Lizhi, 1995, Acta Entomologica Sinica, V38, P284; OGAARD L, 1983, Entomologiske Meddelelser, V50, P36; Ou YF, 2013, CHINESE J APPL ENTOM, V50, P305; Qi G.J., 2011, CHINA PLANT PROT, V31, P18; Rankin M.A., 1986, P27; RILEY JR, 1995, B ENTOMOL RES, V85, P397, DOI 10.1017/S0007485300036130; Rojas JC, 2000, J INSECT BEHAV, V13, P247, DOI 10.1023/A:1007792332046; SAS Institute, 1990, SAS STAT US GUID; SHI BC, 2005, CHINA VEGET, V9, P56; Showers WB, 1997, ANNU REV ENTOMOL, V42, P393, DOI 10.1146/annurev.ento.42.1.393; TURNOCK WJ, 1995, BIOCONTROL SCI TECHN, V5, P55, DOI 10.1080/09583159550040015; van Geffen KG, 2014, ECOL EVOL, V4, P2082, DOI 10.1002/ece3.1090; WADA T, 1988, ENTOMOL EXP APPL, V46, P141, DOI 10.1007/BF00190844; Wu Kong-ming, 2006, Acta Phytophylacica Sinica, V33, P163; Wu Kongming, 1998, Acta Phytophylacica Sinica, V25, P337; WU KQ, 2013, J AGR, V3, P25; ZHANG XX, 2008, J SHANXI AGR U NAT S, V28, P442	43	15	20	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2015	10	7							e0132904	10.1371/journal.pone.0132904	http://dx.doi.org/10.1371/journal.pone.0132904			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1RL	26176951	Green Published, gold, Green Submitted			2022-12-26	WOS:000358197600176
J	Bruffaerts, N; Pedersen, LE; Vandermeulen, G; Preat, V; Stockhofe-Zurwieden, N; Huygen, K; Romano, M				Bruffaerts, Nicolas; Pedersen, Lasse E.; Vandermeulen, Gaelle; Preat, Veronique; Stockhofe-Zurwieden, Norbert; Huygen, Kris; Romano, Marta			Increased B and T Cell Responses in M-bovis Bacille Calmette-Guerin Vaccinated Pigs Co-Immunized with Plasmid DNA Encoding a Prototype Tuberculosis Antigen	PLOS ONE			English	Article							AVIUM SUBSP PARATUBERCULOSIS; PRIME-BOOST VACCINATION; MYCOBACTERIUM-TUBERCULOSIS; PROTECTIVE EFFICACY; PEPTIDE-BINDING; HLA-A; BCG; IMMUNOGENICITY; EPITOPES; SWINE	The only tuberculosis vaccine currently available, bacille Calmette-Guerin (BCG) is a poor inducer of CD8(+) T cells, which are particularly important for the control of latent tuberculosis and protection against reactivation. As the induction of strong CD8(+) T cell responses is a hallmark of DNA vaccines, a combination of BCG with plasmid DNA encoding a prototype TB antigen (Ag85A) was tested. As an alternative animal model, pigs were primed with BCG mixed with empty vector or codon-optimized pAg85A by the intradermal route and boosted with plasmid delivered by intramuscular electroporation. Control pigs received unformulated BCG. The BCG-pAg85A combination stimulated robust and sustained Ag85A specific antibody, lymphoproliferative, IL-6, IL-10 and IFN-gamma responses. IgG1/IgG2 antibody isotype ratio reflected the Th1 helper type biased response. T lymphocyte responses against purified protein derivative of tuberculin (PPD) were induced in all (BCG) vaccinated animals, but responses were much stronger in BCG-pAg85A vaccinated pigs. Finally, Ag85A-specific IFN-gamma producing CD8(+) T cells were detected by intracellular cytokine staining and a synthetic peptide, spanning Ag85A131-150 and encompassing two regions with strong predicted SLA-1*0401/SLA-1*0801 binding affinity, was promiscuously recognized by 6/6 animals vaccinated with the BCG-pAg85A combination. Our study provides a proof of concept in a large mammalian species, for a new Th1 and CD8(+) targeting tuberculosis vaccine, based on BCG-plasmid DNA co-administration.	[Bruffaerts, Nicolas; Huygen, Kris; Romano, Marta] Sci Inst Publ Hlth, Serv Immunol, Brussels, Belgium; [Pedersen, Lasse E.] Tech Univ Denmark, Sect Immunol & Vaccinol, Bulowsvej Frederiksberg C, Denmark; [Vandermeulen, Gaelle; Preat, Veronique] Catholic Univ Louvain, Louvain Drug Res Inst, Pharmaceut & Drug Delivery, B-1200 Brussels, Belgium; [Stockhofe-Zurwieden, Norbert] Cent Vet Inst, Div Infect Biol, Lelystad, Netherlands	Technical University of Denmark; Universite Catholique Louvain; Wageningen University & Research	Huygen, K (corresponding author), Sci Inst Publ Hlth, Serv Immunol, WIV ISP Site Ukkel, Brussels, Belgium.	kris.huygen@wiv-isp.be	Vandermeulen, Gaëlle/A-4074-2011; ROMANO, Marta/ABD-9517-2021; Bruffaerts, Nicolas/AAQ-2647-2020	Vandermeulen, Gaëlle/0000-0002-8696-9642; ROMANO, Marta/0000-0001-8996-7899; Bruffaerts, Nicolas/0000-0001-6310-9140; Pedersen, Lasse Eggers/0000-0002-9159-5585; Huygen, Kris/0000-0001-7808-0512	FWO-Vlaanderen; EDCTP [MVA85A IP.2007.32080.002]; EU (FP7 NEWTBVAC);  [TRANSVAC-TNA1204-6]	FWO-Vlaanderen(FWO); EDCTP; EU (FP7 NEWTBVAC); 	Gaelle Vandermeulen is a postdoctoral researcher of the Fonds de la Recherche Scientifique-FNRS. This work was partially supported by FWO-Vlaanderen, EDCTP (MVA85A IP.2007.32080.002), EU (FP7 NEWTBVAC) and TRANSVAC-TNA1204-6.	Bafica A, 2005, J EXP MED, V202, P1715, DOI 10.1084/jem.20051782; Baldwin SL, 1998, INFECT IMMUN, V66, P2951, DOI 10.1128/IAI.66.6.2951-2959.1998; Barandiaran S, 2015, EPIDEMIOL INFECT, V143, P966, DOI 10.1017/S095026881400332X; Bloom Barry R., 1994, P531; Bolin CA, 1997, J INFECT DIS, V176, P1559, DOI 10.1086/514155; Brennan MJ, 2012, VACCINE, V30, P2811, DOI 10.1016/j.vaccine.2012.02.036; Brennan MJ, 2012, TUBERCULOSIS, V92, pS6, DOI 10.1016/S1472-9792(12)70005-7; BRODSKY FM, 1979, EUR J IMMUNOL, V9, P536, DOI 10.1002/eji.1830090709; Bruffaerts N, 2014, VACCINES, V2, P181, DOI 10.3390/vaccines2010181; Bruffaerts N, 2014, EXPERT OPIN BIOL TH, V14, P1801, DOI 10.1517/14712598.2014.951630; Bruns H, 2009, J CLIN INVEST, V119, P1167, DOI 10.1172/JCI38482; Cai H, 2006, DNA CELL BIOL, V25, P438, DOI 10.1089/dna.2006.25.438; Cardoso-Toset F, 2015, VET J, V204, P232, DOI 10.1016/j.tvjl.2015.01.022; D'Souza S, 2003, INFECT IMMUN, V71, P483, DOI 10.1128/IAI.71.1.483-493.2003; de Brito C, 2011, J IMMUNOL, V186, P1503, DOI 10.4049/jimmunol.1001022; Denis O, 1998, INFECT IMMUN, V66, P1527, DOI 10.1128/IAI.66.4.1527-1533.1998; Desmet CJ, 2012, NAT REV IMMUNOL, V12, P479, DOI 10.1038/nri3247; Dou J, 2012, INT J IMMUNOGENET, V39, P183, DOI 10.1111/j.1744-313X.2011.01066.x; Feng CG, 2001, INFECT IMMUN, V69, P4174, DOI 10.1128/IAI.69.6.4174-4176.2001; FINE PEM, 1995, LANCET, V346, P1339, DOI 10.1016/S0140-6736(95)92348-9; Gartner T, 2007, IMMUNOL LETT, V111, P26, DOI 10.1016/j.imlet.2007.04.010; Gil O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010030; Hengge UR, 1996, J CLIN INVEST, V97, P2911, DOI 10.1172/JCI118750; HENGGE UR, 1995, NAT GENET, V10, P161, DOI 10.1038/ng0695-161; Ho CS, 2009, ANIM GENET, V40, P468, DOI 10.1111/j.1365-2052.2009.01860.x; Hoof I, 2009, IMMUNOGENETICS, V61, P1, DOI 10.1007/s00251-008-0341-z; Huygen K, 1996, NAT MED, V2, P893, DOI 10.1038/nm0896-893; HUYGEN K, 1994, INFECT IMMUN, V62, P363, DOI 10.1128/IAI.62.2.363-370.1994; Huygen K, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00321; KAST WM, 1994, J IMMUNOL, V152, P3904; Kibuuka H, 2015, LANCET, V385, P1545, DOI 10.1016/S0140-6736(14)62385-0; Launois P, 2010, CLIN DEV IMMUNOL, V2011; Lee J, 2004, INFECT IMMUN, V72, P1504, DOI 10.1128/IAI.72.3.1504-1511.2004; Lin MY, 2007, INFECT IMMUN, V75, P3523, DOI 10.1128/IAI.01999-06; Liu MA, 2003, J INTERN MED, V253, P402, DOI 10.1046/j.1365-2796.2003.01140.x; Luckay A, 2007, J VIROL, V81, P5257, DOI 10.1128/JVI.00055-07; Lundegaard C, 2011, J IMMUNOL METHODS, V374, P26, DOI 10.1016/j.jim.2010.10.011; Meurens F, 2012, TRENDS MICROBIOL, V20, P50, DOI 10.1016/j.tim.2011.11.002; Montgomery DL, 1997, CELL MOL BIOL, V43, P285; Ndiaye BP, 2015, LANCET RESP MED, V3, P190, DOI 10.1016/S2213-2600(15)00037-5; Nielsen M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000796; Olin MR, 2005, J IMMUNOL METHODS, V297, P1, DOI 10.1016/j.jim.2004.10.002; Panas MW, 2014, INFECT IMMUN, V82, P5317, DOI 10.1128/IAI.02100-14; Pedersen LE, 2014, VET IMMUNOL IMMUNOP, V162, P108, DOI 10.1016/j.vetimm.2014.10.007; Pedersen LE, 2011, IMMUNOGENETICS, V63, P821, DOI 10.1007/s00251-011-0555-3; Rahman S, 2012, MOL MED, V18, P647, DOI 10.2119/molmed.2011.00222; Romano M, 2006, VACCINE, V24, P3353, DOI 10.1016/j.vaccine.2005.12.066; Romano M, 2014, ART SCI TUBERCULOSIS, P741; Romano M, 2008, VACCINE, V26, P6053, DOI 10.1016/j.vaccine.2008.09.025; Romano M, 2012, EXPERT OPIN BIOL TH, V12, P1601, DOI 10.1517/14712598.2012.721768; Rosseels V, 2006, INFECT IMMUN, V74, P202, DOI 10.1128/IAI.74.1.202-212.2006; Roupie V, 2007, INFECT IMMUN, V75, P941, DOI 10.1128/IAI.01137-06; Roupie V, 2012, VET IMMUNOL IMMUNOP, V145, P74, DOI 10.1016/j.vetimm.2011.10.012; Ryan AA, 2009, J IMMUNOL, V182, P7172, DOI 10.4049/jimmunol.0801694; Saade F, 2012, EXPERT REV VACCINES, V11, P189, DOI [10.1586/erv.11.188, 10.1586/ERV.11.188]; Skinner MA, 2003, INFECT IMMUN, V71, P4901, DOI 10.1128/IAI.71.9.4901-4907.2003; Smith DM, 2005, TISSUE ANTIGENS, V65, P136, DOI 10.1111/j.1399-0039.2005.00337.x; Sylvester-Hvid C, 2002, TISSUE ANTIGENS, V59, P251, DOI 10.1034/j.1399-0039.2002.590402.x; Tameris M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087340; Tameris MD, 2013, LANCET, V381, P1021, DOI 10.1016/S0140-6736(13)60177-4; Tollefsen S, 2003, SCAND J IMMUNOL, V57, P229, DOI 10.1046/j.1365-3083.2003.01218.x; van Pinxteren LAH, 2000, EUR J IMMUNOL, V30, P3689, DOI 10.1002/1521-4141(200012)30:12<3689::AID-IMMU3689>3.3.CO;2-W; WIKER HG, 1992, MICROBIOL REV, V56, P648, DOI 10.1128/MMBR.56.4.648-661.1992	63	1	1	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132288	10.1371/journal.pone.0132288	http://dx.doi.org/10.1371/journal.pone.0132288			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26172261	gold, Green Published, Green Submitted			2022-12-26	WOS:000358194900039
J	Chan, CYS; Chiu, JMY				Chan, Christine Ying Shan; Chiu, Jill Man Ying			Chronic Effects of Coated Silver Nanoparticles on Marine Invertebrate Larvae: A Proof of Concept Study	PLOS ONE			English	Article							CRASSOSTREA-VIRGINICA; AQUATIC ORGANISMS; RAINBOW-TROUT; IONIC AG; TOXICITY; RESPONSES; EXPOSURE; GROWTH; FOOD; BIOAVAILABILITY	Silver nanoparticles (AgNPs), owing to their unique physical and chemical properties, have become increasingly popular in consumer products. However, data on their potential biological effects on marine organisms, especially invertebrates, remain very limited. This proof of principle study reports the chronic sub-lethal toxicity of two coated AgNPs (oleic acid coated AgNPs and polyvinylpyrrolidone coated AgNPs) on marine benthic invertebrate larvae across three phyla (i.e., the barnacle Balanus Amphitrite, the slipper-limpet Crepidula onyx, and the polychaete Hydroides elegans) in terms of growth, development, and metamorphosis. Bioaccumulation and biodistribution of silver were also investigated. Larvae were also exposed to silver nitrate (AgNO3) in parallel to distinguish the toxic effects derived from nano-silver and the aqueous form of silver. The sub-lethal effect of chronic exposure to coated AgNPs resulted in a significant retardation in growth and development, and reduction of larval settlement rate. The larval settlement rate of H. elegans was significantly lower in the coated AgNP treatment than the AgNO3 treatment, suggesting that the toxicity of coated AgNPs might not be solely evoked by the release of silver ions (Ag+) in the test medium. The three species accumulated silver effectively from coated AgNPs as well as AgNO3, and coated AgNPs were observed in the vacuoles of epithelial cell in the digestive tract of C. onyx. Types of surface coatings did not affect the sub-lethal toxicity of AgNPs. This study demonstrated that coated AgNPs exerted toxic effects in a species-specific manner, and their exposure might allow bioaccumulation of silver, and affect growth, development, and settlement of marine invertebrate larvae. This study also highlighted the possibility that coated AgNPs could be taken up through diet and the toxicity of coated AgNPs might be mediated through toxic Ag+ as well as the novel modalities of coated AgNPs.	[Chan, Christine Ying Shan; Chiu, Jill Man Ying] Hong Kong Baptist Univ, Dept Biol, Kowloon, Hong Kong, Peoples R China	Hong Kong Baptist University	Chiu, JMY (corresponding author), Hong Kong Baptist Univ, Dept Biol, Kowloon, Hong Kong, Peoples R China.	jillchiu@hkbu.edu.hk			Hong Kong Baptist University [FRG 2/12-13/084]	Hong Kong Baptist University	The work described in this paper was fully supported by grants from Hong Kong Baptist University (FRG 2/12-13/084) to JMYC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahearn GA, 2004, J COMP PHYSIOL B, V174, P439, DOI 10.1007/s00360-004-0438-0; Al-Sid-Cheikh M, 2013, MAR ENVIRON RES, V86, P21, DOI 10.1016/j.marenvres.2013.02.003; [Anonymous], 2007, NAN WHIT PAP; Baker TJ, 2014, ENVIRON POLLUT, V186, P257, DOI 10.1016/j.envpol.2013.11.014; Brix KV, 2012, ARCH ENVIRON CON TOX, V63, P95, DOI 10.1007/s00244-012-9757-4; Buffet PE, 2013, ECOTOX ENVIRON SAFE, V89, P117, DOI 10.1016/j.ecoenv.2012.11.019; Burchardt AD, 2012, ENVIRON SCI TECHNOL, V46, P11336, DOI 10.1021/es300989e; Canesi L, 2012, MAR ENVIRON RES, V76, P16, DOI 10.1016/j.marenvres.2011.06.005; Chiu JMY, 2008, MAR ECOL PROG SER, V358, P41, DOI 10.3354/meps07310; Chiu JMY, 2007, MAR ECOL PROG SER, V343, P173, DOI 10.3354/meps06928; Chiu JMY, 2012, ENVIRON SCI TECHNOL, V46, P7772, DOI 10.1021/es300261c; Choi O, 2008, ENVIRON SCI TECHNOL, V42, P4583, DOI 10.1021/es703238h; Croteau MN, 2011, ENVIRON SCI TECHNOL, V45, P6600, DOI 10.1021/es200880c; Dutta S, 2011, LANGMUIR, V27, P5000, DOI 10.1021/la104903z; Engel D. W., 1981, BIOL MONITORING MARI, P127; Erickson RJ, 1998, ENVIRON TOXICOL CHEM, V17, P572, DOI 10.1002/etc.5620170407; Fabrega J, 2011, ENVIRON INT, V37, P517, DOI 10.1016/j.envint.2010.10.012; Fabrega J, 2009, ENVIRON SCI TECHNOL, V43, P7285, DOI 10.1021/es803259g; Farkas J, 2011, AQUAT TOXICOL, V101, P117, DOI 10.1016/j.aquatox.2010.09.010; Farre M, 2009, ANAL BIOANAL CHEM, V393, P81, DOI 10.1007/s00216-008-2458-1; French RA, 2009, ENVIRON SCI TECHNOL, V43, P1354, DOI 10.1021/es802628n; Gao J, 2009, ENVIRON SCI TECHNOL, V43, P3322, DOI 10.1021/es803315v; Garcia-Alonso J, 2014, SCI TOTAL ENVIRON, V476, P688, DOI 10.1016/j.scitotenv.2014.01.039; Garcia-Aonso J, 2011, ENVIRON SCI TECHNOL, V45, P4630, DOI 10.1021/es2005122; Gomes T, 2013, AQUAT TOXICOL, V136, P79, DOI 10.1016/j.aquatox.2013.03.021; Griffitt RJ, 2012, ENVIRON TOXICOL CHEM, V31, P160, DOI 10.1002/etc.709; Groh KJ, 2015, NANOTOXICOLOGY, V9, P81, DOI 10.3109/17435390.2014.893379; Guillard R.R.L., 1975, CULTURE MARINE INVER, P29, DOI [10.1007/978-1-4615-8714-9_3., 10.1007/978-1-4615-8714-9_3]; Haase A, 2012, TOXICOL SCI, V126, P457, DOI 10.1093/toxsci/kfs003; He D, 2012, ENVIRON SCI TECHNOL, V46, P8731, DOI 10.1021/es300588a; Hwang ET, 2008, SMALL, V4, P765, DOI [10.1002/smll.200700580, DOI 10.1002/SMLL.200700580]; Iversen TG, 2011, NANO TODAY, V6, P176, DOI 10.1016/j.nantod.2011.02.003; Kim KT, 2013, NANOTECHNOLOGY, V24, DOI 10.1088/0957-4484/24/11/115101; Klaine SJ, 2008, ENVIRON TOXICOL CHEM, V27, P1825, DOI 10.1897/08-090.1; Kvitek L, 2009, J PHYS CHEM C, V113, P4296, DOI 10.1021/jp808645e; Kwok KWH, 2012, AQUAT TOXICOL, V120, P59, DOI 10.1016/j.aquatox.2012.04.012; Luoma S. N., SILVER NANOTECHNOLOG SILVER NANOTECHNOLOG; Ma XM, 2010, SCI TOTAL ENVIRON, V408, P3053, DOI 10.1016/j.scitotenv.2010.03.031; Macken A, 2012, ECOTOX ENVIRON SAFE, V86, P101, DOI 10.1016/j.ecoenv.2012.08.025; MATILE P, 1978, ANNU REV PLANT PHYS, V29, P193, DOI 10.1146/annurev.pp.29.060178.001205; McCarthy MP, 2013, AQUAT TOXICOL, V138, P123, DOI 10.1016/j.aquatox.2013.04.015; Menge BA, 2001, MARINE COMMUNITY ECOLOGY, P221; Meyer JN, 2010, AQUAT TOXICOL, V100, P140, DOI 10.1016/j.aquatox.2010.07.016; Miao AJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015196; Miao AJ, 2009, ENVIRON POLLUT, V157, P3034, DOI 10.1016/j.envpol.2009.05.047; Navarro E, 2008, ENVIRON SCI TECHNOL, V42, P8959, DOI 10.1021/es801785m; Oukarroum A, 2013, ENVIRON TOXICOL CHEM, V32, P902, DOI 10.1002/etc.2131; Pechenik JA, 1999, MAR ECOL PROG SER, V177, P269, DOI 10.3354/meps177269; Powers CM, 2011, NEUROTOXICOL TERATOL, V33, P708, DOI 10.1016/j.ntt.2011.02.002; Qiu JW, 1997, J EXP MAR BIOL ECOL, V217, P47, DOI 10.1016/S0022-0981(97)00037-3; Quik JTK, 2011, ENVIRON INT, V37, P1068, DOI 10.1016/j.envint.2011.01.015; Reinfelder JR, 1999, ENVIRON SCI TECHNOL, V33, P1860, DOI 10.1021/es980896w; Ringwood AH, 2010, MAR ENVIRON RES, V69, pS49, DOI 10.1016/j.marenvres.2009.10.011; Scown TM, 2010, TOXICOL SCI, V115, P521, DOI 10.1093/toxsci/kfq076; Shapiro SS, 1965, BIOMETRIKA, V52, P59; Shikuma N., 2005, BIOFILMS, V2, P231, DOI [10.1017/s1479050506002018, DOI 10.1017/S1479050506002018, 10.1017/S1479050506002018]; Shoults-Wilson WA, 2011, NANOTOXICOLOGY, V5, P432, DOI 10.3109/17435390.2010.537382; Siller L, 2013, ENVIRON POLLUT, V178, P498, DOI 10.1016/j.envpol.2013.03.010; Stumpp M, 2013, NAT CLIM CHANGE, V3, P1044, DOI 10.1038/NCLIMATE2028; Turner A, 2012, ECOTOXICOLOGY, V21, P148, DOI 10.1007/s10646-011-0774-2; Underwood AJ, 2001, MARINE COMMUNITY ECOLOGY, P183; US Environmental Protection Agency, 1992, SW 846 REF METH METH; Ward JE, 2009, MAR ENVIRON RES, V68, P137, DOI 10.1016/j.marenvres.2009.05.002; WARD JE, 1993, LIMNOL OCEANOGR, V38, P265, DOI 10.4319/lo.1993.38.2.0265; WARD JE, 1994, BIOL BULL, V186, P221, DOI 10.2307/1542056; Wong SWY, 2010, ANAL BIOANAL CHEM, V396, P609, DOI 10.1007/s00216-009-3249-z; WoodrowWilson International Center for Scholars, 2011, PROJ EM NAN; Yang XY, 2012, ENVIRON SCI TECHNOL, V46, P1119, DOI 10.1021/es202417t; Yu SJ, 2013, ENVIRON SCI TECHNOL, V47, P3268, DOI 10.1021/es304346p; Zar JH, 1999, BIOSTATISTICAL ANAL; Zuykov M, 2011, MAR ENVIRON RES, V71, P17, DOI 10.1016/j.marenvres.2010.09.004	71	30	30	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132457	10.1371/journal.pone.0132457	http://dx.doi.org/10.1371/journal.pone.0132457			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26171857	Green Published, Green Submitted, gold			2022-12-26	WOS:000358194900051
J	Ferguson, AA; Bilonick, RA; Buchanich, JM; Marsh, GM; Fisher, AL				Ferguson, Annabel A.; Bilonick, Richard A.; Buchanich, Jeanine M.; Marsh, Gary M.; Fisher, Alfred L.			How Well Do Raters Agree on the Development Stage of Caenorhabditis elegans?	PLOS ONE			English	Article							INTERRATER AGREEMENT	The assessment of inter-rater reliability is a topic that is infrequently addressed in Caenorhabditis elegans research, despite the existence of sophisticated statistical methods and the strong interest in the field in obtaining reliable and accurate data. This study applies statistical modeling as a robust means of analyzing the performance of worm researchers measuring the stage of worm development in terms of the two independent factors that comprise "agreement", which are (1) accuracy, representing trueness, a lack of systematic differences, or lack of bias, and (2) precision, representing reliability or the extent to which random differences are small. In our study, multiple raters assessed the same sample of worms to determine the developmental stage of each animal, and we collected data linking each scorer with their assessment for each worm. To describe the agreement of the raters, we developed a structural equation model with latent variables and thresholds, which assumes that all the raters are jointly scoring each worm. This common factor model separately quantifies the two aspects of agreement. The stage-specific thresholds examine accuracy and characterize the relative biases of each rater during the scoring process. The factor loadings for each rater examine the precision and characterizes the random error of the rater. Within our group, we found that the overall agreement was good, while certain adjustments in particular raters would have decreased systematic differences. Hence, the use of developmental stage as an experimental outcome can be both accurate and precise.	[Ferguson, Annabel A.; Bilonick, Richard A.; Buchanich, Jeanine M.; Marsh, Gary M.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Biostat, Pittsburgh, PA 15261 USA; [Bilonick, Richard A.] Univ Pittsburgh, Sch Med, Dept Ophthalmol, Pittsburgh, PA 15261 USA; [Bilonick, Richard A.] Univ Pittsburgh, Sch Dent Med, Dept Orthodont, Pittsburgh, PA USA; [Buchanich, Jeanine M.; Marsh, Gary M.] Univ Pittsburgh, Grad Sch Publ Hlth, Ctr Occupat Biostat & Epidemiol, Pittsburgh, PA USA; [Fisher, Alfred L.] UTHSCSA, Dept Med, Div Geriatr Gerontol & Palliat Med, San Antonio, TX 78229 USA; [Fisher, Alfred L.] UTHSCSA, Ctr Hlth Aging, San Antonio, TX USA; [Fisher, Alfred L.] STVAHCS, San Antonio GRECC, San Antonio, TX USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio	Fisher, AL (corresponding author), UTHSCSA, Dept Med, Div Geriatr Gerontol & Palliat Med, San Antonio, TX 78229 USA.	fishera2@uthscsa.edu		Fisher, Alfred/0000-0001-6451-2644	South Texas Veteran's Affairs Healthcare System; National Institutes of Health [ES017761, AG044768, AG013319]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES017761] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG044768, P30AG013319] Funding Source: NIH RePORTER	South Texas Veteran's Affairs Healthcare System; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by funds from the South Texas Veteran's Affairs Healthcare System (ALF) as well as National Institutes of Health grants ES017761, AG044768, and AG013319 to ALF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahante JE, 1998, GENETICS, V149, P1335; Ambros V., 1997, C ELEGANS; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Boker S.M., 2012, OPENMX 1 3 USER GUID; Boker S, 2011, PSYCHOMETRIKA, V76, P306, DOI 10.1007/s11336-010-9200-6; CASSADA RC, 1975, DEV BIOL, V46, P326, DOI 10.1016/0012-1606(75)90109-8; COHEN J, 1968, PSYCHOL BULL, V70, P213, DOI 10.1037/h0026256; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Ferguson AA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1004020; Gisev N, 2013, RES SOC ADMIN PHARM, V9, P330, DOI 10.1016/j.sapharm.2012.04.004; Moore BT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057142; RIDDLE DL, 1981, NATURE, V290, P668, DOI 10.1038/290668a0; UEBERSAX JS, 1990, STAT MED, V9, P559, DOI 10.1002/sim.4780090509; UEBERSAX JS, 1992, INVEST RADIOL, V27, P738, DOI 10.1097/00004424-199209000-00017; UEBERSAX JS, 1993, BIOMETRICS, V49, P823, DOI 10.2307/2532202; UEBERSAX JS, 1987, PSYCHOL BULL, V101, P140, DOI 10.1037/0033-2909.101.1.140	16	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132365	10.1371/journal.pone.0132365	http://dx.doi.org/10.1371/journal.pone.0132365			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26172989	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000358194900045
J	Hernandez-Rodriguez, M; Correa-Basurto, J; Nicolas-Vazquez, MI; Miranda-Ruvalcaba, R; Benitez-Cardoza, CG; Resendiz-Albor, AA; Mendez-Mendez, JV; Rosales-Hernandez, MC				Hernandez-Rodriguez, Maricarmen; Correa-Basurto, Jose; Ines Nicolas-Vazquez, Maria; Miranda-Ruvalcaba, Rene; Guadalupe Benitez-Cardoza, Claudia; Arturo Resendiz-Albor, Aldo; Vicente Mendez-Mendez, Juan; Rosales-Hernandez, Martha C.			Virtual and In Vitro Screens Reveal a Potential Pharmacophore that Avoids the Fibrillization of A beta(1-42)	PLOS ONE			English	Article							AMYLOID-BETA-PROTEIN; ALZHEIMERS-DISEASE; SECONDARY STRUCTURE; AGGREGATION; INHIBITORS; OLIGOMERS; IDENTIFICATION; NUCLEATION; PEPTIDES; DESIGN	Among the multiple factors that induce Alzheimer's disease, aggregation of the amyloid beta peptide (A beta) is considered the most important due to the ability of the 42-amino acid A beta peptides (A beta(1-42)) to form oligomers and fibrils, which constitute A beta pathological aggregates. For this reason, the development of inhibitors of A beta 1-42 pathological aggregation represents a field of research interest. Several A beta(1-42) fibrillization inhibitors possess tertiary amine and aromatic moieties. In the present study, we selected 26 compounds containing tertiary amine and aromatic moieties with or without substituents and performed theoretical studies that allowed us to select four compounds according to their free energy values for A beta(1-42) in alpha-helix (A beta-alpha), random coil (A beta-RC) and beta-sheet (A beta-beta) conformations. Docking studies revealed that compound 5 had a higher affinity for A beta-alpha and A beta-RC than the other compounds. In vitro, this compound was able to abolish Thioflavin T fluorescence and favored an RC conformation of A beta(1-42) in circular dichroism studies, resulting in the formation of amorphous aggregates as shown by atomic force microscopy. The results obtained from quantum studies allowed us to identify a possible pharmacophore that can be used to design A beta(1-42) aggregation inhibitors. In conclusion, compounds with higher affinity for A beta-alpha and A beta-RC prevented the formation of oligomeric species.	[Hernandez-Rodriguez, Maricarmen; Correa-Basurto, Jose] Inst Politecn Nacl, Escuela Super Med, Lab Modelado Mol & Diseno Farm, Mexico City, DF, Mexico; [Hernandez-Rodriguez, Maricarmen; Rosales-Hernandez, Martha C.] Inst Politecn Nacl, Escuela Super Med, Lab Biofis & Biocatalisis, Mexico City, DF, Mexico; [Ines Nicolas-Vazquez, Maria; Miranda-Ruvalcaba, Rene] Univ Nacl Autonoma Mexico, Dept Ciencias Quim, Fac Estudios Super Cuautitlan Campo 1, Quim Inorgan Organ, Cuautitlan, Estado De Mexic, Mexico; [Guadalupe Benitez-Cardoza, Claudia] Inst Politecn Nacl, Escuela Nacl Med & Homeopatia, Lab Invest Bioquim, Secc Estudios Posgrad & Invest, Mexico City, DF, Mexico; [Arturo Resendiz-Albor, Aldo] Inst Politecn Nacl, Escuela Super Med, Lab Invest Inmunol, Mexico City, DF, Mexico; [Vicente Mendez-Mendez, Juan] Inst Politecn Nacl, Ctr Nanociencias & Micro & Nanotecnol, Mexico City, DF, Mexico	Instituto Politecnico Nacional - Mexico; Instituto Politecnico Nacional - Mexico; Universidad Nacional Autonoma de Mexico; Instituto Politecnico Nacional - Mexico; Instituto Politecnico Nacional - Mexico; Instituto Politecnico Nacional - Mexico	Correa-Basurto, J (corresponding author), Inst Politecn Nacl, Escuela Super Med, Lab Modelado Mol & Diseno Farm, Plan San Luis & Diaz Miron S-N, Mexico City, DF, Mexico.	corrjose@gmail.com; marcrh2002@yahoo.com.mx	hernendez, Martha Cecilia rosales/AAD-3536-2021; Mendez Mendez, Juan Vicente/R-2225-2018	Mendez Mendez, Juan Vicente/0000-0002-1227-8072; Hernandez, Maricarmen/0000-0001-9371-1095; Resendiz Albor, Aldo Arturo/0000-0003-1415-5524; RODRIGUEZ-CORTES, OCTAVIO/0000-0002-7380-5665; Benitez Cardoza, Claudia Guadalupe/0000-0002-7841-5711	Instituto de Ciencia y Tecnologia del Distrito Federal [1276/2011, 42/2012]; Consejo Nacional de Ciencia y Tecnologia [84119, 132353, 356817]; PIFI-SIPCOFAA-IPN [SIP20150944]	Instituto de Ciencia y Tecnologia del Distrito Federal; Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); PIFI-SIPCOFAA-IPN	This work was supported by grants from Instituto de Ciencia y Tecnologia del Distrito Federal/1276/2011 and 42/2012 JCB, Consejo Nacional de Ciencia y Tecnologia 84119 MCRH and 132353 JCB, PIFI-SIPCOFAA-IPN, SIP20150944 and scholarships from Consejo Nacional de Ciencia y Tecnologia to study PhD 356817 to HMR. The funders played no role in data collection and analysis, decision to publish and preparation of the manuscript.	Aloisi A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068159; Bansode SB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105196; Cardoso FL, 2010, BRAIN RES REV, V64, P328, DOI 10.1016/j.brainresrev.2010.05.003; Chadwick W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021660; Chebaro Y, 2012, J PHYS CHEM B, V116, P8412, DOI 10.1021/jp2118778; Chen WT, 2011, J BIOL CHEM, V286, P9646, DOI 10.1074/jbc.M110.177246; Cohen FE, 2003, NATURE, V426, P905, DOI 10.1038/nature02265; Cui LL, 2013, J ALZHEIMERS DIS, V37, P19, DOI 10.3233/JAD-130164; Dahlgren KN, 2002, J BIOL CHEM, V277, P32046, DOI 10.1074/jbc.M201750200; De Strooper B, 2010, NAT REV NEUROL, V6, P99, DOI 10.1038/nrneurol.2009.218; DEWAR MJS, 1985, J AM CHEM SOC, V107, P3902, DOI 10.1021/ja00299a024; Doig AJ, 2015, CURR OPIN STRUC BIOL, V30, P50, DOI 10.1016/j.sbi.2014.12.004; Esteras-Chopo A, 2008, J MOL BIOL, V383, P266, DOI 10.1016/j.jmb.2008.07.076; Fezoui Y, 2002, J BIOL CHEM, V277, P36948, DOI 10.1074/jbc.M204168200; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; FUKUI K, 1982, SCIENCE, V218, P747, DOI 10.1126/science.218.4574.747; Glenner G G, 1984, Appl Pathol, V2, P357; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hehre W.J., 1998, MOL MODELING WORKBOO; Hernandez-Rodriguez M, 2013, PROTEIN SCI, V22, P1320, DOI 10.1002/pro.2319; Hunter CA, 2004, ANGEW CHEM INT EDIT, V43, P5310, DOI 10.1002/anie.200301739; Ito M, 2011, PLOS ONE, V3, P1; Kirkitadze MD, 2001, J MOL BIOL, V312, P1103, DOI 10.1006/jmbi.2001.4970; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Landau M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001080; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; Levine H, 2007, AMYLOID, V14, P185, DOI 10.1080/13506120701461020; Li J, 2013, NEUROCHEM RES, V38, P443, DOI 10.1007/s11064-012-0939-2; Lue LF, 1999, AM J PATHOL, V155, P853, DOI 10.1016/S0002-9440(10)65184-X; Mason JM, 2003, CURR OPIN STRUC BIOL, V13, P526, DOI 10.1016/S0959-440X(03)00100-3; Matharu B, 2009, J NEUROL SCI, V280, P49, DOI 10.1016/j.jns.2009.01.024; Matsubara E, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/984041; MERLINI G, 1995, P NATL ACAD SCI USA, V92, P2959, DOI 10.1073/pnas.92.7.2959; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Nasica-Labouze J, 2015, CHEM REV, V115, P3518, DOI 10.1021/cr500638n; Nerelius C, 2009, P NATL ACAD SCI USA, V106, P9191, DOI 10.1073/pnas.0810364106; Nguyent P, 2014, ACCOUNTS CHEM RES, V47, P603, DOI 10.1021/ar4002075; Novick PA, 2012, J MED CHEM, V55, P3002, DOI 10.1021/jm201332p; Orlando RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031869; Pappolla M, 1998, J BIOL CHEM, V273, P7185, DOI 10.1074/jbc.273.13.7185; Perez-Iratxeta C, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-25; Pohl G, 2013, J CHEM PHYS, V138, DOI 10.1063/1.4811712; POLITZER P, 1985, ENVIRON HEALTH PERSP, V61, P191, DOI 10.2307/3430072; Salomon AR, 1996, BIOCHEMISTRY-US, V35, P13568, DOI 10.1021/bi9617264; Sciarretta KL, 2005, BIOCHEMISTRY-US, V44, P6003, DOI 10.1021/bi0474867; Seeliger D, 2010, J COMPUT AID MOL DES, V24, P417, DOI 10.1007/s10822-010-9352-6; Selkoe DJ, 2003, ANNU REV PHARMACOL, V43, P545, DOI 10.1146/annurev.pharmtox.43.100901.140248; SELKOE DJ, 1991, NEURON, V6, P487, DOI 10.1016/0896-6273(91)90052-2; Shaw JE, 2012, ACS CHEM NEUROSCI, V3, P167, DOI 10.1021/cn2000926; Singh SK, 2014, NEUROTOX RES, V26, P331, DOI 10.1007/s12640-014-9466-z; SREERAMA N, 1993, ANAL BIOCHEM, V209, P32, DOI 10.1006/abio.1993.1079; Tarus B, 2015, EUR J MED CHEM, V91, P43, DOI 10.1016/j.ejmech.2014.07.002; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Walsh DM, 2002, BIOCHEM SOC T, V30, P552, DOI 10.1042/BST0300552; Wheeler SE, 2009, J CHEM THEORY COMPUT, V5, P2301, DOI 10.1021/ct900344g; Xie Q, 2008, J MED CHEM, V51, P2027, DOI 10.1021/jm070154q; Yadav A, 2009, EUR J MED CHEM, V44, P3866, DOI 10.1016/j.ejmech.2009.04.013; Zhang T, 2014, ACS CHEM NEUROSCI, V5, P148, DOI 10.1021/cn400197x	58	12	12	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0130263	10.1371/journal.pone.0130263	http://dx.doi.org/10.1371/journal.pone.0130263			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1QN	26172152	Green Submitted, gold, Green Published			2022-12-26	WOS:000358194900006
J	Ayyappan, V; Kalavacharla, V; Thimmapuram, J; Bhide, KP; Sripathi, VR; Smolinski, TG; Manoharan, M; Thurston, Y; Todd, A; Kingham, B				Ayyappan, Vasudevan; Kalavacharla, Venu; Thimmapuram, Jyothi; Bhide, Ketaki P.; Sripathi, Venkateswara R.; Smolinski, Tomasz G.; Manoharan, Muthusamy; Thurston, Yaqoob; Todd, Antonette; Kingham, Bruce			Genome-Wide Profiling of Histone Modifications (H3K9(me2) and H4K12(ac)) and Gene Expression in Rust (Uromyces appendiculatus) Inoculated Common Bean (Phaseolus vulgaris L.)	PLOS ONE			English	Article							WRKY TRANSCRIPTION FACTORS; DISEASE RESISTANCE; STRESS RESPONSES; ARABIDOPSIS; PATHOGEN; PROTEIN; IDENTIFICATION; RNA; VIRULENCE; CROSSTALK	Histone modifications such as methylation and acetylation play a significant role in controlling gene expression in unstressed and stressed plants. Genome-wide analysis of such stress-responsive modifications and genes in non-model crops is limited. We report the genome-wide profiling of histone methylation (H3K9(me2)) and acetylation (H4K12(ac)) in common bean (Phaseolus vulgaris L.) under rust (Uromyces appendiculatus) stress using two high-throughput approaches, chromatin immunoprecipitation sequencing (ChIP-Seq) and RNA sequencing (RNA-Seq). ChIP-Seq analysis revealed 1,235 and 556 histone methylation and acetylation responsive genes from common bean leaves treated with the rust pathogen at 0, 12 and 84 hour-after-inoculation (hai), while RNA-Seq analysis identified 145 and 1,763 genes differentially expressed between mock-inoculated and inoculated plants. The combined ChIP-Seq and RNA-Seq analyses identified some key defense responsive genes (calmodulin, cytochrome p450, chitinase, DNA Pol II, and LRR) and transcription factors (WRKY, bZIP, MYB, HSFB3, GRAS, NAC, and NMRA) in bean-rust interaction. Differential methylation and acetylation affected a large proportion of stress-responsive genes including resistant (R) proteins, detoxifying enzymes, and genes involved in ion flux and cell death. The genes identified were functionally classified using Gene Ontology (GO) and EuKaryotic Orthologous Groups (KOGs). The Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis identified a putative pathway with ten key genes involved in plant-pathogen interactions. This first report of an integrated analysis of histone modifications and gene expression involved in the bean-rust interaction as reported here provides a comprehensive resource for other epigenomic regulation studies in non-model species under stress.	[Ayyappan, Vasudevan; Kalavacharla, Venu; Sripathi, Venkateswara R.; Thurston, Yaqoob; Todd, Antonette] Delaware State Univ, Mol Genet & Epigen Lab, Dover, DE 19901 USA; [Kalavacharla, Venu] Delaware State Univ, Ctr Integrated Biol & Environm Res, Dover, DE USA; [Thimmapuram, Jyothi; Bhide, Ketaki P.] Purdue Univ, Bioinformat Core, W Lafayette, IN 47907 USA; [Smolinski, Tomasz G.] Delaware State Univ, Computat Intelligence & Biol Informat Lab CIBiL, Dover, DE USA; [Manoharan, Muthusamy] Univ Arkansas, Dept Agr, Pine Bluff, AR USA; [Kingham, Bruce] Delaware Biotechnol Inst, Sequencing & Genotyping Ctr, Newark, DE USA	Delaware State University; Delaware State University; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Delaware State University; University of Arkansas System; University of Arkansas Fayetteville	Kalavacharla, V (corresponding author), Delaware State Univ, Mol Genet & Epigen Lab, Dover, DE 19901 USA.	vkalavacharla@desu.edu			USDA Capacity Building Grant [2008-38814-04735, 2010-38821-21540]; National Science Foundation Grant [EPS-0814251]; State of Delaware; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103446] Funding Source: NIH RePORTER; Office Of The Director [1003970] Funding Source: National Science Foundation	USDA Capacity Building Grant; National Science Foundation Grant(National Science Foundation (NSF)); State of Delaware; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Office Of The Director(National Science Foundation (NSF)NSF - Office of the Director (OD))	This work was supported by USDA Capacity Building Grant 2008-38814-04735 to VK, USDA Capacity Building Grant 2010-38821-21540 to MM and VK and Delaware EPSCoR grant from the National Science Foundation Grant EPS-0814251 and the State of Delaware in part to VK.	AbuQamar S, 2009, PLANT J, V58, P347, DOI 10.1111/j.1365-313X.2008.03783.x; Acevedo M, 2013, PLANT DIS, V97, P652, DOI 10.1094/PDIS-02-12-0169-RE; Ahuja I, 2010, TRENDS PLANT SCI, V15, P664, DOI 10.1016/j.tplants.2010.08.002; Alves MS, 2013, INT J MOL SCI, V14, P7815, DOI 10.3390/ijms14047815; Blair MW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049488; Boudsocq M, 2010, NATURE, V464, P418, DOI 10.1038/nature08794; Boyko A, 2011, CURR OPIN PLANT BIOL, V14, P260, DOI 10.1016/j.pbi.2011.03.003; Chan ZL, 2012, GENOMICS, V100, P110, DOI 10.1016/j.ygeno.2012.06.004; Cortes AJ, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-58; Costas C, 2011, NAT STRUCT MOL BIOL, V18, P395, DOI 10.1038/nsmb.1988; Diener AC, 2001, PLANT CELL, V13, P1625, DOI 10.1105/tpc.13.7.1625; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Dong XN, 1998, CURR OPIN PLANT BIOL, V1, P316, DOI 10.1016/1369-5266(88)80053-0; Eulgem T, 2000, TRENDS PLANT SCI, V5, P199, DOI 10.1016/S1360-1385(00)01600-9; Ferreyra MLF, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00222; Foerster AM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002331; Gaude N, 2012, PLANT J, V69, P510, DOI 10.1111/j.1365-313X.2011.04810.x; Gayacharan, 2013, PHYSIOL MOL BIOL PLA, V19, P379, DOI 10.1007/s12298-013-0176-4; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; Guo N, 2011, GENOME, V54, P954, DOI [10.1139/g11-050, 10.1139/G11-050]; Gutzat R, 2012, CURR OPIN PLANT BIOL, V15, P568, DOI 10.1016/j.pbi.2012.08.007; Hahne F, 2008, USE R, P207, DOI 10.1007/978-0-387-77240-0_14; He GM, 2010, PLANT CELL, V22, P17, DOI 10.1105/tpc.109.072041; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hu YF, 2012, P NATL ACAD SCI USA, V109, P5773, DOI 10.1073/pnas.1203148109; Huang Shengxiong, 2013, Chinese Journal of Applied and Environmental Biology, V19, P205, DOI 10.3724/SP.J.1145.2013.00205; Jang IC, 2011, PLANT CELL, V23, P459, DOI 10.1105/tpc.110.080481; Jaskiewicz M, 2011, EMBO REP, V12, P50, DOI 10.1038/embor.2010.186; Jochua C, 2008, PLANT DIS, V92, P401, DOI 10.1094/PDIS-92-3-0401; Kalavacharla V, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-135; Kang YJ, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-139; Kapazoglou A, 2011, ABIOTIC STRESS IN PLANTS - MECHANISMS AND ADAPTATIONS, P395; Kim KC, 2006, PLANT PHYSIOL, V142, P1180, DOI 10.1104/pp.106.082487; Koornneef A, 2008, PLANT PHYSIOL, V146, P839, DOI 10.1104/pp.107.112029; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lata C, 2011, J EXP BOT, V62, P4731, DOI 10.1093/jxb/err210; Leba LJ, 2012, PLANT J, V71, P976, DOI 10.1111/j.1365-313X.2012.05045.x; Lee SC, 2012, PLANT CELL ENVIRON, V35, P53, DOI 10.1111/j.1365-3040.2011.02426.x; Li Y, 2013, PLANT PATHOLOGY J, V29, P168, DOI 10.5423/PPJ.SI.08.2012.0125; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo CY, 2014, METHODS MOL BIOL, V1112, P177, DOI 10.1007/978-1-62703-773-0_12; Luo CY, 2013, PLANT J, V73, P77, DOI 10.1111/tpj.12017; Luo M, 2005, PHYTOPATHOLOGY, V95, P381, DOI 10.1094/PHYTO-95-0381; Mi HY, 2013, NAT PROTOC, V8, P1551, DOI 10.1038/nprot.2013.092; Mmbaga MT, 1996, J PHYTOPATHOL, V144, P533, DOI 10.1111/j.1439-0434.1996.tb00295.x; Munoz-Bodnar A, 2014, PLANT CELL REP, V33, P1901, DOI 10.1007/s00299-014-1667-7; Narusaka Y, 2004, PLANT MOL BIOL, V55, P327, DOI 10.1007/s11103-004-0685-1; O'Rourke JA, 2013, PLANT PHYSIOL, V161, P705, DOI 10.1104/pp.112.209254; Okay S, 2014, MOL GENET GENOMICS, V289, P765, DOI 10.1007/s00438-014-0849-x; Paris S, 2003, BIOCHEM J, V372, P391, DOI 10.1042/BJ20030047; Pecinka A, 2012, PLANT CELL PHYSIOL, V53, P801, DOI 10.1093/pcp/pcs044; Perez-Clemente RM, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/654120; Porch TG, 2013, AGRONOMY-BASEL, V3, P433, DOI 10.3390/agronomy3020433; PUNJA ZK, 1993, J NEMATOL, V25, P526; Qiao Weihua, 2011, [Frontiers in Biology, 生物学前沿], V6, P477; Ramegowda V, 2015, J PLANT PHYSIOL, V176, P47, DOI 10.1016/j.jplph.2014.11.008; Roudier F, 2009, TRENDS GENET, V25, P511, DOI 10.1016/j.tig.2009.09.013; Ruthenburg AJ, 2007, MOL CELL, V25, P15, DOI 10.1016/j.molcel.2006.12.014; Sandlin CM, 1999, PLANT DIS, V83, P108, DOI 10.1094/PDIS.1999.83.2.108; Schmutz J, 2014, NAT GENET, V46, P707, DOI 10.1038/ng.3008; Shahbazian MD, 2007, ANNU REV BIOCHEM, V76, P75, DOI 10.1146/annurev.biochem.76.052705.162114; Shamimuzzaman M, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-477; Sharma R, 2013, MOL PLANT, V6, P250, DOI 10.1093/mp/sss147; Shen HS, 2012, PLANT CELL, V24, P875, DOI 10.1105/tpc.111.094870; Singh P, 2014, PLANT CELL, V26, P2676, DOI 10.1105/tpc.114.123356; Soar A, 2014, MOL BIOL REP, V41, P7683, DOI [10.1007/s11033-014-3661-0, DOI 10.1007/S11033-014-3661-0]; Sridha S, 2006, PLANT J, V46, P124, DOI 10.1111/j.1365-313X.2006.02678.x; Stokes TL, 2002, P NATL ACAD SCI USA, V99, P7792, DOI 10.1073/pnas.112040999; Stracke R, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0249-8; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Torres-Martin M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065868; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Tsuda K, 2010, CURR OPIN PLANT BIOL, V13, P459, DOI 10.1016/j.pbi.2010.04.006; Turra D, 2014, ANNU REV PHYTOPATHOL, V52, P267, DOI 10.1146/annurev-phyto-102313-050143; van Ooijen G, 2008, J EXP BOT, P1, DOI [10.1093/jxb/em045, DOI 10.1093/JXB/EM045]; Wakasa Y, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-101; Wang XF, 2009, PLANT CELL, V21, P1053, DOI 10.1105/tpc.109.065714; Wang XW, 2011, NAT GENET, V43, P1035, DOI 10.1038/ng.919; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815; Young ND, 2011, NATURE, V480, P520, DOI 10.1038/nature10625; Zhang Guo-Bin, 2013, Yichuan, V35, P971, DOI 10.3724/SP.J.1005.2013.00971; Zhao JP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044968; Zhao SR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0078644; Zhong SL, 2013, NAT BIOTECHNOL, V31, P154, DOI 10.1038/nbt.2462; Zhuang XF, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-668	86	25	25	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0132176	10.1371/journal.pone.0132176	http://dx.doi.org/10.1371/journal.pone.0132176			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26167691	gold, Green Published, Green Submitted			2022-12-26	WOS:000358193100026
J	Pennacchio, A; Varriale, A; Esposito, MG; Scala, A; Marzullo, VM; Staiano, M; D'Auria, S				Pennacchio, Anna; Varriale, Antonio; Esposito, Maria Grazia; Scala, Andrea; Marzullo, Vincenzo Manuel; Staiano, Maria; D'Auria, Sabato			A Rapid and Sensitive Assay for the Detection of Benzylpenicillin (PenG) in Milk	PLOS ONE			English	Article							RESONANCE-BASED BIOCHIP; (DIHYDRO)STREPTOMYCIN RESIDUES; ANTIBIOTIC-RESIDUES; PATULIN TOXIN; BIOSENSOR; DIHYDROSTREPTOMYCIN; IMMUNOASSAYS; STREPTOMYCIN; INHIBITORS; PENICILLIN	Antibiotics, such as benzyl-penicillin (PenG) and cephalosporin, are the most common compounds used in animal therapy. Their massive and illegal use in animal therapy and prophylaxis inevitably causes the presence of traces in foods of animal origin (milk and meat), which creates several problems for human health. With the aim to prevent the negative impact of beta-lactam and, in particular, PenG residues present in the milk on customer health, many countries have established maximum residue limits (MRLs). To cope with this problem here, we propose an effective alternative, compared to the analytical methods actually employed, to quantify the presence of penicillin G using the surface plasmon resonance (SPR) method. In particular, the PenG molecule was conjugated to a protein carrier to immunize a rabbit and produce polyclonal antibodies (anti-PenG). The produced antibodies were used as molecular recognition elements for the design of a competitive immune-assay for the detection of PenG by SPR experiments. The detection limit of the developed assay was found to be 8.0 pM, a value much lower than the MRL of the EU regulation limit that is fixed at 12 nM. Thus, our results clearly show that this system could be successfully suitable for the accurate and easy determination of PenG.	[Pennacchio, Anna; Varriale, Antonio; Esposito, Maria Grazia; Scala, Andrea; Marzullo, Vincenzo Manuel; Staiano, Maria] CNR, IBP, Lab Mol Sensing, I-80125 Naples, Italy; [Varriale, Antonio; Scala, Andrea; Staiano, Maria; D'Auria, Sabato] CNR, Inst Food Sci, ISA, Avellino, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biochimica delle Proteine (IBP-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze dell' Alimentazione (ISA-CNR)	Varriale, A (corresponding author), CNR, IBP, Lab Mol Sensing, I-80125 Naples, Italy.	a.varriale@ibp.cnr.it; sabato.dauria@cnr.it	Varriale, Antonio/AAL-1439-2020; STAIANO, MARIA/B-9584-2015; Marzullo, Vincenzo Manuel/ABG-8416-2020	STAIANO, MARIA/0000-0003-0223-1825; Marzullo, Vincenzo Manuel/0000-0001-8746-1296	project "SAFE & SMART-Nuove tecnologie abilitanti per la food safety e l'integrita delle filiere agro-alimentari in uno scenario globale" [CTN01_00230_240864]; CNR project "Conoscenze integrate per sostenibilita ed innovazione del Made in Italy agro-alimentare (CISIA)"	project "SAFE & SMART-Nuove tecnologie abilitanti per la food safety e l'integrita delle filiere agro-alimentari in uno scenario globale"; CNR project "Conoscenze integrate per sostenibilita ed innovazione del Made in Italy agro-alimentare (CISIA)"	This project was realized in the frame of the CNR Commessa "Progettazione e Sviluppo di Biochip per la Sicurezza Alimentare e Salute Umana (SD; MS; AV)". This Project was partially funded by the project CTN01_00230_240864 "SAFE & SMART-Nuove tecnologie abilitanti per la food safety e l'integrita delle filiere agro-alimentari in uno scenario globale", and it was also partially funded by the CNR project "Conoscenze integrate per sostenibilita ed innovazione del Made in Italy agro-alimentare (CISIA)".	Abbasi H, 1998, ANALYST, V123, P2725, DOI 10.1039/a804910f; Abuknesha RA, 2005, ANALYST, V130, P964, DOI 10.1039/b418107g; ADETUNJI VO, 2002, NAT SCI, V10, P60; Baxter GA, 2001, J AGR FOOD CHEM, V49, P3204, DOI 10.1021/jf001484l; Bencini R, 1997, AUST J EXP AGR, V37, P485, DOI 10.1071/EA96014; Caldow M, 2005, J AGR FOOD CHEM, V53, P7367, DOI 10.1021/jf050725s; de Champdore M, 2007, ANAL CHEM, V79, P751, DOI 10.1021/ac0618526; Epstein JB, 2000, J AM DENT ASSOC, V131, P1600, DOI 10.14219/jada.archive.2000.0090; Fejzic N, 2014, BOSNIAN J BASIC MED, V14, P155, DOI 10.17305/bjbms.2014.3.109; Ferrini AM, 2008, J AGR FOOD CHEM, V56, P784, DOI 10.1021/jf071479i; Haasnoot W, 1999, ANALYST, V124, P301, DOI 10.1039/a807846g; Haasnoot W, 2002, FOOD AGR IMMUNOL, V14, P15, DOI 10.1080/09540100220137637; Heinrich-Balard L, 2015, MOL CELL ENDOCRINOL, V399, P201, DOI 10.1016/j.mce.2014.10.002; Homola J, 2008, CHEM REV, V108, P462, DOI 10.1021/cr068107d; Kuck LR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109616; LEVINE BB, 1962, J MED PHARMACEUT CH, V5, P1025, DOI 10.1021/jm01240a016; Li MJ, 2014, ANTIMICROB AGENTS CH, V58, P4495, DOI 10.1128/AAC.02806-14; MCEWEN SA, 1991, J FOOD PROTECT, V54, P454, DOI 10.4315/0362-028X-54.6.454; Payne MA, 2006, EXTRA LABEL USE PENI; Pennacchio A, 2014, OPT MATER, V36, P1670, DOI 10.1016/j.optmat.2013.12.045; Preu M, 1999, J CHROMATOGR A, V840, P81, DOI 10.1016/S0021-9673(99)00163-6; Pry, 2008, CLIN BIOCHEM REV, V29, pS49; Raz SR, 2009, ANAL CHEM, V81, P7743, DOI 10.1021/ac901230v; Shepherd CA, 2014, PROGR BIOPHYSICS MOL, VXXX, P1; Staiano M, 2005, BIOCHEMISTRY-US, V44, P5625, DOI 10.1021/bi0478300; Varriale A, 2012, ANAL METHODS-UK, V4, P1940, DOI 10.1039/c2ay25231g; Verheijen R, 2000, FOOD AGR IMMUNOL, V12, P31, DOI 10.1080/09540100099607; Zacco E, 2007, BIOSENS BIOELECTRON, V22, P2184, DOI 10.1016/j.bios.2006.10.014	28	12	13	3	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0132396	10.1371/journal.pone.0132396	http://dx.doi.org/10.1371/journal.pone.0132396			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26168259	Green Submitted, gold, Green Published			2022-12-26	WOS:000358193100040
J	Stefani, V; Pires, TL; Torezan-Silingardi, HM; Del-Claro, K				Stefani, Vanessa; Pires, Tayna Lopes; Torezan-Silingardi, Helena Maura; Del-Claro, Kleber			Beneficial Effects of Ants and Spiders on the Reproductive Value of Eriotheca gracilipes (Malvaceae) in a Tropical Savanna	PLOS ONE			English	Article							EXTRAFLORAL NECTARIES; HERBIVORE INTERACTIONS; PLANT INTERACTIONS; FRUIT-SET; POLLINATORS; SYSTEMS; COST	Predators affect plant fitness when they forage on them and reduce the action of herbivores. Our study evaluates the complementary effects of spiders and ants that visit the extrafloral nectaries of Eriotheca gracilipes(Malvaceae) on the production of fruits and viable seeds of these savanna trees. Four experimental groups were established: control group - with free access of spiders and ants; exclusion group - spiders and ants excluded; ant group absence of spiders; and spider group - absence of ants. The presence of ants reduced the spider richness; however, the presence of spiders did not affect the ant richness. A significantly higher number of fruits per buds were found in the presence of spiders alone or spiders and ants together (control group) compared with the absence of both predators (exclusion group). The number of seeds per fruits and seed viability were higher in the control group. This is the first study showing that spiders and ants may exert a positive and complementary effect on the reproductive value of an extrafloral nectaried plant. Mostly the impact of ants and/or spiders on herbivores is considered, whereas our study reinforces the importance of evaluating the effect of multiple predators simultaneously, exploring how the interactions among predators with distinct skills may affect the herbivores and the plants on which they forage.	[Stefani, Vanessa; Pires, Tayna Lopes; Torezan-Silingardi, Helena Maura; Del-Claro, Kleber] Univ Fed Uberlandia, Inst Biol, Programa Posgrad Ecol & Conservacao Recursos Nat, Lab Ecol Comportamental & Interacoes, BR-38400 Uberlandia, MG, Brazil	Universidade Federal de Uberlandia	Del-Claro, K (corresponding author), Univ Fed Uberlandia, Inst Biol, Programa Posgrad Ecol & Conservacao Recursos Nat, Lab Ecol Comportamental & Interacoes, Av Engenheiro Dinz 1178,CP 593, BR-38400 Uberlandia, MG, Brazil.	delclaro@ufu.br	Torezan-Silingardi, Helena Maura/AAH-2880-2019; Del-Claro, K/C-5570-2013; Del-Claro, Kleber/N-3700-2019	Torezan-Silingardi, Helena Maura/0000-0002-0393-869X; Del-Claro, K/0000-0001-8886-9568; Stefani, Vanessa/0000-0002-8659-9194	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; CNPq [473055/2012, 72046/2011, 301248/2009]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior Plano Nacional de Pos-Doutorado, CAPES-PNPD [2556/2011]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior Plano Nacional de Pos-Doutorado, CAPES-PNPD	The authors (HMTS and KDC) had financial support of the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; CNPq - Grant numbers 473055/2012; 72046/2011; 301248/2009. VS thanks the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior Plano Nacional de Pos-Doutorado, CAPES-PNPD, number 2556/2011). The authors ensure that the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves-Silva E, 2013, NATURWISSENSCHAFTEN, V100, P525, DOI 10.1007/s00114-013-1048-z; Assuncao MA, 2014, FLORA, V209, P244, DOI 10.1016/j.flora.2014.03.003; Bronstein JL, 2009, J ECOL, V97, P1160, DOI 10.1111/j.1365-2745.2009.01566.x; Byk J, 2011, POPUL ECOL, V53, P327, DOI 10.1007/s10144-010-0240-7; Christianini AV, 2004, ENTOMOL EXP APPL, V112, P81, DOI 10.1111/j.0013-8703.2004.00188.x; COSTA NP, 1994, INFORM ABRATES, V4, P53; Dattilo W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099838; Davidson DW, 2003, SCIENCE, V300, P969, DOI 10.1126/science.1082074; de Souza ALT, 2004, J ARACHNOL, V32, P345; de Souza AUT, 2005, BIOTROPICA, V37, P416, DOI 10.1111/j.1744-7429.2005.00055.x; Del-Claro K, 2013, SOCIOBIOLOGY, V60, P217; Del-Claro K, 2009, NEOTROP ENTOMOL, V38, P159, DOI 10.1590/S1519-566X2009000200001; Del-Claro Stefani V, 2005, NEOTROP ENTOMOL, V34, P881; DelClaro K, 1996, J TROP ECOL, V12, P887, DOI 10.1017/S0266467400010142; Delouche J.C., 1976, TESTE TETRAZOLIO VIA, P103; DICKE M, 1990, J CHEM ECOL, V16, P3091, DOI 10.1007/BF00979614; Diniz Suzana, 2012, Psyche (Cambridge), P791395, DOI 10.1155/2012/791395; Durigan Giselda, 2002, Acta Bot. Bras., V16, P251, DOI 10.1590/S0102-33062002000300002; Ferreira CA, 2013, SOCIOBIOLOGY, V60, P323; Foelix R, 2010, BIOL SPIDERS; FRANCA-NETO J.B., 1988, METODOLOGIA TESTE TE; Goncalves-Souza T, 2008, ECOLOGY, V89, P2407, DOI 10.1890/07-1881.1; Halaj J, 2001, AM NAT, V157, P262, DOI 10.1086/319190; Heikkinen MW, 2004, J ARACHNOL, V32, P313, DOI 10.1636/M02-1; Heil M, 2003, ANNU REV ECOL EVOL S, V34, P425, DOI 10.1146/annurev.ecolsys.34.011802.132410; Hofer H., 2001, ANDRIAS, V15, P99; Lange D, 2013, ECOL ENTOMOL, V38, P463, DOI 10.1111/een.12036; LOUDA SM, 1982, OECOLOGIA, V55, P185, DOI 10.1007/BF00384486; Machado SR, 2008, PLANT BIOLOGY, V10, P660, DOI 10.1111/j.1438-8677.2008.00068.x; Nahas L, 2012, BIOTROPICA, V44, P498, DOI 10.1111/j.1744-7429.2011.00850.x; Nascimento EA, 2010, FLORA, V205, P754, DOI 10.1016/j.flora.2009.12.040; Nelson XJ, 2013, CHEMOECOLOGY, V23, P149, DOI 10.1007/s00049-013-0130-5; OLIVEIRA PE, 1992, PLANT SYST EVOL, V179, P207, DOI 10.1007/BF00937597; Oliveira PS, 2002, CERRADOS BRAZIL ECOL; Price P.W., 2011, INSECT ECOLOGY BEHAV; PRICE PW, 1980, ANNU REV ECOL SYST, V11, P41, DOI 10.1146/annurev.es.11.110180.000353; Romero G. Q., 2007, ECOLOGIA COMPORTAMEN, P277; Romero GQ, 2004, ECOLOGY, V85, P446, DOI 10.1890/02-0327; Rosa C, 2008, LIVRO CURSO CAMPO EC; Rosumek FB, 2009, OECOLOGIA, V160, P537, DOI 10.1007/s00442-009-1309-x; Ruhren S, 1999, OECOLOGIA, V119, P227, DOI 10.1007/s004420050780; Sanders D, 2008, BASIC APPL ECOL, V9, P152, DOI 10.1016/j.baae.2007.01.003; Sanders D, 2011, OIKOS, V120, P418, DOI 10.1111/j.1600-0706.2010.18924.x; Schmitz OJ, 2007, ECOLOGY, V88, P2415, DOI 10.1890/06-0937.1; SILBERBAUERGOTTSBERGER I, 1987, PHYTON-ANN REI BOT A, V27, P55; Terborgh J., 2010, TROPHIC CASCADES PRE; THOMAS CD, 1989, OIKOS, V55, P291, DOI 10.2307/3565587; Thompson J. N., 2005, INTERSPEC INTERACT; Thompson John N., 1997, P285; Torezan-Silingardi HM, 2011, SOCIOBIOLOGY, V57, P181; Torres-Hernandez Leonel, 2000, Acta Zoologica Mexicana Nueva Serie, P13; TURLINGS TCJ, 1990, SCIENCE, V250, P1251, DOI 10.1126/science.250.4985.1251; Vilela AA, 2014, FLORA, V209, P359, DOI 10.1016/j.flora.2014.04.004	53	22	22	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0131843	10.1371/journal.pone.0131843	http://dx.doi.org/10.1371/journal.pone.0131843			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26168036	gold, Green Published, Green Submitted			2022-12-26	WOS:000358193100015
J	Wang, XM; Kindzierski, W; Kaul, P				Wang, Xiaoming; Kindzierski, Warren; Kaul, Padma			Air Pollution and Acute Myocardial Infarction Hospital Admission in Alberta, Canada: A Three-Step Procedure Case-Crossover Study	PLOS ONE			English	Article							POTENTIALLY SENSITIVE GROUPS; PARTICULATE MATTER; EMERGENCY ADMISSIONS; REFERENT SELECTION; FINE PARTICLES; MINAP DATABASE; TIME-SERIES; EXPOSURE; RISK; MORTALITY	Adverse associations between air pollution and myocardial infarction (MI) are widely reported in medical literature. However, inconsistency and sensitivity of the findings are still big concerns. An exploratory investigation was undertaken to examine associations between air pollutants and risk of acute MI (AMI) hospitalization in Alberta, Canada. A time stratified case-crossover design was used to assess the transient effect of five air pollutants (carbon monoxide (CO), nitrogen dioxide (NO2), nitric oxide (NO), ozone (O-3) and particulate matter with an aerodynamic diameter <= 2.5 (PM2.5)) on the risk of AMI hospitalization over the period 1999-2009. Subgroups were predefined to see if any susceptible group of individuals existed. A three-step procedure, including univariate analysis, multivariate analysis, and bootstrap model averaging, was used. The multivariate analysis was used in an effort to address adjustment uncertainty; whereas the bootstrap technique was used as a way to account for regression model uncertainty. There were 25,894 AMI hospital admissions during the 11-year period. Estimating health effects that are properly adjusted for all possible confounding factors and accounting for model uncertainty are important for making interpretations of air pollution-health effect associations. The most robust findings included: (1) only 1-day lag NO2 concentrations (6-, 12- or 24-hour average), but not those of CO, NO, O-3 or PM2.5, were associated with an elevated risk of AMI hospitalization; (2) evidence was suggested for an effect of elevated risk of hospitalization for NSTEMI (Non-ST Segment Elevation Myocardial Infarction), but not for STEMI (ST segment elevation myocardial infarction); and (3) susceptible subgroups included elders (age >= 65) and elders with hypertension. As this was only an exploratory study there is a need to replicate these findings with other methodologies and datasets.	[Wang, Xiaoming; Kindzierski, Warren] Univ Alberta, Sch Publ Hlth, Edmonton, AB, Canada; [Kaul, Padma] Univ Alberta, Dept Med, Canadian Vigour Ctr, Edmonton, AB, Canada	University of Alberta; University of Alberta	Kindzierski, W (corresponding author), Univ Alberta, Sch Publ Hlth, Edmonton, AB, Canada.	warrenk@ualberta.ca		Kaul, Padma/0000-0003-2239-3944	Alberta Public Health Information Network Project	Alberta Public Health Information Network Project	This study was funded by the Alberta Public Health Information Network Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bard D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100307; Barnett AG, 2006, ENVIRON HEALTH PERSP, V114, P1018, DOI 10.1289/ehp.8674; Bateson TF, 2004, EPIDEMIOLOGY, V15, P143, DOI 10.1097/01.ede.0000112210.68754.fa; Berglind N, 2010, INT J ENV RES PUB HE, V7, P1486, DOI 10.3390/ijerph7041486; Bhaskaran K, 2009, HEART, V95, P1746, DOI 10.1136/hrt.2009.175018; Bhaskaran K, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5531; Cadum E, 2009, EPIDEMIOL PREV, V33, P113; Cheng MF, 2009, J TOXICOL ENV HEAL A, V72, P1135, DOI 10.1080/15287390903091756; Clyde M, 2000, ENVIRONMETRICS, V11, P745, DOI 10.1002/1099-095X(200011/12)11:6<745::AID-ENV431>3.0.CO;2-N; D'Ippoliti D, 2003, EPIDEMIOLOGY, V14, P528, DOI 10.1097/01.ede.0000082046.22919.72; Dominici F, 2004, J AM STAT ASSOC, V99, P938, DOI 10.1198/016214504000000656; Dominici F, 2008, EPIDEMIOLOGY, V19, P558, DOI 10.1097/EDE.0b013e31817307dc; Dominici F, 2014, SCIENCE, V344, P257, DOI 10.1126/science.1247348; Environment Canada, 2013, NAT AIR POLL SURV NA; Gardner B, 2014, PART FIBRE TOXICOL, V11, DOI 10.1186/1743-8977-11-1; Hastie T., 2009, UNSUPERVISED LEARNIN; Hodas N, 2013, J EXPO SCI ENV EPID, V23, P573, DOI 10.1038/jes.2013.24; Hsieh YL, 2010, J TOXICOL ENV HEAL A, V73, P757, DOI 10.1080/15287391003684789; Janes H, 2005, STAT MED, V24, P285, DOI 10.1002/sim.1889; Janes H, 2005, EPIDEMIOLOGY, V16, P717, DOI 10.1097/01.ede.0000181315.18836.9d; Kioumourtzoglou MA, 2013, ENVIRON HEALTH-GLOB, V12, DOI 10.1186/1476-069X-12-68; Koop G, 2010, ENVIRON MODELL SOFTW, V25, P873, DOI 10.1016/j.envsoft.2010.01.010; Levinsson A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099043; Levy D, 2001, EPIDEMIOLOGY, V12, P186, DOI 10.1097/00001648-200103000-00010; MACLURE M, 1991, AM J EPIDEMIOL, V133, P144, DOI 10.1093/oxfordjournals.aje.a115853; Milojevic A, 2014, HEART, V100, P1093, DOI 10.1136/heartjnl-2013-304963; Mustafic H, 2012, JAMA-J AM MED ASSOC, V307, P713, DOI 10.1001/jama.2012.126; National Oceanic and Atmospheric Administration (NOAA), 2013, LAND BAS STAT DAT; Nuvolone D, 2011, AM J EPIDEMIOL, V174, P63, DOI 10.1093/aje/kwr046; Peel JL, 2007, AM J EPIDEMIOL, V165, P625, DOI 10.1093/aje/kwk051; Peters A, 2001, CIRCULATION, V103, P2810; Poloniecki JD, 1997, OCCUP ENVIRON MED, V54, P535, DOI 10.1136/oem.54.8.535; Rich DQ, 2013, ENVIRON SCI TECHNOL, V47, P9414, DOI 10.1021/es4027248; Rich DQ, 2010, ENVIRON HEALTH PERSP, V118, P1229, DOI 10.1289/ehp.0901624; Rosenthal FS, 2013, J EXPO SCI ENV EPID, V23, P281, DOI 10.1038/jes.2012.121; Ruidavets JB, 2005, CIRCULATION, V111, P563, DOI 10.1161/01.CIR.0000154546.32135.6E; Schwartz Joel, 1991, Public Health Reviews, V19, P39; Simmons JP, 2011, PSYCHOL SCI, V22, P1359, DOI 10.1177/0956797611417632; Stylianou M, 2009, ENVIRON POLLUT, V157, P2216, DOI 10.1016/j.envpol.2009.04.011; Sullivan J, 2005, EPIDEMIOLOGY, V16, P41, DOI 10.1097/01.ede.0000147116.34813.56; Tsai SS, 2012, J TOXICOL ENV HEAL A, V75, P242, DOI 10.1080/15287394.2012.641202; Turin TC, 2012, NEUROEPIDEMIOLOGY, V38, P84, DOI 10.1159/000335654; von Klot S, 2011, PROG CARDIOVASC DIS, V53, P361, DOI 10.1016/j.pcad.2011.01.002; Wichmann J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062059; Wichmann J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053684; Wichmann J, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-19; Zanobetti A, 2000, ENVIRON HEALTH PERSP, V108, P841, DOI 10.2307/3434991; Zanobetti A, 2005, ENVIRON HEALTH PERSP, V113, P978, DOI 10.1289/ehp.7550; Zanobetti A, 2006, J EPIDEMIOL COMMUN H, V60, P890, DOI 10.1136/jech.2005.039834	49	42	42	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2015	10	7							e0132769	10.1371/journal.pone.0132769	http://dx.doi.org/10.1371/journal.pone.0132769			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1PW	26167938	Green Published, gold, Green Submitted			2022-12-26	WOS:000358193100078
